Advertisement

Close

%PDF-1.5 1 0 obj <> endobj 3 0 obj <> endobj 4 0 obj <> stream 0 0 0 RG /GS0 gs 2.50 w 0 i [] 0 d 0 J 0 j 3 M 35.5 757.1 m 575.5 757.1 l s 0 0 0 RG /GS0 gs 2.50 w 0 i [] 0 d 0 J 0 j 3 M 35.5 753.1 m 575.5 753.1 l s BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F2 14.00 Tf ET q 0 0 0 rg BT 251.20 733.80 Td (UNITED ST) Tj ET Q q 0 0 0 rg BT 325.24 733.80 Td (A) Tj ET Q q 0 0 0 rg BT 334.31 733.80 Td (TES) Tj ET Q BT /F2 14.00 Tf ET q 0 0 0 rg BT 155.65 717.00 Td (SECURITIES ) Tj ET Q q 0 0 0 rg BT 243.19 717.00 Td (AND EXCHANGE COMMISSION) Tj ET Q BT /F2 12.00 Tf ET q 0 0 0 rg BT 244.15 702.60 Td (W) Tj ET Q q 0 0 0 rg BT 255.49 702.60 Td (ashington, D.C. 20549) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.50 690.60 Td (_______________) Tj ET Q BT /F2 14.00 Tf ET q 0 0 0 rg BT 268.05 673.60 Td (FORM 10-K) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.50 663.60 Td (_______________) Tj ET Q BT /F1 5.00 Tf ET q 0 0 0 rg BT 306.00 657.60 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 155.50 645.60 Td (ANNUAL) Tj ET Q q 0 0 0 rg BT 197.73 645.60 Td ( REPOR) Tj ET Q q 0 0 0 rg BT 234.88 645.60 Td (T) Tj ET Q q 0 0 0 rg BT 241.36 645.60 Td ( PURSUANT) Tj ET Q q 0 0 0 rg BT 298.13 645.60 Td ( ) Tj ET Q q 0 0 0 rg BT 300.45 645.60 Td (T) Tj ET Q q 0 0 0 rg BT 306.94 645.60 Td (O SECTION 13 OR 15\(d\) OF) Tj ET Q q 0 0 0 rg BT 432.97 645.60 Td ( ) Tj ET Q q 0 0 0 rg BT 435.29 645.60 Td (THE) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 214.85 633.60 Td (SECURITIES EXCHANGE ) Tj ET Q q 0 0 0 rg BT 337.66 633.60 Td (ACT) Tj ET Q q 0 0 0 rg BT 358.60 633.60 Td ( OF) Tj ET Q q 0 0 0 rg BT 374.61 633.60 Td ( 1934) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 211.85 615.60 Td (For) Tj ET Q q 0 0 0 rg BT 227.22 615.60 Td ( the fiscal year) Tj ET Q q 0 0 0 rg BT 288.96 615.60 Td ( ended December) Tj ET Q q 0 0 0 rg BT 362.65 615.60 Td ( 31, ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 380.15 615.60 Td (2016) Tj ET Q BT /F2 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 236.20 597.60 Td (Commission File Number) Tj ET Q q 0 0 0 rg BT 345.46 597.60 Td ( 1-1) Tj ET Q q 0 0 0 rg BT 360.74 597.60 Td (136) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.50 585.60 Td (_______________) Tj ET Q BT /F2 18.00 Tf ET q 0 0 0 rg BT 146.10 564.60 Td (BRIST) Tj ET Q q 0 0 0 rg BT 199.80 564.60 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 427.48 564.60 Td (ANY) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 223.15 555.60 Td (\(Exact name of r) Tj ET Q q 0 0 0 rg BT 276.54 555.60 Td (egistrant as specified in its charter\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 266.00 545.60 Td (________________) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 142.80 525.83 Td (Delaware) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 293.00 527.05 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 401.80 525.83 Td (22-0790350) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 116.25 515.52 Td (\(State or) Tj ET Q q 0 0 0 rg BT 143.81 515.52 Td ( other) Tj ET Q q 0 0 0 rg BT 162.63 515.52 Td ( jurisdiction of) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 114.10 508.02 Td (incorporation or) Tj ET Q q 0 0 0 rg BT 167.09 508.02 Td ( organization\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 293.00 509.35 Td ( ) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 401.75 515.52 Td (\(IRS Employer) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 396.60 508.02 Td (Identification No.\)) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 220.90 490.60 Td (345 Park ) Tj ET Q q 0 0 0 rg BT 261.46 490.60 Td (A) Tj ET Q q 0 0 0 rg BT 267.94 490.60 Td (venue, New ) Tj ET Q q 0 0 0 rg BT 318.95 490.60 Td (Y) Tj ET Q q 0 0 0 rg BT 325.06 490.60 Td (ork, N.Y) Tj ET Q q 0 0 0 rg BT 361.09 490.60 Td (. 10154) Tj ET Q BT /F2 7.50 Tf ET q 0 0 0 rg BT 243.95 481.60 Td (\(Addr) Tj ET Q q 0 0 0 rg BT 263.40 481.60 Td (ess of principal executive offices\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 250.05 469.60 Td (T) Tj ET Q q 0 0 0 rg BT 255.80 469.60 Td (elephone: \(212\) 546-4000) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 183.95 454.60 Td (Securities r) Tj ET Q q 0 0 0 rg BT 232.36 454.60 Td (egister) Tj ET Q q 0 0 0 rg BT 260.50 454.60 Td (ed pursuant to Section 12\(b\) of the ) Tj ET Q q 0 0 0 rg BT 409.67 454.60 Td (Act:) Tj ET Q BT /F2 7.50 Tf ET 0 0 0 RG /GS0 gs 0.71 w 0 i [] 0 d 1 J 1 j 3 M 134.8 434.0467041015625 m 191.11494140625 434.0467041015625 l s q 0 0 0 rg BT 134.80 435.22 Td (Title of each class) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 293.00 435.35 Td ( ) Tj ET Q BT /F2 7.50 Tf ET 0 0 0 RG /GS0 gs 0.71 w 0 i [] 0 d 1 J 1 j 3 M 370.35 434.0467041015625 m 509.6400390625 434.0467041015625 l s q 0 0 0 rg BT 370.35 435.22 Td (Name of each exchange on which registered) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 101.05 422.50 Td (Common Stock, $0.10 Par Value) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 293.00 422.36 Td ( ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 389.25 422.50 Td (New York Stock Exchange) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 118.25 409.50 Td (1.000% Notes due 2025) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 389.25 409.50 Td (New York Stock Exchange) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 118.25 396.50 Td (1.750% Notes due 2035) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 389.25 396.50 Td (New York Stock Exchange) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 184.25 377.60 Td (Securities r) Tj ET Q q 0 0 0 rg BT 232.66 377.60 Td (egister) Tj ET Q q 0 0 0 rg BT 260.80 377.60 Td (ed pursuant to Section 12\(g\) of the ) Tj ET Q q 0 0 0 rg BT 409.41 377.60 Td (Act: ) Tj ET Q BT /F2 7.50 Tf ET 0 0 0 RG /GS0 gs 0.71 w 0 i [] 0 d 1 J 1 j 3 M 276.8 357.0467041015625 m 333.11494140625 357.0467041015625 l s q 0 0 0 rg BT 276.80 358.22 Td (Title of each class) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 218.35 345.50 Td ($2 Convertible Preferred Stock, $1 Par Value) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.50 331.60 Td (_________________) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 317.80 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 93.75 317.80 Td (by ) Tj ET Q q 0 0 0 rg BT 105.51 317.80 Td (check ) Tj ET Q q 0 0 0 rg BT 129.75 317.80 Td (mark ) Tj ET Q q 0 0 0 rg BT 153.00 317.80 Td (if ) Tj ET Q q 0 0 0 rg BT 160.74 317.80 Td (the ) Tj ET Q q 0 0 0 rg BT 174.99 317.80 Td (r) Tj ET Q q 0 0 0 rg BT 178.82 317.80 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 215.07 317.80 Td (is ) Tj ET Q q 0 0 0 rg BT 223.32 317.80 Td (a ) Tj ET Q q 0 0 0 rg BT 230.07 317.80 Td (well-known ) Tj ET Q q 0 0 0 rg BT 276.83 317.80 Td (seasoned ) Tj ET Q q 0 0 0 rg BT 313.08 317.80 Td (issuer) Tj ET Q q 0 0 0 rg BT 334.75 317.80 Td (, ) Tj ET Q q 0 0 0 rg BT 339.25 317.80 Td (as ) Tj ET Q q 0 0 0 rg BT 349.51 317.80 Td (defined ) Tj ET Q q 0 0 0 rg BT 380.26 317.80 Td (in ) Tj ET Q q 0 0 0 rg BT 390.02 317.80 Td (Rule ) Tj ET Q q 0 0 0 rg BT 410.27 317.80 Td (405 ) Tj ET Q q 0 0 0 rg BT 426.02 317.80 Td (of ) Tj ET Q q 0 0 0 rg BT 435.76 317.80 Td (the ) Tj ET Q q 0 0 0 rg BT 450.01 317.80 Td (Securities ) Tj ET Q q 0 0 0 rg BT 489.25 317.80 Td (Act.    ) Tj ET Q q 0 0 0 rg BT 513.66 317.80 Td (Y) Tj ET Q q 0 0 0 rg BT 519.16 317.80 Td (es  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 531.16 315.86 cm /I1 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 540.70 317.80 Td (    No  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 565.20 315.86 cm /I2 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 304.00 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 93.21 304.00 Td (by ) Tj ET Q q 0 0 0 rg BT 104.43 304.00 Td (check ) Tj ET Q q 0 0 0 rg BT 128.14 304.00 Td (mark ) Tj ET Q q 0 0 0 rg BT 150.85 304.00 Td (if ) Tj ET Q q 0 0 0 rg BT 158.06 304.00 Td (the ) Tj ET Q q 0 0 0 rg BT 171.77 304.00 Td (r) Tj ET Q q 0 0 0 rg BT 175.61 304.00 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 211.31 304.00 Td (is ) Tj ET Q q 0 0 0 rg BT 219.03 304.00 Td (not ) Tj ET Q q 0 0 0 rg BT 233.25 304.00 Td (r) Tj ET Q q 0 0 0 rg BT 237.08 304.00 Td (equir) Tj ET Q q 0 0 0 rg BT 257.42 304.00 Td (ed ) Tj ET Q q 0 0 0 rg BT 268.13 304.00 Td (to ) Tj ET Q q 0 0 0 rg BT 277.34 304.00 Td (file ) Tj ET Q q 0 0 0 rg BT 291.05 304.00 Td (r) Tj ET Q q 0 0 0 rg BT 294.88 304.00 Td (eports ) Tj ET Q q 0 0 0 rg BT 320.59 304.00 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 357.32 304.00 Td (to ) Tj ET Q q 0 0 0 rg BT 366.53 304.00 Td (Section 13 ) Tj ET Q q 0 0 0 rg BT 407.49 304.00 Td (or) Tj ET Q q 0 0 0 rg BT 415.82 304.00 Td ( ) Tj ET Q q 0 0 0 rg BT 417.53 304.00 Td (Section 15\(d\) ) Tj ET Q q 0 0 0 rg BT 469.50 304.00 Td (of ) Tj ET Q q 0 0 0 rg BT 478.71 304.00 Td (the ) Tj ET Q q 0 0 0 rg BT 492.04 304.00 Td (Act.    ) Tj ET Q q 0 0 0 rg BT 516.45 304.00 Td (Y) Tj ET Q q 0 0 0 rg BT 521.95 304.00 Td (es  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 533.95 302.06 cm /I3 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 541.97 304.00 Td (    No  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 566.46 302.06 cm /I4 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 290.20 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 92.98 290.20 Td (by ) Tj ET Q q 0 0 0 rg BT 103.97 290.20 Td (check ) Tj ET Q q 0 0 0 rg BT 127.44 290.20 Td (mark ) Tj ET Q q 0 0 0 rg BT 149.92 290.20 Td (whether) Tj ET Q q 0 0 0 rg BT 181.25 290.20 Td ( ) Tj ET Q q 0 0 0 rg BT 182.73 290.20 Td (the ) Tj ET Q q 0 0 0 rg BT 196.20 290.20 Td (r) Tj ET Q q 0 0 0 rg BT 200.03 290.20 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 235.51 290.20 Td (\(1\) has ) Tj ET Q q 0 0 0 rg BT 262.74 290.20 Td (filed ) Tj ET Q q 0 0 0 rg BT 281.22 290.20 Td (all ) Tj ET Q q 0 0 0 rg BT 292.20 290.20 Td (r) Tj ET Q q 0 0 0 rg BT 296.03 290.20 Td (eports ) Tj ET Q q 0 0 0 rg BT 321.50 290.20 Td (r) Tj ET Q q 0 0 0 rg BT 325.34 290.20 Td (equir) Tj ET Q q 0 0 0 rg BT 345.67 290.20 Td (ed ) Tj ET Q q 0 0 0 rg BT 356.15 290.20 Td (to ) Tj ET Q q 0 0 0 rg BT 365.13 290.20 Td (be ) Tj ET Q q 0 0 0 rg BT 375.61 290.20 Td (filed ) Tj ET Q q 0 0 0 rg BT 394.09 290.20 Td (by ) Tj ET Q q 0 0 0 rg BT 405.07 290.20 Td (Section 13 ) Tj ET Q q 0 0 0 rg BT 445.80 290.20 Td (or) Tj ET Q q 0 0 0 rg BT 454.13 290.20 Td ( ) Tj ET Q q 0 0 0 rg BT 455.61 290.20 Td (15\(d\) ) Tj ET Q q 0 0 0 rg BT 477.09 290.20 Td (of ) Tj ET Q q 0 0 0 rg BT 486.07 290.20 Td (the ) Tj ET Q q 0 0 0 rg BT 499.55 290.20 Td (Securities ) Tj ET Q q 0 0 0 rg BT 538.52 290.20 Td (Exchange ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 279.40 Td (Act ) Tj ET Q q 0 0 0 rg BT 51.71 279.40 Td (of ) Tj ET Q q 0 0 0 rg BT 61.43 279.40 Td (1934 ) Tj ET Q q 0 0 0 rg BT 81.66 279.40 Td (during ) Tj ET Q q 0 0 0 rg BT 109.89 279.40 Td (the ) Tj ET Q q 0 0 0 rg BT 124.11 279.40 Td (pr) Tj ET Q q 0 0 0 rg BT 132.95 279.40 Td (eceding ) Tj ET Q q 0 0 0 rg BT 164.17 279.40 Td (12 ) Tj ET Q q 0 0 0 rg BT 175.39 279.40 Td (months ) Tj ET Q q 0 0 0 rg BT 206.12 279.40 Td (\(or) Tj ET Q q 0 0 0 rg BT 217.45 279.40 Td ( ) Tj ET Q q 0 0 0 rg BT 219.67 279.40 Td (for) Tj ET Q q 0 0 0 rg BT 231.00 279.40 Td ( ) Tj ET Q q 0 0 0 rg BT 233.22 279.40 Td (such ) Tj ET Q q 0 0 0 rg BT 252.95 279.40 Td (shorter) Tj ET Q q 0 0 0 rg BT 280.78 279.40 Td ( ) Tj ET Q q 0 0 0 rg BT 283.00 279.40 Td (period ) Tj ET Q q 0 0 0 rg BT 310.22 279.40 Td (that ) Tj ET Q q 0 0 0 rg BT 327.95 279.40 Td (the ) Tj ET Q q 0 0 0 rg BT 342.17 279.40 Td (r) Tj ET Q q 0 0 0 rg BT 346.00 279.40 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 382.21 279.40 Td (was ) Tj ET Q q 0 0 0 rg BT 398.94 279.40 Td (r) Tj ET Q q 0 0 0 rg BT 402.77 279.40 Td (equir) Tj ET Q q 0 0 0 rg BT 423.11 279.40 Td (ed ) Tj ET Q q 0 0 0 rg BT 434.33 279.40 Td (to ) Tj ET Q q 0 0 0 rg BT 444.05 279.40 Td (file ) Tj ET Q q 0 0 0 rg BT 458.26 279.40 Td (such ) Tj ET Q q 0 0 0 rg BT 477.99 279.40 Td (r) Tj ET Q q 0 0 0 rg BT 481.83 279.40 Td (eports\), ) Tj ET Q q 0 0 0 rg BT 513.29 279.40 Td (and ) Tj ET Q q 0 0 0 rg BT 530.02 279.40 Td (\(2\) has ) Tj ET Q q 0 0 0 rg BT 558.00 279.40 Td (been ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 268.60 Td (subject ) Tj ET Q q 0 0 0 rg BT 65.75 268.60 Td (to ) Tj ET Q q 0 0 0 rg BT 75.49 268.60 Td (such ) Tj ET Q q 0 0 0 rg BT 95.25 268.60 Td (filing ) Tj ET Q q 0 0 0 rg BT 117.51 268.60 Td (r) Tj ET Q q 0 0 0 rg BT 121.34 268.60 Td (equir) Tj ET Q q 0 0 0 rg BT 141.68 268.60 Td (ements ) Tj ET Q q 0 0 0 rg BT 170.92 268.60 Td (for) Tj ET Q q 0 0 0 rg BT 182.25 268.60 Td ( ) Tj ET Q q 0 0 0 rg BT 184.50 268.60 Td (the ) Tj ET Q q 0 0 0 rg BT 198.74 268.60 Td (past ) Tj ET Q q 0 0 0 rg BT 217.00 268.60 Td (90 ) Tj ET Q q 0 0 0 rg BT 228.25 268.60 Td (days.    ) Tj ET Q q 0 0 0 rg BT 256.67 268.60 Td (Y) Tj ET Q q 0 0 0 rg BT 262.17 268.60 Td (es  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 274.17 266.66 cm /I5 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 283.71 268.60 Td (    No  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 308.21 266.66 cm /I6 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 254.80 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 93.28 254.80 Td (by ) Tj ET Q q 0 0 0 rg BT 104.57 254.80 Td (check ) Tj ET Q q 0 0 0 rg BT 128.35 254.80 Td (mark ) Tj ET Q q 0 0 0 rg BT 151.13 254.80 Td (whether) Tj ET Q q 0 0 0 rg BT 182.46 254.80 Td ( ) Tj ET Q q 0 0 0 rg BT 184.25 254.80 Td (the ) Tj ET Q q 0 0 0 rg BT 198.03 254.80 Td (r) Tj ET Q q 0 0 0 rg BT 201.86 254.80 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 237.64 254.80 Td (has ) Tj ET Q q 0 0 0 rg BT 252.43 254.80 Td (submitted ) Tj ET Q q 0 0 0 rg BT 292.72 254.80 Td (electr) Tj ET Q q 0 0 0 rg BT 314.03 254.80 Td (onically ) Tj ET Q q 0 0 0 rg BT 345.82 254.80 Td (and ) Tj ET Q q 0 0 0 rg BT 362.11 254.80 Td (posted ) Tj ET Q q 0 0 0 rg BT 388.90 254.80 Td (on ) Tj ET Q q 0 0 0 rg BT 400.19 254.80 Td (its ) Tj ET Q q 0 0 0 rg BT 410.97 254.80 Td (corporate ) Tj ET Q q 0 0 0 rg BT 450.11 254.80 Td (W) Tj ET Q q 0 0 0 rg BT 458.61 254.80 Td (eb ) Tj ET Q q 0 0 0 rg BT 469.40 254.80 Td (site, ) Tj ET Q q 0 0 0 rg BT 486.43 254.80 Td (if ) Tj ET Q q 0 0 0 rg BT 493.71 254.80 Td (any) Tj ET Q q 0 0 0 rg BT 507.22 254.80 Td (, ) Tj ET Q q 0 0 0 rg BT 511.25 254.80 Td (every ) Tj ET Q q 0 0 0 rg BT 534.02 254.80 Td (Interactive ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 244.00 Td (Data ) Tj ET Q q 0 0 0 rg BT 56.14 244.00 Td (File ) Tj ET Q q 0 0 0 rg BT 72.28 244.00 Td (r) Tj ET Q q 0 0 0 rg BT 76.12 244.00 Td (equir) Tj ET Q q 0 0 0 rg BT 96.45 244.00 Td (ed ) Tj ET Q q 0 0 0 rg BT 107.10 244.00 Td (to ) Tj ET Q q 0 0 0 rg BT 116.24 244.00 Td (be ) Tj ET Q q 0 0 0 rg BT 126.89 244.00 Td (submitted ) Tj ET Q q 0 0 0 rg BT 167.04 244.00 Td (and ) Tj ET Q q 0 0 0 rg BT 183.20 244.00 Td (posted ) Tj ET Q q 0 0 0 rg BT 209.85 244.00 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 246.52 244.00 Td (to ) Tj ET Q q 0 0 0 rg BT 255.66 244.00 Td (Rule ) Tj ET Q q 0 0 0 rg BT 275.31 244.00 Td (405 ) Tj ET Q q 0 0 0 rg BT 290.45 244.00 Td (of ) Tj ET Q q 0 0 0 rg BT 299.60 244.00 Td (Regulation ) Tj ET Q q 0 0 0 rg BT 343.25 244.00 Td (S-T) Tj ET Q q 0 0 0 rg BT 357.09 244.00 Td ( ) Tj ET Q q 0 0 0 rg BT 358.74 244.00 Td (\(§232.405 ) Tj ET Q q 0 0 0 rg BT 397.13 244.00 Td (of ) Tj ET Q q 0 0 0 rg BT 406.28 244.00 Td (this ) Tj ET Q q 0 0 0 rg BT 421.93 244.00 Td (chapter\) ) Tj ET Q q 0 0 0 rg BT 456.06 244.00 Td (during ) Tj ET Q q 0 0 0 rg BT 483.72 244.00 Td (the ) Tj ET Q q 0 0 0 rg BT 497.37 244.00 Td (pr) Tj ET Q q 0 0 0 rg BT 506.20 244.00 Td (eceding ) Tj ET Q q 0 0 0 rg BT 536.85 244.00 Td (12 ) Tj ET Q q 0 0 0 rg BT 547.49 244.00 Td (months ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 233.20 Td (\(or) Tj ET Q q 0 0 0 rg BT 47.33 233.20 Td ( ) Tj ET Q q 0 0 0 rg BT 49.58 233.20 Td (for) Tj ET Q q 0 0 0 rg BT 60.91 233.20 Td ( ) Tj ET Q q 0 0 0 rg BT 63.16 233.20 Td (such ) Tj ET Q q 0 0 0 rg BT 82.92 233.20 Td (shorter) Tj ET Q q 0 0 0 rg BT 110.74 233.20 Td ( ) Tj ET Q q 0 0 0 rg BT 112.99 233.20 Td (period ) Tj ET Q q 0 0 0 rg BT 140.24 233.20 Td (that ) Tj ET Q q 0 0 0 rg BT 157.99 233.20 Td (the ) Tj ET Q q 0 0 0 rg BT 172.24 233.20 Td (r) Tj ET Q q 0 0 0 rg BT 176.07 233.20 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 212.31 233.20 Td (was ) Tj ET Q q 0 0 0 rg BT 229.06 233.20 Td (r) Tj ET Q q 0 0 0 rg BT 232.90 233.20 Td (equir) Tj ET Q q 0 0 0 rg BT 253.23 233.20 Td (ed ) Tj ET Q q 0 0 0 rg BT 264.48 233.20 Td (to ) Tj ET Q q 0 0 0 rg BT 274.23 233.20 Td (submit ) Tj ET Q q 0 0 0 rg BT 302.99 233.20 Td (and ) Tj ET Q q 0 0 0 rg BT 319.75 233.20 Td (post ) Tj ET Q q 0 0 0 rg BT 338.01 233.20 Td (such ) Tj ET Q q 0 0 0 rg BT 357.76 233.20 Td (files\).    ) Tj ET Q q 0 0 0 rg BT 387.17 233.20 Td (Y) Tj ET Q q 0 0 0 rg BT 392.67 233.20 Td (es  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 404.67 231.26 cm /I7 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 414.21 233.20 Td (  No  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 434.21 231.26 cm /I8 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 219.40 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 93.06 219.40 Td (by ) Tj ET Q q 0 0 0 rg BT 104.12 219.40 Td (check ) Tj ET Q q 0 0 0 rg BT 127.67 219.40 Td (mark ) Tj ET Q q 0 0 0 rg BT 150.22 219.40 Td (if ) Tj ET Q q 0 0 0 rg BT 157.27 219.40 Td (disclosur) Tj ET Q q 0 0 0 rg BT 191.62 219.40 Td (e ) Tj ET Q q 0 0 0 rg BT 197.17 219.40 Td (of ) Tj ET Q q 0 0 0 rg BT 206.22 219.40 Td (delinquent ) Tj ET Q q 0 0 0 rg BT 248.79 219.40 Td (filers ) Tj ET Q q 0 0 0 rg BT 269.83 219.40 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 306.41 219.40 Td (to ) Tj ET Q q 0 0 0 rg BT 315.46 219.40 Td (Item 405 ) Tj ET Q q 0 0 0 rg BT 350.76 219.40 Td (of ) Tj ET Q q 0 0 0 rg BT 359.81 219.40 Td (Regulation ) Tj ET Q q 0 0 0 rg BT 403.37 219.40 Td (S-K ) Tj ET Q q 0 0 0 rg BT 419.93 219.40 Td (\(§229.405 ) Tj ET Q q 0 0 0 rg BT 458.23 219.40 Td (of ) Tj ET Q q 0 0 0 rg BT 467.28 219.40 Td (this ) Tj ET Q q 0 0 0 rg BT 482.84 219.40 Td (chapter\) ) Tj ET Q q 0 0 0 rg BT 516.89 219.40 Td (is ) Tj ET Q q 0 0 0 rg BT 524.44 219.40 Td (not ) Tj ET Q q 0 0 0 rg BT 538.50 219.40 Td (contained ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 208.60 Td (her) Tj ET Q q 0 0 0 rg BT 48.83 208.60 Td (ein, ) Tj ET Q q 0 0 0 rg BT 65.65 208.60 Td (and ) Tj ET Q q 0 0 0 rg BT 83.22 208.60 Td (will ) Tj ET Q q 0 0 0 rg BT 100.28 208.60 Td (not ) Tj ET Q q 0 0 0 rg BT 115.85 208.60 Td (be ) Tj ET Q q 0 0 0 rg BT 127.91 208.60 Td (contained, ) Tj ET Q q 0 0 0 rg BT 170.73 208.60 Td (to ) Tj ET Q q 0 0 0 rg BT 181.29 208.60 Td (the ) Tj ET Q q 0 0 0 rg BT 196.35 208.60 Td (best ) Tj ET Q q 0 0 0 rg BT 214.91 208.60 Td (of ) Tj ET Q q 0 0 0 rg BT 225.47 208.60 Td (the ) Tj ET Q q 0 0 0 rg BT 240.53 208.60 Td (r) Tj ET Q q 0 0 0 rg BT 244.36 208.60 Td (egistrant’) Tj ET Q q 0 0 0 rg BT 281.02 208.60 Td (s ) Tj ET Q q 0 0 0 rg BT 287.58 208.60 Td (knowledge, ) Tj ET Q q 0 0 0 rg BT 333.90 208.60 Td (in ) Tj ET Q q 0 0 0 rg BT 344.47 208.60 Td (definitive ) Tj ET Q q 0 0 0 rg BT 383.53 208.60 Td (pr) Tj ET Q q 0 0 0 rg BT 392.37 208.60 Td (oxy ) Tj ET Q q 0 0 0 rg BT 408.93 208.60 Td (or) Tj ET Q q 0 0 0 rg BT 417.26 208.60 Td ( ) Tj ET Q q 0 0 0 rg BT 420.32 208.60 Td (information ) Tj ET Q q 0 0 0 rg BT 469.38 208.60 Td (statements ) Tj ET Q q 0 0 0 rg BT 513.44 208.60 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 566.49 208.60 Td (by ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 197.80 Td (r) Tj ET Q q 0 0 0 rg BT 39.83 197.80 Td (efer) Tj ET Q q 0 0 0 rg BT 54.65 197.80 Td (ence ) Tj ET Q q 0 0 0 rg BT 73.89 197.80 Td (in ) Tj ET Q q 0 0 0 rg BT 83.65 197.80 Td (Part ) Tj ET Q q 0 0 0 rg BT 102.88 197.80 Td (III ) Tj ET Q q 0 0 0 rg BT 115.64 197.80 Td (of ) Tj ET Q q 0 0 0 rg BT 125.39 197.80 Td (this ) Tj ET Q q 0 0 0 rg BT 141.64 197.80 Td (Form ) Tj ET Q q 0 0 0 rg BT 165.38 197.80 Td (10-K ) Tj ET Q q 0 0 0 rg BT 186.63 197.80 Td (or) Tj ET Q q 0 0 0 rg BT 194.96 197.80 Td ( ) Tj ET Q q 0 0 0 rg BT 197.21 197.80 Td (any ) Tj ET Q q 0 0 0 rg BT 213.47 197.80 Td (amendment ) Tj ET Q q 0 0 0 rg BT 261.22 197.80 Td (to ) Tj ET Q q 0 0 0 rg BT 270.96 197.80 Td (this ) Tj ET Q q 0 0 0 rg BT 287.22 197.80 Td (Form ) Tj ET Q q 0 0 0 rg BT 310.96 197.80 Td (10-K.  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 336.70 195.86 cm /I9 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 184.00 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 92.97 184.00 Td (by ) Tj ET Q q 0 0 0 rg BT 103.94 184.00 Td (check ) Tj ET Q q 0 0 0 rg BT 127.40 184.00 Td (mark ) Tj ET Q q 0 0 0 rg BT 149.86 184.00 Td (whether) Tj ET Q q 0 0 0 rg BT 181.19 184.00 Td ( ) Tj ET Q q 0 0 0 rg BT 182.66 184.00 Td (the ) Tj ET Q q 0 0 0 rg BT 196.12 184.00 Td (r) Tj ET Q q 0 0 0 rg BT 199.96 184.00 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 235.41 184.00 Td (is ) Tj ET Q q 0 0 0 rg BT 242.88 184.00 Td (a ) Tj ET Q q 0 0 0 rg BT 248.85 184.00 Td (large ) Tj ET Q q 0 0 0 rg BT 269.81 184.00 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 314.74 184.00 Td (filer) Tj ET Q q 0 0 0 rg BT 329.91 184.00 Td (, ) Tj ET Q q 0 0 0 rg BT 333.62 184.00 Td (an ) Tj ET Q q 0 0 0 rg BT 344.59 184.00 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 389.53 184.00 Td (filer) Tj ET Q q 0 0 0 rg BT 404.69 184.00 Td (, ) Tj ET Q q 0 0 0 rg BT 408.41 184.00 Td (a ) Tj ET Q q 0 0 0 rg BT 414.38 184.00 Td (non-accelerated ) Tj ET Q q 0 0 0 rg BT 476.82 184.00 Td (filer) Tj ET Q q 0 0 0 rg BT 492.65 184.00 Td ( ) Tj ET Q q 0 0 0 rg BT 494.11 184.00 Td (or) Tj ET Q q 0 0 0 rg BT 502.45 184.00 Td ( ) Tj ET Q q 0 0 0 rg BT 503.91 184.00 Td (a ) Tj ET Q q 0 0 0 rg BT 509.88 184.00 Td (smaller) Tj ET Q q 0 0 0 rg BT 538.21 184.00 Td ( ) Tj ET Q q 0 0 0 rg BT 539.67 184.00 Td (r) Tj ET Q q 0 0 0 rg BT 543.51 184.00 Td (eporting ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 173.20 Td (company) Tj ET Q q 0 0 0 rg BT 70.51 173.20 Td (. ) Tj ET Q q 0 0 0 rg BT 74.92 173.20 Td (See ) Tj ET Q q 0 0 0 rg BT 90.08 173.20 Td (definitions ) Tj ET Q q 0 0 0 rg BT 132.76 173.20 Td (of ) Tj ET Q q 0 0 0 rg BT 142.42 173.20 Td (“large ) Tj ET Q q 0 0 0 rg BT 168.58 173.20 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 214.22 173.20 Td (filer”, ) Tj ET Q q 0 0 0 rg BT 239.12 173.20 Td (“accelerated ) Tj ET Q q 0 0 0 rg BT 289.26 173.20 Td (filer” ) Tj ET Q q 0 0 0 rg BT 311.91 173.20 Td (and ) Tj ET Q q 0 0 0 rg BT 328.59 173.20 Td (“smaller) Tj ET Q q 0 0 0 rg BT 361.42 173.20 Td ( ) Tj ET Q q 0 0 0 rg BT 363.58 173.20 Td (r) Tj ET Q q 0 0 0 rg BT 367.41 173.20 Td (eporting ) Tj ET Q q 0 0 0 rg BT 402.08 173.20 Td (company” ) Tj ET Q q 0 0 0 rg BT 443.75 173.20 Td (in ) Tj ET Q q 0 0 0 rg BT 453.42 173.20 Td (Rule ) Tj ET Q q 0 0 0 rg BT 473.59 173.20 Td (12b-2 ) Tj ET Q q 0 0 0 rg BT 497.25 173.20 Td (of ) Tj ET Q q 0 0 0 rg BT 506.92 173.20 Td (the ) Tj ET Q q 0 0 0 rg BT 521.08 173.20 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 560.27 173.20 Td (Act. ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 61.50 152.15 Td (Large ) Tj ET Q q 0 0 0 rg BT 86.74 152.15 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 132.46 152.15 Td (filer) Tj ET Q q 0 0 0 rg BT 148.29 152.15 Td (  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 152.79 150.21 cm /I10 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 176.50 152.15 Td (  ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 180.50 152.15 Td (Accelerated ) Tj ET Q q 0 0 0 rg BT 228.22 152.15 Td (filer) Tj ET Q q 0 0 0 rg BT 244.04 152.15 Td (  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 248.54 150.21 cm /I11 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 278.50 152.15 Td (  ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 282.50 152.15 Td (Non-accelerated ) Tj ET Q q 0 0 0 rg BT 347.22 152.15 Td (filer) Tj ET Q q 0 0 0 rg BT 363.05 152.15 Td (  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 367.55 150.21 cm /I12 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 390.50 152.15 Td (  ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 394.50 152.15 Td (Smaller) Tj ET Q q 0 0 0 rg BT 424.33 152.15 Td ( r) Tj ET Q q 0 0 0 rg BT 430.41 152.15 Td (eporting company  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 504.66 150.21 cm /I13 Do Q BT /F1 10.00 Tf ET BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 134.40 Td (Indicate ) Tj ET Q q 0 0 0 rg BT 93.75 134.40 Td (by ) Tj ET Q q 0 0 0 rg BT 105.51 134.40 Td (check ) Tj ET Q q 0 0 0 rg BT 129.75 134.40 Td (mark ) Tj ET Q q 0 0 0 rg BT 153.00 134.40 Td (if ) Tj ET Q q 0 0 0 rg BT 160.74 134.40 Td (the ) Tj ET Q q 0 0 0 rg BT 174.99 134.40 Td (r) Tj ET Q q 0 0 0 rg BT 178.82 134.40 Td (egistrant ) Tj ET Q q 0 0 0 rg BT 215.07 134.40 Td (is ) Tj ET Q q 0 0 0 rg BT 223.32 134.40 Td (a ) Tj ET Q q 0 0 0 rg BT 230.07 134.40 Td (shell ) Tj ET Q q 0 0 0 rg BT 249.82 134.40 Td (company ) Tj ET Q q 0 0 0 rg BT 287.07 134.40 Td (\(as ) Tj ET Q q 0 0 0 rg BT 300.32 134.40 Td (defined ) Tj ET Q q 0 0 0 rg BT 331.08 134.40 Td (in ) Tj ET Q q 0 0 0 rg BT 340.83 134.40 Td (Rule ) Tj ET Q q 0 0 0 rg BT 361.08 134.40 Td (12b-2 ) Tj ET Q q 0 0 0 rg BT 384.83 134.40 Td (of ) Tj ET Q q 0 0 0 rg BT 394.58 134.40 Td (the ) Tj ET Q q 0 0 0 rg BT 408.83 134.40 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 448.09 134.40 Td (Act\).    ) Tj ET Q q 0 0 0 rg BT 475.49 134.40 Td (Y) Tj ET Q q 0 0 0 rg BT 480.99 134.40 Td (es  ) Tj ET Q /GS0 gs q 8.02 0 0 9.04 492.99 132.46 cm /I14 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 501.01 134.40 Td (    No  ) Tj ET Q /GS0 gs q 9.54 0 0 9.04 525.51 132.46 cm /I15 Do Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 120.60 Td (The ) Tj ET Q q 0 0 0 rg BT 77.50 120.60 Td (aggr) Tj ET Q q 0 0 0 rg BT 94.84 120.60 Td (egate ) Tj ET Q q 0 0 0 rg BT 117.32 120.60 Td (market ) Tj ET Q q 0 0 0 rg BT 147.81 120.60 Td (value ) Tj ET Q q 0 0 0 rg BT 170.82 120.60 Td (of ) Tj ET Q q 0 0 0 rg BT 180.81 120.60 Td (the ) Tj ET Q q 0 0 0 rg BT 195.31 120.60 Td (1,669,074,782 ) Tj ET Q q 0 0 0 rg BT 249.56 120.60 Td (shar) Tj ET Q q 0 0 0 rg BT 266.40 120.60 Td (es ) Tj ET Q q 0 0 0 rg BT 276.40 120.60 Td (of ) Tj ET Q q 0 0 0 rg BT 286.40 120.60 Td (voting ) Tj ET Q q 0 0 0 rg BT 312.91 120.60 Td (common ) Tj ET Q q 0 0 0 rg BT 348.40 120.60 Td (equity ) Tj ET Q q 0 0 0 rg BT 374.91 120.60 Td (held ) Tj ET Q q 0 0 0 rg BT 393.91 120.60 Td (by ) Tj ET Q q 0 0 0 rg BT 405.92 120.60 Td (non-affiliates ) Tj ET Q q 0 0 0 rg BT 458.92 120.60 Td (of ) Tj ET Q q 0 0 0 rg BT 468.92 120.60 Td (the ) Tj ET Q q 0 0 0 rg BT 483.42 120.60 Td (r) Tj ET Q q 0 0 0 rg BT 487.25 120.60 Td (egistrant, ) Tj ET Q q 0 0 0 rg BT 525.99 120.60 Td (computed ) Tj ET Q q 0 0 0 rg BT 566.49 120.60 Td (by ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 109.80 Td (r) Tj ET Q q 0 0 0 rg BT 39.83 109.80 Td (efer) Tj ET Q q 0 0 0 rg BT 54.65 109.80 Td (ence ) Tj ET Q q 0 0 0 rg BT 73.30 109.80 Td (to ) Tj ET Q q 0 0 0 rg BT 82.45 109.80 Td (the ) Tj ET Q q 0 0 0 rg BT 96.10 109.80 Td (closing ) Tj ET Q q 0 0 0 rg BT 124.26 109.80 Td (price ) Tj ET Q q 0 0 0 rg BT 145.41 109.80 Td (as ) Tj ET Q q 0 0 0 rg BT 155.06 109.80 Td (r) Tj ET Q q 0 0 0 rg BT 158.90 109.80 Td (eported ) Tj ET Q q 0 0 0 rg BT 190.04 109.80 Td (on ) Tj ET Q q 0 0 0 rg BT 201.20 109.80 Td (the ) Tj ET Q q 0 0 0 rg BT 214.86 109.80 Td (New ) Tj ET Q q 0 0 0 rg BT 233.26 109.80 Td (Y) Tj ET Q q 0 0 0 rg BT 238.76 109.80 Td (ork ) Tj ET Q q 0 0 0 rg BT 253.92 109.80 Td (Stock ) Tj ET Q q 0 0 0 rg BT 277.08 109.80 Td (Exchange, ) Tj ET Q q 0 0 0 rg BT 318.49 109.80 Td (as ) Tj ET Q q 0 0 0 rg BT 328.14 109.80 Td (of ) Tj ET Q q 0 0 0 rg BT 337.30 109.80 Td (the ) Tj ET Q q 0 0 0 rg BT 350.95 109.80 Td (last ) Tj ET Q q 0 0 0 rg BT 366.10 109.80 Td (business ) Tj ET Q q 0 0 0 rg BT 399.78 109.80 Td (day ) Tj ET Q q 0 0 0 rg BT 415.44 109.80 Td (of ) Tj ET Q q 0 0 0 rg BT 424.59 109.80 Td (the ) Tj ET Q q 0 0 0 rg BT 438.25 109.80 Td (r) Tj ET Q q 0 0 0 rg BT 442.08 109.80 Td (egistrant’) Tj ET Q q 0 0 0 rg BT 478.73 109.80 Td (s ) Tj ET Q q 0 0 0 rg BT 483.89 109.80 Td (most ) Tj ET Q q 0 0 0 rg BT 504.04 109.80 Td (r) Tj ET Q q 0 0 0 rg BT 507.88 109.80 Td (ecently ) Tj ET Q q 0 0 0 rg BT 536.52 109.80 Td (completed ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 99.00 Td (second ) Tj ET Q q 0 0 0 rg BT 65.79 99.00 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 89.58 99.00 Td (quarter) Tj ET Q q 0 0 0 rg BT 118.91 99.00 Td ( ) Tj ET Q q 0 0 0 rg BT 122.70 99.00 Td (\(June ) Tj ET Q q 0 0 0 rg BT 147.99 99.00 Td (30, ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 163.03 99.00 Td (2016) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 181.03 99.00 Td (\) ) Tj ET Q q 0 0 0 rg BT 187.82 99.00 Td (was ) Tj ET Q q 0 0 0 rg BT 206.11 99.00 Td (appr) Tj ET Q q 0 0 0 rg BT 224.45 99.00 Td (oximately ) Tj ET Q q 0 0 0 rg BT 265.73 99.00 Td ($122,760,450,216. ) Tj ET Q q 0 0 0 rg BT 337.03 99.00 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 394.30 99.00 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 425.62 99.00 Td (has ) Tj ET Q q 0 0 0 rg BT 442.41 99.00 Td (no ) Tj ET Q q 0 0 0 rg BT 455.71 99.00 Td (non-voting ) Tj ET Q q 0 0 0 rg BT 501.01 99.00 Td (common ) Tj ET Q q 0 0 0 rg BT 537.80 99.00 Td (equity) Tj ET Q q 0 0 0 rg BT 561.30 99.00 Td (. ) Tj ET Q q 0 0 0 rg BT 566.51 99.00 Td (At ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 88.20 Td (February 1, ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 83.74 88.20 Td (2017) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 101.74 88.20 Td (, ) Tj ET Q q 0 0 0 rg BT 106.24 88.20 Td (ther) Tj ET Q q 0 0 0 rg BT 122.07 88.20 Td (e ) Tj ET Q q 0 0 0 rg BT 128.32 88.20 Td (wer) Tj ET Q q 0 0 0 rg BT 142.64 88.20 Td (e ) Tj ET Q q 0 0 0 rg BT 148.89 88.20 Td (1,672,715,340 ) Tj ET Q q 0 0 0 rg BT 202.89 88.20 Td (shar) Tj ET Q q 0 0 0 rg BT 219.73 88.20 Td (es ) Tj ET Q q 0 0 0 rg BT 229.47 88.20 Td (of ) Tj ET Q q 0 0 0 rg BT 239.22 88.20 Td (common ) Tj ET Q q 0 0 0 rg BT 274.46 88.20 Td (stock ) Tj ET Q q 0 0 0 rg BT 296.71 88.20 Td (outstanding.) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 60.00 72.40 Td (DOCUMENTS ) Tj ET Q q 0 0 0 rg BT 123.21 72.40 Td (INCORPORA) Tj ET Q q 0 0 0 rg BT 178.04 72.40 Td (TED ) Tj ET Q q 0 0 0 rg BT 201.25 72.40 Td (BY) Tj ET Q q 0 0 0 rg BT 213.42 72.40 Td ( ) Tj ET Q q 0 0 0 rg BT 218.13 72.40 Td (REFERENCE: ) Tj ET Q q 0 0 0 rg BT 281.34 72.40 Td (Portions ) Tj ET Q q 0 0 0 rg BT 318.55 72.40 Td (of ) Tj ET Q q 0 0 0 rg BT 330.75 72.40 Td (the ) Tj ET Q q 0 0 0 rg BT 347.45 72.40 Td (Pr) Tj ET Q q 0 0 0 rg BT 356.78 72.40 Td (oxy ) Tj ET Q q 0 0 0 rg BT 374.99 72.40 Td (Statement ) Tj ET Q q 0 0 0 rg BT 418.69 72.40 Td (for) Tj ET Q q 0 0 0 rg BT 430.02 72.40 Td ( ) Tj ET Q q 0 0 0 rg BT 434.72 72.40 Td (the ) Tj ET Q q 0 0 0 rg BT 451.43 72.40 Td (r) Tj ET Q q 0 0 0 rg BT 455.26 72.40 Td (egistrant’) Tj ET Q q 0 0 0 rg BT 491.91 72.40 Td (s ) Tj ET Q q 0 0 0 rg BT 499.08 72.40 Td (Annual ) Tj ET Q q 0 0 0 rg BT 532.31 72.40 Td (Meeting ) Tj ET Q q 0 0 0 rg BT 568.50 72.40 Td (of ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 61.60 Td (Stockholders ) Tj ET Q q 0 0 0 rg BT 88.48 61.60 Td (to ) Tj ET Q q 0 0 0 rg BT 98.46 61.60 Td (be ) Tj ET Q q 0 0 0 rg BT 109.93 61.60 Td (held ) Tj ET Q q 0 0 0 rg BT 128.91 61.60 Td (May 2, ) Tj ET Q q 0 0 0 rg BT 157.89 61.60 Td (2017, ) Tj ET Q q 0 0 0 rg BT 180.61 61.60 Td (to ) Tj ET Q q 0 0 0 rg BT 190.59 61.60 Td (be ) Tj ET Q q 0 0 0 rg BT 202.06 61.60 Td (filed ) Tj ET Q q 0 0 0 rg BT 221.54 61.60 Td (within ) Tj ET Q q 0 0 0 rg BT 248.52 61.60 Td (120 ) Tj ET Q q 0 0 0 rg BT 264.50 61.60 Td (days ) Tj ET Q q 0 0 0 rg BT 284.48 61.60 Td (after) Tj ET Q q 0 0 0 rg BT 302.80 61.60 Td ( ) Tj ET Q q 0 0 0 rg BT 305.28 61.60 Td (the ) Tj ET Q q 0 0 0 rg BT 319.75 61.60 Td (conclusion ) Tj ET Q q 0 0 0 rg BT 362.74 61.60 Td (of ) Tj ET Q q 0 0 0 rg BT 372.71 61.60 Td (the ) Tj ET Q q 0 0 0 rg BT 387.19 61.60 Td (r) Tj ET Q q 0 0 0 rg BT 391.02 61.60 Td (egistrant's ) Tj ET Q q 0 0 0 rg BT 433.49 61.60 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 455.96 61.60 Td (year) Tj ET Q q 0 0 0 rg BT 472.79 61.60 Td ( ) Tj ET Q q 0 0 0 rg BT 475.26 61.60 Td (ended ) Tj ET Q q 0 0 0 rg BT 500.75 61.60 Td (December) Tj ET Q q 0 0 0 rg BT 539.56 61.60 Td ( ) Tj ET Q q 0 0 0 rg BT 542.04 61.60 Td (31, ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 555.76 61.60 Td (2016) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 573.76 61.60 Td (, ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 36.00 50.80 Td (ar) Tj ET Q q 0 0 0 rg BT 44.33 50.80 Td (e ) Tj ET Q q 0 0 0 rg BT 50.58 50.80 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 102.82 50.80 Td (by ) Tj ET Q q 0 0 0 rg BT 114.57 50.80 Td (r) Tj ET Q q 0 0 0 rg BT 118.41 50.80 Td (efer) Tj ET Q q 0 0 0 rg BT 133.22 50.80 Td (ence ) Tj ET Q q 0 0 0 rg BT 152.46 50.80 Td (into ) Tj ET Q q 0 0 0 rg BT 169.72 50.80 Td (Part III ) Tj ET Q q 0 0 0 rg BT 201.71 50.80 Td (of ) Tj ET Q q 0 0 0 rg BT 211.46 50.80 Td (this ) Tj ET Q q 0 0 0 rg BT 227.22 50.80 Td (Annual ) Tj ET Q q 0 0 0 rg BT 257.99 50.80 Td (Report ) Tj ET Q q 0 0 0 rg BT 287.23 50.80 Td (on ) Tj ET Q q 0 0 0 rg BT 298.98 50.80 Td (Form 10-K.) Tj ET Q 0 0 0 RG /GS0 gs 2.50 w 0 i [] 0 d 0 J 0 j 3 M 35.5 37.299999999999955 m 575.5 37.299999999999955 l s 0 0 0 RG /GS0 gs 2.50 w 0 i [] 0 d 0 J 0 j 3 M 35.5 33.299999999999955 m 575.5 33.299999999999955 l s BT /F1 10.00 Tf ET endstream endobj 5 0 obj <><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>] /Rotate 0 /Contents 6 0 R>> endobj 6 0 obj <> stream BT /F2 10.00 Tf ET q 0 0 0 rg BT 217.15 749.25 Td (BRIST) Tj ET Q q 0 0 0 rg BT 246.98 749.25 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 373.47 749.25 Td (ANY) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 253.25 737.25 Td (INDEX ) Tj ET Q q 0 0 0 rg BT 287.80 737.25 Td (T) Tj ET Q q 0 0 0 rg BT 294.29 737.25 Td (O FORM 10-K) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 258.35 725.25 Td (DECEMBER 31, 2016) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 353.63 725.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 680.0333984375 m 68.6923828125 680.0333984375 l s q 0 0 1 rg BT 39.00 681.37 Td (P) Tj ET Q q 0 0 1 rg BT 43.64 681.37 Td (AR) Tj ET Q q 0 0 1 rg BT 56.93 681.37 Td (T) Tj ET Q q 0 0 1 rg BT 62.86 681.37 Td ( I) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 668.0333984375 m 115.3251953125 668.0333984375 l s q 0 0 1 rg BT 87.00 669.37 Td (Item 1.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 668.0333984375 m 164.5615234375 668.0333984375 l s q 0 0 1 rg BT 129.00 669.37 Td (Business) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 656.0333984375 m 247.3203125 656.0333984375 l s q 0 0 1 rg BT 129.00 657.37 Td (Acquisitions and Divestitures) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 644.0333984375 m 349.5126953125 644.0333984375 l s q 0 0 1 rg BT 129.00 645.37 Td (Products, Intellectual Property and Product Exclusivity) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 632.0333984375 m 238.9560546875 632.0333984375 l s q 0 0 1 rg BT 129.00 633.37 Td (Research and Development) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 620.0333984375 m 166.763671875 620.0333984375 l s q 0 0 1 rg BT 129.00 621.37 Td (Alliances) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 608.0333984375 m 286.20703125 608.0333984375 l s q 0 0 1 rg BT 129.00 609.37 Td (Marketing, Distribution and Customers) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 596.0333984375 m 179 596.0333984375 l s q 0 0 1 rg BT 129.00 597.37 Td (Competition) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 584.0333984375 m 310.07421875 584.0333984375 l s q 0 0 1 rg BT 129.00 585.37 Td (Pricing, Price Constraints and Market ) Tj ET Q q 0 0 1 rg BT 281.75 585.37 Td (Access) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 572.0333984375 m 225.3671875 572.0333984375 l s q 0 0 1 rg BT 129.00 573.37 Td (Government Regulation) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 560.0333984375 m 298.4970703125 560.0333984375 l s q 0 0 1 rg BT 129.00 561.37 Td (Sources and ) Tj ET Q q 0 0 1 rg BT 179.55 561.37 Td (A) Tj ET Q q 0 0 1 rg BT 186.03 561.37 Td (vailability of Raw Materials) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 548.0333984375 m 281.4560546875 548.0333984375 l s q 0 0 1 rg BT 129.00 549.37 Td (Manufacturing and Quality ) Tj ET Q q 0 0 1 rg BT 239.81 549.37 Td (Assurance) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 536.0333984375 m 234.810546875 536.0333984375 l s q 0 0 1 rg BT 129.00 537.37 Td (Environmental Regulation) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 524.0333984375 m 173.43359375 524.0333984375 l s q 0 0 1 rg BT 129.00 525.37 Td (Employees) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 512.0333984375 m 206.4853515625 512.0333984375 l s q 0 0 1 rg BT 129.00 513.37 Td (Foreign Operations) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 500.0333984375 m 250.23046875 500.0333984375 l s q 0 0 1 rg BT 129.00 501.37 Td (Bristol-Myers Squibb ) Tj ET Q q 0 0 1 rg BT 218.27 501.37 Td (W) Tj ET Q q 0 0 1 rg BT 226.91 501.37 Td (ebsite) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 488.0333984375 m 122.546875 488.0333984375 l s q 0 0 1 rg BT 87.00 489.37 Td (Item 1A.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 488.0333984375 m 179.2783203125 488.0333984375 l s q 0 0 1 rg BT 129.00 489.37 Td (Risk Factors) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 476.0333984375 m 121.9951171875 476.0333984375 l s q 0 0 1 rg BT 87.00 477.37 Td (Item 1B.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 476.0333984375 m 242.69140625 476.0333984375 l s q 0 0 1 rg BT 129.00 477.37 Td (Unresolved Staf) Tj ET Q q 0 0 1 rg BT 193.53 477.37 Td (f Comments) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 464.0333984375 m 115.3251953125 464.0333984375 l s q 0 0 1 rg BT 87.00 465.37 Td (Item 2.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 464.0333984375 m 169.546875 464.0333984375 l s q 0 0 1 rg BT 129.00 465.37 Td (Properties) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 452.0333984375 m 115.3251953125 452.0333984375 l s q 0 0 1 rg BT 87.00 453.37 Td (Item 3.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 452.0333984375 m 203.140625 452.0333984375 l s q 0 0 1 rg BT 129.00 453.37 Td (Legal Proceedings) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 440.0333984375 m 115.3251953125 440.0333984375 l s q 0 0 1 rg BT 87.00 441.37 Td (Item 4.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 440.0333984375 m 227.3154296875 440.0333984375 l s q 0 0 1 rg BT 129.00 441.37 Td (Mine Safety Disclosures) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 416.0333984375 m 75.63818359375 416.0333984375 l s q 0 0 1 rg BT 39.00 417.37 Td (P) Tj ET Q q 0 0 1 rg BT 43.64 417.37 Td (AR) Tj ET Q q 0 0 1 rg BT 56.93 417.37 Td (T) Tj ET Q q 0 0 1 rg BT 62.86 417.37 Td ( IA) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 416.0333984375 m 273.208984375 416.0333984375 l s q 0 0 1 rg BT 129.00 417.37 Td (Executive Of) Tj ET Q q 0 0 1 rg BT 181.85 417.37 Td (ficers of the Registrant) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 392.0333984375 m 72.0224609375 392.0333984375 l s q 0 0 1 rg BT 39.00 393.37 Td (P) Tj ET Q q 0 0 1 rg BT 43.64 393.37 Td (AR) Tj ET Q q 0 0 1 rg BT 56.93 393.37 Td (T) Tj ET Q q 0 0 1 rg BT 62.86 393.37 Td ( II) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 380.0333984375 m 115.3251953125 380.0333984375 l s q 0 0 1 rg BT 87.00 381.37 Td (Item 5.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 380.0333984375 m 427.134765625 380.0333984375 l s q 0 0 1 rg BT 129.00 381.37 Td (Market for the Registrant's Common Stock and Other Stockholder Matters) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 368.0333984375 m 115.3251953125 368.0333984375 l s q 0 0 1 rg BT 87.00 369.37 Td (Item 6.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 368.0333984375 m 223.9609375 368.0333984375 l s q 0 0 1 rg BT 129.00 369.37 Td (Selected Financial Data) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 356.0333984375 m 115.3251953125 356.0333984375 l s q 0 0 1 rg BT 87.00 357.37 Td (Item 7.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 356.0333984375 m 486.314453125 356.0333984375 l s q 0 0 1 rg BT 129.00 357.37 Td (Management's Discussion and ) Tj ET Q q 0 0 1 rg BT 252.17 357.37 Td (Analysis of Financial Condition and Results of Operations) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 344.0333984375 m 122.546875 344.0333984375 l s q 0 0 1 rg BT 87.00 345.37 Td (Item 7A.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 344.0333984375 m 370.62109375 344.0333984375 l s q 0 0 1 rg BT 129.00 345.37 Td (Quantitative and Qualitative Disclosures ) Tj ET Q q 0 0 1 rg BT 293.40 345.37 Td (About Market Risk) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 332.0333984375 m 115.3251953125 332.0333984375 l s q 0 0 1 rg BT 87.00 333.37 Td (Item 8.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 332.0333984375 m 313.951171875 332.0333984375 l s q 0 0 1 rg BT 129.00 333.37 Td (Financial Statements and Supplementary Data) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 320.0333984375 m 391.7197265625 320.0333984375 l s q 0 0 1 rg BT 129.00 321.37 Td (Consolidated Statements of Earnings and Comprehensive Income) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 308.0333984375 m 245.083984375 308.0333984375 l s q 0 0 1 rg BT 129.00 309.37 Td (Consolidated Balance Sheets) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 296.0333984375 m 288.4384765625 296.0333984375 l s q 0 0 1 rg BT 129.00 297.37 Td (Consolidated Statements of Cash Flows) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 284.0333984375 m 263.4189453125 284.0333984375 l s q 0 0 1 rg BT 129.00 285.37 Td (Notes to the Financial Statements) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 272.03339843749995 m 115.3251953125 272.03339843749995 l s q 0 0 1 rg BT 87.00 273.37 Td (Item 9.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 272.03339843749995 m 487.8134765625 272.03339843749995 l s q 0 0 1 rg BT 129.00 273.37 Td (Changes in and Disagreements with ) Tj ET Q q 0 0 1 rg BT 274.81 273.37 Td (Accountants on ) Tj ET Q q 0 0 1 rg BT 339.24 273.37 Td (Accounting and Financial Disclosure) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 260.03339843749995 m 122.546875 260.03339843749995 l s q 0 0 1 rg BT 87.00 261.37 Td (Item 9A.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 260.03339843749995 m 227.3154296875 260.03339843749995 l s q 0 0 1 rg BT 129.00 261.37 Td (Controls and Procedures) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 248.03339843749995 m 121.9951171875 248.03339843749995 l s q 0 0 1 rg BT 87.00 249.37 Td (Item 9B.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 248.03339843749995 m 202.0322265625 248.03339843749995 l s q 0 0 1 rg BT 129.00 249.37 Td (Other Information) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 224.03339843749995 m 75.3525390625 224.03339843749995 l s q 0 0 1 rg BT 39.00 225.37 Td (P) Tj ET Q q 0 0 1 rg BT 43.64 225.37 Td (AR) Tj ET Q q 0 0 1 rg BT 56.93 225.37 Td (T) Tj ET Q q 0 0 1 rg BT 62.86 225.37 Td ( III) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 212.03339843749995 m 120.3251953125 212.03339843749995 l s q 0 0 1 rg BT 87.00 213.37 Td (Item 10.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 212.03339843749995 m 329.8544921875 212.03339843749995 l s q 0 0 1 rg BT 129.00 213.37 Td (Directors and Executive Of) Tj ET Q q 0 0 1 rg BT 238.50 213.37 Td (ficers of the Registrant) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 200.03339843749995 m 119.9541015625 200.03339843749995 l s q 0 0 1 rg BT 87.00 201.37 Td (Item 1) Tj ET Q q 0 0 1 rg BT 112.45 201.37 Td (1.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 200.03339843749995 m 229.25390625 200.03339843749995 l s q 0 0 1 rg BT 129.00 201.37 Td (Executive Compensation) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 188.03339843749995 m 120.3251953125 188.03339843749995 l s q 0 0 1 rg BT 87.00 189.37 Td (Item 12.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 188.03339843749995 m 534.15625 188.03339843749995 l s q 0 0 1 rg BT 129.00 189.37 Td (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 176.03339843749995 m 120.3251953125 176.03339843749995 l s q 0 0 1 rg BT 87.00 177.37 Td (Item 13.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 176.03339843749995 m 318.4189453125 176.03339843749995 l s q 0 0 1 rg BT 129.00 177.37 Td (Certain Relationships and Related ) Tj ET Q q 0 0 1 rg BT 267.68 177.37 Td (T) Tj ET Q q 0 0 1 rg BT 273.43 177.37 Td (ransactions) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 164.03339843749995 m 120.3251953125 164.03339843749995 l s q 0 0 1 rg BT 87.00 165.37 Td (Item 14.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 164.03339843749995 m 180.9384765625 164.03339843749995 l s q 0 0 1 rg BT 129.00 165.37 Td (Auditor Fees) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 140.03339843749995 m 75.82373046875 140.03339843749995 l s q 0 0 1 rg BT 39.00 141.37 Td (P) Tj ET Q q 0 0 1 rg BT 43.64 141.37 Td (AR) Tj ET Q q 0 0 1 rg BT 56.93 141.37 Td (T) Tj ET Q q 0 0 1 rg BT 62.86 141.37 Td ( IV) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 128.03339843749995 m 120.3251953125 128.03339843749995 l s q 0 0 1 rg BT 87.00 129.37 Td (Item 15.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 128.03339843749995 m 300.630859375 128.03339843749995 l s q 0 0 1 rg BT 129.00 129.37 Td (Exhibits and Financial Statement Schedule) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 87 116.03339843749995 m 120.3251953125 116.03339843749995 l s q 0 0 1 rg BT 87.00 117.37 Td (Item 16.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 129 116.03339843749995 m 215.1083984375 116.03339843749995 l s q 0 0 1 rg BT 129.00 117.37 Td (Form 10-K Summary) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 92.03339843749995 m 100.1181640625 92.03339843749995 l s q 0 0 1 rg BT 39.00 93.37 Td (SIGNA) Tj ET Q q 0 0 1 rg BT 68.45 93.37 Td (TURES) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 80.03339843749995 m 212.0908203125 80.03339843749995 l s q 0 0 1 rg BT 39.00 81.37 Td (SUMMAR) Tj ET Q q 0 0 1 rg BT 82.91 81.37 Td (Y) Tj ET Q q 0 0 1 rg BT 89.76 81.37 Td ( OF ) Tj ET Q q 0 0 1 rg BT 106.99 81.37 Td (ABBREVIA) Tj ET Q q 0 0 1 rg BT 156.99 81.37 Td (TED ) Tj ET Q q 0 0 1 rg BT 178.75 81.37 Td (TERMS) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 39 68.03339843749995 m 112.4130859375 68.03339843749995 l s q 0 0 1 rg BT 39.00 69.37 Td (EXHIBIT) Tj ET Q q 0 0 1 rg BT 78.81 69.37 Td ( INDEX) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET BT /F1 8.50 Tf ET q 0 0 0 rg BT 36.00 49.85 Td (* ) Tj ET Q q 0 0 0 rg BT 54.00 49.85 Td (Indicates ) Tj ET Q q 0 0 0 rg BT 86.81 49.85 Td (brand ) Tj ET Q q 0 0 0 rg BT 108.28 49.85 Td (names ) Tj ET Q q 0 0 0 rg BT 132.13 49.85 Td (of ) Tj ET Q q 0 0 0 rg BT 141.33 49.85 Td (products ) Tj ET Q q 0 0 0 rg BT 172.73 49.85 Td (which ) Tj ET Q q 0 0 0 rg BT 195.63 49.85 Td (are ) Tj ET Q q 0 0 0 rg BT 208.13 49.85 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 248.02 49.85 Td (not ) Tj ET Q q 0 0 0 rg BT 261.00 49.85 Td (owned ) Tj ET Q q 0 0 0 rg BT 285.79 49.85 Td (by ) Tj ET Q q 0 0 0 rg BT 296.41 49.85 Td (BMS. ) Tj ET Q q 0 0 0 rg BT 318.62 49.85 Td (Specific ) Tj ET Q q 0 0 0 rg BT 348.60 49.85 Td (trademark ) Tj ET Q q 0 0 0 rg BT 385.17 49.85 Td (ownership ) Tj ET Q q 0 0 0 rg BT 422.71 49.85 Td (information ) Tj ET Q q 0 0 0 rg BT 464.97 49.85 Td (is ) Tj ET Q q 0 0 0 rg BT 472.76 49.85 Td (included ) Tj ET Q q 0 0 0 rg BT 504.16 49.85 Td (in ) Tj ET Q q 0 0 0 rg BT 512.89 49.85 Td (the ) Tj ET Q q 0 0 0 rg BT 525.40 49.85 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 552.56 49.85 Td (Index.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 668.0333984375 m 559 668.0333984375 l s q 0 0 1 rg BT 554.00 669.37 Td (3) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 656.0333984375 m 559 656.0333984375 l s q 0 0 1 rg BT 554.00 657.37 Td (3) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 644.0333984375 m 559 644.0333984375 l s q 0 0 1 rg BT 554.00 645.37 Td (3) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 632.0333984375 m 559 632.0333984375 l s q 0 0 1 rg BT 554.00 633.37 Td (8) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 620.0333984375 m 564 620.0333984375 l s q 0 0 1 rg BT 554.00 621.37 Td (10) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 608.0333984375 m 564 608.0333984375 l s q 0 0 1 rg BT 554.00 609.37 Td (12) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 596.0333984375 m 564 596.0333984375 l s q 0 0 1 rg BT 554.00 597.37 Td (13) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 584.0333984375 m 564 584.0333984375 l s q 0 0 1 rg BT 554.00 585.37 Td (13) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 572.0333984375 m 564 572.0333984375 l s q 0 0 1 rg BT 554.00 573.37 Td (14) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 560.0333984375 m 564 560.0333984375 l s q 0 0 1 rg BT 554.00 561.37 Td (16) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 548.0333984375 m 564 548.0333984375 l s q 0 0 1 rg BT 554.00 549.37 Td (16) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 536.0333984375 m 564 536.0333984375 l s q 0 0 1 rg BT 554.00 537.37 Td (16) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 524.0333984375 m 564 524.0333984375 l s q 0 0 1 rg BT 554.00 525.37 Td (17) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 512.0333984375 m 564 512.0333984375 l s q 0 0 1 rg BT 554.00 513.37 Td (17) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 500.0333984375 m 564 500.0333984375 l s q 0 0 1 rg BT 554.00 501.37 Td (17) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 488.0333984375 m 564 488.0333984375 l s q 0 0 1 rg BT 554.00 489.37 Td (18) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 476.0333984375 m 564 476.0333984375 l s q 0 0 1 rg BT 554.00 477.37 Td (23) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 464.0333984375 m 564 464.0333984375 l s q 0 0 1 rg BT 554.00 465.37 Td (23) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 452.0333984375 m 564 452.0333984375 l s q 0 0 1 rg BT 554.00 453.37 Td (23) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 440.0333984375 m 564 440.0333984375 l s q 0 0 1 rg BT 554.00 441.37 Td (23) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 416.0333984375 m 564 416.0333984375 l s q 0 0 1 rg BT 554.00 417.37 Td (24) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 380.0333984375 m 564 380.0333984375 l s q 0 0 1 rg BT 554.00 381.37 Td (25) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 368.0333984375 m 564 368.0333984375 l s q 0 0 1 rg BT 554.00 369.37 Td (27) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 356.0333984375 m 564 356.0333984375 l s q 0 0 1 rg BT 554.00 357.37 Td (28) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 344.0333984375 m 564 344.0333984375 l s q 0 0 1 rg BT 554.00 345.37 Td (52) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 332.0333984375 m 564 332.0333984375 l s q 0 0 1 rg BT 554.00 333.37 Td (53) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 320.0333984375 m 564 320.0333984375 l s q 0 0 1 rg BT 554.00 321.37 Td (53) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 308.0333984375 m 564 308.0333984375 l s q 0 0 1 rg BT 554.00 309.37 Td (54) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 296.0333984375 m 564 296.0333984375 l s q 0 0 1 rg BT 554.00 297.37 Td (55) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 284.0333984375 m 564 284.0333984375 l s q 0 0 1 rg BT 554.00 285.37 Td (56) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 272.03339843749995 m 569 272.03339843749995 l s q 0 0 1 rg BT 554.00 273.37 Td (101) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 260.03339843749995 m 569 260.03339843749995 l s q 0 0 1 rg BT 554.00 261.37 Td (101) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 248.03339843749995 m 569 248.03339843749995 l s q 0 0 1 rg BT 554.00 249.37 Td (101) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 212.03339843749995 m 569 212.03339843749995 l s q 0 0 1 rg BT 554.00 213.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 200.03339843749995 m 569 200.03339843749995 l s q 0 0 1 rg BT 554.00 201.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 188.03339843749995 m 569 188.03339843749995 l s q 0 0 1 rg BT 554.00 189.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 176.03339843749995 m 569 176.03339843749995 l s q 0 0 1 rg BT 554.00 177.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 164.03339843749995 m 569 164.03339843749995 l s q 0 0 1 rg BT 554.00 165.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 128.03339843749995 m 569 128.03339843749995 l s q 0 0 1 rg BT 554.00 129.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 116.03339843749995 m 569 116.03339843749995 l s q 0 0 1 rg BT 554.00 117.37 Td (103) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 92.03339843749995 m 569 92.03339843749995 l s q 0 0 1 rg BT 554.00 93.37 Td (104) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 80.03339843749995 m 569 80.03339843749995 l s q 0 0 1 rg BT 554.00 81.37 Td (105) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 554 68.03339843749995 m 569 68.03339843749995 l s q 0 0 1 rg BT 554.00 69.37 Td (106) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL endstream endobj 7 0 obj <> endobj 8 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (3) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 289.80 749.25 Td (P) Tj ET Q q 0 0 0 rg BT 295.17 749.25 Td (AR) Tj ET Q q 0 0 0 rg BT 309.26 749.25 Td (T) Tj ET Q q 0 0 0 rg BT 315.75 749.25 Td ( I) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 729.48 Td (Item 1.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 729.48 Td (BUSINESS.) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 702.25 Td (General) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 678.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 94.27 678.25 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 124.78 678.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 165.83 678.25 Td (was ) Tj ET Q q 0 0 0 rg BT 183.55 678.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 236.25 678.25 Td (under ) Tj ET Q q 0 0 0 rg BT 261.18 678.25 Td (the ) Tj ET Q q 0 0 0 rg BT 275.56 678.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 296.06 678.25 Td (of ) Tj ET Q q 0 0 0 rg BT 306.55 678.25 Td (the ) Tj ET Q q 0 0 0 rg BT 320.94 678.25 Td (State ) Tj ET Q q 0 0 0 rg BT 343.10 678.25 Td (of ) Tj ET Q q 0 0 0 rg BT 353.59 678.25 Td (Delaware ) Tj ET Q q 0 0 0 rg BT 394.06 678.25 Td (in ) Tj ET Q q 0 0 0 rg BT 403.53 678.25 Td (August ) Tj ET Q q 0 0 0 rg BT 434.59 678.25 Td (1933 ) Tj ET Q q 0 0 0 rg BT 456.75 678.25 Td (under ) Tj ET Q q 0 0 0 rg BT 481.69 678.25 Td (the ) Tj ET Q q 0 0 0 rg BT 496.07 678.25 Td (name ) Tj ET Q q 0 0 0 rg BT 519.89 678.25 Td (Bristol-Myers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 666.25 Td (Company) Tj ET Q q 0 0 0 rg BT 74.24 666.25 Td (, ) Tj ET Q q 0 0 0 rg BT 79.76 666.25 Td (as ) Tj ET Q q 0 0 0 rg BT 91.12 666.25 Td (successor ) Tj ET Q q 0 0 0 rg BT 132.46 666.25 Td (to ) Tj ET Q q 0 0 0 rg BT 143.26 666.25 Td (a ) Tj ET Q q 0 0 0 rg BT 150.72 666.25 Td (New ) Tj ET Q q 0 0 0 rg BT 172.18 666.25 Td (Y) Tj ET Q q 0 0 0 rg BT 178.40 666.25 Td (ork ) Tj ET Q q 0 0 0 rg BT 194.76 666.25 Td (business ) Tj ET Q q 0 0 0 rg BT 231.67 666.25 Td (started ) Tj ET Q q 0 0 0 rg BT 261.35 666.25 Td (in ) Tj ET Q q 0 0 0 rg BT 272.15 666.25 Td (1887. ) Tj ET Q q 0 0 0 rg BT 297.68 666.25 Td (In ) Tj ET Q q 0 0 0 rg BT 309.03 666.25 Td (1989, ) Tj ET Q q 0 0 0 rg BT 334.55 666.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 393.69 666.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 435.60 666.25 Td (changed ) Tj ET Q q 0 0 0 rg BT 471.94 666.25 Td (its ) Tj ET Q q 0 0 0 rg BT 484.41 666.25 Td (name ) Tj ET Q q 0 0 0 rg BT 509.09 666.25 Td (to ) Tj ET Q q 0 0 0 rg BT 519.89 666.25 Td (Bristol-Myers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 654.25 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 66.17 654.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 106.90 654.25 Td (as ) Tj ET Q q 0 0 0 rg BT 117.06 654.25 Td (a ) Tj ET Q q 0 0 0 rg BT 123.33 654.25 Td (result ) Tj ET Q q 0 0 0 rg BT 147.39 654.25 Td (of ) Tj ET Q q 0 0 0 rg BT 157.55 654.25 Td (a ) Tj ET Q q 0 0 0 rg BT 163.83 654.25 Td (mer) Tj ET Q q 0 0 0 rg BT 179.19 654.25 Td (ger) Tj ET Q q 0 0 0 rg BT 191.41 654.25 Td (. ) Tj ET Q q 0 0 0 rg BT 195.61 654.25 Td (W) Tj ET Q q 0 0 0 rg BT 204.25 654.25 Td (e ) Tj ET Q q 0 0 0 rg BT 210.52 654.25 Td (are ) Tj ET Q q 0 0 0 rg BT 224.56 654.25 Td (engaged ) Tj ET Q q 0 0 0 rg BT 259.71 654.25 Td (in ) Tj ET Q q 0 0 0 rg BT 269.33 654.25 Td (the ) Tj ET Q q 0 0 0 rg BT 283.38 654.25 Td (discovery) Tj ET Q q 0 0 0 rg BT 321.61 654.25 Td (, ) Tj ET Q q 0 0 0 rg BT 325.94 654.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 381.93 654.25 Td (licensing, ) Tj ET Q q 0 0 0 rg BT 422.37 654.25 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 485.01 654.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 529.89 654.25 Td (distribution ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 642.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.91 642.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 70.93 642.25 Td (of ) Tj ET Q q 0 0 0 rg BT 81.73 642.25 Td (biopharmaceutical ) Tj ET Q q 0 0 0 rg BT 158.06 642.25 Td (products ) Tj ET Q q 0 0 0 rg BT 194.97 642.25 Td (on ) Tj ET Q q 0 0 0 rg BT 207.44 642.25 Td (a ) Tj ET Q q 0 0 0 rg BT 214.35 642.25 Td (global ) Tj ET Q q 0 0 0 rg BT 241.82 642.25 Td (basis. ) Tj ET Q q 0 0 0 rg BT 266.79 642.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 291.47 642.25 Td (to ) Tj ET Q q 0 0 0 rg BT 301.72 642.25 Td (the ) Tj ET Q q 0 0 0 rg BT 316.41 642.25 Td (Summary ) Tj ET Q q 0 0 0 rg BT 357.77 642.25 Td (of ) Tj ET Q q 0 0 0 rg BT 368.02 642.25 Td (Abbreviated ) Tj ET Q q 0 0 0 rg BT 419.74 642.25 Td (T) Tj ET Q q 0 0 0 rg BT 425.15 642.25 Td (erms ) Tj ET Q q 0 0 0 rg BT 447.06 642.25 Td (at ) Tj ET Q q 0 0 0 rg BT 456.75 642.25 Td (the ) Tj ET Q q 0 0 0 rg BT 471.44 642.25 Td (end ) Tj ET Q q 0 0 0 rg BT 488.35 642.25 Td (of ) Tj ET Q q 0 0 0 rg BT 499.15 642.25 Td (this ) Tj ET Q q 0 0 0 rg BT 516.07 642.25 Td (2016 ) Tj ET Q q 0 0 0 rg BT 538.54 642.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 562.69 642.25 Td (10-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 630.25 Td (K ) Tj ET Q q 0 0 0 rg BT 45.72 630.25 Td (for ) Tj ET Q q 0 0 0 rg BT 59.88 630.25 Td (terms ) Tj ET Q q 0 0 0 rg BT 84.60 630.25 Td (used ) Tj ET Q q 0 0 0 rg BT 105.43 630.25 Td (throughout ) Tj ET Q q 0 0 0 rg BT 151.82 630.25 Td (the ) Tj ET Q q 0 0 0 rg BT 166.53 630.25 Td (document.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 606.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 606.25 Td (e ) Tj ET Q q 0 0 0 rg BT 52.97 606.25 Td (operate ) Tj ET Q q 0 0 0 rg BT 86.29 606.25 Td (in ) Tj ET Q q 0 0 0 rg BT 97.97 606.25 Td (one ) Tj ET Q q 0 0 0 rg BT 116.30 606.25 Td (segment—BioPharmaceuticals. ) Tj ET Q q 0 0 0 rg BT 246.00 606.25 Td (For ) Tj ET Q q 0 0 0 rg BT 263.79 606.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 307.67 606.25 Td (information ) Tj ET Q q 0 0 0 rg BT 358.78 606.25 Td (about ) Tj ET Q q 0 0 0 rg BT 384.89 606.25 Td (business ) Tj ET Q q 0 0 0 rg BT 422.68 606.25 Td (segments, ) Tj ET Q q 0 0 0 rg BT 466.29 606.25 Td (refer ) Tj ET Q q 0 0 0 rg BT 489.06 606.25 Td (to ) Tj ET Q q 0 0 0 rg BT 500.73 606.25 Td (“Item ) Tj ET Q q 0 0 0 rg BT 527.39 606.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 538.79 606.25 Td (Financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 594.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.82 594.25 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 116.82 594.25 Td (. ) Tj ET Q q 0 0 0 rg BT 121.82 594.25 Td (Business ) Tj ET Q q 0 0 0 rg BT 159.88 594.25 Td (Segment ) Tj ET Q q 0 0 0 rg BT 197.38 594.25 Td (Information.”) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 570.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 570.25 Td (e ) Tj ET Q q 0 0 0 rg BT 52.15 570.25 Td (compete ) Tj ET Q q 0 0 0 rg BT 89.09 570.25 Td (with ) Tj ET Q q 0 0 0 rg BT 109.93 570.25 Td (other ) Tj ET Q q 0 0 0 rg BT 133.55 570.25 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 179.39 570.25 Td (research-based ) Tj ET Q q 0 0 0 rg BT 241.86 570.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 263.26 570.25 Td (companies, ) Tj ET Q q 0 0 0 rg BT 311.59 570.25 Td (smaller ) Tj ET Q q 0 0 0 rg BT 344.09 570.25 Td (research ) Tj ET Q q 0 0 0 rg BT 380.47 570.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 426.30 570.25 Td (and ) Tj ET Q q 0 0 0 rg BT 443.81 570.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 476.30 570.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 497.70 570.25 Td (manufacturers. ) Tj ET Q q 0 0 0 rg BT 560.46 570.25 Td (Our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 558.25 Td (products ) Tj ET Q q 0 0 0 rg BT 72.82 558.25 Td (are ) Tj ET Q q 0 0 0 rg BT 87.41 558.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 106.46 558.25 Td (worldwide, ) Tj ET Q q 0 0 0 rg BT 154.11 558.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 193.70 558.25 Td (to ) Tj ET Q q 0 0 0 rg BT 203.86 558.25 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 255.94 558.25 Td (retail ) Tj ET Q q 0 0 0 rg BT 278.87 558.25 Td (pharmacies, ) Tj ET Q q 0 0 0 rg BT 329.28 558.25 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 369.72 558.25 Td (government ) Tj ET Q q 0 0 0 rg BT 419.86 558.25 Td (entities ) Tj ET Q q 0 0 0 rg BT 451.12 558.25 Td (and ) Tj ET Q q 0 0 0 rg BT 467.94 558.25 Td (the ) Tj ET Q q 0 0 0 rg BT 482.54 558.25 Td (medical ) Tj ET Q q 0 0 0 rg BT 516.57 558.25 Td (profession. ) Tj ET Q q 0 0 0 rg BT 562.94 558.25 Td (W) Tj ET Q q 0 0 0 rg BT 571.58 558.25 Td (e ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 546.25 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 88.46 546.25 Td (products ) Tj ET Q q 0 0 0 rg BT 125.39 546.25 Td (in ) Tj ET Q q 0 0 0 rg BT 135.67 546.25 Td (the ) Tj ET Q q 0 0 0 rg BT 150.38 546.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 173.15 546.25 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 201.75 546.25 Td (Rico ) Tj ET Q q 0 0 0 rg BT 223.13 546.25 Td (and ) Tj ET Q q 0 0 0 rg BT 240.06 546.25 Td (in ) Tj ET Q q 0 0 0 rg BT 250.33 546.25 Td (five ) Tj ET Q q 0 0 0 rg BT 268.37 546.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 299.74 546.25 Td (countries. ) Tj ET Q q 0 0 0 rg BT 341.39 546.25 Td (Most ) Tj ET Q q 0 0 0 rg BT 364.44 546.25 Td (of ) Tj ET Q q 0 0 0 rg BT 375.27 546.25 Td (our ) Tj ET Q q 0 0 0 rg BT 391.09 546.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 429.12 546.25 Td (come ) Tj ET Q q 0 0 0 rg BT 453.27 546.25 Td (from ) Tj ET Q q 0 0 0 rg BT 475.20 546.25 Td (products ) Tj ET Q q 0 0 0 rg BT 512.13 546.25 Td (in ) Tj ET Q q 0 0 0 rg BT 522.40 546.25 Td (the ) Tj ET Q q 0 0 0 rg BT 537.11 546.25 Td (following ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 534.25 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 82.92 534.25 Td (classes: ) Tj ET Q q 0 0 0 rg BT 115.97 534.25 Td (oncology; ) Tj ET Q q 0 0 0 rg BT 158.46 534.25 Td (cardiovascular; ) Tj ET Q q 0 0 0 rg BT 222.04 534.25 Td (immunoscience; ) Tj ET Q q 0 0 0 rg BT 290.08 534.25 Td (and ) Tj ET Q q 0 0 0 rg BT 307.02 534.25 Td (virology) Tj ET Q q 0 0 0 rg BT 340.25 534.25 Td (, ) Tj ET Q q 0 0 0 rg BT 345.25 534.25 Td (including ) Tj ET Q q 0 0 0 rg BT 385.53 534.25 Td (HIV) Tj ET Q q 0 0 0 rg BT 403.12 534.25 Td ( ) Tj ET Q q 0 0 0 rg BT 405.62 534.25 Td (infection.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 510.25 Td (The percentage of revenues by significant region/country were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 473.75 318.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 473.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 473.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 473.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 473.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 473.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 473.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 447.75 318.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 447.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 447.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 447.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 447.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 447.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 447.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 421.75 318.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 421.75 4.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 421.75 69.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 421.75 4.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 421.75 69.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 421.75 4.00 -4.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 421.75 70.00 -4.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 358.5 486.75 m 427.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 486.75 m 431.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 486.75 m 500.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 486.75 m 504.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504.5 486.75 m 574.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 358.5 486.75 m 427.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 358.5 473.75 m 427.5 473.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 486.75 m 431.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 486.75 m 500.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 473.75 m 500.5 473.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 486.75 m 504.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504.5 486.75 m 574.5 486.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504.5 473.75 m 574.5 473.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 473.75 m 500.5 473.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504.5 473.75 m 574.5 473.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 491.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 490.98 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 478.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.50 477.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 457.50 477.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 531.00 477.98 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 464.32 Td (United States) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 464.32 Td (55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 464.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 464.32 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.65 464.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.65 464.32 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 565.65 464.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 451.32 Td (Europe) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 451.32 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 451.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 451.32 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.65 451.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.65 451.32 Td (23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 565.65 451.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 438.32 Td (Japan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 438.32 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 438.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 438.32 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.65 438.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.65 438.32 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 565.65 438.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 425.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 425.32 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 425.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 425.32 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.65 425.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.65 425.32 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 565.65 425.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 408.32 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 361.00 408.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.15 408.32 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 408.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.15 408.32 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.00 408.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 538.15 408.32 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 381.25 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 91.29 381.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.92 381.25 Td (Divestitur) Tj ET Q q 0 0 0 rg BT 152.50 381.25 Td (es) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 357.25 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 89.15 357.25 Td (in ) Tj ET Q q 0 0 0 rg BT 99.53 357.25 Td (the ) Tj ET Q q 0 0 0 rg BT 114.34 357.25 Td (last ) Tj ET Q q 0 0 0 rg BT 130.83 357.25 Td (five ) Tj ET Q q 0 0 0 rg BT 148.97 357.25 Td (years ) Tj ET Q q 0 0 0 rg BT 172.67 357.25 Td (include ) Tj ET Q q 0 0 0 rg BT 204.70 357.25 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 250.62 357.25 Td (and ) Tj ET Q q 0 0 0 rg BT 267.66 357.25 Td (Padlock ) Tj ET Q q 0 0 0 rg BT 302.47 357.25 Td (in ) Tj ET Q q 0 0 0 rg BT 312.85 357.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 337.95 357.25 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 380.54 357.25 Td (and ) Tj ET Q q 0 0 0 rg BT 397.58 357.25 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 426.84 357.25 Td (in ) Tj ET Q q 0 0 0 rg BT 437.22 357.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 462.32 357.25 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 496.02 357.25 Td (in ) Tj ET Q q 0 0 0 rg BT 506.40 357.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 528.99 357.25 Td (and ) Tj ET Q q 0 0 0 rg BT 545.46 357.25 Td (Amylin ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 345.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.21 345.25 Td (Inhibitex ) Tj ET Q q 0 0 0 rg BT 92.09 345.25 Td (in ) Tj ET Q q 0 0 0 rg BT 102.64 345.25 Td (2012 ) Tj ET Q q 0 0 0 rg BT 125.41 345.25 Td (and ) Tj ET Q q 0 0 0 rg BT 142.63 345.25 Td (we ) Tj ET Q q 0 0 0 rg BT 157.06 345.25 Td (also ) Tj ET Q q 0 0 0 rg BT 175.94 345.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 208.14 345.25 Td (into ) Tj ET Q q 0 0 0 rg BT 226.47 345.25 Td (several ) Tj ET Q q 0 0 0 rg BT 257.56 345.25 Td (license ) Tj ET Q q 0 0 0 rg BT 288.09 345.25 Td (and ) Tj ET Q q 0 0 0 rg BT 305.31 345.25 Td (other ) Tj ET Q q 0 0 0 rg BT 328.63 345.25 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 384.16 345.25 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 443.29 345.25 Td (Divestitures ) Tj ET Q q 0 0 0 rg BT 494.39 345.25 Td (in ) Tj ET Q q 0 0 0 rg BT 504.95 345.25 Td (the ) Tj ET Q q 0 0 0 rg BT 519.94 345.25 Td (last ) Tj ET Q q 0 0 0 rg BT 536.60 345.25 Td (five ) Tj ET Q q 0 0 0 rg BT 554.92 345.25 Td (years ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 333.25 Td (include ) Tj ET Q q 0 0 0 rg BT 67.72 333.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 97.20 333.25 Td (OTC ) Tj ET Q q 0 0 0 rg BT 119.49 333.25 Td (products ) Tj ET Q q 0 0 0 rg BT 156.21 333.25 Td (and ) Tj ET Q q 0 0 0 rg BT 172.93 333.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 234.09 333.25 Td (HIV) Tj ET Q q 0 0 0 rg BT 251.69 333.25 Td ( ) Tj ET Q q 0 0 0 rg BT 253.97 333.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 296.80 333.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 341.30 333.25 Td (in ) Tj ET Q q 0 0 0 rg BT 351.37 333.25 Td (2016, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 376.15 333.25 Td (Erbitux* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.43 333.25 Td (in ) Tj ET Q q 0 0 0 rg BT 423.49 333.25 Td (North ) Tj ET Q q 0 0 0 rg BT 448.60 333.25 Td (America ) Tj ET Q q 0 0 0 rg BT 485.31 333.25 Td (and ) Tj ET Q q 0 0 0 rg BT 502.03 333.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 531.52 333.25 Td (mature ) Tj ET Q q 0 0 0 rg BT 561.57 333.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 321.25 Td (other ) Tj ET Q q 0 0 0 rg BT 58.88 321.25 Td (OTC ) Tj ET Q q 0 0 0 rg BT 81.20 321.25 Td (product ) Tj ET Q q 0 0 0 rg BT 114.08 321.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 158.63 321.25 Td (in ) Tj ET Q q 0 0 0 rg BT 168.73 321.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 191.06 321.25 Td (and ) Tj ET Q q 0 0 0 rg BT 207.83 321.25 Td (our ) Tj ET Q q 0 0 0 rg BT 223.49 321.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 258.58 321.25 Td (business ) Tj ET Q q 0 0 0 rg BT 294.80 321.25 Td (in ) Tj ET Q q 0 0 0 rg BT 304.91 321.25 Td (2014. ) Tj ET Q q 0 0 0 rg BT 329.56 321.25 Td (These ) Tj ET Q q 0 0 0 rg BT 355.77 321.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 405.86 321.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 442.62 321.25 Td (to ) Tj ET Q q 0 0 0 rg BT 452.73 321.25 Td (allow ) Tj ET Q q 0 0 0 rg BT 477.27 321.25 Td (us ) Tj ET Q q 0 0 0 rg BT 488.49 321.25 Td (to ) Tj ET Q q 0 0 0 rg BT 498.60 321.25 Td (focus ) Tj ET Q q 0 0 0 rg BT 522.59 321.25 Td (our ) Tj ET Q q 0 0 0 rg BT 538.25 321.25 Td (resources ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 309.25 Td (behind ) Tj ET Q q 0 0 0 rg BT 65.72 309.25 Td (growth ) Tj ET Q q 0 0 0 rg BT 96.55 309.25 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 151.82 309.25 Td (which ) Tj ET Q q 0 0 0 rg BT 178.76 309.25 Td (drive ) Tj ET Q q 0 0 0 rg BT 201.81 309.25 Td (the ) Tj ET Q q 0 0 0 rg BT 216.52 309.25 Td (greatest ) Tj ET Q q 0 0 0 rg BT 250.12 309.25 Td (long-term ) Tj ET Q q 0 0 0 rg BT 292.05 309.25 Td (value.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 285.25 Td (Pr) Tj ET Q q 0 0 0 rg BT 46.37 285.25 Td (oducts, Intellectual Pr) Tj ET Q q 0 0 0 rg BT 140.34 285.25 Td (operty and Pr) Tj ET Q q 0 0 0 rg BT 199.60 285.25 Td (oduct Exclusivity) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 261.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.09 261.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 115.71 261.25 Td (products ) Tj ET Q q 0 0 0 rg BT 151.69 261.25 Td (include ) Tj ET Q q 0 0 0 rg BT 182.66 261.25 Td (chemically-synthesized ) Tj ET Q q 0 0 0 rg BT 278.05 261.25 Td (drugs, ) Tj ET Q q 0 0 0 rg BT 304.32 261.25 Td (or ) Tj ET Q q 0 0 0 rg BT 314.19 261.25 Td (small ) Tj ET Q q 0 0 0 rg BT 337.39 261.25 Td (molecules, ) Tj ET Q q 0 0 0 rg BT 381.97 261.25 Td (and ) Tj ET Q q 0 0 0 rg BT 397.95 261.25 Td (products ) Tj ET Q q 0 0 0 rg BT 433.93 261.25 Td (produced ) Tj ET Q q 0 0 0 rg BT 472.68 261.25 Td (from ) Tj ET Q q 0 0 0 rg BT 493.66 261.25 Td (biological ) Tj ET Q q 0 0 0 rg BT 535.19 261.25 Td (processes, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 249.25 Td (called ) Tj ET Q q 0 0 0 rg BT 61.76 249.25 Td (“biologics.” ) Tj ET Q q 0 0 0 rg BT 111.70 249.25 Td (Small ) Tj ET Q q 0 0 0 rg BT 136.92 249.25 Td (molecule ) Tj ET Q q 0 0 0 rg BT 175.46 249.25 Td (drugs ) Tj ET Q q 0 0 0 rg BT 199.58 249.25 Td (are ) Tj ET Q q 0 0 0 rg BT 213.67 249.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 250.56 249.25 Td (administered ) Tj ET Q q 0 0 0 rg BT 304.10 249.25 Td (orally) Tj ET Q q 0 0 0 rg BT 326.77 249.25 Td (, ) Tj ET Q q 0 0 0 rg BT 331.16 249.25 Td (e.g., ) Tj ET Q q 0 0 0 rg BT 349.99 249.25 Td (in ) Tj ET Q q 0 0 0 rg BT 359.66 249.25 Td (the ) Tj ET Q q 0 0 0 rg BT 373.77 249.25 Td (form ) Tj ET Q q 0 0 0 rg BT 395.10 249.25 Td (of ) Tj ET Q q 0 0 0 rg BT 405.32 249.25 Td (a ) Tj ET Q q 0 0 0 rg BT 411.65 249.25 Td (pill ) Tj ET Q q 0 0 0 rg BT 426.88 249.25 Td (or ) Tj ET Q q 0 0 0 rg BT 437.10 249.25 Td (tablet, ) Tj ET Q q 0 0 0 rg BT 463.70 249.25 Td (although ) Tj ET Q q 0 0 0 rg BT 500.59 249.25 Td (other ) Tj ET Q q 0 0 0 rg BT 523.03 249.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 543.25 249.25 Td (delivery ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 237.25 Td (mechanisms ) Tj ET Q q 0 0 0 rg BT 87.93 237.25 Td (are ) Tj ET Q q 0 0 0 rg BT 102.64 237.25 Td (used ) Tj ET Q q 0 0 0 rg BT 123.47 237.25 Td (as ) Tj ET Q q 0 0 0 rg BT 134.30 237.25 Td (well. ) Tj ET Q q 0 0 0 rg BT 156.52 237.25 Td (Biologics ) Tj ET Q q 0 0 0 rg BT 197.35 237.25 Td (are ) Tj ET Q q 0 0 0 rg BT 212.06 237.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 249.55 237.25 Td (administered ) Tj ET Q q 0 0 0 rg BT 303.70 237.25 Td (to ) Tj ET Q q 0 0 0 rg BT 313.98 237.25 Td (patients ) Tj ET Q q 0 0 0 rg BT 347.58 237.25 Td (through ) Tj ET Q q 0 0 0 rg BT 381.19 237.25 Td (injections ) Tj ET Q q 0 0 0 rg BT 422.57 237.25 Td (or ) Tj ET Q q 0 0 0 rg BT 433.40 237.25 Td (by ) Tj ET Q q 0 0 0 rg BT 445.90 237.25 Td (intravenous ) Tj ET Q q 0 0 0 rg BT 495.06 237.25 Td (infusion. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 213.25 Td (Below ) Tj ET Q q 0 0 0 rg BT 64.90 213.25 Td (is ) Tj ET Q q 0 0 0 rg BT 74.36 213.25 Td (a ) Tj ET Q q 0 0 0 rg BT 81.59 213.25 Td (product ) Tj ET Q q 0 0 0 rg BT 114.93 213.25 Td (summary ) Tj ET Q q 0 0 0 rg BT 154.94 213.25 Td (including ) Tj ET Q q 0 0 0 rg BT 195.51 213.25 Td (approved ) Tj ET Q q 0 0 0 rg BT 235.50 213.25 Td (indications. ) Tj ET Q q 0 0 0 rg BT 284.68 213.25 Td (For ) Tj ET Q q 0 0 0 rg BT 301.36 213.25 Td (information ) Tj ET Q q 0 0 0 rg BT 351.37 213.25 Td (about ) Tj ET Q q 0 0 0 rg BT 376.38 213.25 Td (our ) Tj ET Q q 0 0 0 rg BT 392.50 213.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 426.38 213.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 483.03 213.25 Td (for ) Tj ET Q q 0 0 0 rg BT 497.48 213.25 Td (the ) Tj ET Q q 0 0 0 rg BT 512.49 213.25 Td (products ) Tj ET Q q 0 0 0 rg BT 549.72 213.25 Td (below) Tj ET Q q 0 0 0 rg BT 573.51 213.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 201.25 Td (refer ) Tj ET Q q 0 0 0 rg BT 57.37 201.25 Td (to ) Tj ET Q q 0 0 0 rg BT 67.65 201.25 Td (“—Alliances" ) Tj ET Q q 0 0 0 rg BT 126.43 201.25 Td (below ) Tj ET Q q 0 0 0 rg BT 153.37 201.25 Td (and ) Tj ET Q q 0 0 0 rg BT 170.31 201.25 Td ("Item ) Tj ET Q q 0 0 0 rg BT 195.21 201.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 205.21 201.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 244.93 201.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.75 201.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.75 201.25 Td (. ) Tj ET Q q 0 0 0 rg BT 330.19 201.25 Td (Alliances.”) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 183.25 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.66 183.25 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 183.25 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 167.16 183.25 Td (, ) Tj ET Q q 0 0 0 rg BT 172.16 183.25 Td (a ) Tj ET Q q 0 0 0 rg BT 179.10 183.25 Td (biological ) Tj ET Q q 0 0 0 rg BT 221.59 183.25 Td (product, ) Tj ET Q q 0 0 0 rg BT 257.14 183.25 Td (is ) Tj ET Q q 0 0 0 rg BT 266.31 183.25 Td (a ) Tj ET Q q 0 0 0 rg BT 273.24 183.25 Td (humanized ) Tj ET Q q 0 0 0 rg BT 319.62 183.25 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 369.33 183.25 Td (antibody ) Tj ET Q q 0 0 0 rg BT 406.82 183.25 Td (for ) Tj ET Q q 0 0 0 rg BT 420.98 183.25 Td (the ) Tj ET Q q 0 0 0 rg BT 435.70 183.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 475.96 183.25 Td (of ) Tj ET Q q 0 0 0 rg BT 486.79 183.25 Td (multiple ) Tj ET Q q 0 0 0 rg BT 522.62 183.25 Td (myeloma. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 165.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.44 165.25 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 165.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.94 165.25 Td (, ) Tj ET Q q 0 0 0 rg BT 164.94 165.25 Td (a ) Tj ET Q q 0 0 0 rg BT 171.88 165.25 Td (biological ) Tj ET Q q 0 0 0 rg BT 214.37 165.25 Td (product, ) Tj ET Q q 0 0 0 rg BT 249.92 165.25 Td (is ) Tj ET Q q 0 0 0 rg BT 259.09 165.25 Td (a ) Tj ET Q q 0 0 0 rg BT 266.03 165.25 Td (fully ) Tj ET Q q 0 0 0 rg BT 287.42 165.25 Td (human ) Tj ET Q q 0 0 0 rg BT 317.14 165.25 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 366.85 165.25 Td (antibody ) Tj ET Q q 0 0 0 rg BT 404.35 165.25 Td (that ) Tj ET Q q 0 0 0 rg BT 421.84 165.25 Td (binds ) Tj ET Q q 0 0 0 rg BT 446.02 165.25 Td (to ) Tj ET Q q 0 0 0 rg BT 456.30 165.25 Td (the ) Tj ET Q q 0 0 0 rg BT 471.01 165.25 Td (PD-1 ) Tj ET Q q 0 0 0 rg BT 494.63 165.25 Td (on ) Tj ET Q q 0 0 0 rg BT 506.95 165.25 Td (T) Tj ET Q q 0 0 0 rg BT 512.88 165.25 Td ( ) Tj ET Q q 0 0 0 rg BT 515.38 165.25 Td (and ) Tj ET Q q 0 0 0 rg BT 532.32 165.25 Td (NKT) Tj ET Q q 0 0 0 rg BT 552.69 165.25 Td ( ) Tj ET Q q 0 0 0 rg BT 555.19 165.25 Td (cells. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 153.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.94 153.25 Td ( ) Tj ET Q q 0 0 0 rg BT 161.59 153.25 Td (has ) Tj ET Q q 0 0 0 rg BT 176.58 153.25 Td (received ) Tj ET Q q 0 0 0 rg BT 212.09 153.25 Td (approvals ) Tj ET Q q 0 0 0 rg BT 252.63 153.25 Td (for ) Tj ET Q q 0 0 0 rg BT 265.94 153.25 Td (several ) Tj ET Q q 0 0 0 rg BT 295.91 153.25 Td (indications ) Tj ET Q q 0 0 0 rg BT 341.45 153.25 Td (including ) Tj ET Q q 0 0 0 rg BT 380.87 153.25 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 426.68 153.25 Td (head ) Tj ET Q q 0 0 0 rg BT 447.21 153.25 Td (and ) Tj ET Q q 0 0 0 rg BT 463.30 153.25 Td (neck, ) Tj ET Q q 0 0 0 rg BT 486.33 153.25 Td (lung, ) Tj ET Q q 0 0 0 rg BT 508.27 153.25 Td (kidney ) Tj ET Q q 0 0 0 rg BT 537.14 153.25 Td (and ) Tj ET Q q 0 0 0 rg BT 553.23 153.25 Td (blood ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 141.25 Td (cancer) Tj ET Q q 0 0 0 rg BT 156.03 141.25 Td (. ) Tj ET Q q 0 0 0 rg BT 160.85 141.25 Td (The ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 178.89 141.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 208.33 141.25 Td (+) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 213.96 141.25 Td (Y) Tj ET Q q 0 0 0 rg BT 218.61 141.25 Td (ervoy ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 243.31 141.25 Td (regimen ) Tj ET Q q 0 0 0 rg BT 278.57 141.25 Td (also ) Tj ET Q q 0 0 0 rg BT 297.17 141.25 Td (is ) Tj ET Q q 0 0 0 rg BT 306.33 141.25 Td (approved ) Tj ET Q q 0 0 0 rg BT 346.04 141.25 Td (in ) Tj ET Q q 0 0 0 rg BT 356.31 141.25 Td (multiple ) Tj ET Q q 0 0 0 rg BT 392.13 141.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 426.28 141.25 Td (for ) Tj ET Q q 0 0 0 rg BT 440.44 141.25 Td (the ) Tj ET Q q 0 0 0 rg BT 455.15 141.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 495.40 141.25 Td (of ) Tj ET Q q 0 0 0 rg BT 506.22 141.25 Td (melanoma. ) Tj ET Q q 0 0 0 rg BT 552.69 141.25 Td (There ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 129.25 Td (are ) Tj ET Q q 0 0 0 rg BT 145.21 129.25 Td (several ) Tj ET Q q 0 0 0 rg BT 176.02 129.25 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 211.30 129.25 Td (potentially ) Tj ET Q q 0 0 0 rg BT 256.57 129.25 Td (registrational ) Tj ET Q q 0 0 0 rg BT 311.83 129.25 Td (trials ) Tj ET Q q 0 0 0 rg BT 334.32 129.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 348.48 129.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 377.92 129.25 Td ( ) Tj ET Q q 0 0 0 rg BT 380.42 129.25 Td (across ) Tj ET Q q 0 0 0 rg BT 407.91 129.25 Td (other ) Tj ET Q q 0 0 0 rg BT 430.96 129.25 Td (tumor ) Tj ET Q q 0 0 0 rg BT 457.35 129.25 Td (types ) Tj ET Q q 0 0 0 rg BT 480.95 129.25 Td (and ) Tj ET Q q 0 0 0 rg BT 497.89 129.25 Td (other ) Tj ET Q q 0 0 0 rg BT 520.94 129.25 Td (disease ) Tj ET Q q 0 0 0 rg BT 552.32 129.25 Td (areas.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 111.25 Td (Sprycel ) Tj ET Q q 0 0 0 rg BT 130.50 111.25 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 160.49 111.25 Td ( ) Tj ET Q q 0 0 0 rg BT 161.98 111.25 Td (is ) Tj ET Q q 0 0 0 rg BT 170.15 111.25 Td (a ) Tj ET Q q 0 0 0 rg BT 176.09 111.25 Td (multi-tar) Tj ET Q q 0 0 0 rg BT 210.90 111.25 Td (geted ) Tj ET Q q 0 0 0 rg BT 234.05 111.25 Td (tyrosine ) Tj ET Q q 0 0 0 rg BT 267.77 111.25 Td (kinase ) Tj ET Q q 0 0 0 rg BT 294.82 111.25 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 330.76 111.25 Td (approved ) Tj ET Q q 0 0 0 rg BT 369.46 111.25 Td (for ) Tj ET Q q 0 0 0 rg BT 382.62 111.25 Td (the ) Tj ET Q q 0 0 0 rg BT 396.34 111.25 Td (first-line ) Tj ET Q q 0 0 0 rg BT 432.27 111.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 471.53 111.25 Td (of ) Tj ET Q q 0 0 0 rg BT 481.36 111.25 Td (adults ) Tj ET Q q 0 0 0 rg BT 506.75 111.25 Td (with ) Tj ET Q q 0 0 0 rg BT 526.02 111.25 Td (Philadelphia ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 99.25 Td (chromosome-positive ) Tj ET Q q 0 0 0 rg BT 221.15 99.25 Td (chronic ) Tj ET Q q 0 0 0 rg BT 255.14 99.25 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 291.91 99.25 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 332.56 99.25 Td (in ) Tj ET Q q 0 0 0 rg BT 344.34 99.25 Td (chronic ) Tj ET Q q 0 0 0 rg BT 378.33 99.25 Td (phase ) Tj ET Q q 0 0 0 rg BT 405.10 99.25 Td (and ) Tj ET Q q 0 0 0 rg BT 423.54 99.25 Td (the ) Tj ET Q q 0 0 0 rg BT 439.76 99.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 481.52 99.25 Td (of ) Tj ET Q q 0 0 0 rg BT 493.85 99.25 Td (adults ) Tj ET Q q 0 0 0 rg BT 521.73 99.25 Td (with ) Tj ET Q q 0 0 0 rg BT 543.51 99.25 Td (chronic, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 87.25 Td (accelerated, ) Tj ET Q q 0 0 0 rg BT 180.09 87.25 Td (or ) Tj ET Q q 0 0 0 rg BT 190.56 87.25 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 225.47 87.25 Td (or ) Tj ET Q q 0 0 0 rg BT 235.93 87.25 Td (lymphoid ) Tj ET Q q 0 0 0 rg BT 276.41 87.25 Td (blast ) Tj ET Q q 0 0 0 rg BT 297.43 87.25 Td (phase ) Tj ET Q q 0 0 0 rg BT 322.33 87.25 Td (chronic ) Tj ET Q q 0 0 0 rg BT 354.46 87.25 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 389.36 87.25 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 428.15 87.25 Td (with ) Tj ET Q q 0 0 0 rg BT 448.07 87.25 Td (resistance ) Tj ET Q q 0 0 0 rg BT 489.63 87.25 Td (or ) Tj ET Q q 0 0 0 rg BT 500.09 87.25 Td (intolerance ) Tj ET Q q 0 0 0 rg BT 546.65 87.25 Td (to ) Tj ET Q q 0 0 0 rg BT 556.56 87.25 Td (prior ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 75.25 Td (therapy) Tj ET Q q 0 0 0 rg BT 159.84 75.25 Td (, ) Tj ET Q q 0 0 0 rg BT 164.84 75.25 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 205.11 75.25 Td (Gleevec* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 244.80 75.25 Td (\(imatinib ) Tj ET Q q 0 0 0 rg BT 283.96 75.25 Td (mesylate\). ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 57.25 Td (Y) Tj ET Q q 0 0 0 rg BT 40.64 57.25 Td (ervoy ) Tj ET Q q 0 0 0 rg BT 130.50 57.25 Td (Y) Tj ET Q q 0 0 0 rg BT 135.14 57.25 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.35 57.25 Td (, ) Tj ET Q q 0 0 0 rg BT 161.48 57.25 Td (a ) Tj ET Q q 0 0 0 rg BT 167.55 57.25 Td (biological ) Tj ET Q q 0 0 0 rg BT 209.16 57.25 Td (product, ) Tj ET Q q 0 0 0 rg BT 243.84 57.25 Td (is ) Tj ET Q q 0 0 0 rg BT 252.14 57.25 Td (a ) Tj ET Q q 0 0 0 rg BT 258.21 57.25 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 307.05 57.25 Td (antibody ) Tj ET Q q 0 0 0 rg BT 343.67 57.25 Td (for ) Tj ET Q q 0 0 0 rg BT 356.96 57.25 Td (the ) Tj ET Q q 0 0 0 rg BT 370.80 57.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 410.19 57.25 Td (of ) Tj ET Q q 0 0 0 rg BT 420.15 57.25 Td (patients ) Tj ET Q q 0 0 0 rg BT 452.88 57.25 Td (with ) Tj ET Q q 0 0 0 rg BT 472.29 57.25 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 523.89 57.25 Td ( ) Tj ET Q q 0 0 0 rg BT 525.51 57.25 Td (or ) Tj ET Q q 0 0 0 rg BT 535.47 57.25 Td (metastatic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 45.25 Td (melanoma. ) Tj ET Q endstream endobj 9 0 obj <> endobj 10 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (4) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Eliquis ) Tj ET Q q 0 0 0 rg BT 130.50 749.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 158.83 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 161.92 749.10 Td (is ) Tj ET Q q 0 0 0 rg BT 171.68 749.10 Td (an ) Tj ET Q q 0 0 0 rg BT 184.21 749.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 202.84 749.10 Td (Factor ) Tj ET Q q 0 0 0 rg BT 231.47 749.10 Td (Xa ) Tj ET Q q 0 0 0 rg BT 246.22 749.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 283.75 749.10 Td (tar) Tj ET Q q 0 0 0 rg BT 294.12 749.10 Td (geted ) Tj ET Q q 0 0 0 rg BT 318.86 749.10 Td (at ) Tj ET Q q 0 0 0 rg BT 329.17 749.10 Td (stroke ) Tj ET Q q 0 0 0 rg BT 356.69 749.10 Td (prevention ) Tj ET Q q 0 0 0 rg BT 402.54 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 413.41 749.10 Td (atrial ) Tj ET Q q 0 0 0 rg BT 437.04 749.10 Td (fibrillation ) Tj ET Q q 0 0 0 rg BT 482.89 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 500.42 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 515.72 749.10 Td (prevention ) Tj ET Q q 0 0 0 rg BT 561.57 749.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 737.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 170.76 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 181.41 737.10 Td (VTE ) Tj ET Q q 0 0 0 rg BT 203.35 737.10 Td (disorders. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 719.10 Td (Or) Tj ET Q q 0 0 0 rg BT 46.74 719.10 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.40 719.10 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 719.10 Td (Or) Tj ET Q q 0 0 0 rg BT 141.24 719.10 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 162.90 719.10 Td (, ) Tj ET Q q 0 0 0 rg BT 167.29 719.10 Td (a ) Tj ET Q q 0 0 0 rg BT 173.62 719.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 215.50 719.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 250.44 719.10 Td (is ) Tj ET Q q 0 0 0 rg BT 259.00 719.10 Td (a ) Tj ET Q q 0 0 0 rg BT 265.33 719.10 Td (fusion ) Tj ET Q q 0 0 0 rg BT 292.23 719.10 Td (protein ) Tj ET Q q 0 0 0 rg BT 322.44 719.10 Td (with ) Tj ET Q q 0 0 0 rg BT 342.11 719.10 Td (novel ) Tj ET Q q 0 0 0 rg BT 366.22 719.10 Td (immunosuppressive ) Tj ET Q q 0 0 0 rg BT 448.11 719.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 479.99 719.10 Td (tar) Tj ET Q q 0 0 0 rg BT 490.36 719.10 Td (geted ) Tj ET Q q 0 0 0 rg BT 513.91 719.10 Td (initially ) Tj ET Q q 0 0 0 rg BT 546.91 719.10 Td (at ) Tj ET Q q 0 0 0 rg BT 556.02 719.10 Td (adult ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 707.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 163.35 707.10 Td (with ) Tj ET Q q 0 0 0 rg BT 182.87 707.10 Td (moderately ) Tj ET Q q 0 0 0 rg BT 229.59 707.10 Td (to ) Tj ET Q q 0 0 0 rg BT 239.11 707.10 Td (severely ) Tj ET Q q 0 0 0 rg BT 274.17 707.10 Td (active ) Tj ET Q q 0 0 0 rg BT 299.79 707.10 Td (RA) Tj ET Q q 0 0 0 rg BT 313.13 707.10 Td ( ) Tj ET Q q 0 0 0 rg BT 314.87 707.10 Td (who ) Tj ET Q q 0 0 0 rg BT 333.83 707.10 Td (have ) Tj ET Q q 0 0 0 rg BT 354.46 707.10 Td (had ) Tj ET Q q 0 0 0 rg BT 370.64 707.10 Td (an ) Tj ET Q q 0 0 0 rg BT 381.82 707.10 Td (inadequate ) Tj ET Q q 0 0 0 rg BT 426.87 707.10 Td (response ) Tj ET Q q 0 0 0 rg BT 463.61 707.10 Td (to ) Tj ET Q q 0 0 0 rg BT 473.13 707.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 502.07 707.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 539.91 707.10 Td (available ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 695.10 Td (treatments. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (Baraclude ) Tj ET Q q 0 0 0 rg BT 130.50 677.10 Td (Baraclude) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 172.16 677.10 Td ( ) Tj ET Q q 0 0 0 rg BT 174.66 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 183.83 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 190.76 677.10 Td (potent ) Tj ET Q q 0 0 0 rg BT 218.26 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 235.20 677.10 Td (selective ) Tj ET Q q 0 0 0 rg BT 272.68 677.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 309.62 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 320.45 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 335.17 677.10 Td (hepatitis ) Tj ET Q q 0 0 0 rg BT 371.55 677.10 Td (B ) Tj ET Q q 0 0 0 rg BT 380.72 677.10 Td (virus. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 659.10 Td (Hepatitis ) Tj ET Q q 0 0 0 rg BT 74.60 659.10 Td (C ) Tj ET Q q 0 0 0 rg BT 83.77 659.10 Td (Franchise ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 659.10 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 166.61 659.10 Td ( ) Tj ET Q q 0 0 0 rg BT 168.98 659.10 Td (\(daclatasvir ) Tj ET Q q 0 0 0 rg BT 218.00 659.10 Td (\(DCV\)\) ) Tj ET Q q 0 0 0 rg BT 251.48 659.10 Td (is ) Tj ET Q q 0 0 0 rg BT 260.52 659.10 Td (an ) Tj ET Q q 0 0 0 rg BT 272.34 659.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 290.26 659.10 Td (small ) Tj ET Q q 0 0 0 rg BT 314.30 659.10 Td (molecule ) Tj ET Q q 0 0 0 rg BT 353.33 659.10 Td (NS5A) Tj ET Q q 0 0 0 rg BT 377.78 659.10 Td ( ) Tj ET Q q 0 0 0 rg BT 380.16 659.10 Td (replication ) Tj ET Q q 0 0 0 rg BT 425.29 659.10 Td (complex ) Tj ET Q q 0 0 0 rg BT 462.10 659.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 498.92 659.10 Td (for ) Tj ET Q q 0 0 0 rg BT 512.95 659.10 Td (the ) Tj ET Q q 0 0 0 rg BT 527.55 659.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 567.68 659.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 647.10 Td (HCV) Tj ET Q q 0 0 0 rg BT 151.43 647.10 Td ( ) Tj ET Q q 0 0 0 rg BT 153.93 647.10 Td (and ) Tj ET Q q 0 0 0 rg BT 170.87 647.10 Td (was ) Tj ET Q q 0 0 0 rg BT 188.92 647.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 228.63 647.10 Td (for ) Tj ET Q q 0 0 0 rg BT 242.79 647.10 Td (use ) Tj ET Q q 0 0 0 rg BT 258.62 647.10 Td (with ) Tj ET Q q 0 0 0 rg BT 278.90 647.10 Td (Gilead's ) Tj ET Q q 0 0 0 rg BT 313.75 647.10 Td (sofosbuvir) Tj ET Q q 0 0 0 rg BT 355.42 647.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 629.10 Td (Sunvepra ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 170.64 629.10 Td (\(asunaprevir ) Tj ET Q q 0 0 0 rg BT 222.98 629.10 Td (\(ASV\)\) ) Tj ET Q q 0 0 0 rg BT 255.34 629.10 Td (is ) Tj ET Q q 0 0 0 rg BT 264.38 629.10 Td (an ) Tj ET Q q 0 0 0 rg BT 276.18 629.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 294.10 629.10 Td (small ) Tj ET Q q 0 0 0 rg BT 318.13 629.10 Td (molecule ) Tj ET Q q 0 0 0 rg BT 357.15 629.10 Td (NS3 ) Tj ET Q q 0 0 0 rg BT 377.30 629.10 Td (protease ) Tj ET Q q 0 0 0 rg BT 412.98 629.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 449.79 629.10 Td (for ) Tj ET Q q 0 0 0 rg BT 463.82 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 478.40 629.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 518.53 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 529.23 629.10 Td (HCV) Tj ET Q q 0 0 0 rg BT 550.16 629.10 Td ( ) Tj ET Q q 0 0 0 rg BT 552.53 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 569.33 629.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 617.10 Td (part ) Tj ET Q q 0 0 0 rg BT 148.55 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 159.38 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 174.09 617.10 Td (dual ) Tj ET Q q 0 0 0 rg BT 193.81 617.10 Td (regimen ) Tj ET Q q 0 0 0 rg BT 229.07 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 239.90 617.10 Td (DCV+ASV) Tj ET Q q 0 0 0 rg BT 286.48 617.10 Td ( ) Tj ET Q q 0 0 0 rg BT 288.98 617.10 Td (in ) Tj ET Q q 0 0 0 rg BT 299.26 617.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 324.53 617.10 Td (which ) Tj ET Q q 0 0 0 rg BT 351.47 617.10 Td (is ) Tj ET Q q 0 0 0 rg BT 360.64 617.10 Td (also ) Tj ET Q q 0 0 0 rg BT 379.25 617.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 417.84 617.10 Td (in ) Tj ET Q q 0 0 0 rg BT 428.12 617.10 Td (registration ) Tj ET Q q 0 0 0 rg BT 476.16 617.10 Td (in ) Tj ET Q q 0 0 0 rg BT 486.44 617.10 Td (China.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 599.10 Td (Beclabuvir ) Tj ET Q q 0 0 0 rg BT 176.54 599.10 Td (\(BCV\) ) Tj ET Q q 0 0 0 rg BT 205.93 599.10 Td (is ) Tj ET Q q 0 0 0 rg BT 214.77 599.10 Td (an ) Tj ET Q q 0 0 0 rg BT 226.38 599.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 244.10 599.10 Td (small ) Tj ET Q q 0 0 0 rg BT 267.94 599.10 Td (molecule ) Tj ET Q q 0 0 0 rg BT 306.76 599.10 Td (non-nucleoside ) Tj ET Q q 0 0 0 rg BT 370.02 599.10 Td (NS5B ) Tj ET Q q 0 0 0 rg BT 396.65 599.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 433.26 599.10 Td (for ) Tj ET Q q 0 0 0 rg BT 447.09 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 461.48 599.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 501.41 599.10 Td (of ) Tj ET Q q 0 0 0 rg BT 511.91 599.10 Td (HCV) Tj ET Q q 0 0 0 rg BT 532.84 599.10 Td ( ) Tj ET Q q 0 0 0 rg BT 535.01 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 551.62 599.10 Td (is ) Tj ET Q q 0 0 0 rg BT 560.46 599.10 Td (part ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 587.10 Td (of ) Tj ET Q q 0 0 0 rg BT 141.33 587.10 Td (the ) Tj ET Q q 0 0 0 rg BT 156.05 587.10 Td (triple ) Tj ET Q q 0 0 0 rg BT 179.65 587.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 232.14 587.10 Td (tablet, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 259.35 587.10 Td (Ximency) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.78 587.10 Td (, ) Tj ET Q q 0 0 0 rg BT 298.78 587.10 Td (\(DCV+ASV+BCV\) ) Tj ET Q q 0 0 0 rg BT 380.90 587.10 Td (in ) Tj ET Q q 0 0 0 rg BT 391.17 587.10 Td (Japan.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (Reyataz ) Tj ET Q q 0 0 0 rg BT 70.16 569.10 Td (Franchise ) Tj ET Q q 0 0 0 rg BT 130.50 569.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 162.16 569.10 Td ( ) Tj ET Q q 0 0 0 rg BT 163.97 569.10 Td (is ) Tj ET Q q 0 0 0 rg BT 172.45 569.10 Td (a ) Tj ET Q q 0 0 0 rg BT 178.70 569.10 Td (protease ) Tj ET Q q 0 0 0 rg BT 213.83 569.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 250.09 569.10 Td (for ) Tj ET Q q 0 0 0 rg BT 263.56 569.10 Td (the ) Tj ET Q q 0 0 0 rg BT 277.59 569.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 317.16 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 327.31 569.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 343.79 569.10 Td (. ) Tj ET Q q 0 0 0 rg BT 347.97 569.10 Td (The ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 365.33 569.10 Td (Reyataz ) Tj ET Q q 0 0 0 rg BT 398.80 569.10 Td (Franchise ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.16 569.10 Td (includes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 476.30 569.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.95 569.10 Td ( ) Tj ET Q q 0 0 0 rg BT 509.77 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 526.02 569.10 Td (combination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 557.10 Td (therapy ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 162.24 557.10 Td (Evotaz ) Tj ET Q q 0 0 0 rg BT 191.22 557.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.55 557.10 Td (atazanavir ) Tj ET Q q 0 0 0 rg BT 237.39 557.10 Td (300 ) Tj ET Q q 0 0 0 rg BT 254.15 557.10 Td (mg ) Tj ET Q q 0 0 0 rg BT 268.69 557.10 Td (and ) Tj ET Q q 0 0 0 rg BT 284.88 557.10 Td (cobicistat ) Tj ET Q q 0 0 0 rg BT 324.96 557.10 Td (150 ) Tj ET Q q 0 0 0 rg BT 341.72 557.10 Td (mg\), ) Tj ET Q q 0 0 0 rg BT 362.09 557.10 Td (a ) Tj ET Q q 0 0 0 rg BT 368.29 557.10 Td (once-daily ) Tj ET Q q 0 0 0 rg BT 412.25 557.10 Td (single ) Tj ET Q q 0 0 0 rg BT 437.90 557.10 Td (tablet ) Tj ET Q q 0 0 0 rg BT 461.87 557.10 Td (two ) Tj ET Q q 0 0 0 rg BT 478.63 557.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 498.72 557.10 Td (regimen ) Tj ET Q q 0 0 0 rg BT 533.24 557.10 Td (combining ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 545.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 162.16 545.10 Td ( ) Tj ET Q q 0 0 0 rg BT 164.66 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 181.59 545.10 Td (Gilead's ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 216.44 545.10 Td (T) Tj ET Q q 0 0 0 rg BT 221.26 545.10 Td (ybost*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.37 545.10 Td ( ) Tj ET Q q 0 0 0 rg BT 249.87 545.10 Td (\(cobicistat\) ) Tj ET Q q 0 0 0 rg BT 297.35 545.10 Td (for ) Tj ET Q q 0 0 0 rg BT 311.51 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 326.23 545.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 366.49 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 377.32 545.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 394.17 545.10 Td (-1 ) Tj ET Q q 0 0 0 rg BT 405.00 545.10 Td (infection ) Tj ET Q q 0 0 0 rg BT 443.04 545.10 Td (in ) Tj ET Q q 0 0 0 rg BT 453.32 545.10 Td (adults.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 527.10 Td (Sustiva ) Tj ET Q q 0 0 0 rg BT 67.39 527.10 Td (Franchise ) Tj ET Q q 0 0 0 rg BT 130.50 527.10 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 160.95 527.10 Td (is ) Tj ET Q q 0 0 0 rg BT 169.18 527.10 Td (a ) Tj ET Q q 0 0 0 rg BT 175.18 527.10 Td (non-nucleoside ) Tj ET Q q 0 0 0 rg BT 237.84 527.10 Td (reverse ) Tj ET Q q 0 0 0 rg BT 268.27 527.10 Td (transcriptase ) Tj ET Q q 0 0 0 rg BT 320.36 527.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 356.37 527.10 Td (for ) Tj ET Q q 0 0 0 rg BT 369.59 527.10 Td (the ) Tj ET Q q 0 0 0 rg BT 383.37 527.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 422.69 527.10 Td (of ) Tj ET Q q 0 0 0 rg BT 432.58 527.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 449.07 527.10 Td (. ) Tj ET Q q 0 0 0 rg BT 453.02 527.10 Td (The ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 470.13 527.10 Td (Sustiva ) Tj ET Q q 0 0 0 rg BT 500.58 527.10 Td (Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.12 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 542.69 527.10 Td (includes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 130.50 515.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.39 515.10 Td (, ) Tj ET Q q 0 0 0 rg BT 164.85 515.10 Td (an ) Tj ET Q q 0 0 0 rg BT 177.26 515.10 Td (antiretroviral ) Tj ET Q q 0 0 0 rg BT 232.42 515.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 253.72 515.10 Td (used ) Tj ET Q q 0 0 0 rg BT 275.01 515.10 Td (in ) Tj ET Q q 0 0 0 rg BT 285.76 515.10 Td (the ) Tj ET Q q 0 0 0 rg BT 300.94 515.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 341.67 515.10 Td (of ) Tj ET Q q 0 0 0 rg BT 352.96 515.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 369.45 515.10 Td (, ) Tj ET Q q 0 0 0 rg BT 374.91 515.10 Td (as ) Tj ET Q q 0 0 0 rg BT 386.21 515.10 Td (well ) Tj ET Q q 0 0 0 rg BT 406.39 515.10 Td (as ) Tj ET Q q 0 0 0 rg BT 417.69 515.10 Td (bulk ) Tj ET Q q 0 0 0 rg BT 438.43 515.10 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 478.59 515.10 Td (which ) Tj ET Q q 0 0 0 rg BT 506.00 515.10 Td (is ) Tj ET Q q 0 0 0 rg BT 515.63 515.10 Td (included ) Tj ET Q q 0 0 0 rg BT 553.03 515.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 515.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 503.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 182.91 503.10 Td (therapy ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 215.31 503.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.65 503.10 Td ( ) Tj ET Q q 0 0 0 rg BT 251.07 503.10 Td (\(efavirenz ) Tj ET Q q 0 0 0 rg BT 294.01 503.10 Td (600 ) Tj ET Q q 0 0 0 rg BT 311.43 503.10 Td (mg/ ) Tj ET Q q 0 0 0 rg BT 329.41 503.10 Td (emtricitabine ) Tj ET Q q 0 0 0 rg BT 384.58 503.10 Td (200 ) Tj ET Q q 0 0 0 rg BT 402.00 503.10 Td (mg/ ) Tj ET Q q 0 0 0 rg BT 419.98 503.10 Td (tenofovir ) Tj ET Q q 0 0 0 rg BT 459.05 503.10 Td (disoproxil ) Tj ET Q q 0 0 0 rg BT 502.03 503.10 Td (fumarate ) Tj ET Q q 0 0 0 rg BT 539.98 503.10 Td (300 ) Tj ET Q q 0 0 0 rg BT 557.40 503.10 Td (mg\), ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 491.10 Td (a ) Tj ET Q q 0 0 0 rg BT 137.76 491.10 Td (once-daily ) Tj ET Q q 0 0 0 rg BT 182.79 491.10 Td (single ) Tj ET Q q 0 0 0 rg BT 209.51 491.10 Td (tablet ) Tj ET Q q 0 0 0 rg BT 234.54 491.10 Td (three-drug ) Tj ET Q q 0 0 0 rg BT 279.02 491.10 Td (regimen ) Tj ET Q q 0 0 0 rg BT 314.61 491.10 Td (combining ) Tj ET Q q 0 0 0 rg BT 360.21 491.10 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 376.36 491.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.25 491.10 Td ( ) Tj ET Q q 0 0 0 rg BT 408.07 491.10 Td (and ) Tj ET Q q 0 0 0 rg BT 425.34 491.10 Td (Gilead’) Tj ET Q q 0 0 0 rg BT 454.77 491.10 Td (s ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 461.49 491.10 Td (T) Tj ET Q q 0 0 0 rg BT 466.50 491.10 Td (ruvada*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.83 491.10 Td ( ) Tj ET Q q 0 0 0 rg BT 502.66 491.10 Td (\(emtricitabine ) Tj ET Q q 0 0 0 rg BT 561.57 491.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.50 479.10 Td (tenofovir ) Tj ET Q q 0 0 0 rg BT 169.66 479.10 Td (disoproxil ) Tj ET Q q 0 0 0 rg BT 212.71 479.10 Td (fumarate\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 458.70 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 458.70 Td (e ) Tj ET Q q 0 0 0 rg BT 51.37 458.70 Td (own ) Tj ET Q q 0 0 0 rg BT 70.89 458.70 Td (or ) Tj ET Q q 0 0 0 rg BT 81.52 458.70 Td (license ) Tj ET Q q 0 0 0 rg BT 111.58 458.70 Td (a ) Tj ET Q q 0 0 0 rg BT 118.32 458.70 Td (number ) Tj ET Q q 0 0 0 rg BT 151.16 458.70 Td (of ) Tj ET Q q 0 0 0 rg BT 161.79 458.70 Td (patents ) Tj ET Q q 0 0 0 rg BT 192.41 458.70 Td (in ) Tj ET Q q 0 0 0 rg BT 202.49 458.70 Td (the ) Tj ET Q q 0 0 0 rg BT 217.00 458.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 237.08 458.70 Td (and ) Tj ET Q q 0 0 0 rg BT 253.82 458.70 Td (foreign ) Tj ET Q q 0 0 0 rg BT 284.99 458.70 Td (countries ) Tj ET Q q 0 0 0 rg BT 323.94 458.70 Td (primarily ) Tj ET Q q 0 0 0 rg BT 363.45 458.70 Td (covering ) Tj ET Q q 0 0 0 rg BT 400.74 458.70 Td (our ) Tj ET Q q 0 0 0 rg BT 416.36 458.70 Td (products. ) Tj ET Q q 0 0 0 rg BT 455.43 458.70 Td (W) Tj ET Q q 0 0 0 rg BT 464.07 458.70 Td (e ) Tj ET Q q 0 0 0 rg BT 470.81 458.70 Td (have ) Tj ET Q q 0 0 0 rg BT 491.98 458.70 Td (also ) Tj ET Q q 0 0 0 rg BT 510.39 458.70 Td (developed ) Tj ET Q q 0 0 0 rg BT 553.78 458.70 Td (many ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 446.70 Td (brand ) Tj ET Q q 0 0 0 rg BT 60.51 446.70 Td (names ) Tj ET Q q 0 0 0 rg BT 87.80 446.70 Td (and ) Tj ET Q q 0 0 0 rg BT 103.98 446.70 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 150.14 446.70 Td (for ) Tj ET Q q 0 0 0 rg BT 163.54 446.70 Td (our ) Tj ET Q q 0 0 0 rg BT 178.61 446.70 Td (products. ) Tj ET Q q 0 0 0 rg BT 217.17 446.70 Td (W) Tj ET Q q 0 0 0 rg BT 225.80 446.70 Td (e ) Tj ET Q q 0 0 0 rg BT 231.98 446.70 Td (consider ) Tj ET Q q 0 0 0 rg BT 267.60 446.70 Td (the ) Tj ET Q q 0 0 0 rg BT 281.56 446.70 Td (overall ) Tj ET Q q 0 0 0 rg BT 311.06 446.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 353.34 446.70 Td (of ) Tj ET Q q 0 0 0 rg BT 363.42 446.70 Td (our ) Tj ET Q q 0 0 0 rg BT 378.49 446.70 Td (patents, ) Tj ET Q q 0 0 0 rg BT 411.05 446.70 Td (trademarks, ) Tj ET Q q 0 0 0 rg BT 459.72 446.70 Td (licenses ) Tj ET Q q 0 0 0 rg BT 493.11 446.70 Td (and ) Tj ET Q q 0 0 0 rg BT 509.29 446.70 Td (other ) Tj ET Q q 0 0 0 rg BT 531.58 446.70 Td (intellectual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 434.70 Td (property ) Tj ET Q q 0 0 0 rg BT 72.38 434.70 Td (rights ) Tj ET Q q 0 0 0 rg BT 97.66 434.70 Td (to ) Tj ET Q q 0 0 0 rg BT 107.93 434.70 Td (be ) Tj ET Q q 0 0 0 rg BT 119.87 434.70 Td (of ) Tj ET Q q 0 0 0 rg BT 130.70 434.70 Td (material ) Tj ET Q q 0 0 0 rg BT 165.96 434.70 Td (value ) Tj ET Q q 0 0 0 rg BT 190.12 434.70 Td (and ) Tj ET Q q 0 0 0 rg BT 207.05 434.70 Td (act ) Tj ET Q q 0 0 0 rg BT 221.21 434.70 Td (to ) Tj ET Q q 0 0 0 rg BT 231.49 434.70 Td (protect ) Tj ET Q q 0 0 0 rg BT 261.75 434.70 Td (these ) Tj ET Q q 0 0 0 rg BT 284.80 434.70 Td (rights ) Tj ET Q q 0 0 0 rg BT 310.08 434.70 Td (from ) Tj ET Q q 0 0 0 rg BT 332.02 434.70 Td (infringement.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 411.90 Td (In ) Tj ET Q q 0 0 0 rg BT 46.87 411.90 Td (the ) Tj ET Q q 0 0 0 rg BT 61.63 411.90 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 125.25 411.90 Td (industry) Tj ET Q q 0 0 0 rg BT 157.38 411.90 Td (, ) Tj ET Q q 0 0 0 rg BT 162.42 411.90 Td (the ) Tj ET Q q 0 0 0 rg BT 177.18 411.90 Td (majority ) Tj ET Q q 0 0 0 rg BT 213.61 411.90 Td (of ) Tj ET Q q 0 0 0 rg BT 224.48 411.90 Td (an ) Tj ET Q q 0 0 0 rg BT 236.46 411.90 Td (innovative ) Tj ET Q q 0 0 0 rg BT 281.22 411.90 Td (product’) Tj ET Q q 0 0 0 rg BT 314.54 411.90 Td (s ) Tj ET Q q 0 0 0 rg BT 320.98 411.90 Td (commercial ) Tj ET Q q 0 0 0 rg BT 370.72 411.90 Td (value ) Tj ET Q q 0 0 0 rg BT 394.91 411.90 Td (is ) Tj ET Q q 0 0 0 rg BT 404.13 411.90 Td (usually ) Tj ET Q q 0 0 0 rg BT 435.56 411.90 Td (realized ) Tj ET Q q 0 0 0 rg BT 469.74 411.90 Td (during ) Tj ET Q q 0 0 0 rg BT 498.39 411.90 Td (the ) Tj ET Q q 0 0 0 rg BT 513.15 411.90 Td (period ) Tj ET Q q 0 0 0 rg BT 541.24 411.90 Td (in ) Tj ET Q q 0 0 0 rg BT 551.56 411.90 Td (which ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 399.90 Td (the ) Tj ET Q q 0 0 0 rg BT 50.68 399.90 Td (product ) Tj ET Q q 0 0 0 rg BT 83.70 399.90 Td (has ) Tj ET Q q 0 0 0 rg BT 99.50 399.90 Td (market ) Tj ET Q q 0 0 0 rg BT 129.73 399.90 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 172.96 399.90 Td (. ) Tj ET Q q 0 0 0 rg BT 177.38 399.90 Td (A) Tj ET Q q 0 0 0 rg BT 184.05 399.90 Td ( ) Tj ET Q q 0 0 0 rg BT 186.52 399.90 Td (product’) Tj ET Q q 0 0 0 rg BT 219.84 399.90 Td (s ) Tj ET Q q 0 0 0 rg BT 226.20 399.90 Td (market ) Tj ET Q q 0 0 0 rg BT 256.43 399.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 302.78 399.90 Td (is ) Tj ET Q q 0 0 0 rg BT 311.92 399.90 Td (generally ) Tj ET Q q 0 0 0 rg BT 351.59 399.90 Td (determined ) Tj ET Q q 0 0 0 rg BT 399.04 399.90 Td (by ) Tj ET Q q 0 0 0 rg BT 411.50 399.90 Td (two ) Tj ET Q q 0 0 0 rg BT 428.97 399.90 Td (forms ) Tj ET Q q 0 0 0 rg BT 454.77 399.90 Td (of ) Tj ET Q q 0 0 0 rg BT 465.57 399.90 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 512.46 399.90 Td (property: ) Tj ET Q q 0 0 0 rg BT 551.58 399.90 Td (patent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 387.90 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.28 387.90 Td (held ) Tj ET Q q 0 0 0 rg BT 81.00 387.90 Td (by ) Tj ET Q q 0 0 0 rg BT 93.50 387.90 Td (the ) Tj ET Q q 0 0 0 rg BT 108.21 387.90 Td (innovator ) Tj ET Q q 0 0 0 rg BT 149.04 387.90 Td (company ) Tj ET Q q 0 0 0 rg BT 188.19 387.90 Td (and ) Tj ET Q q 0 0 0 rg BT 205.13 387.90 Td (any ) Tj ET Q q 0 0 0 rg BT 222.07 387.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 265.66 387.90 Td (forms ) Tj ET Q q 0 0 0 rg BT 291.49 387.90 Td (of ) Tj ET Q q 0 0 0 rg BT 302.32 387.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 348.71 387.90 Td (to ) Tj ET Q q 0 0 0 rg BT 358.98 387.90 Td (which ) Tj ET Q q 0 0 0 rg BT 385.92 387.90 Td (the ) Tj ET Q q 0 0 0 rg BT 400.64 387.90 Td (innovative ) Tj ET Q q 0 0 0 rg BT 445.35 387.90 Td (drug ) Tj ET Q q 0 0 0 rg BT 466.18 387.90 Td (is ) Tj ET Q q 0 0 0 rg BT 475.35 387.90 Td (entitled.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (Patents ) Tj ET Q q 0 0 0 rg BT 67.77 365.10 Td (are ) Tj ET Q q 0 0 0 rg BT 82.87 365.10 Td (a ) Tj ET Q q 0 0 0 rg BT 90.20 365.10 Td (key ) Tj ET Q q 0 0 0 rg BT 107.52 365.10 Td (determinant ) Tj ET Q q 0 0 0 rg BT 158.17 365.10 Td (of ) Tj ET Q q 0 0 0 rg BT 169.39 365.10 Td (market ) Tj ET Q q 0 0 0 rg BT 200.04 365.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 246.81 365.10 Td (for ) Tj ET Q q 0 0 0 rg BT 261.36 365.10 Td (most ) Tj ET Q q 0 0 0 rg BT 283.70 365.10 Td (branded ) Tj ET Q q 0 0 0 rg BT 318.79 365.10 Td (pharmaceuticals. ) Tj ET Q q 0 0 0 rg BT 389.14 365.10 Td (Patents ) Tj ET Q q 0 0 0 rg BT 420.92 365.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 454.35 365.10 Td (the ) Tj ET Q q 0 0 0 rg BT 469.46 365.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 510.67 365.10 Td (with ) Tj ET Q q 0 0 0 rg BT 531.34 365.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.44 365.10 Td (right ) Tj ET Q q 0 0 0 rg BT 568.22 365.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.10 Td (exclude ) Tj ET Q q 0 0 0 rg BT 70.24 353.10 Td (others ) Tj ET Q q 0 0 0 rg BT 97.83 353.10 Td (from ) Tj ET Q q 0 0 0 rg BT 120.42 353.10 Td (practicing ) Tj ET Q q 0 0 0 rg BT 163.55 353.10 Td (an ) Tj ET Q q 0 0 0 rg BT 176.14 353.10 Td (invention ) Tj ET Q q 0 0 0 rg BT 217.06 353.10 Td (related ) Tj ET Q q 0 0 0 rg BT 247.41 353.10 Td (to ) Tj ET Q q 0 0 0 rg BT 258.34 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 273.71 353.10 Td (medicine. ) Tj ET Q q 0 0 0 rg BT 316.00 353.10 Td (Patents ) Tj ET Q q 0 0 0 rg BT 348.04 353.10 Td (may ) Tj ET Q q 0 0 0 rg BT 368.41 353.10 Td (cover) Tj ET Q q 0 0 0 rg BT 390.21 353.10 Td (, ) Tj ET Q q 0 0 0 rg BT 395.86 353.10 Td (among ) Tj ET Q q 0 0 0 rg BT 426.23 353.10 Td (other ) Tj ET Q q 0 0 0 rg BT 449.93 353.10 Td (things, ) Tj ET Q q 0 0 0 rg BT 480.02 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 495.39 353.10 Td (active ) Tj ET Q q 0 0 0 rg BT 522.41 353.10 Td (ingredient\(s\), ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (various ) Tj ET Q q 0 0 0 rg BT 68.29 341.10 Td (uses ) Tj ET Q q 0 0 0 rg BT 88.37 341.10 Td (of ) Tj ET Q q 0 0 0 rg BT 99.55 341.10 Td (a ) Tj ET Q q 0 0 0 rg BT 106.84 341.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 128.02 341.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 163.92 341.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 227.85 341.10 Td (formulations, ) Tj ET Q q 0 0 0 rg BT 284.31 341.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 305.49 341.10 Td (delivery ) Tj ET Q q 0 0 0 rg BT 341.11 341.10 Td (mechanisms ) Tj ET Q q 0 0 0 rg BT 393.39 341.10 Td (and ) Tj ET Q q 0 0 0 rg BT 410.69 341.10 Td (processes ) Tj ET Q q 0 0 0 rg BT 451.86 341.10 Td (for ) Tj ET Q q 0 0 0 rg BT 466.37 341.10 Td (\(or ) Tj ET Q q 0 0 0 rg BT 480.89 341.10 Td (intermediates ) Tj ET Q q 0 0 0 rg BT 537.61 341.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 564.90 341.10 Td (in\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.02 329.10 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 103.79 329.10 Td (of ) Tj ET Q q 0 0 0 rg BT 114.93 329.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 154.67 329.10 Td (Protection ) Tj ET Q q 0 0 0 rg BT 198.57 329.10 Td (for ) Tj ET Q q 0 0 0 rg BT 213.04 329.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 256.39 329.10 Td (products ) Tj ET Q q 0 0 0 rg BT 293.63 329.10 Td (extends ) Tj ET Q q 0 0 0 rg BT 326.98 329.10 Td (for ) Tj ET Q q 0 0 0 rg BT 341.44 329.10 Td (varying ) Tj ET Q q 0 0 0 rg BT 374.79 329.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 407.04 329.10 Td (in ) Tj ET Q q 0 0 0 rg BT 417.62 329.10 Td (accordance ) Tj ET Q q 0 0 0 rg BT 465.38 329.10 Td (with ) Tj ET Q q 0 0 0 rg BT 485.96 329.10 Td (the ) Tj ET Q q 0 0 0 rg BT 500.98 329.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 544.33 329.10 Td (dates ) Tj ET Q q 0 0 0 rg BT 567.67 329.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 66.60 317.10 Td (in ) Tj ET Q q 0 0 0 rg BT 76.66 317.10 Td (the ) Tj ET Q q 0 0 0 rg BT 91.15 317.10 Td (various ) Tj ET Q q 0 0 0 rg BT 122.87 317.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 164.14 317.10 Td (The ) Tj ET Q q 0 0 0 rg BT 181.96 317.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 224.78 317.10 Td (af) Tj ET Q q 0 0 0 rg BT 232.37 317.10 Td (forded, ) Tj ET Q q 0 0 0 rg BT 263.25 317.10 Td (which ) Tj ET Q q 0 0 0 rg BT 289.96 317.10 Td (may ) Tj ET Q q 0 0 0 rg BT 309.46 317.10 Td (also ) Tj ET Q q 0 0 0 rg BT 327.84 317.10 Td (vary ) Tj ET Q q 0 0 0 rg BT 347.89 317.10 Td (from ) Tj ET Q q 0 0 0 rg BT 369.61 317.10 Td (country ) Tj ET Q q 0 0 0 rg BT 402.43 317.10 Td (to ) Tj ET Q q 0 0 0 rg BT 412.49 317.10 Td (country) Tj ET Q q 0 0 0 rg BT 442.39 317.10 Td (, ) Tj ET Q q 0 0 0 rg BT 447.16 317.10 Td (depends ) Tj ET Q q 0 0 0 rg BT 482.21 317.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 504.49 317.10 Td (the ) Tj ET Q q 0 0 0 rg BT 518.98 317.10 Td (type ) Tj ET Q q 0 0 0 rg BT 538.48 317.10 Td (of ) Tj ET Q q 0 0 0 rg BT 549.08 317.10 Td (patent, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.10 Td (its ) Tj ET Q q 0 0 0 rg BT 47.95 305.10 Td (scope ) Tj ET Q q 0 0 0 rg BT 73.22 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 84.05 305.10 Td (coverage ) Tj ET Q q 0 0 0 rg BT 122.63 305.10 Td (and ) Tj ET Q q 0 0 0 rg BT 139.57 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 154.29 305.10 Td (availability ) Tj ET Q q 0 0 0 rg BT 201.77 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 212.60 305.10 Td (meaningful ) Tj ET Q q 0 0 0 rg BT 260.64 305.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 282.58 305.10 Td (remedies ) Tj ET Q q 0 0 0 rg BT 321.17 305.10 Td (in ) Tj ET Q q 0 0 0 rg BT 331.45 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 346.17 305.10 Td (country) Tj ET Q q 0 0 0 rg BT 376.06 305.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 282.30 Td (Market ) Tj ET Q q 0 0 0 rg BT 67.94 282.30 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 114.89 282.30 Td (is ) Tj ET Q q 0 0 0 rg BT 124.63 282.30 Td (also ) Tj ET Q q 0 0 0 rg BT 143.80 282.30 Td (sometimes ) Tj ET Q q 0 0 0 rg BT 189.64 282.30 Td (influenced ) Tj ET Q q 0 0 0 rg BT 234.91 282.30 Td (by ) Tj ET Q q 0 0 0 rg BT 247.98 282.30 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 292.14 282.30 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 339.63 282.30 Td (property ) Tj ET Q q 0 0 0 rg BT 376.57 282.30 Td (rights. ) Tj ET Q q 0 0 0 rg BT 404.92 282.30 Td (Many ) Tj ET Q q 0 0 0 rg BT 431.31 282.30 Td (developed ) Tj ET Q q 0 0 0 rg BT 475.47 282.30 Td (countries ) Tj ET Q q 0 0 0 rg BT 515.19 282.30 Td (provide ) Tj ET Q q 0 0 0 rg BT 548.81 282.30 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 270.30 Td (non-patent ) Tj ET Q q 0 0 0 rg BT 81.05 270.30 Td (incentives ) Tj ET Q q 0 0 0 rg BT 123.89 270.30 Td (for ) Tj ET Q q 0 0 0 rg BT 137.84 270.30 Td (the ) Tj ET Q q 0 0 0 rg BT 152.34 270.30 Td (development ) Tj ET Q q 0 0 0 rg BT 206.28 270.30 Td (of ) Tj ET Q q 0 0 0 rg BT 216.90 270.30 Td (medicines. ) Tj ET Q q 0 0 0 rg BT 262.24 270.30 Td (For ) Tj ET Q q 0 0 0 rg BT 278.42 270.30 Td (example, ) Tj ET Q q 0 0 0 rg BT 317.08 270.30 Td (in ) Tj ET Q q 0 0 0 rg BT 327.15 270.30 Td (the ) Tj ET Q q 0 0 0 rg BT 341.65 270.30 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 364.23 270.30 Td (the ) Tj ET Q q 0 0 0 rg BT 378.73 270.30 Td (EU, ) Tj ET Q q 0 0 0 rg BT 396.85 270.30 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 424.41 270.30 Td (and ) Tj ET Q q 0 0 0 rg BT 441.14 270.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 470.63 270.30 Td (other ) Tj ET Q q 0 0 0 rg BT 493.47 270.30 Td (countries, ) Tj ET Q q 0 0 0 rg BT 534.92 270.30 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 258.30 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 82.47 258.30 Td (property ) Tj ET Q q 0 0 0 rg BT 118.40 258.30 Td (rights ) Tj ET Q q 0 0 0 rg BT 143.22 258.30 Td (are ) Tj ET Q q 0 0 0 rg BT 157.48 258.30 Td (of) Tj ET Q q 0 0 0 rg BT 165.63 258.30 Td (fered ) Tj ET Q q 0 0 0 rg BT 188.21 258.30 Td (as ) Tj ET Q q 0 0 0 rg BT 198.59 258.30 Td (incentives ) Tj ET Q q 0 0 0 rg BT 241.18 258.30 Td (for ) Tj ET Q q 0 0 0 rg BT 254.88 258.30 Td (research ) Tj ET Q q 0 0 0 rg BT 290.24 258.30 Td (on ) Tj ET Q q 0 0 0 rg BT 302.28 258.30 Td (medicines ) Tj ET Q q 0 0 0 rg BT 344.87 258.30 Td (for ) Tj ET Q q 0 0 0 rg BT 358.58 258.30 Td (rare ) Tj ET Q q 0 0 0 rg BT 376.17 258.30 Td (diseases, ) Tj ET Q q 0 0 0 rg BT 413.48 258.30 Td (or ) Tj ET Q q 0 0 0 rg BT 423.86 258.30 Td (orphan ) Tj ET Q q 0 0 0 rg BT 453.67 258.30 Td (drugs, ) Tj ET Q q 0 0 0 rg BT 480.44 258.30 Td (and ) Tj ET Q q 0 0 0 rg BT 496.93 258.30 Td (on ) Tj ET Q q 0 0 0 rg BT 508.98 258.30 Td (medicines ) Tj ET Q q 0 0 0 rg BT 551.57 258.30 Td (useful ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 246.30 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 246.30 Td (treating ) Tj ET Q q 0 0 0 rg BT 79.32 246.30 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 116.80 246.30 Td (patients. ) Tj ET Q q 0 0 0 rg BT 152.72 246.30 Td (These ) Tj ET Q q 0 0 0 rg BT 179.10 246.30 Td (incentives ) Tj ET Q q 0 0 0 rg BT 222.14 246.30 Td (can ) Tj ET Q q 0 0 0 rg BT 238.52 246.30 Td (extend ) Tj ET Q q 0 0 0 rg BT 267.67 246.30 Td (the ) Tj ET Q q 0 0 0 rg BT 282.39 246.30 Td (market ) Tj ET Q q 0 0 0 rg BT 312.66 246.30 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 359.04 246.30 Td (period ) Tj ET Q q 0 0 0 rg BT 387.08 246.30 Td (on ) Tj ET Q q 0 0 0 rg BT 399.58 246.30 Td (a ) Tj ET Q q 0 0 0 rg BT 406.52 246.30 Td (product ) Tj ET Q q 0 0 0 rg BT 439.57 246.30 Td (beyond ) Tj ET Q q 0 0 0 rg BT 471.51 246.30 Td (the ) Tj ET Q q 0 0 0 rg BT 486.22 246.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 513.16 246.30 Td (term.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 223.50 Td (The ) Tj ET Q q 0 0 0 rg BT 54.25 223.50 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 77.24 223.50 Td (EU ) Tj ET Q q 0 0 0 rg BT 93.27 223.50 Td (and ) Tj ET Q q 0 0 0 rg BT 110.42 223.50 Td (Japan ) Tj ET Q q 0 0 0 rg BT 135.89 223.50 Td (also ) Tj ET Q q 0 0 0 rg BT 154.70 223.50 Td (each ) Tj ET Q q 0 0 0 rg BT 175.72 223.50 Td (provide ) Tj ET Q q 0 0 0 rg BT 208.97 223.50 Td (for ) Tj ET Q q 0 0 0 rg BT 223.33 223.50 Td (a ) Tj ET Q q 0 0 0 rg BT 230.48 223.50 Td (minimum ) Tj ET Q q 0 0 0 rg BT 272.07 223.50 Td (period ) Tj ET Q q 0 0 0 rg BT 300.32 223.50 Td (of ) Tj ET Q q 0 0 0 rg BT 311.36 223.50 Td (time ) Tj ET Q q 0 0 0 rg BT 331.84 223.50 Td (after ) Tj ET Q q 0 0 0 rg BT 352.86 223.50 Td (the ) Tj ET Q q 0 0 0 rg BT 367.78 223.50 Td (approval ) Tj ET Q q 0 0 0 rg BT 405.47 223.50 Td (of ) Tj ET Q q 0 0 0 rg BT 416.50 223.50 Td (a ) Tj ET Q q 0 0 0 rg BT 423.64 223.50 Td (new ) Tj ET Q q 0 0 0 rg BT 443.01 223.50 Td (drug ) Tj ET Q q 0 0 0 rg BT 464.04 223.50 Td (during ) Tj ET Q q 0 0 0 rg BT 492.85 223.50 Td (which ) Tj ET Q q 0 0 0 rg BT 520.00 223.50 Td (the ) Tj ET Q q 0 0 0 rg BT 534.92 223.50 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 211.50 Td (agency ) Tj ET Q q 0 0 0 rg BT 66.43 211.50 Td (may ) Tj ET Q q 0 0 0 rg BT 85.76 211.50 Td (not ) Tj ET Q q 0 0 0 rg BT 100.65 211.50 Td (rely ) Tj ET Q q 0 0 0 rg BT 118.30 211.50 Td (upon ) Tj ET Q q 0 0 0 rg BT 140.42 211.50 Td (the ) Tj ET Q q 0 0 0 rg BT 154.75 211.50 Td (innovator) Tj ET Q q 0 0 0 rg BT 193.44 211.50 Td (’) Tj ET Q q 0 0 0 rg BT 196.22 211.50 Td (s ) Tj ET Q q 0 0 0 rg BT 202.22 211.50 Td (data ) Tj ET Q q 0 0 0 rg BT 220.99 211.50 Td (to ) Tj ET Q q 0 0 0 rg BT 230.88 211.50 Td (approve ) Tj ET Q q 0 0 0 rg BT 265.20 211.50 Td (a ) Tj ET Q q 0 0 0 rg BT 271.75 211.50 Td (competitor) Tj ET Q q 0 0 0 rg BT 315.44 211.50 Td (’) Tj ET Q q 0 0 0 rg BT 318.22 211.50 Td (s ) Tj ET Q q 0 0 0 rg BT 324.22 211.50 Td (generic ) Tj ET Q q 0 0 0 rg BT 355.76 211.50 Td (copy) Tj ET Q q 0 0 0 rg BT 374.55 211.50 Td (, ) Tj ET Q q 0 0 0 rg BT 379.16 211.50 Td (or ) Tj ET Q q 0 0 0 rg BT 389.60 211.50 Td (data ) Tj ET Q q 0 0 0 rg BT 408.37 211.50 Td (protection. ) Tj ET Q q 0 0 0 rg BT 453.52 211.50 Td (In ) Tj ET Q q 0 0 0 rg BT 463.96 211.50 Td (some ) Tj ET Q q 0 0 0 rg BT 487.18 211.50 Td (regions ) Tj ET Q q 0 0 0 rg BT 518.73 211.50 Td (such ) Tj ET Q q 0 0 0 rg BT 539.18 211.50 Td (as ) Tj ET Q q 0 0 0 rg BT 549.62 211.50 Td (China, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 199.50 Td (however) Tj ET Q q 0 0 0 rg BT 70.03 199.50 Td (, ) Tj ET Q q 0 0 0 rg BT 74.55 199.50 Td (it ) Tj ET Q q 0 0 0 rg BT 82.13 199.50 Td (is ) Tj ET Q q 0 0 0 rg BT 90.82 199.50 Td (questionable ) Tj ET Q q 0 0 0 rg BT 143.38 199.50 Td (whether ) Tj ET Q q 0 0 0 rg BT 177.61 199.50 Td (such ) Tj ET Q q 0 0 0 rg BT 197.96 199.50 Td (data ) Tj ET Q q 0 0 0 rg BT 216.64 199.50 Td (protection ) Tj ET Q q 0 0 0 rg BT 259.20 199.50 Td (laws ) Tj ET Q q 0 0 0 rg BT 279.55 199.50 Td (are ) Tj ET Q q 0 0 0 rg BT 293.78 199.50 Td (enforceable. ) Tj ET Q q 0 0 0 rg BT 344.94 199.50 Td (In ) Tj ET Q q 0 0 0 rg BT 355.29 199.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 384.51 199.50 Td (markets ) Tj ET Q q 0 0 0 rg BT 418.19 199.50 Td (where ) Tj ET Q q 0 0 0 rg BT 444.64 199.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 471.09 199.50 Td (protection ) Tj ET Q q 0 0 0 rg BT 513.66 199.50 Td (and ) Tj ET Q q 0 0 0 rg BT 530.12 199.50 Td (other ) Tj ET Q q 0 0 0 rg BT 552.68 199.50 Td (forms ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 187.50 Td (of ) Tj ET Q q 0 0 0 rg BT 46.66 187.50 Td (market ) Tj ET Q q 0 0 0 rg BT 76.76 187.50 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 122.97 187.50 Td (may ) Tj ET Q q 0 0 0 rg BT 142.52 187.50 Td (have ) Tj ET Q q 0 0 0 rg BT 163.73 187.50 Td (expired, ) Tj ET Q q 0 0 0 rg BT 198.55 187.50 Td (data ) Tj ET Q q 0 0 0 rg BT 217.54 187.50 Td (protection ) Tj ET Q q 0 0 0 rg BT 260.42 187.50 Td (can ) Tj ET Q q 0 0 0 rg BT 276.63 187.50 Td (be ) Tj ET Q q 0 0 0 rg BT 288.40 187.50 Td (of ) Tj ET Q q 0 0 0 rg BT 299.06 187.50 Td (particular ) Tj ET Q q 0 0 0 rg BT 339.70 187.50 Td (importance. ) Tj ET Q q 0 0 0 rg BT 389.52 187.50 Td (However) Tj ET Q q 0 0 0 rg BT 425.77 187.50 Td (, ) Tj ET Q q 0 0 0 rg BT 430.60 187.50 Td (most ) Tj ET Q q 0 0 0 rg BT 452.38 187.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 495.81 187.50 Td (forms ) Tj ET Q q 0 0 0 rg BT 521.47 187.50 Td (of ) Tj ET Q q 0 0 0 rg BT 532.13 187.50 Td (exclusivity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 175.50 Td (do ) Tj ET Q q 0 0 0 rg BT 48.92 175.50 Td (not ) Tj ET Q q 0 0 0 rg BT 64.61 175.50 Td (prevent ) Tj ET Q q 0 0 0 rg BT 97.52 175.50 Td (a ) Tj ET Q q 0 0 0 rg BT 104.87 175.50 Td (competitor ) Tj ET Q q 0 0 0 rg BT 151.11 175.50 Td (from ) Tj ET Q q 0 0 0 rg BT 173.47 175.50 Td (gaining ) Tj ET Q q 0 0 0 rg BT 206.38 175.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 250.39 175.50 Td (approval ) Tj ET Q q 0 0 0 rg BT 288.29 175.50 Td (prior ) Tj ET Q q 0 0 0 rg BT 310.65 175.50 Td (to ) Tj ET Q q 0 0 0 rg BT 321.34 175.50 Td (the ) Tj ET Q q 0 0 0 rg BT 336.48 175.50 Td (expiration ) Tj ET Q q 0 0 0 rg BT 379.94 175.50 Td (of ) Tj ET Q q 0 0 0 rg BT 391.19 175.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 435.20 175.50 Td (data ) Tj ET Q q 0 0 0 rg BT 454.77 175.50 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 501.57 175.50 Td (on ) Tj ET Q q 0 0 0 rg BT 514.49 175.50 Td (the ) Tj ET Q q 0 0 0 rg BT 529.62 175.50 Td (basis ) Tj ET Q q 0 0 0 rg BT 552.54 175.50 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 175.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 163.50 Td (competitor) Tj ET Q q 0 0 0 rg BT 79.69 163.50 Td (’) Tj ET Q q 0 0 0 rg BT 82.47 163.50 Td (s ) Tj ET Q q 0 0 0 rg BT 88.86 163.50 Td (own ) Tj ET Q q 0 0 0 rg BT 108.58 163.50 Td (safety ) Tj ET Q q 0 0 0 rg BT 134.96 163.50 Td (and ) Tj ET Q q 0 0 0 rg BT 151.90 163.50 Td (ef) Tj ET Q q 0 0 0 rg BT 159.49 163.50 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 186.41 163.50 Td (data ) Tj ET Q q 0 0 0 rg BT 205.57 163.50 Td (on ) Tj ET Q q 0 0 0 rg BT 218.07 163.50 Td (its ) Tj ET Q q 0 0 0 rg BT 230.01 163.50 Td (drug, ) Tj ET Q q 0 0 0 rg BT 253.34 163.50 Td (even ) Tj ET Q q 0 0 0 rg BT 274.72 163.50 Td (when ) Tj ET Q q 0 0 0 rg BT 298.88 163.50 Td (that ) Tj ET Q q 0 0 0 rg BT 316.38 163.50 Td (drug ) Tj ET Q q 0 0 0 rg BT 337.21 163.50 Td (is ) Tj ET Q q 0 0 0 rg BT 346.38 163.50 Td (identical ) Tj ET Q q 0 0 0 rg BT 383.30 163.50 Td (to ) Tj ET Q q 0 0 0 rg BT 393.58 163.50 Td (that ) Tj ET Q q 0 0 0 rg BT 411.08 163.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 450.78 163.50 Td (by ) Tj ET Q q 0 0 0 rg BT 463.28 163.50 Td (the ) Tj ET Q q 0 0 0 rg BT 478.00 163.50 Td (innovator) Tj ET Q q 0 0 0 rg BT 515.77 163.50 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 140.70 Td (Specific ) Tj ET Q q 0 0 0 rg BT 72.08 140.70 Td (aspects ) Tj ET Q q 0 0 0 rg BT 104.27 140.70 Td (of ) Tj ET Q q 0 0 0 rg BT 115.92 140.70 Td (the ) Tj ET Q q 0 0 0 rg BT 131.45 140.70 Td (law ) Tj ET Q q 0 0 0 rg BT 149.20 140.70 Td (governing ) Tj ET Q q 0 0 0 rg BT 193.07 140.70 Td (market ) Tj ET Q q 0 0 0 rg BT 224.14 140.70 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 271.34 140.70 Td (and ) Tj ET Q q 0 0 0 rg BT 289.10 140.70 Td (data ) Tj ET Q q 0 0 0 rg BT 309.07 140.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 352.92 140.70 Td (for ) Tj ET Q q 0 0 0 rg BT 367.90 140.70 Td (pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 436.18 140.70 Td (vary ) Tj ET Q q 0 0 0 rg BT 457.26 140.70 Td (from ) Tj ET Q q 0 0 0 rg BT 480.02 140.70 Td (country ) Tj ET Q q 0 0 0 rg BT 513.88 140.70 Td (to ) Tj ET Q q 0 0 0 rg BT 524.97 140.70 Td (country) Tj ET Q q 0 0 0 rg BT 554.87 140.70 Td (. ) Tj ET Q q 0 0 0 rg BT 560.45 140.70 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 128.70 Td (following ) Tj ET Q q 0 0 0 rg BT 77.39 128.70 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 127.65 128.70 Td (key ) Tj ET Q q 0 0 0 rg BT 144.59 128.70 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 190.97 128.70 Td (rules ) Tj ET Q q 0 0 0 rg BT 212.91 128.70 Td (in ) Tj ET Q q 0 0 0 rg BT 223.19 128.70 Td (markets ) Tj ET Q q 0 0 0 rg BT 257.34 128.70 Td (representing ) Tj ET Q q 0 0 0 rg BT 309.27 128.70 Td (significant ) Tj ET Q q 0 0 0 rg BT 353.98 128.70 Td (sales:) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 105.90 Td (United States) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 87.90 Td (In ) Tj ET Q q 0 0 0 rg BT 46.87 87.90 Td (the ) Tj ET Q q 0 0 0 rg BT 61.63 87.90 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 84.45 87.90 Td (most ) Tj ET Q q 0 0 0 rg BT 106.43 87.90 Td (of ) Tj ET Q q 0 0 0 rg BT 117.30 87.90 Td (our ) Tj ET Q q 0 0 0 rg BT 133.17 87.90 Td (key ) Tj ET Q q 0 0 0 rg BT 150.15 87.90 Td (products ) Tj ET Q q 0 0 0 rg BT 187.13 87.90 Td (are ) Tj ET Q q 0 0 0 rg BT 201.87 87.90 Td (protected ) Tj ET Q q 0 0 0 rg BT 241.62 87.90 Td (by ) Tj ET Q q 0 0 0 rg BT 254.15 87.90 Td (patents ) Tj ET Q q 0 0 0 rg BT 285.02 87.90 Td (with ) Tj ET Q q 0 0 0 rg BT 305.34 87.90 Td (varying ) Tj ET Q q 0 0 0 rg BT 338.42 87.90 Td (terms ) Tj ET Q q 0 0 0 rg BT 363.18 87.90 Td (depending ) Tj ET Q q 0 0 0 rg BT 407.37 87.90 Td (on ) Tj ET Q q 0 0 0 rg BT 419.91 87.90 Td (the ) Tj ET Q q 0 0 0 rg BT 434.67 87.90 Td (type ) Tj ET Q q 0 0 0 rg BT 454.42 87.90 Td (of ) Tj ET Q q 0 0 0 rg BT 465.29 87.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 492.26 87.90 Td (and ) Tj ET Q q 0 0 0 rg BT 509.24 87.90 Td (the ) Tj ET Q q 0 0 0 rg BT 524.00 87.90 Td (filing ) Tj ET Q q 0 0 0 rg BT 548.20 87.90 Td (date. ) Tj ET Q q 0 0 0 rg BT 569.34 87.90 Td (A) Tj ET Q q 0 0 0 rg BT 576.01 87.90 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 75.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 81.62 75.90 Td (portion ) Tj ET Q q 0 0 0 rg BT 113.92 75.90 Td (of ) Tj ET Q q 0 0 0 rg BT 125.67 75.90 Td (a ) Tj ET Q q 0 0 0 rg BT 133.52 75.90 Td (product’) Tj ET Q q 0 0 0 rg BT 166.84 75.90 Td (s ) Tj ET Q q 0 0 0 rg BT 174.14 75.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 201.99 75.90 Td (life, ) Tj ET Q q 0 0 0 rg BT 221.23 75.90 Td (however) Tj ET Q q 0 0 0 rg BT 255.26 75.90 Td (, ) Tj ET Q q 0 0 0 rg BT 261.17 75.90 Td (is ) Tj ET Q q 0 0 0 rg BT 271.25 75.90 Td (lost ) Tj ET Q q 0 0 0 rg BT 289.11 75.90 Td (during ) Tj ET Q q 0 0 0 rg BT 318.63 75.90 Td (the ) Tj ET Q q 0 0 0 rg BT 334.26 75.90 Td (time ) Tj ET Q q 0 0 0 rg BT 355.45 75.90 Td (it ) Tj ET Q q 0 0 0 rg BT 364.41 75.90 Td (takes ) Tj ET Q q 0 0 0 rg BT 388.37 75.90 Td (an ) Tj ET Q q 0 0 0 rg BT 401.22 75.90 Td (innovative ) Tj ET Q q 0 0 0 rg BT 446.85 75.90 Td (company ) Tj ET Q q 0 0 0 rg BT 486.92 75.90 Td (to ) Tj ET Q q 0 0 0 rg BT 498.11 75.90 Td (develop ) Tj ET Q q 0 0 0 rg BT 533.17 75.90 Td (and ) Tj ET Q q 0 0 0 rg BT 551.02 75.90 Td (obtain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 63.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.65 63.90 Td (approval ) Tj ET Q q 0 0 0 rg BT 117.20 63.90 Td (of ) Tj ET Q q 0 0 0 rg BT 128.09 63.90 Td (a ) Tj ET Q q 0 0 0 rg BT 135.09 63.90 Td (new ) Tj ET Q q 0 0 0 rg BT 154.31 63.90 Td (drug. ) Tj ET Q q 0 0 0 rg BT 177.13 63.90 Td (As ) Tj ET Q q 0 0 0 rg BT 190.81 63.90 Td (compensation ) Tj ET Q q 0 0 0 rg BT 248.91 63.90 Td (at ) Tj ET Q q 0 0 0 rg BT 258.69 63.90 Td (least ) Tj ET Q q 0 0 0 rg BT 279.57 63.90 Td (in ) Tj ET Q q 0 0 0 rg BT 289.91 63.90 Td (part ) Tj ET Q q 0 0 0 rg BT 308.02 63.90 Td (for ) Tj ET Q q 0 0 0 rg BT 322.24 63.90 Td (the ) Tj ET Q q 0 0 0 rg BT 337.01 63.90 Td (lost ) Tj ET Q q 0 0 0 rg BT 354.02 63.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 381.01 63.90 Td (term, ) Tj ET Q q 0 0 0 rg BT 404.40 63.90 Td (the ) Tj ET Q q 0 0 0 rg BT 419.18 63.90 Td (innovator ) Tj ET Q q 0 0 0 rg BT 460.06 63.90 Td (may) Tj ET Q q 0 0 0 rg BT 476.63 63.90 Td (, ) Tj ET Q q 0 0 0 rg BT 481.69 63.90 Td (depending ) Tj ET Q q 0 0 0 rg BT 525.90 63.90 Td (on ) Tj ET Q q 0 0 0 rg BT 538.46 63.90 Td (a ) Tj ET Q q 0 0 0 rg BT 545.46 63.90 Td (number ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 51.90 Td (of ) Tj ET Q q 0 0 0 rg BT 47.29 51.90 Td (factors, ) Tj ET Q q 0 0 0 rg BT 79.95 51.90 Td (extend ) Tj ET Q q 0 0 0 rg BT 109.56 51.90 Td (the ) Tj ET Q q 0 0 0 rg BT 124.73 51.90 Td (expiration ) Tj ET Q q 0 0 0 rg BT 168.23 51.90 Td (date ) Tj ET Q q 0 0 0 rg BT 187.84 51.90 Td (of ) Tj ET Q q 0 0 0 rg BT 199.13 51.90 Td (one ) Tj ET Q q 0 0 0 rg BT 216.52 51.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 243.91 51.90 Td (up ) Tj ET Q q 0 0 0 rg BT 256.86 51.90 Td (to ) Tj ET Q q 0 0 0 rg BT 267.60 51.90 Td (a ) Tj ET Q q 0 0 0 rg BT 274.99 51.90 Td (maximum ) Tj ET Q q 0 0 0 rg BT 318.50 51.90 Td (term ) Tj ET Q q 0 0 0 rg BT 339.78 51.90 Td (of ) Tj ET Q q 0 0 0 rg BT 351.07 51.90 Td (five ) Tj ET Q q 0 0 0 rg BT 369.57 51.90 Td (years, ) Tj ET Q q 0 0 0 rg BT 396.12 51.90 Td (provided ) Tj ET Q q 0 0 0 rg BT 434.63 51.90 Td (that ) Tj ET Q q 0 0 0 rg BT 452.58 51.90 Td (the ) Tj ET Q q 0 0 0 rg BT 467.75 51.90 Td (extension ) Tj ET Q q 0 0 0 rg BT 509.03 51.90 Td (cannot ) Tj ET Q q 0 0 0 rg BT 538.64 51.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 563.80 51.90 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 39.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 62.93 39.90 Td (to ) Tj ET Q q 0 0 0 rg BT 73.21 39.90 Td (be ) Tj ET Q q 0 0 0 rg BT 85.15 39.90 Td (in ) Tj ET Q q 0 0 0 rg BT 95.43 39.90 Td (ef) Tj ET Q q 0 0 0 rg BT 103.02 39.90 Td (fect ) Tj ET Q q 0 0 0 rg BT 120.50 39.90 Td (for ) Tj ET Q q 0 0 0 rg BT 134.66 39.90 Td (more ) Tj ET Q q 0 0 0 rg BT 157.71 39.90 Td (than ) Tj ET Q q 0 0 0 rg BT 177.43 39.90 Td (14 ) Tj ET Q q 0 0 0 rg BT 189.93 39.90 Td (years ) Tj ET Q q 0 0 0 rg BT 213.52 39.90 Td (from ) Tj ET Q q 0 0 0 rg BT 235.46 39.90 Td (the ) Tj ET Q q 0 0 0 rg BT 250.18 39.90 Td (date ) Tj ET Q q 0 0 0 rg BT 269.33 39.90 Td (of ) Tj ET Q q 0 0 0 rg BT 280.17 39.90 Td (drug ) Tj ET Q q 0 0 0 rg BT 301.00 39.90 Td (approval.) Tj ET Q endstream endobj 11 0 obj <> endobj 12 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 45.67 749.10 Td (company ) Tj ET Q q 0 0 0 rg BT 85.32 749.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 118.86 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 129.63 749.10 Td (market ) Tj ET Q q 0 0 0 rg BT 160.39 749.10 Td (an ) Tj ET Q q 0 0 0 rg BT 172.83 749.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 218.03 749.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 282.10 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 292.88 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 308.09 749.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 328.87 749.10 Td (must ) Tj ET Q q 0 0 0 rg BT 351.31 749.10 Td (submit ) Tj ET Q q 0 0 0 rg BT 381.53 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 388.97 749.10 Td (complete ) Tj ET Q q 0 0 0 rg BT 428.61 749.10 Td (set ) Tj ET Q q 0 0 0 rg BT 442.72 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 454.04 749.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 480.92 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 498.35 749.10 Td (ef) Tj ET Q q 0 0 0 rg BT 505.94 749.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 533.36 749.10 Td (data ) Tj ET Q q 0 0 0 rg BT 553.01 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 563.78 749.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (FDA. ) Tj ET Q q 0 0 0 rg BT 60.89 737.10 Td (If ) Tj ET Q q 0 0 0 rg BT 69.94 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 84.54 737.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 129.14 737.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 192.60 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 201.66 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 208.48 737.10 Td (chemical, ) Tj ET Q q 0 0 0 rg BT 249.46 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 264.06 737.10 Td (company ) Tj ET Q q 0 0 0 rg BT 303.10 737.10 Td (files ) Tj ET Q q 0 0 0 rg BT 322.71 737.10 Td (an ) Tj ET Q q 0 0 0 rg BT 334.53 737.10 Td (NDA. ) Tj ET Q q 0 0 0 rg BT 361.08 737.10 Td (If ) Tj ET Q q 0 0 0 rg BT 370.13 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 384.74 737.10 Td (medicine ) Tj ET Q q 0 0 0 rg BT 423.77 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 432.83 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 439.65 737.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 482.03 737.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 517.46 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 524.29 737.10 Td (BLA) Tj ET Q q 0 0 0 rg BT 543.74 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 546.13 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 555.18 737.10 Td (filed. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 725.10 Td (type ) Tj ET Q q 0 0 0 rg BT 73.76 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 84.59 725.10 Td (application ) Tj ET Q q 0 0 0 rg BT 131.52 725.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 152.35 725.10 Td (af) Tj ET Q q 0 0 0 rg BT 159.94 725.10 Td (fects ) Tj ET Q q 0 0 0 rg BT 181.31 725.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 224.91 725.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 271.29 725.10 Td (rights.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 699.7669921875 m 111.4541015625 699.7669921875 l s q 0 0 0 rg BT 36.00 701.10 Td (Chemical pr) Tj ET Q q 0 0 0 rg BT 85.35 701.10 Td (oducts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.10 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 683.10 Td ( ) Tj ET Q q 0 0 0 rg BT 45.37 683.10 Td (competitor ) Tj ET Q q 0 0 0 rg BT 91.40 683.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 124.65 683.10 Td (to ) Tj ET Q q 0 0 0 rg BT 135.13 683.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 164.48 683.10 Td (a ) Tj ET Q q 0 0 0 rg BT 171.63 683.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 203.75 683.10 Td (substitute ) Tj ET Q q 0 0 0 rg BT 244.79 683.10 Td (of ) Tj ET Q q 0 0 0 rg BT 255.82 683.10 Td (a ) Tj ET Q q 0 0 0 rg BT 262.96 683.10 Td (chemical ) Tj ET Q q 0 0 0 rg BT 301.75 683.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 346.67 683.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 367.70 683.10 Td (in ) Tj ET Q q 0 0 0 rg BT 378.18 683.10 Td (the ) Tj ET Q q 0 0 0 rg BT 393.10 683.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 413.59 683.10 Td (must ) Tj ET Q q 0 0 0 rg BT 435.74 683.10 Td (file ) Tj ET Q q 0 0 0 rg BT 451.77 683.10 Td (an ) Tj ET Q q 0 0 0 rg BT 463.91 683.10 Td (aNDA) Tj ET Q q 0 0 0 rg BT 489.46 683.10 Td ( ) Tj ET Q q 0 0 0 rg BT 492.16 683.10 Td (with ) Tj ET Q q 0 0 0 rg BT 512.64 683.10 Td (the ) Tj ET Q q 0 0 0 rg BT 527.56 683.10 Td (FDA. ) Tj ET Q q 0 0 0 rg BT 552.77 683.10 Td (In ) Tj ET Q q 0 0 0 rg BT 563.80 683.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 671.10 Td (aNDA, ) Tj ET Q q 0 0 0 rg BT 66.41 671.10 Td (the ) Tj ET Q q 0 0 0 rg BT 80.44 671.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 111.67 671.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 166.78 671.10 Td (needs ) Tj ET Q q 0 0 0 rg BT 191.36 671.10 Td (to ) Tj ET Q q 0 0 0 rg BT 200.95 671.10 Td (demonstrate ) Tj ET Q q 0 0 0 rg BT 251.63 671.10 Td (only ) Tj ET Q q 0 0 0 rg BT 271.21 671.10 Td (“bioequivalence” ) Tj ET Q q 0 0 0 rg BT 342.43 671.10 Td (between ) Tj ET Q q 0 0 0 rg BT 377.55 671.10 Td (the ) Tj ET Q q 0 0 0 rg BT 391.58 671.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 422.81 671.10 Td (substitute ) Tj ET Q q 0 0 0 rg BT 462.96 671.10 Td (and ) Tj ET Q q 0 0 0 rg BT 479.20 671.10 Td (the ) Tj ET Q q 0 0 0 rg BT 493.23 671.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 532.25 671.10 Td (NDA) Tj ET Q q 0 0 0 rg BT 553.36 671.10 Td ( ) Tj ET Q q 0 0 0 rg BT 555.17 671.10 Td (drug. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 659.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 659.10 Td (aNDA) Tj ET Q q 0 0 0 rg BT 79.60 659.10 Td ( ) Tj ET Q q 0 0 0 rg BT 82.10 659.10 Td (relies ) Tj ET Q q 0 0 0 rg BT 106.25 659.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 128.75 659.10 Td (the ) Tj ET Q q 0 0 0 rg BT 143.47 659.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 169.85 659.10 Td (and ) Tj ET Q q 0 0 0 rg BT 186.79 659.10 Td (ef) Tj ET Q q 0 0 0 rg BT 194.37 659.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 221.30 659.10 Td (data ) Tj ET Q q 0 0 0 rg BT 240.45 659.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 285.17 659.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 306.00 659.10 Td (by ) Tj ET Q q 0 0 0 rg BT 318.50 659.10 Td (the ) Tj ET Q q 0 0 0 rg BT 333.21 659.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 374.04 659.10 Td (in ) Tj ET Q q 0 0 0 rg BT 384.32 659.10 Td (its ) Tj ET Q q 0 0 0 rg BT 396.26 659.10 Td (NDA.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 635.10 Td (An ) Tj ET Q q 0 0 0 rg BT 50.91 635.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 91.92 635.10 Td (company ) Tj ET Q q 0 0 0 rg BT 131.26 635.10 Td (is ) Tj ET Q q 0 0 0 rg BT 140.61 635.10 Td (required ) Tj ET Q q 0 0 0 rg BT 176.62 635.10 Td (to ) Tj ET Q q 0 0 0 rg BT 187.08 635.10 Td (list ) Tj ET Q q 0 0 0 rg BT 201.99 635.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 231.88 635.10 Td (of ) Tj ET Q q 0 0 0 rg BT 242.89 635.10 Td (its ) Tj ET Q q 0 0 0 rg BT 255.03 635.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 286.04 635.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 323.71 635.10 Td (the ) Tj ET Q q 0 0 0 rg BT 338.61 635.10 Td (medicine ) Tj ET Q q 0 0 0 rg BT 377.95 635.10 Td (with ) Tj ET Q q 0 0 0 rg BT 398.41 635.10 Td (the ) Tj ET Q q 0 0 0 rg BT 413.31 635.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 432.77 635.10 Td ( ) Tj ET Q q 0 0 0 rg BT 435.45 635.10 Td (in ) Tj ET Q q 0 0 0 rg BT 445.92 635.10 Td (what ) Tj ET Q q 0 0 0 rg BT 468.04 635.10 Td (is ) Tj ET Q q 0 0 0 rg BT 477.40 635.10 Td (commonly ) Tj ET Q q 0 0 0 rg BT 522.86 635.10 Td (known ) Tj ET Q q 0 0 0 rg BT 552.76 635.10 Td (as ) Tj ET Q q 0 0 0 rg BT 563.78 635.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (Orange ) Tj ET Q q 0 0 0 rg BT 68.09 623.10 Td (Book. ) Tj ET Q q 0 0 0 rg BT 94.34 623.10 Td (Absent ) Tj ET Q q 0 0 0 rg BT 125.34 623.10 Td (a ) Tj ET Q q 0 0 0 rg BT 132.44 623.10 Td (successful ) Tj ET Q q 0 0 0 rg BT 176.21 623.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 203.31 623.10 Td (challenge, ) Tj ET Q q 0 0 0 rg BT 246.78 623.10 Td (the ) Tj ET Q q 0 0 0 rg BT 261.67 623.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 281.12 623.10 Td ( ) Tj ET Q q 0 0 0 rg BT 283.79 623.10 Td (cannot ) Tj ET Q q 0 0 0 rg BT 313.11 623.10 Td (approve ) Tj ET Q q 0 0 0 rg BT 347.98 623.10 Td (an ) Tj ET Q q 0 0 0 rg BT 360.08 623.10 Td (aNDA) Tj ET Q q 0 0 0 rg BT 385.64 623.10 Td ( ) Tj ET Q q 0 0 0 rg BT 388.30 623.10 Td (until ) Tj ET Q q 0 0 0 rg BT 409.30 623.10 Td (after ) Tj ET Q q 0 0 0 rg BT 430.28 623.10 Td (the ) Tj ET Q q 0 0 0 rg BT 445.17 623.10 Td (innovator) Tj ET Q q 0 0 0 rg BT 483.86 623.10 Td (’) Tj ET Q q 0 0 0 rg BT 486.64 623.10 Td (s ) Tj ET Q q 0 0 0 rg BT 493.20 623.10 Td (listed ) Tj ET Q q 0 0 0 rg BT 517.53 623.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 548.52 623.10 Td (expire. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 611.10 Td (However) Tj ET Q q 0 0 0 rg BT 72.25 611.10 Td (, ) Tj ET Q q 0 0 0 rg BT 77.53 611.10 Td (after ) Tj ET Q q 0 0 0 rg BT 98.63 611.10 Td (the ) Tj ET Q q 0 0 0 rg BT 113.62 611.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 154.73 611.10 Td (has ) Tj ET Q q 0 0 0 rg BT 170.84 611.10 Td (marketed ) Tj ET Q q 0 0 0 rg BT 210.82 611.10 Td (its ) Tj ET Q q 0 0 0 rg BT 223.05 611.10 Td (product ) Tj ET Q q 0 0 0 rg BT 256.38 611.10 Td (for ) Tj ET Q q 0 0 0 rg BT 270.82 611.10 Td (four ) Tj ET Q q 0 0 0 rg BT 290.26 611.10 Td (years, ) Tj ET Q q 0 0 0 rg BT 316.64 611.10 Td (a ) Tj ET Q q 0 0 0 rg BT 323.86 611.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 356.07 611.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 412.15 611.10 Td (may ) Tj ET Q q 0 0 0 rg BT 432.15 611.10 Td (file ) Tj ET Q q 0 0 0 rg BT 448.25 611.10 Td (an ) Tj ET Q q 0 0 0 rg BT 460.47 611.10 Td (aNDA) Tj ET Q q 0 0 0 rg BT 486.02 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 488.80 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 506.02 611.10 Td (allege ) Tj ET Q q 0 0 0 rg BT 532.67 611.10 Td (that ) Tj ET Q q 0 0 0 rg BT 550.45 611.10 Td (one ) Tj ET Q q 0 0 0 rg BT 567.67 611.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 599.10 Td (more ) Tj ET Q q 0 0 0 rg BT 59.06 599.10 Td (of ) Tj ET Q q 0 0 0 rg BT 69.90 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 84.62 599.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 115.46 599.10 Td (listed ) Tj ET Q q 0 0 0 rg BT 139.63 599.10 Td (in ) Tj ET Q q 0 0 0 rg BT 149.92 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 164.65 599.10 Td (Orange ) Tj ET Q q 0 0 0 rg BT 196.59 599.10 Td (Book ) Tj ET Q q 0 0 0 rg BT 220.77 599.10 Td (under ) Tj ET Q q 0 0 0 rg BT 246.04 599.10 Td (an ) Tj ET Q q 0 0 0 rg BT 257.99 599.10 Td (innovator) Tj ET Q q 0 0 0 rg BT 296.69 599.10 Td (’) Tj ET Q q 0 0 0 rg BT 299.47 599.10 Td (s ) Tj ET Q q 0 0 0 rg BT 305.87 599.10 Td (NDA) Tj ET Q q 0 0 0 rg BT 326.98 599.10 Td ( ) Tj ET Q q 0 0 0 rg BT 329.49 599.10 Td (is ) Tj ET Q q 0 0 0 rg BT 338.67 599.10 Td (either ) Tj ET Q q 0 0 0 rg BT 363.94 599.10 Td (invalid ) Tj ET Q q 0 0 0 rg BT 394.23 599.10 Td (or ) Tj ET Q q 0 0 0 rg BT 405.07 599.10 Td (not ) Tj ET Q q 0 0 0 rg BT 420.36 599.10 Td (infringed. ) Tj ET Q q 0 0 0 rg BT 461.84 599.10 Td (This ) Tj ET Q q 0 0 0 rg BT 482.13 599.10 Td (allegation ) Tj ET Q q 0 0 0 rg BT 524.07 599.10 Td (is ) Tj ET Q q 0 0 0 rg BT 533.25 599.10 Td (commonly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 587.10 Td (known ) Tj ET Q q 0 0 0 rg BT 66.40 587.10 Td (as ) Tj ET Q q 0 0 0 rg BT 77.92 587.10 Td (a ) Tj ET Q q 0 0 0 rg BT 85.54 587.10 Td (Paragraph ) Tj ET Q q 0 0 0 rg BT 129.26 587.10 Td (IV) Tj ET Q q 0 0 0 rg BT 139.63 587.10 Td ( ) Tj ET Q q 0 0 0 rg BT 142.81 587.10 Td (certification. ) Tj ET Q q 0 0 0 rg BT 196.57 587.10 Td (The ) Tj ET Q q 0 0 0 rg BT 215.30 587.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 256.81 587.10 Td (then ) Tj ET Q q 0 0 0 rg BT 277.21 587.10 Td (must ) Tj ET Q q 0 0 0 rg BT 299.84 587.10 Td (decide ) Tj ET Q q 0 0 0 rg BT 329.11 587.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 364.50 587.10 Td (to ) Tj ET Q q 0 0 0 rg BT 375.46 587.10 Td (file ) Tj ET Q q 0 0 0 rg BT 391.97 587.10 Td (a ) Tj ET Q q 0 0 0 rg BT 399.59 587.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 427.21 587.10 Td (infringement ) Tj ET Q q 0 0 0 rg BT 482.04 587.10 Td (suit ) Tj ET Q q 0 0 0 rg BT 499.67 587.10 Td (against ) Tj ET Q q 0 0 0 rg BT 531.18 587.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.58 587.10 Td (generic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 575.10 Td (manufacturer) Tj ET Q q 0 0 0 rg BT 88.75 575.10 Td (. ) Tj ET Q q 0 0 0 rg BT 94.32 575.10 Td (From ) Tj ET Q q 0 0 0 rg BT 119.06 575.10 Td (time ) Tj ET Q q 0 0 0 rg BT 139.90 575.10 Td (to ) Tj ET Q q 0 0 0 rg BT 150.75 575.10 Td (time, ) Tj ET Q q 0 0 0 rg BT 174.10 575.10 Td (aNDAs, ) Tj ET Q q 0 0 0 rg BT 209.66 575.10 Td (including ) Tj ET Q q 0 0 0 rg BT 250.50 575.10 Td (Paragraph ) Tj ET Q q 0 0 0 rg BT 294.11 575.10 Td (IV) Tj ET Q q 0 0 0 rg BT 304.48 575.10 Td ( ) Tj ET Q q 0 0 0 rg BT 307.55 575.10 Td (certifications, ) Tj ET Q q 0 0 0 rg BT 365.32 575.10 Td (are ) Tj ET Q q 0 0 0 rg BT 380.60 575.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 401.99 575.10 Td (with ) Tj ET Q q 0 0 0 rg BT 422.84 575.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 454.23 575.10 Td (to ) Tj ET Q q 0 0 0 rg BT 465.08 575.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 495.35 575.10 Td (of ) Tj ET Q q 0 0 0 rg BT 506.75 575.10 Td (our ) Tj ET Q q 0 0 0 rg BT 523.15 575.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 562.94 575.10 Td (W) Tj ET Q q 0 0 0 rg BT 571.57 575.10 Td (e ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 563.10 Td (evaluate ) Tj ET Q q 0 0 0 rg BT 71.17 563.10 Td (these ) Tj ET Q q 0 0 0 rg BT 93.58 563.10 Td (aNDAs ) Tj ET Q q 0 0 0 rg BT 125.43 563.10 Td (on ) Tj ET Q q 0 0 0 rg BT 137.29 563.10 Td (a ) Tj ET Q q 0 0 0 rg BT 143.59 563.10 Td (case-by-case ) Tj ET Q q 0 0 0 rg BT 196.52 563.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 218.38 563.10 Td (and, ) Tj ET Q q 0 0 0 rg BT 237.18 563.10 Td (where ) Tj ET Q q 0 0 0 rg BT 263.47 563.10 Td (warranted, ) Tj ET Q q 0 0 0 rg BT 307.80 563.10 Td (file ) Tj ET Q q 0 0 0 rg BT 322.99 563.10 Td (suit ) Tj ET Q q 0 0 0 rg BT 339.29 563.10 Td (against ) Tj ET Q q 0 0 0 rg BT 369.48 563.10 Td (the ) Tj ET Q q 0 0 0 rg BT 383.55 563.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 414.84 563.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 470.00 563.10 Td (to ) Tj ET Q q 0 0 0 rg BT 479.64 563.10 Td (protect ) Tj ET Q q 0 0 0 rg BT 509.26 563.10 Td (our ) Tj ET Q q 0 0 0 rg BT 524.45 563.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 550.74 563.10 Td (rights.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.29 539.10 Td (addition ) Tj ET Q q 0 0 0 rg BT 81.03 539.10 Td (to ) Tj ET Q q 0 0 0 rg BT 90.77 539.10 Td (benefiting ) Tj ET Q q 0 0 0 rg BT 133.28 539.10 Td (from ) Tj ET Q q 0 0 0 rg BT 154.68 539.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 181.07 539.10 Td (protection, ) Tj ET Q q 0 0 0 rg BT 226.08 539.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 255.24 539.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 299.42 539.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 362.46 539.10 Td (products ) Tj ET Q q 0 0 0 rg BT 398.86 539.10 Td (can ) Tj ET Q q 0 0 0 rg BT 414.70 539.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 445.52 539.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 476.92 539.10 Td (of ) Tj ET Q q 0 0 0 rg BT 487.22 539.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 530.27 539.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 573.50 539.10 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 527.10 Td (An ) Tj ET Q q 0 0 0 rg BT 50.80 527.10 Td (NDA) Tj ET Q q 0 0 0 rg BT 71.92 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 74.50 527.10 Td (that ) Tj ET Q q 0 0 0 rg BT 92.08 527.10 Td (is ) Tj ET Q q 0 0 0 rg BT 101.33 527.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 146.68 527.10 Td (as ) Tj ET Q q 0 0 0 rg BT 157.59 527.10 Td (an ) Tj ET Q q 0 0 0 rg BT 169.61 527.10 Td (orphan ) Tj ET Q q 0 0 0 rg BT 199.96 527.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 220.88 527.10 Td (can ) Tj ET Q q 0 0 0 rg BT 237.34 527.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 268.78 527.10 Td (seven ) Tj ET Q q 0 0 0 rg BT 294.13 527.10 Td (years ) Tj ET Q q 0 0 0 rg BT 317.82 527.10 Td (of ) Tj ET Q q 0 0 0 rg BT 328.73 527.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 375.19 527.10 Td (for ) Tj ET Q q 0 0 0 rg BT 389.44 527.10 Td (the ) Tj ET Q q 0 0 0 rg BT 404.24 527.10 Td (orphan ) Tj ET Q q 0 0 0 rg BT 434.59 527.10 Td (indication. ) Tj ET Q q 0 0 0 rg BT 479.66 527.10 Td (During ) Tj ET Q q 0 0 0 rg BT 510.58 527.10 Td (this ) Tj ET Q q 0 0 0 rg BT 527.61 527.10 Td (time ) Tj ET Q q 0 0 0 rg BT 547.96 527.10 Td (period, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 515.10 Td (neither ) Tj ET Q q 0 0 0 rg BT 66.21 515.10 Td (NDAs ) Tj ET Q q 0 0 0 rg BT 94.22 515.10 Td (nor ) Tj ET Q q 0 0 0 rg BT 109.99 515.10 Td (aNDAs ) Tj ET Q q 0 0 0 rg BT 142.44 515.10 Td (for ) Tj ET Q q 0 0 0 rg BT 156.54 515.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.21 515.10 Td (same ) Tj ET Q q 0 0 0 rg BT 194.20 515.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 214.98 515.10 Td (product ) Tj ET Q q 0 0 0 rg BT 247.98 515.10 Td (can ) Tj ET Q q 0 0 0 rg BT 264.30 515.10 Td (be ) Tj ET Q q 0 0 0 rg BT 276.19 515.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 315.84 515.10 Td (for ) Tj ET Q q 0 0 0 rg BT 329.95 515.10 Td (the ) Tj ET Q q 0 0 0 rg BT 344.61 515.10 Td (same ) Tj ET Q q 0 0 0 rg BT 367.61 515.10 Td (orphan ) Tj ET Q q 0 0 0 rg BT 397.83 515.10 Td (use. ) Tj ET Q q 0 0 0 rg BT 415.56 515.10 Td (A) Tj ET Q q 0 0 0 rg BT 422.23 515.10 Td ( ) Tj ET Q q 0 0 0 rg BT 424.68 515.10 Td (company ) Tj ET Q q 0 0 0 rg BT 463.78 515.10 Td (may ) Tj ET Q q 0 0 0 rg BT 483.45 515.10 Td (also ) Tj ET Q q 0 0 0 rg BT 502.00 515.10 Td (earn ) Tj ET Q q 0 0 0 rg BT 521.66 515.10 Td (six ) Tj ET Q q 0 0 0 rg BT 535.78 515.10 Td (months ) Tj ET Q q 0 0 0 rg BT 567.67 515.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 79.09 503.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 126.07 503.10 Td (for ) Tj ET Q q 0 0 0 rg BT 140.83 503.10 Td (a ) Tj ET Q q 0 0 0 rg BT 148.37 503.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 169.80 503.10 Td (where ) Tj ET Q q 0 0 0 rg BT 197.33 503.10 Td (specific ) Tj ET Q q 0 0 0 rg BT 231.52 503.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 264.05 503.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 287.14 503.10 Td (are ) Tj ET Q q 0 0 0 rg BT 302.45 503.10 Td (conducted ) Tj ET Q q 0 0 0 rg BT 346.64 503.10 Td (at ) Tj ET Q q 0 0 0 rg BT 356.96 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 372.28 503.10 Td (written ) Tj ET Q q 0 0 0 rg BT 403.70 503.10 Td (request ) Tj ET Q q 0 0 0 rg BT 435.68 503.10 Td (of ) Tj ET Q q 0 0 0 rg BT 447.11 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 462.42 503.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 481.88 503.10 Td ( ) Tj ET Q q 0 0 0 rg BT 484.98 503.10 Td (to ) Tj ET Q q 0 0 0 rg BT 495.85 503.10 Td (study ) Tj ET Q q 0 0 0 rg BT 520.62 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 535.94 503.10 Td (use ) Tj ET Q q 0 0 0 rg BT 552.37 503.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 503.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 491.10 Td (medicine ) Tj ET Q q 0 0 0 rg BT 75.15 491.10 Td (to ) Tj ET Q q 0 0 0 rg BT 85.43 491.10 Td (treat ) Tj ET Q q 0 0 0 rg BT 105.69 491.10 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 143.17 491.10 Td (patients, ) Tj ET Q q 0 0 0 rg BT 179.28 491.10 Td (and ) Tj ET Q q 0 0 0 rg BT 196.21 491.10 Td (submission ) Tj ET Q q 0 0 0 rg BT 243.72 491.10 Td (to ) Tj ET Q q 0 0 0 rg BT 254.00 491.10 Td (the ) Tj ET Q q 0 0 0 rg BT 268.72 491.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 288.17 491.10 Td ( ) Tj ET Q q 0 0 0 rg BT 290.67 491.10 Td (is ) Tj ET Q q 0 0 0 rg BT 299.84 491.10 Td (made ) Tj ET Q q 0 0 0 rg BT 324.00 491.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 345.94 491.10 Td (to ) Tj ET Q q 0 0 0 rg BT 356.21 491.10 Td (the ) Tj ET Q q 0 0 0 rg BT 370.93 491.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 388.99 491.10 Td (of ) Tj ET Q q 0 0 0 rg BT 399.82 491.10 Td (basic ) Tj ET Q q 0 0 0 rg BT 422.87 491.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 466.10 491.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 467.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 79.97 467.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 119.49 467.10 Td (under ) Tj ET Q q 0 0 0 rg BT 144.57 467.10 Td (an ) Tj ET Q q 0 0 0 rg BT 156.33 467.10 Td (NDA) Tj ET Q q 0 0 0 rg BT 177.44 467.10 Td ( ) Tj ET Q q 0 0 0 rg BT 179.75 467.10 Td (can ) Tj ET Q q 0 0 0 rg BT 195.95 467.10 Td (also ) Tj ET Q q 0 0 0 rg BT 214.37 467.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 245.55 467.10 Td (several ) Tj ET Q q 0 0 0 rg BT 276.18 467.10 Td (types ) Tj ET Q q 0 0 0 rg BT 299.60 467.10 Td (of ) Tj ET Q q 0 0 0 rg BT 310.24 467.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 353.65 467.10 Td (data ) Tj ET Q q 0 0 0 rg BT 372.62 467.10 Td (protection. ) Tj ET Q q 0 0 0 rg BT 417.47 467.10 Td (An ) Tj ET Q q 0 0 0 rg BT 432.00 467.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 476.53 467.10 Td (chemical ) Tj ET Q q 0 0 0 rg BT 514.93 467.10 Td (pharmaceutical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 455.10 Td (is ) Tj ET Q q 0 0 0 rg BT 45.85 455.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 79.01 455.10 Td (to ) Tj ET Q q 0 0 0 rg BT 89.96 455.10 Td (five ) Tj ET Q q 0 0 0 rg BT 108.69 455.10 Td (years ) Tj ET Q q 0 0 0 rg BT 132.96 455.10 Td (of ) Tj ET Q q 0 0 0 rg BT 144.47 455.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 188.73 455.10 Td (data ) Tj ET Q q 0 0 0 rg BT 208.57 455.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 252.28 455.10 Td (in ) Tj ET Q q 0 0 0 rg BT 263.24 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 278.63 455.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 302.09 455.10 Td (during ) Tj ET Q q 0 0 0 rg BT 331.37 455.10 Td (which ) Tj ET Q q 0 0 0 rg BT 358.98 455.10 Td (competitors ) Tj ET Q q 0 0 0 rg BT 409.37 455.10 Td (cannot ) Tj ET Q q 0 0 0 rg BT 439.20 455.10 Td (file ) Tj ET Q q 0 0 0 rg BT 455.70 455.10 Td (with ) Tj ET Q q 0 0 0 rg BT 476.66 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 492.05 455.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 511.50 455.10 Td ( ) Tj ET Q q 0 0 0 rg BT 514.68 455.10 Td (for ) Tj ET Q q 0 0 0 rg BT 529.51 455.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 567.67 455.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 443.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 67.76 443.10 Td (substitutes. ) Tj ET Q q 0 0 0 rg BT 114.83 443.10 Td (If ) Tj ET Q q 0 0 0 rg BT 123.83 443.10 Td (an ) Tj ET Q q 0 0 0 rg BT 135.60 443.10 Td (innovator) Tj ET Q q 0 0 0 rg BT 174.30 443.10 Td (’) Tj ET Q q 0 0 0 rg BT 177.08 443.10 Td (s ) Tj ET Q q 0 0 0 rg BT 183.31 443.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 210.08 443.10 Td (is ) Tj ET Q q 0 0 0 rg BT 219.09 443.10 Td (challenged, ) Tj ET Q q 0 0 0 rg BT 267.24 443.10 Td (as ) Tj ET Q q 0 0 0 rg BT 277.91 443.10 Td (described ) Tj ET Q q 0 0 0 rg BT 318.56 443.10 Td (above, ) Tj ET Q q 0 0 0 rg BT 347.28 443.10 Td (a ) Tj ET Q q 0 0 0 rg BT 354.06 443.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 385.82 443.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 441.46 443.10 Td (may ) Tj ET Q q 0 0 0 rg BT 461.01 443.10 Td (file ) Tj ET Q q 0 0 0 rg BT 476.68 443.10 Td (its ) Tj ET Q q 0 0 0 rg BT 488.47 443.10 Td (aNDA) Tj ET Q q 0 0 0 rg BT 514.02 443.10 Td ( ) Tj ET Q q 0 0 0 rg BT 516.36 443.10 Td (after ) Tj ET Q q 0 0 0 rg BT 537.01 443.10 Td (the ) Tj ET Q q 0 0 0 rg BT 551.57 443.10 Td (fourth ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 431.10 Td (year ) Tj ET Q q 0 0 0 rg BT 56.01 431.10 Td (of ) Tj ET Q q 0 0 0 rg BT 67.15 431.10 Td (the ) Tj ET Q q 0 0 0 rg BT 82.17 431.10 Td (five-year ) Tj ET Q q 0 0 0 rg BT 121.06 431.10 Td (data ) Tj ET Q q 0 0 0 rg BT 140.53 431.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 183.88 431.10 Td (period. ) Tj ET Q q 0 0 0 rg BT 214.11 431.10 Td (A) Tj ET Q q 0 0 0 rg BT 220.78 431.10 Td ( ) Tj ET Q q 0 0 0 rg BT 223.59 431.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 287.47 431.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 308.60 431.10 Td (product ) Tj ET Q q 0 0 0 rg BT 341.96 431.10 Td (that ) Tj ET Q q 0 0 0 rg BT 359.76 431.10 Td (contains ) Tj ET Q q 0 0 0 rg BT 395.89 431.10 Td (an ) Tj ET Q q 0 0 0 rg BT 408.14 431.10 Td (active ) Tj ET Q q 0 0 0 rg BT 434.81 431.10 Td (ingredient ) Tj ET Q q 0 0 0 rg BT 478.16 431.10 Td (that ) Tj ET Q q 0 0 0 rg BT 495.96 431.10 Td (has ) Tj ET Q q 0 0 0 rg BT 512.10 431.10 Td (been ) Tj ET Q q 0 0 0 rg BT 533.78 431.10 Td (previously ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 419.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 75.36 419.10 Td (in ) Tj ET Q q 0 0 0 rg BT 85.30 419.10 Td (an ) Tj ET Q q 0 0 0 rg BT 96.89 419.10 Td (NDA, ) Tj ET Q q 0 0 0 rg BT 123.21 419.10 Td (but ) Tj ET Q q 0 0 0 rg BT 138.15 419.10 Td (is ) Tj ET Q q 0 0 0 rg BT 146.97 419.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 186.33 419.10 Td (in ) Tj ET Q q 0 0 0 rg BT 196.27 419.10 Td (a ) Tj ET Q q 0 0 0 rg BT 202.86 419.10 Td (new ) Tj ET Q q 0 0 0 rg BT 221.68 419.10 Td (formulation, ) Tj ET Q q 0 0 0 rg BT 273.55 419.10 Td (but ) Tj ET Q q 0 0 0 rg BT 288.48 419.10 Td (not ) Tj ET Q q 0 0 0 rg BT 303.41 419.10 Td (for ) Tj ET Q q 0 0 0 rg BT 317.23 419.10 Td (the ) Tj ET Q q 0 0 0 rg BT 331.60 419.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 352.09 419.10 Td (itself, ) Tj ET Q q 0 0 0 rg BT 376.74 419.10 Td (or ) Tj ET Q q 0 0 0 rg BT 387.23 419.10 Td (for ) Tj ET Q q 0 0 0 rg BT 401.04 419.10 Td (a ) Tj ET Q q 0 0 0 rg BT 407.64 419.10 Td (new ) Tj ET Q q 0 0 0 rg BT 426.45 419.10 Td (indication ) Tj ET Q q 0 0 0 rg BT 468.60 419.10 Td (on ) Tj ET Q q 0 0 0 rg BT 480.75 419.10 Td (the ) Tj ET Q q 0 0 0 rg BT 495.13 419.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 517.28 419.10 Td (of ) Tj ET Q q 0 0 0 rg BT 527.77 419.10 Td (new ) Tj ET Q q 0 0 0 rg BT 546.58 419.10 Td (clinical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 407.10 Td (trials, ) Tj ET Q q 0 0 0 rg BT 61.00 407.10 Td (receives ) Tj ET Q q 0 0 0 rg BT 96.25 407.10 Td (three ) Tj ET Q q 0 0 0 rg BT 118.73 407.10 Td (years ) Tj ET Q q 0 0 0 rg BT 142.33 407.10 Td (of ) Tj ET Q q 0 0 0 rg BT 153.16 407.10 Td (data ) Tj ET Q q 0 0 0 rg BT 172.32 407.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 215.36 407.10 Td (for ) Tj ET Q q 0 0 0 rg BT 229.52 407.10 Td (that ) Tj ET Q q 0 0 0 rg BT 247.02 407.10 Td (formulation ) Tj ET Q q 0 0 0 rg BT 296.73 407.10 Td (or ) Tj ET Q q 0 0 0 rg BT 307.56 407.10 Td (indication.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 381.7669921875 m 107.0107421875 381.7669921875 l s q 0 0 0 rg BT 36.00 383.10 Td (Biologic pr) Tj ET Q q 0 0 0 rg BT 80.90 383.10 Td (oducts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.37 365.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.97 365.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 118.87 365.10 Td (legislation ) Tj ET Q q 0 0 0 rg BT 163.35 365.10 Td (enacted ) Tj ET Q q 0 0 0 rg BT 196.71 365.10 Td (in ) Tj ET Q q 0 0 0 rg BT 207.31 365.10 Td (2010 ) Tj ET Q q 0 0 0 rg BT 230.13 365.10 Td (created ) Tj ET Q q 0 0 0 rg BT 261.81 365.10 Td (an ) Tj ET Q q 0 0 0 rg BT 274.07 365.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 311.88 365.10 Td (pathway ) Tj ET Q q 0 0 0 rg BT 348.58 365.10 Td (for ) Tj ET Q q 0 0 0 rg BT 363.06 365.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 406.43 365.10 Td (versions ) Tj ET Q q 0 0 0 rg BT 442.58 365.10 Td (of ) Tj ET Q q 0 0 0 rg BT 453.73 365.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 498.77 365.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 541.58 365.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.10 Td (that ) Tj ET Q q 0 0 0 rg BT 54.23 353.10 Td (did ) Tj ET Q q 0 0 0 rg BT 70.25 353.10 Td (not ) Tj ET Q q 0 0 0 rg BT 86.26 353.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 131.71 353.10 Td (exist. ) Tj ET Q q 0 0 0 rg BT 156.34 353.10 Td (Prior ) Tj ET Q q 0 0 0 rg BT 179.57 353.10 Td (to ) Tj ET Q q 0 0 0 rg BT 190.59 353.10 Td (that ) Tj ET Q q 0 0 0 rg BT 208.82 353.10 Td (time, ) Tj ET Q q 0 0 0 rg BT 232.33 353.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 277.78 353.10 Td (biologics ) Tj ET Q q 0 0 0 rg BT 317.68 353.10 Td (had ) Tj ET Q q 0 0 0 rg BT 335.35 353.10 Td (essentially ) Tj ET Q q 0 0 0 rg BT 380.80 353.10 Td (unlimited ) Tj ET Q q 0 0 0 rg BT 422.37 353.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 466.70 353.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 509.93 353.10 Td (. ) Tj ET Q q 0 0 0 rg BT 515.67 353.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 543.89 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 559.35 353.10 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.52 341.10 Td (mechanism, ) Tj ET Q q 0 0 0 rg BT 129.99 341.10 Td (the ) Tj ET Q q 0 0 0 rg BT 144.64 341.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 164.09 341.10 Td ( ) Tj ET Q q 0 0 0 rg BT 166.52 341.10 Td (can ) Tj ET Q q 0 0 0 rg BT 182.82 341.10 Td (approve ) Tj ET Q q 0 0 0 rg BT 217.46 341.10 Td (products ) Tj ET Q q 0 0 0 rg BT 254.33 341.10 Td (that ) Tj ET Q q 0 0 0 rg BT 271.75 341.10 Td (are ) Tj ET Q q 0 0 0 rg BT 286.38 341.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 316.59 341.10 Td (to ) Tj ET Q q 0 0 0 rg BT 326.79 341.10 Td (\(but ) Tj ET Q q 0 0 0 rg BT 345.33 341.10 Td (not ) Tj ET Q q 0 0 0 rg BT 360.54 341.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 392.39 341.10 Td (copies ) Tj ET Q q 0 0 0 rg BT 420.36 341.10 Td (of\) ) Tj ET Q q 0 0 0 rg BT 434.45 341.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 479.09 341.10 Td (biologics ) Tj ET Q q 0 0 0 rg BT 518.18 341.10 Td (on ) Tj ET Q q 0 0 0 rg BT 530.61 341.10 Td (the ) Tj ET Q q 0 0 0 rg BT 545.26 341.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 567.69 341.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.10 Td (less ) Tj ET Q q 0 0 0 rg BT 53.33 329.10 Td (extensive ) Tj ET Q q 0 0 0 rg BT 93.42 329.10 Td (data ) Tj ET Q q 0 0 0 rg BT 112.40 329.10 Td (than ) Tj ET Q q 0 0 0 rg BT 131.94 329.10 Td (is ) Tj ET Q q 0 0 0 rg BT 140.93 329.10 Td (required ) Tj ET Q q 0 0 0 rg BT 176.58 329.10 Td (by ) Tj ET Q q 0 0 0 rg BT 188.90 329.10 Td (a ) Tj ET Q q 0 0 0 rg BT 195.67 329.10 Td (full ) Tj ET Q q 0 0 0 rg BT 211.88 329.10 Td (BLA. ) Tj ET Q q 0 0 0 rg BT 236.19 329.10 Td (After ) Tj ET Q q 0 0 0 rg BT 259.61 329.10 Td (an ) Tj ET Q q 0 0 0 rg BT 271.38 329.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 312.03 329.10 Td (has ) Tj ET Q q 0 0 0 rg BT 327.68 329.10 Td (marketed ) Tj ET Q q 0 0 0 rg BT 367.21 329.10 Td (its ) Tj ET Q q 0 0 0 rg BT 378.99 329.10 Td (product ) Tj ET Q q 0 0 0 rg BT 411.86 329.10 Td (for ) Tj ET Q q 0 0 0 rg BT 425.84 329.10 Td (four ) Tj ET Q q 0 0 0 rg BT 444.83 329.10 Td (years, ) Tj ET Q q 0 0 0 rg BT 470.75 329.10 Td (any ) Tj ET Q q 0 0 0 rg BT 487.52 329.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 543.15 329.10 Td (may ) Tj ET Q q 0 0 0 rg BT 562.69 329.10 Td (file ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.10 Td (an ) Tj ET Q q 0 0 0 rg BT 46.86 317.10 Td (application ) Tj ET Q q 0 0 0 rg BT 92.70 317.10 Td (for ) Tj ET Q q 0 0 0 rg BT 105.78 317.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 142.19 317.10 Td (of ) Tj ET Q q 0 0 0 rg BT 151.94 317.10 Td (a ) Tj ET Q q 0 0 0 rg BT 157.79 317.10 Td (“biosimilar” ) Tj ET Q q 0 0 0 rg BT 208.64 317.10 Td (version ) Tj ET Q q 0 0 0 rg BT 239.50 317.10 Td (of ) Tj ET Q q 0 0 0 rg BT 249.24 317.10 Td (the ) Tj ET Q q 0 0 0 rg BT 262.88 317.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 302.62 317.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 337.09 317.10 Td (However) Tj ET Q q 0 0 0 rg BT 373.34 317.10 Td (, ) Tj ET Q q 0 0 0 rg BT 377.26 317.10 Td (although ) Tj ET Q q 0 0 0 rg BT 413.67 317.10 Td (an ) Tj ET Q q 0 0 0 rg BT 424.53 317.10 Td (application ) Tj ET Q q 0 0 0 rg BT 470.38 317.10 Td (for ) Tj ET Q q 0 0 0 rg BT 483.45 317.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 519.86 317.10 Td (of ) Tj ET Q q 0 0 0 rg BT 529.61 317.10 Td (a ) Tj ET Q q 0 0 0 rg BT 535.46 317.10 Td (biosimilar ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.10 Td (may ) Tj ET Q q 0 0 0 rg BT 54.96 305.10 Td (be ) Tj ET Q q 0 0 0 rg BT 66.15 305.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 86.22 305.10 Td (four ) Tj ET Q q 0 0 0 rg BT 104.62 305.10 Td (years ) Tj ET Q q 0 0 0 rg BT 127.47 305.10 Td (after ) Tj ET Q q 0 0 0 rg BT 147.53 305.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 184.26 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 194.33 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 208.30 305.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 248.37 305.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 283.16 305.10 Td (qualified ) Tj ET Q q 0 0 0 rg BT 320.45 305.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 364.41 305.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 406.14 305.10 Td (products ) Tj ET Q q 0 0 0 rg BT 442.33 305.10 Td (will ) Tj ET Q q 0 0 0 rg BT 459.63 305.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 490.24 305.10 Td (12 ) Tj ET Q q 0 0 0 rg BT 501.98 305.10 Td (years ) Tj ET Q q 0 0 0 rg BT 524.83 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 534.90 305.10 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 79.23 293.10 Td (, ) Tj ET Q q 0 0 0 rg BT 84.34 293.10 Td (meaning ) Tj ET Q q 0 0 0 rg BT 121.38 293.10 Td (that ) Tj ET Q q 0 0 0 rg BT 138.99 293.10 Td (the ) Tj ET Q q 0 0 0 rg BT 153.81 293.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 173.27 293.10 Td ( ) Tj ET Q q 0 0 0 rg BT 175.88 293.10 Td (may ) Tj ET Q q 0 0 0 rg BT 195.70 293.10 Td (not ) Tj ET Q q 0 0 0 rg BT 211.09 293.10 Td (approve ) Tj ET Q q 0 0 0 rg BT 245.90 293.10 Td (a ) Tj ET Q q 0 0 0 rg BT 252.95 293.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 296.11 293.10 Td (version ) Tj ET Q q 0 0 0 rg BT 328.16 293.10 Td (until ) Tj ET Q q 0 0 0 rg BT 349.10 293.10 Td (12 ) Tj ET Q q 0 0 0 rg BT 361.71 293.10 Td (years ) Tj ET Q q 0 0 0 rg BT 385.42 293.10 Td (after ) Tj ET Q q 0 0 0 rg BT 406.34 293.10 Td (the ) Tj ET Q q 0 0 0 rg BT 421.17 293.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 465.99 293.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 508.59 293.10 Td (product ) Tj ET Q q 0 0 0 rg BT 541.75 293.10 Td (was ) Tj ET Q q 0 0 0 rg BT 559.91 293.10 Td (first ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 75.01 281.10 Td (by ) Tj ET Q q 0 0 0 rg BT 86.82 281.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.84 281.10 Td (FDA. ) Tj ET Q q 0 0 0 rg BT 125.02 281.10 Td (The ) Tj ET Q q 0 0 0 rg BT 142.38 281.10 Td (law ) Tj ET Q q 0 0 0 rg BT 158.62 281.10 Td (also ) Tj ET Q q 0 0 0 rg BT 176.54 281.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 212.78 281.10 Td (a ) Tj ET Q q 0 0 0 rg BT 219.03 281.10 Td (mechanism ) Tj ET Q q 0 0 0 rg BT 266.38 281.10 Td (for ) Tj ET Q q 0 0 0 rg BT 279.84 281.10 Td (innovators ) Tj ET Q q 0 0 0 rg BT 323.87 281.10 Td (to ) Tj ET Q q 0 0 0 rg BT 333.45 281.10 Td (enforce ) Tj ET Q q 0 0 0 rg BT 365.23 281.10 Td (the ) Tj ET Q q 0 0 0 rg BT 379.26 281.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 409.39 281.10 Td (that ) Tj ET Q q 0 0 0 rg BT 426.19 281.10 Td (protect ) Tj ET Q q 0 0 0 rg BT 455.76 281.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 499.78 281.10 Td (biological ) Tj ET Q q 0 0 0 rg BT 541.58 281.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.18 269.10 Td (for ) Tj ET Q q 0 0 0 rg BT 65.58 269.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 107.88 269.10 Td (applicants ) Tj ET Q q 0 0 0 rg BT 150.16 269.10 Td (to ) Tj ET Q q 0 0 0 rg BT 159.68 269.10 Td (challenge ) Tj ET Q q 0 0 0 rg BT 199.73 269.10 Td (the ) Tj ET Q q 0 0 0 rg BT 213.69 269.10 Td (patents. ) Tj ET Q q 0 0 0 rg BT 246.26 269.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 268.00 269.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 294.18 269.10 Td (litigation ) Tj ET Q q 0 0 0 rg BT 332.03 269.10 Td (may ) Tj ET Q q 0 0 0 rg BT 350.99 269.10 Td (begin ) Tj ET Q q 0 0 0 rg BT 374.95 269.10 Td (as ) Tj ET Q q 0 0 0 rg BT 385.02 269.10 Td (early ) Tj ET Q q 0 0 0 rg BT 406.75 269.10 Td (as ) Tj ET Q q 0 0 0 rg BT 416.82 269.10 Td (four ) Tj ET Q q 0 0 0 rg BT 435.22 269.10 Td (years ) Tj ET Q q 0 0 0 rg BT 458.06 269.10 Td (after ) Tj ET Q q 0 0 0 rg BT 478.12 269.10 Td (the ) Tj ET Q q 0 0 0 rg BT 492.08 269.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 536.03 269.10 Td (biological ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.10 Td (product ) Tj ET Q q 0 0 0 rg BT 69.05 257.10 Td (is ) Tj ET Q q 0 0 0 rg BT 78.22 257.10 Td (first ) Tj ET Q q 0 0 0 rg BT 96.83 257.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 136.53 257.10 Td (by ) Tj ET Q q 0 0 0 rg BT 149.03 257.10 Td (the ) Tj ET Q q 0 0 0 rg BT 163.75 257.10 Td (FDA.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.29 233.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.46 233.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 85.70 233.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.88 233.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 141.59 233.10 Td (likelihood ) Tj ET Q q 0 0 0 rg BT 185.10 233.10 Td (of ) Tj ET Q q 0 0 0 rg BT 196.39 233.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 228.77 233.10 Td (and ) Tj ET Q q 0 0 0 rg BT 246.17 233.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 289.68 233.10 Td (challenges ) Tj ET Q q 0 0 0 rg BT 334.84 233.10 Td (to ) Tj ET Q q 0 0 0 rg BT 345.57 233.10 Td (innovators’) Tj ET Q q 0 0 0 rg BT 390.38 233.10 Td ( ) Tj ET Q q 0 0 0 rg BT 393.34 233.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 440.72 233.10 Td (property ) Tj ET Q q 0 0 0 rg BT 477.55 233.10 Td (has ) Tj ET Q q 0 0 0 rg BT 493.84 233.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 534.55 233.10 Td (the ) Tj ET Q q 0 0 0 rg BT 549.73 233.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 567.69 233.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 53.79 221.10 Td (of ) Tj ET Q q 0 0 0 rg BT 64.34 221.10 Td (innovators’) Tj ET Q q 0 0 0 rg BT 109.15 221.10 Td ( ) Tj ET Q q 0 0 0 rg BT 111.37 221.10 Td (market ) Tj ET Q q 0 0 0 rg BT 141.36 221.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 184.59 221.10 Td (. ) Tj ET Q q 0 0 0 rg BT 189.32 221.10 Td (First, ) Tj ET Q q 0 0 0 rg BT 212.39 221.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 244.04 221.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 289.02 221.10 Td (have ) Tj ET Q q 0 0 0 rg BT 310.13 221.10 Td (increasingly ) Tj ET Q q 0 0 0 rg BT 361.22 221.10 Td (sought ) Tj ET Q q 0 0 0 rg BT 390.12 221.10 Td (to ) Tj ET Q q 0 0 0 rg BT 400.12 221.10 Td (challenge ) Tj ET Q q 0 0 0 rg BT 440.66 221.10 Td (innovators’) Tj ET Q q 0 0 0 rg BT 485.46 221.10 Td ( ) Tj ET Q q 0 0 0 rg BT 487.69 221.10 Td (basic ) Tj ET Q q 0 0 0 rg BT 510.46 221.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 541.01 221.10 Td (covering ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.10 Td (major ) Tj ET Q q 0 0 0 rg BT 62.63 209.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 127.02 209.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 167.27 209.10 Td (Second, ) Tj ET Q q 0 0 0 rg BT 202.51 209.10 Td (statutory ) Tj ET Q q 0 0 0 rg BT 240.82 209.10 Td (and ) Tj ET Q q 0 0 0 rg BT 258.57 209.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 302.97 209.10 Td (provisions ) Tj ET Q q 0 0 0 rg BT 347.95 209.10 Td (in ) Tj ET Q q 0 0 0 rg BT 359.04 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 374.56 209.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 395.66 209.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 417.86 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 433.38 209.10 Td (ability ) Tj ET Q q 0 0 0 rg BT 462.25 209.10 Td (of ) Tj ET Q q 0 0 0 rg BT 473.89 209.10 Td (an ) Tj ET Q q 0 0 0 rg BT 486.63 209.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 528.27 209.10 Td (company ) Tj ET Q q 0 0 0 rg BT 568.23 209.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.10 Td (prevent ) Tj ET Q q 0 0 0 rg BT 69.08 197.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 101.60 197.10 Td (and ) Tj ET Q q 0 0 0 rg BT 119.13 197.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 162.78 197.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 188.09 197.10 Td (from ) Tj ET Q q 0 0 0 rg BT 210.63 197.10 Td (being ) Tj ET Q q 0 0 0 rg BT 235.94 197.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 276.24 197.10 Td (and ) Tj ET Q q 0 0 0 rg BT 293.77 197.10 Td (launched ) Tj ET Q q 0 0 0 rg BT 332.96 197.10 Td (while ) Tj ET Q q 0 0 0 rg BT 358.27 197.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 385.80 197.10 Td (litigation ) Tj ET Q q 0 0 0 rg BT 425.01 197.10 Td (is ) Tj ET Q q 0 0 0 rg BT 434.77 197.10 Td (ongoing. ) Tj ET Q q 0 0 0 rg BT 472.46 197.10 Td (As ) Tj ET Q q 0 0 0 rg BT 486.67 197.10 Td (a ) Tj ET Q q 0 0 0 rg BT 494.20 197.10 Td (result ) Tj ET Q q 0 0 0 rg BT 519.51 197.10 Td (of ) Tj ET Q q 0 0 0 rg BT 530.94 197.10 Td (all ) Tj ET Q q 0 0 0 rg BT 544.03 197.10 Td (of ) Tj ET Q q 0 0 0 rg BT 555.45 197.10 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.10 Td (developments, ) Tj ET Q q 0 0 0 rg BT 97.13 185.10 Td (it ) Tj ET Q q 0 0 0 rg BT 105.78 185.10 Td (is ) Tj ET Q q 0 0 0 rg BT 115.53 185.10 Td (not ) Tj ET Q q 0 0 0 rg BT 131.40 185.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 167.27 185.10 Td (to ) Tj ET Q q 0 0 0 rg BT 178.13 185.10 Td (predict ) Tj ET Q q 0 0 0 rg BT 208.99 185.10 Td (the ) Tj ET Q q 0 0 0 rg BT 224.29 185.10 Td (length ) Tj ET Q q 0 0 0 rg BT 252.37 185.10 Td (of ) Tj ET Q q 0 0 0 rg BT 263.79 185.10 Td (market ) Tj ET Q q 0 0 0 rg BT 294.65 185.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 341.62 185.10 Td (for ) Tj ET Q q 0 0 0 rg BT 356.36 185.10 Td (a ) Tj ET Q q 0 0 0 rg BT 363.89 185.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 405.29 185.10 Td (product ) Tj ET Q q 0 0 0 rg BT 438.92 185.10 Td (with ) Tj ET Q q 0 0 0 rg BT 459.79 185.10 Td (certainty ) Tj ET Q q 0 0 0 rg BT 497.86 185.10 Td (based ) Tj ET Q q 0 0 0 rg BT 523.72 185.10 Td (solely ) Tj ET Q q 0 0 0 rg BT 550.69 185.10 Td (on ) Tj ET Q q 0 0 0 rg BT 563.78 185.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 79.04 173.10 Td (of ) Tj ET Q q 0 0 0 rg BT 89.87 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 104.59 173.10 Td (relevant ) Tj ET Q q 0 0 0 rg BT 139.29 173.10 Td (patent\(s\) ) Tj ET Q q 0 0 0 rg BT 176.78 173.10 Td (or ) Tj ET Q q 0 0 0 rg BT 187.61 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 202.32 173.10 Td (current ) Tj ET Q q 0 0 0 rg BT 233.14 173.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 258.97 173.10 Td (of ) Tj ET Q q 0 0 0 rg BT 269.80 173.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 313.39 173.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 356.63 173.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 149.10 Td (Eur) Tj ET Q q 0 0 0 rg BT 50.63 149.10 Td (opean Union) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 131.10 Td (Patents ) Tj ET Q q 0 0 0 rg BT 66.92 131.10 Td (on ) Tj ET Q q 0 0 0 rg BT 78.95 131.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 142.05 131.10 Td (products ) Tj ET Q q 0 0 0 rg BT 178.52 131.10 Td (are ) Tj ET Q q 0 0 0 rg BT 192.76 131.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 231.99 131.10 Td (enforceable ) Tj ET Q q 0 0 0 rg BT 280.65 131.10 Td (in ) Tj ET Q q 0 0 0 rg BT 290.46 131.10 Td (the ) Tj ET Q q 0 0 0 rg BT 304.71 131.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 320.07 131.10 Td (and, ) Tj ET Q q 0 0 0 rg BT 339.04 131.10 Td (as ) Tj ET Q q 0 0 0 rg BT 349.40 131.10 Td (in ) Tj ET Q q 0 0 0 rg BT 359.21 131.10 Td (the ) Tj ET Q q 0 0 0 rg BT 373.45 131.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 395.77 131.10 Td (may ) Tj ET Q q 0 0 0 rg BT 415.01 131.10 Td (be ) Tj ET Q q 0 0 0 rg BT 426.48 131.10 Td (extended ) Tj ET Q q 0 0 0 rg BT 464.61 131.10 Td (to ) Tj ET Q q 0 0 0 rg BT 474.41 131.10 Td (compensate ) Tj ET Q q 0 0 0 rg BT 523.65 131.10 Td (for ) Tj ET Q q 0 0 0 rg BT 537.34 131.10 Td (the ) Tj ET Q q 0 0 0 rg BT 551.58 131.10 Td (patent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 119.10 Td (term ) Tj ET Q q 0 0 0 rg BT 56.83 119.10 Td (lost ) Tj ET Q q 0 0 0 rg BT 73.77 119.10 Td (during ) Tj ET Q q 0 0 0 rg BT 102.38 119.10 Td (the ) Tj ET Q q 0 0 0 rg BT 117.10 119.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 160.69 119.10 Td (review ) Tj ET Q q 0 0 0 rg BT 190.40 119.10 Td (process. ) Tj ET Q q 0 0 0 rg BT 225.39 119.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 247.89 119.10 Td (extensions ) Tj ET Q q 0 0 0 rg BT 292.61 119.10 Td (are ) Tj ET Q q 0 0 0 rg BT 307.31 119.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 339.80 119.10 Td (on ) Tj ET Q q 0 0 0 rg BT 352.30 119.10 Td (a ) Tj ET Q q 0 0 0 rg BT 359.24 119.10 Td (country-by-country ) Tj ET Q q 0 0 0 rg BT 439.49 119.10 Td (basis.) Tj ET Q endstream endobj 13 0 obj <> endobj 14 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.59 749.10 Td (primary ) Tj ET Q q 0 0 0 rg BT 87.29 749.10 Td (route ) Tj ET Q q 0 0 0 rg BT 109.88 749.10 Td (we ) Tj ET Q q 0 0 0 rg BT 123.58 749.10 Td (use ) Tj ET Q q 0 0 0 rg BT 138.96 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 148.78 749.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 175.82 749.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 218.40 749.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 273.20 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.58 749.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 346.70 749.10 Td (products ) Tj ET Q q 0 0 0 rg BT 383.18 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 393.00 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 407.26 749.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 422.63 749.10 Td (is ) Tj ET Q q 0 0 0 rg BT 431.35 749.10 Td (through ) Tj ET Q q 0 0 0 rg BT 464.50 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 478.76 749.10 Td (“centralized ) Tj ET Q q 0 0 0 rg BT 529.10 749.10 Td (procedure.” ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (This ) Tj ET Q q 0 0 0 rg BT 57.40 737.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 101.00 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 111.29 737.10 Td (compulsory ) Tj ET Q q 0 0 0 rg BT 162.13 737.10 Td (for ) Tj ET Q q 0 0 0 rg BT 177.41 737.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 208.24 737.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 272.93 737.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 313.49 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 324.89 737.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 366.83 737.10 Td (those ) Tj ET Q q 0 0 0 rg BT 391.56 737.10 Td (using ) Tj ET Q q 0 0 0 rg BT 416.85 737.10 Td (biotechnological ) Tj ET Q q 0 0 0 rg BT 487.12 737.10 Td (processes, ) Tj ET Q q 0 0 0 rg BT 531.56 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 549.62 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 559.91 737.10 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (available ) Tj ET Q q 0 0 0 rg BT 73.94 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 87.45 725.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 116.50 725.10 Td (new ) Tj ET Q q 0 0 0 rg BT 135.01 725.10 Td (chemical ) Tj ET Q q 0 0 0 rg BT 172.95 725.10 Td (compounds ) Tj ET Q q 0 0 0 rg BT 220.91 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 237.19 725.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 275.57 725.10 Td (A) Tj ET Q q 0 0 0 rg BT 282.24 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 284.09 725.10 Td (company ) Tj ET Q q 0 0 0 rg BT 322.60 725.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 355.00 725.10 Td (to ) Tj ET Q q 0 0 0 rg BT 364.62 725.10 Td (market ) Tj ET Q q 0 0 0 rg BT 394.24 725.10 Td (an ) Tj ET Q q 0 0 0 rg BT 405.52 725.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 449.59 725.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 512.51 725.10 Td (product ) Tj ET Q q 0 0 0 rg BT 544.91 725.10 Td (through ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.28 713.10 Td (centralized ) Tj ET Q q 0 0 0 rg BT 98.21 713.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 141.25 713.10 Td (must ) Tj ET Q q 0 0 0 rg BT 163.76 713.10 Td (file ) Tj ET Q q 0 0 0 rg BT 180.15 713.10 Td (a ) Tj ET Q q 0 0 0 rg BT 187.65 713.10 Td (complete ) Tj ET Q q 0 0 0 rg BT 227.37 713.10 Td (set ) Tj ET Q q 0 0 0 rg BT 241.54 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 252.94 713.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 279.88 713.10 Td (data ) Tj ET Q q 0 0 0 rg BT 299.60 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 317.11 713.10 Td (ef) Tj ET Q q 0 0 0 rg BT 324.69 713.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 352.18 713.10 Td (data ) Tj ET Q q 0 0 0 rg BT 371.90 713.10 Td (as ) Tj ET Q q 0 0 0 rg BT 383.30 713.10 Td (part ) Tj ET Q q 0 0 0 rg BT 401.91 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 413.31 713.10 Td (an ) Tj ET Q q 0 0 0 rg BT 425.81 713.10 Td (MAA) Tj ET Q q 0 0 0 rg BT 448.59 713.10 Td ( ) Tj ET Q q 0 0 0 rg BT 451.66 713.10 Td (with ) Tj ET Q q 0 0 0 rg BT 472.50 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 487.79 713.10 Td (EMA. ) Tj ET Q q 0 0 0 rg BT 514.90 713.10 Td (After ) Tj ET Q q 0 0 0 rg BT 539.06 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 554.34 713.10 Td (EMA) Tj ET Q q 0 0 0 rg BT 576.01 713.10 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (evaluates ) Tj ET Q q 0 0 0 rg BT 75.94 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 90.89 701.10 Td (MAA, ) Tj ET Q q 0 0 0 rg BT 119.46 701.10 Td (it ) Tj ET Q q 0 0 0 rg BT 127.76 701.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 164.93 701.10 Td (a ) Tj ET Q q 0 0 0 rg BT 172.11 701.10 Td (recommendation ) Tj ET Q q 0 0 0 rg BT 242.04 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 252.56 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 267.51 701.10 Td (EC ) Tj ET Q q 0 0 0 rg BT 283.03 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 300.20 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 315.16 701.10 Td (EC ) Tj ET Q q 0 0 0 rg BT 330.67 701.10 Td (then ) Tj ET Q q 0 0 0 rg BT 350.62 701.10 Td (approves ) Tj ET Q q 0 0 0 rg BT 389.46 701.10 Td (or ) Tj ET Q q 0 0 0 rg BT 400.53 701.10 Td (denies ) Tj ET Q q 0 0 0 rg BT 428.81 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 443.76 701.10 Td (MAA. ) Tj ET Q q 0 0 0 rg BT 472.34 701.10 Td (It ) Tj ET Q q 0 0 0 rg BT 481.18 701.10 Td (is ) Tj ET Q q 0 0 0 rg BT 490.59 701.10 Td (also ) Tj ET Q q 0 0 0 rg BT 509.43 701.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 544.95 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 559.34 701.10 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (chemical ) Tj ET Q q 0 0 0 rg BT 73.96 689.10 Td (products ) Tj ET Q q 0 0 0 rg BT 110.26 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 119.91 689.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 146.77 689.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 189.18 689.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 243.80 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 253.45 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 267.53 689.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 282.73 689.10 Td (through ) Tj ET Q q 0 0 0 rg BT 315.70 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 322.01 689.10 Td (“mutual ) Tj ET Q q 0 0 0 rg BT 356.09 689.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 403.49 689.10 Td (procedure,” ) Tj ET Q q 0 0 0 rg BT 452.28 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 461.92 689.10 Td (which ) Tj ET Q q 0 0 0 rg BT 488.23 689.10 Td (an ) Tj ET Q q 0 0 0 rg BT 499.53 689.10 Td (application ) Tj ET Q q 0 0 0 rg BT 545.83 689.10 Td (is ) Tj ET Q q 0 0 0 rg BT 554.36 689.10 Td (made ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.71 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 54.07 677.10 Td (single ) Tj ET Q q 0 0 0 rg BT 80.89 677.10 Td (member ) Tj ET Q q 0 0 0 rg BT 116.58 677.10 Td (state, ) Tj ET Q q 0 0 0 rg BT 140.33 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 157.69 677.10 Td (if ) Tj ET Q q 0 0 0 rg BT 166.73 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 181.87 677.10 Td (member ) Tj ET Q q 0 0 0 rg BT 217.56 677.10 Td (state ) Tj ET Q q 0 0 0 rg BT 238.82 677.10 Td (approves ) Tj ET Q q 0 0 0 rg BT 277.84 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 292.99 677.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 356.99 677.10 Td (product ) Tj ET Q q 0 0 0 rg BT 390.46 677.10 Td (under ) Tj ET Q q 0 0 0 rg BT 416.16 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 423.52 677.10 Td (national ) Tj ET Q q 0 0 0 rg BT 458.66 677.10 Td (procedure, ) Tj ET Q q 0 0 0 rg BT 504.07 677.10 Td (then ) Tj ET Q q 0 0 0 rg BT 524.21 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 539.35 677.10 Td (applicant ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (may ) Tj ET Q q 0 0 0 rg BT 55.72 665.10 Td (submit ) Tj ET Q q 0 0 0 rg BT 85.44 665.10 Td (that ) Tj ET Q q 0 0 0 rg BT 102.94 665.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 140.42 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 150.70 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 165.42 665.10 Td (mutual ) Tj ET Q q 0 0 0 rg BT 195.69 665.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 243.73 665.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 286.21 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 297.04 665.10 Td (some ) Tj ET Q q 0 0 0 rg BT 320.65 665.10 Td (or ) Tj ET Q q 0 0 0 rg BT 331.48 665.10 Td (all ) Tj ET Q q 0 0 0 rg BT 343.97 665.10 Td (other ) Tj ET Q q 0 0 0 rg BT 367.02 665.10 Td (member ) Tj ET Q q 0 0 0 rg BT 402.28 665.10 Td (states.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (After ) Tj ET Q q 0 0 0 rg BT 60.04 641.10 Td (obtaining ) Tj ET Q q 0 0 0 rg BT 100.75 641.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 144.23 641.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 199.93 641.10 Td (approval, ) Tj ET Q q 0 0 0 rg BT 240.35 641.10 Td (a ) Tj ET Q q 0 0 0 rg BT 247.73 641.10 Td (company ) Tj ET Q q 0 0 0 rg BT 287.32 641.10 Td (must ) Tj ET Q q 0 0 0 rg BT 309.71 641.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 337.64 641.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 368.91 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 386.28 641.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 449.20 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 463.80 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 478.96 641.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 542.97 641.10 Td (product, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (which ) Tj ET Q q 0 0 0 rg BT 63.02 629.10 Td (is ) Tj ET Q q 0 0 0 rg BT 72.26 629.10 Td (typically ) Tj ET Q q 0 0 0 rg BT 109.83 629.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 140.74 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 151.09 629.10 Td (member ) Tj ET Q q 0 0 0 rg BT 186.43 629.10 Td (state ) Tj ET Q q 0 0 0 rg BT 207.34 629.10 Td (law) Tj ET Q q 0 0 0 rg BT 221.13 629.10 Td (. ) Tj ET Q q 0 0 0 rg BT 226.21 629.10 Td (In ) Tj ET Q q 0 0 0 rg BT 237.11 629.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 266.89 629.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 282.80 629.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 324.54 629.10 Td (this ) Tj ET Q q 0 0 0 rg BT 341.56 629.10 Td (process ) Tj ET Q q 0 0 0 rg BT 374.13 629.10 Td (can ) Tj ET Q q 0 0 0 rg BT 390.58 629.10 Td (take ) Tj ET Q q 0 0 0 rg BT 409.82 629.10 Td (place ) Tj ET Q q 0 0 0 rg BT 433.49 629.10 Td (simultaneously ) Tj ET Q q 0 0 0 rg BT 496.62 629.10 Td (while ) Tj ET Q q 0 0 0 rg BT 521.42 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 536.21 629.10 Td (product ) Tj ET Q q 0 0 0 rg BT 569.33 629.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (marketed ) Tj ET Q q 0 0 0 rg BT 75.97 617.10 Td (but ) Tj ET Q q 0 0 0 rg BT 91.52 617.10 Td (in ) Tj ET Q q 0 0 0 rg BT 102.07 617.10 Td (other ) Tj ET Q q 0 0 0 rg BT 125.39 617.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 141.49 617.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 183.41 617.10 Td (this ) Tj ET Q q 0 0 0 rg BT 200.63 617.10 Td (process ) Tj ET Q q 0 0 0 rg BT 233.39 617.10 Td (must ) Tj ET Q q 0 0 0 rg BT 255.61 617.10 Td (be ) Tj ET Q q 0 0 0 rg BT 267.82 617.10 Td (completed ) Tj ET Q q 0 0 0 rg BT 312.24 617.10 Td (before ) Tj ET Q q 0 0 0 rg BT 340.54 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 355.53 617.10 Td (company ) Tj ET Q q 0 0 0 rg BT 394.96 617.10 Td (can ) Tj ET Q q 0 0 0 rg BT 411.60 617.10 Td (market ) Tj ET Q q 0 0 0 rg BT 442.14 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 457.12 617.10 Td (new ) Tj ET Q q 0 0 0 rg BT 476.55 617.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 512.17 617.10 Td (The ) Tj ET Q q 0 0 0 rg BT 530.49 617.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 561.58 617.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 98.48 605.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 140.96 605.10 Td (can ) Tj ET Q q 0 0 0 rg BT 157.33 605.10 Td (take ) Tj ET Q q 0 0 0 rg BT 176.49 605.10 Td (months ) Tj ET Q q 0 0 0 rg BT 208.44 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 225.38 605.10 Td (sometimes ) Tj ET Q q 0 0 0 rg BT 270.65 605.10 Td (years ) Tj ET Q q 0 0 0 rg BT 294.25 605.10 Td (to ) Tj ET Q q 0 0 0 rg BT 304.53 605.10 Td (complete.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (Throughout ) Tj ET Q q 0 0 0 rg BT 86.42 581.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.84 581.10 Td (EU, ) Tj ET Q q 0 0 0 rg BT 120.88 581.10 Td (all ) Tj ET Q q 0 0 0 rg BT 134.08 581.10 Td (products ) Tj ET Q q 0 0 0 rg BT 171.72 581.10 Td (for ) Tj ET Q q 0 0 0 rg BT 186.58 581.10 Td (which ) Tj ET Q q 0 0 0 rg BT 214.23 581.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 257.97 581.10 Td (authorizations ) Tj ET Q q 0 0 0 rg BT 317.83 581.10 Td (have ) Tj ET Q q 0 0 0 rg BT 339.91 581.10 Td (been ) Tj ET Q q 0 0 0 rg BT 361.99 581.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 383.52 581.10 Td (after ) Tj ET Q q 0 0 0 rg BT 405.04 581.10 Td (October/November ) Tj ET Q q 0 0 0 rg BT 485.44 581.10 Td (2005 ) Tj ET Q q 0 0 0 rg BT 508.64 581.10 Td (are ) Tj ET Q q 0 0 0 rg BT 524.06 581.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 555.59 581.10 Td (to ) Tj ET Q q 0 0 0 rg BT 566.57 581.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (“8+2+1” ) Tj ET Q q 0 0 0 rg BT 72.88 569.10 Td (regime. ) Tj ET Q q 0 0 0 rg BT 104.88 569.10 Td (Eight ) Tj ET Q q 0 0 0 rg BT 128.27 569.10 Td (years ) Tj ET Q q 0 0 0 rg BT 151.09 569.10 Td (after ) Tj ET Q q 0 0 0 rg BT 171.14 569.10 Td (the ) Tj ET Q q 0 0 0 rg BT 185.08 569.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 225.13 569.10 Td (has ) Tj ET Q q 0 0 0 rg BT 240.19 569.10 Td (received ) Tj ET Q q 0 0 0 rg BT 275.78 569.10 Td (its ) Tj ET Q q 0 0 0 rg BT 286.96 569.10 Td (first ) Tj ET Q q 0 0 0 rg BT 304.79 569.10 Td (community ) Tj ET Q q 0 0 0 rg BT 352.07 569.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 406.56 569.10 Td (for ) Tj ET Q q 0 0 0 rg BT 419.95 569.10 Td (a ) Tj ET Q q 0 0 0 rg BT 426.11 569.10 Td (medicinal ) Tj ET Q q 0 0 0 rg BT 467.27 569.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 502.04 569.10 Td (a ) Tj ET Q q 0 0 0 rg BT 508.21 569.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 539.36 569.10 Td (company ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (may ) Tj ET Q q 0 0 0 rg BT 55.87 557.10 Td (file ) Tj ET Q q 0 0 0 rg BT 71.84 557.10 Td (a ) Tj ET Q q 0 0 0 rg BT 78.93 557.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 122.12 557.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 177.53 557.10 Td (application ) Tj ET Q q 0 0 0 rg BT 224.60 557.10 Td (for ) Tj ET Q q 0 0 0 rg BT 238.91 557.10 Td (that ) Tj ET Q q 0 0 0 rg BT 256.56 557.10 Td (product ) Tj ET Q q 0 0 0 rg BT 289.75 557.10 Td (with ) Tj ET Q q 0 0 0 rg BT 310.18 557.10 Td (the ) Tj ET Q q 0 0 0 rg BT 325.05 557.10 Td (health ) Tj ET Q q 0 0 0 rg BT 352.13 557.10 Td (authorities. ) Tj ET Q q 0 0 0 rg BT 399.49 557.10 Td (If ) Tj ET Q q 0 0 0 rg BT 408.80 557.10 Td (the ) Tj ET Q q 0 0 0 rg BT 423.66 557.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 466.85 557.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 522.26 557.10 Td (application ) Tj ET Q q 0 0 0 rg BT 569.34 557.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (approved, ) Tj ET Q q 0 0 0 rg BT 77.49 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 91.50 545.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 122.71 545.10 Td (company ) Tj ET Q q 0 0 0 rg BT 161.15 545.10 Td (may ) Tj ET Q q 0 0 0 rg BT 180.16 545.10 Td (not ) Tj ET Q q 0 0 0 rg BT 194.72 545.10 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 255.36 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 269.36 545.10 Td (product ) Tj ET Q q 0 0 0 rg BT 301.70 545.10 Td (until ) Tj ET Q q 0 0 0 rg BT 321.82 545.10 Td (after ) Tj ET Q q 0 0 0 rg BT 341.92 545.10 Td (either ) Tj ET Q q 0 0 0 rg BT 366.47 545.10 Td (10 ) Tj ET Q q 0 0 0 rg BT 378.26 545.10 Td (or ) Tj ET Q q 0 0 0 rg BT 388.38 545.10 Td (1) Tj ET Q q 0 0 0 rg BT 393.01 545.10 Td (1 ) Tj ET Q q 0 0 0 rg BT 399.79 545.10 Td (years ) Tj ET Q q 0 0 0 rg BT 422.68 545.10 Td (have ) Tj ET Q q 0 0 0 rg BT 443.34 545.10 Td (elapsed ) Tj ET Q q 0 0 0 rg BT 475.12 545.10 Td (from ) Tj ET Q q 0 0 0 rg BT 496.34 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 510.35 545.10 Td (initial ) Tj ET Q q 0 0 0 rg BT 535.46 545.10 Td (marketing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 91.23 533.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 123.69 533.10 Td (to ) Tj ET Q q 0 0 0 rg BT 133.95 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 148.64 533.10 Td (innovator) Tj ET Q q 0 0 0 rg BT 186.41 533.10 Td (. ) Tj ET Q q 0 0 0 rg BT 191.21 533.10 Td (The ) Tj ET Q q 0 0 0 rg BT 209.23 533.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 244.48 533.10 Td (extension ) Tj ET Q q 0 0 0 rg BT 285.28 533.10 Td (to ) Tj ET Q q 0 0 0 rg BT 295.53 533.10 Td (1) Tj ET Q q 0 0 0 rg BT 300.16 533.10 Td (1 ) Tj ET Q q 0 0 0 rg BT 307.64 533.10 Td (years ) Tj ET Q q 0 0 0 rg BT 331.21 533.10 Td (is ) Tj ET Q q 0 0 0 rg BT 340.35 533.10 Td (available ) Tj ET Q q 0 0 0 rg BT 378.92 533.10 Td (if ) Tj ET Q q 0 0 0 rg BT 387.50 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 402.19 533.10 Td (innovator) Tj ET Q q 0 0 0 rg BT 440.12 533.10 Td (, ) Tj ET Q q 0 0 0 rg BT 445.09 533.10 Td (during ) Tj ET Q q 0 0 0 rg BT 473.68 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 488.37 533.10 Td (first ) Tj ET Q q 0 0 0 rg BT 506.95 533.10 Td (eight ) Tj ET Q q 0 0 0 rg BT 529.42 533.10 Td (years ) Tj ET Q q 0 0 0 rg BT 552.99 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 533.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 78.58 521.10 Td (authorization, ) Tj ET Q q 0 0 0 rg BT 135.87 521.10 Td (obtains ) Tj ET Q q 0 0 0 rg BT 166.79 521.10 Td (an ) Tj ET Q q 0 0 0 rg BT 178.26 521.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 220.28 521.10 Td (indication ) Tj ET Q q 0 0 0 rg BT 262.31 521.10 Td (that ) Tj ET Q q 0 0 0 rg BT 279.34 521.10 Td (is ) Tj ET Q q 0 0 0 rg BT 288.04 521.10 Td (of ) Tj ET Q q 0 0 0 rg BT 298.40 521.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 342.65 521.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 374.11 521.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 403.91 521.10 Td (in ) Tj ET Q q 0 0 0 rg BT 413.72 521.10 Td (comparison ) Tj ET Q q 0 0 0 rg BT 462.41 521.10 Td (with ) Tj ET Q q 0 0 0 rg BT 482.22 521.10 Td (existing ) Tj ET Q q 0 0 0 rg BT 515.92 521.10 Td (treatments. ) Tj ET Q q 0 0 0 rg BT 562.11 521.10 Td (For ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.10 Td (products ) Tj ET Q q 0 0 0 rg BT 73.10 509.10 Td (that ) Tj ET Q q 0 0 0 rg BT 90.75 509.10 Td (were ) Tj ET Q q 0 0 0 rg BT 112.84 509.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 133.82 509.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 155.91 509.10 Td (to ) Tj ET Q q 0 0 0 rg BT 166.35 509.10 Td (October/November ) Tj ET Q q 0 0 0 rg BT 246.20 509.10 Td (2005, ) Tj ET Q q 0 0 0 rg BT 271.36 509.10 Td (there ) Tj ET Q q 0 0 0 rg BT 294.00 509.10 Td (is ) Tj ET Q q 0 0 0 rg BT 303.33 509.10 Td (a ) Tj ET Q q 0 0 0 rg BT 310.43 509.10 Td (10-year ) Tj ET Q q 0 0 0 rg BT 343.62 509.10 Td (period ) Tj ET Q q 0 0 0 rg BT 371.82 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 382.81 509.10 Td (data ) Tj ET Q q 0 0 0 rg BT 402.13 509.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 445.33 509.10 Td (under ) Tj ET Q q 0 0 0 rg BT 470.75 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 485.63 509.10 Td (centralized ) Tj ET Q q 0 0 0 rg BT 532.14 509.10 Td (procedures ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 497.10 Td (a ) Tj ET Q q 0 0 0 rg BT 59.88 497.10 Td (period ) Tj ET Q q 0 0 0 rg BT 87.92 497.10 Td (of ) Tj ET Q q 0 0 0 rg BT 98.75 497.10 Td (either ) Tj ET Q q 0 0 0 rg BT 124.02 497.10 Td (six ) Tj ET Q q 0 0 0 rg BT 138.19 497.10 Td (or ) Tj ET Q q 0 0 0 rg BT 149.02 497.10 Td (10 ) Tj ET Q q 0 0 0 rg BT 161.52 497.10 Td (years ) Tj ET Q q 0 0 0 rg BT 185.12 497.10 Td (under ) Tj ET Q q 0 0 0 rg BT 210.38 497.10 Td (the ) Tj ET Q q 0 0 0 rg BT 225.10 497.10 Td (mutual ) Tj ET Q q 0 0 0 rg BT 255.38 497.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 303.42 497.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 345.89 497.10 Td (\(depending ) Tj ET Q q 0 0 0 rg BT 393.38 497.10 Td (on ) Tj ET Q q 0 0 0 rg BT 405.88 497.10 Td (the ) Tj ET Q q 0 0 0 rg BT 420.59 497.10 Td (member ) Tj ET Q q 0 0 0 rg BT 455.86 497.10 Td (state\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.98 473.10 Td (contrast ) Tj ET Q q 0 0 0 rg BT 81.29 473.10 Td (to ) Tj ET Q q 0 0 0 rg BT 91.73 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 106.60 473.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 129.53 473.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 160.51 473.10 Td (in ) Tj ET Q q 0 0 0 rg BT 170.94 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 185.81 473.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 201.80 473.10 Td (are ) Tj ET Q q 0 0 0 rg BT 216.66 473.10 Td (not ) Tj ET Q q 0 0 0 rg BT 232.09 473.10 Td (listed ) Tj ET Q q 0 0 0 rg BT 256.41 473.10 Td (with ) Tj ET Q q 0 0 0 rg BT 276.84 473.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 320.59 473.10 Td (authorities. ) Tj ET Q q 0 0 0 rg BT 367.96 473.10 Td (Generic ) Tj ET Q q 0 0 0 rg BT 402.25 473.10 Td (versions ) Tj ET Q q 0 0 0 rg BT 438.24 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 449.22 473.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 512.95 473.10 Td (products ) Tj ET Q q 0 0 0 rg BT 550.04 473.10 Td (can ) Tj ET Q q 0 0 0 rg BT 566.57 473.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 76.07 461.10 Td (after ) Tj ET Q q 0 0 0 rg BT 97.25 461.10 Td (data ) Tj ET Q q 0 0 0 rg BT 116.77 461.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 160.18 461.10 Td (expires, ) Tj ET Q q 0 0 0 rg BT 194.42 461.10 Td (regardless ) Tj ET Q q 0 0 0 rg BT 237.83 461.10 Td (of ) Tj ET Q q 0 0 0 rg BT 249.02 461.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 284.09 461.10 Td (the ) Tj ET Q q 0 0 0 rg BT 299.17 461.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 340.37 461.10 Td (holds ) Tj ET Q q 0 0 0 rg BT 364.90 461.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 396.09 461.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 433.94 461.10 Td (its ) Tj ET Q q 0 0 0 rg BT 446.25 461.10 Td (drug. ) Tj ET Q q 0 0 0 rg BT 469.74 461.10 Td (Thus, ) Tj ET Q q 0 0 0 rg BT 495.11 461.10 Td (it ) Tj ET Q q 0 0 0 rg BT 503.53 461.10 Td (is ) Tj ET Q q 0 0 0 rg BT 513.06 461.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 548.71 461.10 Td (that ) Tj ET Q q 0 0 0 rg BT 566.57 461.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 77.23 449.10 Td (may ) Tj ET Q q 0 0 0 rg BT 97.35 449.10 Td (be ) Tj ET Q q 0 0 0 rg BT 109.69 449.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 143.13 449.10 Td (to ) Tj ET Q q 0 0 0 rg BT 153.81 449.10 Td (enforce ) Tj ET Q q 0 0 0 rg BT 186.69 449.10 Td (its ) Tj ET Q q 0 0 0 rg BT 199.04 449.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 230.27 449.10 Td (against ) Tj ET Q q 0 0 0 rg BT 261.50 449.10 Td (a ) Tj ET Q q 0 0 0 rg BT 268.84 449.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 301.16 449.10 Td (competitor ) Tj ET Q q 0 0 0 rg BT 347.38 449.10 Td (that ) Tj ET Q q 0 0 0 rg BT 365.28 449.10 Td (is ) Tj ET Q q 0 0 0 rg BT 374.85 449.10 Td (already ) Tj ET Q q 0 0 0 rg BT 407.18 449.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 450.62 449.10 Td (its ) Tj ET Q q 0 0 0 rg BT 462.97 449.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 498.28 449.10 Td (Also, ) Tj ET Q q 0 0 0 rg BT 522.57 449.10 Td (the ) Tj ET Q q 0 0 0 rg BT 537.69 449.10 Td (European ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 63.71 437.10 Td (system ) Tj ET Q q 0 0 0 rg BT 94.77 437.10 Td (has ) Tj ET Q q 0 0 0 rg BT 111.38 437.10 Td (an ) Tj ET Q q 0 0 0 rg BT 124.09 437.10 Td (opposition ) Tj ET Q q 0 0 0 rg BT 169.60 437.10 Td (procedure ) Tj ET Q q 0 0 0 rg BT 212.85 437.10 Td (in ) Tj ET Q q 0 0 0 rg BT 223.91 437.10 Td (which ) Tj ET Q q 0 0 0 rg BT 251.62 437.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 284.32 437.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 344.79 437.10 Td (may ) Tj ET Q q 0 0 0 rg BT 365.29 437.10 Td (challenge ) Tj ET Q q 0 0 0 rg BT 406.88 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.37 437.10 Td (validity ) Tj ET Q q 0 0 0 rg BT 456.20 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 467.81 437.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 499.41 437.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 537.68 437.10 Td (innovator ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.10 Td (products ) Tj ET Q q 0 0 0 rg BT 72.94 425.10 Td (within ) Tj ET Q q 0 0 0 rg BT 101.00 425.10 Td (nine ) Tj ET Q q 0 0 0 rg BT 120.71 425.10 Td (months ) Tj ET Q q 0 0 0 rg BT 152.66 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 163.49 425.10 Td (grant.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.51 401.10 Td (general, ) Tj ET Q q 0 0 0 rg BT 80.62 401.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 96.14 401.10 Td (law ) Tj ET Q q 0 0 0 rg BT 112.76 401.10 Td (treats ) Tj ET Q q 0 0 0 rg BT 136.60 401.10 Td (chemically-synthesized ) Tj ET Q q 0 0 0 rg BT 232.63 401.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 257.04 401.10 Td (and ) Tj ET Q q 0 0 0 rg BT 273.66 401.10 Td (biologically-derived ) Tj ET Q q 0 0 0 rg BT 356.93 401.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 381.34 401.10 Td (the ) Tj ET Q q 0 0 0 rg BT 395.74 401.10 Td (same ) Tj ET Q q 0 0 0 rg BT 418.47 401.10 Td (with ) Tj ET Q q 0 0 0 rg BT 438.43 401.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 468.93 401.10 Td (to ) Tj ET Q q 0 0 0 rg BT 478.89 401.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 525.50 401.10 Td (property ) Tj ET Q q 0 0 0 rg BT 561.56 401.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.10 Td (data ) Tj ET Q q 0 0 0 rg BT 54.83 389.10 Td (protection. ) Tj ET Q q 0 0 0 rg BT 100.04 389.10 Td (In ) Tj ET Q q 0 0 0 rg BT 110.54 389.10 Td (addition ) Tj ET Q q 0 0 0 rg BT 145.49 389.10 Td (to ) Tj ET Q q 0 0 0 rg BT 155.44 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 169.83 389.10 Td (relevant ) Tj ET Q q 0 0 0 rg BT 204.20 389.10 Td (legislation ) Tj ET Q q 0 0 0 rg BT 248.03 389.10 Td (and ) Tj ET Q q 0 0 0 rg BT 264.64 389.10 Td (annexes ) Tj ET Q q 0 0 0 rg BT 299.02 389.10 Td (related ) Tj ET Q q 0 0 0 rg BT 328.40 389.10 Td (to ) Tj ET Q q 0 0 0 rg BT 338.35 389.10 Td (biologic ) Tj ET Q q 0 0 0 rg BT 373.29 389.10 Td (medicinal ) Tj ET Q q 0 0 0 rg BT 414.89 389.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 454.00 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 468.39 389.10 Td (EMA) Tj ET Q q 0 0 0 rg BT 490.06 389.10 Td ( ) Tj ET Q q 0 0 0 rg BT 492.23 389.10 Td (has ) Tj ET Q q 0 0 0 rg BT 507.74 389.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 534.91 389.10 Td (guidelines ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.10 Td (that ) Tj ET Q q 0 0 0 rg BT 54.11 377.10 Td (outline ) Tj ET Q q 0 0 0 rg BT 85.00 377.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.34 377.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 143.45 377.10 Td (information ) Tj ET Q q 0 0 0 rg BT 193.78 377.10 Td (to ) Tj ET Q q 0 0 0 rg BT 204.67 377.10 Td (be ) Tj ET Q q 0 0 0 rg BT 217.23 377.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 255.89 377.10 Td (for ) Tj ET Q q 0 0 0 rg BT 270.67 377.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 314.34 377.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 354.40 377.10 Td (also ) Tj ET Q q 0 0 0 rg BT 373.62 377.10 Td (known ) Tj ET Q q 0 0 0 rg BT 403.96 377.10 Td (as ) Tj ET Q q 0 0 0 rg BT 415.41 377.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 447.95 377.10 Td (biologics, ) Tj ET Q q 0 0 0 rg BT 490.23 377.10 Td (in ) Tj ET Q q 0 0 0 rg BT 501.13 377.10 Td (order ) Tj ET Q q 0 0 0 rg BT 525.35 377.10 Td (to ) Tj ET Q q 0 0 0 rg BT 536.24 377.10 Td (review ) Tj ET Q q 0 0 0 rg BT 566.57 377.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (application ) Tj ET Q q 0 0 0 rg BT 82.93 365.10 Td (for ) Tj ET Q q 0 0 0 rg BT 97.09 365.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 140.13 365.10 Td (approval.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (Japan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.72 323.10 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 74.38 323.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 117.31 323.10 Td (of ) Tj ET Q q 0 0 0 rg BT 128.03 323.10 Td (new ) Tj ET Q q 0 0 0 rg BT 147.08 323.10 Td (chemical ) Tj ET Q q 0 0 0 rg BT 185.55 323.10 Td (entities ) Tj ET Q q 0 0 0 rg BT 216.83 323.10 Td (are ) Tj ET Q q 0 0 0 rg BT 231.42 323.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 271.01 323.10 Td (af) Tj ET Q q 0 0 0 rg BT 278.60 323.10 Td (forded ) Tj ET Q q 0 0 0 rg BT 307.09 323.10 Td (eight ) Tj ET Q q 0 0 0 rg BT 329.47 323.10 Td (years ) Tj ET Q q 0 0 0 rg BT 352.96 323.10 Td (of ) Tj ET Q q 0 0 0 rg BT 363.68 323.10 Td (data ) Tj ET Q q 0 0 0 rg BT 382.72 323.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 429.00 323.10 Td (for ) Tj ET Q q 0 0 0 rg BT 443.04 323.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 482.64 323.10 Td (indications ) Tj ET Q q 0 0 0 rg BT 528.91 323.10 Td (and ) Tj ET Q q 0 0 0 rg BT 545.74 323.10 Td (dosage. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.10 Td (Patents ) Tj ET Q q 0 0 0 rg BT 68.04 311.10 Td (on ) Tj ET Q q 0 0 0 rg BT 81.20 311.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 145.44 311.10 Td (products ) Tj ET Q q 0 0 0 rg BT 183.03 311.10 Td (are ) Tj ET Q q 0 0 0 rg BT 198.40 311.10 Td (enforceable. ) Tj ET Q q 0 0 0 rg BT 250.69 311.10 Td (Generic ) Tj ET Q q 0 0 0 rg BT 285.49 311.10 Td (copies ) Tj ET Q q 0 0 0 rg BT 314.20 311.10 Td (can ) Tj ET Q q 0 0 0 rg BT 331.23 311.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 363.25 311.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 407.50 311.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 445.65 311.10 Td (after ) Tj ET Q q 0 0 0 rg BT 467.12 311.10 Td (data ) Tj ET Q q 0 0 0 rg BT 486.93 311.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 533.97 311.10 Td (and ) Tj ET Q q 0 0 0 rg BT 551.57 311.10 Td (patent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.10 Td (expirations. ) Tj ET Q q 0 0 0 rg BT 84.54 299.10 Td (As ) Tj ET Q q 0 0 0 rg BT 97.71 299.10 Td (in ) Tj ET Q q 0 0 0 rg BT 107.55 299.10 Td (the ) Tj ET Q q 0 0 0 rg BT 121.83 299.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 144.17 299.10 Td (patents ) Tj ET Q q 0 0 0 rg BT 174.56 299.10 Td (in ) Tj ET Q q 0 0 0 rg BT 184.40 299.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 209.23 299.10 Td (may ) Tj ET Q q 0 0 0 rg BT 228.50 299.10 Td (be ) Tj ET Q q 0 0 0 rg BT 240.00 299.10 Td (extended ) Tj ET Q q 0 0 0 rg BT 278.16 299.10 Td (to ) Tj ET Q q 0 0 0 rg BT 288.00 299.10 Td (compensate ) Tj ET Q q 0 0 0 rg BT 337.26 299.10 Td (for ) Tj ET Q q 0 0 0 rg BT 350.98 299.10 Td (the ) Tj ET Q q 0 0 0 rg BT 365.26 299.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 391.75 299.10 Td (term ) Tj ET Q q 0 0 0 rg BT 412.14 299.10 Td (lost ) Tj ET Q q 0 0 0 rg BT 428.65 299.10 Td (during ) Tj ET Q q 0 0 0 rg BT 456.81 299.10 Td (the ) Tj ET Q q 0 0 0 rg BT 471.09 299.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 514.25 299.10 Td (review ) Tj ET Q q 0 0 0 rg BT 543.51 299.10 Td (process.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.65 275.10 Td (general, ) Tj ET Q q 0 0 0 rg BT 80.90 275.10 Td (Japanese ) Tj ET Q q 0 0 0 rg BT 118.76 275.10 Td (law ) Tj ET Q q 0 0 0 rg BT 135.52 275.10 Td (treats ) Tj ET Q q 0 0 0 rg BT 159.49 275.10 Td (chemically-synthesized ) Tj ET Q q 0 0 0 rg BT 255.67 275.10 Td (and ) Tj ET Q q 0 0 0 rg BT 272.43 275.10 Td (biologically-derived ) Tj ET Q q 0 0 0 rg BT 355.83 275.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 380.38 275.10 Td (the ) Tj ET Q q 0 0 0 rg BT 394.92 275.10 Td (same ) Tj ET Q q 0 0 0 rg BT 417.78 275.10 Td (with ) Tj ET Q q 0 0 0 rg BT 437.88 275.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 468.52 275.10 Td (to ) Tj ET Q q 0 0 0 rg BT 478.62 275.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 525.37 275.10 Td (property ) Tj ET Q q 0 0 0 rg BT 561.57 275.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.10 Td (market ) Tj ET Q q 0 0 0 rg BT 66.26 263.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 109.50 263.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 239.10 Td (Rest of the W) Tj ET Q q 0 0 0 rg BT 88.12 239.10 Td (orld) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.33 221.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 84.98 221.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 115.87 221.10 Td (of ) Tj ET Q q 0 0 0 rg BT 126.20 221.10 Td (the ) Tj ET Q q 0 0 0 rg BT 140.41 221.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 162.69 221.10 Td (the ) Tj ET Q q 0 0 0 rg BT 176.91 221.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 192.24 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 208.67 221.10 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 235.94 221.10 Td (there ) Tj ET Q q 0 0 0 rg BT 257.93 221.10 Td (is ) Tj ET Q q 0 0 0 rg BT 266.59 221.10 Td (a ) Tj ET Q q 0 0 0 rg BT 273.03 221.10 Td (wide ) Tj ET Q q 0 0 0 rg BT 294.47 221.10 Td (variety ) Tj ET Q q 0 0 0 rg BT 324.23 221.10 Td (of ) Tj ET Q q 0 0 0 rg BT 334.56 221.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 355.99 221.10 Td (systems ) Tj ET Q q 0 0 0 rg BT 389.66 221.10 Td (with ) Tj ET Q q 0 0 0 rg BT 409.44 221.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 439.75 221.10 Td (to ) Tj ET Q q 0 0 0 rg BT 449.53 221.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 495.95 221.10 Td (property ) Tj ET Q q 0 0 0 rg BT 531.82 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 548.26 221.10 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 82.45 209.10 Td (of ) Tj ET Q q 0 0 0 rg BT 93.35 209.10 Td (pharmaceuticals. ) Tj ET Q q 0 0 0 rg BT 163.39 209.10 Td (Most ) Tj ET Q q 0 0 0 rg BT 186.52 209.10 Td (other ) Tj ET Q q 0 0 0 rg BT 209.64 209.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 253.30 209.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 292.52 209.10 Td (utilize ) Tj ET Q q 0 0 0 rg BT 320.08 209.10 Td (systems ) Tj ET Q q 0 0 0 rg BT 354.32 209.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 384.67 209.10 Td (to ) Tj ET Q q 0 0 0 rg BT 395.02 209.10 Td (either ) Tj ET Q q 0 0 0 rg BT 420.35 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 435.14 209.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 455.49 209.10 Td (or ) Tj ET Q q 0 0 0 rg BT 466.39 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 481.17 209.10 Td (EU. ) Tj ET Q q 0 0 0 rg BT 499.01 209.10 Td (Among ) Tj ET Q q 0 0 0 rg BT 531.58 209.10 Td (developing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 78.19 197.10 Td (some ) Tj ET Q q 0 0 0 rg BT 102.33 197.10 Td (have ) Tj ET Q q 0 0 0 rg BT 124.24 197.10 Td (adopted ) Tj ET Q q 0 0 0 rg BT 158.92 197.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 186.39 197.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 207.75 197.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 236.33 197.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 280.46 197.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 327.37 197.10 Td (laws, ) Tj ET Q q 0 0 0 rg BT 351.23 197.10 Td (while ) Tj ET Q q 0 0 0 rg BT 376.48 197.10 Td (others ) Tj ET Q q 0 0 0 rg BT 403.95 197.10 Td (have ) Tj ET Q q 0 0 0 rg BT 425.86 197.10 Td (not. ) Tj ET Q q 0 0 0 rg BT 444.17 197.10 Td (Some ) Tj ET Q q 0 0 0 rg BT 469.98 197.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 517.45 197.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 557.14 197.10 Td (have ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.10 Td (formally ) Tj ET Q q 0 0 0 rg BT 73.22 185.10 Td (adopted ) Tj ET Q q 0 0 0 rg BT 107.67 185.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 128.78 185.10 Td (in ) Tj ET Q q 0 0 0 rg BT 139.35 185.10 Td (order ) Tj ET Q q 0 0 0 rg BT 163.24 185.10 Td (to ) Tj ET Q q 0 0 0 rg BT 173.80 185.10 Td (comply ) Tj ET Q q 0 0 0 rg BT 206.59 185.10 Td (with ) Tj ET Q q 0 0 0 rg BT 226.95 185.10 Td (WT) Tj ET Q q 0 0 0 rg BT 242.32 185.10 Td (O ) Tj ET Q q 0 0 0 rg BT 252.33 185.10 Td (commitments, ) Tj ET Q q 0 0 0 rg BT 312.05 185.10 Td (but ) Tj ET Q q 0 0 0 rg BT 327.62 185.10 Td (have ) Tj ET Q q 0 0 0 rg BT 349.28 185.10 Td (not ) Tj ET Q q 0 0 0 rg BT 364.85 185.10 Td (taken ) Tj ET Q q 0 0 0 rg BT 389.29 185.10 Td (steps ) Tj ET Q q 0 0 0 rg BT 412.08 185.10 Td (to ) Tj ET Q q 0 0 0 rg BT 422.65 185.10 Td (implement ) Tj ET Q q 0 0 0 rg BT 468.21 185.10 Td (these ) Tj ET Q q 0 0 0 rg BT 491.54 185.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 512.66 185.10 Td (in ) Tj ET Q q 0 0 0 rg BT 523.23 185.10 Td (a ) Tj ET Q q 0 0 0 rg BT 530.45 185.10 Td (meaningful ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.10 Td (way) Tj ET Q q 0 0 0 rg BT 52.01 173.10 Td (. ) Tj ET Q q 0 0 0 rg BT 56.88 173.10 Td (Enforcement ) Tj ET Q q 0 0 0 rg BT 110.88 173.10 Td (of ) Tj ET Q q 0 0 0 rg BT 121.40 173.10 Td (WT) Tj ET Q q 0 0 0 rg BT 136.77 173.10 Td (O ) Tj ET Q q 0 0 0 rg BT 146.36 173.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 177.05 173.10 Td (is ) Tj ET Q q 0 0 0 rg BT 186.08 173.10 Td (a ) Tj ET Q q 0 0 0 rg BT 192.89 173.10 Td (long ) Tj ET Q q 0 0 0 rg BT 213.03 173.10 Td (process ) Tj ET Q q 0 0 0 rg BT 245.38 173.10 Td (between ) Tj ET Q q 0 0 0 rg BT 281.06 173.10 Td (governments, ) Tj ET Q q 0 0 0 rg BT 337.58 173.10 Td (and ) Tj ET Q q 0 0 0 rg BT 354.39 173.10 Td (there ) Tj ET Q q 0 0 0 rg BT 376.74 173.10 Td (is ) Tj ET Q q 0 0 0 rg BT 385.77 173.10 Td (no ) Tj ET Q q 0 0 0 rg BT 398.14 173.10 Td (assurance ) Tj ET Q q 0 0 0 rg BT 439.37 173.10 Td (of ) Tj ET Q q 0 0 0 rg BT 450.06 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 464.64 173.10 Td (outcome. ) Tj ET Q q 0 0 0 rg BT 503.77 173.10 Td (Thus, ) Tj ET Q q 0 0 0 rg BT 528.64 173.10 Td (in ) Tj ET Q q 0 0 0 rg BT 538.78 173.10 Td (assessing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.35 161.10 Td (likely ) Tj ET Q q 0 0 0 rg BT 75.26 161.10 Td (future ) Tj ET Q q 0 0 0 rg BT 101.28 161.10 Td (market ) Tj ET Q q 0 0 0 rg BT 131.18 161.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 177.19 161.10 Td (of ) Tj ET Q q 0 0 0 rg BT 187.66 161.10 Td (our ) Tj ET Q q 0 0 0 rg BT 203.13 161.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 247.47 161.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 271.83 161.10 Td (in ) Tj ET Q q 0 0 0 rg BT 281.75 161.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 328.32 161.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 369.61 161.10 Td (we ) Tj ET Q q 0 0 0 rg BT 383.40 161.10 Td (take ) Tj ET Q q 0 0 0 rg BT 402.20 161.10 Td (into ) Tj ET Q q 0 0 0 rg BT 419.89 161.10 Td (account ) Tj ET Q q 0 0 0 rg BT 453.12 161.10 Td (not ) Tj ET Q q 0 0 0 rg BT 468.03 161.10 Td (only ) Tj ET Q q 0 0 0 rg BT 487.95 161.10 Td (formal ) Tj ET Q q 0 0 0 rg BT 516.74 161.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 538.31 161.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 563.22 161.10 Td (but ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 149.10 Td (political ) Tj ET Q q 0 0 0 rg BT 71.27 149.10 Td (and ) Tj ET Q q 0 0 0 rg BT 88.21 149.10 Td (other ) Tj ET Q q 0 0 0 rg BT 111.25 149.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 140.96 149.10 Td (as ) Tj ET Q q 0 0 0 rg BT 151.79 149.10 Td (well.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.09 125.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.07 125.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 85.11 125.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.09 125.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 116.18 125.10 Td (and ) Tj ET Q q 0 0 0 rg BT 133.38 125.10 Td (some ) Tj ET Q q 0 0 0 rg BT 157.25 125.10 Td (other ) Tj ET Q q 0 0 0 rg BT 180.55 125.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 222.47 125.10 Td (when ) Tj ET Q q 0 0 0 rg BT 246.89 125.10 Td (these ) Tj ET Q q 0 0 0 rg BT 270.20 125.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 297.39 125.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 322.93 125.10 Td (and ) Tj ET Q q 0 0 0 rg BT 340.13 125.10 Td (other ) Tj ET Q q 0 0 0 rg BT 363.43 125.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 389.52 125.10 Td (of ) Tj ET Q q 0 0 0 rg BT 400.61 125.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 447.26 125.10 Td (expire ) Tj ET Q q 0 0 0 rg BT 475.00 125.10 Td (and ) Tj ET Q q 0 0 0 rg BT 492.20 125.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 524.39 125.10 Td (versions ) Tj ET Q q 0 0 0 rg BT 560.48 125.10 Td (of ) Tj ET Q q 0 0 0 rg BT 571.57 125.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.10 Td (medicine ) Tj ET Q q 0 0 0 rg BT 75.47 113.10 Td (are ) Tj ET Q q 0 0 0 rg BT 90.49 113.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 130.51 113.10 Td (and ) Tj ET Q q 0 0 0 rg BT 147.76 113.10 Td (marketed, ) Tj ET Q q 0 0 0 rg BT 190.28 113.10 Td (there ) Tj ET Q q 0 0 0 rg BT 213.08 113.10 Td (are ) Tj ET Q q 0 0 0 rg BT 228.10 113.10 Td (often ) Tj ET Q q 0 0 0 rg BT 251.46 113.10 Td (substantial ) Tj ET Q q 0 0 0 rg BT 297.05 113.10 Td (and ) Tj ET Q q 0 0 0 rg BT 314.31 113.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 337.67 113.10 Td (declines ) Tj ET Q q 0 0 0 rg BT 373.25 113.10 Td (in ) Tj ET Q q 0 0 0 rg BT 383.84 113.10 Td (the ) Tj ET Q q 0 0 0 rg BT 398.87 113.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 421.12 113.10 Td (of ) Tj ET Q q 0 0 0 rg BT 432.27 113.10 Td (the ) Tj ET Q q 0 0 0 rg BT 447.30 113.10 Td (original ) Tj ET Q q 0 0 0 rg BT 481.22 113.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 526.25 113.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 562.11 113.10 Td (For ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.10 Td (further ) Tj ET Q q 0 0 0 rg BT 65.58 101.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 109.62 101.10 Td (of ) Tj ET Q q 0 0 0 rg BT 120.33 101.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 147.13 101.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 172.28 101.10 Td (and ) Tj ET Q q 0 0 0 rg BT 189.10 101.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 232.56 101.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 258.27 101.10 Td (of ) Tj ET Q q 0 0 0 rg BT 268.97 101.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 312.20 101.10 Td (, ) Tj ET Q q 0 0 0 rg BT 317.07 101.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 338.31 101.10 Td (to ) Tj ET Q q 0 0 0 rg BT 348.47 101.10 Td (“—Intellectual ) Tj ET Q q 0 0 0 rg BT 410.25 101.10 Td (Property ) Tj ET Q q 0 0 0 rg BT 447.06 101.10 Td (and ) Tj ET Q q 0 0 0 rg BT 463.88 101.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 497.36 101.10 Td (Exclusivity” ) Tj ET Q q 0 0 0 rg BT 549.72 101.10 Td (below) Tj ET Q q 0 0 0 rg BT 573.51 101.10 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.10 Td (For ) Tj ET Q q 0 0 0 rg BT 52.39 89.10 Td (further ) Tj ET Q q 0 0 0 rg BT 82.10 89.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 126.27 89.10 Td (of ) Tj ET Q q 0 0 0 rg BT 137.10 89.10 Td (the ) Tj ET Q q 0 0 0 rg BT 151.82 89.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 181.53 89.10 Td (of ) Tj ET Q q 0 0 0 rg BT 192.36 89.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 224.28 89.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 274.55 89.10 Td (on ) Tj ET Q q 0 0 0 rg BT 287.05 89.10 Td (our ) Tj ET Q q 0 0 0 rg BT 302.88 89.10 Td (business, ) Tj ET Q q 0 0 0 rg BT 341.77 89.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 363.14 89.10 Td (to ) Tj ET Q q 0 0 0 rg BT 373.42 89.10 Td (“—) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 387.86 89.10 Td (Generic ) Tj ET Q q 0 0 0 rg BT 422.56 89.10 Td (Competition) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.01 89.10 Td (” ) Tj ET Q q 0 0 0 rg BT 478.94 89.10 Td (below) Tj ET Q q 0 0 0 rg BT 502.73 89.10 Td (.) Tj ET Q endstream endobj 15 0 obj <> endobj 16 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.86 749.10 Td (following ) Tj ET Q q 0 0 0 rg BT 97.06 749.10 Td (chart ) Tj ET Q q 0 0 0 rg BT 120.36 749.10 Td (shows ) Tj ET Q q 0 0 0 rg BT 148.68 749.10 Td (our ) Tj ET Q q 0 0 0 rg BT 165.33 749.10 Td (key ) Tj ET Q q 0 0 0 rg BT 183.08 749.10 Td (products ) Tj ET Q q 0 0 0 rg BT 220.83 749.10 Td (together ) Tj ET Q q 0 0 0 rg BT 256.91 749.10 Td (with ) Tj ET Q q 0 0 0 rg BT 278.00 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 293.53 749.10 Td (year ) Tj ET Q q 0 0 0 rg BT 314.06 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 325.15 749.10 Td (which ) Tj ET Q q 0 0 0 rg BT 352.90 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 368.43 749.10 Td (earliest ) Tj ET Q q 0 0 0 rg BT 400.62 749.10 Td (basic ) Tj ET Q q 0 0 0 rg BT 424.48 749.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 471.68 749.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 490.55 749.10 Td (\(patent ) Tj ET Q q 0 0 0 rg BT 521.63 749.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 547.72 749.10 Td (or ) Tj ET Q q 0 0 0 rg BT 559.37 749.10 Td (data ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (exclusivity\) ) Tj ET Q q 0 0 0 rg BT 85.61 737.10 Td (occurred ) Tj ET Q q 0 0 0 rg BT 122.99 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 133.72 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 142.79 737.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 181.29 737.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 222.01 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 232.19 737.10 Td (occur ) Tj ET Q q 0 0 0 rg BT 256.80 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 266.98 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 281.60 737.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 304.28 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 318.90 737.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 334.63 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 351.47 737.10 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 378.97 737.10 Td (W) Tj ET Q q 0 0 0 rg BT 387.60 737.10 Td (e ) Tj ET Q q 0 0 0 rg BT 394.44 737.10 Td (also ) Tj ET Q q 0 0 0 rg BT 412.95 737.10 Td (sell ) Tj ET Q q 0 0 0 rg BT 429.24 737.10 Td (our ) Tj ET Q q 0 0 0 rg BT 444.97 737.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 508.45 737.10 Td (products ) Tj ET Q q 0 0 0 rg BT 545.29 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 555.47 737.10 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (countries; ) Tj ET Q q 0 0 0 rg BT 78.13 725.10 Td (however) Tj ET Q q 0 0 0 rg BT 112.16 725.10 Td (, ) Tj ET Q q 0 0 0 rg BT 117.36 725.10 Td (data ) Tj ET Q q 0 0 0 rg BT 136.71 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 146.07 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 161.55 725.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 199.79 725.10 Td (on ) Tj ET Q q 0 0 0 rg BT 212.49 725.10 Td (a ) Tj ET Q q 0 0 0 rg BT 219.63 725.10 Td (country-by-country ) Tj ET Q q 0 0 0 rg BT 300.08 725.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 322.77 725.10 Td (because ) Tj ET Q q 0 0 0 rg BT 357.11 725.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 400.36 725.10 Td (country ) Tj ET Q q 0 0 0 rg BT 433.61 725.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 471.84 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 486.74 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 502.22 725.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 547.13 725.10 Td (outside ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.53 713.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 73.12 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 87.65 713.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 103.29 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 120.03 713.10 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 147.61 713.10 Td (In ) Tj ET Q q 0 0 0 rg BT 158.25 713.10 Td (many ) Tj ET Q q 0 0 0 rg BT 182.78 713.10 Td (instances, ) Tj ET Q q 0 0 0 rg BT 224.24 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 238.77 713.10 Td (basic ) Tj ET Q q 0 0 0 rg BT 261.63 713.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 307.82 713.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 325.69 713.10 Td (date ) Tj ET Q q 0 0 0 rg BT 344.65 713.10 Td (listed ) Tj ET Q q 0 0 0 rg BT 368.63 713.10 Td (below ) Tj ET Q q 0 0 0 rg BT 395.38 713.10 Td (is ) Tj ET Q q 0 0 0 rg BT 404.35 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 418.88 713.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 461.73 713.10 Td (date ) Tj ET Q q 0 0 0 rg BT 480.70 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 491.34 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 505.86 713.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 532.61 713.10 Td (that ) Tj ET Q q 0 0 0 rg BT 549.91 713.10 Td (claims ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.58 701.10 Td (active ) Tj ET Q q 0 0 0 rg BT 76.83 701.10 Td (ingredient ) Tj ET Q q 0 0 0 rg BT 119.74 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 130.43 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 145.02 701.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 165.72 701.10 Td (or ) Tj ET Q q 0 0 0 rg BT 176.42 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 191.00 701.10 Td (method ) Tj ET Q q 0 0 0 rg BT 223.36 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 234.06 701.10 Td (using ) Tj ET Q q 0 0 0 rg BT 258.10 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 272.68 701.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 293.38 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 307.41 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 322.00 701.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 361.57 701.10 Td (indication, ) Tj ET Q q 0 0 0 rg BT 406.43 701.10 Td (if ) Tj ET Q q 0 0 0 rg BT 414.91 701.10 Td (there ) Tj ET Q q 0 0 0 rg BT 437.26 701.10 Td (is ) Tj ET Q q 0 0 0 rg BT 446.30 701.10 Td (only ) Tj ET Q q 0 0 0 rg BT 466.44 701.10 Td (one ) Tj ET Q q 0 0 0 rg BT 483.25 701.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 522.83 701.10 Td (indication. ) Tj ET Q q 0 0 0 rg BT 567.68 701.10 Td (In ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (some ) Tj ET Q q 0 0 0 rg BT 59.51 689.10 Td (instances, ) Tj ET Q q 0 0 0 rg BT 101.08 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 115.70 689.10 Td (basic ) Tj ET Q q 0 0 0 rg BT 138.65 689.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 184.94 689.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 202.91 689.10 Td (date ) Tj ET Q q 0 0 0 rg BT 221.97 689.10 Td (listed ) Tj ET Q q 0 0 0 rg BT 246.04 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 256.23 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 270.85 689.10 Td (chart ) Tj ET Q q 0 0 0 rg BT 293.24 689.10 Td (is ) Tj ET Q q 0 0 0 rg BT 302.32 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 316.94 689.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 359.89 689.10 Td (date ) Tj ET Q q 0 0 0 rg BT 378.95 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 389.69 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 404.31 689.10 Td (data ) Tj ET Q q 0 0 0 rg BT 423.37 689.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 469.66 689.10 Td (period. ) Tj ET Q q 0 0 0 rg BT 500.11 689.10 Td (In ) Tj ET Q q 0 0 0 rg BT 510.85 689.10 Td (situations ) Tj ET Q q 0 0 0 rg BT 551.59 689.10 Td (where ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (there ) Tj ET Q q 0 0 0 rg BT 58.52 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 67.73 677.10 Td (only ) Tj ET Q q 0 0 0 rg BT 88.04 677.10 Td (data ) Tj ET Q q 0 0 0 rg BT 107.24 677.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 153.65 677.10 Td (without ) Tj ET Q q 0 0 0 rg BT 186.75 677.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 213.72 677.10 Td (protection, ) Tj ET Q q 0 0 0 rg BT 259.30 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 266.27 677.10 Td (competitor ) Tj ET Q q 0 0 0 rg BT 312.13 677.10 Td (could ) Tj ET Q q 0 0 0 rg BT 336.88 677.10 Td (seek ) Tj ET Q q 0 0 0 rg BT 357.19 677.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 400.82 677.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 438.34 677.10 Td (by ) Tj ET Q q 0 0 0 rg BT 450.88 677.10 Td (submitting ) Tj ET Q q 0 0 0 rg BT 496.20 677.10 Td (its ) Tj ET Q q 0 0 0 rg BT 508.18 677.10 Td (own ) Tj ET Q q 0 0 0 rg BT 527.94 677.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 559.90 677.10 Td (trial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (data ) Tj ET Q q 0 0 0 rg BT 55.16 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 65.43 665.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 92.93 665.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 135.97 665.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 173.46 665.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 195.39 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 205.67 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 220.39 665.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 263.43 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 274.26 665.10 Td (data ) Tj ET Q q 0 0 0 rg BT 293.42 665.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 336.65 665.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 641.10 Td (e ) Tj ET Q q 0 0 0 rg BT 52.38 641.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 89.00 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 104.52 641.10 Td (market ) Tj ET Q q 0 0 0 rg BT 135.59 641.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 182.77 641.10 Td (period ) Tj ET Q q 0 0 0 rg BT 211.62 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 226.58 641.10 Td (each ) Tj ET Q q 0 0 0 rg BT 248.20 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 259.83 641.10 Td (our ) Tj ET Q q 0 0 0 rg BT 276.46 641.10 Td (products ) Tj ET Q q 0 0 0 rg BT 314.20 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 329.17 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 344.69 641.10 Td (purpose ) Tj ET Q q 0 0 0 rg BT 379.65 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 391.28 641.10 Td (business ) Tj ET Q q 0 0 0 rg BT 428.47 641.10 Td (planning ) Tj ET Q q 0 0 0 rg BT 466.77 641.10 Td (only) Tj ET Q q 0 0 0 rg BT 483.90 641.10 Td (. ) Tj ET Q q 0 0 0 rg BT 489.46 641.10 Td (The ) Tj ET Q q 0 0 0 rg BT 508.31 641.10 Td (length ) Tj ET Q q 0 0 0 rg BT 536.61 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 548.24 641.10 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 81.53 629.10 Td (for ) Tj ET Q q 0 0 0 rg BT 94.84 629.10 Td (any ) Tj ET Q q 0 0 0 rg BT 110.92 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 120.90 629.10 Td (our ) Tj ET Q q 0 0 0 rg BT 135.88 629.10 Td (products ) Tj ET Q q 0 0 0 rg BT 171.97 629.10 Td (is ) Tj ET Q q 0 0 0 rg BT 180.28 629.10 Td (impossible ) Tj ET Q q 0 0 0 rg BT 225.27 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 234.69 629.10 Td (predict ) Tj ET Q q 0 0 0 rg BT 264.11 629.10 Td (with ) Tj ET Q q 0 0 0 rg BT 283.53 629.10 Td (certainty ) Tj ET Q q 0 0 0 rg BT 320.16 629.10 Td (because ) Tj ET Q q 0 0 0 rg BT 353.45 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 363.43 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 377.30 629.10 Td (complex ) Tj ET Q q 0 0 0 rg BT 413.38 629.10 Td (interaction ) Tj ET Q q 0 0 0 rg BT 457.78 629.10 Td (between ) Tj ET Q q 0 0 0 rg BT 492.75 629.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 518.83 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 534.92 629.10 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 62.14 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 73.29 617.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 119.98 617.10 Td (and ) Tj ET Q q 0 0 0 rg BT 137.24 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 152.27 617.10 Td (inherent ) Tj ET Q q 0 0 0 rg BT 187.84 617.10 Td (uncertainties ) Tj ET Q q 0 0 0 rg BT 241.75 617.10 Td (regarding ) Tj ET Q q 0 0 0 rg BT 282.88 617.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 310.12 617.10 Td (litigation. ) Tj ET Q q 0 0 0 rg BT 351.34 617.10 Td (There ) Tj ET Q q 0 0 0 rg BT 377.47 617.10 Td (can ) Tj ET Q q 0 0 0 rg BT 394.16 617.10 Td (be ) Tj ET Q q 0 0 0 rg BT 406.42 617.10 Td (no ) Tj ET Q q 0 0 0 rg BT 419.23 617.10 Td (assurance ) Tj ET Q q 0 0 0 rg BT 460.91 617.10 Td (that ) Tj ET Q q 0 0 0 rg BT 478.72 617.10 Td (a ) Tj ET Q q 0 0 0 rg BT 485.97 617.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 527.10 617.10 Td (product ) Tj ET Q q 0 0 0 rg BT 560.46 617.10 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (enjoy ) Tj ET Q q 0 0 0 rg BT 60.72 605.10 Td (market ) Tj ET Q q 0 0 0 rg BT 90.98 605.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 137.36 605.10 Td (for ) Tj ET Q q 0 0 0 rg BT 151.52 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 166.24 605.10 Td (full ) Tj ET Q q 0 0 0 rg BT 182.63 605.10 Td (period ) Tj ET Q q 0 0 0 rg BT 210.67 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 221.50 605.10 Td (time ) Tj ET Q q 0 0 0 rg BT 241.78 605.10 Td (that ) Tj ET Q q 0 0 0 rg BT 259.27 605.10 Td (appears ) Tj ET Q q 0 0 0 rg BT 292.31 605.10 Td (in ) Tj ET Q q 0 0 0 rg BT 302.59 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 317.30 605.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 353.12 605.10 Td (or ) Tj ET Q q 0 0 0 rg BT 363.95 605.10 Td (that ) Tj ET Q q 0 0 0 rg BT 381.45 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 396.17 605.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 442.55 605.10 Td (will ) Tj ET Q q 0 0 0 rg BT 460.60 605.10 Td (be ) Tj ET Q q 0 0 0 rg BT 472.54 605.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 503.37 605.10 Td (to ) Tj ET Q q 0 0 0 rg BT 513.65 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 528.37 605.10 Td (estimate.) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 565.60 201.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 565.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 565.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 565.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 565.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 565.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 565.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 565.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 565.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 565.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 541.60 201.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 541.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 541.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 541.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 541.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 541.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 541.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 541.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 541.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 541.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 541.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 517.60 201.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 517.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 517.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 517.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 517.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 517.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 517.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 517.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 517.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 517.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 517.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 493.60 201.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 493.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 493.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 493.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 493.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 493.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 493.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 493.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 493.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 493.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 493.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 469.60 201.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 469.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 469.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 469.60 38.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 469.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 469.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 469.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 469.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 469.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 469.60 51.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 469.60 16.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 445.60 201.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 445.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 445.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 445.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 445.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 445.60 16.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 445.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 445.60 16.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 445.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 445.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 445.60 16.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 419.60 201.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 241.50 419.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 279.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 419.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 419.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 419.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 419.60 16.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 419.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 419.60 16.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 419.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 419.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 560.50 419.60 16.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 582.6 m 279.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 279.5 582.6 m 283.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 283.5 582.6 m 321.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 321.5 582.6 m 325.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 582.6 m 363.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 582.6 m 418.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 582.6 m 434.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 582.6 m 438.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 438.5 582.6 m 489.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 489.5 582.6 m 505.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 582.6 m 509.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 509.5 582.6 m 560.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 560.5 582.6 m 576.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 565.6 m 279.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 283.5 582.6 m 321.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 283.5 565.6 m 321.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 321.5 582.6 m 325.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 582.6 m 363.5 582.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 565.6 m 363.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 565.6 m 418.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 438.5 565.6 m 489.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 509.5 565.6 m 560.5 565.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 586.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 256.10 586.68 Td (Total Revenues by Product) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 371.20 586.68 Td (Past or Currently Estimated Year of Basic Exclusivity Loss) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 569.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 252.00 569.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 294.00 569.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 336.00 569.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 385.35 569.83 Td (U.S.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 421.00 569.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 454.15 569.83 Td (EU) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 465.26 574.36 Td (\(a\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 492.00 569.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 524.05 569.83 Td (Japan) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 563.00 569.85 Td ( ) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 557.00 Td (Oncology) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 544.85 Td (Empliciti \(elotuzumab\)) Tj ET Q BT /F1 9.00 Tf ET BT /F1 5.85 Tf ET q 0 0 0 rg BT 121.74 548.93 Td (\(b\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 544.86 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 262.50 544.86 Td (150) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 286.00 544.86 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 313.50 544.86 Td (3) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 328.00 544.86 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 351.00 544.86 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 544.86 Td (2026) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 544.86 Td (2026) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 544.86 Td (2024) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 532.85 Td (Opdivo \(nivolumab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 532.86 Td (3,774) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 304.50 532.86 Td (942) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 355.50 532.86 Td (6) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 532.86 Td (2027) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 538.70 Td (\(c\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 532.86 Td (2026) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 538.70 Td (\(c\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 532.86 Td (2031) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 563.00 538.70 Td (\(c\)) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 520.85 Td (Sprycel \(dasatinib\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 520.86 Td (1,824) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 520.86 Td (1,620) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 520.86 Td (1,493) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 520.86 Td (2020) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 526.70 Td (\(d\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 477.55 520.86 Td (^^) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 520.86 Td (2021) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 563.00 520.86 Td (  ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 508.85 Td (Yervoy \(ipilimumab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 508.86 Td (1,053) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 508.86 Td (1,126) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 508.86 Td (1,308) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 508.86 Td (2025) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 514.70 Td (\(e\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 508.86 Td (2025) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 514.70 Td (\(f\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 508.86 Td (2025) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 563.00 514.70 Td (\(g\)) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 497.00 Td (Cardiovascular) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 484.85 Td (Eliquis \(apixaban\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 484.86 Td (3,343) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 484.86 Td (1,860) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.50 484.86 Td (774) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 484.86 Td (2023) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 490.70 Td (\(h\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 484.86 Td (2022) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 490.70 Td (\(i\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 484.86 Td (2026) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 563.00 490.70 Td (\(i\)) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 473.00 Td (Immunoscience) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 460.85 Td (Orencia \(abatacept\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 460.86 Td (2,265) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 460.86 Td (1,885) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 460.86 Td (1,652) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 460.86 Td (2019) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 466.70 Td (\(j\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 460.86 Td (2017) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 466.70 Td (\(k\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 460.86 Td (2018) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 563.00 466.70 Td (\(l\)) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 449.00 Td (Virology) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 436.85 Td (Baraclude \(entecavir\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 436.86 Td (1,192) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 436.86 Td (1,312) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 436.86 Td (1,441) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 436.86 Td (2014) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 447.30 436.86 Td (2011-2016) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 441.70 Td (\(m\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 436.86 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 563.00 436.86 Td (  ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 39.00 423.86 Td (Hepatitis C Franchise) Tj ET Q BT /F1 9.00 Tf ET BT /F1 5.85 Tf ET q 0 0 0 rg BT 116.99 427.94 Td (\(n\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 423.86 Td (1,578) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 423.86 Td (1,603) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.50 423.86 Td (256) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 423.86 Td (2028) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 423.86 Td (2027) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 423.86 Td (2028) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 563.00 428.70 Td (\(o\)) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 410.85 Td (Reyataz \(atazanavir sulfate\) Franchise) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 262.50 410.86 Td (912) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 410.86 Td (1,139) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 410.86 Td (1,362) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 410.86 Td (2017) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 421.00 410.86 Td (  ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 447.00 410.86 Td (2017-2019) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 415.70 Td (\(p\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 539.00 410.86 Td (2019) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 563.00 410.86 Td (  ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 397.85 Td (Sustiva \(efavirenz\) Franchise) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 255.75 397.86 Td (1,065) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 297.75 397.86 Td (1,252) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 339.75 397.86 Td (1,444) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.00 397.86 Td (2017) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 421.00 402.70 Td (\(q\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 468.00 397.86 Td (2013) Tj ET Q BT /F1 5.85 Tf ET q 0 0 0 rg BT 492.00 402.70 Td (\(r\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 546.80 397.86 Td (++) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 563.00 397.86 Td (  ) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 382.50 Td (Note: ) Tj ET Q q 0 0 0 rg BT 55.53 382.50 Td (The ) Tj ET Q q 0 0 0 rg BT 69.87 382.50 Td (currently ) Tj ET Q q 0 0 0 rg BT 100.64 382.50 Td (estimated ) Tj ET Q q 0 0 0 rg BT 133.19 382.50 Td (earliest ) Tj ET Q q 0 0 0 rg BT 158.19 382.50 Td (year ) Tj ET Q q 0 0 0 rg BT 173.85 382.50 Td (of ) Tj ET Q q 0 0 0 rg BT 182.41 382.50 Td (basic ) Tj ET Q q 0 0 0 rg BT 200.74 382.50 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 237.74 382.50 Td (loss ) Tj ET Q q 0 0 0 rg BT 252.09 382.50 Td (includes ) Tj ET Q q 0 0 0 rg BT 280.65 382.50 Td (any ) Tj ET Q q 0 0 0 rg BT 294.09 382.50 Td (statutory ) Tj ET Q q 0 0 0 rg BT 323.99 382.50 Td (extensions ) Tj ET Q q 0 0 0 rg BT 359.66 382.50 Td (of ) Tj ET Q q 0 0 0 rg BT 368.22 382.50 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 405.22 382.50 Td (that ) Tj ET Q q 0 0 0 rg BT 419.11 382.50 Td (have ) Tj ET Q q 0 0 0 rg BT 436.11 382.50 Td (been ) Tj ET Q q 0 0 0 rg BT 453.11 382.50 Td (granted. ) Tj ET Q q 0 0 0 rg BT 480.99 382.50 Td (In ) Tj ET Q q 0 0 0 rg BT 489.55 382.50 Td (some ) Tj ET Q q 0 0 0 rg BT 508.34 382.50 Td (instances, ) Tj ET Q q 0 0 0 rg BT 541.56 382.50 Td (we ) Tj ET Q q 0 0 0 rg BT 552.78 382.50 Td (may ) Tj ET Q q 0 0 0 rg BT 568.45 382.50 Td (be ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 372.90 Td (able ) Tj ET Q q 0 0 0 rg BT 51.23 372.90 Td (to ) Tj ET Q q 0 0 0 rg BT 59.37 372.90 Td (obtain ) Tj ET Q q 0 0 0 rg BT 81.27 372.90 Td (an ) Tj ET Q q 0 0 0 rg BT 90.73 372.90 Td (additional ) Tj ET Q q 0 0 0 rg BT 124.64 372.90 Td (six ) Tj ET Q q 0 0 0 rg BT 135.88 372.90 Td (months ) Tj ET Q q 0 0 0 rg BT 161.35 372.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 198.37 372.90 Td (for ) Tj ET Q q 0 0 0 rg BT 209.61 372.90 Td (a ) Tj ET Q q 0 0 0 rg BT 215.07 372.90 Td (product ) Tj ET Q q 0 0 0 rg BT 241.41 372.90 Td (based ) Tj ET Q q 0 0 0 rg BT 261.54 372.90 Td (on ) Tj ET Q q 0 0 0 rg BT 271.45 372.90 Td (the ) Tj ET Q q 0 0 0 rg BT 283.13 372.90 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 313.03 372.90 Td (extension. ) Tj ET Q q 0 0 0 rg BT 347.60 372.90 Td (In ) Tj ET Q q 0 0 0 rg BT 356.17 372.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 379.84 372.90 Td (other ) Tj ET Q q 0 0 0 rg BT 398.19 372.90 Td (instances, ) Tj ET Q q 0 0 0 rg BT 431.43 372.90 Td (there ) Tj ET Q q 0 0 0 rg BT 449.32 372.90 Td (may ) Tj ET Q q 0 0 0 rg BT 465.01 372.90 Td (be ) Tj ET Q q 0 0 0 rg BT 474.47 372.90 Td (later) Tj ET Q q 0 0 0 rg BT 488.52 372.90 Td (-expiring ) Tj ET Q q 0 0 0 rg BT 519.75 372.90 Td (patents ) Tj ET Q q 0 0 0 rg BT 544.32 372.90 Td (that ) Tj ET Q q 0 0 0 rg BT 558.23 372.90 Td (cover ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 363.30 Td (particular ) Tj ET Q q 0 0 0 rg BT 68.50 363.30 Td (forms ) Tj ET Q q 0 0 0 rg BT 89.01 363.30 Td (or ) Tj ET Q q 0 0 0 rg BT 97.52 363.30 Td (compositions ) Tj ET Q q 0 0 0 rg BT 142.04 363.30 Td (of ) Tj ET Q q 0 0 0 rg BT 150.55 363.30 Td (the ) Tj ET Q q 0 0 0 rg BT 162.17 363.30 Td (drug, ) Tj ET Q q 0 0 0 rg BT 180.69 363.30 Td (as ) Tj ET Q q 0 0 0 rg BT 189.20 363.30 Td (well ) Tj ET Q q 0 0 0 rg BT 204.82 363.30 Td (as ) Tj ET Q q 0 0 0 rg BT 213.33 363.30 Td (methods ) Tj ET Q q 0 0 0 rg BT 242.29 363.30 Td (of ) Tj ET Q q 0 0 0 rg BT 250.80 363.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 299.30 363.30 Td (or ) Tj ET Q q 0 0 0 rg BT 307.81 363.30 Td (methods ) Tj ET Q q 0 0 0 rg BT 336.77 363.30 Td (of ) Tj ET Q q 0 0 0 rg BT 345.29 363.30 Td (using ) Tj ET Q q 0 0 0 rg BT 364.47 363.30 Td (the ) Tj ET Q q 0 0 0 rg BT 376.09 363.30 Td (drug. ) Tj ET Q q 0 0 0 rg BT 394.60 363.30 Td (Such ) Tj ET Q q 0 0 0 rg BT 412.45 363.30 Td (patents ) Tj ET Q q 0 0 0 rg BT 436.96 363.30 Td (may ) Tj ET Q q 0 0 0 rg BT 452.58 363.30 Td (sometimes ) Tj ET Q q 0 0 0 rg BT 488.65 363.30 Td (result ) Tj ET Q q 0 0 0 rg BT 508.27 363.30 Td (in ) Tj ET Q q 0 0 0 rg BT 516.34 363.30 Td (a ) Tj ET Q q 0 0 0 rg BT 521.74 363.30 Td (favorable ) Tj ET Q q 0 0 0 rg BT 553.80 363.30 Td (market ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 353.70 Td (position ) Tj ET Q q 0 0 0 rg BT 63.63 353.70 Td (for ) Tj ET Q q 0 0 0 rg BT 74.81 353.70 Td (our ) Tj ET Q q 0 0 0 rg BT 87.32 353.70 Td (products, ) Tj ET Q q 0 0 0 rg BT 118.72 353.70 Td (but ) Tj ET Q q 0 0 0 rg BT 130.79 353.70 Td (product ) Tj ET Q q 0 0 0 rg BT 157.08 353.70 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 194.04 353.70 Td (cannot ) Tj ET Q q 0 0 0 rg BT 217.21 353.70 Td (be ) Tj ET Q q 0 0 0 rg BT 226.61 353.70 Td (predicted ) Tj ET Q q 0 0 0 rg BT 258.22 353.70 Td (or ) Tj ET Q q 0 0 0 rg BT 266.74 353.70 Td (assured. ) Tj ET Q q 0 0 0 rg BT 294.58 353.70 Td (Under ) Tj ET Q q 0 0 0 rg BT 316.42 353.70 Td (the ) Tj ET Q q 0 0 0 rg BT 328.04 353.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 344.12 353.70 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 378.83 353.70 Td (law ) Tj ET Q q 0 0 0 rg BT 392.23 353.70 Td (enacted ) Tj ET Q q 0 0 0 rg BT 418.51 353.70 Td (in ) Tj ET Q q 0 0 0 rg BT 426.58 353.70 Td (2010, ) Tj ET Q q 0 0 0 rg BT 446.43 353.70 Td (qualifying ) Tj ET Q q 0 0 0 rg BT 481.16 353.70 Td (biologic ) Tj ET Q q 0 0 0 rg BT 509.23 353.70 Td (products ) Tj ET Q q 0 0 0 rg BT 538.63 353.70 Td (will ) Tj ET Q q 0 0 0 rg BT 552.93 353.70 Td (receive ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 344.10 Td (12 ) Tj ET Q q 0 0 0 rg BT 46.00 344.10 Td (years ) Tj ET Q q 0 0 0 rg BT 64.88 344.10 Td (of ) Tj ET Q q 0 0 0 rg BT 73.54 344.10 Td (data ) Tj ET Q q 0 0 0 rg BT 88.87 344.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 125.97 344.10 Td (before ) Tj ET Q q 0 0 0 rg BT 148.40 344.10 Td (a ) Tj ET Q q 0 0 0 rg BT 153.95 344.10 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 188.39 344.10 Td (can ) Tj ET Q q 0 0 0 rg BT 201.50 344.10 Td (enter ) Tj ET Q q 0 0 0 rg BT 219.48 344.10 Td (the ) Tj ET Q q 0 0 0 rg BT 231.26 344.10 Td (market, ) Tj ET Q q 0 0 0 rg BT 257.47 344.10 Td (as ) Tj ET Q q 0 0 0 rg BT 266.13 344.10 Td (described ) Tj ET Q q 0 0 0 rg BT 298.79 344.10 Td (in ) Tj ET Q q 0 0 0 rg BT 307.01 344.10 Td (more ) Tj ET Q q 0 0 0 rg BT 325.45 344.10 Td (detail ) Tj ET Q q 0 0 0 rg BT 345.21 344.10 Td (in ) Tj ET Q q 0 0 0 rg BT 353.44 344.10 Td (“—Intellectual ) Tj ET Q q 0 0 0 rg BT 402.97 344.10 Td (Property ) Tj ET Q q 0 0 0 rg BT 432.52 344.10 Td (and ) Tj ET Q q 0 0 0 rg BT 446.07 344.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 472.96 344.10 Td (Exclusivity” ) Tj ET Q q 0 0 0 rg BT 514.95 344.10 Td (below) Tj ET Q q 0 0 0 rg BT 533.98 344.10 Td (.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 328.50 Td (++ ) Tj ET Q q 0 0 0 rg BT 54.00 328.50 Td (W) Tj ET Q q 0 0 0 rg BT 60.91 328.50 Td (e ) Tj ET Q q 0 0 0 rg BT 66.46 328.50 Td (do ) Tj ET Q q 0 0 0 rg BT 76.46 328.50 Td (not ) Tj ET Q q 0 0 0 rg BT 88.68 328.50 Td (currently ) Tj ET Q q 0 0 0 rg BT 119.56 328.50 Td (market ) Tj ET Q q 0 0 0 rg BT 143.77 328.50 Td (the ) Tj ET Q q 0 0 0 rg BT 155.54 328.50 Td (product ) Tj ET Q q 0 0 0 rg BT 181.98 328.50 Td (in ) Tj ET Q q 0 0 0 rg BT 190.20 328.50 Td (the ) Tj ET Q q 0 0 0 rg BT 201.98 328.50 Td (country ) Tj ET Q q 0 0 0 rg BT 228.41 328.50 Td (or ) Tj ET Q q 0 0 0 rg BT 237.08 328.50 Td (region ) Tj ET Q q 0 0 0 rg BT 259.52 328.50 Td (indicated.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 318.90 Td (^^ ) Tj ET Q q 0 0 0 rg BT 54.00 318.90 Td (In ) Tj ET Q q 0 0 0 rg BT 62.83 318.90 Td (May ) Tj ET Q q 0 0 0 rg BT 79.66 318.90 Td (2013, ) Tj ET Q q 0 0 0 rg BT 99.35 318.90 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 125.06 318.90 Td (Inc., ) Tj ET Q q 0 0 0 rg BT 140.96 318.90 Td (Actavis ) Tj ET Q q 0 0 0 rg BT 167.57 318.90 Td (Group ) Tj ET Q q 0 0 0 rg BT 190.17 318.90 Td (PTC ) Tj ET Q q 0 0 0 rg BT 207.01 318.90 Td (ehf, ) Tj ET Q q 0 0 0 rg BT 221.39 318.90 Td (Generics ) Tj ET Q q 0 0 0 rg BT 251.98 318.90 Td ([UK] ) Tj ET Q q 0 0 0 rg BT 271.03 318.90 Td (Limited ) Tj ET Q q 0 0 0 rg BT 298.52 318.90 Td (\(Mylan\) ) Tj ET Q q 0 0 0 rg BT 326.90 318.90 Td (and ) Tj ET Q q 0 0 0 rg BT 340.62 318.90 Td (an ) Tj ET Q q 0 0 0 rg BT 350.34 318.90 Td (unnamed ) Tj ET Q q 0 0 0 rg BT 381.83 318.90 Td (company ) Tj ET Q q 0 0 0 rg BT 413.31 318.90 Td (filed ) Tj ET Q q 0 0 0 rg BT 430.14 318.90 Td (oppositions ) Tj ET Q q 0 0 0 rg BT 469.20 318.90 Td (in ) Tj ET Q q 0 0 0 rg BT 477.59 318.90 Td (the ) Tj ET Q q 0 0 0 rg BT 489.53 318.90 Td (EPO ) Tj ET Q q 0 0 0 rg BT 506.80 318.90 Td (seeking ) Tj ET Q q 0 0 0 rg BT 533.41 318.90 Td (revocation ) Tj ET Q q 0 0 0 rg BT 569.33 318.90 Td (of ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 309.30 Td (European ) Tj ET Q q 0 0 0 rg BT 86.67 309.30 Td (Patent ) Tj ET Q q 0 0 0 rg BT 108.69 309.30 Td (No. ) Tj ET Q q 0 0 0 rg BT 122.49 309.30 Td (1) Tj ET Q q 0 0 0 rg BT 126.19 309.30 Td (169038 ) Tj ET Q q 0 0 0 rg BT 152.21 309.30 Td (\(the ) Tj ET Q q 0 0 0 rg BT 166.67 309.30 Td ('038 ) Tj ET Q q 0 0 0 rg BT 182.13 309.30 Td (patent\) ) Tj ET Q q 0 0 0 rg BT 206.36 309.30 Td (covering ) Tj ET Q q 0 0 0 rg BT 236.37 309.30 Td (dasatinib, ) Tj ET Q q 0 0 0 rg BT 269.27 309.30 Td (the ) Tj ET Q q 0 0 0 rg BT 281.07 309.30 Td (active ) Tj ET Q q 0 0 0 rg BT 302.19 309.30 Td (ingredient ) Tj ET Q q 0 0 0 rg BT 336.64 309.30 Td (in ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 344.88 309.30 Td (Sprycel) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 368.87 309.30 Td (. ) Tj ET Q q 0 0 0 rg BT 372.75 309.30 Td (The ) Tj ET Q q 0 0 0 rg BT 387.20 309.30 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 403.89 309.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 425.46 309.30 Td (is ) Tj ET Q q 0 0 0 rg BT 432.81 309.30 Td (scheduled ) Tj ET Q q 0 0 0 rg BT 466.82 309.30 Td (to ) Tj ET Q q 0 0 0 rg BT 475.06 309.30 Td (expire ) Tj ET Q q 0 0 0 rg BT 497.07 309.30 Td (in ) Tj ET Q q 0 0 0 rg BT 504.87 309.30 Td (April ) Tj ET Q q 0 0 0 rg BT 523.78 309.30 Td (2020 ) Tj ET Q q 0 0 0 rg BT 541.80 309.30 Td (\(excluding ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 299.70 Td (potential ) Tj ET Q q 0 0 0 rg BT 83.45 299.70 Td (term ) Tj ET Q q 0 0 0 rg BT 99.58 299.70 Td (extensions\). ) Tj ET Q q 0 0 0 rg BT 139.48 299.70 Td (On ) Tj ET Q q 0 0 0 rg BT 150.71 299.70 Td (January ) Tj ET Q q 0 0 0 rg BT 177.06 299.70 Td (20, ) Tj ET Q q 0 0 0 rg BT 188.52 299.70 Td (2016, ) Tj ET Q q 0 0 0 rg BT 207.98 299.70 Td (the ) Tj ET Q q 0 0 0 rg BT 219.21 299.70 Td (Opposition ) Tj ET Q q 0 0 0 rg BT 256.24 299.70 Td (Division ) Tj ET Q q 0 0 0 rg BT 285.26 299.70 Td (of ) Tj ET Q q 0 0 0 rg BT 293.38 299.70 Td (the ) Tj ET Q q 0 0 0 rg BT 304.62 299.70 Td (EPO ) Tj ET Q q 0 0 0 rg BT 321.19 299.70 Td (revoked ) Tj ET Q q 0 0 0 rg BT 348.42 299.70 Td (the ) Tj ET Q q 0 0 0 rg BT 359.66 299.70 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 375.78 299.70 Td (patent. ) Tj ET Q q 0 0 0 rg BT 398.79 299.70 Td (In ) Tj ET Q q 0 0 0 rg BT 406.92 299.70 Td (May ) Tj ET Q q 0 0 0 rg BT 423.04 299.70 Td (2016, ) Tj ET Q q 0 0 0 rg BT 442.50 299.70 Td (the ) Tj ET Q q 0 0 0 rg BT 453.74 299.70 Td (Company ) Tj ET Q q 0 0 0 rg BT 486.31 299.70 Td (appealed ) Tj ET Q q 0 0 0 rg BT 516.20 299.70 Td (the ) Tj ET Q q 0 0 0 rg BT 527.43 299.70 Td (EPO’) Tj ET Q q 0 0 0 rg BT 544.77 299.70 Td (s ) Tj ET Q q 0 0 0 rg BT 549.34 299.70 Td (decision ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 290.10 Td (to ) Tj ET Q q 0 0 0 rg BT 62.80 290.10 Td (the ) Tj ET Q q 0 0 0 rg BT 75.15 290.10 Td (EPO ) Tj ET Q q 0 0 0 rg BT 92.85 290.10 Td (Board ) Tj ET Q q 0 0 0 rg BT 114.98 290.10 Td (of ) Tj ET Q q 0 0 0 rg BT 123.65 290.10 Td (Appeal ) Tj ET Q q 0 0 0 rg BT 149.33 290.10 Td (and ) Tj ET Q q 0 0 0 rg BT 163.46 290.10 Td (in ) Tj ET Q q 0 0 0 rg BT 172.26 290.10 Td (February ) Tj ET Q q 0 0 0 rg BT 203.72 290.10 Td (2017, ) Tj ET Q q 0 0 0 rg BT 224.30 290.10 Td (the ) Tj ET Q q 0 0 0 rg BT 236.65 290.10 Td (EPO ) Tj ET Q q 0 0 0 rg BT 254.34 290.10 Td (Board ) Tj ET Q q 0 0 0 rg BT 276.47 290.10 Td (of ) Tj ET Q q 0 0 0 rg BT 285.15 290.10 Td (Appeal ) Tj ET Q q 0 0 0 rg BT 310.83 290.10 Td (upheld ) Tj ET Q q 0 0 0 rg BT 335.18 290.10 Td (the ) Tj ET Q q 0 0 0 rg BT 347.53 290.10 Td (Opposition’) Tj ET Q q 0 0 0 rg BT 385.32 290.10 Td (s ) Tj ET Q q 0 0 0 rg BT 391.01 290.10 Td (decision, ) Tj ET Q q 0 0 0 rg BT 422.25 290.10 Td (and ) Tj ET Q q 0 0 0 rg BT 436.38 290.10 Td (the ) Tj ET Q q 0 0 0 rg BT 448.73 290.10 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 465.97 290.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 488.10 290.10 Td (has ) Tj ET Q q 0 0 0 rg BT 501.34 290.10 Td (been ) Tj ET Q q 0 0 0 rg BT 519.02 290.10 Td (revoked. ) Tj ET Q q 0 0 0 rg BT 549.18 290.10 Td (W) Tj ET Q q 0 0 0 rg BT 556.09 290.10 Td (e ) Tj ET Q q 0 0 0 rg BT 562.22 290.10 Td (may ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 280.50 Td (experience ) Tj ET Q q 0 0 0 rg BT 90.15 280.50 Td (a ) Tj ET Q q 0 0 0 rg BT 95.22 280.50 Td (decline ) Tj ET Q q 0 0 0 rg BT 119.83 280.50 Td (in ) Tj ET Q q 0 0 0 rg BT 127.56 280.50 Td (European ) Tj ET Q q 0 0 0 rg BT 159.73 280.50 Td (revenues ) Tj ET Q q 0 0 0 rg BT 189.67 280.50 Td (in ) Tj ET Q q 0 0 0 rg BT 197.41 280.50 Td (the ) Tj ET Q q 0 0 0 rg BT 208.69 280.50 Td (second ) Tj ET Q q 0 0 0 rg BT 232.42 280.50 Td (half ) Tj ET Q q 0 0 0 rg BT 246.37 280.50 Td (of ) Tj ET Q q 0 0 0 rg BT 254.55 280.50 Td (2017 ) Tj ET Q q 0 0 0 rg BT 272.06 280.50 Td (due ) Tj ET Q q 0 0 0 rg BT 285.12 280.50 Td (to ) Tj ET Q q 0 0 0 rg BT 292.86 280.50 Td (the ) Tj ET Q q 0 0 0 rg BT 304.14 280.50 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 343.86 280.50 Td (the ) Tj ET Q q 0 0 0 rg BT 355.15 280.50 Td (EPO ) Tj ET Q q 0 0 0 rg BT 371.77 280.50 Td (Board ) Tj ET Q q 0 0 0 rg BT 392.83 280.50 Td (of ) Tj ET Q q 0 0 0 rg BT 400.68 280.50 Td (Appeal's ) Tj ET Q q 0 0 0 rg BT 429.85 280.50 Td (decision. ) Tj ET Q q 0 0 0 rg BT 459.91 280.50 Td (The ) Tj ET Q q 0 0 0 rg BT 473.86 280.50 Td (EPO ) Tj ET Q q 0 0 0 rg BT 490.49 280.50 Td (Board ) Tj ET Q q 0 0 0 rg BT 511.55 280.50 Td (of ) Tj ET Q q 0 0 0 rg BT 519.39 280.50 Td (Appeal’) Tj ET Q q 0 0 0 rg BT 544.72 280.50 Td (s ) Tj ET Q q 0 0 0 rg BT 549.34 280.50 Td (decision ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 270.90 Td (does ) Tj ET Q q 0 0 0 rg BT 71.02 270.90 Td (not ) Tj ET Q q 0 0 0 rg BT 83.61 270.90 Td (af) Tj ET Q q 0 0 0 rg BT 89.68 270.90 Td (fect ) Tj ET Q q 0 0 0 rg BT 104.02 270.90 Td (the ) Tj ET Q q 0 0 0 rg BT 116.16 270.90 Td (validity ) Tj ET Q q 0 0 0 rg BT 142.96 270.90 Td (of ) Tj ET Q q 0 0 0 rg BT 151.98 270.90 Td (our ) Tj ET Q q 0 0 0 rg BT 165.00 270.90 Td (other ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 183.80 270.90 Td (Sprycel) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 207.79 270.90 Td ( ) Tj ET Q q 0 0 0 rg BT 210.15 270.90 Td (patents, ) Tj ET Q q 0 0 0 rg BT 237.17 270.90 Td (including ) Tj ET Q q 0 0 0 rg BT 269.75 270.90 Td (dif) Tj ET Q q 0 0 0 rg BT 278.49 270.90 Td (ferent ) Tj ET Q q 0 0 0 rg BT 299.50 270.90 Td (patents ) Tj ET Q q 0 0 0 rg BT 324.52 270.90 Td (that ) Tj ET Q q 0 0 0 rg BT 338.88 270.90 Td (cover ) Tj ET Q q 0 0 0 rg BT 359.00 270.90 Td (the ) Tj ET Q q 0 0 0 rg BT 371.13 270.90 Td (monohydrate ) Tj ET Q q 0 0 0 rg BT 415.70 270.90 Td (form ) Tj ET Q q 0 0 0 rg BT 433.61 270.90 Td (of ) Tj ET Q q 0 0 0 rg BT 442.64 270.90 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 473.88 270.90 Td (and ) Tj ET Q q 0 0 0 rg BT 487.79 270.90 Td (the ) Tj ET Q q 0 0 0 rg BT 499.92 270.90 Td (use ) Tj ET Q q 0 0 0 rg BT 512.95 270.90 Td (of ) Tj ET Q q 0 0 0 rg BT 521.97 270.90 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 553.21 270.90 Td (to ) Tj ET Q q 0 0 0 rg BT 561.79 270.90 Td (treat ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 261.30 Td (chronic ) Tj ET Q q 0 0 0 rg BT 79.86 261.30 Td (myelogenous ) Tj ET Q q 0 0 0 rg BT 124.39 261.30 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 155.58 261.30 Td (\(CML\). ) Tj ET Q q 0 0 0 rg BT 181.70 261.30 Td (Additionally) Tj ET Q q 0 0 0 rg BT 221.62 261.30 Td (, ) Tj ET Q q 0 0 0 rg BT 225.49 261.30 Td (in ) Tj ET Q q 0 0 0 rg BT 233.59 261.30 Td (February ) Tj ET Q q 0 0 0 rg BT 264.33 261.30 Td (2017, ) Tj ET Q q 0 0 0 rg BT 284.20 261.30 Td (the ) Tj ET Q q 0 0 0 rg BT 295.85 261.30 Td (EPO ) Tj ET Q q 0 0 0 rg BT 312.83 261.30 Td (Board ) Tj ET Q q 0 0 0 rg BT 334.25 261.30 Td (of ) Tj ET Q q 0 0 0 rg BT 342.37 261.30 Td (Appeal ) Tj ET Q q 0 0 0 rg BT 367.35 261.30 Td (reversed ) Tj ET Q q 0 0 0 rg BT 396.31 261.30 Td (and ) Tj ET Q q 0 0 0 rg BT 409.73 261.30 Td (remanded ) Tj ET Q q 0 0 0 rg BT 443.14 261.30 Td (an ) Tj ET Q q 0 0 0 rg BT 452.56 261.30 Td (invalidity ) Tj ET Q q 0 0 0 rg BT 485.09 261.30 Td (decision ) Tj ET Q q 0 0 0 rg BT 513.63 261.30 Td (on ) Tj ET Q q 0 0 0 rg BT 523.50 261.30 Td (European ) Tj ET Q q 0 0 0 rg BT 556.02 261.30 Td (Patent ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 251.70 Td (No. ) Tj ET Q q 0 0 0 rg BT 67.43 251.70 Td (1610780 ) Tj ET Q q 0 0 0 rg BT 97.08 251.70 Td (and ) Tj ET Q q 0 0 0 rg BT 110.28 251.70 Td (its ) Tj ET Q q 0 0 0 rg BT 119.48 251.70 Td (claim ) Tj ET Q q 0 0 0 rg BT 138.90 251.70 Td (to ) Tj ET Q q 0 0 0 rg BT 146.78 251.70 Td (the ) Tj ET Q q 0 0 0 rg BT 158.20 251.70 Td (use ) Tj ET Q q 0 0 0 rg BT 170.51 251.70 Td (of ) Tj ET Q q 0 0 0 rg BT 178.83 251.70 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 209.36 251.70 Td (to ) Tj ET Q q 0 0 0 rg BT 217.23 251.70 Td (treat ) Tj ET Q q 0 0 0 rg BT 233.09 251.70 Td (CML, ) Tj ET Q q 0 0 0 rg BT 254.08 251.70 Td (which ) Tj ET Q q 0 0 0 rg BT 275.28 251.70 Td (the ) Tj ET Q q 0 0 0 rg BT 286.70 251.70 Td (EPO’) Tj ET Q q 0 0 0 rg BT 304.03 251.70 Td (s ) Tj ET Q q 0 0 0 rg BT 308.80 251.70 Td (Opposition ) Tj ET Q q 0 0 0 rg BT 346.00 251.70 Td (Division ) Tj ET Q q 0 0 0 rg BT 375.21 251.70 Td (had ) Tj ET Q q 0 0 0 rg BT 388.41 251.70 Td (revoked ) Tj ET Q q 0 0 0 rg BT 415.83 251.70 Td (in ) Tj ET Q q 0 0 0 rg BT 423.70 251.70 Td (October ) Tj ET Q q 0 0 0 rg BT 451.12 251.70 Td (2012. ) Tj ET Q q 0 0 0 rg BT 470.65 251.70 Td (W) Tj ET Q q 0 0 0 rg BT 477.56 251.70 Td (e ) Tj ET Q q 0 0 0 rg BT 482.76 251.70 Td (intend ) Tj ET Q q 0 0 0 rg BT 504.40 251.70 Td (to ) Tj ET Q q 0 0 0 rg BT 512.27 251.70 Td (pursue ) Tj ET Q q 0 0 0 rg BT 535.25 251.70 Td (legal ) Tj ET Q q 0 0 0 rg BT 552.45 251.70 Td (options ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 242.10 Td (to ) Tj ET Q q 0 0 0 rg BT 62.22 242.10 Td (defend ) Tj ET Q q 0 0 0 rg BT 85.99 242.10 Td (our ) Tj ET Q q 0 0 0 rg BT 98.65 242.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 136.19 242.10 Td (property ) Tj ET Q q 0 0 0 rg BT 165.29 242.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 185.52 242.10 Td (from ) Tj ET Q q 0 0 0 rg BT 203.07 242.10 Td (any ) Tj ET Q q 0 0 0 rg BT 216.62 242.10 Td (future ) Tj ET Q q 0 0 0 rg BT 237.72 242.10 Td (infringement. ) Tj ET Q q 0 0 0 rg BT 283.04 242.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 302.80 242.10 Td (to ) Tj ET Q q 0 0 0 rg BT 311.03 242.10 Td (“Note ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 332.13 242.10 Td (18) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 340.13 242.10 Td (. ) Tj ET Q q 0 0 0 rg BT 344.13 242.10 Td (Legal ) Tj ET Q q 0 0 0 rg BT 364.34 242.10 Td (Proceedings ) Tj ET Q q 0 0 0 rg BT 405.44 242.10 Td (and ) Tj ET Q q 0 0 0 rg BT 418.99 242.10 Td (Contingencies” ) Tj ET Q q 0 0 0 rg BT 470.31 242.10 Td (for ) Tj ET Q q 0 0 0 rg BT 481.64 242.10 Td (more ) Tj ET Q q 0 0 0 rg BT 500.08 242.10 Td (information.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 232.50 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 232.50 Td (References ) Tj ET Q q 0 0 0 rg BT 91.49 232.50 Td (to ) Tj ET Q q 0 0 0 rg BT 99.68 232.50 Td (the ) Tj ET Q q 0 0 0 rg BT 111.41 232.50 Td (EU ) Tj ET Q q 0 0 0 rg BT 124.04 232.50 Td (throughout ) Tj ET Q q 0 0 0 rg BT 161.11 232.50 Td (this ) Tj ET Q q 0 0 0 rg BT 174.63 232.50 Td (Form ) Tj ET Q q 0 0 0 rg BT 193.93 232.50 Td (10-K ) Tj ET Q q 0 0 0 rg BT 212.33 232.50 Td (include ) Tj ET Q q 0 0 0 rg BT 237.84 232.50 Td (all ) Tj ET Q q 0 0 0 rg BT 247.80 232.50 Td (member ) Tj ET Q q 0 0 0 rg BT 275.97 232.50 Td (states ) Tj ET Q q 0 0 0 rg BT 295.71 232.50 Td (of ) Tj ET Q q 0 0 0 rg BT 304.33 232.50 Td (the ) Tj ET Q q 0 0 0 rg BT 316.07 232.50 Td (EU ) Tj ET Q q 0 0 0 rg BT 328.69 232.50 Td (during ) Tj ET Q q 0 0 0 rg BT 351.54 232.50 Td (the ) Tj ET Q q 0 0 0 rg BT 363.28 232.50 Td (year ) Tj ET Q q 0 0 0 rg BT 379.01 232.50 Td (ended ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 400.07 232.50 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 446.90 232.50 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 462.90 232.50 Td (. ) Tj ET Q q 0 0 0 rg BT 466.86 232.50 Td (Basic ) Tj ET Q q 0 0 0 rg BT 486.60 232.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 508.10 232.50 Td (applications ) Tj ET Q q 0 0 0 rg BT 548.72 232.50 Td (have ) Tj ET Q q 0 0 0 rg BT 565.79 232.50 Td (not ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 222.90 Td (been ) Tj ET Q q 0 0 0 rg BT 70.77 222.90 Td (filed ) Tj ET Q q 0 0 0 rg BT 87.09 222.90 Td (in ) Tj ET Q q 0 0 0 rg BT 94.98 222.90 Td (all ) Tj ET Q q 0 0 0 rg BT 104.64 222.90 Td (current ) Tj ET Q q 0 0 0 rg BT 128.96 222.90 Td (member ) Tj ET Q q 0 0 0 rg BT 156.84 222.90 Td (states ) Tj ET Q q 0 0 0 rg BT 176.28 222.90 Td (for ) Tj ET Q q 0 0 0 rg BT 187.27 222.90 Td (all ) Tj ET Q q 0 0 0 rg BT 196.94 222.90 Td (of ) Tj ET Q q 0 0 0 rg BT 205.27 222.90 Td (the ) Tj ET Q q 0 0 0 rg BT 216.71 222.90 Td (listed ) Tj ET Q q 0 0 0 rg BT 235.70 222.90 Td (products. ) Tj ET Q q 0 0 0 rg BT 266.92 222.90 Td (In ) Tj ET Q q 0 0 0 rg BT 275.25 222.90 Td (some ) Tj ET Q q 0 0 0 rg BT 293.80 222.90 Td (instances, ) Tj ET Q q 0 0 0 rg BT 326.79 222.90 Td (the ) Tj ET Q q 0 0 0 rg BT 338.23 222.90 Td (date ) Tj ET Q q 0 0 0 rg BT 353.22 222.90 Td (of ) Tj ET Q q 0 0 0 rg BT 361.55 222.90 Td (basic ) Tj ET Q q 0 0 0 rg BT 379.66 222.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 416.43 222.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 430.54 222.90 Td (will ) Tj ET Q q 0 0 0 rg BT 444.65 222.90 Td (be ) Tj ET Q q 0 0 0 rg BT 453.87 222.90 Td (dif) Tj ET Q q 0 0 0 rg BT 462.61 222.90 Td (ferent ) Tj ET Q q 0 0 0 rg BT 482.93 222.90 Td (in ) Tj ET Q q 0 0 0 rg BT 490.82 222.90 Td (various ) Tj ET Q q 0 0 0 rg BT 516.04 222.90 Td (EU ) Tj ET Q q 0 0 0 rg BT 528.37 222.90 Td (member ) Tj ET Q q 0 0 0 rg BT 556.24 222.90 Td (states. ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 213.30 Td (For ) Tj ET Q q 0 0 0 rg BT 67.11 213.30 Td (those ) Tj ET Q q 0 0 0 rg BT 86.00 213.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 98.66 213.30 Td (countries ) Tj ET Q q 0 0 0 rg BT 129.99 213.30 Td (where ) Tj ET Q q 0 0 0 rg BT 151.53 213.30 Td (the ) Tj ET Q q 0 0 0 rg BT 163.30 213.30 Td (basic ) Tj ET Q q 0 0 0 rg BT 181.74 213.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 203.29 213.30 Td (was ) Tj ET Q q 0 0 0 rg BT 217.73 213.30 Td (not ) Tj ET Q q 0 0 0 rg BT 229.95 213.30 Td (obtained, ) Tj ET Q q 0 0 0 rg BT 261.50 213.30 Td (there ) Tj ET Q q 0 0 0 rg BT 279.49 213.30 Td (may ) Tj ET Q q 0 0 0 rg BT 295.26 213.30 Td (be ) Tj ET Q q 0 0 0 rg BT 304.81 213.30 Td (data ) Tj ET Q q 0 0 0 rg BT 320.14 213.30 Td (protection ) Tj ET Q q 0 0 0 rg BT 354.57 213.30 Td (available.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 203.70 Td (\(b\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 203.70 Td (Empliciti) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 83.33 203.70 Td (: ) Tj ET Q q 0 0 0 rg BT 87.80 203.70 Td (W) Tj ET Q q 0 0 0 rg BT 94.71 203.70 Td (e ) Tj ET Q q 0 0 0 rg BT 100.70 203.70 Td (have ) Tj ET Q q 0 0 0 rg BT 118.23 203.70 Td (a ) Tj ET Q q 0 0 0 rg BT 124.21 203.70 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 186.16 203.70 Td (agreement ) Tj ET Q q 0 0 0 rg BT 221.91 203.70 Td (with ) Tj ET Q q 0 0 0 rg BT 238.02 203.70 Td (AbbV) Tj ET Q q 0 0 0 rg BT 257.10 203.70 Td (ie ) Tj ET Q q 0 0 0 rg BT 265.30 203.70 Td (for ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 277.06 203.70 Td (Empliciti) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 306.39 203.70 Td (. ) Tj ET Q q 0 0 0 rg BT 310.82 203.70 Td (For ) Tj ET Q q 0 0 0 rg BT 324.36 203.70 Td (more ) Tj ET Q q 0 0 0 rg BT 343.23 203.70 Td (information ) Tj ET Q q 0 0 0 rg BT 383.42 203.70 Td (about ) Tj ET Q q 0 0 0 rg BT 403.63 203.70 Td (our ) Tj ET Q q 0 0 0 rg BT 416.72 203.70 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 459.13 203.70 Td (with ) Tj ET Q q 0 0 0 rg BT 475.24 203.70 Td (AbbV) Tj ET Q q 0 0 0 rg BT 494.32 203.70 Td (ie, ) Tj ET Q q 0 0 0 rg BT 504.52 203.70 Td (refer ) Tj ET Q q 0 0 0 rg BT 522.04 203.70 Td (to ) Tj ET Q q 0 0 0 rg BT 530.70 203.70 Td (“—Alliances” ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 194.10 Td (below ) Tj ET Q q 0 0 0 rg BT 75.86 194.10 Td (and ) Tj ET Q q 0 0 0 rg BT 89.73 194.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 110.25 194.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 118.56 194.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 150.64 194.10 Td (Statements—Note ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 211.61 194.10 Td (3) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 215.61 194.10 Td (. ) Tj ET Q q 0 0 0 rg BT 219.42 194.10 Td (Alliances.” ) Tj ET Q q 0 0 0 rg BT 256.98 194.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 276.05 194.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 284.14 194.10 Td (owns ) Tj ET Q q 0 0 0 rg BT 303.34 194.10 Td (a ) Tj ET Q q 0 0 0 rg BT 309.21 194.10 Td (composition ) Tj ET Q q 0 0 0 rg BT 351.07 194.10 Td (of ) Tj ET Q q 0 0 0 rg BT 360.05 194.10 Td (matter ) Tj ET Q q 0 0 0 rg BT 382.80 194.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 404.66 194.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 434.96 194.10 Td (elotuzumab ) Tj ET Q q 0 0 0 rg BT 474.59 194.10 Td (that ) Tj ET Q q 0 0 0 rg BT 488.90 194.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 514.31 194.10 Td (in ) Tj ET Q q 0 0 0 rg BT 522.85 194.10 Td (2026 ) Tj ET Q q 0 0 0 rg BT 541.16 194.10 Td (in ) Tj ET Q q 0 0 0 rg BT 549.69 194.10 Td (the ) Tj ET Q q 0 0 0 rg BT 561.78 194.10 Td (U.S. ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 184.50 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 90.48 184.50 Td (potential ) Tj ET Q q 0 0 0 rg BT 120.74 184.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 142.55 184.50 Td (term ) Tj ET Q q 0 0 0 rg BT 159.48 184.50 Td (extension\) ) Tj ET Q q 0 0 0 rg BT 195.07 184.50 Td (and ) Tj ET Q q 0 0 0 rg BT 208.88 184.50 Td (2024 ) Tj ET Q q 0 0 0 rg BT 227.15 184.50 Td (in ) Tj ET Q q 0 0 0 rg BT 235.64 184.50 Td (the ) Tj ET Q q 0 0 0 rg BT 247.68 184.50 Td (EU ) Tj ET Q q 0 0 0 rg BT 260.61 184.50 Td (and ) Tj ET Q q 0 0 0 rg BT 274.43 184.50 Td (Japan ) Tj ET Q q 0 0 0 rg BT 294.91 184.50 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 331.39 184.50 Td (potential ) Tj ET Q q 0 0 0 rg BT 361.65 184.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 383.46 184.50 Td (term ) Tj ET Q q 0 0 0 rg BT 400.39 184.50 Td (extensions\). ) Tj ET Q q 0 0 0 rg BT 441.09 184.50 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 479.80 184.50 Td (period ) Tj ET Q q 0 0 0 rg BT 502.50 184.50 Td (in ) Tj ET Q q 0 0 0 rg BT 510.99 184.50 Td (Europe ) Tj ET Q q 0 0 0 rg BT 536.36 184.50 Td (and ) Tj ET Q q 0 0 0 rg BT 550.18 184.50 Td (Japan ) Tj ET Q q 0 0 0 rg BT 570.66 184.50 Td (is ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 174.90 Td (based ) Tj ET Q q 0 0 0 rg BT 74.21 174.90 Td (on ) Tj ET Q q 0 0 0 rg BT 84.21 174.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 119.09 174.90 Td (data ) Tj ET Q q 0 0 0 rg BT 134.41 174.90 Td (protection.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 165.30 Td (\(c\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 165.30 Td (Opdivo) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 77.55 165.30 Td (: ) Tj ET Q q 0 0 0 rg BT 81.22 165.30 Td (W) Tj ET Q q 0 0 0 rg BT 88.13 165.30 Td (e ) Tj ET Q q 0 0 0 rg BT 93.25 165.30 Td (jointly ) Tj ET Q q 0 0 0 rg BT 115.70 165.30 Td (own ) Tj ET Q q 0 0 0 rg BT 131.04 165.30 Td (a ) Tj ET Q q 0 0 0 rg BT 136.16 165.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 157.27 165.30 Td (with ) Tj ET Q q 0 0 0 rg BT 173.05 165.30 Td (Ono ) Tj ET Q q 0 0 0 rg BT 188.40 165.30 Td (covering ) Tj ET Q q 0 0 0 rg BT 217.95 165.30 Td (nivolumab ) Tj ET Q q 0 0 0 rg BT 253.73 165.30 Td (as ) Tj ET Q q 0 0 0 rg BT 261.96 165.30 Td (a ) Tj ET Q q 0 0 0 rg BT 267.07 165.30 Td (composition ) Tj ET Q q 0 0 0 rg BT 308.19 165.30 Td (of ) Tj ET Q q 0 0 0 rg BT 316.42 165.30 Td (matter ) Tj ET Q q 0 0 0 rg BT 338.41 165.30 Td (that ) Tj ET Q q 0 0 0 rg BT 351.97 165.30 Td (expires ) Tj ET Q q 0 0 0 rg BT 376.64 165.30 Td (in ) Tj ET Q q 0 0 0 rg BT 384.42 165.30 Td (2027 ) Tj ET Q q 0 0 0 rg BT 401.99 165.30 Td (in ) Tj ET Q q 0 0 0 rg BT 409.77 165.30 Td (the ) Tj ET Q q 0 0 0 rg BT 421.11 165.30 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 436.90 165.30 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 472.68 165.30 Td (potential ) Tj ET Q q 0 0 0 rg BT 502.23 165.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 523.34 165.30 Td (term ) Tj ET Q q 0 0 0 rg BT 539.56 165.30 Td (extensions\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 155.70 Td (and ) Tj ET Q q 0 0 0 rg BT 67.15 155.70 Td (2026 ) Tj ET Q q 0 0 0 rg BT 84.76 155.70 Td (in ) Tj ET Q q 0 0 0 rg BT 92.58 155.70 Td (the ) Tj ET Q q 0 0 0 rg BT 103.96 155.70 Td (EU ) Tj ET Q q 0 0 0 rg BT 116.23 155.70 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 152.04 155.70 Td (potential ) Tj ET Q q 0 0 0 rg BT 181.64 155.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 202.79 155.70 Td (term ) Tj ET Q q 0 0 0 rg BT 219.05 155.70 Td (extensions\). ) Tj ET Q q 0 0 0 rg BT 258.98 155.70 Td (The ) Tj ET Q q 0 0 0 rg BT 273.02 155.70 Td (composition ) Tj ET Q q 0 0 0 rg BT 314.18 155.70 Td (of ) Tj ET Q q 0 0 0 rg BT 322.44 155.70 Td (matter ) Tj ET Q q 0 0 0 rg BT 344.48 155.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 365.63 155.70 Td (covering ) Tj ET Q q 0 0 0 rg BT 395.22 155.70 Td (nivolumab ) Tj ET Q q 0 0 0 rg BT 431.05 155.70 Td (in ) Tj ET Q q 0 0 0 rg BT 438.87 155.70 Td (Japan ) Tj ET Q q 0 0 0 rg BT 458.69 155.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 483.40 155.70 Td (in ) Tj ET Q q 0 0 0 rg BT 491.22 155.70 Td (2031 ) Tj ET Q q 0 0 0 rg BT 508.83 155.70 Td (including ) Tj ET Q q 0 0 0 rg BT 540.65 155.70 Td (the ) Tj ET Q q 0 0 0 rg BT 552.02 155.70 Td (granted ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 146.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 75.55 146.10 Td (term ) Tj ET Q q 0 0 0 rg BT 92.21 146.10 Td (extension.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 136.50 Td (\(d\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 136.50 Td (Sprycel) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 77.99 136.50 Td (: ) Tj ET Q q 0 0 0 rg BT 81.98 136.50 Td (A) Tj ET Q q 0 0 0 rg BT 87.31 136.50 Td ( ) Tj ET Q q 0 0 0 rg BT 89.57 136.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 111.39 136.50 Td (term ) Tj ET Q q 0 0 0 rg BT 128.31 136.50 Td (extension ) Tj ET Q q 0 0 0 rg BT 161.23 136.50 Td (has ) Tj ET Q q 0 0 0 rg BT 174.16 136.50 Td (been ) Tj ET Q q 0 0 0 rg BT 191.53 136.50 Td (granted ) Tj ET Q q 0 0 0 rg BT 217.78 136.50 Td (in ) Tj ET Q q 0 0 0 rg BT 226.26 136.50 Td (the ) Tj ET Q q 0 0 0 rg BT 238.30 136.50 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 254.79 136.50 Td (extending ) Tj ET Q q 0 0 0 rg BT 288.60 136.50 Td (the ) Tj ET Q q 0 0 0 rg BT 300.64 136.50 Td (term ) Tj ET Q q 0 0 0 rg BT 317.56 136.50 Td (on ) Tj ET Q q 0 0 0 rg BT 327.83 136.50 Td (the ) Tj ET Q q 0 0 0 rg BT 339.86 136.50 Td (basic ) Tj ET Q q 0 0 0 rg BT 358.56 136.50 Td (composition ) Tj ET Q q 0 0 0 rg BT 400.38 136.50 Td (of ) Tj ET Q q 0 0 0 rg BT 409.31 136.50 Td (matter ) Tj ET Q q 0 0 0 rg BT 432.01 136.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 453.82 136.50 Td (covering ) Tj ET Q q 0 0 0 rg BT 484.07 136.50 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 515.22 136.50 Td (until ) Tj ET Q q 0 0 0 rg BT 532.15 136.50 Td (June ) Tj ET Q q 0 0 0 rg BT 549.08 136.50 Td (2020. ) Tj ET Q q 0 0 0 rg BT 569.34 136.50 Td (In ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 126.90 Td (2013, ) Tj ET Q q 0 0 0 rg BT 73.43 126.90 Td (the ) Tj ET Q q 0 0 0 rg BT 84.63 126.90 Td (Company ) Tj ET Q q 0 0 0 rg BT 117.17 126.90 Td (entered ) Tj ET Q q 0 0 0 rg BT 142.14 126.90 Td (into ) Tj ET Q q 0 0 0 rg BT 156.02 126.90 Td (a ) Tj ET Q q 0 0 0 rg BT 161.00 126.90 Td (settlement ) Tj ET Q q 0 0 0 rg BT 195.30 126.90 Td (agreement ) Tj ET Q q 0 0 0 rg BT 230.05 126.90 Td (with ) Tj ET Q q 0 0 0 rg BT 245.38 126.90 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 270.36 126.90 Td (regarding ) Tj ET Q q 0 0 0 rg BT 302.45 126.90 Td (a ) Tj ET Q q 0 0 0 rg BT 307.43 126.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 328.40 126.90 Td (infringement ) Tj ET Q q 0 0 0 rg BT 371.15 126.90 Td (suit ) Tj ET Q q 0 0 0 rg BT 384.14 126.90 Td (covering ) Tj ET Q q 0 0 0 rg BT 413.56 126.90 Td (the ) Tj ET Q q 0 0 0 rg BT 424.76 126.90 Td (monohydrate ) Tj ET Q q 0 0 0 rg BT 468.40 126.90 Td (form ) Tj ET Q q 0 0 0 rg BT 485.38 126.90 Td (of ) Tj ET Q q 0 0 0 rg BT 493.48 126.90 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 523.79 126.90 Td (whereby ) Tj ET Q q 0 0 0 rg BT 552.45 126.90 Td (Apotex ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 117.30 Td (can ) Tj ET Q q 0 0 0 rg BT 67.10 117.30 Td (launch ) Tj ET Q q 0 0 0 rg BT 90.43 117.30 Td (its ) Tj ET Q q 0 0 0 rg BT 99.98 117.30 Td (generic ) Tj ET Q q 0 0 0 rg BT 125.52 117.30 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 156.41 117.30 Td (monohydrate ) Tj ET Q q 0 0 0 rg BT 200.62 117.30 Td (aNDA) Tj ET Q q 0 0 0 rg BT 221.06 117.30 Td ( ) Tj ET Q q 0 0 0 rg BT 223.06 117.30 Td (product ) Tj ET Q q 0 0 0 rg BT 249.50 117.30 Td (in ) Tj ET Q q 0 0 0 rg BT 257.72 117.30 Td (September ) Tj ET Q q 0 0 0 rg BT 293.93 117.30 Td (2024, ) Tj ET Q q 0 0 0 rg BT 313.93 117.30 Td (or ) Tj ET Q q 0 0 0 rg BT 322.59 117.30 Td (earlier ) Tj ET Q q 0 0 0 rg BT 345.02 117.30 Td (in ) Tj ET Q q 0 0 0 rg BT 353.24 117.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 377.00 117.30 Td (circumstances.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 107.70 Td (\(e\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 107.70 Td (Y) Tj ET Q q 0 0 0 rg BT 57.71 107.70 Td (ervoy ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 78.01 107.70 Td (U.S.: ) Tj ET Q q 0 0 0 rg BT 96.99 107.70 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 135.96 107.70 Td (period ) Tj ET Q q 0 0 0 rg BT 158.93 107.70 Td (is ) Tj ET Q q 0 0 0 rg BT 166.80 107.70 Td (based ) Tj ET Q q 0 0 0 rg BT 187.54 107.70 Td (on ) Tj ET Q q 0 0 0 rg BT 198.07 107.70 Td (the ) Tj ET Q q 0 0 0 rg BT 210.38 107.70 Td (composition ) Tj ET Q q 0 0 0 rg BT 252.46 107.70 Td (of ) Tj ET Q q 0 0 0 rg BT 261.65 107.70 Td (matter ) Tj ET Q q 0 0 0 rg BT 284.62 107.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 306.70 107.70 Td (that ) Tj ET Q q 0 0 0 rg BT 321.22 107.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 346.85 107.70 Td (in ) Tj ET Q q 0 0 0 rg BT 355.61 107.70 Td (2025 ) Tj ET Q q 0 0 0 rg BT 374.14 107.70 Td (including ) Tj ET Q q 0 0 0 rg BT 406.89 107.70 Td (the ) Tj ET Q q 0 0 0 rg BT 419.19 107.70 Td (granted ) Tj ET Q q 0 0 0 rg BT 445.71 107.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 467.79 107.70 Td (term ) Tj ET Q q 0 0 0 rg BT 484.98 107.70 Td (extensions. ) Tj ET Q q 0 0 0 rg BT 523.28 107.70 Td (Data ) Tj ET Q q 0 0 0 rg BT 540.91 107.70 Td (exclusivity ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 98.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 79.23 98.10 Td (in ) Tj ET Q q 0 0 0 rg BT 87.57 98.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.47 98.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 115.82 98.10 Td (in ) Tj ET Q q 0 0 0 rg BT 124.17 98.10 Td (2023. ) Tj ET Q q 0 0 0 rg BT 144.14 98.10 Td (W) Tj ET Q q 0 0 0 rg BT 151.05 98.10 Td (e ) Tj ET Q q 0 0 0 rg BT 156.73 98.10 Td (own ) Tj ET Q q 0 0 0 rg BT 172.63 98.10 Td (a ) Tj ET Q q 0 0 0 rg BT 178.31 98.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 199.98 98.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 230.09 98.10 Td (ipilimumab ) Tj ET Q q 0 0 0 rg BT 269.10 98.10 Td (as ) Tj ET Q q 0 0 0 rg BT 277.89 98.10 Td (a ) Tj ET Q q 0 0 0 rg BT 283.57 98.10 Td (composition ) Tj ET Q q 0 0 0 rg BT 325.25 98.10 Td (of ) Tj ET Q q 0 0 0 rg BT 334.04 98.10 Td (matter ) Tj ET Q q 0 0 0 rg BT 356.60 98.10 Td (that ) Tj ET Q q 0 0 0 rg BT 370.72 98.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 401.72 98.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 426.94 98.10 Td (in ) Tj ET Q q 0 0 0 rg BT 435.29 98.10 Td (2022 ) Tj ET Q q 0 0 0 rg BT 453.42 98.10 Td (in ) Tj ET Q q 0 0 0 rg BT 461.76 98.10 Td (the ) Tj ET Q q 0 0 0 rg BT 473.66 98.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 490.01 98.10 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 526.35 98.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 556.47 98.10 Td (patent ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 88.50 Td (term ) Tj ET Q q 0 0 0 rg BT 70.66 88.50 Td (extension\). ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 78.90 Td (\(f\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 78.90 Td (Y) Tj ET Q q 0 0 0 rg BT 57.71 78.90 Td (ervoy) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 75.48 78.90 Td ( ) Tj ET Q q 0 0 0 rg BT 76.73 78.90 Td (EU: ) Tj ET Q q 0 0 0 rg BT 90.87 78.90 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 128.56 78.90 Td (period ) Tj ET Q q 0 0 0 rg BT 150.25 78.90 Td (is ) Tj ET Q q 0 0 0 rg BT 156.83 78.90 Td (based ) Tj ET Q q 0 0 0 rg BT 176.30 78.90 Td (on ) Tj ET Q q 0 0 0 rg BT 185.55 78.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 219.67 78.90 Td (data ) Tj ET Q q 0 0 0 rg BT 234.25 78.90 Td (protection. ) Tj ET Q q 0 0 0 rg BT 269.93 78.90 Td (Data ) Tj ET Q q 0 0 0 rg BT 286.28 78.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 322.64 78.90 Td (expires ) Tj ET Q q 0 0 0 rg BT 346.99 78.90 Td (in ) Tj ET Q q 0 0 0 rg BT 354.46 78.90 Td (the ) Tj ET Q q 0 0 0 rg BT 365.48 78.90 Td (EU ) Tj ET Q q 0 0 0 rg BT 377.40 78.90 Td (in ) Tj ET Q q 0 0 0 rg BT 384.87 78.90 Td (2021. ) Tj ET Q q 0 0 0 rg BT 404.03 78.90 Td (W) Tj ET Q q 0 0 0 rg BT 410.94 78.90 Td (e ) Tj ET Q q 0 0 0 rg BT 415.74 78.90 Td (own ) Tj ET Q q 0 0 0 rg BT 430.77 78.90 Td (a ) Tj ET Q q 0 0 0 rg BT 435.57 78.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 456.37 78.90 Td (covering ) Tj ET Q q 0 0 0 rg BT 485.60 78.90 Td (ipilimumab ) Tj ET Q q 0 0 0 rg BT 523.74 78.90 Td (as ) Tj ET Q q 0 0 0 rg BT 531.66 78.90 Td (a ) Tj ET Q q 0 0 0 rg BT 536.46 78.90 Td (composition ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 69.30 Td (of ) Tj ET Q q 0 0 0 rg BT 62.12 69.30 Td (matter ) Tj ET Q q 0 0 0 rg BT 84.00 69.30 Td (that ) Tj ET Q q 0 0 0 rg BT 97.45 69.30 Td (currently ) Tj ET Q q 0 0 0 rg BT 127.77 69.30 Td (expires ) Tj ET Q q 0 0 0 rg BT 152.33 69.30 Td (in ) Tj ET Q q 0 0 0 rg BT 160.00 69.30 Td (2020 ) Tj ET Q q 0 0 0 rg BT 177.45 69.30 Td (in ) Tj ET Q q 0 0 0 rg BT 185.13 69.30 Td (the ) Tj ET Q q 0 0 0 rg BT 196.35 69.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 208.46 69.30 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 244.13 69.30 Td (potential ) Tj ET Q q 0 0 0 rg BT 273.57 69.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 294.57 69.30 Td (term ) Tj ET Q q 0 0 0 rg BT 310.68 69.30 Td (extensions\). ) Tj ET Q q 0 0 0 rg BT 350.46 69.30 Td (The ) Tj ET Q q 0 0 0 rg BT 364.35 69.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 385.35 69.30 Td (term ) Tj ET Q q 0 0 0 rg BT 401.46 69.30 Td (extension ) Tj ET Q q 0 0 0 rg BT 433.57 69.30 Td (has ) Tj ET Q q 0 0 0 rg BT 445.69 69.30 Td (been ) Tj ET Q q 0 0 0 rg BT 462.24 69.30 Td (granted ) Tj ET Q q 0 0 0 rg BT 487.68 69.30 Td (in ) Tj ET Q q 0 0 0 rg BT 495.35 69.30 Td (many ) Tj ET Q q 0 0 0 rg BT 514.58 69.30 Td (European ) Tj ET Q q 0 0 0 rg BT 546.68 69.30 Td (countries ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 59.70 Td (and ) Tj ET Q q 0 0 0 rg BT 67.55 59.70 Td (in ) Tj ET Q q 0 0 0 rg BT 75.77 59.70 Td (those ) Tj ET Q q 0 0 0 rg BT 94.66 59.70 Td (countries, ) Tj ET Q q 0 0 0 rg BT 127.98 59.70 Td (the ) Tj ET Q q 0 0 0 rg BT 139.76 59.70 Td (composition ) Tj ET Q q 0 0 0 rg BT 181.31 59.70 Td (of ) Tj ET Q q 0 0 0 rg BT 189.98 59.70 Td (matter ) Tj ET Q q 0 0 0 rg BT 212.41 59.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 233.96 59.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 259.06 59.70 Td (in ) Tj ET Q q 0 0 0 rg BT 267.28 59.70 Td (2025.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 50.10 Td (\(g\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 50.10 Td (Y) Tj ET Q q 0 0 0 rg BT 57.71 50.10 Td (ervoy ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 77.48 50.10 Td (Japan: ) Tj ET Q q 0 0 0 rg BT 99.92 50.10 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 138.36 50.10 Td (period ) Tj ET Q q 0 0 0 rg BT 160.80 50.10 Td (is ) Tj ET Q q 0 0 0 rg BT 168.13 50.10 Td (based ) Tj ET Q q 0 0 0 rg BT 188.35 50.10 Td (on ) Tj ET Q q 0 0 0 rg BT 198.35 50.10 Td (the ) Tj ET Q q 0 0 0 rg BT 210.12 50.10 Td (composition ) Tj ET Q q 0 0 0 rg BT 251.68 50.10 Td (of ) Tj ET Q q 0 0 0 rg BT 260.34 50.10 Td (matter ) Tj ET Q q 0 0 0 rg BT 282.77 50.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 304.32 50.10 Td (that ) Tj ET Q q 0 0 0 rg BT 318.32 50.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 343.42 50.10 Td (in ) Tj ET Q q 0 0 0 rg BT 351.64 50.10 Td (2025, ) Tj ET Q q 0 0 0 rg BT 371.64 50.10 Td (including ) Tj ET Q q 0 0 0 rg BT 403.86 50.10 Td (the ) Tj ET Q q 0 0 0 rg BT 415.63 50.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 441.62 50.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 463.17 50.10 Td (term ) Tj ET Q q 0 0 0 rg BT 479.83 50.10 Td (extension.) Tj ET Q endstream endobj 17 0 obj <> endobj 18 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (8) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 750.50 Td (\(h\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 750.50 Td (Eliquis) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 76.67 750.50 Td ( ) Tj ET Q q 0 0 0 rg BT 79.00 750.50 Td (U.S.: ) Tj ET Q q 0 0 0 rg BT 97.61 750.50 Td (The ) Tj ET Q q 0 0 0 rg BT 112.38 750.50 Td (composition ) Tj ET Q q 0 0 0 rg BT 154.27 750.50 Td (of ) Tj ET Q q 0 0 0 rg BT 163.27 750.50 Td (matter ) Tj ET Q q 0 0 0 rg BT 186.03 750.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 207.91 750.50 Td (covering ) Tj ET Q q 0 0 0 rg BT 238.23 750.50 Td (apixaban ) Tj ET Q q 0 0 0 rg BT 269.44 750.50 Td (in ) Tj ET Q q 0 0 0 rg BT 277.99 750.50 Td (the ) Tj ET Q q 0 0 0 rg BT 290.10 750.50 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 306.66 750.50 Td (expires ) Tj ET Q q 0 0 0 rg BT 332.09 750.50 Td (in ) Tj ET Q q 0 0 0 rg BT 340.64 750.50 Td (February ) Tj ET Q q 0 0 0 rg BT 371.85 750.50 Td (2023 ) Tj ET Q q 0 0 0 rg BT 390.19 750.50 Td (and ) Tj ET Q q 0 0 0 rg BT 404.07 750.50 Td (a ) Tj ET Q q 0 0 0 rg BT 409.95 750.50 Td (request ) Tj ET Q q 0 0 0 rg BT 435.39 750.50 Td (for ) Tj ET Q q 0 0 0 rg BT 447.05 750.50 Td (a ) Tj ET Q q 0 0 0 rg BT 452.93 750.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 474.81 750.50 Td (term ) Tj ET Q q 0 0 0 rg BT 491.80 750.50 Td (restoration ) Tj ET Q q 0 0 0 rg BT 528.34 750.50 Td (extension ) Tj ET Q q 0 0 0 rg BT 561.34 750.50 Td (until ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 740.90 Td (2026 ) Tj ET Q q 0 0 0 rg BT 72.00 740.90 Td (is ) Tj ET Q q 0 0 0 rg BT 79.34 740.90 Td (pending ) Tj ET Q q 0 0 0 rg BT 107.11 740.90 Td (\(does ) Tj ET Q q 0 0 0 rg BT 126.44 740.90 Td (not ) Tj ET Q q 0 0 0 rg BT 138.66 740.90 Td (include ) Tj ET Q q 0 0 0 rg BT 164.21 740.90 Td (a ) Tj ET Q q 0 0 0 rg BT 169.76 740.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 199.75 740.90 Td (six ) Tj ET Q q 0 0 0 rg BT 211.09 740.90 Td (month ) Tj ET Q q 0 0 0 rg BT 233.53 740.90 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 263.52 740.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 300.62 740.90 Td (extension, ) Tj ET Q q 0 0 0 rg BT 335.28 740.90 Td (which ) Tj ET Q q 0 0 0 rg BT 356.83 740.90 Td (if ) Tj ET Q q 0 0 0 rg BT 363.72 740.90 Td (granted ) Tj ET Q q 0 0 0 rg BT 389.71 740.90 Td (would ) Tj ET Q q 0 0 0 rg BT 411.71 740.90 Td (provide ) Tj ET Q q 0 0 0 rg BT 438.14 740.90 Td (protection ) Tj ET Q q 0 0 0 rg BT 472.58 740.90 Td (until ) Tj ET Q q 0 0 0 rg BT 489.25 740.90 Td (2027\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 731.30 Td (\(i\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 731.30 Td (Eliquis) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 76.67 731.30 Td ( ) Tj ET Q q 0 0 0 rg BT 78.41 731.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 90.81 731.30 Td (and ) Tj ET Q q 0 0 0 rg BT 104.09 731.30 Td (Japan: ) Tj ET Q q 0 0 0 rg BT 126.14 731.30 Td (The ) Tj ET Q q 0 0 0 rg BT 140.32 731.30 Td (composition ) Tj ET Q q 0 0 0 rg BT 181.61 731.30 Td (of ) Tj ET Q q 0 0 0 rg BT 190.01 731.30 Td (matter ) Tj ET Q q 0 0 0 rg BT 212.18 731.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 233.47 731.30 Td (covering ) Tj ET Q q 0 0 0 rg BT 263.19 731.30 Td (apixaban ) Tj ET Q q 0 0 0 rg BT 293.81 731.30 Td (in ) Tj ET Q q 0 0 0 rg BT 301.77 731.30 Td (the ) Tj ET Q q 0 0 0 rg BT 313.28 731.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 325.68 731.30 Td (expires ) Tj ET Q q 0 0 0 rg BT 350.52 731.30 Td (in ) Tj ET Q q 0 0 0 rg BT 358.48 731.30 Td (2022. ) Tj ET Q q 0 0 0 rg BT 378.09 731.30 Td (W) Tj ET Q q 0 0 0 rg BT 385.00 731.30 Td (e ) Tj ET Q q 0 0 0 rg BT 390.29 731.30 Td (have ) Tj ET Q q 0 0 0 rg BT 407.13 731.30 Td (applied ) Tj ET Q q 0 0 0 rg BT 432.41 731.30 Td (for ) Tj ET Q q 0 0 0 rg BT 443.47 731.30 Td (supplementary ) Tj ET Q q 0 0 0 rg BT 492.31 731.30 Td (protection ) Tj ET Q q 0 0 0 rg BT 526.48 731.30 Td (certificates.The ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 721.70 Td (supplementary ) Tj ET Q q 0 0 0 rg BT 102.82 721.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 136.98 721.70 Td (certificates ) Tj ET Q q 0 0 0 rg BT 173.79 721.70 Td (in ) Tj ET Q q 0 0 0 rg BT 181.73 721.70 Td (most ) Tj ET Q q 0 0 0 rg BT 199.01 721.70 Td (European ) Tj ET Q q 0 0 0 rg BT 231.39 721.70 Td (countries ) Tj ET Q q 0 0 0 rg BT 262.43 721.70 Td (have ) Tj ET Q q 0 0 0 rg BT 279.26 721.70 Td (been ) Tj ET Q q 0 0 0 rg BT 296.08 721.70 Td (granted ) Tj ET Q q 0 0 0 rg BT 321.79 721.70 Td (and ) Tj ET Q q 0 0 0 rg BT 335.07 721.70 Td (expire ) Tj ET Q q 0 0 0 rg BT 356.78 721.70 Td (in ) Tj ET Q q 0 0 0 rg BT 364.72 721.70 Td (2026. ) Tj ET Q q 0 0 0 rg BT 384.45 721.70 Td (Data ) Tj ET Q q 0 0 0 rg BT 401.27 721.70 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 438.10 721.70 Td (in ) Tj ET Q q 0 0 0 rg BT 446.04 721.70 Td (the ) Tj ET Q q 0 0 0 rg BT 457.54 721.70 Td (EU ) Tj ET Q q 0 0 0 rg BT 469.93 721.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 494.75 721.70 Td (in ) Tj ET Q q 0 0 0 rg BT 502.70 721.70 Td (2021. ) Tj ET Q q 0 0 0 rg BT 522.29 721.70 Td (The ) Tj ET Q q 0 0 0 rg BT 536.45 721.70 Td (composition ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 712.10 Td (of ) Tj ET Q q 0 0 0 rg BT 62.66 712.10 Td (matter ) Tj ET Q q 0 0 0 rg BT 85.10 712.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 106.64 712.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 136.63 712.10 Td (apixaban ) Tj ET Q q 0 0 0 rg BT 167.51 712.10 Td (in ) Tj ET Q q 0 0 0 rg BT 175.73 712.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 195.95 712.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 221.05 712.10 Td (in ) Tj ET Q q 0 0 0 rg BT 229.27 712.10 Td (2026 ) Tj ET Q q 0 0 0 rg BT 247.27 712.10 Td (including ) Tj ET Q q 0 0 0 rg BT 279.49 712.10 Td (the ) Tj ET Q q 0 0 0 rg BT 291.26 712.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 317.25 712.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 338.80 712.10 Td (term ) Tj ET Q q 0 0 0 rg BT 355.46 712.10 Td (extension.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 702.50 Td (\(j\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 702.50 Td (Or) Tj ET Q q 0 0 0 rg BT 62.59 702.50 Td (encia) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 79.92 702.50 Td ( ) Tj ET Q q 0 0 0 rg BT 81.81 702.50 Td (U.S.: ) Tj ET Q q 0 0 0 rg BT 100.01 702.50 Td (W) Tj ET Q q 0 0 0 rg BT 106.92 702.50 Td (e ) Tj ET Q q 0 0 0 rg BT 112.36 702.50 Td (have ) Tj ET Q q 0 0 0 rg BT 129.35 702.50 Td (a ) Tj ET Q q 0 0 0 rg BT 134.79 702.50 Td (series ) Tj ET Q q 0 0 0 rg BT 154.90 702.50 Td (of ) Tj ET Q q 0 0 0 rg BT 163.45 702.50 Td (patents ) Tj ET Q q 0 0 0 rg BT 188.00 702.50 Td (covering ) Tj ET Q q 0 0 0 rg BT 217.88 702.50 Td (abatacept ) Tj ET Q q 0 0 0 rg BT 249.97 702.50 Td (and ) Tj ET Q q 0 0 0 rg BT 263.41 702.50 Td (its ) Tj ET Q q 0 0 0 rg BT 272.86 702.50 Td (method ) Tj ET Q q 0 0 0 rg BT 298.74 702.50 Td (of ) Tj ET Q q 0 0 0 rg BT 307.29 702.50 Td (use. ) Tj ET Q q 0 0 0 rg BT 321.85 702.50 Td (In ) Tj ET Q q 0 0 0 rg BT 330.40 702.50 Td (the ) Tj ET Q q 0 0 0 rg BT 342.07 702.50 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 360.18 702.50 Td (a ) Tj ET Q q 0 0 0 rg BT 365.62 702.50 Td (patent ) Tj ET Q q 0 0 0 rg BT 387.06 702.50 Td (term ) Tj ET Q q 0 0 0 rg BT 403.61 702.50 Td (extension ) Tj ET Q q 0 0 0 rg BT 436.16 702.50 Td (has ) Tj ET Q q 0 0 0 rg BT 448.71 702.50 Td (been ) Tj ET Q q 0 0 0 rg BT 465.70 702.50 Td (granted ) Tj ET Q q 0 0 0 rg BT 491.58 702.50 Td (for ) Tj ET Q q 0 0 0 rg BT 502.80 702.50 Td (one ) Tj ET Q q 0 0 0 rg BT 516.24 702.50 Td (of ) Tj ET Q q 0 0 0 rg BT 524.79 702.50 Td (the ) Tj ET Q q 0 0 0 rg BT 536.46 702.50 Td (composition ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 692.90 Td (of ) Tj ET Q q 0 0 0 rg BT 62.45 692.90 Td (matter ) Tj ET Q q 0 0 0 rg BT 84.66 692.90 Td (patents, ) Tj ET Q q 0 0 0 rg BT 111.10 692.90 Td (extending ) Tj ET Q q 0 0 0 rg BT 144.43 692.90 Td (the ) Tj ET Q q 0 0 0 rg BT 155.99 692.90 Td (term ) Tj ET Q q 0 0 0 rg BT 172.43 692.90 Td (of ) Tj ET Q q 0 0 0 rg BT 180.88 692.90 Td (the ) Tj ET Q q 0 0 0 rg BT 192.43 692.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 208.44 692.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 229.77 692.90 Td (to ) Tj ET Q q 0 0 0 rg BT 237.78 692.90 Td (2019. ) Tj ET Q q 0 0 0 rg BT 257.56 692.90 Td (Data ) Tj ET Q q 0 0 0 rg BT 274.44 692.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 311.33 692.90 Td (expires ) Tj ET Q q 0 0 0 rg BT 336.21 692.90 Td (in ) Tj ET Q q 0 0 0 rg BT 344.22 692.90 Td (the ) Tj ET Q q 0 0 0 rg BT 355.77 692.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 371.78 692.90 Td (in ) Tj ET Q q 0 0 0 rg BT 379.79 692.90 Td (December ) Tj ET Q q 0 0 0 rg BT 414.44 692.90 Td (2017 ) Tj ET Q q 0 0 0 rg BT 432.22 692.90 Td (and ) Tj ET Q q 0 0 0 rg BT 445.55 692.90 Td (the ) Tj ET Q q 0 0 0 rg BT 457.11 692.90 Td (method ) Tj ET Q q 0 0 0 rg BT 482.89 692.90 Td (of ) Tj ET Q q 0 0 0 rg BT 491.33 692.90 Td (use ) Tj ET Q q 0 0 0 rg BT 503.78 692.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 525.11 692.90 Td (expires ) Tj ET Q q 0 0 0 rg BT 549.99 692.90 Td (in ) Tj ET Q q 0 0 0 rg BT 558.00 692.90 Td (2021.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 683.30 Td (\(k\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 683.30 Td (Or) Tj ET Q q 0 0 0 rg BT 62.59 683.30 Td (encia) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 79.92 683.30 Td ( ) Tj ET Q q 0 0 0 rg BT 81.66 683.30 Td (EU: ) Tj ET Q q 0 0 0 rg BT 96.29 683.30 Td (In ) Tj ET Q q 0 0 0 rg BT 104.70 683.30 Td (the ) Tj ET Q q 0 0 0 rg BT 116.22 683.30 Td (EU, ) Tj ET Q q 0 0 0 rg BT 130.63 683.30 Td (the ) Tj ET Q q 0 0 0 rg BT 142.14 683.30 Td (composition ) Tj ET Q q 0 0 0 rg BT 183.44 683.30 Td (of ) Tj ET Q q 0 0 0 rg BT 191.85 683.30 Td (matter ) Tj ET Q q 0 0 0 rg BT 214.03 683.30 Td (patent ) Tj ET Q q 0 0 0 rg BT 235.32 683.30 Td (covering ) Tj ET Q q 0 0 0 rg BT 265.05 683.30 Td (abatacept ) Tj ET Q q 0 0 0 rg BT 297.00 683.30 Td (expired ) Tj ET Q q 0 0 0 rg BT 322.73 683.30 Td (in ) Tj ET Q q 0 0 0 rg BT 330.70 683.30 Td (2012. ) Tj ET Q q 0 0 0 rg BT 350.44 683.30 Td (In ) Tj ET Q q 0 0 0 rg BT 358.85 683.30 Td (the ) Tj ET Q q 0 0 0 rg BT 370.37 683.30 Td (majority ) Tj ET Q q 0 0 0 rg BT 399.21 683.30 Td (of ) Tj ET Q q 0 0 0 rg BT 407.62 683.30 Td (the ) Tj ET Q q 0 0 0 rg BT 419.14 683.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 431.55 683.30 Td (countries, ) Tj ET Q q 0 0 0 rg BT 464.62 683.30 Td (we ) Tj ET Q q 0 0 0 rg BT 475.69 683.30 Td (have ) Tj ET Q q 0 0 0 rg BT 492.54 683.30 Td (applied ) Tj ET Q q 0 0 0 rg BT 517.83 683.30 Td (for ) Tj ET Q q 0 0 0 rg BT 528.90 683.30 Td (supplementary ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 673.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 88.97 673.70 Td (certificates ) Tj ET Q q 0 0 0 rg BT 126.60 673.70 Td (and ) Tj ET Q q 0 0 0 rg BT 140.69 673.70 Td (also ) Tj ET Q q 0 0 0 rg BT 156.11 673.70 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 186.64 673.70 Td (extension ) Tj ET Q q 0 0 0 rg BT 219.84 673.70 Td (of ) Tj ET Q q 0 0 0 rg BT 229.04 673.70 Td (the ) Tj ET Q q 0 0 0 rg BT 241.35 673.70 Td (supplementary ) Tj ET Q q 0 0 0 rg BT 290.99 673.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 325.96 673.70 Td (certificates ) Tj ET Q q 0 0 0 rg BT 363.59 673.70 Td (for ) Tj ET Q q 0 0 0 rg BT 375.45 673.70 Td (protection ) Tj ET Q q 0 0 0 rg BT 410.43 673.70 Td (until ) Tj ET Q q 0 0 0 rg BT 427.63 673.70 Td (December ) Tj ET Q q 0 0 0 rg BT 463.04 673.70 Td (2017. ) Tj ET Q q 0 0 0 rg BT 483.39 673.70 Td (The ) Tj ET Q q 0 0 0 rg BT 498.37 673.70 Td (supplemental ) Tj ET Q q 0 0 0 rg BT 543.57 673.70 Td (protection ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 664.10 Td (certificates ) Tj ET Q q 0 0 0 rg BT 91.09 664.10 Td (in ) Tj ET Q q 0 0 0 rg BT 99.31 664.10 Td (most ) Tj ET Q q 0 0 0 rg BT 116.87 664.10 Td (European ) Tj ET Q q 0 0 0 rg BT 149.52 664.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 180.84 664.10 Td (have ) Tj ET Q q 0 0 0 rg BT 197.95 664.10 Td (been ) Tj ET Q q 0 0 0 rg BT 215.05 664.10 Td (granted. ) Tj ET Q q 0 0 0 rg BT 243.04 664.10 Td (Data ) Tj ET Q q 0 0 0 rg BT 260.14 664.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 297.24 664.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 322.34 664.10 Td (in ) Tj ET Q q 0 0 0 rg BT 330.57 664.10 Td (the ) Tj ET Q q 0 0 0 rg BT 342.34 664.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 355.00 664.10 Td (in ) Tj ET Q q 0 0 0 rg BT 363.23 664.10 Td (May ) Tj ET Q q 0 0 0 rg BT 379.89 664.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 397.89 664.10 Td (and ) Tj ET Q q 0 0 0 rg BT 411.44 664.10 Td (the ) Tj ET Q q 0 0 0 rg BT 423.21 664.10 Td (method ) Tj ET Q q 0 0 0 rg BT 449.21 664.10 Td (of ) Tj ET Q q 0 0 0 rg BT 457.88 664.10 Td (use ) Tj ET Q q 0 0 0 rg BT 470.54 664.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 492.09 664.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 517.19 664.10 Td (in ) Tj ET Q q 0 0 0 rg BT 525.41 664.10 Td (2021.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 654.50 Td (\(l\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 654.50 Td (Or) Tj ET Q q 0 0 0 rg BT 62.59 654.50 Td (encia) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 79.92 654.50 Td ( ) Tj ET Q q 0 0 0 rg BT 81.92 654.50 Td (Japan: ) Tj ET Q q 0 0 0 rg BT 104.36 654.50 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 142.80 654.50 Td (period ) Tj ET Q q 0 0 0 rg BT 165.23 654.50 Td (is ) Tj ET Q q 0 0 0 rg BT 172.57 654.50 Td (based ) Tj ET Q q 0 0 0 rg BT 192.79 654.50 Td (on ) Tj ET Q q 0 0 0 rg BT 202.79 654.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 237.66 654.50 Td (data ) Tj ET Q q 0 0 0 rg BT 252.98 654.50 Td (protection, ) Tj ET Q q 0 0 0 rg BT 289.42 654.50 Td (which ) Tj ET Q q 0 0 0 rg BT 310.97 654.50 Td (expires ) Tj ET Q q 0 0 0 rg BT 336.07 654.50 Td (in ) Tj ET Q q 0 0 0 rg BT 344.29 654.50 Td (2018.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 644.90 Td (\(m\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 644.90 Td (Baraclude) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 87.32 644.90 Td ( ) Tj ET Q q 0 0 0 rg BT 89.32 644.90 Td (EU: ) Tj ET Q q 0 0 0 rg BT 104.07 644.90 Td (The ) Tj ET Q q 0 0 0 rg BT 118.50 644.90 Td (composition ) Tj ET Q q 0 0 0 rg BT 160.06 644.90 Td (of ) Tj ET Q q 0 0 0 rg BT 168.72 644.90 Td (matter ) Tj ET Q q 0 0 0 rg BT 191.16 644.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 212.70 644.90 Td (expired ) Tj ET Q q 0 0 0 rg BT 238.69 644.90 Td (in ) Tj ET Q q 0 0 0 rg BT 246.91 644.90 Td (the ) Tj ET Q q 0 0 0 rg BT 258.69 644.90 Td (EU ) Tj ET Q q 0 0 0 rg BT 271.35 644.90 Td (between ) Tj ET Q q 0 0 0 rg BT 300.00 644.90 Td (201) Tj ET Q q 0 0 0 rg BT 311.71 644.90 Td (1 ) Tj ET Q q 0 0 0 rg BT 317.71 644.90 Td (and ) Tj ET Q q 0 0 0 rg BT 331.26 644.90 Td (2016.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 635.30 Td (\(n\) ) Tj ET Q q 0 0 0 rg BT 54.00 635.30 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 92.44 635.30 Td (period ) Tj ET Q q 0 0 0 rg BT 114.88 635.30 Td (relates ) Tj ET Q q 0 0 0 rg BT 137.75 635.30 Td (to ) Tj ET Q q 0 0 0 rg BT 145.98 635.30 Td (the ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 157.75 635.30 Td (Daklinza) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 186.64 635.30 Td ( ) Tj ET Q q 0 0 0 rg BT 188.64 635.30 Td (brand. ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 625.70 Td (\(o\) ) Tj ET Q q 0 0 0 rg BT 54.00 625.70 Td (The ) Tj ET Q q 0 0 0 rg BT 68.44 625.70 Td (composition ) Tj ET Q q 0 0 0 rg BT 109.99 625.70 Td (of ) Tj ET Q q 0 0 0 rg BT 118.66 625.70 Td (matter ) Tj ET Q q 0 0 0 rg BT 141.09 625.70 Td (covering ) Tj ET Q q 0 0 0 rg BT 171.08 625.70 Td (daclatasvir ) Tj ET Q q 0 0 0 rg BT 207.73 625.70 Td (in ) Tj ET Q q 0 0 0 rg BT 215.95 625.70 Td (Japan ) Tj ET Q q 0 0 0 rg BT 236.16 625.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 261.27 625.70 Td (in ) Tj ET Q q 0 0 0 rg BT 269.49 625.70 Td (2028 ) Tj ET Q q 0 0 0 rg BT 287.49 625.70 Td (including ) Tj ET Q q 0 0 0 rg BT 319.71 625.70 Td (granted ) Tj ET Q q 0 0 0 rg BT 345.70 625.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 367.24 625.70 Td (term ) Tj ET Q q 0 0 0 rg BT 383.90 625.70 Td (extension.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 616.10 Td (\(p\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 616.10 Td (Reyataz ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 81.32 616.10 Td (EU: ) Tj ET Q q 0 0 0 rg BT 96.21 616.10 Td (Data ) Tj ET Q q 0 0 0 rg BT 113.31 616.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 150.42 616.10 Td (in ) Tj ET Q q 0 0 0 rg BT 158.64 616.10 Td (the ) Tj ET Q q 0 0 0 rg BT 170.41 616.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 183.08 616.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 209.07 616.10 Td (in ) Tj ET Q q 0 0 0 rg BT 217.29 616.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 235.29 616.10 Td (and ) Tj ET Q q 0 0 0 rg BT 248.84 616.10 Td (market ) Tj ET Q q 0 0 0 rg BT 273.05 616.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 310.16 616.10 Td (is ) Tj ET Q q 0 0 0 rg BT 317.49 616.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 349.25 616.10 Td (to ) Tj ET Q q 0 0 0 rg BT 357.48 616.10 Td (expire ) Tj ET Q q 0 0 0 rg BT 379.46 616.10 Td (between ) Tj ET Q q 0 0 0 rg BT 408.12 616.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 426.12 616.10 Td (and ) Tj ET Q q 0 0 0 rg BT 439.67 616.10 Td (2019.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 606.50 Td (\(q\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 606.50 Td (Sustiva) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 77.11 606.50 Td ( ) Tj ET Q q 0 0 0 rg BT 79.23 606.50 Td (U.S.: ) Tj ET Q q 0 0 0 rg BT 97.80 606.50 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 136.37 606.50 Td (period ) Tj ET Q q 0 0 0 rg BT 158.93 606.50 Td (relates ) Tj ET Q q 0 0 0 rg BT 181.92 606.50 Td (to ) Tj ET Q q 0 0 0 rg BT 190.27 606.50 Td (the ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 202.16 606.50 Td (Sustiva ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 227.39 606.50 Td (brand ) Tj ET Q q 0 0 0 rg BT 247.73 606.50 Td (and ) Tj ET Q q 0 0 0 rg BT 261.40 606.50 Td (does ) Tj ET Q q 0 0 0 rg BT 278.19 606.50 Td (not ) Tj ET Q q 0 0 0 rg BT 290.54 606.50 Td (include ) Tj ET Q q 0 0 0 rg BT 316.20 606.50 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 353.43 606.50 Td (related ) Tj ET Q q 0 0 0 rg BT 377.32 606.50 Td (to ) Tj ET Q q 0 0 0 rg BT 385.66 606.50 Td (any ) Tj ET Q q 0 0 0 rg BT 399.33 606.50 Td (combination ) Tj ET Q q 0 0 0 rg BT 441.45 606.50 Td (therapy) Tj ET Q q 0 0 0 rg BT 464.92 606.50 Td (. ) Tj ET Q q 0 0 0 rg BT 468.88 606.50 Td (The ) Tj ET Q q 0 0 0 rg BT 483.44 606.50 Td (composition ) Tj ET Q q 0 0 0 rg BT 525.12 606.50 Td (of ) Tj ET Q q 0 0 0 rg BT 533.91 606.50 Td (matter ) Tj ET Q q 0 0 0 rg BT 556.46 606.50 Td (patent ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 596.90 Td (for ) Tj ET Q q 0 0 0 rg BT 65.33 596.90 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 97.09 596.90 Td (in ) Tj ET Q q 0 0 0 rg BT 105.31 596.90 Td (the ) Tj ET Q q 0 0 0 rg BT 117.09 596.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 133.32 596.90 Td (expired ) Tj ET Q q 0 0 0 rg BT 159.31 596.90 Td (in ) Tj ET Q q 0 0 0 rg BT 167.54 596.90 Td (2013 ) Tj ET Q q 0 0 0 rg BT 185.54 596.90 Td (and ) Tj ET Q q 0 0 0 rg BT 199.09 596.90 Td (the ) Tj ET Q q 0 0 0 rg BT 210.87 596.90 Td (method ) Tj ET Q q 0 0 0 rg BT 236.87 596.90 Td (of ) Tj ET Q q 0 0 0 rg BT 245.54 596.90 Td (use ) Tj ET Q q 0 0 0 rg BT 258.20 596.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 279.75 596.90 Td (for ) Tj ET Q q 0 0 0 rg BT 291.08 596.90 Td (the ) Tj ET Q q 0 0 0 rg BT 302.86 596.90 Td (treatment ) Tj ET Q q 0 0 0 rg BT 335.07 596.90 Td (of ) Tj ET Q q 0 0 0 rg BT 343.74 596.90 Td (HIV) Tj ET Q q 0 0 0 rg BT 357.81 596.90 Td ( ) Tj ET Q q 0 0 0 rg BT 359.81 596.90 Td (infection ) Tj ET Q q 0 0 0 rg BT 390.25 596.90 Td (expired ) Tj ET Q q 0 0 0 rg BT 416.24 596.90 Td (in ) Tj ET Q q 0 0 0 rg BT 424.47 596.90 Td (September ) Tj ET Q q 0 0 0 rg BT 460.68 596.90 Td (2014. ) Tj ET Q q 0 0 0 rg BT 480.68 596.90 Td (Pediatric ) Tj ET Q q 0 0 0 rg BT 511.12 596.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 548.23 596.90 Td (has ) Tj ET Q q 0 0 0 rg BT 560.90 596.90 Td (been ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 587.30 Td (granted, ) Tj ET Q q 0 0 0 rg BT 82.33 587.30 Td (which ) Tj ET Q q 0 0 0 rg BT 104.23 587.30 Td (provides ) Tj ET Q q 0 0 0 rg BT 134.13 587.30 Td (an ) Tj ET Q q 0 0 0 rg BT 144.03 587.30 Td (additional ) Tj ET Q q 0 0 0 rg BT 178.37 587.30 Td (six ) Tj ET Q q 0 0 0 rg BT 190.05 587.30 Td (month ) Tj ET Q q 0 0 0 rg BT 212.84 587.30 Td (period ) Tj ET Q q 0 0 0 rg BT 235.63 587.30 Td (of ) Tj ET Q q 0 0 0 rg BT 244.64 587.30 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 282.09 587.30 Td (added ) Tj ET Q q 0 0 0 rg BT 303.54 587.30 Td (to ) Tj ET Q q 0 0 0 rg BT 312.11 587.30 Td (the ) Tj ET Q q 0 0 0 rg BT 324.23 587.30 Td (term ) Tj ET Q q 0 0 0 rg BT 341.23 587.30 Td (of ) Tj ET Q q 0 0 0 rg BT 350.24 587.30 Td (the ) Tj ET Q q 0 0 0 rg BT 362.36 587.30 Td (patents ) Tj ET Q q 0 0 0 rg BT 387.37 587.30 Td (listed ) Tj ET Q q 0 0 0 rg BT 407.05 587.30 Td (in ) Tj ET Q q 0 0 0 rg BT 415.62 587.30 Td (the ) Tj ET Q q 0 0 0 rg BT 427.74 587.30 Td (Orange ) Tj ET Q q 0 0 0 rg BT 453.63 587.30 Td (Book. ) Tj ET Q q 0 0 0 rg BT 475.31 587.30 Td (In ) Tj ET Q q 0 0 0 rg BT 484.32 587.30 Td (October ) Tj ET Q q 0 0 0 rg BT 512.43 587.30 Td (2014, ) Tj ET Q q 0 0 0 rg BT 532.78 587.30 Td (the ) Tj ET Q q 0 0 0 rg BT 544.90 587.30 Td (Company ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 577.70 Td (announced ) Tj ET Q q 0 0 0 rg BT 91.17 577.70 Td (that ) Tj ET Q q 0 0 0 rg BT 105.69 577.70 Td (it ) Tj ET Q q 0 0 0 rg BT 112.66 577.70 Td (has ) Tj ET Q q 0 0 0 rg BT 125.84 577.70 Td (successfully ) Tj ET Q q 0 0 0 rg BT 167.46 577.70 Td (resolved ) Tj ET Q q 0 0 0 rg BT 197.08 577.70 Td (all ) Tj ET Q q 0 0 0 rg BT 207.60 577.70 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 247.45 577.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 264.20 577.70 Td (patent ) Tj ET Q q 0 0 0 rg BT 286.27 577.70 Td (litigation ) Tj ET Q q 0 0 0 rg BT 317.67 577.70 Td (relating ) Tj ET Q q 0 0 0 rg BT 344.63 577.70 Td (to ) Tj ET Q q 0 0 0 rg BT 353.37 577.70 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 385.65 577.70 Td (and ) Tj ET Q q 0 0 0 rg BT 399.72 577.70 Td (that ) Tj ET Q q 0 0 0 rg BT 414.23 577.70 Td (loss ) Tj ET Q q 0 0 0 rg BT 429.20 577.70 Td (of ) Tj ET Q q 0 0 0 rg BT 438.39 577.70 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 476.01 577.70 Td (in ) Tj ET Q q 0 0 0 rg BT 484.76 577.70 Td (the ) Tj ET Q q 0 0 0 rg BT 497.05 577.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 513.80 577.70 Td (for ) Tj ET Q q 0 0 0 rg BT 525.65 577.70 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 557.92 577.70 Td (is ) Tj ET Q q 0 0 0 rg BT 565.78 577.70 Td (not ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 568.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 84.27 568.10 Td (to ) Tj ET Q q 0 0 0 rg BT 92.34 568.10 Td (occur ) Tj ET Q q 0 0 0 rg BT 111.95 568.10 Td (until ) Tj ET Q q 0 0 0 rg BT 128.47 568.10 Td (December ) Tj ET Q q 0 0 0 rg BT 163.18 568.10 Td (2017. ) Tj ET Q q 0 0 0 rg BT 182.90 568.10 Td (The ) Tj ET Q q 0 0 0 rg BT 197.18 568.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 213.69 568.10 Td (venture ) Tj ET Q q 0 0 0 rg BT 239.53 568.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 274.69 568.10 Td (with ) Tj ET Q q 0 0 0 rg BT 290.76 568.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 313.93 568.10 Td (to ) Tj ET Q q 0 0 0 rg BT 322.00 568.10 Td (commercialize ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 370.93 568.10 Td (Atripla*) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 397.60 568.10 Td ( ) Tj ET Q q 0 0 0 rg BT 399.44 568.10 Td (may ) Tj ET Q q 0 0 0 rg BT 415.06 568.10 Td (be ) Tj ET Q q 0 0 0 rg BT 424.46 568.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 460.51 568.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 478.36 568.10 Td (the ) Tj ET Q q 0 0 0 rg BT 489.98 568.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 513.15 568.10 Td (of ) Tj ET Q q 0 0 0 rg BT 521.66 568.10 Td (a ) Tj ET Q q 0 0 0 rg BT 527.06 568.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 552.44 568.10 Td (version ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 558.50 Td (of ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 62.66 558.50 Td (Sustiva) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 85.77 558.50 Td (.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 548.90 Td (\(r\) ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 54.00 548.90 Td (Sustiva ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 78.68 548.90 Td (EU: ) Tj ET Q q 0 0 0 rg BT 93.14 548.90 Td (Exclusivity ) Tj ET Q q 0 0 0 rg BT 131.16 548.90 Td (period ) Tj ET Q q 0 0 0 rg BT 153.17 548.90 Td (relates ) Tj ET Q q 0 0 0 rg BT 175.62 548.90 Td (to ) Tj ET Q q 0 0 0 rg BT 183.42 548.90 Td (the ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 194.77 548.90 Td (Sustiva) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 217.88 548.90 Td ( ) Tj ET Q q 0 0 0 rg BT 219.45 548.90 Td (brand ) Tj ET Q q 0 0 0 rg BT 239.24 548.90 Td (and ) Tj ET Q q 0 0 0 rg BT 252.36 548.90 Td (does ) Tj ET Q q 0 0 0 rg BT 268.60 548.90 Td (not ) Tj ET Q q 0 0 0 rg BT 280.40 548.90 Td (include ) Tj ET Q q 0 0 0 rg BT 305.52 548.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 342.20 548.90 Td (related ) Tj ET Q q 0 0 0 rg BT 365.54 548.90 Td (to ) Tj ET Q q 0 0 0 rg BT 373.33 548.90 Td (any ) Tj ET Q q 0 0 0 rg BT 386.46 548.90 Td (combination ) Tj ET Q q 0 0 0 rg BT 428.02 548.90 Td (therapy) Tj ET Q q 0 0 0 rg BT 451.49 548.90 Td (. ) Tj ET Q q 0 0 0 rg BT 455.07 548.90 Td (Market ) Tj ET Q q 0 0 0 rg BT 479.74 548.90 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 516.42 548.90 Td (for ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 527.32 548.90 Td (Sustiva) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 550.43 548.90 Td ( ) Tj ET Q q 0 0 0 rg BT 552.01 548.90 Td (expired ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 539.30 Td (in ) Tj ET Q q 0 0 0 rg BT 62.22 539.30 Td (November ) Tj ET Q q 0 0 0 rg BT 97.99 539.30 Td (2013 ) Tj ET Q q 0 0 0 rg BT 115.99 539.30 Td (in ) Tj ET Q q 0 0 0 rg BT 124.21 539.30 Td (countries ) Tj ET Q q 0 0 0 rg BT 155.54 539.30 Td (in ) Tj ET Q q 0 0 0 rg BT 163.76 539.30 Td (the ) Tj ET Q q 0 0 0 rg BT 175.53 539.30 Td (EU. ) Tj ET Q q 0 0 0 rg BT 190.20 539.30 Td (Data ) Tj ET Q q 0 0 0 rg BT 207.30 539.30 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 244.40 539.30 Td (for ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 255.73 539.30 Td (Sustiva) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 278.84 539.30 Td ( ) Tj ET Q q 0 0 0 rg BT 280.84 539.30 Td (expired ) Tj ET Q q 0 0 0 rg BT 306.83 539.30 Td (in ) Tj ET Q q 0 0 0 rg BT 315.05 539.30 Td (the ) Tj ET Q q 0 0 0 rg BT 326.82 539.30 Td (EU ) Tj ET Q q 0 0 0 rg BT 339.49 539.30 Td (in ) Tj ET Q q 0 0 0 rg BT 347.71 539.30 Td (2009.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 516.50 Td (Resear) Tj ET Q q 0 0 0 rg BT 65.25 516.50 Td (ch and Development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.90 Td (R&D ) Tj ET Q q 0 0 0 rg BT 61.16 494.90 Td (is ) Tj ET Q q 0 0 0 rg BT 71.31 494.90 Td (critical ) Tj ET Q q 0 0 0 rg BT 102.56 494.90 Td (to ) Tj ET Q q 0 0 0 rg BT 113.82 494.90 Td (our ) Tj ET Q q 0 0 0 rg BT 130.64 494.90 Td (long-term ) Tj ET Q q 0 0 0 rg BT 173.56 494.90 Td (competitiveness. ) Tj ET Q q 0 0 0 rg BT 243.72 494.90 Td (W) Tj ET Q q 0 0 0 rg BT 252.36 494.90 Td (e ) Tj ET Q q 0 0 0 rg BT 260.28 494.90 Td (have ) Tj ET Q q 0 0 0 rg BT 282.65 494.90 Td (major ) Tj ET Q q 0 0 0 rg BT 309.46 494.90 Td (R&D ) Tj ET Q q 0 0 0 rg BT 334.62 494.90 Td (sites ) Tj ET Q q 0 0 0 rg BT 355.88 494.90 Td (throughout ) Tj ET Q q 0 0 0 rg BT 403.25 494.90 Td (the ) Tj ET Q q 0 0 0 rg BT 418.96 494.90 Td (world. ) Tj ET Q q 0 0 0 rg BT 447.50 494.90 Td (As ) Tj ET Q q 0 0 0 rg BT 462.10 494.90 Td (part ) Tj ET Q q 0 0 0 rg BT 481.14 494.90 Td (of ) Tj ET Q q 0 0 0 rg BT 492.95 494.90 Td (our ) Tj ET Q q 0 0 0 rg BT 509.77 494.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 551.02 494.90 Td (model ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 482.90 Td (evolution ) Tj ET Q q 0 0 0 rg BT 76.19 482.90 Td (the ) Tj ET Q q 0 0 0 rg BT 90.83 482.90 Td (geographic ) Tj ET Q q 0 0 0 rg BT 137.68 482.90 Td (footprint ) Tj ET Q q 0 0 0 rg BT 175.09 482.90 Td (will ) Tj ET Q q 0 0 0 rg BT 193.07 482.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 245.48 482.90 Td (transform ) Tj ET Q q 0 0 0 rg BT 286.78 482.90 Td (to ) Tj ET Q q 0 0 0 rg BT 296.98 482.90 Td (foster ) Tj ET Q q 0 0 0 rg BT 322.17 482.90 Td (speed ) Tj ET Q q 0 0 0 rg BT 347.36 482.90 Td (and ) Tj ET Q q 0 0 0 rg BT 364.22 482.90 Td (innovation ) Tj ET Q q 0 0 0 rg BT 409.41 482.90 Td (in ) Tj ET Q q 0 0 0 rg BT 419.61 482.90 Td (the ) Tj ET Q q 0 0 0 rg BT 434.25 482.90 Td (future. ) Tj ET Q q 0 0 0 rg BT 462.87 482.90 Td (The ) Tj ET Q q 0 0 0 rg BT 480.84 482.90 Td (transformation ) Tj ET Q q 0 0 0 rg BT 542.13 482.90 Td (involves ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 470.90 Td (the ) Tj ET Q q 0 0 0 rg BT 50.93 470.90 Td (closing ) Tj ET Q q 0 0 0 rg BT 82.52 470.90 Td (of ) Tj ET Q q 0 0 0 rg BT 93.56 470.90 Td (several ) Tj ET Q q 0 0 0 rg BT 124.59 470.90 Td (existing ) Tj ET Q q 0 0 0 rg BT 158.96 470.90 Td (R&D ) Tj ET Q q 0 0 0 rg BT 183.34 470.90 Td (sites ) Tj ET Q q 0 0 0 rg BT 203.83 470.90 Td (accompanied ) Tj ET Q q 0 0 0 rg BT 259.29 470.90 Td (by ) Tj ET Q q 0 0 0 rg BT 272.00 470.90 Td (increased ) Tj ET Q q 0 0 0 rg BT 312.46 470.90 Td (investment ) Tj ET Q q 0 0 0 rg BT 359.06 470.90 Td (in ) Tj ET Q q 0 0 0 rg BT 369.54 470.90 Td (the ) Tj ET Q q 0 0 0 rg BT 384.47 470.90 Td (expansion ) Tj ET Q q 0 0 0 rg BT 427.73 470.90 Td (of ) Tj ET Q q 0 0 0 rg BT 438.77 470.90 Td (others, ) Tj ET Q q 0 0 0 rg BT 468.42 470.90 Td (specifically ) Tj ET Q q 0 0 0 rg BT 517.22 470.90 Td (in ) Tj ET Q q 0 0 0 rg BT 527.70 470.90 Td (the ) Tj ET Q q 0 0 0 rg BT 542.63 470.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 562.93 470.90 Td (W) Tj ET Q q 0 0 0 rg BT 571.57 470.90 Td (e ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 458.90 Td (supplement ) Tj ET Q q 0 0 0 rg BT 84.20 458.90 Td (our ) Tj ET Q q 0 0 0 rg BT 99.64 458.90 Td (internal ) Tj ET Q q 0 0 0 rg BT 132.28 458.90 Td (drug ) Tj ET Q q 0 0 0 rg BT 152.71 458.90 Td (discovery ) Tj ET Q q 0 0 0 rg BT 193.69 458.90 Td (and ) Tj ET Q q 0 0 0 rg BT 210.23 458.90 Td (development ) Tj ET Q q 0 0 0 rg BT 263.98 458.90 Td (programs ) Tj ET Q q 0 0 0 rg BT 303.85 458.90 Td (with ) Tj ET Q q 0 0 0 rg BT 323.73 458.90 Td (alliances ) Tj ET Q q 0 0 0 rg BT 360.81 458.90 Td (and ) Tj ET Q q 0 0 0 rg BT 377.35 458.90 Td (collaborative ) Tj ET Q q 0 0 0 rg BT 431.65 458.90 Td (agreements ) Tj ET Q q 0 0 0 rg BT 479.28 458.90 Td (which ) Tj ET Q q 0 0 0 rg BT 505.82 458.90 Td (help ) Tj ET Q q 0 0 0 rg BT 525.14 458.90 Td (us ) Tj ET Q q 0 0 0 rg BT 536.13 458.90 Td (bring ) Tj ET Q q 0 0 0 rg BT 559.34 458.90 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 446.90 Td (molecular ) Tj ET Q q 0 0 0 rg BT 78.25 446.90 Td (agents, ) Tj ET Q q 0 0 0 rg BT 108.57 446.90 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 156.38 446.90 Td (and ) Tj ET Q q 0 0 0 rg BT 173.09 446.90 Td (platforms ) Tj ET Q q 0 0 0 rg BT 213.69 446.90 Td (into ) Tj ET Q q 0 0 0 rg BT 231.52 446.90 Td (our ) Tj ET Q q 0 0 0 rg BT 247.13 446.90 Td (pipeline. ) Tj ET Q q 0 0 0 rg BT 284.11 446.90 Td (Management ) Tj ET Q q 0 0 0 rg BT 338.59 446.90 Td (continues ) Tj ET Q q 0 0 0 rg BT 379.18 446.90 Td (to ) Tj ET Q q 0 0 0 rg BT 389.23 446.90 Td (emphasize ) Tj ET Q q 0 0 0 rg BT 433.71 446.90 Td (leadership, ) Tj ET Q q 0 0 0 rg BT 479.58 446.90 Td (innovation, ) Tj ET Q q 0 0 0 rg BT 527.12 446.90 Td (productivity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 434.90 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 434.90 Td (quality ) Tj ET Q q 0 0 0 rg BT 83.21 434.90 Td (as ) Tj ET Q q 0 0 0 rg BT 94.04 434.90 Td (strategies ) Tj ET Q q 0 0 0 rg BT 134.31 434.90 Td (for ) Tj ET Q q 0 0 0 rg BT 148.47 434.90 Td (success ) Tj ET Q q 0 0 0 rg BT 180.96 434.90 Td (in ) Tj ET Q q 0 0 0 rg BT 191.23 434.90 Td (our ) Tj ET Q q 0 0 0 rg BT 207.06 434.90 Td (R&D ) Tj ET Q q 0 0 0 rg BT 231.23 434.90 Td (activities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.30 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 413.30 Td (e ) Tj ET Q q 0 0 0 rg BT 53.76 413.30 Td (concentrate ) Tj ET Q q 0 0 0 rg BT 104.51 413.30 Td (our ) Tj ET Q q 0 0 0 rg BT 122.52 413.30 Td (R&D ) Tj ET Q q 0 0 0 rg BT 148.87 413.30 Td (ef) Tj ET Q q 0 0 0 rg BT 156.46 413.30 Td (forts ) Tj ET Q q 0 0 0 rg BT 179.47 413.30 Td (in ) Tj ET Q q 0 0 0 rg BT 191.93 413.30 Td (the ) Tj ET Q q 0 0 0 rg BT 208.83 413.30 Td (following ) Tj ET Q q 0 0 0 rg BT 252.39 413.30 Td (disease ) Tj ET Q q 0 0 0 rg BT 285.95 413.30 Td (areas ) Tj ET Q q 0 0 0 rg BT 311.17 413.30 Td (with ) Tj ET Q q 0 0 0 rg BT 333.62 413.30 Td (significant ) Tj ET Q q 0 0 0 rg BT 380.52 413.30 Td (unmet ) Tj ET Q q 0 0 0 rg BT 410.19 413.30 Td (medical ) Tj ET Q q 0 0 0 rg BT 446.52 413.30 Td (needs: ) Tj ET Q q 0 0 0 rg BT 476.75 413.30 Td (oncology) Tj ET Q q 0 0 0 rg BT 513.31 413.30 Td (, ) Tj ET Q q 0 0 0 rg BT 520.49 413.30 Td (including ) Tj ET Q q 0 0 0 rg BT 562.95 413.30 Td (IO, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.30 Td (immunoscience, ) Tj ET Q q 0 0 0 rg BT 103.95 401.30 Td (cardiovascular) Tj ET Q q 0 0 0 rg BT 161.85 401.30 Td (, ) Tj ET Q q 0 0 0 rg BT 167.04 401.30 Td (fibrotic ) Tj ET Q q 0 0 0 rg BT 199.16 401.30 Td (disease ) Tj ET Q q 0 0 0 rg BT 230.73 401.30 Td (and ) Tj ET Q q 0 0 0 rg BT 247.86 401.30 Td (GDD. ) Tj ET Q q 0 0 0 rg BT 274.52 401.30 Td (W) Tj ET Q q 0 0 0 rg BT 283.16 401.30 Td (e ) Tj ET Q q 0 0 0 rg BT 290.29 401.30 Td (also ) Tj ET Q q 0 0 0 rg BT 309.09 401.30 Td (continue ) Tj ET Q q 0 0 0 rg BT 346.21 401.30 Td (to ) Tj ET Q q 0 0 0 rg BT 356.68 401.30 Td (analyze ) Tj ET Q q 0 0 0 rg BT 389.90 401.30 Td (and ) Tj ET Q q 0 0 0 rg BT 407.03 401.30 Td (may ) Tj ET Q q 0 0 0 rg BT 426.94 401.30 Td (selectively ) Tj ET Q q 0 0 0 rg BT 472.39 401.30 Td (pursue ) Tj ET Q q 0 0 0 rg BT 501.74 401.30 Td (promising ) Tj ET Q q 0 0 0 rg BT 544.99 401.30 Td (leads ) Tj ET Q q 0 0 0 rg BT 568.22 401.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.30 Td (other ) Tj ET Q q 0 0 0 rg BT 58.80 389.30 Td (areas. ) Tj ET Q q 0 0 0 rg BT 84.10 389.30 Td (In ) Tj ET Q q 0 0 0 rg BT 94.68 389.30 Td (addition ) Tj ET Q q 0 0 0 rg BT 129.71 389.30 Td (to ) Tj ET Q q 0 0 0 rg BT 139.75 389.30 Td (discovering ) Tj ET Q q 0 0 0 rg BT 188.66 389.30 Td (and ) Tj ET Q q 0 0 0 rg BT 205.35 389.30 Td (developing ) Tj ET Q q 0 0 0 rg BT 252.04 389.30 Td (new ) Tj ET Q q 0 0 0 rg BT 270.96 389.30 Td (molecular ) Tj ET Q q 0 0 0 rg BT 313.19 389.30 Td (entities, ) Tj ET Q q 0 0 0 rg BT 346.83 389.30 Td (we ) Tj ET Q q 0 0 0 rg BT 360.75 389.30 Td (look ) Tj ET Q q 0 0 0 rg BT 380.78 389.30 Td (for ) Tj ET Q q 0 0 0 rg BT 394.70 389.30 Td (ways ) Tj ET Q q 0 0 0 rg BT 417.50 389.30 Td (to ) Tj ET Q q 0 0 0 rg BT 427.54 389.30 Td (expand ) Tj ET Q q 0 0 0 rg BT 458.67 389.30 Td (the ) Tj ET Q q 0 0 0 rg BT 473.14 389.30 Td (value ) Tj ET Q q 0 0 0 rg BT 497.05 389.30 Td (of ) Tj ET Q q 0 0 0 rg BT 507.64 389.30 Td (existing ) Tj ET Q q 0 0 0 rg BT 541.56 389.30 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.30 Td (through ) Tj ET Q q 0 0 0 rg BT 69.61 377.30 Td (new ) Tj ET Q q 0 0 0 rg BT 88.77 377.30 Td (indications ) Tj ET Q q 0 0 0 rg BT 135.15 377.30 Td (and ) Tj ET Q q 0 0 0 rg BT 152.09 377.30 Td (formulations ) Tj ET Q q 0 0 0 rg BT 205.69 377.30 Td (that ) Tj ET Q q 0 0 0 rg BT 223.19 377.30 Td (can ) Tj ET Q q 0 0 0 rg BT 239.56 377.30 Td (provide ) Tj ET Q q 0 0 0 rg BT 272.61 377.30 Td (additional ) Tj ET Q q 0 0 0 rg BT 315.10 377.30 Td (benefits ) Tj ET Q q 0 0 0 rg BT 349.26 377.30 Td (to ) Tj ET Q q 0 0 0 rg BT 359.54 377.30 Td (patients.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.70 Td (In ) Tj ET Q q 0 0 0 rg BT 46.56 355.70 Td (order ) Tj ET Q q 0 0 0 rg BT 69.89 355.70 Td (for ) Tj ET Q q 0 0 0 rg BT 83.78 355.70 Td (a ) Tj ET Q q 0 0 0 rg BT 90.45 355.70 Td (new ) Tj ET Q q 0 0 0 rg BT 109.34 355.70 Td (drug ) Tj ET Q q 0 0 0 rg BT 129.90 355.70 Td (to ) Tj ET Q q 0 0 0 rg BT 139.91 355.70 Td (reach ) Tj ET Q q 0 0 0 rg BT 163.79 355.70 Td (the ) Tj ET Q q 0 0 0 rg BT 178.23 355.70 Td (market, ) Tj ET Q q 0 0 0 rg BT 210.73 355.70 Td (industry ) Tj ET Q q 0 0 0 rg BT 245.74 355.70 Td (practice ) Tj ET Q q 0 0 0 rg BT 279.61 355.70 Td (and ) Tj ET Q q 0 0 0 rg BT 296.28 355.70 Td (government ) Tj ET Q q 0 0 0 rg BT 346.27 355.70 Td (regulations ) Tj ET Q q 0 0 0 rg BT 392.93 355.70 Td (in ) Tj ET Q q 0 0 0 rg BT 402.94 355.70 Td (the ) Tj ET Q q 0 0 0 rg BT 417.39 355.70 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 439.90 355.70 Td (the ) Tj ET Q q 0 0 0 rg BT 454.35 355.70 Td (EU ) Tj ET Q q 0 0 0 rg BT 469.91 355.70 Td (and ) Tj ET Q q 0 0 0 rg BT 486.58 355.70 Td (most ) Tj ET Q q 0 0 0 rg BT 508.26 355.70 Td (foreign ) Tj ET Q q 0 0 0 rg BT 539.37 355.70 Td (countries ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 343.70 Td (provide ) Tj ET Q q 0 0 0 rg BT 68.63 343.70 Td (for ) Tj ET Q q 0 0 0 rg BT 82.37 343.70 Td (the ) Tj ET Q q 0 0 0 rg BT 96.67 343.70 Td (determination ) Tj ET Q q 0 0 0 rg BT 154.29 343.70 Td (of ) Tj ET Q q 0 0 0 rg BT 164.70 343.70 Td (a ) Tj ET Q q 0 0 0 rg BT 171.22 343.70 Td (drug’) Tj ET Q q 0 0 0 rg BT 192.33 343.70 Td (s ) Tj ET Q q 0 0 0 rg BT 198.31 343.70 Td (ef) Tj ET Q q 0 0 0 rg BT 205.90 343.70 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 252.40 343.70 Td (and ) Tj ET Q q 0 0 0 rg BT 268.92 343.70 Td (safety ) Tj ET Q q 0 0 0 rg BT 294.88 343.70 Td (through ) Tj ET Q q 0 0 0 rg BT 328.07 343.70 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 372.35 343.70 Td (tests ) Tj ET Q q 0 0 0 rg BT 392.21 343.70 Td (and ) Tj ET Q q 0 0 0 rg BT 408.73 343.70 Td (controlled ) Tj ET Q q 0 0 0 rg BT 451.36 343.70 Td (clinical ) Tj ET Q q 0 0 0 rg BT 482.87 343.70 Td (evaluation. ) Tj ET Q q 0 0 0 rg BT 528.95 343.70 Td (The ) Tj ET Q q 0 0 0 rg BT 546.58 343.70 Td (clinical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 331.70 Td (development ) Tj ET Q q 0 0 0 rg BT 89.64 331.70 Td (of ) Tj ET Q q 0 0 0 rg BT 99.96 331.70 Td (a ) Tj ET Q q 0 0 0 rg BT 106.39 331.70 Td (potential ) Tj ET Q q 0 0 0 rg BT 143.37 331.70 Td (new ) Tj ET Q q 0 0 0 rg BT 162.02 331.70 Td (drug ) Tj ET Q q 0 0 0 rg BT 182.34 331.70 Td (includes ) Tj ET Q q 0 0 0 rg BT 217.65 331.70 Td (Phase ) Tj ET Q q 0 0 0 rg BT 242.97 331.70 Td (I, ) Tj ET Q q 0 0 0 rg BT 250.79 331.70 Td (Phase ) Tj ET Q q 0 0 0 rg BT 276.11 331.70 Td (II ) Tj ET Q q 0 0 0 rg BT 284.76 331.70 Td (and ) Tj ET Q q 0 0 0 rg BT 301.19 331.70 Td (Phase ) Tj ET Q q 0 0 0 rg BT 326.51 331.70 Td (III ) Tj ET Q q 0 0 0 rg BT 338.49 331.70 Td (clinical ) Tj ET Q q 0 0 0 rg BT 369.91 331.70 Td (trials ) Tj ET Q q 0 0 0 rg BT 391.89 331.70 Td (that ) Tj ET Q q 0 0 0 rg BT 408.88 331.70 Td (have ) Tj ET Q q 0 0 0 rg BT 429.75 331.70 Td (been ) Tj ET Q q 0 0 0 rg BT 450.61 331.70 Td (designed ) Tj ET Q q 0 0 0 rg BT 488.15 331.70 Td (specifically ) Tj ET Q q 0 0 0 rg BT 536.23 331.70 Td (to ) Tj ET Q q 0 0 0 rg BT 546.00 331.70 Td (support ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 319.70 Td (a ) Tj ET Q q 0 0 0 rg BT 42.94 319.70 Td (new ) Tj ET Q q 0 0 0 rg BT 62.10 319.70 Td (drug ) Tj ET Q q 0 0 0 rg BT 82.93 319.70 Td (application ) Tj ET Q q 0 0 0 rg BT 129.86 319.70 Td (for ) Tj ET Q q 0 0 0 rg BT 144.02 319.70 Td (a ) Tj ET Q q 0 0 0 rg BT 150.96 319.70 Td (particular ) Tj ET Q q 0 0 0 rg BT 191.77 319.70 Td (indication, ) Tj ET Q q 0 0 0 rg BT 236.76 319.70 Td (assuming ) Tj ET Q q 0 0 0 rg BT 277.04 319.70 Td (the ) Tj ET Q q 0 0 0 rg BT 291.75 319.70 Td (trials ) Tj ET Q q 0 0 0 rg BT 314.25 319.70 Td (are ) Tj ET Q q 0 0 0 rg BT 328.95 319.70 Td (successful.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 298.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 61.77 298.10 Td (I ) Tj ET Q q 0 0 0 rg BT 67.54 298.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 99.41 298.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 121.85 298.10 Td (involve ) Tj ET Q q 0 0 0 rg BT 154.28 298.10 Td (a ) Tj ET Q q 0 0 0 rg BT 161.16 298.10 Td (small ) Tj ET Q q 0 0 0 rg BT 185.27 298.10 Td (number ) Tj ET Q q 0 0 0 rg BT 218.25 298.10 Td (of ) Tj ET Q q 0 0 0 rg BT 229.02 298.10 Td (healthy ) Tj ET Q q 0 0 0 rg BT 260.90 298.10 Td (volunteers ) Tj ET Q q 0 0 0 rg BT 304.99 298.10 Td (or ) Tj ET Q q 0 0 0 rg BT 315.76 298.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 349.31 298.10 Td (suf) Tj ET Q q 0 0 0 rg BT 361.35 298.10 Td (fering ) Tj ET Q q 0 0 0 rg BT 387.67 298.10 Td (from ) Tj ET Q q 0 0 0 rg BT 409.54 298.10 Td (the ) Tj ET Q q 0 0 0 rg BT 424.20 298.10 Td (indicated ) Tj ET Q q 0 0 0 rg BT 463.29 298.10 Td (disease ) Tj ET Q q 0 0 0 rg BT 494.61 298.10 Td (to ) Tj ET Q q 0 0 0 rg BT 504.83 298.10 Td (test ) Tj ET Q q 0 0 0 rg BT 521.16 298.10 Td (for ) Tj ET Q q 0 0 0 rg BT 535.26 298.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 561.57 298.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 286.10 Td (proper ) Tj ET Q q 0 0 0 rg BT 64.82 286.10 Td (dosing. ) Tj ET Q q 0 0 0 rg BT 96.71 286.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 122.76 286.10 Td (II ) Tj ET Q q 0 0 0 rg BT 132.14 286.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 164.29 286.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 187.01 286.10 Td (involve ) Tj ET Q q 0 0 0 rg BT 219.73 286.10 Td (a ) Tj ET Q q 0 0 0 rg BT 226.89 286.10 Td (lar) Tj ET Q q 0 0 0 rg BT 237.25 286.10 Td (ger ) Tj ET Q q 0 0 0 rg BT 252.74 286.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 282.67 286.10 Td (population ) Tj ET Q q 0 0 0 rg BT 328.17 286.10 Td (to ) Tj ET Q q 0 0 0 rg BT 338.67 286.10 Td (investigate ) Tj ET Q q 0 0 0 rg BT 384.71 286.10 Td (side ) Tj ET Q q 0 0 0 rg BT 403.54 286.10 Td (ef) Tj ET Q q 0 0 0 rg BT 411.13 286.10 Td (fects, ) Tj ET Q q 0 0 0 rg BT 435.23 286.10 Td (ef) Tj ET Q q 0 0 0 rg BT 442.81 286.10 Td (ficacy) Tj ET Q q 0 0 0 rg BT 466.59 286.10 Td (, ) Tj ET Q q 0 0 0 rg BT 471.81 286.10 Td (and ) Tj ET Q q 0 0 0 rg BT 488.97 286.10 Td (optimal ) Tj ET Q q 0 0 0 rg BT 522.24 286.10 Td (dosage ) Tj ET Q q 0 0 0 rg BT 552.73 286.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.78 286.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 274.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 56.53 274.10 Td (candidate. ) Tj ET Q q 0 0 0 rg BT 99.54 274.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 125.07 274.10 Td (III ) Tj ET Q q 0 0 0 rg BT 137.27 274.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 168.90 274.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 191.09 274.10 Td (are ) Tj ET Q q 0 0 0 rg BT 205.50 274.10 Td (conducted ) Tj ET Q q 0 0 0 rg BT 248.79 274.10 Td (to ) Tj ET Q q 0 0 0 rg BT 258.77 274.10 Td (confirm ) Tj ET Q q 0 0 0 rg BT 292.63 274.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 318.16 274.10 Td (II ) Tj ET Q q 0 0 0 rg BT 327.02 274.10 Td (results ) Tj ET Q q 0 0 0 rg BT 355.33 274.10 Td (in ) Tj ET Q q 0 0 0 rg BT 365.31 274.10 Td (a ) Tj ET Q q 0 0 0 rg BT 371.95 274.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 424.14 274.10 Td (lar) Tj ET Q q 0 0 0 rg BT 434.51 274.10 Td (ger ) Tj ET Q q 0 0 0 rg BT 449.48 274.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 478.89 274.10 Td (population ) Tj ET Q q 0 0 0 rg BT 523.87 274.10 Td (over ) Tj ET Q q 0 0 0 rg BT 543.84 274.10 Td (a ) Tj ET Q q 0 0 0 rg BT 550.48 274.10 Td (longer ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 262.10 Td (term ) Tj ET Q q 0 0 0 rg BT 56.94 262.10 Td (and ) Tj ET Q q 0 0 0 rg BT 74.00 262.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.40 262.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 117.56 262.10 Td (reliable ) Tj ET Q q 0 0 0 rg BT 150.16 262.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.22 262.10 Td (conclusive ) Tj ET Q q 0 0 0 rg BT 212.60 262.10 Td (data ) Tj ET Q q 0 0 0 rg BT 231.88 262.10 Td (regarding ) Tj ET Q q 0 0 0 rg BT 272.81 262.10 Td (the ) Tj ET Q q 0 0 0 rg BT 287.65 262.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 314.14 262.10 Td (and ) Tj ET Q q 0 0 0 rg BT 331.20 262.10 Td (ef) Tj ET Q q 0 0 0 rg BT 338.79 262.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 365.83 262.10 Td (of ) Tj ET Q q 0 0 0 rg BT 376.78 262.10 Td (a ) Tj ET Q q 0 0 0 rg BT 383.83 262.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 404.78 262.10 Td (candidate. ) Tj ET Q q 0 0 0 rg BT 447.63 262.10 Td (Although ) Tj ET Q q 0 0 0 rg BT 488.03 262.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 531.74 262.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 569.35 262.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 250.10 Td (typically ) Tj ET Q q 0 0 0 rg BT 73.49 250.10 Td (based ) Tj ET Q q 0 0 0 rg BT 98.76 250.10 Td (on ) Tj ET Q q 0 0 0 rg BT 111.26 250.10 Td (the ) Tj ET Q q 0 0 0 rg BT 125.98 250.10 Td (results ) Tj ET Q q 0 0 0 rg BT 154.58 250.10 Td (of ) Tj ET Q q 0 0 0 rg BT 165.41 250.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 191.24 250.10 Td (III ) Tj ET Q q 0 0 0 rg BT 203.73 250.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 235.66 250.10 Td (trials, ) Tj ET Q q 0 0 0 rg BT 260.66 250.10 Td (there ) Tj ET Q q 0 0 0 rg BT 283.14 250.10 Td (are ) Tj ET Q q 0 0 0 rg BT 297.85 250.10 Td (times ) Tj ET Q q 0 0 0 rg BT 322.02 250.10 Td (when ) Tj ET Q q 0 0 0 rg BT 346.18 250.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 383.66 250.10 Td (can ) Tj ET Q q 0 0 0 rg BT 400.04 250.10 Td (be ) Tj ET Q q 0 0 0 rg BT 411.98 250.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 444.46 250.10 Td (based ) Tj ET Q q 0 0 0 rg BT 469.73 250.10 Td (on ) Tj ET Q q 0 0 0 rg BT 482.23 250.10 Td (data ) Tj ET Q q 0 0 0 rg BT 501.39 250.10 Td (from ) Tj ET Q q 0 0 0 rg BT 523.32 250.10 Td (earlier ) Tj ET Q q 0 0 0 rg BT 551.36 250.10 Td (trials.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 228.50 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 228.50 Td (e ) Tj ET Q q 0 0 0 rg BT 50.69 228.50 Td (consider ) Tj ET Q q 0 0 0 rg BT 86.19 228.50 Td (our ) Tj ET Q q 0 0 0 rg BT 101.14 228.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 124.43 228.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 163.81 228.50 Td (in ) Tj ET Q q 0 0 0 rg BT 173.21 228.50 Td (Phase ) Tj ET Q q 0 0 0 rg BT 198.16 228.50 Td (III ) Tj ET Q q 0 0 0 rg BT 209.77 228.50 Td (to ) Tj ET Q q 0 0 0 rg BT 219.17 228.50 Td (be ) Tj ET Q q 0 0 0 rg BT 230.22 228.50 Td (our ) Tj ET Q q 0 0 0 rg BT 245.17 228.50 Td (significant ) Tj ET Q q 0 0 0 rg BT 289.00 228.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 312.29 228.50 Td (programs. ) Tj ET Q q 0 0 0 rg BT 354.06 228.50 Td (These ) Tj ET Q q 0 0 0 rg BT 379.56 228.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 418.94 228.50 Td (include ) Tj ET Q q 0 0 0 rg BT 450.00 228.50 Td (both ) Tj ET Q q 0 0 0 rg BT 469.39 228.50 Td (investigational ) Tj ET Q q 0 0 0 rg BT 529.89 228.50 Td (compounds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 216.50 Td (in ) Tj ET Q q 0 0 0 rg BT 46.86 216.50 Td (Phase ) Tj ET Q q 0 0 0 rg BT 73.27 216.50 Td (III ) Tj ET Q q 0 0 0 rg BT 86.33 216.50 Td (development ) Tj ET Q q 0 0 0 rg BT 141.06 216.50 Td (for ) Tj ET Q q 0 0 0 rg BT 155.80 216.50 Td (initial ) Tj ET Q q 0 0 0 rg BT 182.21 216.50 Td (indications ) Tj ET Q q 0 0 0 rg BT 229.17 216.50 Td (and ) Tj ET Q q 0 0 0 rg BT 246.69 216.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 286.97 216.50 Td (products ) Tj ET Q q 0 0 0 rg BT 324.49 216.50 Td (that ) Tj ET Q q 0 0 0 rg BT 342.56 216.50 Td (are ) Tj ET Q q 0 0 0 rg BT 357.85 216.50 Td (in ) Tj ET Q q 0 0 0 rg BT 368.70 216.50 Td (Phase ) Tj ET Q q 0 0 0 rg BT 395.11 216.50 Td (III ) Tj ET Q q 0 0 0 rg BT 408.18 216.50 Td (development ) Tj ET Q q 0 0 0 rg BT 462.91 216.50 Td (for ) Tj ET Q q 0 0 0 rg BT 477.65 216.50 Td (additional ) Tj ET Q q 0 0 0 rg BT 520.72 216.50 Td (indications ) Tj ET Q q 0 0 0 rg BT 567.68 216.50 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 204.50 Td (formulations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 182.90 Td (Drug ) Tj ET Q q 0 0 0 rg BT 59.11 182.90 Td (development ) Tj ET Q q 0 0 0 rg BT 113.32 182.90 Td (is ) Tj ET Q q 0 0 0 rg BT 122.54 182.90 Td (time ) Tj ET Q q 0 0 0 rg BT 142.88 182.90 Td (consuming, ) Tj ET Q q 0 0 0 rg BT 191.82 182.90 Td (expensive ) Tj ET Q q 0 0 0 rg BT 234.36 182.90 Td (and ) Tj ET Q q 0 0 0 rg BT 251.36 182.90 Td (risky) Tj ET Q q 0 0 0 rg BT 270.71 182.90 Td (. ) Tj ET Q q 0 0 0 rg BT 275.58 182.90 Td (The ) Tj ET Q q 0 0 0 rg BT 293.69 182.90 Td (R&D ) Tj ET Q q 0 0 0 rg BT 317.91 182.90 Td (process ) Tj ET Q q 0 0 0 rg BT 350.46 182.90 Td (typically ) Tj ET Q q 0 0 0 rg BT 388.01 182.90 Td (takes ) Tj ET Q q 0 0 0 rg BT 411.11 182.90 Td (about ) Tj ET Q q 0 0 0 rg BT 435.89 182.90 Td (fourteen ) Tj ET Q q 0 0 0 rg BT 471.76 182.90 Td (years, ) Tj ET Q q 0 0 0 rg BT 497.92 182.90 Td (with ) Tj ET Q q 0 0 0 rg BT 518.25 182.90 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 170.90 Td (two ) Tj ET Q q 0 0 0 rg BT 54.01 170.90 Td (and ) Tj ET Q q 0 0 0 rg BT 71.46 170.90 Td (a ) Tj ET Q q 0 0 0 rg BT 78.91 170.90 Td (half ) Tj ET Q q 0 0 0 rg BT 97.46 170.90 Td (years ) Tj ET Q q 0 0 0 rg BT 121.57 170.90 Td (often ) Tj ET Q q 0 0 0 rg BT 145.13 170.90 Td (spent ) Tj ET Q q 0 0 0 rg BT 169.25 170.90 Td (in ) Tj ET Q q 0 0 0 rg BT 180.04 170.90 Td (Phase ) Tj ET Q q 0 0 0 rg BT 206.38 170.90 Td (III, ) Tj ET Q q 0 0 0 rg BT 221.88 170.90 Td (or ) Tj ET Q q 0 0 0 rg BT 233.22 170.90 Td (late-stage, ) Tj ET Q q 0 0 0 rg BT 277.04 170.90 Td (development. ) Tj ET Q q 0 0 0 rg BT 334.20 170.90 Td (On ) Tj ET Q q 0 0 0 rg BT 349.43 170.90 Td (average, ) Tj ET Q q 0 0 0 rg BT 386.03 170.90 Td (only ) Tj ET Q q 0 0 0 rg BT 406.82 170.90 Td (about ) Tj ET Q q 0 0 0 rg BT 432.04 170.90 Td (one ) Tj ET Q q 0 0 0 rg BT 449.49 170.90 Td (in ) Tj ET Q q 0 0 0 rg BT 460.28 170.90 Td (10,000 ) Tj ET Q q 0 0 0 rg BT 490.79 170.90 Td (chemical ) Tj ET Q q 0 0 0 rg BT 529.89 170.90 Td (compounds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 158.90 Td (discovered ) Tj ET Q q 0 0 0 rg BT 80.84 158.90 Td (by ) Tj ET Q q 0 0 0 rg BT 92.36 158.90 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 154.95 158.90 Td (industry ) Tj ET Q q 0 0 0 rg BT 189.25 158.90 Td (researchers ) Tj ET Q q 0 0 0 rg BT 235.73 158.90 Td (proves ) Tj ET Q q 0 0 0 rg BT 263.91 158.90 Td (to ) Tj ET Q q 0 0 0 rg BT 273.21 158.90 Td (be ) Tj ET Q q 0 0 0 rg BT 284.17 158.90 Td (both ) Tj ET Q q 0 0 0 rg BT 303.47 158.90 Td (medically ) Tj ET Q q 0 0 0 rg BT 344.42 158.90 Td (ef) Tj ET Q q 0 0 0 rg BT 352.01 158.90 Td (fective ) Tj ET Q q 0 0 0 rg BT 380.73 158.90 Td (and ) Tj ET Q q 0 0 0 rg BT 396.69 158.90 Td (safe ) Tj ET Q q 0 0 0 rg BT 414.31 158.90 Td (enough ) Tj ET Q q 0 0 0 rg BT 445.26 158.90 Td (to ) Tj ET Q q 0 0 0 rg BT 454.56 158.90 Td (become ) Tj ET Q q 0 0 0 rg BT 487.18 158.90 Td (an ) Tj ET Q q 0 0 0 rg BT 498.13 158.90 Td (approved ) Tj ET Q q 0 0 0 rg BT 536.86 158.90 Td (medicine. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 146.90 Td (Drug ) Tj ET Q q 0 0 0 rg BT 58.51 146.90 Td (candidates ) Tj ET Q q 0 0 0 rg BT 102.67 146.90 Td (can ) Tj ET Q q 0 0 0 rg BT 118.50 146.90 Td (fail ) Tj ET Q q 0 0 0 rg BT 133.78 146.90 Td (at ) Tj ET Q q 0 0 0 rg BT 142.95 146.90 Td (any ) Tj ET Q q 0 0 0 rg BT 159.34 146.90 Td (stage ) Tj ET Q q 0 0 0 rg BT 181.85 146.90 Td (of ) Tj ET Q q 0 0 0 rg BT 192.13 146.90 Td (the ) Tj ET Q q 0 0 0 rg BT 206.31 146.90 Td (process, ) Tj ET Q q 0 0 0 rg BT 240.75 146.90 Td (and ) Tj ET Q q 0 0 0 rg BT 257.15 146.90 Td (even ) Tj ET Q q 0 0 0 rg BT 277.98 146.90 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 318.24 146.90 Td (product ) Tj ET Q q 0 0 0 rg BT 350.75 146.90 Td (candidates ) Tj ET Q q 0 0 0 rg BT 394.90 146.90 Td (sometimes ) Tj ET Q q 0 0 0 rg BT 439.63 146.90 Td (fail ) Tj ET Q q 0 0 0 rg BT 454.91 146.90 Td (to ) Tj ET Q q 0 0 0 rg BT 464.65 146.90 Td (receive ) Tj ET Q q 0 0 0 rg BT 495.47 146.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 538.51 146.90 Td (approval. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.90 Td (According ) Tj ET Q q 0 0 0 rg BT 80.66 134.90 Td (to ) Tj ET Q q 0 0 0 rg BT 90.89 134.90 Td (the ) Tj ET Q q 0 0 0 rg BT 105.56 134.90 Td (KMR ) Tj ET Q q 0 0 0 rg BT 130.80 134.90 Td (Group, ) Tj ET Q q 0 0 0 rg BT 161.30 134.90 Td (based ) Tj ET Q q 0 0 0 rg BT 186.52 134.90 Td (on ) Tj ET Q q 0 0 0 rg BT 198.97 134.90 Td (industry ) Tj ET Q q 0 0 0 rg BT 234.21 134.90 Td (success ) Tj ET Q q 0 0 0 rg BT 266.65 134.90 Td (rates ) Tj ET Q q 0 0 0 rg BT 287.98 134.90 Td (from ) Tj ET Q q 0 0 0 rg BT 309.87 134.90 Td (201) Tj ET Q q 0 0 0 rg BT 324.50 134.90 Td (1-2015, ) Tj ET Q q 0 0 0 rg BT 357.78 134.90 Td (approximately ) Tj ET Q q 0 0 0 rg BT 417.99 134.90 Td (90% ) Tj ET Q q 0 0 0 rg BT 438.77 134.90 Td (of ) Tj ET Q q 0 0 0 rg BT 449.56 134.90 Td (the ) Tj ET Q q 0 0 0 rg BT 464.23 134.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 512.79 134.90 Td (that ) Tj ET Q q 0 0 0 rg BT 530.24 134.90 Td (enter ) Tj ET Q q 0 0 0 rg BT 552.67 134.90 Td (Phase ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 122.90 Td (I ) Tj ET Q q 0 0 0 rg BT 41.50 122.90 Td (development ) Tj ET Q q 0 0 0 rg BT 95.32 122.90 Td (fail ) Tj ET Q q 0 0 0 rg BT 110.81 122.90 Td (to ) Tj ET Q q 0 0 0 rg BT 120.76 122.90 Td (achieve ) Tj ET Q q 0 0 0 rg BT 153.46 122.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 196.72 122.90 Td (approval. ) Tj ET Q q 0 0 0 rg BT 236.21 122.90 Td (The ) Tj ET Q q 0 0 0 rg BT 253.93 122.90 Td (failure ) Tj ET Q q 0 0 0 rg BT 282.19 122.90 Td (rate ) Tj ET Q q 0 0 0 rg BT 299.34 122.90 Td (for ) Tj ET Q q 0 0 0 rg BT 313.17 122.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 361.45 122.90 Td (that ) Tj ET Q q 0 0 0 rg BT 378.61 122.90 Td (enter ) Tj ET Q q 0 0 0 rg BT 400.77 122.90 Td (Phase ) Tj ET Q q 0 0 0 rg BT 426.26 122.90 Td (II ) Tj ET Q q 0 0 0 rg BT 435.09 122.90 Td (development ) Tj ET Q q 0 0 0 rg BT 488.91 122.90 Td (is ) Tj ET Q q 0 0 0 rg BT 497.75 122.90 Td (approximately ) Tj ET Q q 0 0 0 rg BT 557.67 122.90 Td (77% ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 110.90 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 110.90 Td (for ) Tj ET Q q 0 0 0 rg BT 67.10 110.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 115.71 110.90 Td (that ) Tj ET Q q 0 0 0 rg BT 133.20 110.90 Td (enter ) Tj ET Q q 0 0 0 rg BT 155.69 110.90 Td (Phase ) Tj ET Q q 0 0 0 rg BT 181.52 110.90 Td (III ) Tj ET Q q 0 0 0 rg BT 194.01 110.90 Td (development, ) Tj ET Q q 0 0 0 rg BT 250.66 110.90 Td (it ) Tj ET Q q 0 0 0 rg BT 258.71 110.90 Td (is ) Tj ET Q q 0 0 0 rg BT 267.88 110.90 Td (approximately ) Tj ET Q q 0 0 0 rg BT 328.14 110.90 Td (29%.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.30 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 89.30 Td (otal ) Tj ET Q q 0 0 0 rg BT 59.48 89.30 Td (R&D ) Tj ET Q q 0 0 0 rg BT 84.23 89.30 Td (expenses ) Tj ET Q q 0 0 0 rg BT 123.41 89.30 Td (include ) Tj ET Q q 0 0 0 rg BT 155.92 89.30 Td (the ) Tj ET Q q 0 0 0 rg BT 171.21 89.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 194.29 89.30 Td (of ) Tj ET Q q 0 0 0 rg BT 205.70 89.30 Td (discovery ) Tj ET Q q 0 0 0 rg BT 247.65 89.30 Td (research, ) Tj ET Q q 0 0 0 rg BT 286.54 89.30 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 331.81 89.30 Td (development, ) Tj ET Q q 0 0 0 rg BT 389.04 89.30 Td (early- ) Tj ET Q q 0 0 0 rg BT 415.43 89.30 Td (and ) Tj ET Q q 0 0 0 rg BT 432.95 89.30 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 474.34 89.30 Td (clinical ) Tj ET Q q 0 0 0 rg BT 506.84 89.30 Td (development ) Tj ET Q q 0 0 0 rg BT 561.57 89.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 77.30 Td (drug ) Tj ET Q q 0 0 0 rg BT 56.79 77.30 Td (formulation, ) Tj ET Q q 0 0 0 rg BT 108.95 77.30 Td (as ) Tj ET Q q 0 0 0 rg BT 119.74 77.30 Td (well ) Tj ET Q q 0 0 0 rg BT 139.41 77.30 Td (as ) Tj ET Q q 0 0 0 rg BT 150.20 77.30 Td (post-commercialization ) Tj ET Q q 0 0 0 rg BT 247.06 77.30 Td (and ) Tj ET Q q 0 0 0 rg BT 263.96 77.30 Td (medical ) Tj ET Q q 0 0 0 rg BT 298.07 77.30 Td (support ) Tj ET Q q 0 0 0 rg BT 330.52 77.30 Td (of ) Tj ET Q q 0 0 0 rg BT 341.31 77.30 Td (marketed ) Tj ET Q q 0 0 0 rg BT 380.97 77.30 Td (products, ) Tj ET Q q 0 0 0 rg BT 420.36 77.30 Td (proportionate ) Tj ET Q q 0 0 0 rg BT 476.69 77.30 Td (allocations ) Tj ET Q q 0 0 0 rg BT 522.46 77.30 Td (of ) Tj ET Q q 0 0 0 rg BT 533.25 77.30 Td (enterprise-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 65.30 Td (wide ) Tj ET Q q 0 0 0 rg BT 58.33 65.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 81.23 65.30 Td (and ) Tj ET Q q 0 0 0 rg BT 98.56 65.30 Td (licensing ) Tj ET Q q 0 0 0 rg BT 137.56 65.30 Td (and ) Tj ET Q q 0 0 0 rg BT 154.89 65.30 Td (acquiring ) Tj ET Q q 0 0 0 rg BT 195.55 65.30 Td (assets. ) Tj ET Q q 0 0 0 rg BT 224.27 65.30 Td (R&D ) Tj ET Q q 0 0 0 rg BT 248.84 65.30 Td (expenses ) Tj ET Q q 0 0 0 rg BT 287.83 65.30 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.16 65.30 Td ($4.9 ) Tj ET Q q 0 0 0 rg BT 330.55 65.30 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 356.66 65.30 Td ( ) Tj ET Q q 0 0 0 rg BT 359.56 65.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.23 65.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.23 65.30 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.63 65.30 Td ($5.9 ) Tj ET Q q 0 0 0 rg BT 416.02 65.30 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.13 65.30 Td ( ) Tj ET Q q 0 0 0 rg BT 445.03 65.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.70 65.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.70 65.30 Td ( ) Tj ET Q q 0 0 0 rg BT 478.59 65.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.93 65.30 Td ($4.5 ) Tj ET Q q 0 0 0 rg BT 516.32 65.30 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.44 65.30 Td ( ) Tj ET Q q 0 0 0 rg BT 545.33 65.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.00 65.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 53.30 Td (including ) Tj ET Q q 0 0 0 rg BT 76.65 53.30 Td (license ) Tj ET Q q 0 0 0 rg BT 107.30 53.30 Td (and ) Tj ET Q q 0 0 0 rg BT 124.62 53.30 Td (asset ) Tj ET Q q 0 0 0 rg BT 146.93 53.30 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 193.70 53.30 Td (char) Tj ET Q q 0 0 0 rg BT 210.72 53.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 226.93 53.30 Td (of ) Tj ET Q q 0 0 0 rg BT 238.14 53.30 Td (approximately ) Tj ET Q q 0 0 0 rg BT 298.78 53.30 Td ($440 ) Tj ET Q q 0 0 0 rg BT 321.66 53.30 Td (million, ) Tj ET Q q 0 0 0 rg BT 355.93 53.30 Td ($1.7 ) Tj ET Q q 0 0 0 rg BT 376.31 53.30 Td (billion ) Tj ET Q q 0 0 0 rg BT 405.30 53.30 Td (and ) Tj ET Q q 0 0 0 rg BT 422.62 53.30 Td ($280 ) Tj ET Q q 0 0 0 rg BT 445.50 53.30 Td (million ) Tj ET Q q 0 0 0 rg BT 477.27 53.30 Td (in ) Tj ET Q q 0 0 0 rg BT 487.93 53.30 Td (2016, ) Tj ET Q q 0 0 0 rg BT 513.31 53.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 536.19 53.30 Td (and ) Tj ET Q q 0 0 0 rg BT 553.51 53.30 Td (2014, ) Tj ET Q endstream endobj 19 0 obj <> endobj 20 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.50 24.60 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 83.66 749.10 Td (. ) Tj ET Q q 0 0 0 rg BT 87.81 749.10 Td (At ) Tj ET Q q 0 0 0 rg BT 99.92 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 114.25 749.10 Td (end ) Tj ET Q q 0 0 0 rg BT 130.80 749.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 141.25 749.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.25 749.10 Td (, ) Tj ET Q q 0 0 0 rg BT 165.86 749.10 Td (we ) Tj ET Q q 0 0 0 rg BT 179.63 749.10 Td (employed ) Tj ET Q q 0 0 0 rg BT 221.18 749.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 281.05 749.10 Td (8,400 ) Tj ET Q q 0 0 0 rg BT 305.67 749.10 Td (people ) Tj ET Q q 0 0 0 rg BT 334.43 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 344.33 749.10 Td (R&D ) Tj ET Q q 0 0 0 rg BT 368.11 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 384.66 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 413.98 749.10 Td (support ) Tj ET Q q 0 0 0 rg BT 446.09 749.10 Td (activities, ) Tj ET Q q 0 0 0 rg BT 486.80 749.10 Td (including ) Tj ET Q q 0 0 0 rg BT 526.69 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 533.24 749.10 Td (substantial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (number ) Tj ET Q q 0 0 0 rg BT 69.05 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 79.88 737.10 Td (physicians, ) Tj ET Q q 0 0 0 rg BT 127.09 737.10 Td (scientists ) Tj ET Q q 0 0 0 rg BT 166.26 737.10 Td (holding ) Tj ET Q q 0 0 0 rg BT 199.32 737.10 Td (graduate ) Tj ET Q q 0 0 0 rg BT 236.24 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 247.07 737.10 Td (postgraduate ) Tj ET Q q 0 0 0 rg BT 300.66 737.10 Td (degrees ) Tj ET Q q 0 0 0 rg BT 333.70 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 350.64 737.10 Td (higher) Tj ET Q q 0 0 0 rg BT 375.99 737.10 Td (-skilled ) Tj ET Q q 0 0 0 rg BT 408.48 737.10 Td (technical ) Tj ET Q q 0 0 0 rg BT 447.07 737.10 Td (personnel.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 715.50 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 715.50 Td (e ) Tj ET Q q 0 0 0 rg BT 51.69 715.50 Td (manage ) Tj ET Q q 0 0 0 rg BT 85.40 715.50 Td (our ) Tj ET Q q 0 0 0 rg BT 101.35 715.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 125.64 715.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 166.02 715.50 Td (on ) Tj ET Q q 0 0 0 rg BT 178.64 715.50 Td (a ) Tj ET Q q 0 0 0 rg BT 185.70 715.50 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 223.31 715.50 Td (basis, ) Tj ET Q q 0 0 0 rg BT 248.43 715.50 Td (investing ) Tj ET Q q 0 0 0 rg BT 287.71 715.50 Td (resources ) Tj ET Q q 0 0 0 rg BT 328.08 715.50 Td (in ) Tj ET Q q 0 0 0 rg BT 338.48 715.50 Td (each ) Tj ET Q q 0 0 0 rg BT 359.41 715.50 Td (stage ) Tj ET Q q 0 0 0 rg BT 382.58 715.50 Td (of ) Tj ET Q q 0 0 0 rg BT 393.52 715.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 417.81 715.50 Td (from ) Tj ET Q q 0 0 0 rg BT 439.87 715.50 Td (early ) Tj ET Q q 0 0 0 rg BT 462.47 715.50 Td (discovery ) Tj ET Q q 0 0 0 rg BT 503.96 715.50 Td (through ) Tj ET Q q 0 0 0 rg BT 537.69 715.50 Td (late-stage ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 703.50 Td (development. ) Tj ET Q q 0 0 0 rg BT 92.36 703.50 Td (W) Tj ET Q q 0 0 0 rg BT 100.99 703.50 Td (e ) Tj ET Q q 0 0 0 rg BT 107.81 703.50 Td (continually ) Tj ET Q q 0 0 0 rg BT 155.18 703.50 Td (evaluate ) Tj ET Q q 0 0 0 rg BT 190.87 703.50 Td (our ) Tj ET Q q 0 0 0 rg BT 206.58 703.50 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 243.95 703.50 Td (of ) Tj ET Q q 0 0 0 rg BT 254.66 703.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 278.70 703.50 Td (assets ) Tj ET Q q 0 0 0 rg BT 304.41 703.50 Td (to ) Tj ET Q q 0 0 0 rg BT 314.57 703.50 Td (ensure ) Tj ET Q q 0 0 0 rg BT 343.04 703.50 Td (that ) Tj ET Q q 0 0 0 rg BT 360.42 703.50 Td (there ) Tj ET Q q 0 0 0 rg BT 382.78 703.50 Td (is ) Tj ET Q q 0 0 0 rg BT 391.83 703.50 Td (an ) Tj ET Q q 0 0 0 rg BT 403.65 703.50 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 451.56 703.50 Td (balance ) Tj ET Q q 0 0 0 rg BT 484.47 703.50 Td (of ) Tj ET Q q 0 0 0 rg BT 495.17 703.50 Td (early-stage ) Tj ET Q q 0 0 0 rg BT 541.41 703.50 Td (and ) Tj ET Q q 0 0 0 rg BT 558.23 703.50 Td (late-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 691.50 Td (stage ) Tj ET Q q 0 0 0 rg BT 58.05 691.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 97.32 691.50 Td (to ) Tj ET Q q 0 0 0 rg BT 106.60 691.50 Td (support ) Tj ET Q q 0 0 0 rg BT 138.10 691.50 Td (the ) Tj ET Q q 0 0 0 rg BT 151.82 691.50 Td (future ) Tj ET Q q 0 0 0 rg BT 177.20 691.50 Td (growth ) Tj ET Q q 0 0 0 rg BT 207.03 691.50 Td (of ) Tj ET Q q 0 0 0 rg BT 216.86 691.50 Td (the ) Tj ET Q q 0 0 0 rg BT 230.58 691.50 Td (Company) Tj ET Q q 0 0 0 rg BT 268.81 691.50 Td (. ) Tj ET Q q 0 0 0 rg BT 272.82 691.50 Td (Spending ) Tj ET Q q 0 0 0 rg BT 312.10 691.50 Td (on ) Tj ET Q q 0 0 0 rg BT 323.60 691.50 Td (our ) Tj ET Q q 0 0 0 rg BT 338.43 691.50 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 378.24 691.50 Td (development ) Tj ET Q q 0 0 0 rg BT 431.39 691.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 470.66 691.50 Td (represented ) Tj ET Q q 0 0 0 rg BT 518.25 691.50 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 679.50 Td (30-45% ) Tj ET Q q 0 0 0 rg BT 70.37 679.50 Td (of ) Tj ET Q q 0 0 0 rg BT 81.41 679.50 Td (our ) Tj ET Q q 0 0 0 rg BT 97.45 679.50 Td (annual ) Tj ET Q q 0 0 0 rg BT 126.81 679.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 151.19 679.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 190.00 679.50 Td (in ) Tj ET Q q 0 0 0 rg BT 200.49 679.50 Td (the ) Tj ET Q q 0 0 0 rg BT 215.41 679.50 Td (last ) Tj ET Q q 0 0 0 rg BT 232.01 679.50 Td (three ) Tj ET Q q 0 0 0 rg BT 254.70 679.50 Td (years. ) Tj ET Q q 0 0 0 rg BT 281.01 679.50 Td (No ) Tj ET Q q 0 0 0 rg BT 295.94 679.50 Td (individual ) Tj ET Q q 0 0 0 rg BT 339.20 679.50 Td (investigational ) Tj ET Q q 0 0 0 rg BT 400.79 679.50 Td (compound ) Tj ET Q q 0 0 0 rg BT 445.71 679.50 Td (or ) Tj ET Q q 0 0 0 rg BT 456.75 679.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 496.66 679.50 Td (product ) Tj ET Q q 0 0 0 rg BT 529.92 679.50 Td (represented ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 667.50 Td (10% ) Tj ET Q q 0 0 0 rg BT 56.83 667.50 Td (or ) Tj ET Q q 0 0 0 rg BT 67.66 667.50 Td (more ) Tj ET Q q 0 0 0 rg BT 90.71 667.50 Td (of ) Tj ET Q q 0 0 0 rg BT 101.54 667.50 Td (our ) Tj ET Q q 0 0 0 rg BT 117.37 667.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 141.54 667.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 180.14 667.50 Td (in ) Tj ET Q q 0 0 0 rg BT 190.41 667.50 Td (any ) Tj ET Q q 0 0 0 rg BT 207.35 667.50 Td (of ) Tj ET Q q 0 0 0 rg BT 218.18 667.50 Td (the ) Tj ET Q q 0 0 0 rg BT 232.90 667.50 Td (last ) Tj ET Q q 0 0 0 rg BT 249.29 667.50 Td (three ) Tj ET Q q 0 0 0 rg BT 271.77 667.50 Td (years, ) Tj ET Q q 0 0 0 rg BT 297.87 667.50 Td (except ) Tj ET Q q 0 0 0 rg BT 326.46 667.50 Td (Opdivo ) Tj ET Q q 0 0 0 rg BT 358.96 667.50 Td (in ) Tj ET Q q 0 0 0 rg BT 369.24 667.50 Td (both ) Tj ET Q q 0 0 0 rg BT 389.52 667.50 Td (2016 ) Tj ET Q q 0 0 0 rg BT 412.02 667.50 Td (and ) Tj ET Q q 0 0 0 rg BT 428.96 667.50 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 645.90 Td (Listed ) Tj ET Q q 0 0 0 rg BT 63.65 645.90 Td (below ) Tj ET Q q 0 0 0 rg BT 90.74 645.90 Td (are ) Tj ET Q q 0 0 0 rg BT 105.60 645.90 Td (our ) Tj ET Q q 0 0 0 rg BT 121.58 645.90 Td (investigational ) Tj ET Q q 0 0 0 rg BT 183.11 645.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 231.87 645.90 Td (that ) Tj ET Q q 0 0 0 rg BT 249.52 645.90 Td (we ) Tj ET Q q 0 0 0 rg BT 263.83 645.90 Td (have ) Tj ET Q q 0 0 0 rg BT 285.36 645.90 Td (in ) Tj ET Q q 0 0 0 rg BT 295.79 645.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 327.88 645.90 Td (trials ) Tj ET Q q 0 0 0 rg BT 350.52 645.90 Td (as ) Tj ET Q q 0 0 0 rg BT 361.51 645.90 Td (well ) Tj ET Q q 0 0 0 rg BT 381.38 645.90 Td (as ) Tj ET Q q 0 0 0 rg BT 392.36 645.90 Td (the ) Tj ET Q q 0 0 0 rg BT 407.23 645.90 Td (approved ) Tj ET Q q 0 0 0 rg BT 447.09 645.90 Td (and ) Tj ET Q q 0 0 0 rg BT 464.18 645.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 501.82 645.90 Td (indications ) Tj ET Q q 0 0 0 rg BT 548.36 645.90 Td (for ) Tj ET Q q 0 0 0 rg BT 562.67 645.90 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 633.90 Td (marketed ) Tj ET Q q 0 0 0 rg BT 76.47 633.90 Td (products ) Tj ET Q q 0 0 0 rg BT 114.18 633.90 Td (in ) Tj ET Q q 0 0 0 rg BT 125.23 633.90 Td (the ) Tj ET Q q 0 0 0 rg BT 140.72 633.90 Td (related ) Tj ET Q q 0 0 0 rg BT 171.20 633.90 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 218.89 633.90 Td (area ) Tj ET Q q 0 0 0 rg BT 238.80 633.90 Td (as ) Tj ET Q q 0 0 0 rg BT 250.40 633.90 Td (of ) Tj ET Q q 0 0 0 rg BT 262.01 633.90 Td (January ) Tj ET Q q 0 0 0 rg BT 296.38 633.90 Td (1, ) Tj ET Q q 0 0 0 rg BT 307.15 633.90 Td (2017. ) Tj ET Q q 0 0 0 rg BT 332.68 633.90 Td (Whether ) Tj ET Q q 0 0 0 rg BT 370.38 633.90 Td (any ) Tj ET Q q 0 0 0 rg BT 388.09 633.90 Td (of ) Tj ET Q q 0 0 0 rg BT 399.69 633.90 Td (the ) Tj ET Q q 0 0 0 rg BT 415.18 633.90 Td (listed ) Tj ET Q q 0 0 0 rg BT 440.11 633.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 489.49 633.90 Td (ultimately ) Tj ET Q q 0 0 0 rg BT 533.31 633.90 Td (becomes ) Tj ET Q q 0 0 0 rg BT 571.57 633.90 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 621.90 Td (marketed ) Tj ET Q q 0 0 0 rg BT 75.63 621.90 Td (product ) Tj ET Q q 0 0 0 rg BT 108.61 621.90 Td (depends ) Tj ET Q q 0 0 0 rg BT 143.80 621.90 Td (on ) Tj ET Q q 0 0 0 rg BT 156.23 621.90 Td (the ) Tj ET Q q 0 0 0 rg BT 170.88 621.90 Td (results ) Tj ET Q q 0 0 0 rg BT 199.41 621.90 Td (of ) Tj ET Q q 0 0 0 rg BT 210.17 621.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 242.03 621.90 Td (studies, ) Tj ET Q q 0 0 0 rg BT 274.73 621.90 Td (the ) Tj ET Q q 0 0 0 rg BT 289.38 621.90 Td (competitive ) Tj ET Q q 0 0 0 rg BT 339.01 621.90 Td (landscape ) Tj ET Q q 0 0 0 rg BT 380.87 621.90 Td (of ) Tj ET Q q 0 0 0 rg BT 391.62 621.90 Td (the ) Tj ET Q q 0 0 0 rg BT 406.27 621.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 443.69 621.90 Td (product’) Tj ET Q q 0 0 0 rg BT 477.01 621.90 Td (s ) Tj ET Q q 0 0 0 rg BT 483.33 621.90 Td (market, ) Tj ET Q q 0 0 0 rg BT 516.02 621.90 Td (reimbursement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 609.90 Td (decisions ) Tj ET Q q 0 0 0 rg BT 76.27 609.90 Td (by ) Tj ET Q q 0 0 0 rg BT 89.32 609.90 Td (payers ) Tj ET Q q 0 0 0 rg BT 118.47 609.90 Td (and ) Tj ET Q q 0 0 0 rg BT 135.96 609.90 Td (the ) Tj ET Q q 0 0 0 rg BT 151.22 609.90 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 212.59 609.90 Td (processes ) Tj ET Q q 0 0 0 rg BT 253.96 609.90 Td (necessary ) Tj ET Q q 0 0 0 rg BT 295.88 609.90 Td (to ) Tj ET Q q 0 0 0 rg BT 306.70 609.90 Td (produce ) Tj ET Q q 0 0 0 rg BT 341.96 609.90 Td (the ) Tj ET Q q 0 0 0 rg BT 357.23 609.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 395.27 609.90 Td (product ) Tj ET Q q 0 0 0 rg BT 428.87 609.90 Td (on ) Tj ET Q q 0 0 0 rg BT 441.92 609.90 Td (a ) Tj ET Q q 0 0 0 rg BT 449.41 609.90 Td (commercial ) Tj ET Q q 0 0 0 rg BT 499.66 609.90 Td (scale, ) Tj ET Q q 0 0 0 rg BT 525.19 609.90 Td (among ) Tj ET Q q 0 0 0 rg BT 555.46 609.90 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 597.90 Td (factors. ) Tj ET Q q 0 0 0 rg BT 68.13 597.90 Td (There ) Tj ET Q q 0 0 0 rg BT 94.06 597.90 Td (can ) Tj ET Q q 0 0 0 rg BT 110.55 597.90 Td (be ) Tj ET Q q 0 0 0 rg BT 122.60 597.90 Td (no ) Tj ET Q q 0 0 0 rg BT 135.21 597.90 Td (assurance ) Tj ET Q q 0 0 0 rg BT 176.69 597.90 Td (that ) Tj ET Q q 0 0 0 rg BT 194.30 597.90 Td (we ) Tj ET Q q 0 0 0 rg BT 208.57 597.90 Td (will ) Tj ET Q q 0 0 0 rg BT 226.74 597.90 Td (seek ) Tj ET Q q 0 0 0 rg BT 247.12 597.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 290.83 597.90 Td (approval ) Tj ET Q q 0 0 0 rg BT 328.42 597.90 Td (of ) Tj ET Q q 0 0 0 rg BT 339.37 597.90 Td (any ) Tj ET Q q 0 0 0 rg BT 356.42 597.90 Td (of ) Tj ET Q q 0 0 0 rg BT 367.36 597.90 Td (these ) Tj ET Q q 0 0 0 rg BT 390.52 597.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 439.24 597.90 Td (or ) Tj ET Q q 0 0 0 rg BT 450.18 597.90 Td (that, ) Tj ET Q q 0 0 0 rg BT 470.29 597.90 Td (if ) Tj ET Q q 0 0 0 rg BT 479.01 597.90 Td (such ) Tj ET Q q 0 0 0 rg BT 499.95 597.90 Td (approval ) Tj ET Q q 0 0 0 rg BT 537.55 597.90 Td (is ) Tj ET Q q 0 0 0 rg BT 546.83 597.90 Td (sought, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 585.90 Td (it ) Tj ET Q q 0 0 0 rg BT 44.38 585.90 Td (will ) Tj ET Q q 0 0 0 rg BT 62.76 585.90 Td (be ) Tj ET Q q 0 0 0 rg BT 75.02 585.90 Td (obtained. ) Tj ET Q q 0 0 0 rg BT 114.57 585.90 Td (There ) Tj ET Q q 0 0 0 rg BT 140.71 585.90 Td (is ) Tj ET Q q 0 0 0 rg BT 150.20 585.90 Td (also ) Tj ET Q q 0 0 0 rg BT 169.13 585.90 Td (no ) Tj ET Q q 0 0 0 rg BT 181.95 585.90 Td (assurance ) Tj ET Q q 0 0 0 rg BT 223.64 585.90 Td (that ) Tj ET Q q 0 0 0 rg BT 241.46 585.90 Td (a ) Tj ET Q q 0 0 0 rg BT 248.72 585.90 Td (compound ) Tj ET Q q 0 0 0 rg BT 293.76 585.90 Td (which ) Tj ET Q q 0 0 0 rg BT 321.02 585.90 Td (gets ) Tj ET Q q 0 0 0 rg BT 339.95 585.90 Td (approved ) Tj ET Q q 0 0 0 rg BT 379.98 585.90 Td (will ) Tj ET Q q 0 0 0 rg BT 398.36 585.90 Td (be ) Tj ET Q q 0 0 0 rg BT 410.62 585.90 Td (commercially ) Tj ET Q q 0 0 0 rg BT 468.42 585.90 Td (successful. ) Tj ET Q q 0 0 0 rg BT 514.22 585.90 Td (At ) Tj ET Q q 0 0 0 rg BT 527.04 585.90 Td (this ) Tj ET Q q 0 0 0 rg BT 544.31 585.90 Td (stage ) Tj ET Q q 0 0 0 rg BT 567.68 585.90 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 573.90 Td (development, ) Tj ET Q q 0 0 0 rg BT 92.40 573.90 Td (we ) Tj ET Q q 0 0 0 rg BT 106.31 573.90 Td (cannot ) Tj ET Q q 0 0 0 rg BT 135.22 573.90 Td (determine ) Tj ET Q q 0 0 0 rg BT 177.45 573.90 Td (all ) Tj ET Q q 0 0 0 rg BT 189.69 573.90 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 236.37 573.90 Td (property ) Tj ET Q q 0 0 0 rg BT 272.49 573.90 Td (issues ) Tj ET Q q 0 0 0 rg BT 298.63 573.90 Td (or ) Tj ET Q q 0 0 0 rg BT 309.21 573.90 Td (all ) Tj ET Q q 0 0 0 rg BT 321.46 573.90 Td (the ) Tj ET Q q 0 0 0 rg BT 335.93 573.90 Td (patent ) Tj ET Q q 0 0 0 rg BT 362.61 573.90 Td (protection ) Tj ET Q q 0 0 0 rg BT 405.40 573.90 Td (that ) Tj ET Q q 0 0 0 rg BT 422.65 573.90 Td (may) Tj ET Q q 0 0 0 rg BT 439.21 573.90 Td (, ) Tj ET Q q 0 0 0 rg BT 443.96 573.90 Td (or ) Tj ET Q q 0 0 0 rg BT 454.54 573.90 Td (may ) Tj ET Q q 0 0 0 rg BT 474.01 573.90 Td (not, ) Tj ET Q q 0 0 0 rg BT 491.54 573.90 Td (be ) Tj ET Q q 0 0 0 rg BT 503.23 573.90 Td (available ) Tj ET Q q 0 0 0 rg BT 541.57 573.90 Td (for ) Tj ET Q q 0 0 0 rg BT 555.48 573.90 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 561.90 Td (investigational ) Tj ET Q q 0 0 0 rg BT 97.38 561.90 Td (compounds. ) Tj ET Q /GS0 gs q 448.00 0 0 507.95 82.00 48.95 cm /I16 Do Q endstream endobj 21 0 obj <> endobj 22 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (10) Tj ET Q /GS0 gs q 436.00 0 0 412.00 88.00 344.00 cm /I17 Do Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 320.00 Td (As ) Tj ET Q q 0 0 0 rg BT 49.61 320.00 Td (of ) Tj ET Q q 0 0 0 rg BT 60.44 320.00 Td (January ) Tj ET Q q 0 0 0 rg BT 94.04 320.00 Td (10, ) Tj ET Q q 0 0 0 rg BT 109.04 320.00 Td (2017, ) Tj ET Q q 0 0 0 rg BT 134.04 320.00 Td (the ) Tj ET Q q 0 0 0 rg BT 148.76 320.00 Td (following ) Tj ET Q q 0 0 0 rg BT 190.15 320.00 Td (potential ) Tj ET Q q 0 0 0 rg BT 227.64 320.00 Td (registrational ) Tj ET Q q 0 0 0 rg BT 282.89 320.00 Td (trial ) Tj ET Q q 0 0 0 rg BT 301.50 320.00 Td (readouts ) Tj ET Q q 0 0 0 rg BT 337.88 320.00 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 352.04 320.00 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.47 320.00 Td ( ) Tj ET Q q 0 0 0 rg BT 383.97 320.00 Td (are ) Tj ET Q q 0 0 0 rg BT 398.68 320.00 Td (anticipated ) Tj ET Q q 0 0 0 rg BT 445.05 320.00 Td (through ) Tj ET Q q 0 0 0 rg BT 478.66 320.00 Td (2018:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 292.50 148.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 292.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 270.50 148.00 -26.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 266.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 244.50 148.00 -22.00 re f /GS0 gs 0.8705882352941177 0.9529411764705882 0.7529411764705882 rg /GS0 gs 343.50 244.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 222.50 148.00 -26.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 218.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 192.50 148.00 -22.00 re f /GS0 gs 0.8705882352941177 0.9529411764705882 0.7529411764705882 rg /GS0 gs 343.50 192.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 170.50 148.00 -26.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 166.50 232.00 -22.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 112.50 141.50 148.00 -29.00 re f /GS0 gs 0.8705882352941177 0.9529411764705882 0.7529411764705882 rg /GS0 gs 343.50 141.50 232.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 126.50 232.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 309.5 m 35.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 309.5 m 108.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 309.5 m 108.5 309.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 295.5 m 108.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 309.5 m 112.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 309.5 m 260.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 309.5 m 260.5 309.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 295.5 m 260.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 309.5 m 268.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 309.5 m 339.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 309.5 m 339.5 309.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 295.5 m 339.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 309.5 m 343.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 309.5 m 575.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 309.5 m 575.5 309.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 295.5 m 575.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 292.5 m 35.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 292.5 m 108.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 292.5 m 108.5 292.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 292.5 m 112.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 292.5 m 260.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 292.5 m 260.5 292.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 292.5 m 268.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 292.5 m 339.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 292.5 m 339.5 292.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 270.5 m 339.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 292.5 m 343.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 292.5 m 575.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 292.5 m 575.5 292.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 270.5 m 575.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 270.5 m 35.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 270.5 m 108.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 270.5 m 112.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 270.5 m 260.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 270.5 m 260.5 270.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 266.5 m 35.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 266.5 m 108.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 266.5 m 112.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 266.5 m 260.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 266.5 m 268.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 266.5 m 339.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 266.5 m 339.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 266.5 m 343.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 266.5 m 575.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 266.5 m 575.5 266.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 244.5 m 35.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 244.5 m 108.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 244.5 m 108.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 244.5 m 112.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 244.5 m 260.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 244.5 m 260.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 222.5 m 260.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 244.5 m 268.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 244.5 m 339.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 222.5 m 339.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 244.5 m 343.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 244.5 m 575.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 244.5 m 575.5 244.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 222.5 m 575.5 222.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 222.5 m 35.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 222.5 m 108.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 222.5 m 112.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 222.5 m 260.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 218.5 m 35.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 218.5 m 108.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 196.5 m 108.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 218.5 m 112.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 218.5 m 260.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 196.5 m 260.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 218.5 m 268.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 218.5 m 339.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 218.5 m 339.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 196.5 m 339.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 218.5 m 343.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 218.5 m 575.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 218.5 m 575.5 218.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 196.5 m 575.5 196.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 192.5 m 35.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 192.5 m 108.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 192.5 m 108.5 192.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 192.5 m 112.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 192.5 m 260.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 192.5 m 260.5 192.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 192.5 m 268.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 192.5 m 339.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 192.5 m 339.5 192.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 170.5 m 339.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 192.5 m 343.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 192.5 m 575.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 192.5 m 575.5 192.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 170.5 m 575.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 170.5 m 35.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 170.5 m 108.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 170.5 m 112.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 170.5 m 260.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 170.5 m 260.5 170.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 166.5 m 35.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 166.5 m 108.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 144.5 m 108.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 166.5 m 112.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 166.5 m 260.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 144.5 m 260.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 166.5 m 268.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 166.5 m 339.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 166.5 m 339.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 144.5 m 339.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 166.5 m 343.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 166.5 m 575.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 166.5 m 575.5 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 144.5 m 575.5 144.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 141.5 m 35.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 141.5 m 108.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 141.5 m 108.5 141.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 141.5 m 112.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 141.5 m 260.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 141.5 m 260.5 141.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 141.5 m 268.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 141.5 m 339.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 141.5 m 339.5 141.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 141.5 m 343.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 141.5 m 575.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 141.5 m 575.5 141.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 126.5 m 35.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 108.5 126.5 m 108.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 112.5 m 108.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 126.5 m 112.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 126.5 m 260.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 112.5 112.5 m 260.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 126.5 m 268.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 339.5 126.5 m 339.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 268.5 112.5 m 339.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 126.5 m 343.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 126.5 m 575.5 112.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 126.5 m 575.5 126.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 112.5 m 575.5 112.5 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.05 300.07 Td (Tumor) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.00 300.07 Td (Trial Details) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.05 300.07 Td (Tumor) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 300.07 Td (Trial Details) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.95 271.12 Td (Non-Small Cell) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 261.12 Td (Lung Cancer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 279.12 Td (CM-227 - Opdivo + Yervoy \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.05 283.07 Td (Hepatocellular) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 281.55 273.12 Td (Carcinoma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 279.12 Td (CM-459 - Opdivo \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 255.12 Td (CM-078 - Opdivo \(2L / Asia\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 276.55 242.12 Td (Glioblastoma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 253.12 Td (CM-143 - Opdivo \(2L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.25 223.12 Td (Small Cell) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 213.12 Td (Lung Cancer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 231.12 Td (CM-331 - Opdivo \(2L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 231.12 Td (CM-548 - Opdivo + Standard of Care \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 207.12 Td (CM-451 - Opdivo + Yervoy \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 276.00 205.12 Td (Head & Neck) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 205.12 Td (CM-651 - Opdivo + Yervoy \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.10 166.12 Td (Melanoma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 179.12 Td (CM-511 - Opdivo + Yervoy \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 275.70 183.07 Td (Non-Hodgkin) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 280.70 173.12 Td (Lymphoma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 179.12 Td (CM-140 - Opdivo \(2L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 155.12 Td (CM-238 - Opdivo \(Adjuvant\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 284.30 153.12 Td (Myeloma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 153.12 Td (CM-602 - Opdivo + Empliciti + Standard of Care \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.25 129.62 Td (Renal Cell) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.55 119.62 Td (Carcinoma) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.00 124.62 Td (CM-214 - Opdivo + Yervoy \(1L\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.75 124.62 Td (Key:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 131.62 Td (Phase II) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 117.07 Td (Phase III) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 23 0 obj <> endobj 24 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.15 24.60 Td (1) Tj ET Q q 0 0 0 rg BT 305.78 24.60 Td (1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Alliances) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 725.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.21 725.25 Td (enter ) Tj ET Q q 0 0 0 rg BT 73.32 725.25 Td (into ) Tj ET Q q 0 0 0 rg BT 91.00 725.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 128.11 725.25 Td (with ) Tj ET Q q 0 0 0 rg BT 148.02 725.25 Td (third ) Tj ET Q q 0 0 0 rg BT 169.04 725.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 197.82 725.25 Td (that ) Tj ET Q q 0 0 0 rg BT 214.95 725.25 Td (transfer ) Tj ET Q q 0 0 0 rg BT 247.61 725.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 272.52 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 282.43 725.25 Td (develop, ) Tj ET Q q 0 0 0 rg BT 318.71 725.25 Td (manufacture, ) Tj ET Q q 0 0 0 rg BT 373.31 725.25 Td (market ) Tj ET Q q 0 0 0 rg BT 403.20 725.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 430.88 725.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 446.89 725.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 510.10 725.25 Td (products ) Tj ET Q q 0 0 0 rg BT 546.66 725.25 Td (that ) Tj ET Q q 0 0 0 rg BT 563.79 725.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (owned ) Tj ET Q q 0 0 0 rg BT 65.62 713.25 Td (by ) Tj ET Q q 0 0 0 rg BT 78.58 713.25 Td (other ) Tj ET Q q 0 0 0 rg BT 102.08 713.25 Td (parties. ) Tj ET Q q 0 0 0 rg BT 133.98 713.25 Td (These ) Tj ET Q q 0 0 0 rg BT 160.82 713.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 198.76 713.25 Td (include ) Tj ET Q q 0 0 0 rg BT 231.15 713.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 270.21 713.25 Td (arrangements, ) Tj ET Q q 0 0 0 rg BT 329.54 713.25 Td (co-development ) Tj ET Q q 0 0 0 rg BT 396.91 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 414.31 713.25 Td (co-marketing ) Tj ET Q q 0 0 0 rg BT 470.58 713.25 Td (agreements, ) Tj ET Q q 0 0 0 rg BT 521.57 713.25 Td (co-promotion ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 92.26 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.10 701.25 Td (joint ) Tj ET Q q 0 0 0 rg BT 129.83 701.25 Td (ventures. ) Tj ET Q q 0 0 0 rg BT 168.43 701.25 Td (When ) Tj ET Q q 0 0 0 rg BT 194.70 701.25 Td (such ) Tj ET Q q 0 0 0 rg BT 215.43 701.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 252.81 701.25 Td (involve ) Tj ET Q q 0 0 0 rg BT 285.20 701.25 Td (sharing ) Tj ET Q q 0 0 0 rg BT 317.04 701.25 Td (research ) Tj ET Q q 0 0 0 rg BT 352.74 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 369.58 701.25 Td (development ) Tj ET Q q 0 0 0 rg BT 423.62 701.25 Td (costs, ) Tj ET Q q 0 0 0 rg BT 448.52 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 463.14 701.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 480.53 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 491.26 701.25 Td (incurring ) Tj ET Q q 0 0 0 rg BT 530.31 701.25 Td (all ) Tj ET Q q 0 0 0 rg BT 542.71 701.25 Td (research ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.66 689.25 Td (development ) Tj ET Q q 0 0 0 rg BT 106.54 689.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 144.86 689.25 Td (for ) Tj ET Q q 0 0 0 rg BT 158.74 689.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 207.08 689.25 Td (that ) Tj ET Q q 0 0 0 rg BT 224.30 689.25 Td (do ) Tj ET Q q 0 0 0 rg BT 236.52 689.25 Td (not ) Tj ET Q q 0 0 0 rg BT 251.52 689.25 Td (lead ) Tj ET Q q 0 0 0 rg BT 270.40 689.25 Td (to ) Tj ET Q q 0 0 0 rg BT 280.40 689.25 Td (revenue-generating ) Tj ET Q q 0 0 0 rg BT 359.81 689.25 Td (products ) Tj ET Q q 0 0 0 rg BT 396.47 689.25 Td (is ) Tj ET Q q 0 0 0 rg BT 405.36 689.25 Td (reduced. ) Tj ET Q q 0 0 0 rg BT 441.73 689.25 Td (However) Tj ET Q q 0 0 0 rg BT 477.98 689.25 Td (, ) Tj ET Q q 0 0 0 rg BT 482.71 689.25 Td (profitability ) Tj ET Q q 0 0 0 rg BT 532.70 689.25 Td (on ) Tj ET Q q 0 0 0 rg BT 544.92 689.25 Td (alliance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (products ) Tj ET Q q 0 0 0 rg BT 74.41 677.25 Td (is ) Tj ET Q q 0 0 0 rg BT 85.06 677.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 126.24 677.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 152.98 677.25 Td (because ) Tj ET Q q 0 0 0 rg BT 188.60 677.25 Td (profits ) Tj ET Q q 0 0 0 rg BT 218.69 677.25 Td (from ) Tj ET Q q 0 0 0 rg BT 242.10 677.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 277.17 677.25 Td (products ) Tj ET Q q 0 0 0 rg BT 315.58 677.25 Td (are ) Tj ET Q q 0 0 0 rg BT 331.76 677.25 Td (shared ) Tj ET Q q 0 0 0 rg BT 361.84 677.25 Td (with ) Tj ET Q q 0 0 0 rg BT 383.59 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 400.90 677.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 435.96 677.25 Td (partners. ) Tj ET Q q 0 0 0 rg BT 474.36 677.25 Td (W) Tj ET Q q 0 0 0 rg BT 482.99 677.25 Td (e ) Tj ET Q q 0 0 0 rg BT 491.41 677.25 Td (actively ) Tj ET Q q 0 0 0 rg BT 527.03 677.25 Td (pursue ) Tj ET Q q 0 0 0 rg BT 557.67 677.25 Td (such ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 92.36 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.30 665.25 Td (view ) Tj ET Q q 0 0 0 rg BT 131.24 665.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 168.72 665.25 Td (as ) Tj ET Q q 0 0 0 rg BT 179.55 665.25 Td (an ) Tj ET Q q 0 0 0 rg BT 191.49 665.25 Td (important ) Tj ET Q q 0 0 0 rg BT 232.87 665.25 Td (complement ) Tj ET Q q 0 0 0 rg BT 284.80 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 295.08 665.25 Td (our ) Tj ET Q q 0 0 0 rg BT 310.91 665.25 Td (own ) Tj ET Q q 0 0 0 rg BT 330.63 665.25 Td (discovery) Tj ET Q q 0 0 0 rg BT 368.86 665.25 Td (, ) Tj ET Q q 0 0 0 rg BT 373.86 665.25 Td (development ) Tj ET Q q 0 0 0 rg BT 428.01 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 444.95 665.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 521.85 665.25 Td (activities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (Each ) Tj ET Q q 0 0 0 rg BT 57.91 641.25 Td (of ) Tj ET Q q 0 0 0 rg BT 68.17 641.25 Td (our ) Tj ET Q q 0 0 0 rg BT 83.42 641.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 120.33 641.25 Td (with ) Tj ET Q q 0 0 0 rg BT 140.03 641.25 Td (third ) Tj ET Q q 0 0 0 rg BT 160.84 641.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 189.42 641.25 Td (who ) Tj ET Q q 0 0 0 rg BT 208.57 641.25 Td (own ) Tj ET Q q 0 0 0 rg BT 227.72 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 241.86 641.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 266.56 641.25 Td (to ) Tj ET Q q 0 0 0 rg BT 276.27 641.25 Td (manufacture, ) Tj ET Q q 0 0 0 rg BT 330.66 641.25 Td (market ) Tj ET Q q 0 0 0 rg BT 360.35 641.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 387.82 641.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 403.64 641.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 466.64 641.25 Td (products ) Tj ET Q q 0 0 0 rg BT 503.00 641.25 Td (contain ) Tj ET Q q 0 0 0 rg BT 534.36 641.25 Td (customary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (early ) Tj ET Q q 0 0 0 rg BT 58.47 629.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 107.05 629.25 Td (provisions ) Tj ET Q q 0 0 0 rg BT 151.20 629.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 188.67 629.25 Td (found ) Tj ET Q q 0 0 0 rg BT 214.48 629.25 Td (in ) Tj ET Q q 0 0 0 rg BT 224.74 629.25 Td (agreements ) Tj ET Q q 0 0 0 rg BT 272.76 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 283.57 629.25 Td (this ) Tj ET Q q 0 0 0 rg BT 300.50 629.25 Td (kind ) Tj ET Q q 0 0 0 rg BT 320.76 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 337.68 629.25 Td (are ) Tj ET Q q 0 0 0 rg BT 352.37 629.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 392.05 629.25 Td (based ) Tj ET Q q 0 0 0 rg BT 417.30 629.25 Td (on ) Tj ET Q q 0 0 0 rg BT 429.79 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 444.49 629.25 Td (material ) Tj ET Q q 0 0 0 rg BT 479.73 629.25 Td (breach ) Tj ET Q q 0 0 0 rg BT 508.85 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 519.67 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 534.36 629.25 Td (agreement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (by ) Tj ET Q q 0 0 0 rg BT 49.49 617.25 Td (a ) Tj ET Q q 0 0 0 rg BT 57.42 617.25 Td (party) Tj ET Q q 0 0 0 rg BT 77.32 617.25 Td (, ) Tj ET Q q 0 0 0 rg BT 83.31 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 95.13 617.25 Td (bankruptcy ) Tj ET Q q 0 0 0 rg BT 143.61 617.25 Td (\(voluntary ) Tj ET Q q 0 0 0 rg BT 188.75 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 200.58 617.25 Td (involuntary\) ) Tj ET Q q 0 0 0 rg BT 253.50 617.25 Td (of ) Tj ET Q q 0 0 0 rg BT 265.32 617.25 Td (a ) Tj ET Q q 0 0 0 rg BT 273.25 617.25 Td (party ) Tj ET Q q 0 0 0 rg BT 297.29 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 309.11 617.25 Td (product ) Tj ET Q q 0 0 0 rg BT 343.15 617.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 370.52 617.25 Td (concerns. ) Tj ET Q q 0 0 0 rg BT 411.79 617.25 Td (The ) Tj ET Q q 0 0 0 rg BT 430.83 617.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 464.32 617.25 Td (of ) Tj ET Q q 0 0 0 rg BT 476.14 617.25 Td (notice ) Tj ET Q q 0 0 0 rg BT 504.06 617.25 Td (required ) Tj ET Q q 0 0 0 rg BT 540.87 617.25 Td (for ) Tj ET Q q 0 0 0 rg BT 556.02 617.25 Td (early ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 84.61 605.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 124.33 605.25 Td (ranges ) Tj ET Q q 0 0 0 rg BT 152.94 605.25 Td (from ) Tj ET Q q 0 0 0 rg BT 174.89 605.25 Td (immediately ) Tj ET Q q 0 0 0 rg BT 227.38 605.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 249.90 605.25 Td (notice ) Tj ET Q q 0 0 0 rg BT 276.84 605.25 Td (to ) Tj ET Q q 0 0 0 rg BT 287.13 605.25 Td (180 ) Tj ET Q q 0 0 0 rg BT 304.65 605.25 Td (days ) Tj ET Q q 0 0 0 rg BT 325.49 605.25 Td (after ) Tj ET Q q 0 0 0 rg BT 346.31 605.25 Td (receipt ) Tj ET Q q 0 0 0 rg BT 376.03 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 386.87 605.25 Td (notice. ) Tj ET Q q 0 0 0 rg BT 416.14 605.25 Td (T) Tj ET Q q 0 0 0 rg BT 421.55 605.25 Td (ermination ) Tj ET Q q 0 0 0 rg BT 467.38 605.25 Td (immediately ) Tj ET Q q 0 0 0 rg BT 519.88 605.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 542.39 605.25 Td (notice ) Tj ET Q q 0 0 0 rg BT 569.33 605.25 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 75.43 593.25 Td (available ) Tj ET Q q 0 0 0 rg BT 113.75 593.25 Td (where ) Tj ET Q q 0 0 0 rg BT 140.41 593.25 Td (the ) Tj ET Q q 0 0 0 rg BT 154.86 593.25 Td (other ) Tj ET Q q 0 0 0 rg BT 177.64 593.25 Td (party ) Tj ET Q q 0 0 0 rg BT 200.42 593.25 Td (files ) Tj ET Q q 0 0 0 rg BT 219.87 593.25 Td (a ) Tj ET Q q 0 0 0 rg BT 226.54 593.25 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 267.09 593.25 Td (bankruptcy ) Tj ET Q q 0 0 0 rg BT 314.31 593.25 Td (petition ) Tj ET Q q 0 0 0 rg BT 347.09 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 357.66 593.25 Td (if ) Tj ET Q q 0 0 0 rg BT 366.00 593.25 Td (a ) Tj ET Q q 0 0 0 rg BT 372.67 593.25 Td (material ) Tj ET Q q 0 0 0 rg BT 407.66 593.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 433.76 593.25 Td (issue ) Tj ET Q q 0 0 0 rg BT 456.00 593.25 Td (arises ) Tj ET Q q 0 0 0 rg BT 481.00 593.25 Td (with ) Tj ET Q q 0 0 0 rg BT 501.00 593.25 Td (a ) Tj ET Q q 0 0 0 rg BT 507.67 593.25 Td (product ) Tj ET Q q 0 0 0 rg BT 540.45 593.25 Td (such ) Tj ET Q q 0 0 0 rg BT 561.01 593.25 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.98 581.25 Td (medical ) Tj ET Q q 0 0 0 rg BT 85.39 581.25 Td (risk/benefit ) Tj ET Q q 0 0 0 rg BT 133.69 581.25 Td (is ) Tj ET Q q 0 0 0 rg BT 143.12 581.25 Td (incompatible ) Tj ET Q q 0 0 0 rg BT 198.09 581.25 Td (with ) Tj ET Q q 0 0 0 rg BT 218.63 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 233.61 581.25 Td (welfare ) Tj ET Q q 0 0 0 rg BT 266.35 581.25 Td (of ) Tj ET Q q 0 0 0 rg BT 277.44 581.25 Td (patients ) Tj ET Q q 0 0 0 rg BT 311.30 581.25 Td (to ) Tj ET Q q 0 0 0 rg BT 321.84 581.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 359.04 581.25 Td (to ) Tj ET Q q 0 0 0 rg BT 369.58 581.25 Td (develop ) Tj ET Q q 0 0 0 rg BT 403.99 581.25 Td (or ) Tj ET Q q 0 0 0 rg BT 415.08 581.25 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 476.70 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 491.68 581.25 Td (product. ) Tj ET Q q 0 0 0 rg BT 527.28 581.25 Td (T) Tj ET Q q 0 0 0 rg BT 532.69 581.25 Td (ermination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (with ) Tj ET Q q 0 0 0 rg BT 56.80 569.25 Td (a ) Tj ET Q q 0 0 0 rg BT 64.26 569.25 Td (notice ) Tj ET Q q 0 0 0 rg BT 91.72 569.25 Td (period ) Tj ET Q q 0 0 0 rg BT 120.29 569.25 Td (is ) Tj ET Q q 0 0 0 rg BT 129.99 569.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 170.21 569.25 Td (available ) Tj ET Q q 0 0 0 rg BT 209.33 569.25 Td (where ) Tj ET Q q 0 0 0 rg BT 236.78 569.25 Td (an ) Tj ET Q q 0 0 0 rg BT 249.24 569.25 Td (involuntary ) Tj ET Q q 0 0 0 rg BT 298.37 569.25 Td (bankruptcy ) Tj ET Q q 0 0 0 rg BT 346.38 569.25 Td (petition ) Tj ET Q q 0 0 0 rg BT 379.95 569.25 Td (has ) Tj ET Q q 0 0 0 rg BT 396.31 569.25 Td (been ) Tj ET Q q 0 0 0 rg BT 418.21 569.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 439.56 569.25 Td (\(and ) Tj ET Q q 0 0 0 rg BT 460.35 569.25 Td (has ) Tj ET Q q 0 0 0 rg BT 476.70 569.25 Td (not ) Tj ET Q q 0 0 0 rg BT 492.51 569.25 Td (been ) Tj ET Q q 0 0 0 rg BT 514.41 569.25 Td (dismissed\) ) Tj ET Q q 0 0 0 rg BT 560.21 569.25 Td (or ) Tj ET Q q 0 0 0 rg BT 571.56 569.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (material ) Tj ET Q q 0 0 0 rg BT 70.99 557.25 Td (breach ) Tj ET Q q 0 0 0 rg BT 99.87 557.25 Td (by ) Tj ET Q q 0 0 0 rg BT 112.10 557.25 Td (a ) Tj ET Q q 0 0 0 rg BT 118.77 557.25 Td (party ) Tj ET Q q 0 0 0 rg BT 141.55 557.25 Td (has ) Tj ET Q q 0 0 0 rg BT 157.11 557.25 Td (occurred ) Tj ET Q q 0 0 0 rg BT 194.32 557.25 Td (\(and ) Tj ET Q q 0 0 0 rg BT 214.32 557.25 Td (not ) Tj ET Q q 0 0 0 rg BT 229.33 557.25 Td (been ) Tj ET Q q 0 0 0 rg BT 250.43 557.25 Td (cured\). ) Tj ET Q q 0 0 0 rg BT 280.70 557.25 Td (Most ) Tj ET Q q 0 0 0 rg BT 303.50 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 314.06 557.25 Td (our ) Tj ET Q q 0 0 0 rg BT 329.62 557.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 362.94 557.25 Td (agreements ) Tj ET Q q 0 0 0 rg BT 410.70 557.25 Td (also ) Tj ET Q q 0 0 0 rg BT 429.04 557.25 Td (permit ) Tj ET Q q 0 0 0 rg BT 457.38 557.25 Td (us ) Tj ET Q q 0 0 0 rg BT 468.50 557.25 Td (to ) Tj ET Q q 0 0 0 rg BT 478.51 557.25 Td (terminate ) Tj ET Q q 0 0 0 rg BT 518.50 557.25 Td (without ) Tj ET Q q 0 0 0 rg BT 551.29 557.25 Td (cause, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (which ) Tj ET Q q 0 0 0 rg BT 62.85 545.25 Td (is ) Tj ET Q q 0 0 0 rg BT 71.92 545.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 109.32 545.25 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 156.70 545.25 Td (with ) Tj ET Q q 0 0 0 rg BT 176.88 545.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 222.06 545.25 Td (advance ) Tj ET Q q 0 0 0 rg BT 257.23 545.25 Td (written ) Tj ET Q q 0 0 0 rg BT 287.96 545.25 Td (notice ) Tj ET Q q 0 0 0 rg BT 314.80 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 331.64 545.25 Td (is ) Tj ET Q q 0 0 0 rg BT 340.72 545.25 Td (sometimes ) Tj ET Q q 0 0 0 rg BT 385.90 545.25 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 433.28 545.25 Td (only ) Tj ET Q q 0 0 0 rg BT 453.47 545.25 Td (after ) Tj ET Q q 0 0 0 rg BT 474.19 545.25 Td (a ) Tj ET Q q 0 0 0 rg BT 481.03 545.25 Td (specified ) Tj ET Q q 0 0 0 rg BT 519.54 545.25 Td (period ) Tj ET Q q 0 0 0 rg BT 547.49 545.25 Td (of ) Tj ET Q q 0 0 0 rg BT 558.23 545.25 Td (time ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (has ) Tj ET Q q 0 0 0 rg BT 51.38 533.25 Td (elapsed ) Tj ET Q q 0 0 0 rg BT 83.42 533.25 Td (after ) Tj ET Q q 0 0 0 rg BT 103.78 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 118.05 533.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 151.19 533.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 194.88 533.25 Td (is ) Tj ET Q q 0 0 0 rg BT 203.60 533.25 Td (signed. ) Tj ET Q q 0 0 0 rg BT 234.26 533.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 251.86 533.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 288.90 533.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 325.94 533.25 Td (do ) Tj ET Q q 0 0 0 rg BT 337.99 533.25 Td (not ) Tj ET Q q 0 0 0 rg BT 352.82 533.25 Td (otherwise ) Tj ET Q q 0 0 0 rg BT 393.74 533.25 Td (contain ) Tj ET Q q 0 0 0 rg BT 425.23 533.25 Td (provisions ) Tj ET Q q 0 0 0 rg BT 468.95 533.25 Td (that ) Tj ET Q q 0 0 0 rg BT 486.00 533.25 Td (provide ) Tj ET Q q 0 0 0 rg BT 518.59 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 532.86 533.25 Td (other ) Tj ET Q q 0 0 0 rg BT 555.46 533.25 Td (party ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 521.25 Td (right ) Tj ET Q q 0 0 0 rg BT 72.10 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 82.38 521.25 Td (terminate ) Tj ET Q q 0 0 0 rg BT 122.64 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 137.36 521.25 Td (alliance.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.17 497.25 Td (general, ) Tj ET Q q 0 0 0 rg BT 81.94 497.25 Td (we ) Tj ET Q q 0 0 0 rg BT 96.44 497.25 Td (do ) Tj ET Q q 0 0 0 rg BT 109.29 497.25 Td (not ) Tj ET Q q 0 0 0 rg BT 124.91 497.25 Td (retain ) Tj ET Q q 0 0 0 rg BT 150.52 497.25 Td (any ) Tj ET Q q 0 0 0 rg BT 167.80 497.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 193.42 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 204.04 497.25 Td (a ) Tj ET Q q 0 0 0 rg BT 211.32 497.25 Td (product ) Tj ET Q q 0 0 0 rg BT 244.71 497.25 Td (brought ) Tj ET Q q 0 0 0 rg BT 278.66 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 289.29 497.25 Td (an ) Tj ET Q q 0 0 0 rg BT 301.57 497.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 335.50 497.25 Td (by ) Tj ET Q q 0 0 0 rg BT 348.34 497.25 Td (another ) Tj ET Q q 0 0 0 rg BT 381.17 497.25 Td (party ) Tj ET Q q 0 0 0 rg BT 404.56 497.25 Td (or ) Tj ET Q q 0 0 0 rg BT 415.73 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 426.36 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 441.42 497.25 Td (other ) Tj ET Q q 0 0 0 rg BT 464.81 497.25 Td (party’) Tj ET Q q 0 0 0 rg BT 488.13 497.25 Td (s ) Tj ET Q q 0 0 0 rg BT 494.87 497.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 542.13 497.25 Td (property ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (after ) Tj ET Q q 0 0 0 rg BT 56.74 485.25 Td (an ) Tj ET Q q 0 0 0 rg BT 68.61 485.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 102.12 485.25 Td (terminates. ) Tj ET Q q 0 0 0 rg BT 148.52 485.25 Td (The ) Tj ET Q q 0 0 0 rg BT 166.49 485.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 184.48 485.25 Td (of ) Tj ET Q q 0 0 0 rg BT 195.24 485.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 220.44 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 230.65 485.25 Td (one ) Tj ET Q q 0 0 0 rg BT 247.51 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 258.27 485.25 Td (more ) Tj ET Q q 0 0 0 rg BT 281.24 485.25 Td (products ) Tj ET Q q 0 0 0 rg BT 318.10 485.25 Td (that ) Tj ET Q q 0 0 0 rg BT 335.52 485.25 Td (are ) Tj ET Q q 0 0 0 rg BT 350.16 485.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 389.78 485.25 Td (and ) Tj ET Q q 0 0 0 rg BT 406.65 485.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 425.74 485.25 Td (by ) Tj ET Q q 0 0 0 rg BT 438.17 485.25 Td (us ) Tj ET Q q 0 0 0 rg BT 449.49 485.25 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 486.35 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 496.56 485.25 Td (an ) Tj ET Q q 0 0 0 rg BT 508.42 485.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 541.93 485.25 Td (could ) Tj ET Q q 0 0 0 rg BT 566.58 485.25 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (material ) Tj ET Q q 0 0 0 rg BT 71.87 473.25 Td (to ) Tj ET Q q 0 0 0 rg BT 82.76 473.25 Td (our ) Tj ET Q q 0 0 0 rg BT 99.20 473.25 Td (results ) Tj ET Q q 0 0 0 rg BT 128.41 473.25 Td (of ) Tj ET Q q 0 0 0 rg BT 139.85 473.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 184.62 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 202.17 473.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 223.04 473.25 Td (flows ) Tj ET Q q 0 0 0 rg BT 248.37 473.25 Td (could ) Tj ET Q q 0 0 0 rg BT 273.70 473.25 Td (be ) Tj ET Q q 0 0 0 rg BT 286.25 473.25 Td (material ) Tj ET Q q 0 0 0 rg BT 322.12 473.25 Td (to ) Tj ET Q q 0 0 0 rg BT 333.00 473.25 Td (our ) Tj ET Q q 0 0 0 rg BT 349.44 473.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 387.53 473.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 428.42 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 445.96 473.25 Td (liquidity) Tj ET Q q 0 0 0 rg BT 479.21 473.25 Td (. ) Tj ET Q q 0 0 0 rg BT 484.13 473.25 Td (As ) Tj ET Q q 0 0 0 rg BT 498.35 473.25 Td (is ) Tj ET Q q 0 0 0 rg BT 508.13 473.25 Td (customary ) Tj ET Q q 0 0 0 rg BT 552.90 473.25 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 473.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 99.33 461.25 Td (industry) Tj ET Q q 0 0 0 rg BT 131.46 461.25 Td (, ) Tj ET Q q 0 0 0 rg BT 136.21 461.25 Td (the ) Tj ET Q q 0 0 0 rg BT 150.68 461.25 Td (terms ) Tj ET Q q 0 0 0 rg BT 175.15 461.25 Td (of ) Tj ET Q q 0 0 0 rg BT 185.73 461.25 Td (our ) Tj ET Q q 0 0 0 rg BT 201.31 461.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 238.54 461.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 278.00 461.25 Td (are ) Tj ET Q q 0 0 0 rg BT 292.46 461.25 Td (co-extensive ) Tj ET Q q 0 0 0 rg BT 345.24 461.25 Td (with ) Tj ET Q q 0 0 0 rg BT 365.27 461.25 Td (the ) Tj ET Q q 0 0 0 rg BT 379.74 461.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 425.88 461.25 Td (period ) Tj ET Q q 0 0 0 rg BT 453.68 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 470.37 461.25 Td (may ) Tj ET Q q 0 0 0 rg BT 489.84 461.25 Td (vary ) Tj ET Q q 0 0 0 rg BT 509.86 461.25 Td (on ) Tj ET Q q 0 0 0 rg BT 522.11 461.25 Td (a ) Tj ET Q q 0 0 0 rg BT 528.80 461.25 Td (country-by-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (country ) Tj ET Q q 0 0 0 rg BT 69.05 449.25 Td (basis.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.00 425.25 Td (most ) Tj ET Q q 0 0 0 rg BT 75.90 425.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 120.56 425.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 157.99 425.25 Td (for ) Tj ET Q q 0 0 0 rg BT 172.10 425.25 Td (both ) Tj ET Q q 0 0 0 rg BT 192.33 425.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 230.88 425.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 270.53 425.25 Td (products ) Tj ET Q q 0 0 0 rg BT 307.42 425.25 Td (and ) Tj ET Q q 0 0 0 rg BT 324.31 425.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 385.63 425.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 434.19 425.25 Td (are ) Tj ET Q q 0 0 0 rg BT 448.85 425.25 Td (described ) Tj ET Q q 0 0 0 rg BT 489.61 425.25 Td (below) Tj ET Q q 0 0 0 rg BT 513.40 425.25 Td (. ) Tj ET Q q 0 0 0 rg BT 518.35 425.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 543.01 425.25 Td (to ) Tj ET Q q 0 0 0 rg BT 553.24 425.25 Td (“Item ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 45.45 413.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 84.61 413.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.88 413.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 164.88 413.25 Td (. ) Tj ET Q q 0 0 0 rg BT 168.90 413.25 Td (Alliances” ) Tj ET Q q 0 0 0 rg BT 213.05 413.25 Td (for ) Tj ET Q q 0 0 0 rg BT 226.65 413.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 268.59 413.25 Td (information ) Tj ET Q q 0 0 0 rg BT 317.75 413.25 Td (on ) Tj ET Q q 0 0 0 rg BT 329.70 413.25 Td (these ) Tj ET Q q 0 0 0 rg BT 352.20 413.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 385.23 413.25 Td (agreements ) Tj ET Q q 0 0 0 rg BT 432.71 413.25 Td (as ) Tj ET Q q 0 0 0 rg BT 442.99 413.25 Td (well ) Tj ET Q q 0 0 0 rg BT 462.16 413.25 Td (as ) Tj ET Q q 0 0 0 rg BT 472.44 413.25 Td (other ) Tj ET Q q 0 0 0 rg BT 494.93 413.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 527.97 413.25 Td (agreements.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 393.9169921875 m 59.876953125 393.9169921875 l s q 0 0 0 rg BT 36.00 395.25 Td (Pfizer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 380.25 Td (The ) Tj ET Q q 0 0 0 rg BT 55.12 380.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 97.58 380.25 Td (and ) Tj ET Q q 0 0 0 rg BT 115.59 380.25 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 143.04 380.25 Td (are ) Tj ET Q q 0 0 0 rg BT 158.81 380.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 189.04 380.25 Td (to ) Tj ET Q q 0 0 0 rg BT 200.39 380.25 Td (a ) Tj ET Q q 0 0 0 rg BT 208.40 380.25 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 254.74 380.25 Td (co-development ) Tj ET Q q 0 0 0 rg BT 322.73 380.25 Td (and ) Tj ET Q q 0 0 0 rg BT 340.74 380.25 Td (co-commercialization ) Tj ET Q q 0 0 0 rg BT 431.49 380.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 476.71 380.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 491.94 380.25 Td (Eliquis. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.34 380.25 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 553.79 380.25 Td (funds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 368.25 Td (between ) Tj ET Q q 0 0 0 rg BT 71.98 368.25 Td (50% ) Tj ET Q q 0 0 0 rg BT 92.97 368.25 Td (and ) Tj ET Q q 0 0 0 rg BT 110.07 368.25 Td (60% ) Tj ET Q q 0 0 0 rg BT 131.07 368.25 Td (of ) Tj ET Q q 0 0 0 rg BT 142.06 368.25 Td (all ) Tj ET Q q 0 0 0 rg BT 154.72 368.25 Td (development ) Tj ET Q q 0 0 0 rg BT 209.03 368.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 231.70 368.25 Td (depending ) Tj ET Q q 0 0 0 rg BT 276.02 368.25 Td (on ) Tj ET Q q 0 0 0 rg BT 288.68 368.25 Td (the ) Tj ET Q q 0 0 0 rg BT 303.56 368.25 Td (study) Tj ET Q q 0 0 0 rg BT 324.58 368.25 Td (. ) Tj ET Q q 0 0 0 rg BT 329.55 368.25 Td (The ) Tj ET Q q 0 0 0 rg BT 347.76 368.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 393.19 368.25 Td (share ) Tj ET Q q 0 0 0 rg BT 416.95 368.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 494.03 368.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 532.79 368.25 Td (and ) Tj ET Q q 0 0 0 rg BT 549.89 368.25 Td (profits ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 356.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.73 356.25 Td (losses ) Tj ET Q q 0 0 0 rg BT 78.91 356.25 Td (equally ) Tj ET Q q 0 0 0 rg BT 110.63 356.25 Td (on ) Tj ET Q q 0 0 0 rg BT 122.92 356.25 Td (a ) Tj ET Q q 0 0 0 rg BT 129.65 356.25 Td (global ) Tj ET Q q 0 0 0 rg BT 156.93 356.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 179.22 356.25 Td (except ) Tj ET Q q 0 0 0 rg BT 207.60 356.25 Td (in ) Tj ET Q q 0 0 0 rg BT 217.67 356.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 247.16 356.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 286.11 356.25 Td (where ) Tj ET Q q 0 0 0 rg BT 312.82 356.25 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 338.99 356.25 Td (commercializes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 404.02 356.25 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.36 356.25 Td ( ) Tj ET Q q 0 0 0 rg BT 434.65 356.25 Td (and ) Tj ET Q q 0 0 0 rg BT 451.38 356.25 Td (pays ) Tj ET Q q 0 0 0 rg BT 471.99 356.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 495.41 356.25 Td (compensation ) Tj ET Q q 0 0 0 rg BT 553.24 356.25 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 344.25 Td (on ) Tj ET Q q 0 0 0 rg BT 48.50 344.25 Td (a ) Tj ET Q q 0 0 0 rg BT 55.44 344.25 Td (percentage ) Tj ET Q q 0 0 0 rg BT 101.24 344.25 Td (of ) Tj ET Q q 0 0 0 rg BT 112.07 344.25 Td (net ) Tj ET Q q 0 0 0 rg BT 126.79 344.25 Td (sales.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 324.9169921875 m 62.6552734375 324.9169921875 l s q 0 0 0 rg BT 36.00 326.25 Td (Gilead) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 311.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.27 311.25 Td (have ) Tj ET Q q 0 0 0 rg BT 72.35 311.25 Td (joint ) Tj ET Q q 0 0 0 rg BT 92.88 311.25 Td (ventures ) Tj ET Q q 0 0 0 rg BT 128.95 311.25 Td (with ) Tj ET Q q 0 0 0 rg BT 148.92 311.25 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 177.78 311.25 Td (to ) Tj ET Q q 0 0 0 rg BT 187.75 311.25 Td (develop ) Tj ET Q q 0 0 0 rg BT 221.60 311.25 Td (and ) Tj ET Q q 0 0 0 rg BT 238.24 311.25 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 299.29 311.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.62 311.25 Td ( ) Tj ET Q q 0 0 0 rg BT 334.82 311.25 Td (in ) Tj ET Q q 0 0 0 rg BT 344.79 311.25 Td (the ) Tj ET Q q 0 0 0 rg BT 359.21 311.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 381.68 311.25 Td (Canada ) Tj ET Q q 0 0 0 rg BT 413.87 311.25 Td (and ) Tj ET Q q 0 0 0 rg BT 430.50 311.25 Td (in ) Tj ET Q q 0 0 0 rg BT 440.48 311.25 Td (Europe. ) Tj ET Q q 0 0 0 rg BT 473.89 311.25 Td (The ) Tj ET Q q 0 0 0 rg BT 491.63 311.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 532.72 311.25 Td (and ) Tj ET Q q 0 0 0 rg BT 549.35 311.25 Td (Gilead ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.25 Td (share ) Tj ET Q q 0 0 0 rg BT 59.33 299.25 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 116.00 299.25 Td (for ) Tj ET Q q 0 0 0 rg BT 129.90 299.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 159.33 299.25 Td (activities ) Tj ET Q q 0 0 0 rg BT 197.66 299.25 Td (related ) Tj ET Q q 0 0 0 rg BT 227.09 299.25 Td (to ) Tj ET Q q 0 0 0 rg BT 237.10 299.25 Td (the ) Tj ET Q q 0 0 0 rg BT 251.55 299.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 328.19 299.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 338.75 299.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.09 299.25 Td ( ) Tj ET Q q 0 0 0 rg BT 374.32 299.25 Td (in ) Tj ET Q q 0 0 0 rg BT 384.33 299.25 Td (the ) Tj ET Q q 0 0 0 rg BT 398.78 299.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 421.29 299.25 Td (Canada, ) Tj ET Q q 0 0 0 rg BT 456.01 299.25 Td (throughout ) Tj ET Q q 0 0 0 rg BT 502.13 299.25 Td (the ) Tj ET Q q 0 0 0 rg BT 516.58 299.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 532.14 299.25 Td (and ) Tj ET Q q 0 0 0 rg BT 548.81 299.25 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.82 287.25 Td (European ) Tj ET Q q 0 0 0 rg BT 101.41 287.25 Td (countries. ) Tj ET Q q 0 0 0 rg BT 143.84 287.25 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 173.77 287.25 Td (recognizes ) Tj ET Q q 0 0 0 rg BT 219.80 287.25 Td (100% ) Tj ET Q q 0 0 0 rg BT 246.40 287.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 258.00 287.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 291.34 287.25 Td ( ) Tj ET Q q 0 0 0 rg BT 294.61 287.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 333.42 287.25 Td (in ) Tj ET Q q 0 0 0 rg BT 344.48 287.25 Td (the ) Tj ET Q q 0 0 0 rg BT 359.97 287.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 383.52 287.25 Td (Canada ) Tj ET Q q 0 0 0 rg BT 416.78 287.25 Td (and ) Tj ET Q q 0 0 0 rg BT 434.50 287.25 Td (most ) Tj ET Q q 0 0 0 rg BT 457.22 287.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 497.15 287.25 Td (in ) Tj ET Q q 0 0 0 rg BT 508.20 287.25 Td (Europe. ) Tj ET Q q 0 0 0 rg BT 542.13 287.25 Td (Alliance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 69.91 275.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 116.04 275.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 129.97 275.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 163.31 275.25 Td ( ) Tj ET Q q 0 0 0 rg BT 165.58 275.25 Td (include ) Tj ET Q q 0 0 0 rg BT 197.28 275.25 Td (only ) Tj ET Q q 0 0 0 rg BT 217.32 275.25 Td (the ) Tj ET Q q 0 0 0 rg BT 231.81 275.25 Td (bulk ) Tj ET Q q 0 0 0 rg BT 251.85 275.25 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 291.31 275.25 Td (component ) Tj ET Q q 0 0 0 rg BT 338.02 275.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 348.61 275.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.95 275.25 Td ( ) Tj ET Q q 0 0 0 rg BT 384.22 275.25 Td (which ) Tj ET Q q 0 0 0 rg BT 410.92 275.25 Td (is ) Tj ET Q q 0 0 0 rg BT 419.86 275.25 Td (calculated ) Tj ET Q q 0 0 0 rg BT 462.66 275.25 Td (dif) Tj ET Q q 0 0 0 rg BT 473.59 275.25 Td (ferently ) Tj ET Q q 0 0 0 rg BT 506.95 275.25 Td (in ) Tj ET Q q 0 0 0 rg BT 516.99 275.25 Td (the ) Tj ET Q q 0 0 0 rg BT 531.48 275.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 547.08 275.25 Td (and ) Tj ET Q q 0 0 0 rg BT 563.78 275.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 56.05 263.25 Td (following ) Tj ET Q q 0 0 0 rg BT 97.20 263.25 Td (the ) Tj ET Q q 0 0 0 rg BT 111.68 263.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 129.50 263.25 Td (of ) Tj ET Q q 0 0 0 rg BT 140.09 263.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 186.24 263.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 196.83 263.25 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.98 263.25 Td (in ) Tj ET Q q 0 0 0 rg BT 238.02 263.25 Td (the ) Tj ET Q q 0 0 0 rg BT 252.50 263.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 268.10 263.25 Td (in ) Tj ET Q q 0 0 0 rg BT 278.14 263.25 Td (2013. ) Tj ET Q q 0 0 0 rg BT 302.40 263.25 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 338.54 263.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 372.45 263.25 Td (is ) Tj ET Q q 0 0 0 rg BT 381.38 263.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 416.95 263.25 Td (and ) Tj ET Q q 0 0 0 rg BT 433.65 263.25 Td (the ) Tj ET Q q 0 0 0 rg BT 448.13 263.25 Td (related ) Tj ET Q q 0 0 0 rg BT 477.60 263.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 510.95 263.25 Td (receivable ) Tj ET Q q 0 0 0 rg BT 554.29 263.25 Td (is ) Tj ET Q q 0 0 0 rg BT 563.22 263.25 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 251.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 82.36 251.25 Td (until ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 103.20 251.25 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 136.53 251.25 Td ( ) Tj ET Q q 0 0 0 rg BT 139.03 251.25 Td (is ) Tj ET Q q 0 0 0 rg BT 148.20 251.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 167.37 251.25 Td (to ) Tj ET Q q 0 0 0 rg BT 177.65 251.25 Td (third-party ) Tj ET Q q 0 0 0 rg BT 222.91 251.25 Td (customers. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 227.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.93 227.25 Td (the ) Tj ET Q q 0 0 0 rg BT 61.74 227.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 84.62 227.25 Td (the ) Tj ET Q q 0 0 0 rg BT 99.43 227.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 143.66 227.25 Td (may ) Tj ET Q q 0 0 0 rg BT 163.48 227.25 Td (be ) Tj ET Q q 0 0 0 rg BT 175.51 227.25 Td (terminated ) Tj ET Q q 0 0 0 rg BT 220.86 227.25 Td (by ) Tj ET Q q 0 0 0 rg BT 233.46 227.25 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 262.71 227.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 285.30 227.25 Td (the ) Tj ET Q q 0 0 0 rg BT 300.12 227.25 Td (launch ) Tj ET Q q 0 0 0 rg BT 329.37 227.25 Td (of ) Tj ET Q q 0 0 0 rg BT 340.29 227.25 Td (a ) Tj ET Q q 0 0 0 rg BT 347.33 227.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 379.34 227.25 Td (version ) Tj ET Q q 0 0 0 rg BT 411.38 227.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 422.30 227.25 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.79 227.25 Td (or ) Tj ET Q q 0 0 0 rg BT 464.71 227.25 Td (by ) Tj ET Q q 0 0 0 rg BT 477.31 227.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 501.02 227.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 523.62 227.25 Td (the ) Tj ET Q q 0 0 0 rg BT 538.43 227.25 Td (launch ) Tj ET Q q 0 0 0 rg BT 567.68 227.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.25 Td (a ) Tj ET Q q 0 0 0 rg BT 42.52 215.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 74.03 215.25 Td (version ) Tj ET Q q 0 0 0 rg BT 105.55 215.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 115.96 215.25 Td (T) Tj ET Q q 0 0 0 rg BT 120.97 215.25 Td (ruvada* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 156.38 215.25 Td (or ) Tj ET Q q 0 0 0 rg BT 166.80 215.25 Td (its ) Tj ET Q q 0 0 0 rg BT 178.33 215.25 Td (individual ) Tj ET Q q 0 0 0 rg BT 220.96 215.25 Td (components) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 269.29 215.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.79 215.25 Td ( ) Tj ET Q q 0 0 0 rg BT 273.72 215.25 Td (The ) Tj ET Q q 0 0 0 rg BT 291.35 215.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 308.99 215.25 Td (of ) Tj ET Q q 0 0 0 rg BT 319.40 215.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 365.37 215.25 Td (in ) Tj ET Q q 0 0 0 rg BT 375.23 215.25 Td (the ) Tj ET Q q 0 0 0 rg BT 389.53 215.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 409.39 215.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 423.14 215.25 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.11 215.25 Td (is ) Tj ET Q q 0 0 0 rg BT 462.86 215.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 500.47 215.25 Td (in ) Tj ET Q q 0 0 0 rg BT 510.33 215.25 Td (December ) Tj ET Q q 0 0 0 rg BT 553.50 215.25 Td (2017.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 192.9169921875 m 64.330078125 192.9169921875 l s q 0 0 0 rg BT 36.00 194.25 Td (Otsuka) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 179.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.05 179.25 Td (and ) Tj ET Q q 0 0 0 rg BT 75.41 179.25 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 105.67 179.25 Td (have ) Tj ET Q q 0 0 0 rg BT 126.47 179.25 Td (an ) Tj ET Q q 0 0 0 rg BT 137.84 179.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 170.85 179.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 184.44 179.25 Td (Sprycel ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 216.35 179.25 Td (in ) Tj ET Q q 0 0 0 rg BT 226.06 179.25 Td (the ) Tj ET Q q 0 0 0 rg BT 240.20 179.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 262.41 179.25 Td (Japan ) Tj ET Q q 0 0 0 rg BT 287.10 179.25 Td (and ) Tj ET Q q 0 0 0 rg BT 303.47 179.25 Td (the ) Tj ET Q q 0 0 0 rg BT 317.61 179.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 332.87 179.25 Td (\(the ) Tj ET Q q 0 0 0 rg BT 350.34 179.25 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 391.57 179.25 Td (T) Tj ET Q q 0 0 0 rg BT 396.98 179.25 Td (erritory\). ) Tj ET Q q 0 0 0 rg BT 434.72 179.25 Td (In ) Tj ET Q q 0 0 0 rg BT 444.97 179.25 Td (February ) Tj ET Q q 0 0 0 rg BT 483.00 179.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 507.43 179.25 Td (the ) Tj ET Q q 0 0 0 rg BT 521.57 179.25 Td (co-promotion ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 167.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 79.73 167.25 Td (with ) Tj ET Q q 0 0 0 rg BT 99.60 167.25 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 130.03 167.25 Td (was ) Tj ET Q q 0 0 0 rg BT 147.67 167.25 Td (terminated ) Tj ET Q q 0 0 0 rg BT 192.52 167.25 Td (in ) Tj ET Q q 0 0 0 rg BT 202.39 167.25 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 229.29 167.25 Td (A) Tj ET Q q 0 0 0 rg BT 235.96 167.25 Td ( ) Tj ET Q q 0 0 0 rg BT 238.05 167.25 Td (fee ) Tj ET Q q 0 0 0 rg BT 252.35 167.25 Td (is ) Tj ET Q q 0 0 0 rg BT 261.11 167.25 Td (paid ) Tj ET Q q 0 0 0 rg BT 280.42 167.25 Td (to ) Tj ET Q q 0 0 0 rg BT 290.29 167.25 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 320.72 167.25 Td (based ) Tj ET Q q 0 0 0 rg BT 345.58 167.25 Td (on ) Tj ET Q q 0 0 0 rg BT 357.67 167.25 Td (the ) Tj ET Q q 0 0 0 rg BT 371.98 167.25 Td (combined ) Tj ET Q q 0 0 0 rg BT 413.50 167.25 Td (annual ) Tj ET Q q 0 0 0 rg BT 442.25 167.25 Td (net ) Tj ET Q q 0 0 0 rg BT 456.56 167.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 478.09 167.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 488.51 167.25 Td (Sprycel ) Tj ET Q q 0 0 0 rg BT 520.59 167.25 Td (and ) Tj ET Q q 0 0 0 rg BT 537.68 167.25 Td (Ixempra* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 155.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.91 155.25 Td (the ) Tj ET Q q 0 0 0 rg BT 62.26 155.25 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 104.61 155.25 Td (T) Tj ET Q q 0 0 0 rg BT 110.02 155.25 Td (erritory) Tj ET Q q 0 0 0 rg BT 139.35 155.25 Td (. ) Tj ET Q q 0 0 0 rg BT 144.76 155.25 Td (W) Tj ET Q q 0 0 0 rg BT 153.40 155.25 Td (e ) Tj ET Q q 0 0 0 rg BT 160.97 155.25 Td (also ) Tj ET Q q 0 0 0 rg BT 180.21 155.25 Td (maintain ) Tj ET Q q 0 0 0 rg BT 218.34 155.25 Td (a ) Tj ET Q q 0 0 0 rg BT 225.91 155.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 303.45 155.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 348.23 155.25 Td (with ) Tj ET Q q 0 0 0 rg BT 369.14 155.25 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 400.60 155.25 Td (to ) Tj ET Q q 0 0 0 rg BT 411.52 155.25 Td (co-develop ) Tj ET Q q 0 0 0 rg BT 459.07 155.25 Td (and ) Tj ET Q q 0 0 0 rg BT 476.65 155.25 Td (co-promote ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 525.87 155.25 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.53 155.25 Td ( ) Tj ET Q q 0 0 0 rg BT 560.67 155.25 Td (in ) Tj ET Q q 0 0 0 rg BT 571.58 155.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 143.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 66.83 143.25 Td (number ) Tj ET Q q 0 0 0 rg BT 99.88 143.25 Td (of ) Tj ET Q q 0 0 0 rg BT 110.71 143.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 149.86 143.25 Td (outside ) Tj ET Q q 0 0 0 rg BT 181.25 143.25 Td (of ) Tj ET Q q 0 0 0 rg BT 192.08 143.25 Td (the ) Tj ET Q q 0 0 0 rg BT 206.80 143.25 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 120.9169921875 m 53.2216796875 120.9169921875 l s q 0 0 0 rg BT 36.00 122.25 Td (Ono) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 107.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.73 107.25 Td (is ) Tj ET Q q 0 0 0 rg BT 69.00 107.25 Td (the ) Tj ET Q q 0 0 0 rg BT 83.82 107.25 Td (principal ) Tj ET Q q 0 0 0 rg BT 121.97 107.25 Td (in ) Tj ET Q q 0 0 0 rg BT 132.35 107.25 Td (the ) Tj ET Q q 0 0 0 rg BT 147.18 107.25 Td (end ) Tj ET Q q 0 0 0 rg BT 164.22 107.25 Td (customer ) Tj ET Q q 0 0 0 rg BT 203.48 107.25 Td (product ) Tj ET Q q 0 0 0 rg BT 236.63 107.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 258.68 107.25 Td (and ) Tj ET Q q 0 0 0 rg BT 275.72 107.25 Td (has ) Tj ET Q q 0 0 0 rg BT 291.65 107.25 Td (the ) Tj ET Q q 0 0 0 rg BT 306.48 107.25 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 346.84 107.25 Td (right ) Tj ET Q q 0 0 0 rg BT 368.34 107.25 Td (to ) Tj ET Q q 0 0 0 rg BT 378.72 107.25 Td (develop, ) Tj ET Q q 0 0 0 rg BT 415.48 107.25 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 468.06 107.25 Td (and ) Tj ET Q q 0 0 0 rg BT 485.10 107.25 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 546.56 107.25 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 576.00 107.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 95.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.08 95.25 Td (all ) Tj ET Q q 0 0 0 rg BT 58.39 95.25 Td (territories ) Tj ET Q q 0 0 0 rg BT 99.56 95.25 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 144.64 95.25 Td (except ) Tj ET Q q 0 0 0 rg BT 173.04 95.25 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 200.61 95.25 Td (South ) Tj ET Q q 0 0 0 rg BT 226.26 95.25 Td (Korea ) Tj ET Q q 0 0 0 rg BT 252.99 95.25 Td (and ) Tj ET Q q 0 0 0 rg BT 269.57 95.25 Td (T) Tj ET Q q 0 0 0 rg BT 274.98 95.25 Td (aiwan. ) Tj ET Q q 0 0 0 rg BT 303.67 95.25 Td (Ono ) Tj ET Q q 0 0 0 rg BT 323.19 95.25 Td (is ) Tj ET Q q 0 0 0 rg BT 332.17 95.25 Td (entitled ) Tj ET Q q 0 0 0 rg BT 364.47 95.25 Td (to ) Tj ET Q q 0 0 0 rg BT 374.55 95.25 Td (receive ) Tj ET Q q 0 0 0 rg BT 405.72 95.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 442.46 95.25 Td (following ) Tj ET Q q 0 0 0 rg BT 483.65 95.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 527.05 95.25 Td (approvals ) Tj ET Q q 0 0 0 rg BT 568.23 95.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 83.25 Td (all ) Tj ET Q q 0 0 0 rg BT 47.72 83.25 Td (territories ) Tj ET Q q 0 0 0 rg BT 88.32 83.25 Td (excluding ) Tj ET Q q 0 0 0 rg BT 129.49 83.25 Td (the ) Tj ET Q q 0 0 0 rg BT 143.43 83.25 Td (three ) Tj ET Q q 0 0 0 rg BT 165.15 83.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 203.53 83.25 Td (listed ) Tj ET Q q 0 0 0 rg BT 226.92 83.25 Td (above. ) Tj ET Q q 0 0 0 rg BT 255.03 83.25 Td (Royalty ) Tj ET Q q 0 0 0 rg BT 288.42 83.25 Td (rates ) Tj ET Q q 0 0 0 rg BT 309.03 83.25 Td (on ) Tj ET Q q 0 0 0 rg BT 320.76 83.25 Td (net ) Tj ET Q q 0 0 0 rg BT 334.70 83.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 355.87 83.25 Td (are ) Tj ET Q q 0 0 0 rg BT 369.80 83.25 Td (4% ) Tj ET Q q 0 0 0 rg BT 384.86 83.25 Td (in ) Tj ET Q q 0 0 0 rg BT 394.37 83.25 Td (North ) Tj ET Q q 0 0 0 rg BT 419.05 83.25 Td (America ) Tj ET Q q 0 0 0 rg BT 455.20 83.25 Td (and ) Tj ET Q q 0 0 0 rg BT 471.37 83.25 Td (15% ) Tj ET Q q 0 0 0 rg BT 491.42 83.25 Td (in ) Tj ET Q q 0 0 0 rg BT 500.93 83.25 Td (all ) Tj ET Q q 0 0 0 rg BT 512.65 83.25 Td (other ) Tj ET Q q 0 0 0 rg BT 534.93 83.25 Td (applicable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 71.25 Td (territories, ) Tj ET Q q 0 0 0 rg BT 79.87 71.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 110.70 71.25 Td (to ) Tj ET Q q 0 0 0 rg BT 120.98 71.25 Td (customary ) Tj ET Q q 0 0 0 rg BT 165.13 71.25 Td (adjustments.) Tj ET Q endstream endobj 25 0 obj <> endobj 26 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.26 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 86.06 749.10 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 137.75 749.10 Td (also ) Tj ET Q q 0 0 0 rg BT 155.57 749.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 190.60 749.10 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 245.08 749.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 282.89 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 292.38 749.10 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 319.36 749.10 Td (South ) Tj ET Q q 0 0 0 rg BT 344.41 749.10 Td (Korea ) Tj ET Q q 0 0 0 rg BT 370.55 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 386.58 749.10 Td (T) Tj ET Q q 0 0 0 rg BT 391.99 749.10 Td (aiwan ) Tj ET Q q 0 0 0 rg BT 417.58 749.10 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 459.84 749.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 469.33 749.10 Td (Opdivo, ) Tj ET Q q 0 0 0 rg BT 502.98 749.10 Td (Y) Tj ET Q q 0 0 0 rg BT 507.62 749.10 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 529.83 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 531.54 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 547.69 749.10 Td (several ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.45 737.10 Td (investigational ) Tj ET Q q 0 0 0 rg BT 120.65 737.10 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 171.59 737.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 193.36 737.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 222.34 737.10 Td (have ) Tj ET Q q 0 0 0 rg BT 243.54 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 258.09 737.10 Td (right ) Tj ET Q q 0 0 0 rg BT 279.30 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 296.06 737.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 338.94 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 349.04 737.10 Td (jointly ) Tj ET Q q 0 0 0 rg BT 377.48 737.10 Td (develop ) Tj ET Q q 0 0 0 rg BT 411.46 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 428.23 737.10 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 489.41 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 503.95 737.10 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 554.88 737.10 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 44.72 725.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 92.32 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 106.04 725.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 134.76 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 145.14 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 159.41 725.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 198.40 725.10 Td (Profits, ) Tj ET Q q 0 0 0 rg BT 229.63 725.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 255.57 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 272.06 725.10 Td (development ) Tj ET Q q 0 0 0 rg BT 325.77 725.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 347.82 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 362.08 725.10 Td (shared ) Tj ET Q q 0 0 0 rg BT 390.23 725.10 Td (equally ) Tj ET Q q 0 0 0 rg BT 421.72 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 435.43 725.10 Td (all ) Tj ET Q q 0 0 0 rg BT 447.48 725.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 499.53 725.10 Td (therapies ) Tj ET Q q 0 0 0 rg BT 537.67 725.10 Td (involving ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (compounds ) Tj ET Q q 0 0 0 rg BT 84.61 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 95.44 713.10 Td (both ) Tj ET Q q 0 0 0 rg BT 115.72 713.10 Td (parties. ) Tj ET Q q 0 0 0 rg BT 147.37 713.10 Td (Otherwise, ) Tj ET Q q 0 0 0 rg BT 193.47 713.10 Td (sharing ) Tj ET Q q 0 0 0 rg BT 225.41 713.10 Td (is ) Tj ET Q q 0 0 0 rg BT 234.58 713.10 Td (80% ) Tj ET Q q 0 0 0 rg BT 255.41 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 272.35 713.10 Td (20% ) Tj ET Q q 0 0 0 rg BT 293.18 713.10 Td (for ) Tj ET Q q 0 0 0 rg BT 307.34 713.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 345.94 713.10 Td (involving ) Tj ET Q q 0 0 0 rg BT 386.77 713.10 Td (only ) Tj ET Q q 0 0 0 rg BT 407.05 713.10 Td (one ) Tj ET Q q 0 0 0 rg BT 423.99 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 434.82 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 449.54 713.10 Td (party’) Tj ET Q q 0 0 0 rg BT 472.86 713.10 Td (s ) Tj ET Q q 0 0 0 rg BT 479.25 713.10 Td (compounds. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.47 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 76.25 689.10 Td (Ono ) Tj ET Q q 0 0 0 rg BT 95.82 689.10 Td (also ) Tj ET Q q 0 0 0 rg BT 114.28 689.10 Td (have ) Tj ET Q q 0 0 0 rg BT 135.50 689.10 Td (an ) Tj ET Q q 0 0 0 rg BT 147.28 689.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 180.72 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 190.84 689.10 Td (co-develop ) Tj ET Q q 0 0 0 rg BT 237.61 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 254.40 689.10 Td (co-commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 328.37 689.10 Td (Or) Tj ET Q q 0 0 0 rg BT 339.11 689.10 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.76 689.10 Td ( ) Tj ET Q q 0 0 0 rg BT 363.11 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 373.23 689.10 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 400.85 689.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 424.32 689.10 Td (is ) Tj ET Q q 0 0 0 rg BT 433.33 689.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 481.23 689.10 Td (for ) Tj ET Q q 0 0 0 rg BT 495.23 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 509.80 689.10 Td (order ) Tj ET Q q 0 0 0 rg BT 533.24 689.10 Td (fulfillment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.08 677.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 101.83 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 112.79 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 127.65 677.10 Td (intravenous ) Tj ET Q q 0 0 0 rg BT 176.94 677.10 Td (formulation ) Tj ET Q q 0 0 0 rg BT 226.79 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 243.86 677.10 Td (Ono ) Tj ET Q q 0 0 0 rg BT 263.72 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 273.03 677.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 321.21 677.10 Td (for ) Tj ET Q q 0 0 0 rg BT 335.51 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 350.36 677.10 Td (subcutaneous ) Tj ET Q q 0 0 0 rg BT 406.87 677.10 Td (formulation. ) Tj ET Q q 0 0 0 rg BT 459.22 677.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 481.31 677.10 Td (formulations ) Tj ET Q q 0 0 0 rg BT 535.05 677.10 Td (are ) Tj ET Q q 0 0 0 rg BT 549.89 677.10 Td (jointly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (promoted ) Tj ET Q q 0 0 0 rg BT 76.99 665.10 Td (by ) Tj ET Q q 0 0 0 rg BT 89.66 665.10 Td (both ) Tj ET Q q 0 0 0 rg BT 110.10 665.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 139.42 665.10 Td (with ) Tj ET Q q 0 0 0 rg BT 159.86 665.10 Td (assigned ) Tj ET Q q 0 0 0 rg BT 196.97 665.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 236.29 665.10 Td (accounts ) Tj ET Q q 0 0 0 rg BT 273.94 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 291.04 665.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 314.83 665.10 Td (is ) Tj ET Q q 0 0 0 rg BT 324.16 665.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 372.38 665.10 Td (for ) Tj ET Q q 0 0 0 rg BT 386.70 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 401.58 665.10 Td (product ) Tj ET Q q 0 0 0 rg BT 434.79 665.10 Td (supply) Tj ET Q q 0 0 0 rg BT 460.81 665.10 Td (. ) Tj ET Q q 0 0 0 rg BT 465.39 665.10 Td (A) Tj ET Q q 0 0 0 rg BT 472.06 665.10 Td ( ) Tj ET Q q 0 0 0 rg BT 474.73 665.10 Td (co-promotion ) Tj ET Q q 0 0 0 rg BT 531.82 665.10 Td (fee ) Tj ET Q q 0 0 0 rg BT 546.70 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 557.69 665.10 Td (60% ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (is ) Tj ET Q q 0 0 0 rg BT 45.17 653.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 64.89 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 75.17 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 89.88 653.10 Td (other ) Tj ET Q q 0 0 0 rg BT 112.93 653.10 Td (party ) Tj ET Q q 0 0 0 rg BT 135.98 653.10 Td (when ) Tj ET Q q 0 0 0 rg BT 160.14 653.10 Td (a ) Tj ET Q q 0 0 0 rg BT 167.07 653.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 185.12 653.10 Td (is ) Tj ET Q q 0 0 0 rg BT 194.29 653.10 Td (made ) Tj ET Q q 0 0 0 rg BT 218.45 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 228.72 653.10 Td (that ) Tj ET Q q 0 0 0 rg BT 246.22 653.10 Td (other ) Tj ET Q q 0 0 0 rg BT 269.27 653.10 Td (party’) Tj ET Q q 0 0 0 rg BT 292.59 653.10 Td (s ) Tj ET Q q 0 0 0 rg BT 298.98 653.10 Td (assigned ) Tj ET Q q 0 0 0 rg BT 335.92 653.10 Td (customer) Tj ET Q q 0 0 0 rg BT 372.03 653.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 627.7669921875 m 67.0595703125 627.7669921875 l s q 0 0 0 rg BT 36.00 629.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 59.84 629.10 Td (ie) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 614.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.30 614.10 Td (and ) Tj ET Q q 0 0 0 rg BT 75.43 614.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 99.27 614.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 108.67 614.10 Td (have ) Tj ET Q q 0 0 0 rg BT 129.72 614.10 Td (an ) Tj ET Q q 0 0 0 rg BT 141.33 614.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 174.60 614.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 188.43 614.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 225.09 614.10 Td (. ) Tj ET Q q 0 0 0 rg BT 229.77 614.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 256.93 614.10 Td (the ) Tj ET Q q 0 0 0 rg BT 271.33 614.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 295.72 614.10 Td (of ) Tj ET Q q 0 0 0 rg BT 306.22 614.10 Td (the ) Tj ET Q q 0 0 0 rg BT 320.62 614.10 Td (alliance, ) Tj ET Q q 0 0 0 rg BT 356.38 614.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 379.68 614.10 Td (was ) Tj ET Q q 0 0 0 rg BT 397.40 614.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 429.57 614.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 469.50 614.10 Td (global ) Tj ET Q q 0 0 0 rg BT 496.67 614.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 521.63 614.10 Td (to ) Tj ET Q q 0 0 0 rg BT 531.58 614.10 Td (co-develop ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 602.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.96 602.10 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 114.33 602.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 150.99 602.10 Td ( ) Tj ET Q q 0 0 0 rg BT 153.51 602.10 Td (from ) Tj ET Q q 0 0 0 rg BT 175.47 602.10 Td (PDL) Tj ET Q q 0 0 0 rg BT 193.99 602.10 Td ( ) Tj ET Q q 0 0 0 rg BT 196.51 602.10 Td (BioPharma, ) Tj ET Q q 0 0 0 rg BT 246.52 602.10 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 264.31 602.10 Td (\(now ) Tj ET Q q 0 0 0 rg BT 287.38 602.10 Td (part ) Tj ET Q q 0 0 0 rg BT 305.45 602.10 Td (of ) Tj ET Q q 0 0 0 rg BT 315.74 602.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 339.58 602.10 Td (ie\). ) Tj ET Q q 0 0 0 rg BT 355.15 602.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 377.12 602.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 406.29 602.10 Td (are ) Tj ET Q q 0 0 0 rg BT 421.02 602.10 Td (co-developing ) Tj ET Q q 0 0 0 rg BT 480.74 602.10 Td (the ) Tj ET Q q 0 0 0 rg BT 495.48 602.10 Td (product ) Tj ET Q q 0 0 0 rg BT 528.54 602.10 Td (and ) Tj ET Q q 0 0 0 rg BT 544.95 602.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 568.79 602.10 Td (ie ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 590.10 Td (funds ) Tj ET Q q 0 0 0 rg BT 60.63 590.10 Td (20% ) Tj ET Q q 0 0 0 rg BT 81.37 590.10 Td (of ) Tj ET Q q 0 0 0 rg BT 92.10 590.10 Td (global ) Tj ET Q q 0 0 0 rg BT 119.51 590.10 Td (development ) Tj ET Q q 0 0 0 rg BT 173.56 590.10 Td (costs. ) Tj ET Q q 0 0 0 rg BT 198.47 590.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 222.00 590.10 Td (is ) Tj ET Q q 0 0 0 rg BT 231.08 590.10 Td (solely ) Tj ET Q q 0 0 0 rg BT 257.37 590.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 305.33 590.10 Td (for ) Tj ET Q q 0 0 0 rg BT 319.39 590.10 Td (supply) Tj ET Q q 0 0 0 rg BT 345.41 590.10 Td (, ) Tj ET Q q 0 0 0 rg BT 350.32 590.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 398.84 590.10 Td (and ) Tj ET Q q 0 0 0 rg BT 415.69 590.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 437.53 590.10 Td (and ) Tj ET Q q 0 0 0 rg BT 454.38 590.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 497.33 590.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 535.83 590.10 Td (within ) Tj ET Q q 0 0 0 rg BT 563.80 590.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 578.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 69.53 578.10 Td (and ) Tj ET Q q 0 0 0 rg BT 86.41 578.10 Td (is ) Tj ET Q q 0 0 0 rg BT 95.52 578.10 Td (the ) Tj ET Q q 0 0 0 rg BT 110.18 578.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 148.16 578.10 Td (in ) Tj ET Q q 0 0 0 rg BT 158.38 578.10 Td (the ) Tj ET Q q 0 0 0 rg BT 173.03 578.10 Td (end ) Tj ET Q q 0 0 0 rg BT 189.91 578.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 229.01 578.10 Td (product ) Tj ET Q q 0 0 0 rg BT 262.00 578.10 Td (sales. ) Tj ET Q q 0 0 0 rg BT 285.84 578.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 309.68 578.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 319.34 578.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 346.77 578.10 Td (30% ) Tj ET Q q 0 0 0 rg BT 367.54 578.10 Td (of ) Tj ET Q q 0 0 0 rg BT 378.31 578.10 Td (all ) Tj ET Q q 0 0 0 rg BT 390.74 578.10 Td (profits ) Tj ET Q q 0 0 0 rg BT 419.29 578.10 Td (and ) Tj ET Q q 0 0 0 rg BT 436.17 578.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 462.50 578.10 Td (in ) Tj ET Q q 0 0 0 rg BT 472.72 578.10 Td (the ) Tj ET Q q 0 0 0 rg BT 487.38 578.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 507.60 578.10 Td (and ) Tj ET Q q 0 0 0 rg BT 524.48 578.10 Td (is ) Tj ET Q q 0 0 0 rg BT 533.59 578.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 553.25 578.10 Td (tiered ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 566.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 72.85 566.10 Td (on ) Tj ET Q q 0 0 0 rg BT 85.27 566.10 Td (net ) Tj ET Q q 0 0 0 rg BT 99.91 566.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 121.76 566.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 132.51 566.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 169.17 566.10 Td ( ) Tj ET Q q 0 0 0 rg BT 171.59 566.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 202.90 566.10 Td (of ) Tj ET Q q 0 0 0 rg BT 213.64 566.10 Td (the ) Tj ET Q q 0 0 0 rg BT 228.28 566.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 248.48 566.10 Td (In ) Tj ET Q q 0 0 0 rg BT 259.23 566.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 296.39 566.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 320.23 566.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 329.86 566.10 Td (is ) Tj ET Q q 0 0 0 rg BT 338.95 566.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 371.36 566.10 Td (to ) Tj ET Q q 0 0 0 rg BT 381.56 566.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 412.84 566.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 454.14 566.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 494.88 566.10 Td (from ) Tj ET Q q 0 0 0 rg BT 516.74 566.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 540.28 566.10 Td (if ) Tj ET Q q 0 0 0 rg BT 548.81 566.10 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 554.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.59 554.10 Td (events ) Tj ET Q q 0 0 0 rg BT 107.64 554.10 Td (and ) Tj ET Q q 0 0 0 rg BT 124.58 554.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 146.52 554.10 Td (thresholds ) Tj ET Q q 0 0 0 rg BT 190.13 554.10 Td (are ) Tj ET Q q 0 0 0 rg BT 204.83 554.10 Td (achieved.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 531.7669921875 m 159.6962890625 531.7669921875 l s q 0 0 0 rg BT 36.00 533.10 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.83 533.10 Td (Licensing ) Tj ET Q q 0 0 0 rg BT 103.04 533.10 Td (Arrangements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 518.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.86 518.10 Td (addition ) Tj ET Q q 0 0 0 rg BT 82.16 518.10 Td (to ) Tj ET Q q 0 0 0 rg BT 92.47 518.10 Td (the ) Tj ET Q q 0 0 0 rg BT 107.21 518.10 Td (alliances ) Tj ET Q q 0 0 0 rg BT 144.72 518.10 Td (described ) Tj ET Q q 0 0 0 rg BT 185.56 518.10 Td (above, ) Tj ET Q q 0 0 0 rg BT 214.47 518.10 Td (we ) Tj ET Q q 0 0 0 rg BT 228.66 518.10 Td (have ) Tj ET Q q 0 0 0 rg BT 250.06 518.10 Td (other ) Tj ET Q q 0 0 0 rg BT 273.14 518.10 Td (in-licensing ) Tj ET Q q 0 0 0 rg BT 322.88 518.10 Td (and ) Tj ET Q q 0 0 0 rg BT 339.85 518.10 Td (out-licensing ) Tj ET Q q 0 0 0 rg BT 394.59 518.10 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 453.29 518.10 Td (W) Tj ET Q q 0 0 0 rg BT 462.33 518.10 Td (ith ) Tj ET Q q 0 0 0 rg BT 475.42 518.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 506.26 518.10 Td (to ) Tj ET Q q 0 0 0 rg BT 516.57 518.10 Td (in-licenses, ) Tj ET Q q 0 0 0 rg BT 564.36 518.10 Td (we ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 506.10 Td (have ) Tj ET Q q 0 0 0 rg BT 57.53 506.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 105.72 506.10 Td (with ) Tj ET Q q 0 0 0 rg BT 126.16 506.10 Td (Novartis ) Tj ET Q q 0 0 0 rg BT 163.26 506.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 177.57 506.10 Td (Reyataz ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.89 506.10 Td (and ) Tj ET Q q 0 0 0 rg BT 228.98 506.10 Td (with ) Tj ET Q q 0 0 0 rg BT 249.42 506.10 Td (Merck ) Tj ET Q q 0 0 0 rg BT 278.18 506.10 Td (for ) Tj ET Q q 0 0 0 rg BT 292.49 506.10 Td (efavirenz, ) Tj ET Q q 0 0 0 rg BT 334.84 506.10 Td (among ) Tj ET Q q 0 0 0 rg BT 364.72 506.10 Td (others. ) Tj ET Q q 0 0 0 rg BT 394.12 506.10 Td (W) Tj ET Q q 0 0 0 rg BT 402.76 506.10 Td (e ) Tj ET Q q 0 0 0 rg BT 409.86 506.10 Td (also ) Tj ET Q q 0 0 0 rg BT 428.62 506.10 Td (own ) Tj ET Q q 0 0 0 rg BT 448.50 506.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 478.36 506.10 Td (compounds ) Tj ET Q q 0 0 0 rg BT 527.13 506.10 Td (out-licensed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.10 Td (to ) Tj ET Q q 0 0 0 rg BT 45.17 494.10 Td (third ) Tj ET Q q 0 0 0 rg BT 65.44 494.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 93.48 494.10 Td (for ) Tj ET Q q 0 0 0 rg BT 106.53 494.10 Td (development ) Tj ET Q q 0 0 0 rg BT 159.57 494.10 Td (and ) Tj ET Q q 0 0 0 rg BT 175.40 494.10 Td (commercialization, ) Tj ET Q q 0 0 0 rg BT 253.70 494.10 Td (including ) Tj ET Q q 0 0 0 rg BT 292.86 494.10 Td (those ) Tj ET Q q 0 0 0 rg BT 315.35 494.10 Td (obtained ) Tj ET Q q 0 0 0 rg BT 351.18 494.10 Td (from ) Tj ET Q q 0 0 0 rg BT 372.00 494.10 Td (our ) Tj ET Q q 0 0 0 rg BT 386.72 494.10 Td (acquisitions. ) Tj ET Q q 0 0 0 rg BT 438.28 494.10 Td (W) Tj ET Q q 0 0 0 rg BT 446.92 494.10 Td (e ) Tj ET Q q 0 0 0 rg BT 452.75 494.10 Td (are ) Tj ET Q q 0 0 0 rg BT 466.34 494.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 497.72 494.10 Td (to ) Tj ET Q q 0 0 0 rg BT 506.89 494.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 537.14 494.10 Td (milestone ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 482.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 77.07 482.10 Td (as ) Tj ET Q q 0 0 0 rg BT 88.14 482.10 Td (these ) Tj ET Q q 0 0 0 rg BT 111.43 482.10 Td (compounds ) Tj ET Q q 0 0 0 rg BT 160.28 482.10 Td (move ) Tj ET Q q 0 0 0 rg BT 185.24 482.10 Td (through ) Tj ET Q q 0 0 0 rg BT 219.09 482.10 Td (the ) Tj ET Q q 0 0 0 rg BT 234.05 482.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 277.89 482.10 Td (process ) Tj ET Q q 0 0 0 rg BT 310.63 482.10 Td (and ) Tj ET Q q 0 0 0 rg BT 327.81 482.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 364.98 482.10 Td (based ) Tj ET Q q 0 0 0 rg BT 390.50 482.10 Td (on ) Tj ET Q q 0 0 0 rg BT 403.24 482.10 Td (net ) Tj ET Q q 0 0 0 rg BT 418.20 482.10 Td (product ) Tj ET Q q 0 0 0 rg BT 451.49 482.10 Td (sales, ) Tj ET Q q 0 0 0 rg BT 476.17 482.10 Td (if ) Tj ET Q q 0 0 0 rg BT 485.02 482.10 Td (and ) Tj ET Q q 0 0 0 rg BT 502.20 482.10 Td (when ) Tj ET Q q 0 0 0 rg BT 526.61 482.10 Td (the ) Tj ET Q q 0 0 0 rg BT 541.57 482.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 470.10 Td (are ) Tj ET Q q 0 0 0 rg BT 50.71 470.10 Td (commercialized.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 446.10 Td (Marketing, Distribution and Customers) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 422.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 422.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.82 422.10 Td (promote ) Tj ET Q q 0 0 0 rg BT 87.88 422.10 Td (the ) Tj ET Q q 0 0 0 rg BT 102.84 422.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 151.11 422.10 Td (use ) Tj ET Q q 0 0 0 rg BT 167.18 422.10 Td (of ) Tj ET Q q 0 0 0 rg BT 178.25 422.10 Td (our ) Tj ET Q q 0 0 0 rg BT 194.32 422.10 Td (products ) Tj ET Q q 0 0 0 rg BT 231.49 422.10 Td (directly ) Tj ET Q q 0 0 0 rg BT 264.77 422.10 Td (to ) Tj ET Q q 0 0 0 rg BT 275.29 422.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 319.11 422.10 Td (professionals ) Tj ET Q q 0 0 0 rg BT 374.62 422.10 Td (and ) Tj ET Q q 0 0 0 rg BT 391.80 422.10 Td (providers ) Tj ET Q q 0 0 0 rg BT 432.30 422.10 Td (such ) Tj ET Q q 0 0 0 rg BT 453.37 422.10 Td (as ) Tj ET Q q 0 0 0 rg BT 464.44 422.10 Td (doctors, ) Tj ET Q q 0 0 0 rg BT 499.12 422.10 Td (nurse ) Tj ET Q q 0 0 0 rg BT 523.52 422.10 Td (practitioners, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 410.10 Td (physician ) Tj ET Q q 0 0 0 rg BT 76.88 410.10 Td (assistants, ) Tj ET Q q 0 0 0 rg BT 119.70 410.10 Td (pharmacists, ) Tj ET Q q 0 0 0 rg BT 172.52 410.10 Td (technologists, ) Tj ET Q q 0 0 0 rg BT 230.34 410.10 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 270.95 410.10 Td (PBMs ) Tj ET Q q 0 0 0 rg BT 298.51 410.10 Td (and ) Tj ET Q q 0 0 0 rg BT 315.50 410.10 Td (MCOs. ) Tj ET Q q 0 0 0 rg BT 347.04 410.10 Td (W) Tj ET Q q 0 0 0 rg BT 355.68 410.10 Td (e ) Tj ET Q q 0 0 0 rg BT 362.67 410.10 Td (also ) Tj ET Q q 0 0 0 rg BT 381.33 410.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 414.43 410.10 Td (information ) Tj ET Q q 0 0 0 rg BT 464.19 410.10 Td (about ) Tj ET Q q 0 0 0 rg BT 488.95 410.10 Td (the ) Tj ET Q q 0 0 0 rg BT 503.72 410.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 551.80 410.10 Td (use ) Tj ET Q q 0 0 0 rg BT 567.68 410.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 398.10 Td (our ) Tj ET Q q 0 0 0 rg BT 50.82 398.10 Td (products ) Tj ET Q q 0 0 0 rg BT 86.75 398.10 Td (to ) Tj ET Q q 0 0 0 rg BT 96.01 398.10 Td (consumers ) Tj ET Q q 0 0 0 rg BT 140.27 398.10 Td (in ) Tj ET Q q 0 0 0 rg BT 149.54 398.10 Td (the ) Tj ET Q q 0 0 0 rg BT 163.24 398.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 182.51 398.10 Td (through ) Tj ET Q q 0 0 0 rg BT 215.11 398.10 Td (direct-to-consumer ) Tj ET Q q 0 0 0 rg BT 292.68 398.10 Td (print, ) Tj ET Q q 0 0 0 rg BT 315.55 398.10 Td (radio, ) Tj ET Q q 0 0 0 rg BT 340.09 398.10 Td (television ) Tj ET Q q 0 0 0 rg BT 380.46 398.10 Td (and ) Tj ET Q q 0 0 0 rg BT 396.38 398.10 Td (digital ) Tj ET Q q 0 0 0 rg BT 423.42 398.10 Td (advertising ) Tj ET Q q 0 0 0 rg BT 469.34 398.10 Td (and ) Tj ET Q q 0 0 0 rg BT 485.27 398.10 Td (promotion. ) Tj ET Q q 0 0 0 rg BT 530.92 398.10 Td (In ) Tj ET Q q 0 0 0 rg BT 540.74 398.10 Td (addition, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 386.10 Td (we ) Tj ET Q q 0 0 0 rg BT 50.34 386.10 Td (sponsor ) Tj ET Q q 0 0 0 rg BT 84.14 386.10 Td (general ) Tj ET Q q 0 0 0 rg BT 116.25 386.10 Td (advertising ) Tj ET Q q 0 0 0 rg BT 163.37 386.10 Td (to ) Tj ET Q q 0 0 0 rg BT 173.83 386.10 Td (educate ) Tj ET Q q 0 0 0 rg BT 207.05 386.10 Td (the ) Tj ET Q q 0 0 0 rg BT 221.95 386.10 Td (public ) Tj ET Q q 0 0 0 rg BT 249.63 386.10 Td (about ) Tj ET Q q 0 0 0 rg BT 274.53 386.10 Td (our ) Tj ET Q q 0 0 0 rg BT 290.55 386.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 335.44 386.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 369.78 386.10 Td (research ) Tj ET Q q 0 0 0 rg BT 405.77 386.10 Td (and ) Tj ET Q q 0 0 0 rg BT 422.89 386.10 Td (corporate ) Tj ET Q q 0 0 0 rg BT 463.33 386.10 Td (mission. ) Tj ET Q q 0 0 0 rg BT 499.63 386.10 Td (For ) Tj ET Q q 0 0 0 rg BT 516.21 386.10 Td (a ) Tj ET Q q 0 0 0 rg BT 523.33 386.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 567.69 386.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 374.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 374.10 Td (regulation ) Tj ET Q q 0 0 0 rg BT 93.76 374.10 Td (of ) Tj ET Q q 0 0 0 rg BT 104.59 374.10 Td (promotion ) Tj ET Q q 0 0 0 rg BT 148.75 374.10 Td (and ) Tj ET Q q 0 0 0 rg BT 165.69 374.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 208.73 374.10 Td (of ) Tj ET Q q 0 0 0 rg BT 219.56 374.10 Td (pharmaceuticals, ) Tj ET Q q 0 0 0 rg BT 289.53 374.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 310.90 374.10 Td (to ) Tj ET Q q 0 0 0 rg BT 321.18 374.10 Td (“—Government ) Tj ET Q q 0 0 0 rg BT 388.10 374.10 Td (Regulation” ) Tj ET Q q 0 0 0 rg BT 438.92 374.10 Td (below) Tj ET Q q 0 0 0 rg BT 462.71 374.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 350.10 Td (Through ) Tj ET Q q 0 0 0 rg BT 73.46 350.10 Td (our ) Tj ET Q q 0 0 0 rg BT 89.81 350.10 Td (field ) Tj ET Q q 0 0 0 rg BT 111.15 350.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 133.61 350.10 Td (and ) Tj ET Q q 0 0 0 rg BT 151.07 350.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 185.74 350.10 Td (or) Tj ET Q q 0 0 0 rg BT 193.88 350.10 Td (ganizations, ) Tj ET Q q 0 0 0 rg BT 244.95 350.10 Td (we ) Tj ET Q q 0 0 0 rg BT 259.63 350.10 Td (explain ) Tj ET Q q 0 0 0 rg BT 292.08 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 307.31 350.10 Td (risks ) Tj ET Q q 0 0 0 rg BT 329.22 350.10 Td (and ) Tj ET Q q 0 0 0 rg BT 346.68 350.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 381.36 350.10 Td (of ) Tj ET Q q 0 0 0 rg BT 392.71 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 407.94 350.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 448.17 350.10 Td (uses ) Tj ET Q q 0 0 0 rg BT 468.41 350.10 Td (of ) Tj ET Q q 0 0 0 rg BT 479.76 350.10 Td (our ) Tj ET Q q 0 0 0 rg BT 496.11 350.10 Td (products ) Tj ET Q q 0 0 0 rg BT 533.56 350.10 Td (to ) Tj ET Q q 0 0 0 rg BT 544.36 350.10 Td (medical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 338.10 Td (professionals. ) Tj ET Q q 0 0 0 rg BT 94.35 338.10 Td (W) Tj ET Q q 0 0 0 rg BT 102.99 338.10 Td (e ) Tj ET Q q 0 0 0 rg BT 110.75 338.10 Td (work ) Tj ET Q q 0 0 0 rg BT 134.62 338.10 Td (to ) Tj ET Q q 0 0 0 rg BT 145.73 338.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 166.27 338.10 Td (access ) Tj ET Q q 0 0 0 rg BT 195.13 338.10 Td (for ) Tj ET Q q 0 0 0 rg BT 210.11 338.10 Td (our ) Tj ET Q q 0 0 0 rg BT 226.76 338.10 Td (products ) Tj ET Q q 0 0 0 rg BT 264.52 338.10 Td (on ) Tj ET Q q 0 0 0 rg BT 277.84 338.10 Td (formularies ) Tj ET Q q 0 0 0 rg BT 327.26 338.10 Td (and ) Tj ET Q q 0 0 0 rg BT 345.02 338.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 408.33 338.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 432.76 338.10 Td (\(lists ) Tj ET Q q 0 0 0 rg BT 455.53 338.10 Td (of ) Tj ET Q q 0 0 0 rg BT 467.18 338.10 Td (recommended ) Tj ET Q q 0 0 0 rg BT 527.14 338.10 Td (or ) Tj ET Q q 0 0 0 rg BT 538.80 338.10 Td (approved ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 326.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 79.47 326.10 Td (and ) Tj ET Q q 0 0 0 rg BT 96.83 326.10 Td (other ) Tj ET Q q 0 0 0 rg BT 120.30 326.10 Td (products\), ) Tj ET Q q 0 0 0 rg BT 163.50 326.10 Td (including ) Tj ET Q q 0 0 0 rg BT 204.19 326.10 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 244.87 326.10 Td (Part ) Tj ET Q q 0 0 0 rg BT 263.91 326.10 Td (D ) Tj ET Q q 0 0 0 rg BT 274.05 326.10 Td (plans, ) Tj ET Q q 0 0 0 rg BT 300.58 326.10 Td (by ) Tj ET Q q 0 0 0 rg BT 313.51 326.10 Td (providing ) Tj ET Q q 0 0 0 rg BT 355.32 326.10 Td (information ) Tj ET Q q 0 0 0 rg BT 405.46 326.10 Td (about ) Tj ET Q q 0 0 0 rg BT 430.60 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 445.74 326.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 478.09 326.10 Td (profiles ) Tj ET Q q 0 0 0 rg BT 511.57 326.10 Td (of ) Tj ET Q q 0 0 0 rg BT 522.82 326.10 Td (our ) Tj ET Q q 0 0 0 rg BT 539.08 326.10 Td (products. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 314.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.60 314.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 98.19 314.10 Td (and ) Tj ET Q q 0 0 0 rg BT 115.68 314.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 138.17 314.10 Td (of ) Tj ET Q q 0 0 0 rg BT 149.55 314.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 200.36 314.10 Td (pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 268.38 314.10 Td (is ) Tj ET Q q 0 0 0 rg BT 278.09 314.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 309.47 314.10 Td (to ) Tj ET Q q 0 0 0 rg BT 320.30 314.10 Td (the ) Tj ET Q q 0 0 0 rg BT 335.57 314.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 375.82 314.10 Td (uses ) Tj ET Q q 0 0 0 rg BT 396.10 314.10 Td (of ) Tj ET Q q 0 0 0 rg BT 407.47 314.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.74 314.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 464.10 314.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 500.20 314.10 Td (but ) Tj ET Q q 0 0 0 rg BT 516.02 314.10 Td (we ) Tj ET Q q 0 0 0 rg BT 530.73 314.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 568.22 314.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 302.10 Td (develop ) Tj ET Q q 0 0 0 rg BT 70.38 302.10 Td (scientific ) Tj ET Q q 0 0 0 rg BT 109.75 302.10 Td (data ) Tj ET Q q 0 0 0 rg BT 129.13 302.10 Td (and ) Tj ET Q q 0 0 0 rg BT 146.30 302.10 Td (other ) Tj ET Q q 0 0 0 rg BT 169.57 302.10 Td (information ) Tj ET Q q 0 0 0 rg BT 219.51 302.10 Td (about ) Tj ET Q q 0 0 0 rg BT 244.45 302.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 282.16 302.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 324.88 302.10 Td (uses ) Tj ET Q q 0 0 0 rg BT 344.82 302.10 Td (of ) Tj ET Q q 0 0 0 rg BT 355.88 302.10 Td (our ) Tj ET Q q 0 0 0 rg BT 371.93 302.10 Td (products ) Tj ET Q q 0 0 0 rg BT 409.10 302.10 Td (and ) Tj ET Q q 0 0 0 rg BT 426.26 302.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 459.53 302.10 Td (such ) Tj ET Q q 0 0 0 rg BT 480.58 302.10 Td (information ) Tj ET Q q 0 0 0 rg BT 530.52 302.10 Td (in ) Tj ET Q q 0 0 0 rg BT 541.02 302.10 Td (response ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 290.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 290.10 Td (unsolicited ) Tj ET Q q 0 0 0 rg BT 92.66 290.10 Td (inquiries ) Tj ET Q q 0 0 0 rg BT 130.16 290.10 Td (from ) Tj ET Q q 0 0 0 rg BT 152.09 290.10 Td (doctors, ) Tj ET Q q 0 0 0 rg BT 186.53 290.10 Td (other ) Tj ET Q q 0 0 0 rg BT 209.58 290.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 243.73 290.10 Td (professionals ) Tj ET Q q 0 0 0 rg BT 299.00 290.10 Td (and ) Tj ET Q q 0 0 0 rg BT 315.94 290.10 Td (MCOs.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 266.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.53 266.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 99.15 266.10 Td (include ) Tj ET Q q 0 0 0 rg BT 131.56 266.10 Td (several ) Tj ET Q q 0 0 0 rg BT 162.85 266.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 206.37 266.10 Td (and ) Tj ET Q q 0 0 0 rg BT 223.78 266.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 246.19 266.10 Td (or) Tj ET Q q 0 0 0 rg BT 254.34 266.10 Td (ganizations. ) Tj ET Q q 0 0 0 rg BT 305.36 266.10 Td (Each ) Tj ET Q q 0 0 0 rg BT 328.31 266.10 Td (product ) Tj ET Q q 0 0 0 rg BT 361.83 266.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 405.35 266.10 Td (or) Tj ET Q q 0 0 0 rg BT 413.50 266.10 Td (ganization ) Tj ET Q q 0 0 0 rg BT 458.12 266.10 Td (is ) Tj ET Q q 0 0 0 rg BT 467.77 266.10 Td (supported ) Tj ET Q q 0 0 0 rg BT 510.18 266.10 Td (by ) Tj ET Q q 0 0 0 rg BT 523.15 266.10 Td (a ) Tj ET Q q 0 0 0 rg BT 530.57 266.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 552.98 266.10 Td (force, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 254.10 Td (which ) Tj ET Q q 0 0 0 rg BT 61.97 254.10 Td (may ) Tj ET Q q 0 0 0 rg BT 80.71 254.10 Td (be ) Tj ET Q q 0 0 0 rg BT 91.68 254.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 138.75 254.10 Td (for ) Tj ET Q q 0 0 0 rg BT 151.94 254.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 180.14 254.10 Td (one ) Tj ET Q q 0 0 0 rg BT 196.10 254.10 Td (or ) Tj ET Q q 0 0 0 rg BT 205.96 254.10 Td (more ) Tj ET Q q 0 0 0 rg BT 228.04 254.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 266.39 254.10 Td (W) Tj ET Q q 0 0 0 rg BT 275.03 254.10 Td (e ) Tj ET Q q 0 0 0 rg BT 281.00 254.10 Td (also ) Tj ET Q q 0 0 0 rg BT 298.63 254.10 Td (have ) Tj ET Q q 0 0 0 rg BT 319.04 254.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 361.11 254.10 Td (or) Tj ET Q q 0 0 0 rg BT 369.26 254.10 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 416.33 254.10 Td (that ) Tj ET Q q 0 0 0 rg BT 432.85 254.10 Td (focus ) Tj ET Q q 0 0 0 rg BT 456.04 254.10 Td (on ) Tj ET Q q 0 0 0 rg BT 467.57 254.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 496.30 254.10 Td (classes ) Tj ET Q q 0 0 0 rg BT 525.60 254.10 Td (of ) Tj ET Q q 0 0 0 rg BT 535.46 254.10 Td (customers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 242.10 Td (such ) Tj ET Q q 0 0 0 rg BT 57.09 242.10 Td (as ) Tj ET Q q 0 0 0 rg BT 68.18 242.10 Td (managed ) Tj ET Q q 0 0 0 rg BT 107.03 242.10 Td (care ) Tj ET Q q 0 0 0 rg BT 126.43 242.10 Td (entities ) Tj ET Q q 0 0 0 rg BT 158.08 242.10 Td (or ) Tj ET Q q 0 0 0 rg BT 169.16 242.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 199.13 242.10 Td (types ) Tj ET Q q 0 0 0 rg BT 222.99 242.10 Td (of ) Tj ET Q q 0 0 0 rg BT 234.08 242.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 277.38 242.10 Td (tools, ) Tj ET Q q 0 0 0 rg BT 302.09 242.10 Td (such ) Tj ET Q q 0 0 0 rg BT 323.18 242.10 Td (as ) Tj ET Q q 0 0 0 rg BT 334.27 242.10 Td (digital ) Tj ET Q q 0 0 0 rg BT 362.58 242.10 Td (or ) Tj ET Q q 0 0 0 rg BT 373.67 242.10 Td (consumer ) Tj ET Q q 0 0 0 rg BT 415.30 242.10 Td (communications. ) Tj ET Q q 0 0 0 rg BT 486.66 242.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 504.97 242.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 527.17 242.10 Td (forces ) Tj ET Q q 0 0 0 rg BT 554.35 242.10 Td (focus ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 230.10 Td (on ) Tj ET Q q 0 0 0 rg BT 47.35 230.10 Td (communicating ) Tj ET Q q 0 0 0 rg BT 110.91 230.10 Td (information ) Tj ET Q q 0 0 0 rg BT 159.47 230.10 Td (about ) Tj ET Q q 0 0 0 rg BT 183.04 230.10 Td (new ) Tj ET Q q 0 0 0 rg BT 201.05 230.10 Td (products ) Tj ET Q q 0 0 0 rg BT 236.84 230.10 Td (or ) Tj ET Q q 0 0 0 rg BT 246.53 230.10 Td (new ) Tj ET Q q 0 0 0 rg BT 264.54 230.10 Td (uses, ) Tj ET Q q 0 0 0 rg BT 285.61 230.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.29 230.10 Td (well ) Tj ET Q q 0 0 0 rg BT 313.86 230.10 Td (as ) Tj ET Q q 0 0 0 rg BT 323.54 230.10 Td (established ) Tj ET Q q 0 0 0 rg BT 369.33 230.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 407.62 230.10 Td (and ) Tj ET Q q 0 0 0 rg BT 423.41 230.10 Td (promotion ) Tj ET Q q 0 0 0 rg BT 466.42 230.10 Td (to ) Tj ET Q q 0 0 0 rg BT 475.55 230.10 Td (physicians ) Tj ET Q q 0 0 0 rg BT 519.12 230.10 Td (is ) Tj ET Q q 0 0 0 rg BT 527.14 230.10 Td (increasingly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 218.10 Td (tar) Tj ET Q q 0 0 0 rg BT 46.37 218.10 Td (geted ) Tj ET Q q 0 0 0 rg BT 70.52 218.10 Td (at ) Tj ET Q q 0 0 0 rg BT 80.24 218.10 Td (physician ) Tj ET Q q 0 0 0 rg BT 121.06 218.10 Td (specialists ) Tj ET Q q 0 0 0 rg BT 164.67 218.10 Td (who ) Tj ET Q q 0 0 0 rg BT 184.39 218.10 Td (treat ) Tj ET Q q 0 0 0 rg BT 204.65 218.10 Td (the ) Tj ET Q q 0 0 0 rg BT 219.37 218.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 252.97 218.10 Td (in ) Tj ET Q q 0 0 0 rg BT 263.25 218.10 Td (need ) Tj ET Q q 0 0 0 rg BT 284.63 218.10 Td (of ) Tj ET Q q 0 0 0 rg BT 295.46 218.10 Td (our ) Tj ET Q q 0 0 0 rg BT 311.29 218.10 Td (medicines.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 194.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.24 194.10 Td (products ) Tj ET Q q 0 0 0 rg BT 91.38 194.10 Td (are ) Tj ET Q q 0 0 0 rg BT 106.28 194.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 125.64 194.10 Td (principally ) Tj ET Q q 0 0 0 rg BT 171.65 194.10 Td (to ) Tj ET Q q 0 0 0 rg BT 182.12 194.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 234.52 194.10 Td (and ) Tj ET Q q 0 0 0 rg BT 251.65 194.10 Td (to ) Tj ET Q q 0 0 0 rg BT 262.13 194.10 Td (a ) Tj ET Q q 0 0 0 rg BT 269.26 194.10 Td (lesser ) Tj ET Q q 0 0 0 rg BT 294.72 194.10 Td (extent, ) Tj ET Q q 0 0 0 rg BT 324.34 194.10 Td (directly ) Tj ET Q q 0 0 0 rg BT 357.58 194.10 Td (to ) Tj ET Q q 0 0 0 rg BT 368.05 194.10 Td (distributors, ) Tj ET Q q 0 0 0 rg BT 418.80 194.10 Td (retailers, ) Tj ET Q q 0 0 0 rg BT 456.20 194.10 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 496.94 194.10 Td (clinics, ) Tj ET Q q 0 0 0 rg BT 528.24 194.10 Td (government ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 182.10 Td (agencies ) Tj ET Q q 0 0 0 rg BT 72.30 182.10 Td (and ) Tj ET Q q 0 0 0 rg BT 88.62 182.10 Td (pharmacies. ) Tj ET Q q 0 0 0 rg BT 138.52 182.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 162.61 182.10 Td (to ) Tj ET Q q 0 0 0 rg BT 172.26 182.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 196.90 182.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 206.28 182.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 245.37 182.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.56 182.10 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.56 182.10 Td (. ) Tj ET Q q 0 0 0 rg BT 329.94 182.10 Td (Business ) Tj ET Q q 0 0 0 rg BT 367.38 182.10 Td (Segment ) Tj ET Q q 0 0 0 rg BT 404.25 182.10 Td (Information” ) Tj ET Q q 0 0 0 rg BT 458.33 182.10 Td (for ) Tj ET Q q 0 0 0 rg BT 471.87 182.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 494.85 182.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 532.27 182.10 Td (to ) Tj ET Q q 0 0 0 rg BT 541.92 182.10 Td (the ) Tj ET Q q 0 0 0 rg BT 556.02 182.10 Td (three ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 170.10 Td (lar) Tj ET Q q 0 0 0 rg BT 46.37 170.10 Td (gest ) Tj ET Q q 0 0 0 rg BT 64.97 170.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 128.55 170.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 178.26 170.10 Td (in ) Tj ET Q q 0 0 0 rg BT 188.53 170.10 Td (the ) Tj ET Q q 0 0 0 rg BT 203.25 170.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 223.53 170.10 Td (as ) Tj ET Q q 0 0 0 rg BT 234.36 170.10 Td (a ) Tj ET Q q 0 0 0 rg BT 241.30 170.10 Td (percentage ) Tj ET Q q 0 0 0 rg BT 287.10 170.10 Td (of ) Tj ET Q q 0 0 0 rg BT 297.93 170.10 Td (our ) Tj ET Q q 0 0 0 rg BT 313.76 170.10 Td (global ) Tj ET Q q 0 0 0 rg BT 341.26 170.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 364.87 170.10 Td (revenues.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 146.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 55.06 146.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 76.34 146.10 Td (business ) Tj ET Q q 0 0 0 rg BT 113.74 146.10 Td (has ) Tj ET Q q 0 0 0 rg BT 130.57 146.10 Td (IMAs ) Tj ET Q q 0 0 0 rg BT 157.41 146.10 Td (with ) Tj ET Q q 0 0 0 rg BT 178.69 146.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 232.75 146.10 Td (all ) Tj ET Q q 0 0 0 rg BT 246.24 146.10 Td (of ) Tj ET Q q 0 0 0 rg BT 258.08 146.10 Td (our ) Tj ET Q q 0 0 0 rg BT 274.91 146.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 301.18 146.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 348.00 146.10 Td (and ) Tj ET Q q 0 0 0 rg BT 365.94 146.10 Td (distributor ) Tj ET Q q 0 0 0 rg BT 411.11 146.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 455.16 146.10 Td (that ) Tj ET Q q 0 0 0 rg BT 473.66 146.10 Td (allow ) Tj ET Q q 0 0 0 rg BT 499.38 146.10 Td (us ) Tj ET Q q 0 0 0 rg BT 511.77 146.10 Td (to ) Tj ET Q q 0 0 0 rg BT 523.05 146.10 Td (monitor ) Tj ET Q q 0 0 0 rg BT 558.22 146.10 Td (U.S. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 81.46 134.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 121.93 134.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 147.39 134.10 Td (and ) Tj ET Q q 0 0 0 rg BT 163.97 134.10 Td (requires ) Tj ET Q q 0 0 0 rg BT 198.32 134.10 Td (those ) Tj ET Q q 0 0 0 rg BT 221.58 134.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 270.92 134.10 Td (and ) Tj ET Q q 0 0 0 rg BT 287.51 134.10 Td (distributors ) Tj ET Q q 0 0 0 rg BT 335.21 134.10 Td (to ) Tj ET Q q 0 0 0 rg BT 345.13 134.10 Td (maintain ) Tj ET Q q 0 0 0 rg BT 382.26 134.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 422.73 134.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 448.19 134.10 Td (that ) Tj ET Q q 0 0 0 rg BT 465.33 134.10 Td (are ) Tj ET Q q 0 0 0 rg BT 479.68 134.10 Td (no ) Tj ET Q q 0 0 0 rg BT 491.82 134.10 Td (more ) Tj ET Q q 0 0 0 rg BT 514.51 134.10 Td (than ) Tj ET Q q 0 0 0 rg BT 533.87 134.10 Td (one ) Tj ET Q q 0 0 0 rg BT 550.45 134.10 Td (month ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 122.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.89 122.10 Td (their ) Tj ET Q q 0 0 0 rg BT 67.77 122.10 Td (demand. ) Tj ET Q q 0 0 0 rg BT 104.30 122.10 Td (The ) Tj ET Q q 0 0 0 rg BT 122.40 122.10 Td (IMAs, ) Tj ET Q q 0 0 0 rg BT 150.80 122.10 Td (including ) Tj ET Q q 0 0 0 rg BT 191.13 122.10 Td (those ) Tj ET Q q 0 0 0 rg BT 214.79 122.10 Td (with ) Tj ET Q q 0 0 0 rg BT 235.13 122.10 Td (our ) Tj ET Q q 0 0 0 rg BT 251.02 122.10 Td (three ) Tj ET Q q 0 0 0 rg BT 273.56 122.10 Td (lar) Tj ET Q q 0 0 0 rg BT 283.93 122.10 Td (gest ) Tj ET Q q 0 0 0 rg BT 302.59 122.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 354.86 122.10 Td (expire ) Tj ET Q q 0 0 0 rg BT 382.40 122.10 Td (in ) Tj ET Q q 0 0 0 rg BT 392.73 122.10 Td (December ) Tj ET Q q 0 0 0 rg BT 436.38 122.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 458.93 122.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 489.82 122.10 Td (to ) Tj ET Q q 0 0 0 rg BT 500.15 122.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 529.91 122.10 Td (termination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 110.10 Td (provisions.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 86.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.73 86.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 92.03 86.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 136.43 86.10 Td (have ) Tj ET Q q 0 0 0 rg BT 157.48 86.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 209.65 86.10 Td (more ) Tj ET Q q 0 0 0 rg BT 232.38 86.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 257.33 86.10 Td (customers. ) Tj ET Q q 0 0 0 rg BT 302.55 86.10 Td (Information ) Tj ET Q q 0 0 0 rg BT 352.50 86.10 Td (on ) Tj ET Q q 0 0 0 rg BT 364.68 86.10 Td (available ) Tj ET Q q 0 0 0 rg BT 402.95 86.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 427.89 86.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 466.73 86.10 Td (product ) Tj ET Q q 0 0 0 rg BT 499.45 86.10 Td (level ) Tj ET Q q 0 0 0 rg BT 521.07 86.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 561.57 86.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 74.10 Td (corresponding ) Tj ET Q q 0 0 0 rg BT 94.72 74.10 Td (out-movement ) Tj ET Q q 0 0 0 rg BT 154.55 74.10 Td (information ) Tj ET Q q 0 0 0 rg BT 203.28 74.10 Td (and ) Tj ET Q q 0 0 0 rg BT 219.23 74.10 Td (the ) Tj ET Q q 0 0 0 rg BT 232.96 74.10 Td (reliability ) Tj ET Q q 0 0 0 rg BT 273.35 74.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.20 74.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 327.47 74.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 360.64 74.10 Td (information ) Tj ET Q q 0 0 0 rg BT 409.37 74.10 Td (varies ) Tj ET Q q 0 0 0 rg BT 434.76 74.10 Td (widely) Tj ET Q q 0 0 0 rg BT 461.33 74.10 Td (. ) Tj ET Q q 0 0 0 rg BT 465.23 74.10 Td (W) Tj ET Q q 0 0 0 rg BT 473.87 74.10 Td (e ) Tj ET Q q 0 0 0 rg BT 479.82 74.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 500.23 74.10 Td (our ) Tj ET Q q 0 0 0 rg BT 515.07 74.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 539.35 74.10 Td (customer ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 62.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 57.94 62.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 91.53 62.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 132.36 62.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 171.51 62.10 Td (to ) Tj ET Q q 0 0 0 rg BT 181.79 62.10 Td (where ) Tj ET Q q 0 0 0 rg BT 208.72 62.10 Td (we ) Tj ET Q q 0 0 0 rg BT 222.88 62.10 Td (can ) Tj ET Q q 0 0 0 rg BT 239.26 62.10 Td (reliably ) Tj ET Q q 0 0 0 rg BT 272.30 62.10 Td (gather ) Tj ET Q q 0 0 0 rg BT 299.78 62.10 Td (and ) Tj ET Q q 0 0 0 rg BT 316.72 62.10 Td (report ) Tj ET Q q 0 0 0 rg BT 343.10 62.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 383.92 62.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 409.75 62.10 Td (from ) Tj ET Q q 0 0 0 rg BT 431.69 62.10 Td (our ) Tj ET Q q 0 0 0 rg BT 447.52 62.10 Td (customers.) Tj ET Q endstream endobj 27 0 obj <> endobj 28 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.15 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 54.41 749.10 Td (number ) Tj ET Q q 0 0 0 rg BT 87.77 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 98.92 749.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 138.40 749.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 170.11 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 181.26 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 196.29 749.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 219.40 749.10 Td (we ) Tj ET Q q 0 0 0 rg BT 233.88 749.10 Td (contract ) Tj ET Q q 0 0 0 rg BT 268.90 749.10 Td (with ) Tj ET Q q 0 0 0 rg BT 289.50 749.10 Td (distributors ) Tj ET Q q 0 0 0 rg BT 337.87 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 348.47 749.10 Td (support ) Tj ET Q q 0 0 0 rg BT 381.29 749.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 411.31 749.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 450.87 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 469.23 749.10 Td (services ) Tj ET Q q 0 0 0 rg BT 504.26 749.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 542.63 749.10 Td (by ) Tj ET Q q 0 0 0 rg BT 555.45 749.10 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (distributors ) Tj ET Q q 0 0 0 rg BT 84.41 737.10 Td (vary ) Tj ET Q q 0 0 0 rg BT 105.04 737.10 Td (by ) Tj ET Q q 0 0 0 rg BT 117.89 737.10 Td (market, ) Tj ET Q q 0 0 0 rg BT 151.01 737.10 Td (but ) Tj ET Q q 0 0 0 rg BT 166.64 737.10 Td (may ) Tj ET Q q 0 0 0 rg BT 186.72 737.10 Td (include ) Tj ET Q q 0 0 0 rg BT 219.01 737.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 267.97 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 285.27 737.10 Td (logistics; ) Tj ET Q q 0 0 0 rg BT 324.24 737.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 368.19 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 385.48 737.10 Td (pharmacovigilance; ) Tj ET Q q 0 0 0 rg BT 467.19 737.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 495.59 737.10 Td (sales, ) Tj ET Q q 0 0 0 rg BT 520.38 737.10 Td (advertising ) Tj ET Q q 0 0 0 rg BT 567.67 737.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (promotion. ) Tj ET Q q 0 0 0 rg BT 82.67 725.10 Td (Sales ) Tj ET Q q 0 0 0 rg BT 106.27 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 116.55 725.10 Td (these ) Tj ET Q q 0 0 0 rg BT 139.60 725.10 Td (distributor) Tj ET Q q 0 0 0 rg BT 181.06 725.10 Td (-based ) Tj ET Q q 0 0 0 rg BT 209.66 725.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 248.82 725.10 Td (represented ) Tj ET Q q 0 0 0 rg BT 297.40 725.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 357.66 725.10 Td (1% ) Tj ET Q q 0 0 0 rg BT 373.49 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 384.32 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 399.04 725.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 440.70 725.10 Td (s ) Tj ET Q q 0 0 0 rg BT 447.09 725.10 Td (total ) Tj ET Q q 0 0 0 rg BT 467.37 725.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 505.40 725.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.68 725.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 535.68 725.10 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (Competition) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.94 677.10 Td (markets ) Tj ET Q q 0 0 0 rg BT 88.00 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 98.17 677.10 Td (which ) Tj ET Q q 0 0 0 rg BT 125.00 677.10 Td (we ) Tj ET Q q 0 0 0 rg BT 139.06 677.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 175.33 677.10 Td (are ) Tj ET Q q 0 0 0 rg BT 189.93 677.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 229.53 677.10 Td (broad ) Tj ET Q q 0 0 0 rg BT 254.70 677.10 Td (based ) Tj ET Q q 0 0 0 rg BT 279.86 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 296.70 677.10 Td (highly ) Tj ET Q q 0 0 0 rg BT 324.65 677.10 Td (competitive. ) Tj ET Q q 0 0 0 rg BT 376.58 677.10 Td (W) Tj ET Q q 0 0 0 rg BT 385.22 677.10 Td (e ) Tj ET Q q 0 0 0 rg BT 392.05 677.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 428.32 677.10 Td (with ) Tj ET Q q 0 0 0 rg BT 448.50 677.10 Td (other ) Tj ET Q q 0 0 0 rg BT 471.44 677.10 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 516.60 677.10 Td (research-based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 57.97 665.10 Td (companies, ) Tj ET Q q 0 0 0 rg BT 106.88 665.10 Td (many ) Tj ET Q q 0 0 0 rg BT 132.74 665.10 Td (smaller ) Tj ET Q q 0 0 0 rg BT 165.81 665.10 Td (research ) Tj ET Q q 0 0 0 rg BT 202.76 665.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 249.17 665.10 Td (with ) Tj ET Q q 0 0 0 rg BT 270.59 665.10 Td (more ) Tj ET Q q 0 0 0 rg BT 294.78 665.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 326.75 665.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 374.81 665.10 Td (focus ) Tj ET Q q 0 0 0 rg BT 400.12 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 418.20 665.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 451.26 665.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 473.24 665.10 Td (manufacturers. ) Tj ET Q q 0 0 0 rg BT 536.57 665.10 Td (Important ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 85.53 653.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 115.05 653.10 Td (include ) Tj ET Q q 0 0 0 rg BT 146.80 653.10 Td (product ) Tj ET Q q 0 0 0 rg BT 179.67 653.10 Td (ef) Tj ET Q q 0 0 0 rg BT 187.26 653.10 Td (ficacy) Tj ET Q q 0 0 0 rg BT 211.03 653.10 Td (, ) Tj ET Q q 0 0 0 rg BT 215.85 653.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 242.04 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 258.80 653.10 Td (ease ) Tj ET Q q 0 0 0 rg BT 278.33 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 288.97 653.10 Td (use, ) Tj ET Q q 0 0 0 rg BT 307.12 653.10 Td (price ) Tj ET Q q 0 0 0 rg BT 329.43 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 346.18 653.10 Td (demonstrated ) Tj ET Q q 0 0 0 rg BT 402.37 653.10 Td (cost-ef) Tj ET Q q 0 0 0 rg BT 429.40 653.10 Td (fectiveness, ) Tj ET Q q 0 0 0 rg BT 478.64 653.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 521.50 653.10 Td (ef) Tj ET Q q 0 0 0 rg BT 529.09 653.10 Td (fectiveness, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (product ) Tj ET Q q 0 0 0 rg BT 69.04 641.10 Td (labeling, ) Tj ET Q q 0 0 0 rg BT 106.25 641.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 145.40 641.10 Td (service ) Tj ET Q q 0 0 0 rg BT 176.21 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 193.14 641.10 Td (R&D ) Tj ET Q q 0 0 0 rg BT 217.30 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 228.13 641.10 Td (new ) Tj ET Q q 0 0 0 rg BT 247.28 641.10 Td (products ) Tj ET Q q 0 0 0 rg BT 284.21 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 301.15 641.10 Td (processes. ) Tj ET Q q 0 0 0 rg BT 344.46 641.10 Td (Sales ) Tj ET Q q 0 0 0 rg BT 368.06 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 378.89 641.10 Td (our ) Tj ET Q q 0 0 0 rg BT 394.71 641.10 Td (products ) Tj ET Q q 0 0 0 rg BT 431.64 641.10 Td (can ) Tj ET Q q 0 0 0 rg BT 448.02 641.10 Td (be ) Tj ET Q q 0 0 0 rg BT 459.95 641.10 Td (impacted ) Tj ET Q q 0 0 0 rg BT 499.09 641.10 Td (by ) Tj ET Q q 0 0 0 rg BT 511.59 641.10 Td (new ) Tj ET Q q 0 0 0 rg BT 530.74 641.10 Td (studies ) Tj ET Q q 0 0 0 rg BT 561.01 641.10 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (indicate ) Tj ET Q q 0 0 0 rg BT 69.76 629.10 Td (a ) Tj ET Q q 0 0 0 rg BT 76.32 629.10 Td (competitor) Tj ET Q q 0 0 0 rg BT 120.01 629.10 Td (’) Tj ET Q q 0 0 0 rg BT 122.79 629.10 Td (s ) Tj ET Q q 0 0 0 rg BT 128.79 629.10 Td (product ) Tj ET Q q 0 0 0 rg BT 161.45 629.10 Td (is ) Tj ET Q q 0 0 0 rg BT 170.24 629.10 Td (safer ) Tj ET Q q 0 0 0 rg BT 191.78 629.10 Td (or ) Tj ET Q q 0 0 0 rg BT 202.23 629.10 Td (more ) Tj ET Q q 0 0 0 rg BT 224.89 629.10 Td (ef) Tj ET Q q 0 0 0 rg BT 232.47 629.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 261.79 629.10 Td (for ) Tj ET Q q 0 0 0 rg BT 275.57 629.10 Td (treating ) Tj ET Q q 0 0 0 rg BT 308.22 629.10 Td (a ) Tj ET Q q 0 0 0 rg BT 314.77 629.10 Td (disease ) Tj ET Q q 0 0 0 rg BT 345.77 629.10 Td (or ) Tj ET Q q 0 0 0 rg BT 356.21 629.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 396.63 629.10 Td (form ) Tj ET Q q 0 0 0 rg BT 418.19 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 428.63 629.10 Td (disease ) Tj ET Q q 0 0 0 rg BT 459.62 629.10 Td (than ) Tj ET Q q 0 0 0 rg BT 478.95 629.10 Td (one ) Tj ET Q q 0 0 0 rg BT 495.51 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 505.95 629.10 Td (our ) Tj ET Q q 0 0 0 rg BT 521.40 629.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 560.45 629.10 Td (Our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 74.35 617.10 Td (also ) Tj ET Q q 0 0 0 rg BT 93.28 617.10 Td (can ) Tj ET Q q 0 0 0 rg BT 109.97 617.10 Td (be ) Tj ET Q q 0 0 0 rg BT 122.23 617.10 Td (impacted ) Tj ET Q q 0 0 0 rg BT 161.69 617.10 Td (by ) Tj ET Q q 0 0 0 rg BT 174.51 617.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 217.32 617.10 Td (labeling ) Tj ET Q q 0 0 0 rg BT 252.34 617.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 307.36 617.10 Td (relating ) Tj ET Q q 0 0 0 rg BT 340.72 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 351.32 617.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 378.01 617.10 Td (or ) Tj ET Q q 0 0 0 rg BT 389.16 617.10 Td (convenience ) Tj ET Q q 0 0 0 rg BT 441.94 617.10 Td (that ) Tj ET Q q 0 0 0 rg BT 459.75 617.10 Td (may ) Tj ET Q q 0 0 0 rg BT 479.79 617.10 Td (be ) Tj ET Q q 0 0 0 rg BT 492.04 617.10 Td (imposed ) Tj ET Q q 0 0 0 rg BT 528.75 617.10 Td (on ) Tj ET Q q 0 0 0 rg BT 541.56 617.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (by ) Tj ET Q q 0 0 0 rg BT 47.99 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.20 605.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 81.65 605.10 Td ( ) Tj ET Q q 0 0 0 rg BT 83.65 605.10 Td (or ) Tj ET Q q 0 0 0 rg BT 93.97 605.10 Td (by ) Tj ET Q q 0 0 0 rg BT 105.96 605.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 135.73 605.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 178.81 605.10 Td (agencies ) Tj ET Q q 0 0 0 rg BT 215.23 605.10 Td (in ) Tj ET Q q 0 0 0 rg BT 225.00 605.10 Td (dif) Tj ET Q q 0 0 0 rg BT 235.93 605.10 Td (ferent ) Tj ET Q q 0 0 0 rg BT 261.23 605.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 302.38 605.10 Td (If ) Tj ET Q q 0 0 0 rg BT 311.03 605.10 Td (competitors ) Tj ET Q q 0 0 0 rg BT 360.24 605.10 Td (introduce ) Tj ET Q q 0 0 0 rg BT 399.99 605.10 Td (new ) Tj ET Q q 0 0 0 rg BT 418.65 605.10 Td (products ) Tj ET Q q 0 0 0 rg BT 455.08 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 471.51 605.10 Td (processes ) Tj ET Q q 0 0 0 rg BT 511.82 605.10 Td (with ) Tj ET Q q 0 0 0 rg BT 531.59 605.10 Td (therapeutic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 46.83 593.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 65.44 593.10 Td (advantages, ) Tj ET Q q 0 0 0 rg BT 114.86 593.10 Td (our ) Tj ET Q q 0 0 0 rg BT 130.69 593.10 Td (products ) Tj ET Q q 0 0 0 rg BT 167.63 593.10 Td (can ) Tj ET Q q 0 0 0 rg BT 184.01 593.10 Td (be ) Tj ET Q q 0 0 0 rg BT 195.95 593.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 226.77 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 237.05 593.10 Td (progressive ) Tj ET Q q 0 0 0 rg BT 285.65 593.10 Td (price ) Tj ET Q q 0 0 0 rg BT 308.13 593.10 Td (reductions ) Tj ET Q q 0 0 0 rg BT 352.29 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 363.12 593.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 405.03 593.10 Td (volume ) Tj ET Q q 0 0 0 rg BT 437.53 593.10 Td (of ) Tj ET Q q 0 0 0 rg BT 448.36 593.10 Td (sales, ) Tj ET Q q 0 0 0 rg BT 472.80 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 483.63 593.10 Td (both.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (Generic ) Tj ET Q q 0 0 0 rg BT 70.71 569.10 Td (Competition) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 551.10 Td (One ) Tj ET Q q 0 0 0 rg BT 54.13 551.10 Td (of ) Tj ET Q q 0 0 0 rg BT 63.92 551.10 Td (the ) Tj ET Q q 0 0 0 rg BT 77.61 551.10 Td (biggest ) Tj ET Q q 0 0 0 rg BT 107.96 551.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 156.63 551.10 Td (challenges ) Tj ET Q q 0 0 0 rg BT 200.30 551.10 Td (that ) Tj ET Q q 0 0 0 rg BT 216.76 551.10 Td (we ) Tj ET Q q 0 0 0 rg BT 229.89 551.10 Td (face ) Tj ET Q q 0 0 0 rg BT 248.00 551.10 Td (is ) Tj ET Q q 0 0 0 rg BT 256.14 551.10 Td (from ) Tj ET Q q 0 0 0 rg BT 277.04 551.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 307.93 551.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 370.47 551.10 Td (manufacturers. ) Tj ET Q q 0 0 0 rg BT 431.63 551.10 Td (In ) Tj ET Q q 0 0 0 rg BT 441.43 551.10 Td (the ) Tj ET Q q 0 0 0 rg BT 455.11 551.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 474.36 551.10 Td (and ) Tj ET Q q 0 0 0 rg BT 490.26 551.10 Td (the ) Tj ET Q q 0 0 0 rg BT 503.95 551.10 Td (EU, ) Tj ET Q q 0 0 0 rg BT 521.24 551.10 Td (the ) Tj ET Q q 0 0 0 rg BT 534.93 551.10 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 74.36 539.10 Td (process ) Tj ET Q q 0 0 0 rg BT 107.73 539.10 Td (exempts ) Tj ET Q q 0 0 0 rg BT 144.44 539.10 Td (generics ) Tj ET Q q 0 0 0 rg BT 181.13 539.10 Td (from ) Tj ET Q q 0 0 0 rg BT 203.95 539.10 Td (costly ) Tj ET Q q 0 0 0 rg BT 231.21 539.10 Td (and ) Tj ET Q q 0 0 0 rg BT 249.03 539.10 Td (time-consuming ) Tj ET Q q 0 0 0 rg BT 317.40 539.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 350.21 539.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 373.58 539.10 Td (to ) Tj ET Q q 0 0 0 rg BT 384.74 539.10 Td (demonstrate ) Tj ET Q q 0 0 0 rg BT 436.99 539.10 Td (their ) Tj ET Q q 0 0 0 rg BT 458.70 539.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 485.95 539.10 Td (and ) Tj ET Q q 0 0 0 rg BT 503.77 539.10 Td (ef) Tj ET Q q 0 0 0 rg BT 511.36 539.10 Td (ficacy) Tj ET Q q 0 0 0 rg BT 535.13 539.10 Td (, ) Tj ET Q q 0 0 0 rg BT 541.01 539.10 Td (allowing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 527.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 68.67 527.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 129.10 527.10 Td (to ) Tj ET Q q 0 0 0 rg BT 140.12 527.10 Td (rely ) Tj ET Q q 0 0 0 rg BT 158.91 527.10 Td (on ) Tj ET Q q 0 0 0 rg BT 172.15 527.10 Td (the ) Tj ET Q q 0 0 0 rg BT 187.61 527.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 214.73 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 232.41 527.10 Td (ef) Tj ET Q q 0 0 0 rg BT 240.00 527.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 267.67 527.10 Td (of ) Tj ET Q q 0 0 0 rg BT 279.24 527.10 Td (the ) Tj ET Q q 0 0 0 rg BT 294.70 527.10 Td (innovator ) Tj ET Q q 0 0 0 rg BT 336.26 527.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 371.84 527.10 Td (As ) Tj ET Q q 0 0 0 rg BT 386.19 527.10 Td (a ) Tj ET Q q 0 0 0 rg BT 393.87 527.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 421.83 527.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 454.50 527.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 518.81 527.10 Td (manufacturers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 515.10 Td (typically ) Tj ET Q q 0 0 0 rg BT 73.06 515.10 Td (invest ) Tj ET Q q 0 0 0 rg BT 99.02 515.10 Td (far ) Tj ET Q q 0 0 0 rg BT 112.19 515.10 Td (less ) Tj ET Q q 0 0 0 rg BT 129.26 515.10 Td (in ) Tj ET Q q 0 0 0 rg BT 139.11 515.10 Td (R&D ) Tj ET Q q 0 0 0 rg BT 162.85 515.10 Td (than ) Tj ET Q q 0 0 0 rg BT 182.14 515.10 Td (research-based ) Tj ET Q q 0 0 0 rg BT 243.62 515.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 306.77 515.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 351.60 515.10 Td (and ) Tj ET Q q 0 0 0 rg BT 368.11 515.10 Td (therefore ) Tj ET Q q 0 0 0 rg BT 406.27 515.10 Td (can ) Tj ET Q q 0 0 0 rg BT 422.22 515.10 Td (price ) Tj ET Q q 0 0 0 rg BT 444.27 515.10 Td (their ) Tj ET Q q 0 0 0 rg BT 464.67 515.10 Td (products ) Tj ET Q q 0 0 0 rg BT 501.18 515.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 553.24 515.10 Td (lower ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.10 Td (than ) Tj ET Q q 0 0 0 rg BT 56.30 503.10 Td (branded ) Tj ET Q q 0 0 0 rg BT 91.59 503.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 130.93 503.10 Td (Accordingly) Tj ET Q q 0 0 0 rg BT 180.27 503.10 Td (, ) Tj ET Q q 0 0 0 rg BT 185.85 503.10 Td (when ) Tj ET Q q 0 0 0 rg BT 210.60 503.10 Td (a ) Tj ET Q q 0 0 0 rg BT 218.12 503.10 Td (branded ) Tj ET Q q 0 0 0 rg BT 253.41 503.10 Td (product ) Tj ET Q q 0 0 0 rg BT 287.04 503.10 Td (loses ) Tj ET Q q 0 0 0 rg BT 310.12 503.10 Td (its ) Tj ET Q q 0 0 0 rg BT 322.65 503.10 Td (market ) Tj ET Q q 0 0 0 rg BT 353.50 503.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 396.73 503.10 Td (, ) Tj ET Q q 0 0 0 rg BT 402.32 503.10 Td (it ) Tj ET Q q 0 0 0 rg BT 410.96 503.10 Td (normally ) Tj ET Q q 0 0 0 rg BT 450.14 503.10 Td (faces ) Tj ET Q q 0 0 0 rg BT 473.76 503.10 Td (intense ) Tj ET Q q 0 0 0 rg BT 505.17 503.10 Td (price ) Tj ET Q q 0 0 0 rg BT 528.24 503.10 Td (competition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 491.10 Td (from ) Tj ET Q q 0 0 0 rg BT 58.63 491.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 91.25 491.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 117.78 491.10 Td (of ) Tj ET Q q 0 0 0 rg BT 129.30 491.10 Td (the ) Tj ET Q q 0 0 0 rg BT 144.71 491.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 180.96 491.10 Td (Upon ) Tj ET Q q 0 0 0 rg BT 206.37 491.10 Td (the ) Tj ET Q q 0 0 0 rg BT 221.78 491.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 265.52 491.10 Td (or ) Tj ET Q q 0 0 0 rg BT 277.04 491.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 295.80 491.10 Td (of ) Tj ET Q q 0 0 0 rg BT 307.33 491.10 Td (market ) Tj ET Q q 0 0 0 rg BT 338.28 491.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 385.36 491.10 Td (on ) Tj ET Q q 0 0 0 rg BT 398.56 491.10 Td (a ) Tj ET Q q 0 0 0 rg BT 406.19 491.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 442.43 491.10 Td (we ) Tj ET Q q 0 0 0 rg BT 457.29 491.10 Td (can ) Tj ET Q q 0 0 0 rg BT 474.36 491.10 Td (lose ) Tj ET Q q 0 0 0 rg BT 493.66 491.10 Td (the ) Tj ET Q q 0 0 0 rg BT 509.07 491.10 Td (major ) Tj ET Q q 0 0 0 rg BT 535.59 491.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 567.67 491.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 479.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 74.04 479.10 Td (of ) Tj ET Q q 0 0 0 rg BT 84.87 479.10 Td (that ) Tj ET Q q 0 0 0 rg BT 102.36 479.10 Td (product ) Tj ET Q q 0 0 0 rg BT 135.41 479.10 Td (in ) Tj ET Q q 0 0 0 rg BT 145.69 479.10 Td (a ) Tj ET Q q 0 0 0 rg BT 152.63 479.10 Td (very ) Tj ET Q q 0 0 0 rg BT 172.89 479.10 Td (short ) Tj ET Q q 0 0 0 rg BT 195.39 479.10 Td (period ) Tj ET Q q 0 0 0 rg BT 223.44 479.10 Td (of ) Tj ET Q q 0 0 0 rg BT 234.27 479.10 Td (time.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 455.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.02 455.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 71.49 455.10 Td (of ) Tj ET Q q 0 0 0 rg BT 82.29 455.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 120.31 455.10 Td (decline ) Tj ET Q q 0 0 0 rg BT 151.66 455.10 Td (of ) Tj ET Q q 0 0 0 rg BT 162.46 455.10 Td (a ) Tj ET Q q 0 0 0 rg BT 169.38 455.10 Td (product ) Tj ET Q q 0 0 0 rg BT 202.40 455.10 Td (after ) Tj ET Q q 0 0 0 rg BT 223.20 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 237.89 455.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 280.91 455.10 Td (of ) Tj ET Q q 0 0 0 rg BT 291.72 455.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 338.07 455.10 Td (varies ) Tj ET Q q 0 0 0 rg BT 364.43 455.10 Td (by ) Tj ET Q q 0 0 0 rg BT 376.91 455.10 Td (country) Tj ET Q q 0 0 0 rg BT 406.80 455.10 Td (. ) Tj ET Q q 0 0 0 rg BT 411.78 455.10 Td (In ) Tj ET Q q 0 0 0 rg BT 422.59 455.10 Td (general, ) Tj ET Q q 0 0 0 rg BT 456.99 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 471.68 455.10 Td (decline ) Tj ET Q q 0 0 0 rg BT 503.03 455.10 Td (in ) Tj ET Q q 0 0 0 rg BT 513.29 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 527.98 455.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 548.24 455.10 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 443.10 Td (is ) Tj ET Q q 0 0 0 rg BT 44.81 443.10 Td (more ) Tj ET Q q 0 0 0 rg BT 67.50 443.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 90.19 443.10 Td (than ) Tj ET Q q 0 0 0 rg BT 109.54 443.10 Td (in ) Tj ET Q q 0 0 0 rg BT 119.46 443.10 Td (most ) Tj ET Q q 0 0 0 rg BT 141.05 443.10 Td (other ) Tj ET Q q 0 0 0 rg BT 163.74 443.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 206.98 443.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 248.27 443.10 Td (though ) Tj ET Q q 0 0 0 rg BT 278.19 443.10 Td (we ) Tj ET Q q 0 0 0 rg BT 291.99 443.10 Td (have ) Tj ET Q q 0 0 0 rg BT 313.01 443.10 Td (observed ) Tj ET Q q 0 0 0 rg BT 351.25 443.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 373.94 443.10 Td (declines ) Tj ET Q q 0 0 0 rg BT 408.84 443.10 Td (in ) Tj ET Q q 0 0 0 rg BT 418.76 443.10 Td (a ) Tj ET Q q 0 0 0 rg BT 425.34 443.10 Td (number ) Tj ET Q q 0 0 0 rg BT 458.03 443.10 Td (of ) Tj ET Q q 0 0 0 rg BT 468.50 443.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 483.97 443.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 522.77 443.10 Td (as ) Tj ET Q q 0 0 0 rg BT 533.24 443.10 Td (well. ) Tj ET Q q 0 0 0 rg BT 554.63 443.10 Td (Also, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 431.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.66 431.10 Td (declines ) Tj ET Q q 0 0 0 rg BT 85.86 431.10 Td (in ) Tj ET Q q 0 0 0 rg BT 96.08 431.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 139.61 431.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 178.70 431.10 Td (tend ) Tj ET Q q 0 0 0 rg BT 198.36 431.10 Td (to ) Tj ET Q q 0 0 0 rg BT 208.58 431.10 Td (be ) Tj ET Q q 0 0 0 rg BT 220.45 431.10 Td (more ) Tj ET Q q 0 0 0 rg BT 243.44 431.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 266.42 431.10 Td (than ) Tj ET Q q 0 0 0 rg BT 286.08 431.10 Td (in ) Tj ET Q q 0 0 0 rg BT 296.30 431.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 343.17 431.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 384.59 431.10 Td (The ) Tj ET Q q 0 0 0 rg BT 402.57 431.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 420.00 431.10 Td (of ) Tj ET Q q 0 0 0 rg BT 430.77 431.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 468.74 431.10 Td (decline ) Tj ET Q q 0 0 0 rg BT 500.05 431.10 Td (after ) Tj ET Q q 0 0 0 rg BT 520.81 431.10 Td (the ) Tj ET Q q 0 0 0 rg BT 535.46 431.10 Td (expiration ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 419.10 Td (of ) Tj ET Q q 0 0 0 rg BT 45.93 419.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 91.42 419.10 Td (has ) Tj ET Q q 0 0 0 rg BT 106.35 419.10 Td (also ) Tj ET Q q 0 0 0 rg BT 124.06 419.10 Td (historically ) Tj ET Q q 0 0 0 rg BT 170.65 419.10 Td (been ) Tj ET Q q 0 0 0 rg BT 191.13 419.10 Td (influenced ) Tj ET Q q 0 0 0 rg BT 234.93 419.10 Td (by ) Tj ET Q q 0 0 0 rg BT 246.53 419.10 Td (product ) Tj ET Q q 0 0 0 rg BT 278.68 419.10 Td (characteristics. ) Tj ET Q q 0 0 0 rg BT 339.97 419.10 Td (For ) Tj ET Q q 0 0 0 rg BT 355.46 419.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 393.44 419.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 417.26 419.10 Td (that ) Tj ET Q q 0 0 0 rg BT 433.86 419.10 Td (are ) Tj ET Q q 0 0 0 rg BT 447.67 419.10 Td (used ) Tj ET Q q 0 0 0 rg BT 467.60 419.10 Td (in ) Tj ET Q q 0 0 0 rg BT 476.98 419.10 Td (a ) Tj ET Q q 0 0 0 rg BT 483.02 419.10 Td (lar) Tj ET Q q 0 0 0 rg BT 493.38 419.10 Td (ge ) Tj ET Q q 0 0 0 rg BT 504.42 419.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 533.24 419.10 Td (population ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 407.10 Td (\(e.g., ) Tj ET Q q 0 0 0 rg BT 58.24 407.10 Td (those ) Tj ET Q q 0 0 0 rg BT 81.32 407.10 Td (prescribed ) Tj ET Q q 0 0 0 rg BT 124.93 407.10 Td (by ) Tj ET Q q 0 0 0 rg BT 136.90 407.10 Td (key ) Tj ET Q q 0 0 0 rg BT 153.31 407.10 Td (primary ) Tj ET Q q 0 0 0 rg BT 186.93 407.10 Td (care ) Tj ET Q q 0 0 0 rg BT 205.55 407.10 Td (physicians\) ) Tj ET Q q 0 0 0 rg BT 253.06 407.10 Td (tend ) Tj ET Q q 0 0 0 rg BT 272.25 407.10 Td (to ) Tj ET Q q 0 0 0 rg BT 282.00 407.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 327.27 407.10 Td (more ) Tj ET Q q 0 0 0 rg BT 349.78 407.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 372.30 407.10 Td (declines ) Tj ET Q q 0 0 0 rg BT 407.03 407.10 Td (than ) Tj ET Q q 0 0 0 rg BT 426.22 407.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 450.41 407.10 Td (in ) Tj ET Q q 0 0 0 rg BT 460.16 407.10 Td (specialized ) Tj ET Q q 0 0 0 rg BT 506.54 407.10 Td (areas ) Tj ET Q q 0 0 0 rg BT 529.05 407.10 Td (of ) Tj ET Q q 0 0 0 rg BT 539.35 407.10 Td (medicine ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 395.10 Td (\(e.g., ) Tj ET Q q 0 0 0 rg BT 58.58 395.10 Td (oncology\). ) Tj ET Q q 0 0 0 rg BT 103.94 395.10 Td (Drugs ) Tj ET Q q 0 0 0 rg BT 130.69 395.10 Td (that ) Tj ET Q q 0 0 0 rg BT 148.00 395.10 Td (are ) Tj ET Q q 0 0 0 rg BT 162.52 395.10 Td (more ) Tj ET Q q 0 0 0 rg BT 185.37 395.10 Td (complex ) Tj ET Q q 0 0 0 rg BT 222.12 395.10 Td (to ) Tj ET Q q 0 0 0 rg BT 232.21 395.10 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 284.49 395.10 Td (\(e.g., ) Tj ET Q q 0 0 0 rg BT 307.07 395.10 Td (sterile ) Tj ET Q q 0 0 0 rg BT 333.81 395.10 Td (injectable ) Tj ET Q q 0 0 0 rg BT 374.99 395.10 Td (products\) ) Tj ET Q q 0 0 0 rg BT 415.07 395.10 Td (usually ) Tj ET Q q 0 0 0 rg BT 446.27 395.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 491.88 395.10 Td (a ) Tj ET Q q 0 0 0 rg BT 498.63 395.10 Td (slower ) Tj ET Q q 0 0 0 rg BT 527.60 395.10 Td (decline ) Tj ET Q q 0 0 0 rg BT 558.79 395.10 Td (than ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 383.10 Td (those ) Tj ET Q q 0 0 0 rg BT 59.61 383.10 Td (that ) Tj ET Q q 0 0 0 rg BT 77.10 383.10 Td (are ) Tj ET Q q 0 0 0 rg BT 91.81 383.10 Td (simpler ) Tj ET Q q 0 0 0 rg BT 124.31 383.10 Td (to ) Tj ET Q q 0 0 0 rg BT 134.58 383.10 Td (manufacture.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 359.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.99 359.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 76.85 359.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 116.17 359.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 147.71 359.10 Td (the ) Tj ET Q q 0 0 0 rg BT 162.59 359.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 185.54 359.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 212.63 359.10 Td (protection ) Tj ET Q q 0 0 0 rg BT 255.83 359.10 Td (is ) Tj ET Q q 0 0 0 rg BT 265.16 359.10 Td (weak ) Tj ET Q q 0 0 0 rg BT 288.92 359.10 Td (or ) Tj ET Q q 0 0 0 rg BT 299.91 359.10 Td (nonexistent ) Tj ET Q q 0 0 0 rg BT 348.67 359.10 Td (and ) Tj ET Q q 0 0 0 rg BT 365.77 359.10 Td (we ) Tj ET Q q 0 0 0 rg BT 380.09 359.10 Td (must ) Tj ET Q q 0 0 0 rg BT 402.20 359.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 438.73 359.10 Td (with ) Tj ET Q q 0 0 0 rg BT 459.17 359.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 491.26 359.10 Td (versions ) Tj ET Q q 0 0 0 rg BT 527.25 359.10 Td (shortly ) Tj ET Q q 0 0 0 rg BT 557.68 359.10 Td (after ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 347.10 Td (we ) Tj ET Q q 0 0 0 rg BT 50.38 347.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 79.76 347.10 Td (our ) Tj ET Q q 0 0 0 rg BT 95.81 347.10 Td (innovative ) Tj ET Q q 0 0 0 rg BT 140.74 347.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 180.40 347.10 Td (In ) Tj ET Q q 0 0 0 rg BT 191.45 347.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 229.45 347.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 261.59 347.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 325.39 347.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 370.87 347.10 Td (may ) Tj ET Q q 0 0 0 rg BT 390.81 347.10 Td (introduce ) Tj ET Q q 0 0 0 rg BT 431.30 347.10 Td (a ) Tj ET Q q 0 0 0 rg BT 438.46 347.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 470.60 347.10 Td (product ) Tj ET Q q 0 0 0 rg BT 503.87 347.10 Td (before ) Tj ET Q q 0 0 0 rg BT 532.13 347.10 Td (exclusivity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 335.10 Td (has ) Tj ET Q q 0 0 0 rg BT 50.68 335.10 Td (expired, ) Tj ET Q q 0 0 0 rg BT 84.51 335.10 Td (and ) Tj ET Q q 0 0 0 rg BT 100.29 335.10 Td (before ) Tj ET Q q 0 0 0 rg BT 127.17 335.10 Td (the ) Tj ET Q q 0 0 0 rg BT 140.73 335.10 Td (resolution ) Tj ET Q q 0 0 0 rg BT 182.07 335.10 Td (of ) Tj ET Q q 0 0 0 rg BT 191.75 335.10 Td (any ) Tj ET Q q 0 0 0 rg BT 207.53 335.10 Td (related ) Tj ET Q q 0 0 0 rg BT 236.08 335.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 261.86 335.10 Td (litigation. ) Tj ET Q q 0 0 0 rg BT 301.81 335.10 Td (For ) Tj ET Q q 0 0 0 rg BT 317.05 335.10 Td (more ) Tj ET Q q 0 0 0 rg BT 338.94 335.10 Td (information ) Tj ET Q q 0 0 0 rg BT 387.50 335.10 Td (about ) Tj ET Q q 0 0 0 rg BT 411.06 335.10 Td (market ) Tj ET Q q 0 0 0 rg BT 440.17 335.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 483.40 335.10 Td (, ) Tj ET Q q 0 0 0 rg BT 487.25 335.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 507.46 335.10 Td (to ) Tj ET Q q 0 0 0 rg BT 516.58 335.10 Td (“—Intellectual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.10 Td (Property ) Tj ET Q q 0 0 0 rg BT 72.94 323.10 Td (and ) Tj ET Q q 0 0 0 rg BT 89.88 323.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 123.49 323.10 Td (Exclusivity” ) Tj ET Q q 0 0 0 rg BT 175.98 323.10 Td (above.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 299.10 Td (e ) Tj ET Q q 0 0 0 rg BT 50.52 299.10 Td (believe ) Tj ET Q q 0 0 0 rg BT 80.83 299.10 Td (our ) Tj ET Q q 0 0 0 rg BT 95.61 299.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 136.48 299.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 185.13 299.10 Td (position ) Tj ET Q q 0 0 0 rg BT 218.80 299.10 Td (depends ) Tj ET Q q 0 0 0 rg BT 253.01 299.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 274.46 299.10 Td (our ) Tj ET Q q 0 0 0 rg BT 289.23 299.10 Td (success ) Tj ET Q q 0 0 0 rg BT 320.66 299.10 Td (in ) Tj ET Q q 0 0 0 rg BT 329.88 299.10 Td (discovering ) Tj ET Q q 0 0 0 rg BT 377.98 299.10 Td (and ) Tj ET Q q 0 0 0 rg BT 393.86 299.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 439.74 299.10 Td (innovative, ) Tj ET Q q 0 0 0 rg BT 485.90 299.10 Td (cost-ef) Tj ET Q q 0 0 0 rg BT 512.92 299.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 541.57 299.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.10 Td (that ) Tj ET Q q 0 0 0 rg BT 53.45 287.10 Td (serve ) Tj ET Q q 0 0 0 rg BT 77.01 287.10 Td (unmet ) Tj ET Q q 0 0 0 rg BT 104.46 287.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 138.57 287.10 Td (needs, ) Tj ET Q q 0 0 0 rg BT 166.30 287.10 Td (together ) Tj ET Q q 0 0 0 rg BT 201.52 287.10 Td (with ) Tj ET Q q 0 0 0 rg BT 221.76 287.10 Td (our ) Tj ET Q q 0 0 0 rg BT 237.55 287.10 Td (ability ) Tj ET Q q 0 0 0 rg BT 265.56 287.10 Td (to ) Tj ET Q q 0 0 0 rg BT 275.79 287.10 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 328.22 287.10 Td (products ) Tj ET Q q 0 0 0 rg BT 365.12 287.10 Td (ef) Tj ET Q q 0 0 0 rg BT 372.71 287.10 Td (ficiently ) Tj ET Q q 0 0 0 rg BT 408.49 287.10 Td (and ) Tj ET Q q 0 0 0 rg BT 425.38 287.10 Td (to ) Tj ET Q q 0 0 0 rg BT 435.62 287.10 Td (market ) Tj ET Q q 0 0 0 rg BT 465.84 287.10 Td (them ) Tj ET Q q 0 0 0 rg BT 488.30 287.10 Td (ef) Tj ET Q q 0 0 0 rg BT 495.89 287.10 Td (fectively ) Tj ET Q q 0 0 0 rg BT 533.32 287.10 Td (in ) Tj ET Q q 0 0 0 rg BT 543.56 287.10 Td (a ) Tj ET Q q 0 0 0 rg BT 550.46 287.10 Td (highly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 85.71 275.10 Td (environment.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 251.10 Td (Pricing, Price Constraints and Market ) Tj ET Q q 0 0 0 rg BT 202.09 251.10 Td (Access) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 227.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.67 227.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 96.33 227.10 Td (are ) Tj ET Q q 0 0 0 rg BT 110.65 227.10 Td (priced ) Tj ET Q q 0 0 0 rg BT 137.75 227.10 Td (based ) Tj ET Q q 0 0 0 rg BT 162.64 227.10 Td (on ) Tj ET Q q 0 0 0 rg BT 174.75 227.10 Td (a ) Tj ET Q q 0 0 0 rg BT 181.31 227.10 Td (number ) Tj ET Q q 0 0 0 rg BT 213.97 227.10 Td (of ) Tj ET Q q 0 0 0 rg BT 224.42 227.10 Td (factors, ) Tj ET Q q 0 0 0 rg BT 256.24 227.10 Td (including ) Tj ET Q q 0 0 0 rg BT 296.13 227.10 Td (the ) Tj ET Q q 0 0 0 rg BT 310.47 227.10 Td (value ) Tj ET Q q 0 0 0 rg BT 334.24 227.10 Td (of ) Tj ET Q q 0 0 0 rg BT 344.69 227.10 Td (scientific ) Tj ET Q q 0 0 0 rg BT 383.45 227.10 Td (innovation ) Tj ET Q q 0 0 0 rg BT 428.34 227.10 Td (for ) Tj ET Q q 0 0 0 rg BT 442.12 227.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 475.34 227.10 Td (and ) Tj ET Q q 0 0 0 rg BT 491.90 227.10 Td (society ) Tj ET Q q 0 0 0 rg BT 522.34 227.10 Td (in ) Tj ET Q q 0 0 0 rg BT 532.23 227.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.57 227.10 Td (context ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.96 215.10 Td (overall ) Tj ET Q q 0 0 0 rg BT 77.35 215.10 Td (health ) Tj ET Q q 0 0 0 rg BT 104.42 215.10 Td (care ) Tj ET Q q 0 0 0 rg BT 123.69 215.10 Td (spend, ) Tj ET Q q 0 0 0 rg BT 152.15 215.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 193.65 215.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 223.49 215.10 Td (impacting ) Tj ET Q q 0 0 0 rg BT 266.11 215.10 Td (health ) Tj ET Q q 0 0 0 rg BT 293.17 215.10 Td (care ) Tj ET Q q 0 0 0 rg BT 312.45 215.10 Td (systems’) Tj ET Q q 0 0 0 rg BT 346.70 215.10 Td ( ) Tj ET Q q 0 0 0 rg BT 349.33 215.10 Td (ability ) Tj ET Q q 0 0 0 rg BT 377.51 215.10 Td (to ) Tj ET Q q 0 0 0 rg BT 387.92 215.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 421.10 215.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 469.26 215.10 Td (and ) Tj ET Q q 0 0 0 rg BT 486.33 215.10 Td (sustainable ) Tj ET Q q 0 0 0 rg BT 533.39 215.10 Td (access ) Tj ET Q q 0 0 0 rg BT 561.56 215.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 203.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.01 203.10 Td (necessity ) Tj ET Q q 0 0 0 rg BT 90.47 203.10 Td (to ) Tj ET Q q 0 0 0 rg BT 101.04 203.10 Td (sustain ) Tj ET Q q 0 0 0 rg BT 131.62 203.10 Td (our ) Tj ET Q q 0 0 0 rg BT 147.75 203.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 194.43 203.10 Td (in ) Tj ET Q q 0 0 0 rg BT 205.00 203.10 Td (innovation ) Tj ET Q q 0 0 0 rg BT 250.58 203.10 Td (platforms ) Tj ET Q q 0 0 0 rg BT 291.70 203.10 Td (to ) Tj ET Q q 0 0 0 rg BT 302.27 203.10 Td (address ) Tj ET Q q 0 0 0 rg BT 335.06 203.10 Td (serious ) Tj ET Q q 0 0 0 rg BT 366.19 203.10 Td (unmet ) Tj ET Q q 0 0 0 rg BT 393.98 203.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 428.43 203.10 Td (needs. ) Tj ET Q q 0 0 0 rg BT 456.50 203.10 Td (Central ) Tj ET Q q 0 0 0 rg BT 488.73 203.10 Td (to ) Tj ET Q q 0 0 0 rg BT 499.31 203.10 Td (price ) Tj ET Q q 0 0 0 rg BT 522.09 203.10 Td (is ) Tj ET Q q 0 0 0 rg BT 531.56 203.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.57 203.10 Td (clinical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 191.10 Td (value ) Tj ET Q q 0 0 0 rg BT 60.44 191.10 Td (that ) Tj ET Q q 0 0 0 rg BT 78.22 191.10 Td (this ) Tj ET Q q 0 0 0 rg BT 95.46 191.10 Td (innovation ) Tj ET Q q 0 0 0 rg BT 141.02 191.10 Td (brings ) Tj ET Q q 0 0 0 rg BT 168.81 191.10 Td (to ) Tj ET Q q 0 0 0 rg BT 179.37 191.10 Td (the ) Tj ET Q q 0 0 0 rg BT 194.38 191.10 Td (market, ) Tj ET Q q 0 0 0 rg BT 227.43 191.10 Td (the ) Tj ET Q q 0 0 0 rg BT 242.43 191.10 Td (current ) Tj ET Q q 0 0 0 rg BT 273.53 191.10 Td (landscape ) Tj ET Q q 0 0 0 rg BT 315.75 191.10 Td (of ) Tj ET Q q 0 0 0 rg BT 326.86 191.10 Td (alternative ) Tj ET Q q 0 0 0 rg BT 371.85 191.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 412.39 191.10 Td (options, ) Tj ET Q q 0 0 0 rg BT 447.13 191.10 Td (the ) Tj ET Q q 0 0 0 rg BT 462.13 191.10 Td (goal ) Tj ET Q q 0 0 0 rg BT 482.14 191.10 Td (of ) Tj ET Q q 0 0 0 rg BT 493.25 191.10 Td (ensuring ) Tj ET Q q 0 0 0 rg BT 530.48 191.10 Td (appropriate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 179.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 65.01 179.10 Td (access ) Tj ET Q q 0 0 0 rg BT 92.35 179.10 Td (to ) Tj ET Q q 0 0 0 rg BT 101.92 179.10 Td (this ) Tj ET Q q 0 0 0 rg BT 118.17 179.10 Td (innovation ) Tj ET Q q 0 0 0 rg BT 162.74 179.10 Td (and ) Tj ET Q q 0 0 0 rg BT 178.98 179.10 Td (sustaining ) Tj ET Q q 0 0 0 rg BT 221.33 179.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 267.01 179.10 Td (in ) Tj ET Q q 0 0 0 rg BT 276.59 179.10 Td (creative ) Tj ET Q q 0 0 0 rg BT 310.03 179.10 Td (platforms. ) Tj ET Q q 0 0 0 rg BT 352.52 179.10 Td (W) Tj ET Q q 0 0 0 rg BT 361.16 179.10 Td (e ) Tj ET Q q 0 0 0 rg BT 367.40 179.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 403.63 179.10 Td (to ) Tj ET Q q 0 0 0 rg BT 413.20 179.10 Td (explore ) Tj ET Q q 0 0 0 rg BT 444.99 179.10 Td (new ) Tj ET Q q 0 0 0 rg BT 463.45 179.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 493.57 179.10 Td (approaches ) Tj ET Q q 0 0 0 rg BT 540.34 179.10 Td (to ) Tj ET Q q 0 0 0 rg BT 549.92 179.10 Td (ensure ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 167.10 Td (that ) Tj ET Q q 0 0 0 rg BT 53.14 167.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 86.38 167.10 Td (have ) Tj ET Q q 0 0 0 rg BT 107.40 167.10 Td (access ) Tj ET Q q 0 0 0 rg BT 135.08 167.10 Td (to ) Tj ET Q q 0 0 0 rg BT 145.00 167.10 Td (our ) Tj ET Q q 0 0 0 rg BT 160.48 167.10 Td (medicines. ) Tj ET Q q 0 0 0 rg BT 205.66 167.10 Td (Enhancing ) Tj ET Q q 0 0 0 rg BT 250.57 167.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 279.92 167.10 Td (access ) Tj ET Q q 0 0 0 rg BT 307.60 167.10 Td (to ) Tj ET Q q 0 0 0 rg BT 317.52 167.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 360.21 167.10 Td (is ) Tj ET Q q 0 0 0 rg BT 369.02 167.10 Td (a ) Tj ET Q q 0 0 0 rg BT 375.60 167.10 Td (priority ) Tj ET Q q 0 0 0 rg BT 407.74 167.10 Td (for ) Tj ET Q q 0 0 0 rg BT 421.54 167.10 Td (us. ) Tj ET Q q 0 0 0 rg BT 435.25 167.10 Td (W) Tj ET Q q 0 0 0 rg BT 443.89 167.10 Td (e ) Tj ET Q q 0 0 0 rg BT 450.47 167.10 Td (are ) Tj ET Q q 0 0 0 rg BT 464.82 167.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 498.06 167.10 Td (on ) Tj ET Q q 0 0 0 rg BT 510.20 167.10 Td (of) Tj ET Q q 0 0 0 rg BT 518.35 167.10 Td (fering ) Tj ET Q q 0 0 0 rg BT 544.37 167.10 Td (creative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 155.10 Td (tiered ) Tj ET Q q 0 0 0 rg BT 60.33 155.10 Td (pricing, ) Tj ET Q q 0 0 0 rg BT 92.72 155.10 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 132.61 155.10 Td (licensing, ) Tj ET Q q 0 0 0 rg BT 172.78 155.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 234.33 155.10 Td (support ) Tj ET Q q 0 0 0 rg BT 265.90 155.10 Td (and ) Tj ET Q q 0 0 0 rg BT 281.90 155.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 310.68 155.10 Td (assistance ) Tj ET Q q 0 0 0 rg BT 352.23 155.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 391.57 155.10 Td (to ) Tj ET Q q 0 0 0 rg BT 400.91 155.10 Td (optimize ) Tj ET Q q 0 0 0 rg BT 437.47 155.10 Td (access ) Tj ET Q q 0 0 0 rg BT 464.57 155.10 Td (while ) Tj ET Q q 0 0 0 rg BT 488.35 155.10 Td (protecting ) Tj ET Q q 0 0 0 rg BT 530.46 155.10 Td (innovation; ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 143.10 Td (advocating ) Tj ET Q q 0 0 0 rg BT 84.45 143.10 Td (for ) Tj ET Q q 0 0 0 rg BT 100.69 143.10 Td (sustainable ) Tj ET Q q 0 0 0 rg BT 149.70 143.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 195.36 143.10 Td (policies ) Tj ET Q q 0 0 0 rg BT 231.05 143.10 Td (and ) Tj ET Q q 0 0 0 rg BT 250.06 143.10 Td (infrastructure, ) Tj ET Q q 0 0 0 rg BT 311.01 143.10 Td (leveraging ) Tj ET Q q 0 0 0 rg BT 357.79 143.10 Td (advocacy/payer) Tj ET Q q 0 0 0 rg BT 420.90 143.10 Td (’) Tj ET Q q 0 0 0 rg BT 423.68 143.10 Td (s ) Tj ET Q q 0 0 0 rg BT 432.15 143.10 Td (input ) Tj ET Q q 0 0 0 rg BT 457.28 143.10 Td (and ) Tj ET Q q 0 0 0 rg BT 476.30 143.10 Td (utilizing ) Tj ET Q q 0 0 0 rg BT 514.21 143.10 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 567.67 143.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 131.10 Td (appropriate; ) Tj ET Q q 0 0 0 rg BT 85.94 131.10 Td (and ) Tj ET Q q 0 0 0 rg BT 102.00 131.10 Td (improving ) Tj ET Q q 0 0 0 rg BT 145.29 131.10 Td (access ) Tj ET Q q 0 0 0 rg BT 172.46 131.10 Td (to ) Tj ET Q q 0 0 0 rg BT 181.86 131.10 Td (care ) Tj ET Q q 0 0 0 rg BT 200.13 131.10 Td (and ) Tj ET Q q 0 0 0 rg BT 216.20 131.10 Td (supportive ) Tj ET Q q 0 0 0 rg BT 260.04 131.10 Td (services ) Tj ET Q q 0 0 0 rg BT 293.87 131.10 Td (for ) Tj ET Q q 0 0 0 rg BT 307.16 131.10 Td (vulnerable ) Tj ET Q q 0 0 0 rg BT 350.99 131.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 383.71 131.10 Td (through ) Tj ET Q q 0 0 0 rg BT 416.45 131.10 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 466.95 131.10 Td (and ) Tj ET Q q 0 0 0 rg BT 483.02 131.10 Td (demonstration ) Tj ET Q q 0 0 0 rg BT 541.85 131.10 Td (projects.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 107.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.03 107.10 Td (growth ) Tj ET Q q 0 0 0 rg BT 84.84 107.10 Td (of ) Tj ET Q q 0 0 0 rg BT 95.66 107.10 Td (MCOs ) Tj ET Q q 0 0 0 rg BT 124.81 107.10 Td (in ) Tj ET Q q 0 0 0 rg BT 135.07 107.10 Td (the ) Tj ET Q q 0 0 0 rg BT 149.77 107.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 170.04 107.10 Td (is ) Tj ET Q q 0 0 0 rg BT 179.19 107.10 Td (also ) Tj ET Q q 0 0 0 rg BT 197.78 107.10 Td (a ) Tj ET Q q 0 0 0 rg BT 204.71 107.10 Td (major ) Tj ET Q q 0 0 0 rg BT 230.51 107.10 Td (factor ) Tj ET Q q 0 0 0 rg BT 256.31 107.10 Td (in ) Tj ET Q q 0 0 0 rg BT 266.57 107.10 Td (the ) Tj ET Q q 0 0 0 rg BT 281.27 107.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 324.84 107.10 Td (marketplace. ) Tj ET Q q 0 0 0 rg BT 378.68 107.10 Td (Over ) Tj ET Q q 0 0 0 rg BT 401.15 107.10 Td (half ) Tj ET Q q 0 0 0 rg BT 419.18 107.10 Td (of ) Tj ET Q q 0 0 0 rg BT 429.99 107.10 Td (the ) Tj ET Q q 0 0 0 rg BT 444.69 107.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 464.96 107.10 Td (population ) Tj ET Q q 0 0 0 rg BT 510.21 107.10 Td (now ) Tj ET Q q 0 0 0 rg BT 529.92 107.10 Td (participates ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 95.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.85 95.10 Td (some ) Tj ET Q q 0 0 0 rg BT 71.02 95.10 Td (version ) Tj ET Q q 0 0 0 rg BT 103.53 95.10 Td (of ) Tj ET Q q 0 0 0 rg BT 114.93 95.10 Td (managed ) Tj ET Q q 0 0 0 rg BT 154.09 95.10 Td (care. ) Tj ET Q q 0 0 0 rg BT 176.31 95.10 Td (MCOs ) Tj ET Q q 0 0 0 rg BT 206.05 95.10 Td (can ) Tj ET Q q 0 0 0 rg BT 223.00 95.10 Td (include ) Tj ET Q q 0 0 0 rg BT 255.50 95.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 290.22 95.10 Td (insurance ) Tj ET Q q 0 0 0 rg BT 331.60 95.10 Td (companies, ) Tj ET Q q 0 0 0 rg BT 379.94 95.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 414.65 95.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 434.94 95.10 Td (administrators, ) Tj ET Q q 0 0 0 rg BT 497.72 95.10 Td (health-maintenance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 83.10 Td (or) Tj ET Q q 0 0 0 rg BT 44.15 83.10 Td (ganizations, ) Tj ET Q q 0 0 0 rg BT 94.93 83.10 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 135.42 83.10 Td (Part ) Tj ET Q q 0 0 0 rg BT 154.26 83.10 Td (D ) Tj ET Q q 0 0 0 rg BT 164.22 83.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 214.72 83.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 235.78 83.10 Td (plans, ) Tj ET Q q 0 0 0 rg BT 262.13 83.10 Td (alliances ) Tj ET Q q 0 0 0 rg BT 299.84 83.10 Td (of ) Tj ET Q q 0 0 0 rg BT 310.91 83.10 Td (hospitals ) Tj ET Q q 0 0 0 rg BT 349.20 83.10 Td (and ) Tj ET Q q 0 0 0 rg BT 366.38 83.10 Td (physicians ) Tj ET Q q 0 0 0 rg BT 411.33 83.10 Td (and ) Tj ET Q q 0 0 0 rg BT 428.50 83.10 Td (other ) Tj ET Q q 0 0 0 rg BT 451.79 83.10 Td (physician ) Tj ET Q q 0 0 0 rg BT 492.85 83.10 Td (or) Tj ET Q q 0 0 0 rg BT 501.00 83.10 Td (ganizations. ) Tj ET Q q 0 0 0 rg BT 551.58 83.10 Td (Those ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 71.10 Td (or) Tj ET Q q 0 0 0 rg BT 44.15 71.10 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 92.19 71.10 Td (have ) Tj ET Q q 0 0 0 rg BT 113.57 71.10 Td (been ) Tj ET Q q 0 0 0 rg BT 134.95 71.10 Td (consolidating ) Tj ET Q q 0 0 0 rg BT 191.33 71.10 Td (into ) Tj ET Q q 0 0 0 rg BT 209.38 71.10 Td (fewer) Tj ET Q q 0 0 0 rg BT 231.74 71.10 Td (, ) Tj ET Q q 0 0 0 rg BT 236.74 71.10 Td (lar) Tj ET Q q 0 0 0 rg BT 247.11 71.10 Td (ger ) Tj ET Q q 0 0 0 rg BT 262.38 71.10 Td (entities, ) Tj ET Q q 0 0 0 rg BT 296.26 71.10 Td (thus ) Tj ET Q q 0 0 0 rg BT 315.43 71.10 Td (enhancing ) Tj ET Q q 0 0 0 rg BT 359.02 71.10 Td (their ) Tj ET Q q 0 0 0 rg BT 379.85 71.10 Td (purchasing ) Tj ET Q q 0 0 0 rg BT 426.22 71.10 Td (strength ) Tj ET Q q 0 0 0 rg BT 460.94 71.10 Td (and ) Tj ET Q q 0 0 0 rg BT 477.88 71.10 Td (importance ) Tj ET Q q 0 0 0 rg BT 525.36 71.10 Td (to ) Tj ET Q q 0 0 0 rg BT 535.64 71.10 Td (us.) Tj ET Q endstream endobj 29 0 obj <> endobj 30 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 749.10 Td (o ) Tj ET Q q 0 0 0 rg BT 48.86 749.10 Td (successfully ) Tj ET Q q 0 0 0 rg BT 100.19 749.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 136.52 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 150.63 749.10 Td (business ) Tj ET Q q 0 0 0 rg BT 186.97 749.10 Td (with ) Tj ET Q q 0 0 0 rg BT 207.21 749.10 Td (MCOs, ) Tj ET Q q 0 0 0 rg BT 238.83 749.10 Td (we ) Tj ET Q q 0 0 0 rg BT 252.95 749.10 Td (must ) Tj ET Q q 0 0 0 rg BT 274.85 749.10 Td (often ) Tj ET Q q 0 0 0 rg BT 297.85 749.10 Td (demonstrate ) Tj ET Q q 0 0 0 rg BT 349.17 749.10 Td (that ) Tj ET Q q 0 0 0 rg BT 366.62 749.10 Td (our ) Tj ET Q q 0 0 0 rg BT 382.40 749.10 Td (products ) Tj ET Q q 0 0 0 rg BT 419.29 749.10 Td (of) Tj ET Q q 0 0 0 rg BT 427.44 749.10 Td (fer ) Tj ET Q q 0 0 0 rg BT 440.99 749.10 Td (not ) Tj ET Q q 0 0 0 rg BT 456.22 749.10 Td (only ) Tj ET Q q 0 0 0 rg BT 476.45 749.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 510.56 749.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 544.67 749.10 Td (but ) Tj ET Q q 0 0 0 rg BT 559.90 749.10 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 54.41 737.10 Td (advantages ) Tj ET Q q 0 0 0 rg BT 101.13 737.10 Td (as ) Tj ET Q q 0 0 0 rg BT 111.75 737.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 153.48 737.10 Td (with ) Tj ET Q q 0 0 0 rg BT 173.55 737.10 Td (other ) Tj ET Q q 0 0 0 rg BT 196.40 737.10 Td (forms ) Tj ET Q q 0 0 0 rg BT 222.02 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 232.65 737.10 Td (care. ) Tj ET Q q 0 0 0 rg BT 254.09 737.10 Td (Most ) Tj ET Q q 0 0 0 rg BT 276.95 737.10 Td (new ) Tj ET Q q 0 0 0 rg BT 295.91 737.10 Td (products ) Tj ET Q q 0 0 0 rg BT 332.65 737.10 Td (that ) Tj ET Q q 0 0 0 rg BT 349.94 737.10 Td (we ) Tj ET Q q 0 0 0 rg BT 363.90 737.10 Td (introduce ) Tj ET Q q 0 0 0 rg BT 403.96 737.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 440.13 737.10 Td (with ) Tj ET Q q 0 0 0 rg BT 460.20 737.10 Td (other ) Tj ET Q q 0 0 0 rg BT 483.05 737.10 Td (products ) Tj ET Q q 0 0 0 rg BT 519.78 737.10 Td (already ) Tj ET Q q 0 0 0 rg BT 551.50 737.10 Td (on ) Tj ET Q q 0 0 0 rg BT 563.80 737.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (market ) Tj ET Q q 0 0 0 rg BT 66.32 725.10 Td (or ) Tj ET Q q 0 0 0 rg BT 77.20 725.10 Td (products ) Tj ET Q q 0 0 0 rg BT 114.19 725.10 Td (that ) Tj ET Q q 0 0 0 rg BT 131.74 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 146.50 725.10 Td (later ) Tj ET Q q 0 0 0 rg BT 166.82 725.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 210.47 725.10 Td (by ) Tj ET Q q 0 0 0 rg BT 223.02 725.10 Td (competitors. ) Tj ET Q q 0 0 0 rg BT 274.72 725.10 Td (As ) Tj ET Q q 0 0 0 rg BT 288.39 725.10 Td (noted ) Tj ET Q q 0 0 0 rg BT 313.16 725.10 Td (above, ) Tj ET Q q 0 0 0 rg BT 342.09 725.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 374.07 725.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 398.84 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 413.61 725.10 Td (exempt ) Tj ET Q q 0 0 0 rg BT 445.59 725.10 Td (from ) Tj ET Q q 0 0 0 rg BT 467.58 725.10 Td (costly ) Tj ET Q q 0 0 0 rg BT 494.03 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 511.02 725.10 Td (time-consuming ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 68.63 713.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 91.82 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 102.80 713.10 Td (demonstrate ) Tj ET Q q 0 0 0 rg BT 154.87 713.10 Td (their ) Tj ET Q q 0 0 0 rg BT 176.39 713.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 203.47 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 221.10 713.10 Td (ef) Tj ET Q q 0 0 0 rg BT 228.69 713.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 256.31 713.10 Td (and, ) Tj ET Q q 0 0 0 rg BT 276.45 713.10 Td (as ) Tj ET Q q 0 0 0 rg BT 287.98 713.10 Td (such, ) Tj ET Q q 0 0 0 rg BT 312.01 713.10 Td (often ) Tj ET Q q 0 0 0 rg BT 335.75 713.10 Td (have ) Tj ET Q q 0 0 0 rg BT 357.83 713.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 383.79 713.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 406.99 713.10 Td (than ) Tj ET Q q 0 0 0 rg BT 427.41 713.10 Td (brand-name ) Tj ET Q q 0 0 0 rg BT 478.36 713.10 Td (drugs. ) Tj ET Q q 0 0 0 rg BT 506.28 713.10 Td (MCOs ) Tj ET Q q 0 0 0 rg BT 536.15 713.10 Td (that ) Tj ET Q q 0 0 0 rg BT 554.34 713.10 Td (focus ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 75.80 701.10 Td (on ) Tj ET Q q 0 0 0 rg BT 88.39 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 103.19 701.10 Td (immediate ) Tj ET Q q 0 0 0 rg BT 147.99 701.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 166.68 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 177.60 701.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 202.41 701.10 Td (often ) Tj ET Q q 0 0 0 rg BT 225.55 701.10 Td (favor ) Tj ET Q q 0 0 0 rg BT 249.23 701.10 Td (generics ) Tj ET Q q 0 0 0 rg BT 285.14 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 299.38 701.10 Td (this ) Tj ET Q q 0 0 0 rg BT 316.42 701.10 Td (reason. ) Tj ET Q q 0 0 0 rg BT 347.61 701.10 Td (Many ) Tj ET Q q 0 0 0 rg BT 373.52 701.10 Td (governments ) Tj ET Q q 0 0 0 rg BT 427.77 701.10 Td (also ) Tj ET Q q 0 0 0 rg BT 446.46 701.10 Td (encourage ) Tj ET Q q 0 0 0 rg BT 490.14 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 504.94 701.10 Td (use ) Tj ET Q q 0 0 0 rg BT 520.86 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 531.78 701.10 Td (generics ) Tj ET Q q 0 0 0 rg BT 567.68 701.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (alternatives ) Tj ET Q q 0 0 0 rg BT 84.40 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 94.49 689.10 Td (brand-name ) Tj ET Q q 0 0 0 rg BT 144.55 689.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 169.08 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 179.17 689.10 Td (their ) Tj ET Q q 0 0 0 rg BT 199.80 689.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 243.19 689.10 Td (programs. ) Tj ET Q q 0 0 0 rg BT 285.77 689.10 Td (Laws ) Tj ET Q q 0 0 0 rg BT 309.74 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 319.83 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 334.35 689.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 354.45 689.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 393.96 689.10 Td (allow) Tj ET Q q 0 0 0 rg BT 415.53 689.10 Td (, ) Tj ET Q q 0 0 0 rg BT 420.34 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 437.08 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 447.17 689.10 Td (many ) Tj ET Q q 0 0 0 rg BT 471.70 689.10 Td (cases ) Tj ET Q q 0 0 0 rg BT 495.11 689.10 Td (require, ) Tj ET Q q 0 0 0 rg BT 528.23 689.10 Td (pharmacists ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.83 677.10 Td (substitute ) Tj ET Q q 0 0 0 rg BT 88.21 677.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 120.68 677.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 145.95 677.10 Td (that ) Tj ET Q q 0 0 0 rg BT 164.00 677.10 Td (have ) Tj ET Q q 0 0 0 rg BT 185.92 677.10 Td (been ) Tj ET Q q 0 0 0 rg BT 207.85 677.10 Td (rated ) Tj ET Q q 0 0 0 rg BT 230.88 677.10 Td (under ) Tj ET Q q 0 0 0 rg BT 256.70 677.10 Td (government ) Tj ET Q q 0 0 0 rg BT 307.51 677.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 354.42 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 365.25 677.10 Td (be ) Tj ET Q q 0 0 0 rg BT 377.74 677.10 Td (essentially ) Tj ET Q q 0 0 0 rg BT 423.00 677.10 Td (equivalent ) Tj ET Q q 0 0 0 rg BT 467.70 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 478.52 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 486.01 677.10 Td (brand-name ) Tj ET Q q 0 0 0 rg BT 536.81 677.10 Td (drug. ) Tj ET Q q 0 0 0 rg BT 560.47 677.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (substitution ) Tj ET Q q 0 0 0 rg BT 85.17 665.10 Td (must ) Tj ET Q q 0 0 0 rg BT 107.12 665.10 Td (be ) Tj ET Q q 0 0 0 rg BT 119.06 665.10 Td (made ) Tj ET Q q 0 0 0 rg BT 143.22 665.10 Td (unless ) Tj ET Q q 0 0 0 rg BT 170.72 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 185.43 665.10 Td (prescribing ) Tj ET Q q 0 0 0 rg BT 232.92 665.10 Td (physician ) Tj ET Q q 0 0 0 rg BT 273.74 665.10 Td (expressly ) Tj ET Q q 0 0 0 rg BT 314.01 665.10 Td (forbids ) Tj ET Q q 0 0 0 rg BT 344.84 665.10 Td (it.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (Exclusion ) Tj ET Q q 0 0 0 rg BT 77.40 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 87.13 641.10 Td (a ) Tj ET Q q 0 0 0 rg BT 92.97 641.10 Td (product ) Tj ET Q q 0 0 0 rg BT 124.92 641.10 Td (from ) Tj ET Q q 0 0 0 rg BT 145.76 641.10 Td (a ) Tj ET Q q 0 0 0 rg BT 151.60 641.10 Td (formulary ) Tj ET Q q 0 0 0 rg BT 192.98 641.10 Td (can ) Tj ET Q q 0 0 0 rg BT 208.26 641.10 Td (lead ) Tj ET Q q 0 0 0 rg BT 226.32 641.10 Td (to ) Tj ET Q q 0 0 0 rg BT 235.50 641.10 Td (its ) Tj ET Q q 0 0 0 rg BT 246.35 641.10 Td (sharply ) Tj ET Q q 0 0 0 rg BT 277.19 641.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 310.23 641.10 Td (usage ) Tj ET Q q 0 0 0 rg BT 334.40 641.10 Td (in ) Tj ET Q q 0 0 0 rg BT 343.58 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 357.20 641.10 Td (MCO ) Tj ET Q q 0 0 0 rg BT 381.39 641.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 410.00 641.10 Td (population. ) Tj ET Q q 0 0 0 rg BT 456.67 641.10 Td (Consequently) Tj ET Q q 0 0 0 rg BT 511.02 641.10 Td (, ) Tj ET Q q 0 0 0 rg BT 514.92 641.10 Td (pharmaceutical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 81.29 629.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 117.68 629.10 Td (aggressively ) Tj ET Q q 0 0 0 rg BT 170.19 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 180.49 629.10 Td (have ) Tj ET Q q 0 0 0 rg BT 201.89 629.10 Td (their ) Tj ET Q q 0 0 0 rg BT 222.73 629.10 Td (products ) Tj ET Q q 0 0 0 rg BT 259.69 629.10 Td (included. ) Tj ET Q q 0 0 0 rg BT 298.97 629.10 Td (Where ) Tj ET Q q 0 0 0 rg BT 328.13 629.10 Td (possible, ) Tj ET Q q 0 0 0 rg BT 365.94 629.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 411.22 629.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 447.61 629.10 Td (for ) Tj ET Q q 0 0 0 rg BT 461.80 629.10 Td (inclusion ) Tj ET Q q 0 0 0 rg BT 500.98 629.10 Td (based ) Tj ET Q q 0 0 0 rg BT 526.27 629.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 548.80 629.10 Td (unique ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (features ) Tj ET Q q 0 0 0 rg BT 70.05 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 80.78 617.10 Td (their ) Tj ET Q q 0 0 0 rg BT 101.50 617.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 140.84 617.10 Td (such ) Tj ET Q q 0 0 0 rg BT 161.57 617.10 Td (as ) Tj ET Q q 0 0 0 rg BT 172.30 617.10 Td (greater ) Tj ET Q q 0 0 0 rg BT 202.45 617.10 Td (ef) Tj ET Q q 0 0 0 rg BT 210.04 617.10 Td (ficacy) Tj ET Q q 0 0 0 rg BT 233.81 617.10 Td (, ) Tj ET Q q 0 0 0 rg BT 238.71 617.10 Td (better ) Tj ET Q q 0 0 0 rg BT 263.88 617.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 293.49 617.10 Td (ease ) Tj ET Q q 0 0 0 rg BT 313.10 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 323.83 617.10 Td (use ) Tj ET Q q 0 0 0 rg BT 339.56 617.10 Td (or ) Tj ET Q q 0 0 0 rg BT 350.29 617.10 Td (fewer ) Tj ET Q q 0 0 0 rg BT 375.45 617.10 Td (side ) Tj ET Q q 0 0 0 rg BT 393.95 617.10 Td (ef) Tj ET Q q 0 0 0 rg BT 401.54 617.10 Td (fects. ) Tj ET Q q 0 0 0 rg BT 424.79 617.10 Td (A) Tj ET Q q 0 0 0 rg BT 431.46 617.10 Td ( ) Tj ET Q q 0 0 0 rg BT 433.86 617.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 459.03 617.10 Td (overall ) Tj ET Q q 0 0 0 rg BT 489.19 617.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 507.70 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 518.43 617.10 Td (therapy ) Tj ET Q q 0 0 0 rg BT 550.81 617.10 Td (is ) Tj ET Q q 0 0 0 rg BT 559.88 617.10 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (an ) Tj ET Q q 0 0 0 rg BT 48.32 605.10 Td (important ) Tj ET Q q 0 0 0 rg BT 90.08 605.10 Td (factor) Tj ET Q q 0 0 0 rg BT 112.85 605.10 Td (. ) Tj ET Q q 0 0 0 rg BT 118.23 605.10 Td (Products ) Tj ET Q q 0 0 0 rg BT 156.11 605.10 Td (that ) Tj ET Q q 0 0 0 rg BT 173.98 605.10 Td (demonstrate ) Tj ET Q q 0 0 0 rg BT 225.74 605.10 Td (fewer ) Tj ET Q q 0 0 0 rg BT 251.38 605.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 298.68 605.10 Td (advantages ) Tj ET Q q 0 0 0 rg BT 345.98 605.10 Td (must ) Tj ET Q q 0 0 0 rg BT 368.31 605.10 Td (compete ) Tj ET Q q 0 0 0 rg BT 405.06 605.10 Td (for ) Tj ET Q q 0 0 0 rg BT 419.60 605.10 Td (inclusion ) Tj ET Q q 0 0 0 rg BT 459.15 605.10 Td (based ) Tj ET Q q 0 0 0 rg BT 484.80 605.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 524.89 605.10 Td (on ) Tj ET Q q 0 0 0 rg BT 537.77 605.10 Td (price. ) Tj ET Q q 0 0 0 rg BT 562.93 605.10 Td (W) Tj ET Q q 0 0 0 rg BT 571.57 605.10 Td (e ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (have ) Tj ET Q q 0 0 0 rg BT 57.38 593.10 Td (been ) Tj ET Q q 0 0 0 rg BT 78.75 593.10 Td (generally) Tj ET Q q 0 0 0 rg BT 115.31 593.10 Td (, ) Tj ET Q q 0 0 0 rg BT 120.31 593.10 Td (although ) Tj ET Q q 0 0 0 rg BT 157.80 593.10 Td (not ) Tj ET Q q 0 0 0 rg BT 173.08 593.10 Td (universally) Tj ET Q q 0 0 0 rg BT 216.86 593.10 Td (, ) Tj ET Q q 0 0 0 rg BT 221.86 593.10 Td (successful ) Tj ET Q q 0 0 0 rg BT 265.46 593.10 Td (in ) Tj ET Q q 0 0 0 rg BT 275.74 593.10 Td (having ) Tj ET Q q 0 0 0 rg BT 305.46 593.10 Td (our ) Tj ET Q q 0 0 0 rg BT 321.29 593.10 Td (major ) Tj ET Q q 0 0 0 rg BT 347.11 593.10 Td (products ) Tj ET Q q 0 0 0 rg BT 384.05 593.10 Td (included ) Tj ET Q q 0 0 0 rg BT 420.99 593.10 Td (on ) Tj ET Q q 0 0 0 rg BT 433.49 593.10 Td (MCO ) Tj ET Q q 0 0 0 rg BT 458.77 593.10 Td (formularies.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.37 569.10 Td (many ) Tj ET Q q 0 0 0 rg BT 70.62 569.10 Td (markets ) Tj ET Q q 0 0 0 rg BT 104.31 569.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 135.23 569.10 Td (the ) Tj ET Q q 0 0 0 rg BT 149.49 569.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 171.81 569.10 Td (we ) Tj ET Q q 0 0 0 rg BT 185.50 569.10 Td (operate ) Tj ET Q q 0 0 0 rg BT 216.96 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 226.78 569.10 Td (an ) Tj ET Q q 0 0 0 rg BT 238.25 569.10 Td (environment ) Tj ET Q q 0 0 0 rg BT 290.83 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 301.20 569.10 Td (government-mandated, ) Tj ET Q q 0 0 0 rg BT 395.70 569.10 Td (cost-containment ) Tj ET Q q 0 0 0 rg BT 466.60 569.10 Td (programs. ) Tj ET Q q 0 0 0 rg BT 508.91 569.10 Td (In ) Tj ET Q q 0 0 0 rg BT 519.27 569.10 Td (these ) Tj ET Q q 0 0 0 rg BT 541.85 569.10 Td (markets, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (a ) Tj ET Q q 0 0 0 rg BT 42.77 557.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 87.31 557.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 118.53 557.10 Td (of ) Tj ET Q q 0 0 0 rg BT 129.19 557.10 Td (funding ) Tj ET Q q 0 0 0 rg BT 162.63 557.10 Td (for ) Tj ET Q q 0 0 0 rg BT 176.63 557.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 220.04 557.10 Td (services ) Tj ET Q q 0 0 0 rg BT 254.57 557.10 Td (and ) Tj ET Q q 0 0 0 rg BT 271.34 557.10 Td (the ) Tj ET Q q 0 0 0 rg BT 285.89 557.10 Td (determination ) Tj ET Q q 0 0 0 rg BT 343.76 557.10 Td (of ) Tj ET Q q 0 0 0 rg BT 354.42 557.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 385.08 557.10 Td (and ) Tj ET Q q 0 0 0 rg BT 401.85 557.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 464.16 557.10 Td (for ) Tj ET Q q 0 0 0 rg BT 478.15 557.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 541.56 557.10 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (is ) Tj ET Q q 0 0 0 rg BT 44.58 545.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 74.82 545.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.51 545.10 Td (government ) Tj ET Q q 0 0 0 rg BT 134.18 545.10 Td (control. ) Tj ET Q q 0 0 0 rg BT 166.49 545.10 Td (As ) Tj ET Q q 0 0 0 rg BT 179.52 545.10 Td (a ) Tj ET Q q 0 0 0 rg BT 185.87 545.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 212.49 545.10 Td (our ) Tj ET Q q 0 0 0 rg BT 227.73 545.10 Td (products ) Tj ET Q q 0 0 0 rg BT 264.08 545.10 Td (may ) Tj ET Q q 0 0 0 rg BT 283.21 545.10 Td (face ) Tj ET Q q 0 0 0 rg BT 301.77 545.10 Td (restricted ) Tj ET Q q 0 0 0 rg BT 340.88 545.10 Td (access ) Tj ET Q q 0 0 0 rg BT 368.33 545.10 Td (by ) Tj ET Q q 0 0 0 rg BT 380.24 545.10 Td (both ) Tj ET Q q 0 0 0 rg BT 399.93 545.10 Td (public ) Tj ET Q q 0 0 0 rg BT 426.83 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 443.18 545.10 Td (private ) Tj ET Q q 0 0 0 rg BT 472.86 545.10 Td (payers ) Tj ET Q q 0 0 0 rg BT 500.87 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 517.22 545.10 Td (may ) Tj ET Q q 0 0 0 rg BT 536.34 545.10 Td (be ) Tj ET Q q 0 0 0 rg BT 547.69 545.10 Td (subject ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.75 533.10 Td (assessments ) Tj ET Q q 0 0 0 rg BT 98.05 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 109.34 533.10 Td (comparative ) Tj ET Q q 0 0 0 rg BT 161.73 533.10 Td (value ) Tj ET Q q 0 0 0 rg BT 186.36 533.10 Td (and ) Tj ET Q q 0 0 0 rg BT 203.76 533.10 Td (ef) Tj ET Q q 0 0 0 rg BT 211.35 533.10 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 258.74 533.10 Td (against ) Tj ET Q q 0 0 0 rg BT 290.04 533.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 340.21 533.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 380.12 533.10 Td (Several ) Tj ET Q q 0 0 0 rg BT 413.08 533.10 Td (governments ) Tj ET Q q 0 0 0 rg BT 467.70 533.10 Td (have ) Tj ET Q q 0 0 0 rg BT 489.54 533.10 Td (placed ) Tj ET Q q 0 0 0 rg BT 518.61 533.10 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 566.01 533.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (physician ) Tj ET Q q 0 0 0 rg BT 76.43 521.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 126.30 521.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 151.73 521.10 Td (and ) Tj ET Q q 0 0 0 rg BT 168.28 521.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 197.60 521.10 Td (reimbursements, ) Tj ET Q q 0 0 0 rg BT 266.08 521.10 Td (emphasized ) Tj ET Q q 0 0 0 rg BT 315.39 521.10 Td (greater ) Tj ET Q q 0 0 0 rg BT 345.25 521.10 Td (use ) Tj ET Q q 0 0 0 rg BT 360.69 521.10 Td (of ) Tj ET Q q 0 0 0 rg BT 371.12 521.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 402.65 521.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 426.98 521.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 454.64 521.10 Td (enacted ) Tj ET Q q 0 0 0 rg BT 487.27 521.10 Td (across-the-board ) Tj ET Q q 0 0 0 rg BT 556.02 521.10 Td (price ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.10 Td (cuts ) Tj ET Q q 0 0 0 rg BT 54.81 509.10 Td (as ) Tj ET Q q 0 0 0 rg BT 65.83 509.10 Td (methods ) Tj ET Q q 0 0 0 rg BT 102.42 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 113.44 509.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 132.25 509.10 Td (control. ) Tj ET Q q 0 0 0 rg BT 165.77 509.10 Td (In ) Tj ET Q q 0 0 0 rg BT 176.80 509.10 Td (most ) Tj ET Q q 0 0 0 rg BT 198.94 509.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 214.97 509.10 Td (countries, ) Tj ET Q q 0 0 0 rg BT 256.82 509.10 Td (for ) Tj ET Q q 0 0 0 rg BT 271.18 509.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 310.25 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 325.16 509.10 Td (government ) Tj ET Q q 0 0 0 rg BT 375.62 509.10 Td (regulates ) Tj ET Q q 0 0 0 rg BT 414.41 509.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 445.43 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 456.46 509.10 Td (a ) Tj ET Q q 0 0 0 rg BT 463.59 509.10 Td (new ) Tj ET Q q 0 0 0 rg BT 482.95 509.10 Td (product ) Tj ET Q q 0 0 0 rg BT 516.20 509.10 Td (at ) Tj ET Q q 0 0 0 rg BT 526.11 509.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 555.46 509.10 Td (often ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (through ) Tj ET Q q 0 0 0 rg BT 70.52 497.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 96.70 497.10 Td (price ) Tj ET Q q 0 0 0 rg BT 120.10 497.10 Td (controls, ) Tj ET Q q 0 0 0 rg BT 158.23 497.10 Td (international ) Tj ET Q q 0 0 0 rg BT 212.18 497.10 Td (price ) Tj ET Q q 0 0 0 rg BT 235.58 497.10 Td (comparisons, ) Tj ET Q q 0 0 0 rg BT 292.05 497.10 Td (controlling ) Tj ET Q q 0 0 0 rg BT 339.34 497.10 Td (profits ) Tj ET Q q 0 0 0 rg BT 368.86 497.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 397.83 497.10 Td (reference ) Tj ET Q q 0 0 0 rg BT 438.42 497.10 Td (pricing. ) Tj ET Q q 0 0 0 rg BT 472.66 497.10 Td (In ) Tj ET Q q 0 0 0 rg BT 484.41 497.10 Td (other ) Tj ET Q q 0 0 0 rg BT 508.37 497.10 Td (markets, ) Tj ET Q q 0 0 0 rg BT 545.94 497.10 Td (such ) Tj ET Q q 0 0 0 rg BT 567.68 497.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.10 Td (Germany) Tj ET Q q 0 0 0 rg BT 72.56 485.10 Td (, ) Tj ET Q q 0 0 0 rg BT 77.68 485.10 Td (the ) Tj ET Q q 0 0 0 rg BT 92.51 485.10 Td (government ) Tj ET Q q 0 0 0 rg BT 142.90 485.10 Td (does ) Tj ET Q q 0 0 0 rg BT 163.85 485.10 Td (not ) Tj ET Q q 0 0 0 rg BT 179.24 485.10 Td (set ) Tj ET Q q 0 0 0 rg BT 192.97 485.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 223.92 485.10 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 270.97 485.10 Td (at ) Tj ET Q q 0 0 0 rg BT 280.81 485.10 Td (launch, ) Tj ET Q q 0 0 0 rg BT 312.58 485.10 Td (but ) Tj ET Q q 0 0 0 rg BT 327.98 485.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 358.92 485.10 Td (freedom ) Tj ET Q q 0 0 0 rg BT 394.86 485.10 Td (is ) Tj ET Q q 0 0 0 rg BT 404.15 485.10 Td (subsequently ) Tj ET Q q 0 0 0 rg BT 458.99 485.10 Td (limited. ) Tj ET Q q 0 0 0 rg BT 492.44 485.10 Td (Companies ) Tj ET Q q 0 0 0 rg BT 540.05 485.10 Td (may ) Tj ET Q q 0 0 0 rg BT 559.89 485.10 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (face ) Tj ET Q q 0 0 0 rg BT 55.21 473.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 99.98 473.10 Td (delays ) Tj ET Q q 0 0 0 rg BT 128.08 473.10 Td (in ) Tj ET Q q 0 0 0 rg BT 138.42 473.10 Td (market ) Tj ET Q q 0 0 0 rg BT 168.75 473.10 Td (access ) Tj ET Q q 0 0 0 rg BT 196.84 473.10 Td (for ) Tj ET Q q 0 0 0 rg BT 211.06 473.10 Td (new ) Tj ET Q q 0 0 0 rg BT 230.28 473.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 269.78 473.10 Td (mainly ) Tj ET Q q 0 0 0 rg BT 300.12 473.10 Td (in ) Tj ET Q q 0 0 0 rg BT 310.45 473.10 Td (France, ) Tj ET Q q 0 0 0 rg BT 342.72 473.10 Td (Spain, ) Tj ET Q q 0 0 0 rg BT 370.56 473.10 Td (Italy ) Tj ET Q q 0 0 0 rg BT 391.45 473.10 Td (and ) Tj ET Q q 0 0 0 rg BT 408.44 473.10 Td (Belgium, ) Tj ET Q q 0 0 0 rg BT 447.95 473.10 Td (and ) Tj ET Q q 0 0 0 rg BT 464.95 473.10 Td (more ) Tj ET Q q 0 0 0 rg BT 488.05 473.10 Td (than ) Tj ET Q q 0 0 0 rg BT 507.83 473.10 Td (a ) Tj ET Q q 0 0 0 rg BT 514.83 473.10 Td (year ) Tj ET Q q 0 0 0 rg BT 534.60 473.10 Td (can ) Tj ET Q q 0 0 0 rg BT 551.03 473.10 Td (elapse ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (before ) Tj ET Q q 0 0 0 rg BT 64.12 461.10 Td (new ) Tj ET Q q 0 0 0 rg BT 83.35 461.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 126.47 461.10 Td (become ) Tj ET Q q 0 0 0 rg BT 160.15 461.10 Td (available ) Tj ET Q q 0 0 0 rg BT 198.81 461.10 Td (on ) Tj ET Q q 0 0 0 rg BT 211.39 461.10 Td (some ) Tj ET Q q 0 0 0 rg BT 235.08 461.10 Td (national ) Tj ET Q q 0 0 0 rg BT 269.87 461.10 Td (markets. ) Tj ET Q q 0 0 0 rg BT 306.03 461.10 Td (Additionally) Tj ET Q q 0 0 0 rg BT 355.93 461.10 Td (, ) Tj ET Q q 0 0 0 rg BT 361.01 461.10 Td (member ) Tj ET Q q 0 0 0 rg BT 396.35 461.10 Td (states ) Tj ET Q q 0 0 0 rg BT 421.15 461.10 Td (of ) Tj ET Q q 0 0 0 rg BT 432.06 461.10 Td (the ) Tj ET Q q 0 0 0 rg BT 446.85 461.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 462.76 461.10 Td (have ) Tj ET Q q 0 0 0 rg BT 484.22 461.10 Td (regularly ) Tj ET Q q 0 0 0 rg BT 522.89 461.10 Td (imposed ) Tj ET Q q 0 0 0 rg BT 559.35 461.10 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (or ) Tj ET Q q 0 0 0 rg BT 46.59 449.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 88.84 449.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 107.21 449.10 Td (containment ) Tj ET Q q 0 0 0 rg BT 158.90 449.10 Td (measures ) Tj ET Q q 0 0 0 rg BT 198.37 449.10 Td (for ) Tj ET Q q 0 0 0 rg BT 212.29 449.10 Td (pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 279.52 449.10 Td (such ) Tj ET Q q 0 0 0 rg BT 300.11 449.10 Td (as ) Tj ET Q q 0 0 0 rg BT 310.70 449.10 Td (volume ) Tj ET Q q 0 0 0 rg BT 342.95 449.10 Td (discounts, ) Tj ET Q q 0 0 0 rg BT 385.49 449.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 403.86 449.10 Td (caps, ) Tj ET Q q 0 0 0 rg BT 426.39 449.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 444.76 449.10 Td (sharing ) Tj ET Q q 0 0 0 rg BT 476.46 449.10 Td (for ) Tj ET Q q 0 0 0 rg BT 490.38 449.10 Td (increases ) Tj ET Q q 0 0 0 rg BT 529.29 449.10 Td (in ) Tj ET Q q 0 0 0 rg BT 539.33 449.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 567.68 449.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 58.52 437.10 Td (year ) Tj ET Q q 0 0 0 rg BT 78.81 437.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 101.89 437.10 Td (for ) Tj ET Q q 0 0 0 rg BT 116.63 437.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 160.26 437.10 Td (products ) Tj ET Q q 0 0 0 rg BT 197.78 437.10 Td (or ) Tj ET Q q 0 0 0 rg BT 209.19 437.10 Td (aggregated ) Tj ET Q q 0 0 0 rg BT 256.14 437.10 Td (market ) Tj ET Q q 0 0 0 rg BT 286.98 437.10 Td (level ) Tj ET Q q 0 0 0 rg BT 309.50 437.10 Td (spending, ) Tj ET Q q 0 0 0 rg BT 351.19 437.10 Td (outcome-based ) Tj ET Q q 0 0 0 rg BT 414.80 437.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 446.21 437.10 Td (schemes ) Tj ET Q q 0 0 0 rg BT 483.16 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 500.68 437.10 Td (free ) Tj ET Q q 0 0 0 rg BT 519.30 437.10 Td (products ) Tj ET Q q 0 0 0 rg BT 556.82 437.10 Td (for ) Tj ET Q q 0 0 0 rg BT 571.56 437.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 66.92 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 77.29 425.10 Td (the ) Tj ET Q q 0 0 0 rg BT 91.55 425.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 129.12 425.10 Td (therapy ) Tj ET Q q 0 0 0 rg BT 161.14 425.10 Td (period. ) Tj ET Q q 0 0 0 rg BT 191.22 425.10 Td (In ) Tj ET Q q 0 0 0 rg BT 201.59 425.10 Td (recent ) Tj ET Q q 0 0 0 rg BT 228.05 425.10 Td (years, ) Tj ET Q q 0 0 0 rg BT 253.69 425.10 Td (Italy) Tj ET Q q 0 0 0 rg BT 271.36 425.10 Td (, ) Tj ET Q q 0 0 0 rg BT 275.90 425.10 Td (for ) Tj ET Q q 0 0 0 rg BT 289.60 425.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 328.01 425.10 Td (has ) Tj ET Q q 0 0 0 rg BT 343.38 425.10 Td (imposed ) Tj ET Q q 0 0 0 rg BT 379.30 425.10 Td (mandatory ) Tj ET Q q 0 0 0 rg BT 424.10 425.10 Td (price ) Tj ET Q q 0 0 0 rg BT 446.13 425.10 Td (decreases. ) Tj ET Q q 0 0 0 rg BT 488.82 425.10 Td (The ) Tj ET Q q 0 0 0 rg BT 506.41 425.10 Td (existence ) Tj ET Q q 0 0 0 rg BT 545.65 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 556.01 425.10 Td (price ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.10 Td (dif) Tj ET Q q 0 0 0 rg BT 46.93 413.10 Td (ferentials ) Tj ET Q q 0 0 0 rg BT 86.63 413.10 Td (within ) Tj ET Q q 0 0 0 rg BT 114.69 413.10 Td (the ) Tj ET Q q 0 0 0 rg BT 129.40 413.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 145.23 413.10 Td (due ) Tj ET Q q 0 0 0 rg BT 162.17 413.10 Td (to ) Tj ET Q q 0 0 0 rg BT 172.45 413.10 Td (the ) Tj ET Q q 0 0 0 rg BT 187.17 413.10 Td (dif) Tj ET Q q 0 0 0 rg BT 198.09 413.10 Td (ferent ) Tj ET Q q 0 0 0 rg BT 223.91 413.10 Td (national ) Tj ET Q q 0 0 0 rg BT 258.62 413.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 289.45 413.10 Td (and ) Tj ET Q q 0 0 0 rg BT 306.39 413.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 368.87 413.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 389.70 413.10 Td (leads ) Tj ET Q q 0 0 0 rg BT 412.74 413.10 Td (to ) Tj ET Q q 0 0 0 rg BT 423.02 413.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 467.73 413.10 Td (parallel ) Tj ET Q q 0 0 0 rg BT 500.21 413.10 Td (trade ) Tj ET Q q 0 0 0 rg BT 522.70 413.10 Td (flows.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 389.10 Td (Government Regulation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.29 365.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 118.10 365.10 Td (industry ) Tj ET Q q 0 0 0 rg BT 153.62 365.10 Td (is ) Tj ET Q q 0 0 0 rg BT 163.04 365.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 194.10 365.10 Td (to ) Tj ET Q q 0 0 0 rg BT 204.62 365.10 Td (extensive ) Tj ET Q q 0 0 0 rg BT 245.13 365.10 Td (global ) Tj ET Q q 0 0 0 rg BT 272.87 365.10 Td (regulation ) Tj ET Q q 0 0 0 rg BT 316.15 365.10 Td (by ) Tj ET Q q 0 0 0 rg BT 328.89 365.10 Td (regional, ) Tj ET Q q 0 0 0 rg BT 366.90 365.10 Td (country) Tj ET Q q 0 0 0 rg BT 396.79 365.10 Td (, ) Tj ET Q q 0 0 0 rg BT 402.04 365.10 Td (state ) Tj ET Q q 0 0 0 rg BT 423.10 365.10 Td (and ) Tj ET Q q 0 0 0 rg BT 440.28 365.10 Td (local ) Tj ET Q q 0 0 0 rg BT 462.46 365.10 Td (agencies. ) Tj ET Q q 0 0 0 rg BT 501.92 365.10 Td (The ) Tj ET Q q 0 0 0 rg BT 520.21 365.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 552.94 365.10 Td (Food, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.10 Td (Drug, ) Tj ET Q q 0 0 0 rg BT 61.07 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 77.53 353.10 Td (Cosmetic ) Tj ET Q q 0 0 0 rg BT 116.88 353.10 Td (Act, ) Tj ET Q q 0 0 0 rg BT 135.83 353.10 Td (other ) Tj ET Q q 0 0 0 rg BT 158.40 353.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 190.40 353.10 Td (statutes ) Tj ET Q q 0 0 0 rg BT 222.42 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 238.87 353.10 Td (regulations, ) Tj ET Q q 0 0 0 rg BT 287.83 353.10 Td (various ) Tj ET Q q 0 0 0 rg BT 319.28 353.10 Td (state ) Tj ET Q q 0 0 0 rg BT 339.63 353.10 Td (statutes ) Tj ET Q q 0 0 0 rg BT 371.64 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 388.10 353.10 Td (regulations, ) Tj ET Q q 0 0 0 rg BT 437.05 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 453.51 353.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 473.86 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 490.32 353.10 Td (regulations ) Tj ET Q q 0 0 0 rg BT 536.77 353.10 Td (of ) Tj ET Q q 0 0 0 rg BT 547.12 353.10 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (governments ) Tj ET Q q 0 0 0 rg BT 90.59 341.10 Td (govern ) Tj ET Q q 0 0 0 rg BT 121.30 341.10 Td (to ) Tj ET Q q 0 0 0 rg BT 132.02 341.10 Td (varying ) Tj ET Q q 0 0 0 rg BT 165.50 341.10 Td (degrees ) Tj ET Q q 0 0 0 rg BT 198.98 341.10 Td (the ) Tj ET Q q 0 0 0 rg BT 214.13 341.10 Td (testing, ) Tj ET Q q 0 0 0 rg BT 246.24 341.10 Td (approval, ) Tj ET Q q 0 0 0 rg BT 286.66 341.10 Td (production, ) Tj ET Q q 0 0 0 rg BT 335.42 341.10 Td (labeling, ) Tj ET Q q 0 0 0 rg BT 373.08 341.10 Td (distribution, ) Tj ET Q q 0 0 0 rg BT 424.63 341.10 Td (post-market ) Tj ET Q q 0 0 0 rg BT 475.33 341.10 Td (surveillance, ) Tj ET Q q 0 0 0 rg BT 529.08 341.10 Td (advertising, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.10 Td (dissemination ) Tj ET Q q 0 0 0 rg BT 95.38 329.10 Td (of ) Tj ET Q q 0 0 0 rg BT 107.54 329.10 Td (information ) Tj ET Q q 0 0 0 rg BT 158.59 329.10 Td (and ) Tj ET Q q 0 0 0 rg BT 176.85 329.10 Td (promotion ) Tj ET Q q 0 0 0 rg BT 222.35 329.10 Td (of ) Tj ET Q q 0 0 0 rg BT 234.51 329.10 Td (our ) Tj ET Q q 0 0 0 rg BT 251.67 329.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 292.16 329.10 Td (The ) Tj ET Q q 0 0 0 rg BT 311.54 329.10 Td (lengthy ) Tj ET Q q 0 0 0 rg BT 345.37 329.10 Td (process ) Tj ET Q q 0 0 0 rg BT 379.19 329.10 Td (of ) Tj ET Q q 0 0 0 rg BT 391.35 329.10 Td (laboratory ) Tj ET Q q 0 0 0 rg BT 436.27 329.10 Td (and ) Tj ET Q q 0 0 0 rg BT 454.54 329.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 487.80 329.10 Td (testing, ) Tj ET Q q 0 0 0 rg BT 520.80 329.10 Td (data ) Tj ET Q q 0 0 0 rg BT 541.28 329.10 Td (analysis, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 101.69 317.10 Td (development ) Tj ET Q q 0 0 0 rg BT 158.21 317.10 Td (and ) Tj ET Q q 0 0 0 rg BT 177.52 317.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 223.49 317.10 Td (review ) Tj ET Q q 0 0 0 rg BT 255.58 317.10 Td (necessary ) Tj ET Q q 0 0 0 rg BT 299.32 317.10 Td (for ) Tj ET Q q 0 0 0 rg BT 315.85 317.10 Td (required ) Tj ET Q q 0 0 0 rg BT 354.04 317.10 Td (governmental ) Tj ET Q q 0 0 0 rg BT 413.90 317.10 Td (approvals ) Tj ET Q q 0 0 0 rg BT 457.65 317.10 Td (is ) Tj ET Q q 0 0 0 rg BT 469.20 317.10 Td (extremely ) Tj ET Q q 0 0 0 rg BT 514.05 317.10 Td (costly ) Tj ET Q q 0 0 0 rg BT 542.81 317.10 Td (and ) Tj ET Q q 0 0 0 rg BT 562.13 317.10 Td (can ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 89.16 305.10 Td (delay ) Tj ET Q q 0 0 0 rg BT 113.98 305.10 Td (product ) Tj ET Q q 0 0 0 rg BT 147.69 305.10 Td (introductions ) Tj ET Q q 0 0 0 rg BT 203.63 305.10 Td (in ) Tj ET Q q 0 0 0 rg BT 214.57 305.10 Td (a ) Tj ET Q q 0 0 0 rg BT 222.18 305.10 Td (given ) Tj ET Q q 0 0 0 rg BT 247.56 305.10 Td (market. ) Tj ET Q q 0 0 0 rg BT 280.99 305.10 Td (Promotion, ) Tj ET Q q 0 0 0 rg BT 328.88 305.10 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 375.09 305.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 436.56 305.10 Td (and ) Tj ET Q q 0 0 0 rg BT 454.17 305.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 503.45 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 514.94 305.10 Td (pharmaceutical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.10 Td (products ) Tj ET Q q 0 0 0 rg BT 73.36 293.10 Td (are ) Tj ET Q q 0 0 0 rg BT 88.48 293.10 Td (extensively ) Tj ET Q q 0 0 0 rg BT 136.94 293.10 Td (regulated ) Tj ET Q q 0 0 0 rg BT 177.07 293.10 Td (in ) Tj ET Q q 0 0 0 rg BT 187.76 293.10 Td (all ) Tj ET Q q 0 0 0 rg BT 200.68 293.10 Td (major ) Tj ET Q q 0 0 0 rg BT 226.92 293.10 Td (world ) Tj ET Q q 0 0 0 rg BT 253.17 293.10 Td (markets. ) Tj ET Q q 0 0 0 rg BT 290.24 293.10 Td (In ) Tj ET Q q 0 0 0 rg BT 301.49 293.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 339.69 293.10 Td (our ) Tj ET Q q 0 0 0 rg BT 355.93 293.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 400.51 293.10 Td (are ) Tj ET Q q 0 0 0 rg BT 415.63 293.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 446.88 293.10 Td (to ) Tj ET Q q 0 0 0 rg BT 457.58 293.10 Td (complex ) Tj ET Q q 0 0 0 rg BT 494.93 293.10 Td (Federal, ) Tj ET Q q 0 0 0 rg BT 530.33 293.10 Td (state, ) Tj ET Q q 0 0 0 rg BT 554.08 293.10 Td (local, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 54.33 281.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 87.10 281.10 Td (environmental ) Tj ET Q q 0 0 0 rg BT 148.75 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.08 281.10 Td (occupational ) Tj ET Q q 0 0 0 rg BT 222.06 281.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 249.83 281.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 272.06 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 290.39 281.10 Td (regulations. ) Tj ET Q q 0 0 0 rg BT 340.93 281.10 Td (W) Tj ET Q q 0 0 0 rg BT 349.57 281.10 Td (e ) Tj ET Q q 0 0 0 rg BT 357.90 281.10 Td (anticipate ) Tj ET Q q 0 0 0 rg BT 400.66 281.10 Td (that ) Tj ET Q q 0 0 0 rg BT 419.55 281.10 Td (the ) Tj ET Q q 0 0 0 rg BT 435.66 281.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 457.88 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 476.21 281.10 Td (regulations ) Tj ET Q q 0 0 0 rg BT 524.54 281.10 Td (af) Tj ET Q q 0 0 0 rg BT 532.13 281.10 Td (fecting ) Tj ET Q q 0 0 0 rg BT 563.78 281.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.10 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 87.97 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 104.41 269.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 121.95 269.10 Td (of ) Tj ET Q q 0 0 0 rg BT 132.28 269.10 Td (current ) Tj ET Q q 0 0 0 rg BT 162.59 269.10 Td (products ) Tj ET Q q 0 0 0 rg BT 199.03 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 215.47 269.10 Td (the ) Tj ET Q q 0 0 0 rg BT 229.68 269.10 Td (introduction ) Tj ET Q q 0 0 0 rg BT 280.56 269.10 Td (of ) Tj ET Q q 0 0 0 rg BT 290.89 269.10 Td (new ) Tj ET Q q 0 0 0 rg BT 309.55 269.10 Td (products ) Tj ET Q q 0 0 0 rg BT 345.99 269.10 Td (will ) Tj ET Q q 0 0 0 rg BT 363.54 269.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 399.98 269.10 Td (to ) Tj ET Q q 0 0 0 rg BT 409.75 269.10 Td (require ) Tj ET Q q 0 0 0 rg BT 440.07 269.10 Td (substantial ) Tj ET Q q 0 0 0 rg BT 484.84 269.10 Td (scientific ) Tj ET Q q 0 0 0 rg BT 523.49 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 539.92 269.10 Td (technical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.10 Td (ef) Tj ET Q q 0 0 0 rg BT 43.59 257.10 Td (fort, ) Tj ET Q q 0 0 0 rg BT 63.03 257.10 Td (time ) Tj ET Q q 0 0 0 rg BT 83.30 257.10 Td (and ) Tj ET Q q 0 0 0 rg BT 100.24 257.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 134.95 257.10 Td (as ) Tj ET Q q 0 0 0 rg BT 145.78 257.10 Td (well ) Tj ET Q q 0 0 0 rg BT 165.49 257.10 Td (as ) Tj ET Q q 0 0 0 rg BT 176.32 257.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 221.03 257.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 250.18 257.10 Td (investments.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.10 Td (Of ) Tj ET Q q 0 0 0 rg BT 48.99 233.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 89.74 233.10 Td (importance ) Tj ET Q q 0 0 0 rg BT 137.16 233.10 Td (is ) Tj ET Q q 0 0 0 rg BT 146.27 233.10 Td (the ) Tj ET Q q 0 0 0 rg BT 160.93 233.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 180.38 233.10 Td ( ) Tj ET Q q 0 0 0 rg BT 182.83 233.10 Td (in ) Tj ET Q q 0 0 0 rg BT 193.04 233.10 Td (the ) Tj ET Q q 0 0 0 rg BT 207.70 233.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 227.92 233.10 Td (It ) Tj ET Q q 0 0 0 rg BT 236.47 233.10 Td (has ) Tj ET Q q 0 0 0 rg BT 252.24 233.10 Td (jurisdiction ) Tj ET Q q 0 0 0 rg BT 300.24 233.10 Td (over ) Tj ET Q q 0 0 0 rg BT 320.45 233.10 Td (virtually ) Tj ET Q q 0 0 0 rg BT 356.77 233.10 Td (all ) Tj ET Q q 0 0 0 rg BT 369.20 233.10 Td (of ) Tj ET Q q 0 0 0 rg BT 379.97 233.10 Td (our ) Tj ET Q q 0 0 0 rg BT 395.74 233.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 434.28 233.10 Td (and ) Tj ET Q q 0 0 0 rg BT 451.16 233.10 Td (imposes ) Tj ET Q q 0 0 0 rg BT 486.38 233.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 541.02 233.10 Td (covering ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.44 221.10 Td (testing, ) Tj ET Q q 0 0 0 rg BT 83.83 221.10 Td (safety) Tj ET Q q 0 0 0 rg BT 107.06 221.10 Td (, ) Tj ET Q q 0 0 0 rg BT 112.79 221.10 Td (ef) Tj ET Q q 0 0 0 rg BT 120.38 221.10 Td (fectiveness, ) Tj ET Q q 0 0 0 rg BT 170.53 221.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 234.56 221.10 Td (labeling, ) Tj ET Q q 0 0 0 rg BT 272.50 221.10 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 318.77 221.10 Td (advertising ) Tj ET Q q 0 0 0 rg BT 366.43 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 384.10 221.10 Td (post-marketing ) Tj ET Q q 0 0 0 rg BT 447.87 221.10 Td (surveillance ) Tj ET Q q 0 0 0 rg BT 499.40 221.10 Td (of ) Tj ET Q q 0 0 0 rg BT 510.96 221.10 Td (our ) Tj ET Q q 0 0 0 rg BT 527.52 221.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 567.68 221.10 Td (In ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.10 Td (many ) Tj ET Q q 0 0 0 rg BT 60.65 209.10 Td (cases, ) Tj ET Q q 0 0 0 rg BT 86.67 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.32 209.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 120.77 209.10 Td ( ) Tj ET Q q 0 0 0 rg BT 123.20 209.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 177.83 209.10 Td (have ) Tj ET Q q 0 0 0 rg BT 199.13 209.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 239.32 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 253.96 209.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 286.38 209.10 Td (of ) Tj ET Q q 0 0 0 rg BT 297.14 209.10 Td (time ) Tj ET Q q 0 0 0 rg BT 317.34 209.10 Td (and ) Tj ET Q q 0 0 0 rg BT 334.21 209.10 Td (money ) Tj ET Q q 0 0 0 rg BT 363.86 209.10 Td (necessary ) Tj ET Q q 0 0 0 rg BT 405.15 209.10 Td (to ) Tj ET Q q 0 0 0 rg BT 415.36 209.10 Td (develop ) Tj ET Q q 0 0 0 rg BT 449.44 209.10 Td (new ) Tj ET Q q 0 0 0 rg BT 468.53 209.10 Td (products ) Tj ET Q q 0 0 0 rg BT 505.40 209.10 Td (and ) Tj ET Q q 0 0 0 rg BT 522.26 209.10 Td (bring ) Tj ET Q q 0 0 0 rg BT 545.80 209.10 Td (them ) Tj ET Q q 0 0 0 rg BT 568.22 209.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.10 Td (market ) Tj ET Q q 0 0 0 rg BT 66.26 197.10 Td (in ) Tj ET Q q 0 0 0 rg BT 76.54 197.10 Td (the ) Tj ET Q q 0 0 0 rg BT 91.26 197.10 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.97 173.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 73.42 173.10 Td ( ) Tj ET Q q 0 0 0 rg BT 75.85 173.10 Td (mandates ) Tj ET Q q 0 0 0 rg BT 116.04 173.10 Td (that ) Tj ET Q q 0 0 0 rg BT 133.46 173.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 158.10 173.10 Td (be ) Tj ET Q q 0 0 0 rg BT 169.96 173.10 Td (manufactured, ) Tj ET Q q 0 0 0 rg BT 229.86 173.10 Td (packaged ) Tj ET Q q 0 0 0 rg BT 270.04 173.10 Td (and ) Tj ET Q q 0 0 0 rg BT 286.90 173.10 Td (labeled ) Tj ET Q q 0 0 0 rg BT 318.20 173.10 Td (in ) Tj ET Q q 0 0 0 rg BT 328.40 173.10 Td (conformity ) Tj ET Q q 0 0 0 rg BT 375.26 173.10 Td (with ) Tj ET Q q 0 0 0 rg BT 395.46 173.10 Td (cGMP) Tj ET Q q 0 0 0 rg BT 421.20 173.10 Td ( ) Tj ET Q q 0 0 0 rg BT 423.63 173.10 Td (established ) Tj ET Q q 0 0 0 rg BT 470.48 173.10 Td (by ) Tj ET Q q 0 0 0 rg BT 482.91 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 497.55 173.10 Td (FDA. ) Tj ET Q q 0 0 0 rg BT 522.48 173.10 Td (In ) Tj ET Q q 0 0 0 rg BT 533.23 173.10 Td (complying ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.10 Td (with ) Tj ET Q q 0 0 0 rg BT 55.93 161.10 Td (cGMP) Tj ET Q q 0 0 0 rg BT 81.67 161.10 Td ( ) Tj ET Q q 0 0 0 rg BT 83.82 161.10 Td (regulations, ) Tj ET Q q 0 0 0 rg BT 132.90 161.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 192.24 161.10 Td (must ) Tj ET Q q 0 0 0 rg BT 213.84 161.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 250.42 161.10 Td (to ) Tj ET Q q 0 0 0 rg BT 260.35 161.10 Td (expend ) Tj ET Q q 0 0 0 rg BT 291.37 161.10 Td (time, ) Tj ET Q q 0 0 0 rg BT 313.79 161.10 Td (money ) Tj ET Q q 0 0 0 rg BT 343.16 161.10 Td (and ) Tj ET Q q 0 0 0 rg BT 359.75 161.10 Td (ef) Tj ET Q q 0 0 0 rg BT 367.33 161.10 Td (fort ) Tj ET Q q 0 0 0 rg BT 383.92 161.10 Td (in ) Tj ET Q q 0 0 0 rg BT 393.85 161.10 Td (production, ) Tj ET Q q 0 0 0 rg BT 441.82 161.10 Td (recordkeeping ) Tj ET Q q 0 0 0 rg BT 501.16 161.10 Td (and ) Tj ET Q q 0 0 0 rg BT 517.75 161.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 547.67 161.10 Td (control ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 149.10 Td (to ) Tj ET Q q 0 0 0 rg BT 45.71 149.10 Td (ensure ) Tj ET Q q 0 0 0 rg BT 73.74 149.10 Td (that ) Tj ET Q q 0 0 0 rg BT 90.67 149.10 Td (products ) Tj ET Q q 0 0 0 rg BT 127.04 149.10 Td (meet ) Tj ET Q q 0 0 0 rg BT 148.41 149.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 191.43 149.10 Td (specifications ) Tj ET Q q 0 0 0 rg BT 248.34 149.10 Td (and ) Tj ET Q q 0 0 0 rg BT 264.71 149.10 Td (other ) Tj ET Q q 0 0 0 rg BT 287.19 149.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 341.33 149.10 Td (to ) Tj ET Q q 0 0 0 rg BT 351.04 149.10 Td (ensure ) Tj ET Q q 0 0 0 rg BT 379.07 149.10 Td (product ) Tj ET Q q 0 0 0 rg BT 411.55 149.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 437.36 149.10 Td (and ) Tj ET Q q 0 0 0 rg BT 453.73 149.10 Td (ef) Tj ET Q q 0 0 0 rg BT 461.32 149.10 Td (ficacy) Tj ET Q q 0 0 0 rg BT 485.09 149.10 Td (. ) Tj ET Q q 0 0 0 rg BT 489.38 149.10 Td (The ) Tj ET Q q 0 0 0 rg BT 506.86 149.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 526.32 149.10 Td ( ) Tj ET Q q 0 0 0 rg BT 528.25 149.10 Td (periodically ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 137.10 Td (inspects ) Tj ET Q q 0 0 0 rg BT 70.16 137.10 Td (our ) Tj ET Q q 0 0 0 rg BT 85.43 137.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 105.70 137.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 165.96 137.10 Td (facilities ) Tj ET Q q 0 0 0 rg BT 202.33 137.10 Td (to ) Tj ET Q q 0 0 0 rg BT 212.05 137.10 Td (ensure ) Tj ET Q q 0 0 0 rg BT 240.09 137.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 288.12 137.10 Td (with ) Tj ET Q q 0 0 0 rg BT 307.84 137.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 350.87 137.10 Td (cGMP) Tj ET Q q 0 0 0 rg BT 376.62 137.10 Td ( ) Tj ET Q q 0 0 0 rg BT 378.56 137.10 Td (requirements. ) Tj ET Q q 0 0 0 rg BT 435.20 137.10 Td (Failure ) Tj ET Q q 0 0 0 rg BT 465.47 137.10 Td (to ) Tj ET Q q 0 0 0 rg BT 475.19 137.10 Td (comply ) Tj ET Q q 0 0 0 rg BT 507.13 137.10 Td (with ) Tj ET Q q 0 0 0 rg BT 526.85 137.10 Td (the ) Tj ET Q q 0 0 0 rg BT 541.01 137.10 Td (statutory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.10 125.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 96.86 125.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 151.72 125.10 Td (subjects ) Tj ET Q q 0 0 0 rg BT 186.60 125.10 Td (us ) Tj ET Q q 0 0 0 rg BT 198.16 125.10 Td (to ) Tj ET Q q 0 0 0 rg BT 208.60 125.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 244.04 125.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 266.13 125.10 Td (or ) Tj ET Q q 0 0 0 rg BT 277.13 125.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 320.88 125.10 Td (action, ) Tj ET Q q 0 0 0 rg BT 350.48 125.10 Td (such ) Tj ET Q q 0 0 0 rg BT 371.47 125.10 Td (as ) Tj ET Q q 0 0 0 rg BT 382.46 125.10 Td (suspension ) Tj ET Q q 0 0 0 rg BT 429.02 125.10 Td (of ) Tj ET Q q 0 0 0 rg BT 440.01 125.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 503.48 125.10 Td (seizure ) Tj ET Q q 0 0 0 rg BT 534.46 125.10 Td (of ) Tj ET Q q 0 0 0 rg BT 545.46 125.10 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.10 Td (or ) Tj ET Q q 0 0 0 rg BT 47.76 113.10 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 89.52 113.10 Td (recall ) Tj ET Q q 0 0 0 rg BT 115.16 113.10 Td (of ) Tj ET Q q 0 0 0 rg BT 126.92 113.10 Td (a ) Tj ET Q q 0 0 0 rg BT 134.80 113.10 Td (product. ) Tj ET Q q 0 0 0 rg BT 170.52 113.10 Td (Adverse ) Tj ET Q q 0 0 0 rg BT 207.27 113.10 Td (experiences ) Tj ET Q q 0 0 0 rg BT 257.90 113.10 Td (with ) Tj ET Q q 0 0 0 rg BT 279.11 113.10 Td (the ) Tj ET Q q 0 0 0 rg BT 294.76 113.10 Td (use ) Tj ET Q q 0 0 0 rg BT 311.53 113.10 Td (of ) Tj ET Q q 0 0 0 rg BT 323.29 113.10 Td (products ) Tj ET Q q 0 0 0 rg BT 361.16 113.10 Td (must ) Tj ET Q q 0 0 0 rg BT 384.05 113.10 Td (be ) Tj ET Q q 0 0 0 rg BT 396.92 113.10 Td (reported ) Tj ET Q q 0 0 0 rg BT 433.67 113.10 Td (to ) Tj ET Q q 0 0 0 rg BT 444.88 113.10 Td (the ) Tj ET Q q 0 0 0 rg BT 460.53 113.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 479.98 113.10 Td ( ) Tj ET Q q 0 0 0 rg BT 483.42 113.10 Td (and ) Tj ET Q q 0 0 0 rg BT 501.29 113.10 Td (could ) Tj ET Q q 0 0 0 rg BT 526.94 113.10 Td (result ) Tj ET Q q 0 0 0 rg BT 552.59 113.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.81 113.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.10 Td (imposition ) Tj ET Q q 0 0 0 rg BT 81.00 101.10 Td (of ) Tj ET Q q 0 0 0 rg BT 91.54 101.10 Td (market ) Tj ET Q q 0 0 0 rg BT 121.52 101.10 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 168.17 101.10 Td (through ) Tj ET Q q 0 0 0 rg BT 201.49 101.10 Td (labeling ) Tj ET Q q 0 0 0 rg BT 235.92 101.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 270.34 101.10 Td (or ) Tj ET Q q 0 0 0 rg BT 280.88 101.10 Td (product ) Tj ET Q q 0 0 0 rg BT 313.64 101.10 Td (removal. ) Tj ET Q q 0 0 0 rg BT 351.12 101.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 384.44 101.10 Td (approvals ) Tj ET Q q 0 0 0 rg BT 425.54 101.10 Td (may ) Tj ET Q q 0 0 0 rg BT 444.97 101.10 Td (be ) Tj ET Q q 0 0 0 rg BT 456.62 101.10 Td (withdrawn ) Tj ET Q q 0 0 0 rg BT 501.60 101.10 Td (if ) Tj ET Q q 0 0 0 rg BT 509.93 101.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 558.23 101.10 Td (with ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.59 89.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 134.30 89.10 Td (is ) Tj ET Q q 0 0 0 rg BT 143.47 89.10 Td (not ) Tj ET Q q 0 0 0 rg BT 158.74 89.10 Td (maintained ) Tj ET Q q 0 0 0 rg BT 205.67 89.10 Td (or ) Tj ET Q q 0 0 0 rg BT 216.50 89.10 Td (if ) Tj ET Q q 0 0 0 rg BT 225.11 89.10 Td (problems ) Tj ET Q q 0 0 0 rg BT 264.83 89.10 Td (concerning ) Tj ET Q q 0 0 0 rg BT 311.75 89.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 338.13 89.10 Td (or ) Tj ET Q q 0 0 0 rg BT 348.96 89.10 Td (ef) Tj ET Q q 0 0 0 rg BT 356.55 89.10 Td (ficacy ) Tj ET Q q 0 0 0 rg BT 383.47 89.10 Td (occur ) Tj ET Q q 0 0 0 rg BT 408.18 89.10 Td (following ) Tj ET Q q 0 0 0 rg BT 449.56 89.10 Td (approval.) Tj ET Q endstream endobj 31 0 obj <> endobj 32 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.21 749.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 86.86 749.10 Td (government ) Tj ET Q q 0 0 0 rg BT 137.28 749.10 Td (has ) Tj ET Q q 0 0 0 rg BT 153.28 749.10 Td (extensive ) Tj ET Q q 0 0 0 rg BT 193.70 749.10 Td (enforcement ) Tj ET Q q 0 0 0 rg BT 246.34 749.10 Td (powers ) Tj ET Q q 0 0 0 rg BT 277.88 749.10 Td (over ) Tj ET Q q 0 0 0 rg BT 298.31 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 313.19 749.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 351.95 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 362.94 749.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 426.68 749.10 Td (manufacturers, ) Tj ET Q q 0 0 0 rg BT 489.04 749.10 Td (including ) Tj ET Q q 0 0 0 rg BT 529.47 749.10 Td (authority ) Tj ET Q q 0 0 0 rg BT 568.24 749.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (withdraw ) Tj ET Q q 0 0 0 rg BT 76.00 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 86.56 737.10 Td (delay ) Tj ET Q q 0 0 0 rg BT 110.45 737.10 Td (product ) Tj ET Q q 0 0 0 rg BT 143.22 737.10 Td (approvals, ) Tj ET Q q 0 0 0 rg BT 186.83 737.10 Td (commence ) Tj ET Q q 0 0 0 rg BT 232.37 737.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 262.93 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 272.94 737.10 Td (seize ) Tj ET Q q 0 0 0 rg BT 295.15 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 311.82 737.10 Td (prohibit ) Tj ET Q q 0 0 0 rg BT 345.72 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 360.16 737.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 377.94 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 388.50 737.10 Td (unapproved ) Tj ET Q q 0 0 0 rg BT 437.94 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 448.50 737.10 Td (non-complying ) Tj ET Q q 0 0 0 rg BT 511.83 737.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 551.00 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 561.01 737.10 Td (halt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 96.91 725.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 141.17 725.10 Td (that ) Tj ET Q q 0 0 0 rg BT 158.76 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 173.57 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 188.95 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 199.33 725.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 248.01 725.10 Td (with ) Tj ET Q q 0 0 0 rg BT 268.39 725.10 Td (cGMPs, ) Tj ET Q q 0 0 0 rg BT 303.50 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 320.54 725.10 Td (to ) Tj ET Q q 0 0 0 rg BT 330.91 725.10 Td (impose ) Tj ET Q q 0 0 0 rg BT 362.40 725.10 Td (or ) Tj ET Q q 0 0 0 rg BT 373.33 725.10 Td (seek ) Tj ET Q q 0 0 0 rg BT 393.70 725.10 Td (injunctions, ) Tj ET Q q 0 0 0 rg BT 443.24 725.10 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 484.17 725.10 Td (recalls, ) Tj ET Q q 0 0 0 rg BT 515.36 725.10 Td (civil, ) Tj ET Q q 0 0 0 rg BT 538.24 725.10 Td (monetary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.88 713.10 Td (criminal ) Tj ET Q q 0 0 0 rg BT 88.63 713.10 Td (penalties. ) Tj ET Q q 0 0 0 rg BT 129.11 713.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 151.55 713.10 Td (a ) Tj ET Q q 0 0 0 rg BT 158.43 713.10 Td (restriction ) Tj ET Q q 0 0 0 rg BT 201.41 713.10 Td (or ) Tj ET Q q 0 0 0 rg BT 212.18 713.10 Td (prohibition ) Tj ET Q q 0 0 0 rg BT 259.06 713.10 Td (on ) Tj ET Q q 0 0 0 rg BT 271.50 713.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 293.37 713.10 Td (or ) Tj ET Q q 0 0 0 rg BT 304.14 713.10 Td (withdrawal ) Tj ET Q q 0 0 0 rg BT 351.56 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 362.33 713.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 399.76 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 410.52 713.10 Td (products ) Tj ET Q q 0 0 0 rg BT 447.40 713.10 Td (marketed ) Tj ET Q q 0 0 0 rg BT 487.04 713.10 Td (by ) Tj ET Q q 0 0 0 rg BT 499.48 713.10 Td (us ) Tj ET Q q 0 0 0 rg BT 510.81 713.10 Td (could ) Tj ET Q q 0 0 0 rg BT 535.46 713.10 Td (materially ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (adversely ) Tj ET Q q 0 0 0 rg BT 76.82 701.10 Td (af) Tj ET Q q 0 0 0 rg BT 84.40 701.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 101.89 701.10 Td (our ) Tj ET Q q 0 0 0 rg BT 117.72 701.10 Td (business, ) Tj ET Q q 0 0 0 rg BT 156.61 701.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 194.09 701.10 Td (condition ) Tj ET Q q 0 0 0 rg BT 234.36 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 251.30 701.10 Td (results ) Tj ET Q q 0 0 0 rg BT 279.91 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 290.74 701.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 334.90 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 351.83 701.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 372.10 701.10 Td (flows.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (Marketing ) Tj ET Q q 0 0 0 rg BT 79.95 677.10 Td (authorization ) Tj ET Q q 0 0 0 rg BT 135.01 677.10 Td (for ) Tj ET Q q 0 0 0 rg BT 148.97 677.10 Td (our ) Tj ET Q q 0 0 0 rg BT 164.59 677.10 Td (products ) Tj ET Q q 0 0 0 rg BT 201.33 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 210.30 677.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 240.92 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 251.00 677.10 Td (revocation ) Tj ET Q q 0 0 0 rg BT 295.49 677.10 Td (by ) Tj ET Q q 0 0 0 rg BT 307.79 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 322.31 677.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 365.69 677.10 Td (governmental ) Tj ET Q q 0 0 0 rg BT 422.97 677.10 Td (agencies. ) Tj ET Q q 0 0 0 rg BT 462.19 677.10 Td (In ) Tj ET Q q 0 0 0 rg BT 472.82 677.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 510.39 677.10 Td (modifications ) Tj ET Q q 0 0 0 rg BT 567.68 677.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (enhancements ) Tj ET Q q 0 0 0 rg BT 94.11 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 103.90 665.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 142.57 665.10 Td (products ) Tj ET Q q 0 0 0 rg BT 178.48 665.10 Td (or ) Tj ET Q q 0 0 0 rg BT 188.27 665.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 221.94 665.10 Td (in ) Tj ET Q q 0 0 0 rg BT 231.19 665.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 290.96 665.10 Td (locations ) Tj ET Q q 0 0 0 rg BT 328.53 665.10 Td (are ) Tj ET Q q 0 0 0 rg BT 342.20 665.10 Td (in ) Tj ET Q q 0 0 0 rg BT 351.44 665.10 Td (many ) Tj ET Q q 0 0 0 rg BT 375.13 665.10 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 433.23 665.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 463.02 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 472.26 665.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 513.72 665.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 533.17 665.10 Td ( ) Tj ET Q q 0 0 0 rg BT 534.64 665.10 Td (approvals, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (which ) Tj ET Q q 0 0 0 rg BT 62.94 653.10 Td (may ) Tj ET Q q 0 0 0 rg BT 82.66 653.10 Td (or ) Tj ET Q q 0 0 0 rg BT 93.49 653.10 Td (may ) Tj ET Q q 0 0 0 rg BT 113.20 653.10 Td (not ) Tj ET Q q 0 0 0 rg BT 128.48 653.10 Td (be ) Tj ET Q q 0 0 0 rg BT 140.42 653.10 Td (received ) Tj ET Q q 0 0 0 rg BT 176.78 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 193.72 653.10 Td (which ) Tj ET Q q 0 0 0 rg BT 220.66 653.10 Td (may ) Tj ET Q q 0 0 0 rg BT 240.38 653.10 Td (be ) Tj ET Q q 0 0 0 rg BT 252.31 653.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 283.14 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 293.42 653.10 Td (a ) Tj ET Q q 0 0 0 rg BT 300.36 653.10 Td (lengthy ) Tj ET Q q 0 0 0 rg BT 332.85 653.10 Td (application ) Tj ET Q q 0 0 0 rg BT 379.78 653.10 Td (process.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.52 629.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 101.60 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 111.91 629.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 174.95 629.10 Td (products ) Tj ET Q q 0 0 0 rg BT 211.36 629.10 Td (is ) Tj ET Q q 0 0 0 rg BT 220.00 629.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 250.30 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 260.05 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 274.24 629.10 Td (PDMA) Tj ET Q q 0 0 0 rg BT 302.58 629.10 Td ( ) Tj ET Q q 0 0 0 rg BT 304.55 629.10 Td (as ) Tj ET Q q 0 0 0 rg BT 314.86 629.10 Td (part ) Tj ET Q q 0 0 0 rg BT 332.38 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 342.68 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 356.87 629.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 388.82 629.10 Td (Food, ) Tj ET Q q 0 0 0 rg BT 413.86 629.10 Td (Drug, ) Tj ET Q q 0 0 0 rg BT 438.88 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 455.29 629.10 Td (Cosmetic ) Tj ET Q q 0 0 0 rg BT 494.60 629.10 Td (Act, ) Tj ET Q q 0 0 0 rg BT 513.51 629.10 Td (which ) Tj ET Q q 0 0 0 rg BT 539.92 629.10 Td (regulates ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (such ) Tj ET Q q 0 0 0 rg BT 57.48 617.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 96.72 617.10 Td (at ) Tj ET Q q 0 0 0 rg BT 107.08 617.10 Td (both ) Tj ET Q q 0 0 0 rg BT 128.01 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 143.37 617.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 176.50 617.10 Td (and ) Tj ET Q q 0 0 0 rg BT 194.09 617.10 Td (state ) Tj ET Q q 0 0 0 rg BT 215.56 617.10 Td (level. ) Tj ET Q q 0 0 0 rg BT 240.64 617.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 268.77 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 284.14 617.10 Td (PDMA) Tj ET Q q 0 0 0 rg BT 312.48 617.10 Td ( ) Tj ET Q q 0 0 0 rg BT 315.63 617.10 Td (and ) Tj ET Q q 0 0 0 rg BT 333.21 617.10 Td (its ) Tj ET Q q 0 0 0 rg BT 345.81 617.10 Td (implementing ) Tj ET Q q 0 0 0 rg BT 404.50 617.10 Td (regulations, ) Tj ET Q q 0 0 0 rg BT 454.58 617.10 Td (states ) Tj ET Q q 0 0 0 rg BT 479.94 617.10 Td (are ) Tj ET Q q 0 0 0 rg BT 495.29 617.10 Td (permitted ) Tj ET Q q 0 0 0 rg BT 536.76 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 547.68 617.10 Td (require ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (registration ) Tj ET Q q 0 0 0 rg BT 84.10 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 94.99 605.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 154.74 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 171.74 605.10 Td (distributors ) Tj ET Q q 0 0 0 rg BT 219.86 605.10 Td (who ) Tj ET Q q 0 0 0 rg BT 239.64 605.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 272.75 605.10 Td (pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 340.27 605.10 Td (even ) Tj ET Q q 0 0 0 rg BT 361.71 605.10 Td (if ) Tj ET Q q 0 0 0 rg BT 370.38 605.10 Td (such ) Tj ET Q q 0 0 0 rg BT 391.27 605.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 451.02 605.10 Td (or ) Tj ET Q q 0 0 0 rg BT 461.91 605.10 Td (distributors ) Tj ET Q q 0 0 0 rg BT 510.03 605.10 Td (have ) Tj ET Q q 0 0 0 rg BT 531.47 605.10 Td (no ) Tj ET Q q 0 0 0 rg BT 544.03 605.10 Td (place ) Tj ET Q q 0 0 0 rg BT 567.68 605.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (business ) Tj ET Q q 0 0 0 rg BT 71.39 593.10 Td (within ) Tj ET Q q 0 0 0 rg BT 98.44 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 112.16 593.10 Td (state. ) Tj ET Q q 0 0 0 rg BT 134.48 593.10 Td (States ) Tj ET Q q 0 0 0 rg BT 159.87 593.10 Td (are ) Tj ET Q q 0 0 0 rg BT 173.57 593.10 Td (also ) Tj ET Q q 0 0 0 rg BT 191.18 593.10 Td (permitted ) Tj ET Q q 0 0 0 rg BT 231.00 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 240.27 593.10 Td (adopt ) Tj ET Q q 0 0 0 rg BT 263.99 593.10 Td (regulations ) Tj ET Q q 0 0 0 rg BT 309.92 593.10 Td (limiting ) Tj ET Q q 0 0 0 rg BT 343.09 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 356.80 593.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 404.41 593.10 Td (of ) Tj ET Q q 0 0 0 rg BT 414.24 593.10 Td (product ) Tj ET Q q 0 0 0 rg BT 446.29 593.10 Td (samples ) Tj ET Q q 0 0 0 rg BT 480.00 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 489.28 593.10 Td (licensed ) Tj ET Q q 0 0 0 rg BT 523.54 593.10 Td (practitioners. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.03 581.10 Td (PDMA) Tj ET Q q 0 0 0 rg BT 81.37 581.10 Td ( ) Tj ET Q q 0 0 0 rg BT 82.85 581.10 Td (also ) Tj ET Q q 0 0 0 rg BT 100.44 581.10 Td (imposes ) Tj ET Q q 0 0 0 rg BT 134.69 581.10 Td (extensive ) Tj ET Q q 0 0 0 rg BT 173.93 581.10 Td (licensing, ) Tj ET Q q 0 0 0 rg BT 214.02 581.10 Td (personnel ) Tj ET Q q 0 0 0 rg BT 254.37 581.10 Td (recordkeeping, ) Tj ET Q q 0 0 0 rg BT 315.54 581.10 Td (packaging, ) Tj ET Q q 0 0 0 rg BT 360.62 581.10 Td (quantity) Tj ET Q q 0 0 0 rg BT 392.74 581.10 Td (, ) Tj ET Q q 0 0 0 rg BT 396.72 581.10 Td (labeling, ) Tj ET Q q 0 0 0 rg BT 432.91 581.10 Td (product ) Tj ET Q q 0 0 0 rg BT 464.93 581.10 Td (handling ) Tj ET Q q 0 0 0 rg BT 501.41 581.10 Td (and ) Tj ET Q q 0 0 0 rg BT 517.32 581.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 547.12 581.10 Td (storage ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 569.10 Td (security ) Tj ET Q q 0 0 0 rg BT 87.09 569.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 141.80 569.10 Td (intended ) Tj ET Q q 0 0 0 rg BT 178.73 569.10 Td (to ) Tj ET Q q 0 0 0 rg BT 189.01 569.10 Td (prevent ) Tj ET Q q 0 0 0 rg BT 221.49 569.10 Td (the ) Tj ET Q q 0 0 0 rg BT 236.21 569.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 254.26 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 265.09 569.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 328.66 569.10 Td (product ) Tj ET Q q 0 0 0 rg BT 361.71 569.10 Td (samples ) Tj ET Q q 0 0 0 rg BT 396.42 569.10 Td (or ) Tj ET Q q 0 0 0 rg BT 407.25 569.10 Td (other ) Tj ET Q q 0 0 0 rg BT 430.30 569.10 Td (product ) Tj ET Q q 0 0 0 rg BT 463.35 569.10 Td (diversions.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (The ) Tj ET Q q 0 0 0 rg BT 55.22 545.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 74.67 545.10 Td ( ) Tj ET Q q 0 0 0 rg BT 77.54 545.10 Td (Amendments ) Tj ET Q q 0 0 0 rg BT 133.73 545.10 Td (Act ) Tj ET Q q 0 0 0 rg BT 151.84 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 163.84 545.10 Td (2007 ) Tj ET Q q 0 0 0 rg BT 187.52 545.10 Td (imposed ) Tj ET Q q 0 0 0 rg BT 225.08 545.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 268.74 545.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 316.86 545.10 Td (on ) Tj ET Q q 0 0 0 rg BT 330.54 545.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 395.28 545.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 441.72 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 459.83 545.10 Td (delegated ) Tj ET Q q 0 0 0 rg BT 501.82 545.10 Td (more ) Tj ET Q q 0 0 0 rg BT 526.04 545.10 Td (enforcement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (authority ) Tj ET Q q 0 0 0 rg BT 75.09 533.10 Td (to ) Tj ET Q q 0 0 0 rg BT 85.86 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.07 533.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 120.52 533.10 Td ( ) Tj ET Q q 0 0 0 rg BT 123.51 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 134.28 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 149.49 533.10 Td (area ) Tj ET Q q 0 0 0 rg BT 169.13 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 180.45 533.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 201.77 533.10 Td (safety) Tj ET Q q 0 0 0 rg BT 225.00 533.10 Td (. ) Tj ET Q q 0 0 0 rg BT 230.49 533.10 Td (Key ) Tj ET Q q 0 0 0 rg BT 250.14 533.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 288.67 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 299.99 533.10 Td (this ) Tj ET Q q 0 0 0 rg BT 317.43 533.10 Td (legislation ) Tj ET Q q 0 0 0 rg BT 362.08 533.10 Td (give ) Tj ET Q q 0 0 0 rg BT 382.29 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 397.50 533.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 416.95 533.10 Td ( ) Tj ET Q q 0 0 0 rg BT 419.94 533.10 Td (authority ) Tj ET Q q 0 0 0 rg BT 459.03 533.10 Td (to ) Tj ET Q q 0 0 0 rg BT 469.80 533.10 Td (\(1\) require ) Tj ET Q q 0 0 0 rg BT 515.27 533.10 Td (that ) Tj ET Q q 0 0 0 rg BT 533.26 533.10 Td (companies ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (conduct ) Tj ET Q q 0 0 0 rg BT 70.27 521.10 Td (post-marketing ) Tj ET Q q 0 0 0 rg BT 133.44 521.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 159.93 521.10 Td (studies ) Tj ET Q q 0 0 0 rg BT 190.33 521.10 Td (of ) Tj ET Q q 0 0 0 rg BT 201.28 521.10 Td (drugs, ) Tj ET Q q 0 0 0 rg BT 228.62 521.10 Td (\(2\) impose ) Tj ET Q q 0 0 0 rg BT 274.29 521.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 304.11 521.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 325.06 521.10 Td (labeling ) Tj ET Q q 0 0 0 rg BT 359.89 521.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 394.72 521.10 Td (relating ) Tj ET Q q 0 0 0 rg BT 427.88 521.10 Td (to ) Tj ET Q q 0 0 0 rg BT 438.28 521.10 Td (safety) Tj ET Q q 0 0 0 rg BT 461.51 521.10 Td (, ) Tj ET Q q 0 0 0 rg BT 466.63 521.10 Td (\(3\) mandate ) Tj ET Q q 0 0 0 rg BT 517.28 521.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 534.90 521.10 Td (mitigation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.10 Td (measures ) Tj ET Q q 0 0 0 rg BT 76.19 509.10 Td (such ) Tj ET Q q 0 0 0 rg BT 97.51 509.10 Td (as ) Tj ET Q q 0 0 0 rg BT 108.82 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 124.02 509.10 Td (education ) Tj ET Q q 0 0 0 rg BT 165.88 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 177.20 509.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 221.26 509.10 Td (providers ) Tj ET Q q 0 0 0 rg BT 262.01 509.10 Td (and ) Tj ET Q q 0 0 0 rg BT 279.44 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 294.64 509.10 Td (restricted ) Tj ET Q q 0 0 0 rg BT 334.82 509.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 383.92 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 395.24 509.10 Td (medicines, ) Tj ET Q q 0 0 0 rg BT 441.26 509.10 Td (\(4\) require ) Tj ET Q q 0 0 0 rg BT 486.73 509.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 532.47 509.10 Td (to ) Tj ET Q q 0 0 0 rg BT 543.24 509.10 Td (publicly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (disclose ) Tj ET Q q 0 0 0 rg BT 70.72 497.10 Td (data ) Tj ET Q q 0 0 0 rg BT 89.87 497.10 Td (from ) Tj ET Q q 0 0 0 rg BT 111.81 497.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 143.74 497.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 166.23 497.10 Td (and ) Tj ET Q q 0 0 0 rg BT 183.17 497.10 Td (\(5\) pre-review ) Tj ET Q q 0 0 0 rg BT 243.14 497.10 Td (television ) Tj ET Q q 0 0 0 rg BT 284.52 497.10 Td (advertisements.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.67 473.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 96.33 473.10 Td (practices ) Tj ET Q q 0 0 0 rg BT 133.99 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 144.44 473.10 Td (all ) Tj ET Q q 0 0 0 rg BT 156.56 473.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 176.47 473.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 239.67 473.10 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 298.98 473.10 Td (are ) Tj ET Q q 0 0 0 rg BT 313.31 473.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 343.76 473.10 Td (to ) Tj ET Q q 0 0 0 rg BT 353.66 473.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 385.77 473.10 Td (and ) Tj ET Q q 0 0 0 rg BT 402.33 473.10 Td (state ) Tj ET Q q 0 0 0 rg BT 422.78 473.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 465.98 473.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 486.43 473.10 Td (that ) Tj ET Q q 0 0 0 rg BT 503.55 473.10 Td (are ) Tj ET Q q 0 0 0 rg BT 517.88 473.10 Td (used ) Tj ET Q q 0 0 0 rg BT 538.33 473.10 Td (to ) Tj ET Q q 0 0 0 rg BT 548.24 473.10 Td (protect ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.25 461.10 Td (integrity ) Tj ET Q q 0 0 0 rg BT 88.16 461.10 Td (of ) Tj ET Q q 0 0 0 rg BT 99.52 461.10 Td (government ) Tj ET Q q 0 0 0 rg BT 150.32 461.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 194.43 461.10 Td (programs. ) Tj ET Q q 0 0 0 rg BT 237.51 461.10 Td (The ) Tj ET Q q 0 0 0 rg BT 256.09 461.10 Td (OIG ) Tj ET Q q 0 0 0 rg BT 276.89 461.10 Td (oversees ) Tj ET Q q 0 0 0 rg BT 314.35 461.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 363.47 461.10 Td (with ) Tj ET Q q 0 0 0 rg BT 384.28 461.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 428.40 461.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 461.42 461.10 Td (laws, ) Tj ET Q q 0 0 0 rg BT 485.28 461.10 Td (in ) Tj ET Q q 0 0 0 rg BT 496.09 461.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 542.99 461.10 Td (with ) Tj ET Q q 0 0 0 rg BT 563.80 461.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 72.42 449.10 Td (for ) Tj ET Q q 0 0 0 rg BT 86.06 449.10 Td (products ) Tj ET Q q 0 0 0 rg BT 122.48 449.10 Td (by ) Tj ET Q q 0 0 0 rg BT 134.46 449.10 Td (government ) Tj ET Q q 0 0 0 rg BT 184.21 449.10 Td (funded ) Tj ET Q q 0 0 0 rg BT 213.96 449.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 253.71 449.10 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 296.23 449.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 335.98 449.10 Td (and ) Tj ET Q q 0 0 0 rg BT 352.40 449.10 Td (Medicare\). ) Tj ET Q q 0 0 0 rg BT 397.82 449.10 Td (These ) Tj ET Q q 0 0 0 rg BT 423.68 449.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 444.00 449.10 Td (include ) Tj ET Q q 0 0 0 rg BT 475.41 449.10 Td (the ) Tj ET Q q 0 0 0 rg BT 489.61 449.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 521.58 449.10 Td (anti-kickback ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (statute, ) Tj ET Q q 0 0 0 rg BT 67.20 437.10 Td (which ) Tj ET Q q 0 0 0 rg BT 94.23 437.10 Td (criminalizes ) Tj ET Q q 0 0 0 rg BT 145.69 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 160.50 437.10 Td (of) Tj ET Q q 0 0 0 rg BT 168.65 437.10 Td (fering ) Tj ET Q q 0 0 0 rg BT 195.12 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 206.04 437.10 Td (something ) Tj ET Q q 0 0 0 rg BT 250.30 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 261.22 437.10 Td (value ) Tj ET Q q 0 0 0 rg BT 285.47 437.10 Td (to ) Tj ET Q q 0 0 0 rg BT 295.84 437.10 Td (induce ) Tj ET Q q 0 0 0 rg BT 325.09 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 339.90 437.10 Td (recommendation, ) Tj ET Q q 0 0 0 rg BT 412.19 437.10 Td (order ) Tj ET Q q 0 0 0 rg BT 435.88 437.10 Td (or ) Tj ET Q q 0 0 0 rg BT 446.80 437.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 484.93 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 495.85 437.10 Td (products ) Tj ET Q q 0 0 0 rg BT 532.88 437.10 Td (or ) Tj ET Q q 0 0 0 rg BT 543.81 437.10 Td (services ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.10 Td (reimbursed ) Tj ET Q q 0 0 0 rg BT 83.73 425.10 Td (under ) Tj ET Q q 0 0 0 rg BT 109.24 425.10 Td (a ) Tj ET Q q 0 0 0 rg BT 116.42 425.10 Td (government ) Tj ET Q q 0 0 0 rg BT 166.93 425.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 210.76 425.10 Td (program. ) Tj ET Q q 0 0 0 rg BT 249.68 425.10 Td (The ) Tj ET Q q 0 0 0 rg BT 267.97 425.10 Td (OIG ) Tj ET Q q 0 0 0 rg BT 288.49 425.10 Td (has ) Tj ET Q q 0 0 0 rg BT 304.56 425.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 332.31 425.10 Td (a ) Tj ET Q q 0 0 0 rg BT 339.49 425.10 Td (series ) Tj ET Q q 0 0 0 rg BT 365.00 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 376.08 425.10 Td (Guidances ) Tj ET Q q 0 0 0 rg BT 421.03 425.10 Td (to ) Tj ET Q q 0 0 0 rg BT 431.55 425.10 Td (segments ) Tj ET Q q 0 0 0 rg BT 471.51 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 482.58 425.10 Td (the ) Tj ET Q q 0 0 0 rg BT 497.54 425.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 541.37 425.10 Td (industry) Tj ET Q q 0 0 0 rg BT 573.50 425.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.10 Td (including ) Tj ET Q q 0 0 0 rg BT 79.19 413.10 Td (the ) Tj ET Q q 0 0 0 rg BT 96.83 413.10 Td (2003 ) Tj ET Q q 0 0 0 rg BT 122.25 413.10 Td (Compliance ) Tj ET Q q 0 0 0 rg BT 175.98 413.10 Td (Program ) Tj ET Q q 0 0 0 rg BT 215.84 413.10 Td (Guidance ) Tj ET Q q 0 0 0 rg BT 259.58 413.10 Td (for ) Tj ET Q q 0 0 0 rg BT 276.65 413.10 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 343.71 413.10 Td (Manufacturers, ) Tj ET Q q 0 0 0 rg BT 409.93 413.10 Td (which ) Tj ET Q q 0 0 0 rg BT 439.79 413.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 478.53 413.10 Td (a ) Tj ET Q q 0 0 0 rg BT 488.39 413.10 Td (recommendation ) Tj ET Q q 0 0 0 rg BT 561.01 413.10 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 98.80 401.10 Td (manufacturers, ) Tj ET Q q 0 0 0 rg BT 160.22 401.10 Td (at ) Tj ET Q q 0 0 0 rg BT 169.17 401.10 Td (a ) Tj ET Q q 0 0 0 rg BT 175.34 401.10 Td (minimum, ) Tj ET Q q 0 0 0 rg BT 218.46 401.10 Td (adhere ) Tj ET Q q 0 0 0 rg BT 246.83 401.10 Td (to ) Tj ET Q q 0 0 0 rg BT 256.34 401.10 Td (the ) Tj ET Q q 0 0 0 rg BT 270.28 401.10 Td (PhRMA) Tj ET Q q 0 0 0 rg BT 303.08 401.10 Td ( ) Tj ET Q q 0 0 0 rg BT 304.80 401.10 Td (Code, ) Tj ET Q q 0 0 0 rg BT 330.14 401.10 Td (a ) Tj ET Q q 0 0 0 rg BT 336.31 401.10 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 376.36 401.10 Td (industry ) Tj ET Q q 0 0 0 rg BT 410.87 401.10 Td (code ) Tj ET Q q 0 0 0 rg BT 431.47 401.10 Td (of ) Tj ET Q q 0 0 0 rg BT 441.53 401.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 483.80 401.10 Td (practices. ) Tj ET Q q 0 0 0 rg BT 523.44 401.10 Td (W) Tj ET Q q 0 0 0 rg BT 532.08 401.10 Td (e ) Tj ET Q q 0 0 0 rg BT 538.24 401.10 Td (subscribe ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.10 Td (to ) Tj ET Q q 0 0 0 rg BT 45.25 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 58.95 389.10 Td (PhRMA) Tj ET Q q 0 0 0 rg BT 91.74 389.10 Td ( ) Tj ET Q q 0 0 0 rg BT 93.22 389.10 Td (Code, ) Tj ET Q q 0 0 0 rg BT 118.30 389.10 Td (and ) Tj ET Q q 0 0 0 rg BT 134.22 389.10 Td (have ) Tj ET Q q 0 0 0 rg BT 154.57 389.10 Td (implemented ) Tj ET Q q 0 0 0 rg BT 208.25 389.10 Td (a ) Tj ET Q q 0 0 0 rg BT 214.17 389.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 261.73 389.10 Td (program ) Tj ET Q q 0 0 0 rg BT 297.08 389.10 Td (to ) Tj ET Q q 0 0 0 rg BT 306.34 389.10 Td (address ) Tj ET Q q 0 0 0 rg BT 337.80 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 351.50 389.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 405.18 389.10 Td (set ) Tj ET Q q 0 0 0 rg BT 417.76 389.10 Td (forth ) Tj ET Q q 0 0 0 rg BT 438.67 389.10 Td (in ) Tj ET Q q 0 0 0 rg BT 447.93 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 461.62 389.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 499.19 389.10 Td (and ) Tj ET Q q 0 0 0 rg BT 515.11 389.10 Td (our ) Tj ET Q q 0 0 0 rg BT 529.91 389.10 Td (compliance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.10 Td (with ) Tj ET Q q 0 0 0 rg BT 55.75 377.10 Td (the ) Tj ET Q q 0 0 0 rg BT 69.93 377.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 112.98 377.10 Td (laws. ) Tj ET Q q 0 0 0 rg BT 135.78 377.10 Td (Failure ) Tj ET Q q 0 0 0 rg BT 166.07 377.10 Td (to ) Tj ET Q q 0 0 0 rg BT 175.81 377.10 Td (comply ) Tj ET Q q 0 0 0 rg BT 207.78 377.10 Td (with ) Tj ET Q q 0 0 0 rg BT 227.52 377.10 Td (these ) Tj ET Q q 0 0 0 rg BT 250.04 377.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 293.08 377.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 313.38 377.10 Td (could ) Tj ET Q q 0 0 0 rg BT 337.57 377.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 367.86 377.10 Td (us ) Tj ET Q q 0 0 0 rg BT 378.72 377.10 Td (to ) Tj ET Q q 0 0 0 rg BT 388.47 377.10 Td (administrative ) Tj ET Q q 0 0 0 rg BT 447.64 377.10 Td (and ) Tj ET Q q 0 0 0 rg BT 464.05 377.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 485.45 377.10 Td (proceedings, ) Tj ET Q q 0 0 0 rg BT 538.23 377.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 66.50 365.10 Td (by ) Tj ET Q q 0 0 0 rg BT 78.67 365.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 110.83 365.10 Td (and ) Tj ET Q q 0 0 0 rg BT 127.45 365.10 Td (state ) Tj ET Q q 0 0 0 rg BT 147.95 365.10 Td (government ) Tj ET Q q 0 0 0 rg BT 197.88 365.10 Td (agencies. ) Tj ET Q q 0 0 0 rg BT 236.98 365.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 259.16 365.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 289.66 365.10 Td (could ) Tj ET Q q 0 0 0 rg BT 314.05 365.10 Td (result ) Tj ET Q q 0 0 0 rg BT 338.44 365.10 Td (in ) Tj ET Q q 0 0 0 rg BT 348.39 365.10 Td (the ) Tj ET Q q 0 0 0 rg BT 362.78 365.10 Td (imposition ) Tj ET Q q 0 0 0 rg BT 407.74 365.10 Td (of ) Tj ET Q q 0 0 0 rg BT 418.24 365.10 Td (civil ) Tj ET Q q 0 0 0 rg BT 438.19 365.10 Td (and ) Tj ET Q q 0 0 0 rg BT 454.80 365.10 Td (criminal ) Tj ET Q q 0 0 0 rg BT 490.30 365.10 Td (sanctions, ) Tj ET Q q 0 0 0 rg BT 532.19 365.10 Td (which ) Tj ET Q q 0 0 0 rg BT 558.80 365.10 Td (may ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.10 Td (include ) Tj ET Q q 0 0 0 rg BT 67.89 353.10 Td (fines, ) Tj ET Q q 0 0 0 rg BT 92.28 353.10 Td (penalties ) Tj ET Q q 0 0 0 rg BT 130.28 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 147.18 353.10 Td (injunctive ) Tj ET Q q 0 0 0 rg BT 189.62 353.10 Td (remedies, ) Tj ET Q q 0 0 0 rg BT 230.67 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 245.35 353.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 275.01 353.10 Td (of ) Tj ET Q q 0 0 0 rg BT 285.80 353.10 Td (which ) Tj ET Q q 0 0 0 rg BT 312.69 353.10 Td (could ) Tj ET Q q 0 0 0 rg BT 337.37 353.10 Td (materially ) Tj ET Q q 0 0 0 rg BT 380.36 353.10 Td (adversely ) Tj ET Q q 0 0 0 rg BT 421.13 353.10 Td (af) Tj ET Q q 0 0 0 rg BT 428.72 353.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 446.16 353.10 Td (our ) Tj ET Q q 0 0 0 rg BT 461.95 353.10 Td (business, ) Tj ET Q q 0 0 0 rg BT 500.79 353.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 538.23 353.10 Td (condition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 341.10 Td (results ) Tj ET Q q 0 0 0 rg BT 81.55 341.10 Td (of ) Tj ET Q q 0 0 0 rg BT 92.38 341.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 136.53 341.10 Td (and ) Tj ET Q q 0 0 0 rg BT 153.47 341.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 173.74 341.10 Td (flows.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 317.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.64 317.10 Td (are ) Tj ET Q q 0 0 0 rg BT 66.41 317.10 Td (also ) Tj ET Q q 0 0 0 rg BT 85.08 317.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 115.97 317.10 Td (to ) Tj ET Q q 0 0 0 rg BT 126.31 317.10 Td (the ) Tj ET Q q 0 0 0 rg BT 141.09 317.10 Td (jurisdiction ) Tj ET Q q 0 0 0 rg BT 189.21 317.10 Td (of ) Tj ET Q q 0 0 0 rg BT 200.10 317.10 Td (various ) Tj ET Q q 0 0 0 rg BT 232.10 317.10 Td (other ) Tj ET Q q 0 0 0 rg BT 255.21 317.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 287.76 317.10 Td (and ) Tj ET Q q 0 0 0 rg BT 304.76 317.10 Td (state ) Tj ET Q q 0 0 0 rg BT 325.65 317.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 369.31 317.10 Td (and ) Tj ET Q q 0 0 0 rg BT 386.31 317.10 Td (enforcement ) Tj ET Q q 0 0 0 rg BT 438.85 317.10 Td (departments ) Tj ET Q q 0 0 0 rg BT 490.28 317.10 Td (and ) Tj ET Q q 0 0 0 rg BT 507.28 317.10 Td (agencies, ) Tj ET Q q 0 0 0 rg BT 546.77 317.10 Td (such ) Tj ET Q q 0 0 0 rg BT 567.67 317.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.14 305.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 83.85 305.10 Td (T) Tj ET Q q 0 0 0 rg BT 89.60 305.10 Td (rade ) Tj ET Q q 0 0 0 rg BT 109.74 305.10 Td (Commission, ) Tj ET Q q 0 0 0 rg BT 165.73 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 180.87 305.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 231.00 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 242.26 305.10 Td (Justice ) Tj ET Q q 0 0 0 rg BT 272.40 305.10 Td (and ) Tj ET Q q 0 0 0 rg BT 289.77 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 304.91 305.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 355.04 305.10 Td (of ) Tj ET Q q 0 0 0 rg BT 366.30 305.10 Td (Health ) Tj ET Q q 0 0 0 rg BT 395.88 305.10 Td (and ) Tj ET Q q 0 0 0 rg BT 413.25 305.10 Td (Human ) Tj ET Q q 0 0 0 rg BT 445.62 305.10 Td (Services ) Tj ET Q q 0 0 0 rg BT 482.42 305.10 Td (in ) Tj ET Q q 0 0 0 rg BT 493.13 305.10 Td (the ) Tj ET Q q 0 0 0 rg BT 508.27 305.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 528.77 305.10 Td (W) Tj ET Q q 0 0 0 rg BT 537.41 305.10 Td (e ) Tj ET Q q 0 0 0 rg BT 544.77 305.10 Td (are ) Tj ET Q q 0 0 0 rg BT 559.91 305.10 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.10 Td (licensed ) Tj ET Q q 0 0 0 rg BT 72.04 293.10 Td (by ) Tj ET Q q 0 0 0 rg BT 85.31 293.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.79 293.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 121.85 293.10 Td (Drug ) Tj ET Q q 0 0 0 rg BT 145.67 293.10 Td (Enforcement ) Tj ET Q q 0 0 0 rg BT 199.86 293.10 Td (Agency ) Tj ET Q q 0 0 0 rg BT 234.23 293.10 Td (to ) Tj ET Q q 0 0 0 rg BT 245.28 293.10 Td (procure ) Tj ET Q q 0 0 0 rg BT 279.09 293.10 Td (and ) Tj ET Q q 0 0 0 rg BT 296.80 293.10 Td (produce ) Tj ET Q q 0 0 0 rg BT 332.28 293.10 Td (controlled ) Tj ET Q q 0 0 0 rg BT 376.09 293.10 Td (substances. ) Tj ET Q q 0 0 0 rg BT 424.40 293.10 Td (W) Tj ET Q q 0 0 0 rg BT 433.03 293.10 Td (e ) Tj ET Q q 0 0 0 rg BT 440.74 293.10 Td (are, ) Tj ET Q q 0 0 0 rg BT 458.72 293.10 Td (therefore, ) Tj ET Q q 0 0 0 rg BT 500.58 293.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 532.18 293.10 Td (to ) Tj ET Q q 0 0 0 rg BT 543.23 293.10 Td (possible ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.10 Td (administrative ) Tj ET Q q 0 0 0 rg BT 95.67 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 112.56 281.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 134.45 281.10 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 185.23 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 202.13 281.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 232.91 281.10 Td (by ) Tj ET Q q 0 0 0 rg BT 245.37 281.10 Td (these ) Tj ET Q q 0 0 0 rg BT 268.37 281.10 Td (or) Tj ET Q q 0 0 0 rg BT 276.52 281.10 Td (ganizations. ) Tj ET Q q 0 0 0 rg BT 327.02 281.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 349.48 281.10 Td (actions ) Tj ET Q q 0 0 0 rg BT 380.27 281.10 Td (may ) Tj ET Q q 0 0 0 rg BT 399.94 281.10 Td (result ) Tj ET Q q 0 0 0 rg BT 424.62 281.10 Td (in ) Tj ET Q q 0 0 0 rg BT 434.85 281.10 Td (the ) Tj ET Q q 0 0 0 rg BT 449.53 281.10 Td (imposition ) Tj ET Q q 0 0 0 rg BT 494.77 281.10 Td (of ) Tj ET Q q 0 0 0 rg BT 505.56 281.10 Td (civil ) Tj ET Q q 0 0 0 rg BT 525.79 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 542.69 281.10 Td (criminal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.10 Td (sanctions, ) Tj ET Q q 0 0 0 rg BT 78.22 269.10 Td (which ) Tj ET Q q 0 0 0 rg BT 105.16 269.10 Td (may ) Tj ET Q q 0 0 0 rg BT 124.87 269.10 Td (include ) Tj ET Q q 0 0 0 rg BT 156.81 269.10 Td (fines, ) Tj ET Q q 0 0 0 rg BT 181.24 269.10 Td (penalties ) Tj ET Q q 0 0 0 rg BT 219.29 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 236.22 269.10 Td (injunctive ) Tj ET Q q 0 0 0 rg BT 278.71 269.10 Td (or ) Tj ET Q q 0 0 0 rg BT 289.54 269.10 Td (administrative ) Tj ET Q q 0 0 0 rg BT 349.25 269.10 Td (remedies.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.62 245.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 73.48 245.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 116.64 245.10 Td (industry ) Tj ET Q q 0 0 0 rg BT 151.49 245.10 Td (is ) Tj ET Q q 0 0 0 rg BT 160.24 245.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 190.64 245.10 Td (to ) Tj ET Q q 0 0 0 rg BT 200.50 245.10 Td (various ) Tj ET Q q 0 0 0 rg BT 232.01 245.10 Td (government-imposed ) Tj ET Q q 0 0 0 rg BT 319.07 245.10 Td (regulations ) Tj ET Q q 0 0 0 rg BT 365.58 245.10 Td (authorizing ) Tj ET Q q 0 0 0 rg BT 413.20 245.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 439.15 245.10 Td (or ) Tj ET Q q 0 0 0 rg BT 449.56 245.10 Td (price ) Tj ET Q q 0 0 0 rg BT 471.62 245.10 Td (controls ) Tj ET Q q 0 0 0 rg BT 505.91 245.10 Td (that ) Tj ET Q q 0 0 0 rg BT 522.99 245.10 Td (have ) Tj ET Q q 0 0 0 rg BT 543.94 245.10 Td (and ) Tj ET Q q 0 0 0 rg BT 560.46 245.10 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 72.02 233.10 Td (to ) Tj ET Q q 0 0 0 rg BT 81.39 233.10 Td (have ) Tj ET Q q 0 0 0 rg BT 101.85 233.10 Td (an ) Tj ET Q q 0 0 0 rg BT 112.88 233.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 141.68 233.10 Td (on ) Tj ET Q q 0 0 0 rg BT 153.27 233.10 Td (our ) Tj ET Q q 0 0 0 rg BT 168.19 233.10 Td (total ) Tj ET Q q 0 0 0 rg BT 187.55 233.10 Td (revenues. ) Tj ET Q q 0 0 0 rg BT 227.06 233.10 Td (W) Tj ET Q q 0 0 0 rg BT 235.70 233.10 Td (e ) Tj ET Q q 0 0 0 rg BT 241.72 233.10 Td (participate ) Tj ET Q q 0 0 0 rg BT 285.51 233.10 Td (in ) Tj ET Q q 0 0 0 rg BT 294.88 233.10 Td (state ) Tj ET Q q 0 0 0 rg BT 314.79 233.10 Td (government ) Tj ET Q q 0 0 0 rg BT 364.14 233.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 403.49 233.10 Td (programs, ) Tj ET Q q 0 0 0 rg BT 445.35 233.10 Td (as ) Tj ET Q q 0 0 0 rg BT 455.27 233.10 Td (well ) Tj ET Q q 0 0 0 rg BT 474.08 233.10 Td (as ) Tj ET Q q 0 0 0 rg BT 483.99 233.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 512.78 233.10 Td (other ) Tj ET Q q 0 0 0 rg BT 534.92 233.10 Td (qualifying ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 68.30 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 85.05 221.10 Td (state ) Tj ET Q q 0 0 0 rg BT 105.69 221.10 Td (government ) Tj ET Q q 0 0 0 rg BT 155.77 221.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 195.85 221.10 Td (whereby ) Tj ET Q q 0 0 0 rg BT 232.60 221.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 272.69 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 289.44 221.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 320.07 221.10 Td (are ) Tj ET Q q 0 0 0 rg BT 334.59 221.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 372.46 221.10 Td (to ) Tj ET Q q 0 0 0 rg BT 382.55 221.10 Td (participating ) Tj ET Q q 0 0 0 rg BT 435.40 221.10 Td (state ) Tj ET Q q 0 0 0 rg BT 456.04 221.10 Td (and ) Tj ET Q q 0 0 0 rg BT 472.79 221.10 Td (local ) Tj ET Q q 0 0 0 rg BT 494.54 221.10 Td (government ) Tj ET Q q 0 0 0 rg BT 544.62 221.10 Td (entities. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 209.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.63 209.10 Td (also ) Tj ET Q q 0 0 0 rg BT 70.29 209.10 Td (participate ) Tj ET Q q 0 0 0 rg BT 115.04 209.10 Td (in ) Tj ET Q q 0 0 0 rg BT 125.37 209.10 Td (government ) Tj ET Q q 0 0 0 rg BT 175.68 209.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 216.00 209.10 Td (that ) Tj ET Q q 0 0 0 rg BT 233.55 209.10 Td (specify ) Tj ET Q q 0 0 0 rg BT 264.97 209.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 305.30 209.10 Td (to ) Tj ET Q q 0 0 0 rg BT 315.63 209.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 345.39 209.10 Td (government ) Tj ET Q q 0 0 0 rg BT 395.70 209.10 Td (entities, ) Tj ET Q q 0 0 0 rg BT 429.64 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 444.40 209.10 Td (most ) Tj ET Q q 0 0 0 rg BT 466.40 209.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 511.17 209.10 Td (of ) Tj ET Q q 0 0 0 rg BT 522.05 209.10 Td (which ) Tj ET Q q 0 0 0 rg BT 549.04 209.10 Td (are ) Tj ET Q q 0 0 0 rg BT 563.80 209.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 56.03 197.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 105.49 197.10 Td (of ) Tj ET Q q 0 0 0 rg BT 116.07 197.10 Td (Defense ) Tj ET Q q 0 0 0 rg BT 151.07 197.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.76 197.10 Td (the ) Tj ET Q q 0 0 0 rg BT 182.23 197.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 202.26 197.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 251.71 197.10 Td (of ) Tj ET Q q 0 0 0 rg BT 262.13 197.10 Td (V) Tj ET Q q 0 0 0 rg BT 268.25 197.10 Td (eterans ) Tj ET Q q 0 0 0 rg BT 298.31 197.10 Td (Af) Tj ET Q q 0 0 0 rg BT 308.69 197.10 Td (fairs. ) Tj ET Q q 0 0 0 rg BT 331.04 197.10 Td (These ) Tj ET Q q 0 0 0 rg BT 357.17 197.10 Td (entities ) Tj ET Q q 0 0 0 rg BT 388.30 197.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 419.41 197.10 Td (minimum ) Tj ET Q q 0 0 0 rg BT 460.55 197.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 500.58 197.10 Td (based ) Tj ET Q q 0 0 0 rg BT 525.60 197.10 Td (of) Tj ET Q q 0 0 0 rg BT 533.75 197.10 Td (f ) Tj ET Q q 0 0 0 rg BT 539.33 197.10 Td (a ) Tj ET Q q 0 0 0 rg BT 546.02 197.10 Td (defined ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.10 Td (“non-federal ) Tj ET Q q 0 0 0 rg BT 88.66 185.10 Td (average ) Tj ET Q q 0 0 0 rg BT 121.87 185.10 Td (manufacturer ) Tj ET Q q 0 0 0 rg BT 177.31 185.10 Td (price” ) Tj ET Q q 0 0 0 rg BT 203.86 185.10 Td (for ) Tj ET Q q 0 0 0 rg BT 217.66 185.10 Td (purchases. ) Tj ET Q q 0 0 0 rg BT 261.25 185.10 Td (As ) Tj ET Q q 0 0 0 rg BT 274.49 185.10 Td (a ) Tj ET Q q 0 0 0 rg BT 281.06 185.10 Td (result ) Tj ET Q q 0 0 0 rg BT 305.41 185.10 Td (of ) Tj ET Q q 0 0 0 rg BT 315.88 185.10 Td (the ) Tj ET Q q 0 0 0 rg BT 330.23 185.10 Td (Patient ) Tj ET Q q 0 0 0 rg BT 360.13 185.10 Td (Protection ) Tj ET Q q 0 0 0 rg BT 403.37 185.10 Td (and ) Tj ET Q q 0 0 0 rg BT 419.47 185.10 Td (Af) Tj ET Q q 0 0 0 rg BT 429.84 185.10 Td (fordable ) Tj ET Q q 0 0 0 rg BT 465.29 185.10 Td (Care ) Tj ET Q q 0 0 0 rg BT 485.83 185.10 Td (Act ) Tj ET Q q 0 0 0 rg BT 502.40 185.10 Td (\(HR ) Tj ET Q q 0 0 0 rg BT 521.75 185.10 Td (3590\) ) Tj ET Q q 0 0 0 rg BT 547.22 185.10 Td (and ) Tj ET Q q 0 0 0 rg BT 563.79 185.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.10 Td (reconciliation ) Tj ET Q q 0 0 0 rg BT 93.11 173.10 Td (bill ) Tj ET Q q 0 0 0 rg BT 108.58 173.10 Td (containing ) Tj ET Q q 0 0 0 rg BT 152.92 173.10 Td (a ) Tj ET Q q 0 0 0 rg BT 159.49 173.10 Td (package ) Tj ET Q q 0 0 0 rg BT 194.38 173.10 Td (of ) Tj ET Q q 0 0 0 rg BT 204.84 173.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 239.18 173.10 Td (to ) Tj ET Q q 0 0 0 rg BT 249.09 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 263.44 173.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 306.65 173.10 Td (bill, ) Tj ET Q q 0 0 0 rg BT 324.62 173.10 Td (we ) Tj ET Q q 0 0 0 rg BT 338.42 173.10 Td (have ) Tj ET Q q 0 0 0 rg BT 359.42 173.10 Td (experienced ) Tj ET Q q 0 0 0 rg BT 409.86 173.10 Td (and ) Tj ET Q q 0 0 0 rg BT 426.43 173.10 Td (will ) Tj ET Q q 0 0 0 rg BT 444.12 173.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 480.69 173.10 Td (to ) Tj ET Q q 0 0 0 rg BT 490.60 173.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 536.03 173.10 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 73.02 161.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 95.05 161.10 Td (and ) Tj ET Q q 0 0 0 rg BT 111.53 161.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 140.77 161.10 Td (other ) Tj ET Q q 0 0 0 rg BT 163.35 161.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 197.59 161.10 Td (to ) Tj ET Q q 0 0 0 rg BT 207.41 161.10 Td (our ) Tj ET Q q 0 0 0 rg BT 222.77 161.10 Td (business. ) Tj ET Q q 0 0 0 rg BT 261.20 161.10 Td (For ) Tj ET Q q 0 0 0 rg BT 277.13 161.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 315.54 161.10 Td (minimum ) Tj ET Q q 0 0 0 rg BT 356.46 161.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 386.82 161.10 Td (on ) Tj ET Q q 0 0 0 rg BT 398.85 161.10 Td (our ) Tj ET Q q 0 0 0 rg BT 414.22 161.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 454.02 161.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 474.38 161.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 495.86 161.10 Td (have ) Tj ET Q q 0 0 0 rg BT 516.77 161.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 556.56 161.10 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 149.10 Td (15.1 ) Tj ET Q q 0 0 0 rg BT 55.80 149.10 Td (percent ) Tj ET Q q 0 0 0 rg BT 87.52 149.10 Td (to ) Tj ET Q q 0 0 0 rg BT 97.60 149.10 Td (23.1 ) Tj ET Q q 0 0 0 rg BT 117.40 149.10 Td (percent ) Tj ET Q q 0 0 0 rg BT 149.12 149.10 Td (and ) Tj ET Q q 0 0 0 rg BT 165.86 149.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 205.92 149.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 236.53 149.10 Td (have ) Tj ET Q q 0 0 0 rg BT 257.71 149.10 Td (also ) Tj ET Q q 0 0 0 rg BT 276.12 149.10 Td (been ) Tj ET Q q 0 0 0 rg BT 297.29 149.10 Td (extended ) Tj ET Q q 0 0 0 rg BT 335.69 149.10 Td (to ) Tj ET Q q 0 0 0 rg BT 345.76 149.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 370.28 149.10 Td (used ) Tj ET Q q 0 0 0 rg BT 390.91 149.10 Td (in ) Tj ET Q q 0 0 0 rg BT 400.99 149.10 Td (risk-based ) Tj ET Q q 0 0 0 rg BT 444.39 149.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 484.45 149.10 Td (managed ) Tj ET Q q 0 0 0 rg BT 522.84 149.10 Td (care ) Tj ET Q q 0 0 0 rg BT 541.79 149.10 Td (plans. ) Tj ET Q q 0 0 0 rg BT 567.69 149.10 Td (In ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 137.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 73.42 137.10 Td (we ) Tj ET Q q 0 0 0 rg BT 87.22 137.10 Td (extend ) Tj ET Q q 0 0 0 rg BT 116.02 137.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 155.95 137.10 Td (to ) Tj ET Q q 0 0 0 rg BT 165.87 137.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 195.22 137.10 Td (critical ) Tj ET Q q 0 0 0 rg BT 225.12 137.10 Td (access ) Tj ET Q q 0 0 0 rg BT 252.80 137.10 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 293.01 137.10 Td (cancer ) Tj ET Q q 0 0 0 rg BT 321.23 137.10 Td (hospitals ) Tj ET Q q 0 0 0 rg BT 358.94 137.10 Td (and ) Tj ET Q q 0 0 0 rg BT 375.52 137.10 Td (other ) Tj ET Q q 0 0 0 rg BT 398.21 137.10 Td (covered ) Tj ET Q q 0 0 0 rg BT 432.00 137.10 Td (entities ) Tj ET Q q 0 0 0 rg BT 463.03 137.10 Td (as ) Tj ET Q q 0 0 0 rg BT 473.50 137.10 Td (required ) Tj ET Q q 0 0 0 rg BT 508.96 137.10 Td (by ) Tj ET Q q 0 0 0 rg BT 521.11 137.10 Td (the ) Tj ET Q q 0 0 0 rg BT 535.47 137.10 Td (expansion ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 125.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.55 125.10 Td (340B ) Tj ET Q q 0 0 0 rg BT 85.72 125.10 Td (Drug ) Tj ET Q q 0 0 0 rg BT 108.77 125.10 Td (Pricing ) Tj ET Q q 0 0 0 rg BT 140.16 125.10 Td (Program ) Tj ET Q q 0 0 0 rg BT 177.09 125.10 Td (under ) Tj ET Q q 0 0 0 rg BT 202.36 125.10 Td (the ) Tj ET Q q 0 0 0 rg BT 217.08 125.10 Td (Public ) Tj ET Q q 0 0 0 rg BT 245.14 125.10 Td (Health ) Tj ET Q q 0 0 0 rg BT 274.29 125.10 Td (Service ) Tj ET Q q 0 0 0 rg BT 306.22 125.10 Td (Act.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 101.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.28 101.10 Td (are ) Tj ET Q q 0 0 0 rg BT 65.70 101.10 Td (required ) Tj ET Q q 0 0 0 rg BT 101.22 101.10 Td (to ) Tj ET Q q 0 0 0 rg BT 111.20 101.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 143.95 101.10 Td (a ) Tj ET Q q 0 0 0 rg BT 150.60 101.10 Td (50 ) Tj ET Q q 0 0 0 rg BT 162.80 101.10 Td (percent ) Tj ET Q q 0 0 0 rg BT 194.43 101.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 230.53 101.10 Td (on ) Tj ET Q q 0 0 0 rg BT 242.73 101.10 Td (our ) Tj ET Q q 0 0 0 rg BT 258.27 101.10 Td (brand-name ) Tj ET Q q 0 0 0 rg BT 308.23 101.10 Td (drugs ) Tj ET Q q 0 0 0 rg BT 332.66 101.10 Td (to ) Tj ET Q q 0 0 0 rg BT 342.64 101.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 375.95 101.10 Td (who ) Tj ET Q q 0 0 0 rg BT 395.38 101.10 Td (fall ) Tj ET Q q 0 0 0 rg BT 410.91 101.10 Td (within ) Tj ET Q q 0 0 0 rg BT 438.67 101.10 Td (the ) Tj ET Q q 0 0 0 rg BT 453.10 101.10 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 493.06 101.10 Td (Part ) Tj ET Q q 0 0 0 rg BT 511.37 101.10 Td (D ) Tj ET Q q 0 0 0 rg BT 520.80 101.10 Td (coverage ) Tj ET Q q 0 0 0 rg BT 559.09 101.10 Td (gap, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.10 Td (also ) Tj ET Q q 0 0 0 rg BT 55.00 89.10 Td (referred ) Tj ET Q q 0 0 0 rg BT 89.52 89.10 Td (to ) Tj ET Q q 0 0 0 rg BT 100.19 89.10 Td (as ) Tj ET Q q 0 0 0 rg BT 111.41 89.10 Td (the ) Tj ET Q q 0 0 0 rg BT 126.51 89.10 Td (“donut ) Tj ET Q q 0 0 0 rg BT 156.62 89.10 Td (hole” ) Tj ET Q q 0 0 0 rg BT 181.16 89.10 Td (and ) Tj ET Q q 0 0 0 rg BT 198.49 89.10 Td (pay ) Tj ET Q q 0 0 0 rg BT 215.81 89.10 Td (an ) Tj ET Q q 0 0 0 rg BT 228.14 89.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 257.68 89.10 Td (non-tax-deductible ) Tj ET Q q 0 0 0 rg BT 336.10 89.10 Td (fee ) Tj ET Q q 0 0 0 rg BT 351.19 89.10 Td (to ) Tj ET Q q 0 0 0 rg BT 361.86 89.10 Td (the ) Tj ET Q q 0 0 0 rg BT 376.96 89.10 Td (federal ) Tj ET Q q 0 0 0 rg BT 407.61 89.10 Td (government ) Tj ET Q q 0 0 0 rg BT 458.26 89.10 Td (based ) Tj ET Q q 0 0 0 rg BT 483.92 89.10 Td (on ) Tj ET Q q 0 0 0 rg BT 496.80 89.10 Td (an ) Tj ET Q q 0 0 0 rg BT 509.13 89.10 Td (allocation ) Tj ET Q q 0 0 0 rg BT 551.45 89.10 Td (of ) Tj ET Q q 0 0 0 rg BT 562.67 89.10 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 77.10 Td (market ) Tj ET Q q 0 0 0 rg BT 67.17 77.10 Td (share ) Tj ET Q q 0 0 0 rg BT 91.67 77.10 Td (of ) Tj ET Q q 0 0 0 rg BT 103.40 77.10 Td (branded ) Tj ET Q q 0 0 0 rg BT 139.01 77.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 160.74 77.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 183.58 77.10 Td (to ) Tj ET Q q 0 0 0 rg BT 194.76 77.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 225.37 77.10 Td (government ) Tj ET Q q 0 0 0 rg BT 276.53 77.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 317.70 77.10 Td (including ) Tj ET Q q 0 0 0 rg BT 358.88 77.10 Td (Medicare, ) Tj ET Q q 0 0 0 rg BT 402.54 77.10 Td (Medicaid, ) Tj ET Q q 0 0 0 rg BT 446.20 77.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 496.81 77.10 Td (of ) Tj ET Q q 0 0 0 rg BT 508.29 77.10 Td (V) Tj ET Q q 0 0 0 rg BT 514.41 77.10 Td (eterans ) Tj ET Q q 0 0 0 rg BT 545.37 77.10 Td (Af) Tj ET Q q 0 0 0 rg BT 555.74 77.10 Td (fairs, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 65.10 Td (Department ) Tj ET Q q 0 0 0 rg BT 85.70 65.10 Td (of ) Tj ET Q q 0 0 0 rg BT 96.53 65.10 Td (Defense ) Tj ET Q q 0 0 0 rg BT 131.79 65.10 Td (and ) Tj ET Q q 0 0 0 rg BT 148.55 65.10 Td (TRICARE.) Tj ET Q endstream endobj 33 0 obj <> endobj 34 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 56.06 749.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 96.66 749.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 130.05 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 146.78 749.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 169.07 749.10 Td (are ) Tj ET Q q 0 0 0 rg BT 185.78 749.10 Td (also ) Tj ET Q q 0 0 0 rg BT 206.39 749.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 239.22 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 251.51 749.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 297.11 749.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 353.82 749.10 Td (governing ) Tj ET Q q 0 0 0 rg BT 398.87 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 415.59 749.10 Td (testing, ) Tj ET Q q 0 0 0 rg BT 449.26 749.10 Td (approval, ) Tj ET Q q 0 0 0 rg BT 491.25 749.10 Td (safety) Tj ET Q q 0 0 0 rg BT 514.48 749.10 Td (, ) Tj ET Q q 0 0 0 rg BT 521.49 749.10 Td (ef) Tj ET Q q 0 0 0 rg BT 529.08 749.10 Td (fectiveness, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 99.94 737.10 Td (labeling ) Tj ET Q q 0 0 0 rg BT 135.29 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 152.85 737.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 196.53 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 207.99 737.10 Td (our ) Tj ET Q q 0 0 0 rg BT 224.45 737.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 264.29 737.10 Td (These ) Tj ET Q q 0 0 0 rg BT 291.30 737.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 335.53 737.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 390.86 737.10 Td (vary ) Tj ET Q q 0 0 0 rg BT 411.76 737.10 Td (from ) Tj ET Q q 0 0 0 rg BT 434.33 737.10 Td (country ) Tj ET Q q 0 0 0 rg BT 468.01 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 478.92 737.10 Td (country) Tj ET Q q 0 0 0 rg BT 508.82 737.10 Td (. ) Tj ET Q q 0 0 0 rg BT 514.22 737.10 Td (Whether ) Tj ET Q q 0 0 0 rg BT 551.78 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 563.24 737.10 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (FDA) Tj ET Q q 0 0 0 rg BT 55.45 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 58.25 725.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 96.04 725.10 Td (or ) Tj ET Q q 0 0 0 rg BT 107.17 725.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 144.95 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 156.08 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.10 725.10 Td (EC ) Tj ET Q q 0 0 0 rg BT 186.67 725.10 Td (has ) Tj ET Q q 0 0 0 rg BT 202.80 725.10 Td (been ) Tj ET Q q 0 0 0 rg BT 224.48 725.10 Td (obtained ) Tj ET Q q 0 0 0 rg BT 261.71 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 276.17 725.10 Td (a ) Tj ET Q q 0 0 0 rg BT 283.41 725.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 319.26 725.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 357.04 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 368.17 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 383.19 725.10 Td (product ) Tj ET Q q 0 0 0 rg BT 416.53 725.10 Td (by ) Tj ET Q q 0 0 0 rg BT 429.33 725.10 Td (comparable ) Tj ET Q q 0 0 0 rg BT 478.77 725.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 522.67 725.10 Td (authorities ) Tj ET Q q 0 0 0 rg BT 567.68 725.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 75.81 713.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 107.85 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 119.33 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 134.70 713.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 155.63 713.10 Td (or ) Tj ET Q q 0 0 0 rg BT 167.11 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 182.48 713.10 Td (EU, ) Tj ET Q q 0 0 0 rg BT 201.46 713.10 Td (as ) Tj ET Q q 0 0 0 rg BT 212.95 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 228.31 713.10 Td (case ) Tj ET Q q 0 0 0 rg BT 248.67 713.10 Td (may ) Tj ET Q q 0 0 0 rg BT 269.04 713.10 Td (be, ) Tj ET Q q 0 0 0 rg BT 284.13 713.10 Td (must ) Tj ET Q q 0 0 0 rg BT 306.73 713.10 Td (be ) Tj ET Q q 0 0 0 rg BT 319.32 713.10 Td (obtained ) Tj ET Q q 0 0 0 rg BT 356.91 713.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 379.50 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 390.43 713.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 434.12 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 449.49 713.10 Td (product ) Tj ET Q q 0 0 0 rg BT 483.19 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 494.12 713.10 Td (those ) Tj ET Q q 0 0 0 rg BT 518.38 713.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 560.46 713.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 73.21 701.10 Td (process ) Tj ET Q q 0 0 0 rg BT 105.42 701.10 Td (may ) Tj ET Q q 0 0 0 rg BT 124.86 701.10 Td (be ) Tj ET Q q 0 0 0 rg BT 136.52 701.10 Td (more ) Tj ET Q q 0 0 0 rg BT 159.29 701.10 Td (or ) Tj ET Q q 0 0 0 rg BT 169.84 701.10 Td (less ) Tj ET Q q 0 0 0 rg BT 187.06 701.10 Td (rigorous ) Tj ET Q q 0 0 0 rg BT 222.61 701.10 Td (from ) Tj ET Q q 0 0 0 rg BT 244.27 701.10 Td (country ) Tj ET Q q 0 0 0 rg BT 277.04 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 287.04 701.10 Td (country) Tj ET Q q 0 0 0 rg BT 316.94 701.10 Td (, ) Tj ET Q q 0 0 0 rg BT 321.66 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 338.32 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 352.76 701.10 Td (time ) Tj ET Q q 0 0 0 rg BT 372.75 701.10 Td (required ) Tj ET Q q 0 0 0 rg BT 408.29 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 422.17 701.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 459.38 701.10 Td (may ) Tj ET Q q 0 0 0 rg BT 478.82 701.10 Td (be ) Tj ET Q q 0 0 0 rg BT 490.48 701.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 518.25 701.10 Td (or ) Tj ET Q q 0 0 0 rg BT 528.80 701.10 Td (shorter ) Tj ET Q q 0 0 0 rg BT 558.79 701.10 Td (than ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (that ) Tj ET Q q 0 0 0 rg BT 53.50 689.10 Td (required ) Tj ET Q q 0 0 0 rg BT 89.31 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 99.59 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 114.31 689.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 134.04 689.10 Td (Approval ) Tj ET Q q 0 0 0 rg BT 174.31 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 184.58 689.10 Td (one ) Tj ET Q q 0 0 0 rg BT 201.52 689.10 Td (country ) Tj ET Q q 0 0 0 rg BT 234.57 689.10 Td (does ) Tj ET Q q 0 0 0 rg BT 255.40 689.10 Td (not ) Tj ET Q q 0 0 0 rg BT 270.68 689.10 Td (assure ) Tj ET Q q 0 0 0 rg BT 298.17 689.10 Td (that ) Tj ET Q q 0 0 0 rg BT 315.66 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 322.60 689.10 Td (product ) Tj ET Q q 0 0 0 rg BT 355.65 689.10 Td (will ) Tj ET Q q 0 0 0 rg BT 373.71 689.10 Td (be ) Tj ET Q q 0 0 0 rg BT 385.64 689.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 425.35 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 435.63 689.10 Td (another ) Tj ET Q q 0 0 0 rg BT 468.11 689.10 Td (country) Tj ET Q q 0 0 0 rg BT 498.01 689.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (For ) Tj ET Q q 0 0 0 rg BT 52.74 665.10 Td (further ) Tj ET Q q 0 0 0 rg BT 82.80 665.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 127.32 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 138.50 665.10 Td (these ) Tj ET Q q 0 0 0 rg BT 161.90 665.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 193.06 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 210.35 665.10 Td (programs, ) Tj ET Q q 0 0 0 rg BT 253.47 665.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 275.19 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 285.82 665.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 311.43 665.10 Td (7. ) Tj ET Q q 0 0 0 rg BT 321.78 665.10 Td (Management’) Tj ET Q q 0 0 0 rg BT 376.76 665.10 Td (s ) Tj ET Q q 0 0 0 rg BT 383.51 665.10 Td (Discussion ) Tj ET Q q 0 0 0 rg BT 430.25 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 446.91 665.10 Td (Analysis ) Tj ET Q q 0 0 0 rg BT 484.76 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 495.94 665.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 536.00 665.10 Td (Condition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 653.10 Td (Results ) Tj ET Q q 0 0 0 rg BT 84.89 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 95.72 653.10 Td (Operations—T) Tj ET Q q 0 0 0 rg BT 155.00 653.10 Td (otal ) Tj ET Q q 0 0 0 rg BT 172.50 653.10 Td (Revenues” ) Tj ET Q q 0 0 0 rg BT 218.31 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 235.25 653.10 Td (“—Critical ) Tj ET Q q 0 0 0 rg BT 281.63 653.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 330.79 653.10 Td (Policies.”) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (Sour) Tj ET Q q 0 0 0 rg BT 56.38 629.10 Td (ces and ) Tj ET Q q 0 0 0 rg BT 89.72 629.10 Td (A) Tj ET Q q 0 0 0 rg BT 96.20 629.10 Td (vailability of Raw Materials) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.24 605.10 Td (general, ) Tj ET Q q 0 0 0 rg BT 80.08 605.10 Td (we ) Tj ET Q q 0 0 0 rg BT 93.66 605.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 131.11 605.10 Td (our ) Tj ET Q q 0 0 0 rg BT 146.35 605.10 Td (raw ) Tj ET Q q 0 0 0 rg BT 163.26 605.10 Td (materials ) Tj ET Q q 0 0 0 rg BT 201.82 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 218.17 605.10 Td (supplies ) Tj ET Q q 0 0 0 rg BT 252.87 605.10 Td (required ) Tj ET Q q 0 0 0 rg BT 288.09 605.10 Td (for ) Tj ET Q q 0 0 0 rg BT 301.67 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 315.80 605.10 Td (production ) Tj ET Q q 0 0 0 rg BT 361.04 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 371.28 605.10 Td (our ) Tj ET Q q 0 0 0 rg BT 386.53 605.10 Td (products ) Tj ET Q q 0 0 0 rg BT 422.88 605.10 Td (in ) Tj ET Q q 0 0 0 rg BT 432.57 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 446.70 605.10 Td (open ) Tj ET Q q 0 0 0 rg BT 468.06 605.10 Td (market. ) Tj ET Q q 0 0 0 rg BT 500.23 605.10 Td (For ) Tj ET Q q 0 0 0 rg BT 516.04 605.10 Td (some ) Tj ET Q q 0 0 0 rg BT 539.06 605.10 Td (products, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (we ) Tj ET Q q 0 0 0 rg BT 49.65 593.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 87.17 593.10 Td (our ) Tj ET Q q 0 0 0 rg BT 102.49 593.10 Td (raw ) Tj ET Q q 0 0 0 rg BT 119.47 593.10 Td (materials ) Tj ET Q q 0 0 0 rg BT 158.11 593.10 Td (and ) Tj ET Q q 0 0 0 rg BT 174.54 593.10 Td (supplies ) Tj ET Q q 0 0 0 rg BT 209.31 593.10 Td (from ) Tj ET Q q 0 0 0 rg BT 230.73 593.10 Td (one ) Tj ET Q q 0 0 0 rg BT 247.16 593.10 Td (source ) Tj ET Q q 0 0 0 rg BT 275.25 593.10 Td (\(the ) Tj ET Q q 0 0 0 rg BT 292.78 593.10 Td (only ) Tj ET Q q 0 0 0 rg BT 312.55 593.10 Td (source ) Tj ET Q q 0 0 0 rg BT 340.64 593.10 Td (available ) Tj ET Q q 0 0 0 rg BT 378.72 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 388.48 593.10 Td (us\) ) Tj ET Q q 0 0 0 rg BT 402.69 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 413.01 593.10 Td (a ) Tj ET Q q 0 0 0 rg BT 419.44 593.10 Td (single ) Tj ET Q q 0 0 0 rg BT 445.31 593.10 Td (source ) Tj ET Q q 0 0 0 rg BT 473.40 593.10 Td (\(the ) Tj ET Q q 0 0 0 rg BT 490.94 593.10 Td (only ) Tj ET Q q 0 0 0 rg BT 510.71 593.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 549.90 593.10 Td (source ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (among ) Tj ET Q q 0 0 0 rg BT 65.77 581.10 Td (many ) Tj ET Q q 0 0 0 rg BT 90.54 581.10 Td (available ) Tj ET Q q 0 0 0 rg BT 129.19 581.10 Td (to ) Tj ET Q q 0 0 0 rg BT 139.52 581.10 Td (us\), ) Tj ET Q q 0 0 0 rg BT 156.80 581.10 Td (thereby ) Tj ET Q q 0 0 0 rg BT 189.34 581.10 Td (requiring ) Tj ET Q q 0 0 0 rg BT 228.55 581.10 Td (us ) Tj ET Q q 0 0 0 rg BT 240.00 581.10 Td (to ) Tj ET Q q 0 0 0 rg BT 250.33 581.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 277.88 581.10 Td (such ) Tj ET Q q 0 0 0 rg BT 298.77 581.10 Td (raw ) Tj ET Q q 0 0 0 rg BT 316.31 581.10 Td (materials ) Tj ET Q q 0 0 0 rg BT 355.52 581.10 Td (and ) Tj ET Q q 0 0 0 rg BT 372.51 581.10 Td (supplies ) Tj ET Q q 0 0 0 rg BT 407.84 581.10 Td (from ) Tj ET Q q 0 0 0 rg BT 429.84 581.10 Td (that ) Tj ET Q q 0 0 0 rg BT 447.39 581.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 488.25 581.10 Td (source. ) Tj ET Q q 0 0 0 rg BT 519.22 581.10 Td (W) Tj ET Q q 0 0 0 rg BT 527.86 581.10 Td (e ) Tj ET Q q 0 0 0 rg BT 534.85 581.10 Td (attempt, ) Tj ET Q q 0 0 0 rg BT 569.90 581.10 Td (if ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (possible, ) Tj ET Q q 0 0 0 rg BT 75.16 569.10 Td (to ) Tj ET Q q 0 0 0 rg BT 86.82 569.10 Td (mitigate ) Tj ET Q q 0 0 0 rg BT 123.46 569.10 Td (our ) Tj ET Q q 0 0 0 rg BT 140.67 569.10 Td (raw ) Tj ET Q q 0 0 0 rg BT 159.54 569.10 Td (material ) Tj ET Q q 0 0 0 rg BT 196.18 569.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 226.73 569.10 Td (risks, ) Tj ET Q q 0 0 0 rg BT 252.00 569.10 Td (through ) Tj ET Q q 0 0 0 rg BT 286.99 569.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 329.20 569.10 Td (management ) Tj ET Q q 0 0 0 rg BT 384.17 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 402.49 569.10 Td (alternative ) Tj ET Q q 0 0 0 rg BT 448.56 569.10 Td (sourcing ) Tj ET Q q 0 0 0 rg BT 486.88 569.10 Td (strategies. ) Tj ET Q q 0 0 0 rg BT 531.02 569.10 Td (For ) Tj ET Q q 0 0 0 rg BT 548.80 569.10 Td (further ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 80.17 557.10 Td (of ) Tj ET Q q 0 0 0 rg BT 91.00 557.10 Td (sourcing, ) Tj ET Q q 0 0 0 rg BT 130.44 557.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 151.81 557.10 Td (to ) Tj ET Q q 0 0 0 rg BT 162.08 557.10 Td (“—Manufacturing ) Tj ET Q q 0 0 0 rg BT 238.45 557.10 Td (and ) Tj ET Q q 0 0 0 rg BT 255.38 557.10 Td (Quality ) Tj ET Q q 0 0 0 rg BT 287.33 557.10 Td (Assurance” ) Tj ET Q q 0 0 0 rg BT 335.92 557.10 Td (below ) Tj ET Q q 0 0 0 rg BT 362.86 557.10 Td (and ) Tj ET Q q 0 0 0 rg BT 379.79 557.10 Td (discussions ) Tj ET Q q 0 0 0 rg BT 427.86 557.10 Td (of ) Tj ET Q q 0 0 0 rg BT 438.69 557.10 Td (particular ) Tj ET Q q 0 0 0 rg BT 479.50 557.10 Td (products.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (Manufacturing and Quality ) Tj ET Q q 0 0 0 rg BT 156.30 533.10 Td (Assurance) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 510.30 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 510.30 Td (e ) Tj ET Q q 0 0 0 rg BT 51.89 510.30 Td (operate ) Tj ET Q q 0 0 0 rg BT 84.12 510.30 Td (and ) Tj ET Q q 0 0 0 rg BT 101.37 510.30 Td (manage ) Tj ET Q q 0 0 0 rg BT 135.27 510.30 Td (our ) Tj ET Q q 0 0 0 rg BT 151.41 510.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 212.53 510.30 Td (network ) Tj ET Q q 0 0 0 rg BT 248.11 510.30 Td (in ) Tj ET Q q 0 0 0 rg BT 258.70 510.30 Td (a ) Tj ET Q q 0 0 0 rg BT 265.95 510.30 Td (manner ) Tj ET Q q 0 0 0 rg BT 298.74 510.30 Td (that ) Tj ET Q q 0 0 0 rg BT 316.55 510.30 Td (permits ) Tj ET Q q 0 0 0 rg BT 349.35 510.30 Td (us ) Tj ET Q q 0 0 0 rg BT 361.06 510.30 Td (to ) Tj ET Q q 0 0 0 rg BT 371.64 510.30 Td (improve ) Tj ET Q q 0 0 0 rg BT 407.78 510.30 Td (ef) Tj ET Q q 0 0 0 rg BT 415.37 510.30 Td (ficiency ) Tj ET Q q 0 0 0 rg BT 450.38 510.30 Td (while ) Tj ET Q q 0 0 0 rg BT 475.41 510.30 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 525.99 510.30 Td (flexibility ) Tj ET Q q 0 0 0 rg BT 568.23 510.30 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 498.30 Td (reallocate ) Tj ET Q q 0 0 0 rg BT 77.21 498.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 137.88 498.30 Td (capacity) Tj ET Q q 0 0 0 rg BT 170.54 498.30 Td (. ) Tj ET Q q 0 0 0 rg BT 175.39 498.30 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 239.38 498.30 Td (production ) Tj ET Q q 0 0 0 rg BT 285.06 498.30 Td (processes ) Tj ET Q q 0 0 0 rg BT 325.73 498.30 Td (are ) Tj ET Q q 0 0 0 rg BT 340.29 498.30 Td (complex, ) Tj ET Q q 0 0 0 rg BT 379.58 498.30 Td (highly ) Tj ET Q q 0 0 0 rg BT 407.49 498.30 Td (regulated ) Tj ET Q q 0 0 0 rg BT 447.04 498.30 Td (and ) Tj ET Q q 0 0 0 rg BT 463.84 498.30 Td (vary ) Tj ET Q q 0 0 0 rg BT 483.96 498.30 Td (widely ) Tj ET Q q 0 0 0 rg BT 513.53 498.30 Td (from ) Tj ET Q q 0 0 0 rg BT 535.32 498.30 Td (product ) Tj ET Q q 0 0 0 rg BT 568.22 498.30 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 486.30 Td (product. ) Tj ET Q q 0 0 0 rg BT 70.74 486.30 Td (Given ) Tj ET Q q 0 0 0 rg BT 96.87 486.30 Td (that ) Tj ET Q q 0 0 0 rg BT 113.56 486.30 Td (shifting ) Tj ET Q q 0 0 0 rg BT 145.80 486.30 Td (or ) Tj ET Q q 0 0 0 rg BT 155.83 486.30 Td (adding ) Tj ET Q q 0 0 0 rg BT 184.74 486.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 244.74 486.30 Td (capacity ) Tj ET Q q 0 0 0 rg BT 279.74 486.30 Td (can ) Tj ET Q q 0 0 0 rg BT 295.31 486.30 Td (be ) Tj ET Q q 0 0 0 rg BT 306.44 486.30 Td (a ) Tj ET Q q 0 0 0 rg BT 312.57 486.30 Td (lengthy ) Tj ET Q q 0 0 0 rg BT 344.26 486.30 Td (process ) Tj ET Q q 0 0 0 rg BT 375.94 486.30 Td (requiring ) Tj ET Q q 0 0 0 rg BT 414.29 486.30 Td (significant ) Tj ET Q q 0 0 0 rg BT 458.19 486.30 Td (capital ) Tj ET Q q 0 0 0 rg BT 486.53 486.30 Td (and ) Tj ET Q q 0 0 0 rg BT 502.66 486.30 Td (other ) Tj ET Q q 0 0 0 rg BT 524.90 486.30 Td (expenditures ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 474.30 Td (as ) Tj ET Q q 0 0 0 rg BT 46.10 474.30 Td (well ) Tj ET Q q 0 0 0 rg BT 65.09 474.30 Td (as ) Tj ET Q q 0 0 0 rg BT 75.19 474.30 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 118.05 474.30 Td (approvals, ) Tj ET Q q 0 0 0 rg BT 161.20 474.30 Td (we ) Tj ET Q q 0 0 0 rg BT 174.63 474.30 Td (maintain ) Tj ET Q q 0 0 0 rg BT 211.39 474.30 Td (and ) Tj ET Q q 0 0 0 rg BT 227.60 474.30 Td (operate ) Tj ET Q q 0 0 0 rg BT 258.79 474.30 Td (our ) Tj ET Q q 0 0 0 rg BT 273.89 474.30 Td (flexible ) Tj ET Q q 0 0 0 rg BT 306.20 474.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 366.28 474.30 Td (network, ) Tj ET Q q 0 0 0 rg BT 403.32 474.30 Td (consisting ) Tj ET Q q 0 0 0 rg BT 445.65 474.30 Td (of ) Tj ET Q q 0 0 0 rg BT 455.75 474.30 Td (internal ) Tj ET Q q 0 0 0 rg BT 488.06 474.30 Td (and ) Tj ET Q q 0 0 0 rg BT 504.27 474.30 Td (external ) Tj ET Q q 0 0 0 rg BT 538.24 474.30 Td (resources ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 462.30 Td (that ) Tj ET Q q 0 0 0 rg BT 52.61 462.30 Td (minimize ) Tj ET Q q 0 0 0 rg BT 91.99 462.30 Td (unnecessary ) Tj ET Q q 0 0 0 rg BT 142.47 462.30 Td (product ) Tj ET Q q 0 0 0 rg BT 174.63 462.30 Td (transfers ) Tj ET Q q 0 0 0 rg BT 210.67 462.30 Td (and ) Tj ET Q q 0 0 0 rg BT 226.72 462.30 Td (inef) Tj ET Q q 0 0 0 rg BT 242.09 462.30 Td (ficient ) Tj ET Q q 0 0 0 rg BT 269.24 462.30 Td (uses ) Tj ET Q q 0 0 0 rg BT 288.08 462.30 Td (of ) Tj ET Q q 0 0 0 rg BT 298.02 462.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 357.94 462.30 Td (capacity) Tj ET Q q 0 0 0 rg BT 390.60 462.30 Td (. ) Tj ET Q q 0 0 0 rg BT 394.72 462.30 Td (For ) Tj ET Q q 0 0 0 rg BT 410.22 462.30 Td (further ) Tj ET Q q 0 0 0 rg BT 439.04 462.30 Td (discussion ) Tj ET Q q 0 0 0 rg BT 482.32 462.30 Td (of ) Tj ET Q q 0 0 0 rg BT 492.27 462.30 Td (the ) Tj ET Q q 0 0 0 rg BT 506.10 462.30 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 548.80 462.30 Td (impact ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 450.30 Td (on ) Tj ET Q q 0 0 0 rg BT 48.50 450.30 Td (our ) Tj ET Q q 0 0 0 rg BT 64.33 450.30 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 127.64 450.30 Td (refer ) Tj ET Q q 0 0 0 rg BT 149.01 450.30 Td (to ) Tj ET Q q 0 0 0 rg BT 159.29 450.30 Td (“—Government ) Tj ET Q q 0 0 0 rg BT 226.21 450.30 Td (Regulation ) Tj ET Q q 0 0 0 rg BT 272.59 450.30 Td (and ) Tj ET Q q 0 0 0 rg BT 289.53 450.30 Td (Price ) Tj ET Q q 0 0 0 rg BT 312.58 450.30 Td (Constraints” ) Tj ET Q q 0 0 0 rg BT 365.07 450.30 Td (above.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 427.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.73 427.50 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 118.99 427.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 180.48 427.50 Td (facilities ) Tj ET Q q 0 0 0 rg BT 218.09 427.50 Td (are ) Tj ET Q q 0 0 0 rg BT 233.47 427.50 Td (located ) Tj ET Q q 0 0 0 rg BT 265.53 427.50 Td (in ) Tj ET Q q 0 0 0 rg BT 276.48 427.50 Td (the ) Tj ET Q q 0 0 0 rg BT 291.88 427.50 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 315.34 427.50 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 344.63 427.50 Td (Rico, ) Tj ET Q q 0 0 0 rg BT 369.20 427.50 Td (France, ) Tj ET Q q 0 0 0 rg BT 402.09 427.50 Td (Italy) Tj ET Q q 0 0 0 rg BT 419.76 427.50 Td (, ) Tj ET Q q 0 0 0 rg BT 425.44 427.50 Td (Ireland, ) Tj ET Q q 0 0 0 rg BT 459.44 427.50 Td (Japan ) Tj ET Q q 0 0 0 rg BT 485.39 427.50 Td (and ) Tj ET Q q 0 0 0 rg BT 503.01 427.50 Td (China ) Tj ET Q q 0 0 0 rg BT 530.07 427.50 Td (and ) Tj ET Q q 0 0 0 rg BT 547.69 427.50 Td (require ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.50 Td (significant ) Tj ET Q q 0 0 0 rg BT 80.34 415.50 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 115.25 415.50 Td (capital ) Tj ET Q q 0 0 0 rg BT 144.03 415.50 Td (investment ) Tj ET Q q 0 0 0 rg BT 190.04 415.50 Td (for ) Tj ET Q q 0 0 0 rg BT 203.83 415.50 Td (both ) Tj ET Q q 0 0 0 rg BT 223.73 415.50 Td (maintenance ) Tj ET Q q 0 0 0 rg BT 276.39 415.50 Td (and ) Tj ET Q q 0 0 0 rg BT 292.96 415.50 Td (compliance ) Tj ET Q q 0 0 0 rg BT 341.18 415.50 Td (with ) Tj ET Q q 0 0 0 rg BT 361.08 415.50 Td (increasing ) Tj ET Q q 0 0 0 rg BT 404.31 415.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 447.53 415.50 Td (requirements. ) Tj ET Q q 0 0 0 rg BT 504.36 415.50 Td (In ) Tj ET Q q 0 0 0 rg BT 514.82 415.50 Td (addition, ) Tj ET Q q 0 0 0 rg BT 552.22 415.50 Td (as ) Tj ET Q q 0 0 0 rg BT 562.68 415.50 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 403.50 Td (product ) Tj ET Q q 0 0 0 rg BT 69.73 403.50 Td (line ) Tj ET Q q 0 0 0 rg BT 87.91 403.50 Td (changes ) Tj ET Q q 0 0 0 rg BT 123.30 403.50 Td (over ) Tj ET Q q 0 0 0 rg BT 144.25 403.50 Td (the ) Tj ET Q q 0 0 0 rg BT 159.65 403.50 Td (next ) Tj ET Q q 0 0 0 rg BT 180.05 403.50 Td (several ) Tj ET Q q 0 0 0 rg BT 211.54 403.50 Td (years, ) Tj ET Q q 0 0 0 rg BT 238.33 403.50 Td (we ) Tj ET Q q 0 0 0 rg BT 253.17 403.50 Td (expect ) Tj ET Q q 0 0 0 rg BT 282.45 403.50 Td (to ) Tj ET Q q 0 0 0 rg BT 293.41 403.50 Td (continue ) Tj ET Q q 0 0 0 rg BT 331.02 403.50 Td (modification ) Tj ET Q q 0 0 0 rg BT 385.30 403.50 Td (of ) Tj ET Q q 0 0 0 rg BT 396.82 403.50 Td (our ) Tj ET Q q 0 0 0 rg BT 413.33 403.50 Td (existing ) Tj ET Q q 0 0 0 rg BT 448.18 403.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 509.67 403.50 Td (network ) Tj ET Q q 0 0 0 rg BT 545.62 403.50 Td (to ) Tj ET Q q 0 0 0 rg BT 556.58 403.50 Td (meet ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 391.50 Td (complex ) Tj ET Q q 0 0 0 rg BT 72.22 391.50 Td (processing ) Tj ET Q q 0 0 0 rg BT 116.77 391.50 Td (standards ) Tj ET Q q 0 0 0 rg BT 156.33 391.50 Td (that ) Tj ET Q q 0 0 0 rg BT 173.11 391.50 Td (may ) Tj ET Q q 0 0 0 rg BT 192.11 391.50 Td (be ) Tj ET Q q 0 0 0 rg BT 203.34 391.50 Td (required ) Tj ET Q q 0 0 0 rg BT 238.44 391.50 Td (for ) Tj ET Q q 0 0 0 rg BT 251.89 391.50 Td (newly ) Tj ET Q q 0 0 0 rg BT 278.11 391.50 Td (introduced ) Tj ET Q q 0 0 0 rg BT 322.66 391.50 Td (products, ) Tj ET Q q 0 0 0 rg BT 361.38 391.50 Td (including ) Tj ET Q q 0 0 0 rg BT 400.94 391.50 Td (biologics. ) Tj ET Q q 0 0 0 rg BT 441.90 391.50 Td (Biologics ) Tj ET Q q 0 0 0 rg BT 482.02 391.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 542.11 391.50 Td (involves ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 379.50 Td (more ) Tj ET Q q 0 0 0 rg BT 60.04 379.50 Td (complex ) Tj ET Q q 0 0 0 rg BT 97.97 379.50 Td (processes ) Tj ET Q q 0 0 0 rg BT 139.78 379.50 Td (than ) Tj ET Q q 0 0 0 rg BT 160.49 379.50 Td (those ) Tj ET Q q 0 0 0 rg BT 185.09 379.50 Td (of ) Tj ET Q q 0 0 0 rg BT 196.91 379.50 Td (traditional ) Tj ET Q q 0 0 0 rg BT 241.50 379.50 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 306.07 379.50 Td (operations. ) Tj ET Q q 0 0 0 rg BT 353.47 379.50 Td (The ) Tj ET Q q 0 0 0 rg BT 372.51 379.50 Td (FDA) Tj ET Q q 0 0 0 rg BT 391.96 379.50 Td ( ) Tj ET Q q 0 0 0 rg BT 395.45 379.50 Td (approved ) Tj ET Q q 0 0 0 rg BT 436.15 379.50 Td (our ) Tj ET Q q 0 0 0 rg BT 452.97 379.50 Td (lar) Tj ET Q q 0 0 0 rg BT 463.34 379.50 Td (ge ) Tj ET Q q 0 0 0 rg BT 476.27 379.50 Td (scale ) Tj ET Q q 0 0 0 rg BT 499.75 379.50 Td (multi-product ) Tj ET Q q 0 0 0 rg BT 558.23 379.50 Td (bulk ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 367.50 Td (biologics ) Tj ET Q q 0 0 0 rg BT 74.92 367.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 135.49 367.50 Td (facility ) Tj ET Q q 0 0 0 rg BT 166.06 367.50 Td (in ) Tj ET Q q 0 0 0 rg BT 176.10 367.50 Td (Devens, ) Tj ET Q q 0 0 0 rg BT 210.84 367.50 Td (Massachusetts ) Tj ET Q q 0 0 0 rg BT 270.87 367.50 Td (in ) Tj ET Q q 0 0 0 rg BT 280.90 367.50 Td (May ) Tj ET Q q 0 0 0 rg BT 301.49 367.50 Td (2012 ) Tj ET Q q 0 0 0 rg BT 323.74 367.50 Td (and ) Tj ET Q q 0 0 0 rg BT 340.44 367.50 Td (we ) Tj ET Q q 0 0 0 rg BT 354.35 367.50 Td (continue ) Tj ET Q q 0 0 0 rg BT 391.04 367.50 Td (to ) Tj ET Q q 0 0 0 rg BT 401.08 367.50 Td (make ) Tj ET Q q 0 0 0 rg BT 424.99 367.50 Td (capital ) Tj ET Q q 0 0 0 rg BT 453.90 367.50 Td (investments ) Tj ET Q q 0 0 0 rg BT 503.92 367.50 Td (in ) Tj ET Q q 0 0 0 rg BT 513.96 367.50 Td (this ) Tj ET Q q 0 0 0 rg BT 530.66 367.50 Td (facility) Tj ET Q q 0 0 0 rg BT 558.33 367.50 Td (. ) Tj ET Q q 0 0 0 rg BT 562.93 367.50 Td (W) Tj ET Q q 0 0 0 rg BT 571.56 367.50 Td (e ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.50 Td (are ) Tj ET Q q 0 0 0 rg BT 50.71 355.50 Td (building ) Tj ET Q q 0 0 0 rg BT 86.54 355.50 Td (a ) Tj ET Q q 0 0 0 rg BT 93.48 355.50 Td (new ) Tj ET Q q 0 0 0 rg BT 112.64 355.50 Td (lar) Tj ET Q q 0 0 0 rg BT 123.01 355.50 Td (ge-scale ) Tj ET Q q 0 0 0 rg BT 158.26 355.50 Td (biologics ) Tj ET Q q 0 0 0 rg BT 197.43 355.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 258.24 355.50 Td (facility ) Tj ET Q q 0 0 0 rg BT 289.06 355.50 Td (in ) Tj ET Q q 0 0 0 rg BT 299.33 355.50 Td (Cruiserath, ) Tj ET Q q 0 0 0 rg BT 345.99 355.50 Td (Ireland.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 332.70 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 332.70 Td (e ) Tj ET Q q 0 0 0 rg BT 51.13 332.70 Td (rely ) Tj ET Q q 0 0 0 rg BT 68.73 332.70 Td (on ) Tj ET Q q 0 0 0 rg BT 80.79 332.70 Td (third ) Tj ET Q q 0 0 0 rg BT 101.73 332.70 Td (parties ) Tj ET Q q 0 0 0 rg BT 130.44 332.70 Td (to ) Tj ET Q q 0 0 0 rg BT 140.27 332.70 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 192.30 332.70 Td (or ) Tj ET Q q 0 0 0 rg BT 202.68 332.70 Td (supply ) Tj ET Q q 0 0 0 rg BT 231.41 332.70 Td (us ) Tj ET Q q 0 0 0 rg BT 242.35 332.70 Td (with ) Tj ET Q q 0 0 0 rg BT 262.19 332.70 Td (all ) Tj ET Q q 0 0 0 rg BT 274.24 332.70 Td (or ) Tj ET Q q 0 0 0 rg BT 284.62 332.70 Td (a ) Tj ET Q q 0 0 0 rg BT 291.11 332.70 Td (portion ) Tj ET Q q 0 0 0 rg BT 322.05 332.70 Td (of ) Tj ET Q q 0 0 0 rg BT 332.44 332.70 Td (the ) Tj ET Q q 0 0 0 rg BT 346.71 332.70 Td (active ) Tj ET Q q 0 0 0 rg BT 372.64 332.70 Td (ingredients ) Tj ET Q q 0 0 0 rg BT 419.13 332.70 Td (necessary ) Tj ET Q q 0 0 0 rg BT 460.05 332.70 Td (for ) Tj ET Q q 0 0 0 rg BT 473.76 332.70 Td (us ) Tj ET Q q 0 0 0 rg BT 484.71 332.70 Td (to ) Tj ET Q q 0 0 0 rg BT 494.54 332.70 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 546.57 332.70 Td (various ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 320.70 Td (products, ) Tj ET Q q 0 0 0 rg BT 75.35 320.70 Td (such ) Tj ET Q q 0 0 0 rg BT 96.09 320.70 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 106.83 320.70 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 136.27 320.70 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 141.18 320.70 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 171.17 320.70 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 176.08 320.70 Td (Y) Tj ET Q q 0 0 0 rg BT 180.72 320.70 Td (ervoy) Tj ET Q q 0 0 0 rg BT 202.38 320.70 Td (, ) Tj ET Q q 0 0 0 rg BT 207.29 320.70 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.62 320.70 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 240.53 320.70 Td (Or) Tj ET Q q 0 0 0 rg BT 251.28 320.70 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.93 320.70 Td (,) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 275.43 320.70 Td ( ) Tj ET Q q 0 0 0 rg BT 277.84 320.70 Td (Baraclude) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 319.50 320.70 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 324.41 320.70 Td (Reyataz ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.48 320.70 Td (and ) Tj ET Q q 0 0 0 rg BT 375.33 320.70 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 389.95 320.70 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.84 320.70 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 421.25 320.70 Td (Franchise.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.30 320.70 Td ( ) Tj ET Q q 0 0 0 rg BT 466.53 320.70 Td (T) Tj ET Q q 0 0 0 rg BT 471.94 320.70 Td (o ) Tj ET Q q 0 0 0 rg BT 479.36 320.70 Td (maintain ) Tj ET Q q 0 0 0 rg BT 516.76 320.70 Td (a ) Tj ET Q q 0 0 0 rg BT 523.61 320.70 Td (stable ) Tj ET Q q 0 0 0 rg BT 549.34 320.70 Td (supply ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 308.70 Td (of ) Tj ET Q q 0 0 0 rg BT 47.12 308.70 Td (these ) Tj ET Q q 0 0 0 rg BT 70.45 308.70 Td (products, ) Tj ET Q q 0 0 0 rg BT 110.18 308.70 Td (we ) Tj ET Q q 0 0 0 rg BT 124.63 308.70 Td (take ) Tj ET Q q 0 0 0 rg BT 144.07 308.70 Td (a ) Tj ET Q q 0 0 0 rg BT 151.30 308.70 Td (variety ) Tj ET Q q 0 0 0 rg BT 181.85 308.70 Td (of ) Tj ET Q q 0 0 0 rg BT 192.97 308.70 Td (actions ) Tj ET Q q 0 0 0 rg BT 224.08 308.70 Td (including ) Tj ET Q q 0 0 0 rg BT 264.64 308.70 Td (inventory ) Tj ET Q q 0 0 0 rg BT 305.76 308.70 Td (management ) Tj ET Q q 0 0 0 rg BT 359.63 308.70 Td (and ) Tj ET Q q 0 0 0 rg BT 376.86 308.70 Td (maintenance ) Tj ET Q q 0 0 0 rg BT 430.17 308.70 Td (of ) Tj ET Q q 0 0 0 rg BT 441.29 308.70 Td (additional ) Tj ET Q q 0 0 0 rg BT 484.07 308.70 Td (quantities ) Tj ET Q q 0 0 0 rg BT 525.74 308.70 Td (of ) Tj ET Q q 0 0 0 rg BT 536.86 308.70 Td (materials, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 296.70 Td (when ) Tj ET Q q 0 0 0 rg BT 60.38 296.70 Td (possible, ) Tj ET Q q 0 0 0 rg BT 98.37 296.70 Td (designed ) Tj ET Q q 0 0 0 rg BT 136.63 296.70 Td (to ) Tj ET Q q 0 0 0 rg BT 147.13 296.70 Td (provide ) Tj ET Q q 0 0 0 rg BT 180.39 296.70 Td (for ) Tj ET Q q 0 0 0 rg BT 194.77 296.70 Td (a ) Tj ET Q q 0 0 0 rg BT 201.92 296.70 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 247.39 296.70 Td (level ) Tj ET Q q 0 0 0 rg BT 269.54 296.70 Td (of ) Tj ET Q q 0 0 0 rg BT 280.59 296.70 Td (these ) Tj ET Q q 0 0 0 rg BT 303.85 296.70 Td (ingredients ) Tj ET Q q 0 0 0 rg BT 351.00 296.70 Td (to ) Tj ET Q q 0 0 0 rg BT 361.50 296.70 Td (be ) Tj ET Q q 0 0 0 rg BT 373.65 296.70 Td (held ) Tj ET Q q 0 0 0 rg BT 393.59 296.70 Td (by ) Tj ET Q q 0 0 0 rg BT 406.30 296.70 Td (the ) Tj ET Q q 0 0 0 rg BT 421.23 296.70 Td (third-party ) Tj ET Q q 0 0 0 rg BT 466.71 296.70 Td (supplier) Tj ET Q q 0 0 0 rg BT 498.53 296.70 Td (, ) Tj ET Q q 0 0 0 rg BT 503.75 296.70 Td (us ) Tj ET Q q 0 0 0 rg BT 515.36 296.70 Td (or ) Tj ET Q q 0 0 0 rg BT 526.40 296.70 Td (both, ) Tj ET Q q 0 0 0 rg BT 549.40 296.70 Td (so ) Tj ET Q q 0 0 0 rg BT 561.00 296.70 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 284.70 Td (our ) Tj ET Q q 0 0 0 rg BT 51.32 284.70 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 111.62 284.70 Td (operations ) Tj ET Q q 0 0 0 rg BT 155.27 284.70 Td (are ) Tj ET Q q 0 0 0 rg BT 169.46 284.70 Td (not ) Tj ET Q q 0 0 0 rg BT 184.23 284.70 Td (interrupted. ) Tj ET Q q 0 0 0 rg BT 232.15 284.70 Td (As ) Tj ET Q q 0 0 0 rg BT 245.26 284.70 Td (an ) Tj ET Q q 0 0 0 rg BT 256.68 284.70 Td (additional ) Tj ET Q q 0 0 0 rg BT 298.66 284.70 Td (protection, ) Tj ET Q q 0 0 0 rg BT 343.70 284.70 Td (in ) Tj ET Q q 0 0 0 rg BT 353.46 284.70 Td (some ) Tj ET Q q 0 0 0 rg BT 376.56 284.70 Td (cases, ) Tj ET Q q 0 0 0 rg BT 402.15 284.70 Td (we ) Tj ET Q q 0 0 0 rg BT 415.80 284.70 Td (take ) Tj ET Q q 0 0 0 rg BT 434.45 284.70 Td (steps ) Tj ET Q q 0 0 0 rg BT 456.44 284.70 Td (to ) Tj ET Q q 0 0 0 rg BT 466.20 284.70 Td (maintain ) Tj ET Q q 0 0 0 rg BT 503.18 284.70 Td (an ) Tj ET Q q 0 0 0 rg BT 514.61 284.70 Td (approved ) Tj ET Q q 0 0 0 rg BT 553.81 284.70 Td (back-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 272.70 Td (up ) Tj ET Q q 0 0 0 rg BT 48.43 272.70 Td (source ) Tj ET Q q 0 0 0 rg BT 76.96 272.70 Td (where ) Tj ET Q q 0 0 0 rg BT 103.82 272.70 Td (available. ) Tj ET Q q 0 0 0 rg BT 144.84 272.70 Td (For ) Tj ET Q q 0 0 0 rg BT 161.16 272.70 Td (example, ) Tj ET Q q 0 0 0 rg BT 199.96 272.70 Td (we ) Tj ET Q q 0 0 0 rg BT 214.05 272.70 Td (rely ) Tj ET Q q 0 0 0 rg BT 232.03 272.70 Td (on ) Tj ET Q q 0 0 0 rg BT 244.46 272.70 Td (the ) Tj ET Q q 0 0 0 rg BT 259.11 272.70 Td (capacity ) Tj ET Q q 0 0 0 rg BT 294.85 272.70 Td (of ) Tj ET Q q 0 0 0 rg BT 305.61 272.70 Td (our ) Tj ET Q q 0 0 0 rg BT 321.37 272.70 Td (Devens, ) Tj ET Q q 0 0 0 rg BT 356.29 272.70 Td (Massachusetts ) Tj ET Q q 0 0 0 rg BT 416.49 272.70 Td (facility ) Tj ET Q q 0 0 0 rg BT 447.24 272.70 Td (and ) Tj ET Q q 0 0 0 rg BT 464.11 272.70 Td (the ) Tj ET Q q 0 0 0 rg BT 478.76 272.70 Td (capacity ) Tj ET Q q 0 0 0 rg BT 514.50 272.70 Td (available ) Tj ET Q q 0 0 0 rg BT 553.02 272.70 Td (at ) Tj ET Q q 0 0 0 rg BT 562.67 272.70 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 260.70 Td (third-party ) Tj ET Q q 0 0 0 rg BT 81.26 260.70 Td (contract ) Tj ET Q q 0 0 0 rg BT 115.97 260.70 Td (manufacturers ) Tj ET Q q 0 0 0 rg BT 175.66 260.70 Td (to ) Tj ET Q q 0 0 0 rg BT 185.94 260.70 Td (manufacture ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 238.41 260.70 Td (Or) Tj ET Q q 0 0 0 rg BT 249.15 260.70 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 270.80 260.70 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 237.90 Td (In ) Tj ET Q q 0 0 0 rg BT 48.65 237.90 Td (connection ) Tj ET Q q 0 0 0 rg BT 96.85 237.90 Td (with ) Tj ET Q q 0 0 0 rg BT 118.95 237.90 Td (divestitures, ) Tj ET Q q 0 0 0 rg BT 171.88 237.90 Td (licensing ) Tj ET Q q 0 0 0 rg BT 212.30 237.90 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 270.49 237.90 Td (or ) Tj ET Q q 0 0 0 rg BT 283.14 237.90 Td (distribution ) Tj ET Q q 0 0 0 rg BT 333.58 237.90 Td (agreements ) Tj ET Q q 0 0 0 rg BT 383.43 237.90 Td (of ) Tj ET Q q 0 0 0 rg BT 396.08 237.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 427.61 237.90 Td (of ) Tj ET Q q 0 0 0 rg BT 440.26 237.90 Td (our ) Tj ET Q q 0 0 0 rg BT 457.91 237.90 Td (products, ) Tj ET Q q 0 0 0 rg BT 499.17 237.90 Td (or ) Tj ET Q q 0 0 0 rg BT 511.83 237.90 Td (in ) Tj ET Q q 0 0 0 rg BT 523.93 237.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 555.45 237.90 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 225.90 Td (circumstances, ) Tj ET Q q 0 0 0 rg BT 98.32 225.90 Td (we ) Tj ET Q q 0 0 0 rg BT 113.15 225.90 Td (have ) Tj ET Q q 0 0 0 rg BT 135.20 225.90 Td (entered ) Tj ET Q q 0 0 0 rg BT 167.80 225.90 Td (into ) Tj ET Q q 0 0 0 rg BT 186.53 225.90 Td (agreements ) Tj ET Q q 0 0 0 rg BT 235.24 225.90 Td (under ) Tj ET Q q 0 0 0 rg BT 261.19 225.90 Td (which ) Tj ET Q q 0 0 0 rg BT 288.80 225.90 Td (we ) Tj ET Q q 0 0 0 rg BT 303.64 225.90 Td (have ) Tj ET Q q 0 0 0 rg BT 325.69 225.90 Td (agreed ) Tj ET Q q 0 0 0 rg BT 355.51 225.90 Td (to ) Tj ET Q q 0 0 0 rg BT 366.46 225.90 Td (supply ) Tj ET Q q 0 0 0 rg BT 396.31 225.90 Td (such ) Tj ET Q q 0 0 0 rg BT 417.81 225.90 Td (products ) Tj ET Q q 0 0 0 rg BT 455.43 225.90 Td (to ) Tj ET Q q 0 0 0 rg BT 466.38 225.90 Td (third ) Tj ET Q q 0 0 0 rg BT 488.44 225.90 Td (parties. ) Tj ET Q q 0 0 0 rg BT 520.77 225.90 Td (In ) Tj ET Q q 0 0 0 rg BT 532.28 225.90 Td (addition ) Tj ET Q q 0 0 0 rg BT 568.23 225.90 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 213.90 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 75.82 213.90 Td (that ) Tj ET Q q 0 0 0 rg BT 93.42 213.90 Td (could ) Tj ET Q q 0 0 0 rg BT 118.24 213.90 Td (arise ) Tj ET Q q 0 0 0 rg BT 139.73 213.90 Td (from ) Tj ET Q q 0 0 0 rg BT 161.77 213.90 Td (our ) Tj ET Q q 0 0 0 rg BT 177.70 213.90 Td (failure ) Tj ET Q q 0 0 0 rg BT 206.40 213.90 Td (to ) Tj ET Q q 0 0 0 rg BT 216.79 213.90 Td (supply ) Tj ET Q q 0 0 0 rg BT 246.06 213.90 Td (such ) Tj ET Q q 0 0 0 rg BT 267.00 213.90 Td (products ) Tj ET Q q 0 0 0 rg BT 304.04 213.90 Td (under ) Tj ET Q q 0 0 0 rg BT 329.41 213.90 Td (the ) Tj ET Q q 0 0 0 rg BT 344.23 213.90 Td (agreements, ) Tj ET Q q 0 0 0 rg BT 394.87 213.90 Td (these ) Tj ET Q q 0 0 0 rg BT 418.02 213.90 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 474.49 213.90 Td (could ) Tj ET Q q 0 0 0 rg BT 499.31 213.90 Td (require ) Tj ET Q q 0 0 0 rg BT 530.23 213.90 Td (us ) Tj ET Q q 0 0 0 rg BT 541.73 213.90 Td (to ) Tj ET Q q 0 0 0 rg BT 552.11 213.90 Td (invest ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 201.90 Td (in ) Tj ET Q q 0 0 0 rg BT 46.02 201.90 Td (facilities ) Tj ET Q q 0 0 0 rg BT 82.70 201.90 Td (for ) Tj ET Q q 0 0 0 rg BT 96.60 201.90 Td (the ) Tj ET Q q 0 0 0 rg BT 111.06 201.90 Td (production ) Tj ET Q q 0 0 0 rg BT 156.63 201.90 Td (of ) Tj ET Q q 0 0 0 rg BT 167.21 201.90 Td (non-strategic ) Tj ET Q q 0 0 0 rg BT 221.66 201.90 Td (products, ) Tj ET Q q 0 0 0 rg BT 260.84 201.90 Td (result ) Tj ET Q q 0 0 0 rg BT 285.30 201.90 Td (in ) Tj ET Q q 0 0 0 rg BT 295.33 201.90 Td (additional ) Tj ET Q q 0 0 0 rg BT 337.56 201.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 380.90 201.90 Td (filings ) Tj ET Q q 0 0 0 rg BT 408.70 201.90 Td (and ) Tj ET Q q 0 0 0 rg BT 425.39 201.90 Td (obligations ) Tj ET Q q 0 0 0 rg BT 472.07 201.90 Td (or ) Tj ET Q q 0 0 0 rg BT 482.65 201.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 507.10 201.90 Td (an ) Tj ET Q q 0 0 0 rg BT 518.79 201.90 Td (interruption ) Tj ET Q q 0 0 0 rg BT 568.24 201.90 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 189.90 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 189.90 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 111.53 189.90 Td (of ) Tj ET Q q 0 0 0 rg BT 122.36 189.90 Td (our ) Tj ET Q q 0 0 0 rg BT 138.19 189.90 Td (own ) Tj ET Q q 0 0 0 rg BT 157.91 189.90 Td (products.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 167.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.54 167.10 Td (success ) Tj ET Q q 0 0 0 rg BT 85.52 167.10 Td (depends ) Tj ET Q q 0 0 0 rg BT 120.27 167.10 Td (in ) Tj ET Q q 0 0 0 rg BT 130.04 167.10 Td (great ) Tj ET Q q 0 0 0 rg BT 152.01 167.10 Td (measure ) Tj ET Q q 0 0 0 rg BT 187.31 167.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 209.30 167.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 247.94 167.10 Td (confidence ) Tj ET Q q 0 0 0 rg BT 293.79 167.10 Td (in ) Tj ET Q q 0 0 0 rg BT 303.56 167.10 Td (the ) Tj ET Q q 0 0 0 rg BT 317.76 167.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 347.52 167.10 Td (of ) Tj ET Q q 0 0 0 rg BT 357.84 167.10 Td (our ) Tj ET Q q 0 0 0 rg BT 373.16 167.10 Td (products ) Tj ET Q q 0 0 0 rg BT 409.58 167.10 Td (and ) Tj ET Q q 0 0 0 rg BT 426.01 167.10 Td (in ) Tj ET Q q 0 0 0 rg BT 435.78 167.10 Td (the ) Tj ET Q q 0 0 0 rg BT 449.98 167.10 Td (integrity ) Tj ET Q q 0 0 0 rg BT 485.85 167.10 Td (of ) Tj ET Q q 0 0 0 rg BT 496.17 167.10 Td (the ) Tj ET Q q 0 0 0 rg BT 510.37 167.10 Td (data ) Tj ET Q q 0 0 0 rg BT 529.01 167.10 Td (that ) Tj ET Q q 0 0 0 rg BT 546.00 167.10 Td (support ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 155.10 Td (their ) Tj ET Q q 0 0 0 rg BT 56.59 155.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 82.74 155.10 Td (and ) Tj ET Q q 0 0 0 rg BT 99.44 155.10 Td (ef) Tj ET Q q 0 0 0 rg BT 107.03 155.10 Td (fectiveness. ) Tj ET Q q 0 0 0 rg BT 156.22 155.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 189.60 155.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 219.64 155.10 Td (arises ) Tj ET Q q 0 0 0 rg BT 244.67 155.10 Td (from ) Tj ET Q q 0 0 0 rg BT 266.38 155.10 Td (a ) Tj ET Q q 0 0 0 rg BT 273.08 155.10 Td (total ) Tj ET Q q 0 0 0 rg BT 293.12 155.10 Td (commitment ) Tj ET Q q 0 0 0 rg BT 345.94 155.10 Td (to ) Tj ET Q q 0 0 0 rg BT 355.98 155.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 386.02 155.10 Td (in ) Tj ET Q q 0 0 0 rg BT 396.07 155.10 Td (all ) Tj ET Q q 0 0 0 rg BT 408.33 155.10 Td (parts ) Tj ET Q q 0 0 0 rg BT 430.04 155.10 Td (of ) Tj ET Q q 0 0 0 rg BT 440.63 155.10 Td (our ) Tj ET Q q 0 0 0 rg BT 456.23 155.10 Td (operations, ) Tj ET Q q 0 0 0 rg BT 502.65 155.10 Td (including ) Tj ET Q q 0 0 0 rg BT 542.69 155.10 Td (research ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 143.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.68 143.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 109.08 143.10 Td (purchasing, ) Tj ET Q q 0 0 0 rg BT 157.70 143.10 Td (facilities ) Tj ET Q q 0 0 0 rg BT 194.38 143.10 Td (planning, ) Tj ET Q q 0 0 0 rg BT 234.12 143.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 297.17 143.10 Td (and ) Tj ET Q q 0 0 0 rg BT 313.85 143.10 Td (distribution. ) Tj ET Q q 0 0 0 rg BT 364.55 143.10 Td (W) Tj ET Q q 0 0 0 rg BT 373.19 143.10 Td (e ) Tj ET Q q 0 0 0 rg BT 379.87 143.10 Td (maintain ) Tj ET Q q 0 0 0 rg BT 417.11 143.10 Td (quality-assurance ) Tj ET Q q 0 0 0 rg BT 489.32 143.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 535.44 143.10 Td (relating ) Tj ET Q q 0 0 0 rg BT 568.22 143.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 131.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 131.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 80.99 131.10 Td (and ) Tj ET Q q 0 0 0 rg BT 97.93 131.10 Td (integrity ) Tj ET Q q 0 0 0 rg BT 134.31 131.10 Td (of ) Tj ET Q q 0 0 0 rg BT 145.14 131.10 Td (technical ) Tj ET Q q 0 0 0 rg BT 183.73 131.10 Td (information ) Tj ET Q q 0 0 0 rg BT 233.44 131.10 Td (and ) Tj ET Q q 0 0 0 rg BT 250.38 131.10 Td (production ) Tj ET Q q 0 0 0 rg BT 296.21 131.10 Td (processes.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 108.30 Td (Control ) Tj ET Q q 0 0 0 rg BT 70.56 108.30 Td (of ) Tj ET Q q 0 0 0 rg BT 82.90 108.30 Td (production ) Tj ET Q q 0 0 0 rg BT 130.23 108.30 Td (processes ) Tj ET Q q 0 0 0 rg BT 172.56 108.30 Td (involves ) Tj ET Q q 0 0 0 rg BT 210.45 108.30 Td (detailed ) Tj ET Q q 0 0 0 rg BT 246.11 108.30 Td (specifications ) Tj ET Q q 0 0 0 rg BT 305.09 108.30 Td (for ) Tj ET Q q 0 0 0 rg BT 320.76 108.30 Td (ingredients, ) Tj ET Q q 0 0 0 rg BT 371.70 108.30 Td (equipment ) Tj ET Q q 0 0 0 rg BT 417.92 108.30 Td (and ) Tj ET Q q 0 0 0 rg BT 436.36 108.30 Td (facilities, ) Tj ET Q q 0 0 0 rg BT 477.30 108.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 539.62 108.30 Td (methods, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 96.30 Td (processes, ) Tj ET Q q 0 0 0 rg BT 78.77 96.30 Td (packaging ) Tj ET Q q 0 0 0 rg BT 121.80 96.30 Td (materials ) Tj ET Q q 0 0 0 rg BT 160.40 96.30 Td (and ) Tj ET Q q 0 0 0 rg BT 176.78 96.30 Td (labeling. ) Tj ET Q q 0 0 0 rg BT 213.30 96.30 Td (W) Tj ET Q q 0 0 0 rg BT 221.94 96.30 Td (e ) Tj ET Q q 0 0 0 rg BT 228.32 96.30 Td (perform ) Tj ET Q q 0 0 0 rg BT 262.47 96.30 Td (tests ) Tj ET Q q 0 0 0 rg BT 282.19 96.30 Td (at ) Tj ET Q q 0 0 0 rg BT 291.36 96.30 Td (various ) Tj ET Q q 0 0 0 rg BT 322.74 96.30 Td (stages ) Tj ET Q q 0 0 0 rg BT 349.12 96.30 Td (of ) Tj ET Q q 0 0 0 rg BT 359.40 96.30 Td (production ) Tj ET Q q 0 0 0 rg BT 404.67 96.30 Td (processes ) Tj ET Q q 0 0 0 rg BT 444.93 96.30 Td (and ) Tj ET Q q 0 0 0 rg BT 461.32 96.30 Td (on ) Tj ET Q q 0 0 0 rg BT 473.26 96.30 Td (the ) Tj ET Q q 0 0 0 rg BT 487.42 96.30 Td (final ) Tj ET Q q 0 0 0 rg BT 507.69 96.30 Td (product ) Tj ET Q q 0 0 0 rg BT 540.18 96.30 Td (to ) Tj ET Q q 0 0 0 rg BT 549.91 96.30 Td (ensure ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 84.30 Td (that ) Tj ET Q q 0 0 0 rg BT 54.09 84.30 Td (the ) Tj ET Q q 0 0 0 rg BT 69.40 84.30 Td (product ) Tj ET Q q 0 0 0 rg BT 103.05 84.30 Td (meets ) Tj ET Q q 0 0 0 rg BT 129.47 84.30 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 173.66 84.30 Td (requirements ) Tj ET Q q 0 0 0 rg BT 228.95 84.30 Td (and ) Tj ET Q q 0 0 0 rg BT 246.49 84.30 Td (our ) Tj ET Q q 0 0 0 rg BT 262.91 84.30 Td (standards. ) Tj ET Q q 0 0 0 rg BT 306.05 84.30 Td (These ) Tj ET Q q 0 0 0 rg BT 333.03 84.30 Td (tests ) Tj ET Q q 0 0 0 rg BT 353.90 84.30 Td (may ) Tj ET Q q 0 0 0 rg BT 374.21 84.30 Td (involve ) Tj ET Q q 0 0 0 rg BT 407.30 84.30 Td (chemical ) Tj ET Q q 0 0 0 rg BT 446.49 84.30 Td (and ) Tj ET Q q 0 0 0 rg BT 464.02 84.30 Td (physical ) Tj ET Q q 0 0 0 rg BT 500.44 84.30 Td (chemical ) Tj ET Q q 0 0 0 rg BT 539.63 84.30 Td (analyses, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 72.30 Td (microbiological ) Tj ET Q q 0 0 0 rg BT 102.48 72.30 Td (testing ) Tj ET Q q 0 0 0 rg BT 132.32 72.30 Td (or ) Tj ET Q q 0 0 0 rg BT 143.82 72.30 Td (a ) Tj ET Q q 0 0 0 rg BT 151.42 72.30 Td (combination ) Tj ET Q q 0 0 0 rg BT 204.58 72.30 Td (of ) Tj ET Q q 0 0 0 rg BT 216.08 72.30 Td (these ) Tj ET Q q 0 0 0 rg BT 239.80 72.30 Td (along ) Tj ET Q q 0 0 0 rg BT 265.18 72.30 Td (with ) Tj ET Q q 0 0 0 rg BT 286.13 72.30 Td (other ) Tj ET Q q 0 0 0 rg BT 309.85 72.30 Td (analyses. ) Tj ET Q q 0 0 0 rg BT 349.39 72.30 Td (Quality ) Tj ET Q q 0 0 0 rg BT 382.56 72.30 Td (control ) Tj ET Q q 0 0 0 rg BT 414.05 72.30 Td (is ) Tj ET Q q 0 0 0 rg BT 423.89 72.30 Td (provided ) Tj ET Q q 0 0 0 rg BT 462.61 72.30 Td (by ) Tj ET Q q 0 0 0 rg BT 475.78 72.30 Td (business ) Tj ET Q q 0 0 0 rg BT 512.84 72.30 Td (unit/site ) Tj ET Q q 0 0 0 rg BT 548.23 72.30 Td (quality ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 60.30 Td (assurance ) Tj ET Q q 0 0 0 rg BT 77.37 60.30 Td (groups ) Tj ET Q q 0 0 0 rg BT 107.09 60.30 Td (that ) Tj ET Q q 0 0 0 rg BT 124.58 60.30 Td (monitor ) Tj ET Q q 0 0 0 rg BT 158.75 60.30 Td (existing ) Tj ET Q q 0 0 0 rg BT 192.91 60.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 253.72 60.30 Td (procedures ) Tj ET Q q 0 0 0 rg BT 300.09 60.30 Td (and ) Tj ET Q q 0 0 0 rg BT 317.03 60.30 Td (systems ) Tj ET Q q 0 0 0 rg BT 351.20 60.30 Td (used ) Tj ET Q q 0 0 0 rg BT 372.03 60.30 Td (by ) Tj ET Q q 0 0 0 rg BT 384.53 60.30 Td (us, ) Tj ET Q q 0 0 0 rg BT 398.42 60.30 Td (our ) Tj ET Q q 0 0 0 rg BT 414.25 60.30 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 463.97 60.30 Td (and ) Tj ET Q q 0 0 0 rg BT 480.91 60.30 Td (third-party ) Tj ET Q q 0 0 0 rg BT 526.17 60.30 Td (suppliers.) Tj ET Q endstream endobj 35 0 obj <> endobj 36 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (17) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Envir) Tj ET Q q 0 0 0 rg BT 60.27 749.25 Td (onmental Regulation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 726.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.80 726.45 Td (facilities ) Tj ET Q q 0 0 0 rg BT 92.48 726.45 Td (and ) Tj ET Q q 0 0 0 rg BT 110.17 726.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 155.07 726.45 Td (are ) Tj ET Q q 0 0 0 rg BT 170.53 726.45 Td (subject ) Tj ET Q q 0 0 0 rg BT 202.10 726.45 Td (to ) Tj ET Q q 0 0 0 rg BT 213.13 726.45 Td (extensive ) Tj ET Q q 0 0 0 rg BT 254.14 726.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 275.18 726.45 Td (and ) Tj ET Q q 0 0 0 rg BT 292.87 726.45 Td (foreign ) Tj ET Q q 0 0 0 rg BT 324.99 726.45 Td (laws ) Tj ET Q q 0 0 0 rg BT 346.57 726.45 Td (and ) Tj ET Q q 0 0 0 rg BT 364.26 726.45 Td (regulations ) Tj ET Q q 0 0 0 rg BT 411.94 726.45 Td (relating ) Tj ET Q q 0 0 0 rg BT 445.73 726.45 Td (to ) Tj ET Q q 0 0 0 rg BT 456.76 726.45 Td (environmental ) Tj ET Q q 0 0 0 rg BT 517.77 726.45 Td (protection ) Tj ET Q q 0 0 0 rg BT 561.56 726.45 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 714.45 Td (human ) Tj ET Q q 0 0 0 rg BT 65.54 714.45 Td (health ) Tj ET Q q 0 0 0 rg BT 92.30 714.45 Td (and ) Tj ET Q q 0 0 0 rg BT 109.07 714.45 Td (safety) Tj ET Q q 0 0 0 rg BT 132.30 714.45 Td (, ) Tj ET Q q 0 0 0 rg BT 137.12 714.45 Td (including ) Tj ET Q q 0 0 0 rg BT 177.22 714.45 Td (those ) Tj ET Q q 0 0 0 rg BT 200.66 714.45 Td (governing ) Tj ET Q q 0 0 0 rg BT 243.53 714.45 Td (dischar) Tj ET Q q 0 0 0 rg BT 272.23 714.45 Td (ges ) Tj ET Q q 0 0 0 rg BT 287.88 714.45 Td (of ) Tj ET Q q 0 0 0 rg BT 298.54 714.45 Td (pollutants ) Tj ET Q q 0 0 0 rg BT 340.31 714.45 Td (into ) Tj ET Q q 0 0 0 rg BT 358.19 714.45 Td (the ) Tj ET Q q 0 0 0 rg BT 372.74 714.45 Td (air ) Tj ET Q q 0 0 0 rg BT 385.61 714.45 Td (and ) Tj ET Q q 0 0 0 rg BT 402.38 714.45 Td (water; ) Tj ET Q q 0 0 0 rg BT 429.69 714.45 Td (the ) Tj ET Q q 0 0 0 rg BT 444.23 714.45 Td (use, ) Tj ET Q q 0 0 0 rg BT 462.39 714.45 Td (management ) Tj ET Q q 0 0 0 rg BT 515.80 714.45 Td (and ) Tj ET Q q 0 0 0 rg BT 532.57 714.45 Td (disposal ) Tj ET Q q 0 0 0 rg BT 567.67 714.45 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 702.45 Td (hazardous, ) Tj ET Q q 0 0 0 rg BT 80.98 702.45 Td (radioactive ) Tj ET Q q 0 0 0 rg BT 127.33 702.45 Td (and ) Tj ET Q q 0 0 0 rg BT 143.71 702.45 Td (biological ) Tj ET Q q 0 0 0 rg BT 185.64 702.45 Td (materials ) Tj ET Q q 0 0 0 rg BT 224.23 702.45 Td (and ) Tj ET Q q 0 0 0 rg BT 240.60 702.45 Td (wastes; ) Tj ET Q q 0 0 0 rg BT 271.98 702.45 Td (and ) Tj ET Q q 0 0 0 rg BT 288.36 702.45 Td (the ) Tj ET Q q 0 0 0 rg BT 302.51 702.45 Td (cleanup ) Tj ET Q q 0 0 0 rg BT 335.55 702.45 Td (of ) Tj ET Q q 0 0 0 rg BT 345.81 702.45 Td (contamination. ) Tj ET Q q 0 0 0 rg BT 407.46 702.45 Td (Pollution ) Tj ET Q q 0 0 0 rg BT 446.07 702.45 Td (controls ) Tj ET Q q 0 0 0 rg BT 480.23 702.45 Td (and ) Tj ET Q q 0 0 0 rg BT 496.61 702.45 Td (permits ) Tj ET Q q 0 0 0 rg BT 528.54 702.45 Td (are ) Tj ET Q q 0 0 0 rg BT 542.68 702.45 Td (required ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 690.45 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 690.45 Td (many ) Tj ET Q q 0 0 0 rg BT 74.88 690.45 Td (of ) Tj ET Q q 0 0 0 rg BT 85.71 690.45 Td (our ) Tj ET Q q 0 0 0 rg BT 101.54 690.45 Td (operations, ) Tj ET Q q 0 0 0 rg BT 148.19 690.45 Td (and ) Tj ET Q q 0 0 0 rg BT 165.13 690.45 Td (these ) Tj ET Q q 0 0 0 rg BT 188.18 690.45 Td (permits ) Tj ET Q q 0 0 0 rg BT 220.67 690.45 Td (are ) Tj ET Q q 0 0 0 rg BT 235.38 690.45 Td (subject ) Tj ET Q q 0 0 0 rg BT 266.21 690.45 Td (to ) Tj ET Q q 0 0 0 rg BT 276.48 690.45 Td (modification, ) Tj ET Q q 0 0 0 rg BT 332.58 690.45 Td (renewal ) Tj ET Q q 0 0 0 rg BT 366.73 690.45 Td (or ) Tj ET Q q 0 0 0 rg BT 377.56 690.45 Td (revocation ) Tj ET Q q 0 0 0 rg BT 422.26 690.45 Td (by ) Tj ET Q q 0 0 0 rg BT 434.76 690.45 Td (the ) Tj ET Q q 0 0 0 rg BT 449.48 690.45 Td (issuing ) Tj ET Q q 0 0 0 rg BT 480.32 690.45 Td (authorities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 667.65 Td (Our ) Tj ET Q q 0 0 0 rg BT 55.29 667.65 Td (environment, ) Tj ET Q q 0 0 0 rg BT 112.08 667.65 Td (health ) Tj ET Q q 0 0 0 rg BT 140.25 667.65 Td (and ) Tj ET Q q 0 0 0 rg BT 158.43 667.65 Td (safety ) Tj ET Q q 0 0 0 rg BT 186.05 667.65 Td (group ) Tj ET Q q 0 0 0 rg BT 213.12 667.65 Td (monitors ) Tj ET Q q 0 0 0 rg BT 252.42 667.65 Td (our ) Tj ET Q q 0 0 0 rg BT 269.49 667.65 Td (operations ) Tj ET Q q 0 0 0 rg BT 314.89 667.65 Td (around ) Tj ET Q q 0 0 0 rg BT 346.40 667.65 Td (the ) Tj ET Q q 0 0 0 rg BT 362.36 667.65 Td (world, ) Tj ET Q q 0 0 0 rg BT 391.93 667.65 Td (providing ) Tj ET Q q 0 0 0 rg BT 434.56 667.65 Td (us ) Tj ET Q q 0 0 0 rg BT 447.19 667.65 Td (with ) Tj ET Q q 0 0 0 rg BT 468.71 667.65 Td (an ) Tj ET Q q 0 0 0 rg BT 481.89 667.65 Td (overview ) Tj ET Q q 0 0 0 rg BT 522.84 667.65 Td (of ) Tj ET Q q 0 0 0 rg BT 534.91 667.65 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 655.65 Td (requirements ) Tj ET Q q 0 0 0 rg BT 91.37 655.65 Td (and ) Tj ET Q q 0 0 0 rg BT 108.98 655.65 Td (overseeing ) Tj ET Q q 0 0 0 rg BT 155.46 655.65 Td (the ) Tj ET Q q 0 0 0 rg BT 170.85 655.65 Td (implementation ) Tj ET Q q 0 0 0 rg BT 236.78 655.65 Td (of ) Tj ET Q q 0 0 0 rg BT 248.28 655.65 Td (our ) Tj ET Q q 0 0 0 rg BT 264.78 655.65 Td (standards ) Tj ET Q q 0 0 0 rg BT 305.72 655.65 Td (for ) Tj ET Q q 0 0 0 rg BT 320.55 655.65 Td (compliance. ) Tj ET Q q 0 0 0 rg BT 372.07 655.65 Td (W) Tj ET Q q 0 0 0 rg BT 380.71 655.65 Td (e ) Tj ET Q q 0 0 0 rg BT 388.32 655.65 Td (also ) Tj ET Q q 0 0 0 rg BT 407.60 655.65 Td (incur ) Tj ET Q q 0 0 0 rg BT 431.31 655.65 Td (operating ) Tj ET Q q 0 0 0 rg BT 472.25 655.65 Td (and ) Tj ET Q q 0 0 0 rg BT 489.85 655.65 Td (capital ) Tj ET Q q 0 0 0 rg BT 519.67 655.65 Td (costs ) Tj ET Q q 0 0 0 rg BT 542.84 655.65 Td (for ) Tj ET Q q 0 0 0 rg BT 557.67 655.65 Td (such ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 643.65 Td (matters ) Tj ET Q q 0 0 0 rg BT 67.79 643.65 Td (on ) Tj ET Q q 0 0 0 rg BT 80.15 643.65 Td (an ) Tj ET Q q 0 0 0 rg BT 91.94 643.65 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 127.07 643.65 Td (basis, ) Tj ET Q q 0 0 0 rg BT 151.93 643.65 Td (which ) Tj ET Q q 0 0 0 rg BT 178.72 643.65 Td (were ) Tj ET Q q 0 0 0 rg BT 200.51 643.65 Td (not ) Tj ET Q q 0 0 0 rg BT 215.64 643.65 Td (material ) Tj ET Q q 0 0 0 rg BT 250.76 643.65 Td (for ) Tj ET Q q 0 0 0 rg BT 264.77 643.65 Td (2016, ) Tj ET Q q 0 0 0 rg BT 289.63 643.65 Td (2015 ) Tj ET Q q 0 0 0 rg BT 311.99 643.65 Td (and ) Tj ET Q q 0 0 0 rg BT 328.78 643.65 Td (2014. ) Tj ET Q q 0 0 0 rg BT 353.64 643.65 Td (In ) Tj ET Q q 0 0 0 rg BT 364.32 643.65 Td (addition, ) Tj ET Q q 0 0 0 rg BT 401.95 643.65 Td (we ) Tj ET Q q 0 0 0 rg BT 415.97 643.65 Td (invested ) Tj ET Q q 0 0 0 rg BT 451.65 643.65 Td (in ) Tj ET Q q 0 0 0 rg BT 461.78 643.65 Td (projects ) Tj ET Q q 0 0 0 rg BT 495.79 643.65 Td (that ) Tj ET Q q 0 0 0 rg BT 513.15 643.65 Td (reduce ) Tj ET Q q 0 0 0 rg BT 542.15 643.65 Td (resource ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 631.65 Td (use ) Tj ET Q q 0 0 0 rg BT 52.37 631.65 Td (of ) Tj ET Q q 0 0 0 rg BT 63.73 631.65 Td (ener) Tj ET Q q 0 0 0 rg BT 80.76 631.65 Td (gy ) Tj ET Q q 0 0 0 rg BT 93.80 631.65 Td (and ) Tj ET Q q 0 0 0 rg BT 111.27 631.65 Td (water) Tj ET Q q 0 0 0 rg BT 132.93 631.65 Td (. ) Tj ET Q q 0 0 0 rg BT 137.80 631.65 Td (Although ) Tj ET Q q 0 0 0 rg BT 178.61 631.65 Td (we ) Tj ET Q q 0 0 0 rg BT 193.31 631.65 Td (believe ) Tj ET Q q 0 0 0 rg BT 225.22 631.65 Td (that ) Tj ET Q q 0 0 0 rg BT 243.25 631.65 Td (we ) Tj ET Q q 0 0 0 rg BT 257.95 631.65 Td (are ) Tj ET Q q 0 0 0 rg BT 273.19 631.65 Td (in ) Tj ET Q q 0 0 0 rg BT 284.01 631.65 Td (substantial ) Tj ET Q q 0 0 0 rg BT 329.82 631.65 Td (compliance ) Tj ET Q q 0 0 0 rg BT 378.94 631.65 Td (with ) Tj ET Q q 0 0 0 rg BT 399.76 631.65 Td (applicable ) Tj ET Q q 0 0 0 rg BT 443.88 631.65 Td (environmental, ) Tj ET Q q 0 0 0 rg BT 507.18 631.65 Td (health ) Tj ET Q q 0 0 0 rg BT 534.65 631.65 Td (and ) Tj ET Q q 0 0 0 rg BT 552.13 631.65 Td (safety ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 619.65 Td (requirements ) Tj ET Q q 0 0 0 rg BT 90.74 619.65 Td (and ) Tj ET Q q 0 0 0 rg BT 107.72 619.65 Td (the ) Tj ET Q q 0 0 0 rg BT 122.48 619.65 Td (permits ) Tj ET Q q 0 0 0 rg BT 155.01 619.65 Td (required ) Tj ET Q q 0 0 0 rg BT 190.87 619.65 Td (for ) Tj ET Q q 0 0 0 rg BT 205.07 619.65 Td (our ) Tj ET Q q 0 0 0 rg BT 220.94 619.65 Td (operations, ) Tj ET Q q 0 0 0 rg BT 267.64 619.65 Td (we ) Tj ET Q q 0 0 0 rg BT 281.84 619.65 Td (nevertheless ) Tj ET Q q 0 0 0 rg BT 333.80 619.65 Td (could ) Tj ET Q q 0 0 0 rg BT 358.56 619.65 Td (incur ) Tj ET Q q 0 0 0 rg BT 381.65 619.65 Td (additional ) Tj ET Q q 0 0 0 rg BT 424.18 619.65 Td (costs, ) Tj ET Q q 0 0 0 rg BT 449.22 619.65 Td (including ) Tj ET Q q 0 0 0 rg BT 489.53 619.65 Td (civil ) Tj ET Q q 0 0 0 rg BT 509.85 619.65 Td (or ) Tj ET Q q 0 0 0 rg BT 520.72 619.65 Td (criminal ) Tj ET Q q 0 0 0 rg BT 556.58 619.65 Td (fines ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 607.65 Td (or ) Tj ET Q q 0 0 0 rg BT 46.83 607.65 Td (penalties, ) Tj ET Q q 0 0 0 rg BT 87.37 607.65 Td (clean-up ) Tj ET Q q 0 0 0 rg BT 124.30 607.65 Td (costs ) Tj ET Q q 0 0 0 rg BT 146.80 607.65 Td (or ) Tj ET Q q 0 0 0 rg BT 157.63 607.65 Td (third-party ) Tj ET Q q 0 0 0 rg BT 202.89 607.65 Td (claims ) Tj ET Q q 0 0 0 rg BT 231.49 607.65 Td (for ) Tj ET Q q 0 0 0 rg BT 245.65 607.65 Td (property ) Tj ET Q q 0 0 0 rg BT 282.03 607.65 Td (damage ) Tj ET Q q 0 0 0 rg BT 315.62 607.65 Td (or ) Tj ET Q q 0 0 0 rg BT 326.45 607.65 Td (personal ) Tj ET Q q 0 0 0 rg BT 362.83 607.65 Td (injury) Tj ET Q q 0 0 0 rg BT 386.07 607.65 Td (, ) Tj ET Q q 0 0 0 rg BT 391.07 607.65 Td (for ) Tj ET Q q 0 0 0 rg BT 405.23 607.65 Td (violations ) Tj ET Q q 0 0 0 rg BT 447.17 607.65 Td (or ) Tj ET Q q 0 0 0 rg BT 458.00 607.65 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 497.72 607.65 Td (under ) Tj ET Q q 0 0 0 rg BT 522.99 607.65 Td (these ) Tj ET Q q 0 0 0 rg BT 546.03 607.65 Td (laws.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 584.85 Td (Many ) Tj ET Q q 0 0 0 rg BT 61.49 584.85 Td (of ) Tj ET Q q 0 0 0 rg BT 71.98 584.85 Td (our ) Tj ET Q q 0 0 0 rg BT 87.47 584.85 Td (current ) Tj ET Q q 0 0 0 rg BT 117.94 584.85 Td (and ) Tj ET Q q 0 0 0 rg BT 134.54 584.85 Td (former ) Tj ET Q q 0 0 0 rg BT 163.91 584.85 Td (facilities ) Tj ET Q q 0 0 0 rg BT 200.50 584.85 Td (have ) Tj ET Q q 0 0 0 rg BT 221.53 584.85 Td (been ) Tj ET Q q 0 0 0 rg BT 242.57 584.85 Td (in ) Tj ET Q q 0 0 0 rg BT 252.51 584.85 Td (operation ) Tj ET Q q 0 0 0 rg BT 292.43 584.85 Td (for ) Tj ET Q q 0 0 0 rg BT 306.25 584.85 Td (many ) Tj ET Q q 0 0 0 rg BT 330.63 584.85 Td (years, ) Tj ET Q q 0 0 0 rg BT 356.39 584.85 Td (and ) Tj ET Q q 0 0 0 rg BT 372.98 584.85 Td (over ) Tj ET Q q 0 0 0 rg BT 392.91 584.85 Td (time, ) Tj ET Q q 0 0 0 rg BT 415.35 584.85 Td (we ) Tj ET Q q 0 0 0 rg BT 429.17 584.85 Td (and ) Tj ET Q q 0 0 0 rg BT 445.76 584.85 Td (other ) Tj ET Q q 0 0 0 rg BT 468.47 584.85 Td (operators ) Tj ET Q q 0 0 0 rg BT 507.84 584.85 Td (of ) Tj ET Q q 0 0 0 rg BT 518.33 584.85 Td (those ) Tj ET Q q 0 0 0 rg BT 541.60 584.85 Td (facilities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 572.85 Td (have ) Tj ET Q q 0 0 0 rg BT 58.55 572.85 Td (generated, ) Tj ET Q q 0 0 0 rg BT 103.58 572.85 Td (used, ) Tj ET Q q 0 0 0 rg BT 128.07 572.85 Td (stored ) Tj ET Q q 0 0 0 rg BT 156.18 572.85 Td (or ) Tj ET Q q 0 0 0 rg BT 168.18 572.85 Td (disposed ) Tj ET Q q 0 0 0 rg BT 206.85 572.85 Td (of ) Tj ET Q q 0 0 0 rg BT 218.85 572.85 Td (substances ) Tj ET Q q 0 0 0 rg BT 265.28 572.85 Td (or ) Tj ET Q q 0 0 0 rg BT 277.28 572.85 Td (wastes ) Tj ET Q q 0 0 0 rg BT 307.61 572.85 Td (that ) Tj ET Q q 0 0 0 rg BT 326.27 572.85 Td (are ) Tj ET Q q 0 0 0 rg BT 342.15 572.85 Td (considered ) Tj ET Q q 0 0 0 rg BT 389.13 572.85 Td (hazardous ) Tj ET Q q 0 0 0 rg BT 433.34 572.85 Td (under ) Tj ET Q q 0 0 0 rg BT 459.78 572.85 Td (Federal, ) Tj ET Q q 0 0 0 rg BT 495.93 572.85 Td (state ) Tj ET Q q 0 0 0 rg BT 517.92 572.85 Td (and/or ) Tj ET Q q 0 0 0 rg BT 547.14 572.85 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 560.85 Td (environmental ) Tj ET Q q 0 0 0 rg BT 97.58 560.85 Td (laws, ) Tj ET Q q 0 0 0 rg BT 122.22 560.85 Td (including ) Tj ET Q q 0 0 0 rg BT 163.81 560.85 Td (CERCLA. ) Tj ET Q q 0 0 0 rg BT 208.73 560.85 Td (As ) Tj ET Q q 0 0 0 rg BT 223.66 560.85 Td (a ) Tj ET Q q 0 0 0 rg BT 231.92 560.85 Td (result, ) Tj ET Q q 0 0 0 rg BT 260.45 560.85 Td (the ) Tj ET Q q 0 0 0 rg BT 276.48 560.85 Td (soil ) Tj ET Q q 0 0 0 rg BT 294.75 560.85 Td (and ) Tj ET Q q 0 0 0 rg BT 313.00 560.85 Td (groundwater ) Tj ET Q q 0 0 0 rg BT 367.36 560.85 Td (at ) Tj ET Q q 0 0 0 rg BT 378.39 560.85 Td (or ) Tj ET Q q 0 0 0 rg BT 390.54 560.85 Td (under ) Tj ET Q q 0 0 0 rg BT 417.12 560.85 Td (certain ) Tj ET Q q 0 0 0 rg BT 448.14 560.85 Td (of ) Tj ET Q q 0 0 0 rg BT 460.29 560.85 Td (these ) Tj ET Q q 0 0 0 rg BT 484.65 560.85 Td (facilities ) Tj ET Q q 0 0 0 rg BT 522.90 560.85 Td (is ) Tj ET Q q 0 0 0 rg BT 533.38 560.85 Td (or ) Tj ET Q q 0 0 0 rg BT 545.53 560.85 Td (may ) Tj ET Q q 0 0 0 rg BT 566.56 560.85 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 548.85 Td (contaminated, ) Tj ET Q q 0 0 0 rg BT 95.11 548.85 Td (and ) Tj ET Q q 0 0 0 rg BT 112.28 548.85 Td (we ) Tj ET Q q 0 0 0 rg BT 126.68 548.85 Td (may ) Tj ET Q q 0 0 0 rg BT 146.64 548.85 Td (be ) Tj ET Q q 0 0 0 rg BT 158.82 548.85 Td (required ) Tj ET Q q 0 0 0 rg BT 194.87 548.85 Td (to ) Tj ET Q q 0 0 0 rg BT 205.39 548.85 Td (make ) Tj ET Q q 0 0 0 rg BT 229.78 548.85 Td (significant ) Tj ET Q q 0 0 0 rg BT 274.74 548.85 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 328.57 548.85 Td (to ) Tj ET Q q 0 0 0 rg BT 339.09 548.85 Td (investigate, ) Tj ET Q q 0 0 0 rg BT 387.65 548.85 Td (control ) Tj ET Q q 0 0 0 rg BT 418.71 548.85 Td (and ) Tj ET Q q 0 0 0 rg BT 435.89 548.85 Td (remediate ) Tj ET Q q 0 0 0 rg BT 478.05 548.85 Td (such ) Tj ET Q q 0 0 0 rg BT 499.12 548.85 Td (contamination, ) Tj ET Q q 0 0 0 rg BT 561.56 548.85 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 536.85 Td (in ) Tj ET Q q 0 0 0 rg BT 46.38 536.85 Td (some ) Tj ET Q q 0 0 0 rg BT 70.10 536.85 Td (cases ) Tj ET Q q 0 0 0 rg BT 93.80 536.85 Td (to ) Tj ET Q q 0 0 0 rg BT 104.19 536.85 Td (provide ) Tj ET Q q 0 0 0 rg BT 137.34 536.85 Td (compensation ) Tj ET Q q 0 0 0 rg BT 195.49 536.85 Td (and/or ) Tj ET Q q 0 0 0 rg BT 223.64 536.85 Td (restoration ) Tj ET Q q 0 0 0 rg BT 269.01 536.85 Td (for ) Tj ET Q q 0 0 0 rg BT 283.28 536.85 Td (damages ) Tj ET Q q 0 0 0 rg BT 320.87 536.85 Td (to ) Tj ET Q q 0 0 0 rg BT 331.26 536.85 Td (natural ) Tj ET Q q 0 0 0 rg BT 361.63 536.85 Td (resources. ) Tj ET Q q 0 0 0 rg BT 404.49 536.85 Td (Currently) Tj ET Q q 0 0 0 rg BT 442.17 536.85 Td (, ) Tj ET Q q 0 0 0 rg BT 447.28 536.85 Td (we ) Tj ET Q q 0 0 0 rg BT 461.54 536.85 Td (are ) Tj ET Q q 0 0 0 rg BT 476.36 536.85 Td (involved ) Tj ET Q q 0 0 0 rg BT 513.96 536.85 Td (in ) Tj ET Q q 0 0 0 rg BT 524.34 536.85 Td (investigation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 524.85 Td (and ) Tj ET Q q 0 0 0 rg BT 51.92 524.85 Td (remediation ) Tj ET Q q 0 0 0 rg BT 101.17 524.85 Td (at ) Tj ET Q q 0 0 0 rg BT 109.87 524.85 Td (14 ) Tj ET Q q 0 0 0 rg BT 121.36 524.85 Td (current ) Tj ET Q q 0 0 0 rg BT 151.16 524.85 Td (or ) Tj ET Q q 0 0 0 rg BT 160.97 524.85 Td (former ) Tj ET Q q 0 0 0 rg BT 189.67 524.85 Td (facilities. ) Tj ET Q q 0 0 0 rg BT 227.97 524.85 Td (W) Tj ET Q q 0 0 0 rg BT 236.61 524.85 Td (e ) Tj ET Q q 0 0 0 rg BT 242.54 524.85 Td (have ) Tj ET Q q 0 0 0 rg BT 262.90 524.85 Td (also ) Tj ET Q q 0 0 0 rg BT 280.49 524.85 Td (been ) Tj ET Q q 0 0 0 rg BT 300.86 524.85 Td (identified ) Tj ET Q q 0 0 0 rg BT 340.66 524.85 Td (as ) Tj ET Q q 0 0 0 rg BT 350.48 524.85 Td (a ) Tj ET Q q 0 0 0 rg BT 356.40 524.85 Td (PRP) Tj ET Q q 0 0 0 rg BT 373.82 524.85 Td ( ) Tj ET Q q 0 0 0 rg BT 375.31 524.85 Td (under ) Tj ET Q q 0 0 0 rg BT 399.56 524.85 Td (applicable ) Tj ET Q q 0 0 0 rg BT 442.14 524.85 Td (laws ) Tj ET Q q 0 0 0 rg BT 461.96 524.85 Td (for ) Tj ET Q q 0 0 0 rg BT 475.10 524.85 Td (environmental ) Tj ET Q q 0 0 0 rg BT 534.35 524.85 Td (conditions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 512.85 Td (at ) Tj ET Q q 0 0 0 rg BT 45.71 512.85 Td (approximately ) Tj ET Q q 0 0 0 rg BT 105.96 512.85 Td (20 ) Tj ET Q q 0 0 0 rg BT 118.46 512.85 Td (former ) Tj ET Q q 0 0 0 rg BT 148.16 512.85 Td (waste ) Tj ET Q q 0 0 0 rg BT 173.42 512.85 Td (disposal ) Tj ET Q q 0 0 0 rg BT 208.69 512.85 Td (or ) Tj ET Q q 0 0 0 rg BT 219.52 512.85 Td (reprocessing ) Tj ET Q q 0 0 0 rg BT 272.55 512.85 Td (facilities ) Tj ET Q q 0 0 0 rg BT 309.47 512.85 Td (operated ) Tj ET Q q 0 0 0 rg BT 346.39 512.85 Td (by ) Tj ET Q q 0 0 0 rg BT 358.88 512.85 Td (third ) Tj ET Q q 0 0 0 rg BT 380.27 512.85 Td (parties ) Tj ET Q q 0 0 0 rg BT 409.42 512.85 Td (at ) Tj ET Q q 0 0 0 rg BT 419.13 512.85 Td (which ) Tj ET Q q 0 0 0 rg BT 446.06 512.85 Td (investigation ) Tj ET Q q 0 0 0 rg BT 500.21 512.85 Td (and/or ) Tj ET Q q 0 0 0 rg BT 528.25 512.85 Td (remediation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 500.85 Td (activities ) Tj ET Q q 0 0 0 rg BT 74.60 500.85 Td (are ) Tj ET Q q 0 0 0 rg BT 89.31 500.85 Td (ongoing.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 478.05 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 478.05 Td (e ) Tj ET Q q 0 0 0 rg BT 52.21 478.05 Td (may ) Tj ET Q q 0 0 0 rg BT 72.55 478.05 Td (face ) Tj ET Q q 0 0 0 rg BT 92.33 478.05 Td (liability ) Tj ET Q q 0 0 0 rg BT 126.56 478.05 Td (under ) Tj ET Q q 0 0 0 rg BT 152.46 478.05 Td (CERCLA) Tj ET Q q 0 0 0 rg BT 191.36 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 194.49 478.05 Td (and ) Tj ET Q q 0 0 0 rg BT 212.05 478.05 Td (other ) Tj ET Q q 0 0 0 rg BT 235.73 478.05 Td (Federal, ) Tj ET Q q 0 0 0 rg BT 271.34 478.05 Td (state ) Tj ET Q q 0 0 0 rg BT 292.80 478.05 Td (and ) Tj ET Q q 0 0 0 rg BT 310.36 478.05 Td (foreign ) Tj ET Q q 0 0 0 rg BT 342.37 478.05 Td (laws ) Tj ET Q q 0 0 0 rg BT 363.83 478.05 Td (for ) Tj ET Q q 0 0 0 rg BT 378.62 478.05 Td (the ) Tj ET Q q 0 0 0 rg BT 393.96 478.05 Td (entire ) Tj ET Q q 0 0 0 rg BT 419.86 478.05 Td (cost ) Tj ET Q q 0 0 0 rg BT 439.09 478.05 Td (of ) Tj ET Q q 0 0 0 rg BT 450.55 478.05 Td (investigation ) Tj ET Q q 0 0 0 rg BT 505.34 478.05 Td (or ) Tj ET Q q 0 0 0 rg BT 516.80 478.05 Td (remediation ) Tj ET Q q 0 0 0 rg BT 567.69 478.05 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 466.05 Td (contaminated ) Tj ET Q q 0 0 0 rg BT 92.57 466.05 Td (sites, ) Tj ET Q q 0 0 0 rg BT 115.56 466.05 Td (or ) Tj ET Q q 0 0 0 rg BT 126.60 466.05 Td (for ) Tj ET Q q 0 0 0 rg BT 140.97 466.05 Td (natural ) Tj ET Q q 0 0 0 rg BT 171.44 466.05 Td (resource ) Tj ET Q q 0 0 0 rg BT 208.01 466.05 Td (damages, ) Tj ET Q q 0 0 0 rg BT 248.20 466.05 Td (regardless ) Tj ET Q q 0 0 0 rg BT 291.45 466.05 Td (of ) Tj ET Q q 0 0 0 rg BT 302.49 466.05 Td (fault ) Tj ET Q q 0 0 0 rg BT 323.52 466.05 Td (or ) Tj ET Q q 0 0 0 rg BT 334.56 466.05 Td (ownership ) Tj ET Q q 0 0 0 rg BT 378.92 466.05 Td (at ) Tj ET Q q 0 0 0 rg BT 388.85 466.05 Td (the ) Tj ET Q q 0 0 0 rg BT 403.77 466.05 Td (time ) Tj ET Q q 0 0 0 rg BT 424.25 466.05 Td (of ) Tj ET Q q 0 0 0 rg BT 435.29 466.05 Td (the ) Tj ET Q q 0 0 0 rg BT 450.22 466.05 Td (disposal ) Tj ET Q q 0 0 0 rg BT 485.70 466.05 Td (or ) Tj ET Q q 0 0 0 rg BT 496.74 466.05 Td (release. ) Tj ET Q q 0 0 0 rg BT 529.70 466.05 Td (In ) Tj ET Q q 0 0 0 rg BT 540.74 466.05 Td (addition, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 454.05 Td (at ) Tj ET Q q 0 0 0 rg BT 45.87 454.05 Td (certain ) Tj ET Q q 0 0 0 rg BT 75.73 454.05 Td (sites ) Tj ET Q q 0 0 0 rg BT 96.16 454.05 Td (we ) Tj ET Q q 0 0 0 rg BT 110.48 454.05 Td (bear ) Tj ET Q q 0 0 0 rg BT 130.34 454.05 Td (remediation ) Tj ET Q q 0 0 0 rg BT 180.75 454.05 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 237.85 454.05 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 274.95 454.05 Td (to ) Tj ET Q q 0 0 0 rg BT 285.38 454.05 Td (contractual ) Tj ET Q q 0 0 0 rg BT 332.46 454.05 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 382.05 454.05 Td (Generally) Tj ET Q q 0 0 0 rg BT 420.83 454.05 Td (, ) Tj ET Q q 0 0 0 rg BT 425.98 454.05 Td (at ) Tj ET Q q 0 0 0 rg BT 435.86 454.05 Td (third-party ) Tj ET Q q 0 0 0 rg BT 481.27 454.05 Td (operator ) Tj ET Q q 0 0 0 rg BT 517.25 454.05 Td (sites ) Tj ET Q q 0 0 0 rg BT 537.68 454.05 Td (involving ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 442.05 Td (multiple ) Tj ET Q q 0 0 0 rg BT 71.92 442.05 Td (PRPs, ) Tj ET Q q 0 0 0 rg BT 98.69 442.05 Td (liability ) Tj ET Q q 0 0 0 rg BT 132.38 442.05 Td (has ) Tj ET Q q 0 0 0 rg BT 148.29 442.05 Td (been ) Tj ET Q q 0 0 0 rg BT 169.76 442.05 Td (or ) Tj ET Q q 0 0 0 rg BT 180.67 442.05 Td (is ) Tj ET Q q 0 0 0 rg BT 189.93 442.05 Td (expected ) Tj ET Q q 0 0 0 rg BT 228.05 442.05 Td (to ) Tj ET Q q 0 0 0 rg BT 238.41 442.05 Td (be ) Tj ET Q q 0 0 0 rg BT 250.43 442.05 Td (apportioned ) Tj ET Q q 0 0 0 rg BT 300.78 442.05 Td (based ) Tj ET Q q 0 0 0 rg BT 326.14 442.05 Td (on ) Tj ET Q q 0 0 0 rg BT 338.72 442.05 Td (the ) Tj ET Q q 0 0 0 rg BT 353.52 442.05 Td (nature ) Tj ET Q q 0 0 0 rg BT 381.10 442.05 Td (and ) Tj ET Q q 0 0 0 rg BT 398.12 442.05 Td (amount ) Tj ET Q q 0 0 0 rg BT 430.70 442.05 Td (of ) Tj ET Q q 0 0 0 rg BT 441.62 442.05 Td (hazardous ) Tj ET Q q 0 0 0 rg BT 484.74 442.05 Td (substances ) Tj ET Q q 0 0 0 rg BT 530.09 442.05 Td (disposed ) Tj ET Q q 0 0 0 rg BT 567.68 442.05 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 430.05 Td (by ) Tj ET Q q 0 0 0 rg BT 49.10 430.05 Td (each ) Tj ET Q q 0 0 0 rg BT 70.52 430.05 Td (party ) Tj ET Q q 0 0 0 rg BT 94.16 430.05 Td (at ) Tj ET Q q 0 0 0 rg BT 104.48 430.05 Td (the ) Tj ET Q q 0 0 0 rg BT 119.80 430.05 Td (site ) Tj ET Q q 0 0 0 rg BT 136.79 430.05 Td (and ) Tj ET Q q 0 0 0 rg BT 154.33 430.05 Td (the ) Tj ET Q q 0 0 0 rg BT 169.64 430.05 Td (number ) Tj ET Q q 0 0 0 rg BT 203.29 430.05 Td (of ) Tj ET Q q 0 0 0 rg BT 214.72 430.05 Td (financially ) Tj ET Q q 0 0 0 rg BT 260.58 430.05 Td (viable ) Tj ET Q q 0 0 0 rg BT 288.11 430.05 Td (PRPs. ) Tj ET Q q 0 0 0 rg BT 315.40 430.05 Td (For ) Tj ET Q q 0 0 0 rg BT 332.39 430.05 Td (additional ) Tj ET Q q 0 0 0 rg BT 375.48 430.05 Td (information ) Tj ET Q q 0 0 0 rg BT 425.79 430.05 Td (about ) Tj ET Q q 0 0 0 rg BT 451.11 430.05 Td (these ) Tj ET Q q 0 0 0 rg BT 474.76 430.05 Td (matters, ) Tj ET Q q 0 0 0 rg BT 509.79 430.05 Td (refer ) Tj ET Q q 0 0 0 rg BT 531.76 430.05 Td (to ) Tj ET Q q 0 0 0 rg BT 542.64 430.05 Td (“Item ) Tj ET Q q 0 0 0 rg BT 568.50 430.05 Td (8. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 418.05 Td (Financial ) Tj ET Q q 0 0 0 rg BT 75.71 418.05 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.53 418.05 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.53 418.05 Td (. ) Tj ET Q q 0 0 0 rg BT 166.53 418.05 Td (Legal ) Tj ET Q q 0 0 0 rg BT 191.80 418.05 Td (Proceedings ) Tj ET Q q 0 0 0 rg BT 243.17 418.05 Td (and ) Tj ET Q q 0 0 0 rg BT 260.11 418.05 Td (Contingencies.”) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 395.25 Td (Employees) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 372.45 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 372.45 Td (e ) Tj ET Q q 0 0 0 rg BT 51.58 372.45 Td (have ) Tj ET Q q 0 0 0 rg BT 72.95 372.45 Td (approximately ) Tj ET Q q 0 0 0 rg BT 133.21 372.45 Td (25,000 ) Tj ET Q q 0 0 0 rg BT 163.21 372.45 Td (employees ) Tj ET Q q 0 0 0 rg BT 208.48 372.45 Td (as ) Tj ET Q q 0 0 0 rg BT 219.31 372.45 Td (of ) Tj ET Q q 0 0 0 rg BT 230.14 372.45 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.72 372.45 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.72 372.45 Td (. ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 348.45 Td (For) Tj ET Q q 0 0 0 rg BT 51.37 348.45 Td (eign Operations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 324.45 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 324.45 Td (e ) Tj ET Q q 0 0 0 rg BT 51.58 324.45 Td (have ) Tj ET Q q 0 0 0 rg BT 72.95 324.45 Td (significant ) Tj ET Q q 0 0 0 rg BT 117.67 324.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 161.82 324.45 Td (outside ) Tj ET Q q 0 0 0 rg BT 193.21 324.45 Td (the ) Tj ET Q q 0 0 0 rg BT 207.92 324.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 228.03 324.45 Td (They ) Tj ET Q q 0 0 0 rg BT 251.07 324.45 Td (are ) Tj ET Q q 0 0 0 rg BT 265.78 324.45 Td (conducted ) Tj ET Q q 0 0 0 rg BT 309.37 324.45 Td (both ) Tj ET Q q 0 0 0 rg BT 329.65 324.45 Td (through ) Tj ET Q q 0 0 0 rg BT 363.26 324.45 Td (our ) Tj ET Q q 0 0 0 rg BT 379.09 324.45 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 428.81 324.45 Td (and ) Tj ET Q q 0 0 0 rg BT 445.75 324.45 Td (through ) Tj ET Q q 0 0 0 rg BT 479.35 324.45 Td (distributors.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 300.45 Td (International ) Tj ET Q q 0 0 0 rg BT 90.46 300.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 135.49 300.45 Td (are ) Tj ET Q q 0 0 0 rg BT 151.07 300.45 Td (subject ) Tj ET Q q 0 0 0 rg BT 182.76 300.45 Td (to ) Tj ET Q q 0 0 0 rg BT 193.91 300.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 224.49 300.45 Td (risks, ) Tj ET Q q 0 0 0 rg BT 249.25 300.45 Td (which ) Tj ET Q q 0 0 0 rg BT 277.06 300.45 Td (are ) Tj ET Q q 0 0 0 rg BT 292.64 300.45 Td (inherent ) Tj ET Q q 0 0 0 rg BT 328.77 300.45 Td (in ) Tj ET Q q 0 0 0 rg BT 339.92 300.45 Td (conducting ) Tj ET Q q 0 0 0 rg BT 387.73 300.45 Td (business ) Tj ET Q q 0 0 0 rg BT 424.99 300.45 Td (abroad, ) Tj ET Q q 0 0 0 rg BT 458.07 300.45 Td (including, ) Tj ET Q q 0 0 0 rg BT 501.72 300.45 Td (but ) Tj ET Q q 0 0 0 rg BT 517.87 300.45 Td (not ) Tj ET Q q 0 0 0 rg BT 534.02 300.45 Td (limited ) Tj ET Q q 0 0 0 rg BT 565.72 300.45 Td (to, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 288.45 Td (currency ) Tj ET Q q 0 0 0 rg BT 73.09 288.45 Td (fluctuations, ) Tj ET Q q 0 0 0 rg BT 124.92 288.45 Td (possible ) Tj ET Q q 0 0 0 rg BT 159.81 288.45 Td (nationalization ) Tj ET Q q 0 0 0 rg BT 221.35 288.45 Td (or ) Tj ET Q q 0 0 0 rg BT 231.80 288.45 Td (expropriation, ) Tj ET Q q 0 0 0 rg BT 290.29 288.45 Td (price ) Tj ET Q q 0 0 0 rg BT 312.39 288.45 Td (and ) Tj ET Q q 0 0 0 rg BT 328.94 288.45 Td (exchange ) Tj ET Q q 0 0 0 rg BT 368.81 288.45 Td (controls, ) Tj ET Q q 0 0 0 rg BT 405.64 288.45 Td (counterfeit ) Tj ET Q q 0 0 0 rg BT 451.07 288.45 Td (products, ) Tj ET Q q 0 0 0 rg BT 490.12 288.45 Td (limitations ) Tj ET Q q 0 0 0 rg BT 535.02 288.45 Td (on ) Tj ET Q q 0 0 0 rg BT 547.13 288.45 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.45 Td (participation ) Tj ET Q q 0 0 0 rg BT 88.68 276.45 Td (in ) Tj ET Q q 0 0 0 rg BT 98.61 276.45 Td (local ) Tj ET Q q 0 0 0 rg BT 120.19 276.45 Td (enterprises ) Tj ET Q q 0 0 0 rg BT 165.65 276.45 Td (and ) Tj ET Q q 0 0 0 rg BT 182.23 276.45 Td (other ) Tj ET Q q 0 0 0 rg BT 204.93 276.45 Td (restrictive ) Tj ET Q q 0 0 0 rg BT 247.05 276.45 Td (governmental ) Tj ET Q q 0 0 0 rg BT 304.18 276.45 Td (actions. ) Tj ET Q q 0 0 0 rg BT 337.15 276.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 354.85 276.45 Td (international ) Tj ET Q q 0 0 0 rg BT 407.53 276.45 Td (businesses ) Tj ET Q q 0 0 0 rg BT 451.90 276.45 Td (are ) Tj ET Q q 0 0 0 rg BT 466.25 276.45 Td (also ) Tj ET Q q 0 0 0 rg BT 484.51 276.45 Td (subject ) Tj ET Q q 0 0 0 rg BT 514.98 276.45 Td (to ) Tj ET Q q 0 0 0 rg BT 524.90 276.45 Td (government-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.45 Td (imposed ) Tj ET Q q 0 0 0 rg BT 72.39 264.45 Td (constraints, ) Tj ET Q q 0 0 0 rg BT 120.71 264.45 Td (including ) Tj ET Q q 0 0 0 rg BT 160.99 264.45 Td (laws ) Tj ET Q q 0 0 0 rg BT 181.82 264.45 Td (on ) Tj ET Q q 0 0 0 rg BT 194.32 264.45 Td (pricing ) Tj ET Q q 0 0 0 rg BT 225.14 264.45 Td (or ) Tj ET Q q 0 0 0 rg BT 235.97 264.45 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 298.45 264.45 Td (for ) Tj ET Q q 0 0 0 rg BT 312.61 264.45 Td (use ) Tj ET Q q 0 0 0 rg BT 328.44 264.45 Td (of ) Tj ET Q q 0 0 0 rg BT 339.27 264.45 Td (products.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 240.45 Td (Bristol-Myers Squibb ) Tj ET Q q 0 0 0 rg BT 130.83 240.45 Td (W) Tj ET Q q 0 0 0 rg BT 140.28 240.45 Td (ebsite) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 216.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.69 216.45 Td (internet ) Tj ET Q q 0 0 0 rg BT 88.37 216.45 Td (website ) Tj ET Q q 0 0 0 rg BT 122.06 216.45 Td (address ) Tj ET Q q 0 0 0 rg BT 155.19 216.45 Td (is ) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 164.994140625 215.11699218750005 m 224.896484375 215.11699218750005 l s q 0 0 0 rg BT 164.99 216.45 Td (www) Tj ET Q q 0 0 0 rg BT 186.01 216.45 Td (.bms.com) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 224.90 216.45 Td (. ) Tj ET Q q 0 0 0 rg BT 230.54 216.45 Td (On ) Tj ET Q q 0 0 0 rg BT 245.90 216.45 Td (our ) Tj ET Q q 0 0 0 rg BT 262.36 216.45 Td (website, ) Tj ET Q q 0 0 0 rg BT 298.55 216.45 Td (we ) Tj ET Q q 0 0 0 rg BT 313.35 216.45 Td (make ) Tj ET Q q 0 0 0 rg BT 338.14 216.45 Td (available, ) Tj ET Q q 0 0 0 rg BT 379.87 216.45 Td (free ) Tj ET Q q 0 0 0 rg BT 398.55 216.45 Td (of ) Tj ET Q q 0 0 0 rg BT 410.01 216.45 Td (char) Tj ET Q q 0 0 0 rg BT 427.04 216.45 Td (ge, ) Tj ET Q q 0 0 0 rg BT 442.12 216.45 Td (our ) Tj ET Q q 0 0 0 rg BT 458.59 216.45 Td (annual, ) Tj ET Q q 0 0 0 rg BT 490.88 216.45 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 530.11 216.45 Td (and ) Tj ET Q q 0 0 0 rg BT 547.69 216.45 Td (current ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 204.45 Td (reports, ) Tj ET Q q 0 0 0 rg BT 68.19 204.45 Td (including ) Tj ET Q q 0 0 0 rg BT 107.89 204.45 Td (amendments ) Tj ET Q q 0 0 0 rg BT 160.36 204.45 Td (to ) Tj ET Q q 0 0 0 rg BT 170.06 204.45 Td (such ) Tj ET Q q 0 0 0 rg BT 190.32 204.45 Td (reports, ) Tj ET Q q 0 0 0 rg BT 222.51 204.45 Td (as ) Tj ET Q q 0 0 0 rg BT 232.77 204.45 Td (soon ) Tj ET Q q 0 0 0 rg BT 253.58 204.45 Td (as ) Tj ET Q q 0 0 0 rg BT 263.84 204.45 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 309.08 204.45 Td (practicable ) Tj ET Q q 0 0 0 rg BT 354.86 204.45 Td (after ) Tj ET Q q 0 0 0 rg BT 375.10 204.45 Td (we ) Tj ET Q q 0 0 0 rg BT 388.69 204.45 Td (electronically ) Tj ET Q q 0 0 0 rg BT 445.03 204.45 Td (file ) Tj ET Q q 0 0 0 rg BT 460.28 204.45 Td (such ) Tj ET Q q 0 0 0 rg BT 480.54 204.45 Td (material ) Tj ET Q q 0 0 0 rg BT 515.22 204.45 Td (with, ) Tj ET Q q 0 0 0 rg BT 537.42 204.45 Td (or ) Tj ET Q q 0 0 0 rg BT 547.68 204.45 Td (furnish ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 192.45 Td (such ) Tj ET Q q 0 0 0 rg BT 56.83 192.45 Td (material ) Tj ET Q q 0 0 0 rg BT 92.09 192.45 Td (to, ) Tj ET Q q 0 0 0 rg BT 104.87 192.45 Td (the ) Tj ET Q q 0 0 0 rg BT 119.58 192.45 Td (SEC.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 168.45 Td (Information ) Tj ET Q q 0 0 0 rg BT 86.59 168.45 Td (relating ) Tj ET Q q 0 0 0 rg BT 119.95 168.45 Td (to ) Tj ET Q q 0 0 0 rg BT 130.56 168.45 Td (corporate ) Tj ET Q q 0 0 0 rg BT 171.13 168.45 Td (governance ) Tj ET Q q 0 0 0 rg BT 220.04 168.45 Td (at ) Tj ET Q q 0 0 0 rg BT 230.08 168.45 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 289.01 168.45 Td (Squibb, ) Tj ET Q q 0 0 0 rg BT 322.68 168.45 Td (including ) Tj ET Q q 0 0 0 rg BT 363.27 168.45 Td (our ) Tj ET Q q 0 0 0 rg BT 379.43 168.45 Td (Principles ) Tj ET Q q 0 0 0 rg BT 422.25 168.45 Td (of ) Tj ET Q q 0 0 0 rg BT 433.40 168.45 Td (Integrity) Tj ET Q q 0 0 0 rg BT 467.18 168.45 Td (, ) Tj ET Q q 0 0 0 rg BT 472.51 168.45 Td (Code ) Tj ET Q q 0 0 0 rg BT 496.44 168.45 Td (of ) Tj ET Q q 0 0 0 rg BT 507.59 168.45 Td (Ethics ) Tj ET Q q 0 0 0 rg BT 535.41 168.45 Td (for ) Tj ET Q q 0 0 0 rg BT 549.90 168.45 Td (Senior ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 156.45 Td (Financial ) Tj ET Q q 0 0 0 rg BT 75.89 156.45 Td (Of) Tj ET Q q 0 0 0 rg BT 86.26 156.45 Td (ficers, ) Tj ET Q q 0 0 0 rg BT 113.64 156.45 Td (Code ) Tj ET Q q 0 0 0 rg BT 137.43 156.45 Td (of ) Tj ET Q q 0 0 0 rg BT 148.44 156.45 Td (Business ) Tj ET Q q 0 0 0 rg BT 186.68 156.45 Td (Conduct ) Tj ET Q q 0 0 0 rg BT 223.24 156.45 Td (and ) Tj ET Q q 0 0 0 rg BT 240.36 156.45 Td (Ethics ) Tj ET Q q 0 0 0 rg BT 268.03 156.45 Td (for ) Tj ET Q q 0 0 0 rg BT 282.37 156.45 Td (Directors, ) Tj ET Q q 0 0 0 rg BT 324.75 156.45 Td (\(collectively) Tj ET Q q 0 0 0 rg BT 374.08 156.45 Td (, ) Tj ET Q q 0 0 0 rg BT 379.25 156.45 Td (the ) Tj ET Q q 0 0 0 rg BT 394.15 156.45 Td (“Codes”\), ) Tj ET Q q 0 0 0 rg BT 436.53 156.45 Td (Corporate ) Tj ET Q q 0 0 0 rg BT 479.19 156.45 Td (Governance ) Tj ET Q q 0 0 0 rg BT 530.18 156.45 Td (Guidelines, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 144.45 Td (and ) Tj ET Q q 0 0 0 rg BT 53.32 144.45 Td (information ) Tj ET Q q 0 0 0 rg BT 103.41 144.45 Td (concerning ) Tj ET Q q 0 0 0 rg BT 150.71 144.45 Td (our ) Tj ET Q q 0 0 0 rg BT 166.92 144.45 Td (Executive ) Tj ET Q q 0 0 0 rg BT 209.78 144.45 Td (Committee, ) Tj ET Q q 0 0 0 rg BT 259.60 144.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 286.92 144.45 Td (of ) Tj ET Q q 0 0 0 rg BT 298.13 144.45 Td (Directors, ) Tj ET Q q 0 0 0 rg BT 340.72 144.45 Td (including ) Tj ET Q q 0 0 0 rg BT 381.37 144.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 408.69 144.45 Td (Committees ) Tj ET Q q 0 0 0 rg BT 459.90 144.45 Td (and ) Tj ET Q q 0 0 0 rg BT 477.22 144.45 Td (Committee ) Tj ET Q q 0 0 0 rg BT 524.54 144.45 Td (charters, ) Tj ET Q q 0 0 0 rg BT 561.56 144.45 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 132.45 Td (transactions ) Tj ET Q q 0 0 0 rg BT 86.64 132.45 Td (in ) Tj ET Q q 0 0 0 rg BT 97.30 132.45 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 156.29 132.45 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 187.50 132.45 Td (securities ) Tj ET Q q 0 0 0 rg BT 228.15 132.45 Td (by ) Tj ET Q q 0 0 0 rg BT 241.02 132.45 Td (directors ) Tj ET Q q 0 0 0 rg BT 278.89 132.45 Td (and ) Tj ET Q q 0 0 0 rg BT 296.21 132.45 Td (executive ) Tj ET Q q 0 0 0 rg BT 337.39 132.45 Td (of) Tj ET Q q 0 0 0 rg BT 345.54 132.45 Td (ficers, ) Tj ET Q q 0 0 0 rg BT 373.13 132.45 Td (is ) Tj ET Q q 0 0 0 rg BT 382.68 132.45 Td (available ) Tj ET Q q 0 0 0 rg BT 421.64 132.45 Td (on ) Tj ET Q q 0 0 0 rg BT 434.52 132.45 Td (our ) Tj ET Q q 0 0 0 rg BT 450.73 132.45 Td (website ) Tj ET Q q 0 0 0 rg BT 484.16 132.45 Td (under ) Tj ET Q q 0 0 0 rg BT 509.80 132.45 Td (the ) Tj ET Q q 0 0 0 rg BT 524.90 132.45 Td (“Investors—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 120.45 Td (Corporate ) Tj ET Q q 0 0 0 rg BT 78.07 120.45 Td (Governance” ) Tj ET Q q 0 0 0 rg BT 132.89 120.45 Td (caption ) Tj ET Q q 0 0 0 rg BT 164.41 120.45 Td (and ) Tj ET Q q 0 0 0 rg BT 180.93 120.45 Td (in ) Tj ET Q q 0 0 0 rg BT 190.79 120.45 Td (print ) Tj ET Q q 0 0 0 rg BT 211.76 120.45 Td (to ) Tj ET Q q 0 0 0 rg BT 221.62 120.45 Td (any ) Tj ET Q q 0 0 0 rg BT 238.14 120.45 Td (stockholder ) Tj ET Q q 0 0 0 rg BT 286.88 120.45 Td (upon ) Tj ET Q q 0 0 0 rg BT 308.96 120.45 Td (request. ) Tj ET Q q 0 0 0 rg BT 341.96 120.45 Td (Any ) Tj ET Q q 0 0 0 rg BT 361.27 120.45 Td (waivers ) Tj ET Q q 0 0 0 rg BT 394.45 120.45 Td (to ) Tj ET Q q 0 0 0 rg BT 404.31 120.45 Td (the ) Tj ET Q q 0 0 0 rg BT 418.61 120.45 Td (Codes ) Tj ET Q q 0 0 0 rg BT 445.69 120.45 Td (by ) Tj ET Q q 0 0 0 rg BT 457.77 120.45 Td (directors ) Tj ET Q q 0 0 0 rg BT 494.84 120.45 Td (or ) Tj ET Q q 0 0 0 rg BT 505.25 120.45 Td (executive ) Tj ET Q q 0 0 0 rg BT 545.65 120.45 Td (of) Tj ET Q q 0 0 0 rg BT 553.80 120.45 Td (ficers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 108.45 Td (and ) Tj ET Q q 0 0 0 rg BT 52.73 108.45 Td (any ) Tj ET Q q 0 0 0 rg BT 69.46 108.45 Td (material ) Tj ET Q q 0 0 0 rg BT 104.51 108.45 Td (amendment ) Tj ET Q q 0 0 0 rg BT 153.45 108.45 Td (to ) Tj ET Q q 0 0 0 rg BT 163.52 108.45 Td (the ) Tj ET Q q 0 0 0 rg BT 178.03 108.45 Td (Code ) Tj ET Q q 0 0 0 rg BT 201.43 108.45 Td (of ) Tj ET Q q 0 0 0 rg BT 212.05 108.45 Td (Business ) Tj ET Q q 0 0 0 rg BT 249.90 108.45 Td (Conduct ) Tj ET Q q 0 0 0 rg BT 286.08 108.45 Td (and ) Tj ET Q q 0 0 0 rg BT 302.81 108.45 Td (Ethics ) Tj ET Q q 0 0 0 rg BT 330.10 108.45 Td (for ) Tj ET Q q 0 0 0 rg BT 344.05 108.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 383.55 108.45 Td (and ) Tj ET Q q 0 0 0 rg BT 400.28 108.45 Td (Code ) Tj ET Q q 0 0 0 rg BT 423.68 108.45 Td (of ) Tj ET Q q 0 0 0 rg BT 434.30 108.45 Td (Ethics ) Tj ET Q q 0 0 0 rg BT 461.59 108.45 Td (for ) Tj ET Q q 0 0 0 rg BT 475.54 108.45 Td (Senior ) Tj ET Q q 0 0 0 rg BT 503.94 108.45 Td (Financial ) Tj ET Q q 0 0 0 rg BT 543.44 108.45 Td (Of) Tj ET Q q 0 0 0 rg BT 553.81 108.45 Td (ficers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 96.45 Td (will ) Tj ET Q q 0 0 0 rg BT 54.67 96.45 Td (be ) Tj ET Q q 0 0 0 rg BT 67.22 96.45 Td (posted ) Tj ET Q q 0 0 0 rg BT 96.43 96.45 Td (promptly ) Tj ET Q q 0 0 0 rg BT 136.21 96.45 Td (on ) Tj ET Q q 0 0 0 rg BT 149.32 96.45 Td (our ) Tj ET Q q 0 0 0 rg BT 165.76 96.45 Td (website. ) Tj ET Q q 0 0 0 rg BT 201.92 96.45 Td (Information ) Tj ET Q q 0 0 0 rg BT 252.79 96.45 Td (relating ) Tj ET Q q 0 0 0 rg BT 286.44 96.45 Td (to ) Tj ET Q q 0 0 0 rg BT 297.33 96.45 Td (stockholder ) Tj ET Q q 0 0 0 rg BT 347.10 96.45 Td (services, ) Tj ET Q q 0 0 0 rg BT 384.92 96.45 Td (including ) Tj ET Q q 0 0 0 rg BT 425.80 96.45 Td (our ) Tj ET Q q 0 0 0 rg BT 442.24 96.45 Td (Dividend ) Tj ET Q q 0 0 0 rg BT 482.57 96.45 Td (Reinvestment ) Tj ET Q q 0 0 0 rg BT 540.67 96.45 Td (Plan ) Tj ET Q q 0 0 0 rg BT 561.56 96.45 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 84.45 Td (direct ) Tj ET Q q 0 0 0 rg BT 61.67 84.45 Td (deposit ) Tj ET Q q 0 0 0 rg BT 93.47 84.45 Td (of ) Tj ET Q q 0 0 0 rg BT 104.70 84.45 Td (dividends, ) Tj ET Q q 0 0 0 rg BT 149.00 84.45 Td (is ) Tj ET Q q 0 0 0 rg BT 158.58 84.45 Td (available ) Tj ET Q q 0 0 0 rg BT 197.57 84.45 Td (on ) Tj ET Q q 0 0 0 rg BT 210.48 84.45 Td (our ) Tj ET Q q 0 0 0 rg BT 226.72 84.45 Td (website ) Tj ET Q q 0 0 0 rg BT 260.17 84.45 Td (under ) Tj ET Q q 0 0 0 rg BT 285.85 84.45 Td (the ) Tj ET Q q 0 0 0 rg BT 300.97 84.45 Td (“Investors—Stockholder ) Tj ET Q q 0 0 0 rg BT 403.30 84.45 Td (Services” ) Tj ET Q q 0 0 0 rg BT 444.53 84.45 Td (caption. ) Tj ET Q q 0 0 0 rg BT 479.37 84.45 Td (In ) Tj ET Q q 0 0 0 rg BT 490.61 84.45 Td (addition, ) Tj ET Q q 0 0 0 rg BT 528.79 84.45 Td (information ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 72.45 Td (about ) Tj ET Q q 0 0 0 rg BT 60.72 72.45 Td (our ) Tj ET Q q 0 0 0 rg BT 76.55 72.45 Td (Sustainability ) Tj ET Q q 0 0 0 rg BT 134.05 72.45 Td (programs ) Tj ET Q q 0 0 0 rg BT 174.32 72.45 Td (is ) Tj ET Q q 0 0 0 rg BT 183.49 72.45 Td (available ) Tj ET Q q 0 0 0 rg BT 222.07 72.45 Td (on ) Tj ET Q q 0 0 0 rg BT 234.57 72.45 Td (our ) Tj ET Q q 0 0 0 rg BT 250.40 72.45 Td (website ) Tj ET Q q 0 0 0 rg BT 283.45 72.45 Td (under ) Tj ET Q q 0 0 0 rg BT 308.72 72.45 Td (the ) Tj ET Q q 0 0 0 rg BT 323.44 72.45 Td ("Responsibility" ) Tj ET Q q 0 0 0 rg BT 391.88 72.45 Td (caption.) Tj ET Q endstream endobj 37 0 obj <> endobj 38 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 749.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.88 749.10 Td (incorporate ) Tj ET Q q 0 0 0 rg BT 100.21 749.10 Td (by ) Tj ET Q q 0 0 0 rg BT 113.01 749.10 Td (reference ) Tj ET Q q 0 0 0 rg BT 152.99 749.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 182.99 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 233.01 749.10 Td (from ) Tj ET Q q 0 0 0 rg BT 255.25 749.10 Td (parts ) Tj ET Q q 0 0 0 rg BT 277.48 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 288.61 749.10 Td (our ) Tj ET Q q 0 0 0 rg BT 304.75 749.10 Td (proxy ) Tj ET Q q 0 0 0 rg BT 330.88 749.10 Td (statement ) Tj ET Q q 0 0 0 rg BT 372.00 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 386.46 749.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.47 749.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.47 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 423.66 749.10 Td (Annual ) Tj ET Q q 0 0 0 rg BT 455.89 749.10 Td (Meeting ) Tj ET Q q 0 0 0 rg BT 492.02 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 503.15 749.10 Td (Stockholders. ) Tj ET Q q 0 0 0 rg BT 560.47 749.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (SEC ) Tj ET Q q 0 0 0 rg BT 56.73 737.10 Td (allows ) Tj ET Q q 0 0 0 rg BT 85.22 737.10 Td (us ) Tj ET Q q 0 0 0 rg BT 96.50 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 106.67 737.10 Td (disclose ) Tj ET Q q 0 0 0 rg BT 141.27 737.10 Td (important ) Tj ET Q q 0 0 0 rg BT 182.54 737.10 Td (information ) Tj ET Q q 0 0 0 rg BT 232.14 737.10 Td (by ) Tj ET Q q 0 0 0 rg BT 244.52 737.10 Td (referring ) Tj ET Q q 0 0 0 rg BT 281.88 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 292.05 737.10 Td (it ) Tj ET Q q 0 0 0 rg BT 299.99 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 310.16 737.10 Td (that ) Tj ET Q q 0 0 0 rg BT 327.54 737.10 Td (manner) Tj ET Q q 0 0 0 rg BT 356.97 737.10 Td (. ) Tj ET Q q 0 0 0 rg BT 361.86 737.10 Td (Please ) Tj ET Q q 0 0 0 rg BT 389.79 737.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 411.05 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 421.21 737.10 Td (such ) Tj ET Q q 0 0 0 rg BT 441.93 737.10 Td (information. ) Tj ET Q q 0 0 0 rg BT 494.03 737.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 511.97 737.10 Td (proxy ) Tj ET Q q 0 0 0 rg BT 537.68 737.10 Td (statement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 51.02 725.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.60 725.10 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 86.60 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 89.21 725.10 Td (Annual ) Tj ET Q q 0 0 0 rg BT 122.01 725.10 Td (Meeting ) Tj ET Q q 0 0 0 rg BT 158.70 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 170.39 725.10 Td (Stockholders ) Tj ET Q q 0 0 0 rg BT 225.96 725.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 243.76 725.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.76 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 266.38 725.10 Td (Annual ) Tj ET Q q 0 0 0 rg BT 299.18 725.10 Td (Report ) Tj ET Q q 0 0 0 rg BT 329.75 725.10 Td (will ) Tj ET Q q 0 0 0 rg BT 348.67 725.10 Td (be ) Tj ET Q q 0 0 0 rg BT 361.47 725.10 Td (available ) Tj ET Q q 0 0 0 rg BT 400.91 725.10 Td (on ) Tj ET Q q 0 0 0 rg BT 414.27 725.10 Td (our ) Tj ET Q q 0 0 0 rg BT 430.96 725.10 Td (website ) Tj ET Q q 0 0 0 rg BT 464.87 725.10 Td (under ) Tj ET Q q 0 0 0 rg BT 491.00 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 506.57 725.10 Td (“Investors—SEC ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Filings” ) Tj ET Q q 0 0 0 rg BT 70.73 713.10 Td (caption ) Tj ET Q q 0 0 0 rg BT 102.66 713.10 Td (on ) Tj ET Q q 0 0 0 rg BT 115.16 713.10 Td (or ) Tj ET Q q 0 0 0 rg BT 125.99 713.10 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 150.71 713.10 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 194.31 713.10 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.31 713.10 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 681.33 Td (Item 1A.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 681.33 Td (RISK FACTORS.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 658.90 Td (Any ) Tj ET Q q 0 0 0 rg BT 54.97 658.90 Td (of ) Tj ET Q q 0 0 0 rg BT 65.06 658.90 Td (the ) Tj ET Q q 0 0 0 rg BT 79.03 658.90 Td (factors ) Tj ET Q q 0 0 0 rg BT 107.99 658.90 Td (described ) Tj ET Q q 0 0 0 rg BT 148.06 658.90 Td (below ) Tj ET Q q 0 0 0 rg BT 174.25 658.90 Td (could ) Tj ET Q q 0 0 0 rg BT 198.22 658.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 249.96 658.90 Td (and ) Tj ET Q q 0 0 0 rg BT 266.15 658.90 Td (negatively ) Tj ET Q q 0 0 0 rg BT 309.55 658.90 Td (af) Tj ET Q q 0 0 0 rg BT 317.14 658.90 Td (fect ) Tj ET Q q 0 0 0 rg BT 333.88 658.90 Td (our ) Tj ET Q q 0 0 0 rg BT 348.96 658.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 387.11 658.90 Td (prospects, ) Tj ET Q q 0 0 0 rg BT 429.13 658.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 465.86 658.90 Td (condition, ) Tj ET Q q 0 0 0 rg BT 507.89 658.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 547.41 658.90 Td (results, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 646.90 Td (or ) Tj ET Q q 0 0 0 rg BT 47.17 646.90 Td (credit ) Tj ET Q q 0 0 0 rg BT 72.78 646.90 Td (ratings, ) Tj ET Q q 0 0 0 rg BT 105.34 646.90 Td (which ) Tj ET Q q 0 0 0 rg BT 132.63 646.90 Td (could ) Tj ET Q q 0 0 0 rg BT 157.69 646.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 182.74 646.90 Td (the ) Tj ET Q q 0 0 0 rg BT 197.80 646.90 Td (trading ) Tj ET Q q 0 0 0 rg BT 228.97 646.90 Td (price ) Tj ET Q q 0 0 0 rg BT 251.80 646.90 Td (of ) Tj ET Q q 0 0 0 rg BT 262.97 646.90 Td (our ) Tj ET Q q 0 0 0 rg BT 279.15 646.90 Td (common ) Tj ET Q q 0 0 0 rg BT 316.99 646.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 340.94 646.90 Td (to ) Tj ET Q q 0 0 0 rg BT 351.56 646.90 Td (decline. ) Tj ET Q q 0 0 0 rg BT 385.15 646.90 Td (Additional ) Tj ET Q q 0 0 0 rg BT 430.77 646.90 Td (risks ) Tj ET Q q 0 0 0 rg BT 452.50 646.90 Td (and ) Tj ET Q q 0 0 0 rg BT 469.79 646.90 Td (uncertainties ) Tj ET Q q 0 0 0 rg BT 523.72 646.90 Td (not ) Tj ET Q q 0 0 0 rg BT 539.34 646.90 Td (presently ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 634.90 Td (known ) Tj ET Q q 0 0 0 rg BT 65.72 634.90 Td (to ) Tj ET Q q 0 0 0 rg BT 76.00 634.90 Td (us, ) Tj ET Q q 0 0 0 rg BT 89.89 634.90 Td (or ) Tj ET Q q 0 0 0 rg BT 100.72 634.90 Td (risks ) Tj ET Q q 0 0 0 rg BT 122.11 634.90 Td (that ) Tj ET Q q 0 0 0 rg BT 139.61 634.90 Td (we ) Tj ET Q q 0 0 0 rg BT 153.77 634.90 Td (currently ) Tj ET Q q 0 0 0 rg BT 192.36 634.90 Td (consider ) Tj ET Q q 0 0 0 rg BT 228.74 634.90 Td (immaterial, ) Tj ET Q q 0 0 0 rg BT 277.05 634.90 Td (could ) Tj ET Q q 0 0 0 rg BT 301.77 634.90 Td (also ) Tj ET Q q 0 0 0 rg BT 320.38 634.90 Td (impair ) Tj ET Q q 0 0 0 rg BT 348.98 634.90 Td (our ) Tj ET Q q 0 0 0 rg BT 364.81 634.90 Td (operations ) Tj ET Q q 0 0 0 rg BT 408.97 634.90 Td (or ) Tj ET Q q 0 0 0 rg BT 419.80 634.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 457.28 634.90 Td (condition.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 610.90 Td (The ) Tj ET Q q 0 0 0 rg BT 54.50 610.90 Td (public ) Tj ET Q q 0 0 0 rg BT 82.45 610.90 Td (announcement ) Tj ET Q q 0 0 0 rg BT 146.53 610.90 Td (of ) Tj ET Q q 0 0 0 rg BT 157.25 610.90 Td (data ) Tj ET Q q 0 0 0 rg BT 177.42 610.90 Td (from ) Tj ET Q q 0 0 0 rg BT 199.82 610.90 Td (our ) Tj ET Q q 0 0 0 rg BT 216.66 610.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 249.61 610.90 Td (studies, ) Tj ET Q q 0 0 0 rg BT 282.84 610.90 Td (or ) Tj ET Q q 0 0 0 rg BT 294.13 610.90 Td (those ) Tj ET Q q 0 0 0 rg BT 318.19 610.90 Td (of ) Tj ET Q q 0 0 0 rg BT 328.92 610.90 Td (our ) Tj ET Q q 0 0 0 rg BT 345.77 610.90 Td (competitors, ) Tj ET Q q 0 0 0 rg BT 398.43 610.90 Td (or ) Tj ET Q q 0 0 0 rg BT 409.72 610.90 Td (news ) Tj ET Q q 0 0 0 rg BT 432.67 610.90 Td (of ) Tj ET Q q 0 0 0 rg BT 443.40 610.90 Td (any ) Tj ET Q q 0 0 0 rg BT 460.79 610.90 Td (developments ) Tj ET Q q 0 0 0 rg BT 518.73 610.90 Td (related ) Tj ET Q q 0 0 0 rg BT 549.45 610.90 Td (to ) Tj ET Q q 0 0 0 rg BT 559.62 610.90 Td (our) Tj ET Q q 0 0 0 rg BT 573.52 610.90 Td (, ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 598.90 Td (or ) Tj ET Q q 0 0 0 rg BT 47.80 598.90 Td (our ) Tj ET Q q 0 0 0 rg BT 65.16 598.90 Td (competitors', ) Tj ET Q q 0 0 0 rg BT 121.12 598.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 135.15 598.90 Td (products ) Tj ET Q q 0 0 0 rg BT 173.62 598.90 Td (or ) Tj ET Q q 0 0 0 rg BT 185.42 598.90 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 227.76 598.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 277.90 598.90 Td (may ) Tj ET Q q 0 0 0 rg BT 298.03 598.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 324.27 598.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 371.07 598.90 Td (volatility ) Tj ET Q q 0 0 0 rg BT 409.53 598.90 Td (in ) Tj ET Q q 0 0 0 rg BT 420.78 598.90 Td (our ) Tj ET Q q 0 0 0 rg BT 438.14 598.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 462.16 598.90 Td (price ) Tj ET Q q 0 0 0 rg BT 485.61 598.90 Td (and ) Tj ET Q q 0 0 0 rg BT 504.08 598.90 Td (depending ) Tj ET Q q 0 0 0 rg BT 549.77 598.90 Td (on ) Tj ET Q q 0 0 0 rg BT 563.24 598.90 Td (the ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 586.90 Td (news, ) Tj ET Q q 0 0 0 rg BT 61.60 586.90 Td (may ) Tj ET Q q 0 0 0 rg BT 81.35 586.90 Td (result ) Tj ET Q q 0 0 0 rg BT 107.23 586.90 Td (in ) Tj ET Q q 0 0 0 rg BT 118.10 586.90 Td (an ) Tj ET Q q 0 0 0 rg BT 131.20 586.90 Td (adverse ) Tj ET Q q 0 0 0 rg BT 164.84 586.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 195.15 586.90 Td (on ) Tj ET Q q 0 0 0 rg BT 208.25 586.90 Td (our ) Tj ET Q q 0 0 0 rg BT 225.24 586.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 265.29 586.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 305.05 586.90 Td (condition ) Tj ET Q q 0 0 0 rg BT 346.48 586.90 Td (or ) Tj ET Q q 0 0 0 rg BT 357.91 586.90 Td (results ) Tj ET Q q 0 0 0 rg BT 387.68 586.90 Td (of ) Tj ET Q q 0 0 0 rg BT 398.55 586.90 Td (operation. ) Tj ET Q q 0 0 0 rg BT 443.03 586.90 Td (If ) Tj ET Q q 0 0 0 rg BT 452.79 586.90 Td (the ) Tj ET Q q 0 0 0 rg BT 468.10 586.90 Td (development ) Tj ET Q q 0 0 0 rg BT 522.29 586.90 Td (of ) Tj ET Q q 0 0 0 rg BT 533.16 586.90 Td (any ) Tj ET Q q 0 0 0 rg BT 550.69 586.90 Td (of ) Tj ET Q q 0 0 0 rg BT 561.56 586.90 Td (our ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 574.90 Td (key ) Tj ET Q q 0 0 0 rg BT 53.19 574.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 67.61 574.90 Td (compounds, ) Tj ET Q q 0 0 0 rg BT 120.65 574.90 Td (whether ) Tj ET Q q 0 0 0 rg BT 157.30 574.90 Td (alone ) Tj ET Q q 0 0 0 rg BT 183.39 574.90 Td (or ) Tj ET Q q 0 0 0 rg BT 195.59 574.90 Td (as ) Tj ET Q q 0 0 0 rg BT 207.80 574.90 Td (part ) Tj ET Q q 0 0 0 rg BT 227.78 574.90 Td (of ) Tj ET Q q 0 0 0 rg BT 239.42 574.90 Td (a ) Tj ET Q q 0 0 0 rg BT 247.73 574.90 Td (combination ) Tj ET Q q 0 0 0 rg BT 302.71 574.90 Td (therapy) Tj ET Q q 0 0 0 rg BT 333.45 574.90 Td (, ) Tj ET Q q 0 0 0 rg BT 339.26 574.90 Td (is ) Tj ET Q q 0 0 0 rg BT 349.24 574.90 Td (delayed ) Tj ET Q q 0 0 0 rg BT 383.65 574.90 Td (or ) Tj ET Q q 0 0 0 rg BT 395.85 574.90 Td (discontinued, ) Tj ET Q q 0 0 0 rg BT 454.45 574.90 Td (our ) Tj ET Q q 0 0 0 rg BT 472.21 574.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 496.63 574.90 Td (price ) Tj ET Q q 0 0 0 rg BT 520.49 574.90 Td (could ) Tj ET Q q 0 0 0 rg BT 546.58 574.90 Td (decline ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 562.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 89.61 562.90 Td (and ) Tj ET Q q 0 0 0 rg BT 107.67 562.90 Td (there ) Tj ET Q q 0 0 0 rg BT 131.28 562.90 Td (may ) Tj ET Q q 0 0 0 rg BT 151.00 562.90 Td (be ) Tj ET Q q 0 0 0 rg BT 162.94 562.90 Td (an ) Tj ET Q q 0 0 0 rg BT 176.00 562.90 Td (adverse ) Tj ET Q q 0 0 0 rg BT 209.60 562.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 239.87 562.90 Td (on ) Tj ET Q q 0 0 0 rg BT 252.93 562.90 Td (our ) Tj ET Q q 0 0 0 rg BT 269.89 562.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 309.90 562.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 349.63 562.90 Td (condition ) Tj ET Q q 0 0 0 rg BT 391.02 562.90 Td (or ) Tj ET Q q 0 0 0 rg BT 402.42 562.90 Td (results ) Tj ET Q q 0 0 0 rg BT 432.15 562.90 Td (of ) Tj ET Q q 0 0 0 rg BT 442.98 562.90 Td (operations.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 550.90 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 550.90 Td (e ) Tj ET Q q 0 0 0 rg BT 50.77 550.90 Td (ar) Tj ET Q q 0 0 0 rg BT 59.29 550.90 Td (e ) Tj ET Q q 0 0 0 rg BT 66.64 550.90 Td (focusing ) Tj ET Q q 0 0 0 rg BT 103.45 550.90 Td (our ) Tj ET Q q 0 0 0 rg BT 120.26 550.90 Td (efforts ) Tj ET Q q 0 0 0 rg BT 148.73 550.90 Td (and ) Tj ET Q q 0 0 0 rg BT 166.65 550.90 Td (r) Tj ET Q q 0 0 0 rg BT 170.17 550.90 Td (esour) Tj ET Q q 0 0 0 rg BT 192.02 550.90 Td (ces ) Tj ET Q q 0 0 0 rg BT 207.71 550.90 Td (in ) Tj ET Q q 0 0 0 rg BT 218.40 550.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 249.65 550.90 Td (disease ) Tj ET Q q 0 0 0 rg BT 282.00 550.90 Td (ar) Tj ET Q q 0 0 0 rg BT 290.52 550.90 Td (eas. ) Tj ET Q q 0 0 0 rg BT 309.27 550.90 Td (W) Tj ET Q q 0 0 0 rg BT 317.05 550.90 Td (ith ) Tj ET Q q 0 0 0 rg BT 330.52 550.90 Td (our ) Tj ET Q q 0 0 0 rg BT 347.33 550.90 Td (mor) Tj ET Q q 0 0 0 rg BT 363.07 550.90 Td (e ) Tj ET Q q 0 0 0 rg BT 370.43 550.90 Td (focused ) Tj ET Q q 0 0 0 rg BT 403.89 550.90 Td (portfolio, ) Tj ET Q q 0 0 0 rg BT 444.32 550.90 Td (investors ) Tj ET Q q 0 0 0 rg BT 483.34 550.90 Td (ar) Tj ET Q q 0 0 0 rg BT 491.86 550.90 Td (e ) Tj ET Q q 0 0 0 rg BT 499.22 550.90 Td (placing ) Tj ET Q q 0 0 0 rg BT 532.13 550.90 Td (heightened ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 538.90 Td (scrutiny ) Tj ET Q q 0 0 0 rg BT 70.48 538.90 Td (on ) Tj ET Q q 0 0 0 rg BT 82.75 538.90 Td (some ) Tj ET Q q 0 0 0 rg BT 105.57 538.90 Td (of ) Tj ET Q q 0 0 0 rg BT 115.62 538.90 Td (our ) Tj ET Q q 0 0 0 rg BT 131.77 538.90 Td (pr) Tj ET Q q 0 0 0 rg BT 140.29 538.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 168.67 538.90 Td (or ) Tj ET Q q 0 0 0 rg BT 179.83 538.90 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 221.53 538.90 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 271.85 538.90 Td (In ) Tj ET Q q 0 0 0 rg BT 282.45 538.90 Td (particular) Tj ET Q q 0 0 0 rg BT 321.89 538.90 Td (, ) Tj ET Q q 0 0 0 rg BT 326.66 538.90 Td (Opdivo ) Tj ET Q q 0 0 0 rg BT 358.37 538.90 Td (is ) Tj ET Q q 0 0 0 rg BT 367.30 538.90 Td (an ) Tj ET Q q 0 0 0 rg BT 379.57 538.90 Td (important ) Tj ET Q q 0 0 0 rg BT 421.29 538.90 Td (asset ) Tj ET Q q 0 0 0 rg BT 443.55 538.90 Td (in ) Tj ET Q q 0 0 0 rg BT 453.60 538.90 Td (our ) Tj ET Q q 0 0 0 rg BT 469.76 538.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 482.58 538.90 Td (portfolio. ) Tj ET Q q 0 0 0 rg BT 522.35 538.90 Td (During ) Tj ET Q q 0 0 0 rg BT 553.51 538.90 Td (2016, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 526.90 Td (we ) Tj ET Q q 0 0 0 rg BT 49.75 526.90 Td (announced ) Tj ET Q q 0 0 0 rg BT 96.26 526.90 Td (multiple ) Tj ET Q q 0 0 0 rg BT 131.67 526.90 Td (r) Tj ET Q q 0 0 0 rg BT 135.19 526.90 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 176.15 526.90 Td (milestones ) Tj ET Q q 0 0 0 rg BT 221.00 526.90 Td (for ) Tj ET Q q 0 0 0 rg BT 235.31 526.90 Td (Opdivo. ) Tj ET Q q 0 0 0 rg BT 269.89 526.90 Td (W) Tj ET Q q 0 0 0 rg BT 277.30 526.90 Td (e ) Tj ET Q q 0 0 0 rg BT 284.37 526.90 Td (also, ) Tj ET Q q 0 0 0 rg BT 306.18 526.90 Td (however) Tj ET Q q 0 0 0 rg BT 338.95 526.90 Td (, ) Tj ET Q q 0 0 0 rg BT 344.09 526.90 Td (encounter) Tj ET Q q 0 0 0 rg BT 383.70 526.90 Td (ed ) Tj ET Q q 0 0 0 rg BT 395.78 526.90 Td (a ) Tj ET Q q 0 0 0 rg BT 403.41 526.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 448.27 526.90 Td (setback ) Tj ET Q q 0 0 0 rg BT 480.89 526.90 Td (in ) Tj ET Q q 0 0 0 rg BT 491.31 526.90 Td (first-line ) Tj ET Q q 0 0 0 rg BT 528.39 526.90 Td (lung ) Tj ET Q q 0 0 0 rg BT 548.80 526.90 Td (cancer ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 514.90 Td (with ) Tj ET Q q 0 0 0 rg BT 56.36 514.90 Td (the ) Tj ET Q q 0 0 0 rg BT 71.71 514.90 Td (announcement ) Tj ET Q q 0 0 0 rg BT 133.16 514.90 Td (of ) Tj ET Q q 0 0 0 rg BT 144.07 514.90 Td (the ) Tj ET Q q 0 0 0 rg BT 159.42 514.90 Td (negative ) Tj ET Q q 0 0 0 rg BT 196.43 514.90 Td (r) Tj ET Q q 0 0 0 rg BT 199.95 514.90 Td (esults ) Tj ET Q q 0 0 0 rg BT 225.86 514.90 Td (of ) Tj ET Q q 0 0 0 rg BT 236.77 514.90 Td (CheckMate-026 ) Tj ET Q q 0 0 0 rg BT 303.77 514.90 Td (and ) Tj ET Q q 0 0 0 rg BT 321.90 514.90 Td (we ) Tj ET Q q 0 0 0 rg BT 336.15 514.90 Td (announced ) Tj ET Q q 0 0 0 rg BT 383.16 514.90 Td (we ) Tj ET Q q 0 0 0 rg BT 397.40 514.90 Td (would ) Tj ET Q q 0 0 0 rg BT 424.98 514.90 Td (not ) Tj ET Q q 0 0 0 rg BT 440.89 514.90 Td (pursue ) Tj ET Q q 0 0 0 rg BT 471.25 514.90 Td (an ) Tj ET Q q 0 0 0 rg BT 484.38 514.90 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 534.16 514.90 Td (r) Tj ET Q q 0 0 0 rg BT 537.68 514.90 Td (egulatory ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 502.90 Td (pathway ) Tj ET Q q 0 0 0 rg BT 72.81 502.90 Td (for ) Tj ET Q q 0 0 0 rg BT 87.41 502.90 Td (the ) Tj ET Q q 0 0 0 rg BT 102.56 502.90 Td (combination ) Tj ET Q q 0 0 0 rg BT 155.48 502.90 Td (of ) Tj ET Q q 0 0 0 rg BT 166.18 502.90 Td (Opdivo+Y) Tj ET Q q 0 0 0 rg BT 207.01 502.90 Td (ervoy ) Tj ET Q q 0 0 0 rg BT 232.15 502.90 Td (which ) Tj ET Q q 0 0 0 rg BT 258.96 502.90 Td (had ) Tj ET Q q 0 0 0 rg BT 276.89 502.90 Td (negative ) Tj ET Q q 0 0 0 rg BT 313.69 502.90 Td (impacts ) Tj ET Q q 0 0 0 rg BT 347.72 502.90 Td (on ) Tj ET Q q 0 0 0 rg BT 360.65 502.90 Td (our ) Tj ET Q q 0 0 0 rg BT 377.47 502.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 400.94 502.90 Td (price. ) Tj ET Q q 0 0 0 rg BT 426.92 502.90 Td (In ) Tj ET Q q 0 0 0 rg BT 438.18 502.90 Td (2017, ) Tj ET Q q 0 0 0 rg BT 463.60 502.90 Td (we ) Tj ET Q q 0 0 0 rg BT 477.64 502.90 Td (expect ) Tj ET Q q 0 0 0 rg BT 506.10 502.90 Td (to ) Tj ET Q q 0 0 0 rg BT 516.80 502.90 Td (r) Tj ET Q q 0 0 0 rg BT 520.32 502.90 Td (eceive ) Tj ET Q q 0 0 0 rg BT 548.22 502.90 Td (further ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 490.90 Td (news ) Tj ET Q q 0 0 0 rg BT 58.50 490.90 Td (fr) Tj ET Q q 0 0 0 rg BT 64.80 490.90 Td (om ) Tj ET Q q 0 0 0 rg BT 79.52 490.90 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 114.80 490.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 147.29 490.90 Td (trials ) Tj ET Q q 0 0 0 rg BT 170.91 490.90 Td (and ) Tj ET Q q 0 0 0 rg BT 188.41 490.90 Td (health ) Tj ET Q q 0 0 0 rg BT 215.90 490.90 Td (authorities ) Tj ET Q q 0 0 0 rg BT 261.74 490.90 Td (for ) Tj ET Q q 0 0 0 rg BT 275.91 490.90 Td (several ) Tj ET Q q 0 0 0 rg BT 307.28 490.90 Td (new ) Tj ET Q q 0 0 0 rg BT 325.89 490.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 363.94 490.90 Td (indications.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 466.90 Td (The ) Tj ET Q q 0 0 0 rg BT 54.08 466.90 Td (announcement ) Tj ET Q q 0 0 0 rg BT 115.47 466.90 Td (of ) Tj ET Q q 0 0 0 rg BT 126.33 466.90 Td (data ) Tj ET Q q 0 0 0 rg BT 147.19 466.90 Td (fr) Tj ET Q q 0 0 0 rg BT 153.49 466.90 Td (om ) Tj ET Q q 0 0 0 rg BT 168.79 466.90 Td (our ) Tj ET Q q 0 0 0 rg BT 185.76 466.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 218.82 466.90 Td (studies, ) Tj ET Q q 0 0 0 rg BT 252.18 466.90 Td (or ) Tj ET Q q 0 0 0 rg BT 264.15 466.90 Td (those ) Tj ET Q q 0 0 0 rg BT 288.34 466.90 Td (of ) Tj ET Q q 0 0 0 rg BT 299.20 466.90 Td (our ) Tj ET Q q 0 0 0 rg BT 316.17 466.90 Td (competitors, ) Tj ET Q q 0 0 0 rg BT 368.96 466.90 Td (or ) Tj ET Q q 0 0 0 rg BT 380.93 466.90 Td (news ) Tj ET Q q 0 0 0 rg BT 404.01 466.90 Td (of ) Tj ET Q q 0 0 0 rg BT 414.87 466.90 Td (any ) Tj ET Q q 0 0 0 rg BT 432.38 466.90 Td (developments ) Tj ET Q q 0 0 0 rg BT 489.89 466.90 Td (r) Tj ET Q q 0 0 0 rg BT 493.41 466.90 Td (elated ) Tj ET Q q 0 0 0 rg BT 520.92 466.90 Td (to ) Tj ET Q q 0 0 0 rg BT 531.78 466.90 Td (our) Tj ET Q q 0 0 0 rg BT 544.56 466.90 Td (, ) Tj ET Q q 0 0 0 rg BT 550.14 466.90 Td (or ) Tj ET Q q 0 0 0 rg BT 562.11 466.90 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 454.90 Td (competitors', ) Tj ET Q q 0 0 0 rg BT 90.68 454.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 104.05 454.90 Td (pr) Tj ET Q q 0 0 0 rg BT 112.58 454.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 141.51 454.90 Td (or ) Tj ET Q q 0 0 0 rg BT 153.22 454.90 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 195.48 454.90 Td (compounds, ) Tj ET Q q 0 0 0 rg BT 246.36 454.90 Td (such ) Tj ET Q q 0 0 0 rg BT 267.51 454.90 Td (as ) Tj ET Q q 0 0 0 rg BT 279.22 454.90 Td (Opdivo, ) Tj ET Q q 0 0 0 rg BT 313.99 454.90 Td (may ) Tj ET Q q 0 0 0 rg BT 333.47 454.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 359.06 454.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 404.11 454.90 Td (volatility ) Tj ET Q q 0 0 0 rg BT 442.48 454.90 Td (in ) Tj ET Q q 0 0 0 rg BT 453.08 454.90 Td (our ) Tj ET Q q 0 0 0 rg BT 469.80 454.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 493.17 454.90 Td (price ) Tj ET Q q 0 0 0 rg BT 516.54 454.90 Td (and ) Tj ET Q q 0 0 0 rg BT 534.36 454.90 Td (depending ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 442.90 Td (on ) Tj ET Q q 0 0 0 rg BT 47.89 442.90 Td (the ) Tj ET Q q 0 0 0 rg BT 62.00 442.90 Td (news, ) Tj ET Q q 0 0 0 rg BT 86.39 442.90 Td (may ) Tj ET Q q 0 0 0 rg BT 104.95 442.90 Td (r) Tj ET Q q 0 0 0 rg BT 108.47 442.90 Td (esult ) Tj ET Q q 0 0 0 rg BT 129.24 442.90 Td (in ) Tj ET Q q 0 0 0 rg BT 138.92 442.90 Td (an ) Tj ET Q q 0 0 0 rg BT 150.81 442.90 Td (adverse ) Tj ET Q q 0 0 0 rg BT 183.80 442.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 212.91 442.90 Td (on ) Tj ET Q q 0 0 0 rg BT 224.80 442.90 Td (our ) Tj ET Q q 0 0 0 rg BT 240.58 442.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 278.87 442.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 316.31 442.90 Td (condition ) Tj ET Q q 0 0 0 rg BT 355.98 442.90 Td (or ) Tj ET Q q 0 0 0 rg BT 366.76 442.90 Td (r) Tj ET Q q 0 0 0 rg BT 370.28 442.90 Td (esults ) Tj ET Q q 0 0 0 rg BT 394.95 442.90 Td (of ) Tj ET Q q 0 0 0 rg BT 404.62 442.90 Td (operation. ) Tj ET Q q 0 0 0 rg BT 447.90 442.90 Td (Furthermor) Tj ET Q q 0 0 0 rg BT 494.75 442.90 Td (e, ) Tj ET Q q 0 0 0 rg BT 503.58 442.90 Td (the ) Tj ET Q q 0 0 0 rg BT 517.69 442.90 Td (announcement ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 430.90 Td (of ) Tj ET Q q 0 0 0 rg BT 46.31 430.90 Td (any ) Tj ET Q q 0 0 0 rg BT 63.28 430.90 Td (negative ) Tj ET Q q 0 0 0 rg BT 99.68 430.90 Td (or ) Tj ET Q q 0 0 0 rg BT 111.10 430.90 Td (unexpected ) Tj ET Q q 0 0 0 rg BT 158.60 430.90 Td (data ) Tj ET Q q 0 0 0 rg BT 178.91 430.90 Td (or ) Tj ET Q q 0 0 0 rg BT 190.33 430.90 Td (the ) Tj ET Q q 0 0 0 rg BT 205.07 430.90 Td (discontinuation ) Tj ET Q q 0 0 0 rg BT 269.82 430.90 Td (of ) Tj ET Q q 0 0 0 rg BT 280.13 430.90 Td (development ) Tj ET Q q 0 0 0 rg BT 333.19 430.90 Td (of ) Tj ET Q q 0 0 0 rg BT 343.50 430.90 Td (any ) Tj ET Q q 0 0 0 rg BT 360.47 430.90 Td (of ) Tj ET Q q 0 0 0 rg BT 370.78 430.90 Td (our ) Tj ET Q q 0 0 0 rg BT 387.20 430.90 Td (key ) Tj ET Q q 0 0 0 rg BT 403.04 430.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 416.12 430.90 Td (compounds, ) Tj ET Q q 0 0 0 rg BT 466.70 430.90 Td (whether ) Tj ET Q q 0 0 0 rg BT 501.45 430.90 Td (alone ) Tj ET Q q 0 0 0 rg BT 526.20 430.90 Td (or ) Tj ET Q q 0 0 0 rg BT 537.62 430.90 Td (as ) Tj ET Q q 0 0 0 rg BT 549.04 430.90 Td (part ) Tj ET Q q 0 0 0 rg BT 568.24 430.90 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 418.90 Td (a ) Tj ET Q q 0 0 0 rg BT 44.68 418.90 Td (combination ) Tj ET Q q 0 0 0 rg BT 98.36 418.90 Td (therapy) Tj ET Q q 0 0 0 rg BT 128.36 418.90 Td (, ) Tj ET Q q 0 0 0 rg BT 134.54 418.90 Td (any ) Tj ET Q q 0 0 0 rg BT 152.66 418.90 Td (delay ) Tj ET Q q 0 0 0 rg BT 178.00 418.90 Td (in ) Tj ET Q q 0 0 0 rg BT 189.46 418.90 Td (our ) Tj ET Q q 0 0 0 rg BT 207.04 418.90 Td (anticipated ) Tj ET Q q 0 0 0 rg BT 255.71 418.90 Td (timelines ) Tj ET Q q 0 0 0 rg BT 295.50 418.90 Td (for ) Tj ET Q q 0 0 0 rg BT 310.85 418.90 Td (filing ) Tj ET Q q 0 0 0 rg BT 335.65 418.90 Td (for ) Tj ET Q q 0 0 0 rg BT 351.00 418.90 Td (r) Tj ET Q q 0 0 0 rg BT 354.52 418.90 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 396.53 418.90 Td (appr) Tj ET Q q 0 0 0 rg BT 415.05 418.90 Td (oval ) Tj ET Q q 0 0 0 rg BT 435.95 418.90 Td (or ) Tj ET Q q 0 0 0 rg BT 448.52 418.90 Td (a ) Tj ET Q q 0 0 0 rg BT 457.21 418.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 503.11 418.90 Td (advancement ) Tj ET Q q 0 0 0 rg BT 559.55 418.90 Td (of ) Tj ET Q q 0 0 0 rg BT 571.01 418.90 Td (a ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 406.90 Td (competitor) Tj ET Q q 0 0 0 rg BT 78.22 406.90 Td (, ) Tj ET Q q 0 0 0 rg BT 83.39 406.90 Td (may ) Tj ET Q q 0 0 0 rg BT 102.72 406.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 128.16 406.90 Td (our ) Tj ET Q q 0 0 0 rg BT 144.73 406.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 167.95 406.90 Td (price ) Tj ET Q q 0 0 0 rg BT 191.17 406.90 Td (to ) Tj ET Q q 0 0 0 rg BT 201.62 406.90 Td (decline ) Tj ET Q q 0 0 0 rg BT 233.16 406.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 285.27 406.90 Td (and ) Tj ET Q q 0 0 0 rg BT 302.94 406.90 Td (may ) Tj ET Q q 0 0 0 rg BT 322.28 406.90 Td (have ) Tj ET Q q 0 0 0 rg BT 343.83 406.90 Td (an ) Tj ET Q q 0 0 0 rg BT 356.50 406.90 Td (adverse ) Tj ET Q q 0 0 0 rg BT 390.27 406.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 420.16 406.90 Td (on ) Tj ET Q q 0 0 0 rg BT 432.83 406.90 Td (our ) Tj ET Q q 0 0 0 rg BT 449.39 406.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 488.46 406.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 526.68 406.90 Td (condition ) Tj ET Q q 0 0 0 rg BT 567.13 406.90 Td (or ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 394.90 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 394.90 Td (esults ) Tj ET Q q 0 0 0 rg BT 64.98 394.90 Td (of ) Tj ET Q q 0 0 0 rg BT 75.44 394.90 Td (operations. ) Tj ET Q q 0 0 0 rg BT 123.40 394.90 Td (Ther) Tj ET Q q 0 0 0 rg BT 141.92 394.90 Td (e ) Tj ET Q q 0 0 0 rg BT 149.04 394.90 Td (is ) Tj ET Q q 0 0 0 rg BT 158.39 394.90 Td (no ) Tj ET Q q 0 0 0 rg BT 171.07 394.90 Td (assurance ) Tj ET Q q 0 0 0 rg BT 214.30 394.90 Td (that ) Tj ET Q q 0 0 0 rg BT 232.54 394.90 Td (data ) Tj ET Q q 0 0 0 rg BT 253.00 394.90 Td (fr) Tj ET Q q 0 0 0 rg BT 259.30 394.90 Td (om ) Tj ET Q q 0 0 0 rg BT 274.20 394.90 Td (our ) Tj ET Q q 0 0 0 rg BT 290.77 394.90 Td (clinical ) Tj ET Q q 0 0 0 rg BT 323.44 394.90 Td (studies ) Tj ET Q q 0 0 0 rg BT 353.90 394.90 Td (will ) Tj ET Q q 0 0 0 rg BT 371.59 394.90 Td (support ) Tj ET Q q 0 0 0 rg BT 404.83 394.90 Td (filings ) Tj ET Q q 0 0 0 rg BT 432.51 394.90 Td (for ) Tj ET Q q 0 0 0 rg BT 446.86 394.90 Td (r) Tj ET Q q 0 0 0 rg BT 450.38 394.90 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 491.39 394.90 Td (appr) Tj ET Q q 0 0 0 rg BT 509.91 394.90 Td (oval, ) Tj ET Q q 0 0 0 rg BT 532.31 394.90 Td (or ) Tj ET Q q 0 0 0 rg BT 543.88 394.90 Td (that ) Tj ET Q q 0 0 0 rg BT 562.12 394.90 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 382.90 Td (key ) Tj ET Q q 0 0 0 rg BT 51.90 382.90 Td (IO ) Tj ET Q q 0 0 0 rg BT 65.04 382.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 113.17 382.90 Td (may ) Tj ET Q q 0 0 0 rg BT 132.42 382.90 Td (pr) Tj ET Q q 0 0 0 rg BT 140.94 382.90 Td (ove ) Tj ET Q q 0 0 0 rg BT 157.40 382.90 Td (to ) Tj ET Q q 0 0 0 rg BT 167.76 382.90 Td (be ) Tj ET Q q 0 0 0 rg BT 179.78 382.90 Td (effective ) Tj ET Q q 0 0 0 rg BT 215.67 382.90 Td (or ) Tj ET Q q 0 0 0 rg BT 227.15 382.90 Td (as ) Tj ET Q q 0 0 0 rg BT 238.63 382.90 Td (effective ) Tj ET Q q 0 0 0 rg BT 274.52 382.90 Td (as ) Tj ET Q q 0 0 0 rg BT 285.99 382.90 Td (other ) Tj ET Q q 0 0 0 rg BT 309.69 382.90 Td (competing ) Tj ET Q q 0 0 0 rg BT 353.93 382.90 Td (compounds, ) Tj ET Q q 0 0 0 rg BT 404.56 382.90 Td (or ) Tj ET Q q 0 0 0 rg BT 416.04 382.90 Td (even ) Tj ET Q q 0 0 0 rg BT 436.94 382.90 Td (if ) Tj ET Q q 0 0 0 rg BT 445.08 382.90 Td (appr) Tj ET Q q 0 0 0 rg BT 463.60 382.90 Td (oved, ) Tj ET Q q 0 0 0 rg BT 487.56 382.90 Td (that ) Tj ET Q q 0 0 0 rg BT 505.70 382.90 Td (any ) Tj ET Q q 0 0 0 rg BT 522.73 382.90 Td (of ) Tj ET Q q 0 0 0 rg BT 533.09 382.90 Td (our ) Tj ET Q q 0 0 0 rg BT 549.56 382.90 Td (key ) Tj ET Q q 0 0 0 rg BT 565.46 382.90 Td (IO ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 370.90 Td (compounds ) Tj ET Q q 0 0 0 rg BT 84.05 370.90 Td (will ) Tj ET Q q 0 0 0 rg BT 101.56 370.90 Td (become ) Tj ET Q q 0 0 0 rg BT 134.59 370.90 Td (commer) Tj ET Q q 0 0 0 rg BT 166.43 370.90 Td (cially ) Tj ET Q q 0 0 0 rg BT 191.15 370.90 Td (successful ) Tj ET Q q 0 0 0 rg BT 234.19 370.90 Td (for ) Tj ET Q q 0 0 0 rg BT 248.36 370.90 Td (all ) Tj ET Q q 0 0 0 rg BT 261.42 370.90 Td (appr) Tj ET Q q 0 0 0 rg BT 279.94 370.90 Td (oved ) Tj ET Q q 0 0 0 rg BT 301.32 370.90 Td (indications.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 346.90 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 346.90 Td (e ) Tj ET Q q 0 0 0 rg BT 51.09 346.90 Td (depend ) Tj ET Q q 0 0 0 rg BT 83.03 346.90 Td (on ) Tj ET Q q 0 0 0 rg BT 96.09 346.90 Td (several ) Tj ET Q q 0 0 0 rg BT 127.46 346.90 Td (key ) Tj ET Q q 0 0 0 rg BT 143.84 346.90 Td (products ) Tj ET Q q 0 0 0 rg BT 181.90 346.90 Td (for ) Tj ET Q q 0 0 0 rg BT 196.63 346.90 Td (most ) Tj ET Q q 0 0 0 rg BT 218.57 346.90 Td (of ) Tj ET Q q 0 0 0 rg BT 229.40 346.90 Td (our ) Tj ET Q q 0 0 0 rg BT 246.36 346.90 Td (revenues, ) Tj ET Q q 0 0 0 rg BT 288.02 346.90 Td (cash ) Tj ET Q q 0 0 0 rg BT 309.41 346.90 Td (flows ) Tj ET Q q 0 0 0 rg BT 333.58 346.90 Td (and ) Tj ET Q q 0 0 0 rg BT 351.64 346.90 Td (earnings.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 334.90 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 334.90 Td (e ) Tj ET Q q 0 0 0 rg BT 49.86 334.90 Td (have ) Tj ET Q q 0 0 0 rg BT 70.75 334.90 Td (historically ) Tj ET Q q 0 0 0 rg BT 118.31 334.90 Td (derived ) Tj ET Q q 0 0 0 rg BT 150.30 334.90 Td (a ) Tj ET Q q 0 0 0 rg BT 157.31 334.90 Td (majority ) Tj ET Q q 0 0 0 rg BT 193.21 334.90 Td (of ) Tj ET Q q 0 0 0 rg BT 202.99 334.90 Td (our ) Tj ET Q q 0 0 0 rg BT 218.90 334.90 Td (r) Tj ET Q q 0 0 0 rg BT 222.42 334.90 Td (evenue ) Tj ET Q q 0 0 0 rg BT 252.18 334.90 Td (and ) Tj ET Q q 0 0 0 rg BT 269.19 334.90 Td (earnings ) Tj ET Q q 0 0 0 rg BT 306.20 334.90 Td (fr) Tj ET Q q 0 0 0 rg BT 312.50 334.90 Td (om ) Tj ET Q q 0 0 0 rg BT 326.73 334.90 Td (several ) Tj ET Q q 0 0 0 rg BT 357.61 334.90 Td (key ) Tj ET Q q 0 0 0 rg BT 372.94 334.90 Td (pr) Tj ET Q q 0 0 0 rg BT 381.46 334.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 409.58 334.90 Td (and ) Tj ET Q q 0 0 0 rg BT 426.59 334.90 Td (while ) Tj ET Q q 0 0 0 rg BT 450.26 334.90 Td (we ) Tj ET Q q 0 0 0 rg BT 463.38 334.90 Td (ar) Tj ET Q q 0 0 0 rg BT 471.90 334.90 Td (e ) Tj ET Q q 0 0 0 rg BT 478.35 334.90 Td (not ) Tj ET Q q 0 0 0 rg BT 493.13 334.90 Td (as ) Tj ET Q q 0 0 0 rg BT 504.03 334.90 Td (heavily ) Tj ET Q q 0 0 0 rg BT 534.92 334.90 Td (dependent ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 322.90 Td (on ) Tj ET Q q 0 0 0 rg BT 47.86 322.90 Td (one ) Tj ET Q q 0 0 0 rg BT 64.16 322.90 Td (or ) Tj ET Q q 0 0 0 rg BT 74.92 322.90 Td (two ) Tj ET Q q 0 0 0 rg BT 91.23 322.90 Td (pr) Tj ET Q q 0 0 0 rg BT 99.75 322.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 127.72 322.90 Td (as ) Tj ET Q q 0 0 0 rg BT 138.48 322.90 Td (in ) Tj ET Q q 0 0 0 rg BT 148.12 322.90 Td (past ) Tj ET Q q 0 0 0 rg BT 166.65 322.90 Td (years, ) Tj ET Q q 0 0 0 rg BT 192.67 322.90 Td (our ) Tj ET Q q 0 0 0 rg BT 208.43 322.90 Td (dependence ) Tj ET Q q 0 0 0 rg BT 257.48 322.90 Td (on ) Tj ET Q q 0 0 0 rg BT 269.34 322.90 Td (the ) Tj ET Q q 0 0 0 rg BT 283.42 322.90 Td (pr) Tj ET Q q 0 0 0 rg BT 291.94 322.90 Td (ofitability ) Tj ET Q q 0 0 0 rg BT 332.69 322.90 Td (of ) Tj ET Q q 0 0 0 rg BT 342.34 322.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 372.52 322.90 Td (pr) Tj ET Q q 0 0 0 rg BT 381.04 322.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 409.02 322.90 Td (is ) Tj ET Q q 0 0 0 rg BT 417.55 322.90 Td (likely ) Tj ET Q q 0 0 0 rg BT 441.06 322.90 Td (to ) Tj ET Q q 0 0 0 rg BT 450.70 322.90 Td (continue. ) Tj ET Q q 0 0 0 rg BT 489.50 322.90 Td (W) Tj ET Q q 0 0 0 rg BT 496.91 322.90 Td (e ) Tj ET Q q 0 0 0 rg BT 503.21 322.90 Td (expect ) Tj ET Q q 0 0 0 rg BT 530.61 322.90 Td (that ) Tj ET Q q 0 0 0 rg BT 548.03 322.90 Td (gr) Tj ET Q q 0 0 0 rg BT 556.55 322.90 Td (owth ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 310.90 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 310.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 73.07 310.90 Td (such ) Tj ET Q q 0 0 0 rg BT 93.84 310.90 Td (as ) Tj ET Q q 0 0 0 rg BT 105.17 310.90 Td (Opdivo ) Tj ET Q q 0 0 0 rg BT 137.05 310.90 Td (and ) Tj ET Q q 0 0 0 rg BT 154.50 310.90 Td (Eliquis ) Tj ET Q q 0 0 0 rg BT 185.27 310.90 Td (will ) Tj ET Q q 0 0 0 rg BT 202.72 310.90 Td (become ) Tj ET Q q 0 0 0 rg BT 235.70 310.90 Td (an ) Tj ET Q q 0 0 0 rg BT 248.14 310.90 Td (incr) Tj ET Q q 0 0 0 rg BT 263.88 310.90 Td (easingly ) Tj ET Q q 0 0 0 rg BT 299.64 310.90 Td (important ) Tj ET Q q 0 0 0 rg BT 341.53 310.90 Td (part ) Tj ET Q q 0 0 0 rg BT 360.64 310.90 Td (of ) Tj ET Q q 0 0 0 rg BT 370.86 310.90 Td (our ) Tj ET Q q 0 0 0 rg BT 387.20 310.90 Td (r) Tj ET Q q 0 0 0 rg BT 390.72 310.90 Td (evenue ) Tj ET Q q 0 0 0 rg BT 420.91 310.90 Td (base. ) Tj ET Q q 0 0 0 rg BT 444.01 310.90 Td (A) Tj ET Q q 0 0 0 rg BT 449.94 310.90 Td ( ) Tj ET Q q 0 0 0 rg BT 452.38 310.90 Td (r) Tj ET Q q 0 0 0 rg BT 455.90 310.90 Td (eduction ) Tj ET Q q 0 0 0 rg BT 492.77 310.90 Td (in ) Tj ET Q q 0 0 0 rg BT 502.99 310.90 Td (r) Tj ET Q q 0 0 0 rg BT 506.51 310.90 Td (evenues ) Tj ET Q q 0 0 0 rg BT 540.60 310.90 Td (fr) Tj ET Q q 0 0 0 rg BT 546.90 310.90 Td (om ) Tj ET Q q 0 0 0 rg BT 561.56 310.90 Td (one ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 298.90 Td (of ) Tj ET Q q 0 0 0 rg BT 46.28 298.90 Td (these ) Tj ET Q q 0 0 0 rg BT 69.33 298.90 Td (pr) Tj ET Q q 0 0 0 rg BT 77.85 298.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 106.45 298.90 Td (could ) Tj ET Q q 0 0 0 rg BT 131.17 298.90 Td (have ) Tj ET Q q 0 0 0 rg BT 152.55 298.90 Td (an ) Tj ET Q q 0 0 0 rg BT 165.05 298.90 Td (adverse ) Tj ET Q q 0 0 0 rg BT 198.65 298.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 228.36 298.90 Td (our ) Tj ET Q q 0 0 0 rg BT 244.75 298.90 Td (r) Tj ET Q q 0 0 0 rg BT 248.28 298.90 Td (evenues, ) Tj ET Q q 0 0 0 rg BT 284.92 298.90 Td (cash ) Tj ET Q q 0 0 0 rg BT 305.75 298.90 Td (flows ) Tj ET Q q 0 0 0 rg BT 329.37 298.90 Td (and ) Tj ET Q q 0 0 0 rg BT 346.87 298.90 Td (earnings.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 274.90 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 274.90 Td (e ) Tj ET Q q 0 0 0 rg BT 51.09 274.90 Td (may ) Tj ET Q q 0 0 0 rg BT 70.80 274.90 Td (experience ) Tj ET Q q 0 0 0 rg BT 117.73 274.90 Td (dif) Tj ET Q q 0 0 0 rg BT 128.66 274.90 Td (ficulties ) Tj ET Q q 0 0 0 rg BT 163.93 274.90 Td (or ) Tj ET Q q 0 0 0 rg BT 175.32 274.90 Td (delays ) Tj ET Q q 0 0 0 rg BT 203.37 274.90 Td (in ) Tj ET Q q 0 0 0 rg BT 214.21 274.90 Td (the ) Tj ET Q q 0 0 0 rg BT 229.49 274.90 Td (development ) Tj ET Q q 0 0 0 rg BT 283.64 274.90 Td (and ) Tj ET Q q 0 0 0 rg BT 301.70 274.90 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 380.31 274.90 Td (of ) Tj ET Q q 0 0 0 rg BT 391.14 274.90 Td (new ) Tj ET Q q 0 0 0 rg BT 410.31 274.90 Td (products.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 262.90 Td (Compounds ) Tj ET Q q 0 0 0 rg BT 86.27 262.90 Td (or ) Tj ET Q q 0 0 0 rg BT 97.66 262.90 Td (pr) Tj ET Q q 0 0 0 rg BT 106.18 262.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 134.77 262.90 Td (may ) Tj ET Q q 0 0 0 rg BT 153.92 262.90 Td (appear ) Tj ET Q q 0 0 0 rg BT 184.75 262.90 Td (pr) Tj ET Q q 0 0 0 rg BT 193.27 262.90 Td (omising ) Tj ET Q q 0 0 0 rg BT 227.43 262.90 Td (in ) Tj ET Q q 0 0 0 rg BT 237.69 262.90 Td (development ) Tj ET Q q 0 0 0 rg BT 290.72 262.90 Td (but ) Tj ET Q q 0 0 0 rg BT 305.99 262.90 Td (fail ) Tj ET Q q 0 0 0 rg BT 321.81 262.90 Td (to ) Tj ET Q q 0 0 0 rg BT 332.08 262.90 Td (r) Tj ET Q q 0 0 0 rg BT 335.60 262.90 Td (each ) Tj ET Q q 0 0 0 rg BT 356.97 262.90 Td (market ) Tj ET Q q 0 0 0 rg BT 387.23 262.90 Td (within ) Tj ET Q q 0 0 0 rg BT 414.72 262.90 Td (the ) Tj ET Q q 0 0 0 rg BT 429.43 262.90 Td (expected ) Tj ET Q q 0 0 0 rg BT 466.89 262.90 Td (or ) Tj ET Q q 0 0 0 rg BT 478.27 262.90 Td (optimal ) Tj ET Q q 0 0 0 rg BT 511.32 262.90 Td (timeframe, ) Tj ET Q q 0 0 0 rg BT 556.85 262.90 Td (or ) Tj ET Q q 0 0 0 rg BT 568.24 262.90 Td (at ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 250.90 Td (all. ) Tj ET Q q 0 0 0 rg BT 52.06 250.90 Td (In ) Tj ET Q q 0 0 0 rg BT 63.40 250.90 Td (addition, ) Tj ET Q q 0 0 0 rg BT 102.25 250.90 Td (pr) Tj ET Q q 0 0 0 rg BT 110.77 250.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 135.99 250.90 Td (extensions ) Tj ET Q q 0 0 0 rg BT 180.65 250.90 Td (or ) Tj ET Q q 0 0 0 rg BT 192.55 250.90 Td (additional ) Tj ET Q q 0 0 0 rg BT 236.67 250.90 Td (indications ) Tj ET Q q 0 0 0 rg BT 284.13 250.90 Td (may ) Tj ET Q q 0 0 0 rg BT 303.79 250.90 Td (not ) Tj ET Q q 0 0 0 rg BT 319.58 250.90 Td (be ) Tj ET Q q 0 0 0 rg BT 332.03 250.90 Td (appr) Tj ET Q q 0 0 0 rg BT 350.55 250.90 Td (oved. ) Tj ET Q q 0 0 0 rg BT 374.93 250.90 Td (Developing ) Tj ET Q q 0 0 0 rg BT 424.03 250.90 Td (and ) Tj ET Q q 0 0 0 rg BT 442.04 250.90 Td (commer) Tj ET Q q 0 0 0 rg BT 473.88 250.90 Td (cializing ) Tj ET Q q 0 0 0 rg BT 511.33 250.90 Td (new ) Tj ET Q q 0 0 0 rg BT 530.45 250.90 Td (compounds ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 238.90 Td (and ) Tj ET Q q 0 0 0 rg BT 53.97 238.90 Td (pr) Tj ET Q q 0 0 0 rg BT 62.49 238.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 91.57 238.90 Td (include ) Tj ET Q q 0 0 0 rg BT 123.97 238.90 Td (inher) Tj ET Q q 0 0 0 rg BT 144.71 238.90 Td (ent ) Tj ET Q q 0 0 0 rg BT 159.90 238.90 Td (risks ) Tj ET Q q 0 0 0 rg BT 181.76 238.90 Td (and ) Tj ET Q q 0 0 0 rg BT 199.73 238.90 Td (uncertainties, ) Tj ET Q q 0 0 0 rg BT 257.41 238.90 Td (including ) Tj ET Q q 0 0 0 rg BT 298.16 238.90 Td (\(i\) ) Tj ET Q q 0 0 0 rg BT 310.56 238.90 Td (due ) Tj ET Q q 0 0 0 rg BT 327.97 238.90 Td (to ) Tj ET Q q 0 0 0 rg BT 338.72 238.90 Td (efficacy ) Tj ET Q q 0 0 0 rg BT 372.78 238.90 Td (and ) Tj ET Q q 0 0 0 rg BT 390.75 238.90 Td (safety ) Tj ET Q q 0 0 0 rg BT 417.05 238.90 Td (concerns, ) Tj ET Q q 0 0 0 rg BT 458.61 238.90 Td (delayed ) Tj ET Q q 0 0 0 rg BT 492.68 238.90 Td (or ) Tj ET Q q 0 0 0 rg BT 504.54 238.90 Td (denied ) Tj ET Q q 0 0 0 rg BT 534.17 238.90 Td (r) Tj ET Q q 0 0 0 rg BT 537.69 238.90 Td (egulatory ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 226.90 Td (appr) Tj ET Q q 0 0 0 rg BT 54.52 226.90 Td (ovals, ) Tj ET Q q 0 0 0 rg BT 80.91 226.90 Td (delays ) Tj ET Q q 0 0 0 rg BT 109.24 226.90 Td (or ) Tj ET Q q 0 0 0 rg BT 120.92 226.90 Td (challenges ) Tj ET Q q 0 0 0 rg BT 166.46 226.90 Td (with ) Tj ET Q q 0 0 0 rg BT 186.47 226.90 Td (pr) Tj ET Q q 0 0 0 rg BT 194.99 226.90 Td (oducing ) Tj ET Q q 0 0 0 rg BT 229.99 226.90 Td (pr) Tj ET Q q 0 0 0 rg BT 238.51 226.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 267.41 226.90 Td (on ) Tj ET Q q 0 0 0 rg BT 280.19 226.90 Td (a ) Tj ET Q q 0 0 0 rg BT 287.97 226.90 Td (commer) Tj ET Q q 0 0 0 rg BT 319.81 226.90 Td (cial ) Tj ET Q q 0 0 0 rg BT 337.59 226.90 Td (scale ) Tj ET Q q 0 0 0 rg BT 360.92 226.90 Td (or ) Tj ET Q q 0 0 0 rg BT 372.60 226.90 Td (excessive ) Tj ET Q q 0 0 0 rg BT 412.57 226.90 Td (costs ) Tj ET Q q 0 0 0 rg BT 435.36 226.90 Td (to ) Tj ET Q q 0 0 0 rg BT 445.92 226.90 Td (manufactur) Tj ET Q q 0 0 0 rg BT 491.65 226.90 Td (e ) Tj ET Q q 0 0 0 rg BT 498.88 226.90 Td (them; ) Tj ET Q q 0 0 0 rg BT 524.43 226.90 Td (\(ii\) failur) Tj ET Q q 0 0 0 rg BT 561.00 226.90 Td (e ) Tj ET Q q 0 0 0 rg BT 568.22 226.90 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 214.90 Td (enter ) Tj ET Q q 0 0 0 rg BT 59.93 214.90 Td (into ) Tj ET Q q 0 0 0 rg BT 78.88 214.90 Td (or ) Tj ET Q q 0 0 0 rg BT 91.15 214.90 Td (implement ) Tj ET Q q 0 0 0 rg BT 136.20 214.90 Td (optimal ) Tj ET Q q 0 0 0 rg BT 170.14 214.90 Td (alliances ) Tj ET Q q 0 0 0 rg BT 209.63 214.90 Td (for ) Tj ET Q q 0 0 0 rg BT 224.68 214.90 Td (the ) Tj ET Q q 0 0 0 rg BT 240.29 214.90 Td (development ) Tj ET Q q 0 0 0 rg BT 294.21 214.90 Td (and/or ) Tj ET Q q 0 0 0 rg BT 324.26 214.90 Td (commer) Tj ET Q q 0 0 0 rg BT 356.10 214.90 Td (cialization ) Tj ET Q q 0 0 0 rg BT 401.71 214.90 Td (of ) Tj ET Q q 0 0 0 rg BT 412.88 214.90 Td (new ) Tj ET Q q 0 0 0 rg BT 432.37 214.90 Td (pr) Tj ET Q q 0 0 0 rg BT 440.89 214.90 Td (oducts; ) Tj ET Q q 0 0 0 rg BT 473.71 214.90 Td (\(iii\) failur) Tj ET Q q 0 0 0 rg BT 513.07 214.90 Td (e ) Tj ET Q q 0 0 0 rg BT 520.89 214.90 Td (to ) Tj ET Q q 0 0 0 rg BT 532.05 214.90 Td (maintain ) Tj ET Q q 0 0 0 rg BT 571.00 214.90 Td (a ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 202.90 Td (consistent ) Tj ET Q q 0 0 0 rg BT 77.46 202.90 Td (scope ) Tj ET Q q 0 0 0 rg BT 101.69 202.90 Td (and ) Tj ET Q q 0 0 0 rg BT 118.16 202.90 Td (variety ) Tj ET Q q 0 0 0 rg BT 147.38 202.90 Td (of ) Tj ET Q q 0 0 0 rg BT 156.63 202.90 Td (pr) Tj ET Q q 0 0 0 rg BT 165.15 202.90 Td (omising ) Tj ET Q q 0 0 0 rg BT 198.28 202.90 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 239.18 202.90 Td (pr) Tj ET Q q 0 0 0 rg BT 247.70 202.90 Td (oducts; ) Tj ET Q q 0 0 0 rg BT 278.60 202.90 Td (\(iv\) failur) Tj ET Q q 0 0 0 rg BT 316.83 202.90 Td (e ) Tj ET Q q 0 0 0 rg BT 322.73 202.90 Td (of ) Tj ET Q q 0 0 0 rg BT 331.98 202.90 Td (one ) Tj ET Q q 0 0 0 rg BT 347.88 202.90 Td (or ) Tj ET Q q 0 0 0 rg BT 358.23 202.90 Td (mor) Tj ET Q q 0 0 0 rg BT 373.98 202.90 Td (e ) Tj ET Q q 0 0 0 rg BT 379.88 202.90 Td (of ) Tj ET Q q 0 0 0 rg BT 389.12 202.90 Td (our ) Tj ET Q q 0 0 0 rg BT 404.48 202.90 Td (pr) Tj ET Q q 0 0 0 rg BT 413.00 202.90 Td (oducts ) Tj ET Q q 0 0 0 rg BT 440.57 202.90 Td (to ) Tj ET Q q 0 0 0 rg BT 449.81 202.90 Td (achieve ) Tj ET Q q 0 0 0 rg BT 481.81 202.90 Td (or ) Tj ET Q q 0 0 0 rg BT 492.16 202.90 Td (maintain ) Tj ET Q q 0 0 0 rg BT 529.18 202.90 Td (commer) Tj ET Q q 0 0 0 rg BT 561.02 202.90 Td (cial ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 190.90 Td (viability; ) Tj ET Q q 0 0 0 rg BT 74.60 190.90 Td (and ) Tj ET Q q 0 0 0 rg BT 92.10 190.90 Td (\(v\) ) Tj ET Q q 0 0 0 rg BT 105.70 190.90 Td (changes ) Tj ET Q q 0 0 0 rg BT 140.97 190.90 Td (in ) Tj ET Q q 0 0 0 rg BT 151.24 190.90 Td (r) Tj ET Q q 0 0 0 rg BT 154.76 190.90 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 195.59 190.90 Td (appr) Tj ET Q q 0 0 0 rg BT 214.11 190.90 Td (oval ) Tj ET Q q 0 0 0 rg BT 233.83 190.90 Td (pr) Tj ET Q q 0 0 0 rg BT 242.35 190.90 Td (ocesses ) Tj ET Q q 0 0 0 rg BT 274.84 190.90 Td (may ) Tj ET Q q 0 0 0 rg BT 294.00 190.90 Td (cause ) Tj ET Q q 0 0 0 rg BT 319.27 190.90 Td (delays ) Tj ET Q q 0 0 0 rg BT 347.31 190.90 Td (or ) Tj ET Q q 0 0 0 rg BT 358.71 190.90 Td (denials ) Tj ET Q q 0 0 0 rg BT 390.09 190.90 Td (of ) Tj ET Q q 0 0 0 rg BT 400.37 190.90 Td (new ) Tj ET Q q 0 0 0 rg BT 418.98 190.90 Td (pr) Tj ET Q q 0 0 0 rg BT 427.50 190.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 452.22 190.90 Td (appr) Tj ET Q q 0 0 0 rg BT 470.74 190.90 Td (ovals.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 166.90 Td (Regulatory ) Tj ET Q q 0 0 0 rg BT 83.32 166.90 Td (appr) Tj ET Q q 0 0 0 rg BT 101.84 166.90 Td (oval ) Tj ET Q q 0 0 0 rg BT 121.94 166.90 Td (delays ) Tj ET Q q 0 0 0 rg BT 150.38 166.90 Td (ar) Tj ET Q q 0 0 0 rg BT 158.90 166.90 Td (e ) Tj ET Q q 0 0 0 rg BT 166.22 166.90 Td (especially ) Tj ET Q q 0 0 0 rg BT 209.09 166.90 Td (common ) Tj ET Q q 0 0 0 rg BT 245.85 166.90 Td (when ) Tj ET Q q 0 0 0 rg BT 269.85 166.90 Td (a ) Tj ET Q q 0 0 0 rg BT 277.73 166.90 Td (pr) Tj ET Q q 0 0 0 rg BT 286.25 166.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 311.36 166.90 Td (is ) Tj ET Q q 0 0 0 rg BT 320.91 166.90 Td (expected ) Tj ET Q q 0 0 0 rg BT 358.77 166.90 Td (to ) Tj ET Q q 0 0 0 rg BT 369.43 166.90 Td (have ) Tj ET Q q 0 0 0 rg BT 391.20 166.90 Td (a ) Tj ET Q q 0 0 0 rg BT 399.08 166.90 Td (Risk ) Tj ET Q q 0 0 0 rg BT 419.18 166.90 Td (Evaluation ) Tj ET Q q 0 0 0 rg BT 465.95 166.90 Td (and ) Tj ET Q q 0 0 0 rg BT 483.84 166.90 Td (Mitigation ) Tj ET Q q 0 0 0 rg BT 528.94 166.90 Td (Strategy) Tj ET Q q 0 0 0 rg BT 561.72 166.90 Td (, ) Tj ET Q q 0 0 0 rg BT 567.10 166.90 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 154.90 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 154.90 Td (equir) Tj ET Q q 0 0 0 rg BT 60.26 154.90 Td (ed ) Tj ET Q q 0 0 0 rg BT 72.72 154.90 Td (by ) Tj ET Q q 0 0 0 rg BT 85.17 154.90 Td (the ) Tj ET Q q 0 0 0 rg BT 100.41 154.90 Td (FDA) Tj ET Q q 0 0 0 rg BT 119.67 154.90 Td ( ) Tj ET Q q 0 0 0 rg BT 122.69 154.90 Td (to ) Tj ET Q q 0 0 0 rg BT 133.49 154.90 Td (addr) Tj ET Q q 0 0 0 rg BT 152.01 154.90 Td (ess ) Tj ET Q q 0 0 0 rg BT 167.25 154.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 212.49 154.90 Td (risk/benefit ) Tj ET Q q 0 0 0 rg BT 260.50 154.90 Td (issues. ) Tj ET Q q 0 0 0 rg BT 289.91 154.90 Td (The ) Tj ET Q q 0 0 0 rg BT 307.93 154.90 Td (inability ) Tj ET Q q 0 0 0 rg BT 344.28 154.90 Td (to ) Tj ET Q q 0 0 0 rg BT 355.08 154.90 Td (bring ) Tj ET Q q 0 0 0 rg BT 379.77 154.90 Td (a ) Tj ET Q q 0 0 0 rg BT 387.79 154.90 Td (pr) Tj ET Q q 0 0 0 rg BT 396.31 154.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 421.55 154.90 Td (to ) Tj ET Q q 0 0 0 rg BT 432.35 154.90 Td (market ) Tj ET Q q 0 0 0 rg BT 463.14 154.90 Td (or ) Tj ET Q q 0 0 0 rg BT 475.05 154.90 Td (a ) Tj ET Q q 0 0 0 rg BT 483.07 154.90 Td (significant ) Tj ET Q q 0 0 0 rg BT 528.31 154.90 Td (delay ) Tj ET Q q 0 0 0 rg BT 552.98 154.90 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 154.90 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 142.90 Td (expected ) Tj ET Q q 0 0 0 rg BT 73.58 142.90 Td (appr) Tj ET Q q 0 0 0 rg BT 92.10 142.90 Td (oval ) Tj ET Q q 0 0 0 rg BT 111.92 142.90 Td (and ) Tj ET Q q 0 0 0 rg BT 129.53 142.90 Td (r) Tj ET Q q 0 0 0 rg BT 133.05 142.90 Td (elated ) Tj ET Q q 0 0 0 rg BT 160.09 142.90 Td (launch ) Tj ET Q q 0 0 0 rg BT 189.92 142.90 Td (date ) Tj ET Q q 0 0 0 rg BT 209.74 142.90 Td (of ) Tj ET Q q 0 0 0 rg BT 220.13 142.90 Td (a ) Tj ET Q q 0 0 0 rg BT 227.73 142.90 Td (new ) Tj ET Q q 0 0 0 rg BT 246.45 142.90 Td (pr) Tj ET Q q 0 0 0 rg BT 254.97 142.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 279.79 142.90 Td (could ) Tj ET Q q 0 0 0 rg BT 304.62 142.90 Td (negatively ) Tj ET Q q 0 0 0 rg BT 348.31 142.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 378.14 142.90 Td (our ) Tj ET Q q 0 0 0 rg BT 394.64 142.90 Td (r) Tj ET Q q 0 0 0 rg BT 398.16 142.90 Td (evenues ) Tj ET Q q 0 0 0 rg BT 432.41 142.90 Td (and ) Tj ET Q q 0 0 0 rg BT 450.02 142.90 Td (earnings. ) Tj ET Q q 0 0 0 rg BT 490.13 142.90 Td (In ) Tj ET Q q 0 0 0 rg BT 501.06 142.90 Td (addition, ) Tj ET Q q 0 0 0 rg BT 539.51 142.90 Td (if ) Tj ET Q q 0 0 0 rg BT 547.67 142.90 Td (certain ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 130.90 Td (acquir) Tj ET Q q 0 0 0 rg BT 61.74 130.90 Td (ed ) Tj ET Q q 0 0 0 rg BT 72.73 130.90 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 106.50 130.90 Td (pr) Tj ET Q q 0 0 0 rg BT 115.02 130.90 Td (ograms ) Tj ET Q q 0 0 0 rg BT 146.59 130.90 Td (\(including ) Tj ET Q q 0 0 0 rg BT 189.25 130.90 Td (IPRD\) ) Tj ET Q q 0 0 0 rg BT 216.90 130.90 Td (ar) Tj ET Q q 0 0 0 rg BT 225.42 130.90 Td (e ) Tj ET Q q 0 0 0 rg BT 231.42 130.90 Td (canceled ) Tj ET Q q 0 0 0 rg BT 268.51 130.90 Td (or ) Tj ET Q q 0 0 0 rg BT 278.96 130.90 Td (we ) Tj ET Q q 0 0 0 rg BT 291.63 130.90 Td (believe ) Tj ET Q q 0 0 0 rg BT 321.49 130.90 Td (their ) Tj ET Q q 0 0 0 rg BT 341.94 130.90 Td (commer) Tj ET Q q 0 0 0 rg BT 373.78 130.90 Td (cial ) Tj ET Q q 0 0 0 rg BT 390.33 130.90 Td (pr) Tj ET Q q 0 0 0 rg BT 398.85 130.90 Td (ospects ) Tj ET Q q 0 0 0 rg BT 429.85 130.90 Td (have ) Tj ET Q q 0 0 0 rg BT 450.28 130.90 Td (been ) Tj ET Q q 0 0 0 rg BT 470.72 130.90 Td (r) Tj ET Q q 0 0 0 rg BT 474.24 130.90 Td (educed, ) Tj ET Q q 0 0 0 rg BT 506.61 130.90 Td (we ) Tj ET Q q 0 0 0 rg BT 519.28 130.90 Td (may ) Tj ET Q q 0 0 0 rg BT 537.49 130.90 Td (r) Tj ET Q q 0 0 0 rg BT 541.01 130.90 Td (ecognize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 118.90 Td (material ) Tj ET Q q 0 0 0 rg BT 72.65 118.90 Td (non-cash ) Tj ET Q q 0 0 0 rg BT 112.06 118.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 160.93 118.90 Td (char) Tj ET Q q 0 0 0 rg BT 178.89 118.90 Td (ges ) Tj ET Q q 0 0 0 rg BT 194.98 118.90 Td (for ) Tj ET Q q 0 0 0 rg BT 209.41 118.90 Td (those ) Tj ET Q q 0 0 0 rg BT 233.28 118.90 Td (pr) Tj ET Q q 0 0 0 rg BT 241.80 118.90 Td (ograms. ) Tj ET Q q 0 0 0 rg BT 277.06 118.90 Td (Finally) Tj ET Q q 0 0 0 rg BT 305.39 118.90 Td (, ) Tj ET Q q 0 0 0 rg BT 310.65 118.90 Td (losing ) Tj ET Q q 0 0 0 rg BT 337.86 118.90 Td (key ) Tj ET Q q 0 0 0 rg BT 353.93 118.90 Td (molecules ) Tj ET Q q 0 0 0 rg BT 396.67 118.90 Td (and ) Tj ET Q q 0 0 0 rg BT 414.43 118.90 Td (intermediaries ) Tj ET Q q 0 0 0 rg BT 475.52 118.90 Td (or ) Tj ET Q q 0 0 0 rg BT 487.17 118.90 Td (our ) Tj ET Q q 0 0 0 rg BT 503.82 118.90 Td (compound ) Tj ET Q q 0 0 0 rg BT 548.24 118.90 Td (library ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 106.90 Td (thr) Tj ET Q q 0 0 0 rg BT 47.30 106.90 Td (ough ) Tj ET Q q 0 0 0 rg BT 69.80 106.90 Td (a ) Tj ET Q q 0 0 0 rg BT 77.30 106.90 Td (natural ) Tj ET Q q 0 0 0 rg BT 109.25 106.90 Td (or ) Tj ET Q q 0 0 0 rg BT 120.64 106.90 Td (man-made ) Tj ET Q q 0 0 0 rg BT 165.35 106.90 Td (disaster ) Tj ET Q q 0 0 0 rg BT 199.52 106.90 Td (or ) Tj ET Q q 0 0 0 rg BT 210.91 106.90 Td (act ) Tj ET Q q 0 0 0 rg BT 225.63 106.90 Td (of ) Tj ET Q q 0 0 0 rg BT 235.91 106.90 Td (sabotage ) Tj ET Q q 0 0 0 rg BT 274.52 106.90 Td (could ) Tj ET Q q 0 0 0 rg BT 299.23 106.90 Td (negatively ) Tj ET Q q 0 0 0 rg BT 342.82 106.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 372.54 106.90 Td (the ) Tj ET Q q 0 0 0 rg BT 387.25 106.90 Td (pr) Tj ET Q q 0 0 0 rg BT 395.78 106.90 Td (oduct ) Tj ET Q q 0 0 0 rg BT 420.49 106.90 Td (development ) Tj ET Q q 0 0 0 rg BT 473.52 106.90 Td (cycle.) Tj ET Q endstream endobj 39 0 obj <> endobj 40 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (19) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 749.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.08 749.25 Td (face ) Tj ET Q q 0 0 0 rg BT 70.78 749.25 Td (intense ) Tj ET Q q 0 0 0 rg BT 102.73 749.25 Td (competition ) Tj ET Q q 0 0 0 rg BT 153.55 749.25 Td (from ) Tj ET Q q 0 0 0 rg BT 176.04 749.25 Td (other ) Tj ET Q q 0 0 0 rg BT 200.21 749.25 Td (manufacturers, ) Tj ET Q q 0 0 0 rg BT 266.33 749.25 Td (including ) Tj ET Q q 0 0 0 rg BT 308.28 749.25 Td (for ) Tj ET Q q 0 0 0 rg BT 322.99 749.25 Td (both ) Tj ET Q q 0 0 0 rg BT 343.83 749.25 Td (innovative ) Tj ET Q q 0 0 0 rg BT 389.09 749.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 432.69 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 450.75 749.25 Td (lower-priced ) Tj ET Q q 0 0 0 rg BT 504.90 749.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 537.94 749.25 Td (products.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 737.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 57.48 737.25 Td (is ) Tj ET Q q 0 0 0 rg BT 66.19 737.25 Td (dependent ) Tj ET Q q 0 0 0 rg BT 109.33 737.25 Td (on ) Tj ET Q q 0 0 0 rg BT 121.37 737.25 Td (the ) Tj ET Q q 0 0 0 rg BT 135.63 737.25 Td (market ) Tj ET Q q 0 0 0 rg BT 165.44 737.25 Td (access, ) Tj ET Q q 0 0 0 rg BT 196.08 737.25 Td (uptake ) Tj ET Q q 0 0 0 rg BT 224.78 737.25 Td (and ) Tj ET Q q 0 0 0 rg BT 241.82 737.25 Td (expansion ) Tj ET Q q 0 0 0 rg BT 284.41 737.25 Td (for ) Tj ET Q q 0 0 0 rg BT 298.13 737.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 337.38 737.25 Td (brands, ) Tj ET Q q 0 0 0 rg BT 369.70 737.25 Td (new ) Tj ET Q q 0 0 0 rg BT 387.85 737.25 Td (pr) Tj ET Q q 0 0 0 rg BT 396.37 737.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 420.63 737.25 Td (intr) Tj ET Q q 0 0 0 rg BT 434.71 737.25 Td (oductions, ) Tj ET Q q 0 0 0 rg BT 478.14 737.25 Td (new ) Tj ET Q q 0 0 0 rg BT 496.29 737.25 Td (indications, ) Tj ET Q q 0 0 0 rg BT 545.27 737.25 Td (pr) Tj ET Q q 0 0 0 rg BT 553.79 737.25 Td (oduct ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (extensions ) Tj ET Q q 0 0 0 rg BT 80.71 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 98.77 725.25 Td (co-pr) Tj ET Q q 0 0 0 rg BT 120.06 725.25 Td (omotional ) Tj ET Q q 0 0 0 rg BT 163.67 725.25 Td (activities ) Tj ET Q q 0 0 0 rg BT 202.82 725.25 Td (with ) Tj ET Q q 0 0 0 rg BT 223.10 725.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 258.37 725.25 Td (partners, ) Tj ET Q q 0 0 0 rg BT 297.82 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 308.65 725.25 Td (deliver ) Tj ET Q q 0 0 0 rg BT 339.47 725.25 Td (futur) Tj ET Q q 0 0 0 rg BT 358.55 725.25 Td (e ) Tj ET Q q 0 0 0 rg BT 366.04 725.25 Td (gr) Tj ET Q q 0 0 0 rg BT 374.56 725.25 Td (owth. ) Tj ET Q q 0 0 0 rg BT 399.57 725.25 Td (Competition ) Tj ET Q q 0 0 0 rg BT 452.07 725.25 Td (is ) Tj ET Q q 0 0 0 rg BT 461.79 725.25 Td (keen ) Tj ET Q q 0 0 0 rg BT 483.16 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 501.22 725.25 Td (includes ) Tj ET Q q 0 0 0 rg BT 537.60 725.25 Td (\(i\) ) Tj ET Q q 0 0 0 rg BT 550.09 725.25 Td (lower) Tj ET Q q 0 0 0 rg BT 572.67 725.25 Td (-) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (priced ) Tj ET Q q 0 0 0 rg BT 64.21 713.25 Td (generics ) Tj ET Q q 0 0 0 rg BT 100.75 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 118.41 713.25 Td (incr) Tj ET Q q 0 0 0 rg BT 134.15 713.25 Td (easingly ) Tj ET Q q 0 0 0 rg BT 170.14 713.25 Td (aggr) Tj ET Q q 0 0 0 rg BT 188.66 713.25 Td (essive ) Tj ET Q q 0 0 0 rg BT 215.20 713.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 247.84 713.25 Td (commer) Tj ET Q q 0 0 0 rg BT 279.69 713.25 Td (cialization ) Tj ET Q q 0 0 0 rg BT 324.57 713.25 Td (tactics, ) Tj ET Q q 0 0 0 rg BT 355.84 713.25 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 370.72 713.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 396.16 713.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 423.26 713.25 Td (for ) Tj ET Q q 0 0 0 rg BT 437.59 713.25 Td (other ) Tj ET Q q 0 0 0 rg BT 461.36 713.25 Td (companies' ) Tj ET Q q 0 0 0 rg BT 508.93 713.25 Td (pr) Tj ET Q q 0 0 0 rg BT 517.45 713.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 548.72 713.25 Td (r) Tj ET Q q 0 0 0 rg BT 552.24 713.25 Td (eal ) Tj ET Q q 0 0 0 rg BT 567.12 713.25 Td (or ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (per) Tj ET Q q 0 0 0 rg BT 48.96 701.25 Td (ceived ) Tj ET Q q 0 0 0 rg BT 77.72 701.25 Td (superior ) Tj ET Q q 0 0 0 rg BT 114.84 701.25 Td (efficacy ) Tj ET Q q 0 0 0 rg BT 149.16 701.25 Td (\(benefit\) ) Tj ET Q q 0 0 0 rg BT 186.26 701.25 Td (or ) Tj ET Q q 0 0 0 rg BT 198.39 701.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 224.94 701.25 Td (\(risk\) ) Tj ET Q q 0 0 0 rg BT 249.83 701.25 Td (pr) Tj ET Q q 0 0 0 rg BT 258.35 701.25 Td (ofiles ) Tj ET Q q 0 0 0 rg BT 283.25 701.25 Td (or ) Tj ET Q q 0 0 0 rg BT 295.37 701.25 Td (other ) Tj ET Q q 0 0 0 rg BT 319.71 701.25 Td (differ) Tj ET Q q 0 0 0 rg BT 341.00 701.25 Td (entiating ) Tj ET Q q 0 0 0 rg BT 379.78 701.25 Td (factors, ) Tj ET Q q 0 0 0 rg BT 413.29 701.25 Td (\(iii\) technological ) Tj ET Q q 0 0 0 rg BT 488.44 701.25 Td (advances ) Tj ET Q q 0 0 0 rg BT 528.88 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 547.11 701.25 Td (patents ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (attained ) Tj ET Q q 0 0 0 rg BT 71.21 689.25 Td (by ) Tj ET Q q 0 0 0 rg BT 83.08 689.25 Td (our ) Tj ET Q q 0 0 0 rg BT 99.40 689.25 Td (competitors, ) Tj ET Q q 0 0 0 rg BT 151.55 689.25 Td (\(iv\) ) Tj ET Q q 0 0 0 rg BT 167.86 689.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 200.29 689.25 Td (study ) Tj ET Q q 0 0 0 rg BT 223.83 689.25 Td (r) Tj ET Q q 0 0 0 rg BT 227.35 689.25 Td (esults ) Tj ET Q q 0 0 0 rg BT 252.56 689.25 Td (fr) Tj ET Q q 0 0 0 rg BT 258.86 689.25 Td (om ) Tj ET Q q 0 0 0 rg BT 273.51 689.25 Td (our ) Tj ET Q q 0 0 0 rg BT 289.84 689.25 Td (pr) Tj ET Q q 0 0 0 rg BT 298.36 689.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 326.90 689.25 Td (or ) Tj ET Q q 0 0 0 rg BT 338.22 689.25 Td (a ) Tj ET Q q 0 0 0 rg BT 345.66 689.25 Td (competitor) Tj ET Q q 0 0 0 rg BT 389.35 689.25 Td (’) Tj ET Q q 0 0 0 rg BT 391.40 689.25 Td (s ) Tj ET Q q 0 0 0 rg BT 397.72 689.25 Td (pr) Tj ET Q q 0 0 0 rg BT 406.24 689.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 434.78 689.25 Td (that ) Tj ET Q q 0 0 0 rg BT 452.77 689.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 477.42 689.25 Td (the ) Tj ET Q q 0 0 0 rg BT 492.07 689.25 Td (value ) Tj ET Q q 0 0 0 rg BT 516.15 689.25 Td (pr) Tj ET Q q 0 0 0 rg BT 524.68 689.25 Td (oposition ) Tj ET Q q 0 0 0 rg BT 564.33 689.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 52.51 677.25 Td (pr) Tj ET Q q 0 0 0 rg BT 61.03 677.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 92.25 677.25 Td (\(v\) business ) Tj ET Q q 0 0 0 rg BT 142.35 677.25 Td (combinations ) Tj ET Q q 0 0 0 rg BT 198.86 677.25 Td (among ) Tj ET Q q 0 0 0 rg BT 228.69 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 245.20 677.25 Td (competitors ) Tj ET Q q 0 0 0 rg BT 295.03 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 312.65 677.25 Td (major ) Tj ET Q q 0 0 0 rg BT 339.15 677.25 Td (thir) Tj ET Q q 0 0 0 rg BT 353.23 677.25 Td (d-party ) Tj ET Q q 0 0 0 rg BT 385.28 677.25 Td (payers ) Tj ET Q q 0 0 0 rg BT 414.56 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 432.17 677.25 Td (\(vi\) competing ) Tj ET Q q 0 0 0 rg BT 492.82 677.25 Td (inter) Tj ET Q q 0 0 0 rg BT 511.33 677.25 Td (ests ) Tj ET Q q 0 0 0 rg BT 528.95 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 543.23 677.25 Td (external ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 89.07 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 99.36 665.25 Td (develop ) Tj ET Q q 0 0 0 rg BT 132.96 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 150.47 665.25 Td (bring ) Tj ET Q q 0 0 0 rg BT 174.65 665.25 Td (new ) Tj ET Q q 0 0 0 rg BT 193.26 665.25 Td (pr) Tj ET Q q 0 0 0 rg BT 201.79 665.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 230.40 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 240.69 665.25 Td (markets. ) Tj ET Q q 0 0 0 rg BT 277.36 665.25 Td (If ) Tj ET Q q 0 0 0 rg BT 285.98 665.25 Td (we ) Tj ET Q q 0 0 0 rg BT 299.59 665.25 Td (ar) Tj ET Q q 0 0 0 rg BT 308.11 665.25 Td (e ) Tj ET Q q 0 0 0 rg BT 315.06 665.25 Td (unable ) Tj ET Q q 0 0 0 rg BT 344.79 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 355.07 665.25 Td (compete ) Tj ET Q q 0 0 0 rg BT 390.90 665.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 441.17 665.25 Td (against ) Tj ET Q q 0 0 0 rg BT 473.13 665.25 Td (our ) Tj ET Q q 0 0 0 rg BT 489.53 665.25 Td (competitors' ) Tj ET Q q 0 0 0 rg BT 541.39 665.25 Td (pr) Tj ET Q q 0 0 0 rg BT 549.91 665.25 Td (oducts ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 653.25 Td (the ) Tj ET Q q 0 0 0 rg BT 61.00 653.25 Td (marketplace, ) Tj ET Q q 0 0 0 rg BT 115.42 653.25 Td (this ) Tj ET Q q 0 0 0 rg BT 132.37 653.25 Td (could ) Tj ET Q q 0 0 0 rg BT 157.08 653.25 Td (have ) Tj ET Q q 0 0 0 rg BT 178.46 653.25 Td (a ) Tj ET Q q 0 0 0 rg BT 185.96 653.25 Td (material ) Tj ET Q q 0 0 0 rg BT 222.35 653.25 Td (negative ) Tj ET Q q 0 0 0 rg BT 258.72 653.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 288.44 653.25 Td (on ) Tj ET Q q 0 0 0 rg BT 300.94 653.25 Td (our ) Tj ET Q q 0 0 0 rg BT 317.33 653.25 Td (r) Tj ET Q q 0 0 0 rg BT 320.85 653.25 Td (evenues ) Tj ET Q q 0 0 0 rg BT 354.99 653.25 Td (and ) Tj ET Q q 0 0 0 rg BT 372.49 653.25 Td (earnings.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (Litigation ) Tj ET Q q 0 0 0 rg BT 79.06 629.25 Td (claiming ) Tj ET Q q 0 0 0 rg BT 117.67 629.25 Td (infringement ) Tj ET Q q 0 0 0 rg BT 174.07 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 184.90 629.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 233.51 629.25 Td (property ) Tj ET Q q 0 0 0 rg BT 270.45 629.25 Td (may ) Tj ET Q q 0 0 0 rg BT 290.17 629.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 330.98 629.25 Td (af) Tj ET Q q 0 0 0 rg BT 339.13 629.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 356.62 629.25 Td (our ) Tj ET Q q 0 0 0 rg BT 373.57 629.25 Td (future ) Tj ET Q q 0 0 0 rg BT 401.63 629.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 440.79 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 458.85 629.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 500.80 629.25 Td (earnings.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (Thir) Tj ET Q q 0 0 0 rg BT 52.86 617.25 Td (d ) Tj ET Q q 0 0 0 rg BT 60.50 617.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 90.93 617.25 Td (may ) Tj ET Q q 0 0 0 rg BT 110.23 617.25 Td (claim ) Tj ET Q q 0 0 0 rg BT 135.09 617.25 Td (that ) Tj ET Q q 0 0 0 rg BT 153.29 617.25 Td (we ) Tj ET Q q 0 0 0 rg BT 167.04 617.25 Td (infringe ) Tj ET Q q 0 0 0 rg BT 201.35 617.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 224.00 617.25 Td (their ) Tj ET Q q 0 0 0 rg BT 245.53 617.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 293.16 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 301.68 617.25 Td (operty) Tj ET Q q 0 0 0 rg BT 326.67 617.25 Td (. ) Tj ET Q q 0 0 0 rg BT 331.82 617.25 Td (Resolving ) Tj ET Q q 0 0 0 rg BT 373.90 617.25 Td (an ) Tj ET Q q 0 0 0 rg BT 386.54 617.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 434.17 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 442.69 617.25 Td (operty ) Tj ET Q q 0 0 0 rg BT 470.88 617.25 Td (infringement ) Tj ET Q q 0 0 0 rg BT 524.63 617.25 Td (claim ) Tj ET Q q 0 0 0 rg BT 549.49 617.25 Td (can ) Tj ET Q q 0 0 0 rg BT 566.57 617.25 Td (be ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (costly ) Tj ET Q q 0 0 0 rg BT 61.52 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 78.72 605.25 Td (time ) Tj ET Q q 0 0 0 rg BT 98.13 605.25 Td (consuming ) Tj ET Q q 0 0 0 rg BT 143.66 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 160.85 605.25 Td (may ) Tj ET Q q 0 0 0 rg BT 179.71 605.25 Td (r) Tj ET Q q 0 0 0 rg BT 183.23 605.25 Td (equir) Tj ET Q q 0 0 0 rg BT 203.97 605.25 Td (e ) Tj ET Q q 0 0 0 rg BT 210.60 605.25 Td (us ) Tj ET Q q 0 0 0 rg BT 221.69 605.25 Td (to ) Tj ET Q q 0 0 0 rg BT 231.67 605.25 Td (enter ) Tj ET Q q 0 0 0 rg BT 254.41 605.25 Td (into ) Tj ET Q q 0 0 0 rg BT 272.16 605.25 Td (license ) Tj ET Q q 0 0 0 rg BT 302.12 605.25 Td (agr) Tj ET Q q 0 0 0 rg BT 315.64 605.25 Td (eements, ) Tj ET Q q 0 0 0 rg BT 352.54 605.25 Td (which ) Tj ET Q q 0 0 0 rg BT 378.63 605.25 Td (may ) Tj ET Q q 0 0 0 rg BT 397.48 605.25 Td (not ) Tj ET Q q 0 0 0 rg BT 412.46 605.25 Td (be ) Tj ET Q q 0 0 0 rg BT 424.09 605.25 Td (available ) Tj ET Q q 0 0 0 rg BT 463.50 605.25 Td (on ) Tj ET Q q 0 0 0 rg BT 475.70 605.25 Td (commer) Tj ET Q q 0 0 0 rg BT 507.54 605.25 Td (cially ) Tj ET Q q 0 0 0 rg BT 531.95 605.25 Td (r) Tj ET Q q 0 0 0 rg BT 535.47 605.25 Td (easonable ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (terms. ) Tj ET Q q 0 0 0 rg BT 63.14 593.25 Td (A) Tj ET Q q 0 0 0 rg BT 69.06 593.25 Td ( ) Tj ET Q q 0 0 0 rg BT 71.66 593.25 Td (successful ) Tj ET Q q 0 0 0 rg BT 114.81 593.25 Td (claim ) Tj ET Q q 0 0 0 rg BT 139.63 593.25 Td (of ) Tj ET Q q 0 0 0 rg BT 150.01 593.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 177.61 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 189.10 593.25 Td (other ) Tj ET Q q 0 0 0 rg BT 212.81 593.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 260.40 593.25 Td (pr) Tj ET Q q 0 0 0 rg BT 268.92 593.25 Td (operty ) Tj ET Q q 0 0 0 rg BT 297.07 593.25 Td (infringement ) Tj ET Q q 0 0 0 rg BT 350.77 593.25 Td (could ) Tj ET Q q 0 0 0 rg BT 375.59 593.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 406.52 593.25 Td (us ) Tj ET Q q 0 0 0 rg BT 418.01 593.25 Td (to ) Tj ET Q q 0 0 0 rg BT 428.39 593.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 473.21 593.25 Td (damages ) Tj ET Q q 0 0 0 rg BT 511.37 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 522.86 593.25 Td (an ) Tj ET Q q 0 0 0 rg BT 535.46 593.25 Td (injunction ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 581.25 Td (eventing ) Tj ET Q q 0 0 0 rg BT 80.76 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 95.34 581.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 141.08 581.25 Td (e, ) Tj ET Q q 0 0 0 rg BT 150.39 581.25 Td (sale, ) Tj ET Q q 0 0 0 rg BT 171.36 581.25 Td (or ) Tj ET Q q 0 0 0 rg BT 182.62 581.25 Td (use ) Tj ET Q q 0 0 0 rg BT 198.32 581.25 Td (of ) Tj ET Q q 0 0 0 rg BT 208.46 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 223.05 581.25 Td (affected ) Tj ET Q q 0 0 0 rg BT 257.07 581.25 Td (pr) Tj ET Q q 0 0 0 rg BT 265.59 581.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 290.17 581.25 Td (or ) Tj ET Q q 0 0 0 rg BT 301.43 581.25 Td (pr) Tj ET Q q 0 0 0 rg BT 309.95 581.25 Td (oducts. ) Tj ET Q q 0 0 0 rg BT 340.75 581.25 Td (Any ) Tj ET Q q 0 0 0 rg BT 358.67 581.25 Td (of ) Tj ET Q q 0 0 0 rg BT 368.81 581.25 Td (these ) Tj ET Q q 0 0 0 rg BT 391.73 581.25 Td (events ) Tj ET Q q 0 0 0 rg BT 419.08 581.25 Td (could ) Tj ET Q q 0 0 0 rg BT 443.66 581.25 Td (have ) Tj ET Q q 0 0 0 rg BT 464.91 581.25 Td (a ) Tj ET Q q 0 0 0 rg BT 472.27 581.25 Td (material ) Tj ET Q q 0 0 0 rg BT 508.53 581.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 541.99 581.25 Td (effect ) Tj ET Q q 0 0 0 rg BT 566.01 581.25 Td (on ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (our ) Tj ET Q q 0 0 0 rg BT 52.39 569.25 Td (pr) Tj ET Q q 0 0 0 rg BT 60.91 569.25 Td (ofitability ) Tj ET Q q 0 0 0 rg BT 102.30 569.25 Td (and ) Tj ET Q q 0 0 0 rg BT 119.80 569.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 157.85 569.25 Td (condition.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (Adverse ) Tj ET Q q 0 0 0 rg BT 71.27 545.25 Td (outcomes ) Tj ET Q q 0 0 0 rg BT 112.66 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 123.50 545.25 Td (other ) Tj ET Q q 0 0 0 rg BT 147.67 545.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 170.16 545.25 Td (matters ) Tj ET Q q 0 0 0 rg BT 203.22 545.25 Td (could ) Tj ET Q q 0 0 0 rg BT 228.50 545.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 272.65 545.25 Td (af) Tj ET Q q 0 0 0 rg BT 280.79 545.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 298.28 545.25 Td (our ) Tj ET Q q 0 0 0 rg BT 315.23 545.25 Td (business.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (Curr) Tj ET Q q 0 0 0 rg BT 55.08 533.25 Td (ent ) Tj ET Q q 0 0 0 rg BT 70.48 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 82.54 533.25 Td (futur) Tj ET Q q 0 0 0 rg BT 101.62 533.25 Td (e ) Tj ET Q q 0 0 0 rg BT 109.23 533.25 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 147.70 533.25 Td (claims, ) Tj ET Q q 0 0 0 rg BT 179.48 533.25 Td (pr) Tj ET Q q 0 0 0 rg BT 188.00 533.25 Td (oceedings ) Tj ET Q q 0 0 0 rg BT 231.17 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 249.34 533.25 Td (government ) Tj ET Q q 0 0 0 rg BT 299.73 533.25 Td (investigations ) Tj ET Q q 0 0 0 rg BT 358.45 533.25 Td (could ) Tj ET Q q 0 0 0 rg BT 383.85 533.25 Td (pr) Tj ET Q q 0 0 0 rg BT 392.37 533.25 Td (eclude ) Tj ET Q q 0 0 0 rg BT 421.64 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 433.71 533.25 Td (delay ) Tj ET Q q 0 0 0 rg BT 458.54 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 473.93 533.25 Td (commer) Tj ET Q q 0 0 0 rg BT 505.77 533.25 Td (cialization ) Tj ET Q q 0 0 0 rg BT 551.17 533.25 Td (of ) Tj ET Q q 0 0 0 rg BT 562.12 533.25 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 521.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 72.99 521.25 Td (or ) Tj ET Q q 0 0 0 rg BT 84.25 521.25 Td (could ) Tj ET Q q 0 0 0 rg BT 108.83 521.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 149.52 521.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 174.09 521.25 Td (our ) Tj ET Q q 0 0 0 rg BT 190.35 521.25 Td (operations, ) Tj ET Q q 0 0 0 rg BT 237.99 521.25 Td (pr) Tj ET Q q 0 0 0 rg BT 246.52 521.25 Td (ofitability) Tj ET Q q 0 0 0 rg BT 284.85 521.25 Td (, ) Tj ET Q q 0 0 0 rg BT 289.72 521.25 Td (liquidity ) Tj ET Q q 0 0 0 rg BT 325.41 521.25 Td (or ) Tj ET Q q 0 0 0 rg BT 336.67 521.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 374.59 521.25 Td (condition, ) Tj ET Q q 0 0 0 rg BT 417.23 521.25 Td (after ) Tj ET Q q 0 0 0 rg BT 438.48 521.25 Td (any ) Tj ET Q q 0 0 0 rg BT 455.28 521.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 490.43 521.25 Td (insurance ) Tj ET Q q 0 0 0 rg BT 532.23 521.25 Td (r) Tj ET Q q 0 0 0 rg BT 535.75 521.25 Td (ecoveries, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (wher) Tj ET Q q 0 0 0 rg BT 55.63 509.25 Td (e ) Tj ET Q q 0 0 0 rg BT 61.52 509.25 Td (available. ) Tj ET Q q 0 0 0 rg BT 102.67 509.25 Td (Such ) Tj ET Q q 0 0 0 rg BT 123.56 509.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 145.00 509.25 Td (matters ) Tj ET Q q 0 0 0 rg BT 176.45 509.25 Td (include ) Tj ET Q q 0 0 0 rg BT 207.33 509.25 Td (\(i\) intellectual ) Tj ET Q q 0 0 0 rg BT 265.70 509.25 Td (pr) Tj ET Q q 0 0 0 rg BT 274.23 509.25 Td (operty ) Tj ET Q q 0 0 0 rg BT 301.22 509.25 Td (disputes; ) Tj ET Q q 0 0 0 rg BT 338.78 509.25 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 352.44 509.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 384.99 509.25 Td (decisions ) Tj ET Q q 0 0 0 rg BT 423.65 509.25 Td (in ) Tj ET Q q 0 0 0 rg BT 432.88 509.25 Td (litigation, ) Tj ET Q q 0 0 0 rg BT 473.50 509.25 Td (including ) Tj ET Q q 0 0 0 rg BT 512.72 509.25 Td (pr) Tj ET Q q 0 0 0 rg BT 521.24 509.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 544.90 509.25 Td (liability ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 54.84 497.25 Td (commer) Tj ET Q q 0 0 0 rg BT 86.69 497.25 Td (cial ) Tj ET Q q 0 0 0 rg BT 105.53 497.25 Td (cases; ) Tj ET Q q 0 0 0 rg BT 134.36 497.25 Td (\(iii\) anti-bribery ) Tj ET Q q 0 0 0 rg BT 204.03 497.25 Td (r) Tj ET Q q 0 0 0 rg BT 207.55 497.25 Td (egulations, ) Tj ET Q q 0 0 0 rg BT 255.56 497.25 Td (such ) Tj ET Q q 0 0 0 rg BT 277.73 497.25 Td (as ) Tj ET Q q 0 0 0 rg BT 290.47 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 306.53 497.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 327.59 497.25 Td (For) Tj ET Q q 0 0 0 rg BT 342.22 497.25 Td (eign ) Tj ET Q q 0 0 0 rg BT 363.29 497.25 Td (Corrupt ) Tj ET Q q 0 0 0 rg BT 399.36 497.25 Td (Practice ) Tj ET Q q 0 0 0 rg BT 436.80 497.25 Td (Act ) Tj ET Q q 0 0 0 rg BT 453.97 497.25 Td (or ) Tj ET Q q 0 0 0 rg BT 466.71 497.25 Td (UK ) Tj ET Q q 0 0 0 rg BT 484.44 497.25 Td (Bribery ) Tj ET Q q 0 0 0 rg BT 518.56 497.25 Td (Act, ) Tj ET Q q 0 0 0 rg BT 538.23 497.25 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (compliance ) Tj ET Q q 0 0 0 rg BT 86.62 485.25 Td (with ) Tj ET Q q 0 0 0 rg BT 108.37 485.25 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 145.67 485.25 Td (r) Tj ET Q q 0 0 0 rg BT 149.19 485.25 Td (eporting ) Tj ET Q q 0 0 0 rg BT 187.60 485.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 237.12 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 249.42 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 266.16 485.25 Td (government ) Tj ET Q q 0 0 0 rg BT 317.89 485.25 Td (r) Tj ET Q q 0 0 0 rg BT 321.41 485.25 Td (esulting ) Tj ET Q q 0 0 0 rg BT 357.60 485.25 Td (fr) Tj ET Q q 0 0 0 rg BT 363.90 485.25 Td (om ) Tj ET Q q 0 0 0 rg BT 380.64 485.25 Td (any ) Tj ET Q q 0 0 0 rg BT 399.60 485.25 Td (settlements, ) Tj ET Q q 0 0 0 rg BT 451.06 485.25 Td (\(iv\) ) Tj ET Q q 0 0 0 rg BT 469.46 485.25 Td (r) Tj ET Q q 0 0 0 rg BT 472.98 485.25 Td (ecalls ) Tj ET Q q 0 0 0 rg BT 500.83 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 514.24 485.25 Td (withdrawals ) Tj ET Q q 0 0 0 rg BT 568.22 485.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 101.04 473.25 Td (pr) Tj ET Q q 0 0 0 rg BT 109.56 473.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 137.94 473.25 Td (or ) Tj ET Q q 0 0 0 rg BT 149.11 473.25 Td (for) Tj ET Q q 0 0 0 rg BT 160.41 473.25 Td (ced ) Tj ET Q q 0 0 0 rg BT 176.56 473.25 Td (closings ) Tj ET Q q 0 0 0 rg BT 211.61 473.25 Td (of ) Tj ET Q q 0 0 0 rg BT 221.66 473.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 282.82 473.25 Td (plants; ) Tj ET Q q 0 0 0 rg BT 312.88 473.25 Td (\(v\) the ) Tj ET Q q 0 0 0 rg BT 340.97 473.25 Td (failur) Tj ET Q q 0 0 0 rg BT 362.82 473.25 Td (e ) Tj ET Q q 0 0 0 rg BT 369.54 473.25 Td (to ) Tj ET Q q 0 0 0 rg BT 379.59 473.25 Td (fulfill ) Tj ET Q q 0 0 0 rg BT 403.53 473.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 450.81 473.25 Td (under ) Tj ET Q q 0 0 0 rg BT 476.42 473.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 504.80 473.25 Td (contracts ) Tj ET Q q 0 0 0 rg BT 544.29 473.25 Td (with ) Tj ET Q q 0 0 0 rg BT 563.79 473.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (government ) Tj ET Q q 0 0 0 rg BT 86.26 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 104.31 461.25 Td (other ) Tj ET Q q 0 0 0 rg BT 128.48 461.25 Td (customers; ) Tj ET Q q 0 0 0 rg BT 175.41 461.25 Td (\(vi\) pr) Tj ET Q q 0 0 0 rg BT 200.31 461.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 225.58 461.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 257.52 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 275.57 461.25 Td (pr) Tj ET Q q 0 0 0 rg BT 284.09 461.25 Td (omotional ) Tj ET Q q 0 0 0 rg BT 327.70 461.25 Td (matters; ) Tj ET Q q 0 0 0 rg BT 364.08 461.25 Td (\(vii\) lawsuits ) Tj ET Q q 0 0 0 rg BT 419.08 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 437.13 461.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 466.30 461.25 Td (asserting, ) Tj ET Q q 0 0 0 rg BT 508.52 461.25 Td (or ) Tj ET Q q 0 0 0 rg BT 520.46 461.25 Td (investigations ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (into, ) Tj ET Q q 0 0 0 rg BT 56.00 449.25 Td (violations ) Tj ET Q q 0 0 0 rg BT 97.39 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 107.11 449.25 Td (securities, ) Tj ET Q q 0 0 0 rg BT 149.88 449.25 Td (antitrust, ) Tj ET Q q 0 0 0 rg BT 188.22 449.25 Td (Federal ) Tj ET Q q 0 0 0 rg BT 221.82 449.25 Td (and ) Tj ET Q q 0 0 0 rg BT 238.76 449.25 Td (state ) Tj ET Q q 0 0 0 rg BT 259.59 449.25 Td (pricing, ) Tj ET Q q 0 0 0 rg BT 292.92 449.25 Td (consumer ) Tj ET Q q 0 0 0 rg BT 333.74 449.25 Td (pr) Tj ET Q q 0 0 0 rg BT 342.26 449.25 Td (otection, ) Tj ET Q q 0 0 0 rg BT 378.92 449.25 Td (data ) Tj ET Q q 0 0 0 rg BT 398.64 449.25 Td (privacy ) Tj ET Q q 0 0 0 rg BT 430.57 449.25 Td (and ) Tj ET Q q 0 0 0 rg BT 447.51 449.25 Td (other ) Tj ET Q q 0 0 0 rg BT 470.57 449.25 Td (laws; ) Tj ET Q q 0 0 0 rg BT 494.18 449.25 Td (\(viii\) envir) Tj ET Q q 0 0 0 rg BT 536.29 449.25 Td (onmental, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (health, ) Tj ET Q q 0 0 0 rg BT 66.00 437.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 91.82 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.32 437.25 Td (sustainability ) Tj ET Q q 0 0 0 rg BT 165.71 437.25 Td (matters; ) Tj ET Q q 0 0 0 rg BT 201.54 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 219.04 437.25 Td (\(ix\) tax ) Tj ET Q q 0 0 0 rg BT 250.14 437.25 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 290.41 437.25 Td (r) Tj ET Q q 0 0 0 rg BT 293.93 437.25 Td (esulting ) Tj ET Q q 0 0 0 rg BT 328.10 437.25 Td (fr) Tj ET Q q 0 0 0 rg BT 334.40 437.25 Td (om ) Tj ET Q q 0 0 0 rg BT 349.12 437.25 Td (assessments ) Tj ET Q q 0 0 0 rg BT 399.96 437.25 Td (fr) Tj ET Q q 0 0 0 rg BT 406.25 437.25 Td (om ) Tj ET Q q 0 0 0 rg BT 420.98 437.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 435.69 437.25 Td (authorities.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 413.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.09 413.25 Td (could ) Tj ET Q q 0 0 0 rg BT 76.37 413.25 Td (lose ) Tj ET Q q 0 0 0 rg BT 94.97 413.25 Td (market ) Tj ET Q q 0 0 0 rg BT 126.36 413.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 172.18 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 183.01 413.25 Td (a ) Tj ET Q q 0 0 0 rg BT 190.51 413.25 Td (product ) Tj ET Q q 0 0 0 rg BT 224.68 413.25 Td (earlier ) Tj ET Q q 0 0 0 rg BT 254.40 413.25 Td (than ) Tj ET Q q 0 0 0 rg BT 275.80 413.25 Td (expected.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.00 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 59.88 401.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 124.31 401.25 Td (and ) Tj ET Q q 0 0 0 rg BT 140.98 401.25 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 199.29 401.25 Td (industries, ) Tj ET Q q 0 0 0 rg BT 242.91 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 256.79 401.25 Td (majority ) Tj ET Q q 0 0 0 rg BT 292.34 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 301.79 401.25 Td (an ) Tj ET Q q 0 0 0 rg BT 313.46 401.25 Td (innovative ) Tj ET Q q 0 0 0 rg BT 356.77 401.25 Td (pr) Tj ET Q q 0 0 0 rg BT 365.29 401.25 Td (oduct’) Tj ET Q q 0 0 0 rg BT 389.55 401.25 Td (s ) Tj ET Q q 0 0 0 rg BT 395.11 401.25 Td (commer) Tj ET Q q 0 0 0 rg BT 426.95 401.25 Td (cial ) Tj ET Q q 0 0 0 rg BT 443.61 401.25 Td (value ) Tj ET Q q 0 0 0 rg BT 466.93 401.25 Td (is ) Tj ET Q q 0 0 0 rg BT 475.27 401.25 Td (r) Tj ET Q q 0 0 0 rg BT 478.79 401.25 Td (ealized ) Tj ET Q q 0 0 0 rg BT 508.78 401.25 Td (during ) Tj ET Q q 0 0 0 rg BT 537.12 401.25 Td (its ) Tj ET Q q 0 0 0 rg BT 548.23 401.25 Td (market ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 81.57 389.25 Td (period. ) Tj ET Q q 0 0 0 rg BT 113.54 389.25 Td (In ) Tj ET Q q 0 0 0 rg BT 125.24 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 140.83 389.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 161.42 389.25 Td (and ) Tj ET Q q 0 0 0 rg BT 179.79 389.25 Td (in ) Tj ET Q q 0 0 0 rg BT 190.94 389.25 Td (some ) Tj ET Q q 0 0 0 rg BT 214.86 389.25 Td (other ) Tj ET Q q 0 0 0 rg BT 239.33 389.25 Td (countries, ) Tj ET Q q 0 0 0 rg BT 282.42 389.25 Td (when ) Tj ET Q q 0 0 0 rg BT 306.90 389.25 Td (market ) Tj ET Q q 0 0 0 rg BT 338.04 389.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 383.60 389.25 Td (expir) Tj ET Q q 0 0 0 rg BT 403.78 389.25 Td (es ) Tj ET Q q 0 0 0 rg BT 415.48 389.25 Td (and ) Tj ET Q q 0 0 0 rg BT 433.85 389.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 467.20 389.25 Td (versions ) Tj ET Q q 0 0 0 rg BT 503.90 389.25 Td (ar) Tj ET Q q 0 0 0 rg BT 512.42 389.25 Td (e ) Tj ET Q q 0 0 0 rg BT 520.23 389.25 Td (appr) Tj ET Q q 0 0 0 rg BT 538.75 389.25 Td (oved ) Tj ET Q q 0 0 0 rg BT 561.00 389.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 75.21 377.25 Td (or ) Tj ET Q q 0 0 0 rg BT 86.10 377.25 Td (when ) Tj ET Q q 0 0 0 rg BT 109.21 377.25 Td (biosimilars ) Tj ET Q q 0 0 0 rg BT 156.22 377.25 Td (ar) Tj ET Q q 0 0 0 rg BT 164.74 377.25 Td (e ) Tj ET Q q 0 0 0 rg BT 171.18 377.25 Td (intr) Tj ET Q q 0 0 0 rg BT 185.26 377.25 Td (oduced ) Tj ET Q q 0 0 0 rg BT 216.14 377.25 Td (\(even ) Tj ET Q q 0 0 0 rg BT 239.78 377.25 Td (if ) Tj ET Q q 0 0 0 rg BT 247.34 377.25 Td (only ) Tj ET Q q 0 0 0 rg BT 266.56 377.25 Td (for ) Tj ET Q q 0 0 0 rg BT 280.23 377.25 Td (a ) Tj ET Q q 0 0 0 rg BT 287.23 377.25 Td (competing ) Tj ET Q q 0 0 0 rg BT 330.89 377.25 Td (pr) Tj ET Q q 0 0 0 rg BT 339.41 377.25 Td (oduct\), ) Tj ET Q q 0 0 0 rg BT 369.45 377.25 Td (ther) Tj ET Q q 0 0 0 rg BT 385.19 377.25 Td (e ) Tj ET Q q 0 0 0 rg BT 391.63 377.25 Td (ar) Tj ET Q q 0 0 0 rg BT 400.15 377.25 Td (e ) Tj ET Q q 0 0 0 rg BT 406.59 377.25 Td (usually ) Tj ET Q q 0 0 0 rg BT 437.48 377.25 Td (very ) Tj ET Q q 0 0 0 rg BT 456.69 377.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 502.58 377.25 Td (and ) Tj ET Q q 0 0 0 rg BT 519.58 377.25 Td (rapid ) Tj ET Q q 0 0 0 rg BT 543.26 377.25 Td (declines ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 365.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 365.25 Td (a ) Tj ET Q q 0 0 0 rg BT 53.78 365.25 Td (pr) Tj ET Q q 0 0 0 rg BT 62.30 365.25 Td (oduct’) Tj ET Q q 0 0 0 rg BT 86.56 365.25 Td (s ) Tj ET Q q 0 0 0 rg BT 92.95 365.25 Td (r) Tj ET Q q 0 0 0 rg BT 96.47 365.25 Td (evenues.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (Market ) Tj ET Q q 0 0 0 rg BT 66.91 341.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 111.15 341.25 Td (for ) Tj ET Q q 0 0 0 rg BT 124.85 341.25 Td (our ) Tj ET Q q 0 0 0 rg BT 140.78 341.25 Td (pr) Tj ET Q q 0 0 0 rg BT 149.30 341.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 177.45 341.25 Td (is ) Tj ET Q q 0 0 0 rg BT 186.15 341.25 Td (based ) Tj ET Q q 0 0 0 rg BT 211.52 341.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 233.55 341.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 260.58 341.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 285.96 341.25 Td (and ) Tj ET Q q 0 0 0 rg BT 303.00 341.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 333.36 341.25 Td (r) Tj ET Q q 0 0 0 rg BT 336.88 341.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 377.24 341.25 Td (forms ) Tj ET Q q 0 0 0 rg BT 402.06 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 411.87 341.25 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 453.52 341.25 Td (. ) Tj ET Q q 0 0 0 rg BT 458.06 341.25 Td (The ) Tj ET Q q 0 0 0 rg BT 475.09 341.25 Td (scope ) Tj ET Q q 0 0 0 rg BT 499.90 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 509.71 341.25 Td (our ) Tj ET Q q 0 0 0 rg BT 525.64 341.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 552.67 341.25 Td (rights ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (varies ) Tj ET Q q 0 0 0 rg BT 63.11 329.25 Td (fr) Tj ET Q q 0 0 0 rg BT 69.41 329.25 Td (om ) Tj ET Q q 0 0 0 rg BT 84.30 329.25 Td (country ) Tj ET Q q 0 0 0 rg BT 117.51 329.25 Td (to ) Tj ET Q q 0 0 0 rg BT 127.96 329.25 Td (country ) Tj ET Q q 0 0 0 rg BT 161.17 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 178.84 329.25 Td (may ) Tj ET Q q 0 0 0 rg BT 198.17 329.25 Td (also ) Tj ET Q q 0 0 0 rg BT 217.51 329.25 Td (be ) Tj ET Q q 0 0 0 rg BT 229.62 329.25 Td (dependent ) Tj ET Q q 0 0 0 rg BT 273.38 329.25 Td (on ) Tj ET Q q 0 0 0 rg BT 286.05 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 300.93 329.25 Td (availability ) Tj ET Q q 0 0 0 rg BT 349.15 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 359.59 329.25 Td (meaningful ) Tj ET Q q 0 0 0 rg BT 407.26 329.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 429.92 329.25 Td (r) Tj ET Q q 0 0 0 rg BT 433.44 329.25 Td (emedies ) Tj ET Q q 0 0 0 rg BT 468.32 329.25 Td (in ) Tj ET Q q 0 0 0 rg BT 478.76 329.25 Td (a ) Tj ET Q q 0 0 0 rg BT 486.43 329.25 Td (country) Tj ET Q q 0 0 0 rg BT 516.43 329.25 Td (. ) Tj ET Q q 0 0 0 rg BT 521.60 329.25 Td (The ) Tj ET Q q 0 0 0 rg BT 539.26 329.25 Td (failur) Tj ET Q q 0 0 0 rg BT 561.12 329.25 Td (e ) Tj ET Q q 0 0 0 rg BT 568.23 329.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (obtain ) Tj ET Q q 0 0 0 rg BT 64.65 317.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 92.75 317.25 Td (and ) Tj ET Q q 0 0 0 rg BT 110.84 317.25 Td (other ) Tj ET Q q 0 0 0 rg BT 135.05 317.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 183.13 317.25 Td (pr) Tj ET Q q 0 0 0 rg BT 191.65 317.25 Td (operty ) Tj ET Q q 0 0 0 rg BT 220.30 317.25 Td (rights, ) Tj ET Q q 0 0 0 rg BT 249.23 317.25 Td (or ) Tj ET Q q 0 0 0 rg BT 261.22 317.25 Td (limitations ) Tj ET Q q 0 0 0 rg BT 307.10 317.25 Td (on ) Tj ET Q q 0 0 0 rg BT 320.20 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 335.51 317.25 Td (use ) Tj ET Q q 0 0 0 rg BT 351.94 317.25 Td (or ) Tj ET Q q 0 0 0 rg BT 363.93 317.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 382.59 317.25 Td (of ) Tj ET Q q 0 0 0 rg BT 393.46 317.25 Td (such ) Tj ET Q q 0 0 0 rg BT 414.89 317.25 Td (rights, ) Tj ET Q q 0 0 0 rg BT 443.83 317.25 Td (could ) Tj ET Q q 0 0 0 rg BT 469.14 317.25 Td (be ) Tj ET Q q 0 0 0 rg BT 481.68 317.25 Td (material ) Tj ET Q q 0 0 0 rg BT 518.66 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 529.54 317.25 Td (us. ) Tj ET Q q 0 0 0 rg BT 544.03 317.25 Td (In ) Tj ET Q q 0 0 0 rg BT 555.45 317.25 Td (some ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (countries, ) Tj ET Q q 0 0 0 rg BT 77.89 305.25 Td (including ) Tj ET Q q 0 0 0 rg BT 117.85 305.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 148.35 305.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 163.86 305.25 Td (member ) Tj ET Q q 0 0 0 rg BT 198.25 305.25 Td (states, ) Tj ET Q q 0 0 0 rg BT 225.70 305.25 Td (basic ) Tj ET Q q 0 0 0 rg BT 248.99 305.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 276.16 305.25 Td (pr) Tj ET Q q 0 0 0 rg BT 284.68 305.25 Td (otections ) Tj ET Q q 0 0 0 rg BT 322.96 305.25 Td (for ) Tj ET Q q 0 0 0 rg BT 336.81 305.25 Td (our ) Tj ET Q q 0 0 0 rg BT 352.88 305.25 Td (pr) Tj ET Q q 0 0 0 rg BT 361.40 305.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 389.69 305.25 Td (may ) Tj ET Q q 0 0 0 rg BT 408.52 305.25 Td (not ) Tj ET Q q 0 0 0 rg BT 423.48 305.25 Td (exist ) Tj ET Q q 0 0 0 rg BT 443.98 305.25 Td (because ) Tj ET Q q 0 0 0 rg BT 478.37 305.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 508.87 305.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 548.27 305.25 Td (did ) Tj ET Q q 0 0 0 rg BT 563.22 305.25 Td (not ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (historically ) Tj ET Q q 0 0 0 rg BT 83.99 293.25 Td (offer ) Tj ET Q q 0 0 0 rg BT 105.32 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 119.98 293.25 Td (right ) Tj ET Q q 0 0 0 rg BT 141.88 293.25 Td (to ) Tj ET Q q 0 0 0 rg BT 152.10 293.25 Td (obtain ) Tj ET Q q 0 0 0 rg BT 180.10 293.25 Td (specific ) Tj ET Q q 0 0 0 rg BT 213.08 293.25 Td (types ) Tj ET Q q 0 0 0 rg BT 236.07 293.25 Td (of ) Tj ET Q q 0 0 0 rg BT 246.29 293.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 277.62 293.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 306.73 293.25 Td (we ) Tj ET Q q 0 0 0 rg BT 320.29 293.25 Td (\(or ) Tj ET Q q 0 0 0 rg BT 334.95 293.25 Td (our ) Tj ET Q q 0 0 0 rg BT 351.28 293.25 Td (licensors\) ) Tj ET Q q 0 0 0 rg BT 393.17 293.25 Td (did ) Tj ET Q q 0 0 0 rg BT 408.39 293.25 Td (not ) Tj ET Q q 0 0 0 rg BT 423.61 293.25 Td (file ) Tj ET Q q 0 0 0 rg BT 438.82 293.25 Td (in ) Tj ET Q q 0 0 0 rg BT 449.05 293.25 Td (those ) Tj ET Q q 0 0 0 rg BT 472.60 293.25 Td (countries. ) Tj ET Q q 0 0 0 rg BT 514.76 293.25 Td (In ) Tj ET Q q 0 0 0 rg BT 525.53 293.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 563.81 293.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 62.89 281.25 Td (envir) Tj ET Q q 0 0 0 rg BT 83.06 281.25 Td (onment ) Tj ET Q q 0 0 0 rg BT 114.40 281.25 Td (can ) Tj ET Q q 0 0 0 rg BT 130.73 281.25 Td (be ) Tj ET Q q 0 0 0 rg BT 142.06 281.25 Td (unpr) Tj ET Q q 0 0 0 rg BT 160.58 281.25 Td (edictable ) Tj ET Q q 0 0 0 rg BT 199.13 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 216.02 281.25 Td (the ) Tj ET Q q 0 0 0 rg BT 230.13 281.25 Td (validity ) Tj ET Q q 0 0 0 rg BT 262.01 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 278.91 281.25 Td (enfor) Tj ET Q q 0 0 0 rg BT 299.64 281.25 Td (ceability ) Tj ET Q q 0 0 0 rg BT 335.97 281.25 Td (of ) Tj ET Q q 0 0 0 rg BT 345.64 281.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 376.42 281.25 Td (cannot ) Tj ET Q q 0 0 0 rg BT 405.53 281.25 Td (be ) Tj ET Q q 0 0 0 rg BT 416.86 281.25 Td (pr) Tj ET Q q 0 0 0 rg BT 425.38 281.25 Td (edicted ) Tj ET Q q 0 0 0 rg BT 456.15 281.25 Td (with ) Tj ET Q q 0 0 0 rg BT 475.27 281.25 Td (certainty) Tj ET Q q 0 0 0 rg BT 510.26 281.25 Td (. ) Tj ET Q q 0 0 0 rg BT 514.51 281.25 Td (Absent ) Tj ET Q q 0 0 0 rg BT 543.62 281.25 Td (r) Tj ET Q q 0 0 0 rg BT 547.14 281.25 Td (elevant ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 269.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 63.50 269.25 Td (pr) Tj ET Q q 0 0 0 rg BT 72.02 269.25 Td (otection ) Tj ET Q q 0 0 0 rg BT 106.73 269.25 Td (for ) Tj ET Q q 0 0 0 rg BT 120.90 269.25 Td (a ) Tj ET Q q 0 0 0 rg BT 128.40 269.25 Td (pr) Tj ET Q q 0 0 0 rg BT 136.92 269.25 Td (oduct, ) Tj ET Q q 0 0 0 rg BT 164.13 269.25 Td (once ) Tj ET Q q 0 0 0 rg BT 185.51 269.25 Td (the ) Tj ET Q q 0 0 0 rg BT 200.23 269.25 Td (data ) Tj ET Q q 0 0 0 rg BT 220.51 269.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 265.20 269.25 Td (period ) Tj ET Q q 0 0 0 rg BT 293.81 269.25 Td (expir) Tj ET Q q 0 0 0 rg BT 313.99 269.25 Td (es, ) Tj ET Q q 0 0 0 rg BT 327.32 269.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 359.80 269.25 Td (versions ) Tj ET Q q 0 0 0 rg BT 395.63 269.25 Td (can ) Tj ET Q q 0 0 0 rg BT 412.57 269.25 Td (be ) Tj ET Q q 0 0 0 rg BT 424.51 269.25 Td (appr) Tj ET Q q 0 0 0 rg BT 443.03 269.25 Td (oved ) Tj ET Q q 0 0 0 rg BT 464.41 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 481.91 269.25 Td (marketed. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (Generic ) Tj ET Q q 0 0 0 rg BT 70.51 245.25 Td (and ) Tj ET Q q 0 0 0 rg BT 87.80 245.25 Td (biosimilar ) Tj ET Q q 0 0 0 rg BT 131.22 245.25 Td (pr) Tj ET Q q 0 0 0 rg BT 139.74 245.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 164.26 245.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 210.00 245.25 Td (ers ) Tj ET Q q 0 0 0 rg BT 224.52 245.25 Td (as ) Tj ET Q q 0 0 0 rg BT 235.71 245.25 Td (well ) Tj ET Q q 0 0 0 rg BT 254.67 245.25 Td (as ) Tj ET Q q 0 0 0 rg BT 265.86 245.25 Td (other ) Tj ET Q q 0 0 0 rg BT 289.27 245.25 Td (gr) Tj ET Q q 0 0 0 rg BT 297.79 245.25 Td (oups ) Tj ET Q q 0 0 0 rg BT 318.98 245.25 Td (seeking ) Tj ET Q q 0 0 0 rg BT 351.26 245.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 389.11 245.25 Td (gain ) Tj ET Q q 0 0 0 rg BT 409.19 245.25 Td (ar) Tj ET Q q 0 0 0 rg BT 417.71 245.25 Td (e ) Tj ET Q q 0 0 0 rg BT 424.45 245.25 Td (also ) Tj ET Q q 0 0 0 rg BT 443.42 245.25 Td (incr) Tj ET Q q 0 0 0 rg BT 459.15 245.25 Td (easingly ) Tj ET Q q 0 0 0 rg BT 494.78 245.25 Td (seeking ) Tj ET Q q 0 0 0 rg BT 527.06 245.25 Td (to ) Tj ET Q q 0 0 0 rg BT 537.14 245.25 Td (challenge ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 67.45 233.25 Td (befor) Tj ET Q q 0 0 0 rg BT 88.19 233.25 Td (e ) Tj ET Q q 0 0 0 rg BT 95.19 233.25 Td (they ) Tj ET Q q 0 0 0 rg BT 114.41 233.25 Td (expir) Tj ET Q q 0 0 0 rg BT 134.58 233.25 Td (e, ) Tj ET Q q 0 0 0 rg BT 144.09 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 161.65 233.25 Td (we ) Tj ET Q q 0 0 0 rg BT 175.32 233.25 Td (could ) Tj ET Q q 0 0 0 rg BT 200.10 233.25 Td (face ) Tj ET Q q 0 0 0 rg BT 219.32 233.25 Td (earlier) Tj ET Q q 0 0 0 rg BT 246.34 233.25 Td (-than-expected ) Tj ET Q q 0 0 0 rg BT 308.31 233.25 Td (competition ) Tj ET Q q 0 0 0 rg BT 358.08 233.25 Td (for ) Tj ET Q q 0 0 0 rg BT 372.32 233.25 Td (any ) Tj ET Q q 0 0 0 rg BT 389.32 233.25 Td (pr) Tj ET Q q 0 0 0 rg BT 397.84 233.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 426.51 233.25 Td (at ) Tj ET Q q 0 0 0 rg BT 436.85 233.25 Td (any ) Tj ET Q q 0 0 0 rg BT 453.86 233.25 Td (time. ) Tj ET Q q 0 0 0 rg BT 476.14 233.25 Td (Patents ) Tj ET Q q 0 0 0 rg BT 508.70 233.25 Td (covering ) Tj ET Q q 0 0 0 rg BT 546.24 233.25 Td (our ) Tj ET Q q 0 0 0 rg BT 562.70 233.25 Td (key ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 221.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 221.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 73.25 221.25 Td (have ) Tj ET Q q 0 0 0 rg BT 94.75 221.25 Td (been, ) Tj ET Q q 0 0 0 rg BT 118.75 221.25 Td (and ) Tj ET Q q 0 0 0 rg BT 136.37 221.25 Td (ar) Tj ET Q q 0 0 0 rg BT 144.89 221.25 Td (e ) Tj ET Q q 0 0 0 rg BT 151.95 221.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 176.22 221.25 Td (to ) Tj ET Q q 0 0 0 rg BT 186.63 221.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 223.68 221.25 Td (to ) Tj ET Q q 0 0 0 rg BT 234.08 221.25 Td (be, ) Tj ET Q q 0 0 0 rg BT 248.64 221.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 279.59 221.25 Td (to ) Tj ET Q q 0 0 0 rg BT 289.99 221.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 317.61 221.25 Td (litigation. ) Tj ET Q q 0 0 0 rg BT 359.40 221.25 Td (For ) Tj ET Q q 0 0 0 rg BT 377.02 221.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 415.46 221.25 Td (in ) Tj ET Q q 0 0 0 rg BT 425.86 221.25 Td (February ) Tj ET Q q 0 0 0 rg BT 466.25 221.25 Td (2017 ) Tj ET Q q 0 0 0 rg BT 488.87 221.25 Td (one ) Tj ET Q q 0 0 0 rg BT 505.93 221.25 Td (of ) Tj ET Q q 0 0 0 rg BT 516.33 221.25 Td (the ) Tj ET Q q 0 0 0 rg BT 531.17 221.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 547.12 221.25 Td (patents ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.41 209.25 Td (Sprycel ) Tj ET Q q 0 0 0 rg BT 83.13 209.25 Td (was ) Tj ET Q q 0 0 0 rg BT 101.43 209.25 Td (r) Tj ET Q q 0 0 0 rg BT 104.95 209.25 Td (evoked ) Tj ET Q q 0 0 0 rg BT 135.44 209.25 Td (by ) Tj ET Q q 0 0 0 rg BT 147.61 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 162.57 209.25 Td (Opposition ) Tj ET Q q 0 0 0 rg BT 209.75 209.25 Td (Division ) Tj ET Q q 0 0 0 rg BT 246.38 209.25 Td (of ) Tj ET Q q 0 0 0 rg BT 256.89 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 271.84 209.25 Td (EPO. ) Tj ET Q q 0 0 0 rg BT 296.32 209.25 Td (As ) Tj ET Q q 0 0 0 rg BT 309.06 209.25 Td (a ) Tj ET Q q 0 0 0 rg BT 316.80 209.25 Td (r) Tj ET Q q 0 0 0 rg BT 320.32 209.25 Td (esult, ) Tj ET Q q 0 0 0 rg BT 344.44 209.25 Td (we ) Tj ET Q q 0 0 0 rg BT 358.29 209.25 Td (may ) Tj ET Q q 0 0 0 rg BT 377.68 209.25 Td (experience ) Tj ET Q q 0 0 0 rg BT 423.72 209.25 Td (a ) Tj ET Q q 0 0 0 rg BT 431.46 209.25 Td (decline ) Tj ET Q q 0 0 0 rg BT 463.07 209.25 Td (in ) Tj ET Q q 0 0 0 rg BT 473.58 209.25 Td (Eur) Tj ET Q q 0 0 0 rg BT 488.21 209.25 Td (opean ) Tj ET Q q 0 0 0 rg BT 515.38 209.25 Td (r) Tj ET Q q 0 0 0 rg BT 518.91 209.25 Td (evenues ) Tj ET Q q 0 0 0 rg BT 553.29 209.25 Td (in ) Tj ET Q q 0 0 0 rg BT 563.80 209.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 197.25 Td (second ) Tj ET Q q 0 0 0 rg BT 66.54 197.25 Td (half ) Tj ET Q q 0 0 0 rg BT 84.86 197.25 Td (of ) Tj ET Q q 0 0 0 rg BT 95.41 197.25 Td (2017. ) Tj ET Q q 0 0 0 rg BT 120.67 197.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 145.10 197.25 Td (to ) Tj ET Q q 0 0 0 rg BT 155.64 197.25 Td ("Item ) Tj ET Q q 0 0 0 rg BT 180.38 197.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 190.65 197.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 232.29 197.25 Td (Statements—Note ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 306.17 197.25 Td (18) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 316.17 197.25 Td (. ) Tj ET Q q 0 0 0 rg BT 321.43 197.25 Td (Legal ) Tj ET Q q 0 0 0 rg BT 346.98 197.25 Td (Pr) Tj ET Q q 0 0 0 rg BT 356.61 197.25 Td (oceedings ) Tj ET Q q 0 0 0 rg BT 399.36 197.25 Td (and ) Tj ET Q q 0 0 0 rg BT 417.13 197.25 Td (Contingencies" ) Tj ET Q q 0 0 0 rg BT 481.31 197.25 Td (for ) Tj ET Q q 0 0 0 rg BT 495.75 197.25 Td (further ) Tj ET Q q 0 0 0 rg BT 526.29 197.25 Td (information. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.79 185.25 Td (some ) Tj ET Q q 0 0 0 rg BT 69.81 185.25 Td (cases, ) Tj ET Q q 0 0 0 rg BT 96.44 185.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 142.17 185.25 Td (ers ) Tj ET Q q 0 0 0 rg BT 156.86 185.25 Td (may ) Tj ET Q q 0 0 0 rg BT 175.99 185.25 Td (seek ) Tj ET Q q 0 0 0 rg BT 195.66 185.25 Td (r) Tj ET Q q 0 0 0 rg BT 199.18 185.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 239.97 185.25 Td (appr) Tj ET Q q 0 0 0 rg BT 258.49 185.25 Td (oval ) Tj ET Q q 0 0 0 rg BT 278.17 185.25 Td (by ) Tj ET Q q 0 0 0 rg BT 290.07 185.25 Td (submitting ) Tj ET Q q 0 0 0 rg BT 334.76 185.25 Td (their ) Tj ET Q q 0 0 0 rg BT 356.12 185.25 Td (own ) Tj ET Q q 0 0 0 rg BT 375.25 185.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 407.71 185.25 Td (trial ) Tj ET Q q 0 0 0 rg BT 427.40 185.25 Td (data ) Tj ET Q q 0 0 0 rg BT 447.64 185.25 Td (to ) Tj ET Q q 0 0 0 rg BT 457.88 185.25 Td (obtain ) Tj ET Q q 0 0 0 rg BT 485.91 185.25 Td (marketing ) Tj ET Q q 0 0 0 rg BT 528.92 185.25 Td (appr) Tj ET Q q 0 0 0 rg BT 547.44 185.25 Td (oval ) Tj ET Q q 0 0 0 rg BT 567.12 185.25 Td (or ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (choose ) Tj ET Q q 0 0 0 rg BT 65.82 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 75.65 173.25 Td (launch ) Tj ET Q q 0 0 0 rg BT 104.91 173.25 Td (a ) Tj ET Q q 0 0 0 rg BT 111.96 173.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 144.00 173.25 Td (pr) Tj ET Q q 0 0 0 rg BT 152.52 173.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 176.79 173.25 Td (“at ) Tj ET Q q 0 0 0 rg BT 192.17 173.25 Td (risk” ) Tj ET Q q 0 0 0 rg BT 214.79 173.25 Td (befor) Tj ET Q q 0 0 0 rg BT 235.52 173.25 Td (e ) Tj ET Q q 0 0 0 rg BT 242.01 173.25 Td (the ) Tj ET Q q 0 0 0 rg BT 256.28 173.25 Td (expiration ) Tj ET Q q 0 0 0 rg BT 299.43 173.25 Td (of ) Tj ET Q q 0 0 0 rg BT 309.26 173.25 Td (the ) Tj ET Q q 0 0 0 rg BT 323.53 173.25 Td (applicable ) Tj ET Q q 0 0 0 rg BT 367.79 173.25 Td (patent\(s\) ) Tj ET Q q 0 0 0 rg BT 405.38 173.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 434.10 173.25 Td (befor) Tj ET Q q 0 0 0 rg BT 454.84 173.25 Td (e ) Tj ET Q q 0 0 0 rg BT 461.33 173.25 Td (the ) Tj ET Q q 0 0 0 rg BT 475.60 173.25 Td (final ) Tj ET Q q 0 0 0 rg BT 495.98 173.25 Td (r) Tj ET Q q 0 0 0 rg BT 499.50 173.25 Td (esolution ) Tj ET Q q 0 0 0 rg BT 538.22 173.25 Td (of ) Tj ET Q q 0 0 0 rg BT 548.04 173.25 Td (r) Tj ET Q q 0 0 0 rg BT 551.57 173.25 Td (elated ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 63.22 161.25 Td (litigation. ) Tj ET Q q 0 0 0 rg BT 104.61 161.25 Td (Ther) Tj ET Q q 0 0 0 rg BT 123.13 161.25 Td (e ) Tj ET Q q 0 0 0 rg BT 129.79 161.25 Td (is ) Tj ET Q q 0 0 0 rg BT 138.68 161.25 Td (no ) Tj ET Q q 0 0 0 rg BT 150.90 161.25 Td (assurance ) Tj ET Q q 0 0 0 rg BT 193.68 161.25 Td (that ) Tj ET Q q 0 0 0 rg BT 211.45 161.25 Td (a ) Tj ET Q q 0 0 0 rg BT 218.68 161.25 Td (particular ) Tj ET Q q 0 0 0 rg BT 261.45 161.25 Td (pr) Tj ET Q q 0 0 0 rg BT 269.97 161.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 294.41 161.25 Td (will ) Tj ET Q q 0 0 0 rg BT 311.64 161.25 Td (enjoy ) Tj ET Q q 0 0 0 rg BT 335.52 161.25 Td (market ) Tj ET Q q 0 0 0 rg BT 365.51 161.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 409.93 161.25 Td (for ) Tj ET Q q 0 0 0 rg BT 423.82 161.25 Td (the ) Tj ET Q q 0 0 0 rg BT 438.26 161.25 Td (full ) Tj ET Q q 0 0 0 rg BT 453.81 161.25 Td (time ) Tj ET Q q 0 0 0 rg BT 473.25 161.25 Td (period ) Tj ET Q q 0 0 0 rg BT 501.58 161.25 Td (that ) Tj ET Q q 0 0 0 rg BT 519.36 161.25 Td (appears ) Tj ET Q q 0 0 0 rg BT 553.80 161.25 Td (in ) Tj ET Q q 0 0 0 rg BT 563.80 161.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 75.76 149.25 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 115.53 149.25 Td (in ) Tj ET Q q 0 0 0 rg BT 125.85 149.25 Td (this ) Tj ET Q q 0 0 0 rg BT 142.85 149.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 167.61 149.25 Td (10-K ) Tj ET Q q 0 0 0 rg BT 190.16 149.25 Td (or ) Tj ET Q q 0 0 0 rg BT 201.60 149.25 Td (that ) Tj ET Q q 0 0 0 rg BT 219.70 149.25 Td (we ) Tj ET Q q 0 0 0 rg BT 233.36 149.25 Td (assume ) Tj ET Q q 0 0 0 rg BT 265.35 149.25 Td (when ) Tj ET Q q 0 0 0 rg BT 289.00 149.25 Td (we ) Tj ET Q q 0 0 0 rg BT 302.66 149.25 Td (pr) Tj ET Q q 0 0 0 rg BT 311.18 149.25 Td (ovide ) Tj ET Q q 0 0 0 rg BT 335.38 149.25 Td (our ) Tj ET Q q 0 0 0 rg BT 351.82 149.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 389.91 149.25 Td (guidance. ) Tj ET Q q 0 0 0 rg BT 431.62 149.25 Td (In ) Tj ET Q q 0 0 0 rg BT 442.49 149.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 480.87 149.25 Td (some ) Tj ET Q q 0 0 0 rg BT 503.97 149.25 Td (countries, ) Tj ET Q q 0 0 0 rg BT 546.23 149.25 Td (such ) Tj ET Q q 0 0 0 rg BT 567.11 149.25 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 137.25 Td (India, ) Tj ET Q q 0 0 0 rg BT 62.06 137.25 Td (ar) Tj ET Q q 0 0 0 rg BT 70.58 137.25 Td (e ) Tj ET Q q 0 0 0 rg BT 77.46 137.25 Td (allowing ) Tj ET Q q 0 0 0 rg BT 114.92 137.25 Td (competitors ) Tj ET Q q 0 0 0 rg BT 164.58 137.25 Td (to ) Tj ET Q q 0 0 0 rg BT 174.81 137.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 220.54 137.25 Td (e ) Tj ET Q q 0 0 0 rg BT 227.43 137.25 Td (and ) Tj ET Q q 0 0 0 rg BT 244.88 137.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 261.21 137.25 Td (competing ) Tj ET Q q 0 0 0 rg BT 305.31 137.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 337.75 137.25 Td (pr) Tj ET Q q 0 0 0 rg BT 346.27 137.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 377.32 137.25 Td (which ) Tj ET Q q 0 0 0 rg BT 403.66 137.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 447.20 137.25 Td (impacts ) Tj ET Q q 0 0 0 rg BT 480.75 137.25 Td (the ) Tj ET Q q 0 0 0 rg BT 495.42 137.25 Td (pr) Tj ET Q q 0 0 0 rg BT 503.94 137.25 Td (otections ) Tj ET Q q 0 0 0 rg BT 542.49 137.25 Td (affor) Tj ET Q q 0 0 0 rg BT 561.57 137.25 Td (ded ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 125.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.36 125.25 Td (Company) Tj ET Q q 0 0 0 rg BT 89.14 125.25 Td (. ) Tj ET Q q 0 0 0 rg BT 94.79 125.25 Td (Lower) Tj ET Q q 0 0 0 rg BT 120.15 125.25 Td (-priced ) Tj ET Q q 0 0 0 rg BT 152.17 125.25 Td (biosimilars ) Tj ET Q q 0 0 0 rg BT 200.33 125.25 Td (for ) Tj ET Q q 0 0 0 rg BT 215.15 125.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 237.73 125.25 Td (biologic ) Tj ET Q q 0 0 0 rg BT 273.65 125.25 Td (pr) Tj ET Q q 0 0 0 rg BT 282.17 125.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 311.43 125.25 Td (or ) Tj ET Q q 0 0 0 rg BT 323.47 125.25 Td (competing ) Tj ET Q q 0 0 0 rg BT 368.27 125.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 408.08 125.25 Td (could ) Tj ET Q q 0 0 0 rg BT 433.45 125.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 477.68 125.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 508.05 125.25 Td (our ) Tj ET Q q 0 0 0 rg BT 525.08 125.25 Td (volumes ) Tj ET Q q 0 0 0 rg BT 561.00 125.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td (prices.) Tj ET Q endstream endobj 41 0 obj <> endobj 42 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (20) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Increased ) Tj ET Q q 0 0 0 rg BT 80.09 749.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 113.07 749.25 Td (pressure ) Tj ET Q q 0 0 0 rg BT 151.61 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 170.71 749.25 Td (other ) Tj ET Q q 0 0 0 rg BT 195.92 749.25 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 245.57 749.25 Td (in ) Tj ET Q q 0 0 0 rg BT 257.45 749.25 Td (the ) Tj ET Q q 0 0 0 rg BT 273.77 749.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 295.09 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 314.18 749.25 Td (abroad ) Tj ET Q q 0 0 0 rg BT 346.61 749.25 Td (from ) Tj ET Q q 0 0 0 rg BT 370.15 749.25 Td (MCOs, ) Tj ET Q q 0 0 0 rg BT 402.86 749.25 Td (institutional ) Tj ET Q q 0 0 0 rg BT 456.42 749.25 Td (purchasers, ) Tj ET Q q 0 0 0 rg BT 508.02 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 527.12 749.25 Td (government ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 737.25 Td (agencies ) Tj ET Q q 0 0 0 rg BT 74.05 737.25 Td (and ) Tj ET Q q 0 0 0 rg BT 92.11 737.25 Td (programs, ) Tj ET Q q 0 0 0 rg BT 136.56 737.25 Td (among ) Tj ET Q q 0 0 0 rg BT 167.40 737.25 Td (others, ) Tj ET Q q 0 0 0 rg BT 197.96 737.25 Td (could ) Tj ET Q q 0 0 0 rg BT 223.24 737.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 267.39 737.25 Td (af) Tj ET Q q 0 0 0 rg BT 275.54 737.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 293.03 737.25 Td (our ) Tj ET Q q 0 0 0 rg BT 309.98 737.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 349.14 737.25 Td (and ) Tj ET Q q 0 0 0 rg BT 367.20 737.25 Td (profit ) Tj ET Q q 0 0 0 rg BT 392.48 737.25 Td (margins.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.62 725.25 Td (pr) Tj ET Q q 0 0 0 rg BT 63.14 725.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 91.75 725.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 128.69 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 138.97 725.25 Td (be ) Tj ET Q q 0 0 0 rg BT 150.91 725.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 181.74 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 192.02 725.25 Td (incr) Tj ET Q q 0 0 0 rg BT 207.76 725.25 Td (easing ) Tj ET Q q 0 0 0 rg BT 236.37 725.25 Td (pr) Tj ET Q q 0 0 0 rg BT 244.89 725.25 Td (essur) Tj ET Q q 0 0 0 rg BT 265.64 725.25 Td (es ) Tj ET Q q 0 0 0 rg BT 276.47 725.25 Td (acr) Tj ET Q q 0 0 0 rg BT 289.43 725.25 Td (oss ) Tj ET Q q 0 0 0 rg BT 304.72 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 319.44 725.25 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 356.95 725.25 Td (fr) Tj ET Q q 0 0 0 rg BT 363.24 725.25 Td (om ) Tj ET Q q 0 0 0 rg BT 377.97 725.25 Td (market ) Tj ET Q q 0 0 0 rg BT 408.24 725.25 Td (access, ) Tj ET Q q 0 0 0 rg BT 439.34 725.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 470.74 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 488.24 725.25 Td (discounting ) Tj ET Q q 0 0 0 rg BT 537.41 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 554.91 725.25 Td (other ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 713.25 Td (estrictions ) Tj ET Q q 0 0 0 rg BT 83.33 713.25 Td (in ) Tj ET Q q 0 0 0 rg BT 93.26 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 107.63 713.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 129.50 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 143.86 713.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 159.34 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 176.49 713.25 Td (other ) Tj ET Q q 0 0 0 rg BT 199.75 713.25 Td (r) Tj ET Q q 0 0 0 rg BT 203.27 713.25 Td (egions ) Tj ET Q q 0 0 0 rg BT 231.52 713.25 Td (ar) Tj ET Q q 0 0 0 rg BT 240.04 713.25 Td (ound ) Tj ET Q q 0 0 0 rg BT 262.19 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 276.56 713.25 Td (world, ) Tj ET Q q 0 0 0 rg BT 304.54 713.25 Td (including ) Tj ET Q q 0 0 0 rg BT 344.47 713.25 Td (fr) Tj ET Q q 0 0 0 rg BT 350.77 713.25 Td (om ) Tj ET Q q 0 0 0 rg BT 365.14 713.25 Td (\(i\) rules ) Tj ET Q q 0 0 0 rg BT 399.22 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 416.37 713.25 Td (practices ) Tj ET Q q 0 0 0 rg BT 455.17 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 465.10 713.25 Td (MCOs ) Tj ET Q q 0 0 0 rg BT 493.36 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 510.51 713.25 Td (institutional ) Tj ET Q q 0 0 0 rg BT 561.00 713.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (governmental ) Tj ET Q q 0 0 0 rg BT 93.17 701.25 Td (pur) Tj ET Q q 0 0 0 rg BT 106.69 701.25 Td (chasers; ) Tj ET Q q 0 0 0 rg BT 142.76 701.25 Td (\(ii\) judicial ) Tj ET Q q 0 0 0 rg BT 190.22 701.25 Td (decisions ) Tj ET Q q 0 0 0 rg BT 229.62 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 246.81 701.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 281.76 701.25 Td (in ) Tj ET Q q 0 0 0 rg BT 291.73 701.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 312.25 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 329.44 701.25 Td (r) Tj ET Q q 0 0 0 rg BT 332.96 701.25 Td (egulations ) Tj ET Q q 0 0 0 rg BT 376.81 701.25 Td (for ) Tj ET Q q 0 0 0 rg BT 390.67 701.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 421.18 701.25 Td (healthcar) Tj ET Q q 0 0 0 rg BT 459.13 701.25 Td (e ) Tj ET Q q 0 0 0 rg BT 465.76 701.25 Td (pr) Tj ET Q q 0 0 0 rg BT 474.28 701.25 Td (ograms ) Tj ET Q q 0 0 0 rg BT 506.47 701.25 Td (such ) Tj ET Q q 0 0 0 rg BT 526.99 701.25 Td (as ) Tj ET Q q 0 0 0 rg BT 538.06 701.25 Td (Medicar) Tj ET Q q 0 0 0 rg BT 571.57 701.25 Td (e ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.37 689.25 Td (Medicaid, ) Tj ET Q q 0 0 0 rg BT 96.01 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 113.38 689.25 Td (other ) Tj ET Q q 0 0 0 rg BT 136.86 689.25 Td (government ) Tj ET Q q 0 0 0 rg BT 186.44 689.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 217.70 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 235.08 689.25 Td (inquiries; ) Tj ET Q q 0 0 0 rg BT 276.34 689.25 Td (\(iii\) the ) Tj ET Q q 0 0 0 rg BT 308.42 689.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 346.35 689.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 375.94 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 386.09 689.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 421.23 689.25 Td (to ) Tj ET Q q 0 0 0 rg BT 431.38 689.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 496.52 689.25 Td (r) Tj ET Q q 0 0 0 rg BT 500.04 689.25 Td (eimbursement, ) Tj ET Q q 0 0 0 rg BT 561.01 689.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (incr) Tj ET Q q 0 0 0 rg BT 51.74 677.25 Td (eased ) Tj ET Q q 0 0 0 rg BT 76.48 677.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 107.34 677.25 Td (pr) Tj ET Q q 0 0 0 rg BT 115.86 677.25 Td (essur) Tj ET Q q 0 0 0 rg BT 136.61 677.25 Td (e ) Tj ET Q q 0 0 0 rg BT 143.02 677.25 Td (fr) Tj ET Q q 0 0 0 rg BT 149.32 677.25 Td (om ) Tj ET Q q 0 0 0 rg BT 163.51 677.25 Td (Medicar) Tj ET Q q 0 0 0 rg BT 197.02 677.25 Td (e ) Tj ET Q q 0 0 0 rg BT 203.43 677.25 Td (Part ) Tj ET Q q 0 0 0 rg BT 223.19 677.25 Td (D ) Tj ET Q q 0 0 0 rg BT 232.38 677.25 Td (formularies, ) Tj ET Q q 0 0 0 rg BT 283.53 677.25 Td (Medicar) Tj ET Q q 0 0 0 rg BT 317.04 677.25 Td (e ) Tj ET Q q 0 0 0 rg BT 323.45 677.25 Td (Part ) Tj ET Q q 0 0 0 rg BT 343.20 677.25 Td (B ) Tj ET Q q 0 0 0 rg BT 351.29 677.25 Td (r) Tj ET Q q 0 0 0 rg BT 354.81 677.25 Td (eimbursement ) Tj ET Q q 0 0 0 rg BT 412.88 677.25 Td (rates ) Tj ET Q q 0 0 0 rg BT 434.85 677.25 Td (to ) Tj ET Q q 0 0 0 rg BT 444.61 677.25 Td (physicians ) Tj ET Q q 0 0 0 rg BT 488.80 677.25 Td (as ) Tj ET Q q 0 0 0 rg BT 499.67 677.25 Td (well ) Tj ET Q q 0 0 0 rg BT 518.31 677.25 Td (as ) Tj ET Q q 0 0 0 rg BT 529.17 677.25 Td (commer) Tj ET Q q 0 0 0 rg BT 561.01 677.25 Td (cial ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (formularies ) Tj ET Q q 0 0 0 rg BT 86.14 665.25 Td (in ) Tj ET Q q 0 0 0 rg BT 97.38 665.25 Td (general; ) Tj ET Q q 0 0 0 rg BT 134.73 665.25 Td (\(iv\) r) Tj ET Q q 0 0 0 rg BT 154.62 665.25 Td (eimbursement ) Tj ET Q q 0 0 0 rg BT 214.19 665.25 Td (delays; ) Tj ET Q q 0 0 0 rg BT 246.53 665.25 Td (\(v\) government ) Tj ET Q q 0 0 0 rg BT 310.80 665.25 Td (price ) Tj ET Q q 0 0 0 rg BT 334.82 665.25 Td (er) Tj ET Q q 0 0 0 rg BT 342.78 665.25 Td (osion ) Tj ET Q q 0 0 0 rg BT 367.91 665.25 Td (mechanisms ) Tj ET Q q 0 0 0 rg BT 420.26 665.25 Td (acr) Tj ET Q q 0 0 0 rg BT 433.22 665.25 Td (oss ) Tj ET Q q 0 0 0 rg BT 449.47 665.25 Td (Eur) Tj ET Q q 0 0 0 rg BT 464.10 665.25 Td (ope ) Tj ET Q q 0 0 0 rg BT 482.01 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 500.47 665.25 Td (in ) Tj ET Q q 0 0 0 rg BT 511.72 665.25 Td (other ) Tj ET Q q 0 0 0 rg BT 536.29 665.25 Td (countries, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 653.25 Td (esulting ) Tj ET Q q 0 0 0 rg BT 73.36 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 83.31 653.25 Td (deflation ) Tj ET Q q 0 0 0 rg BT 121.04 653.25 Td (for ) Tj ET Q q 0 0 0 rg BT 134.89 653.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 199.83 653.25 Td (pr) Tj ET Q q 0 0 0 rg BT 208.35 653.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 232.74 653.25 Td (pricing; ) Tj ET Q q 0 0 0 rg BT 267.13 653.25 Td (\(vi\) collection ) Tj ET Q q 0 0 0 rg BT 325.11 653.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 352.83 653.25 Td (or ) Tj ET Q q 0 0 0 rg BT 363.90 653.25 Td (failur) Tj ET Q q 0 0 0 rg BT 385.76 653.25 Td (es ) Tj ET Q q 0 0 0 rg BT 396.26 653.25 Td (to ) Tj ET Q q 0 0 0 rg BT 406.21 653.25 Td (pay ) Tj ET Q q 0 0 0 rg BT 422.83 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 432.78 653.25 Td (government-funded ) Tj ET Q q 0 0 0 rg BT 512.71 653.25 Td (public ) Tj ET Q q 0 0 0 rg BT 539.88 653.25 Td (hospitals ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (outside ) Tj ET Q q 0 0 0 rg BT 67.49 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 82.32 641.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 102.15 641.25 Td (\(vii\) ) Tj ET Q q 0 0 0 rg BT 121.41 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 136.23 641.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 166.06 641.25 Td (on ) Tj ET Q q 0 0 0 rg BT 178.67 641.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 210.16 641.25 Td (fr) Tj ET Q q 0 0 0 rg BT 216.46 641.25 Td (om ) Tj ET Q q 0 0 0 rg BT 231.29 641.25 Td (parallel ) Tj ET Q q 0 0 0 rg BT 265.56 641.25 Td (trade ) Tj ET Q q 0 0 0 rg BT 289.28 641.25 Td (acr) Tj ET Q q 0 0 0 rg BT 302.24 641.25 Td (oss ) Tj ET Q q 0 0 0 rg BT 317.63 641.25 Td (bor) Tj ET Q q 0 0 0 rg BT 331.15 641.25 Td (ders; ) Tj ET Q q 0 0 0 rg BT 354.31 641.25 Td (\(viii\) ) Tj ET Q q 0 0 0 rg BT 376.35 641.25 Td (other ) Tj ET Q q 0 0 0 rg BT 400.06 641.25 Td (developments ) Tj ET Q q 0 0 0 rg BT 457.09 641.25 Td (in ) Tj ET Q q 0 0 0 rg BT 467.48 641.25 Td (technology ) Tj ET Q q 0 0 0 rg BT 513.96 641.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 543.24 641.25 Td (industry ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (practices ) Tj ET Q q 0 0 0 rg BT 75.08 629.25 Td (that ) Tj ET Q q 0 0 0 rg BT 93.07 629.25 Td (could ) Tj ET Q q 0 0 0 rg BT 117.72 629.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 147.36 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 162.01 629.25 Td (r) Tj ET Q q 0 0 0 rg BT 165.53 629.25 Td (eimbursement ) Tj ET Q q 0 0 0 rg BT 224.06 629.25 Td (policies ) Tj ET Q q 0 0 0 rg BT 257.59 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 275.02 629.25 Td (practices ) Tj ET Q q 0 0 0 rg BT 314.10 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 324.31 629.25 Td (thir) Tj ET Q q 0 0 0 rg BT 338.39 629.25 Td (d-party ) Tj ET Q q 0 0 0 rg BT 370.26 629.25 Td (payers; ) Tj ET Q q 0 0 0 rg BT 402.67 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 420.10 629.25 Td (\(ix\) inhibited ) Tj ET Q q 0 0 0 rg BT 474.46 629.25 Td (market ) Tj ET Q q 0 0 0 rg BT 504.66 629.25 Td (access ) Tj ET Q q 0 0 0 rg BT 533.19 629.25 Td (due ) Tj ET Q q 0 0 0 rg BT 550.06 629.25 Td (to ) Tj ET Q q 0 0 0 rg BT 560.26 629.25 Td (r) Tj ET Q q 0 0 0 rg BT 563.78 629.25 Td (eal ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 47.39 617.25 Td (per) Tj ET Q q 0 0 0 rg BT 60.35 617.25 Td (ceived ) Tj ET Q q 0 0 0 rg BT 88.38 617.25 Td (differ) Tj ET Q q 0 0 0 rg BT 109.68 617.25 Td (ences ) Tj ET Q q 0 0 0 rg BT 134.38 617.25 Td (in ) Tj ET Q q 0 0 0 rg BT 144.66 617.25 Td (value ) Tj ET Q q 0 0 0 rg BT 168.82 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 177.34 617.25 Td (opositions ) Tj ET Q q 0 0 0 rg BT 220.96 617.25 Td (for ) Tj ET Q q 0 0 0 rg BT 235.13 617.25 Td (our ) Tj ET Q q 0 0 0 rg BT 251.52 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 260.04 617.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 288.65 617.25 Td (compar) Tj ET Q q 0 0 0 rg BT 318.83 617.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 330.77 617.25 Td (to ) Tj ET Q q 0 0 0 rg BT 341.04 617.25 Td (competing ) Tj ET Q q 0 0 0 rg BT 385.20 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 393.72 617.25 Td (oducts.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (Changes ) Tj ET Q q 0 0 0 rg BT 74.61 593.25 Td (in ) Tj ET Q q 0 0 0 rg BT 85.45 593.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 105.72 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 117.10 593.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 149.60 593.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 170.43 593.25 Td (and ) Tj ET Q q 0 0 0 rg BT 188.48 593.25 Td (regulations ) Tj ET Q q 0 0 0 rg BT 237.65 593.25 Td (\(including ) Tj ET Q q 0 0 0 rg BT 282.93 593.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 298.20 593.25 Td (regulations\) ) Tj ET Q q 0 0 0 rg BT 350.70 593.25 Td (may ) Tj ET Q q 0 0 0 rg BT 370.41 593.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 414.55 593.25 Td (af) Tj ET Q q 0 0 0 rg BT 422.70 593.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 440.18 593.25 Td (our ) Tj ET Q q 0 0 0 rg BT 457.13 593.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 496.28 593.25 Td (and ) Tj ET Q q 0 0 0 rg BT 514.33 593.25 Td (profit ) Tj ET Q q 0 0 0 rg BT 539.60 593.25 Td (margins.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 581.25 Td (e ) Tj ET Q q 0 0 0 rg BT 50.02 581.25 Td (could ) Tj ET Q q 0 0 0 rg BT 74.40 581.25 Td (become ) Tj ET Q q 0 0 0 rg BT 107.11 581.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 137.60 581.25 Td (to ) Tj ET Q q 0 0 0 rg BT 147.55 581.25 Td (new ) Tj ET Q q 0 0 0 rg BT 165.82 581.25 Td (government ) Tj ET Q q 0 0 0 rg BT 215.20 581.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 235.71 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 252.88 581.25 Td (r) Tj ET Q q 0 0 0 rg BT 256.40 581.25 Td (egulations, ) Tj ET Q q 0 0 0 rg BT 302.73 581.25 Td (which ) Tj ET Q q 0 0 0 rg BT 328.78 581.25 Td (could ) Tj ET Q q 0 0 0 rg BT 353.17 581.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 396.42 581.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 420.80 581.25 Td (our ) Tj ET Q q 0 0 0 rg BT 436.86 581.25 Td (business, ) Tj ET Q q 0 0 0 rg BT 475.42 581.25 Td (our ) Tj ET Q q 0 0 0 rg BT 491.48 581.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 532.54 581.25 Td (r) Tj ET Q q 0 0 0 rg BT 536.06 581.25 Td (esults ) Tj ET Q q 0 0 0 rg BT 561.00 581.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.90 569.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 89.14 569.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 129.61 569.25 Td (of ) Tj ET Q q 0 0 0 rg BT 140.07 569.25 Td (our ) Tj ET Q q 0 0 0 rg BT 156.65 569.25 Td (Company) Tj ET Q q 0 0 0 rg BT 194.43 569.25 Td (, ) Tj ET Q q 0 0 0 rg BT 199.62 569.25 Td (such ) Tj ET Q q 0 0 0 rg BT 220.64 569.25 Td (as ) Tj ET Q q 0 0 0 rg BT 232.22 569.25 Td (\(i\) additional ) Tj ET Q q 0 0 0 rg BT 287.96 569.25 Td (healthcar) Tj ET Q q 0 0 0 rg BT 325.91 569.25 Td (e ) Tj ET Q q 0 0 0 rg BT 333.04 569.25 Td (r) Tj ET Q q 0 0 0 rg BT 336.56 569.25 Td (eform ) Tj ET Q q 0 0 0 rg BT 362.57 569.25 Td (initiatives ) Tj ET Q q 0 0 0 rg BT 404.70 569.25 Td (in ) Tj ET Q q 0 0 0 rg BT 415.17 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 430.07 569.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 449.98 569.25 Td (or ) Tj ET Q q 0 0 0 rg BT 461.56 569.25 Td (in ) Tj ET Q q 0 0 0 rg BT 472.03 569.25 Td (other ) Tj ET Q q 0 0 0 rg BT 495.82 569.25 Td (countries, ) Tj ET Q q 0 0 0 rg BT 538.23 569.25 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 80.14 557.25 Td (mandatory ) Tj ET Q q 0 0 0 rg BT 126.50 557.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 167.30 557.25 Td (or ) Tj ET Q q 0 0 0 rg BT 179.22 557.25 Td (fees; ) Tj ET Q q 0 0 0 rg BT 201.12 557.25 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 216.37 557.25 Td (changing ) Tj ET Q q 0 0 0 rg BT 256.61 557.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 271.85 557.25 Td (rates; ) Tj ET Q q 0 0 0 rg BT 298.21 557.25 Td (changing ) Tj ET Q q 0 0 0 rg BT 338.45 557.25 Td (the ) Tj ET Q q 0 0 0 rg BT 353.69 557.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 368.94 557.25 Td (base ) Tj ET Q q 0 0 0 rg BT 390.29 557.25 Td (including ) Tj ET Q q 0 0 0 rg BT 431.09 557.25 Td (limiting, ) Tj ET Q q 0 0 0 rg BT 467.73 557.25 Td (phasing-out ) Tj ET Q q 0 0 0 rg BT 518.54 557.25 Td (or ) Tj ET Q q 0 0 0 rg BT 530.46 557.25 Td (eliminating ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (deductions ) Tj ET Q q 0 0 0 rg BT 80.82 545.25 Td (or ) Tj ET Q q 0 0 0 rg BT 91.21 545.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 104.93 545.25 Td (cr) Tj ET Q q 0 0 0 rg BT 112.89 545.25 Td (edits; ) Tj ET Q q 0 0 0 rg BT 136.60 545.25 Td (taxing ) Tj ET Q q 0 0 0 rg BT 163.09 545.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 192.92 545.25 Td (excess ) Tj ET Q q 0 0 0 rg BT 219.95 545.25 Td (income ) Tj ET Q q 0 0 0 rg BT 250.33 545.25 Td (fr) Tj ET Q q 0 0 0 rg BT 256.63 545.25 Td (om ) Tj ET Q q 0 0 0 rg BT 270.35 545.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 316.83 545.25 Td (pr) Tj ET Q q 0 0 0 rg BT 325.35 545.25 Td (operty; ) Tj ET Q q 0 0 0 rg BT 355.73 545.25 Td (changing ) Tj ET Q q 0 0 0 rg BT 394.44 545.25 Td (rules ) Tj ET Q q 0 0 0 rg BT 415.94 545.25 Td (for ) Tj ET Q q 0 0 0 rg BT 429.11 545.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 465.60 545.25 Td (r) Tj ET Q q 0 0 0 rg BT 469.13 545.25 Td (epatriations; ) Tj ET Q q 0 0 0 rg BT 522.29 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 538.79 545.25 Td (changing ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.57 533.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 74.25 533.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 95.06 533.25 Td (in ) Tj ET Q q 0 0 0 rg BT 105.30 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 119.98 533.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 139.67 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 151.03 533.25 Td (other ) Tj ET Q q 0 0 0 rg BT 174.60 533.25 Td (countries; ) Tj ET Q q 0 0 0 rg BT 217.61 533.25 Td (\(iii\) new ) Tj ET Q q 0 0 0 rg BT 253.68 533.25 Td (laws, ) Tj ET Q q 0 0 0 rg BT 276.99 533.25 Td (r) Tj ET Q q 0 0 0 rg BT 280.51 533.25 Td (egulations ) Tj ET Q q 0 0 0 rg BT 324.64 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 342.10 533.25 Td (judicial ) Tj ET Q q 0 0 0 rg BT 375.12 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 386.47 533.25 Td (other ) Tj ET Q q 0 0 0 rg BT 410.05 533.25 Td (governmental ) Tj ET Q q 0 0 0 rg BT 467.50 533.25 Td (decisions ) Tj ET Q q 0 0 0 rg BT 507.18 533.25 Td (affecting ) Tj ET Q q 0 0 0 rg BT 544.63 533.25 Td (pricing, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 57.42 521.25 Td (r) Tj ET Q q 0 0 0 rg BT 60.94 521.25 Td (eimbursement, ) Tj ET Q q 0 0 0 rg BT 122.07 521.25 Td (r) Tj ET Q q 0 0 0 rg BT 125.59 521.25 Td (eceivable ) Tj ET Q q 0 0 0 rg BT 165.88 521.25 Td (payments, ) Tj ET Q q 0 0 0 rg BT 208.68 521.25 Td (and ) Tj ET Q q 0 0 0 rg BT 226.21 521.25 Td (access ) Tj ET Q q 0 0 0 rg BT 254.84 521.25 Td (or ) Tj ET Q q 0 0 0 rg BT 266.26 521.25 Td (marketing ) Tj ET Q q 0 0 0 rg BT 309.34 521.25 Td (within ) Tj ET Q q 0 0 0 rg BT 336.88 521.25 Td (or ) Tj ET Q q 0 0 0 rg BT 348.30 521.25 Td (acr) Tj ET Q q 0 0 0 rg BT 361.26 521.25 Td (oss ) Tj ET Q q 0 0 0 rg BT 376.57 521.25 Td (jurisdictions; ) Tj ET Q q 0 0 0 rg BT 432.44 521.25 Td (\(iv\) changes ) Tj ET Q q 0 0 0 rg BT 484.12 521.25 Td (in ) Tj ET Q q 0 0 0 rg BT 494.43 521.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 541.94 521.25 Td (pr) Tj ET Q q 0 0 0 rg BT 550.47 521.25 Td (operty ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (law; ) Tj ET Q q 0 0 0 rg BT 57.31 509.25 Td (\(v\) changes ) Tj ET Q q 0 0 0 rg BT 107.21 509.25 Td (in ) Tj ET Q q 0 0 0 rg BT 118.52 509.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 166.49 509.25 Td (standar) Tj ET Q q 0 0 0 rg BT 196.68 509.25 Td (ds; ) Tj ET Q q 0 0 0 rg BT 212.43 509.25 Td (\(vi\) incr) Tj ET Q q 0 0 0 rg BT 244.55 509.25 Td (easing ) Tj ET Q q 0 0 0 rg BT 274.19 509.25 Td (data ) Tj ET Q q 0 0 0 rg BT 295.50 509.25 Td (privacy ) Tj ET Q q 0 0 0 rg BT 329.02 509.25 Td (r) Tj ET Q q 0 0 0 rg BT 332.54 509.25 Td (egulations ) Tj ET Q q 0 0 0 rg BT 377.74 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 396.27 509.25 Td (enfor) Tj ET Q q 0 0 0 rg BT 417.01 509.25 Td (cement; ) Tj ET Q q 0 0 0 rg BT 452.18 509.25 Td (\(vii\) emer) Tj ET Q q 0 0 0 rg BT 490.96 509.25 Td (ging ) Tj ET Q q 0 0 0 rg BT 512.27 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 530.80 509.25 Td (new ) Tj ET Q q 0 0 0 rg BT 550.44 509.25 Td (global ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 497.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 80.33 497.25 Td (r) Tj ET Q q 0 0 0 rg BT 83.85 497.25 Td (equir) Tj ET Q q 0 0 0 rg BT 104.59 497.25 Td (ements ) Tj ET Q q 0 0 0 rg BT 134.85 497.25 Td (for ) Tj ET Q q 0 0 0 rg BT 149.01 497.25 Td (r) Tj ET Q q 0 0 0 rg BT 152.53 497.25 Td (eporting ) Tj ET Q q 0 0 0 rg BT 188.90 497.25 Td (payments ) Tj ET Q q 0 0 0 rg BT 229.16 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 246.64 497.25 Td (other ) Tj ET Q q 0 0 0 rg BT 270.24 497.25 Td (value ) Tj ET Q q 0 0 0 rg BT 294.38 497.25 Td (transfers ) Tj ET Q q 0 0 0 rg BT 332.43 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 342.70 497.25 Td (healthcar) Tj ET Q q 0 0 0 rg BT 380.65 497.25 Td (e ) Tj ET Q q 0 0 0 rg BT 387.58 497.25 Td (pr) Tj ET Q q 0 0 0 rg BT 396.10 497.25 Td (ofessionals; ) Tj ET Q q 0 0 0 rg BT 446.37 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 463.85 497.25 Td (\(viii\) ) Tj ET Q q 0 0 0 rg BT 485.78 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 500.48 497.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 538.52 497.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 568.22 497.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (importation ) Tj ET Q q 0 0 0 rg BT 85.73 485.25 Td (r) Tj ET Q q 0 0 0 rg BT 89.25 485.25 Td (estrictions, ) Tj ET Q q 0 0 0 rg BT 135.91 485.25 Td (legislative ) Tj ET Q q 0 0 0 rg BT 179.51 485.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 208.68 485.25 Td (other ) Tj ET Q q 0 0 0 rg BT 232.29 485.25 Td (r) Tj ET Q q 0 0 0 rg BT 235.81 485.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 276.63 485.25 Td (changes.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (Third-party ) Tj ET Q q 0 0 0 rg BT 86.28 461.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 123.77 461.25 Td (represent ) Tj ET Q q 0 0 0 rg BT 164.60 461.25 Td (a ) Tj ET Q q 0 0 0 rg BT 172.10 461.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 218.50 461.25 Td (percentage ) Tj ET Q q 0 0 0 rg BT 265.99 461.25 Td (of ) Tj ET Q q 0 0 0 rg BT 276.82 461.25 Td (our ) Tj ET Q q 0 0 0 rg BT 293.77 461.25 Td (pretax ) Tj ET Q q 0 0 0 rg BT 322.38 461.25 Td (income ) Tj ET Q q 0 0 0 rg BT 354.87 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 372.93 461.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 414.88 461.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 436.27 461.25 Td (flow) Tj ET Q q 0 0 0 rg BT 453.68 461.25 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 449.25 Td (e ) Tj ET Q q 0 0 0 rg BT 49.91 449.25 Td (have ) Tj ET Q q 0 0 0 rg BT 70.84 449.25 Td (enter) Tj ET Q q 0 0 0 rg BT 91.02 449.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 102.52 449.25 Td (into ) Tj ET Q q 0 0 0 rg BT 120.13 449.25 Td (several ) Tj ET Q q 0 0 0 rg BT 151.07 449.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 208.68 449.25 Td (which ) Tj ET Q q 0 0 0 rg BT 234.62 449.25 Td (entitle ) Tj ET Q q 0 0 0 rg BT 261.67 449.25 Td (us ) Tj ET Q q 0 0 0 rg BT 272.62 449.25 Td (to ) Tj ET Q q 0 0 0 rg BT 282.46 449.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 320.06 449.25 Td (r) Tj ET Q q 0 0 0 rg BT 323.59 449.25 Td (oyalties ) Tj ET Q q 0 0 0 rg BT 356.75 449.25 Td (fr) Tj ET Q q 0 0 0 rg BT 363.05 449.25 Td (om ) Tj ET Q q 0 0 0 rg BT 377.33 449.25 Td (thir) Tj ET Q q 0 0 0 rg BT 391.40 449.25 Td (d ) Tj ET Q q 0 0 0 rg BT 398.46 449.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 428.30 449.25 Td (for ) Tj ET Q q 0 0 0 rg BT 442.03 449.25 Td (out-licensed ) Tj ET Q q 0 0 0 rg BT 492.96 449.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 540.00 449.25 Td (pr) Tj ET Q q 0 0 0 rg BT 548.52 449.25 Td (operty) Tj ET Q q 0 0 0 rg BT 573.51 449.25 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (commer) Tj ET Q q 0 0 0 rg BT 67.84 437.25 Td (cialization ) Tj ET Q q 0 0 0 rg BT 112.16 437.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 137.61 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 154.71 437.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 203.47 437.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 247.78 437.25 Td (pr) Tj ET Q q 0 0 0 rg BT 256.31 437.25 Td (oceeds ) Tj ET Q q 0 0 0 rg BT 285.61 437.25 Td (r) Tj ET Q q 0 0 0 rg BT 289.13 437.25 Td (elated ) Tj ET Q q 0 0 0 rg BT 315.67 437.25 Td (to ) Tj ET Q q 0 0 0 rg BT 325.55 437.25 Td (the ) Tj ET Q q 0 0 0 rg BT 339.87 437.25 Td (divestitur) Tj ET Q q 0 0 0 rg BT 377.27 437.25 Td (e ) Tj ET Q q 0 0 0 rg BT 383.81 437.25 Td (of ) Tj ET Q q 0 0 0 rg BT 393.69 437.25 Td (businesses. ) Tj ET Q q 0 0 0 rg BT 440.52 437.25 Td (In ) Tj ET Q q 0 0 0 rg BT 450.95 437.25 Td (many ) Tj ET Q q 0 0 0 rg BT 474.71 437.25 Td (of ) Tj ET Q q 0 0 0 rg BT 484.59 437.25 Td (these ) Tj ET Q q 0 0 0 rg BT 507.24 437.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 564.89 437.25 Td (we ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (have ) Tj ET Q q 0 0 0 rg BT 58.20 425.25 Td (minimal, ) Tj ET Q q 0 0 0 rg BT 96.80 425.25 Td (if ) Tj ET Q q 0 0 0 rg BT 105.68 425.25 Td (any) Tj ET Q q 0 0 0 rg BT 119.57 425.25 Td (, ) Tj ET Q q 0 0 0 rg BT 125.40 425.25 Td (continuing ) Tj ET Q q 0 0 0 rg BT 171.49 425.25 Td (involvement ) Tj ET Q q 0 0 0 rg BT 223.13 425.25 Td (that ) Tj ET Q q 0 0 0 rg BT 242.01 425.25 Td (contribute ) Tj ET Q q 0 0 0 rg BT 286.44 425.25 Td (to ) Tj ET Q q 0 0 0 rg BT 297.54 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 313.08 425.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 351.96 425.25 Td (success ) Tj ET Q q 0 0 0 rg BT 385.27 425.25 Td (of ) Tj ET Q q 0 0 0 rg BT 396.37 425.25 Td (those ) Tj ET Q q 0 0 0 rg BT 420.81 425.25 Td (activities. ) Tj ET Q q 0 0 0 rg BT 462.73 425.25 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 503.26 425.25 Td (have ) Tj ET Q q 0 0 0 rg BT 525.47 425.25 Td (continued ) Tj ET Q q 0 0 0 rg BT 568.22 425.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 413.25 Td (epr) Tj ET Q q 0 0 0 rg BT 52.48 413.25 Td (esent ) Tj ET Q q 0 0 0 rg BT 75.32 413.25 Td (a ) Tj ET Q q 0 0 0 rg BT 82.62 413.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 127.13 413.25 Td (per) Tj ET Q q 0 0 0 rg BT 140.09 413.25 Td (centage ) Tj ET Q q 0 0 0 rg BT 173.48 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 183.55 413.25 Td (our ) Tj ET Q q 0 0 0 rg BT 199.74 413.25 Td (pr) Tj ET Q q 0 0 0 rg BT 208.26 413.25 Td (etax ) Tj ET Q q 0 0 0 rg BT 227.21 413.25 Td (income, ) Tj ET Q q 0 0 0 rg BT 260.88 413.25 Td (including ) Tj ET Q q 0 0 0 rg BT 300.95 413.25 Td (r) Tj ET Q q 0 0 0 rg BT 304.47 413.25 Td (oyalties ) Tj ET Q q 0 0 0 rg BT 337.87 413.25 Td (r) Tj ET Q q 0 0 0 rg BT 341.39 413.25 Td (elated ) Tj ET Q q 0 0 0 rg BT 368.12 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 378.19 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 392.70 413.25 Td (divestitur) Tj ET Q q 0 0 0 rg BT 430.11 413.25 Td (e ) Tj ET Q q 0 0 0 rg BT 436.84 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 446.91 413.25 Td (our ) Tj ET Q q 0 0 0 rg BT 463.10 413.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 498.72 413.25 Td (business ) Tj ET Q q 0 0 0 rg BT 534.91 413.25 Td (\(including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.10 401.25 Td (transfer ) Tj ET Q q 0 0 0 rg BT 85.65 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 96.31 401.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 127.52 401.25 Td (futur) Tj ET Q q 0 0 0 rg BT 146.60 401.25 Td (e ) Tj ET Q q 0 0 0 rg BT 153.92 401.25 Td (r) Tj ET Q q 0 0 0 rg BT 157.44 401.25 Td (oyalty ) Tj ET Q q 0 0 0 rg BT 184.75 401.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 210.98 401.25 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 255.52 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 265.98 401.25 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 297.18 401.25 Td (pr) Tj ET Q q 0 0 0 rg BT 305.70 401.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 330.80 401.25 Td (sales\), ) Tj ET Q q 0 0 0 rg BT 359.52 401.25 Td (our ) Tj ET Q q 0 0 0 rg BT 376.29 401.25 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 404.73 401.25 Td (alliance,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.44 401.25 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 442.32 401.25 Td (out-licensed ) Tj ET Q q 0 0 0 rg BT 494.08 401.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 541.94 401.25 Td (pr) Tj ET Q q 0 0 0 rg BT 550.46 401.25 Td (operty ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.04 389.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 97.29 389.25 Td (pr) Tj ET Q q 0 0 0 rg BT 105.81 389.25 Td (oceeds ) Tj ET Q q 0 0 0 rg BT 135.05 389.25 Td (r) Tj ET Q q 0 0 0 rg BT 138.57 389.25 Td (esulting ) Tj ET Q q 0 0 0 rg BT 172.28 389.25 Td (fr) Tj ET Q q 0 0 0 rg BT 178.57 389.25 Td (om ) Tj ET Q q 0 0 0 rg BT 192.83 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 207.09 389.25 Td (Erbitux* ) Tj ET Q q 0 0 0 rg BT 244.12 389.25 Td (businesses. Pr) Tj ET Q q 0 0 0 rg BT 300.97 389.25 Td (etax ) Tj ET Q q 0 0 0 rg BT 319.66 389.25 Td (income ) Tj ET Q q 0 0 0 rg BT 350.58 389.25 Td (generated ) Tj ET Q q 0 0 0 rg BT 392.60 389.25 Td (fr) Tj ET Q q 0 0 0 rg BT 398.90 389.25 Td (om ) Tj ET Q q 0 0 0 rg BT 413.16 389.25 Td (r) Tj ET Q q 0 0 0 rg BT 416.68 389.25 Td (oyalties ) Tj ET Q q 0 0 0 rg BT 449.82 389.25 Td (wer) Tj ET Q q 0 0 0 rg BT 464.45 389.25 Td (e ) Tj ET Q q 0 0 0 rg BT 470.93 389.25 Td (appr) Tj ET Q q 0 0 0 rg BT 489.45 389.25 Td (oximately ) Tj ET Q q 0 0 0 rg BT 530.36 389.25 Td ($1.0 ) Tj ET Q q 0 0 0 rg BT 549.89 389.25 Td (billion ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 377.25 Td (2016. Our ) Tj ET Q q 0 0 0 rg BT 89.89 377.25 Td (pr) Tj ET Q q 0 0 0 rg BT 98.41 377.25 Td (etax ) Tj ET Q q 0 0 0 rg BT 117.57 377.25 Td (income ) Tj ET Q q 0 0 0 rg BT 148.94 377.25 Td (could ) Tj ET Q q 0 0 0 rg BT 173.66 377.25 Td (be ) Tj ET Q q 0 0 0 rg BT 185.60 377.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 226.42 377.25 Td (affected ) Tj ET Q q 0 0 0 rg BT 260.57 377.25 Td (if ) Tj ET Q q 0 0 0 rg BT 268.62 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 283.34 377.25 Td (r) Tj ET Q q 0 0 0 rg BT 286.86 377.25 Td (oyalty ) Tj ET Q q 0 0 0 rg BT 313.79 377.25 Td (str) Tj ET Q q 0 0 0 rg BT 323.98 377.25 Td (eams ) Tj ET Q q 0 0 0 rg BT 347.04 377.25 Td (decline ) Tj ET Q q 0 0 0 rg BT 378.41 377.25 Td (in ) Tj ET Q q 0 0 0 rg BT 388.69 377.25 Td (futur) Tj ET Q q 0 0 0 rg BT 407.76 377.25 Td (e ) Tj ET Q q 0 0 0 rg BT 414.70 377.25 Td (periods.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (Failure ) Tj ET Q q 0 0 0 rg BT 69.62 353.25 Td (to ) Tj ET Q q 0 0 0 rg BT 79.90 353.25 Td (execute ) Tj ET Q q 0 0 0 rg BT 113.49 353.25 Td (our ) Tj ET Q q 0 0 0 rg BT 130.44 353.25 Td (business ) Tj ET Q q 0 0 0 rg BT 167.96 353.25 Td (strategy ) Tj ET Q q 0 0 0 rg BT 202.67 353.25 Td (could ) Tj ET Q q 0 0 0 rg BT 227.95 353.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 268.77 353.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 299.04 353.25 Td (our ) Tj ET Q q 0 0 0 rg BT 316.00 353.25 Td (growth ) Tj ET Q q 0 0 0 rg BT 347.40 353.25 Td (and ) Tj ET Q q 0 0 0 rg BT 365.46 353.25 Td (profitability) Tj ET Q q 0 0 0 rg BT 413.42 353.25 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.36 341.25 Td (strategy ) Tj ET Q q 0 0 0 rg BT 88.83 341.25 Td (is ) Tj ET Q q 0 0 0 rg BT 97.74 341.25 Td (focused ) Tj ET Q q 0 0 0 rg BT 130.54 341.25 Td (on ) Tj ET Q q 0 0 0 rg BT 142.78 341.25 Td (delivering ) Tj ET Q q 0 0 0 rg BT 185.57 341.25 Td (innovative, ) Tj ET Q q 0 0 0 rg BT 231.97 341.25 Td (transformational ) Tj ET Q q 0 0 0 rg BT 302.01 341.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 344.24 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 354.27 341.25 Td (patients. ) Tj ET Q q 0 0 0 rg BT 390.68 341.25 Td (If ) Tj ET Q q 0 0 0 rg BT 399.04 341.25 Td (we ) Tj ET Q q 0 0 0 rg BT 412.39 341.25 Td (ar) Tj ET Q q 0 0 0 rg BT 420.91 341.25 Td (e ) Tj ET Q q 0 0 0 rg BT 427.60 341.25 Td (unable ) Tj ET Q q 0 0 0 rg BT 457.06 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 467.09 341.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 517.10 341.25 Td (execute ) Tj ET Q q 0 0 0 rg BT 549.32 341.25 Td (on ) Tj ET Q q 0 0 0 rg BT 561.56 341.25 Td (this ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (strategy) Tj ET Q q 0 0 0 rg BT 67.67 329.25 Td (, ) Tj ET Q q 0 0 0 rg BT 73.34 329.25 Td (this ) Tj ET Q q 0 0 0 rg BT 90.97 329.25 Td (could ) Tj ET Q q 0 0 0 rg BT 116.36 329.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 160.63 329.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 191.02 329.25 Td (our ) Tj ET Q q 0 0 0 rg BT 208.09 329.25 Td (futur) Tj ET Q q 0 0 0 rg BT 227.17 329.25 Td (e ) Tj ET Q q 0 0 0 rg BT 234.79 329.25 Td (r) Tj ET Q q 0 0 0 rg BT 238.31 329.25 Td (esults ) Tj ET Q q 0 0 0 rg BT 264.26 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 275.22 329.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 321.18 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 339.35 329.25 Td (market ) Tj ET Q q 0 0 0 rg BT 370.30 329.25 Td (capitalization. ) Tj ET Q q 0 0 0 rg BT 430.98 329.25 Td (In ) Tj ET Q q 0 0 0 rg BT 442.49 329.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 489.54 329.25 Td (with ) Tj ET Q q 0 0 0 rg BT 509.94 329.25 Td (this ) Tj ET Q q 0 0 0 rg BT 527.57 329.25 Td (strategy) Tj ET Q q 0 0 0 rg BT 559.23 329.25 Td (, ) Tj ET Q q 0 0 0 rg BT 564.91 329.25 Td (we ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 317.25 Td (ecently ) Tj ET Q q 0 0 0 rg BT 71.00 317.25 Td (announced ) Tj ET Q q 0 0 0 rg BT 118.04 317.25 Td (an ) Tj ET Q q 0 0 0 rg BT 131.20 317.25 Td (evolution ) Tj ET Q q 0 0 0 rg BT 171.58 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 182.52 317.25 Td (our ) Tj ET Q q 0 0 0 rg BT 199.57 317.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 241.63 317.25 Td (model ) Tj ET Q q 0 0 0 rg BT 269.23 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 280.17 317.25 Td (focus ) Tj ET Q q 0 0 0 rg BT 304.44 317.25 Td (on ) Tj ET Q q 0 0 0 rg BT 317.61 317.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 363.53 317.25 Td (in ) Tj ET Q q 0 0 0 rg BT 374.48 317.25 Td (commer) Tj ET Q q 0 0 0 rg BT 406.32 317.25 Td (cial ) Tj ET Q q 0 0 0 rg BT 424.48 317.25 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 480.98 317.25 Td (against ) Tj ET Q q 0 0 0 rg BT 513.59 317.25 Td (key ) Tj ET Q q 0 0 0 rg BT 530.07 317.25 Td (brands ) Tj ET Q q 0 0 0 rg BT 561.01 317.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (markets, ) Tj ET Q q 0 0 0 rg BT 71.73 305.25 Td (accelerate ) Tj ET Q q 0 0 0 rg BT 114.95 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 128.74 305.25 Td (pipeline, ) Tj ET Q q 0 0 0 rg BT 165.02 305.25 Td (str) Tj ET Q q 0 0 0 rg BT 175.21 305.25 Td (eamline ) Tj ET Q q 0 0 0 rg BT 208.44 305.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 252.80 305.25 Td (and ) Tj ET Q q 0 0 0 rg BT 269.37 305.25 Td (r) Tj ET Q q 0 0 0 rg BT 272.89 305.25 Td (ealign ) Tj ET Q q 0 0 0 rg BT 299.46 305.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 359.92 305.25 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 408.15 305.25 Td (that ) Tj ET Q q 0 0 0 rg BT 425.28 305.25 Td (br) Tj ET Q q 0 0 0 rg BT 433.80 305.25 Td (oaden ) Tj ET Q q 0 0 0 rg BT 459.82 305.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 498.06 305.25 Td (capabilities, ) Tj ET Q q 0 0 0 rg BT 548.79 305.25 Td (among ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.38 293.25 Td (things. ) Tj ET Q q 0 0 0 rg BT 88.61 293.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 107.00 293.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 134.82 293.25 Td (to ) Tj ET Q q 0 0 0 rg BT 144.88 293.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 194.92 293.25 Td (execute ) Tj ET Q q 0 0 0 rg BT 227.16 293.25 Td (our ) Tj ET Q q 0 0 0 rg BT 243.33 293.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 284.49 293.25 Td (model ) Tj ET Q q 0 0 0 rg BT 311.21 293.25 Td (evolution ) Tj ET Q q 0 0 0 rg BT 350.69 293.25 Td (could ) Tj ET Q q 0 0 0 rg BT 375.18 293.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 404.68 293.25 Td (our ) Tj ET Q q 0 0 0 rg BT 420.84 293.25 Td (r) Tj ET Q q 0 0 0 rg BT 424.36 293.25 Td (esults. ) Tj ET Q q 0 0 0 rg BT 451.92 293.25 Td (For ) Tj ET Q q 0 0 0 rg BT 469.19 293.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 507.28 293.25 Td (if ) Tj ET Q q 0 0 0 rg BT 515.12 293.25 Td (we ) Tj ET Q q 0 0 0 rg BT 528.50 293.25 Td (ar) Tj ET Q q 0 0 0 rg BT 537.02 293.25 Td (e ) Tj ET Q q 0 0 0 rg BT 543.73 293.25 Td (not ) Tj ET Q q 0 0 0 rg BT 558.79 293.25 Td (able ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (to ) Tj ET Q q 0 0 0 rg BT 46.37 281.25 Td (achieve ) Tj ET Q q 0 0 0 rg BT 79.50 281.25 Td (the ) Tj ET Q q 0 0 0 rg BT 94.31 281.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 113.01 281.25 Td (savings ) Tj ET Q q 0 0 0 rg BT 145.60 281.25 Td (we ) Tj ET Q q 0 0 0 rg BT 159.30 281.25 Td (expect, ) Tj ET Q q 0 0 0 rg BT 189.93 281.25 Td (this ) Tj ET Q q 0 0 0 rg BT 206.97 281.25 Td (could ) Tj ET Q q 0 0 0 rg BT 231.78 281.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 275.46 281.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 305.27 281.25 Td (our ) Tj ET Q q 0 0 0 rg BT 321.75 281.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 363.23 281.25 Td (mar) Tj ET Q q 0 0 0 rg BT 378.97 281.25 Td (gin ) Tj ET Q q 0 0 0 rg BT 394.34 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 411.94 281.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 449.53 281.25 Td (r) Tj ET Q q 0 0 0 rg BT 453.05 281.25 Td (esults. ) Tj ET Q q 0 0 0 rg BT 480.92 281.25 Td (In ) Tj ET Q q 0 0 0 rg BT 491.84 281.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 530.27 281.25 Td (we ) Tj ET Q q 0 0 0 rg BT 543.97 281.25 Td (may ) Tj ET Q q 0 0 0 rg BT 563.23 281.25 Td (not ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 269.25 Td (be ) Tj ET Q q 0 0 0 rg BT 48.47 269.25 Td (able ) Tj ET Q q 0 0 0 rg BT 68.72 269.25 Td (to ) Tj ET Q q 0 0 0 rg BT 79.53 269.25 Td (consistently ) Tj ET Q q 0 0 0 rg BT 129.77 269.25 Td (maintain ) Tj ET Q q 0 0 0 rg BT 168.36 269.25 Td (a ) Tj ET Q q 0 0 0 rg BT 176.40 269.25 Td (rich ) Tj ET Q q 0 0 0 rg BT 195.54 269.25 Td (pipeline, ) Tj ET Q q 0 0 0 rg BT 233.28 269.25 Td (thr) Tj ET Q q 0 0 0 rg BT 244.58 269.25 Td (ough ) Tj ET Q q 0 0 0 rg BT 267.61 269.25 Td (internal ) Tj ET Q q 0 0 0 rg BT 302.31 269.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 326.45 269.25 Td (pr) Tj ET Q q 0 0 0 rg BT 334.97 269.25 Td (ograms ) Tj ET Q q 0 0 0 rg BT 368.01 269.25 Td (or ) Tj ET Q q 0 0 0 rg BT 379.93 269.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 432.41 269.25 Td (with ) Tj ET Q q 0 0 0 rg BT 452.67 269.25 Td (thir) Tj ET Q q 0 0 0 rg BT 466.75 269.25 Td (d ) Tj ET Q q 0 0 0 rg BT 474.78 269.25 Td (parties, ) Tj ET Q q 0 0 0 rg BT 508.09 269.25 Td (to ) Tj ET Q q 0 0 0 rg BT 518.90 269.25 Td (support ) Tj ET Q q 0 0 0 rg BT 552.49 269.25 Td (futur) Tj ET Q q 0 0 0 rg BT 571.57 269.25 Td (e ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 257.25 Td (evenue ) Tj ET Q q 0 0 0 rg BT 70.02 257.25 Td (gr) Tj ET Q q 0 0 0 rg BT 78.54 257.25 Td (owth. ) Tj ET Q q 0 0 0 rg BT 103.23 257.25 Td (Competition ) Tj ET Q q 0 0 0 rg BT 155.42 257.25 Td (among ) Tj ET Q q 0 0 0 rg BT 185.39 257.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 250.90 257.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 296.41 257.25 Td (for ) Tj ET Q q 0 0 0 rg BT 310.83 257.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 358.02 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 375.76 257.25 Td (pr) Tj ET Q q 0 0 0 rg BT 384.28 257.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 409.25 257.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 448.10 257.25 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 504.18 257.25 Td (is ) Tj ET Q q 0 0 0 rg BT 513.59 257.25 Td (intense, ) Tj ET Q q 0 0 0 rg BT 547.16 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 564.91 257.25 Td (we ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (may ) Tj ET Q q 0 0 0 rg BT 54.43 245.25 Td (not ) Tj ET Q q 0 0 0 rg BT 68.98 245.25 Td (be ) Tj ET Q q 0 0 0 rg BT 80.18 245.25 Td (able ) Tj ET Q q 0 0 0 rg BT 99.17 245.25 Td (to ) Tj ET Q q 0 0 0 rg BT 108.72 245.25 Td (locate ) Tj ET Q q 0 0 0 rg BT 134.92 245.25 Td (suitable ) Tj ET Q q 0 0 0 rg BT 168.35 245.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 214.57 245.25 Td (tar) Tj ET Q q 0 0 0 rg BT 225.87 245.25 Td (gets ) Tj ET Q q 0 0 0 rg BT 243.74 245.25 Td (or ) Tj ET Q q 0 0 0 rg BT 254.40 245.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 292.28 245.25 Td (partners ) Tj ET Q q 0 0 0 rg BT 327.94 245.25 Td (at ) Tj ET Q q 0 0 0 rg BT 337.48 245.25 Td (r) Tj ET Q q 0 0 0 rg BT 341.00 245.25 Td (easonable ) Tj ET Q q 0 0 0 rg BT 383.32 245.25 Td (prices, ) Tj ET Q q 0 0 0 rg BT 412.03 245.25 Td (or ) Tj ET Q q 0 0 0 rg BT 422.69 245.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 472.22 245.25 Td (execute ) Tj ET Q q 0 0 0 rg BT 503.96 245.25 Td (such ) Tj ET Q q 0 0 0 rg BT 524.06 245.25 Td (transactions. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (If ) Tj ET Q q 0 0 0 rg BT 44.23 233.25 Td (we ) Tj ET Q q 0 0 0 rg BT 57.47 233.25 Td (ar) Tj ET Q q 0 0 0 rg BT 65.99 233.25 Td (e ) Tj ET Q q 0 0 0 rg BT 72.56 233.25 Td (unable ) Tj ET Q q 0 0 0 rg BT 101.90 233.25 Td (to ) Tj ET Q q 0 0 0 rg BT 111.80 233.25 Td (support ) Tj ET Q q 0 0 0 rg BT 144.49 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 161.62 233.25 Td (gr) Tj ET Q q 0 0 0 rg BT 170.14 233.25 Td (ow ) Tj ET Q q 0 0 0 rg BT 183.93 233.25 Td (our ) Tj ET Q q 0 0 0 rg BT 199.95 233.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 239.29 233.25 Td (pr) Tj ET Q q 0 0 0 rg BT 247.81 233.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 278.54 233.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 328.43 233.25 Td (execute ) Tj ET Q q 0 0 0 rg BT 360.53 233.25 Td (the ) Tj ET Q q 0 0 0 rg BT 374.87 233.25 Td (launches ) Tj ET Q q 0 0 0 rg BT 412.55 233.25 Td (of ) Tj ET Q q 0 0 0 rg BT 422.45 233.25 Td (newly ) Tj ET Q q 0 0 0 rg BT 447.90 233.25 Td (appr) Tj ET Q q 0 0 0 rg BT 466.42 233.25 Td (oved ) Tj ET Q q 0 0 0 rg BT 487.43 233.25 Td (pr) Tj ET Q q 0 0 0 rg BT 495.95 233.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 526.68 233.25 Td (advance ) Tj ET Q q 0 0 0 rg BT 562.12 233.25 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 221.25 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 78.30 221.25 Td (pipeline, ) Tj ET Q q 0 0 0 rg BT 115.89 221.25 Td (manage ) Tj ET Q q 0 0 0 rg BT 150.42 221.25 Td (change ) Tj ET Q q 0 0 0 rg BT 182.16 221.25 Td (and ) Tj ET Q q 0 0 0 rg BT 200.03 221.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 241.79 221.25 Td (model ) Tj ET Q q 0 0 0 rg BT 269.10 221.25 Td (evolution ) Tj ET Q q 0 0 0 rg BT 309.18 221.25 Td (issues ) Tj ET Q q 0 0 0 rg BT 335.94 221.25 Td (and ) Tj ET Q q 0 0 0 rg BT 353.81 221.25 Td (manage ) Tj ET Q q 0 0 0 rg BT 388.34 221.25 Td (our ) Tj ET Q q 0 0 0 rg BT 405.10 221.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 427.97 221.25 Td (effectively) Tj ET Q q 0 0 0 rg BT 467.95 221.25 Td (, ) Tj ET Q q 0 0 0 rg BT 473.32 221.25 Td (our ) Tj ET Q q 0 0 0 rg BT 490.08 221.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 531.83 221.25 Td (r) Tj ET Q q 0 0 0 rg BT 535.35 221.25 Td (esults ) Tj ET Q q 0 0 0 rg BT 561.00 221.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 74.05 209.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 114.33 209.25 Td (could ) Tj ET Q q 0 0 0 rg BT 139.04 209.25 Td (be ) Tj ET Q q 0 0 0 rg BT 150.98 209.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 194.57 209.25 Td (impacted. ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (Failure ) Tj ET Q q 0 0 0 rg BT 69.62 185.25 Td (to ) Tj ET Q q 0 0 0 rg BT 79.90 185.25 Td (attract ) Tj ET Q q 0 0 0 rg BT 109.06 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 127.12 185.25 Td (retain ) Tj ET Q q 0 0 0 rg BT 154.07 185.25 Td (highly ) Tj ET Q q 0 0 0 rg BT 182.69 185.25 Td (qualified ) Tj ET Q q 0 0 0 rg BT 221.85 185.25 Td (personnel ) Tj ET Q q 0 0 0 rg BT 264.92 185.25 Td (could ) Tj ET Q q 0 0 0 rg BT 290.19 185.25 Td (af) Tj ET Q q 0 0 0 rg BT 298.34 185.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 315.83 185.25 Td (our ) Tj ET Q q 0 0 0 rg BT 332.78 185.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 360.83 185.25 Td (to ) Tj ET Q q 0 0 0 rg BT 371.11 185.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 423.05 185.25 Td (develop ) Tj ET Q q 0 0 0 rg BT 456.64 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 474.71 185.25 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 536.63 185.25 Td (products.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 55.14 173.25 Td (success ) Tj ET Q q 0 0 0 rg BT 88.15 173.25 Td (is ) Tj ET Q q 0 0 0 rg BT 97.85 173.25 Td (lar) Tj ET Q q 0 0 0 rg BT 109.15 173.25 Td (gely ) Tj ET Q q 0 0 0 rg BT 128.83 173.25 Td (dependent ) Tj ET Q q 0 0 0 rg BT 172.95 173.25 Td (on ) Tj ET Q q 0 0 0 rg BT 185.97 173.25 Td (our ) Tj ET Q q 0 0 0 rg BT 202.89 173.25 Td (continued ) Tj ET Q q 0 0 0 rg BT 245.35 173.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 273.92 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 284.73 173.25 Td (attract ) Tj ET Q q 0 0 0 rg BT 314.42 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 332.44 173.25 Td (r) Tj ET Q q 0 0 0 rg BT 335.96 173.25 Td (etain ) Tj ET Q q 0 0 0 rg BT 358.98 173.25 Td (highly ) Tj ET Q q 0 0 0 rg BT 387.00 173.25 Td (qualified ) Tj ET Q q 0 0 0 rg BT 425.58 173.25 Td (scientific, ) Tj ET Q q 0 0 0 rg BT 467.20 173.25 Td (technical ) Tj ET Q q 0 0 0 rg BT 506.88 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 524.90 173.25 Td (management ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (personnel, ) Tj ET Q q 0 0 0 rg BT 79.50 161.25 Td (as ) Tj ET Q q 0 0 0 rg BT 89.95 161.25 Td (well ) Tj ET Q q 0 0 0 rg BT 108.18 161.25 Td (as ) Tj ET Q q 0 0 0 rg BT 118.63 161.25 Td (personnel ) Tj ET Q q 0 0 0 rg BT 159.63 161.25 Td (with ) Tj ET Q q 0 0 0 rg BT 178.42 161.25 Td (expertise ) Tj ET Q q 0 0 0 rg BT 216.08 161.25 Td (in ) Tj ET Q q 0 0 0 rg BT 225.42 161.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 256.97 161.25 Td (R&D, ) Tj ET Q q 0 0 0 rg BT 282.14 161.25 Td (governmental ) Tj ET Q q 0 0 0 rg BT 338.68 161.25 Td (r) Tj ET Q q 0 0 0 rg BT 342.21 161.25 Td (egulation ) Tj ET Q q 0 0 0 rg BT 381.54 161.25 Td (and ) Tj ET Q q 0 0 0 rg BT 398.10 161.25 Td (commer) Tj ET Q q 0 0 0 rg BT 429.94 161.25 Td (cialization. ) Tj ET Q q 0 0 0 rg BT 476.23 161.25 Td (Competition ) Tj ET Q q 0 0 0 rg BT 527.23 161.25 Td (for ) Tj ET Q q 0 0 0 rg BT 540.46 161.25 Td (qualified ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (personnel ) Tj ET Q q 0 0 0 rg BT 77.68 149.25 Td (in ) Tj ET Q q 0 0 0 rg BT 87.69 149.25 Td (the ) Tj ET Q q 0 0 0 rg BT 102.15 149.25 Td (biopharmaceutical ) Tj ET Q q 0 0 0 rg BT 179.93 149.25 Td (field ) Tj ET Q q 0 0 0 rg BT 199.94 149.25 Td (is ) Tj ET Q q 0 0 0 rg BT 208.85 149.25 Td (intense. ) Tj ET Q q 0 0 0 rg BT 241.91 149.25 Td (W) Tj ET Q q 0 0 0 rg BT 249.32 149.25 Td (e ) Tj ET Q q 0 0 0 rg BT 256.00 149.25 Td (cannot ) Tj ET Q q 0 0 0 rg BT 285.45 149.25 Td (be ) Tj ET Q q 0 0 0 rg BT 297.13 149.25 Td (sur) Tj ET Q q 0 0 0 rg BT 309.54 149.25 Td (e ) Tj ET Q q 0 0 0 rg BT 316.22 149.25 Td (that ) Tj ET Q q 0 0 0 rg BT 334.01 149.25 Td (we ) Tj ET Q q 0 0 0 rg BT 347.36 149.25 Td (will ) Tj ET Q q 0 0 0 rg BT 364.60 149.25 Td (be ) Tj ET Q q 0 0 0 rg BT 376.28 149.25 Td (able ) Tj ET Q q 0 0 0 rg BT 395.73 149.25 Td (to ) Tj ET Q q 0 0 0 rg BT 405.75 149.25 Td (attract ) Tj ET Q q 0 0 0 rg BT 434.65 149.25 Td (and ) Tj ET Q q 0 0 0 rg BT 451.89 149.25 Td (r) Tj ET Q q 0 0 0 rg BT 455.41 149.25 Td (etain ) Tj ET Q q 0 0 0 rg BT 477.64 149.25 Td (quality ) Tj ET Q q 0 0 0 rg BT 507.65 149.25 Td (personnel ) Tj ET Q q 0 0 0 rg BT 549.33 149.25 Td (or ) Tj ET Q q 0 0 0 rg BT 560.46 149.25 Td (that ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 137.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 137.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 73.22 137.25 Td (of ) Tj ET Q q 0 0 0 rg BT 83.50 137.25 Td (doing ) Tj ET Q q 0 0 0 rg BT 108.77 137.25 Td (so ) Tj ET Q q 0 0 0 rg BT 120.17 137.25 Td (will ) Tj ET Q q 0 0 0 rg BT 137.67 137.25 Td (not ) Tj ET Q q 0 0 0 rg BT 152.95 137.25 Td (materially ) Tj ET Q q 0 0 0 rg BT 196.55 137.25 Td (incr) Tj ET Q q 0 0 0 rg BT 212.29 137.25 Td (ease.) Tj ET Q endstream endobj 43 0 obj <> endobj 44 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (21) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Any ) Tj ET Q q 0 0 0 rg BT 55.03 749.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 100.73 749.25 Td (or ) Tj ET Q q 0 0 0 rg BT 111.99 749.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 138.24 749.25 Td (we ) Tj ET Q q 0 0 0 rg BT 151.71 749.25 Td (acquire ) Tj ET Q q 0 0 0 rg BT 185.17 749.25 Td (in ) Tj ET Q q 0 0 0 rg BT 195.87 749.25 Td (the ) Tj ET Q q 0 0 0 rg BT 211.01 749.25 Td (future ) Tj ET Q q 0 0 0 rg BT 238.93 749.25 Td (may ) Tj ET Q q 0 0 0 rg BT 258.51 749.25 Td (underperform, ) Tj ET Q q 0 0 0 rg BT 321.15 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 339.07 749.25 Td (we ) Tj ET Q q 0 0 0 rg BT 352.54 749.25 Td (may ) Tj ET Q q 0 0 0 rg BT 372.12 749.25 Td (not ) Tj ET Q q 0 0 0 rg BT 387.82 749.25 Td (be ) Tj ET Q q 0 0 0 rg BT 399.62 749.25 Td (able ) Tj ET Q q 0 0 0 rg BT 419.19 749.25 Td (to ) Tj ET Q q 0 0 0 rg BT 429.33 749.25 Td (successfully ) Tj ET Q q 0 0 0 rg BT 481.13 749.25 Td (integrate ) Tj ET Q q 0 0 0 rg BT 520.16 749.25 Td (them ) Tj ET Q q 0 0 0 rg BT 543.07 749.25 Td (into ) Tj ET Q q 0 0 0 rg BT 561.55 749.25 Td (our ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 737.25 Td (existing ) Tj ET Q q 0 0 0 rg BT 70.73 737.25 Td (business.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 725.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.00 725.25 Td (may ) Tj ET Q q 0 0 0 rg BT 70.81 725.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 108.40 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 119.33 725.25 Td (support ) Tj ET Q q 0 0 0 rg BT 153.04 725.25 Td (our ) Tj ET Q q 0 0 0 rg BT 170.09 725.25 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 205.45 725.25 Td (with ) Tj ET Q q 0 0 0 rg BT 225.83 725.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 274.53 725.25 Td (or ) Tj ET Q q 0 0 0 rg BT 286.58 725.25 Td (pr) Tj ET Q q 0 0 0 rg BT 295.10 725.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 324.36 725.25 Td (obtained ) Tj ET Q q 0 0 0 rg BT 362.50 725.25 Td (thr) Tj ET Q q 0 0 0 rg BT 373.80 725.25 Td (ough ) Tj ET Q q 0 0 0 rg BT 396.95 725.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 436.21 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 454.36 725.25 Td (acquisitions. ) Tj ET Q q 0 0 0 rg BT 508.35 725.25 Td (Futur) Tj ET Q q 0 0 0 rg BT 530.76 725.25 Td (e ) Tj ET Q q 0 0 0 rg BT 538.35 725.25 Td (r) Tj ET Q q 0 0 0 rg BT 541.87 725.25 Td (evenues, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 713.25 Td (ofits ) Tj ET Q q 0 0 0 rg BT 63.53 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 80.32 713.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 100.44 713.25 Td (flows ) Tj ET Q q 0 0 0 rg BT 123.34 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 132.91 713.25 Td (an ) Tj ET Q q 0 0 0 rg BT 144.70 713.25 Td (acquir) Tj ET Q q 0 0 0 rg BT 170.43 713.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 181.66 713.25 Td (company’) Tj ET Q q 0 0 0 rg BT 219.80 713.25 Td (s ) Tj ET Q q 0 0 0 rg BT 225.48 713.25 Td (pr) Tj ET Q q 0 0 0 rg BT 234.00 713.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 264.39 713.25 Td (technologies ) Tj ET Q q 0 0 0 rg BT 316.72 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 333.51 713.25 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 367.51 713.25 Td (candidates, ) Tj ET Q q 0 0 0 rg BT 415.12 713.25 Td (may ) Tj ET Q q 0 0 0 rg BT 433.57 713.25 Td (not ) Tj ET Q q 0 0 0 rg BT 448.13 713.25 Td (materialize ) Tj ET Q q 0 0 0 rg BT 494.92 713.25 Td (due ) Tj ET Q q 0 0 0 rg BT 511.14 713.25 Td (to ) Tj ET Q q 0 0 0 rg BT 520.71 713.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 545.27 713.25 Td (pr) Tj ET Q q 0 0 0 rg BT 553.79 713.25 Td (oduct ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (uptake, ) Tj ET Q q 0 0 0 rg BT 68.29 701.25 Td (delayed ) Tj ET Q q 0 0 0 rg BT 102.53 701.25 Td (or ) Tj ET Q q 0 0 0 rg BT 114.56 701.25 Td (missed ) Tj ET Q q 0 0 0 rg BT 144.92 701.25 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 180.27 701.25 Td (opportunities, ) Tj ET Q q 0 0 0 rg BT 239.24 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 254.60 701.25 Td (inability ) Tj ET Q q 0 0 0 rg BT 291.07 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 301.98 701.25 Td (captur) Tj ET Q q 0 0 0 rg BT 327.72 701.25 Td (e ) Tj ET Q q 0 0 0 rg BT 335.30 701.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 373.41 701.25 Td (syner) Tj ET Q q 0 0 0 rg BT 394.70 701.25 Td (gies, ) Tj ET Q q 0 0 0 rg BT 416.44 701.25 Td (incr) Tj ET Q q 0 0 0 rg BT 432.18 701.25 Td (eased ) Tj ET Q q 0 0 0 rg BT 458.09 701.25 Td (competition, ) Tj ET Q q 0 0 0 rg BT 510.94 701.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 537.40 701.25 Td (concerns, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 689.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 80.16 689.25 Td (issues, ) Tj ET Q q 0 0 0 rg BT 108.86 689.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 137.28 689.25 Td (chain ) Tj ET Q q 0 0 0 rg BT 161.81 689.25 Td (pr) Tj ET Q q 0 0 0 rg BT 170.33 689.25 Td (oblems ) Tj ET Q q 0 0 0 rg BT 200.97 689.25 Td (or ) Tj ET Q q 0 0 0 rg BT 212.18 689.25 Td (other ) Tj ET Q q 0 0 0 rg BT 235.60 689.25 Td (factors ) Tj ET Q q 0 0 0 rg BT 265.69 689.25 Td (beyond ) Tj ET Q q 0 0 0 rg BT 296.88 689.25 Td (our ) Tj ET Q q 0 0 0 rg BT 313.08 689.25 Td (contr) Tj ET Q q 0 0 0 rg BT 333.82 689.25 Td (ol. ) Tj ET Q q 0 0 0 rg BT 346.41 689.25 Td (Substantial ) Tj ET Q q 0 0 0 rg BT 393.72 689.25 Td (difficulties, ) Tj ET Q q 0 0 0 rg BT 440.75 689.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 463.07 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 480.38 689.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 508.24 689.25 Td (could ) Tj ET Q q 0 0 0 rg BT 532.77 689.25 Td (r) Tj ET Q q 0 0 0 rg BT 536.29 689.25 Td (esult ) Tj ET Q q 0 0 0 rg BT 557.48 689.25 Td (fr) Tj ET Q q 0 0 0 rg BT 563.78 689.25 Td (om ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (integrating ) Tj ET Q q 0 0 0 rg BT 82.16 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 97.77 677.25 Td (acquisitions, ) Tj ET Q q 0 0 0 rg BT 150.33 677.25 Td (including ) Tj ET Q q 0 0 0 rg BT 189.82 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 203.21 677.25 Td (\(i\) R&D, ) Tj ET Q q 0 0 0 rg BT 240.47 677.25 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 303.58 677.25 Td (distribution, ) Tj ET Q q 0 0 0 rg BT 354.47 677.25 Td (sales, ) Tj ET Q q 0 0 0 rg BT 378.69 677.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 423.46 677.25 Td (pr) Tj ET Q q 0 0 0 rg BT 431.98 677.25 Td (omotion ) Tj ET Q q 0 0 0 rg BT 466.47 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 483.19 677.25 Td (information ) Tj ET Q q 0 0 0 rg BT 532.14 677.25 Td (technology ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (activities; ) Tj ET Q q 0 0 0 rg BT 78.03 665.25 Td (\(ii\) policies, ) Tj ET Q q 0 0 0 rg BT 128.95 665.25 Td (pr) Tj ET Q q 0 0 0 rg BT 137.47 665.25 Td (ocedur) Tj ET Q q 0 0 0 rg BT 164.87 665.25 Td (es, ) Tj ET Q q 0 0 0 rg BT 178.30 665.25 Td (pr) Tj ET Q q 0 0 0 rg BT 186.83 665.25 Td (ocesses, ) Tj ET Q q 0 0 0 rg BT 221.92 665.25 Td (contr) Tj ET Q q 0 0 0 rg BT 242.66 665.25 Td (ols ) Tj ET Q q 0 0 0 rg BT 256.93 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 274.53 665.25 Td (compliance; ) Tj ET Q q 0 0 0 rg BT 326.56 665.25 Td (\(iii\) company ) Tj ET Q q 0 0 0 rg BT 382.75 665.25 Td (cultur) Tj ET Q q 0 0 0 rg BT 406.27 665.25 Td (es; ) Tj ET Q q 0 0 0 rg BT 420.53 665.25 Td (\(iv\) compensation ) Tj ET Q q 0 0 0 rg BT 495.06 665.25 Td (structur) Tj ET Q q 0 0 0 rg BT 526.36 665.25 Td (es ) Tj ET Q q 0 0 0 rg BT 537.29 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 554.89 665.25 Td (other ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (human ) Tj ET Q q 0 0 0 rg BT 65.72 653.25 Td (r) Tj ET Q q 0 0 0 rg BT 69.24 653.25 Td (esour) Tj ET Q q 0 0 0 rg BT 91.09 653.25 Td (ce ) Tj ET Q q 0 0 0 rg BT 102.47 653.25 Td (activities; ) Tj ET Q q 0 0 0 rg BT 144.40 653.25 Td (and ) Tj ET Q q 0 0 0 rg BT 161.90 653.25 Td (\(v\) tax ) Tj ET Q q 0 0 0 rg BT 190.21 653.25 Td (considerations.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 629.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.09 629.25 Td (could ) Tj ET Q q 0 0 0 rg BT 76.37 629.25 Td (experience ) Tj ET Q q 0 0 0 rg BT 123.29 629.25 Td (dif) Tj ET Q q 0 0 0 rg BT 134.22 629.25 Td (ficulties ) Tj ET Q q 0 0 0 rg BT 169.49 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 187.55 629.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 215.60 629.25 Td (in ) Tj ET Q q 0 0 0 rg BT 226.44 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 241.72 629.25 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 308.96 629.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 359.26 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 377.32 629.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 395.93 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 406.76 629.25 Td (our ) Tj ET Q q 0 0 0 rg BT 423.71 629.25 Td (products.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.96 617.25 Td (pr) Tj ET Q q 0 0 0 rg BT 63.49 617.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 88.55 617.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 117.51 617.25 Td (and ) Tj ET Q q 0 0 0 rg BT 135.37 617.25 Td (r) Tj ET Q q 0 0 0 rg BT 138.89 617.25 Td (elated ) Tj ET Q q 0 0 0 rg BT 166.17 617.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 196.80 617.25 Td (access ) Tj ET Q q 0 0 0 rg BT 225.75 617.25 Td (could ) Tj ET Q q 0 0 0 rg BT 250.81 617.25 Td (be ) Tj ET Q q 0 0 0 rg BT 263.10 617.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 307.04 617.25 Td (impacted ) Tj ET Q q 0 0 0 rg BT 346.55 617.25 Td (by) Tj ET Q q 0 0 0 rg BT 355.44 617.25 Td (, ) Tj ET Q q 0 0 0 rg BT 360.79 617.25 Td (among ) Tj ET Q q 0 0 0 rg BT 390.86 617.25 Td (other ) Tj ET Q q 0 0 0 rg BT 414.82 617.25 Td (things: ) Tj ET Q q 0 0 0 rg BT 445.45 617.25 Td (\(i\) pr) Tj ET Q q 0 0 0 rg BT 465.91 617.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 490.98 617.25 Td (seizur) Tj ET Q q 0 0 0 rg BT 514.50 617.25 Td (es ) Tj ET Q q 0 0 0 rg BT 525.68 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 537.43 617.25 Td (r) Tj ET Q q 0 0 0 rg BT 540.95 617.25 Td (ecalls ) Tj ET Q q 0 0 0 rg BT 567.12 617.25 Td (or ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (for) Tj ET Q q 0 0 0 rg BT 47.30 605.25 Td (ced ) Tj ET Q q 0 0 0 rg BT 63.18 605.25 Td (closings ) Tj ET Q q 0 0 0 rg BT 97.97 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 107.75 605.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 168.64 605.25 Td (plants; ) Tj ET Q q 0 0 0 rg BT 198.43 605.25 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 212.65 605.25 Td (our ) Tj ET Q q 0 0 0 rg BT 228.55 605.25 Td (failur) Tj ET Q q 0 0 0 rg BT 250.40 605.25 Td (e, ) Tj ET Q q 0 0 0 rg BT 259.35 605.25 Td (or ) Tj ET Q q 0 0 0 rg BT 270.24 605.25 Td (the ) Tj ET Q q 0 0 0 rg BT 284.47 605.25 Td (failur) Tj ET Q q 0 0 0 rg BT 306.32 605.25 Td (e ) Tj ET Q q 0 0 0 rg BT 312.77 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 322.55 605.25 Td (any ) Tj ET Q q 0 0 0 rg BT 339.00 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 348.78 605.25 Td (our ) Tj ET Q q 0 0 0 rg BT 364.68 605.25 Td (suppliers, ) Tj ET Q q 0 0 0 rg BT 405.85 605.25 Td (to ) Tj ET Q q 0 0 0 rg BT 415.64 605.25 Td (comply ) Tj ET Q q 0 0 0 rg BT 446.52 605.25 Td (with ) Tj ET Q q 0 0 0 rg BT 465.75 605.25 Td (cGMP) Tj ET Q q 0 0 0 rg BT 491.67 605.25 Td ( ) Tj ET Q q 0 0 0 rg BT 493.68 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 510.68 605.25 Td (other ) Tj ET Q q 0 0 0 rg BT 533.80 605.25 Td (applicable ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 593.25 Td (egulations ) Tj ET Q q 0 0 0 rg BT 85.41 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 98.52 593.25 Td (quality ) Tj ET Q q 0 0 0 rg BT 130.51 593.25 Td (assurance ) Tj ET Q q 0 0 0 rg BT 175.28 593.25 Td (guidelines ) Tj ET Q q 0 0 0 rg BT 220.61 593.25 Td (that ) Tj ET Q q 0 0 0 rg BT 240.38 593.25 Td (could ) Tj ET Q q 0 0 0 rg BT 266.82 593.25 Td (lead ) Tj ET Q q 0 0 0 rg BT 288.26 593.25 Td (to ) Tj ET Q q 0 0 0 rg BT 300.26 593.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 363.36 593.25 Td (shutdowns, ) Tj ET Q q 0 0 0 rg BT 412.31 593.25 Td (pr) Tj ET Q q 0 0 0 rg BT 420.84 593.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 447.27 593.25 Td (shortages ) Tj ET Q q 0 0 0 rg BT 490.38 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 503.50 593.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 533.26 593.25 Td (in ) Tj ET Q q 0 0 0 rg BT 545.26 593.25 Td (pr) Tj ET Q q 0 0 0 rg BT 553.78 593.25 Td (oduct ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (manufacturing; ) Tj ET Q q 0 0 0 rg BT 100.11 581.25 Td (\(iii\) manufacturing, ) Tj ET Q q 0 0 0 rg BT 180.88 581.25 Td (quality ) Tj ET Q q 0 0 0 rg BT 210.54 581.25 Td (assurance/quality ) Tj ET Q q 0 0 0 rg BT 283.53 581.25 Td (contr) Tj ET Q q 0 0 0 rg BT 304.27 581.25 Td (ol, ) Tj ET Q q 0 0 0 rg BT 316.44 581.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 344.44 581.25 Td (pr) Tj ET Q q 0 0 0 rg BT 352.96 581.25 Td (oblems ) Tj ET Q q 0 0 0 rg BT 383.18 581.25 Td (or ) Tj ET Q q 0 0 0 rg BT 393.96 581.25 Td (governmental ) Tj ET Q q 0 0 0 rg BT 450.83 581.25 Td (appr) Tj ET Q q 0 0 0 rg BT 469.35 581.25 Td (oval ) Tj ET Q q 0 0 0 rg BT 488.46 581.25 Td (delays; ) Tj ET Q q 0 0 0 rg BT 519.23 581.25 Td (\(iv\) the ) Tj ET Q q 0 0 0 rg BT 549.71 581.25 Td (failur) Tj ET Q q 0 0 0 rg BT 571.57 581.25 Td (e ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.06 569.25 Td (a ) Tj ET Q q 0 0 0 rg BT 53.34 569.25 Td (sole ) Tj ET Q q 0 0 0 rg BT 71.72 569.25 Td (sour) Tj ET Q q 0 0 0 rg BT 89.14 569.25 Td (ce ) Tj ET Q q 0 0 0 rg BT 100.29 569.25 Td (or ) Tj ET Q q 0 0 0 rg BT 111.46 569.25 Td (single ) Tj ET Q q 0 0 0 rg BT 137.63 569.25 Td (sour) Tj ET Q q 0 0 0 rg BT 155.04 569.25 Td (ce ) Tj ET Q q 0 0 0 rg BT 166.20 569.25 Td (supplier ) Tj ET Q q 0 0 0 rg BT 201.26 569.25 Td (to ) Tj ET Q q 0 0 0 rg BT 211.31 569.25 Td (pr) Tj ET Q q 0 0 0 rg BT 219.83 569.25 Td (ovide ) Tj ET Q q 0 0 0 rg BT 243.77 569.25 Td (us ) Tj ET Q q 0 0 0 rg BT 254.94 569.25 Td (with ) Tj ET Q q 0 0 0 rg BT 274.45 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 288.94 569.25 Td (necessary ) Tj ET Q q 0 0 0 rg BT 330.65 569.25 Td (raw ) Tj ET Q q 0 0 0 rg BT 348.49 569.25 Td (materials, ) Tj ET Q q 0 0 0 rg BT 391.05 569.25 Td (supplies ) Tj ET Q q 0 0 0 rg BT 426.11 569.25 Td (or ) Tj ET Q q 0 0 0 rg BT 437.28 569.25 Td (finished ) Tj ET Q q 0 0 0 rg BT 471.22 569.25 Td (goods ) Tj ET Q q 0 0 0 rg BT 497.39 569.25 Td (within ) Tj ET Q q 0 0 0 rg BT 524.68 569.25 Td (a ) Tj ET Q q 0 0 0 rg BT 531.96 569.25 Td (r) Tj ET Q q 0 0 0 rg BT 535.48 569.25 Td (easonable ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (timeframe ) Tj ET Q q 0 0 0 rg BT 79.43 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 97.30 557.25 Td (with ) Tj ET Q q 0 0 0 rg BT 117.41 557.25 Td (r) Tj ET Q q 0 0 0 rg BT 120.93 557.25 Td (equir) Tj ET Q q 0 0 0 rg BT 141.67 557.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 153.98 557.25 Td (quality; ) Tj ET Q q 0 0 0 rg BT 187.97 557.25 Td (\(v\) the ) Tj ET Q q 0 0 0 rg BT 216.66 557.25 Td (failur) Tj ET Q q 0 0 0 rg BT 238.51 557.25 Td (e ) Tj ET Q q 0 0 0 rg BT 245.83 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 256.49 557.25 Td (a ) Tj ET Q q 0 0 0 rg BT 264.37 557.25 Td (thir) Tj ET Q q 0 0 0 rg BT 278.44 557.25 Td (d-party ) Tj ET Q q 0 0 0 rg BT 310.76 557.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 356.50 557.25 Td (er ) Tj ET Q q 0 0 0 rg BT 367.71 557.25 Td (to ) Tj ET Q q 0 0 0 rg BT 378.36 557.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 407.35 557.25 Td (us ) Tj ET Q q 0 0 0 rg BT 419.12 557.25 Td (with ) Tj ET Q q 0 0 0 rg BT 439.23 557.25 Td (bulk ) Tj ET Q q 0 0 0 rg BT 459.32 557.25 Td (active ) Tj ET Q q 0 0 0 rg BT 486.07 557.25 Td (or ) Tj ET Q q 0 0 0 rg BT 497.84 557.25 Td (finished ) Tj ET Q q 0 0 0 rg BT 532.38 557.25 Td (pr) Tj ET Q q 0 0 0 rg BT 540.90 557.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 566.00 557.25 Td (on ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (time; ) Tj ET Q q 0 0 0 rg BT 58.78 545.25 Td (\(vi\) construction ) Tj ET Q q 0 0 0 rg BT 127.39 545.25 Td (or ) Tj ET Q q 0 0 0 rg BT 138.52 545.25 Td (r) Tj ET Q q 0 0 0 rg BT 142.04 545.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 182.61 545.25 Td (appr) Tj ET Q q 0 0 0 rg BT 201.13 545.25 Td (oval ) Tj ET Q q 0 0 0 rg BT 220.58 545.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 248.37 545.25 Td (for ) Tj ET Q q 0 0 0 rg BT 262.27 545.25 Td (new ) Tj ET Q q 0 0 0 rg BT 280.62 545.25 Td (facilities ) Tj ET Q q 0 0 0 rg BT 317.30 545.25 Td (or ) Tj ET Q q 0 0 0 rg BT 328.43 545.25 Td (the ) Tj ET Q q 0 0 0 rg BT 342.88 545.25 Td (expansion ) Tj ET Q q 0 0 0 rg BT 385.67 545.25 Td (of ) Tj ET Q q 0 0 0 rg BT 395.68 545.25 Td (existing ) Tj ET Q q 0 0 0 rg BT 429.02 545.25 Td (facilities, ) Tj ET Q q 0 0 0 rg BT 468.20 545.25 Td (including ) Tj ET Q q 0 0 0 rg BT 508.21 545.25 Td (those ) Tj ET Q q 0 0 0 rg BT 531.56 545.25 Td (intended ) Tj ET Q q 0 0 0 rg BT 568.23 545.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (support ) Tj ET Q q 0 0 0 rg BT 69.87 533.25 Td (futur) Tj ET Q q 0 0 0 rg BT 88.94 533.25 Td (e ) Tj ET Q q 0 0 0 rg BT 96.69 533.25 Td (demand ) Tj ET Q q 0 0 0 rg BT 131.65 533.25 Td (for ) Tj ET Q q 0 0 0 rg BT 146.63 533.25 Td (our ) Tj ET Q q 0 0 0 rg BT 163.83 533.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 203.80 533.25 Td (pr) Tj ET Q q 0 0 0 rg BT 212.32 533.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 244.23 533.25 Td (such ) Tj ET Q q 0 0 0 rg BT 265.87 533.25 Td (as ) Tj ET Q q 0 0 0 rg BT 278.07 533.25 Td (Opdivo; ) Tj ET Q q 0 0 0 rg BT 314.14 533.25 Td (\(vii\) the ) Tj ET Q q 0 0 0 rg BT 348.82 533.25 Td (failur) Tj ET Q q 0 0 0 rg BT 370.67 533.25 Td (e ) Tj ET Q q 0 0 0 rg BT 378.42 533.25 Td (to ) Tj ET Q q 0 0 0 rg BT 389.50 533.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 411.68 533.25 Td (new ) Tj ET Q q 0 0 0 rg BT 431.10 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 449.40 533.25 Td (emer) Tj ET Q q 0 0 0 rg BT 469.02 533.25 Td (ging ) Tj ET Q q 0 0 0 rg BT 490.11 533.25 Td (r) Tj ET Q q 0 0 0 rg BT 493.63 533.25 Td (egulations ) Tj ET Q q 0 0 0 rg BT 538.60 533.25 Td (r) Tj ET Q q 0 0 0 rg BT 542.12 533.25 Td (equiring ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 521.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 74.07 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 85.29 521.25 Td (be ) Tj ET Q q 0 0 0 rg BT 98.17 521.25 Td (tracked ) Tj ET Q q 0 0 0 rg BT 131.60 521.25 Td (thr) Tj ET Q q 0 0 0 rg BT 142.90 521.25 Td (oughout ) Tj ET Q q 0 0 0 rg BT 179.12 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 194.77 521.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 244.89 521.25 Td (channels ) Tj ET Q q 0 0 0 rg BT 283.88 521.25 Td (using ) Tj ET Q q 0 0 0 rg BT 308.99 521.25 Td (unique ) Tj ET Q q 0 0 0 rg BT 339.65 521.25 Td (identifiers ) Tj ET Q q 0 0 0 rg BT 383.64 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 394.86 521.25 Td (verify ) Tj ET Q q 0 0 0 rg BT 421.07 521.25 Td (their ) Tj ET Q q 0 0 0 rg BT 443.39 521.25 Td (authenticity ) Tj ET Q q 0 0 0 rg BT 494.04 521.25 Td (in ) Tj ET Q q 0 0 0 rg BT 505.26 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 520.92 521.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 550.47 521.25 Td (chain; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (\(viii\) other ) Tj ET Q q 0 0 0 rg BT 80.51 509.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 140.87 509.25 Td (or ) Tj ET Q q 0 0 0 rg BT 151.23 509.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 199.37 509.25 Td (issues, ) Tj ET Q q 0 0 0 rg BT 227.23 509.25 Td (including ) Tj ET Q q 0 0 0 rg BT 266.47 509.25 Td (limits ) Tj ET Q q 0 0 0 rg BT 290.17 509.25 Td (to ) Tj ET Q q 0 0 0 rg BT 299.42 509.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 359.77 509.25 Td (capacity ) Tj ET Q q 0 0 0 rg BT 395.11 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 411.58 509.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 445.82 509.25 Td (in ) Tj ET Q q 0 0 0 rg BT 455.06 509.25 Td (the ) Tj ET Q q 0 0 0 rg BT 468.75 509.25 Td (types ) Tj ET Q q 0 0 0 rg BT 490.77 509.25 Td (of ) Tj ET Q q 0 0 0 rg BT 500.01 509.25 Td (pr) Tj ET Q q 0 0 0 rg BT 508.53 509.25 Td (oducts ) Tj ET Q q 0 0 0 rg BT 536.11 509.25 Td (pr) Tj ET Q q 0 0 0 rg BT 544.63 509.25 Td (oduced, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (such ) Tj ET Q q 0 0 0 rg BT 57.61 497.25 Td (as ) Tj ET Q q 0 0 0 rg BT 69.77 497.25 Td (biologics, ) Tj ET Q q 0 0 0 rg BT 112.21 497.25 Td (physical ) Tj ET Q q 0 0 0 rg BT 148.81 497.25 Td (limitations ) Tj ET Q q 0 0 0 rg BT 194.87 497.25 Td (or ) Tj ET Q q 0 0 0 rg BT 207.04 497.25 Td (other ) Tj ET Q q 0 0 0 rg BT 231.42 497.25 Td (business ) Tj ET Q q 0 0 0 rg BT 268.59 497.25 Td (interruptions; ) Tj ET Q q 0 0 0 rg BT 327.42 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 345.70 497.25 Td (\(ix\) ) Tj ET Q q 0 0 0 rg BT 362.85 497.25 Td (disruption ) Tj ET Q q 0 0 0 rg BT 407.24 497.25 Td (in ) Tj ET Q q 0 0 0 rg BT 418.30 497.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 447.68 497.25 Td (chain ) Tj ET Q q 0 0 0 rg BT 473.17 497.25 Td (continuity ) Tj ET Q q 0 0 0 rg BT 516.44 497.25 Td (including ) Tj ET Q q 0 0 0 rg BT 557.49 497.25 Td (fr) Tj ET Q q 0 0 0 rg BT 563.79 497.25 Td (om ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (natural ) Tj ET Q q 0 0 0 rg BT 68.01 485.25 Td (disasters, ) Tj ET Q q 0 0 0 rg BT 108.63 485.25 Td (acts ) Tj ET Q q 0 0 0 rg BT 127.29 485.25 Td (of ) Tj ET Q q 0 0 0 rg BT 137.63 485.25 Td (war ) Tj ET Q q 0 0 0 rg BT 155.75 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 167.20 485.25 Td (terr) Tj ET Q q 0 0 0 rg BT 181.83 485.25 Td (orism ) Tj ET Q q 0 0 0 rg BT 207.17 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 218.62 485.25 Td (other ) Tj ET Q q 0 0 0 rg BT 242.29 485.25 Td (external ) Tj ET Q q 0 0 0 rg BT 277.61 485.25 Td (factors ) Tj ET Q q 0 0 0 rg BT 307.95 485.25 Td (over ) Tj ET Q q 0 0 0 rg BT 328.28 485.25 Td (which ) Tj ET Q q 0 0 0 rg BT 354.72 485.25 Td (we ) Tj ET Q q 0 0 0 rg BT 368.39 485.25 Td (have ) Tj ET Q q 0 0 0 rg BT 389.82 485.25 Td (no ) Tj ET Q q 0 0 0 rg BT 402.38 485.25 Td (contr) Tj ET Q q 0 0 0 rg BT 423.12 485.25 Td (ol ) Tj ET Q q 0 0 0 rg BT 433.46 485.25 Td (impacting ) Tj ET Q q 0 0 0 rg BT 476.01 485.25 Td (one ) Tj ET Q q 0 0 0 rg BT 493.01 485.25 Td (of ) Tj ET Q q 0 0 0 rg BT 503.34 485.25 Td (our ) Tj ET Q q 0 0 0 rg BT 519.79 485.25 Td (facilities ) Tj ET Q q 0 0 0 rg BT 556.79 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 568.24 485.25 Td (at ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (a ) Tj ET Q q 0 0 0 rg BT 43.50 473.25 Td (critical ) Tj ET Q q 0 0 0 rg BT 74.88 473.25 Td (supplier) Tj ET Q q 0 0 0 rg BT 106.55 473.25 Td (.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (Product ) Tj ET Q q 0 0 0 rg BT 71.28 449.25 Td (labeling ) Tj ET Q q 0 0 0 rg BT 107.11 449.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 143.50 449.25 Td (for ) Tj ET Q q 0 0 0 rg BT 158.23 449.25 Td (our ) Tj ET Q q 0 0 0 rg BT 175.18 449.25 Td (marketed ) Tj ET Q q 0 0 0 rg BT 216.00 449.25 Td (products ) Tj ET Q q 0 0 0 rg BT 254.07 449.25 Td (could ) Tj ET Q q 0 0 0 rg BT 279.34 449.25 Td (result ) Tj ET Q q 0 0 0 rg BT 305.18 449.25 Td (in ) Tj ET Q q 0 0 0 rg BT 316.02 449.25 Td (a ) Tj ET Q q 0 0 0 rg BT 323.52 449.25 Td (negative ) Tj ET Q q 0 0 0 rg BT 360.46 449.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 390.73 449.25 Td (on ) Tj ET Q q 0 0 0 rg BT 403.79 449.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 442.95 449.25 Td (and ) Tj ET Q q 0 0 0 rg BT 461.01 449.25 Td (profit ) Tj ET Q q 0 0 0 rg BT 486.29 449.25 Td (margins.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 437.25 Td (e ) Tj ET Q q 0 0 0 rg BT 49.47 437.25 Td (or ) Tj ET Q q 0 0 0 rg BT 59.98 437.25 Td (r) Tj ET Q q 0 0 0 rg BT 63.50 437.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 103.45 437.25 Td (authorities ) Tj ET Q q 0 0 0 rg BT 148.41 437.25 Td (may ) Tj ET Q q 0 0 0 rg BT 166.69 437.25 Td (need ) Tj ET Q q 0 0 0 rg BT 187.19 437.25 Td (to ) Tj ET Q q 0 0 0 rg BT 196.59 437.25 Td (change ) Tj ET Q q 0 0 0 rg BT 227.08 437.25 Td (the ) Tj ET Q q 0 0 0 rg BT 240.92 437.25 Td (labeling ) Tj ET Q q 0 0 0 rg BT 275.32 437.25 Td (for ) Tj ET Q q 0 0 0 rg BT 288.61 437.25 Td (any ) Tj ET Q q 0 0 0 rg BT 304.67 437.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 369.05 437.25 Td (pr) Tj ET Q q 0 0 0 rg BT 377.57 437.25 Td (oduct, ) Tj ET Q q 0 0 0 rg BT 403.91 437.25 Td (including ) Tj ET Q q 0 0 0 rg BT 443.30 437.25 Td (after ) Tj ET Q q 0 0 0 rg BT 463.81 437.25 Td (a ) Tj ET Q q 0 0 0 rg BT 470.43 437.25 Td (pr) Tj ET Q q 0 0 0 rg BT 478.95 437.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 502.79 437.25 Td (has ) Tj ET Q q 0 0 0 rg BT 518.30 437.25 Td (been ) Tj ET Q q 0 0 0 rg BT 538.80 437.25 Td (marketed ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.04 425.25 Td (several ) Tj ET Q q 0 0 0 rg BT 81.28 425.25 Td (years. ) Tj ET Q q 0 0 0 rg BT 107.80 425.25 Td (These ) Tj ET Q q 0 0 0 rg BT 133.50 425.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 168.63 425.25 Td (ar) Tj ET Q q 0 0 0 rg BT 177.15 425.25 Td (e ) Tj ET Q q 0 0 0 rg BT 183.96 425.25 Td (often ) Tj ET Q q 0 0 0 rg BT 206.32 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 220.90 425.25 Td (r) Tj ET Q q 0 0 0 rg BT 224.42 425.25 Td (esult ) Tj ET Q q 0 0 0 rg BT 245.68 425.25 Td (of ) Tj ET Q q 0 0 0 rg BT 255.82 425.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 299.30 425.25 Td (data ) Tj ET Q q 0 0 0 rg BT 319.44 425.25 Td (fr) Tj ET Q q 0 0 0 rg BT 325.74 425.25 Td (om ) Tj ET Q q 0 0 0 rg BT 340.33 425.25 Td (post-marketing ) Tj ET Q q 0 0 0 rg BT 403.24 425.25 Td (studies, ) Tj ET Q q 0 0 0 rg BT 435.89 425.25 Td (head-to-head ) Tj ET Q q 0 0 0 rg BT 491.57 425.25 Td (trials, ) Tj ET Q q 0 0 0 rg BT 517.55 425.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 551.01 425.25 Td (events ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 413.25 Td (eports, ) Tj ET Q q 0 0 0 rg BT 69.97 413.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 100.70 413.25 Td (that ) Tj ET Q q 0 0 0 rg BT 119.21 413.25 Td (identify ) Tj ET Q q 0 0 0 rg BT 152.15 413.25 Td (biomarkers ) Tj ET Q q 0 0 0 rg BT 200.66 413.25 Td (\(objective ) Tj ET Q q 0 0 0 rg BT 243.03 413.25 Td (characteristics ) Tj ET Q q 0 0 0 rg BT 305.41 413.25 Td (that ) Tj ET Q q 0 0 0 rg BT 323.92 413.25 Td (can ) Tj ET Q q 0 0 0 rg BT 341.31 413.25 Td (indicate ) Tj ET Q q 0 0 0 rg BT 376.47 413.25 Td (a ) Tj ET Q q 0 0 0 rg BT 384.43 413.25 Td (particular ) Tj ET Q q 0 0 0 rg BT 427.93 413.25 Td (r) Tj ET Q q 0 0 0 rg BT 431.45 413.25 Td (esponse ) Tj ET Q q 0 0 0 rg BT 466.07 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 476.80 413.25 Td (a ) Tj ET Q q 0 0 0 rg BT 484.75 413.25 Td (pr) Tj ET Q q 0 0 0 rg BT 493.27 413.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 518.44 413.25 Td (or ) Tj ET Q q 0 0 0 rg BT 530.28 413.25 Td (therapy\) ) Tj ET Q q 0 0 0 rg BT 567.11 413.25 Td (or ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.43 401.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 89.52 401.25 Td (or ) Tj ET Q q 0 0 0 rg BT 100.73 401.25 Td (post-marketing ) Tj ET Q q 0 0 0 rg BT 163.60 401.25 Td (experience ) Tj ET Q q 0 0 0 rg BT 209.22 401.25 Td (that ) Tj ET Q q 0 0 0 rg BT 227.09 401.25 Td (pr) Tj ET Q q 0 0 0 rg BT 235.61 401.25 Td (oduce ) Tj ET Q q 0 0 0 rg BT 261.81 401.25 Td (important ) Tj ET Q q 0 0 0 rg BT 303.58 401.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 347.01 401.25 Td (information ) Tj ET Q q 0 0 0 rg BT 396.55 401.25 Td (about ) Tj ET Q q 0 0 0 rg BT 421.65 401.25 Td (a ) Tj ET Q q 0 0 0 rg BT 428.97 401.25 Td (pr) Tj ET Q q 0 0 0 rg BT 437.49 401.25 Td (oduct. ) Tj ET Q q 0 0 0 rg BT 464.52 401.25 Td (New ) Tj ET Q q 0 0 0 rg BT 484.62 401.25 Td (information ) Tj ET Q q 0 0 0 rg BT 534.16 401.25 Td (added ) Tj ET Q q 0 0 0 rg BT 560.92 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 571.02 401.25 Td (a ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 389.25 Td (oduct’) Tj ET Q q 0 0 0 rg BT 68.78 389.25 Td (s ) Tj ET Q q 0 0 0 rg BT 74.49 389.25 Td (label ) Tj ET Q q 0 0 0 rg BT 96.31 389.25 Td (can ) Tj ET Q q 0 0 0 rg BT 112.57 389.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 136.60 389.25 Td (its ) Tj ET Q q 0 0 0 rg BT 147.87 389.25 Td (risk-benefit ) Tj ET Q q 0 0 0 rg BT 195.23 389.25 Td (pr) Tj ET Q q 0 0 0 rg BT 203.75 389.25 Td (ofile, ) Tj ET Q q 0 0 0 rg BT 225.85 389.25 Td (leading ) Tj ET Q q 0 0 0 rg BT 257.67 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 267.26 389.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 304.64 389.25 Td (r) Tj ET Q q 0 0 0 rg BT 308.16 389.25 Td (ecalls, ) Tj ET Q q 0 0 0 rg BT 335.80 389.25 Td (withdrawals ) Tj ET Q q 0 0 0 rg BT 387.08 389.25 Td (or ) Tj ET Q q 0 0 0 rg BT 397.80 389.25 Td (declining ) Tj ET Q q 0 0 0 rg BT 436.83 389.25 Td (r) Tj ET Q q 0 0 0 rg BT 440.35 389.25 Td (evenue, ) Tj ET Q q 0 0 0 rg BT 472.43 389.25 Td (as ) Tj ET Q q 0 0 0 rg BT 483.14 389.25 Td (well ) Tj ET Q q 0 0 0 rg BT 501.63 389.25 Td (as ) Tj ET Q q 0 0 0 rg BT 512.34 389.25 Td (pr) Tj ET Q q 0 0 0 rg BT 520.86 389.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 544.90 389.25 Td (liability ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (claims. ) Tj ET Q q 0 0 0 rg BT 66.89 377.25 Td (Sometimes ) Tj ET Q q 0 0 0 rg BT 111.94 377.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 155.34 377.25 Td (information ) Tj ET Q q 0 0 0 rg BT 204.84 377.25 Td (fr) Tj ET Q q 0 0 0 rg BT 211.14 377.25 Td (om ) Tj ET Q q 0 0 0 rg BT 225.65 377.25 Td (these ) Tj ET Q q 0 0 0 rg BT 248.47 377.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 278.53 377.25 Td (identifies ) Tj ET Q q 0 0 0 rg BT 317.48 377.25 Td (a ) Tj ET Q q 0 0 0 rg BT 324.76 377.25 Td (portion ) Tj ET Q q 0 0 0 rg BT 356.49 377.25 Td (of ) Tj ET Q q 0 0 0 rg BT 366.55 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 381.05 377.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 411.10 377.25 Td (population ) Tj ET Q q 0 0 0 rg BT 456.72 377.25 Td (that ) Tj ET Q q 0 0 0 rg BT 474.56 377.25 Td (may ) Tj ET Q q 0 0 0 rg BT 493.50 377.25 Td (be ) Tj ET Q q 0 0 0 rg BT 505.22 377.25 Td (non-r) Tj ET Q q 0 0 0 rg BT 527.07 377.25 Td (esponsive ) Tj ET Q q 0 0 0 rg BT 568.23 377.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 365.25 Td (a ) Tj ET Q q 0 0 0 rg BT 43.31 365.25 Td (medicine ) Tj ET Q q 0 0 0 rg BT 81.71 365.25 Td (or ) Tj ET Q q 0 0 0 rg BT 92.90 365.25 Td (would ) Tj ET Q q 0 0 0 rg BT 119.66 365.25 Td (be ) Tj ET Q q 0 0 0 rg BT 131.40 365.25 Td (at ) Tj ET Q q 0 0 0 rg BT 141.49 365.25 Td (higher ) Tj ET Q q 0 0 0 rg BT 169.90 365.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 187.21 365.25 Td (of ) Tj ET Q q 0 0 0 rg BT 197.29 365.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 230.70 365.25 Td (r) Tj ET Q q 0 0 0 rg BT 234.22 365.25 Td (eactions ) Tj ET Q q 0 0 0 rg BT 269.85 365.25 Td (and ) Tj ET Q q 0 0 0 rg BT 287.16 365.25 Td (labeling ) Tj ET Q q 0 0 0 rg BT 322.23 365.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 357.31 365.25 Td (based ) Tj ET Q q 0 0 0 rg BT 382.95 365.25 Td (on ) Tj ET Q q 0 0 0 rg BT 395.25 365.25 Td (such ) Tj ET Q q 0 0 0 rg BT 415.89 365.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 445.97 365.25 Td (may ) Tj ET Q q 0 0 0 rg BT 464.94 365.25 Td (limit ) Tj ET Q q 0 0 0 rg BT 485.58 365.25 Td (the ) Tj ET Q q 0 0 0 rg BT 500.10 365.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 530.18 365.25 Td (population. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.49 353.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 83.75 353.25 Td (pr) Tj ET Q q 0 0 0 rg BT 92.27 353.25 Td (oviding ) Tj ET Q q 0 0 0 rg BT 124.76 353.25 Td (such ) Tj ET Q q 0 0 0 rg BT 145.58 353.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 189.18 353.25 Td (information ) Tj ET Q q 0 0 0 rg BT 238.89 353.25 Td (may ) Tj ET Q q 0 0 0 rg BT 258.04 353.25 Td (be ) Tj ET Q q 0 0 0 rg BT 269.96 353.25 Td (sponsor) Tj ET Q q 0 0 0 rg BT 301.27 353.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 313.19 353.25 Td (by ) Tj ET Q q 0 0 0 rg BT 325.12 353.25 Td (us, ) Tj ET Q q 0 0 0 rg BT 339.00 353.25 Td (but ) Tj ET Q q 0 0 0 rg BT 354.27 353.25 Td (they ) Tj ET Q q 0 0 0 rg BT 373.41 353.25 Td (could ) Tj ET Q q 0 0 0 rg BT 398.11 353.25 Td (also ) Tj ET Q q 0 0 0 rg BT 417.27 353.25 Td (be ) Tj ET Q q 0 0 0 rg BT 429.20 353.25 Td (sponsor) Tj ET Q q 0 0 0 rg BT 460.50 353.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 472.43 353.25 Td (by ) Tj ET Q q 0 0 0 rg BT 484.35 353.25 Td (competitors, ) Tj ET Q q 0 0 0 rg BT 536.56 353.25 Td (insurance ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (companies, ) Tj ET Q q 0 0 0 rg BT 83.75 341.25 Td (government ) Tj ET Q q 0 0 0 rg BT 133.44 341.25 Td (institutions, ) Tj ET Q q 0 0 0 rg BT 182.87 341.25 Td (managed ) Tj ET Q q 0 0 0 rg BT 222.02 341.25 Td (car) Tj ET Q q 0 0 0 rg BT 234.98 341.25 Td (e ) Tj ET Q q 0 0 0 rg BT 241.90 341.25 Td (or) Tj ET Q q 0 0 0 rg BT 250.42 341.25 Td (ganizations, ) Tj ET Q q 0 0 0 rg BT 301.52 341.25 Td (scientists, ) Tj ET Q q 0 0 0 rg BT 343.16 341.25 Td (investigators, ) Tj ET Q q 0 0 0 rg BT 399.81 341.25 Td (or ) Tj ET Q q 0 0 0 rg BT 411.18 341.25 Td (other ) Tj ET Q q 0 0 0 rg BT 434.77 341.25 Td (inter) Tj ET Q q 0 0 0 rg BT 453.29 341.25 Td (ested ) Tj ET Q q 0 0 0 rg BT 476.32 341.25 Td (parties. ) Tj ET Q q 0 0 0 rg BT 509.08 341.25 Td (While ) Tj ET Q q 0 0 0 rg BT 534.89 341.25 Td (additional ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (safety ) Tj ET Q q 0 0 0 rg BT 62.05 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 79.77 329.25 Td (efficacy ) Tj ET Q q 0 0 0 rg BT 113.58 329.25 Td (information ) Tj ET Q q 0 0 0 rg BT 163.54 329.25 Td (fr) Tj ET Q q 0 0 0 rg BT 169.83 329.25 Td (om ) Tj ET Q q 0 0 0 rg BT 184.78 329.25 Td (such ) Tj ET Q q 0 0 0 rg BT 205.83 329.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 236.33 329.25 Td (assist ) Tj ET Q q 0 0 0 rg BT 261.29 329.25 Td (us ) Tj ET Q q 0 0 0 rg BT 272.91 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 290.63 329.25 Td (healthcar) Tj ET Q q 0 0 0 rg BT 328.58 329.25 Td (e ) Tj ET Q q 0 0 0 rg BT 335.75 329.25 Td (pr) Tj ET Q q 0 0 0 rg BT 344.27 329.25 Td (oviders ) Tj ET Q q 0 0 0 rg BT 376.43 329.25 Td (in ) Tj ET Q q 0 0 0 rg BT 386.93 329.25 Td (identifying ) Tj ET Q q 0 0 0 rg BT 432.42 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 447.36 329.25 Td (best ) Tj ET Q q 0 0 0 rg BT 466.19 329.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 496.69 329.25 Td (population ) Tj ET Q q 0 0 0 rg BT 542.75 329.25 Td (for ) Tj ET Q q 0 0 0 rg BT 557.14 329.25 Td (each ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 317.25 Td (oduct, ) Tj ET Q q 0 0 0 rg BT 72.82 317.25 Td (it ) Tj ET Q q 0 0 0 rg BT 81.96 317.25 Td (can ) Tj ET Q q 0 0 0 rg BT 99.98 317.25 Td (also ) Tj ET Q q 0 0 0 rg BT 120.23 317.25 Td (negatively ) Tj ET Q q 0 0 0 rg BT 164.90 317.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 195.70 317.25 Td (our ) Tj ET Q q 0 0 0 rg BT 213.17 317.25 Td (r) Tj ET Q q 0 0 0 rg BT 216.69 317.25 Td (evenues ) Tj ET Q q 0 0 0 rg BT 251.92 317.25 Td (due ) Tj ET Q q 0 0 0 rg BT 269.94 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 281.30 317.25 Td (inventory ) Tj ET Q q 0 0 0 rg BT 322.64 317.25 Td (r) Tj ET Q q 0 0 0 rg BT 326.16 317.25 Td (eturns ) Tj ET Q q 0 0 0 rg BT 354.75 317.25 Td (and ) Tj ET Q q 0 0 0 rg BT 373.33 317.25 Td (a ) Tj ET Q q 0 0 0 rg BT 381.91 317.25 Td (mor) Tj ET Q q 0 0 0 rg BT 397.65 317.25 Td (e ) Tj ET Q q 0 0 0 rg BT 405.67 317.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 437.03 317.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 468.38 317.25 Td (population ) Tj ET Q q 0 0 0 rg BT 515.30 317.25 Td (going ) Tj ET Q q 0 0 0 rg BT 541.66 317.25 Td (forwar) Tj ET Q q 0 0 0 rg BT 568.52 317.25 Td (d. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (Additionally) Tj ET Q q 0 0 0 rg BT 84.89 305.25 Td (, ) Tj ET Q q 0 0 0 rg BT 91.05 305.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 123.03 305.25 Td (study ) Tj ET Q q 0 0 0 rg BT 147.80 305.25 Td (r) Tj ET Q q 0 0 0 rg BT 151.32 305.25 Td (esults, ) Tj ET Q q 0 0 0 rg BT 180.26 305.25 Td (especially ) Tj ET Q q 0 0 0 rg BT 223.91 305.25 Td (fr) Tj ET Q q 0 0 0 rg BT 230.20 305.25 Td (om ) Tj ET Q q 0 0 0 rg BT 246.09 305.25 Td (head-to-head ) Tj ET Q q 0 0 0 rg BT 303.06 305.25 Td (trials, ) Tj ET Q q 0 0 0 rg BT 330.34 305.25 Td (could ) Tj ET Q q 0 0 0 rg BT 356.22 305.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 382.09 305.25 Td (a ) Tj ET Q q 0 0 0 rg BT 390.75 305.25 Td (pr) Tj ET Q q 0 0 0 rg BT 399.28 305.25 Td (oduct’) Tj ET Q q 0 0 0 rg BT 423.53 305.25 Td (s ) Tj ET Q q 0 0 0 rg BT 431.09 305.25 Td (formulary ) Tj ET Q q 0 0 0 rg BT 474.75 305.25 Td (listing, ) Tj ET Q q 0 0 0 rg BT 505.91 305.25 Td (which ) Tj ET Q q 0 0 0 rg BT 533.46 305.25 Td (could ) Tj ET Q q 0 0 0 rg BT 559.34 305.25 Td (also ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 76.82 293.25 Td (affect ) Tj ET Q q 0 0 0 rg BT 101.53 293.25 Td (r) Tj ET Q q 0 0 0 rg BT 105.05 293.25 Td (evenues.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 269.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.61 269.25 Td (failure ) Tj ET Q q 0 0 0 rg BT 84.89 269.25 Td (of ) Tj ET Q q 0 0 0 rg BT 95.72 269.25 Td (third ) Tj ET Q q 0 0 0 rg BT 118.23 269.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 148.50 269.25 Td (to ) Tj ET Q q 0 0 0 rg BT 158.78 269.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 180.72 269.25 Td (their ) Tj ET Q q 0 0 0 rg BT 202.67 269.25 Td (contractual, ) Tj ET Q q 0 0 0 rg BT 254.89 269.25 Td (regulatory) Tj ET Q q 0 0 0 rg BT 297.30 269.25 Td (, ) Tj ET Q q 0 0 0 rg BT 302.30 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 320.36 269.25 Td (other ) Tj ET Q q 0 0 0 rg BT 344.53 269.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 392.60 269.25 Td (could ) Tj ET Q q 0 0 0 rg BT 417.88 269.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 458.69 269.25 Td (af) Tj ET Q q 0 0 0 rg BT 466.84 269.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 484.33 269.25 Td (our ) Tj ET Q q 0 0 0 rg BT 501.28 269.25 Td (business.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 257.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.97 257.25 Td (r) Tj ET Q q 0 0 0 rg BT 55.50 257.25 Td (ely ) Tj ET Q q 0 0 0 rg BT 71.27 257.25 Td (on ) Tj ET Q q 0 0 0 rg BT 85.40 257.25 Td (suppliers, ) Tj ET Q q 0 0 0 rg BT 128.69 257.25 Td (vendors, ) Tj ET Q q 0 0 0 rg BT 166.98 257.25 Td (outsour) Tj ET Q q 0 0 0 rg BT 197.17 257.25 Td (cing ) Tj ET Q q 0 0 0 rg BT 218.51 257.25 Td (partners, ) Tj ET Q q 0 0 0 rg BT 259.02 257.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 295.36 257.25 Td (partners ) Tj ET Q q 0 0 0 rg BT 333.38 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 352.50 257.25 Td (other ) Tj ET Q q 0 0 0 rg BT 377.73 257.25 Td (thir) Tj ET Q q 0 0 0 rg BT 391.81 257.25 Td (d ) Tj ET Q q 0 0 0 rg BT 400.93 257.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 432.83 257.25 Td (to ) Tj ET Q q 0 0 0 rg BT 444.74 257.25 Td (r) Tj ET Q q 0 0 0 rg BT 448.26 257.25 Td (esear) Tj ET Q q 0 0 0 rg BT 469.55 257.25 Td (ch, ) Tj ET Q q 0 0 0 rg BT 485.61 257.25 Td (develop, ) Tj ET Q q 0 0 0 rg BT 523.33 257.25 Td (manufactur) Tj ET Q q 0 0 0 rg BT 569.06 257.25 Td (e, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (commer) Tj ET Q q 0 0 0 rg BT 67.84 245.25 Td (cialize, ) Tj ET Q q 0 0 0 rg BT 99.39 245.25 Td (co-pr) Tj ET Q q 0 0 0 rg BT 120.68 245.25 Td (omote ) Tj ET Q q 0 0 0 rg BT 148.06 245.25 Td (and ) Tj ET Q q 0 0 0 rg BT 166.00 245.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 182.84 245.25 Td (our ) Tj ET Q q 0 0 0 rg BT 199.67 245.25 Td (pr) Tj ET Q q 0 0 0 rg BT 208.19 245.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 239.75 245.25 Td (manage ) Tj ET Q q 0 0 0 rg BT 274.35 245.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 305.62 245.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 351.61 245.25 Td (selling, ) Tj ET Q q 0 0 0 rg BT 383.72 245.25 Td (human ) Tj ET Q q 0 0 0 rg BT 413.89 245.25 Td (r) Tj ET Q q 0 0 0 rg BT 417.41 245.25 Td (esour) Tj ET Q q 0 0 0 rg BT 439.26 245.25 Td (ce, ) Tj ET Q q 0 0 0 rg BT 453.58 245.25 Td (finance, ) Tj ET Q q 0 0 0 rg BT 488.46 245.25 Td (IT) Tj ET Q q 0 0 0 rg BT 497.17 245.25 Td ( ) Tj ET Q q 0 0 0 rg BT 500.11 245.25 Td (and ) Tj ET Q q 0 0 0 rg BT 518.06 245.25 Td (other ) Tj ET Q q 0 0 0 rg BT 542.11 245.25 Td (business ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (unit ) Tj ET Q q 0 0 0 rg BT 54.22 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 71.87 233.25 Td (functional ) Tj ET Q q 0 0 0 rg BT 115.08 233.25 Td (services, ) Tj ET Q q 0 0 0 rg BT 152.45 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 170.11 233.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 191.64 233.25 Td (their ) Tj ET Q q 0 0 0 rg BT 213.19 233.25 Td (contractual, ) Tj ET Q q 0 0 0 rg BT 264.45 233.25 Td (r) Tj ET Q q 0 0 0 rg BT 267.97 233.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 308.96 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 326.62 233.25 Td (other ) Tj ET Q q 0 0 0 rg BT 350.38 233.25 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 400.55 233.25 Td (Using ) Tj ET Q q 0 0 0 rg BT 427.10 233.25 Td (these ) Tj ET Q q 0 0 0 rg BT 450.30 233.25 Td (thir) Tj ET Q q 0 0 0 rg BT 464.38 233.25 Td (d ) Tj ET Q q 0 0 0 rg BT 472.04 233.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 502.47 233.25 Td (poses ) Tj ET Q q 0 0 0 rg BT 527.35 233.25 Td (a ) Tj ET Q q 0 0 0 rg BT 535.01 233.25 Td (number ) Tj ET Q q 0 0 0 rg BT 568.22 233.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 221.25 Td (risks, ) Tj ET Q q 0 0 0 rg BT 59.82 221.25 Td (such ) Tj ET Q q 0 0 0 rg BT 80.58 221.25 Td (as: ) Tj ET Q q 0 0 0 rg BT 95.24 221.25 Td (\(i\) ) Tj ET Q q 0 0 0 rg BT 107.11 221.25 Td (they ) Tj ET Q q 0 0 0 rg BT 126.20 221.25 Td (may ) Tj ET Q q 0 0 0 rg BT 145.29 221.25 Td (not ) Tj ET Q q 0 0 0 rg BT 160.50 221.25 Td (perform ) Tj ET Q q 0 0 0 rg BT 195.15 221.25 Td (to ) Tj ET Q q 0 0 0 rg BT 205.36 221.25 Td (our ) Tj ET Q q 0 0 0 rg BT 221.68 221.25 Td (standar) Tj ET Q q 0 0 0 rg BT 251.87 221.25 Td (ds ) Tj ET Q q 0 0 0 rg BT 263.20 221.25 Td (or ) Tj ET Q q 0 0 0 rg BT 274.52 221.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 296.95 221.25 Td (r) Tj ET Q q 0 0 0 rg BT 300.47 221.25 Td (equir) Tj ET Q q 0 0 0 rg BT 321.21 221.25 Td (ements; ) Tj ET Q q 0 0 0 rg BT 354.74 221.25 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 369.38 221.25 Td (they ) Tj ET Q q 0 0 0 rg BT 388.47 221.25 Td (may ) Tj ET Q q 0 0 0 rg BT 407.56 221.25 Td (not ) Tj ET Q q 0 0 0 rg BT 422.77 221.25 Td (pr) Tj ET Q q 0 0 0 rg BT 431.29 221.25 Td (oduce ) Tj ET Q q 0 0 0 rg BT 457.60 221.25 Td (r) Tj ET Q q 0 0 0 rg BT 461.12 221.25 Td (eliable ) Tj ET Q q 0 0 0 rg BT 490.77 221.25 Td (r) Tj ET Q q 0 0 0 rg BT 494.29 221.25 Td (esults; ) Tj ET Q q 0 0 0 rg BT 522.83 221.25 Td (\(iii\) ) Tj ET Q q 0 0 0 rg BT 540.25 221.25 Td (they ) Tj ET Q q 0 0 0 rg BT 559.34 221.25 Td (may ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (not ) Tj ET Q q 0 0 0 rg BT 51.52 209.25 Td (perform ) Tj ET Q q 0 0 0 rg BT 86.49 209.25 Td (in ) Tj ET Q q 0 0 0 rg BT 97.01 209.25 Td (a ) Tj ET Q q 0 0 0 rg BT 104.75 209.25 Td (timely ) Tj ET Q q 0 0 0 rg BT 131.93 209.25 Td (manner; ) Tj ET Q q 0 0 0 rg BT 168.56 209.25 Td (\(iv\) ) Tj ET Q q 0 0 0 rg BT 185.18 209.25 Td (they ) Tj ET Q q 0 0 0 rg BT 204.58 209.25 Td (may ) Tj ET Q q 0 0 0 rg BT 223.98 209.25 Td (not ) Tj ET Q q 0 0 0 rg BT 239.51 209.25 Td (maintain ) Tj ET Q q 0 0 0 rg BT 277.81 209.25 Td (confidentiality ) Tj ET Q q 0 0 0 rg BT 338.31 209.25 Td (of ) Tj ET Q q 0 0 0 rg BT 348.84 209.25 Td (our ) Tj ET Q q 0 0 0 rg BT 365.47 209.25 Td (pr) Tj ET Q q 0 0 0 rg BT 373.99 209.25 Td (oprietary ) Tj ET Q q 0 0 0 rg BT 413.95 209.25 Td (information; ) Tj ET Q q 0 0 0 rg BT 467.25 209.25 Td (\(v\) ) Tj ET Q q 0 0 0 rg BT 481.10 209.25 Td (disputes ) Tj ET Q q 0 0 0 rg BT 516.62 209.25 Td (may ) Tj ET Q q 0 0 0 rg BT 536.02 209.25 Td (arise ) Tj ET Q q 0 0 0 rg BT 558.77 209.25 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 197.25 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 197.25 Td (espect ) Tj ET Q q 0 0 0 rg BT 67.02 197.25 Td (to ) Tj ET Q q 0 0 0 rg BT 77.31 197.25 Td (ownership ) Tj ET Q q 0 0 0 rg BT 121.50 197.25 Td (of ) Tj ET Q q 0 0 0 rg BT 131.79 197.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 157.65 197.25 Td (to ) Tj ET Q q 0 0 0 rg BT 167.94 197.25 Td (technology ) Tj ET Q q 0 0 0 rg BT 214.33 197.25 Td (developed ) Tj ET Q q 0 0 0 rg BT 257.37 197.25 Td (with ) Tj ET Q q 0 0 0 rg BT 277.11 197.25 Td (our ) Tj ET Q q 0 0 0 rg BT 293.52 197.25 Td (partners; ) Tj ET Q q 0 0 0 rg BT 333.26 197.25 Td (and ) Tj ET Q q 0 0 0 rg BT 350.77 197.25 Td (\(vi\) ) Tj ET Q q 0 0 0 rg BT 367.16 197.25 Td (disagr) Tj ET Q q 0 0 0 rg BT 392.35 197.25 Td (eements ) Tj ET Q q 0 0 0 rg BT 427.07 197.25 Td (could ) Tj ET Q q 0 0 0 rg BT 451.81 197.25 Td (cause ) Tj ET Q q 0 0 0 rg BT 477.09 197.25 Td (delays ) Tj ET Q q 0 0 0 rg BT 505.15 197.25 Td (in, ) Tj ET Q q 0 0 0 rg BT 517.94 197.25 Td (or ) Tj ET Q q 0 0 0 rg BT 529.35 197.25 Td (termination ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (of, ) Tj ET Q q 0 0 0 rg BT 48.63 185.25 Td (the ) Tj ET Q q 0 0 0 rg BT 63.20 185.25 Td (r) Tj ET Q q 0 0 0 rg BT 66.72 185.25 Td (esear) Tj ET Q q 0 0 0 rg BT 88.01 185.25 Td (ch, ) Tj ET Q q 0 0 0 rg BT 102.30 185.25 Td (development ) Tj ET Q q 0 0 0 rg BT 155.19 185.25 Td (or ) Tj ET Q q 0 0 0 rg BT 166.43 185.25 Td (commer) Tj ET Q q 0 0 0 rg BT 198.27 185.25 Td (cialization ) Tj ET Q q 0 0 0 rg BT 242.84 185.25 Td (of ) Tj ET Q q 0 0 0 rg BT 252.98 185.25 Td (the ) Tj ET Q q 0 0 0 rg BT 267.54 185.25 Td (pr) Tj ET Q q 0 0 0 rg BT 276.07 185.25 Td (oduct ) Tj ET Q q 0 0 0 rg BT 300.63 185.25 Td (or ) Tj ET Q q 0 0 0 rg BT 311.88 185.25 Td (r) Tj ET Q q 0 0 0 rg BT 315.40 185.25 Td (esult ) Tj ET Q q 0 0 0 rg BT 336.64 185.25 Td (in ) Tj ET Q q 0 0 0 rg BT 346.77 185.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 385.79 185.25 Td (or ) Tj ET Q q 0 0 0 rg BT 397.04 185.25 Td (arbitration. ) Tj ET Q q 0 0 0 rg BT 445.79 185.25 Td (Mor) Tj ET Q q 0 0 0 rg BT 462.64 185.25 Td (eover) Tj ET Q q 0 0 0 rg BT 483.73 185.25 Td (, ) Tj ET Q q 0 0 0 rg BT 488.59 185.25 Td (some ) Tj ET Q q 0 0 0 rg BT 511.49 185.25 Td (thir) Tj ET Q q 0 0 0 rg BT 525.57 185.25 Td (d ) Tj ET Q q 0 0 0 rg BT 532.92 185.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 563.05 185.25 Td (ar) Tj ET Q q 0 0 0 rg BT 571.57 185.25 Td (e ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (located ) Tj ET Q q 0 0 0 rg BT 67.99 173.25 Td (in ) Tj ET Q q 0 0 0 rg BT 78.33 173.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 112.55 173.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 143.43 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 153.77 173.25 Td (political ) Tj ET Q q 0 0 0 rg BT 189.66 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 207.22 173.25 Td (social ) Tj ET Q q 0 0 0 rg BT 233.66 173.25 Td (risk, ) Tj ET Q q 0 0 0 rg BT 253.72 173.25 Td (corruption, ) Tj ET Q q 0 0 0 rg BT 301.56 173.25 Td (infrastructur) Tj ET Q q 0 0 0 rg BT 352.30 173.25 Td (e ) Tj ET Q q 0 0 0 rg BT 359.30 173.25 Td (pr) Tj ET Q q 0 0 0 rg BT 367.82 173.25 Td (oblems ) Tj ET Q q 0 0 0 rg BT 398.71 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 416.27 173.25 Td (natural ) Tj ET Q q 0 0 0 rg BT 448.28 173.25 Td (disasters, ) Tj ET Q q 0 0 0 rg BT 488.90 173.25 Td (in ) Tj ET Q q 0 0 0 rg BT 499.23 173.25 Td (addition ) Tj ET Q q 0 0 0 rg BT 535.13 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 545.46 173.25 Td (country ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (specific ) Tj ET Q q 0 0 0 rg BT 68.82 161.25 Td (privacy ) Tj ET Q q 0 0 0 rg BT 101.08 161.25 Td (and ) Tj ET Q q 0 0 0 rg BT 118.35 161.25 Td (data ) Tj ET Q q 0 0 0 rg BT 138.41 161.25 Td (security ) Tj ET Q q 0 0 0 rg BT 172.34 161.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 189.61 161.25 Td (given ) Tj ET Q q 0 0 0 rg BT 213.54 161.25 Td (curr) Tj ET Q q 0 0 0 rg BT 230.39 161.25 Td (ent ) Tj ET Q q 0 0 0 rg BT 244.89 161.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 267.16 161.25 Td (and ) Tj ET Q q 0 0 0 rg BT 284.43 161.25 Td (r) Tj ET Q q 0 0 0 rg BT 287.95 161.25 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 328.55 161.25 Td (envir) Tj ET Q q 0 0 0 rg BT 348.73 161.25 Td (onments. ) Tj ET Q q 0 0 0 rg BT 386.83 161.25 Td (The ) Tj ET Q q 0 0 0 rg BT 404.11 161.25 Td (failur) Tj ET Q q 0 0 0 rg BT 425.97 161.25 Td (e ) Tj ET Q q 0 0 0 rg BT 432.68 161.25 Td (of ) Tj ET Q q 0 0 0 rg BT 442.73 161.25 Td (any ) Tj ET Q q 0 0 0 rg BT 459.45 161.25 Td (critical ) Tj ET Q q 0 0 0 rg BT 490.60 161.25 Td (thir) Tj ET Q q 0 0 0 rg BT 504.68 161.25 Td (d ) Tj ET Q q 0 0 0 rg BT 511.96 161.25 Td (party ) Tj ET Q q 0 0 0 rg BT 535.34 161.25 Td (to ) Tj ET Q q 0 0 0 rg BT 545.39 161.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 566.55 161.25 Td (its ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (obligations, ) Tj ET Q q 0 0 0 rg BT 86.41 149.25 Td (including ) Tj ET Q q 0 0 0 rg BT 127.08 149.25 Td (for ) Tj ET Q q 0 0 0 rg BT 141.65 149.25 Td (futur) Tj ET Q q 0 0 0 rg BT 160.73 149.25 Td (e ) Tj ET Q q 0 0 0 rg BT 168.07 149.25 Td (r) Tj ET Q q 0 0 0 rg BT 171.59 149.25 Td (oyalty ) Tj ET Q q 0 0 0 rg BT 198.92 149.25 Td (and ) Tj ET Q q 0 0 0 rg BT 216.82 149.25 Td (milestone ) Tj ET Q q 0 0 0 rg BT 258.05 149.25 Td (payments; ) Tj ET Q q 0 0 0 rg BT 302.04 149.25 Td (adequately ) Tj ET Q q 0 0 0 rg BT 348.82 149.25 Td (deploy ) Tj ET Q q 0 0 0 rg BT 378.37 149.25 Td (business ) Tj ET Q q 0 0 0 rg BT 415.17 149.25 Td (continuity ) Tj ET Q q 0 0 0 rg BT 458.06 149.25 Td (plans ) Tj ET Q q 0 0 0 rg BT 482.63 149.25 Td (in ) Tj ET Q q 0 0 0 rg BT 493.30 149.25 Td (the ) Tj ET Q q 0 0 0 rg BT 508.42 149.25 Td (event ) Tj ET Q q 0 0 0 rg BT 532.42 149.25 Td (of ) Tj ET Q q 0 0 0 rg BT 543.09 149.25 Td (a ) Tj ET Q q 0 0 0 rg BT 551.00 149.25 Td (crisis; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 137.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 65.65 137.25 Td (satisfactorily ) Tj ET Q q 0 0 0 rg BT 120.85 137.25 Td (r) Tj ET Q q 0 0 0 rg BT 124.37 137.25 Td (esolve ) Tj ET Q q 0 0 0 rg BT 152.34 137.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 197.54 137.25 Td (disagr) Tj ET Q q 0 0 0 rg BT 222.73 137.25 Td (eements ) Tj ET Q q 0 0 0 rg BT 257.92 137.25 Td (with ) Tj ET Q q 0 0 0 rg BT 278.13 137.25 Td (us ) Tj ET Q q 0 0 0 rg BT 290.00 137.25 Td (or ) Tj ET Q q 0 0 0 rg BT 301.87 137.25 Td (addr) Tj ET Q q 0 0 0 rg BT 320.39 137.25 Td (ess ) Tj ET Q q 0 0 0 rg BT 335.60 137.25 Td (other ) Tj ET Q q 0 0 0 rg BT 359.69 137.25 Td (factors, ) Tj ET Q q 0 0 0 rg BT 392.95 137.25 Td (could ) Tj ET Q q 0 0 0 rg BT 418.14 137.25 Td (have ) Tj ET Q q 0 0 0 rg BT 440.00 137.25 Td (a ) Tj ET Q q 0 0 0 rg BT 447.98 137.25 Td (material ) Tj ET Q q 0 0 0 rg BT 484.85 137.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 518.93 137.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 549.13 137.25 Td (on ) Tj ET Q q 0 0 0 rg BT 562.11 137.25 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 125.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 81.38 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 98.98 125.25 Td (r) Tj ET Q q 0 0 0 rg BT 102.50 125.25 Td (esults. ) Tj ET Q q 0 0 0 rg BT 130.38 125.25 Td (In ) Tj ET Q q 0 0 0 rg BT 141.31 125.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 179.74 125.25 Td (if ) Tj ET Q q 0 0 0 rg BT 187.90 125.25 Td (these ) Tj ET Q q 0 0 0 rg BT 211.05 125.25 Td (thir) Tj ET Q q 0 0 0 rg BT 225.12 125.25 Td (d ) Tj ET Q q 0 0 0 rg BT 232.72 125.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 263.10 125.25 Td (violate, ) Tj ET Q q 0 0 0 rg BT 295.41 125.25 Td (or ) Tj ET Q q 0 0 0 rg BT 306.91 125.25 Td (ar) Tj ET Q q 0 0 0 rg BT 315.43 125.25 Td (e ) Tj ET Q q 0 0 0 rg BT 322.46 125.25 Td (alleged ) Tj ET Q q 0 0 0 rg BT 354.50 125.25 Td (to ) Tj ET Q q 0 0 0 rg BT 364.88 125.25 Td (have ) Tj ET Q q 0 0 0 rg BT 386.35 125.25 Td (violated, ) Tj ET Q q 0 0 0 rg BT 423.67 125.25 Td (any ) Tj ET Q q 0 0 0 rg BT 440.70 125.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 461.64 125.25 Td (or ) Tj ET Q q 0 0 0 rg BT 473.14 125.25 Td (r) Tj ET Q q 0 0 0 rg BT 476.66 125.25 Td (egulations, ) Tj ET Q q 0 0 0 rg BT 523.42 125.25 Td (including ) Tj ET Q q 0 0 0 rg BT 563.80 125.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td (local ) Tj ET Q q 0 0 0 rg BT 59.51 113.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 125.79 113.25 Td (code, ) Tj ET Q q 0 0 0 rg BT 150.68 113.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 171.42 113.25 Td (For) Tj ET Q q 0 0 0 rg BT 186.04 113.25 Td (eign ) Tj ET Q q 0 0 0 rg BT 206.78 113.25 Td (Corrupt ) Tj ET Q q 0 0 0 rg BT 242.52 113.25 Td (Practice ) Tj ET Q q 0 0 0 rg BT 279.65 113.25 Td (Act, ) Tj ET Q q 0 0 0 rg BT 298.99 113.25 Td (UK ) Tj ET Q q 0 0 0 rg BT 316.40 113.25 Td (Bribery ) Tj ET Q q 0 0 0 rg BT 350.21 113.25 Td (Act ) Tj ET Q q 0 0 0 rg BT 367.05 113.25 Td (and ) Tj ET Q q 0 0 0 rg BT 385.56 113.25 Td (other ) Tj ET Q q 0 0 0 rg BT 410.19 113.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 442.04 113.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 463.89 113.25 Td (and ) Tj ET Q q 0 0 0 rg BT 482.41 113.25 Td (r) Tj ET Q q 0 0 0 rg BT 485.93 113.25 Td (egulations, ) Tj ET Q q 0 0 0 rg BT 533.61 113.25 Td (during ) Tj ET Q q 0 0 0 rg BT 563.79 113.25 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 101.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 89.73 101.25 Td (of ) Tj ET Q q 0 0 0 rg BT 100.14 101.25 Td (their ) Tj ET Q q 0 0 0 rg BT 121.66 101.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 169.30 101.25 Td (for ) Tj ET Q q 0 0 0 rg BT 183.60 101.25 Td (us, ) Tj ET Q q 0 0 0 rg BT 197.62 101.25 Td (it ) Tj ET Q q 0 0 0 rg BT 205.81 101.25 Td (is ) Tj ET Q q 0 0 0 rg BT 215.11 101.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 250.52 101.25 Td (that ) Tj ET Q q 0 0 0 rg BT 268.71 101.25 Td (we ) Tj ET Q q 0 0 0 rg BT 282.45 101.25 Td (could ) Tj ET Q q 0 0 0 rg BT 307.30 101.25 Td (suffer ) Tj ET Q q 0 0 0 rg BT 332.71 101.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 370.89 101.25 Td (and ) Tj ET Q q 0 0 0 rg BT 388.52 101.25 Td (r) Tj ET Q q 0 0 0 rg BT 392.04 101.25 Td (eputational ) Tj ET Q q 0 0 0 rg BT 440.23 101.25 Td (harm ) Tj ET Q q 0 0 0 rg BT 463.97 101.25 Td (or ) Tj ET Q q 0 0 0 rg BT 475.50 101.25 Td (other ) Tj ET Q q 0 0 0 rg BT 499.24 101.25 Td (negative ) Tj ET Q q 0 0 0 rg BT 535.74 101.25 Td (outcomes, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 89.25 Td (including ) Tj ET Q q 0 0 0 rg BT 76.27 89.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 111.55 89.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 134.05 89.25 Td (consequences.) Tj ET Q endstream endobj 45 0 obj <> endobj 46 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (22) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.91 749.25 Td (illegal ) Tj ET Q q 0 0 0 rg BT 81.26 749.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 130.85 749.25 Td (and ) Tj ET Q q 0 0 0 rg BT 148.21 749.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 166.12 749.25 Td (by ) Tj ET Q q 0 0 0 rg BT 177.36 749.25 Td (third ) Tj ET Q q 0 0 0 rg BT 199.16 749.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 228.74 749.25 Td (of ) Tj ET Q q 0 0 0 rg BT 238.87 749.25 Td (counterfeit ) Tj ET Q q 0 0 0 rg BT 285.66 749.25 Td (versions ) Tj ET Q q 0 0 0 rg BT 321.35 749.25 Td (of ) Tj ET Q q 0 0 0 rg BT 331.48 749.25 Td (our ) Tj ET Q q 0 0 0 rg BT 347.73 749.25 Td (products ) Tj ET Q q 0 0 0 rg BT 385.09 749.25 Td (or ) Tj ET Q q 0 0 0 rg BT 395.78 749.25 Td (stolen ) Tj ET Q q 0 0 0 rg BT 422.03 749.25 Td (products ) Tj ET Q q 0 0 0 rg BT 459.39 749.25 Td (could ) Tj ET Q q 0 0 0 rg BT 483.97 749.25 Td (have ) Tj ET Q q 0 0 0 rg BT 505.20 749.25 Td (a ) Tj ET Q q 0 0 0 rg BT 512.00 749.25 Td (negative ) Tj ET Q q 0 0 0 rg BT 548.23 749.25 Td (impact ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 737.25 Td (on ) Tj ET Q q 0 0 0 rg BT 49.06 737.25 Td (our ) Tj ET Q q 0 0 0 rg BT 66.01 737.25 Td (reputation ) Tj ET Q q 0 0 0 rg BT 111.30 737.25 Td (and ) Tj ET Q q 0 0 0 rg BT 129.36 737.25 Td (business.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Thir) Tj ET Q q 0 0 0 rg BT 52.86 725.25 Td (d ) Tj ET Q q 0 0 0 rg BT 60.54 725.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 90.99 725.25 Td (may ) Tj ET Q q 0 0 0 rg BT 110.33 725.25 Td (illegally ) Tj ET Q q 0 0 0 rg BT 145.78 725.25 Td (distribute ) Tj ET Q q 0 0 0 rg BT 186.79 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 204.47 725.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 221.03 725.25 Td (counterfeit ) Tj ET Q q 0 0 0 rg BT 267.03 725.25 Td (versions ) Tj ET Q q 0 0 0 rg BT 303.03 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 313.49 725.25 Td (our ) Tj ET Q q 0 0 0 rg BT 330.06 725.25 Td (pr) Tj ET Q q 0 0 0 rg BT 338.58 725.25 Td (oducts, ) Tj ET Q q 0 0 0 rg BT 369.87 725.25 Td (which ) Tj ET Q q 0 0 0 rg BT 396.43 725.25 Td (do ) Tj ET Q q 0 0 0 rg BT 409.11 725.25 Td (not ) Tj ET Q q 0 0 0 rg BT 424.56 725.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 446.12 725.25 Td (our ) Tj ET Q q 0 0 0 rg BT 462.69 725.25 Td (rigor) Tj ET Q q 0 0 0 rg BT 482.88 725.25 Td (ous ) Tj ET Q q 0 0 0 rg BT 499.44 725.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 561.01 725.25 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (testing ) Tj ET Q q 0 0 0 rg BT 64.40 713.25 Td (standar) Tj ET Q q 0 0 0 rg BT 94.59 713.25 Td (ds. ) Tj ET Q q 0 0 0 rg BT 107.58 713.25 Td (A) Tj ET Q q 0 0 0 rg BT 113.51 713.25 Td ( ) Tj ET Q q 0 0 0 rg BT 115.24 713.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 144.74 713.25 Td (who ) Tj ET Q q 0 0 0 rg BT 163.14 713.25 Td (r) Tj ET Q q 0 0 0 rg BT 166.66 713.25 Td (eceives ) Tj ET Q q 0 0 0 rg BT 197.26 713.25 Td (a ) Tj ET Q q 0 0 0 rg BT 203.99 713.25 Td (counterfeit ) Tj ET Q q 0 0 0 rg BT 249.04 713.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 269.66 713.25 Td (may ) Tj ET Q q 0 0 0 rg BT 288.05 713.25 Td (be ) Tj ET Q q 0 0 0 rg BT 299.22 713.25 Td (at ) Tj ET Q q 0 0 0 rg BT 308.72 713.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 325.45 713.25 Td (for ) Tj ET Q q 0 0 0 rg BT 338.85 713.25 Td (a ) Tj ET Q q 0 0 0 rg BT 345.58 713.25 Td (number ) Tj ET Q q 0 0 0 rg BT 377.87 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 387.37 713.25 Td (danger) Tj ET Q q 0 0 0 rg BT 415.33 713.25 Td (ous ) Tj ET Q q 0 0 0 rg BT 430.95 713.25 Td (health ) Tj ET Q q 0 0 0 rg BT 457.68 713.25 Td (consequences. ) Tj ET Q q 0 0 0 rg BT 516.89 713.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 534.73 713.25 Td (r) Tj ET Q q 0 0 0 rg BT 538.25 713.25 Td (eputation ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.02 701.25 Td (business ) Tj ET Q q 0 0 0 rg BT 88.93 701.25 Td (could ) Tj ET Q q 0 0 0 rg BT 113.16 701.25 Td (suffer ) Tj ET Q q 0 0 0 rg BT 137.96 701.25 Td (harm ) Tj ET Q q 0 0 0 rg BT 161.09 701.25 Td (as ) Tj ET Q q 0 0 0 rg BT 172.00 701.25 Td (a ) Tj ET Q q 0 0 0 rg BT 179.02 701.25 Td (r) Tj ET Q q 0 0 0 rg BT 182.54 701.25 Td (esult ) Tj ET Q q 0 0 0 rg BT 203.44 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 213.24 701.25 Td (counterfeit ) Tj ET Q q 0 0 0 rg BT 258.58 701.25 Td (drugs ) Tj ET Q q 0 0 0 rg BT 283.38 701.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 302.07 701.25 Td (under ) Tj ET Q q 0 0 0 rg BT 327.42 701.25 Td (our ) Tj ET Q q 0 0 0 rg BT 343.33 701.25 Td (brand ) Tj ET Q q 0 0 0 rg BT 369.23 701.25 Td (name. ) Tj ET Q q 0 0 0 rg BT 395.41 701.25 Td (In ) Tj ET Q q 0 0 0 rg BT 405.76 701.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 443.61 701.25 Td (thefts ) Tj ET Q q 0 0 0 rg BT 467.30 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 477.09 701.25 Td (inventory ) Tj ET Q q 0 0 0 rg BT 516.88 701.25 Td (at ) Tj ET Q q 0 0 0 rg BT 526.67 701.25 Td (war) Tj ET Q q 0 0 0 rg BT 541.86 701.25 Td (ehouses, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (plants ) Tj ET Q q 0 0 0 rg BT 62.89 689.25 Td (or ) Tj ET Q q 0 0 0 rg BT 74.22 689.25 Td (while ) Tj ET Q q 0 0 0 rg BT 98.32 689.25 Td (in-transit, ) Tj ET Q q 0 0 0 rg BT 140.49 689.25 Td (which ) Tj ET Q q 0 0 0 rg BT 166.81 689.25 Td (ar) Tj ET Q q 0 0 0 rg BT 175.33 689.25 Td (e ) Tj ET Q q 0 0 0 rg BT 182.21 689.25 Td (then ) Tj ET Q q 0 0 0 rg BT 201.87 689.25 Td (not ) Tj ET Q q 0 0 0 rg BT 217.08 689.25 Td (pr) Tj ET Q q 0 0 0 rg BT 225.60 689.25 Td (operly ) Tj ET Q q 0 0 0 rg BT 253.59 689.25 Td (stor) Tj ET Q q 0 0 0 rg BT 268.78 689.25 Td (ed ) Tj ET Q q 0 0 0 rg BT 280.66 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 298.10 689.25 Td (ar) Tj ET Q q 0 0 0 rg BT 306.62 689.25 Td (e ) Tj ET Q q 0 0 0 rg BT 313.50 689.25 Td (later ) Tj ET Q q 0 0 0 rg BT 334.82 689.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 353.93 689.25 Td (thr) Tj ET Q q 0 0 0 rg BT 365.23 689.25 Td (ough ) Tj ET Q q 0 0 0 rg BT 387.67 689.25 Td (unauthorized ) Tj ET Q q 0 0 0 rg BT 442.88 689.25 Td (channels, ) Tj ET Q q 0 0 0 rg BT 483.37 689.25 Td (could ) Tj ET Q q 0 0 0 rg BT 508.03 689.25 Td (adversely ) Tj ET Q q 0 0 0 rg BT 548.78 689.25 Td (impact ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (patient ) Tj ET Q q 0 0 0 rg BT 66.27 677.25 Td (safety) Tj ET Q q 0 0 0 rg BT 89.05 677.25 Td (, ) Tj ET Q q 0 0 0 rg BT 94.05 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 110.44 677.25 Td (r) Tj ET Q q 0 0 0 rg BT 113.96 677.25 Td (eputation ) Tj ET Q q 0 0 0 rg BT 154.23 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 171.73 677.25 Td (our ) Tj ET Q q 0 0 0 rg BT 188.12 677.25 Td (business.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 654.45 Td (W) Tj ET Q q 0 0 0 rg BT 44.15 654.45 Td (e ) Tj ET Q q 0 0 0 rg BT 51.74 654.45 Td (are ) Tj ET Q q 0 0 0 rg BT 68.22 654.45 Td (dependent ) Tj ET Q q 0 0 0 rg BT 113.59 654.45 Td (on ) Tj ET Q q 0 0 0 rg BT 127.31 654.45 Td (information ) Tj ET Q q 0 0 0 rg BT 179.92 654.45 Td (technology ) Tj ET Q q 0 0 0 rg BT 228.07 654.45 Td (and ) Tj ET Q q 0 0 0 rg BT 246.78 654.45 Td (our ) Tj ET Q q 0 0 0 rg BT 264.39 654.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 298.65 654.45 Td (and ) Tj ET Q q 0 0 0 rg BT 317.37 654.45 Td (infrastructure ) Tj ET Q q 0 0 0 rg BT 378.31 654.45 Td (face ) Tj ET Q q 0 0 0 rg BT 398.67 654.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 430.71 654.45 Td (risks, ) Tj ET Q q 0 0 0 rg BT 455.82 654.45 Td (including ) Tj ET Q q 0 0 0 rg BT 498.43 654.45 Td (from ) Tj ET Q q 0 0 0 rg BT 521.58 654.45 Td (cybersecurity ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 642.45 Td (breaches ) Tj ET Q q 0 0 0 rg BT 75.16 642.45 Td (and ) Tj ET Q q 0 0 0 rg BT 93.22 642.45 Td (data ) Tj ET Q q 0 0 0 rg BT 113.50 642.45 Td (leakage.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 630.45 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 630.45 Td (e ) Tj ET Q q 0 0 0 rg BT 49.56 630.45 Td (r) Tj ET Q q 0 0 0 rg BT 53.08 630.45 Td (ely ) Tj ET Q q 0 0 0 rg BT 66.45 630.45 Td (extensively ) Tj ET Q q 0 0 0 rg BT 112.02 630.45 Td (on ) Tj ET Q q 0 0 0 rg BT 123.73 630.45 Td (IT) Tj ET Q q 0 0 0 rg BT 132.44 630.45 Td ( ) Tj ET Q q 0 0 0 rg BT 134.15 630.45 Td (systems, ) Tj ET Q q 0 0 0 rg BT 168.91 630.45 Td (networks ) Tj ET Q q 0 0 0 rg BT 206.73 630.45 Td (and ) Tj ET Q q 0 0 0 rg BT 223.44 630.45 Td (services, ) Tj ET Q q 0 0 0 rg BT 259.86 630.45 Td (including ) Tj ET Q q 0 0 0 rg BT 299.34 630.45 Td (internet ) Tj ET Q q 0 0 0 rg BT 332.15 630.45 Td (sites, ) Tj ET Q q 0 0 0 rg BT 354.14 630.45 Td (data ) Tj ET Q q 0 0 0 rg BT 373.63 630.45 Td (hosting ) Tj ET Q q 0 0 0 rg BT 404.79 630.45 Td (and ) Tj ET Q q 0 0 0 rg BT 421.50 630.45 Td (pr) Tj ET Q q 0 0 0 rg BT 430.02 630.45 Td (ocessing ) Tj ET Q q 0 0 0 rg BT 466.17 630.45 Td (facilities ) Tj ET Q q 0 0 0 rg BT 502.32 630.45 Td (and ) Tj ET Q q 0 0 0 rg BT 519.03 630.45 Td (tools, ) Tj ET Q q 0 0 0 rg BT 542.69 630.45 Td (physical ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 618.45 Td (security ) Tj ET Q q 0 0 0 rg BT 70.27 618.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 103.43 618.45 Td (and ) Tj ET Q q 0 0 0 rg BT 121.04 618.45 Td (other ) Tj ET Q q 0 0 0 rg BT 144.76 618.45 Td (har) Tj ET Q q 0 0 0 rg BT 158.29 618.45 Td (dwar) Tj ET Q q 0 0 0 rg BT 178.48 618.45 Td (e, ) Tj ET Q q 0 0 0 rg BT 188.03 618.45 Td (softwar) Tj ET Q q 0 0 0 rg BT 217.67 618.45 Td (e ) Tj ET Q q 0 0 0 rg BT 224.72 618.45 Td (and ) Tj ET Q q 0 0 0 rg BT 242.33 618.45 Td (technical ) Tj ET Q q 0 0 0 rg BT 281.59 618.45 Td (applications ) Tj ET Q q 0 0 0 rg BT 333.65 618.45 Td (and ) Tj ET Q q 0 0 0 rg BT 351.26 618.45 Td (platforms, ) Tj ET Q q 0 0 0 rg BT 394.71 618.45 Td (some ) Tj ET Q q 0 0 0 rg BT 417.88 618.45 Td (of ) Tj ET Q q 0 0 0 rg BT 428.27 618.45 Td (which ) Tj ET Q q 0 0 0 rg BT 454.76 618.45 Td (ar) Tj ET Q q 0 0 0 rg BT 463.29 618.45 Td (e ) Tj ET Q q 0 0 0 rg BT 470.34 618.45 Td (managed, ) Tj ET Q q 0 0 0 rg BT 512.11 618.45 Td (hosted ) Tj ET Q q 0 0 0 rg BT 540.83 618.45 Td (pr) Tj ET Q q 0 0 0 rg BT 549.35 618.45 Td (ovided ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 606.45 Td (and/or ) Tj ET Q q 0 0 0 rg BT 66.35 606.45 Td (used ) Tj ET Q q 0 0 0 rg BT 88.36 606.45 Td (for ) Tj ET Q q 0 0 0 rg BT 103.71 606.45 Td (thir) Tj ET Q q 0 0 0 rg BT 117.79 606.45 Td (d-parties ) Tj ET Q q 0 0 0 rg BT 157.58 606.45 Td (or ) Tj ET Q q 0 0 0 rg BT 170.16 606.45 Td (their ) Tj ET Q q 0 0 0 rg BT 192.72 606.45 Td (vendors, ) Tj ET Q q 0 0 0 rg BT 230.57 606.45 Td (to ) Tj ET Q q 0 0 0 rg BT 242.03 606.45 Td (assist ) Tj ET Q q 0 0 0 rg BT 267.94 606.45 Td (in ) Tj ET Q q 0 0 0 rg BT 279.40 606.45 Td (conducting ) Tj ET Q q 0 0 0 rg BT 327.51 606.45 Td (our ) Tj ET Q q 0 0 0 rg BT 345.09 606.45 Td (business. ) Tj ET Q q 0 0 0 rg BT 384.89 606.45 Td (A) Tj ET Q q 0 0 0 rg BT 390.82 606.45 Td ( ) Tj ET Q q 0 0 0 rg BT 394.50 606.45 Td (significant ) Tj ET Q q 0 0 0 rg BT 440.41 606.45 Td (br) Tj ET Q q 0 0 0 rg BT 448.93 606.45 Td (eakdown, ) Tj ET Q q 0 0 0 rg BT 490.66 606.45 Td (invasion, ) Tj ET Q q 0 0 0 rg BT 530.72 606.45 Td (corruption, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 594.45 Td (destruction ) Tj ET Q q 0 0 0 rg BT 83.23 594.45 Td (or ) Tj ET Q q 0 0 0 rg BT 94.36 594.45 Td (interruption ) Tj ET Q q 0 0 0 rg BT 144.93 594.45 Td (of ) Tj ET Q q 0 0 0 rg BT 154.95 594.45 Td (critical ) Tj ET Q q 0 0 0 rg BT 186.06 594.45 Td (information ) Tj ET Q q 0 0 0 rg BT 235.53 594.45 Td (technology ) Tj ET Q q 0 0 0 rg BT 281.63 594.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 314.42 594.45 Td (or ) Tj ET Q q 0 0 0 rg BT 325.55 594.45 Td (infrastructur) Tj ET Q q 0 0 0 rg BT 376.30 594.45 Td (e, ) Tj ET Q q 0 0 0 rg BT 385.47 594.45 Td (by ) Tj ET Q q 0 0 0 rg BT 397.15 594.45 Td (our ) Tj ET Q q 0 0 0 rg BT 413.28 594.45 Td (workfor) Tj ET Q q 0 0 0 rg BT 444.57 594.45 Td (ce, ) Tj ET Q q 0 0 0 rg BT 458.19 594.45 Td (others ) Tj ET Q q 0 0 0 rg BT 485.42 594.45 Td (with ) Tj ET Q q 0 0 0 rg BT 504.89 594.45 Td (authorized ) Tj ET Q q 0 0 0 rg BT 549.90 594.45 Td (access ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 582.45 Td (to ) Tj ET Q q 0 0 0 rg BT 45.26 582.45 Td (our ) Tj ET Q q 0 0 0 rg BT 60.62 582.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 92.65 582.45 Td (or ) Tj ET Q q 0 0 0 rg BT 103.02 582.45 Td (unauthorized ) Tj ET Q q 0 0 0 rg BT 157.28 582.45 Td (persons ) Tj ET Q q 0 0 0 rg BT 189.87 582.45 Td (could ) Tj ET Q q 0 0 0 rg BT 213.56 582.45 Td (negatively ) Tj ET Q q 0 0 0 rg BT 256.13 582.45 Td (impact ) Tj ET Q q 0 0 0 rg BT 284.82 582.45 Td (operations. ) Tj ET Q q 0 0 0 rg BT 331.58 582.45 Td (The ) Tj ET Q q 0 0 0 rg BT 348.05 582.45 Td (ever) Tj ET Q q 0 0 0 rg BT 365.06 582.45 Td (-incr) Tj ET Q q 0 0 0 rg BT 384.13 582.45 Td (easing ) Tj ET Q q 0 0 0 rg BT 411.71 582.45 Td (use ) Tj ET Q q 0 0 0 rg BT 426.52 582.45 Td (and ) Tj ET Q q 0 0 0 rg BT 443.00 582.45 Td (evolution ) Tj ET Q q 0 0 0 rg BT 481.69 582.45 Td (of ) Tj ET Q q 0 0 0 rg BT 490.94 582.45 Td (technology) Tj ET Q q 0 0 0 rg BT 534.26 582.45 Td (, ) Tj ET Q q 0 0 0 rg BT 538.24 582.45 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 570.45 Td (cloud-based ) Tj ET Q q 0 0 0 rg BT 87.32 570.45 Td (computing, ) Tj ET Q q 0 0 0 rg BT 134.49 570.45 Td (cr) Tj ET Q q 0 0 0 rg BT 142.45 570.45 Td (eates ) Tj ET Q q 0 0 0 rg BT 165.44 570.45 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 221.22 570.45 Td (for ) Tj ET Q q 0 0 0 rg BT 235.34 570.45 Td (the ) Tj ET Q q 0 0 0 rg BT 250.00 570.45 Td (unintentional ) Tj ET Q q 0 0 0 rg BT 305.78 570.45 Td (dissemination ) Tj ET Q q 0 0 0 rg BT 363.78 570.45 Td (or ) Tj ET Q q 0 0 0 rg BT 375.12 570.45 Td (intentional ) Tj ET Q q 0 0 0 rg BT 420.89 570.45 Td (destruction ) Tj ET Q q 0 0 0 rg BT 468.33 570.45 Td (of ) Tj ET Q q 0 0 0 rg BT 478.56 570.45 Td (confidential ) Tj ET Q q 0 0 0 rg BT 528.77 570.45 Td (information ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 558.45 Td (stor) Tj ET Q q 0 0 0 rg BT 51.19 558.45 Td (ed ) Tj ET Q q 0 0 0 rg BT 62.81 558.45 Td (in ) Tj ET Q q 0 0 0 rg BT 72.76 558.45 Td (our ) Tj ET Q q 0 0 0 rg BT 88.83 558.45 Td (or ) Tj ET Q q 0 0 0 rg BT 99.90 558.45 Td (our ) Tj ET Q q 0 0 0 rg BT 115.97 558.45 Td (thir) Tj ET Q q 0 0 0 rg BT 130.04 558.45 Td (d-party ) Tj ET Q q 0 0 0 rg BT 161.66 558.45 Td (pr) Tj ET Q q 0 0 0 rg BT 170.18 558.45 Td (oviders' ) Tj ET Q q 0 0 0 rg BT 203.93 558.45 Td (systems, ) Tj ET Q q 0 0 0 rg BT 239.16 558.45 Td (portable ) Tj ET Q q 0 0 0 rg BT 275.22 558.45 Td (media ) Tj ET Q q 0 0 0 rg BT 301.84 558.45 Td (or ) Tj ET Q q 0 0 0 rg BT 312.91 558.45 Td (storage ) Tj ET Q q 0 0 0 rg BT 345.08 558.45 Td (devices. ) Tj ET Q q 0 0 0 rg BT 379.19 558.45 Td (W) Tj ET Q q 0 0 0 rg BT 386.60 558.45 Td (e ) Tj ET Q q 0 0 0 rg BT 393.21 558.45 Td (could ) Tj ET Q q 0 0 0 rg BT 417.61 558.45 Td (also ) Tj ET Q q 0 0 0 rg BT 436.45 558.45 Td (experience ) Tj ET Q q 0 0 0 rg BT 481.93 558.45 Td (a ) Tj ET Q q 0 0 0 rg BT 489.11 558.45 Td (business ) Tj ET Q q 0 0 0 rg BT 525.18 558.45 Td (interruption, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 546.45 Td (theft ) Tj ET Q q 0 0 0 rg BT 56.26 546.45 Td (of ) Tj ET Q q 0 0 0 rg BT 66.52 546.45 Td (confidential ) Tj ET Q q 0 0 0 rg BT 116.77 546.45 Td (information ) Tj ET Q q 0 0 0 rg BT 166.47 546.45 Td (or ) Tj ET Q q 0 0 0 rg BT 177.85 546.45 Td (r) Tj ET Q q 0 0 0 rg BT 181.37 546.45 Td (eputational ) Tj ET Q q 0 0 0 rg BT 229.40 546.45 Td (damage ) Tj ET Q q 0 0 0 rg BT 263.54 546.45 Td (fr) Tj ET Q q 0 0 0 rg BT 269.84 546.45 Td (om ) Tj ET Q q 0 0 0 rg BT 284.55 546.45 Td (industrial ) Tj ET Q q 0 0 0 rg BT 325.93 546.45 Td (espionage ) Tj ET Q q 0 0 0 rg BT 368.95 546.45 Td (attacks, ) Tj ET Q q 0 0 0 rg BT 402.26 546.45 Td (malwar) Tj ET Q q 0 0 0 rg BT 432.45 546.45 Td (e ) Tj ET Q q 0 0 0 rg BT 439.37 546.45 Td (or ) Tj ET Q q 0 0 0 rg BT 450.75 546.45 Td (other ) Tj ET Q q 0 0 0 rg BT 474.34 546.45 Td (cyber) Tj ET Q q 0 0 0 rg BT 496.34 546.45 Td (-attacks, ) Tj ET Q q 0 0 0 rg BT 532.98 546.45 Td (which ) Tj ET Q q 0 0 0 rg BT 559.35 546.45 Td (may ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 534.45 Td (compr) Tj ET Q q 0 0 0 rg BT 61.18 534.45 Td (omise ) Tj ET Q q 0 0 0 rg BT 87.00 534.45 Td (our ) Tj ET Q q 0 0 0 rg BT 103.39 534.45 Td (system ) Tj ET Q q 0 0 0 rg BT 132.54 534.45 Td (infrastructur) Tj ET Q q 0 0 0 rg BT 183.29 534.45 Td (e ) Tj ET Q q 0 0 0 rg BT 190.22 534.45 Td (or ) Tj ET Q q 0 0 0 rg BT 201.60 534.45 Td (lead ) Tj ET Q q 0 0 0 rg BT 221.31 534.45 Td (to ) Tj ET Q q 0 0 0 rg BT 231.58 534.45 Td (data ) Tj ET Q q 0 0 0 rg BT 251.85 534.45 Td (leakage, ) Tj ET Q q 0 0 0 rg BT 287.94 534.45 Td (either ) Tj ET Q q 0 0 0 rg BT 313.76 534.45 Td (internally ) Tj ET Q q 0 0 0 rg BT 355.13 534.45 Td (or ) Tj ET Q q 0 0 0 rg BT 366.52 534.45 Td (at ) Tj ET Q q 0 0 0 rg BT 376.79 534.45 Td (our ) Tj ET Q q 0 0 0 rg BT 393.17 534.45 Td (thir) Tj ET Q q 0 0 0 rg BT 407.25 534.45 Td (d-party ) Tj ET Q q 0 0 0 rg BT 439.18 534.45 Td (pr) Tj ET Q q 0 0 0 rg BT 447.70 534.45 Td (oviders. ) Tj ET Q q 0 0 0 rg BT 481.95 534.45 Td (Although ) Tj ET Q q 0 0 0 rg BT 521.11 534.45 Td (the ) Tj ET Q q 0 0 0 rg BT 535.82 534.45 Td (aggr) Tj ET Q q 0 0 0 rg BT 554.34 534.45 Td (egate ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 522.45 Td (impact ) Tj ET Q q 0 0 0 rg BT 66.28 522.45 Td (on ) Tj ET Q q 0 0 0 rg BT 79.35 522.45 Td (our ) Tj ET Q q 0 0 0 rg BT 96.31 522.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 142.16 522.45 Td (and ) Tj ET Q q 0 0 0 rg BT 160.23 522.45 Td (financial ) Tj ET Q q 0 0 0 rg BT 198.85 522.45 Td (condition ) Tj ET Q q 0 0 0 rg BT 239.69 522.45 Td (has ) Tj ET Q q 0 0 0 rg BT 256.65 522.45 Td (not ) Tj ET Q q 0 0 0 rg BT 272.49 522.45 Td (been ) Tj ET Q q 0 0 0 rg BT 294.44 522.45 Td (material ) Tj ET Q q 0 0 0 rg BT 331.39 522.45 Td (to ) Tj ET Q q 0 0 0 rg BT 342.24 522.45 Td (date, ) Tj ET Q q 0 0 0 rg BT 365.02 522.45 Td (we ) Tj ET Q q 0 0 0 rg BT 379.20 522.45 Td (have ) Tj ET Q q 0 0 0 rg BT 401.14 522.45 Td (been ) Tj ET Q q 0 0 0 rg BT 423.09 522.45 Td (the ) Tj ET Q q 0 0 0 rg BT 438.37 522.45 Td (tar) Tj ET Q q 0 0 0 rg BT 449.67 522.45 Td (get ) Tj ET Q q 0 0 0 rg BT 464.96 522.45 Td (of ) Tj ET Q q 0 0 0 rg BT 475.80 522.45 Td (events ) Tj ET Q q 0 0 0 rg BT 503.86 522.45 Td (of ) Tj ET Q q 0 0 0 rg BT 514.70 522.45 Td (this ) Tj ET Q q 0 0 0 rg BT 532.22 522.45 Td (natur) Tj ET Q q 0 0 0 rg BT 553.52 522.45 Td (e ) Tj ET Q q 0 0 0 rg BT 561.02 522.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 510.45 Td (expect ) Tj ET Q q 0 0 0 rg BT 63.22 510.45 Td (them ) Tj ET Q q 0 0 0 rg BT 84.35 510.45 Td (to ) Tj ET Q q 0 0 0 rg BT 93.81 510.45 Td (continue ) Tj ET Q q 0 0 0 rg BT 129.94 510.45 Td (as ) Tj ET Q q 0 0 0 rg BT 140.52 510.45 Td (cybersecurity ) Tj ET Q q 0 0 0 rg BT 196.07 510.45 Td (thr) Tj ET Q q 0 0 0 rg BT 207.37 510.45 Td (eats ) Tj ET Q q 0 0 0 rg BT 225.16 510.45 Td (have ) Tj ET Q q 0 0 0 rg BT 245.73 510.45 Td (been ) Tj ET Q q 0 0 0 rg BT 266.29 510.45 Td (rapidly ) Tj ET Q q 0 0 0 rg BT 296.87 510.45 Td (evolving ) Tj ET Q q 0 0 0 rg BT 332.43 510.45 Td (in ) Tj ET Q q 0 0 0 rg BT 341.90 510.45 Td (sophistication ) Tj ET Q q 0 0 0 rg BT 399.70 510.45 Td (and ) Tj ET Q q 0 0 0 rg BT 416.39 510.45 Td (becoming ) Tj ET Q q 0 0 0 rg BT 456.95 510.45 Td (mor) Tj ET Q q 0 0 0 rg BT 472.69 510.45 Td (e ) Tj ET Q q 0 0 0 rg BT 478.82 510.45 Td (pr) Tj ET Q q 0 0 0 rg BT 487.34 510.45 Td (evalent ) Tj ET Q q 0 0 0 rg BT 517.90 510.45 Td (in ) Tj ET Q q 0 0 0 rg BT 527.37 510.45 Td (the ) Tj ET Q q 0 0 0 rg BT 541.27 510.45 Td (industry) Tj ET Q q 0 0 0 rg BT 573.50 510.45 Td (. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 498.45 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 498.45 Td (e ) Tj ET Q q 0 0 0 rg BT 50.39 498.45 Td (have ) Tj ET Q q 0 0 0 rg BT 71.81 498.45 Td (invested ) Tj ET Q q 0 0 0 rg BT 107.12 498.45 Td (in ) Tj ET Q q 0 0 0 rg BT 117.44 498.45 Td (industry ) Tj ET Q q 0 0 0 rg BT 152.76 498.45 Td (appr) Tj ET Q q 0 0 0 rg BT 171.28 498.45 Td (opriate ) Tj ET Q q 0 0 0 rg BT 202.71 498.45 Td (pr) Tj ET Q q 0 0 0 rg BT 211.23 498.45 Td (otections ) Tj ET Q q 0 0 0 rg BT 249.88 498.45 Td (and ) Tj ET Q q 0 0 0 rg BT 267.42 498.45 Td (monitoring ) Tj ET Q q 0 0 0 rg BT 314.41 498.45 Td (practices ) Tj ET Q q 0 0 0 rg BT 353.61 498.45 Td (of ) Tj ET Q q 0 0 0 rg BT 363.93 498.45 Td (our ) Tj ET Q q 0 0 0 rg BT 380.37 498.45 Td (data ) Tj ET Q q 0 0 0 rg BT 400.69 498.45 Td (and ) Tj ET Q q 0 0 0 rg BT 418.23 498.45 Td (IT) Tj ET Q q 0 0 0 rg BT 426.94 498.45 Td ( ) Tj ET Q q 0 0 0 rg BT 429.49 498.45 Td (to ) Tj ET Q q 0 0 0 rg BT 439.81 498.45 Td (r) Tj ET Q q 0 0 0 rg BT 443.33 498.45 Td (educe ) Tj ET Q q 0 0 0 rg BT 469.19 498.45 Td (these ) Tj ET Q q 0 0 0 rg BT 492.28 498.45 Td (risks ) Tj ET Q q 0 0 0 rg BT 513.71 498.45 Td (and ) Tj ET Q q 0 0 0 rg BT 531.25 498.45 Td (continue ) Tj ET Q q 0 0 0 rg BT 568.23 498.45 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 486.45 Td (monitor ) Tj ET Q q 0 0 0 rg BT 70.21 486.45 Td (our ) Tj ET Q q 0 0 0 rg BT 86.64 486.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 119.73 486.45 Td (on ) Tj ET Q q 0 0 0 rg BT 132.27 486.45 Td (an ) Tj ET Q q 0 0 0 rg BT 144.81 486.45 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 180.13 486.45 Td (basis ) Tj ET Q q 0 0 0 rg BT 203.23 486.45 Td (for ) Tj ET Q q 0 0 0 rg BT 217.44 486.45 Td (any ) Tj ET Q q 0 0 0 rg BT 234.41 486.45 Td (curr) Tj ET Q q 0 0 0 rg BT 251.26 486.45 Td (ent ) Tj ET Q q 0 0 0 rg BT 266.02 486.45 Td (or ) Tj ET Q q 0 0 0 rg BT 277.45 486.45 Td (potential ) Tj ET Q q 0 0 0 rg BT 315.54 486.45 Td (thr) Tj ET Q q 0 0 0 rg BT 326.84 486.45 Td (eats. ) Tj ET Q q 0 0 0 rg BT 347.99 486.45 Td (Ther) Tj ET Q q 0 0 0 rg BT 366.51 486.45 Td (e ) Tj ET Q q 0 0 0 rg BT 373.49 486.45 Td (can ) Tj ET Q q 0 0 0 rg BT 390.46 486.45 Td (be ) Tj ET Q q 0 0 0 rg BT 402.44 486.45 Td (no ) Tj ET Q q 0 0 0 rg BT 414.98 486.45 Td (assurance, ) Tj ET Q q 0 0 0 rg BT 460.57 486.45 Td (however) Tj ET Q q 0 0 0 rg BT 493.34 486.45 Td (, ) Tj ET Q q 0 0 0 rg BT 498.38 486.45 Td (that ) Tj ET Q q 0 0 0 rg BT 516.47 486.45 Td (our ) Tj ET Q q 0 0 0 rg BT 532.90 486.45 Td (efforts ) Tj ET Q q 0 0 0 rg BT 561.00 486.45 Td (will ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 474.45 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 474.45 Td (event ) Tj ET Q q 0 0 0 rg BT 68.11 474.45 Td (br) Tj ET Q q 0 0 0 rg BT 76.63 474.45 Td (eakdowns ) Tj ET Q q 0 0 0 rg BT 118.57 474.45 Td (or ) Tj ET Q q 0 0 0 rg BT 129.96 474.45 Td (br) Tj ET Q q 0 0 0 rg BT 138.49 474.45 Td (eaches ) Tj ET Q q 0 0 0 rg BT 168.19 474.45 Td (to ) Tj ET Q q 0 0 0 rg BT 178.47 474.45 Td (our ) Tj ET Q q 0 0 0 rg BT 194.86 474.45 Td (or ) Tj ET Q q 0 0 0 rg BT 206.25 474.45 Td (our ) Tj ET Q q 0 0 0 rg BT 222.65 474.45 Td (thir) Tj ET Q q 0 0 0 rg BT 236.72 474.45 Td (d-party ) Tj ET Q q 0 0 0 rg BT 268.66 474.45 Td (pr) Tj ET Q q 0 0 0 rg BT 277.18 474.45 Td (oviders’) Tj ET Q q 0 0 0 rg BT 308.84 474.45 Td ( ) Tj ET Q q 0 0 0 rg BT 311.34 474.45 Td (databases ) Tj ET Q q 0 0 0 rg BT 353.84 474.45 Td (or ) Tj ET Q q 0 0 0 rg BT 365.23 474.45 Td (systems ) Tj ET Q q 0 0 0 rg BT 398.29 474.45 Td (that ) Tj ET Q q 0 0 0 rg BT 416.34 474.45 Td (could ) Tj ET Q q 0 0 0 rg BT 441.06 474.45 Td (adversely ) Tj ET Q q 0 0 0 rg BT 481.87 474.45 Td (affect ) Tj ET Q q 0 0 0 rg BT 506.59 474.45 Td (our ) Tj ET Q q 0 0 0 rg BT 522.98 474.45 Td (business.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 450.45 Td (Increased ) Tj ET Q q 0 0 0 rg BT 79.05 450.45 Td (use ) Tj ET Q q 0 0 0 rg BT 95.44 450.45 Td (of ) Tj ET Q q 0 0 0 rg BT 106.27 450.45 Td (social ) Tj ET Q q 0 0 0 rg BT 132.66 450.45 Td (media ) Tj ET Q q 0 0 0 rg BT 160.16 450.45 Td (platforms ) Tj ET Q q 0 0 0 rg BT 202.10 450.45 Td (present ) Tj ET Q q 0 0 0 rg BT 234.60 450.45 Td (risks ) Tj ET Q q 0 0 0 rg BT 256.56 450.45 Td (and ) Tj ET Q q 0 0 0 rg BT 274.62 450.45 Td (challenges.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 438.45 Td (W) Tj ET Q q 0 0 0 rg BT 43.41 438.45 Td (e ) Tj ET Q q 0 0 0 rg BT 50.87 438.45 Td (ar) Tj ET Q q 0 0 0 rg BT 59.39 438.45 Td (e ) Tj ET Q q 0 0 0 rg BT 66.85 438.45 Td (incr) Tj ET Q q 0 0 0 rg BT 82.59 438.45 Td (easing ) Tj ET Q q 0 0 0 rg BT 111.72 438.45 Td (our ) Tj ET Q q 0 0 0 rg BT 128.63 438.45 Td (use ) Tj ET Q q 0 0 0 rg BT 144.98 438.45 Td (of ) Tj ET Q q 0 0 0 rg BT 155.78 438.45 Td (social ) Tj ET Q q 0 0 0 rg BT 182.68 438.45 Td (media ) Tj ET Q q 0 0 0 rg BT 210.14 438.45 Td (to ) Tj ET Q q 0 0 0 rg BT 220.94 438.45 Td (communicate ) Tj ET Q q 0 0 0 rg BT 277.27 438.45 Td (Company ) Tj ET Q q 0 0 0 rg BT 318.62 438.45 Td (news ) Tj ET Q q 0 0 0 rg BT 341.64 438.45 Td (and ) Tj ET Q q 0 0 0 rg BT 359.66 438.45 Td (events. ) Tj ET Q q 0 0 0 rg BT 390.17 438.45 Td (The ) Tj ET Q q 0 0 0 rg BT 408.19 438.45 Td (inappr) Tj ET Q q 0 0 0 rg BT 434.49 438.45 Td (opriate ) Tj ET Q q 0 0 0 rg BT 466.40 438.45 Td (and/or ) Tj ET Q q 0 0 0 rg BT 496.09 438.45 Td (unauthorized ) Tj ET Q q 0 0 0 rg BT 551.88 438.45 Td (use ) Tj ET Q q 0 0 0 rg BT 568.23 438.45 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 426.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 66.11 426.45 Td (media ) Tj ET Q q 0 0 0 rg BT 92.33 426.45 Td (vehicles ) Tj ET Q q 0 0 0 rg BT 126.32 426.45 Td (could ) Tj ET Q q 0 0 0 rg BT 150.32 426.45 Td (cause ) Tj ET Q q 0 0 0 rg BT 174.87 426.45 Td (brand ) Tj ET Q q 0 0 0 rg BT 200.54 426.45 Td (damage ) Tj ET Q q 0 0 0 rg BT 233.99 426.45 Td (or ) Tj ET Q q 0 0 0 rg BT 244.66 426.45 Td (information ) Tj ET Q q 0 0 0 rg BT 293.67 426.45 Td (leakage ) Tj ET Q q 0 0 0 rg BT 326.55 426.45 Td (or ) Tj ET Q q 0 0 0 rg BT 337.23 426.45 Td (could ) Tj ET Q q 0 0 0 rg BT 361.23 426.45 Td (lead ) Tj ET Q q 0 0 0 rg BT 380.23 426.45 Td (to ) Tj ET Q q 0 0 0 rg BT 389.79 426.45 Td (legal ) Tj ET Q q 0 0 0 rg BT 411.57 426.45 Td (implications, ) Tj ET Q q 0 0 0 rg BT 465.30 426.45 Td (including ) Tj ET Q q 0 0 0 rg BT 504.85 426.45 Td (fr) Tj ET Q q 0 0 0 rg BT 511.15 426.45 Td (om ) Tj ET Q q 0 0 0 rg BT 525.16 426.45 Td (the ) Tj ET Q q 0 0 0 rg BT 539.16 426.45 Td (impr) Tj ET Q q 0 0 0 rg BT 557.68 426.45 Td (oper ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 414.45 Td (collection ) Tj ET Q q 0 0 0 rg BT 79.54 414.45 Td (and/or ) Tj ET Q q 0 0 0 rg BT 110.31 414.45 Td (dissemination ) Tj ET Q q 0 0 0 rg BT 169.97 414.45 Td (of ) Tj ET Q q 0 0 0 rg BT 181.86 414.45 Td (personally ) Tj ET Q q 0 0 0 rg BT 228.18 414.45 Td (identifiable ) Tj ET Q q 0 0 0 rg BT 277.84 414.45 Td (information ) Tj ET Q q 0 0 0 rg BT 329.17 414.45 Td (fr) Tj ET Q q 0 0 0 rg BT 335.47 414.45 Td (om ) Tj ET Q q 0 0 0 rg BT 351.80 414.45 Td (employees, ) Tj ET Q q 0 0 0 rg BT 400.05 414.45 Td (patients, ) Tj ET Q q 0 0 0 rg BT 438.32 414.45 Td (healthcar) Tj ET Q q 0 0 0 rg BT 476.27 414.45 Td (e ) Tj ET Q q 0 0 0 rg BT 484.82 414.45 Td (pr) Tj ET Q q 0 0 0 rg BT 493.34 414.45 Td (ofessionals ) Tj ET Q q 0 0 0 rg BT 541.89 414.45 Td (or ) Tj ET Q q 0 0 0 rg BT 554.89 414.45 Td (other ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 402.45 Td (stakeholders. ) Tj ET Q q 0 0 0 rg BT 92.66 402.45 Td (In ) Tj ET Q q 0 0 0 rg BT 104.61 402.45 Td (addition, ) Tj ET Q q 0 0 0 rg BT 144.06 402.45 Td (negative ) Tj ET Q q 0 0 0 rg BT 181.54 402.45 Td (or ) Tj ET Q q 0 0 0 rg BT 194.05 402.45 Td (inaccurate ) Tj ET Q q 0 0 0 rg BT 240.43 402.45 Td (posts ) Tj ET Q q 0 0 0 rg BT 264.60 402.45 Td (or ) Tj ET Q q 0 0 0 rg BT 277.11 402.45 Td (comments ) Tj ET Q q 0 0 0 rg BT 320.72 402.45 Td (about ) Tj ET Q q 0 0 0 rg BT 347.11 402.45 Td (us ) Tj ET Q q 0 0 0 rg BT 359.61 402.45 Td (on ) Tj ET Q q 0 0 0 rg BT 373.23 402.45 Td (any ) Tj ET Q q 0 0 0 rg BT 391.28 402.45 Td (social ) Tj ET Q q 0 0 0 rg BT 418.78 402.45 Td (networking ) Tj ET Q q 0 0 0 rg BT 467.39 402.45 Td (website ) Tj ET Q q 0 0 0 rg BT 501.00 402.45 Td (could ) Tj ET Q q 0 0 0 rg BT 526.84 402.45 Td (damage ) Tj ET Q q 0 0 0 rg BT 562.11 402.45 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 390.45 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 390.45 Td (eputation, ) Tj ET Q q 0 0 0 rg BT 82.18 390.45 Td (brand ) Tj ET Q q 0 0 0 rg BT 108.45 390.45 Td (image ) Tj ET Q q 0 0 0 rg BT 135.27 390.45 Td (and ) Tj ET Q q 0 0 0 rg BT 152.65 390.45 Td (goodwill. ) Tj ET Q q 0 0 0 rg BT 192.54 390.45 Td (Further) Tj ET Q q 0 0 0 rg BT 222.54 390.45 Td (, ) Tj ET Q q 0 0 0 rg BT 227.42 390.45 Td (the ) Tj ET Q q 0 0 0 rg BT 242.02 390.45 Td (disclosur) Tj ET Q q 0 0 0 rg BT 278.32 390.45 Td (e ) Tj ET Q q 0 0 0 rg BT 285.14 390.45 Td (of ) Tj ET Q q 0 0 0 rg BT 295.30 390.45 Td (non-public ) Tj ET Q q 0 0 0 rg BT 341.00 390.45 Td (Company-sensitive ) Tj ET Q q 0 0 0 rg BT 419.48 390.45 Td (information ) Tj ET Q q 0 0 0 rg BT 469.09 390.45 Td (by ) Tj ET Q q 0 0 0 rg BT 480.91 390.45 Td (our ) Tj ET Q q 0 0 0 rg BT 497.18 390.45 Td (workfor) Tj ET Q q 0 0 0 rg BT 528.48 390.45 Td (ce ) Tj ET Q q 0 0 0 rg BT 539.74 390.45 Td (or ) Tj ET Q q 0 0 0 rg BT 551.01 390.45 Td (others ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 378.45 Td (thr) Tj ET Q q 0 0 0 rg BT 47.30 378.45 Td (ough ) Tj ET Q q 0 0 0 rg BT 70.41 378.45 Td (external ) Tj ET Q q 0 0 0 rg BT 106.28 378.45 Td (media ) Tj ET Q q 0 0 0 rg BT 133.82 378.45 Td (channels ) Tj ET Q q 0 0 0 rg BT 172.48 378.45 Td (could ) Tj ET Q q 0 0 0 rg BT 197.80 378.45 Td (lead ) Tj ET Q q 0 0 0 rg BT 218.13 378.45 Td (to ) Tj ET Q q 0 0 0 rg BT 229.02 378.45 Td (information ) Tj ET Q q 0 0 0 rg BT 279.35 378.45 Td (loss. ) Tj ET Q q 0 0 0 rg BT 300.52 378.45 Td (Identifying ) Tj ET Q q 0 0 0 rg BT 346.95 378.45 Td (new ) Tj ET Q q 0 0 0 rg BT 366.16 378.45 Td (points ) Tj ET Q q 0 0 0 rg BT 393.72 378.45 Td (of ) Tj ET Q q 0 0 0 rg BT 404.61 378.45 Td (entry ) Tj ET Q q 0 0 0 rg BT 428.26 378.45 Td (as ) Tj ET Q q 0 0 0 rg BT 440.26 378.45 Td (social ) Tj ET Q q 0 0 0 rg BT 467.25 378.45 Td (media ) Tj ET Q q 0 0 0 rg BT 494.80 378.45 Td (continues ) Tj ET Q q 0 0 0 rg BT 536.23 378.45 Td (to ) Tj ET Q q 0 0 0 rg BT 547.12 378.45 Td (expand ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 366.45 Td (pr) Tj ET Q q 0 0 0 rg BT 44.52 366.45 Td (esents ) Tj ET Q q 0 0 0 rg BT 71.46 366.45 Td (new ) Tj ET Q q 0 0 0 rg BT 90.07 366.45 Td (challenges.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 342.45 Td (Adverse ) Tj ET Q q 0 0 0 rg BT 71.27 342.45 Td (changes ) Tj ET Q q 0 0 0 rg BT 107.66 342.45 Td (in ) Tj ET Q q 0 0 0 rg BT 118.50 342.45 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 141.28 342.45 Td (global, ) Tj ET Q q 0 0 0 rg BT 171.84 342.45 Td (regional ) Tj ET Q q 0 0 0 rg BT 208.79 342.45 Td (or ) Tj ET Q q 0 0 0 rg BT 220.18 342.45 Td (local ) Tj ET Q q 0 0 0 rg BT 242.67 342.45 Td (economic ) Tj ET Q q 0 0 0 rg BT 284.61 342.45 Td (conditions ) Tj ET Q q 0 0 0 rg BT 329.90 342.45 Td (could ) Tj ET Q q 0 0 0 rg BT 355.17 342.45 Td (adversely ) Tj ET Q q 0 0 0 rg BT 395.99 342.45 Td (af) Tj ET Q q 0 0 0 rg BT 404.14 342.45 Td (fect ) Tj ET Q q 0 0 0 rg BT 421.63 342.45 Td (our ) Tj ET Q q 0 0 0 rg BT 438.58 342.45 Td (profitability) Tj ET Q q 0 0 0 rg BT 486.54 342.45 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 330.45 Td (Global ) Tj ET Q q 0 0 0 rg BT 66.70 330.45 Td (economic ) Tj ET Q q 0 0 0 rg BT 107.93 330.45 Td (risks ) Tj ET Q q 0 0 0 rg BT 129.75 330.45 Td (pose ) Tj ET Q q 0 0 0 rg BT 151.00 330.45 Td (significant ) Tj ET Q q 0 0 0 rg BT 196.14 330.45 Td (challenges ) Tj ET Q q 0 0 0 rg BT 241.82 330.45 Td (to ) Tj ET Q q 0 0 0 rg BT 252.52 330.45 Td (a ) Tj ET Q q 0 0 0 rg BT 260.44 330.45 Td (company’) Tj ET Q q 0 0 0 rg BT 298.58 330.45 Td (s ) Tj ET Q q 0 0 0 rg BT 305.39 330.45 Td (gr) Tj ET Q q 0 0 0 rg BT 313.91 330.45 Td (owth ) Tj ET Q q 0 0 0 rg BT 336.28 330.45 Td (and ) Tj ET Q q 0 0 0 rg BT 354.20 330.45 Td (pr) Tj ET Q q 0 0 0 rg BT 362.72 330.45 Td (ofitability ) Tj ET Q q 0 0 0 rg BT 404.53 330.45 Td (and ) Tj ET Q q 0 0 0 rg BT 422.45 330.45 Td (ar) Tj ET Q q 0 0 0 rg BT 430.97 330.45 Td (e ) Tj ET Q q 0 0 0 rg BT 438.32 330.45 Td (difficult ) Tj ET Q q 0 0 0 rg BT 472.35 330.45 Td (to ) Tj ET Q q 0 0 0 rg BT 483.05 330.45 Td (mitigate. ) Tj ET Q q 0 0 0 rg BT 521.24 330.45 Td (W) Tj ET Q q 0 0 0 rg BT 528.66 330.45 Td (e ) Tj ET Q q 0 0 0 rg BT 536.01 330.45 Td (generated ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 318.45 Td (appr) Tj ET Q q 0 0 0 rg BT 54.52 318.45 Td (oximately ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 95.86 318.45 Td (45%) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 114.19 318.45 Td ( ) Tj ET Q q 0 0 0 rg BT 116.66 318.45 Td (of ) Tj ET Q q 0 0 0 rg BT 126.91 318.45 Td (our ) Tj ET Q q 0 0 0 rg BT 143.28 318.45 Td (r) Tj ET Q q 0 0 0 rg BT 146.80 318.45 Td (evenues ) Tj ET Q q 0 0 0 rg BT 180.91 318.45 Td (outside ) Tj ET Q q 0 0 0 rg BT 212.27 318.45 Td (of ) Tj ET Q q 0 0 0 rg BT 222.52 318.45 Td (the ) Tj ET Q q 0 0 0 rg BT 237.21 318.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 256.90 318.45 Td (in ) Tj ET Q q 0 0 0 rg BT 267.15 318.45 Td (2016. ) Tj ET Q q 0 0 0 rg BT 291.94 318.45 Td (As ) Tj ET Q q 0 0 0 rg BT 304.41 318.45 Td (such, ) Tj ET Q q 0 0 0 rg BT 327.71 318.45 Td (our ) Tj ET Q q 0 0 0 rg BT 344.07 318.45 Td (r) Tj ET Q q 0 0 0 rg BT 347.59 318.45 Td (evenues, ) Tj ET Q q 0 0 0 rg BT 384.21 318.45 Td (earnings ) Tj ET Q q 0 0 0 rg BT 421.68 318.45 Td (and ) Tj ET Q q 0 0 0 rg BT 439.15 318.45 Td (cash ) Tj ET Q q 0 0 0 rg BT 459.95 318.45 Td (flow ) Tj ET Q q 0 0 0 rg BT 479.65 318.45 Td (ar) Tj ET Q q 0 0 0 rg BT 488.17 318.45 Td (e ) Tj ET Q q 0 0 0 rg BT 495.08 318.45 Td (exposed ) Tj ET Q q 0 0 0 rg BT 529.76 318.45 Td (to ) Tj ET Q q 0 0 0 rg BT 540.01 318.45 Td (risk ) Tj ET Q q 0 0 0 rg BT 557.48 318.45 Td (fr) Tj ET Q q 0 0 0 rg BT 563.78 318.45 Td (om ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 306.45 Td (a ) Tj ET Q q 0 0 0 rg BT 43.22 306.45 Td (str) Tj ET Q q 0 0 0 rg BT 53.41 306.45 Td (engthening ) Tj ET Q q 0 0 0 rg BT 100.07 306.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 119.51 306.45 Td (dollar) Tj ET Q q 0 0 0 rg BT 142.85 306.45 Td (. ) Tj ET Q q 0 0 0 rg BT 147.57 306.45 Td (The ) Tj ET Q q 0 0 0 rg BT 164.79 306.45 Td (world’) Tj ET Q q 0 0 0 rg BT 190.17 306.45 Td (s ) Tj ET Q q 0 0 0 rg BT 196.28 306.45 Td (major ) Tj ET Q q 0 0 0 rg BT 222.39 306.45 Td (economies ) Tj ET Q q 0 0 0 rg BT 266.82 306.45 Td (hold ) Tj ET Q q 0 0 0 rg BT 286.82 306.45 Td (historically-high ) Tj ET Q q 0 0 0 rg BT 355.70 306.45 Td (debt ) Tj ET Q q 0 0 0 rg BT 375.14 306.45 Td (levels ) Tj ET Q q 0 0 0 rg BT 400.12 306.45 Td (and ) Tj ET Q q 0 0 0 rg BT 417.34 306.45 Td (many ) Tj ET Q q 0 0 0 rg BT 441.23 306.45 Td (ar) Tj ET Q q 0 0 0 rg BT 449.75 306.45 Td (e ) Tj ET Q q 0 0 0 rg BT 456.41 306.45 Td (experiencing ) Tj ET Q q 0 0 0 rg BT 510.27 306.45 Td (slow ) Tj ET Q q 0 0 0 rg BT 530.83 306.45 Td (gr) Tj ET Q q 0 0 0 rg BT 539.35 306.45 Td (owth ) Tj ET Q q 0 0 0 rg BT 561.02 306.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 294.45 Td (high ) Tj ET Q q 0 0 0 rg BT 57.60 294.45 Td (unemployment ) Tj ET Q q 0 0 0 rg BT 119.75 294.45 Td (rates. ) Tj ET Q q 0 0 0 rg BT 146.07 294.45 Td (W) Tj ET Q q 0 0 0 rg BT 153.49 294.45 Td (e ) Tj ET Q q 0 0 0 rg BT 161.75 294.45 Td (have ) Tj ET Q q 0 0 0 rg BT 184.45 294.45 Td (exposur) Tj ET Q q 0 0 0 rg BT 215.74 294.45 Td (e ) Tj ET Q q 0 0 0 rg BT 224.01 294.45 Td (to ) Tj ET Q q 0 0 0 rg BT 235.61 294.45 Td (customer ) Tj ET Q q 0 0 0 rg BT 276.10 294.45 Td (cr) Tj ET Q q 0 0 0 rg BT 284.06 294.45 Td (edit ) Tj ET Q q 0 0 0 rg BT 302.88 294.45 Td (risks ) Tj ET Q q 0 0 0 rg BT 325.60 294.45 Td (in ) Tj ET Q q 0 0 0 rg BT 337.20 294.45 Td (Eur) Tj ET Q q 0 0 0 rg BT 351.83 294.45 Td (ope, ) Tj ET Q q 0 0 0 rg BT 372.60 294.45 Td (South ) Tj ET Q q 0 0 0 rg BT 398.93 294.45 Td (America ) Tj ET Q q 0 0 0 rg BT 436.63 294.45 Td (and ) Tj ET Q q 0 0 0 rg BT 455.46 294.45 Td (other ) Tj ET Q q 0 0 0 rg BT 480.39 294.45 Td (markets ) Tj ET Q q 0 0 0 rg BT 515.88 294.45 Td (including ) Tj ET Q q 0 0 0 rg BT 557.48 294.45 Td (fr) Tj ET Q q 0 0 0 rg BT 563.78 294.45 Td (om ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 282.45 Td (government-guaranteed ) Tj ET Q q 0 0 0 rg BT 135.38 282.45 Td (hospital ) Tj ET Q q 0 0 0 rg BT 170.91 282.45 Td (r) Tj ET Q q 0 0 0 rg BT 174.43 282.45 Td (eceivables ) Tj ET Q q 0 0 0 rg BT 219.37 282.45 Td (in ) Tj ET Q q 0 0 0 rg BT 230.45 282.45 Td (markets ) Tj ET Q q 0 0 0 rg BT 265.41 282.45 Td (wher) Tj ET Q q 0 0 0 rg BT 285.04 282.45 Td (e ) Tj ET Q q 0 0 0 rg BT 292.78 282.45 Td (payments ) Tj ET Q q 0 0 0 rg BT 333.85 282.45 Td (ar) Tj ET Q q 0 0 0 rg BT 342.37 282.45 Td (e ) Tj ET Q q 0 0 0 rg BT 350.11 282.45 Td (not ) Tj ET Q q 0 0 0 rg BT 366.19 282.45 Td (r) Tj ET Q q 0 0 0 rg BT 369.71 282.45 Td (eceived ) Tj ET Q q 0 0 0 rg BT 402.98 282.45 Td (on ) Tj ET Q q 0 0 0 rg BT 416.28 282.45 Td (time. ) Tj ET Q q 0 0 0 rg BT 439.30 282.45 Td (W) Tj ET Q q 0 0 0 rg BT 446.71 282.45 Td (e ) Tj ET Q q 0 0 0 rg BT 454.45 282.45 Td (have ) Tj ET Q q 0 0 0 rg BT 476.63 282.45 Td (significant ) Tj ET Q q 0 0 0 rg BT 522.15 282.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 568.23 282.45 Td (in ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 270.45 Td (Eur) Tj ET Q q 0 0 0 rg BT 50.63 270.45 Td (ope, ) Tj ET Q q 0 0 0 rg BT 69.46 270.45 Td (including ) Tj ET Q q 0 0 0 rg BT 109.13 270.45 Td (for ) Tj ET Q q 0 0 0 rg BT 122.70 270.45 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 183.49 270.45 Td (and ) Tj ET Q q 0 0 0 rg BT 200.38 270.45 Td (distribution. ) Tj ET Q q 0 0 0 rg BT 251.45 270.45 Td (The ) Tj ET Q q 0 0 0 rg BT 268.35 270.45 Td (r) Tj ET Q q 0 0 0 rg BT 271.87 270.45 Td (esults ) Tj ET Q q 0 0 0 rg BT 296.55 270.45 Td (of ) Tj ET Q q 0 0 0 rg BT 306.22 270.45 Td (our ) Tj ET Q q 0 0 0 rg BT 322.01 270.45 Td (operations ) Tj ET Q q 0 0 0 rg BT 366.69 270.45 Td (could ) Tj ET Q q 0 0 0 rg BT 390.80 270.45 Td (be ) Tj ET Q q 0 0 0 rg BT 402.14 270.45 Td (negatively ) Tj ET Q q 0 0 0 rg BT 445.12 270.45 Td (impacted ) Tj ET Q q 0 0 0 rg BT 483.67 270.45 Td (by ) Tj ET Q q 0 0 0 rg BT 495.01 270.45 Td (any ) Tj ET Q q 0 0 0 rg BT 511.34 270.45 Td (member ) Tj ET Q q 0 0 0 rg BT 545.45 270.45 Td (country ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 258.45 Td (exiting ) Tj ET Q q 0 0 0 rg BT 64.73 258.45 Td (the ) Tj ET Q q 0 0 0 rg BT 78.47 258.45 Td (eur) Tj ET Q q 0 0 0 rg BT 91.43 258.45 Td (ozone ) Tj ET Q q 0 0 0 rg BT 116.28 258.45 Td (monetary ) Tj ET Q q 0 0 0 rg BT 155.57 258.45 Td (union ) Tj ET Q q 0 0 0 rg BT 179.87 258.45 Td (or ) Tj ET Q q 0 0 0 rg BT 190.28 258.45 Td (EU, ) Tj ET Q q 0 0 0 rg BT 207.63 258.45 Td (including ) Tj ET Q q 0 0 0 rg BT 246.93 258.45 Td (the ) Tj ET Q q 0 0 0 rg BT 260.67 258.45 Td (exit ) Tj ET Q q 0 0 0 rg BT 276.62 258.45 Td (of ) Tj ET Q q 0 0 0 rg BT 285.92 258.45 Td (the ) Tj ET Q q 0 0 0 rg BT 299.66 258.45 Td (UK ) Tj ET Q q 0 0 0 rg BT 315.07 258.45 Td (fr) Tj ET Q q 0 0 0 rg BT 321.37 258.45 Td (om ) Tj ET Q q 0 0 0 rg BT 335.11 258.45 Td (the ) Tj ET Q q 0 0 0 rg BT 348.85 258.45 Td (EU. ) Tj ET Q q 0 0 0 rg BT 366.20 258.45 Td ( ) Tj ET Q q 0 0 0 rg BT 367.72 258.45 Td (In ) Tj ET Q q 0 0 0 rg BT 377.57 258.45 Td (addition, ) Tj ET Q q 0 0 0 rg BT 414.93 258.45 Td (futur) Tj ET Q q 0 0 0 rg BT 434.01 258.45 Td (e ) Tj ET Q q 0 0 0 rg BT 439.96 258.45 Td (pension ) Tj ET Q q 0 0 0 rg BT 472.59 258.45 Td (plan ) Tj ET Q q 0 0 0 rg BT 491.89 258.45 Td (funding ) Tj ET Q q 0 0 0 rg BT 523.97 258.45 Td (r) Tj ET Q q 0 0 0 rg BT 527.49 258.45 Td (equir) Tj ET Q q 0 0 0 rg BT 548.23 258.45 Td (ements ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 246.45 Td (continue ) Tj ET Q q 0 0 0 rg BT 72.93 246.45 Td (to ) Tj ET Q q 0 0 0 rg BT 83.21 246.45 Td (be ) Tj ET Q q 0 0 0 rg BT 95.15 246.45 Td (sensitive ) Tj ET Q q 0 0 0 rg BT 132.08 246.45 Td (to ) Tj ET Q q 0 0 0 rg BT 142.36 246.45 Td (global ) Tj ET Q q 0 0 0 rg BT 170.42 246.45 Td (economic ) Tj ET Q q 0 0 0 rg BT 211.23 246.45 Td (conditions ) Tj ET Q q 0 0 0 rg BT 255.40 246.45 Td (and ) Tj ET Q q 0 0 0 rg BT 272.90 246.45 Td (the ) Tj ET Q q 0 0 0 rg BT 287.62 246.45 Td (r) Tj ET Q q 0 0 0 rg BT 291.14 246.45 Td (elated ) Tj ET Q q 0 0 0 rg BT 318.07 246.45 Td (impact ) Tj ET Q q 0 0 0 rg BT 347.79 246.45 Td (on ) Tj ET Q q 0 0 0 rg BT 360.29 246.45 Td (equity ) Tj ET Q q 0 0 0 rg BT 387.22 246.45 Td (markets.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 222.45 Td (There ) Tj ET Q q 0 0 0 rg BT 62.94 222.45 Td (can ) Tj ET Q q 0 0 0 rg BT 80.44 222.45 Td (be ) Tj ET Q q 0 0 0 rg BT 92.38 222.45 Td (no ) Tj ET Q q 0 0 0 rg BT 105.44 222.45 Td (guarantee ) Tj ET Q q 0 0 0 rg BT 149.61 222.45 Td (that ) Tj ET Q q 0 0 0 rg BT 168.23 222.45 Td (we ) Tj ET Q q 0 0 0 rg BT 181.83 222.45 Td (will ) Tj ET Q q 0 0 0 rg BT 199.34 222.45 Td (pay ) Tj ET Q q 0 0 0 rg BT 216.28 222.45 Td (dividends ) Tj ET Q q 0 0 0 rg BT 257.67 222.45 Td (or ) Tj ET Q q 0 0 0 rg BT 269.06 222.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 317.67 222.45 Td (stock.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 210.45 Td (The ) Tj ET Q q 0 0 0 rg BT 52.80 210.45 Td (declaration, ) Tj ET Q q 0 0 0 rg BT 103.20 210.45 Td (amount ) Tj ET Q q 0 0 0 rg BT 134.99 210.45 Td (and ) Tj ET Q q 0 0 0 rg BT 151.79 210.45 Td (timing ) Tj ET Q q 0 0 0 rg BT 179.14 210.45 Td (of ) Tj ET Q q 0 0 0 rg BT 188.71 210.45 Td (any ) Tj ET Q q 0 0 0 rg BT 204.95 210.45 Td (dividends ) Tj ET Q q 0 0 0 rg BT 245.07 210.45 Td (fall ) Tj ET Q q 0 0 0 rg BT 260.20 210.45 Td (within ) Tj ET Q q 0 0 0 rg BT 287.00 210.45 Td (the ) Tj ET Q q 0 0 0 rg BT 301.01 210.45 Td (discr) Tj ET Q q 0 0 0 rg BT 320.64 210.45 Td (etion ) Tj ET Q q 0 0 0 rg BT 342.43 210.45 Td (of ) Tj ET Q q 0 0 0 rg BT 352.01 210.45 Td (our ) Tj ET Q q 0 0 0 rg BT 367.70 210.45 Td (Boar) Tj ET Q q 0 0 0 rg BT 387.32 210.45 Td (d ) Tj ET Q q 0 0 0 rg BT 394.12 210.45 Td (of ) Tj ET Q q 0 0 0 rg BT 403.69 210.45 Td (Dir) Tj ET Q q 0 0 0 rg BT 417.21 210.45 Td (ectors. ) Tj ET Q q 0 0 0 rg BT 445.95 210.45 Td (The ) Tj ET Q q 0 0 0 rg BT 462.75 210.45 Td (Boar) Tj ET Q q 0 0 0 rg BT 482.37 210.45 Td (d's ) Tj ET Q q 0 0 0 rg BT 495.20 210.45 Td (decision ) Tj ET Q q 0 0 0 rg BT 530.32 210.45 Td (will ) Tj ET Q q 0 0 0 rg BT 547.12 210.45 Td (depend ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 198.45 Td (on ) Tj ET Q q 0 0 0 rg BT 49.31 198.45 Td (many ) Tj ET Q q 0 0 0 rg BT 74.29 198.45 Td (factors, ) Tj ET Q q 0 0 0 rg BT 107.88 198.45 Td (including ) Tj ET Q q 0 0 0 rg BT 148.96 198.45 Td (our ) Tj ET Q q 0 0 0 rg BT 166.17 198.45 Td (financial ) Tj ET Q q 0 0 0 rg BT 205.03 198.45 Td (condition, ) Tj ET Q q 0 0 0 rg BT 248.62 198.45 Td (earnings, ) Tj ET Q q 0 0 0 rg BT 289.43 198.45 Td (capital ) Tj ET Q q 0 0 0 rg BT 320.52 198.45 Td (r) Tj ET Q q 0 0 0 rg BT 324.04 198.45 Td (equir) Tj ET Q q 0 0 0 rg BT 344.78 198.45 Td (ements, ) Tj ET Q q 0 0 0 rg BT 378.36 198.45 Td (debt ) Tj ET Q q 0 0 0 rg BT 398.89 198.45 Td (service ) Tj ET Q q 0 0 0 rg BT 430.52 198.45 Td (obligations, ) Tj ET Q q 0 0 0 rg BT 481.33 198.45 Td (industry ) Tj ET Q q 0 0 0 rg BT 517.43 198.45 Td (practice, ) Tj ET Q q 0 0 0 rg BT 556.00 198.45 Td (legal ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 186.45 Td (r) Tj ET Q q 0 0 0 rg BT 39.52 186.45 Td (equir) Tj ET Q q 0 0 0 rg BT 60.26 186.45 Td (ements, ) Tj ET Q q 0 0 0 rg BT 92.79 186.45 Td (r) Tj ET Q q 0 0 0 rg BT 96.31 186.45 Td (egulatory ) Tj ET Q q 0 0 0 rg BT 136.90 186.45 Td (constraints ) Tj ET Q q 0 0 0 rg BT 183.61 186.45 Td (and ) Tj ET Q q 0 0 0 rg BT 200.87 186.45 Td (other ) Tj ET Q q 0 0 0 rg BT 224.24 186.45 Td (factors ) Tj ET Q q 0 0 0 rg BT 254.29 186.45 Td (that ) Tj ET Q q 0 0 0 rg BT 272.11 186.45 Td (our ) Tj ET Q q 0 0 0 rg BT 288.26 186.45 Td (Boar) Tj ET Q q 0 0 0 rg BT 307.89 186.45 Td (d ) Tj ET Q q 0 0 0 rg BT 315.15 186.45 Td (of ) Tj ET Q q 0 0 0 rg BT 325.19 186.45 Td (Dir) Tj ET Q q 0 0 0 rg BT 338.71 186.45 Td (ectors ) Tj ET Q q 0 0 0 rg BT 365.42 186.45 Td (may ) Tj ET Q q 0 0 0 rg BT 384.34 186.45 Td (deem ) Tj ET Q q 0 0 0 rg BT 407.70 186.45 Td (r) Tj ET Q q 0 0 0 rg BT 411.22 186.45 Td (elevant. ) Tj ET Q q 0 0 0 rg BT 444.69 186.45 Td (A) Tj ET Q q 0 0 0 rg BT 450.62 186.45 Td ( ) Tj ET Q q 0 0 0 rg BT 452.88 186.45 Td (r) Tj ET Q q 0 0 0 rg BT 456.41 186.45 Td (eduction ) Tj ET Q q 0 0 0 rg BT 493.10 186.45 Td (or ) Tj ET Q q 0 0 0 rg BT 504.26 186.45 Td (elimination ) Tj ET Q q 0 0 0 rg BT 552.07 186.45 Td (of ) Tj ET Q q 0 0 0 rg BT 562.11 186.45 Td (our ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 174.45 Td (dividend ) Tj ET Q q 0 0 0 rg BT 72.60 174.45 Td (payments ) Tj ET Q q 0 0 0 rg BT 112.54 174.45 Td (or ) Tj ET Q q 0 0 0 rg BT 123.60 174.45 Td (dividend ) Tj ET Q q 0 0 0 rg BT 160.21 174.45 Td (pr) Tj ET Q q 0 0 0 rg BT 168.73 174.45 Td (ogram ) Tj ET Q q 0 0 0 rg BT 197.01 174.45 Td (could ) Tj ET Q q 0 0 0 rg BT 221.39 174.45 Td (adversely ) Tj ET Q q 0 0 0 rg BT 261.88 174.45 Td (affect ) Tj ET Q q 0 0 0 rg BT 286.26 174.45 Td (our ) Tj ET Q q 0 0 0 rg BT 302.32 174.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 325.04 174.45 Td (price. ) Tj ET Q q 0 0 0 rg BT 350.25 174.45 Td (In ) Tj ET Q q 0 0 0 rg BT 360.75 174.45 Td (addition, ) Tj ET Q q 0 0 0 rg BT 398.76 174.45 Td (we ) Tj ET Q q 0 0 0 rg BT 412.04 174.45 Td (could, ) Tj ET Q q 0 0 0 rg BT 438.92 174.45 Td (at ) Tj ET Q q 0 0 0 rg BT 448.87 174.45 Td (any ) Tj ET Q q 0 0 0 rg BT 465.48 174.45 Td (time, ) Tj ET Q q 0 0 0 rg BT 487.36 174.45 Td (decide ) Tj ET Q q 0 0 0 rg BT 515.63 174.45 Td (not ) Tj ET Q q 0 0 0 rg BT 530.58 174.45 Td (to ) Tj ET Q q 0 0 0 rg BT 540.52 174.45 Td (buy ) Tj ET Q q 0 0 0 rg BT 557.13 174.45 Td (back ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 162.45 Td (any ) Tj ET Q q 0 0 0 rg BT 52.94 162.45 Td (mor) Tj ET Q q 0 0 0 rg BT 68.68 162.45 Td (e ) Tj ET Q q 0 0 0 rg BT 75.62 162.45 Td (shar) Tj ET Q q 0 0 0 rg BT 93.03 162.45 Td (es ) Tj ET Q q 0 0 0 rg BT 103.86 162.45 Td (in ) Tj ET Q q 0 0 0 rg BT 114.14 162.45 Td (the ) Tj ET Q q 0 0 0 rg BT 128.86 162.45 Td (market, ) Tj ET Q q 0 0 0 rg BT 161.63 162.45 Td (which ) Tj ET Q q 0 0 0 rg BT 188.01 162.45 Td (could ) Tj ET Q q 0 0 0 rg BT 212.73 162.45 Td (also ) Tj ET Q q 0 0 0 rg BT 231.90 162.45 Td (adversely ) Tj ET Q q 0 0 0 rg BT 272.71 162.45 Td (affect ) Tj ET Q q 0 0 0 rg BT 297.43 162.45 Td (our ) Tj ET Q q 0 0 0 rg BT 313.82 162.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 336.86 162.45 Td (price.) Tj ET Q endstream endobj 47 0 obj <> endobj 48 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (23) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 746.23 Td (Item 1B.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 746.23 Td (UNRESOLVED STAFF COMMENTS.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 718.00 Td (None.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 686.23 Td (Item 2.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 686.23 Td (PROPERTIES.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 666.00 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.46 666.00 Td (principal ) Tj ET Q q 0 0 0 rg BT 90.91 666.00 Td (executive ) Tj ET Q q 0 0 0 rg BT 131.12 666.00 Td (of) Tj ET Q q 0 0 0 rg BT 139.27 666.00 Td (fices ) Tj ET Q q 0 0 0 rg BT 160.05 666.00 Td (are ) Tj ET Q q 0 0 0 rg BT 174.17 666.00 Td (located ) Tj ET Q q 0 0 0 rg BT 204.94 666.00 Td (at ) Tj ET Q q 0 0 0 rg BT 214.07 666.00 Td (345 ) Tj ET Q q 0 0 0 rg BT 230.97 666.00 Td (Park ) Tj ET Q q 0 0 0 rg BT 250.79 666.00 Td (A) Tj ET Q q 0 0 0 rg BT 257.27 666.00 Td (venue, ) Tj ET Q q 0 0 0 rg BT 285.55 666.00 Td (New ) Tj ET Q q 0 0 0 rg BT 306.05 666.00 Td (Y) Tj ET Q q 0 0 0 rg BT 312.27 666.00 Td (ork, ) Tj ET Q q 0 0 0 rg BT 330.01 666.00 Td (NY) Tj ET Q q 0 0 0 rg BT 343.17 666.00 Td (. ) Tj ET Q q 0 0 0 rg BT 347.43 666.00 Td (W) Tj ET Q q 0 0 0 rg BT 356.07 666.00 Td (e ) Tj ET Q q 0 0 0 rg BT 362.41 666.00 Td (own ) Tj ET Q q 0 0 0 rg BT 381.54 666.00 Td (or ) Tj ET Q q 0 0 0 rg BT 391.78 666.00 Td (lease ) Tj ET Q q 0 0 0 rg BT 413.67 666.00 Td (approximately ) Tj ET Q q 0 0 0 rg BT 473.33 666.00 Td (165 ) Tj ET Q q 0 0 0 rg BT 490.24 666.00 Td (properties ) Tj ET Q q 0 0 0 rg BT 532.13 666.00 Td (throughout ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 654.00 Td (the ) Tj ET Q q 0 0 0 rg BT 51.02 654.00 Td (world ) Tj ET Q q 0 0 0 rg BT 77.15 654.00 Td (for ) Tj ET Q q 0 0 0 rg BT 91.60 654.00 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 155.21 654.00 Td (R&D, ) Tj ET Q q 0 0 0 rg BT 182.18 654.00 Td (administration, ) Tj ET Q q 0 0 0 rg BT 245.25 654.00 Td (storage ) Tj ET Q q 0 0 0 rg BT 276.93 654.00 Td (and ) Tj ET Q q 0 0 0 rg BT 294.17 654.00 Td (distribution. ) Tj ET Q q 0 0 0 rg BT 345.38 654.00 Td (W) Tj ET Q q 0 0 0 rg BT 354.01 654.00 Td (e ) Tj ET Q q 0 0 0 rg BT 361.25 654.00 Td (believe ) Tj ET Q q 0 0 0 rg BT 392.92 654.00 Td (our ) Tj ET Q q 0 0 0 rg BT 409.05 654.00 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 470.16 654.00 Td (properties, ) Tj ET Q q 0 0 0 rg BT 515.45 654.00 Td (in ) Tj ET Q q 0 0 0 rg BT 526.02 654.00 Td (combination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 642.00 Td (with ) Tj ET Q q 0 0 0 rg BT 56.43 642.00 Td (our ) Tj ET Q q 0 0 0 rg BT 72.41 642.00 Td (third-party ) Tj ET Q q 0 0 0 rg BT 117.82 642.00 Td (manufacturers, ) Tj ET Q q 0 0 0 rg BT 180.17 642.00 Td (provide ) Tj ET Q q 0 0 0 rg BT 213.36 642.00 Td (adequate ) Tj ET Q q 0 0 0 rg BT 251.55 642.00 Td (production ) Tj ET Q q 0 0 0 rg BT 297.52 642.00 Td (capacity ) Tj ET Q q 0 0 0 rg BT 333.48 642.00 Td (for ) Tj ET Q q 0 0 0 rg BT 347.79 642.00 Td (our ) Tj ET Q q 0 0 0 rg BT 363.77 642.00 Td (current ) Tj ET Q q 0 0 0 rg BT 394.74 642.00 Td (operations. ) Tj ET Q q 0 0 0 rg BT 441.54 642.00 Td (For ) Tj ET Q q 0 0 0 rg BT 458.09 642.00 Td (further ) Tj ET Q q 0 0 0 rg BT 487.94 642.00 Td (information ) Tj ET Q q 0 0 0 rg BT 537.81 642.00 Td (about ) Tj ET Q q 0 0 0 rg BT 562.67 642.00 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 630.00 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 96.81 630.00 Td (properties, ) Tj ET Q q 0 0 0 rg BT 141.80 630.00 Td (refer ) Tj ET Q q 0 0 0 rg BT 163.16 630.00 Td (to ) Tj ET Q q 0 0 0 rg BT 173.44 630.00 Td (“Item ) Tj ET Q q 0 0 0 rg BT 198.71 630.00 Td (1. ) Tj ET Q q 0 0 0 rg BT 208.71 630.00 Td (Business—Manufacturing ) Tj ET Q q 0 0 0 rg BT 316.19 630.00 Td (and ) Tj ET Q q 0 0 0 rg BT 333.13 630.00 Td (Quality ) Tj ET Q q 0 0 0 rg BT 365.07 630.00 Td (Assurance.") Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 613.00 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.05 613.00 Td (significant ) Tj ET Q q 0 0 0 rg BT 98.76 613.00 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 159.57 613.00 Td (and ) Tj ET Q q 0 0 0 rg BT 176.51 613.00 Td (R&D ) Tj ET Q q 0 0 0 rg BT 200.68 613.00 Td (locations ) Tj ET Q q 0 0 0 rg BT 239.29 613.00 Td (by ) Tj ET Q q 0 0 0 rg BT 251.79 613.00 Td (geographic ) Tj ET Q q 0 0 0 rg BT 298.71 613.00 Td (area ) Tj ET Q q 0 0 0 rg BT 317.86 613.00 Td (were ) Tj ET Q q 0 0 0 rg BT 339.78 613.00 Td (as ) Tj ET Q q 0 0 0 rg BT 350.61 613.00 Td (follows ) Tj ET Q q 0 0 0 rg BT 383.11 613.00 Td (at ) Tj ET Q q 0 0 0 rg BT 392.83 613.00 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.42 613.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.42 613.00 Td (:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 590.50 394.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 590.50 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 590.50 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 590.50 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 566.50 394.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 566.50 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 566.50 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 566.50 71.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 590.5 m 501.5 590.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 590.5 m 576.5 590.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 590.5 m 501.5 590.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 566.5 m 501.5 566.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 555.5 m 501.5 555.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 553.5 m 501.5 553.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 566.5 m 576.5 566.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 555.5 m 576.5 555.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 553.5 m 576.5 553.5 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 439.50 594.58 Td (Manufacturing) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 531.35 594.58 Td (R&D) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 581.12 Td (United States) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 581.12 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 581.12 Td (5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 569.12 Td (Europe) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 569.12 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 569.12 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 557.12 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 557.12 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 557.12 Td (7) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 523.23 Td (Item 3.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 523.23 Td (LEGAL PROCEEDINGS.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 495.00 Td (Information ) Tj ET Q q 0 0 0 rg BT 88.91 495.00 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 134.60 495.00 Td (to ) Tj ET Q q 0 0 0 rg BT 147.53 495.00 Td (legal ) Tj ET Q q 0 0 0 rg BT 172.11 495.00 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 225.57 495.00 Td (can ) Tj ET Q q 0 0 0 rg BT 244.60 495.00 Td (be ) Tj ET Q q 0 0 0 rg BT 259.18 495.00 Td (found ) Tj ET Q q 0 0 0 rg BT 287.66 495.00 Td (in ) Tj ET Q q 0 0 0 rg BT 300.59 495.00 Td (“Item ) Tj ET Q q 0 0 0 rg BT 328.50 495.00 Td (8. ) Tj ET Q q 0 0 0 rg BT 341.15 495.00 Td (Financial ) Tj ET Q q 0 0 0 rg BT 383.51 495.00 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.98 495.00 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.98 495.00 Td (. ) Tj ET Q q 0 0 0 rg BT 479.62 495.00 Td (Legal ) Tj ET Q q 0 0 0 rg BT 507.54 495.00 Td (Proceedings ) Tj ET Q q 0 0 0 rg BT 561.56 495.00 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 483.00 Td (Contingencies” ) Tj ET Q q 0 0 0 rg BT 100.15 483.00 Td (and ) Tj ET Q q 0 0 0 rg BT 117.09 483.00 Td (is ) Tj ET Q q 0 0 0 rg BT 126.26 483.00 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 179.29 483.00 Td (by ) Tj ET Q q 0 0 0 rg BT 191.79 483.00 Td (reference ) Tj ET Q q 0 0 0 rg BT 231.47 483.00 Td (herein.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 451.23 Td (Item 4.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 451.23 Td (MINE SAFETY DISCLOSURES.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 423.00 Td (Not applicable.) Tj ET Q endstream endobj 49 0 obj <> endobj 50 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (24) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (P) Tj ET Q q 0 0 0 rg BT 41.37 749.25 Td (AR) Tj ET Q q 0 0 0 rg BT 55.46 749.25 Td (T) Tj ET Q q 0 0 0 rg BT 61.95 749.25 Td ( IA) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 732.25 Td (Executive Officers of the Registrant) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 720.25 Td (Listed ) Tj ET Q q 0 0 0 rg BT 63.56 720.25 Td (below ) Tj ET Q q 0 0 0 rg BT 90.57 720.25 Td (is ) Tj ET Q q 0 0 0 rg BT 99.81 720.25 Td (information ) Tj ET Q q 0 0 0 rg BT 149.59 720.25 Td (on ) Tj ET Q q 0 0 0 rg BT 162.16 720.25 Td (our ) Tj ET Q q 0 0 0 rg BT 178.06 720.25 Td (executive ) Tj ET Q q 0 0 0 rg BT 218.94 720.25 Td (of) Tj ET Q q 0 0 0 rg BT 227.09 720.25 Td (ficers ) Tj ET Q q 0 0 0 rg BT 251.87 720.25 Td (as ) Tj ET Q q 0 0 0 rg BT 262.77 720.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 273.67 720.25 Td (February 21, ) Tj ET Q q 0 0 0 rg BT 327.34 720.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.34 720.25 Td (. ) Tj ET Q q 0 0 0 rg BT 352.41 720.25 Td (Executive ) Tj ET Q q 0 0 0 rg BT 394.96 720.25 Td (of) Tj ET Q q 0 0 0 rg BT 403.11 720.25 Td (ficers ) Tj ET Q q 0 0 0 rg BT 427.89 720.25 Td (are ) Tj ET Q q 0 0 0 rg BT 442.66 720.25 Td (elected ) Tj ET Q q 0 0 0 rg BT 473.54 720.25 Td (by ) Tj ET Q q 0 0 0 rg BT 486.11 720.25 Td (the ) Tj ET Q q 0 0 0 rg BT 500.90 720.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 527.91 720.25 Td (of ) Tj ET Q q 0 0 0 rg BT 538.81 720.25 Td (Directors ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 708.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.06 708.25 Td (an ) Tj ET Q q 0 0 0 rg BT 61.90 708.25 Td (initial ) Tj ET Q q 0 0 0 rg BT 87.63 708.25 Td (term, ) Tj ET Q q 0 0 0 rg BT 110.86 708.25 Td (which ) Tj ET Q q 0 0 0 rg BT 137.70 708.25 Td (continues ) Tj ET Q q 0 0 0 rg BT 178.43 708.25 Td (until ) Tj ET Q q 0 0 0 rg BT 199.16 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 213.78 708.25 Td (first ) Tj ET Q q 0 0 0 rg BT 232.29 708.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 259.13 708.25 Td (meeting ) Tj ET Q q 0 0 0 rg BT 293.74 708.25 Td (following ) Tj ET Q q 0 0 0 rg BT 335.03 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 349.65 708.25 Td (next ) Tj ET Q q 0 0 0 rg BT 368.74 708.25 Td (Annual ) Tj ET Q q 0 0 0 rg BT 400.58 708.25 Td (Meeting ) Tj ET Q q 0 0 0 rg BT 436.30 708.25 Td (of ) Tj ET Q q 0 0 0 rg BT 447.04 708.25 Td (Stockholders, ) Tj ET Q q 0 0 0 rg BT 504.15 708.25 Td (and ) Tj ET Q q 0 0 0 rg BT 520.99 708.25 Td (thereafter) Tj ET Q q 0 0 0 rg BT 558.89 708.25 Td (, ) Tj ET Q q 0 0 0 rg BT 563.79 708.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 696.25 Td (elected ) Tj ET Q q 0 0 0 rg BT 66.27 696.25 Td (for ) Tj ET Q q 0 0 0 rg BT 79.90 696.25 Td (a ) Tj ET Q q 0 0 0 rg BT 86.30 696.25 Td (one-year ) Tj ET Q q 0 0 0 rg BT 123.24 696.25 Td (term ) Tj ET Q q 0 0 0 rg BT 143.53 696.25 Td (or ) Tj ET Q q 0 0 0 rg BT 153.83 696.25 Td (until ) Tj ET Q q 0 0 0 rg BT 174.13 696.25 Td (their ) Tj ET Q q 0 0 0 rg BT 194.42 696.25 Td (successors ) Tj ET Q q 0 0 0 rg BT 238.59 696.25 Td (have ) Tj ET Q q 0 0 0 rg BT 259.43 696.25 Td (been ) Tj ET Q q 0 0 0 rg BT 280.27 696.25 Td (elected. ) Tj ET Q q 0 0 0 rg BT 313.05 696.25 Td (Executive ) Tj ET Q q 0 0 0 rg BT 354.99 696.25 Td (of) Tj ET Q q 0 0 0 rg BT 363.14 696.25 Td (ficers ) Tj ET Q q 0 0 0 rg BT 387.31 696.25 Td (serve ) Tj ET Q q 0 0 0 rg BT 410.38 696.25 Td (at ) Tj ET Q q 0 0 0 rg BT 419.56 696.25 Td (the ) Tj ET Q q 0 0 0 rg BT 433.74 696.25 Td (discretion ) Tj ET Q q 0 0 0 rg BT 475.14 696.25 Td (of ) Tj ET Q q 0 0 0 rg BT 485.43 696.25 Td (the ) Tj ET Q q 0 0 0 rg BT 499.61 696.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 526.02 696.25 Td (of ) Tj ET Q q 0 0 0 rg BT 536.31 696.25 Td (Directors.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 39 674.86259765625 m 156.87109375 674.86259765625 l s q 0 0 0 rg BT 39.00 676.43 Td (Name and Current Position) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 225.15 674.86259765625 m 241.81015625 674.86259765625 l s q 0 0 0 rg BT 225.15 676.43 Td (Age) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 252 674.86259765625 m 426.9755859375 674.86259765625 l s q 0 0 0 rg BT 252.00 676.43 Td (Employment History for the Past 5 Years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 662.32 Td (Giovanni Caforio, M.D. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 652.31 Td (Chief Executive Officer and Dir) Tj ET Q q 0 0 0 rg BT 166.37 652.31 Td (ector) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 642.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 642.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 662.32 Td (52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 662.32 Td (201) Tj ET Q q 0 0 0 rg BT 266.63 662.32 Td (1 ) Tj ET Q q 0 0 0 rg BT 274.13 662.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.41 662.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 306.91 662.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.41 662.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 356.62 662.32 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 376.91 662.32 Td (Pharmaceuticals) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 652.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 274.50 652.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 652.32 Td (2014 ) Tj ET Q q 0 0 0 rg BT 307.28 652.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 652.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 357.08 652.32 Td (V) Tj ET Q q 0 0 0 rg BT 363.70 652.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 377.85 652.32 Td (President ) Tj ET Q q 0 0 0 rg BT 417.57 652.32 Td (and ) Tj ET Q q 0 0 0 rg BT 434.51 652.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 459.23 652.32 Td (Commercial ) Tj ET Q q 0 0 0 rg BT 511.16 652.32 Td (Of) Tj ET Q q 0 0 0 rg BT 521.53 652.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 642.32 Td (2014 ) Tj ET Q q 0 0 0 rg BT 274.50 642.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 642.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 307.28 642.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 642.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 339.50 642.32 Td (Operating ) Tj ET Q q 0 0 0 rg BT 381.98 642.32 Td (Of) Tj ET Q q 0 0 0 rg BT 392.35 642.32 Td (ficer ) Tj ET Q q 0 0 0 rg BT 413.17 642.32 Td (and ) Tj ET Q q 0 0 0 rg BT 430.11 642.32 Td (Director ) Tj ET Q q 0 0 0 rg BT 465.92 642.32 Td (of ) Tj ET Q q 0 0 0 rg BT 476.75 642.32 Td (the ) Tj ET Q q 0 0 0 rg BT 491.47 642.32 Td (Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 632.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 274.50 632.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 632.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 632.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 632.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 348.37 632.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 390.85 632.32 Td (Of) Tj ET Q q 0 0 0 rg BT 401.22 632.32 Td (ficer ) Tj ET Q q 0 0 0 rg BT 422.04 632.32 Td (and ) Tj ET Q q 0 0 0 rg BT 438.98 632.32 Td (Director ) Tj ET Q q 0 0 0 rg BT 474.79 632.32 Td (of ) Tj ET Q q 0 0 0 rg BT 485.62 632.32 Td (the ) Tj ET Q q 0 0 0 rg BT 500.34 632.32 Td (Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 617.32 Td (Charles Bancroft ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 607.31 Td (Chief Financial Officer and Executive V) Tj ET Q q 0 0 0 rg BT 199.60 607.31 Td (ice ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 597.31 Td (Pr) Tj ET Q q 0 0 0 rg BT 48.63 597.31 Td (esident, Global Business Operations) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 587.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 587.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 617.32 Td (57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 617.32 Td (2011 to 2016 - Chief Financial Officer and Executive Vice President, Global) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 607.32 Td (Services) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 597.32 Td (2016 to Present - Chief Financial Officer and Executive Vice President,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 587.32 Td (Global Business Operations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 572.32 Td (Emmanuel Blin ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 562.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 562.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 562.31 Td (esident, Chief Strategy ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 552.31 Td (Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 542.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 542.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 572.32 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 572.32 Td (2010 ) Tj ET Q q 0 0 0 rg BT 274.50 572.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 572.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 307.28 572.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 572.32 Td (President ) Tj ET Q q 0 0 0 rg BT 354.50 572.32 Td (& ) Tj ET Q q 0 0 0 rg BT 364.77 572.32 Td (General ) Tj ET Q q 0 0 0 rg BT 398.92 572.32 Td (Manager) Tj ET Q q 0 0 0 rg BT 434.06 572.32 Td (, ) Tj ET Q q 0 0 0 rg BT 439.06 572.32 Td (Japan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 562.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 274.50 562.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 562.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 307.28 562.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 562.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 357.00 562.32 Td (Global ) Tj ET Q q 0 0 0 rg BT 386.71 562.32 Td (Commercialization) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 552.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 274.43 552.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.64 552.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 307.07 552.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.50 552.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 342.86 552.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.49 552.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.57 552.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 405.72 552.32 Td (Head ) Tj ET Q q 0 0 0 rg BT 429.25 552.32 Td (of ) Tj ET Q q 0 0 0 rg BT 440.01 552.32 Td (Commercialization, ) Tj ET Q q 0 0 0 rg BT 521.58 552.32 Td (Policy ) Tj ET Q q 0 0 0 rg BT 549.57 552.32 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 542.32 Td (Operations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 532.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 274.50 532.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 532.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 532.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 532.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 352.08 532.32 Td (V) Tj ET Q q 0 0 0 rg BT 358.70 532.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 372.86 532.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 415.08 532.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 439.79 532.32 Td (Strategy ) Tj ET Q q 0 0 0 rg BT 475.62 532.32 Td (Of) Tj ET Q q 0 0 0 rg BT 485.99 532.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 517.32 Td (Joseph C. Caldarella) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 507.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 507.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 507.31 Td (esident and Corporate ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 497.31 Td (Contr) Tj ET Q q 0 0 0 rg BT 61.97 497.31 Td (oller) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 517.32 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 517.32 Td (2010 ) Tj ET Q q 0 0 0 rg BT 274.50 517.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 517.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 517.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 517.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 352.08 517.32 Td (V) Tj ET Q q 0 0 0 rg BT 358.70 517.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 372.86 517.32 Td (President ) Tj ET Q q 0 0 0 rg BT 412.58 517.32 Td (and ) Tj ET Q q 0 0 0 rg BT 429.51 517.32 Td (Corporate ) Tj ET Q q 0 0 0 rg BT 472.00 517.32 Td (Controller) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 482.32 Td (Francis Cuss, MB BChir) Tj ET Q q 0 0 0 rg BT 137.50 482.32 Td (, FRCP) Tj ET Q q 0 0 0 rg BT 166.59 482.32 Td ( ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 472.31 Td (Executive V) Tj ET Q q 0 0 0 rg BT 85.72 472.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 109.51 472.31 Td (esident and Chief ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 462.31 Td (Scientific Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 452.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 452.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 482.32 Td (62) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 482.32 Td (2010 ) Tj ET Q q 0 0 0 rg BT 274.50 482.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 482.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 307.28 482.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 482.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 343.21 482.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.83 482.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.98 482.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 406.20 482.32 Td (Research) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 472.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 274.50 472.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 472.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 472.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 472.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 365.96 472.32 Td (V) Tj ET Q q 0 0 0 rg BT 372.58 472.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 386.73 472.32 Td (President ) Tj ET Q q 0 0 0 rg BT 426.45 472.32 Td (and ) Tj ET Q q 0 0 0 rg BT 443.39 472.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 468.10 472.32 Td (Scientific ) Tj ET Q q 0 0 0 rg BT 508.92 472.32 Td (Of) Tj ET Q q 0 0 0 rg BT 519.29 472.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 437.32 Td (John E. Elicker) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 427.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 427.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 427.31 Td (esident, Public ) Tj ET Q q 0 0 0 rg BT 158.51 427.31 Td (Affairs and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 417.31 Td (Investor Relations) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 407.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 407.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 437.32 Td (57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 437.32 Td (2012 ) Tj ET Q q 0 0 0 rg BT 274.50 437.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 437.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 437.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 437.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 352.17 437.32 Td (V) Tj ET Q q 0 0 0 rg BT 359.00 437.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 372.86 437.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 415.08 437.32 Td (Public ) Tj ET Q q 0 0 0 rg BT 442.86 437.32 Td (Af) Tj ET Q q 0 0 0 rg BT 453.04 437.32 Td (fairs ) Tj ET Q q 0 0 0 rg BT 473.22 437.32 Td (and ) Tj ET Q q 0 0 0 rg BT 490.16 437.32 Td (Investor ) Tj ET Q q 0 0 0 rg BT 525.43 437.32 Td (Relations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 392.32 Td (Murdo Gordon) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 382.31 Td (Executive V) Tj ET Q q 0 0 0 rg BT 85.72 382.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 109.51 382.31 Td (esident, Chief ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 372.31 Td (Commer) Tj ET Q q 0 0 0 rg BT 73.07 372.31 Td (cial Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 362.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 362.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 392.32 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 392.32 Td (201) Tj ET Q q 0 0 0 rg BT 266.63 392.32 Td (1 ) Tj ET Q q 0 0 0 rg BT 274.13 392.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.41 392.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 306.91 392.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.41 392.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 342.83 392.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.46 392.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.61 392.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 405.83 392.32 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 447.77 392.32 Td (and ) Tj ET Q q 0 0 0 rg BT 464.71 392.32 Td (Immunology) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 382.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 274.50 382.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 382.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 307.28 382.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 382.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 357.00 382.32 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 377.28 382.32 Td (Pharmaceuticals) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 372.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 274.50 372.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 372.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 307.28 372.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 372.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 343.21 372.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.83 372.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.98 372.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 406.20 372.32 Td (Head ) Tj ET Q q 0 0 0 rg BT 429.80 372.32 Td (of ) Tj ET Q q 0 0 0 rg BT 440.45 372.32 Td (W) Tj ET Q q 0 0 0 rg BT 449.08 372.32 Td (orldwide ) Tj ET Q q 0 0 0 rg BT 487.13 372.32 Td (Markets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 362.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 274.50 362.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 362.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 362.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 362.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 365.96 362.32 Td (V) Tj ET Q q 0 0 0 rg BT 372.58 362.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 386.73 362.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 428.95 362.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 453.67 362.32 Td (Commercial ) Tj ET Q q 0 0 0 rg BT 505.59 362.32 Td (Of) Tj ET Q q 0 0 0 rg BT 515.96 362.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 347.32 Td (Ann Powell Judge) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 337.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 337.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 337.31 Td (esident, Chief Human ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 327.31 Td (Resour) Tj ET Q q 0 0 0 rg BT 66.96 327.31 Td (ces Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 317.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 317.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 347.32 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 347.32 Td (2009 ) Tj ET Q q 0 0 0 rg BT 274.50 347.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 347.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 307.28 347.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 347.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 339.50 347.32 Td (Human ) Tj ET Q q 0 0 0 rg BT 371.43 347.32 Td (Resources ) Tj ET Q q 0 0 0 rg BT 415.03 347.32 Td (Of) Tj ET Q q 0 0 0 rg BT 425.40 347.32 Td (ficer) Tj ET Q q 0 0 0 rg BT 443.32 347.32 Td (, ) Tj ET Q q 0 0 0 rg BT 448.32 347.32 Td (Shire ) Tj ET Q q 0 0 0 rg BT 471.93 347.32 Td (Pharmaceuticals) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 336.32 Td (2013 ) Tj ET Q q 0 0 0 rg BT 274.50 336.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 336.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 307.28 336.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 336.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 343.21 336.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.83 336.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.98 336.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 406.20 336.32 Td (Global ) Tj ET Q q 0 0 0 rg BT 435.92 336.32 Td (Human ) Tj ET Q q 0 0 0 rg BT 467.85 336.32 Td (Resources) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 326.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 274.50 326.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 326.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 326.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 326.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 352.08 326.32 Td (V) Tj ET Q q 0 0 0 rg BT 358.70 326.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 372.86 326.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 415.08 326.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 439.79 326.32 Td (Human ) Tj ET Q q 0 0 0 rg BT 471.73 326.32 Td (Resources ) Tj ET Q q 0 0 0 rg BT 515.33 326.32 Td (Of) Tj ET Q q 0 0 0 rg BT 525.70 326.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 300.32 Td (Sandra Leung ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 290.31 Td (Executive V) Tj ET Q q 0 0 0 rg BT 85.72 290.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 109.51 290.31 Td (esident, General Counsel) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 280.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 280.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 300.32 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 300.32 Td (2007 ) Tj ET Q q 0 0 0 rg BT 274.50 300.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 300.32 Td (2014 ) Tj ET Q q 0 0 0 rg BT 307.28 300.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.78 300.32 Td (General ) Tj ET Q q 0 0 0 rg BT 348.92 300.32 Td (Counsel ) Tj ET Q q 0 0 0 rg BT 384.20 300.32 Td (and ) Tj ET Q q 0 0 0 rg BT 401.14 300.32 Td (Corporate ) Tj ET Q q 0 0 0 rg BT 443.63 300.32 Td (Secretary) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 290.32 Td (2014 ) Tj ET Q q 0 0 0 rg BT 276.27 290.32 Td (to ) Tj ET Q q 0 0 0 rg BT 288.32 290.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 312.59 290.32 Td (– ) Tj ET Q q 0 0 0 rg BT 321.86 290.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 365.81 290.32 Td (V) Tj ET Q q 0 0 0 rg BT 372.43 290.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 388.35 290.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 432.34 290.32 Td (General ) Tj ET Q q 0 0 0 rg BT 468.26 290.32 Td (Counsel ) Tj ET Q q 0 0 0 rg BT 505.31 290.32 Td (and ) Tj ET Q q 0 0 0 rg BT 524.02 290.32 Td (Corporate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 280.32 Td (Secretary) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 270.32 Td (2015 ) Tj ET Q q 0 0 0 rg BT 274.50 270.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 270.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 270.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 270.32 Td (Executive ) Tj ET Q q 0 0 0 rg BT 365.96 270.32 Td (V) Tj ET Q q 0 0 0 rg BT 372.58 270.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 386.73 270.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 428.95 270.32 Td (General ) Tj ET Q q 0 0 0 rg BT 463.09 270.32 Td (Counsel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 254.32 Td (Anne Nielsen) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 244.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 244.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 244.31 Td (esident, Chief Compliance ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 234.31 Td (and Ethics Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 224.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 224.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 254.32 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 254.32 Td (2009 to 2013 – Vice President and Associate General Counsel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 244.32 Td (2013 to 2013 – Senior Vice President and Deputy General Counsel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 234.32 Td (2013 to present – Senior Vice President and Chief Compliance and Ethics) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 224.32 Td (Officer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 208.32 Td (Louis S. Schmukler) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 198.31 Td (Pr) Tj ET Q q 0 0 0 rg BT 48.63 198.31 Td (esident, Global Manufacturing and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 188.31 Td (Supply) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 178.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 178.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 208.32 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 208.32 Td (201) Tj ET Q q 0 0 0 rg BT 266.63 208.32 Td (1 ) Tj ET Q q 0 0 0 rg BT 274.13 208.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.41 208.32 Td (present ) Tj ET Q q 0 0 0 rg BT 315.78 208.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.28 208.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 365.50 208.32 Td (Global ) Tj ET Q q 0 0 0 rg BT 395.22 208.32 Td (Manufacturing ) Tj ET Q q 0 0 0 rg BT 457.14 208.32 Td (and ) Tj ET Q q 0 0 0 rg BT 474.08 208.32 Td (Supply) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 163.32 Td (Paul von ) Tj ET Q q 0 0 0 rg BT 76.23 163.32 Td (Autenried) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 153.31 Td (Senior V) Tj ET Q q 0 0 0 rg BT 72.97 153.31 Td (ice Pr) Tj ET Q q 0 0 0 rg BT 96.76 153.31 Td (esident, Chief Information ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 143.31 Td (Officer) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 133.31 Td (Member of the Leadership T) Tj ET Q q 0 0 0 rg BT 151.96 133.31 Td (eam) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.65 163.32 Td (55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 163.32 Td (201) Tj ET Q q 0 0 0 rg BT 266.63 163.32 Td (1 ) Tj ET Q q 0 0 0 rg BT 274.13 163.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.41 163.32 Td (2012 ) Tj ET Q q 0 0 0 rg BT 306.91 163.32 Td (– ) Tj ET Q q 0 0 0 rg BT 314.41 163.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 342.83 163.32 Td (V) Tj ET Q q 0 0 0 rg BT 349.46 163.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 363.61 163.32 Td (President ) Tj ET Q q 0 0 0 rg BT 403.33 163.32 Td (and ) Tj ET Q q 0 0 0 rg BT 420.27 163.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 444.98 163.32 Td (Information ) Tj ET Q q 0 0 0 rg BT 495.25 163.32 Td (Of) Tj ET Q q 0 0 0 rg BT 505.62 163.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 153.32 Td (2012 ) Tj ET Q q 0 0 0 rg BT 273.44 153.32 Td (to ) Tj ET Q q 0 0 0 rg BT 282.66 153.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 304.10 153.32 Td (– ) Tj ET Q q 0 0 0 rg BT 310.54 153.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 337.98 153.32 Td (V) Tj ET Q q 0 0 0 rg BT 344.60 153.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 357.70 153.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 398.85 153.32 Td (Enterprise ) Tj ET Q q 0 0 0 rg BT 441.38 153.32 Td (Services ) Tj ET Q q 0 0 0 rg BT 476.70 153.32 Td (and ) Tj ET Q q 0 0 0 rg BT 492.58 153.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 516.24 153.32 Td (Information ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 143.32 Td (Of) Tj ET Q q 0 0 0 rg BT 262.37 143.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.00 133.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 274.50 133.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.78 133.32 Td (present ) Tj ET Q q 0 0 0 rg BT 316.16 133.32 Td (– ) Tj ET Q q 0 0 0 rg BT 323.66 133.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 352.08 133.32 Td (V) Tj ET Q q 0 0 0 rg BT 358.70 133.32 Td (ice ) Tj ET Q q 0 0 0 rg BT 372.86 133.32 Td (President, ) Tj ET Q q 0 0 0 rg BT 415.08 133.32 Td (Chief ) Tj ET Q q 0 0 0 rg BT 439.79 133.32 Td (Information ) Tj ET Q q 0 0 0 rg BT 490.06 133.32 Td (Of) Tj ET Q q 0 0 0 rg BT 500.43 133.32 Td (ficer) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 51 0 obj <> endobj 52 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (25) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 287.85 749.25 Td (P) Tj ET Q q 0 0 0 rg BT 293.22 749.25 Td (AR) Tj ET Q q 0 0 0 rg BT 307.31 749.25 Td (T) Tj ET Q q 0 0 0 rg BT 313.80 749.25 Td ( II) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 718.68 Td (Item 5.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 718.68 Td (MARKET FOR THE REGISTRANT’S COMMON STOCK AND OTHER STOCKHOLDER MATTERS.) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 693.45 Td (Market Prices) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 676.45 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 94.60 676.45 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 125.43 676.45 Td (common ) Tj ET Q q 0 0 0 rg BT 162.91 676.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 186.51 676.45 Td (is ) Tj ET Q q 0 0 0 rg BT 195.67 676.45 Td (traded ) Tj ET Q q 0 0 0 rg BT 223.14 676.45 Td (on ) Tj ET Q q 0 0 0 rg BT 235.63 676.45 Td (the ) Tj ET Q q 0 0 0 rg BT 250.34 676.45 Td (NYSE ) Tj ET Q q 0 0 0 rg BT 278.94 676.45 Td (\(Symbol: ) Tj ET Q q 0 0 0 rg BT 318.66 676.45 Td (BMY\). ) Tj ET Q q 0 0 0 rg BT 349.21 676.45 Td (A) Tj ET Q q 0 0 0 rg BT 355.88 676.45 Td ( ) Tj ET Q q 0 0 0 rg BT 358.37 676.45 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 396.95 676.45 Td (summary ) Tj ET Q q 0 0 0 rg BT 436.66 676.45 Td (of ) Tj ET Q q 0 0 0 rg BT 447.48 676.45 Td (the ) Tj ET Q q 0 0 0 rg BT 462.18 676.45 Td (high ) Tj ET Q q 0 0 0 rg BT 482.45 676.45 Td (and ) Tj ET Q q 0 0 0 rg BT 499.38 676.45 Td (low ) Tj ET Q q 0 0 0 rg BT 516.87 676.45 Td (closing ) Tj ET Q q 0 0 0 rg BT 548.24 676.45 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 664.45 Td (price ) Tj ET Q q 0 0 0 rg BT 58.49 664.45 Td (is ) Tj ET Q q 0 0 0 rg BT 67.66 664.45 Td (presented ) Tj ET Q q 0 0 0 rg BT 108.47 664.45 Td (below:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 629.95 260.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 296.50 629.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 300.50 629.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 629.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 629.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.50 629.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 440.50 629.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 629.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 629.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 601.95 260.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 296.50 601.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 300.50 601.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 601.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 601.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.50 601.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 440.50 601.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 601.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 601.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 573.95 260.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 296.50 573.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 300.50 573.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 573.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 573.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.50 573.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 440.50 573.95 66.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 573.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 573.95 66.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 300.5 641.95 m 366.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 366.5 641.95 m 370.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 641.95 m 436.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 440.5 641.95 m 506.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 641.95 m 510.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 510.5 641.95 m 576.5 641.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 300.5 629.95 m 366.5 629.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 629.95 m 436.5 629.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 440.5 629.95 m 506.5 629.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 510.5 629.95 m 576.5 629.95 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 645.90 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 360.00 646.03 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 500.00 646.03 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 633.90 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 324.55 634.03 Td (High) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 395.40 634.03 Td (Low) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 464.55 634.03 Td (High) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 535.40 634.03 Td (Low) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 620.68 Td (Common:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 606.52 Td (First Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.00 606.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.15 606.52 Td (68.35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.00 606.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 606.52 Td (58.87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.00 606.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 606.52 Td (68.47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.00 606.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 606.52 Td (58.48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 592.52 Td (Second Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.15 592.52 Td (74.29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 592.52 Td (64.91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 592.52 Td (69.15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 592.52 Td (63.00) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 578.52 Td (Third Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.15 578.52 Td (76.77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 578.52 Td (53.87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 578.52 Td (70.06) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 578.52 Td (57.30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 564.52 Td (Fourth Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.15 564.52 Td (59.61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 564.52 Td (49.23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 564.52 Td (70.71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 564.52 Td (59.88) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 536.45 Td (Holders of Common Stock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 512.45 Td (The number of record holders of common stock at December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.13 512.45 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.13 512.45 Td ( was 43,866.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 491.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.72 491.45 Td (number ) Tj ET Q q 0 0 0 rg BT 88.44 491.45 Td (of ) Tj ET Q q 0 0 0 rg BT 99.94 491.45 Td (record ) Tj ET Q q 0 0 0 rg BT 128.65 491.45 Td (holders ) Tj ET Q q 0 0 0 rg BT 161.26 491.45 Td (is ) Tj ET Q q 0 0 0 rg BT 171.10 491.45 Td (based ) Tj ET Q q 0 0 0 rg BT 197.04 491.45 Td (upon ) Tj ET Q q 0 0 0 rg BT 220.21 491.45 Td (the ) Tj ET Q q 0 0 0 rg BT 235.60 491.45 Td (actual ) Tj ET Q q 0 0 0 rg BT 262.64 491.45 Td (number ) Tj ET Q q 0 0 0 rg BT 296.36 491.45 Td (of ) Tj ET Q q 0 0 0 rg BT 307.86 491.45 Td (holders ) Tj ET Q q 0 0 0 rg BT 340.47 491.45 Td (registered ) Tj ET Q q 0 0 0 rg BT 383.07 491.45 Td (on ) Tj ET Q q 0 0 0 rg BT 396.24 491.45 Td (our ) Tj ET Q q 0 0 0 rg BT 412.74 491.45 Td (books ) Tj ET Q q 0 0 0 rg BT 439.80 491.45 Td (at ) Tj ET Q q 0 0 0 rg BT 450.19 491.45 Td (such ) Tj ET Q q 0 0 0 rg BT 471.69 491.45 Td (date ) Tj ET Q q 0 0 0 rg BT 491.52 491.45 Td (and ) Tj ET Q q 0 0 0 rg BT 509.13 491.45 Td (does ) Tj ET Q q 0 0 0 rg BT 530.63 491.45 Td (not ) Tj ET Q q 0 0 0 rg BT 546.58 491.45 Td (include ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 479.45 Td (holders ) Tj ET Q q 0 0 0 rg BT 68.50 479.45 Td (of ) Tj ET Q q 0 0 0 rg BT 79.90 479.45 Td (shares ) Tj ET Q q 0 0 0 rg BT 107.95 479.45 Td (in ) Tj ET Q q 0 0 0 rg BT 118.79 479.45 Td (“street ) Tj ET Q q 0 0 0 rg BT 147.95 479.45 Td (names” ) Tj ET Q q 0 0 0 rg BT 181.00 479.45 Td (or ) Tj ET Q q 0 0 0 rg BT 192.39 479.45 Td (persons, ) Tj ET Q q 0 0 0 rg BT 228.51 479.45 Td (partnerships, ) Tj ET Q q 0 0 0 rg BT 282.95 479.45 Td (associations, ) Tj ET Q q 0 0 0 rg BT 336.84 479.45 Td (corporations ) Tj ET Q q 0 0 0 rg BT 389.89 479.45 Td (or ) Tj ET Q q 0 0 0 rg BT 401.28 479.45 Td (other ) Tj ET Q q 0 0 0 rg BT 424.89 479.45 Td (entities ) Tj ET Q q 0 0 0 rg BT 456.84 479.45 Td (identified ) Tj ET Q q 0 0 0 rg BT 498.22 479.45 Td (in ) Tj ET Q q 0 0 0 rg BT 509.07 479.45 Td (security ) Tj ET Q q 0 0 0 rg BT 543.79 479.45 Td (position ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 467.45 Td (listings ) Tj ET Q q 0 0 0 rg BT 67.40 467.45 Td (maintained ) Tj ET Q q 0 0 0 rg BT 114.33 467.45 Td (by ) Tj ET Q q 0 0 0 rg BT 126.83 467.45 Td (depository ) Tj ET Q q 0 0 0 rg BT 171.54 467.45 Td (trust ) Tj ET Q q 0 0 0 rg BT 191.82 467.45 Td (companies.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 441.45 Td (Dividends) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 424.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.05 424.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 80.99 424.45 Td (of ) Tj ET Q q 0 0 0 rg BT 91.82 424.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 131.53 424.45 Td (declared ) Tj ET Q q 0 0 0 rg BT 167.89 424.45 Td (the ) Tj ET Q q 0 0 0 rg BT 182.61 424.45 Td (following ) Tj ET Q q 0 0 0 rg BT 223.99 424.45 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 262.59 424.45 Td (dividends ) Tj ET Q q 0 0 0 rg BT 303.97 424.45 Td (per ) Tj ET Q q 0 0 0 rg BT 319.24 424.45 Td (share, ) Tj ET Q q 0 0 0 rg BT 345.34 424.45 Td (which ) Tj ET Q q 0 0 0 rg BT 372.28 424.45 Td (were ) Tj ET Q q 0 0 0 rg BT 394.21 424.45 Td (paid ) Tj ET Q q 0 0 0 rg BT 413.92 424.45 Td (in ) Tj ET Q q 0 0 0 rg BT 424.20 424.45 Td (the ) Tj ET Q q 0 0 0 rg BT 438.92 424.45 Td (periods ) Tj ET Q q 0 0 0 rg BT 470.86 424.45 Td (indicated ) Tj ET Q q 0 0 0 rg BT 510.01 424.45 Td (below:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 389.95 266.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 302.50 389.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 306.50 389.95 65.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 371.50 389.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 375.50 389.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 439.50 389.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 389.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 389.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 389.95 65.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 361.95 266.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 302.50 361.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 306.50 361.95 65.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 371.50 361.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 375.50 361.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 439.50 361.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 361.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 361.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 361.95 65.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 333.95 266.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 302.50 333.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 306.50 333.95 65.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 371.50 333.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 375.50 333.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 439.50 333.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 333.95 64.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 333.95 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 333.95 65.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 306.5 401.95 m 371.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 371.5 401.95 m 375.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 401.95 m 439.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 401.95 m 507.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 401.95 m 511.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 401.95 m 576.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 306.5 389.95 m 371.5 389.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 401.95 m 439.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 389.95 m 439.5 389.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 389.95 m 507.5 389.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 401.95 m 576.5 401.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 389.95 m 576.5 389.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 389.95 m 439.5 389.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 306.5 333.95 m 371.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 333.95 m 439.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 333.95 m 507.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 333.95 m 576.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 306.5 320.95 m 371.5 320.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 306.5 318.95 m 371.5 318.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 333.95 m 439.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 320.95 m 439.5 320.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 375.5 318.95 m 439.5 318.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 333.95 m 507.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 320.95 m 507.5 320.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 318.95 m 507.5 318.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 333.95 m 576.5 333.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 320.95 m 576.5 320.95 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 318.95 m 576.5 318.95 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 405.90 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 356.70 406.03 Td (Common) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 492.95 406.03 Td (Preferred) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 393.90 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 330.50 394.03 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 399.00 394.03 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 467.00 394.03 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 535.50 394.03 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 380.52 Td (First Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.00 380.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.15 380.52 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.00 380.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.15 380.52 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.00 380.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 380.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 380.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 380.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 366.52 Td (Second Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.15 366.52 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.15 366.52 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 366.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 366.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 352.52 Td (Third Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.15 352.52 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.15 352.52 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 352.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 352.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 338.52 Td (Fourth Quarter) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.15 338.52 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.15 338.52 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 338.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 338.52 Td (0.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.00 324.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.15 324.52 Td (1.52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.00 324.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.15 324.52 Td (1.48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.00 324.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 324.52 Td (2.00) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 324.52 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 324.52 Td (2.00) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.45 Td (In ) Tj ET Q q 0 0 0 rg BT 47.24 299.45 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 91.24 299.45 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.24 299.45 Td (, ) Tj ET Q q 0 0 0 rg BT 116.65 299.45 Td (our ) Tj ET Q q 0 0 0 rg BT 132.89 299.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 160.24 299.45 Td (of ) Tj ET Q q 0 0 0 rg BT 171.48 299.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 211.60 299.45 Td (declared ) Tj ET Q q 0 0 0 rg BT 248.38 299.45 Td (a ) Tj ET Q q 0 0 0 rg BT 255.73 299.45 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 294.73 299.45 Td (dividend ) Tj ET Q q 0 0 0 rg BT 332.64 299.45 Td (of ) Tj ET Q q 0 0 0 rg BT 343.88 299.45 Td ($0.39 ) Tj ET Q q 0 0 0 rg BT 369.29 299.45 Td (per ) Tj ET Q q 0 0 0 rg BT 384.97 299.45 Td (share ) Tj ET Q q 0 0 0 rg BT 408.98 299.45 Td (on ) Tj ET Q q 0 0 0 rg BT 421.89 299.45 Td (our ) Tj ET Q q 0 0 0 rg BT 438.13 299.45 Td (common ) Tj ET Q q 0 0 0 rg BT 476.04 299.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 500.06 299.45 Td (which ) Tj ET Q q 0 0 0 rg BT 527.41 299.45 Td (was ) Tj ET Q q 0 0 0 rg BT 545.87 299.45 Td (paid ) Tj ET Q q 0 0 0 rg BT 566.00 299.45 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.45 Td (February ) Tj ET Q q 0 0 0 rg BT 74.36 287.45 Td (1, ) Tj ET Q q 0 0 0 rg BT 84.12 287.45 Td (2017 ) Tj ET Q q 0 0 0 rg BT 106.39 287.45 Td (to ) Tj ET Q q 0 0 0 rg BT 116.43 287.45 Td (shareholders ) Tj ET Q q 0 0 0 rg BT 169.23 287.45 Td (of ) Tj ET Q q 0 0 0 rg BT 179.82 287.45 Td (record ) Tj ET Q q 0 0 0 rg BT 207.62 287.45 Td (as ) Tj ET Q q 0 0 0 rg BT 218.21 287.45 Td (of ) Tj ET Q q 0 0 0 rg BT 228.80 287.45 Td (January ) Tj ET Q q 0 0 0 rg BT 262.16 287.45 Td (6, ) Tj ET Q q 0 0 0 rg BT 271.92 287.45 Td (2017. ) Tj ET Q q 0 0 0 rg BT 296.52 287.45 Td (The ) Tj ET Q q 0 0 0 rg BT 314.33 287.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 341.03 287.45 Td (of ) Tj ET Q q 0 0 0 rg BT 351.63 287.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 391.09 287.45 Td (also ) Tj ET Q q 0 0 0 rg BT 409.46 287.45 Td (declared ) Tj ET Q q 0 0 0 rg BT 445.59 287.45 Td (a ) Tj ET Q q 0 0 0 rg BT 452.29 287.45 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 490.65 287.45 Td (dividend ) Tj ET Q q 0 0 0 rg BT 527.90 287.45 Td (of ) Tj ET Q q 0 0 0 rg BT 538.50 287.45 Td ($0.50 ) Tj ET Q q 0 0 0 rg BT 563.26 287.45 Td (per ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.45 Td (share ) Tj ET Q q 0 0 0 rg BT 59.60 275.45 Td (on ) Tj ET Q q 0 0 0 rg BT 72.10 275.45 Td (our ) Tj ET Q q 0 0 0 rg BT 87.93 275.45 Td (preferred ) Tj ET Q q 0 0 0 rg BT 127.06 275.45 Td (stock, ) Tj ET Q q 0 0 0 rg BT 153.17 275.45 Td (payable ) Tj ET Q q 0 0 0 rg BT 186.77 275.45 Td (on ) Tj ET Q q 0 0 0 rg BT 199.27 275.45 Td (March ) Tj ET Q q 0 0 0 rg BT 227.87 275.45 Td (1, ) Tj ET Q q 0 0 0 rg BT 237.87 275.45 Td (2017 ) Tj ET Q q 0 0 0 rg BT 260.37 275.45 Td (to ) Tj ET Q q 0 0 0 rg BT 270.64 275.45 Td (shareholders ) Tj ET Q q 0 0 0 rg BT 323.68 275.45 Td (of ) Tj ET Q q 0 0 0 rg BT 334.51 275.45 Td (record ) Tj ET Q q 0 0 0 rg BT 362.55 275.45 Td (as ) Tj ET Q q 0 0 0 rg BT 373.38 275.45 Td (of ) Tj ET Q q 0 0 0 rg BT 384.21 275.45 Td (February ) Tj ET Q q 0 0 0 rg BT 422.81 275.45 Td (7, ) Tj ET Q q 0 0 0 rg BT 432.81 275.45 Td (2017.) Tj ET Q endstream endobj 53 0 obj <> endobj 54 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (26) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (UNREGISTERED SALES OF) Tj ET Q q 0 0 0 rg BT 166.22 749.25 Td ( EQUITY) Tj ET Q q 0 0 0 rg BT 207.80 749.25 Td ( SECURITIES ) Tj ET Q q 0 0 0 rg BT 272.83 749.25 Td (AND USE OF) Tj ET Q q 0 0 0 rg BT 332.46 749.25 Td ( PROCEEDS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 720.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 720.25 Td (following ) Tj ET Q q 0 0 0 rg BT 95.43 720.25 Td (table ) Tj ET Q q 0 0 0 rg BT 117.37 720.25 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 167.63 720.25 Td (the ) Tj ET Q q 0 0 0 rg BT 182.35 720.25 Td (surrenders ) Tj ET Q q 0 0 0 rg BT 226.50 720.25 Td (of ) Tj ET Q q 0 0 0 rg BT 237.33 720.25 Td (our ) Tj ET Q q 0 0 0 rg BT 253.16 720.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 280.65 720.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 320.92 720.25 Td (during ) Tj ET Q q 0 0 0 rg BT 349.53 720.25 Td (the ) Tj ET Q q 0 0 0 rg BT 364.24 720.25 Td (twelve ) Tj ET Q q 0 0 0 rg BT 393.40 720.25 Td (month ) Tj ET Q q 0 0 0 rg BT 421.45 720.25 Td (period ) Tj ET Q q 0 0 0 rg BT 449.50 720.25 Td (ended ) Tj ET Q q 0 0 0 rg BT 475.88 720.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 534.46 720.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.46 720.25 Td (:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 643.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 643.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 643.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 643.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 643.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 643.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 643.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 643.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 643.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 613.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 613.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 613.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 613.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 613.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 613.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 613.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 613.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 613.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 583.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 583.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 583.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 583.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 583.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 583.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 583.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 583.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 583.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 553.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 553.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 553.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 553.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 553.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 553.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 553.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 553.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 553.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 523.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 523.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 523.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 523.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 523.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 523.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 523.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 523.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 523.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 493.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 493.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 493.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 493.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 493.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 463.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 463.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 463.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 463.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 463.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 463.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 463.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 463.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 463.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 433.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 433.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 433.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 433.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 433.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 433.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 433.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 433.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 433.75 100.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 403.75 212.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 248.50 403.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 252.50 403.75 78.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 403.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 334.50 403.75 58.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 403.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 403.75 76.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 403.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 403.75 100.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 656.75 m 248.5 656.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 656.75 m 330.5 656.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 334.5 656.75 m 392.5 656.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 656.75 m 472.5 656.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 476.5 656.75 m 576.5 656.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 598.75 m 330.5 598.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 598.75 m 472.5 598.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 583.75 m 330.5 583.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 583.75 m 472.5 583.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 538.75 m 330.5 538.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 538.75 m 472.5 538.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 523.75 m 330.5 523.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 523.75 m 472.5 523.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 478.75 m 330.5 478.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 478.75 m 472.5 478.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 463.75 m 330.5 463.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 463.75 m 472.5 463.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 418.75 m 330.5 418.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 418.75 m 472.5 418.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 403.75 m 330.5 403.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 403.75 m 472.5 403.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 252.5 388.75 m 330.5 388.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 388.75 m 472.5 388.75 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 39.00 660.98 Td (Period) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 262.75 668.98 Td (T) Tj ET Q q 0 0 0 rg BT 267.35 668.98 Td (otal Number) Tj ET Q q 0 0 0 rg BT 310.54 668.98 Td ( of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 256.75 660.98 Td (Shar) Tj ET Q q 0 0 0 rg BT 273.05 660.98 Td (es Pur) Tj ET Q q 0 0 0 rg BT 294.46 660.98 Td (chased) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 317.57 665.51 Td (\(a\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 339.20 676.98 Td (A) Tj ET Q q 0 0 0 rg BT 344.38 676.98 Td (verage Price) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 355.20 668.98 Td (Paid) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 342.55 660.98 Td (per) Tj ET Q q 0 0 0 rg BT 353.96 660.98 Td ( Shar) Tj ET Q q 0 0 0 rg BT 372.26 660.98 Td (e) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 375.81 665.51 Td (\(a\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 405.75 700.98 Td (T) Tj ET Q q 0 0 0 rg BT 410.35 700.98 Td (otal Number) Tj ET Q q 0 0 0 rg BT 453.54 700.98 Td ( of  ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 422.50 692.98 Td (Shar) Tj ET Q q 0 0 0 rg BT 438.80 692.98 Td (es) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 402.95 684.98 Td (Pur) Tj ET Q q 0 0 0 rg BT 415.69 684.98 Td (chased as Part ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 430.65 676.98 Td (of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 399.65 668.98 Td (Publicly ) Tj ET Q q 0 0 0 rg BT 429.21 668.98 Td (Announced ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 413.20 660.98 Td (Pr) Tj ET Q q 0 0 0 rg BT 421.49 660.98 Td (ograms) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 446.82 665.51 Td (\(b\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.00 684.98 Td (Appr) Tj ET Q q 0 0 0 rg BT 499.08 684.98 Td (oximate Dollar) Tj ET Q q 0 0 0 rg BT 549.81 684.98 Td ( ) Tj ET Q q 0 0 0 rg BT 551.67 684.98 Td (V) Tj ET Q q 0 0 0 rg BT 556.71 684.98 Td (alue) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.65 676.98 Td (of Shar) Tj ET Q q 0 0 0 rg BT 506.62 676.98 Td (es that May ) Tj ET Q q 0 0 0 rg BT 548.31 676.98 Td (Y) Tj ET Q q 0 0 0 rg BT 553.20 676.98 Td (et Be) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.90 668.98 Td (Pur) Tj ET Q q 0 0 0 rg BT 502.64 668.98 Td (chased Under) Tj ET Q q 0 0 0 rg BT 549.39 668.98 Td ( the) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 505.20 660.98 Td (Pr) Tj ET Q q 0 0 0 rg BT 513.49 660.98 Td (ograms) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 538.82 665.51 Td (\(b\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 648.00 Td (Dollars in Millions, Except Per Share Data) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 255.00 648.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 337.00 648.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 399.00 648.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 479.00 648.00 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 634.32 Td (January 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 633.42 Td (29,768) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 633.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 633.42 Td (68.96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 633.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 633.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 633.42 Td (1,368) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 619.32 Td (February 1 to 29, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.65 618.42 Td (1,334,226) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 618.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 618.42 Td (62.45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 618.42 Td (1,193,017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 618.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 618.42 Td (1,294) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 604.32 Td (March 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.65 603.42 Td (4,008,710) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 603.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 603.42 Td (64.12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 603.42 Td (2,464,576) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 603.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 603.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 589.32 Td (Three months ended March 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.65 588.42 Td (5,372,704) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 588.42 Td (3,657,593) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 574.32 Td (April 1 to 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 304.15 573.42 Td (7,807) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 573.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 573.42 Td (64.78) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 573.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 573.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 573.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 559.32 Td (May 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 558.42 Td (13,948) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 558.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 558.42 Td (71.50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 558.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 558.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 558.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 544.32 Td (June 1 to 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 543.42 Td (10,311) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 543.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 543.42 Td (71.96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 543.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 543.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 543.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 529.32 Td (Three months ended June 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 528.42 Td (32,066) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 528.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 514.32 Td (July 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 513.42 Td (15,069) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 513.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 513.42 Td (73.72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 513.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 513.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 513.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 499.32 Td (August 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 304.15 498.42 Td (6,223) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 498.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 498.42 Td (75.10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 498.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 498.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 498.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 484.32 Td (September 1 to 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 304.15 483.42 Td (5,702) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 483.42 Td (57.36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 483.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 483.42 Td (1,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 469.32 Td (Three months ended September 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 468.42 Td (26,994) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 468.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 454.32 Td (October 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 304.15 453.42 Td (6,881) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 453.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 453.42 Td (54.61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 453.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 453.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 453.42 Td (4,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 439.32 Td (November 1 to 30, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 438.42 Td (11,011) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 438.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 438.42 Td (51.54) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 438.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 438.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 438.42 Td (4,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 424.32 Td (December 1 to 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 423.42 Td (22,220) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.00 423.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.15 423.42 Td (55.72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 423.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 423.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 423.42 Td (4,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 409.32 Td (Three months ended December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.15 408.42 Td (40,112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 408.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 394.32 Td (Twelve months ended December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.65 393.42 Td (5,471,876) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 393.42 Td (3,657,593) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 367.65 Td (\(a\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 367.65 Td (Includes ) Tj ET Q q 0 0 0 rg BT 89.95 367.65 Td (shares ) Tj ET Q q 0 0 0 rg BT 111.44 367.65 Td (repurchased ) Tj ET Q q 0 0 0 rg BT 151.59 367.65 Td (as ) Tj ET Q q 0 0 0 rg BT 159.75 367.65 Td (part ) Tj ET Q q 0 0 0 rg BT 173.69 367.65 Td (of ) Tj ET Q q 0 0 0 rg BT 181.85 367.65 Td (publicly ) Tj ET Q q 0 0 0 rg BT 209.57 367.65 Td (announced ) Tj ET Q q 0 0 0 rg BT 245.72 367.65 Td (programs ) Tj ET Q q 0 0 0 rg BT 277.44 367.65 Td (and ) Tj ET Q q 0 0 0 rg BT 290.49 367.65 Td (shares ) Tj ET Q q 0 0 0 rg BT 311.98 367.65 Td (of ) Tj ET Q q 0 0 0 rg BT 320.15 367.65 Td (common ) Tj ET Q q 0 0 0 rg BT 349.64 367.65 Td (stock ) Tj ET Q q 0 0 0 rg BT 368.03 367.65 Td (surrendered ) Tj ET Q q 0 0 0 rg BT 407.29 367.65 Td (to ) Tj ET Q q 0 0 0 rg BT 415.01 367.65 Td (the ) Tj ET Q q 0 0 0 rg BT 426.28 367.65 Td (Company ) Tj ET Q q 0 0 0 rg BT 458.89 367.65 Td (to ) Tj ET Q q 0 0 0 rg BT 466.62 367.65 Td (satisfy ) Tj ET Q q 0 0 0 rg BT 489.00 367.65 Td (tax ) Tj ET Q q 0 0 0 rg BT 500.28 367.65 Td (withholding ) Tj ET Q q 0 0 0 rg BT 540.44 367.65 Td (obligations ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 358.05 Td (in ) Tj ET Q q 0 0 0 rg BT 69.57 358.05 Td (connection ) Tj ET Q q 0 0 0 rg BT 106.67 358.05 Td (with ) Tj ET Q q 0 0 0 rg BT 122.89 358.05 Td (the ) Tj ET Q q 0 0 0 rg BT 134.67 358.05 Td (vesting ) Tj ET Q q 0 0 0 rg BT 159.78 358.05 Td (of ) Tj ET Q q 0 0 0 rg BT 168.44 358.05 Td (awards ) Tj ET Q q 0 0 0 rg BT 193.10 358.05 Td (under ) Tj ET Q q 0 0 0 rg BT 213.31 358.05 Td (our ) Tj ET Q q 0 0 0 rg BT 225.97 358.05 Td (long-term ) Tj ET Q q 0 0 0 rg BT 259.52 358.05 Td (incentive ) Tj ET Q q 0 0 0 rg BT 290.84 358.05 Td (program.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 348.45 Td (\(b\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 348.45 Td (In ) Tj ET Q q 0 0 0 rg BT 69.57 348.45 Td (May ) Tj ET Q q 0 0 0 rg BT 85.78 348.45 Td (2010, ) Tj ET Q q 0 0 0 rg BT 105.33 348.45 Td (the ) Tj ET Q q 0 0 0 rg BT 116.66 348.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 137.76 348.45 Td (of ) Tj ET Q q 0 0 0 rg BT 145.98 348.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 177.29 348.45 Td (authorized ) Tj ET Q q 0 0 0 rg BT 212.61 348.45 Td (the ) Tj ET Q q 0 0 0 rg BT 223.93 348.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 260.13 348.45 Td (of ) Tj ET Q q 0 0 0 rg BT 268.35 348.45 Td (up ) Tj ET Q q 0 0 0 rg BT 277.90 348.45 Td (to ) Tj ET Q q 0 0 0 rg BT 285.67 348.45 Td ($3.0 ) Tj ET Q q 0 0 0 rg BT 301.22 348.45 Td (billion ) Tj ET Q q 0 0 0 rg BT 323.67 348.45 Td (of ) Tj ET Q q 0 0 0 rg BT 331.88 348.45 Td (common ) Tj ET Q q 0 0 0 rg BT 361.43 348.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 379.87 348.45 Td (and ) Tj ET Q q 0 0 0 rg BT 392.97 348.45 Td (in ) Tj ET Q q 0 0 0 rg BT 400.74 348.45 Td (June ) Tj ET Q q 0 0 0 rg BT 416.96 348.45 Td (2012 ) Tj ET Q q 0 0 0 rg BT 434.51 348.45 Td (increased ) Tj ET Q q 0 0 0 rg BT 466.27 348.45 Td (its ) Tj ET Q q 0 0 0 rg BT 475.38 348.45 Td (authorization ) Tj ET Q q 0 0 0 rg BT 519.14 348.45 Td (for ) Tj ET Q q 0 0 0 rg BT 530.02 348.45 Td (the ) Tj ET Q q 0 0 0 rg BT 541.34 348.45 Td (repurchase ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 338.85 Td (of ) Tj ET Q q 0 0 0 rg BT 70.08 338.85 Td (common ) Tj ET Q q 0 0 0 rg BT 100.15 338.85 Td (stock ) Tj ET Q q 0 0 0 rg BT 119.11 338.85 Td (by ) Tj ET Q q 0 0 0 rg BT 129.18 338.85 Td (an ) Tj ET Q q 0 0 0 rg BT 138.80 338.85 Td (additional ) Tj ET Q q 0 0 0 rg BT 172.86 338.85 Td ($3.0 ) Tj ET Q q 0 0 0 rg BT 188.93 338.85 Td (billion. ) Tj ET Q q 0 0 0 rg BT 213.89 338.85 Td (In ) Tj ET Q q 0 0 0 rg BT 222.63 338.85 Td (October ) Tj ET Q q 0 0 0 rg BT 250.46 338.85 Td (2016, ) Tj ET Q q 0 0 0 rg BT 270.53 338.85 Td (the ) Tj ET Q q 0 0 0 rg BT 282.38 338.85 Td (Board ) Tj ET Q q 0 0 0 rg BT 304.00 338.85 Td (of ) Tj ET Q q 0 0 0 rg BT 312.73 338.85 Td (Directors ) Tj ET Q q 0 0 0 rg BT 344.57 338.85 Td (approved ) Tj ET Q q 0 0 0 rg BT 376.40 338.85 Td (a ) Tj ET Q q 0 0 0 rg BT 382.03 338.85 Td (new ) Tj ET Q q 0 0 0 rg BT 397.42 338.85 Td (share ) Tj ET Q q 0 0 0 rg BT 416.37 338.85 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 453.09 338.85 Td (program ) Tj ET Q q 0 0 0 rg BT 482.26 338.85 Td (authorizing ) Tj ET Q q 0 0 0 rg BT 520.76 338.85 Td (the ) Tj ET Q q 0 0 0 rg BT 532.61 338.85 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 569.32 338.85 Td (of ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 329.25 Td (an ) Tj ET Q q 0 0 0 rg BT 70.90 329.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 104.89 329.25 Td ($3.0 ) Tj ET Q q 0 0 0 rg BT 120.89 329.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 143.78 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 152.45 329.25 Td (common ) Tj ET Q q 0 0 0 rg BT 182.44 329.25 Td (stock. ) Tj ET Q q 0 0 0 rg BT 203.19 329.25 Td (The ) Tj ET Q q 0 0 0 rg BT 217.62 329.25 Td (stock ) Tj ET Q q 0 0 0 rg BT 236.51 329.25 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 273.15 329.25 Td (program ) Tj ET Q q 0 0 0 rg BT 302.26 329.25 Td (does ) Tj ET Q q 0 0 0 rg BT 318.92 329.25 Td (not ) Tj ET Q q 0 0 0 rg BT 331.14 329.25 Td (have ) Tj ET Q q 0 0 0 rg BT 348.24 329.25 Td (an ) Tj ET Q q 0 0 0 rg BT 357.80 329.25 Td (expiration ) Tj ET Q q 0 0 0 rg BT 392.23 329.25 Td (date.) Tj ET Q endstream endobj 55 0 obj <> endobj 56 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (27) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 746.23 Td (Item 6.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 746.23 Td (SELECTED FINANCIAL DATA.) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 721.00 Td (Five ) Tj ET Q q 0 0 0 rg BT 56.45 721.00 Td (Y) Tj ET Q q 0 0 0 rg BT 62.57 721.00 Td (ear) Tj ET Q q 0 0 0 rg BT 76.26 721.00 Td ( Financial Summary) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 697.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 697.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 697.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 697.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 697.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 697.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 697.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 697.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 697.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 697.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 697.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 671.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 671.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 671.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 671.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 671.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 671.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 671.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 671.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 671.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 671.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 671.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 645.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 645.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 645.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 645.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 645.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 645.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 645.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 645.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 645.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 645.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 645.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 619.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 619.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 619.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 619.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 619.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 619.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 619.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 619.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 619.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 619.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 619.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 593.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 593.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 593.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 593.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 593.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 593.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 593.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 593.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 593.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 593.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 593.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 567.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 567.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 567.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 567.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 567.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 567.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 567.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 567.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 567.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 567.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 567.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 541.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 541.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 541.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 541.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 541.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 541.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 541.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 541.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 541.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 541.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 541.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 515.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 515.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 515.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 515.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 515.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 515.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 515.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 515.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 515.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 515.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 515.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 489.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 489.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 489.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 489.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 489.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 489.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 489.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 489.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 489.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 489.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 489.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 463.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 463.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 463.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 463.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 463.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 463.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 463.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 463.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 463.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 463.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 463.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 437.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 437.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 437.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 437.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 437.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 437.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 437.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 437.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 437.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 437.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 437.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 411.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 411.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 411.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 411.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 411.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 411.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 411.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 411.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 411.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 411.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 411.50 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 385.50 249.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 385.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 289.50 385.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 385.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 347.50 385.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 385.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 385.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 385.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 385.50 54.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 385.50 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 385.50 55.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 289.5 697.5 m 343.5 697.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 347.5 697.5 m 401.5 697.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 405.5 697.5 m 459.5 697.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 463.5 697.5 m 517.5 697.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 697.5 m 576.5 697.5 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 701.75 Td (Amounts in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 308.00 701.73 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 366.00 701.73 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 424.00 701.73 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 482.00 701.73 Td (2013) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 540.50 701.73 Td (2012) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 688.23 Td (Income Statement Data:) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 142.86 692.76 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 675.07 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 675.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 312.15 675.07 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 675.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.15 675.07 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 675.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.15 675.07 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 675.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 675.07 Td (16,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 675.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 675.07 Td (17,621) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 662.06 Td (Continuing Operations:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 649.07 Td (Net Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 649.07 Td (4,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 649.07 Td (1,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 649.07 Td (2,029) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 649.07 Td (2,580) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 649.07 Td (2,501) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 636.07 Td (Net Earnings Attributable to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 623.07 Td (Noncontrolling Interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.65 623.07 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.65 623.07 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 623.07 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 623.07 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 623.07 Td (541) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 610.07 Td (BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 610.07 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 610.07 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 610.07 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 610.07 Td (2,563) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 610.07 Td (1,960) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 584.07 Td (Net Earnings per Common Share Attributable to BMS:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 571.07 Td (Basic) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 571.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.15 571.07 Td (2.67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 571.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.15 571.07 Td (0.94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 571.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.15 571.07 Td (1.21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 571.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.15 571.07 Td (1.56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 571.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 571.07 Td (1.17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 558.07 Td (Diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 558.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.15 558.07 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 558.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.15 558.07 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 558.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.15 558.07 Td (1.20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 558.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.15 558.07 Td (1.54) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 558.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 558.07 Td (1.16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 532.07 Td (Average common shares outstanding:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 519.07 Td (Basic) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 519.07 Td (1,671) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 519.07 Td (1,667) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 519.07 Td (1,657) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 519.07 Td (1,644) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 519.07 Td (1,670) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 506.07 Td (Diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 506.07 Td (1,680) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 506.07 Td (1,679) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 506.07 Td (1,670) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 506.07 Td (1,662) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 506.07 Td (1,688) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 480.07 Td (Cash dividends paid on BMS common and preferred stock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 480.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 480.07 Td (2,547) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 480.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 480.07 Td (2,477) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 480.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 480.07 Td (2,398) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 480.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 480.07 Td (2,309) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 480.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 480.07 Td (2,286) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 454.07 Td (Cash dividends declared per common share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 454.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.15 454.07 Td (1.53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 454.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.15 454.07 Td (1.49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 454.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.15 454.07 Td (1.45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 454.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.15 454.07 Td (1.41) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 454.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 454.07 Td (1.37) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 428.23 Td (Financial Position Data at December 31:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 415.07 Td (Cash and cash equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.00 415.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 415.07 Td (4,237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.00 415.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 415.07 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.00 415.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 415.07 Td (5,571) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 415.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 415.07 Td (3,586) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 415.07 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 415.07 Td (1,656) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 402.07 Td (Marketable securities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 124.80 406.60 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 402.07 Td (4,832) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 402.07 Td (6,545) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 402.07 Td (6,272) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 402.07 Td (4,686) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 402.07 Td (4,696) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 389.07 Td (Total Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 312.15 389.07 Td (33,707) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.15 389.07 Td (31,748) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.15 389.07 Td (33,749) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 389.07 Td (38,592) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 389.07 Td (35,897) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 376.07 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 101.48 380.60 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.15 376.07 Td (6,465) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.15 376.07 Td (6,550) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.15 376.07 Td (7,242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 376.07 Td (7,981) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 376.07 Td (7,232) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 363.07 Td (Equity) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 312.15 363.07 Td (16,347) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.15 363.07 Td (14,424) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.15 363.07 Td (14,983) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 363.07 Td (15,236) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 363.07 Td (13,638) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 340.80 Td (\(a\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 340.80 Td (For ) Tj ET Q q 0 0 0 rg BT 74.39 340.80 Td (a ) Tj ET Q q 0 0 0 rg BT 79.88 340.80 Td (discussion ) Tj ET Q q 0 0 0 rg BT 115.14 340.80 Td (of ) Tj ET Q q 0 0 0 rg BT 123.74 340.80 Td (items ) Tj ET Q q 0 0 0 rg BT 143.00 340.80 Td (that ) Tj ET Q q 0 0 0 rg BT 156.93 340.80 Td (af) Tj ET Q q 0 0 0 rg BT 163.00 340.80 Td (fected ) Tj ET Q q 0 0 0 rg BT 184.47 340.80 Td (the ) Tj ET Q q 0 0 0 rg BT 196.18 340.80 Td (comparability ) Tj ET Q q 0 0 0 rg BT 242.54 340.80 Td (of ) Tj ET Q q 0 0 0 rg BT 251.14 340.80 Td (results ) Tj ET Q q 0 0 0 rg BT 273.95 340.80 Td (for ) Tj ET Q q 0 0 0 rg BT 285.21 340.80 Td (the ) Tj ET Q q 0 0 0 rg BT 296.92 340.80 Td (years ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 315.73 340.80 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 331.73 340.80 Td (, ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 335.66 340.80 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 351.66 340.80 Td ( ) Tj ET Q q 0 0 0 rg BT 353.59 340.80 Td (and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 367.07 340.80 Td (2014) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 383.07 340.80 Td (, ) Tj ET Q q 0 0 0 rg BT 387.01 340.80 Td (refer ) Tj ET Q q 0 0 0 rg BT 404.03 340.80 Td (to ) Tj ET Q q 0 0 0 rg BT 412.19 340.80 Td (“Item ) Tj ET Q q 0 0 0 rg BT 432.33 340.80 Td (7. ) Tj ET Q q 0 0 0 rg BT 440.26 340.80 Td (Management’) Tj ET Q q 0 0 0 rg BT 484.24 340.80 Td (s ) Tj ET Q q 0 0 0 rg BT 489.29 340.80 Td (Discussion ) Tj ET Q q 0 0 0 rg BT 526.33 340.80 Td (and ) Tj ET Q q 0 0 0 rg BT 539.39 340.80 Td (Analysis ) Tj ET Q q 0 0 0 rg BT 569.32 340.80 Td (of ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 331.20 Td (Financial ) Tj ET Q q 0 0 0 rg BT 93.12 331.20 Td (Condition ) Tj ET Q q 0 0 0 rg BT 127.12 331.20 Td (and ) Tj ET Q q 0 0 0 rg BT 140.67 331.20 Td (Results ) Tj ET Q q 0 0 0 rg BT 166.23 331.20 Td (of ) Tj ET Q q 0 0 0 rg BT 174.90 331.20 Td (Operations—Non-GAAP) Tj ET Q q 0 0 0 rg BT 255.92 331.20 Td ( ) Tj ET Q q 0 0 0 rg BT 257.92 331.20 Td (Financial ) Tj ET Q q 0 0 0 rg BT 289.69 331.20 Td (Measures.”) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 321.60 Td (\(b\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 321.60 Td (Includes ) Tj ET Q q 0 0 0 rg BT 90.45 321.60 Td (current ) Tj ET Q q 0 0 0 rg BT 115.10 321.60 Td (and ) Tj ET Q q 0 0 0 rg BT 128.65 321.60 Td (non-current ) Tj ET Q q 0 0 0 rg BT 167.97 321.60 Td (portion.) Tj ET Q endstream endobj 57 0 obj <> endobj 58 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (28) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Item 7.        MANAGEMENT’S ) Tj ET Q q 0 0 0 rg BT 178.20 749.25 Td (DISCUSSION ) Tj ET Q q 0 0 0 rg BT 245.38 749.25 Td (AND ) Tj ET Q q 0 0 0 rg BT 273.10 749.25 Td (ANAL) Tj ET Q q 0 0 0 rg BT 300.52 749.25 Td (YSIS ) Tj ET Q q 0 0 0 rg BT 330.52 749.25 Td (OF) Tj ET Q q 0 0 0 rg BT 344.03 749.25 Td ( ) Tj ET Q q 0 0 0 rg BT 351.80 749.25 Td (FINANCIAL) Tj ET Q q 0 0 0 rg BT 407.92 749.25 Td ( ) Tj ET Q q 0 0 0 rg BT 415.68 749.25 Td (CONDITION ) Tj ET Q q 0 0 0 rg BT 480.63 749.25 Td (AND ) Tj ET Q q 0 0 0 rg BT 510.06 749.25 Td (RESUL) Tj ET Q q 0 0 0 rg BT 542.49 749.25 Td (TS ) Tj ET Q q 0 0 0 rg BT 562.48 749.25 Td (OF) Tj ET Q q 0 0 0 rg BT 576.00 749.25 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 737.25 Td (OPERA) Tj ET Q q 0 0 0 rg BT 70.26 737.25 Td (TIONS.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 715.65 Td (EXECUTIVE SUMMAR) Tj ET Q q 0 0 0 rg BT 143.71 715.65 Td (Y) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 694.05 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 95.46 694.05 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 127.15 694.05 Td (Company ) Tj ET Q q 0 0 0 rg BT 169.38 694.05 Td (is ) Tj ET Q q 0 0 0 rg BT 179.40 694.05 Td (a ) Tj ET Q q 0 0 0 rg BT 187.19 694.05 Td (global ) Tj ET Q q 0 0 0 rg BT 215.53 694.05 Td (specialty ) Tj ET Q q 0 0 0 rg BT 254.42 694.05 Td (biopharmaceutical ) Tj ET Q q 0 0 0 rg BT 331.62 694.05 Td (company ) Tj ET Q q 0 0 0 rg BT 371.63 694.05 Td (whose ) Tj ET Q q 0 0 0 rg BT 400.53 694.05 Td (mission ) Tj ET Q q 0 0 0 rg BT 434.99 694.05 Td (is ) Tj ET Q q 0 0 0 rg BT 445.01 694.05 Td (to ) Tj ET Q q 0 0 0 rg BT 456.14 694.05 Td (discover) Tj ET Q q 0 0 0 rg BT 489.62 694.05 Td (, ) Tj ET Q q 0 0 0 rg BT 495.46 694.05 Td (develop ) Tj ET Q q 0 0 0 rg BT 530.47 694.05 Td (and ) Tj ET Q q 0 0 0 rg BT 548.25 694.05 Td (deliver ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 682.05 Td (innovative ) Tj ET Q q 0 0 0 rg BT 80.36 682.05 Td (medicines ) Tj ET Q q 0 0 0 rg BT 123.05 682.05 Td (that ) Tj ET Q q 0 0 0 rg BT 140.19 682.05 Td (help ) Tj ET Q q 0 0 0 rg BT 159.56 682.05 Td (patients ) Tj ET Q q 0 0 0 rg BT 192.81 682.05 Td (prevail ) Tj ET Q q 0 0 0 rg BT 222.72 682.05 Td (over ) Tj ET Q q 0 0 0 rg BT 242.63 682.05 Td (serious ) Tj ET Q q 0 0 0 rg BT 273.11 682.05 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 310.53 682.05 Td (Refer ) Tj ET Q q 0 0 0 rg BT 334.88 682.05 Td (to ) Tj ET Q q 0 0 0 rg BT 344.81 682.05 Td (the ) Tj ET Q q 0 0 0 rg BT 359.17 682.05 Td (Summary ) Tj ET Q q 0 0 0 rg BT 400.21 682.05 Td (of ) Tj ET Q q 0 0 0 rg BT 410.21 682.05 Td (Abbreviated ) Tj ET Q q 0 0 0 rg BT 461.63 682.05 Td (T) Tj ET Q q 0 0 0 rg BT 467.04 682.05 Td (erms ) Tj ET Q q 0 0 0 rg BT 488.62 682.05 Td (at ) Tj ET Q q 0 0 0 rg BT 497.99 682.05 Td (the ) Tj ET Q q 0 0 0 rg BT 512.35 682.05 Td (end ) Tj ET Q q 0 0 0 rg BT 528.94 682.05 Td (of ) Tj ET Q q 0 0 0 rg BT 539.41 682.05 Td (this ) Tj ET Q q 0 0 0 rg BT 556.01 682.05 Td (2016 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 670.05 Td (Form ) Tj ET Q q 0 0 0 rg BT 60.17 670.05 Td (10-K ) Tj ET Q q 0 0 0 rg BT 83.22 670.05 Td (for ) Tj ET Q q 0 0 0 rg BT 97.38 670.05 Td (terms ) Tj ET Q q 0 0 0 rg BT 122.10 670.05 Td (used ) Tj ET Q q 0 0 0 rg BT 142.93 670.05 Td (throughout ) Tj ET Q q 0 0 0 rg BT 189.32 670.05 Td (the ) Tj ET Q q 0 0 0 rg BT 204.03 670.05 Td (document.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 646.05 Td (In ) Tj ET Q q 0 0 0 rg BT 47.23 646.05 Td (2016, ) Tj ET Q q 0 0 0 rg BT 72.62 646.05 Td (we ) Tj ET Q q 0 0 0 rg BT 87.18 646.05 Td (received ) Tj ET Q q 0 0 0 rg BT 123.93 646.05 Td (19 ) Tj ET Q q 0 0 0 rg BT 136.83 646.05 Td (approvals ) Tj ET Q q 0 0 0 rg BT 178.60 646.05 Td (for ) Tj ET Q q 0 0 0 rg BT 193.16 646.05 Td (new ) Tj ET Q q 0 0 0 rg BT 212.71 646.05 Td (medicines ) Tj ET Q q 0 0 0 rg BT 256.15 646.05 Td (and ) Tj ET Q q 0 0 0 rg BT 273.49 646.05 Td (additional ) Tj ET Q q 0 0 0 rg BT 316.37 646.05 Td (indications ) Tj ET Q q 0 0 0 rg BT 363.15 646.05 Td (and ) Tj ET Q q 0 0 0 rg BT 380.48 646.05 Td (formulations ) Tj ET Q q 0 0 0 rg BT 434.48 646.05 Td (of ) Tj ET Q q 0 0 0 rg BT 445.71 646.05 Td (currently ) Tj ET Q q 0 0 0 rg BT 484.70 646.05 Td (marketed ) Tj ET Q q 0 0 0 rg BT 524.79 646.05 Td (medicines ) Tj ET Q q 0 0 0 rg BT 568.23 646.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 634.05 Td (major ) Tj ET Q q 0 0 0 rg BT 60.79 634.05 Td (markets ) Tj ET Q q 0 0 0 rg BT 93.92 634.05 Td (\(the ) Tj ET Q q 0 0 0 rg BT 110.94 634.05 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 132.69 634.05 Td (EU ) Tj ET Q q 0 0 0 rg BT 147.49 634.05 Td (and ) Tj ET Q q 0 0 0 rg BT 163.40 634.05 Td (Japan\) ) Tj ET Q q 0 0 0 rg BT 190.97 634.05 Td (as ) Tj ET Q q 0 0 0 rg BT 200.77 634.05 Td (well ) Tj ET Q q 0 0 0 rg BT 219.45 634.05 Td (as ) Tj ET Q q 0 0 0 rg BT 229.25 634.05 Td (announced ) Tj ET Q q 0 0 0 rg BT 274.04 634.05 Td (multiple ) Tj ET Q q 0 0 0 rg BT 308.84 634.05 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 351.40 634.05 Td (milestone ) Tj ET Q q 0 0 0 rg BT 391.75 634.05 Td (achievements ) Tj ET Q q 0 0 0 rg BT 447.64 634.05 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 460.77 634.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.21 634.05 Td (. ) Tj ET Q q 0 0 0 rg BT 495.03 634.05 Td (W) Tj ET Q q 0 0 0 rg BT 503.67 634.05 Td (e ) Tj ET Q q 0 0 0 rg BT 509.57 634.05 Td (also ) Tj ET Q q 0 0 0 rg BT 527.15 634.05 Td (encountered ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 622.05 Td (a ) Tj ET Q q 0 0 0 rg BT 42.64 622.05 Td (significant ) Tj ET Q q 0 0 0 rg BT 87.05 622.05 Td (setback ) Tj ET Q q 0 0 0 rg BT 119.24 622.05 Td (in ) Tj ET Q q 0 0 0 rg BT 129.22 622.05 Td (first-line ) Tj ET Q q 0 0 0 rg BT 165.86 622.05 Td (lung ) Tj ET Q q 0 0 0 rg BT 185.84 622.05 Td (cancer ) Tj ET Q q 0 0 0 rg BT 214.13 622.05 Td (with ) Tj ET Q q 0 0 0 rg BT 234.11 622.05 Td (the ) Tj ET Q q 0 0 0 rg BT 248.52 622.05 Td (announcement ) Tj ET Q q 0 0 0 rg BT 309.04 622.05 Td (of ) Tj ET Q q 0 0 0 rg BT 319.57 622.05 Td (negative ) Tj ET Q q 0 0 0 rg BT 355.64 622.05 Td (results ) Tj ET Q q 0 0 0 rg BT 383.95 622.05 Td (of ) Tj ET Q q 0 0 0 rg BT 394.49 622.05 Td (CheckMate-026 ) Tj ET Q q 0 0 0 rg BT 461.11 622.05 Td (and ) Tj ET Q q 0 0 0 rg BT 477.75 622.05 Td (we ) Tj ET Q q 0 0 0 rg BT 491.62 622.05 Td (announced ) Tj ET Q q 0 0 0 rg BT 537.13 622.05 Td (we ) Tj ET Q q 0 0 0 rg BT 551.00 622.05 Td (would ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 610.05 Td (not ) Tj ET Q q 0 0 0 rg BT 51.72 610.05 Td (pursue ) Tj ET Q q 0 0 0 rg BT 81.32 610.05 Td (an ) Tj ET Q q 0 0 0 rg BT 93.69 610.05 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 141.59 610.05 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 185.62 610.05 Td (pathway ) Tj ET Q q 0 0 0 rg BT 222.43 610.05 Td (for ) Tj ET Q q 0 0 0 rg BT 237.03 610.05 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 252.19 610.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 281.63 610.05 Td (+) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 287.27 610.05 Td (Y) Tj ET Q q 0 0 0 rg BT 291.91 610.05 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.12 610.05 Td ( ) Tj ET Q q 0 0 0 rg BT 317.06 610.05 Td (combination ) Tj ET Q q 0 0 0 rg BT 369.98 610.05 Td (therapy ) Tj ET Q q 0 0 0 rg BT 402.91 610.05 Td (in ) Tj ET Q q 0 0 0 rg BT 413.63 610.05 Td (first-line ) Tj ET Q q 0 0 0 rg BT 451.00 610.05 Td (lung ) Tj ET Q q 0 0 0 rg BT 471.71 610.05 Td (cancer) Tj ET Q q 0 0 0 rg BT 497.25 610.05 Td (. ) Tj ET Q q 0 0 0 rg BT 502.47 610.05 Td (W) Tj ET Q q 0 0 0 rg BT 511.11 610.05 Td (e ) Tj ET Q q 0 0 0 rg BT 518.49 610.05 Td (are ) Tj ET Q q 0 0 0 rg BT 533.63 610.05 Td (pursuing ) Tj ET Q q 0 0 0 rg BT 571.57 610.05 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 598.05 Td (broad ) Tj ET Q q 0 0 0 rg BT 60.74 598.05 Td (program ) Tj ET Q q 0 0 0 rg BT 96.59 598.05 Td (in ) Tj ET Q q 0 0 0 rg BT 106.35 598.05 Td (first-line ) Tj ET Q q 0 0 0 rg BT 142.75 598.05 Td (lung ) Tj ET Q q 0 0 0 rg BT 162.51 598.05 Td (cancer ) Tj ET Q q 0 0 0 rg BT 190.56 598.05 Td (encompassing ) Tj ET Q q 0 0 0 rg BT 249.19 598.05 Td (combinations ) Tj ET Q q 0 0 0 rg BT 305.05 598.05 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 315.35 598.05 Td (Opdivo+Y) Tj ET Q q 0 0 0 rg BT 356.18 598.05 Td (ervoy) Tj ET Q q 0 0 0 rg BT 377.84 598.05 Td (, ) Tj ET Q q 0 0 0 rg BT 382.31 598.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.75 598.05 Td ( ) Tj ET Q q 0 0 0 rg BT 413.73 598.05 Td (and ) Tj ET Q q 0 0 0 rg BT 430.14 598.05 Td (chemotherapy ) Tj ET Q q 0 0 0 rg BT 488.75 598.05 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 505.17 598.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 534.60 598.05 Td ( ) Tj ET Q q 0 0 0 rg BT 536.58 598.05 Td (combined ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 586.05 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 56.12 586.05 Td (Y) Tj ET Q q 0 0 0 rg BT 60.77 586.05 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 82.98 586.05 Td ( ) Tj ET Q q 0 0 0 rg BT 85.32 586.05 Td (and ) Tj ET Q q 0 0 0 rg BT 102.11 586.05 Td (chemotherapy) Tj ET Q q 0 0 0 rg BT 158.10 586.05 Td (. ) Tj ET Q q 0 0 0 rg BT 162.77 586.05 Td (W) Tj ET Q q 0 0 0 rg BT 171.41 586.05 Td (e ) Tj ET Q q 0 0 0 rg BT 178.20 586.05 Td (are ) Tj ET Q q 0 0 0 rg BT 192.75 586.05 Td (also ) Tj ET Q q 0 0 0 rg BT 211.20 586.05 Td (committed ) Tj ET Q q 0 0 0 rg BT 256.32 586.05 Td (to ) Tj ET Q q 0 0 0 rg BT 266.44 586.05 Td (investigating ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 320.45 586.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 349.89 586.05 Td ( ) Tj ET Q q 0 0 0 rg BT 352.23 586.05 Td (in ) Tj ET Q q 0 0 0 rg BT 362.36 586.05 Td (combination ) Tj ET Q q 0 0 0 rg BT 414.70 586.05 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 434.82 586.05 Td (Y) Tj ET Q q 0 0 0 rg BT 439.46 586.05 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.67 586.05 Td ( ) Tj ET Q q 0 0 0 rg BT 464.02 586.05 Td (and ) Tj ET Q q 0 0 0 rg BT 480.80 586.05 Td (other ) Tj ET Q q 0 0 0 rg BT 503.69 586.05 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 550.45 586.05 Td (agents ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 574.05 Td (for ) Tj ET Q q 0 0 0 rg BT 50.10 574.05 Td (other ) Tj ET Q q 0 0 0 rg BT 73.09 574.05 Td (tumor ) Tj ET Q q 0 0 0 rg BT 99.42 574.05 Td (types. ) Tj ET Q q 0 0 0 rg BT 125.29 574.05 Td (W) Tj ET Q q 0 0 0 rg BT 133.92 574.05 Td (e ) Tj ET Q q 0 0 0 rg BT 140.80 574.05 Td (continue ) Tj ET Q q 0 0 0 rg BT 177.68 574.05 Td (to ) Tj ET Q q 0 0 0 rg BT 187.90 574.05 Td (believe ) Tj ET Q q 0 0 0 rg BT 219.21 574.05 Td (that ) Tj ET Q q 0 0 0 rg BT 236.64 574.05 Td (the ) Tj ET Q q 0 0 0 rg BT 251.30 574.05 Td (breadth ) Tj ET Q q 0 0 0 rg BT 283.73 574.05 Td (and ) Tj ET Q q 0 0 0 rg BT 300.61 574.05 Td (depth ) Tj ET Q q 0 0 0 rg BT 325.26 574.05 Td (of ) Tj ET Q q 0 0 0 rg BT 336.03 574.05 Td (our ) Tj ET Q q 0 0 0 rg BT 351.80 574.05 Td (IO ) Tj ET Q q 0 0 0 rg BT 364.80 574.05 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 402.23 574.05 Td (positions ) Tj ET Q q 0 0 0 rg BT 440.79 574.05 Td (us ) Tj ET Q q 0 0 0 rg BT 452.12 574.05 Td (well ) Tj ET Q q 0 0 0 rg BT 471.78 574.05 Td (for ) Tj ET Q q 0 0 0 rg BT 485.88 574.05 Td (the ) Tj ET Q q 0 0 0 rg BT 500.54 574.05 Td (future. ) Tj ET Q q 0 0 0 rg BT 529.18 574.05 Td (W) Tj ET Q q 0 0 0 rg BT 537.82 574.05 Td (e ) Tj ET Q q 0 0 0 rg BT 544.70 574.05 Td (have ) Tj ET Q q 0 0 0 rg BT 566.01 574.05 Td (10 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 562.05 Td (new ) Tj ET Q q 0 0 0 rg BT 55.34 562.05 Td (IO ) Tj ET Q q 0 0 0 rg BT 68.58 562.05 Td (compounds ) Tj ET Q q 0 0 0 rg BT 117.37 562.05 Td (in ) Tj ET Q q 0 0 0 rg BT 127.83 562.05 Td (clinical ) Tj ET Q q 0 0 0 rg BT 159.94 562.05 Td (development ) Tj ET Q q 0 0 0 rg BT 214.28 562.05 Td (and ) Tj ET Q q 0 0 0 rg BT 231.40 562.05 Td (trials ) Tj ET Q q 0 0 0 rg BT 254.08 562.05 Td (across ) Tj ET Q q 0 0 0 rg BT 281.75 562.05 Td (35 ) Tj ET Q q 0 0 0 rg BT 294.43 562.05 Td (dif) Tj ET Q q 0 0 0 rg BT 305.36 562.05 Td (ferent ) Tj ET Q q 0 0 0 rg BT 331.36 562.05 Td (tumor ) Tj ET Q q 0 0 0 rg BT 357.93 562.05 Td (types. ) Tj ET Q q 0 0 0 rg BT 384.22 562.05 Td (In ) Tj ET Q q 0 0 0 rg BT 395.23 562.05 Td (October ) Tj ET Q q 0 0 0 rg BT 430.12 562.05 Td (2016, ) Tj ET Q q 0 0 0 rg BT 455.31 562.05 Td (we ) Tj ET Q q 0 0 0 rg BT 469.65 562.05 Td (announced ) Tj ET Q q 0 0 0 rg BT 515.65 562.05 Td (an ) Tj ET Q q 0 0 0 rg BT 527.77 562.05 Td (evolution ) Tj ET Q q 0 0 0 rg BT 568.23 562.05 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 550.05 Td (our ) Tj ET Q q 0 0 0 rg BT 51.83 550.05 Td (operating ) Tj ET Q q 0 0 0 rg BT 92.09 550.05 Td (model ) Tj ET Q q 0 0 0 rg BT 119.59 550.05 Td (which ) Tj ET Q q 0 0 0 rg BT 146.53 550.05 Td (is ) Tj ET Q q 0 0 0 rg BT 155.70 550.05 Td (discussed ) Tj ET Q q 0 0 0 rg BT 196.53 550.05 Td (in ) Tj ET Q q 0 0 0 rg BT 206.81 550.05 Td ("—Strategy" ) Tj ET Q q 0 0 0 rg BT 260.79 550.05 Td (below) Tj ET Q q 0 0 0 rg BT 284.58 550.05 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 526.05 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.36 526.05 Td (revenues ) Tj ET Q q 0 0 0 rg BT 92.71 526.05 Td (increased ) Tj ET Q q 0 0 0 rg BT 133.28 526.05 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.09 526.05 Td (17%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 164.42 526.05 Td ( ) Tj ET Q q 0 0 0 rg BT 167.24 526.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 177.83 526.05 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 197.83 526.05 Td ( ) Tj ET Q q 0 0 0 rg BT 200.64 526.05 Td (as ) Tj ET Q q 0 0 0 rg BT 211.78 526.05 Td (a ) Tj ET Q q 0 0 0 rg BT 219.03 526.05 Td (result ) Tj ET Q q 0 0 0 rg BT 244.06 526.05 Td (of ) Tj ET Q q 0 0 0 rg BT 255.20 526.05 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 283.56 526.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.00 526.05 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 318.31 526.05 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.65 526.05 Td ( ) Tj ET Q q 0 0 0 rg BT 349.46 526.05 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 366.71 526.05 Td (Or) Tj ET Q q 0 0 0 rg BT 377.46 526.05 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.11 526.05 Td ( ) Tj ET Q q 0 0 0 rg BT 401.92 526.05 Td (product ) Tj ET Q q 0 0 0 rg BT 435.28 526.05 Td (sales. ) Tj ET Q q 0 0 0 rg BT 459.83 526.05 Td (These ) Tj ET Q q 0 0 0 rg BT 486.52 526.05 Td (impacts ) Tj ET Q q 0 0 0 rg BT 520.44 526.05 Td (were ) Tj ET Q q 0 0 0 rg BT 542.68 526.05 Td (partially ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 514.05 Td (of) Tj ET Q q 0 0 0 rg BT 44.15 514.05 Td (fset ) Tj ET Q q 0 0 0 rg BT 61.09 514.05 Td (by ) Tj ET Q q 0 0 0 rg BT 73.59 514.05 Td (the ) Tj ET Q q 0 0 0 rg BT 88.31 514.05 Td (expiration ) Tj ET Q q 0 0 0 rg BT 131.36 514.05 Td (of ) Tj ET Q q 0 0 0 rg BT 142.19 514.05 Td (our ) Tj ET Q q 0 0 0 rg BT 158.02 514.05 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 178.31 514.05 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 255.22 514.05 Td (rights ) Tj ET Q q 0 0 0 rg BT 280.50 514.05 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 290.78 514.05 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.44 514.05 Td (, ) Tj ET Q q 0 0 0 rg BT 327.44 514.05 Td (the ) Tj ET Q q 0 0 0 rg BT 342.16 514.05 Td (transfer ) Tj ET Q q 0 0 0 rg BT 375.20 514.05 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 386.03 514.05 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.03 514.05 Td ( ) Tj ET Q q 0 0 0 rg BT 423.53 514.05 Td (rights ) Tj ET Q q 0 0 0 rg BT 448.81 514.05 Td (in ) Tj ET Q q 0 0 0 rg BT 459.09 514.05 Td (North ) Tj ET Q q 0 0 0 rg BT 484.37 514.05 Td (America ) Tj ET Q q 0 0 0 rg BT 521.30 514.05 Td (and ) Tj ET Q q 0 0 0 rg BT 538.24 514.05 Td (increased ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 502.05 Td (competition ) Tj ET Q q 0 0 0 rg BT 86.27 502.05 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 100.43 502.05 Td (Reyataz, ) Tj ET Q q 0 0 0 rg BT 137.08 502.05 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 168.47 502.05 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 185.41 502.05 Td (Baraclude) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.06 502.05 Td ( ) Tj ET Q q 0 0 0 rg BT 229.56 502.05 Td (in ) Tj ET Q q 0 0 0 rg BT 239.84 502.05 Td (certain ) Tj ET Q q 0 0 0 rg BT 269.54 502.05 Td (markets.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 478.05 Td (The ) Tj ET Q q 0 0 0 rg BT 54.21 478.05 Td (increase ) Tj ET Q q 0 0 0 rg BT 89.63 478.05 Td (in ) Tj ET Q q 0 0 0 rg BT 100.08 478.05 Td (GAAP) Tj ET Q q 0 0 0 rg BT 126.93 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 129.60 478.05 Td (EPS ) Tj ET Q q 0 0 0 rg BT 149.50 478.05 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 171.60 478.05 Td ($0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.10 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 196.77 478.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 207.21 478.05 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.21 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 229.88 478.05 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.32 478.05 Td ($2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.82 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 265.49 478.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 275.93 478.05 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.93 478.05 Td ( ) Tj ET Q q 0 0 0 rg BT 298.60 478.05 Td (was ) Tj ET Q q 0 0 0 rg BT 316.82 478.05 Td (due ) Tj ET Q q 0 0 0 rg BT 333.92 478.05 Td (to ) Tj ET Q q 0 0 0 rg BT 344.36 478.05 Td (higher ) Tj ET Q q 0 0 0 rg BT 372.58 478.05 Td (revenues, ) Tj ET Q q 0 0 0 rg BT 413.28 478.05 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 458.16 478.05 Td (gains ) Tj ET Q q 0 0 0 rg BT 481.93 478.05 Td (and ) Tj ET Q q 0 0 0 rg BT 499.04 478.05 Td (royalties ) Tj ET Q q 0 0 0 rg BT 536.14 478.05 Td (and ) Tj ET Q q 0 0 0 rg BT 553.24 478.05 Td (lower ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 466.05 Td (R&D ) Tj ET Q q 0 0 0 rg BT 60.12 466.05 Td (license ) Tj ET Q q 0 0 0 rg BT 90.33 466.05 Td (and ) Tj ET Q q 0 0 0 rg BT 107.22 466.05 Td (asset ) Tj ET Q q 0 0 0 rg BT 129.11 466.05 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 175.44 466.05 Td (char) Tj ET Q q 0 0 0 rg BT 192.46 466.05 Td (ges ) Tj ET Q q 0 0 0 rg BT 208.24 466.05 Td (partially ) Tj ET Q q 0 0 0 rg BT 244.01 466.05 Td (of) Tj ET Q q 0 0 0 rg BT 252.16 466.05 Td (fset ) Tj ET Q q 0 0 0 rg BT 269.05 466.05 Td (by ) Tj ET Q q 0 0 0 rg BT 281.50 466.05 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 309.49 466.05 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.83 466.05 Td ( ) Tj ET Q q 0 0 0 rg BT 340.27 466.05 Td (profit ) Tj ET Q q 0 0 0 rg BT 364.94 466.05 Td (sharing ) Tj ET Q q 0 0 0 rg BT 396.83 466.05 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 413.71 466.05 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.15 466.05 Td ( ) Tj ET Q q 0 0 0 rg BT 445.60 466.05 Td (related ) Tj ET Q q 0 0 0 rg BT 475.25 466.05 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 516.12 466.05 Td (The ) Tj ET Q q 0 0 0 rg BT 534.12 466.05 Td (tax ) Tj ET Q q 0 0 0 rg BT 548.78 466.05 Td (impact ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 454.05 Td (of ) Tj ET Q q 0 0 0 rg BT 46.59 454.05 Td (specified ) Tj ET Q q 0 0 0 rg BT 84.95 454.05 Td (items ) Tj ET Q q 0 0 0 rg BT 108.88 454.05 Td (and ) Tj ET Q q 0 0 0 rg BT 125.58 454.05 Td (earnings ) Tj ET Q q 0 0 0 rg BT 161.72 454.05 Td (mix ) Tj ET Q q 0 0 0 rg BT 179.54 454.05 Td (contributed ) Tj ET Q q 0 0 0 rg BT 227.35 454.05 Td (to ) Tj ET Q q 0 0 0 rg BT 237.39 454.05 Td (the ) Tj ET Q q 0 0 0 rg BT 251.87 454.05 Td (change ) Tj ET Q q 0 0 0 rg BT 282.45 454.05 Td (in ) Tj ET Q q 0 0 0 rg BT 292.49 454.05 Td (the ) Tj ET Q q 0 0 0 rg BT 306.97 454.05 Td (ef) Tj ET Q q 0 0 0 rg BT 314.55 454.05 Td (fective ) Tj ET Q q 0 0 0 rg BT 344.02 454.05 Td (tax ) Tj ET Q q 0 0 0 rg BT 358.50 454.05 Td (rate. ) Tj ET Q q 0 0 0 rg BT 377.75 454.05 Td (After ) Tj ET Q q 0 0 0 rg BT 401.11 454.05 Td (adjusting ) Tj ET Q q 0 0 0 rg BT 440.04 454.05 Td (for ) Tj ET Q q 0 0 0 rg BT 453.96 454.05 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 498.44 454.05 Td (gains, ) Tj ET Q q 0 0 0 rg BT 524.31 454.05 Td (R&D ) Tj ET Q q 0 0 0 rg BT 548.24 454.05 Td (license ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 442.05 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 442.05 Td (asset ) Tj ET Q q 0 0 0 rg BT 74.88 442.05 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 121.26 442.05 Td (char) Tj ET Q q 0 0 0 rg BT 138.29 442.05 Td (ges ) Tj ET Q q 0 0 0 rg BT 154.12 442.05 Td (and ) Tj ET Q q 0 0 0 rg BT 171.05 442.05 Td (other ) Tj ET Q q 0 0 0 rg BT 194.10 442.05 Td (specified ) Tj ET Q q 0 0 0 rg BT 232.69 442.05 Td (items, ) Tj ET Q q 0 0 0 rg BT 259.36 442.05 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 304.54 442.05 Td ( ) Tj ET Q q 0 0 0 rg BT 307.04 442.05 Td (EPS ) Tj ET Q q 0 0 0 rg BT 326.78 442.05 Td (increased ) Tj ET Q q 0 0 0 rg BT 367.03 442.05 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.97 442.05 Td ($2.01) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.47 442.05 Td ( ) Tj ET Q q 0 0 0 rg BT 413.97 442.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.25 442.05 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.25 442.05 Td ( ) Tj ET Q q 0 0 0 rg BT 446.75 442.05 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.03 442.05 Td ($2.83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.53 442.05 Td ( ) Tj ET Q q 0 0 0 rg BT 482.03 442.05 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.30 442.05 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.30 442.05 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 418.05 Td (Highlights) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.05 Td (The following table summarizes our financial information:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 366.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 366.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 366.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 366.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 366.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 366.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 366.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 340.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 340.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 340.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 340.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 340.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 340.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 340.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 314.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 314.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 314.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 314.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 314.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 314.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 314.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 288.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 288.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 288.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 288.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 288.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 288.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 288.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 262.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 262.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 262.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 262.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 262.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 262.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 262.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 236.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 236.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 236.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 236.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 236.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 236.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 236.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 210.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 210.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 210.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 210.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 210.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 210.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 210.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 184.55 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 184.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 184.55 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 184.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 184.55 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 184.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 184.55 71.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 378.54999999999995 m 426.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 426.5 378.54999999999995 m 430.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 378.54999999999995 m 501.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 378.54999999999995 m 505.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 378.54999999999995 m 576.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 366.54999999999995 m 426.5 366.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 378.54999999999995 m 501.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 366.54999999999995 m 501.5 366.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 378.54999999999995 m 505.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 378.54999999999995 m 576.5 378.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 366.54999999999995 m 576.5 366.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 366.54999999999995 m 501.5 366.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 366.54999999999995 m 576.5 366.54999999999995 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 382.50 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 382.63 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 370.50 Td (Dollars in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.00 370.63 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 457.50 370.63 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 370.63 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 357.12 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.00 357.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.15 357.12 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 357.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 357.12 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 357.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.15 357.12 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 344.12 Td (Total Expenses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.15 344.12 Td (13,512) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 344.12 Td (14,483) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.15 344.12 Td (13,498) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 331.12 Td (Earnings before Income Taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.15 331.12 Td (5,915) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 331.12 Td (2,077) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 331.12 Td (2,381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 318.12 Td (Provision for Income Taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.15 318.12 Td (1,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 318.12 Td (446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 552.65 318.12 Td (352) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 57.00 305.11 Td (Effective tax rate) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 400.15 305.11 Td (23.8) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 417.65 305.11 Td (%) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 475.15 305.11 Td (21.5) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 492.65 305.11 Td (%) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 550.15 305.11 Td (14.8) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 567.65 305.11 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 279.12 Td (Net Earnings Attributable to BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 266.12 Td (GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.15 266.12 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 266.12 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 266.12 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 253.12 Td (Non-GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.15 253.12 Td (4,750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 253.12 Td (3,378) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 253.12 Td (3,085) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 227.12 Td (Diluted Earnings Per Share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 214.12 Td (GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 214.12 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 214.12 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 214.12 Td (1.20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 201.12 Td (Non-GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 201.12 Td (2.83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 201.12 Td (2.01) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 201.12 Td (1.85) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 175.12 Td (Cash, Cash Equivalents and Marketable Securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.15 175.12 Td (9,069) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 175.12 Td (8,930) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.15 175.12 Td (11,843) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 150.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.86 150.45 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 99.05 150.45 Td ( ) Tj ET Q q 0 0 0 rg BT 101.36 150.45 Td (financial ) Tj ET Q q 0 0 0 rg BT 138.65 150.45 Td (measures, ) Tj ET Q q 0 0 0 rg BT 180.67 150.45 Td (including ) Tj ET Q q 0 0 0 rg BT 220.76 150.45 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 265.94 150.45 Td ( ) Tj ET Q q 0 0 0 rg BT 268.26 150.45 Td (earnings ) Tj ET Q q 0 0 0 rg BT 304.44 150.45 Td (and ) Tj ET Q q 0 0 0 rg BT 321.20 150.45 Td (related ) Tj ET Q q 0 0 0 rg BT 350.71 150.45 Td (EPS ) Tj ET Q q 0 0 0 rg BT 370.25 150.45 Td (information, ) Tj ET Q q 0 0 0 rg BT 422.28 150.45 Td (are ) Tj ET Q q 0 0 0 rg BT 436.80 150.45 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 472.43 150.45 Td (to ) Tj ET Q q 0 0 0 rg BT 482.52 150.45 Td (exclude ) Tj ET Q q 0 0 0 rg BT 515.93 150.45 Td (specified ) Tj ET Q q 0 0 0 rg BT 554.33 150.45 Td (items ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 138.45 Td (that ) Tj ET Q q 0 0 0 rg BT 53.86 138.45 Td (represent ) Tj ET Q q 0 0 0 rg BT 93.36 138.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 123.42 138.45 Td (costs, ) Tj ET Q q 0 0 0 rg BT 148.78 138.45 Td (expenses, ) Tj ET Q q 0 0 0 rg BT 190.24 138.45 Td (gains ) Tj ET Q q 0 0 0 rg BT 214.21 138.45 Td (and ) Tj ET Q q 0 0 0 rg BT 231.51 138.45 Td (losses ) Tj ET Q q 0 0 0 rg BT 258.26 138.45 Td (and ) Tj ET Q q 0 0 0 rg BT 275.56 138.45 Td (other ) Tj ET Q q 0 0 0 rg BT 298.97 138.45 Td (items ) Tj ET Q q 0 0 0 rg BT 323.49 138.45 Td (impacting ) Tj ET Q q 0 0 0 rg BT 366.34 138.45 Td (the ) Tj ET Q q 0 0 0 rg BT 381.42 138.45 Td (comparability ) Tj ET Q q 0 0 0 rg BT 439.82 138.45 Td (of ) Tj ET Q q 0 0 0 rg BT 451.01 138.45 Td (financial ) Tj ET Q q 0 0 0 rg BT 488.85 138.45 Td (results. ) Tj ET Q q 0 0 0 rg BT 520.32 138.45 Td (For ) Tj ET Q q 0 0 0 rg BT 537.07 138.45 Td (a ) Tj ET Q q 0 0 0 rg BT 544.37 138.45 Td (detailed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 126.45 Td (listing ) Tj ET Q q 0 0 0 rg BT 62.50 126.45 Td (of ) Tj ET Q q 0 0 0 rg BT 72.32 126.45 Td (all ) Tj ET Q q 0 0 0 rg BT 83.80 126.45 Td (specified ) Tj ET Q q 0 0 0 rg BT 121.39 126.45 Td (items ) Tj ET Q q 0 0 0 rg BT 144.54 126.45 Td (and ) Tj ET Q q 0 0 0 rg BT 160.47 126.45 Td (further ) Tj ET Q q 0 0 0 rg BT 189.17 126.45 Td (information ) Tj ET Q q 0 0 0 rg BT 237.87 126.45 Td (and ) Tj ET Q q 0 0 0 rg BT 253.80 126.45 Td (reconciliations ) Tj ET Q q 0 0 0 rg BT 314.16 126.45 Td (of ) Tj ET Q q 0 0 0 rg BT 323.98 126.45 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 369.17 126.45 Td ( ) Tj ET Q q 0 0 0 rg BT 370.66 126.45 Td (financial ) Tj ET Q q 0 0 0 rg BT 407.13 126.45 Td (measures ) Tj ET Q q 0 0 0 rg BT 445.83 126.45 Td (refer ) Tj ET Q q 0 0 0 rg BT 466.18 126.45 Td (to ) Tj ET Q q 0 0 0 rg BT 475.45 126.45 Td (“—Non-GAAP) Tj ET Q q 0 0 0 rg BT 537.30 126.45 Td ( ) Tj ET Q q 0 0 0 rg BT 538.79 126.45 Td (Financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 114.45 Td (Measures.") Tj ET Q endstream endobj 59 0 obj <> endobj 60 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (29) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Significant Pr) Tj ET Q q 0 0 0 rg BT 94.98 749.25 Td (oduct and Pipeline ) Tj ET Q q 0 0 0 rg BT 176.39 749.25 Td (Appr) Tj ET Q q 0 0 0 rg BT 198.99 749.25 Td (ovals) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 727.65 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 727.65 Td (following ) Tj ET Q q 0 0 0 rg BT 95.43 727.65 Td (is ) Tj ET Q q 0 0 0 rg BT 104.60 727.65 Td (a ) Tj ET Q q 0 0 0 rg BT 111.54 727.65 Td (summary ) Tj ET Q q 0 0 0 rg BT 151.26 727.65 Td (of ) Tj ET Q q 0 0 0 rg BT 162.09 727.65 Td (the ) Tj ET Q q 0 0 0 rg BT 176.81 727.65 Td (19 ) Tj ET Q q 0 0 0 rg BT 189.31 727.65 Td (significant ) Tj ET Q q 0 0 0 rg BT 234.02 727.65 Td (approvals ) Tj ET Q q 0 0 0 rg BT 275.39 727.65 Td (received ) Tj ET Q q 0 0 0 rg BT 311.76 727.65 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.04 727.65 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.04 727.65 Td (.) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 717.15 m 35.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 717.15 m 134.5 717.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 702.15 m 134.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 717.15 m 134.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 717.15 m 210.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 717.15 m 210.5 717.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 717.15 m 210.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 717.15 m 575.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 717.15 m 575.5 717.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 702.15 m 35.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 702.15 m 134.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 702.15 m 134.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 702.15 m 210.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 702.15 m 210.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 702.15 m 210.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 702.15 m 575.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 702.15 m 575.5 702.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 677.15 m 575.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 677.15 m 35.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 677.15 m 134.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 677.15 m 134.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 677.15 m 210.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 677.15 m 210.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 677.15 m 210.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 677.15 m 575.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 677.15 m 575.5 677.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 652.15 m 575.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 652.15 m 35.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 652.15 m 134.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 652.15 m 134.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 652.15 m 210.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 652.15 m 210.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 652.15 m 210.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 652.15 m 575.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 652.15 m 575.5 652.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 627.15 m 575.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 627.15 m 35.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 627.15 m 134.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 627.15 m 134.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 627.15 m 210.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 627.15 m 210.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 627.15 m 210.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 627.15 m 575.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 627.15 m 575.5 627.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 602.15 m 575.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 602.15 m 35.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 602.15 m 134.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 602.15 m 134.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 602.15 m 210.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 602.15 m 210.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 602.15 m 210.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 602.15 m 575.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 602.15 m 575.5 602.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 577.15 m 575.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 577.15 m 35.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 577.15 m 134.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 577.15 m 134.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 577.15 m 210.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 577.15 m 210.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 577.15 m 210.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 577.15 m 575.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 577.15 m 575.5 577.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 562.15 m 35.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 562.15 m 134.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 562.15 m 134.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 562.15 m 210.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 562.15 m 210.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 562.15 m 210.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 562.15 m 575.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 562.15 m 575.5 562.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 547.15 m 35.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 547.15 m 134.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 547.15 m 134.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 547.15 m 210.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 547.15 m 210.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 547.15 m 210.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 547.15 m 575.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 547.15 m 575.5 547.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 522.15 m 35.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 522.15 m 134.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 522.15 m 134.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 522.15 m 210.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 522.15 m 210.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 522.15 m 210.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 522.15 m 575.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 522.15 m 575.5 522.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 497.15 m 575.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 497.15 m 35.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 497.15 m 134.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 497.15 m 210.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 497.15 m 210.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 497.15 m 210.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 497.15 m 575.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 497.15 m 575.5 497.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 472.15 m 35.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 472.15 m 134.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 472.15 m 134.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 472.15 m 210.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 472.15 m 210.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 447.15 m 210.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 472.15 m 210.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 472.15 m 575.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 472.15 m 575.5 472.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 447.15 m 575.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 447.15 m 35.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 422.15 m 134.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 447.15 m 134.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 447.15 m 210.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 447.15 m 210.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 422.15 m 210.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 447.15 m 210.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 447.15 m 575.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 447.15 m 575.5 447.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 422.15 m 575.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 422.15 m 35.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 422.15 m 134.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 422.15 m 134.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 422.15 m 210.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 422.15 m 210.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 397.15 m 210.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 422.15 m 210.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 422.15 m 575.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 422.15 m 575.5 422.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 397.15 m 575.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 397.15 m 35.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 397.15 m 134.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 397.15 m 210.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 397.15 m 210.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 372.15 m 210.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 397.15 m 210.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 397.15 m 575.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 397.15 m 575.5 397.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 372.15 m 575.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 372.15 m 35.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 347.15 m 134.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 372.15 m 134.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 372.15 m 210.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 372.15 m 210.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 347.15 m 210.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 372.15 m 210.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 372.15 m 575.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 372.15 m 575.5 372.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 347.15 m 575.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 347.15 m 35.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 347.15 m 134.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 347.15 m 134.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 347.15 m 210.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 347.15 m 210.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 322.15 m 210.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 347.15 m 210.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 347.15 m 575.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 347.15 m 575.5 347.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 322.15 m 575.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 322.15 m 35.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 322.15 m 134.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 322.15 m 210.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 322.15 m 210.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 297.15 m 210.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 322.15 m 210.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 322.15 m 575.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 322.15 m 575.5 322.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 297.15 m 575.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 297.15 m 35.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 272.15 m 134.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 297.15 m 134.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 297.15 m 210.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 297.15 m 210.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 272.15 m 210.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 297.15 m 210.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 297.15 m 575.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 297.15 m 575.5 297.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 272.15 m 575.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 272.15 m 35.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 272.15 m 134.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 247.14999999999998 m 134.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 272.15 m 134.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 272.15 m 210.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 272.15 m 210.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 134.5 247.14999999999998 m 210.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 272.15 m 210.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 272.15 m 575.5 247.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 272.15 m 575.5 272.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 210.5 247.14999999999998 m 575.5 247.14999999999998 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 67.35 706.83 Td (Product) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 162.00 706.83 Td (Date) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 372.30 706.83 Td (Approval) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 69.75 609.81 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 140.20 687.27 Td (December 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 691.82 Td (JMHL) Tj ET Q q 0 0 0 rg BT 238.74 691.82 Td (W) Tj ET Q q 0 0 0 rg BT 247.72 691.82 Td ( ) Tj ET Q q 0 0 0 rg BT 249.91 691.82 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 310.50 691.82 Td (and ) Tj ET Q q 0 0 0 rg BT 327.22 691.82 Td (marketing ) Tj ET Q q 0 0 0 rg BT 370.04 691.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 407.30 691.82 Td (for ) Tj ET Q q 0 0 0 rg BT 421.24 691.82 Td (the ) Tj ET Q q 0 0 0 rg BT 435.74 691.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 475.78 691.82 Td (of ) Tj ET Q q 0 0 0 rg BT 486.38 691.82 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 521.98 691.82 Td (or ) Tj ET Q q 0 0 0 rg BT 532.59 691.82 Td (refractory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 681.82 Td (cHL, ) Tj ET Q q 0 0 0 rg BT 235.77 681.82 Td (received ) Tj ET Q q 0 0 0 rg BT 272.13 681.82 Td (by ) Tj ET Q q 0 0 0 rg BT 284.63 681.82 Td (our ) Tj ET Q q 0 0 0 rg BT 300.46 681.82 Td (alliance ) Tj ET Q q 0 0 0 rg BT 334.05 681.82 Td (partner) Tj ET Q q 0 0 0 rg BT 362.17 681.82 Td (, ) Tj ET Q q 0 0 0 rg BT 366.96 681.82 Td (Ono.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.60 662.27 Td (November 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 666.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 227.97 666.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 265.15 666.82 Td (for ) Tj ET Q q 0 0 0 rg BT 279.01 666.82 Td (the ) Tj ET Q q 0 0 0 rg BT 293.42 666.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 333.37 666.82 Td (of ) Tj ET Q q 0 0 0 rg BT 343.90 666.82 Td (adult ) Tj ET Q q 0 0 0 rg BT 366.09 666.82 Td (patients ) Tj ET Q q 0 0 0 rg BT 399.39 666.82 Td (with ) Tj ET Q q 0 0 0 rg BT 419.36 666.82 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 454.87 666.82 Td (or ) Tj ET Q q 0 0 0 rg BT 465.40 666.82 Td (refractory ) Tj ET Q q 0 0 0 rg BT 507.00 666.82 Td (cHL) Tj ET Q q 0 0 0 rg BT 524.59 666.82 Td ( ) Tj ET Q q 0 0 0 rg BT 526.60 666.82 Td (after ) Tj ET Q q 0 0 0 rg BT 546.90 666.82 Td (ASCT) Tj ET Q q 0 0 0 rg BT 572.09 666.82 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 656.82 Td (and ) Tj ET Q q 0 0 0 rg BT 229.94 656.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 270.20 656.82 Td (with ) Tj ET Q q 0 0 0 rg BT 290.48 656.82 Td (brentuximab ) Tj ET Q q 0 0 0 rg BT 343.52 656.82 Td (vedotin.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.60 637.27 Td (November 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 641.82 Td (FDA) Tj ET Q q 0 0 0 rg BT 232.73 641.82 Td ( ) Tj ET Q q 0 0 0 rg BT 235.59 641.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 273.70 641.82 Td (for ) Tj ET Q q 0 0 0 rg BT 288.50 641.82 Td (the ) Tj ET Q q 0 0 0 rg BT 303.84 641.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 344.74 641.82 Td (of ) Tj ET Q q 0 0 0 rg BT 356.20 641.82 Td (patients ) Tj ET Q q 0 0 0 rg BT 390.43 641.82 Td (with ) Tj ET Q q 0 0 0 rg BT 411.34 641.82 Td (SCCHN ) Tj ET Q q 0 0 0 rg BT 447.82 641.82 Td (with ) Tj ET Q q 0 0 0 rg BT 468.73 641.82 Td (disease ) Tj ET Q q 0 0 0 rg BT 500.74 641.82 Td (progression ) Tj ET Q q 0 0 0 rg BT 550.53 641.82 Td (on ) Tj ET Q q 0 0 0 rg BT 563.67 641.82 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 631.82 Td (after ) Tj ET Q q 0 0 0 rg BT 233.82 631.82 Td (platinum-based ) Tj ET Q q 0 0 0 rg BT 297.97 631.82 Td (therapy) Tj ET Q q 0 0 0 rg BT 327.63 631.82 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.30 612.27 Td (August 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 616.82 Td (JMHLW manufacturing and marketing approval for the treatment of unresectable or) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 606.82 Td (metastatic RCC, received by our alliance partner, Ono.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.55 587.27 Td (May 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 591.82 Td (FDA) Tj ET Q q 0 0 0 rg BT 232.73 591.82 Td ( ) Tj ET Q q 0 0 0 rg BT 234.52 591.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 271.57 591.82 Td (for ) Tj ET Q q 0 0 0 rg BT 285.30 591.82 Td (the ) Tj ET Q q 0 0 0 rg BT 299.58 591.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 339.41 591.82 Td (of ) Tj ET Q q 0 0 0 rg BT 349.81 591.82 Td (patients ) Tj ET Q q 0 0 0 rg BT 382.98 591.82 Td (with ) Tj ET Q q 0 0 0 rg BT 402.82 591.82 Td (cHL) Tj ET Q q 0 0 0 rg BT 420.40 591.82 Td ( ) Tj ET Q q 0 0 0 rg BT 422.29 591.82 Td (who ) Tj ET Q q 0 0 0 rg BT 441.57 591.82 Td (have ) Tj ET Q q 0 0 0 rg BT 462.52 591.82 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 497.90 591.82 Td (or ) Tj ET Q q 0 0 0 rg BT 508.30 591.82 Td (progressed ) Tj ET Q q 0 0 0 rg BT 553.68 591.82 Td (after ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 581.82 Td (auto-HSCT) Tj ET Q q 0 0 0 rg BT 259.02 581.82 Td ( ) Tj ET Q q 0 0 0 rg BT 261.43 581.82 Td (and ) Tj ET Q q 0 0 0 rg BT 278.37 581.82 Td (post-transplantation ) Tj ET Q q 0 0 0 rg BT 360.29 581.82 Td (brentuximab ) Tj ET Q q 0 0 0 rg BT 413.34 581.82 Td (vedotin.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 150.15 567.27 Td (April 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 566.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 228.28 566.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 265.76 566.82 Td (for ) Tj ET Q q 0 0 0 rg BT 279.92 566.82 Td (the ) Tj ET Q q 0 0 0 rg BT 294.64 566.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 334.90 566.82 Td (of ) Tj ET Q q 0 0 0 rg BT 345.73 566.82 Td (previously ) Tj ET Q q 0 0 0 rg BT 390.45 566.82 Td (treated ) Tj ET Q q 0 0 0 rg BT 420.15 566.82 Td (RCC.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 150.15 552.27 Td (April 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 551.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 228.09 551.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 265.38 551.82 Td (for ) Tj ET Q q 0 0 0 rg BT 279.35 551.82 Td (the ) Tj ET Q q 0 0 0 rg BT 293.88 551.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 333.94 551.82 Td (of ) Tj ET Q q 0 0 0 rg BT 344.58 551.82 Td (previously ) Tj ET Q q 0 0 0 rg BT 389.11 551.82 Td (treated ) Tj ET Q q 0 0 0 rg BT 418.62 551.82 Td (patients ) Tj ET Q q 0 0 0 rg BT 452.03 551.82 Td (with ) Tj ET Q q 0 0 0 rg BT 472.12 551.82 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 514.96 551.82 Td (NSQ ) Tj ET Q q 0 0 0 rg BT 537.28 551.82 Td (NSCLC.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 142.70 532.27 Td (February 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 536.82 Td (JMHL) Tj ET Q q 0 0 0 rg BT 238.74 536.82 Td (W) Tj ET Q q 0 0 0 rg BT 247.72 536.82 Td ( ) Tj ET Q q 0 0 0 rg BT 250.30 536.82 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 311.28 536.82 Td (and ) Tj ET Q q 0 0 0 rg BT 328.39 536.82 Td (marketing ) Tj ET Q q 0 0 0 rg BT 371.60 536.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 409.26 536.82 Td (for ) Tj ET Q q 0 0 0 rg BT 423.59 536.82 Td (the ) Tj ET Q q 0 0 0 rg BT 438.48 536.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 478.91 536.82 Td (of ) Tj ET Q q 0 0 0 rg BT 489.91 536.82 Td (previously ) Tj ET Q q 0 0 0 rg BT 534.80 536.82 Td (untreated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 526.82 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 265.47 526.82 Td (melanoma.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 66.95 499.81 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 96.39 499.81 Td (+) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 71.05 489.81 Td (Y) Tj ET Q q 0 0 0 rg BT 75.69 489.81 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.55 507.27 Td (May 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 511.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 227.72 511.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 264.65 511.82 Td (for ) Tj ET Q q 0 0 0 rg BT 278.25 511.82 Td (the ) Tj ET Q q 0 0 0 rg BT 292.40 511.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 332.10 511.82 Td (of ) Tj ET Q q 0 0 0 rg BT 342.38 511.82 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 394.29 511.82 Td (or ) Tj ET Q q 0 0 0 rg BT 404.56 511.82 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 447.04 511.82 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 493.13 511.82 Td (regardless ) Tj ET Q q 0 0 0 rg BT 535.60 511.82 Td (of ) Tj ET Q q 0 0 0 rg BT 545.88 511.82 Td (BRAF ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 501.82 Td (mutational ) Tj ET Q q 0 0 0 rg BT 258.27 501.82 Td (status.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 145.20 482.27 Td (January 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 487.72 Td (FDA) Tj ET Q q 0 0 0 rg BT 232.45 487.72 Td ( ) Tj ET Q q 0 0 0 rg BT 236.06 487.72 Td (expanded ) Tj ET Q q 0 0 0 rg BT 277.98 487.72 Td (use ) Tj ET Q q 0 0 0 rg BT 294.92 487.72 Td (for ) Tj ET Q q 0 0 0 rg BT 310.19 487.72 Td (the ) Tj ET Q q 0 0 0 rg BT 326.01 487.72 Td (treatment ) Tj ET Q q 0 0 0 rg BT 367.38 487.72 Td (of ) Tj ET Q q 0 0 0 rg BT 379.32 487.72 Td (previously ) Tj ET Q q 0 0 0 rg BT 425.14 487.72 Td (untreated ) Tj ET Q q 0 0 0 rg BT 465.95 487.72 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 519.53 487.72 Td (or ) Tj ET Q q 0 0 0 rg BT 531.47 487.72 Td (metastatic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 477.72 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 259.65 477.72 Td (regardless ) Tj ET Q q 0 0 0 rg BT 302.69 477.72 Td (of ) Tj ET Q q 0 0 0 rg BT 313.52 477.72 Td (BRAF ) Tj ET Q q 0 0 0 rg BT 342.14 477.72 Td (mutational ) Tj ET Q q 0 0 0 rg BT 387.41 477.72 Td (status.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 66.15 444.81 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.35 457.27 Td (September 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 461.82 Td (JMHL) Tj ET Q q 0 0 0 rg BT 238.37 461.82 Td (W) Tj ET Q q 0 0 0 rg BT 247.63 461.82 Td ( ) Tj ET Q q 0 0 0 rg BT 252.69 461.82 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 316.07 461.82 Td (and ) Tj ET Q q 0 0 0 rg BT 335.57 461.82 Td (marketing ) Tj ET Q q 0 0 0 rg BT 381.17 461.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 421.22 461.82 Td (in ) Tj ET Q q 0 0 0 rg BT 434.06 461.82 Td (combination ) Tj ET Q q 0 0 0 rg BT 489.11 461.82 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 511.96 461.82 Td (Revlimid*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 552.50 461.82 Td ( ) Tj ET Q q 0 0 0 rg BT 557.56 461.82 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 451.82 Td (dexamethasone ) Tj ET Q q 0 0 0 rg BT 277.14 451.82 Td (for ) Tj ET Q q 0 0 0 rg BT 291.30 451.82 Td (the ) Tj ET Q q 0 0 0 rg BT 306.02 451.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 346.28 451.82 Td (of ) Tj ET Q q 0 0 0 rg BT 357.11 451.82 Td (multiple ) Tj ET Q q 0 0 0 rg BT 392.94 451.82 Td (myeloma.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.55 432.27 Td (May 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 436.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 227.79 436.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 264.78 436.82 Td (for ) Tj ET Q q 0 0 0 rg BT 278.45 436.82 Td (the ) Tj ET Q q 0 0 0 rg BT 292.68 436.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 332.45 436.82 Td (of ) Tj ET Q q 0 0 0 rg BT 342.79 436.82 Td (multiple ) Tj ET Q q 0 0 0 rg BT 378.12 436.82 Td (myeloma ) Tj ET Q q 0 0 0 rg BT 417.35 436.82 Td (as ) Tj ET Q q 0 0 0 rg BT 427.69 436.82 Td (combination ) Tj ET Q q 0 0 0 rg BT 479.68 436.82 Td (therapy ) Tj ET Q q 0 0 0 rg BT 511.68 436.82 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 531.47 436.82 Td (Revlimid*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.01 436.82 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 426.82 Td (and ) Tj ET Q q 0 0 0 rg BT 229.94 426.82 Td (dexamethasone ) Tj ET Q q 0 0 0 rg BT 294.08 426.82 Td (in ) Tj ET Q q 0 0 0 rg BT 304.36 426.82 Td (patients ) Tj ET Q q 0 0 0 rg BT 337.96 426.82 Td (who ) Tj ET Q q 0 0 0 rg BT 357.68 426.82 Td (have ) Tj ET Q q 0 0 0 rg BT 379.06 426.82 Td (received ) Tj ET Q q 0 0 0 rg BT 415.42 426.82 Td (at ) Tj ET Q q 0 0 0 rg BT 425.14 426.82 Td (least ) Tj ET Q q 0 0 0 rg BT 445.96 426.82 Td (one ) Tj ET Q q 0 0 0 rg BT 462.90 426.82 Td (prior ) Tj ET Q q 0 0 0 rg BT 484.84 426.82 Td (therapy) Tj ET Q q 0 0 0 rg BT 514.18 426.82 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 68.30 382.31 Td (Orencia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.35 407.27 Td (September 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 412.72 Td (EC ) Tj ET Q q 0 0 0 rg BT 228.36 412.72 Td (approval ) Tj ET Q q 0 0 0 rg BT 265.92 412.72 Td (in ) Tj ET Q q 0 0 0 rg BT 276.28 412.72 Td (combination ) Tj ET Q q 0 0 0 rg BT 328.85 412.72 Td (with ) Tj ET Q q 0 0 0 rg BT 349.21 412.72 Td (MTX ) Tj ET Q q 0 0 0 rg BT 374.02 412.72 Td (for ) Tj ET Q q 0 0 0 rg BT 388.26 412.72 Td (the ) Tj ET Q q 0 0 0 rg BT 403.05 412.72 Td (treatment ) Tj ET Q q 0 0 0 rg BT 443.39 412.72 Td (of ) Tj ET Q q 0 0 0 rg BT 454.30 412.72 Td (highly ) Tj ET Q q 0 0 0 rg BT 482.44 412.72 Td (active ) Tj ET Q q 0 0 0 rg BT 508.89 412.72 Td (and ) Tj ET Q q 0 0 0 rg BT 525.91 412.72 Td (progressive ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 402.72 Td (disease ) Tj ET Q q 0 0 0 rg BT 244.38 402.72 Td (in ) Tj ET Q q 0 0 0 rg BT 254.66 402.72 Td (adult ) Tj ET Q q 0 0 0 rg BT 277.15 402.72 Td (patients ) Tj ET Q q 0 0 0 rg BT 310.75 402.72 Td (with ) Tj ET Q q 0 0 0 rg BT 331.03 402.72 Td (RA) Tj ET Q q 0 0 0 rg BT 344.37 402.72 Td ( ) Tj ET Q q 0 0 0 rg BT 346.87 402.72 Td (not ) Tj ET Q q 0 0 0 rg BT 362.15 402.72 Td (previously ) Tj ET Q q 0 0 0 rg BT 406.87 402.72 Td (treated ) Tj ET Q q 0 0 0 rg BT 436.57 402.72 Td (with ) Tj ET Q q 0 0 0 rg BT 456.85 402.72 Td (MTX.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 152.40 382.27 Td (July 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 386.82 Td (Announced ) Tj ET Q q 0 0 0 rg BT 261.42 386.82 Td (the ) Tj ET Q q 0 0 0 rg BT 275.97 386.82 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 296.08 386.82 Td (commercial ) Tj ET Q q 0 0 0 rg BT 345.60 386.82 Td (launch ) Tj ET Q q 0 0 0 rg BT 374.58 386.82 Td (of ) Tj ET Q q 0 0 0 rg BT 385.24 386.82 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 399.78 386.82 Td (Or) Tj ET Q q 0 0 0 rg BT 410.52 386.82 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.18 386.82 Td ( ) Tj ET Q q 0 0 0 rg BT 434.50 386.82 Td (ClickJect ) Tj ET Q q 0 0 0 rg BT 473.52 386.82 Td (Autoinjector) Tj ET Q q 0 0 0 rg BT 523.67 386.82 Td (, ) Tj ET Q q 0 0 0 rg BT 528.49 386.82 Td (a ) Tj ET Q q 0 0 0 rg BT 535.26 386.82 Td (new ) Tj ET Q q 0 0 0 rg BT 554.24 386.82 Td (self-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 376.82 Td (administered ) Tj ET Q q 0 0 0 rg BT 267.15 376.82 Td (autoinjector ) Tj ET Q q 0 0 0 rg BT 317.41 376.82 Td (for ) Tj ET Q q 0 0 0 rg BT 331.57 376.82 Td (adults ) Tj ET Q q 0 0 0 rg BT 357.96 376.82 Td (with ) Tj ET Q q 0 0 0 rg BT 378.23 376.82 Td (moderate ) Tj ET Q q 0 0 0 rg BT 417.94 376.82 Td (to ) Tj ET Q q 0 0 0 rg BT 428.21 376.82 Td (severe ) Tj ET Q q 0 0 0 rg BT 456.25 376.82 Td (RA.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.55 357.27 Td (May 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 361.82 Td (Announced ) Tj ET Q q 0 0 0 rg BT 260.80 361.82 Td (the ) Tj ET Q q 0 0 0 rg BT 274.72 361.82 Td (commercial ) Tj ET Q q 0 0 0 rg BT 323.62 361.82 Td (launch ) Tj ET Q q 0 0 0 rg BT 351.97 361.82 Td (in ) Tj ET Q q 0 0 0 rg BT 361.45 361.82 Td (Japan ) Tj ET Q q 0 0 0 rg BT 385.92 361.82 Td (of ) Tj ET Q q 0 0 0 rg BT 395.96 361.82 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 409.88 361.82 Td (Or) Tj ET Q q 0 0 0 rg BT 420.62 361.82 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.27 361.82 Td ( ) Tj ET Q q 0 0 0 rg BT 443.97 361.82 Td (ClickJect ) Tj ET Q q 0 0 0 rg BT 482.51 361.82 Td (Autoinjector ) Tj ET Q q 0 0 0 rg BT 534.76 361.82 Td (for ) Tj ET Q q 0 0 0 rg BT 548.12 361.82 Td (adults ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 351.82 Td (with ) Tj ET Q q 0 0 0 rg BT 233.28 351.82 Td (moderate ) Tj ET Q q 0 0 0 rg BT 272.98 351.82 Td (to ) Tj ET Q q 0 0 0 rg BT 283.26 351.82 Td (severe ) Tj ET Q q 0 0 0 rg BT 311.30 351.82 Td (RA.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 41.15 307.27 Td (Hepatitis C Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 140.20 332.27 Td (December 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 336.82 Td (JMHL) Tj ET Q q 0 0 0 rg BT 238.37 336.82 Td (W) Tj ET Q q 0 0 0 rg BT 247.63 336.82 Td ( ) Tj ET Q q 0 0 0 rg BT 251.71 336.82 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 314.09 336.82 Td (and ) Tj ET Q q 0 0 0 rg BT 332.61 336.82 Td (marketing ) Tj ET Q q 0 0 0 rg BT 377.23 336.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 416.29 336.82 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 428.70 336.82 Td (Ximency ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.20 336.82 Td (combination ) Tj ET Q q 0 0 0 rg BT 521.27 336.82 Td (tablet ) Tj ET Q q 0 0 0 rg BT 547.56 336.82 Td (which ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 326.82 Td (contains ) Tj ET Q q 0 0 0 rg BT 248.83 326.82 Td (daclatasvir) Tj ET Q q 0 0 0 rg BT 291.74 326.82 Td (, ) Tj ET Q q 0 0 0 rg BT 296.74 326.82 Td (asunaprevir ) Tj ET Q q 0 0 0 rg BT 345.88 326.82 Td (and ) Tj ET Q q 0 0 0 rg BT 362.82 326.82 Td (beclabuvir ) Tj ET Q q 0 0 0 rg BT 407.52 326.82 Td (for ) Tj ET Q q 0 0 0 rg BT 421.68 326.82 Td (the ) Tj ET Q q 0 0 0 rg BT 436.40 326.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 476.66 326.82 Td (of ) Tj ET Q q 0 0 0 rg BT 487.49 326.82 Td (HCV) Tj ET Q q 0 0 0 rg BT 508.42 326.82 Td ( ) Tj ET Q q 0 0 0 rg BT 510.92 326.82 Td (in ) Tj ET Q q 0 0 0 rg BT 521.20 326.82 Td (genotype ) Tj ET Q q 0 0 0 rg BT 560.35 326.82 Td (1.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 142.70 307.27 Td (February 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 311.82 Td (FDA) Tj ET Q q 0 0 0 rg BT 232.45 311.82 Td ( ) Tj ET Q q 0 0 0 rg BT 235.77 311.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 274.08 311.82 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 285.73 311.82 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.83 311.82 Td ( ) Tj ET Q q 0 0 0 rg BT 325.15 311.82 Td (for ) Tj ET Q q 0 0 0 rg BT 340.13 311.82 Td (use ) Tj ET Q q 0 0 0 rg BT 356.78 311.82 Td (with ) Tj ET Q q 0 0 0 rg BT 377.88 311.82 Td (sofosbuvir ) Tj ET Q q 0 0 0 rg BT 423.42 311.82 Td (for ) Tj ET Q q 0 0 0 rg BT 438.40 311.82 Td (the ) Tj ET Q q 0 0 0 rg BT 453.94 311.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 495.02 311.82 Td (of ) Tj ET Q q 0 0 0 rg BT 506.67 311.82 Td (chronic ) Tj ET Q q 0 0 0 rg BT 539.97 311.82 Td (HCV) Tj ET Q q 0 0 0 rg BT 560.90 311.82 Td ( ) Tj ET Q q 0 0 0 rg BT 564.22 311.82 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 301.82 Td (genotypes ) Tj ET Q q 0 0 0 rg BT 256.05 301.82 Td (1 ) Tj ET Q q 0 0 0 rg BT 263.55 301.82 Td (and ) Tj ET Q q 0 0 0 rg BT 280.49 301.82 Td (3 ) Tj ET Q q 0 0 0 rg BT 287.99 301.82 Td (in ) Tj ET Q q 0 0 0 rg BT 298.26 301.82 Td (three ) Tj ET Q q 0 0 0 rg BT 320.75 301.82 Td (additional ) Tj ET Q q 0 0 0 rg BT 363.24 301.82 Td (patient ) Tj ET Q q 0 0 0 rg BT 392.95 301.82 Td (populations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 145.20 282.27 Td (January 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 286.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 227.99 286.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 265.19 286.82 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 275.73 286.82 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 311.83 286.82 Td ( ) Tj ET Q q 0 0 0 rg BT 314.05 286.82 Td (for ) Tj ET Q q 0 0 0 rg BT 327.92 286.82 Td (use ) Tj ET Q q 0 0 0 rg BT 343.46 286.82 Td (with ) Tj ET Q q 0 0 0 rg BT 363.45 286.82 Td (sofosbuvir ) Tj ET Q q 0 0 0 rg BT 407.88 286.82 Td (for ) Tj ET Q q 0 0 0 rg BT 421.75 286.82 Td (the ) Tj ET Q q 0 0 0 rg BT 436.18 286.82 Td (treatment ) Tj ET Q q 0 0 0 rg BT 476.15 286.82 Td (of ) Tj ET Q q 0 0 0 rg BT 486.69 286.82 Td (chronic ) Tj ET Q q 0 0 0 rg BT 518.89 286.82 Td (HCV) Tj ET Q q 0 0 0 rg BT 539.82 286.82 Td ( ) Tj ET Q q 0 0 0 rg BT 542.03 286.82 Td (in ) Tj ET Q q 0 0 0 rg BT 552.02 286.82 Td (three ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 276.82 Td (new ) Tj ET Q q 0 0 0 rg BT 232.16 276.82 Td (patient ) Tj ET Q q 0 0 0 rg BT 261.87 276.82 Td (populations.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 68.65 257.31 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.55 257.27 Td (June 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 261.82 Td (EC ) Tj ET Q q 0 0 0 rg BT 227.70 261.82 Td (approval ) Tj ET Q q 0 0 0 rg BT 264.62 261.82 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 278.20 261.82 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.86 261.82 Td ( ) Tj ET Q q 0 0 0 rg BT 311.78 261.82 Td (oral ) Tj ET Q q 0 0 0 rg BT 329.26 261.82 Td (powder ) Tj ET Q q 0 0 0 rg BT 361.17 261.82 Td (indicated ) Tj ET Q q 0 0 0 rg BT 399.75 261.82 Td (in ) Tj ET Q q 0 0 0 rg BT 409.46 261.82 Td (HIV) Tj ET Q q 0 0 0 rg BT 426.31 261.82 Td (-infected ) Tj ET Q q 0 0 0 rg BT 463.77 261.82 Td (children ) Tj ET Q q 0 0 0 rg BT 498.46 261.82 Td (at ) Tj ET Q q 0 0 0 rg BT 507.60 261.82 Td (least ) Tj ET Q q 0 0 0 rg BT 527.85 261.82 Td (3 ) Tj ET Q q 0 0 0 rg BT 534.78 261.82 Td (months/5 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.00 251.82 Td (kg ) Tj ET Q q 0 0 0 rg BT 225.50 251.82 Td (and ) Tj ET Q q 0 0 0 rg BT 242.44 251.82 Td (the ) Tj ET Q q 0 0 0 rg BT 257.16 251.82 Td (optimized ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 299.65 251.82 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.30 251.82 Td ( ) Tj ET Q q 0 0 0 rg BT 333.80 251.82 Td (capsule ) Tj ET Q q 0 0 0 rg BT 366.29 251.82 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 403.77 251.82 Td (dosing ) Tj ET Q q 0 0 0 rg BT 432.94 251.82 Td (recommendations.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 230.65 Td (Refer to "—Product and Pipeline Developments" for all of the developments in our marketed products and late-stage pipeline in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.97 230.65 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 570.97 230.65 Td (. ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 206.65 Td (Strategy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 182.65 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.25 182.65 Td (focus ) Tj ET Q q 0 0 0 rg BT 76.60 182.65 Td (as ) Tj ET Q q 0 0 0 rg BT 86.63 182.65 Td (a ) Tj ET Q q 0 0 0 rg BT 92.76 182.65 Td (specialty ) Tj ET Q q 0 0 0 rg BT 129.99 182.65 Td (biopharmaceutical ) Tj ET Q q 0 0 0 rg BT 205.54 182.65 Td (company ) Tj ET Q q 0 0 0 rg BT 243.89 182.65 Td (is ) Tj ET Q q 0 0 0 rg BT 252.25 182.65 Td (on ) Tj ET Q q 0 0 0 rg BT 263.95 182.65 Td (discovering, ) Tj ET Q q 0 0 0 rg BT 314.80 182.65 Td (developing ) Tj ET Q q 0 0 0 rg BT 360.93 182.65 Td (and ) Tj ET Q q 0 0 0 rg BT 377.06 182.65 Td (delivering ) Tj ET Q q 0 0 0 rg BT 419.30 182.65 Td (transformational ) Tj ET Q q 0 0 0 rg BT 487.08 182.65 Td (medicines ) Tj ET Q q 0 0 0 rg BT 529.32 182.65 Td (that ) Tj ET Q q 0 0 0 rg BT 546.00 182.65 Td (address ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 170.65 Td (serious ) Tj ET Q q 0 0 0 rg BT 66.53 170.65 Td (unmet ) Tj ET Q q 0 0 0 rg BT 93.73 170.65 Td (medical ) Tj ET Q q 0 0 0 rg BT 127.59 170.65 Td (needs. ) Tj ET Q q 0 0 0 rg BT 155.06 170.65 Td (Our ) Tj ET Q q 0 0 0 rg BT 172.82 170.65 Td (strategy ) Tj ET Q q 0 0 0 rg BT 206.68 170.65 Td (is ) Tj ET Q q 0 0 0 rg BT 215.55 170.65 Td (to ) Tj ET Q q 0 0 0 rg BT 225.54 170.65 Td (combine ) Tj ET Q q 0 0 0 rg BT 262.17 170.65 Td (the ) Tj ET Q q 0 0 0 rg BT 276.60 170.65 Td (resources, ) Tj ET Q q 0 0 0 rg BT 319.06 170.65 Td (scale ) Tj ET Q q 0 0 0 rg BT 341.25 170.65 Td (and ) Tj ET Q q 0 0 0 rg BT 357.89 170.65 Td (capability ) Tj ET Q q 0 0 0 rg BT 399.53 170.65 Td (of ) Tj ET Q q 0 0 0 rg BT 410.06 170.65 Td (a ) Tj ET Q q 0 0 0 rg BT 416.70 170.65 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 479.98 170.65 Td (company ) Tj ET Q q 0 0 0 rg BT 518.84 170.65 Td (with ) Tj ET Q q 0 0 0 rg BT 538.82 170.65 Td (the ) Tj ET Q q 0 0 0 rg BT 553.25 170.65 Td (speed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 158.65 Td (and ) Tj ET Q q 0 0 0 rg BT 52.57 158.65 Td (focus ) Tj ET Q q 0 0 0 rg BT 76.35 158.65 Td (on ) Tj ET Q q 0 0 0 rg BT 88.48 158.65 Td (innovation ) Tj ET Q q 0 0 0 rg BT 133.38 158.65 Td (of ) Tj ET Q q 0 0 0 rg BT 143.84 158.65 Td (the ) Tj ET Q q 0 0 0 rg BT 158.19 158.65 Td (biotech ) Tj ET Q q 0 0 0 rg BT 189.75 158.65 Td (industry) Tj ET Q q 0 0 0 rg BT 221.88 158.65 Td (. ) Tj ET Q q 0 0 0 rg BT 226.50 158.65 Td (Our ) Tj ET Q q 0 0 0 rg BT 244.18 158.65 Td (four ) Tj ET Q q 0 0 0 rg BT 262.97 158.65 Td (strategic ) Tj ET Q q 0 0 0 rg BT 298.97 158.65 Td (priorities ) Tj ET Q q 0 0 0 rg BT 337.20 158.65 Td (are ) Tj ET Q q 0 0 0 rg BT 351.54 158.65 Td (to ) Tj ET Q q 0 0 0 rg BT 361.45 158.65 Td (drive ) Tj ET Q q 0 0 0 rg BT 384.12 158.65 Td (business ) Tj ET Q q 0 0 0 rg BT 420.14 158.65 Td (performance, ) Tj ET Q q 0 0 0 rg BT 475.29 158.65 Td (continue ) Tj ET Q q 0 0 0 rg BT 511.85 158.65 Td (to ) Tj ET Q q 0 0 0 rg BT 521.76 158.65 Td (build ) Tj ET Q q 0 0 0 rg BT 544.44 158.65 Td (a ) Tj ET Q q 0 0 0 rg BT 551.01 158.65 Td (strong ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 146.65 Td (franchise ) Tj ET Q q 0 0 0 rg BT 74.56 146.65 Td (in ) Tj ET Q q 0 0 0 rg BT 84.25 146.65 Td (IO, ) Tj ET Q q 0 0 0 rg BT 99.21 146.65 Td (maintain ) Tj ET Q q 0 0 0 rg BT 136.11 146.65 Td (a ) Tj ET Q q 0 0 0 rg BT 142.46 146.65 Td (diversified ) Tj ET Q q 0 0 0 rg BT 187.13 146.65 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 224.04 146.65 Td (both ) Tj ET Q q 0 0 0 rg BT 243.73 146.65 Td (within ) Tj ET Q q 0 0 0 rg BT 271.19 146.65 Td (and ) Tj ET Q q 0 0 0 rg BT 287.54 146.65 Td (outside ) Tj ET Q q 0 0 0 rg BT 318.34 146.65 Td (of ) Tj ET Q q 0 0 0 rg BT 328.58 146.65 Td (IO, ) Tj ET Q q 0 0 0 rg BT 343.54 146.65 Td (and ) Tj ET Q q 0 0 0 rg BT 359.89 146.65 Td (continue ) Tj ET Q q 0 0 0 rg BT 396.24 146.65 Td (our ) Tj ET Q q 0 0 0 rg BT 411.48 146.65 Td (disciplined ) Tj ET Q q 0 0 0 rg BT 457.27 146.65 Td (approach ) Tj ET Q q 0 0 0 rg BT 495.83 146.65 Td (to ) Tj ET Q q 0 0 0 rg BT 505.52 146.65 Td (capital ) Tj ET Q q 0 0 0 rg BT 534.08 146.65 Td (allocation, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.65 Td (including ) Tj ET Q q 0 0 0 rg BT 76.35 134.65 Td (establishing ) Tj ET Q q 0 0 0 rg BT 126.70 134.65 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 178.15 134.65 Td (and ) Tj ET Q q 0 0 0 rg BT 195.16 134.65 Td (collaborations ) Tj ET Q q 0 0 0 rg BT 254.39 134.65 Td (as ) Tj ET Q q 0 0 0 rg BT 265.29 134.65 Td (an ) Tj ET Q q 0 0 0 rg BT 277.30 134.65 Td (essential ) Tj ET Q q 0 0 0 rg BT 314.31 134.65 Td (component ) Tj ET Q q 0 0 0 rg BT 361.32 134.65 Td (of ) Tj ET Q q 0 0 0 rg BT 372.23 134.65 Td (successfully ) Tj ET Q q 0 0 0 rg BT 423.68 134.65 Td (delivering ) Tj ET Q q 0 0 0 rg BT 466.79 134.65 Td (transformational ) Tj ET Q q 0 0 0 rg BT 535.46 134.65 Td (medicines ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 122.65 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 122.65 Td (patients.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 98.65 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 98.65 Td (e ) Tj ET Q q 0 0 0 rg BT 50.59 98.65 Td (are ) Tj ET Q q 0 0 0 rg BT 64.32 98.65 Td (developing ) Tj ET Q q 0 0 0 rg BT 110.27 98.65 Td (new ) Tj ET Q q 0 0 0 rg BT 128.45 98.65 Td (medicines ) Tj ET Q q 0 0 0 rg BT 170.51 98.65 Td (in ) Tj ET Q q 0 0 0 rg BT 179.80 98.65 Td (the ) Tj ET Q q 0 0 0 rg BT 193.54 98.65 Td (following ) Tj ET Q q 0 0 0 rg BT 233.94 98.65 Td (core ) Tj ET Q q 0 0 0 rg BT 252.67 98.65 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 298.60 98.65 Td (areas: ) Tj ET Q q 0 0 0 rg BT 323.44 98.65 Td (oncology) Tj ET Q q 0 0 0 rg BT 360.00 98.65 Td (, ) Tj ET Q q 0 0 0 rg BT 364.02 98.65 Td (including ) Tj ET Q q 0 0 0 rg BT 403.31 98.65 Td (IO, ) Tj ET Q q 0 0 0 rg BT 417.88 98.65 Td (immunoscience, ) Tj ET Q q 0 0 0 rg BT 484.66 98.65 Td (cardiovascular) Tj ET Q q 0 0 0 rg BT 542.56 98.65 Td (, ) Tj ET Q q 0 0 0 rg BT 546.58 98.65 Td (fibrotic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 86.65 Td (disease ) Tj ET Q q 0 0 0 rg BT 67.46 86.65 Td (and ) Tj ET Q q 0 0 0 rg BT 84.48 86.65 Td (GDD. ) Tj ET Q q 0 0 0 rg BT 111.22 86.65 Td (In ) Tj ET Q q 0 0 0 rg BT 122.13 86.65 Td (IO, ) Tj ET Q q 0 0 0 rg BT 137.77 86.65 Td (we ) Tj ET Q q 0 0 0 rg BT 152.01 86.65 Td (continue ) Tj ET Q q 0 0 0 rg BT 189.02 86.65 Td (to ) Tj ET Q q 0 0 0 rg BT 199.38 86.65 Td (invest ) Tj ET Q q 0 0 0 rg BT 225.85 86.65 Td (through ) Tj ET Q q 0 0 0 rg BT 259.54 86.65 Td (new ) Tj ET Q q 0 0 0 rg BT 278.78 86.65 Td (studies ) Tj ET Q q 0 0 0 rg BT 309.13 86.65 Td (in ) Tj ET Q q 0 0 0 rg BT 319.49 86.65 Td (monotherapy) Tj ET Q q 0 0 0 rg BT 371.61 86.65 Td (, ) Tj ET Q q 0 0 0 rg BT 376.69 86.65 Td (combination ) Tj ET Q q 0 0 0 rg BT 429.26 86.65 Td (therapy ) Tj ET Q q 0 0 0 rg BT 461.83 86.65 Td (and ) Tj ET Q q 0 0 0 rg BT 478.84 86.65 Td (with ) Tj ET Q q 0 0 0 rg BT 499.20 86.65 Td (new ) Tj ET Q q 0 0 0 rg BT 518.44 86.65 Td (molecules ) Tj ET Q q 0 0 0 rg BT 561.57 86.65 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 74.65 Td (mechanisms ) Tj ET Q q 0 0 0 rg BT 88.67 74.65 Td (of ) Tj ET Q q 0 0 0 rg BT 100.24 74.65 Td (action. ) Tj ET Q q 0 0 0 rg BT 130.41 74.65 Td (Delivering ) Tj ET Q q 0 0 0 rg BT 176.41 74.65 Td (promising ) Tj ET Q q 0 0 0 rg BT 220.20 74.65 Td (new ) Tj ET Q q 0 0 0 rg BT 240.10 74.65 Td (treatment ) Tj ET Q q 0 0 0 rg BT 281.10 74.65 Td (options ) Tj ET Q q 0 0 0 rg BT 313.78 74.65 Td (to ) Tj ET Q q 0 0 0 rg BT 324.80 74.65 Td (patients ) Tj ET Q q 0 0 0 rg BT 359.14 74.65 Td (with ) Tj ET Q q 0 0 0 rg BT 380.16 74.65 Td (lung ) Tj ET Q q 0 0 0 rg BT 401.17 74.65 Td (cancer ) Tj ET Q q 0 0 0 rg BT 430.49 74.65 Td (as ) Tj ET Q q 0 0 0 rg BT 442.06 74.65 Td (quickly ) Tj ET Q q 0 0 0 rg BT 475.29 74.65 Td (as ) Tj ET Q q 0 0 0 rg BT 486.86 74.65 Td (possible ) Tj ET Q q 0 0 0 rg BT 522.88 74.65 Td (has ) Tj ET Q q 0 0 0 rg BT 539.44 74.65 Td (been ) Tj ET Q q 0 0 0 rg BT 561.56 74.65 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 62.65 Td (continues ) Tj ET Q q 0 0 0 rg BT 76.94 62.65 Td (to ) Tj ET Q q 0 0 0 rg BT 87.33 62.65 Td (be ) Tj ET Q q 0 0 0 rg BT 99.38 62.65 Td (a ) Tj ET Q q 0 0 0 rg BT 106.43 62.65 Td (priority ) Tj ET Q q 0 0 0 rg BT 139.04 62.65 Td (for ) Tj ET Q q 0 0 0 rg BT 153.31 62.65 Td (our ) Tj ET Q q 0 0 0 rg BT 169.25 62.65 Td (company) Tj ET Q q 0 0 0 rg BT 205.26 62.65 Td (. ) Tj ET Q q 0 0 0 rg BT 210.18 62.65 Td (W) Tj ET Q q 0 0 0 rg BT 218.82 62.65 Td (e ) Tj ET Q q 0 0 0 rg BT 225.87 62.65 Td (continue ) Tj ET Q q 0 0 0 rg BT 262.92 62.65 Td (to ) Tj ET Q q 0 0 0 rg BT 273.31 62.65 Td (invest ) Tj ET Q q 0 0 0 rg BT 299.81 62.65 Td (significantly ) Tj ET Q q 0 0 0 rg BT 352.41 62.65 Td (in ) Tj ET Q q 0 0 0 rg BT 362.80 62.65 Td (our ) Tj ET Q q 0 0 0 rg BT 378.74 62.65 Td (deep ) Tj ET Q q 0 0 0 rg BT 400.23 62.65 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 435.05 62.65 Td (of ) Tj ET Q q 0 0 0 rg BT 446.00 62.65 Td (innovative ) Tj ET Q q 0 0 0 rg BT 490.82 62.65 Td (medicines ) Tj ET Q q 0 0 0 rg BT 533.98 62.65 Td (covering ) Tj ET Q q 0 0 0 rg BT 571.57 62.65 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 50.65 Td (broad ) Tj ET Q q 0 0 0 rg BT 61.73 50.65 Td (array ) Tj ET Q q 0 0 0 rg BT 85.24 50.65 Td (of ) Tj ET Q q 0 0 0 rg BT 96.53 50.65 Td (cancers ) Tj ET Q q 0 0 0 rg BT 129.48 50.65 Td (and ) Tj ET Q q 0 0 0 rg BT 146.88 50.65 Td (have ) Tj ET Q q 0 0 0 rg BT 168.72 50.65 Td (entered ) Tj ET Q q 0 0 0 rg BT 201.11 50.65 Td (into ) Tj ET Q q 0 0 0 rg BT 219.64 50.65 Td (several ) Tj ET Q q 0 0 0 rg BT 250.92 50.65 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 306.64 50.65 Td (agreements ) Tj ET Q q 0 0 0 rg BT 355.14 50.65 Td (to ) Tj ET Q q 0 0 0 rg BT 365.89 50.65 Td (research ) Tj ET Q q 0 0 0 rg BT 402.16 50.65 Td (and ) Tj ET Q q 0 0 0 rg BT 419.56 50.65 Td (develop ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 454.19 50.65 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.62 50.65 Td ( ) Tj ET Q q 0 0 0 rg BT 486.59 50.65 Td (and ) Tj ET Q q 0 0 0 rg BT 504.00 50.65 Td (other ) Tj ET Q q 0 0 0 rg BT 527.51 50.65 Td (approved ) Tj ET Q q 0 0 0 rg BT 567.68 50.65 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 38.65 Td (investigational ) Tj ET Q q 0 0 0 rg BT 97.09 38.65 Td (oncology ) Tj ET Q q 0 0 0 rg BT 136.52 38.65 Td (agents ) Tj ET Q q 0 0 0 rg BT 164.27 38.65 Td (in ) Tj ET Q q 0 0 0 rg BT 174.26 38.65 Td (combination ) Tj ET Q q 0 0 0 rg BT 226.46 38.65 Td (regimens, ) Tj ET Q q 0 0 0 rg BT 267.83 38.65 Td (including ) Tj ET Q q 0 0 0 rg BT 307.81 38.65 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 327.80 38.65 Td (Y) Tj ET Q q 0 0 0 rg BT 332.45 38.65 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.65 38.65 Td (. ) Tj ET Q q 0 0 0 rg BT 359.21 38.65 Td (W) Tj ET Q q 0 0 0 rg BT 367.84 38.65 Td (e ) Tj ET Q q 0 0 0 rg BT 374.49 38.65 Td (remain ) Tj ET Q q 0 0 0 rg BT 404.47 38.65 Td (focused ) Tj ET Q q 0 0 0 rg BT 437.78 38.65 Td (and ) Tj ET Q q 0 0 0 rg BT 454.43 38.65 Td (well-resourced ) Tj ET Q q 0 0 0 rg BT 516.05 38.65 Td (in ) Tj ET Q q 0 0 0 rg BT 526.04 38.65 Td (our ) Tj ET Q q 0 0 0 rg BT 541.58 38.65 Td (first-line ) Tj ET Q endstream endobj 61 0 obj <> endobj 62 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (lung ) Tj ET Q q 0 0 0 rg BT 55.70 749.10 Td (development ) Tj ET Q q 0 0 0 rg BT 109.27 749.10 Td (programs, ) Tj ET Q q 0 0 0 rg BT 151.46 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.82 749.10 Td (continuously ) Tj ET Q q 0 0 0 rg BT 221.40 749.10 Td (look ) Tj ET Q q 0 0 0 rg BT 241.10 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 254.68 749.10 Td (ways ) Tj ET Q q 0 0 0 rg BT 277.15 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 286.85 749.10 Td (strengthen ) Tj ET Q q 0 0 0 rg BT 330.43 749.10 Td (our ) Tj ET Q q 0 0 0 rg BT 345.68 749.10 Td (broad ) Tj ET Q q 0 0 0 rg BT 370.37 749.10 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 407.28 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 423.64 749.10 Td (bring ) Tj ET Q q 0 0 0 rg BT 446.67 749.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 480.24 749.10 Td (new ) Tj ET Q q 0 0 0 rg BT 498.82 749.10 Td (treatments. ) Tj ET Q q 0 0 0 rg BT 544.89 749.10 Td (Beyond ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (cancer) Tj ET Q q 0 0 0 rg BT 61.68 737.10 Td (, ) Tj ET Q q 0 0 0 rg BT 66.15 737.10 Td (we ) Tj ET Q q 0 0 0 rg BT 79.78 737.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 116.19 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 125.94 737.10 Td (strengthen ) Tj ET Q q 0 0 0 rg BT 169.56 737.10 Td (our ) Tj ET Q q 0 0 0 rg BT 184.86 737.10 Td (early ) Tj ET Q q 0 0 0 rg BT 206.82 737.10 Td (stage ) Tj ET Q q 0 0 0 rg BT 229.33 737.10 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 266.30 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 276.05 737.10 Td (immunoscience, ) Tj ET Q q 0 0 0 rg BT 343.28 737.10 Td (cardiovascular) Tj ET Q q 0 0 0 rg BT 401.18 737.10 Td (, ) Tj ET Q q 0 0 0 rg BT 405.65 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 422.06 737.10 Td (fibrotic ) Tj ET Q q 0 0 0 rg BT 453.46 737.10 Td (diseases ) Tj ET Q q 0 0 0 rg BT 488.20 737.10 Td (internally ) Tj ET Q q 0 0 0 rg BT 528.49 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 544.90 737.10 Td (through ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (our ) Tj ET Q q 0 0 0 rg BT 52.04 725.10 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 103.63 725.10 Td (with ) Tj ET Q q 0 0 0 rg BT 124.11 725.10 Td (a ) Tj ET Q q 0 0 0 rg BT 131.26 725.10 Td (diverse ) Tj ET Q q 0 0 0 rg BT 162.85 725.10 Td (group ) Tj ET Q q 0 0 0 rg BT 188.88 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 199.92 725.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 245.40 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 262.54 725.10 Td (academic ) Tj ET Q q 0 0 0 rg BT 303.00 725.10 Td (institutions ) Tj ET Q q 0 0 0 rg BT 350.16 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 360.65 725.10 Td (new ) Tj ET Q q 0 0 0 rg BT 380.02 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 397.17 725.10 Td (expanded ) Tj ET Q q 0 0 0 rg BT 438.19 725.10 Td (research ) Tj ET Q q 0 0 0 rg BT 474.21 725.10 Td (activities. ) Tj ET Q q 0 0 0 rg BT 515.32 725.10 Td (W) Tj ET Q q 0 0 0 rg BT 523.96 725.10 Td (e ) Tj ET Q q 0 0 0 rg BT 531.10 725.10 Td (believe ) Tj ET Q q 0 0 0 rg BT 562.69 725.10 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 69.04 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 85.98 713.10 Td (external ) Tj ET Q q 0 0 0 rg BT 120.68 713.10 Td (focus ) Tj ET Q q 0 0 0 rg BT 144.84 713.10 Td (is ) Tj ET Q q 0 0 0 rg BT 154.01 713.10 Td (dif) Tj ET Q q 0 0 0 rg BT 164.94 713.10 Td (ferentiated ) Tj ET Q q 0 0 0 rg BT 210.19 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 227.13 713.10 Td (contributes ) Tj ET Q q 0 0 0 rg BT 274.06 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 284.34 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 299.06 713.10 Td (transformation ) Tj ET Q q 0 0 0 rg BT 360.43 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 371.26 713.10 Td (our ) Tj ET Q q 0 0 0 rg BT 387.09 713.10 Td (portfolio.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 691.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.27 691.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 102.19 691.50 Td (model ) Tj ET Q q 0 0 0 rg BT 128.91 691.50 Td (continues ) Tj ET Q q 0 0 0 rg BT 168.95 691.50 Td (to ) Tj ET Q q 0 0 0 rg BT 178.45 691.50 Td (evolve ) Tj ET Q q 0 0 0 rg BT 206.83 691.50 Td (and ) Tj ET Q q 0 0 0 rg BT 222.99 691.50 Td (our ) Tj ET Q q 0 0 0 rg BT 238.04 691.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 276.96 691.50 Td (product ) Tj ET Q q 0 0 0 rg BT 309.23 691.50 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 345.95 691.50 Td (is ) Tj ET Q q 0 0 0 rg BT 354.34 691.50 Td (growing ) Tj ET Q q 0 0 0 rg BT 389.39 691.50 Td (in ) Tj ET Q q 0 0 0 rg BT 398.89 691.50 Td (a ) Tj ET Q q 0 0 0 rg BT 405.05 691.50 Td (manner ) Tj ET Q q 0 0 0 rg BT 436.76 691.50 Td (consistent ) Tj ET Q q 0 0 0 rg BT 478.47 691.50 Td (with ) Tj ET Q q 0 0 0 rg BT 497.97 691.50 Td (our ) Tj ET Q q 0 0 0 rg BT 513.02 691.50 Td (overall ) Tj ET Q q 0 0 0 rg BT 542.51 691.50 Td (strategy) Tj ET Q q 0 0 0 rg BT 573.51 691.50 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 679.50 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 679.50 Td (e ) Tj ET Q q 0 0 0 rg BT 50.60 679.50 Td (continue ) Tj ET Q q 0 0 0 rg BT 86.56 679.50 Td (to ) Tj ET Q q 0 0 0 rg BT 95.87 679.50 Td (drive ) Tj ET Q q 0 0 0 rg BT 117.94 679.50 Td (growth ) Tj ET Q q 0 0 0 rg BT 147.79 679.50 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 157.65 679.50 Td (Opdivo ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 188.61 679.50 Td (by ) Tj ET Q q 0 0 0 rg BT 200.14 679.50 Td (expanding ) Tj ET Q q 0 0 0 rg BT 243.32 679.50 Td (into ) Tj ET Q q 0 0 0 rg BT 260.40 679.50 Td (additional ) Tj ET Q q 0 0 0 rg BT 301.92 679.50 Td (indications ) Tj ET Q q 0 0 0 rg BT 347.33 679.50 Td (and ) Tj ET Q q 0 0 0 rg BT 363.29 679.50 Td (tumor ) Tj ET Q q 0 0 0 rg BT 388.71 679.50 Td (types ) Tj ET Q q 0 0 0 rg BT 411.34 679.50 Td (both ) Tj ET Q q 0 0 0 rg BT 430.64 679.50 Td (as ) Tj ET Q q 0 0 0 rg BT 440.50 679.50 Td (a ) Tj ET Q q 0 0 0 rg BT 446.46 679.50 Td (monotherapy ) Tj ET Q q 0 0 0 rg BT 500.75 679.50 Td (and ) Tj ET Q q 0 0 0 rg BT 516.72 679.50 Td (in ) Tj ET Q q 0 0 0 rg BT 526.02 679.50 Td (combination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 667.50 Td (with ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 56.92 667.50 Td (Y) Tj ET Q q 0 0 0 rg BT 61.57 667.50 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 83.77 667.50 Td ( ) Tj ET Q q 0 0 0 rg BT 86.92 667.50 Td (and ) Tj ET Q q 0 0 0 rg BT 104.51 667.50 Td (other ) Tj ET Q q 0 0 0 rg BT 128.20 667.50 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 175.75 667.50 Td (agents. ) Tj ET Q q 0 0 0 rg BT 206.95 667.50 Td (Beyond ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 241.20 667.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 270.64 667.50 Td ( ) Tj ET Q q 0 0 0 rg BT 273.79 667.50 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 291.37 667.50 Td (Y) Tj ET Q q 0 0 0 rg BT 296.01 667.50 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.22 667.50 Td (, ) Tj ET Q q 0 0 0 rg BT 323.87 667.50 Td (we ) Tj ET Q q 0 0 0 rg BT 338.67 667.50 Td (are ) Tj ET Q q 0 0 0 rg BT 354.03 667.50 Td (building ) Tj ET Q q 0 0 0 rg BT 390.51 667.50 Td (on ) Tj ET Q q 0 0 0 rg BT 403.65 667.50 Td (the ) Tj ET Q q 0 0 0 rg BT 419.02 667.50 Td (continued ) Tj ET Q q 0 0 0 rg BT 461.59 667.50 Td (success ) Tj ET Q q 0 0 0 rg BT 494.73 667.50 Td (and ) Tj ET Q q 0 0 0 rg BT 512.32 667.50 Td (remain ) Tj ET Q q 0 0 0 rg BT 543.23 667.50 Td (strongly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 655.50 Td (committed ) Tj ET Q q 0 0 0 rg BT 81.27 655.50 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 91.55 655.50 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 119.88 655.50 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 124.88 655.50 Td (Or) Tj ET Q q 0 0 0 rg BT 135.62 655.50 Td (encia ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.78 655.50 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 176.72 655.50 Td (Sprycel. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.70 655.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 229.75 655.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 279.45 655.50 Td (infrastructure ) Tj ET Q q 0 0 0 rg BT 335.81 655.50 Td (is ) Tj ET Q q 0 0 0 rg BT 344.98 655.50 Td (uniquely ) Tj ET Q q 0 0 0 rg BT 382.48 655.50 Td (leveraged ) Tj ET Q q 0 0 0 rg BT 423.84 655.50 Td (for ) Tj ET Q q 0 0 0 rg BT 438.00 655.50 Td (potential ) Tj ET Q q 0 0 0 rg BT 475.49 655.50 Td (growth.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 631.50 Td (In ) Tj ET Q q 0 0 0 rg BT 47.52 631.50 Td (2016, ) Tj ET Q q 0 0 0 rg BT 73.21 631.50 Td (we ) Tj ET Q q 0 0 0 rg BT 88.06 631.50 Td (announced ) Tj ET Q q 0 0 0 rg BT 134.56 631.50 Td (plans ) Tj ET Q q 0 0 0 rg BT 158.86 631.50 Td (for ) Tj ET Q q 0 0 0 rg BT 173.71 631.50 Td (a ) Tj ET Q q 0 0 0 rg BT 181.33 631.50 Td (multi-year ) Tj ET Q q 0 0 0 rg BT 226.17 631.50 Td (evolution ) Tj ET Q q 0 0 0 rg BT 267.13 631.50 Td (to ) Tj ET Q q 0 0 0 rg BT 278.10 631.50 Td (our ) Tj ET Q q 0 0 0 rg BT 294.62 631.50 Td (operating ) Tj ET Q q 0 0 0 rg BT 335.57 631.50 Td (model ) Tj ET Q q 0 0 0 rg BT 363.75 631.50 Td (by ) Tj ET Q q 0 0 0 rg BT 376.94 631.50 Td (focusing ) Tj ET Q q 0 0 0 rg BT 414.57 631.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 464.96 631.50 Td (and ) Tj ET Q q 0 0 0 rg BT 482.58 631.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 507.44 631.50 Td (resources ) Tj ET Q q 0 0 0 rg BT 548.39 631.50 Td (on ) Tj ET Q q 0 0 0 rg BT 561.58 631.50 Td (key ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 619.50 Td (brands ) Tj ET Q q 0 0 0 rg BT 65.02 619.50 Td (and ) Tj ET Q q 0 0 0 rg BT 81.81 619.50 Td (markets, ) Tj ET Q q 0 0 0 rg BT 118.32 619.50 Td (delivering ) Tj ET Q q 0 0 0 rg BT 161.22 619.50 Td (leaner ) Tj ET Q q 0 0 0 rg BT 187.99 619.50 Td (administrative ) Tj ET Q q 0 0 0 rg BT 247.56 619.50 Td (functions ) Tj ET Q q 0 0 0 rg BT 287.13 619.50 Td (and ) Tj ET Q q 0 0 0 rg BT 303.92 619.50 Td (streamlining ) Tj ET Q q 0 0 0 rg BT 356.27 619.50 Td (our ) Tj ET Q q 0 0 0 rg BT 371.95 619.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 432.62 619.50 Td (network ) Tj ET Q q 0 0 0 rg BT 467.74 619.50 Td (to ) Tj ET Q q 0 0 0 rg BT 477.87 619.50 Td (reflect ) Tj ET Q q 0 0 0 rg BT 505.76 619.50 Td (the ) Tj ET Q q 0 0 0 rg BT 520.33 619.50 Td (importance ) Tj ET Q q 0 0 0 rg BT 567.67 619.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 607.50 Td (biologics ) Tj ET Q q 0 0 0 rg BT 75.38 607.50 Td (in ) Tj ET Q q 0 0 0 rg BT 85.87 607.50 Td (our ) Tj ET Q q 0 0 0 rg BT 101.92 607.50 Td (current ) Tj ET Q q 0 0 0 rg BT 132.94 607.50 Td (and ) Tj ET Q q 0 0 0 rg BT 150.10 607.50 Td (future ) Tj ET Q q 0 0 0 rg BT 176.69 607.50 Td (portfolio. ) Tj ET Q q 0 0 0 rg BT 216.70 607.50 Td (The ) Tj ET Q q 0 0 0 rg BT 234.96 607.50 Td (new ) Tj ET Q q 0 0 0 rg BT 254.33 607.50 Td (operating ) Tj ET Q q 0 0 0 rg BT 294.81 607.50 Td (model ) Tj ET Q q 0 0 0 rg BT 322.52 607.50 Td (will ) Tj ET Q q 0 0 0 rg BT 340.79 607.50 Td (enable ) Tj ET Q q 0 0 0 rg BT 369.60 607.50 Td (us ) Tj ET Q q 0 0 0 rg BT 381.21 607.50 Td (to ) Tj ET Q q 0 0 0 rg BT 391.70 607.50 Td (deliver ) Tj ET Q q 0 0 0 rg BT 422.17 607.50 Td (the ) Tj ET Q q 0 0 0 rg BT 437.11 607.50 Td (strategic, ) Tj ET Q q 0 0 0 rg BT 476.19 607.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 513.89 607.50 Td (and ) Tj ET Q q 0 0 0 rg BT 531.04 607.50 Td (operational ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 595.50 Td (flexibility ) Tj ET Q q 0 0 0 rg BT 77.94 595.50 Td (necessary ) Tj ET Q q 0 0 0 rg BT 119.31 595.50 Td (to ) Tj ET Q q 0 0 0 rg BT 129.58 595.50 Td (invest ) Tj ET Q q 0 0 0 rg BT 155.97 595.50 Td (in ) Tj ET Q q 0 0 0 rg BT 166.25 595.50 Td (the ) Tj ET Q q 0 0 0 rg BT 180.97 595.50 Td (highest ) Tj ET Q q 0 0 0 rg BT 212.35 595.50 Td (priorities. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 573.90 Td (Looking ) Tj ET Q q 0 0 0 rg BT 72.10 573.90 Td (ahead, ) Tj ET Q q 0 0 0 rg BT 100.13 573.90 Td (we ) Tj ET Q q 0 0 0 rg BT 114.01 573.90 Td (will ) Tj ET Q q 0 0 0 rg BT 131.78 573.90 Td (continue ) Tj ET Q q 0 0 0 rg BT 168.43 573.90 Td (to ) Tj ET Q q 0 0 0 rg BT 178.43 573.90 Td (implement ) Tj ET Q q 0 0 0 rg BT 223.41 573.90 Td (our ) Tj ET Q q 0 0 0 rg BT 238.96 573.90 Td (biopharma ) Tj ET Q q 0 0 0 rg BT 283.94 573.90 Td (strategy ) Tj ET Q q 0 0 0 rg BT 317.81 573.90 Td (by ) Tj ET Q q 0 0 0 rg BT 330.02 573.90 Td (driving ) Tj ET Q q 0 0 0 rg BT 361.13 573.90 Td (the ) Tj ET Q q 0 0 0 rg BT 375.56 573.90 Td (growth ) Tj ET Q q 0 0 0 rg BT 406.10 573.90 Td (of ) Tj ET Q q 0 0 0 rg BT 416.65 573.90 Td (key ) Tj ET Q q 0 0 0 rg BT 433.30 573.90 Td (brands, ) Tj ET Q q 0 0 0 rg BT 464.68 573.90 Td (executing ) Tj ET Q q 0 0 0 rg BT 505.77 573.90 Td (product ) Tj ET Q q 0 0 0 rg BT 538.53 573.90 Td (launches, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 561.90 Td (investing ) Tj ET Q q 0 0 0 rg BT 75.58 561.90 Td (in ) Tj ET Q q 0 0 0 rg BT 86.27 561.90 Td (our ) Tj ET Q q 0 0 0 rg BT 102.52 561.90 Td (diverse ) Tj ET Q q 0 0 0 rg BT 134.31 561.90 Td (and ) Tj ET Q q 0 0 0 rg BT 151.66 561.90 Td (innovative ) Tj ET Q q 0 0 0 rg BT 196.79 561.90 Td (pipeline, ) Tj ET Q q 0 0 0 rg BT 234.42 561.90 Td (including ) Tj ET Q q 0 0 0 rg BT 275.11 561.90 Td (through ) Tj ET Q q 0 0 0 rg BT 309.13 561.90 Td (business ) Tj ET Q q 0 0 0 rg BT 345.94 561.90 Td (development, ) Tj ET Q q 0 0 0 rg BT 403.00 561.90 Td (focusing ) Tj ET Q q 0 0 0 rg BT 440.36 561.90 Td (on ) Tj ET Q q 0 0 0 rg BT 453.27 561.90 Td (prioritized ) Tj ET Q q 0 0 0 rg BT 497.84 561.90 Td (markets, ) Tj ET Q q 0 0 0 rg BT 534.91 561.90 Td (increasing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 549.90 Td (investments ) Tj ET Q q 0 0 0 rg BT 86.27 549.90 Td (in ) Tj ET Q q 0 0 0 rg BT 96.55 549.90 Td (our ) Tj ET Q q 0 0 0 rg BT 112.38 549.90 Td (biologics ) Tj ET Q q 0 0 0 rg BT 151.55 549.90 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 212.36 549.90 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 260.39 549.90 Td (and ) Tj ET Q q 0 0 0 rg BT 277.33 549.90 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 327.60 549.90 Td (a ) Tj ET Q q 0 0 0 rg BT 334.54 549.90 Td (culture ) Tj ET Q q 0 0 0 rg BT 364.80 549.90 Td (of ) Tj ET Q q 0 0 0 rg BT 375.63 549.90 Td (continuous ) Tj ET Q q 0 0 0 rg BT 422.02 549.90 Td (improvement.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 525.90 Td (Acquisition ) Tj ET Q q 0 0 0 rg BT 87.40 525.90 Td (and ) Tj ET Q q 0 0 0 rg BT 106.02 525.90 Td (Licensing ) Tj ET Q q 0 0 0 rg BT 149.09 525.90 Td (Arrangements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 508.90 Td (Acquisition ) Tj ET Q q 0 0 0 rg BT 85.08 508.90 Td (and ) Tj ET Q q 0 0 0 rg BT 101.93 508.90 Td (licensing ) Tj ET Q q 0 0 0 rg BT 140.45 508.90 Td (transactions ) Tj ET Q q 0 0 0 rg BT 190.63 508.90 Td (allow ) Tj ET Q q 0 0 0 rg BT 215.26 508.90 Td (us ) Tj ET Q q 0 0 0 rg BT 226.57 508.90 Td (to ) Tj ET Q q 0 0 0 rg BT 236.76 508.90 Td (focus ) Tj ET Q q 0 0 0 rg BT 260.83 508.90 Td (our ) Tj ET Q q 0 0 0 rg BT 276.58 508.90 Td (resources ) Tj ET Q q 0 0 0 rg BT 316.75 508.90 Td (behind ) Tj ET Q q 0 0 0 rg BT 346.38 508.90 Td (our ) Tj ET Q q 0 0 0 rg BT 362.13 508.90 Td (growth ) Tj ET Q q 0 0 0 rg BT 392.87 508.90 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 448.06 508.90 Td (that ) Tj ET Q q 0 0 0 rg BT 465.47 508.90 Td (drive ) Tj ET Q q 0 0 0 rg BT 488.43 508.90 Td (the ) Tj ET Q q 0 0 0 rg BT 503.06 508.90 Td (greatest ) Tj ET Q q 0 0 0 rg BT 536.57 508.90 Td (long-term ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 496.90 Td (value. ) Tj ET Q q 0 0 0 rg BT 63.42 496.90 Td (W) Tj ET Q q 0 0 0 rg BT 72.06 496.90 Td (e ) Tj ET Q q 0 0 0 rg BT 80.02 496.90 Td (are ) Tj ET Q q 0 0 0 rg BT 95.75 496.90 Td (focused ) Tj ET Q q 0 0 0 rg BT 130.37 496.90 Td (on ) Tj ET Q q 0 0 0 rg BT 143.89 496.90 Td (the ) Tj ET Q q 0 0 0 rg BT 159.63 496.90 Td (following ) Tj ET Q q 0 0 0 rg BT 202.04 496.90 Td (core ) Tj ET Q q 0 0 0 rg BT 222.77 496.90 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 270.71 496.90 Td (areas: ) Tj ET Q q 0 0 0 rg BT 297.55 496.90 Td (oncology) Tj ET Q q 0 0 0 rg BT 334.11 496.90 Td (, ) Tj ET Q q 0 0 0 rg BT 340.14 496.90 Td (including ) Tj ET Q q 0 0 0 rg BT 381.43 496.90 Td (IO, ) Tj ET Q q 0 0 0 rg BT 398.01 496.90 Td (immunoscience, ) Tj ET Q q 0 0 0 rg BT 466.79 496.90 Td (cardiovascular ) Tj ET Q q 0 0 0 rg BT 528.61 496.90 Td (and ) Tj ET Q q 0 0 0 rg BT 546.57 496.90 Td (fibrotic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 484.90 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 73.77 484.90 Td (Significant ) Tj ET Q q 0 0 0 rg BT 120.15 484.90 Td (transactions ) Tj ET Q q 0 0 0 rg BT 170.41 484.90 Td (entered ) Tj ET Q q 0 0 0 rg BT 202.34 484.90 Td (into ) Tj ET Q q 0 0 0 rg BT 220.39 484.90 Td (in ) Tj ET Q q 0 0 0 rg BT 230.67 484.90 Td (2016 ) Tj ET Q q 0 0 0 rg BT 253.17 484.90 Td (are ) Tj ET Q q 0 0 0 rg BT 267.88 484.90 Td (summarized ) Tj ET Q q 0 0 0 rg BT 319.25 484.90 Td (below: ) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 459.5669921875 m 85.716796875 459.5669921875 l s q 0 0 0 rg BT 36.00 460.90 Td (Nitto Denko) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 448.90 Td (In ) Tj ET Q q 0 0 0 rg BT 46.41 448.90 Td (December ) Tj ET Q q 0 0 0 rg BT 89.57 448.90 Td (2016, ) Tj ET Q q 0 0 0 rg BT 114.14 448.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 137.34 448.90 Td (and ) Tj ET Q q 0 0 0 rg BT 153.86 448.90 Td (Nitto ) Tj ET Q q 0 0 0 rg BT 176.49 448.90 Td (Denko ) Tj ET Q q 0 0 0 rg BT 205.23 448.90 Td (entered ) Tj ET Q q 0 0 0 rg BT 236.73 448.90 Td (into ) Tj ET Q q 0 0 0 rg BT 254.36 448.90 Td (an ) Tj ET Q q 0 0 0 rg BT 265.88 448.90 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 305.72 448.90 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 350.56 448.90 Td (license ) Tj ET Q q 0 0 0 rg BT 380.40 448.90 Td (agreement ) Tj ET Q q 0 0 0 rg BT 424.12 448.90 Td (granting ) Tj ET Q q 0 0 0 rg BT 459.52 448.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 482.72 448.90 Td (the ) Tj ET Q q 0 0 0 rg BT 497.02 448.90 Td (right ) Tj ET Q q 0 0 0 rg BT 517.98 448.90 Td (to ) Tj ET Q q 0 0 0 rg BT 527.83 448.90 Td (develop ) Tj ET Q q 0 0 0 rg BT 561.57 448.90 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 436.90 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 97.71 436.90 Td (Nitto ) Tj ET Q q 0 0 0 rg BT 121.12 436.90 Td (Denko's ) Tj ET Q q 0 0 0 rg BT 156.32 436.90 Td (investigational ) Tj ET Q q 0 0 0 rg BT 218.05 436.90 Td (siRNA) Tj ET Q q 0 0 0 rg BT 245.28 436.90 Td ( ) Tj ET Q q 0 0 0 rg BT 248.14 436.90 Td (molecules ) Tj ET Q q 0 0 0 rg BT 291.53 436.90 Td (tar) Tj ET Q q 0 0 0 rg BT 301.90 436.90 Td (geting ) Tj ET Q q 0 0 0 rg BT 329.75 436.90 Td (HSP47 ) Tj ET Q q 0 0 0 rg BT 360.94 436.90 Td (in ) Tj ET Q q 0 0 0 rg BT 371.57 436.90 Td (vitamin ) Tj ET Q q 0 0 0 rg BT 404.35 436.90 Td (A) Tj ET Q q 0 0 0 rg BT 411.02 436.90 Td ( ) Tj ET Q q 0 0 0 rg BT 413.87 436.90 Td (containing ) Tj ET Q q 0 0 0 rg BT 458.94 436.90 Td (formulations, ) Tj ET Q q 0 0 0 rg BT 515.39 436.90 Td (which ) Tj ET Q q 0 0 0 rg BT 542.69 436.90 Td (includes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 424.90 Td (Nitto ) Tj ET Q q 0 0 0 rg BT 59.64 424.90 Td (Denko's ) Tj ET Q q 0 0 0 rg BT 95.08 424.90 Td (lead ) Tj ET Q q 0 0 0 rg BT 114.82 424.90 Td (asset ) Tj ET Q q 0 0 0 rg BT 137.34 424.90 Td (ND-L02-s0201, ) Tj ET Q q 0 0 0 rg BT 204.02 424.90 Td (currently ) Tj ET Q q 0 0 0 rg BT 243.20 424.90 Td (in ) Tj ET Q q 0 0 0 rg BT 254.06 424.90 Td (Phase ) Tj ET Q q 0 0 0 rg BT 280.48 424.90 Td (Ib ) Tj ET Q q 0 0 0 rg BT 291.89 424.90 Td (study ) Tj ET Q q 0 0 0 rg BT 316.64 424.90 Td (for ) Tj ET Q q 0 0 0 rg BT 331.39 424.90 Td (the ) Tj ET Q q 0 0 0 rg BT 346.69 424.90 Td (treatment ) Tj ET Q q 0 0 0 rg BT 387.53 424.90 Td (of ) Tj ET Q q 0 0 0 rg BT 398.94 424.90 Td (advanced ) Tj ET Q q 0 0 0 rg BT 439.78 424.90 Td (liver ) Tj ET Q q 0 0 0 rg BT 461.19 424.90 Td (fibrosis. ) Tj ET Q q 0 0 0 rg BT 496.55 424.90 Td (The ) Tj ET Q q 0 0 0 rg BT 515.18 424.90 Td (agreement ) Tj ET Q q 0 0 0 rg BT 559.91 424.90 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 412.90 Td (grants ) Tj ET Q q 0 0 0 rg BT 63.11 412.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 86.91 412.90 Td (the ) Tj ET Q q 0 0 0 rg BT 101.80 412.90 Td (option ) Tj ET Q q 0 0 0 rg BT 130.03 412.90 Td (to ) Tj ET Q q 0 0 0 rg BT 140.48 412.90 Td (receive ) Tj ET Q q 0 0 0 rg BT 172.02 412.90 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 212.45 412.90 Td (licenses ) Tj ET Q q 0 0 0 rg BT 246.78 412.90 Td (for ) Tj ET Q q 0 0 0 rg BT 261.11 412.90 Td (HSP47 ) Tj ET Q q 0 0 0 rg BT 292.13 412.90 Td (siRNAs ) Tj ET Q q 0 0 0 rg BT 326.48 412.90 Td (in ) Tj ET Q q 0 0 0 rg BT 336.93 412.90 Td (vitamin ) Tj ET Q q 0 0 0 rg BT 369.57 412.90 Td (A) Tj ET Q q 0 0 0 rg BT 376.24 412.90 Td ( ) Tj ET Q q 0 0 0 rg BT 378.91 412.90 Td (containing ) Tj ET Q q 0 0 0 rg BT 423.80 412.90 Td (formulations ) Tj ET Q q 0 0 0 rg BT 477.57 412.90 Td (for ) Tj ET Q q 0 0 0 rg BT 491.91 412.90 Td (the ) Tj ET Q q 0 0 0 rg BT 506.80 412.90 Td (treatment ) Tj ET Q q 0 0 0 rg BT 547.23 412.90 Td (of ) Tj ET Q q 0 0 0 rg BT 558.23 412.90 Td (lung ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 400.90 Td (fibrosis ) Tj ET Q q 0 0 0 rg BT 68.50 400.90 Td (and ) Tj ET Q q 0 0 0 rg BT 85.44 400.90 Td (other ) Tj ET Q q 0 0 0 rg BT 108.49 400.90 Td (or) Tj ET Q q 0 0 0 rg BT 116.63 400.90 Td (gan ) Tj ET Q q 0 0 0 rg BT 133.57 400.90 Td (fibrosis.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 379.1669921875 m 79.3251953125 379.1669921875 l s q 0 0 0 rg BT 36.00 380.50 Td (Cormorant) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 368.50 Td (In ) Tj ET Q q 0 0 0 rg BT 46.74 368.50 Td (July ) Tj ET Q q 0 0 0 rg BT 65.81 368.50 Td (2016, ) Tj ET Q q 0 0 0 rg BT 90.72 368.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 114.25 368.50 Td (acquired ) Tj ET Q q 0 0 0 rg BT 151.08 368.50 Td (all ) Tj ET Q q 0 0 0 rg BT 163.48 368.50 Td (of ) Tj ET Q q 0 0 0 rg BT 174.22 368.50 Td (the ) Tj ET Q q 0 0 0 rg BT 188.84 368.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 237.91 368.50 Td (shares ) Tj ET Q q 0 0 0 rg BT 265.31 368.50 Td (of ) Tj ET Q q 0 0 0 rg BT 276.04 368.50 Td (Cormorant, ) Tj ET Q q 0 0 0 rg BT 324.27 368.50 Td (a ) Tj ET Q q 0 0 0 rg BT 331.12 368.50 Td (private ) Tj ET Q q 0 0 0 rg BT 361.29 368.50 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 424.77 368.50 Td (company ) Tj ET Q q 0 0 0 rg BT 463.83 368.50 Td (focused ) Tj ET Q q 0 0 0 rg BT 497.34 368.50 Td (on ) Tj ET Q q 0 0 0 rg BT 509.74 368.50 Td (the ) Tj ET Q q 0 0 0 rg BT 524.37 368.50 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 356.50 Td (of ) Tj ET Q q 0 0 0 rg BT 47.30 356.50 Td (therapies ) Tj ET Q q 0 0 0 rg BT 86.36 356.50 Td (for ) Tj ET Q q 0 0 0 rg BT 100.98 356.50 Td (cancer ) Tj ET Q q 0 0 0 rg BT 130.03 356.50 Td (and ) Tj ET Q q 0 0 0 rg BT 147.44 356.50 Td (rare ) Tj ET Q q 0 0 0 rg BT 165.94 356.50 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 203.96 356.50 Td (The ) Tj ET Q q 0 0 0 rg BT 222.48 356.50 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 269.32 356.50 Td (provides ) Tj ET Q q 0 0 0 rg BT 306.73 356.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 330.82 356.50 Td (with ) Tj ET Q q 0 0 0 rg BT 351.56 356.50 Td (full ) Tj ET Q q 0 0 0 rg BT 368.42 356.50 Td (rights ) Tj ET Q q 0 0 0 rg BT 394.16 356.50 Td (to ) Tj ET Q q 0 0 0 rg BT 404.90 356.50 Td (Cormorant's ) Tj ET Q q 0 0 0 rg BT 456.89 356.50 Td (lead ) Tj ET Q q 0 0 0 rg BT 476.51 356.50 Td (candidate ) Tj ET Q q 0 0 0 rg BT 517.79 356.50 Td (HuMax-IL8, ) Tj ET Q q 0 0 0 rg BT 571.57 356.50 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 344.50 Td (Phase ) Tj ET Q q 0 0 0 rg BT 62.25 344.50 Td (I/II ) Tj ET Q q 0 0 0 rg BT 77.94 344.50 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 128.07 344.50 Td (antibody ) Tj ET Q q 0 0 0 rg BT 165.99 344.50 Td (that ) Tj ET Q q 0 0 0 rg BT 183.90 344.50 Td (represents ) Tj ET Q q 0 0 0 rg BT 227.36 344.50 Td (a ) Tj ET Q q 0 0 0 rg BT 234.72 344.50 Td (potentially ) Tj ET Q q 0 0 0 rg BT 280.40 344.50 Td (complementary ) Tj ET Q q 0 0 0 rg BT 345.52 344.50 Td (IO ) Tj ET Q q 0 0 0 rg BT 358.99 344.50 Td (mechanism ) Tj ET Q q 0 0 0 rg BT 407.46 344.50 Td (of ) Tj ET Q q 0 0 0 rg BT 418.71 344.50 Td (action ) Tj ET Q q 0 0 0 rg BT 446.06 344.50 Td (to ) Tj ET Q q 0 0 0 rg BT 456.55 344.50 Td (T) Tj ET Q q 0 0 0 rg BT 461.74 344.50 Td (-cell ) Tj ET Q q 0 0 0 rg BT 482.42 344.50 Td (directed ) Tj ET Q q 0 0 0 rg BT 517.54 344.50 Td (antibodies ) Tj ET Q q 0 0 0 rg BT 561.57 344.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 332.50 Td (co-stimulatory ) Tj ET Q q 0 0 0 rg BT 96.82 332.50 Td (molecules.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 310.7669921875 m 68.216796875 310.7669921875 l s q 0 0 0 rg BT 36.00 312.10 Td (Padlock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 300.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.08 300.10 Td (April ) Tj ET Q q 0 0 0 rg BT 71.72 300.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 97.74 300.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 122.39 300.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 160.35 300.10 Td (all ) Tj ET Q q 0 0 0 rg BT 173.87 300.10 Td (of ) Tj ET Q q 0 0 0 rg BT 185.73 300.10 Td (the ) Tj ET Q q 0 0 0 rg BT 201.47 300.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 251.66 300.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 280.18 300.10 Td (of ) Tj ET Q q 0 0 0 rg BT 292.04 300.10 Td (Padlock, ) Tj ET Q q 0 0 0 rg BT 330.28 300.10 Td (a ) Tj ET Q q 0 0 0 rg BT 338.25 300.10 Td (private ) Tj ET Q q 0 0 0 rg BT 369.54 300.10 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 430.28 300.10 Td (company ) Tj ET Q q 0 0 0 rg BT 470.47 300.10 Td (dedicated ) Tj ET Q q 0 0 0 rg BT 512.30 300.10 Td (to ) Tj ET Q q 0 0 0 rg BT 523.61 300.10 Td (creating ) Tj ET Q q 0 0 0 rg BT 559.34 300.10 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 288.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 78.69 288.10 Td (to ) Tj ET Q q 0 0 0 rg BT 88.61 288.10 Td (treat ) Tj ET Q q 0 0 0 rg BT 108.51 288.10 Td (destructive ) Tj ET Q q 0 0 0 rg BT 154.53 288.10 Td (autoimmune ) Tj ET Q q 0 0 0 rg BT 206.66 288.10 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 243.92 288.10 Td (The ) Tj ET Q q 0 0 0 rg BT 261.61 288.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 307.64 288.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 344.22 288.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 367.49 288.10 Td (with ) Tj ET Q q 0 0 0 rg BT 387.41 288.10 Td (full ) Tj ET Q q 0 0 0 rg BT 403.44 288.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 428.36 288.10 Td (to ) Tj ET Q q 0 0 0 rg BT 438.28 288.10 Td (Padlock’) Tj ET Q q 0 0 0 rg BT 473.28 288.10 Td (s ) Tj ET Q q 0 0 0 rg BT 479.31 288.10 Td (P) Tj ET Q q 0 0 0 rg BT 483.96 288.10 Td (AD ) Tj ET Q q 0 0 0 rg BT 500.54 288.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 537.13 288.10 Td (discovery ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.10 Td (program ) Tj ET Q q 0 0 0 rg BT 71.39 276.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 104.00 276.10 Td (on ) Tj ET Q q 0 0 0 rg BT 115.51 276.10 Td (the ) Tj ET Q q 0 0 0 rg BT 129.24 276.10 Td (development ) Tj ET Q q 0 0 0 rg BT 182.40 276.10 Td (of ) Tj ET Q q 0 0 0 rg BT 192.24 276.10 Td (potentially ) Tj ET Q q 0 0 0 rg BT 236.52 276.10 Td (transformational ) Tj ET Q q 0 0 0 rg BT 304.12 276.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 343.39 276.10 Td (approaches ) Tj ET Q q 0 0 0 rg BT 389.88 276.10 Td (for ) Tj ET Q q 0 0 0 rg BT 403.05 276.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 435.66 276.10 Td (with ) Tj ET Q q 0 0 0 rg BT 454.95 276.10 Td (rheumatoid ) Tj ET Q q 0 0 0 rg BT 502.01 276.10 Td (arthritis. ) Tj ET Q q 0 0 0 rg BT 537.12 276.10 Td (Padlock’) Tj ET Q q 0 0 0 rg BT 572.12 276.10 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.10 Td (P) Tj ET Q q 0 0 0 rg BT 40.64 264.10 Td (AD ) Tj ET Q q 0 0 0 rg BT 57.59 264.10 Td (discovery ) Tj ET Q q 0 0 0 rg BT 98.96 264.10 Td (program ) Tj ET Q q 0 0 0 rg BT 135.34 264.10 Td (may ) Tj ET Q q 0 0 0 rg BT 155.06 264.10 Td (have ) Tj ET Q q 0 0 0 rg BT 176.43 264.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 218.92 264.10 Td (utility ) Tj ET Q q 0 0 0 rg BT 245.32 264.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.59 264.10 Td (treating ) Tj ET Q q 0 0 0 rg BT 288.64 264.10 Td (systemic ) Tj ET Q q 0 0 0 rg BT 326.13 264.10 Td (lupus ) Tj ET Q q 0 0 0 rg BT 350.30 264.10 Td (erythematosus ) Tj ET Q q 0 0 0 rg BT 410.57 264.10 Td (and ) Tj ET Q q 0 0 0 rg BT 427.50 264.10 Td (other ) Tj ET Q q 0 0 0 rg BT 450.55 264.10 Td (autoimmune ) Tj ET Q q 0 0 0 rg BT 503.04 264.10 Td (diseases.) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 242.36699218750005 m 64.88671875 242.36699218750005 l s q 0 0 0 rg BT 36.00 243.70 Td (Portola) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 231.70 Td (In ) Tj ET Q q 0 0 0 rg BT 47.28 231.70 Td (February ) Tj ET Q q 0 0 0 rg BT 86.33 231.70 Td (2016, ) Tj ET Q q 0 0 0 rg BT 111.77 231.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 135.84 231.70 Td (and ) Tj ET Q q 0 0 0 rg BT 153.23 231.70 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 180.06 231.70 Td (entered ) Tj ET Q q 0 0 0 rg BT 212.43 231.70 Td (into ) Tj ET Q q 0 0 0 rg BT 230.93 231.70 Td (a ) Tj ET Q q 0 0 0 rg BT 238.32 231.70 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 294.03 231.70 Td (and ) Tj ET Q q 0 0 0 rg BT 311.41 231.70 Td (license ) Tj ET Q q 0 0 0 rg BT 342.13 231.70 Td (agreement ) Tj ET Q q 0 0 0 rg BT 386.71 231.70 Td (with ) Tj ET Q q 0 0 0 rg BT 407.44 231.70 Td (Portola ) Tj ET Q q 0 0 0 rg BT 439.28 231.70 Td (to ) Tj ET Q q 0 0 0 rg BT 450.00 231.70 Td (develop ) Tj ET Q q 0 0 0 rg BT 484.61 231.70 Td (and ) Tj ET Q q 0 0 0 rg BT 501.99 231.70 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 563.79 231.70 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 219.70 Td (investigational ) Tj ET Q q 0 0 0 rg BT 97.76 219.70 Td (agent ) Tj ET Q q 0 0 0 rg BT 122.30 219.70 Td (andexanet ) Tj ET Q q 0 0 0 rg BT 165.72 219.70 Td (alfa ) Tj ET Q q 0 0 0 rg BT 183.59 219.70 Td (in ) Tj ET Q q 0 0 0 rg BT 194.26 219.70 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 221.77 219.70 Td (Andexanet ) Tj ET Q q 0 0 0 rg BT 267.98 219.70 Td (alfa ) Tj ET Q q 0 0 0 rg BT 285.85 219.70 Td (is ) Tj ET Q q 0 0 0 rg BT 295.40 219.70 Td (designed ) Tj ET Q q 0 0 0 rg BT 333.83 219.70 Td (to ) Tj ET Q q 0 0 0 rg BT 344.50 219.70 Td (reverse ) Tj ET Q q 0 0 0 rg BT 376.25 219.70 Td (the ) Tj ET Q q 0 0 0 rg BT 391.35 219.70 Td (anticoagulant ) Tj ET Q q 0 0 0 rg BT 448.11 219.70 Td (activity ) Tj ET Q q 0 0 0 rg BT 480.98 219.70 Td (of ) Tj ET Q q 0 0 0 rg BT 492.20 219.70 Td (Factor ) Tj ET Q q 0 0 0 rg BT 520.63 219.70 Td (Xa ) Tj ET Q q 0 0 0 rg BT 535.18 219.70 Td (inhibitors, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 207.70 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 77.22 207.70 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.55 207.70 Td (. ) Tj ET Q q 0 0 0 rg BT 111.50 207.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 136.07 207.70 Td (and ) Tj ET Q q 0 0 0 rg BT 153.95 207.70 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 181.27 207.70 Td (are ) Tj ET Q q 0 0 0 rg BT 196.92 207.70 Td (responsible ) Tj ET Q q 0 0 0 rg BT 245.91 207.70 Td (for ) Tj ET Q q 0 0 0 rg BT 261.02 207.70 Td (all ) Tj ET Q q 0 0 0 rg BT 274.46 207.70 Td (development ) Tj ET Q q 0 0 0 rg BT 329.55 207.70 Td (and ) Tj ET Q q 0 0 0 rg BT 347.44 207.70 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 391.98 207.70 Td (activities ) Tj ET Q q 0 0 0 rg BT 431.52 207.70 Td (for ) Tj ET Q q 0 0 0 rg BT 446.63 207.70 Td (andexanet ) Tj ET Q q 0 0 0 rg BT 490.60 207.70 Td (alfa ) Tj ET Q q 0 0 0 rg BT 509.03 207.70 Td (in ) Tj ET Q q 0 0 0 rg BT 520.26 207.70 Td (Japan ) Tj ET Q q 0 0 0 rg BT 546.47 207.70 Td (and ) Tj ET Q q 0 0 0 rg BT 564.35 207.70 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 195.70 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 84.04 195.70 Td (commercializing ) Tj ET Q q 0 0 0 rg BT 153.72 195.70 Td (the ) Tj ET Q q 0 0 0 rg BT 168.44 195.70 Td (agent ) Tj ET Q q 0 0 0 rg BT 192.59 195.70 Td (in ) Tj ET Q q 0 0 0 rg BT 202.86 195.70 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 230.62 195.70 Td (Portola ) Tj ET Q q 0 0 0 rg BT 262.01 195.70 Td (retains ) Tj ET Q q 0 0 0 rg BT 291.16 195.70 Td (the ) Tj ET Q q 0 0 0 rg BT 305.87 195.70 Td (rights ) Tj ET Q q 0 0 0 rg BT 331.14 195.70 Td (to ) Tj ET Q q 0 0 0 rg BT 341.42 195.70 Td (andexanet ) Tj ET Q q 0 0 0 rg BT 384.44 195.70 Td (alfa ) Tj ET Q q 0 0 0 rg BT 401.92 195.70 Td (outside ) Tj ET Q q 0 0 0 rg BT 433.30 195.70 Td (of ) Tj ET Q q 0 0 0 rg BT 444.13 195.70 Td (Japan ) Tj ET Q q 0 0 0 rg BT 469.39 195.70 Td (and ) Tj ET Q q 0 0 0 rg BT 486.33 195.70 Td (will ) Tj ET Q q 0 0 0 rg BT 504.38 195.70 Td (be ) Tj ET Q q 0 0 0 rg BT 516.31 195.70 Td (responsible ) Tj ET Q q 0 0 0 rg BT 564.35 195.70 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 183.70 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 183.70 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 111.53 183.70 Td (supply) Tj ET Q q 0 0 0 rg BT 137.55 183.70 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 159.70 Td (In ) Tj ET Q q 0 0 0 rg BT 46.82 159.70 Td (addition ) Tj ET Q q 0 0 0 rg BT 82.09 159.70 Td (to ) Tj ET Q q 0 0 0 rg BT 92.36 159.70 Td (the ) Tj ET Q q 0 0 0 rg BT 107.07 159.70 Td (above ) Tj ET Q q 0 0 0 rg BT 133.44 159.70 Td (transactions, ) Tj ET Q q 0 0 0 rg BT 186.20 159.70 Td (in ) Tj ET Q q 0 0 0 rg BT 196.47 159.70 Td (2016, ) Tj ET Q q 0 0 0 rg BT 221.46 159.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 245.07 159.70 Td (provided ) Tj ET Q q 0 0 0 rg BT 283.11 159.70 Td (notice ) Tj ET Q q 0 0 0 rg BT 310.04 159.70 Td (of ) Tj ET Q q 0 0 0 rg BT 320.86 159.70 Td (terminations ) Tj ET Q q 0 0 0 rg BT 373.35 159.70 Td (to ) Tj ET Q q 0 0 0 rg BT 383.62 159.70 Td (the ) Tj ET Q q 0 0 0 rg BT 398.33 159.70 Td (California ) Tj ET Q q 0 0 0 rg BT 441.36 159.70 Td (Institute ) Tj ET Q q 0 0 0 rg BT 476.63 159.70 Td (for ) Tj ET Q q 0 0 0 rg BT 490.78 159.70 Td (Biomedical ) Tj ET Q q 0 0 0 rg BT 539.37 159.70 Td (Research ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 147.70 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 78.60 147.70 Td (to ) Tj ET Q q 0 0 0 rg BT 88.43 147.70 Td (a ) Tj ET Q q 0 0 0 rg BT 94.92 147.70 Td (research ) Tj ET Q q 0 0 0 rg BT 130.28 147.70 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 185.10 147.70 Td (agreement ) Tj ET Q q 0 0 0 rg BT 228.79 147.70 Td (for ) Tj ET Q q 0 0 0 rg BT 242.51 147.70 Td (the ) Tj ET Q q 0 0 0 rg BT 256.78 147.70 Td (development ) Tj ET Q q 0 0 0 rg BT 310.48 147.70 Td (of ) Tj ET Q q 0 0 0 rg BT 320.87 147.70 Td (anti-fibrotic ) Tj ET Q q 0 0 0 rg BT 370.68 147.70 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 414.93 147.70 Td (compounds ) Tj ET Q q 0 0 0 rg BT 463.10 147.70 Td (and ) Tj ET Q q 0 0 0 rg BT 479.59 147.70 Td (Dual ) Tj ET Q q 0 0 0 rg BT 500.93 147.70 Td (Therapeutics, ) Tj ET Q q 0 0 0 rg BT 557.13 147.70 Td (LLC ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 135.70 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 79.04 135.70 Td (to ) Tj ET Q q 0 0 0 rg BT 89.32 135.70 Td (a ) Tj ET Q q 0 0 0 rg BT 96.26 135.70 Td (research ) Tj ET Q q 0 0 0 rg BT 132.06 135.70 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 187.32 135.70 Td (agreement ) Tj ET Q q 0 0 0 rg BT 231.46 135.70 Td (for ) Tj ET Q q 0 0 0 rg BT 245.62 135.70 Td (the ) Tj ET Q q 0 0 0 rg BT 260.34 135.70 Td (development ) Tj ET Q q 0 0 0 rg BT 314.49 135.70 Td (of ) Tj ET Q q 0 0 0 rg BT 325.32 135.70 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 372.23 135.70 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 416.93 135.70 Td (compounds.) Tj ET Q endstream endobj 63 0 obj <> endobj 64 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (31) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (RESUL) Tj ET Q q 0 0 0 rg BT 68.43 749.25 Td (TS OF) Tj ET Q q 0 0 0 rg BT 96.67 749.25 Td ( OPERA) Tj ET Q q 0 0 0 rg BT 133.43 749.25 Td (TIONS) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Regional Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 708.25 Td (The composition of the changes in revenues was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 649.75 187.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 223.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 227.50 649.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 272.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 649.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 649.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 374.50 649.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 419.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 423.50 649.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 473.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 477.50 649.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 649.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 623.75 187.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 223.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 227.50 623.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 272.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 623.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 623.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 374.50 623.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 419.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 423.50 623.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 473.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 477.50 623.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 623.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 597.75 187.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 223.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 227.50 597.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 272.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 597.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 321.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 325.50 597.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 374.50 597.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 419.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 423.50 597.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 473.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 477.50 597.75 45.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 597.75 50.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 685.75 m 272.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 272.5 685.75 m 276.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 685.75 m 321.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 321.5 685.75 m 325.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 685.75 m 370.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 374.5 685.75 m 419.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 419.5 685.75 m 423.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 423.5 685.75 m 473.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 477.5 685.75 m 522.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 522.5 685.75 m 526.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 685.75 m 576.5 685.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 672.75 m 272.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 272.5 672.75 m 276.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 672.75 m 321.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 321.5 672.75 m 325.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 672.75 m 370.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 374.5 672.75 m 419.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 419.5 672.75 m 423.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 423.5 672.75 m 473.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 477.5 672.75 m 522.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 522.5 672.75 m 526.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 672.75 m 576.5 672.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 649.75 m 272.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 649.75 m 321.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 649.75 m 370.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 374.5 649.75 m 419.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 423.5 649.75 m 473.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 477.5 649.75 m 522.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 649.75 m 576.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 649.75 m 272.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 649.75 m 321.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 649.75 m 370.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 477.5 649.75 m 522.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 649.75 m 576.5 649.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 597.75 m 272.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 597.75 m 321.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 597.75 m 370.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 585.75 m 272.5 585.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 227.5 583.75 m 272.5 583.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 585.75 m 321.5 585.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 583.75 m 321.5 583.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 585.75 m 370.5 585.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 325.5 583.75 m 370.5 583.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 689.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 254.20 689.83 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 400.90 689.83 Td (2016 vs. 2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 503.90 689.83 Td (2015 vs. 2014) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 677.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 272.50 676.98 Td (Total Revenues) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 385.60 676.98 Td (Analysis of % Change) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 488.60 676.98 Td (Analysis of % Change) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 664.70 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 230.00 664.70 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 279.00 664.70 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 328.00 664.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.75 664.83 Td (Total) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 434.70 664.83 Td (Foreign) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 664.83 Td (Total) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.70 664.83 Td (Foreign) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 653.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 241.50 653.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 290.50 653.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 339.50 653.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.35 653.83 Td (Change) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 426.15 653.83 Td ( Exchange) Tj ET Q BT /F2 8.00 Tf ET BT /F2 5.20 Tf ET q 0 0 0 rg BT 463.49 657.46 Td (\(b\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 486.35 653.83 Td (Change) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 529.15 653.83 Td ( Exchange) Tj ET Q BT /F2 8.00 Tf ET BT /F2 5.20 Tf ET q 0 0 0 rg BT 566.49 657.46 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.32 Td (United States) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 230.00 640.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 241.10 640.32 Td (10,720) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.00 640.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.15 640.32 Td (8,188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 328.00 640.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.15 640.32 Td (7,716) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.30 640.32 Td (31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 640.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.25 640.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.30 640.32 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.65 640.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.25 640.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 627.32 Td (Europe) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.15 627.32 Td (4,215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.15 627.32 Td (3,491) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.15 627.32 Td (3,592) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.30 627.32 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 627.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.95 627.32 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.30 627.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.95 627.32 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.30 627.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.95 627.37 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 627.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 614.32 Td (Rest of the World) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.15 614.32 Td (3,964) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.15 614.32 Td (4,142) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.15 614.32 Td (3,459) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 398.95 614.32 Td (\(4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 614.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.95 614.32 Td (\(4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.30 614.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.30 614.32 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.65 614.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.95 614.37 Td (\(13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 614.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 601.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 61.77 605.85 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.65 601.32 Td (528) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.65 601.32 Td (739) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.15 601.32 Td (1,112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 393.95 601.32 Td (\(29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 601.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.30 601.32 Td (N/A) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.95 601.32 Td (\(34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.30 601.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.30 601.32 Td (N/A) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 588.32 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 230.00 588.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 241.10 588.32 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.00 588.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.10 588.32 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 328.00 588.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 339.10 588.32 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.30 588.32 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 588.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.95 588.32 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.30 588.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.30 588.32 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.65 588.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.95 588.37 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 588.32 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 572.65 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 58.50 572.65 Td (Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial or) Tj ET Q q 0 0 0 rg BT 425.11 572.65 Td (ganizations.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 563.05 Td (\(b\) ) Tj ET Q q 0 0 0 rg BT 58.50 563.05 Td (Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 541.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.42 541.45 Td (increase ) Tj ET Q q 0 0 0 rg BT 90.05 541.45 Td (in ) Tj ET Q q 0 0 0 rg BT 100.70 541.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 121.36 541.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 159.77 541.45 Td (in ) Tj ET Q q 0 0 0 rg BT 170.42 541.45 Td (2016 ) Tj ET Q q 0 0 0 rg BT 193.29 541.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 227.82 541.45 Td (from ) Tj ET Q q 0 0 0 rg BT 250.13 541.45 Td (higher ) Tj ET Q q 0 0 0 rg BT 278.55 541.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 313.08 541.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 327.62 541.45 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.05 541.45 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 362.43 541.45 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.76 541.45 Td ( ) Tj ET Q q 0 0 0 rg BT 393.64 541.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 410.95 541.45 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 447.06 541.45 Td (, ) Tj ET Q q 0 0 0 rg BT 452.43 541.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 488.62 541.45 Td (of) Tj ET Q q 0 0 0 rg BT 496.77 541.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 514.09 541.45 Td (by ) Tj ET Q q 0 0 0 rg BT 526.96 541.45 Td (the ) Tj ET Q q 0 0 0 rg BT 542.05 541.45 Td (full ) Tj ET Q q 0 0 0 rg BT 558.81 541.45 Td (year ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 529.45 Td (impact ) Tj ET Q q 0 0 0 rg BT 66.79 529.45 Td (of ) Tj ET Q q 0 0 0 rg BT 78.70 529.45 Td (the ) Tj ET Q q 0 0 0 rg BT 94.50 529.45 Td (expiration/transfer ) Tj ET Q q 0 0 0 rg BT 171.94 529.45 Td (of ) Tj ET Q q 0 0 0 rg BT 183.85 529.45 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 261.84 529.45 Td (rights ) Tj ET Q q 0 0 0 rg BT 288.20 529.45 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 299.56 529.45 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.22 529.45 Td ( ) Tj ET Q q 0 0 0 rg BT 334.80 529.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 352.82 529.45 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.81 529.45 Td (. ) Tj ET Q q 0 0 0 rg BT 393.10 529.45 Td (A) Tj ET Q q 0 0 0 rg BT 399.58 529.45 Td (verage ) Tj ET Q q 0 0 0 rg BT 429.81 529.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 451.17 529.45 Td (net ) Tj ET Q q 0 0 0 rg BT 466.97 529.45 Td (selling ) Tj ET Q q 0 0 0 rg BT 497.21 529.45 Td (prices ) Tj ET Q q 0 0 0 rg BT 524.67 529.45 Td (increased ) Tj ET Q q 0 0 0 rg BT 566.01 529.45 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 517.45 Td (approximately ) Tj ET Q q 0 0 0 rg BT 98.48 517.45 Td (5% ) Tj ET Q q 0 0 0 rg BT 116.53 517.45 Td (after ) Tj ET Q q 0 0 0 rg BT 139.56 517.45 Td (char) Tj ET Q q 0 0 0 rg BT 156.59 517.45 Td (ge-backs, ) Tj ET Q q 0 0 0 rg BT 199.34 517.45 Td (rebates ) Tj ET Q q 0 0 0 rg BT 232.38 517.45 Td (and ) Tj ET Q q 0 0 0 rg BT 251.53 517.45 Td (discounts. ) Tj ET Q q 0 0 0 rg BT 296.53 517.45 Td (Refer ) Tj ET Q q 0 0 0 rg BT 323.46 517.45 Td (to ) Tj ET Q q 0 0 0 rg BT 335.95 517.45 Td ("—Product ) Tj ET Q q 0 0 0 rg BT 385.86 517.45 Td (Revenues ) Tj ET Q q 0 0 0 rg BT 429.46 517.45 Td (Commentary" ) Tj ET Q q 0 0 0 rg BT 490.47 517.45 Td (below ) Tj ET Q q 0 0 0 rg BT 519.63 517.45 Td (for ) Tj ET Q q 0 0 0 rg BT 536.01 517.45 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 505.45 Td (information.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 481.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.81 481.45 Td (increase ) Tj ET Q q 0 0 0 rg BT 90.82 481.45 Td (in ) Tj ET Q q 0 0 0 rg BT 101.86 481.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 122.91 481.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 161.71 481.45 Td (in ) Tj ET Q q 0 0 0 rg BT 172.75 481.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 196.01 481.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 230.93 481.45 Td (from ) Tj ET Q q 0 0 0 rg BT 253.63 481.45 Td (the ) Tj ET Q q 0 0 0 rg BT 269.11 481.45 Td (launch ) Tj ET Q q 0 0 0 rg BT 299.02 481.45 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 310.61 481.45 Td (Opdivo ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.31 481.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 361.01 481.45 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.12 481.45 Td ( ) Tj ET Q q 0 0 0 rg BT 400.38 481.45 Td (and ) Tj ET Q q 0 0 0 rg BT 418.08 481.45 Td (higher ) Tj ET Q q 0 0 0 rg BT 446.89 481.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 481.81 481.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 496.73 481.45 Td (Eliquis ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.33 481.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 546.03 481.45 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 469.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 72.12 469.45 Td (of) Tj ET Q q 0 0 0 rg BT 80.27 469.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 97.50 469.45 Td (by ) Tj ET Q q 0 0 0 rg BT 110.30 469.45 Td (the ) Tj ET Q q 0 0 0 rg BT 125.31 469.45 Td (partial ) Tj ET Q q 0 0 0 rg BT 153.65 469.45 Td (year ) Tj ET Q q 0 0 0 rg BT 173.66 469.45 Td (impact ) Tj ET Q q 0 0 0 rg BT 203.66 469.45 Td (of ) Tj ET Q q 0 0 0 rg BT 214.79 469.45 Td (the ) Tj ET Q q 0 0 0 rg BT 229.80 469.45 Td (expiration/transfer ) Tj ET Q q 0 0 0 rg BT 306.46 469.45 Td (of ) Tj ET Q q 0 0 0 rg BT 317.59 469.45 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 394.79 469.45 Td (rights ) Tj ET Q q 0 0 0 rg BT 420.37 469.45 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 430.94 469.45 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.60 469.45 Td ( ) Tj ET Q q 0 0 0 rg BT 465.40 469.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 482.63 469.45 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.63 469.45 Td (. ) Tj ET Q q 0 0 0 rg BT 522.31 469.45 Td (A) Tj ET Q q 0 0 0 rg BT 528.79 469.45 Td (verage ) Tj ET Q q 0 0 0 rg BT 558.23 469.45 Td (U.S. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 457.45 Td (net ) Tj ET Q q 0 0 0 rg BT 50.72 457.45 Td (selling ) Tj ET Q q 0 0 0 rg BT 79.88 457.45 Td (prices ) Tj ET Q q 0 0 0 rg BT 106.26 457.45 Td (increased ) Tj ET Q q 0 0 0 rg BT 146.51 457.45 Td (by ) Tj ET Q q 0 0 0 rg BT 159.01 457.45 Td (approximately ) Tj ET Q q 0 0 0 rg BT 219.27 457.45 Td (3% ) Tj ET Q q 0 0 0 rg BT 235.10 457.45 Td (after ) Tj ET Q q 0 0 0 rg BT 255.92 457.45 Td (char) Tj ET Q q 0 0 0 rg BT 272.94 457.45 Td (ge-backs, ) Tj ET Q q 0 0 0 rg BT 313.48 457.45 Td (rebates ) Tj ET Q q 0 0 0 rg BT 344.30 457.45 Td (and ) Tj ET Q q 0 0 0 rg BT 361.23 457.45 Td (discounts. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 433.45 Td (The ) Tj ET Q q 0 0 0 rg BT 53.37 433.45 Td (increase ) Tj ET Q q 0 0 0 rg BT 87.94 433.45 Td (in ) Tj ET Q q 0 0 0 rg BT 97.54 433.45 Td (Europe ) Tj ET Q q 0 0 0 rg BT 128.24 433.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 165.59 433.45 Td (in ) Tj ET Q q 0 0 0 rg BT 175.19 433.45 Td (2016 ) Tj ET Q q 0 0 0 rg BT 197.01 433.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 230.49 433.45 Td (from ) Tj ET Q q 0 0 0 rg BT 251.75 433.45 Td (higher ) Tj ET Q q 0 0 0 rg BT 279.12 433.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 312.59 433.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 326.07 433.45 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.51 433.45 Td ( ) Tj ET Q q 0 0 0 rg BT 357.33 433.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 373.59 433.45 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.92 433.45 Td ( ) Tj ET Q q 0 0 0 rg BT 403.74 433.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 438.88 433.45 Td (of) Tj ET Q q 0 0 0 rg BT 447.03 433.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 463.29 433.45 Td (by ) Tj ET Q q 0 0 0 rg BT 475.11 433.45 Td (lower ) Tj ET Q q 0 0 0 rg BT 499.70 433.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 533.18 433.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 546.66 433.45 Td (Y) Tj ET Q q 0 0 0 rg BT 551.30 433.45 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.51 433.45 Td (.) Tj ET Q BT /F3 10.00 Tf ET BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 421.45 Td (Europe ) Tj ET Q q 0 0 0 rg BT 67.38 421.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 105.41 421.45 Td (in ) Tj ET Q q 0 0 0 rg BT 115.69 421.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 138.19 421.45 Td (included ) Tj ET Q q 0 0 0 rg BT 175.13 421.45 Td (the ) Tj ET Q q 0 0 0 rg BT 189.84 421.45 Td (recognition ) Tj ET Q q 0 0 0 rg BT 237.88 421.45 Td (of ) Tj ET Q q 0 0 0 rg BT 248.71 421.45 Td (approximately ) Tj ET Q q 0 0 0 rg BT 308.97 421.45 Td ($170 ) Tj ET Q q 0 0 0 rg BT 331.47 421.45 Td (million ) Tj ET Q q 0 0 0 rg BT 362.87 421.45 Td (of ) Tj ET Q q 0 0 0 rg BT 373.70 421.45 Td (previously ) Tj ET Q q 0 0 0 rg BT 418.41 421.45 Td (deferred ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 454.22 421.45 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.33 421.45 Td ( ) Tj ET Q q 0 0 0 rg BT 492.83 421.45 Td (revenue ) Tj ET Q q 0 0 0 rg BT 526.97 421.45 Td (in ) Tj ET Q q 0 0 0 rg BT 537.25 421.45 Td (France.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 397.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.00 397.45 Td (decrease ) Tj ET Q q 0 0 0 rg BT 90.86 397.45 Td (in ) Tj ET Q q 0 0 0 rg BT 101.09 397.45 Td (Europe ) Tj ET Q q 0 0 0 rg BT 132.42 397.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 170.40 397.45 Td (in ) Tj ET Q q 0 0 0 rg BT 180.63 397.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 203.08 397.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 237.19 397.45 Td (from ) Tj ET Q q 0 0 0 rg BT 259.08 397.45 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 309.28 397.45 Td (foreign ) Tj ET Q q 0 0 0 rg BT 340.61 397.45 Td (exchange ) Tj ET Q q 0 0 0 rg BT 380.81 397.45 Td (and ) Tj ET Q q 0 0 0 rg BT 397.70 397.45 Td (the ) Tj ET Q q 0 0 0 rg BT 412.37 397.45 Td (expiration ) Tj ET Q q 0 0 0 rg BT 455.36 397.45 Td (of ) Tj ET Q q 0 0 0 rg BT 466.14 397.45 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 543.00 397.45 Td (rights ) Tj ET Q q 0 0 0 rg BT 568.23 397.45 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 385.45 Td (Abilify* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.03 385.45 Td (in ) Tj ET Q q 0 0 0 rg BT 80.17 385.45 Td (the ) Tj ET Q q 0 0 0 rg BT 94.76 385.45 Td (EU ) Tj ET Q q 0 0 0 rg BT 110.46 385.45 Td (in ) Tj ET Q q 0 0 0 rg BT 120.60 385.45 Td (June ) Tj ET Q q 0 0 0 rg BT 141.30 385.45 Td (2014 ) Tj ET Q q 0 0 0 rg BT 163.67 385.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 199.36 385.45 Td (of) Tj ET Q q 0 0 0 rg BT 207.51 385.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 224.32 385.45 Td (by ) Tj ET Q q 0 0 0 rg BT 236.68 385.45 Td (the ) Tj ET Q q 0 0 0 rg BT 251.27 385.45 Td (launch ) Tj ET Q q 0 0 0 rg BT 280.29 385.45 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 290.99 385.45 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.10 385.45 Td ( ) Tj ET Q q 0 0 0 rg BT 329.47 385.45 Td (in ) Tj ET Q q 0 0 0 rg BT 339.61 385.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 369.18 385.45 Td (EU ) Tj ET Q q 0 0 0 rg BT 384.88 385.45 Td (countries ) Tj ET Q q 0 0 0 rg BT 423.91 385.45 Td (in ) Tj ET Q q 0 0 0 rg BT 434.05 385.45 Td (the ) Tj ET Q q 0 0 0 rg BT 448.64 385.45 Td (third ) Tj ET Q q 0 0 0 rg BT 469.89 385.45 Td (quarter ) Tj ET Q q 0 0 0 rg BT 500.58 385.45 Td (of ) Tj ET Q q 0 0 0 rg BT 511.27 385.45 Td (2014 ) Tj ET Q q 0 0 0 rg BT 533.64 385.45 Td (and ) Tj ET Q q 0 0 0 rg BT 550.45 385.45 Td (higher ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 373.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 70.00 373.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 84.01 373.45 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 112.35 373.45 Td (. ) Tj ET Q q 0 0 0 rg BT 117.20 373.45 Td (Europe ) Tj ET Q q 0 0 0 rg BT 148.42 373.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 186.31 373.45 Td (in ) Tj ET Q q 0 0 0 rg BT 196.43 373.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 218.78 373.45 Td (were ) Tj ET Q q 0 0 0 rg BT 240.56 373.45 Td (also ) Tj ET Q q 0 0 0 rg BT 259.02 373.45 Td (impacted ) Tj ET Q q 0 0 0 rg BT 298.02 373.45 Td (by ) Tj ET Q q 0 0 0 rg BT 310.37 373.45 Td (the ) Tj ET Q q 0 0 0 rg BT 324.93 373.45 Td (recognition ) Tj ET Q q 0 0 0 rg BT 372.82 373.45 Td (of ) Tj ET Q q 0 0 0 rg BT 383.50 373.45 Td (previously ) Tj ET Q q 0 0 0 rg BT 428.07 373.45 Td (deferred ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 463.72 373.45 Td (Daklinza ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.18 373.45 Td (revenue ) Tj ET Q q 0 0 0 rg BT 536.17 373.45 Td (in ) Tj ET Q q 0 0 0 rg BT 546.30 373.45 Td (France.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 349.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.83 349.45 Td (decrease ) Tj ET Q q 0 0 0 rg BT 92.53 349.45 Td (in ) Tj ET Q q 0 0 0 rg BT 103.59 349.45 Td (Rest ) Tj ET Q q 0 0 0 rg BT 124.66 349.45 Td (of ) Tj ET Q q 0 0 0 rg BT 136.27 349.45 Td (the ) Tj ET Q q 0 0 0 rg BT 151.54 349.45 Td (W) Tj ET Q q 0 0 0 rg BT 160.18 349.45 Td (orld ) Tj ET Q q 0 0 0 rg BT 179.57 349.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 218.39 349.45 Td (in ) Tj ET Q q 0 0 0 rg BT 229.45 349.45 Td (2016 ) Tj ET Q q 0 0 0 rg BT 252.74 349.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 287.68 349.45 Td (from ) Tj ET Q q 0 0 0 rg BT 310.40 349.45 Td (increased ) Tj ET Q q 0 0 0 rg BT 351.44 349.45 Td (competition ) Tj ET Q q 0 0 0 rg BT 402.50 349.45 Td (for ) Tj ET Q q 0 0 0 rg BT 417.44 349.45 Td (the ) Tj ET Q q 0 0 0 rg BT 432.94 349.45 Td (Hepatitis ) Tj ET Q q 0 0 0 rg BT 472.33 349.45 Td (C ) Tj ET Q q 0 0 0 rg BT 482.29 349.45 Td (Franchise ) Tj ET Q q 0 0 0 rg BT 524.45 349.45 Td (in ) Tj ET Q q 0 0 0 rg BT 535.51 349.45 Td (Japan ) Tj ET Q q 0 0 0 rg BT 561.57 349.45 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 337.45 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 86.25 337.45 Td (foreign ) Tj ET Q q 0 0 0 rg BT 117.63 337.45 Td (exchange ) Tj ET Q q 0 0 0 rg BT 157.88 337.45 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 200.93 337.45 Td (Latin ) Tj ET Q q 0 0 0 rg BT 223.98 337.45 Td (America\) ) Tj ET Q q 0 0 0 rg BT 264.23 337.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 300.05 337.45 Td (of) Tj ET Q q 0 0 0 rg BT 308.20 337.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 325.14 337.45 Td (by ) Tj ET Q q 0 0 0 rg BT 337.64 337.45 Td (higher ) Tj ET Q q 0 0 0 rg BT 365.69 337.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 399.84 337.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 414.00 337.45 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.44 337.45 Td ( ) Tj ET Q q 0 0 0 rg BT 445.94 337.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 462.88 337.45 Td (Eliquis.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 313.45 Td (The ) Tj ET Q q 0 0 0 rg BT 53.98 313.45 Td (increase ) Tj ET Q q 0 0 0 rg BT 89.16 313.45 Td (in ) Tj ET Q q 0 0 0 rg BT 99.37 313.45 Td (Rest ) Tj ET Q q 0 0 0 rg BT 119.58 313.45 Td (of ) Tj ET Q q 0 0 0 rg BT 130.35 313.45 Td (the ) Tj ET Q q 0 0 0 rg BT 144.82 313.45 Td (W) Tj ET Q q 0 0 0 rg BT 153.46 313.45 Td (orld ) Tj ET Q q 0 0 0 rg BT 172.00 313.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 209.96 313.45 Td (in ) Tj ET Q q 0 0 0 rg BT 220.17 313.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 242.61 313.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 276.69 313.45 Td (from ) Tj ET Q q 0 0 0 rg BT 298.56 313.45 Td (the ) Tj ET Q q 0 0 0 rg BT 313.21 313.45 Td (launch ) Tj ET Q q 0 0 0 rg BT 342.30 313.45 Td (of ) Tj ET Q q 0 0 0 rg BT 353.06 313.45 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 367.71 313.45 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.82 313.45 Td ( ) Tj ET Q q 0 0 0 rg BT 406.25 313.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 423.12 313.45 Td (Sunvepra) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.89 313.45 Td ( ) Tj ET Q q 0 0 0 rg BT 463.32 313.45 Td (dual ) Tj ET Q q 0 0 0 rg BT 482.97 313.45 Td (regimen ) Tj ET Q q 0 0 0 rg BT 518.16 313.45 Td (in ) Tj ET Q q 0 0 0 rg BT 528.37 313.45 Td (Japan ) Tj ET Q q 0 0 0 rg BT 553.57 313.45 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 313.45 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 301.45 Td (third ) Tj ET Q q 0 0 0 rg BT 57.39 301.45 Td (quarter ) Tj ET Q q 0 0 0 rg BT 88.20 301.45 Td (of ) Tj ET Q q 0 0 0 rg BT 99.03 301.45 Td (2014 ) Tj ET Q q 0 0 0 rg BT 121.53 301.45 Td (and ) Tj ET Q q 0 0 0 rg BT 138.47 301.45 Td (higher ) Tj ET Q q 0 0 0 rg BT 166.52 301.45 Td (demand ) Tj ET Q q 0 0 0 rg BT 200.67 301.45 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 214.83 301.45 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 243.17 301.45 Td (, ) Tj ET Q q 0 0 0 rg BT 248.17 301.45 Td (partially ) Tj ET Q q 0 0 0 rg BT 283.99 301.45 Td (of) Tj ET Q q 0 0 0 rg BT 292.14 301.45 Td (fset ) Tj ET Q q 0 0 0 rg BT 309.08 301.45 Td (by ) Tj ET Q q 0 0 0 rg BT 321.58 301.45 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 371.83 301.45 Td (foreign ) Tj ET Q q 0 0 0 rg BT 403.21 301.45 Td (exchange ) Tj ET Q q 0 0 0 rg BT 443.46 301.45 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 486.50 301.45 Td (in ) Tj ET Q q 0 0 0 rg BT 496.78 301.45 Td (Japan\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 277.45 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 277.45 Td (decrease ) Tj ET Q q 0 0 0 rg BT 90.97 277.45 Td (in ) Tj ET Q q 0 0 0 rg BT 101.26 277.45 Td (Other ) Tj ET Q q 0 0 0 rg BT 126.53 277.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 164.58 277.45 Td (in ) Tj ET Q q 0 0 0 rg BT 174.86 277.45 Td (2016 ) Tj ET Q q 0 0 0 rg BT 197.37 277.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 231.53 277.45 Td (from ) Tj ET Q q 0 0 0 rg BT 253.47 277.45 Td (the ) Tj ET Q q 0 0 0 rg BT 268.20 277.45 Td (expiration ) Tj ET Q q 0 0 0 rg BT 311.25 277.45 Td (of ) Tj ET Q q 0 0 0 rg BT 322.08 277.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 351.79 277.45 Td (supply ) Tj ET Q q 0 0 0 rg BT 380.97 277.45 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 439.65 277.45 Td (The ) Tj ET Q q 0 0 0 rg BT 457.71 277.45 Td (decrease ) Tj ET Q q 0 0 0 rg BT 494.63 277.45 Td (in ) Tj ET Q q 0 0 0 rg BT 504.91 277.45 Td (Other ) Tj ET Q q 0 0 0 rg BT 530.19 277.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 568.23 277.45 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 265.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 57.32 265.45 Td (resulted ) Tj ET Q q 0 0 0 rg BT 90.29 265.45 Td (from ) Tj ET Q q 0 0 0 rg BT 111.04 265.45 Td (the ) Tj ET Q q 0 0 0 rg BT 124.57 265.45 Td (expiration/transfer ) Tj ET Q q 0 0 0 rg BT 199.75 265.45 Td (of ) Tj ET Q q 0 0 0 rg BT 209.39 265.45 Td (certain ) Tj ET Q q 0 0 0 rg BT 237.91 265.45 Td (licensing ) Tj ET Q q 0 0 0 rg BT 275.33 265.45 Td (and ) Tj ET Q q 0 0 0 rg BT 291.09 265.45 Td (royalty ) Tj ET Q q 0 0 0 rg BT 320.73 265.45 Td (rights. ) Tj ET Q q 0 0 0 rg BT 347.32 265.45 Td (Refer ) Tj ET Q q 0 0 0 rg BT 370.84 265.45 Td (to ) Tj ET Q q 0 0 0 rg BT 379.94 265.45 Td ("Item ) Tj ET Q q 0 0 0 rg BT 403.66 265.45 Td (8. ) Tj ET Q q 0 0 0 rg BT 412.48 265.45 Td (Financial ) Tj ET Q q 0 0 0 rg BT 451.00 265.45 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.64 265.45 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 530.64 265.45 Td (. ) Tj ET Q q 0 0 0 rg BT 534.17 265.45 Td (Alliances" ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 253.45 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 253.45 Td (further ) Tj ET Q q 0 0 0 rg BT 79.87 253.45 Td (discussion ) Tj ET Q q 0 0 0 rg BT 124.04 253.45 Td (of ) Tj ET Q q 0 0 0 rg BT 134.87 253.45 Td (the ) Tj ET Q q 0 0 0 rg BT 149.58 253.45 Td (alliances.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 229.45 Td (No ) Tj ET Q q 0 0 0 rg BT 50.13 229.45 Td (single ) Tj ET Q q 0 0 0 rg BT 75.93 229.45 Td (country ) Tj ET Q q 0 0 0 rg BT 108.39 229.45 Td (outside ) Tj ET Q q 0 0 0 rg BT 139.19 229.45 Td (the ) Tj ET Q q 0 0 0 rg BT 153.32 229.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 173.02 229.45 Td (contributed ) Tj ET Q q 0 0 0 rg BT 220.48 229.45 Td (more ) Tj ET Q q 0 0 0 rg BT 242.94 229.45 Td (than ) Tj ET Q q 0 0 0 rg BT 262.07 229.45 Td (10% ) Tj ET Q q 0 0 0 rg BT 282.31 229.45 Td (of ) Tj ET Q q 0 0 0 rg BT 292.55 229.45 Td (total ) Tj ET Q q 0 0 0 rg BT 312.24 229.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 349.69 229.45 Td (in ) Tj ET Q q 0 0 0 rg BT 359.38 229.45 Td (2016, ) Tj ET Q q 0 0 0 rg BT 383.79 229.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 405.71 229.45 Td (or ) Tj ET Q q 0 0 0 rg BT 415.95 229.45 Td (2014 ) Tj ET Q q 0 0 0 rg BT 437.86 229.45 Td (except ) Tj ET Q q 0 0 0 rg BT 465.87 229.45 Td (for ) Tj ET Q q 0 0 0 rg BT 479.44 229.45 Td (Japan ) Tj ET Q q 0 0 0 rg BT 504.12 229.45 Td (which ) Tj ET Q q 0 0 0 rg BT 530.48 229.45 Td (contributed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 217.45 Td (10% ) Tj ET Q q 0 0 0 rg BT 56.83 217.45 Td (of ) Tj ET Q q 0 0 0 rg BT 67.66 217.45 Td (total ) Tj ET Q q 0 0 0 rg BT 87.93 217.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 125.97 217.45 Td (in ) Tj ET Q q 0 0 0 rg BT 136.25 217.45 Td (2015.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 193.45 Td (Gross-to-Net ) Tj ET Q q 0 0 0 rg BT 90.90 193.45 Td (Adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 169.45 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 169.45 Td (e ) Tj ET Q q 0 0 0 rg BT 51.25 169.45 Td (recognize ) Tj ET Q q 0 0 0 rg BT 92.29 169.45 Td (revenue ) Tj ET Q q 0 0 0 rg BT 126.11 169.45 Td (net ) Tj ET Q q 0 0 0 rg BT 140.50 169.45 Td (of ) Tj ET Q q 0 0 0 rg BT 151.01 169.45 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 200.95 169.45 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 250.90 169.45 Td (that ) Tj ET Q q 0 0 0 rg BT 268.07 169.45 Td (are ) Tj ET Q q 0 0 0 rg BT 282.45 169.45 Td (further ) Tj ET Q q 0 0 0 rg BT 311.83 169.45 Td (described ) Tj ET Q q 0 0 0 rg BT 352.33 169.45 Td (in ) Tj ET Q q 0 0 0 rg BT 362.28 169.45 Td ("—Critical ) Tj ET Q q 0 0 0 rg BT 408.05 169.45 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 456.88 169.45 Td (Policies". ) Tj ET Q q 0 0 0 rg BT 497.30 169.45 Td (Our ) Tj ET Q q 0 0 0 rg BT 515.03 169.45 Td (share ) Tj ET Q q 0 0 0 rg BT 538.30 169.45 Td (of ) Tj ET Q q 0 0 0 rg BT 548.81 169.45 Td (certain ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 157.45 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.66 157.45 Td ( ) Tj ET Q q 0 0 0 rg BT 70.23 157.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 87.23 157.45 Td (Atripla* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 123.14 157.45 Td (revenues ) Tj ET Q q 0 0 0 rg BT 161.24 157.45 Td (is ) Tj ET Q q 0 0 0 rg BT 170.48 157.45 Td (reflected ) Tj ET Q q 0 0 0 rg BT 208.02 157.45 Td (net ) Tj ET Q q 0 0 0 rg BT 222.80 157.45 Td (of ) Tj ET Q q 0 0 0 rg BT 233.70 157.45 Td (all ) Tj ET Q q 0 0 0 rg BT 246.26 157.45 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 296.60 157.45 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 346.94 157.45 Td (in ) Tj ET Q q 0 0 0 rg BT 357.28 157.45 Td (alliance ) Tj ET Q q 0 0 0 rg BT 390.94 157.45 Td (and ) Tj ET Q q 0 0 0 rg BT 407.94 157.45 Td (other ) Tj ET Q q 0 0 0 rg BT 431.06 157.45 Td (revenues. ) Tj ET Q q 0 0 0 rg BT 471.10 157.45 Td (Although ) Tj ET Q q 0 0 0 rg BT 511.44 157.45 Td (not ) Tj ET Q q 0 0 0 rg BT 526.79 157.45 Td (presented ) Tj ET Q q 0 0 0 rg BT 567.67 157.45 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 145.45 Td (a ) Tj ET Q q 0 0 0 rg BT 42.13 145.45 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 91.60 145.45 Td (adjustment ) Tj ET Q q 0 0 0 rg BT 137.17 145.45 Td (in ) Tj ET Q q 0 0 0 rg BT 146.64 145.45 Td (the ) Tj ET Q q 0 0 0 rg BT 160.56 145.45 Td (tables ) Tj ET Q q 0 0 0 rg BT 185.58 145.45 Td (below) Tj ET Q q 0 0 0 rg BT 209.36 145.45 Td (, ) Tj ET Q q 0 0 0 rg BT 213.56 145.45 Td (our ) Tj ET Q q 0 0 0 rg BT 228.58 145.45 Td (share ) Tj ET Q q 0 0 0 rg BT 251.38 145.45 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 261.40 145.45 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.06 145.45 Td ( ) Tj ET Q q 0 0 0 rg BT 294.75 145.45 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 310.89 145.45 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.22 145.45 Td ( ) Tj ET Q q 0 0 0 rg BT 345.92 145.45 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 395.38 145.45 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 444.85 145.45 Td (were ) Tj ET Q q 0 0 0 rg BT 465.97 145.45 Td (approximately ) Tj ET Q q 0 0 0 rg BT 525.42 145.45 Td ($460 ) Tj ET Q q 0 0 0 rg BT 547.12 145.45 Td (million ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 133.45 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.24 133.45 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.24 133.45 Td (, ) Tj ET Q q 0 0 0 rg BT 71.20 133.45 Td ($1.1 ) Tj ET Q q 0 0 0 rg BT 91.17 133.45 Td (billion ) Tj ET Q q 0 0 0 rg BT 119.74 133.45 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 129.98 133.45 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 149.98 133.45 Td ( ) Tj ET Q q 0 0 0 rg BT 152.44 133.45 Td (and ) Tj ET Q q 0 0 0 rg BT 169.35 133.45 Td ($1.6 ) Tj ET Q q 0 0 0 rg BT 189.31 133.45 Td (billion ) Tj ET Q q 0 0 0 rg BT 217.88 133.45 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.12 133.45 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.12 133.45 Td (. ) Tj ET Q q 0 0 0 rg BT 252.91 133.45 Td (These ) Tj ET Q q 0 0 0 rg BT 279.25 133.45 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 329.48 133.45 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 379.71 133.45 Td (decreased ) Tj ET Q q 0 0 0 rg BT 421.59 133.45 Td (in ) Tj ET Q q 0 0 0 rg BT 431.83 133.45 Td (2016 ) Tj ET Q q 0 0 0 rg BT 454.29 133.45 Td (and ) Tj ET Q q 0 0 0 rg BT 471.19 133.45 Td (2015 ) Tj ET Q q 0 0 0 rg BT 493.66 133.45 Td (due ) Tj ET Q q 0 0 0 rg BT 510.56 133.45 Td (to ) Tj ET Q q 0 0 0 rg BT 520.80 133.45 Td (the ) Tj ET Q q 0 0 0 rg BT 535.48 133.45 Td (expiration ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 121.45 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 121.45 Td (our ) Tj ET Q q 0 0 0 rg BT 62.66 121.45 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 82.94 121.45 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 159.85 121.45 Td (rights ) Tj ET Q q 0 0 0 rg BT 185.13 121.45 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 195.41 121.45 Td (Abilify* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.57 121.45 Td (in ) Tj ET Q q 0 0 0 rg BT 239.30 121.45 Td (April ) Tj ET Q q 0 0 0 rg BT 262.90 121.45 Td (2015.) Tj ET Q endstream endobj 65 0 obj <> endobj 66 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 749.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 92.65 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 109.58 749.10 Td (ending ) Tj ET Q q 0 0 0 rg BT 139.30 749.10 Td (reserve ) Tj ET Q q 0 0 0 rg BT 170.67 749.10 Td (balances ) Tj ET Q q 0 0 0 rg BT 207.59 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 221.75 749.10 Td (each ) Tj ET Q q 0 0 0 rg BT 242.57 749.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 287.28 749.10 Td (category ) Tj ET Q q 0 0 0 rg BT 324.20 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 335.03 749.10 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 385.30 749.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 435.58 749.10 Td (were ) Tj ET Q q 0 0 0 rg BT 457.50 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 468.33 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 709.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 709.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 709.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 709.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 709.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 709.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 709.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 709.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 709.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 685.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 685.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 685.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 685.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 685.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 685.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 685.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 685.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 685.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 661.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 661.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 661.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 661.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 661.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 661.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 661.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 661.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 661.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 637.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 637.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 637.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 637.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 637.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 637.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 637.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 637.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 637.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 613.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 613.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 613.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 613.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 613.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 613.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 613.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 613.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 613.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 589.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 589.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 589.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 589.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 589.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 565.60 220.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 256.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 260.50 565.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 336.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 565.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 416.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 565.60 76.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 565.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 565.60 76.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 709.6 m 336.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 709.6 m 416.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 709.6 m 496.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 709.6 m 576.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 709.6 m 416.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 709.6 m 496.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 709.6 m 576.5 709.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 637.6 m 336.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 637.6 m 416.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 637.6 m 496.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 637.6 m 576.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 565.6 m 336.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 565.6 m 416.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 565.6 m 496.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 565.6 m 576.5 565.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 554.6 m 336.5 554.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 260.5 552.6 m 336.5 552.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 554.6 m 416.5 554.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 552.6 m 416.5 552.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 554.6 m 496.5 554.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 552.6 m 496.5 552.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 554.6 m 576.5 554.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 552.6 m 576.5 552.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 713.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 266.30 721.83 Td (Charge-Backs and) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 271.65 713.83 Td (Cash Discounts) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 354.55 721.83 Td (Medicaid and) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 347.30 713.83 Td (Medicare Rebates) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 432.30 729.83 Td (Other Rebates,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 425.55 721.83 Td (Returns, Discounts) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 428.95 713.83 Td (and Adjustments) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 529.25 713.83 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 700.22 Td (Balance at January 1, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 700.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 700.22 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.00 700.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.65 700.22 Td (267) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.00 700.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 700.22 Td (584) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.00 700.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 700.22 Td (907) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 688.22 Td (Provision related to sale made in:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 676.22 Td (Current period) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.15 676.22 Td (1,043) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.65 676.22 Td (878) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 676.22 Td (1,315) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 676.22 Td (3,236) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 664.22 Td (Prior period) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 664.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.30 664.22 Td (\(19) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 664.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 664.22 Td (\(96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 664.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 664.22 Td (\(115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 664.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 652.22 Td (Returns and payments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 306.80 652.22 Td (\(1,002) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.65 652.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.30 652.22 Td (\(688) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 652.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 652.22 Td (\(867) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 652.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 652.22 Td (\(2,557) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 652.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.22 Td (Foreign currency translation and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 640.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 640.22 Td (\(4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 640.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 640.22 Td (\(46) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 640.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 640.22 Td (\(50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 640.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 628.22 Td (Balance at December 31, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 628.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 628.22 Td (97) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.00 628.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.65 628.22 Td (434) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.00 628.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 628.22 Td (890) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.00 628.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 628.22 Td (1,421) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 616.22 Td (Provision related to sale made in:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 604.22 Td (Current period) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.15 604.22 Td (1,582) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.15 604.22 Td (1,438) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 604.22 Td (1,797) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 604.22 Td (4,817) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 592.22 Td (Prior period) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 592.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.30 592.22 Td (\(56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 592.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 592.22 Td (\(99) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 592.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 592.22 Td (\(155) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 592.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 580.22 Td (Returns and payments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 306.80 580.22 Td (\(1,553) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.65 580.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.80 580.22 Td (\(1,296) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 580.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.80 580.22 Td (\(1,397) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 580.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 580.22 Td (\(4,246) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 580.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 568.22 Td (Foreign currency translation and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.65 568.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 402.65 568.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 568.22 Td (\(31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 568.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 568.22 Td (\(31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 568.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 556.22 Td (Balance at December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 556.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.65 556.22 Td (126) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.00 556.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.65 556.22 Td (520) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.00 556.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 556.22 Td (1,160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.00 556.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 556.22 Td (1,806) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 530.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.57 530.10 Td (reconciliation ) Tj ET Q q 0 0 0 rg BT 112.56 530.10 Td (of ) Tj ET Q q 0 0 0 rg BT 123.91 530.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 148.05 530.10 Td (product ) Tj ET Q q 0 0 0 rg BT 181.61 530.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 204.07 530.10 Td (to ) Tj ET Q q 0 0 0 rg BT 214.87 530.10 Td (net ) Tj ET Q q 0 0 0 rg BT 230.11 530.10 Td (product ) Tj ET Q q 0 0 0 rg BT 263.67 530.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 286.13 530.10 Td (by ) Tj ET Q q 0 0 0 rg BT 299.15 530.10 Td (each ) Tj ET Q q 0 0 0 rg BT 320.49 530.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 365.72 530.10 Td (category ) Tj ET Q q 0 0 0 rg BT 403.16 530.10 Td (of ) Tj ET Q q 0 0 0 rg BT 414.51 530.10 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 465.30 530.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 516.10 530.10 Td (was ) Tj ET Q q 0 0 0 rg BT 534.67 530.10 Td (as ) Tj ET Q q 0 0 0 rg BT 546.02 530.10 Td (follows ) Tj ET Q q 0 0 0 rg BT 578.52 530.10 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 518.10 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 81.26 518.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 114.85 518.10 Td (and ) Tj ET Q q 0 0 0 rg BT 131.79 518.10 Td (other ) Tj ET Q q 0 0 0 rg BT 154.84 518.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 192.88 518.10 Td (such ) Tj ET Q q 0 0 0 rg BT 213.71 518.10 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 224.54 518.10 Td (Abilify* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 258.70 518.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 275.63 518.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.97 518.10 Td (\):) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 483.60 277.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 483.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 483.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 483.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 483.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 483.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 483.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 483.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 467.50 483.60 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 483.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 483.60 52.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 459.60 277.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 459.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 459.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 459.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 459.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 459.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 459.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 459.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 467.50 459.60 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 459.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 459.60 52.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 435.60 277.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 435.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 435.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 435.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 435.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 435.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 435.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 435.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 467.50 435.60 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 435.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 435.60 52.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 411.60 277.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 411.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 411.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 411.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 411.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 411.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 411.60 46.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 411.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 467.50 411.60 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 411.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 411.60 52.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 495.6 m 363.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 363.5 495.6 m 367.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 495.6 m 413.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 495.6 m 417.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 495.6 m 463.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 495.6 m 520.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 520.5 495.6 m 524.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 495.6 m 576.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 483.6 m 363.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 483.6 m 413.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 483.6 m 463.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 483.6 m 520.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 483.6 m 576.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 483.6 m 520.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 483.6 m 576.5 483.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 423.6 m 363.5 423.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 423.6 m 413.5 423.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 423.6 m 463.5 423.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 423.6 m 520.5 423.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 423.6 m 576.5 423.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 411.6 m 363.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 411.6 m 413.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 411.6 m 463.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 411.6 m 520.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 411.6 m 576.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 400.6 m 363.5 400.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 398.6 m 363.5 398.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 400.6 m 413.5 400.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 398.6 m 413.5 398.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 400.6 m 463.5 400.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 398.6 m 463.5 398.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 400.6 m 520.5 400.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 467.5 398.6 m 520.5 398.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 400.6 m 576.5 400.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 398.6 m 576.5 398.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 499.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 345.70 499.68 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 503.35 499.68 Td (% Change) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 487.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 332.00 487.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 382.00 487.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 432.00 487.68 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 470.90 487.68 Td (2016 vs. 2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.40 487.68 Td (2015 vs. 2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 474.33 Td (Gross product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.00 474.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.10 474.22 Td (22,364) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 474.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 474.22 Td (17,166) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.00 474.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.10 474.22 Td (13,793) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 474.22 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 474.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 474.22 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 474.22 Td (%) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 462.33 Td (Gross-to-Net Adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 450.22 Td (Charge-backs and cash discounts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.80 450.22 Td (\(1,582) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 450.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.80 450.22 Td (\(1,043) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.65 450.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.30 450.22 Td (\(755) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.65 450.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 450.22 Td (52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 450.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 450.22 Td (38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 450.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 438.22 Td (Medicaid and Medicare rebates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.80 438.22 Td (\(1,382) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 438.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.30 438.22 Td (\(859) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.65 438.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.30 438.22 Td (\(551) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.65 438.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 438.22 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 438.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 438.22 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 438.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 426.22 Td (Other rebates, returns, discounts and adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.80 426.22 Td (\(1,698) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 426.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.80 426.22 Td (\(1,219) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.65 426.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.30 426.22 Td (\(827) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.65 426.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 426.22 Td (39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 426.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 426.22 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 426.22 Td (%) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 414.33 Td (Total Gross-to-Net Adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.80 414.22 Td (\(4,662) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 414.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.80 414.22 Td (\(3,121) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.65 414.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.80 414.22 Td (\(2,133) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.65 414.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 414.22 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 414.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 414.22 Td (46) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 414.22 Td (%) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 402.33 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.00 402.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.10 402.22 Td (17,702) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 402.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 402.22 Td (14,045) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.00 402.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.10 402.22 Td (11,660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 402.22 Td (26) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.65 402.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 402.22 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 402.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 382.10 Td (Changes ) Tj ET Q q 0 0 0 rg BT 72.10 382.10 Td (in ) Tj ET Q q 0 0 0 rg BT 81.54 382.10 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 130.97 382.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 180.41 382.10 Td (are ) Tj ET Q q 0 0 0 rg BT 194.27 382.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 233.15 382.10 Td (a ) Tj ET Q q 0 0 0 rg BT 239.25 382.10 Td (function ) Tj ET Q q 0 0 0 rg BT 274.23 382.10 Td (of ) Tj ET Q q 0 0 0 rg BT 284.23 382.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 318.09 382.10 Td (in ) Tj ET Q q 0 0 0 rg BT 327.53 382.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 348.63 382.10 Td (volume ) Tj ET Q q 0 0 0 rg BT 380.29 382.10 Td (and ) Tj ET Q q 0 0 0 rg BT 396.39 382.10 Td (payer ) Tj ET Q q 0 0 0 rg BT 420.26 382.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 453.02 382.10 Td (mix, ) Tj ET Q q 0 0 0 rg BT 472.73 382.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 518.81 382.10 Td (and ) Tj ET Q q 0 0 0 rg BT 534.91 382.10 Td (legislative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 370.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 77.08 370.10 Td (and ) Tj ET Q q 0 0 0 rg BT 94.81 370.10 Td (rebates. ) Tj ET Q q 0 0 0 rg BT 128.92 370.10 Td (Gross-to-net ) Tj ET Q q 0 0 0 rg BT 182.21 370.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 233.28 370.10 Td (have ) Tj ET Q q 0 0 0 rg BT 255.46 370.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 296.51 370.10 Td (at ) Tj ET Q q 0 0 0 rg BT 307.02 370.10 Td (a ) Tj ET Q q 0 0 0 rg BT 314.76 370.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 343.60 370.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 361.89 370.10 Td (than ) Tj ET Q q 0 0 0 rg BT 382.40 370.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 406.81 370.10 Td (product ) Tj ET Q q 0 0 0 rg BT 440.65 370.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 463.39 370.10 Td (in ) Tj ET Q q 0 0 0 rg BT 474.47 370.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 497.76 370.10 Td (and ) Tj ET Q q 0 0 0 rg BT 515.50 370.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 538.80 370.10 Td (primarily ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 358.10 Td (because ) Tj ET Q q 0 0 0 rg BT 70.15 358.10 Td (of ) Tj ET Q q 0 0 0 rg BT 80.98 358.10 Td (the ) Tj ET Q q 0 0 0 rg BT 95.69 358.10 Td (increasing ) Tj ET Q q 0 0 0 rg BT 139.29 358.10 Td (mix ) Tj ET Q q 0 0 0 rg BT 157.34 358.10 Td (of ) Tj ET Q q 0 0 0 rg BT 168.17 358.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 188.46 358.10 Td (versus ) Tj ET Q q 0 0 0 rg BT 216.51 358.10 Td (international ) Tj ET Q q 0 0 0 rg BT 269.54 358.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 293.16 358.10 Td (product ) Tj ET Q q 0 0 0 rg BT 326.21 358.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 348.14 358.10 Td (where ) Tj ET Q q 0 0 0 rg BT 375.07 358.10 Td (the ) Tj ET Q q 0 0 0 rg BT 389.79 358.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 440.06 358.10 Td (are ) Tj ET Q q 0 0 0 rg BT 454.77 358.10 Td (much ) Tj ET Q q 0 0 0 rg BT 479.49 358.10 Td (higher) Tj ET Q q 0 0 0 rg BT 504.48 358.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 344.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 344.10 Td (Char) Tj ET Q q 0 0 0 rg BT 91.26 344.10 Td (ge-backs ) Tj ET Q q 0 0 0 rg BT 128.98 344.10 Td (and ) Tj ET Q q 0 0 0 rg BT 145.60 344.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 165.56 344.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 205.52 344.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 245.46 344.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.42 344.10 Td (both ) Tj ET Q q 0 0 0 rg BT 275.39 344.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 307.01 344.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 346.41 344.10 Td (due ) Tj ET Q q 0 0 0 rg BT 363.03 344.10 Td (to ) Tj ET Q q 0 0 0 rg BT 372.99 344.10 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 400.73 344.10 Td (Eliquis ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.25 344.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 447.87 344.10 Td (Opdivo ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.49 344.10 Td (product ) Tj ET Q q 0 0 0 rg BT 512.22 344.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 533.85 344.10 Td (in ) Tj ET Q q 0 0 0 rg BT 543.81 344.10 Td (the ) Tj ET Q q 0 0 0 rg BT 558.21 344.10 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 331.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 331.10 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 112.26 331.10 Td (and ) Tj ET Q q 0 0 0 rg BT 129.20 331.10 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 169.46 331.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 200.27 331.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 240.53 331.10 Td (in ) Tj ET Q q 0 0 0 rg BT 250.80 331.10 Td (both ) Tj ET Q q 0 0 0 rg BT 271.08 331.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 303.02 331.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 342.73 331.10 Td (due ) Tj ET Q q 0 0 0 rg BT 359.67 331.10 Td (to ) Tj ET Q q 0 0 0 rg BT 369.95 331.10 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 398.00 331.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.33 331.10 Td ( ) Tj ET Q q 0 0 0 rg BT 428.83 331.10 Td (product ) Tj ET Q q 0 0 0 rg BT 461.88 331.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 483.82 331.10 Td (in ) Tj ET Q q 0 0 0 rg BT 494.09 331.10 Td (the ) Tj ET Q q 0 0 0 rg BT 508.81 331.10 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 318.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 318.10 Td (Other ) Tj ET Q q 0 0 0 rg BT 98.08 318.10 Td (rebates, ) Tj ET Q q 0 0 0 rg BT 132.21 318.10 Td (returns, ) Tj ET Q q 0 0 0 rg BT 165.80 318.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 206.89 318.10 Td (and ) Tj ET Q q 0 0 0 rg BT 224.64 318.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 275.73 318.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 316.80 318.10 Td (in ) Tj ET Q q 0 0 0 rg BT 327.89 318.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 351.21 318.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 391.73 318.10 Td (due ) Tj ET Q q 0 0 0 rg BT 409.48 318.10 Td (to ) Tj ET Q q 0 0 0 rg BT 420.58 318.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 449.44 318.10 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 495.52 318.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 518.27 318.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 529.92 318.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.25 318.10 Td ( ) Tj ET Q q 0 0 0 rg BT 561.57 318.10 Td (and) Tj ET Q BT /F3 10.00 Tf ET BT /F3 10.00 Tf ET q 0 0 0 rg BT 72.00 306.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 101.44 306.10 Td ( ) Tj ET Q q 0 0 0 rg BT 103.82 306.10 Td (and ) Tj ET Q q 0 0 0 rg BT 120.64 306.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 160.77 306.10 Td (in ) Tj ET Q q 0 0 0 rg BT 170.93 306.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 193.31 306.10 Td (due ) Tj ET Q q 0 0 0 rg BT 210.13 306.10 Td (to ) Tj ET Q q 0 0 0 rg BT 220.29 306.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 248.22 306.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 270.03 306.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 280.75 306.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.08 306.10 Td ( ) Tj ET Q q 0 0 0 rg BT 311.46 306.10 Td (and ) Tj ET Q q 0 0 0 rg BT 328.28 306.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 370.65 306.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 401.35 306.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 415.39 306.10 Td (Daklinza ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.88 306.10 Td (of ) Tj ET Q q 0 0 0 rg BT 464.59 306.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 524.72 306.10 Td ($180 ) Tj ET Q q 0 0 0 rg BT 547.10 306.10 Td (million ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 294.10 Td (for ) Tj ET Q q 0 0 0 rg BT 86.16 294.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 122.55 294.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 167.26 294.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 203.07 294.10 Td (in ) Tj ET Q q 0 0 0 rg BT 213.35 294.10 Td (France.) Tj ET Q endstream endobj 67 0 obj <> endobj 68 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (33) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Product ) Tj ET Q q 0 0 0 rg BT 71.28 749.25 Td (Revenues) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 704.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 704.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 704.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 704.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 704.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 704.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 704.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 704.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 704.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 704.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 704.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 678.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 678.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 678.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 678.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 678.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 678.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 678.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 678.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 678.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 678.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 678.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 652.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 652.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 652.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 652.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 652.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 652.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 652.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 652.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 652.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 652.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 652.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 632.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 632.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 632.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 632.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 632.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 632.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 632.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 632.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 632.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 632.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 632.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 606.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 606.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 606.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 606.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 606.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 606.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 606.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 606.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 606.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 606.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 606.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 586.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 586.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 586.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 586.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 586.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 586.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 586.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 586.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 586.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 586.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 586.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 560.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 560.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 560.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 560.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 560.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 560.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 560.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 560.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 560.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 560.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 560.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 540.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 540.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 540.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 540.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 540.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 540.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 514.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 514.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 514.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 514.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 514.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 514.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 514.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 514.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 514.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 514.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 514.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 494.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 494.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 494.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 494.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 494.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 494.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 494.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 494.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 494.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 494.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 494.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 468.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 468.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 468.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 468.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 468.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 468.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 468.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 468.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 468.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 468.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 468.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 448.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 448.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 448.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 448.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 448.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 448.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 448.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 448.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 448.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 448.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 448.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 422.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 422.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 422.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 422.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 422.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 422.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 422.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 422.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 422.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 422.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 422.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 402.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 402.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 402.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 402.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 402.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 402.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 402.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 402.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 402.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 402.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 402.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 376.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 376.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 376.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 376.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 376.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 376.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 376.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 376.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 376.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 376.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 376.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 350.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 350.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 350.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 350.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 350.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 350.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 350.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 350.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 350.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 350.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 350.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 330.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 330.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 330.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 330.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 330.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 330.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 330.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 330.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 330.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 330.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 330.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 304.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 304.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 304.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 304.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 304.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 304.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 304.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 304.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 304.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 304.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 304.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 284.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 284.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 284.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 284.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 284.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 284.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 284.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 284.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 284.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 284.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 284.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 258.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 258.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 258.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 258.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 258.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 258.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 258.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 258.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 258.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 258.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 258.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 238.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 238.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 238.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 238.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 238.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 238.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 238.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 238.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 238.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 238.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 238.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 212.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 212.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 212.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 212.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 212.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 212.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 212.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 212.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 212.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 212.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 212.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 192.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 192.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 192.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 192.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 192.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 192.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 192.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 192.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 192.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 192.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 192.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 166.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 166.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 166.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 166.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 166.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 166.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 166.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 166.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 166.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 166.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 166.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 146.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 146.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 146.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 146.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 146.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 146.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 146.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 146.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 146.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 146.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 146.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 120.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 120.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 120.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 120.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 120.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 120.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 120.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 120.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 120.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 120.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 120.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 94.75 275.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 94.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 94.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 94.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 94.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 94.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 94.75 43.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 94.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 94.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 94.75 4.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 94.75 58.00 -7.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 74.75 275.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 74.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 315.50 74.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 358.50 74.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 362.50 74.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 405.50 74.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 74.75 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 74.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 456.50 74.75 58.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 74.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 74.75 58.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 315.5 717.75 m 358.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 358.5 717.75 m 362.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 362.5 717.75 m 405.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 405.5 717.75 m 409.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 409.5 717.75 m 452.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 456.5 717.75 m 514.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 717.75 m 518.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 717.75 m 576.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 315.5 704.75 m 358.5 704.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 362.5 704.75 m 405.5 704.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 409.5 704.75 m 452.5 704.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 456.5 704.75 m 514.5 704.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 717.75 m 576.5 717.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 704.75 m 576.5 704.75 l s BT /F1 8.50 Tf ET q 0 0 0 rg BT 39.00 722.11 Td ( ) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 336.40 722.09 Td (Year Ended December 31,) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 496.75 722.09 Td (% Change) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 39.00 709.11 Td (Dollars in Millions) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 328.00 709.09 Td (2016) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 375.00 709.09 Td (2015) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 422.00 709.09 Td (2014) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 461.00 709.09 Td (2016 vs. 2015) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 523.00 709.09 Td (2015 vs. 2014) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 696.15 Td (Oncology) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 683.00 Td (Empliciti \(elotuzumab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 318.00 683.01 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 683.01 Td (150) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 365.00 683.01 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.50 683.01 Td (3) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 412.00 683.01 Td ($) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 440.00 683.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 683.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 557.95 683.01 Td (N/A) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 670.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 670.01 Td (133) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 397.50 670.01 Td (3) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 440.00 670.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 670.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 557.95 670.01 Td (N/A) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 657.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 657.01 Td (17) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 393.00 657.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 440.00 657.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 495.95 657.01 Td (N/A) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 557.95 657.01 Td (N/A) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 637.00 Td (Erbitux* \(cetuximab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 637.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 637.01 Td (501) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 637.01 Td (723) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 487.00 637.01 Td (\(100) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 637.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 637.01 Td (\(31) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 637.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 624.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 624.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 624.01 Td (487) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 624.01 Td (682) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 487.00 624.01 Td (\(100) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 624.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 624.01 Td (\(29) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 624.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 611.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 611.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 393.00 611.01 Td (14) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 440.00 611.01 Td (41) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 487.00 611.01 Td (\(100) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 611.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 611.01 Td (\(66) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 611.01 Td (\)%) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 591.00 Td (Opdivo \(nivolumab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 591.01 Td (3,774) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 591.01 Td (942) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 444.50 591.01 Td (6) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 591.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 591.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 578.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 578.01 Td (2,664) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 578.01 Td (823) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 444.50 578.01 Td (1) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 578.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 578.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 565.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 565.01 Td (1,110) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 565.01 Td (119) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 444.50 565.01 Td (5) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 565.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 565.01 Td (**) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 545.00 Td (Sprycel \(dasatinib\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 545.01 Td (1,824) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 545.01 Td (1,620) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 545.01 Td (1,493) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 545.01 Td (13) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 545.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 561.00 545.01 Td (9) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 568.50 545.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 532.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 532.01 Td (969) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 532.01 Td (829) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 532.01 Td (671) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 532.01 Td (17) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 532.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 556.50 532.01 Td (24) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 568.50 532.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 519.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 519.01 Td (855) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 519.01 Td (791) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 519.01 Td (822) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 499.00 519.01 Td (8) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 519.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 558.00 519.01 Td (\(4) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 519.01 Td (\)%) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 499.00 Td (Yervoy \(ipilimumab\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 499.01 Td (1,053) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 499.01 Td (1,126) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 499.01 Td (1,308) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 496.00 499.01 Td (\(6) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 499.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 499.01 Td (\(14) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 499.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 486.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 486.01 Td (802) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 486.01 Td (602) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 486.01 Td (709) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 486.01 Td (33) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 486.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 486.01 Td (\(15) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 486.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 473.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 473.01 Td (251) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 473.01 Td (524) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 473.01 Td (599) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 473.01 Td (\(52) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 473.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 473.01 Td (\(13) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 473.01 Td (\)%) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 453.15 Td (Cardiovascular) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 440.00 Td (Eliquis \(apixaban\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 440.01 Td (3,343) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 440.01 Td (1,860) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 440.01 Td (774) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 440.01 Td (80) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 440.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 440.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 427.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 427.01 Td (1,963) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 427.01 Td (1,023) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 427.01 Td (404) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 427.01 Td (92) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 427.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 427.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 414.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 414.01 Td (1,380) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 414.01 Td (837) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 414.01 Td (370) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 414.01 Td (65) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 414.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 414.01 Td (**) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 394.15 Td (Immunoscience) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 381.00 Td (Orencia \(abatacept\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 381.01 Td (2,265) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 381.01 Td (1,885) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 381.01 Td (1,652) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 381.01 Td (20) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 381.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 556.50 381.01 Td (14) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 568.50 381.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 368.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 368.01 Td (1,532) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 368.01 Td (1,271) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 368.01 Td (1,064) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 368.01 Td (21) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 368.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 556.50 368.01 Td (19) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 568.50 368.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 355.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 355.01 Td (733) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 355.01 Td (614) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 355.01 Td (588) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 494.50 355.01 Td (19) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 506.50 355.01 Td (%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 561.00 355.01 Td (4) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 568.50 355.01 Td (%) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 335.15 Td (Virology) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 322.00 Td (Baraclude \(entecavir\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 322.01 Td (1,192) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 322.01 Td (1,312) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 322.01 Td (1,441) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 496.00 322.01 Td (\(9) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 322.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 558.00 322.01 Td (\(9) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 322.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 309.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 309.01 Td (66) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 309.01 Td (135) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 309.01 Td (215) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 309.01 Td (\(51) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 309.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 309.01 Td (\(37) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 309.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 296.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 296.01 Td (1,126) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 296.01 Td (1,177) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 296.01 Td (1,226) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 496.00 296.01 Td (\(4) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 296.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 558.00 296.01 Td (\(4) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 296.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 39.00 276.01 Td (Hepatitis C Franchise ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 119.24 276.01 Td (\(daclatasvir and asunapr) Tj ET Q q 0 0 0 rg BT 209.90 276.01 Td (evir\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 276.01 Td (1,578) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 276.01 Td (1,603) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 276.01 Td (256) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 496.00 276.01 Td (\(2) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 276.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 276.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 263.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 263.01 Td (827) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 263.01 Td (323) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 440.00 263.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 502.00 263.01 Td (**) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 557.95 263.01 Td (N/A) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 250.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 250.01 Td (751) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 250.01 Td (1,280) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 250.01 Td (256) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 250.01 Td (\(41) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 250.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 564.00 250.01 Td (**) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 230.00 Td (Reyataz \(atazanavir sulfate\) Franchise) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 230.01 Td (912) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 230.01 Td (1,139) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 230.01 Td (1,362) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 230.01 Td (\(20) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 230.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 230.01 Td (\(16) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 230.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 217.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 217.01 Td (484) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 217.01 Td (591) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 217.01 Td (689) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 217.01 Td (\(18) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 217.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 217.01 Td (\(14) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 217.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 204.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 204.01 Td (428) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 204.01 Td (548) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 204.01 Td (673) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 204.01 Td (\(22) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 204.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 204.01 Td (\(19) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 204.01 Td (\)%) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 184.00 Td (Sustiva \(efavirenz\) Franchise) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 184.01 Td (1,065) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 184.01 Td (1,252) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 184.01 Td (1,444) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 184.01 Td (\(15) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 184.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 184.01 Td (\(13) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 184.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 171.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 171.01 Td (901) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 171.01 Td (1,041) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 171.01 Td (1,118) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 171.01 Td (\(13) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 171.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 558.00 171.01 Td (\(7) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 171.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 158.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 158.01 Td (164) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 158.01 Td (211) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 158.01 Td (326) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 158.01 Td (\(22) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 158.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 158.01 Td (\(35) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 158.01 Td (\)%) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 138.15 Td (Neuroscience) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 39.00 125.00 Td (Abilify* \(aripiprazole\)) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 125.01 Td (128) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 125.01 Td (746) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 125.01 Td (2,020) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 125.01 Td (\(83) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 125.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 125.01 Td (\(63) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 125.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 112.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 346.00 112.01 Td (—) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 112.01 Td (600) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 112.01 Td (1,572) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 487.00 112.01 Td (\(100) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 112.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 112.01 Td (\(62) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 112.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 99.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 99.01 Td (128) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 99.01 Td (146) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 99.01 Td (448) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 99.01 Td (\(12) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 99.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 99.01 Td (\(67) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 99.01 Td (\)%) Tj ET Q BT /F2 9.00 Tf ET q 0 0 0 rg BT 39.00 79.15 Td (Mature Products and All Other) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 79.01 Td (2,143) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 79.01 Td (2,571) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 79.01 Td (3,400) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 79.01 Td (\(17) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 79.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 79.01 Td (\(24) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 79.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 66.01 Td (U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 341.50 66.01 Td (379) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 388.50 66.01 Td (460) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.50 66.01 Td (591) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 66.01 Td (\(18) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 66.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 66.01 Td (\(22) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 66.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 57.00 53.01 Td (Non-U.S.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 334.75 53.01 Td (1,764) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 381.75 53.01 Td (2,111) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 428.75 53.01 Td (2,809) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 491.50 53.01 Td (\(16) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 503.50 53.01 Td (\)%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 553.50 53.01 Td (\(25) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 565.50 53.01 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 39.65 Td (** ) Tj ET Q q 0 0 0 rg BT 58.50 39.65 Td (Change ) Tj ET Q q 0 0 0 rg BT 84.94 39.65 Td (in ) Tj ET Q q 0 0 0 rg BT 93.16 39.65 Td (excess ) Tj ET Q q 0 0 0 rg BT 116.04 39.65 Td (of ) Tj ET Q q 0 0 0 rg BT 124.70 39.65 Td (100%) Tj ET Q endstream endobj 69 0 obj <> endobj 70 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (34) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.66 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 75.16 749.10 Td (- ) Tj ET Q q 0 0 0 rg BT 80.99 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 87.93 749.10 Td (humanized ) Tj ET Q q 0 0 0 rg BT 134.30 749.10 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 184.01 749.10 Td (antibody ) Tj ET Q q 0 0 0 rg BT 221.51 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 235.67 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 250.38 749.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 290.64 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 301.47 749.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 337.30 749.10 Td (myeloma. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 43.35 731.10 Td (• ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 61.35 731.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.01 731.10 Td ( ) Tj ET Q q 0 0 0 rg BT 100.51 731.10 Td (was ) Tj ET Q q 0 0 0 rg BT 118.56 731.10 Td (launched ) Tj ET Q q 0 0 0 rg BT 157.16 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 167.43 731.10 Td (the ) Tj ET Q q 0 0 0 rg BT 182.15 731.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 202.43 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 212.71 731.10 Td (December ) Tj ET Q q 0 0 0 rg BT 256.30 731.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 281.30 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 291.57 731.10 Td (the ) Tj ET Q q 0 0 0 rg BT 306.29 731.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 322.12 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 332.40 731.10 Td (May ) Tj ET Q q 0 0 0 rg BT 353.23 731.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 375.73 731.10 Td (and ) Tj ET Q q 0 0 0 rg BT 392.67 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 402.95 731.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 428.22 731.10 Td (in ) Tj ET Q q 0 0 0 rg BT 438.49 731.10 Td (September ) Tj ET Q q 0 0 0 rg BT 483.76 731.10 Td (2016.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Erbitux) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.00 713.10 Td (* ) Tj ET Q q 0 0 0 rg BT 73.50 713.10 Td (—a ) Tj ET Q q 0 0 0 rg BT 90.43 713.10 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 140.15 713.10 Td (antibody ) Tj ET Q q 0 0 0 rg BT 177.64 713.10 Td (for ) Tj ET Q q 0 0 0 rg BT 191.80 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 206.52 713.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 246.78 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 257.61 713.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 287.31 713.10 Td (types ) Tj ET Q q 0 0 0 rg BT 310.92 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 321.75 713.10 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 364.78 713.10 Td (colorectal ) Tj ET Q q 0 0 0 rg BT 406.70 713.10 Td (cancer ) Tj ET Q q 0 0 0 rg BT 435.29 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 452.23 713.10 Td (SCCHN.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 695.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 695.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 85.11 695.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 131.06 695.10 Td (its ) Tj ET Q q 0 0 0 rg BT 143.14 695.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 168.56 695.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 178.98 695.10 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.97 695.10 Td ( ) Tj ET Q q 0 0 0 rg BT 216.61 695.10 Td (in ) Tj ET Q q 0 0 0 rg BT 227.03 695.10 Td (North ) Tj ET Q q 0 0 0 rg BT 252.42 695.10 Td (America ) Tj ET Q q 0 0 0 rg BT 289.48 695.10 Td (to ) Tj ET Q q 0 0 0 rg BT 299.90 695.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 321.98 695.10 Td (in ) Tj ET Q q 0 0 0 rg BT 332.40 695.10 Td (October ) Tj ET Q q 0 0 0 rg BT 367.24 695.10 Td (2015. ) Tj ET Q q 0 0 0 rg BT 392.38 695.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 417.23 695.10 Td (to ) Tj ET Q q 0 0 0 rg BT 427.65 695.10 Td ("Item ) Tj ET Q q 0 0 0 rg BT 452.69 695.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 462.83 695.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 502.68 695.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 683.10 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.35 683.10 Td (. ) Tj ET Q q 0 0 0 rg BT 70.80 683.10 Td (Alliances” ) Tj ET Q q 0 0 0 rg BT 115.50 683.10 Td (for ) Tj ET Q q 0 0 0 rg BT 129.66 683.10 Td (further ) Tj ET Q q 0 0 0 rg BT 159.37 683.10 Td (discussion.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.44 665.10 Td ( — a ) Tj ET Q q 0 0 0 rg BT 87.69 665.10 Td (fully ) Tj ET Q q 0 0 0 rg BT 109.38 665.10 Td (human ) Tj ET Q q 0 0 0 rg BT 139.41 665.10 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 189.43 665.10 Td (antibody ) Tj ET Q q 0 0 0 rg BT 227.23 665.10 Td (that ) Tj ET Q q 0 0 0 rg BT 245.04 665.10 Td (binds ) Tj ET Q q 0 0 0 rg BT 269.52 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 280.10 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 295.13 665.10 Td (PD-1 ) Tj ET Q q 0 0 0 rg BT 319.05 665.10 Td (on ) Tj ET Q q 0 0 0 rg BT 331.66 665.10 Td (T) Tj ET Q q 0 0 0 rg BT 337.59 665.10 Td ( ) Tj ET Q q 0 0 0 rg BT 340.39 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 357.64 665.10 Td (NKT) Tj ET Q q 0 0 0 rg BT 378.01 665.10 Td ( ) Tj ET Q q 0 0 0 rg BT 380.82 665.10 Td (cells ) Tj ET Q q 0 0 0 rg BT 401.96 665.10 Td (that ) Tj ET Q q 0 0 0 rg BT 419.76 665.10 Td (has ) Tj ET Q q 0 0 0 rg BT 435.90 665.10 Td (been ) Tj ET Q q 0 0 0 rg BT 457.59 665.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 497.60 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 514.85 665.10 Td (continues ) Tj ET Q q 0 0 0 rg BT 555.98 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 566.57 665.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (investigated ) Tj ET Q q 0 0 0 rg BT 87.00 653.10 Td (as ) Tj ET Q q 0 0 0 rg BT 98.02 653.10 Td (an ) Tj ET Q q 0 0 0 rg BT 110.14 653.10 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 157.24 653.10 Td (treatment. ) Tj ET Q q 0 0 0 rg BT 200.18 653.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 225.07 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 235.53 653.10 Td ("—Significant ) Tj ET Q q 0 0 0 rg BT 296.18 653.10 Td (Product ) Tj ET Q q 0 0 0 rg BT 329.98 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 347.10 653.10 Td (Pipeline ) Tj ET Q q 0 0 0 rg BT 381.96 653.10 Td (Approvals" ) Tj ET Q q 0 0 0 rg BT 430.39 653.10 Td (for ) Tj ET Q q 0 0 0 rg BT 444.74 653.10 Td (further ) Tj ET Q q 0 0 0 rg BT 474.63 653.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 518.98 653.10 Td (on ) Tj ET Q q 0 0 0 rg BT 531.67 653.10 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 546.57 653.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (approvals ) Tj ET Q q 0 0 0 rg BT 77.38 641.10 Td (in ) Tj ET Q q 0 0 0 rg BT 87.66 641.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 110.16 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 127.09 641.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 623.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 623.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 81.84 623.10 Td (and ) Tj ET Q q 0 0 0 rg BT 98.98 623.10 Td (international ) Tj ET Q q 0 0 0 rg BT 152.22 623.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 190.46 623.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 230.91 623.10 Td (in ) Tj ET Q q 0 0 0 rg BT 241.39 623.10 Td (both ) Tj ET Q q 0 0 0 rg BT 261.87 623.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 294.02 623.10 Td (due ) Tj ET Q q 0 0 0 rg BT 311.16 623.10 Td (to ) Tj ET Q q 0 0 0 rg BT 321.64 623.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 349.89 623.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 384.25 623.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 421.94 623.10 Td (from ) Tj ET Q q 0 0 0 rg BT 444.08 623.10 Td (the ) Tj ET Q q 0 0 0 rg BT 459.00 623.10 Td (rapid ) Tj ET Q q 0 0 0 rg BT 482.25 623.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 532.15 623.10 Td (acceptance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 611.10 Td (for ) Tj ET Q q 0 0 0 rg BT 75.59 611.10 Td (several ) Tj ET Q q 0 0 0 rg BT 106.48 611.10 Td (indications ) Tj ET Q q 0 0 0 rg BT 152.93 611.10 Td (including ) Tj ET Q q 0 0 0 rg BT 193.28 611.10 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 240.01 611.10 Td (head ) Tj ET Q q 0 0 0 rg BT 261.46 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 278.48 611.10 Td (neck, ) Tj ET Q q 0 0 0 rg BT 302.43 611.10 Td (lung, ) Tj ET Q q 0 0 0 rg BT 325.28 611.10 Td (kidney ) Tj ET Q q 0 0 0 rg BT 355.08 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 372.09 611.10 Td (blood ) Tj ET Q q 0 0 0 rg BT 397.44 611.10 Td (cancer) Tj ET Q q 0 0 0 rg BT 422.98 611.10 Td (. ) Tj ET Q q 0 0 0 rg BT 427.87 611.10 Td (W) Tj ET Q q 0 0 0 rg BT 436.50 611.10 Td (e ) Tj ET Q q 0 0 0 rg BT 443.52 611.10 Td (expect ) Tj ET Q q 0 0 0 rg BT 472.19 611.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 522.53 611.10 Td (to ) Tj ET Q q 0 0 0 rg BT 532.89 611.10 Td (increase ) Tj ET Q q 0 0 0 rg BT 568.21 611.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 599.10 Td (2017.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.99 581.10 Td ( —an ) Tj ET Q q 0 0 0 rg BT 91.11 581.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 109.84 581.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 147.47 581.10 Td (of ) Tj ET Q q 0 0 0 rg BT 158.99 581.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 195.50 581.10 Td (tyrosine ) Tj ET Q q 0 0 0 rg BT 230.91 581.10 Td (kinase ) Tj ET Q q 0 0 0 rg BT 259.64 581.10 Td (indicated ) Tj ET Q q 0 0 0 rg BT 299.48 581.10 Td (for ) Tj ET Q q 0 0 0 rg BT 314.32 581.10 Td (the ) Tj ET Q q 0 0 0 rg BT 329.73 581.10 Td (first-line ) Tj ET Q q 0 0 0 rg BT 367.35 581.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 408.29 581.10 Td (of ) Tj ET Q q 0 0 0 rg BT 419.81 581.10 Td (adults ) Tj ET Q q 0 0 0 rg BT 446.88 581.10 Td (with ) Tj ET Q q 0 0 0 rg BT 467.84 581.10 Td (Philadelphia ) Tj ET Q q 0 0 0 rg BT 521.02 581.10 Td (chromosome-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (positive ) Tj ET Q q 0 0 0 rg BT 70.16 569.10 Td (chronic ) Tj ET Q q 0 0 0 rg BT 102.64 569.10 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 137.91 569.10 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 177.05 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 187.32 569.10 Td (chronic ) Tj ET Q q 0 0 0 rg BT 219.80 569.10 Td (phase ) Tj ET Q q 0 0 0 rg BT 245.07 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 262.00 569.10 Td (the ) Tj ET Q q 0 0 0 rg BT 276.71 569.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 316.96 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 327.79 569.10 Td (adults ) Tj ET Q q 0 0 0 rg BT 354.17 569.10 Td (with ) Tj ET Q q 0 0 0 rg BT 374.44 569.10 Td (chronic, ) Tj ET Q q 0 0 0 rg BT 409.42 569.10 Td (accelerated, ) Tj ET Q q 0 0 0 rg BT 459.37 569.10 Td (or ) Tj ET Q q 0 0 0 rg BT 470.19 569.10 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 505.46 569.10 Td (or ) Tj ET Q q 0 0 0 rg BT 516.29 569.10 Td (lymphoid ) Tj ET Q q 0 0 0 rg BT 557.11 569.10 Td (blast ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (phase ) Tj ET Q q 0 0 0 rg BT 61.27 557.10 Td (chronic ) Tj ET Q q 0 0 0 rg BT 93.75 557.10 Td (myeloid ) Tj ET Q q 0 0 0 rg BT 129.03 557.10 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 168.18 557.10 Td (with ) Tj ET Q q 0 0 0 rg BT 188.46 557.10 Td (resistance ) Tj ET Q q 0 0 0 rg BT 230.38 557.10 Td (or ) Tj ET Q q 0 0 0 rg BT 241.21 557.10 Td (intolerance ) Tj ET Q q 0 0 0 rg BT 288.13 557.10 Td (to ) Tj ET Q q 0 0 0 rg BT 298.41 557.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 320.35 557.10 Td (therapy) Tj ET Q q 0 0 0 rg BT 349.68 557.10 Td (, ) Tj ET Q q 0 0 0 rg BT 354.68 557.10 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 394.96 557.10 Td (Gleevec* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 557.10 Td (\(imatinib ) Tj ET Q q 0 0 0 rg BT 473.81 557.10 Td (meslylate\).) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 36.00 540.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 540.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.28 540.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.32 540.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 152.57 540.60 Td (in ) Tj ET Q q 0 0 0 rg BT 162.85 540.60 Td (both ) Tj ET Q q 0 0 0 rg BT 183.13 540.60 Td (periods ) Tj ET Q q 0 0 0 rg BT 215.07 540.60 Td (due ) Tj ET Q q 0 0 0 rg BT 232.01 540.60 Td (to ) Tj ET Q q 0 0 0 rg BT 242.29 540.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 270.33 540.60 Td (average ) Tj ET Q q 0 0 0 rg BT 303.92 540.60 Td (net ) Tj ET Q q 0 0 0 rg BT 318.63 540.60 Td (selling ) Tj ET Q q 0 0 0 rg BT 347.80 540.60 Td (prices ) Tj ET Q q 0 0 0 rg BT 374.18 540.60 Td (and ) Tj ET Q q 0 0 0 rg BT 391.11 540.60 Td (demand. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 525.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 525.60 Td (International ) Tj ET Q q 0 0 0 rg BT 107.16 525.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 144.77 525.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 184.60 525.60 Td (in ) Tj ET Q q 0 0 0 rg BT 194.46 525.60 Td (2016 ) Tj ET Q q 0 0 0 rg BT 216.53 525.60 Td (due ) Tj ET Q q 0 0 0 rg BT 233.04 525.60 Td (to ) Tj ET Q q 0 0 0 rg BT 242.89 525.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 270.52 525.60 Td (demand. ) Tj ET Q q 0 0 0 rg BT 306.75 525.60 Td (International ) Tj ET Q q 0 0 0 rg BT 359.91 525.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 397.52 525.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 439.01 525.60 Td (in ) Tj ET Q q 0 0 0 rg BT 448.86 525.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 470.93 525.60 Td (due ) Tj ET Q q 0 0 0 rg BT 487.45 525.60 Td (to ) Tj ET Q q 0 0 0 rg BT 497.30 525.60 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 547.13 525.60 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 513.60 Td (exchange ) Tj ET Q q 0 0 0 rg BT 94.44 513.60 Td (partially ) Tj ET Q q 0 0 0 rg BT 130.45 513.60 Td (of) Tj ET Q q 0 0 0 rg BT 138.60 513.60 Td (fset ) Tj ET Q q 0 0 0 rg BT 155.73 513.60 Td (by ) Tj ET Q q 0 0 0 rg BT 168.41 513.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 196.65 513.60 Td (demand. ) Tj ET Q q 0 0 0 rg BT 233.30 513.60 Td (W) Tj ET Q q 0 0 0 rg BT 241.94 513.60 Td (e ) Tj ET Q q 0 0 0 rg BT 249.06 513.60 Td (may ) Tj ET Q q 0 0 0 rg BT 268.97 513.60 Td (experience ) Tj ET Q q 0 0 0 rg BT 314.96 513.60 Td (a ) Tj ET Q q 0 0 0 rg BT 322.08 513.60 Td (decline ) Tj ET Q q 0 0 0 rg BT 353.64 513.60 Td (in ) Tj ET Q q 0 0 0 rg BT 364.11 513.60 Td (European ) Tj ET Q q 0 0 0 rg BT 405.11 513.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 443.34 513.60 Td (in ) Tj ET Q q 0 0 0 rg BT 453.80 513.60 Td (the ) Tj ET Q q 0 0 0 rg BT 468.71 513.60 Td (second ) Tj ET Q q 0 0 0 rg BT 499.16 513.60 Td (half ) Tj ET Q q 0 0 0 rg BT 517.40 513.60 Td (of ) Tj ET Q q 0 0 0 rg BT 528.42 513.60 Td (2017 ) Tj ET Q q 0 0 0 rg BT 551.11 513.60 Td (due ) Tj ET Q q 0 0 0 rg BT 568.23 513.60 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 501.60 Td (the ) Tj ET Q q 0 0 0 rg BT 68.72 501.60 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 118.97 501.60 Td (EPO ) Tj ET Q q 0 0 0 rg BT 140.36 501.60 Td (Board ) Tj ET Q q 0 0 0 rg BT 167.30 501.60 Td (of ) Tj ET Q q 0 0 0 rg BT 177.58 501.60 Td (Appeal's ) Tj ET Q q 0 0 0 rg BT 214.65 501.60 Td (decision. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 483.60 Td (Y) Tj ET Q q 0 0 0 rg BT 40.64 483.60 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.85 483.60 Td ( ) Tj ET Q q 0 0 0 rg BT 65.35 483.60 Td (— ) Tj ET Q q 0 0 0 rg BT 77.85 483.60 Td (a ) Tj ET Q q 0 0 0 rg BT 84.79 483.60 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 134.50 483.60 Td (antibody ) Tj ET Q q 0 0 0 rg BT 172.00 483.60 Td (for ) Tj ET Q q 0 0 0 rg BT 186.16 483.60 Td (the ) Tj ET Q q 0 0 0 rg BT 200.87 483.60 Td (treatment ) Tj ET Q q 0 0 0 rg BT 241.13 483.60 Td (of ) Tj ET Q q 0 0 0 rg BT 251.96 483.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 285.57 483.60 Td (with ) Tj ET Q q 0 0 0 rg BT 305.84 483.60 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 358.31 483.60 Td (or ) Tj ET Q q 0 0 0 rg BT 369.14 483.60 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 412.18 483.60 Td (melanoma.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 468.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 468.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.63 468.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 113.01 468.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 153.61 468.60 Td (in ) Tj ET Q q 0 0 0 rg BT 164.23 468.60 Td (2016 ) Tj ET Q q 0 0 0 rg BT 187.07 468.60 Td (due ) Tj ET Q q 0 0 0 rg BT 204.36 468.60 Td (to ) Tj ET Q q 0 0 0 rg BT 214.98 468.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 243.37 468.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 277.87 468.60 Td (as ) Tj ET Q q 0 0 0 rg BT 289.04 468.60 Td (a ) Tj ET Q q 0 0 0 rg BT 296.33 468.60 Td (result ) Tj ET Q q 0 0 0 rg BT 321.39 468.60 Td (of ) Tj ET Q q 0 0 0 rg BT 332.56 468.60 Td (the ) Tj ET Q q 0 0 0 rg BT 347.62 468.60 Td (approvals ) Tj ET Q q 0 0 0 rg BT 389.34 468.60 Td (for ) Tj ET Q q 0 0 0 rg BT 403.85 468.60 Td (adjuvant ) Tj ET Q q 0 0 0 rg BT 441.13 468.60 Td (treatment ) Tj ET Q q 0 0 0 rg BT 481.73 468.60 Td (and ) Tj ET Q q 0 0 0 rg BT 499.01 468.60 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 514.07 468.60 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.51 468.60 Td (+) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 549.15 468.60 Td (Y) Tj ET Q q 0 0 0 rg BT 553.79 468.60 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 456.60 Td (regimen ) Tj ET Q q 0 0 0 rg BT 88.50 456.60 Td (for ) Tj ET Q q 0 0 0 rg BT 101.91 456.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 134.75 456.60 Td (with ) Tj ET Q q 0 0 0 rg BT 154.27 456.60 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 196.55 456.60 Td (melanoma. ) Tj ET Q q 0 0 0 rg BT 242.44 456.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 261.96 456.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 299.24 456.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 340.39 456.60 Td (in ) Tj ET Q q 0 0 0 rg BT 349.91 456.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 371.65 456.60 Td (due ) Tj ET Q q 0 0 0 rg BT 387.83 456.60 Td (to ) Tj ET Q q 0 0 0 rg BT 397.35 456.60 Td (lower ) Tj ET Q q 0 0 0 rg BT 421.86 456.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 455.26 456.60 Td (resulting ) Tj ET Q q 0 0 0 rg BT 491.99 456.60 Td (from ) Tj ET Q q 0 0 0 rg BT 513.17 456.60 Td (the ) Tj ET Q q 0 0 0 rg BT 527.13 456.60 Td (introduction ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 444.60 Td (of ) Tj ET Q q 0 0 0 rg BT 64.83 444.60 Td (other ) Tj ET Q q 0 0 0 rg BT 87.88 444.60 Td (IO ) Tj ET Q q 0 0 0 rg BT 100.93 444.60 Td (products ) Tj ET Q q 0 0 0 rg BT 137.87 444.60 Td (being ) Tj ET Q q 0 0 0 rg BT 162.58 444.60 Td (used ) Tj ET Q q 0 0 0 rg BT 183.41 444.60 Td (to ) Tj ET Q q 0 0 0 rg BT 193.69 444.60 Td (treat ) Tj ET Q q 0 0 0 rg BT 213.96 444.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 247.56 444.60 Td (with ) Tj ET Q q 0 0 0 rg BT 267.84 444.60 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 314.49 444.60 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 354.76 444.60 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 384.20 444.60 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 428.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 428.60 Td (International ) Tj ET Q q 0 0 0 rg BT 107.92 428.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 146.29 428.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 188.54 428.60 Td (in ) Tj ET Q q 0 0 0 rg BT 199.15 428.60 Td (2016 ) Tj ET Q q 0 0 0 rg BT 221.99 428.60 Td (due ) Tj ET Q q 0 0 0 rg BT 239.26 428.60 Td (to ) Tj ET Q q 0 0 0 rg BT 249.87 428.60 Td (lower ) Tj ET Q q 0 0 0 rg BT 275.47 428.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 309.96 428.60 Td (resulting ) Tj ET Q q 0 0 0 rg BT 347.79 428.60 Td (from ) Tj ET Q q 0 0 0 rg BT 370.06 428.60 Td (the ) Tj ET Q q 0 0 0 rg BT 385.11 428.60 Td (introduction ) Tj ET Q q 0 0 0 rg BT 436.83 428.60 Td (of ) Tj ET Q q 0 0 0 rg BT 447.99 428.60 Td (other ) Tj ET Q q 0 0 0 rg BT 471.37 428.60 Td (IO ) Tj ET Q q 0 0 0 rg BT 484.76 428.60 Td (products ) Tj ET Q q 0 0 0 rg BT 522.03 428.60 Td (being ) Tj ET Q q 0 0 0 rg BT 547.08 428.60 Td (used ) Tj ET Q q 0 0 0 rg BT 568.24 428.60 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 416.60 Td (treat ) Tj ET Q q 0 0 0 rg BT 74.26 416.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 107.87 416.60 Td (with ) Tj ET Q q 0 0 0 rg BT 128.15 416.60 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 174.80 416.60 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 215.07 416.60 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 244.51 416.60 Td (. ) Tj ET Q q 0 0 0 rg BT 249.51 416.60 Td (International ) Tj ET Q q 0 0 0 rg BT 303.10 416.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 341.13 416.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 383.05 416.60 Td (in ) Tj ET Q q 0 0 0 rg BT 393.33 416.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 415.83 416.60 Td (due ) Tj ET Q q 0 0 0 rg BT 432.76 416.60 Td (to ) Tj ET Q q 0 0 0 rg BT 443.04 416.60 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 493.30 416.60 Td (foreign ) Tj ET Q q 0 0 0 rg BT 524.67 416.60 Td (exchange.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 396.60 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.33 396.60 Td ( ) Tj ET Q q 0 0 0 rg BT 66.14 396.60 Td (— ) Tj ET Q q 0 0 0 rg BT 77.94 396.60 Td (an ) Tj ET Q q 0 0 0 rg BT 89.18 396.60 Td (oral ) Tj ET Q q 0 0 0 rg BT 106.52 396.60 Td (Factor ) Tj ET Q q 0 0 0 rg BT 133.87 396.60 Td (Xa ) Tj ET Q q 0 0 0 rg BT 147.33 396.60 Td (inhibitor) Tj ET Q q 0 0 0 rg BT 181.38 396.60 Td (, ) Tj ET Q q 0 0 0 rg BT 185.68 396.60 Td (tar) Tj ET Q q 0 0 0 rg BT 196.04 396.60 Td (geted ) Tj ET Q q 0 0 0 rg BT 219.50 396.60 Td (at ) Tj ET Q q 0 0 0 rg BT 228.52 396.60 Td (stroke ) Tj ET Q q 0 0 0 rg BT 254.75 396.60 Td (prevention ) Tj ET Q q 0 0 0 rg BT 299.32 396.60 Td (in ) Tj ET Q q 0 0 0 rg BT 308.90 396.60 Td (adult ) Tj ET Q q 0 0 0 rg BT 330.69 396.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 363.60 396.60 Td (with ) Tj ET Q q 0 0 0 rg BT 383.18 396.60 Td (non-valvular ) Tj ET Q q 0 0 0 rg BT 436.07 396.60 Td (atrial ) Tj ET Q q 0 0 0 rg BT 458.42 396.60 Td (fibrillation ) Tj ET Q q 0 0 0 rg BT 502.98 396.60 Td (and ) Tj ET Q q 0 0 0 rg BT 519.22 396.60 Td (the ) Tj ET Q q 0 0 0 rg BT 533.24 396.60 Td (prevention ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 384.60 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 384.60 Td (treatment ) Tj ET Q q 0 0 0 rg BT 93.20 384.60 Td (of ) Tj ET Q q 0 0 0 rg BT 104.03 384.60 Td (venous ) Tj ET Q q 0 0 0 rg BT 134.86 384.60 Td (thromboembolic ) Tj ET Q q 0 0 0 rg BT 203.46 384.60 Td (disorders.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 368.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 368.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.14 368.60 Td (and ) Tj ET Q q 0 0 0 rg BT 90.93 368.60 Td (international ) Tj ET Q q 0 0 0 rg BT 143.82 368.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 181.71 368.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 221.81 368.60 Td (in ) Tj ET Q q 0 0 0 rg BT 231.94 368.60 Td (both ) Tj ET Q q 0 0 0 rg BT 252.07 368.60 Td (periods ) Tj ET Q q 0 0 0 rg BT 283.87 368.60 Td (due ) Tj ET Q q 0 0 0 rg BT 300.66 368.60 Td (to ) Tj ET Q q 0 0 0 rg BT 310.79 368.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 338.69 368.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 372.69 368.60 Td (resulting ) Tj ET Q q 0 0 0 rg BT 410.04 368.60 Td (from ) Tj ET Q q 0 0 0 rg BT 431.83 368.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 471.94 368.60 Td (commercial ) Tj ET Q q 0 0 0 rg BT 521.49 368.60 Td (acceptance ) Tj ET Q q 0 0 0 rg BT 567.69 368.60 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 356.60 Td (novel ) Tj ET Q q 0 0 0 rg BT 78.72 356.60 Td (oral ) Tj ET Q q 0 0 0 rg BT 96.76 356.60 Td (anticoagulants ) Tj ET Q q 0 0 0 rg BT 157.02 356.60 Td (and ) Tj ET Q q 0 0 0 rg BT 173.96 356.60 Td (market ) Tj ET Q q 0 0 0 rg BT 204.22 356.60 Td (share ) Tj ET Q q 0 0 0 rg BT 227.82 356.60 Td (gains. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 335.60 Td (Or) Tj ET Q q 0 0 0 rg BT 46.74 335.60 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.40 335.60 Td ( ) Tj ET Q q 0 0 0 rg BT 71.10 335.60 Td (— ) Tj ET Q q 0 0 0 rg BT 83.80 335.60 Td (a ) Tj ET Q q 0 0 0 rg BT 90.94 335.60 Td (fusion ) Tj ET Q q 0 0 0 rg BT 118.64 335.60 Td (protein ) Tj ET Q q 0 0 0 rg BT 149.66 335.60 Td (indicated ) Tj ET Q q 0 0 0 rg BT 189.01 335.60 Td (for ) Tj ET Q q 0 0 0 rg BT 203.37 335.60 Td (adult ) Tj ET Q q 0 0 0 rg BT 226.07 335.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 259.87 335.60 Td (with ) Tj ET Q q 0 0 0 rg BT 280.35 335.60 Td (moderate ) Tj ET Q q 0 0 0 rg BT 320.25 335.60 Td (to ) Tj ET Q q 0 0 0 rg BT 330.73 335.60 Td (severe ) Tj ET Q q 0 0 0 rg BT 358.97 335.60 Td (active ) Tj ET Q q 0 0 0 rg BT 385.54 335.60 Td (RA) Tj ET Q q 0 0 0 rg BT 398.88 335.60 Td ( ) Tj ET Q q 0 0 0 rg BT 401.58 335.60 Td (and ) Tj ET Q q 0 0 0 rg BT 418.72 335.60 Td (is ) Tj ET Q q 0 0 0 rg BT 428.09 335.60 Td (also ) Tj ET Q q 0 0 0 rg BT 446.90 335.60 Td (indicated ) Tj ET Q q 0 0 0 rg BT 486.25 335.60 Td (for ) Tj ET Q q 0 0 0 rg BT 500.61 335.60 Td (reducing ) Tj ET Q q 0 0 0 rg BT 538.29 335.60 Td (signs ) Tj ET Q q 0 0 0 rg BT 561.56 335.60 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.60 Td (symptoms ) Tj ET Q q 0 0 0 rg BT 79.62 323.60 Td (in ) Tj ET Q q 0 0 0 rg BT 89.90 323.60 Td (certain ) Tj ET Q q 0 0 0 rg BT 119.60 323.60 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 157.08 323.60 Td (patients ) Tj ET Q q 0 0 0 rg BT 190.68 323.60 Td (with ) Tj ET Q q 0 0 0 rg BT 210.96 323.60 Td (moderately ) Tj ET Q q 0 0 0 rg BT 258.44 323.60 Td (to ) Tj ET Q q 0 0 0 rg BT 268.72 323.60 Td (severely ) Tj ET Q q 0 0 0 rg BT 304.54 323.60 Td (active ) Tj ET Q q 0 0 0 rg BT 330.91 323.60 Td (polyarticular ) Tj ET Q q 0 0 0 rg BT 384.50 323.60 Td (juvenile ) Tj ET Q q 0 0 0 rg BT 419.21 323.60 Td (idiopathic ) Tj ET Q q 0 0 0 rg BT 461.70 323.60 Td (arthritis.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 307.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 307.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.28 307.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.32 307.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 152.57 307.60 Td (in ) Tj ET Q q 0 0 0 rg BT 162.85 307.60 Td (both ) Tj ET Q q 0 0 0 rg BT 183.13 307.60 Td (periods ) Tj ET Q q 0 0 0 rg BT 215.07 307.60 Td (due ) Tj ET Q q 0 0 0 rg BT 232.01 307.60 Td (to ) Tj ET Q q 0 0 0 rg BT 242.29 307.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 270.33 307.60 Td (average ) Tj ET Q q 0 0 0 rg BT 303.92 307.60 Td (net ) Tj ET Q q 0 0 0 rg BT 318.63 307.60 Td (selling ) Tj ET Q q 0 0 0 rg BT 347.80 307.60 Td (prices ) Tj ET Q q 0 0 0 rg BT 374.18 307.60 Td (and ) Tj ET Q q 0 0 0 rg BT 391.11 307.60 Td (demand.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 292.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 292.60 Td (International ) Tj ET Q q 0 0 0 rg BT 107.59 292.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 145.63 292.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 185.88 292.60 Td (in ) Tj ET Q q 0 0 0 rg BT 196.16 292.60 Td (both ) Tj ET Q q 0 0 0 rg BT 216.44 292.60 Td (periods ) Tj ET Q q 0 0 0 rg BT 248.38 292.60 Td (due ) Tj ET Q q 0 0 0 rg BT 265.31 292.60 Td (to ) Tj ET Q q 0 0 0 rg BT 275.59 292.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 303.64 292.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 337.79 292.60 Td (partially ) Tj ET Q q 0 0 0 rg BT 373.61 292.60 Td (of) Tj ET Q q 0 0 0 rg BT 381.76 292.60 Td (fset ) Tj ET Q q 0 0 0 rg BT 398.70 292.60 Td (by ) Tj ET Q q 0 0 0 rg BT 411.20 292.60 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 461.46 292.60 Td (foreign ) Tj ET Q q 0 0 0 rg BT 492.83 292.60 Td (exchange ) Tj ET Q q 0 0 0 rg BT 533.09 292.60 Td (in ) Tj ET Q q 0 0 0 rg BT 543.37 292.60 Td (2015.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 272.60 Td (Baraclude) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 77.66 272.60 Td ( ) Tj ET Q q 0 0 0 rg BT 80.16 272.60 Td (— ) Tj ET Q q 0 0 0 rg BT 92.66 272.60 Td (an ) Tj ET Q q 0 0 0 rg BT 104.59 272.60 Td (oral ) Tj ET Q q 0 0 0 rg BT 122.64 272.60 Td (antiviral ) Tj ET Q q 0 0 0 rg BT 158.46 272.60 Td (agent ) Tj ET Q q 0 0 0 rg BT 182.62 272.60 Td (for ) Tj ET Q q 0 0 0 rg BT 196.78 272.60 Td (the ) Tj ET Q q 0 0 0 rg BT 211.49 272.60 Td (treatment ) Tj ET Q q 0 0 0 rg BT 251.75 272.60 Td (of ) Tj ET Q q 0 0 0 rg BT 262.58 272.60 Td (chronic ) Tj ET Q q 0 0 0 rg BT 295.07 272.60 Td (hepatitis ) Tj ET Q q 0 0 0 rg BT 331.45 272.60 Td (B.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 36.00 256.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 256.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.28 256.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.32 256.60 Td (continued ) Tj ET Q q 0 0 0 rg BT 154.25 256.60 Td (to ) Tj ET Q q 0 0 0 rg BT 164.53 256.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 201.45 256.60 Td (in ) Tj ET Q q 0 0 0 rg BT 211.72 256.60 Td (both ) Tj ET Q q 0 0 0 rg BT 232.00 256.60 Td (periods ) Tj ET Q q 0 0 0 rg BT 263.94 256.60 Td (due ) Tj ET Q q 0 0 0 rg BT 280.88 256.60 Td (to ) Tj ET Q q 0 0 0 rg BT 291.16 256.60 Td (the ) Tj ET Q q 0 0 0 rg BT 305.88 256.60 Td (loss ) Tj ET Q q 0 0 0 rg BT 323.94 256.60 Td (of ) Tj ET Q q 0 0 0 rg BT 334.77 256.60 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 381.15 256.60 Td (in ) Tj ET Q q 0 0 0 rg BT 391.43 256.60 Td (September ) Tj ET Q q 0 0 0 rg BT 436.69 256.60 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 240.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 240.60 Td (International ) Tj ET Q q 0 0 0 rg BT 107.72 240.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 145.88 240.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 187.92 240.60 Td (in ) Tj ET Q q 0 0 0 rg BT 198.33 240.60 Td (2016 ) Tj ET Q q 0 0 0 rg BT 220.95 240.60 Td (following ) Tj ET Q q 0 0 0 rg BT 262.47 240.60 Td (the ) Tj ET Q q 0 0 0 rg BT 277.31 240.60 Td (loss ) Tj ET Q q 0 0 0 rg BT 295.50 240.60 Td (of ) Tj ET Q q 0 0 0 rg BT 306.46 240.60 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 352.96 240.60 Td (in ) Tj ET Q q 0 0 0 rg BT 363.37 240.60 Td (South ) Tj ET Q q 0 0 0 rg BT 389.34 240.60 Td (Korea ) Tj ET Q q 0 0 0 rg BT 416.39 240.60 Td (in ) Tj ET Q q 0 0 0 rg BT 426.80 240.60 Td (October ) Tj ET Q q 0 0 0 rg BT 461.63 240.60 Td (2015. ) Tj ET Q q 0 0 0 rg BT 486.76 240.60 Td (International ) Tj ET Q q 0 0 0 rg BT 540.47 240.60 Td (revenues ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 228.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 95.91 228.60 Td (in ) Tj ET Q q 0 0 0 rg BT 106.19 228.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 128.69 228.60 Td (due ) Tj ET Q q 0 0 0 rg BT 145.63 228.60 Td (to ) Tj ET Q q 0 0 0 rg BT 155.91 228.60 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 206.16 228.60 Td (foreign ) Tj ET Q q 0 0 0 rg BT 237.54 228.60 Td (exchange ) Tj ET Q q 0 0 0 rg BT 277.79 228.60 Td (partially ) Tj ET Q q 0 0 0 rg BT 313.61 228.60 Td (of) Tj ET Q q 0 0 0 rg BT 321.76 228.60 Td (fset ) Tj ET Q q 0 0 0 rg BT 338.70 228.60 Td (by ) Tj ET Q q 0 0 0 rg BT 351.20 228.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 379.25 228.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 413.40 228.60 Td (in ) Tj ET Q q 0 0 0 rg BT 423.68 228.60 Td (certain ) Tj ET Q q 0 0 0 rg BT 453.38 228.60 Td (countries.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 208.60 Td (Hepatitis ) Tj ET Q q 0 0 0 rg BT 74.60 208.60 Td (C ) Tj ET Q q 0 0 0 rg BT 83.77 208.60 Td (Franchise ) Tj ET Q q 0 0 0 rg BT 125.15 208.60 Td (— ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 137.65 208.60 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 173.76 208.60 Td ( ) Tj ET Q q 0 0 0 rg BT 176.26 208.60 Td (- ) Tj ET Q q 0 0 0 rg BT 182.09 208.60 Td (an ) Tj ET Q q 0 0 0 rg BT 194.03 208.60 Td (NS5A) Tj ET Q q 0 0 0 rg BT 218.48 208.60 Td ( ) Tj ET Q q 0 0 0 rg BT 220.98 208.60 Td (replication ) Tj ET Q q 0 0 0 rg BT 266.24 208.60 Td (complex ) Tj ET Q q 0 0 0 rg BT 303.17 208.60 Td (inhibitor; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 342.89 208.60 Td (Sunvepra) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.66 208.60 Td ( ) Tj ET Q q 0 0 0 rg BT 383.16 208.60 Td (- ) Tj ET Q q 0 0 0 rg BT 388.99 208.60 Td (an ) Tj ET Q q 0 0 0 rg BT 400.93 208.60 Td (NS3 ) Tj ET Q q 0 0 0 rg BT 421.21 208.60 Td (protease ) Tj ET Q q 0 0 0 rg BT 457.03 208.60 Td (inhibitor) Tj ET Q q 0 0 0 rg BT 490.92 208.60 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 192.60 Td (• ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 54.00 192.60 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 90.11 192.60 Td ( ) Tj ET Q q 0 0 0 rg BT 92.61 192.60 Td (was ) Tj ET Q q 0 0 0 rg BT 110.66 192.60 Td (launched ) Tj ET Q q 0 0 0 rg BT 149.25 192.60 Td (in ) Tj ET Q q 0 0 0 rg BT 159.53 192.60 Td (the ) Tj ET Q q 0 0 0 rg BT 174.25 192.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 194.53 192.60 Td (in ) Tj ET Q q 0 0 0 rg BT 204.81 192.60 Td (July ) Tj ET Q q 0 0 0 rg BT 223.98 192.60 Td (2015. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 176.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 176.60 Td (International ) Tj ET Q q 0 0 0 rg BT 106.82 176.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 144.09 176.60 Td (decreased ) Tj ET Q q 0 0 0 rg BT 185.24 176.60 Td (in ) Tj ET Q q 0 0 0 rg BT 194.75 176.60 Td (2016 ) Tj ET Q q 0 0 0 rg BT 216.49 176.60 Td (due ) Tj ET Q q 0 0 0 rg BT 232.66 176.60 Td (to ) Tj ET Q q 0 0 0 rg BT 242.17 176.60 Td (lower ) Tj ET Q q 0 0 0 rg BT 266.67 176.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 300.06 176.60 Td (resulting ) Tj ET Q q 0 0 0 rg BT 336.79 176.60 Td (from ) Tj ET Q q 0 0 0 rg BT 357.96 176.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 397.45 176.60 Td (competition, ) Tj ET Q q 0 0 0 rg BT 449.45 176.60 Td (primarily ) Tj ET Q q 0 0 0 rg BT 488.39 176.60 Td (in ) Tj ET Q q 0 0 0 rg BT 497.91 176.60 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 524.91 176.60 Td (International ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 164.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 92.26 164.60 Td (in ) Tj ET Q q 0 0 0 rg BT 102.76 164.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 125.49 164.60 Td (also ) Tj ET Q q 0 0 0 rg BT 144.32 164.60 Td (included ) Tj ET Q q 0 0 0 rg BT 181.48 164.60 Td (the ) Tj ET Q q 0 0 0 rg BT 196.42 164.60 Td (recognition ) Tj ET Q q 0 0 0 rg BT 244.69 164.60 Td (of ) Tj ET Q q 0 0 0 rg BT 255.74 164.60 Td (approximately ) Tj ET Q q 0 0 0 rg BT 316.23 164.60 Td ($170 ) Tj ET Q q 0 0 0 rg BT 338.95 164.60 Td (million ) Tj ET Q q 0 0 0 rg BT 370.57 164.60 Td (of ) Tj ET Q q 0 0 0 rg BT 381.62 164.60 Td (previously ) Tj ET Q q 0 0 0 rg BT 426.56 164.60 Td (deferred ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 462.59 164.60 Td (Daklinza ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.43 164.60 Td (revenue ) Tj ET Q q 0 0 0 rg BT 535.80 164.60 Td (in ) Tj ET Q q 0 0 0 rg BT 546.30 164.60 Td (France. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 152.60 Td (International ) Tj ET Q q 0 0 0 rg BT 107.67 152.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 145.79 152.60 Td (increased ) Tj ET Q q 0 0 0 rg BT 186.12 152.60 Td (in ) Tj ET Q q 0 0 0 rg BT 196.48 152.60 Td (2015 ) Tj ET Q q 0 0 0 rg BT 219.06 152.60 Td (due ) Tj ET Q q 0 0 0 rg BT 236.08 152.60 Td (to ) Tj ET Q q 0 0 0 rg BT 246.44 152.60 Td (higher ) Tj ET Q q 0 0 0 rg BT 274.57 152.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 308.80 152.60 Td (following ) Tj ET Q q 0 0 0 rg BT 350.27 152.60 Td (the ) Tj ET Q q 0 0 0 rg BT 365.07 152.60 Td (launch ) Tj ET Q q 0 0 0 rg BT 394.30 152.60 Td (in ) Tj ET Q q 0 0 0 rg BT 404.66 152.60 Td (certain ) Tj ET Q q 0 0 0 rg BT 434.44 152.60 Td (EU ) Tj ET Q q 0 0 0 rg BT 450.35 152.60 Td (countries ) Tj ET Q q 0 0 0 rg BT 489.59 152.60 Td (and ) Tj ET Q q 0 0 0 rg BT 506.61 152.60 Td (Japan ) Tj ET Q q 0 0 0 rg BT 531.96 152.60 Td (in ) Tj ET Q q 0 0 0 rg BT 542.32 152.60 Td (the ) Tj ET Q q 0 0 0 rg BT 557.12 152.60 Td (third ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 140.60 Td (quarter ) Tj ET Q q 0 0 0 rg BT 84.82 140.60 Td (of ) Tj ET Q q 0 0 0 rg BT 95.65 140.60 Td (2014 ) Tj ET Q q 0 0 0 rg BT 118.15 140.60 Td (and ) Tj ET Q q 0 0 0 rg BT 135.08 140.60 Td (the ) Tj ET Q q 0 0 0 rg BT 149.80 140.60 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 196.74 140.60 Td (approvals ) Tj ET Q q 0 0 0 rg BT 238.12 140.60 Td (in ) Tj ET Q q 0 0 0 rg BT 248.39 140.60 Td (other ) Tj ET Q q 0 0 0 rg BT 271.44 140.60 Td (international ) Tj ET Q q 0 0 0 rg BT 324.48 140.60 Td (markets ) Tj ET Q q 0 0 0 rg BT 358.63 140.60 Td (in ) Tj ET Q q 0 0 0 rg BT 368.91 140.60 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 124.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 124.60 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 76.06 124.60 Td (and ) Tj ET Q q 0 0 0 rg BT 94.78 124.60 Td (international ) Tj ET Q q 0 0 0 rg BT 149.59 124.60 Td (revenues ) Tj ET Q q 0 0 0 rg BT 189.41 124.60 Td (are ) Tj ET Q q 0 0 0 rg BT 205.89 124.60 Td (expected ) Tj ET Q q 0 0 0 rg BT 245.70 124.60 Td (to ) Tj ET Q q 0 0 0 rg BT 257.75 124.60 Td (significantly ) Tj ET Q q 0 0 0 rg BT 312.02 124.60 Td (decline ) Tj ET Q q 0 0 0 rg BT 345.17 124.60 Td (in ) Tj ET Q q 0 0 0 rg BT 357.23 124.60 Td (2017 ) Tj ET Q q 0 0 0 rg BT 381.50 124.60 Td (due ) Tj ET Q q 0 0 0 rg BT 400.22 124.60 Td (to ) Tj ET Q q 0 0 0 rg BT 412.28 124.60 Td (lower ) Tj ET Q q 0 0 0 rg BT 439.32 124.60 Td (demand ) Tj ET Q q 0 0 0 rg BT 475.25 124.60 Td (resulting ) Tj ET Q q 0 0 0 rg BT 514.53 124.60 Td (from ) Tj ET Q q 0 0 0 rg BT 538.24 124.60 Td (increased ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 112.60 Td (competition.) Tj ET Q endstream endobj 71 0 obj <> endobj 72 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (35) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Reyataz ) Tj ET Q q 0 0 0 rg BT 70.03 749.10 Td (Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 110.58 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 112.96 749.10 Td (—Includes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 159.22 749.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 190.87 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 193.25 749.10 Td (- ) Tj ET Q q 0 0 0 rg BT 198.96 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 205.78 749.10 Td (protease ) Tj ET Q q 0 0 0 rg BT 241.47 749.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 278.30 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 292.34 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 306.93 749.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 347.07 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 357.78 749.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 375.37 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 377.75 749.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 394.57 749.10 Td (Evotaz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.79 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 424.17 749.10 Td (\(atazanavir ) Tj ET Q q 0 0 0 rg BT 470.96 749.10 Td (300 ) Tj ET Q q 0 0 0 rg BT 488.33 749.10 Td (mg ) Tj ET Q q 0 0 0 rg BT 503.49 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 520.31 749.10 Td (cobicistat ) Tj ET Q q 0 0 0 rg BT 561.01 749.10 Td (150 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (mg\) ) Tj ET Q q 0 0 0 rg BT 54.61 737.10 Td (- ) Tj ET Q q 0 0 0 rg BT 60.44 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 67.38 737.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 119.87 737.10 Td (therapy ) Tj ET Q q 0 0 0 rg BT 152.35 737.10 Td (containing ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 197.06 737.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.72 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 231.22 737.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 248.16 737.10 Td (T) Tj ET Q q 0 0 0 rg BT 252.98 737.10 Td (ybost*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.09 737.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 722.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 722.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.54 722.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.83 722.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 155.01 722.10 Td (to ) Tj ET Q q 0 0 0 rg BT 165.54 722.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 202.71 722.10 Td (in ) Tj ET Q q 0 0 0 rg BT 213.24 722.10 Td (both ) Tj ET Q q 0 0 0 rg BT 233.77 722.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 265.96 722.10 Td (due ) Tj ET Q q 0 0 0 rg BT 283.16 722.10 Td (to ) Tj ET Q q 0 0 0 rg BT 293.69 722.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 319.21 722.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 353.62 722.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 391.37 722.10 Td (from ) Tj ET Q q 0 0 0 rg BT 413.56 722.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 454.06 722.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 504.58 722.10 Td (partially ) Tj ET Q q 0 0 0 rg BT 540.66 722.10 Td (of) Tj ET Q q 0 0 0 rg BT 548.81 722.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 566.00 722.10 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 710.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 81.84 710.10 Td (average ) Tj ET Q q 0 0 0 rg BT 115.22 710.10 Td (net ) Tj ET Q q 0 0 0 rg BT 129.73 710.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 158.69 710.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 184.86 710.10 Td (in ) Tj ET Q q 0 0 0 rg BT 194.94 710.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 219.57 710.10 Td (The ) Tj ET Q q 0 0 0 rg BT 237.41 710.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 255.26 710.10 Td (of ) Tj ET Q q 0 0 0 rg BT 265.89 710.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 312.07 710.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 326.02 710.10 Td (Reyataz) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.68 710.10 Td ( ) Tj ET Q q 0 0 0 rg BT 359.97 710.10 Td (is ) Tj ET Q q 0 0 0 rg BT 368.94 710.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 406.76 710.10 Td (in ) Tj ET Q q 0 0 0 rg BT 416.84 710.10 Td (December ) Tj ET Q q 0 0 0 rg BT 460.22 710.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 482.51 710.10 Td (and ) Tj ET Q q 0 0 0 rg BT 499.24 710.10 Td (we ) Tj ET Q q 0 0 0 rg BT 513.20 710.10 Td (may ) Tj ET Q q 0 0 0 rg BT 532.71 710.10 Td (experience ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 698.10 Td (a ) Tj ET Q q 0 0 0 rg BT 60.94 698.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 88.99 698.10 Td (decline ) Tj ET Q q 0 0 0 rg BT 120.36 698.10 Td (in ) Tj ET Q q 0 0 0 rg BT 130.64 698.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 164.78 698.10 Td (in ) Tj ET Q q 0 0 0 rg BT 175.06 698.10 Td (future ) Tj ET Q q 0 0 0 rg BT 201.44 698.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 233.38 698.10 Td (due ) Tj ET Q q 0 0 0 rg BT 250.31 698.10 Td (to ) Tj ET Q q 0 0 0 rg BT 260.59 698.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 292.52 698.10 Td (competition.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 683.10 Td (International ) Tj ET Q q 0 0 0 rg BT 109.32 683.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 149.09 683.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 192.76 683.10 Td (to ) Tj ET Q q 0 0 0 rg BT 204.77 683.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 243.41 683.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.42 683.10 Td (both ) Tj ET Q q 0 0 0 rg BT 277.44 683.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 311.11 683.10 Td (due ) Tj ET Q q 0 0 0 rg BT 329.78 683.10 Td (to ) Tj ET Q q 0 0 0 rg BT 341.79 683.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 368.79 683.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 404.68 683.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 443.90 683.10 Td (from ) Tj ET Q q 0 0 0 rg BT 467.58 683.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 509.56 683.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 561.56 683.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 671.10 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 104.25 671.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 135.63 671.10 Td (exchange.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 651.10 Td (Sustiva ) Tj ET Q q 0 0 0 rg BT 67.18 651.10 Td (Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 107.73 651.10 Td ( ) Tj ET Q q 0 0 0 rg BT 110.02 651.10 Td (— ) Tj ET Q q 0 0 0 rg BT 122.31 651.10 Td ( a ) Tj ET Q q 0 0 0 rg BT 131.54 651.10 Td (non-nucleoside ) Tj ET Q q 0 0 0 rg BT 194.92 651.10 Td (reverse ) Tj ET Q q 0 0 0 rg BT 226.08 651.10 Td (transcriptase ) Tj ET Q q 0 0 0 rg BT 278.91 651.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 315.64 651.10 Td (for ) Tj ET Q q 0 0 0 rg BT 329.59 651.10 Td (the ) Tj ET Q q 0 0 0 rg BT 344.10 651.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 384.15 651.10 Td (of ) Tj ET Q q 0 0 0 rg BT 394.77 651.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 411.26 651.10 Td (, ) Tj ET Q q 0 0 0 rg BT 416.05 651.10 Td (which ) Tj ET Q q 0 0 0 rg BT 442.78 651.10 Td (includes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 478.40 651.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.28 651.10 Td (, ) Tj ET Q q 0 0 0 rg BT 512.07 651.10 Td (an ) Tj ET Q q 0 0 0 rg BT 523.80 651.10 Td (antiretroviral ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 639.10 Td (drug, ) Tj ET Q q 0 0 0 rg BT 59.33 639.10 Td (and ) Tj ET Q q 0 0 0 rg BT 76.27 639.10 Td (bulk ) Tj ET Q q 0 0 0 rg BT 96.55 639.10 Td (efavirenz, ) Tj ET Q q 0 0 0 rg BT 138.74 639.10 Td (which ) Tj ET Q q 0 0 0 rg BT 165.68 639.10 Td (is ) Tj ET Q q 0 0 0 rg BT 174.85 639.10 Td (also ) Tj ET Q q 0 0 0 rg BT 193.46 639.10 Td (included ) Tj ET Q q 0 0 0 rg BT 230.39 639.10 Td (in ) Tj ET Q q 0 0 0 rg BT 240.67 639.10 Td (the ) Tj ET Q q 0 0 0 rg BT 255.38 639.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 307.88 639.10 Td (therapy) Tj ET Q q 0 0 0 rg BT 337.21 639.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 342.21 639.10 Td (Atripla*.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 623.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.54 623.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.83 623.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 155.01 623.10 Td (to ) Tj ET Q q 0 0 0 rg BT 165.54 623.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 202.71 623.10 Td (in ) Tj ET Q q 0 0 0 rg BT 213.24 623.10 Td (both ) Tj ET Q q 0 0 0 rg BT 233.77 623.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 265.96 623.10 Td (due ) Tj ET Q q 0 0 0 rg BT 283.16 623.10 Td (to ) Tj ET Q q 0 0 0 rg BT 293.69 623.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 319.21 623.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 353.62 623.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 391.37 623.10 Td (from ) Tj ET Q q 0 0 0 rg BT 413.56 623.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 454.06 623.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 504.58 623.10 Td (partially ) Tj ET Q q 0 0 0 rg BT 540.66 623.10 Td (of) Tj ET Q q 0 0 0 rg BT 548.81 623.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 566.00 623.10 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 611.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 81.23 611.10 Td (average ) Tj ET Q q 0 0 0 rg BT 114.00 611.10 Td (net ) Tj ET Q q 0 0 0 rg BT 127.90 611.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 156.25 611.10 Td (prices. ) Tj ET Q q 0 0 0 rg BT 184.19 611.10 Td (The ) Tj ET Q q 0 0 0 rg BT 201.42 611.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 218.66 611.10 Td (of ) Tj ET Q q 0 0 0 rg BT 228.67 611.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 274.24 611.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 287.58 611.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 316.47 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 318.15 611.10 Td (is ) Tj ET Q q 0 0 0 rg BT 326.51 611.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 363.72 611.10 Td (in ) Tj ET Q q 0 0 0 rg BT 373.19 611.10 Td (December ) Tj ET Q q 0 0 0 rg BT 415.95 611.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 437.64 611.10 Td (which ) Tj ET Q q 0 0 0 rg BT 463.76 611.10 Td (may ) Tj ET Q q 0 0 0 rg BT 482.66 611.10 Td (result ) Tj ET Q q 0 0 0 rg BT 506.56 611.10 Td (in ) Tj ET Q q 0 0 0 rg BT 516.02 611.10 Td (the ) Tj ET Q q 0 0 0 rg BT 529.92 611.10 Td (termination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 599.10 Td (of ) Tj ET Q q 0 0 0 rg BT 64.83 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 79.55 599.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 100.38 599.10 Td (venture ) Tj ET Q q 0 0 0 rg BT 132.87 599.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 177.01 599.10 Td (with ) Tj ET Q q 0 0 0 rg BT 197.29 599.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 226.44 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 243.38 599.10 Td (may ) Tj ET Q q 0 0 0 rg BT 263.10 599.10 Td (further ) Tj ET Q q 0 0 0 rg BT 292.80 599.10 Td (reduce ) Tj ET Q q 0 0 0 rg BT 321.95 599.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 359.99 599.10 Td (beyond ) Tj ET Q q 0 0 0 rg BT 391.92 599.10 Td (2017.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 583.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 583.10 Td (International ) Tj ET Q q 0 0 0 rg BT 107.59 583.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 145.63 583.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 187.56 583.10 Td (to ) Tj ET Q q 0 0 0 rg BT 197.84 583.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 234.75 583.10 Td (in ) Tj ET Q q 0 0 0 rg BT 245.03 583.10 Td (both ) Tj ET Q q 0 0 0 rg BT 265.31 583.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 297.25 583.10 Td (due ) Tj ET Q q 0 0 0 rg BT 314.19 583.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 324.46 583.10 Td (Sustiva's) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.38 583.10 Td ( ) Tj ET Q q 0 0 0 rg BT 361.88 583.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 379.94 583.10 Td (of ) Tj ET Q q 0 0 0 rg BT 390.77 583.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 437.15 583.10 Td (in ) Tj ET Q q 0 0 0 rg BT 447.43 583.10 Td (Europe ) Tj ET Q q 0 0 0 rg BT 478.81 583.10 Td (in ) Tj ET Q q 0 0 0 rg BT 489.09 583.10 Td (November ) Tj ET Q q 0 0 0 rg BT 533.79 583.10 Td (2013.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 563.10 Td (Abilify* ) Tj ET Q q 0 0 0 rg BT 70.16 563.10 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.05 563.10 Td (an ) Tj ET Q q 0 0 0 rg BT 90.99 563.10 Td (antipsychotic ) Tj ET Q q 0 0 0 rg BT 146.81 563.10 Td (agent ) Tj ET Q q 0 0 0 rg BT 170.97 563.10 Td (for ) Tj ET Q q 0 0 0 rg BT 185.13 563.10 Td (the ) Tj ET Q q 0 0 0 rg BT 199.84 563.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 240.10 563.10 Td (of ) Tj ET Q q 0 0 0 rg BT 250.93 563.10 Td (schizophrenia, ) Tj ET Q q 0 0 0 rg BT 311.46 563.10 Td (bipolar ) Tj ET Q q 0 0 0 rg BT 342.29 563.10 Td (mania ) Tj ET Q q 0 0 0 rg BT 369.22 563.10 Td (disorder ) Tj ET Q q 0 0 0 rg BT 404.49 563.10 Td (and ) Tj ET Q q 0 0 0 rg BT 421.43 563.10 Td (major ) Tj ET Q q 0 0 0 rg BT 447.25 563.10 Td (depressive ) Tj ET Q q 0 0 0 rg BT 491.96 563.10 Td (disorder) Tj ET Q q 0 0 0 rg BT 524.18 563.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 548.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 548.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.28 548.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 151.19 548.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 176.47 548.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 186.75 548.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.41 548.10 Td ( ) Tj ET Q q 0 0 0 rg BT 220.91 548.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 253.39 548.10 Td (in ) Tj ET Q q 0 0 0 rg BT 263.12 548.10 Td (April ) Tj ET Q q 0 0 0 rg BT 286.73 548.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 533.10 Td (International ) Tj ET Q q 0 0 0 rg BT 108.42 533.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 147.28 533.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 190.03 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 201.13 533.10 Td (both ) Tj ET Q q 0 0 0 rg BT 222.24 533.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 255.01 533.10 Td (following ) Tj ET Q q 0 0 0 rg BT 297.23 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 312.77 533.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 356.64 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 368.30 533.10 Td (our ) Tj ET Q q 0 0 0 rg BT 384.96 533.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 401.62 533.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 479.36 533.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 505.47 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 516.57 533.10 Td (June ) Tj ET Q q 0 0 0 rg BT 538.23 533.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 561.56 533.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 521.10 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 84.83 521.10 Td (becoming ) Tj ET Q q 0 0 0 rg BT 126.76 521.10 Td (the ) Tj ET Q q 0 0 0 rg BT 141.48 521.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 179.52 521.10 Td (for ) Tj ET Q q 0 0 0 rg BT 193.68 521.10 Td (the ) Tj ET Q q 0 0 0 rg BT 208.40 521.10 Td (end ) Tj ET Q q 0 0 0 rg BT 225.34 521.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 264.49 521.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 286.43 521.10 Td (in ) Tj ET Q q 0 0 0 rg BT 296.71 521.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 326.41 521.10 Td (markets.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 501.10 Td (Mature ) Tj ET Q q 0 0 0 rg BT 67.13 501.10 Td (Products ) Tj ET Q q 0 0 0 rg BT 104.38 501.10 Td (and ) Tj ET Q q 0 0 0 rg BT 120.58 501.10 Td (All ) Tj ET Q q 0 0 0 rg BT 135.61 501.10 Td (Other ) Tj ET Q q 0 0 0 rg BT 160.63 501.10 Td (— ) Tj ET Q q 0 0 0 rg BT 172.89 501.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 208.46 501.10 Td (all ) Tj ET Q q 0 0 0 rg BT 220.71 501.10 Td (other ) Tj ET Q q 0 0 0 rg BT 243.51 501.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 282.70 501.10 Td (including ) Tj ET Q q 0 0 0 rg BT 322.73 501.10 Td (those ) Tj ET Q q 0 0 0 rg BT 346.09 501.10 Td (which ) Tj ET Q q 0 0 0 rg BT 372.79 501.10 Td (have ) Tj ET Q q 0 0 0 rg BT 393.92 501.10 Td (lost ) Tj ET Q q 0 0 0 rg BT 410.62 501.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 456.75 501.10 Td (in ) Tj ET Q q 0 0 0 rg BT 466.78 501.10 Td (major ) Tj ET Q q 0 0 0 rg BT 492.36 501.10 Td (markets, ) Tj ET Q q 0 0 0 rg BT 528.77 501.10 Td (the ) Tj ET Q q 0 0 0 rg BT 543.24 501.10 Td (diabetes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 489.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 69.59 489.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 109.03 489.10 Td (OTC ) Tj ET Q q 0 0 0 rg BT 131.53 489.10 Td (brands ) Tj ET Q q 0 0 0 rg BT 160.69 489.10 Td (and ) Tj ET Q q 0 0 0 rg BT 177.63 489.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 208.45 489.10 Td (revenue.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 474.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 474.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 73.91 474.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 111.58 474.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 153.13 474.10 Td (in ) Tj ET Q q 0 0 0 rg BT 163.04 474.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 185.17 474.10 Td (due ) Tj ET Q q 0 0 0 rg BT 201.74 474.10 Td (to ) Tj ET Q q 0 0 0 rg BT 211.65 474.10 Td (the ) Tj ET Q q 0 0 0 rg BT 226.00 474.10 Td (favorable ) Tj ET Q q 0 0 0 rg BT 265.88 474.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 295.23 474.10 Td (of ) Tj ET Q q 0 0 0 rg BT 305.69 474.10 Td (the ) Tj ET Q q 0 0 0 rg BT 320.04 474.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 341.60 474.10 Td (return ) Tj ET Q q 0 0 0 rg BT 367.61 474.10 Td (reserve ) Tj ET Q q 0 0 0 rg BT 398.61 474.10 Td (reduction ) Tj ET Q q 0 0 0 rg BT 438.51 474.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 452.30 474.10 Td (Plavix* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.97 474.10 Td (of ) Tj ET Q q 0 0 0 rg BT 495.43 474.10 Td ($63 ) Tj ET Q q 0 0 0 rg BT 512.56 474.10 Td (million ) Tj ET Q q 0 0 0 rg BT 543.59 474.10 Td (in ) Tj ET Q q 0 0 0 rg BT 553.50 474.10 Td (2015. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 462.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.28 462.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 112.32 462.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 154.23 462.10 Td (in ) Tj ET Q q 0 0 0 rg BT 164.51 462.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 187.01 462.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 226.72 462.10 Td (due ) Tj ET Q q 0 0 0 rg BT 243.66 462.10 Td (to ) Tj ET Q q 0 0 0 rg BT 253.94 462.10 Td (the ) Tj ET Q q 0 0 0 rg BT 268.66 462.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 303.92 462.10 Td (business ) Tj ET Q q 0 0 0 rg BT 340.31 462.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 385.03 462.10 Td (in ) Tj ET Q q 0 0 0 rg BT 395.30 462.10 Td (February ) Tj ET Q q 0 0 0 rg BT 433.90 462.10 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 447.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 447.10 Td (International ) Tj ET Q q 0 0 0 rg BT 107.59 447.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 145.62 447.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 187.53 447.10 Td (in ) Tj ET Q q 0 0 0 rg BT 197.81 447.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 220.31 447.10 Td (due ) Tj ET Q q 0 0 0 rg BT 237.24 447.10 Td (to ) Tj ET Q q 0 0 0 rg BT 247.52 447.10 Td (the ) Tj ET Q q 0 0 0 rg BT 262.23 447.10 Td (expiration ) Tj ET Q q 0 0 0 rg BT 305.27 447.10 Td (of ) Tj ET Q q 0 0 0 rg BT 316.10 447.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 345.80 447.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 374.97 447.10 Td (arrangements, ) Tj ET Q q 0 0 0 rg BT 433.83 447.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 459.09 447.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 481.03 447.10 Td (due ) Tj ET Q q 0 0 0 rg BT 497.96 447.10 Td (to ) Tj ET Q q 0 0 0 rg BT 508.24 447.10 Td (the ) Tj ET Q q 0 0 0 rg BT 522.96 447.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 567.66 447.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 435.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 82.91 435.10 Td (mature ) Tj ET Q q 0 0 0 rg BT 112.37 435.10 Td (and ) Tj ET Q q 0 0 0 rg BT 128.51 435.10 Td (other ) Tj ET Q q 0 0 0 rg BT 150.76 435.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 189.41 435.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 228.86 435.10 Td (competition ) Tj ET Q q 0 0 0 rg BT 278.33 435.10 Td (for ) Tj ET Q q 0 0 0 rg BT 291.70 435.10 Td (OTC ) Tj ET Q q 0 0 0 rg BT 313.40 435.10 Td (products ) Tj ET Q q 0 0 0 rg BT 349.54 435.10 Td (and ) Tj ET Q q 0 0 0 rg BT 365.68 435.10 Td (unfavorable ) Tj ET Q q 0 0 0 rg BT 415.14 435.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 445.72 435.10 Td (exchange. ) Tj ET Q q 0 0 0 rg BT 487.68 435.10 Td (International ) Tj ET Q q 0 0 0 rg BT 540.47 435.10 Td (revenues ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 423.10 Td (decreased ) Tj ET Q q 0 0 0 rg BT 95.50 423.10 Td (in ) Tj ET Q q 0 0 0 rg BT 105.37 423.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 127.46 423.10 Td (due ) Tj ET Q q 0 0 0 rg BT 143.99 423.10 Td (to ) Tj ET Q q 0 0 0 rg BT 153.85 423.10 Td (the ) Tj ET Q q 0 0 0 rg BT 168.16 423.10 Td (expiration/transfer ) Tj ET Q q 0 0 0 rg BT 244.11 423.10 Td (of ) Tj ET Q q 0 0 0 rg BT 254.52 423.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 283.82 423.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 322.01 423.10 Td (and ) Tj ET Q q 0 0 0 rg BT 338.54 423.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 368.95 423.10 Td (rights, ) Tj ET Q q 0 0 0 rg BT 396.32 423.10 Td (the ) Tj ET Q q 0 0 0 rg BT 410.62 423.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 445.47 423.10 Td (business ) Tj ET Q q 0 0 0 rg BT 481.46 423.10 Td (divestiture, ) Tj ET Q q 0 0 0 rg BT 528.26 423.10 Td (unfavorable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 411.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 85.38 411.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 125.63 411.10 Td (and ) Tj ET Q q 0 0 0 rg BT 142.57 411.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 184.50 411.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 216.43 411.10 Td (erosion.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 387.10 Td (Estimated End-User Demand) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 369.10 Td (Pursuant ) Tj ET Q q 0 0 0 rg BT 73.77 369.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.32 369.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.31 369.10 Td (SEC ) Tj ET Q q 0 0 0 rg BT 120.42 369.10 Td (Consent ) Tj ET Q q 0 0 0 rg BT 155.96 369.10 Td (Order ) Tj ET Q q 0 0 0 rg BT 182.05 369.10 Td (described ) Tj ET Q q 0 0 0 rg BT 223.14 369.10 Td (below ) Tj ET Q q 0 0 0 rg BT 250.35 369.10 Td (under ) Tj ET Q q 0 0 0 rg BT 275.89 369.10 Td (“—SEC ) Tj ET Q q 0 0 0 rg BT 311.43 369.10 Td (Consent ) Tj ET Q q 0 0 0 rg BT 346.98 369.10 Td (Order”, ) Tj ET Q q 0 0 0 rg BT 380.01 369.10 Td (we ) Tj ET Q q 0 0 0 rg BT 394.44 369.10 Td (monitor ) Tj ET Q q 0 0 0 rg BT 428.88 369.10 Td (the ) Tj ET Q q 0 0 0 rg BT 443.86 369.10 Td (level ) Tj ET Q q 0 0 0 rg BT 466.07 369.10 Td (of ) Tj ET Q q 0 0 0 rg BT 477.17 369.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 518.26 369.10 Td (on ) Tj ET Q q 0 0 0 rg BT 531.03 369.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 553.24 369.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.79 369.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 357.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 56.87 357.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 103.27 357.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 152.47 357.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 186.66 357.10 Td (and ) Tj ET Q q 0 0 0 rg BT 204.18 357.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 236.16 357.10 Td (of ) Tj ET Q q 0 0 0 rg BT 247.57 357.10 Td (the ) Tj ET Q q 0 0 0 rg BT 262.88 357.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 283.75 357.10 Td (in ) Tj ET Q q 0 0 0 rg BT 294.61 357.10 Td (the ) Tj ET Q q 0 0 0 rg BT 309.92 357.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 335.77 357.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 375.51 357.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 424.71 357.10 Td (channel. ) Tj ET Q q 0 0 0 rg BT 461.17 357.10 Td (W) Tj ET Q q 0 0 0 rg BT 469.81 357.10 Td (e ) Tj ET Q q 0 0 0 rg BT 477.33 357.10 Td (are ) Tj ET Q q 0 0 0 rg BT 492.63 357.10 Td (obligated ) Tj ET Q q 0 0 0 rg BT 532.93 357.10 Td (to ) Tj ET Q q 0 0 0 rg BT 543.79 357.10 Td (disclose ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 345.10 Td (products ) Tj ET Q q 0 0 0 rg BT 73.49 345.10 Td (with ) Tj ET Q q 0 0 0 rg BT 94.32 345.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 120.69 345.10 Td (of ) Tj ET Q q 0 0 0 rg BT 132.07 345.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 173.44 345.10 Td (in ) Tj ET Q q 0 0 0 rg BT 184.27 345.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 213.42 345.10 Td (of ) Tj ET Q q 0 0 0 rg BT 224.80 345.10 Td (one ) Tj ET Q q 0 0 0 rg BT 242.29 345.10 Td (month ) Tj ET Q q 0 0 0 rg BT 270.89 345.10 Td (on ) Tj ET Q q 0 0 0 rg BT 283.94 345.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 306.43 345.10 Td (or ) Tj ET Q q 0 0 0 rg BT 317.81 345.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 356.39 345.10 Td (demand, ) Tj ET Q q 0 0 0 rg BT 393.60 345.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 424.97 345.10 Td (to ) Tj ET Q q 0 0 0 rg BT 435.80 345.10 Td (a ) Tj ET Q q 0 0 0 rg BT 443.29 345.10 Td (de ) Tj ET Q q 0 0 0 rg BT 455.77 345.10 Td (minimis ) Tj ET Q q 0 0 0 rg BT 491.61 345.10 Td (exception. ) Tj ET Q q 0 0 0 rg BT 536.03 345.10 Td (Estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 333.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 61.58 333.10 Td (of ) Tj ET Q q 0 0 0 rg BT 72.16 333.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 112.74 333.10 Td (in ) Tj ET Q q 0 0 0 rg BT 122.77 333.10 Td (the ) Tj ET Q q 0 0 0 rg BT 137.24 333.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 185.60 333.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 218.95 333.10 Td (in ) Tj ET Q q 0 0 0 rg BT 228.98 333.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 257.33 333.10 Td (of ) Tj ET Q q 0 0 0 rg BT 267.91 333.10 Td (one ) Tj ET Q q 0 0 0 rg BT 284.60 333.10 Td (month ) Tj ET Q q 0 0 0 rg BT 312.41 333.10 Td (on ) Tj ET Q q 0 0 0 rg BT 324.67 333.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 346.36 333.10 Td (for ) Tj ET Q q 0 0 0 rg BT 360.27 333.10 Td (the ) Tj ET Q q 0 0 0 rg BT 374.74 333.10 Td (following ) Tj ET Q q 0 0 0 rg BT 415.88 333.10 Td (products ) Tj ET Q q 0 0 0 rg BT 452.57 333.10 Td (were ) Tj ET Q q 0 0 0 rg BT 474.25 333.10 Td (not ) Tj ET Q q 0 0 0 rg BT 489.28 333.10 Td (material ) Tj ET Q q 0 0 0 rg BT 524.29 333.10 Td (to ) Tj ET Q q 0 0 0 rg BT 534.32 333.10 Td (our ) Tj ET Q q 0 0 0 rg BT 549.91 333.10 Td (results ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 321.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.08 321.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 91.48 321.10 Td (as ) Tj ET Q q 0 0 0 rg BT 102.56 321.10 Td (of ) Tj ET Q q 0 0 0 rg BT 113.63 321.10 Td (the ) Tj ET Q q 0 0 0 rg BT 128.60 321.10 Td (dates ) Tj ET Q q 0 0 0 rg BT 151.89 321.10 Td (indicated. ) Tj ET Q q 0 0 0 rg BT 193.79 321.10 Td (No ) Tj ET Q q 0 0 0 rg BT 208.75 321.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 229.28 321.10 Td (products ) Tj ET Q q 0 0 0 rg BT 266.47 321.10 Td (had ) Tj ET Q q 0 0 0 rg BT 283.65 321.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 324.72 321.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 350.79 321.10 Td (of ) Tj ET Q q 0 0 0 rg BT 361.87 321.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 402.94 321.10 Td (in ) Tj ET Q q 0 0 0 rg BT 413.47 321.10 Td (the ) Tj ET Q q 0 0 0 rg BT 428.43 321.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 477.29 321.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 511.13 321.10 Td (in ) Tj ET Q q 0 0 0 rg BT 521.65 321.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 550.50 321.10 Td (of ) Tj ET Q q 0 0 0 rg BT 561.58 321.10 Td (one ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 309.10 Td (month ) Tj ET Q q 0 0 0 rg BT 63.73 309.10 Td (on ) Tj ET Q q 0 0 0 rg BT 75.91 309.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 97.52 309.10 Td (at ) Tj ET Q q 0 0 0 rg BT 106.91 309.10 Td (December ) Tj ET Q q 0 0 0 rg BT 150.17 309.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 164.84 309.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 189.52 309.10 Td (Below ) Tj ET Q q 0 0 0 rg BT 217.80 309.10 Td (are ) Tj ET Q q 0 0 0 rg BT 232.18 309.10 Td (international ) Tj ET Q q 0 0 0 rg BT 284.89 309.10 Td (products ) Tj ET Q q 0 0 0 rg BT 321.50 309.10 Td (that ) Tj ET Q q 0 0 0 rg BT 338.67 309.10 Td (had ) Tj ET Q q 0 0 0 rg BT 355.29 309.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 395.78 309.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 421.28 309.10 Td (of ) Tj ET Q q 0 0 0 rg BT 431.79 309.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 472.28 309.10 Td (in ) Tj ET Q q 0 0 0 rg BT 482.24 309.10 Td (the ) Tj ET Q q 0 0 0 rg BT 496.63 309.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 544.92 309.10 Td (channel ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 297.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 297.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 74.88 297.10 Td (of ) Tj ET Q q 0 0 0 rg BT 85.71 297.10 Td (one ) Tj ET Q q 0 0 0 rg BT 102.65 297.10 Td (month ) Tj ET Q q 0 0 0 rg BT 130.70 297.10 Td (on ) Tj ET Q q 0 0 0 rg BT 143.20 297.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 165.14 297.10 Td (at ) Tj ET Q q 0 0 0 rg BT 174.86 297.10 Td (September ) Tj ET Q q 0 0 0 rg BT 220.12 297.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 235.12 297.10 Td (2016.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 72.00 278.10 Td (Dafalgan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 109.78 278.10 Td (, ) Tj ET Q q 0 0 0 rg BT 113.73 278.10 Td (an ) Tj ET Q q 0 0 0 rg BT 124.62 278.10 Td (analgesic ) Tj ET Q q 0 0 0 rg BT 163.27 278.10 Td (product ) Tj ET Q q 0 0 0 rg BT 195.26 278.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 213.38 278.10 Td (principally ) Tj ET Q q 0 0 0 rg BT 258.15 278.10 Td (in ) Tj ET Q q 0 0 0 rg BT 267.38 278.10 Td (Europe, ) Tj ET Q q 0 0 0 rg BT 300.21 278.10 Td (had ) Tj ET Q q 0 0 0 rg BT 316.09 278.10 Td (1.2 ) Tj ET Q q 0 0 0 rg BT 330.04 278.10 Td (months ) Tj ET Q q 0 0 0 rg BT 360.94 278.10 Td (of ) Tj ET Q q 0 0 0 rg BT 370.72 278.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 410.49 278.10 Td (on ) Tj ET Q q 0 0 0 rg BT 421.94 278.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 442.83 278.10 Td (internationally ) Tj ET Q q 0 0 0 rg BT 502.59 278.10 Td (at ) Tj ET Q q 0 0 0 rg BT 511.26 278.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 535.47 278.10 Td (customers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 266.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 113.43 266.10 Td (to ) Tj ET Q q 0 0 0 rg BT 123.22 266.10 Td (1.2 ) Tj ET Q q 0 0 0 rg BT 137.73 266.10 Td (months ) Tj ET Q q 0 0 0 rg BT 169.19 266.10 Td (of ) Tj ET Q q 0 0 0 rg BT 179.53 266.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 219.86 266.10 Td (on ) Tj ET Q q 0 0 0 rg BT 231.87 266.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 253.32 266.10 Td (at ) Tj ET Q q 0 0 0 rg BT 262.54 266.10 Td (June ) Tj ET Q q 0 0 0 rg BT 282.88 266.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 297.39 266.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 321.76 266.10 Td (The ) Tj ET Q q 0 0 0 rg BT 339.31 266.10 Td (level ) Tj ET Q q 0 0 0 rg BT 360.76 266.10 Td (of ) Tj ET Q q 0 0 0 rg BT 371.10 266.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 411.43 266.10 Td (on ) Tj ET Q q 0 0 0 rg BT 423.44 266.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 444.89 266.10 Td (was ) Tj ET Q q 0 0 0 rg BT 462.45 266.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 501.67 266.10 Td (due ) Tj ET Q q 0 0 0 rg BT 518.12 266.10 Td (to ) Tj ET Q q 0 0 0 rg BT 527.90 266.10 Td (the ) Tj ET Q q 0 0 0 rg BT 542.13 266.10 Td (ordering ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 254.10 Td (patterns ) Tj ET Q q 0 0 0 rg BT 106.16 254.10 Td (of ) Tj ET Q q 0 0 0 rg BT 116.99 254.10 Td (pharmacists ) Tj ET Q q 0 0 0 rg BT 167.25 254.10 Td (in ) Tj ET Q q 0 0 0 rg BT 177.53 254.10 Td (France.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 72.00 235.10 Td (Efferalgan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 114.77 235.10 Td (, ) Tj ET Q q 0 0 0 rg BT 120.90 235.10 Td (an ) Tj ET Q q 0 0 0 rg BT 133.96 235.10 Td (analgesic ) Tj ET Q q 0 0 0 rg BT 174.79 235.10 Td (product ) Tj ET Q q 0 0 0 rg BT 208.96 235.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 229.25 235.10 Td (principally ) Tj ET Q q 0 0 0 rg BT 276.20 235.10 Td (in ) Tj ET Q q 0 0 0 rg BT 287.60 235.10 Td (Europe, ) Tj ET Q q 0 0 0 rg BT 322.60 235.10 Td (had ) Tj ET Q q 0 0 0 rg BT 340.67 235.10 Td (1.1 ) Tj ET Q q 0 0 0 rg BT 356.79 235.10 Td (months ) Tj ET Q q 0 0 0 rg BT 389.86 235.10 Td (of ) Tj ET Q q 0 0 0 rg BT 401.82 235.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 443.77 235.10 Td (on ) Tj ET Q q 0 0 0 rg BT 457.39 235.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 480.45 235.10 Td (internationally ) Tj ET Q q 0 0 0 rg BT 542.39 235.10 Td (at ) Tj ET Q q 0 0 0 rg BT 553.24 235.10 Td (direct ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 223.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 114.90 223.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 156.68 223.10 Td (to ) Tj ET Q q 0 0 0 rg BT 166.81 223.10 Td (1.2 ) Tj ET Q q 0 0 0 rg BT 181.66 223.10 Td (months ) Tj ET Q q 0 0 0 rg BT 213.46 223.10 Td (of ) Tj ET Q q 0 0 0 rg BT 224.15 223.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 264.83 223.10 Td (on ) Tj ET Q q 0 0 0 rg BT 277.18 223.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 298.97 223.10 Td (at ) Tj ET Q q 0 0 0 rg BT 308.54 223.10 Td (June ) Tj ET Q q 0 0 0 rg BT 329.23 223.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 344.08 223.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 368.76 223.10 Td (The ) Tj ET Q q 0 0 0 rg BT 386.66 223.10 Td (level ) Tj ET Q q 0 0 0 rg BT 408.45 223.10 Td (of ) Tj ET Q q 0 0 0 rg BT 419.13 223.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 459.81 223.10 Td (on ) Tj ET Q q 0 0 0 rg BT 472.17 223.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 493.96 223.10 Td (was ) Tj ET Q q 0 0 0 rg BT 511.86 223.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 551.43 223.10 Td (due ) Tj ET Q q 0 0 0 rg BT 568.22 223.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 211.10 Td (the ) Tj ET Q q 0 0 0 rg BT 86.72 211.10 Td (ordering ) Tj ET Q q 0 0 0 rg BT 123.09 211.10 Td (patterns ) Tj ET Q q 0 0 0 rg BT 157.25 211.10 Td (of ) Tj ET Q q 0 0 0 rg BT 168.08 211.10 Td (pharmacists ) Tj ET Q q 0 0 0 rg BT 218.34 211.10 Td (in ) Tj ET Q q 0 0 0 rg BT 228.62 211.10 Td (France.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 72.00 192.10 Td (Fervex) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 99.75 192.10 Td (, ) Tj ET Q q 0 0 0 rg BT 104.86 192.10 Td (a ) Tj ET Q q 0 0 0 rg BT 111.90 192.10 Td (cold ) Tj ET Q q 0 0 0 rg BT 131.72 192.10 Td (and ) Tj ET Q q 0 0 0 rg BT 148.76 192.10 Td (flu ) Tj ET Q q 0 0 0 rg BT 162.48 192.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 198.13 192.10 Td (had ) Tj ET Q q 0 0 0 rg BT 215.17 192.10 Td (4.8 ) Tj ET Q q 0 0 0 rg BT 230.27 192.10 Td (months ) Tj ET Q q 0 0 0 rg BT 262.33 192.10 Td (of ) Tj ET Q q 0 0 0 rg BT 273.26 192.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 314.19 192.10 Td (on ) Tj ET Q q 0 0 0 rg BT 326.79 192.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 348.84 192.10 Td (at ) Tj ET Q q 0 0 0 rg BT 358.66 192.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 384.02 192.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 427.17 192.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 469.20 192.10 Td (to ) Tj ET Q q 0 0 0 rg BT 479.58 192.10 Td (4.2 ) Tj ET Q q 0 0 0 rg BT 494.69 192.10 Td (months ) Tj ET Q q 0 0 0 rg BT 526.74 192.10 Td (of ) Tj ET Q q 0 0 0 rg BT 537.68 192.10 Td (inventory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 180.10 Td (on ) Tj ET Q q 0 0 0 rg BT 84.50 180.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 106.44 180.10 Td (at ) Tj ET Q q 0 0 0 rg BT 116.16 180.10 Td (June ) Tj ET Q q 0 0 0 rg BT 136.99 180.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 151.99 180.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 176.80 180.10 Td (The ) Tj ET Q q 0 0 0 rg BT 194.85 180.10 Td (level ) Tj ET Q q 0 0 0 rg BT 216.79 180.10 Td (of ) Tj ET Q q 0 0 0 rg BT 227.62 180.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 268.44 180.10 Td (on ) Tj ET Q q 0 0 0 rg BT 280.94 180.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 302.88 180.10 Td (was ) Tj ET Q q 0 0 0 rg BT 320.93 180.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 360.64 180.10 Td (in ) Tj ET Q q 0 0 0 rg BT 370.92 180.10 Td (France ) Tj ET Q q 0 0 0 rg BT 400.63 180.10 Td (to ) Tj ET Q q 0 0 0 rg BT 410.91 180.10 Td (support ) Tj ET Q q 0 0 0 rg BT 443.41 180.10 Td (product ) Tj ET Q q 0 0 0 rg BT 476.45 180.10 Td (seasonality) Tj ET Q q 0 0 0 rg BT 520.24 180.10 Td (. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 72.00 161.10 Td (Perfalgan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 112.00 161.10 Td (, ) Tj ET Q q 0 0 0 rg BT 116.24 161.10 Td (an ) Tj ET Q q 0 0 0 rg BT 127.42 161.10 Td (analgesic ) Tj ET Q q 0 0 0 rg BT 166.36 161.10 Td (product, ) Tj ET Q q 0 0 0 rg BT 201.15 161.10 Td (had ) Tj ET Q q 0 0 0 rg BT 217.33 161.10 Td (2.4 ) Tj ET Q q 0 0 0 rg BT 231.57 161.10 Td (months ) Tj ET Q q 0 0 0 rg BT 262.76 161.10 Td (of ) Tj ET Q q 0 0 0 rg BT 272.84 161.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 312.90 161.10 Td (on ) Tj ET Q q 0 0 0 rg BT 324.65 161.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 345.83 161.10 Td (internationally ) Tj ET Q q 0 0 0 rg BT 405.88 161.10 Td (at ) Tj ET Q q 0 0 0 rg BT 414.84 161.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 439.35 161.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 481.64 161.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 522.80 161.10 Td (to ) Tj ET Q q 0 0 0 rg BT 532.33 161.10 Td (2.9 ) Tj ET Q q 0 0 0 rg BT 546.57 161.10 Td (months ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 149.10 Td (of ) Tj ET Q q 0 0 0 rg BT 83.18 149.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 124.36 149.10 Td (on ) Tj ET Q q 0 0 0 rg BT 137.21 149.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 159.50 149.10 Td (at ) Tj ET Q q 0 0 0 rg BT 169.57 149.10 Td (June ) Tj ET Q q 0 0 0 rg BT 190.75 149.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 206.10 149.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 231.25 149.10 Td (The ) Tj ET Q q 0 0 0 rg BT 249.65 149.10 Td (level ) Tj ET Q q 0 0 0 rg BT 271.93 149.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.11 149.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 324.29 149.10 Td (on ) Tj ET Q q 0 0 0 rg BT 337.14 149.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 359.43 149.10 Td (was ) Tj ET Q q 0 0 0 rg BT 377.83 149.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 417.90 149.10 Td (in ) Tj ET Q q 0 0 0 rg BT 428.53 149.10 Td (the ) Tj ET Q q 0 0 0 rg BT 443.60 149.10 Td (Gulf ) Tj ET Q q 0 0 0 rg BT 464.78 149.10 Td (Countries ) Tj ET Q q 0 0 0 rg BT 506.52 149.10 Td (and ) Tj ET Q q 0 0 0 rg BT 523.81 149.10 Td (Saudi ) Tj ET Q q 0 0 0 rg BT 548.81 149.10 Td (Arabia ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 137.10 Td (due ) Tj ET Q q 0 0 0 rg BT 88.94 137.10 Td (to ) Tj ET Q q 0 0 0 rg BT 99.22 137.10 Td (extended ) Tj ET Q q 0 0 0 rg BT 137.81 137.10 Td (delivery ) Tj ET Q q 0 0 0 rg BT 173.07 137.10 Td (lead ) Tj ET Q q 0 0 0 rg BT 192.23 137.10 Td (time. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 118.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.43 118.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.75 118.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 86.13 118.10 Td (we ) Tj ET Q q 0 0 0 rg BT 100.89 118.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 141.19 118.10 Td (determine ) Tj ET Q q 0 0 0 rg BT 184.27 118.10 Td (our ) Tj ET Q q 0 0 0 rg BT 200.70 118.10 Td (months ) Tj ET Q q 0 0 0 rg BT 233.25 118.10 Td (on ) Tj ET Q q 0 0 0 rg BT 246.35 118.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 268.89 118.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 309.20 118.10 Td (using ) Tj ET Q q 0 0 0 rg BT 333.97 118.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 375.39 118.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 401.82 118.10 Td (of ) Tj ET Q q 0 0 0 rg BT 413.25 118.10 Td (product ) Tj ET Q q 0 0 0 rg BT 446.89 118.10 Td (on ) Tj ET Q q 0 0 0 rg BT 459.99 118.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 482.53 118.10 Td (and ) Tj ET Q q 0 0 0 rg BT 500.07 118.10 Td (the ) Tj ET Q q 0 0 0 rg BT 515.38 118.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 548.48 118.10 Td (of ) Tj ET Q q 0 0 0 rg BT 559.91 118.10 Td (out-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 106.10 Td (movement ) Tj ET Q q 0 0 0 rg BT 80.33 106.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 118.00 106.10 Td (by ) Tj ET Q q 0 0 0 rg BT 130.13 106.10 Td (our ) Tj ET Q q 0 0 0 rg BT 145.58 106.10 Td (three ) Tj ET Q q 0 0 0 rg BT 167.69 106.10 Td (lar) Tj ET Q q 0 0 0 rg BT 178.06 106.10 Td (gest ) Tj ET Q q 0 0 0 rg BT 196.29 106.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 248.12 106.10 Td (which ) Tj ET Q q 0 0 0 rg BT 274.68 106.10 Td (account ) Tj ET Q q 0 0 0 rg BT 307.90 106.10 Td (for ) Tj ET Q q 0 0 0 rg BT 321.68 106.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 381.56 106.10 Td (95% ) Tj ET Q q 0 0 0 rg BT 402.01 106.10 Td (of ) Tj ET Q q 0 0 0 rg BT 412.47 106.10 Td (total ) Tj ET Q q 0 0 0 rg BT 432.36 106.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 455.60 106.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 477.16 106.10 Td (of ) Tj ET Q q 0 0 0 rg BT 487.61 106.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 507.52 106.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 546.58 106.10 Td (Factors ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 94.10 Td (that ) Tj ET Q q 0 0 0 rg BT 54.50 94.10 Td (may ) Tj ET Q q 0 0 0 rg BT 75.22 94.10 Td (influence ) Tj ET Q q 0 0 0 rg BT 115.93 94.10 Td (our ) Tj ET Q q 0 0 0 rg BT 132.77 94.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 173.49 94.10 Td (include ) Tj ET Q q 0 0 0 rg BT 206.42 94.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 239.35 94.10 Td (competition, ) Tj ET Q q 0 0 0 rg BT 293.13 94.10 Td (seasonality ) Tj ET Q q 0 0 0 rg BT 341.07 94.10 Td (of ) Tj ET Q q 0 0 0 rg BT 352.90 94.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 393.35 94.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 440.17 94.10 Td (purchases ) Tj ET Q q 0 0 0 rg BT 483.10 94.10 Td (in ) Tj ET Q q 0 0 0 rg BT 494.39 94.10 Td (light ) Tj ET Q q 0 0 0 rg BT 516.23 94.10 Td (of ) Tj ET Q q 0 0 0 rg BT 528.07 94.10 Td (increases ) Tj ET Q q 0 0 0 rg BT 568.22 94.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 82.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 82.09 82.10 Td (list ) Tj ET Q q 0 0 0 rg BT 97.08 82.10 Td (prices, ) Tj ET Q q 0 0 0 rg BT 126.23 82.10 Td (new ) Tj ET Q q 0 0 0 rg BT 145.66 82.10 Td (product ) Tj ET Q q 0 0 0 rg BT 178.98 82.10 Td (launches, ) Tj ET Q q 0 0 0 rg BT 219.23 82.10 Td (new ) Tj ET Q q 0 0 0 rg BT 238.66 82.10 Td (warehouse ) Tj ET Q q 0 0 0 rg BT 284.19 82.10 Td (openings ) Tj ET Q q 0 0 0 rg BT 323.07 82.10 Td (by ) Tj ET Q q 0 0 0 rg BT 335.84 82.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 385.82 82.10 Td (and ) Tj ET Q q 0 0 0 rg BT 403.02 82.10 Td (new ) Tj ET Q q 0 0 0 rg BT 422.45 82.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 461.88 82.10 Td (stockings ) Tj ET Q q 0 0 0 rg BT 502.43 82.10 Td (by ) Tj ET Q q 0 0 0 rg BT 515.20 82.10 Td (wholesalers. ) Tj ET Q q 0 0 0 rg BT 567.68 82.10 Td (In ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 70.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 73.77 70.10 Td (these ) Tj ET Q q 0 0 0 rg BT 96.82 70.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 136.53 70.10 Td (are ) Tj ET Q q 0 0 0 rg BT 151.24 70.10 Td (calculated ) Tj ET Q q 0 0 0 rg BT 194.27 70.10 Td (using ) Tj ET Q q 0 0 0 rg BT 218.44 70.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 263.70 70.10 Td (data, ) Tj ET Q q 0 0 0 rg BT 285.36 70.10 Td (which ) Tj ET Q q 0 0 0 rg BT 312.29 70.10 Td (may ) Tj ET Q q 0 0 0 rg BT 332.01 70.10 Td (be ) Tj ET Q q 0 0 0 rg BT 343.95 70.10 Td (impacted ) Tj ET Q q 0 0 0 rg BT 383.10 70.10 Td (by ) Tj ET Q q 0 0 0 rg BT 395.60 70.10 Td (their ) Tj ET Q q 0 0 0 rg BT 416.42 70.10 Td (recordkeeping ) Tj ET Q q 0 0 0 rg BT 476.12 70.10 Td (processes.) Tj ET Q endstream endobj 73 0 obj <> endobj 74 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.73 749.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 92.03 749.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 136.43 749.10 Td (have ) Tj ET Q q 0 0 0 rg BT 157.48 749.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 209.65 749.10 Td (more ) Tj ET Q q 0 0 0 rg BT 232.38 749.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 257.33 749.10 Td (customers. ) Tj ET Q q 0 0 0 rg BT 302.55 749.10 Td (Information ) Tj ET Q q 0 0 0 rg BT 352.50 749.10 Td (on ) Tj ET Q q 0 0 0 rg BT 364.68 749.10 Td (available ) Tj ET Q q 0 0 0 rg BT 402.95 749.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 427.89 749.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 466.73 749.10 Td (product ) Tj ET Q q 0 0 0 rg BT 499.45 749.10 Td (level ) Tj ET Q q 0 0 0 rg BT 521.07 749.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 561.57 749.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (corresponding ) Tj ET Q q 0 0 0 rg BT 94.72 737.10 Td (out-movement ) Tj ET Q q 0 0 0 rg BT 154.55 737.10 Td (information ) Tj ET Q q 0 0 0 rg BT 203.28 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 219.23 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 232.96 737.10 Td (reliability ) Tj ET Q q 0 0 0 rg BT 273.35 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.20 737.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 327.47 737.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 360.64 737.10 Td (information ) Tj ET Q q 0 0 0 rg BT 409.37 737.10 Td (varies ) Tj ET Q q 0 0 0 rg BT 434.76 737.10 Td (widely) Tj ET Q q 0 0 0 rg BT 461.33 737.10 Td (. ) Tj ET Q q 0 0 0 rg BT 465.23 737.10 Td (W) Tj ET Q q 0 0 0 rg BT 473.87 737.10 Td (e ) Tj ET Q q 0 0 0 rg BT 479.82 737.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 500.23 737.10 Td (our ) Tj ET Q q 0 0 0 rg BT 515.07 737.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 539.35 737.10 Td (customer ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 57.68 725.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 91.01 725.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 131.57 725.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 170.47 725.10 Td (to ) Tj ET Q q 0 0 0 rg BT 180.48 725.10 Td (where ) Tj ET Q q 0 0 0 rg BT 207.15 725.10 Td (we ) Tj ET Q q 0 0 0 rg BT 221.05 725.10 Td (can ) Tj ET Q q 0 0 0 rg BT 237.17 725.10 Td (influence ) Tj ET Q q 0 0 0 rg BT 276.61 725.10 Td (demand. ) Tj ET Q q 0 0 0 rg BT 312.84 725.10 Td (When ) Tj ET Q q 0 0 0 rg BT 338.96 725.10 Td (this ) Tj ET Q q 0 0 0 rg BT 355.64 725.10 Td (information ) Tj ET Q q 0 0 0 rg BT 405.09 725.10 Td (does ) Tj ET Q q 0 0 0 rg BT 425.66 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 440.68 725.10 Td (exist ) Tj ET Q q 0 0 0 rg BT 461.81 725.10 Td (or ) Tj ET Q q 0 0 0 rg BT 472.37 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 481.28 725.10 Td (otherwise ) Tj ET Q q 0 0 0 rg BT 522.40 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 537.42 725.10 Td (available, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (we ) Tj ET Q q 0 0 0 rg BT 49.90 713.10 Td (have ) Tj ET Q q 0 0 0 rg BT 71.02 713.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 114.36 713.10 Td (a ) Tj ET Q q 0 0 0 rg BT 121.04 713.10 Td (variety ) Tj ET Q q 0 0 0 rg BT 151.05 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 161.63 713.10 Td (methodologies ) Tj ET Q q 0 0 0 rg BT 222.75 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 232.77 713.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 268.34 713.10 Td (such ) Tj ET Q q 0 0 0 rg BT 288.91 713.10 Td (data, ) Tj ET Q q 0 0 0 rg BT 310.31 713.10 Td (including ) Tj ET Q q 0 0 0 rg BT 350.33 713.10 Td (using ) Tj ET Q q 0 0 0 rg BT 374.24 713.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 413.70 713.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 435.38 713.10 Td (made ) Tj ET Q q 0 0 0 rg BT 459.28 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 469.30 713.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 494.31 713.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 537.10 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 553.78 713.10 Td (third-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (party ) Tj ET Q q 0 0 0 rg BT 59.30 701.10 Td (market ) Tj ET Q q 0 0 0 rg BT 89.81 701.10 Td (research ) Tj ET Q q 0 0 0 rg BT 125.87 701.10 Td (data ) Tj ET Q q 0 0 0 rg BT 145.28 701.10 Td (related ) Tj ET Q q 0 0 0 rg BT 175.23 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 185.76 701.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 236.28 701.10 Td (trends ) Tj ET Q q 0 0 0 rg BT 263.47 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 280.66 701.10 Td (end-user ) Tj ET Q q 0 0 0 rg BT 317.84 701.10 Td (demand. ) Tj ET Q q 0 0 0 rg BT 354.74 701.10 Td (Given ) Tj ET Q q 0 0 0 rg BT 381.93 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 396.90 701.10 Td (dif) Tj ET Q q 0 0 0 rg BT 407.83 701.10 Td (ficulties ) Tj ET Q q 0 0 0 rg BT 442.79 701.10 Td (inherent ) Tj ET Q q 0 0 0 rg BT 478.31 701.10 Td (in ) Tj ET Q q 0 0 0 rg BT 488.84 701.10 Td (estimating ) Tj ET Q q 0 0 0 rg BT 533.25 701.10 Td (third-party ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 69.65 689.10 Td (information, ) Tj ET Q q 0 0 0 rg BT 121.37 689.10 Td (we ) Tj ET Q q 0 0 0 rg BT 135.03 689.10 Td (evaluate ) Tj ET Q q 0 0 0 rg BT 170.34 689.10 Td (our ) Tj ET Q q 0 0 0 rg BT 185.67 689.10 Td (methodologies ) Tj ET Q q 0 0 0 rg BT 246.55 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 256.32 689.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 291.64 689.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 316.41 689.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 355.06 689.10 Td (product ) Tj ET Q q 0 0 0 rg BT 387.61 689.10 Td (level ) Tj ET Q q 0 0 0 rg BT 409.04 689.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 449.37 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 465.80 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 475.58 689.10 Td (calculate ) Tj ET Q q 0 0 0 rg BT 513.11 689.10 Td (months ) Tj ET Q q 0 0 0 rg BT 544.56 689.10 Td (on ) Tj ET Q q 0 0 0 rg BT 556.56 689.10 Td (hand ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (on ) Tj ET Q q 0 0 0 rg BT 48.83 677.10 Td (an ) Tj ET Q q 0 0 0 rg BT 61.10 677.10 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 96.71 677.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 119.54 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 136.81 677.10 Td (make ) Tj ET Q q 0 0 0 rg BT 161.30 677.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 196.33 677.10 Td (as ) Tj ET Q q 0 0 0 rg BT 207.50 677.10 Td (necessary) Tj ET Q q 0 0 0 rg BT 245.71 677.10 Td (. ) Tj ET Q q 0 0 0 rg BT 251.04 677.10 Td (Factors ) Tj ET Q q 0 0 0 rg BT 283.31 677.10 Td (that ) Tj ET Q q 0 0 0 rg BT 301.14 677.10 Td (may ) Tj ET Q q 0 0 0 rg BT 321.19 677.10 Td (af) Tj ET Q q 0 0 0 rg BT 328.78 677.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 346.59 677.10 Td (our ) Tj ET Q q 0 0 0 rg BT 362.75 677.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 402.80 677.10 Td (include ) Tj ET Q q 0 0 0 rg BT 435.06 677.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 467.32 677.10 Td (competition, ) Tj ET Q q 0 0 0 rg BT 520.42 677.10 Td (seasonality ) Tj ET Q q 0 0 0 rg BT 567.68 677.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 74.32 665.10 Td (price ) Tj ET Q q 0 0 0 rg BT 95.69 665.10 Td (increases, ) Tj ET Q q 0 0 0 rg BT 136.21 665.10 Td (new ) Tj ET Q q 0 0 0 rg BT 154.26 665.10 Td (product ) Tj ET Q q 0 0 0 rg BT 186.19 665.10 Td (launches, ) Tj ET Q q 0 0 0 rg BT 225.05 665.10 Td (new ) Tj ET Q q 0 0 0 rg BT 243.09 665.10 Td (warehouse ) Tj ET Q q 0 0 0 rg BT 287.24 665.10 Td (openings ) Tj ET Q q 0 0 0 rg BT 324.73 665.10 Td (by ) Tj ET Q q 0 0 0 rg BT 336.11 665.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 360.25 665.10 Td (customers, ) Tj ET Q q 0 0 0 rg BT 404.68 665.10 Td (new ) Tj ET Q q 0 0 0 rg BT 422.72 665.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 460.76 665.10 Td (stockings ) Tj ET Q q 0 0 0 rg BT 499.92 665.10 Td (by ) Tj ET Q q 0 0 0 rg BT 511.30 665.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 535.45 665.10 Td (customers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.67 653.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 90.42 653.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 115.41 653.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 154.30 653.10 Td (purchases ) Tj ET Q q 0 0 0 rg BT 195.95 653.10 Td (for ) Tj ET Q q 0 0 0 rg BT 209.84 653.10 Td (governmental ) Tj ET Q q 0 0 0 rg BT 267.04 653.10 Td (bidding ) Tj ET Q q 0 0 0 rg BT 299.83 653.10 Td (situations. ) Tj ET Q q 0 0 0 rg BT 342.40 653.10 Td (As ) Tj ET Q q 0 0 0 rg BT 355.74 653.10 Td (such, ) Tj ET Q q 0 0 0 rg BT 378.79 653.10 Td (all ) Tj ET Q q 0 0 0 rg BT 391.02 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 401.57 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 416.02 653.10 Td (information ) Tj ET Q q 0 0 0 rg BT 465.46 653.10 Td (required ) Tj ET Q q 0 0 0 rg BT 501.00 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 511.00 653.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 546.55 653.10 Td (months ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (on ) Tj ET Q q 0 0 0 rg BT 48.31 641.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 70.06 641.10 Td (in ) Tj ET Q q 0 0 0 rg BT 80.14 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 94.67 641.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 119.74 641.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 158.70 641.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 207.13 641.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 240.53 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 254.50 641.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 292.92 641.10 Td (business ) Tj ET Q q 0 0 0 rg BT 329.12 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 343.09 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 357.61 641.10 Td (year ) Tj ET Q q 0 0 0 rg BT 377.13 641.10 Td (ended ) Tj ET Q q 0 0 0 rg BT 403.31 641.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.71 641.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.71 641.10 Td ( ) Tj ET Q q 0 0 0 rg BT 484.02 641.10 Td (is ) Tj ET Q q 0 0 0 rg BT 492.99 641.10 Td (not ) Tj ET Q q 0 0 0 rg BT 508.08 641.10 Td (available ) Tj ET Q q 0 0 0 rg BT 546.48 641.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 568.23 641.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.81 629.10 Td (filing ) Tj ET Q q 0 0 0 rg BT 75.06 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 85.98 629.10 Td (this ) Tj ET Q q 0 0 0 rg BT 103.02 629.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 132.26 629.10 Td (report ) Tj ET Q q 0 0 0 rg BT 158.73 629.10 Td (on ) Tj ET Q q 0 0 0 rg BT 171.32 629.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 195.58 629.10 Td (10-K. ) Tj ET Q q 0 0 0 rg BT 221.03 629.10 Td (W) Tj ET Q q 0 0 0 rg BT 229.67 629.10 Td (e ) Tj ET Q q 0 0 0 rg BT 236.70 629.10 Td (will ) Tj ET Q q 0 0 0 rg BT 254.84 629.10 Td (disclose ) Tj ET Q q 0 0 0 rg BT 289.65 629.10 Td (any ) Tj ET Q q 0 0 0 rg BT 306.68 629.10 Td (product ) Tj ET Q q 0 0 0 rg BT 339.81 629.10 Td (with ) Tj ET Q q 0 0 0 rg BT 360.18 629.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 386.09 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 397.01 629.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 437.93 629.10 Td (in ) Tj ET Q q 0 0 0 rg BT 448.30 629.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 476.98 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 487.90 629.10 Td (one ) Tj ET Q q 0 0 0 rg BT 504.93 629.10 Td (month ) Tj ET Q q 0 0 0 rg BT 533.08 629.10 Td (on ) Tj ET Q q 0 0 0 rg BT 545.67 629.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 567.69 629.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 74.03 617.10 Td (demand, ) Tj ET Q q 0 0 0 rg BT 110.69 617.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 141.51 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 151.79 617.10 Td (a ) Tj ET Q q 0 0 0 rg BT 158.73 617.10 Td (de ) Tj ET Q q 0 0 0 rg BT 170.67 617.10 Td (minimis ) Tj ET Q q 0 0 0 rg BT 205.95 617.10 Td (exception, ) Tj ET Q q 0 0 0 rg BT 249.82 617.10 Td (in ) Tj ET Q q 0 0 0 rg BT 260.10 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 274.82 617.10 Td (next ) Tj ET Q q 0 0 0 rg BT 294.54 617.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 333.13 617.10 Td (report ) Tj ET Q q 0 0 0 rg BT 359.51 617.10 Td (on ) Tj ET Q q 0 0 0 rg BT 372.01 617.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 396.18 617.10 Td (10-Q.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (Expenses) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 556.60 226.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 262.50 556.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 266.50 556.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 322.50 556.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 556.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 382.50 556.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 556.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 442.50 556.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 556.60 63.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 556.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 556.60 63.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 532.60 226.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 262.50 532.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 266.50 532.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 322.50 532.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 532.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 382.50 532.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 532.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 442.50 532.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 532.60 63.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 532.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 532.60 63.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 508.60 226.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 262.50 508.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 266.50 508.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 322.50 508.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 508.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 382.50 508.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 508.60 56.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 442.50 508.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 508.60 63.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 508.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 508.60 63.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 446.5 569.6 m 509.5 569.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 509.5 569.6 m 513.5 569.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 569.6 m 576.5 569.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 266.5 556.6 m 322.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 326.5 556.6 m 382.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 556.6 m 442.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 446.5 556.6 m 509.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 569.6 m 576.5 569.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 556.6 m 576.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 326.5 556.6 m 382.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 556.6 m 442.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 556.6 m 576.5 556.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 266.5 508.6 m 322.5 508.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 326.5 508.6 m 382.5 508.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 508.6 m 442.5 508.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 266.5 497.6 m 322.5 497.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 266.5 495.6 m 322.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 326.5 497.6 m 382.5 497.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 326.5 495.6 m 382.5 495.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 497.6 m 442.5 497.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 495.6 m 442.5 495.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 573.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 269.00 573.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 329.00 573.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 389.00 573.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 492.85 573.83 Td (% Change) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 560.85 Td (Dollar in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 286.00 560.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 346.00 560.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 406.00 560.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 454.90 560.83 Td (2016 vs. 2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 521.90 560.83 Td (2015 vs. 2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 547.22 Td (Cost of products sold) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 269.00 547.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 296.15 547.22 Td (4,946) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.00 547.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 356.15 547.22 Td (3,909) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.00 547.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.15 547.22 Td (3,932) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.30 547.22 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 547.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.95 547.22 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 547.22 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 535.22 Td (Marketing, selling and administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 296.15 535.22 Td (4,911) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 356.15 535.22 Td (4,841) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.15 535.22 Td (4,822) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.30 535.22 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 535.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 535.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 523.22 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 296.15 523.22 Td (4,940) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 356.15 523.22 Td (5,920) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.15 523.22 Td (4,534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.95 523.22 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.30 523.22 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 523.22 Td (31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 523.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 511.22 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.80 511.22 Td (\(1,285) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.65 511.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.30 511.22 Td (\(187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.65 511.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.65 511.22 Td (210) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.00 511.22 Td (**) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.00 511.22 Td (**) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 499.22 Td (Total Expenses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 269.00 499.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 291.15 499.22 Td (13,512) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.00 499.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 351.15 499.22 Td (14,483) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.00 499.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.15 499.22 Td (13,498) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.95 499.22 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.30 499.22 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 499.22 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 499.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 482.50 Td (** ) Tj ET Q q 0 0 0 rg BT 58.50 482.50 Td (Change ) Tj ET Q q 0 0 0 rg BT 84.94 482.50 Td (in ) Tj ET Q q 0 0 0 rg BT 93.16 482.50 Td (excess ) Tj ET Q q 0 0 0 rg BT 116.04 482.50 Td (of ) Tj ET Q q 0 0 0 rg BT 124.70 482.50 Td (100%) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 461.9669921875 m 120.9169921875 461.9669921875 l s q 0 0 0 rg BT 36.00 463.30 Td (Cost of pr) Tj ET Q q 0 0 0 rg BT 75.64 463.30 Td (oducts sold) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 439.30 Td (Cost ) Tj ET Q q 0 0 0 rg BT 57.39 439.30 Td (of ) Tj ET Q q 0 0 0 rg BT 68.77 439.30 Td (products ) Tj ET Q q 0 0 0 rg BT 106.25 439.30 Td (sold ) Tj ET Q q 0 0 0 rg BT 125.97 439.30 Td (include ) Tj ET Q q 0 0 0 rg BT 158.45 439.30 Td (material, ) Tj ET Q q 0 0 0 rg BT 196.76 439.30 Td (internal ) Tj ET Q q 0 0 0 rg BT 230.35 439.30 Td (labor ) Tj ET Q q 0 0 0 rg BT 253.95 439.30 Td (and ) Tj ET Q q 0 0 0 rg BT 271.43 439.30 Td (overhead ) Tj ET Q q 0 0 0 rg BT 311.13 439.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 334.18 439.30 Td (from ) Tj ET Q q 0 0 0 rg BT 356.66 439.30 Td (our ) Tj ET Q q 0 0 0 rg BT 373.04 439.30 Td (owned ) Tj ET Q q 0 0 0 rg BT 402.75 439.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 464.11 439.30 Td (sites, ) Tj ET Q q 0 0 0 rg BT 487.43 439.30 Td (third-party ) Tj ET Q q 0 0 0 rg BT 533.25 439.30 Td (processing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 427.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 58.81 427.30 Td (and ) Tj ET Q q 0 0 0 rg BT 76.05 427.30 Td (other ) Tj ET Q q 0 0 0 rg BT 99.41 427.30 Td (supply ) Tj ET Q q 0 0 0 rg BT 128.89 427.30 Td (chain ) Tj ET Q q 0 0 0 rg BT 153.35 427.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 176.16 427.30 Td (managed ) Tj ET Q q 0 0 0 rg BT 215.06 427.30 Td (by ) Tj ET Q q 0 0 0 rg BT 227.87 427.30 Td (our ) Tj ET Q q 0 0 0 rg BT 244.00 427.30 Td (global ) Tj ET Q q 0 0 0 rg BT 271.81 427.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 332.92 427.30 Td (and ) Tj ET Q q 0 0 0 rg BT 350.17 427.30 Td (supply ) Tj ET Q q 0 0 0 rg BT 379.65 427.30 Td (or) Tj ET Q q 0 0 0 rg BT 387.80 427.30 Td (ganization. ) Tj ET Q q 0 0 0 rg BT 434.75 427.30 Td (Cost ) Tj ET Q q 0 0 0 rg BT 455.90 427.30 Td (of ) Tj ET Q q 0 0 0 rg BT 467.04 427.30 Td (products ) Tj ET Q q 0 0 0 rg BT 504.29 427.30 Td (sold ) Tj ET Q q 0 0 0 rg BT 523.76 427.30 Td (also ) Tj ET Q q 0 0 0 rg BT 542.68 427.30 Td (includes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.30 Td (royalties ) Tj ET Q q 0 0 0 rg BT 73.73 415.30 Td (and ) Tj ET Q q 0 0 0 rg BT 91.46 415.30 Td (profit ) Tj ET Q q 0 0 0 rg BT 116.98 415.30 Td (sharing ) Tj ET Q q 0 0 0 rg BT 149.71 415.30 Td (attributed ) Tj ET Q q 0 0 0 rg BT 191.33 415.30 Td (to ) Tj ET Q q 0 0 0 rg BT 202.40 415.30 Td (licensed ) Tj ET Q q 0 0 0 rg BT 238.46 415.30 Td (products ) Tj ET Q q 0 0 0 rg BT 276.20 415.30 Td (and ) Tj ET Q q 0 0 0 rg BT 293.93 415.30 Td (alliances, ) Tj ET Q q 0 0 0 rg BT 334.71 415.30 Td (foreign ) Tj ET Q q 0 0 0 rg BT 366.88 415.30 Td (currency ) Tj ET Q q 0 0 0 rg BT 405.15 415.30 Td (hedge ) Tj ET Q q 0 0 0 rg BT 432.32 415.30 Td (settlement ) Tj ET Q q 0 0 0 rg BT 476.72 415.30 Td (gains ) Tj ET Q q 0 0 0 rg BT 501.12 415.30 Td (and ) Tj ET Q q 0 0 0 rg BT 518.86 415.30 Td (losses ) Tj ET Q q 0 0 0 rg BT 546.04 415.30 Td (and ) Tj ET Q q 0 0 0 rg BT 563.78 415.30 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 403.30 Td (amortization ) Tj ET Q q 0 0 0 rg BT 89.04 403.30 Td (of ) Tj ET Q q 0 0 0 rg BT 99.87 403.30 Td (acquired ) Tj ET Q q 0 0 0 rg BT 136.79 403.30 Td (developed ) Tj ET Q q 0 0 0 rg BT 180.38 403.30 Td (technology ) Tj ET Q q 0 0 0 rg BT 227.32 403.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 249.82 403.30 Td (from ) Tj ET Q q 0 0 0 rg BT 271.76 403.30 Td (business ) Tj ET Q q 0 0 0 rg BT 308.15 403.30 Td (combinations ) Tj ET Q q 0 0 0 rg BT 364.53 403.30 Td (and ) Tj ET Q q 0 0 0 rg BT 381.47 403.30 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 425.06 403.30 Td (approval ) Tj ET Q q 0 0 0 rg BT 462.55 403.30 Td (milestones.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 379.30 Td (Cost ) Tj ET Q q 0 0 0 rg BT 57.35 379.30 Td (of ) Tj ET Q q 0 0 0 rg BT 68.68 379.30 Td (products ) Tj ET Q q 0 0 0 rg BT 106.13 379.30 Td (sold ) Tj ET Q q 0 0 0 rg BT 125.81 379.30 Td (typically ) Tj ET Q q 0 0 0 rg BT 163.80 379.30 Td (vary ) Tj ET Q q 0 0 0 rg BT 184.58 379.30 Td (between ) Tj ET Q q 0 0 0 rg BT 220.90 379.30 Td (periods ) Tj ET Q q 0 0 0 rg BT 253.35 379.30 Td (as ) Tj ET Q q 0 0 0 rg BT 264.68 379.30 Td (a ) Tj ET Q q 0 0 0 rg BT 272.13 379.30 Td (result ) Tj ET Q q 0 0 0 rg BT 297.35 379.30 Td (of ) Tj ET Q q 0 0 0 rg BT 308.69 379.30 Td (product ) Tj ET Q q 0 0 0 rg BT 342.24 379.30 Td (mix ) Tj ET Q q 0 0 0 rg BT 360.81 379.30 Td (and ) Tj ET Q q 0 0 0 rg BT 378.25 379.30 Td (volume ) Tj ET Q q 0 0 0 rg BT 411.25 379.30 Td (\(particularly ) Tj ET Q q 0 0 0 rg BT 463.68 379.30 Td (resulting ) Tj ET Q q 0 0 0 rg BT 501.68 379.30 Td (from ) Tj ET Q q 0 0 0 rg BT 524.13 379.30 Td (royalties ) Tj ET Q q 0 0 0 rg BT 561.57 379.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 367.30 Td (profit ) Tj ET Q q 0 0 0 rg BT 62.32 367.30 Td (sharing ) Tj ET Q q 0 0 0 rg BT 95.86 367.30 Td (expenses ) Tj ET Q q 0 0 0 rg BT 136.06 367.30 Td (in ) Tj ET Q q 0 0 0 rg BT 147.95 367.30 Td (connection ) Tj ET Q q 0 0 0 rg BT 195.92 367.30 Td (with ) Tj ET Q q 0 0 0 rg BT 217.80 367.30 Td (our ) Tj ET Q q 0 0 0 rg BT 235.24 367.30 Td (alliances\), ) Tj ET Q q 0 0 0 rg BT 280.15 367.30 Td (changes ) Tj ET Q q 0 0 0 rg BT 316.46 367.30 Td (in ) Tj ET Q q 0 0 0 rg BT 328.34 367.30 Td (foreign ) Tj ET Q q 0 0 0 rg BT 361.32 367.30 Td (currency) Tj ET Q q 0 0 0 rg BT 395.65 367.30 Td (, ) Tj ET Q q 0 0 0 rg BT 402.25 367.30 Td (price, ) Tj ET Q q 0 0 0 rg BT 428.84 367.30 Td (inflation ) Tj ET Q q 0 0 0 rg BT 466.83 367.30 Td (and ) Tj ET Q q 0 0 0 rg BT 485.37 367.30 Td (costs ) Tj ET Q q 0 0 0 rg BT 509.47 367.30 Td (attributed ) Tj ET Q q 0 0 0 rg BT 551.90 367.30 Td (to ) Tj ET Q q 0 0 0 rg BT 563.78 367.30 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.30 Td (rationalization ) Tj ET Q q 0 0 0 rg BT 96.25 355.30 Td (of ) Tj ET Q q 0 0 0 rg BT 107.08 355.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 167.89 355.30 Td (sites ) Tj ET Q q 0 0 0 rg BT 188.17 355.30 Td (resulting ) Tj ET Q q 0 0 0 rg BT 225.67 355.30 Td (in ) Tj ET Q q 0 0 0 rg BT 235.95 355.30 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 283.40 355.30 Td (depreciation, ) Tj ET Q q 0 0 0 rg BT 337.82 355.30 Td (impairment ) Tj ET Q q 0 0 0 rg BT 386.42 355.30 Td (char) Tj ET Q q 0 0 0 rg BT 403.45 355.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 419.28 355.30 Td (and ) Tj ET Q q 0 0 0 rg BT 436.21 355.30 Td (other ) Tj ET Q q 0 0 0 rg BT 459.26 355.30 Td (stranded ) Tj ET Q q 0 0 0 rg BT 495.64 355.30 Td (costs.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 332.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 332.50 Td (Cost ) Tj ET Q q 0 0 0 rg BT 82.85 332.50 Td (of ) Tj ET Q q 0 0 0 rg BT 94.34 332.50 Td (products ) Tj ET Q q 0 0 0 rg BT 131.94 332.50 Td (sold ) Tj ET Q q 0 0 0 rg BT 151.77 332.50 Td (increased ) Tj ET Q q 0 0 0 rg BT 192.68 332.50 Td (in ) Tj ET Q q 0 0 0 rg BT 203.62 332.50 Td (2016 ) Tj ET Q q 0 0 0 rg BT 226.77 332.50 Td (primarily ) Tj ET Q q 0 0 0 rg BT 267.15 332.50 Td (due ) Tj ET Q q 0 0 0 rg BT 284.74 332.50 Td (to ) Tj ET Q q 0 0 0 rg BT 295.68 332.50 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 324.39 332.50 Td (Eliquis ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.88 332.50 Td (profit ) Tj ET Q q 0 0 0 rg BT 381.26 332.50 Td (sharing ) Tj ET Q q 0 0 0 rg BT 413.85 332.50 Td (of ) Tj ET Q q 0 0 0 rg BT 425.34 332.50 Td ($700 ) Tj ET Q q 0 0 0 rg BT 448.50 332.50 Td (million, ) Tj ET Q q 0 0 0 rg BT 483.05 332.50 Td (lower ) Tj ET Q q 0 0 0 rg BT 508.98 332.50 Td (foreign ) Tj ET Q q 0 0 0 rg BT 541.02 332.50 Td (currency ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 320.50 Td (hedge ) Tj ET Q q 0 0 0 rg BT 87.73 320.50 Td (settlement ) Tj ET Q q 0 0 0 rg BT 131.33 320.50 Td (gains ) Tj ET Q q 0 0 0 rg BT 154.93 320.50 Td (and ) Tj ET Q q 0 0 0 rg BT 171.87 320.50 Td (higher ) Tj ET Q q 0 0 0 rg BT 199.92 320.50 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 228.53 320.50 Td (Rico ) Tj ET Q q 0 0 0 rg BT 249.91 320.50 Td (excise ) Tj ET Q q 0 0 0 rg BT 277.40 320.50 Td (tax.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 302.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 302.50 Td (Cost ) Tj ET Q q 0 0 0 rg BT 82.88 302.50 Td (of ) Tj ET Q q 0 0 0 rg BT 94.40 302.50 Td (products ) Tj ET Q q 0 0 0 rg BT 132.03 302.50 Td (sold ) Tj ET Q q 0 0 0 rg BT 151.89 302.50 Td (remained ) Tj ET Q q 0 0 0 rg BT 192.29 302.50 Td (relatively ) Tj ET Q q 0 0 0 rg BT 233.23 302.50 Td (flat ) Tj ET Q q 0 0 0 rg BT 249.75 302.50 Td (in ) Tj ET Q q 0 0 0 rg BT 260.72 302.50 Td (2015 ) Tj ET Q q 0 0 0 rg BT 283.91 302.50 Td (as ) Tj ET Q q 0 0 0 rg BT 295.43 302.50 Td (higher ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 324.17 302.50 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.50 302.50 Td ( ) Tj ET Q q 0 0 0 rg BT 355.70 302.50 Td (profit ) Tj ET Q q 0 0 0 rg BT 381.10 302.50 Td (sharing ) Tj ET Q q 0 0 0 rg BT 413.73 302.50 Td (of ) Tj ET Q q 0 0 0 rg BT 425.25 302.50 Td ($532 ) Tj ET Q q 0 0 0 rg BT 448.44 302.50 Td (million ) Tj ET Q q 0 0 0 rg BT 480.53 302.50 Td (was ) Tj ET Q q 0 0 0 rg BT 499.27 302.50 Td (of) Tj ET Q q 0 0 0 rg BT 507.42 302.50 Td (fset ) Tj ET Q q 0 0 0 rg BT 525.05 302.50 Td (by ) Tj ET Q q 0 0 0 rg BT 538.24 302.50 Td (favorable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 290.50 Td (foreign ) Tj ET Q q 0 0 0 rg BT 92.73 290.50 Td (exchange.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 265.1669921875 m 187.09375 265.1669921875 l s q 0 0 0 rg BT 36.00 266.50 Td (Marketing, selling and administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 242.50 Td (Marketing, ) Tj ET Q q 0 0 0 rg BT 82.22 242.50 Td (selling ) Tj ET Q q 0 0 0 rg BT 110.95 242.50 Td (and ) Tj ET Q q 0 0 0 rg BT 127.46 242.50 Td (administrative ) Tj ET Q q 0 0 0 rg BT 186.73 242.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 224.90 242.50 Td (include ) Tj ET Q q 0 0 0 rg BT 256.40 242.50 Td (salary ) Tj ET Q q 0 0 0 rg BT 282.34 242.50 Td (and ) Tj ET Q q 0 0 0 rg BT 298.85 242.50 Td (benefit ) Tj ET Q q 0 0 0 rg BT 328.68 242.50 Td (costs, ) Tj ET Q q 0 0 0 rg BT 353.25 242.50 Td (third-party ) Tj ET Q q 0 0 0 rg BT 398.08 242.50 Td (professional ) Tj ET Q q 0 0 0 rg BT 449.02 242.50 Td (and ) Tj ET Q q 0 0 0 rg BT 465.53 242.50 Td (marketing ) Tj ET Q q 0 0 0 rg BT 508.13 242.50 Td (fees, ) Tj ET Q q 0 0 0 rg BT 528.80 242.50 Td (outsourcing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 230.50 Td (fees, ) Tj ET Q q 0 0 0 rg BT 56.71 230.50 Td (shipping ) Tj ET Q q 0 0 0 rg BT 93.26 230.50 Td (and ) Tj ET Q q 0 0 0 rg BT 109.81 230.50 Td (handling ) Tj ET Q q 0 0 0 rg BT 146.91 230.50 Td (costs, ) Tj ET Q q 0 0 0 rg BT 171.52 230.50 Td (advertising ) Tj ET Q q 0 0 0 rg BT 218.06 230.50 Td (and ) Tj ET Q q 0 0 0 rg BT 234.60 230.50 Td (product ) Tj ET Q q 0 0 0 rg BT 267.25 230.50 Td (promotion ) Tj ET Q q 0 0 0 rg BT 311.03 230.50 Td (and ) Tj ET Q q 0 0 0 rg BT 327.57 230.50 Td (other ) Tj ET Q q 0 0 0 rg BT 350.23 230.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 388.43 230.50 Td (that ) Tj ET Q q 0 0 0 rg BT 405.53 230.50 Td (are ) Tj ET Q q 0 0 0 rg BT 419.85 230.50 Td (not ) Tj ET Q q 0 0 0 rg BT 434.73 230.50 Td (attributed ) Tj ET Q q 0 0 0 rg BT 475.16 230.50 Td (to ) Tj ET Q q 0 0 0 rg BT 485.05 230.50 Td (product ) Tj ET Q q 0 0 0 rg BT 517.70 230.50 Td (manufacturing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 218.50 Td (costs ) Tj ET Q q 0 0 0 rg BT 57.86 218.50 Td (or ) Tj ET Q q 0 0 0 rg BT 68.05 218.50 Td (research ) Tj ET Q q 0 0 0 rg BT 103.21 218.50 Td (and ) Tj ET Q q 0 0 0 rg BT 119.51 218.50 Td (development ) Tj ET Q q 0 0 0 rg BT 173.02 218.50 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 213.48 218.50 Td (Expenses ) Tj ET Q q 0 0 0 rg BT 253.11 218.50 Td (are ) Tj ET Q q 0 0 0 rg BT 267.17 218.50 Td (managed ) Tj ET Q q 0 0 0 rg BT 305.13 218.50 Td (through ) Tj ET Q q 0 0 0 rg BT 338.09 218.50 Td (regional ) Tj ET Q q 0 0 0 rg BT 372.72 218.50 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 448.99 218.50 Td (or) Tj ET Q q 0 0 0 rg BT 457.14 218.50 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 504.54 218.50 Td (or ) Tj ET Q q 0 0 0 rg BT 514.73 218.50 Td (global ) Tj ET Q q 0 0 0 rg BT 541.58 218.50 Td (enabling ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 206.50 Td (functions ) Tj ET Q q 0 0 0 rg BT 75.63 206.50 Td (such ) Tj ET Q q 0 0 0 rg BT 96.37 206.50 Td (as ) Tj ET Q q 0 0 0 rg BT 107.12 206.50 Td (finance, ) Tj ET Q q 0 0 0 rg BT 141.46 206.50 Td (legal, ) Tj ET Q q 0 0 0 rg BT 165.80 206.50 Td (information ) Tj ET Q q 0 0 0 rg BT 215.43 206.50 Td (technology ) Tj ET Q q 0 0 0 rg BT 262.27 206.50 Td (and ) Tj ET Q q 0 0 0 rg BT 279.13 206.50 Td (human ) Tj ET Q q 0 0 0 rg BT 308.76 206.50 Td (resources. ) Tj ET Q q 0 0 0 rg BT 351.43 206.50 Td (Certain ) Tj ET Q q 0 0 0 rg BT 383.28 206.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 421.79 206.50 Td (are ) Tj ET Q q 0 0 0 rg BT 436.41 206.50 Td (shared ) Tj ET Q q 0 0 0 rg BT 464.92 206.50 Td (with ) Tj ET Q q 0 0 0 rg BT 485.11 206.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 518.62 206.50 Td (partners ) Tj ET Q q 0 0 0 rg BT 553.24 206.50 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 194.50 Td (upon ) Tj ET Q q 0 0 0 rg BT 58.50 194.50 Td (contractual ) Tj ET Q q 0 0 0 rg BT 105.42 194.50 Td (agreements. ) Tj ET Q q 0 0 0 rg BT 155.95 194.50 Td (Expenses ) Tj ET Q q 0 0 0 rg BT 196.22 194.50 Td (typically ) Tj ET Q q 0 0 0 rg BT 233.71 194.50 Td (vary ) Tj ET Q q 0 0 0 rg BT 253.98 194.50 Td (between ) Tj ET Q q 0 0 0 rg BT 289.79 194.50 Td (periods ) Tj ET Q q 0 0 0 rg BT 321.73 194.50 Td (due ) Tj ET Q q 0 0 0 rg BT 338.67 194.50 Td (to ) Tj ET Q q 0 0 0 rg BT 348.95 194.50 Td (new ) Tj ET Q q 0 0 0 rg BT 368.11 194.50 Td (product ) Tj ET Q q 0 0 0 rg BT 401.16 194.50 Td (launch ) Tj ET Q q 0 0 0 rg BT 430.31 194.50 Td (promotional ) Tj ET Q q 0 0 0 rg BT 481.69 194.50 Td (activities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 176.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 176.50 Td (Marketing, ) Tj ET Q q 0 0 0 rg BT 108.32 176.50 Td (selling ) Tj ET Q q 0 0 0 rg BT 137.80 176.50 Td (and ) Tj ET Q q 0 0 0 rg BT 155.06 176.50 Td (administrative ) Tj ET Q q 0 0 0 rg BT 215.08 176.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 254.00 176.50 Td (increased ) Tj ET Q q 0 0 0 rg BT 294.57 176.50 Td (in ) Tj ET Q q 0 0 0 rg BT 305.16 176.50 Td (2016 ) Tj ET Q q 0 0 0 rg BT 327.98 176.50 Td (due ) Tj ET Q q 0 0 0 rg BT 345.23 176.50 Td (to ) Tj ET Q q 0 0 0 rg BT 355.83 176.50 Td (higher ) Tj ET Q q 0 0 0 rg BT 384.19 176.50 Td (advertising ) Tj ET Q q 0 0 0 rg BT 431.44 176.50 Td (and ) Tj ET Q q 0 0 0 rg BT 448.70 176.50 Td (promotion ) Tj ET Q q 0 0 0 rg BT 493.18 176.50 Td (and ) Tj ET Q q 0 0 0 rg BT 510.43 176.50 Td (additional ) Tj ET Q q 0 0 0 rg BT 553.24 176.50 Td (sales-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 164.50 Td (related ) Tj ET Q q 0 0 0 rg BT 91.05 164.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 129.65 164.50 Td (supporting ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 174.93 164.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 204.37 164.50 Td ( ) Tj ET Q q 0 0 0 rg BT 206.87 164.50 Td (partially ) Tj ET Q q 0 0 0 rg BT 242.69 164.50 Td (of) Tj ET Q q 0 0 0 rg BT 250.84 164.50 Td (fset ) Tj ET Q q 0 0 0 rg BT 267.78 164.50 Td (by ) Tj ET Q q 0 0 0 rg BT 280.28 164.50 Td (lower ) Tj ET Q q 0 0 0 rg BT 305.54 164.50 Td (spend ) Tj ET Q q 0 0 0 rg BT 331.37 164.50 Td (for ) Tj ET Q q 0 0 0 rg BT 345.53 164.50 Td (virology ) Tj ET Q q 0 0 0 rg BT 381.92 164.50 Td (products ) Tj ET Q q 0 0 0 rg BT 418.86 164.50 Td (and ) Tj ET Q q 0 0 0 rg BT 435.80 164.50 Td (favorable ) Tj ET Q q 0 0 0 rg BT 476.05 164.50 Td (foreign ) Tj ET Q q 0 0 0 rg BT 507.43 164.50 Td (exchange.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 146.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 146.50 Td (Marketing, ) Tj ET Q q 0 0 0 rg BT 108.73 146.50 Td (selling ) Tj ET Q q 0 0 0 rg BT 138.61 146.50 Td (and ) Tj ET Q q 0 0 0 rg BT 156.27 146.50 Td (administrative ) Tj ET Q q 0 0 0 rg BT 216.70 146.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 256.02 146.50 Td (remained ) Tj ET Q q 0 0 0 rg BT 296.44 146.50 Td (relatively ) Tj ET Q q 0 0 0 rg BT 337.42 146.50 Td (flat ) Tj ET Q q 0 0 0 rg BT 353.96 146.50 Td (in ) Tj ET Q q 0 0 0 rg BT 364.96 146.50 Td (2015 ) Tj ET Q q 0 0 0 rg BT 388.18 146.50 Td (as ) Tj ET Q q 0 0 0 rg BT 399.73 146.50 Td (increased ) Tj ET Q q 0 0 0 rg BT 440.71 146.50 Td (sales-related ) Tj ET Q q 0 0 0 rg BT 493.90 146.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 533.22 146.50 Td (supporting ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 61.35 134.50 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 89.68 134.50 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 94.79 134.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 124.23 134.50 Td ( ) Tj ET Q q 0 0 0 rg BT 126.84 134.50 Td (and ) Tj ET Q q 0 0 0 rg BT 143.88 134.50 Td (the ) Tj ET Q q 0 0 0 rg BT 158.70 134.50 Td (Hepatitis ) Tj ET Q q 0 0 0 rg BT 197.41 134.50 Td (C ) Tj ET Q q 0 0 0 rg BT 206.69 134.50 Td (Franchise ) Tj ET Q q 0 0 0 rg BT 248.17 134.50 Td (were ) Tj ET Q q 0 0 0 rg BT 270.21 134.50 Td (of) Tj ET Q q 0 0 0 rg BT 278.36 134.50 Td (fset ) Tj ET Q q 0 0 0 rg BT 295.40 134.50 Td (by ) Tj ET Q q 0 0 0 rg BT 308.01 134.50 Td (favorable ) Tj ET Q q 0 0 0 rg BT 348.37 134.50 Td (foreign ) Tj ET Q q 0 0 0 rg BT 379.85 134.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 420.21 134.50 Td (and ) Tj ET Q q 0 0 0 rg BT 437.26 134.50 Td ($96 ) Tj ET Q q 0 0 0 rg BT 454.87 134.50 Td (million ) Tj ET Q q 0 0 0 rg BT 486.36 134.50 Td (of ) Tj ET Q q 0 0 0 rg BT 497.30 134.50 Td (additional ) Tj ET Q q 0 0 0 rg BT 539.90 134.50 Td (expenses ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 122.50 Td (related ) Tj ET Q q 0 0 0 rg BT 91.05 122.50 Td (to ) Tj ET Q q 0 0 0 rg BT 101.33 122.50 Td (the ) Tj ET Q q 0 0 0 rg BT 116.05 122.50 Td (Branded ) Tj ET Q q 0 0 0 rg BT 152.42 122.50 Td (Prescription ) Tj ET Q q 0 0 0 rg BT 203.25 122.50 Td (Drug ) Tj ET Q q 0 0 0 rg BT 226.30 122.50 Td (Fee ) Tj ET Q q 0 0 0 rg BT 243.24 122.50 Td (in ) Tj ET Q q 0 0 0 rg BT 253.52 122.50 Td (2014 ) Tj ET Q q 0 0 0 rg BT 276.02 122.50 Td (resulting ) Tj ET Q q 0 0 0 rg BT 313.51 122.50 Td (from ) Tj ET Q q 0 0 0 rg BT 335.45 122.50 Td (changes ) Tj ET Q q 0 0 0 rg BT 370.16 122.50 Td (in ) Tj ET Q q 0 0 0 rg BT 380.44 122.50 Td (IRS ) Tj ET Q q 0 0 0 rg BT 398.50 122.50 Td (guidelines.) Tj ET Q endstream endobj 75 0 obj <> endobj 76 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (37) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 143.3681640625 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Resear) Tj ET Q q 0 0 0 rg BT 63.40 749.10 Td (ch ) Tj ET Q q 0 0 0 rg BT 75.34 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 92.84 749.10 Td (development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (Research ) Tj ET Q q 0 0 0 rg BT 74.24 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 90.27 725.10 Td (development ) Tj ET Q q 0 0 0 rg BT 143.51 725.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 181.21 725.10 Td (include ) Tj ET Q q 0 0 0 rg BT 212.23 725.10 Td (discovery ) Tj ET Q q 0 0 0 rg BT 252.70 725.10 Td (research, ) Tj ET Q q 0 0 0 rg BT 290.10 725.10 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 333.89 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 349.92 725.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 380.95 725.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 436.69 725.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 456.61 725.10 Td (formulation, ) Tj ET Q q 0 0 0 rg BT 507.92 725.10 Td (as ) Tj ET Q q 0 0 0 rg BT 517.84 725.10 Td (well ) Tj ET Q q 0 0 0 rg BT 536.65 725.10 Td (as ) Tj ET Q q 0 0 0 rg BT 546.58 725.10 Td (clinical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (trials ) Tj ET Q q 0 0 0 rg BT 58.81 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 76.07 713.10 Td (medical ) Tj ET Q q 0 0 0 rg BT 110.53 713.10 Td (support ) Tj ET Q q 0 0 0 rg BT 143.35 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 154.50 713.10 Td (marketed ) Tj ET Q q 0 0 0 rg BT 194.51 713.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 234.27 713.10 Td (Expenses ) Tj ET Q q 0 0 0 rg BT 274.85 713.10 Td (include ) Tj ET Q q 0 0 0 rg BT 307.10 713.10 Td (salary ) Tj ET Q q 0 0 0 rg BT 333.80 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 351.05 713.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 381.63 713.10 Td (costs, ) Tj ET Q q 0 0 0 rg BT 406.95 713.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 452.53 713.10 Td (grants ) Tj ET Q q 0 0 0 rg BT 479.78 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 497.04 713.10 Td (fees ) Tj ET Q q 0 0 0 rg BT 515.95 713.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 535.99 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 546.58 713.10 Td (clinical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (research ) Tj ET Q q 0 0 0 rg BT 73.26 701.10 Td (or) Tj ET Q q 0 0 0 rg BT 81.41 701.10 Td (ganizations, ) Tj ET Q q 0 0 0 rg BT 133.40 701.10 Td (supplies, ) Tj ET Q q 0 0 0 rg BT 172.63 701.10 Td (upfront ) Tj ET Q q 0 0 0 rg BT 206.02 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 224.41 701.10 Td (contingent ) Tj ET Q q 0 0 0 rg BT 270.57 701.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 313.40 701.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 355.68 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 371.29 701.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 411.34 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 429.73 701.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 453.12 701.10 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 504.84 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 517.13 701.10 Td (investigational ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (compounds, ) Tj ET Q q 0 0 0 rg BT 89.43 689.10 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 117.03 689.10 Td (impairment ) Tj ET Q q 0 0 0 rg BT 167.94 689.10 Td (char) Tj ET Q q 0 0 0 rg BT 184.97 689.10 Td (ges ) Tj ET Q q 0 0 0 rg BT 203.11 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 222.37 689.10 Td (proportionate ) Tj ET Q q 0 0 0 rg BT 281.06 689.10 Td (allocations ) Tj ET Q q 0 0 0 rg BT 329.20 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 342.34 689.10 Td (enterprise-wide ) Tj ET Q q 0 0 0 rg BT 409.35 689.10 Td (costs. ) Tj ET Q q 0 0 0 rg BT 436.32 689.10 Td (The ) Tj ET Q q 0 0 0 rg BT 456.68 689.10 Td (allocations ) Tj ET Q q 0 0 0 rg BT 504.82 689.10 Td (include ) Tj ET Q q 0 0 0 rg BT 539.07 689.10 Td (facilities, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (information ) Tj ET Q q 0 0 0 rg BT 84.65 677.10 Td (technology) Tj ET Q q 0 0 0 rg BT 128.44 677.10 Td (, ) Tj ET Q q 0 0 0 rg BT 132.38 677.10 Td (employee ) Tj ET Q q 0 0 0 rg BT 172.69 677.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 195.24 677.10 Td (compensation ) Tj ET Q q 0 0 0 rg BT 252.22 677.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 273.66 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 289.54 677.10 Td (other ) Tj ET Q q 0 0 0 rg BT 311.53 677.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 358.50 677.10 Td (costs. ) Tj ET Q q 0 0 0 rg BT 382.44 677.10 Td (Certain ) Tj ET Q q 0 0 0 rg BT 413.31 677.10 Td (expenses ) Tj ET Q q 0 0 0 rg BT 450.85 677.10 Td (are ) Tj ET Q q 0 0 0 rg BT 464.50 677.10 Td (shared ) Tj ET Q q 0 0 0 rg BT 492.04 677.10 Td (with ) Tj ET Q q 0 0 0 rg BT 511.26 677.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 543.79 677.10 Td (partners ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (based ) Tj ET Q q 0 0 0 rg BT 61.27 665.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 83.77 665.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 130.69 665.10 Td (agreements.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 642.30 Td (Expenses ) Tj ET Q q 0 0 0 rg BT 75.85 642.30 Td (typically ) Tj ET Q q 0 0 0 rg BT 112.93 642.30 Td (vary ) Tj ET Q q 0 0 0 rg BT 132.79 642.30 Td (between ) Tj ET Q q 0 0 0 rg BT 168.19 642.30 Td (periods ) Tj ET Q q 0 0 0 rg BT 199.71 642.30 Td (for ) Tj ET Q q 0 0 0 rg BT 213.46 642.30 Td (a ) Tj ET Q q 0 0 0 rg BT 219.98 642.30 Td (number ) Tj ET Q q 0 0 0 rg BT 252.62 642.30 Td (of ) Tj ET Q q 0 0 0 rg BT 263.03 642.30 Td (reasons, ) Tj ET Q q 0 0 0 rg BT 297.61 642.30 Td (including ) Tj ET Q q 0 0 0 rg BT 337.47 642.30 Td (the ) Tj ET Q q 0 0 0 rg BT 351.77 642.30 Td (timing ) Tj ET Q q 0 0 0 rg BT 379.97 642.30 Td (of ) Tj ET Q q 0 0 0 rg BT 390.39 642.30 Td (license ) Tj ET Q q 0 0 0 rg BT 420.24 642.30 Td (and ) Tj ET Q q 0 0 0 rg BT 436.77 642.30 Td (asset ) Tj ET Q q 0 0 0 rg BT 458.29 642.30 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 504.26 642.30 Td (char) Tj ET Q q 0 0 0 rg BT 521.29 642.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 536.70 642.30 Td (and ) Tj ET Q q 0 0 0 rg BT 553.23 642.30 Td (IPRD ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 630.30 Td (impairment ) Tj ET Q q 0 0 0 rg BT 84.60 630.30 Td (char) Tj ET Q q 0 0 0 rg BT 101.63 630.30 Td (ges.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 613.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 613.30 Td (Research ) Tj ET Q q 0 0 0 rg BT 100.75 613.30 Td (and ) Tj ET Q q 0 0 0 rg BT 117.95 613.30 Td (development ) Tj ET Q q 0 0 0 rg BT 172.36 613.30 Td (expenses ) Tj ET Q q 0 0 0 rg BT 211.21 613.30 Td (decreased ) Tj ET Q q 0 0 0 rg BT 253.39 613.30 Td (in ) Tj ET Q q 0 0 0 rg BT 263.92 613.30 Td (2016 ) Tj ET Q q 0 0 0 rg BT 286.68 613.30 Td (due ) Tj ET Q q 0 0 0 rg BT 303.88 613.30 Td (to ) Tj ET Q q 0 0 0 rg BT 314.41 613.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 339.94 613.30 Td (license ) Tj ET Q q 0 0 0 rg BT 370.46 613.30 Td (and ) Tj ET Q q 0 0 0 rg BT 387.66 613.30 Td (asset ) Tj ET Q q 0 0 0 rg BT 409.85 613.30 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 456.49 613.30 Td (char) Tj ET Q q 0 0 0 rg BT 473.52 613.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 489.61 613.30 Td (partially ) Tj ET Q q 0 0 0 rg BT 525.68 613.30 Td (of) Tj ET Q q 0 0 0 rg BT 533.83 613.30 Td (fset ) Tj ET Q q 0 0 0 rg BT 551.03 613.30 Td (by ) Tj ET Q q 0 0 0 rg BT 563.79 613.30 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 601.30 Td (acceleration ) Tj ET Q q 0 0 0 rg BT 112.15 601.30 Td (and ) Tj ET Q q 0 0 0 rg BT 129.08 601.30 Td (expansion ) Tj ET Q q 0 0 0 rg BT 172.13 601.30 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 182.96 601.30 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 212.40 601.30 Td ( ) Tj ET Q q 0 0 0 rg BT 214.90 601.30 Td (development ) Tj ET Q q 0 0 0 rg BT 269.05 601.30 Td (programs ) Tj ET Q q 0 0 0 rg BT 309.32 601.30 Td (and ) Tj ET Q q 0 0 0 rg BT 326.26 601.30 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 374.29 601.30 Td (and ) Tj ET Q q 0 0 0 rg BT 391.23 601.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 416.50 601.30 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 441.78 601.30 Td (impairment ) Tj ET Q q 0 0 0 rg BT 490.38 601.30 Td (char) Tj ET Q q 0 0 0 rg BT 507.41 601.30 Td (ges.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 584.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 584.30 Td (Research ) Tj ET Q q 0 0 0 rg BT 100.06 584.30 Td (and ) Tj ET Q q 0 0 0 rg BT 116.57 584.30 Td (development ) Tj ET Q q 0 0 0 rg BT 170.29 584.30 Td (expenses ) Tj ET Q q 0 0 0 rg BT 208.46 584.30 Td (increased ) Tj ET Q q 0 0 0 rg BT 248.28 584.30 Td (in ) Tj ET Q q 0 0 0 rg BT 258.13 584.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 280.20 584.30 Td (due ) Tj ET Q q 0 0 0 rg BT 296.71 584.30 Td (to ) Tj ET Q q 0 0 0 rg BT 306.56 584.30 Td (higher ) Tj ET Q q 0 0 0 rg BT 334.17 584.30 Td (license ) Tj ET Q q 0 0 0 rg BT 364.01 584.30 Td (and ) Tj ET Q q 0 0 0 rg BT 380.51 584.30 Td (asset ) Tj ET Q q 0 0 0 rg BT 402.02 584.30 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 447.97 584.30 Td (char) Tj ET Q q 0 0 0 rg BT 465.00 584.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 480.40 584.30 Td (and ) Tj ET Q q 0 0 0 rg BT 496.91 584.30 Td (the ) Tj ET Q q 0 0 0 rg BT 511.19 584.30 Td (acceleration ) Tj ET Q q 0 0 0 rg BT 561.56 584.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 572.30 Td (expansion ) Tj ET Q q 0 0 0 rg BT 105.02 572.30 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 116.47 572.30 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 145.91 572.30 Td ( ) Tj ET Q q 0 0 0 rg BT 149.03 572.30 Td (development ) Tj ET Q q 0 0 0 rg BT 203.80 572.30 Td (programs ) Tj ET Q q 0 0 0 rg BT 244.69 572.30 Td (and ) Tj ET Q q 0 0 0 rg BT 262.25 572.30 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 310.91 572.30 Td (partially ) Tj ET Q q 0 0 0 rg BT 347.35 572.30 Td (of) Tj ET Q q 0 0 0 rg BT 355.50 572.30 Td (fset ) Tj ET Q q 0 0 0 rg BT 373.06 572.30 Td (by ) Tj ET Q q 0 0 0 rg BT 386.18 572.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 412.07 572.30 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 437.98 572.30 Td (impairment ) Tj ET Q q 0 0 0 rg BT 487.20 572.30 Td (char) Tj ET Q q 0 0 0 rg BT 504.23 572.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 520.68 572.30 Td (and ) Tj ET Q q 0 0 0 rg BT 538.24 572.30 Td (favorable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 560.30 Td (foreign ) Tj ET Q q 0 0 0 rg BT 92.73 560.30 Td (exchange. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 543.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 543.30 Td (License ) Tj ET Q q 0 0 0 rg BT 95.27 543.30 Td (and ) Tj ET Q q 0 0 0 rg BT 112.54 543.30 Td (asset ) Tj ET Q q 0 0 0 rg BT 134.81 543.30 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 181.52 543.30 Td (char) Tj ET Q q 0 0 0 rg BT 198.54 543.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 214.70 543.30 Td (were ) Tj ET Q q 0 0 0 rg BT 236.96 543.30 Td ($439 ) Tj ET Q q 0 0 0 rg BT 259.79 543.30 Td (million ) Tj ET Q q 0 0 0 rg BT 291.51 543.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.12 543.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 322.12 543.30 Td (, ) Tj ET Q q 0 0 0 rg BT 327.44 543.30 Td ($1.7 ) Tj ET Q q 0 0 0 rg BT 347.77 543.30 Td (billion ) Tj ET Q q 0 0 0 rg BT 376.71 543.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.32 543.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.32 543.30 Td ( ) Tj ET Q q 0 0 0 rg BT 410.15 543.30 Td (and ) Tj ET Q q 0 0 0 rg BT 427.42 543.30 Td ($278 ) Tj ET Q q 0 0 0 rg BT 450.25 543.30 Td (million ) Tj ET Q q 0 0 0 rg BT 481.97 543.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.57 543.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.57 543.30 Td ( ) Tj ET Q q 0 0 0 rg BT 515.40 543.30 Td (including ) Tj ET Q q 0 0 0 rg BT 556.00 543.30 Td ($374 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 531.30 Td (million ) Tj ET Q q 0 0 0 rg BT 92.85 531.30 Td (for ) Tj ET Q q 0 0 0 rg BT 107.12 531.30 Td (Padlock, ) Tj ET Q q 0 0 0 rg BT 144.45 531.30 Td (Nitto ) Tj ET Q q 0 0 0 rg BT 167.61 531.30 Td (Denko, ) Tj ET Q q 0 0 0 rg BT 199.38 531.30 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 228.66 531.30 Td (and ) Tj ET Q q 0 0 0 rg BT 245.71 531.30 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 291.65 531.30 Td (in ) Tj ET Q q 0 0 0 rg BT 302.04 531.30 Td (2016, ) Tj ET Q q 0 0 0 rg BT 327.15 531.30 Td ($1.3 ) Tj ET Q q 0 0 0 rg BT 347.26 531.30 Td (billion ) Tj ET Q q 0 0 0 rg BT 375.98 531.30 Td (for ) Tj ET Q q 0 0 0 rg BT 390.25 531.30 Td (Flexus, ) Tj ET Q q 0 0 0 rg BT 422.03 531.30 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 464.63 531.30 Td (and ) Tj ET Q q 0 0 0 rg BT 481.68 531.30 Td (Five ) Tj ET Q q 0 0 0 rg BT 502.07 531.30 Td (Prime ) Tj ET Q q 0 0 0 rg BT 528.57 531.30 Td (in ) Tj ET Q q 0 0 0 rg BT 538.95 531.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 561.56 531.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 519.30 Td ($148 ) Tj ET Q q 0 0 0 rg BT 83.88 519.30 Td (million ) Tj ET Q q 0 0 0 rg BT 115.30 519.30 Td (for ) Tj ET Q q 0 0 0 rg BT 129.49 519.30 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 163.12 519.30 Td (in ) Tj ET Q q 0 0 0 rg BT 173.43 519.30 Td (2014. ) Tj ET Q q 0 0 0 rg BT 197.90 519.30 Td (A) Tj ET Q q 0 0 0 rg BT 204.57 519.30 Td ( ) Tj ET Q q 0 0 0 rg BT 207.10 519.30 Td ($100 ) Tj ET Q q 0 0 0 rg BT 229.63 519.30 Td (million ) Tj ET Q q 0 0 0 rg BT 261.05 519.30 Td (milestone ) Tj ET Q q 0 0 0 rg BT 302.46 519.30 Td (was ) Tj ET Q q 0 0 0 rg BT 320.54 519.30 Td (paid ) Tj ET Q q 0 0 0 rg BT 340.29 519.30 Td (to ) Tj ET Q q 0 0 0 rg BT 350.60 519.30 Td (former ) Tj ET Q q 0 0 0 rg BT 380.33 519.30 Td (shareowners ) Tj ET Q q 0 0 0 rg BT 432.84 519.30 Td (of ) Tj ET Q q 0 0 0 rg BT 443.70 519.30 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 472.90 519.30 Td (for ) Tj ET Q q 0 0 0 rg BT 487.09 519.30 Td (the ) Tj ET Q q 0 0 0 rg BT 501.84 519.30 Td (commencement ) Tj ET Q q 0 0 0 rg BT 567.67 519.30 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 507.30 Td (a ) Tj ET Q q 0 0 0 rg BT 68.29 507.30 Td (Phase ) Tj ET Q q 0 0 0 rg BT 94.12 507.30 Td (I ) Tj ET Q q 0 0 0 rg BT 99.95 507.30 Td (clinical ) Tj ET Q q 0 0 0 rg BT 131.88 507.30 Td (trial ) Tj ET Q q 0 0 0 rg BT 150.48 507.30 Td (in ) Tj ET Q q 0 0 0 rg BT 160.76 507.30 Td (2016.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 490.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 490.30 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 86.92 490.30 Td (impairment ) Tj ET Q q 0 0 0 rg BT 135.80 490.30 Td (char) Tj ET Q q 0 0 0 rg BT 152.83 490.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 168.95 490.30 Td (were ) Tj ET Q q 0 0 0 rg BT 191.16 490.30 Td ($13 ) Tj ET Q q 0 0 0 rg BT 208.95 490.30 Td (million ) Tj ET Q q 0 0 0 rg BT 240.62 490.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.19 490.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.19 490.30 Td (, ) Tj ET Q q 0 0 0 rg BT 276.47 490.30 Td ($160 ) Tj ET Q q 0 0 0 rg BT 299.26 490.30 Td (million ) Tj ET Q q 0 0 0 rg BT 330.93 490.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 341.50 490.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 361.50 490.30 Td ( ) Tj ET Q q 0 0 0 rg BT 364.28 490.30 Td (and ) Tj ET Q q 0 0 0 rg BT 381.51 490.30 Td ($343 ) Tj ET Q q 0 0 0 rg BT 404.29 490.30 Td (million ) Tj ET Q q 0 0 0 rg BT 435.97 490.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.54 490.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.54 490.30 Td ( ) Tj ET Q q 0 0 0 rg BT 469.32 490.30 Td (including ) Tj ET Q q 0 0 0 rg BT 509.88 490.30 Td ($160 ) Tj ET Q q 0 0 0 rg BT 532.67 490.30 Td (million ) Tj ET Q q 0 0 0 rg BT 564.34 490.30 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 478.30 Td (LP) Tj ET Q q 0 0 0 rg BT 72.10 478.30 Td (A1 ) Tj ET Q q 0 0 0 rg BT 86.27 478.30 Td (Antagonist ) Tj ET Q q 0 0 0 rg BT 132.66 478.30 Td (in ) Tj ET Q q 0 0 0 rg BT 142.94 478.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 165.44 478.30 Td (and ) Tj ET Q q 0 0 0 rg BT 182.38 478.30 Td ($310 ) Tj ET Q q 0 0 0 rg BT 204.88 478.30 Td (million ) Tj ET Q q 0 0 0 rg BT 236.27 478.30 Td (for ) Tj ET Q q 0 0 0 rg BT 250.43 478.30 Td (peginterferon ) Tj ET Q q 0 0 0 rg BT 306.79 478.30 Td (lambda ) Tj ET Q q 0 0 0 rg BT 338.72 478.30 Td (in ) Tj ET Q q 0 0 0 rg BT 349.00 478.30 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.35 461.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 461.30 Td (Accelerated ) Tj ET Q q 0 0 0 rg BT 111.50 461.30 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 163.32 461.30 Td (was ) Tj ET Q q 0 0 0 rg BT 181.28 461.30 Td ($70 ) Tj ET Q q 0 0 0 rg BT 198.68 461.30 Td (million ) Tj ET Q q 0 0 0 rg BT 229.98 461.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.17 461.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 260.17 461.30 Td ( ) Tj ET Q q 0 0 0 rg BT 262.57 461.30 Td (and ) Tj ET Q q 0 0 0 rg BT 279.42 461.30 Td ($29 ) Tj ET Q q 0 0 0 rg BT 296.82 461.30 Td (million ) Tj ET Q q 0 0 0 rg BT 328.12 461.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.31 461.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.31 461.30 Td ( ) Tj ET Q q 0 0 0 rg BT 360.71 461.30 Td (as ) Tj ET Q q 0 0 0 rg BT 371.45 461.30 Td (a ) Tj ET Q q 0 0 0 rg BT 378.29 461.30 Td (result ) Tj ET Q q 0 0 0 rg BT 402.92 461.30 Td (of ) Tj ET Q q 0 0 0 rg BT 413.65 461.30 Td (the ) Tj ET Q q 0 0 0 rg BT 428.28 461.30 Td (expected ) Tj ET Q q 0 0 0 rg BT 466.22 461.30 Td (exit ) Tj ET Q q 0 0 0 rg BT 483.62 461.30 Td (of ) Tj ET Q q 0 0 0 rg BT 494.35 461.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 523.96 461.30 Td (R&D ) Tj ET Q q 0 0 0 rg BT 548.04 461.30 Td (sites ) Tj ET Q q 0 0 0 rg BT 568.22 461.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 449.30 Td (the ) Tj ET Q q 0 0 0 rg BT 75.43 449.30 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 94.67 449.30 Td (Accelerated ) Tj ET Q q 0 0 0 rg BT 144.27 449.30 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 195.55 449.30 Td (results ) Tj ET Q q 0 0 0 rg BT 223.53 449.30 Td (from ) Tj ET Q q 0 0 0 rg BT 244.83 449.30 Td (the ) Tj ET Q q 0 0 0 rg BT 258.91 449.30 Td (reduction ) Tj ET Q q 0 0 0 rg BT 298.54 449.30 Td (in ) Tj ET Q q 0 0 0 rg BT 308.18 449.30 Td (the ) Tj ET Q q 0 0 0 rg BT 322.26 449.30 Td (estimated ) Tj ET Q q 0 0 0 rg BT 362.45 449.30 Td (useful ) Tj ET Q q 0 0 0 rg BT 388.75 449.30 Td (lives ) Tj ET Q q 0 0 0 rg BT 409.50 449.30 Td (of ) Tj ET Q q 0 0 0 rg BT 419.69 449.30 Td (the ) Tj ET Q q 0 0 0 rg BT 433.78 449.30 Td (related ) Tj ET Q q 0 0 0 rg BT 462.84 449.30 Td (assets ) Tj ET Q q 0 0 0 rg BT 488.04 449.30 Td (for ) Tj ET Q q 0 0 0 rg BT 501.56 449.30 Td (each ) Tj ET Q q 0 0 0 rg BT 521.74 449.30 Td (site ) Tj ET Q q 0 0 0 rg BT 537.49 449.30 Td (at ) Tj ET Q q 0 0 0 rg BT 546.57 449.30 Td (various ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.35 437.30 Td (dates ) Tj ET Q q 0 0 0 rg BT 84.40 437.30 Td (through ) Tj ET Q q 0 0 0 rg BT 118.01 437.30 Td (2020 ) Tj ET Q q 0 0 0 rg BT 140.51 437.30 Td (and ) Tj ET Q q 0 0 0 rg BT 157.44 437.30 Td (is ) Tj ET Q q 0 0 0 rg BT 166.61 437.30 Td (expected ) Tj ET Q q 0 0 0 rg BT 204.65 437.30 Td (to ) Tj ET Q q 0 0 0 rg BT 214.92 437.30 Td (approximate ) Tj ET Q q 0 0 0 rg BT 267.40 437.30 Td ($250 ) Tj ET Q q 0 0 0 rg BT 289.90 437.30 Td (million ) Tj ET Q q 0 0 0 rg BT 321.30 437.30 Td (in ) Tj ET Q q 0 0 0 rg BT 331.57 437.30 Td (2017. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 419.30 Td (Refer ) Tj ET Q q 0 0 0 rg BT 61.63 419.30 Td (to ) Tj ET Q q 0 0 0 rg BT 72.84 419.30 Td ("Item ) Tj ET Q q 0 0 0 rg BT 98.68 419.30 Td (8. ) Tj ET Q q 0 0 0 rg BT 109.60 419.30 Td (Financial ) Tj ET Q q 0 0 0 rg BT 150.24 419.30 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 226.99 419.30 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.99 419.30 Td (. ) Tj ET Q q 0 0 0 rg BT 237.16 419.30 Td (Alliances, ) Tj ET Q q 0 0 0 rg BT 280.85 419.30 Td (Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.72 419.30 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.72 419.30 Td (. ) Tj ET Q q 0 0 0 rg BT 313.89 419.30 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 367.88 419.30 Td (and ) Tj ET Q q 0 0 0 rg BT 385.74 419.30 Td (Divestitures ) Tj ET Q q 0 0 0 rg BT 437.50 419.30 Td (and ) Tj ET Q q 0 0 0 rg BT 455.36 419.30 Td (Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.23 419.30 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.23 419.30 Td (. ) Tj ET Q q 0 0 0 rg BT 494.16 419.30 Td (Goodwill ) Tj ET Q q 0 0 0 rg BT 535.36 419.30 Td (and ) Tj ET Q q 0 0 0 rg BT 553.23 419.30 Td (Other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 407.30 Td (Intangible ) Tj ET Q q 0 0 0 rg BT 78.14 407.30 Td (Assets" ) Tj ET Q q 0 0 0 rg BT 110.40 407.30 Td (and ) Tj ET Q q 0 0 0 rg BT 126.89 407.30 Td ("—Acquisition ) Tj ET Q q 0 0 0 rg BT 189.69 407.30 Td (and ) Tj ET Q q 0 0 0 rg BT 206.19 407.30 Td (Licensing ) Tj ET Q q 0 0 0 rg BT 247.22 407.30 Td (Arrangements ) Tj ET Q q 0 0 0 rg BT 305.92 407.30 Td (and ) Tj ET Q q 0 0 0 rg BT 322.42 407.30 Td (—Non-GAAP) Tj ET Q q 0 0 0 rg BT 379.82 407.30 Td ( ) Tj ET Q q 0 0 0 rg BT 381.88 407.30 Td (Financial ) Tj ET Q q 0 0 0 rg BT 421.15 407.30 Td (Measures ) Tj ET Q q 0 0 0 rg BT 461.52 407.30 Td (- ) Tj ET Q q 0 0 0 rg BT 466.91 407.30 Td (Specified ) Tj ET Q q 0 0 0 rg BT 506.73 407.30 Td (Items" ) Tj ET Q q 0 0 0 rg BT 535.08 407.30 Td (for ) Tj ET Q q 0 0 0 rg BT 548.80 407.30 Td (further ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 395.30 Td (information. ) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 369.9669921875 m 131.791015625 369.9669921875 l s q 0 0 0 rg BT 36.00 371.30 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 347.30 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.62 347.30 Td (income ) Tj ET Q q 0 0 0 rg BT 93.90 347.30 Td (increased ) Tj ET Q q 0 0 0 rg BT 134.51 347.30 Td ($1.1 ) Tj ET Q q 0 0 0 rg BT 154.86 347.30 Td (billion ) Tj ET Q q 0 0 0 rg BT 183.82 347.30 Td (in ) Tj ET Q q 0 0 0 rg BT 194.45 347.30 Td (2016 ) Tj ET Q q 0 0 0 rg BT 217.30 347.30 Td (due ) Tj ET Q q 0 0 0 rg BT 234.59 347.30 Td (to ) Tj ET Q q 0 0 0 rg BT 245.22 347.30 Td (higher ) Tj ET Q q 0 0 0 rg BT 273.62 347.30 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 318.68 347.30 Td (gains ) Tj ET Q q 0 0 0 rg BT 342.64 347.30 Td (and ) Tj ET Q q 0 0 0 rg BT 359.93 347.30 Td (royalties ) Tj ET Q q 0 0 0 rg BT 397.21 347.30 Td (and ) Tj ET Q q 0 0 0 rg BT 414.50 347.30 Td (licensing ) Tj ET Q q 0 0 0 rg BT 453.46 347.30 Td (income, ) Tj ET Q q 0 0 0 rg BT 488.24 347.30 Td (and ) Tj ET Q q 0 0 0 rg BT 505.53 347.30 Td (to ) Tj ET Q q 0 0 0 rg BT 516.16 347.30 Td (a ) Tj ET Q q 0 0 0 rg BT 523.45 347.30 Td (lesser ) Tj ET Q q 0 0 0 rg BT 549.07 347.30 Td (extent, ) Tj ET Q q 0 0 0 rg BT 578.50 347.30 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 335.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 61.27 335.30 Td (litigation ) Tj ET Q q 0 0 0 rg BT 99.88 335.30 Td (and ) Tj ET Q q 0 0 0 rg BT 116.82 335.30 Td (other ) Tj ET Q q 0 0 0 rg BT 139.86 335.30 Td (settlements, ) Tj ET Q q 0 0 0 rg BT 189.85 335.30 Td (pension ) Tj ET Q q 0 0 0 rg BT 223.46 335.30 Td (and ) Tj ET Q q 0 0 0 rg BT 240.40 335.30 Td (debt ) Tj ET Q q 0 0 0 rg BT 260.12 335.30 Td (redemption ) Tj ET Q q 0 0 0 rg BT 308.16 335.30 Td (char) Tj ET Q q 0 0 0 rg BT 325.18 335.30 Td (ges. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 318.30 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.27 318.30 Td (expense ) Tj ET Q q 0 0 0 rg BT 95.98 318.30 Td (decreased ) Tj ET Q q 0 0 0 rg BT 137.89 318.30 Td ($397 ) Tj ET Q q 0 0 0 rg BT 160.39 318.30 Td (million ) Tj ET Q q 0 0 0 rg BT 191.78 318.30 Td (in ) Tj ET Q q 0 0 0 rg BT 202.06 318.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 224.56 318.30 Td (due ) Tj ET Q q 0 0 0 rg BT 241.50 318.30 Td (to ) Tj ET Q q 0 0 0 rg BT 251.78 318.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 277.04 318.30 Td (pension ) Tj ET Q q 0 0 0 rg BT 310.65 318.30 Td (char) Tj ET Q q 0 0 0 rg BT 327.68 318.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 343.51 318.30 Td (partially ) Tj ET Q q 0 0 0 rg BT 379.33 318.30 Td (of) Tj ET Q q 0 0 0 rg BT 387.48 318.30 Td (fset ) Tj ET Q q 0 0 0 rg BT 404.42 318.30 Td (by ) Tj ET Q q 0 0 0 rg BT 416.92 318.30 Td (lower ) Tj ET Q q 0 0 0 rg BT 442.19 318.30 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 486.90 318.30 Td (gains. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 301.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 301.30 Td (Divestiture ) Tj ET Q q 0 0 0 rg BT 109.80 301.30 Td (gains ) Tj ET Q q 0 0 0 rg BT 133.27 301.30 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 155.06 301.30 Td ($576 ) Tj ET Q q 0 0 0 rg BT 177.42 301.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.31 301.30 Td ( ) Tj ET Q q 0 0 0 rg BT 208.67 301.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.81 301.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 238.81 301.30 Td (, ) Tj ET Q q 0 0 0 rg BT 243.68 301.30 Td ($196 ) Tj ET Q q 0 0 0 rg BT 266.04 301.30 Td (million ) Tj ET Q q 0 0 0 rg BT 297.29 301.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.43 301.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.43 301.30 Td ( ) Tj ET Q q 0 0 0 rg BT 329.80 301.30 Td (and ) Tj ET Q q 0 0 0 rg BT 346.60 301.30 Td ($564 ) Tj ET Q q 0 0 0 rg BT 368.96 301.30 Td (million ) Tj ET Q q 0 0 0 rg BT 400.21 301.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.35 301.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.35 301.30 Td ( ) Tj ET Q q 0 0 0 rg BT 432.72 301.30 Td (including ) Tj ET Q q 0 0 0 rg BT 472.85 301.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 502.42 301.30 Td (OTC ) Tj ET Q q 0 0 0 rg BT 524.78 301.30 Td (products ) Tj ET Q q 0 0 0 rg BT 561.58 301.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 289.30 Td (investigational ) Tj ET Q q 0 0 0 rg BT 125.07 289.30 Td (HIV) Tj ET Q q 0 0 0 rg BT 142.67 289.30 Td ( ) Tj ET Q q 0 0 0 rg BT 145.86 289.30 Td (medicines ) Tj ET Q q 0 0 0 rg BT 189.60 289.30 Td (businesses ) Tj ET Q q 0 0 0 rg BT 235.02 289.30 Td (in ) Tj ET Q q 0 0 0 rg BT 245.99 289.30 Td (2016, ) Tj ET Q q 0 0 0 rg BT 271.69 289.30 Td (the ) Tj ET Q q 0 0 0 rg BT 287.10 289.30 Td (Mount ) Tj ET Q q 0 0 0 rg BT 316.73 289.30 Td (V) Tj ET Q q 0 0 0 rg BT 322.85 289.30 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 351.31 289.30 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 384.49 289.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 446.00 289.30 Td (facility) Tj ET Q q 0 0 0 rg BT 473.67 289.30 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 479.37 289.30 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.36 289.30 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 520.06 289.30 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.38 289.30 Td ( ) Tj ET Q q 0 0 0 rg BT 561.57 289.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 277.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 92.70 277.30 Td (mature ) Tj ET Q q 0 0 0 rg BT 122.97 277.30 Td (and ) Tj ET Q q 0 0 0 rg BT 139.90 277.30 Td (other ) Tj ET Q q 0 0 0 rg BT 162.95 277.30 Td (OTC ) Tj ET Q q 0 0 0 rg BT 185.45 277.30 Td (product ) Tj ET Q q 0 0 0 rg BT 218.50 277.30 Td (businesses ) Tj ET Q q 0 0 0 rg BT 263.22 277.30 Td (in ) Tj ET Q q 0 0 0 rg BT 273.50 277.30 Td (2015 ) Tj ET Q q 0 0 0 rg BT 296.00 277.30 Td (and ) Tj ET Q q 0 0 0 rg BT 312.94 277.30 Td (the ) Tj ET Q q 0 0 0 rg BT 327.65 277.30 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 362.92 277.30 Td (business ) Tj ET Q q 0 0 0 rg BT 399.31 277.30 Td (in ) Tj ET Q q 0 0 0 rg BT 409.59 277.30 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 260.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 260.30 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 103.35 260.30 Td (and ) Tj ET Q q 0 0 0 rg BT 120.36 260.30 Td (licensing ) Tj ET Q q 0 0 0 rg BT 159.04 260.30 Td (income ) Tj ET Q q 0 0 0 rg BT 191.04 260.30 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.04 260.30 Td ($719 ) Tj ET Q q 0 0 0 rg BT 235.62 260.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.51 260.30 Td ( ) Tj ET Q q 0 0 0 rg BT 267.08 260.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 277.43 260.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.43 260.30 Td (, ) Tj ET Q q 0 0 0 rg BT 302.51 260.30 Td ($383 ) Tj ET Q q 0 0 0 rg BT 325.08 260.30 Td (million ) Tj ET Q q 0 0 0 rg BT 356.54 260.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.90 260.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.90 260.30 Td ( ) Tj ET Q q 0 0 0 rg BT 389.47 260.30 Td (and ) Tj ET Q q 0 0 0 rg BT 406.48 260.30 Td ($283 ) Tj ET Q q 0 0 0 rg BT 429.05 260.30 Td (million ) Tj ET Q q 0 0 0 rg BT 460.52 260.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.87 260.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.87 260.30 Td ( ) Tj ET Q q 0 0 0 rg BT 493.44 260.30 Td (including ) Tj ET Q q 0 0 0 rg BT 533.79 260.30 Td (contingent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 248.30 Td (consideration ) Tj ET Q q 0 0 0 rg BT 118.82 248.30 Td (from ) Tj ET Q q 0 0 0 rg BT 140.21 248.30 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 154.38 248.30 Td (Erbitux* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 191.33 248.30 Td (and ) Tj ET Q q 0 0 0 rg BT 207.71 248.30 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 242.43 248.30 Td (business ) Tj ET Q q 0 0 0 rg BT 278.27 248.30 Td (divestitures, ) Tj ET Q q 0 0 0 rg BT 328.83 248.30 Td (including ) Tj ET Q q 0 0 0 rg BT 368.55 248.30 Td (the ) Tj ET Q q 0 0 0 rg BT 382.72 248.30 Td (transfer ) Tj ET Q q 0 0 0 rg BT 415.20 248.30 Td (of ) Tj ET Q q 0 0 0 rg BT 425.49 248.30 Td (certain ) Tj ET Q q 0 0 0 rg BT 454.64 248.30 Td (future ) Tj ET Q q 0 0 0 rg BT 480.47 248.30 Td (royalty ) Tj ET Q q 0 0 0 rg BT 510.74 248.30 Td (rights ) Tj ET Q q 0 0 0 rg BT 535.47 248.30 Td (pertaining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 236.30 Td (to ) Tj ET Q q 0 0 0 rg BT 72.73 236.30 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 105.78 236.30 Td (product ) Tj ET Q q 0 0 0 rg BT 138.83 236.30 Td (sales.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 219.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 219.30 Td (Pension ) Tj ET Q q 0 0 0 rg BT 96.91 219.30 Td (char) Tj ET Q q 0 0 0 rg BT 113.94 219.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 129.51 219.30 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.18 219.30 Td ($91 ) Tj ET Q q 0 0 0 rg BT 168.42 219.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 197.31 219.30 Td ( ) Tj ET Q q 0 0 0 rg BT 199.55 219.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 209.57 219.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.57 219.30 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.31 219.30 Td ($160 ) Tj ET Q q 0 0 0 rg BT 256.55 219.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 285.45 219.30 Td ( ) Tj ET Q q 0 0 0 rg BT 287.69 219.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.71 219.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 317.71 219.30 Td ( ) Tj ET Q q 0 0 0 rg BT 319.95 219.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 336.63 219.30 Td ($877 ) Tj ET Q q 0 0 0 rg BT 358.87 219.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.76 219.30 Td ( ) Tj ET Q q 0 0 0 rg BT 390.00 219.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.02 219.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.02 219.30 Td ( ) Tj ET Q q 0 0 0 rg BT 422.26 219.30 Td (including ) Tj ET Q q 0 0 0 rg BT 462.28 219.30 Td (an ) Tj ET Q q 0 0 0 rg BT 473.96 219.30 Td (additional ) Tj ET Q q 0 0 0 rg BT 516.19 219.30 Td (pension ) Tj ET Q q 0 0 0 rg BT 549.54 219.30 Td (char) Tj ET Q q 0 0 0 rg BT 566.56 219.30 Td (ge ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 207.30 Td (of ) Tj ET Q q 0 0 0 rg BT 73.68 207.30 Td ($713 ) Tj ET Q q 0 0 0 rg BT 96.03 207.30 Td (million ) Tj ET Q q 0 0 0 rg BT 127.27 207.30 Td (following ) Tj ET Q q 0 0 0 rg BT 168.51 207.30 Td (the ) Tj ET Q q 0 0 0 rg BT 183.08 207.30 Td (purchase ) Tj ET Q q 0 0 0 rg BT 220.97 207.30 Td (of ) Tj ET Q q 0 0 0 rg BT 231.65 207.30 Td (a ) Tj ET Q q 0 0 0 rg BT 238.44 207.30 Td (group ) Tj ET Q q 0 0 0 rg BT 264.12 207.30 Td (annuity ) Tj ET Q q 0 0 0 rg BT 296.47 207.30 Td (contract ) Tj ET Q q 0 0 0 rg BT 331.02 207.30 Td (from ) Tj ET Q q 0 0 0 rg BT 352.64 207.30 Td (The ) Tj ET Q q 0 0 0 rg BT 370.54 207.30 Td (Prudential ) Tj ET Q q 0 0 0 rg BT 413.99 207.30 Td (Insurance ) Tj ET Q q 0 0 0 rg BT 455.21 207.30 Td (Company ) Tj ET Q q 0 0 0 rg BT 496.45 207.30 Td (of ) Tj ET Q q 0 0 0 rg BT 506.61 207.30 Td (America ) Tj ET Q q 0 0 0 rg BT 543.39 207.30 Td (in ) Tj ET Q q 0 0 0 rg BT 553.51 207.30 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 190.30 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 190.30 Td (Provision ) Tj ET Q q 0 0 0 rg BT 102.92 190.30 Td (for ) Tj ET Q q 0 0 0 rg BT 116.16 190.30 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 168.83 190.30 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.96 190.30 Td ($109 ) Tj ET Q q 0 0 0 rg BT 207.54 190.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.43 190.30 Td ( ) Tj ET Q q 0 0 0 rg BT 238.01 190.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.37 190.30 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.37 190.30 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.44 190.30 Td ($1) Tj ET Q q 0 0 0 rg BT 281.07 190.30 Td (18 ) Tj ET Q q 0 0 0 rg BT 292.65 190.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.54 190.30 Td ( ) Tj ET Q q 0 0 0 rg BT 323.12 190.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.48 190.30 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.48 190.30 Td ( ) Tj ET Q q 0 0 0 rg BT 354.06 190.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.07 190.30 Td ($163 ) Tj ET Q q 0 0 0 rg BT 391.65 190.30 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.54 190.30 Td ( ) Tj ET Q q 0 0 0 rg BT 422.12 190.30 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.48 190.30 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.48 190.30 Td (. ) Tj ET Q q 0 0 0 rg BT 455.56 190.30 Td (In ) Tj ET Q q 0 0 0 rg BT 465.47 190.30 Td (October ) Tj ET Q q 0 0 0 rg BT 499.25 190.30 Td (2016, ) Tj ET Q q 0 0 0 rg BT 523.33 190.30 Td (the ) Tj ET Q q 0 0 0 rg BT 537.13 190.30 Td (Company ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 178.30 Td (announced ) Tj ET Q q 0 0 0 rg BT 109.33 178.30 Td (an ) Tj ET Q q 0 0 0 rg BT 121.78 178.30 Td (evolution ) Tj ET Q q 0 0 0 rg BT 162.56 178.30 Td (to ) Tj ET Q q 0 0 0 rg BT 173.35 178.30 Td (its ) Tj ET Q q 0 0 0 rg BT 185.81 178.30 Td (operating ) Tj ET Q q 0 0 0 rg BT 226.59 178.30 Td (model ) Tj ET Q q 0 0 0 rg BT 254.59 178.30 Td (to ) Tj ET Q q 0 0 0 rg BT 265.38 178.30 Td (drive ) Tj ET Q q 0 0 0 rg BT 288.94 178.30 Td (the ) Tj ET Q q 0 0 0 rg BT 304.17 178.30 Td (Company’) Tj ET Q q 0 0 0 rg BT 345.84 178.30 Td (s ) Tj ET Q q 0 0 0 rg BT 352.74 178.30 Td (continued ) Tj ET Q q 0 0 0 rg BT 395.19 178.30 Td (success ) Tj ET Q q 0 0 0 rg BT 428.19 178.30 Td (in ) Tj ET Q q 0 0 0 rg BT 438.98 178.30 Td (the ) Tj ET Q q 0 0 0 rg BT 454.21 178.30 Td (near) Tj ET Q q 0 0 0 rg BT 471.21 178.30 Td (- ) Tj ET Q q 0 0 0 rg BT 477.55 178.30 Td (and ) Tj ET Q q 0 0 0 rg BT 495.00 178.30 Td (long-term ) Tj ET Q q 0 0 0 rg BT 537.45 178.30 Td (through ) Tj ET Q q 0 0 0 rg BT 571.57 178.30 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 166.30 Td (more ) Tj ET Q q 0 0 0 rg BT 85.36 166.30 Td (focused ) Tj ET Q q 0 0 0 rg BT 118.27 166.30 Td (investment ) Tj ET Q q 0 0 0 rg BT 163.97 166.30 Td (in ) Tj ET Q q 0 0 0 rg BT 173.56 166.30 Td (commercial ) Tj ET Q q 0 0 0 rg BT 222.57 166.30 Td (opportunities ) Tj ET Q q 0 0 0 rg BT 277.16 166.30 Td (for ) Tj ET Q q 0 0 0 rg BT 290.63 166.30 Td (key ) Tj ET Q q 0 0 0 rg BT 306.89 166.30 Td (brands ) Tj ET Q q 0 0 0 rg BT 335.36 166.30 Td (and ) Tj ET Q q 0 0 0 rg BT 351.61 166.30 Td (markets, ) Tj ET Q q 0 0 0 rg BT 387.58 166.30 Td (a ) Tj ET Q q 0 0 0 rg BT 393.83 166.30 Td (competitive ) Tj ET Q q 0 0 0 rg BT 442.86 166.30 Td (and ) Tj ET Q q 0 0 0 rg BT 459.11 166.30 Td (more ) Tj ET Q q 0 0 0 rg BT 481.47 166.30 Td (agile ) Tj ET Q q 0 0 0 rg BT 502.72 166.30 Td (R&D ) Tj ET Q q 0 0 0 rg BT 526.20 166.30 Td (or) Tj ET Q q 0 0 0 rg BT 534.35 166.30 Td (ganization ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 154.30 Td (that ) Tj ET Q q 0 0 0 rg BT 79.71 154.30 Td (can ) Tj ET Q q 0 0 0 rg BT 95.31 154.30 Td (accelerate ) Tj ET Q q 0 0 0 rg BT 136.98 154.30 Td (the ) Tj ET Q q 0 0 0 rg BT 150.92 154.30 Td (pipeline, ) Tj ET Q q 0 0 0 rg BT 187.35 154.30 Td (streamlined ) Tj ET Q q 0 0 0 rg BT 235.71 154.30 Td (operations ) Tj ET Q q 0 0 0 rg BT 279.09 154.30 Td (and ) Tj ET Q q 0 0 0 rg BT 295.24 154.30 Td (realigned ) Tj ET Q q 0 0 0 rg BT 334.16 154.30 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 394.19 154.30 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 441.45 154.30 Td (that ) Tj ET Q q 0 0 0 rg BT 458.16 154.30 Td (broaden ) Tj ET Q q 0 0 0 rg BT 492.08 154.30 Td (biologics ) Tj ET Q q 0 0 0 rg BT 530.47 154.30 Td (capabilities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 142.30 Td (to ) Tj ET Q q 0 0 0 rg BT 72.89 142.30 Td (reflect ) Tj ET Q q 0 0 0 rg BT 100.53 142.30 Td (the ) Tj ET Q q 0 0 0 rg BT 114.86 142.30 Td (current ) Tj ET Q q 0 0 0 rg BT 145.29 142.30 Td (and ) Tj ET Q q 0 0 0 rg BT 161.84 142.30 Td (future ) Tj ET Q q 0 0 0 rg BT 187.83 142.30 Td (portfolio. ) Tj ET Q q 0 0 0 rg BT 227.28 142.30 Td (The ) Tj ET Q q 0 0 0 rg BT 244.94 142.30 Td (new ) Tj ET Q q 0 0 0 rg BT 263.71 142.30 Td (operating ) Tj ET Q q 0 0 0 rg BT 303.59 142.30 Td (model ) Tj ET Q q 0 0 0 rg BT 330.70 142.30 Td (will ) Tj ET Q q 0 0 0 rg BT 348.36 142.30 Td (enable ) Tj ET Q q 0 0 0 rg BT 376.57 142.30 Td (the ) Tj ET Q q 0 0 0 rg BT 390.90 142.30 Td (Company ) Tj ET Q q 0 0 0 rg BT 431.90 142.30 Td (to ) Tj ET Q q 0 0 0 rg BT 441.79 142.30 Td (deliver ) Tj ET Q q 0 0 0 rg BT 471.66 142.30 Td (the ) Tj ET Q q 0 0 0 rg BT 485.99 142.30 Td (strategic, ) Tj ET Q q 0 0 0 rg BT 524.48 142.30 Td (financial ) Tj ET Q q 0 0 0 rg BT 561.57 142.30 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 130.30 Td (operational ) Tj ET Q q 0 0 0 rg BT 110.93 130.30 Td (flexibility ) Tj ET Q q 0 0 0 rg BT 153.32 130.30 Td (necessary ) Tj ET Q q 0 0 0 rg BT 195.13 130.30 Td (to ) Tj ET Q q 0 0 0 rg BT 205.86 130.30 Td (invest ) Tj ET Q q 0 0 0 rg BT 232.70 130.30 Td (in ) Tj ET Q q 0 0 0 rg BT 243.42 130.30 Td (the ) Tj ET Q q 0 0 0 rg BT 258.59 130.30 Td (highest ) Tj ET Q q 0 0 0 rg BT 290.43 130.30 Td (priorities ) Tj ET Q q 0 0 0 rg BT 329.48 130.30 Td (across ) Tj ET Q q 0 0 0 rg BT 357.42 130.30 Td (the ) Tj ET Q q 0 0 0 rg BT 372.58 130.30 Td (Company) Tj ET Q q 0 0 0 rg BT 410.82 130.30 Td (. ) Tj ET Q q 0 0 0 rg BT 416.27 130.30 Td (Restructuring ) Tj ET Q q 0 0 0 rg BT 473.65 130.30 Td (char) Tj ET Q q 0 0 0 rg BT 490.68 130.30 Td (ges ) Tj ET Q q 0 0 0 rg BT 506.96 130.30 Td (of ) Tj ET Q q 0 0 0 rg BT 518.24 130.30 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 118.30 Td ($300 ) Tj ET Q q 0 0 0 rg BT 85.06 118.30 Td (million ) Tj ET Q q 0 0 0 rg BT 116.02 118.30 Td (are ) Tj ET Q q 0 0 0 rg BT 130.28 118.30 Td (expected ) Tj ET Q q 0 0 0 rg BT 167.88 118.30 Td (to ) Tj ET Q q 0 0 0 rg BT 177.72 118.30 Td (be ) Tj ET Q q 0 0 0 rg BT 189.22 118.30 Td (incurred ) Tj ET Q q 0 0 0 rg BT 224.60 118.30 Td (in ) Tj ET Q q 0 0 0 rg BT 234.44 118.30 Td (2017 ) Tj ET Q q 0 0 0 rg BT 256.50 118.30 Td (for ) Tj ET Q q 0 0 0 rg BT 270.22 118.30 Td (all ) Tj ET Q q 0 0 0 rg BT 282.28 118.30 Td (actions ) Tj ET Q q 0 0 0 rg BT 312.67 118.30 Td (in ) Tj ET Q q 0 0 0 rg BT 322.51 118.30 Td (addition ) Tj ET Q q 0 0 0 rg BT 357.34 118.30 Td (to ) Tj ET Q q 0 0 0 rg BT 367.18 118.30 Td (the ) Tj ET Q q 0 0 0 rg BT 381.46 118.30 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 428.48 118.30 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 479.96 118.30 Td (impact ) Tj ET Q q 0 0 0 rg BT 509.23 118.30 Td (discussed ) Tj ET Q q 0 0 0 rg BT 549.63 118.30 Td (above.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 100.30 Td (Refer ) Tj ET Q q 0 0 0 rg BT 60.70 100.30 Td (to ) Tj ET Q q 0 0 0 rg BT 70.98 100.30 Td ("Item ) Tj ET Q q 0 0 0 rg BT 95.88 100.30 Td (8. ) Tj ET Q q 0 0 0 rg BT 105.87 100.30 Td (Financial ) Tj ET Q q 0 0 0 rg BT 145.58 100.30 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 221.40 100.30 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 226.40 100.30 Td (. ) Tj ET Q q 0 0 0 rg BT 230.84 100.30 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 283.89 100.30 Td (and ) Tj ET Q q 0 0 0 rg BT 300.83 100.30 Td (Divestitures, ) Tj ET Q q 0 0 0 rg BT 354.15 100.30 Td (Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 376.08 100.30 Td (5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.08 100.30 Td (. ) Tj ET Q q 0 0 0 rg BT 386.07 100.30 Td (Other ) Tj ET Q q 0 0 0 rg BT 411.34 100.30 Td (\(Income\)/Expense, ) Tj ET Q q 0 0 0 rg BT 489.63 100.30 Td (Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 511.57 100.30 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.57 100.30 Td (. ) Tj ET Q q 0 0 0 rg BT 521.56 100.30 Td (Restructuring ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 88.30 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 88.30 Td (Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.88 88.30 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 84.88 88.30 Td (. ) Tj ET Q q 0 0 0 rg BT 89.88 88.30 Td (Pension ) Tj ET Q q 0 0 0 rg BT 124.05 88.30 Td (and ) Tj ET Q q 0 0 0 rg BT 140.99 88.30 Td (Postretirement ) Tj ET Q q 0 0 0 rg BT 201.81 88.30 Td (Benefit ) Tj ET Q q 0 0 0 rg BT 233.74 88.30 Td (Plans" ) Tj ET Q q 0 0 0 rg BT 261.99 88.30 Td (for ) Tj ET Q q 0 0 0 rg BT 276.15 88.30 Td (further ) Tj ET Q q 0 0 0 rg BT 305.86 88.30 Td (information.) Tj ET Q endstream endobj 77 0 obj <> endobj 78 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (38) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Income T) Tj ET Q q 0 0 0 rg BT 74.80 749.25 Td (axes) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 725.75 343.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 378.50 725.75 63.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 441.50 725.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 725.75 63.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.50 725.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 725.75 63.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 699.75 343.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 378.50 699.75 63.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 441.50 699.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 699.75 63.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.50 699.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 699.75 63.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 378.5 725.75 m 441.5 725.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 445.5 725.75 m 508.5 725.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.75 m 575.5 725.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 378.5 725.75 m 441.5 725.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 445.5 725.75 m 508.5 725.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.75 m 575.5 725.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 730.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 401.50 729.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 468.50 729.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 535.50 729.98 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 716.32 Td (Earnings Before Income Taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.00 716.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 716.32 Td (5,915) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 448.00 716.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 716.32 Td (2,077) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.00 716.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 716.32 Td (2,381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 703.32 Td (Provision for income taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.15 703.32 Td (1,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 703.32 Td (446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 551.65 703.32 Td (352) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 690.32 Td (Effective tax rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.15 690.32 Td (23.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.65 690.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 690.32 Td (21.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 690.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 690.32 Td (14.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 566.65 690.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 663.25 Td (Historically) Tj ET Q q 0 0 0 rg BT 82.56 663.25 Td (, ) Tj ET Q q 0 0 0 rg BT 88.13 663.25 Td (the ) Tj ET Q q 0 0 0 rg BT 103.41 663.25 Td (ef) Tj ET Q q 0 0 0 rg BT 110.99 663.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 141.26 663.25 Td (income ) Tj ET Q q 0 0 0 rg BT 173.75 663.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 189.03 663.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 207.08 663.25 Td (is ) Tj ET Q q 0 0 0 rg BT 216.82 663.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 242.65 663.25 Td (than ) Tj ET Q q 0 0 0 rg BT 262.93 663.25 Td (the ) Tj ET Q q 0 0 0 rg BT 278.21 663.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 299.05 663.25 Td (statutory ) Tj ET Q q 0 0 0 rg BT 337.11 663.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 355.16 663.25 Td (of ) Tj ET Q q 0 0 0 rg BT 366.55 663.25 Td (35% ) Tj ET Q q 0 0 0 rg BT 387.95 663.25 Td (due ) Tj ET Q q 0 0 0 rg BT 405.45 663.25 Td (to ) Tj ET Q q 0 0 0 rg BT 416.29 663.25 Td (our ) Tj ET Q q 0 0 0 rg BT 432.68 663.25 Td (decision ) Tj ET Q q 0 0 0 rg BT 469.07 663.25 Td (to ) Tj ET Q q 0 0 0 rg BT 479.91 663.25 Td (indefinitely ) Tj ET Q q 0 0 0 rg BT 529.07 663.25 Td (reinvest ) Tj ET Q q 0 0 0 rg BT 563.79 663.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 651.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 71.96 651.25 Td (for ) Tj ET Q q 0 0 0 rg BT 85.71 651.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 114.99 651.25 Td (of ) Tj ET Q q 0 0 0 rg BT 125.41 651.25 Td (our ) Tj ET Q q 0 0 0 rg BT 140.82 651.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 201.21 651.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 244.95 651.25 Td (in ) Tj ET Q q 0 0 0 rg BT 254.82 651.25 Td (low ) Tj ET Q q 0 0 0 rg BT 271.90 651.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 286.20 651.25 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 337.73 651.25 Td (such ) Tj ET Q q 0 0 0 rg BT 358.14 651.25 Td (as ) Tj ET Q q 0 0 0 rg BT 368.56 651.25 Td (Switzerland, ) Tj ET Q q 0 0 0 rg BT 420.90 651.25 Td (Ireland ) Tj ET Q q 0 0 0 rg BT 451.30 651.25 Td (and ) Tj ET Q q 0 0 0 rg BT 467.83 651.25 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 496.02 651.25 Td (Rico. ) Tj ET Q q 0 0 0 rg BT 519.49 651.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 542.70 651.25 Td (operates ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 639.25 Td (under ) Tj ET Q q 0 0 0 rg BT 61.27 639.25 Td (a ) Tj ET Q q 0 0 0 rg BT 68.21 639.25 Td (favorable ) Tj ET Q q 0 0 0 rg BT 108.46 639.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 123.18 639.25 Td (grant ) Tj ET Q q 0 0 0 rg BT 146.22 639.25 Td (in ) Tj ET Q q 0 0 0 rg BT 156.50 639.25 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 185.11 639.25 Td (Rico ) Tj ET Q q 0 0 0 rg BT 206.50 639.25 Td (not ) Tj ET Q q 0 0 0 rg BT 221.78 639.25 Td (scheduled ) Tj ET Q q 0 0 0 rg BT 264.26 639.25 Td (to ) Tj ET Q q 0 0 0 rg BT 274.54 639.25 Td (expire ) Tj ET Q q 0 0 0 rg BT 302.03 639.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 323.96 639.25 Td (to ) Tj ET Q q 0 0 0 rg BT 334.24 639.25 Td (2023.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 615.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.45 615.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 67.56 615.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 96.67 615.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 136.89 615.25 Td (to ) Tj ET Q q 0 0 0 rg BT 146.57 615.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 170.14 615.25 Td (char) Tj ET Q q 0 0 0 rg BT 187.17 615.25 Td (ges, ) Tj ET Q q 0 0 0 rg BT 204.90 615.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 249.01 615.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 298.67 615.25 Td (and ) Tj ET Q q 0 0 0 rg BT 315.01 615.25 Td (other ) Tj ET Q q 0 0 0 rg BT 337.46 615.25 Td (specified ) Tj ET Q q 0 0 0 rg BT 375.45 615.25 Td (items ) Tj ET Q q 0 0 0 rg BT 399.01 615.25 Td (including ) Tj ET Q q 0 0 0 rg BT 438.69 615.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 480.58 615.25 Td (transfer ) Tj ET Q q 0 0 0 rg BT 513.01 615.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 543.24 615.25 Td (reserves ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 603.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.58 603.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 69.38 603.25 Td (increased ) Tj ET Q q 0 0 0 rg BT 109.93 603.25 Td (the ) Tj ET Q q 0 0 0 rg BT 124.95 603.25 Td (ef) Tj ET Q q 0 0 0 rg BT 132.53 603.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 162.54 603.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 177.55 603.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 195.34 603.25 Td (by ) Tj ET Q q 0 0 0 rg BT 208.14 603.25 Td (1.8% ) Tj ET Q q 0 0 0 rg BT 231.77 603.25 Td (in ) Tj ET Q q 0 0 0 rg BT 242.34 603.25 Td (2016 ) Tj ET Q q 0 0 0 rg BT 265.14 603.25 Td (and ) Tj ET Q q 0 0 0 rg BT 282.38 603.25 Td (0.3% ) Tj ET Q q 0 0 0 rg BT 306.01 603.25 Td (in ) Tj ET Q q 0 0 0 rg BT 316.59 603.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 339.39 603.25 Td (and ) Tj ET Q q 0 0 0 rg BT 356.62 603.25 Td (reduced ) Tj ET Q q 0 0 0 rg BT 391.07 603.25 Td (the ) Tj ET Q q 0 0 0 rg BT 406.08 603.25 Td (ef) Tj ET Q q 0 0 0 rg BT 413.67 603.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 443.67 603.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 458.69 603.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 476.48 603.25 Td (by ) Tj ET Q q 0 0 0 rg BT 489.27 603.25 Td (5.1% ) Tj ET Q q 0 0 0 rg BT 512.90 603.25 Td (in ) Tj ET Q q 0 0 0 rg BT 523.48 603.25 Td (2014. ) Tj ET Q q 0 0 0 rg BT 548.78 603.25 Td (No ) Tj ET Q q 0 0 0 rg BT 563.80 603.25 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 591.25 Td (benefits ) Tj ET Q q 0 0 0 rg BT 70.29 591.25 Td (were ) Tj ET Q q 0 0 0 rg BT 92.35 591.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 133.30 591.25 Td (to ) Tj ET Q q 0 0 0 rg BT 143.72 591.25 Td (the ) Tj ET Q q 0 0 0 rg BT 158.57 591.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 182.87 591.25 Td (char) Tj ET Q q 0 0 0 rg BT 199.90 591.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 215.86 591.25 Td (for ) Tj ET Q q 0 0 0 rg BT 230.15 591.25 Td (Padlock, ) Tj ET Q q 0 0 0 rg BT 267.50 591.25 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 296.81 591.25 Td (and ) Tj ET Q q 0 0 0 rg BT 313.88 591.25 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 359.84 591.25 Td (in ) Tj ET Q q 0 0 0 rg BT 370.25 591.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 395.38 591.25 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 424.68 591.25 Td (and ) Tj ET Q q 0 0 0 rg BT 441.76 591.25 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 484.38 591.25 Td (in ) Tj ET Q q 0 0 0 rg BT 494.80 591.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 517.43 591.25 Td (and ) Tj ET Q q 0 0 0 rg BT 534.50 591.25 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 568.24 591.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 579.25 Td (2014. ) Tj ET Q q 0 0 0 rg BT 60.52 579.25 Td (Lower ) Tj ET Q q 0 0 0 rg BT 88.63 579.25 Td (non-deductible ) Tj ET Q q 0 0 0 rg BT 150.63 579.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 188.21 579.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 226.31 579.25 Td (to ) Tj ET Q q 0 0 0 rg BT 236.11 579.25 Td (business ) Tj ET Q q 0 0 0 rg BT 272.02 579.25 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 320.14 579.25 Td (in ) Tj ET Q q 0 0 0 rg BT 329.94 579.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 351.96 579.25 Td (and ) Tj ET Q q 0 0 0 rg BT 368.41 579.25 Td (higher ) Tj ET Q q 0 0 0 rg BT 395.98 579.25 Td (valuation ) Tj ET Q q 0 0 0 rg BT 435.21 579.25 Td (allowances ) Tj ET Q q 0 0 0 rg BT 481.65 579.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 521.99 579.25 Td (to ) Tj ET Q q 0 0 0 rg BT 531.79 579.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 560.45 579.25 Td (loss ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 567.25 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 94.03 567.25 Td (released ) Tj ET Q q 0 0 0 rg BT 128.73 567.25 Td (in ) Tj ET Q q 0 0 0 rg BT 138.46 567.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 160.41 567.25 Td (impacted ) Tj ET Q q 0 0 0 rg BT 199.02 567.25 Td (the ) Tj ET Q q 0 0 0 rg BT 213.18 567.25 Td (ef) Tj ET Q q 0 0 0 rg BT 220.77 567.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 249.92 567.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 264.09 567.25 Td (rates. ) Tj ET Q q 0 0 0 rg BT 287.42 567.25 Td (Minimal ) Tj ET Q q 0 0 0 rg BT 323.81 567.25 Td (income ) Tj ET Q q 0 0 0 rg BT 355.20 567.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 377.69 567.25 Td (were ) Tj ET Q q 0 0 0 rg BT 399.07 567.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 439.34 567.25 Td (to ) Tj ET Q q 0 0 0 rg BT 449.07 567.25 Td (the ) Tj ET Q q 0 0 0 rg BT 463.24 567.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 497.96 567.25 Td (business ) Tj ET Q q 0 0 0 rg BT 533.80 567.25 Td (divestiture ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 555.25 Td (gain ) Tj ET Q q 0 0 0 rg BT 56.19 555.25 Td (in ) Tj ET Q q 0 0 0 rg BT 66.95 555.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 89.92 555.25 Td (because ) Tj ET Q q 0 0 0 rg BT 124.54 555.25 Td (of ) Tj ET Q q 0 0 0 rg BT 135.85 555.25 Td (the ) Tj ET Q q 0 0 0 rg BT 151.04 555.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 180.66 555.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 199.20 555.25 Td (deduction ) Tj ET Q q 0 0 0 rg BT 241.61 555.25 Td (on ) Tj ET Q q 0 0 0 rg BT 254.58 555.25 Td (the ) Tj ET Q q 0 0 0 rg BT 269.78 555.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 288.30 555.25 Td (of ) Tj ET Q q 0 0 0 rg BT 299.60 555.25 Td (the ) Tj ET Q q 0 0 0 rg BT 314.14 555.25 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 347.67 555.25 Td (shares ) Tj ET Q q 0 0 0 rg BT 375.64 555.25 Td (and ) Tj ET Q q 0 0 0 rg BT 393.05 555.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 408.24 555.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 431.22 555.25 Td (dif) Tj ET Q q 0 0 0 rg BT 442.14 555.25 Td (ferences ) Tj ET Q q 0 0 0 rg BT 478.42 555.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 516.39 555.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 556.58 555.25 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 543.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 74.27 543.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 112.01 543.25 Td (and ) Tj ET Q q 0 0 0 rg BT 128.14 543.25 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 160.88 543.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 196.37 543.25 Td (taxes. ) Tj ET Q q 0 0 0 rg BT 221.59 543.25 Td (Unfavorable ) Tj ET Q q 0 0 0 rg BT 273.75 543.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 309.81 543.25 Td (mix ) Tj ET Q q 0 0 0 rg BT 327.54 543.25 Td (between ) Tj ET Q q 0 0 0 rg BT 363.04 543.25 Td (high ) Tj ET Q q 0 0 0 rg BT 383.00 543.25 Td (and ) Tj ET Q q 0 0 0 rg BT 399.62 543.25 Td (low ) Tj ET Q q 0 0 0 rg BT 416.80 543.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 431.19 543.25 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 482.82 543.25 Td (and ) Tj ET Q q 0 0 0 rg BT 499.44 543.25 Td (higher ) Tj ET Q q 0 0 0 rg BT 527.16 543.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 547.13 543.25 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 531.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 51.61 531.25 Td (credits ) Tj ET Q q 0 0 0 rg BT 81.65 531.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 120.04 531.25 Td (from ) Tj ET Q q 0 0 0 rg BT 142.87 531.25 Td (the ) Tj ET Q q 0 0 0 rg BT 158.48 531.25 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 187.98 531.25 Td (Rico ) Tj ET Q q 0 0 0 rg BT 210.26 531.25 Td (excise ) Tj ET Q q 0 0 0 rg BT 238.63 531.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 254.24 531.25 Td (in ) Tj ET Q q 0 0 0 rg BT 265.41 531.25 Td (all ) Tj ET Q q 0 0 0 rg BT 278.80 531.25 Td (periods ) Tj ET Q q 0 0 0 rg BT 311.63 531.25 Td (also ) Tj ET Q q 0 0 0 rg BT 331.12 531.25 Td (impacted ) Tj ET Q q 0 0 0 rg BT 371.17 531.25 Td (the ) Tj ET Q q 0 0 0 rg BT 386.77 531.25 Td (ef) Tj ET Q q 0 0 0 rg BT 394.36 531.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 424.96 531.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 440.56 531.25 Td (rates. ) Tj ET Q q 0 0 0 rg BT 465.33 531.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 490.93 531.25 Td (to ) Tj ET Q q 0 0 0 rg BT 502.10 531.25 Td ("Item ) Tj ET Q q 0 0 0 rg BT 527.90 531.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 538.79 531.25 Td (Financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 519.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.82 519.25 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 116.82 519.25 Td (. ) Tj ET Q q 0 0 0 rg BT 121.82 519.25 Td (Income ) Tj ET Q q 0 0 0 rg BT 154.13 519.25 Td (T) Tj ET Q q 0 0 0 rg BT 159.54 519.25 Td (axes" ) Tj ET Q q 0 0 0 rg BT 183.89 519.25 Td (for ) Tj ET Q q 0 0 0 rg BT 198.05 519.25 Td (further ) Tj ET Q q 0 0 0 rg BT 227.75 519.25 Td (information.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 495.25 Td (Comprehensive ) Tj ET Q q 0 0 0 rg BT 101.04 495.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 121.10 495.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 135.59 495.25 Td (reform ) Tj ET Q q 0 0 0 rg BT 165.07 495.25 Td (continues ) Tj ET Q q 0 0 0 rg BT 205.67 495.25 Td (to ) Tj ET Q q 0 0 0 rg BT 215.72 495.25 Td (be ) Tj ET Q q 0 0 0 rg BT 227.43 495.25 Td (discussed ) Tj ET Q q 0 0 0 rg BT 268.04 495.25 Td (and ) Tj ET Q q 0 0 0 rg BT 284.75 495.25 Td (proposed, ) Tj ET Q q 0 0 0 rg BT 326.19 495.25 Td (including ) Tj ET Q q 0 0 0 rg BT 366.23 495.25 Td (among ) Tj ET Q q 0 0 0 rg BT 395.72 495.25 Td (other ) Tj ET Q q 0 0 0 rg BT 418.55 495.25 Td (items, ) Tj ET Q q 0 0 0 rg BT 444.99 495.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 479.47 495.25 Td (to ) Tj ET Q q 0 0 0 rg BT 489.52 495.25 Td (the ) Tj ET Q q 0 0 0 rg BT 504.01 495.25 Td (corporate ) Tj ET Q q 0 0 0 rg BT 544.04 495.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 558.53 495.25 Td (rate, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 483.25 Td (a ) Tj ET Q q 0 0 0 rg BT 42.90 483.25 Td (border ) Tj ET Q q 0 0 0 rg BT 71.45 483.25 Td (adjustment ) Tj ET Q q 0 0 0 rg BT 117.79 483.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 132.47 483.25 Td (and ) Tj ET Q q 0 0 0 rg BT 149.36 483.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 184.03 483.25 Td (to ) Tj ET Q q 0 0 0 rg BT 194.26 483.25 Td (how ) Tj ET Q q 0 0 0 rg BT 213.94 483.25 Td (the ) Tj ET Q q 0 0 0 rg BT 228.62 483.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 248.86 483.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 271.86 483.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 303.20 483.25 Td (earnings.  ) Tj ET Q q 0 0 0 rg BT 344.53 483.25 Td (It ) Tj ET Q q 0 0 0 rg BT 353.10 483.25 Td (is ) Tj ET Q q 0 0 0 rg BT 362.22 483.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 400.77 483.25 Td (uncertain ) Tj ET Q q 0 0 0 rg BT 440.43 483.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 475.10 483.25 Td (any ) Tj ET Q q 0 0 0 rg BT 491.99 483.25 Td (of ) Tj ET Q q 0 0 0 rg BT 502.78 483.25 Td (these ) Tj ET Q q 0 0 0 rg BT 525.79 483.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 560.45 483.25 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 471.25 Td (be ) Tj ET Q q 0 0 0 rg BT 47.40 471.25 Td (enacted, ) Tj ET Q q 0 0 0 rg BT 82.40 471.25 Td (and ) Tj ET Q q 0 0 0 rg BT 98.80 471.25 Td (if ) Tj ET Q q 0 0 0 rg BT 106.87 471.25 Td (so, ) Tj ET Q q 0 0 0 rg BT 120.22 471.25 Td (the ) Tj ET Q q 0 0 0 rg BT 134.40 471.25 Td (ef) Tj ET Q q 0 0 0 rg BT 141.99 471.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 171.16 471.25 Td (dates. ) Tj ET Q q 0 0 0 rg BT 196.17 471.25 Td (If ) Tj ET Q q 0 0 0 rg BT 204.79 471.25 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 267.28 471.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 281.46 471.25 Td (reform ) Tj ET Q q 0 0 0 rg BT 310.63 471.25 Td (occurs, ) Tj ET Q q 0 0 0 rg BT 341.20 471.25 Td (our ) Tj ET Q q 0 0 0 rg BT 356.49 471.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 393.43 471.25 Td (condition, ) Tj ET Q q 0 0 0 rg BT 435.67 471.25 Td (results ) Tj ET Q q 0 0 0 rg BT 463.74 471.25 Td (of ) Tj ET Q q 0 0 0 rg BT 474.03 471.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 517.65 471.25 Td (and ) Tj ET Q q 0 0 0 rg BT 534.05 471.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 553.78 471.25 Td (flows ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 459.25 Td (could ) Tj ET Q q 0 0 0 rg BT 60.72 459.25 Td (be ) Tj ET Q q 0 0 0 rg BT 72.66 459.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 125.15 459.25 Td (impacted. ) Tj ET Q q 0 0 0 rg BT 166.80 459.25 Td (However) Tj ET Q q 0 0 0 rg BT 203.05 459.25 Td (, ) Tj ET Q q 0 0 0 rg BT 208.05 459.25 Td (we ) Tj ET Q q 0 0 0 rg BT 222.21 459.25 Td (are ) Tj ET Q q 0 0 0 rg BT 236.91 459.25 Td (unable ) Tj ET Q q 0 0 0 rg BT 266.07 459.25 Td (to ) Tj ET Q q 0 0 0 rg BT 276.35 459.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 318.83 459.25 Td (the ) Tj ET Q q 0 0 0 rg BT 333.54 459.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 371.03 459.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 400.75 459.25 Td (at ) Tj ET Q q 0 0 0 rg BT 410.46 459.25 Td (this ) Tj ET Q q 0 0 0 rg BT 427.41 459.25 Td (time.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 435.25 Td (Non-GAAP) Tj ET Q q 0 0 0 rg BT 83.41 435.25 Td ( Financial Measures) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 411.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.37 411.25 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 99.55 411.25 Td ( ) Tj ET Q q 0 0 0 rg BT 102.37 411.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 140.17 411.25 Td (measures, ) Tj ET Q q 0 0 0 rg BT 182.69 411.25 Td (including ) Tj ET Q q 0 0 0 rg BT 223.28 411.25 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 268.47 411.25 Td ( ) Tj ET Q q 0 0 0 rg BT 271.28 411.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 307.98 411.25 Td (and ) Tj ET Q q 0 0 0 rg BT 325.23 411.25 Td (related ) Tj ET Q q 0 0 0 rg BT 355.25 411.25 Td (EPS ) Tj ET Q q 0 0 0 rg BT 375.30 411.25 Td (information, ) Tj ET Q q 0 0 0 rg BT 427.83 411.25 Td (are ) Tj ET Q q 0 0 0 rg BT 442.85 411.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 478.99 411.25 Td (to ) Tj ET Q q 0 0 0 rg BT 489.58 411.25 Td (exclude ) Tj ET Q q 0 0 0 rg BT 523.50 411.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 553.51 411.25 Td (costs, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 399.25 Td (expenses, ) Tj ET Q q 0 0 0 rg BT 76.87 399.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 100.24 399.25 Td (and ) Tj ET Q q 0 0 0 rg BT 116.95 399.25 Td (losses ) Tj ET Q q 0 0 0 rg BT 143.11 399.25 Td (and ) Tj ET Q q 0 0 0 rg BT 159.81 399.25 Td (other ) Tj ET Q q 0 0 0 rg BT 182.63 399.25 Td (specified ) Tj ET Q q 0 0 0 rg BT 220.99 399.25 Td (items ) Tj ET Q q 0 0 0 rg BT 244.92 399.25 Td (that ) Tj ET Q q 0 0 0 rg BT 262.18 399.25 Td (are ) Tj ET Q q 0 0 0 rg BT 276.65 399.25 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 317.23 399.25 Td (on ) Tj ET Q q 0 0 0 rg BT 329.50 399.25 Td (an ) Tj ET Q q 0 0 0 rg BT 341.20 399.25 Td (individual ) Tj ET Q q 0 0 0 rg BT 384.02 399.25 Td (basis. ) Tj ET Q q 0 0 0 rg BT 408.63 399.25 Td (These ) Tj ET Q q 0 0 0 rg BT 434.77 399.25 Td (items ) Tj ET Q q 0 0 0 rg BT 458.70 399.25 Td (are ) Tj ET Q q 0 0 0 rg BT 473.18 399.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 508.77 399.25 Td (after ) Tj ET Q q 0 0 0 rg BT 529.35 399.25 Td (considering ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 387.25 Td (their ) Tj ET Q q 0 0 0 rg BT 56.91 387.25 Td (quantitative ) Tj ET Q q 0 0 0 rg BT 106.70 387.25 Td (and ) Tj ET Q q 0 0 0 rg BT 123.72 387.25 Td (qualitative ) Tj ET Q q 0 0 0 rg BT 168.51 387.25 Td (aspects ) Tj ET Q q 0 0 0 rg BT 199.97 387.25 Td (and ) Tj ET Q q 0 0 0 rg BT 216.99 387.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 254.56 387.25 Td (have ) Tj ET Q q 0 0 0 rg BT 276.02 387.25 Td (one ) Tj ET Q q 0 0 0 rg BT 293.05 387.25 Td (or ) Tj ET Q q 0 0 0 rg BT 303.96 387.25 Td (more ) Tj ET Q q 0 0 0 rg BT 327.09 387.25 Td (of ) Tj ET Q q 0 0 0 rg BT 338.00 387.25 Td (the ) Tj ET Q q 0 0 0 rg BT 352.80 387.25 Td (following ) Tj ET Q q 0 0 0 rg BT 394.27 387.25 Td (characteristics, ) Tj ET Q q 0 0 0 rg BT 456.54 387.25 Td (such ) Tj ET Q q 0 0 0 rg BT 477.46 387.25 Td (as ) Tj ET Q q 0 0 0 rg BT 488.37 387.25 Td (being ) Tj ET Q q 0 0 0 rg BT 513.17 387.25 Td (highly ) Tj ET Q q 0 0 0 rg BT 541.31 387.25 Td (variable, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 375.25 Td (dif) Tj ET Q q 0 0 0 rg BT 46.93 375.25 Td (ficult ) Tj ET Q q 0 0 0 rg BT 70.42 375.25 Td (to ) Tj ET Q q 0 0 0 rg BT 80.58 375.25 Td (project, ) Tj ET Q q 0 0 0 rg BT 113.23 375.25 Td (unusual ) Tj ET Q q 0 0 0 rg BT 146.72 375.25 Td (in ) Tj ET Q q 0 0 0 rg BT 156.88 375.25 Td (nature, ) Tj ET Q q 0 0 0 rg BT 186.75 375.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 231.35 375.25 Td (to ) Tj ET Q q 0 0 0 rg BT 241.51 375.25 Td (the ) Tj ET Q q 0 0 0 rg BT 256.11 375.25 Td (results ) Tj ET Q q 0 0 0 rg BT 284.60 375.25 Td (of ) Tj ET Q q 0 0 0 rg BT 295.32 375.25 Td (a ) Tj ET Q q 0 0 0 rg BT 302.14 375.25 Td (particular ) Tj ET Q q 0 0 0 rg BT 342.84 375.25 Td (period ) Tj ET Q q 0 0 0 rg BT 370.77 375.25 Td (or ) Tj ET Q q 0 0 0 rg BT 381.48 375.25 Td (not ) Tj ET Q q 0 0 0 rg BT 396.64 375.25 Td (indicative ) Tj ET Q q 0 0 0 rg BT 438.46 375.25 Td (of ) Tj ET Q q 0 0 0 rg BT 449.17 375.25 Td (future ) Tj ET Q q 0 0 0 rg BT 475.43 375.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 515.58 375.25 Td (results. ) Tj ET Q q 0 0 0 rg BT 546.57 375.25 Td (Similar ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 363.25 Td (char) Tj ET Q q 0 0 0 rg BT 53.03 363.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 69.70 363.25 Td (or ) Tj ET Q q 0 0 0 rg BT 81.36 363.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 105.81 363.25 Td (were ) Tj ET Q q 0 0 0 rg BT 128.58 363.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 175.78 363.25 Td (in ) Tj ET Q q 0 0 0 rg BT 186.90 363.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 209.67 363.25 Td (periods ) Tj ET Q q 0 0 0 rg BT 242.45 363.25 Td (and ) Tj ET Q q 0 0 0 rg BT 260.23 363.25 Td (will ) Tj ET Q q 0 0 0 rg BT 279.13 363.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 305.24 363.25 Td (reoccur ) Tj ET Q q 0 0 0 rg BT 338.55 363.25 Td (in ) Tj ET Q q 0 0 0 rg BT 349.67 363.25 Td (future ) Tj ET Q q 0 0 0 rg BT 376.88 363.25 Td (periods ) Tj ET Q q 0 0 0 rg BT 409.66 363.25 Td (including ) Tj ET Q q 0 0 0 rg BT 450.77 363.25 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 505.21 363.25 Td (costs, ) Tj ET Q q 0 0 0 rg BT 531.05 363.25 Td (accelerated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 351.25 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 87.82 351.25 Td (and ) Tj ET Q q 0 0 0 rg BT 104.66 351.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 153.16 351.25 Td (of ) Tj ET Q q 0 0 0 rg BT 163.89 351.25 Td (property) Tj ET Q q 0 0 0 rg BT 197.11 351.25 Td (, ) Tj ET Q q 0 0 0 rg BT 202.01 351.25 Td (plant ) Tj ET Q q 0 0 0 rg BT 224.41 351.25 Td (and ) Tj ET Q q 0 0 0 rg BT 241.25 351.25 Td (equipment ) Tj ET Q q 0 0 0 rg BT 285.86 351.25 Td (and ) Tj ET Q q 0 0 0 rg BT 302.70 351.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 345.09 351.25 Td (assets, ) Tj ET Q q 0 0 0 rg BT 373.32 351.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 397.39 351.25 Td (char) Tj ET Q q 0 0 0 rg BT 414.41 351.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 430.14 351.25 Td (in ) Tj ET Q q 0 0 0 rg BT 440.32 351.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 486.59 351.25 Td (with ) Tj ET Q q 0 0 0 rg BT 506.77 351.25 Td (the ) Tj ET Q q 0 0 0 rg BT 521.39 351.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 567.67 351.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 339.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 75.08 339.25 Td (of ) Tj ET Q q 0 0 0 rg BT 86.39 339.25 Td (third ) Tj ET Q q 0 0 0 rg BT 108.25 339.25 Td (party ) Tj ET Q q 0 0 0 rg BT 131.78 339.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 179.18 339.25 Td (property ) Tj ET Q q 0 0 0 rg BT 216.03 339.25 Td (rights, ) Tj ET Q q 0 0 0 rg BT 244.29 339.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 289.48 339.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 313.56 339.25 Td (or ) Tj ET Q q 0 0 0 rg BT 324.87 339.25 Td (losses, ) Tj ET Q q 0 0 0 rg BT 354.24 339.25 Td (pension, ) Tj ET Q q 0 0 0 rg BT 390.83 339.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 413.24 339.25 Td (and ) Tj ET Q q 0 0 0 rg BT 430.65 339.25 Td (other ) Tj ET Q q 0 0 0 rg BT 454.18 339.25 Td (contractual ) Tj ET Q q 0 0 0 rg BT 501.58 339.25 Td (settlement ) Tj ET Q q 0 0 0 rg BT 545.65 339.25 Td (char) Tj ET Q q 0 0 0 rg BT 562.68 339.25 Td (ges ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 327.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.28 327.25 Td (debt ) Tj ET Q q 0 0 0 rg BT 73.34 327.25 Td (redemption ) Tj ET Q q 0 0 0 rg BT 121.72 327.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 145.67 327.25 Td (or ) Tj ET Q q 0 0 0 rg BT 156.84 327.25 Td (losses, ) Tj ET Q q 0 0 0 rg BT 186.08 327.25 Td (among ) Tj ET Q q 0 0 0 rg BT 216.14 327.25 Td (other ) Tj ET Q q 0 0 0 rg BT 239.53 327.25 Td (items. ) Tj ET Q q 0 0 0 rg BT 266.53 327.25 Td (Deferred ) Tj ET Q q 0 0 0 rg BT 304.90 327.25 Td (and ) Tj ET Q q 0 0 0 rg BT 322.18 327.25 Td (current ) Tj ET Q q 0 0 0 rg BT 353.34 327.25 Td (income ) Tj ET Q q 0 0 0 rg BT 385.61 327.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 409.00 327.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 450.17 327.25 Td (to ) Tj ET Q q 0 0 0 rg BT 460.79 327.25 Td (these ) Tj ET Q q 0 0 0 rg BT 484.17 327.25 Td (items ) Tj ET Q q 0 0 0 rg BT 508.68 327.25 Td (are ) Tj ET Q q 0 0 0 rg BT 523.73 327.25 Td (also ) Tj ET Q q 0 0 0 rg BT 542.68 327.25 Td (adjusted ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 315.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 315.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 99.32 315.25 Td (their ) Tj ET Q q 0 0 0 rg BT 120.14 315.25 Td (individual ) Tj ET Q q 0 0 0 rg BT 163.19 315.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 192.90 315.25 Td (to ) Tj ET Q q 0 0 0 rg BT 203.18 315.25 Td (the ) Tj ET Q q 0 0 0 rg BT 217.90 315.25 Td (overall ) Tj ET Q q 0 0 0 rg BT 248.16 315.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 262.88 315.25 Td (expense, ) Tj ET Q q 0 0 0 rg BT 300.09 315.25 Td (deductibility ) Tj ET Q q 0 0 0 rg BT 353.13 315.25 Td (and ) Tj ET Q q 0 0 0 rg BT 370.07 315.25 Td (jurisdictional ) Tj ET Q q 0 0 0 rg BT 425.34 315.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 440.06 315.25 Td (rates. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 291.25 Td (Non-GAAP) Tj ET Q q 0 0 0 rg BT 83.41 291.25 Td ( ) Tj ET Q q 0 0 0 rg BT 85.43 291.25 Td (information ) Tj ET Q q 0 0 0 rg BT 134.67 291.25 Td (is ) Tj ET Q q 0 0 0 rg BT 143.37 291.25 Td (intended ) Tj ET Q q 0 0 0 rg BT 179.82 291.25 Td (to ) Tj ET Q q 0 0 0 rg BT 189.63 291.25 Td (portray ) Tj ET Q q 0 0 0 rg BT 220.53 291.25 Td (the ) Tj ET Q q 0 0 0 rg BT 234.77 291.25 Td (results ) Tj ET Q q 0 0 0 rg BT 262.91 291.25 Td (of ) Tj ET Q q 0 0 0 rg BT 273.26 291.25 Td (our ) Tj ET Q q 0 0 0 rg BT 288.62 291.25 Td (baseline ) Tj ET Q q 0 0 0 rg BT 323.41 291.25 Td (performance, ) Tj ET Q q 0 0 0 rg BT 378.45 291.25 Td (supplement ) Tj ET Q q 0 0 0 rg BT 426.58 291.25 Td (or ) Tj ET Q q 0 0 0 rg BT 436.94 291.25 Td (enhance ) Tj ET Q q 0 0 0 rg BT 471.72 291.25 Td (management, ) Tj ET Q q 0 0 0 rg BT 527.33 291.25 Td (analysts ) Tj ET Q q 0 0 0 rg BT 561.57 291.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 279.25 Td (investors ) Tj ET Q q 0 0 0 rg BT 73.65 279.25 Td (overall ) Tj ET Q q 0 0 0 rg BT 102.95 279.25 Td (understanding ) Tj ET Q q 0 0 0 rg BT 161.15 279.25 Td (of ) Tj ET Q q 0 0 0 rg BT 171.02 279.25 Td (our ) Tj ET Q q 0 0 0 rg BT 185.89 279.25 Td (underlying ) Tj ET Q q 0 0 0 rg BT 230.75 279.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 267.27 279.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 319.33 279.25 Td (and ) Tj ET Q q 0 0 0 rg BT 335.31 279.25 Td (facilitate ) Tj ET Q q 0 0 0 rg BT 371.83 279.25 Td (comparisons ) Tj ET Q q 0 0 0 rg BT 423.91 279.25 Td (among ) Tj ET Q q 0 0 0 rg BT 452.67 279.25 Td (current, ) Tj ET Q q 0 0 0 rg BT 485.02 279.25 Td (past ) Tj ET Q q 0 0 0 rg BT 502.67 279.25 Td (and ) Tj ET Q q 0 0 0 rg BT 518.65 279.25 Td (future ) Tj ET Q q 0 0 0 rg BT 544.07 279.25 Td (periods. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 267.25 Td (For ) Tj ET Q q 0 0 0 rg BT 52.16 267.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 90.79 267.25 Td (non-GAAP) Tj ET Q q 0 0 0 rg BT 135.98 267.25 Td ( ) Tj ET Q q 0 0 0 rg BT 138.24 267.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 174.38 267.25 Td (and ) Tj ET Q q 0 0 0 rg BT 191.09 267.25 Td (EPS ) Tj ET Q q 0 0 0 rg BT 210.58 267.25 Td (information ) Tj ET Q q 0 0 0 rg BT 260.06 267.25 Td (is ) Tj ET Q q 0 0 0 rg BT 269.00 267.25 Td (an ) Tj ET Q q 0 0 0 rg BT 280.70 267.25 Td (indication ) Tj ET Q q 0 0 0 rg BT 322.95 267.25 Td (of ) Tj ET Q q 0 0 0 rg BT 333.55 267.25 Td (our ) Tj ET Q q 0 0 0 rg BT 349.14 267.25 Td (baseline ) Tj ET Q q 0 0 0 rg BT 384.17 267.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 436.96 267.25 Td (before ) Tj ET Q q 0 0 0 rg BT 464.76 267.25 Td (items ) Tj ET Q q 0 0 0 rg BT 488.69 267.25 Td (that ) Tj ET Q q 0 0 0 rg BT 505.95 267.25 Td (are ) Tj ET Q q 0 0 0 rg BT 520.42 267.25 Td (considered ) Tj ET Q q 0 0 0 rg BT 566.00 267.25 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 255.25 Td (us ) Tj ET Q q 0 0 0 rg BT 46.84 255.25 Td (to ) Tj ET Q q 0 0 0 rg BT 56.57 255.25 Td (not ) Tj ET Q q 0 0 0 rg BT 71.30 255.25 Td (be ) Tj ET Q q 0 0 0 rg BT 82.69 255.25 Td (reflective ) Tj ET Q q 0 0 0 rg BT 122.38 255.25 Td (of ) Tj ET Q q 0 0 0 rg BT 132.66 255.25 Td (our ) Tj ET Q q 0 0 0 rg BT 147.94 255.25 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 182.67 255.25 Td (results. ) Tj ET Q q 0 0 0 rg BT 213.23 255.25 Td (In ) Tj ET Q q 0 0 0 rg BT 223.51 255.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 260.73 255.25 Td (this ) Tj ET Q q 0 0 0 rg BT 277.13 255.25 Td (information ) Tj ET Q q 0 0 0 rg BT 326.29 255.25 Td (is ) Tj ET Q q 0 0 0 rg BT 334.91 255.25 Td (among ) Tj ET Q q 0 0 0 rg BT 364.08 255.25 Td (the ) Tj ET Q q 0 0 0 rg BT 378.25 255.25 Td (primary ) Tj ET Q q 0 0 0 rg BT 411.85 255.25 Td (indicators ) Tj ET Q q 0 0 0 rg BT 453.23 255.25 Td (we ) Tj ET Q q 0 0 0 rg BT 466.84 255.25 Td (use ) Tj ET Q q 0 0 0 rg BT 482.12 255.25 Td (as ) Tj ET Q q 0 0 0 rg BT 492.40 255.25 Td (a ) Tj ET Q q 0 0 0 rg BT 498.79 255.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 520.74 255.25 Td (for ) Tj ET Q q 0 0 0 rg BT 534.35 255.25 Td (evaluating ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 243.25 Td (performance, ) Tj ET Q q 0 0 0 rg BT 90.44 243.25 Td (allocating ) Tj ET Q q 0 0 0 rg BT 131.29 243.25 Td (resources, ) Tj ET Q q 0 0 0 rg BT 172.97 243.25 Td (setting ) Tj ET Q q 0 0 0 rg BT 201.05 243.25 Td (incentive ) Tj ET Q q 0 0 0 rg BT 239.13 243.25 Td (compensation ) Tj ET Q q 0 0 0 rg BT 296.09 243.25 Td (tar) Tj ET Q q 0 0 0 rg BT 306.45 243.25 Td (gets ) Tj ET Q q 0 0 0 rg BT 323.98 243.25 Td (and ) Tj ET Q q 0 0 0 rg BT 339.84 243.25 Td (planning ) Tj ET Q q 0 0 0 rg BT 376.25 243.25 Td (and ) Tj ET Q q 0 0 0 rg BT 392.11 243.25 Td (forecasting ) Tj ET Q q 0 0 0 rg BT 437.96 243.25 Td (for ) Tj ET Q q 0 0 0 rg BT 451.04 243.25 Td (future ) Tj ET Q q 0 0 0 rg BT 476.33 243.25 Td (periods. ) Tj ET Q q 0 0 0 rg BT 509.59 243.25 Td (This ) Tj ET Q q 0 0 0 rg BT 528.79 243.25 Td (information ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 231.25 Td (is ) Tj ET Q q 0 0 0 rg BT 45.17 231.25 Td (not ) Tj ET Q q 0 0 0 rg BT 60.45 231.25 Td (intended ) Tj ET Q q 0 0 0 rg BT 97.38 231.25 Td (to ) Tj ET Q q 0 0 0 rg BT 107.66 231.25 Td (be ) Tj ET Q q 0 0 0 rg BT 119.60 231.25 Td (considered ) Tj ET Q q 0 0 0 rg BT 165.41 231.25 Td (in ) Tj ET Q q 0 0 0 rg BT 175.69 231.25 Td (isolation ) Tj ET Q q 0 0 0 rg BT 212.64 231.25 Td (or ) Tj ET Q q 0 0 0 rg BT 223.47 231.25 Td (as ) Tj ET Q q 0 0 0 rg BT 234.30 231.25 Td (a ) Tj ET Q q 0 0 0 rg BT 241.23 231.25 Td (substitute ) Tj ET Q q 0 0 0 rg BT 282.07 231.25 Td (for ) Tj ET Q q 0 0 0 rg BT 296.23 231.25 Td (net ) Tj ET Q q 0 0 0 rg BT 310.95 231.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 347.32 231.25 Td (or ) Tj ET Q q 0 0 0 rg BT 358.15 231.25 Td (diluted ) Tj ET Q q 0 0 0 rg BT 388.43 231.25 Td (EPS ) Tj ET Q q 0 0 0 rg BT 408.16 231.25 Td (prepared ) Tj ET Q q 0 0 0 rg BT 445.63 231.25 Td (in ) Tj ET Q q 0 0 0 rg BT 455.91 231.25 Td (accordance ) Tj ET Q q 0 0 0 rg BT 503.37 231.25 Td (with ) Tj ET Q q 0 0 0 rg BT 523.65 231.25 Td (GAAP) Tj ET Q q 0 0 0 rg BT 549.77 231.25 Td (.) Tj ET Q endstream endobj 79 0 obj <> endobj 80 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Specified items were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 714.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 714.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 714.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 714.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 714.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 714.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 714.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 694.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 694.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 694.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 694.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 694.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 694.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 694.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 670.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 670.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 670.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 670.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 670.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 670.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 670.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 650.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 650.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 650.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 650.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 650.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 650.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 650.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 626.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 626.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 626.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 626.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 626.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 626.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 626.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 602.60 321.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 602.60 4.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 602.60 69.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 602.60 4.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 602.60 69.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 602.60 4.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 602.60 69.00 -8.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 582.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 582.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 582.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 582.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 582.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 582.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 582.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 558.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 558.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 558.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 558.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 558.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 558.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 558.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 534.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 534.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 534.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 534.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 534.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 534.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 534.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 510.60 321.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 510.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 510.60 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 510.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 510.60 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 510.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 510.60 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 480.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 480.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 480.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 480.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 480.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 480.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 480.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 460.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 460.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 460.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 460.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 460.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 460.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 460.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 440.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 440.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 440.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 440.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 440.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 440.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 440.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 415.60 321.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 415.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 415.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 415.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 415.60 69.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 415.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 415.60 69.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 726.6 m 430.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 726.6 m 434.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 726.6 m 503.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 503.5 726.6 m 507.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 714.6 m 430.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 726.6 m 503.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 714.6 m 503.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 503.5 726.6 m 507.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 714.6 m 576.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 670.6 m 430.5 670.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 670.6 m 503.5 670.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 670.6 m 576.5 670.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 614.6 m 430.5 614.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 614.6 m 503.5 614.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 614.6 m 576.5 614.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 480.6 m 430.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 480.6 m 503.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 480.6 m 576.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 415.6 m 430.5 415.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 415.6 m 503.5 415.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 415.6 m 576.5 415.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 403.6 m 430.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 403.6 m 503.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 403.6 m 576.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 392.6 m 430.5 392.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 390.6 m 430.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 392.6 m 503.5 392.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 390.6 m 503.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 392.6 m 576.5 392.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 390.6 m 576.5 390.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 730.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 424.20 730.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.50 718.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.50 718.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.50 718.68 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 705.33 Td (Cost of pr) Tj ET Q q 0 0 0 rg BT 81.59 705.33 Td (oducts sold) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 129.11 709.86 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 705.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 705.22 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 705.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 705.22 Td (84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 705.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 705.22 Td (151) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 685.22 Td (Additional year of Branded Prescription Drug Fee) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 685.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 685.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 685.22 Td (96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 673.22 Td (Process standardization implementation costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 673.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 673.22 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 673.22 Td (9) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 661.33 Td (Marketing, selling and administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 661.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 661.22 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 661.22 Td (105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 641.22 Td (License and asset acquisition charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 641.22 Td (439) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 641.22 Td (1,679) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 641.22 Td (278) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 629.22 Td (IPRD impairments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 629.22 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 629.22 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 629.22 Td (343) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 617.22 Td (Accelerated depreciation and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 617.22 Td (83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 617.22 Td (44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 617.22 Td (—) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 605.33 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 605.22 Td (535) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 605.22 Td (1,883) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 605.22 Td (621) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 585.22 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 585.22 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 585.22 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 585.22 Td (163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 573.22 Td (Litigation and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 573.22 Td (40) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 573.22 Td (158) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 573.22 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 561.22 Td (Divestiture gains) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.30 561.22 Td (\(559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 561.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 561.22 Td (\(187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 561.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 561.22 Td (\(559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 561.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 549.22 Td (Royalties and licensing income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.30 549.22 Td (\(10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 549.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 549.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 549.22 Td (\(10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 549.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 537.22 Td (Pension charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 537.22 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 537.22 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 537.22 Td (877) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 525.22 Td (Intangible asset impairment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 525.22 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 525.22 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 525.22 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 513.22 Td (Written option adjustment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 513.22 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 513.22 Td (\(123) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 513.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 513.22 Td (32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 501.17 Td (Loss on debt redemption) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 500.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 500.27 Td (180) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 500.27 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 486.17 Td (Other) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 61.77 490.70 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 485.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 485.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 485.27 Td (40) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 471.33 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.30 471.22 Td (\(314) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 471.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 471.22 Td (316) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 471.22 Td (626) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 451.33 Td (Increase to pretax income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 451.22 Td (242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 451.22 Td (2,293) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 451.22 Td (1,503) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 431.22 Td (Income taxes on items above) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 431.22 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 431.22 Td (\(480) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 431.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 431.22 Td (\(545) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 431.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 419.17 Td (Specified tax char) Tj ET Q q 0 0 0 rg BT 111.01 419.17 Td (ge) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 120.45 423.70 Td (\(c\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 419.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 419.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 419.17 Td (123) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 406.33 Td (Income taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 406.22 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 406.22 Td (\(480) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 406.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 406.22 Td (\(422) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 406.22 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 394.33 Td (Increase to net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 394.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 394.22 Td (293) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 394.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 394.22 Td (1,813) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 394.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 394.22 Td (1,081) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 372.90 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 372.90 Td (Specified ) Tj ET Q q 0 0 0 rg BT 86.21 372.90 Td (items ) Tj ET Q q 0 0 0 rg BT 105.54 372.90 Td (in ) Tj ET Q q 0 0 0 rg BT 113.77 372.90 Td (cost ) Tj ET Q q 0 0 0 rg BT 128.65 372.90 Td (of ) Tj ET Q q 0 0 0 rg BT 137.32 372.90 Td (products ) Tj ET Q q 0 0 0 rg BT 166.87 372.90 Td (sold ) Tj ET Q q 0 0 0 rg BT 182.20 372.90 Td (are ) Tj ET Q q 0 0 0 rg BT 193.97 372.90 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 231.93 372.90 Td (depreciation, ) Tj ET Q q 0 0 0 rg BT 275.47 372.90 Td (asset ) Tj ET Q q 0 0 0 rg BT 293.02 372.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 331.90 372.90 Td (and ) Tj ET Q q 0 0 0 rg BT 345.45 372.90 Td (other ) Tj ET Q q 0 0 0 rg BT 363.89 372.90 Td (shutdown ) Tj ET Q q 0 0 0 rg BT 397.00 372.90 Td (costs.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 363.30 Td (\(b\) ) Tj ET Q q 0 0 0 rg BT 54.00 363.30 Td (Includes ) Tj ET Q q 0 0 0 rg BT 83.10 363.30 Td ($16 ) Tj ET Q q 0 0 0 rg BT 97.10 363.30 Td (million ) Tj ET Q q 0 0 0 rg BT 122.21 363.30 Td (of ) Tj ET Q q 0 0 0 rg BT 130.88 363.30 Td (additional ) Tj ET Q q 0 0 0 rg BT 164.87 363.30 Td (year ) Tj ET Q q 0 0 0 rg BT 180.64 363.30 Td (of ) Tj ET Q q 0 0 0 rg BT 189.30 363.30 Td (Branded ) Tj ET Q q 0 0 0 rg BT 218.40 363.30 Td (Prescription ) Tj ET Q q 0 0 0 rg BT 259.06 363.30 Td (Drug ) Tj ET Q q 0 0 0 rg BT 277.50 363.30 Td (Fee ) Tj ET Q q 0 0 0 rg BT 291.05 363.30 Td (in ) Tj ET Q q 0 0 0 rg BT 299.28 363.30 Td (2014.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 353.70 Td (\(c\) ) Tj ET Q q 0 0 0 rg BT 54.00 353.70 Td (The ) Tj ET Q q 0 0 0 rg BT 68.44 353.70 Td (2014 ) Tj ET Q q 0 0 0 rg BT 86.44 353.70 Td (specified ) Tj ET Q q 0 0 0 rg BT 117.31 353.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 129.09 353.70 Td (char) Tj ET Q q 0 0 0 rg BT 142.71 353.70 Td (ge ) Tj ET Q q 0 0 0 rg BT 152.26 353.70 Td (relates ) Tj ET Q q 0 0 0 rg BT 175.13 353.70 Td (to ) Tj ET Q q 0 0 0 rg BT 183.36 353.70 Td (transfer ) Tj ET Q q 0 0 0 rg BT 209.79 353.70 Td (pricing ) Tj ET Q q 0 0 0 rg BT 234.45 353.70 Td (matters.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.70 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 329.70 Td (reconciliations ) Tj ET Q q 0 0 0 rg BT 115.41 329.70 Td (from ) Tj ET Q q 0 0 0 rg BT 137.35 329.70 Td (GAAP) Tj ET Q q 0 0 0 rg BT 164.21 329.70 Td ( ) Tj ET Q q 0 0 0 rg BT 166.71 329.70 Td (to ) Tj ET Q q 0 0 0 rg BT 176.99 329.70 Td (Non-GAAP) Tj ET Q q 0 0 0 rg BT 224.39 329.70 Td ( ) Tj ET Q q 0 0 0 rg BT 226.89 329.70 Td (were ) Tj ET Q q 0 0 0 rg BT 248.82 329.70 Td (as ) Tj ET Q q 0 0 0 rg BT 259.65 329.70 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 295.20 351.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 295.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 391.50 295.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 295.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 295.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 295.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 295.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 267.20 351.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 267.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 391.50 267.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 267.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 267.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 267.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 267.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 239.20 351.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 239.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 391.50 239.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 239.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 239.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 239.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 239.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 211.20 351.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 211.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 391.50 211.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 211.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 211.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 211.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 211.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 183.20 351.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 183.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 391.50 183.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 183.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 183.20 59.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 513.50 183.20 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 183.20 59.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 307.20000000000005 m 450.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 307.20000000000005 m 454.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 307.20000000000005 m 513.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 307.20000000000005 m 517.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 307.20000000000005 m 576.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 295.20000000000005 m 450.5 295.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 307.20000000000005 m 513.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 295.20000000000005 m 513.5 295.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 513.5 307.20000000000005 m 517.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 307.20000000000005 m 576.5 307.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 295.20000000000005 m 576.5 295.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 267.20000000000005 m 450.5 267.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 267.20000000000005 m 513.5 267.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 267.20000000000005 m 576.5 267.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 254.20000000000005 m 450.5 254.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 252.20000000000005 m 450.5 252.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 254.20000000000005 m 513.5 254.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 252.20000000000005 m 513.5 252.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 254.20000000000005 m 576.5 254.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 252.20000000000005 m 576.5 252.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 183.20000000000005 m 513.5 183.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 183.20000000000005 m 576.5 183.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 183.20000000000005 m 450.5 183.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 170.20000000000005 m 450.5 170.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 391.5 168.20000000000005 m 450.5 168.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 183.20000000000005 m 513.5 183.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 170.20000000000005 m 513.5 170.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 168.20000000000005 m 513.5 168.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 170.20000000000005 m 576.5 170.20000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 168.20000000000005 m 576.5 168.20000000000005 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 311.15 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 439.20 311.28 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 299.15 Td (Dollars in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 412.50 299.28 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 475.50 299.28 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.50 299.28 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 285.77 Td (Net Earnings Attributable to BMS used for Diluted EPS Calculation — GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.00 285.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.15 285.77 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 285.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.15 285.77 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.00 285.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 285.77 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 271.77 Td (Specified Items) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 271.77 Td (293) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.15 271.77 Td (1,813) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 271.77 Td (1,081) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 257.77 Td (Net Earnings Attributable to BMS used for Diluted EPS Calculation — Non-GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.00 257.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.15 257.77 Td (4,750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 257.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.15 257.77 Td (3,378) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.00 257.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 257.77 Td (3,085) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 229.77 Td (Average Common Shares Outstanding — Diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.15 229.77 Td (1,680) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.15 229.77 Td (1,679) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 229.77 Td (1,670) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 201.77 Td (Diluted EPS Attributable to BMS — GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.00 201.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.15 201.77 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 201.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.15 201.77 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.00 201.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 201.77 Td (1.20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 187.77 Td (Diluted EPS Attributable to Specified Items) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.15 187.77 Td (0.18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.15 187.77 Td (1.08) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 187.77 Td (0.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 173.77 Td (Diluted EPS Attributable to BMS — Non-GAAP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.00 173.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.15 173.77 Td (2.83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 173.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.15 173.77 Td (2.01) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.00 173.77 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 173.77 Td (1.85) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 81 0 obj <> endobj 82 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (40) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Financial Position, Liquidity and Capital Resour) Tj ET Q q 0 0 0 rg BT 243.64 749.25 Td (ces) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Our net cash position was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 701.75 375.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 701.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 415.50 701.75 78.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 701.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 701.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 675.75 375.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 675.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 415.50 675.75 78.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 675.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 675.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 649.75 375.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 415.50 649.75 78.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 649.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 649.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 623.75 375.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 415.50 623.75 78.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 623.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 623.75 79.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 701.75 m 493.5 701.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 701.75 m 576.5 701.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 701.75 m 493.5 701.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 701.75 m 576.5 701.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 662.75 m 493.5 662.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 662.75 m 576.5 662.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 623.75 m 493.5 623.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 623.75 m 576.5 623.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 611.75 m 493.5 611.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 415.5 609.75 m 493.5 609.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 611.75 m 576.5 611.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 609.75 m 576.5 609.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 706.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 446.00 705.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.50 705.98 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 692.32 Td (Cash and cash equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.00 692.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 692.32 Td (4,237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 692.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 692.32 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.32 Td (Marketable securities — current) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 679.32 Td (2,113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 679.32 Td (1,885) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 666.32 Td (Marketable securities — non-current) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 666.32 Td (2,719) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 666.32 Td (4,660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 653.32 Td (Total cash, cash equivalents and marketable securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 653.32 Td (9,069) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 653.32 Td (8,930) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.32 Td (Short-term borrowings and current portion of long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 640.37 Td (\(992) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 640.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 640.32 Td (\(139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 640.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 627.32 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 463.80 627.37 Td (\(5,716) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 627.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 627.32 Td (\(6,550) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 627.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 614.32 Td (Net cash position) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.00 614.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 614.32 Td (2,361) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 614.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 614.32 Td (2,241) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 587.25 Td (Cash, ) Tj ET Q q 0 0 0 rg BT 61.39 587.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 82.04 587.25 Td (equivalents ) Tj ET Q q 0 0 0 rg BT 130.48 587.25 Td (and ) Tj ET Q q 0 0 0 rg BT 147.80 587.25 Td (marketable ) Tj ET Q q 0 0 0 rg BT 195.11 587.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 235.76 587.25 Td (held ) Tj ET Q q 0 0 0 rg BT 255.87 587.25 Td (in ) Tj ET Q q 0 0 0 rg BT 266.53 587.25 Td (the ) Tj ET Q q 0 0 0 rg BT 281.64 587.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 302.31 587.25 Td (were ) Tj ET Q q 0 0 0 rg BT 324.63 587.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 385.27 587.25 Td ($1.1 ) Tj ET Q q 0 0 0 rg BT 405.66 587.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.77 587.25 Td ( ) Tj ET Q q 0 0 0 rg BT 434.66 587.25 Td (at ) Tj ET Q q 0 0 0 rg BT 444.77 587.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.74 587.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.74 587.25 Td (. ) Tj ET Q q 0 0 0 rg BT 529.13 587.25 Td (Most ) Tj ET Q q 0 0 0 rg BT 552.58 587.25 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 587.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 575.25 Td (remaining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 78.20 575.25 Td ($8.0 ) Tj ET Q q 0 0 0 rg BT 97.35 575.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 123.46 575.25 Td ( ) Tj ET Q q 0 0 0 rg BT 125.12 575.25 Td (is ) Tj ET Q q 0 0 0 rg BT 133.44 575.25 Td (held ) Tj ET Q q 0 0 0 rg BT 152.31 575.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 191.18 575.25 Td (in ) Tj ET Q q 0 0 0 rg BT 200.61 575.25 Td (low-tax ) Tj ET Q q 0 0 0 rg BT 232.81 575.25 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 283.91 575.25 Td (and ) Tj ET Q q 0 0 0 rg BT 300.00 575.25 Td (attributable ) Tj ET Q q 0 0 0 rg BT 347.20 575.25 Td (to ) Tj ET Q q 0 0 0 rg BT 356.63 575.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 392.16 575.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 429.35 575.25 Td (to ) Tj ET Q q 0 0 0 rg BT 438.78 575.25 Td (be ) Tj ET Q q 0 0 0 rg BT 449.87 575.25 Td (indefinitely ) Tj ET Q q 0 0 0 rg BT 497.62 575.25 Td (reinvested ) Tj ET Q q 0 0 0 rg BT 540.37 575.25 Td (of) Tj ET Q q 0 0 0 rg BT 548.52 575.25 Td (fshore. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 563.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 58.24 563.25 Td (repatriations ) Tj ET Q q 0 0 0 rg BT 110.47 563.25 Td (are ) Tj ET Q q 0 0 0 rg BT 124.92 563.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 155.49 563.25 Td (to ) Tj ET Q q 0 0 0 rg BT 165.51 563.25 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 212.19 563.25 Td (in ) Tj ET Q q 0 0 0 rg BT 222.21 563.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 251.65 563.25 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 303.34 563.25 Td (and ) Tj ET Q q 0 0 0 rg BT 320.02 563.25 Td (may ) Tj ET Q q 0 0 0 rg BT 339.48 563.25 Td (be ) Tj ET Q q 0 0 0 rg BT 351.17 563.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 381.73 563.25 Td (to ) Tj ET Q q 0 0 0 rg BT 391.76 563.25 Td (withholding ) Tj ET Q q 0 0 0 rg BT 442.34 563.25 Td (and ) Tj ET Q q 0 0 0 rg BT 459.02 563.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 501.25 563.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 521.28 563.25 Td (income ) Tj ET Q q 0 0 0 rg BT 552.96 563.25 Td (taxes. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 551.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 551.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.37 551.25 Td (believe ) Tj ET Q q 0 0 0 rg BT 82.54 551.25 Td (that ) Tj ET Q q 0 0 0 rg BT 99.83 551.25 Td (our ) Tj ET Q q 0 0 0 rg BT 115.45 551.25 Td (existing ) Tj ET Q q 0 0 0 rg BT 149.41 551.25 Td (cash, ) Tj ET Q q 0 0 0 rg BT 171.97 551.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 192.03 551.25 Td (equivalents ) Tj ET Q q 0 0 0 rg BT 239.87 551.25 Td (and ) Tj ET Q q 0 0 0 rg BT 256.60 551.25 Td (marketable ) Tj ET Q q 0 0 0 rg BT 303.31 551.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 343.37 551.25 Td (together ) Tj ET Q q 0 0 0 rg BT 378.43 551.25 Td (with ) Tj ET Q q 0 0 0 rg BT 398.50 551.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 418.56 551.25 Td (generated ) Tj ET Q q 0 0 0 rg BT 459.72 551.25 Td (from ) Tj ET Q q 0 0 0 rg BT 481.45 551.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 525.40 551.25 Td (and ) Tj ET Q q 0 0 0 rg BT 542.13 551.25 Td (issuance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.25 Td (of ) Tj ET Q q 0 0 0 rg BT 47.67 539.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 98.20 539.25 Td (paper ) Tj ET Q q 0 0 0 rg BT 123.74 539.25 Td (in ) Tj ET Q q 0 0 0 rg BT 134.86 539.25 Td (the ) Tj ET Q q 0 0 0 rg BT 150.41 539.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 171.53 539.25 Td (will ) Tj ET Q q 0 0 0 rg BT 190.42 539.25 Td (be ) Tj ET Q q 0 0 0 rg BT 203.20 539.25 Td (suf) Tj ET Q q 0 0 0 rg BT 215.24 539.25 Td (ficient ) Tj ET Q q 0 0 0 rg BT 244.12 539.25 Td (to ) Tj ET Q q 0 0 0 rg BT 255.23 539.25 Td (satisfy ) Tj ET Q q 0 0 0 rg BT 284.68 539.25 Td (our ) Tj ET Q q 0 0 0 rg BT 301.34 539.25 Td (normal ) Tj ET Q q 0 0 0 rg BT 333.01 539.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 354.11 539.25 Td (requirements ) Tj ET Q q 0 0 0 rg BT 409.65 539.25 Td (for ) Tj ET Q q 0 0 0 rg BT 424.65 539.25 Td (at ) Tj ET Q q 0 0 0 rg BT 435.20 539.25 Td (least ) Tj ET Q q 0 0 0 rg BT 456.86 539.25 Td (the ) Tj ET Q q 0 0 0 rg BT 472.41 539.25 Td (next ) Tj ET Q q 0 0 0 rg BT 492.97 539.25 Td (few ) Tj ET Q q 0 0 0 rg BT 511.29 539.25 Td (years, ) Tj ET Q q 0 0 0 rg BT 538.23 539.25 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 527.25 Td (dividends, ) Tj ET Q q 0 0 0 rg BT 79.89 527.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 109.04 527.25 Td (expenditures, ) Tj ET Q q 0 0 0 rg BT 165.13 527.25 Td (milestone ) Tj ET Q q 0 0 0 rg BT 206.51 527.25 Td (payments, ) Tj ET Q q 0 0 0 rg BT 249.84 527.25 Td (working ) Tj ET Q q 0 0 0 rg BT 285.67 527.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 314.82 527.25 Td (and ) Tj ET Q q 0 0 0 rg BT 331.76 527.25 Td (maturities ) Tj ET Q q 0 0 0 rg BT 374.25 527.25 Td (of ) Tj ET Q q 0 0 0 rg BT 385.08 527.25 Td (long-term ) Tj ET Q q 0 0 0 rg BT 427.01 527.25 Td (debt.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.25 Td (Management ) Tj ET Q q 0 0 0 rg BT 90.50 503.25 Td (continuously ) Tj ET Q q 0 0 0 rg BT 144.46 503.25 Td (evaluates ) Tj ET Q q 0 0 0 rg BT 183.96 503.25 Td (the ) Tj ET Q q 0 0 0 rg BT 198.47 503.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 240.14 503.25 Td (s ) Tj ET Q q 0 0 0 rg BT 246.32 503.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 275.27 503.25 Td (structure ) Tj ET Q q 0 0 0 rg BT 312.55 503.25 Td (to ) Tj ET Q q 0 0 0 rg BT 322.63 503.25 Td (ensure ) Tj ET Q q 0 0 0 rg BT 351.02 503.25 Td (the ) Tj ET Q q 0 0 0 rg BT 365.54 503.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 406.72 503.25 Td (is ) Tj ET Q q 0 0 0 rg BT 415.69 503.25 Td (financed ) Tj ET Q q 0 0 0 rg BT 452.41 503.25 Td (ef) Tj ET Q q 0 0 0 rg BT 459.99 503.25 Td (ficiently) Tj ET Q q 0 0 0 rg BT 492.66 503.25 Td (, ) Tj ET Q q 0 0 0 rg BT 497.46 503.25 Td (which ) Tj ET Q q 0 0 0 rg BT 524.20 503.25 Td (may ) Tj ET Q q 0 0 0 rg BT 543.71 503.25 Td (result ) Tj ET Q q 0 0 0 rg BT 568.22 503.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 491.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.10 491.25 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 97.29 491.25 Td (of ) Tj ET Q q 0 0 0 rg BT 108.50 491.25 Td (common ) Tj ET Q q 0 0 0 rg BT 146.38 491.25 Td (stock ) Tj ET Q q 0 0 0 rg BT 170.37 491.25 Td (and ) Tj ET Q q 0 0 0 rg BT 187.69 491.25 Td (debt ) Tj ET Q q 0 0 0 rg BT 207.79 491.25 Td (securities, ) Tj ET Q q 0 0 0 rg BT 250.94 491.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 299.92 491.25 Td (of ) Tj ET Q q 0 0 0 rg BT 311.14 491.25 Td (interest ) Tj ET Q q 0 0 0 rg BT 343.45 491.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 361.32 491.25 Td (swap ) Tj ET Q q 0 0 0 rg BT 384.76 491.25 Td (contracts ) Tj ET Q q 0 0 0 rg BT 423.73 491.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 446.06 491.25 Td (to ) Tj ET Q q 0 0 0 rg BT 456.72 491.25 Td (maturity ) Tj ET Q q 0 0 0 rg BT 493.48 491.25 Td (and ) Tj ET Q q 0 0 0 rg BT 510.80 491.25 Td (issuance ) Tj ET Q q 0 0 0 rg BT 547.56 491.25 Td (of ) Tj ET Q q 0 0 0 rg BT 558.78 491.25 Td (debt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 479.25 Td (securities. ) Tj ET Q q 0 0 0 rg BT 77.96 479.25 Td (For ) Tj ET Q q 0 0 0 rg BT 93.56 479.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 131.63 479.25 Td (we ) Tj ET Q q 0 0 0 rg BT 144.99 479.25 Td (issued ) Tj ET Q q 0 0 0 rg BT 171.69 479.25 Td (senior ) Tj ET Q q 0 0 0 rg BT 197.83 479.25 Td (unsecured ) Tj ET Q q 0 0 0 rg BT 240.07 479.25 Td (notes ) Tj ET Q q 0 0 0 rg BT 262.88 479.25 Td (in ) Tj ET Q q 0 0 0 rg BT 272.36 479.25 Td (a ) Tj ET Q q 0 0 0 rg BT 278.50 479.25 Td (registered ) Tj ET Q q 0 0 0 rg BT 319.62 479.25 Td (public ) Tj ET Q q 0 0 0 rg BT 346.32 479.25 Td (of) Tj ET Q q 0 0 0 rg BT 354.46 479.25 Td (fering ) Tj ET Q q 0 0 0 rg BT 380.04 479.25 Td (generating ) Tj ET Q q 0 0 0 rg BT 423.95 479.25 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 461.18 479.25 Td (of ) Tj ET Q q 0 0 0 rg BT 471.21 479.25 Td ($1.3 ) Tj ET Q q 0 0 0 rg BT 490.41 479.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 518.23 479.25 Td (and ) Tj ET Q q 0 0 0 rg BT 534.37 479.25 Td (redeemed/) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 467.25 Td (repurchased ) Tj ET Q q 0 0 0 rg BT 86.36 467.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 115.61 467.25 Td (notes ) Tj ET Q q 0 0 0 rg BT 138.77 467.25 Td (for ) Tj ET Q q 0 0 0 rg BT 152.48 467.25 Td (nearly ) Tj ET Q q 0 0 0 rg BT 179.52 467.25 Td ($2.0 ) Tj ET Q q 0 0 0 rg BT 199.07 467.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 227.23 467.25 Td (during ) Tj ET Q q 0 0 0 rg BT 255.39 467.25 Td (2015. Refer ) Tj ET Q q 0 0 0 rg BT 304.65 467.25 Td (to ) Tj ET Q q 0 0 0 rg BT 314.48 467.25 Td (“Item ) Tj ET Q q 0 0 0 rg BT 339.29 467.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 348.84 467.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 388.10 467.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 463.48 467.25 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.48 467.25 Td (. ) Tj ET Q q 0 0 0 rg BT 473.03 467.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 512.29 467.25 Td (Instruments ) Tj ET Q q 0 0 0 rg BT 561.56 467.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 455.25 Td (Fair ) Tj ET Q q 0 0 0 rg BT 54.43 455.25 Td (V) Tj ET Q q 0 0 0 rg BT 60.54 455.25 Td (alue ) Tj ET Q q 0 0 0 rg BT 79.70 455.25 Td (Measurements” ) Tj ET Q q 0 0 0 rg BT 144.95 455.25 Td (for ) Tj ET Q q 0 0 0 rg BT 159.11 455.25 Td (further ) Tj ET Q q 0 0 0 rg BT 188.82 455.25 Td (details. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 431.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.91 431.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 95.57 431.25 Td (s ) Tj ET Q q 0 0 0 rg BT 101.83 431.25 Td (common ) Tj ET Q q 0 0 0 rg BT 139.18 431.25 Td (stock ) Tj ET Q q 0 0 0 rg BT 162.65 431.25 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 208.32 431.25 Td (capacity ) Tj ET Q q 0 0 0 rg BT 243.99 431.25 Td (was ) Tj ET Q q 0 0 0 rg BT 261.90 431.25 Td (increased ) Tj ET Q q 0 0 0 rg BT 302.02 431.25 Td (to ) Tj ET Q q 0 0 0 rg BT 312.15 431.25 Td ($4.1 ) Tj ET Q q 0 0 0 rg BT 332.02 431.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 360.49 431.25 Td (during ) Tj ET Q q 0 0 0 rg BT 388.96 431.25 Td (October ) Tj ET Q q 0 0 0 rg BT 423.53 431.25 Td (2016. ) Tj ET Q q 0 0 0 rg BT 448.22 431.25 Td (The ) Tj ET Q q 0 0 0 rg BT 466.13 431.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 507.37 431.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 539.16 431.25 Td (into ) Tj ET Q q 0 0 0 rg BT 556.55 431.25 Td (ASR ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 419.25 Td (agreements ) Tj ET Q q 0 0 0 rg BT 83.91 419.25 Td (to ) Tj ET Q q 0 0 0 rg BT 94.07 419.25 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 139.75 419.25 Td (approximately ) Tj ET Q q 0 0 0 rg BT 199.89 419.25 Td ($2.0 ) Tj ET Q q 0 0 0 rg BT 219.76 419.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 248.26 419.25 Td (of ) Tj ET Q q 0 0 0 rg BT 258.96 419.25 Td (common ) Tj ET Q q 0 0 0 rg BT 296.34 419.25 Td (stock ) Tj ET Q q 0 0 0 rg BT 319.82 419.25 Td (in ) Tj ET Q q 0 0 0 rg BT 329.98 419.25 Td (February ) Tj ET Q q 0 0 0 rg BT 368.46 419.25 Td (2017. ) Tj ET Q q 0 0 0 rg BT 393.33 419.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 417.92 419.25 Td (to ) Tj ET Q q 0 0 0 rg BT 428.08 419.25 Td (“Item ) Tj ET Q q 0 0 0 rg BT 453.22 419.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 463.09 419.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 502.68 419.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 407.25 Td (15. ) Tj ET Q q 0 0 0 rg BT 51.00 407.25 Td (Equity” ) Tj ET Q q 0 0 0 rg BT 84.60 407.25 Td (for ) Tj ET Q q 0 0 0 rg BT 98.76 407.25 Td (further ) Tj ET Q q 0 0 0 rg BT 128.47 407.25 Td (details. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 383.25 Td (Dividend ) Tj ET Q q 0 0 0 rg BT 76.04 383.25 Td (payments ) Tj ET Q q 0 0 0 rg BT 117.18 383.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.43 383.25 Td ($2.5 ) Tj ET Q q 0 0 0 rg BT 159.75 383.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.86 383.25 Td ( ) Tj ET Q q 0 0 0 rg BT 188.68 383.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.28 383.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.28 383.25 Td ( ) Tj ET Q q 0 0 0 rg BT 222.10 383.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 239.36 383.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.36 383.25 Td ( ) Tj ET Q q 0 0 0 rg BT 262.18 383.25 Td (and ) Tj ET Q q 0 0 0 rg BT 279.44 383.25 Td ($2.4 ) Tj ET Q q 0 0 0 rg BT 299.76 383.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 328.69 383.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 339.29 383.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.29 383.25 Td (. ) Tj ET Q q 0 0 0 rg BT 364.61 383.25 Td (Dividend ) Tj ET Q q 0 0 0 rg BT 404.65 383.25 Td (decisions ) Tj ET Q q 0 0 0 rg BT 444.68 383.25 Td (are ) Tj ET Q q 0 0 0 rg BT 459.71 383.25 Td (made ) Tj ET Q q 0 0 0 rg BT 484.18 383.25 Td (on ) Tj ET Q q 0 0 0 rg BT 497.00 383.25 Td (a ) Tj ET Q q 0 0 0 rg BT 504.26 383.25 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 543.18 383.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 566.00 383.25 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 371.25 Td (our ) Tj ET Q q 0 0 0 rg BT 52.10 371.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 79.31 371.25 Td (of ) Tj ET Q q 0 0 0 rg BT 90.40 371.25 Td (Directors. ) Tj ET Q q 0 0 0 rg BT 132.88 371.25 Td (Capital ) Tj ET Q q 0 0 0 rg BT 164.53 371.25 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 218.39 371.25 Td (were ) Tj ET Q q 0 0 0 rg BT 240.59 371.25 Td (approximately ) Tj ET Q q 0 0 0 rg BT 301.12 371.25 Td ($1.2 ) Tj ET Q q 0 0 0 rg BT 321.39 371.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 350.27 371.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.81 371.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.81 371.25 Td (, ) Tj ET Q q 0 0 0 rg BT 386.08 371.25 Td ($800 ) Tj ET Q q 0 0 0 rg BT 408.85 371.25 Td (million ) Tj ET Q q 0 0 0 rg BT 440.51 371.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.06 371.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.06 371.25 Td ( ) Tj ET Q q 0 0 0 rg BT 473.83 371.25 Td (and ) Tj ET Q q 0 0 0 rg BT 491.03 371.25 Td ($500 ) Tj ET Q q 0 0 0 rg BT 513.80 371.25 Td (million ) Tj ET Q q 0 0 0 rg BT 545.46 371.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.01 371.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 359.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.72 359.25 Td (are ) Tj ET Q q 0 0 0 rg BT 69.20 359.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 108.01 359.25 Td (to ) Tj ET Q q 0 0 0 rg BT 119.07 359.25 Td (be ) Tj ET Q q 0 0 0 rg BT 131.78 359.25 Td (approximately ) Tj ET Q q 0 0 0 rg BT 192.82 359.25 Td ($1.0 ) Tj ET Q q 0 0 0 rg BT 213.60 359.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 242.99 359.25 Td (in ) Tj ET Q q 0 0 0 rg BT 254.05 359.25 Td (2017 ) Tj ET Q q 0 0 0 rg BT 277.32 359.25 Td (and ) Tj ET Q q 0 0 0 rg BT 295.04 359.25 Td ($900 ) Tj ET Q q 0 0 0 rg BT 318.32 359.25 Td (million ) Tj ET Q q 0 0 0 rg BT 350.49 359.25 Td (in ) Tj ET Q q 0 0 0 rg BT 361.54 359.25 Td (2018. ) Tj ET Q q 0 0 0 rg BT 387.08 359.25 Td (The ) Tj ET Q q 0 0 0 rg BT 405.91 359.25 Td (higher ) Tj ET Q q 0 0 0 rg BT 434.73 359.25 Td (spending ) Tj ET Q q 0 0 0 rg BT 474.12 359.25 Td (is ) Tj ET Q q 0 0 0 rg BT 484.07 359.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 522.88 359.25 Td (as ) Tj ET Q q 0 0 0 rg BT 534.48 359.25 Td (a ) Tj ET Q q 0 0 0 rg BT 542.20 359.25 Td (result ) Tj ET Q q 0 0 0 rg BT 567.70 359.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 347.25 Td (expanding ) Tj ET Q q 0 0 0 rg BT 80.42 347.25 Td (our ) Tj ET Q q 0 0 0 rg BT 96.52 347.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 135.95 347.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 197.03 347.25 Td (capabilities ) Tj ET Q q 0 0 0 rg BT 245.34 347.25 Td (and ) Tj ET Q q 0 0 0 rg BT 262.54 347.25 Td (other ) Tj ET Q q 0 0 0 rg BT 285.86 347.25 Td (facility-related ) Tj ET Q q 0 0 0 rg BT 347.48 347.25 Td (activities. ) Tj ET Q q 0 0 0 rg BT 388.84 347.25 Td (For ) Tj ET Q q 0 0 0 rg BT 405.50 347.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 444.64 347.25 Td (we ) Tj ET Q q 0 0 0 rg BT 459.07 347.25 Td (are ) Tj ET Q q 0 0 0 rg BT 474.04 347.25 Td (constructing ) Tj ET Q q 0 0 0 rg BT 526.25 347.25 Td (a ) Tj ET Q q 0 0 0 rg BT 533.45 347.25 Td (new ) Tj ET Q q 0 0 0 rg BT 552.88 347.25 Td (lar) Tj ET Q q 0 0 0 rg BT 563.25 347.25 Td (ge-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 335.25 Td (scale ) Tj ET Q q 0 0 0 rg BT 58.05 335.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 96.79 335.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 157.16 335.25 Td (facility ) Tj ET Q q 0 0 0 rg BT 187.55 335.25 Td (in ) Tj ET Q q 0 0 0 rg BT 197.40 335.25 Td (Ireland ) Tj ET Q q 0 0 0 rg BT 227.78 335.25 Td (that ) Tj ET Q q 0 0 0 rg BT 244.85 335.25 Td (will ) Tj ET Q q 0 0 0 rg BT 262.47 335.25 Td (produce ) Tj ET Q q 0 0 0 rg BT 296.74 335.25 Td (multiple ) Tj ET Q q 0 0 0 rg BT 332.14 335.25 Td (therapies ) Tj ET Q q 0 0 0 rg BT 370.30 335.25 Td (for ) Tj ET Q q 0 0 0 rg BT 384.03 335.25 Td (our ) Tj ET Q q 0 0 0 rg BT 399.43 335.25 Td (growing ) Tj ET Q q 0 0 0 rg BT 434.83 335.25 Td (biologics ) Tj ET Q q 0 0 0 rg BT 473.56 335.25 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 510.62 335.25 Td (when ) Tj ET Q q 0 0 0 rg BT 534.35 335.25 Td (completed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 323.25 Td (2019.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.48 299.25 Td (marketable ) Tj ET Q q 0 0 0 rg BT 101.83 299.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 142.53 299.25 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 180.46 299.25 Td (is ) Tj ET Q q 0 0 0 rg BT 190.06 299.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 221.32 299.25 Td (to ) Tj ET Q q 0 0 0 rg BT 232.03 299.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 267.17 299.25 Td (in ) Tj ET Q q 0 0 0 rg BT 277.88 299.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 294.69 299.25 Td (value ) Tj ET Q q 0 0 0 rg BT 319.27 299.25 Td (as ) Tj ET Q q 0 0 0 rg BT 330.54 299.25 Td (a ) Tj ET Q q 0 0 0 rg BT 337.91 299.25 Td (result ) Tj ET Q q 0 0 0 rg BT 363.06 299.25 Td (of ) Tj ET Q q 0 0 0 rg BT 374.32 299.25 Td (interest ) Tj ET Q q 0 0 0 rg BT 406.68 299.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 424.60 299.25 Td (fluctuations ) Tj ET Q q 0 0 0 rg BT 474.75 299.25 Td (and ) Tj ET Q q 0 0 0 rg BT 492.12 299.25 Td (other ) Tj ET Q q 0 0 0 rg BT 515.59 299.25 Td (market ) Tj ET Q q 0 0 0 rg BT 546.29 299.25 Td (factors, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.25 Td (which ) Tj ET Q q 0 0 0 rg BT 62.26 287.25 Td (may ) Tj ET Q q 0 0 0 rg BT 81.29 287.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 110.32 287.25 Td (our ) Tj ET Q q 0 0 0 rg BT 125.47 287.25 Td (results ) Tj ET Q q 0 0 0 rg BT 153.40 287.25 Td (of ) Tj ET Q q 0 0 0 rg BT 163.54 287.25 Td (operations. ) Tj ET Q q 0 0 0 rg BT 209.52 287.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 226.89 287.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 272.59 287.25 Td (policy ) Tj ET Q q 0 0 0 rg BT 299.40 287.25 Td (places ) Tj ET Q q 0 0 0 rg BT 326.20 287.25 Td (limits ) Tj ET Q q 0 0 0 rg BT 350.80 287.25 Td (on ) Tj ET Q q 0 0 0 rg BT 362.62 287.25 Td (these ) Tj ET Q q 0 0 0 rg BT 384.99 287.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 434.58 287.25 Td (and ) Tj ET Q q 0 0 0 rg BT 450.83 287.25 Td (the ) Tj ET Q q 0 0 0 rg BT 464.87 287.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 496.68 287.25 Td (and ) Tj ET Q q 0 0 0 rg BT 512.94 287.25 Td (time ) Tj ET Q q 0 0 0 rg BT 532.53 287.25 Td (to ) Tj ET Q q 0 0 0 rg BT 542.12 287.25 Td (maturity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.05 275.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 95.55 275.25 Td (with ) Tj ET Q q 0 0 0 rg BT 115.05 275.25 Td (any ) Tj ET Q q 0 0 0 rg BT 131.21 275.25 Td (institution. ) Tj ET Q q 0 0 0 rg BT 175.88 275.25 Td (The ) Tj ET Q q 0 0 0 rg BT 193.15 275.25 Td (policy ) Tj ET Q q 0 0 0 rg BT 219.86 275.25 Td (also ) Tj ET Q q 0 0 0 rg BT 237.70 275.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 271.63 275.25 Td (that ) Tj ET Q q 0 0 0 rg BT 288.35 275.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 337.84 275.25 Td (are ) Tj ET Q q 0 0 0 rg BT 351.77 275.25 Td (only ) Tj ET Q q 0 0 0 rg BT 371.28 275.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 402.42 275.25 Td (into ) Tj ET Q q 0 0 0 rg BT 419.70 275.25 Td (with ) Tj ET Q q 0 0 0 rg BT 439.21 275.25 Td (corporate ) Tj ET Q q 0 0 0 rg BT 478.68 275.25 Td (and ) Tj ET Q q 0 0 0 rg BT 494.85 275.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 531.55 275.25 Td (institutions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.25 Td (that ) Tj ET Q q 0 0 0 rg BT 55.78 263.25 Td (meet ) Tj ET Q q 0 0 0 rg BT 79.99 263.25 Td (high ) Tj ET Q q 0 0 0 rg BT 102.56 263.25 Td (credit ) Tj ET Q q 0 0 0 rg BT 130.10 263.25 Td (quality ) Tj ET Q q 0 0 0 rg BT 162.66 263.25 Td (standards. ) Tj ET Q q 0 0 0 rg BT 207.71 263.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 234.70 263.25 Td (to ) Tj ET Q q 0 0 0 rg BT 247.26 263.25 Td (“Item ) Tj ET Q q 0 0 0 rg BT 274.81 263.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 287.09 263.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 329.08 263.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.19 263.25 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.19 263.25 Td (. ) Tj ET Q q 0 0 0 rg BT 419.47 263.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 461.46 263.25 Td (Instruments ) Tj ET Q q 0 0 0 rg BT 513.46 263.25 Td (and ) Tj ET Q q 0 0 0 rg BT 532.68 263.25 Td (Fair ) Tj ET Q q 0 0 0 rg BT 553.23 263.25 Td (V) Tj ET Q q 0 0 0 rg BT 559.34 263.25 Td (alue ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 251.25 Td (Measurements” ) Tj ET Q q 0 0 0 rg BT 101.25 251.25 Td (for ) Tj ET Q q 0 0 0 rg BT 115.41 251.25 Td (further ) Tj ET Q q 0 0 0 rg BT 145.12 251.25 Td (details.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 227.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 227.25 Td (e ) Tj ET Q q 0 0 0 rg BT 51.71 227.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 90.44 227.25 Td (have ) Tj ET Q q 0 0 0 rg BT 111.95 227.25 Td (two ) Tj ET Q q 0 0 0 rg BT 129.59 227.25 Td (separate ) Tj ET Q q 0 0 0 rg BT 164.98 227.25 Td ($1.5 ) Tj ET Q q 0 0 0 rg BT 185.12 227.25 Td (billion ) Tj ET Q q 0 0 0 rg BT 213.86 227.25 Td (revolving ) Tj ET Q q 0 0 0 rg BT 254.83 227.25 Td (credit ) Tj ET Q q 0 0 0 rg BT 280.22 227.25 Td (facilities ) Tj ET Q q 0 0 0 rg BT 317.29 227.25 Td (from ) Tj ET Q q 0 0 0 rg BT 339.36 227.25 Td (a ) Tj ET Q q 0 0 0 rg BT 346.44 227.25 Td (syndicate ) Tj ET Q q 0 0 0 rg BT 386.84 227.25 Td (of ) Tj ET Q q 0 0 0 rg BT 397.80 227.25 Td (lenders. ) Tj ET Q q 0 0 0 rg BT 431.62 227.25 Td (The ) Tj ET Q q 0 0 0 rg BT 449.81 227.25 Td (facilities ) Tj ET Q q 0 0 0 rg BT 486.87 227.25 Td (provide ) Tj ET Q q 0 0 0 rg BT 520.05 227.25 Td (for ) Tj ET Q q 0 0 0 rg BT 534.35 227.25 Td (customary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.25 Td (terms ) Tj ET Q q 0 0 0 rg BT 60.35 215.25 Td (and ) Tj ET Q q 0 0 0 rg BT 76.92 215.25 Td (conditions ) Tj ET Q q 0 0 0 rg BT 120.72 215.25 Td (with ) Tj ET Q q 0 0 0 rg BT 140.63 215.25 Td (no ) Tj ET Q q 0 0 0 rg BT 152.77 215.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 189.88 215.25 Td (covenants ) Tj ET Q q 0 0 0 rg BT 232.00 215.25 Td (and ) Tj ET Q q 0 0 0 rg BT 248.57 215.25 Td (were ) Tj ET Q q 0 0 0 rg BT 270.14 215.25 Td (extended ) Tj ET Q q 0 0 0 rg BT 308.36 215.25 Td (to ) Tj ET Q q 0 0 0 rg BT 318.28 215.25 Td (October ) Tj ET Q q 0 0 0 rg BT 352.62 215.25 Td (2020 ) Tj ET Q q 0 0 0 rg BT 374.75 215.25 Td (and ) Tj ET Q q 0 0 0 rg BT 391.32 215.25 Td (July ) Tj ET Q q 0 0 0 rg BT 410.13 215.25 Td (2021. ) Tj ET Q q 0 0 0 rg BT 434.76 215.25 Td (Each ) Tj ET Q q 0 0 0 rg BT 456.88 215.25 Td (facility ) Tj ET Q q 0 0 0 rg BT 487.33 215.25 Td (is ) Tj ET Q q 0 0 0 rg BT 496.14 215.25 Td (extendable ) Tj ET Q q 0 0 0 rg BT 541.58 215.25 Td (annually ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 203.25 Td (by ) Tj ET Q q 0 0 0 rg BT 47.89 203.25 Td (one ) Tj ET Q q 0 0 0 rg BT 64.22 203.25 Td (year ) Tj ET Q q 0 0 0 rg BT 83.31 203.25 Td (on ) Tj ET Q q 0 0 0 rg BT 95.20 203.25 Td (the ) Tj ET Q q 0 0 0 rg BT 109.31 203.25 Td (anniversary ) Tj ET Q q 0 0 0 rg BT 157.85 203.25 Td (date ) Tj ET Q q 0 0 0 rg BT 176.39 203.25 Td (with ) Tj ET Q q 0 0 0 rg BT 196.06 203.25 Td (the ) Tj ET Q q 0 0 0 rg BT 210.17 203.25 Td (consent ) Tj ET Q q 0 0 0 rg BT 242.60 203.25 Td (of ) Tj ET Q q 0 0 0 rg BT 252.82 203.25 Td (the ) Tj ET Q q 0 0 0 rg BT 266.93 203.25 Td (lenders. ) Tj ET Q q 0 0 0 rg BT 300.19 203.25 Td ( ) Tj ET Q q 0 0 0 rg BT 302.08 203.25 Td (No ) Tj ET Q q 0 0 0 rg BT 316.20 203.25 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 363.64 203.25 Td (were ) Tj ET Q q 0 0 0 rg BT 384.96 203.25 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 433.51 203.25 Td (under ) Tj ET Q q 0 0 0 rg BT 458.17 203.25 Td (either ) Tj ET Q q 0 0 0 rg BT 482.82 203.25 Td (revolving ) Tj ET Q q 0 0 0 rg BT 523.04 203.25 Td (credit ) Tj ET Q q 0 0 0 rg BT 547.69 203.25 Td (facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 191.25 Td (at ) Tj ET Q q 0 0 0 rg BT 45.72 191.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 104.30 191.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 124.30 191.25 Td ( ) Tj ET Q q 0 0 0 rg BT 126.80 191.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.63 191.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.63 191.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 167.25 Td (Additional ) Tj ET Q q 0 0 0 rg BT 80.70 167.25 Td (regulations ) Tj ET Q q 0 0 0 rg BT 127.06 167.25 Td (in ) Tj ET Q q 0 0 0 rg BT 136.77 167.25 Td (the ) Tj ET Q q 0 0 0 rg BT 150.92 167.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 170.63 167.25 Td (could ) Tj ET Q q 0 0 0 rg BT 194.77 167.25 Td (be ) Tj ET Q q 0 0 0 rg BT 206.14 167.25 Td (passed ) Tj ET Q q 0 0 0 rg BT 234.73 167.25 Td (in ) Tj ET Q q 0 0 0 rg BT 244.44 167.25 Td (the ) Tj ET Q q 0 0 0 rg BT 258.58 167.25 Td (future, ) Tj ET Q q 0 0 0 rg BT 286.89 167.25 Td (which ) Tj ET Q q 0 0 0 rg BT 313.26 167.25 Td (may ) Tj ET Q q 0 0 0 rg BT 332.40 167.25 Td (reduce ) Tj ET Q q 0 0 0 rg BT 360.98 167.25 Td (our ) Tj ET Q q 0 0 0 rg BT 376.23 167.25 Td (results ) Tj ET Q q 0 0 0 rg BT 404.27 167.25 Td (of ) Tj ET Q q 0 0 0 rg BT 414.53 167.25 Td (operations, ) Tj ET Q q 0 0 0 rg BT 460.61 167.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 500.31 167.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 520.00 167.25 Td (flow) Tj ET Q q 0 0 0 rg BT 537.68 167.25 Td (, ) Tj ET Q q 0 0 0 rg BT 542.11 167.25 Td (liquidity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 155.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.65 155.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 89.85 155.25 Td (flexibility) Tj ET Q q 0 0 0 rg BT 128.64 155.25 Td (. ) Tj ET Q q 0 0 0 rg BT 133.19 155.25 Td (W) Tj ET Q q 0 0 0 rg BT 141.83 155.25 Td (e ) Tj ET Q q 0 0 0 rg BT 148.48 155.25 Td (continue ) Tj ET Q q 0 0 0 rg BT 185.13 155.25 Td (to ) Tj ET Q q 0 0 0 rg BT 195.12 155.25 Td (monitor ) Tj ET Q q 0 0 0 rg BT 229.00 155.25 Td (the ) Tj ET Q q 0 0 0 rg BT 243.43 155.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 280.64 155.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 310.06 155.25 Td (of ) Tj ET Q q 0 0 0 rg BT 320.61 155.25 Td (the ) Tj ET Q q 0 0 0 rg BT 335.04 155.25 Td (economic ) Tj ET Q q 0 0 0 rg BT 376.13 155.25 Td (conditions ) Tj ET Q q 0 0 0 rg BT 420.00 155.25 Td (in ) Tj ET Q q 0 0 0 rg BT 430.00 155.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 459.41 155.25 Td (European ) Tj ET Q q 0 0 0 rg BT 499.94 155.25 Td (and ) Tj ET Q q 0 0 0 rg BT 516.60 155.25 Td (other ) Tj ET Q q 0 0 0 rg BT 539.36 155.25 Td (countries ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 143.25 Td (and ) Tj ET Q q 0 0 0 rg BT 54.07 143.25 Td (the ) Tj ET Q q 0 0 0 rg BT 69.92 143.25 Td (related ) Tj ET Q q 0 0 0 rg BT 100.76 143.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 131.61 143.25 Td (on ) Tj ET Q q 0 0 0 rg BT 145.24 143.25 Td (prescription ) Tj ET Q q 0 0 0 rg BT 196.64 143.25 Td (trends, ) Tj ET Q q 0 0 0 rg BT 227.21 143.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 259.17 143.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 300.58 143.25 Td (and ) Tj ET Q q 0 0 0 rg BT 318.66 143.25 Td (creditworthiness ) Tj ET Q q 0 0 0 rg BT 388.38 143.25 Td (of ) Tj ET Q q 0 0 0 rg BT 400.35 143.25 Td (our ) Tj ET Q q 0 0 0 rg BT 417.31 143.25 Td (customers. ) Tj ET Q q 0 0 0 rg BT 463.73 143.25 Td (W) Tj ET Q q 0 0 0 rg BT 472.37 143.25 Td (e ) Tj ET Q q 0 0 0 rg BT 480.44 143.25 Td (believe ) Tj ET Q q 0 0 0 rg BT 512.95 143.25 Td (these ) Tj ET Q q 0 0 0 rg BT 537.13 143.25 Td (economic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 131.25 Td (conditions ) Tj ET Q q 0 0 0 rg BT 80.17 131.25 Td (will ) Tj ET Q q 0 0 0 rg BT 98.22 131.25 Td (not ) Tj ET Q q 0 0 0 rg BT 113.50 131.25 Td (have ) Tj ET Q q 0 0 0 rg BT 134.88 131.25 Td (a ) Tj ET Q q 0 0 0 rg BT 141.82 131.25 Td (material ) Tj ET Q q 0 0 0 rg BT 177.07 131.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 206.79 131.25 Td (on ) Tj ET Q q 0 0 0 rg BT 219.29 131.25 Td (our ) Tj ET Q q 0 0 0 rg BT 235.12 131.25 Td (liquidity) Tj ET Q q 0 0 0 rg BT 268.36 131.25 Td (, ) Tj ET Q q 0 0 0 rg BT 273.36 131.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 293.63 131.25 Td (flow ) Tj ET Q q 0 0 0 rg BT 314.46 131.25 Td (or ) Tj ET Q q 0 0 0 rg BT 325.29 131.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 362.77 131.25 Td (flexibility) Tj ET Q q 0 0 0 rg BT 401.56 131.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 107.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.25 107.25 Td (UK ) Tj ET Q q 0 0 0 rg BT 71.39 107.25 Td (voted ) Tj ET Q q 0 0 0 rg BT 96.31 107.25 Td (to ) Tj ET Q q 0 0 0 rg BT 106.79 107.25 Td (depart ) Tj ET Q q 0 0 0 rg BT 134.48 107.25 Td (from ) Tj ET Q q 0 0 0 rg BT 156.62 107.25 Td (the ) Tj ET Q q 0 0 0 rg BT 171.54 107.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 187.57 107.25 Td (during ) Tj ET Q q 0 0 0 rg BT 216.38 107.25 Td (June ) Tj ET Q q 0 0 0 rg BT 237.41 107.25 Td (2016. Similar ) Tj ET Q q 0 0 0 rg BT 294.56 107.25 Td (to ) Tj ET Q q 0 0 0 rg BT 305.04 107.25 Td (other ) Tj ET Q q 0 0 0 rg BT 328.28 107.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 373.75 107.25 Td (in ) Tj ET Q q 0 0 0 rg BT 384.23 107.25 Td (our ) Tj ET Q q 0 0 0 rg BT 400.26 107.25 Td (industry) Tj ET Q q 0 0 0 rg BT 432.39 107.25 Td (, ) Tj ET Q q 0 0 0 rg BT 437.59 107.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 467.50 107.25 Td (regulatory) Tj ET Q q 0 0 0 rg BT 507.94 107.25 Td (, ) Tj ET Q q 0 0 0 rg BT 513.14 107.25 Td (trade, ) Tj ET Q q 0 0 0 rg BT 538.33 107.25 Td (labor ) Tj ET Q q 0 0 0 rg BT 561.58 107.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 95.25 Td (other ) Tj ET Q q 0 0 0 rg BT 58.91 95.25 Td (aspects ) Tj ET Q q 0 0 0 rg BT 90.14 95.25 Td (of ) Tj ET Q q 0 0 0 rg BT 100.83 95.25 Td (our ) Tj ET Q q 0 0 0 rg BT 116.52 95.25 Td (business ) Tj ET Q q 0 0 0 rg BT 152.77 95.25 Td (will ) Tj ET Q q 0 0 0 rg BT 170.68 95.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 195.81 95.25 Td (be ) Tj ET Q q 0 0 0 rg BT 207.61 95.25 Td (af) Tj ET Q q 0 0 0 rg BT 215.20 95.25 Td (fected ) Tj ET Q q 0 0 0 rg BT 241.98 95.25 Td (over ) Tj ET Q q 0 0 0 rg BT 262.11 95.25 Td (time. ) Tj ET Q q 0 0 0 rg BT 284.74 95.25 Td (However) Tj ET Q q 0 0 0 rg BT 320.99 95.25 Td (, ) Tj ET Q q 0 0 0 rg BT 325.85 95.25 Td (we ) Tj ET Q q 0 0 0 rg BT 339.87 95.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 378.32 95.25 Td (do ) Tj ET Q q 0 0 0 rg BT 390.68 95.25 Td (not ) Tj ET Q q 0 0 0 rg BT 405.81 95.25 Td (believe ) Tj ET Q q 0 0 0 rg BT 437.04 95.25 Td (that ) Tj ET Q q 0 0 0 rg BT 454.40 95.25 Td (these ) Tj ET Q q 0 0 0 rg BT 477.30 95.25 Td (matters ) Tj ET Q q 0 0 0 rg BT 509.10 95.25 Td (and ) Tj ET Q q 0 0 0 rg BT 525.89 95.25 Td (other ) Tj ET Q q 0 0 0 rg BT 548.80 95.25 Td (related ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 83.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 73.20 83.25 Td (ef) Tj ET Q q 0 0 0 rg BT 80.79 83.25 Td (fects ) Tj ET Q q 0 0 0 rg BT 101.88 83.25 Td (will ) Tj ET Q q 0 0 0 rg BT 119.65 83.25 Td (have ) Tj ET Q q 0 0 0 rg BT 140.75 83.25 Td (a ) Tj ET Q q 0 0 0 rg BT 147.40 83.25 Td (material ) Tj ET Q q 0 0 0 rg BT 182.38 83.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 211.81 83.25 Td (on ) Tj ET Q q 0 0 0 rg BT 224.02 83.25 Td (our ) Tj ET Q q 0 0 0 rg BT 239.57 83.25 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 292.33 83.25 Td (results ) Tj ET Q q 0 0 0 rg BT 320.65 83.25 Td (of ) Tj ET Q q 0 0 0 rg BT 331.20 83.25 Td (operations, ) Tj ET Q q 0 0 0 rg BT 377.57 83.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 414.77 83.25 Td (position ) Tj ET Q q 0 0 0 rg BT 449.21 83.25 Td (or ) Tj ET Q q 0 0 0 rg BT 459.76 83.25 Td (liquidity) Tj ET Q q 0 0 0 rg BT 493.00 83.25 Td (. ) Tj ET Q q 0 0 0 rg BT 497.72 83.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 515.49 83.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 537.14 83.25 Td (in ) Tj ET Q q 0 0 0 rg BT 547.14 83.25 Td (the ) Tj ET Q q 0 0 0 rg BT 561.57 83.25 Td (UK ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 71.25 Td (represent ) Tj ET Q q 0 0 0 rg BT 75.15 71.25 Td (less ) Tj ET Q q 0 0 0 rg BT 92.65 71.25 Td (than ) Tj ET Q q 0 0 0 rg BT 112.36 71.25 Td (2% ) Tj ET Q q 0 0 0 rg BT 128.19 71.25 Td (of ) Tj ET Q q 0 0 0 rg BT 139.02 71.25 Td (total ) Tj ET Q q 0 0 0 rg BT 159.30 71.25 Td (revenues.) Tj ET Q endstream endobj 83 0 obj <> endobj 84 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (41) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Cr) Tj ET Q q 0 0 0 rg BT 46.19 749.10 Td (edit Ratings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 65.19 725.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 106.99 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 123.80 725.10 Td (short-term ) Tj ET Q q 0 0 0 rg BT 167.83 725.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 192.97 725.10 Td (ratings ) Tj ET Q q 0 0 0 rg BT 222.56 725.10 Td (assigned ) Tj ET Q q 0 0 0 rg BT 259.37 725.10 Td (by ) Tj ET Q q 0 0 0 rg BT 271.74 725.10 Td (Moody's ) Tj ET Q q 0 0 0 rg BT 308.70 725.10 Td (Investors ) Tj ET Q q 0 0 0 rg BT 347.73 725.10 Td (Service ) Tj ET Q q 0 0 0 rg BT 380.09 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 394.14 725.10 Td (A2 ) Tj ET Q q 0 0 0 rg BT 408.73 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 425.55 725.10 Td (Prime-1, ) Tj ET Q q 0 0 0 rg BT 462.63 725.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 510.30 725.10 Td (, ) Tj ET Q q 0 0 0 rg BT 515.17 725.10 Td (with ) Tj ET Q q 0 0 0 rg BT 535.32 725.10 Td (a ) Tj ET Q q 0 0 0 rg BT 542.13 725.10 Td (negative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 78.09 713.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 103.52 713.10 Td (outlook. ) Tj ET Q q 0 0 0 rg BT 139.24 713.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 168.71 713.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 210.81 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 227.91 713.10 Td (short-term ) Tj ET Q q 0 0 0 rg BT 272.23 713.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 297.65 713.10 Td (ratings ) Tj ET Q q 0 0 0 rg BT 327.53 713.10 Td (assigned ) Tj ET Q q 0 0 0 rg BT 364.63 713.10 Td (by ) Tj ET Q q 0 0 0 rg BT 377.29 713.10 Td (Standard ) Tj ET Q q 0 0 0 rg BT 415.50 713.10 Td (& ) Tj ET Q q 0 0 0 rg BT 425.94 713.10 Td (Poor's ) Tj ET Q q 0 0 0 rg BT 453.18 713.10 Td (are ) Tj ET Q q 0 0 0 rg BT 467.46 713.10 Td (A+ ) Tj ET Q q 0 0 0 rg BT 482.99 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 499.50 713.10 Td (A-1+, ) Tj ET Q q 0 0 0 rg BT 525.85 713.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 573.51 713.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (with ) Tj ET Q q 0 0 0 rg BT 55.99 701.10 Td (a ) Tj ET Q q 0 0 0 rg BT 62.64 701.10 Td (stable ) Tj ET Q q 0 0 0 rg BT 88.17 701.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 129.81 701.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 154.79 701.10 Td (outlook. ) Tj ET Q q 0 0 0 rg BT 190.05 701.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 219.08 701.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 260.72 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 277.37 701.10 Td (short-term ) Tj ET Q q 0 0 0 rg BT 321.23 701.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 346.21 701.10 Td (ratings ) Tj ET Q q 0 0 0 rg BT 375.63 701.10 Td (assigned ) Tj ET Q q 0 0 0 rg BT 412.28 701.10 Td (by ) Tj ET Q q 0 0 0 rg BT 424.49 701.10 Td (Fitch ) Tj ET Q q 0 0 0 rg BT 447.26 701.10 Td (are ) Tj ET Q q 0 0 0 rg BT 461.19 701.10 Td (A- ) Tj ET Q q 0 0 0 rg BT 473.95 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 490.60 701.10 Td (F2, ) Tj ET Q q 0 0 0 rg BT 505.87 701.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 553.53 701.10 Td (, ) Tj ET Q q 0 0 0 rg BT 558.24 701.10 Td (with ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 43.15 689.10 Td (stable ) Tj ET Q q 0 0 0 rg BT 69.19 689.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 111.34 689.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 136.82 689.10 Td (outlook. ) Tj ET Q q 0 0 0 rg BT 172.59 689.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 190.85 689.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 233.00 689.10 Td (ratings ) Tj ET Q q 0 0 0 rg BT 262.93 689.10 Td (reflect ) Tj ET Q q 0 0 0 rg BT 291.18 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 306.11 689.10 Td (agencies' ) Tj ET Q q 0 0 0 rg BT 345.05 689.10 Td (opinion ) Tj ET Q q 0 0 0 rg BT 378.32 689.10 Td (that ) Tj ET Q q 0 0 0 rg BT 396.03 689.10 Td (we ) Tj ET Q q 0 0 0 rg BT 410.40 689.10 Td (have ) Tj ET Q q 0 0 0 rg BT 431.99 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 439.14 689.10 Td (low ) Tj ET Q q 0 0 0 rg BT 456.86 689.10 Td (default ) Tj ET Q q 0 0 0 rg BT 487.33 689.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 505.05 689.10 Td (but ) Tj ET Q q 0 0 0 rg BT 520.54 689.10 Td (are ) Tj ET Q q 0 0 0 rg BT 535.46 689.10 Td (somewhat ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (susceptible ) Tj ET Q q 0 0 0 rg BT 82.75 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 92.85 677.10 Td (adverse ) Tj ET Q q 0 0 0 rg BT 125.70 677.10 Td (ef) Tj ET Q q 0 0 0 rg BT 133.29 677.10 Td (fects ) Tj ET Q q 0 0 0 rg BT 154.49 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 165.14 677.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 199.66 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 209.76 677.10 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 268.72 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 285.47 677.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 326.66 677.10 Td (conditions. ) Tj ET Q q 0 0 0 rg BT 373.15 677.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 391.02 677.10 Td (short-term ) Tj ET Q q 0 0 0 rg BT 434.99 677.10 Td (ratings ) Tj ET Q q 0 0 0 rg BT 464.53 677.10 Td (reflect ) Tj ET Q q 0 0 0 rg BT 492.38 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 506.91 677.10 Td (agencies' ) Tj ET Q q 0 0 0 rg BT 545.46 677.10 Td (opinion ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (that ) Tj ET Q q 0 0 0 rg BT 53.86 665.10 Td (we ) Tj ET Q q 0 0 0 rg BT 68.39 665.10 Td (have ) Tj ET Q q 0 0 0 rg BT 90.13 665.10 Td (good ) Tj ET Q q 0 0 0 rg BT 113.00 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 123.64 665.10 Td (extremely ) Tj ET Q q 0 0 0 rg BT 166.49 665.10 Td (strong ) Tj ET Q q 0 0 0 rg BT 194.35 665.10 Td (capacity ) Tj ET Q q 0 0 0 rg BT 230.53 665.10 Td (for ) Tj ET Q q 0 0 0 rg BT 245.06 665.10 Td (timely ) Tj ET Q q 0 0 0 rg BT 273.48 665.10 Td (repayment. ) Tj ET Q q 0 0 0 rg BT 320.41 665.10 Td (Any ) Tj ET Q q 0 0 0 rg BT 340.50 665.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 366.13 665.10 Td (rating ) Tj ET Q q 0 0 0 rg BT 392.32 665.10 Td (downgrade ) Tj ET Q q 0 0 0 rg BT 439.62 665.10 Td (may ) Tj ET Q q 0 0 0 rg BT 459.70 665.10 Td (af) Tj ET Q q 0 0 0 rg BT 467.29 665.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 485.14 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 500.22 665.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 532.52 665.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 550.37 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 561.57 665.10 Td (any ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 55.72 653.10 Td (we ) Tj ET Q q 0 0 0 rg BT 69.88 653.10 Td (may ) Tj ET Q q 0 0 0 rg BT 89.59 653.10 Td (incur) Tj ET Q q 0 0 0 rg BT 109.74 653.10 Td (, ) Tj ET Q q 0 0 0 rg BT 114.74 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 129.46 653.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 145.83 653.10 Td (market ) Tj ET Q q 0 0 0 rg BT 176.10 653.10 Td (value ) Tj ET Q q 0 0 0 rg BT 200.25 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 211.08 653.10 Td (existing ) Tj ET Q q 0 0 0 rg BT 245.25 653.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 264.96 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 281.90 653.10 Td (our ) Tj ET Q q 0 0 0 rg BT 297.73 653.10 Td (ability ) Tj ET Q q 0 0 0 rg BT 325.79 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 336.06 653.10 Td (access ) Tj ET Q q 0 0 0 rg BT 364.10 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 378.82 653.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 407.97 653.10 Td (markets ) Tj ET Q q 0 0 0 rg BT 442.12 653.10 Td (generally) Tj ET Q q 0 0 0 rg BT 478.68 653.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (Cash Flows) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 612.10 Td (The following is a discussion of cash flow activities:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 589.60 320.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 589.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 589.60 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 589.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 589.60 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 589.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 589.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 561.60 320.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 561.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 561.60 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 561.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 561.60 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 561.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 561.60 70.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 589.6 m 429.5 589.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 589.6 m 502.5 589.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 589.6 m 576.5 589.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 593.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 593.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 593.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.00 593.68 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 580.17 Td (Cash flow provided by/\(used in\):) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 566.17 Td (Operating activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 566.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 566.17 Td (2,850) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 566.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.15 566.17 Td (1,832) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 566.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 566.17 Td (3,148) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 552.17 Td (Investing activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 552.17 Td (1,480) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.80 552.22 Td (\(1,572) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 552.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 552.17 Td (1,216) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 538.17 Td (Financing activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.80 538.22 Td (\(2,445) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 538.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.80 538.22 Td (\(3,351) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 538.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 538.17 Td (\(2,437) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 538.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 508.7669921875 m 116.634765625 508.7669921875 l s q 0 0 0 rg BT 36.00 510.10 Td (Operating ) Tj ET Q q 0 0 0 rg BT 79.43 510.10 Td (Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 492.10 Td (Cash ) Tj ET Q q 0 0 0 rg BT 59.11 492.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 80.55 492.10 Td (from ) Tj ET Q q 0 0 0 rg BT 103.09 492.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 143.96 492.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 183.17 492.10 Td (represents ) Tj ET Q q 0 0 0 rg BT 226.82 492.10 Td (the ) Tj ET Q q 0 0 0 rg BT 242.14 492.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 263.02 492.10 Td (receipts ) Tj ET Q q 0 0 0 rg BT 297.22 492.10 Td (and ) Tj ET Q q 0 0 0 rg BT 314.76 492.10 Td (disbursements ) Tj ET Q q 0 0 0 rg BT 375.09 492.10 Td (from ) Tj ET Q q 0 0 0 rg BT 397.64 492.10 Td (all ) Tj ET Q q 0 0 0 rg BT 410.74 492.10 Td (of ) Tj ET Q q 0 0 0 rg BT 422.18 492.10 Td (our ) Tj ET Q q 0 0 0 rg BT 438.61 492.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 477.82 492.10 Td (other ) Tj ET Q q 0 0 0 rg BT 501.48 492.10 Td (than ) Tj ET Q q 0 0 0 rg BT 521.80 492.10 Td (investing ) Tj ET Q q 0 0 0 rg BT 561.57 492.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 480.10 Td (financing ) Tj ET Q q 0 0 0 rg BT 75.91 480.10 Td (activities. ) Tj ET Q q 0 0 0 rg BT 116.66 480.10 Td (Operating ) Tj ET Q q 0 0 0 rg BT 158.79 480.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 178.71 480.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 199.19 480.10 Td (is ) Tj ET Q q 0 0 0 rg BT 208.01 480.10 Td (derived ) Tj ET Q q 0 0 0 rg BT 240.14 480.10 Td (by ) Tj ET Q q 0 0 0 rg BT 252.29 480.10 Td (adjusting ) Tj ET Q q 0 0 0 rg BT 291.10 480.10 Td (net ) Tj ET Q q 0 0 0 rg BT 305.47 480.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 341.49 480.10 Td (for ) Tj ET Q q 0 0 0 rg BT 355.30 480.10 Td (noncontrolling ) Tj ET Q q 0 0 0 rg BT 416.33 480.10 Td (interest, ) Tj ET Q q 0 0 0 rg BT 450.41 480.10 Td (non-cash ) Tj ET Q q 0 0 0 rg BT 488.66 480.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 528.57 480.10 Td (items, ) Tj ET Q q 0 0 0 rg BT 554.89 480.10 Td (gains ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 468.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.59 468.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 78.63 468.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 119.09 468.10 Td (to ) Tj ET Q q 0 0 0 rg BT 129.02 468.10 Td (investing ) Tj ET Q q 0 0 0 rg BT 167.83 468.10 Td (and ) Tj ET Q q 0 0 0 rg BT 184.42 468.10 Td (financing ) Tj ET Q q 0 0 0 rg BT 224.33 468.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 262.57 468.10 Td (and ) Tj ET Q q 0 0 0 rg BT 279.16 468.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 313.51 468.10 Td (in ) Tj ET Q q 0 0 0 rg BT 323.44 468.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 363.35 468.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 388.83 468.10 Td (and ) Tj ET Q q 0 0 0 rg BT 405.42 468.10 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 444.78 468.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 481.92 468.10 Td (from ) Tj ET Q q 0 0 0 rg BT 503.51 468.10 Td (timing ) Tj ET Q q 0 0 0 rg BT 531.77 468.10 Td (dif) Tj ET Q q 0 0 0 rg BT 542.70 468.10 Td (ferences ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 456.10 Td (between ) Tj ET Q q 0 0 0 rg BT 71.72 456.10 Td (the ) Tj ET Q q 0 0 0 rg BT 86.34 456.10 Td (receipts ) Tj ET Q q 0 0 0 rg BT 119.84 456.10 Td (and ) Tj ET Q q 0 0 0 rg BT 136.69 456.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 177.42 456.10 Td (of ) Tj ET Q q 0 0 0 rg BT 188.16 456.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 208.33 456.10 Td (and ) Tj ET Q q 0 0 0 rg BT 225.18 456.10 Td (when ) Tj ET Q q 0 0 0 rg BT 249.24 456.10 Td (the ) Tj ET Q q 0 0 0 rg BT 263.87 456.10 Td (transactions ) Tj ET Q q 0 0 0 rg BT 314.04 456.10 Td (are ) Tj ET Q q 0 0 0 rg BT 328.65 456.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 374.92 456.10 Td (in ) Tj ET Q q 0 0 0 rg BT 385.10 456.10 Td (our ) Tj ET Q q 0 0 0 rg BT 400.84 456.10 Td (results ) Tj ET Q q 0 0 0 rg BT 429.35 456.10 Td (of ) Tj ET Q q 0 0 0 rg BT 440.09 456.10 Td (operations. ) Tj ET Q q 0 0 0 rg BT 486.12 456.10 Td (As ) Tj ET Q q 0 0 0 rg BT 499.64 456.10 Td (a ) Tj ET Q q 0 0 0 rg BT 506.48 456.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 533.61 456.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 568.22 456.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 444.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 55.96 444.10 Td (from ) Tj ET Q q 0 0 0 rg BT 77.58 444.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 117.53 444.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 155.82 444.10 Td (reflect ) Tj ET Q q 0 0 0 rg BT 183.53 444.10 Td (the ) Tj ET Q q 0 0 0 rg BT 197.94 444.10 Td (timing ) Tj ET Q q 0 0 0 rg BT 226.24 444.10 Td (of ) Tj ET Q q 0 0 0 rg BT 236.75 444.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 256.71 444.10 Td (collections ) Tj ET Q q 0 0 0 rg BT 302.22 444.10 Td (from ) Tj ET Q q 0 0 0 rg BT 323.84 444.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 366.57 444.10 Td (and ) Tj ET Q q 0 0 0 rg BT 383.20 444.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 416.47 444.10 Td (partners; ) Tj ET Q q 0 0 0 rg BT 453.65 444.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 494.16 444.10 Td (to ) Tj ET Q q 0 0 0 rg BT 504.12 444.10 Td (suppliers, ) Tj ET Q q 0 0 0 rg BT 544.92 444.10 Td (alliance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 432.10 Td (partners ) Tj ET Q q 0 0 0 rg BT 71.61 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 89.45 432.10 Td (employees; ) Tj ET Q q 0 0 0 rg BT 138.40 432.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 178.46 432.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 219.64 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 237.48 432.10 Td (rebates; ) Tj ET Q q 0 0 0 rg BT 271.98 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 289.82 432.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 305.44 432.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 347.17 432.10 Td (in ) Tj ET Q q 0 0 0 rg BT 358.35 432.10 Td (the ) Tj ET Q q 0 0 0 rg BT 373.97 432.10 Td (ordinary ) Tj ET Q q 0 0 0 rg BT 411.25 432.10 Td (course ) Tj ET Q q 0 0 0 rg BT 440.75 432.10 Td (of ) Tj ET Q q 0 0 0 rg BT 452.48 432.10 Td (business. ) Tj ET Q q 0 0 0 rg BT 492.28 432.10 Td (For ) Tj ET Q q 0 0 0 rg BT 509.57 432.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 549.35 432.10 Td (annual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 420.10 Td (employee ) Tj ET Q q 0 0 0 rg BT 77.39 420.10 Td (bonuses ) Tj ET Q q 0 0 0 rg BT 112.14 420.10 Td (are ) Tj ET Q q 0 0 0 rg BT 126.86 420.10 Td (typically ) Tj ET Q q 0 0 0 rg BT 164.38 420.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 184.11 420.10 Td (in ) Tj ET Q q 0 0 0 rg BT 194.41 420.10 Td (the ) Tj ET Q q 0 0 0 rg BT 209.15 420.10 Td (first ) Tj ET Q q 0 0 0 rg BT 227.78 420.10 Td (quarter ) Tj ET Q q 0 0 0 rg BT 258.62 420.10 Td (of ) Tj ET Q q 0 0 0 rg BT 269.47 420.10 Td (the ) Tj ET Q q 0 0 0 rg BT 284.20 420.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 331.16 420.10 Td (year) Tj ET Q q 0 0 0 rg BT 347.82 420.10 Td (. ) Tj ET Q q 0 0 0 rg BT 352.84 420.10 Td (In ) Tj ET Q q 0 0 0 rg BT 363.69 420.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 401.49 420.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 421.78 420.10 Td (collections ) Tj ET Q q 0 0 0 rg BT 467.62 420.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 504.57 420.10 Td (to ) Tj ET Q q 0 0 0 rg BT 514.87 420.10 Td (be ) Tj ET Q q 0 0 0 rg BT 526.83 420.10 Td (impacted ) Tj ET Q q 0 0 0 rg BT 566.00 420.10 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 408.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 64.54 408.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 101.96 408.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 127.17 408.10 Td (for ) Tj ET Q q 0 0 0 rg BT 141.82 408.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 172.01 408.10 Td (biologic ) Tj ET Q q 0 0 0 rg BT 207.78 408.10 Td (products ) Tj ET Q q 0 0 0 rg BT 245.21 408.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.98 408.10 Td (the ) Tj ET Q q 0 0 0 rg BT 271.18 408.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 294.46 408.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 334.66 408.10 Td (our ) Tj ET Q q 0 0 0 rg BT 350.98 408.10 Td (newer ) Tj ET Q q 0 0 0 rg BT 378.40 408.10 Td (oncology ) Tj ET Q q 0 0 0 rg BT 418.61 408.10 Td (products ) Tj ET Q q 0 0 0 rg BT 456.04 408.10 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 496.80 408.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.24 408.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 531.73 408.10 Td (Y) Tj ET Q q 0 0 0 rg BT 536.37 408.10 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.58 408.10 Td ( ) Tj ET Q q 0 0 0 rg BT 561.57 408.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 396.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.66 396.10 Td ( ) Tj ET Q q 0 0 0 rg BT 74.99 396.10 Td (\(120 ) Tj ET Q q 0 0 0 rg BT 95.65 396.10 Td (days ) Tj ET Q q 0 0 0 rg BT 116.31 396.10 Td (to ) Tj ET Q q 0 0 0 rg BT 126.42 396.10 Td (150 ) Tj ET Q q 0 0 0 rg BT 143.75 396.10 Td (days\). ) Tj ET Q q 0 0 0 rg BT 170.07 396.10 Td (The ) Tj ET Q q 0 0 0 rg BT 187.95 396.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 215.83 396.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 252.59 396.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 277.14 396.10 Td (are ) Tj ET Q q 0 0 0 rg BT 291.68 396.10 Td (used ) Tj ET Q q 0 0 0 rg BT 312.34 396.10 Td (to ) Tj ET Q q 0 0 0 rg BT 322.45 396.10 Td (more ) Tj ET Q q 0 0 0 rg BT 345.32 396.10 Td (closely ) Tj ET Q q 0 0 0 rg BT 375.98 396.10 Td (align ) Tj ET Q q 0 0 0 rg BT 398.31 396.10 Td (with ) Tj ET Q q 0 0 0 rg BT 418.42 396.10 Td (the ) Tj ET Q q 0 0 0 rg BT 432.96 396.10 Td (insurance ) Tj ET Q q 0 0 0 rg BT 473.61 396.10 Td (reimbursement ) Tj ET Q q 0 0 0 rg BT 535.92 396.10 Td (timing ) Tj ET Q q 0 0 0 rg BT 564.36 396.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 384.10 Td (physicians ) Tj ET Q q 0 0 0 rg BT 80.72 384.10 Td (and ) Tj ET Q q 0 0 0 rg BT 97.66 384.10 Td (cancer ) Tj ET Q q 0 0 0 rg BT 126.24 384.10 Td (centers ) Tj ET Q q 0 0 0 rg BT 157.05 384.10 Td (following ) Tj ET Q q 0 0 0 rg BT 198.44 384.10 Td (administration ) Tj ET Q q 0 0 0 rg BT 258.71 384.10 Td (to ) Tj ET Q q 0 0 0 rg BT 268.99 384.10 Td (the ) Tj ET Q q 0 0 0 rg BT 283.71 384.10 Td (patients.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 366.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 366.10 Td ($1.0 ) Tj ET Q q 0 0 0 rg BT 74.05 366.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.16 366.10 Td ( ) Tj ET Q q 0 0 0 rg BT 102.66 366.10 Td (increase ) Tj ET Q q 0 0 0 rg BT 137.91 366.10 Td (in ) Tj ET Q q 0 0 0 rg BT 148.19 366.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 168.46 366.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 206.51 366.10 Td (by ) Tj ET Q q 0 0 0 rg BT 219.01 366.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 259.27 366.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 297.87 366.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.15 366.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 328.15 366.10 Td ( ) Tj ET Q q 0 0 0 rg BT 330.65 366.10 Td (was ) Tj ET Q q 0 0 0 rg BT 348.70 366.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 388.41 366.10 Td (attributable ) Tj ET Q q 0 0 0 rg BT 436.45 366.10 Td (to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 354.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 354.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.83 354.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 138.15 354.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 158.48 354.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 179.38 354.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 220.26 354.10 Td (to ) Tj ET Q q 0 0 0 rg BT 230.60 354.10 Td (increased ) Tj ET Q q 0 0 0 rg BT 270.91 354.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 292.91 354.10 Td (and ) Tj ET Q q 0 0 0 rg BT 309.91 354.10 Td (the ) Tj ET Q q 0 0 0 rg BT 324.69 354.10 Td (timing ) Tj ET Q q 0 0 0 rg BT 353.36 354.10 Td (of ) Tj ET Q q 0 0 0 rg BT 364.25 354.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 384.58 354.10 Td (collections ) Tj ET Q q 0 0 0 rg BT 430.46 354.10 Td (and ) Tj ET Q q 0 0 0 rg BT 447.46 354.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 488.35 354.10 Td (in ) Tj ET Q q 0 0 0 rg BT 498.69 354.10 Td (the ) Tj ET Q q 0 0 0 rg BT 513.47 354.10 Td (ordinary ) Tj ET Q q 0 0 0 rg BT 549.90 354.10 Td (course ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 342.10 Td (of ) Tj ET Q q 0 0 0 rg BT 78.33 342.10 Td (business ) Tj ET Q q 0 0 0 rg BT 114.72 342.10 Td (including ) Tj ET Q q 0 0 0 rg BT 155.00 342.10 Td (the ) Tj ET Q q 0 0 0 rg BT 169.71 342.10 Td (wind-down ) Tj ET Q q 0 0 0 rg BT 217.76 342.10 Td (of ) Tj ET Q q 0 0 0 rg BT 228.59 342.10 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 243.31 342.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.97 342.10 Td ( ) Tj ET Q q 0 0 0 rg BT 277.47 342.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 311.06 342.10 Td (in ) Tj ET Q q 0 0 0 rg BT 321.34 342.10 Td (2015; ) Tj ET Q q 0 0 0 rg BT 346.62 342.10 Td (and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 330.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 330.10 Td (Lower ) Tj ET Q q 0 0 0 rg BT 96.10 330.10 Td (upfront ) Tj ET Q q 0 0 0 rg BT 128.04 330.10 Td (and ) Tj ET Q q 0 0 0 rg BT 144.98 330.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 186.36 330.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 227.18 330.10 Td (for ) Tj ET Q q 0 0 0 rg BT 241.34 330.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 274.93 330.10 Td (and ) Tj ET Q q 0 0 0 rg BT 291.87 330.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 330.47 330.10 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 386.84 330.10 Td (\(approximately ) Tj ET Q q 0 0 0 rg BT 450.42 330.10 Td ($600 ) Tj ET Q q 0 0 0 rg BT 472.92 330.10 Td (million\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 318.10 Td (Partially ) Tj ET Q q 0 0 0 rg BT 90.38 318.10 Td (of) Tj ET Q q 0 0 0 rg BT 98.53 318.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 115.47 318.10 Td (by:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 306.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 306.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.77 306.10 Td (income ) Tj ET Q q 0 0 0 rg BT 129.70 306.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 144.42 306.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 185.24 306.10 Td (of ) Tj ET Q q 0 0 0 rg BT 196.07 306.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 256.33 306.10 Td ($1.4 ) Tj ET Q q 0 0 0 rg BT 276.33 306.10 Td (billion.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 284.50 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 284.50 Td ($1.3 ) Tj ET Q q 0 0 0 rg BT 74.05 284.50 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.16 284.50 Td ( ) Tj ET Q q 0 0 0 rg BT 102.66 284.50 Td (decrease ) Tj ET Q q 0 0 0 rg BT 139.57 284.50 Td (in ) Tj ET Q q 0 0 0 rg BT 149.85 284.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 170.12 284.50 Td (provided ) Tj ET Q q 0 0 0 rg BT 208.17 284.50 Td (by ) Tj ET Q q 0 0 0 rg BT 220.67 284.50 Td (operating ) Tj ET Q q 0 0 0 rg BT 260.93 284.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 299.53 284.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.81 284.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.81 284.50 Td ( ) Tj ET Q q 0 0 0 rg BT 332.31 284.50 Td (was ) Tj ET Q q 0 0 0 rg BT 350.36 284.50 Td (primarily ) Tj ET Q q 0 0 0 rg BT 390.07 284.50 Td (attributable ) Tj ET Q q 0 0 0 rg BT 438.11 284.50 Td (to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 272.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 272.50 Td (T) Tj ET Q q 0 0 0 rg BT 73.26 272.50 Td (iming of payments with alliance partners \(approximately $700 million\), particularly active product ingredient supply and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 260.50 Td (Medicaid rebates for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 152.74 260.50 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 184.40 260.50 Td (;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 248.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 248.50 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.77 248.50 Td (upfront ) Tj ET Q q 0 0 0 rg BT 129.71 248.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 170.53 248.50 Td (for ) Tj ET Q q 0 0 0 rg BT 184.69 248.50 Td (new ) Tj ET Q q 0 0 0 rg BT 203.85 248.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 237.44 248.50 Td (and ) Tj ET Q q 0 0 0 rg BT 254.38 248.50 Td (licensing ) Tj ET Q q 0 0 0 rg BT 292.98 248.50 Td (agreements ) Tj ET Q q 0 0 0 rg BT 341.02 248.50 Td (\(approximately ) Tj ET Q q 0 0 0 rg BT 404.60 248.50 Td ($600 ) Tj ET Q q 0 0 0 rg BT 427.10 248.50 Td (million\); ) Tj ET Q q 0 0 0 rg BT 464.60 248.50 Td (and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 236.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 236.50 Td (T) Tj ET Q q 0 0 0 rg BT 73.26 236.50 Td (iming ) Tj ET Q q 0 0 0 rg BT 99.24 236.50 Td (of ) Tj ET Q q 0 0 0 rg BT 110.21 236.50 Td (customer ) Tj ET Q q 0 0 0 rg BT 149.51 236.50 Td (collections ) Tj ET Q q 0 0 0 rg BT 195.47 236.50 Td (resulting ) Tj ET Q q 0 0 0 rg BT 233.11 236.50 Td (primarily ) Tj ET Q q 0 0 0 rg BT 272.97 236.50 Td (from ) Tj ET Q q 0 0 0 rg BT 295.05 236.50 Td (higher ) Tj ET Q q 0 0 0 rg BT 323.24 236.50 Td (net ) Tj ET Q q 0 0 0 rg BT 338.10 236.50 Td (product ) Tj ET Q q 0 0 0 rg BT 371.29 236.50 Td (sales ) Tj ET Q q 0 0 0 rg BT 393.38 236.50 Td (including ) Tj ET Q q 0 0 0 rg BT 433.79 236.50 Td (those ) Tj ET Q q 0 0 0 rg BT 457.55 236.50 Td (with ) Tj ET Q q 0 0 0 rg BT 477.97 236.50 Td (extended ) Tj ET Q q 0 0 0 rg BT 516.71 236.50 Td (payment ) Tj ET Q q 0 0 0 rg BT 553.78 236.50 Td (terms ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 224.50 Td (for ) Tj ET Q q 0 0 0 rg BT 81.66 224.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 111.36 224.50 Td (new ) Tj ET Q q 0 0 0 rg BT 130.52 224.50 Td (products ) Tj ET Q q 0 0 0 rg BT 167.46 224.50 Td (and ) Tj ET Q q 0 0 0 rg BT 184.40 224.50 Td (less ) Tj ET Q q 0 0 0 rg BT 201.90 224.50 Td (factoring ) Tj ET Q q 0 0 0 rg BT 240.49 224.50 Td (\(approximately ) Tj ET Q q 0 0 0 rg BT 304.08 224.50 Td ($400 ) Tj ET Q q 0 0 0 rg BT 326.58 224.50 Td (million\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 212.50 Td (Partially ) Tj ET Q q 0 0 0 rg BT 90.38 212.50 Td (of) Tj ET Q q 0 0 0 rg BT 98.53 212.50 Td (fset ) Tj ET Q q 0 0 0 rg BT 115.47 212.50 Td (by:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 200.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 200.50 Td (The ) Tj ET Q q 0 0 0 rg BT 85.80 200.50 Td (timing ) Tj ET Q q 0 0 0 rg BT 114.66 200.50 Td (of ) Tj ET Q q 0 0 0 rg BT 125.74 200.50 Td (other ) Tj ET Q q 0 0 0 rg BT 149.03 200.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 169.55 200.50 Td (collections ) Tj ET Q q 0 0 0 rg BT 215.62 200.50 Td (and ) Tj ET Q q 0 0 0 rg BT 232.81 200.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 273.88 200.50 Td (in ) Tj ET Q q 0 0 0 rg BT 284.41 200.50 Td (the ) Tj ET Q q 0 0 0 rg BT 299.38 200.50 Td (ordinary ) Tj ET Q q 0 0 0 rg BT 336.00 200.50 Td (course ) Tj ET Q q 0 0 0 rg BT 364.85 200.50 Td (of ) Tj ET Q q 0 0 0 rg BT 375.93 200.50 Td (business ) Tj ET Q q 0 0 0 rg BT 412.57 200.50 Td (including ) Tj ET Q q 0 0 0 rg BT 453.09 200.50 Td (among ) Tj ET Q q 0 0 0 rg BT 483.06 200.50 Td (other ) Tj ET Q q 0 0 0 rg BT 506.35 200.50 Td (items, ) Tj ET Q q 0 0 0 rg BT 533.27 200.50 Td (changes ) Tj ET Q q 0 0 0 rg BT 568.22 200.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 188.50 Td (inventory ) Tj ET Q q 0 0 0 rg BT 108.33 188.50 Td (levels, ) Tj ET Q q 0 0 0 rg BT 136.65 188.50 Td (particularly ) Tj ET Q q 0 0 0 rg BT 185.24 188.50 Td (those ) Tj ET Q q 0 0 0 rg BT 208.85 188.50 Td (related ) Tj ET Q q 0 0 0 rg BT 238.55 188.50 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 248.83 188.50 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 280.49 188.50 Td (.) Tj ET Q endstream endobj 85 0 obj <> endobj 86 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (42) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 112.181640625 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Investing ) Tj ET Q q 0 0 0 rg BT 74.97 749.10 Td (Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 731.10 Td (Cash ) Tj ET Q q 0 0 0 rg BT 58.77 731.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 113.74 731.10 Td (from ) Tj ET Q q 0 0 0 rg BT 135.95 731.10 Td (investing ) Tj ET Q q 0 0 0 rg BT 175.39 731.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 214.26 731.10 Td (include ) Tj ET Q q 0 0 0 rg BT 246.46 731.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 267.00 731.10 Td (used ) Tj ET Q q 0 0 0 rg BT 288.10 731.10 Td (for ) Tj ET Q q 0 0 0 rg BT 302.54 731.10 Td (acquisitions, ) Tj ET Q q 0 0 0 rg BT 355.58 731.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 416.66 731.10 Td (and ) Tj ET Q q 0 0 0 rg BT 433.87 731.10 Td (facility-related ) Tj ET Q q 0 0 0 rg BT 495.49 731.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 524.92 731.10 Td (expenditures ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 719.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.19 719.10 Td (purchases ) Tj ET Q q 0 0 0 rg BT 95.38 719.10 Td (of ) Tj ET Q q 0 0 0 rg BT 106.46 719.10 Td (marketable ) Tj ET Q q 0 0 0 rg BT 153.64 719.10 Td (securities ) Tj ET Q q 0 0 0 rg BT 194.16 719.10 Td (with ) Tj ET Q q 0 0 0 rg BT 214.69 719.10 Td (maturities ) Tj ET Q q 0 0 0 rg BT 257.44 719.10 Td (greater ) Tj ET Q q 0 0 0 rg BT 287.95 719.10 Td (than ) Tj ET Q q 0 0 0 rg BT 307.92 719.10 Td (90 ) Tj ET Q q 0 0 0 rg BT 320.67 719.10 Td (days ) Tj ET Q q 0 0 0 rg BT 341.76 719.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 376.16 719.10 Td (by ) Tj ET Q q 0 0 0 rg BT 388.91 719.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 427.21 719.10 Td (from ) Tj ET Q q 0 0 0 rg BT 449.40 719.10 Td (business ) Tj ET Q q 0 0 0 rg BT 486.05 719.10 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 534.91 719.10 Td (\(including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 707.10 Td (royalties\) ) Tj ET Q q 0 0 0 rg BT 76.26 707.10 Td (and ) Tj ET Q q 0 0 0 rg BT 93.20 707.10 Td (the ) Tj ET Q q 0 0 0 rg BT 107.92 707.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 125.97 707.10 Td (and ) Tj ET Q q 0 0 0 rg BT 142.90 707.10 Td (maturity ) Tj ET Q q 0 0 0 rg BT 179.29 707.10 Td (of ) Tj ET Q q 0 0 0 rg BT 190.12 707.10 Td (marketable ) Tj ET Q q 0 0 0 rg BT 237.04 707.10 Td (securities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 683.10 Td ($3.1 ) Tj ET Q q 0 0 0 rg BT 74.05 683.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.16 683.10 Td ( ) Tj ET Q q 0 0 0 rg BT 102.66 683.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 139.57 683.10 Td (in ) Tj ET Q q 0 0 0 rg BT 149.85 683.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 170.12 683.10 Td (used ) Tj ET Q q 0 0 0 rg BT 190.95 683.10 Td (in ) Tj ET Q q 0 0 0 rg BT 201.23 683.10 Td (investing ) Tj ET Q q 0 0 0 rg BT 240.39 683.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 278.99 683.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 289.27 683.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.27 683.10 Td ( ) Tj ET Q q 0 0 0 rg BT 311.77 683.10 Td (was ) Tj ET Q q 0 0 0 rg BT 329.82 683.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 369.54 683.10 Td (attributable ) Tj ET Q q 0 0 0 rg BT 417.57 683.10 Td (to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 671.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 671.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.33 671.10 Td (net ) Tj ET Q q 0 0 0 rg BT 111.61 671.10 Td (redemptions ) Tj ET Q q 0 0 0 rg BT 163.10 671.10 Td (of ) Tj ET Q q 0 0 0 rg BT 173.50 671.10 Td (marketable ) Tj ET Q q 0 0 0 rg BT 219.98 671.10 Td (securities ) Tj ET Q q 0 0 0 rg BT 259.80 671.10 Td (of ) Tj ET Q q 0 0 0 rg BT 270.20 671.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 330.02 671.10 Td ($2.1 ) Tj ET Q q 0 0 0 rg BT 349.58 671.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 377.75 671.10 Td (in ) Tj ET Q q 0 0 0 rg BT 387.59 671.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 409.66 671.10 Td (which ) Tj ET Q q 0 0 0 rg BT 436.16 671.10 Td (were ) Tj ET Q q 0 0 0 rg BT 457.65 671.10 Td (reinvested ) Tj ET Q q 0 0 0 rg BT 500.80 671.10 Td (in ) Tj ET Q q 0 0 0 rg BT 510.64 671.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 530.47 671.10 Td (equivalents ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 659.10 Td (to ) Tj ET Q q 0 0 0 rg BT 77.78 659.10 Td (manage ) Tj ET Q q 0 0 0 rg BT 111.37 659.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 136.64 659.10 Td (and ) Tj ET Q q 0 0 0 rg BT 153.57 659.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 185.51 659.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 202.99 659.10 Td (risks;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 647.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 647.10 Td (Lower ) Tj ET Q q 0 0 0 rg BT 95.60 647.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 117.05 647.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 162.94 647.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 203.27 647.10 Td (of ) Tj ET Q q 0 0 0 rg BT 213.60 647.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 273.37 647.10 Td ($800 ) Tj ET Q q 0 0 0 rg BT 295.37 647.10 Td (million. ) Tj ET Q q 0 0 0 rg BT 328.33 647.10 Td (Asset ) Tj ET Q q 0 0 0 rg BT 352.56 647.10 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 402.34 647.10 Td (include ) Tj ET Q q 0 0 0 rg BT 433.77 647.10 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 479.11 647.10 Td (and ) Tj ET Q q 0 0 0 rg BT 495.55 647.10 Td (Padlock ) Tj ET Q q 0 0 0 rg BT 529.77 647.10 Td (in ) Tj ET Q q 0 0 0 rg BT 539.56 647.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 561.56 647.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 635.10 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 96.67 635.10 Td (and ) Tj ET Q q 0 0 0 rg BT 113.61 635.10 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 156.10 635.10 Td (in ) Tj ET Q q 0 0 0 rg BT 166.38 635.10 Td (2015; ) Tj ET Q q 0 0 0 rg BT 191.66 635.10 Td (and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 623.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 623.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 99.18 623.10 Td (business ) Tj ET Q q 0 0 0 rg BT 136.98 623.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 183.10 623.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 222.55 623.10 Td (of ) Tj ET Q q 0 0 0 rg BT 234.79 623.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 296.46 623.10 Td ($600 ) Tj ET Q q 0 0 0 rg BT 320.37 623.10 Td (million ) Tj ET Q q 0 0 0 rg BT 353.17 623.10 Td (including ) Tj ET Q q 0 0 0 rg BT 394.85 623.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 433.20 623.10 Td (and ) Tj ET Q q 0 0 0 rg BT 451.55 623.10 Td (other ) Tj ET Q q 0 0 0 rg BT 476.00 623.10 Td (contingent ) Tj ET Q q 0 0 0 rg BT 522.13 623.10 Td (consideration ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 611.10 Td (received ) Tj ET Q q 0 0 0 rg BT 104.38 611.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 151.83 611.10 Td (to ) Tj ET Q q 0 0 0 rg BT 162.62 611.10 Td (the ) Tj ET Q q 0 0 0 rg BT 177.85 611.10 Td (divestiture. ) Tj ET Q q 0 0 0 rg BT 225.57 611.10 Td (Divestitures ) Tj ET Q q 0 0 0 rg BT 276.91 611.10 Td (include ) Tj ET Q q 0 0 0 rg BT 309.36 611.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 339.57 611.10 Td (OTC ) Tj ET Q q 0 0 0 rg BT 362.58 611.10 Td (products ) Tj ET Q q 0 0 0 rg BT 400.03 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 417.49 611.10 Td (investigational ) Tj ET Q q 0 0 0 rg BT 479.38 611.10 Td (HIV) Tj ET Q q 0 0 0 rg BT 496.97 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 499.98 611.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 545.21 611.10 Td (in ) Tj ET Q q 0 0 0 rg BT 556.01 611.10 Td (2016 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 84.44 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.16 599.10 Td (Mount ) Tj ET Q q 0 0 0 rg BT 128.14 599.10 Td (V) Tj ET Q q 0 0 0 rg BT 134.26 599.10 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 162.03 599.10 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 194.51 599.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 255.32 599.10 Td (facility) Tj ET Q q 0 0 0 rg BT 282.99 599.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 287.99 599.10 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 326.31 599.10 Td ( ) Tj ET Q q 0 0 0 rg BT 328.81 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 345.75 599.10 Td (mature ) Tj ET Q q 0 0 0 rg BT 376.02 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 392.95 599.10 Td (other ) Tj ET Q q 0 0 0 rg BT 416.00 599.10 Td (OTC ) Tj ET Q q 0 0 0 rg BT 438.50 599.10 Td (product ) Tj ET Q q 0 0 0 rg BT 471.55 599.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 516.27 599.10 Td (in ) Tj ET Q q 0 0 0 rg BT 526.55 599.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 587.10 Td (Partially ) Tj ET Q q 0 0 0 rg BT 90.38 587.10 Td (of) Tj ET Q q 0 0 0 rg BT 98.53 587.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 115.47 587.10 Td (by:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 575.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 575.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.77 575.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 126.92 575.10 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 180.51 575.10 Td (of ) Tj ET Q q 0 0 0 rg BT 191.34 575.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 251.60 575.10 Td ($400 ) Tj ET Q q 0 0 0 rg BT 274.10 575.10 Td (million.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 551.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 551.10 Td ($2.8 ) Tj ET Q q 0 0 0 rg BT 74.05 551.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.16 551.10 Td ( ) Tj ET Q q 0 0 0 rg BT 102.66 551.10 Td (decrease ) Tj ET Q q 0 0 0 rg BT 139.57 551.10 Td (in ) Tj ET Q q 0 0 0 rg BT 149.85 551.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 170.12 551.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 208.17 551.10 Td (by ) Tj ET Q q 0 0 0 rg BT 220.67 551.10 Td (investing ) Tj ET Q q 0 0 0 rg BT 259.83 551.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 298.43 551.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.71 551.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 328.71 551.10 Td ( ) Tj ET Q q 0 0 0 rg BT 331.21 551.10 Td (was ) Tj ET Q q 0 0 0 rg BT 349.26 551.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 388.97 551.10 Td (attributable ) Tj ET Q q 0 0 0 rg BT 437.01 551.10 Td (to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 539.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 539.10 Td (Lower ) Tj ET Q q 0 0 0 rg BT 97.18 539.10 Td (business ) Tj ET Q q 0 0 0 rg BT 134.65 539.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 180.44 539.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 219.55 539.10 Td (of ) Tj ET Q q 0 0 0 rg BT 231.46 539.10 Td ($2.9 ) Tj ET Q q 0 0 0 rg BT 252.54 539.10 Td (billion. ) Tj ET Q q 0 0 0 rg BT 284.73 539.10 Td (Divestitures ) Tj ET Q q 0 0 0 rg BT 336.63 539.10 Td (include ) Tj ET Q q 0 0 0 rg BT 369.64 539.10 Td (the ) Tj ET Q q 0 0 0 rg BT 385.44 539.10 Td (Mount ) Tj ET Q q 0 0 0 rg BT 415.43 539.10 Td (V) Tj ET Q q 0 0 0 rg BT 421.54 539.10 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 450.39 539.10 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 483.95 539.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 545.84 539.10 Td (facility) Tj ET Q q 0 0 0 rg BT 573.51 539.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 67.50 527.10 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.82 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 108.32 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 125.26 527.10 Td (mature ) Tj ET Q q 0 0 0 rg BT 155.52 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 172.46 527.10 Td (other ) Tj ET Q q 0 0 0 rg BT 195.51 527.10 Td (OTC ) Tj ET Q q 0 0 0 rg BT 218.01 527.10 Td (product ) Tj ET Q q 0 0 0 rg BT 251.05 527.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 295.78 527.10 Td (in ) Tj ET Q q 0 0 0 rg BT 306.05 527.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 328.55 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 345.49 527.10 Td (the ) Tj ET Q q 0 0 0 rg BT 360.21 527.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 395.47 527.10 Td (business ) Tj ET Q q 0 0 0 rg BT 431.87 527.10 Td (in ) Tj ET Q q 0 0 0 rg BT 442.14 527.10 Td (2014;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 515.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 515.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.73 515.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 119.63 515.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 165.98 515.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 206.77 515.10 Td (of ) Tj ET Q q 0 0 0 rg BT 217.56 515.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 277.78 515.10 Td ($900 ) Tj ET Q q 0 0 0 rg BT 300.25 515.10 Td (million. ) Tj ET Q q 0 0 0 rg BT 333.56 515.10 Td (Asset ) Tj ET Q q 0 0 0 rg BT 358.24 515.10 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 408.48 515.10 Td (include ) Tj ET Q q 0 0 0 rg BT 440.38 515.10 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 469.51 515.10 Td (and ) Tj ET Q q 0 0 0 rg BT 486.41 515.10 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 528.87 515.10 Td (in ) Tj ET Q q 0 0 0 rg BT 539.11 515.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 561.58 515.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 503.10 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 101.10 503.10 Td (in ) Tj ET Q q 0 0 0 rg BT 111.38 503.10 Td (2014; ) Tj ET Q q 0 0 0 rg BT 136.66 503.10 Td (and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 491.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 491.10 Td (Higher ) Tj ET Q q 0 0 0 rg BT 97.77 491.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 126.92 491.10 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 180.51 491.10 Td (of ) Tj ET Q q 0 0 0 rg BT 191.34 491.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 251.60 491.10 Td ($300 ) Tj ET Q q 0 0 0 rg BT 274.10 491.10 Td (million.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 479.10 Td (Partially ) Tj ET Q q 0 0 0 rg BT 90.38 479.10 Td (of) Tj ET Q q 0 0 0 rg BT 98.53 479.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 115.47 479.10 Td (by:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 467.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 467.10 Td (Lower ) Tj ET Q q 0 0 0 rg BT 96.10 467.10 Td (net ) Tj ET Q q 0 0 0 rg BT 110.82 467.10 Td (purchases ) Tj ET Q q 0 0 0 rg BT 152.74 467.10 Td (of ) Tj ET Q q 0 0 0 rg BT 163.57 467.10 Td (marketable ) Tj ET Q q 0 0 0 rg BT 210.49 467.10 Td (securities ) Tj ET Q q 0 0 0 rg BT 250.76 467.10 Td (of ) Tj ET Q q 0 0 0 rg BT 261.59 467.10 Td ($1.3 ) Tj ET Q q 0 0 0 rg BT 281.59 467.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 310.20 467.10 Td (in ) Tj ET Q q 0 0 0 rg BT 320.48 467.10 Td (2015; ) Tj ET Q q 0 0 0 rg BT 345.76 467.10 Td (and) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 444.1669921875 m 116.6298828125 444.1669921875 l s q 0 0 0 rg BT 36.00 445.50 Td (Financing ) Tj ET Q q 0 0 0 rg BT 79.42 445.50 Td (Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 427.50 Td (Cash ) Tj ET Q q 0 0 0 rg BT 58.12 427.50 Td (requirements ) Tj ET Q q 0 0 0 rg BT 112.45 427.50 Td (from ) Tj ET Q q 0 0 0 rg BT 134.01 427.50 Td (financing ) Tj ET Q q 0 0 0 rg BT 173.90 427.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 212.12 427.50 Td (include ) Tj ET Q q 0 0 0 rg BT 243.68 427.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 263.57 427.50 Td (used ) Tj ET Q q 0 0 0 rg BT 284.03 427.50 Td (to ) Tj ET Q q 0 0 0 rg BT 293.93 427.50 Td (pay ) Tj ET Q q 0 0 0 rg BT 310.49 427.50 Td (dividends, ) Tj ET Q q 0 0 0 rg BT 354.00 427.50 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 399.43 427.50 Td (common ) Tj ET Q q 0 0 0 rg BT 436.55 427.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 459.78 427.50 Td (and ) Tj ET Q q 0 0 0 rg BT 476.35 427.50 Td (repay ) Tj ET Q q 0 0 0 rg BT 500.68 427.50 Td (long-term ) Tj ET Q q 0 0 0 rg BT 542.24 427.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 561.58 427.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.50 Td (other ) Tj ET Q q 0 0 0 rg BT 59.05 415.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 107.10 415.50 Td (reduced ) Tj ET Q q 0 0 0 rg BT 141.24 415.50 Td (by ) Tj ET Q q 0 0 0 rg BT 153.74 415.50 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 191.78 415.50 Td (from ) Tj ET Q q 0 0 0 rg BT 213.72 415.50 Td (the ) Tj ET Q q 0 0 0 rg BT 228.44 415.50 Td (exercise ) Tj ET Q q 0 0 0 rg BT 263.69 415.50 Td (of ) Tj ET Q q 0 0 0 rg BT 274.52 415.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 298.13 415.50 Td (options ) Tj ET Q q 0 0 0 rg BT 330.08 415.50 Td (and ) Tj ET Q q 0 0 0 rg BT 347.02 415.50 Td (issuance ) Tj ET Q q 0 0 0 rg BT 383.39 415.50 Td (of ) Tj ET Q q 0 0 0 rg BT 394.22 415.50 Td (long-term ) Tj ET Q q 0 0 0 rg BT 436.16 415.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 455.87 415.50 Td (and ) Tj ET Q q 0 0 0 rg BT 472.81 415.50 Td (other ) Tj ET Q q 0 0 0 rg BT 495.86 415.50 Td (borrowings.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 391.50 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 391.50 Td ($906 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.44 391.50 Td ( decrease in cash used in financing activities in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.65 391.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 391.50 Td ( was primarily attributable to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 379.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 379.50 Td (Lower long-term net debt repayments of approximately $700 million; and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 367.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 367.50 Td (Higher net short-term borrowings of approximately $600 million in 2016, consisting primarily of changes in bank overdrafts.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 355.50 Td (Partially ) Tj ET Q q 0 0 0 rg BT 90.38 355.50 Td (of) Tj ET Q q 0 0 0 rg BT 98.53 355.50 Td (fset ) Tj ET Q q 0 0 0 rg BT 115.47 355.50 Td (by:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 343.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 343.50 Td (Repurchase ) Tj ET Q q 0 0 0 rg BT 116.65 343.50 Td (of ) Tj ET Q q 0 0 0 rg BT 127.48 343.50 Td (common ) Tj ET Q q 0 0 0 rg BT 164.97 343.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 188.58 343.50 Td (of ) Tj ET Q q 0 0 0 rg BT 199.41 343.50 Td (approximately ) Tj ET Q q 0 0 0 rg BT 259.67 343.50 Td ($200 ) Tj ET Q q 0 0 0 rg BT 282.17 343.50 Td (million ) Tj ET Q q 0 0 0 rg BT 313.56 343.50 Td (in ) Tj ET Q q 0 0 0 rg BT 323.84 343.50 Td (2016 ) Tj ET Q q 0 0 0 rg BT 346.34 343.50 Td (\(none ) Tj ET Q q 0 0 0 rg BT 371.61 343.50 Td (in ) Tj ET Q q 0 0 0 rg BT 381.88 343.50 Td (2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 319.50 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.05 319.50 Td ($914 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.44 319.50 Td ( increase in cash used in financing activities in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.99 319.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.99 319.50 Td ( was primarily attributable to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 307.50 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.50 307.50 Td (Lower ) Tj ET Q q 0 0 0 rg BT 96.10 307.50 Td (net ) Tj ET Q q 0 0 0 rg BT 110.82 307.50 Td (short-term ) Tj ET Q q 0 0 0 rg BT 154.97 307.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 203.02 307.50 Td (of ) Tj ET Q q 0 0 0 rg BT 213.85 307.50 Td (approximately ) Tj ET Q q 0 0 0 rg BT 274.11 307.50 Td ($700 ) Tj ET Q q 0 0 0 rg BT 296.61 307.50 Td (million ) Tj ET Q q 0 0 0 rg BT 328.00 307.50 Td (in ) Tj ET Q q 0 0 0 rg BT 338.28 307.50 Td (2015, ) Tj ET Q q 0 0 0 rg BT 363.28 307.50 Td (consisting ) Tj ET Q q 0 0 0 rg BT 406.34 307.50 Td (primarily ) Tj ET Q q 0 0 0 rg BT 446.05 307.50 Td (of ) Tj ET Q q 0 0 0 rg BT 456.88 307.50 Td (changes ) Tj ET Q q 0 0 0 rg BT 491.59 307.50 Td (in ) Tj ET Q q 0 0 0 rg BT 501.87 307.50 Td (bank ) Tj ET Q q 0 0 0 rg BT 523.80 307.50 Td (overdrafts.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 283.50 Td (Contractual Obligations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 266.50 Td (Payments due by period for our contractual obligations at December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.03 266.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.03 266.50 Td ( were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 232.00 163.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 199.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 203.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 253.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 257.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 307.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 232.00 49.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 232.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 232.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 204.00 163.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 199.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 203.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 253.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 257.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 307.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 204.00 49.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 204.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 204.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 176.00 163.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 199.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 203.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 253.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 257.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 307.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 176.00 49.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 176.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 176.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 148.00 163.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 199.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 203.50 148.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 253.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 257.50 148.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 307.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 311.50 148.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 148.00 49.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 148.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 148.00 50.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 148.00 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 148.00 50.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 203.5 244 m 253.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 253.5 244 m 257.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 244 m 307.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 307.5 244 m 311.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 244 m 361.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 244 m 365.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 244 m 414.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 244 m 418.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 244 m 468.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 244 m 472.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 244 m 522.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 522.5 244 m 526.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 244 m 576.5 244 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 203.5 232 m 253.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 232 m 307.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 232 m 361.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 232 m 414.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 232 m 468.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 232 m 522.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 232 m 576.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 232 m 307.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 232 m 361.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 232 m 414.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 232 m 468.5 232 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 203.5 134 m 253.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 134 m 307.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 134 m 361.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 134 m 414.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 134 m 468.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 134 m 522.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 134 m 576.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 203.5 121 m 253.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 203.5 119 m 253.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 134 m 307.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 121 m 307.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 257.5 119 m 307.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 134 m 361.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 121 m 361.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 311.5 119 m 361.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 134 m 414.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 121 m 414.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 119 m 414.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 134 m 468.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 121 m 468.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 119 m 468.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 134 m 522.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 121 m 522.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 472.5 119 m 522.5 119 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 134 m 576.5 134 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 121 m 576.5 121 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 526.5 119 m 576.5 119 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 247.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 336.00 248.08 Td (Obligations Expiring by Period) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 235.95 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 219.25 236.08 Td (Total) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 274.00 236.08 Td (2017) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 328.00 236.08 Td (2018) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 381.50 236.08 Td (2019) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 435.00 236.08 Td (2020) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.00 236.08 Td (2021) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 531.10 236.08 Td (Later Years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 222.57 Td (Short-term borrowings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.65 222.57 Td (243) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 260.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.65 222.57 Td (243) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 222.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 222.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 222.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 222.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 529.00 222.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 222.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 208.57 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.15 208.57 Td (6,261) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.65 208.57 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 208.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.65 208.57 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 208.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 208.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 208.57 Td (5,011) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 194.57 Td (Interest on long-term debt) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 143.14 199.10 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.15 194.57 Td (4,133) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.65 194.57 Td (194) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 194.57 Td (194) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.65 194.57 Td (188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 194.57 Td (187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 194.57 Td (187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 194.57 Td (3,183) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 180.57 Td (Operating leases) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.65 180.57 Td (783) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.65 180.57 Td (123) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 180.57 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 180.57 Td (86) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 180.57 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 180.57 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 180.57 Td (340) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 166.57 Td (Purchase obligations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.15 166.57 Td (2,799) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 281.15 166.57 Td (1,265) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 166.57 Td (537) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.65 166.57 Td (406) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 166.57 Td (345) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 166.57 Td (156) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 166.57 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 152.57 Td (Uncertain tax positions) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 131.76 157.10 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 239.65 152.57 Td (70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.65 152.57 Td (70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 152.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 152.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 152.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 152.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 152.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 138.57 Td (Other long-term liabilities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 143.42 143.10 Td (\(c\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.65 138.57 Td (526) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.65 138.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 138.57 Td (126) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 138.57 Td (67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 138.57 Td (58) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 138.57 Td (37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 138.57 Td (238) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 124.57 Td (    Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 222.15 124.57 Td (14,815) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 260.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 281.15 124.57 Td (2,645) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 124.57 Td (964) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.15 124.57 Td (1,247) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 124.57 Td (656) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 124.57 Td (441) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 529.00 124.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 124.57 Td (8,862) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 34.35 108.50 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.23 108.50 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 108.50 Td (Includes ) Tj ET Q q 0 0 0 rg BT 90.45 108.50 Td (estimated ) Tj ET Q q 0 0 0 rg BT 123.11 108.50 Td (future ) Tj ET Q q 0 0 0 rg BT 144.21 108.50 Td (interest ) Tj ET Q q 0 0 0 rg BT 169.76 108.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 202.42 108.50 Td (and ) Tj ET Q q 0 0 0 rg BT 215.97 108.50 Td (periodic ) Tj ET Q q 0 0 0 rg BT 244.18 108.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 260.39 108.50 Td (settlements ) Tj ET Q q 0 0 0 rg BT 298.38 108.50 Td (of ) Tj ET Q q 0 0 0 rg BT 307.05 108.50 Td (derivatives.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 34.35 98.90 Td (\(b\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 98.90 Td (Includes ) Tj ET Q q 0 0 0 rg BT 90.45 98.90 Td (only ) Tj ET Q q 0 0 0 rg BT 106.67 98.90 Td (short-term ) Tj ET Q q 0 0 0 rg BT 142.00 98.90 Td (uncertain ) Tj ET Q q 0 0 0 rg BT 173.76 98.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 185.53 98.90 Td (benefits ) Tj ET Q q 0 0 0 rg BT 212.86 98.90 Td (because ) Tj ET Q q 0 0 0 rg BT 240.17 98.90 Td (of ) Tj ET Q q 0 0 0 rg BT 248.84 98.90 Td (uncertainties ) Tj ET Q q 0 0 0 rg BT 291.71 98.90 Td (regarding ) Tj ET Q q 0 0 0 rg BT 324.36 98.90 Td (the ) Tj ET Q q 0 0 0 rg BT 336.13 98.90 Td (timing ) Tj ET Q q 0 0 0 rg BT 359.03 98.90 Td (of ) Tj ET Q q 0 0 0 rg BT 367.69 98.90 Td (resolution.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 34.35 89.30 Td (\(c\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 89.30 Td (Does ) Tj ET Q q 0 0 0 rg BT 79.79 89.30 Td (not ) Tj ET Q q 0 0 0 rg BT 92.01 89.30 Td (include ) Tj ET Q q 0 0 0 rg BT 117.56 89.30 Td (pension ) Tj ET Q q 0 0 0 rg BT 144.45 89.30 Td (liability) Tj ET Q q 0 0 0 rg BT 168.81 89.30 Td (.) Tj ET Q endstream endobj 87 0 obj <> endobj 88 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (In ) Tj ET Q q 0 0 0 rg BT 45.95 749.10 Td (addition ) Tj ET Q q 0 0 0 rg BT 80.34 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 89.74 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 103.58 749.10 Td (above, ) Tj ET Q q 0 0 0 rg BT 131.58 749.10 Td (we ) Tj ET Q q 0 0 0 rg BT 144.86 749.10 Td (are ) Tj ET Q q 0 0 0 rg BT 158.68 749.10 Td (committed ) Tj ET Q q 0 0 0 rg BT 203.07 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 212.47 749.10 Td (an ) Tj ET Q q 0 0 0 rg BT 223.53 749.10 Td (aggregated ) Tj ET Q q 0 0 0 rg BT 269.01 749.10 Td ($10.4 ) Tj ET Q q 0 0 0 rg BT 293.13 749.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 320.87 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 330.82 749.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 367.43 749.10 Td (future ) Tj ET Q q 0 0 0 rg BT 392.92 749.10 Td (research ) Tj ET Q q 0 0 0 rg BT 427.85 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 443.91 749.10 Td (development ) Tj ET Q q 0 0 0 rg BT 497.18 749.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 537.68 749.10 Td (payments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 45.76 737.10 Td (third ) Tj ET Q q 0 0 0 rg BT 66.64 737.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 95.28 737.10 Td (for ) Tj ET Q q 0 0 0 rg BT 108.93 737.10 Td (in-licensing, ) Tj ET Q q 0 0 0 rg BT 160.62 737.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 182.05 737.10 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 231.81 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 248.23 737.10 Td (development ) Tj ET Q q 0 0 0 rg BT 301.87 737.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 341.63 737.10 Td (including ) Tj ET Q q 0 0 0 rg BT 381.38 737.10 Td (early-stage ) Tj ET Q q 0 0 0 rg BT 427.23 737.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 471.99 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 482.31 737.10 Td ($3.0 ) Tj ET Q q 0 0 0 rg BT 501.80 737.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 529.90 737.10 Td (\(milestones ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (achieved ) Tj ET Q q 0 0 0 rg BT 74.47 725.10 Td (through ) Tj ET Q q 0 0 0 rg BT 108.52 725.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 134.80 725.10 Td (III ) Tj ET Q q 0 0 0 rg BT 147.73 725.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 180.10 725.10 Td (trials\) ) Tj ET Q q 0 0 0 rg BT 206.37 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 223.75 725.10 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 265.00 725.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 310.71 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 321.99 725.10 Td ($7.4 ) Tj ET Q q 0 0 0 rg BT 342.43 725.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 371.48 725.10 Td (\(milestones ) Tj ET Q q 0 0 0 rg BT 420.53 725.10 Td (achieved ) Tj ET Q q 0 0 0 rg BT 459.00 725.10 Td (post ) Tj ET Q q 0 0 0 rg BT 478.61 725.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 504.89 725.10 Td (III ) Tj ET Q q 0 0 0 rg BT 517.82 725.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 550.19 725.10 Td (trials\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Payments ) Tj ET Q q 0 0 0 rg BT 76.63 713.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 115.57 713.10 Td (are ) Tj ET Q q 0 0 0 rg BT 129.52 713.10 Td (due ) Tj ET Q q 0 0 0 rg BT 145.69 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 161.87 713.10 Td (payable ) Tj ET Q q 0 0 0 rg BT 194.71 713.10 Td (only ) Tj ET Q q 0 0 0 rg BT 214.22 713.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 235.96 713.10 Td (achievement ) Tj ET Q q 0 0 0 rg BT 288.23 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 298.30 713.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 327.24 713.10 Td (developmental ) Tj ET Q q 0 0 0 rg BT 387.85 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 404.03 713.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 446.86 713.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 491.37 713.10 Td (for ) Tj ET Q q 0 0 0 rg BT 504.77 713.10 Td (which ) Tj ET Q q 0 0 0 rg BT 530.95 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 544.91 713.10 Td (specific ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (timing ) Tj ET Q q 0 0 0 rg BT 64.34 701.10 Td (cannot ) Tj ET Q q 0 0 0 rg BT 93.23 701.10 Td (be ) Tj ET Q q 0 0 0 rg BT 104.90 701.10 Td (predicted. ) Tj ET Q q 0 0 0 rg BT 146.83 701.10 Td (Some ) Tj ET Q q 0 0 0 rg BT 171.84 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 182.40 701.10 Td (these ) Tj ET Q q 0 0 0 rg BT 205.18 701.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 252.94 701.10 Td (also ) Tj ET Q q 0 0 0 rg BT 271.28 701.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 304.06 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 317.95 701.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 365.71 701.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 410.72 701.10 Td (aggregating ) Tj ET Q q 0 0 0 rg BT 460.15 701.10 Td ($2.5 ) Tj ET Q q 0 0 0 rg BT 479.88 701.10 Td (billion ) Tj ET Q q 0 0 0 rg BT 508.23 701.10 Td (that ) Tj ET Q q 0 0 0 rg BT 525.45 701.10 Td (we ) Tj ET Q q 0 0 0 rg BT 539.34 701.10 Td (would ) Tj ET Q q 0 0 0 rg BT 566.57 701.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (obligated ) Tj ET Q q 0 0 0 rg BT 75.19 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.94 689.10 Td (pay ) Tj ET Q q 0 0 0 rg BT 101.35 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 111.10 689.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 144.17 689.10 Td (partners ) Tj ET Q q 0 0 0 rg BT 178.35 689.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 200.32 689.10 Td (achievement ) Tj ET Q q 0 0 0 rg BT 252.82 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 263.13 689.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 292.30 689.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 313.72 689.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 339.02 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 348.77 689.10 Td (addition ) Tj ET Q q 0 0 0 rg BT 383.52 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 393.27 689.10 Td (royalties. ) Tj ET Q q 0 0 0 rg BT 432.03 689.10 Td (W) Tj ET Q q 0 0 0 rg BT 440.67 689.10 Td (e ) Tj ET Q q 0 0 0 rg BT 447.08 689.10 Td (also ) Tj ET Q q 0 0 0 rg BT 465.17 689.10 Td (have ) Tj ET Q q 0 0 0 rg BT 486.02 689.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 515.19 689.10 Td (manufacturing, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (development ) Tj ET Q q 0 0 0 rg BT 89.83 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 106.46 677.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 183.05 677.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 229.68 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 239.64 677.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 285.70 677.10 Td (with ) Tj ET Q q 0 0 0 rg BT 305.66 677.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 338.93 677.10 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 397.48 677.10 Td (It ) Tj ET Q q 0 0 0 rg BT 405.77 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 414.62 677.10 Td (not ) Tj ET Q q 0 0 0 rg BT 429.59 677.10 Td (practicable ) Tj ET Q q 0 0 0 rg BT 475.63 677.10 Td (to ) Tj ET Q q 0 0 0 rg BT 485.59 677.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 521.10 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 535.50 677.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 567.68 677.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (these ) Tj ET Q q 0 0 0 rg BT 59.05 665.10 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 108.49 665.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 133.20 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 143.48 665.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 168.74 665.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 178.74 665.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 218.45 665.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 294.27 665.10 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.27 665.10 Td (. ) Tj ET Q q 0 0 0 rg BT 303.72 665.10 Td (Alliances” ) Tj ET Q q 0 0 0 rg BT 348.42 665.10 Td (for ) Tj ET Q q 0 0 0 rg BT 362.58 665.10 Td (further ) Tj ET Q q 0 0 0 rg BT 392.29 665.10 Td (information ) Tj ET Q q 0 0 0 rg BT 442.00 665.10 Td (regarding ) Tj ET Q q 0 0 0 rg BT 482.82 665.10 Td (our ) Tj ET Q q 0 0 0 rg BT 498.65 665.10 Td (alliances.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 644.10 Td (For ) Tj ET Q q 0 0 0 rg BT 53.83 644.10 Td (a ) Tj ET Q q 0 0 0 rg BT 62.21 644.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 107.82 644.10 Td (of ) Tj ET Q q 0 0 0 rg BT 120.09 644.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 168.44 644.10 Td (obligations, ) Tj ET Q q 0 0 0 rg BT 219.33 644.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 242.13 644.10 Td (to ) Tj ET Q q 0 0 0 rg BT 253.85 644.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 280.55 644.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 291.99 644.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 333.14 644.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.40 644.10 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.40 644.10 Td (. ) Tj ET Q q 0 0 0 rg BT 421.84 644.10 Td (Income ) Tj ET Q q 0 0 0 rg BT 455.48 644.10 Td (T) Tj ET Q q 0 0 0 rg BT 460.89 644.10 Td (axes,” ) Tj ET Q q 0 0 0 rg BT 489.54 644.10 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.35 644.10 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 532.35 644.10 Td (. ) Tj ET Q q 0 0 0 rg BT 538.79 644.10 Td (Financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 632.10 Td (Instruments ) Tj ET Q q 0 0 0 rg BT 85.72 632.10 Td (and ) Tj ET Q q 0 0 0 rg BT 102.66 632.10 Td (Fair ) Tj ET Q q 0 0 0 rg BT 121.08 632.10 Td (V) Tj ET Q q 0 0 0 rg BT 127.20 632.10 Td (alue ) Tj ET Q q 0 0 0 rg BT 146.35 632.10 Td (Measurements,”and ) Tj ET Q q 0 0 0 rg BT 228.54 632.10 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.92 632.10 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.92 632.10 Td (. ) Tj ET Q q 0 0 0 rg BT 279.92 632.10 Td (Pension, ) Tj ET Q q 0 0 0 rg BT 316.59 632.10 Td (Postretirement ) Tj ET Q q 0 0 0 rg BT 377.41 632.10 Td (and ) Tj ET Q q 0 0 0 rg BT 394.35 632.10 Td (Postemployment ) Tj ET Q q 0 0 0 rg BT 464.07 632.10 Td (Liabilities.”) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 608.10 Td (SEC Consent Order) Tj ET Q q 0 0 0 rg BT 121.93 608.10 Td ( / FCP) Tj ET Q q 0 0 0 rg BT 148.41 608.10 Td (A) Tj ET Q q 0 0 0 rg BT 155.08 608.10 Td ( Settlement) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 584.10 Td (As ) Tj ET Q q 0 0 0 rg BT 50.17 584.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 95.44 584.10 Td (disclosed, ) Tj ET Q q 0 0 0 rg BT 138.21 584.10 Td (on ) Tj ET Q q 0 0 0 rg BT 150.59 584.10 Td (August 4, ) Tj ET Q q 0 0 0 rg BT 192.53 584.10 Td (2004, ) Tj ET Q q 0 0 0 rg BT 218.08 584.10 Td (we ) Tj ET Q q 0 0 0 rg BT 232.80 584.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 265.27 584.10 Td (into ) Tj ET Q q 0 0 0 rg BT 283.88 584.10 Td (a ) Tj ET Q q 0 0 0 rg BT 291.38 584.10 Td (final ) Tj ET Q q 0 0 0 rg BT 312.75 584.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 356.91 584.10 Td (with ) Tj ET Q q 0 0 0 rg BT 377.74 584.10 Td (the ) Tj ET Q q 0 0 0 rg BT 393.01 584.10 Td (SEC, ) Tj ET Q q 0 0 0 rg BT 416.90 584.10 Td (concluding ) Tj ET Q q 0 0 0 rg BT 464.39 584.10 Td (an ) Tj ET Q q 0 0 0 rg BT 476.88 584.10 Td (investigation ) Tj ET Q q 0 0 0 rg BT 531.59 584.10 Td (concerning ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 572.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 66.00 572.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 112.12 572.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 153.24 572.10 Td (and ) Tj ET Q q 0 0 0 rg BT 170.48 572.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 217.15 572.10 Td (matters. ) Tj ET Q q 0 0 0 rg BT 251.68 572.10 Td (The ) Tj ET Q q 0 0 0 rg BT 270.03 572.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 313.92 572.10 Td (was ) Tj ET Q q 0 0 0 rg BT 332.28 572.10 Td (reached ) Tj ET Q q 0 0 0 rg BT 366.16 572.10 Td (through ) Tj ET Q q 0 0 0 rg BT 400.07 572.10 Td (a ) Tj ET Q q 0 0 0 rg BT 407.30 572.10 Td (Consent, ) Tj ET Q q 0 0 0 rg BT 445.38 572.10 Td (a ) Tj ET Q q 0 0 0 rg BT 452.62 572.10 Td (copy ) Tj ET Q q 0 0 0 rg BT 474.86 572.10 Td (of ) Tj ET Q q 0 0 0 rg BT 485.99 572.10 Td (which ) Tj ET Q q 0 0 0 rg BT 513.22 572.10 Td (was ) Tj ET Q q 0 0 0 rg BT 531.58 572.10 Td (attached ) Tj ET Q q 0 0 0 rg BT 567.69 572.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 560.10 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 67.94 560.10 Td (10 ) Tj ET Q q 0 0 0 rg BT 80.44 560.10 Td (to ) Tj ET Q q 0 0 0 rg BT 90.72 560.10 Td (our ) Tj ET Q q 0 0 0 rg BT 106.55 560.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 145.15 560.10 Td (report ) Tj ET Q q 0 0 0 rg BT 171.52 560.10 Td (on ) Tj ET Q q 0 0 0 rg BT 184.02 560.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 208.19 560.10 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 231.24 560.10 Td (for ) Tj ET Q q 0 0 0 rg BT 245.40 560.10 Td (the ) Tj ET Q q 0 0 0 rg BT 260.12 560.10 Td (period ) Tj ET Q q 0 0 0 rg BT 288.17 560.10 Td (ended ) Tj ET Q q 0 0 0 rg BT 314.54 560.10 Td (September 30, ) Tj ET Q q 0 0 0 rg BT 374.81 560.10 Td (2004.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 536.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 62.97 536.10 Td (the ) Tj ET Q q 0 0 0 rg BT 77.16 536.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 101.35 536.10 Td (of ) Tj ET Q q 0 0 0 rg BT 111.65 536.10 Td (the ) Tj ET Q q 0 0 0 rg BT 125.85 536.10 Td (Consent, ) Tj ET Q q 0 0 0 rg BT 163.10 536.10 Td (we ) Tj ET Q q 0 0 0 rg BT 176.73 536.10 Td (agreed, ) Tj ET Q q 0 0 0 rg BT 207.86 536.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 238.16 536.10 Td (to ) Tj ET Q q 0 0 0 rg BT 247.91 536.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 277.09 536.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 309.05 536.10 Td (exceptions, ) Tj ET Q q 0 0 0 rg BT 356.29 536.10 Td (to ) Tj ET Q q 0 0 0 rg BT 366.04 536.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 386.91 536.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 408.32 536.10 Td (of ) Tj ET Q q 0 0 0 rg BT 418.62 536.10 Td (all ) Tj ET Q q 0 0 0 rg BT 430.59 536.10 Td (products ) Tj ET Q q 0 0 0 rg BT 467.01 536.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 485.65 536.10 Td (to ) Tj ET Q q 0 0 0 rg BT 495.41 536.10 Td (our ) Tj ET Q q 0 0 0 rg BT 510.71 536.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 535.45 536.10 Td (customers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 524.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 79.85 524.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 132.31 524.10 Td (distributors, ) Tj ET Q q 0 0 0 rg BT 183.12 524.10 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 223.93 524.10 Td (retail ) Tj ET Q q 0 0 0 rg BT 247.22 524.10 Td (outlets, ) Tj ET Q q 0 0 0 rg BT 279.14 524.10 Td (pharmacies ) Tj ET Q q 0 0 0 rg BT 327.42 524.10 Td (and ) Tj ET Q q 0 0 0 rg BT 344.61 524.10 Td (government ) Tj ET Q q 0 0 0 rg BT 395.13 524.10 Td (purchasers\) ) Tj ET Q q 0 0 0 rg BT 443.97 524.10 Td (based ) Tj ET Q q 0 0 0 rg BT 469.49 524.10 Td (on ) Tj ET Q q 0 0 0 rg BT 482.24 524.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 520.52 524.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 554.93 524.10 Td (or ) Tj ET Q q 0 0 0 rg BT 566.01 524.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 512.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 72.23 512.10 Td (that ) Tj ET Q q 0 0 0 rg BT 89.58 512.10 Td (do ) Tj ET Q q 0 0 0 rg BT 101.92 512.10 Td (not ) Tj ET Q q 0 0 0 rg BT 117.05 512.10 Td (exceed ) Tj ET Q q 0 0 0 rg BT 147.15 512.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 207.26 512.10 Td (one ) Tj ET Q q 0 0 0 rg BT 224.04 512.10 Td (month ) Tj ET Q q 0 0 0 rg BT 251.95 512.10 Td (of ) Tj ET Q q 0 0 0 rg BT 262.63 512.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 303.30 512.10 Td (on ) Tj ET Q q 0 0 0 rg BT 315.65 512.10 Td (hand, ) Tj ET Q q 0 0 0 rg BT 339.93 512.10 Td (without ) Tj ET Q q 0 0 0 rg BT 372.84 512.10 Td (making ) Tj ET Q q 0 0 0 rg BT 405.18 512.10 Td (a ) Tj ET Q q 0 0 0 rg BT 411.97 512.10 Td (timely ) Tj ET Q q 0 0 0 rg BT 439.87 512.10 Td (public ) Tj ET Q q 0 0 0 rg BT 467.21 512.10 Td (disclosure ) Tj ET Q q 0 0 0 rg BT 510.10 512.10 Td (of ) Tj ET Q q 0 0 0 rg BT 520.78 512.10 Td (any ) Tj ET Q q 0 0 0 rg BT 537.57 512.10 Td (change ) Tj ET Q q 0 0 0 rg BT 568.23 512.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 500.10 Td (practice. ) Tj ET Q q 0 0 0 rg BT 72.72 500.10 Td (W) Tj ET Q q 0 0 0 rg BT 81.36 500.10 Td (e ) Tj ET Q q 0 0 0 rg BT 88.58 500.10 Td (also ) Tj ET Q q 0 0 0 rg BT 107.47 500.10 Td (agreed ) Tj ET Q q 0 0 0 rg BT 136.90 500.10 Td (in ) Tj ET Q q 0 0 0 rg BT 147.46 500.10 Td (the ) Tj ET Q q 0 0 0 rg BT 162.46 500.10 Td (Consent ) Tj ET Q q 0 0 0 rg BT 198.03 500.10 Td (to ) Tj ET Q q 0 0 0 rg BT 208.59 500.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 238.57 500.10 Td (measures ) Tj ET Q q 0 0 0 rg BT 278.56 500.10 Td (that ) Tj ET Q q 0 0 0 rg BT 296.34 500.10 Td (we ) Tj ET Q q 0 0 0 rg BT 310.78 500.10 Td (have ) Tj ET Q q 0 0 0 rg BT 332.44 500.10 Td (implemented ) Tj ET Q q 0 0 0 rg BT 387.43 500.10 Td (including: ) Tj ET Q q 0 0 0 rg BT 430.77 500.10 Td (\(a\) establishing ) Tj ET Q q 0 0 0 rg BT 494.92 500.10 Td (a ) Tj ET Q q 0 0 0 rg BT 502.15 500.10 Td (formal ) Tj ET Q q 0 0 0 rg BT 531.58 500.10 Td (review ) Tj ET Q q 0 0 0 rg BT 561.58 500.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 488.10 Td (certification ) Tj ET Q q 0 0 0 rg BT 88.16 488.10 Td (process ) Tj ET Q q 0 0 0 rg BT 122.00 488.10 Td (of ) Tj ET Q q 0 0 0 rg BT 134.17 488.10 Td (our ) Tj ET Q q 0 0 0 rg BT 151.35 488.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 181.86 488.10 Td (and ) Tj ET Q q 0 0 0 rg BT 200.15 488.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 240.09 488.10 Td (reports ) Tj ET Q q 0 0 0 rg BT 271.71 488.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 293.88 488.10 Td (with ) Tj ET Q q 0 0 0 rg BT 315.51 488.10 Td (the ) Tj ET Q q 0 0 0 rg BT 331.58 488.10 Td (SEC; ) Tj ET Q q 0 0 0 rg BT 356.55 488.10 Td (\(b\) establishing ) Tj ET Q q 0 0 0 rg BT 422.33 488.10 Td (a ) Tj ET Q q 0 0 0 rg BT 430.62 488.10 Td (business ) Tj ET Q q 0 0 0 rg BT 468.36 488.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 487.21 488.10 Td (and ) Tj ET Q q 0 0 0 rg BT 505.50 488.10 Td (disclosure ) Tj ET Q q 0 0 0 rg BT 549.89 488.10 Td (group; ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 476.10 Td (\(c\) retaining ) Tj ET Q q 0 0 0 rg BT 88.62 476.10 Td (an ) Tj ET Q q 0 0 0 rg BT 101.53 476.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 133.89 476.10 Td (consultant ) Tj ET Q q 0 0 0 rg BT 178.47 476.10 Td (to ) Tj ET Q q 0 0 0 rg BT 189.73 476.10 Td (comprehensively ) Tj ET Q q 0 0 0 rg BT 261.51 476.10 Td (study ) Tj ET Q q 0 0 0 rg BT 286.66 476.10 Td (and ) Tj ET Q q 0 0 0 rg BT 304.57 476.10 Td (help ) Tj ET Q q 0 0 0 rg BT 325.26 476.10 Td (re-engineer ) Tj ET Q q 0 0 0 rg BT 374.26 476.10 Td (our ) Tj ET Q q 0 0 0 rg BT 391.07 476.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 438.42 476.10 Td (and ) Tj ET Q q 0 0 0 rg BT 456.33 476.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 494.79 476.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 534.92 476.10 Td (processes; ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 464.10 Td (\(d\) publicly ) Tj ET Q q 0 0 0 rg BT 85.45 464.10 Td (disclosing ) Tj ET Q q 0 0 0 rg BT 128.52 464.10 Td (any ) Tj ET Q q 0 0 0 rg BT 145.48 464.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 167.44 464.10 Td (incentives ) Tj ET Q q 0 0 0 rg BT 210.49 464.10 Td (of) Tj ET Q q 0 0 0 rg BT 218.64 464.10 Td (fered ) Tj ET Q q 0 0 0 rg BT 241.70 464.10 Td (to ) Tj ET Q q 0 0 0 rg BT 251.99 464.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 277.27 464.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 320.34 464.10 Td (for ) Tj ET Q q 0 0 0 rg BT 334.52 464.10 Td (the ) Tj ET Q q 0 0 0 rg BT 349.25 464.10 Td (purpose ) Tj ET Q q 0 0 0 rg BT 383.43 464.10 Td (of ) Tj ET Q q 0 0 0 rg BT 394.27 464.10 Td (inducing ) Tj ET Q q 0 0 0 rg BT 431.79 464.10 Td (them ) Tj ET Q q 0 0 0 rg BT 454.30 464.10 Td (to ) Tj ET Q q 0 0 0 rg BT 464.59 464.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 502.65 464.10 Td (products ) Tj ET Q q 0 0 0 rg BT 539.60 464.10 Td (in ) Tj ET Q q 0 0 0 rg BT 549.90 464.10 Td (excess ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 452.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.98 452.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 85.17 452.10 Td (demand; ) Tj ET Q q 0 0 0 rg BT 122.25 452.10 Td (and ) Tj ET Q q 0 0 0 rg BT 139.35 452.10 Td (\(e\) ensuring ) Tj ET Q q 0 0 0 rg BT 190.04 452.10 Td (that ) Tj ET Q q 0 0 0 rg BT 207.68 452.10 Td (our ) Tj ET Q q 0 0 0 rg BT 223.67 452.10 Td (budget ) Tj ET Q q 0 0 0 rg BT 253.54 452.10 Td (process ) Tj ET Q q 0 0 0 rg BT 286.18 452.10 Td (gives ) Tj ET Q q 0 0 0 rg BT 309.94 452.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 358.13 452.10 Td (weight ) Tj ET Q q 0 0 0 rg BT 388.00 452.10 Td (to ) Tj ET Q q 0 0 0 rg BT 398.43 452.10 Td (inputs ) Tj ET Q q 0 0 0 rg BT 425.53 452.10 Td (that ) Tj ET Q q 0 0 0 rg BT 443.18 452.10 Td (come ) Tj ET Q q 0 0 0 rg BT 467.48 452.10 Td (from ) Tj ET Q q 0 0 0 rg BT 489.57 452.10 Td (the ) Tj ET Q q 0 0 0 rg BT 504.44 452.10 Td (bottom ) Tj ET Q q 0 0 0 rg BT 535.43 452.10 Td (to ) Tj ET Q q 0 0 0 rg BT 545.86 452.10 Td (the ) Tj ET Q q 0 0 0 rg BT 560.73 452.10 Td (top, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 440.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 440.10 Td (not ) Tj ET Q q 0 0 0 rg BT 68.22 440.10 Td (just ) Tj ET Q q 0 0 0 rg BT 85.17 440.10 Td (from ) Tj ET Q q 0 0 0 rg BT 107.10 440.10 Td (the ) Tj ET Q q 0 0 0 rg BT 121.82 440.10 Td (top ) Tj ET Q q 0 0 0 rg BT 137.10 440.10 Td (to ) Tj ET Q q 0 0 0 rg BT 147.38 440.10 Td (the ) Tj ET Q q 0 0 0 rg BT 162.09 440.10 Td (bottom, ) Tj ET Q q 0 0 0 rg BT 195.43 440.10 Td (and ) Tj ET Q q 0 0 0 rg BT 212.37 440.10 Td (adequately ) Tj ET Q q 0 0 0 rg BT 258.18 440.10 Td (documenting ) Tj ET Q q 0 0 0 rg BT 312.89 440.10 Td (that ) Tj ET Q q 0 0 0 rg BT 330.38 440.10 Td (process.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 416.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 416.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.68 416.10 Td (have ) Tj ET Q q 0 0 0 rg BT 73.17 416.10 Td (established ) Tj ET Q q 0 0 0 rg BT 120.21 416.10 Td (a ) Tj ET Q q 0 0 0 rg BT 127.25 416.10 Td (company-wide ) Tj ET Q q 0 0 0 rg BT 189.28 416.10 Td (policy ) Tj ET Q q 0 0 0 rg BT 216.88 416.10 Td (to ) Tj ET Q q 0 0 0 rg BT 227.27 416.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 248.77 416.10 Td (our ) Tj ET Q q 0 0 0 rg BT 264.70 416.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 286.75 416.10 Td (to ) Tj ET Q q 0 0 0 rg BT 297.13 416.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 322.50 416.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 365.66 416.10 Td (for ) Tj ET Q q 0 0 0 rg BT 379.92 416.10 Td (the ) Tj ET Q q 0 0 0 rg BT 394.75 416.10 Td (purpose ) Tj ET Q q 0 0 0 rg BT 429.01 416.10 Td (of ) Tj ET Q q 0 0 0 rg BT 439.95 416.10 Td (complying ) Tj ET Q q 0 0 0 rg BT 485.33 416.10 Td (with ) Tj ET Q q 0 0 0 rg BT 505.71 416.10 Td (the ) Tj ET Q q 0 0 0 rg BT 520.54 416.10 Td (Consent. ) Tj ET Q q 0 0 0 rg BT 558.23 416.10 Td (This ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 404.10 Td (policy ) Tj ET Q q 0 0 0 rg BT 64.04 404.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 100.42 404.10 Td (the ) Tj ET Q q 0 0 0 rg BT 115.69 404.10 Td (adoption ) Tj ET Q q 0 0 0 rg BT 153.73 404.10 Td (of ) Tj ET Q q 0 0 0 rg BT 165.11 404.10 Td (various ) Tj ET Q q 0 0 0 rg BT 197.60 404.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 244.51 404.10 Td (to ) Tj ET Q q 0 0 0 rg BT 255.34 404.10 Td (monitor ) Tj ET Q q 0 0 0 rg BT 290.06 404.10 Td (and ) Tj ET Q q 0 0 0 rg BT 307.54 404.10 Td (limit ) Tj ET Q q 0 0 0 rg BT 329.48 404.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 351.97 404.10 Td (to ) Tj ET Q q 0 0 0 rg BT 362.80 404.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 388.61 404.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 432.21 404.10 Td (in ) Tj ET Q q 0 0 0 rg BT 443.04 404.10 Td (accordance ) Tj ET Q q 0 0 0 rg BT 491.05 404.10 Td (with ) Tj ET Q q 0 0 0 rg BT 511.87 404.10 Td (the ) Tj ET Q q 0 0 0 rg BT 527.14 404.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 552.41 404.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 404.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 392.10 Td (Consent. ) Tj ET Q q 0 0 0 rg BT 73.80 392.10 Td (These ) Tj ET Q q 0 0 0 rg BT 100.39 392.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 146.98 392.10 Td (include ) Tj ET Q q 0 0 0 rg BT 179.13 392.10 Td (a ) Tj ET Q q 0 0 0 rg BT 186.28 392.10 Td (governance ) Tj ET Q q 0 0 0 rg BT 235.08 392.10 Td (process ) Tj ET Q q 0 0 0 rg BT 267.79 392.10 Td (to ) Tj ET Q q 0 0 0 rg BT 278.28 392.10 Td (escalate ) Tj ET Q q 0 0 0 rg BT 312.64 392.10 Td (to ) Tj ET Q q 0 0 0 rg BT 323.13 392.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 371.38 392.10 Td (management ) Tj ET Q q 0 0 0 rg BT 425.19 392.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 451.23 392.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 488.93 392.10 Td (questions ) Tj ET Q q 0 0 0 rg BT 529.43 392.10 Td (or ) Tj ET Q q 0 0 0 rg BT 540.48 392.10 Td (concerns ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 380.10 Td (regarding ) Tj ET Q q 0 0 0 rg BT 77.39 380.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 126.56 380.10 Td (with ) Tj ET Q q 0 0 0 rg BT 147.42 380.10 Td (the ) Tj ET Q q 0 0 0 rg BT 162.71 380.10 Td (policy ) Tj ET Q q 0 0 0 rg BT 190.78 380.10 Td (and ) Tj ET Q q 0 0 0 rg BT 208.30 380.10 Td (timely ) Tj ET Q q 0 0 0 rg BT 236.93 380.10 Td (resolution ) Tj ET Q q 0 0 0 rg BT 280.00 380.10 Td (of ) Tj ET Q q 0 0 0 rg BT 291.41 380.10 Td (such ) Tj ET Q q 0 0 0 rg BT 312.82 380.10 Td (questions ) Tj ET Q q 0 0 0 rg BT 353.67 380.10 Td (or ) Tj ET Q q 0 0 0 rg BT 365.08 380.10 Td (concerns. ) Tj ET Q q 0 0 0 rg BT 406.19 380.10 Td (In ) Tj ET Q q 0 0 0 rg BT 417.60 380.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 455.95 380.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 505.12 380.10 Td (with ) Tj ET Q q 0 0 0 rg BT 525.98 380.10 Td (the ) Tj ET Q q 0 0 0 rg BT 541.27 380.10 Td (policy ) Tj ET Q q 0 0 0 rg BT 569.34 380.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 368.10 Td (monitored ) Tj ET Q q 0 0 0 rg BT 79.60 368.10 Td (on ) Tj ET Q q 0 0 0 rg BT 92.10 368.10 Td (a ) Tj ET Q q 0 0 0 rg BT 99.04 368.10 Td (regular ) Tj ET Q q 0 0 0 rg BT 129.86 368.10 Td (basis.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 344.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 344.10 Td (e ) Tj ET Q q 0 0 0 rg BT 52.11 344.10 Td (maintain ) Tj ET Q q 0 0 0 rg BT 90.13 344.10 Td (IMAs ) Tj ET Q q 0 0 0 rg BT 116.50 344.10 Td (with ) Tj ET Q q 0 0 0 rg BT 137.31 344.10 Td (our ) Tj ET Q q 0 0 0 rg BT 153.67 344.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 174.49 344.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 238.59 344.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 291.33 344.10 Td (which ) Tj ET Q q 0 0 0 rg BT 318.80 344.10 Td (account ) Tj ET Q q 0 0 0 rg BT 352.93 344.10 Td (for ) Tj ET Q q 0 0 0 rg BT 367.62 344.10 Td (nearly ) Tj ET Q q 0 0 0 rg BT 395.64 344.10 Td (100% ) Tj ET Q q 0 0 0 rg BT 422.00 344.10 Td (of ) Tj ET Q q 0 0 0 rg BT 433.36 344.10 Td (our ) Tj ET Q q 0 0 0 rg BT 449.73 344.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 473.87 344.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 494.69 344.10 Td (revenues. ) Tj ET Q q 0 0 0 rg BT 535.76 344.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 563.78 344.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 332.10 Td (current ) Tj ET Q q 0 0 0 rg BT 66.76 332.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 91.43 332.10 Td (of ) Tj ET Q q 0 0 0 rg BT 102.21 332.10 Td (the ) Tj ET Q q 0 0 0 rg BT 116.87 332.10 Td (IMAs, ) Tj ET Q q 0 0 0 rg BT 145.16 332.10 Td (our ) Tj ET Q q 0 0 0 rg BT 160.94 332.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 206.70 332.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 249.70 332.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 282.69 332.10 Td (us ) Tj ET Q q 0 0 0 rg BT 294.03 332.10 Td (with ) Tj ET Q q 0 0 0 rg BT 314.26 332.10 Td (weekly ) Tj ET Q q 0 0 0 rg BT 345.58 332.10 Td (information ) Tj ET Q q 0 0 0 rg BT 395.25 332.10 Td (with ) Tj ET Q q 0 0 0 rg BT 415.47 332.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 446.24 332.10 Td (to ) Tj ET Q q 0 0 0 rg BT 456.46 332.10 Td (months ) Tj ET Q q 0 0 0 rg BT 488.36 332.10 Td (on ) Tj ET Q q 0 0 0 rg BT 500.81 332.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 522.70 332.10 Td (product-level ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 320.10 Td (inventories ) Tj ET Q q 0 0 0 rg BT 82.73 320.10 Td (and ) Tj ET Q q 0 0 0 rg BT 99.47 320.10 Td (the ) Tj ET Q q 0 0 0 rg BT 113.98 320.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 146.27 320.10 Td (of ) Tj ET Q q 0 0 0 rg BT 156.90 320.10 Td (out-movement ) Tj ET Q q 0 0 0 rg BT 217.52 320.10 Td (of ) Tj ET Q q 0 0 0 rg BT 228.15 320.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 267.22 320.10 Td (The ) Tj ET Q q 0 0 0 rg BT 285.06 320.10 Td (three ) Tj ET Q q 0 0 0 rg BT 307.34 320.10 Td (lar) Tj ET Q q 0 0 0 rg BT 317.71 320.10 Td (gest ) Tj ET Q q 0 0 0 rg BT 336.11 320.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 385.62 320.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 424.01 320.10 Td (account ) Tj ET Q q 0 0 0 rg BT 457.40 320.10 Td (for ) Tj ET Q q 0 0 0 rg BT 471.36 320.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 531.42 320.10 Td (95% ) Tj ET Q q 0 0 0 rg BT 552.04 320.10 Td (of ) Tj ET Q q 0 0 0 rg BT 562.67 320.10 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 308.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 59.09 308.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 78.85 308.10 Td (revenues. ) Tj ET Q q 0 0 0 rg BT 118.72 308.10 Td (The ) Tj ET Q q 0 0 0 rg BT 136.24 308.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 176.55 308.10 Td (information ) Tj ET Q q 0 0 0 rg BT 225.73 308.10 Td (received ) Tj ET Q q 0 0 0 rg BT 261.57 308.10 Td (from ) Tj ET Q q 0 0 0 rg BT 282.99 308.10 Td (our ) Tj ET Q q 0 0 0 rg BT 298.29 308.10 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 349.98 308.10 Td (together ) Tj ET Q q 0 0 0 rg BT 384.72 308.10 Td (with ) Tj ET Q q 0 0 0 rg BT 404.47 308.10 Td (our ) Tj ET Q q 0 0 0 rg BT 419.78 308.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 452.30 308.10 Td (information, ) Tj ET Q q 0 0 0 rg BT 503.99 308.10 Td (is ) Tj ET Q q 0 0 0 rg BT 512.63 308.10 Td (used ) Tj ET Q q 0 0 0 rg BT 532.94 308.10 Td (to ) Tj ET Q q 0 0 0 rg BT 542.69 308.10 Td (estimate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 296.10 Td (months ) Tj ET Q q 0 0 0 rg BT 66.87 296.10 Td (on ) Tj ET Q q 0 0 0 rg BT 78.30 296.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 99.16 296.10 Td (product ) Tj ET Q q 0 0 0 rg BT 131.14 296.10 Td (level ) Tj ET Q q 0 0 0 rg BT 152.00 296.10 Td (inventories ) Tj ET Q q 0 0 0 rg BT 197.86 296.10 Td (at ) Tj ET Q q 0 0 0 rg BT 206.50 296.10 Td (these ) Tj ET Q q 0 0 0 rg BT 228.47 296.10 Td (wholesalers. ) Tj ET Q q 0 0 0 rg BT 279.50 296.10 Td (W) Tj ET Q q 0 0 0 rg BT 288.14 296.10 Td (e ) Tj ET Q q 0 0 0 rg BT 294.00 296.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 328.75 296.10 Td (months ) Tj ET Q q 0 0 0 rg BT 359.62 296.10 Td (on ) Tj ET Q q 0 0 0 rg BT 371.05 296.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 391.91 296.10 Td (product ) Tj ET Q q 0 0 0 rg BT 423.89 296.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 463.64 296.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 488.39 296.10 Td (for ) Tj ET Q q 0 0 0 rg BT 501.47 296.10 Td (our ) Tj ET Q q 0 0 0 rg BT 516.23 296.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 535.44 296.10 Td (business’) Tj ET Q q 0 0 0 rg BT 572.11 296.10 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 284.10 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 81.86 284.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 124.95 284.10 Td (other ) Tj ET Q q 0 0 0 rg BT 148.04 284.10 Td (than ) Tj ET Q q 0 0 0 rg BT 167.80 284.10 Td (the ) Tj ET Q q 0 0 0 rg BT 182.56 284.10 Td (three ) Tj ET Q q 0 0 0 rg BT 205.09 284.10 Td (lar) Tj ET Q q 0 0 0 rg BT 215.46 284.10 Td (gest ) Tj ET Q q 0 0 0 rg BT 234.11 284.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 283.86 284.10 Td (by ) Tj ET Q q 0 0 0 rg BT 296.41 284.10 Td (extrapolating ) Tj ET Q q 0 0 0 rg BT 351.71 284.10 Td (from ) Tj ET Q q 0 0 0 rg BT 373.69 284.10 Td (the ) Tj ET Q q 0 0 0 rg BT 388.45 284.10 Td (months ) Tj ET Q q 0 0 0 rg BT 420.44 284.10 Td (on ) Tj ET Q q 0 0 0 rg BT 432.99 284.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 454.97 284.10 Td (calculated ) Tj ET Q q 0 0 0 rg BT 498.04 284.10 Td (for ) Tj ET Q q 0 0 0 rg BT 512.25 284.10 Td (the ) Tj ET Q q 0 0 0 rg BT 527.01 284.10 Td (three ) Tj ET Q q 0 0 0 rg BT 549.54 284.10 Td (lar) Tj ET Q q 0 0 0 rg BT 559.90 284.10 Td (gest ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 272.10 Td (wholesalers. ) Tj ET Q q 0 0 0 rg BT 88.16 272.10 Td (In ) Tj ET Q q 0 0 0 rg BT 98.95 272.10 Td (contrast, ) Tj ET Q q 0 0 0 rg BT 135.56 272.10 Td (our ) Tj ET Q q 0 0 0 rg BT 151.35 272.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 189.92 272.10 Td (business ) Tj ET Q q 0 0 0 rg BT 226.26 272.10 Td (has ) Tj ET Q q 0 0 0 rg BT 242.05 272.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 294.50 272.10 Td (more ) Tj ET Q q 0 0 0 rg BT 317.50 272.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 342.72 272.10 Td (customers, ) Tj ET Q q 0 0 0 rg BT 388.22 272.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 419.01 272.10 Td (information ) Tj ET Q q 0 0 0 rg BT 468.68 272.10 Td (on ) Tj ET Q q 0 0 0 rg BT 481.13 272.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 506.35 272.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 545.46 272.10 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 260.10 Td (level ) Tj ET Q q 0 0 0 rg BT 58.58 260.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 100.05 260.10 Td (and ) Tj ET Q q 0 0 0 rg BT 117.64 260.10 Td (corresponding ) Tj ET Q q 0 0 0 rg BT 177.99 260.10 Td (out-movement ) Tj ET Q q 0 0 0 rg BT 239.46 260.10 Td (information ) Tj ET Q q 0 0 0 rg BT 289.82 260.10 Td (and ) Tj ET Q q 0 0 0 rg BT 307.40 260.10 Td (the ) Tj ET Q q 0 0 0 rg BT 322.77 260.10 Td (reliability ) Tj ET Q q 0 0 0 rg BT 364.79 260.10 Td (of ) Tj ET Q q 0 0 0 rg BT 376.27 260.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 422.18 260.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 456.98 260.10 Td (information, ) Tj ET Q q 0 0 0 rg BT 509.84 260.10 Td (where ) Tj ET Q q 0 0 0 rg BT 537.42 260.10 Td (available, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 248.10 Td (varies ) Tj ET Q q 0 0 0 rg BT 61.86 248.10 Td (widely) Tj ET Q q 0 0 0 rg BT 88.42 248.10 Td (. ) Tj ET Q q 0 0 0 rg BT 92.47 248.10 Td (Accordingly) Tj ET Q q 0 0 0 rg BT 141.80 248.10 Td (, ) Tj ET Q q 0 0 0 rg BT 146.28 248.10 Td (we ) Tj ET Q q 0 0 0 rg BT 159.92 248.10 Td (rely ) Tj ET Q q 0 0 0 rg BT 177.45 248.10 Td (on ) Tj ET Q q 0 0 0 rg BT 189.43 248.10 Td (a ) Tj ET Q q 0 0 0 rg BT 195.85 248.10 Td (variety ) Tj ET Q q 0 0 0 rg BT 225.59 248.10 Td (of ) Tj ET Q q 0 0 0 rg BT 235.90 248.10 Td (methods ) Tj ET Q q 0 0 0 rg BT 271.77 248.10 Td (to ) Tj ET Q q 0 0 0 rg BT 281.53 248.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 316.83 248.10 Td (months ) Tj ET Q q 0 0 0 rg BT 348.26 248.10 Td (on ) Tj ET Q q 0 0 0 rg BT 360.24 248.10 Td (hand ) Tj ET Q q 0 0 0 rg BT 381.65 248.10 Td (product ) Tj ET Q q 0 0 0 rg BT 414.18 248.10 Td (level ) Tj ET Q q 0 0 0 rg BT 435.59 248.10 Td (inventories ) Tj ET Q q 0 0 0 rg BT 482.01 248.10 Td (for ) Tj ET Q q 0 0 0 rg BT 495.65 248.10 Td (these ) Tj ET Q q 0 0 0 rg BT 518.18 248.10 Td (business ) Tj ET Q q 0 0 0 rg BT 554.05 248.10 Td (units.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 224.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 224.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.58 224.10 Td (believe ) Tj ET Q q 0 0 0 rg BT 82.95 224.10 Td (the ) Tj ET Q q 0 0 0 rg BT 97.67 224.10 Td (above-described ) Tj ET Q q 0 0 0 rg BT 165.69 224.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 212.05 224.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 245.10 224.10 Td (a ) Tj ET Q q 0 0 0 rg BT 252.04 224.10 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 297.29 224.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 319.79 224.10 Td (to ) Tj ET Q q 0 0 0 rg BT 330.07 224.10 Td (ensure ) Tj ET Q q 0 0 0 rg BT 358.67 224.10 Td (compliance ) Tj ET Q q 0 0 0 rg BT 407.26 224.10 Td (with ) Tj ET Q q 0 0 0 rg BT 427.54 224.10 Td (the ) Tj ET Q q 0 0 0 rg BT 442.25 224.10 Td (Consent.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 200.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.81 200.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 84.57 200.10 Td (as ) Tj ET Q q 0 0 0 rg BT 95.38 200.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 140.08 200.10 Td (disclosed, ) Tj ET Q q 0 0 0 rg BT 182.28 200.10 Td (in ) Tj ET Q q 0 0 0 rg BT 192.54 200.10 Td (October ) Tj ET Q q 0 0 0 rg BT 227.23 200.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 252.21 200.10 Td (the ) Tj ET Q q 0 0 0 rg BT 266.91 200.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 308.28 200.10 Td (reached ) Tj ET Q q 0 0 0 rg BT 341.84 200.10 Td (a ) Tj ET Q q 0 0 0 rg BT 348.76 200.10 Td (civil ) Tj ET Q q 0 0 0 rg BT 369.02 200.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 412.60 200.10 Td (with ) Tj ET Q q 0 0 0 rg BT 432.86 200.10 Td (the ) Tj ET Q q 0 0 0 rg BT 447.56 200.10 Td (SEC ) Tj ET Q q 0 0 0 rg BT 468.38 200.10 Td (of ) Tj ET Q q 0 0 0 rg BT 479.19 200.10 Td (alleged ) Tj ET Q q 0 0 0 rg BT 510.54 200.10 Td (FCP) Tj ET Q q 0 0 0 rg BT 527.42 200.10 Td (A) Tj ET Q q 0 0 0 rg BT 534.09 200.10 Td ( ) Tj ET Q q 0 0 0 rg BT 536.57 200.10 Td (violations ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 188.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.12 188.10 Td (which ) Tj ET Q q 0 0 0 rg BT 72.91 188.10 Td (the ) Tj ET Q q 0 0 0 rg BT 87.47 188.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 128.71 188.10 Td (agreed ) Tj ET Q q 0 0 0 rg BT 157.70 188.10 Td (to ) Tj ET Q q 0 0 0 rg BT 167.82 188.10 Td (pay ) Tj ET Q q 0 0 0 rg BT 184.61 188.10 Td (approximately $14.7 ) Tj ET Q q 0 0 0 rg BT 269.71 188.10 Td (million in ) Tj ET Q q 0 0 0 rg BT 311.23 188.10 Td (disgor) Tj ET Q q 0 0 0 rg BT 336.05 188.10 Td (gement, ) Tj ET Q q 0 0 0 rg BT 370.33 188.10 Td (penalties ) Tj ET Q q 0 0 0 rg BT 408.21 188.10 Td (and ) Tj ET Q q 0 0 0 rg BT 425.00 188.10 Td (interest.  ) Tj ET Q q 0 0 0 rg BT 461.26 188.10 Td (As ) Tj ET Q q 0 0 0 rg BT 474.72 188.10 Td (part ) Tj ET Q q 0 0 0 rg BT 492.61 188.10 Td (of ) Tj ET Q q 0 0 0 rg BT 503.29 188.10 Td (the ) Tj ET Q q 0 0 0 rg BT 517.85 188.10 Td (settlement, ) Tj ET Q q 0 0 0 rg BT 563.80 188.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 176.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 78.23 176.10 Td (also ) Tj ET Q q 0 0 0 rg BT 97.68 176.10 Td (agreed ) Tj ET Q q 0 0 0 rg BT 127.66 176.10 Td (to ) Tj ET Q q 0 0 0 rg BT 138.78 176.10 Td (a ) Tj ET Q q 0 0 0 rg BT 146.56 176.10 Td (two-year ) Tj ET Q q 0 0 0 rg BT 185.44 176.10 Td (self-monitoring ) Tj ET Q q 0 0 0 rg BT 251.00 176.10 Td (period ) Tj ET Q q 0 0 0 rg BT 279.88 176.10 Td (of ) Tj ET Q q 0 0 0 rg BT 291.56 176.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 331.55 176.10 Td (to ) Tj ET Q q 0 0 0 rg BT 342.67 176.10 Td (the ) Tj ET Q q 0 0 0 rg BT 358.23 176.10 Td (government ) Tj ET Q q 0 0 0 rg BT 409.33 176.10 Td (and ) Tj ET Q q 0 0 0 rg BT 427.11 176.10 Td (is ) Tj ET Q q 0 0 0 rg BT 437.13 176.10 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 488.24 176.10 Td ( ) Tj ET Q q 0 0 0 rg BT 491.58 176.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 538.79 176.10 Td (to ) Tj ET Q q 0 0 0 rg BT 549.90 176.10 Td (ensure ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 164.10 Td (compliance.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 140.10 Td (Recently Issued ) Tj ET Q q 0 0 0 rg BT 104.89 140.10 Td (Accounting Standards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 116.10 Td (For ) Tj ET Q q 0 0 0 rg BT 54.28 116.10 Td (recently ) Tj ET Q q 0 0 0 rg BT 90.86 116.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 120.25 116.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 168.50 116.10 Td (standards, ) Tj ET Q q 0 0 0 rg BT 213.16 116.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 236.41 116.10 Td (to ) Tj ET Q q 0 0 0 rg BT 248.57 116.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 275.72 116.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 287.60 116.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 329.20 116.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.90 116.10 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.90 116.10 Td (. ) Tj ET Q q 0 0 0 rg BT 417.82 116.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 468.86 116.10 Td (Policies—Recently ) Tj ET Q q 0 0 0 rg BT 550.45 116.10 Td (Issued ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 104.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 85.16 104.10 Td (Standards.”) Tj ET Q endstream endobj 89 0 obj <> endobj 90 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (44) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Critical ) Tj ET Q q 0 0 0 rg BT 70.71 749.25 Td (Accounting Policies) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.87 725.25 Td (preparation ) Tj ET Q q 0 0 0 rg BT 103.72 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 115.38 725.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 153.68 725.25 Td (statements ) Tj ET Q q 0 0 0 rg BT 199.22 725.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 234.75 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 250.28 725.25 Td (use ) Tj ET Q q 0 0 0 rg BT 266.94 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 278.59 725.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 319.13 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 336.89 725.25 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 389.66 725.25 Td (that ) Tj ET Q q 0 0 0 rg BT 407.98 725.25 Td (af) Tj ET Q q 0 0 0 rg BT 415.56 725.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 433.87 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 449.41 725.25 Td (reported ) Tj ET Q q 0 0 0 rg BT 486.05 725.25 Td (amounts ) Tj ET Q q 0 0 0 rg BT 523.26 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 534.91 725.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 561.56 725.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 76.48 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 94.19 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 109.67 713.25 Td (reported ) Tj ET Q q 0 0 0 rg BT 146.25 713.25 Td (amounts ) Tj ET Q q 0 0 0 rg BT 183.41 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 195.00 713.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 229.92 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 247.62 713.25 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 289.49 713.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 308.30 713.25 Td (critical ) Tj ET Q q 0 0 0 rg BT 339.33 713.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 386.47 713.25 Td (policies ) Tj ET Q q 0 0 0 rg BT 420.84 713.25 Td (are ) Tj ET Q q 0 0 0 rg BT 436.31 713.25 Td (those ) Tj ET Q q 0 0 0 rg BT 460.69 713.25 Td (that ) Tj ET Q q 0 0 0 rg BT 478.95 713.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 532.21 713.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 562.68 713.25 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 73.14 701.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 113.07 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 129.67 701.25 Td (results ) Tj ET Q q 0 0 0 rg BT 157.94 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 168.43 701.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 212.24 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 228.84 701.25 Td (require ) Tj ET Q q 0 0 0 rg BT 259.32 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 273.69 701.25 Td (most ) Tj ET Q q 0 0 0 rg BT 295.30 701.25 Td (dif) Tj ET Q q 0 0 0 rg BT 306.23 701.25 Td (ficult, ) Tj ET Q q 0 0 0 rg BT 331.99 701.25 Td (subjective ) Tj ET Q q 0 0 0 rg BT 374.69 701.25 Td (or ) Tj ET Q q 0 0 0 rg BT 385.18 701.25 Td (complex ) Tj ET Q q 0 0 0 rg BT 421.78 701.25 Td (judgments, ) Tj ET Q q 0 0 0 rg BT 468.10 701.25 Td (often ) Tj ET Q q 0 0 0 rg BT 490.81 701.25 Td (as ) Tj ET Q q 0 0 0 rg BT 501.30 701.25 Td (a ) Tj ET Q q 0 0 0 rg BT 507.90 701.25 Td (result ) Tj ET Q q 0 0 0 rg BT 532.27 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 542.76 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 557.14 701.25 Td (need ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (to ) Tj ET Q q 0 0 0 rg BT 45.84 689.25 Td (make ) Tj ET Q q 0 0 0 rg BT 69.55 689.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 108.83 689.25 Td (about ) Tj ET Q q 0 0 0 rg BT 133.10 689.25 Td (the ) Tj ET Q q 0 0 0 rg BT 147.38 689.25 Td (ef) Tj ET Q q 0 0 0 rg BT 154.97 689.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 172.02 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 182.41 689.25 Td (matters ) Tj ET Q q 0 0 0 rg BT 213.90 689.25 Td (that ) Tj ET Q q 0 0 0 rg BT 230.96 689.25 Td (are ) Tj ET Q q 0 0 0 rg BT 245.22 689.25 Td (inherently ) Tj ET Q q 0 0 0 rg BT 287.83 689.25 Td (uncertain. ) Tj ET Q q 0 0 0 rg BT 329.59 689.25 Td (Because ) Tj ET Q q 0 0 0 rg BT 364.96 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 375.36 689.25 Td (this ) Tj ET Q q 0 0 0 rg BT 391.86 689.25 Td (uncertainty) Tj ET Q q 0 0 0 rg BT 436.20 689.25 Td (, ) Tj ET Q q 0 0 0 rg BT 440.76 689.25 Td (actual ) Tj ET Q q 0 0 0 rg BT 466.69 689.25 Td (results ) Tj ET Q q 0 0 0 rg BT 494.86 689.25 Td (may ) Tj ET Q q 0 0 0 rg BT 514.13 689.25 Td (vary ) Tj ET Q q 0 0 0 rg BT 533.96 689.25 Td (from ) Tj ET Q q 0 0 0 rg BT 555.46 689.25 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (estimates.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (Revenue Recognition) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.44 629.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 101.20 629.25 Td (policy ) Tj ET Q q 0 0 0 rg BT 129.09 629.25 Td (for ) Tj ET Q q 0 0 0 rg BT 143.64 629.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 178.17 629.25 Td (recognition ) Tj ET Q q 0 0 0 rg BT 226.60 629.25 Td (has ) Tj ET Q q 0 0 0 rg BT 242.82 629.25 Td (a ) Tj ET Q q 0 0 0 rg BT 250.15 629.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 295.82 629.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 325.92 629.25 Td (on ) Tj ET Q q 0 0 0 rg BT 338.81 629.25 Td (reported ) Tj ET Q q 0 0 0 rg BT 375.01 629.25 Td (results ) Tj ET Q q 0 0 0 rg BT 404.01 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 421.34 629.25 Td (relies ) Tj ET Q q 0 0 0 rg BT 445.88 629.25 Td (on ) Tj ET Q q 0 0 0 rg BT 458.77 629.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 488.86 629.25 Td (estimates. ) Tj ET Q q 0 0 0 rg BT 531.47 629.25 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 569.34 629.25 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 81.51 617.25 Td (when ) Tj ET Q q 0 0 0 rg BT 104.82 617.25 Td (persuasive ) Tj ET Q q 0 0 0 rg BT 148.67 617.25 Td (evidence ) Tj ET Q q 0 0 0 rg BT 185.85 617.25 Td (of ) Tj ET Q q 0 0 0 rg BT 195.83 617.25 Td (an ) Tj ET Q q 0 0 0 rg BT 206.92 617.25 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 258.54 617.25 Td (exists, ) Tj ET Q q 0 0 0 rg BT 285.46 617.25 Td (the ) Tj ET Q q 0 0 0 rg BT 299.33 617.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 320.41 617.25 Td (price ) Tj ET Q q 0 0 0 rg BT 342.05 617.25 Td (is ) Tj ET Q q 0 0 0 rg BT 350.37 617.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 372.56 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 382.54 617.25 Td (determinable, ) Tj ET Q q 0 0 0 rg BT 438.88 617.25 Td (collectability ) Tj ET Q q 0 0 0 rg BT 492.73 617.25 Td (is ) Tj ET Q q 0 0 0 rg BT 501.05 617.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 546.01 617.25 Td (assured ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.72 605.25 Td (title ) Tj ET Q q 0 0 0 rg BT 72.56 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 90.29 605.25 Td (substantially ) Tj ET Q q 0 0 0 rg BT 144.13 605.25 Td (all ) Tj ET Q q 0 0 0 rg BT 157.41 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 169.02 605.25 Td (the ) Tj ET Q q 0 0 0 rg BT 184.53 605.25 Td (risks ) Tj ET Q q 0 0 0 rg BT 206.70 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 224.43 605.25 Td (rewards ) Tj ET Q q 0 0 0 rg BT 259.36 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 270.98 605.25 Td (ownership ) Tj ET Q q 0 0 0 rg BT 315.93 605.25 Td (have ) Tj ET Q q 0 0 0 rg BT 338.09 605.25 Td (transferred ) Tj ET Q q 0 0 0 rg BT 384.68 605.25 Td (\(generally ) Tj ET Q q 0 0 0 rg BT 428.50 605.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 451.79 605.25 Td (shipment ) Tj ET Q q 0 0 0 rg BT 491.74 605.25 Td (except ) Tj ET Q q 0 0 0 rg BT 521.12 605.25 Td (in ) Tj ET Q q 0 0 0 rg BT 532.18 605.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 562.67 605.25 Td (EU ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 69.91 593.25 Td (which ) Tj ET Q q 0 0 0 rg BT 96.61 593.25 Td (does ) Tj ET Q q 0 0 0 rg BT 117.20 593.25 Td (not ) Tj ET Q q 0 0 0 rg BT 132.23 593.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 156.70 593.25 Td (until ) Tj ET Q q 0 0 0 rg BT 177.29 593.25 Td (delivery ) Tj ET Q q 0 0 0 rg BT 212.31 593.25 Td (of ) Tj ET Q q 0 0 0 rg BT 222.90 593.25 Td (the ) Tj ET Q q 0 0 0 rg BT 237.37 593.25 Td (products ) Tj ET Q q 0 0 0 rg BT 274.07 593.25 Td (to ) Tj ET Q q 0 0 0 rg BT 284.10 593.25 Td (the ) Tj ET Q q 0 0 0 rg BT 298.58 593.25 Td (customer\). ) Tj ET Q q 0 0 0 rg BT 343.32 593.25 Td (In ) Tj ET Q q 0 0 0 rg BT 353.91 593.25 Td (2014, ) Tj ET Q q 0 0 0 rg BT 378.66 593.25 Td (we ) Tj ET Q q 0 0 0 rg BT 392.58 593.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 428.14 593.25 Td (approximately ) Tj ET Q q 0 0 0 rg BT 488.16 593.25 Td ($300 ) Tj ET Q q 0 0 0 rg BT 510.42 593.25 Td (million ) Tj ET Q q 0 0 0 rg BT 541.57 593.25 Td (invoiced ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 50.38 581.25 Td (Daklinza) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 86.49 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 89.22 581.25 Td (under ) Tj ET Q q 0 0 0 rg BT 114.71 581.25 Td (an ) Tj ET Q q 0 0 0 rg BT 126.87 581.25 Td (early ) Tj ET Q q 0 0 0 rg BT 149.58 581.25 Td (access ) Tj ET Q q 0 0 0 rg BT 177.85 581.25 Td (program ) Tj ET Q q 0 0 0 rg BT 214.45 581.25 Td (in ) Tj ET Q q 0 0 0 rg BT 224.95 581.25 Td (France. ) Tj ET Q q 0 0 0 rg BT 256.78 581.25 Td (A) Tj ET Q q 0 0 0 rg BT 263.45 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 266.17 581.25 Td (portion ) Tj ET Q q 0 0 0 rg BT 297.79 581.25 Td (of ) Tj ET Q q 0 0 0 rg BT 308.84 581.25 Td (this ) Tj ET Q q 0 0 0 rg BT 326.01 581.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 358.73 581.25 Td (was ) Tj ET Q q 0 0 0 rg BT 377.01 581.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 423.60 581.25 Td (as ) Tj ET Q q 0 0 0 rg BT 434.65 581.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 469.02 581.25 Td (in ) Tj ET Q q 0 0 0 rg BT 479.52 581.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 502.25 581.25 Td (when ) Tj ET Q q 0 0 0 rg BT 526.63 581.25 Td (final ) Tj ET Q q 0 0 0 rg BT 547.68 581.25 Td (pricing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (was ) Tj ET Q q 0 0 0 rg BT 53.79 569.25 Td (obtained. ) Tj ET Q q 0 0 0 rg BT 92.96 569.25 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 130.18 569.25 Td (is ) Tj ET Q q 0 0 0 rg BT 139.08 569.25 Td (also ) Tj ET Q q 0 0 0 rg BT 157.43 569.25 Td (reduced ) Tj ET Q q 0 0 0 rg BT 191.31 569.25 Td (for ) Tj ET Q q 0 0 0 rg BT 205.20 569.25 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 255.21 569.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 276.88 569.25 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 326.89 569.25 Td (discussed ) Tj ET Q q 0 0 0 rg BT 367.45 569.25 Td (below) Tj ET Q q 0 0 0 rg BT 391.24 569.25 Td (, ) Tj ET Q q 0 0 0 rg BT 395.98 569.25 Td (all ) Tj ET Q q 0 0 0 rg BT 408.21 569.25 Td (of ) Tj ET Q q 0 0 0 rg BT 418.77 569.25 Td (which ) Tj ET Q q 0 0 0 rg BT 445.45 569.25 Td (involve ) Tj ET Q q 0 0 0 rg BT 477.68 569.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 522.13 569.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 561.57 569.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (judgment ) Tj ET Q q 0 0 0 rg BT 75.25 557.25 Td (after ) Tj ET Q q 0 0 0 rg BT 95.03 557.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 143.16 557.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 164.07 557.25 Td (interpretations ) Tj ET Q q 0 0 0 rg BT 223.30 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 233.10 557.25 Td (applicable ) Tj ET Q q 0 0 0 rg BT 275.66 557.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 295.46 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 311.37 557.25 Td (regulations, ) Tj ET Q q 0 0 0 rg BT 359.78 557.25 Td (historical ) Tj ET Q q 0 0 0 rg BT 398.46 557.25 Td (experience, ) Tj ET Q q 0 0 0 rg BT 445.74 557.25 Td (payer ) Tj ET Q q 0 0 0 rg BT 469.42 557.25 Td (channel ) Tj ET Q q 0 0 0 rg BT 501.98 557.25 Td (mix ) Tj ET Q q 0 0 0 rg BT 519.01 557.25 Td (\(e.g. ) Tj ET Q q 0 0 0 rg BT 538.25 557.25 Td (Medicare ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (or ) Tj ET Q q 0 0 0 rg BT 47.30 545.25 Td (Medicaid\), ) Tj ET Q q 0 0 0 rg BT 93.87 545.25 Td (current ) Tj ET Q q 0 0 0 rg BT 125.16 545.25 Td (contract ) Tj ET Q q 0 0 0 rg BT 160.33 545.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 187.18 545.25 Td (under ) Tj ET Q q 0 0 0 rg BT 212.92 545.25 Td (applicable ) Tj ET Q q 0 0 0 rg BT 256.98 545.25 Td (programs, ) Tj ET Q q 0 0 0 rg BT 300.23 545.25 Td (unbilled ) Tj ET Q q 0 0 0 rg BT 335.97 545.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 365.05 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 382.46 545.25 Td (processing ) Tj ET Q q 0 0 0 rg BT 428.20 545.25 Td (time ) Tj ET Q q 0 0 0 rg BT 448.95 545.25 Td (lags ) Tj ET Q q 0 0 0 rg BT 468.03 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 485.44 545.25 Td (inventory ) Tj ET Q q 0 0 0 rg BT 526.74 545.25 Td (levels ) Tj ET Q q 0 0 0 rg BT 553.03 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 563.79 545.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 84.61 533.25 Td (channel. ) Tj ET Q q 0 0 0 rg BT 120.71 533.25 Td (Estimates ) Tj ET Q q 0 0 0 rg BT 162.09 533.25 Td (are ) Tj ET Q q 0 0 0 rg BT 176.80 533.25 Td (assessed ) Tj ET Q q 0 0 0 rg BT 213.18 533.25 Td (each ) Tj ET Q q 0 0 0 rg BT 233.99 533.25 Td (period ) Tj ET Q q 0 0 0 rg BT 262.04 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 278.98 533.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 314.80 533.25 Td (as ) Tj ET Q q 0 0 0 rg BT 325.63 533.25 Td (required ) Tj ET Q q 0 0 0 rg BT 361.45 533.25 Td (to ) Tj ET Q q 0 0 0 rg BT 371.73 533.25 Td (revised ) Tj ET Q q 0 0 0 rg BT 403.10 533.25 Td (information ) Tj ET Q q 0 0 0 rg BT 452.82 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 463.65 533.25 Td (actual ) Tj ET Q q 0 0 0 rg BT 490.02 533.25 Td (experience. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.75 509.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 80.27 509.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 136.55 509.25 Td (involving ) Tj ET Q q 0 0 0 rg BT 177.31 509.25 Td (the ) Tj ET Q q 0 0 0 rg BT 191.95 509.25 Td (delivery ) Tj ET Q q 0 0 0 rg BT 227.14 509.25 Td (of ) Tj ET Q q 0 0 0 rg BT 237.90 509.25 Td (more ) Tj ET Q q 0 0 0 rg BT 260.87 509.25 Td (than ) Tj ET Q q 0 0 0 rg BT 280.51 509.25 Td (one ) Tj ET Q q 0 0 0 rg BT 297.37 509.25 Td (element, ) Tj ET Q q 0 0 0 rg BT 333.95 509.25 Td (each ) Tj ET Q q 0 0 0 rg BT 354.69 509.25 Td (undelivered ) Tj ET Q q 0 0 0 rg BT 404.31 509.25 Td (element ) Tj ET Q q 0 0 0 rg BT 438.39 509.25 Td (is ) Tj ET Q q 0 0 0 rg BT 447.48 509.25 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 488.22 509.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 522.85 509.25 Td (it ) Tj ET Q q 0 0 0 rg BT 530.83 509.25 Td (qualifies ) Tj ET Q q 0 0 0 rg BT 567.69 509.25 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (a ) Tj ET Q q 0 0 0 rg BT 41.90 497.25 Td (separate ) Tj ET Q q 0 0 0 rg BT 76.11 497.25 Td (unit ) Tj ET Q q 0 0 0 rg BT 93.12 497.25 Td (of ) Tj ET Q q 0 0 0 rg BT 102.91 497.25 Td (accounting. ) Tj ET Q q 0 0 0 rg BT 150.63 497.25 Td (The ) Tj ET Q q 0 0 0 rg BT 167.64 497.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 222.97 497.25 Td (that ) Tj ET Q q 0 0 0 rg BT 239.42 497.25 Td (is ) Tj ET Q q 0 0 0 rg BT 247.55 497.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 269.55 497.25 Td (or ) Tj ET Q q 0 0 0 rg BT 279.34 497.25 Td (determinable ) Tj ET Q q 0 0 0 rg BT 332.99 497.25 Td (is ) Tj ET Q q 0 0 0 rg BT 341.12 497.25 Td (then ) Tj ET Q q 0 0 0 rg BT 359.80 497.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 397.34 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 406.58 497.25 Td (each ) Tj ET Q q 0 0 0 rg BT 426.35 497.25 Td (undelivered ) Tj ET Q q 0 0 0 rg BT 475.01 497.25 Td (element ) Tj ET Q q 0 0 0 rg BT 508.12 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 524.01 497.25 Td (is ) Tj ET Q q 0 0 0 rg BT 532.14 497.25 Td (recognized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (as ) Tj ET Q q 0 0 0 rg BT 46.77 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 61.42 485.25 Td (related ) Tj ET Q q 0 0 0 rg BT 91.06 485.25 Td (goods ) Tj ET Q q 0 0 0 rg BT 117.38 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 128.15 485.25 Td (services ) Tj ET Q q 0 0 0 rg BT 162.79 485.25 Td (are ) Tj ET Q q 0 0 0 rg BT 177.43 485.25 Td (delivered, ) Tj ET Q q 0 0 0 rg BT 219.57 485.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 250.34 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 260.55 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 275.20 485.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 331.51 485.25 Td (that ) Tj ET Q q 0 0 0 rg BT 348.94 485.25 Td (is ) Tj ET Q q 0 0 0 rg BT 358.05 485.25 Td (not ) Tj ET Q q 0 0 0 rg BT 373.26 485.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 417.91 485.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 440.34 485.25 Td (future ) Tj ET Q q 0 0 0 rg BT 466.66 485.25 Td (deliverables. ) Tj ET Q q 0 0 0 rg BT 519.90 485.25 Td (Consideration ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (associated ) Tj ET Q q 0 0 0 rg BT 79.05 473.25 Td (with ) Tj ET Q q 0 0 0 rg BT 98.78 473.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 142.95 473.25 Td (milestones ) Tj ET Q q 0 0 0 rg BT 187.68 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 204.07 473.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 240.46 473.25 Td (are ) Tj ET Q q 0 0 0 rg BT 254.62 473.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 292.66 473.25 Td (among ) Tj ET Q q 0 0 0 rg BT 321.83 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 336.00 473.25 Td (underlying ) Tj ET Q q 0 0 0 rg BT 381.28 473.25 Td (elements ) Tj ET Q q 0 0 0 rg BT 418.78 473.25 Td (if ) Tj ET Q q 0 0 0 rg BT 426.84 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 443.24 473.25 Td (when ) Tj ET Q q 0 0 0 rg BT 466.85 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 481.02 473.25 Td (amounts ) Tj ET Q q 0 0 0 rg BT 516.86 473.25 Td (are ) Tj ET Q q 0 0 0 rg BT 531.03 473.25 Td (determined ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 461.25 Td (be ) Tj ET Q q 0 0 0 rg BT 58.22 461.25 Td (payable ) Tj ET Q q 0 0 0 rg BT 91.81 461.25 Td (to ) Tj ET Q q 0 0 0 rg BT 102.09 461.25 Td (BMS.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (Gross-to-Net ) Tj ET Q q 0 0 0 rg BT 90.90 437.25 Td (Adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.39 413.25 Td (following ) Tj ET Q q 0 0 0 rg BT 96.13 413.25 Td (categories ) Tj ET Q q 0 0 0 rg BT 139.51 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 150.68 413.25 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 201.30 413.25 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 251.92 413.25 Td (involve ) Tj ET Q q 0 0 0 rg BT 284.76 413.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 329.82 413.25 Td (estimates, ) Tj ET Q q 0 0 0 rg BT 372.38 413.25 Td (judgments ) Tj ET Q q 0 0 0 rg BT 416.89 413.25 Td (and ) Tj ET Q q 0 0 0 rg BT 434.17 413.25 Td (information ) Tj ET Q q 0 0 0 rg BT 484.23 413.25 Td (obtained ) Tj ET Q q 0 0 0 rg BT 521.51 413.25 Td (from ) Tj ET Q q 0 0 0 rg BT 543.80 413.25 Td (external ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (sources. ) Tj ET Q q 0 0 0 rg BT 72.58 401.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 98.87 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 110.74 401.25 Td (“—T) Tj ET Q q 0 0 0 rg BT 130.58 401.25 Td (otal ) Tj ET Q q 0 0 0 rg BT 149.67 401.25 Td (Revenues” ) Tj ET Q q 0 0 0 rg BT 197.07 401.25 Td (above ) Tj ET Q q 0 0 0 rg BT 225.03 401.25 Td (for ) Tj ET Q q 0 0 0 rg BT 240.78 401.25 Td (further ) Tj ET Q q 0 0 0 rg BT 272.07 401.25 Td (discussion ) Tj ET Q q 0 0 0 rg BT 317.83 401.25 Td (and ) Tj ET Q q 0 0 0 rg BT 336.36 401.25 Td (analysis ) Tj ET Q q 0 0 0 rg BT 372.66 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 385.08 401.25 Td (each ) Tj ET Q q 0 0 0 rg BT 407.48 401.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 453.78 401.25 Td (category ) Tj ET Q q 0 0 0 rg BT 492.29 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 504.71 401.25 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 556.56 401.25 Td (sales ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (adjustments.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 363.9169921875 m 170.3359375 363.9169921875 l s q 0 0 0 rg BT 36.00 365.25 Td (Char) Tj ET Q q 0 0 0 rg BT 56.19 365.25 Td (ge-backs and cash discounts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.03 341.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 74.29 341.25 Td (business ) Tj ET Q q 0 0 0 rg BT 110.66 341.25 Td (participates ) Tj ET Q q 0 0 0 rg BT 159.23 341.25 Td (in ) Tj ET Q q 0 0 0 rg BT 169.48 341.25 Td (programs ) Tj ET Q q 0 0 0 rg BT 209.73 341.25 Td (with ) Tj ET Q q 0 0 0 rg BT 229.99 341.25 Td (government ) Tj ET Q q 0 0 0 rg BT 280.23 341.25 Td (entities, ) Tj ET Q q 0 0 0 rg BT 314.09 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 328.78 341.25 Td (most ) Tj ET Q q 0 0 0 rg BT 350.71 341.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 395.40 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 406.21 341.25 Td (which ) Tj ET Q q 0 0 0 rg BT 433.12 341.25 Td (are ) Tj ET Q q 0 0 0 rg BT 447.81 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 462.50 341.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 482.77 341.25 Td (Department ) Tj ET Q q 0 0 0 rg BT 532.45 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 543.25 341.25 Td (Defense ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.31 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 66.41 329.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 86.06 329.25 Td (Department ) Tj ET Q q 0 0 0 rg BT 135.14 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 145.21 329.25 Td (V) Tj ET Q q 0 0 0 rg BT 151.32 329.25 Td (eterans ) Tj ET Q q 0 0 0 rg BT 181.10 329.25 Td (Af) Tj ET Q q 0 0 0 rg BT 191.47 329.25 Td (fairs, ) Tj ET Q q 0 0 0 rg BT 213.62 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 229.93 329.25 Td (other ) Tj ET Q q 0 0 0 rg BT 252.35 329.25 Td (parties, ) Tj ET Q q 0 0 0 rg BT 283.38 329.25 Td (including ) Tj ET Q q 0 0 0 rg BT 323.03 329.25 Td (covered ) Tj ET Q q 0 0 0 rg BT 356.55 329.25 Td (entities ) Tj ET Q q 0 0 0 rg BT 387.31 329.25 Td (under ) Tj ET Q q 0 0 0 rg BT 411.95 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 426.04 329.25 Td (340B ) Tj ET Q q 0 0 0 rg BT 449.59 329.25 Td (Drug ) Tj ET Q q 0 0 0 rg BT 472.01 329.25 Td (Pricing ) Tj ET Q q 0 0 0 rg BT 502.78 329.25 Td (Program, ) Tj ET Q q 0 0 0 rg BT 541.59 329.25 Td (whereby ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (pricing ) Tj ET Q q 0 0 0 rg BT 66.32 317.25 Td (on ) Tj ET Q q 0 0 0 rg BT 78.31 317.25 Td (products ) Tj ET Q q 0 0 0 rg BT 114.75 317.25 Td (is ) Tj ET Q q 0 0 0 rg BT 123.41 317.25 Td (extended ) Tj ET Q q 0 0 0 rg BT 161.50 317.25 Td (below ) Tj ET Q q 0 0 0 rg BT 187.93 317.25 Td (wholesaler ) Tj ET Q q 0 0 0 rg BT 233.24 317.25 Td (list ) Tj ET Q q 0 0 0 rg BT 247.46 317.25 Td (price ) Tj ET Q q 0 0 0 rg BT 269.44 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 279.22 317.25 Td (participating ) Tj ET Q q 0 0 0 rg BT 331.75 317.25 Td (entities. ) Tj ET Q q 0 0 0 rg BT 364.98 317.25 Td (These ) Tj ET Q q 0 0 0 rg BT 390.85 317.25 Td (entities ) Tj ET Q q 0 0 0 rg BT 421.73 317.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 459.26 317.25 Td (products ) Tj ET Q q 0 0 0 rg BT 495.69 317.25 Td (through ) Tj ET Q q 0 0 0 rg BT 528.80 317.25 Td (wholesalers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (at ) Tj ET Q q 0 0 0 rg BT 45.48 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 59.96 305.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 84.99 305.25 Td (program ) Tj ET Q q 0 0 0 rg BT 121.13 305.25 Td (price ) Tj ET Q q 0 0 0 rg BT 143.38 305.25 Td (and ) Tj ET Q q 0 0 0 rg BT 160.08 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 174.56 305.25 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 224.03 305.25 Td (then ) Tj ET Q q 0 0 0 rg BT 243.51 305.25 Td (char) Tj ET Q q 0 0 0 rg BT 260.54 305.25 Td (ge ) Tj ET Q q 0 0 0 rg BT 272.24 305.25 Td (us ) Tj ET Q q 0 0 0 rg BT 283.40 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 297.88 305.25 Td (dif) Tj ET Q q 0 0 0 rg BT 308.80 305.25 Td (ference ) Tj ET Q q 0 0 0 rg BT 340.48 305.25 Td (between ) Tj ET Q q 0 0 0 rg BT 376.06 305.25 Td (their ) Tj ET Q q 0 0 0 rg BT 396.65 305.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 442.79 305.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 461.16 305.25 Td (and ) Tj ET Q q 0 0 0 rg BT 477.87 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 492.35 305.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 517.38 305.25 Td (program ) Tj ET Q q 0 0 0 rg BT 553.52 305.25 Td (price. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (Accounts ) Tj ET Q q 0 0 0 rg BT 75.95 293.25 Td (receivable ) Tj ET Q q 0 0 0 rg BT 119.22 293.25 Td (is ) Tj ET Q q 0 0 0 rg BT 128.07 293.25 Td (reduced ) Tj ET Q q 0 0 0 rg BT 161.90 293.25 Td (for ) Tj ET Q q 0 0 0 rg BT 175.74 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 190.14 293.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 230.65 293.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 262.83 293.25 Td (of ) Tj ET Q q 0 0 0 rg BT 273.34 293.25 Td (unprocessed ) Tj ET Q q 0 0 0 rg BT 324.96 293.25 Td (char) Tj ET Q q 0 0 0 rg BT 341.98 293.25 Td (ge-back ) Tj ET Q q 0 0 0 rg BT 375.81 293.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 404.10 293.25 Td (attributable ) Tj ET Q q 0 0 0 rg BT 451.82 293.25 Td (to ) Tj ET Q q 0 0 0 rg BT 461.78 293.25 Td (a ) Tj ET Q q 0 0 0 rg BT 468.40 293.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 486.14 293.25 Td (\(typically ) Tj ET Q q 0 0 0 rg BT 526.64 293.25 Td (within ) Tj ET Q q 0 0 0 rg BT 554.38 293.25 Td (a ) Tj ET Q q 0 0 0 rg BT 561.00 293.25 Td (two ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 281.25 Td (four ) Tj ET Q q 0 0 0 rg BT 65.44 281.25 Td (week ) Tj ET Q q 0 0 0 rg BT 89.04 281.25 Td (time ) Tj ET Q q 0 0 0 rg BT 109.31 281.25 Td (lag\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.07 257.25 Td (the ) Tj ET Q q 0 0 0 rg BT 62.03 257.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 82.55 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 99.73 257.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 129.67 257.25 Td (other ) Tj ET Q q 0 0 0 rg BT 152.96 257.25 Td (countries, ) Tj ET Q q 0 0 0 rg BT 194.86 257.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 215.37 257.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 255.89 257.25 Td (are ) Tj ET Q q 0 0 0 rg BT 270.83 257.25 Td (of) Tj ET Q q 0 0 0 rg BT 278.98 257.25 Td (fered ) Tj ET Q q 0 0 0 rg BT 302.26 257.25 Td (as ) Tj ET Q q 0 0 0 rg BT 313.33 257.25 Td (an ) Tj ET Q q 0 0 0 rg BT 325.51 257.25 Td (incentive ) Tj ET Q q 0 0 0 rg BT 364.90 257.25 Td (for ) Tj ET Q q 0 0 0 rg BT 379.30 257.25 Td (prompt ) Tj ET Q q 0 0 0 rg BT 410.93 257.25 Td (payment, ) Tj ET Q q 0 0 0 rg BT 450.60 257.25 Td (generally ) Tj ET Q q 0 0 0 rg BT 490.55 257.25 Td (approximating ) Tj ET Q q 0 0 0 rg BT 551.61 257.25 Td (2% ) Tj ET Q q 0 0 0 rg BT 567.68 257.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.14 245.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 73.50 245.25 Td (price. ) Tj ET Q q 0 0 0 rg BT 98.27 245.25 Td (Accounts ) Tj ET Q q 0 0 0 rg BT 138.96 245.25 Td (receivable ) Tj ET Q q 0 0 0 rg BT 182.96 245.25 Td (is ) Tj ET Q q 0 0 0 rg BT 192.56 245.25 Td (reduced ) Tj ET Q q 0 0 0 rg BT 227.13 245.25 Td (for ) Tj ET Q q 0 0 0 rg BT 241.71 245.25 Td (the ) Tj ET Q q 0 0 0 rg BT 256.85 245.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 298.09 245.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 331.01 245.25 Td (of ) Tj ET Q q 0 0 0 rg BT 342.27 245.25 Td (unprocessed ) Tj ET Q q 0 0 0 rg BT 394.62 245.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 415.31 245.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 456.01 245.25 Td (\(typically ) Tj ET Q q 0 0 0 rg BT 497.26 245.25 Td (within ) Tj ET Q q 0 0 0 rg BT 525.74 245.25 Td (a ) Tj ET Q q 0 0 0 rg BT 533.10 245.25 Td (one ) Tj ET Q q 0 0 0 rg BT 550.46 245.25 Td (month ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (time ) Tj ET Q q 0 0 0 rg BT 56.27 233.25 Td (lag\).) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 207.9169921875 m 163.275390625 207.9169921875 l s q 0 0 0 rg BT 36.00 209.25 Td (Medicaid and Medicar) Tj ET Q q 0 0 0 rg BT 127.27 209.25 Td (e r) Tj ET Q q 0 0 0 rg BT 137.73 209.25 Td (ebates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.86 185.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 75.95 185.25 Td (business ) Tj ET Q q 0 0 0 rg BT 113.15 185.25 Td (participates ) Tj ET Q q 0 0 0 rg BT 162.55 185.25 Td (in ) Tj ET Q q 0 0 0 rg BT 173.63 185.25 Td (state ) Tj ET Q q 0 0 0 rg BT 195.27 185.25 Td (government ) Tj ET Q q 0 0 0 rg BT 246.34 185.25 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 287.41 185.25 Td (programs ) Tj ET Q q 0 0 0 rg BT 328.49 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 346.23 185.25 Td (other ) Tj ET Q q 0 0 0 rg BT 370.09 185.25 Td (qualifying ) Tj ET Q q 0 0 0 rg BT 414.50 185.25 Td (Federal ) Tj ET Q q 0 0 0 rg BT 447.79 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 465.54 185.25 Td (state ) Tj ET Q q 0 0 0 rg BT 487.17 185.25 Td (government ) Tj ET Q q 0 0 0 rg BT 538.25 185.25 Td (programs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (requiring ) Tj ET Q q 0 0 0 rg BT 75.79 173.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 116.71 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 134.28 173.25 Td (rebates ) Tj ET Q q 0 0 0 rg BT 165.74 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 176.65 173.25 Td (participating ) Tj ET Q q 0 0 0 rg BT 230.33 173.25 Td (state ) Tj ET Q q 0 0 0 rg BT 251.79 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 269.36 173.25 Td (local ) Tj ET Q q 0 0 0 rg BT 291.94 173.25 Td (government ) Tj ET Q q 0 0 0 rg BT 342.84 173.25 Td (entities. ) Tj ET Q q 0 0 0 rg BT 376.66 173.25 Td (All ) Tj ET Q q 0 0 0 rg BT 392.58 173.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 433.49 173.25 Td (and ) Tj ET Q q 0 0 0 rg BT 451.07 173.25 Td (rebates ) Tj ET Q q 0 0 0 rg BT 482.52 173.25 Td (provided ) Tj ET Q q 0 0 0 rg BT 521.21 173.25 Td (through ) Tj ET Q q 0 0 0 rg BT 555.45 173.25 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (programs ) Tj ET Q q 0 0 0 rg BT 76.66 161.25 Td (are ) Tj ET Q q 0 0 0 rg BT 91.76 161.25 Td (included ) Tj ET Q q 0 0 0 rg BT 129.09 161.25 Td (in ) Tj ET Q q 0 0 0 rg BT 139.76 161.25 Td (our ) Tj ET Q q 0 0 0 rg BT 155.98 161.25 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 196.63 161.25 Td (rebate ) Tj ET Q q 0 0 0 rg BT 223.95 161.25 Td (accrual. ) Tj ET Q q 0 0 0 rg BT 258.20 161.25 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 298.86 161.25 Td (rebates ) Tj ET Q q 0 0 0 rg BT 330.07 161.25 Td (have ) Tj ET Q q 0 0 0 rg BT 351.84 161.25 Td (also ) Tj ET Q q 0 0 0 rg BT 370.84 161.25 Td (been ) Tj ET Q q 0 0 0 rg BT 392.61 161.25 Td (extended ) Tj ET Q q 0 0 0 rg BT 431.59 161.25 Td (to ) Tj ET Q q 0 0 0 rg BT 442.26 161.25 Td (drugs ) Tj ET Q q 0 0 0 rg BT 467.38 161.25 Td (used ) Tj ET Q q 0 0 0 rg BT 488.60 161.25 Td (in ) Tj ET Q q 0 0 0 rg BT 499.27 161.25 Td (managed ) Tj ET Q q 0 0 0 rg BT 538.25 161.25 Td (Medicaid ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (plans. ) Tj ET Q q 0 0 0 rg BT 61.93 149.25 Td (The ) Tj ET Q q 0 0 0 rg BT 79.97 149.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 120.79 149.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 153.29 149.25 Td (of ) Tj ET Q q 0 0 0 rg BT 164.12 149.25 Td (unpaid ) Tj ET Q q 0 0 0 rg BT 193.84 149.25 Td (or ) Tj ET Q q 0 0 0 rg BT 204.67 149.25 Td (unbilled ) Tj ET Q q 0 0 0 rg BT 239.94 149.25 Td (rebates ) Tj ET Q q 0 0 0 rg BT 270.76 149.25 Td (is ) Tj ET Q q 0 0 0 rg BT 279.93 149.25 Td (presented ) Tj ET Q q 0 0 0 rg BT 320.74 149.25 Td (as ) Tj ET Q q 0 0 0 rg BT 331.57 149.25 Td (a ) Tj ET Q q 0 0 0 rg BT 338.51 149.25 Td (liability) Tj ET Q q 0 0 0 rg BT 368.97 149.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.25 Td (Rebates ) Tj ET Q q 0 0 0 rg BT 70.20 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 87.19 125.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 127.52 125.25 Td (are ) Tj ET Q q 0 0 0 rg BT 142.27 125.25 Td (of) Tj ET Q q 0 0 0 rg BT 150.42 125.25 Td (fered ) Tj ET Q q 0 0 0 rg BT 173.51 125.25 Td (to ) Tj ET Q q 0 0 0 rg BT 183.84 125.25 Td (managed ) Tj ET Q q 0 0 0 rg BT 222.48 125.25 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 266.11 125.25 Td (or) Tj ET Q q 0 0 0 rg BT 274.26 125.25 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 322.35 125.25 Td (in ) Tj ET Q q 0 0 0 rg BT 332.67 125.25 Td (the ) Tj ET Q q 0 0 0 rg BT 347.44 125.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 367.77 125.25 Td (managing ) Tj ET Q q 0 0 0 rg BT 409.75 125.25 Td (prescription ) Tj ET Q q 0 0 0 rg BT 460.07 125.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 480.95 125.25 Td (programs ) Tj ET Q q 0 0 0 rg BT 521.26 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 538.25 125.25 Td (Medicare ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td (Advantage ) Tj ET Q q 0 0 0 rg BT 81.35 113.25 Td (prescription ) Tj ET Q q 0 0 0 rg BT 131.15 113.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 151.51 113.25 Td (plans ) Tj ET Q q 0 0 0 rg BT 174.65 113.25 Td (covering ) Tj ET Q q 0 0 0 rg BT 211.67 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 225.92 113.25 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 265.71 113.25 Td (Part ) Tj ET Q q 0 0 0 rg BT 283.85 113.25 Td (D ) Tj ET Q q 0 0 0 rg BT 293.11 113.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 313.47 113.25 Td (benefit. ) Tj ET Q q 0 0 0 rg BT 345.62 113.25 Td (W) Tj ET Q q 0 0 0 rg BT 354.26 113.25 Td (e ) Tj ET Q q 0 0 0 rg BT 360.73 113.25 Td (also ) Tj ET Q q 0 0 0 rg BT 378.87 113.25 Td (pay ) Tj ET Q q 0 0 0 rg BT 395.35 113.25 Td (a ) Tj ET Q q 0 0 0 rg BT 401.82 113.25 Td (50% ) Tj ET Q q 0 0 0 rg BT 422.18 113.25 Td (point ) Tj ET Q q 0 0 0 rg BT 444.77 113.25 Td (of ) Tj ET Q q 0 0 0 rg BT 455.14 113.25 Td (service ) Tj ET Q q 0 0 0 rg BT 485.48 113.25 Td (discount ) Tj ET Q q 0 0 0 rg BT 521.40 113.25 Td (to ) Tj ET Q q 0 0 0 rg BT 531.22 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 545.47 113.25 Td (Centers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.25 Td (for ) Tj ET Q q 0 0 0 rg BT 49.73 101.25 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 89.55 101.25 Td (& ) Tj ET Q q 0 0 0 rg BT 99.40 101.25 Td (Medicaid ) Tj ET Q q 0 0 0 rg BT 139.23 101.25 Td (Services ) Tj ET Q q 0 0 0 rg BT 175.18 101.25 Td (when ) Tj ET Q q 0 0 0 rg BT 198.91 101.25 Td (the ) Tj ET Q q 0 0 0 rg BT 213.20 101.25 Td (Medicare ) Tj ET Q q 0 0 0 rg BT 253.02 101.25 Td (Part ) Tj ET Q q 0 0 0 rg BT 271.20 101.25 Td (D ) Tj ET Q q 0 0 0 rg BT 280.49 101.25 Td (beneficiaries ) Tj ET Q q 0 0 0 rg BT 333.64 101.25 Td (are ) Tj ET Q q 0 0 0 rg BT 347.91 101.25 Td (in ) Tj ET Q q 0 0 0 rg BT 357.76 101.25 Td (the ) Tj ET Q q 0 0 0 rg BT 372.05 101.25 Td (coverage ) Tj ET Q q 0 0 0 rg BT 410.20 101.25 Td (gap ) Tj ET Q q 0 0 0 rg BT 426.71 101.25 Td (\("donut ) Tj ET Q q 0 0 0 rg BT 458.97 101.25 Td (hole"\). ) Tj ET Q q 0 0 0 rg BT 488.02 101.25 Td (The ) Tj ET Q q 0 0 0 rg BT 505.63 101.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 546.02 101.25 Td (amount ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 89.25 Td (unpaid ) Tj ET Q q 0 0 0 rg BT 76.55 89.25 Td (or ) Tj ET Q q 0 0 0 rg BT 87.38 89.25 Td (unbilled ) Tj ET Q q 0 0 0 rg BT 122.65 89.25 Td (rebates ) Tj ET Q q 0 0 0 rg BT 153.47 89.25 Td (and ) Tj ET Q q 0 0 0 rg BT 170.40 89.25 Td (discounts ) Tj ET Q q 0 0 0 rg BT 210.68 89.25 Td (is ) Tj ET Q q 0 0 0 rg BT 219.85 89.25 Td (presented ) Tj ET Q q 0 0 0 rg BT 260.67 89.25 Td (as ) Tj ET Q q 0 0 0 rg BT 271.50 89.25 Td (a ) Tj ET Q q 0 0 0 rg BT 278.44 89.25 Td (liability) Tj ET Q q 0 0 0 rg BT 308.90 89.25 Td (. ) Tj ET Q endstream endobj 91 0 obj <> endobj 92 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (45) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 234.974609375 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Other r) Tj ET Q q 0 0 0 rg BT 65.35 749.10 Td (ebates, r) Tj ET Q q 0 0 0 rg BT 99.42 749.10 Td (eturns, discounts and adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (Other ) Tj ET Q q 0 0 0 rg BT 60.97 725.10 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 110.94 725.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 132.57 725.10 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 182.55 725.10 Td (include ) Tj ET Q q 0 0 0 rg BT 214.18 725.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 235.82 725.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 265.79 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 282.43 725.10 Td (all ) Tj ET Q q 0 0 0 rg BT 294.62 725.10 Td (other ) Tj ET Q q 0 0 0 rg BT 317.37 725.10 Td (programs ) Tj ET Q q 0 0 0 rg BT 357.34 725.10 Td (based ) Tj ET Q q 0 0 0 rg BT 382.30 725.10 Td (on ) Tj ET Q q 0 0 0 rg BT 394.50 725.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 437.79 725.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 458.32 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 474.96 725.10 Td (regulations ) Tj ET Q q 0 0 0 rg BT 521.59 725.10 Td (for ) Tj ET Q q 0 0 0 rg BT 535.45 725.10 Td (individual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 74.55 713.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 113.64 713.10 Td (as ) Tj ET Q q 0 0 0 rg BT 124.41 713.10 Td (well ) Tj ET Q q 0 0 0 rg BT 144.07 713.10 Td (as ) Tj ET Q q 0 0 0 rg BT 154.84 713.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 185.59 713.10 Td (of) Tj ET Q q 0 0 0 rg BT 193.74 713.10 Td (fered ) Tj ET Q q 0 0 0 rg BT 216.71 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 226.93 713.10 Td (managed ) Tj ET Q q 0 0 0 rg BT 265.46 713.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 308.98 713.10 Td (or) Tj ET Q q 0 0 0 rg BT 317.13 713.10 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 365.11 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 375.32 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 389.98 713.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 410.20 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 420.42 713.10 Td (a ) Tj ET Q q 0 0 0 rg BT 427.29 713.10 Td (lesser ) Tj ET Q q 0 0 0 rg BT 452.50 713.10 Td (extent. ) Tj ET Q q 0 0 0 rg BT 481.69 713.10 Td (The ) Tj ET Q q 0 0 0 rg BT 499.68 713.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 538.23 713.10 Td (programs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (include ) Tj ET Q q 0 0 0 rg BT 68.06 701.10 Td (several ) Tj ET Q q 0 0 0 rg BT 99.00 701.10 Td (dif) Tj ET Q q 0 0 0 rg BT 109.93 701.10 Td (ferent ) Tj ET Q q 0 0 0 rg BT 135.87 701.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 166.83 701.10 Td (schemes ) Tj ET Q q 0 0 0 rg BT 203.33 701.10 Td (such ) Tj ET Q q 0 0 0 rg BT 224.29 701.10 Td (as ) Tj ET Q q 0 0 0 rg BT 235.24 701.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 253.98 701.10 Td (caps, ) Tj ET Q q 0 0 0 rg BT 276.87 701.10 Td (volume ) Tj ET Q q 0 0 0 rg BT 309.50 701.10 Td (discounts, ) Tj ET Q q 0 0 0 rg BT 352.40 701.10 Td (outcome-based ) Tj ET Q q 0 0 0 rg BT 415.56 701.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 446.51 701.10 Td (schemes ) Tj ET Q q 0 0 0 rg BT 483.02 701.10 Td (and ) Tj ET Q q 0 0 0 rg BT 500.08 701.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 531.03 701.10 Td (claw-backs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (that ) Tj ET Q q 0 0 0 rg BT 54.25 689.10 Td (are ) Tj ET Q q 0 0 0 rg BT 69.72 689.10 Td (based ) Tj ET Q q 0 0 0 rg BT 95.74 689.10 Td (on ) Tj ET Q q 0 0 0 rg BT 109.00 689.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 131.69 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 143.28 689.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 187.09 689.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 233.11 689.10 Td (or ) Tj ET Q q 0 0 0 rg BT 244.70 689.10 Td (an ) Tj ET Q q 0 0 0 rg BT 257.39 689.10 Td (aggregation ) Tj ET Q q 0 0 0 rg BT 307.85 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 319.44 689.10 Td (all ) Tj ET Q q 0 0 0 rg BT 332.69 689.10 Td (companies ) Tj ET Q q 0 0 0 rg BT 378.71 689.10 Td (participating ) Tj ET Q q 0 0 0 rg BT 432.50 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 443.54 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 451.23 689.10 Td (specific ) Tj ET Q q 0 0 0 rg BT 485.58 689.10 Td (market. ) Tj ET Q q 0 0 0 rg BT 518.87 689.10 Td (The ) Tj ET Q q 0 0 0 rg BT 537.67 689.10 Td (estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 68.50 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 79.33 677.10 Td (unpaid ) Tj ET Q q 0 0 0 rg BT 109.04 677.10 Td (or ) Tj ET Q q 0 0 0 rg BT 119.87 677.10 Td (unbilled ) Tj ET Q q 0 0 0 rg BT 155.15 677.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 185.96 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 202.90 677.10 Td (discounts ) Tj ET Q q 0 0 0 rg BT 243.18 677.10 Td (is ) Tj ET Q q 0 0 0 rg BT 252.35 677.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 293.16 677.10 Td (as ) Tj ET Q q 0 0 0 rg BT 303.99 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 310.93 677.10 Td (liability) Tj ET Q q 0 0 0 rg BT 341.39 677.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (Estimated ) Tj ET Q q 0 0 0 rg BT 78.95 653.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 109.69 653.10 Td (for ) Tj ET Q q 0 0 0 rg BT 124.31 653.10 Td (established ) Tj ET Q q 0 0 0 rg BT 171.71 653.10 Td (products ) Tj ET Q q 0 0 0 rg BT 209.11 653.10 Td (are ) Tj ET Q q 0 0 0 rg BT 224.28 653.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 272.23 653.10 Td (after ) Tj ET Q q 0 0 0 rg BT 293.50 653.10 Td (considering ) Tj ET Q q 0 0 0 rg BT 343.12 653.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 383.30 653.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 429.56 653.10 Td (and ) Tj ET Q q 0 0 0 rg BT 446.97 653.10 Td (other ) Tj ET Q q 0 0 0 rg BT 470.48 653.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 500.65 653.10 Td (including ) Tj ET Q q 0 0 0 rg BT 541.39 653.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 567.67 653.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 76.05 641.10 Td (in ) Tj ET Q q 0 0 0 rg BT 85.56 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.51 641.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 147.35 641.10 Td (channel, ) Tj ET Q q 0 0 0 rg BT 182.67 641.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 222.72 641.10 Td (shelf ) Tj ET Q q 0 0 0 rg BT 243.89 641.10 Td (life, ) Tj ET Q q 0 0 0 rg BT 261.44 641.10 Td (product ) Tj ET Q q 0 0 0 rg BT 293.71 641.10 Td (recalls, ) Tj ET Q q 0 0 0 rg BT 324.04 641.10 Td (product ) Tj ET Q q 0 0 0 rg BT 356.31 641.10 Td (discontinuances, ) Tj ET Q q 0 0 0 rg BT 424.41 641.10 Td (price ) Tj ET Q q 0 0 0 rg BT 446.13 641.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 480.06 641.10 Td (of ) Tj ET Q q 0 0 0 rg BT 490.12 641.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 539.06 641.10 Td (products, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (introductions ) Tj ET Q q 0 0 0 rg BT 91.61 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 102.78 629.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 135.04 629.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 174.81 629.10 Td (introductions ) Tj ET Q q 0 0 0 rg BT 230.42 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 241.58 629.10 Td (competitive ) Tj ET Q q 0 0 0 rg BT 291.63 629.10 Td (new ) Tj ET Q q 0 0 0 rg BT 311.12 629.10 Td (products ) Tj ET Q q 0 0 0 rg BT 348.40 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 365.67 629.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 391.28 629.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 425.77 629.10 Td (following ) Tj ET Q q 0 0 0 rg BT 467.49 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 482.54 629.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 500.94 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 512.11 629.10 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 555.34 629.10 Td (. ) Tj ET Q q 0 0 0 rg BT 560.47 629.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 76.82 617.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 109.32 617.10 Td (for ) Tj ET Q q 0 0 0 rg BT 123.48 617.10 Td (product ) Tj ET Q q 0 0 0 rg BT 156.52 617.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 186.79 617.10 Td (is ) Tj ET Q q 0 0 0 rg BT 195.96 617.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 236.78 617.10 Td (as ) Tj ET Q q 0 0 0 rg BT 247.61 617.10 Td (a ) Tj ET Q q 0 0 0 rg BT 254.54 617.10 Td (liability) Tj ET Q q 0 0 0 rg BT 285.00 617.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (Estimated ) Tj ET Q q 0 0 0 rg BT 78.36 593.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 108.50 593.10 Td (for ) Tj ET Q q 0 0 0 rg BT 122.54 593.10 Td (new ) Tj ET Q q 0 0 0 rg BT 141.57 593.10 Td (products ) Tj ET Q q 0 0 0 rg BT 178.38 593.10 Td (are ) Tj ET Q q 0 0 0 rg BT 192.96 593.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 240.31 593.10 Td (after ) Tj ET Q q 0 0 0 rg BT 261.00 593.10 Td (considering ) Tj ET Q q 0 0 0 rg BT 310.02 593.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 349.61 593.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 371.42 593.10 Td (return ) Tj ET Q q 0 0 0 rg BT 397.67 593.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 443.34 593.10 Td (of ) Tj ET Q q 0 0 0 rg BT 454.04 593.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 484.19 593.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 523.50 593.10 Td (such ) Tj ET Q q 0 0 0 rg BT 544.20 593.10 Td (as ) Tj ET Q q 0 0 0 rg BT 554.90 593.10 Td (those ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (within ) Tj ET Q q 0 0 0 rg BT 64.16 581.10 Td (the ) Tj ET Q q 0 0 0 rg BT 78.98 581.10 Td (same ) Tj ET Q q 0 0 0 rg BT 102.14 581.10 Td (product ) Tj ET Q q 0 0 0 rg BT 135.29 581.10 Td (line, ) Tj ET Q q 0 0 0 rg BT 155.39 581.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 185.77 581.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 232.79 581.10 Td (area ) Tj ET Q q 0 0 0 rg BT 252.04 581.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 280.19 581.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 310.57 581.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 359.29 581.10 Td (model. ) Tj ET Q q 0 0 0 rg BT 389.20 581.10 Td (W) Tj ET Q q 0 0 0 rg BT 397.84 581.10 Td (e ) Tj ET Q q 0 0 0 rg BT 404.88 581.10 Td (defer ) Tj ET Q q 0 0 0 rg BT 428.02 581.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 476.17 581.10 Td (of ) Tj ET Q q 0 0 0 rg BT 487.11 581.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 521.36 581.10 Td (until ) Tj ET Q q 0 0 0 rg BT 542.30 581.10 Td (the ) Tj ET Q q 0 0 0 rg BT 557.12 581.10 Td (right ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.37 569.10 Td (return ) Tj ET Q q 0 0 0 rg BT 74.28 569.10 Td (expires, ) Tj ET Q q 0 0 0 rg BT 108.70 569.10 Td (suf) Tj ET Q q 0 0 0 rg BT 120.74 569.10 Td (ficient ) Tj ET Q q 0 0 0 rg BT 149.32 569.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 189.57 569.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 235.91 569.10 Td (to ) Tj ET Q q 0 0 0 rg BT 246.73 569.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 283.09 569.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 305.56 569.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 336.37 569.10 Td (is ) Tj ET Q q 0 0 0 rg BT 346.08 569.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 390.21 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 401.03 569.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 432.40 569.10 Td (circumstances, ) Tj ET Q q 0 0 0 rg BT 494.58 569.10 Td (or ) Tj ET Q q 0 0 0 rg BT 505.95 569.10 Td (when ) Tj ET Q q 0 0 0 rg BT 530.64 569.10 Td (insuf) Tj ET Q q 0 0 0 rg BT 550.46 569.10 Td (ficient ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 76.01 557.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 122.11 557.10 Td (with ) Tj ET Q q 0 0 0 rg BT 142.69 557.10 Td (products ) Tj ET Q q 0 0 0 rg BT 179.93 557.10 Td (in ) Tj ET Q q 0 0 0 rg BT 190.51 557.10 Td (a ) Tj ET Q q 0 0 0 rg BT 197.75 557.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 228.32 557.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 275.54 557.10 Td (area, ) Tj ET Q q 0 0 0 rg BT 297.49 557.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 346.40 557.10 Td (method ) Tj ET Q q 0 0 0 rg BT 379.20 557.10 Td (or ) Tj ET Q q 0 0 0 rg BT 390.33 557.10 Td (other ) Tj ET Q q 0 0 0 rg BT 413.67 557.10 Td (characteristic ) Tj ET Q q 0 0 0 rg BT 469.77 557.10 Td (is ) Tj ET Q q 0 0 0 rg BT 479.24 557.10 Td (available. ) Tj ET Q q 0 0 0 rg BT 520.43 557.10 Td (This ) Tj ET Q q 0 0 0 rg BT 541.01 557.10 Td (typically ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (occurs ) Tj ET Q q 0 0 0 rg BT 64.69 545.10 Td (when ) Tj ET Q q 0 0 0 rg BT 88.94 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 103.75 545.10 Td (new ) Tj ET Q q 0 0 0 rg BT 123.00 545.10 Td (product ) Tj ET Q q 0 0 0 rg BT 156.14 545.10 Td (is ) Tj ET Q q 0 0 0 rg BT 165.40 545.10 Td (not ) Tj ET Q q 0 0 0 rg BT 180.77 545.10 Td (an ) Tj ET Q q 0 0 0 rg BT 192.80 545.10 Td (extension ) Tj ET Q q 0 0 0 rg BT 233.72 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 244.64 545.10 Td (an ) Tj ET Q q 0 0 0 rg BT 256.67 545.10 Td (existing ) Tj ET Q q 0 0 0 rg BT 290.93 545.10 Td (line ) Tj ET Q q 0 0 0 rg BT 308.52 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 319.44 545.10 Td (product ) Tj ET Q q 0 0 0 rg BT 352.58 545.10 Td (or ) Tj ET Q q 0 0 0 rg BT 363.50 545.10 Td (when ) Tj ET Q q 0 0 0 rg BT 387.75 545.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 427.55 545.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 473.45 545.10 Td (with ) Tj ET Q q 0 0 0 rg BT 493.82 545.10 Td (products ) Tj ET Q q 0 0 0 rg BT 530.85 545.10 Td (in ) Tj ET Q q 0 0 0 rg BT 541.22 545.10 Td (a ) Tj ET Q q 0 0 0 rg BT 548.25 545.10 Td (similar ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 83.35 533.10 Td (category ) Tj ET Q q 0 0 0 rg BT 120.70 533.10 Td (is ) Tj ET Q q 0 0 0 rg BT 130.29 533.10 Td (lacking. ) Tj ET Q q 0 0 0 rg BT 165.16 533.10 Td (Estimated ) Tj ET Q q 0 0 0 rg BT 208.07 533.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 234.33 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 245.58 533.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 286.83 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 297.54 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 312.68 533.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 361.73 533.10 Td (channel ) Tj ET Q q 0 0 0 rg BT 395.75 533.10 Td (and ) Tj ET Q q 0 0 0 rg BT 413.11 533.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 453.24 533.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 487.82 533.10 Td (are ) Tj ET Q q 0 0 0 rg BT 502.96 533.10 Td (also ) Tj ET Q q 0 0 0 rg BT 521.99 533.10 Td (considered ) Tj ET Q q 0 0 0 rg BT 568.24 533.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (estimating ) Tj ET Q q 0 0 0 rg BT 80.16 521.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 102.10 521.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 132.37 521.10 Td (for ) Tj ET Q q 0 0 0 rg BT 146.53 521.10 Td (new ) Tj ET Q q 0 0 0 rg BT 165.69 521.10 Td (products.) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 495.7669921875 m 200.521484375 495.7669921875 l s q 0 0 0 rg BT 36.00 497.10 Td (Use of information fr) Tj ET Q q 0 0 0 rg BT 120.36 497.10 Td (om external sour) Tj ET Q q 0 0 0 rg BT 187.75 497.10 Td (ces) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (Information ) Tj ET Q q 0 0 0 rg BT 86.50 473.10 Td (from ) Tj ET Q q 0 0 0 rg BT 108.68 473.10 Td (external ) Tj ET Q q 0 0 0 rg BT 143.63 473.10 Td (sources ) Tj ET Q q 0 0 0 rg BT 176.36 473.10 Td (is ) Tj ET Q q 0 0 0 rg BT 185.77 473.10 Td (used ) Tj ET Q q 0 0 0 rg BT 206.84 473.10 Td (to ) Tj ET Q q 0 0 0 rg BT 217.36 473.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 253.42 473.10 Td (gross-to-net ) Tj ET Q q 0 0 0 rg BT 303.93 473.10 Td (adjustments. ) Tj ET Q q 0 0 0 rg BT 356.94 473.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 375.23 473.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 411.30 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 422.37 473.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 463.43 473.10 Td (at ) Tj ET Q q 0 0 0 rg BT 473.39 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 488.35 473.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 538.30 473.10 Td (are ) Tj ET Q q 0 0 0 rg BT 553.24 473.10 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (on ) Tj ET Q q 0 0 0 rg BT 48.66 461.10 Td (the ) Tj ET Q q 0 0 0 rg BT 63.53 461.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 103.38 461.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 153.80 461.10 Td (demand-based ) Tj ET Q q 0 0 0 rg BT 214.21 461.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 236.31 461.10 Td (for ) Tj ET Q q 0 0 0 rg BT 250.62 461.10 Td (our ) Tj ET Q q 0 0 0 rg BT 266.61 461.10 Td (products ) Tj ET Q q 0 0 0 rg BT 303.70 461.10 Td (and ) Tj ET Q q 0 0 0 rg BT 320.79 461.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 360.66 461.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 401.64 461.10 Td (experience, ) Tj ET Q q 0 0 0 rg BT 450.10 461.10 Td (as ) Tj ET Q q 0 0 0 rg BT 461.08 461.10 Td (well ) Tj ET Q q 0 0 0 rg BT 480.96 461.10 Td (as ) Tj ET Q q 0 0 0 rg BT 491.94 461.10 Td (our ) Tj ET Q q 0 0 0 rg BT 507.93 461.10 Td (analysis ) Tj ET Q q 0 0 0 rg BT 542.80 461.10 Td (of ) Tj ET Q q 0 0 0 rg BT 553.78 461.10 Td (third-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (party ) Tj ET Q q 0 0 0 rg BT 59.48 449.10 Td (information, ) Tj ET Q q 0 0 0 rg BT 112.13 449.10 Td (including ) Tj ET Q q 0 0 0 rg BT 152.84 449.10 Td (written ) Tj ET Q q 0 0 0 rg BT 184.10 449.10 Td (and ) Tj ET Q q 0 0 0 rg BT 201.47 449.10 Td (oral ) Tj ET Q q 0 0 0 rg BT 219.95 449.10 Td (information ) Tj ET Q q 0 0 0 rg BT 270.10 449.10 Td (obtained ) Tj ET Q q 0 0 0 rg BT 307.46 449.10 Td (from ) Tj ET Q q 0 0 0 rg BT 329.84 449.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 359.97 449.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 410.12 449.10 Td (with ) Tj ET Q q 0 0 0 rg BT 430.83 449.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 462.08 449.10 Td (to ) Tj ET Q q 0 0 0 rg BT 472.79 449.10 Td (their ) Tj ET Q q 0 0 0 rg BT 494.05 449.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 535.31 449.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 561.57 449.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (sell-through ) Tj ET Q q 0 0 0 rg BT 87.06 437.10 Td (to ) Tj ET Q q 0 0 0 rg BT 97.57 437.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 140.85 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 158.02 437.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 203.51 437.10 Td (market ) Tj ET Q q 0 0 0 rg BT 234.01 437.10 Td (research ) Tj ET Q q 0 0 0 rg BT 270.05 437.10 Td (data, ) Tj ET Q q 0 0 0 rg BT 291.93 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 309.10 437.10 Td (our ) Tj ET Q q 0 0 0 rg BT 325.17 437.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 358.44 437.10 Td (information. ) Tj ET Q q 0 0 0 rg BT 410.69 437.10 Td (The ) Tj ET Q q 0 0 0 rg BT 428.96 437.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 470.02 437.10 Td (information ) Tj ET Q q 0 0 0 rg BT 519.97 437.10 Td (received ) Tj ET Q q 0 0 0 rg BT 556.56 437.10 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.10 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 85.20 425.10 Td (is ) Tj ET Q q 0 0 0 rg BT 93.87 425.10 Td (a ) Tj ET Q q 0 0 0 rg BT 100.30 425.10 Td (product ) Tj ET Q q 0 0 0 rg BT 132.84 425.10 Td (of ) Tj ET Q q 0 0 0 rg BT 143.17 425.10 Td (their ) Tj ET Q q 0 0 0 rg BT 163.49 425.10 Td (recordkeeping ) Tj ET Q q 0 0 0 rg BT 222.67 425.10 Td (process ) Tj ET Q q 0 0 0 rg BT 254.66 425.10 Td (and ) Tj ET Q q 0 0 0 rg BT 271.09 425.10 Td (excludes ) Tj ET Q q 0 0 0 rg BT 308.07 425.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 348.39 425.10 Td (held ) Tj ET Q q 0 0 0 rg BT 367.60 425.10 Td (by ) Tj ET Q q 0 0 0 rg BT 379.60 425.10 Td (intermediaries ) Tj ET Q q 0 0 0 rg BT 438.79 425.10 Td (to ) Tj ET Q q 0 0 0 rg BT 448.56 425.10 Td (whom ) Tj ET Q q 0 0 0 rg BT 475.56 425.10 Td (they ) Tj ET Q q 0 0 0 rg BT 494.77 425.10 Td (sell, ) Tj ET Q q 0 0 0 rg BT 513.15 425.10 Td (such ) Tj ET Q q 0 0 0 rg BT 533.47 425.10 Td (as ) Tj ET Q q 0 0 0 rg BT 543.80 425.10 Td (retailers ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 413.10 Td (hospitals.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 389.10 Td (e ) Tj ET Q q 0 0 0 rg BT 50.63 389.10 Td (have ) Tj ET Q q 0 0 0 rg BT 71.06 389.10 Td (also ) Tj ET Q q 0 0 0 rg BT 88.72 389.10 Td (continued ) Tj ET Q q 0 0 0 rg BT 129.71 389.10 Td (the ) Tj ET Q q 0 0 0 rg BT 143.48 389.10 Td (practice ) Tj ET Q q 0 0 0 rg BT 176.67 389.10 Td (of ) Tj ET Q q 0 0 0 rg BT 186.55 389.10 Td (combining ) Tj ET Q q 0 0 0 rg BT 230.88 389.10 Td (retail ) Tj ET Q q 0 0 0 rg BT 252.97 389.10 Td (and ) Tj ET Q q 0 0 0 rg BT 268.96 389.10 Td (mail ) Tj ET Q q 0 0 0 rg BT 288.29 389.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 337.61 389.10 Td (volume ) Tj ET Q q 0 0 0 rg BT 369.15 389.10 Td (on ) Tj ET Q q 0 0 0 rg BT 380.71 389.10 Td (a ) Tj ET Q q 0 0 0 rg BT 386.70 389.10 Td (retail-equivalent ) Tj ET Q q 0 0 0 rg BT 453.77 389.10 Td (basis. ) Tj ET Q q 0 0 0 rg BT 477.71 389.10 Td (W) Tj ET Q q 0 0 0 rg BT 486.35 389.10 Td (e ) Tj ET Q q 0 0 0 rg BT 492.34 389.10 Td (use ) Tj ET Q q 0 0 0 rg BT 507.23 389.10 Td (this ) Tj ET Q q 0 0 0 rg BT 523.23 389.10 Td (methodology ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.10 Td (for ) Tj ET Q q 0 0 0 rg BT 49.82 377.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 82.53 377.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 116.35 377.10 Td (forecasts. ) Tj ET Q q 0 0 0 rg BT 156.39 377.10 Td (W) Tj ET Q q 0 0 0 rg BT 165.03 377.10 Td (e ) Tj ET Q q 0 0 0 rg BT 171.63 377.10 Td (also ) Tj ET Q q 0 0 0 rg BT 189.90 377.10 Td (use ) Tj ET Q q 0 0 0 rg BT 205.39 377.10 Td (information ) Tj ET Q q 0 0 0 rg BT 254.77 377.10 Td (from ) Tj ET Q q 0 0 0 rg BT 276.37 377.10 Td (external ) Tj ET Q q 0 0 0 rg BT 310.74 377.10 Td (sources ) Tj ET Q q 0 0 0 rg BT 342.89 377.10 Td (to ) Tj ET Q q 0 0 0 rg BT 352.83 377.10 Td (identify ) Tj ET Q q 0 0 0 rg BT 386.10 377.10 Td (prescription ) Tj ET Q q 0 0 0 rg BT 436.02 377.10 Td (trends, ) Tj ET Q q 0 0 0 rg BT 465.13 377.10 Td (patient ) Tj ET Q q 0 0 0 rg BT 494.50 377.10 Td (demand ) Tj ET Q q 0 0 0 rg BT 528.32 377.10 Td (and ) Tj ET Q q 0 0 0 rg BT 544.92 377.10 Td (average ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 65.64 365.10 Td (prices. ) Tj ET Q q 0 0 0 rg BT 94.98 365.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 113.51 365.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 153.69 365.10 Td (are ) Tj ET Q q 0 0 0 rg BT 168.87 365.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 200.17 365.10 Td (to ) Tj ET Q q 0 0 0 rg BT 210.91 365.10 Td (inherent ) Tj ET Q q 0 0 0 rg BT 246.65 365.10 Td (limitations ) Tj ET Q q 0 0 0 rg BT 292.40 365.10 Td (of ) Tj ET Q q 0 0 0 rg BT 303.70 365.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 343.88 365.10 Td (that ) Tj ET Q q 0 0 0 rg BT 361.85 365.10 Td (rely ) Tj ET Q q 0 0 0 rg BT 380.37 365.10 Td (on ) Tj ET Q q 0 0 0 rg BT 393.34 365.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 439.07 365.10 Td (information, ) Tj ET Q q 0 0 0 rg BT 491.76 365.10 Td (as ) Tj ET Q q 0 0 0 rg BT 503.06 365.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 533.23 365.10 Td (third-party ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.10 Td (information ) Tj ET Q q 0 0 0 rg BT 86.54 353.10 Td (was ) Tj ET Q q 0 0 0 rg BT 105.42 353.10 Td (itself ) Tj ET Q q 0 0 0 rg BT 128.74 353.10 Td (in ) Tj ET Q q 0 0 0 rg BT 139.85 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 155.39 353.10 Td (form ) Tj ET Q q 0 0 0 rg BT 178.16 353.10 Td (of ) Tj ET Q q 0 0 0 rg BT 189.82 353.10 Td (estimates, ) Tj ET Q q 0 0 0 rg BT 232.86 353.10 Td (and ) Tj ET Q q 0 0 0 rg BT 250.62 353.10 Td (reflect ) Tj ET Q q 0 0 0 rg BT 279.48 353.10 Td (other ) Tj ET Q q 0 0 0 rg BT 303.36 353.10 Td (limitations ) Tj ET Q q 0 0 0 rg BT 349.46 353.10 Td (including ) Tj ET Q q 0 0 0 rg BT 390.56 353.10 Td (lags ) Tj ET Q q 0 0 0 rg BT 410.00 353.10 Td (between ) Tj ET Q q 0 0 0 rg BT 446.64 353.10 Td (the ) Tj ET Q q 0 0 0 rg BT 462.19 353.10 Td (date ) Tj ET Q q 0 0 0 rg BT 482.17 353.10 Td (as ) Tj ET Q q 0 0 0 rg BT 493.83 353.10 Td (of ) Tj ET Q q 0 0 0 rg BT 505.48 353.10 Td (which ) Tj ET Q q 0 0 0 rg BT 533.25 353.10 Td (third-party ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.10 Td (information ) Tj ET Q q 0 0 0 rg BT 85.71 341.10 Td (is ) Tj ET Q q 0 0 0 rg BT 94.88 341.10 Td (generated ) Tj ET Q q 0 0 0 rg BT 136.24 341.10 Td (and ) Tj ET Q q 0 0 0 rg BT 153.18 341.10 Td (the ) Tj ET Q q 0 0 0 rg BT 167.90 341.10 Td (date ) Tj ET Q q 0 0 0 rg BT 187.05 341.10 Td (on ) Tj ET Q q 0 0 0 rg BT 199.55 341.10 Td (which ) Tj ET Q q 0 0 0 rg BT 226.49 341.10 Td (we ) Tj ET Q q 0 0 0 rg BT 240.65 341.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 272.02 341.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 317.28 341.10 Td (information.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 317.10 Td (Retirement ) Tj ET Q q 0 0 0 rg BT 84.05 317.10 Td (Benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 84.71 293.10 Td (for ) Tj ET Q q 0 0 0 rg BT 98.43 293.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 131.60 293.10 Td (and ) Tj ET Q q 0 0 0 rg BT 148.09 293.10 Td (postretirement ) Tj ET Q q 0 0 0 rg BT 207.91 293.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 237.73 293.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 260.90 293.10 Td (requires ) Tj ET Q q 0 0 0 rg BT 295.17 293.10 Td (actuarial ) Tj ET Q q 0 0 0 rg BT 331.64 293.10 Td (valuations ) Tj ET Q q 0 0 0 rg BT 374.80 293.10 Td (based ) Tj ET Q q 0 0 0 rg BT 399.63 293.10 Td (on ) Tj ET Q q 0 0 0 rg BT 411.69 293.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 455.96 293.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 507.46 293.10 Td (for ) Tj ET Q q 0 0 0 rg BT 521.18 293.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 557.13 293.10 Td (rates ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.11 281.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 91.31 281.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 133.41 281.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 154.96 281.10 Td (of ) Tj ET Q q 0 0 0 rg BT 165.95 281.10 Td (return ) Tj ET Q q 0 0 0 rg BT 192.50 281.10 Td (on ) Tj ET Q q 0 0 0 rg BT 205.17 281.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 225.05 281.10 Td (assets. ) Tj ET Q q 0 0 0 rg BT 253.55 281.10 Td (In ) Tj ET Q q 0 0 0 rg BT 264.55 281.10 Td (consultation ) Tj ET Q q 0 0 0 rg BT 316.10 281.10 Td (with ) Tj ET Q q 0 0 0 rg BT 336.55 281.10 Td (our ) Tj ET Q q 0 0 0 rg BT 352.55 281.10 Td (actuaries, ) Tj ET Q q 0 0 0 rg BT 393.25 281.10 Td (these ) Tj ET Q q 0 0 0 rg BT 416.46 281.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 461.34 281.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 513.46 281.10 Td (and ) Tj ET Q q 0 0 0 rg BT 530.57 281.10 Td (others ) Tj ET Q q 0 0 0 rg BT 557.67 281.10 Td (such ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.10 Td (as ) Tj ET Q q 0 0 0 rg BT 47.10 269.10 Td (salary ) Tj ET Q q 0 0 0 rg BT 73.74 269.10 Td (growth, ) Tj ET Q q 0 0 0 rg BT 107.34 269.10 Td (retirement, ) Tj ET Q q 0 0 0 rg BT 153.69 269.10 Td (turnover) Tj ET Q q 0 0 0 rg BT 187.17 269.10 Td (, ) Tj ET Q q 0 0 0 rg BT 192.43 269.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 236.28 269.10 Td (trends ) Tj ET Q q 0 0 0 rg BT 263.48 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 280.69 269.10 Td (mortality ) Tj ET Q q 0 0 0 rg BT 320.11 269.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 341.76 269.10 Td (are ) Tj ET Q q 0 0 0 rg BT 356.73 269.10 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 397.81 269.10 Td (and ) Tj ET Q q 0 0 0 rg BT 415.01 269.10 Td (selected ) Tj ET Q q 0 0 0 rg BT 449.98 269.10 Td (based ) Tj ET Q q 0 0 0 rg BT 475.51 269.10 Td (on ) Tj ET Q q 0 0 0 rg BT 488.28 269.10 Td (expectations ) Tj ET Q q 0 0 0 rg BT 541.03 269.10 Td (or ) Tj ET Q q 0 0 0 rg BT 552.12 269.10 Td (actual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 80.95 257.10 Td (during ) Tj ET Q q 0 0 0 rg BT 108.70 257.10 Td (each ) Tj ET Q q 0 0 0 rg BT 128.67 257.10 Td (remeasurement ) Tj ET Q q 0 0 0 rg BT 191.39 257.10 Td (date. ) Tj ET Q q 0 0 0 rg BT 212.19 257.10 Td (Pension ) Tj ET Q q 0 0 0 rg BT 245.51 257.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 279.36 257.10 Td (could ) Tj ET Q q 0 0 0 rg BT 303.23 257.10 Td (vary ) Tj ET Q q 0 0 0 rg BT 322.64 257.10 Td (within ) Tj ET Q q 0 0 0 rg BT 349.85 257.10 Td (a ) Tj ET Q q 0 0 0 rg BT 355.93 257.10 Td (range ) Tj ET Q q 0 0 0 rg BT 379.79 257.10 Td (of ) Tj ET Q q 0 0 0 rg BT 389.76 257.10 Td (outcomes ) Tj ET Q q 0 0 0 rg BT 429.74 257.10 Td (and ) Tj ET Q q 0 0 0 rg BT 445.82 257.10 Td (have ) Tj ET Q q 0 0 0 rg BT 466.35 257.10 Td (a ) Tj ET Q q 0 0 0 rg BT 472.43 257.10 Td (material ) Tj ET Q q 0 0 0 rg BT 506.84 257.10 Td (ef) Tj ET Q q 0 0 0 rg BT 514.42 257.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 531.06 257.10 Td (on ) Tj ET Q q 0 0 0 rg BT 542.70 257.10 Td (reported ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.10 Td (earnings, ) Tj ET Q q 0 0 0 rg BT 74.53 245.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 113.88 245.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 143.79 245.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 190.39 245.10 Td (and ) Tj ET Q q 0 0 0 rg BT 206.97 245.10 Td (future ) Tj ET Q q 0 0 0 rg BT 233.00 245.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 252.92 245.10 Td (funding. ) Tj ET Q q 0 0 0 rg BT 288.20 245.10 Td (Actual ) Tj ET Q q 0 0 0 rg BT 317.01 245.10 Td (results ) Tj ET Q q 0 0 0 rg BT 345.27 245.10 Td (in ) Tj ET Q q 0 0 0 rg BT 355.19 245.10 Td (any ) Tj ET Q q 0 0 0 rg BT 371.78 245.10 Td (given ) Tj ET Q q 0 0 0 rg BT 396.15 245.10 Td (year ) Tj ET Q q 0 0 0 rg BT 415.51 245.10 Td (may ) Tj ET Q q 0 0 0 rg BT 434.87 245.10 Td (dif) Tj ET Q q 0 0 0 rg BT 445.80 245.10 Td (fer ) Tj ET Q q 0 0 0 rg BT 459.05 245.10 Td (from ) Tj ET Q q 0 0 0 rg BT 480.64 245.10 Td (those ) Tj ET Q q 0 0 0 rg BT 503.90 245.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 544.37 245.10 Td (because ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 233.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 88.20 233.10 Td (and ) Tj ET Q q 0 0 0 rg BT 105.14 233.10 Td (other ) Tj ET Q q 0 0 0 rg BT 128.19 233.10 Td (factors.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.16 209.10 Td (yield ) Tj ET Q q 0 0 0 rg BT 76.77 209.10 Td (on ) Tj ET Q q 0 0 0 rg BT 89.39 209.10 Td (high ) Tj ET Q q 0 0 0 rg BT 109.78 209.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 140.17 209.10 Td (corporate ) Tj ET Q q 0 0 0 rg BT 180.54 209.10 Td (bonds ) Tj ET Q q 0 0 0 rg BT 207.04 209.10 Td (that ) Tj ET Q q 0 0 0 rg BT 224.65 209.10 Td (coincides ) Tj ET Q q 0 0 0 rg BT 265.03 209.10 Td (with ) Tj ET Q q 0 0 0 rg BT 285.42 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 300.26 209.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 320.64 209.10 Td (flows ) Tj ET Q q 0 0 0 rg BT 345.48 209.10 Td (of ) Tj ET Q q 0 0 0 rg BT 356.42 209.10 Td (the ) Tj ET Q q 0 0 0 rg BT 371.25 209.10 Td (plans’) Tj ET Q q 0 0 0 rg BT 394.95 209.10 Td ( ) Tj ET Q q 0 0 0 rg BT 397.56 209.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 438.50 209.10 Td (payouts ) Tj ET Q q 0 0 0 rg BT 472.22 209.10 Td (is ) Tj ET Q q 0 0 0 rg BT 481.51 209.10 Td (used ) Tj ET Q q 0 0 0 rg BT 502.45 209.10 Td (in ) Tj ET Q q 0 0 0 rg BT 512.84 209.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 563.78 209.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 72.18 197.10 Td (rate. ) Tj ET Q q 0 0 0 rg BT 91.80 197.10 Td (The ) Tj ET Q q 0 0 0 rg BT 109.65 197.10 Td (Citi ) Tj ET Q q 0 0 0 rg BT 126.95 197.10 Td (Pension ) Tj ET Q q 0 0 0 rg BT 160.91 197.10 Td (Discount ) Tj ET Q q 0 0 0 rg BT 199.32 197.10 Td (curve ) Tj ET Q q 0 0 0 rg BT 223.82 197.10 Td (is ) Tj ET Q q 0 0 0 rg BT 232.79 197.10 Td (used ) Tj ET Q q 0 0 0 rg BT 253.42 197.10 Td (for ) Tj ET Q q 0 0 0 rg BT 267.38 197.10 Td (the ) Tj ET Q q 0 0 0 rg BT 281.89 197.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 301.97 197.10 Td (plans. ) Tj ET Q q 0 0 0 rg BT 327.71 197.10 Td (The ) Tj ET Q q 0 0 0 rg BT 345.56 197.10 Td (present ) Tj ET Q q 0 0 0 rg BT 376.73 197.10 Td (value ) Tj ET Q q 0 0 0 rg BT 400.68 197.10 Td (of ) Tj ET Q q 0 0 0 rg BT 411.31 197.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 441.37 197.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 488.11 197.10 Td (at ) Tj ET Q q 0 0 0 rg BT 497.63 197.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.01 197.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.10 Td (for ) Tj ET Q q 0 0 0 rg BT 49.91 185.10 Td (the ) Tj ET Q q 0 0 0 rg BT 64.38 185.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 84.42 185.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 117.78 185.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 141.14 185.10 Td (was ) Tj ET Q q 0 0 0 rg BT 158.95 185.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 206.18 185.10 Td (using ) Tj ET Q q 0 0 0 rg BT 230.11 185.10 Td (a ) Tj ET Q q 0 0 0 rg BT 236.80 185.10 Td (4.0% ) Tj ET Q q 0 0 0 rg BT 259.88 185.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 296.02 185.10 Td (rate. ) Tj ET Q q 0 0 0 rg BT 315.76 185.10 Td (If ) Tj ET Q q 0 0 0 rg BT 324.67 185.10 Td (the ) Tj ET Q q 0 0 0 rg BT 339.14 185.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 375.84 185.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 411.98 185.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 429.22 185.10 Td (used ) Tj ET Q q 0 0 0 rg BT 449.80 185.10 Td (in ) Tj ET Q q 0 0 0 rg BT 459.83 185.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 510.40 185.10 Td (the ) Tj ET Q q 0 0 0 rg BT 524.87 185.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 544.91 185.10 Td (pension ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.10 Td (plans’) Tj ET Q q 0 0 0 rg BT 59.70 173.10 Td ( ) Tj ET Q q 0 0 0 rg BT 61.34 173.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 100.18 173.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 129.59 173.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 171.78 173.10 Td (at ) Tj ET Q q 0 0 0 rg BT 180.64 173.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 238.37 173.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 258.37 173.10 Td ( ) Tj ET Q q 0 0 0 rg BT 260.01 173.10 Td (was ) Tj ET Q q 0 0 0 rg BT 277.20 173.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 310.49 173.10 Td (by ) Tj ET Q q 0 0 0 rg BT 322.13 173.10 Td (an ) Tj ET Q q 0 0 0 rg BT 333.21 173.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 374.85 173.10 Td (1%, ) Tj ET Q q 0 0 0 rg BT 392.32 173.10 Td (the ) Tj ET Q q 0 0 0 rg BT 406.18 173.10 Td (projected ) Tj ET Q q 0 0 0 rg BT 445.02 173.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 474.43 173.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 516.62 173.10 Td (would ) Tj ET Q q 0 0 0 rg BT 543.26 173.10 Td (increase ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.10 Td (by ) Tj ET Q q 0 0 0 rg BT 48.50 161.10 Td (approximately ) Tj ET Q q 0 0 0 rg BT 108.76 161.10 Td ($900 ) Tj ET Q q 0 0 0 rg BT 131.26 161.10 Td (million.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 137.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.53 137.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 91.04 137.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 132.46 137.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 149.42 137.10 Td (of ) Tj ET Q q 0 0 0 rg BT 159.74 137.10 Td (return ) Tj ET Q q 0 0 0 rg BT 185.59 137.10 Td (on ) Tj ET Q q 0 0 0 rg BT 197.58 137.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 216.77 137.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 242.08 137.10 Td (is ) Tj ET Q q 0 0 0 rg BT 250.74 137.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 291.04 137.10 Td (considering ) Tj ET Q q 0 0 0 rg BT 339.67 137.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 377.19 137.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 406.94 137.10 Td (for ) Tj ET Q q 0 0 0 rg BT 420.58 137.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 463.11 137.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 484.53 137.10 Td (classes ) Tj ET Q q 0 0 0 rg BT 514.28 137.10 Td (with ) Tj ET Q q 0 0 0 rg BT 534.04 137.10 Td (input ) Tj ET Q q 0 0 0 rg BT 556.58 137.10 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.10 Td (external ) Tj ET Q q 0 0 0 rg BT 72.05 125.10 Td (advisors. ) Tj ET Q q 0 0 0 rg BT 111.44 125.10 Td (W) Tj ET Q q 0 0 0 rg BT 120.08 125.10 Td (e ) Tj ET Q q 0 0 0 rg BT 128.36 125.10 Td (also ) Tj ET Q q 0 0 0 rg BT 148.31 125.10 Td (consider ) Tj ET Q q 0 0 0 rg BT 186.03 125.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 229.31 125.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 270.36 125.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 301.98 125.10 Td (including ) Tj ET Q q 0 0 0 rg BT 343.59 125.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 371.31 125.10 Td (performance ) Tj ET Q q 0 0 0 rg BT 425.67 125.10 Td (compared ) Tj ET Q q 0 0 0 rg BT 468.94 125.10 Td (to ) Tj ET Q q 0 0 0 rg BT 480.56 125.10 Td (benchmarks ) Tj ET Q q 0 0 0 rg BT 532.72 125.10 Td (for ) Tj ET Q q 0 0 0 rg BT 548.22 125.10 Td (similar ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.10 Td (investments. ) Tj ET Q q 0 0 0 rg BT 88.42 113.10 Td (The ) Tj ET Q q 0 0 0 rg BT 106.28 113.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 126.37 113.10 Td (plans’) Tj ET Q q 0 0 0 rg BT 150.07 113.10 Td ( ) Tj ET Q q 0 0 0 rg BT 152.38 113.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 185.80 113.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 220.32 113.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.29 113.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 254.29 113.10 Td ( ) Tj ET Q q 0 0 0 rg BT 256.60 113.10 Td (was ) Tj ET Q q 0 0 0 rg BT 274.47 113.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 321.76 113.10 Td (using ) Tj ET Q q 0 0 0 rg BT 345.74 113.10 Td (a ) Tj ET Q q 0 0 0 rg BT 352.49 113.10 Td (7.8% ) Tj ET Q q 0 0 0 rg BT 375.64 113.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 413.48 113.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 455.23 113.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 472.52 113.10 Td (of ) Tj ET Q q 0 0 0 rg BT 483.16 113.10 Td (return ) Tj ET Q q 0 0 0 rg BT 509.35 113.10 Td (on ) Tj ET Q q 0 0 0 rg BT 521.67 113.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 541.19 113.10 Td (assets. ) Tj ET Q q 0 0 0 rg BT 569.34 113.10 Td (If ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.90 101.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 89.11 101.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 131.22 101.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 148.89 101.10 Td (of ) Tj ET Q q 0 0 0 rg BT 159.90 101.10 Td (return ) Tj ET Q q 0 0 0 rg BT 186.45 101.10 Td (on ) Tj ET Q q 0 0 0 rg BT 199.13 101.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 219.03 101.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 245.04 101.10 Td (used ) Tj ET Q q 0 0 0 rg BT 266.05 101.10 Td (in ) Tj ET Q q 0 0 0 rg BT 276.51 101.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 327.51 101.10 Td (the ) Tj ET Q q 0 0 0 rg BT 342.40 101.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 362.87 101.10 Td (plans’) Tj ET Q q 0 0 0 rg BT 386.56 101.10 Td ( ) Tj ET Q q 0 0 0 rg BT 389.24 101.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 423.03 101.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 457.92 101.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.26 101.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.26 101.10 Td ( ) Tj ET Q q 0 0 0 rg BT 494.94 101.10 Td (was ) Tj ET Q q 0 0 0 rg BT 513.17 101.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 547.49 101.10 Td (by ) Tj ET Q q 0 0 0 rg BT 560.17 101.10 Td (1%, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.10 Td (such ) Tj ET Q q 0 0 0 rg BT 56.83 89.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 91.54 89.10 Td (would ) Tj ET Q q 0 0 0 rg BT 119.04 89.10 Td (increase ) Tj ET Q q 0 0 0 rg BT 154.29 89.10 Td (by ) Tj ET Q q 0 0 0 rg BT 166.79 89.10 Td ($41 ) Tj ET Q q 0 0 0 rg BT 184.29 89.10 Td (million.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 65.10 Td (For ) Tj ET Q q 0 0 0 rg BT 53.17 65.10 Td (a ) Tj ET Q q 0 0 0 rg BT 60.88 65.10 Td (more ) Tj ET Q q 0 0 0 rg BT 84.71 65.10 Td (detailed ) Tj ET Q q 0 0 0 rg BT 119.63 65.10 Td (discussion ) Tj ET Q q 0 0 0 rg BT 164.58 65.10 Td (on ) Tj ET Q q 0 0 0 rg BT 177.86 65.10 Td (retirement ) Tj ET Q q 0 0 0 rg BT 222.22 65.10 Td (benefits, ) Tj ET Q q 0 0 0 rg BT 259.65 65.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 281.80 65.10 Td (to ) Tj ET Q q 0 0 0 rg BT 292.85 65.10 Td (“Item ) Tj ET Q q 0 0 0 rg BT 318.89 65.10 Td (8. ) Tj ET Q q 0 0 0 rg BT 329.67 65.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 370.16 65.10 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.75 65.10 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.75 65.10 Td (. ) Tj ET Q q 0 0 0 rg BT 462.53 65.10 Td (Pension, ) Tj ET Q q 0 0 0 rg BT 499.97 65.10 Td (Postretirement ) Tj ET Q q 0 0 0 rg BT 561.57 65.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 53.10 Td (Postemployment ) Tj ET Q q 0 0 0 rg BT 105.72 53.10 Td (Liabilities.”) Tj ET Q endstream endobj 93 0 obj <> endobj 94 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (46) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Business Combinations and Divestitures) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Goodwill ) Tj ET Q q 0 0 0 rg BT 76.08 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 92.82 725.25 Td (other ) Tj ET Q q 0 0 0 rg BT 115.66 725.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 157.95 725.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 183.58 725.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 220.31 725.25 Td (in ) Tj ET Q q 0 0 0 rg BT 230.38 725.25 Td (business ) Tj ET Q q 0 0 0 rg BT 266.58 725.25 Td (combinations, ) Tj ET Q q 0 0 0 rg BT 325.26 725.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 363.66 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 380.40 725.25 Td (other ) Tj ET Q q 0 0 0 rg BT 403.25 725.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 453.31 725.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.04 725.25 Td ($8.3 ) Tj ET Q q 0 0 0 rg BT 494.84 725.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.95 725.25 Td ( ) Tj ET Q q 0 0 0 rg BT 523.25 725.25 Td (\(representing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (25%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.33 713.25 Td ( ) Tj ET Q q 0 0 0 rg BT 56.83 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 67.66 713.25 Td (total ) Tj ET Q q 0 0 0 rg BT 87.93 713.25 Td (assets\) ) Tj ET Q q 0 0 0 rg BT 117.09 713.25 Td (at ) Tj ET Q q 0 0 0 rg BT 126.81 713.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.39 713.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 205.39 713.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 85.25 689.25 Td (for ) Tj ET Q q 0 0 0 rg BT 99.50 689.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 149.86 689.25 Td (as ) Tj ET Q q 0 0 0 rg BT 160.79 689.25 Td (business ) Tj ET Q q 0 0 0 rg BT 197.27 689.25 Td (combinations ) Tj ET Q q 0 0 0 rg BT 253.75 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 270.78 689.25 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 319.48 689.25 Td (is ) Tj ET Q q 0 0 0 rg BT 328.74 689.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 381.33 689.25 Td (dif) Tj ET Q q 0 0 0 rg BT 392.25 689.25 Td (ferent ) Tj ET Q q 0 0 0 rg BT 418.16 689.25 Td (than ) Tj ET Q q 0 0 0 rg BT 437.98 689.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 460.01 689.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 510.38 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 527.41 689.25 Td (divestitures. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (For ) Tj ET Q q 0 0 0 rg BT 51.99 677.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 90.46 677.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 126.98 677.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 151.87 677.25 Td (is ) Tj ET Q q 0 0 0 rg BT 160.63 677.25 Td (capitalized ) Tj ET Q q 0 0 0 rg BT 206.04 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 219.80 677.25 Td (business ) Tj ET Q q 0 0 0 rg BT 255.79 677.25 Td (combinations ) Tj ET Q q 0 0 0 rg BT 311.77 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 328.30 677.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 367.61 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 381.37 677.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 402.91 677.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 452.78 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 469.32 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 483.63 677.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 499.61 677.25 Td (value ) Tj ET Q q 0 0 0 rg BT 523.36 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 533.79 677.25 Td (contingent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 92.44 665.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.45 665.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 147.58 665.25 Td (are ) Tj ET Q q 0 0 0 rg BT 162.35 665.25 Td (only ) Tj ET Q q 0 0 0 rg BT 182.70 665.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 229.13 665.25 Td (in ) Tj ET Q q 0 0 0 rg BT 239.48 665.25 Td (business ) Tj ET Q q 0 0 0 rg BT 275.94 665.25 Td (combination ) Tj ET Q q 0 0 0 rg BT 328.50 665.25 Td (transactions. ) Tj ET Q q 0 0 0 rg BT 381.34 665.25 Td (Likewise, ) Tj ET Q q 0 0 0 rg BT 423.06 665.25 Td (when ) Tj ET Q q 0 0 0 rg BT 447.29 665.25 Td (a ) Tj ET Q q 0 0 0 rg BT 454.30 665.25 Td (portion ) Tj ET Q q 0 0 0 rg BT 485.76 665.25 Td (of ) Tj ET Q q 0 0 0 rg BT 496.66 665.25 Td (a ) Tj ET Q q 0 0 0 rg BT 503.67 665.25 Td (reporting ) Tj ET Q q 0 0 0 rg BT 542.89 665.25 Td (unit ) Tj ET Q q 0 0 0 rg BT 561.02 665.25 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (constitutes ) Tj ET Q q 0 0 0 rg BT 81.10 653.25 Td (a ) Tj ET Q q 0 0 0 rg BT 87.86 653.25 Td (business ) Tj ET Q q 0 0 0 rg BT 124.08 653.25 Td (is ) Tj ET Q q 0 0 0 rg BT 133.07 653.25 Td (divested, ) Tj ET Q q 0 0 0 rg BT 171.22 653.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 209.10 653.25 Td (associated ) Tj ET Q q 0 0 0 rg BT 252.52 653.25 Td (with ) Tj ET Q q 0 0 0 rg BT 272.62 653.25 Td (that ) Tj ET Q q 0 0 0 rg BT 289.94 653.25 Td (business ) Tj ET Q q 0 0 0 rg BT 326.16 653.25 Td (is ) Tj ET Q q 0 0 0 rg BT 335.15 653.25 Td (included ) Tj ET Q q 0 0 0 rg BT 371.91 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 382.01 653.25 Td (the ) Tj ET Q q 0 0 0 rg BT 396.55 653.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 432.19 653.25 Td (value ) Tj ET Q q 0 0 0 rg BT 456.17 653.25 Td (of ) Tj ET Q q 0 0 0 rg BT 466.83 653.25 Td (the ) Tj ET Q q 0 0 0 rg BT 481.37 653.25 Td (business ) Tj ET Q q 0 0 0 rg BT 517.58 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 527.68 653.25 Td (determining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.09 641.25 Td (gain ) Tj ET Q q 0 0 0 rg BT 69.17 641.25 Td (or ) Tj ET Q q 0 0 0 rg BT 79.37 641.25 Td (loss. ) Tj ET Q q 0 0 0 rg BT 99.31 641.25 Td (Derecognition ) Tj ET Q q 0 0 0 rg BT 158.38 641.25 Td (of ) Tj ET Q q 0 0 0 rg BT 168.58 641.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 206.00 641.25 Td (does ) Tj ET Q q 0 0 0 rg BT 226.21 641.25 Td (not ) Tj ET Q q 0 0 0 rg BT 240.85 641.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 264.93 641.25 Td (in ) Tj ET Q q 0 0 0 rg BT 274.58 641.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 295.89 641.25 Td (dispositions. ) Tj ET Q q 0 0 0 rg BT 347.63 641.25 Td (As ) Tj ET Q q 0 0 0 rg BT 360.62 641.25 Td (a ) Tj ET Q q 0 0 0 rg BT 366.93 641.25 Td (result, ) Tj ET Q q 0 0 0 rg BT 393.51 641.25 Td (it ) Tj ET Q q 0 0 0 rg BT 400.94 641.25 Td (is ) Tj ET Q q 0 0 0 rg BT 409.48 641.25 Td (important ) Tj ET Q q 0 0 0 rg BT 450.23 641.25 Td (to ) Tj ET Q q 0 0 0 rg BT 459.88 641.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 501.73 641.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 535.81 641.25 Td (a ) Tj ET Q q 0 0 0 rg BT 542.12 641.25 Td (business ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (or ) Tj ET Q q 0 0 0 rg BT 46.88 629.25 Td (an ) Tj ET Q q 0 0 0 rg BT 58.87 629.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 80.85 629.25 Td (or ) Tj ET Q q 0 0 0 rg BT 91.73 629.25 Td (group ) Tj ET Q q 0 0 0 rg BT 117.61 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 128.49 629.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 154.37 629.25 Td (is ) Tj ET Q q 0 0 0 rg BT 163.59 629.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 200.56 629.25 Td (or ) Tj ET Q q 0 0 0 rg BT 211.44 629.25 Td (divested. ) Tj ET Q q 0 0 0 rg BT 249.25 629.25 Td (A) Tj ET Q q 0 0 0 rg BT 255.92 629.25 Td ( ) Tj ET Q q 0 0 0 rg BT 258.47 629.25 Td (business ) Tj ET Q q 0 0 0 rg BT 294.91 629.25 Td (is ) Tj ET Q q 0 0 0 rg BT 304.13 629.25 Td (defined ) Tj ET Q q 0 0 0 rg BT 336.66 629.25 Td (in ) Tj ET Q q 0 0 0 rg BT 346.43 629.25 Td (ASC ) Tj ET Q q 0 0 0 rg BT 368.43 629.25 Td (805 ) Tj ET Q q 0 0 0 rg BT 385.98 629.25 Td (- ) Tj ET Q q 0 0 0 rg BT 391.86 629.25 Td (Business ) Tj ET Q q 0 0 0 rg BT 429.97 629.25 Td (Combinations ) Tj ET Q q 0 0 0 rg BT 488.63 629.25 Td (as ) Tj ET Q q 0 0 0 rg BT 499.51 629.25 Td (an ) Tj ET Q q 0 0 0 rg BT 511.50 629.25 Td (integrated ) Tj ET Q q 0 0 0 rg BT 554.03 629.25 Td (set ) Tj ET Q q 0 0 0 rg BT 567.68 629.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 63.36 617.25 Td (and ) Tj ET Q q 0 0 0 rg BT 80.72 617.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 121.95 617.25 Td (that ) Tj ET Q q 0 0 0 rg BT 139.86 617.25 Td (are ) Tj ET Q q 0 0 0 rg BT 154.98 617.25 Td (capable ) Tj ET Q q 0 0 0 rg BT 188.43 617.25 Td (of ) Tj ET Q q 0 0 0 rg BT 199.68 617.25 Td (generating ) Tj ET Q q 0 0 0 rg BT 244.79 617.25 Td (outputs ) Tj ET Q q 0 0 0 rg BT 277.16 617.25 Td (that ) Tj ET Q q 0 0 0 rg BT 295.07 617.25 Td (have ) Tj ET Q q 0 0 0 rg BT 316.86 617.25 Td (the ) Tj ET Q q 0 0 0 rg BT 331.99 617.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 360.46 617.25 Td (to ) Tj ET Q q 0 0 0 rg BT 371.15 617.25 Td (provide ) Tj ET Q q 0 0 0 rg BT 404.61 617.25 Td (a ) Tj ET Q q 0 0 0 rg BT 411.97 617.25 Td (return ) Tj ET Q q 0 0 0 rg BT 438.76 617.25 Td (to ) Tj ET Q q 0 0 0 rg BT 449.45 617.25 Td (its ) Tj ET Q q 0 0 0 rg BT 461.82 617.25 Td (investors ) Tj ET Q q 0 0 0 rg BT 500.84 617.25 Td (or ) Tj ET Q q 0 0 0 rg BT 512.08 617.25 Td (owners. ) Tj ET Q q 0 0 0 rg BT 546.17 617.25 Td (T) Tj ET Q q 0 0 0 rg BT 551.58 617.25 Td (ypical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 63.59 605.25 Td (include ) Tj ET Q q 0 0 0 rg BT 96.16 605.25 Td (long-lived ) Tj ET Q q 0 0 0 rg BT 140.40 605.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 166.87 605.25 Td (\(including ) Tj ET Q q 0 0 0 rg BT 211.11 605.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 254.24 605.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 280.71 605.25 Td (or ) Tj ET Q q 0 0 0 rg BT 292.18 605.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 318.10 605.25 Td (to ) Tj ET Q q 0 0 0 rg BT 329.01 605.25 Td (use ) Tj ET Q q 0 0 0 rg BT 345.48 605.25 Td (long-lived ) Tj ET Q q 0 0 0 rg BT 389.72 605.25 Td (assets\), ) Tj ET Q q 0 0 0 rg BT 422.02 605.25 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 469.58 605.25 Td (property ) Tj ET Q q 0 0 0 rg BT 506.60 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 524.18 605.25 Td (the ) Tj ET Q q 0 0 0 rg BT 539.53 605.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 568.22 605.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (obtain ) Tj ET Q q 0 0 0 rg BT 62.83 593.25 Td (access ) Tj ET Q q 0 0 0 rg BT 90.21 593.25 Td (to ) Tj ET Q q 0 0 0 rg BT 99.82 593.25 Td (required ) Tj ET Q q 0 0 0 rg BT 134.98 593.25 Td (resources. ) Tj ET Q q 0 0 0 rg BT 176.94 593.25 Td (T) Tj ET Q q 0 0 0 rg BT 182.35 593.25 Td (ypical ) Tj ET Q q 0 0 0 rg BT 208.62 593.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 248.78 593.25 Td (include ) Tj ET Q q 0 0 0 rg BT 280.05 593.25 Td (strategic, ) Tj ET Q q 0 0 0 rg BT 318.26 593.25 Td (operational ) Tj ET Q q 0 0 0 rg BT 365.08 593.25 Td (and ) Tj ET Q q 0 0 0 rg BT 381.35 593.25 Td (resource ) Tj ET Q q 0 0 0 rg BT 417.06 593.25 Td (management ) Tj ET Q q 0 0 0 rg BT 469.98 593.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 510.14 593.25 Td (that ) Tj ET Q q 0 0 0 rg BT 526.97 593.25 Td (are ) Tj ET Q q 0 0 0 rg BT 541.02 593.25 Td (typically ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (documented ) Tj ET Q q 0 0 0 rg BT 87.37 581.25 Td (or ) Tj ET Q q 0 0 0 rg BT 98.20 581.25 Td (evident ) Tj ET Q q 0 0 0 rg BT 130.14 581.25 Td (through ) Tj ET Q q 0 0 0 rg BT 163.74 581.25 Td (an ) Tj ET Q q 0 0 0 rg BT 175.68 581.25 Td (or) Tj ET Q q 0 0 0 rg BT 183.83 581.25 Td (ganized ) Tj ET Q q 0 0 0 rg BT 217.43 581.25 Td (workforce.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 557.25 Td (e ) Tj ET Q q 0 0 0 rg BT 50.36 557.25 Td (consider ) Tj ET Q q 0 0 0 rg BT 85.52 557.25 Td (all ) Tj ET Q q 0 0 0 rg BT 96.80 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 106.42 557.25 Td (the ) Tj ET Q q 0 0 0 rg BT 119.92 557.25 Td (above ) Tj ET Q q 0 0 0 rg BT 145.08 557.25 Td (factors ) Tj ET Q q 0 0 0 rg BT 173.57 557.25 Td (when ) Tj ET Q q 0 0 0 rg BT 196.51 557.25 Td (determining ) Tj ET Q q 0 0 0 rg BT 246.12 557.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 279.61 557.25 Td (a ) Tj ET Q q 0 0 0 rg BT 285.33 557.25 Td (business ) Tj ET Q q 0 0 0 rg BT 320.51 557.25 Td (was ) Tj ET Q q 0 0 0 rg BT 337.34 557.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 373.05 557.25 Td (\(or ) Tj ET Q q 0 0 0 rg BT 386.00 557.25 Td (divested\) ) Tj ET Q q 0 0 0 rg BT 423.93 557.25 Td (as ) Tj ET Q q 0 0 0 rg BT 433.55 557.25 Td (well ) Tj ET Q q 0 0 0 rg BT 452.05 557.25 Td (as ) Tj ET Q q 0 0 0 rg BT 461.66 557.25 Td (the ) Tj ET Q q 0 0 0 rg BT 475.17 557.25 Td (compound's ) Tj ET Q q 0 0 0 rg BT 524.36 557.25 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (phase ) Tj ET Q q 0 0 0 rg BT 60.90 545.25 Td (if ) Tj ET Q q 0 0 0 rg BT 69.13 545.25 Td (no ) Tj ET Q q 0 0 0 rg BT 81.26 545.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 130.58 545.25 Td (products ) Tj ET Q q 0 0 0 rg BT 167.15 545.25 Td (are ) Tj ET Q q 0 0 0 rg BT 181.48 545.25 Td (involved. ) Tj ET Q q 0 0 0 rg BT 221.10 545.25 Td (For ) Tj ET Q q 0 0 0 rg BT 237.12 545.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 275.62 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 285.52 545.25 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 329.30 545.25 Td (our ) Tj ET Q q 0 0 0 rg BT 344.75 545.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 394.65 545.25 Td (of ) Tj ET Q q 0 0 0 rg BT 405.11 545.25 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 450.56 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 467.13 545.25 Td (Padlock ) Tj ET Q q 0 0 0 rg BT 501.47 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 511.38 545.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 536.00 545.25 Td (Cardioxyl ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.25 533.25 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 82.73 533.25 Td (in ) Tj ET Q q 0 0 0 rg BT 93.32 533.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 116.13 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 133.38 533.25 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 167.30 533.25 Td (in ) Tj ET Q q 0 0 0 rg BT 177.89 533.25 Td (2014, ) Tj ET Q q 0 0 0 rg BT 203.20 533.25 Td (we ) Tj ET Q q 0 0 0 rg BT 217.67 533.25 Td (concluded ) Tj ET Q q 0 0 0 rg BT 261.58 533.25 Td (that ) Tj ET Q q 0 0 0 rg BT 279.38 533.25 Td (no ) Tj ET Q q 0 0 0 rg BT 292.19 533.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 337.22 533.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 378.35 533.25 Td (were ) Tj ET Q q 0 0 0 rg BT 400.59 533.25 Td (transferred ) Tj ET Q q 0 0 0 rg BT 446.71 533.25 Td (to ) Tj ET Q q 0 0 0 rg BT 457.30 533.25 Td (us, ) Tj ET Q q 0 0 0 rg BT 471.50 533.25 Td (thus ) Tj ET Q q 0 0 0 rg BT 490.98 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 506.01 533.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 556.58 533.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (accounted ) Tj ET Q q 0 0 0 rg BT 79.82 521.25 Td (for ) Tj ET Q q 0 0 0 rg BT 94.78 521.25 Td (as ) Tj ET Q q 0 0 0 rg BT 106.40 521.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 129.13 521.25 Td (acquisitions. ) Tj ET Q q 0 0 0 rg BT 181.97 521.25 Td (As ) Tj ET Q q 0 0 0 rg BT 196.38 521.25 Td (a ) Tj ET Q q 0 0 0 rg BT 204.11 521.25 Td (result, ) Tj ET Q q 0 0 0 rg BT 232.12 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 247.63 521.25 Td (amounts ) Tj ET Q q 0 0 0 rg BT 284.80 521.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 324.19 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 335.26 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 350.77 521.25 Td (lead ) Tj ET Q q 0 0 0 rg BT 370.71 521.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 432.88 521.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 482.28 521.25 Td (were ) Tj ET Q q 0 0 0 rg BT 505.00 521.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 545.50 521.25 Td (and ) Tj ET Q q 0 0 0 rg BT 563.24 521.25 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (capitalized. ) Tj ET Q q 0 0 0 rg BT 83.81 509.25 Td (In ) Tj ET Q q 0 0 0 rg BT 94.14 509.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 131.42 509.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 175.63 509.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 231.51 509.25 Td (from ) Tj ET Q q 0 0 0 rg BT 252.95 509.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 289.95 509.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 346.10 509.25 Td (regulatory) Tj ET Q q 0 0 0 rg BT 386.54 509.25 Td (, ) Tj ET Q q 0 0 0 rg BT 391.05 509.25 Td (approval ) Tj ET Q q 0 0 0 rg BT 428.04 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 444.48 509.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 492.02 509.25 Td (milestones ) Tj ET Q q 0 0 0 rg BT 536.80 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 553.24 509.25 Td (sales-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (based ) Tj ET Q q 0 0 0 rg BT 61.18 497.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 98.02 497.25 Td (were ) Tj ET Q q 0 0 0 rg BT 119.86 497.25 Td (not ) Tj ET Q q 0 0 0 rg BT 135.04 497.25 Td (included ) Tj ET Q q 0 0 0 rg BT 171.89 497.25 Td (in ) Tj ET Q q 0 0 0 rg BT 182.07 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 196.70 497.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 234.64 497.25 Td (price. ) Tj ET Q q 0 0 0 rg BT 259.54 497.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 284.15 497.25 Td (to ) Tj ET Q q 0 0 0 rg BT 294.34 497.25 Td ("Item ) Tj ET Q q 0 0 0 rg BT 319.16 497.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 329.07 497.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 368.69 497.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.42 497.25 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.42 497.25 Td (. ) Tj ET Q q 0 0 0 rg BT 453.79 497.25 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 506.76 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 523.60 497.25 Td (Divestitures" ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 485.25 Td (further ) Tj ET Q q 0 0 0 rg BT 79.87 485.25 Td (discussion ) Tj ET Q q 0 0 0 rg BT 124.04 485.25 Td (on ) Tj ET Q q 0 0 0 rg BT 136.54 485.25 Td (our ) Tj ET Q q 0 0 0 rg BT 152.37 485.25 Td (acquisitions. ) Tj ET Q q 0 0 0 rg BT 205.14 485.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (Similarly) Tj ET Q q 0 0 0 rg BT 72.57 461.25 Td (, ) Tj ET Q q 0 0 0 rg BT 78.18 461.25 Td (in ) Tj ET Q q 0 0 0 rg BT 89.07 461.25 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 133.83 461.25 Td (our ) Tj ET Q q 0 0 0 rg BT 150.27 461.25 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 199.49 461.25 Td (of ) Tj ET Q q 0 0 0 rg BT 210.93 461.25 Td (our ) Tj ET Q q 0 0 0 rg BT 227.37 461.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 289.35 461.25 Td (HIV) Tj ET Q q 0 0 0 rg BT 306.95 461.25 Td ( ) Tj ET Q q 0 0 0 rg BT 310.06 461.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 353.71 461.25 Td (business ) Tj ET Q q 0 0 0 rg BT 390.71 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 408.26 461.25 Td (the ) Tj ET Q q 0 0 0 rg BT 423.59 461.25 Td (business ) Tj ET Q q 0 0 0 rg BT 460.59 461.25 Td (comprising ) Tj ET Q q 0 0 0 rg BT 508.70 461.25 Td (the ) Tj ET Q q 0 0 0 rg BT 524.02 461.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 558.22 461.25 Td (with ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 70.28 449.25 Td (in ) Tj ET Q q 0 0 0 rg BT 83.47 449.25 Td (2016, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 111.37 449.25 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.36 449.25 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 154.27 449.25 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 192.59 449.25 Td ( ) Tj ET Q q 0 0 0 rg BT 197.99 449.25 Td (and ) Tj ET Q q 0 0 0 rg BT 217.83 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 235.45 449.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 283.08 449.25 Td (comprising ) Tj ET Q q 0 0 0 rg BT 333.47 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 351.09 449.25 Td (alliances ) Tj ET Q q 0 0 0 rg BT 391.48 449.25 Td (with ) Tj ET Q q 0 0 0 rg BT 414.27 449.25 Td (The ) Tj ET Q q 0 0 0 rg BT 435.22 449.25 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 482.27 449.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 526.56 449.25 Td (and ) Tj ET Q q 0 0 0 rg BT 546.01 449.25 Td (V) Tj ET Q q 0 0 0 rg BT 552.13 449.25 Td (aleant ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (Pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 103.62 437.25 Td (International, ) Tj ET Q q 0 0 0 rg BT 159.31 437.25 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 176.67 437.25 Td (in ) Tj ET Q q 0 0 0 rg BT 186.54 437.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 211.14 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 227.67 437.25 Td (our ) Tj ET Q q 0 0 0 rg BT 243.09 437.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 277.95 437.25 Td (business ) Tj ET Q q 0 0 0 rg BT 313.94 437.25 Td (to ) Tj ET Q q 0 0 0 rg BT 323.35 437.25 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 375.97 437.25 Td (in ) Tj ET Q q 0 0 0 rg BT 385.84 437.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 407.94 437.25 Td (we ) Tj ET Q q 0 0 0 rg BT 421.69 437.25 Td (concluded ) Tj ET Q q 0 0 0 rg BT 464.88 437.25 Td (that ) Tj ET Q q 0 0 0 rg BT 481.97 437.25 Td (all ) Tj ET Q q 0 0 0 rg BT 494.06 437.25 Td (necessary ) Tj ET Q q 0 0 0 rg BT 535.02 437.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 561.56 437.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 76.62 425.25 Td (were ) Tj ET Q q 0 0 0 rg BT 98.34 425.25 Td (transferred, ) Tj ET Q q 0 0 0 rg BT 146.44 425.25 Td (and ) Tj ET Q q 0 0 0 rg BT 163.17 425.25 Td (consequently ) Tj ET Q q 0 0 0 rg BT 218.23 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 232.74 425.25 Td (transactions ) Tj ET Q q 0 0 0 rg BT 282.80 425.25 Td (were ) Tj ET Q q 0 0 0 rg BT 304.53 425.25 Td (accounted ) Tj ET Q q 0 0 0 rg BT 347.35 425.25 Td (for ) Tj ET Q q 0 0 0 rg BT 361.31 425.25 Td (as ) Tj ET Q q 0 0 0 rg BT 371.93 425.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 393.67 425.25 Td (of ) Tj ET Q q 0 0 0 rg BT 404.29 425.25 Td (businesses, ) Tj ET Q q 0 0 0 rg BT 451.31 425.25 Td (which ) Tj ET Q q 0 0 0 rg BT 478.04 425.25 Td (resulted ) Tj ET Q q 0 0 0 rg BT 511.99 425.25 Td (in ) Tj ET Q q 0 0 0 rg BT 522.06 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 536.58 425.25 Td (allocation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.88 413.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 84.99 413.25 Td (\($98 ) Tj ET Q q 0 0 0 rg BT 105.87 413.25 Td (million ) Tj ET Q q 0 0 0 rg BT 137.31 413.25 Td (in ) Tj ET Q q 0 0 0 rg BT 147.64 413.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 172.69 413.25 Td ($73 ) Tj ET Q q 0 0 0 rg BT 190.25 413.25 Td (million ) Tj ET Q q 0 0 0 rg BT 221.69 413.25 Td (in ) Tj ET Q q 0 0 0 rg BT 232.02 413.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 254.57 413.25 Td (and ) Tj ET Q q 0 0 0 rg BT 271.56 413.25 Td ($600 ) Tj ET Q q 0 0 0 rg BT 294.11 413.25 Td (million ) Tj ET Q q 0 0 0 rg BT 325.55 413.25 Td (in ) Tj ET Q q 0 0 0 rg BT 335.88 413.25 Td (2014\) ) Tj ET Q q 0 0 0 rg BT 361.76 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 372.09 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 386.86 413.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 422.73 413.25 Td (value ) Tj ET Q q 0 0 0 rg BT 446.94 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 457.82 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 472.58 413.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 517.36 413.25 Td (in ) Tj ET Q q 0 0 0 rg BT 527.69 413.25 Td (determining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 401.25 Td (gain ) Tj ET Q q 0 0 0 rg BT 70.43 401.25 Td (on ) Tj ET Q q 0 0 0 rg BT 82.93 401.25 Td (sale. ) Tj ET Q q 0 0 0 rg BT 103.48 401.25 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 150.42 401.25 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 188.46 401.25 Td (related ) Tj ET Q q 0 0 0 rg BT 218.16 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 228.44 401.25 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 277.04 401.25 Td (are ) Tj ET Q q 0 0 0 rg BT 291.75 401.25 Td (not ) Tj ET Q q 0 0 0 rg BT 307.03 401.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 353.39 401.25 Td (until ) Tj ET Q q 0 0 0 rg BT 374.23 401.25 Td (realized.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (V) Tj ET Q q 0 0 0 rg BT 42.11 377.25 Td (aluation ) Tj ET Q q 0 0 0 rg BT 76.98 377.25 Td (processes ) Tj ET Q q 0 0 0 rg BT 117.95 377.25 Td (are ) Tj ET Q q 0 0 0 rg BT 132.81 377.25 Td (also ) Tj ET Q q 0 0 0 rg BT 151.57 377.25 Td (required ) Tj ET Q q 0 0 0 rg BT 187.53 377.25 Td (for ) Tj ET Q q 0 0 0 rg BT 201.84 377.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 231.70 377.25 Td (multiple ) Tj ET Q q 0 0 0 rg BT 267.68 377.25 Td (element ) Tj ET Q q 0 0 0 rg BT 301.98 377.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 358.50 377.25 Td (and ) Tj ET Q q 0 0 0 rg BT 375.58 377.25 Td (include ) Tj ET Q q 0 0 0 rg BT 407.67 377.25 Td (determination ) Tj ET Q q 0 0 0 rg BT 465.86 377.25 Td (of ) Tj ET Q q 0 0 0 rg BT 476.84 377.25 Td (judgmental ) Tj ET Q q 0 0 0 rg BT 524.48 377.25 Td (and ) Tj ET Q q 0 0 0 rg BT 541.57 377.25 Td (complex ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.25 Td (matters, ) Tj ET Q q 0 0 0 rg BT 69.73 365.25 Td (discussed ) Tj ET Q q 0 0 0 rg BT 109.86 365.25 Td (above. For ) Tj ET Q q 0 0 0 rg BT 154.42 365.25 Td (example, ) Tj ET Q q 0 0 0 rg BT 192.59 365.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 215.51 365.25 Td (purchased ) Tj ET Q q 0 0 0 rg BT 257.85 365.25 Td (a ) Tj ET Q q 0 0 0 rg BT 264.08 365.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 296.42 365.25 Td (in ) Tj ET Q q 0 0 0 rg BT 305.99 365.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 327.79 365.25 Td (that ) Tj ET Q q 0 0 0 rg BT 344.58 365.25 Td (gives ) Tj ET Q q 0 0 0 rg BT 367.48 365.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 390.40 365.25 Td (the ) Tj ET Q q 0 0 0 rg BT 404.42 365.25 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 443.98 365.25 Td (right ) Tj ET Q q 0 0 0 rg BT 464.66 365.25 Td (to ) Tj ET Q q 0 0 0 rg BT 474.24 365.25 Td (acquire ) Tj ET Q q 0 0 0 rg BT 505.46 365.25 Td (Promedior) Tj ET Q q 0 0 0 rg BT 547.27 365.25 Td (, ) Tj ET Q q 0 0 0 rg BT 551.57 365.25 Td (which ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (required ) Tj ET Q q 0 0 0 rg BT 71.85 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 86.61 353.25 Td (determination ) Tj ET Q q 0 0 0 rg BT 144.68 353.25 Td (of ) Tj ET Q q 0 0 0 rg BT 155.55 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 170.31 353.25 Td (best ) Tj ET Q q 0 0 0 rg BT 188.95 353.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 229.81 353.25 Td (selling ) Tj ET Q q 0 0 0 rg BT 259.01 353.25 Td (price ) Tj ET Q q 0 0 0 rg BT 281.54 353.25 Td (of ) Tj ET Q q 0 0 0 rg BT 292.41 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 307.16 353.25 Td (two ) Tj ET Q q 0 0 0 rg BT 324.70 353.25 Td (separate ) Tj ET Q q 0 0 0 rg BT 359.99 353.25 Td (elements ) Tj ET Q q 0 0 0 rg BT 398.07 353.25 Td (identified ) Tj ET Q q 0 0 0 rg BT 438.93 353.25 Td (in ) Tj ET Q q 0 0 0 rg BT 449.25 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 464.00 353.25 Td (transaction ) Tj ET Q q 0 0 0 rg BT 510.41 353.25 Td (\(the ) Tj ET Q q 0 0 0 rg BT 528.50 353.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 561.57 353.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.65 341.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 82.51 341.25 Td (development ) Tj ET Q q 0 0 0 rg BT 136.60 341.25 Td (services\). ) Tj ET Q q 0 0 0 rg BT 177.07 341.25 Td (Similarly) Tj ET Q q 0 0 0 rg BT 213.64 341.25 Td (, ) Tj ET Q q 0 0 0 rg BT 218.57 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 233.22 341.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 277.87 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 288.63 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 303.28 341.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 338.48 341.25 Td (business ) Tj ET Q q 0 0 0 rg BT 374.80 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 384.47 341.25 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 437.43 341.25 Td (in ) Tj ET Q q 0 0 0 rg BT 447.64 341.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 470.07 341.25 Td (required ) Tj ET Q q 0 0 0 rg BT 505.82 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 520.47 341.25 Td (determination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 45.59 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 59.07 329.25 Td (best ) Tj ET Q q 0 0 0 rg BT 76.43 329.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 116.01 329.25 Td (selling ) Tj ET Q q 0 0 0 rg BT 143.94 329.25 Td (price ) Tj ET Q q 0 0 0 rg BT 165.18 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 174.77 329.25 Td (several ) Tj ET Q q 0 0 0 rg BT 204.35 329.25 Td (elements ) Tj ET Q q 0 0 0 rg BT 241.15 329.25 Td (including ) Tj ET Q q 0 0 0 rg BT 280.18 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 293.66 329.25 Td (business, ) Tj ET Q q 0 0 0 rg BT 331.31 329.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 359.24 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 374.94 329.25 Td (development ) Tj ET Q q 0 0 0 rg BT 427.85 329.25 Td (agreements ) Tj ET Q q 0 0 0 rg BT 474.64 329.25 Td (\(including ) Tj ET Q q 0 0 0 rg BT 517.01 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 530.48 329.25 Td (appropriate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (mark-ups\) ) Tj ET Q q 0 0 0 rg BT 80.36 317.25 Td (and ) Tj ET Q q 0 0 0 rg BT 98.06 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 113.53 317.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 155.11 317.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 172.25 317.25 Td (value ) Tj ET Q q 0 0 0 rg BT 197.16 317.25 Td (of ) Tj ET Q q 0 0 0 rg BT 208.75 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 224.23 317.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 285.80 317.25 Td (facility) Tj ET Q q 0 0 0 rg BT 313.47 317.25 Td (. ) Tj ET Q q 0 0 0 rg BT 319.23 317.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 344.69 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 355.73 317.25 Td ("Item ) Tj ET Q q 0 0 0 rg BT 381.40 317.25 Td (8. ) Tj ET Q q 0 0 0 rg BT 392.16 317.25 Td (Financial ) Tj ET Q q 0 0 0 rg BT 432.63 317.25 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.21 317.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.21 317.25 Td (. ) Tj ET Q q 0 0 0 rg BT 519.25 317.25 Td (Alliances" ) Tj ET Q q 0 0 0 rg BT 564.35 317.25 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (further ) Tj ET Q q 0 0 0 rg BT 65.71 305.25 Td (discussion ) Tj ET Q q 0 0 0 rg BT 109.88 305.25 Td (on ) Tj ET Q q 0 0 0 rg BT 122.38 305.25 Td (both ) Tj ET Q q 0 0 0 rg BT 142.66 305.25 Td (transactions.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (Impairment) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 258.3169921875 m 198.294921875 258.3169921875 l s q 0 0 0 rg BT 36.00 259.65 Td (Other Intangible ) Tj ET Q q 0 0 0 rg BT 105.25 259.65 Td (Assets, including IPRD) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 238.05 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.47 238.05 Td (intangible ) Tj ET Q q 0 0 0 rg BT 104.15 238.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 130.18 238.05 Td (were ) Tj ET Q q 0 0 0 rg BT 152.30 238.05 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.30 238.05 Td (1.4 ) Tj ET Q q 0 0 0 rg BT 172.50 238.05 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 198.61 238.05 Td ( ) Tj ET Q q 0 0 0 rg BT 201.31 238.05 Td (at ) Tj ET Q q 0 0 0 rg BT 211.23 238.05 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 270.01 238.05 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.01 238.05 Td (, ) Tj ET Q q 0 0 0 rg BT 295.20 238.05 Td (including ) Tj ET Q q 0 0 0 rg BT 335.67 238.05 Td (licenses ) Tj ET Q q 0 0 0 rg BT 370.02 238.05 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.35 238.05 Td ($248 ) Tj ET Q q 0 0 0 rg BT 396.05 238.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.94 238.05 Td ( ) Tj ET Q q 0 0 0 rg BT 427.64 238.05 Td (of ) Tj ET Q q 0 0 0 rg BT 438.67 238.05 Td (which ) Tj ET Q q 0 0 0 rg BT 465.80 238.05 Td ($155 ) Tj ET Q q 0 0 0 rg BT 488.50 238.05 Td (million ) Tj ET Q q 0 0 0 rg BT 520.09 238.05 Td (is ) Tj ET Q q 0 0 0 rg BT 529.45 238.05 Td (allocated ) Tj ET Q q 0 0 0 rg BT 568.24 238.05 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 226.05 Td (unapproved ) Tj ET Q q 0 0 0 rg BT 87.32 226.05 Td (products\), ) Tj ET Q q 0 0 0 rg BT 131.71 226.05 Td (developed ) Tj ET Q q 0 0 0 rg BT 176.91 226.05 Td (technology ) Tj ET Q q 0 0 0 rg BT 225.46 226.05 Td (rights ) Tj ET Q q 0 0 0 rg BT 252.35 226.05 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 255.69 226.05 Td ($669 ) Tj ET Q q 0 0 0 rg BT 279.80 226.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.69 226.05 Td (\), ) Tj ET Q q 0 0 0 rg BT 318.64 226.05 Td (capitalized ) Tj ET Q q 0 0 0 rg BT 366.06 226.05 Td (software ) Tj ET Q q 0 0 0 rg BT 404.60 226.05 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.93 226.05 Td ($361 ) Tj ET Q q 0 0 0 rg BT 432.04 226.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.94 226.05 Td (\) ) Tj ET Q q 0 0 0 rg BT 468.38 226.05 Td (and ) Tj ET Q q 0 0 0 rg BT 486.93 226.05 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 513.83 226.05 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.16 226.05 Td ($107 ) Tj ET Q q 0 0 0 rg BT 541.28 226.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 570.17 226.05 Td (\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 214.05 Td (Intangible ) Tj ET Q q 0 0 0 rg BT 79.41 214.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 105.61 214.05 Td (are ) Tj ET Q q 0 0 0 rg BT 120.69 214.05 Td (assessed ) Tj ET Q q 0 0 0 rg BT 157.45 214.05 Td (for ) Tj ET Q q 0 0 0 rg BT 171.98 214.05 Td (impairment ) Tj ET Q q 0 0 0 rg BT 220.95 214.05 Td (whenever ) Tj ET Q q 0 0 0 rg BT 262.68 214.05 Td (current ) Tj ET Q q 0 0 0 rg BT 293.87 214.05 Td (facts ) Tj ET Q q 0 0 0 rg BT 315.62 214.05 Td (or ) Tj ET Q q 0 0 0 rg BT 326.82 214.05 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 386.33 214.05 Td (warrant ) Tj ET Q q 0 0 0 rg BT 419.74 214.05 Td (a ) Tj ET Q q 0 0 0 rg BT 427.05 214.05 Td (review) Tj ET Q q 0 0 0 rg BT 453.61 214.05 Td (, ) Tj ET Q q 0 0 0 rg BT 458.98 214.05 Td (although ) Tj ET Q q 0 0 0 rg BT 496.84 214.05 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 522.50 214.05 Td (is ) Tj ET Q q 0 0 0 rg BT 532.04 214.05 Td (assessed ) Tj ET Q q 0 0 0 rg BT 568.79 214.05 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 202.05 Td (least ) Tj ET Q q 0 0 0 rg BT 57.24 202.05 Td (annually) Tj ET Q q 0 0 0 rg BT 91.02 202.05 Td (. ) Tj ET Q q 0 0 0 rg BT 96.43 202.05 Td (Intangible ) Tj ET Q q 0 0 0 rg BT 139.89 202.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 166.13 202.05 Td (are ) Tj ET Q q 0 0 0 rg BT 181.25 202.05 Td (highly ) Tj ET Q q 0 0 0 rg BT 209.71 202.05 Td (vulnerable ) Tj ET Q q 0 0 0 rg BT 254.83 202.05 Td (to ) Tj ET Q q 0 0 0 rg BT 265.52 202.05 Td (impairment ) Tj ET Q q 0 0 0 rg BT 314.53 202.05 Td (char) Tj ET Q q 0 0 0 rg BT 331.56 202.05 Td (ges, ) Tj ET Q q 0 0 0 rg BT 350.30 202.05 Td (particularly ) Tj ET Q q 0 0 0 rg BT 399.30 202.05 Td (newly ) Tj ET Q q 0 0 0 rg BT 426.65 202.05 Td (acquired ) Tj ET Q q 0 0 0 rg BT 463.98 202.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 490.22 202.05 Td (for ) Tj ET Q q 0 0 0 rg BT 504.80 202.05 Td (recently ) Tj ET Q q 0 0 0 rg BT 539.91 202.05 Td (launched ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 190.05 Td (products ) Tj ET Q q 0 0 0 rg BT 73.47 190.05 Td (or ) Tj ET Q q 0 0 0 rg BT 84.84 190.05 Td (IPRD. ) Tj ET Q q 0 0 0 rg BT 112.93 190.05 Td (These ) Tj ET Q q 0 0 0 rg BT 139.84 190.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 166.21 190.05 Td (are ) Tj ET Q q 0 0 0 rg BT 181.45 190.05 Td (initially ) Tj ET Q q 0 0 0 rg BT 215.59 190.05 Td (measured ) Tj ET Q q 0 0 0 rg BT 256.94 190.05 Td (at ) Tj ET Q q 0 0 0 rg BT 267.19 190.05 Td (fair ) Tj ET Q q 0 0 0 rg BT 284.10 190.05 Td (value ) Tj ET Q q 0 0 0 rg BT 308.79 190.05 Td (and ) Tj ET Q q 0 0 0 rg BT 326.26 190.05 Td (therefore ) Tj ET Q q 0 0 0 rg BT 365.38 190.05 Td (any ) Tj ET Q q 0 0 0 rg BT 382.85 190.05 Td (reduction ) Tj ET Q q 0 0 0 rg BT 423.65 190.05 Td (in ) Tj ET Q q 0 0 0 rg BT 434.46 190.05 Td (expectations ) Tj ET Q q 0 0 0 rg BT 487.48 190.05 Td (used ) Tj ET Q q 0 0 0 rg BT 508.84 190.05 Td (in ) Tj ET Q q 0 0 0 rg BT 519.65 190.05 Td (the ) Tj ET Q q 0 0 0 rg BT 534.90 190.05 Td (valuations ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 178.05 Td (could ) Tj ET Q q 0 0 0 rg BT 60.63 178.05 Td (potentially ) Tj ET Q q 0 0 0 rg BT 105.82 178.05 Td (lead ) Tj ET Q q 0 0 0 rg BT 124.89 178.05 Td (to ) Tj ET Q q 0 0 0 rg BT 135.08 178.05 Td (impairment. ) Tj ET Q q 0 0 0 rg BT 186.10 178.05 Td (Some ) Tj ET Q q 0 0 0 rg BT 211.29 178.05 Td (of ) Tj ET Q q 0 0 0 rg BT 222.04 178.05 Td (the ) Tj ET Q q 0 0 0 rg BT 236.67 178.05 Td (more ) Tj ET Q q 0 0 0 rg BT 259.63 178.05 Td (common ) Tj ET Q q 0 0 0 rg BT 297.04 178.05 Td (potential ) Tj ET Q q 0 0 0 rg BT 334.45 178.05 Td (risks ) Tj ET Q q 0 0 0 rg BT 355.76 178.05 Td (leading ) Tj ET Q q 0 0 0 rg BT 387.61 178.05 Td (to ) Tj ET Q q 0 0 0 rg BT 397.80 178.05 Td (impairment ) Tj ET Q q 0 0 0 rg BT 446.32 178.05 Td (include ) Tj ET Q q 0 0 0 rg BT 478.17 178.05 Td (competition, ) Tj ET Q q 0 0 0 rg BT 530.85 178.05 Td (earlier ) Tj ET Q q 0 0 0 rg BT 558.80 178.05 Td (than ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 166.05 Td (expected ) Tj ET Q q 0 0 0 rg BT 74.34 166.05 Td (loss ) Tj ET Q q 0 0 0 rg BT 92.71 166.05 Td (of ) Tj ET Q q 0 0 0 rg BT 103.85 166.05 Td (exclusivity) Tj ET Q q 0 0 0 rg BT 147.08 166.05 Td (, ) Tj ET Q q 0 0 0 rg BT 152.39 166.05 Td (pricing ) Tj ET Q q 0 0 0 rg BT 183.53 166.05 Td (pressures, ) Tj ET Q q 0 0 0 rg BT 226.05 166.05 Td (adverse ) Tj ET Q q 0 0 0 rg BT 259.39 166.05 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 303.30 166.05 Td (changes ) Tj ET Q q 0 0 0 rg BT 338.31 166.05 Td (or ) Tj ET Q q 0 0 0 rg BT 349.45 166.05 Td (clinical ) Tj ET Q q 0 0 0 rg BT 381.69 166.05 Td (trial ) Tj ET Q q 0 0 0 rg BT 400.60 166.05 Td (results, ) Tj ET Q q 0 0 0 rg BT 432.02 166.05 Td (delay ) Tj ET Q q 0 0 0 rg BT 456.48 166.05 Td (or ) Tj ET Q q 0 0 0 rg BT 467.62 166.05 Td (failure ) Tj ET Q q 0 0 0 rg BT 496.53 166.05 Td (to ) Tj ET Q q 0 0 0 rg BT 507.11 166.05 Td (obtain ) Tj ET Q q 0 0 0 rg BT 534.92 166.05 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 154.05 Td (approval ) Tj ET Q q 0 0 0 rg BT 73.09 154.05 Td (and ) Tj ET Q q 0 0 0 rg BT 89.63 154.05 Td (additional ) Tj ET Q q 0 0 0 rg BT 131.72 154.05 Td (development ) Tj ET Q q 0 0 0 rg BT 185.48 154.05 Td (costs, ) Tj ET Q q 0 0 0 rg BT 210.08 154.05 Td (inability ) Tj ET Q q 0 0 0 rg BT 245.52 154.05 Td (to ) Tj ET Q q 0 0 0 rg BT 255.40 154.05 Td (achieve ) Tj ET Q q 0 0 0 rg BT 288.03 154.05 Td (expected ) Tj ET Q q 0 0 0 rg BT 325.67 154.05 Td (syner) Tj ET Q q 0 0 0 rg BT 347.15 154.05 Td (gies, ) Tj ET Q q 0 0 0 rg BT 367.86 154.05 Td (higher ) Tj ET Q q 0 0 0 rg BT 395.51 154.05 Td (operating ) Tj ET Q q 0 0 0 rg BT 435.38 154.05 Td (costs, ) Tj ET Q q 0 0 0 rg BT 459.98 154.05 Td (changes ) Tj ET Q q 0 0 0 rg BT 494.29 154.05 Td (in ) Tj ET Q q 0 0 0 rg BT 504.17 154.05 Td (tax ) Tj ET Q q 0 0 0 rg BT 518.49 154.05 Td (laws ) Tj ET Q q 0 0 0 rg BT 538.93 154.05 Td (and ) Tj ET Q q 0 0 0 rg BT 555.47 154.05 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 142.05 Td (macro-economic ) Tj ET Q q 0 0 0 rg BT 105.06 142.05 Td (changes. ) Tj ET Q q 0 0 0 rg BT 141.50 142.05 Td (The ) Tj ET Q q 0 0 0 rg BT 158.92 142.05 Td (complexity ) Tj ET Q q 0 0 0 rg BT 205.79 142.05 Td (in ) Tj ET Q q 0 0 0 rg BT 215.44 142.05 Td (estimating ) Tj ET Q q 0 0 0 rg BT 258.97 142.05 Td (the ) Tj ET Q q 0 0 0 rg BT 273.06 142.05 Td (fair ) Tj ET Q q 0 0 0 rg BT 288.81 142.05 Td (value ) Tj ET Q q 0 0 0 rg BT 312.34 142.05 Td (of ) Tj ET Q q 0 0 0 rg BT 322.54 142.05 Td (intangible ) Tj ET Q q 0 0 0 rg BT 364.40 142.05 Td (assets ) Tj ET Q q 0 0 0 rg BT 389.60 142.05 Td (in ) Tj ET Q q 0 0 0 rg BT 399.26 142.05 Td (connection ) Tj ET Q q 0 0 0 rg BT 445.00 142.05 Td (with ) Tj ET Q q 0 0 0 rg BT 464.65 142.05 Td (an ) Tj ET Q q 0 0 0 rg BT 475.96 142.05 Td (impairment ) Tj ET Q q 0 0 0 rg BT 523.93 142.05 Td (test ) Tj ET Q q 0 0 0 rg BT 539.69 142.05 Td (is ) Tj ET Q q 0 0 0 rg BT 548.24 142.05 Td (similar ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 130.05 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 130.05 Td (the ) Tj ET Q q 0 0 0 rg BT 61.00 130.05 Td (initial ) Tj ET Q q 0 0 0 rg BT 86.83 130.05 Td (valuation.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 106.05 Td (Considering ) Tj ET Q q 0 0 0 rg BT 87.52 106.05 Td (the ) Tj ET Q q 0 0 0 rg BT 102.37 106.05 Td (high ) Tj ET Q q 0 0 0 rg BT 122.78 106.05 Td (risk ) Tj ET Q q 0 0 0 rg BT 140.41 106.05 Td (nature ) Tj ET Q q 0 0 0 rg BT 168.03 106.05 Td (of ) Tj ET Q q 0 0 0 rg BT 178.99 106.05 Td (research ) Tj ET Q q 0 0 0 rg BT 214.93 106.05 Td (and ) Tj ET Q q 0 0 0 rg BT 232.00 106.05 Td (development ) Tj ET Q q 0 0 0 rg BT 286.28 106.05 Td (and ) Tj ET Q q 0 0 0 rg BT 303.35 106.05 Td (the ) Tj ET Q q 0 0 0 rg BT 318.20 106.05 Td (industry’) Tj ET Q q 0 0 0 rg BT 353.75 106.05 Td (s ) Tj ET Q q 0 0 0 rg BT 360.28 106.05 Td (success ) Tj ET Q q 0 0 0 rg BT 392.90 106.05 Td (rate ) Tj ET Q q 0 0 0 rg BT 410.52 106.05 Td (of ) Tj ET Q q 0 0 0 rg BT 421.48 106.05 Td (bringing ) Tj ET Q q 0 0 0 rg BT 458.00 106.05 Td (developmental ) Tj ET Q q 0 0 0 rg BT 519.50 106.05 Td (compounds ) Tj ET Q q 0 0 0 rg BT 568.24 106.05 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 94.05 Td (market, ) Tj ET Q q 0 0 0 rg BT 68.84 94.05 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 94.20 94.05 Td (impairment ) Tj ET Q q 0 0 0 rg BT 142.87 94.05 Td (char) Tj ET Q q 0 0 0 rg BT 159.90 94.05 Td (ges ) Tj ET Q q 0 0 0 rg BT 175.80 94.05 Td (are ) Tj ET Q q 0 0 0 rg BT 190.59 94.05 Td (likely ) Tj ET Q q 0 0 0 rg BT 215.94 94.05 Td (to ) Tj ET Q q 0 0 0 rg BT 226.29 94.05 Td (occur ) Tj ET Q q 0 0 0 rg BT 251.07 94.05 Td (in ) Tj ET Q q 0 0 0 rg BT 261.43 94.05 Td (future ) Tj ET Q q 0 0 0 rg BT 287.88 94.05 Td (periods. ) Tj ET Q q 0 0 0 rg BT 322.21 94.05 Td (W) Tj ET Q q 0 0 0 rg BT 330.85 94.05 Td (e ) Tj ET Q q 0 0 0 rg BT 337.86 94.05 Td (recognized ) Tj ET Q q 0 0 0 rg BT 384.30 94.05 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.31 94.05 Td ($160 ) Tj ET Q q 0 0 0 rg BT 413.89 94.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.78 94.05 Td ( ) Tj ET Q q 0 0 0 rg BT 445.35 94.05 Td (char) Tj ET Q q 0 0 0 rg BT 462.38 94.05 Td (ge ) Tj ET Q q 0 0 0 rg BT 474.40 94.05 Td (in ) Tj ET Q q 0 0 0 rg BT 484.75 94.05 Td (2015 ) Tj ET Q q 0 0 0 rg BT 507.33 94.05 Td (for ) Tj ET Q q 0 0 0 rg BT 521.56 94.05 Td (BMS-986020 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 82.05 Td (which ) Tj ET Q q 0 0 0 rg BT 63.38 82.05 Td (was ) Tj ET Q q 0 0 0 rg BT 81.87 82.05 Td (in ) Tj ET Q q 0 0 0 rg BT 92.58 82.05 Td (Phase ) Tj ET Q q 0 0 0 rg BT 118.85 82.05 Td (II ) Tj ET Q q 0 0 0 rg BT 128.45 82.05 Td (development ) Tj ET Q q 0 0 0 rg BT 183.04 82.05 Td (for ) Tj ET Q q 0 0 0 rg BT 197.64 82.05 Td (treatment ) Tj ET Q q 0 0 0 rg BT 238.34 82.05 Td (of ) Tj ET Q q 0 0 0 rg BT 249.60 82.05 Td (IPF ) Tj ET Q q 0 0 0 rg BT 267.00 82.05 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 284.37 82.05 Td ($343 ) Tj ET Q q 0 0 0 rg BT 307.31 82.05 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 336.20 82.05 Td ( ) Tj ET Q q 0 0 0 rg BT 339.14 82.05 Td (in ) Tj ET Q q 0 0 0 rg BT 349.86 82.05 Td (2014, ) Tj ET Q q 0 0 0 rg BT 375.30 82.05 Td (including ) Tj ET Q q 0 0 0 rg BT 416.01 82.05 Td (a ) Tj ET Q q 0 0 0 rg BT 423.39 82.05 Td ($310 ) Tj ET Q q 0 0 0 rg BT 446.32 82.05 Td (million ) Tj ET Q q 0 0 0 rg BT 478.15 82.05 Td (char) Tj ET Q q 0 0 0 rg BT 495.18 82.05 Td (ge ) Tj ET Q q 0 0 0 rg BT 507.56 82.05 Td (for ) Tj ET Q q 0 0 0 rg BT 522.16 82.05 Td (peginterferon ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 70.05 Td (lambda ) Tj ET Q q 0 0 0 rg BT 68.42 70.05 Td (which ) Tj ET Q q 0 0 0 rg BT 95.85 70.05 Td (was ) Tj ET Q q 0 0 0 rg BT 114.40 70.05 Td (in ) Tj ET Q q 0 0 0 rg BT 125.17 70.05 Td (Phase ) Tj ET Q q 0 0 0 rg BT 151.49 70.05 Td (III ) Tj ET Q q 0 0 0 rg BT 164.47 70.05 Td (development ) Tj ET Q q 0 0 0 rg BT 219.11 70.05 Td (for ) Tj ET Q q 0 0 0 rg BT 233.76 70.05 Td (treatment ) Tj ET Q q 0 0 0 rg BT 274.51 70.05 Td (of ) Tj ET Q q 0 0 0 rg BT 285.83 70.05 Td (HCV) Tj ET Q q 0 0 0 rg BT 305.65 70.05 Td (. ) Tj ET Q q 0 0 0 rg BT 311.14 70.05 Td (For ) Tj ET Q q 0 0 0 rg BT 328.03 70.05 Td (discussion ) Tj ET Q q 0 0 0 rg BT 372.69 70.05 Td (on ) Tj ET Q q 0 0 0 rg BT 385.68 70.05 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 411.45 70.05 Td (impairments, ) Tj ET Q q 0 0 0 rg BT 466.93 70.05 Td ( ) Tj ET Q q 0 0 0 rg BT 469.92 70.05 Td (refer ) Tj ET Q q 0 0 0 rg BT 491.78 70.05 Td (to ) Tj ET Q q 0 0 0 rg BT 502.55 70.05 Td (“Item ) Tj ET Q q 0 0 0 rg BT 528.30 70.05 Td (8. ) Tj ET Q q 0 0 0 rg BT 538.80 70.05 Td (Financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 58.05 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.82 58.05 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 121.82 58.05 Td (. ) Tj ET Q q 0 0 0 rg BT 126.82 58.05 Td (Goodwill ) Tj ET Q q 0 0 0 rg BT 167.10 58.05 Td (and ) Tj ET Q q 0 0 0 rg BT 184.04 58.05 Td (Other ) Tj ET Q q 0 0 0 rg BT 209.31 58.05 Td (Intangible ) Tj ET Q q 0 0 0 rg BT 251.80 58.05 Td (Assets.") Tj ET Q endstream endobj 95 0 obj <> endobj 96 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (47) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 160.6142578125 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Pr) Tj ET Q q 0 0 0 rg BT 45.63 749.10 Td (operty) Tj ET Q q 0 0 0 rg BT 70.62 749.10 Td (, ) Tj ET Q q 0 0 0 rg BT 75.62 749.10 Td (Plant ) Tj ET Q q 0 0 0 rg BT 99.79 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 117.29 749.10 Td (Equipment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 727.50 Td (Property) Tj ET Q q 0 0 0 rg BT 69.79 727.50 Td (, ) Tj ET Q q 0 0 0 rg BT 74.72 727.50 Td (plant ) Tj ET Q q 0 0 0 rg BT 97.14 727.50 Td (and ) Tj ET Q q 0 0 0 rg BT 114.00 727.50 Td (equipment ) Tj ET Q q 0 0 0 rg BT 158.64 727.50 Td (is ) Tj ET Q q 0 0 0 rg BT 167.74 727.50 Td (tested ) Tj ET Q q 0 0 0 rg BT 193.49 727.50 Td (for ) Tj ET Q q 0 0 0 rg BT 207.58 727.50 Td (impairment ) Tj ET Q q 0 0 0 rg BT 256.10 727.50 Td (whenever ) Tj ET Q q 0 0 0 rg BT 297.40 727.50 Td (current ) Tj ET Q q 0 0 0 rg BT 328.14 727.50 Td (facts ) Tj ET Q q 0 0 0 rg BT 349.44 727.50 Td (or ) Tj ET Q q 0 0 0 rg BT 360.20 727.50 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 419.27 727.50 Td (require ) Tj ET Q q 0 0 0 rg BT 450.01 727.50 Td (a ) Tj ET Q q 0 0 0 rg BT 456.87 727.50 Td (review ) Tj ET Q q 0 0 0 rg BT 486.51 727.50 Td (including ) Tj ET Q q 0 0 0 rg BT 526.71 727.50 Td (whether ) Tj ET Q q 0 0 0 rg BT 561.34 727.50 Td (it ) Tj ET Q q 0 0 0 rg BT 569.33 727.50 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 715.50 Td (more ) Tj ET Q q 0 0 0 rg BT 59.36 715.50 Td (likely ) Tj ET Q q 0 0 0 rg BT 84.96 715.50 Td (than ) Tj ET Q q 0 0 0 rg BT 104.99 715.50 Td (not ) Tj ET Q q 0 0 0 rg BT 120.58 715.50 Td (that ) Tj ET Q q 0 0 0 rg BT 138.40 715.50 Td (the ) Tj ET Q q 0 0 0 rg BT 153.43 715.50 Td (asset ) Tj ET Q q 0 0 0 rg BT 175.69 715.50 Td (will ) Tj ET Q q 0 0 0 rg BT 194.06 715.50 Td (be ) Tj ET Q q 0 0 0 rg BT 206.32 715.50 Td (disposed ) Tj ET Q q 0 0 0 rg BT 244.13 715.50 Td (of ) Tj ET Q q 0 0 0 rg BT 255.28 715.50 Td (prior ) Tj ET Q q 0 0 0 rg BT 277.54 715.50 Td (to ) Tj ET Q q 0 0 0 rg BT 288.13 715.50 Td (its ) Tj ET Q q 0 0 0 rg BT 300.40 715.50 Td (estimated ) Tj ET Q q 0 0 0 rg BT 341.54 715.50 Td (remaining ) Tj ET Q q 0 0 0 rg BT 384.90 715.50 Td (useful ) Tj ET Q q 0 0 0 rg BT 412.15 715.50 Td (life. ) Tj ET Q q 0 0 0 rg BT 430.17 715.50 Td (Additionally) Tj ET Q q 0 0 0 rg BT 480.08 715.50 Td (, ) Tj ET Q q 0 0 0 rg BT 485.39 715.50 Td (these ) Tj ET Q q 0 0 0 rg BT 508.76 715.50 Td (long-lived ) Tj ET Q q 0 0 0 rg BT 552.68 715.50 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 703.50 Td (are ) Tj ET Q q 0 0 0 rg BT 50.41 703.50 Td (periodically ) Tj ET Q q 0 0 0 rg BT 100.38 703.50 Td (reviewed ) Tj ET Q q 0 0 0 rg BT 139.23 703.50 Td (to ) Tj ET Q q 0 0 0 rg BT 149.22 703.50 Td (determine ) Tj ET Q q 0 0 0 rg BT 191.41 703.50 Td (if ) Tj ET Q q 0 0 0 rg BT 199.72 703.50 Td (any ) Tj ET Q q 0 0 0 rg BT 216.37 703.50 Td (change ) Tj ET Q q 0 0 0 rg BT 246.89 703.50 Td (in ) Tj ET Q q 0 0 0 rg BT 256.87 703.50 Td (facts ) Tj ET Q q 0 0 0 rg BT 277.96 703.50 Td (or ) Tj ET Q q 0 0 0 rg BT 288.50 703.50 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 347.34 703.50 Td (would ) Tj ET Q q 0 0 0 rg BT 374.55 703.50 Td (result ) Tj ET Q q 0 0 0 rg BT 398.97 703.50 Td (in ) Tj ET Q q 0 0 0 rg BT 408.96 703.50 Td (a ) Tj ET Q q 0 0 0 rg BT 415.60 703.50 Td (change ) Tj ET Q q 0 0 0 rg BT 446.13 703.50 Td (to ) Tj ET Q q 0 0 0 rg BT 456.11 703.50 Td (the ) Tj ET Q q 0 0 0 rg BT 470.54 703.50 Td (estimated ) Tj ET Q q 0 0 0 rg BT 511.06 703.50 Td (useful ) Tj ET Q q 0 0 0 rg BT 537.71 703.50 Td (life ) Tj ET Q q 0 0 0 rg BT 553.24 703.50 Td (of ) Tj ET Q q 0 0 0 rg BT 563.78 703.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 691.50 Td (asset, ) Tj ET Q q 0 0 0 rg BT 60.71 691.50 Td (possibly ) Tj ET Q q 0 0 0 rg BT 96.82 691.50 Td (resulting ) Tj ET Q q 0 0 0 rg BT 134.59 691.50 Td (in ) Tj ET Q q 0 0 0 rg BT 145.14 691.50 Td (the ) Tj ET Q q 0 0 0 rg BT 160.13 691.50 Td (acceleration ) Tj ET Q q 0 0 0 rg BT 211.20 691.50 Td (of ) Tj ET Q q 0 0 0 rg BT 222.30 691.50 Td (depreciation. ) Tj ET Q q 0 0 0 rg BT 276.99 691.50 Td (If ) Tj ET Q q 0 0 0 rg BT 286.43 691.50 Td (such ) Tj ET Q q 0 0 0 rg BT 307.53 691.50 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 366.94 691.50 Td (exist, ) Tj ET Q q 0 0 0 rg BT 391.10 691.50 Td (an ) Tj ET Q q 0 0 0 rg BT 403.31 691.50 Td (estimate ) Tj ET Q q 0 0 0 rg BT 439.40 691.50 Td (of ) Tj ET Q q 0 0 0 rg BT 450.51 691.50 Td (undiscounted ) Tj ET Q q 0 0 0 rg BT 506.60 691.50 Td (future ) Tj ET Q q 0 0 0 rg BT 533.25 691.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 553.79 691.50 Td (flows ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 679.50 Td (generated ) Tj ET Q q 0 0 0 rg BT 76.83 679.50 Td (by ) Tj ET Q q 0 0 0 rg BT 88.80 679.50 Td (the ) Tj ET Q q 0 0 0 rg BT 102.98 679.50 Td (asset, ) Tj ET Q q 0 0 0 rg BT 126.88 679.50 Td (or ) Tj ET Q q 0 0 0 rg BT 137.18 679.50 Td (the ) Tj ET Q q 0 0 0 rg BT 151.37 679.50 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 198.86 679.50 Td (grouping ) Tj ET Q q 0 0 0 rg BT 236.94 679.50 Td (of ) Tj ET Q q 0 0 0 rg BT 247.24 679.50 Td (assets, ) Tj ET Q q 0 0 0 rg BT 275.03 679.50 Td (is ) Tj ET Q q 0 0 0 rg BT 283.67 679.50 Td (compared ) Tj ET Q q 0 0 0 rg BT 325.06 679.50 Td (to ) Tj ET Q q 0 0 0 rg BT 334.81 679.50 Td (the ) Tj ET Q q 0 0 0 rg BT 348.99 679.50 Td (carrying ) Tj ET Q q 0 0 0 rg BT 384.27 679.50 Td (value ) Tj ET Q q 0 0 0 rg BT 407.89 679.50 Td (to ) Tj ET Q q 0 0 0 rg BT 417.64 679.50 Td (determine ) Tj ET Q q 0 0 0 rg BT 459.59 679.50 Td (whether ) Tj ET Q q 0 0 0 rg BT 493.76 679.50 Td (an ) Tj ET Q q 0 0 0 rg BT 505.17 679.50 Td (impairment ) Tj ET Q q 0 0 0 rg BT 553.23 679.50 Td (exists ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 667.50 Td (at ) Tj ET Q q 0 0 0 rg BT 45.20 667.50 Td (its ) Tj ET Q q 0 0 0 rg BT 56.63 667.50 Td (lowest ) Tj ET Q q 0 0 0 rg BT 84.72 667.50 Td (level ) Tj ET Q q 0 0 0 rg BT 106.14 667.50 Td (of ) Tj ET Q q 0 0 0 rg BT 116.45 667.50 Td (identifiable ) Tj ET Q q 0 0 0 rg BT 163.97 667.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 183.72 667.50 Td (flows. ) Tj ET Q q 0 0 0 rg BT 210.42 667.50 Td (If ) Tj ET Q q 0 0 0 rg BT 219.07 667.50 Td (an ) Tj ET Q q 0 0 0 rg BT 230.49 667.50 Td (asset ) Tj ET Q q 0 0 0 rg BT 251.91 667.50 Td (is ) Tj ET Q q 0 0 0 rg BT 260.56 667.50 Td (determined ) Tj ET Q q 0 0 0 rg BT 307.52 667.50 Td (to ) Tj ET Q q 0 0 0 rg BT 317.28 667.50 Td (be ) Tj ET Q q 0 0 0 rg BT 328.71 667.50 Td (impaired, ) Tj ET Q q 0 0 0 rg BT 368.73 667.50 Td (the ) Tj ET Q q 0 0 0 rg BT 382.93 667.50 Td (loss ) Tj ET Q q 0 0 0 rg BT 400.47 667.50 Td (is ) Tj ET Q q 0 0 0 rg BT 409.13 667.50 Td (measured ) Tj ET Q q 0 0 0 rg BT 449.42 667.50 Td (based ) Tj ET Q q 0 0 0 rg BT 474.17 667.50 Td (on ) Tj ET Q q 0 0 0 rg BT 486.16 667.50 Td (the ) Tj ET Q q 0 0 0 rg BT 500.36 667.50 Td (dif) Tj ET Q q 0 0 0 rg BT 511.28 667.50 Td (ference ) Tj ET Q q 0 0 0 rg BT 542.68 667.50 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 655.50 Td (the ) Tj ET Q q 0 0 0 rg BT 50.86 655.50 Td (asset’) Tj ET Q q 0 0 0 rg BT 73.08 655.50 Td (s ) Tj ET Q q 0 0 0 rg BT 79.62 655.50 Td (fair ) Tj ET Q q 0 0 0 rg BT 96.15 655.50 Td (value ) Tj ET Q q 0 0 0 rg BT 120.45 655.50 Td (and ) Tj ET Q q 0 0 0 rg BT 137.54 655.50 Td (its ) Tj ET Q q 0 0 0 rg BT 149.63 655.50 Td (carrying ) Tj ET Q q 0 0 0 rg BT 185.60 655.50 Td (value. ) Tj ET Q q 0 0 0 rg BT 212.40 655.50 Td (Expectations ) Tj ET Q q 0 0 0 rg BT 266.70 655.50 Td (of ) Tj ET Q q 0 0 0 rg BT 277.67 655.50 Td (future ) Tj ET Q q 0 0 0 rg BT 304.20 655.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 324.62 655.50 Td (flows ) Tj ET Q q 0 0 0 rg BT 349.49 655.50 Td (are ) Tj ET Q q 0 0 0 rg BT 364.34 655.50 Td (subject ) Tj ET Q q 0 0 0 rg BT 395.31 655.50 Td (to ) Tj ET Q q 0 0 0 rg BT 405.74 655.50 Td (change ) Tj ET Q q 0 0 0 rg BT 436.70 655.50 Td (based ) Tj ET Q q 0 0 0 rg BT 462.12 655.50 Td (upon ) Tj ET Q q 0 0 0 rg BT 484.77 655.50 Td (the ) Tj ET Q q 0 0 0 rg BT 499.63 655.50 Td (near ) Tj ET Q q 0 0 0 rg BT 519.49 655.50 Td (and ) Tj ET Q q 0 0 0 rg BT 536.57 655.50 Td (long-term ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 643.50 Td (production ) Tj ET Q q 0 0 0 rg BT 81.37 643.50 Td (volumes ) Tj ET Q q 0 0 0 rg BT 117.31 643.50 Td (and ) Tj ET Q q 0 0 0 rg BT 133.79 643.50 Td (mar) Tj ET Q q 0 0 0 rg BT 149.16 643.50 Td (gins ) Tj ET Q q 0 0 0 rg BT 167.88 643.50 Td (generated ) Tj ET Q q 0 0 0 rg BT 208.79 643.50 Td (by ) Tj ET Q q 0 0 0 rg BT 220.83 643.50 Td (the ) Tj ET Q q 0 0 0 rg BT 235.10 643.50 Td (asset ) Tj ET Q q 0 0 0 rg BT 256.58 643.50 Td (as ) Tj ET Q q 0 0 0 rg BT 266.96 643.50 Td (well ) Tj ET Q q 0 0 0 rg BT 286.22 643.50 Td (as ) Tj ET Q q 0 0 0 rg BT 296.60 643.50 Td (any ) Tj ET Q q 0 0 0 rg BT 313.09 643.50 Td (potential ) Tj ET Q q 0 0 0 rg BT 350.13 643.50 Td (alternative ) Tj ET Q q 0 0 0 rg BT 394.37 643.50 Td (future ) Tj ET Q q 0 0 0 rg BT 420.29 643.50 Td (use. ) Tj ET Q q 0 0 0 rg BT 437.72 643.50 Td (Accelerated ) Tj ET Q q 0 0 0 rg BT 487.51 643.50 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 538.97 643.50 Td (and ) Tj ET Q q 0 0 0 rg BT 555.46 643.50 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 631.50 Td (related ) Tj ET Q q 0 0 0 rg BT 65.40 631.50 Td (char) Tj ET Q q 0 0 0 rg BT 82.43 631.50 Td (ges ) Tj ET Q q 0 0 0 rg BT 97.96 631.50 Td (for ) Tj ET Q q 0 0 0 rg BT 111.82 631.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 141.23 631.50 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 201.74 631.50 Td (and ) Tj ET Q q 0 0 0 rg BT 218.38 631.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 242.25 631.50 Td (facilities ) Tj ET Q q 0 0 0 rg BT 278.88 631.50 Td (were ) Tj ET Q q 0 0 0 rg BT 300.51 631.50 Td ($104 ) Tj ET Q q 0 0 0 rg BT 322.71 631.50 Td (million ) Tj ET Q q 0 0 0 rg BT 353.80 631.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.78 631.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.78 631.50 Td (, ) Tj ET Q q 0 0 0 rg BT 388.48 631.50 Td ($1) Tj ET Q q 0 0 0 rg BT 398.11 631.50 Td (15 ) Tj ET Q q 0 0 0 rg BT 410.31 631.50 Td (million ) Tj ET Q q 0 0 0 rg BT 441.41 631.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.38 631.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.38 631.50 Td ( ) Tj ET Q q 0 0 0 rg BT 473.59 631.50 Td (and ) Tj ET Q q 0 0 0 rg BT 490.23 631.50 Td ($151 ) Tj ET Q q 0 0 0 rg BT 512.43 631.50 Td (million ) Tj ET Q q 0 0 0 rg BT 543.52 631.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.50 631.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.50 631.50 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 619.50 Td (Additional ) Tj ET Q q 0 0 0 rg BT 81.27 619.50 Td (char) Tj ET Q q 0 0 0 rg BT 98.30 619.50 Td (ges ) Tj ET Q q 0 0 0 rg BT 114.13 619.50 Td (will ) Tj ET Q q 0 0 0 rg BT 132.19 619.50 Td (continue ) Tj ET Q q 0 0 0 rg BT 169.12 619.50 Td (to ) Tj ET Q q 0 0 0 rg BT 179.40 619.50 Td (occur ) Tj ET Q q 0 0 0 rg BT 204.11 619.50 Td (as ) Tj ET Q q 0 0 0 rg BT 214.94 619.50 Td (a ) Tj ET Q q 0 0 0 rg BT 221.87 619.50 Td (result ) Tj ET Q q 0 0 0 rg BT 246.59 619.50 Td (of ) Tj ET Q q 0 0 0 rg BT 257.42 619.50 Td (the ) Tj ET Q q 0 0 0 rg BT 272.14 619.50 Td (Company’) Tj ET Q q 0 0 0 rg BT 313.80 619.50 Td (s ) Tj ET Q q 0 0 0 rg BT 320.19 619.50 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 373.79 619.50 Td (actions ) Tj ET Q q 0 0 0 rg BT 404.61 619.50 Td (announced ) Tj ET Q q 0 0 0 rg BT 450.43 619.50 Td (in ) Tj ET Q q 0 0 0 rg BT 460.71 619.50 Td (the ) Tj ET Q q 0 0 0 rg BT 475.42 619.50 Td (fourth ) Tj ET Q q 0 0 0 rg BT 502.36 619.50 Td (quarter ) Tj ET Q q 0 0 0 rg BT 533.18 619.50 Td (of ) Tj ET Q q 0 0 0 rg BT 544.01 619.50 Td (2016.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 597.90 Td (Contingencies) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 576.30 Td (In ) Tj ET Q q 0 0 0 rg BT 46.82 576.30 Td (the ) Tj ET Q q 0 0 0 rg BT 61.54 576.30 Td (normal ) Tj ET Q q 0 0 0 rg BT 92.35 576.30 Td (course ) Tj ET Q q 0 0 0 rg BT 120.95 576.30 Td (of ) Tj ET Q q 0 0 0 rg BT 131.77 576.30 Td (business, ) Tj ET Q q 0 0 0 rg BT 170.66 576.30 Td (we ) Tj ET Q q 0 0 0 rg BT 184.81 576.30 Td (are ) Tj ET Q q 0 0 0 rg BT 199.51 576.30 Td (subject ) Tj ET Q q 0 0 0 rg BT 230.33 576.30 Td (to ) Tj ET Q q 0 0 0 rg BT 240.60 576.30 Td (contingencies, ) Tj ET Q q 0 0 0 rg BT 300.58 576.30 Td (such ) Tj ET Q q 0 0 0 rg BT 321.40 576.30 Td (as ) Tj ET Q q 0 0 0 rg BT 332.23 576.30 Td (legal ) Tj ET Q q 0 0 0 rg BT 354.16 576.30 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 404.96 576.30 Td (and ) Tj ET Q q 0 0 0 rg BT 421.90 576.30 Td (claims ) Tj ET Q q 0 0 0 rg BT 450.50 576.30 Td (arising ) Tj ET Q q 0 0 0 rg BT 480.21 576.30 Td (out ) Tj ET Q q 0 0 0 rg BT 495.48 576.30 Td (of ) Tj ET Q q 0 0 0 rg BT 506.30 576.30 Td (our ) Tj ET Q q 0 0 0 rg BT 522.13 576.30 Td (business, ) Tj ET Q q 0 0 0 rg BT 561.01 576.30 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 564.30 Td (cover ) Tj ET Q q 0 0 0 rg BT 61.31 564.30 Td (a ) Tj ET Q q 0 0 0 rg BT 68.85 564.30 Td (wide ) Tj ET Q q 0 0 0 rg BT 91.39 564.30 Td (range ) Tj ET Q q 0 0 0 rg BT 116.70 564.30 Td (of ) Tj ET Q q 0 0 0 rg BT 128.14 564.30 Td (matters, ) Tj ET Q q 0 0 0 rg BT 163.17 564.30 Td (including, ) Tj ET Q q 0 0 0 rg BT 206.55 564.30 Td (among ) Tj ET Q q 0 0 0 rg BT 236.87 564.30 Td (others, ) Tj ET Q q 0 0 0 rg BT 266.91 564.30 Td (government ) Tj ET Q q 0 0 0 rg BT 317.78 564.30 Td (investigations, ) Tj ET Q q 0 0 0 rg BT 378.93 564.30 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 428.68 564.30 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 467.06 564.30 Td (product ) Tj ET Q q 0 0 0 rg BT 500.71 564.30 Td (and ) Tj ET Q q 0 0 0 rg BT 518.25 564.30 Td (environmental ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 552.30 Td (liability) Tj ET Q q 0 0 0 rg BT 66.46 552.30 Td (, ) Tj ET Q q 0 0 0 rg BT 72.16 552.30 Td (contractual ) Tj ET Q q 0 0 0 rg BT 119.79 552.30 Td (claims ) Tj ET Q q 0 0 0 rg BT 149.10 552.30 Td (and ) Tj ET Q q 0 0 0 rg BT 166.74 552.30 Td (tax ) Tj ET Q q 0 0 0 rg BT 182.16 552.30 Td (matters. ) Tj ET Q q 0 0 0 rg BT 217.07 552.30 Td (W) Tj ET Q q 0 0 0 rg BT 225.70 552.30 Td (e ) Tj ET Q q 0 0 0 rg BT 233.35 552.30 Td (recognize ) Tj ET Q q 0 0 0 rg BT 275.41 552.30 Td (accruals ) Tj ET Q q 0 0 0 rg BT 311.37 552.30 Td (for ) Tj ET Q q 0 0 0 rg BT 326.24 552.30 Td (such ) Tj ET Q q 0 0 0 rg BT 347.77 552.30 Td (contingencies ) Tj ET Q q 0 0 0 rg BT 405.96 552.30 Td (when ) Tj ET Q q 0 0 0 rg BT 430.82 552.30 Td (it ) Tj ET Q q 0 0 0 rg BT 439.58 552.30 Td (is ) Tj ET Q q 0 0 0 rg BT 449.46 552.30 Td (probable ) Tj ET Q q 0 0 0 rg BT 487.65 552.30 Td (that ) Tj ET Q q 0 0 0 rg BT 505.85 552.30 Td (a ) Tj ET Q q 0 0 0 rg BT 513.49 552.30 Td (liability ) Tj ET Q q 0 0 0 rg BT 547.80 552.30 Td (will ) Tj ET Q q 0 0 0 rg BT 566.56 552.30 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 540.30 Td (incurred ) Tj ET Q q 0 0 0 rg BT 71.76 540.30 Td (and ) Tj ET Q q 0 0 0 rg BT 88.65 540.30 Td (the ) Tj ET Q q 0 0 0 rg BT 103.31 540.30 Td (amount ) Tj ET Q q 0 0 0 rg BT 135.76 540.30 Td (of ) Tj ET Q q 0 0 0 rg BT 146.53 540.30 Td (the ) Tj ET Q q 0 0 0 rg BT 161.20 540.30 Td (loss ) Tj ET Q q 0 0 0 rg BT 179.21 540.30 Td (can ) Tj ET Q q 0 0 0 rg BT 195.53 540.30 Td (be ) Tj ET Q q 0 0 0 rg BT 207.42 540.30 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 253.18 540.30 Td (estimated. ) Tj ET Q q 0 0 0 rg BT 296.27 540.30 Td (These ) Tj ET Q q 0 0 0 rg BT 322.60 540.30 Td (estimates ) Tj ET Q q 0 0 0 rg BT 362.26 540.30 Td (are ) Tj ET Q q 0 0 0 rg BT 376.91 540.30 Td (subject ) Tj ET Q q 0 0 0 rg BT 407.69 540.30 Td (to ) Tj ET Q q 0 0 0 rg BT 417.91 540.30 Td (uncertainties ) Tj ET Q q 0 0 0 rg BT 471.45 540.30 Td (that ) Tj ET Q q 0 0 0 rg BT 488.89 540.30 Td (are ) Tj ET Q q 0 0 0 rg BT 503.55 540.30 Td (dif) Tj ET Q q 0 0 0 rg BT 514.47 540.30 Td (ficult ) Tj ET Q q 0 0 0 rg BT 538.02 540.30 Td (to ) Tj ET Q q 0 0 0 rg BT 548.25 540.30 Td (predict ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 528.30 Td (and, ) Tj ET Q q 0 0 0 rg BT 55.44 528.30 Td (as ) Tj ET Q q 0 0 0 rg BT 66.27 528.30 Td (such, ) Tj ET Q q 0 0 0 rg BT 89.60 528.30 Td (actual ) Tj ET Q q 0 0 0 rg BT 115.97 528.30 Td (results ) Tj ET Q q 0 0 0 rg BT 144.58 528.30 Td (could ) Tj ET Q q 0 0 0 rg BT 169.30 528.30 Td (vary ) Tj ET Q q 0 0 0 rg BT 189.56 528.30 Td (from ) Tj ET Q q 0 0 0 rg BT 211.50 528.30 Td (these ) Tj ET Q q 0 0 0 rg BT 234.55 528.30 Td (estimates.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 506.70 Td (For ) Tj ET Q q 0 0 0 rg BT 53.11 506.70 Td (discussions ) Tj ET Q q 0 0 0 rg BT 101.88 506.70 Td (on ) Tj ET Q q 0 0 0 rg BT 115.10 506.70 Td (contingencies, ) Tj ET Q q 0 0 0 rg BT 175.79 506.70 Td (refer ) Tj ET Q q 0 0 0 rg BT 197.87 506.70 Td (to ) Tj ET Q q 0 0 0 rg BT 208.87 506.70 Td (“Item ) Tj ET Q q 0 0 0 rg BT 234.84 506.70 Td (8. ) Tj ET Q q 0 0 0 rg BT 245.56 506.70 Td (Financial ) Tj ET Q q 0 0 0 rg BT 285.98 506.70 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.52 506.70 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.52 506.70 Td (. ) Tj ET Q q 0 0 0 rg BT 372.52 506.70 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 422.39 506.70 Td (Policies—Contingencies,” ) Tj ET Q q 0 0 0 rg BT 531.42 506.70 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 568.51 506.70 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.51 506.70 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.70 Td (Income ) Tj ET Q q 0 0 0 rg BT 68.30 494.70 Td (T) Tj ET Q q 0 0 0 rg BT 73.71 494.70 Td (axes” ) Tj ET Q q 0 0 0 rg BT 98.42 494.70 Td (and ) Tj ET Q q 0 0 0 rg BT 115.36 494.70 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.74 494.70 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.74 494.70 Td (. ) Tj ET Q q 0 0 0 rg BT 166.74 494.70 Td (Legal ) Tj ET Q q 0 0 0 rg BT 192.00 494.70 Td (Proceedings ) Tj ET Q q 0 0 0 rg BT 243.38 494.70 Td (and ) Tj ET Q q 0 0 0 rg BT 260.32 494.70 Td (Contingencies.”) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 470.70 Td (Income T) Tj ET Q q 0 0 0 rg BT 74.80 470.70 Td (axes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 446.70 Td (V) Tj ET Q q 0 0 0 rg BT 42.11 446.70 Td (aluation ) Tj ET Q q 0 0 0 rg BT 76.91 446.70 Td (allowances ) Tj ET Q q 0 0 0 rg BT 123.91 446.70 Td (are ) Tj ET Q q 0 0 0 rg BT 138.70 446.70 Td (recognized ) Tj ET Q q 0 0 0 rg BT 185.15 446.70 Td (to ) Tj ET Q q 0 0 0 rg BT 195.51 446.70 Td (reduce ) Tj ET Q q 0 0 0 rg BT 224.73 446.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 260.62 446.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 275.42 446.70 Td (assets ) Tj ET Q q 0 0 0 rg BT 301.33 446.70 Td (when ) Tj ET Q q 0 0 0 rg BT 325.58 446.70 Td (it ) Tj ET Q q 0 0 0 rg BT 333.71 446.70 Td (is ) Tj ET Q q 0 0 0 rg BT 342.97 446.70 Td (more ) Tj ET Q q 0 0 0 rg BT 366.09 446.70 Td (likely ) Tj ET Q q 0 0 0 rg BT 391.45 446.70 Td (than ) Tj ET Q q 0 0 0 rg BT 411.25 446.70 Td (not ) Tj ET Q q 0 0 0 rg BT 426.61 446.70 Td (that ) Tj ET Q q 0 0 0 rg BT 444.19 446.70 Td (a ) Tj ET Q q 0 0 0 rg BT 451.21 446.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 466.01 446.70 Td (benefit ) Tj ET Q q 0 0 0 rg BT 496.35 446.70 Td (will ) Tj ET Q q 0 0 0 rg BT 514.49 446.70 Td (not ) Tj ET Q q 0 0 0 rg BT 529.85 446.70 Td (be ) Tj ET Q q 0 0 0 rg BT 541.87 446.70 Td (realized. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 434.70 Td (The ) Tj ET Q q 0 0 0 rg BT 54.30 434.70 Td (assessment ) Tj ET Q q 0 0 0 rg BT 101.50 434.70 Td (of ) Tj ET Q q 0 0 0 rg BT 112.58 434.70 Td (whether ) Tj ET Q q 0 0 0 rg BT 147.54 434.70 Td (or ) Tj ET Q q 0 0 0 rg BT 158.63 434.70 Td (not ) Tj ET Q q 0 0 0 rg BT 174.16 434.70 Td (a ) Tj ET Q q 0 0 0 rg BT 181.36 434.70 Td (valuation ) Tj ET Q q 0 0 0 rg BT 221.32 434.70 Td (allowance ) Tj ET Q q 0 0 0 rg BT 264.61 434.70 Td (is ) Tj ET Q q 0 0 0 rg BT 274.04 434.70 Td (required ) Tj ET Q q 0 0 0 rg BT 310.11 434.70 Td (often ) Tj ET Q q 0 0 0 rg BT 333.41 434.70 Td (requires ) Tj ET Q q 0 0 0 rg BT 368.37 434.70 Td (significant ) Tj ET Q q 0 0 0 rg BT 413.34 434.70 Td (judgment ) Tj ET Q q 0 0 0 rg BT 453.87 434.70 Td (including ) Tj ET Q q 0 0 0 rg BT 494.40 434.70 Td (long-range ) Tj ET Q q 0 0 0 rg BT 540.47 434.70 Td (forecasts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 422.70 Td (of ) Tj ET Q q 0 0 0 rg BT 47.34 422.70 Td (future ) Tj ET Q q 0 0 0 rg BT 74.23 422.70 Td (taxable ) Tj ET Q q 0 0 0 rg BT 106.12 422.70 Td (income ) Tj ET Q q 0 0 0 rg BT 138.56 422.70 Td (and ) Tj ET Q q 0 0 0 rg BT 156.01 422.70 Td (evaluation ) Tj ET Q q 0 0 0 rg BT 200.68 422.70 Td (of ) Tj ET Q q 0 0 0 rg BT 212.02 422.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 227.25 422.70 Td (planning ) Tj ET Q q 0 0 0 rg BT 265.26 422.70 Td (initiatives. ) Tj ET Q q 0 0 0 rg BT 309.54 422.70 Td (Adjustments ) Tj ET Q q 0 0 0 rg BT 363.11 422.70 Td (to ) Tj ET Q q 0 0 0 rg BT 373.90 422.70 Td (the ) Tj ET Q q 0 0 0 rg BT 389.13 422.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 425.45 422.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 440.68 422.70 Td (valuation ) Tj ET Q q 0 0 0 rg BT 480.91 422.70 Td (allowances ) Tj ET Q q 0 0 0 rg BT 528.34 422.70 Td (are ) Tj ET Q q 0 0 0 rg BT 543.56 422.70 Td (made ) Tj ET Q q 0 0 0 rg BT 568.23 422.70 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 410.70 Td (earnings ) Tj ET Q q 0 0 0 rg BT 71.99 410.70 Td (in ) Tj ET Q q 0 0 0 rg BT 81.89 410.70 Td (the ) Tj ET Q q 0 0 0 rg BT 96.22 410.70 Td (period ) Tj ET Q q 0 0 0 rg BT 123.89 410.70 Td (when ) Tj ET Q q 0 0 0 rg BT 147.66 410.70 Td (such ) Tj ET Q q 0 0 0 rg BT 168.11 410.70 Td (assessments ) Tj ET Q q 0 0 0 rg BT 218.56 410.70 Td (are ) Tj ET Q q 0 0 0 rg BT 232.88 410.70 Td (made. ) Tj ET Q q 0 0 0 rg BT 259.15 410.70 Td (Our ) Tj ET Q q 0 0 0 rg BT 276.82 410.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 312.24 410.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 326.58 410.70 Td (assets ) Tj ET Q q 0 0 0 rg BT 352.02 410.70 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.57 410.70 Td ($4.3 ) Tj ET Q q 0 0 0 rg BT 393.19 410.70 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.30 410.70 Td ( ) Tj ET Q q 0 0 0 rg BT 421.42 410.70 Td (at ) Tj ET Q q 0 0 0 rg BT 430.75 410.70 Td (December ) Tj ET Q q 0 0 0 rg BT 473.95 410.70 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.57 410.70 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.57 410.70 Td ( ) Tj ET Q q 0 0 0 rg BT 510.68 410.70 Td (\(net ) Tj ET Q q 0 0 0 rg BT 528.35 410.70 Td (of ) Tj ET Q q 0 0 0 rg BT 538.79 410.70 Td (valuation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 398.70 Td (allowances ) Tj ET Q q 0 0 0 rg BT 82.92 398.70 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 93.75 398.70 Td ($3.1 ) Tj ET Q q 0 0 0 rg BT 113.75 398.70 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.87 398.70 Td (\) ) Tj ET Q q 0 0 0 rg BT 145.70 398.70 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 162.64 398.70 Td ($4.1 ) Tj ET Q q 0 0 0 rg BT 182.64 398.70 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 208.75 398.70 Td ( ) Tj ET Q q 0 0 0 rg BT 211.25 398.70 Td (at ) Tj ET Q q 0 0 0 rg BT 220.97 398.70 Td (December ) Tj ET Q q 0 0 0 rg BT 264.55 398.70 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.55 398.70 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.55 398.70 Td ( ) Tj ET Q q 0 0 0 rg BT 302.05 398.70 Td (\(net ) Tj ET Q q 0 0 0 rg BT 320.10 398.70 Td (of ) Tj ET Q q 0 0 0 rg BT 330.93 398.70 Td (valuation ) Tj ET Q q 0 0 0 rg BT 370.64 398.70 Td (allowances ) Tj ET Q q 0 0 0 rg BT 417.56 398.70 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.39 398.70 Td ($3.5 ) Tj ET Q q 0 0 0 rg BT 448.39 398.70 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.51 398.70 Td (\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 374.70 Td (Deferred ) Tj ET Q q 0 0 0 rg BT 74.05 374.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 88.79 374.70 Td (assets ) Tj ET Q q 0 0 0 rg BT 114.64 374.70 Td (related ) Tj ET Q q 0 0 0 rg BT 144.37 374.70 Td (to ) Tj ET Q q 0 0 0 rg BT 154.67 374.70 Td (a ) Tj ET Q q 0 0 0 rg BT 161.63 374.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 181.94 374.70 Td (Federal ) Tj ET Q q 0 0 0 rg BT 214.45 374.70 Td (net ) Tj ET Q q 0 0 0 rg BT 229.19 374.70 Td (operating ) Tj ET Q q 0 0 0 rg BT 269.48 374.70 Td (loss ) Tj ET Q q 0 0 0 rg BT 287.56 374.70 Td (carryforward ) Tj ET Q q 0 0 0 rg BT 342.27 374.70 Td (of ) Tj ET Q q 0 0 0 rg BT 353.13 374.70 Td ($129 ) Tj ET Q q 0 0 0 rg BT 375.65 374.70 Td (million ) Tj ET Q q 0 0 0 rg BT 407.06 374.70 Td (and ) Tj ET Q q 0 0 0 rg BT 424.03 374.70 Td (a ) Tj ET Q q 0 0 0 rg BT 430.99 374.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 451.29 374.70 Td (Federal ) Tj ET Q q 0 0 0 rg BT 483.80 374.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 498.54 374.70 Td (credit ) Tj ET Q q 0 0 0 rg BT 523.83 374.70 Td (carryforward ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 362.70 Td (of ) Tj ET Q q 0 0 0 rg BT 47.48 362.70 Td ($27 ) Tj ET Q q 0 0 0 rg BT 65.64 362.70 Td (million ) Tj ET Q q 0 0 0 rg BT 97.68 362.70 Td (were ) Tj ET Q q 0 0 0 rg BT 120.27 362.70 Td (recognized ) Tj ET Q q 0 0 0 rg BT 167.28 362.70 Td (at ) Tj ET Q q 0 0 0 rg BT 177.66 362.70 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.89 362.70 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.89 362.70 Td (. ) Tj ET Q q 0 0 0 rg BT 262.32 362.70 Td (The ) Tj ET Q q 0 0 0 rg BT 281.02 362.70 Td (net ) Tj ET Q q 0 0 0 rg BT 296.39 362.70 Td (operating ) Tj ET Q q 0 0 0 rg BT 337.31 362.70 Td (loss ) Tj ET Q q 0 0 0 rg BT 356.03 362.70 Td (carryforward ) Tj ET Q q 0 0 0 rg BT 411.37 362.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 443.40 362.70 Td (in ) Tj ET Q q 0 0 0 rg BT 454.33 362.70 Td (varying ) Tj ET Q q 0 0 0 rg BT 488.03 362.70 Td (amounts ) Tj ET Q q 0 0 0 rg BT 525.07 362.70 Td (beginning ) Tj ET Q q 0 0 0 rg BT 568.22 362.70 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 350.70 Td (2022. ) Tj ET Q q 0 0 0 rg BT 60.78 350.70 Td (The ) Tj ET Q q 0 0 0 rg BT 78.78 350.70 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 99.02 350.70 Td (Federal ) Tj ET Q q 0 0 0 rg BT 131.46 350.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 146.13 350.70 Td (credit ) Tj ET Q q 0 0 0 rg BT 171.35 350.70 Td (carryforward ) Tj ET Q q 0 0 0 rg BT 225.99 350.70 Td (expires ) Tj ET Q q 0 0 0 rg BT 257.32 350.70 Td (in ) Tj ET Q q 0 0 0 rg BT 267.56 350.70 Td (varying ) Tj ET Q q 0 0 0 rg BT 300.56 350.70 Td (amounts ) Tj ET Q q 0 0 0 rg BT 336.90 350.70 Td (beginning ) Tj ET Q q 0 0 0 rg BT 379.35 350.70 Td (in ) Tj ET Q q 0 0 0 rg BT 389.58 350.70 Td (2017. ) Tj ET Q q 0 0 0 rg BT 414.36 350.70 Td (The ) Tj ET Q q 0 0 0 rg BT 432.36 350.70 Td (realization ) Tj ET Q q 0 0 0 rg BT 477.02 350.70 Td (of ) Tj ET Q q 0 0 0 rg BT 487.80 350.70 Td (these ) Tj ET Q q 0 0 0 rg BT 510.80 350.70 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 569.34 350.70 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 338.70 Td (dependent ) Tj ET Q q 0 0 0 rg BT 79.80 338.70 Td (on ) Tj ET Q q 0 0 0 rg BT 92.50 338.70 Td (generating ) Tj ET Q q 0 0 0 rg BT 137.41 338.70 Td (suf) Tj ET Q q 0 0 0 rg BT 149.45 338.70 Td (ficient ) Tj ET Q q 0 0 0 rg BT 177.70 338.70 Td (domestic-sourced ) Tj ET Q q 0 0 0 rg BT 250.93 338.70 Td (taxable ) Tj ET Q q 0 0 0 rg BT 282.51 338.70 Td (income ) Tj ET Q q 0 0 0 rg BT 314.65 338.70 Td (prior ) Tj ET Q q 0 0 0 rg BT 336.79 338.70 Td (to ) Tj ET Q q 0 0 0 rg BT 347.27 338.70 Td (their ) Tj ET Q q 0 0 0 rg BT 368.30 338.70 Td (expiration. ) Tj ET Q q 0 0 0 rg BT 413.45 338.70 Td (An ) Tj ET Q q 0 0 0 rg BT 428.37 338.70 Td ($1) Tj ET Q q 0 0 0 rg BT 438.00 338.70 Td (1 ) Tj ET Q q 0 0 0 rg BT 445.71 338.70 Td (million ) Tj ET Q q 0 0 0 rg BT 477.30 338.70 Td (valuation ) Tj ET Q q 0 0 0 rg BT 517.22 338.70 Td (allowance ) Tj ET Q q 0 0 0 rg BT 560.46 338.70 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 326.70 Td (established ) Tj ET Q q 0 0 0 rg BT 83.21 326.70 Td (for ) Tj ET Q q 0 0 0 rg BT 97.64 326.70 Td (this ) Tj ET Q q 0 0 0 rg BT 114.87 326.70 Td (item ) Tj ET Q q 0 0 0 rg BT 135.42 326.70 Td (at ) Tj ET Q q 0 0 0 rg BT 145.41 326.70 Td (December ) Tj ET Q q 0 0 0 rg BT 189.27 326.70 Td (31, ) Tj ET Q q 0 0 0 rg BT 204.54 326.70 Td (2016. ) Tj ET Q q 0 0 0 rg BT 229.20 326.70 Td (Although ) Tj ET Q q 0 0 0 rg BT 269.76 326.70 Td (not ) Tj ET Q q 0 0 0 rg BT 285.31 326.70 Td (assured, ) Tj ET Q q 0 0 0 rg BT 320.57 326.70 Td (we ) Tj ET Q q 0 0 0 rg BT 335.01 326.70 Td (believe ) Tj ET Q q 0 0 0 rg BT 366.66 326.70 Td (it ) Tj ET Q q 0 0 0 rg BT 374.99 326.70 Td (is ) Tj ET Q q 0 0 0 rg BT 384.43 326.70 Td (more ) Tj ET Q q 0 0 0 rg BT 407.75 326.70 Td (likely ) Tj ET Q q 0 0 0 rg BT 433.30 326.70 Td (than ) Tj ET Q q 0 0 0 rg BT 453.29 326.70 Td (not ) Tj ET Q q 0 0 0 rg BT 468.85 326.70 Td (that ) Tj ET Q q 0 0 0 rg BT 486.62 326.70 Td (the ) Tj ET Q q 0 0 0 rg BT 501.61 326.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 537.69 326.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 552.68 326.70 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 314.70 Td (not ) Tj ET Q q 0 0 0 rg BT 51.28 314.70 Td (valued ) Tj ET Q q 0 0 0 rg BT 80.43 314.70 Td (will ) Tj ET Q q 0 0 0 rg BT 98.49 314.70 Td (be ) Tj ET Q q 0 0 0 rg BT 110.43 314.70 Td (realized.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 290.70 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 290.70 Td (axes ) Tj ET Q q 0 0 0 rg BT 61.68 290.70 Td (are ) Tj ET Q q 0 0 0 rg BT 76.39 290.70 Td (not ) Tj ET Q q 0 0 0 rg BT 91.66 290.70 Td (provided ) Tj ET Q q 0 0 0 rg BT 129.71 290.70 Td (on ) Tj ET Q q 0 0 0 rg BT 142.21 290.70 Td (undistributed ) Tj ET Q q 0 0 0 rg BT 197.48 290.70 Td (earnings ) Tj ET Q q 0 0 0 rg BT 233.86 290.70 Td (of ) Tj ET Q q 0 0 0 rg BT 244.69 290.70 Td (foreign ) Tj ET Q q 0 0 0 rg BT 276.07 290.70 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 325.79 290.70 Td (expected ) Tj ET Q q 0 0 0 rg BT 363.82 290.70 Td (to ) Tj ET Q q 0 0 0 rg BT 374.10 290.70 Td (be ) Tj ET Q q 0 0 0 rg BT 386.03 290.70 Td (reinvested ) Tj ET Q q 0 0 0 rg BT 429.63 290.70 Td (indefinitely ) Tj ET Q q 0 0 0 rg BT 478.23 290.70 Td (of) Tj ET Q q 0 0 0 rg BT 486.38 290.70 Td (fshore. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 266.70 Td (Prior ) Tj ET Q q 0 0 0 rg BT 58.69 266.70 Td (to ) Tj ET Q q 0 0 0 rg BT 69.15 266.70 Td (the ) Tj ET Q q 0 0 0 rg BT 84.05 266.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 109.51 266.70 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 144.97 266.70 Td (split-of) Tj ET Q q 0 0 0 rg BT 173.68 266.70 Td (f ) Tj ET Q q 0 0 0 rg BT 179.70 266.70 Td (in ) Tj ET Q q 0 0 0 rg BT 190.16 266.70 Td (2009, ) Tj ET Q q 0 0 0 rg BT 215.35 266.70 Td (the ) Tj ET Q q 0 0 0 rg BT 230.25 266.70 Td (following ) Tj ET Q q 0 0 0 rg BT 271.82 266.70 Td (transactions ) Tj ET Q q 0 0 0 rg BT 322.27 266.70 Td (occurred: ) Tj ET Q q 0 0 0 rg BT 362.71 266.70 Td (\(i\) an ) Tj ET Q q 0 0 0 rg BT 386.77 266.70 Td (internal ) Tj ET Q q 0 0 0 rg BT 420.00 266.70 Td (spin-of) Tj ET Q q 0 0 0 rg BT 448.15 266.70 Td (f ) Tj ET Q q 0 0 0 rg BT 454.16 266.70 Td (of ) Tj ET Q q 0 0 0 rg BT 465.18 266.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 490.63 266.70 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 526.10 266.70 Td (shares ) Tj ET Q q 0 0 0 rg BT 553.78 266.70 Td (while ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 254.70 Td (still ) Tj ET Q q 0 0 0 rg BT 53.29 254.70 Td (owned ) Tj ET Q q 0 0 0 rg BT 82.23 254.70 Td (by ) Tj ET Q q 0 0 0 rg BT 94.52 254.70 Td (us; ) Tj ET Q q 0 0 0 rg BT 108.47 254.70 Td (\(ii\) conversion ) Tj ET Q q 0 0 0 rg BT 169.35 254.70 Td (of ) Tj ET Q q 0 0 0 rg BT 179.96 254.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 205.02 254.70 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 240.08 254.70 Td (Class ) Tj ET Q q 0 0 0 rg BT 264.04 254.70 Td (B ) Tj ET Q q 0 0 0 rg BT 272.99 254.70 Td (shares ) Tj ET Q q 0 0 0 rg BT 300.27 254.70 Td (to ) Tj ET Q q 0 0 0 rg BT 310.33 254.70 Td (Class ) Tj ET Q q 0 0 0 rg BT 333.95 254.70 Td (A) Tj ET Q q 0 0 0 rg BT 340.62 254.70 Td ( ) Tj ET Q q 0 0 0 rg BT 342.90 254.70 Td (shares; ) Tj ET Q q 0 0 0 rg BT 372.95 254.70 Td (and; ) Tj ET Q q 0 0 0 rg BT 392.46 254.70 Td (\(iii\) conversion ) Tj ET Q q 0 0 0 rg BT 456.11 254.70 Td (of ) Tj ET Q q 0 0 0 rg BT 466.73 254.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 491.78 254.70 Td (Johnson & ) Tj ET Q q 0 0 0 rg BT 537.12 254.70 Td (Company ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 242.70 Td (to ) Tj ET Q q 0 0 0 rg BT 46.29 242.70 Td (a ) Tj ET Q q 0 0 0 rg BT 53.24 242.70 Td (limited ) Tj ET Q q 0 0 0 rg BT 84.08 242.70 Td (liability ) Tj ET Q q 0 0 0 rg BT 117.70 242.70 Td (company) Tj ET Q q 0 0 0 rg BT 153.71 242.70 Td (. ) Tj ET Q q 0 0 0 rg BT 158.54 242.70 Td (These ) Tj ET Q q 0 0 0 rg BT 184.92 242.70 Td (transactions ) Tj ET Q q 0 0 0 rg BT 235.20 242.70 Td (as ) Tj ET Q q 0 0 0 rg BT 246.04 242.70 Td (well ) Tj ET Q q 0 0 0 rg BT 265.77 242.70 Td (as ) Tj ET Q q 0 0 0 rg BT 276.61 242.70 Td (the ) Tj ET Q q 0 0 0 rg BT 291.34 242.70 Td (split-of) Tj ET Q q 0 0 0 rg BT 320.04 242.70 Td (f ) Tj ET Q q 0 0 0 rg BT 325.88 242.70 Td (of ) Tj ET Q q 0 0 0 rg BT 336.73 242.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 362.01 242.70 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 397.30 242.70 Td (through ) Tj ET Q q 0 0 0 rg BT 430.92 242.70 Td (the ) Tj ET Q q 0 0 0 rg BT 445.65 242.70 Td (exchange ) Tj ET Q q 0 0 0 rg BT 485.91 242.70 Td (of) Tj ET Q q 0 0 0 rg BT 494.06 242.70 Td (fer ) Tj ET Q q 0 0 0 rg BT 507.67 242.70 Td (should ) Tj ET Q q 0 0 0 rg BT 536.85 242.70 Td (qualify ) Tj ET Q q 0 0 0 rg BT 567.69 242.70 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 230.70 Td (tax-exempt ) Tj ET Q q 0 0 0 rg BT 83.43 230.70 Td (transactions ) Tj ET Q q 0 0 0 rg BT 133.64 230.70 Td (under ) Tj ET Q q 0 0 0 rg BT 158.86 230.70 Td (the ) Tj ET Q q 0 0 0 rg BT 173.53 230.70 Td (Internal ) Tj ET Q q 0 0 0 rg BT 207.07 230.70 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 244.51 230.70 Td (Code ) Tj ET Q q 0 0 0 rg BT 268.07 230.70 Td (based ) Tj ET Q q 0 0 0 rg BT 293.29 230.70 Td (upon ) Tj ET Q q 0 0 0 rg BT 315.74 230.70 Td (a ) Tj ET Q q 0 0 0 rg BT 322.63 230.70 Td (private ) Tj ET Q q 0 0 0 rg BT 352.84 230.70 Td (letter ) Tj ET Q q 0 0 0 rg BT 375.83 230.70 Td (ruling ) Tj ET Q q 0 0 0 rg BT 402.17 230.70 Td (received ) Tj ET Q q 0 0 0 rg BT 438.48 230.70 Td (from ) Tj ET Q q 0 0 0 rg BT 460.37 230.70 Td (the ) Tj ET Q q 0 0 0 rg BT 475.04 230.70 Td (Internal ) Tj ET Q q 0 0 0 rg BT 508.58 230.70 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 546.02 230.70 Td (Service ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 218.70 Td (related ) Tj ET Q q 0 0 0 rg BT 65.70 218.70 Td (to ) Tj ET Q q 0 0 0 rg BT 75.98 218.70 Td (the ) Tj ET Q q 0 0 0 rg BT 90.70 218.70 Td (conversion ) Tj ET Q q 0 0 0 rg BT 137.07 218.70 Td (of ) Tj ET Q q 0 0 0 rg BT 147.90 218.70 Td (Mead ) Tj ET Q q 0 0 0 rg BT 173.17 218.70 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 208.46 218.70 Td (Class ) Tj ET Q q 0 0 0 rg BT 232.63 218.70 Td (B ) Tj ET Q q 0 0 0 rg BT 241.80 218.70 Td (shares ) Tj ET Q q 0 0 0 rg BT 269.29 218.70 Td (to ) Tj ET Q q 0 0 0 rg BT 279.56 218.70 Td (Class ) Tj ET Q q 0 0 0 rg BT 303.18 218.70 Td (A) Tj ET Q q 0 0 0 rg BT 309.85 218.70 Td ( ) Tj ET Q q 0 0 0 rg BT 312.35 218.70 Td (shares, ) Tj ET Q q 0 0 0 rg BT 342.34 218.70 Td (and ) Tj ET Q q 0 0 0 rg BT 359.28 218.70 Td (outside ) Tj ET Q q 0 0 0 rg BT 390.67 218.70 Td (legal ) Tj ET Q q 0 0 0 rg BT 412.60 218.70 Td (opinions. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 199.50 Td (Certain ) Tj ET Q q 0 0 0 rg BT 67.86 199.50 Td (assumptions, ) Tj ET Q q 0 0 0 rg BT 122.24 199.50 Td (representations ) Tj ET Q q 0 0 0 rg BT 185.21 199.50 Td (and ) Tj ET Q q 0 0 0 rg BT 202.08 199.50 Td (covenants ) Tj ET Q q 0 0 0 rg BT 244.49 199.50 Td (by ) Tj ET Q q 0 0 0 rg BT 256.92 199.50 Td (Mead ) Tj ET Q q 0 0 0 rg BT 282.12 199.50 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 317.33 199.50 Td (were ) Tj ET Q q 0 0 0 rg BT 339.19 199.50 Td (relied ) Tj ET Q q 0 0 0 rg BT 364.39 199.50 Td (upon ) Tj ET Q q 0 0 0 rg BT 386.82 199.50 Td (regarding ) Tj ET Q q 0 0 0 rg BT 427.57 199.50 Td (the ) Tj ET Q q 0 0 0 rg BT 442.21 199.50 Td (future ) Tj ET Q q 0 0 0 rg BT 468.52 199.50 Td (conduct ) Tj ET Q q 0 0 0 rg BT 502.61 199.50 Td (of ) Tj ET Q q 0 0 0 rg BT 513.37 199.50 Td (its ) Tj ET Q q 0 0 0 rg BT 525.25 199.50 Td (business ) Tj ET Q q 0 0 0 rg BT 561.57 199.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 187.50 Td (other ) Tj ET Q q 0 0 0 rg BT 58.74 187.50 Td (matters ) Tj ET Q q 0 0 0 rg BT 90.36 187.50 Td (which ) Tj ET Q q 0 0 0 rg BT 116.99 187.50 Td (could ) Tj ET Q q 0 0 0 rg BT 141.39 187.50 Td (af) Tj ET Q q 0 0 0 rg BT 148.98 187.50 Td (fect ) Tj ET Q q 0 0 0 rg BT 166.15 187.50 Td (the ) Tj ET Q q 0 0 0 rg BT 180.56 187.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 194.97 187.50 Td (treatment ) Tj ET Q q 0 0 0 rg BT 234.91 187.50 Td (of ) Tj ET Q q 0 0 0 rg BT 245.43 187.50 Td (the ) Tj ET Q q 0 0 0 rg BT 259.84 187.50 Td (exchange. ) Tj ET Q q 0 0 0 rg BT 302.28 187.50 Td (For ) Tj ET Q q 0 0 0 rg BT 318.36 187.50 Td (example, ) Tj ET Q q 0 0 0 rg BT 356.92 187.50 Td (the ) Tj ET Q q 0 0 0 rg BT 371.33 187.50 Td (current ) Tj ET Q q 0 0 0 rg BT 401.83 187.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 416.24 187.50 Td (law ) Tj ET Q q 0 0 0 rg BT 432.87 187.50 Td (generally ) Tj ET Q q 0 0 0 rg BT 472.26 187.50 Td (creates ) Tj ET Q q 0 0 0 rg BT 502.20 187.50 Td (a ) Tj ET Q q 0 0 0 rg BT 508.83 187.50 Td (presumption ) Tj ET Q q 0 0 0 rg BT 561.01 187.50 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 175.50 Td (the ) Tj ET Q q 0 0 0 rg BT 50.83 175.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 91.19 175.50 Td (would ) Tj ET Q q 0 0 0 rg BT 118.80 175.50 Td (be ) Tj ET Q q 0 0 0 rg BT 130.85 175.50 Td (taxable ) Tj ET Q q 0 0 0 rg BT 162.34 175.50 Td (to ) Tj ET Q q 0 0 0 rg BT 172.73 175.50 Td (us, ) Tj ET Q q 0 0 0 rg BT 186.73 175.50 Td (if ) Tj ET Q q 0 0 0 rg BT 195.45 175.50 Td (Mead ) Tj ET Q q 0 0 0 rg BT 220.83 175.50 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 256.22 175.50 Td (or ) Tj ET Q q 0 0 0 rg BT 267.17 175.50 Td (its ) Tj ET Q q 0 0 0 rg BT 279.23 175.50 Td (shareholders ) Tj ET Q q 0 0 0 rg BT 332.37 175.50 Td (were ) Tj ET Q q 0 0 0 rg BT 354.41 175.50 Td (to ) Tj ET Q q 0 0 0 rg BT 364.80 175.50 Td (engage ) Tj ET Q q 0 0 0 rg BT 395.73 175.50 Td (in ) Tj ET Q q 0 0 0 rg BT 406.12 175.50 Td (transactions ) Tj ET Q q 0 0 0 rg BT 456.50 175.50 Td (that ) Tj ET Q q 0 0 0 rg BT 474.10 175.50 Td (result ) Tj ET Q q 0 0 0 rg BT 498.93 175.50 Td (in ) Tj ET Q q 0 0 0 rg BT 509.32 175.50 Td (a ) Tj ET Q q 0 0 0 rg BT 516.37 175.50 Td (50% ) Tj ET Q q 0 0 0 rg BT 537.31 175.50 Td (or ) Tj ET Q q 0 0 0 rg BT 548.25 175.50 Td (greater ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 163.50 Td (change ) Tj ET Q q 0 0 0 rg BT 67.04 163.50 Td (in ) Tj ET Q q 0 0 0 rg BT 77.54 163.50 Td (its ) Tj ET Q q 0 0 0 rg BT 89.71 163.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 113.54 163.50 Td (ownership ) Tj ET Q q 0 0 0 rg BT 157.93 163.50 Td (during ) Tj ET Q q 0 0 0 rg BT 186.76 163.50 Td (a ) Tj ET Q q 0 0 0 rg BT 193.92 163.50 Td (four ) Tj ET Q q 0 0 0 rg BT 213.31 163.50 Td (year ) Tj ET Q q 0 0 0 rg BT 233.24 163.50 Td (period ) Tj ET Q q 0 0 0 rg BT 261.51 163.50 Td (beginning ) Tj ET Q q 0 0 0 rg BT 304.23 163.50 Td (two ) Tj ET Q q 0 0 0 rg BT 321.95 163.50 Td (years ) Tj ET Q q 0 0 0 rg BT 345.77 163.50 Td (before ) Tj ET Q q 0 0 0 rg BT 374.03 163.50 Td (the ) Tj ET Q q 0 0 0 rg BT 388.97 163.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 429.45 163.50 Td (of) Tj ET Q q 0 0 0 rg BT 437.60 163.50 Td (fer) Tj ET Q q 0 0 0 rg BT 448.30 163.50 Td (, ) Tj ET Q q 0 0 0 rg BT 453.52 163.50 Td (unless ) Tj ET Q q 0 0 0 rg BT 481.25 163.50 Td (it ) Tj ET Q q 0 0 0 rg BT 489.53 163.50 Td (is ) Tj ET Q q 0 0 0 rg BT 498.92 163.50 Td (established ) Tj ET Q q 0 0 0 rg BT 546.08 163.50 Td (that ) Tj ET Q q 0 0 0 rg BT 563.80 163.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 151.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 76.60 151.50 Td (of) Tj ET Q q 0 0 0 rg BT 84.75 151.50 Td (fer ) Tj ET Q q 0 0 0 rg BT 98.69 151.50 Td (were ) Tj ET Q q 0 0 0 rg BT 120.96 151.50 Td (not ) Tj ET Q q 0 0 0 rg BT 136.59 151.50 Td (part ) Tj ET Q q 0 0 0 rg BT 154.98 151.50 Td (of ) Tj ET Q q 0 0 0 rg BT 166.15 151.50 Td (a ) Tj ET Q q 0 0 0 rg BT 173.43 151.50 Td (plan ) Tj ET Q q 0 0 0 rg BT 193.50 151.50 Td (or ) Tj ET Q q 0 0 0 rg BT 204.67 151.50 Td (series ) Tj ET Q q 0 0 0 rg BT 230.28 151.50 Td (of ) Tj ET Q q 0 0 0 rg BT 241.46 151.50 Td (related ) Tj ET Q q 0 0 0 rg BT 271.50 151.50 Td (transactions ) Tj ET Q q 0 0 0 rg BT 322.11 151.50 Td (to ) Tj ET Q q 0 0 0 rg BT 332.73 151.50 Td (ef) Tj ET Q q 0 0 0 rg BT 340.32 151.50 Td (fect ) Tj ET Q q 0 0 0 rg BT 358.15 151.50 Td (such ) Tj ET Q q 0 0 0 rg BT 379.33 151.50 Td (a ) Tj ET Q q 0 0 0 rg BT 386.61 151.50 Td (change ) Tj ET Q q 0 0 0 rg BT 417.77 151.50 Td (in ) Tj ET Q q 0 0 0 rg BT 428.39 151.50 Td (ownership. ) Tj ET Q q 0 0 0 rg BT 475.39 151.50 Td (If ) Tj ET Q q 0 0 0 rg BT 484.90 151.50 Td (the ) Tj ET Q q 0 0 0 rg BT 499.96 151.50 Td (internal ) Tj ET Q q 0 0 0 rg BT 533.35 151.50 Td (spin-of) Tj ET Q q 0 0 0 rg BT 561.50 151.50 Td (f ) Tj ET Q q 0 0 0 rg BT 567.67 151.50 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 139.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 76.05 139.50 Td (of) Tj ET Q q 0 0 0 rg BT 84.20 139.50 Td (fer ) Tj ET Q q 0 0 0 rg BT 97.60 139.50 Td (were ) Tj ET Q q 0 0 0 rg BT 119.33 139.50 Td (determined ) Tj ET Q q 0 0 0 rg BT 166.61 139.50 Td (not ) Tj ET Q q 0 0 0 rg BT 181.69 139.50 Td (to ) Tj ET Q q 0 0 0 rg BT 191.77 139.50 Td (qualify ) Tj ET Q q 0 0 0 rg BT 222.39 139.50 Td (as ) Tj ET Q q 0 0 0 rg BT 233.02 139.50 Td (a ) Tj ET Q q 0 0 0 rg BT 239.76 139.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 254.28 139.50 Td (exempt ) Tj ET Q q 0 0 0 rg BT 286.01 139.50 Td (transaction, ) Tj ET Q q 0 0 0 rg BT 334.68 139.50 Td (the ) Tj ET Q q 0 0 0 rg BT 349.20 139.50 Td (transaction ) Tj ET Q q 0 0 0 rg BT 395.37 139.50 Td (could ) Tj ET Q q 0 0 0 rg BT 419.89 139.50 Td (be ) Tj ET Q q 0 0 0 rg BT 431.63 139.50 Td (subject ) Tj ET Q q 0 0 0 rg BT 462.25 139.50 Td (to ) Tj ET Q q 0 0 0 rg BT 472.33 139.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 486.84 139.50 Td (as ) Tj ET Q q 0 0 0 rg BT 497.47 139.50 Td (if ) Tj ET Q q 0 0 0 rg BT 505.88 139.50 Td (the ) Tj ET Q q 0 0 0 rg BT 520.40 139.50 Td (exchange ) Tj ET Q q 0 0 0 rg BT 560.45 139.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 127.50 Td (a ) Tj ET Q q 0 0 0 rg BT 42.94 127.50 Td (taxable ) Tj ET Q q 0 0 0 rg BT 74.31 127.50 Td (sale ) Tj ET Q q 0 0 0 rg BT 92.36 127.50 Td (by ) Tj ET Q q 0 0 0 rg BT 104.86 127.50 Td (us ) Tj ET Q q 0 0 0 rg BT 116.25 127.50 Td (at ) Tj ET Q q 0 0 0 rg BT 125.97 127.50 Td (market ) Tj ET Q q 0 0 0 rg BT 156.23 127.50 Td (value.) Tj ET Q endstream endobj 97 0 obj <> endobj 98 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.54 749.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 86.02 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 93.67 749.10 Td (negative ) Tj ET Q q 0 0 0 rg BT 130.76 749.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 153.97 749.10 Td (or ) Tj ET Q q 0 0 0 rg BT 165.51 749.10 Td (ELA) Tj ET Q q 0 0 0 rg BT 184.39 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 187.60 749.10 Td (existed ) Tj ET Q q 0 0 0 rg BT 219.14 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 230.13 749.10 Td (our ) Tj ET Q q 0 0 0 rg BT 246.67 749.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 293.76 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 304.75 749.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 329.07 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 340.61 749.10 Td (Mead ) Tj ET Q q 0 0 0 rg BT 366.59 749.10 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 402.58 749.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 425.23 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 436.22 749.10 Td (these ) Tj ET Q q 0 0 0 rg BT 459.98 749.10 Td (transactions. ) Tj ET Q q 0 0 0 rg BT 513.22 749.10 Td (W) Tj ET Q q 0 0 0 rg BT 521.86 749.10 Td (e ) Tj ET Q q 0 0 0 rg BT 529.51 749.10 Td (received ) Tj ET Q q 0 0 0 rg BT 566.58 749.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (opinion ) Tj ET Q q 0 0 0 rg BT 69.37 737.10 Td (from ) Tj ET Q q 0 0 0 rg BT 91.63 737.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 123.33 737.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 145.58 737.10 Td (counsel ) Tj ET Q q 0 0 0 rg BT 178.94 737.10 Td (to ) Tj ET Q q 0 0 0 rg BT 189.53 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 204.56 737.10 Td (ef) Tj ET Q q 0 0 0 rg BT 212.15 737.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 229.95 737.10 Td (that ) Tj ET Q q 0 0 0 rg BT 247.76 737.10 Td (it ) Tj ET Q q 0 0 0 rg BT 256.13 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 265.62 737.10 Td (more ) Tj ET Q q 0 0 0 rg BT 288.98 737.10 Td (likely ) Tj ET Q q 0 0 0 rg BT 314.57 737.10 Td (than ) Tj ET Q q 0 0 0 rg BT 334.60 737.10 Td (not ) Tj ET Q q 0 0 0 rg BT 350.19 737.10 Td (that ) Tj ET Q q 0 0 0 rg BT 368.00 737.10 Td (we ) Tj ET Q q 0 0 0 rg BT 382.48 737.10 Td (eliminated ) Tj ET Q q 0 0 0 rg BT 427.50 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 442.53 737.10 Td (ELA) Tj ET Q q 0 0 0 rg BT 461.42 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 464.23 737.10 Td (as ) Tj ET Q q 0 0 0 rg BT 475.38 737.10 Td (part ) Tj ET Q q 0 0 0 rg BT 493.74 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 504.88 737.10 Td (these ) Tj ET Q q 0 0 0 rg BT 528.25 737.10 Td (transactions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.16 725.10 Td (do ) Tj ET Q q 0 0 0 rg BT 65.88 725.10 Td (not ) Tj ET Q q 0 0 0 rg BT 81.38 725.10 Td (have ) Tj ET Q q 0 0 0 rg BT 102.97 725.10 Td (taxable ) Tj ET Q q 0 0 0 rg BT 134.56 725.10 Td (income ) Tj ET Q q 0 0 0 rg BT 166.72 725.10 Td (with ) Tj ET Q q 0 0 0 rg BT 187.22 725.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 218.25 725.10 Td (to ) Tj ET Q q 0 0 0 rg BT 228.75 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 243.69 725.10 Td (ELA. ) Tj ET Q q 0 0 0 rg BT 268.15 725.10 Td (The ) Tj ET Q q 0 0 0 rg BT 286.41 725.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 301.35 725.10 Td (law ) Tj ET Q q 0 0 0 rg BT 318.51 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 329.01 725.10 Td (this ) Tj ET Q q 0 0 0 rg BT 346.17 725.10 Td (area ) Tj ET Q q 0 0 0 rg BT 365.54 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 374.93 725.10 Td (complex ) Tj ET Q q 0 0 0 rg BT 412.08 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 429.24 725.10 Td (it ) Tj ET Q q 0 0 0 rg BT 437.52 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 446.91 725.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 482.40 725.10 Td (that ) Tj ET Q q 0 0 0 rg BT 500.12 725.10 Td (even ) Tj ET Q q 0 0 0 rg BT 521.72 725.10 Td (if ) Tj ET Q q 0 0 0 rg BT 530.54 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 545.48 725.10 Td (internal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (spin-of) Tj ET Q q 0 0 0 rg BT 64.15 713.10 Td (f ) Tj ET Q q 0 0 0 rg BT 70.56 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 88.08 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 103.38 713.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 144.22 713.10 Td (of) Tj ET Q q 0 0 0 rg BT 152.37 713.10 Td (fer ) Tj ET Q q 0 0 0 rg BT 166.55 713.10 Td (is ) Tj ET Q q 0 0 0 rg BT 176.30 713.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 191.60 713.10 Td (exempt ) Tj ET Q q 0 0 0 rg BT 224.12 713.10 Td (under ) Tj ET Q q 0 0 0 rg BT 249.97 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 265.27 713.10 Td (Internal ) Tj ET Q q 0 0 0 rg BT 299.44 713.10 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 337.51 713.10 Td (Code, ) Tj ET Q q 0 0 0 rg BT 364.20 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 379.50 713.10 Td (IRS ) Tj ET Q q 0 0 0 rg BT 398.15 713.10 Td (could ) Tj ET Q q 0 0 0 rg BT 423.45 713.10 Td (assert ) Tj ET Q q 0 0 0 rg BT 449.30 713.10 Td (that ) Tj ET Q q 0 0 0 rg BT 467.37 713.10 Td (we ) Tj ET Q q 0 0 0 rg BT 482.12 713.10 Td (have ) Tj ET Q q 0 0 0 rg BT 504.08 713.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 547.15 713.10 Td (taxable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (income ) Tj ET Q q 0 0 0 rg BT 67.15 701.10 Td (for ) Tj ET Q q 0 0 0 rg BT 80.52 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 94.44 701.10 Td (period ) Tj ET Q q 0 0 0 rg BT 121.70 701.10 Td (with ) Tj ET Q q 0 0 0 rg BT 141.19 701.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 171.22 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 180.71 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 194.64 701.10 Td (ELA. ) Tj ET Q q 0 0 0 rg BT 218.16 701.10 Td (W) Tj ET Q q 0 0 0 rg BT 226.80 701.10 Td (e ) Tj ET Q q 0 0 0 rg BT 232.95 701.10 Td (could ) Tj ET Q q 0 0 0 rg BT 256.88 701.10 Td (be ) Tj ET Q q 0 0 0 rg BT 268.03 701.10 Td (exposed ) Tj ET Q q 0 0 0 rg BT 302.51 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 312.00 701.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 353.70 701.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 375.96 701.10 Td (if ) Tj ET Q q 0 0 0 rg BT 383.78 701.10 Td (this ) Tj ET Q q 0 0 0 rg BT 399.94 701.10 Td (were ) Tj ET Q q 0 0 0 rg BT 421.08 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 430.57 701.10 Td (occur) Tj ET Q q 0 0 0 rg BT 452.22 701.10 Td (. ) Tj ET Q q 0 0 0 rg BT 456.44 701.10 Td (Based ) Tj ET Q q 0 0 0 rg BT 482.59 701.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 504.30 701.10 Td (our ) Tj ET Q q 0 0 0 rg BT 519.34 701.10 Td (understanding ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.57 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.03 689.10 Td (Internal ) Tj ET Q q 0 0 0 rg BT 94.37 689.10 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 131.60 689.10 Td (Code ) Tj ET Q q 0 0 0 rg BT 154.95 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 171.63 689.10 Td (opinion ) Tj ET Q q 0 0 0 rg BT 204.43 689.10 Td (from ) Tj ET Q q 0 0 0 rg BT 226.11 689.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 257.24 689.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 278.92 689.10 Td (counsel, ) Tj ET Q q 0 0 0 rg BT 314.20 689.10 Td (a ) Tj ET Q q 0 0 0 rg BT 320.89 689.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 335.35 689.10 Td (reserve ) Tj ET Q q 0 0 0 rg BT 366.46 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 377.03 689.10 Td ($244 ) Tj ET Q q 0 0 0 rg BT 399.27 689.10 Td (million ) Tj ET Q q 0 0 0 rg BT 430.40 689.10 Td (was ) Tj ET Q q 0 0 0 rg BT 448.20 689.10 Td (established ) Tj ET Q q 0 0 0 rg BT 494.88 689.10 Td (reducing ) Tj ET Q q 0 0 0 rg BT 532.10 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.56 689.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 566.02 689.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (disposal ) Tj ET Q q 0 0 0 rg BT 71.28 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 82.11 677.10 Td (Mead ) Tj ET Q q 0 0 0 rg BT 107.38 677.10 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 142.66 677.10 Td (included ) Tj ET Q q 0 0 0 rg BT 179.59 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 189.87 677.10 Td (discontinued ) Tj ET Q q 0 0 0 rg BT 243.48 677.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 287.63 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 297.91 677.10 Td (2009.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 657.90 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 657.90 Td (e ) Tj ET Q q 0 0 0 rg BT 51.39 657.90 Td (agreed ) Tj ET Q q 0 0 0 rg BT 80.34 657.90 Td (to ) Tj ET Q q 0 0 0 rg BT 90.43 657.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 119.94 657.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 134.47 657.90 Td (related ) Tj ET Q q 0 0 0 rg BT 163.98 657.90 Td (indemnities ) Tj ET Q q 0 0 0 rg BT 212.95 657.90 Td (with ) Tj ET Q q 0 0 0 rg BT 233.04 657.90 Td (Mead ) Tj ET Q q 0 0 0 rg BT 258.11 657.90 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 293.21 657.90 Td (as ) Tj ET Q q 0 0 0 rg BT 303.85 657.90 Td (set ) Tj ET Q q 0 0 0 rg BT 317.26 657.90 Td (forth ) Tj ET Q q 0 0 0 rg BT 339.01 657.90 Td (in ) Tj ET Q q 0 0 0 rg BT 349.10 657.90 Td (the ) Tj ET Q q 0 0 0 rg BT 363.63 657.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 378.15 657.90 Td (sharing ) Tj ET Q q 0 0 0 rg BT 409.90 657.90 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 456.35 657.90 Td (including ) Tj ET Q q 0 0 0 rg BT 496.43 657.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 525.95 657.90 Td (taxes ) Tj ET Q q 0 0 0 rg BT 548.80 657.90 Td (related ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 645.90 Td (to ) Tj ET Q q 0 0 0 rg BT 46.71 645.90 Td (its ) Tj ET Q q 0 0 0 rg BT 59.09 645.90 Td (business ) Tj ET Q q 0 0 0 rg BT 95.92 645.90 Td (prior ) Tj ET Q q 0 0 0 rg BT 118.29 645.90 Td (to ) Tj ET Q q 0 0 0 rg BT 129.00 645.90 Td (the ) Tj ET Q q 0 0 0 rg BT 144.15 645.90 Td (completion ) Tj ET Q q 0 0 0 rg BT 192.08 645.90 Td (of ) Tj ET Q q 0 0 0 rg BT 203.34 645.90 Td (the ) Tj ET Q q 0 0 0 rg BT 218.49 645.90 Td (IPO ) Tj ET Q q 0 0 0 rg BT 237.54 645.90 Td (and ) Tj ET Q q 0 0 0 rg BT 254.91 645.90 Td (created ) Tj ET Q q 0 0 0 rg BT 286.71 645.90 Td (as ) Tj ET Q q 0 0 0 rg BT 297.97 645.90 Td (part ) Tj ET Q q 0 0 0 rg BT 316.45 645.90 Td (of ) Tj ET Q q 0 0 0 rg BT 327.71 645.90 Td (the ) Tj ET Q q 0 0 0 rg BT 342.86 645.90 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 396.89 645.90 Td (to ) Tj ET Q q 0 0 0 rg BT 407.60 645.90 Td (facilitate ) Tj ET Q q 0 0 0 rg BT 445.51 645.90 Td (the ) Tj ET Q q 0 0 0 rg BT 460.66 645.90 Td (IPO. ) Tj ET Q q 0 0 0 rg BT 482.21 645.90 Td (Mead ) Tj ET Q q 0 0 0 rg BT 507.91 645.90 Td (Johnson ) Tj ET Q q 0 0 0 rg BT 543.63 645.90 Td (has ) Tj ET Q q 0 0 0 rg BT 559.89 645.90 Td (also ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 633.90 Td (agreed ) Tj ET Q q 0 0 0 rg BT 65.53 633.90 Td (to ) Tj ET Q q 0 0 0 rg BT 76.19 633.90 Td (indemnify ) Tj ET Q q 0 0 0 rg BT 120.17 633.90 Td (us ) Tj ET Q q 0 0 0 rg BT 131.94 633.90 Td (for ) Tj ET Q q 0 0 0 rg BT 146.48 633.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 184.35 633.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 199.45 633.90 Td (ef) Tj ET Q q 0 0 0 rg BT 207.04 633.90 Td (fects ) Tj ET Q q 0 0 0 rg BT 228.80 633.90 Td (resulting ) Tj ET Q q 0 0 0 rg BT 266.67 633.90 Td (from ) Tj ET Q q 0 0 0 rg BT 288.99 633.90 Td (the ) Tj ET Q q 0 0 0 rg BT 304.09 633.90 Td (breach ) Tj ET Q q 0 0 0 rg BT 333.62 633.90 Td (of ) Tj ET Q q 0 0 0 rg BT 344.83 633.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 374.91 633.90 Td (representations ) Tj ET Q q 0 0 0 rg BT 438.32 633.90 Td (discussed ) Tj ET Q q 0 0 0 rg BT 479.54 633.90 Td (above ) Tj ET Q q 0 0 0 rg BT 506.29 633.90 Td (as ) Tj ET Q q 0 0 0 rg BT 517.50 633.90 Td (well ) Tj ET Q q 0 0 0 rg BT 537.60 633.90 Td (as ) Tj ET Q q 0 0 0 rg BT 548.81 633.90 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 621.90 Td (transactions ) Tj ET Q q 0 0 0 rg BT 86.26 621.90 Td (related ) Tj ET Q q 0 0 0 rg BT 115.97 621.90 Td (to ) Tj ET Q q 0 0 0 rg BT 126.24 621.90 Td (the ) Tj ET Q q 0 0 0 rg BT 140.96 621.90 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 187.34 621.90 Td (of ) Tj ET Q q 0 0 0 rg BT 198.17 621.90 Td (Mead ) Tj ET Q q 0 0 0 rg BT 223.44 621.90 Td (Johnson’) Tj ET Q q 0 0 0 rg BT 259.00 621.90 Td (s ) Tj ET Q q 0 0 0 rg BT 265.39 621.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 289.00 621.90 Td (or ) Tj ET Q q 0 0 0 rg BT 299.83 621.90 Td (assets.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 602.70 Td (Liabilities ) Tj ET Q q 0 0 0 rg BT 79.18 602.70 Td (are ) Tj ET Q q 0 0 0 rg BT 94.01 602.70 Td (established ) Tj ET Q q 0 0 0 rg BT 141.08 602.70 Td (for ) Tj ET Q q 0 0 0 rg BT 155.37 602.70 Td (possible ) Tj ET Q q 0 0 0 rg BT 190.77 602.70 Td (assessments ) Tj ET Q q 0 0 0 rg BT 241.73 602.70 Td (by ) Tj ET Q q 0 0 0 rg BT 254.36 602.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 269.21 602.70 Td (authorities ) Tj ET Q q 0 0 0 rg BT 314.05 602.70 Td (resulting ) Tj ET Q q 0 0 0 rg BT 351.67 602.70 Td (from ) Tj ET Q q 0 0 0 rg BT 373.74 602.70 Td (known ) Tj ET Q q 0 0 0 rg BT 403.59 602.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 418.44 602.70 Td (exposures ) Tj ET Q q 0 0 0 rg BT 461.06 602.70 Td (including, ) Tj ET Q q 0 0 0 rg BT 503.96 602.70 Td (but ) Tj ET Q q 0 0 0 rg BT 519.37 602.70 Td (not ) Tj ET Q q 0 0 0 rg BT 534.78 602.70 Td (limited ) Tj ET Q q 0 0 0 rg BT 565.74 602.70 Td (to, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 590.70 Td (transfer ) Tj ET Q q 0 0 0 rg BT 70.08 590.70 Td (pricing ) Tj ET Q q 0 0 0 rg BT 101.94 590.70 Td (matters, ) Tj ET Q q 0 0 0 rg BT 137.42 590.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 153.17 590.70 Td (credits ) Tj ET Q q 0 0 0 rg BT 183.37 590.70 Td (and ) Tj ET Q q 0 0 0 rg BT 201.35 590.70 Td (deductibility ) Tj ET Q q 0 0 0 rg BT 255.43 590.70 Td (of ) Tj ET Q q 0 0 0 rg BT 267.30 590.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 298.05 590.70 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 340.18 590.70 Td (Such ) Tj ET Q q 0 0 0 rg BT 363.72 590.70 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 404.48 590.70 Td (represent ) Tj ET Q q 0 0 0 rg BT 444.67 590.70 Td (a ) Tj ET Q q 0 0 0 rg BT 452.65 590.70 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 498.94 590.70 Td (provision ) Tj ET Q q 0 0 0 rg BT 540.26 590.70 Td (for ) Tj ET Q q 0 0 0 rg BT 555.46 590.70 Td (taxes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 578.70 Td (ultimately ) Tj ET Q q 0 0 0 rg BT 79.64 578.70 Td (expected ) Tj ET Q q 0 0 0 rg BT 118.26 578.70 Td (to ) Tj ET Q q 0 0 0 rg BT 129.13 578.70 Td (be ) Tj ET Q q 0 0 0 rg BT 141.66 578.70 Td (paid ) Tj ET Q q 0 0 0 rg BT 161.97 578.70 Td (and ) Tj ET Q q 0 0 0 rg BT 179.50 578.70 Td (may ) Tj ET Q q 0 0 0 rg BT 199.80 578.70 Td (need ) Tj ET Q q 0 0 0 rg BT 221.77 578.70 Td (to ) Tj ET Q q 0 0 0 rg BT 232.64 578.70 Td (be ) Tj ET Q q 0 0 0 rg BT 245.17 578.70 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 281.59 578.70 Td (over ) Tj ET Q q 0 0 0 rg BT 302.45 578.70 Td (time ) Tj ET Q q 0 0 0 rg BT 323.31 578.70 Td (as ) Tj ET Q q 0 0 0 rg BT 334.73 578.70 Td (more ) Tj ET Q q 0 0 0 rg BT 358.37 578.70 Td (information ) Tj ET Q q 0 0 0 rg BT 408.67 578.70 Td (becomes ) Tj ET Q q 0 0 0 rg BT 446.75 578.70 Td (known. ) Tj ET Q q 0 0 0 rg BT 479.56 578.70 Td (For ) Tj ET Q q 0 0 0 rg BT 496.54 578.70 Td (example, ) Tj ET Q q 0 0 0 rg BT 536.00 578.70 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 566.70 Td (reserves ) Tj ET Q q 0 0 0 rg BT 71.26 566.70 Td (of ) Tj ET Q q 0 0 0 rg BT 82.09 566.70 Td ($123 ) Tj ET Q q 0 0 0 rg BT 104.59 566.70 Td (million ) Tj ET Q q 0 0 0 rg BT 135.98 566.70 Td (were ) Tj ET Q q 0 0 0 rg BT 157.91 566.70 Td (established ) Tj ET Q q 0 0 0 rg BT 204.84 566.70 Td (in ) Tj ET Q q 0 0 0 rg BT 215.12 566.70 Td (2014 ) Tj ET Q q 0 0 0 rg BT 237.62 566.70 Td (for ) Tj ET Q q 0 0 0 rg BT 251.78 566.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 281.48 566.70 Td (transfer ) Tj ET Q q 0 0 0 rg BT 314.52 566.70 Td (pricing ) Tj ET Q q 0 0 0 rg BT 345.35 566.70 Td (matters ) Tj ET Q q 0 0 0 rg BT 377.28 566.70 Td (related ) Tj ET Q q 0 0 0 rg BT 406.98 566.70 Td (to ) Tj ET Q q 0 0 0 rg BT 417.26 566.70 Td (periods ) Tj ET Q q 0 0 0 rg BT 449.20 566.70 Td (from ) Tj ET Q q 0 0 0 rg BT 471.14 566.70 Td (2008 ) Tj ET Q q 0 0 0 rg BT 493.64 566.70 Td (through ) Tj ET Q q 0 0 0 rg BT 527.25 566.70 Td (2014. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 547.50 Td (For ) Tj ET Q q 0 0 0 rg BT 52.37 547.50 Td (discussions ) Tj ET Q q 0 0 0 rg BT 100.41 547.50 Td (on ) Tj ET Q q 0 0 0 rg BT 112.89 547.50 Td (income ) Tj ET Q q 0 0 0 rg BT 144.80 547.50 Td (taxes, ) Tj ET Q q 0 0 0 rg BT 170.32 547.50 Td (refer ) Tj ET Q q 0 0 0 rg BT 191.67 547.50 Td (to ) Tj ET Q q 0 0 0 rg BT 201.93 547.50 Td (“Item ) Tj ET Q q 0 0 0 rg BT 227.17 547.50 Td (8. ) Tj ET Q q 0 0 0 rg BT 237.15 547.50 Td (Financial ) Tj ET Q q 0 0 0 rg BT 276.83 547.50 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.63 547.50 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.63 547.50 Td (. ) Tj ET Q q 0 0 0 rg BT 362.06 547.50 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 411.20 547.50 Td (Policies—Income ) Tj ET Q q 0 0 0 rg BT 485.15 547.50 Td (T) Tj ET Q q 0 0 0 rg BT 490.56 547.50 Td (axes” ) Tj ET Q q 0 0 0 rg BT 515.24 547.50 Td (and ) Tj ET Q q 0 0 0 rg BT 532.16 547.50 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 568.51 547.50 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.51 547.50 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 535.50 Td (Income ) Tj ET Q q 0 0 0 rg BT 68.30 535.50 Td (T) Tj ET Q q 0 0 0 rg BT 73.71 535.50 Td (axes.”) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 511.50 Td (Pr) Tj ET Q q 0 0 0 rg BT 46.37 511.50 Td (oduct and Pipeline Developments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 53.42 494.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 76.96 494.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 116.60 494.50 Td (are ) Tj ET Q q 0 0 0 rg BT 130.68 494.50 Td (managed ) Tj ET Q q 0 0 0 rg BT 168.65 494.50 Td (on ) Tj ET Q q 0 0 0 rg BT 180.52 494.50 Td (a ) Tj ET Q q 0 0 0 rg BT 186.83 494.50 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 223.70 494.50 Td (basis ) Tj ET Q q 0 0 0 rg BT 245.57 494.50 Td (from ) Tj ET Q q 0 0 0 rg BT 266.88 494.50 Td (early ) Tj ET Q q 0 0 0 rg BT 288.74 494.50 Td (discovery ) Tj ET Q q 0 0 0 rg BT 329.48 494.50 Td (through ) Tj ET Q q 0 0 0 rg BT 362.46 494.50 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 402.65 494.50 Td (development ) Tj ET Q q 0 0 0 rg BT 456.17 494.50 Td (and ) Tj ET Q q 0 0 0 rg BT 472.48 494.50 Td (include ) Tj ET Q q 0 0 0 rg BT 503.78 494.50 Td (a ) Tj ET Q q 0 0 0 rg BT 510.09 494.50 Td (balance ) Tj ET Q q 0 0 0 rg BT 542.50 494.50 Td (of ) Tj ET Q q 0 0 0 rg BT 552.70 494.50 Td (early-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 482.50 Td (stage ) Tj ET Q q 0 0 0 rg BT 58.00 482.50 Td (and ) Tj ET Q q 0 0 0 rg BT 73.90 482.50 Td (late-stage ) Tj ET Q q 0 0 0 rg BT 113.66 482.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 152.88 482.50 Td (to ) Tj ET Q q 0 0 0 rg BT 162.12 482.50 Td (support ) Tj ET Q q 0 0 0 rg BT 193.57 482.50 Td (future ) Tj ET Q q 0 0 0 rg BT 218.91 482.50 Td (growth. ) Tj ET Q q 0 0 0 rg BT 251.19 482.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 268.20 482.50 Td (late ) Tj ET Q q 0 0 0 rg BT 284.09 482.50 Td (stage ) Tj ET Q q 0 0 0 rg BT 306.09 482.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 329.21 482.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 368.44 482.50 Td (in ) Tj ET Q q 0 0 0 rg BT 377.67 482.50 Td (Phase ) Tj ET Q q 0 0 0 rg BT 402.46 482.50 Td (III ) Tj ET Q q 0 0 0 rg BT 413.90 482.50 Td (development ) Tj ET Q q 0 0 0 rg BT 467.01 482.50 Td (include ) Tj ET Q q 0 0 0 rg BT 497.89 482.50 Td (both ) Tj ET Q q 0 0 0 rg BT 517.13 482.50 Td (investigational ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 470.50 Td (compounds ) Tj ET Q q 0 0 0 rg BT 83.90 470.50 Td (for ) Tj ET Q q 0 0 0 rg BT 97.36 470.50 Td (initial ) Tj ET Q q 0 0 0 rg BT 122.49 470.50 Td (indications ) Tj ET Q q 0 0 0 rg BT 168.16 470.50 Td (and ) Tj ET Q q 0 0 0 rg BT 184.40 470.50 Td (additional ) Tj ET Q q 0 0 0 rg BT 226.18 470.50 Td (indications ) Tj ET Q q 0 0 0 rg BT 271.86 470.50 Td (or ) Tj ET Q q 0 0 0 rg BT 281.99 470.50 Td (formulations ) Tj ET Q q 0 0 0 rg BT 334.89 470.50 Td (for ) Tj ET Q q 0 0 0 rg BT 348.34 470.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 387.34 470.50 Td (products. ) Tj ET Q q 0 0 0 rg BT 426.08 470.50 Td (Spending ) Tj ET Q q 0 0 0 rg BT 465.65 470.50 Td (on ) Tj ET Q q 0 0 0 rg BT 477.45 470.50 Td (these ) Tj ET Q q 0 0 0 rg BT 499.79 470.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 539.35 470.50 Td (represent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 458.50 Td (approximately ) Tj ET Q q 0 0 0 rg BT 95.82 458.50 Td (30-45% ) Tj ET Q q 0 0 0 rg BT 129.54 458.50 Td (of ) Tj ET Q q 0 0 0 rg BT 139.93 458.50 Td (our ) Tj ET Q q 0 0 0 rg BT 155.32 458.50 Td (annual ) Tj ET Q q 0 0 0 rg BT 184.04 458.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 207.77 458.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 245.93 458.50 Td (in ) Tj ET Q q 0 0 0 rg BT 255.77 458.50 Td (the ) Tj ET Q q 0 0 0 rg BT 270.04 458.50 Td (last ) Tj ET Q q 0 0 0 rg BT 285.99 458.50 Td (three ) Tj ET Q q 0 0 0 rg BT 308.04 458.50 Td (years. ) Tj ET Q q 0 0 0 rg BT 333.70 458.50 Td (No ) Tj ET Q q 0 0 0 rg BT 347.98 458.50 Td (individual ) Tj ET Q q 0 0 0 rg BT 390.59 458.50 Td (investigational ) Tj ET Q q 0 0 0 rg BT 451.53 458.50 Td (compound ) Tj ET Q q 0 0 0 rg BT 495.80 458.50 Td (or ) Tj ET Q q 0 0 0 rg BT 506.20 458.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 545.46 458.50 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 446.50 Td (represented ) Tj ET Q q 0 0 0 rg BT 85.35 446.50 Td (10% ) Tj ET Q q 0 0 0 rg BT 106.95 446.50 Td (or ) Tj ET Q q 0 0 0 rg BT 118.55 446.50 Td (more ) Tj ET Q q 0 0 0 rg BT 142.36 446.50 Td (of ) Tj ET Q q 0 0 0 rg BT 153.96 446.50 Td (our ) Tj ET Q q 0 0 0 rg BT 170.56 446.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 195.50 446.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 234.86 446.50 Td (in ) Tj ET Q q 0 0 0 rg BT 245.91 446.50 Td (any ) Tj ET Q q 0 0 0 rg BT 263.62 446.50 Td (of ) Tj ET Q q 0 0 0 rg BT 275.22 446.50 Td (the ) Tj ET Q q 0 0 0 rg BT 290.70 446.50 Td (last ) Tj ET Q q 0 0 0 rg BT 307.85 446.50 Td (three ) Tj ET Q q 0 0 0 rg BT 331.11 446.50 Td (years, ) Tj ET Q q 0 0 0 rg BT 357.98 446.50 Td (except ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 387.34 446.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.78 446.50 Td ( ) Tj ET Q q 0 0 0 rg BT 420.04 446.50 Td (in ) Tj ET Q q 0 0 0 rg BT 431.09 446.50 Td (both ) Tj ET Q q 0 0 0 rg BT 452.14 446.50 Td (2016 ) Tj ET Q q 0 0 0 rg BT 475.40 446.50 Td (and ) Tj ET Q q 0 0 0 rg BT 493.11 446.50 Td (2015. ) Tj ET Q q 0 0 0 rg BT 518.88 446.50 Td (Our ) Tj ET Q q 0 0 0 rg BT 537.70 446.50 Td (late-stage ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 434.50 Td (development ) Tj ET Q q 0 0 0 rg BT 90.26 434.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 130.64 434.50 Td (could ) Tj ET Q q 0 0 0 rg BT 155.47 434.50 Td (potentially ) Tj ET Q q 0 0 0 rg BT 200.85 434.50 Td (have ) Tj ET Q q 0 0 0 rg BT 222.34 434.50 Td (an ) Tj ET Q q 0 0 0 rg BT 234.39 434.50 Td (impact ) Tj ET Q q 0 0 0 rg BT 264.22 434.50 Td (on ) Tj ET Q q 0 0 0 rg BT 276.83 434.50 Td (our ) Tj ET Q q 0 0 0 rg BT 292.77 434.50 Td (revenue ) Tj ET Q q 0 0 0 rg BT 327.03 434.50 Td (and ) Tj ET Q q 0 0 0 rg BT 344.08 434.50 Td (earnings ) Tj ET Q q 0 0 0 rg BT 380.57 434.50 Td (within ) Tj ET Q q 0 0 0 rg BT 408.74 434.50 Td (the ) Tj ET Q q 0 0 0 rg BT 423.57 434.50 Td (next ) Tj ET Q q 0 0 0 rg BT 443.40 434.50 Td (few ) Tj ET Q q 0 0 0 rg BT 461.00 434.50 Td (years ) Tj ET Q q 0 0 0 rg BT 484.71 434.50 Td (if ) Tj ET Q q 0 0 0 rg BT 493.43 434.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 537.14 434.50 Td (approvals ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 422.50 Td (are ) Tj ET Q q 0 0 0 rg BT 50.68 422.50 Td (obtained ) Tj ET Q q 0 0 0 rg BT 87.59 422.50 Td (and ) Tj ET Q q 0 0 0 rg BT 104.51 422.50 Td (products ) Tj ET Q q 0 0 0 rg BT 141.42 422.50 Td (are ) Tj ET Q q 0 0 0 rg BT 156.10 422.50 Td (successfully ) Tj ET Q q 0 0 0 rg BT 207.46 422.50 Td (commercialized. ) Tj ET Q q 0 0 0 rg BT 276.10 422.50 Td (The ) Tj ET Q q 0 0 0 rg BT 294.13 422.50 Td (following ) Tj ET Q q 0 0 0 rg BT 335.49 422.50 Td (are ) Tj ET Q q 0 0 0 rg BT 350.17 422.50 Td (the ) Tj ET Q q 0 0 0 rg BT 364.86 422.50 Td (developments ) Tj ET Q q 0 0 0 rg BT 422.88 422.50 Td (in ) Tj ET Q q 0 0 0 rg BT 433.14 422.50 Td (our ) Tj ET Q q 0 0 0 rg BT 448.94 422.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 488.62 422.50 Td (products ) Tj ET Q q 0 0 0 rg BT 525.53 422.50 Td (and ) Tj ET Q q 0 0 0 rg BT 542.45 422.50 Td (our ) Tj ET Q q 0 0 0 rg BT 558.25 422.50 Td (late-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 410.50 Td (stage ) Tj ET Q q 0 0 0 rg BT 59.05 410.50 Td (pipeline:) Tj ET Q endstream endobj 99 0 obj <> endobj 100 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (49) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 755.5 m 35.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 755.5 m 98.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 755.5 m 98.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 755.5 m 180.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 755.5 m 180.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 755.5 m 241.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 755.5 m 241.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 755.5 m 575.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 755.5 m 575.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 740.5 m 35.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 740.5 m 98.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 740.5 m 98.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 740.5 m 180.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 740.5 m 180.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 740.5 m 241.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 740.5 m 241.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 740.5 m 575.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 740.5 m 575.5 740.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 717.5 m 35.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 717.5 m 98.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 717.5 m 180.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 717.5 m 241.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 717.5 m 241.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 717.5 m 575.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 717.5 m 575.5 717.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 694.5 m 35.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 694.5 m 98.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 694.5 m 180.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 694.5 m 241.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 694.5 m 241.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 694.5 m 575.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 694.5 m 575.5 694.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 671.5 m 35.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 671.5 m 98.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 671.5 m 180.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 671.5 m 241.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 671.5 m 241.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 671.5 m 575.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 671.5 m 575.5 671.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 639.5 m 35.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 639.5 m 98.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 639.5 m 180.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 639.5 m 241.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 639.5 m 241.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 616.5 m 241.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 639.5 m 241.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 639.5 m 575.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 639.5 m 575.5 639.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 616.5 m 35.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 616.5 m 98.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 616.5 m 180.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 616.5 m 241.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 616.5 m 241.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 616.5 m 575.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 616.5 m 575.5 616.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 593.5 m 35.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 593.5 m 98.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 593.5 m 180.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 593.5 m 180.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 593.5 m 241.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 593.5 m 241.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 593.5 m 575.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 593.5 m 575.5 593.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 552.5 m 35.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 552.5 m 98.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 552.5 m 180.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 552.5 m 241.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 552.5 m 241.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 552.5 m 575.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 552.5 m 575.5 552.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 529.5 m 35.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 529.5 m 98.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 529.5 m 180.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 529.5 m 180.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 529.5 m 241.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 529.5 m 241.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 529.5 m 575.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 529.5 m 575.5 529.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 506.5 m 35.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 506.5 m 98.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 506.5 m 180.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 506.5 m 241.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 506.5 m 241.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 506.5 m 575.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 506.5 m 575.5 506.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 483.5 m 35.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 483.5 m 98.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 483.5 m 180.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 483.5 m 180.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 483.5 m 241.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 483.5 m 241.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 483.5 m 575.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 483.5 m 575.5 483.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 460.5 m 35.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 460.5 m 98.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 460.5 m 180.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 460.5 m 241.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 460.5 m 241.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 460.5 m 575.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 460.5 m 575.5 460.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 437.5 m 35.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 437.5 m 98.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 437.5 m 180.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 437.5 m 241.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 437.5 m 241.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 437.5 m 575.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 437.5 m 575.5 437.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 405.5 m 35.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 405.5 m 98.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 405.5 m 180.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 382.5 m 180.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 405.5 m 241.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 405.5 m 241.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 405.5 m 575.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 405.5 m 575.5 405.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 382.5 m 35.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 382.5 m 98.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 382.5 m 180.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 382.5 m 180.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 382.5 m 241.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 382.5 m 241.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 382.5 m 575.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 382.5 m 575.5 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 359.5 m 35.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 359.5 m 98.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 359.5 m 180.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 359.5 m 241.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 359.5 m 241.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 359.5 m 575.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 359.5 m 575.5 359.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 318.5 m 35.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 318.5 m 98.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 318.5 m 180.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 318.5 m 241.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 318.5 m 241.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 318.5 m 575.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 318.5 m 575.5 318.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 295.5 m 35.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 295.5 m 98.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 295.5 m 180.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 295.5 m 241.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 295.5 m 241.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 295.5 m 575.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 295.5 m 575.5 295.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 280.5 m 35.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 280.5 m 98.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 280.5 m 180.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 280.5 m 180.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 280.5 m 241.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 280.5 m 241.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 280.5 m 575.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 280.5 m 575.5 280.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 257.5 m 35.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 257.5 m 98.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 257.5 m 180.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 257.5 m 241.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 257.5 m 241.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 257.5 m 575.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 257.5 m 575.5 257.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 225.5 m 35.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 225.5 m 98.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 225.5 m 180.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 225.5 m 241.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 225.5 m 241.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 225.5 m 575.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 225.5 m 575.5 225.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 210.5 m 35.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 210.5 m 98.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 210.5 m 180.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 210.5 m 180.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 210.5 m 241.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 210.5 m 241.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 210.5 m 575.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 210.5 m 575.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 187.5 m 35.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 187.5 m 98.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 187.5 m 180.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 187.5 m 241.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 187.5 m 241.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 187.5 m 575.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 187.5 m 575.5 187.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 155.5 m 35.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 155.5 m 98.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 155.5 m 180.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 155.5 m 241.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 155.5 m 241.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 155.5 m 575.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 155.5 m 575.5 155.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 132.5 m 35.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 132.5 m 98.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 91.5 m 98.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 132.5 m 180.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 91.5 m 180.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 132.5 m 241.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 91.5 m 241.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 132.5 m 241.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 132.5 m 575.5 91.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 132.5 m 575.5 132.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 91.5 m 575.5 91.5 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 49.35 745.18 Td (Product) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 117.00 745.18 Td (Indication) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 200.50 745.18 Td (Date) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 378.00 745.18 Td (Developments) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 53.25 413.95 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 131.15 664.86 Td (cHL) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 731.36 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 722.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 730.96 Td (JMHL) Tj ET Q q 0 0 0 rg BT 267.17 730.96 Td (W) Tj ET Q q 0 0 0 rg BT 275.25 730.96 Td ( ) Tj ET Q q 0 0 0 rg BT 277.66 730.96 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 332.64 730.96 Td (and ) Tj ET Q q 0 0 0 rg BT 348.13 730.96 Td (marketing ) Tj ET Q q 0 0 0 rg BT 387.12 730.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 421.10 730.96 Td (for ) Tj ET Q q 0 0 0 rg BT 434.09 730.96 Td (the ) Tj ET Q q 0 0 0 rg BT 447.58 730.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 484.06 730.96 Td (of ) Tj ET Q q 0 0 0 rg BT 494.06 730.96 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 526.54 730.96 Td (or ) Tj ET Q q 0 0 0 rg BT 536.53 730.96 Td (refractory ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 721.96 Td (cHL, ) Tj ET Q q 0 0 0 rg BT 264.49 721.96 Td (received ) Tj ET Q q 0 0 0 rg BT 297.22 721.96 Td (by ) Tj ET Q q 0 0 0 rg BT 308.47 721.96 Td (our ) Tj ET Q q 0 0 0 rg BT 322.71 721.96 Td (alliance ) Tj ET Q q 0 0 0 rg BT 352.94 721.96 Td (partner) Tj ET Q q 0 0 0 rg BT 378.25 721.96 Td (, ) Tj ET Q q 0 0 0 rg BT 382.57 721.96 Td (Ono.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 708.36 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 699.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 707.96 Td (BMS ) Tj ET Q q 0 0 0 rg BT 264.25 707.96 Td (and ) Tj ET Q q 0 0 0 rg BT 278.48 707.96 Td (Seattle ) Tj ET Q q 0 0 0 rg BT 304.21 707.96 Td (Genetics, ) Tj ET Q q 0 0 0 rg BT 339.18 707.96 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 354.16 707.96 Td (announced ) Tj ET Q q 0 0 0 rg BT 394.38 707.96 Td (results ) Tj ET Q q 0 0 0 rg BT 419.12 707.96 Td (from ) Tj ET Q q 0 0 0 rg BT 437.85 707.96 Td (a ) Tj ET Q q 0 0 0 rg BT 443.08 707.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 465.32 707.96 Td (I/II ) Tj ET Q q 0 0 0 rg BT 478.04 707.96 Td (study ) Tj ET Q q 0 0 0 rg BT 498.78 707.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 537.51 707.96 Td (Adcetris*) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 572.00 707.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 698.96 Td (\(brentuximab\) ) Tj ET Q q 0 0 0 rg BT 297.73 698.96 Td (in ) Tj ET Q q 0 0 0 rg BT 306.98 698.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 354.22 698.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 372.47 698.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 398.97 698.96 Td ( ) Tj ET Q q 0 0 0 rg BT 401.22 698.96 Td (in ) Tj ET Q q 0 0 0 rg BT 410.47 698.96 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 442.70 698.96 Td (or ) Tj ET Q q 0 0 0 rg BT 452.45 698.96 Td (refractory ) Tj ET Q q 0 0 0 rg BT 490.17 698.96 Td (cHL.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.50 685.36 Td (November) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 676.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 684.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.83 684.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.65 684.96 Td (for ) Tj ET Q q 0 0 0 rg BT 304.48 684.96 Td (the ) Tj ET Q q 0 0 0 rg BT 317.80 684.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 354.12 684.96 Td (of ) Tj ET Q q 0 0 0 rg BT 363.95 684.96 Td (adult ) Tj ET Q q 0 0 0 rg BT 384.27 684.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 414.60 684.96 Td (with ) Tj ET Q q 0 0 0 rg BT 432.93 684.96 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 465.25 684.96 Td (or ) Tj ET Q q 0 0 0 rg BT 475.07 684.96 Td (refractory ) Tj ET Q q 0 0 0 rg BT 512.88 684.96 Td (cHL) Tj ET Q q 0 0 0 rg BT 528.70 684.96 Td ( ) Tj ET Q q 0 0 0 rg BT 530.87 684.96 Td (after ) Tj ET Q q 0 0 0 rg BT 549.42 684.96 Td (ASCT) Tj ET Q q 0 0 0 rg BT 572.09 684.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 675.96 Td (and ) Tj ET Q q 0 0 0 rg BT 259.24 675.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 295.48 675.96 Td (with ) Tj ET Q q 0 0 0 rg BT 313.73 675.96 Td (brentuximab ) Tj ET Q q 0 0 0 rg BT 361.47 675.96 Td (vedotin.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 653.36 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 661.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.64 661.96 Td (new ) Tj ET Q q 0 0 0 rg BT 304.79 661.96 Td (results ) Tj ET Q q 0 0 0 rg BT 330.44 661.96 Td (from ) Tj ET Q q 0 0 0 rg BT 350.09 661.96 Td (CheckMate-205, ) Tj ET Q q 0 0 0 rg BT 412.47 661.96 Td (a ) Tj ET Q q 0 0 0 rg BT 418.62 661.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 441.77 661.96 Td (II ) Tj ET Q q 0 0 0 rg BT 449.92 661.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 466.57 661.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 506.20 661.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 532.70 661.96 Td ( ) Tj ET Q q 0 0 0 rg BT 534.85 661.96 Td (in ) Tj ET Q q 0 0 0 rg BT 544.01 661.96 Td (patients ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 652.96 Td (with ) Tj ET Q q 0 0 0 rg BT 261.61 652.96 Td (cHL, ) Tj ET Q q 0 0 0 rg BT 281.47 652.96 Td (including ) Tj ET Q q 0 0 0 rg BT 317.08 652.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 346.69 652.96 Td (who ) Tj ET Q q 0 0 0 rg BT 363.80 652.96 Td (had ) Tj ET Q q 0 0 0 rg BT 378.41 652.96 Td (received ) Tj ET Q q 0 0 0 rg BT 410.50 652.96 Td (brentuximab ) Tj ET Q q 0 0 0 rg BT 457.60 652.96 Td (vedotin ) Tj ET Q q 0 0 0 rg BT 486.21 652.96 Td (before ) Tj ET Q q 0 0 0 rg BT 510.81 652.96 Td (and/or ) Tj ET Q q 0 0 0 rg BT 535.41 652.96 Td (after ) Tj ET Q q 0 0 0 rg BT 553.51 652.96 Td (auto-) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 643.96 Td (HSCT) Tj ET Q q 0 0 0 rg BT 266.34 643.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 625.86 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 629.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.56 629.96 Td (results ) Tj ET Q q 0 0 0 rg BT 313.13 629.96 Td (from ) Tj ET Q q 0 0 0 rg BT 332.69 629.96 Td (CheckMate-205, ) Tj ET Q q 0 0 0 rg BT 394.99 629.96 Td (a ) Tj ET Q q 0 0 0 rg BT 401.06 629.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 424.12 629.96 Td (II ) Tj ET Q q 0 0 0 rg BT 432.19 629.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 448.75 629.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 488.31 629.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 514.80 629.96 Td ( ) Tj ET Q q 0 0 0 rg BT 516.87 629.96 Td (in ) Tj ET Q q 0 0 0 rg BT 525.94 629.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 556.00 629.96 Td (with ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 620.96 Td (cHL.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 602.86 Td (May 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 606.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.76 606.96 Td ( ) Tj ET Q q 0 0 0 rg BT 263.72 606.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 297.42 606.96 Td (for ) Tj ET Q q 0 0 0 rg BT 310.12 606.96 Td (the ) Tj ET Q q 0 0 0 rg BT 323.33 606.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 359.52 606.96 Td (of ) Tj ET Q q 0 0 0 rg BT 369.23 606.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 399.43 606.96 Td (with ) Tj ET Q q 0 0 0 rg BT 417.64 606.96 Td (cHL) Tj ET Q q 0 0 0 rg BT 433.47 606.96 Td ( ) Tj ET Q q 0 0 0 rg BT 435.51 606.96 Td (who ) Tj ET Q q 0 0 0 rg BT 453.22 606.96 Td (have ) Tj ET Q q 0 0 0 rg BT 472.42 606.96 Td (relapsed ) Tj ET Q q 0 0 0 rg BT 504.61 606.96 Td (or ) Tj ET Q q 0 0 0 rg BT 514.32 606.96 Td (progressed ) Tj ET Q q 0 0 0 rg BT 555.52 606.96 Td (after ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 597.96 Td (auto-HSCT) Tj ET Q q 0 0 0 rg BT 285.42 597.96 Td ( ) Tj ET Q q 0 0 0 rg BT 287.58 597.96 Td (and ) Tj ET Q q 0 0 0 rg BT 302.83 597.96 Td (post-transplantation ) Tj ET Q q 0 0 0 rg BT 376.57 597.96 Td (brentuximab ) Tj ET Q q 0 0 0 rg BT 424.30 597.96 Td (vedotin.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 113.10 559.36 Td (Gastric cancer) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 186.35 570.86 Td (January 2017) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 583.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 288.60 583.96 Td (results ) Tj ET Q q 0 0 0 rg BT 315.21 583.96 Td (of ) Tj ET Q q 0 0 0 rg BT 325.81 583.96 Td (ONO-4538-12, ) Tj ET Q q 0 0 0 rg BT 383.67 583.96 Td (a ) Tj ET Q q 0 0 0 rg BT 390.77 583.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 414.88 583.96 Td (III ) Tj ET Q q 0 0 0 rg BT 426.98 583.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 444.58 583.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 485.18 583.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 511.68 583.96 Td ( ) Tj ET Q q 0 0 0 rg BT 514.79 583.96 Td (in ) Tj ET Q q 0 0 0 rg BT 524.90 583.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 556.00 583.96 Td (with ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 574.96 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 292.53 574.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 330.07 574.96 Td (or ) Tj ET Q q 0 0 0 rg BT 341.13 574.96 Td (recurrent ) Tj ET Q q 0 0 0 rg BT 377.17 574.96 Td (gastric ) Tj ET Q q 0 0 0 rg BT 404.72 574.96 Td (cancer ) Tj ET Q q 0 0 0 rg BT 431.75 574.96 Td (refractory ) Tj ET Q q 0 0 0 rg BT 470.79 574.96 Td (to ) Tj ET Q q 0 0 0 rg BT 481.35 574.96 Td (or ) Tj ET Q q 0 0 0 rg BT 492.41 574.96 Td (intolerant ) Tj ET Q q 0 0 0 rg BT 530.45 574.96 Td (of ) Tj ET Q q 0 0 0 rg BT 541.51 574.96 Td (standard ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 565.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 270.40 565.96 Td (. ) Tj ET Q q 0 0 0 rg BT 274.04 565.96 Td (A) Tj ET Q q 0 0 0 rg BT 280.04 565.96 Td ( ) Tj ET Q q 0 0 0 rg BT 281.81 565.96 Td (November ) Tj ET Q q 0 0 0 rg BT 321.57 565.96 Td (2016 ) Tj ET Q q 0 0 0 rg BT 341.35 565.96 Td (announcement ) Tj ET Q q 0 0 0 rg BT 395.60 565.96 Td (stated ) Tj ET Q q 0 0 0 rg BT 418.37 565.96 Td (that ) Tj ET Q q 0 0 0 rg BT 433.64 565.96 Td (the ) Tj ET Q q 0 0 0 rg BT 446.41 565.96 Td (study ) Tj ET Q q 0 0 0 rg BT 467.69 565.96 Td (had ) Tj ET Q q 0 0 0 rg BT 482.45 565.96 Td (met ) Tj ET Q q 0 0 0 rg BT 497.72 565.96 Td (its ) Tj ET Q q 0 0 0 rg BT 508.00 565.96 Td (primary ) Tj ET Q q 0 0 0 rg BT 538.27 565.96 Td (endpoint. ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 556.96 Td (Ono, ) Tj ET Q q 0 0 0 rg BT 264.00 556.96 Td (our ) Tj ET Q q 0 0 0 rg BT 278.25 556.96 Td (alliance ) Tj ET Q q 0 0 0 rg BT 308.48 556.96 Td (partner) Tj ET Q q 0 0 0 rg BT 333.60 556.96 Td (, ) Tj ET Q q 0 0 0 rg BT 338.10 556.96 Td (conducted ) Tj ET Q q 0 0 0 rg BT 377.33 556.96 Td (the ) Tj ET Q q 0 0 0 rg BT 390.58 556.96 Td (trial.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 543.36 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 534.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 542.96 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 272.21 542.96 Td (alliance ) Tj ET Q q 0 0 0 rg BT 304.26 542.96 Td (partner) Tj ET Q q 0 0 0 rg BT 329.39 542.96 Td (, ) Tj ET Q q 0 0 0 rg BT 335.71 542.96 Td (Ono, ) Tj ET Q q 0 0 0 rg BT 357.53 542.96 Td (submitted ) Tj ET Q q 0 0 0 rg BT 397.11 542.96 Td (a ) Tj ET Q q 0 0 0 rg BT 405.18 542.96 Td (supplemental ) Tj ET Q q 0 0 0 rg BT 457.24 542.96 Td (application ) Tj ET Q q 0 0 0 rg BT 501.30 542.96 Td (for ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 515.87 542.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 542.36 542.96 Td ( ) Tj ET Q q 0 0 0 rg BT 546.44 542.96 Td (for ) Tj ET Q q 0 0 0 rg BT 561.00 542.96 Td (the ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 533.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 280.23 533.96 Td (of ) Tj ET Q q 0 0 0 rg BT 289.98 533.96 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 337.20 533.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 373.43 533.96 Td (or ) Tj ET Q q 0 0 0 rg BT 383.18 533.96 Td (recurrent ) Tj ET Q q 0 0 0 rg BT 417.90 533.96 Td (gastric ) Tj ET Q q 0 0 0 rg BT 444.14 533.96 Td (cancer) Tj ET Q q 0 0 0 rg BT 467.12 533.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 119.75 504.36 Td (Melanoma) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 190.85 515.86 Td (April 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 519.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.81 519.96 Td (extended ) Tj ET Q q 0 0 0 rg BT 322.61 519.96 Td (follow-up ) Tj ET Q q 0 0 0 rg BT 360.43 519.96 Td (data ) Tj ET Q q 0 0 0 rg BT 377.74 519.96 Td (from ) Tj ET Q q 0 0 0 rg BT 397.55 519.96 Td (CA209-003, ) Tj ET Q q 0 0 0 rg BT 444.62 519.96 Td (a ) Tj ET Q q 0 0 0 rg BT 450.94 519.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 474.26 519.96 Td (I ) Tj ET Q q 0 0 0 rg BT 479.57 519.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 496.39 519.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 536.19 519.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 562.69 519.96 Td ( ) Tj ET Q q 0 0 0 rg BT 565.01 519.96 Td (in ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 510.96 Td (heavily ) Tj ET Q q 0 0 0 rg BT 272.74 510.96 Td (pretreated ) Tj ET Q q 0 0 0 rg BT 310.96 510.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 347.19 510.96 Td (melanoma ) Tj ET Q q 0 0 0 rg BT 386.93 510.96 Td (patients.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 186.35 492.86 Td (January 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 496.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.51 496.96 Td ( ) Tj ET Q q 0 0 0 rg BT 264.23 496.96 Td (expanded ) Tj ET Q q 0 0 0 rg BT 301.43 496.96 Td (the ) Tj ET Q q 0 0 0 rg BT 315.14 496.96 Td (use ) Tj ET Q q 0 0 0 rg BT 329.86 496.96 Td (of ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 340.08 496.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 366.57 496.96 Td ( ) Tj ET Q q 0 0 0 rg BT 369.29 496.96 Td (as ) Tj ET Q q 0 0 0 rg BT 379.51 496.96 Td (a ) Tj ET Q q 0 0 0 rg BT 386.22 496.96 Td (single ) Tj ET Q q 0 0 0 rg BT 410.44 496.96 Td (agent ) Tj ET Q q 0 0 0 rg BT 432.65 496.96 Td (to ) Tj ET Q q 0 0 0 rg BT 442.37 496.96 Td (include ) Tj ET Q q 0 0 0 rg BT 471.58 496.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 512.29 496.96 Td (untreated ) Tj ET Q q 0 0 0 rg BT 548.49 496.96 Td (BRAF ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 487.96 Td (mutation ) Tj ET Q q 0 0 0 rg BT 278.25 487.96 Td (positive ) Tj ET Q q 0 0 0 rg BT 309.00 487.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 345.22 487.96 Td (melanoma ) Tj ET Q q 0 0 0 rg BT 384.96 487.96 Td (patients.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 129.20 430.86 Td (mUC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 184.10 469.86 Td (February 2017) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 473.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.76 473.96 Td ( ) Tj ET Q q 0 0 0 rg BT 263.19 473.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 296.36 473.96 Td (for ) Tj ET Q q 0 0 0 rg BT 308.53 473.96 Td (the ) Tj ET Q q 0 0 0 rg BT 321.21 473.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 356.87 473.96 Td (of ) Tj ET Q q 0 0 0 rg BT 366.05 473.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 395.73 473.96 Td (with ) Tj ET Q q 0 0 0 rg BT 413.41 473.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 453.08 473.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 479.25 473.96 Td (locally ) Tj ET Q q 0 0 0 rg BT 505.42 473.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 541.08 473.96 Td (or ) Tj ET Q q 0 0 0 rg BT 550.26 473.96 Td (mUC, ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 464.96 Td (a ) Tj ET Q q 0 0 0 rg BT 250.24 464.96 Td (type ) Tj ET Q q 0 0 0 rg BT 267.99 464.96 Td (of ) Tj ET Q q 0 0 0 rg BT 277.74 464.96 Td (bladder ) Tj ET Q q 0 0 0 rg BT 306.97 464.96 Td (cancer) Tj ET Q q 0 0 0 rg BT 330.20 464.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 446.86 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 450.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 288.56 450.96 Td (results ) Tj ET Q q 0 0 0 rg BT 315.14 450.96 Td (from ) Tj ET Q q 0 0 0 rg BT 335.71 450.96 Td (CheckMate-275, ) Tj ET Q q 0 0 0 rg BT 399.02 450.96 Td (a ) Tj ET Q q 0 0 0 rg BT 406.09 450.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 430.16 450.96 Td (II ) Tj ET Q q 0 0 0 rg BT 439.23 450.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 456.80 450.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 497.36 450.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 523.86 450.96 Td ( ) Tj ET Q q 0 0 0 rg BT 526.93 450.96 Td (in ) Tj ET Q q 0 0 0 rg BT 537.01 450.96 Td (platinum-) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 441.96 Td (refractory ) Tj ET Q q 0 0 0 rg BT 281.72 441.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 311.97 441.96 Td (with ) Tj ET Q q 0 0 0 rg BT 330.22 441.96 Td (mUC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.25 423.86 Td (September) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 414.86 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 427.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.99 427.96 Td (the ) Tj ET Q q 0 0 0 rg BT 301.48 427.96 Td (EMA) Tj ET Q q 0 0 0 rg BT 321.23 427.96 Td ( ) Tj ET Q q 0 0 0 rg BT 323.48 427.96 Td (validated ) Tj ET Q q 0 0 0 rg BT 358.96 427.96 Td (the ) Tj ET Q q 0 0 0 rg BT 372.45 427.96 Td (Company's ) Tj ET Q q 0 0 0 rg BT 415.07 427.96 Td (type ) Tj ET Q q 0 0 0 rg BT 433.06 427.96 Td (II ) Tj ET Q q 0 0 0 rg BT 441.56 427.96 Td (variation ) Tj ET Q q 0 0 0 rg BT 476.04 427.96 Td (application ) Tj ET Q q 0 0 0 rg BT 518.52 427.96 Td (which ) Tj ET Q q 0 0 0 rg BT 543.01 427.96 Td (seeks ) Tj ET Q q 0 0 0 rg BT 565.01 427.96 Td (to ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 418.96 Td (extend ) Tj ET Q q 0 0 0 rg BT 270.73 418.96 Td (the ) Tj ET Q q 0 0 0 rg BT 284.46 418.96 Td (current ) Tj ET Q q 0 0 0 rg BT 312.69 418.96 Td (indications ) Tj ET Q q 0 0 0 rg BT 354.92 418.96 Td (to ) Tj ET Q q 0 0 0 rg BT 364.66 418.96 Td (include ) Tj ET Q q 0 0 0 rg BT 393.89 418.96 Td (the ) Tj ET Q q 0 0 0 rg BT 407.62 418.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 444.34 418.96 Td (of ) Tj ET Q q 0 0 0 rg BT 454.58 418.96 Td (locally ) Tj ET Q q 0 0 0 rg BT 481.81 418.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 518.52 418.96 Td (mUC ) Tj ET Q q 0 0 0 rg BT 540.77 418.96 Td (in ) Tj ET Q q 0 0 0 rg BT 550.50 418.96 Td (adults ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 409.96 Td (after ) Tj ET Q q 0 0 0 rg BT 262.73 409.96 Td (failure ) Tj ET Q q 0 0 0 rg BT 288.47 409.96 Td (of ) Tj ET Q q 0 0 0 rg BT 298.22 409.96 Td (prior ) Tj ET Q q 0 0 0 rg BT 317.96 409.96 Td (platinum-containing ) Tj ET Q q 0 0 0 rg BT 393.19 409.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 419.89 409.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 391.86 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 395.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.81 395.96 Td (data ) Tj ET Q q 0 0 0 rg BT 305.12 395.96 Td (from ) Tj ET Q q 0 0 0 rg BT 324.93 395.96 Td (CheckMate-032, ) Tj ET Q q 0 0 0 rg BT 387.49 395.96 Td (a ) Tj ET Q q 0 0 0 rg BT 393.80 395.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 417.12 395.96 Td (I/II ) Tj ET Q q 0 0 0 rg BT 430.93 395.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 447.74 395.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 487.55 395.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 514.04 395.96 Td ( ) Tj ET Q q 0 0 0 rg BT 516.36 395.96 Td (in ) Tj ET Q q 0 0 0 rg BT 525.69 395.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 556.00 395.96 Td (with ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 386.96 Td (mUC ) Tj ET Q q 0 0 0 rg BT 265.75 386.96 Td (after ) Tj ET Q q 0 0 0 rg BT 284.49 386.96 Td (platinum-based ) Tj ET Q q 0 0 0 rg BT 342.22 386.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 368.62 386.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 124.45 329.36 Td (NSCLC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 368.86 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 372.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.55 372.96 Td (updated ) Tj ET Q q 0 0 0 rg BT 318.10 372.96 Td (results ) Tj ET Q q 0 0 0 rg BT 343.66 372.96 Td (from ) Tj ET Q q 0 0 0 rg BT 363.21 372.96 Td (two ) Tj ET Q q 0 0 0 rg BT 378.77 372.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 401.83 372.96 Td (III ) Tj ET Q q 0 0 0 rg BT 412.88 372.96 Td (trials ) Tj ET Q q 0 0 0 rg BT 432.94 372.96 Td (\(CheckMate-057 ) Tj ET Q q 0 0 0 rg BT 495.97 372.96 Td (and ) Tj ET Q q 0 0 0 rg BT 511.03 372.96 Td (CheckMate-017\) ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 363.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 283.74 363.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 310.23 363.96 Td ( ) Tj ET Q q 0 0 0 rg BT 312.48 363.96 Td (in ) Tj ET Q q 0 0 0 rg BT 321.73 363.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 361.98 363.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 388.71 363.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 427.44 363.96 Td (NSCLC ) Tj ET Q q 0 0 0 rg BT 458.70 363.96 Td (patients.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 336.86 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 349.96 Td (Presented ) Tj ET Q q 0 0 0 rg BT 281.31 349.96 Td (the ) Tj ET Q q 0 0 0 rg BT 294.63 349.96 Td (final ) Tj ET Q q 0 0 0 rg BT 313.44 349.96 Td (primary ) Tj ET Q q 0 0 0 rg BT 344.25 349.96 Td (analysis ) Tj ET Q q 0 0 0 rg BT 375.57 349.96 Td (of ) Tj ET Q q 0 0 0 rg BT 385.39 349.96 Td (CheckMate-026, ) Tj ET Q q 0 0 0 rg BT 447.94 349.96 Td (a ) Tj ET Q q 0 0 0 rg BT 454.26 349.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 477.57 349.96 Td (III ) Tj ET Q q 0 0 0 rg BT 488.89 349.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 505.70 349.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 545.51 349.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 572.00 349.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 340.96 Td (as ) Tj ET Q q 0 0 0 rg BT 253.67 340.96 Td (a ) Tj ET Q q 0 0 0 rg BT 259.84 340.96 Td (first-line ) Tj ET Q q 0 0 0 rg BT 293.00 340.96 Td (monotherapy ) Tj ET Q q 0 0 0 rg BT 342.66 340.96 Td (in ) Tj ET Q q 0 0 0 rg BT 351.83 340.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 381.99 340.96 Td (with ) Tj ET Q q 0 0 0 rg BT 400.17 340.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 436.32 340.96 Td (NSCLC ) Tj ET Q q 0 0 0 rg BT 467.50 340.96 Td (whose ) Tj ET Q q 0 0 0 rg BT 492.67 340.96 Td (tumors ) Tj ET Q q 0 0 0 rg BT 519.84 340.96 Td (expressed ) Tj ET Q q 0 0 0 rg BT 557.50 340.96 Td (PD-) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 331.96 Td (L1 ) Tj ET Q /GS0 gs q 7.56 0 0 9.18 256.61 330.02 cm /I18 Do Q q 0 0 0 rg BT 264.17 331.96 Td (1%. ) Tj ET Q q 0 0 0 rg BT 280.85 331.96 Td (The ) Tj ET Q q 0 0 0 rg BT 297.46 331.96 Td (top ) Tj ET Q q 0 0 0 rg BT 311.57 331.96 Td (line ) Tj ET Q q 0 0 0 rg BT 327.69 331.96 Td (results ) Tj ET Q q 0 0 0 rg BT 353.80 331.96 Td (were ) Tj ET Q q 0 0 0 rg BT 373.90 331.96 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 410.02 331.96 Td (in ) Tj ET Q q 0 0 0 rg BT 419.06 331.96 Td (August ) Tj ET Q q 0 0 0 rg BT 447.68 331.96 Td (2016 ) Tj ET Q q 0 0 0 rg BT 468.29 331.96 Td (and ) Tj ET Q q 0 0 0 rg BT 483.90 331.96 Td (showed ) Tj ET Q q 0 0 0 rg BT 514.02 331.96 Td (CheckMate-026 ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 322.96 Td (did ) Tj ET Q q 0 0 0 rg BT 257.75 322.96 Td (not ) Tj ET Q q 0 0 0 rg BT 271.50 322.96 Td (meet ) Tj ET Q q 0 0 0 rg BT 291.24 322.96 Td (the ) Tj ET Q q 0 0 0 rg BT 304.49 322.96 Td (primary ) Tj ET Q q 0 0 0 rg BT 335.23 322.96 Td (endpoint ) Tj ET Q q 0 0 0 rg BT 368.97 322.96 Td (of ) Tj ET Q q 0 0 0 rg BT 378.72 322.96 Td (superior ) Tj ET Q q 0 0 0 rg BT 410.46 322.96 Td (PFS.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 304.86 Td (May 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 308.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.50 308.96 Td (data ) Tj ET Q q 0 0 0 rg BT 304.50 308.96 Td (from ) Tj ET Q q 0 0 0 rg BT 324.01 308.96 Td (two ) Tj ET Q q 0 0 0 rg BT 339.52 308.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 362.52 308.96 Td (III ) Tj ET Q q 0 0 0 rg BT 373.53 308.96 Td (trials ) Tj ET Q q 0 0 0 rg BT 393.53 308.96 Td (\(CheckMate-017 ) Tj ET Q q 0 0 0 rg BT 456.52 308.96 Td (and ) Tj ET Q q 0 0 0 rg BT 471.53 308.96 Td (CheckMate-057\) ) Tj ET Q q 0 0 0 rg BT 534.52 308.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 244.00 299.95 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 270.49 299.95 Td ( ) Tj ET Q q 0 0 0 rg BT 272.74 299.95 Td (versus ) Tj ET Q q 0 0 0 rg BT 297.99 299.95 Td (docetaxel ) Tj ET Q q 0 0 0 rg BT 334.72 299.95 Td (in ) Tj ET Q q 0 0 0 rg BT 343.97 299.95 Td (previously ) Tj ET Q q 0 0 0 rg BT 384.22 299.95 Td (treated ) Tj ET Q q 0 0 0 rg BT 410.95 299.95 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 449.68 299.95 Td (NSCLC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 190.85 285.86 Td (April 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 284.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.75 284.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.49 284.96 Td (for ) Tj ET Q q 0 0 0 rg BT 304.23 284.96 Td (the ) Tj ET Q q 0 0 0 rg BT 317.48 284.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 353.71 284.96 Td (of ) Tj ET Q q 0 0 0 rg BT 363.46 284.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 403.70 284.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 430.43 284.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 460.68 284.96 Td (with ) Tj ET Q q 0 0 0 rg BT 478.93 284.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 517.66 284.96 Td (NSQ ) Tj ET Q q 0 0 0 rg BT 537.92 284.96 Td (NSCLC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 129.95 243.36 Td (RCC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 187.35 266.86 Td (August 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 270.96 Td (JMHL) Tj ET Q q 0 0 0 rg BT 267.17 270.96 Td (W) Tj ET Q q 0 0 0 rg BT 275.25 270.96 Td ( ) Tj ET Q q 0 0 0 rg BT 279.96 270.96 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 337.23 270.96 Td (and ) Tj ET Q q 0 0 0 rg BT 355.02 270.96 Td (marketing ) Tj ET Q q 0 0 0 rg BT 396.31 270.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 432.59 270.96 Td (for ) Tj ET Q q 0 0 0 rg BT 447.88 270.96 Td (the ) Tj ET Q q 0 0 0 rg BT 463.67 270.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 502.44 270.96 Td (of ) Tj ET Q q 0 0 0 rg BT 514.73 270.96 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 564.50 270.96 Td (or ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 261.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 282.73 261.96 Td (RCC, ) Tj ET Q q 0 0 0 rg BT 305.24 261.96 Td (received ) Tj ET Q q 0 0 0 rg BT 337.97 261.96 Td (by ) Tj ET Q q 0 0 0 rg BT 349.22 261.96 Td (our ) Tj ET Q q 0 0 0 rg BT 363.47 261.96 Td (alliance ) Tj ET Q q 0 0 0 rg BT 393.70 261.96 Td (partner) Tj ET Q q 0 0 0 rg BT 419.00 261.96 Td (, ) Tj ET Q q 0 0 0 rg BT 423.32 261.96 Td (Ono.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 239.36 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 247.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.79 247.96 Td (long-term ) Tj ET Q q 0 0 0 rg BT 325.58 247.96 Td (results ) Tj ET Q q 0 0 0 rg BT 351.38 247.96 Td (from ) Tj ET Q q 0 0 0 rg BT 371.17 247.96 Td (two ) Tj ET Q q 0 0 0 rg BT 386.98 247.96 Td (dose-ranging ) Tj ET Q q 0 0 0 rg BT 436.26 247.96 Td (studies, ) Tj ET Q q 0 0 0 rg BT 465.81 247.96 Td (the ) Tj ET Q q 0 0 0 rg BT 479.11 247.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 502.41 247.96 Td (I ) Tj ET Q q 0 0 0 rg BT 507.71 247.96 Td (CA209-003 ) Tj ET Q q 0 0 0 rg BT 552.51 247.96 Td (study ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 238.96 Td (and ) Tj ET Q q 0 0 0 rg BT 259.99 238.96 Td (the ) Tj ET Q q 0 0 0 rg BT 273.97 238.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 297.96 238.96 Td (II ) Tj ET Q q 0 0 0 rg BT 306.95 238.96 Td (CA209-010 ) Tj ET Q q 0 0 0 rg BT 352.44 238.96 Td (study) Tj ET Q q 0 0 0 rg BT 371.36 238.96 Td (, ) Tj ET Q q 0 0 0 rg BT 376.60 238.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 417.08 238.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 443.57 238.96 Td ( ) Tj ET Q q 0 0 0 rg BT 446.56 238.96 Td (in ) Tj ET Q q 0 0 0 rg BT 456.55 238.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 487.54 238.96 Td (with ) Tj ET Q q 0 0 0 rg BT 506.53 238.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 547.52 238.96 Td (treated ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 229.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 280.23 229.96 Td (RCC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 190.85 215.86 Td (April 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 214.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.75 214.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.49 214.96 Td (for ) Tj ET Q q 0 0 0 rg BT 304.23 214.96 Td (the ) Tj ET Q q 0 0 0 rg BT 317.48 214.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 353.71 214.96 Td (of ) Tj ET Q q 0 0 0 rg BT 363.46 214.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 403.70 214.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 430.43 214.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 460.68 214.96 Td (with ) Tj ET Q q 0 0 0 rg BT 478.93 214.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 515.16 214.96 Td (RCC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 123.95 148.86 Td (SCCHN) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.50 201.36 Td (November) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 192.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 200.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.51 200.96 Td ( ) Tj ET Q q 0 0 0 rg BT 263.30 200.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 296.58 200.96 Td (for ) Tj ET Q q 0 0 0 rg BT 308.86 200.96 Td (the ) Tj ET Q q 0 0 0 rg BT 321.65 200.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 357.42 200.96 Td (of ) Tj ET Q q 0 0 0 rg BT 366.71 200.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 396.49 200.96 Td (with ) Tj ET Q q 0 0 0 rg BT 414.29 200.96 Td (SCCHN ) Tj ET Q q 0 0 0 rg BT 446.09 200.96 Td (with ) Tj ET Q q 0 0 0 rg BT 463.88 200.96 Td (disease ) Tj ET Q q 0 0 0 rg BT 491.66 200.96 Td (progression ) Tj ET Q q 0 0 0 rg BT 535.44 200.96 Td (on ) Tj ET Q q 0 0 0 rg BT 546.23 200.96 Td (or ) Tj ET Q q 0 0 0 rg BT 555.52 200.96 Td (after ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 191.96 Td (platinum-based ) Tj ET Q q 0 0 0 rg BT 301.74 191.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 328.14 191.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 169.36 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 177.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 288.10 177.96 Td (new ) Tj ET Q q 0 0 0 rg BT 305.71 177.96 Td (data ) Tj ET Q q 0 0 0 rg BT 323.31 177.96 Td (from ) Tj ET Q q 0 0 0 rg BT 343.42 177.96 Td (CheckMate-141, ) Tj ET Q q 0 0 0 rg BT 406.26 177.96 Td (a ) Tj ET Q q 0 0 0 rg BT 412.87 177.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 436.48 177.96 Td (III ) Tj ET Q q 0 0 0 rg BT 448.08 177.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 465.19 177.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 505.29 177.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 531.78 177.96 Td ( ) Tj ET Q q 0 0 0 rg BT 534.40 177.96 Td (in ) Tj ET Q q 0 0 0 rg BT 544.01 177.96 Td (patients ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 168.96 Td (with ) Tj ET Q q 0 0 0 rg BT 261.50 168.96 Td (recurrent ) Tj ET Q q 0 0 0 rg BT 295.47 168.96 Td (or ) Tj ET Q q 0 0 0 rg BT 304.47 168.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 342.45 168.96 Td (SCCHN ) Tj ET Q q 0 0 0 rg BT 373.96 168.96 Td (after ) Tj ET Q q 0 0 0 rg BT 391.94 168.96 Td (platinum ) Tj ET Q q 0 0 0 rg BT 425.44 168.96 Td (therapy ) Tj ET Q q 0 0 0 rg BT 453.92 168.96 Td (compared ) Tj ET Q q 0 0 0 rg BT 490.90 168.96 Td (to ) Tj ET Q q 0 0 0 rg BT 499.40 168.96 Td (investigator's ) Tj ET Q q 0 0 0 rg BT 548.51 168.96 Td (choice ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 159.96 Td (of ) Tj ET Q q 0 0 0 rg BT 253.75 159.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 280.15 159.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.85 141.86 Td (July 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 145.96 Td (The ) Tj ET Q q 0 0 0 rg BT 261.20 145.96 Td (EMA) Tj ET Q q 0 0 0 rg BT 280.70 145.96 Td ( ) Tj ET Q q 0 0 0 rg BT 283.90 145.96 Td (validated ) Tj ET Q q 0 0 0 rg BT 320.09 145.96 Td (and ) Tj ET Q q 0 0 0 rg BT 336.29 145.96 Td (in ) Tj ET Q q 0 0 0 rg BT 346.50 145.96 Td (Japan ) Tj ET Q q 0 0 0 rg BT 370.19 145.96 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 397.53 145.96 Td (alliance ) Tj ET Q q 0 0 0 rg BT 428.72 145.96 Td (partner ) Tj ET Q q 0 0 0 rg BT 457.41 145.96 Td (Ono ) Tj ET Q q 0 0 0 rg BT 476.11 145.96 Td (submitted ) Tj ET Q q 0 0 0 rg BT 514.81 145.96 Td (applications ) Tj ET Q q 0 0 0 rg BT 561.51 145.96 Td (for ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 244.00 136.95 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 270.49 136.95 Td ( ) Tj ET Q q 0 0 0 rg BT 272.74 136.95 Td (for ) Tj ET Q q 0 0 0 rg BT 285.49 136.95 Td (patients ) Tj ET Q q 0 0 0 rg BT 315.73 136.95 Td (with ) Tj ET Q q 0 0 0 rg BT 333.98 136.95 Td (previously ) Tj ET Q q 0 0 0 rg BT 374.23 136.95 Td (treated ) Tj ET Q q 0 0 0 rg BT 400.96 136.95 Td (recurrent ) Tj ET Q q 0 0 0 rg BT 435.69 136.95 Td (or ) Tj ET Q q 0 0 0 rg BT 445.43 136.95 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 484.17 136.95 Td (SCCHN.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 190.85 109.86 Td (April 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 122.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 288.02 122.96 Td (data ) Tj ET Q q 0 0 0 rg BT 305.54 122.96 Td (from ) Tj ET Q q 0 0 0 rg BT 325.56 122.96 Td (CheckMate-141, ) Tj ET Q q 0 0 0 rg BT 388.32 122.96 Td (a ) Tj ET Q q 0 0 0 rg BT 394.85 122.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 418.37 122.96 Td (III ) Tj ET Q q 0 0 0 rg BT 429.89 122.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 446.92 122.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 486.93 122.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 513.42 122.96 Td ( ) Tj ET Q q 0 0 0 rg BT 515.95 122.96 Td (in ) Tj ET Q q 0 0 0 rg BT 525.48 122.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 556.01 122.96 Td (with ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 113.96 Td (recurrent ) Tj ET Q q 0 0 0 rg BT 278.75 113.96 Td (or ) Tj ET Q q 0 0 0 rg BT 288.52 113.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 327.27 113.96 Td (SCCHN ) Tj ET Q q 0 0 0 rg BT 359.55 113.96 Td (after ) Tj ET Q q 0 0 0 rg BT 378.31 113.96 Td (platinum ) Tj ET Q q 0 0 0 rg BT 412.58 113.96 Td (therapy ) Tj ET Q q 0 0 0 rg BT 441.84 113.96 Td (compared ) Tj ET Q q 0 0 0 rg BT 479.59 113.96 Td (to ) Tj ET Q q 0 0 0 rg BT 488.86 113.96 Td (investigator's ) Tj ET Q q 0 0 0 rg BT 538.75 113.96 Td (choice ) Tj ET Q q 0 0 0 rg BT 564.51 113.96 Td (of ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 104.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 270.40 104.96 Td (. ) Tj ET Q q 0 0 0 rg BT 275.50 104.96 Td (In ) Tj ET Q q 0 0 0 rg BT 285.84 104.96 Td (January ) Tj ET Q q 0 0 0 rg BT 316.68 104.96 Td (2016, ) Tj ET Q q 0 0 0 rg BT 339.78 104.96 Td (CheckMate-141 ) Tj ET Q q 0 0 0 rg BT 400.61 104.96 Td (was ) Tj ET Q q 0 0 0 rg BT 417.45 104.96 Td (stopped ) Tj ET Q q 0 0 0 rg BT 448.30 104.96 Td (early ) Tj ET Q q 0 0 0 rg BT 469.13 104.96 Td (due ) Tj ET Q q 0 0 0 rg BT 484.97 104.96 Td (to ) Tj ET Q q 0 0 0 rg BT 494.82 104.96 Td (the ) Tj ET Q q 0 0 0 rg BT 508.67 104.96 Td (DMC ) Tj ET Q q 0 0 0 rg BT 532.02 104.96 Td (concluding ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 95.96 Td (that ) Tj ET Q q 0 0 0 rg BT 259.75 95.96 Td (the ) Tj ET Q q 0 0 0 rg BT 272.99 95.96 Td (study ) Tj ET Q q 0 0 0 rg BT 294.74 95.96 Td (met ) Tj ET Q q 0 0 0 rg BT 310.49 95.96 Td (its ) Tj ET Q q 0 0 0 rg BT 321.24 95.96 Td (primary ) Tj ET Q q 0 0 0 rg BT 351.98 95.96 Td (endpoint.) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 101 0 obj <> endobj 102 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (50) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 755.5 m 35.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 755.5 m 98.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 741.5 m 98.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 755.5 m 98.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 755.5 m 180.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 741.5 m 180.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 755.5 m 180.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 755.5 m 241.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 741.5 m 241.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 755.5 m 241.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 755.5 m 575.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 755.5 m 575.5 755.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 741.5 m 575.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 741.5 m 35.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 741.5 m 98.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 741.5 m 98.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 741.5 m 180.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 741.5 m 180.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 709.5 m 180.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 741.5 m 241.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 741.5 m 241.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 741.5 m 575.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 741.5 m 575.5 741.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 709.5 m 35.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 709.5 m 98.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 709.5 m 180.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 709.5 m 180.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 709.5 m 241.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 709.5 m 241.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 709.5 m 575.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 709.5 m 575.5 709.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 677.5 m 35.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 677.5 m 98.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 677.5 m 180.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 677.5 m 241.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 677.5 m 241.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 677.5 m 575.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 677.5 m 575.5 677.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 653.5 m 35.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 653.5 m 98.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 653.5 m 180.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 653.5 m 241.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 653.5 m 241.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 653.5 m 575.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 653.5 m 575.5 653.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 630.5 m 35.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 630.5 m 98.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 630.5 m 180.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 607.5 m 180.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 630.5 m 241.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 607.5 m 241.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 630.5 m 241.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 630.5 m 575.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 630.5 m 575.5 630.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 607.5 m 575.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 607.5 m 35.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 607.5 m 98.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 607.5 m 180.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 607.5 m 180.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 607.5 m 241.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 607.5 m 241.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 607.5 m 575.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 607.5 m 575.5 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 575.5 m 35.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 575.5 m 98.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 575.5 m 180.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 575.5 m 180.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 543.5 m 180.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 575.5 m 241.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 575.5 m 241.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 575.5 m 575.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 575.5 m 575.5 575.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 543.5 m 35.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 543.5 m 98.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 543.5 m 180.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 511.5 m 180.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 543.5 m 241.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 543.5 m 241.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 543.5 m 575.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 543.5 m 575.5 543.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 511.5 m 35.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 511.5 m 98.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 488.5 m 98.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 511.5 m 98.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 511.5 m 180.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 488.5 m 180.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 511.5 m 241.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 511.5 m 241.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 511.5 m 575.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 511.5 m 575.5 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 478.5 m 98.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 478.5 m 180.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 488.5 m 241.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 488.5 m 575.5 488.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 478.5 m 35.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 478.5 m 98.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 478.5 m 98.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 478.5 m 180.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 478.5 m 180.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 478.5 m 241.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 478.5 m 241.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 478.5 m 575.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 478.5 m 575.5 478.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 455.5 m 35.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 432.5 m 98.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 455.5 m 98.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 455.5 m 180.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 432.5 m 180.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 455.5 m 241.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 432.5 m 241.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 455.5 m 241.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 455.5 m 575.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 455.5 m 575.5 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 432.5 m 575.5 432.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 422.5 m 35.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 422.5 m 98.5 422.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 399.5 m 98.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 422.5 m 98.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 422.5 m 180.5 422.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 399.5 m 180.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 422.5 m 180.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 422.5 m 241.5 422.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 399.5 m 241.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 422.5 m 241.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 422.5 m 575.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 422.5 m 575.5 422.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 399.5 m 575.5 399.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 389.5 m 35.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 389.5 m 98.5 389.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 389.5 m 98.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 389.5 m 180.5 389.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 389.5 m 180.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 389.5 m 241.5 389.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 389.5 m 241.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 389.5 m 575.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 389.5 m 575.5 389.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 366.5 m 35.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 366.5 m 98.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 366.5 m 180.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 366.5 m 241.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 366.5 m 241.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 366.5 m 575.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 366.5 m 575.5 366.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 343.5 m 35.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 311.5 m 98.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 343.5 m 98.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 311.5 m 180.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 343.5 m 180.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 343.5 m 241.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 311.5 m 241.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 343.5 m 241.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 343.5 m 575.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 343.5 m 575.5 343.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 311.5 m 575.5 311.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 301.5 m 35.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 301.5 m 98.5 301.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 301.5 m 98.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 301.5 m 180.5 301.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 301.5 m 180.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 301.5 m 241.5 301.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 301.5 m 241.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 301.5 m 575.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 301.5 m 575.5 301.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 279.5 m 575.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 279.5 m 35.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 279.5 m 98.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 279.5 m 180.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 279.5 m 241.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 279.5 m 241.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 279.5 m 575.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 279.5 m 575.5 279.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 256.5 m 35.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 256.5 m 98.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 256.5 m 180.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 256.5 m 241.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 256.5 m 241.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 256.5 m 575.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 256.5 m 575.5 256.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 233.5 m 35.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 210.5 m 98.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 233.5 m 98.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 210.5 m 180.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 233.5 m 180.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 233.5 m 241.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 210.5 m 241.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 233.5 m 241.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 233.5 m 575.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 233.5 m 575.5 233.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 210.5 m 575.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 210.5 m 98.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 200.5 m 98.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 210.5 m 180.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 200.5 m 180.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 210.5 m 241.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 200.5 m 241.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 210.5 m 575.5 210.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 200.5 m 575.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 200.5 m 35.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 200.5 m 98.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 177.5 m 98.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 200.5 m 98.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 200.5 m 180.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 98.5 177.5 m 180.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 200.5 m 180.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 200.5 m 241.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 180.5 177.5 m 241.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 200.5 m 241.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 575.5 200.5 m 575.5 177.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 200.5 m 575.5 200.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 241.5 177.5 m 575.5 177.5 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 49.35 746.18 Td (Product) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 117.00 746.18 Td (Indication) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 200.50 746.18 Td (Date) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 378.00 746.18 Td (Developments) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 38.40 612.95 Td (Opdivo+Yervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 107.35 723.36 Td (Colorectal cancer) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 723.36 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 731.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.68 731.96 Td (data ) Tj ET Q q 0 0 0 rg BT 308.87 731.96 Td (from ) Tj ET Q q 0 0 0 rg BT 330.56 731.96 Td (CheckMate-142, ) Tj ET Q q 0 0 0 rg BT 394.99 731.96 Td (a ) Tj ET Q q 0 0 0 rg BT 403.18 731.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 428.37 731.96 Td (II ) Tj ET Q q 0 0 0 rg BT 438.56 731.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 457.25 731.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 498.93 731.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 525.43 731.96 Td ( ) Tj ET Q q 0 0 0 rg BT 529.62 731.96 Td (alone ) Tj ET Q q 0 0 0 rg BT 553.31 731.96 Td (or ) Tj ET Q q 0 0 0 rg BT 565.00 731.96 Td (in ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 722.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 292.20 722.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 311.40 722.96 Td (Y) Tj ET Q q 0 0 0 rg BT 315.58 722.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 335.57 722.96 Td ( ) Tj ET Q q 0 0 0 rg BT 338.77 722.96 Td (in ) Tj ET Q q 0 0 0 rg BT 348.98 722.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 380.17 722.96 Td (with ) Tj ET Q q 0 0 0 rg BT 399.38 722.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 440.58 722.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 468.27 722.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 507.95 722.96 Td (colorectal ) Tj ET Q q 0 0 0 rg BT 546.63 722.96 Td (cancer) Tj ET Q q 0 0 0 rg BT 569.75 722.96 Td (, ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 713.96 Td (including ) Tj ET Q q 0 0 0 rg BT 280.25 713.96 Td (those ) Tj ET Q q 0 0 0 rg BT 301.49 713.96 Td (with ) Tj ET Q q 0 0 0 rg BT 319.74 713.96 Td (MSI-H.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 119.75 656.36 Td (Melanoma) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 691.36 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 699.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 287.70 699.96 Td (results ) Tj ET Q q 0 0 0 rg BT 313.42 699.96 Td (from ) Tj ET Q q 0 0 0 rg BT 333.13 699.96 Td (two ) Tj ET Q q 0 0 0 rg BT 348.84 699.96 Td (trials ) Tj ET Q q 0 0 0 rg BT 369.06 699.96 Td (\(CheckMate-067 ) Tj ET Q q 0 0 0 rg BT 432.25 699.96 Td (- ) Tj ET Q q 0 0 0 rg BT 437.46 699.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 460.68 699.96 Td (III; ) Tj ET Q q 0 0 0 rg BT 474.38 699.96 Td (CheckMate-069 ) Tj ET Q q 0 0 0 rg BT 534.58 699.96 Td (- ) Tj ET Q q 0 0 0 rg BT 539.79 699.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 563.01 699.96 Td (II\) ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 690.96 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 285.97 690.96 Td (the ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 301.44 690.96 Td (Opdivo+Y) Tj ET Q q 0 0 0 rg BT 338.19 690.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 358.18 690.96 Td ( ) Tj ET Q q 0 0 0 rg BT 362.66 690.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 412.13 690.96 Td (regimen ) Tj ET Q q 0 0 0 rg BT 446.10 690.96 Td (in ) Tj ET Q q 0 0 0 rg BT 457.58 690.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 500.06 690.96 Td (untreated ) Tj ET Q q 0 0 0 rg BT 538.02 690.96 Td (advanced ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 681.96 Td (melanoma.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 663.36 Td (May 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 668.76 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.66 668.76 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.30 668.76 Td (for ) Tj ET Q q 0 0 0 rg BT 303.95 668.76 Td (the ) Tj ET Q q 0 0 0 rg BT 317.10 668.76 Td (treatment ) Tj ET Q q 0 0 0 rg BT 353.24 668.76 Td (of ) Tj ET Q q 0 0 0 rg BT 362.89 668.76 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 410.02 668.76 Td (or ) Tj ET Q q 0 0 0 rg BT 419.67 668.76 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 458.31 668.76 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 500.20 668.76 Td (regardless ) Tj ET Q q 0 0 0 rg BT 538.84 668.76 Td (of ) Tj ET Q q 0 0 0 rg BT 548.50 668.76 Td (BRAF ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 659.76 Td (mutational ) Tj ET Q q 0 0 0 rg BT 284.74 659.76 Td (status.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 190.85 639.86 Td (April 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 643.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 290.72 643.96 Td (data ) Tj ET Q q 0 0 0 rg BT 310.94 643.96 Td (from ) Tj ET Q q 0 0 0 rg BT 333.67 643.96 Td (CheckMate-069, ) Tj ET Q q 0 0 0 rg BT 399.14 643.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 425.37 643.96 Td (II ) Tj ET Q q 0 0 0 rg BT 436.59 643.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 456.32 643.96 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 499.04 643.96 Td (the ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 515.27 643.96 Td (Opdivo+Y) Tj ET Q q 0 0 0 rg BT 552.01 643.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 572.00 643.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 634.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 291.24 634.96 Td (regimen ) Tj ET Q q 0 0 0 rg BT 322.98 634.96 Td (in ) Tj ET Q q 0 0 0 rg BT 332.23 634.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 372.47 634.96 Td (untreated ) Tj ET Q q 0 0 0 rg BT 408.21 634.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 444.43 634.96 Td (melanoma.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 186.35 616.86 Td (January 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 620.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.76 620.96 Td ( ) Tj ET Q q 0 0 0 rg BT 265.20 620.96 Td (expanded ) Tj ET Q q 0 0 0 rg BT 303.38 620.96 Td (use ) Tj ET Q q 0 0 0 rg BT 319.06 620.96 Td (for ) Tj ET Q q 0 0 0 rg BT 333.25 620.96 Td (the ) Tj ET Q q 0 0 0 rg BT 347.94 620.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 385.61 620.96 Td (of ) Tj ET Q q 0 0 0 rg BT 396.80 620.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 438.49 620.96 Td (untreated ) Tj ET Q q 0 0 0 rg BT 475.66 620.96 Td (unresectable ) Tj ET Q q 0 0 0 rg BT 524.33 620.96 Td (or ) Tj ET Q q 0 0 0 rg BT 535.52 620.96 Td (metastatic ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 611.96 Td (melanoma, ) Tj ET Q q 0 0 0 rg BT 285.99 611.96 Td (regardless ) Tj ET Q q 0 0 0 rg BT 324.72 611.96 Td (of ) Tj ET Q q 0 0 0 rg BT 334.47 611.96 Td (BRAF ) Tj ET Q q 0 0 0 rg BT 360.23 611.96 Td (mutational ) Tj ET Q q 0 0 0 rg BT 400.97 611.96 Td (status.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 129.20 589.36 Td (mUC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.50 593.86 Td (November) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 584.86 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 597.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.32 597.96 Td (additional ) Tj ET Q q 0 0 0 rg BT 329.15 597.96 Td (results ) Tj ET Q q 0 0 0 rg BT 356.48 597.96 Td (from ) Tj ET Q q 0 0 0 rg BT 377.80 597.96 Td (CheckMate-032, ) Tj ET Q q 0 0 0 rg BT 441.87 597.96 Td (a ) Tj ET Q q 0 0 0 rg BT 449.69 597.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 474.52 597.96 Td (I/II ) Tj ET Q q 0 0 0 rg BT 489.85 597.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 508.17 597.96 Td (investigating ) Tj ET Q q 0 0 0 rg BT 558.50 597.96 Td (two ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 588.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 293.82 588.96 Td (schedules ) Tj ET Q q 0 0 0 rg BT 333.65 588.96 Td (of ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 345.98 588.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 372.47 588.96 Td (+) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 377.55 588.96 Td (Y) Tj ET Q q 0 0 0 rg BT 381.72 588.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 401.71 588.96 Td ( ) Tj ET Q q 0 0 0 rg BT 406.54 588.96 Td (in ) Tj ET Q q 0 0 0 rg BT 418.38 588.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 451.20 588.96 Td (with ) Tj ET Q q 0 0 0 rg BT 472.04 588.96 Td (locally ) Tj ET Q q 0 0 0 rg BT 501.36 588.96 Td (advanced ) Tj ET Q q 0 0 0 rg BT 540.17 588.96 Td (or ) Tj ET Q q 0 0 0 rg BT 552.50 588.96 Td (mUC ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 579.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 284.25 579.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 310.98 579.96 Td (with ) Tj ET Q q 0 0 0 rg BT 329.23 579.96 Td (platinum-based ) Tj ET Q q 0 0 0 rg BT 386.96 579.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 413.37 579.96 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 124.45 557.36 Td (NSCLC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 561.86 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 552.86 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 565.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.47 565.96 Td (updated ) Tj ET Q q 0 0 0 rg BT 321.95 565.96 Td (findings ) Tj ET Q q 0 0 0 rg BT 355.43 565.96 Td (from ) Tj ET Q q 0 0 0 rg BT 376.91 565.96 Td (CheckMate-012, ) Tj ET Q q 0 0 0 rg BT 441.12 565.96 Td (a ) Tj ET Q q 0 0 0 rg BT 449.10 565.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 474.08 565.96 Td (Ib ) Tj ET Q q 0 0 0 rg BT 485.56 565.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 504.04 565.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 545.51 565.96 Td (Opdivo ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 556.96 Td (monotherapy ) Tj ET Q q 0 0 0 rg BT 293.73 556.96 Td (or ) Tj ET Q q 0 0 0 rg BT 303.47 556.96 Td (in ) Tj ET Q q 0 0 0 rg BT 312.71 556.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 359.94 556.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 378.19 556.96 Td (Y) Tj ET Q q 0 0 0 rg BT 382.37 556.96 Td (ervoy ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 404.60 556.96 Td (in ) Tj ET Q q 0 0 0 rg BT 413.84 556.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 444.07 556.96 Td (with ) Tj ET Q q 0 0 0 rg BT 462.32 556.96 Td (chemotherapy-naïve ) Tj ET Q q 0 0 0 rg BT 538.02 556.96 Td (advanced ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 547.96 Td (NSCLC. ) Tj ET Q q 0 0 0 rg BT 277.51 547.96 Td (Data ) Tj ET Q q 0 0 0 rg BT 296.75 547.96 Td (was ) Tj ET Q q 0 0 0 rg BT 312.99 547.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 353.24 547.96 Td (announced ) Tj ET Q q 0 0 0 rg BT 394.47 547.96 Td (in ) Tj ET Q q 0 0 0 rg BT 403.72 547.96 Td (June ) Tj ET Q q 0 0 0 rg BT 422.47 547.96 Td (2016.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 129.95 525.36 Td (RCC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 525.36 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 533.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 288.51 533.96 Td (updated ) Tj ET Q q 0 0 0 rg BT 320.03 533.96 Td (results ) Tj ET Q q 0 0 0 rg BT 346.55 533.96 Td (from ) Tj ET Q q 0 0 0 rg BT 367.07 533.96 Td (CheckMate-016, ) Tj ET Q q 0 0 0 rg BT 430.32 533.96 Td (a ) Tj ET Q q 0 0 0 rg BT 437.34 533.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 461.36 533.96 Td (I ) Tj ET Q q 0 0 0 rg BT 467.39 533.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 484.90 533.96 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 525.41 533.96 Td (the ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 539.43 533.96 Td (Opdivo+ ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 244.00 524.95 Td (Y) Tj ET Q q 0 0 0 rg BT 248.18 524.95 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 268.17 524.95 Td ( ) Tj ET Q q 0 0 0 rg BT 273.32 524.95 Td (combination ) Tj ET Q q 0 0 0 rg BT 323.47 524.95 Td (regimen ) Tj ET Q q 0 0 0 rg BT 358.12 524.95 Td (in ) Tj ET Q q 0 0 0 rg BT 370.28 524.95 Td (previously ) Tj ET Q q 0 0 0 rg BT 413.43 524.95 Td (treated ) Tj ET Q q 0 0 0 rg BT 443.07 524.95 Td (and ) Tj ET Q q 0 0 0 rg BT 461.22 524.95 Td (treatment-naïve ) Tj ET Q q 0 0 0 rg BT 522.85 524.95 Td (patients ) Tj ET Q q 0 0 0 rg BT 556.00 524.95 Td (with ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 515.96 Td (metastatic ) Tj ET Q q 0 0 0 rg BT 282.73 515.96 Td (RCC.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 127.70 497.86 Td (SCLC) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 502.36 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 493.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 501.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.72 501.96 Td (updated ) Tj ET Q q 0 0 0 rg BT 322.45 501.96 Td (results ) Tj ET Q q 0 0 0 rg BT 350.18 501.96 Td (from ) Tj ET Q q 0 0 0 rg BT 371.91 501.96 Td (CheckMate-032, ) Tj ET Q q 0 0 0 rg BT 436.38 501.96 Td (a ) Tj ET Q q 0 0 0 rg BT 444.61 501.96 Td (phase ) Tj ET Q q 0 0 0 rg BT 469.33 501.96 Td (I/II ) Tj ET Q q 0 0 0 rg BT 485.06 501.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 503.79 501.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 545.51 501.96 Td (Opdivo) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 572.00 501.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 492.96 Td (monotherapy ) Tj ET Q q 0 0 0 rg BT 293.74 492.96 Td (and ) Tj ET Q q 0 0 0 rg BT 308.98 492.96 Td (in ) Tj ET Q q 0 0 0 rg BT 318.23 492.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 365.47 492.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 383.72 492.96 Td (Y) Tj ET Q q 0 0 0 rg BT 387.90 492.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 407.89 492.96 Td ( ) Tj ET Q q 0 0 0 rg BT 410.14 492.96 Td (in ) Tj ET Q q 0 0 0 rg BT 419.39 492.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 459.64 492.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 486.37 492.96 Td (SCLC ) Tj ET Q q 0 0 0 rg BT 511.13 492.96 Td (patients.) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 49.45 453.45 Td (Empliciti) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 105.10 453.36 Td (Multiple Myeloma) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.25 469.36 Td (September) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 460.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 468.96 Td (JMHL) Tj ET Q q 0 0 0 rg BT 266.83 468.96 Td (W) Tj ET Q q 0 0 0 rg BT 275.17 468.96 Td ( ) Tj ET Q q 0 0 0 rg BT 282.53 468.96 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 342.37 468.96 Td (and ) Tj ET Q q 0 0 0 rg BT 362.73 468.96 Td (marketing ) Tj ET Q q 0 0 0 rg BT 406.58 468.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 445.43 468.96 Td (in ) Tj ET Q q 0 0 0 rg BT 459.79 468.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 512.15 468.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 535.51 468.96 Td (Revlimid* ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 459.96 Td (\(lenalidomide\) ) Tj ET Q q 0 0 0 rg BT 299.23 459.96 Td (and ) Tj ET Q q 0 0 0 rg BT 314.48 459.96 Td (dexamethasone ) Tj ET Q q 0 0 0 rg BT 372.20 459.96 Td (for ) Tj ET Q q 0 0 0 rg BT 384.95 459.96 Td (the ) Tj ET Q q 0 0 0 rg BT 398.19 459.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 434.42 459.96 Td (of ) Tj ET Q q 0 0 0 rg BT 444.17 459.96 Td (multiple ) Tj ET Q q 0 0 0 rg BT 476.42 459.96 Td (myeloma.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 441.86 Td (May 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 445.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.72 445.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.42 445.96 Td (for ) Tj ET Q q 0 0 0 rg BT 304.13 445.96 Td (the ) Tj ET Q q 0 0 0 rg BT 317.34 445.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 353.54 445.96 Td (of ) Tj ET Q q 0 0 0 rg BT 363.25 445.96 Td (multiple ) Tj ET Q q 0 0 0 rg BT 395.46 445.96 Td (myeloma ) Tj ET Q q 0 0 0 rg BT 431.17 445.96 Td (as ) Tj ET Q q 0 0 0 rg BT 440.88 445.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 488.09 445.96 Td (therapy ) Tj ET Q q 0 0 0 rg BT 517.29 445.96 Td (with ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 535.51 445.96 Td (Revlimid*) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 572.00 445.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 436.96 Td (and ) Tj ET Q q 0 0 0 rg BT 259.24 436.96 Td (dexamethasone ) Tj ET Q q 0 0 0 rg BT 316.97 436.96 Td (in ) Tj ET Q q 0 0 0 rg BT 326.22 436.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 356.46 436.96 Td (who ) Tj ET Q q 0 0 0 rg BT 374.21 436.96 Td (have ) Tj ET Q q 0 0 0 rg BT 393.45 436.96 Td (received ) Tj ET Q q 0 0 0 rg BT 426.18 436.96 Td (at ) Tj ET Q q 0 0 0 rg BT 434.92 436.96 Td (least ) Tj ET Q q 0 0 0 rg BT 453.67 436.96 Td (one ) Tj ET Q q 0 0 0 rg BT 468.91 436.96 Td (prior ) Tj ET Q q 0 0 0 rg BT 488.66 436.96 Td (therapy) Tj ET Q q 0 0 0 rg BT 515.06 436.96 Td (.) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 54.25 408.95 Td (Yervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 119.75 408.86 Td (Melanoma) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 185.85 408.86 Td (October 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 412.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.31 412.96 Td (new ) Tj ET Q q 0 0 0 rg BT 308.12 412.96 Td (data ) Tj ET Q q 0 0 0 rg BT 326.94 412.96 Td (from ) Tj ET Q q 0 0 0 rg BT 348.25 412.96 Td (CA184-029, ) Tj ET Q q 0 0 0 rg BT 396.82 412.96 Td (a ) Tj ET Q q 0 0 0 rg BT 404.64 412.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 429.45 412.96 Td (III ) Tj ET Q q 0 0 0 rg BT 442.27 412.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 460.58 412.96 Td (evaluating ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 501.89 412.96 Td (Y) Tj ET Q q 0 0 0 rg BT 506.07 412.96 Td (ervoy) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 526.05 412.96 Td ( ) Tj ET Q q 0 0 0 rg BT 529.87 412.96 Td (in ) Tj ET Q q 0 0 0 rg BT 540.69 412.96 Td (stage ) Tj ET Q q 0 0 0 rg BT 563.01 412.96 Td (III ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 403.96 Td (melanoma ) Tj ET Q q 0 0 0 rg BT 283.45 403.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 313.40 403.96 Td (who ) Tj ET Q q 0 0 0 rg BT 330.86 403.96 Td (are ) Tj ET Q q 0 0 0 rg BT 343.81 403.96 Td (at ) Tj ET Q q 0 0 0 rg BT 352.26 403.96 Td (high ) Tj ET Q q 0 0 0 rg BT 370.23 403.96 Td (risk ) Tj ET Q q 0 0 0 rg BT 385.69 403.96 Td (of ) Tj ET Q q 0 0 0 rg BT 395.14 403.96 Td (recurrence ) Tj ET Q q 0 0 0 rg BT 435.07 403.96 Td (following ) Tj ET Q q 0 0 0 rg BT 472.03 403.96 Td (complete ) Tj ET Q q 0 0 0 rg BT 506.98 403.96 Td (sur) Tj ET Q q 0 0 0 rg BT 517.81 403.96 Td (gical ) Tj ET Q q 0 0 0 rg BT 537.26 403.96 Td (resection.) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 51.50 348.45 Td (Orencia) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 132.95 348.36 Td (RA) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 191.25 380.36 Td (September) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 371.36 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 379.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 258.20 379.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 292.39 379.96 Td (in ) Tj ET Q q 0 0 0 rg BT 302.09 379.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 349.78 379.96 Td (with ) Tj ET Q q 0 0 0 rg BT 368.48 379.96 Td (MTX ) Tj ET Q q 0 0 0 rg BT 391.17 379.96 Td (for ) Tj ET Q q 0 0 0 rg BT 404.37 379.96 Td (the ) Tj ET Q q 0 0 0 rg BT 418.06 379.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 454.74 379.96 Td (of ) Tj ET Q q 0 0 0 rg BT 464.94 379.96 Td (highly ) Tj ET Q q 0 0 0 rg BT 490.64 379.96 Td (active ) Tj ET Q q 0 0 0 rg BT 514.82 379.96 Td (and ) Tj ET Q q 0 0 0 rg BT 530.52 379.96 Td (progressive ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 370.96 Td (disease ) Tj ET Q q 0 0 0 rg BT 272.24 370.96 Td (in ) Tj ET Q q 0 0 0 rg BT 281.49 370.96 Td (adult ) Tj ET Q q 0 0 0 rg BT 301.74 370.96 Td (patients ) Tj ET Q q 0 0 0 rg BT 331.98 370.96 Td (with ) Tj ET Q q 0 0 0 rg BT 350.23 370.96 Td (RA) Tj ET Q q 0 0 0 rg BT 362.48 370.96 Td ( ) Tj ET Q q 0 0 0 rg BT 364.48 370.96 Td (not ) Tj ET Q q 0 0 0 rg BT 378.24 370.96 Td (previously ) Tj ET Q q 0 0 0 rg BT 418.48 370.96 Td (treated ) Tj ET Q q 0 0 0 rg BT 445.21 370.96 Td (with ) Tj ET Q q 0 0 0 rg BT 463.46 370.96 Td (MTX.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.85 352.86 Td (July 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 356.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.71 356.96 Td (the ) Tj ET Q q 0 0 0 rg BT 304.94 356.96 Td (commercial ) Tj ET Q q 0 0 0 rg BT 351.64 356.96 Td (launch ) Tj ET Q q 0 0 0 rg BT 379.85 356.96 Td (of ) Tj ET Q q 0 0 0 rg BT 391.58 356.96 Td (the ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 406.80 356.96 Td (Or) Tj ET Q q 0 0 0 rg BT 416.46 356.96 Td (encia) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 435.95 356.96 Td ( ) Tj ET Q q 0 0 0 rg BT 440.18 356.96 Td (ClickJect ) Tj ET Q q 0 0 0 rg BT 476.96 356.96 Td (Autoinjector) Tj ET Q q 0 0 0 rg BT 522.09 356.96 Td (, ) Tj ET Q q 0 0 0 rg BT 528.57 356.96 Td (a ) Tj ET Q q 0 0 0 rg BT 536.79 356.96 Td (new ) Tj ET Q q 0 0 0 rg BT 556.01 356.96 Td (self-) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 347.96 Td (administered ) Tj ET Q q 0 0 0 rg BT 292.74 347.96 Td (autoinjector ) Tj ET Q q 0 0 0 rg BT 337.97 347.96 Td (for ) Tj ET Q q 0 0 0 rg BT 350.71 347.96 Td (adults ) Tj ET Q q 0 0 0 rg BT 374.46 347.96 Td (with ) Tj ET Q q 0 0 0 rg BT 392.71 347.96 Td (moderate ) Tj ET Q q 0 0 0 rg BT 428.44 347.96 Td (to ) Tj ET Q q 0 0 0 rg BT 437.69 347.96 Td (severe ) Tj ET Q q 0 0 0 rg BT 462.93 347.96 Td (RA.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 325.36 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 333.96 Td (Presented ) Tj ET Q q 0 0 0 rg BT 281.20 333.96 Td (findings ) Tj ET Q q 0 0 0 rg BT 312.92 333.96 Td (from ) Tj ET Q q 0 0 0 rg BT 332.63 333.96 Td (the ) Tj ET Q q 0 0 0 rg BT 345.83 333.96 Td (first ) Tj ET Q q 0 0 0 rg BT 362.55 333.96 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 380.77 333.96 Td (observational ) Tj ET Q q 0 0 0 rg BT 431.46 333.96 Td (study ) Tj ET Q q 0 0 0 rg BT 453.18 333.96 Td (exploring ) Tj ET Q q 0 0 0 rg BT 489.89 333.96 Td (moderate ) Tj ET Q q 0 0 0 rg BT 525.58 333.96 Td (to ) Tj ET Q q 0 0 0 rg BT 534.80 333.96 Td (severe ) Tj ET Q q 0 0 0 rg BT 559.99 333.96 Td (RA) Tj ET Q q 0 0 0 rg BT 572.00 333.96 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 324.96 Td (patients' ) Tj ET Q q 0 0 0 rg BT 276.80 324.96 Td (response ) Tj ET Q q 0 0 0 rg BT 311.48 324.96 Td (to ) Tj ET Q q 0 0 0 rg BT 321.67 324.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 358.85 324.96 Td (based ) Tj ET Q q 0 0 0 rg BT 382.53 324.96 Td (on ) Tj ET Q q 0 0 0 rg BT 394.72 324.96 Td (their ) Tj ET Q q 0 0 0 rg BT 414.40 324.96 Td (baseline ) Tj ET Q q 0 0 0 rg BT 447.08 324.96 Td (status ) Tj ET Q q 0 0 0 rg BT 470.77 324.96 Td (for ) Tj ET Q q 0 0 0 rg BT 484.45 324.96 Td (two ) Tj ET Q q 0 0 0 rg BT 501.14 324.96 Td (biomarkers ) Tj ET Q q 0 0 0 rg BT 544.82 324.96 Td (of ) Tj ET Q q 0 0 0 rg BT 555.50 324.96 Td (poor ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 315.96 Td (prognosis, ) Tj ET Q q 0 0 0 rg BT 283.50 315.96 Td (anti-CCP) Tj ET Q q 0 0 0 rg BT 316.67 315.96 Td ( ) Tj ET Q q 0 0 0 rg BT 318.92 315.96 Td (and ) Tj ET Q q 0 0 0 rg BT 334.17 315.96 Td (RF) Tj ET Q q 0 0 0 rg BT 344.45 315.96 Td (.) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 45.60 258.45 Td (Hepatitis C) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 50.00 249.45 Td (Portfolio) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 129.55 253.86 Td (HCV) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.00 292.76 Td (December) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 201.50 283.76 Td (2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 292.76 Td (JMHL) Tj ET Q q 0 0 0 rg BT 266.83 292.76 Td (W) Tj ET Q q 0 0 0 rg BT 275.17 292.76 Td ( ) Tj ET Q q 0 0 0 rg BT 279.38 292.76 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 336.07 292.76 Td (and ) Tj ET Q q 0 0 0 rg BT 353.28 292.76 Td (marketing ) Tj ET Q q 0 0 0 rg BT 393.99 292.76 Td (approval ) Tj ET Q q 0 0 0 rg BT 429.69 292.76 Td (of ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 441.40 292.76 Td (Ximency) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 472.38 292.76 Td ( ) Tj ET Q q 0 0 0 rg BT 476.59 292.76 Td (combination ) Tj ET Q q 0 0 0 rg BT 525.80 292.76 Td (tablet ) Tj ET Q q 0 0 0 rg BT 550.00 292.76 Td (which ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 283.76 Td (contains ) Tj ET Q q 0 0 0 rg BT 276.24 283.76 Td (daclatasvir) Tj ET Q q 0 0 0 rg BT 314.86 283.76 Td (, ) Tj ET Q q 0 0 0 rg BT 319.36 283.76 Td (asunaprevir ) Tj ET Q q 0 0 0 rg BT 363.59 283.76 Td (and ) Tj ET Q q 0 0 0 rg BT 378.84 283.76 Td (beclabuvir ) Tj ET Q q 0 0 0 rg BT 419.07 283.76 Td (for ) Tj ET Q q 0 0 0 rg BT 431.81 283.76 Td (the ) Tj ET Q q 0 0 0 rg BT 445.06 283.76 Td (treatment ) Tj ET Q q 0 0 0 rg BT 481.29 283.76 Td (of ) Tj ET Q q 0 0 0 rg BT 491.04 283.76 Td (HCV) Tj ET Q q 0 0 0 rg BT 509.88 283.76 Td ( ) Tj ET Q q 0 0 0 rg BT 512.13 283.76 Td (in ) Tj ET Q q 0 0 0 rg BT 521.38 283.76 Td (genotype ) Tj ET Q q 0 0 0 rg BT 556.62 283.76 Td (1.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 184.10 265.86 Td (February 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 269.96 Td (FDA) Tj ET Q q 0 0 0 rg BT 261.51 269.96 Td ( ) Tj ET Q q 0 0 0 rg BT 264.85 269.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 299.67 269.96 Td (of ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 310.51 269.96 Td (Daklinza) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 343.00 269.96 Td ( ) Tj ET Q q 0 0 0 rg BT 346.34 269.96 Td (for ) Tj ET Q q 0 0 0 rg BT 360.17 269.96 Td (use ) Tj ET Q q 0 0 0 rg BT 375.51 269.96 Td (with ) Tj ET Q q 0 0 0 rg BT 394.85 269.96 Td (sofosbuvir ) Tj ET Q q 0 0 0 rg BT 436.18 269.96 Td (for ) Tj ET Q q 0 0 0 rg BT 450.02 269.96 Td (the ) Tj ET Q q 0 0 0 rg BT 464.35 269.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 501.67 269.96 Td (of ) Tj ET Q q 0 0 0 rg BT 512.50 269.96 Td (chronic ) Tj ET Q q 0 0 0 rg BT 542.83 269.96 Td (HCV) Tj ET Q q 0 0 0 rg BT 561.67 269.96 Td ( ) Tj ET Q q 0 0 0 rg BT 565.01 269.96 Td (in ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 260.96 Td (genotypes ) Tj ET Q q 0 0 0 rg BT 282.74 260.96 Td (1 ) Tj ET Q q 0 0 0 rg BT 289.49 260.96 Td (and ) Tj ET Q q 0 0 0 rg BT 304.74 260.96 Td (3 ) Tj ET Q q 0 0 0 rg BT 311.49 260.96 Td (in ) Tj ET Q q 0 0 0 rg BT 320.74 260.96 Td (three ) Tj ET Q q 0 0 0 rg BT 340.97 260.96 Td (additional ) Tj ET Q q 0 0 0 rg BT 379.22 260.96 Td (patient ) Tj ET Q q 0 0 0 rg BT 405.96 260.96 Td (populations.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 184.10 242.86 Td (February 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 246.96 Td (Announced ) Tj ET Q q 0 0 0 rg BT 289.01 246.96 Td (results ) Tj ET Q q 0 0 0 rg BT 316.03 246.96 Td (from ) Tj ET Q q 0 0 0 rg BT 337.05 246.96 Td (the ) Tj ET Q q 0 0 0 rg BT 351.57 246.96 Td (first ) Tj ET Q q 0 0 0 rg BT 369.59 246.96 Td (completed ) Tj ET Q q 0 0 0 rg BT 410.59 246.96 Td (all-oral ) Tj ET Q q 0 0 0 rg BT 440.10 246.96 Td (chronic ) Tj ET Q q 0 0 0 rg BT 470.61 246.96 Td (HCV) Tj ET Q q 0 0 0 rg BT 489.45 246.96 Td ( ) Tj ET Q q 0 0 0 rg BT 492.97 246.96 Td (regimen ) Tj ET Q q 0 0 0 rg BT 525.98 246.96 Td (\() Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 528.98 246.96 Td (Daklinza) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 561.48 246.96 Td ( ) Tj ET Q q 0 0 0 rg BT 565.00 246.96 Td (in ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 237.96 Td (combination ) Tj ET Q q 0 0 0 rg BT 291.24 237.96 Td (with ) Tj ET Q q 0 0 0 rg BT 309.49 237.96 Td (asunaprevir\) ) Tj ET Q q 0 0 0 rg BT 356.72 237.96 Td (Phase ) Tj ET Q q 0 0 0 rg BT 379.97 237.96 Td (III ) Tj ET Q q 0 0 0 rg BT 391.21 237.96 Td (trial ) Tj ET Q q 0 0 0 rg BT 407.95 237.96 Td (that ) Tj ET Q q 0 0 0 rg BT 423.70 237.96 Td (includes ) Tj ET Q q 0 0 0 rg BT 455.94 237.96 Td (a ) Tj ET Q q 0 0 0 rg BT 462.18 237.96 Td (Chinese ) Tj ET Q q 0 0 0 rg BT 493.43 237.96 Td (patient ) Tj ET Q q 0 0 0 rg BT 520.17 237.96 Td (population.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 186.35 219.86 Td (January 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 223.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.82 223.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.62 223.96 Td (of ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 301.44 223.96 Td (Daklinza) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 333.93 223.96 Td ( ) Tj ET Q q 0 0 0 rg BT 336.25 223.96 Td (for ) Tj ET Q q 0 0 0 rg BT 349.06 223.96 Td (use ) Tj ET Q q 0 0 0 rg BT 363.37 223.96 Td (with ) Tj ET Q q 0 0 0 rg BT 381.69 223.96 Td (sofosbuvir ) Tj ET Q q 0 0 0 rg BT 422.01 223.96 Td (for ) Tj ET Q q 0 0 0 rg BT 434.82 223.96 Td (the ) Tj ET Q q 0 0 0 rg BT 448.13 223.96 Td (treatment ) Tj ET Q q 0 0 0 rg BT 484.43 223.96 Td (of ) Tj ET Q q 0 0 0 rg BT 494.25 223.96 Td (chronic ) Tj ET Q q 0 0 0 rg BT 523.55 223.96 Td (HCV) Tj ET Q q 0 0 0 rg BT 542.39 223.96 Td ( ) Tj ET Q q 0 0 0 rg BT 544.71 223.96 Td (in ) Tj ET Q q 0 0 0 rg BT 554.02 223.96 Td (three ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 214.96 Td (new ) Tj ET Q q 0 0 0 rg BT 261.24 214.96 Td (patient ) Tj ET Q q 0 0 0 rg BT 287.98 214.96 Td (populations.) Tj ET Q BT /F4 9.00 Tf ET q 0 0 0 rg BT 52.00 186.95 Td (Reyataz) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 131.05 186.86 Td (HIV) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 192.10 186.86 Td (June 2016) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 190.96 Td (EC ) Tj ET Q q 0 0 0 rg BT 257.61 190.96 Td (approval ) Tj ET Q q 0 0 0 rg BT 291.21 190.96 Td (for ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 303.81 190.96 Td (Reyataz) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 332.30 190.96 Td ( ) Tj ET Q q 0 0 0 rg BT 334.41 190.96 Td (oral ) Tj ET Q q 0 0 0 rg BT 350.52 190.96 Td (powder ) Tj ET Q q 0 0 0 rg BT 379.62 190.96 Td (indicated ) Tj ET Q q 0 0 0 rg BT 414.71 190.96 Td (in ) Tj ET Q q 0 0 0 rg BT 423.82 190.96 Td (HIV) Tj ET Q q 0 0 0 rg BT 438.99 190.96 Td (-infected ) Tj ET Q q 0 0 0 rg BT 473.08 190.96 Td (children ) Tj ET Q q 0 0 0 rg BT 504.68 190.96 Td (at ) Tj ET Q q 0 0 0 rg BT 513.29 190.96 Td (least ) Tj ET Q q 0 0 0 rg BT 531.89 190.96 Td (3 ) Tj ET Q q 0 0 0 rg BT 538.50 190.96 Td (months/5 ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 244.00 181.96 Td (kg ) Tj ET Q q 0 0 0 rg BT 255.25 181.96 Td (and ) Tj ET Q q 0 0 0 rg BT 270.49 181.96 Td (the ) Tj ET Q q 0 0 0 rg BT 283.74 181.96 Td (optimized ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 321.98 181.96 Td (Reyataz) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 350.47 181.96 Td ( ) Tj ET Q q 0 0 0 rg BT 352.72 181.96 Td (capsule ) Tj ET Q q 0 0 0 rg BT 381.96 181.96 Td (pediatric ) Tj ET Q q 0 0 0 rg BT 415.69 181.96 Td (dosing ) Tj ET Q q 0 0 0 rg BT 441.94 181.96 Td (recommendations.) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 103 0 obj <> endobj 104 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (51) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Special Note Regarding Forward-Looking Statements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 730.05 Td (This ) Tj ET Q q 0 0 0 rg BT 56.19 730.05 Td (annual ) Tj ET Q q 0 0 0 rg BT 85.25 730.05 Td (report ) Tj ET Q q 0 0 0 rg BT 111.53 730.05 Td (on ) Tj ET Q q 0 0 0 rg BT 123.94 730.05 Td (Form ) Tj ET Q q 0 0 0 rg BT 148.02 730.05 Td (10-K ) Tj ET Q q 0 0 0 rg BT 170.98 730.05 Td (\(including ) Tj ET Q q 0 0 0 rg BT 214.49 730.05 Td (documents ) Tj ET Q q 0 0 0 rg BT 260.22 730.05 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 313.16 730.05 Td (by ) Tj ET Q q 0 0 0 rg BT 325.57 730.05 Td (reference\) ) Tj ET Q q 0 0 0 rg BT 368.49 730.05 Td (and ) Tj ET Q q 0 0 0 rg BT 385.33 730.05 Td (other ) Tj ET Q q 0 0 0 rg BT 408.29 730.05 Td (written ) Tj ET Q q 0 0 0 rg BT 439.02 730.05 Td (and ) Tj ET Q q 0 0 0 rg BT 455.86 730.05 Td (oral ) Tj ET Q q 0 0 0 rg BT 473.82 730.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 518.44 730.05 Td (we ) Tj ET Q q 0 0 0 rg BT 532.50 730.05 Td (make ) Tj ET Q q 0 0 0 rg BT 556.57 730.05 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 718.05 Td (time ) Tj ET Q q 0 0 0 rg BT 55.26 718.05 Td (to ) Tj ET Q q 0 0 0 rg BT 64.53 718.05 Td (time ) Tj ET Q q 0 0 0 rg BT 83.79 718.05 Td (contain ) Tj ET Q q 0 0 0 rg BT 114.71 718.05 Td (certain ) Tj ET Q q 0 0 0 rg BT 143.40 718.05 Td (“forward-looking” ) Tj ET Q q 0 0 0 rg BT 219.30 718.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 262.99 718.05 Td (within ) Tj ET Q q 0 0 0 rg BT 290.04 718.05 Td (the ) Tj ET Q q 0 0 0 rg BT 303.74 718.05 Td (meaning ) Tj ET Q q 0 0 0 rg BT 339.66 718.05 Td (of ) Tj ET Q q 0 0 0 rg BT 349.48 718.05 Td (Section 27A) Tj ET Q q 0 0 0 rg BT 398.64 718.05 Td ( ) Tj ET Q q 0 0 0 rg BT 400.13 718.05 Td (of ) Tj ET Q q 0 0 0 rg BT 409.95 718.05 Td (the ) Tj ET Q q 0 0 0 rg BT 423.65 718.05 Td (Securities ) Tj ET Q q 0 0 0 rg BT 464.24 718.05 Td (Act ) Tj ET Q q 0 0 0 rg BT 480.17 718.05 Td (of ) Tj ET Q q 0 0 0 rg BT 489.99 718.05 Td (1933 ) Tj ET Q q 0 0 0 rg BT 511.47 718.05 Td (and ) Tj ET Q q 0 0 0 rg BT 527.40 718.05 Td (Section 21E ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 706.05 Td (of ) Tj ET Q q 0 0 0 rg BT 46.70 706.05 Td (the ) Tj ET Q q 0 0 0 rg BT 61.29 706.05 Td (Securities ) Tj ET Q q 0 0 0 rg BT 103.10 706.05 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 144.37 706.05 Td (Act ) Tj ET Q q 0 0 0 rg BT 161.18 706.05 Td (of ) Tj ET Q q 0 0 0 rg BT 171.88 706.05 Td (1934. ) Tj ET Q q 0 0 0 rg BT 196.40 706.05 Td (Y) Tj ET Q q 0 0 0 rg BT 202.62 706.05 Td (ou ) Tj ET Q q 0 0 0 rg BT 214.99 706.05 Td (can ) Tj ET Q q 0 0 0 rg BT 231.24 706.05 Td (identify ) Tj ET Q q 0 0 0 rg BT 264.72 706.05 Td (these ) Tj ET Q q 0 0 0 rg BT 287.64 706.05 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 355.55 706.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 400.13 706.05 Td (by ) Tj ET Q q 0 0 0 rg BT 412.50 706.05 Td (the ) Tj ET Q q 0 0 0 rg BT 427.09 706.05 Td (fact ) Tj ET Q q 0 0 0 rg BT 444.45 706.05 Td (they ) Tj ET Q q 0 0 0 rg BT 464.04 706.05 Td (use ) Tj ET Q q 0 0 0 rg BT 479.74 706.05 Td (words ) Tj ET Q q 0 0 0 rg BT 506.56 706.05 Td (such ) Tj ET Q q 0 0 0 rg BT 527.26 706.05 Td (as ) Tj ET Q q 0 0 0 rg BT 537.96 706.05 Td (“should”, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 694.05 Td (“expect”, ) Tj ET Q q 0 0 0 rg BT 76.89 694.05 Td (“anticipate”, ) Tj ET Q q 0 0 0 rg BT 130.56 694.05 Td (“estimate”, ) Tj ET Q q 0 0 0 rg BT 178.67 694.05 Td (“tar) Tj ET Q q 0 0 0 rg BT 193.48 694.05 Td (get”, ) Tj ET Q q 0 0 0 rg BT 216.05 694.05 Td (“may”, ) Tj ET Q q 0 0 0 rg BT 248.07 694.05 Td (“project”, ) Tj ET Q q 0 0 0 rg BT 290.63 694.05 Td (“guidance”, ) Tj ET Q q 0 0 0 rg BT 341.52 694.05 Td (“intend”, ) Tj ET Q q 0 0 0 rg BT 381.31 694.05 Td (“plan”, ) Tj ET Q q 0 0 0 rg BT 413.33 694.05 Td (“believe” ) Tj ET Q q 0 0 0 rg BT 454.50 694.05 Td (and ) Tj ET Q q 0 0 0 rg BT 472.35 694.05 Td (other ) Tj ET Q q 0 0 0 rg BT 496.32 694.05 Td (words ) Tj ET Q q 0 0 0 rg BT 524.19 694.05 Td (and ) Tj ET Q q 0 0 0 rg BT 542.04 694.05 Td (terms ) Tj ET Q q 0 0 0 rg BT 567.68 694.05 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 682.05 Td (similar ) Tj ET Q q 0 0 0 rg BT 66.61 682.05 Td (meaning ) Tj ET Q q 0 0 0 rg BT 103.87 682.05 Td (and ) Tj ET Q q 0 0 0 rg BT 121.15 682.05 Td (expression ) Tj ET Q q 0 0 0 rg BT 166.75 682.05 Td (in ) Tj ET Q q 0 0 0 rg BT 177.36 682.05 Td (connection ) Tj ET Q q 0 0 0 rg BT 224.07 682.05 Td (with ) Tj ET Q q 0 0 0 rg BT 244.68 682.05 Td (any ) Tj ET Q q 0 0 0 rg BT 261.95 682.05 Td (discussion ) Tj ET Q q 0 0 0 rg BT 306.45 682.05 Td (of ) Tj ET Q q 0 0 0 rg BT 317.62 682.05 Td (future ) Tj ET Q q 0 0 0 rg BT 344.33 682.05 Td (operating ) Tj ET Q q 0 0 0 rg BT 384.92 682.05 Td (or ) Tj ET Q q 0 0 0 rg BT 396.09 682.05 Td (financial ) Tj ET Q q 0 0 0 rg BT 433.90 682.05 Td (performance. ) Tj ET Q q 0 0 0 rg BT 489.76 682.05 Td (One ) Tj ET Q q 0 0 0 rg BT 509.25 682.05 Td (can ) Tj ET Q q 0 0 0 rg BT 525.96 682.05 Td (also ) Tj ET Q q 0 0 0 rg BT 544.90 682.05 Td (identify ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 670.05 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 104.02 670.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 148.71 670.05 Td (by ) Tj ET Q q 0 0 0 rg BT 161.19 670.05 Td (the ) Tj ET Q q 0 0 0 rg BT 175.89 670.05 Td (fact ) Tj ET Q q 0 0 0 rg BT 193.35 670.05 Td (that ) Tj ET Q q 0 0 0 rg BT 210.83 670.05 Td (they ) Tj ET Q q 0 0 0 rg BT 230.53 670.05 Td (do ) Tj ET Q q 0 0 0 rg BT 243.01 670.05 Td (not ) Tj ET Q q 0 0 0 rg BT 258.27 670.05 Td (relate ) Tj ET Q q 0 0 0 rg BT 282.95 670.05 Td (strictly ) Tj ET Q q 0 0 0 rg BT 313.20 670.05 Td (to ) Tj ET Q q 0 0 0 rg BT 323.46 670.05 Td (historical ) Tj ET Q q 0 0 0 rg BT 363.15 670.05 Td (or ) Tj ET Q q 0 0 0 rg BT 373.96 670.05 Td (current ) Tj ET Q q 0 0 0 rg BT 404.76 670.05 Td (facts. ) Tj ET Q q 0 0 0 rg BT 428.62 670.05 Td (Such ) Tj ET Q q 0 0 0 rg BT 451.10 670.05 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 519.12 670.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 563.81 670.05 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 658.05 Td (based ) Tj ET Q q 0 0 0 rg BT 61.74 658.05 Td (on ) Tj ET Q q 0 0 0 rg BT 74.70 658.05 Td (current ) Tj ET Q q 0 0 0 rg BT 105.99 658.05 Td (expectations ) Tj ET Q q 0 0 0 rg BT 158.94 658.05 Td (and ) Tj ET Q q 0 0 0 rg BT 176.34 658.05 Td (involve ) Tj ET Q q 0 0 0 rg BT 209.30 658.05 Td (inherent ) Tj ET Q q 0 0 0 rg BT 245.04 658.05 Td (risks ) Tj ET Q q 0 0 0 rg BT 266.90 658.05 Td (and ) Tj ET Q q 0 0 0 rg BT 284.30 658.05 Td (uncertainties, ) Tj ET Q q 0 0 0 rg BT 340.86 658.05 Td (including ) Tj ET Q q 0 0 0 rg BT 381.60 658.05 Td (factors ) Tj ET Q q 0 0 0 rg BT 411.77 658.05 Td (that ) Tj ET Q q 0 0 0 rg BT 429.74 658.05 Td (could ) Tj ET Q q 0 0 0 rg BT 454.92 658.05 Td (delay) Tj ET Q q 0 0 0 rg BT 475.93 658.05 Td (, ) Tj ET Q q 0 0 0 rg BT 481.40 658.05 Td (divert ) Tj ET Q q 0 0 0 rg BT 507.69 658.05 Td (or ) Tj ET Q q 0 0 0 rg BT 518.99 658.05 Td (change ) Tj ET Q q 0 0 0 rg BT 550.27 658.05 Td (any ) Tj ET Q q 0 0 0 rg BT 567.68 658.05 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 646.05 Td (them, ) Tj ET Q q 0 0 0 rg BT 61.52 646.05 Td (and ) Tj ET Q q 0 0 0 rg BT 78.99 646.05 Td (could ) Tj ET Q q 0 0 0 rg BT 104.24 646.05 Td (cause ) Tj ET Q q 0 0 0 rg BT 129.47 646.05 Td (actual ) Tj ET Q q 0 0 0 rg BT 156.37 646.05 Td (outcomes ) Tj ET Q q 0 0 0 rg BT 197.73 646.05 Td (to ) Tj ET Q q 0 0 0 rg BT 208.53 646.05 Td (dif) Tj ET Q q 0 0 0 rg BT 219.46 646.05 Td (fer ) Tj ET Q q 0 0 0 rg BT 233.59 646.05 Td (materially ) Tj ET Q q 0 0 0 rg BT 277.16 646.05 Td (from ) Tj ET Q q 0 0 0 rg BT 299.62 646.05 Td (current ) Tj ET Q q 0 0 0 rg BT 330.97 646.05 Td (expectations. ) Tj ET Q q 0 0 0 rg BT 386.26 646.05 Td (These ) Tj ET Q q 0 0 0 rg BT 413.16 646.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 458.40 646.05 Td (are ) Tj ET Q q 0 0 0 rg BT 473.64 646.05 Td (likely ) Tj ET Q q 0 0 0 rg BT 499.44 646.05 Td (to ) Tj ET Q q 0 0 0 rg BT 510.25 646.05 Td (relate ) Tj ET Q q 0 0 0 rg BT 535.48 646.05 Td (to, ) Tj ET Q q 0 0 0 rg BT 548.79 646.05 Td (among ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 634.05 Td (other ) Tj ET Q q 0 0 0 rg BT 58.78 634.05 Td (things, ) Tj ET Q q 0 0 0 rg BT 87.95 634.05 Td (our ) Tj ET Q q 0 0 0 rg BT 103.51 634.05 Td (goals, ) Tj ET Q q 0 0 0 rg BT 129.35 634.05 Td (plans ) Tj ET Q q 0 0 0 rg BT 152.69 634.05 Td (and ) Tj ET Q q 0 0 0 rg BT 169.35 634.05 Td (projections ) Tj ET Q q 0 0 0 rg BT 216.02 634.05 Td (regarding ) Tj ET Q q 0 0 0 rg BT 256.56 634.05 Td (our ) Tj ET Q q 0 0 0 rg BT 272.12 634.05 Td (financial ) Tj ET Q q 0 0 0 rg BT 309.33 634.05 Td (position, ) Tj ET Q q 0 0 0 rg BT 346.29 634.05 Td (results ) Tj ET Q q 0 0 0 rg BT 374.62 634.05 Td (of ) Tj ET Q q 0 0 0 rg BT 385.18 634.05 Td (operations, ) Tj ET Q q 0 0 0 rg BT 431.57 634.05 Td (cash ) Tj ET Q q 0 0 0 rg BT 451.56 634.05 Td (flows, ) Tj ET Q q 0 0 0 rg BT 478.51 634.05 Td (market ) Tj ET Q q 0 0 0 rg BT 508.51 634.05 Td (position, ) Tj ET Q q 0 0 0 rg BT 545.46 634.05 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 622.05 Td (development, ) Tj ET Q q 0 0 0 rg BT 92.72 622.05 Td (product ) Tj ET Q q 0 0 0 rg BT 125.84 622.05 Td (approvals, ) Tj ET Q q 0 0 0 rg BT 169.79 622.05 Td (sales ) Tj ET Q q 0 0 0 rg BT 191.80 622.05 Td (ef) Tj ET Q q 0 0 0 rg BT 199.38 622.05 Td (forts, ) Tj ET Q q 0 0 0 rg BT 222.78 622.05 Td (expenses, ) Tj ET Q q 0 0 0 rg BT 263.95 622.05 Td (performance ) Tj ET Q q 0 0 0 rg BT 317.05 622.05 Td (or ) Tj ET Q q 0 0 0 rg BT 327.95 622.05 Td (results ) Tj ET Q q 0 0 0 rg BT 356.63 622.05 Td (of ) Tj ET Q q 0 0 0 rg BT 367.53 622.05 Td (current ) Tj ET Q q 0 0 0 rg BT 398.41 622.05 Td (and ) Tj ET Q q 0 0 0 rg BT 415.42 622.05 Td (anticipated ) Tj ET Q q 0 0 0 rg BT 461.86 622.05 Td (products ) Tj ET Q q 0 0 0 rg BT 498.87 622.05 Td (and ) Tj ET Q q 0 0 0 rg BT 515.88 622.05 Td (the ) Tj ET Q q 0 0 0 rg BT 530.67 622.05 Td (outcome ) Tj ET Q q 0 0 0 rg BT 567.67 622.05 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 610.05 Td (contingencies ) Tj ET Q q 0 0 0 rg BT 93.97 610.05 Td (such ) Tj ET Q q 0 0 0 rg BT 115.29 610.05 Td (as ) Tj ET Q q 0 0 0 rg BT 126.61 610.05 Td (legal ) Tj ET Q q 0 0 0 rg BT 149.03 610.05 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 200.33 610.05 Td (and ) Tj ET Q q 0 0 0 rg BT 217.76 610.05 Td (financial ) Tj ET Q q 0 0 0 rg BT 255.73 610.05 Td (results, ) Tj ET Q q 0 0 0 rg BT 287.32 610.05 Td (which ) Tj ET Q q 0 0 0 rg BT 314.75 610.05 Td (are ) Tj ET Q q 0 0 0 rg BT 329.95 610.05 Td (based ) Tj ET Q q 0 0 0 rg BT 355.70 610.05 Td (on ) Tj ET Q q 0 0 0 rg BT 368.69 610.05 Td (current ) Tj ET Q q 0 0 0 rg BT 399.99 610.05 Td (expectations ) Tj ET Q q 0 0 0 rg BT 452.96 610.05 Td (that ) Tj ET Q q 0 0 0 rg BT 470.95 610.05 Td (involve ) Tj ET Q q 0 0 0 rg BT 503.93 610.05 Td (inherent ) Tj ET Q q 0 0 0 rg BT 539.68 610.05 Td (risks ) Tj ET Q q 0 0 0 rg BT 561.56 610.05 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 598.05 Td (uncertainties, ) Tj ET Q q 0 0 0 rg BT 92.73 598.05 Td (including ) Tj ET Q q 0 0 0 rg BT 133.65 598.05 Td (internal ) Tj ET Q q 0 0 0 rg BT 167.34 598.05 Td (or ) Tj ET Q q 0 0 0 rg BT 178.82 598.05 Td (external ) Tj ET Q q 0 0 0 rg BT 214.17 598.05 Td (factors ) Tj ET Q q 0 0 0 rg BT 244.52 598.05 Td (that ) Tj ET Q q 0 0 0 rg BT 262.66 598.05 Td (could ) Tj ET Q q 0 0 0 rg BT 288.02 598.05 Td (delay) Tj ET Q q 0 0 0 rg BT 309.03 598.05 Td (, ) Tj ET Q q 0 0 0 rg BT 314.68 598.05 Td (divert ) Tj ET Q q 0 0 0 rg BT 341.15 598.05 Td (or ) Tj ET Q q 0 0 0 rg BT 352.62 598.05 Td (change ) Tj ET Q q 0 0 0 rg BT 384.08 598.05 Td (any ) Tj ET Q q 0 0 0 rg BT 401.67 598.05 Td (of ) Tj ET Q q 0 0 0 rg BT 413.14 598.05 Td (them ) Tj ET Q q 0 0 0 rg BT 436.29 598.05 Td (in ) Tj ET Q q 0 0 0 rg BT 447.21 598.05 Td (the ) Tj ET Q q 0 0 0 rg BT 462.57 598.05 Td (next ) Tj ET Q q 0 0 0 rg BT 482.94 598.05 Td (several ) Tj ET Q q 0 0 0 rg BT 514.40 598.05 Td (years. ) Tj ET Q q 0 0 0 rg BT 540.91 598.05 Td (W) Tj ET Q q 0 0 0 rg BT 549.55 598.05 Td (e ) Tj ET Q q 0 0 0 rg BT 557.14 598.05 Td (have ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 586.05 Td (included ) Tj ET Q q 0 0 0 rg BT 72.69 586.05 Td (important ) Tj ET Q q 0 0 0 rg BT 113.83 586.05 Td (factors ) Tj ET Q q 0 0 0 rg BT 143.29 586.05 Td (in ) Tj ET Q q 0 0 0 rg BT 153.32 586.05 Td (the ) Tj ET Q q 0 0 0 rg BT 167.80 586.05 Td (cautionary ) Tj ET Q q 0 0 0 rg BT 212.25 586.05 Td (statements ) Tj ET Q q 0 0 0 rg BT 256.72 586.05 Td (included ) Tj ET Q q 0 0 0 rg BT 293.41 586.05 Td (in ) Tj ET Q q 0 0 0 rg BT 303.45 586.05 Td (this ) Tj ET Q q 0 0 0 rg BT 319.65 586.05 Td (Annual ) Tj ET Q q 0 0 0 rg BT 351.35 586.05 Td (Report ) Tj ET Q q 0 0 0 rg BT 380.82 586.05 Td (on ) Tj ET Q q 0 0 0 rg BT 393.08 586.05 Td (Form ) Tj ET Q q 0 0 0 rg BT 417.00 586.05 Td (10-K, ) Tj ET Q q 0 0 0 rg BT 442.31 586.05 Td (particularly ) Tj ET Q q 0 0 0 rg BT 490.65 586.05 Td (under ) Tj ET Q q 0 0 0 rg BT 515.68 586.05 Td (“Item ) Tj ET Q q 0 0 0 rg BT 540.70 586.05 Td (1A. ) Tj ET Q q 0 0 0 rg BT 557.67 586.05 Td (Risk ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 574.05 Td (Factors,” ) Tj ET Q q 0 0 0 rg BT 74.88 574.05 Td (that ) Tj ET Q q 0 0 0 rg BT 92.37 574.05 Td (we ) Tj ET Q q 0 0 0 rg BT 106.53 574.05 Td (believe ) Tj ET Q q 0 0 0 rg BT 137.90 574.05 Td (could ) Tj ET Q q 0 0 0 rg BT 162.62 574.05 Td (cause ) Tj ET Q q 0 0 0 rg BT 187.33 574.05 Td (actual ) Tj ET Q q 0 0 0 rg BT 213.70 574.05 Td (results ) Tj ET Q q 0 0 0 rg BT 242.31 574.05 Td (to ) Tj ET Q q 0 0 0 rg BT 252.59 574.05 Td (dif) Tj ET Q q 0 0 0 rg BT 263.51 574.05 Td (fer ) Tj ET Q q 0 0 0 rg BT 277.11 574.05 Td (materially ) Tj ET Q q 0 0 0 rg BT 320.15 574.05 Td (from ) Tj ET Q q 0 0 0 rg BT 342.09 574.05 Td (any ) Tj ET Q q 0 0 0 rg BT 359.03 574.05 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 427.06 574.05 Td (statement.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 554.85 Td (Although ) Tj ET Q q 0 0 0 rg BT 76.62 554.85 Td (we ) Tj ET Q q 0 0 0 rg BT 91.12 554.85 Td (believe ) Tj ET Q q 0 0 0 rg BT 122.84 554.85 Td (we ) Tj ET Q q 0 0 0 rg BT 137.34 554.85 Td (have ) Tj ET Q q 0 0 0 rg BT 159.06 554.85 Td (been ) Tj ET Q q 0 0 0 rg BT 180.78 554.85 Td (prudent ) Tj ET Q q 0 0 0 rg BT 214.16 554.85 Td (in ) Tj ET Q q 0 0 0 rg BT 224.78 554.85 Td (our ) Tj ET Q q 0 0 0 rg BT 240.96 554.85 Td (plans ) Tj ET Q q 0 0 0 rg BT 264.91 554.85 Td (and ) Tj ET Q q 0 0 0 rg BT 282.19 554.85 Td (assumptions, ) Tj ET Q q 0 0 0 rg BT 336.98 554.85 Td (no ) Tj ET Q q 0 0 0 rg BT 349.82 554.85 Td (assurance ) Tj ET Q q 0 0 0 rg BT 391.53 554.85 Td (can ) Tj ET Q q 0 0 0 rg BT 408.25 554.85 Td (be ) Tj ET Q q 0 0 0 rg BT 420.53 554.85 Td (given ) Tj ET Q q 0 0 0 rg BT 445.58 554.85 Td (that ) Tj ET Q q 0 0 0 rg BT 463.42 554.85 Td (any ) Tj ET Q q 0 0 0 rg BT 480.70 554.85 Td (goal ) Tj ET Q q 0 0 0 rg BT 500.76 554.85 Td (or ) Tj ET Q q 0 0 0 rg BT 511.93 554.85 Td (plan ) Tj ET Q q 0 0 0 rg BT 531.99 554.85 Td (set ) Tj ET Q q 0 0 0 rg BT 545.94 554.85 Td (forth ) Tj ET Q q 0 0 0 rg BT 568.22 554.85 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 542.85 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 103.81 542.85 Td (statements ) Tj ET Q q 0 0 0 rg BT 148.30 542.85 Td (can ) Tj ET Q q 0 0 0 rg BT 164.46 542.85 Td (be ) Tj ET Q q 0 0 0 rg BT 176.18 542.85 Td (achieved ) Tj ET Q q 0 0 0 rg BT 213.99 542.85 Td (and ) Tj ET Q q 0 0 0 rg BT 230.70 542.85 Td (readers ) Tj ET Q q 0 0 0 rg BT 261.85 542.85 Td (are ) Tj ET Q q 0 0 0 rg BT 276.33 542.85 Td (cautioned ) Tj ET Q q 0 0 0 rg BT 317.48 542.85 Td (not ) Tj ET Q q 0 0 0 rg BT 332.54 542.85 Td (to ) Tj ET Q q 0 0 0 rg BT 342.59 542.85 Td (place ) Tj ET Q q 0 0 0 rg BT 365.97 542.85 Td (undue ) Tj ET Q q 0 0 0 rg BT 392.68 542.85 Td (reliance ) Tj ET Q q 0 0 0 rg BT 426.60 542.85 Td (on ) Tj ET Q q 0 0 0 rg BT 438.88 542.85 Td (such ) Tj ET Q q 0 0 0 rg BT 459.49 542.85 Td (statements, ) Tj ET Q q 0 0 0 rg BT 506.48 542.85 Td (which ) Tj ET Q q 0 0 0 rg BT 533.19 542.85 Td (speak ) Tj ET Q q 0 0 0 rg BT 558.24 542.85 Td (only ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 530.85 Td (as ) Tj ET Q q 0 0 0 rg BT 47.81 530.85 Td (of ) Tj ET Q q 0 0 0 rg BT 59.63 530.85 Td (the ) Tj ET Q q 0 0 0 rg BT 75.33 530.85 Td (date ) Tj ET Q q 0 0 0 rg BT 95.47 530.85 Td (made. ) Tj ET Q q 0 0 0 rg BT 122.85 530.85 Td (W) Tj ET Q q 0 0 0 rg BT 131.49 530.85 Td (e ) Tj ET Q q 0 0 0 rg BT 139.42 530.85 Td (undertake ) Tj ET Q q 0 0 0 rg BT 182.32 530.85 Td (no ) Tj ET Q q 0 0 0 rg BT 195.81 530.85 Td (obligation ) Tj ET Q q 0 0 0 rg BT 239.84 530.85 Td (to ) Tj ET Q q 0 0 0 rg BT 251.10 530.85 Td (release ) Tj ET Q q 0 0 0 rg BT 282.34 530.85 Td (publicly ) Tj ET Q q 0 0 0 rg BT 318.60 530.85 Td (any ) Tj ET Q q 0 0 0 rg BT 336.52 530.85 Td (revisions ) Tj ET Q q 0 0 0 rg BT 376.11 530.85 Td (to ) Tj ET Q q 0 0 0 rg BT 387.38 530.85 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 456.40 530.85 Td (statements ) Tj ET Q q 0 0 0 rg BT 502.09 530.85 Td (as ) Tj ET Q q 0 0 0 rg BT 513.91 530.85 Td (a ) Tj ET Q q 0 0 0 rg BT 521.83 530.85 Td (result ) Tj ET Q q 0 0 0 rg BT 547.53 530.85 Td (of ) Tj ET Q q 0 0 0 rg BT 559.34 530.85 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 518.85 Td (information, ) Tj ET Q q 0 0 0 rg BT 88.21 518.85 Td (future ) Tj ET Q q 0 0 0 rg BT 114.59 518.85 Td (events ) Tj ET Q q 0 0 0 rg BT 142.64 518.85 Td (or ) Tj ET Q q 0 0 0 rg BT 153.47 518.85 Td (otherwise.) Tj ET Q endstream endobj 105 0 obj <> endobj 106 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (52) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 746.23 Td (Item 7A.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 746.23 Td (QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 722.80 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 722.80 Td (e ) Tj ET Q q 0 0 0 rg BT 50.61 722.80 Td (are ) Tj ET Q q 0 0 0 rg BT 64.34 722.80 Td (exposed ) Tj ET Q q 0 0 0 rg BT 98.64 722.80 Td (to ) Tj ET Q q 0 0 0 rg BT 107.95 722.80 Td (market ) Tj ET Q q 0 0 0 rg BT 137.25 722.80 Td (risk ) Tj ET Q q 0 0 0 rg BT 153.78 722.80 Td (resulting ) Tj ET Q q 0 0 0 rg BT 190.30 722.80 Td (from ) Tj ET Q q 0 0 0 rg BT 211.27 722.80 Td (changes ) Tj ET Q q 0 0 0 rg BT 245.01 722.80 Td (in ) Tj ET Q q 0 0 0 rg BT 254.32 722.80 Td (currency ) Tj ET Q q 0 0 0 rg BT 290.83 722.80 Td (exchange ) Tj ET Q q 0 0 0 rg BT 330.11 722.80 Td (rates ) Tj ET Q q 0 0 0 rg BT 350.52 722.80 Td (and ) Tj ET Q q 0 0 0 rg BT 366.49 722.80 Td (interest ) Tj ET Q q 0 0 0 rg BT 397.45 722.80 Td (rates. ) Tj ET Q q 0 0 0 rg BT 420.36 722.80 Td (Certain ) Tj ET Q q 0 0 0 rg BT 451.32 722.80 Td (derivative ) Tj ET Q q 0 0 0 rg BT 492.84 722.80 Td (financial ) Tj ET Q q 0 0 0 rg BT 529.35 722.80 Td (instruments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 710.80 Td (are ) Tj ET Q q 0 0 0 rg BT 50.39 710.80 Td (used ) Tj ET Q q 0 0 0 rg BT 70.90 710.80 Td (when ) Tj ET Q q 0 0 0 rg BT 94.73 710.80 Td (available ) Tj ET Q q 0 0 0 rg BT 133.00 710.80 Td (on ) Tj ET Q q 0 0 0 rg BT 145.18 710.80 Td (a ) Tj ET Q q 0 0 0 rg BT 151.80 710.80 Td (cost-ef) Tj ET Q q 0 0 0 rg BT 178.83 710.80 Td (fective ) Tj ET Q q 0 0 0 rg BT 208.21 710.80 Td (basis ) Tj ET Q q 0 0 0 rg BT 230.39 710.80 Td (to ) Tj ET Q q 0 0 0 rg BT 240.34 710.80 Td (hedge ) Tj ET Q q 0 0 0 rg BT 266.40 710.80 Td (our ) Tj ET Q q 0 0 0 rg BT 281.91 710.80 Td (underlying ) Tj ET Q q 0 0 0 rg BT 327.41 710.80 Td (economic ) Tj ET Q q 0 0 0 rg BT 368.47 710.80 Td (exposure. ) Tj ET Q q 0 0 0 rg BT 408.76 710.80 Td (All ) Tj ET Q q 0 0 0 rg BT 423.72 710.80 Td (of ) Tj ET Q q 0 0 0 rg BT 434.23 710.80 Td (our ) Tj ET Q q 0 0 0 rg BT 449.74 710.80 Td (financial ) Tj ET Q q 0 0 0 rg BT 486.90 710.80 Td (instruments, ) Tj ET Q q 0 0 0 rg BT 538.24 710.80 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 698.80 Td (derivatives, ) Tj ET Q q 0 0 0 rg BT 83.83 698.80 Td (are ) Tj ET Q q 0 0 0 rg BT 97.50 698.80 Td (subject ) Tj ET Q q 0 0 0 rg BT 127.29 698.80 Td (to ) Tj ET Q q 0 0 0 rg BT 136.53 698.80 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 188.53 698.80 Td (credit ) Tj ET Q q 0 0 0 rg BT 212.75 698.80 Td (risk ) Tj ET Q q 0 0 0 rg BT 229.22 698.80 Td (considered ) Tj ET Q q 0 0 0 rg BT 273.99 698.80 Td (as ) Tj ET Q q 0 0 0 rg BT 283.79 698.80 Td (part ) Tj ET Q q 0 0 0 rg BT 300.79 698.80 Td (of ) Tj ET Q q 0 0 0 rg BT 310.59 698.80 Td (the ) Tj ET Q q 0 0 0 rg BT 324.27 698.80 Td (overall ) Tj ET Q q 0 0 0 rg BT 353.49 698.80 Td (fair ) Tj ET Q q 0 0 0 rg BT 368.83 698.80 Td (value ) Tj ET Q q 0 0 0 rg BT 391.95 698.80 Td (measurement. ) Tj ET Q q 0 0 0 rg BT 449.22 698.80 Td (Derivative ) Tj ET Q q 0 0 0 rg BT 492.89 698.80 Td (financial ) Tj ET Q q 0 0 0 rg BT 529.33 698.80 Td (instruments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 686.80 Td (are ) Tj ET Q q 0 0 0 rg BT 50.71 686.80 Td (not ) Tj ET Q q 0 0 0 rg BT 65.99 686.80 Td (used ) Tj ET Q q 0 0 0 rg BT 86.82 686.80 Td (for ) Tj ET Q q 0 0 0 rg BT 100.98 686.80 Td (trading ) Tj ET Q q 0 0 0 rg BT 131.80 686.80 Td (purposes.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 667.60 Td (For) Tj ET Q q 0 0 0 rg BT 51.37 667.60 Td (eign Exchange Risk) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 648.40 Td (Significant ) Tj ET Q q 0 0 0 rg BT 82.47 648.40 Td (amounts ) Tj ET Q q 0 0 0 rg BT 118.95 648.40 Td (of ) Tj ET Q q 0 0 0 rg BT 129.88 648.40 Td (our ) Tj ET Q q 0 0 0 rg BT 145.80 648.40 Td (revenues, ) Tj ET Q q 0 0 0 rg BT 186.43 648.40 Td (earnings ) Tj ET Q q 0 0 0 rg BT 222.90 648.40 Td (and ) Tj ET Q q 0 0 0 rg BT 239.93 648.40 Td (cash ) Tj ET Q q 0 0 0 rg BT 260.29 648.40 Td (flow ) Tj ET Q q 0 0 0 rg BT 281.21 648.40 Td (are ) Tj ET Q q 0 0 0 rg BT 296.01 648.40 Td (exposed ) Tj ET Q q 0 0 0 rg BT 331.38 648.40 Td (to ) Tj ET Q q 0 0 0 rg BT 341.75 648.40 Td (changes ) Tj ET Q q 0 0 0 rg BT 376.55 648.40 Td (in ) Tj ET Q q 0 0 0 rg BT 386.92 648.40 Td (foreign ) Tj ET Q q 0 0 0 rg BT 418.39 648.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 455.96 648.40 Td (rates. ) Tj ET Q q 0 0 0 rg BT 479.93 648.40 Td (Our ) Tj ET Q q 0 0 0 rg BT 498.07 648.40 Td (primary ) Tj ET Q q 0 0 0 rg BT 532.32 648.40 Td (net ) Tj ET Q q 0 0 0 rg BT 547.13 648.40 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 636.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 73.02 636.40 Td (translation ) Tj ET Q q 0 0 0 rg BT 117.28 636.40 Td (exposures ) Tj ET Q q 0 0 0 rg BT 159.32 636.40 Td (are ) Tj ET Q q 0 0 0 rg BT 173.58 636.40 Td (the ) Tj ET Q q 0 0 0 rg BT 187.84 636.40 Td (euro, ) Tj ET Q q 0 0 0 rg BT 210.16 636.40 Td (Japanese ) Tj ET Q q 0 0 0 rg BT 247.75 636.40 Td (yen ) Tj ET Q q 0 0 0 rg BT 264.23 636.40 Td (and ) Tj ET Q q 0 0 0 rg BT 280.72 636.40 Td (Chinese ) Tj ET Q q 0 0 0 rg BT 314.98 636.40 Td (renminbi. ) Tj ET Q q 0 0 0 rg BT 355.64 636.40 Td (Foreign ) Tj ET Q q 0 0 0 rg BT 388.79 636.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 425.82 636.40 Td (forward ) Tj ET Q q 0 0 0 rg BT 459.52 636.40 Td (contracts ) Tj ET Q q 0 0 0 rg BT 497.66 636.40 Td (used ) Tj ET Q q 0 0 0 rg BT 518.04 636.40 Td (to ) Tj ET Q q 0 0 0 rg BT 527.86 636.40 Td (manage ) Tj ET Q q 0 0 0 rg BT 561.00 636.40 Td (risk ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 624.40 Td (which ) Tj ET Q q 0 0 0 rg BT 64.06 624.40 Td (primarily ) Tj ET Q q 0 0 0 rg BT 104.90 624.40 Td (arises ) Tj ET Q q 0 0 0 rg BT 131.29 624.40 Td (from ) Tj ET Q q 0 0 0 rg BT 154.36 624.40 Td (certain ) Tj ET Q q 0 0 0 rg BT 185.18 624.40 Td (intercompany ) Tj ET Q q 0 0 0 rg BT 243.79 624.40 Td (purchase ) Tj ET Q q 0 0 0 rg BT 282.95 624.40 Td (transactions ) Tj ET Q q 0 0 0 rg BT 334.34 624.40 Td (are ) Tj ET Q q 0 0 0 rg BT 350.17 624.40 Td (designated ) Tj ET Q q 0 0 0 rg BT 396.56 624.40 Td (as ) Tj ET Q q 0 0 0 rg BT 408.51 624.40 Td (foreign ) Tj ET Q q 0 0 0 rg BT 441.01 624.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 479.61 624.40 Td (cash ) Tj ET Q q 0 0 0 rg BT 501.01 624.40 Td (flow ) Tj ET Q q 0 0 0 rg BT 522.96 624.40 Td (hedges ) Tj ET Q q 0 0 0 rg BT 554.35 624.40 Td (when ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 612.40 Td (appropriate. ) Tj ET Q q 0 0 0 rg BT 86.72 612.40 Td (In ) Tj ET Q q 0 0 0 rg BT 97.73 612.40 Td (addition, ) Tj ET Q q 0 0 0 rg BT 135.69 612.40 Td (we ) Tj ET Q q 0 0 0 rg BT 150.04 612.40 Td (are ) Tj ET Q q 0 0 0 rg BT 164.93 612.40 Td (exposed ) Tj ET Q q 0 0 0 rg BT 200.38 612.40 Td (to ) Tj ET Q q 0 0 0 rg BT 210.85 612.40 Td (foreign ) Tj ET Q q 0 0 0 rg BT 242.41 612.40 Td (exchange ) Tj ET Q q 0 0 0 rg BT 282.85 612.40 Td (transaction ) Tj ET Q q 0 0 0 rg BT 329.41 612.40 Td (risk ) Tj ET Q q 0 0 0 rg BT 347.09 612.40 Td (arising ) Tj ET Q q 0 0 0 rg BT 377.00 612.40 Td (from ) Tj ET Q q 0 0 0 rg BT 399.12 612.40 Td (non-functional ) Tj ET Q q 0 0 0 rg BT 460.68 612.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 498.34 612.40 Td (denominated ) Tj ET Q q 0 0 0 rg BT 552.67 612.40 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 600.40 Td (and ) Tj ET Q q 0 0 0 rg BT 52.47 600.40 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 91.72 600.40 Td (and ) Tj ET Q q 0 0 0 rg BT 108.19 600.40 Td (earnings ) Tj ET Q q 0 0 0 rg BT 144.10 600.40 Td (denominated ) Tj ET Q q 0 0 0 rg BT 197.78 600.40 Td (in ) Tj ET Q q 0 0 0 rg BT 207.59 600.40 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 245.73 600.40 Td (dollar ) Tj ET Q q 0 0 0 rg BT 271.09 600.40 Td (currencies. ) Tj ET Q q 0 0 0 rg BT 316.70 600.40 Td (Foreign ) Tj ET Q q 0 0 0 rg BT 349.84 600.40 Td (currency ) Tj ET Q q 0 0 0 rg BT 386.85 600.40 Td (forward ) Tj ET Q q 0 0 0 rg BT 420.53 600.40 Td (contracts ) Tj ET Q q 0 0 0 rg BT 458.66 600.40 Td (used ) Tj ET Q q 0 0 0 rg BT 479.02 600.40 Td (to ) Tj ET Q q 0 0 0 rg BT 488.83 600.40 Td (of) Tj ET Q q 0 0 0 rg BT 496.98 600.40 Td (fset ) Tj ET Q q 0 0 0 rg BT 513.45 600.40 Td (these ) Tj ET Q q 0 0 0 rg BT 536.02 600.40 Td (exposures ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 588.40 Td (are ) Tj ET Q q 0 0 0 rg BT 50.71 588.40 Td (not ) Tj ET Q q 0 0 0 rg BT 65.99 588.40 Td (designated ) Tj ET Q q 0 0 0 rg BT 111.25 588.40 Td (as ) Tj ET Q q 0 0 0 rg BT 122.08 588.40 Td (hedges.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.20 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 569.20 Td (e ) Tj ET Q q 0 0 0 rg BT 51.77 569.20 Td (estimate ) Tj ET Q q 0 0 0 rg BT 87.78 569.20 Td (that ) Tj ET Q q 0 0 0 rg BT 105.47 569.20 Td (a ) Tj ET Q q 0 0 0 rg BT 112.60 569.20 Td (10% ) Tj ET Q q 0 0 0 rg BT 133.62 569.20 Td (appreciation ) Tj ET Q q 0 0 0 rg BT 185.74 569.20 Td (in ) Tj ET Q q 0 0 0 rg BT 196.21 569.20 Td (the ) Tj ET Q q 0 0 0 rg BT 211.12 569.20 Td (underlying ) Tj ET Q q 0 0 0 rg BT 257.14 569.20 Td (currencies ) Tj ET Q q 0 0 0 rg BT 300.91 569.20 Td (being ) Tj ET Q q 0 0 0 rg BT 325.82 569.20 Td (hedged ) Tj ET Q q 0 0 0 rg BT 357.39 569.20 Td (from ) Tj ET Q q 0 0 0 rg BT 379.52 569.20 Td (their ) Tj ET Q q 0 0 0 rg BT 400.54 569.20 Td (levels ) Tj ET Q q 0 0 0 rg BT 426.56 569.20 Td (against ) Tj ET Q q 0 0 0 rg BT 457.58 569.20 Td (the ) Tj ET Q q 0 0 0 rg BT 472.49 569.20 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 492.96 569.20 Td (dollar ) Tj ET Q q 0 0 0 rg BT 518.98 569.20 Td (\(with ) Tj ET Q q 0 0 0 rg BT 542.78 569.20 Td (all ) Tj ET Q q 0 0 0 rg BT 555.47 569.20 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.20 Td (variables ) Tj ET Q q 0 0 0 rg BT 75.45 557.20 Td (held ) Tj ET Q q 0 0 0 rg BT 96.03 557.20 Td (constant\) ) Tj ET Q q 0 0 0 rg BT 136.04 557.20 Td (would ) Tj ET Q q 0 0 0 rg BT 164.40 557.20 Td (decrease ) Tj ET Q q 0 0 0 rg BT 202.18 557.20 Td (the ) Tj ET Q q 0 0 0 rg BT 217.75 557.20 Td (fair ) Tj ET Q q 0 0 0 rg BT 234.99 557.20 Td (value ) Tj ET Q q 0 0 0 rg BT 260.00 557.20 Td (of ) Tj ET Q q 0 0 0 rg BT 271.69 557.20 Td (foreign ) Tj ET Q q 0 0 0 rg BT 303.93 557.20 Td (exchange ) Tj ET Q q 0 0 0 rg BT 345.04 557.20 Td (forward ) Tj ET Q q 0 0 0 rg BT 380.05 557.20 Td (contracts ) Tj ET Q q 0 0 0 rg BT 419.51 557.20 Td (by ) Tj ET Q q 0 0 0 rg BT 432.87 557.20 Td ($86 ) Tj ET Q q 0 0 0 rg BT 451.22 557.20 Td (million ) Tj ET Q q 0 0 0 rg BT 483.48 557.20 Td (at ) Tj ET Q q 0 0 0 rg BT 494.05 557.20 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.50 557.20 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.50 557.20 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.20 Td (reducing ) Tj ET Q q 0 0 0 rg BT 73.49 545.20 Td (earnings ) Tj ET Q q 0 0 0 rg BT 109.86 545.20 Td (over ) Tj ET Q q 0 0 0 rg BT 130.13 545.20 Td (the ) Tj ET Q q 0 0 0 rg BT 144.85 545.20 Td (remaining ) Tj ET Q q 0 0 0 rg BT 187.89 545.20 Td (life ) Tj ET Q q 0 0 0 rg BT 203.71 545.20 Td (of ) Tj ET Q q 0 0 0 rg BT 214.54 545.20 Td (the ) Tj ET Q q 0 0 0 rg BT 229.26 545.20 Td (contracts.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 526.00 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 526.00 Td (e ) Tj ET Q q 0 0 0 rg BT 52.07 526.00 Td (are ) Tj ET Q q 0 0 0 rg BT 67.28 526.00 Td (also ) Tj ET Q q 0 0 0 rg BT 86.39 526.00 Td (exposed ) Tj ET Q q 0 0 0 rg BT 122.15 526.00 Td (to ) Tj ET Q q 0 0 0 rg BT 132.93 526.00 Td (translation ) Tj ET Q q 0 0 0 rg BT 178.14 526.00 Td (risk ) Tj ET Q q 0 0 0 rg BT 196.14 526.00 Td (on ) Tj ET Q q 0 0 0 rg BT 209.13 526.00 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 248.25 526.00 Td (dollar) Tj ET Q q 0 0 0 rg BT 271.37 526.00 Td (-denominated ) Tj ET Q q 0 0 0 rg BT 329.35 526.00 Td (net ) Tj ET Q q 0 0 0 rg BT 344.56 526.00 Td (assets. ) Tj ET Q q 0 0 0 rg BT 373.39 526.00 Td (Non-U.S. ) Tj ET Q q 0 0 0 rg BT 414.73 526.00 Td (dollar ) Tj ET Q q 0 0 0 rg BT 441.05 526.00 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 489.60 526.00 Td (are ) Tj ET Q q 0 0 0 rg BT 504.80 526.00 Td (used ) Tj ET Q q 0 0 0 rg BT 526.13 526.00 Td (to ) Tj ET Q q 0 0 0 rg BT 536.91 526.00 Td (hedge ) Tj ET Q q 0 0 0 rg BT 563.78 526.00 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 514.00 Td (foreign ) Tj ET Q q 0 0 0 rg BT 66.54 514.00 Td (currency ) Tj ET Q q 0 0 0 rg BT 103.17 514.00 Td (exposures ) Tj ET Q q 0 0 0 rg BT 144.82 514.00 Td (of ) Tj ET Q q 0 0 0 rg BT 154.81 514.00 Td (our ) Tj ET Q q 0 0 0 rg BT 169.80 514.00 Td (net ) Tj ET Q q 0 0 0 rg BT 183.68 514.00 Td (investment ) Tj ET Q q 0 0 0 rg BT 229.22 514.00 Td (in ) Tj ET Q q 0 0 0 rg BT 238.66 514.00 Td (certain ) Tj ET Q q 0 0 0 rg BT 267.52 514.00 Td (foreign ) Tj ET Q q 0 0 0 rg BT 298.06 514.00 Td (af) Tj ET Q q 0 0 0 rg BT 305.65 514.00 Td (filiates ) Tj ET Q q 0 0 0 rg BT 334.52 514.00 Td (and ) Tj ET Q q 0 0 0 rg BT 350.62 514.00 Td (are ) Tj ET Q q 0 0 0 rg BT 364.49 514.00 Td (designated ) Tj ET Q q 0 0 0 rg BT 408.91 514.00 Td (as ) Tj ET Q q 0 0 0 rg BT 418.90 514.00 Td (hedges ) Tj ET Q q 0 0 0 rg BT 448.33 514.00 Td (of ) Tj ET Q q 0 0 0 rg BT 458.32 514.00 Td (net ) Tj ET Q q 0 0 0 rg BT 472.20 514.00 Td (investments. ) Tj ET Q q 0 0 0 rg BT 524.01 514.00 Td (The ) Tj ET Q q 0 0 0 rg BT 541.22 514.00 Td (ef) Tj ET Q q 0 0 0 rg BT 548.80 514.00 Td (fective ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 502.00 Td (portion ) Tj ET Q q 0 0 0 rg BT 67.73 502.00 Td (of ) Tj ET Q q 0 0 0 rg BT 78.91 502.00 Td (foreign ) Tj ET Q q 0 0 0 rg BT 110.63 502.00 Td (exchange ) Tj ET Q q 0 0 0 rg BT 151.23 502.00 Td (gains ) Tj ET Q q 0 0 0 rg BT 175.18 502.00 Td (or ) Tj ET Q q 0 0 0 rg BT 186.36 502.00 Td (losses ) Tj ET Q q 0 0 0 rg BT 213.10 502.00 Td (on ) Tj ET Q q 0 0 0 rg BT 225.94 502.00 Td (these ) Tj ET Q q 0 0 0 rg BT 249.34 502.00 Td (hedges ) Tj ET Q q 0 0 0 rg BT 279.95 502.00 Td (is ) Tj ET Q q 0 0 0 rg BT 289.47 502.00 Td (included ) Tj ET Q q 0 0 0 rg BT 326.75 502.00 Td (in ) Tj ET Q q 0 0 0 rg BT 337.37 502.00 Td (the ) Tj ET Q q 0 0 0 rg BT 352.43 502.00 Td (foreign ) Tj ET Q q 0 0 0 rg BT 384.15 502.00 Td (currency ) Tj ET Q q 0 0 0 rg BT 421.98 502.00 Td (translation ) Tj ET Q q 0 0 0 rg BT 467.03 502.00 Td (component ) Tj ET Q q 0 0 0 rg BT 514.31 502.00 Td (of ) Tj ET Q q 0 0 0 rg BT 525.49 502.00 Td (accumulated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 490.00 Td (other ) Tj ET Q q 0 0 0 rg BT 59.69 490.00 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 123.37 490.00 Td (income/\(loss\). ) Tj ET Q q 0 0 0 rg BT 183.45 490.00 Td (If ) Tj ET Q q 0 0 0 rg BT 193.26 490.00 Td (our ) Tj ET Q q 0 0 0 rg BT 209.74 490.00 Td (net ) Tj ET Q q 0 0 0 rg BT 225.10 490.00 Td (investment ) Tj ET Q q 0 0 0 rg BT 272.13 490.00 Td (decreases ) Tj ET Q q 0 0 0 rg BT 313.58 490.00 Td (below ) Tj ET Q q 0 0 0 rg BT 341.17 490.00 Td (the ) Tj ET Q q 0 0 0 rg BT 356.53 490.00 Td (equivalent ) Tj ET Q q 0 0 0 rg BT 401.33 490.00 Td (value ) Tj ET Q q 0 0 0 rg BT 426.13 490.00 Td (of ) Tj ET Q q 0 0 0 rg BT 437.61 490.00 Td (the ) Tj ET Q q 0 0 0 rg BT 452.97 490.00 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 492.23 490.00 Td (debt ) Tj ET Q q 0 0 0 rg BT 512.60 490.00 Td (borrowings, ) Tj ET Q q 0 0 0 rg BT 563.80 490.00 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 478.00 Td (change ) Tj ET Q q 0 0 0 rg BT 66.88 478.00 Td (in ) Tj ET Q q 0 0 0 rg BT 77.22 478.00 Td (the ) Tj ET Q q 0 0 0 rg BT 92.00 478.00 Td (remeasurement ) Tj ET Q q 0 0 0 rg BT 155.64 478.00 Td (basis ) Tj ET Q q 0 0 0 rg BT 178.21 478.00 Td (of ) Tj ET Q q 0 0 0 rg BT 189.10 478.00 Td (the ) Tj ET Q q 0 0 0 rg BT 203.88 478.00 Td (debt ) Tj ET Q q 0 0 0 rg BT 223.66 478.00 Td (would ) Tj ET Q q 0 0 0 rg BT 251.22 478.00 Td (be ) Tj ET Q q 0 0 0 rg BT 263.23 478.00 Td (subject ) Tj ET Q q 0 0 0 rg BT 294.12 478.00 Td (to ) Tj ET Q q 0 0 0 rg BT 304.46 478.00 Td (recognition ) Tj ET Q q 0 0 0 rg BT 352.56 478.00 Td (in ) Tj ET Q q 0 0 0 rg BT 362.90 478.00 Td (income ) Tj ET Q q 0 0 0 rg BT 394.90 478.00 Td (as ) Tj ET Q q 0 0 0 rg BT 405.79 478.00 Td (changes ) Tj ET Q q 0 0 0 rg BT 440.57 478.00 Td (occur) Tj ET Q q 0 0 0 rg BT 462.22 478.00 Td (. ) Tj ET Q q 0 0 0 rg BT 467.28 478.00 Td (For ) Tj ET Q q 0 0 0 rg BT 483.74 478.00 Td (additional ) Tj ET Q q 0 0 0 rg BT 526.29 478.00 Td (information, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 466.00 Td (refer ) Tj ET Q q 0 0 0 rg BT 57.37 466.00 Td (to ) Tj ET Q q 0 0 0 rg BT 67.65 466.00 Td (“Item ) Tj ET Q q 0 0 0 rg BT 92.91 466.00 Td (8. ) Tj ET Q q 0 0 0 rg BT 102.91 466.00 Td (Financial ) Tj ET Q q 0 0 0 rg BT 142.62 466.00 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.44 466.00 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 223.44 466.00 Td (. ) Tj ET Q q 0 0 0 rg BT 228.44 466.00 Td (Financial ) Tj ET Q q 0 0 0 rg BT 268.15 466.00 Td (Instruments ) Tj ET Q q 0 0 0 rg BT 317.87 466.00 Td (and ) Tj ET Q q 0 0 0 rg BT 334.81 466.00 Td (Fair ) Tj ET Q q 0 0 0 rg BT 353.24 466.00 Td (V) Tj ET Q q 0 0 0 rg BT 359.35 466.00 Td (alue ) Tj ET Q q 0 0 0 rg BT 378.50 466.00 Td (Measurements.”) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 446.80 Td (Inter) Tj ET Q q 0 0 0 rg BT 57.48 446.80 Td (est Rate Risk) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 427.60 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 427.60 Td (e ) Tj ET Q q 0 0 0 rg BT 52.13 427.60 Td (use ) Tj ET Q q 0 0 0 rg BT 68.51 427.60 Td (fixed-to-floating ) Tj ET Q q 0 0 0 rg BT 137.65 427.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 170.13 427.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 188.17 427.60 Td (swap ) Tj ET Q q 0 0 0 rg BT 211.77 427.60 Td (contracts ) Tj ET Q q 0 0 0 rg BT 250.92 427.60 Td (designated ) Tj ET Q q 0 0 0 rg BT 296.73 427.60 Td (as ) Tj ET Q q 0 0 0 rg BT 308.11 427.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 325.04 427.60 Td (value ) Tj ET Q q 0 0 0 rg BT 349.74 427.60 Td (hedges ) Tj ET Q q 0 0 0 rg BT 380.56 427.60 Td (and ) Tj ET Q q 0 0 0 rg BT 398.05 427.60 Td (forward ) Tj ET Q q 0 0 0 rg BT 432.75 427.60 Td (starting ) Tj ET Q q 0 0 0 rg BT 465.80 427.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 498.28 427.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 516.32 427.60 Td (swap ) Tj ET Q q 0 0 0 rg BT 539.92 427.60 Td (contracts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.60 Td (designated ) Tj ET Q q 0 0 0 rg BT 81.25 415.60 Td (as ) Tj ET Q q 0 0 0 rg BT 92.06 415.60 Td (cash ) Tj ET Q q 0 0 0 rg BT 112.31 415.60 Td (flow ) Tj ET Q q 0 0 0 rg BT 133.12 415.60 Td (hedges ) Tj ET Q q 0 0 0 rg BT 163.38 415.60 Td (as ) Tj ET Q q 0 0 0 rg BT 174.19 415.60 Td (part ) Tj ET Q q 0 0 0 rg BT 192.22 415.60 Td (of ) Tj ET Q q 0 0 0 rg BT 203.03 415.60 Td (our ) Tj ET Q q 0 0 0 rg BT 218.84 415.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 250.76 415.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 268.23 415.60 Td (risk ) Tj ET Q q 0 0 0 rg BT 285.71 415.60 Td (management ) Tj ET Q q 0 0 0 rg BT 339.28 415.60 Td (strategy) Tj ET Q q 0 0 0 rg BT 370.29 415.60 Td (. ) Tj ET Q q 0 0 0 rg BT 375.09 415.60 Td (These ) Tj ET Q q 0 0 0 rg BT 401.45 415.60 Td (contracts ) Tj ET Q q 0 0 0 rg BT 440.03 415.60 Td (are ) Tj ET Q q 0 0 0 rg BT 454.72 415.60 Td (intended ) Tj ET Q q 0 0 0 rg BT 491.64 415.60 Td (to ) Tj ET Q q 0 0 0 rg BT 501.90 415.60 Td (provide ) Tj ET Q q 0 0 0 rg BT 534.93 415.60 Td (us ) Tj ET Q q 0 0 0 rg BT 546.30 415.60 Td (with ) Tj ET Q q 0 0 0 rg BT 566.56 415.60 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 403.60 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 83.65 403.60 Td (balance ) Tj ET Q q 0 0 0 rg BT 116.30 403.60 Td (of ) Tj ET Q q 0 0 0 rg BT 126.75 403.60 Td (fixed ) Tj ET Q q 0 0 0 rg BT 149.42 403.60 Td (and ) Tj ET Q q 0 0 0 rg BT 165.98 403.60 Td (floating ) Tj ET Q q 0 0 0 rg BT 199.20 403.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 216.30 403.60 Td (debt, ) Tj ET Q q 0 0 0 rg BT 238.14 403.60 Td (and ) Tj ET Q q 0 0 0 rg BT 254.70 403.60 Td (forward ) Tj ET Q q 0 0 0 rg BT 288.47 403.60 Td (starting ) Tj ET Q q 0 0 0 rg BT 320.58 403.60 Td (swap ) Tj ET Q q 0 0 0 rg BT 343.25 403.60 Td (contracts ) Tj ET Q q 0 0 0 rg BT 381.46 403.60 Td (are ) Tj ET Q q 0 0 0 rg BT 395.79 403.60 Td (used ) Tj ET Q q 0 0 0 rg BT 416.24 403.60 Td (to ) Tj ET Q q 0 0 0 rg BT 426.14 403.60 Td (manage ) Tj ET Q q 0 0 0 rg BT 459.35 403.60 Td (the ) Tj ET Q q 0 0 0 rg BT 473.69 403.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 505.24 403.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 522.34 403.60 Td (of ) Tj ET Q q 0 0 0 rg BT 532.79 403.60 Td (future ) Tj ET Q q 0 0 0 rg BT 558.79 403.60 Td (debt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 391.60 Td (issuances. ) Tj ET Q q 0 0 0 rg BT 78.56 391.60 Td (W) Tj ET Q q 0 0 0 rg BT 87.19 391.60 Td (e ) Tj ET Q q 0 0 0 rg BT 94.10 391.60 Td (estimate ) Tj ET Q q 0 0 0 rg BT 129.88 391.60 Td (that ) Tj ET Q q 0 0 0 rg BT 147.34 391.60 Td (an ) Tj ET Q q 0 0 0 rg BT 159.24 391.60 Td (increase ) Tj ET Q q 0 0 0 rg BT 194.46 391.60 Td (of ) Tj ET Q q 0 0 0 rg BT 205.26 391.60 Td (100 ) Tj ET Q q 0 0 0 rg BT 222.72 391.60 Td (basis ) Tj ET Q q 0 0 0 rg BT 245.19 391.60 Td (points ) Tj ET Q q 0 0 0 rg BT 272.10 391.60 Td (in ) Tj ET Q q 0 0 0 rg BT 282.34 391.60 Td (short-term ) Tj ET Q q 0 0 0 rg BT 326.46 391.60 Td (or ) Tj ET Q q 0 0 0 rg BT 337.26 391.60 Td (long-term ) Tj ET Q q 0 0 0 rg BT 379.16 391.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 411.06 391.60 Td (rates ) Tj ET Q q 0 0 0 rg BT 432.40 391.60 Td (would ) Tj ET Q q 0 0 0 rg BT 459.86 391.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 496.74 391.60 Td (the ) Tj ET Q q 0 0 0 rg BT 511.42 391.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 527.77 391.60 Td (value ) Tj ET Q q 0 0 0 rg BT 551.89 391.60 Td (of ) Tj ET Q q 0 0 0 rg BT 562.68 391.60 Td (our ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 379.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 67.73 379.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 85.01 379.60 Td (swap ) Tj ET Q q 0 0 0 rg BT 107.85 379.60 Td (contracts ) Tj ET Q q 0 0 0 rg BT 146.24 379.60 Td (by ) Tj ET Q q 0 0 0 rg BT 158.53 379.60 Td ($36 ) Tj ET Q q 0 0 0 rg BT 175.83 379.60 Td (million, ) Tj ET Q q 0 0 0 rg BT 209.51 379.60 Td (or ) Tj ET Q q 0 0 0 rg BT 220.14 379.60 Td (a ) Tj ET Q q 0 0 0 rg BT 226.87 379.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 263.58 379.60 Td (of ) Tj ET Q q 0 0 0 rg BT 274.20 379.60 Td (100 ) Tj ET Q q 0 0 0 rg BT 291.50 379.60 Td (basis ) Tj ET Q q 0 0 0 rg BT 313.79 379.60 Td (points ) Tj ET Q q 0 0 0 rg BT 340.53 379.60 Td (in ) Tj ET Q q 0 0 0 rg BT 350.60 379.60 Td (short-term ) Tj ET Q q 0 0 0 rg BT 394.55 379.60 Td (or ) Tj ET Q q 0 0 0 rg BT 405.18 379.60 Td (long-term ) Tj ET Q q 0 0 0 rg BT 446.91 379.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 478.63 379.60 Td (rates ) Tj ET Q q 0 0 0 rg BT 499.80 379.60 Td (would ) Tj ET Q q 0 0 0 rg BT 527.10 379.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 563.81 379.60 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 367.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 52.52 367.60 Td (value ) Tj ET Q q 0 0 0 rg BT 76.82 367.60 Td (of ) Tj ET Q q 0 0 0 rg BT 87.79 367.60 Td (our ) Tj ET Q q 0 0 0 rg BT 103.76 367.60 Td (forward ) Tj ET Q q 0 0 0 rg BT 138.05 367.60 Td (starting ) Tj ET Q q 0 0 0 rg BT 170.69 367.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 202.76 367.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 220.39 367.60 Td (swap ) Tj ET Q q 0 0 0 rg BT 243.58 367.60 Td (contracts ) Tj ET Q q 0 0 0 rg BT 282.32 367.60 Td (by ) Tj ET Q q 0 0 0 rg BT 294.96 367.60 Td ($125 ) Tj ET Q q 0 0 0 rg BT 317.60 367.60 Td (million, ) Tj ET Q q 0 0 0 rg BT 351.63 367.60 Td (thereby ) Tj ET Q q 0 0 0 rg BT 384.26 367.60 Td (reducing ) Tj ET Q q 0 0 0 rg BT 421.89 367.60 Td (earnings ) Tj ET Q q 0 0 0 rg BT 458.41 367.60 Td (over ) Tj ET Q q 0 0 0 rg BT 478.82 367.60 Td (the ) Tj ET Q q 0 0 0 rg BT 493.68 367.60 Td (remaining ) Tj ET Q q 0 0 0 rg BT 536.86 367.60 Td (life ) Tj ET Q q 0 0 0 rg BT 552.83 367.60 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 367.60 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.60 Td (contracts.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 331.60 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 331.60 Td (e ) Tj ET Q q 0 0 0 rg BT 52.30 331.60 Td (estimate ) Tj ET Q q 0 0 0 rg BT 88.85 331.60 Td (that ) Tj ET Q q 0 0 0 rg BT 107.07 331.60 Td (an ) Tj ET Q q 0 0 0 rg BT 119.74 331.60 Td (increase ) Tj ET Q q 0 0 0 rg BT 155.72 331.60 Td (of ) Tj ET Q q 0 0 0 rg BT 167.27 331.60 Td (100 ) Tj ET Q q 0 0 0 rg BT 185.50 331.60 Td (basis ) Tj ET Q q 0 0 0 rg BT 208.73 331.60 Td (points ) Tj ET Q q 0 0 0 rg BT 236.40 331.60 Td (in ) Tj ET Q q 0 0 0 rg BT 247.41 331.60 Td (long-term ) Tj ET Q q 0 0 0 rg BT 290.07 331.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 322.73 331.60 Td (rates ) Tj ET Q q 0 0 0 rg BT 344.83 331.60 Td (would ) Tj ET Q q 0 0 0 rg BT 373.06 331.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 410.70 331.60 Td (the ) Tj ET Q q 0 0 0 rg BT 426.14 331.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 443.24 331.60 Td (value ) Tj ET Q q 0 0 0 rg BT 468.13 331.60 Td (of ) Tj ET Q q 0 0 0 rg BT 479.68 331.60 Td (long-term ) Tj ET Q q 0 0 0 rg BT 522.34 331.60 Td (debt ) Tj ET Q q 0 0 0 rg BT 542.79 331.60 Td (by ) Tj ET Q q 0 0 0 rg BT 556.01 331.60 Td ($513 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 319.60 Td (million. ) Tj ET Q q 0 0 0 rg BT 70.23 319.60 Td (Our ) Tj ET Q q 0 0 0 rg BT 88.63 319.60 Td (marketable ) Tj ET Q q 0 0 0 rg BT 135.88 319.60 Td (securities ) Tj ET Q q 0 0 0 rg BT 176.49 319.60 Td (are ) Tj ET Q q 0 0 0 rg BT 191.54 319.60 Td (subject ) Tj ET Q q 0 0 0 rg BT 222.70 319.60 Td (to ) Tj ET Q q 0 0 0 rg BT 233.32 319.60 Td (changes ) Tj ET Q q 0 0 0 rg BT 268.37 319.60 Td (in ) Tj ET Q q 0 0 0 rg BT 278.99 319.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 295.71 319.60 Td (value ) Tj ET Q q 0 0 0 rg BT 320.20 319.60 Td (as ) Tj ET Q q 0 0 0 rg BT 331.37 319.60 Td (a ) Tj ET Q q 0 0 0 rg BT 338.65 319.60 Td (result ) Tj ET Q q 0 0 0 rg BT 363.71 319.60 Td (of ) Tj ET Q q 0 0 0 rg BT 374.88 319.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 407.16 319.60 Td (rate ) Tj ET Q q 0 0 0 rg BT 424.98 319.60 Td (fluctuations ) Tj ET Q q 0 0 0 rg BT 475.04 319.60 Td (and ) Tj ET Q q 0 0 0 rg BT 492.31 319.60 Td (other ) Tj ET Q q 0 0 0 rg BT 515.70 319.60 Td (market ) Tj ET Q q 0 0 0 rg BT 546.31 319.60 Td (factors. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 307.60 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.56 307.60 Td (policy ) Tj ET Q q 0 0 0 rg BT 82.56 307.60 Td (is ) Tj ET Q q 0 0 0 rg BT 92.24 307.60 Td (to ) Tj ET Q q 0 0 0 rg BT 103.03 307.60 Td (invest ) Tj ET Q q 0 0 0 rg BT 129.92 307.60 Td (only ) Tj ET Q q 0 0 0 rg BT 150.71 307.60 Td (in ) Tj ET Q q 0 0 0 rg BT 161.49 307.60 Td (institutions ) Tj ET Q q 0 0 0 rg BT 208.95 307.60 Td (that ) Tj ET Q q 0 0 0 rg BT 226.96 307.60 Td (meet ) Tj ET Q q 0 0 0 rg BT 249.40 307.60 Td (high ) Tj ET Q q 0 0 0 rg BT 270.18 307.60 Td (credit ) Tj ET Q q 0 0 0 rg BT 295.96 307.60 Td (quality ) Tj ET Q q 0 0 0 rg BT 326.74 307.60 Td (standards. ) Tj ET Q q 0 0 0 rg BT 369.80 307.60 Td (W) Tj ET Q q 0 0 0 rg BT 378.43 307.60 Td (e ) Tj ET Q q 0 0 0 rg BT 385.88 307.60 Td (estimate ) Tj ET Q q 0 0 0 rg BT 422.21 307.60 Td (that ) Tj ET Q q 0 0 0 rg BT 440.21 307.60 Td (an ) Tj ET Q q 0 0 0 rg BT 452.66 307.60 Td (increase ) Tj ET Q q 0 0 0 rg BT 488.42 307.60 Td (of ) Tj ET Q q 0 0 0 rg BT 499.76 307.60 Td (100 ) Tj ET Q q 0 0 0 rg BT 517.77 307.60 Td (basis ) Tj ET Q q 0 0 0 rg BT 540.77 307.60 Td (points ) Tj ET Q q 0 0 0 rg BT 568.23 307.60 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 295.60 Td (interest ) Tj ET Q q 0 0 0 rg BT 67.93 295.60 Td (rates ) Tj ET Q q 0 0 0 rg BT 89.31 295.60 Td (in ) Tj ET Q q 0 0 0 rg BT 99.59 295.60 Td (general ) Tj ET Q q 0 0 0 rg BT 131.51 295.60 Td (would ) Tj ET Q q 0 0 0 rg BT 159.01 295.60 Td (decrease ) Tj ET Q q 0 0 0 rg BT 195.93 295.60 Td (the ) Tj ET Q q 0 0 0 rg BT 210.64 295.60 Td (fair ) Tj ET Q q 0 0 0 rg BT 227.02 295.60 Td (value ) Tj ET Q q 0 0 0 rg BT 251.18 295.60 Td (of ) Tj ET Q q 0 0 0 rg BT 262.01 295.60 Td (our ) Tj ET Q q 0 0 0 rg BT 277.84 295.60 Td (debt ) Tj ET Q q 0 0 0 rg BT 297.55 295.60 Td (investment ) Tj ET Q q 0 0 0 rg BT 343.93 295.60 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 381.43 295.60 Td (by ) Tj ET Q q 0 0 0 rg BT 393.93 295.60 Td (approximately ) Tj ET Q q 0 0 0 rg BT 454.19 295.60 Td ($68 ) Tj ET Q q 0 0 0 rg BT 471.69 295.60 Td (million.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 276.45 Td (Cr) Tj ET Q q 0 0 0 rg BT 47.48 276.45 Td (edit Risk) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.20 Td (Although ) Tj ET Q q 0 0 0 rg BT 76.69 257.20 Td (not ) Tj ET Q q 0 0 0 rg BT 92.38 257.20 Td (material, ) Tj ET Q q 0 0 0 rg BT 130.55 257.20 Td (certain ) Tj ET Q q 0 0 0 rg BT 160.66 257.20 Td (European ) Tj ET Q q 0 0 0 rg BT 201.89 257.20 Td (government-backed ) Tj ET Q q 0 0 0 rg BT 284.21 257.20 Td (entities ) Tj ET Q q 0 0 0 rg BT 316.01 257.20 Td (with ) Tj ET Q q 0 0 0 rg BT 336.70 257.20 Td (a ) Tj ET Q q 0 0 0 rg BT 344.05 257.20 Td (higher ) Tj ET Q q 0 0 0 rg BT 372.50 257.20 Td (risk ) Tj ET Q q 0 0 0 rg BT 390.42 257.20 Td (of ) Tj ET Q q 0 0 0 rg BT 401.66 257.20 Td (default, ) Tj ET Q q 0 0 0 rg BT 434.83 257.20 Td (such ) Tj ET Q q 0 0 0 rg BT 456.07 257.20 Td (as ) Tj ET Q q 0 0 0 rg BT 467.32 257.20 Td (Greece, ) Tj ET Q q 0 0 0 rg BT 501.03 257.20 Td (Portugal, ) Tj ET Q q 0 0 0 rg BT 540.33 257.20 Td (Italy ) Tj ET Q q 0 0 0 rg BT 561.57 257.20 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.20 Td (Spain, ) Tj ET Q q 0 0 0 rg BT 63.55 245.20 Td (are ) Tj ET Q q 0 0 0 rg BT 78.03 245.20 Td (monitored ) Tj ET Q q 0 0 0 rg BT 121.40 245.20 Td (through ) Tj ET Q q 0 0 0 rg BT 154.78 245.20 Td (economic ) Tj ET Q q 0 0 0 rg BT 195.92 245.20 Td (factors, ) Tj ET Q q 0 0 0 rg BT 227.90 245.20 Td (including ) Tj ET Q q 0 0 0 rg BT 267.94 245.20 Td (credit ) Tj ET Q q 0 0 0 rg BT 292.98 245.20 Td (ratings, ) Tj ET Q q 0 0 0 rg BT 324.96 245.20 Td (credit-default ) Tj ET Q q 0 0 0 rg BT 381.09 245.20 Td (swap ) Tj ET Q q 0 0 0 rg BT 403.92 245.20 Td (rates, ) Tj ET Q q 0 0 0 rg BT 427.56 245.20 Td (debt-to-gross ) Tj ET Q q 0 0 0 rg BT 482.60 245.20 Td (domestic ) Tj ET Q q 0 0 0 rg BT 520.98 245.20 Td (product ) Tj ET Q q 0 0 0 rg BT 553.79 245.20 Td (ratios ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.20 Td (and ) Tj ET Q q 0 0 0 rg BT 53.40 233.20 Td (other ) Tj ET Q q 0 0 0 rg BT 76.91 233.20 Td (entity ) Tj ET Q q 0 0 0 rg BT 102.65 233.20 Td (specific ) Tj ET Q q 0 0 0 rg BT 136.70 233.20 Td (factors. ) Tj ET Q q 0 0 0 rg BT 169.37 233.20 Td (Historically) Tj ET Q q 0 0 0 rg BT 215.94 233.20 Td (, ) Tj ET Q q 0 0 0 rg BT 221.40 233.20 Td (our ) Tj ET Q q 0 0 0 rg BT 237.69 233.20 Td (exposure ) Tj ET Q q 0 0 0 rg BT 276.75 233.20 Td (was ) Tj ET Q q 0 0 0 rg BT 295.27 233.20 Td (limited ) Tj ET Q q 0 0 0 rg BT 326.56 233.20 Td (by ) Tj ET Q q 0 0 0 rg BT 339.52 233.20 Td (factoring ) Tj ET Q q 0 0 0 rg BT 378.58 233.20 Td (receivables. ) Tj ET Q q 0 0 0 rg BT 429.01 233.20 Td (Our ) Tj ET Q q 0 0 0 rg BT 447.53 233.20 Td (credit ) Tj ET Q q 0 0 0 rg BT 473.26 233.20 Td (exposures ) Tj ET Q q 0 0 0 rg BT 516.21 233.20 Td (in ) Tj ET Q q 0 0 0 rg BT 526.95 233.20 Td (Europe ) Tj ET Q q 0 0 0 rg BT 558.79 233.20 Td (may ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.20 Td (increase ) Tj ET Q q 0 0 0 rg BT 71.25 221.20 Td (in ) Tj ET Q q 0 0 0 rg BT 81.53 221.20 Td (the ) Tj ET Q q 0 0 0 rg BT 96.25 221.20 Td (future ) Tj ET Q q 0 0 0 rg BT 122.63 221.20 Td (due ) Tj ET Q q 0 0 0 rg BT 139.56 221.20 Td (to ) Tj ET Q q 0 0 0 rg BT 149.84 221.20 Td (reductions ) Tj ET Q q 0 0 0 rg BT 194.00 221.20 Td (in ) Tj ET Q q 0 0 0 rg BT 204.28 221.20 Td (our ) Tj ET Q q 0 0 0 rg BT 220.11 221.20 Td (factoring ) Tj ET Q q 0 0 0 rg BT 258.70 221.20 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 315.06 221.20 Td (and ) Tj ET Q q 0 0 0 rg BT 332.00 221.20 Td (the ) Tj ET Q q 0 0 0 rg BT 346.72 221.20 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 382.00 221.20 Td (sovereign ) Tj ET Q q 0 0 0 rg BT 423.37 221.20 Td (debt ) Tj ET Q q 0 0 0 rg BT 443.09 221.20 Td (crisis.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 202.00 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 202.00 Td (e ) Tj ET Q q 0 0 0 rg BT 51.86 202.00 Td (monitor ) Tj ET Q q 0 0 0 rg BT 86.31 202.00 Td (our ) Tj ET Q q 0 0 0 rg BT 102.42 202.00 Td (investments ) Tj ET Q q 0 0 0 rg BT 152.98 202.00 Td (with ) Tj ET Q q 0 0 0 rg BT 173.54 202.00 Td (counterparties ) Tj ET Q q 0 0 0 rg BT 232.96 202.00 Td (with ) Tj ET Q q 0 0 0 rg BT 253.52 202.00 Td (the ) Tj ET Q q 0 0 0 rg BT 268.52 202.00 Td (objective ) Tj ET Q q 0 0 0 rg BT 307.96 202.00 Td (of ) Tj ET Q q 0 0 0 rg BT 319.07 202.00 Td (minimizing ) Tj ET Q q 0 0 0 rg BT 367.96 202.00 Td (concentrations ) Tj ET Q q 0 0 0 rg BT 429.06 202.00 Td (of ) Tj ET Q q 0 0 0 rg BT 440.17 202.00 Td (credit ) Tj ET Q q 0 0 0 rg BT 465.72 202.00 Td (risk. ) Tj ET Q q 0 0 0 rg BT 486.00 202.00 Td (Our ) Tj ET Q q 0 0 0 rg BT 504.33 202.00 Td (investment ) Tj ET Q q 0 0 0 rg BT 551.00 202.00 Td (policy ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 190.00 Td (establishes ) Tj ET Q q 0 0 0 rg BT 82.64 190.00 Td (limits ) Tj ET Q q 0 0 0 rg BT 108.73 190.00 Td (on ) Tj ET Q q 0 0 0 rg BT 122.05 190.00 Td (the ) Tj ET Q q 0 0 0 rg BT 137.58 190.00 Td (amount ) Tj ET Q q 0 0 0 rg BT 170.89 190.00 Td (and ) Tj ET Q q 0 0 0 rg BT 188.64 190.00 Td (time ) Tj ET Q q 0 0 0 rg BT 209.72 190.00 Td (to ) Tj ET Q q 0 0 0 rg BT 220.81 190.00 Td (maturity ) Tj ET Q q 0 0 0 rg BT 258.01 190.00 Td (of ) Tj ET Q q 0 0 0 rg BT 269.65 190.00 Td (investments ) Tj ET Q q 0 0 0 rg BT 320.74 190.00 Td (with ) Tj ET Q q 0 0 0 rg BT 341.83 190.00 Td (any ) Tj ET Q q 0 0 0 rg BT 359.58 190.00 Td (individual ) Tj ET Q q 0 0 0 rg BT 403.45 190.00 Td (counterparty) Tj ET Q q 0 0 0 rg BT 453.33 190.00 Td (. ) Tj ET Q q 0 0 0 rg BT 458.90 190.00 Td (The ) Tj ET Q q 0 0 0 rg BT 477.76 190.00 Td (policy ) Tj ET Q q 0 0 0 rg BT 506.07 190.00 Td (also ) Tj ET Q q 0 0 0 rg BT 525.49 190.00 Td (requires ) Tj ET Q q 0 0 0 rg BT 561.01 190.00 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 178.00 Td (investments ) Tj ET Q q 0 0 0 rg BT 86.27 178.00 Td (are ) Tj ET Q q 0 0 0 rg BT 100.98 178.00 Td (only ) Tj ET Q q 0 0 0 rg BT 121.26 178.00 Td (entered ) Tj ET Q q 0 0 0 rg BT 153.18 178.00 Td (into ) Tj ET Q q 0 0 0 rg BT 171.24 178.00 Td (with ) Tj ET Q q 0 0 0 rg BT 191.52 178.00 Td (corporate ) Tj ET Q q 0 0 0 rg BT 231.77 178.00 Td (and ) Tj ET Q q 0 0 0 rg BT 248.71 178.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 286.19 178.00 Td (institutions ) Tj ET Q q 0 0 0 rg BT 333.14 178.00 Td (that ) Tj ET Q q 0 0 0 rg BT 350.64 178.00 Td (meet ) Tj ET Q q 0 0 0 rg BT 372.57 178.00 Td (high ) Tj ET Q q 0 0 0 rg BT 392.85 178.00 Td (credit ) Tj ET Q q 0 0 0 rg BT 418.11 178.00 Td (quality ) Tj ET Q q 0 0 0 rg BT 448.39 178.00 Td (standards.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 158.80 Td (The ) Tj ET Q q 0 0 0 rg BT 54.44 158.80 Td (use ) Tj ET Q q 0 0 0 rg BT 70.67 158.80 Td (of ) Tj ET Q q 0 0 0 rg BT 81.90 158.80 Td (derivative ) Tj ET Q q 0 0 0 rg BT 124.78 158.80 Td (instruments ) Tj ET Q q 0 0 0 rg BT 174.34 158.80 Td (exposes ) Tj ET Q q 0 0 0 rg BT 208.89 158.80 Td (us ) Tj ET Q q 0 0 0 rg BT 220.68 158.80 Td (to ) Tj ET Q q 0 0 0 rg BT 231.36 158.80 Td (credit ) Tj ET Q q 0 0 0 rg BT 257.02 158.80 Td (risk. ) Tj ET Q q 0 0 0 rg BT 277.21 158.80 Td (When ) Tj ET Q q 0 0 0 rg BT 303.98 158.80 Td (the ) Tj ET Q q 0 0 0 rg BT 319.09 158.80 Td (fair ) Tj ET Q q 0 0 0 rg BT 335.87 158.80 Td (value ) Tj ET Q q 0 0 0 rg BT 360.42 158.80 Td (of ) Tj ET Q q 0 0 0 rg BT 371.65 158.80 Td (a ) Tj ET Q q 0 0 0 rg BT 378.98 158.80 Td (derivative ) Tj ET Q q 0 0 0 rg BT 421.86 158.80 Td (instrument ) Tj ET Q q 0 0 0 rg BT 467.53 158.80 Td (contract ) Tj ET Q q 0 0 0 rg BT 502.63 158.80 Td (is ) Tj ET Q q 0 0 0 rg BT 512.20 158.80 Td (positive, ) Tj ET Q q 0 0 0 rg BT 549.26 158.80 Td (we ) Tj ET Q q 0 0 0 rg BT 563.82 158.80 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 146.80 Td (exposed ) Tj ET Q q 0 0 0 rg BT 70.05 146.80 Td (to ) Tj ET Q q 0 0 0 rg BT 79.10 146.80 Td (credit ) Tj ET Q q 0 0 0 rg BT 103.14 146.80 Td (risk ) Tj ET Q q 0 0 0 rg BT 119.42 146.80 Td (if ) Tj ET Q q 0 0 0 rg BT 126.80 146.80 Td (the ) Tj ET Q q 0 0 0 rg BT 140.30 146.80 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 192.11 146.80 Td (fails ) Tj ET Q q 0 0 0 rg BT 210.60 146.80 Td (to ) Tj ET Q q 0 0 0 rg BT 219.65 146.80 Td (perform. ) Tj ET Q q 0 0 0 rg BT 255.55 146.80 Td (When ) Tj ET Q q 0 0 0 rg BT 280.70 146.80 Td (the ) Tj ET Q q 0 0 0 rg BT 294.19 146.80 Td (fair ) Tj ET Q q 0 0 0 rg BT 309.35 146.80 Td (value ) Tj ET Q q 0 0 0 rg BT 332.28 146.80 Td (of ) Tj ET Q q 0 0 0 rg BT 341.89 146.80 Td (a ) Tj ET Q q 0 0 0 rg BT 347.60 146.80 Td (derivative ) Tj ET Q q 0 0 0 rg BT 388.86 146.80 Td (instrument ) Tj ET Q q 0 0 0 rg BT 432.91 146.80 Td (contract ) Tj ET Q q 0 0 0 rg BT 466.39 146.80 Td (is ) Tj ET Q q 0 0 0 rg BT 474.34 146.80 Td (negative, ) Tj ET Q q 0 0 0 rg BT 511.98 146.80 Td (the ) Tj ET Q q 0 0 0 rg BT 525.48 146.80 Td (counterparty ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.80 Td (is ) Tj ET Q q 0 0 0 rg BT 44.96 134.80 Td (exposed ) Tj ET Q q 0 0 0 rg BT 80.01 134.80 Td (to ) Tj ET Q q 0 0 0 rg BT 90.07 134.80 Td (credit ) Tj ET Q q 0 0 0 rg BT 115.12 134.80 Td (risk ) Tj ET Q q 0 0 0 rg BT 132.41 134.80 Td (if ) Tj ET Q q 0 0 0 rg BT 140.80 134.80 Td (we ) Tj ET Q q 0 0 0 rg BT 154.75 134.80 Td (fail ) Tj ET Q q 0 0 0 rg BT 170.36 134.80 Td (to ) Tj ET Q q 0 0 0 rg BT 180.42 134.80 Td (perform ) Tj ET Q q 0 0 0 rg BT 214.91 134.80 Td (our ) Tj ET Q q 0 0 0 rg BT 230.53 134.80 Td (obligation. ) Tj ET Q q 0 0 0 rg BT 275.86 134.80 Td (Collateral ) Tj ET Q q 0 0 0 rg BT 317.58 134.80 Td (is ) Tj ET Q q 0 0 0 rg BT 326.53 134.80 Td (not ) Tj ET Q q 0 0 0 rg BT 341.60 134.80 Td (required ) Tj ET Q q 0 0 0 rg BT 377.20 134.80 Td (by ) Tj ET Q q 0 0 0 rg BT 389.48 134.80 Td (any ) Tj ET Q q 0 0 0 rg BT 406.21 134.80 Td (party ) Tj ET Q q 0 0 0 rg BT 429.04 134.80 Td (whether ) Tj ET Q q 0 0 0 rg BT 463.53 134.80 Td (derivatives ) Tj ET Q q 0 0 0 rg BT 509.69 134.80 Td (are ) Tj ET Q q 0 0 0 rg BT 524.18 134.80 Td (in ) Tj ET Q q 0 0 0 rg BT 534.24 134.80 Td (an ) Tj ET Q q 0 0 0 rg BT 545.97 134.80 Td (asset ) Tj ET Q q 0 0 0 rg BT 567.69 134.80 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 122.80 Td (liability ) Tj ET Q q 0 0 0 rg BT 69.86 122.80 Td (position. ) Tj ET Q q 0 0 0 rg BT 107.13 122.80 Td (W) Tj ET Q q 0 0 0 rg BT 115.77 122.80 Td (e ) Tj ET Q q 0 0 0 rg BT 122.96 122.80 Td (have ) Tj ET Q q 0 0 0 rg BT 144.59 122.80 Td (a ) Tj ET Q q 0 0 0 rg BT 151.77 122.80 Td (policy ) Tj ET Q q 0 0 0 rg BT 179.52 122.80 Td (of ) Tj ET Q q 0 0 0 rg BT 190.60 122.80 Td (diversifying ) Tj ET Q q 0 0 0 rg BT 241.67 122.80 Td (derivatives ) Tj ET Q q 0 0 0 rg BT 288.29 122.80 Td (with ) Tj ET Q q 0 0 0 rg BT 308.82 122.80 Td (counterparties ) Tj ET Q q 0 0 0 rg BT 368.21 122.80 Td (to ) Tj ET Q q 0 0 0 rg BT 378.74 122.80 Td (mitigate ) Tj ET Q q 0 0 0 rg BT 414.25 122.80 Td (the ) Tj ET Q q 0 0 0 rg BT 429.22 122.80 Td (overall ) Tj ET Q q 0 0 0 rg BT 459.73 122.80 Td (risk ) Tj ET Q q 0 0 0 rg BT 477.48 122.80 Td (of ) Tj ET Q q 0 0 0 rg BT 488.56 122.80 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 541.84 122.80 Td (defaults. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 110.80 Td (For ) Tj ET Q q 0 0 0 rg BT 52.39 110.80 Td (additional ) Tj ET Q q 0 0 0 rg BT 94.88 110.80 Td (information, ) Tj ET Q q 0 0 0 rg BT 147.09 110.80 Td (refer ) Tj ET Q q 0 0 0 rg BT 168.46 110.80 Td (to ) Tj ET Q q 0 0 0 rg BT 178.74 110.80 Td (“Item ) Tj ET Q q 0 0 0 rg BT 204.00 110.80 Td (8. ) Tj ET Q q 0 0 0 rg BT 214.00 110.80 Td (Financial ) Tj ET Q q 0 0 0 rg BT 253.71 110.80 Td (Statements—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.54 110.80 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 334.54 110.80 Td (. ) Tj ET Q q 0 0 0 rg BT 339.54 110.80 Td (Financial ) Tj ET Q q 0 0 0 rg BT 379.25 110.80 Td (Instruments ) Tj ET Q q 0 0 0 rg BT 428.96 110.80 Td (and ) Tj ET Q q 0 0 0 rg BT 445.90 110.80 Td (Fair ) Tj ET Q q 0 0 0 rg BT 464.33 110.80 Td (V) Tj ET Q q 0 0 0 rg BT 470.44 110.80 Td (alue ) Tj ET Q q 0 0 0 rg BT 489.60 110.80 Td (Measurements.”) Tj ET Q endstream endobj 107 0 obj <> endobj 108 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (53) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 746.23 Td (Item 8.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 746.23 Td (FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 551.00 742.00 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 217.15 721.00 Td (BRIST) Tj ET Q q 0 0 0 rg BT 246.98 721.00 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 373.47 721.00 Td (ANY) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 195.45 709.00 Td (CONSOLIDA) Tj ET Q q 0 0 0 rg BT 255.27 709.00 Td (TED ST) Tj ET Q q 0 0 0 rg BT 289.82 709.00 Td (A) Tj ET Q q 0 0 0 rg BT 296.30 709.00 Td (TEMENTS OF) Tj ET Q q 0 0 0 rg BT 361.22 709.00 Td ( EARNINGS) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 215.20 697.00 Td (Dollars in Millions, Except Per) Tj ET Q q 0 0 0 rg BT 346.40 697.00 Td ( Shar) Tj ET Q q 0 0 0 rg BT 369.28 697.00 Td (e Data) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 649.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 649.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 649.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 649.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 649.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 649.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 649.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 623.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 623.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 623.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 623.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 623.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 623.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 623.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 597.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 597.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 597.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 597.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 597.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 597.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 597.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 571.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 571.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 571.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 571.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 571.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 571.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 571.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 545.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 545.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 545.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 545.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 545.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 545.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 545.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 519.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 519.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 519.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 519.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 519.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 519.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 519.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 493.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 493.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 493.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 493.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 493.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 493.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 493.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 467.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 467.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 467.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 467.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 467.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 467.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 467.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 441.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 441.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 441.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 441.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 441.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 441.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 441.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 415.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 415.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 415.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 415.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 415.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 415.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 415.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 389.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 381.50 389.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 385.50 389.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 389.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 389.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 389.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 389.70 61.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 662.7 m 446.5 662.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 446.5 662.7 m 450.5 662.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 662.7 m 511.5 662.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 662.7 m 515.5 662.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 662.7 m 576.5 662.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 649.7 m 446.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 649.7 m 511.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 649.7 m 576.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 649.7 m 446.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 649.7 m 511.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 649.7 m 576.5 649.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 623.7 m 446.5 623.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 623.7 m 511.5 623.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 623.7 m 576.5 623.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 545.7 m 446.5 545.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 545.7 m 511.5 545.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 545.7 m 576.5 545.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 532.7 m 446.5 532.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 532.7 m 511.5 532.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 532.7 m 576.5 532.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 493.7 m 446.5 493.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 493.7 m 511.5 493.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 493.7 m 576.5 493.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 480.7 m 446.5 480.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 480.7 m 511.5 480.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 480.7 m 576.5 480.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 467.7 m 446.5 467.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 467.7 m 511.5 467.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 467.7 m 576.5 467.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 455.7 m 446.5 455.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 385.5 453.7 m 446.5 453.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 455.7 m 511.5 455.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 453.7 m 511.5 453.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 455.7 m 576.5 455.7 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 453.7 m 576.5 453.7 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 666.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 436.20 666.93 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 39.00 653.93 Td (EARNINGS) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 407.50 653.93 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 472.50 653.93 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.50 653.93 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.27 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.00 640.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.15 640.27 Td (17,702) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.00 640.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 640.27 Td (14,045) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 640.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 640.27 Td (11,660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 627.27 Td (Alliance and other revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 627.27 Td (1,725) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 627.27 Td (2,515) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 627.27 Td (4,219) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 614.27 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.15 614.27 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 614.27 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 614.27 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 588.27 Td (Cost of products sold) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 588.27 Td (4,946) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 588.27 Td (3,909) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 588.27 Td (3,932) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 575.27 Td (Marketing, selling and administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 575.27 Td (4,911) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 575.27 Td (4,841) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 575.27 Td (4,822) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 562.27 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 562.27 Td (4,940) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 562.27 Td (5,920) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 562.27 Td (4,534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 549.27 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.80 549.32 Td (\(1,285) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.65 549.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.30 549.32 Td (\(187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 549.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 549.27 Td (210) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 43.50 536.27 Td (Total Expenses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.15 536.27 Td (13,512) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.15 536.27 Td (14,483) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 536.27 Td (13,498) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 510.27 Td (Earnings Before Income Taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 510.27 Td (5,915) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 510.27 Td (2,077) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 510.27 Td (2,381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 497.27 Td (Provision for Income Taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 497.27 Td (1,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 497.27 Td (446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 497.27 Td (352) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 484.27 Td (Net Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 484.27 Td (4,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 484.27 Td (1,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 484.27 Td (2,029) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 471.27 Td (Net Earnings Attributable to Noncontrolling Interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.65 471.27 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 471.27 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 471.27 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 458.27 Td (Net Earnings Attributable to BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.00 458.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 458.27 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.00 458.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 458.27 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 458.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 458.27 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 432.27 Td (Earnings per Common Share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 419.27 Td (Basic) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.00 419.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.15 419.27 Td (2.67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.00 419.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 419.27 Td (0.94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 419.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 419.27 Td (1.21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 406.27 Td (Diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.00 406.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.15 406.27 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.00 406.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 406.27 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 406.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 406.27 Td (1.20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 380.27 Td (Cash dividends declared per common share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.00 380.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.15 380.27 Td (1.53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.00 380.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 380.27 Td (1.49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 380.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 380.27 Td (1.45) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 154.75 332.20 Td (CONSOLIDA) Tj ET Q q 0 0 0 rg BT 214.57 332.20 Td (TED ST) Tj ET Q q 0 0 0 rg BT 249.13 332.20 Td (A) Tj ET Q q 0 0 0 rg BT 255.60 332.20 Td (TEMENTS OF) Tj ET Q q 0 0 0 rg BT 320.52 332.20 Td ( COMPREHENSIVE INCOME) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 266.25 320.20 Td (Dollars in Millions) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 274.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 274.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 274.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 274.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 274.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 274.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 274.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 248.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 248.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 248.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 248.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 248.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 248.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 248.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 222.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 222.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 222.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 222.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 222.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 222.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 222.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 196.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 196.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 196.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 196.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 196.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 196.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 196.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 170.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 170.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 170.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 170.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 170.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 170.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 170.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 144.70 345.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 144.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 144.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.50 144.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.50 144.70 61.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 144.70 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 144.70 61.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 287.70000000000005 m 445.5 287.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 445.5 287.70000000000005 m 449.5 287.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 287.70000000000005 m 510.5 287.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 510.5 287.70000000000005 m 514.5 287.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 287.70000000000005 m 575.5 287.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 274.70000000000005 m 445.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 274.70000000000005 m 510.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 274.70000000000005 m 575.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 274.70000000000005 m 445.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 274.70000000000005 m 510.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 274.70000000000005 m 575.5 274.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 196.70000000000005 m 445.5 196.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 196.70000000000005 m 510.5 196.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 196.70000000000005 m 575.5 196.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 183.70000000000005 m 445.5 183.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 183.70000000000005 m 510.5 183.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 183.70000000000005 m 575.5 183.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 144.70000000000005 m 445.5 144.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 144.70000000000005 m 510.5 144.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 144.70000000000005 m 575.5 144.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 132.70000000000005 m 445.5 132.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 130.70000000000005 m 445.5 130.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 132.70000000000005 m 510.5 132.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449.5 130.70000000000005 m 510.5 130.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 132.70000000000005 m 575.5 132.70000000000005 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 130.70000000000005 m 575.5 130.70000000000005 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 291.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 435.20 291.93 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 38.00 278.93 Td (COMPREHENSIVE INCOME) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 406.50 278.93 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.50 278.93 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 536.50 278.93 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 265.27 Td (Net Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.00 265.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.15 265.27 Td (4,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.00 265.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 265.27 Td (1,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.00 265.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 265.27 Td (2,029) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 252.27 Td (Other Comprehensive Income/\(Loss\), net of taxes and reclassifications to earnings:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 239.27 Td (Derivatives qualifying as cash flow hedges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.65 239.27 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.30 239.32 Td (\(51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 239.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 239.27 Td (69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 226.27 Td (Pension and postretirement benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.30 226.32 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.65 226.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.65 226.27 Td (101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 226.27 Td (\(324) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 226.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 213.27 Td (Available-for-sale securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 213.27 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.30 213.32 Td (\(54) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 213.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 566.65 213.27 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 200.27 Td (Foreign currency translation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.30 200.32 Td (\(38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.65 200.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.30 200.32 Td (\(39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 200.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.30 200.27 Td (\(32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 200.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 187.27 Td (Total Other Comprehensive Loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.30 187.32 Td (\(35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.65 187.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.30 187.32 Td (\(43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 187.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 187.27 Td (\(284) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 187.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 161.27 Td (Comprehensive Income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.15 161.27 Td (4,472) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 161.27 Td (1,588) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 161.27 Td (1,745) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 148.27 Td (Comprehensive Income Attributable to Noncontrolling Interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 148.27 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.65 148.27 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 148.27 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 135.27 Td (Comprehensive Income Attributable to BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.00 135.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.15 135.27 Td (4,422) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.00 135.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 135.27 Td (1,522) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.00 135.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 135.27 Td (1,720) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 131.30 111.20 Td (The accompanying notes are an integral part of these consolidated financial statements.) Tj ET Q endstream endobj 109 0 obj <> endobj 110 0 obj <> stream BT /F2 9.50 Tf ET q 0 0 0 rg BT 221.60 773.10 Td (BRIST) Tj ET Q q 0 0 0 rg BT 249.94 773.10 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 370.11 773.10 Td (ANY) Tj ET Q BT /F2 9.50 Tf ET q 0 0 0 rg BT 223.70 761.70 Td (CONSOLIDA) Tj ET Q q 0 0 0 rg BT 280.53 761.70 Td (TED BALANCE SHEETS) Tj ET Q BT /F2 9.50 Tf ET q 0 0 0 rg BT 197.90 750.30 Td (Dollars in Millions, Except Shar) Tj ET Q q 0 0 0 rg BT 327.84 750.30 Td (e and Per) Tj ET Q q 0 0 0 rg BT 366.19 750.30 Td ( Shar) Tj ET Q q 0 0 0 rg BT 387.92 750.30 Td (e Data) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 33.60 Td (54) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 713.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 713.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 713.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 713.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 713.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 689.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 689.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 689.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 689.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 689.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 665.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 665.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 665.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 665.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 665.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 641.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 641.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 641.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 641.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 641.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 617.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 617.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 617.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 617.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 617.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 593.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 593.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 593.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 593.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 593.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 569.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 569.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 569.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 569.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 569.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 545.00 383.00 -11.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 545.00 4.00 -11.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 545.00 61.00 -11.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 545.00 4.00 -11.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 545.00 61.00 -11.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 523.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 523.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 523.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 523.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 523.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 499.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 499.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 499.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 499.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 499.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 475.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 475.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 475.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 475.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 475.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 451.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 451.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 451.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 451.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 451.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 427.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 427.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 427.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 427.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 427.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 403.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 403.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 403.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 403.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 403.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 380.00 383.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 380.00 4.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 380.00 61.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 380.00 4.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 380.00 61.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 359.00 383.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 359.00 4.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 359.00 61.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 359.00 4.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 359.00 61.00 -10.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 336.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 336.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 336.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 336.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 336.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 303.00 383.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 303.00 4.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 303.00 61.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 303.00 4.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 303.00 61.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 271.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 271.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 271.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 271.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 271.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 247.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 247.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 247.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 247.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 247.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 223.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 223.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 223.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 223.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 223.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.00 199.00 383.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 432.00 199.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 436.00 199.00 61.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.00 199.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.00 199.00 61.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 723 m 497 723 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497 723 m 501 723 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 723 m 562 723 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 713 m 497 713 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 713 m 562 713 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 641 m 497 641 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 629 m 497 629 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 641 m 562 641 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 629 m 562 629 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 557 m 497 557 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 546 m 497 546 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 544 m 497 544 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 557 m 562 557 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 546 m 562 546 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 544 m 562 544 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 451 m 497 451 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 439 m 497 439 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 451 m 562 451 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 439 m 562 439 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 391 m 497 391 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 391 m 562 391 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 380 m 497 380 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 380 m 562 380 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 235 m 497 235 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 235 m 562 235 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 211 m 497 211 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 211 m 562 211 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 199 m 497 199 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 199 m 562 199 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 188 m 497 188 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 436 186 m 497 186 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 188 m 562 188 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501 186 m 562 186 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 475.25 725.13 Td (December 31,) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 51.50 714.79 Td (ASSETS) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.00 715.13 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 523.00 715.13 Td (2015) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 704.61 Td (Current Assets:) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 692.61 Td (Cash and cash equivalents) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 438.50 692.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 692.61 Td (4,237) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 503.50 692.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 692.61 Td (2,385) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 680.61 Td (Marketable securities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 680.61 Td (2,113) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 680.61 Td (1,885) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 668.61 Td (Receivables) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 668.61 Td (5,543) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 668.61 Td (4,299) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 656.61 Td (Inventories) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 656.61 Td (1,241) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 656.61 Td (1,221) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 644.61 Td (Prepaid expenses and other) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 644.61 Td (570) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 644.61 Td (625) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 81.50 632.61 Td (Total Current Assets) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 632.61 Td (13,704) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 632.61 Td (10,415) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 620.61 Td (Property, plant and equipment) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 620.61 Td (4,980) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 620.61 Td (4,412) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 608.61 Td (Goodwill) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 608.61 Td (6,875) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 608.61 Td (6,881) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 596.61 Td (Other intangible assets) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 596.61 Td (1,385) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 596.61 Td (1,419) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 584.61 Td (Deferred income taxes) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 584.61 Td (2,996) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 584.61 Td (2,844) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 572.61 Td (Marketable securities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 572.61 Td (2,719) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 572.61 Td (4,660) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 560.61 Td (Other assets) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 560.61 Td (1,048) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 560.61 Td (1,117) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 548.61 Td (Total Assets) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 438.50 548.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 548.61 Td (33,707) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 503.50 548.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 548.61 Td (31,748) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 51.50 525.74 Td (LIABILITIES) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 514.61 Td (Current Liabilities:) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 502.61 Td (Short-term borrowings and current portion of long-term debt) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 438.50 502.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 502.61 Td (992) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 503.50 502.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 502.61 Td (139) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 490.61 Td (Accounts payable) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 490.61 Td (1,664) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 490.61 Td (1,565) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 478.61 Td (Accrued liabilities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 478.61 Td (5,271) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 478.61 Td (4,738) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 466.61 Td (Deferred income) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 466.61 Td (762) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 466.61 Td (1,003) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 69.50 454.61 Td (Income taxes payable) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 454.61 Td (152) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 454.61 Td (572) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 81.50 442.61 Td (Total Current Liabilities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 442.61 Td (8,841) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 442.61 Td (8,017) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 430.61 Td (Deferred income) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 430.61 Td (547) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 430.61 Td (586) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 418.61 Td (Income taxes payable) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 418.61 Td (973) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 418.61 Td (742) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 406.61 Td (Pension and other liabilities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 406.61 Td (1,283) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 406.61 Td (1,429) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 394.61 Td (Long-term debt) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 394.61 Td (5,716) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 394.61 Td (6,550) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 75.50 382.61 Td (Total Liabilities) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 382.61 Td (17,360) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 382.61 Td (17,324) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 361.61 Td (Commitments and contingencies \(Note 18\)) Tj ET Q BT /F2 8.50 Tf ET q 0 0 0 rg BT 51.50 340.74 Td (EQUITY) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 327.61 Td (Bristol-Myers Squibb Company Shareholders’ Equity:) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 315.61 Td (Preferred ) Tj ET Q q 0 0 0 rg BT 98.35 315.61 Td (stock, ) Tj ET Q q 0 0 0 rg BT 121.65 315.61 Td ($2 ) Tj ET Q q 0 0 0 rg BT 133.38 315.61 Td (convertible ) Tj ET Q q 0 0 0 rg BT 174.85 315.61 Td (series, ) Tj ET Q q 0 0 0 rg BT 199.56 315.61 Td (par ) Tj ET Q q 0 0 0 rg BT 213.64 315.61 Td (value ) Tj ET Q q 0 0 0 rg BT 235.28 315.61 Td ($1 ) Tj ET Q q 0 0 0 rg BT 247.01 315.61 Td (per ) Tj ET Q q 0 0 0 rg BT 261.10 315.61 Td (share: ) Tj ET Q q 0 0 0 rg BT 284.15 315.61 Td (Authorized ) Tj ET Q q 0 0 0 rg BT 325.38 315.61 Td (10 ) Tj ET Q q 0 0 0 rg BT 337.12 315.61 Td (million ) Tj ET Q q 0 0 0 rg BT 364.91 315.61 Td (shares; ) Tj ET Q q 0 0 0 rg BT 391.74 315.61 Td (issued ) Tj ET Q q 0 0 0 rg BT 416.22 315.61 Td (and ) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 307.11 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 105.29 307.11 Td (4,129 ) Tj ET Q q 0 0 0 rg BT 126.54 307.11 Td (in ) Tj ET Q q 0 0 0 rg BT 135.28 307.11 Td (2016 ) Tj ET Q q 0 0 0 rg BT 154.40 307.11 Td (and ) Tj ET Q q 0 0 0 rg BT 168.80 307.11 Td (4,161 ) Tj ET Q q 0 0 0 rg BT 190.05 307.11 Td (in ) Tj ET Q q 0 0 0 rg BT 198.79 307.11 Td (2015, ) Tj ET Q q 0 0 0 rg BT 220.04 307.11 Td (liquidation ) Tj ET Q q 0 0 0 rg BT 259.00 307.11 Td (value ) Tj ET Q q 0 0 0 rg BT 279.53 307.11 Td (of ) Tj ET Q q 0 0 0 rg BT 288.73 307.11 Td ($50 ) Tj ET Q q 0 0 0 rg BT 303.61 307.11 Td (per ) Tj ET Q q 0 0 0 rg BT 316.59 307.11 Td (share) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 485.15 307.36 Td (—) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 550.15 307.36 Td (—) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 294.61 Td (Common ) Tj ET Q q 0 0 0 rg BT 97.48 294.61 Td (stock, ) Tj ET Q q 0 0 0 rg BT 119.88 294.61 Td (par ) Tj ET Q q 0 0 0 rg BT 133.08 294.61 Td (value ) Tj ET Q q 0 0 0 rg BT 153.82 294.61 Td (of ) Tj ET Q q 0 0 0 rg BT 163.24 294.61 Td ($0.10 ) Tj ET Q q 0 0 0 rg BT 184.70 294.61 Td (per ) Tj ET Q q 0 0 0 rg BT 197.89 294.61 Td (share: ) Tj ET Q q 0 0 0 rg BT 220.01 294.61 Td (Authorized ) Tj ET Q q 0 0 0 rg BT 260.58 294.61 Td (4.5 ) Tj ET Q q 0 0 0 rg BT 273.54 294.61 Td (billion ) Tj ET Q q 0 0 0 rg BT 298.08 294.61 Td (shares; ) Tj ET Q q 0 0 0 rg BT 324.02 294.61 Td (2.2 ) Tj ET Q q 0 0 0 rg BT 336.98 294.61 Td (billion ) Tj ET Q q 0 0 0 rg BT 361.52 294.61 Td (issued ) Tj ET Q q 0 0 0 rg BT 385.10 294.61 Td (in ) Tj ET Q q 0 0 0 rg BT 394.05 294.61 Td (both ) Tj ET Q q 0 0 0 rg BT 411.50 294.61 Td (2016 ) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 286.11 Td (and ) Tj ET Q q 0 0 0 rg BT 77.90 286.11 Td (2015) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 287.36 Td (221) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 287.36 Td (221) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 274.61 Td (Capital in excess of par value of stock) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 474.50 274.61 Td (1,725) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 539.50 274.61 Td (1,459) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 262.61 Td (Accumulated other comprehensive loss) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 471.65 262.61 Td (\(2,503) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 493.65 262.61 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 536.65 262.61 Td (\(2,468) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 558.65 262.61 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 250.61 Td (Retained earnings) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 250.61 Td (33,513) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 250.61 Td (31,613) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 63.50 238.61 Td (Less cost of treasury stock — 536 million common shares in 2016 and 539 million in 2015) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 467.40 238.61 Td (\(16,779) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 493.65 238.61 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 532.40 238.61 Td (\(16,559) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 558.65 238.61 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 75.50 226.61 Td (Total Bristol-Myers Squibb Company Shareholders' Equity) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 226.61 Td (16,177) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 226.61 Td (14,266) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 214.61 Td (Noncontrolling interest) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 480.90 214.61 Td (170) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 545.90 214.61 Td (158) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 87.50 202.61 Td (Total Equity) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 202.61 Td (16,347) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 202.61 Td (14,424) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 51.50 190.61 Td (Total Liabilities and Equity) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 438.50 190.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 470.25 190.61 Td (33,707) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 503.50 190.61 Td ($) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 535.25 190.61 Td (31,748) Tj ET Q BT /F1 10.00 Tf ET BT /F1 9.00 Tf ET q 0 0 0 rg BT 148.80 165.95 Td (The accompanying notes are an integral part of these consolidated financial statements.) Tj ET Q endstream endobj 111 0 obj <> endobj 112 0 obj <> stream BT /F2 10.00 Tf ET q 0 0 0 rg BT 217.15 772.75 Td (BRIST) Tj ET Q q 0 0 0 rg BT 246.98 772.75 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 373.47 772.75 Td (ANY) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 188.65 760.75 Td (CONSOLIDA) Tj ET Q q 0 0 0 rg BT 248.47 760.75 Td (TED ST) Tj ET Q q 0 0 0 rg BT 283.02 760.75 Td (A) Tj ET Q q 0 0 0 rg BT 289.50 760.75 Td (TEMENTS OF) Tj ET Q q 0 0 0 rg BT 354.42 760.75 Td ( CASH FLOWS) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 266.25 748.75 Td (Dollars in Millions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 33.60 Td (55) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 707.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 707.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 707.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 707.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 707.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 707.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 707.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 681.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 681.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 681.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 681.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 681.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 681.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 681.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 655.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 655.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 655.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 655.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 655.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 655.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 655.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 629.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 629.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 629.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 629.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 629.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 629.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 629.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 603.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 603.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 603.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 603.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 603.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 603.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 603.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 577.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 577.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 577.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 577.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 577.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 577.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 577.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 551.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 551.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 551.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 551.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 551.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 551.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 551.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 525.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 525.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 525.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 525.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 525.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 525.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 525.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 499.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 499.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 499.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 499.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 499.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 499.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 499.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 473.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 473.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 473.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 473.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 473.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 473.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 473.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 447.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 447.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 447.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 447.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 447.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 447.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 447.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 421.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 421.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 421.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 421.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 421.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 421.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 421.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 395.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 395.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 395.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 395.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 395.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 395.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 395.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 369.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 369.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 369.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 369.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 369.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 369.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 369.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 343.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 343.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 343.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 343.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 343.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 343.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 343.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 317.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 317.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 317.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 317.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 317.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 317.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 317.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 291.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 291.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 291.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 291.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 291.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 291.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 291.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 265.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 265.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 265.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 265.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 265.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 265.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 265.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 239.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 239.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 239.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 239.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 239.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 239.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 239.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 50.00 213.00 336.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.00 213.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 390.00 213.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 445.00 213.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 449.00 213.00 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.00 213.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 508.00 213.00 55.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 720 m 445 720 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 445 720 m 449 720 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 720 m 504 720 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504 720 m 508 720 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 720 m 563 720 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 707 m 445 707 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 707 m 504 707 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 707 m 563 707 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 473 m 445 473 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 473 m 504 473 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 473 m 563 473 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 460 m 445 460 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 460 m 504 460 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 460 m 563 460 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 382 m 445 382 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 382 m 504 382 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 382 m 563 382 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 369 m 445 369 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 369 m 504 369 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 369 m 563 369 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 265 m 445 265 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 265 m 504 265 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 265 m 563 265 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 252 m 445 252 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 252 m 504 252 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 252 m 563 252 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 239 m 445 239 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 239 m 504 239 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 239 m 563 239 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 213 m 445 213 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 213 m 504 213 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 213 m 563 213 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 201 m 445 201 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 390 199 m 445 199 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 201 m 504 201 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 449 199 m 504 199 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 201 m 563 201 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 508 199 m 563 199 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 52.50 724.25 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 431.70 724.23 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 52.50 711.25 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 409.00 711.23 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 468.00 711.23 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.00 711.23 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.50 697.73 Td (Cash Flows From Operating Activities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 684.57 Td (Net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.50 684.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 684.57 Td (4,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.50 684.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 684.57 Td (1,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.50 684.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 684.57 Td (2,029) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 671.57 Td (Adjustments to reconcile net earnings to net cash provided by operating activities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 658.57 Td (Depreciation and amortization, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 658.57 Td (382) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 658.57 Td (376) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 658.57 Td (467) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 645.57 Td (Deferred income taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 645.62 Td (\(204) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 645.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 645.62 Td (\(347) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 645.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 645.62 Td (\(542) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 645.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 632.57 Td (Stock-based compensation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 632.57 Td (205) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 632.57 Td (235) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 632.57 Td (213) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 619.57 Td (Impairment charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 619.57 Td (108) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 619.57 Td (192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 619.57 Td (401) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 606.57 Td (Pension settlements and amortization) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 606.57 Td (169) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 606.57 Td (245) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 606.57 Td (971) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 593.57 Td (Divestiture gains and royalties, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 593.62 Td (\(1,187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 593.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 593.62 Td (\(490) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 593.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 593.62 Td (\(760) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 593.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 580.57 Td (Asset acquisition charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 580.57 Td (274) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 580.57 Td (983) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 580.57 Td (148) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 567.57 Td (Other adjustments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.80 567.62 Td (\(44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 567.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 567.57 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.80 567.62 Td (\(21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 567.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 554.57 Td (Changes in operating assets and liabilities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 541.57 Td (Receivables) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 541.62 Td (\(803) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 541.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 541.62 Td (\(942) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 541.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 541.62 Td (\(252) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 541.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 528.57 Td (Inventories) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 528.62 Td (\(152) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 528.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 528.57 Td (97) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 528.62 Td (\(254) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 528.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 515.57 Td (Accounts payable) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 515.57 Td (104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 515.62 Td (\(919) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 515.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.80 515.62 Td (\(44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 515.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 502.57 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.80 502.62 Td (\(64) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 502.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 502.57 Td (218) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 502.57 Td (613) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 489.57 Td (Income taxes payable) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 489.62 Td (\(545) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 489.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 489.57 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 489.57 Td (171) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 476.57 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 476.57 Td (100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 476.57 Td (491) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.15 476.57 Td (8) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 88.50 463.73 Td (Net Cash Provided by Operating Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 463.57 Td (2,850) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 463.57 Td (1,832) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 463.57 Td (3,148) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.50 450.73 Td (Cash Flows From Investing Activities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 437.57 Td (Sale and maturities of marketable securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 437.57 Td (4,809) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 437.57 Td (2,794) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 437.57 Td (4,095) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 424.57 Td (Purchase of marketable securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 424.62 Td (\(3,089) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 424.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 424.62 Td (\(3,143) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 424.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.30 424.62 Td (\(5,719) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 424.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 411.57 Td (Capital expenditures) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 411.62 Td (\(1,215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 411.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 411.62 Td (\(820) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 411.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 411.62 Td (\(526) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 411.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 398.57 Td (Divestiture and other proceeds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 398.57 Td (1,334) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 398.57 Td (708) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 398.57 Td (3,585) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 385.57 Td (Acquisition and other payments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 385.62 Td (\(359) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 385.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 385.62 Td (\(1,111) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 385.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 385.62 Td (\(219) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 385.57 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 88.50 372.73 Td (Net Cash Provided by/\(Used in\) Investing Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 372.57 Td (1,480) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 372.62 Td (\(1,572) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 372.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 372.57 Td (1,216) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.50 359.73 Td (Cash Flows From Financing Activities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 346.57 Td (Short-term borrowings, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 346.57 Td (125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.80 346.62 Td (\(449) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 346.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 346.57 Td (244) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 333.57 Td (Issuance of long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.15 333.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 333.57 Td (1,268) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 333.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 320.57 Td (Repayment of long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.80 320.62 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 320.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 320.62 Td (\(1,957) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 320.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.80 320.62 Td (\(676) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 320.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 307.57 Td (Interest rate swap contract terminations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.15 307.57 Td (42) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.80 307.62 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 307.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 307.57 Td (105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 294.57 Td (Issuance of common stock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.15 294.57 Td (181) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 294.57 Td (266) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 294.57 Td (288) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 281.57 Td (Repurchase of common stock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.80 281.62 Td (\(231) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 281.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.15 281.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 281.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.50 268.57 Td (Dividends) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 268.62 Td (\(2,547) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 268.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 268.62 Td (\(2,477) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 268.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.30 268.62 Td (\(2,398) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 268.57 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 88.50 255.73 Td (Net Cash Used in Financing Activities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 255.62 Td (\(2,445) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 255.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 255.62 Td (\(3,351) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 255.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.30 255.62 Td (\(2,437) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.15 255.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 242.57 Td (Effect of Exchange Rates on Cash and Cash Equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.80 242.62 Td (\(33) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.15 242.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.80 242.62 Td (\(95) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 242.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 242.57 Td (58) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 229.57 Td (Increase/\(Decrease\) in Cash and Cash Equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 229.57 Td (1,852) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 229.62 Td (\(3,186) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 229.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 229.57 Td (1,985) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.50 216.57 Td (Cash and Cash Equivalents at Beginning of Year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 216.57 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 216.57 Td (5,571) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 216.57 Td (3,586) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.50 203.73 Td (Cash and Cash Equivalents at End of Year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.50 203.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.65 203.57 Td (4,237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.50 203.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 203.57 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.50 203.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.65 203.57 Td (5,571) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 131.30 179.50 Td (The accompanying notes are an integral part of these consolidated financial statements.) Tj ET Q endstream endobj 113 0 obj <> endobj 114 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (56) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 737.10 Td (1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 737.10 Td (. ) Tj ET Q q 0 0 0 rg BT 67.94 737.10 Td (ACCOUNTING ) Tj ET Q q 0 0 0 rg BT 139.89 737.10 Td (POLICIES ) Tj ET Q q 0 0 0 rg BT 189.63 737.10 Td (AND ) Tj ET Q q 0 0 0 rg BT 213.79 737.10 Td (RECENTL) Tj ET Q q 0 0 0 rg BT 261.22 737.10 Td (Y) Tj ET Q q 0 0 0 rg BT 268.07 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 270.57 737.10 Td (ISSUED ) Tj ET Q q 0 0 0 rg BT 308.65 737.10 Td (ACCOUNTING ) Tj ET Q q 0 0 0 rg BT 380.59 737.10 Td (ST) Tj ET Q q 0 0 0 rg BT 392.08 737.10 Td (ANDARDS) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Basis ) Tj ET Q q 0 0 0 rg BT 60.73 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 71.56 713.10 Td (Consolidation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (The ) Tj ET Q q 0 0 0 rg BT 55.01 689.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 109.01 689.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 147.46 689.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 193.13 689.10 Td (are ) Tj ET Q q 0 0 0 rg BT 208.80 689.10 Td (prepared ) Tj ET Q q 0 0 0 rg BT 247.24 689.10 Td (in ) Tj ET Q q 0 0 0 rg BT 258.48 689.10 Td (conformity ) Tj ET Q q 0 0 0 rg BT 306.37 689.10 Td (with ) Tj ET Q q 0 0 0 rg BT 327.61 689.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 348.86 689.10 Td (GAAP) Tj ET Q q 0 0 0 rg BT 374.97 689.10 Td (, ) Tj ET Q q 0 0 0 rg BT 380.94 689.10 Td (including ) Tj ET Q q 0 0 0 rg BT 422.17 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 437.85 689.10 Td (accounts ) Tj ET Q q 0 0 0 rg BT 476.30 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 488.09 689.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 547.66 689.10 Td (Squibb ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 78.44 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 96.42 677.10 Td (all ) Tj ET Q q 0 0 0 rg BT 109.97 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 121.85 677.10 Td (its ) Tj ET Q q 0 0 0 rg BT 134.84 677.10 Td (controlled ) Tj ET Q q 0 0 0 rg BT 178.93 677.10 Td (majority-owned ) Tj ET Q q 0 0 0 rg BT 246.35 677.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 297.12 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 315.11 677.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 345.86 677.10 Td (variable ) Tj ET Q q 0 0 0 rg BT 381.61 677.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 414.59 677.10 Td (entities. ) Tj ET Q q 0 0 0 rg BT 448.74 677.10 Td (All ) Tj ET Q q 0 0 0 rg BT 465.07 677.10 Td (intercompany ) Tj ET Q q 0 0 0 rg BT 523.60 677.10 Td (balances ) Tj ET Q q 0 0 0 rg BT 561.57 677.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (transactions ) Tj ET Q q 0 0 0 rg BT 85.32 665.10 Td (are ) Tj ET Q q 0 0 0 rg BT 99.08 665.10 Td (eliminated. ) Tj ET Q q 0 0 0 rg BT 145.34 665.10 Td (Material ) Tj ET Q q 0 0 0 rg BT 180.77 665.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 226.76 665.10 Td (events ) Tj ET Q q 0 0 0 rg BT 253.86 665.10 Td (are ) Tj ET Q q 0 0 0 rg BT 267.62 665.10 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 307.49 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 323.48 665.10 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 362.25 665.10 Td (through ) Tj ET Q q 0 0 0 rg BT 394.91 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 408.68 665.10 Td (report ) Tj ET Q q 0 0 0 rg BT 434.11 665.10 Td (issuance ) Tj ET Q q 0 0 0 rg BT 469.55 665.10 Td (date. ) Tj ET Q q 0 0 0 rg BT 490.26 665.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 514.02 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 523.35 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 537.12 665.10 Td (Summary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.28 653.10 Td (Abbreviated ) Tj ET Q q 0 0 0 rg BT 98.02 653.10 Td (T) Tj ET Q q 0 0 0 rg BT 103.43 653.10 Td (erms ) Tj ET Q q 0 0 0 rg BT 125.37 653.10 Td (at ) Tj ET Q q 0 0 0 rg BT 135.09 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 149.80 653.10 Td (end ) Tj ET Q q 0 0 0 rg BT 166.74 653.10 Td (of ) Tj ET Q q 0 0 0 rg BT 177.57 653.10 Td (this ) Tj ET Q q 0 0 0 rg BT 194.52 653.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 217.02 653.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 241.19 653.10 Td (10-K ) Tj ET Q q 0 0 0 rg BT 264.24 653.10 Td (for ) Tj ET Q q 0 0 0 rg BT 278.40 653.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 303.12 653.10 Td (used ) Tj ET Q q 0 0 0 rg BT 323.95 653.10 Td (throughout ) Tj ET Q q 0 0 0 rg BT 370.34 653.10 Td (the ) Tj ET Q q 0 0 0 rg BT 385.05 653.10 Td (document.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 71.64 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 87.84 629.10 Td (license ) Tj ET Q q 0 0 0 rg BT 117.37 629.10 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 173.00 629.10 Td (are ) Tj ET Q q 0 0 0 rg BT 186.97 629.10 Td (assessed ) Tj ET Q q 0 0 0 rg BT 222.62 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 232.16 629.10 Td (determine ) Tj ET Q q 0 0 0 rg BT 273.91 629.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 307.88 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 321.86 629.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 345.84 629.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 378.15 629.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 418.79 629.10 Td (or ) Tj ET Q q 0 0 0 rg BT 428.89 629.10 Td (other ) Tj ET Q q 0 0 0 rg BT 451.20 629.10 Td (control ) Tj ET Q q 0 0 0 rg BT 481.29 629.10 Td (over ) Tj ET Q q 0 0 0 rg BT 500.82 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 514.80 629.10 Td (entity ) Tj ET Q q 0 0 0 rg BT 539.34 629.10 Td (requiring ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (consolidation ) Tj ET Q q 0 0 0 rg BT 92.66 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 103.77 617.10 Td (an ) Tj ET Q q 0 0 0 rg BT 115.98 617.10 Td (entity) Tj ET Q q 0 0 0 rg BT 138.11 617.10 Td (. ) Tj ET Q q 0 0 0 rg BT 143.38 617.10 Td (Entities ) Tj ET Q q 0 0 0 rg BT 176.71 617.10 Td (controlled ) Tj ET Q q 0 0 0 rg BT 220.03 617.10 Td (by ) Tj ET Q q 0 0 0 rg BT 232.81 617.10 Td (means ) Tj ET Q q 0 0 0 rg BT 261.13 617.10 Td (other ) Tj ET Q q 0 0 0 rg BT 284.46 617.10 Td (than ) Tj ET Q q 0 0 0 rg BT 304.45 617.10 Td (a ) Tj ET Q q 0 0 0 rg BT 311.67 617.10 Td (majority ) Tj ET Q q 0 0 0 rg BT 348.33 617.10 Td (voting ) Tj ET Q q 0 0 0 rg BT 376.66 617.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 408.87 617.10 Td (are ) Tj ET Q q 0 0 0 rg BT 423.86 617.10 Td (referred ) Tj ET Q q 0 0 0 rg BT 458.27 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 468.83 617.10 Td (as ) Tj ET Q q 0 0 0 rg BT 479.93 617.10 Td (variable ) Tj ET Q q 0 0 0 rg BT 514.91 617.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 547.12 617.10 Td (entities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.93 605.10 Td (are ) Tj ET Q q 0 0 0 rg BT 67.63 605.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 120.67 605.10 Td (when ) Tj ET Q q 0 0 0 rg BT 144.82 605.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 168.44 605.10 Td (has ) Tj ET Q q 0 0 0 rg BT 184.27 605.10 Td (both ) Tj ET Q q 0 0 0 rg BT 204.54 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 219.25 605.10 Td (power ) Tj ET Q q 0 0 0 rg BT 246.73 605.10 Td (to ) Tj ET Q q 0 0 0 rg BT 257.01 605.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 282.26 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 296.97 605.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 335.57 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 346.39 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 361.10 605.10 Td (variable ) Tj ET Q q 0 0 0 rg BT 395.80 605.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 427.73 605.10 Td (entity ) Tj ET Q q 0 0 0 rg BT 452.99 605.10 Td (that ) Tj ET Q q 0 0 0 rg BT 470.48 605.10 Td (most ) Tj ET Q q 0 0 0 rg BT 492.43 605.10 Td (significantly ) Tj ET Q q 0 0 0 rg BT 544.91 605.10 Td (impacts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (its ) Tj ET Q q 0 0 0 rg BT 48.13 593.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 89.68 593.10 Td (performance ) Tj ET Q q 0 0 0 rg BT 142.88 593.10 Td (and ) Tj ET Q q 0 0 0 rg BT 160.00 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 174.90 593.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 218.13 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 228.59 593.10 Td (absorb ) Tj ET Q q 0 0 0 rg BT 257.93 593.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 284.50 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 295.51 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 310.40 593.10 Td (right ) Tj ET Q q 0 0 0 rg BT 331.97 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 342.43 593.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 373.97 593.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 408.30 593.10 Td (that ) Tj ET Q q 0 0 0 rg BT 425.98 593.10 Td (could ) Tj ET Q q 0 0 0 rg BT 450.88 593.10 Td (potentially ) Tj ET Q q 0 0 0 rg BT 496.32 593.10 Td (be ) Tj ET Q q 0 0 0 rg BT 508.44 593.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 553.33 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 563.79 593.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (entity) Tj ET Q q 0 0 0 rg BT 58.12 581.10 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (Use of Estimates and Judgments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.76 533.10 Td (preparation ) Tj ET Q q 0 0 0 rg BT 103.51 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 115.06 533.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 153.26 533.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 198.69 533.10 Td (requires ) Tj ET Q q 0 0 0 rg BT 234.12 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 249.55 533.10 Td (use ) Tj ET Q q 0 0 0 rg BT 266.10 533.10 Td (of ) Tj ET Q q 0 0 0 rg BT 277.65 533.10 Td (management ) Tj ET Q q 0 0 0 rg BT 331.95 533.10 Td (estimates, ) Tj ET Q q 0 0 0 rg BT 374.88 533.10 Td (judgments ) Tj ET Q q 0 0 0 rg BT 419.76 533.10 Td (and ) Tj ET Q q 0 0 0 rg BT 437.42 533.10 Td (assumptions. ) Tj ET Q q 0 0 0 rg BT 492.35 533.10 Td (The ) Tj ET Q q 0 0 0 rg BT 511.12 533.10 Td (most ) Tj ET Q q 0 0 0 rg BT 533.79 533.10 Td (significant ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 88.20 521.10 Td (are ) Tj ET Q q 0 0 0 rg BT 103.17 521.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 143.14 521.10 Td (in ) Tj ET Q q 0 0 0 rg BT 153.67 521.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 204.75 521.10 Td (the ) Tj ET Q q 0 0 0 rg BT 219.72 521.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 236.35 521.10 Td (value ) Tj ET Q q 0 0 0 rg BT 260.77 521.10 Td (and ) Tj ET Q q 0 0 0 rg BT 277.96 521.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 315.71 521.10 Td (impairment ) Tj ET Q q 0 0 0 rg BT 364.56 521.10 Td (of ) Tj ET Q q 0 0 0 rg BT 375.65 521.10 Td (intangible ) Tj ET Q q 0 0 0 rg BT 418.40 521.10 Td (assets; ) Tj ET Q q 0 0 0 rg BT 447.26 521.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 469.45 521.10 Td (rebate ) Tj ET Q q 0 0 0 rg BT 496.63 521.10 Td (and ) Tj ET Q q 0 0 0 rg BT 513.83 521.10 Td (return ) Tj ET Q q 0 0 0 rg BT 540.46 521.10 Td (accruals; ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 59.02 509.10 Td (contingencies; ) Tj ET Q q 0 0 0 rg BT 120.37 509.10 Td (income ) Tj ET Q q 0 0 0 rg BT 153.39 509.10 Td (taxes; ) Tj ET Q q 0 0 0 rg BT 180.30 509.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 222.20 509.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 252.46 509.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 279.92 509.10 Td (used ) Tj ET Q q 0 0 0 rg BT 301.83 509.10 Td (in ) Tj ET Q q 0 0 0 rg BT 313.20 509.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 350.12 509.10 Td (element ) Tj ET Q q 0 0 0 rg BT 385.35 509.10 Td (arrangements; ) Tj ET Q q 0 0 0 rg BT 445.58 509.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 497.49 509.10 Td (if ) Tj ET Q q 0 0 0 rg BT 507.18 509.10 Td (an ) Tj ET Q q 0 0 0 rg BT 520.21 509.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 567.67 509.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 80.71 497.10 Td (is ) Tj ET Q q 0 0 0 rg BT 89.88 497.10 Td (a ) Tj ET Q q 0 0 0 rg BT 96.82 497.10 Td (business ) Tj ET Q q 0 0 0 rg BT 133.21 497.10 Td (or ) Tj ET Q q 0 0 0 rg BT 144.04 497.10 Td (an ) Tj ET Q q 0 0 0 rg BT 155.98 497.10 Td (asset; ) Tj ET Q q 0 0 0 rg BT 180.70 497.10 Td (and ) Tj ET Q q 0 0 0 rg BT 197.64 497.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 231.24 497.10 Td (and ) Tj ET Q q 0 0 0 rg BT 248.18 497.10 Td (postretirement ) Tj ET Q q 0 0 0 rg BT 308.44 497.10 Td (benefits. ) Tj ET Q q 0 0 0 rg BT 344.54 497.10 Td (Actual ) Tj ET Q q 0 0 0 rg BT 373.70 497.10 Td (results ) Tj ET Q q 0 0 0 rg BT 402.31 497.10 Td (may ) Tj ET Q q 0 0 0 rg BT 422.03 497.10 Td (dif) Tj ET Q q 0 0 0 rg BT 432.95 497.10 Td (fer ) Tj ET Q q 0 0 0 rg BT 446.55 497.10 Td (from ) Tj ET Q q 0 0 0 rg BT 468.49 497.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 509.31 497.10 Td (results.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (Reclassifications) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (Certain ) Tj ET Q q 0 0 0 rg BT 67.35 449.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 88.71 449.10 Td (period ) Tj ET Q q 0 0 0 rg BT 116.17 449.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 151.98 449.10 Td (were ) Tj ET Q q 0 0 0 rg BT 173.32 449.10 Td (reclassified ) Tj ET Q q 0 0 0 rg BT 220.77 449.10 Td (to ) Tj ET Q q 0 0 0 rg BT 230.47 449.10 Td (conform ) Tj ET Q q 0 0 0 rg BT 266.27 449.10 Td (to ) Tj ET Q q 0 0 0 rg BT 275.96 449.10 Td (the ) Tj ET Q q 0 0 0 rg BT 290.10 449.10 Td (current ) Tj ET Q q 0 0 0 rg BT 320.33 449.10 Td (period ) Tj ET Q q 0 0 0 rg BT 347.79 449.10 Td (presentation. ) Tj ET Q q 0 0 0 rg BT 400.95 449.10 Td (The ) Tj ET Q q 0 0 0 rg BT 418.41 449.10 Td (reclassifications ) Tj ET Q q 0 0 0 rg BT 484.75 449.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 517.21 449.10 Td (a ) Tj ET Q q 0 0 0 rg BT 523.57 449.10 Td (more ) Tj ET Q q 0 0 0 rg BT 546.03 449.10 Td (concise ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 73.48 437.10 Td (statement ) Tj ET Q q 0 0 0 rg BT 114.30 437.10 Td (presentation ) Tj ET Q q 0 0 0 rg BT 165.67 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 182.61 437.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 225.10 437.10 Td (information ) Tj ET Q q 0 0 0 rg BT 274.81 437.10 Td (is ) Tj ET Q q 0 0 0 rg BT 283.98 437.10 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 323.70 437.10 Td (in ) Tj ET Q q 0 0 0 rg BT 333.98 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 348.70 437.10 Td (notes ) Tj ET Q q 0 0 0 rg BT 372.30 437.10 Td (if ) Tj ET Q q 0 0 0 rg BT 380.91 437.10 Td (material. ) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 426.6 m 37.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 426.6 m 139.5 426.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 426.6 m 139.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 426.6 m 379.5 426.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 426.6 m 379.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 426.6 m 573.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 426.6 m 573.5 426.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 412.6 m 37.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 412.6 m 139.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 412.6 m 139.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 390.6 m 139.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 412.6 m 379.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 412.6 m 379.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 390.6 m 379.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 412.6 m 573.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 412.6 m 573.5 412.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 390.6 m 573.5 390.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 390.6 m 37.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 390.6 m 139.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 390.6 m 379.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 390.6 m 573.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 376.6 m 37.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 376.6 m 139.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 376.6 m 379.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 376.6 m 379.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 376.6 m 573.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 376.6 m 573.5 376.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 362.6 m 37.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 362.6 m 139.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 362.6 m 379.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 362.6 m 379.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 362.6 m 573.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 348.6 m 37.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 348.6 m 139.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 348.6 m 379.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 334.6 m 379.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 348.6 m 379.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 348.6 m 573.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 334.6 m 573.5 334.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 334.6 m 37.5 320.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 334.6 m 139.5 320.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 334.6 m 379.5 320.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 334.6 m 573.5 320.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 320.6 m 37.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 306.6 m 139.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 320.6 m 139.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 320.6 m 379.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 320.6 m 379.5 320.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 306.6 m 379.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 320.6 m 573.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 306.6 m 573.5 306.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 306.6 m 37.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 306.6 m 139.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 306.6 m 379.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 306.6 m 573.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 292.6 m 37.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 292.6 m 139.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 292.6 m 379.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 278.6 m 379.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 292.6 m 379.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 292.6 m 573.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 292.6 m 573.5 292.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 278.6 m 573.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 278.6 m 37.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 37.5 264.6 m 139.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 278.6 m 139.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 278.6 m 379.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 139.5 264.6 m 379.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 278.6 m 379.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 573.5 278.6 m 573.5 264.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 278.6 m 573.5 278.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 379.5 264.6 m 573.5 264.6 l s BT /F2 9.50 Tf ET q 0 0 0 rg BT 221.55 417.17 Td (Prior Presentation) Tj ET Q BT /F2 9.50 Tf ET q 0 0 0 rg BT 432.75 417.17 Td (Current Presentation) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 62.90 403.51 Td (Consolidated) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 43.90 394.01 Td (Statements of Earnings) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 399.36 Td (Advertising and product promotion) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 403.51 Td (Included in Marketing, selling and administrative) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 394.01 Td (expenses) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 46.40 351.11 Td (Consolidated Balance) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 75.55 341.61 Td (Sheets) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 381.16 Td (Assets held-for-sale) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 381.16 Td (Included in Prepaid expenses and other) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 367.16 Td (Accrued expenses) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 353.36 Td (Combined as Accrued liabilities) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 353.16 Td (Accrued rebates and returns) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 339.16 Td (Dividends payable) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 325.16 Td (Pension, postretirement and postemployment liabilities) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 318.36 Td (Combined as Pension and other liabilities) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 311.16 Td (Other liabilities) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 40.85 288.11 Td (Consolidated Statements) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 60.55 278.61 Td (of Cash Flows) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 297.16 Td (Net earnings attributable to noncontrolling interest) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 297.16 Td (Included in Other adjustments) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 283.16 Td (Divestiture gains and royalties included in Other adjustments) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 283.16 Td (Divestiture gains and royalties) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 142.00 269.16 Td (Asset acquisition charges included in Other adjustments) Tj ET Q BT /F1 9.50 Tf ET q 0 0 0 rg BT 382.00 269.16 Td (Asset acquisition charges) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 241.10 Td (Revenue Recognition) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 217.10 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 74.39 217.10 Td (is ) Tj ET Q q 0 0 0 rg BT 84.47 217.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 131.73 217.10 Td (when ) Tj ET Q q 0 0 0 rg BT 156.80 217.10 Td (persuasive ) Tj ET Q q 0 0 0 rg BT 202.41 217.10 Td (evidence ) Tj ET Q q 0 0 0 rg BT 241.35 217.10 Td (of ) Tj ET Q q 0 0 0 rg BT 253.09 217.10 Td (an ) Tj ET Q q 0 0 0 rg BT 265.93 217.10 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 319.31 217.10 Td (exists, ) Tj ET Q q 0 0 0 rg BT 347.99 217.10 Td (the ) Tj ET Q q 0 0 0 rg BT 363.61 217.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 386.46 217.10 Td (price ) Tj ET Q q 0 0 0 rg BT 409.85 217.10 Td (is ) Tj ET Q q 0 0 0 rg BT 419.93 217.10 Td (fixed ) Tj ET Q q 0 0 0 rg BT 443.88 217.10 Td (or ) Tj ET Q q 0 0 0 rg BT 455.61 217.10 Td (determinable, ) Tj ET Q q 0 0 0 rg BT 513.72 217.10 Td (collectability ) Tj ET Q q 0 0 0 rg BT 569.33 217.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 205.10 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 81.44 205.10 Td (assured ) Tj ET Q q 0 0 0 rg BT 113.56 205.10 Td (and ) Tj ET Q q 0 0 0 rg BT 130.13 205.10 Td (title ) Tj ET Q q 0 0 0 rg BT 147.81 205.10 Td (and ) Tj ET Q q 0 0 0 rg BT 164.38 205.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 217.06 205.10 Td (all ) Tj ET Q q 0 0 0 rg BT 229.18 205.10 Td (risks ) Tj ET Q q 0 0 0 rg BT 250.20 205.10 Td (and ) Tj ET Q q 0 0 0 rg BT 266.77 205.10 Td (rewards ) Tj ET Q q 0 0 0 rg BT 300.55 205.10 Td (of ) Tj ET Q q 0 0 0 rg BT 311.01 205.10 Td (ownership ) Tj ET Q q 0 0 0 rg BT 354.80 205.10 Td (are ) Tj ET Q q 0 0 0 rg BT 369.13 205.10 Td (transferred, ) Tj ET Q q 0 0 0 rg BT 417.07 205.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 456.40 205.10 Td (at ) Tj ET Q q 0 0 0 rg BT 465.75 205.10 Td (time ) Tj ET Q q 0 0 0 rg BT 485.65 205.10 Td (of ) Tj ET Q q 0 0 0 rg BT 496.11 205.10 Td (shipment ) Tj ET Q q 0 0 0 rg BT 534.90 205.10 Td (\(including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 193.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.78 193.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 80.00 193.10 Td (of ) Tj ET Q q 0 0 0 rg BT 90.89 193.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 140.65 193.10 Td (products ) Tj ET Q q 0 0 0 rg BT 177.65 193.10 Td (to ) Tj ET Q q 0 0 0 rg BT 187.98 193.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 221.63 193.10 Td (partners ) Tj ET Q q 0 0 0 rg BT 256.40 193.10 Td (when ) Tj ET Q q 0 0 0 rg BT 280.61 193.10 Td (they ) Tj ET Q q 0 0 0 rg BT 300.39 193.10 Td (are ) Tj ET Q q 0 0 0 rg BT 315.16 193.10 Td (the ) Tj ET Q q 0 0 0 rg BT 329.93 193.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 368.03 193.10 Td (in ) Tj ET Q q 0 0 0 rg BT 378.37 193.10 Td (the ) Tj ET Q q 0 0 0 rg BT 393.14 193.10 Td (end ) Tj ET Q q 0 0 0 rg BT 410.14 193.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 449.35 193.10 Td (sale\). ) Tj ET Q q 0 0 0 rg BT 473.29 193.10 Td (However) Tj ET Q q 0 0 0 rg BT 509.54 193.10 Td (, ) Tj ET Q q 0 0 0 rg BT 514.60 193.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 544.36 193.10 Td (revenue ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 181.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.86 181.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 85.51 181.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 130.27 181.10 Td (is ) Tj ET Q q 0 0 0 rg BT 139.47 181.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 185.87 181.10 Td (on ) Tj ET Q q 0 0 0 rg BT 198.40 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 213.15 181.10 Td (date ) Tj ET Q q 0 0 0 rg BT 232.34 181.10 Td (of ) Tj ET Q q 0 0 0 rg BT 243.21 181.10 Td (receipt ) Tj ET Q q 0 0 0 rg BT 272.94 181.10 Td (by ) Tj ET Q q 0 0 0 rg BT 285.48 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 300.23 181.10 Td (customer) Tj ET Q q 0 0 0 rg BT 336.33 181.10 Td (. ) Tj ET Q q 0 0 0 rg BT 340.81 181.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 377.21 181.10 Td (and ) Tj ET Q q 0 0 0 rg BT 394.19 181.10 Td (other ) Tj ET Q q 0 0 0 rg BT 417.27 181.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 451.45 181.10 Td (related ) Tj ET Q q 0 0 0 rg BT 481.18 181.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 491.50 181.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.16 181.10 Td ( ) Tj ET Q q 0 0 0 rg BT 525.69 181.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 542.66 181.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 576.00 181.10 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 169.10 Td (is ) Tj ET Q q 0 0 0 rg BT 45.42 169.10 Td (not ) Tj ET Q q 0 0 0 rg BT 60.94 169.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 107.55 169.10 Td (until ) Tj ET Q q 0 0 0 rg BT 128.63 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 143.60 169.10 Td (products ) Tj ET Q q 0 0 0 rg BT 180.78 169.10 Td (are ) Tj ET Q q 0 0 0 rg BT 195.73 169.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 215.15 169.10 Td (to ) Tj ET Q q 0 0 0 rg BT 225.68 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 240.64 169.10 Td (end ) Tj ET Q q 0 0 0 rg BT 257.82 169.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 297.23 169.10 Td (by ) Tj ET Q q 0 0 0 rg BT 309.97 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 324.94 169.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 358.77 169.10 Td (partner) Tj ET Q q 0 0 0 rg BT 386.53 169.10 Td (. ) Tj ET Q q 0 0 0 rg BT 391.78 169.10 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 432.30 169.10 Td (are ) Tj ET Q q 0 0 0 rg BT 447.25 169.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 493.86 169.10 Td (when ) Tj ET Q q 0 0 0 rg BT 518.27 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 533.23 169.10 Td (third-party ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 157.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 57.28 157.10 Td (are ) Tj ET Q q 0 0 0 rg BT 71.33 157.10 Td (reliably ) Tj ET Q q 0 0 0 rg BT 103.71 157.10 Td (measurable ) Tj ET Q q 0 0 0 rg BT 151.08 157.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.36 157.10 Td (collectability ) Tj ET Q q 0 0 0 rg BT 221.41 157.10 Td (is ) Tj ET Q q 0 0 0 rg BT 229.92 157.10 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 275.07 157.10 Td (assured. ) Tj ET Q q 0 0 0 rg BT 309.40 157.10 Td (Refer ) Tj ET Q q 0 0 0 rg BT 333.45 157.10 Td (to ) Tj ET Q q 0 0 0 rg BT 343.07 157.10 Td (“—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.79 157.10 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.79 157.10 Td (. ) Tj ET Q q 0 0 0 rg BT 387.72 157.10 Td (Alliances” ) Tj ET Q q 0 0 0 rg BT 431.77 157.10 Td (for ) Tj ET Q q 0 0 0 rg BT 445.27 157.10 Td (further ) Tj ET Q q 0 0 0 rg BT 474.31 157.10 Td (detail ) Tj ET Q q 0 0 0 rg BT 498.37 157.10 Td (regarding ) Tj ET Q q 0 0 0 rg BT 538.52 157.10 Td (alliances.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 133.10 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 74.24 133.10 Td (is ) Tj ET Q q 0 0 0 rg BT 84.17 133.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 119.07 133.10 Td (at ) Tj ET Q q 0 0 0 rg BT 129.54 133.10 Td (the ) Tj ET Q q 0 0 0 rg BT 145.01 133.10 Td (time ) Tj ET Q q 0 0 0 rg BT 166.04 133.10 Td (of ) Tj ET Q q 0 0 0 rg BT 177.63 133.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 226.43 133.10 Td (for ) Tj ET Q q 0 0 0 rg BT 241.34 133.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 280.13 133.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 302.83 133.10 Td (returns, ) Tj ET Q q 0 0 0 rg BT 336.35 133.10 Td (discounts, ) Tj ET Q q 0 0 0 rg BT 379.88 133.10 Td (rebates ) Tj ET Q q 0 0 0 rg BT 411.46 133.10 Td (and ) Tj ET Q q 0 0 0 rg BT 429.15 133.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 451.84 133.10 Td (allowances ) Tj ET Q q 0 0 0 rg BT 499.52 133.10 Td (based ) Tj ET Q q 0 0 0 rg BT 525.55 133.10 Td (on ) Tj ET Q q 0 0 0 rg BT 538.80 133.10 Td (historical ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 121.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 81.46 121.10 Td (updated ) Tj ET Q q 0 0 0 rg BT 115.27 121.10 Td (for ) Tj ET Q q 0 0 0 rg BT 129.08 121.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 163.44 121.10 Td (in ) Tj ET Q q 0 0 0 rg BT 173.38 121.10 Td (facts ) Tj ET Q q 0 0 0 rg BT 194.41 121.10 Td (and ) Tj ET Q q 0 0 0 rg BT 211.00 121.10 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 269.80 121.10 Td (including ) Tj ET Q q 0 0 0 rg BT 309.72 121.10 Td (the ) Tj ET Q q 0 0 0 rg BT 324.10 121.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 353.46 121.10 Td (of ) Tj ET Q q 0 0 0 rg BT 363.95 121.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 407.19 121.10 Td (healthcare ) Tj ET Q q 0 0 0 rg BT 450.42 121.10 Td (legislation. ) Tj ET Q q 0 0 0 rg BT 496.74 121.10 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 533.88 121.10 Td (is ) Tj ET Q q 0 0 0 rg BT 542.70 121.10 Td (deferred ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 109.10 Td (when ) Tj ET Q q 0 0 0 rg BT 60.02 109.10 Td (there ) Tj ET Q q 0 0 0 rg BT 82.37 109.10 Td (is ) Tj ET Q q 0 0 0 rg BT 91.41 109.10 Td (no ) Tj ET Q q 0 0 0 rg BT 103.77 109.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 143.34 109.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 189.01 109.10 Td (with ) Tj ET Q q 0 0 0 rg BT 209.15 109.10 Td (products ) Tj ET Q q 0 0 0 rg BT 245.95 109.10 Td (in ) Tj ET Q q 0 0 0 rg BT 256.09 109.10 Td (a ) Tj ET Q q 0 0 0 rg BT 262.89 109.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 293.03 109.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 339.81 109.10 Td (category ) Tj ET Q q 0 0 0 rg BT 376.60 109.10 Td (or ) Tj ET Q q 0 0 0 rg BT 387.29 109.10 Td (with ) Tj ET Q q 0 0 0 rg BT 407.44 109.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 437.57 109.10 Td (operational ) Tj ET Q q 0 0 0 rg BT 484.92 109.10 Td (characteristics, ) Tj ET Q q 0 0 0 rg BT 546.97 109.10 Td (or ) Tj ET Q q 0 0 0 rg BT 557.66 109.10 Td (until ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 97.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 97.10 Td (right ) Tj ET Q q 0 0 0 rg BT 72.10 97.10 Td (of ) Tj ET Q q 0 0 0 rg BT 82.93 97.10 Td (return ) Tj ET Q q 0 0 0 rg BT 109.31 97.10 Td (no ) Tj ET Q q 0 0 0 rg BT 121.81 97.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 149.86 97.10 Td (exists ) Tj ET Q q 0 0 0 rg BT 175.14 97.10 Td (or ) Tj ET Q q 0 0 0 rg BT 185.97 97.10 Td (suf) Tj ET Q q 0 0 0 rg BT 198.01 97.10 Td (ficient ) Tj ET Q q 0 0 0 rg BT 226.05 97.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 265.76 97.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 311.56 97.10 Td (to ) Tj ET Q q 0 0 0 rg BT 321.84 97.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 357.66 97.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 379.60 97.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 409.87 97.10 Td (is ) Tj ET Q q 0 0 0 rg BT 419.04 97.10 Td (developed.) Tj ET Q endstream endobj 115 0 obj <> endobj 116 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (57) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Income ) Tj ET Q q 0 0 0 rg BT 69.98 749.25 Td (T) Tj ET Q q 0 0 0 rg BT 75.73 749.25 Td (axes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.21 725.25 Td (provision ) Tj ET Q q 0 0 0 rg BT 94.65 725.25 Td (for ) Tj ET Q q 0 0 0 rg BT 108.97 725.25 Td (income ) Tj ET Q q 0 0 0 rg BT 141.06 725.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 164.27 725.25 Td (includes ) Tj ET Q q 0 0 0 rg BT 200.26 725.25 Td (income ) Tj ET Q q 0 0 0 rg BT 232.35 725.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 255.56 725.25 Td (paid ) Tj ET Q q 0 0 0 rg BT 275.44 725.25 Td (or ) Tj ET Q q 0 0 0 rg BT 286.43 725.25 Td (payable ) Tj ET Q q 0 0 0 rg BT 320.18 725.25 Td (for ) Tj ET Q q 0 0 0 rg BT 334.51 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 349.38 725.25 Td (current ) Tj ET Q q 0 0 0 rg BT 380.36 725.25 Td (year ) Tj ET Q q 0 0 0 rg BT 400.23 725.25 Td (plus ) Tj ET Q q 0 0 0 rg BT 419.56 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 434.44 725.25 Td (change ) Tj ET Q q 0 0 0 rg BT 465.41 725.25 Td (in ) Tj ET Q q 0 0 0 rg BT 475.85 725.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 511.82 725.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 535.03 725.25 Td (during ) Tj ET Q q 0 0 0 rg BT 563.80 725.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (year) Tj ET Q q 0 0 0 rg BT 52.66 713.25 Td (. ) Tj ET Q q 0 0 0 rg BT 57.86 713.25 Td (Deferred ) Tj ET Q q 0 0 0 rg BT 96.09 713.25 Td (taxes ) Tj ET Q q 0 0 0 rg BT 119.34 713.25 Td (result ) Tj ET Q q 0 0 0 rg BT 144.26 713.25 Td (from ) Tj ET Q q 0 0 0 rg BT 166.41 713.25 Td (dif) Tj ET Q q 0 0 0 rg BT 177.33 713.25 Td (ferences ) Tj ET Q q 0 0 0 rg BT 213.34 713.25 Td (between ) Tj ET Q q 0 0 0 rg BT 249.36 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 264.28 713.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 301.97 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 319.11 713.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 334.03 713.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 356.74 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 367.77 713.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 393.80 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 410.95 713.25 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 450.87 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 468.01 713.25 Td (are ) Tj ET Q q 0 0 0 rg BT 482.92 713.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 518.95 713.25 Td (for ) Tj ET Q q 0 0 0 rg BT 533.31 713.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 568.23 713.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 50.29 701.25 Td (rates ) Tj ET Q q 0 0 0 rg BT 71.25 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 87.76 701.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 102.06 701.25 Td (laws ) Tj ET Q q 0 0 0 rg BT 122.46 701.25 Td (when ) Tj ET Q q 0 0 0 rg BT 146.20 701.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 180.48 701.25 Td (are ) Tj ET Q q 0 0 0 rg BT 194.77 701.25 Td (enacted. ) Tj ET Q q 0 0 0 rg BT 229.73 701.25 Td (V) Tj ET Q q 0 0 0 rg BT 235.84 701.25 Td (aluation ) Tj ET Q q 0 0 0 rg BT 270.13 701.25 Td (allowances ) Tj ET Q q 0 0 0 rg BT 316.63 701.25 Td (are ) Tj ET Q q 0 0 0 rg BT 330.91 701.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 376.85 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 386.71 701.25 Td (reduce ) Tj ET Q q 0 0 0 rg BT 415.43 701.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 450.81 701.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 465.10 701.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 490.51 701.25 Td (when ) Tj ET Q q 0 0 0 rg BT 514.25 701.25 Td (it ) Tj ET Q q 0 0 0 rg BT 521.88 701.25 Td (is ) Tj ET Q q 0 0 0 rg BT 530.63 701.25 Td (more ) Tj ET Q q 0 0 0 rg BT 553.25 701.25 Td (likely ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (than ) Tj ET Q q 0 0 0 rg BT 54.96 689.25 Td (not ) Tj ET Q q 0 0 0 rg BT 69.48 689.25 Td (that ) Tj ET Q q 0 0 0 rg BT 86.21 689.25 Td (a ) Tj ET Q q 0 0 0 rg BT 92.39 689.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 106.35 689.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 135.85 689.25 Td (will ) Tj ET Q q 0 0 0 rg BT 153.15 689.25 Td (not ) Tj ET Q q 0 0 0 rg BT 167.67 689.25 Td (be ) Tj ET Q q 0 0 0 rg BT 178.85 689.25 Td (realized. ) Tj ET Q q 0 0 0 rg BT 214.60 689.25 Td (The ) Tj ET Q q 0 0 0 rg BT 231.89 689.25 Td (assessment ) Tj ET Q q 0 0 0 rg BT 278.07 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 288.14 689.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 322.09 689.25 Td (or ) Tj ET Q q 0 0 0 rg BT 332.16 689.25 Td (not ) Tj ET Q q 0 0 0 rg BT 346.68 689.25 Td (a ) Tj ET Q q 0 0 0 rg BT 352.86 689.25 Td (valuation ) Tj ET Q q 0 0 0 rg BT 391.81 689.25 Td (allowance ) Tj ET Q q 0 0 0 rg BT 434.08 689.25 Td (is ) Tj ET Q q 0 0 0 rg BT 442.50 689.25 Td (required ) Tj ET Q q 0 0 0 rg BT 477.55 689.25 Td (often ) Tj ET Q q 0 0 0 rg BT 499.84 689.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 533.79 689.25 Td (significant ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (judgment ) Tj ET Q q 0 0 0 rg BT 76.61 677.25 Td (including ) Tj ET Q q 0 0 0 rg BT 117.22 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 132.27 677.25 Td (long-range ) Tj ET Q q 0 0 0 rg BT 178.43 677.25 Td (forecast ) Tj ET Q q 0 0 0 rg BT 212.91 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 224.08 677.25 Td (future ) Tj ET Q q 0 0 0 rg BT 250.79 677.25 Td (taxable ) Tj ET Q q 0 0 0 rg BT 282.50 677.25 Td (income ) Tj ET Q q 0 0 0 rg BT 314.77 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 332.04 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 347.10 677.25 Td (evaluation ) Tj ET Q q 0 0 0 rg BT 391.59 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 402.75 677.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 417.81 677.25 Td (planning ) Tj ET Q q 0 0 0 rg BT 455.64 677.25 Td (initiatives. ) Tj ET Q q 0 0 0 rg BT 499.79 677.25 Td (Adjustments ) Tj ET Q q 0 0 0 rg BT 553.18 677.25 Td (to ) Tj ET Q q 0 0 0 rg BT 563.80 677.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 71.81 665.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 86.52 665.25 Td (valuation ) Tj ET Q q 0 0 0 rg BT 126.23 665.25 Td (allowances ) Tj ET Q q 0 0 0 rg BT 173.16 665.25 Td (are ) Tj ET Q q 0 0 0 rg BT 187.87 665.25 Td (made ) Tj ET Q q 0 0 0 rg BT 212.02 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 222.30 665.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 258.68 665.25 Td (in ) Tj ET Q q 0 0 0 rg BT 268.95 665.25 Td (the ) Tj ET Q q 0 0 0 rg BT 283.67 665.25 Td (period ) Tj ET Q q 0 0 0 rg BT 311.72 665.25 Td (when ) Tj ET Q q 0 0 0 rg BT 335.88 665.25 Td (such ) Tj ET Q q 0 0 0 rg BT 356.71 665.25 Td (assessments ) Tj ET Q q 0 0 0 rg BT 407.54 665.25 Td (are ) Tj ET Q q 0 0 0 rg BT 422.25 665.25 Td (made.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 641.25 Td (ax ) Tj ET Q q 0 0 0 rg BT 53.92 641.25 Td (benefits ) Tj ET Q q 0 0 0 rg BT 88.64 641.25 Td (are ) Tj ET Q q 0 0 0 rg BT 103.91 641.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 150.84 641.25 Td (from ) Tj ET Q q 0 0 0 rg BT 173.35 641.25 Td (an ) Tj ET Q q 0 0 0 rg BT 185.86 641.25 Td (uncertain ) Tj ET Q q 0 0 0 rg BT 226.13 641.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 241.41 641.25 Td (position ) Tj ET Q q 0 0 0 rg BT 276.71 641.25 Td (only ) Tj ET Q q 0 0 0 rg BT 297.55 641.25 Td (if ) Tj ET Q q 0 0 0 rg BT 306.73 641.25 Td (it ) Tj ET Q q 0 0 0 rg BT 315.35 641.25 Td (is ) Tj ET Q q 0 0 0 rg BT 325.09 641.25 Td (more ) Tj ET Q q 0 0 0 rg BT 348.71 641.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 374.55 641.25 Td (than ) Tj ET Q q 0 0 0 rg BT 394.83 641.25 Td (not ) Tj ET Q q 0 0 0 rg BT 410.68 641.25 Td (that ) Tj ET Q q 0 0 0 rg BT 428.74 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 444.03 641.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 459.31 641.25 Td (position ) Tj ET Q q 0 0 0 rg BT 494.60 641.25 Td (will ) Tj ET Q q 0 0 0 rg BT 513.23 641.25 Td (be ) Tj ET Q q 0 0 0 rg BT 525.74 641.25 Td (sustained ) Tj ET Q q 0 0 0 rg BT 566.02 641.25 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (examination ) Tj ET Q q 0 0 0 rg BT 87.60 629.25 Td (by ) Tj ET Q q 0 0 0 rg BT 99.77 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 114.15 629.25 Td (taxing ) Tj ET Q q 0 0 0 rg BT 141.32 629.25 Td (authorities ) Tj ET Q q 0 0 0 rg BT 185.70 629.25 Td (based ) Tj ET Q q 0 0 0 rg BT 210.64 629.25 Td (on ) Tj ET Q q 0 0 0 rg BT 222.81 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 237.19 629.25 Td (technical ) Tj ET Q q 0 0 0 rg BT 275.45 629.25 Td (merits ) Tj ET Q q 0 0 0 rg BT 302.62 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 313.12 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 327.50 629.25 Td (position. ) Tj ET Q q 0 0 0 rg BT 364.24 629.25 Td (The ) Tj ET Q q 0 0 0 rg BT 381.96 629.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 396.34 629.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 426.28 629.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 472.31 629.25 Td (in ) Tj ET Q q 0 0 0 rg BT 482.26 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 496.64 629.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 533.79 629.25 Td (statements ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 617.25 Td (a ) Tj ET Q q 0 0 0 rg BT 57.10 617.25 Td (particular ) Tj ET Q q 0 0 0 rg BT 97.91 617.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 112.63 617.25 Td (position ) Tj ET Q q 0 0 0 rg BT 147.35 617.25 Td (is ) Tj ET Q q 0 0 0 rg BT 156.52 617.25 Td (based ) Tj ET Q q 0 0 0 rg BT 181.79 617.25 Td (on ) Tj ET Q q 0 0 0 rg BT 194.29 617.25 Td (the ) Tj ET Q q 0 0 0 rg BT 209.01 617.25 Td (lar) Tj ET Q q 0 0 0 rg BT 219.37 617.25 Td (gest ) Tj ET Q q 0 0 0 rg BT 237.98 617.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 268.25 617.25 Td (that ) Tj ET Q q 0 0 0 rg BT 285.74 617.25 Td (is ) Tj ET Q q 0 0 0 rg BT 294.91 617.25 Td (more ) Tj ET Q q 0 0 0 rg BT 317.96 617.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 343.23 617.25 Td (than ) Tj ET Q q 0 0 0 rg BT 362.95 617.25 Td (not ) Tj ET Q q 0 0 0 rg BT 378.23 617.25 Td (to ) Tj ET Q q 0 0 0 rg BT 388.50 617.25 Td (be ) Tj ET Q q 0 0 0 rg BT 400.44 617.25 Td (realized ) Tj ET Q q 0 0 0 rg BT 434.58 617.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 457.08 617.25 Td (settlement.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (Cash and Cash Equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 58.21 569.25 Td (and ) Tj ET Q q 0 0 0 rg BT 74.87 569.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 94.85 569.25 Td (equivalents ) Tj ET Q q 0 0 0 rg BT 142.61 569.25 Td (include ) Tj ET Q q 0 0 0 rg BT 174.25 569.25 Td (bank ) Tj ET Q q 0 0 0 rg BT 195.91 569.25 Td (deposits, ) Tj ET Q q 0 0 0 rg BT 233.40 569.25 Td (time ) Tj ET Q q 0 0 0 rg BT 253.39 569.25 Td (deposits, ) Tj ET Q q 0 0 0 rg BT 290.88 569.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 340.29 569.25 Td (paper ) Tj ET Q q 0 0 0 rg BT 364.71 569.25 Td (and ) Tj ET Q q 0 0 0 rg BT 381.37 569.25 Td (money ) Tj ET Q q 0 0 0 rg BT 410.80 569.25 Td (market ) Tj ET Q q 0 0 0 rg BT 440.78 569.25 Td (funds. ) Tj ET Q q 0 0 0 rg BT 467.71 569.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 489.93 569.25 Td (equivalents ) Tj ET Q q 0 0 0 rg BT 537.68 569.25 Td (consist ) Tj ET Q q 0 0 0 rg BT 567.67 569.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (highly ) Tj ET Q q 0 0 0 rg BT 64.96 557.25 Td (liquid ) Tj ET Q q 0 0 0 rg BT 91.70 557.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 142.88 557.25 Td (with ) Tj ET Q q 0 0 0 rg BT 164.07 557.25 Td (original ) Tj ET Q q 0 0 0 rg BT 198.58 557.25 Td (maturities ) Tj ET Q q 0 0 0 rg BT 241.97 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 253.71 557.25 Td (three ) Tj ET Q q 0 0 0 rg BT 277.10 557.25 Td (months ) Tj ET Q q 0 0 0 rg BT 309.95 557.25 Td (or ) Tj ET Q q 0 0 0 rg BT 321.69 557.25 Td (less ) Tj ET Q q 0 0 0 rg BT 340.09 557.25 Td (at ) Tj ET Q q 0 0 0 rg BT 350.72 557.25 Td (the ) Tj ET Q q 0 0 0 rg BT 366.34 557.25 Td (time ) Tj ET Q q 0 0 0 rg BT 387.52 557.25 Td (of ) Tj ET Q q 0 0 0 rg BT 399.25 557.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 438.20 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 456.04 557.25 Td (are ) Tj ET Q q 0 0 0 rg BT 471.65 557.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 518.92 557.25 Td (at ) Tj ET Q q 0 0 0 rg BT 529.54 557.25 Td (cost, ) Tj ET Q q 0 0 0 rg BT 551.56 557.25 Td (which ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (approximates ) Tj ET Q q 0 0 0 rg BT 92.37 545.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 108.75 545.25 Td (value.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (Marketable ) Tj ET Q q 0 0 0 rg BT 88.49 521.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 132.64 521.25 Td (and ) Tj ET Q q 0 0 0 rg BT 151.26 521.25 Td (Investments ) Tj ET Q q 0 0 0 rg BT 205.43 521.25 Td (in ) Tj ET Q q 0 0 0 rg BT 216.27 521.25 Td (Other) Tj ET Q q 0 0 0 rg BT 241.63 521.25 Td ( ) Tj ET Q q 0 0 0 rg BT 244.13 521.25 Td (Companies) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (Marketable ) Tj ET Q q 0 0 0 rg BT 84.41 497.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 125.05 497.25 Td (are ) Tj ET Q q 0 0 0 rg BT 140.13 497.25 Td (classified ) Tj ET Q q 0 0 0 rg BT 180.77 497.25 Td (as ) Tj ET Q q 0 0 0 rg BT 191.97 497.25 Td (“available-for) Tj ET Q q 0 0 0 rg BT 247.29 497.25 Td (-sale” ) Tj ET Q q 0 0 0 rg BT 273.48 497.25 Td (on ) Tj ET Q q 0 0 0 rg BT 286.35 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 301.45 497.25 Td (date ) Tj ET Q q 0 0 0 rg BT 320.98 497.25 Td (of ) Tj ET Q q 0 0 0 rg BT 332.18 497.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 370.59 497.25 Td (and ) Tj ET Q q 0 0 0 rg BT 387.91 497.25 Td (reported ) Tj ET Q q 0 0 0 rg BT 424.10 497.25 Td (at ) Tj ET Q q 0 0 0 rg BT 434.19 497.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 450.94 497.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 477.97 497.25 Td (Fair ) Tj ET Q q 0 0 0 rg BT 496.96 497.25 Td (value ) Tj ET Q q 0 0 0 rg BT 521.49 497.25 Td (is ) Tj ET Q q 0 0 0 rg BT 531.03 497.25 Td (determined ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (based ) Tj ET Q q 0 0 0 rg BT 62.55 485.25 Td (on ) Tj ET Q q 0 0 0 rg BT 76.33 485.25 Td (observable ) Tj ET Q q 0 0 0 rg BT 123.43 485.25 Td (market ) Tj ET Q q 0 0 0 rg BT 154.98 485.25 Td (quotes ) Tj ET Q q 0 0 0 rg BT 184.87 485.25 Td (or ) Tj ET Q q 0 0 0 rg BT 196.98 485.25 Td (valuation ) Tj ET Q q 0 0 0 rg BT 237.97 485.25 Td (models ) Tj ET Q q 0 0 0 rg BT 270.64 485.25 Td (using ) Tj ET Q q 0 0 0 rg BT 296.09 485.25 Td (assessments ) Tj ET Q q 0 0 0 rg BT 348.21 485.25 Td (of ) Tj ET Q q 0 0 0 rg BT 360.32 485.25 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 414.63 485.25 Td (credit ) Tj ET Q q 0 0 0 rg BT 441.18 485.25 Td (worthiness, ) Tj ET Q q 0 0 0 rg BT 490.79 485.25 Td (credit ) Tj ET Q q 0 0 0 rg BT 517.34 485.25 Td (default ) Tj ET Q q 0 0 0 rg BT 548.88 485.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 567.67 485.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (underlying ) Tj ET Q q 0 0 0 rg BT 81.83 473.25 Td (security ) Tj ET Q q 0 0 0 rg BT 115.98 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 132.92 473.25 Td (overall ) Tj ET Q q 0 0 0 rg BT 163.18 473.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 192.33 473.25 Td (market ) Tj ET Q q 0 0 0 rg BT 222.60 473.25 Td (liquidity) Tj ET Q q 0 0 0 rg BT 255.84 473.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (Investments ) Tj ET Q q 0 0 0 rg BT 87.69 449.25 Td (in ) Tj ET Q q 0 0 0 rg BT 98.84 449.25 Td (50% ) Tj ET Q q 0 0 0 rg BT 120.54 449.25 Td (or ) Tj ET Q q 0 0 0 rg BT 132.24 449.25 Td (less ) Tj ET Q q 0 0 0 rg BT 150.61 449.25 Td (owned ) Tj ET Q q 0 0 0 rg BT 180.64 449.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 226.77 449.25 Td (are ) Tj ET Q q 0 0 0 rg BT 242.35 449.25 Td (accounted ) Tj ET Q q 0 0 0 rg BT 286.25 449.25 Td (for ) Tj ET Q q 0 0 0 rg BT 301.28 449.25 Td (using ) Tj ET Q q 0 0 0 rg BT 326.32 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 341.90 449.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 370.27 449.25 Td (method ) Tj ET Q q 0 0 0 rg BT 403.63 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 415.33 449.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 462.57 449.25 Td (when ) Tj ET Q q 0 0 0 rg BT 487.60 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 503.19 449.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 532.11 449.25 Td (to ) Tj ET Q q 0 0 0 rg BT 543.26 449.25 Td (exercise ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 80.19 437.25 Td (influence ) Tj ET Q q 0 0 0 rg BT 119.36 437.25 Td (is ) Tj ET Q q 0 0 0 rg BT 128.01 437.25 Td (maintained. ) Tj ET Q q 0 0 0 rg BT 176.77 437.25 Td (The ) Tj ET Q q 0 0 0 rg BT 194.29 437.25 Td (share ) Tj ET Q q 0 0 0 rg BT 217.37 437.25 Td (of ) Tj ET Q q 0 0 0 rg BT 227.67 437.25 Td (net ) Tj ET Q q 0 0 0 rg BT 241.86 437.25 Td (income ) Tj ET Q q 0 0 0 rg BT 273.27 437.25 Td (or ) Tj ET Q q 0 0 0 rg BT 283.58 437.25 Td (losses ) Tj ET Q q 0 0 0 rg BT 309.44 437.25 Td (of ) Tj ET Q q 0 0 0 rg BT 319.75 437.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 346.72 437.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 396.47 437.25 Td (is ) Tj ET Q q 0 0 0 rg BT 405.11 437.25 Td (included ) Tj ET Q q 0 0 0 rg BT 441.52 437.25 Td (in ) Tj ET Q q 0 0 0 rg BT 451.27 437.25 Td (other ) Tj ET Q q 0 0 0 rg BT 473.80 437.25 Td (\(income\)/expense. ) Tj ET Q q 0 0 0 rg BT 549.35 437.25 Td (Equity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 86.19 425.25 Td (are ) Tj ET Q q 0 0 0 rg BT 100.81 425.25 Td (reviewed ) Tj ET Q q 0 0 0 rg BT 139.87 425.25 Td (for ) Tj ET Q q 0 0 0 rg BT 153.95 425.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 202.46 425.25 Td (by ) Tj ET Q q 0 0 0 rg BT 214.88 425.25 Td (assessing ) Tj ET Q q 0 0 0 rg BT 254.52 425.25 Td (if ) Tj ET Q q 0 0 0 rg BT 263.04 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 277.68 425.25 Td (decline ) Tj ET Q q 0 0 0 rg BT 308.96 425.25 Td (in ) Tj ET Q q 0 0 0 rg BT 319.16 425.25 Td (market ) Tj ET Q q 0 0 0 rg BT 349.34 425.25 Td (value ) Tj ET Q q 0 0 0 rg BT 373.41 425.25 Td (of ) Tj ET Q q 0 0 0 rg BT 384.16 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 398.79 425.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 445.09 425.25 Td (below ) Tj ET Q q 0 0 0 rg BT 471.94 425.25 Td (the ) Tj ET Q q 0 0 0 rg BT 486.57 425.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 522.30 425.25 Td (value ) Tj ET Q q 0 0 0 rg BT 546.38 425.25 Td (is ) Tj ET Q q 0 0 0 rg BT 555.46 425.25 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (than ) Tj ET Q q 0 0 0 rg BT 55.52 413.25 Td (temporary) Tj ET Q q 0 0 0 rg BT 95.97 413.25 Td (, ) Tj ET Q q 0 0 0 rg BT 100.77 413.25 Td (which ) Tj ET Q q 0 0 0 rg BT 127.52 413.25 Td (considers ) Tj ET Q q 0 0 0 rg BT 167.59 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 182.12 413.25 Td (intent ) Tj ET Q q 0 0 0 rg BT 207.20 413.25 Td (and ) Tj ET Q q 0 0 0 rg BT 223.94 413.25 Td (ability ) Tj ET Q q 0 0 0 rg BT 251.80 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 261.88 413.25 Td (retain ) Tj ET Q q 0 0 0 rg BT 286.95 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 301.48 413.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 347.66 413.25 Td (for ) Tj ET Q q 0 0 0 rg BT 361.63 413.25 Td (a ) Tj ET Q q 0 0 0 rg BT 368.37 413.25 Td (period ) Tj ET Q q 0 0 0 rg BT 396.23 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 406.86 413.25 Td (time ) Tj ET Q q 0 0 0 rg BT 426.94 413.25 Td (suf) Tj ET Q q 0 0 0 rg BT 438.98 413.25 Td (ficient ) Tj ET Q q 0 0 0 rg BT 466.83 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 476.92 413.25 Td (allow ) Tj ET Q q 0 0 0 rg BT 501.44 413.25 Td (for ) Tj ET Q q 0 0 0 rg BT 515.41 413.25 Td (any ) Tj ET Q q 0 0 0 rg BT 532.15 413.25 Td (anticipated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (recovery ) Tj ET Q q 0 0 0 rg BT 73.48 401.25 Td (in ) Tj ET Q q 0 0 0 rg BT 83.75 401.25 Td (market ) Tj ET Q q 0 0 0 rg BT 114.02 401.25 Td (value, ) Tj ET Q q 0 0 0 rg BT 140.67 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 155.39 401.25 Td (duration ) Tj ET Q q 0 0 0 rg BT 191.21 401.25 Td (and ) Tj ET Q q 0 0 0 rg BT 208.15 401.25 Td (extent ) Tj ET Q q 0 0 0 rg BT 235.09 401.25 Td (that ) Tj ET Q q 0 0 0 rg BT 252.58 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 267.30 401.25 Td (market ) Tj ET Q q 0 0 0 rg BT 297.56 401.25 Td (value ) Tj ET Q q 0 0 0 rg BT 321.72 401.25 Td (has ) Tj ET Q q 0 0 0 rg BT 337.55 401.25 Td (been ) Tj ET Q q 0 0 0 rg BT 358.92 401.25 Td (less ) Tj ET Q q 0 0 0 rg BT 376.42 401.25 Td (than ) Tj ET Q q 0 0 0 rg BT 396.14 401.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 414.75 401.25 Td (and ) Tj ET Q q 0 0 0 rg BT 431.69 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 446.41 401.25 Td (investee's ) Tj ET Q q 0 0 0 rg BT 487.36 401.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 524.84 401.25 Td (condition.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (Inventory ) Tj ET Q q 0 0 0 rg BT 80.54 377.25 Td (V) Tj ET Q q 0 0 0 rg BT 86.84 377.25 Td (aluation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (Inventories ) Tj ET Q q 0 0 0 rg BT 83.49 353.25 Td (are ) Tj ET Q q 0 0 0 rg BT 98.19 353.25 Td (stated ) Tj ET Q q 0 0 0 rg BT 124.02 353.25 Td (at ) Tj ET Q q 0 0 0 rg BT 133.73 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 148.45 353.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 173.72 353.25 Td (of ) Tj ET Q q 0 0 0 rg BT 184.55 353.25 Td (average ) Tj ET Q q 0 0 0 rg BT 218.13 353.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 236.74 353.25 Td (or ) Tj ET Q q 0 0 0 rg BT 247.57 353.25 Td (market.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (Pr) Tj ET Q q 0 0 0 rg BT 46.37 329.25 Td (operty) Tj ET Q q 0 0 0 rg BT 73.58 329.25 Td (, Plant and Equipment and Depr) Tj ET Q q 0 0 0 rg BT 212.88 329.25 Td (eciation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (Expenditures ) Tj ET Q q 0 0 0 rg BT 90.80 305.25 Td (for ) Tj ET Q q 0 0 0 rg BT 104.50 305.25 Td (additions, ) Tj ET Q q 0 0 0 rg BT 145.70 305.25 Td (renewals ) Tj ET Q q 0 0 0 rg BT 183.27 305.25 Td (and ) Tj ET Q q 0 0 0 rg BT 199.75 305.25 Td (improvements ) Tj ET Q q 0 0 0 rg BT 258.99 305.25 Td (are ) Tj ET Q q 0 0 0 rg BT 273.24 305.25 Td (capitalized ) Tj ET Q q 0 0 0 rg BT 318.58 305.25 Td (at ) Tj ET Q q 0 0 0 rg BT 327.83 305.25 Td (cost. ) Tj ET Q q 0 0 0 rg BT 348.48 305.25 Td (Depreciation ) Tj ET Q q 0 0 0 rg BT 402.15 305.25 Td (is ) Tj ET Q q 0 0 0 rg BT 410.86 305.25 Td (computed ) Tj ET Q q 0 0 0 rg BT 452.33 305.25 Td (on ) Tj ET Q q 0 0 0 rg BT 464.36 305.25 Td (a ) Tj ET Q q 0 0 0 rg BT 470.84 305.25 Td (straight-line ) Tj ET Q q 0 0 0 rg BT 521.20 305.25 Td (method ) Tj ET Q q 0 0 0 rg BT 553.23 305.25 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (on ) Tj ET Q q 0 0 0 rg BT 48.55 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 63.31 293.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 104.17 293.25 Td (useful ) Tj ET Q q 0 0 0 rg BT 131.16 293.25 Td (lives ) Tj ET Q q 0 0 0 rg BT 152.59 293.25 Td (of ) Tj ET Q q 0 0 0 rg BT 163.46 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 178.23 293.25 Td (related ) Tj ET Q q 0 0 0 rg BT 207.97 293.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 233.85 293.25 Td (ranging ) Tj ET Q q 0 0 0 rg BT 266.94 293.25 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.93 293.25 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.93 293.25 Td ( ) Tj ET Q q 0 0 0 rg BT 301.47 293.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 311.80 293.25 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.80 293.25 Td ( ) Tj ET Q q 0 0 0 rg BT 324.34 293.25 Td (years ) Tj ET Q q 0 0 0 rg BT 347.98 293.25 Td (for ) Tj ET Q q 0 0 0 rg BT 362.19 293.25 Td (buildings ) Tj ET Q q 0 0 0 rg BT 401.96 293.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.95 293.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.95 293.25 Td ( ) Tj ET Q q 0 0 0 rg BT 426.49 293.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.82 293.25 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.82 293.25 Td ( ) Tj ET Q q 0 0 0 rg BT 449.36 293.25 Td (years ) Tj ET Q q 0 0 0 rg BT 473.00 293.25 Td (for ) Tj ET Q q 0 0 0 rg BT 487.21 293.25 Td (machinery) Tj ET Q q 0 0 0 rg BT 528.76 293.25 Td (, ) Tj ET Q q 0 0 0 rg BT 533.81 293.25 Td (equipment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 281.25 Td (fixtures.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (Impairment of Long-Lived ) Tj ET Q q 0 0 0 rg BT 152.95 257.25 Td (Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (Current ) Tj ET Q q 0 0 0 rg BT 68.65 233.25 Td (facts ) Tj ET Q q 0 0 0 rg BT 89.63 233.25 Td (or ) Tj ET Q q 0 0 0 rg BT 100.06 233.25 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 158.80 233.25 Td (are ) Tj ET Q q 0 0 0 rg BT 173.11 233.25 Td (periodically ) Tj ET Q q 0 0 0 rg BT 222.97 233.25 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 263.38 233.25 Td (to ) Tj ET Q q 0 0 0 rg BT 273.26 233.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 315.34 233.25 Td (if ) Tj ET Q q 0 0 0 rg BT 323.55 233.25 Td (the ) Tj ET Q q 0 0 0 rg BT 337.87 233.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 373.28 233.25 Td (value ) Tj ET Q q 0 0 0 rg BT 397.04 233.25 Td (of ) Tj ET Q q 0 0 0 rg BT 407.47 233.25 Td (depreciable ) Tj ET Q q 0 0 0 rg BT 455.65 233.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 481.08 233.25 Td (to ) Tj ET Q q 0 0 0 rg BT 490.96 233.25 Td (be ) Tj ET Q q 0 0 0 rg BT 502.50 233.25 Td (held ) Tj ET Q q 0 0 0 rg BT 521.82 233.25 Td (and ) Tj ET Q q 0 0 0 rg BT 538.36 233.25 Td (used ) Tj ET Q q 0 0 0 rg BT 558.79 233.25 Td (may ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 221.25 Td (not ) Tj ET Q q 0 0 0 rg BT 52.20 221.25 Td (be ) Tj ET Q q 0 0 0 rg BT 65.05 221.25 Td (recoverable. ) Tj ET Q q 0 0 0 rg BT 117.60 221.25 Td (If ) Tj ET Q q 0 0 0 rg BT 127.68 221.25 Td (such ) Tj ET Q q 0 0 0 rg BT 149.42 221.25 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 209.48 221.25 Td (exist, ) Tj ET Q q 0 0 0 rg BT 234.28 221.25 Td (an ) Tj ET Q q 0 0 0 rg BT 247.14 221.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 283.88 221.25 Td (of ) Tj ET Q q 0 0 0 rg BT 295.62 221.25 Td (undiscounted ) Tj ET Q q 0 0 0 rg BT 352.37 221.25 Td (future ) Tj ET Q q 0 0 0 rg BT 379.66 221.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 400.85 221.25 Td (flows ) Tj ET Q q 0 0 0 rg BT 426.48 221.25 Td (generated ) Tj ET Q q 0 0 0 rg BT 468.76 221.25 Td (by ) Tj ET Q q 0 0 0 rg BT 482.18 221.25 Td (the ) Tj ET Q q 0 0 0 rg BT 497.81 221.25 Td (long-lived ) Tj ET Q q 0 0 0 rg BT 542.33 221.25 Td (asset, ) Tj ET Q q 0 0 0 rg BT 567.69 221.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 82.90 209.25 Td (grouping ) Tj ET Q q 0 0 0 rg BT 120.38 209.25 Td (of ) Tj ET Q q 0 0 0 rg BT 130.08 209.25 Td (assets, ) Tj ET Q q 0 0 0 rg BT 157.29 209.25 Td (is ) Tj ET Q q 0 0 0 rg BT 165.33 209.25 Td (compared ) Tj ET Q q 0 0 0 rg BT 206.12 209.25 Td (to ) Tj ET Q q 0 0 0 rg BT 215.27 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 228.86 209.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 263.54 209.25 Td (value ) Tj ET Q q 0 0 0 rg BT 286.57 209.25 Td (to ) Tj ET Q q 0 0 0 rg BT 295.72 209.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 337.07 209.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 370.65 209.25 Td (an ) Tj ET Q q 0 0 0 rg BT 381.46 209.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 428.93 209.25 Td (exists ) Tj ET Q q 0 0 0 rg BT 453.08 209.25 Td (at ) Tj ET Q q 0 0 0 rg BT 461.67 209.25 Td (its ) Tj ET Q q 0 0 0 rg BT 472.49 209.25 Td (lowest ) Tj ET Q q 0 0 0 rg BT 499.97 209.25 Td (level ) Tj ET Q q 0 0 0 rg BT 520.77 209.25 Td (of ) Tj ET Q q 0 0 0 rg BT 530.47 209.25 Td (identifiable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 56.52 197.25 Td (flows. ) Tj ET Q q 0 0 0 rg BT 83.98 197.25 Td (If ) Tj ET Q q 0 0 0 rg BT 93.39 197.25 Td (an ) Tj ET Q q 0 0 0 rg BT 105.58 197.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 127.76 197.25 Td (is ) Tj ET Q q 0 0 0 rg BT 137.18 197.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 184.90 197.25 Td (to ) Tj ET Q q 0 0 0 rg BT 195.43 197.25 Td (be ) Tj ET Q q 0 0 0 rg BT 207.61 197.25 Td (impaired, ) Tj ET Q q 0 0 0 rg BT 248.40 197.25 Td (the ) Tj ET Q q 0 0 0 rg BT 263.37 197.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 281.67 197.25 Td (is ) Tj ET Q q 0 0 0 rg BT 291.09 197.25 Td (measured ) Tj ET Q q 0 0 0 rg BT 332.15 197.25 Td (based ) Tj ET Q q 0 0 0 rg BT 357.67 197.25 Td (on ) Tj ET Q q 0 0 0 rg BT 370.41 197.25 Td (the ) Tj ET Q q 0 0 0 rg BT 385.38 197.25 Td (dif) Tj ET Q q 0 0 0 rg BT 396.31 197.25 Td (ference ) Tj ET Q q 0 0 0 rg BT 428.47 197.25 Td (between ) Tj ET Q q 0 0 0 rg BT 464.53 197.25 Td (the ) Tj ET Q q 0 0 0 rg BT 479.49 197.25 Td (asset’) Tj ET Q q 0 0 0 rg BT 501.71 197.25 Td (s ) Tj ET Q q 0 0 0 rg BT 508.35 197.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 524.97 197.25 Td (value ) Tj ET Q q 0 0 0 rg BT 549.37 197.25 Td (and ) Tj ET Q q 0 0 0 rg BT 566.56 197.25 Td (its ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 72.27 185.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 98.73 185.25 Td (An ) Tj ET Q q 0 0 0 rg BT 113.91 185.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 150.18 185.25 Td (of ) Tj ET Q q 0 0 0 rg BT 161.47 185.25 Td (the ) Tj ET Q q 0 0 0 rg BT 176.64 185.25 Td (asset’) Tj ET Q q 0 0 0 rg BT 198.86 185.25 Td (s ) Tj ET Q q 0 0 0 rg BT 205.70 185.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 222.54 185.25 Td (value ) Tj ET Q q 0 0 0 rg BT 247.15 185.25 Td (is ) Tj ET Q q 0 0 0 rg BT 256.77 185.25 Td (based ) Tj ET Q q 0 0 0 rg BT 282.50 185.25 Td (on ) Tj ET Q q 0 0 0 rg BT 295.45 185.25 Td (quoted ) Tj ET Q q 0 0 0 rg BT 325.63 185.25 Td (market ) Tj ET Q q 0 0 0 rg BT 356.34 185.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 383.18 185.25 Td (in ) Tj ET Q q 0 0 0 rg BT 393.91 185.25 Td (active ) Tj ET Q q 0 0 0 rg BT 420.74 185.25 Td (markets, ) Tj ET Q q 0 0 0 rg BT 457.85 185.25 Td (if ) Tj ET Q q 0 0 0 rg BT 466.91 185.25 Td (available. ) Tj ET Q q 0 0 0 rg BT 508.46 185.25 Td (If ) Tj ET Q q 0 0 0 rg BT 518.07 185.25 Td (quoted ) Tj ET Q q 0 0 0 rg BT 548.25 185.25 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 62.27 173.25 Td (are ) Tj ET Q q 0 0 0 rg BT 76.86 173.25 Td (not ) Tj ET Q q 0 0 0 rg BT 92.03 173.25 Td (available, ) Tj ET Q q 0 0 0 rg BT 133.01 173.25 Td (the ) Tj ET Q q 0 0 0 rg BT 147.61 173.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 183.32 173.25 Td (of ) Tj ET Q q 0 0 0 rg BT 194.04 173.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 210.31 173.25 Td (value ) Tj ET Q q 0 0 0 rg BT 234.35 173.25 Td (is ) Tj ET Q q 0 0 0 rg BT 243.41 173.25 Td (based ) Tj ET Q q 0 0 0 rg BT 268.57 173.25 Td (on ) Tj ET Q q 0 0 0 rg BT 280.96 173.25 Td (various ) Tj ET Q q 0 0 0 rg BT 312.79 173.25 Td (valuation ) Tj ET Q q 0 0 0 rg BT 352.39 173.25 Td (techniques ) Tj ET Q q 0 0 0 rg BT 397.54 173.25 Td (using ) Tj ET Q q 0 0 0 rg BT 421.60 173.25 Td (unobservable ) Tj ET Q q 0 0 0 rg BT 477.30 173.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 493.57 173.25 Td (value ) Tj ET Q q 0 0 0 rg BT 517.61 173.25 Td (inputs, ) Tj ET Q q 0 0 0 rg BT 546.95 173.25 Td (such ) Tj ET Q q 0 0 0 rg BT 567.67 173.25 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (a ) Tj ET Q q 0 0 0 rg BT 42.94 161.25 Td (discounted ) Tj ET Q q 0 0 0 rg BT 88.76 161.25 Td (value ) Tj ET Q q 0 0 0 rg BT 112.92 161.25 Td (of ) Tj ET Q q 0 0 0 rg BT 123.75 161.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 164.57 161.25 Td (future ) Tj ET Q q 0 0 0 rg BT 190.95 161.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 211.21 161.25 Td (flows.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 137.25 Td (Capitalized Softwar) Tj ET Q q 0 0 0 rg BT 121.09 137.25 Td (e) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td (Eligible ) Tj ET Q q 0 0 0 rg BT 70.16 113.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 92.66 113.25 Td (to ) Tj ET Q q 0 0 0 rg BT 102.94 113.25 Td (obtain ) Tj ET Q q 0 0 0 rg BT 130.43 113.25 Td (internal ) Tj ET Q q 0 0 0 rg BT 163.48 113.25 Td (use ) Tj ET Q q 0 0 0 rg BT 179.31 113.25 Td (software ) Tj ET Q q 0 0 0 rg BT 216.23 113.25 Td (are ) Tj ET Q q 0 0 0 rg BT 230.94 113.25 Td (capitalized ) Tj ET Q q 0 0 0 rg BT 276.75 113.25 Td (and ) Tj ET Q q 0 0 0 rg BT 293.69 113.25 Td (amortized ) Tj ET Q q 0 0 0 rg BT 336.17 113.25 Td (over ) Tj ET Q q 0 0 0 rg BT 356.43 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 371.15 113.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 411.97 113.25 Td (useful ) Tj ET Q q 0 0 0 rg BT 438.91 113.25 Td (life ) Tj ET Q q 0 0 0 rg BT 454.74 113.25 Td (of ) Tj ET Q q 0 0 0 rg BT 465.57 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 480.28 113.25 Td (software. ) Tj ET Q endstream endobj 117 0 obj <> endobj 118 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (58) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Acquisitions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Businesses ) Tj ET Q q 0 0 0 rg BT 82.33 725.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 119.20 725.25 Td (are ) Tj ET Q q 0 0 0 rg BT 133.85 725.25 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 186.84 725.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 209.28 725.25 Td (obtaining ) Tj ET Q q 0 0 0 rg BT 249.50 725.25 Td (control. ) Tj ET Q q 0 0 0 rg BT 282.59 725.25 Td (The ) Tj ET Q q 0 0 0 rg BT 300.58 725.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 316.90 725.25 Td (value ) Tj ET Q q 0 0 0 rg BT 340.99 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 351.77 725.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 377.54 725.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 414.41 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 431.29 725.25 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 470.95 725.25 Td (assumed ) Tj ET Q q 0 0 0 rg BT 507.83 725.25 Td (are ) Tj ET Q q 0 0 0 rg BT 522.48 725.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 568.78 725.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.06 713.25 Td (date ) Tj ET Q q 0 0 0 rg BT 68.55 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 78.72 713.25 Td (acquisition. ) Tj ET Q q 0 0 0 rg BT 126.53 713.25 Td (Any ) Tj ET Q q 0 0 0 rg BT 145.59 713.25 Td (excess ) Tj ET Q q 0 0 0 rg BT 173.53 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 183.70 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 197.75 713.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 235.13 713.25 Td (price ) Tj ET Q q 0 0 0 rg BT 256.95 713.25 Td (over ) Tj ET Q q 0 0 0 rg BT 276.56 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 290.61 713.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 330.77 713.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 346.49 713.25 Td (values ) Tj ET Q q 0 0 0 rg BT 373.87 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 384.04 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 398.10 713.25 Td (net ) Tj ET Q q 0 0 0 rg BT 412.15 713.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 437.32 713.25 Td (acquired ) Tj ET Q q 0 0 0 rg BT 473.58 713.25 Td (is ) Tj ET Q q 0 0 0 rg BT 482.09 713.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 527.79 713.25 Td (as ) Tj ET Q q 0 0 0 rg BT 537.96 713.25 Td (goodwill. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (Business ) Tj ET Q q 0 0 0 rg BT 74.02 701.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 120.36 701.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 142.82 701.25 Td (are ) Tj ET Q q 0 0 0 rg BT 157.48 701.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 197.15 701.25 Td (when ) Tj ET Q q 0 0 0 rg BT 221.26 701.25 Td (incurred. ) Tj ET Q q 0 0 0 rg BT 259.54 701.25 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 306.44 701.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 362.77 701.25 Td (from ) Tj ET Q q 0 0 0 rg BT 384.66 701.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 422.11 701.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 478.72 701.25 Td (regulatory) Tj ET Q q 0 0 0 rg BT 519.16 701.25 Td (, ) Tj ET Q q 0 0 0 rg BT 524.12 701.25 Td (approval ) Tj ET Q q 0 0 0 rg BT 561.56 701.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 83.86 689.25 Td (milestones ) Tj ET Q q 0 0 0 rg BT 128.96 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 145.73 689.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 193.59 689.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 230.35 689.25 Td (are ) Tj ET Q q 0 0 0 rg BT 244.88 689.25 Td (included ) Tj ET Q q 0 0 0 rg BT 281.64 689.25 Td (in ) Tj ET Q q 0 0 0 rg BT 291.74 689.25 Td (the ) Tj ET Q q 0 0 0 rg BT 306.29 689.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 344.15 689.25 Td (price ) Tj ET Q q 0 0 0 rg BT 366.46 689.25 Td (for ) Tj ET Q q 0 0 0 rg BT 380.45 689.25 Td (business ) Tj ET Q q 0 0 0 rg BT 416.66 689.25 Td (combinations ) Tj ET Q q 0 0 0 rg BT 472.87 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 489.64 689.25 Td (are ) Tj ET Q q 0 0 0 rg BT 504.17 689.25 Td (excluded ) Tj ET Q q 0 0 0 rg BT 542.59 689.25 Td (for ) Tj ET Q q 0 0 0 rg BT 556.57 689.25 Td (asset ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (acquisitions. ) Tj ET Q q 0 0 0 rg BT 88.22 677.25 Td (Amounts ) Tj ET Q q 0 0 0 rg BT 127.39 677.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 165.98 677.25 Td (to ) Tj ET Q q 0 0 0 rg BT 176.26 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 190.98 677.25 Td (lead ) Tj ET Q q 0 0 0 rg BT 210.13 677.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 271.51 677.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 320.12 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 334.28 677.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 356.21 677.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 406.49 677.25 Td (are ) Tj ET Q q 0 0 0 rg BT 421.20 677.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 460.90 677.25 Td (at ) Tj ET Q q 0 0 0 rg BT 470.62 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 485.34 677.25 Td (date ) Tj ET Q q 0 0 0 rg BT 504.49 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 515.32 677.25 Td (acquisition. ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (Goodwill, ) Tj ET Q q 0 0 0 rg BT 79.34 653.25 Td (Acquir) Tj ET Q q 0 0 0 rg BT 109.16 653.25 Td (ed In-Pr) Tj ET Q q 0 0 0 rg BT 144.81 653.25 Td (ocess Resear) Tj ET Q q 0 0 0 rg BT 198.22 653.25 Td (ch and Development and Other) Tj ET Q q 0 0 0 rg BT 331.93 653.25 Td ( Intangible ) Tj ET Q q 0 0 0 rg BT 380.28 653.25 Td (Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.64 629.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 71.60 629.25 Td (value ) Tj ET Q q 0 0 0 rg BT 96.35 629.25 Td (of ) Tj ET Q q 0 0 0 rg BT 107.77 629.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 150.85 629.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 177.27 629.25 Td (is ) Tj ET Q q 0 0 0 rg BT 187.03 629.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 225.11 629.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 273.18 629.25 Td (using ) Tj ET Q q 0 0 0 rg BT 297.94 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 313.25 629.25 Td (“income ) Tj ET Q q 0 0 0 rg BT 350.21 629.25 Td (method” ) Tj ET Q q 0 0 0 rg BT 387.73 629.25 Td (utilizing ) Tj ET Q q 0 0 0 rg BT 424.15 629.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 450.00 629.25 Td (3 ) Tj ET Q q 0 0 0 rg BT 458.09 629.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 475.06 629.25 Td (value ) Tj ET Q q 0 0 0 rg BT 499.81 629.25 Td (inputs. ) Tj ET Q q 0 0 0 rg BT 529.62 629.25 Td (The ) Tj ET Q q 0 0 0 rg BT 548.26 629.25 Td (market ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (participant ) Tj ET Q q 0 0 0 rg BT 80.68 617.25 Td (valuations ) Tj ET Q q 0 0 0 rg BT 123.70 617.25 Td (assume ) Tj ET Q q 0 0 0 rg BT 155.05 617.25 Td (a ) Tj ET Q q 0 0 0 rg BT 161.41 617.25 Td (global ) Tj ET Q q 0 0 0 rg BT 188.32 617.25 Td (view ) Tj ET Q q 0 0 0 rg BT 209.67 617.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 258.24 617.25 Td (all ) Tj ET Q q 0 0 0 rg BT 270.16 617.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 307.06 617.25 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 358.42 617.25 Td (and ) Tj ET Q q 0 0 0 rg BT 374.78 617.25 Td (indications ) Tj ET Q q 0 0 0 rg BT 420.58 617.25 Td (based ) Tj ET Q q 0 0 0 rg BT 445.26 617.25 Td (on ) Tj ET Q q 0 0 0 rg BT 457.18 617.25 Td (discounted ) Tj ET Q q 0 0 0 rg BT 502.42 617.25 Td (after) Tj ET Q q 0 0 0 rg BT 520.53 617.25 Td (-tax ) Tj ET Q q 0 0 0 rg BT 538.00 617.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 557.68 617.25 Td (flow ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (projections, ) Tj ET Q q 0 0 0 rg BT 85.43 605.25 Td (risk ) Tj ET Q q 0 0 0 rg BT 102.93 605.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 138.76 605.25 Td (for ) Tj ET Q q 0 0 0 rg BT 152.92 605.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 193.74 605.25 Td (probability ) Tj ET Q q 0 0 0 rg BT 240.12 605.25 Td (of ) Tj ET Q q 0 0 0 rg BT 250.95 605.25 Td (technical ) Tj ET Q q 0 0 0 rg BT 289.54 605.25 Td (and ) Tj ET Q q 0 0 0 rg BT 306.48 605.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 350.07 605.25 Td (success ) Tj ET Q q 0 0 0 rg BT 382.56 605.25 Td (\(for ) Tj ET Q q 0 0 0 rg BT 400.05 605.25 Td (IPRD\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (Finite-lived ) Tj ET Q q 0 0 0 rg BT 86.60 581.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 130.53 581.25 Td (assets, ) Tj ET Q q 0 0 0 rg BT 160.30 581.25 Td (including ) Tj ET Q q 0 0 0 rg BT 202.01 581.25 Td (licenses, ) Tj ET Q q 0 0 0 rg BT 240.11 581.25 Td (developed ) Tj ET Q q 0 0 0 rg BT 285.14 581.25 Td (technology ) Tj ET Q q 0 0 0 rg BT 333.51 581.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 360.23 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 378.61 581.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 405.33 581.25 Td (projects ) Tj ET Q q 0 0 0 rg BT 440.93 581.25 Td (that ) Tj ET Q q 0 0 0 rg BT 459.86 581.25 Td (reach ) Tj ET Q q 0 0 0 rg BT 485.45 581.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 563.79 581.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (amortized ) Tj ET Q q 0 0 0 rg BT 78.20 569.25 Td (on ) Tj ET Q q 0 0 0 rg BT 90.41 569.25 Td (a ) Tj ET Q q 0 0 0 rg BT 97.07 569.25 Td (straight-line ) Tj ET Q q 0 0 0 rg BT 147.61 569.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 169.82 569.25 Td (over ) Tj ET Q q 0 0 0 rg BT 189.81 569.25 Td (their ) Tj ET Q q 0 0 0 rg BT 210.35 569.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 250.89 569.25 Td (useful ) Tj ET Q q 0 0 0 rg BT 277.54 569.25 Td (life. ) Tj ET Q q 0 0 0 rg BT 295.58 569.25 Td (Estimated ) Tj ET Q q 0 0 0 rg BT 337.79 569.25 Td (useful ) Tj ET Q q 0 0 0 rg BT 364.45 569.25 Td (lives ) Tj ET Q q 0 0 0 rg BT 385.55 569.25 Td (are ) Tj ET Q q 0 0 0 rg BT 399.97 569.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 447.17 569.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 496.04 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 510.48 569.25 Td (period ) Tj ET Q q 0 0 0 rg BT 538.24 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 552.67 569.25 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (are ) Tj ET Q q 0 0 0 rg BT 50.71 557.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 88.74 557.25 Td (to ) Tj ET Q q 0 0 0 rg BT 99.02 557.25 Td (contribute ) Tj ET Q q 0 0 0 rg BT 142.06 557.25 Td (to ) Tj ET Q q 0 0 0 rg BT 152.34 557.25 Td (future ) Tj ET Q q 0 0 0 rg BT 178.71 557.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 198.98 557.25 Td (flows.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (Goodwill ) Tj ET Q q 0 0 0 rg BT 76.26 533.25 Td (is ) Tj ET Q q 0 0 0 rg BT 85.40 533.25 Td (tested ) Tj ET Q q 0 0 0 rg BT 111.20 533.25 Td (at ) Tj ET Q q 0 0 0 rg BT 120.90 533.25 Td (least ) Tj ET Q q 0 0 0 rg BT 141.70 533.25 Td (annually ) Tj ET Q q 0 0 0 rg BT 178.61 533.25 Td (for ) Tj ET Q q 0 0 0 rg BT 192.75 533.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 241.32 533.25 Td (by ) Tj ET Q q 0 0 0 rg BT 253.80 533.25 Td (assessing ) Tj ET Q q 0 0 0 rg BT 293.50 533.25 Td (qualitative ) Tj ET Q q 0 0 0 rg BT 338.18 533.25 Td (factors ) Tj ET Q q 0 0 0 rg BT 367.87 533.25 Td (or ) Tj ET Q q 0 0 0 rg BT 378.68 533.25 Td (performing ) Tj ET Q q 0 0 0 rg BT 426.14 533.25 Td (a ) Tj ET Q q 0 0 0 rg BT 433.05 533.25 Td (quantitative ) Tj ET Q q 0 0 0 rg BT 482.74 533.25 Td (analysis ) Tj ET Q q 0 0 0 rg BT 517.43 533.25 Td (in ) Tj ET Q q 0 0 0 rg BT 527.69 533.25 Td (determining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 69.94 521.25 Td (it ) Tj ET Q q 0 0 0 rg BT 77.23 521.25 Td (is ) Tj ET Q q 0 0 0 rg BT 85.64 521.25 Td (more ) Tj ET Q q 0 0 0 rg BT 107.92 521.25 Td (likely ) Tj ET Q q 0 0 0 rg BT 132.43 521.25 Td (than ) Tj ET Q q 0 0 0 rg BT 151.38 521.25 Td (not ) Tj ET Q q 0 0 0 rg BT 165.89 521.25 Td (that ) Tj ET Q q 0 0 0 rg BT 182.62 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 196.57 521.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 212.19 521.25 Td (value ) Tj ET Q q 0 0 0 rg BT 235.58 521.25 Td (of ) Tj ET Q q 0 0 0 rg BT 245.64 521.25 Td (net ) Tj ET Q q 0 0 0 rg BT 259.59 521.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 284.66 521.25 Td (are ) Tj ET Q q 0 0 0 rg BT 298.60 521.25 Td (below ) Tj ET Q q 0 0 0 rg BT 324.77 521.25 Td (their ) Tj ET Q q 0 0 0 rg BT 344.83 521.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 379.88 521.25 Td (amounts. ) Tj ET Q q 0 0 0 rg BT 418.01 521.25 Td (Examples ) Tj ET Q q 0 0 0 rg BT 459.17 521.25 Td (of ) Tj ET Q q 0 0 0 rg BT 469.24 521.25 Td (qualitative ) Tj ET Q q 0 0 0 rg BT 513.18 521.25 Td (factors ) Tj ET Q q 0 0 0 rg BT 542.12 521.25 Td (assessed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.78 509.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.78 509.25 Td ( ) Tj ET Q q 0 0 0 rg BT 69.77 509.25 Td (include ) Tj ET Q q 0 0 0 rg BT 102.21 509.25 Td (our ) Tj ET Q q 0 0 0 rg BT 118.53 509.25 Td (share ) Tj ET Q q 0 0 0 rg BT 142.63 509.25 Td (price, ) Tj ET Q q 0 0 0 rg BT 168.11 509.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 206.09 509.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 259.61 509.25 Td (compared ) Tj ET Q q 0 0 0 rg BT 302.04 509.25 Td (to ) Tj ET Q q 0 0 0 rg BT 312.81 509.25 Td (budgets, ) Tj ET Q q 0 0 0 rg BT 349.42 509.25 Td (long-term ) Tj ET Q q 0 0 0 rg BT 391.85 509.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 429.83 509.25 Td (plans, ) Tj ET Q q 0 0 0 rg BT 456.43 509.25 Td (macroeconomic, ) Tj ET Q q 0 0 0 rg BT 525.79 509.25 Td (industry ) Tj ET Q q 0 0 0 rg BT 561.57 509.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (market ) Tj ET Q q 0 0 0 rg BT 66.70 497.25 Td (conditions ) Tj ET Q q 0 0 0 rg BT 111.30 497.25 Td (as ) Tj ET Q q 0 0 0 rg BT 122.57 497.25 Td (well ) Tj ET Q q 0 0 0 rg BT 142.72 497.25 Td (as ) Tj ET Q q 0 0 0 rg BT 153.99 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 169.14 497.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 214.85 497.25 Td (excess ) Tj ET Q q 0 0 0 rg BT 243.89 497.25 Td (of ) Tj ET Q q 0 0 0 rg BT 255.16 497.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 271.97 497.25 Td (value ) Tj ET Q q 0 0 0 rg BT 296.56 497.25 Td (over ) Tj ET Q q 0 0 0 rg BT 317.27 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 332.42 497.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 368.68 497.25 Td (value ) Tj ET Q q 0 0 0 rg BT 393.27 497.25 Td (of ) Tj ET Q q 0 0 0 rg BT 404.54 497.25 Td (net ) Tj ET Q q 0 0 0 rg BT 419.69 497.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 445.96 497.25 Td (from ) Tj ET Q q 0 0 0 rg BT 468.33 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 483.49 497.25 Td (annual ) Tj ET Q q 0 0 0 rg BT 513.08 497.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 562.11 497.25 Td (test ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (performed ) Tj ET Q q 0 0 0 rg BT 80.15 485.25 Td (in ) Tj ET Q q 0 0 0 rg BT 90.42 485.25 Td (a ) Tj ET Q q 0 0 0 rg BT 97.36 485.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 119.30 485.25 Td (year) Tj ET Q q 0 0 0 rg BT 135.96 485.25 Td (. ) Tj ET Q q 0 0 0 rg BT 140.96 485.25 Td (Each ) Tj ET Q q 0 0 0 rg BT 163.44 485.25 Td (relevant ) Tj ET Q q 0 0 0 rg BT 198.14 485.25 Td (factor ) Tj ET Q q 0 0 0 rg BT 223.96 485.25 Td (is ) Tj ET Q q 0 0 0 rg BT 233.13 485.25 Td (assessed ) Tj ET Q q 0 0 0 rg BT 269.51 485.25 Td (both ) Tj ET Q q 0 0 0 rg BT 289.79 485.25 Td (individually ) Tj ET Q q 0 0 0 rg BT 340.62 485.25 Td (and ) Tj ET Q q 0 0 0 rg BT 357.56 485.25 Td (in ) Tj ET Q q 0 0 0 rg BT 367.84 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 382.55 485.25 Td (aggregate.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 61.83 461.25 Td (is ) Tj ET Q q 0 0 0 rg BT 71.55 461.25 Td (tested ) Tj ET Q q 0 0 0 rg BT 97.93 461.25 Td (for ) Tj ET Q q 0 0 0 rg BT 112.64 461.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 161.79 461.25 Td (on ) Tj ET Q q 0 0 0 rg BT 174.84 461.25 Td (an ) Tj ET Q q 0 0 0 rg BT 187.33 461.25 Td (annual ) Tj ET Q q 0 0 0 rg BT 217.04 461.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 240.09 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 257.58 461.25 Td (more ) Tj ET Q q 0 0 0 rg BT 281.17 461.25 Td (frequently ) Tj ET Q q 0 0 0 rg BT 325.32 461.25 Td (if ) Tj ET Q q 0 0 0 rg BT 334.48 461.25 Td (events ) Tj ET Q q 0 0 0 rg BT 363.08 461.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 388.33 461.25 Td (or ) Tj ET Q q 0 0 0 rg BT 399.71 461.25 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 459.41 461.25 Td (change ) Tj ET Q q 0 0 0 rg BT 490.77 461.25 Td (that ) Tj ET Q q 0 0 0 rg BT 508.82 461.25 Td (would ) Tj ET Q q 0 0 0 rg BT 536.87 461.25 Td (indicate ) Tj ET Q q 0 0 0 rg BT 571.57 461.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 73.57 449.25 Td (reduction ) Tj ET Q q 0 0 0 rg BT 113.92 449.25 Td (in ) Tj ET Q q 0 0 0 rg BT 124.27 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 139.07 449.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 155.53 449.25 Td (values ) Tj ET Q q 0 0 0 rg BT 183.66 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 194.57 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 209.36 449.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 235.27 449.25 Td (below ) Tj ET Q q 0 0 0 rg BT 262.29 449.25 Td (their ) Tj ET Q q 0 0 0 rg BT 283.20 449.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 319.10 449.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 345.83 449.25 Td (If ) Tj ET Q q 0 0 0 rg BT 355.07 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 369.87 449.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 405.77 449.25 Td (value ) Tj ET Q q 0 0 0 rg BT 430.00 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 440.91 449.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 466.28 449.25 Td (is ) Tj ET Q q 0 0 0 rg BT 475.53 449.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 523.09 449.25 Td (to ) Tj ET Q q 0 0 0 rg BT 533.45 449.25 Td (exceed ) Tj ET Q q 0 0 0 rg BT 563.78 449.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 52.38 437.25 Td (value, ) Tj ET Q q 0 0 0 rg BT 79.03 437.25 Td (an ) Tj ET Q q 0 0 0 rg BT 90.97 437.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 139.57 437.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 157.63 437.25 Td (is ) Tj ET Q q 0 0 0 rg BT 166.80 437.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 213.16 437.25 Td (for ) Tj ET Q q 0 0 0 rg BT 227.32 437.25 Td (the ) Tj ET Q q 0 0 0 rg BT 242.04 437.25 Td (dif) Tj ET Q q 0 0 0 rg BT 252.97 437.25 Td (ference.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (Finite-lived ) Tj ET Q q 0 0 0 rg BT 85.11 413.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 127.56 413.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 153.34 413.25 Td (are ) Tj ET Q q 0 0 0 rg BT 168.00 413.25 Td (tested ) Tj ET Q q 0 0 0 rg BT 193.78 413.25 Td (for ) Tj ET Q q 0 0 0 rg BT 207.89 413.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 256.45 413.25 Td (when ) Tj ET Q q 0 0 0 rg BT 280.56 413.25 Td (facts ) Tj ET Q q 0 0 0 rg BT 301.89 413.25 Td (or ) Tj ET Q q 0 0 0 rg BT 312.67 413.25 Td (circumstances ) Tj ET Q q 0 0 0 rg BT 371.77 413.25 Td (suggest ) Tj ET Q q 0 0 0 rg BT 404.22 413.25 Td (that ) Tj ET Q q 0 0 0 rg BT 421.67 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 436.34 413.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 472.11 413.25 Td (value ) Tj ET Q q 0 0 0 rg BT 496.22 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 507.00 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 521.67 413.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 543.57 413.25 Td (may ) Tj ET Q q 0 0 0 rg BT 563.24 413.25 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (be ) Tj ET Q q 0 0 0 rg BT 48.31 401.25 Td (recoverable. ) Tj ET Q q 0 0 0 rg BT 100.32 401.25 Td (If ) Tj ET Q q 0 0 0 rg BT 109.86 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 124.95 401.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 161.14 401.25 Td (value ) Tj ET Q q 0 0 0 rg BT 185.67 401.25 Td (exceeds ) Tj ET Q q 0 0 0 rg BT 220.19 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 235.29 401.25 Td (projected ) Tj ET Q q 0 0 0 rg BT 275.37 401.25 Td (undiscounted ) Tj ET Q q 0 0 0 rg BT 331.57 401.25 Td (pretax ) Tj ET Q q 0 0 0 rg BT 359.43 401.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 380.07 401.25 Td (flows ) Tj ET Q q 0 0 0 rg BT 405.17 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 416.38 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 431.47 401.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 474.33 401.25 Td (asset, ) Tj ET Q q 0 0 0 rg BT 499.15 401.25 Td (an ) Tj ET Q q 0 0 0 rg BT 511.46 401.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 560.44 401.25 Td (loss ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (equal ) Tj ET Q q 0 0 0 rg BT 60.16 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 70.43 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 85.15 389.25 Td (excess ) Tj ET Q q 0 0 0 rg BT 113.75 389.25 Td (of ) Tj ET Q q 0 0 0 rg BT 124.58 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 139.30 389.25 Td (carrying ) Tj ET Q q 0 0 0 rg BT 175.11 389.25 Td (value ) Tj ET Q q 0 0 0 rg BT 199.27 389.25 Td (over ) Tj ET Q q 0 0 0 rg BT 219.54 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 234.25 389.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 275.07 389.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 291.45 389.25 Td (value ) Tj ET Q q 0 0 0 rg BT 315.60 389.25 Td (\(discounted ) Tj ET Q q 0 0 0 rg BT 364.76 389.25 Td (after) Tj ET Q q 0 0 0 rg BT 382.88 389.25 Td (-tax ) Tj ET Q q 0 0 0 rg BT 400.92 389.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 421.19 389.25 Td (flows\) ) Tj ET Q q 0 0 0 rg BT 449.24 389.25 Td (is ) Tj ET Q q 0 0 0 rg BT 458.41 389.25 Td (recognized.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 365.25 Td (Restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (Restructuring ) Tj ET Q q 0 0 0 rg BT 93.01 341.25 Td (char) Tj ET Q q 0 0 0 rg BT 110.04 341.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 125.94 341.25 Td (are ) Tj ET Q q 0 0 0 rg BT 140.72 341.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 187.16 341.25 Td (as ) Tj ET Q q 0 0 0 rg BT 198.07 341.25 Td (a ) Tj ET Q q 0 0 0 rg BT 205.08 341.25 Td (result ) Tj ET Q q 0 0 0 rg BT 229.87 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 240.78 341.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 271.68 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 282.04 341.25 Td (streamline ) Tj ET Q q 0 0 0 rg BT 326.26 341.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 370.49 341.25 Td (and ) Tj ET Q q 0 0 0 rg BT 387.51 341.25 Td (rationalize ) Tj ET Q q 0 0 0 rg BT 432.28 341.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 493.17 341.25 Td (facilities. ) Tj ET Q q 0 0 0 rg BT 532.67 341.25 Td (Estimating ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.63 329.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 80.26 329.25 Td (of ) Tj ET Q q 0 0 0 rg BT 91.00 329.25 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 144.51 329.25 Td (plans, ) Tj ET Q q 0 0 0 rg BT 170.53 329.25 Td (including ) Tj ET Q q 0 0 0 rg BT 210.72 329.25 Td (future ) Tj ET Q q 0 0 0 rg BT 237.01 329.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 285.53 329.25 Td (benefits ) Tj ET Q q 0 0 0 rg BT 319.60 329.25 Td (and ) Tj ET Q q 0 0 0 rg BT 336.45 329.25 Td (other ) Tj ET Q q 0 0 0 rg BT 359.41 329.25 Td (exit ) Tj ET Q q 0 0 0 rg BT 376.82 329.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 399.23 329.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 433.86 329.25 Td (judgment. ) Tj ET Q q 0 0 0 rg BT 476.01 329.25 Td (Actual ) Tj ET Q q 0 0 0 rg BT 505.08 329.25 Td (results ) Tj ET Q q 0 0 0 rg BT 533.60 329.25 Td (could ) Tj ET Q q 0 0 0 rg BT 558.24 329.25 Td (vary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (from ) Tj ET Q q 0 0 0 rg BT 57.94 317.25 Td (these ) Tj ET Q q 0 0 0 rg BT 80.99 317.25 Td (estimates.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (Contingencies) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.25 Td (Loss ) Tj ET Q q 0 0 0 rg BT 57.81 269.25 Td (contingencies ) Tj ET Q q 0 0 0 rg BT 115.71 269.25 Td (from ) Tj ET Q q 0 0 0 rg BT 138.06 269.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 160.41 269.25 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 211.65 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 229.00 269.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 258.02 269.25 Td (may ) Tj ET Q q 0 0 0 rg BT 278.16 269.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 303.28 269.25 Td (from ) Tj ET Q q 0 0 0 rg BT 325.64 269.25 Td (a ) Tj ET Q q 0 0 0 rg BT 332.99 269.25 Td (wide ) Tj ET Q q 0 0 0 rg BT 355.35 269.25 Td (range ) Tj ET Q q 0 0 0 rg BT 380.48 269.25 Td (of ) Tj ET Q q 0 0 0 rg BT 391.72 269.25 Td (matters, ) Tj ET Q q 0 0 0 rg BT 426.57 269.25 Td (including ) Tj ET Q q 0 0 0 rg BT 467.26 269.25 Td (government ) Tj ET Q q 0 0 0 rg BT 517.95 269.25 Td (investigations, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 84.60 257.25 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 121.83 257.25 Td (product ) Tj ET Q q 0 0 0 rg BT 154.33 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 170.73 257.25 Td (environmental ) Tj ET Q q 0 0 0 rg BT 230.44 257.25 Td (liability) Tj ET Q q 0 0 0 rg BT 260.90 257.25 Td (, ) Tj ET Q q 0 0 0 rg BT 265.35 257.25 Td (contractual ) Tj ET Q q 0 0 0 rg BT 311.73 257.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 339.79 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 356.18 257.25 Td (tax ) Tj ET Q q 0 0 0 rg BT 370.35 257.25 Td (matters. ) Tj ET Q q 0 0 0 rg BT 403.81 257.25 Td (Accruals ) Tj ET Q q 0 0 0 rg BT 441.30 257.25 Td (are ) Tj ET Q q 0 0 0 rg BT 455.46 257.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 501.28 257.25 Td (when ) Tj ET Q q 0 0 0 rg BT 524.89 257.25 Td (it ) Tj ET Q q 0 0 0 rg BT 532.40 257.25 Td (is ) Tj ET Q q 0 0 0 rg BT 541.03 257.25 Td (probable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (that ) Tj ET Q q 0 0 0 rg BT 53.62 245.25 Td (a ) Tj ET Q q 0 0 0 rg BT 60.69 245.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 94.42 245.25 Td (will ) Tj ET Q q 0 0 0 rg BT 112.60 245.25 Td (be ) Tj ET Q q 0 0 0 rg BT 124.67 245.25 Td (incurred ) Tj ET Q q 0 0 0 rg BT 160.61 245.25 Td (and ) Tj ET Q q 0 0 0 rg BT 177.67 245.25 Td (the ) Tj ET Q q 0 0 0 rg BT 192.52 245.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 225.14 245.25 Td (of ) Tj ET Q q 0 0 0 rg BT 236.09 245.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 254.28 245.25 Td (can ) Tj ET Q q 0 0 0 rg BT 270.78 245.25 Td (be ) Tj ET Q q 0 0 0 rg BT 282.85 245.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 328.79 245.25 Td (estimated. ) Tj ET Q q 0 0 0 rg BT 372.24 245.25 Td (Gain ) Tj ET Q q 0 0 0 rg BT 394.30 245.25 Td (contingencies ) Tj ET Q q 0 0 0 rg BT 451.91 245.25 Td (\(including ) Tj ET Q q 0 0 0 rg BT 495.64 245.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 540.47 245.25 Td (proceeds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (related ) Tj ET Q q 0 0 0 rg BT 65.70 233.25 Td (to ) Tj ET Q q 0 0 0 rg BT 75.98 233.25 Td (the ) Tj ET Q q 0 0 0 rg BT 90.70 233.25 Td (divestitures\) ) Tj ET Q q 0 0 0 rg BT 142.63 233.25 Td (are ) Tj ET Q q 0 0 0 rg BT 157.34 233.25 Td (not ) Tj ET Q q 0 0 0 rg BT 172.62 233.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 218.98 233.25 Td (until ) Tj ET Q q 0 0 0 rg BT 239.81 233.25 Td (realized. ) Tj ET Q q 0 0 0 rg BT 276.45 233.25 Td (Legal ) Tj ET Q q 0 0 0 rg BT 301.72 233.25 Td (fees ) Tj ET Q q 0 0 0 rg BT 320.32 233.25 Td (are ) Tj ET Q q 0 0 0 rg BT 335.02 233.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 374.73 233.25 Td (as ) Tj ET Q q 0 0 0 rg BT 385.56 233.25 Td (incurred.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (Shipping and Handling Costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (Shipping ) Tj ET Q q 0 0 0 rg BT 74.78 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 91.89 185.25 Td (handling ) Tj ET Q q 0 0 0 rg BT 129.55 185.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 152.22 185.25 Td (are ) Tj ET Q q 0 0 0 rg BT 167.09 185.25 Td (included ) Tj ET Q q 0 0 0 rg BT 204.19 185.25 Td (in ) Tj ET Q q 0 0 0 rg BT 214.63 185.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 260.34 185.25 Td (selling ) Tj ET Q q 0 0 0 rg BT 289.67 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 306.78 185.25 Td (administrative ) Tj ET Q q 0 0 0 rg BT 366.65 185.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 405.41 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 422.52 185.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.61 185.25 Td ($70 ) Tj ET Q q 0 0 0 rg BT 462.28 185.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.17 185.25 Td ( ) Tj ET Q q 0 0 0 rg BT 493.84 185.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.28 185.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.28 185.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 529.45 185.25 Td ($85 ) Tj ET Q q 0 0 0 rg BT 547.11 185.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.28 173.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.28 173.25 Td ( ) Tj ET Q q 0 0 0 rg BT 68.78 173.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 85.72 173.25 Td ($1) Tj ET Q q 0 0 0 rg BT 95.35 173.25 Td (15 ) Tj ET Q q 0 0 0 rg BT 107.85 173.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 136.74 173.25 Td ( ) Tj ET Q q 0 0 0 rg BT 139.24 173.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 149.52 173.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 169.52 173.25 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (Advertising and Pr) Tj ET Q q 0 0 0 rg BT 117.49 149.25 Td (oduct Pr) Tj ET Q q 0 0 0 rg BT 154.25 149.25 Td (omotion Costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 125.25 Td (Advertising ) Tj ET Q q 0 0 0 rg BT 85.51 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 102.24 125.25 Td (product ) Tj ET Q q 0 0 0 rg BT 135.07 125.25 Td (promotion ) Tj ET Q q 0 0 0 rg BT 179.03 125.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 201.32 125.25 Td (are ) Tj ET Q q 0 0 0 rg BT 215.81 125.25 Td (included ) Tj ET Q q 0 0 0 rg BT 252.54 125.25 Td (in ) Tj ET Q q 0 0 0 rg BT 262.61 125.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 307.94 125.25 Td (selling ) Tj ET Q q 0 0 0 rg BT 336.89 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 353.62 125.25 Td (administrative ) Tj ET Q q 0 0 0 rg BT 413.12 125.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 451.51 125.25 Td (and ) Tj ET Q q 0 0 0 rg BT 468.24 125.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.96 125.25 Td ($789 ) Tj ET Q q 0 0 0 rg BT 512.25 125.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.14 125.25 Td ( ) Tj ET Q q 0 0 0 rg BT 543.43 125.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.50 125.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.50 125.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td ($825 ) Tj ET Q q 0 0 0 rg BT 58.50 113.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 87.39 113.25 Td ( ) Tj ET Q q 0 0 0 rg BT 89.89 113.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.17 113.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 120.17 113.25 Td ( ) Tj ET Q q 0 0 0 rg BT 122.67 113.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.61 113.25 Td ($734 ) Tj ET Q q 0 0 0 rg BT 162.11 113.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 191.00 113.25 Td ( ) Tj ET Q q 0 0 0 rg BT 193.50 113.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 203.78 113.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 223.78 113.25 Td (. ) Tj ET Q q 0 0 0 rg BT 228.23 113.25 Td (Advertising ) Tj ET Q q 0 0 0 rg BT 277.94 113.25 Td (and ) Tj ET Q q 0 0 0 rg BT 294.88 113.25 Td (product ) Tj ET Q q 0 0 0 rg BT 327.93 113.25 Td (promotion ) Tj ET Q q 0 0 0 rg BT 372.09 113.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 394.59 113.25 Td (are ) Tj ET Q q 0 0 0 rg BT 409.30 113.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 449.01 113.25 Td (as ) Tj ET Q q 0 0 0 rg BT 459.84 113.25 Td (incurred. ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 89.25 Td (For) Tj ET Q q 0 0 0 rg BT 51.37 89.25 Td (eign Curr) Tj ET Q q 0 0 0 rg BT 93.12 89.25 Td (ency ) Tj ET Q q 0 0 0 rg BT 114.88 89.25 Td (T) Tj ET Q q 0 0 0 rg BT 120.81 89.25 Td (ranslation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 65.25 Td (Foreign ) Tj ET Q q 0 0 0 rg BT 70.60 65.25 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 115.21 65.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 152.58 65.25 Td (are ) Tj ET Q q 0 0 0 rg BT 168.29 65.25 Td (translated ) Tj ET Q q 0 0 0 rg BT 210.65 65.25 Td (into ) Tj ET Q q 0 0 0 rg BT 229.71 65.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 250.99 65.25 Td (dollars ) Tj ET Q q 0 0 0 rg BT 281.70 65.25 Td (using ) Tj ET Q q 0 0 0 rg BT 306.86 65.25 Td (average ) Tj ET Q q 0 0 0 rg BT 341.44 65.25 Td (exchange ) Tj ET Q q 0 0 0 rg BT 382.69 65.25 Td (rates. ) Tj ET Q q 0 0 0 rg BT 407.31 65.25 Td (The ) Tj ET Q q 0 0 0 rg BT 426.36 65.25 Td (net ) Tj ET Q q 0 0 0 rg BT 442.07 65.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 468.90 65.25 Td (of ) Tj ET Q q 0 0 0 rg BT 480.72 65.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 513.10 65.25 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 563.81 65.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 53.25 Td (translated ) Tj ET Q q 0 0 0 rg BT 76.26 53.25 Td (into ) Tj ET Q q 0 0 0 rg BT 93.20 53.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 112.36 53.25 Td (dollars ) Tj ET Q q 0 0 0 rg BT 140.97 53.25 Td (using ) Tj ET Q q 0 0 0 rg BT 164.02 53.25 Td (current ) Tj ET Q q 0 0 0 rg BT 193.72 53.25 Td (exchange ) Tj ET Q q 0 0 0 rg BT 232.86 53.25 Td (rates. ) Tj ET Q q 0 0 0 rg BT 255.52 53.25 Td (The ) Tj ET Q q 0 0 0 rg BT 272.45 53.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 291.62 53.25 Td (dollar ) Tj ET Q q 0 0 0 rg BT 316.33 53.25 Td (ef) Tj ET Q q 0 0 0 rg BT 323.92 53.25 Td (fects ) Tj ET Q q 0 0 0 rg BT 344.18 53.25 Td (that ) Tj ET Q q 0 0 0 rg BT 360.56 53.25 Td (arise ) Tj ET Q q 0 0 0 rg BT 380.82 53.25 Td (from ) Tj ET Q q 0 0 0 rg BT 401.64 53.25 Td (translating ) Tj ET Q q 0 0 0 rg BT 445.24 53.25 Td (the ) Tj ET Q q 0 0 0 rg BT 458.84 53.25 Td (net ) Tj ET Q q 0 0 0 rg BT 472.44 53.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 497.15 53.25 Td (of ) Tj ET Q q 0 0 0 rg BT 506.87 53.25 Td (these ) Tj ET Q q 0 0 0 rg BT 528.80 53.25 Td (subsidiaries ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 41.25 Td (at ) Tj ET Q q 0 0 0 rg BT 45.72 41.25 Td (changing ) Tj ET Q q 0 0 0 rg BT 84.87 41.25 Td (rates ) Tj ET Q q 0 0 0 rg BT 106.25 41.25 Td (are ) Tj ET Q q 0 0 0 rg BT 120.96 41.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 167.32 41.25 Td (in ) Tj ET Q q 0 0 0 rg BT 177.60 41.25 Td (OCI.) Tj ET Q endstream endobj 119 0 obj <> endobj 120 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (59) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Resear) Tj ET Q q 0 0 0 rg BT 65.25 749.25 Td (ch and Development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Research ) Tj ET Q q 0 0 0 rg BT 75.98 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 93.74 725.25 Td (development ) Tj ET Q q 0 0 0 rg BT 148.72 725.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 172.05 725.25 Td (are ) Tj ET Q q 0 0 0 rg BT 187.59 725.25 Td (expensed ) Tj ET Q q 0 0 0 rg BT 228.13 725.25 Td (as ) Tj ET Q q 0 0 0 rg BT 239.79 725.25 Td (incurred. ) Tj ET Q q 0 0 0 rg BT 278.93 725.25 Td (Clinical ) Tj ET Q q 0 0 0 rg BT 313.92 725.25 Td (study ) Tj ET Q q 0 0 0 rg BT 338.92 725.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 362.25 725.25 Td (are ) Tj ET Q q 0 0 0 rg BT 377.79 725.25 Td (accrued ) Tj ET Q q 0 0 0 rg BT 412.21 725.25 Td (over ) Tj ET Q q 0 0 0 rg BT 433.30 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 448.85 725.25 Td (service ) Tj ET Q q 0 0 0 rg BT 480.50 725.25 Td (periods ) Tj ET Q q 0 0 0 rg BT 513.27 725.25 Td (specified ) Tj ET Q q 0 0 0 rg BT 552.69 725.25 Td (in ) Tj ET Q q 0 0 0 rg BT 563.80 725.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (contracts ) Tj ET Q q 0 0 0 rg BT 74.79 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 91.93 713.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 127.96 713.25 Td (as ) Tj ET Q q 0 0 0 rg BT 138.99 713.25 Td (necessary ) Tj ET Q q 0 0 0 rg BT 180.56 713.25 Td (based ) Tj ET Q q 0 0 0 rg BT 206.02 713.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 228.72 713.25 Td (an ) Tj ET Q q 0 0 0 rg BT 240.86 713.25 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 276.34 713.25 Td (review ) Tj ET Q q 0 0 0 rg BT 306.25 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 317.28 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 332.20 713.25 Td (level ) Tj ET Q q 0 0 0 rg BT 354.33 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 365.36 713.25 Td (ef) Tj ET Q q 0 0 0 rg BT 372.95 713.25 Td (fort ) Tj ET Q q 0 0 0 rg BT 390.09 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 407.23 713.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 429.93 713.25 Td (actually ) Tj ET Q q 0 0 0 rg BT 464.28 713.25 Td (incurred. ) Tj ET Q q 0 0 0 rg BT 502.79 713.25 Td (Strategic ) Tj ET Q q 0 0 0 rg BT 541.03 713.25 Td (alliances ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (with ) Tj ET Q q 0 0 0 rg BT 56.46 701.25 Td (third ) Tj ET Q q 0 0 0 rg BT 78.02 701.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 107.36 701.25 Td (provide ) Tj ET Q q 0 0 0 rg BT 140.59 701.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 179.37 701.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 204.83 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 215.29 701.25 Td (develop, ) Tj ET Q q 0 0 0 rg BT 252.12 701.25 Td (manufacture, ) Tj ET Q q 0 0 0 rg BT 307.27 701.25 Td (market ) Tj ET Q q 0 0 0 rg BT 337.71 701.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 365.94 701.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 382.51 701.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 446.26 701.25 Td (products, ) Tj ET Q q 0 0 0 rg BT 485.88 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 500.78 701.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 526.23 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 536.69 701.25 Td (which ) Tj ET Q q 0 0 0 rg BT 563.81 701.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (owned ) Tj ET Q q 0 0 0 rg BT 64.34 689.25 Td (by ) Tj ET Q q 0 0 0 rg BT 76.02 689.25 Td (the ) Tj ET Q q 0 0 0 rg BT 89.92 689.25 Td (other ) Tj ET Q q 0 0 0 rg BT 112.15 689.25 Td (party) Tj ET Q q 0 0 0 rg BT 132.05 689.25 Td (. ) Tj ET Q q 0 0 0 rg BT 136.23 689.25 Td (Research ) Tj ET Q q 0 0 0 rg BT 174.56 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 190.68 689.25 Td (development ) Tj ET Q q 0 0 0 rg BT 244.01 689.25 Td (is ) Tj ET Q q 0 0 0 rg BT 252.36 689.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 297.91 689.25 Td (net ) Tj ET Q q 0 0 0 rg BT 311.81 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 321.82 689.25 Td (reimbursements ) Tj ET Q q 0 0 0 rg BT 387.37 689.25 Td (in ) Tj ET Q q 0 0 0 rg BT 396.83 689.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 442.39 689.25 Td (with ) Tj ET Q q 0 0 0 rg BT 461.85 689.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 494.62 689.25 Td (agreements. ) Tj ET Q q 0 0 0 rg BT 544.33 689.25 Td (Upfront ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.19 677.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 98.16 677.25 Td (milestone ) Tj ET Q q 0 0 0 rg BT 139.79 677.25 Td (payments ) Tj ET Q q 0 0 0 rg BT 180.87 677.25 Td (for ) Tj ET Q q 0 0 0 rg BT 195.28 677.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 217.47 677.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 268.00 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 279.08 677.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 340.71 677.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 389.57 677.25 Td (are ) Tj ET Q q 0 0 0 rg BT 404.53 677.25 Td (also ) Tj ET Q q 0 0 0 rg BT 423.40 677.25 Td (included ) Tj ET Q q 0 0 0 rg BT 460.58 677.25 Td (in ) Tj ET Q q 0 0 0 rg BT 471.11 677.25 Td (research ) Tj ET Q q 0 0 0 rg BT 507.17 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 524.36 677.25 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (expenses.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 60.17 641.25 Td (Flow) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.25 Td (Upfront ) Tj ET Q q 0 0 0 rg BT 70.18 617.25 Td (and ) Tj ET Q q 0 0 0 rg BT 87.15 617.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 131.88 617.25 Td (milestone ) Tj ET Q q 0 0 0 rg BT 173.29 617.25 Td (payments ) Tj ET Q q 0 0 0 rg BT 214.14 617.25 Td (for ) Tj ET Q q 0 0 0 rg BT 228.32 617.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 266.95 617.25 Td (of ) Tj ET Q q 0 0 0 rg BT 277.81 617.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 339.21 617.25 Td (compounds ) Tj ET Q q 0 0 0 rg BT 387.84 617.25 Td (are ) Tj ET Q q 0 0 0 rg BT 402.57 617.25 Td (included ) Tj ET Q q 0 0 0 rg BT 439.53 617.25 Td (in ) Tj ET Q q 0 0 0 rg BT 449.83 617.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 490.12 617.25 Td (activities ) Tj ET Q q 0 0 0 rg BT 528.74 617.25 Td (and ) Tj ET Q q 0 0 0 rg BT 545.71 617.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 567.67 617.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.25 Td (business ) Tj ET Q q 0 0 0 rg BT 72.04 605.25 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 121.97 605.25 Td (are ) Tj ET Q q 0 0 0 rg BT 136.33 605.25 Td (included ) Tj ET Q q 0 0 0 rg BT 172.92 605.25 Td (in ) Tj ET Q q 0 0 0 rg BT 182.85 605.25 Td (investing ) Tj ET Q q 0 0 0 rg BT 221.67 605.25 Td (activities. ) Tj ET Q q 0 0 0 rg BT 262.42 605.25 Td (Divestiture ) Tj ET Q q 0 0 0 rg BT 309.01 605.25 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 346.70 605.25 Td (are ) Tj ET Q q 0 0 0 rg BT 361.06 605.25 Td (included ) Tj ET Q q 0 0 0 rg BT 397.65 605.25 Td (in ) Tj ET Q q 0 0 0 rg BT 407.58 605.25 Td (investing ) Tj ET Q q 0 0 0 rg BT 446.40 605.25 Td (activities ) Tj ET Q q 0 0 0 rg BT 484.65 605.25 Td (as ) Tj ET Q q 0 0 0 rg BT 495.13 605.25 Td (well ) Tj ET Q q 0 0 0 rg BT 514.50 605.25 Td (as ) Tj ET Q q 0 0 0 rg BT 524.98 605.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 561.57 605.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.47 593.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 116.27 593.25 Td (received ) Tj ET Q q 0 0 0 rg BT 153.06 593.25 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 200.43 593.25 Td (to ) Tj ET Q q 0 0 0 rg BT 211.13 593.25 Td (the ) Tj ET Q q 0 0 0 rg BT 226.28 593.25 Td (related ) Tj ET Q q 0 0 0 rg BT 256.41 593.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 274.88 593.25 Td (of ) Tj ET Q q 0 0 0 rg BT 286.14 593.25 Td (the ) Tj ET Q q 0 0 0 rg BT 301.28 593.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 323.65 593.25 Td (or ) Tj ET Q q 0 0 0 rg BT 334.91 593.25 Td (business. ) Tj ET Q q 0 0 0 rg BT 374.23 593.25 Td (Other ) Tj ET Q q 0 0 0 rg BT 399.92 593.25 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 450.62 593.25 Td (reflected ) Tj ET Q q 0 0 0 rg BT 488.52 593.25 Td (in ) Tj ET Q q 0 0 0 rg BT 499.23 593.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 539.92 593.25 Td (activities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (include ) Tj ET Q q 0 0 0 rg BT 68.11 581.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 112.99 581.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 136.77 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 153.89 581.25 Td (losses ) Tj ET Q q 0 0 0 rg BT 180.45 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 197.56 581.25 Td (related ) Tj ET Q q 0 0 0 rg BT 227.44 581.25 Td (royalties, ) Tj ET Q q 0 0 0 rg BT 267.04 581.25 Td (research ) Tj ET Q q 0 0 0 rg BT 303.02 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 320.14 581.25 Td (development ) Tj ET Q q 0 0 0 rg BT 374.46 581.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 396.57 581.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 443.13 581.25 Td (char) Tj ET Q q 0 0 0 rg BT 460.15 581.25 Td (ges, ) Tj ET Q q 0 0 0 rg BT 478.66 581.25 Td (gains ) Tj ET Q q 0 0 0 rg BT 502.44 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 519.55 581.25 Td (losses ) Tj ET Q q 0 0 0 rg BT 546.11 581.25 Td (on ) Tj ET Q q 0 0 0 rg BT 558.79 581.25 Td (debt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (redemption ) Tj ET Q q 0 0 0 rg BT 84.04 569.25 Td (and ) Tj ET Q q 0 0 0 rg BT 100.98 569.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 135.69 569.25 Td (in ) Tj ET Q q 0 0 0 rg BT 145.97 569.25 Td (the ) Tj ET Q q 0 0 0 rg BT 160.68 569.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 177.06 569.25 Td (value ) Tj ET Q q 0 0 0 rg BT 201.21 569.25 Td (of ) Tj ET Q q 0 0 0 rg BT 212.04 569.25 Td (written ) Tj ET Q q 0 0 0 rg BT 242.87 569.25 Td (option ) Tj ET Q q 0 0 0 rg BT 270.93 569.25 Td (liabilities.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (Recently ) Tj ET Q q 0 0 0 rg BT 75.71 545.25 Td (Issued ) Tj ET Q q 0 0 0 rg BT 104.89 545.25 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 156.28 545.25 Td (Standards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.15 521.25 Td (May ) Tj ET Q q 0 0 0 rg BT 66.29 521.25 Td (2014, ) Tj ET Q q 0 0 0 rg BT 90.61 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 104.64 521.25 Td (F) Tj ET Q q 0 0 0 rg BT 109.46 521.25 Td (ASB ) Tj ET Q q 0 0 0 rg BT 130.73 521.25 Td (issued ) Tj ET Q q 0 0 0 rg BT 157.54 521.25 Td (a ) Tj ET Q q 0 0 0 rg BT 163.80 521.25 Td (new ) Tj ET Q q 0 0 0 rg BT 182.27 521.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 227.96 521.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 263.65 521.25 Td (related ) Tj ET Q q 0 0 0 rg BT 292.67 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 302.26 521.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 335.72 521.25 Td (recognition, ) Tj ET Q q 0 0 0 rg BT 385.58 521.25 Td (which ) Tj ET Q q 0 0 0 rg BT 411.83 521.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 445.86 521.25 Td (an ) Tj ET Q q 0 0 0 rg BT 457.11 521.25 Td (entity ) Tj ET Q q 0 0 0 rg BT 481.70 521.25 Td (to ) Tj ET Q q 0 0 0 rg BT 491.29 521.25 Td (recognize ) Tj ET Q q 0 0 0 rg BT 531.97 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 546.00 521.25 Td (amount ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.25 Td (of ) Tj ET Q q 0 0 0 rg BT 47.81 509.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 82.94 509.25 Td (to ) Tj ET Q q 0 0 0 rg BT 94.21 509.25 Td (which ) Tj ET Q q 0 0 0 rg BT 122.13 509.25 Td (it ) Tj ET Q q 0 0 0 rg BT 131.17 509.25 Td (expects ) Tj ET Q q 0 0 0 rg BT 164.64 509.25 Td (to ) Tj ET Q q 0 0 0 rg BT 175.90 509.25 Td (be ) Tj ET Q q 0 0 0 rg BT 188.82 509.25 Td (entitled ) Tj ET Q q 0 0 0 rg BT 222.30 509.25 Td (for ) Tj ET Q q 0 0 0 rg BT 237.44 509.25 Td (the ) Tj ET Q q 0 0 0 rg BT 253.14 509.25 Td (transfer ) Tj ET Q q 0 0 0 rg BT 287.16 509.25 Td (of ) Tj ET Q q 0 0 0 rg BT 298.98 509.25 Td (promised ) Tj ET Q q 0 0 0 rg BT 339.68 509.25 Td (goods ) Tj ET Q q 0 0 0 rg BT 367.05 509.25 Td (or ) Tj ET Q q 0 0 0 rg BT 378.87 509.25 Td (services ) Tj ET Q q 0 0 0 rg BT 414.56 509.25 Td (to ) Tj ET Q q 0 0 0 rg BT 425.82 509.25 Td (customers. ) Tj ET Q q 0 0 0 rg BT 472.10 509.25 Td (The ) Tj ET Q q 0 0 0 rg BT 491.13 509.25 Td (new ) Tj ET Q q 0 0 0 rg BT 511.27 509.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 548.63 509.25 Td (and ) Tj ET Q q 0 0 0 rg BT 566.56 509.25 Td (its ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 82.54 497.25 Td (amendments ) Tj ET Q q 0 0 0 rg BT 135.18 497.25 Td (that ) Tj ET Q q 0 0 0 rg BT 152.28 497.25 Td (were ) Tj ET Q q 0 0 0 rg BT 173.81 497.25 Td (issued ) Tj ET Q q 0 0 0 rg BT 200.91 497.25 Td (will ) Tj ET Q q 0 0 0 rg BT 218.57 497.25 Td (replace ) Tj ET Q q 0 0 0 rg BT 249.54 497.25 Td (most ) Tj ET Q q 0 0 0 rg BT 271.09 497.25 Td (of ) Tj ET Q q 0 0 0 rg BT 281.52 497.25 Td (the ) Tj ET Q q 0 0 0 rg BT 295.84 497.25 Td (existing ) Tj ET Q q 0 0 0 rg BT 329.61 497.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 363.35 497.25 Td (recognition ) Tj ET Q q 0 0 0 rg BT 411.00 497.25 Td (standards ) Tj ET Q q 0 0 0 rg BT 450.87 497.25 Td (in ) Tj ET Q q 0 0 0 rg BT 460.75 497.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 480.63 497.25 Td (GAAP) Tj ET Q q 0 0 0 rg BT 507.49 497.25 Td ( ) Tj ET Q q 0 0 0 rg BT 509.59 497.25 Td (when ) Tj ET Q q 0 0 0 rg BT 533.35 497.25 Td (it ) Tj ET Q q 0 0 0 rg BT 541.01 497.25 Td (becomes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (ef) Tj ET Q q 0 0 0 rg BT 43.59 485.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 72.57 485.25 Td (on ) Tj ET Q q 0 0 0 rg BT 84.36 485.25 Td (January ) Tj ET Q q 0 0 0 rg BT 117.24 485.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 126.53 485.25 Td (2018. ) Tj ET Q q 0 0 0 rg BT 150.42 485.25 Td (A) Tj ET Q q 0 0 0 rg BT 157.09 485.25 Td ( ) Tj ET Q q 0 0 0 rg BT 158.87 485.25 Td (five ) Tj ET Q q 0 0 0 rg BT 176.20 485.25 Td (step ) Tj ET Q q 0 0 0 rg BT 194.10 485.25 Td (model ) Tj ET Q q 0 0 0 rg BT 220.88 485.25 Td (will ) Tj ET Q q 0 0 0 rg BT 238.22 485.25 Td (be ) Tj ET Q q 0 0 0 rg BT 249.44 485.25 Td (utilized ) Tj ET Q q 0 0 0 rg BT 281.22 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 290.78 485.25 Td (achieve ) Tj ET Q q 0 0 0 rg BT 323.10 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 337.10 485.25 Td (core ) Tj ET Q q 0 0 0 rg BT 356.09 485.25 Td (principle; ) Tj ET Q q 0 0 0 rg BT 396.19 485.25 Td (\(1\) ) Tj ET Q q 0 0 0 rg BT 409.64 485.25 Td (identify ) Tj ET Q q 0 0 0 rg BT 442.53 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 456.53 485.25 Td (customer ) Tj ET Q q 0 0 0 rg BT 494.97 485.25 Td (contract, ) Tj ET Q q 0 0 0 rg BT 531.46 485.25 Td (\(2\) ) Tj ET Q q 0 0 0 rg BT 544.90 485.25 Td (identify ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.29 473.25 Td (contract’) Tj ET Q q 0 0 0 rg BT 85.27 473.25 Td (s ) Tj ET Q q 0 0 0 rg BT 91.23 473.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 143.83 473.25 Td (obligation, ) Tj ET Q q 0 0 0 rg BT 188.95 473.25 Td (\(3\) ) Tj ET Q q 0 0 0 rg BT 202.69 473.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 244.74 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 259.03 473.25 Td (transaction ) Tj ET Q q 0 0 0 rg BT 304.97 473.25 Td (price, ) Tj ET Q q 0 0 0 rg BT 329.53 473.25 Td (\(4\) ) Tj ET Q q 0 0 0 rg BT 343.27 473.25 Td (allocate ) Tj ET Q q 0 0 0 rg BT 376.43 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 390.72 473.25 Td (transaction ) Tj ET Q q 0 0 0 rg BT 436.66 473.25 Td (price ) Tj ET Q q 0 0 0 rg BT 458.72 473.25 Td (to ) Tj ET Q q 0 0 0 rg BT 468.57 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 482.86 473.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 535.46 473.25 Td (obligation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.51 461.25 Td (\(5\) ) Tj ET Q q 0 0 0 rg BT 66.23 461.25 Td (recognize ) Tj ET Q q 0 0 0 rg BT 107.16 461.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 140.88 461.25 Td (when ) Tj ET Q q 0 0 0 rg BT 164.61 461.25 Td (or ) Tj ET Q q 0 0 0 rg BT 175.00 461.25 Td (as ) Tj ET Q q 0 0 0 rg BT 185.40 461.25 Td (a ) Tj ET Q q 0 0 0 rg BT 191.91 461.25 Td (performance ) Tj ET Q q 0 0 0 rg BT 244.50 461.25 Td (obligation ) Tj ET Q q 0 0 0 rg BT 287.12 461.25 Td (is ) Tj ET Q q 0 0 0 rg BT 295.86 461.25 Td (satisfied. ) Tj ET Q q 0 0 0 rg BT 333.60 461.25 Td (The ) Tj ET Q q 0 0 0 rg BT 351.21 461.25 Td (new ) Tj ET Q q 0 0 0 rg BT 369.94 461.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 405.89 461.25 Td (can ) Tj ET Q q 0 0 0 rg BT 421.83 461.25 Td (be ) Tj ET Q q 0 0 0 rg BT 433.34 461.25 Td (applied ) Tj ET Q q 0 0 0 rg BT 464.84 461.25 Td (retrospectively ) Tj ET Q q 0 0 0 rg BT 526.33 461.25 Td (to ) Tj ET Q q 0 0 0 rg BT 536.17 461.25 Td (each ) Tj ET Q q 0 0 0 rg BT 556.56 461.25 Td (prior ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.25 Td (reporting ) Tj ET Q q 0 0 0 rg BT 75.15 449.25 Td (period ) Tj ET Q q 0 0 0 rg BT 103.19 449.25 Td (presented ) Tj ET Q q 0 0 0 rg BT 144.00 449.25 Td (or ) Tj ET Q q 0 0 0 rg BT 154.82 449.25 Td (retrospectively ) Tj ET Q q 0 0 0 rg BT 216.73 449.25 Td (with ) Tj ET Q q 0 0 0 rg BT 237.00 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 251.71 449.25 Td (cumulative ) Tj ET Q q 0 0 0 rg BT 298.63 449.25 Td (ef) Tj ET Q q 0 0 0 rg BT 306.22 449.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 323.70 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 334.52 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 349.23 449.25 Td (change ) Tj ET Q q 0 0 0 rg BT 380.04 449.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 426.39 449.25 Td (at ) Tj ET Q q 0 0 0 rg BT 436.10 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 450.81 449.25 Td (date ) Tj ET Q q 0 0 0 rg BT 469.96 449.25 Td (of ) Tj ET Q q 0 0 0 rg BT 480.78 449.25 Td (the ) Tj ET Q q 0 0 0 rg BT 495.49 449.25 Td (initial ) Tj ET Q q 0 0 0 rg BT 521.31 449.25 Td (application ) Tj ET Q q 0 0 0 rg BT 568.24 449.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.25 Td (retained ) Tj ET Q q 0 0 0 rg BT 70.68 437.25 Td (earnings. ) Tj ET Q q 0 0 0 rg BT 109.54 437.25 Td (Disclosures ) Tj ET Q q 0 0 0 rg BT 158.67 437.25 Td (regarding ) Tj ET Q q 0 0 0 rg BT 199.47 437.25 Td (the ) Tj ET Q q 0 0 0 rg BT 214.16 437.25 Td (nature, ) Tj ET Q q 0 0 0 rg BT 244.13 437.25 Td (amount, ) Tj ET Q q 0 0 0 rg BT 279.10 437.25 Td (timing ) Tj ET Q q 0 0 0 rg BT 307.69 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 324.61 437.25 Td (uncertainty ) Tj ET Q q 0 0 0 rg BT 372.06 437.25 Td (of ) Tj ET Q q 0 0 0 rg BT 382.87 437.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 417.00 437.25 Td (and ) Tj ET Q q 0 0 0 rg BT 433.91 437.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 454.16 437.25 Td (flows ) Tj ET Q q 0 0 0 rg BT 478.86 437.25 Td (from ) Tj ET Q q 0 0 0 rg BT 500.78 437.25 Td (customer ) Tj ET Q q 0 0 0 rg BT 539.91 437.25 Td (contracts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (will ) Tj ET Q q 0 0 0 rg BT 54.06 425.25 Td (also ) Tj ET Q q 0 0 0 rg BT 72.67 425.25 Td (be ) Tj ET Q q 0 0 0 rg BT 84.60 425.25 Td (required.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.03 401.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 95.70 401.25 Td (s ) Tj ET Q q 0 0 0 rg BT 102.08 401.25 Td (assessment ) Tj ET Q q 0 0 0 rg BT 149.00 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 159.82 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 174.52 401.25 Td (new ) Tj ET Q q 0 0 0 rg BT 193.67 401.25 Td (standard’) Tj ET Q q 0 0 0 rg BT 230.33 401.25 Td (s ) Tj ET Q q 0 0 0 rg BT 236.70 401.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 266.40 401.25 Td (is ) Tj ET Q q 0 0 0 rg BT 275.56 401.25 Td (substantially ) Tj ET Q q 0 0 0 rg BT 328.60 401.25 Td (complete ) Tj ET Q q 0 0 0 rg BT 367.73 401.25 Td (based ) Tj ET Q q 0 0 0 rg BT 392.99 401.25 Td (on ) Tj ET Q q 0 0 0 rg BT 405.48 401.25 Td (our ) Tj ET Q q 0 0 0 rg BT 421.29 401.25 Td (current ) Tj ET Q q 0 0 0 rg BT 452.10 401.25 Td (contracts. ) Tj ET Q q 0 0 0 rg BT 493.00 401.25 Td (W) Tj ET Q q 0 0 0 rg BT 501.63 401.25 Td (e ) Tj ET Q q 0 0 0 rg BT 508.56 401.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 547.14 401.25 Td (believe ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.55 389.25 Td (timing ) Tj ET Q q 0 0 0 rg BT 81.00 389.25 Td (of ) Tj ET Q q 0 0 0 rg BT 92.66 389.25 Td (recognizing ) Tj ET Q q 0 0 0 rg BT 143.20 389.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 178.18 389.25 Td (for ) Tj ET Q q 0 0 0 rg BT 193.17 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 208.72 389.25 Td (typical ) Tj ET Q q 0 0 0 rg BT 239.27 389.25 Td (net ) Tj ET Q q 0 0 0 rg BT 254.82 389.25 Td (product ) Tj ET Q q 0 0 0 rg BT 288.70 389.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 307.58 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 318.69 389.25 Td (our ) Tj ET Q q 0 0 0 rg BT 335.36 389.25 Td (customers ) Tj ET Q q 0 0 0 rg BT 379.24 389.25 Td (will ) Tj ET Q q 0 0 0 rg BT 398.13 389.25 Td (not ) Tj ET Q q 0 0 0 rg BT 414.24 389.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 467.57 389.25 Td (change. ) Tj ET Q q 0 0 0 rg BT 501.71 389.25 Td (However) Tj ET Q q 0 0 0 rg BT 537.96 389.25 Td (, ) Tj ET Q q 0 0 0 rg BT 543.80 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 559.35 389.25 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 72.40 377.25 Td (will ) Tj ET Q q 0 0 0 rg BT 90.49 377.25 Td (no ) Tj ET Q q 0 0 0 rg BT 103.01 377.25 Td (longer ) Tj ET Q q 0 0 0 rg BT 131.08 377.25 Td (require ) Tj ET Q q 0 0 0 rg BT 161.93 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 176.67 377.25 Td (transaction ) Tj ET Q q 0 0 0 rg BT 223.07 377.25 Td (price ) Tj ET Q q 0 0 0 rg BT 245.58 377.25 Td (to ) Tj ET Q q 0 0 0 rg BT 255.88 377.25 Td (be ) Tj ET Q q 0 0 0 rg BT 267.85 377.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 290.92 377.25 Td (or ) Tj ET Q q 0 0 0 rg BT 301.77 377.25 Td (determinable ) Tj ET Q q 0 0 0 rg BT 356.50 377.25 Td (and ) Tj ET Q q 0 0 0 rg BT 373.46 377.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 403.19 377.25 Td (variable ) Tj ET Q q 0 0 0 rg BT 437.92 377.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 494.32 377.25 Td (might ) Tj ET Q q 0 0 0 rg BT 520.18 377.25 Td (be ) Tj ET Q q 0 0 0 rg BT 532.14 377.25 Td (recognized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 56.89 365.25 Td (to ) Tj ET Q q 0 0 0 rg BT 66.13 365.25 Td (the ) Tj ET Q q 0 0 0 rg BT 79.80 365.25 Td (occurrence ) Tj ET Q q 0 0 0 rg BT 125.10 365.25 Td (or ) Tj ET Q q 0 0 0 rg BT 134.89 365.25 Td (resolution ) Tj ET Q q 0 0 0 rg BT 176.34 365.25 Td (of ) Tj ET Q q 0 0 0 rg BT 186.12 365.25 Td (the ) Tj ET Q q 0 0 0 rg BT 199.79 365.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 243.46 365.25 Td (event ) Tj ET Q q 0 0 0 rg BT 266.57 365.25 Td (\(subject ) Tj ET Q q 0 0 0 rg BT 299.68 365.25 Td (to ) Tj ET Q q 0 0 0 rg BT 308.91 365.25 Td (a ) Tj ET Q q 0 0 0 rg BT 314.80 365.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 347.90 365.25 Td (reversal ) Tj ET Q q 0 0 0 rg BT 381.00 365.25 Td (constraint\). ) Tj ET Q q 0 0 0 rg BT 427.40 365.25 Td (As ) Tj ET Q q 0 0 0 rg BT 439.96 365.25 Td (a ) Tj ET Q q 0 0 0 rg BT 445.86 365.25 Td (result, ) Tj ET Q q 0 0 0 rg BT 472.03 365.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 500.68 365.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 533.78 365.25 Td (previously ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (deferred ) Tj ET Q q 0 0 0 rg BT 72.62 353.25 Td (under ) Tj ET Q q 0 0 0 rg BT 98.71 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 114.24 353.25 Td (current ) Tj ET Q q 0 0 0 rg BT 145.87 353.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 183.07 353.25 Td (because ) Tj ET Q q 0 0 0 rg BT 218.03 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 233.56 353.25 Td (transaction ) Tj ET Q q 0 0 0 rg BT 280.75 353.25 Td (price ) Tj ET Q q 0 0 0 rg BT 304.06 353.25 Td (was ) Tj ET Q q 0 0 0 rg BT 322.92 353.25 Td (not ) Tj ET Q q 0 0 0 rg BT 339.02 353.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 362.88 353.25 Td (or ) Tj ET Q q 0 0 0 rg BT 374.53 353.25 Td (determinable ) Tj ET Q q 0 0 0 rg BT 430.04 353.25 Td (\(e.g. ) Tj ET Q q 0 0 0 rg BT 451.13 353.25 Td (early ) Tj ET Q q 0 0 0 rg BT 474.43 353.25 Td (access ) Tj ET Q q 0 0 0 rg BT 503.29 353.25 Td (programs\) ) Tj ET Q q 0 0 0 rg BT 547.70 353.25 Td (will ) Tj ET Q q 0 0 0 rg BT 566.57 353.25 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (accounted ) Tj ET Q q 0 0 0 rg BT 78.34 341.25 Td (for ) Tj ET Q q 0 0 0 rg BT 91.80 341.25 Td (as ) Tj ET Q q 0 0 0 rg BT 101.94 341.25 Td (variable ) Tj ET Q q 0 0 0 rg BT 135.95 341.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 191.63 341.25 Td (and ) Tj ET Q q 0 0 0 rg BT 207.87 341.25 Td (might ) Tj ET Q q 0 0 0 rg BT 233.01 341.25 Td (be ) Tj ET Q q 0 0 0 rg BT 244.25 341.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 289.92 341.25 Td (earlier ) Tj ET Q q 0 0 0 rg BT 317.26 341.25 Td (provided ) Tj ET Q q 0 0 0 rg BT 354.61 341.25 Td (such ) Tj ET Q q 0 0 0 rg BT 374.75 341.25 Td (terms ) Tj ET Q q 0 0 0 rg BT 398.77 341.25 Td (are ) Tj ET Q q 0 0 0 rg BT 412.78 341.25 Td (suf) Tj ET Q q 0 0 0 rg BT 424.82 341.25 Td (ficient ) Tj ET Q q 0 0 0 rg BT 452.17 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 461.76 341.25 Td (reliably ) Tj ET Q q 0 0 0 rg BT 494.10 341.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 529.23 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 543.25 341.25 Td (ultimate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (price ) Tj ET Q q 0 0 0 rg BT 58.49 329.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 96.52 329.25 Td (to ) Tj ET Q q 0 0 0 rg BT 106.80 329.25 Td (be ) Tj ET Q q 0 0 0 rg BT 118.73 329.25 Td (realized.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.83 305.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 84.60 305.25 Td (future ) Tj ET Q q 0 0 0 rg BT 110.98 305.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 147.91 305.25 Td (related ) Tj ET Q q 0 0 0 rg BT 177.62 305.25 Td (to ) Tj ET Q q 0 0 0 rg BT 187.89 305.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 217.60 305.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 251.19 305.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 307.55 305.25 Td (\(e.g. ) Tj ET Q q 0 0 0 rg BT 327.82 305.25 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 356.42 305.25 Td (and ) Tj ET Q q 0 0 0 rg BT 373.36 305.25 Td (Japan ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 398.63 305.25 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.63 305.25 Td ( ) Tj ET Q q 0 0 0 rg BT 436.13 305.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 492.49 305.25 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 532.21 305.25 Td (in ) Tj ET Q q 0 0 0 rg BT 542.48 305.25 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 41.00 293.25 Td (. ) Tj ET Q q 0 0 0 rg BT 44.86 293.25 Td (Alliances"\) ) Tj ET Q q 0 0 0 rg BT 91.78 293.25 Td (will ) Tj ET Q q 0 0 0 rg BT 109.08 293.25 Td (be ) Tj ET Q q 0 0 0 rg BT 120.27 293.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 160.33 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 176.52 293.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 222.13 293.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 243.31 293.25 Td (to ) Tj ET Q q 0 0 0 rg BT 252.83 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 266.80 293.25 Td (third ) Tj ET Q q 0 0 0 rg BT 287.43 293.25 Td (party ) Tj ET Q q 0 0 0 rg BT 309.72 293.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 327.01 293.25 Td (occurring ) Tj ET Q q 0 0 0 rg BT 367.07 293.25 Td (provided ) Tj ET Q q 0 0 0 rg BT 404.37 293.25 Td (it ) Tj ET Q q 0 0 0 rg BT 411.67 293.25 Td (is ) Tj ET Q q 0 0 0 rg BT 420.08 293.25 Td (not ) Tj ET Q q 0 0 0 rg BT 434.61 293.25 Td (probable ) Tj ET Q q 0 0 0 rg BT 471.34 293.25 Td (that ) Tj ET Q q 0 0 0 rg BT 488.08 293.25 Td (the ) Tj ET Q q 0 0 0 rg BT 502.04 293.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 542.11 293.25 Td (amounts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 281.25 Td (would ) Tj ET Q q 0 0 0 rg BT 63.89 281.25 Td (be ) Tj ET Q q 0 0 0 rg BT 76.21 281.25 Td (reversed ) Tj ET Q q 0 0 0 rg BT 112.96 281.25 Td (in ) Tj ET Q q 0 0 0 rg BT 123.63 281.25 Td (the ) Tj ET Q q 0 0 0 rg BT 138.73 281.25 Td (future. ) Tj ET Q q 0 0 0 rg BT 167.99 281.25 Td (However) Tj ET Q q 0 0 0 rg BT 204.24 281.25 Td (, ) Tj ET Q q 0 0 0 rg BT 209.63 281.25 Td (the ) Tj ET Q q 0 0 0 rg BT 224.73 281.25 Td (timing ) Tj ET Q q 0 0 0 rg BT 253.73 281.25 Td (of ) Tj ET Q q 0 0 0 rg BT 264.95 281.25 Td (royalties, ) Tj ET Q q 0 0 0 rg BT 304.76 281.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 353.19 281.25 Td (milestones ) Tj ET Q q 0 0 0 rg BT 398.85 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 416.17 281.25 Td (other ) Tj ET Q q 0 0 0 rg BT 439.60 281.25 Td (forms ) Tj ET Q q 0 0 0 rg BT 465.82 281.25 Td (of ) Tj ET Q q 0 0 0 rg BT 477.04 281.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 522.13 281.25 Td (consideration ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 269.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 72.83 269.25 Td (from ) Tj ET Q q 0 0 0 rg BT 94.11 269.25 Td (the ) Tj ET Q q 0 0 0 rg BT 108.16 269.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 152.21 269.25 Td (of ) Tj ET Q q 0 0 0 rg BT 162.37 269.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 206.43 269.25 Td (\(e.g. ) Tj ET Q q 0 0 0 rg BT 226.03 269.25 Td (the ) Tj ET Q q 0 0 0 rg BT 240.09 269.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 274.69 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 290.96 269.25 Td (North ) Tj ET Q q 0 0 0 rg BT 315.72 269.25 Td (American ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 356.98 269.25 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.98 269.25 Td ( ) Tj ET Q q 0 0 0 rg BT 393.81 269.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 437.87 269.25 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 476.92 269.25 Td (in ) Tj ET Q q 0 0 0 rg BT 486.54 269.25 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.89 269.25 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.89 269.25 Td (. ) Tj ET Q q 0 0 0 rg BT 530.82 269.25 Td (Alliances"\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 257.25 Td (as ) Tj ET Q q 0 0 0 rg BT 47.98 257.25 Td (well ) Tj ET Q q 0 0 0 rg BT 68.85 257.25 Td (as ) Tj ET Q q 0 0 0 rg BT 80.83 257.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 118.92 257.25 Td (and ) Tj ET Q q 0 0 0 rg BT 137.01 257.25 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 186.19 257.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 224.28 257.25 Td (from ) Tj ET Q q 0 0 0 rg BT 247.37 257.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 287.12 257.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 344.64 257.25 Td (is ) Tj ET Q q 0 0 0 rg BT 354.96 257.25 Td (not ) Tj ET Q q 0 0 0 rg BT 371.39 257.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 410.57 257.25 Td (to ) Tj ET Q q 0 0 0 rg BT 422.00 257.25 Td (change. ) Tj ET Q q 0 0 0 rg BT 456.20 257.25 Td (The ) Tj ET Q q 0 0 0 rg BT 475.40 257.25 Td (new ) Tj ET Q q 0 0 0 rg BT 495.71 257.25 Td (standard’) Tj ET Q q 0 0 0 rg BT 532.37 257.25 Td (s ) Tj ET Q q 0 0 0 rg BT 539.91 257.25 Td (guidance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 245.25 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 78.38 245.25 Td (to ) Tj ET Q q 0 0 0 rg BT 88.00 245.25 Td (the ) Tj ET Q q 0 0 0 rg BT 102.06 245.25 Td (separation ) Tj ET Q q 0 0 0 rg BT 145.00 245.25 Td (of ) Tj ET Q q 0 0 0 rg BT 155.17 245.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 193.12 245.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 217.74 245.25 Td (and ) Tj ET Q q 0 0 0 rg BT 234.02 245.25 Td (related ) Tj ET Q q 0 0 0 rg BT 263.06 245.25 Td (fee ) Tj ET Q q 0 0 0 rg BT 277.11 245.25 Td (recognition ) Tj ET Q q 0 0 0 rg BT 324.50 245.25 Td (is ) Tj ET Q q 0 0 0 rg BT 333.01 245.25 Td (not ) Tj ET Q q 0 0 0 rg BT 347.63 245.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 385.00 245.25 Td (to ) Tj ET Q q 0 0 0 rg BT 394.63 245.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 446.46 245.25 Td (change ) Tj ET Q q 0 0 0 rg BT 476.62 245.25 Td (the ) Tj ET Q q 0 0 0 rg BT 490.67 245.25 Td (timing ) Tj ET Q q 0 0 0 rg BT 518.63 245.25 Td (of ) Tj ET Q q 0 0 0 rg BT 528.80 245.25 Td (recognizing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 233.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 70.15 233.25 Td (in ) Tj ET Q q 0 0 0 rg BT 80.42 233.25 Td (our ) Tj ET Q q 0 0 0 rg BT 96.25 233.25 Td (existing ) Tj ET Q q 0 0 0 rg BT 130.42 233.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 164.01 233.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 220.37 233.25 Td (that ) Tj ET Q q 0 0 0 rg BT 237.87 233.25 Td (are ) Tj ET Q q 0 0 0 rg BT 252.57 233.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 291.17 233.25 Td (generating ) Tj ET Q q 0 0 0 rg BT 335.87 233.25 Td (revenue. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 209.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.84 209.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 95.03 209.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 133.42 209.25 Td (anticipates ) Tj ET Q q 0 0 0 rg BT 178.47 209.25 Td (to ) Tj ET Q q 0 0 0 rg BT 188.55 209.25 Td (adopt ) Tj ET Q q 0 0 0 rg BT 213.06 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 227.57 209.25 Td (new ) Tj ET Q q 0 0 0 rg BT 246.53 209.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 282.70 209.25 Td (on ) Tj ET Q q 0 0 0 rg BT 295.00 209.25 Td (a ) Tj ET Q q 0 0 0 rg BT 301.73 209.25 Td (modified ) Tj ET Q q 0 0 0 rg BT 340.13 209.25 Td (retrospective ) Tj ET Q q 0 0 0 rg BT 394.07 209.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 416.37 209.25 Td (with ) Tj ET Q q 0 0 0 rg BT 436.44 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 450.96 209.25 Td (cumulative ) Tj ET Q q 0 0 0 rg BT 497.68 209.25 Td (ef) Tj ET Q q 0 0 0 rg BT 505.27 209.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 522.55 209.25 Td (of ) Tj ET Q q 0 0 0 rg BT 533.18 209.25 Td (the ) Tj ET Q q 0 0 0 rg BT 547.69 209.25 Td (change ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 197.25 Td (reflected ) Tj ET Q q 0 0 0 rg BT 73.16 197.25 Td (in ) Tj ET Q q 0 0 0 rg BT 83.13 197.25 Td (retained ) Tj ET Q q 0 0 0 rg BT 117.52 197.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 153.59 197.25 Td (as ) Tj ET Q q 0 0 0 rg BT 164.11 197.25 Td (of ) Tj ET Q q 0 0 0 rg BT 174.63 197.25 Td (January ) Tj ET Q q 0 0 0 rg BT 207.92 197.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 217.61 197.25 Td (2018 ) Tj ET Q q 0 0 0 rg BT 239.80 197.25 Td (and ) Tj ET Q q 0 0 0 rg BT 256.42 197.25 Td (not ) Tj ET Q q 0 0 0 rg BT 271.39 197.25 Td (restate ) Tj ET Q q 0 0 0 rg BT 299.68 197.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 321.31 197.25 Td (periods. ) Tj ET Q q 0 0 0 rg BT 354.95 197.25 Td (As ) Tj ET Q q 0 0 0 rg BT 368.25 197.25 Td (a ) Tj ET Q q 0 0 0 rg BT 374.88 197.25 Td (result, ) Tj ET Q q 0 0 0 rg BT 401.79 197.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 431.18 197.25 Td (future ) Tj ET Q q 0 0 0 rg BT 457.25 197.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 493.87 197.25 Td (discussed ) Tj ET Q q 0 0 0 rg BT 534.39 197.25 Td (above ) Tj ET Q q 0 0 0 rg BT 560.46 197.25 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 185.25 Td (be ) Tj ET Q q 0 0 0 rg BT 47.52 185.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 87.92 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 104.44 185.25 Td (presented ) Tj ET Q q 0 0 0 rg BT 144.84 185.25 Td (as ) Tj ET Q q 0 0 0 rg BT 155.25 185.25 Td (a ) Tj ET Q q 0 0 0 rg BT 161.77 185.25 Td (cumulative ) Tj ET Q q 0 0 0 rg BT 208.28 185.25 Td (ef) Tj ET Q q 0 0 0 rg BT 215.87 185.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 232.94 185.25 Td (of ) Tj ET Q q 0 0 0 rg BT 243.35 185.25 Td (an ) Tj ET Q q 0 0 0 rg BT 254.87 185.25 Td (accounting ) Tj ET Q q 0 0 0 rg BT 300.82 185.25 Td (change ) Tj ET Q q 0 0 0 rg BT 331.22 185.25 Td (and ) Tj ET Q q 0 0 0 rg BT 347.74 185.25 Td (excluded ) Tj ET Q q 0 0 0 rg BT 385.91 185.25 Td (from ) Tj ET Q q 0 0 0 rg BT 407.43 185.25 Td (the ) Tj ET Q q 0 0 0 rg BT 421.73 185.25 Td (results ) Tj ET Q q 0 0 0 rg BT 449.92 185.25 Td (of ) Tj ET Q q 0 0 0 rg BT 460.33 185.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 504.07 185.25 Td (beginning ) Tj ET Q q 0 0 0 rg BT 546.15 185.25 Td (in ) Tj ET Q q 0 0 0 rg BT 556.01 185.25 Td (2018 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 173.25 Td (\(other ) Tj ET Q q 0 0 0 rg BT 61.99 173.25 Td (than ) Tj ET Q q 0 0 0 rg BT 81.32 173.25 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 127.88 173.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 172.20 173.25 Td (revisions ) Tj ET Q q 0 0 0 rg BT 210.42 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 220.32 173.25 Td (the ) Tj ET Q q 0 0 0 rg BT 234.65 173.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 275.08 173.25 Td (amounts\). ) Tj ET Q q 0 0 0 rg BT 316.76 173.25 Td (V) Tj ET Q q 0 0 0 rg BT 322.87 173.25 Td (ariable ) Tj ET Q q 0 0 0 rg BT 352.19 173.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 408.18 173.25 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 450.83 173.25 Td (to ) Tj ET Q q 0 0 0 rg BT 460.73 173.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 490.61 173.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 546.59 173.25 Td (entered ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 161.25 Td (into ) Tj ET Q q 0 0 0 rg BT 54.49 161.25 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 101.85 161.25 Td (to ) Tj ET Q q 0 0 0 rg BT 112.56 161.25 Td (the ) Tj ET Q q 0 0 0 rg BT 127.71 161.25 Td (adoption ) Tj ET Q q 0 0 0 rg BT 165.63 161.25 Td (of ) Tj ET Q q 0 0 0 rg BT 176.89 161.25 Td (the ) Tj ET Q q 0 0 0 rg BT 192.04 161.25 Td (new ) Tj ET Q q 0 0 0 rg BT 211.63 161.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 248.44 161.25 Td (will ) Tj ET Q q 0 0 0 rg BT 266.92 161.25 Td (also ) Tj ET Q q 0 0 0 rg BT 285.96 161.25 Td (need ) Tj ET Q q 0 0 0 rg BT 307.77 161.25 Td (to ) Tj ET Q q 0 0 0 rg BT 318.48 161.25 Td (be ) Tj ET Q q 0 0 0 rg BT 330.84 161.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 372.09 161.25 Td (and ) Tj ET Q q 0 0 0 rg BT 389.46 161.25 Td (accounted ) Tj ET Q q 0 0 0 rg BT 432.92 161.25 Td (for ) Tj ET Q q 0 0 0 rg BT 447.51 161.25 Td (in ) Tj ET Q q 0 0 0 rg BT 458.22 161.25 Td (a ) Tj ET Q q 0 0 0 rg BT 465.59 161.25 Td (comparable ) Tj ET Q q 0 0 0 rg BT 515.16 161.25 Td (manner ) Tj ET Q q 0 0 0 rg BT 548.08 161.25 Td (but ) Tj ET Q q 0 0 0 rg BT 563.78 161.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 149.25 Td (initial ) Tj ET Q q 0 0 0 rg BT 61.50 149.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 96.99 149.25 Td (will ) Tj ET Q q 0 0 0 rg BT 114.72 149.25 Td (be ) Tj ET Q q 0 0 0 rg BT 126.33 149.25 Td (reflected ) Tj ET Q q 0 0 0 rg BT 163.47 149.25 Td (in ) Tj ET Q q 0 0 0 rg BT 173.42 149.25 Td (revenue ) Tj ET Q q 0 0 0 rg BT 207.23 149.25 Td (and ) Tj ET Q q 0 0 0 rg BT 223.84 149.25 Td (assessed ) Tj ET Q q 0 0 0 rg BT 259.89 149.25 Td (each ) Tj ET Q q 0 0 0 rg BT 280.38 149.25 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 326.99 149.25 Td (reporting ) Tj ET Q q 0 0 0 rg BT 365.81 149.25 Td (period. ) Tj ET Q q 0 0 0 rg BT 396.03 149.25 Td (No ) Tj ET Q q 0 0 0 rg BT 410.42 149.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 454.81 149.25 Td (changes ) Tj ET Q q 0 0 0 rg BT 489.18 149.25 Td (to ) Tj ET Q q 0 0 0 rg BT 499.13 149.25 Td (business ) Tj ET Q q 0 0 0 rg BT 535.19 149.25 Td (processes, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 137.25 Td (systems ) Tj ET Q q 0 0 0 rg BT 70.17 137.25 Td (and ) Tj ET Q q 0 0 0 rg BT 87.11 137.25 Td (controls ) Tj ET Q q 0 0 0 rg BT 121.83 137.25 Td (are ) Tj ET Q q 0 0 0 rg BT 136.53 137.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 175.13 137.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 213.16 137.25 Td (to ) Tj ET Q q 0 0 0 rg BT 223.44 137.25 Td (be ) Tj ET Q q 0 0 0 rg BT 235.38 137.25 Td (required.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 113.25 Td (In ) Tj ET Q q 0 0 0 rg BT 48.43 113.25 Td (January ) Tj ET Q q 0 0 0 rg BT 83.63 113.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 110.23 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 126.55 113.25 Td (F) Tj ET Q q 0 0 0 rg BT 131.37 113.25 Td (ASB ) Tj ET Q q 0 0 0 rg BT 154.92 113.25 Td (issued ) Tj ET Q q 0 0 0 rg BT 184.02 113.25 Td (amended ) Tj ET Q q 0 0 0 rg BT 224.22 113.25 Td (guidance ) Tj ET Q q 0 0 0 rg BT 264.41 113.25 Td (for ) Tj ET Q q 0 0 0 rg BT 280.17 113.25 Td (the ) Tj ET Q q 0 0 0 rg BT 296.49 113.25 Td (recognition, ) Tj ET Q q 0 0 0 rg BT 348.63 113.25 Td (measurement, ) Tj ET Q q 0 0 0 rg BT 408.54 113.25 Td (presentation ) Tj ET Q q 0 0 0 rg BT 461.51 113.25 Td (and ) Tj ET Q q 0 0 0 rg BT 480.05 113.25 Td (disclosures ) Tj ET Q q 0 0 0 rg BT 528.59 113.25 Td (of ) Tj ET Q q 0 0 0 rg BT 541.02 113.25 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 101.25 Td (instruments ) Tj ET Q q 0 0 0 rg BT 84.68 101.25 Td (ef) Tj ET Q q 0 0 0 rg BT 92.27 101.25 Td (fective ) Tj ET Q q 0 0 0 rg BT 121.48 101.25 Td (January ) Tj ET Q q 0 0 0 rg BT 154.60 101.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 164.11 101.25 Td (2018 ) Tj ET Q q 0 0 0 rg BT 186.12 101.25 Td (with ) Tj ET Q q 0 0 0 rg BT 205.92 101.25 Td (early ) Tj ET Q q 0 0 0 rg BT 227.92 101.25 Td (adoption ) Tj ET Q q 0 0 0 rg BT 264.93 101.25 Td (not ) Tj ET Q q 0 0 0 rg BT 279.72 101.25 Td (permitted. ) Tj ET Q q 0 0 0 rg BT 322.41 101.25 Td (The ) Tj ET Q q 0 0 0 rg BT 339.97 101.25 Td (new ) Tj ET Q q 0 0 0 rg BT 358.64 101.25 Td (guidance ) Tj ET Q q 0 0 0 rg BT 396.75 101.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 430.97 101.25 Td (that ) Tj ET Q q 0 0 0 rg BT 447.98 101.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 463.87 101.25 Td (value ) Tj ET Q q 0 0 0 rg BT 487.54 101.25 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 537.33 101.25 Td (for ) Tj ET Q q 0 0 0 rg BT 551.00 101.25 Td (equity ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 89.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 75.94 89.25 Td (with ) Tj ET Q q 0 0 0 rg BT 95.89 89.25 Td (readily ) Tj ET Q q 0 0 0 rg BT 125.82 89.25 Td (determinable ) Tj ET Q q 0 0 0 rg BT 180.19 89.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 196.24 89.25 Td (values ) Tj ET Q q 0 0 0 rg BT 223.96 89.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 262.22 89.25 Td (classified ) Tj ET Q q 0 0 0 rg BT 302.16 89.25 Td (as ) Tj ET Q q 0 0 0 rg BT 312.66 89.25 Td (available-for) Tj ET Q q 0 0 0 rg BT 363.54 89.25 Td (-sale ) Tj ET Q q 0 0 0 rg BT 384.59 89.25 Td (be ) Tj ET Q q 0 0 0 rg BT 396.20 89.25 Td (reported ) Tj ET Q q 0 0 0 rg BT 431.69 89.25 Td (through ) Tj ET Q q 0 0 0 rg BT 464.97 89.25 Td (earnings. ) Tj ET Q q 0 0 0 rg BT 503.36 89.25 Td (The ) Tj ET Q q 0 0 0 rg BT 521.08 89.25 Td (new ) Tj ET Q q 0 0 0 rg BT 539.91 89.25 Td (guidance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 77.25 Td (also ) Tj ET Q q 0 0 0 rg BT 54.50 77.25 Td (requires ) Tj ET Q q 0 0 0 rg BT 89.11 77.25 Td (a ) Tj ET Q q 0 0 0 rg BT 95.94 77.25 Td (qualitative ) Tj ET Q q 0 0 0 rg BT 140.55 77.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 189.04 77.25 Td (assessment ) Tj ET Q q 0 0 0 rg BT 235.88 77.25 Td (for ) Tj ET Q q 0 0 0 rg BT 249.93 77.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 277.33 77.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 327.50 77.25 Td (without ) Tj ET Q q 0 0 0 rg BT 360.45 77.25 Td (a ) Tj ET Q q 0 0 0 rg BT 367.28 77.25 Td (readily ) Tj ET Q q 0 0 0 rg BT 397.44 77.25 Td (determinable ) Tj ET Q q 0 0 0 rg BT 452.04 77.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 468.31 77.25 Td (value ) Tj ET Q q 0 0 0 rg BT 492.36 77.25 Td (and ) Tj ET Q q 0 0 0 rg BT 509.20 77.25 Td (a ) Tj ET Q q 0 0 0 rg BT 516.03 77.25 Td (char) Tj ET Q q 0 0 0 rg BT 533.06 77.25 Td (ge ) Tj ET Q q 0 0 0 rg BT 544.89 77.25 Td (through ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 65.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 71.81 65.25 Td (if ) Tj ET Q q 0 0 0 rg BT 79.85 65.25 Td (an ) Tj ET Q q 0 0 0 rg BT 91.22 65.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 139.25 65.25 Td (exists. ) Tj ET Q q 0 0 0 rg BT 166.32 65.25 Td (The ) Tj ET Q q 0 0 0 rg BT 183.80 65.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 224.62 65.25 Td (does ) Tj ET Q q 0 0 0 rg BT 244.89 65.25 Td (not ) Tj ET Q q 0 0 0 rg BT 259.60 65.25 Td (expect ) Tj ET Q q 0 0 0 rg BT 287.62 65.25 Td (the ) Tj ET Q q 0 0 0 rg BT 301.77 65.25 Td (amended ) Tj ET Q q 0 0 0 rg BT 339.80 65.25 Td (standard ) Tj ET Q q 0 0 0 rg BT 375.61 65.25 Td (to ) Tj ET Q q 0 0 0 rg BT 385.32 65.25 Td (have ) Tj ET Q q 0 0 0 rg BT 406.13 65.25 Td (a ) Tj ET Q q 0 0 0 rg BT 412.50 65.25 Td (material ) Tj ET Q q 0 0 0 rg BT 447.19 65.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 476.34 65.25 Td (on ) Tj ET Q q 0 0 0 rg BT 488.27 65.25 Td (the ) Tj ET Q q 0 0 0 rg BT 502.42 65.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 544.08 65.25 Td (s ) Tj ET Q q 0 0 0 rg BT 549.91 65.25 Td (results ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 53.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 53.25 Td (operations.) Tj ET Q endstream endobj 121 0 obj <> endobj 122 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.99 749.10 Td (February ) Tj ET Q q 0 0 0 rg BT 85.75 749.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 110.91 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 125.79 749.10 Td (F) Tj ET Q q 0 0 0 rg BT 130.61 749.10 Td (ASB ) Tj ET Q q 0 0 0 rg BT 152.72 749.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 180.38 749.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 219.13 749.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 257.89 749.10 Td (on ) Tj ET Q q 0 0 0 rg BT 270.55 749.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 293.19 749.10 Td (accounting. ) Tj ET Q q 0 0 0 rg BT 342.03 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 360.24 749.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 398.99 749.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 437.75 749.10 Td (requires ) Tj ET Q q 0 0 0 rg BT 472.61 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 487.49 749.10 Td (recognition ) Tj ET Q q 0 0 0 rg BT 535.69 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 546.68 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 553.78 749.10 Td (right-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (of-use ) Tj ET Q q 0 0 0 rg BT 63.82 737.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 86.08 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 103.35 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 110.61 737.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 133.42 737.10 Td (liability) Tj ET Q q 0 0 0 rg BT 163.88 737.10 Td (, ) Tj ET Q q 0 0 0 rg BT 169.21 737.10 Td (initially ) Tj ET Q q 0 0 0 rg BT 203.14 737.10 Td (measured ) Tj ET Q q 0 0 0 rg BT 244.28 737.10 Td (at ) Tj ET Q q 0 0 0 rg BT 254.33 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 269.37 737.10 Td (present ) Tj ET Q q 0 0 0 rg BT 301.07 737.10 Td (value ) Tj ET Q q 0 0 0 rg BT 325.55 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 336.71 737.10 Td (future ) Tj ET Q q 0 0 0 rg BT 363.41 737.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 386.22 737.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 427.38 737.10 Td (for ) Tj ET Q q 0 0 0 rg BT 441.86 737.10 Td (leases ) Tj ET Q q 0 0 0 rg BT 468.57 737.10 Td (with ) Tj ET Q q 0 0 0 rg BT 489.17 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 496.43 737.10 Td (term ) Tj ET Q q 0 0 0 rg BT 517.59 737.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 545.96 737.10 Td (than ) Tj ET Q q 0 0 0 rg BT 566.00 737.10 Td (12 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (months. ) Tj ET Q q 0 0 0 rg BT 70.29 725.10 Td (The ) Tj ET Q q 0 0 0 rg BT 88.37 725.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 126.99 725.10 Td (is ) Tj ET Q q 0 0 0 rg BT 136.19 725.10 Td (ef) Tj ET Q q 0 0 0 rg BT 143.78 725.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 173.51 725.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 216.04 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 226.34 725.10 Td (2019 ) Tj ET Q q 0 0 0 rg BT 248.87 725.10 Td (with ) Tj ET Q q 0 0 0 rg BT 269.18 725.10 Td (early ) Tj ET Q q 0 0 0 rg BT 291.70 725.10 Td (adoption ) Tj ET Q q 0 0 0 rg BT 329.22 725.10 Td (permitted ) Tj ET Q q 0 0 0 rg BT 370.07 725.10 Td (on ) Tj ET Q q 0 0 0 rg BT 382.60 725.10 Td (a ) Tj ET Q q 0 0 0 rg BT 389.57 725.10 Td (modified ) Tj ET Q q 0 0 0 rg BT 428.20 725.10 Td (retrospective ) Tj ET Q q 0 0 0 rg BT 482.37 725.10 Td (approach. ) Tj ET Q q 0 0 0 rg BT 523.49 725.10 Td (Although ) Tj ET Q q 0 0 0 rg BT 563.79 725.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 77.67 713.10 Td (s ) Tj ET Q q 0 0 0 rg BT 83.88 713.10 Td (assessment ) Tj ET Q q 0 0 0 rg BT 130.65 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 141.31 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 155.85 713.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 194.27 713.10 Td (standard ) Tj ET Q q 0 0 0 rg BT 230.47 713.10 Td (has ) Tj ET Q q 0 0 0 rg BT 246.13 713.10 Td (not ) Tj ET Q q 0 0 0 rg BT 261.23 713.10 Td (been ) Tj ET Q q 0 0 0 rg BT 282.44 713.10 Td (completed, ) Tj ET Q q 0 0 0 rg BT 328.92 713.10 Td (minimal ) Tj ET Q q 0 0 0 rg BT 364.57 713.10 Td (impacts ) Tj ET Q q 0 0 0 rg BT 398.00 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 408.11 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.65 713.10 Td (results ) Tj ET Q q 0 0 0 rg BT 451.09 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 461.74 713.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 505.72 713.10 Td (are ) Tj ET Q q 0 0 0 rg BT 520.26 713.10 Td (expected. ) Tj ET Q q 0 0 0 rg BT 560.45 713.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (undiscounted ) Tj ET Q q 0 0 0 rg BT 92.70 701.10 Td (value ) Tj ET Q q 0 0 0 rg BT 117.73 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 129.43 701.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 152.79 701.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 200.61 701.10 Td (is ) Tj ET Q q 0 0 0 rg BT 210.65 701.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.79 701.10 Td ($800 ) Tj ET Q q 0 0 0 rg BT 295.16 701.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 324.05 701.10 Td ( ) Tj ET Q q 0 0 0 rg BT 327.43 701.10 Td (at ) Tj ET Q q 0 0 0 rg BT 338.02 701.10 Td (December ) Tj ET Q q 0 0 0 rg BT 382.47 701.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 398.35 701.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 424.22 701.10 Td (consisting ) Tj ET Q q 0 0 0 rg BT 468.15 701.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 508.74 701.10 Td (of ) Tj ET Q q 0 0 0 rg BT 520.44 701.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 552.14 701.10 Td (leases ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (accounted ) Tj ET Q q 0 0 0 rg BT 78.28 689.10 Td (for ) Tj ET Q q 0 0 0 rg BT 91.70 689.10 Td (as ) Tj ET Q q 0 0 0 rg BT 101.78 689.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 141.29 689.10 Td (leases. ) Tj ET Q q 0 0 0 rg BT 169.30 689.10 Td (The ) Tj ET Q q 0 0 0 rg BT 186.59 689.10 Td (initial ) Tj ET Q q 0 0 0 rg BT 211.68 689.10 Td (right-of-use ) Tj ET Q q 0 0 0 rg BT 260.64 689.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 281.83 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 298.02 689.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 319.75 689.10 Td (liability ) Tj ET Q q 0 0 0 rg BT 352.61 689.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 384.36 689.10 Td (reflected ) Tj ET Q q 0 0 0 rg BT 421.08 689.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 442.84 689.10 Td (adoption ) Tj ET Q q 0 0 0 rg BT 479.58 689.10 Td (will ) Tj ET Q q 0 0 0 rg BT 496.89 689.10 Td (be ) Tj ET Q q 0 0 0 rg BT 508.08 689.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 538.16 689.10 Td (to ) Tj ET Q q 0 0 0 rg BT 547.69 689.10 Td (several ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 66.68 677.10 Td (including ) Tj ET Q q 0 0 0 rg BT 107.93 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 123.62 677.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 150.97 677.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 174.43 677.10 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 212.90 677.10 Td (from ) Tj ET Q q 0 0 0 rg BT 235.82 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 251.51 677.10 Td (earliest ) Tj ET Q q 0 0 0 rg BT 283.86 677.10 Td (date ) Tj ET Q q 0 0 0 rg BT 303.99 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 315.79 677.10 Td (initial ) Tj ET Q q 0 0 0 rg BT 342.60 677.10 Td (application, ) Tj ET Q q 0 0 0 rg BT 393.00 677.10 Td (selection ) Tj ET Q q 0 0 0 rg BT 432.02 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 443.83 677.10 Td (an ) Tj ET Q q 0 0 0 rg BT 456.74 677.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 505.75 677.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 543.11 677.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 561.57 677.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 86.82 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.54 665.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 144.59 665.10 Td (fixed ) Tj ET Q q 0 0 0 rg BT 167.64 665.10 Td (lease ) Tj ET Q q 0 0 0 rg BT 190.12 665.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 230.95 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 247.88 665.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 272.60 665.10 Td (including ) Tj ET Q q 0 0 0 rg BT 312.88 665.10 Td (renewal ) Tj ET Q q 0 0 0 rg BT 347.02 665.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 378.96 665.10 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 424.77 665.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 454.48 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 464.75 665.10 Td (occur) Tj ET Q q 0 0 0 rg BT 486.41 665.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.94 641.10 Td (March ) Tj ET Q q 0 0 0 rg BT 75.65 641.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 100.77 641.10 Td (the ) Tj ET Q q 0 0 0 rg BT 115.59 641.10 Td (F) Tj ET Q q 0 0 0 rg BT 120.41 641.10 Td (ASB ) Tj ET Q q 0 0 0 rg BT 142.48 641.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 170.09 641.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 208.80 641.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 247.50 641.10 Td (for ) Tj ET Q q 0 0 0 rg BT 261.78 641.10 Td (share-based ) Tj ET Q q 0 0 0 rg BT 311.59 641.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 348.63 641.10 Td (transactions. ) Tj ET Q q 0 0 0 rg BT 401.51 641.10 Td (Excess ) Tj ET Q q 0 0 0 rg BT 431.89 641.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 446.72 641.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 480.99 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 498.04 641.10 Td (deficiencies ) Tj ET Q q 0 0 0 rg BT 548.40 641.10 Td (will ) Tj ET Q q 0 0 0 rg BT 566.57 641.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 82.49 629.10 Td (in ) Tj ET Q q 0 0 0 rg BT 92.89 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 107.73 629.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 160.89 629.10 Td (statement ) Tj ET Q q 0 0 0 rg BT 201.84 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 212.79 629.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 249.29 629.10 Td (rather ) Tj ET Q q 0 0 0 rg BT 275.23 629.10 Td (than ) Tj ET Q q 0 0 0 rg BT 295.07 629.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 324.34 629.10 Td (in ) Tj ET Q q 0 0 0 rg BT 334.75 629.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 363.47 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 374.42 629.10 Td (par ) Tj ET Q q 0 0 0 rg BT 389.81 629.10 Td (value ) Tj ET Q q 0 0 0 rg BT 414.09 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 425.05 629.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 448.78 629.10 Td (on ) Tj ET Q q 0 0 0 rg BT 461.40 629.10 Td (a ) Tj ET Q q 0 0 0 rg BT 468.46 629.10 Td (prospective ) Tj ET Q q 0 0 0 rg BT 517.18 629.10 Td (basis. ) Tj ET Q q 0 0 0 rg BT 541.73 629.10 Td (A) Tj ET Q q 0 0 0 rg BT 548.40 629.10 Td ( ) Tj ET Q q 0 0 0 rg BT 551.02 629.10 Td (policy ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (election ) Tj ET Q q 0 0 0 rg BT 70.22 617.10 Td (will ) Tj ET Q q 0 0 0 rg BT 88.34 617.10 Td (be ) Tj ET Q q 0 0 0 rg BT 100.34 617.10 Td (available ) Tj ET Q q 0 0 0 rg BT 138.99 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 149.34 617.10 Td (account ) Tj ET Q q 0 0 0 rg BT 183.00 617.10 Td (for ) Tj ET Q q 0 0 0 rg BT 197.22 617.10 Td (forfeitures ) Tj ET Q q 0 0 0 rg BT 241.43 617.10 Td (as ) Tj ET Q q 0 0 0 rg BT 252.33 617.10 Td (they ) Tj ET Q q 0 0 0 rg BT 272.11 617.10 Td (occur) Tj ET Q q 0 0 0 rg BT 293.92 617.10 Td (, ) Tj ET Q q 0 0 0 rg BT 298.98 617.10 Td (with ) Tj ET Q q 0 0 0 rg BT 319.32 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 334.10 617.10 Td (cumulative ) Tj ET Q q 0 0 0 rg BT 381.10 617.10 Td (ef) Tj ET Q q 0 0 0 rg BT 388.69 617.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 406.24 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 417.13 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 431.91 617.10 Td (change ) Tj ET Q q 0 0 0 rg BT 462.79 617.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 509.22 617.10 Td (as ) Tj ET Q q 0 0 0 rg BT 520.12 617.10 Td (an ) Tj ET Q q 0 0 0 rg BT 532.12 617.10 Td (adjustment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.35 605.10 Td (retained ) Tj ET Q q 0 0 0 rg BT 81.12 605.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 117.57 605.10 Td (at ) Tj ET Q q 0 0 0 rg BT 127.36 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 142.15 605.10 Td (date ) Tj ET Q q 0 0 0 rg BT 161.37 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 172.27 605.10 Td (adoption. ) Tj ET Q q 0 0 0 rg BT 212.34 605.10 Td (Excess ) Tj ET Q q 0 0 0 rg BT 242.68 605.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 257.46 605.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 291.69 605.10 Td (within ) Tj ET Q q 0 0 0 rg BT 319.82 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 334.61 605.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 387.72 605.10 Td (statement ) Tj ET Q q 0 0 0 rg BT 428.61 605.10 Td (of ) Tj ET Q q 0 0 0 rg BT 439.51 605.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 459.85 605.10 Td (flows ) Tj ET Q q 0 0 0 rg BT 484.64 605.10 Td (will ) Tj ET Q q 0 0 0 rg BT 502.77 605.10 Td (be ) Tj ET Q q 0 0 0 rg BT 514.78 605.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 555.67 605.10 Td (as ) Tj ET Q q 0 0 0 rg BT 566.57 605.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 76.19 593.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 108.61 593.10 Td (\(prospective ) Tj ET Q q 0 0 0 rg BT 160.46 593.10 Td (or ) Tj ET Q q 0 0 0 rg BT 171.22 593.10 Td (retrospective ) Tj ET Q q 0 0 0 rg BT 225.29 593.10 Td (application\) ) Tj ET Q q 0 0 0 rg BT 275.48 593.10 Td (and ) Tj ET Q q 0 0 0 rg BT 292.34 593.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 312.54 593.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 353.29 593.10 Td (to ) Tj ET Q q 0 0 0 rg BT 363.50 593.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 378.15 593.10 Td (authorities ) Tj ET Q q 0 0 0 rg BT 422.79 593.10 Td (in ) Tj ET Q q 0 0 0 rg BT 432.99 593.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 479.29 593.10 Td (with ) Tj ET Q q 0 0 0 rg BT 499.50 593.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 526.92 593.10 Td (withheld ) Tj ET Q q 0 0 0 rg BT 564.34 593.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (statutory ) Tj ET Q q 0 0 0 rg BT 74.14 581.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 89.50 581.10 Td (withholding ) Tj ET Q q 0 0 0 rg BT 140.98 581.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 196.33 581.10 Td (will ) Tj ET Q q 0 0 0 rg BT 215.03 581.10 Td (be ) Tj ET Q q 0 0 0 rg BT 227.61 581.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 269.07 581.10 Td (as ) Tj ET Q q 0 0 0 rg BT 280.55 581.10 Td (a ) Tj ET Q q 0 0 0 rg BT 288.13 581.10 Td (financing ) Tj ET Q q 0 0 0 rg BT 329.04 581.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 362.17 581.10 Td (\(retrospective ) Tj ET Q q 0 0 0 rg BT 420.29 581.10 Td (application\). ) Tj ET Q q 0 0 0 rg BT 473.46 581.10 Td (The ) Tj ET Q q 0 0 0 rg BT 492.15 581.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 531.39 581.10 Td (is ) Tj ET Q q 0 0 0 rg BT 541.21 581.10 Td (ef) Tj ET Q q 0 0 0 rg BT 548.80 581.10 Td (fective ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 79.03 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 89.84 569.10 Td (2017. ) Tj ET Q q 0 0 0 rg BT 115.16 569.10 Td (The ) Tj ET Q q 0 0 0 rg BT 133.74 569.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 172.30 569.10 Td (reduction ) Tj ET Q q 0 0 0 rg BT 213.10 569.10 Td (of ) Tj ET Q q 0 0 0 rg BT 224.46 569.10 Td (income ) Tj ET Q q 0 0 0 rg BT 256.93 569.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 272.18 569.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 307.42 569.10 Td (for ) Tj ET Q q 0 0 0 rg BT 322.12 569.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 351.25 569.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 366.50 569.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 401.19 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 412.00 569.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 435.03 569.10 Td (is ) Tj ET Q q 0 0 0 rg BT 444.74 569.10 Td (not ) Tj ET Q q 0 0 0 rg BT 460.55 569.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 499.11 569.10 Td (to ) Tj ET Q q 0 0 0 rg BT 509.93 569.10 Td (be ) Tj ET Q q 0 0 0 rg BT 522.40 569.10 Td (material. ) Tj ET Q q 0 0 0 rg BT 560.47 569.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.77 557.10 Td (will ) Tj ET Q q 0 0 0 rg BT 96.21 557.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 133.52 557.10 Td (its ) Tj ET Q q 0 0 0 rg BT 145.85 557.10 Td (current ) Tj ET Q q 0 0 0 rg BT 177.05 557.10 Td (practice ) Tj ET Q q 0 0 0 rg BT 211.58 557.10 Td (relating ) Tj ET Q q 0 0 0 rg BT 245.00 557.10 Td (to ) Tj ET Q q 0 0 0 rg BT 255.66 557.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 302.41 557.10 Td (for ) Tj ET Q q 0 0 0 rg BT 316.96 557.10 Td (forfeitures. ) Tj ET Q q 0 0 0 rg BT 363.78 557.10 Td (The ) Tj ET Q q 0 0 0 rg BT 382.21 557.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 402.86 557.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 424.07 557.10 Td (presentation ) Tj ET Q q 0 0 0 rg BT 475.82 557.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 510.91 557.10 Td (discussed ) Tj ET Q q 0 0 0 rg BT 552.13 557.10 Td (above ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (will ) Tj ET Q q 0 0 0 rg BT 53.73 545.10 Td (increase ) Tj ET Q q 0 0 0 rg BT 88.67 545.10 Td (net ) Tj ET Q q 0 0 0 rg BT 103.06 545.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 123.01 545.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 160.73 545.10 Td (by ) Tj ET Q q 0 0 0 rg BT 172.91 545.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 212.85 545.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 251.13 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 267.74 545.10 Td (net ) Tj ET Q q 0 0 0 rg BT 282.14 545.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 302.08 545.10 Td (used ) Tj ET Q q 0 0 0 rg BT 322.59 545.10 Td (in ) Tj ET Q q 0 0 0 rg BT 332.55 545.10 Td (financing ) Tj ET Q q 0 0 0 rg BT 372.49 545.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 410.77 545.10 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.94 545.10 Td ($208 ) Tj ET Q q 0 0 0 rg BT 445.12 545.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.01 545.10 Td ( ) Tj ET Q q 0 0 0 rg BT 476.19 545.10 Td (in ) Tj ET Q q 0 0 0 rg BT 486.15 545.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 508.32 545.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.94 545.10 Td ($273 ) Tj ET Q q 0 0 0 rg BT 547.12 545.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 533.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 509.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.43 509.10 Td (June ) Tj ET Q q 0 0 0 rg BT 66.86 509.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 91.46 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 105.78 509.10 Td (F) Tj ET Q q 0 0 0 rg BT 110.59 509.10 Td (ASB ) Tj ET Q q 0 0 0 rg BT 132.15 509.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 159.25 509.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 197.44 509.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 235.63 509.10 Td (for ) Tj ET Q q 0 0 0 rg BT 249.39 509.10 Td (the ) Tj ET Q q 0 0 0 rg BT 263.71 509.10 Td (measurement ) Tj ET Q q 0 0 0 rg BT 319.12 509.10 Td (of ) Tj ET Q q 0 0 0 rg BT 329.55 509.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 354.41 509.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 380.40 509.10 Td (on ) Tj ET Q q 0 0 0 rg BT 392.50 509.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 429.58 509.10 Td (instruments. ) Tj ET Q q 0 0 0 rg BT 480.85 509.10 Td (Entities ) Tj ET Q q 0 0 0 rg BT 513.50 509.10 Td (will ) Tj ET Q q 0 0 0 rg BT 531.16 509.10 Td (be ) Tj ET Q q 0 0 0 rg BT 542.69 509.10 Td (required ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (to ) Tj ET Q q 0 0 0 rg BT 45.92 497.10 Td (use ) Tj ET Q q 0 0 0 rg BT 61.39 497.10 Td (a ) Tj ET Q q 0 0 0 rg BT 67.97 497.10 Td (forward-looking ) Tj ET Q q 0 0 0 rg BT 135.65 497.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 176.11 497.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 193.81 497.10 Td (model. ) Tj ET Q q 0 0 0 rg BT 222.98 497.10 Td (A) Tj ET Q q 0 0 0 rg BT 229.46 497.10 Td (vailable-for) Tj ET Q q 0 0 0 rg BT 275.90 497.10 Td (-sale ) Tj ET Q q 0 0 0 rg BT 296.91 497.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 316.27 497.10 Td (security ) Tj ET Q q 0 0 0 rg BT 350.07 497.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 374.97 497.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 401.01 497.10 Td (will ) Tj ET Q q 0 0 0 rg BT 418.70 497.10 Td (be ) Tj ET Q q 0 0 0 rg BT 430.28 497.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 476.29 497.10 Td (as ) Tj ET Q q 0 0 0 rg BT 486.76 497.10 Td (allowances ) Tj ET Q q 0 0 0 rg BT 533.32 497.10 Td (rather ) Tj ET Q q 0 0 0 rg BT 558.78 497.10 Td (than ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.10 Td (a ) Tj ET Q q 0 0 0 rg BT 41.85 485.10 Td (reduction ) Tj ET Q q 0 0 0 rg BT 81.02 485.10 Td (in ) Tj ET Q q 0 0 0 rg BT 90.21 485.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 131.61 485.10 Td (cost. ) Tj ET Q q 0 0 0 rg BT 151.52 485.10 Td (The ) Tj ET Q q 0 0 0 rg BT 168.48 485.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 205.99 485.10 Td (is ) Tj ET Q q 0 0 0 rg BT 214.07 485.10 Td (ef) Tj ET Q q 0 0 0 rg BT 221.65 485.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 250.27 485.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 291.67 485.10 Td (in ) Tj ET Q q 0 0 0 rg BT 300.86 485.10 Td (2020 ) Tj ET Q q 0 0 0 rg BT 322.27 485.10 Td (with ) Tj ET Q q 0 0 0 rg BT 341.46 485.10 Td (early ) Tj ET Q q 0 0 0 rg BT 362.86 485.10 Td (adoption ) Tj ET Q q 0 0 0 rg BT 399.27 485.10 Td (permitted ) Tj ET Q q 0 0 0 rg BT 439.00 485.10 Td (in ) Tj ET Q q 0 0 0 rg BT 448.19 485.10 Td (2019 ) Tj ET Q q 0 0 0 rg BT 469.60 485.10 Td (on ) Tj ET Q q 0 0 0 rg BT 481.01 485.10 Td (a ) Tj ET Q q 0 0 0 rg BT 486.86 485.10 Td (modified ) Tj ET Q q 0 0 0 rg BT 524.37 485.10 Td (retrospective ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (approach. ) Tj ET Q q 0 0 0 rg BT 77.46 473.10 Td (The ) Tj ET Q q 0 0 0 rg BT 95.51 473.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 136.90 473.10 Td (does ) Tj ET Q q 0 0 0 rg BT 157.73 473.10 Td (not ) Tj ET Q q 0 0 0 rg BT 173.01 473.10 Td (expect ) Tj ET Q q 0 0 0 rg BT 201.60 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 216.32 473.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 254.91 473.10 Td (standard ) Tj ET Q q 0 0 0 rg BT 291.29 473.10 Td (to ) Tj ET Q q 0 0 0 rg BT 301.57 473.10 Td (have ) Tj ET Q q 0 0 0 rg BT 322.94 473.10 Td (a ) Tj ET Q q 0 0 0 rg BT 329.88 473.10 Td (material ) Tj ET Q q 0 0 0 rg BT 365.14 473.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 394.85 473.10 Td (on ) Tj ET Q q 0 0 0 rg BT 407.35 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.07 473.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 463.73 473.10 Td (s ) Tj ET Q q 0 0 0 rg BT 470.13 473.10 Td (results ) Tj ET Q q 0 0 0 rg BT 498.73 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 509.56 473.10 Td (operations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.84 449.10 Td (October ) Tj ET Q q 0 0 0 rg BT 81.55 449.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 106.56 449.10 Td (the ) Tj ET Q q 0 0 0 rg BT 121.29 449.10 Td (F) Tj ET Q q 0 0 0 rg BT 126.11 449.10 Td (ASB ) Tj ET Q q 0 0 0 rg BT 148.07 449.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 175.58 449.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 214.18 449.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 252.78 449.10 Td (on ) Tj ET Q q 0 0 0 rg BT 265.29 449.10 Td (income ) Tj ET Q q 0 0 0 rg BT 297.24 449.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 311.96 449.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 358.34 449.10 Td (for ) Tj ET Q q 0 0 0 rg BT 372.51 449.10 Td (intra-entity ) Tj ET Q q 0 0 0 rg BT 419.45 449.10 Td (transfers ) Tj ET Q q 0 0 0 rg BT 456.39 449.10 Td (of ) Tj ET Q q 0 0 0 rg BT 467.22 449.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 493.06 449.10 Td (other ) Tj ET Q q 0 0 0 rg BT 516.12 449.10 Td (than ) Tj ET Q q 0 0 0 rg BT 535.84 449.10 Td (inventory) Tj ET Q q 0 0 0 rg BT 573.52 449.10 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.72 437.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 91.99 437.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 130.26 437.10 Td (requires ) Tj ET Q q 0 0 0 rg BT 164.64 437.10 Td (that ) Tj ET Q q 0 0 0 rg BT 181.81 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 196.21 437.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 210.60 437.10 Td (consequences ) Tj ET Q q 0 0 0 rg BT 267.75 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 278.25 437.10 Td (transfers ) Tj ET Q q 0 0 0 rg BT 314.86 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 325.36 437.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 350.87 437.10 Td (between ) Tj ET Q q 0 0 0 rg BT 386.36 437.10 Td (members ) Tj ET Q q 0 0 0 rg BT 425.19 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 435.69 437.10 Td (a ) Tj ET Q q 0 0 0 rg BT 442.31 437.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 495.03 437.10 Td (group ) Tj ET Q q 0 0 0 rg BT 520.53 437.10 Td (be ) Tj ET Q q 0 0 0 rg BT 532.15 437.10 Td (recognized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.48 425.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.41 425.10 Td (period ) Tj ET Q q 0 0 0 rg BT 89.66 425.10 Td (the ) Tj ET Q q 0 0 0 rg BT 104.58 425.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 137.82 425.10 Td (takes ) Tj ET Q q 0 0 0 rg BT 161.07 425.10 Td (place ) Tj ET Q q 0 0 0 rg BT 184.87 425.10 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 230.34 425.10 Td (inventory\). ) Tj ET Q q 0 0 0 rg BT 277.01 425.10 Td (The ) Tj ET Q q 0 0 0 rg BT 295.26 425.10 Td (guidance ) Tj ET Q q 0 0 0 rg BT 334.06 425.10 Td (is ) Tj ET Q q 0 0 0 rg BT 343.43 425.10 Td (ef) Tj ET Q q 0 0 0 rg BT 351.02 425.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 380.93 425.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 423.63 425.10 Td (in ) Tj ET Q q 0 0 0 rg BT 434.11 425.10 Td (2018 ) Tj ET Q q 0 0 0 rg BT 456.82 425.10 Td (with ) Tj ET Q q 0 0 0 rg BT 477.30 425.10 Td (early ) Tj ET Q q 0 0 0 rg BT 499.99 425.10 Td (adoption ) Tj ET Q q 0 0 0 rg BT 537.69 425.10 Td (permitted ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.24 413.10 Td (the ) Tj ET Q q 0 0 0 rg BT 60.92 413.10 Td (first ) Tj ET Q q 0 0 0 rg BT 79.49 413.10 Td (quarter ) Tj ET Q q 0 0 0 rg BT 110.27 413.10 Td (of ) Tj ET Q q 0 0 0 rg BT 121.07 413.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 143.53 413.10 Td (on ) Tj ET Q q 0 0 0 rg BT 155.99 413.10 Td (a ) Tj ET Q q 0 0 0 rg BT 162.89 413.10 Td (modified ) Tj ET Q q 0 0 0 rg BT 201.46 413.10 Td (retrospective ) Tj ET Q q 0 0 0 rg BT 255.57 413.10 Td (approach. ) Tj ET Q q 0 0 0 rg BT 297.00 413.10 Td (The ) Tj ET Q q 0 0 0 rg BT 315.01 413.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 356.36 413.10 Td (will ) Tj ET Q q 0 0 0 rg BT 374.38 413.10 Td (early ) Tj ET Q q 0 0 0 rg BT 396.83 413.10 Td (adopt ) Tj ET Q q 0 0 0 rg BT 421.51 413.10 Td (the ) Tj ET Q q 0 0 0 rg BT 436.19 413.10 Td (amended ) Tj ET Q q 0 0 0 rg BT 474.74 413.10 Td (standard ) Tj ET Q q 0 0 0 rg BT 511.08 413.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 553.54 413.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 413.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.10 Td (first ) Tj ET Q q 0 0 0 rg BT 55.76 401.10 Td (quarter ) Tj ET Q q 0 0 0 rg BT 87.72 401.10 Td (of ) Tj ET Q q 0 0 0 rg BT 99.70 401.10 Td (2017. ) Tj ET Q q 0 0 0 rg BT 125.05 401.10 Td (As ) Tj ET Q q 0 0 0 rg BT 139.81 401.10 Td (a ) Tj ET Q q 0 0 0 rg BT 147.90 401.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 176.27 401.10 Td (prepaid ) Tj ET Q q 0 0 0 rg BT 209.90 401.10 Td (receivables ) Tj ET Q q 0 0 0 rg BT 258.52 401.10 Td (and ) Tj ET Q q 0 0 0 rg BT 276.61 401.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 313.57 401.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 329.43 401.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 356.41 401.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 398.38 401.10 Td (to ) Tj ET Q q 0 0 0 rg BT 409.81 401.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 444.00 401.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 492.08 401.10 Td (property ) Tj ET Q q 0 0 0 rg BT 529.60 401.10 Td (transfers ) Tj ET Q q 0 0 0 rg BT 567.68 401.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 96.03 389.10 Td ($1 ) Tj ET Q q 0 0 0 rg BT 108.29 389.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 134.41 389.10 Td ( ) Tj ET Q q 0 0 0 rg BT 136.67 389.10 Td (will ) Tj ET Q q 0 0 0 rg BT 154.50 389.10 Td (be ) Tj ET Q q 0 0 0 rg BT 166.20 389.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 200.12 389.10 Td (as ) Tj ET Q q 0 0 0 rg BT 210.71 389.10 Td (a ) Tj ET Q q 0 0 0 rg BT 217.42 389.10 Td (cumulative ) Tj ET Q q 0 0 0 rg BT 264.11 389.10 Td (ef) Tj ET Q q 0 0 0 rg BT 271.70 389.10 Td (fect ) Tj ET Q q 0 0 0 rg BT 288.95 389.10 Td (of ) Tj ET Q q 0 0 0 rg BT 299.55 389.10 Td (an ) Tj ET Q q 0 0 0 rg BT 311.26 389.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 357.40 389.10 Td (change ) Tj ET Q q 0 0 0 rg BT 387.98 389.10 Td (in ) Tj ET Q q 0 0 0 rg BT 398.02 389.10 Td (retained ) Tj ET Q q 0 0 0 rg BT 432.49 389.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 468.64 389.10 Td (and ) Tj ET Q q 0 0 0 rg BT 485.34 389.10 Td (no ) Tj ET Q q 0 0 0 rg BT 497.61 389.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 525.42 389.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 567.67 389.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.10 Td (a ) Tj ET Q q 0 0 0 rg BT 43.07 377.10 Td (component ) Tj ET Q q 0 0 0 rg BT 90.13 377.10 Td (of ) Tj ET Q q 0 0 0 rg BT 101.09 377.10 Td (income ) Tj ET Q q 0 0 0 rg BT 133.15 377.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 156.32 377.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 159.65 377.10 Td ($86 ) Tj ET Q q 0 0 0 rg BT 177.28 377.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.17 377.10 Td ( ) Tj ET Q q 0 0 0 rg BT 208.80 377.10 Td (per ) Tj ET Q q 0 0 0 rg BT 224.20 377.10 Td (year\). ) Tj ET Q q 0 0 0 rg BT 249.87 377.10 Td (In ) Tj ET Q q 0 0 0 rg BT 260.82 377.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 298.73 377.10 Td (the ) Tj ET Q q 0 0 0 rg BT 313.57 377.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 328.42 377.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 358.26 377.10 Td (of ) Tj ET Q q 0 0 0 rg BT 369.22 377.10 Td (future ) Tj ET Q q 0 0 0 rg BT 395.72 377.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 428.89 377.10 Td (transfers ) Tj ET Q q 0 0 0 rg BT 465.95 377.10 Td (of ) Tj ET Q q 0 0 0 rg BT 476.91 377.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 523.96 377.10 Td (property ) Tj ET Q q 0 0 0 rg BT 560.46 377.10 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 365.10 Td (be ) Tj ET Q q 0 0 0 rg BT 47.94 365.10 Td (included ) Tj ET Q q 0 0 0 rg BT 84.87 365.10 Td (in ) Tj ET Q q 0 0 0 rg BT 95.15 365.10 Td (income ) Tj ET Q q 0 0 0 rg BT 127.08 365.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 141.80 365.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 176.51 365.10 Td (when ) Tj ET Q q 0 0 0 rg BT 200.67 365.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 246.47 365.10 Td (and ) Tj ET Q q 0 0 0 rg BT 263.41 365.10 Td (not ) Tj ET Q q 0 0 0 rg BT 278.69 365.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 321.17 365.10 Td (in ) Tj ET Q q 0 0 0 rg BT 331.45 365.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 378.39 365.10 Td (periods.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 339.90 Td (In ) Tj ET Q q 0 0 0 rg BT 46.66 339.90 Td (January ) Tj ET Q q 0 0 0 rg BT 80.09 339.90 Td (2017, ) Tj ET Q q 0 0 0 rg BT 104.92 339.90 Td (the ) Tj ET Q q 0 0 0 rg BT 119.47 339.90 Td (F) Tj ET Q q 0 0 0 rg BT 124.29 339.90 Td (ASB ) Tj ET Q q 0 0 0 rg BT 146.07 339.90 Td (issued ) Tj ET Q q 0 0 0 rg BT 173.40 339.90 Td (amended ) Tj ET Q q 0 0 0 rg BT 211.83 339.90 Td (guidance ) Tj ET Q q 0 0 0 rg BT 250.25 339.90 Td (that ) Tj ET Q q 0 0 0 rg BT 267.58 339.90 Td (revises ) Tj ET Q q 0 0 0 rg BT 297.67 339.90 Td (the ) Tj ET Q q 0 0 0 rg BT 312.22 339.90 Td (definition ) Tj ET Q q 0 0 0 rg BT 353.43 339.90 Td (of ) Tj ET Q q 0 0 0 rg BT 364.10 339.90 Td (a ) Tj ET Q q 0 0 0 rg BT 370.86 339.90 Td (business. ) Tj ET Q q 0 0 0 rg BT 409.42 339.90 Td (The ) Tj ET Q q 0 0 0 rg BT 427.30 339.90 Td (amendments ) Tj ET Q q 0 0 0 rg BT 480.17 339.90 Td (provide ) Tj ET Q q 0 0 0 rg BT 513.05 339.90 Td (an ) Tj ET Q q 0 0 0 rg BT 524.81 339.90 Td (initial ) Tj ET Q q 0 0 0 rg BT 550.48 339.90 Td (screen ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 327.90 Td (that ) Tj ET Q q 0 0 0 rg BT 53.66 327.90 Td (when ) Tj ET Q q 0 0 0 rg BT 77.99 327.90 Td (substantially ) Tj ET Q q 0 0 0 rg BT 131.21 327.90 Td (all ) Tj ET Q q 0 0 0 rg BT 143.88 327.90 Td (of ) Tj ET Q q 0 0 0 rg BT 154.87 327.90 Td (the ) Tj ET Q q 0 0 0 rg BT 169.76 327.90 Td (fair ) Tj ET Q q 0 0 0 rg BT 186.31 327.90 Td (value ) Tj ET Q q 0 0 0 rg BT 210.63 327.90 Td (of ) Tj ET Q q 0 0 0 rg BT 221.63 327.90 Td (the ) Tj ET Q q 0 0 0 rg BT 236.51 327.90 Td (gross ) Tj ET Q q 0 0 0 rg BT 260.29 327.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 286.29 327.90 Td (acquired ) Tj ET Q q 0 0 0 rg BT 323.39 327.90 Td (or ) Tj ET Q q 0 0 0 rg BT 334.38 327.90 Td (disposed ) Tj ET Q q 0 0 0 rg BT 372.05 327.90 Td (of ) Tj ET Q q 0 0 0 rg BT 383.05 327.90 Td (is ) Tj ET Q q 0 0 0 rg BT 392.39 327.90 Td (concentrated ) Tj ET Q q 0 0 0 rg BT 446.14 327.90 Td (in ) Tj ET Q q 0 0 0 rg BT 456.58 327.90 Td (a ) Tj ET Q q 0 0 0 rg BT 463.69 327.90 Td (single ) Tj ET Q q 0 0 0 rg BT 490.25 327.90 Td (identifiable ) Tj ET Q q 0 0 0 rg BT 538.45 327.90 Td (asset ) Tj ET Q q 0 0 0 rg BT 560.56 327.90 Td (or ) Tj ET Q q 0 0 0 rg BT 571.56 327.90 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 315.90 Td (group ) Tj ET Q q 0 0 0 rg BT 61.80 315.90 Td (of ) Tj ET Q q 0 0 0 rg BT 72.60 315.90 Td (similar ) Tj ET Q q 0 0 0 rg BT 102.85 315.90 Td (identifiable ) Tj ET Q q 0 0 0 rg BT 150.86 315.90 Td (assets, ) Tj ET Q q 0 0 0 rg BT 179.16 315.90 Td (the ) Tj ET Q q 0 0 0 rg BT 193.85 315.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 219.65 315.90 Td (would ) Tj ET Q q 0 0 0 rg BT 247.13 315.90 Td (not ) Tj ET Q q 0 0 0 rg BT 262.38 315.90 Td (represent ) Tj ET Q q 0 0 0 rg BT 301.49 315.90 Td (a ) Tj ET Q q 0 0 0 rg BT 308.40 315.90 Td (business. ) Tj ET Q q 0 0 0 rg BT 347.09 315.90 Td (T) Tj ET Q q 0 0 0 rg BT 352.50 315.90 Td (o ) Tj ET Q q 0 0 0 rg BT 359.97 315.90 Td (be ) Tj ET Q q 0 0 0 rg BT 371.88 315.90 Td (considered ) Tj ET Q q 0 0 0 rg BT 417.67 315.90 Td (a ) Tj ET Q q 0 0 0 rg BT 424.58 315.90 Td (business, ) Tj ET Q q 0 0 0 rg BT 463.44 315.90 Td (there ) Tj ET Q q 0 0 0 rg BT 485.90 315.90 Td (must ) Tj ET Q q 0 0 0 rg BT 507.82 315.90 Td (be ) Tj ET Q q 0 0 0 rg BT 519.73 315.90 Td (an ) Tj ET Q q 0 0 0 rg BT 531.64 315.90 Td (input ) Tj ET Q q 0 0 0 rg BT 554.67 315.90 Td (and ) Tj ET Q q 0 0 0 rg BT 571.58 315.90 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 303.90 Td (substantive ) Tj ET Q q 0 0 0 rg BT 83.13 303.90 Td (process ) Tj ET Q q 0 0 0 rg BT 115.25 303.90 Td (that ) Tj ET Q q 0 0 0 rg BT 132.38 303.90 Td (together ) Tj ET Q q 0 0 0 rg BT 167.28 303.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 219.40 303.90 Td (contribute ) Tj ET Q q 0 0 0 rg BT 262.07 303.90 Td (to ) Tj ET Q q 0 0 0 rg BT 271.98 303.90 Td (the ) Tj ET Q q 0 0 0 rg BT 286.33 303.90 Td (ability ) Tj ET Q q 0 0 0 rg BT 314.02 303.90 Td (to ) Tj ET Q q 0 0 0 rg BT 323.93 303.90 Td (create ) Tj ET Q q 0 0 0 rg BT 349.92 303.90 Td (outputs. ) Tj ET Q q 0 0 0 rg BT 383.85 303.90 Td (T) Tj ET Q q 0 0 0 rg BT 389.26 303.90 Td (o ) Tj ET Q q 0 0 0 rg BT 396.39 303.90 Td (be ) Tj ET Q q 0 0 0 rg BT 407.97 303.90 Td (a ) Tj ET Q q 0 0 0 rg BT 414.54 303.90 Td (business ) Tj ET Q q 0 0 0 rg BT 450.56 303.90 Td (without ) Tj ET Q q 0 0 0 rg BT 483.25 303.90 Td (outputs, ) Tj ET Q q 0 0 0 rg BT 517.33 303.90 Td (there ) Tj ET Q q 0 0 0 rg BT 539.45 303.90 Td (will ) Tj ET Q q 0 0 0 rg BT 557.14 303.90 Td (need ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 291.90 Td (to ) Tj ET Q q 0 0 0 rg BT 46.66 291.90 Td (be ) Tj ET Q q 0 0 0 rg BT 58.98 291.90 Td (an ) Tj ET Q q 0 0 0 rg BT 71.30 291.90 Td (or) Tj ET Q q 0 0 0 rg BT 79.45 291.90 Td (ganized ) Tj ET Q q 0 0 0 rg BT 113.42 291.90 Td (workforce. ) Tj ET Q q 0 0 0 rg BT 159.68 291.90 Td (The ) Tj ET Q q 0 0 0 rg BT 178.11 291.90 Td (amendments ) Tj ET Q q 0 0 0 rg BT 231.53 291.90 Td (also ) Tj ET Q q 0 0 0 rg BT 250.52 291.90 Td (narrow ) Tj ET Q q 0 0 0 rg BT 281.72 291.90 Td (the ) Tj ET Q q 0 0 0 rg BT 296.82 291.90 Td (definition ) Tj ET Q q 0 0 0 rg BT 338.58 291.90 Td (of ) Tj ET Q q 0 0 0 rg BT 349.80 291.90 Td (the ) Tj ET Q q 0 0 0 rg BT 364.89 291.90 Td (term ) Tj ET Q q 0 0 0 rg BT 386.10 291.90 Td (outputs. ) Tj ET Q q 0 0 0 rg BT 420.72 291.90 Td (The ) Tj ET Q q 0 0 0 rg BT 439.15 291.90 Td (guidance ) Tj ET Q q 0 0 0 rg BT 478.12 291.90 Td (is ) Tj ET Q q 0 0 0 rg BT 487.67 291.90 Td (ef) Tj ET Q q 0 0 0 rg BT 495.26 291.90 Td (fective ) Tj ET Q q 0 0 0 rg BT 525.34 291.90 Td (beginning ) Tj ET Q q 0 0 0 rg BT 568.22 291.90 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 279.90 Td (2018 ) Tj ET Q q 0 0 0 rg BT 58.50 279.90 Td (with ) Tj ET Q q 0 0 0 rg BT 78.78 279.90 Td (early ) Tj ET Q q 0 0 0 rg BT 101.26 279.90 Td (adoption ) Tj ET Q q 0 0 0 rg BT 138.76 279.90 Td (permitted ) Tj ET Q q 0 0 0 rg BT 179.58 279.90 Td (prospectively) Tj ET Q q 0 0 0 rg BT 232.80 279.90 Td (. ) Tj ET Q q 0 0 0 rg BT 237.62 279.90 Td (The ) Tj ET Q q 0 0 0 rg BT 255.67 279.90 Td (Company ) Tj ET Q q 0 0 0 rg BT 297.05 279.90 Td (is ) Tj ET Q q 0 0 0 rg BT 306.22 279.90 Td (assessing ) Tj ET Q q 0 0 0 rg BT 345.95 279.90 Td (the ) Tj ET Q q 0 0 0 rg BT 360.66 279.90 Td (potential ) Tj ET Q q 0 0 0 rg BT 398.15 279.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 427.87 279.90 Td (of ) Tj ET Q q 0 0 0 rg BT 438.70 279.90 Td (the ) Tj ET Q q 0 0 0 rg BT 453.41 279.90 Td (amended ) Tj ET Q q 0 0 0 rg BT 492.01 279.90 Td (standard.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 255.90 Td (In ) Tj ET Q q 0 0 0 rg BT 46.67 255.90 Td (January ) Tj ET Q q 0 0 0 rg BT 80.11 255.90 Td (2017, ) Tj ET Q q 0 0 0 rg BT 104.95 255.90 Td (the ) Tj ET Q q 0 0 0 rg BT 119.51 255.90 Td (F) Tj ET Q q 0 0 0 rg BT 124.33 255.90 Td (ASB ) Tj ET Q q 0 0 0 rg BT 146.12 255.90 Td (issued ) Tj ET Q q 0 0 0 rg BT 173.46 255.90 Td (amended ) Tj ET Q q 0 0 0 rg BT 211.89 255.90 Td (guidance ) Tj ET Q q 0 0 0 rg BT 250.33 255.90 Td (that ) Tj ET Q q 0 0 0 rg BT 267.66 255.90 Td (simplifies ) Tj ET Q q 0 0 0 rg BT 309.45 255.90 Td (the ) Tj ET Q q 0 0 0 rg BT 324.00 255.90 Td (recognition ) Tj ET Q q 0 0 0 rg BT 371.89 255.90 Td (and ) Tj ET Q q 0 0 0 rg BT 388.67 255.90 Td (measurement ) Tj ET Q q 0 0 0 rg BT 444.32 255.90 Td (of ) Tj ET Q q 0 0 0 rg BT 454.99 255.90 Td (a ) Tj ET Q q 0 0 0 rg BT 461.77 255.90 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 499.66 255.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 548.10 255.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 566.00 255.90 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 243.90 Td (eliminating ) Tj ET Q q 0 0 0 rg BT 84.72 243.90 Td (Step ) Tj ET Q q 0 0 0 rg BT 105.67 243.90 Td (2 ) Tj ET Q q 0 0 0 rg BT 113.84 243.90 Td (of ) Tj ET Q q 0 0 0 rg BT 125.34 243.90 Td (the ) Tj ET Q q 0 0 0 rg BT 140.72 243.90 Td (quantitative ) Tj ET Q q 0 0 0 rg BT 191.10 243.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 240.37 243.90 Td (test. ) Tj ET Q q 0 0 0 rg BT 259.23 243.90 Td (As ) Tj ET Q q 0 0 0 rg BT 273.51 243.90 Td (a ) Tj ET Q q 0 0 0 rg BT 281.12 243.90 Td (result, ) Tj ET Q q 0 0 0 rg BT 309.01 243.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 358.28 243.90 Td (char) Tj ET Q q 0 0 0 rg BT 375.30 243.90 Td (ges ) Tj ET Q q 0 0 0 rg BT 391.80 243.90 Td (will ) Tj ET Q q 0 0 0 rg BT 410.53 243.90 Td (be ) Tj ET Q q 0 0 0 rg BT 423.14 243.90 Td (required ) Tj ET Q q 0 0 0 rg BT 459.63 243.90 Td (for ) Tj ET Q q 0 0 0 rg BT 474.46 243.90 Td (the ) Tj ET Q q 0 0 0 rg BT 489.84 243.90 Td (amount ) Tj ET Q q 0 0 0 rg BT 523.01 243.90 Td (by ) Tj ET Q q 0 0 0 rg BT 536.18 243.90 Td (which ) Tj ET Q q 0 0 0 rg BT 563.79 243.90 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 231.90 Td (reporting ) Tj ET Q q 0 0 0 rg BT 74.41 231.90 Td (units ) Tj ET Q q 0 0 0 rg BT 95.61 231.90 Td (carrying ) Tj ET Q q 0 0 0 rg BT 130.67 231.90 Td (amount ) Tj ET Q q 0 0 0 rg BT 162.42 231.90 Td (exceeds ) Tj ET Q q 0 0 0 rg BT 195.82 231.90 Td (its ) Tj ET Q q 0 0 0 rg BT 207.02 231.90 Td (fair ) Tj ET Q q 0 0 0 rg BT 222.65 231.90 Td (value ) Tj ET Q q 0 0 0 rg BT 246.06 231.90 Td (up ) Tj ET Q q 0 0 0 rg BT 257.81 231.90 Td (to ) Tj ET Q q 0 0 0 rg BT 267.34 231.90 Td (the ) Tj ET Q q 0 0 0 rg BT 281.31 231.90 Td (amount ) Tj ET Q q 0 0 0 rg BT 313.05 231.90 Td (of ) Tj ET Q q 0 0 0 rg BT 323.14 231.90 Td (its ) Tj ET Q q 0 0 0 rg BT 334.34 231.90 Td (allocated ) Tj ET Q q 0 0 0 rg BT 372.18 231.90 Td (goodwill. ) Tj ET Q q 0 0 0 rg BT 411.86 231.90 Td (The ) Tj ET Q q 0 0 0 rg BT 429.16 231.90 Td (guidance ) Tj ET Q q 0 0 0 rg BT 467.00 231.90 Td (is ) Tj ET Q q 0 0 0 rg BT 475.42 231.90 Td (ef) Tj ET Q q 0 0 0 rg BT 483.01 231.90 Td (fective ) Tj ET Q q 0 0 0 rg BT 511.97 231.90 Td (on ) Tj ET Q q 0 0 0 rg BT 523.72 231.90 Td (a ) Tj ET Q q 0 0 0 rg BT 529.91 231.90 Td (prospective ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 219.90 Td (basis ) Tj ET Q q 0 0 0 rg BT 59.54 219.90 Td (in ) Tj ET Q q 0 0 0 rg BT 70.87 219.90 Td (2020, ) Tj ET Q q 0 0 0 rg BT 96.91 219.90 Td (with ) Tj ET Q q 0 0 0 rg BT 118.23 219.90 Td (early ) Tj ET Q q 0 0 0 rg BT 141.76 219.90 Td (adoption ) Tj ET Q q 0 0 0 rg BT 180.30 219.90 Td (permitted ) Tj ET Q q 0 0 0 rg BT 222.17 219.90 Td (for ) Tj ET Q q 0 0 0 rg BT 237.37 219.90 Td (interim ) Tj ET Q q 0 0 0 rg BT 269.79 219.90 Td (or ) Tj ET Q q 0 0 0 rg BT 281.67 219.90 Td (annual ) Tj ET Q q 0 0 0 rg BT 311.87 219.90 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 350.97 219.90 Td (impairment ) Tj ET Q q 0 0 0 rg BT 400.61 219.90 Td (tests ) Tj ET Q q 0 0 0 rg BT 421.93 219.90 Td (performed ) Tj ET Q q 0 0 0 rg BT 467.12 219.90 Td (after ) Tj ET Q q 0 0 0 rg BT 488.98 219.90 Td (January ) Tj ET Q q 0 0 0 rg BT 523.63 219.90 Td (1, ) Tj ET Q q 0 0 0 rg BT 534.67 219.90 Td (2017. ) Tj ET Q q 0 0 0 rg BT 560.46 219.90 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 207.90 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.39 207.90 Td (does ) Tj ET Q q 0 0 0 rg BT 98.22 207.90 Td (not ) Tj ET Q q 0 0 0 rg BT 113.50 207.90 Td (expect ) Tj ET Q q 0 0 0 rg BT 142.09 207.90 Td (the ) Tj ET Q q 0 0 0 rg BT 156.81 207.90 Td (amended ) Tj ET Q q 0 0 0 rg BT 195.40 207.90 Td (standard ) Tj ET Q q 0 0 0 rg BT 231.78 207.90 Td (to ) Tj ET Q q 0 0 0 rg BT 242.05 207.90 Td (have ) Tj ET Q q 0 0 0 rg BT 263.43 207.90 Td (a ) Tj ET Q q 0 0 0 rg BT 270.37 207.90 Td (material ) Tj ET Q q 0 0 0 rg BT 305.63 207.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 335.34 207.90 Td (on ) Tj ET Q q 0 0 0 rg BT 347.84 207.90 Td (the ) Tj ET Q q 0 0 0 rg BT 362.56 207.90 Td (Company’) Tj ET Q q 0 0 0 rg BT 404.22 207.90 Td (s ) Tj ET Q q 0 0 0 rg BT 410.61 207.90 Td (results ) Tj ET Q q 0 0 0 rg BT 439.22 207.90 Td (of ) Tj ET Q q 0 0 0 rg BT 450.05 207.90 Td (operations.) Tj ET Q endstream endobj 123 0 obj <> endobj 124 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (61) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 749.25 Td (2) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 749.25 Td (. BUSINESS SEGMENT) Tj ET Q q 0 0 0 rg BT 169.18 749.25 Td ( INFORMA) Tj ET Q q 0 0 0 rg BT 219.82 749.25 Td (TION) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 732.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.54 732.25 Td (operates ) Tj ET Q q 0 0 0 rg BT 95.27 732.25 Td (in ) Tj ET Q q 0 0 0 rg BT 105.46 732.25 Td (a ) Tj ET Q q 0 0 0 rg BT 112.32 732.25 Td (single ) Tj ET Q q 0 0 0 rg BT 138.62 732.25 Td (segment ) Tj ET Q q 0 0 0 rg BT 174.36 732.25 Td (engaged ) Tj ET Q q 0 0 0 rg BT 210.09 732.25 Td (in ) Tj ET Q q 0 0 0 rg BT 220.29 732.25 Td (the ) Tj ET Q q 0 0 0 rg BT 234.92 732.25 Td (discovery) Tj ET Q q 0 0 0 rg BT 273.15 732.25 Td (, ) Tj ET Q q 0 0 0 rg BT 278.07 732.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 334.63 732.25 Td (licensing, ) Tj ET Q q 0 0 0 rg BT 375.65 732.25 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 438.88 732.25 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 484.34 732.25 Td (distribution ) Tj ET Q q 0 0 0 rg BT 532.87 732.25 Td (and ) Tj ET Q q 0 0 0 rg BT 549.72 732.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 567.68 732.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 720.25 Td (innovative ) Tj ET Q q 0 0 0 rg BT 80.67 720.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 123.66 720.25 Td (that ) Tj ET Q q 0 0 0 rg BT 141.11 720.25 Td (help ) Tj ET Q q 0 0 0 rg BT 160.79 720.25 Td (patients ) Tj ET Q q 0 0 0 rg BT 194.34 720.25 Td (prevail ) Tj ET Q q 0 0 0 rg BT 224.56 720.25 Td (over ) Tj ET Q q 0 0 0 rg BT 244.79 720.25 Td (serious ) Tj ET Q q 0 0 0 rg BT 275.57 720.25 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 312.75 720.25 Td (A) Tj ET Q q 0 0 0 rg BT 319.42 720.25 Td ( ) Tj ET Q q 0 0 0 rg BT 321.88 720.25 Td (global ) Tj ET Q q 0 0 0 rg BT 349.33 720.25 Td (research ) Tj ET Q q 0 0 0 rg BT 385.09 720.25 Td (and ) Tj ET Q q 0 0 0 rg BT 401.98 720.25 Td (development ) Tj ET Q q 0 0 0 rg BT 456.09 720.25 Td (or) Tj ET Q q 0 0 0 rg BT 464.24 720.25 Td (ganization ) Tj ET Q q 0 0 0 rg BT 508.34 720.25 Td (and ) Tj ET Q q 0 0 0 rg BT 525.24 720.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 554.36 720.25 Td (chain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 708.25 Td (or) Tj ET Q q 0 0 0 rg BT 44.15 708.25 Td (ganization ) Tj ET Q q 0 0 0 rg BT 88.09 708.25 Td (are ) Tj ET Q q 0 0 0 rg BT 102.58 708.25 Td (responsible ) Tj ET Q q 0 0 0 rg BT 150.41 708.25 Td (for ) Tj ET Q q 0 0 0 rg BT 164.36 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 178.86 708.25 Td (discovery) Tj ET Q q 0 0 0 rg BT 217.09 708.25 Td (, ) Tj ET Q q 0 0 0 rg BT 221.88 708.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 278.31 708.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 338.91 708.25 Td (and ) Tj ET Q q 0 0 0 rg BT 355.64 708.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 384.59 708.25 Td (of ) Tj ET Q q 0 0 0 rg BT 395.21 708.25 Td (products. ) Tj ET Q q 0 0 0 rg BT 434.44 708.25 Td (Regional ) Tj ET Q q 0 0 0 rg BT 472.83 708.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 522.31 708.25 Td (or) Tj ET Q q 0 0 0 rg BT 530.46 708.25 Td (ganizations ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 696.25 Td (market, ) Tj ET Q q 0 0 0 rg BT 69.83 696.25 Td (distribute ) Tj ET Q q 0 0 0 rg BT 111.17 696.25 Td (and ) Tj ET Q q 0 0 0 rg BT 129.17 696.25 Td (sell ) Tj ET Q q 0 0 0 rg BT 146.62 696.25 Td (the ) Tj ET Q q 0 0 0 rg BT 162.40 696.25 Td (products. ) Tj ET Q q 0 0 0 rg BT 202.65 696.25 Td (The ) Tj ET Q q 0 0 0 rg BT 221.76 696.25 Td (business ) Tj ET Q q 0 0 0 rg BT 259.21 696.25 Td (is ) Tj ET Q q 0 0 0 rg BT 269.45 696.25 Td (also ) Tj ET Q q 0 0 0 rg BT 289.12 696.25 Td (supported ) Tj ET Q q 0 0 0 rg BT 332.12 696.25 Td (by ) Tj ET Q q 0 0 0 rg BT 345.69 696.25 Td (global ) Tj ET Q q 0 0 0 rg BT 374.25 696.25 Td (corporate ) Tj ET Q q 0 0 0 rg BT 415.57 696.25 Td (staf) Tj ET Q q 0 0 0 rg BT 429.82 696.25 Td (f ) Tj ET Q q 0 0 0 rg BT 436.72 696.25 Td (functions. ) Tj ET Q q 0 0 0 rg BT 480.00 696.25 Td (Segment ) Tj ET Q q 0 0 0 rg BT 518.56 696.25 Td (information ) Tj ET Q q 0 0 0 rg BT 569.34 696.25 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 684.25 Td (consistent ) Tj ET Q q 0 0 0 rg BT 79.61 684.25 Td (with ) Tj ET Q q 0 0 0 rg BT 101.01 684.25 Td (the ) Tj ET Q q 0 0 0 rg BT 116.84 684.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 155.44 684.25 Td (information ) Tj ET Q q 0 0 0 rg BT 206.27 684.25 Td (regularly ) Tj ET Q q 0 0 0 rg BT 245.99 684.25 Td (reviewed ) Tj ET Q q 0 0 0 rg BT 286.25 684.25 Td (by ) Tj ET Q q 0 0 0 rg BT 299.87 684.25 Td (the ) Tj ET Q q 0 0 0 rg BT 315.70 684.25 Td (chief ) Tj ET Q q 0 0 0 rg BT 339.31 684.25 Td (executive ) Tj ET Q q 0 0 0 rg BT 381.23 684.25 Td (of) Tj ET Q q 0 0 0 rg BT 389.38 684.25 Td (ficer ) Tj ET Q q 0 0 0 rg BT 411.32 684.25 Td (for ) Tj ET Q q 0 0 0 rg BT 426.60 684.25 Td (purposes ) Tj ET Q q 0 0 0 rg BT 465.77 684.25 Td (of ) Tj ET Q q 0 0 0 rg BT 477.71 684.25 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 522.98 684.25 Td (performance, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 672.25 Td (allocating ) Tj ET Q q 0 0 0 rg BT 77.93 672.25 Td (resources, ) Tj ET Q q 0 0 0 rg BT 120.69 672.25 Td (setting ) Tj ET Q q 0 0 0 rg BT 149.85 672.25 Td (incentive ) Tj ET Q q 0 0 0 rg BT 189.00 672.25 Td (compensation ) Tj ET Q q 0 0 0 rg BT 247.04 672.25 Td (tar) Tj ET Q q 0 0 0 rg BT 257.41 672.25 Td (gets, ) Tj ET Q q 0 0 0 rg BT 278.52 672.25 Td (and ) Tj ET Q q 0 0 0 rg BT 295.46 672.25 Td (planning ) Tj ET Q q 0 0 0 rg BT 332.95 672.25 Td (and ) Tj ET Q q 0 0 0 rg BT 349.89 672.25 Td (forecasting ) Tj ET Q q 0 0 0 rg BT 396.82 672.25 Td (future ) Tj ET Q q 0 0 0 rg BT 423.19 672.25 Td (periods.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 651.25 Td (Products ) Tj ET Q q 0 0 0 rg BT 72.61 651.25 Td (are ) Tj ET Q q 0 0 0 rg BT 86.43 651.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 104.72 651.25 Td (principally ) Tj ET Q q 0 0 0 rg BT 149.65 651.25 Td (to ) Tj ET Q q 0 0 0 rg BT 159.04 651.25 Td (wholesalers, ) Tj ET Q q 0 0 0 rg BT 210.37 651.25 Td (and ) Tj ET Q q 0 0 0 rg BT 226.42 651.25 Td (to ) Tj ET Q q 0 0 0 rg BT 235.81 651.25 Td (a ) Tj ET Q q 0 0 0 rg BT 241.86 651.25 Td (lesser ) Tj ET Q q 0 0 0 rg BT 266.24 651.25 Td (extent, ) Tj ET Q q 0 0 0 rg BT 294.79 651.25 Td (directly ) Tj ET Q q 0 0 0 rg BT 326.95 651.25 Td (to ) Tj ET Q q 0 0 0 rg BT 336.34 651.25 Td (distributors, ) Tj ET Q q 0 0 0 rg BT 386.01 651.25 Td (retailers, ) Tj ET Q q 0 0 0 rg BT 422.33 651.25 Td (hospitals, ) Tj ET Q q 0 0 0 rg BT 462.00 651.25 Td (clinics, ) Tj ET Q q 0 0 0 rg BT 492.21 651.25 Td (government ) Tj ET Q q 0 0 0 rg BT 541.59 651.25 Td (agencies ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 639.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.47 639.25 Td (pharmacies. ) Tj ET Q q 0 0 0 rg BT 102.54 639.25 Td (Gross ) Tj ET Q q 0 0 0 rg BT 127.91 639.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 165.48 639.25 Td (to ) Tj ET Q q 0 0 0 rg BT 175.29 639.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.54 639.25 Td (three) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 209.53 639.25 Td ( ) Tj ET Q q 0 0 0 rg BT 211.56 639.25 Td (lar) Tj ET Q q 0 0 0 rg BT 221.93 639.25 Td (gest ) Tj ET Q q 0 0 0 rg BT 240.07 639.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 303.18 639.25 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 352.42 639.25 Td (in ) Tj ET Q q 0 0 0 rg BT 362.23 639.25 Td (the ) Tj ET Q q 0 0 0 rg BT 376.48 639.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 396.30 639.25 Td (as ) Tj ET Q q 0 0 0 rg BT 406.66 639.25 Td (a ) Tj ET Q q 0 0 0 rg BT 413.13 639.25 Td (percentage ) Tj ET Q q 0 0 0 rg BT 458.47 639.25 Td (of ) Tj ET Q q 0 0 0 rg BT 468.83 639.25 Td (global ) Tj ET Q q 0 0 0 rg BT 495.86 639.25 Td (gross ) Tj ET Q q 0 0 0 rg BT 519.01 639.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 556.58 639.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 627.25 Td (as ) Tj ET Q q 0 0 0 rg BT 46.83 627.25 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 603.75 363.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 603.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 603.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 603.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 603.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 603.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 603.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 577.75 363.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 577.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 577.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 577.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 577.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 577.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 577.75 55.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 603.75 m 458.5 603.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 603.75 m 517.5 603.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 603.75 m 576.5 603.75 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 422.50 607.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.50 607.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 540.50 607.98 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 594.32 Td (McKesson Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 594.32 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 594.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 594.32 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 594.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 594.32 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 594.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 581.32 Td (AmerisourceBergen Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 581.32 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 581.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 581.32 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 581.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 581.32 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 581.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 568.32 Td (Cardinal Health, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 568.32 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 568.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 568.32 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 568.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 568.32 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 568.32 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 544.25 Td (Selected geographic area information was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 507.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 281.50 507.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 507.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 507.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 507.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 507.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 507.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 507.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 507.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 507.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 507.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 481.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 281.50 481.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 481.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 481.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 481.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 481.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 481.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 481.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 481.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 481.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 481.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 455.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 281.50 455.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 285.50 455.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 340.50 455.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 455.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 455.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 455.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 455.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 455.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 517.50 455.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 521.50 455.75 55.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 520.75 m 340.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 340.5 520.75 m 344.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 520.75 m 399.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 399.5 520.75 m 403.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 520.75 m 458.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 520.75 m 517.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 517.5 520.75 m 521.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 520.75 m 576.5 520.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 507.75 m 340.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 507.75 m 399.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 507.75 m 458.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 507.75 m 517.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 507.75 m 576.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 507.75 m 340.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 507.75 m 399.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 507.75 m 458.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 507.75 m 576.5 507.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 455.75 m 340.5 455.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 455.75 m 399.5 455.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 455.75 m 458.5 455.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 455.75 m 517.5 455.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 455.75 m 576.5 455.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 443.75 m 340.5 443.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 285.5 441.75 m 340.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 443.75 m 399.5 443.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 441.75 m 399.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 443.75 m 458.5 443.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 441.75 m 458.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 443.75 m 517.5 443.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 441.75 m 517.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 443.75 m 576.5 443.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 521.5 441.75 m 576.5 441.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 525.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 355.25 524.98 Td (Revenues) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 465.25 524.98 Td (Property, Plant and Equipment) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 512.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 304.50 511.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 363.50 511.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 422.50 511.98 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.50 511.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 540.50 511.98 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 498.32 Td (United States) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.00 498.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.15 498.32 Td (10,720) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.00 498.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 498.32 Td (8,188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 498.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.15 498.32 Td (7,716) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.00 498.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 498.32 Td (3,865) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 498.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 498.32 Td (3,681) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 485.32 Td (Europe) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.15 485.32 Td (4,215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 485.32 Td (3,491) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.15 485.32 Td (3,592) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 485.32 Td (1,003) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 485.32 Td (616) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 472.32 Td (Rest of the ) Tj ET Q q 0 0 0 rg BT 84.64 472.32 Td (W) Tj ET Q q 0 0 0 rg BT 93.28 472.32 Td (orld) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 109.39 476.85 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.15 472.32 Td (3,964) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 472.32 Td (4,142) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.15 472.32 Td (3,459) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 472.32 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 472.32 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 459.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 61.77 463.85 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 69.35 459.32 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.65 459.32 Td (528) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.65 459.32 Td (739) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.15 459.32 Td (1,112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 459.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 459.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 446.32 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.00 446.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.15 446.32 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.00 446.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.15 446.32 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 446.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.15 446.32 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.00 446.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.15 446.32 Td (4,980) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.00 446.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 446.32 Td (4,412) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 430.65 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 430.65 Td (Includes Japan which represented ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 163.73 430.65 Td (7%) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 174.40 430.65 Td (, ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 178.40 430.65 Td (10%) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 193.06 430.65 Td ( and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 208.61 430.65 Td (6%) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 219.28 430.65 Td ( of total revenues in ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 284.81 430.65 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 300.81 430.65 Td (, ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 304.81 430.65 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 320.81 430.65 Td ( and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 336.36 430.65 Td (2014) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 352.36 430.65 Td (, respectively) Tj ET Q q 0 0 0 rg BT 394.49 430.65 Td (. ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 421.05 Td (\(b\) ) Tj ET Q q 0 0 0 rg BT 54.00 421.05 Td (Other ) Tj ET Q q 0 0 0 rg BT 74.21 421.05 Td (revenues ) Tj ET Q q 0 0 0 rg BT 104.64 421.05 Td (include ) Tj ET Q q 0 0 0 rg BT 130.19 421.05 Td (royalties ) Tj ET Q q 0 0 0 rg BT 159.74 421.05 Td (and ) Tj ET Q q 0 0 0 rg BT 173.29 421.05 Td (alliance-related ) Tj ET Q q 0 0 0 rg BT 224.59 421.05 Td (revenues ) Tj ET Q q 0 0 0 rg BT 255.02 421.05 Td (for ) Tj ET Q q 0 0 0 rg BT 266.34 421.05 Td (products ) Tj ET Q q 0 0 0 rg BT 295.89 421.05 Td (not ) Tj ET Q q 0 0 0 rg BT 308.12 421.05 Td (sold ) Tj ET Q q 0 0 0 rg BT 323.45 421.05 Td (by ) Tj ET Q q 0 0 0 rg BT 333.45 421.05 Td (our ) Tj ET Q q 0 0 0 rg BT 346.12 421.05 Td (regional ) Tj ET Q q 0 0 0 rg BT 374.33 421.05 Td (commercial ) Tj ET Q q 0 0 0 rg BT 414.09 421.05 Td (or) Tj ET Q q 0 0 0 rg BT 420.61 421.05 Td (ganizations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 400.05 Td (Product revenues were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 363.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 363.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 363.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 363.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 363.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 363.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 363.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 337.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 337.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 337.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 337.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 337.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 337.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 337.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 311.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 311.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 311.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 311.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 311.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 311.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 311.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 285.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 285.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 285.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 285.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 285.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 285.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 285.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 259.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 259.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 259.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 259.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 259.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 259.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 259.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 233.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 233.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 233.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 233.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 233.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 233.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 233.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 207.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 207.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 207.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 207.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 207.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 207.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 207.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 181.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 181.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 181.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 181.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 181.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 181.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 181.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 155.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 155.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 155.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 155.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 155.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 155.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 155.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 129.55 303.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 339.50 129.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 343.50 129.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 418.50 129.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 422.50 129.55 75.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 129.55 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 129.55 75.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 376.54999999999995 m 418.5 376.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 418.5 376.54999999999995 m 422.5 376.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 422.5 376.54999999999995 m 497.5 376.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 376.54999999999995 m 501.5 376.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 376.54999999999995 m 576.5 376.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 363.54999999999995 m 418.5 363.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 422.5 363.54999999999995 m 497.5 363.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 363.54999999999995 m 576.5 363.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 129.54999999999995 m 576.5 129.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 129.54999999999995 m 418.5 129.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 117.54999999999995 m 418.5 117.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 343.5 115.54999999999995 m 418.5 115.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 422.5 129.54999999999995 m 497.5 129.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 422.5 117.54999999999995 m 497.5 117.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 422.5 115.54999999999995 m 497.5 115.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 129.54999999999995 m 576.5 129.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 117.54999999999995 m 576.5 117.54999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 115.54999999999995 m 576.5 115.54999999999995 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 380.80 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 415.20 380.78 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 367.80 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 372.50 367.78 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 451.50 367.78 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 530.50 367.78 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 354.28 Td (Oncology) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 341.11 Td (Empliciti \(elotuzumab\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 341.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.65 341.12 Td (150) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.00 341.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 341.12 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.00 341.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 341.12 Td (—) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 328.11 Td (Erbitux* \(cetuximab\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.65 328.12 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 328.12 Td (501) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 328.12 Td (723) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 315.11 Td (Opdivo \(nivolumab\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 315.12 Td (3,774) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 315.12 Td (942) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 315.12 Td (6) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 302.11 Td (Sprycel \(dasatinib\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 302.12 Td (1,824) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 302.12 Td (1,620) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 302.12 Td (1,493) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 289.11 Td (Yervoy \(ipilimumab\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 289.12 Td (1,053) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 289.12 Td (1,126) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 289.12 Td (1,308) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 276.28 Td (Cardiovascular) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 263.11 Td (Eliquis \(apixaban\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 263.12 Td (3,343) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 263.12 Td (1,860) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 263.12 Td (774) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 250.28 Td (Immunoscience) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 237.11 Td (Orencia \(abatacept\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 237.12 Td (2,265) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 237.12 Td (1,885) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 237.12 Td (1,652) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 224.28 Td (Virology) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 211.11 Td (Baraclude \(entecavir\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 211.12 Td (1,192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 211.12 Td (1,312) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 211.12 Td (1,441) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 198.12 Td (Hepatitis C Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 198.12 Td (1,578) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 198.12 Td (1,603) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 198.12 Td (256) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 185.11 Td (Reyataz \(atazanavir sulfate\) Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.65 185.12 Td (912) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 185.12 Td (1,139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 185.12 Td (1,362) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 172.11 Td (Sustiva \(efavirenz\) Franchise) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 172.12 Td (1,065) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 172.12 Td (1,252) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 172.12 Td (1,444) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 159.28 Td (Neuroscience) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 146.11 Td (Abilify* \(aripiprazole\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.65 146.12 Td (128) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 146.12 Td (746) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 146.12 Td (2,020) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 133.28 Td (Mature Products and All Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.15 133.12 Td (2,143) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.15 133.12 Td (2,571) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 133.12 Td (3,400) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 120.12 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.00 120.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.15 120.12 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.00 120.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 120.12 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.00 120.12 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 120.12 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 125 0 obj <> endobj 126 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (62) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The composition of total revenues was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 708.60 303.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 338.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 342.50 708.60 75.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 708.60 75.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 708.60 75.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 678.60 303.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 338.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 342.50 678.60 75.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 417.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 678.60 75.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 678.60 75.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 723.6 m 417.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 723.6 m 421.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 723.6 m 496.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 723.6 m 500.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 723.6 m 575.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 723.6 m 417.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 708.6 m 417.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 417.5 723.6 m 421.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 723.6 m 496.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 708.6 m 496.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 723.6 m 500.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 723.6 m 575.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 708.6 m 575.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 663.6 m 417.5 663.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 649.6 m 417.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 342.5 647.6 m 417.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 663.6 m 496.5 663.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 649.6 m 496.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 421.5 647.6 m 496.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 663.6 m 575.5 663.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 649.6 m 575.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 500.5 647.6 m 575.5 647.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 727.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 414.20 727.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 712.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 371.50 712.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 450.50 712.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 529.50 712.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 698.27 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 345.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.15 698.27 Td (17,702) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 698.27 Td (14,045) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 698.27 Td (11,660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 683.27 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.15 683.27 Td (1,629) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.15 683.27 Td (2,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 683.27 Td (3,828) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 668.27 Td (Other revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.65 668.27 Td (96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 668.27 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 668.27 Td (391) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 654.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 345.00 653.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.15 653.27 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.00 653.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 653.27 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.00 653.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.15 653.27 Td (15,879) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 623.10 Td (3) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 623.10 Td (. ) Tj ET Q q 0 0 0 rg BT 67.94 623.10 Td (ALLIANCES) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 599.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.33 599.10 Td (enters ) Tj ET Q q 0 0 0 rg BT 85.42 599.10 Td (into ) Tj ET Q q 0 0 0 rg BT 103.19 599.10 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 158.16 599.10 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 214.23 599.10 Td (with ) Tj ET Q q 0 0 0 rg BT 234.22 599.10 Td (third ) Tj ET Q q 0 0 0 rg BT 255.32 599.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 284.19 599.10 Td (for ) Tj ET Q q 0 0 0 rg BT 298.06 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 312.48 599.10 Td (development ) Tj ET Q q 0 0 0 rg BT 366.35 599.10 Td (and ) Tj ET Q q 0 0 0 rg BT 383.00 599.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 459.62 599.10 Td (of ) Tj ET Q q 0 0 0 rg BT 470.16 599.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 499.57 599.10 Td (products. ) Tj ET Q q 0 0 0 rg BT 538.23 599.10 Td (Although ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 587.10 Td (each ) Tj ET Q q 0 0 0 rg BT 57.37 587.10 Td (of ) Tj ET Q q 0 0 0 rg BT 68.75 587.10 Td (these ) Tj ET Q q 0 0 0 rg BT 92.35 587.10 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 149.26 587.10 Td (is ) Tj ET Q q 0 0 0 rg BT 158.98 587.10 Td (unique ) Tj ET Q q 0 0 0 rg BT 189.25 587.10 Td (in ) Tj ET Q q 0 0 0 rg BT 200.08 587.10 Td (nature, ) Tj ET Q q 0 0 0 rg BT 230.62 587.10 Td (both ) Tj ET Q q 0 0 0 rg BT 251.45 587.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 281.16 587.10 Td (are ) Tj ET Q q 0 0 0 rg BT 296.42 587.10 Td (active ) Tj ET Q q 0 0 0 rg BT 323.34 587.10 Td (participants ) Tj ET Q q 0 0 0 rg BT 373.04 587.10 Td (in ) Tj ET Q q 0 0 0 rg BT 383.87 587.10 Td (the ) Tj ET Q q 0 0 0 rg BT 399.14 587.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 439.96 587.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 479.11 587.10 Td (of ) Tj ET Q q 0 0 0 rg BT 490.49 587.10 Td (the ) Tj ET Q q 0 0 0 rg BT 505.76 587.10 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 561.57 587.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 575.10 Td (exposed ) Tj ET Q q 0 0 0 rg BT 71.42 575.10 Td (to ) Tj ET Q q 0 0 0 rg BT 81.84 575.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 126.70 575.10 Td (risks ) Tj ET Q q 0 0 0 rg BT 148.24 575.10 Td (and ) Tj ET Q q 0 0 0 rg BT 165.33 575.10 Td (rewards ) Tj ET Q q 0 0 0 rg BT 199.63 575.10 Td (depending ) Tj ET Q q 0 0 0 rg BT 243.93 575.10 Td (on ) Tj ET Q q 0 0 0 rg BT 256.58 575.10 Td (the ) Tj ET Q q 0 0 0 rg BT 271.44 575.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 321.29 575.10 Td (success ) Tj ET Q q 0 0 0 rg BT 353.93 575.10 Td (of ) Tj ET Q q 0 0 0 rg BT 364.90 575.10 Td (the ) Tj ET Q q 0 0 0 rg BT 379.77 575.10 Td (activities. ) Tj ET Q q 0 0 0 rg BT 421.02 575.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 444.79 575.10 Td (may ) Tj ET Q q 0 0 0 rg BT 464.65 575.10 Td (either ) Tj ET Q q 0 0 0 rg BT 490.06 575.10 Td (in-license ) Tj ET Q q 0 0 0 rg BT 531.58 575.10 Td (intellectual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 563.10 Td (property ) Tj ET Q q 0 0 0 rg BT 72.78 563.10 Td (owned ) Tj ET Q q 0 0 0 rg BT 102.35 563.10 Td (by ) Tj ET Q q 0 0 0 rg BT 115.25 563.10 Td (the ) Tj ET Q q 0 0 0 rg BT 130.38 563.10 Td (other ) Tj ET Q q 0 0 0 rg BT 153.83 563.10 Td (party ) Tj ET Q q 0 0 0 rg BT 177.28 563.10 Td (or ) Tj ET Q q 0 0 0 rg BT 188.51 563.10 Td (out-license ) Tj ET Q q 0 0 0 rg BT 235.29 563.10 Td (its ) Tj ET Q q 0 0 0 rg BT 247.65 563.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 294.97 563.10 Td (property ) Tj ET Q q 0 0 0 rg BT 331.76 563.10 Td (to ) Tj ET Q q 0 0 0 rg BT 342.44 563.10 Td (the ) Tj ET Q q 0 0 0 rg BT 357.56 563.10 Td (other ) Tj ET Q q 0 0 0 rg BT 381.01 563.10 Td (party) Tj ET Q q 0 0 0 rg BT 400.91 563.10 Td (. ) Tj ET Q q 0 0 0 rg BT 406.11 563.10 Td (These ) Tj ET Q q 0 0 0 rg BT 432.89 563.10 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 489.66 563.10 Td (also ) Tj ET Q q 0 0 0 rg BT 508.67 563.10 Td (typically ) Tj ET Q q 0 0 0 rg BT 546.57 563.10 Td (include ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 551.10 Td (research, ) Tj ET Q q 0 0 0 rg BT 75.02 551.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 132.38 551.10 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 196.40 551.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 225.15 551.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 275.56 551.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 314.87 551.10 Td (and ) Tj ET Q q 0 0 0 rg BT 332.51 551.10 Td (can ) Tj ET Q q 0 0 0 rg BT 349.60 551.10 Td (cover ) Tj ET Q q 0 0 0 rg BT 375.02 551.10 Td (a ) Tj ET Q q 0 0 0 rg BT 382.67 551.10 Td (single ) Tj ET Q q 0 0 0 rg BT 409.76 551.10 Td (investigational ) Tj ET Q q 0 0 0 rg BT 471.85 551.10 Td (compound ) Tj ET Q q 0 0 0 rg BT 517.27 551.10 Td (or ) Tj ET Q q 0 0 0 rg BT 528.81 551.10 Td (commercial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.10 Td (product ) Tj ET Q q 0 0 0 rg BT 69.51 539.10 Td (or ) Tj ET Q q 0 0 0 rg BT 80.81 539.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 117.11 539.10 Td (compounds ) Tj ET Q q 0 0 0 rg BT 166.18 539.10 Td (and/or ) Tj ET Q q 0 0 0 rg BT 194.69 539.10 Td (products ) Tj ET Q q 0 0 0 rg BT 232.10 539.10 Td (in ) Tj ET Q q 0 0 0 rg BT 242.84 539.10 Td (various ) Tj ET Q q 0 0 0 rg BT 275.25 539.10 Td (life ) Tj ET Q q 0 0 0 rg BT 291.54 539.10 Td (cycle ) Tj ET Q q 0 0 0 rg BT 315.60 539.10 Td (stages. ) Tj ET Q q 0 0 0 rg BT 345.29 539.10 Td (The ) Tj ET Q q 0 0 0 rg BT 363.80 539.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 389.55 539.10 Td (and ) Tj ET Q q 0 0 0 rg BT 406.95 539.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 454.36 539.10 Td (of ) Tj ET Q q 0 0 0 rg BT 465.66 539.10 Td (the ) Tj ET Q q 0 0 0 rg BT 480.84 539.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 510.46 539.10 Td (can ) Tj ET Q q 0 0 0 rg BT 527.31 539.10 Td (be ) Tj ET Q q 0 0 0 rg BT 539.71 539.10 Td (global ) Tj ET Q q 0 0 0 rg BT 567.67 539.10 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 527.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 67.00 527.10 Td (to ) Tj ET Q q 0 0 0 rg BT 77.44 527.10 Td (geographic ) Tj ET Q q 0 0 0 rg BT 124.53 527.10 Td (regions. ) Tj ET Q q 0 0 0 rg BT 158.94 527.10 Td (W) Tj ET Q q 0 0 0 rg BT 167.58 527.10 Td (e ) Tj ET Q q 0 0 0 rg BT 174.68 527.10 Td (refer ) Tj ET Q q 0 0 0 rg BT 196.22 527.10 Td (to ) Tj ET Q q 0 0 0 rg BT 206.66 527.10 Td (these ) Tj ET Q q 0 0 0 rg BT 229.87 527.10 Td (collaborations ) Tj ET Q q 0 0 0 rg BT 289.19 527.10 Td (as ) Tj ET Q q 0 0 0 rg BT 300.19 527.10 Td (alliances ) Tj ET Q q 0 0 0 rg BT 337.83 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 354.94 527.10 Td (our ) Tj ET Q q 0 0 0 rg BT 370.93 527.10 Td (partners ) Tj ET Q q 0 0 0 rg BT 405.81 527.10 Td (as ) Tj ET Q q 0 0 0 rg BT 416.80 527.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 450.56 527.10 Td (partners. ) Tj ET Q q 0 0 0 rg BT 487.93 527.10 Td (Several ) Tj ET Q q 0 0 0 rg BT 520.58 527.10 Td (products ) Tj ET Q q 0 0 0 rg BT 557.69 527.10 Td (such ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 515.10 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 47.57 515.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 84.23 515.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 89.96 515.10 Td (Erbitux*, ) Tj ET Q q 0 0 0 rg BT 130.69 515.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 160.13 515.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 165.87 515.10 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 195.85 515.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 201.59 515.10 Td (Y) Tj ET Q q 0 0 0 rg BT 206.23 515.10 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.44 515.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 234.18 515.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.51 515.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 268.25 515.10 Td (Or) Tj ET Q q 0 0 0 rg BT 278.99 515.10 Td (encia, ) Tj ET Q q 0 0 0 rg BT 306.38 515.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.27 515.10 Td ( ) Tj ET Q q 0 0 0 rg BT 338.51 515.10 Td (\() Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 341.84 515.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.17 515.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 381.74 515.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 399.41 515.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.07 515.10 Td ( ) Tj ET Q q 0 0 0 rg BT 434.31 515.10 Td (as ) Tj ET Q q 0 0 0 rg BT 445.88 515.10 Td (well ) Tj ET Q q 0 0 0 rg BT 466.33 515.10 Td (as ) Tj ET Q q 0 0 0 rg BT 477.89 515.10 Td (products ) Tj ET Q q 0 0 0 rg BT 515.57 515.10 Td (comprising ) Tj ET Q q 0 0 0 rg BT 563.80 515.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 71.26 503.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 104.85 503.10 Td (discussed ) Tj ET Q q 0 0 0 rg BT 145.68 503.10 Td (below ) Tj ET Q q 0 0 0 rg BT 172.62 503.10 Td (and ) Tj ET Q q 0 0 0 rg BT 189.56 503.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 219.26 503.10 Td (mature ) Tj ET Q q 0 0 0 rg BT 249.53 503.10 Td (and ) Tj ET Q q 0 0 0 rg BT 266.46 503.10 Td (other ) Tj ET Q q 0 0 0 rg BT 289.51 503.10 Td (brands ) Tj ET Q q 0 0 0 rg BT 318.67 503.10 Td (were ) Tj ET Q q 0 0 0 rg BT 340.60 503.10 Td (included ) Tj ET Q q 0 0 0 rg BT 377.53 503.10 Td (in ) Tj ET Q q 0 0 0 rg BT 387.81 503.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 421.40 503.10 Td (arrangements.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 483.90 Td (Payments ) Tj ET Q q 0 0 0 rg BT 77.50 483.90 Td (between ) Tj ET Q q 0 0 0 rg BT 113.43 483.90 Td (alliance ) Tj ET Q q 0 0 0 rg BT 147.14 483.90 Td (partners ) Tj ET Q q 0 0 0 rg BT 181.96 483.90 Td (are ) Tj ET Q q 0 0 0 rg BT 196.78 483.90 Td (accounted ) Tj ET Q q 0 0 0 rg BT 239.93 483.90 Td (for ) Tj ET Q q 0 0 0 rg BT 254.20 483.90 Td (and ) Tj ET Q q 0 0 0 rg BT 271.25 483.90 Td (presented ) Tj ET Q q 0 0 0 rg BT 312.18 483.90 Td (in ) Tj ET Q q 0 0 0 rg BT 322.58 483.90 Td (the ) Tj ET Q q 0 0 0 rg BT 337.41 483.90 Td (results ) Tj ET Q q 0 0 0 rg BT 366.13 483.90 Td (of ) Tj ET Q q 0 0 0 rg BT 377.08 483.90 Td (operations ) Tj ET Q q 0 0 0 rg BT 421.35 483.90 Td (after ) Tj ET Q q 0 0 0 rg BT 442.28 483.90 Td (considering ) Tj ET Q q 0 0 0 rg BT 491.55 483.90 Td (the ) Tj ET Q q 0 0 0 rg BT 506.38 483.90 Td (specific ) Tj ET Q q 0 0 0 rg BT 540.09 483.90 Td (nature ) Tj ET Q q 0 0 0 rg BT 567.69 483.90 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 471.90 Td (the ) Tj ET Q q 0 0 0 rg BT 50.81 471.90 Td (payment ) Tj ET Q q 0 0 0 rg BT 87.84 471.90 Td (and ) Tj ET Q q 0 0 0 rg BT 104.88 471.90 Td (the ) Tj ET Q q 0 0 0 rg BT 119.69 471.90 Td (underlying ) Tj ET Q q 0 0 0 rg BT 165.61 471.90 Td (activities ) Tj ET Q q 0 0 0 rg BT 204.31 471.90 Td (to ) Tj ET Q q 0 0 0 rg BT 214.68 471.90 Td (which ) Tj ET Q q 0 0 0 rg BT 241.72 471.90 Td (the ) Tj ET Q q 0 0 0 rg BT 256.53 471.90 Td (payments ) Tj ET Q q 0 0 0 rg BT 297.46 471.90 Td (relate. ) Tj ET Q q 0 0 0 rg BT 324.75 471.90 Td (Multiple ) Tj ET Q q 0 0 0 rg BT 361.79 471.90 Td (alliance ) Tj ET Q q 0 0 0 rg BT 395.48 471.90 Td (activities, ) Tj ET Q q 0 0 0 rg BT 436.67 471.90 Td (including ) Tj ET Q q 0 0 0 rg BT 477.04 471.90 Td (the ) Tj ET Q q 0 0 0 rg BT 491.86 471.90 Td (transfer ) Tj ET Q q 0 0 0 rg BT 524.99 471.90 Td (of ) Tj ET Q q 0 0 0 rg BT 535.92 471.90 Td (rights, ) Tj ET Q q 0 0 0 rg BT 563.79 471.90 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 459.90 Td (only ) Tj ET Q q 0 0 0 rg BT 57.25 459.90 Td (separated ) Tj ET Q q 0 0 0 rg BT 98.48 459.90 Td (into ) Tj ET Q q 0 0 0 rg BT 117.51 459.90 Td (individual ) Tj ET Q q 0 0 0 rg BT 161.54 459.90 Td (units ) Tj ET Q q 0 0 0 rg BT 184.46 459.90 Td (of ) Tj ET Q q 0 0 0 rg BT 196.26 459.90 Td (accounting ) Tj ET Q q 0 0 0 rg BT 243.61 459.90 Td (if ) Tj ET Q q 0 0 0 rg BT 253.19 459.90 Td (they ) Tj ET Q q 0 0 0 rg BT 273.88 459.90 Td (have ) Tj ET Q q 0 0 0 rg BT 296.23 459.90 Td (standalone ) Tj ET Q q 0 0 0 rg BT 342.47 459.90 Td (value ) Tj ET Q q 0 0 0 rg BT 367.60 459.90 Td (from ) Tj ET Q q 0 0 0 rg BT 390.51 459.90 Td (other ) Tj ET Q q 0 0 0 rg BT 414.54 459.90 Td (activities ) Tj ET Q q 0 0 0 rg BT 454.11 459.90 Td (that ) Tj ET Q q 0 0 0 rg BT 472.58 459.90 Td (occur ) Tj ET Q q 0 0 0 rg BT 498.26 459.90 Td (over ) Tj ET Q q 0 0 0 rg BT 519.50 459.90 Td (the ) Tj ET Q q 0 0 0 rg BT 535.19 459.90 Td (life ) Tj ET Q q 0 0 0 rg BT 551.99 459.90 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 459.90 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 447.90 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 94.75 447.90 Td (In ) Tj ET Q q 0 0 0 rg BT 105.46 447.90 Td (these ) Tj ET Q q 0 0 0 rg BT 128.39 447.90 Td (situations, ) Tj ET Q q 0 0 0 rg BT 171.61 447.90 Td (the ) Tj ET Q q 0 0 0 rg BT 186.21 447.90 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 238.57 447.90 Td (consideration ) Tj ET Q q 0 0 0 rg BT 294.82 447.90 Td (is ) Tj ET Q q 0 0 0 rg BT 303.88 447.90 Td (allocated ) Tj ET Q q 0 0 0 rg BT 342.35 447.90 Td (to ) Tj ET Q q 0 0 0 rg BT 352.51 447.90 Td (the ) Tj ET Q q 0 0 0 rg BT 367.11 447.90 Td (activities ) Tj ET Q q 0 0 0 rg BT 405.60 447.90 Td (or ) Tj ET Q q 0 0 0 rg BT 416.31 447.90 Td (rights ) Tj ET Q q 0 0 0 rg BT 441.47 447.90 Td (on ) Tj ET Q q 0 0 0 rg BT 453.86 447.90 Td (a ) Tj ET Q q 0 0 0 rg BT 460.68 447.90 Td (relative ) Tj ET Q q 0 0 0 rg BT 493.05 447.90 Td (selling ) Tj ET Q q 0 0 0 rg BT 522.10 447.90 Td (price ) Tj ET Q q 0 0 0 rg BT 544.47 447.90 Td (basis. ) Tj ET Q q 0 0 0 rg BT 569.35 447.90 Td (If ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 435.90 Td (multiple ) Tj ET Q q 0 0 0 rg BT 71.83 435.90 Td (alliance ) Tj ET Q q 0 0 0 rg BT 105.42 435.90 Td (activities ) Tj ET Q q 0 0 0 rg BT 144.02 435.90 Td (or ) Tj ET Q q 0 0 0 rg BT 154.85 435.90 Td (rights ) Tj ET Q q 0 0 0 rg BT 180.13 435.90 Td (do ) Tj ET Q q 0 0 0 rg BT 192.63 435.90 Td (not ) Tj ET Q q 0 0 0 rg BT 207.90 435.90 Td (have ) Tj ET Q q 0 0 0 rg BT 229.28 435.90 Td (standalone ) Tj ET Q q 0 0 0 rg BT 274.54 435.90 Td (value, ) Tj ET Q q 0 0 0 rg BT 301.20 435.90 Td (they ) Tj ET Q q 0 0 0 rg BT 320.92 435.90 Td (are ) Tj ET Q q 0 0 0 rg BT 335.62 435.90 Td (combined ) Tj ET Q q 0 0 0 rg BT 377.56 435.90 Td (into ) Tj ET Q q 0 0 0 rg BT 395.61 435.90 Td (a ) Tj ET Q q 0 0 0 rg BT 402.55 435.90 Td (single ) Tj ET Q q 0 0 0 rg BT 428.94 435.90 Td (unit ) Tj ET Q q 0 0 0 rg BT 447.00 435.90 Td (of ) Tj ET Q q 0 0 0 rg BT 457.83 435.90 Td (accounting.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 411.90 Td (The most common activities between BMS and its alliance partners are presented in results of operations as follows:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 392.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 392.70 Td (When ) Tj ET Q q 0 0 0 rg BT 98.94 392.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 123.12 392.70 Td (is ) Tj ET Q q 0 0 0 rg BT 132.84 392.70 Td (the ) Tj ET Q q 0 0 0 rg BT 148.12 392.70 Td (principal ) Tj ET Q q 0 0 0 rg BT 186.72 392.70 Td (in ) Tj ET Q q 0 0 0 rg BT 197.56 392.70 Td (the ) Tj ET Q q 0 0 0 rg BT 212.83 392.70 Td (end ) Tj ET Q q 0 0 0 rg BT 230.33 392.70 Td (customer ) Tj ET Q q 0 0 0 rg BT 270.04 392.70 Td (sale, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 291.15 392.70 Td (100%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.48 392.70 Td ( ) Tj ET Q q 0 0 0 rg BT 317.53 392.70 Td (of ) Tj ET Q q 0 0 0 rg BT 328.92 392.70 Td (product ) Tj ET Q q 0 0 0 rg BT 362.53 392.70 Td (sales ) Tj ET Q q 0 0 0 rg BT 385.02 392.70 Td (are ) Tj ET Q q 0 0 0 rg BT 400.29 392.70 Td (included ) Tj ET Q q 0 0 0 rg BT 437.78 392.70 Td (in ) Tj ET Q q 0 0 0 rg BT 448.62 392.70 Td (net ) Tj ET Q q 0 0 0 rg BT 463.89 392.70 Td (product ) Tj ET Q q 0 0 0 rg BT 497.50 392.70 Td (sales. ) Tj ET Q q 0 0 0 rg BT 522.27 392.70 Td (When ) Tj ET Q q 0 0 0 rg BT 549.21 392.70 Td (BMS's ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 380.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 105.33 380.70 Td (partner ) Tj ET Q q 0 0 0 rg BT 135.89 380.70 Td (is ) Tj ET Q q 0 0 0 rg BT 144.81 380.70 Td (the ) Tj ET Q q 0 0 0 rg BT 159.27 380.70 Td (principal ) Tj ET Q q 0 0 0 rg BT 197.06 380.70 Td (in ) Tj ET Q q 0 0 0 rg BT 207.08 380.70 Td (the ) Tj ET Q q 0 0 0 rg BT 221.54 380.70 Td (end ) Tj ET Q q 0 0 0 rg BT 238.23 380.70 Td (customer ) Tj ET Q q 0 0 0 rg BT 277.13 380.70 Td (sale, ) Tj ET Q q 0 0 0 rg BT 297.42 380.70 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 326.48 380.70 Td (contractual ) Tj ET Q q 0 0 0 rg BT 373.15 380.70 Td (share ) Tj ET Q q 0 0 0 rg BT 396.49 380.70 Td (of ) Tj ET Q q 0 0 0 rg BT 407.06 380.70 Td (the ) Tj ET Q q 0 0 0 rg BT 421.53 380.70 Td (third-party ) Tj ET Q q 0 0 0 rg BT 466.54 380.70 Td (sales ) Tj ET Q q 0 0 0 rg BT 488.22 380.70 Td (and/or ) Tj ET Q q 0 0 0 rg BT 516.01 380.70 Td (royalty ) Tj ET Q q 0 0 0 rg BT 546.58 380.70 Td (income ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 368.70 Td (are ) Tj ET Q q 0 0 0 rg BT 87.52 368.70 Td (included ) Tj ET Q q 0 0 0 rg BT 125.27 368.70 Td (in ) Tj ET Q q 0 0 0 rg BT 136.36 368.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 170.76 368.70 Td (revenue ) Tj ET Q q 0 0 0 rg BT 205.72 368.70 Td (as ) Tj ET Q q 0 0 0 rg BT 217.36 368.70 Td (the ) Tj ET Q q 0 0 0 rg BT 232.89 368.70 Td (sale ) Tj ET Q q 0 0 0 rg BT 251.75 368.70 Td (of ) Tj ET Q q 0 0 0 rg BT 263.39 368.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 313.90 368.70 Td (products ) Tj ET Q q 0 0 0 rg BT 351.66 368.70 Td (are ) Tj ET Q q 0 0 0 rg BT 367.18 368.70 Td (considered ) Tj ET Q q 0 0 0 rg BT 413.80 368.70 Td (part ) Tj ET Q q 0 0 0 rg BT 432.66 368.70 Td (of ) Tj ET Q q 0 0 0 rg BT 444.31 368.70 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 474.44 368.70 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 510.53 368.70 Td (major ) Tj ET Q q 0 0 0 rg BT 537.17 368.70 Td (or ) Tj ET Q q 0 0 0 rg BT 548.81 368.70 Td (central ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 356.70 Td (operations. ) Tj ET Q q 0 0 0 rg BT 118.29 356.70 Td (Refer ) Tj ET Q q 0 0 0 rg BT 142.64 356.70 Td (to ) Tj ET Q q 0 0 0 rg BT 152.56 356.70 Td ("Revenue ) Tj ET Q q 0 0 0 rg BT 193.76 356.70 Td (Recognition" ) Tj ET Q q 0 0 0 rg BT 248.87 356.70 Td (included ) Tj ET Q q 0 0 0 rg BT 285.44 356.70 Td (in ) Tj ET Q q 0 0 0 rg BT 295.35 356.70 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.01 356.70 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 336.01 356.70 Td (. ) Tj ET Q q 0 0 0 rg BT 340.18 356.70 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 388.97 356.70 Td (Policies" ) Tj ET Q q 0 0 0 rg BT 426.86 356.70 Td (for ) Tj ET Q q 0 0 0 rg BT 440.66 356.70 Td (information ) Tj ET Q q 0 0 0 rg BT 490.01 356.70 Td (regarding ) Tj ET Q q 0 0 0 rg BT 530.46 356.70 Td (recognition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 344.70 Td (criteria.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 329.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 329.70 Td (Amounts ) Tj ET Q q 0 0 0 rg BT 110.43 329.70 Td (payable ) Tj ET Q q 0 0 0 rg BT 143.29 329.70 Td (to ) Tj ET Q q 0 0 0 rg BT 152.83 329.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 175.72 329.70 Td (by ) Tj ET Q q 0 0 0 rg BT 187.48 329.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 220.33 329.70 Td (partners ) Tj ET Q q 0 0 0 rg BT 254.30 329.70 Td (\(who ) Tj ET Q q 0 0 0 rg BT 276.61 329.70 Td (are ) Tj ET Q q 0 0 0 rg BT 290.58 329.70 Td (the ) Tj ET Q q 0 0 0 rg BT 304.56 329.70 Td (principal ) Tj ET Q q 0 0 0 rg BT 341.87 329.70 Td (in ) Tj ET Q q 0 0 0 rg BT 351.41 329.70 Td (the ) Tj ET Q q 0 0 0 rg BT 365.39 329.70 Td (end ) Tj ET Q q 0 0 0 rg BT 381.59 329.70 Td (customer ) Tj ET Q q 0 0 0 rg BT 420.01 329.70 Td (sale\) ) Tj ET Q q 0 0 0 rg BT 440.65 329.70 Td (for ) Tj ET Q q 0 0 0 rg BT 454.07 329.70 Td (supply ) Tj ET Q q 0 0 0 rg BT 482.50 329.70 Td (of ) Tj ET Q q 0 0 0 rg BT 492.60 329.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 541.56 329.70 Td (products ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 317.70 Td (are ) Tj ET Q q 0 0 0 rg BT 87.52 317.70 Td (included ) Tj ET Q q 0 0 0 rg BT 125.27 317.70 Td (in ) Tj ET Q q 0 0 0 rg BT 136.36 317.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 170.76 317.70 Td (revenue ) Tj ET Q q 0 0 0 rg BT 205.72 317.70 Td (as ) Tj ET Q q 0 0 0 rg BT 217.36 317.70 Td (the ) Tj ET Q q 0 0 0 rg BT 232.89 317.70 Td (sale ) Tj ET Q q 0 0 0 rg BT 251.75 317.70 Td (of ) Tj ET Q q 0 0 0 rg BT 263.39 317.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 313.90 317.70 Td (products ) Tj ET Q q 0 0 0 rg BT 351.66 317.70 Td (are ) Tj ET Q q 0 0 0 rg BT 367.18 317.70 Td (considered ) Tj ET Q q 0 0 0 rg BT 413.80 317.70 Td (part ) Tj ET Q q 0 0 0 rg BT 432.66 317.70 Td (of ) Tj ET Q q 0 0 0 rg BT 444.31 317.70 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 474.44 317.70 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 510.53 317.70 Td (major ) Tj ET Q q 0 0 0 rg BT 537.17 317.70 Td (or ) Tj ET Q q 0 0 0 rg BT 548.81 317.70 Td (central ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 305.70 Td (operations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 290.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 290.70 Td (Profit ) Tj ET Q q 0 0 0 rg BT 97.11 290.70 Td (sharing, ) Tj ET Q q 0 0 0 rg BT 131.38 290.70 Td (royalties ) Tj ET Q q 0 0 0 rg BT 168.15 290.70 Td (and ) Tj ET Q q 0 0 0 rg BT 184.92 290.70 Td (other ) Tj ET Q q 0 0 0 rg BT 207.80 290.70 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 255.67 290.70 Td (fees ) Tj ET Q q 0 0 0 rg BT 274.10 290.70 Td (payable ) Tj ET Q q 0 0 0 rg BT 307.53 290.70 Td (by ) Tj ET Q q 0 0 0 rg BT 319.86 290.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 343.32 290.70 Td (to ) Tj ET Q q 0 0 0 rg BT 353.43 290.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 386.85 290.70 Td (partners ) Tj ET Q q 0 0 0 rg BT 421.39 290.70 Td (are ) Tj ET Q q 0 0 0 rg BT 435.93 290.70 Td (included ) Tj ET Q q 0 0 0 rg BT 472.70 290.70 Td (in ) Tj ET Q q 0 0 0 rg BT 482.81 290.70 Td (cost ) Tj ET Q q 0 0 0 rg BT 501.25 290.70 Td (of ) Tj ET Q q 0 0 0 rg BT 511.91 290.70 Td (products ) Tj ET Q q 0 0 0 rg BT 548.69 290.70 Td (sold ) Tj ET Q q 0 0 0 rg BT 567.69 290.70 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 278.70 Td (incurred.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 263.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 263.70 Td (Cost ) Tj ET Q q 0 0 0 rg BT 93.12 263.70 Td (reimbursements ) Tj ET Q q 0 0 0 rg BT 159.77 263.70 Td (between ) Tj ET Q q 0 0 0 rg BT 195.86 263.70 Td (the ) Tj ET Q q 0 0 0 rg BT 210.85 263.70 Td (parties ) Tj ET Q q 0 0 0 rg BT 240.29 263.70 Td (are ) Tj ET Q q 0 0 0 rg BT 255.27 263.70 Td (recognized ) Tj ET Q q 0 0 0 rg BT 301.91 263.70 Td (as ) Tj ET Q q 0 0 0 rg BT 313.02 263.70 Td (incurred ) Tj ET Q q 0 0 0 rg BT 349.11 263.70 Td (and ) Tj ET Q q 0 0 0 rg BT 366.33 263.70 Td (included ) Tj ET Q q 0 0 0 rg BT 403.54 263.70 Td (in ) Tj ET Q q 0 0 0 rg BT 414.09 263.70 Td (cost ) Tj ET Q q 0 0 0 rg BT 432.98 263.70 Td (of ) Tj ET Q q 0 0 0 rg BT 444.09 263.70 Td (products ) Tj ET Q q 0 0 0 rg BT 481.30 263.70 Td (sold; ) Tj ET Q q 0 0 0 rg BT 503.53 263.70 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 549.35 263.70 Td (selling ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 251.70 Td (and ) Tj ET Q q 0 0 0 rg BT 89.56 251.70 Td (administrative ) Tj ET Q q 0 0 0 rg BT 149.90 251.70 Td (expenses; ) Tj ET Q q 0 0 0 rg BT 191.90 251.70 Td (or ) Tj ET Q q 0 0 0 rg BT 203.36 251.70 Td (research ) Tj ET Q q 0 0 0 rg BT 239.79 251.70 Td (and ) Tj ET Q q 0 0 0 rg BT 257.36 251.70 Td (development ) Tj ET Q q 0 0 0 rg BT 312.13 251.70 Td (expenses, ) Tj ET Q q 0 0 0 rg BT 353.86 251.70 Td (based ) Tj ET Q q 0 0 0 rg BT 379.75 251.70 Td (on ) Tj ET Q q 0 0 0 rg BT 392.88 251.70 Td (the ) Tj ET Q q 0 0 0 rg BT 408.22 251.70 Td (underlying ) Tj ET Q q 0 0 0 rg BT 454.67 251.70 Td (nature ) Tj ET Q q 0 0 0 rg BT 482.79 251.70 Td (of ) Tj ET Q q 0 0 0 rg BT 494.24 251.70 Td (the ) Tj ET Q q 0 0 0 rg BT 509.59 251.70 Td (related ) Tj ET Q q 0 0 0 rg BT 539.91 251.70 Td (activities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 239.70 Td (subject ) Tj ET Q q 0 0 0 rg BT 102.83 239.70 Td (to ) Tj ET Q q 0 0 0 rg BT 113.10 239.70 Td (reimbursement.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 224.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 224.70 Td (Upfront ) Tj ET Q q 0 0 0 rg BT 105.12 224.70 Td (and ) Tj ET Q q 0 0 0 rg BT 121.02 224.70 Td (contingent ) Tj ET Q q 0 0 0 rg BT 164.69 224.70 Td (development ) Tj ET Q q 0 0 0 rg BT 217.81 224.70 Td (and ) Tj ET Q q 0 0 0 rg BT 233.71 224.70 Td (approval ) Tj ET Q q 0 0 0 rg BT 270.15 224.70 Td (milestones ) Tj ET Q q 0 0 0 rg BT 314.39 224.70 Td (payable ) Tj ET Q q 0 0 0 rg BT 346.94 224.70 Td (to ) Tj ET Q q 0 0 0 rg BT 356.18 224.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 378.77 224.70 Td (by ) Tj ET Q q 0 0 0 rg BT 390.23 224.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 422.78 224.70 Td (partners ) Tj ET Q q 0 0 0 rg BT 456.45 224.70 Td (for ) Tj ET Q q 0 0 0 rg BT 469.57 224.70 Td (investigational ) Tj ET Q q 0 0 0 rg BT 529.91 224.70 Td (compounds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 212.70 Td (and ) Tj ET Q q 0 0 0 rg BT 88.71 212.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 138.17 212.70 Td (products ) Tj ET Q q 0 0 0 rg BT 174.88 212.70 Td (are ) Tj ET Q q 0 0 0 rg BT 189.35 212.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 224.92 212.70 Td (and ) Tj ET Q q 0 0 0 rg BT 241.63 212.70 Td (amortized ) Tj ET Q q 0 0 0 rg BT 283.88 212.70 Td (over ) Tj ET Q q 0 0 0 rg BT 303.91 212.70 Td (the ) Tj ET Q q 0 0 0 rg BT 318.40 212.70 Td (shorter ) Tj ET Q q 0 0 0 rg BT 348.43 212.70 Td (of ) Tj ET Q q 0 0 0 rg BT 359.03 212.70 Td (the ) Tj ET Q q 0 0 0 rg BT 373.51 212.70 Td (contractual ) Tj ET Q q 0 0 0 rg BT 420.20 212.70 Td (term ) Tj ET Q q 0 0 0 rg BT 440.79 212.70 Td (or ) Tj ET Q q 0 0 0 rg BT 451.39 212.70 Td (the ) Tj ET Q q 0 0 0 rg BT 465.87 212.70 Td (periods ) Tj ET Q q 0 0 0 rg BT 497.58 212.70 Td (in ) Tj ET Q q 0 0 0 rg BT 507.62 212.70 Td (which ) Tj ET Q q 0 0 0 rg BT 534.33 212.70 Td (the ) Tj ET Q q 0 0 0 rg BT 548.81 212.70 Td (related ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 200.70 Td (compounds ) Tj ET Q q 0 0 0 rg BT 120.28 200.70 Td (or ) Tj ET Q q 0 0 0 rg BT 130.78 200.70 Td (products ) Tj ET Q q 0 0 0 rg BT 167.39 200.70 Td (are ) Tj ET Q q 0 0 0 rg BT 181.76 200.70 Td (expected ) Tj ET Q q 0 0 0 rg BT 219.46 200.70 Td (to ) Tj ET Q q 0 0 0 rg BT 229.41 200.70 Td (contribute ) Tj ET Q q 0 0 0 rg BT 272.12 200.70 Td (to ) Tj ET Q q 0 0 0 rg BT 282.07 200.70 Td (future ) Tj ET Q q 0 0 0 rg BT 308.12 200.70 Td (cash ) Tj ET Q q 0 0 0 rg BT 328.05 200.70 Td (flows. ) Tj ET Q q 0 0 0 rg BT 354.79 200.70 Td (The ) Tj ET Q q 0 0 0 rg BT 372.50 200.70 Td (amortization ) Tj ET Q q 0 0 0 rg BT 425.21 200.70 Td (is ) Tj ET Q q 0 0 0 rg BT 434.05 200.70 Td (presented ) Tj ET Q q 0 0 0 rg BT 474.54 200.70 Td (consistent ) Tj ET Q q 0 0 0 rg BT 516.70 200.70 Td (with ) Tj ET Q q 0 0 0 rg BT 536.65 200.70 Td (the ) Tj ET Q q 0 0 0 rg BT 551.03 200.70 Td (nature ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 188.70 Td (of ) Tj ET Q q 0 0 0 rg BT 83.33 188.70 Td (the ) Tj ET Q q 0 0 0 rg BT 98.56 188.70 Td (payment ) Tj ET Q q 0 0 0 rg BT 135.99 188.70 Td (under ) Tj ET Q q 0 0 0 rg BT 161.77 188.70 Td (the ) Tj ET Q q 0 0 0 rg BT 176.99 188.70 Td (arrangement. ) Tj ET Q q 0 0 0 rg BT 232.46 188.70 Td (For ) Tj ET Q q 0 0 0 rg BT 249.36 188.70 Td (example, ) Tj ET Q q 0 0 0 rg BT 288.74 188.70 Td (amounts ) Tj ET Q q 0 0 0 rg BT 325.63 188.70 Td (received ) Tj ET Q q 0 0 0 rg BT 362.49 188.70 Td (for ) Tj ET Q q 0 0 0 rg BT 377.16 188.70 Td (investigational ) Tj ET Q q 0 0 0 rg BT 439.04 188.70 Td (compounds ) Tj ET Q q 0 0 0 rg BT 488.15 188.70 Td (are ) Tj ET Q q 0 0 0 rg BT 503.36 188.70 Td (presented ) Tj ET Q q 0 0 0 rg BT 544.68 188.70 Td (in ) Tj ET Q q 0 0 0 rg BT 555.47 188.70 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 176.70 Td (\(income\)/expense ) Tj ET Q q 0 0 0 rg BT 145.68 176.70 Td (as ) Tj ET Q q 0 0 0 rg BT 156.61 176.70 Td (the ) Tj ET Q q 0 0 0 rg BT 171.42 176.70 Td (activities ) Tj ET Q q 0 0 0 rg BT 210.12 176.70 Td (being ) Tj ET Q q 0 0 0 rg BT 234.94 176.70 Td (performed ) Tj ET Q q 0 0 0 rg BT 279.18 176.70 Td (at ) Tj ET Q q 0 0 0 rg BT 289.00 176.70 Td (that ) Tj ET Q q 0 0 0 rg BT 306.59 176.70 Td (time ) Tj ET Q q 0 0 0 rg BT 326.96 176.70 Td (are ) Tj ET Q q 0 0 0 rg BT 341.77 176.70 Td (not ) Tj ET Q q 0 0 0 rg BT 357.15 176.70 Td (related ) Tj ET Q q 0 0 0 rg BT 386.95 176.70 Td (to ) Tj ET Q q 0 0 0 rg BT 397.33 176.70 Td (the ) Tj ET Q q 0 0 0 rg BT 412.14 176.70 Td (sale ) Tj ET Q q 0 0 0 rg BT 430.29 176.70 Td (of ) Tj ET Q q 0 0 0 rg BT 441.22 176.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 491.01 176.70 Td (products ) Tj ET Q q 0 0 0 rg BT 528.05 176.70 Td (that ) Tj ET Q q 0 0 0 rg BT 545.65 176.70 Td (are ) Tj ET Q q 0 0 0 rg BT 560.45 176.70 Td (part ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 164.70 Td (of ) Tj ET Q q 0 0 0 rg BT 82.77 164.70 Td (BMS’) Tj ET Q q 0 0 0 rg BT 106.67 164.70 Td (s ) Tj ET Q q 0 0 0 rg BT 112.99 164.70 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 148.21 164.70 Td (major ) Tj ET Q q 0 0 0 rg BT 173.97 164.70 Td (or ) Tj ET Q q 0 0 0 rg BT 184.73 164.70 Td (central ) Tj ET Q q 0 0 0 rg BT 214.37 164.70 Td (operations; ) Tj ET Q q 0 0 0 rg BT 261.24 164.70 Td (amounts ) Tj ET Q q 0 0 0 rg BT 297.56 164.70 Td (received ) Tj ET Q q 0 0 0 rg BT 333.86 164.70 Td (for ) Tj ET Q q 0 0 0 rg BT 347.96 164.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 397.59 164.70 Td (products ) Tj ET Q q 0 0 0 rg BT 434.46 164.70 Td (are ) Tj ET Q q 0 0 0 rg BT 449.11 164.70 Td (presented ) Tj ET Q q 0 0 0 rg BT 489.86 164.70 Td (in ) Tj ET Q q 0 0 0 rg BT 500.07 164.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 533.60 164.70 Td (revenue ) Tj ET Q q 0 0 0 rg BT 567.68 164.70 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 152.70 Td (the ) Tj ET Q q 0 0 0 rg BT 86.58 152.70 Td (sale ) Tj ET Q q 0 0 0 rg BT 104.49 152.70 Td (of ) Tj ET Q q 0 0 0 rg BT 115.18 152.70 Td (commercial ) Tj ET Q q 0 0 0 rg BT 164.73 152.70 Td (products ) Tj ET Q q 0 0 0 rg BT 201.53 152.70 Td (are ) Tj ET Q q 0 0 0 rg BT 216.10 152.70 Td (considered ) Tj ET Q q 0 0 0 rg BT 261.78 152.70 Td (part ) Tj ET Q q 0 0 0 rg BT 279.69 152.70 Td (of ) Tj ET Q q 0 0 0 rg BT 290.38 152.70 Td (BMS’) Tj ET Q q 0 0 0 rg BT 314.28 152.70 Td (s ) Tj ET Q q 0 0 0 rg BT 320.53 152.70 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 355.67 152.70 Td (major ) Tj ET Q q 0 0 0 rg BT 381.36 152.70 Td (or ) Tj ET Q q 0 0 0 rg BT 392.05 152.70 Td (central ) Tj ET Q q 0 0 0 rg BT 421.61 152.70 Td (operations ) Tj ET Q q 0 0 0 rg BT 465.63 152.70 Td (\(except ) Tj ET Q q 0 0 0 rg BT 497.41 152.70 Td (for ) Tj ET Q q 0 0 0 rg BT 511.43 152.70 Td (the ) Tj ET Q q 0 0 0 rg BT 525.49 152.70 Td (AstraZeneca ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 140.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 105.59 140.70 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 148.63 140.70 Td (to ) Tj ET Q q 0 0 0 rg BT 158.91 140.70 Td (the ) Tj ET Q q 0 0 0 rg BT 173.07 140.70 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 206.13 140.70 Td (products ) Tj ET Q q 0 0 0 rg BT 243.07 140.70 Td (- ) Tj ET Q q 0 0 0 rg BT 248.90 140.70 Td (see ) Tj ET Q q 0 0 0 rg BT 264.17 140.70 Td (further ) Tj ET Q q 0 0 0 rg BT 293.88 140.70 Td (discussion ) Tj ET Q q 0 0 0 rg BT 338.04 140.70 Td (under ) Tj ET Q q 0 0 0 rg BT 363.31 140.70 Td (the ) Tj ET Q q 0 0 0 rg BT 378.03 140.70 Td (specific ) Tj ET Q q 0 0 0 rg BT 411.07 140.70 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 464.09 140.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 497.68 140.70 Td (disclosure ) Tj ET Q q 0 0 0 rg BT 540.73 140.70 Td (herein\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 124.20 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 124.20 Td (Upfront ) Tj ET Q q 0 0 0 rg BT 106.25 124.20 Td (and ) Tj ET Q q 0 0 0 rg BT 123.27 124.20 Td (contingent ) Tj ET Q q 0 0 0 rg BT 168.07 124.20 Td (approval ) Tj ET Q q 0 0 0 rg BT 205.65 124.20 Td (milestones ) Tj ET Q q 0 0 0 rg BT 251.01 124.20 Td (payable ) Tj ET Q q 0 0 0 rg BT 284.69 124.20 Td (by ) Tj ET Q q 0 0 0 rg BT 297.28 124.20 Td (BMS ) Tj ET Q q 0 0 0 rg BT 320.99 124.20 Td (to ) Tj ET Q q 0 0 0 rg BT 331.36 124.20 Td (alliance ) Tj ET Q q 0 0 0 rg BT 365.03 124.20 Td (partners ) Tj ET Q q 0 0 0 rg BT 399.83 124.20 Td (for ) Tj ET Q q 0 0 0 rg BT 414.08 124.20 Td (commercial ) Tj ET Q q 0 0 0 rg BT 463.86 124.20 Td (products ) Tj ET Q q 0 0 0 rg BT 500.89 124.20 Td (are ) Tj ET Q q 0 0 0 rg BT 515.68 124.20 Td (capitalized ) Tj ET Q q 0 0 0 rg BT 561.58 124.20 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 112.20 Td (amortized ) Tj ET Q q 0 0 0 rg BT 113.85 112.20 Td (over ) Tj ET Q q 0 0 0 rg BT 133.48 112.20 Td (the ) Tj ET Q q 0 0 0 rg BT 147.57 112.20 Td (shorter ) Tj ET Q q 0 0 0 rg BT 177.20 112.20 Td (of ) Tj ET Q q 0 0 0 rg BT 187.40 112.20 Td (the ) Tj ET Q q 0 0 0 rg BT 201.48 112.20 Td (contractual ) Tj ET Q q 0 0 0 rg BT 247.77 112.20 Td (term ) Tj ET Q q 0 0 0 rg BT 267.96 112.20 Td (or ) Tj ET Q q 0 0 0 rg BT 278.16 112.20 Td (the ) Tj ET Q q 0 0 0 rg BT 292.24 112.20 Td (periods ) Tj ET Q q 0 0 0 rg BT 323.54 112.20 Td (in ) Tj ET Q q 0 0 0 rg BT 333.19 112.20 Td (which ) Tj ET Q q 0 0 0 rg BT 359.49 112.20 Td (the ) Tj ET Q q 0 0 0 rg BT 373.58 112.20 Td (related ) Tj ET Q q 0 0 0 rg BT 402.65 112.20 Td (products ) Tj ET Q q 0 0 0 rg BT 438.95 112.20 Td (are ) Tj ET Q q 0 0 0 rg BT 453.03 112.20 Td (expected ) Tj ET Q q 0 0 0 rg BT 490.42 112.20 Td (to ) Tj ET Q q 0 0 0 rg BT 500.07 112.20 Td (contribute ) Tj ET Q q 0 0 0 rg BT 542.48 112.20 Td (to ) Tj ET Q q 0 0 0 rg BT 552.12 112.20 Td (future ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 100.20 Td (cash ) Tj ET Q q 0 0 0 rg BT 92.27 100.20 Td (flows. ) Tj ET Q q 0 0 0 rg BT 119.31 100.20 Td (The ) Tj ET Q q 0 0 0 rg BT 137.36 100.20 Td (amortization ) Tj ET Q q 0 0 0 rg BT 190.39 100.20 Td (is ) Tj ET Q q 0 0 0 rg BT 199.56 100.20 Td (included ) Tj ET Q q 0 0 0 rg BT 236.50 100.20 Td (in ) Tj ET Q q 0 0 0 rg BT 246.78 100.20 Td (cost ) Tj ET Q q 0 0 0 rg BT 265.38 100.20 Td (of ) Tj ET Q q 0 0 0 rg BT 276.21 100.20 Td (products ) Tj ET Q q 0 0 0 rg BT 313.15 100.20 Td (sold.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 83.70 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 83.70 Td (Upfront ) Tj ET Q q 0 0 0 rg BT 106.32 83.70 Td (and ) Tj ET Q q 0 0 0 rg BT 123.43 83.70 Td (contingent ) Tj ET Q q 0 0 0 rg BT 168.30 83.70 Td (milestones ) Tj ET Q q 0 0 0 rg BT 213.74 83.70 Td (payable ) Tj ET Q q 0 0 0 rg BT 247.50 83.70 Td (by ) Tj ET Q q 0 0 0 rg BT 260.16 83.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 283.95 83.70 Td (to ) Tj ET Q q 0 0 0 rg BT 294.39 83.70 Td (alliance ) Tj ET Q q 0 0 0 rg BT 328.14 83.70 Td (partners ) Tj ET Q q 0 0 0 rg BT 363.01 83.70 Td (prior ) Tj ET Q q 0 0 0 rg BT 385.11 83.70 Td (to ) Tj ET Q q 0 0 0 rg BT 395.55 83.70 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 439.31 83.70 Td (approval ) Tj ET Q q 0 0 0 rg BT 476.96 83.70 Td (are ) Tj ET Q q 0 0 0 rg BT 491.83 83.70 Td (expensed ) Tj ET Q q 0 0 0 rg BT 531.70 83.70 Td (as ) Tj ET Q q 0 0 0 rg BT 542.70 83.70 Td (incurred ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 71.70 Td (and ) Tj ET Q q 0 0 0 rg BT 88.94 71.70 Td (included ) Tj ET Q q 0 0 0 rg BT 125.87 71.70 Td (in ) Tj ET Q q 0 0 0 rg BT 136.15 71.70 Td (research ) Tj ET Q q 0 0 0 rg BT 171.96 71.70 Td (and ) Tj ET Q q 0 0 0 rg BT 188.89 71.70 Td (development ) Tj ET Q q 0 0 0 rg BT 243.04 71.70 Td (expenses.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 55.20 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 55.20 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 112.34 55.20 Td (and ) Tj ET Q q 0 0 0 rg BT 129.34 55.20 Td (other ) Tj ET Q q 0 0 0 rg BT 152.45 55.20 Td (contingent ) Tj ET Q q 0 0 0 rg BT 197.22 55.20 Td (consideration ) Tj ET Q q 0 0 0 rg BT 253.66 55.20 Td (payable ) Tj ET Q q 0 0 0 rg BT 287.32 55.20 Td (to ) Tj ET Q q 0 0 0 rg BT 297.66 55.20 Td (BMS ) Tj ET Q q 0 0 0 rg BT 321.35 55.20 Td (by ) Tj ET Q q 0 0 0 rg BT 333.91 55.20 Td (alliance ) Tj ET Q q 0 0 0 rg BT 367.56 55.20 Td (partners ) Tj ET Q q 0 0 0 rg BT 402.33 55.20 Td (related ) Tj ET Q q 0 0 0 rg BT 432.10 55.20 Td (to ) Tj ET Q q 0 0 0 rg BT 442.44 55.20 Td (the ) Tj ET Q q 0 0 0 rg BT 457.22 55.20 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 502.00 55.20 Td (of ) Tj ET Q q 0 0 0 rg BT 512.89 55.20 Td (such ) Tj ET Q q 0 0 0 rg BT 533.78 55.20 Td (businesses ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 43.20 Td (are ) Tj ET Q q 0 0 0 rg BT 86.71 43.20 Td (included ) Tj ET Q q 0 0 0 rg BT 123.64 43.20 Td (in ) Tj ET Q q 0 0 0 rg BT 133.92 43.20 Td (other ) Tj ET Q q 0 0 0 rg BT 156.97 43.20 Td (income ) Tj ET Q q 0 0 0 rg BT 188.90 43.20 Td (when ) Tj ET Q q 0 0 0 rg BT 213.06 43.20 Td (earned.) Tj ET Q endstream endobj 127 0 obj <> endobj 128 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (63) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 749.10 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 749.10 Td (Equity ) Tj ET Q q 0 0 0 rg BT 101.17 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 111.44 749.10 Td (net ) Tj ET Q q 0 0 0 rg BT 126.16 749.10 Td (income ) Tj ET Q q 0 0 0 rg BT 158.09 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 168.92 749.10 Td (af) Tj ET Q q 0 0 0 rg BT 176.51 749.10 Td (filiates ) Tj ET Q q 0 0 0 rg BT 206.22 749.10 Td (is ) Tj ET Q q 0 0 0 rg BT 215.39 749.10 Td (included ) Tj ET Q q 0 0 0 rg BT 252.33 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 262.61 749.10 Td (other ) Tj ET Q q 0 0 0 rg BT 285.65 749.10 Td (\(income\)/expense.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 732.60 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 732.60 Td (All ) Tj ET Q q 0 0 0 rg BT 87.22 732.60 Td (payments ) Tj ET Q q 0 0 0 rg BT 127.98 732.60 Td (between ) Tj ET Q q 0 0 0 rg BT 163.73 732.60 Td (BMS ) Tj ET Q q 0 0 0 rg BT 187.29 732.60 Td (and ) Tj ET Q q 0 0 0 rg BT 204.17 732.60 Td (its ) Tj ET Q q 0 0 0 rg BT 216.06 732.60 Td (alliance ) Tj ET Q q 0 0 0 rg BT 249.58 732.60 Td (partners ) Tj ET Q q 0 0 0 rg BT 284.23 732.60 Td (are ) Tj ET Q q 0 0 0 rg BT 298.87 732.60 Td (presented ) Tj ET Q q 0 0 0 rg BT 339.63 732.60 Td (in ) Tj ET Q q 0 0 0 rg BT 349.84 732.60 Td (cash ) Tj ET Q q 0 0 0 rg BT 370.05 732.60 Td (flows ) Tj ET Q q 0 0 0 rg BT 394.71 732.60 Td (from ) Tj ET Q q 0 0 0 rg BT 416.59 732.60 Td (operating ) Tj ET Q q 0 0 0 rg BT 456.79 732.60 Td (activities, ) Tj ET Q q 0 0 0 rg BT 497.82 732.60 Td (except ) Tj ET Q q 0 0 0 rg BT 526.36 732.60 Td (as ) Tj ET Q q 0 0 0 rg BT 537.12 732.60 Td (otherwise ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.00 720.60 Td (described ) Tj ET Q q 0 0 0 rg BT 112.82 720.60 Td (below) Tj ET Q q 0 0 0 rg BT 136.60 720.60 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 696.60 Td (Selected ) Tj ET Q q 0 0 0 rg BT 72.56 696.60 Td (financial ) Tj ET Q q 0 0 0 rg BT 110.23 696.60 Td (information ) Tj ET Q q 0 0 0 rg BT 160.13 696.60 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 203.35 696.60 Td (to ) Tj ET Q q 0 0 0 rg BT 213.82 696.60 Td (our ) Tj ET Q q 0 0 0 rg BT 229.84 696.60 Td (alliances ) Tj ET Q q 0 0 0 rg BT 267.50 696.60 Td (was ) Tj ET Q q 0 0 0 rg BT 285.74 696.60 Td (as ) Tj ET Q q 0 0 0 rg BT 296.76 696.60 Td (follows, ) Tj ET Q q 0 0 0 rg BT 331.95 696.60 Td (including ) Tj ET Q q 0 0 0 rg BT 372.41 696.60 Td (net ) Tj ET Q q 0 0 0 rg BT 387.31 696.60 Td (product ) Tj ET Q q 0 0 0 rg BT 420.55 696.60 Td (sales ) Tj ET Q q 0 0 0 rg BT 442.67 696.60 Td (when ) Tj ET Q q 0 0 0 rg BT 467.02 696.60 Td (BMS ) Tj ET Q q 0 0 0 rg BT 490.83 696.60 Td (is ) Tj ET Q q 0 0 0 rg BT 500.19 696.60 Td (the ) Tj ET Q q 0 0 0 rg BT 515.09 696.60 Td (principal ) Tj ET Q q 0 0 0 rg BT 553.32 696.60 Td (in ) Tj ET Q q 0 0 0 rg BT 563.78 696.60 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 684.60 Td (third-party ) Tj ET Q q 0 0 0 rg BT 81.48 684.60 Td (customer ) Tj ET Q q 0 0 0 rg BT 120.84 684.60 Td (sale ) Tj ET Q q 0 0 0 rg BT 139.10 684.60 Td (for ) Tj ET Q q 0 0 0 rg BT 153.48 684.60 Td (products ) Tj ET Q q 0 0 0 rg BT 190.63 684.60 Td (subject ) Tj ET Q q 0 0 0 rg BT 221.66 684.60 Td (to ) Tj ET Q q 0 0 0 rg BT 232.15 684.60 Td (the ) Tj ET Q q 0 0 0 rg BT 247.08 684.60 Td (alliance. ) Tj ET Q q 0 0 0 rg BT 283.39 684.60 Td (Expenses ) Tj ET Q q 0 0 0 rg BT 323.87 684.60 Td (summarized ) Tj ET Q q 0 0 0 rg BT 375.45 684.60 Td (below ) Tj ET Q q 0 0 0 rg BT 402.60 684.60 Td (do ) Tj ET Q q 0 0 0 rg BT 415.31 684.60 Td (not ) Tj ET Q q 0 0 0 rg BT 430.80 684.60 Td (include ) Tj ET Q q 0 0 0 rg BT 462.95 684.60 Td (all ) Tj ET Q q 0 0 0 rg BT 475.66 684.60 Td (amounts ) Tj ET Q q 0 0 0 rg BT 512.26 684.60 Td (attributed ) Tj ET Q q 0 0 0 rg BT 553.29 684.60 Td (to ) Tj ET Q q 0 0 0 rg BT 563.78 684.60 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 672.60 Td (activities ) Tj ET Q q 0 0 0 rg BT 74.34 672.60 Td (for ) Tj ET Q q 0 0 0 rg BT 88.25 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 102.71 672.60 Td (products ) Tj ET Q q 0 0 0 rg BT 139.39 672.60 Td (in ) Tj ET Q q 0 0 0 rg BT 149.42 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 163.88 672.60 Td (alliance, ) Tj ET Q q 0 0 0 rg BT 199.71 672.60 Td (but ) Tj ET Q q 0 0 0 rg BT 214.74 672.60 Td (only ) Tj ET Q q 0 0 0 rg BT 234.76 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 249.22 672.60 Td (payments ) Tj ET Q q 0 0 0 rg BT 289.79 672.60 Td (between ) Tj ET Q q 0 0 0 rg BT 325.35 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 339.82 672.60 Td (alliance ) Tj ET Q q 0 0 0 rg BT 373.15 672.60 Td (partners ) Tj ET Q q 0 0 0 rg BT 407.60 672.60 Td (or ) Tj ET Q q 0 0 0 rg BT 418.18 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 432.64 672.60 Td (related ) Tj ET Q q 0 0 0 rg BT 462.09 672.60 Td (amortization ) Tj ET Q q 0 0 0 rg BT 514.87 672.60 Td (if ) Tj ET Q q 0 0 0 rg BT 523.22 672.60 Td (the ) Tj ET Q q 0 0 0 rg BT 537.68 672.60 Td (payments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 660.60 Td (were ) Tj ET Q q 0 0 0 rg BT 57.93 660.60 Td (deferred ) Tj ET Q q 0 0 0 rg BT 93.73 660.60 Td (or ) Tj ET Q q 0 0 0 rg BT 104.56 660.60 Td (capitalized.) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 627.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 627.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 627.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 627.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 627.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 627.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 601.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 601.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 601.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 601.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 601.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 601.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 575.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 575.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 575.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 575.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 575.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 575.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 549.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 549.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 549.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 549.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 549.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 549.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 523.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 523.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 523.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 523.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 523.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 523.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 497.10 350.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 386.50 497.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 446.50 497.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 497.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 497.10 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 497.10 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 638.1 m 446.5 638.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 446.5 638.1 m 451.5 638.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 638.1 m 511.5 638.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 638.1 m 516.5 638.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 638.1 m 576.5 638.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 627.1 m 446.5 627.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 627.1 m 511.5 627.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 627.1 m 576.5 627.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 588.1 m 446.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 588.1 m 511.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 588.1 m 576.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 588.1 m 446.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 576.1 m 446.5 576.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 386.5 574.1 m 446.5 574.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 588.1 m 511.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 576.1 m 511.5 576.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 574.1 m 511.5 574.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 588.1 m 576.5 588.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 576.1 m 576.5 576.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 574.1 m 576.5 574.1 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 436.70 642.18 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 630.05 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 408.00 630.18 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 473.00 630.18 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 630.18 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 617.83 Td (Revenues from alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 604.67 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.00 604.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 604.67 Td (5,568) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 604.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 604.67 Td (4,308) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 604.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 604.67 Td (3,531) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 591.67 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 591.67 Td (1,629) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 591.67 Td (2,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 591.67 Td (3,828) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 578.67 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.00 578.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 578.67 Td (7,197) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 578.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 578.67 Td (6,716) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 578.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 578.67 Td (7,359) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 552.83 Td (Payments to/\(from\) alliance partners:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 539.67 Td (Cost of products sold) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.00 539.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.15 539.67 Td (2,129) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 539.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.15 539.67 Td (1,655) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 539.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 539.67 Td (1,394) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 526.67 Td (Marketing, selling and administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.30 526.72 Td (\(28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.65 526.67 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 526.67 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 526.67 Td (134) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 513.67 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.65 513.67 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 513.67 Td (693) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 513.67 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 500.67 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.80 500.72 Td (\(1,009) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.65 500.67 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.30 500.72 Td (\(733) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 500.67 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 500.67 Td (\(1,076) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 500.67 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 474.67 Td (Noncontrolling interest, pretax) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.65 474.67 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 474.67 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 474.67 Td (38) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 439.10 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 439.10 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 439.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 439.10 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 439.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 413.10 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 413.10 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 413.10 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 413.10 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 413.10 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 450.1 m 512.5 450.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 439.1 m 512.5 439.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 450.1 m 576.5 450.1 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 439.1 m 576.5 439.1 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 451.88 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 453.18 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 442.05 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 442.18 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 442.18 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 429.67 Td (Receivables ) Tj ET Q q 0 0 0 rg BT 89.81 429.67 Td (– ) Tj ET Q q 0 0 0 rg BT 97.31 429.67 Td (from ) Tj ET Q q 0 0 0 rg BT 119.25 429.67 Td (alliance ) Tj ET Q q 0 0 0 rg BT 152.84 429.67 Td (partners) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 429.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 429.67 Td (903) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 429.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 429.67 Td (958) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 416.67 Td (Accounts payable – to alliance partners) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 416.67 Td (555) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 416.67 Td (542) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 403.67 Td (Deferred income from alliances) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 165.88 408.20 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 403.67 Td (1,194) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 403.67 Td (1,459) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 388.00 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 388.00 Td (Includes ) Tj ET Q q 0 0 0 rg BT 82.29 388.00 Td (unamortized ) Tj ET Q q 0 0 0 rg BT 123.47 388.00 Td (upfront, ) Tj ET Q q 0 0 0 rg BT 150.21 388.00 Td (milestone ) Tj ET Q q 0 0 0 rg BT 182.50 388.00 Td (and ) Tj ET Q q 0 0 0 rg BT 195.25 388.00 Td (other ) Tj ET Q q 0 0 0 rg BT 212.87 388.00 Td (licensing ) Tj ET Q q 0 0 0 rg BT 242.95 388.00 Td (proceeds, ) Tj ET Q q 0 0 0 rg BT 274.57 388.00 Td (revenue ) Tj ET Q q 0 0 0 rg BT 301.07 388.00 Td (deferrals ) Tj ET Q q 0 0 0 rg BT 330.24 388.00 Td (attributed ) Tj ET Q q 0 0 0 rg BT 362.09 388.00 Td (to ) Tj ET Q BT /F3 8.00 Tf ET q 0 0 0 rg BT 369.50 388.00 Td (Atripla*) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 396.17 388.00 Td ( ) Tj ET Q q 0 0 0 rg BT 397.36 388.00 Td (and ) Tj ET Q q 0 0 0 rg BT 410.10 388.00 Td (undelivered ) Tj ET Q q 0 0 0 rg BT 449.06 388.00 Td (elements ) Tj ET Q q 0 0 0 rg BT 478.68 388.00 Td (of ) Tj ET Q q 0 0 0 rg BT 486.53 388.00 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 513.94 388.00 Td (business ) Tj ET Q q 0 0 0 rg BT 542.24 388.00 Td (divestiture ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 54.00 378.40 Td (proceeds. ) Tj ET Q q 0 0 0 rg BT 85.99 378.40 Td (Amortization ) Tj ET Q q 0 0 0 rg BT 130.64 378.40 Td (of ) Tj ET Q q 0 0 0 rg BT 139.31 378.40 Td (deferred ) Tj ET Q q 0 0 0 rg BT 167.95 378.40 Td (income ) Tj ET Q q 0 0 0 rg BT 193.50 378.40 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 227.93 378.40 Td (related ) Tj ET Q q 0 0 0 rg BT 251.70 378.40 Td (to ) Tj ET Q q 0 0 0 rg BT 259.92 378.40 Td (alliances\) ) Tj ET Q q 0 0 0 rg BT 292.57 378.40 Td (was ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 307.01 378.40 Td ($244 ) Tj ET Q q 0 0 0 rg BT 325.01 378.40 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 348.12 378.40 Td ( ) Tj ET Q q 0 0 0 rg BT 350.12 378.40 Td (in ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 358.34 378.40 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 374.34 378.40 Td (, ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 378.34 378.40 Td ($307 ) Tj ET Q q 0 0 0 rg BT 396.34 378.40 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 419.46 378.40 Td ( ) Tj ET Q q 0 0 0 rg BT 421.46 378.40 Td (in ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 429.68 378.40 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 445.68 378.40 Td ( ) Tj ET Q q 0 0 0 rg BT 447.68 378.40 Td (and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 461.23 378.40 Td ($362 ) Tj ET Q q 0 0 0 rg BT 479.23 378.40 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 502.34 378.40 Td ( ) Tj ET Q q 0 0 0 rg BT 504.34 378.40 Td (in ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 512.57 378.40 Td (2014) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 528.57 378.40 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 354.40 Td (Upfront ) Tj ET Q q 0 0 0 rg BT 69.35 354.40 Td (payments ) Tj ET Q q 0 0 0 rg BT 109.36 354.40 Td (for ) Tj ET Q q 0 0 0 rg BT 122.71 354.40 Td (new ) Tj ET Q q 0 0 0 rg BT 141.05 354.40 Td (licensing ) Tj ET Q q 0 0 0 rg BT 178.84 354.40 Td (and ) Tj ET Q q 0 0 0 rg BT 194.97 354.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 227.75 354.40 Td (agreements ) Tj ET Q q 0 0 0 rg BT 274.96 354.40 Td (\(including ) Tj ET Q q 0 0 0 rg BT 317.76 354.40 Td (options ) Tj ET Q q 0 0 0 rg BT 348.89 354.40 Td (to ) Tj ET Q q 0 0 0 rg BT 358.36 354.40 Td (license ) Tj ET Q q 0 0 0 rg BT 387.81 354.40 Td (or ) Tj ET Q q 0 0 0 rg BT 397.82 354.40 Td (acquire ) Tj ET Q q 0 0 0 rg BT 428.93 354.40 Td (the ) Tj ET Q q 0 0 0 rg BT 442.84 354.40 Td (related ) Tj ET Q q 0 0 0 rg BT 471.73 354.40 Td (assets\) ) Tj ET Q q 0 0 0 rg BT 500.07 354.40 Td (char) Tj ET Q q 0 0 0 rg BT 517.10 354.40 Td (ged ) Tj ET Q q 0 0 0 rg BT 533.23 354.40 Td (to ) Tj ET Q q 0 0 0 rg BT 542.69 354.40 Td (research ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 342.40 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 342.40 Td (development ) Tj ET Q q 0 0 0 rg BT 107.09 342.40 Td (expenses ) Tj ET Q q 0 0 0 rg BT 145.69 342.40 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 167.62 342.40 Td ($15 ) Tj ET Q q 0 0 0 rg BT 185.12 342.40 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.01 342.40 Td ( ) Tj ET Q q 0 0 0 rg BT 216.51 342.40 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 226.79 342.40 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.79 342.40 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.79 342.40 Td ($619 ) Tj ET Q q 0 0 0 rg BT 274.29 342.40 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.18 342.40 Td ( ) Tj ET Q q 0 0 0 rg BT 305.68 342.40 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.96 342.40 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.96 342.40 Td ( ) Tj ET Q q 0 0 0 rg BT 338.46 342.40 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.39 342.40 Td ($70 ) Tj ET Q q 0 0 0 rg BT 372.89 342.40 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.79 342.40 Td ( ) Tj ET Q q 0 0 0 rg BT 404.29 342.40 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.56 342.40 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.56 342.40 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 318.40 Td (Specific ) Tj ET Q q 0 0 0 rg BT 70.92 318.40 Td (information ) Tj ET Q q 0 0 0 rg BT 120.29 318.40 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 163.00 318.40 Td (to ) Tj ET Q q 0 0 0 rg BT 172.93 318.40 Td (each ) Tj ET Q q 0 0 0 rg BT 193.41 318.40 Td (of ) Tj ET Q q 0 0 0 rg BT 203.90 318.40 Td (our ) Tj ET Q q 0 0 0 rg BT 219.39 318.40 Td (significant ) Tj ET Q q 0 0 0 rg BT 263.76 318.40 Td (alliances ) Tj ET Q q 0 0 0 rg BT 300.90 318.40 Td (is ) Tj ET Q q 0 0 0 rg BT 309.73 318.40 Td (discussed ) Tj ET Q q 0 0 0 rg BT 350.22 318.40 Td (below) Tj ET Q q 0 0 0 rg BT 374.01 318.40 Td (, ) Tj ET Q q 0 0 0 rg BT 378.67 318.40 Td (including ) Tj ET Q q 0 0 0 rg BT 418.60 318.40 Td (their ) Tj ET Q q 0 0 0 rg BT 439.09 318.40 Td (nature ) Tj ET Q q 0 0 0 rg BT 466.23 318.40 Td (and ) Tj ET Q q 0 0 0 rg BT 482.83 318.40 Td (purpose; ) Tj ET Q q 0 0 0 rg BT 519.43 318.40 Td (the ) Tj ET Q q 0 0 0 rg BT 533.80 318.40 Td (significant ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 306.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 62.68 306.40 Td (and ) Tj ET Q q 0 0 0 rg BT 81.01 306.40 Td (obligations ) Tj ET Q q 0 0 0 rg BT 129.35 306.40 Td (of ) Tj ET Q q 0 0 0 rg BT 141.58 306.40 Td (the ) Tj ET Q q 0 0 0 rg BT 157.69 306.40 Td (parties; ) Tj ET Q q 0 0 0 rg BT 191.03 306.40 Td (specific ) Tj ET Q q 0 0 0 rg BT 226.02 306.40 Td (accounting ) Tj ET Q q 0 0 0 rg BT 273.79 306.40 Td (policy ) Tj ET Q q 0 0 0 rg BT 302.68 306.40 Td (elections; ) Tj ET Q q 0 0 0 rg BT 344.90 306.40 Td (and ) Tj ET Q q 0 0 0 rg BT 363.23 306.40 Td (the ) Tj ET Q q 0 0 0 rg BT 379.35 306.40 Td (income ) Tj ET Q q 0 0 0 rg BT 412.68 306.40 Td (statement ) Tj ET Q q 0 0 0 rg BT 454.90 306.40 Td (classification ) Tj ET Q q 0 0 0 rg BT 511.55 306.40 Td (of ) Tj ET Q q 0 0 0 rg BT 523.78 306.40 Td (and ) Tj ET Q q 0 0 0 rg BT 542.12 306.40 Td (amounts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 294.40 Td (attributable ) Tj ET Q q 0 0 0 rg BT 84.04 294.40 Td (to ) Tj ET Q q 0 0 0 rg BT 94.32 294.40 Td (payments ) Tj ET Q q 0 0 0 rg BT 135.14 294.40 Td (between ) Tj ET Q q 0 0 0 rg BT 170.96 294.40 Td (the ) Tj ET Q q 0 0 0 rg BT 185.67 294.40 Td (parties.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 268.83505859375 m 61.44189453125 268.83505859375 l s q 0 0 0 rg BT 36.00 270.40 Td (Pfizer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 246.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 58.99 246.40 Td (and ) Tj ET Q q 0 0 0 rg BT 75.30 246.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 101.05 246.40 Td (are ) Tj ET Q q 0 0 0 rg BT 115.13 246.40 Td (parties ) Tj ET Q q 0 0 0 rg BT 143.65 246.40 Td (to ) Tj ET Q q 0 0 0 rg BT 153.30 246.40 Td (a ) Tj ET Q q 0 0 0 rg BT 159.61 246.40 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 204.25 246.40 Td (co-development ) Tj ET Q q 0 0 0 rg BT 270.54 246.40 Td (and ) Tj ET Q q 0 0 0 rg BT 286.84 246.40 Td (co-commercialization ) Tj ET Q q 0 0 0 rg BT 375.89 246.40 Td (agreement ) Tj ET Q q 0 0 0 rg BT 419.40 246.40 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 432.93 246.40 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.27 246.40 Td (, ) Tj ET Q q 0 0 0 rg BT 465.64 246.40 Td (an ) Tj ET Q q 0 0 0 rg BT 476.95 246.40 Td (anticoagulant ) Tj ET Q q 0 0 0 rg BT 532.68 246.40 Td (discovered ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 234.40 Td (by ) Tj ET Q q 0 0 0 rg BT 48.53 234.40 Td (BMS. ) Tj ET Q q 0 0 0 rg BT 74.69 234.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 101.10 234.40 Td (funds ) Tj ET Q q 0 0 0 rg BT 125.86 234.40 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.71 234.40 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 180.04 234.40 Td ( ) Tj ET Q q 0 0 0 rg BT 182.57 234.40 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.54 234.40 Td (60%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 217.88 234.40 Td ( ) Tj ET Q q 0 0 0 rg BT 220.41 234.40 Td (of ) Tj ET Q q 0 0 0 rg BT 231.27 234.40 Td (all ) Tj ET Q q 0 0 0 rg BT 243.80 234.40 Td (development ) Tj ET Q q 0 0 0 rg BT 297.99 234.40 Td (costs ) Tj ET Q q 0 0 0 rg BT 320.52 234.40 Td (depending ) Tj ET Q q 0 0 0 rg BT 364.71 234.40 Td (on ) Tj ET Q q 0 0 0 rg BT 377.25 234.40 Td (the ) Tj ET Q q 0 0 0 rg BT 392.00 234.40 Td (study) Tj ET Q q 0 0 0 rg BT 413.02 234.40 Td (. ) Tj ET Q q 0 0 0 rg BT 418.05 234.40 Td (Profits ) Tj ET Q q 0 0 0 rg BT 447.25 234.40 Td (and ) Tj ET Q q 0 0 0 rg BT 464.23 234.40 Td (losses ) Tj ET Q q 0 0 0 rg BT 490.65 234.40 Td (are ) Tj ET Q q 0 0 0 rg BT 505.39 234.40 Td (shared ) Tj ET Q q 0 0 0 rg BT 534.03 234.40 Td (equally ) Tj ET Q q 0 0 0 rg BT 566.00 234.40 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 222.40 Td (a ) Tj ET Q q 0 0 0 rg BT 42.59 222.40 Td (global ) Tj ET Q q 0 0 0 rg BT 69.73 222.40 Td (basis ) Tj ET Q q 0 0 0 rg BT 91.88 222.40 Td (except ) Tj ET Q q 0 0 0 rg BT 120.12 222.40 Td (in ) Tj ET Q q 0 0 0 rg BT 130.05 222.40 Td (certain ) Tj ET Q q 0 0 0 rg BT 159.40 222.40 Td (countries ) Tj ET Q q 0 0 0 rg BT 198.20 222.40 Td (where ) Tj ET Q q 0 0 0 rg BT 224.78 222.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 250.80 222.40 Td (commercializes ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 315.70 222.40 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.03 222.40 Td ( ) Tj ET Q q 0 0 0 rg BT 346.18 222.40 Td (and ) Tj ET Q q 0 0 0 rg BT 362.77 222.40 Td (pays ) Tj ET Q q 0 0 0 rg BT 383.25 222.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 406.52 222.40 Td (compensation ) Tj ET Q q 0 0 0 rg BT 464.21 222.40 Td (based ) Tj ET Q q 0 0 0 rg BT 489.13 222.40 Td (on ) Tj ET Q q 0 0 0 rg BT 501.27 222.40 Td (a ) Tj ET Q q 0 0 0 rg BT 507.86 222.40 Td (percentage ) Tj ET Q q 0 0 0 rg BT 553.31 222.40 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 222.40 Td (net ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 210.40 Td (sales. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 186.40 Td (Upon ) Tj ET Q q 0 0 0 rg BT 60.52 186.40 Td (entering ) Tj ET Q q 0 0 0 rg BT 95.59 186.40 Td (into ) Tj ET Q q 0 0 0 rg BT 113.45 186.40 Td (the ) Tj ET Q q 0 0 0 rg BT 127.97 186.40 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 174.41 186.40 Td (co-exclusive ) Tj ET Q q 0 0 0 rg BT 227.25 186.40 Td (license ) Tj ET Q q 0 0 0 rg BT 257.31 186.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 282.39 186.40 Td (for ) Tj ET Q q 0 0 0 rg BT 296.35 186.40 Td (the ) Tj ET Q q 0 0 0 rg BT 310.87 186.40 Td (product ) Tj ET Q q 0 0 0 rg BT 343.72 186.40 Td (were ) Tj ET Q q 0 0 0 rg BT 365.45 186.40 Td (granted ) Tj ET Q q 0 0 0 rg BT 397.74 186.40 Td (to ) Tj ET Q q 0 0 0 rg BT 407.82 186.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 434.00 186.40 Td (in ) Tj ET Q q 0 0 0 rg BT 444.08 186.40 Td (exchange ) Tj ET Q q 0 0 0 rg BT 484.14 186.40 Td (for ) Tj ET Q q 0 0 0 rg BT 498.10 186.40 Td (an ) Tj ET Q q 0 0 0 rg BT 509.84 186.40 Td (upfront ) Tj ET Q q 0 0 0 rg BT 541.58 186.40 Td (payment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 174.40 Td (and ) Tj ET Q q 0 0 0 rg BT 52.66 174.40 Td (potential ) Tj ET Q q 0 0 0 rg BT 89.86 174.40 Td (milestone ) Tj ET Q q 0 0 0 rg BT 130.96 174.40 Td (payments. ) Tj ET Q q 0 0 0 rg BT 174.00 174.40 Td (Both ) Tj ET Q q 0 0 0 rg BT 195.67 174.40 Td (parties ) Tj ET Q q 0 0 0 rg BT 224.54 174.40 Td (assumed ) Tj ET Q q 0 0 0 rg BT 261.20 174.40 Td (certain ) Tj ET Q q 0 0 0 rg BT 290.61 174.40 Td (obligations ) Tj ET Q q 0 0 0 rg BT 337.27 174.40 Td (to ) Tj ET Q q 0 0 0 rg BT 347.27 174.40 Td (actively ) Tj ET Q q 0 0 0 rg BT 381.14 174.40 Td (participate ) Tj ET Q q 0 0 0 rg BT 425.55 174.40 Td (in ) Tj ET Q q 0 0 0 rg BT 435.55 174.40 Td (the ) Tj ET Q q 0 0 0 rg BT 449.98 174.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 483.29 174.40 Td (and ) Tj ET Q q 0 0 0 rg BT 499.94 174.40 Td (actively ) Tj ET Q q 0 0 0 rg BT 533.81 174.40 Td (participate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 162.40 Td (in ) Tj ET Q q 0 0 0 rg BT 46.99 162.40 Td (a ) Tj ET Q q 0 0 0 rg BT 54.64 162.40 Td (joint ) Tj ET Q q 0 0 0 rg BT 76.19 162.40 Td (executive ) Tj ET Q q 0 0 0 rg BT 117.71 162.40 Td (committee ) Tj ET Q q 0 0 0 rg BT 163.13 162.40 Td (and ) Tj ET Q q 0 0 0 rg BT 180.79 162.40 Td (various ) Tj ET Q q 0 0 0 rg BT 213.44 162.40 Td (other ) Tj ET Q q 0 0 0 rg BT 237.20 162.40 Td (operating ) Tj ET Q q 0 0 0 rg BT 278.17 162.40 Td (committees ) Tj ET Q q 0 0 0 rg BT 327.48 162.40 Td (and ) Tj ET Q q 0 0 0 rg BT 345.14 162.40 Td (have ) Tj ET Q q 0 0 0 rg BT 367.23 162.40 Td (joint ) Tj ET Q q 0 0 0 rg BT 388.77 162.40 Td (responsibilities ) Tj ET Q q 0 0 0 rg BT 452.54 162.40 Td (for ) Tj ET Q q 0 0 0 rg BT 467.41 162.40 Td (the ) Tj ET Q q 0 0 0 rg BT 482.84 162.40 Td (research, ) Tj ET Q q 0 0 0 rg BT 521.86 162.40 Td (development, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 150.40 Td (distribution, ) Tj ET Q q 0 0 0 rg BT 86.87 150.40 Td (sales ) Tj ET Q q 0 0 0 rg BT 108.57 150.40 Td (and ) Tj ET Q q 0 0 0 rg BT 125.27 150.40 Td (marketing ) Tj ET Q q 0 0 0 rg BT 168.08 150.40 Td (activities ) Tj ET Q q 0 0 0 rg BT 206.43 150.40 Td (of ) Tj ET Q q 0 0 0 rg BT 217.03 150.40 Td (the ) Tj ET Q q 0 0 0 rg BT 231.50 150.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 264.85 150.40 Td (using ) Tj ET Q q 0 0 0 rg BT 288.78 150.40 Td (resources ) Tj ET Q q 0 0 0 rg BT 328.80 150.40 Td (in ) Tj ET Q q 0 0 0 rg BT 338.84 150.40 Td (their ) Tj ET Q q 0 0 0 rg BT 359.43 150.40 Td (own ) Tj ET Q q 0 0 0 rg BT 378.91 150.40 Td (infrastructures. ) Tj ET Q q 0 0 0 rg BT 441.42 150.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 464.81 150.40 Td (manufactures ) Tj ET Q q 0 0 0 rg BT 520.93 150.40 Td (the ) Tj ET Q q 0 0 0 rg BT 535.41 150.40 Td (product ) Tj ET Q q 0 0 0 rg BT 568.22 150.40 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 138.40 Td (the ) Tj ET Q q 0 0 0 rg BT 50.10 138.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 83.08 138.40 Td (and ) Tj ET Q q 0 0 0 rg BT 99.40 138.40 Td (is ) Tj ET Q q 0 0 0 rg BT 107.95 138.40 Td (the ) Tj ET Q q 0 0 0 rg BT 122.05 138.40 Td (principal ) Tj ET Q q 0 0 0 rg BT 159.48 138.40 Td (in ) Tj ET Q q 0 0 0 rg BT 169.14 138.40 Td (the ) Tj ET Q q 0 0 0 rg BT 183.25 138.40 Td (end ) Tj ET Q q 0 0 0 rg BT 199.57 138.40 Td (customer ) Tj ET Q q 0 0 0 rg BT 238.11 138.40 Td (product ) Tj ET Q q 0 0 0 rg BT 270.54 138.40 Td (sales ) Tj ET Q q 0 0 0 rg BT 291.86 138.40 Td (in ) Tj ET Q q 0 0 0 rg BT 301.53 138.40 Td (the ) Tj ET Q q 0 0 0 rg BT 315.63 138.40 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 337.80 138.40 Td (significant ) Tj ET Q q 0 0 0 rg BT 381.89 138.40 Td (countries ) Tj ET Q q 0 0 0 rg BT 420.43 138.40 Td (in ) Tj ET Q q 0 0 0 rg BT 430.10 138.40 Td (Europe, ) Tj ET Q q 0 0 0 rg BT 463.36 138.40 Td (as ) Tj ET Q q 0 0 0 rg BT 473.57 138.40 Td (well ) Tj ET Q q 0 0 0 rg BT 492.67 138.40 Td (as ) Tj ET Q q 0 0 0 rg BT 502.89 138.40 Td (Canada, ) Tj ET Q q 0 0 0 rg BT 536.84 138.40 Td (Australia, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 126.40 Td (China, ) Tj ET Q q 0 0 0 rg BT 64.91 126.40 Td (Japan ) Tj ET Q q 0 0 0 rg BT 90.20 126.40 Td (and ) Tj ET Q q 0 0 0 rg BT 107.16 126.40 Td (South ) Tj ET Q q 0 0 0 rg BT 133.02 126.40 Td (Korea. ) Tj ET Q q 0 0 0 rg BT 162.47 126.40 Td (In ) Tj ET Q q 0 0 0 rg BT 173.32 126.40 Td (2015, ) Tj ET Q q 0 0 0 rg BT 198.35 126.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 221.99 126.40 Td (transferred ) Tj ET Q q 0 0 0 rg BT 267.82 126.40 Td (full ) Tj ET Q q 0 0 0 rg BT 284.23 126.40 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 361.16 126.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 386.46 126.40 Td (to ) Tj ET Q q 0 0 0 rg BT 396.76 126.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 423.16 126.40 Td (in ) Tj ET Q q 0 0 0 rg BT 433.46 126.40 Td (certain ) Tj ET Q q 0 0 0 rg BT 463.18 126.40 Td (smaller ) Tj ET Q q 0 0 0 rg BT 495.14 126.40 Td (countries ) Tj ET Q q 0 0 0 rg BT 534.32 126.40 Td (in ) Tj ET Q q 0 0 0 rg BT 544.62 126.40 Td (order ) Tj ET Q q 0 0 0 rg BT 568.24 126.40 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 114.40 Td (simplify ) Tj ET Q q 0 0 0 rg BT 72.32 114.40 Td (operations. ) Tj ET Q q 0 0 0 rg BT 119.46 114.40 Td (In ) Tj ET Q q 0 0 0 rg BT 130.78 114.40 Td (the ) Tj ET Q q 0 0 0 rg BT 145.99 114.40 Td (transferred ) Tj ET Q q 0 0 0 rg BT 192.28 114.40 Td (countries, ) Tj ET Q q 0 0 0 rg BT 234.42 114.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 258.53 114.40 Td (supplies ) Tj ET Q q 0 0 0 rg BT 294.30 114.40 Td (the ) Tj ET Q q 0 0 0 rg BT 309.50 114.40 Td (product ) Tj ET Q q 0 0 0 rg BT 343.04 114.40 Td (to ) Tj ET Q q 0 0 0 rg BT 353.80 114.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 380.67 114.40 Td (at ) Tj ET Q q 0 0 0 rg BT 390.87 114.40 Td (cost ) Tj ET Q q 0 0 0 rg BT 409.97 114.40 Td (plus ) Tj ET Q q 0 0 0 rg BT 429.62 114.40 Td (a ) Tj ET Q q 0 0 0 rg BT 437.05 114.40 Td (percentage ) Tj ET Q q 0 0 0 rg BT 483.34 114.40 Td (of ) Tj ET Q q 0 0 0 rg BT 494.65 114.40 Td (the ) Tj ET Q q 0 0 0 rg BT 509.86 114.40 Td (net ) Tj ET Q q 0 0 0 rg BT 525.06 114.40 Td (sales ) Tj ET Q q 0 0 0 rg BT 547.49 114.40 Td (to ) Tj ET Q q 0 0 0 rg BT 558.25 114.40 Td (end-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 102.40 Td (customers.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 78.40 Td (The ) Tj ET Q q 0 0 0 rg BT 54.01 78.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 95.37 78.40 Td (determined ) Tj ET Q q 0 0 0 rg BT 142.82 78.40 Td (the ) Tj ET Q q 0 0 0 rg BT 157.50 78.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 182.75 78.40 Td (transferred ) Tj ET Q q 0 0 0 rg BT 228.52 78.40 Td (to ) Tj ET Q q 0 0 0 rg BT 238.76 78.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 265.11 78.40 Td (did ) Tj ET Q q 0 0 0 rg BT 280.35 78.40 Td (not ) Tj ET Q q 0 0 0 rg BT 295.60 78.40 Td (have ) Tj ET Q q 0 0 0 rg BT 316.94 78.40 Td (standalone ) Tj ET Q q 0 0 0 rg BT 362.17 78.40 Td (value ) Tj ET Q q 0 0 0 rg BT 386.30 78.40 Td (as ) Tj ET Q q 0 0 0 rg BT 397.09 78.40 Td (such ) Tj ET Q q 0 0 0 rg BT 417.89 78.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 443.14 78.40 Td (were ) Tj ET Q q 0 0 0 rg BT 465.03 78.40 Td (not ) Tj ET Q q 0 0 0 rg BT 480.28 78.40 Td (sold ) Tj ET Q q 0 0 0 rg BT 499.42 78.40 Td (separately ) Tj ET Q q 0 0 0 rg BT 542.42 78.40 Td (by ) Tj ET Q q 0 0 0 rg BT 554.88 78.40 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 66.40 Td (or ) Tj ET Q q 0 0 0 rg BT 47.11 66.40 Td (any ) Tj ET Q q 0 0 0 rg BT 64.32 66.40 Td (other ) Tj ET Q q 0 0 0 rg BT 87.65 66.40 Td (party) Tj ET Q q 0 0 0 rg BT 107.54 66.40 Td (, ) Tj ET Q q 0 0 0 rg BT 112.82 66.40 Td (nor ) Tj ET Q q 0 0 0 rg BT 128.93 66.40 Td (could ) Tj ET Q q 0 0 0 rg BT 153.92 66.40 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 180.58 66.40 Td (receive ) Tj ET Q q 0 0 0 rg BT 212.22 66.40 Td (any ) Tj ET Q q 0 0 0 rg BT 229.43 66.40 Td (benefit ) Tj ET Q q 0 0 0 rg BT 259.97 66.40 Td (for ) Tj ET Q q 0 0 0 rg BT 274.41 66.40 Td (the ) Tj ET Q q 0 0 0 rg BT 289.41 66.40 Td (delivered ) Tj ET Q q 0 0 0 rg BT 329.39 66.40 Td (rights ) Tj ET Q q 0 0 0 rg BT 354.94 66.40 Td (without ) Tj ET Q q 0 0 0 rg BT 388.28 66.40 Td (the ) Tj ET Q q 0 0 0 rg BT 403.27 66.40 Td (fulfillment ) Tj ET Q q 0 0 0 rg BT 448.82 66.40 Td (of ) Tj ET Q q 0 0 0 rg BT 459.92 66.40 Td (other ) Tj ET Q q 0 0 0 rg BT 483.25 66.40 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 518.80 66.40 Td (obligations ) Tj ET Q q 0 0 0 rg BT 566.02 66.40 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 54.40 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.48 54.40 Td (under ) Tj ET Q q 0 0 0 rg BT 84.60 54.40 Td (the ) Tj ET Q q 0 0 0 rg BT 99.17 54.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 132.62 54.40 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 179.11 54.40 Td (including ) Tj ET Q q 0 0 0 rg BT 219.24 54.40 Td (the ) Tj ET Q q 0 0 0 rg BT 233.81 54.40 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 273.93 54.40 Td (supply ) Tj ET Q q 0 0 0 rg BT 302.96 54.40 Td (arrangement. ) Tj ET Q q 0 0 0 rg BT 357.26 54.40 Td (As ) Tj ET Q q 0 0 0 rg BT 370.73 54.40 Td (such, ) Tj ET Q q 0 0 0 rg BT 393.92 54.40 Td (the ) Tj ET Q q 0 0 0 rg BT 408.49 54.40 Td (global ) Tj ET Q q 0 0 0 rg BT 435.84 54.40 Td (alliance ) Tj ET Q q 0 0 0 rg BT 469.28 54.40 Td (was ) Tj ET Q q 0 0 0 rg BT 487.19 54.40 Td (treated ) Tj ET Q q 0 0 0 rg BT 516.75 54.40 Td (as ) Tj ET Q q 0 0 0 rg BT 527.43 54.40 Td (a ) Tj ET Q q 0 0 0 rg BT 534.22 54.40 Td (single ) Tj ET Q q 0 0 0 rg BT 560.47 54.40 Td (unit ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 42.40 Td (of ) Tj ET Q q 0 0 0 rg BT 46.55 42.40 Td (accounting ) Tj ET Q q 0 0 0 rg BT 92.64 42.40 Td (and ) Tj ET Q q 0 0 0 rg BT 109.30 42.40 Td (upfront ) Tj ET Q q 0 0 0 rg BT 140.95 42.40 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 178.71 42.40 Td (and ) Tj ET Q q 0 0 0 rg BT 195.36 42.40 Td (any ) Tj ET Q q 0 0 0 rg BT 212.02 42.40 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 258.68 42.40 Td (contingent ) Tj ET Q q 0 0 0 rg BT 303.11 42.40 Td (milestone ) Tj ET Q q 0 0 0 rg BT 344.21 42.40 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 381.96 42.40 Td (are ) Tj ET Q q 0 0 0 rg BT 396.39 42.40 Td (amortized ) Tj ET Q q 0 0 0 rg BT 438.59 42.40 Td (over ) Tj ET Q q 0 0 0 rg BT 458.57 42.40 Td (the ) Tj ET Q q 0 0 0 rg BT 473.01 42.40 Td (life ) Tj ET Q q 0 0 0 rg BT 488.55 42.40 Td (of ) Tj ET Q q 0 0 0 rg BT 499.10 42.40 Td (the ) Tj ET Q q 0 0 0 rg BT 513.54 42.40 Td (related ) Tj ET Q q 0 0 0 rg BT 542.96 42.40 Td (product.) Tj ET Q endstream endobj 129 0 obj <> endobj 130 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (64) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.42 749.10 Td (received ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 95.58 749.10 Td ($884 ) Tj ET Q q 0 0 0 rg BT 117.87 749.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.76 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 149.06 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 159.13 749.10 Td (non-refundable ) Tj ET Q q 0 0 0 rg BT 222.51 749.10 Td (upfront, ) Tj ET Q q 0 0 0 rg BT 256.74 749.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 297.92 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 314.65 749.10 Td (other ) Tj ET Q q 0 0 0 rg BT 337.49 749.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 375.89 749.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 416.51 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 446.01 749.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 456.08 749.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.42 749.10 Td ( ) Tj ET Q q 0 0 0 rg BT 486.71 749.10 Td (through ) Tj ET Q q 0 0 0 rg BT 520.12 749.10 Td (December ) Tj ET Q q 0 0 0 rg BT 563.50 749.10 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 737.10 Td (. ) Tj ET Q q 0 0 0 rg BT 61.93 737.10 Td (Amortization ) Tj ET Q q 0 0 0 rg BT 119.65 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 132.39 737.10 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 149.01 737.10 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 177.34 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 181.74 737.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 219.45 737.10 Td (income ) Tj ET Q q 0 0 0 rg BT 253.29 737.10 Td (is ) Tj ET Q q 0 0 0 rg BT 264.36 737.10 Td (included ) Tj ET Q q 0 0 0 rg BT 303.20 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 315.38 737.10 Td (other ) Tj ET Q q 0 0 0 rg BT 340.33 737.10 Td (income ) Tj ET Q q 0 0 0 rg BT 374.17 737.10 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 386.90 737.10 Td (Eliquis ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.64 737.10 Td (was ) Tj ET Q q 0 0 0 rg BT 439.59 737.10 Td (not ) Tj ET Q q 0 0 0 rg BT 456.77 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 465.61 737.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 517.21 737.10 Td (product ) Tj ET Q q 0 0 0 rg BT 552.16 737.10 Td (at ) Tj ET Q q 0 0 0 rg BT 563.78 737.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (commencement ) Tj ET Q q 0 0 0 rg BT 101.81 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 112.64 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 127.35 725.10 Td (alliance.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 704.10 Td (Summarized financial information related to this alliance was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 667.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 667.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 667.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 667.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 667.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 667.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 667.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 641.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 641.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 641.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 641.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 641.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 641.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 641.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 615.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 615.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 615.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 615.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 615.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 615.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 615.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 589.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 589.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 589.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 589.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 589.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 589.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 589.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 563.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 563.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 563.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 563.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 563.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 563.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 563.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 537.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 537.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 537.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 537.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 537.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 537.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 537.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 680.6 m 448.5 680.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 680.6 m 452.5 680.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 680.6 m 512.5 680.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 680.6 m 516.5 680.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 680.6 m 576.5 680.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 667.6 m 448.5 667.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 667.6 m 512.5 667.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 667.6 m 576.5 667.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 628.6 m 448.5 628.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 616.6 m 448.5 616.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 614.6 m 448.5 614.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 628.6 m 512.5 628.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 616.6 m 512.5 616.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 614.6 m 512.5 614.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 628.6 m 576.5 628.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 616.6 m 576.5 616.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 614.6 m 576.5 614.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 684.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 684.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 671.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 671.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 671.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 671.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 658.33 Td (Revenues from Pfizer alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 645.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 645.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.15 645.17 Td (3,306) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 645.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 645.17 Td (1,849) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 645.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 645.17 Td (771) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 632.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 632.17 Td (37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 632.17 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 632.17 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 619.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 619.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.15 619.17 Td (3,343) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 619.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 619.17 Td (1,860) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 619.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 619.17 Td (774) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 593.33 Td (Payments to/\(from\) Pfizer:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 580.17 Td (Cost of products sold – Profit sharing) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 580.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.15 580.17 Td (1,595) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 580.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 580.17 Td (895) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 580.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 580.17 Td (363) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 567.17 Td (Other \(income\)/expense – Amortization of deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.30 567.22 Td (\(55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 567.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.30 567.22 Td (\(55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 567.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 567.17 Td (\(50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 567.17 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 541.33 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 528.17 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 528.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 528.17 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 528.17 Td (100) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 492.60 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 492.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 492.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 492.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 492.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 503.6 m 511.5 503.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 492.6 m 511.5 492.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 503.6 m 575.5 503.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 492.6 m 575.5 492.6 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 505.38 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.75 506.68 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 495.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 473.00 495.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.00 495.68 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 483.17 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 483.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 483.17 Td (521) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 483.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 483.17 Td (576) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 454.53505859375 m 64.3349609375 454.53505859375 l s q 0 0 0 rg BT 36.00 456.10 Td (Gilead) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 432.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 58.87 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 75.06 432.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 103.47 432.10 Td (have ) Tj ET Q q 0 0 0 rg BT 124.10 432.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 144.18 432.10 Td (ventures ) Tj ET Q q 0 0 0 rg BT 179.81 432.10 Td (in ) Tj ET Q q 0 0 0 rg BT 189.34 432.10 Td (the ) Tj ET Q q 0 0 0 rg BT 203.30 432.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 222.84 432.10 Td (\(for ) Tj ET Q q 0 0 0 rg BT 239.58 432.10 Td (the ) Tj ET Q q 0 0 0 rg BT 253.55 432.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 273.08 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 289.27 432.10 Td (Canada\) ) Tj ET Q q 0 0 0 rg BT 324.33 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 340.52 432.10 Td (in ) Tj ET Q q 0 0 0 rg BT 350.05 432.10 Td (Europe ) Tj ET Q q 0 0 0 rg BT 380.68 432.10 Td (to ) Tj ET Q q 0 0 0 rg BT 390.21 432.10 Td (develop ) Tj ET Q q 0 0 0 rg BT 423.61 432.10 Td (and ) Tj ET Q q 0 0 0 rg BT 439.80 432.10 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 500.41 432.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.74 432.10 Td ( ) Tj ET Q q 0 0 0 rg BT 535.49 432.10 Td (\(efavirenz ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 420.10 Td (600 ) Tj ET Q q 0 0 0 rg BT 52.66 420.10 Td (mg/ ) Tj ET Q q 0 0 0 rg BT 69.87 420.10 Td (emtricitabine ) Tj ET Q q 0 0 0 rg BT 124.28 420.10 Td (200 ) Tj ET Q q 0 0 0 rg BT 140.94 420.10 Td (mg/ ) Tj ET Q q 0 0 0 rg BT 158.15 420.10 Td (tenofovir ) Tj ET Q q 0 0 0 rg BT 196.46 420.10 Td (disoproxil ) Tj ET Q q 0 0 0 rg BT 238.68 420.10 Td (fumarate ) Tj ET Q q 0 0 0 rg BT 275.87 420.10 Td (300 ) Tj ET Q q 0 0 0 rg BT 292.52 420.10 Td (mg\), ) Tj ET Q q 0 0 0 rg BT 312.79 420.10 Td (combining ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 357.22 420.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.10 420.10 Td (, ) Tj ET Q q 0 0 0 rg BT 390.26 420.10 Td (a ) Tj ET Q q 0 0 0 rg BT 396.36 420.10 Td (product ) Tj ET Q q 0 0 0 rg BT 428.56 420.10 Td (of ) Tj ET Q q 0 0 0 rg BT 438.55 420.10 Td (BMS, ) Tj ET Q q 0 0 0 rg BT 463.83 420.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 479.92 420.10 Td (T) Tj ET Q q 0 0 0 rg BT 484.93 420.10 Td (ruvada*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.26 420.10 Td ( ) Tj ET Q q 0 0 0 rg BT 519.92 420.10 Td (\(emtricitabine ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 408.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 408.10 Td (tenofovir ) Tj ET Q q 0 0 0 rg BT 92.09 408.10 Td (disoproxil ) Tj ET Q q 0 0 0 rg BT 135.15 408.10 Td (fumarate\), ) Tj ET Q q 0 0 0 rg BT 179.01 408.10 Td (a ) Tj ET Q q 0 0 0 rg BT 185.95 408.10 Td (product ) Tj ET Q q 0 0 0 rg BT 219.00 408.10 Td (of ) Tj ET Q q 0 0 0 rg BT 229.83 408.10 Td (Gilead. ) Tj ET Q q 0 0 0 rg BT 261.30 408.10 Td (The ) Tj ET Q q 0 0 0 rg BT 279.35 408.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 300.18 408.10 Td (ventures ) Tj ET Q q 0 0 0 rg BT 336.56 408.10 Td (are ) Tj ET Q q 0 0 0 rg BT 351.27 408.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 404.31 408.10 Td (by ) Tj ET Q q 0 0 0 rg BT 416.81 408.10 Td (Gilead.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 384.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 58.39 384.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 87.99 384.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 122.58 384.10 Td (participate ) Tj ET Q q 0 0 0 rg BT 167.72 384.10 Td (in ) Tj ET Q q 0 0 0 rg BT 178.44 384.10 Td (a ) Tj ET Q q 0 0 0 rg BT 185.82 384.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 207.10 384.10 Td (executive ) Tj ET Q q 0 0 0 rg BT 248.35 384.10 Td (committee ) Tj ET Q q 0 0 0 rg BT 293.50 384.10 Td (and ) Tj ET Q q 0 0 0 rg BT 310.88 384.10 Td (various ) Tj ET Q q 0 0 0 rg BT 343.26 384.10 Td (other ) Tj ET Q q 0 0 0 rg BT 366.75 384.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 407.45 384.10 Td (committees ) Tj ET Q q 0 0 0 rg BT 456.49 384.10 Td (with ) Tj ET Q q 0 0 0 rg BT 477.21 384.10 Td (direct ) Tj ET Q q 0 0 0 rg BT 502.92 384.10 Td (oversight ) Tj ET Q q 0 0 0 rg BT 543.08 384.10 Td (over ) Tj ET Q q 0 0 0 rg BT 563.79 384.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 372.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 75.01 372.10 Td (of ) Tj ET Q q 0 0 0 rg BT 86.25 372.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.38 372.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 122.63 372.10 Td (ventures. ) Tj ET Q q 0 0 0 rg BT 161.71 372.10 Td (The ) Tj ET Q q 0 0 0 rg BT 180.17 372.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 201.42 372.10 Td (ventures ) Tj ET Q q 0 0 0 rg BT 238.21 372.10 Td (purchase ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 276.66 372.10 Td (Sustiva) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.54 372.10 Td ( ) Tj ET Q q 0 0 0 rg BT 308.46 372.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 325.81 372.10 Td (T) Tj ET Q q 0 0 0 rg BT 330.82 372.10 Td (ruvada* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.06 372.10 Td (API ) Tj ET Q q 0 0 0 rg BT 386.08 372.10 Td (in ) Tj ET Q q 0 0 0 rg BT 396.78 372.10 Td (bulk ) Tj ET Q q 0 0 0 rg BT 417.47 372.10 Td (form ) Tj ET Q q 0 0 0 rg BT 439.82 372.10 Td (from ) Tj ET Q q 0 0 0 rg BT 462.17 372.10 Td (the ) Tj ET Q q 0 0 0 rg BT 477.30 372.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 506.87 372.10 Td (and ) Tj ET Q q 0 0 0 rg BT 524.22 372.10 Td (complete ) Tj ET Q q 0 0 0 rg BT 563.78 372.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 360.10 Td (finishing ) Tj ET Q q 0 0 0 rg BT 74.43 360.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 85.63 360.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 118.97 360.10 Td (. ) Tj ET Q q 0 0 0 rg BT 124.13 360.10 Td (The ) Tj ET Q q 0 0 0 rg BT 142.56 360.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 163.76 360.10 Td (ventures ) Tj ET Q q 0 0 0 rg BT 200.51 360.10 Td (or ) Tj ET Q q 0 0 0 rg BT 211.72 360.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 241.25 360.10 Td (sell ) Tj ET Q q 0 0 0 rg BT 258.01 360.10 Td (and ) Tj ET Q q 0 0 0 rg BT 275.32 360.10 Td (distribute ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 315.97 360.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 349.30 360.10 Td ( ) Tj ET Q q 0 0 0 rg BT 352.17 360.10 Td (and ) Tj ET Q q 0 0 0 rg BT 369.49 360.10 Td (are ) Tj ET Q q 0 0 0 rg BT 384.57 360.10 Td (the ) Tj ET Q q 0 0 0 rg BT 399.66 360.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 438.07 360.10 Td (in ) Tj ET Q q 0 0 0 rg BT 448.72 360.10 Td (the ) Tj ET Q q 0 0 0 rg BT 463.81 360.10 Td (end ) Tj ET Q q 0 0 0 rg BT 481.13 360.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 520.66 360.10 Td (product ) Tj ET Q q 0 0 0 rg BT 554.08 360.10 Td (sales. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 348.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 348.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 83.20 348.10 Td (no ) Tj ET Q q 0 0 0 rg BT 95.70 348.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 123.75 348.10 Td (coordinate ) Tj ET Q q 0 0 0 rg BT 168.45 348.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 189.29 348.10 Td (promotional ) Tj ET Q q 0 0 0 rg BT 240.67 348.10 Td (activities.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 324.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 72.49 324.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 106.76 324.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 153.24 324.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 167.52 324.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 200.85 324.10 Td ( ) Tj ET Q q 0 0 0 rg BT 203.47 324.10 Td (include ) Tj ET Q q 0 0 0 rg BT 235.53 324.10 Td (only ) Tj ET Q q 0 0 0 rg BT 255.92 324.10 Td (the ) Tj ET Q q 0 0 0 rg BT 270.76 324.10 Td (bulk ) Tj ET Q q 0 0 0 rg BT 291.16 324.10 Td (efavirenz ) Tj ET Q q 0 0 0 rg BT 330.97 324.10 Td (component ) Tj ET Q q 0 0 0 rg BT 378.02 324.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 388.97 324.10 Td (Atripla* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.93 324.10 Td (which ) Tj ET Q q 0 0 0 rg BT 451.99 324.10 Td (is ) Tj ET Q q 0 0 0 rg BT 461.28 324.10 Td (based ) Tj ET Q q 0 0 0 rg BT 486.66 324.10 Td (on ) Tj ET Q q 0 0 0 rg BT 499.28 324.10 Td (the ) Tj ET Q q 0 0 0 rg BT 514.12 324.10 Td (relative ) Tj ET Q q 0 0 0 rg BT 546.72 324.10 Td (ratio ) Tj ET Q q 0 0 0 rg BT 567.67 324.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 312.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.71 312.10 Td (average ) Tj ET Q q 0 0 0 rg BT 84.30 312.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 127.33 312.10 Td (net ) Tj ET Q q 0 0 0 rg BT 142.04 312.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 171.20 312.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 197.58 312.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 208.40 312.10 Td (T) Tj ET Q q 0 0 0 rg BT 213.41 312.10 Td (ruvada*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.74 312.10 Td ( ) Tj ET Q q 0 0 0 rg BT 249.24 312.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 266.18 312.10 Td (Sustiva. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.06 312.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 336.43 312.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 370.58 312.10 Td (is ) Tj ET Q q 0 0 0 rg BT 379.74 312.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 415.55 312.10 Td (and ) Tj ET Q q 0 0 0 rg BT 432.48 312.10 Td (the ) Tj ET Q q 0 0 0 rg BT 447.20 312.10 Td (related ) Tj ET Q q 0 0 0 rg BT 476.90 312.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 510.48 312.10 Td (receivable ) Tj ET Q q 0 0 0 rg BT 554.06 312.10 Td (is ) Tj ET Q q 0 0 0 rg BT 563.23 312.10 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 300.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 82.36 300.10 Td (until ) Tj ET Q q 0 0 0 rg BT 103.20 300.10 Td (the ) Tj ET Q q 0 0 0 rg BT 117.91 300.10 Td (combined ) Tj ET Q q 0 0 0 rg BT 159.85 300.10 Td (product ) Tj ET Q q 0 0 0 rg BT 192.89 300.10 Td (is ) Tj ET Q q 0 0 0 rg BT 202.06 300.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 221.23 300.10 Td (to ) Tj ET Q q 0 0 0 rg BT 231.51 300.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 276.78 300.10 Td (customers.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.53 276.10 Td (Europe, ) Tj ET Q q 0 0 0 rg BT 80.11 276.10 Td (following ) Tj ET Q q 0 0 0 rg BT 121.19 276.10 Td (the ) Tj ET Q q 0 0 0 rg BT 135.61 276.10 Td (2013 ) Tj ET Q q 0 0 0 rg BT 157.81 276.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 175.57 276.10 Td (of ) Tj ET Q q 0 0 0 rg BT 186.10 276.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 232.18 276.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 242.71 276.10 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 273.80 276.10 Td (and ) Tj ET Q q 0 0 0 rg BT 290.44 276.10 Td (ef) Tj ET Q q 0 0 0 rg BT 298.02 276.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 327.43 276.10 Td (January ) Tj ET Q q 0 0 0 rg BT 360.72 276.10 Td (1, ) Tj ET Q q 0 0 0 rg BT 370.42 276.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 395.12 276.10 Td (the ) Tj ET Q q 0 0 0 rg BT 409.54 276.10 Td (percentage ) Tj ET Q q 0 0 0 rg BT 455.04 276.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 465.57 276.10 Td (Atripla) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.91 276.10 Td (* ) Tj ET Q q 0 0 0 rg BT 501.10 276.10 Td (net ) Tj ET Q q 0 0 0 rg BT 515.52 276.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 537.16 276.10 Td (in ) Tj ET Q q 0 0 0 rg BT 547.14 276.10 Td (Europe ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 81.83 264.10 Td (by ) Tj ET Q q 0 0 0 rg BT 93.80 264.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 116.89 264.10 Td (is ) Tj ET Q q 0 0 0 rg BT 125.53 264.10 Td (equal ) Tj ET Q q 0 0 0 rg BT 149.15 264.10 Td (to ) Tj ET Q q 0 0 0 rg BT 158.90 264.10 Td (the ) Tj ET Q q 0 0 0 rg BT 173.08 264.10 Td (dif) Tj ET Q q 0 0 0 rg BT 184.01 264.10 Td (ference ) Tj ET Q q 0 0 0 rg BT 215.39 264.10 Td (between ) Tj ET Q q 0 0 0 rg BT 250.67 264.10 Td (the ) Tj ET Q q 0 0 0 rg BT 264.86 264.10 Td (average ) Tj ET Q q 0 0 0 rg BT 297.91 264.10 Td (net ) Tj ET Q q 0 0 0 rg BT 312.09 264.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 340.73 264.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 366.57 264.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 376.87 264.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.20 264.10 Td ( ) Tj ET Q q 0 0 0 rg BT 412.17 264.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 428.58 264.10 Td (T) Tj ET Q q 0 0 0 rg BT 433.59 264.10 Td (ruvada*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.92 264.10 Td (. ) Tj ET Q q 0 0 0 rg BT 471.24 264.10 Td (This ) Tj ET Q q 0 0 0 rg BT 490.99 264.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 524.05 264.10 Td (will ) Tj ET Q q 0 0 0 rg BT 541.57 264.10 Td (continue ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 252.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 252.10 Td (Europe ) Tj ET Q q 0 0 0 rg BT 77.66 252.10 Td (until ) Tj ET Q q 0 0 0 rg BT 98.49 252.10 Td (either ) Tj ET Q q 0 0 0 rg BT 123.75 252.10 Td (party ) Tj ET Q q 0 0 0 rg BT 146.80 252.10 Td (terminates ) Tj ET Q q 0 0 0 rg BT 190.95 252.10 Td (the ) Tj ET Q q 0 0 0 rg BT 205.67 252.10 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 258.14 252.10 Td (or ) Tj ET Q q 0 0 0 rg BT 268.97 252.10 Td (the ) Tj ET Q q 0 0 0 rg BT 283.69 252.10 Td (last ) Tj ET Q q 0 0 0 rg BT 300.07 252.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 327.01 252.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 358.38 252.10 Td (that ) Tj ET Q q 0 0 0 rg BT 375.88 252.10 Td (allows ) Tj ET Q q 0 0 0 rg BT 404.49 252.10 Td (market ) Tj ET Q q 0 0 0 rg BT 434.75 252.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 481.13 252.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 491.41 252.10 Td (Atripla*.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 228.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.93 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.74 228.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 84.62 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.43 228.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 143.66 228.10 Td (may ) Tj ET Q q 0 0 0 rg BT 163.48 228.10 Td (be ) Tj ET Q q 0 0 0 rg BT 175.51 228.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 220.86 228.10 Td (by ) Tj ET Q q 0 0 0 rg BT 233.46 228.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 262.71 228.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 285.30 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 300.12 228.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 329.37 228.10 Td (of ) Tj ET Q q 0 0 0 rg BT 340.29 228.10 Td (a ) Tj ET Q q 0 0 0 rg BT 347.33 228.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 379.34 228.10 Td (version ) Tj ET Q q 0 0 0 rg BT 411.38 228.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 422.30 228.10 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.79 228.10 Td (or ) Tj ET Q q 0 0 0 rg BT 464.71 228.10 Td (by ) Tj ET Q q 0 0 0 rg BT 477.31 228.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 501.02 228.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 523.62 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.43 228.10 Td (launch ) Tj ET Q q 0 0 0 rg BT 567.68 228.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 216.10 Td (a ) Tj ET Q q 0 0 0 rg BT 42.52 216.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 74.03 216.10 Td (version ) Tj ET Q q 0 0 0 rg BT 105.55 216.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 115.96 216.10 Td (T) Tj ET Q q 0 0 0 rg BT 120.97 216.10 Td (ruvada* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 156.38 216.10 Td (or ) Tj ET Q q 0 0 0 rg BT 166.80 216.10 Td (its ) Tj ET Q q 0 0 0 rg BT 178.33 216.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 220.96 216.10 Td (components) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 269.29 216.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.79 216.10 Td ( ) Tj ET Q q 0 0 0 rg BT 273.72 216.10 Td (The ) Tj ET Q q 0 0 0 rg BT 291.35 216.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 308.99 216.10 Td (of ) Tj ET Q q 0 0 0 rg BT 319.40 216.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 365.37 216.10 Td (in ) Tj ET Q q 0 0 0 rg BT 375.23 216.10 Td (the ) Tj ET Q q 0 0 0 rg BT 389.53 216.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 409.39 216.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 423.14 216.10 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.11 216.10 Td (is ) Tj ET Q q 0 0 0 rg BT 462.86 216.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 500.47 216.10 Td (in ) Tj ET Q q 0 0 0 rg BT 510.33 216.10 Td (December ) Tj ET Q q 0 0 0 rg BT 553.50 216.10 Td (2017. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 204.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.81 204.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.51 204.10 Td (event ) Tj ET Q q 0 0 0 rg BT 85.65 204.10 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 114.79 204.10 Td (terminates ) Tj ET Q q 0 0 0 rg BT 158.92 204.10 Td (the ) Tj ET Q q 0 0 0 rg BT 173.62 204.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 217.74 204.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 240.22 204.10 Td (the ) Tj ET Q q 0 0 0 rg BT 254.92 204.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 272.96 204.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.77 204.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 330.14 204.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 344.28 204.10 Td (Sustiva,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.67 204.10 Td ( ) Tj ET Q q 0 0 0 rg BT 378.15 204.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 401.75 204.10 Td (will ) Tj ET Q q 0 0 0 rg BT 419.79 204.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 451.14 204.10 Td (a ) Tj ET Q q 0 0 0 rg BT 458.06 204.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 496.63 204.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 527.44 204.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 564.36 204.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 192.10 Td (36 ) Tj ET Q q 0 0 0 rg BT 49.39 192.10 Td (months) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 78.84 192.10 Td ( ) Tj ET Q q 0 0 0 rg BT 82.23 192.10 Td (following ) Tj ET Q q 0 0 0 rg BT 124.51 192.10 Td (termination.  ) Tj ET Q q 0 0 0 rg BT 179.00 192.10 Td (Such ) Tj ET Q q 0 0 0 rg BT 202.40 192.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 240.22 192.10 Td (in ) Tj ET Q q 0 0 0 rg BT 251.39 192.10 Td (the ) Tj ET Q q 0 0 0 rg BT 267.00 192.10 Td (first ) Tj ET Q q 0 0 0 rg BT 286.50 192.10 Td (12 ) Tj ET Q q 0 0 0 rg BT 299.90 192.10 Td (months ) Tj ET Q q 0 0 0 rg BT 332.74 192.10 Td (following ) Tj ET Q q 0 0 0 rg BT 375.02 192.10 Td (termination ) Tj ET Q q 0 0 0 rg BT 424.51 192.10 Td (is ) Tj ET Q q 0 0 0 rg BT 434.57 192.10 Td (equal ) Tj ET Q q 0 0 0 rg BT 459.62 192.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.79 192.10 Td (55%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.12 192.10 Td ( ) Tj ET Q q 0 0 0 rg BT 492.51 192.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 504.23 192.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 537.57 192.10 Td ( ) Tj ET Q q 0 0 0 rg BT 540.96 192.10 Td (net ) Tj ET Q q 0 0 0 rg BT 556.57 192.10 Td (sales ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 180.10 Td (multiplied ) Tj ET Q q 0 0 0 rg BT 80.10 180.10 Td (by ) Tj ET Q q 0 0 0 rg BT 93.10 180.10 Td (the ) Tj ET Q q 0 0 0 rg BT 108.31 180.10 Td (ratio ) Tj ET Q q 0 0 0 rg BT 129.63 180.10 Td (of ) Tj ET Q q 0 0 0 rg BT 140.96 180.10 Td (the ) Tj ET Q q 0 0 0 rg BT 156.17 180.10 Td (dif) Tj ET Q q 0 0 0 rg BT 167.10 180.10 Td (ference ) Tj ET Q q 0 0 0 rg BT 199.51 180.10 Td (in ) Tj ET Q q 0 0 0 rg BT 210.28 180.10 Td (the ) Tj ET Q q 0 0 0 rg BT 225.49 180.10 Td (average ) Tj ET Q q 0 0 0 rg BT 259.57 180.10 Td (net ) Tj ET Q q 0 0 0 rg BT 274.79 180.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 304.45 180.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 331.32 180.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 342.65 180.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.98 180.10 Td ( ) Tj ET Q q 0 0 0 rg BT 378.98 180.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 396.41 180.10 Td (T) Tj ET Q q 0 0 0 rg BT 401.42 180.10 Td (ruvada*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.75 180.10 Td ( ) Tj ET Q q 0 0 0 rg BT 437.75 180.10 Td (to ) Tj ET Q q 0 0 0 rg BT 448.52 180.10 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 463.73 180.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.07 180.10 Td ( ) Tj ET Q q 0 0 0 rg BT 500.06 180.10 Td (average ) Tj ET Q q 0 0 0 rg BT 534.14 180.10 Td (net ) Tj ET Q q 0 0 0 rg BT 549.35 180.10 Td (selling ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 168.10 Td (price. In ) Tj ET Q q 0 0 0 rg BT 71.48 168.10 Td (the ) Tj ET Q q 0 0 0 rg BT 85.87 168.10 Td (second ) Tj ET Q q 0 0 0 rg BT 115.80 168.10 Td (and ) Tj ET Q q 0 0 0 rg BT 132.41 168.10 Td (third ) Tj ET Q q 0 0 0 rg BT 153.46 168.10 Td (years ) Tj ET Q q 0 0 0 rg BT 176.73 168.10 Td (following ) Tj ET Q q 0 0 0 rg BT 217.78 168.10 Td (termination, ) Tj ET Q q 0 0 0 rg BT 268.55 168.10 Td (the ) Tj ET Q q 0 0 0 rg BT 282.93 168.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 319.53 168.10 Td (to ) Tj ET Q q 0 0 0 rg BT 329.48 168.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 352.77 168.10 Td (is ) Tj ET Q q 0 0 0 rg BT 361.60 168.10 Td (reduced ) Tj ET Q q 0 0 0 rg BT 395.42 168.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.36 168.10 Td (35%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.69 168.10 Td ( ) Tj ET Q q 0 0 0 rg BT 425.86 168.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.46 168.10 Td (15%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.79 168.10 Td (, ) Tj ET Q q 0 0 0 rg BT 465.46 168.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 513.12 168.10 Td (, ) Tj ET Q q 0 0 0 rg BT 517.79 168.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 528.29 168.10 Td (Atripla*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.62 168.10 Td ( ) Tj ET Q q 0 0 0 rg BT 563.79 168.10 Td (net ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 156.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 57.46 156.10 Td (multiplied ) Tj ET Q q 0 0 0 rg BT 100.59 156.10 Td (by ) Tj ET Q q 0 0 0 rg BT 112.61 156.10 Td (the ) Tj ET Q q 0 0 0 rg BT 126.85 156.10 Td (price ) Tj ET Q q 0 0 0 rg BT 148.86 156.10 Td (ratio ) Tj ET Q q 0 0 0 rg BT 169.20 156.10 Td (described ) Tj ET Q q 0 0 0 rg BT 209.54 156.10 Td (above. ) Tj ET Q q 0 0 0 rg BT 237.94 156.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 261.08 156.10 Td (will ) Tj ET Q q 0 0 0 rg BT 278.66 156.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 315.12 156.10 Td (to ) Tj ET Q q 0 0 0 rg BT 324.92 156.10 Td (supply ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 353.61 156.10 Td (Sustiva ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 384.52 156.10 Td (at ) Tj ET Q q 0 0 0 rg BT 393.75 156.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 411.88 156.10 Td (plus ) Tj ET Q q 0 0 0 rg BT 430.58 156.10 Td (a ) Tj ET Q q 0 0 0 rg BT 437.04 156.10 Td (markup ) Tj ET Q q 0 0 0 rg BT 469.60 156.10 Td (to ) Tj ET Q q 0 0 0 rg BT 479.40 156.10 Td (the ) Tj ET Q q 0 0 0 rg BT 493.64 156.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 514.00 156.10 Td (ventures ) Tj ET Q q 0 0 0 rg BT 549.90 156.10 Td (during ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 144.10 Td (this ) Tj ET Q q 0 0 0 rg BT 52.95 144.10 Td (three-year ) Tj ET Q q 0 0 0 rg BT 95.97 144.10 Td (period, ) Tj ET Q q 0 0 0 rg BT 126.52 144.10 Td (unless ) Tj ET Q q 0 0 0 rg BT 154.02 144.10 Td (either ) Tj ET Q q 0 0 0 rg BT 179.28 144.10 Td (party ) Tj ET Q q 0 0 0 rg BT 202.33 144.10 Td (elects ) Tj ET Q q 0 0 0 rg BT 227.59 144.10 Td (to ) Tj ET Q q 0 0 0 rg BT 237.87 144.10 Td (terminate ) Tj ET Q q 0 0 0 rg BT 278.13 144.10 Td (the ) Tj ET Q q 0 0 0 rg BT 292.85 144.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 322.02 144.10 Td (arrangement.) Tj ET Q endstream endobj 131 0 obj <> endobj 132 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 749.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 749.10 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 749.10 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 714.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 686.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 686.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 686.60 60.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 726.6 m 448.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 726.6 m 452.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 726.6 m 512.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 726.6 m 516.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 714.6 m 448.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 714.6 m 512.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 714.6 m 576.5 714.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 730.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 730.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 718.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 718.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 718.68 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 705.33 Td (Revenues from Gilead alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 691.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 691.17 Td (934) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 691.17 Td (1,096) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 691.17 Td (1,255) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 663.17 Td (Equity in net loss of affiliates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 663.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 663.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 663.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 663.17 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 663.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 663.17 Td (39) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 622.60 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 622.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 622.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 622.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 622.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 635.6 m 512.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 635.6 m 516.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 635.6 m 576.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 622.6 m 512.5 622.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 622.6 m 576.5 622.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 622.6 m 512.5 622.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 622.6 m 576.5 622.6 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 639.33 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 639.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 626.85 Td (Dollars ) Tj ET Q q 0 0 0 rg BT 64.55 626.85 Td (in ) Tj ET Q q 0 0 0 rg BT 72.77 626.85 Td (Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 626.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 626.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 613.17 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 613.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 613.17 Td (634) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 613.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 613.17 Td (699) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 584.53505859375 m 67.123046875 584.53505859375 l s q 0 0 0 rg BT 36.00 586.10 Td (Otsuka) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 562.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.97 562.10 Td (has ) Tj ET Q q 0 0 0 rg BT 78.14 562.10 Td (a ) Tj ET Q q 0 0 0 rg BT 86.43 562.10 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 133.04 562.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 211.29 562.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 256.78 562.10 Td (with ) Tj ET Q q 0 0 0 rg BT 278.40 562.10 Td (Otsuka, ) Tj ET Q q 0 0 0 rg BT 313.08 562.10 Td (to ) Tj ET Q q 0 0 0 rg BT 324.70 562.10 Td (co-develop ) Tj ET Q q 0 0 0 rg BT 372.97 562.10 Td (and ) Tj ET Q q 0 0 0 rg BT 391.25 562.10 Td (co-promote ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 441.19 562.10 Td (Abilify*, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.19 562.10 Td (excluding ) Tj ET Q q 0 0 0 rg BT 522.47 562.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 552.67 562.10 Td (Asian ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 550.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 77.35 550.10 Td (The ) Tj ET Q q 0 0 0 rg BT 95.26 550.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 115.40 550.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 146.65 550.10 Td (of ) Tj ET Q q 0 0 0 rg BT 157.35 550.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.93 550.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 215.93 550.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 248.28 550.10 Td (in ) Tj ET Q q 0 0 0 rg BT 257.90 550.10 Td (April ) Tj ET Q q 0 0 0 rg BT 281.37 550.10 Td (2015. ) Tj ET Q q 0 0 0 rg BT 306.06 550.10 Td (The ) Tj ET Q q 0 0 0 rg BT 323.97 550.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 367.98 550.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 400.33 550.10 Td (in ) Tj ET Q q 0 0 0 rg BT 410.47 550.10 Td (all ) Tj ET Q q 0 0 0 rg BT 422.83 550.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 438.52 550.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 477.54 550.10 Td (in ) Tj ET Q q 0 0 0 rg BT 487.68 550.10 Td (June ) Tj ET Q q 0 0 0 rg BT 508.37 550.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 530.74 550.10 Td (and ) Tj ET Q q 0 0 0 rg BT 547.54 550.10 Td (in ) Tj ET Q q 0 0 0 rg BT 557.68 550.10 Td (each ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 538.10 Td (other ) Tj ET Q q 0 0 0 rg BT 58.91 538.10 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 97.39 538.10 Td (country ) Tj ET Q q 0 0 0 rg BT 130.30 538.10 Td (where ) Tj ET Q q 0 0 0 rg BT 157.10 538.10 Td (we ) Tj ET Q q 0 0 0 rg BT 171.12 538.10 Td (have ) Tj ET Q q 0 0 0 rg BT 192.37 538.10 Td (the ) Tj ET Q q 0 0 0 rg BT 206.95 538.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 247.08 538.10 Td (right ) Tj ET Q q 0 0 0 rg BT 268.33 538.10 Td (to ) Tj ET Q q 0 0 0 rg BT 278.48 538.10 Td (sell ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 294.73 538.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 326.39 538.10 Td (, ) Tj ET Q q 0 0 0 rg BT 331.25 538.10 Td (the ) Tj ET Q q 0 0 0 rg BT 345.84 538.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 389.84 538.10 Td (expires ) Tj ET Q q 0 0 0 rg BT 421.09 538.10 Td (on ) Tj ET Q q 0 0 0 rg BT 433.45 538.10 Td (the ) Tj ET Q q 0 0 0 rg BT 448.03 538.10 Td (later ) Tj ET Q q 0 0 0 rg BT 468.16 538.10 Td (of ) Tj ET Q q 0 0 0 rg BT 478.34 538.10 Td (April ) Tj ET Q q 0 0 0 rg BT 501.81 538.10 Td (20, ) Tj ET Q q 0 0 0 rg BT 516.68 538.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 539.04 538.10 Td (or ) Tj ET Q q 0 0 0 rg BT 549.74 538.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 567.67 538.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 526.10 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 82.38 526.10 Td (in ) Tj ET Q q 0 0 0 rg BT 92.66 526.10 Td (any ) Tj ET Q q 0 0 0 rg BT 109.60 526.10 Td (such ) Tj ET Q q 0 0 0 rg BT 130.43 526.10 Td (country) Tj ET Q q 0 0 0 rg BT 160.33 526.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 502.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 57.47 502.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 86.14 502.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 119.82 502.10 Td (participated ) Tj ET Q q 0 0 0 rg BT 169.03 502.10 Td (in ) Tj ET Q q 0 0 0 rg BT 178.83 502.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 199.19 502.10 Td (executive ) Tj ET Q q 0 0 0 rg BT 239.52 502.10 Td (governance ) Tj ET Q q 0 0 0 rg BT 287.62 502.10 Td (and ) Tj ET Q q 0 0 0 rg BT 304.08 502.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 343.87 502.10 Td (committees. ) Tj ET Q q 0 0 0 rg BT 394.49 502.10 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 424.84 502.10 Td (was ) Tj ET Q q 0 0 0 rg BT 442.41 502.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 489.98 502.10 Td (for ) Tj ET Q q 0 0 0 rg BT 503.66 502.10 Td (providing ) Tj ET Q q 0 0 0 rg BT 544.56 502.10 Td (all ) Tj ET Q q 0 0 0 rg BT 556.58 502.10 Td (sales ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 490.10 Td (force ) Tj ET Q q 0 0 0 rg BT 58.37 490.10 Td (ef) Tj ET Q q 0 0 0 rg BT 65.96 490.10 Td (forts ) Tj ET Q q 0 0 0 rg BT 86.13 490.10 Td (in ) Tj ET Q q 0 0 0 rg BT 95.75 490.10 Td (the ) Tj ET Q q 0 0 0 rg BT 109.80 490.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 129.42 490.10 Td (ef) Tj ET Q q 0 0 0 rg BT 137.01 490.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 166.05 490.10 Td (January ) Tj ET Q q 0 0 0 rg BT 198.98 490.10 Td (2013, ) Tj ET Q q 0 0 0 rg BT 223.32 490.10 Td (however) Tj ET Q q 0 0 0 rg BT 257.35 490.10 Td (, ) Tj ET Q q 0 0 0 rg BT 261.69 490.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 284.65 490.10 Td (was ) Tj ET Q q 0 0 0 rg BT 302.04 490.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 349.42 490.10 Td (for ) Tj ET Q q 0 0 0 rg BT 362.92 490.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 391.96 490.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 431.56 490.10 Td (expenses ) Tj ET Q q 0 0 0 rg BT 469.50 490.10 Td (up ) Tj ET Q q 0 0 0 rg BT 481.33 490.10 Td (to ) Tj ET Q q 0 0 0 rg BT 490.95 490.10 Td (various ) Tj ET Q q 0 0 0 rg BT 522.22 490.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 550.72 490.10 Td (limits. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 478.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.00 478.10 Td (purchased ) Tj ET Q q 0 0 0 rg BT 103.42 478.10 Td (the ) Tj ET Q q 0 0 0 rg BT 117.87 478.10 Td (API ) Tj ET Q q 0 0 0 rg BT 136.86 478.10 Td (from ) Tj ET Q q 0 0 0 rg BT 159.18 478.10 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 190.39 478.10 Td (and ) Tj ET Q q 0 0 0 rg BT 207.70 478.10 Td (completed ) Tj ET Q q 0 0 0 rg BT 252.23 478.10 Td (the ) Tj ET Q q 0 0 0 rg BT 267.33 478.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 328.51 478.10 Td (of ) Tj ET Q q 0 0 0 rg BT 339.72 478.10 Td (the ) Tj ET Q q 0 0 0 rg BT 354.82 478.10 Td (product ) Tj ET Q q 0 0 0 rg BT 388.24 478.10 Td (for ) Tj ET Q q 0 0 0 rg BT 402.78 478.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 450.09 478.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 468.52 478.10 Td (to ) Tj ET Q q 0 0 0 rg BT 479.17 478.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 524.81 478.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 568.24 478.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 466.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.25 466.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 70.07 466.10 Td (and ) Tj ET Q q 0 0 0 rg BT 86.54 466.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 115.78 466.10 Td (other ) Tj ET Q q 0 0 0 rg BT 138.36 466.10 Td (countries. ) Tj ET Q q 0 0 0 rg BT 179.55 466.10 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 209.92 466.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 246.39 466.10 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 302.87 466.10 Td (for ) Tj ET Q q 0 0 0 rg BT 316.57 466.10 Td (providing ) Tj ET Q q 0 0 0 rg BT 357.49 466.10 Td (and ) Tj ET Q q 0 0 0 rg BT 373.96 466.10 Td (funding ) Tj ET Q q 0 0 0 rg BT 407.11 466.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 428.58 466.10 Td (force ) Tj ET Q q 0 0 0 rg BT 451.15 466.10 Td (ef) Tj ET Q q 0 0 0 rg BT 458.74 466.10 Td (forts ) Tj ET Q q 0 0 0 rg BT 479.10 466.10 Td (in ) Tj ET Q q 0 0 0 rg BT 488.92 466.10 Td (the ) Tj ET Q q 0 0 0 rg BT 503.17 466.10 Td (EU ) Tj ET Q q 0 0 0 rg BT 518.54 466.10 Td (ef) Tj ET Q q 0 0 0 rg BT 526.12 466.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 554.91 466.10 Td (April ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 454.10 Td (2013. ) Tj ET Q q 0 0 0 rg BT 59.88 454.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 82.38 454.10 Td (also ) Tj ET Q q 0 0 0 rg BT 99.87 454.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 136.80 454.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 165.38 454.10 Td (other ) Tj ET Q q 0 0 0 rg BT 187.30 454.10 Td (services ) Tj ET Q q 0 0 0 rg BT 220.89 454.10 Td (including ) Tj ET Q q 0 0 0 rg BT 260.04 454.10 Td (distribution, ) Tj ET Q q 0 0 0 rg BT 310.04 454.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 348.07 454.10 Td (management ) Tj ET Q q 0 0 0 rg BT 400.54 454.10 Td (and ) Tj ET Q q 0 0 0 rg BT 416.36 454.10 Td (pharmacovigilance. ) Tj ET Q q 0 0 0 rg BT 496.31 454.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 518.81 454.10 Td (is ) Tj ET Q q 0 0 0 rg BT 526.86 454.10 Td (the ) Tj ET Q q 0 0 0 rg BT 540.46 454.10 Td (principal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 442.10 Td (for ) Tj ET Q q 0 0 0 rg BT 50.94 442.10 Td (the ) Tj ET Q q 0 0 0 rg BT 66.43 442.10 Td (end ) Tj ET Q q 0 0 0 rg BT 84.15 442.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 124.09 442.10 Td (product ) Tj ET Q q 0 0 0 rg BT 157.91 442.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 180.63 442.10 Td (where ) Tj ET Q q 0 0 0 rg BT 208.34 442.10 Td (it ) Tj ET Q q 0 0 0 rg BT 217.17 442.10 Td (is ) Tj ET Q q 0 0 0 rg BT 227.12 442.10 Td (the ) Tj ET Q q 0 0 0 rg BT 242.62 442.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 283.66 442.10 Td (distributor ) Tj ET Q q 0 0 0 rg BT 328.60 442.10 Td (for ) Tj ET Q q 0 0 0 rg BT 343.54 442.10 Td (or ) Tj ET Q q 0 0 0 rg BT 355.15 442.10 Td (has ) Tj ET Q q 0 0 0 rg BT 371.76 442.10 Td (an ) Tj ET Q q 0 0 0 rg BT 384.48 442.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 425.52 442.10 Td (right ) Tj ET Q q 0 0 0 rg BT 447.68 442.10 Td (to ) Tj ET Q q 0 0 0 rg BT 458.74 442.10 Td (sell ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 475.91 442.10 Td (Abilify*. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.35 442.10 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 544.96 442.10 Td (was ) Tj ET Q q 0 0 0 rg BT 563.79 442.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 430.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 74.04 430.10 Td (for ) Tj ET Q q 0 0 0 rg BT 88.20 430.10 Td (the ) Tj ET Q q 0 0 0 rg BT 102.92 430.10 Td (end ) Tj ET Q q 0 0 0 rg BT 119.86 430.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 159.01 430.10 Td (product ) Tj ET Q q 0 0 0 rg BT 192.06 430.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 214.00 430.10 Td (in ) Tj ET Q q 0 0 0 rg BT 224.28 430.10 Td (the ) Tj ET Q q 0 0 0 rg BT 238.99 430.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 259.28 430.10 Td (and ) Tj ET Q q 0 0 0 rg BT 276.21 430.10 Td (in ) Tj ET Q q 0 0 0 rg BT 286.49 430.10 Td (the ) Tj ET Q q 0 0 0 rg BT 301.21 430.10 Td (EU. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 406.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 73.29 406.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 108.35 406.10 Td (only ) Tj ET Q q 0 0 0 rg BT 129.54 406.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 166.28 406.10 Td (BMS’) Tj ET Q q 0 0 0 rg BT 190.18 406.10 Td (s ) Tj ET Q q 0 0 0 rg BT 197.49 406.10 Td (share ) Tj ET Q q 0 0 0 rg BT 222.01 406.10 Td (of ) Tj ET Q q 0 0 0 rg BT 233.75 406.10 Td (total ) Tj ET Q q 0 0 0 rg BT 254.94 406.10 Td (net ) Tj ET Q q 0 0 0 rg BT 270.57 406.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 293.43 406.10 Td (to ) Tj ET Q q 0 0 0 rg BT 304.62 406.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 350.80 406.10 Td (customers ) Tj ET Q q 0 0 0 rg BT 394.76 406.10 Td (in ) Tj ET Q q 0 0 0 rg BT 405.96 406.10 Td (these ) Tj ET Q q 0 0 0 rg BT 429.92 406.10 Td (territories. ) Tj ET Q q 0 0 0 rg BT 473.95 406.10 Td (An ) Tj ET Q q 0 0 0 rg BT 489.59 406.10 Td (assessment ) Tj ET Q q 0 0 0 rg BT 537.44 406.10 Td (of ) Tj ET Q q 0 0 0 rg BT 549.19 406.10 Td (BMS's ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 394.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 74.65 394.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 104.42 394.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 151.96 394.10 Td (share ) Tj ET Q q 0 0 0 rg BT 176.17 394.10 Td (was ) Tj ET Q q 0 0 0 rg BT 194.84 394.10 Td (completed ) Tj ET Q q 0 0 0 rg BT 239.61 394.10 Td (each ) Tj ET Q q 0 0 0 rg BT 261.04 394.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 300.25 394.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 340.02 394.10 Td (period ) Tj ET Q q 0 0 0 rg BT 368.69 394.10 Td (and ) Tj ET Q q 0 0 0 rg BT 386.24 394.10 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 422.68 394.10 Td (based ) Tj ET Q q 0 0 0 rg BT 448.57 394.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 471.68 394.10 Td (reported ) Tj ET Q q 0 0 0 rg BT 508.12 394.10 Td (U.S. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 529.02 394.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.68 394.10 Td ( ) Tj ET Q q 0 0 0 rg BT 563.79 394.10 Td (net ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 382.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 58.28 382.10 Td (at ) Tj ET Q q 0 0 0 rg BT 68.33 382.10 Td (year ) Tj ET Q q 0 0 0 rg BT 88.38 382.10 Td (end. ) Tj ET Q q 0 0 0 rg BT 108.16 382.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 137.81 382.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 167.31 382.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 214.57 382.10 Td (share ) Tj ET Q q 0 0 0 rg BT 238.50 382.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.90 382.10 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 275.23 382.10 Td ( ) Tj ET Q q 0 0 0 rg BT 278.07 382.10 Td (in ) Tj ET Q q 0 0 0 rg BT 288.68 382.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 311.52 382.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 328.80 382.10 Td (33%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.13 382.10 Td ( ) Tj ET Q q 0 0 0 rg BT 349.97 382.10 Td (in ) Tj ET Q q 0 0 0 rg BT 360.59 382.10 Td (2014. ) Tj ET Q q 0 0 0 rg BT 385.72 382.10 Td (The ) Tj ET Q q 0 0 0 rg BT 404.11 382.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 438.04 382.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 472.52 382.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 519.22 382.10 Td (in ) Tj ET Q q 0 0 0 rg BT 529.84 382.10 Td (any ) Tj ET Q q 0 0 0 rg BT 547.12 382.10 Td (interim ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 370.10 Td (period ) Tj ET Q q 0 0 0 rg BT 64.05 370.10 Td (or ) Tj ET Q q 0 0 0 rg BT 74.88 370.10 Td (quarter ) Tj ET Q q 0 0 0 rg BT 105.69 370.10 Td (did ) Tj ET Q q 0 0 0 rg BT 120.97 370.10 Td (not ) Tj ET Q q 0 0 0 rg BT 136.25 370.10 Td (exceed ) Tj ET Q q 0 0 0 rg BT 166.50 370.10 Td (the ) Tj ET Q q 0 0 0 rg BT 181.22 370.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 217.61 370.10 Td (that ) Tj ET Q q 0 0 0 rg BT 235.10 370.10 Td (were ) Tj ET Q q 0 0 0 rg BT 257.03 370.10 Td (due ) Tj ET Q q 0 0 0 rg BT 273.97 370.10 Td (under ) Tj ET Q q 0 0 0 rg BT 299.24 370.10 Td (the ) Tj ET Q q 0 0 0 rg BT 313.95 370.10 Td (contract.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 346.10 Td (BMS’) Tj ET Q q 0 0 0 rg BT 59.90 346.10 Td (s ) Tj ET Q q 0 0 0 rg BT 66.63 346.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 113.89 346.10 Td (share ) Tj ET Q q 0 0 0 rg BT 137.83 346.10 Td (of ) Tj ET Q q 0 0 0 rg BT 149.00 346.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 194.60 346.10 Td (net ) Tj ET Q q 0 0 0 rg BT 209.66 346.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 231.94 346.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 250.33 346.10 Td (65%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.66 346.10 Td ( ) Tj ET Q q 0 0 0 rg BT 271.50 346.10 Td (in ) Tj ET Q q 0 0 0 rg BT 282.11 346.10 Td (the ) Tj ET Q q 0 0 0 rg BT 297.17 346.10 Td (EU. ) Tj ET Q q 0 0 0 rg BT 315.84 346.10 Td (In ) Tj ET Q q 0 0 0 rg BT 327.01 346.10 Td (these ) Tj ET Q q 0 0 0 rg BT 350.39 346.10 Td (countries ) Tj ET Q q 0 0 0 rg BT 389.89 346.10 Td (and ) Tj ET Q q 0 0 0 rg BT 407.17 346.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.22 346.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 445.35 346.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 479.27 346.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 513.76 346.10 Td (was ) Tj ET Q q 0 0 0 rg BT 532.15 346.10 Td (recognized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 334.10 Td (when ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 60.16 334.10 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 91.82 334.10 Td ( ) Tj ET Q q 0 0 0 rg BT 94.32 334.10 Td (was ) Tj ET Q q 0 0 0 rg BT 112.37 334.10 Td (shipped ) Tj ET Q q 0 0 0 rg BT 145.98 334.10 Td (and ) Tj ET Q q 0 0 0 rg BT 162.92 334.10 Td (all ) Tj ET Q q 0 0 0 rg BT 175.41 334.10 Td (risks ) Tj ET Q q 0 0 0 rg BT 196.81 334.10 Td (and ) Tj ET Q q 0 0 0 rg BT 213.74 334.10 Td (rewards ) Tj ET Q q 0 0 0 rg BT 247.89 334.10 Td (of ) Tj ET Q q 0 0 0 rg BT 258.72 334.10 Td (ownership ) Tj ET Q q 0 0 0 rg BT 302.88 334.10 Td (had ) Tj ET Q q 0 0 0 rg BT 319.82 334.10 Td (been ) Tj ET Q q 0 0 0 rg BT 341.20 334.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 387.01 334.10 Td (to ) Tj ET Q q 0 0 0 rg BT 397.28 334.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 442.55 334.10 Td (customers.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 312.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.65 312.50 Td (and ) Tj ET Q q 0 0 0 rg BT 76.61 312.50 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 107.46 312.50 Td (also ) Tj ET Q q 0 0 0 rg BT 126.09 312.50 Td (have ) Tj ET Q q 0 0 0 rg BT 147.49 312.50 Td (an ) Tj ET Q q 0 0 0 rg BT 159.45 312.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 193.06 312.50 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 207.24 312.50 Td (Sprycel ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 239.75 312.50 Td (in ) Tj ET Q q 0 0 0 rg BT 250.05 312.50 Td (the ) Tj ET Q q 0 0 0 rg BT 264.79 312.50 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 287.59 312.50 Td (Japan ) Tj ET Q q 0 0 0 rg BT 312.88 312.50 Td (and ) Tj ET Q q 0 0 0 rg BT 329.84 312.50 Td (the ) Tj ET Q q 0 0 0 rg BT 344.58 312.50 Td (EU ) Tj ET Q q 0 0 0 rg BT 360.43 312.50 Td (\(the ) Tj ET Q q 0 0 0 rg BT 378.50 312.50 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 420.28 312.50 Td (T) Tj ET Q q 0 0 0 rg BT 425.69 312.50 Td (erritory\). ) Tj ET Q q 0 0 0 rg BT 464.03 312.50 Td (Both ) Tj ET Q q 0 0 0 rg BT 486.00 312.50 Td (parties ) Tj ET Q q 0 0 0 rg BT 515.18 312.50 Td (co-promote ) Tj ET Q q 0 0 0 rg BT 563.79 312.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 300.50 Td (product ) Tj ET Q q 0 0 0 rg BT 69.10 300.50 Td (in ) Tj ET Q q 0 0 0 rg BT 79.42 300.50 Td (the ) Tj ET Q q 0 0 0 rg BT 94.19 300.50 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 114.52 300.50 Td (and ) Tj ET Q q 0 0 0 rg BT 131.51 300.50 Td (EU. ) Tj ET Q q 0 0 0 rg BT 149.89 300.50 Td (In ) Tj ET Q q 0 0 0 rg BT 160.77 300.50 Td (February ) Tj ET Q q 0 0 0 rg BT 199.41 300.50 Td (2015, ) Tj ET Q q 0 0 0 rg BT 224.46 300.50 Td (the ) Tj ET Q q 0 0 0 rg BT 239.23 300.50 Td (co-promotion ) Tj ET Q q 0 0 0 rg BT 296.21 300.50 Td (agreement ) Tj ET Q q 0 0 0 rg BT 340.40 300.50 Td (with ) Tj ET Q q 0 0 0 rg BT 360.73 300.50 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 391.61 300.50 Td (was ) Tj ET Q q 0 0 0 rg BT 409.71 300.50 Td (terminated ) Tj ET Q q 0 0 0 rg BT 455.01 300.50 Td (in ) Tj ET Q q 0 0 0 rg BT 465.34 300.50 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 493.16 300.50 Td (Both ) Tj ET Q q 0 0 0 rg BT 515.16 300.50 Td (parties ) Tj ET Q q 0 0 0 rg BT 544.36 300.50 Td (actively ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 288.50 Td (participate ) Tj ET Q q 0 0 0 rg BT 82.53 288.50 Td (in ) Tj ET Q q 0 0 0 rg BT 94.63 288.50 Td (various ) Tj ET Q q 0 0 0 rg BT 128.40 288.50 Td (governance ) Tj ET Q q 0 0 0 rg BT 178.81 288.50 Td (committees, ) Tj ET Q q 0 0 0 rg BT 231.74 288.50 Td (however) Tj ET Q q 0 0 0 rg BT 265.77 288.50 Td (, ) Tj ET Q q 0 0 0 rg BT 272.59 288.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 298.04 288.50 Td (has ) Tj ET Q q 0 0 0 rg BT 315.70 288.50 Td (control ) Tj ET Q q 0 0 0 rg BT 348.36 288.50 Td (over ) Tj ET Q q 0 0 0 rg BT 370.45 288.50 Td (the ) Tj ET Q q 0 0 0 rg BT 387.00 288.50 Td (decision ) Tj ET Q q 0 0 0 rg BT 424.65 288.50 Td (making. ) Tj ET Q q 0 0 0 rg BT 461.47 288.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 486.93 288.50 Td (is ) Tj ET Q q 0 0 0 rg BT 497.92 288.50 Td (responsible ) Tj ET Q q 0 0 0 rg BT 547.80 288.50 Td (for ) Tj ET Q q 0 0 0 rg BT 563.79 288.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.50 Td (development ) Tj ET Q q 0 0 0 rg BT 90.66 276.50 Td (and ) Tj ET Q q 0 0 0 rg BT 108.10 276.50 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 161.08 276.50 Td (of ) Tj ET Q q 0 0 0 rg BT 172.42 276.50 Td (the ) Tj ET Q q 0 0 0 rg BT 187.64 276.50 Td (product ) Tj ET Q q 0 0 0 rg BT 221.19 276.50 Td (and ) Tj ET Q q 0 0 0 rg BT 238.64 276.50 Td (is ) Tj ET Q q 0 0 0 rg BT 248.32 276.50 Td (also ) Tj ET Q q 0 0 0 rg BT 267.43 276.50 Td (the ) Tj ET Q q 0 0 0 rg BT 282.66 276.50 Td (principal ) Tj ET Q q 0 0 0 rg BT 321.20 276.50 Td (in ) Tj ET Q q 0 0 0 rg BT 331.99 276.50 Td (the ) Tj ET Q q 0 0 0 rg BT 347.21 276.50 Td (end ) Tj ET Q q 0 0 0 rg BT 364.66 276.50 Td (customer ) Tj ET Q q 0 0 0 rg BT 404.32 276.50 Td (product ) Tj ET Q q 0 0 0 rg BT 437.87 276.50 Td (sales. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 462.82 276.50 Td (Ixempra* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.15 276.50 Td (\(ixabepilone\) ) Tj ET Q q 0 0 0 rg BT 560.46 276.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.50 Td (included ) Tj ET Q q 0 0 0 rg BT 71.99 264.50 Td (in ) Tj ET Q q 0 0 0 rg BT 81.32 264.50 Td (the ) Tj ET Q q 0 0 0 rg BT 95.09 264.50 Td (above ) Tj ET Q q 0 0 0 rg BT 120.52 264.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 153.16 264.50 Td (prior ) Tj ET Q q 0 0 0 rg BT 174.15 264.50 Td (to ) Tj ET Q q 0 0 0 rg BT 183.48 264.50 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 211.85 264.50 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 255.61 264.50 Td (of ) Tj ET Q q 0 0 0 rg BT 265.50 264.50 Td (that ) Tj ET Q q 0 0 0 rg BT 282.04 264.50 Td (business ) Tj ET Q q 0 0 0 rg BT 317.49 264.50 Td (in ) Tj ET Q q 0 0 0 rg BT 326.82 264.50 Td (2015. ) Tj ET Q q 0 0 0 rg BT 350.53 264.50 Td (A) Tj ET Q q 0 0 0 rg BT 357.20 264.50 Td ( ) Tj ET Q q 0 0 0 rg BT 358.75 264.50 Td (fee ) Tj ET Q q 0 0 0 rg BT 372.51 264.50 Td (is ) Tj ET Q q 0 0 0 rg BT 380.74 264.50 Td (paid ) Tj ET Q q 0 0 0 rg BT 399.50 264.50 Td (to ) Tj ET Q q 0 0 0 rg BT 408.84 264.50 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 438.72 264.50 Td (based ) Tj ET Q q 0 0 0 rg BT 463.04 264.50 Td (on ) Tj ET Q q 0 0 0 rg BT 474.59 264.50 Td (the ) Tj ET Q q 0 0 0 rg BT 488.36 264.50 Td (following ) Tj ET Q q 0 0 0 rg BT 528.80 264.50 Td (percentages ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 252.50 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 252.50 Td (combined ) Tj ET Q q 0 0 0 rg BT 88.76 252.50 Td (annual ) Tj ET Q q 0 0 0 rg BT 117.92 252.50 Td (net ) Tj ET Q q 0 0 0 rg BT 132.64 252.50 Td (sales ) Tj ET Q q 0 0 0 rg BT 154.57 252.50 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 165.40 252.50 Td (Sprycel ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 197.89 252.50 Td (and) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 212.33 252.50 Td ( ) Tj ET Q q 0 0 0 rg BT 214.83 252.50 Td (Ixempra* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 255.65 252.50 Td (in ) Tj ET Q q 0 0 0 rg BT 265.93 252.50 Td (the ) Tj ET Q q 0 0 0 rg BT 280.64 252.50 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 322.40 252.50 Td (T) Tj ET Q q 0 0 0 rg BT 327.81 252.50 Td (erritory ) Tj ET Q q 0 0 0 rg BT 360.30 252.50 Td (\(including ) Tj ET Q q 0 0 0 rg BT 403.90 252.50 Td (post ) Tj ET Q q 0 0 0 rg BT 423.07 252.50 Td (divestiture ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 467.78 252.50 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.10 252.50 Td ( ) Tj ET Q q 0 0 0 rg BT 508.60 252.50 Td (sales\):) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 218.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 218.00 82.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 218.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 218.00 82.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 194.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 194.00 82.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 194.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 194.00 82.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 170.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 170.00 82.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 170.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 170.00 82.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 230 m 490.5 230 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 230 m 494.5 230 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 494.5 230 m 576.5 230 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 218 m 490.5 218 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 494.5 218 m 576.5 218 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 233.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 467.00 234.08 Td (% of Net Sales) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 221.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 429.65 222.08 Td (2010 - 2012) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 515.65 222.08 Td (2013 - 2020) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 208.62 Td ($0 to $400 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.80 208.62 Td (30%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.80 208.62 Td (65%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 196.62 Td ($400 million to $600 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.30 196.62 Td (5%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.80 196.62 Td (12%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 184.62 Td ($600 million to $800 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.30 184.62 Td (3%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.30 184.62 Td (3%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 172.62 Td ($800 million to $1.0 billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.30 172.62 Td (2%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.30 172.62 Td (2%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 160.62 Td (In excess of $1.0 billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 442.30 160.62 Td (1%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.30 160.62 Td (1%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.50 Td (During ) Tj ET Q q 0 0 0 rg BT 66.52 134.50 Td (these ) Tj ET Q q 0 0 0 rg BT 89.25 134.50 Td (annual ) Tj ET Q q 0 0 0 rg BT 118.09 134.50 Td (periods, ) Tj ET Q q 0 0 0 rg BT 152.22 134.50 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 182.73 134.50 Td (contributes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.35 134.50 Td (20%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.68 134.50 Td ( ) Tj ET Q q 0 0 0 rg BT 249.87 134.50 Td (of ) Tj ET Q q 0 0 0 rg BT 260.39 134.50 Td (the ) Tj ET Q q 0 0 0 rg BT 274.79 134.50 Td (first ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.08 134.50 Td ($175 ) Tj ET Q q 0 0 0 rg BT 315.27 134.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.16 134.50 Td ( ) Tj ET Q q 0 0 0 rg BT 346.35 134.50 Td (of ) Tj ET Q q 0 0 0 rg BT 356.87 134.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 386.25 134.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 435.64 134.50 Td (operational ) Tj ET Q q 0 0 0 rg BT 482.81 134.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 521.09 134.50 Td (relating ) Tj ET Q q 0 0 0 rg BT 553.82 134.50 Td (to ) Tj ET Q q 0 0 0 rg BT 563.78 134.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 122.50 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 77.94 122.50 Td (Products ) Tj ET Q q 0 0 0 rg BT 115.44 122.50 Td (in ) Tj ET Q q 0 0 0 rg BT 125.72 122.50 Td (the ) Tj ET Q q 0 0 0 rg BT 140.43 122.50 Td (Oncology ) Tj ET Q q 0 0 0 rg BT 182.19 122.50 Td (T) Tj ET Q q 0 0 0 rg BT 187.60 122.50 Td (erritory ) Tj ET Q q 0 0 0 rg BT 220.09 122.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 237.03 122.50 Td (1%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 250.36 122.50 Td ( ) Tj ET Q q 0 0 0 rg BT 252.86 122.50 Td (of ) Tj ET Q q 0 0 0 rg BT 263.69 122.50 Td (such ) Tj ET Q q 0 0 0 rg BT 284.52 122.50 Td (costs ) Tj ET Q q 0 0 0 rg BT 307.02 122.50 Td (in ) Tj ET Q q 0 0 0 rg BT 317.29 122.50 Td (excess ) Tj ET Q q 0 0 0 rg BT 345.89 122.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 356.72 122.50 Td ($175 ) Tj ET Q q 0 0 0 rg BT 379.22 122.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.11 122.50 Td (.) Tj ET Q endstream endobj 133 0 obj <> endobj 134 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 749.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 749.10 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 749.10 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 712.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 660.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 634.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 608.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 608.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 725.6 m 448.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 725.6 m 452.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 725.6 m 512.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.6 m 516.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 712.6 m 448.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 712.6 m 512.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 673.6 m 448.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 661.6 m 448.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 659.6 m 448.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 673.6 m 512.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 661.6 m 512.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 659.6 m 512.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 673.6 m 576.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 661.6 m 576.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 659.6 m 576.5 659.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 716.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 703.33 Td (Revenues from Otsuka alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.15 690.17 Td (1,670) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 690.17 Td (1,501) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 690.17 Td (1,493) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 677.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 110.91 681.70 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 677.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 677.17 Td (604) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 677.17 Td (1,778) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 664.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.15 664.17 Td (1,672) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.15 664.17 Td (2,105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 664.17 Td (3,271) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 638.33 Td (Payments to/\(from\) Otsuka:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 625.17 Td (Cost of products sold:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 612.17 Td (Oncology fee) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 612.17 Td (304) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 612.17 Td (299) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 612.17 Td (297) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 599.17 Td (Royalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 599.17 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 599.17 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 599.17 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 586.17 Td (Cost of product supply) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 586.17 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 586.17 Td (35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 586.17 Td (67) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 568.10 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 568.10 Td (Includes the amortization of the extension payment as a reduction to alliance revenue of ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 337.45 568.10 Td ($21 million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 374.56 568.10 Td ( in 2015 and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.34 568.10 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 416.84 568.10 Td ($66 million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 453.95 568.10 Td ( in 2014.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 542.53505859375 m 56.0048828125 542.53505859375 l s q 0 0 0 rg BT 36.00 544.10 Td (Lilly) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 520.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 58.63 520.10 Td (had ) Tj ET Q q 0 0 0 rg BT 74.58 520.10 Td (a ) Tj ET Q q 0 0 0 rg BT 80.53 520.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 156.45 520.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 199.61 520.10 Td (with ) Tj ET Q q 0 0 0 rg BT 218.90 520.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 239.85 520.10 Td (through ) Tj ET Q q 0 0 0 rg BT 272.47 520.10 Td (Lilly’) Tj ET Q q 0 0 0 rg BT 294.69 520.10 Td (s ) Tj ET Q q 0 0 0 rg BT 300.09 520.10 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 342.71 520.10 Td (ImClone ) Tj ET Q q 0 0 0 rg BT 379.22 520.10 Td (for ) Tj ET Q q 0 0 0 rg BT 392.39 520.10 Td (the ) Tj ET Q q 0 0 0 rg BT 406.12 520.10 Td (co-development ) Tj ET Q q 0 0 0 rg BT 472.05 520.10 Td (and ) Tj ET Q q 0 0 0 rg BT 488.00 520.10 Td (promotion ) Tj ET Q q 0 0 0 rg BT 531.18 520.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 541.02 520.10 Td (Erbitux) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.01 520.10 Td (* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 508.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.19 508.10 Td (the ) Tj ET Q q 0 0 0 rg BT 60.81 508.10 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 83.50 508.10 Td (Canada ) Tj ET Q q 0 0 0 rg BT 115.89 508.10 Td (and ) Tj ET Q q 0 0 0 rg BT 132.74 508.10 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 160.41 508.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 182.27 508.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 211.33 508.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 245.39 508.10 Td (participated ) Tj ET Q q 0 0 0 rg BT 294.99 508.10 Td (in ) Tj ET Q q 0 0 0 rg BT 305.18 508.10 Td (a ) Tj ET Q q 0 0 0 rg BT 312.03 508.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 332.77 508.10 Td (executive ) Tj ET Q q 0 0 0 rg BT 373.49 508.10 Td (committee ) Tj ET Q q 0 0 0 rg BT 418.10 508.10 Td (and ) Tj ET Q q 0 0 0 rg BT 434.95 508.10 Td (various ) Tj ET Q q 0 0 0 rg BT 466.79 508.10 Td (other ) Tj ET Q q 0 0 0 rg BT 489.75 508.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 529.92 508.10 Td (committees ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 496.10 Td (and ) Tj ET Q q 0 0 0 rg BT 51.72 496.10 Td (shared ) Tj ET Q q 0 0 0 rg BT 79.09 496.10 Td (responsibilities ) Tj ET Q q 0 0 0 rg BT 140.92 496.10 Td (for ) Tj ET Q q 0 0 0 rg BT 153.86 496.10 Td (research ) Tj ET Q q 0 0 0 rg BT 188.45 496.10 Td (and ) Tj ET Q q 0 0 0 rg BT 204.16 496.10 Td (development ) Tj ET Q q 0 0 0 rg BT 257.09 496.10 Td (using ) Tj ET Q q 0 0 0 rg BT 280.04 496.10 Td (resources ) Tj ET Q q 0 0 0 rg BT 319.08 496.10 Td (in ) Tj ET Q q 0 0 0 rg BT 328.13 496.10 Td (their ) Tj ET Q q 0 0 0 rg BT 347.74 496.10 Td (own ) Tj ET Q q 0 0 0 rg BT 366.24 496.10 Td (infrastructures. ) Tj ET Q q 0 0 0 rg BT 427.77 496.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 448.49 496.10 Td (manufactured ) Tj ET Q q 0 0 0 rg BT 504.74 496.10 Td (bulk ) Tj ET Q q 0 0 0 rg BT 523.80 496.10 Td (requirements ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 484.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 50.49 484.10 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 85.48 484.10 Td ( ) Tj ET Q q 0 0 0 rg BT 88.31 484.10 Td (in ) Tj ET Q q 0 0 0 rg BT 98.91 484.10 Td (its ) Tj ET Q q 0 0 0 rg BT 111.19 484.10 Td (own ) Tj ET Q q 0 0 0 rg BT 131.23 484.10 Td (facilities ) Tj ET Q q 0 0 0 rg BT 168.49 484.10 Td (and ) Tj ET Q q 0 0 0 rg BT 185.75 484.10 Td (filling ) Tj ET Q q 0 0 0 rg BT 213.02 484.10 Td (and ) Tj ET Q q 0 0 0 rg BT 230.29 484.10 Td (finishing ) Tj ET Q q 0 0 0 rg BT 268.67 484.10 Td (was ) Tj ET Q q 0 0 0 rg BT 287.05 484.10 Td (performed ) Tj ET Q q 0 0 0 rg BT 331.52 484.10 Td (by ) Tj ET Q q 0 0 0 rg BT 344.35 484.10 Td (a ) Tj ET Q q 0 0 0 rg BT 351.61 484.10 Td (third ) Tj ET Q q 0 0 0 rg BT 373.32 484.10 Td (party ) Tj ET Q q 0 0 0 rg BT 396.70 484.10 Td (for ) Tj ET Q q 0 0 0 rg BT 411.18 484.10 Td (which ) Tj ET Q q 0 0 0 rg BT 438.45 484.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 462.40 484.10 Td (had ) Tj ET Q q 0 0 0 rg BT 479.66 484.10 Td (oversight ) Tj ET Q q 0 0 0 rg BT 519.71 484.10 Td (responsibility) Tj ET Q q 0 0 0 rg BT 573.50 484.10 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 472.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.99 472.10 Td (had ) Tj ET Q q 0 0 0 rg BT 77.29 472.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 117.92 472.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 166.89 472.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 192.54 472.10 Td (in ) Tj ET Q q 0 0 0 rg BT 203.18 472.10 Td (North ) Tj ET Q q 0 0 0 rg BT 228.74 472.10 Td (America ) Tj ET Q q 0 0 0 rg BT 266.03 472.10 Td (and ) Tj ET Q q 0 0 0 rg BT 283.33 472.10 Td (was ) Tj ET Q q 0 0 0 rg BT 301.75 472.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 350.16 472.10 Td (for ) Tj ET Q q 0 0 0 rg BT 364.68 472.10 Td (promotional ) Tj ET Q q 0 0 0 rg BT 416.43 472.10 Td (ef) Tj ET Q q 0 0 0 rg BT 424.01 472.10 Td (forts ) Tj ET Q q 0 0 0 rg BT 445.21 472.10 Td (in ) Tj ET Q q 0 0 0 rg BT 455.85 472.10 Td (North ) Tj ET Q q 0 0 0 rg BT 481.41 472.10 Td (America ) Tj ET Q q 0 0 0 rg BT 518.70 472.10 Td (although ) Tj ET Q q 0 0 0 rg BT 556.56 472.10 Td (Lilly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 460.10 Td (had ) Tj ET Q q 0 0 0 rg BT 52.72 460.10 Td (the ) Tj ET Q q 0 0 0 rg BT 67.22 460.10 Td (right ) Tj ET Q q 0 0 0 rg BT 88.39 460.10 Td (to ) Tj ET Q q 0 0 0 rg BT 98.46 460.10 Td (co-promote ) Tj ET Q q 0 0 0 rg BT 146.83 460.10 Td (in ) Tj ET Q q 0 0 0 rg BT 156.90 460.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.40 460.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 191.47 460.10 Td (at ) Tj ET Q q 0 0 0 rg BT 200.97 460.10 Td (their ) Tj ET Q q 0 0 0 rg BT 221.58 460.10 Td (own ) Tj ET Q q 0 0 0 rg BT 241.08 460.10 Td (expense. ) Tj ET Q q 0 0 0 rg BT 278.07 460.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 301.48 460.10 Td (was ) Tj ET Q q 0 0 0 rg BT 319.32 460.10 Td (the ) Tj ET Q q 0 0 0 rg BT 333.82 460.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 371.64 460.10 Td (in ) Tj ET Q q 0 0 0 rg BT 381.71 460.10 Td (the ) Tj ET Q q 0 0 0 rg BT 396.21 460.10 Td (end ) Tj ET Q q 0 0 0 rg BT 412.93 460.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 451.87 460.10 Td (product ) Tj ET Q q 0 0 0 rg BT 484.70 460.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 506.42 460.10 Td (in ) Tj ET Q q 0 0 0 rg BT 516.49 460.10 Td (North ) Tj ET Q q 0 0 0 rg BT 541.60 460.10 Td (America ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 448.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.26 448.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 73.30 448.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 95.57 448.10 Td (a ) Tj ET Q q 0 0 0 rg BT 102.84 448.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 151.77 448.10 Td (fee ) Tj ET Q q 0 0 0 rg BT 166.81 448.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.29 448.10 Td (39%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.62 448.10 Td ( ) Tj ET Q q 0 0 0 rg BT 202.45 448.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 213.60 448.10 Td (Erbitux) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 243.60 448.10 Td (* ) Tj ET Q q 0 0 0 rg BT 251.42 448.10 Td (net ) Tj ET Q q 0 0 0 rg BT 266.46 448.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 288.72 448.10 Td (in ) Tj ET Q q 0 0 0 rg BT 299.33 448.10 Td (North ) Tj ET Q q 0 0 0 rg BT 324.86 448.10 Td (America ) Tj ET Q q 0 0 0 rg BT 362.11 448.10 Td (plus ) Tj ET Q q 0 0 0 rg BT 381.60 448.10 Td (a ) Tj ET Q q 0 0 0 rg BT 388.87 448.10 Td (share ) Tj ET Q q 0 0 0 rg BT 412.79 448.10 Td (of ) Tj ET Q q 0 0 0 rg BT 423.94 448.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 453.97 448.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 491.23 448.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 511.27 448.10 Td (by ) Tj ET Q q 0 0 0 rg BT 524.09 448.10 Td (Lilly) Tj ET Q q 0 0 0 rg BT 542.89 448.10 Td (. ) Tj ET Q q 0 0 0 rg BT 548.21 448.10 Td (BMS’) Tj ET Q q 0 0 0 rg BT 572.11 448.10 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 436.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.28 436.10 Td (and ) Tj ET Q q 0 0 0 rg BT 78.22 436.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 125.16 436.10 Td (with ) Tj ET Q q 0 0 0 rg BT 145.44 436.10 Td (respect ) Tj ET Q q 0 0 0 rg BT 176.25 436.10 Td (to ) Tj ET Q q 0 0 0 rg BT 186.53 436.10 Td (the ) Tj ET Q q 0 0 0 rg BT 201.25 436.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 278.16 436.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 288.99 436.10 Td (Erbitux) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.98 436.10 Td (* ) Tj ET Q q 0 0 0 rg BT 326.48 436.10 Td (in ) Tj ET Q q 0 0 0 rg BT 336.76 436.10 Td (North ) Tj ET Q q 0 0 0 rg BT 362.04 436.10 Td (America ) Tj ET Q q 0 0 0 rg BT 398.96 436.10 Td (would ) Tj ET Q q 0 0 0 rg BT 426.46 436.10 Td (have ) Tj ET Q q 0 0 0 rg BT 447.84 436.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 480.33 436.10 Td (in ) Tj ET Q q 0 0 0 rg BT 490.60 436.10 Td (September ) Tj ET Q q 0 0 0 rg BT 535.87 436.10 Td (2018.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 412.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.41 412.10 Td (October ) Tj ET Q q 0 0 0 rg BT 82.70 412.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 108.29 412.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 132.49 412.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 178.88 412.10 Td (its ) Tj ET Q q 0 0 0 rg BT 191.42 412.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 217.28 412.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 228.14 412.10 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.13 412.10 Td ( ) Tj ET Q q 0 0 0 rg BT 266.22 412.10 Td (in ) Tj ET Q q 0 0 0 rg BT 277.08 412.10 Td (North ) Tj ET Q q 0 0 0 rg BT 302.81 412.10 Td (America ) Tj ET Q q 0 0 0 rg BT 340.32 412.10 Td (to ) Tj ET Q q 0 0 0 rg BT 351.18 412.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 373.71 412.10 Td (in ) Tj ET Q q 0 0 0 rg BT 384.57 412.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 425.41 412.10 Td (for ) Tj ET Q q 0 0 0 rg BT 440.15 412.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 488.77 412.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 526.29 412.10 Td (as ) Tj ET Q q 0 0 0 rg BT 537.70 412.10 Td (described ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 400.10 Td (below) Tj ET Q q 0 0 0 rg BT 59.79 400.10 Td (. ) Tj ET Q q 0 0 0 rg BT 64.64 400.10 Td (The ) Tj ET Q q 0 0 0 rg BT 82.73 400.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 128.58 400.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 153.89 400.10 Td (include, ) Tj ET Q q 0 0 0 rg BT 188.37 400.10 Td (but ) Tj ET Q q 0 0 0 rg BT 203.68 400.10 Td (are ) Tj ET Q q 0 0 0 rg BT 218.43 400.10 Td (not ) Tj ET Q q 0 0 0 rg BT 233.75 400.10 Td (limited ) Tj ET Q q 0 0 0 rg BT 264.62 400.10 Td (to, ) Tj ET Q q 0 0 0 rg BT 277.43 400.10 Td (full ) Tj ET Q q 0 0 0 rg BT 293.86 400.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 370.81 400.10 Td (and ) Tj ET Q q 0 0 0 rg BT 387.78 400.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 448.63 400.10 Td (responsibilities. ) Tj ET Q q 0 0 0 rg BT 514.04 400.10 Td (The ) Tj ET Q q 0 0 0 rg BT 532.13 400.10 Td (transaction ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 388.10 Td (was ) Tj ET Q q 0 0 0 rg BT 53.94 388.10 Td (accounted ) Tj ET Q q 0 0 0 rg BT 96.86 388.10 Td (for ) Tj ET Q q 0 0 0 rg BT 110.91 388.10 Td (as ) Tj ET Q q 0 0 0 rg BT 121.63 388.10 Td (a ) Tj ET Q q 0 0 0 rg BT 128.46 388.10 Td (business ) Tj ET Q q 0 0 0 rg BT 164.75 388.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 209.35 388.10 Td (and ) Tj ET Q q 0 0 0 rg BT 226.18 388.10 Td (resulted ) Tj ET Q q 0 0 0 rg BT 260.22 388.10 Td (in ) Tj ET Q q 0 0 0 rg BT 270.39 388.10 Td (a ) Tj ET Q q 0 0 0 rg BT 277.22 388.10 Td (non-cash ) Tj ET Q q 0 0 0 rg BT 315.71 388.10 Td (char) Tj ET Q q 0 0 0 rg BT 332.73 388.10 Td (ge ) Tj ET Q q 0 0 0 rg BT 344.56 388.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.28 388.10 Td ($171 ) Tj ET Q q 0 0 0 rg BT 377.67 388.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.56 388.10 Td ( ) Tj ET Q q 0 0 0 rg BT 408.95 388.10 Td (for ) Tj ET Q q 0 0 0 rg BT 423.00 388.10 Td (intangible ) Tj ET Q q 0 0 0 rg BT 465.38 388.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 491.10 388.10 Td (directly ) Tj ET Q q 0 0 0 rg BT 524.04 388.10 Td (related ) Tj ET Q q 0 0 0 rg BT 553.63 388.10 Td (to ) Tj ET Q q 0 0 0 rg BT 563.80 388.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 376.10 Td (business ) Tj ET Q q 0 0 0 rg BT 72.39 376.10 Td (and ) Tj ET Q q 0 0 0 rg BT 89.33 376.10 Td (an ) Tj ET Q q 0 0 0 rg BT 101.27 376.10 Td (allocation ) Tj ET Q q 0 0 0 rg BT 143.20 376.10 Td (of ) Tj ET Q q 0 0 0 rg BT 154.03 376.10 Td (goodwill. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 352.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.18 352.10 Td (will ) Tj ET Q q 0 0 0 rg BT 78.80 352.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 110.72 352.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 148.22 352.10 Td (through ) Tj ET Q q 0 0 0 rg BT 182.39 352.10 Td (September ) Tj ET Q q 0 0 0 rg BT 228.21 352.10 Td (2018, ) Tj ET Q q 0 0 0 rg BT 253.77 352.10 Td (which ) Tj ET Q q 0 0 0 rg BT 281.27 352.10 Td (is ) Tj ET Q q 0 0 0 rg BT 291.00 352.10 Td (included ) Tj ET Q q 0 0 0 rg BT 328.50 352.10 Td (in ) Tj ET Q q 0 0 0 rg BT 339.33 352.10 Td (other ) Tj ET Q q 0 0 0 rg BT 362.94 352.10 Td (income ) Tj ET Q q 0 0 0 rg BT 395.44 352.10 Td (when ) Tj ET Q q 0 0 0 rg BT 420.16 352.10 Td (earned. ) Tj ET Q q 0 0 0 rg BT 452.14 352.10 Td (The ) Tj ET Q q 0 0 0 rg BT 470.75 352.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 502.13 352.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 524.07 352.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 568.22 352.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 340.10 Td (North ) Tj ET Q q 0 0 0 rg BT 61.26 340.10 Td (America ) Tj ET Q q 0 0 0 rg BT 98.17 340.10 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 112.85 340.10 Td (38%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 131.18 340.10 Td ( ) Tj ET Q q 0 0 0 rg BT 133.66 340.10 Td (on ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 146.14 340.10 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.14 340.10 Td ( ) Tj ET Q q 0 0 0 rg BT 183.62 340.10 Td (net ) Tj ET Q q 0 0 0 rg BT 198.31 340.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 220.23 340.10 Td (up ) Tj ET Q q 0 0 0 rg BT 232.71 340.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 242.97 340.10 Td ($165 ) Tj ET Q q 0 0 0 rg BT 265.45 340.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 294.34 340.10 Td ( ) Tj ET Q q 0 0 0 rg BT 296.82 340.10 Td (in ) Tj ET Q q 0 0 0 rg BT 307.08 340.10 Td (2015, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.06 340.10 Td ($650 ) Tj ET Q q 0 0 0 rg BT 354.53 340.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.43 340.10 Td ( ) Tj ET Q q 0 0 0 rg BT 385.91 340.10 Td (in ) Tj ET Q q 0 0 0 rg BT 396.16 340.10 Td (2016, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.14 340.10 Td ($650 ) Tj ET Q q 0 0 0 rg BT 443.62 340.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.51 340.10 Td ( ) Tj ET Q q 0 0 0 rg BT 474.99 340.10 Td (in ) Tj ET Q q 0 0 0 rg BT 485.25 340.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 507.73 340.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.65 340.10 Td ($480 ) Tj ET Q q 0 0 0 rg BT 547.13 340.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 328.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.47 328.10 Td (2018, ) Tj ET Q q 0 0 0 rg BT 71.66 328.10 Td (plus ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 91.02 328.10 Td (20%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 109.35 328.10 Td ( ) Tj ET Q q 0 0 0 rg BT 112.04 328.10 Td (on ) Tj ET Q q 0 0 0 rg BT 124.73 328.10 Td (net ) Tj ET Q q 0 0 0 rg BT 139.64 328.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 161.77 328.10 Td (in ) Tj ET Q q 0 0 0 rg BT 172.24 328.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 201.02 328.10 Td (of ) Tj ET Q q 0 0 0 rg BT 212.04 328.10 Td (those ) Tj ET Q q 0 0 0 rg BT 235.84 328.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 272.42 328.10 Td (in ) Tj ET Q q 0 0 0 rg BT 282.89 328.10 Td (each ) Tj ET Q q 0 0 0 rg BT 303.90 328.10 Td (of ) Tj ET Q q 0 0 0 rg BT 314.92 328.10 Td (the ) Tj ET Q q 0 0 0 rg BT 329.82 328.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 373.05 328.10 Td (years. ) Tj ET Q q 0 0 0 rg BT 399.33 328.10 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 439.80 328.10 Td (earned ) Tj ET Q q 0 0 0 rg BT 469.13 328.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.25 328.10 Td ($227 ) Tj ET Q q 0 0 0 rg BT 513.94 328.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.84 328.10 Td ( ) Tj ET Q q 0 0 0 rg BT 545.53 328.10 Td (in ) Tj ET Q q 0 0 0 rg BT 556.00 328.10 Td (2016 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 316.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.94 316.10 Td ($56 ) Tj ET Q q 0 0 0 rg BT 70.44 316.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 99.33 316.10 Td ( ) Tj ET Q q 0 0 0 rg BT 101.83 316.10 Td (in ) Tj ET Q q 0 0 0 rg BT 112.11 316.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 292.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.11 292.10 Td (shared ) Tj ET Q q 0 0 0 rg BT 89.20 292.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 114.96 292.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 125.73 292.10 Td (Erbitux* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 163.71 292.10 Td (in ) Tj ET Q q 0 0 0 rg BT 174.48 292.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 200.23 292.10 Td (under ) Tj ET Q q 0 0 0 rg BT 225.99 292.10 Td (an ) Tj ET Q q 0 0 0 rg BT 238.41 292.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 283.04 292.10 Td (with ) Tj ET Q q 0 0 0 rg BT 303.81 292.10 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 326.24 292.10 Td (and ) Tj ET Q q 0 0 0 rg BT 343.66 292.10 Td (Merck ) Tj ET Q q 0 0 0 rg BT 372.75 292.10 Td (KGaA) Tj ET Q q 0 0 0 rg BT 398.30 292.10 Td ( ) Tj ET Q q 0 0 0 rg BT 401.29 292.10 Td (and ) Tj ET Q q 0 0 0 rg BT 418.71 292.10 Td (received ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.56 292.10 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.89 292.10 Td ( ) Tj ET Q q 0 0 0 rg BT 476.88 292.10 Td (of ) Tj ET Q q 0 0 0 rg BT 488.20 292.10 Td (the ) Tj ET Q q 0 0 0 rg BT 503.40 292.10 Td (pretax ) Tj ET Q q 0 0 0 rg BT 531.38 292.10 Td (profit ) Tj ET Q q 0 0 0 rg BT 556.58 292.10 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 280.10 Td (Merck ) Tj ET Q q 0 0 0 rg BT 65.09 280.10 Td (KGaA) Tj ET Q q 0 0 0 rg BT 90.09 280.10 Td (’) Tj ET Q q 0 0 0 rg BT 92.86 280.10 Td (s ) Tj ET Q q 0 0 0 rg BT 99.75 280.10 Td (net ) Tj ET Q q 0 0 0 rg BT 114.96 280.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 137.39 280.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 148.71 280.10 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 183.71 280.10 Td ( ) Tj ET Q q 0 0 0 rg BT 186.70 280.10 Td (in ) Tj ET Q q 0 0 0 rg BT 197.47 280.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 223.23 280.10 Td (which ) Tj ET Q q 0 0 0 rg BT 250.66 280.10 Td (was ) Tj ET Q q 0 0 0 rg BT 269.20 280.10 Td (further ) Tj ET Q q 0 0 0 rg BT 299.40 280.10 Td (shared ) Tj ET Q q 0 0 0 rg BT 328.49 280.10 Td (equally ) Tj ET Q q 0 0 0 rg BT 360.92 280.10 Td (with ) Tj ET Q q 0 0 0 rg BT 381.69 280.10 Td (Lilly) Tj ET Q q 0 0 0 rg BT 400.48 280.10 Td (. ) Tj ET Q q 0 0 0 rg BT 405.98 280.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 430.09 280.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 476.39 280.10 Td (its ) Tj ET Q q 0 0 0 rg BT 488.83 280.10 Td (co-commercialization ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 268.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.93 268.10 Td (in ) Tj ET Q q 0 0 0 rg BT 72.87 268.10 Td (Japan ) Tj ET Q q 0 0 0 rg BT 98.79 268.10 Td (to ) Tj ET Q q 0 0 0 rg BT 109.72 268.10 Td (Merck ) Tj ET Q q 0 0 0 rg BT 138.97 268.10 Td (KGaA) Tj ET Q q 0 0 0 rg BT 164.53 268.10 Td ( ) Tj ET Q q 0 0 0 rg BT 167.68 268.10 Td (in ) Tj ET Q q 0 0 0 rg BT 178.61 268.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 201.77 268.10 Td (in ) Tj ET Q q 0 0 0 rg BT 212.70 268.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 253.61 268.10 Td (for ) Tj ET Q q 0 0 0 rg BT 268.42 268.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 317.11 268.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 354.70 268.10 Td (through ) Tj ET Q q 0 0 0 rg BT 388.96 268.10 Td (2032 ) Tj ET Q q 0 0 0 rg BT 412.12 268.10 Td (which ) Tj ET Q q 0 0 0 rg BT 439.71 268.10 Td (is ) Tj ET Q q 0 0 0 rg BT 449.54 268.10 Td (included ) Tj ET Q q 0 0 0 rg BT 487.12 268.10 Td (in ) Tj ET Q q 0 0 0 rg BT 498.06 268.10 Td (other ) Tj ET Q q 0 0 0 rg BT 521.76 268.10 Td (income ) Tj ET Q q 0 0 0 rg BT 554.34 268.10 Td (when ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 256.10 Td (earned. ) Tj ET Q q 0 0 0 rg BT 67.65 256.10 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 107.92 256.10 Td (earned ) Tj ET Q q 0 0 0 rg BT 137.06 256.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 158.99 256.10 Td ($19 ) Tj ET Q q 0 0 0 rg BT 176.49 256.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 205.38 256.10 Td ( ) Tj ET Q q 0 0 0 rg BT 207.88 256.10 Td (in ) Tj ET Q q 0 0 0 rg BT 218.16 256.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 240.66 256.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 257.60 256.10 Td ($14 ) Tj ET Q q 0 0 0 rg BT 275.10 256.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.99 256.10 Td ( ) Tj ET Q q 0 0 0 rg BT 306.49 256.10 Td (in ) Tj ET Q q 0 0 0 rg BT 316.77 256.10 Td (2015.) Tj ET Q endstream endobj 135 0 obj <> endobj 136 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 749.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 749.10 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 749.10 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 712.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 684.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 684.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 684.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 684.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 684.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 684.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 684.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 658.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 658.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 658.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 658.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 658.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 658.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 658.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 632.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 632.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 632.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 632.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 632.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 632.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 632.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 606.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 606.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 606.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 606.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 606.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 606.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 606.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 580.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 580.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 580.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 580.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 580.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 580.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 580.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 554.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 554.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 554.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 554.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 725.6 m 448.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 725.6 m 452.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 725.6 m 512.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.6 m 516.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 712.6 m 448.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 712.6 m 512.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 712.6 m 448.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 712.6 m 512.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 671.6 m 448.5 671.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 659.6 m 448.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 657.6 m 448.5 657.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 671.6 m 512.5 671.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 659.6 m 512.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 657.6 m 512.5 657.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 671.6 m 576.5 671.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 659.6 m 576.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 657.6 m 576.5 657.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 716.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 703.33 Td (Revenues from Lilly alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 689.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 689.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 689.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 689.27 Td (492) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 689.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 689.27 Td (691) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 675.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 675.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 675.17 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 675.17 Td (32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 662.17 Td (Total revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 662.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 662.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 662.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 662.17 Td (501) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 662.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 662.17 Td (723) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 636.33 Td (Payments to/\(from\) Lilly:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 623.17 Td (Cost of products sold:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 610.17 Td (Distribution fees and royalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 610.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 610.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 610.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 610.17 Td (204) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 610.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 610.17 Td (287) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 597.17 Td (Amortization of intangible asset) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 597.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 597.17 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 597.17 Td (37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 584.17 Td (Cost of product supply) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 584.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 584.17 Td (46) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 584.17 Td (69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 558.17 Td (Other \(income\)/expense:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 545.17 Td (Royalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 545.22 Td (\(246) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 545.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.30 545.22 Td (\(70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 545.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 545.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 532.17 Td (Divestiture loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 532.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 532.17 Td (171) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 532.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 503.53505859375 m 90.4287109375 503.53505859375 l s q 0 0 0 rg BT 36.00 505.10 Td (AstraZeneca) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 481.10 Td (Prior ) Tj ET Q q 0 0 0 rg BT 59.25 481.10 Td (to ) Tj ET Q q 0 0 0 rg BT 70.27 481.10 Td (the ) Tj ET Q q 0 0 0 rg BT 85.74 481.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 121.75 481.10 Td (business ) Tj ET Q q 0 0 0 rg BT 158.89 481.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 204.34 481.10 Td (discussed ) Tj ET Q q 0 0 0 rg BT 245.92 481.10 Td (below) Tj ET Q q 0 0 0 rg BT 269.71 481.10 Td (, ) Tj ET Q q 0 0 0 rg BT 275.46 481.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 299.83 481.10 Td (had ) Tj ET Q q 0 0 0 rg BT 317.51 481.10 Td (an ) Tj ET Q q 0 0 0 rg BT 330.20 481.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 364.54 481.10 Td (with ) Tj ET Q q 0 0 0 rg BT 384.84 481.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 438.61 481.10 Td (consisting ) Tj ET Q q 0 0 0 rg BT 482.42 481.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.99 481.10 Td (three) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.98 481.10 Td ( ) Tj ET Q q 0 0 0 rg BT 517.23 481.10 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 563.24 481.10 Td (co-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 469.10 Td (development ) Tj ET Q q 0 0 0 rg BT 89.94 469.10 Td (and ) Tj ET Q q 0 0 0 rg BT 106.67 469.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 183.37 469.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 231.19 469.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 268.47 469.10 Td (\(1\) ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 282.42 469.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.75 469.10 Td ( ) Tj ET Q q 0 0 0 rg BT 323.04 469.10 Td (and ) Tj ET Q q 0 0 0 rg BT 339.76 469.10 Td (related ) Tj ET Q q 0 0 0 rg BT 369.26 469.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 421.54 469.10 Td (products ) Tj ET Q q 0 0 0 rg BT 458.27 469.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 477.23 469.10 Td (under ) Tj ET Q q 0 0 0 rg BT 502.28 469.10 Td (various ) Tj ET Q q 0 0 0 rg BT 534.01 469.10 Td (names, ) Tj ET Q q 0 0 0 rg BT 564.35 469.10 Td (\(2\) ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 457.10 Td (Farxiga* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.61 457.10 Td (and ) Tj ET Q q 0 0 0 rg BT 92.44 457.10 Td (related ) Tj ET Q q 0 0 0 rg BT 122.04 457.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 174.42 457.10 Td (products ) Tj ET Q q 0 0 0 rg BT 211.25 457.10 Td (and, ) Tj ET Q q 0 0 0 rg BT 230.58 457.10 Td (\(3\) ) Tj ET Q q 0 0 0 rg BT 244.63 457.10 Td (beginning ) Tj ET Q q 0 0 0 rg BT 287.02 457.10 Td (in ) Tj ET Q q 0 0 0 rg BT 296.66 457.10 Td (August ) Tj ET Q q 0 0 0 rg BT 327.95 457.10 Td (2012 ) Tj ET Q q 0 0 0 rg BT 350.34 457.10 Td (after ) Tj ET Q q 0 0 0 rg BT 371.05 457.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 400.26 457.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 446.53 457.10 Td (of ) Tj ET Q q 0 0 0 rg BT 456.73 457.10 Td (Amylin, ) Tj ET Q q 0 0 0 rg BT 491.65 457.10 Td (Amylin's ) Tj ET Q q 0 0 0 rg BT 530.29 457.10 Td (portfolio ) Tj ET Q q 0 0 0 rg BT 567.68 457.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 445.10 Td (products ) Tj ET Q q 0 0 0 rg BT 73.25 445.10 Td (including ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 113.83 445.10 Td (Bydur) Tj ET Q q 0 0 0 rg BT 137.90 445.10 Td (eon*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.34 445.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 162.65 445.10 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.19 445.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 198.51 445.10 Td (Symlin* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 233.53 445.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 250.78 445.10 Td (Myalept*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.55 445.10 Td (, ) Tj ET Q q 0 0 0 rg BT 293.86 445.10 Td (as ) Tj ET Q q 0 0 0 rg BT 305.00 445.10 Td (well ) Tj ET Q q 0 0 0 rg BT 325.03 445.10 Td (as ) Tj ET Q q 0 0 0 rg BT 336.17 445.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 366.18 445.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 392.33 445.10 Td (owned ) Tj ET Q q 0 0 0 rg BT 421.80 445.10 Td (by ) Tj ET Q q 0 0 0 rg BT 433.99 445.10 Td (Amylin, ) Tj ET Q q 0 0 0 rg BT 469.86 445.10 Td (including ) Tj ET Q q 0 0 0 rg BT 510.44 445.10 Td (a ) Tj ET Q q 0 0 0 rg BT 517.69 445.10 Td (manufacturing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 433.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 66.82 433.10 Td (located ) Tj ET Q q 0 0 0 rg BT 98.19 433.10 Td (in ) Tj ET Q q 0 0 0 rg BT 108.29 433.10 Td (W) Tj ET Q q 0 0 0 rg BT 116.93 433.10 Td (est ) Tj ET Q q 0 0 0 rg BT 130.54 433.10 Td (Chester) Tj ET Q q 0 0 0 rg BT 160.68 433.10 Td (, ) Tj ET Q q 0 0 0 rg BT 165.68 433.10 Td (Ohio.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 409.10 Td (Co-exclusive ) Tj ET Q q 0 0 0 rg BT 90.49 409.10 Td (license ) Tj ET Q q 0 0 0 rg BT 119.98 409.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 144.49 409.10 Td (for ) Tj ET Q q 0 0 0 rg BT 157.88 409.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.82 409.10 Td (product ) Tj ET Q q 0 0 0 rg BT 204.09 409.10 Td (or ) Tj ET Q q 0 0 0 rg BT 214.15 409.10 Td (products ) Tj ET Q q 0 0 0 rg BT 250.32 409.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 295.37 409.10 Td (each ) Tj ET Q q 0 0 0 rg BT 315.41 409.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 358.78 409.10 Td (were ) Tj ET Q q 0 0 0 rg BT 379.94 409.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 411.65 409.10 Td (to ) Tj ET Q q 0 0 0 rg BT 420.78 409.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 473.03 409.10 Td (in ) Tj ET Q q 0 0 0 rg BT 482.53 409.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 522.01 409.10 Td (for ) Tj ET Q q 0 0 0 rg BT 535.40 409.10 Td (an ) Tj ET Q q 0 0 0 rg BT 546.57 409.10 Td (upfront ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 397.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 72.11 397.10 Td (and ) Tj ET Q q 0 0 0 rg BT 88.22 397.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 124.89 397.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 165.45 397.10 Td (payments, ) Tj ET Q q 0 0 0 rg BT 207.95 397.10 Td (and ) Tj ET Q q 0 0 0 rg BT 224.07 397.10 Td (both ) Tj ET Q q 0 0 0 rg BT 243.52 397.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 271.85 397.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 307.97 397.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 336.84 397.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 382.96 397.10 Td (to ) Tj ET Q q 0 0 0 rg BT 392.42 397.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 425.75 397.10 Td (participate ) Tj ET Q q 0 0 0 rg BT 469.62 397.10 Td (in ) Tj ET Q q 0 0 0 rg BT 479.07 397.10 Td (the ) Tj ET Q q 0 0 0 rg BT 492.97 397.10 Td (alliance. ) Tj ET Q q 0 0 0 rg BT 528.23 397.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 549.36 397.10 Td (parties ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 385.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 69.56 385.10 Td (participated ) Tj ET Q q 0 0 0 rg BT 118.67 385.10 Td (in ) Tj ET Q q 0 0 0 rg BT 128.35 385.10 Td (a ) Tj ET Q q 0 0 0 rg BT 134.70 385.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 154.95 385.10 Td (executive ) Tj ET Q q 0 0 0 rg BT 195.17 385.10 Td (committee ) Tj ET Q q 0 0 0 rg BT 239.28 385.10 Td (and ) Tj ET Q q 0 0 0 rg BT 255.63 385.10 Td (various ) Tj ET Q q 0 0 0 rg BT 286.98 385.10 Td (other ) Tj ET Q q 0 0 0 rg BT 309.43 385.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 349.11 385.10 Td (committees ) Tj ET Q q 0 0 0 rg BT 397.11 385.10 Td (and ) Tj ET Q q 0 0 0 rg BT 413.46 385.10 Td (had ) Tj ET Q q 0 0 0 rg BT 429.81 385.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 450.05 385.10 Td (responsibilities ) Tj ET Q q 0 0 0 rg BT 512.51 385.10 Td (for ) Tj ET Q q 0 0 0 rg BT 526.08 385.10 Td (the ) Tj ET Q q 0 0 0 rg BT 540.21 385.10 Td (research, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 373.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 92.40 373.10 Td (distribution, ) Tj ET Q q 0 0 0 rg BT 143.26 373.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 164.95 373.10 Td (and ) Tj ET Q q 0 0 0 rg BT 181.63 373.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 224.43 373.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 262.77 373.10 Td (of ) Tj ET Q q 0 0 0 rg BT 273.35 373.10 Td (the ) Tj ET Q q 0 0 0 rg BT 287.82 373.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 321.15 373.10 Td (using ) Tj ET Q q 0 0 0 rg BT 345.07 373.10 Td (resources ) Tj ET Q q 0 0 0 rg BT 385.08 373.10 Td (in ) Tj ET Q q 0 0 0 rg BT 395.11 373.10 Td (their ) Tj ET Q q 0 0 0 rg BT 415.68 373.10 Td (own ) Tj ET Q q 0 0 0 rg BT 435.15 373.10 Td (infrastructures. ) Tj ET Q q 0 0 0 rg BT 497.65 373.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 521.02 373.10 Td (manufactured ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 361.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 361.10 Td (products ) Tj ET Q q 0 0 0 rg BT 87.66 361.10 Td (in ) Tj ET Q q 0 0 0 rg BT 97.93 361.10 Td (all ) Tj ET Q q 0 0 0 rg BT 110.43 361.10 Td (three ) Tj ET Q q 0 0 0 rg BT 132.91 361.10 Td (alliances ) Tj ET Q q 0 0 0 rg BT 170.39 361.10 Td (and ) Tj ET Q q 0 0 0 rg BT 187.33 361.10 Td (was ) Tj ET Q q 0 0 0 rg BT 205.38 361.10 Td (the ) Tj ET Q q 0 0 0 rg BT 220.10 361.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 258.14 361.10 Td (in ) Tj ET Q q 0 0 0 rg BT 268.42 361.10 Td (the ) Tj ET Q q 0 0 0 rg BT 283.14 361.10 Td (end ) Tj ET Q q 0 0 0 rg BT 300.08 361.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 339.23 361.10 Td (product ) Tj ET Q q 0 0 0 rg BT 372.28 361.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 394.22 361.10 Td (in ) Tj ET Q q 0 0 0 rg BT 404.50 361.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 457.55 361.10 Td (all ) Tj ET Q q 0 0 0 rg BT 470.04 361.10 Td (countries.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 337.10 Td (For ) Tj ET Q q 0 0 0 rg BT 52.33 337.10 Td (each ) Tj ET Q q 0 0 0 rg BT 73.09 337.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 106.62 337.10 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 153.20 337.10 Td (the ) Tj ET Q q 0 0 0 rg BT 167.86 337.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 193.07 337.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 238.82 337.10 Td (to ) Tj ET Q q 0 0 0 rg BT 248.50 337.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 301.46 337.10 Td (did ) Tj ET Q q 0 0 0 rg BT 316.68 337.10 Td (not ) Tj ET Q q 0 0 0 rg BT 331.90 337.10 Td (have ) Tj ET Q q 0 0 0 rg BT 353.22 337.10 Td (standalone ) Tj ET Q q 0 0 0 rg BT 398.42 337.10 Td (value ) Tj ET Q q 0 0 0 rg BT 422.52 337.10 Td (as ) Tj ET Q q 0 0 0 rg BT 433.29 337.10 Td (such ) Tj ET Q q 0 0 0 rg BT 454.06 337.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 479.28 337.10 Td (were ) Tj ET Q q 0 0 0 rg BT 501.15 337.10 Td (not ) Tj ET Q q 0 0 0 rg BT 516.37 337.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 535.48 337.10 Td (separately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 325.10 Td (by ) Tj ET Q q 0 0 0 rg BT 49.08 325.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 73.27 325.10 Td (or ) Tj ET Q q 0 0 0 rg BT 84.68 325.10 Td (any ) Tj ET Q q 0 0 0 rg BT 102.19 325.10 Td (other ) Tj ET Q q 0 0 0 rg BT 125.81 325.10 Td (party) Tj ET Q q 0 0 0 rg BT 145.71 325.10 Td (, ) Tj ET Q q 0 0 0 rg BT 151.29 325.10 Td (nor ) Tj ET Q q 0 0 0 rg BT 167.69 325.10 Td (could ) Tj ET Q q 0 0 0 rg BT 192.31 325.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 245.90 325.10 Td (have ) Tj ET Q q 0 0 0 rg BT 267.86 325.10 Td (received ) Tj ET Q q 0 0 0 rg BT 304.79 325.10 Td (any ) Tj ET Q q 0 0 0 rg BT 322.31 325.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 353.15 325.10 Td (for ) Tj ET Q q 0 0 0 rg BT 367.88 325.10 Td (the ) Tj ET Q q 0 0 0 rg BT 383.17 325.10 Td (delivered ) Tj ET Q q 0 0 0 rg BT 423.45 325.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 449.30 325.10 Td (without ) Tj ET Q q 0 0 0 rg BT 482.94 325.10 Td (the ) Tj ET Q q 0 0 0 rg BT 498.23 325.10 Td (fulfillment ) Tj ET Q q 0 0 0 rg BT 544.07 325.10 Td (of ) Tj ET Q q 0 0 0 rg BT 555.48 325.10 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 313.10 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 71.42 313.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 118.50 313.10 Td (by ) Tj ET Q q 0 0 0 rg BT 131.15 313.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 154.91 313.10 Td (under ) Tj ET Q q 0 0 0 rg BT 180.32 313.10 Td (the ) Tj ET Q q 0 0 0 rg BT 195.18 313.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 228.91 313.10 Td (agreements, ) Tj ET Q q 0 0 0 rg BT 279.58 313.10 Td (including ) Tj ET Q q 0 0 0 rg BT 320.00 313.10 Td (the ) Tj ET Q q 0 0 0 rg BT 334.86 313.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 375.26 313.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 404.57 313.10 Td (arrangement. ) Tj ET Q q 0 0 0 rg BT 459.10 313.10 Td (As ) Tj ET Q q 0 0 0 rg BT 472.86 313.10 Td (such, ) Tj ET Q q 0 0 0 rg BT 496.33 313.10 Td (each ) Tj ET Q q 0 0 0 rg BT 517.29 313.10 Td (global ) Tj ET Q q 0 0 0 rg BT 544.92 313.10 Td (alliance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 301.10 Td (was ) Tj ET Q q 0 0 0 rg BT 53.36 301.10 Td (treated ) Tj ET Q q 0 0 0 rg BT 82.37 301.10 Td (as ) Tj ET Q q 0 0 0 rg BT 92.50 301.10 Td (a ) Tj ET Q q 0 0 0 rg BT 98.75 301.10 Td (single ) Tj ET Q q 0 0 0 rg BT 124.44 301.10 Td (unit ) Tj ET Q q 0 0 0 rg BT 141.81 301.10 Td (of ) Tj ET Q q 0 0 0 rg BT 151.94 301.10 Td (accounting. ) Tj ET Q q 0 0 0 rg BT 199.72 301.10 Td (As ) Tj ET Q q 0 0 0 rg BT 212.64 301.10 Td (a ) Tj ET Q q 0 0 0 rg BT 218.89 301.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 245.41 301.10 Td (upfront ) Tj ET Q q 0 0 0 rg BT 276.66 301.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 314.00 301.10 Td (and ) Tj ET Q q 0 0 0 rg BT 330.24 301.10 Td (any ) Tj ET Q q 0 0 0 rg BT 346.49 301.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 392.73 301.10 Td (contingent ) Tj ET Q q 0 0 0 rg BT 436.75 301.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 477.44 301.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 514.79 301.10 Td (were ) Tj ET Q q 0 0 0 rg BT 536.02 301.10 Td (amortized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 289.10 Td (over ) Tj ET Q q 0 0 0 rg BT 56.27 289.10 Td (the ) Tj ET Q q 0 0 0 rg BT 70.99 289.10 Td (life ) Tj ET Q q 0 0 0 rg BT 86.81 289.10 Td (of ) Tj ET Q q 0 0 0 rg BT 97.64 289.10 Td (the ) Tj ET Q q 0 0 0 rg BT 112.36 289.10 Td (related ) Tj ET Q q 0 0 0 rg BT 142.06 289.10 Td (products.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 265.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.85 265.10 Td (2012, ) Tj ET Q q 0 0 0 rg BT 71.88 265.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 95.53 265.10 Td (received ) Tj ET Q q 0 0 0 rg BT 131.91 265.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 138.88 265.10 Td ($3.6 ) Tj ET Q q 0 0 0 rg BT 158.90 265.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.01 265.10 Td ( ) Tj ET Q q 0 0 0 rg BT 187.54 265.10 Td (non-refundable, ) Tj ET Q q 0 0 0 rg BT 253.65 265.10 Td (upfront ) Tj ET Q q 0 0 0 rg BT 285.61 265.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 322.57 265.10 Td (from ) Tj ET Q q 0 0 0 rg BT 343.97 265.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 397.02 265.10 Td (in ) Tj ET Q q 0 0 0 rg BT 407.32 265.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 463.72 265.10 Td (for ) Tj ET Q q 0 0 0 rg BT 477.90 265.10 Td (entering ) Tj ET Q q 0 0 0 rg BT 513.19 265.10 Td (into ) Tj ET Q q 0 0 0 rg BT 531.27 265.10 Td (the ) Tj ET Q q 0 0 0 rg BT 545.46 265.10 Td (Amylin ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 253.10 Td (alliance. ) Tj ET Q q 0 0 0 rg BT 71.38 253.10 Td (In ) Tj ET Q q 0 0 0 rg BT 81.51 253.10 Td (2013, ) Tj ET Q q 0 0 0 rg BT 105.41 253.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 157.72 253.10 Td (exercised ) Tj ET Q q 0 0 0 rg BT 197.27 253.10 Td (its ) Tj ET Q q 0 0 0 rg BT 208.51 253.10 Td (option ) Tj ET Q q 0 0 0 rg BT 235.87 253.10 Td (for ) Tj ET Q q 0 0 0 rg BT 249.32 253.10 Td (equal ) Tj ET Q q 0 0 0 rg BT 272.77 253.10 Td (governance ) Tj ET Q q 0 0 0 rg BT 320.65 253.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 345.22 253.10 Td (over ) Tj ET Q q 0 0 0 rg BT 364.78 253.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 393.78 253.10 Td (key ) Tj ET Q q 0 0 0 rg BT 410.01 253.10 Td (strategic ) Tj ET Q q 0 0 0 rg BT 445.68 253.10 Td (and ) Tj ET Q q 0 0 0 rg BT 461.91 253.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 498.69 253.10 Td (decisions ) Tj ET Q q 0 0 0 rg BT 537.70 253.10 Td (regarding ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 241.10 Td (the ) Tj ET Q q 0 0 0 rg BT 49.90 241.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 82.62 241.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 115.87 241.10 Td (and ) Tj ET Q q 0 0 0 rg BT 132.48 241.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 151.86 241.10 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 175.14 241.10 Td ($135 ) Tj ET Q q 0 0 0 rg BT 197.30 241.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 226.20 241.10 Td ( ) Tj ET Q q 0 0 0 rg BT 228.36 241.10 Td (as ) Tj ET Q q 0 0 0 rg BT 238.85 241.10 Td (consideration. ) Tj ET Q q 0 0 0 rg BT 297.23 241.10 Td (These ) Tj ET Q q 0 0 0 rg BT 323.27 241.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 363.76 241.10 Td (were ) Tj ET Q q 0 0 0 rg BT 385.35 241.10 Td (accounted ) Tj ET Q q 0 0 0 rg BT 428.05 241.10 Td (for ) Tj ET Q q 0 0 0 rg BT 441.87 241.10 Td (as ) Tj ET Q q 0 0 0 rg BT 452.36 241.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 487.83 241.10 Td (income ) Tj ET Q q 0 0 0 rg BT 519.43 241.10 Td (and ) Tj ET Q q 0 0 0 rg BT 536.03 241.10 Td (amortized ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 229.10 Td (based ) Tj ET Q q 0 0 0 rg BT 61.42 229.10 Td (on ) Tj ET Q q 0 0 0 rg BT 74.07 229.10 Td (the ) Tj ET Q q 0 0 0 rg BT 88.93 229.10 Td (relative ) Tj ET Q q 0 0 0 rg BT 121.56 229.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 138.09 229.10 Td (value ) Tj ET Q q 0 0 0 rg BT 162.39 229.10 Td (of ) Tj ET Q q 0 0 0 rg BT 173.37 229.10 Td (the ) Tj ET Q q 0 0 0 rg BT 188.24 229.10 Td (predominant ) Tj ET Q q 0 0 0 rg BT 241.43 229.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 279.62 229.10 Td (included ) Tj ET Q q 0 0 0 rg BT 316.70 229.10 Td (in ) Tj ET Q q 0 0 0 rg BT 327.13 229.10 Td (the ) Tj ET Q q 0 0 0 rg BT 341.99 229.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 375.73 229.10 Td (over ) Tj ET Q q 0 0 0 rg BT 396.15 229.10 Td (their ) Tj ET Q q 0 0 0 rg BT 417.12 229.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 458.09 229.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 485.18 229.10 Td (lives ) Tj ET Q q 0 0 0 rg BT 506.72 229.10 Td (\(intangible ) Tj ET Q q 0 0 0 rg BT 552.68 229.10 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 217.10 Td (related ) Tj ET Q q 0 0 0 rg BT 65.28 217.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 75.13 217.10 Td (Bydur) Tj ET Q q 0 0 0 rg BT 99.20 217.10 Td (eon*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 118.64 217.10 Td ( ) Tj ET Q q 0 0 0 rg BT 120.72 217.10 Td (with ) Tj ET Q q 0 0 0 rg BT 140.57 217.10 Td (an ) Tj ET Q q 0 0 0 rg BT 152.09 217.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 192.48 217.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 219.00 217.10 Td (life ) Tj ET Q q 0 0 0 rg BT 234.40 217.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 244.81 217.10 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 254.81 217.10 Td ( ) Tj ET Q q 0 0 0 rg BT 256.88 217.10 Td (years, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 282.56 217.10 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.10 217.10 Td ( ) Tj ET Q q 0 0 0 rg BT 315.18 217.10 Td (with ) Tj ET Q q 0 0 0 rg BT 335.03 217.10 Td (an ) Tj ET Q q 0 0 0 rg BT 346.55 217.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 386.94 217.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 413.46 217.10 Td (life ) Tj ET Q q 0 0 0 rg BT 428.86 217.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.27 217.10 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.27 217.10 Td ( ) Tj ET Q q 0 0 0 rg BT 446.35 217.10 Td (years, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 472.02 217.10 Td (Symlin*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.24 217.10 Td ( ) Tj ET Q q 0 0 0 rg BT 506.31 217.10 Td (with ) Tj ET Q q 0 0 0 rg BT 526.17 217.10 Td (an ) Tj ET Q q 0 0 0 rg BT 537.68 217.10 Td (estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 205.10 Td (life ) Tj ET Q q 0 0 0 rg BT 51.94 205.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.89 205.10 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.89 205.10 Td ( ) Tj ET Q q 0 0 0 rg BT 70.51 205.10 Td (years, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 96.72 205.10 Td (Myalept) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 129.49 205.10 Td (* ) Tj ET Q q 0 0 0 rg BT 137.10 205.10 Td (with ) Tj ET Q q 0 0 0 rg BT 157.50 205.10 Td (an ) Tj ET Q q 0 0 0 rg BT 169.55 205.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 210.49 205.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 237.55 205.10 Td (life ) Tj ET Q q 0 0 0 rg BT 253.49 205.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.44 205.10 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.44 205.10 Td ( ) Tj ET Q q 0 0 0 rg BT 277.05 205.10 Td (years, ) Tj ET Q q 0 0 0 rg BT 303.27 205.10 Td (and ) Tj ET Q q 0 0 0 rg BT 320.33 205.10 Td (the ) Tj ET Q q 0 0 0 rg BT 334.58 205.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 367.76 205.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 428.68 205.10 Td (plant ) Tj ET Q q 0 0 0 rg BT 451.30 205.10 Td (with ) Tj ET Q q 0 0 0 rg BT 471.69 205.10 Td (an ) Tj ET Q q 0 0 0 rg BT 483.75 205.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 524.69 205.10 Td (useful ) Tj ET Q q 0 0 0 rg BT 551.74 205.10 Td (life ) Tj ET Q q 0 0 0 rg BT 567.68 205.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 193.10 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.00 193.10 Td ( ) Tj ET Q q 0 0 0 rg BT 48.09 193.10 Td (years\). ) Tj ET Q q 0 0 0 rg BT 76.96 193.10 Td (The ) Tj ET Q q 0 0 0 rg BT 94.61 193.10 Td (amortization ) Tj ET Q q 0 0 0 rg BT 147.24 193.10 Td (was ) Tj ET Q q 0 0 0 rg BT 164.88 193.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 205.29 193.10 Td (as ) Tj ET Q q 0 0 0 rg BT 215.71 193.10 Td (a ) Tj ET Q q 0 0 0 rg BT 222.25 193.10 Td (reduction ) Tj ET Q q 0 0 0 rg BT 262.10 193.10 Td (to ) Tj ET Q q 0 0 0 rg BT 271.98 193.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 290.18 193.10 Td (of ) Tj ET Q q 0 0 0 rg BT 300.60 193.10 Td (products ) Tj ET Q q 0 0 0 rg BT 337.13 193.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 355.90 193.10 Td (because ) Tj ET Q q 0 0 0 rg BT 389.64 193.10 Td (the ) Tj ET Q q 0 0 0 rg BT 403.95 193.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 437.13 193.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 462.55 193.10 Td (were ) Tj ET Q q 0 0 0 rg BT 484.08 193.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 520.59 193.10 Td (shortly ) Tj ET Q q 0 0 0 rg BT 550.47 193.10 Td (before ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 49.78 181.10 Td (commencement ) Tj ET Q q 0 0 0 rg BT 114.65 181.10 Td (of ) Tj ET Q q 0 0 0 rg BT 124.54 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 138.33 181.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 170.98 181.10 Td (and ) Tj ET Q q 0 0 0 rg BT 186.64 181.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 238.72 181.10 Td (was ) Tj ET Q q 0 0 0 rg BT 255.84 181.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 287.39 181.10 Td (to ) Tj ET Q q 0 0 0 rg BT 296.73 181.10 Td (share ) Tj ET Q q 0 0 0 rg BT 319.40 181.10 Td (in ) Tj ET Q q 0 0 0 rg BT 328.74 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 342.52 181.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 379.62 181.10 Td (from ) Tj ET Q q 0 0 0 rg BT 400.62 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 414.40 181.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 431.51 181.10 Td (of ) Tj ET Q q 0 0 0 rg BT 441.41 181.10 Td (any ) Tj ET Q q 0 0 0 rg BT 457.41 181.10 Td (of ) Tj ET Q q 0 0 0 rg BT 467.31 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 481.09 181.10 Td (assets. ) Tj ET Q q 0 0 0 rg BT 508.37 181.10 Td (The ) Tj ET Q q 0 0 0 rg BT 525.48 181.10 Td (amortization ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 169.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.78 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 63.44 169.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 100.55 169.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 134.55 169.10 Td (intangible ) Tj ET Q q 0 0 0 rg BT 177.99 169.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 204.76 169.10 Td (and ) Tj ET Q q 0 0 0 rg BT 222.65 169.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 284.41 169.10 Td (plant ) Tj ET Q q 0 0 0 rg BT 307.85 169.10 Td (was ) Tj ET Q q 0 0 0 rg BT 326.85 169.10 Td (also ) Tj ET Q q 0 0 0 rg BT 346.40 169.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 388.16 169.10 Td (in ) Tj ET Q q 0 0 0 rg BT 399.39 169.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 418.94 169.10 Td (of ) Tj ET Q q 0 0 0 rg BT 430.72 169.10 Td (products ) Tj ET Q q 0 0 0 rg BT 468.60 169.10 Td (sold. ) Tj ET Q q 0 0 0 rg BT 491.22 169.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 515.79 169.10 Td (was ) Tj ET Q q 0 0 0 rg BT 534.79 169.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 568.22 169.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 157.10 Td (reimbursements ) Tj ET Q q 0 0 0 rg BT 101.75 157.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.29 157.10 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 133.62 157.10 Td ( ) Tj ET Q q 0 0 0 rg BT 135.50 157.10 Td (of ) Tj ET Q q 0 0 0 rg BT 145.71 157.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 174.24 157.10 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 227.22 157.10 Td (related ) Tj ET Q q 0 0 0 rg BT 256.30 157.10 Td (to ) Tj ET Q q 0 0 0 rg BT 265.96 157.10 Td (the ) Tj ET Q q 0 0 0 rg BT 280.05 157.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 315.94 157.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 348.38 157.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 408.57 157.10 Td (facility) Tj ET Q q 0 0 0 rg BT 436.24 157.10 Td (. ) Tj ET Q q 0 0 0 rg BT 440.62 157.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 463.62 157.10 Td (and ) Tj ET Q q 0 0 0 rg BT 479.53 157.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 531.93 157.10 Td (also ) Tj ET Q q 0 0 0 rg BT 549.92 157.10 Td (shared ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 145.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.28 145.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 75.98 145.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 90.70 145.10 Td (attributes ) Tj ET Q q 0 0 0 rg BT 130.41 145.10 Td (related ) Tj ET Q q 0 0 0 rg BT 160.11 145.10 Td (to ) Tj ET Q q 0 0 0 rg BT 170.39 145.10 Td (the ) Tj ET Q q 0 0 0 rg BT 184.55 145.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 217.61 145.10 Td (alliance.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 121.10 Td (Prior ) Tj ET Q q 0 0 0 rg BT 58.57 121.10 Td (to ) Tj ET Q q 0 0 0 rg BT 68.92 121.10 Td (the ) Tj ET Q q 0 0 0 rg BT 83.70 121.10 Td (termination ) Tj ET Q q 0 0 0 rg BT 132.37 121.10 Td (of ) Tj ET Q q 0 0 0 rg BT 143.27 121.10 Td (the ) Tj ET Q q 0 0 0 rg BT 158.06 121.10 Td (alliance, ) Tj ET Q q 0 0 0 rg BT 194.22 121.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 217.91 121.10 Td (received ) Tj ET Q q 0 0 0 rg BT 254.34 121.10 Td (non-refundable ) Tj ET Q q 0 0 0 rg BT 318.00 121.10 Td (upfront, ) Tj ET Q q 0 0 0 rg BT 352.51 121.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 393.96 121.10 Td (and ) Tj ET Q q 0 0 0 rg BT 410.97 121.10 Td (other ) Tj ET Q q 0 0 0 rg BT 434.08 121.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 472.76 121.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 513.65 121.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 524.55 121.10 Td ($300 ) Tj ET Q q 0 0 0 rg BT 547.12 121.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 109.10 Td (related ) Tj ET Q q 0 0 0 rg BT 65.56 109.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 75.70 109.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 114.03 109.10 Td ( ) Tj ET Q q 0 0 0 rg BT 116.39 109.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 133.19 109.10 Td ($250 ) Tj ET Q q 0 0 0 rg BT 155.55 109.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 184.44 109.10 Td ( ) Tj ET Q q 0 0 0 rg BT 186.80 109.10 Td (related ) Tj ET Q q 0 0 0 rg BT 216.36 109.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 226.50 109.10 Td (Farxiga*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.72 109.10 Td (. ) Tj ET Q q 0 0 0 rg BT 268.06 109.10 Td (Amortization ) Tj ET Q q 0 0 0 rg BT 323.74 109.10 Td (of ) Tj ET Q q 0 0 0 rg BT 334.43 109.10 Td (the ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 349.00 109.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.33 109.10 Td ( ) Tj ET Q q 0 0 0 rg BT 389.69 109.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 406.49 109.10 Td (Farxiga*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.71 109.10 Td ( ) Tj ET Q q 0 0 0 rg BT 446.07 109.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 481.73 109.10 Td (income ) Tj ET Q q 0 0 0 rg BT 513.53 109.10 Td (was ) Tj ET Q q 0 0 0 rg BT 531.44 109.10 Td (included ) Tj ET Q q 0 0 0 rg BT 568.23 109.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 97.10 Td (other ) Tj ET Q q 0 0 0 rg BT 59.32 97.10 Td (income ) Tj ET Q q 0 0 0 rg BT 91.53 97.10 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 102.63 97.10 Td (Onglyza* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 143.73 97.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 160.94 97.10 Td (Farxiga* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 200.93 97.10 Td (were ) Tj ET Q q 0 0 0 rg BT 223.13 97.10 Td (not ) Tj ET Q q 0 0 0 rg BT 238.68 97.10 Td (commercial ) Tj ET Q q 0 0 0 rg BT 288.65 97.10 Td (products ) Tj ET Q q 0 0 0 rg BT 325.86 97.10 Td (at ) Tj ET Q q 0 0 0 rg BT 335.85 97.10 Td (the ) Tj ET Q q 0 0 0 rg BT 350.84 97.10 Td (commencement ) Tj ET Q q 0 0 0 rg BT 416.92 97.10 Td (of ) Tj ET Q q 0 0 0 rg BT 428.02 97.10 Td (the ) Tj ET Q q 0 0 0 rg BT 443.01 97.10 Td (alliance. ) Tj ET Q q 0 0 0 rg BT 479.37 97.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 501.59 97.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 531.02 97.10 Td (also ) Tj ET Q q 0 0 0 rg BT 549.90 97.10 Td (shared ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 85.10 Td (most ) Tj ET Q q 0 0 0 rg BT 57.95 85.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 134.86 85.10 Td (and ) Tj ET Q q 0 0 0 rg BT 151.80 85.10 Td (development ) Tj ET Q q 0 0 0 rg BT 205.95 85.10 Td (expenses ) Tj ET Q q 0 0 0 rg BT 244.54 85.10 Td (equally) Tj ET Q q 0 0 0 rg BT 273.33 85.10 Td (, ) Tj ET Q q 0 0 0 rg BT 278.33 85.10 Td (as ) Tj ET Q q 0 0 0 rg BT 289.16 85.10 Td (well ) Tj ET Q q 0 0 0 rg BT 308.88 85.10 Td (as ) Tj ET Q q 0 0 0 rg BT 319.71 85.10 Td (profits ) Tj ET Q q 0 0 0 rg BT 348.31 85.10 Td (and ) Tj ET Q q 0 0 0 rg BT 365.25 85.10 Td (losses.) Tj ET Q endstream endobj 137 0 obj <> endobj 138 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (68) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.61 749.10 Td (February ) Tj ET Q q 0 0 0 rg BT 87.00 749.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 112.78 749.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 137.19 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 154.18 749.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 207.99 749.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 254.03 749.10 Td (their ) Tj ET Q q 0 0 0 rg BT 275.64 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 310.01 749.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 358.83 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 376.55 749.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 400.96 749.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 420.91 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 431.25 749.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 485.06 749.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 538.89 749.10 Td (all ) Tj ET Q q 0 0 0 rg BT 552.17 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.78 749.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 70.15 737.10 Td (business ) Tj ET Q q 0 0 0 rg BT 105.43 737.10 Td (comprising ) Tj ET Q q 0 0 0 rg BT 151.82 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 165.42 737.10 Td (alliance. ) Tj ET Q q 0 0 0 rg BT 200.30 737.10 Td (The ) Tj ET Q q 0 0 0 rg BT 217.24 737.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 260.84 737.10 Td (included ) Tj ET Q q 0 0 0 rg BT 296.66 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 310.27 737.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 336.65 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 346.06 737.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 378.00 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 393.83 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 407.44 737.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 443.82 737.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 475.75 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 485.47 737.10 Td (its ) Tj ET Q q 0 0 0 rg BT 496.31 737.10 Td (Ohio ) Tj ET Q q 0 0 0 rg BT 517.69 737.10 Td (manufacturing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (facility; ) Tj ET Q q 0 0 0 rg BT 68.99 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 83.11 725.10 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 129.43 725.10 Td (property ) Tj ET Q q 0 0 0 rg BT 165.20 725.10 Td (related ) Tj ET Q q 0 0 0 rg BT 194.30 725.10 Td (to) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 202.08 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 203.97 725.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 242.30 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 244.20 725.10 Td (and) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 258.64 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 260.53 725.10 Td (Farxiga*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.75 725.10 Td ( ) Tj ET Q q 0 0 0 rg BT 299.65 725.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 342.65 725.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 371.36 725.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 402.69 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 412.36 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 426.47 725.10 Td (out-licensing ) Tj ET Q q 0 0 0 rg BT 480.58 725.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 524.12 725.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 537.68 725.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 47.04 713.10 Td (Japan\); ) Tj ET Q q 0 0 0 rg BT 79.18 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 96.88 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 112.35 713.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 151.15 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 162.74 713.10 Td (BMS’) Tj ET Q q 0 0 0 rg BT 186.64 713.10 Td (s ) Tj ET Q q 0 0 0 rg BT 193.80 713.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 255.37 713.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 286.95 713.10 Td (located ) Tj ET Q q 0 0 0 rg BT 319.08 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 330.12 713.10 Td (Mount ) Tj ET Q q 0 0 0 rg BT 359.81 713.10 Td (V) Tj ET Q q 0 0 0 rg BT 365.93 713.10 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 394.46 713.10 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 427.70 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 438.74 713.10 Td (2015. ) Tj ET Q q 0 0 0 rg BT 464.50 713.10 Td (Substantially ) Tj ET Q q 0 0 0 rg BT 519.99 713.10 Td (all ) Tj ET Q q 0 0 0 rg BT 533.24 713.10 Td (employees ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (dedicated ) Tj ET Q q 0 0 0 rg BT 76.81 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 87.09 701.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.81 701.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 137.07 701.10 Td (business ) Tj ET Q q 0 0 0 rg BT 173.46 701.10 Td (were ) Tj ET Q q 0 0 0 rg BT 195.39 701.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 241.20 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 250.92 701.10 Td (AstraZeneca.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 58.51 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 74.03 677.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 125.94 677.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 156.75 677.10 Td (into ) Tj ET Q q 0 0 0 rg BT 173.69 677.10 Td (several ) Tj ET Q q 0 0 0 rg BT 203.39 677.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 250.31 677.10 Td (in ) Tj ET Q q 0 0 0 rg BT 259.48 677.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 304.74 677.10 Td (with ) Tj ET Q q 0 0 0 rg BT 323.90 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 337.51 677.10 Td (sale, ) Tj ET Q q 0 0 0 rg BT 356.94 677.10 Td (including ) Tj ET Q q 0 0 0 rg BT 396.10 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 401.92 677.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 429.98 677.10 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 475.51 677.10 Td (a ) Tj ET Q q 0 0 0 rg BT 481.33 677.10 Td (development ) Tj ET Q q 0 0 0 rg BT 534.37 677.10 Td (agreement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.53 665.10 Td (a ) Tj ET Q q 0 0 0 rg BT 59.06 665.10 Td (transitional ) Tj ET Q q 0 0 0 rg BT 106.14 665.10 Td (services ) Tj ET Q q 0 0 0 rg BT 140.44 665.10 Td (agreement. ) Tj ET Q q 0 0 0 rg BT 186.68 665.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 213.76 665.10 Td (those ) Tj ET Q q 0 0 0 rg BT 236.96 665.10 Td (agreements, ) Tj ET Q q 0 0 0 rg BT 287.08 665.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 310.30 665.10 Td (is ) Tj ET Q q 0 0 0 rg BT 319.06 665.10 Td (obligated ) Tj ET Q q 0 0 0 rg BT 358.37 665.10 Td (to ) Tj ET Q q 0 0 0 rg BT 368.24 665.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 397.00 665.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 426.29 665.10 Td (products, ) Tj ET Q q 0 0 0 rg BT 465.32 665.10 Td (including ) Tj ET Q q 0 0 0 rg BT 505.19 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 519.50 665.10 Td (active ) Tj ET Q q 0 0 0 rg BT 545.46 665.10 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (ingredients ) Tj ET Q q 0 0 0 rg BT 84.02 653.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 99.26 653.10 Td (Onglyza*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.59 653.10 Td ( ) Tj ET Q q 0 0 0 rg BT 141.18 653.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 159.20 653.10 Td (Farxiga*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 196.42 653.10 Td ( ) Tj ET Q q 0 0 0 rg BT 200.01 653.10 Td (through ) Tj ET Q q 0 0 0 rg BT 234.70 653.10 Td (2020; ) Tj ET Q q 0 0 0 rg BT 261.06 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 272.43 653.10 Td (perform ) Tj ET Q q 0 0 0 rg BT 308.22 653.10 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 344.58 653.10 Td (development ) Tj ET Q q 0 0 0 rg BT 399.82 653.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 439.50 653.10 Td (for ) Tj ET Q q 0 0 0 rg BT 454.75 653.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 485.54 653.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 518.55 653.10 Td (trial ) Tj ET Q q 0 0 0 rg BT 538.24 653.10 Td (programs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 89.67 641.10 Td (through ) Tj ET Q q 0 0 0 rg BT 123.90 641.10 Td (2016; ) Tj ET Q q 0 0 0 rg BT 149.80 641.10 Td (and ) Tj ET Q q 0 0 0 rg BT 167.36 641.10 Td (to ) Tj ET Q q 0 0 0 rg BT 178.26 641.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 211.92 641.10 Td (transitional ) Tj ET Q q 0 0 0 rg BT 260.03 641.10 Td (services ) Tj ET Q q 0 0 0 rg BT 295.36 641.10 Td (such ) Tj ET Q q 0 0 0 rg BT 316.81 641.10 Td (as ) Tj ET Q q 0 0 0 rg BT 328.26 641.10 Td (accounting, ) Tj ET Q q 0 0 0 rg BT 377.75 641.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 415.85 641.10 Td (services, ) Tj ET Q q 0 0 0 rg BT 453.68 641.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 493.46 641.10 Td (service, ) Tj ET Q q 0 0 0 rg BT 527.39 641.10 Td (distribution, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (regulatory) Tj ET Q q 0 0 0 rg BT 76.44 629.10 Td (, ) Tj ET Q q 0 0 0 rg BT 81.77 629.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 138.75 629.10 Td (information ) Tj ET Q q 0 0 0 rg BT 188.80 629.10 Td (technology ) Tj ET Q q 0 0 0 rg BT 236.06 629.10 Td (and ) Tj ET Q q 0 0 0 rg BT 253.33 629.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 283.36 629.10 Td (other ) Tj ET Q q 0 0 0 rg BT 306.73 629.10 Td (administrative ) Tj ET Q q 0 0 0 rg BT 366.77 629.10 Td (services ) Tj ET Q q 0 0 0 rg BT 401.81 629.10 Td (for ) Tj ET Q q 0 0 0 rg BT 416.30 629.10 Td (various ) Tj ET Q q 0 0 0 rg BT 448.57 629.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 480.83 629.10 Td (in ) Tj ET Q q 0 0 0 rg BT 491.44 629.10 Td (order ) Tj ET Q q 0 0 0 rg BT 515.37 629.10 Td (to ) Tj ET Q q 0 0 0 rg BT 525.98 629.10 Td (facilitate ) Tj ET Q q 0 0 0 rg BT 563.78 629.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (orderly ) Tj ET Q q 0 0 0 rg BT 67.38 617.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 100.41 617.10 Td (of ) Tj ET Q q 0 0 0 rg BT 111.24 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 125.96 617.10 Td (business ) Tj ET Q q 0 0 0 rg BT 162.35 617.10 Td (operations.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (Consideration ) Tj ET Q q 0 0 0 rg BT 94.66 593.10 Td (for ) Tj ET Q q 0 0 0 rg BT 108.89 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 123.66 593.10 Td (transaction ) Tj ET Q q 0 0 0 rg BT 170.10 593.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 205.98 593.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 212.98 593.10 Td ($2.7 ) Tj ET Q q 0 0 0 rg BT 233.04 593.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.16 593.10 Td ( ) Tj ET Q q 0 0 0 rg BT 261.72 593.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 298.71 593.10 Td (at ) Tj ET Q q 0 0 0 rg BT 308.49 593.10 Td (closing; ) Tj ET Q q 0 0 0 rg BT 342.72 593.10 Td (contingent ) Tj ET Q q 0 0 0 rg BT 387.49 593.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 431.14 593.10 Td (and ) Tj ET Q q 0 0 0 rg BT 448.14 593.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 496.24 593.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 537.68 593.10 Td (payments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.82 581.10 Td (up ) Tj ET Q q 0 0 0 rg BT 59.31 581.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 69.58 581.10 Td ($1.4 ) Tj ET Q q 0 0 0 rg BT 89.58 581.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 115.69 581.10 Td ( ) Tj ET Q q 0 0 0 rg BT 118.18 581.10 Td (\(including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.78 581.10 Td ($800 ) Tj ET Q q 0 0 0 rg BT 184.27 581.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.16 581.10 Td ( ) Tj ET Q q 0 0 0 rg BT 215.65 581.10 Td (related ) Tj ET Q q 0 0 0 rg BT 245.34 581.10 Td (to ) Tj ET Q q 0 0 0 rg BT 255.61 581.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 293.09 581.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 338.36 581.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.29 581.10 Td ($600 ) Tj ET Q q 0 0 0 rg BT 377.78 581.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.67 581.10 Td ( ) Tj ET Q q 0 0 0 rg BT 409.16 581.10 Td (related ) Tj ET Q q 0 0 0 rg BT 438.86 581.10 Td (to ) Tj ET Q q 0 0 0 rg BT 449.13 581.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 497.15 581.10 Td (milestones, ) Tj ET Q q 0 0 0 rg BT 544.92 581.10 Td (payable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.34 569.10 Td (2020\); ) Tj ET Q q 0 0 0 rg BT 75.00 569.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 105.88 569.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 146.77 569.10 Td (based ) Tj ET Q q 0 0 0 rg BT 172.09 569.10 Td (on ) Tj ET Q q 0 0 0 rg BT 184.65 569.10 Td (net ) Tj ET Q q 0 0 0 rg BT 199.43 569.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 221.42 569.10 Td (through ) Tj ET Q q 0 0 0 rg BT 255.09 569.10 Td (2025 ) Tj ET Q q 0 0 0 rg BT 277.65 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 294.64 569.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 335.52 569.10 Td (up ) Tj ET Q q 0 0 0 rg BT 348.08 569.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.42 569.10 Td ($225 ) Tj ET Q q 0 0 0 rg BT 380.98 569.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.87 569.10 Td ( ) Tj ET Q q 0 0 0 rg BT 412.42 569.10 Td (if ) Tj ET Q q 0 0 0 rg BT 421.09 569.10 Td (and ) Tj ET Q q 0 0 0 rg BT 438.09 569.10 Td (when ) Tj ET Q q 0 0 0 rg BT 462.30 569.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 492.06 569.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 517.95 569.10 Td (are ) Tj ET Q q 0 0 0 rg BT 532.72 569.10 Td (transferred ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.13 557.10 Td (AstraZeneca. ) Tj ET Q q 0 0 0 rg BT 101.51 557.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 155.05 557.10 Td (will ) Tj ET Q q 0 0 0 rg BT 173.63 557.10 Td (also ) Tj ET Q q 0 0 0 rg BT 192.76 557.10 Td (pay ) Tj ET Q q 0 0 0 rg BT 210.22 557.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 234.37 557.10 Td (for ) Tj ET Q q 0 0 0 rg BT 249.05 557.10 Td (any ) Tj ET Q q 0 0 0 rg BT 266.51 557.10 Td (required ) Tj ET Q q 0 0 0 rg BT 302.84 557.10 Td (product ) Tj ET Q q 0 0 0 rg BT 336.41 557.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 366.10 557.10 Td (at ) Tj ET Q q 0 0 0 rg BT 376.34 557.10 Td (a ) Tj ET Q q 0 0 0 rg BT 383.80 557.10 Td (price ) Tj ET Q q 0 0 0 rg BT 406.81 557.10 Td (approximating ) Tj ET Q q 0 0 0 rg BT 468.15 557.10 Td (the ) Tj ET Q q 0 0 0 rg BT 483.39 557.10 Td (product ) Tj ET Q q 0 0 0 rg BT 516.96 557.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 536.09 557.10 Td (as ) Tj ET Q q 0 0 0 rg BT 547.44 557.10 Td (well ) Tj ET Q q 0 0 0 rg BT 567.68 557.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (negotiated ) Tj ET Q q 0 0 0 rg BT 80.15 545.10 Td (transitional ) Tj ET Q q 0 0 0 rg BT 127.64 545.10 Td (service ) Tj ET Q q 0 0 0 rg BT 158.46 545.10 Td (fees.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (Royalty ) Tj ET Q q 0 0 0 rg BT 70.17 521.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 91.54 521.10 Td (on ) Tj ET Q q 0 0 0 rg BT 104.04 521.10 Td (net ) Tj ET Q q 0 0 0 rg BT 118.76 521.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 140.70 521.10 Td (are ) Tj ET Q q 0 0 0 rg BT 155.40 521.10 Td (as ) Tj ET Q q 0 0 0 rg BT 166.23 521.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 491.60 349.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 491.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 491.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 435.50 491.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 460.50 491.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 485.50 491.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 491.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 491.60 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 465.60 349.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 465.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 465.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 435.50 465.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 460.50 465.60 25.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 485.50 465.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 465.60 26.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 465.60 38.00 -13.00 re f /GS0 gs BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 388.5 494.580078125 m 404.5 494.580078125 l s q 0 0 0 rg BT 388.50 495.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 414 494.580078125 m 430 494.580078125 l s q 0 0 0 rg BT 414.00 495.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 439.5 494.580078125 m 455.5 494.580078125 l s q 0 0 0 rg BT 439.50 495.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 464.5 494.580078125 m 480.5 494.580078125 l s q 0 0 0 rg BT 464.50 495.83 Td (2017) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 490 494.580078125 m 506 494.580078125 l s q 0 0 0 rg BT 490.00 495.83 Td (2018) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 516 494.580078125 m 532 494.580078125 l s q 0 0 0 rg BT 516.00 495.83 Td (2019) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 545.65 501.430078125 m 566.3140625 501.430078125 l s q 0 0 0 rg BT 545.65 502.68 Td (2020 -) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 548 493.430078125 m 564 493.430078125 l s q 0 0 0 rg BT 548.00 494.68 Td (2025) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 38.00 482.85 Td (Onglyza* ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 74.75 482.85 Td (and ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 89.99 482.85 Td (Farxiga*) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 123.49 482.85 Td ( ) Tj ET Q q 0 0 0 rg BT 125.57 482.85 Td (W) Tj ET Q q 0 0 0 rg BT 133.35 482.85 Td (orldwide Net Sales up to $500 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 482.17 Td (44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 482.17 Td (35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.65 482.17 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.65 482.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 482.17 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 482.17 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 482.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.30 482.17 Td (14-25%) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 38.00 469.85 Td (Onglyza*) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 72.50 469.85 Td ( and ) Tj ET Q BT /F3 9.00 Tf ET q 0 0 0 rg BT 89.99 469.85 Td (Farxiga*) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 123.49 469.85 Td ( ) Tj ET Q q 0 0 0 rg BT 125.57 469.85 Td (W) Tj ET Q q 0 0 0 rg BT 133.35 469.85 Td (orldwide Net Sales over $500 million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.65 469.17 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 469.17 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.65 469.17 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.65 469.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 469.17 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 469.17 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 469.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.30 469.17 Td (14-25%) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 38.00 456.86 Td (Amylin products U.S. Net Sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 456.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 456.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 456.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.65 456.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.65 456.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.65 456.17 Td (5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.65 456.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 456.17 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 456.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 456.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 456.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.30 456.17 Td (5-12%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 429.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.24 429.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 76.04 429.10 Td (and ) Tj ET Q q 0 0 0 rg BT 92.17 429.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 113.30 429.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 150.52 429.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 193.86 429.10 Td (contained ) Tj ET Q q 0 0 0 rg BT 234.42 429.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 269.44 429.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 306.67 429.10 Td (to ) Tj ET Q q 0 0 0 rg BT 316.14 429.10 Td (be ) Tj ET Q q 0 0 0 rg BT 327.27 429.10 Td (delivered ) Tj ET Q q 0 0 0 rg BT 366.16 429.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 412.29 429.10 Td (to ) Tj ET Q q 0 0 0 rg BT 421.76 429.10 Td (the ) Tj ET Q q 0 0 0 rg BT 435.67 429.10 Td (closing ) Tj ET Q q 0 0 0 rg BT 466.25 429.10 Td (of ) Tj ET Q q 0 0 0 rg BT 476.27 429.10 Td (the ) Tj ET Q q 0 0 0 rg BT 490.18 429.10 Td (transaction, ) Tj ET Q q 0 0 0 rg BT 538.24 429.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 417.10 Td (the ) Tj ET Q q 0 0 0 rg BT 49.73 417.10 Td (China ) Tj ET Q q 0 0 0 rg BT 75.13 417.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 109.41 417.10 Td (business ) Tj ET Q q 0 0 0 rg BT 144.81 417.10 Td (\(transferred ) Tj ET Q q 0 0 0 rg BT 192.96 417.10 Td (in ) Tj ET Q q 0 0 0 rg BT 202.25 417.10 Td (2014\), ) Tj ET Q q 0 0 0 rg BT 229.59 417.10 Td (the ) Tj ET Q q 0 0 0 rg BT 243.32 417.10 Td (Mount ) Tj ET Q q 0 0 0 rg BT 271.39 417.10 Td (V) Tj ET Q q 0 0 0 rg BT 277.51 417.10 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 304.29 417.10 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 335.79 417.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 395.61 417.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 425.44 417.10 Td (\(transferred ) Tj ET Q q 0 0 0 rg BT 473.59 417.10 Td (in ) Tj ET Q q 0 0 0 rg BT 482.88 417.10 Td (2015\), ) Tj ET Q q 0 0 0 rg BT 510.23 417.10 Td (and ) Tj ET Q q 0 0 0 rg BT 526.18 417.10 Td (the ) Tj ET Q q 0 0 0 rg BT 539.91 417.10 Td (activities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 405.10 Td (under ) Tj ET Q q 0 0 0 rg BT 61.06 405.10 Td (the ) Tj ET Q q 0 0 0 rg BT 75.58 405.10 Td (development ) Tj ET Q q 0 0 0 rg BT 129.52 405.10 Td (and ) Tj ET Q q 0 0 0 rg BT 146.25 405.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 175.22 405.10 Td (agreements. ) Tj ET Q q 0 0 0 rg BT 225.55 405.10 Td (Each ) Tj ET Q q 0 0 0 rg BT 247.83 405.10 Td (of ) Tj ET Q q 0 0 0 rg BT 258.45 405.10 Td (these ) Tj ET Q q 0 0 0 rg BT 281.29 405.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 319.13 405.10 Td (was ) Tj ET Q q 0 0 0 rg BT 336.98 405.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 384.25 405.10 Td (to ) Tj ET Q q 0 0 0 rg BT 394.33 405.10 Td (have ) Tj ET Q q 0 0 0 rg BT 415.50 405.10 Td (a ) Tj ET Q q 0 0 0 rg BT 422.23 405.10 Td (standalone ) Tj ET Q q 0 0 0 rg BT 467.29 405.10 Td (value. ) Tj ET Q q 0 0 0 rg BT 493.23 405.10 Td (As ) Tj ET Q q 0 0 0 rg BT 506.64 405.10 Td (a ) Tj ET Q q 0 0 0 rg BT 513.37 405.10 Td (result, ) Tj ET Q q 0 0 0 rg BT 540.39 405.10 Td (a ) Tj ET Q q 0 0 0 rg BT 547.12 405.10 Td (portion ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 393.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.12 393.10 Td (the ) Tj ET Q q 0 0 0 rg BT 60.14 393.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 115.80 393.10 Td (received ) Tj ET Q q 0 0 0 rg BT 151.46 393.10 Td (at ) Tj ET Q q 0 0 0 rg BT 160.47 393.10 Td (closing ) Tj ET Q q 0 0 0 rg BT 191.15 393.10 Td (was ) Tj ET Q q 0 0 0 rg BT 208.50 393.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 246.38 393.10 Td (to ) Tj ET Q q 0 0 0 rg BT 255.95 393.10 Td (the ) Tj ET Q q 0 0 0 rg BT 269.96 393.10 Td (undelivered ) Tj ET Q q 0 0 0 rg BT 318.96 393.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 356.30 393.10 Td (using ) Tj ET Q q 0 0 0 rg BT 379.76 393.10 Td (the ) Tj ET Q q 0 0 0 rg BT 393.77 393.10 Td (relative ) Tj ET Q q 0 0 0 rg BT 425.55 393.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 454.01 393.10 Td (price ) Tj ET Q q 0 0 0 rg BT 475.79 393.10 Td (method ) Tj ET Q q 0 0 0 rg BT 507.58 393.10 Td (after ) Tj ET Q q 0 0 0 rg BT 527.69 393.10 Td (determining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 381.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.58 381.10 Td (best ) Tj ET Q q 0 0 0 rg BT 69.04 381.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 109.72 381.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 138.74 381.10 Td (price ) Tj ET Q q 0 0 0 rg BT 161.09 381.10 Td (for ) Tj ET Q q 0 0 0 rg BT 175.11 381.10 Td (each ) Tj ET Q q 0 0 0 rg BT 195.78 381.10 Td (element. ) Tj ET Q q 0 0 0 rg BT 232.12 381.10 Td (The ) Tj ET Q q 0 0 0 rg BT 250.02 381.10 Td (remaining ) Tj ET Q q 0 0 0 rg BT 292.92 381.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 325.28 381.10 Td (of ) Tj ET Q q 0 0 0 rg BT 335.97 381.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 392.20 381.10 Td (was ) Tj ET Q q 0 0 0 rg BT 410.11 381.10 Td (included ) Tj ET Q q 0 0 0 rg BT 446.90 381.10 Td (in ) Tj ET Q q 0 0 0 rg BT 457.04 381.10 Td (the ) Tj ET Q q 0 0 0 rg BT 471.61 381.10 Td (calculation ) Tj ET Q q 0 0 0 rg BT 517.84 381.10 Td (for ) Tj ET Q q 0 0 0 rg BT 531.85 381.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.43 381.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 566.01 381.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 369.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 54.19 369.10 Td (of ) Tj ET Q q 0 0 0 rg BT 65.17 369.10 Td (the ) Tj ET Q q 0 0 0 rg BT 80.03 369.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 115.44 369.10 Td (business. ) Tj ET Q q 0 0 0 rg BT 154.48 369.10 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 201.57 369.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 243.10 369.10 Td (and ) Tj ET Q q 0 0 0 rg BT 260.18 369.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 291.16 369.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 332.13 369.10 Td (are ) Tj ET Q q 0 0 0 rg BT 346.98 369.10 Td (similarly ) Tj ET Q q 0 0 0 rg BT 385.18 369.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 423.92 369.10 Td (among ) Tj ET Q q 0 0 0 rg BT 453.78 369.10 Td (the ) Tj ET Q q 0 0 0 rg BT 468.64 369.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 514.61 369.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 552.80 369.10 Td (if ) Tj ET Q q 0 0 0 rg BT 561.56 369.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 357.10 Td (when ) Tj ET Q q 0 0 0 rg BT 60.49 357.10 Td (the ) Tj ET Q q 0 0 0 rg BT 75.53 357.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 112.25 357.10 Td (are ) Tj ET Q q 0 0 0 rg BT 127.29 357.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 175.09 357.10 Td (to ) Tj ET Q q 0 0 0 rg BT 185.70 357.10 Td (be ) Tj ET Q q 0 0 0 rg BT 197.97 357.10 Td (payable ) Tj ET Q q 0 0 0 rg BT 231.89 357.10 Td (to ) Tj ET Q q 0 0 0 rg BT 242.50 357.10 Td (BMS. ) Tj ET Q q 0 0 0 rg BT 268.32 357.10 Td (Amounts ) Tj ET Q q 0 0 0 rg BT 307.82 357.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 346.74 357.10 Td (to ) Tj ET Q q 0 0 0 rg BT 357.35 357.10 Td (the ) Tj ET Q q 0 0 0 rg BT 372.39 357.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 390.77 357.10 Td (of ) Tj ET Q q 0 0 0 rg BT 401.93 357.10 Td (the ) Tj ET Q q 0 0 0 rg BT 416.97 357.10 Td (business ) Tj ET Q q 0 0 0 rg BT 453.69 357.10 Td (are ) Tj ET Q q 0 0 0 rg BT 468.73 357.10 Td (immediately ) Tj ET Q q 0 0 0 rg BT 521.54 357.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 568.23 357.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 345.10 Td (the ) Tj ET Q q 0 0 0 rg BT 51.47 345.10 Td (results ) Tj ET Q q 0 0 0 rg BT 80.84 345.10 Td (of ) Tj ET Q q 0 0 0 rg BT 92.43 345.10 Td (operations. ) Tj ET Q q 0 0 0 rg BT 139.12 345.10 Td (Amounts ) Tj ET Q q 0 0 0 rg BT 179.05 345.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 218.39 345.10 Td (to ) Tj ET Q q 0 0 0 rg BT 229.43 345.10 Td (the ) Tj ET Q q 0 0 0 rg BT 244.90 345.10 Td (other ) Tj ET Q q 0 0 0 rg BT 268.70 345.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 307.50 345.10 Td (are ) Tj ET Q q 0 0 0 rg BT 322.97 345.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 370.09 345.10 Td (in ) Tj ET Q q 0 0 0 rg BT 381.12 345.10 Td (the ) Tj ET Q q 0 0 0 rg BT 396.59 345.10 Td (results ) Tj ET Q q 0 0 0 rg BT 425.96 345.10 Td (of ) Tj ET Q q 0 0 0 rg BT 437.55 345.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 482.46 345.10 Td (only ) Tj ET Q q 0 0 0 rg BT 503.49 345.10 Td (to ) Tj ET Q q 0 0 0 rg BT 514.53 345.10 Td (the ) Tj ET Q q 0 0 0 rg BT 530.00 345.10 Td (extent ) Tj ET Q q 0 0 0 rg BT 557.69 345.10 Td (each ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 333.10 Td (element ) Tj ET Q q 0 0 0 rg BT 70.15 333.10 Td (has ) Tj ET Q q 0 0 0 rg BT 85.98 333.10 Td (been ) Tj ET Q q 0 0 0 rg BT 107.36 333.10 Td (delivered.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 309.10 Td (Consideration ) Tj ET Q q 0 0 0 rg BT 93.70 309.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 103.63 309.10 Td ($3.8 ) Tj ET Q q 0 0 0 rg BT 122.72 309.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 148.83 309.10 Td ( ) Tj ET Q q 0 0 0 rg BT 150.43 309.10 Td (was ) Tj ET Q q 0 0 0 rg BT 167.58 309.10 Td (accounted ) Tj ET Q q 0 0 0 rg BT 209.71 309.10 Td (for ) Tj ET Q q 0 0 0 rg BT 222.96 309.10 Td (in ) Tj ET Q q 0 0 0 rg BT 232.33 309.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 253.93 309.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 296.63 309.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 332.66 309.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 348.69 309.10 Td ($700 ) Tj ET Q q 0 0 0 rg BT 370.29 309.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.18 309.10 Td ( ) Tj ET Q q 0 0 0 rg BT 400.78 309.10 Td (of ) Tj ET Q q 0 0 0 rg BT 410.70 309.10 Td (contingent ) Tj ET Q q 0 0 0 rg BT 454.51 309.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 497.20 309.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 537.68 309.10 Td (payments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 297.10 Td (related ) Tj ET Q q 0 0 0 rg BT 65.40 297.10 Td (to ) Tj ET Q q 0 0 0 rg BT 75.38 297.10 Td (the ) Tj ET Q q 0 0 0 rg BT 89.80 297.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 126.99 297.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 137.52 297.10 Td (Farxiga*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 174.74 297.10 Td ( ) Tj ET Q q 0 0 0 rg BT 176.94 297.10 Td (in ) Tj ET Q q 0 0 0 rg BT 186.92 297.10 Td (both ) Tj ET Q q 0 0 0 rg BT 206.90 297.10 Td (the ) Tj ET Q q 0 0 0 rg BT 221.31 297.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 241.30 297.10 Td (and ) Tj ET Q q 0 0 0 rg BT 257.94 297.10 Td (Japan\). ) Tj ET Q q 0 0 0 rg BT 288.25 297.10 Td (Approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.99 297.10 Td ($3.3 ) Tj ET Q q 0 0 0 rg BT 370.70 297.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.81 297.10 Td ( ) Tj ET Q q 0 0 0 rg BT 399.01 297.10 Td (of ) Tj ET Q q 0 0 0 rg BT 409.54 297.10 Td (the ) Tj ET Q q 0 0 0 rg BT 423.96 297.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 480.03 297.10 Td (was ) Tj ET Q q 0 0 0 rg BT 497.79 297.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 536.08 297.10 Td (to ) Tj ET Q q 0 0 0 rg BT 546.06 297.10 Td (the ) Tj ET Q q 0 0 0 rg BT 560.47 297.10 Td (sale ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 285.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.99 285.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.86 285.10 Td (business ) Tj ET Q q 0 0 0 rg BT 98.41 285.10 Td (and ) Tj ET Q q 0 0 0 rg BT 115.51 285.10 Td (the ) Tj ET Q q 0 0 0 rg BT 130.39 285.10 Td (remaining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 173.59 285.10 Td ($492 ) Tj ET Q q 0 0 0 rg BT 196.25 285.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 225.14 285.10 Td ( ) Tj ET Q q 0 0 0 rg BT 227.80 285.10 Td (was ) Tj ET Q q 0 0 0 rg BT 246.01 285.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 284.75 285.10 Td (to ) Tj ET Q q 0 0 0 rg BT 295.19 285.10 Td (the ) Tj ET Q q 0 0 0 rg BT 310.07 285.10 Td (undelivered ) Tj ET Q q 0 0 0 rg BT 359.93 285.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 398.13 285.10 Td (described ) Tj ET Q q 0 0 0 rg BT 439.10 285.10 Td (above. ) Tj ET Q q 0 0 0 rg BT 467.95 285.10 Td (The ) Tj ET Q q 0 0 0 rg BT 486.15 285.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 542.68 285.10 Td (includes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 273.10 Td ($235 ) Tj ET Q q 0 0 0 rg BT 59.38 273.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.27 273.10 Td ( ) Tj ET Q q 0 0 0 rg BT 91.65 273.10 Td (of ) Tj ET Q q 0 0 0 rg BT 103.37 273.10 Td (earned ) Tj ET Q q 0 0 0 rg BT 133.39 273.10 Td (royalties, ) Tj ET Q q 0 0 0 rg BT 173.71 273.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.86 273.10 Td ($192 ) Tj ET Q q 0 0 0 rg BT 238.24 273.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.14 273.10 Td ( ) Tj ET Q q 0 0 0 rg BT 270.52 273.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 309.99 273.10 Td (to ) Tj ET Q q 0 0 0 rg BT 321.15 273.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 360.07 273.10 Td (that ) Tj ET Q q 0 0 0 rg BT 378.45 273.10 Td (were ) Tj ET Q q 0 0 0 rg BT 401.26 273.10 Td (delivered. ) Tj ET Q q 0 0 0 rg BT 444.10 273.10 Td (The ) Tj ET Q q 0 0 0 rg BT 463.02 273.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 483.62 273.10 Td (on ) Tj ET Q q 0 0 0 rg BT 497.00 273.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 515.93 273.10 Td (of ) Tj ET Q q 0 0 0 rg BT 527.64 273.10 Td (the ) Tj ET Q q 0 0 0 rg BT 543.24 273.10 Td (diabetes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 261.10 Td (business ) Tj ET Q q 0 0 0 rg BT 72.88 261.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 91.42 261.10 Td ($536 ) Tj ET Q q 0 0 0 rg BT 114.42 261.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 143.31 261.10 Td (, ) Tj ET Q q 0 0 0 rg BT 148.80 261.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.56 261.10 Td ($292 ) Tj ET Q q 0 0 0 rg BT 212.55 261.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 241.44 261.10 Td ( ) Tj ET Q q 0 0 0 rg BT 244.44 261.10 Td (during ) Tj ET Q q 0 0 0 rg BT 273.53 261.10 Td (the ) Tj ET Q q 0 0 0 rg BT 288.74 261.10 Td (third ) Tj ET Q q 0 0 0 rg BT 310.62 261.10 Td (quarter ) Tj ET Q q 0 0 0 rg BT 341.93 261.10 Td (of ) Tj ET Q q 0 0 0 rg BT 353.25 261.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 376.24 261.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 414.22 261.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 454.43 261.10 Td (from ) Tj ET Q q 0 0 0 rg BT 476.85 261.10 Td (the ) Tj ET Q q 0 0 0 rg BT 492.06 261.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 525.59 261.10 Td (of ) Tj ET Q q 0 0 0 rg BT 536.91 261.10 Td (the ) Tj ET Q q 0 0 0 rg BT 552.12 261.10 Td (China ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 249.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 71.48 249.10 Td (business ) Tj ET Q q 0 0 0 rg BT 108.08 249.10 Td (to ) Tj ET Q q 0 0 0 rg BT 117.97 249.10 Td (AstraZeneca. ) Tj ET Q q 0 0 0 rg BT 173.51 249.10 Td (The ) Tj ET Q q 0 0 0 rg BT 191.77 249.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 211.69 249.10 Td (was ) Tj ET Q q 0 0 0 rg BT 229.96 249.10 Td (based ) Tj ET Q q 0 0 0 rg BT 255.44 249.10 Td (on ) Tj ET Q q 0 0 0 rg BT 268.15 249.10 Td (the ) Tj ET Q q 0 0 0 rg BT 283.08 249.10 Td (dif) Tj ET Q q 0 0 0 rg BT 294.00 249.10 Td (ference ) Tj ET Q q 0 0 0 rg BT 326.13 249.10 Td (between ) Tj ET Q q 0 0 0 rg BT 362.16 249.10 Td (the ) Tj ET Q q 0 0 0 rg BT 377.08 249.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 433.67 249.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 472.47 249.10 Td (to ) Tj ET Q q 0 0 0 rg BT 482.96 249.10 Td (the ) Tj ET Q q 0 0 0 rg BT 497.89 249.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 516.14 249.10 Td (of ) Tj ET Q q 0 0 0 rg BT 527.19 249.10 Td (the ) Tj ET Q q 0 0 0 rg BT 542.11 249.10 Td (business ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 237.10 Td (excluding ) Tj ET Q q 0 0 0 rg BT 77.47 237.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 113.94 237.10 Td (\(net ) Tj ET Q q 0 0 0 rg BT 131.52 237.10 Td (of ) Tj ET Q q 0 0 0 rg BT 141.89 237.10 Td (transaction ) Tj ET Q q 0 0 0 rg BT 187.80 237.10 Td (fees\) ) Tj ET Q q 0 0 0 rg BT 209.26 237.10 Td (and ) Tj ET Q q 0 0 0 rg BT 225.74 237.10 Td (the ) Tj ET Q q 0 0 0 rg BT 239.99 237.10 Td (carrying ) Tj ET Q q 0 0 0 rg BT 275.34 237.10 Td (value ) Tj ET Q q 0 0 0 rg BT 299.03 237.10 Td (of ) Tj ET Q q 0 0 0 rg BT 309.40 237.10 Td (the ) Tj ET Q q 0 0 0 rg BT 323.65 237.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 358.45 237.10 Td (business ) Tj ET Q q 0 0 0 rg BT 394.38 237.10 Td (net ) Tj ET Q q 0 0 0 rg BT 408.63 237.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 434.00 237.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 477.14 237.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.61 237.10 Td ($600 ) Tj ET Q q 0 0 0 rg BT 505.65 237.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 534.54 237.10 Td ( ) Tj ET Q q 0 0 0 rg BT 536.58 237.10 Td (allocation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 225.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.66 225.10 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 86.55 225.10 Td (and ) Tj ET Q q 0 0 0 rg BT 104.33 225.10 Td (the ) Tj ET Q q 0 0 0 rg BT 119.88 225.10 Td (reversal ) Tj ET Q q 0 0 0 rg BT 154.86 225.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 166.52 225.10 Td ($821 ) Tj ET Q q 0 0 0 rg BT 189.86 225.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.75 225.10 Td ( ) Tj ET Q q 0 0 0 rg BT 222.08 225.10 Td (of ) Tj ET Q q 0 0 0 rg BT 233.75 225.10 Td (net ) Tj ET Q q 0 0 0 rg BT 249.30 225.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 285.94 225.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 301.49 225.10 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 342.04 225.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 383.69 225.10 Td (to ) Tj ET Q q 0 0 0 rg BT 394.07 225.10 Td (Amylin\). ) Tj ET Q q 0 0 0 rg BT 433.79 225.10 Td (Consideration ) Tj ET Q q 0 0 0 rg BT 493.23 225.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.89 225.10 Td ($179 ) Tj ET Q q 0 0 0 rg BT 528.22 225.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.12 225.10 Td ( ) Tj ET Q q 0 0 0 rg BT 560.45 225.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 213.10 Td (received ) Tj ET Q q 0 0 0 rg BT 72.49 213.10 Td (in ) Tj ET Q q 0 0 0 rg BT 82.89 213.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 105.51 213.10 Td (for ) Tj ET Q q 0 0 0 rg BT 119.79 213.10 Td (the ) Tj ET Q q 0 0 0 rg BT 134.64 213.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 167.80 213.10 Td (of ) Tj ET Q q 0 0 0 rg BT 178.75 213.10 Td (the ) Tj ET Q q 0 0 0 rg BT 193.59 213.10 Td (Mount ) Tj ET Q q 0 0 0 rg BT 222.69 213.10 Td (V) Tj ET Q q 0 0 0 rg BT 228.81 213.10 Td (ernon, ) Tj ET Q q 0 0 0 rg BT 256.70 213.10 Td (Indiana ) Tj ET Q q 0 0 0 rg BT 289.31 213.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 350.24 213.10 Td (facility ) Tj ET Q q 0 0 0 rg BT 381.19 213.10 Td (and ) Tj ET Q q 0 0 0 rg BT 398.25 213.10 Td (related ) Tj ET Q q 0 0 0 rg BT 428.07 213.10 Td (inventories ) Tj ET Q q 0 0 0 rg BT 475.13 213.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 512.75 213.10 Td (in ) Tj ET Q q 0 0 0 rg BT 523.15 213.10 Td (a ) Tj ET Q q 0 0 0 rg BT 530.21 213.10 Td (gain ) Tj ET Q q 0 0 0 rg BT 550.05 213.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.01 213.10 Td ($79 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 201.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 201.10 Td ( ) Tj ET Q q 0 0 0 rg BT 67.39 201.10 Td (for ) Tj ET Q q 0 0 0 rg BT 81.55 201.10 Td (the ) Tj ET Q q 0 0 0 rg BT 96.27 201.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 132.66 201.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 171.24 201.10 Td (to ) Tj ET Q q 0 0 0 rg BT 181.52 201.10 Td (the ) Tj ET Q q 0 0 0 rg BT 196.24 201.10 Td (delivered ) Tj ET Q q 0 0 0 rg BT 235.94 201.10 Td (elements. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 177.10 Td (Consideration ) Tj ET Q q 0 0 0 rg BT 94.92 177.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 133.82 177.10 Td (to ) Tj ET Q q 0 0 0 rg BT 144.41 177.10 Td (the ) Tj ET Q q 0 0 0 rg BT 159.43 177.10 Td (development ) Tj ET Q q 0 0 0 rg BT 213.90 177.10 Td (and ) Tj ET Q q 0 0 0 rg BT 231.15 177.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 260.63 177.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 308.97 177.10 Td (are ) Tj ET Q q 0 0 0 rg BT 323.99 177.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 366.78 177.10 Td (over ) Tj ET Q q 0 0 0 rg BT 387.36 177.10 Td (the ) Tj ET Q q 0 0 0 rg BT 402.39 177.10 Td (applicable ) Tj ET Q q 0 0 0 rg BT 446.29 177.10 Td (service ) Tj ET Q q 0 0 0 rg BT 477.42 177.10 Td (periods. ) Tj ET Q q 0 0 0 rg BT 511.55 177.10 Td (Amortization ) Tj ET Q q 0 0 0 rg BT 567.68 177.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 165.10 Td (deferred ) Tj ET Q q 0 0 0 rg BT 71.93 165.10 Td (income ) Tj ET Q q 0 0 0 rg BT 103.98 165.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 144.93 165.10 Td (to ) Tj ET Q q 0 0 0 rg BT 155.33 165.10 Td (the ) Tj ET Q q 0 0 0 rg BT 170.17 165.10 Td (development ) Tj ET Q q 0 0 0 rg BT 224.44 165.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 268.70 165.10 Td (was ) Tj ET Q q 0 0 0 rg BT 286.87 165.10 Td (included ) Tj ET Q q 0 0 0 rg BT 323.93 165.10 Td (in ) Tj ET Q q 0 0 0 rg BT 334.33 165.10 Td (other ) Tj ET Q q 0 0 0 rg BT 357.50 165.10 Td (income ) Tj ET Q q 0 0 0 rg BT 389.55 165.10 Td (as ) Tj ET Q q 0 0 0 rg BT 400.51 165.10 Td (the ) Tj ET Q q 0 0 0 rg BT 415.35 165.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 433.51 165.10 Td (of ) Tj ET Q q 0 0 0 rg BT 444.47 165.10 Td (these ) Tj ET Q q 0 0 0 rg BT 467.64 165.10 Td (services ) Tj ET Q q 0 0 0 rg BT 502.46 165.10 Td (are ) Tj ET Q q 0 0 0 rg BT 517.29 165.10 Td (not ) Tj ET Q q 0 0 0 rg BT 532.69 165.10 Td (considered ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 153.10 Td (part ) Tj ET Q q 0 0 0 rg BT 54.05 153.10 Td (of ) Tj ET Q q 0 0 0 rg BT 64.88 153.10 Td (BMS’) Tj ET Q q 0 0 0 rg BT 88.78 153.10 Td (s ) Tj ET Q q 0 0 0 rg BT 95.17 153.10 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 130.45 153.10 Td (major ) Tj ET Q q 0 0 0 rg BT 156.27 153.10 Td (or ) Tj ET Q q 0 0 0 rg BT 167.10 153.10 Td (central ) Tj ET Q q 0 0 0 rg BT 196.81 153.10 Td (operations. ) Tj ET Q q 0 0 0 rg BT 243.46 153.10 Td (Revenues ) Tj ET Q q 0 0 0 rg BT 284.84 153.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 325.66 153.10 Td (to ) Tj ET Q q 0 0 0 rg BT 335.94 153.10 Td (the ) Tj ET Q q 0 0 0 rg BT 350.65 153.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 379.82 153.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 423.96 153.10 Td (were ) Tj ET Q q 0 0 0 rg BT 445.89 153.10 Td (included ) Tj ET Q q 0 0 0 rg BT 482.83 153.10 Td (in ) Tj ET Q q 0 0 0 rg BT 493.10 153.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 526.69 153.10 Td (revenues.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 129.10 Td (Consideration ) Tj ET Q q 0 0 0 rg BT 93.68 129.10 Td (for ) Tj ET Q q 0 0 0 rg BT 106.92 129.10 Td (the ) Tj ET Q q 0 0 0 rg BT 120.72 129.10 Td (transaction ) Tj ET Q q 0 0 0 rg BT 166.17 129.10 Td (is ) Tj ET Q q 0 0 0 rg BT 174.42 129.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 214.31 129.10 Td (for ) Tj ET Q q 0 0 0 rg BT 227.55 129.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 246.90 129.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 266.80 129.10 Td (purposes ) Tj ET Q q 0 0 0 rg BT 303.93 129.10 Td (based ) Tj ET Q q 0 0 0 rg BT 328.28 129.10 Td (on ) Tj ET Q q 0 0 0 rg BT 339.86 129.10 Td (the ) Tj ET Q q 0 0 0 rg BT 353.66 129.10 Td (allocation ) Tj ET Q q 0 0 0 rg BT 394.66 129.10 Td (process ) Tj ET Q q 0 0 0 rg BT 426.23 129.10 Td (described ) Tj ET Q q 0 0 0 rg BT 466.13 129.10 Td (above, ) Tj ET Q q 0 0 0 rg BT 494.08 129.10 Td (either ) Tj ET Q q 0 0 0 rg BT 518.42 129.10 Td (as ) Tj ET Q q 0 0 0 rg BT 528.33 129.10 Td (an ) Tj ET Q q 0 0 0 rg BT 539.35 129.10 Td (investing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 117.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 68.26 117.10 Td (if ) Tj ET Q q 0 0 0 rg BT 76.63 117.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 117.22 117.10 Td (to ) Tj ET Q q 0 0 0 rg BT 127.26 117.10 Td (the ) Tj ET Q q 0 0 0 rg BT 141.74 117.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 159.55 117.10 Td (of ) Tj ET Q q 0 0 0 rg BT 170.15 117.10 Td (the ) Tj ET Q q 0 0 0 rg BT 184.63 117.10 Td (business ) Tj ET Q q 0 0 0 rg BT 220.79 117.10 Td (or ) Tj ET Q q 0 0 0 rg BT 231.39 117.10 Td (related ) Tj ET Q q 0 0 0 rg BT 260.85 117.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 286.45 117.10 Td (or ) Tj ET Q q 0 0 0 rg BT 297.04 117.10 Td (as ) Tj ET Q q 0 0 0 rg BT 307.64 117.10 Td (an ) Tj ET Q q 0 0 0 rg BT 319.34 117.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 359.37 117.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 391.63 117.10 Td (if ) Tj ET Q q 0 0 0 rg BT 400.00 117.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 440.59 117.10 Td (to ) Tj ET Q q 0 0 0 rg BT 450.63 117.10 Td (the ) Tj ET Q q 0 0 0 rg BT 465.12 117.10 Td (transitional ) Tj ET Q q 0 0 0 rg BT 512.37 117.10 Td (services, ) Tj ET Q q 0 0 0 rg BT 549.34 117.10 Td (supply ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 105.10 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 88.47 105.10 Td (or ) Tj ET Q q 0 0 0 rg BT 99.30 105.10 Td (development ) Tj ET Q q 0 0 0 rg BT 153.45 105.10 Td (agreement.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 81.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.43 81.10 Td (September ) Tj ET Q q 0 0 0 rg BT 93.30 81.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 118.90 81.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 143.13 81.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 189.53 81.10 Td (a ) Tj ET Q q 0 0 0 rg BT 197.07 81.10 Td (percentage ) Tj ET Q q 0 0 0 rg BT 243.48 81.10 Td (of ) Tj ET Q q 0 0 0 rg BT 254.91 81.10 Td (its ) Tj ET Q q 0 0 0 rg BT 267.46 81.10 Td (future ) Tj ET Q q 0 0 0 rg BT 294.44 81.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 325.86 81.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 351.75 81.10 Td (on ) Tj ET Q q 0 0 0 rg BT 364.16 81.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 397.82 81.10 Td (net ) Tj ET Q q 0 0 0 rg BT 413.14 81.10 Td (product ) Tj ET Q q 0 0 0 rg BT 446.79 81.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 469.33 81.10 Td (in ) Tj ET Q q 0 0 0 rg BT 480.21 81.10 Td (the ) Tj ET Q q 0 0 0 rg BT 495.53 81.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 516.41 81.10 Td (to ) Tj ET Q q 0 0 0 rg BT 527.29 81.10 Td (CPPIB. ) Tj ET Q q 0 0 0 rg BT 560.46 81.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 69.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 82.60 69.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 108.68 69.10 Td (represent ) Tj ET Q q 0 0 0 rg BT 148.62 69.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 209.68 69.10 Td (70%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.01 69.10 Td ( ) Tj ET Q q 0 0 0 rg BT 231.31 69.10 Td (of ) Tj ET Q q 0 0 0 rg BT 242.94 69.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 281.23 69.10 Td (future ) Tj ET Q q 0 0 0 rg BT 308.40 69.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 346.13 69.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 370.56 69.10 Td (is ) Tj ET Q q 0 0 0 rg BT 380.52 69.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 413.81 69.10 Td (to ) Tj ET Q q 0 0 0 rg BT 424.89 69.10 Td (in ) Tj ET Q q 0 0 0 rg BT 435.97 69.10 Td (2019 ) Tj ET Q q 0 0 0 rg BT 459.26 69.10 Td (to ) Tj ET Q q 0 0 0 rg BT 470.34 69.10 Td (2025. ) Tj ET Q q 0 0 0 rg BT 496.14 69.10 Td (In ) Tj ET Q q 0 0 0 rg BT 507.77 69.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 548.82 69.10 Td (for ) Tj ET Q q 0 0 0 rg BT 563.78 69.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 57.10 Td (transfer) Tj ET Q q 0 0 0 rg BT 66.14 57.10 Td (, ) Tj ET Q q 0 0 0 rg BT 70.85 57.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 94.19 57.10 Td (will ) Tj ET Q q 0 0 0 rg BT 111.97 57.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 143.05 57.10 Td (an ) Tj ET Q q 0 0 0 rg BT 154.70 57.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 196.91 57.10 Td (tiered-based ) Tj ET Q q 0 0 0 rg BT 247.99 57.10 Td (royalty ) Tj ET Q q 0 0 0 rg BT 278.53 57.10 Td (on ) Tj ET Q q 0 0 0 rg BT 290.26 57.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 323.03 57.10 Td (net ) Tj ET Q q 0 0 0 rg BT 337.46 57.10 Td (product ) Tj ET Q q 0 0 0 rg BT 370.23 57.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 391.88 57.10 Td (in ) Tj ET Q q 0 0 0 rg BT 401.88 57.10 Td (the ) Tj ET Q q 0 0 0 rg BT 416.31 57.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 436.31 57.10 Td (from ) Tj ET Q q 0 0 0 rg BT 457.97 57.10 Td (CPPIB ) Tj ET Q q 0 0 0 rg BT 487.98 57.10 Td (in ) Tj ET Q q 0 0 0 rg BT 497.97 57.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 520.19 57.10 Td (through ) Tj ET Q q 0 0 0 rg BT 553.51 57.10 Td (2018. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 45.10 Td (These ) Tj ET Q q 0 0 0 rg BT 62.38 45.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 99.31 45.10 Td (are ) Tj ET Q q 0 0 0 rg BT 114.02 45.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 154.83 45.10 Td (in ) Tj ET Q q 0 0 0 rg BT 165.11 45.10 Td (other ) Tj ET Q q 0 0 0 rg BT 188.16 45.10 Td (income ) Tj ET Q q 0 0 0 rg BT 220.09 45.10 Td (and ) Tj ET Q q 0 0 0 rg BT 237.03 45.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 258.96 45.10 Td ($134 ) Tj ET Q q 0 0 0 rg BT 281.46 45.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.35 45.10 Td ( ) Tj ET Q q 0 0 0 rg BT 312.85 45.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 323.13 45.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.13 45.10 Td (. ) Tj ET Q endstream endobj 139 0 obj <> endobj 140 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 749.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 230.38 749.10 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 283.40 749.10 Td (alliances ) Tj ET Q q 0 0 0 rg BT 320.88 749.10 Td (was ) Tj ET Q q 0 0 0 rg BT 338.93 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 349.76 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 712.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 660.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 634.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 608.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 582.60 348.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 582.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 582.60 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 582.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 582.60 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 582.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 582.60 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 554.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 554.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 554.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 554.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 554.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 528.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 528.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 528.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 528.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 528.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 528.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 528.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 502.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 502.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 502.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 502.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 502.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 502.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 502.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 476.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 476.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 476.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 476.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 476.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 476.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 476.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 725.6 m 448.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 725.6 m 452.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 725.6 m 512.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.6 m 516.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 712.6 m 448.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 712.6 m 512.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 673.6 m 448.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 661.6 m 448.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 659.6 m 448.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 673.6 m 512.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 661.6 m 512.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 659.6 m 512.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 673.6 m 576.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 661.6 m 576.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 659.6 m 576.5 659.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 716.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 703.33 Td (Revenues from AstraZeneca alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 690.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 690.17 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 690.17 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 677.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 677.17 Td (129) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 677.17 Td (182) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 677.17 Td (135) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 664.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 664.17 Td (129) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 664.17 Td (196) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 664.17 Td (295) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 638.33 Td (Payments to/\(from\) AstraZeneca:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 625.17 Td (Cost of products sold – Profit sharing) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 625.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 625.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 625.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 625.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 625.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 625.17 Td (79) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 599.17 Td (Cost reimbursements from AstraZeneca) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 599.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 599.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 599.17 Td (\(33) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 599.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 573.17 Td (Other \(income\)/expense:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 558.17 Td (Amortization of deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 558.22 Td (\(113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 558.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.30 558.22 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 558.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 558.17 Td (\(80) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 558.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 545.17 Td (Royalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 545.22 Td (\(227) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 545.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.30 545.22 Td (\(215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 545.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 545.17 Td (\(192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 545.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 532.17 Td (Transitional services) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.30 532.22 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 532.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.30 532.22 Td (\(12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 532.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 532.17 Td (\(90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 532.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 519.17 Td (Divestiture gain) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 519.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.30 519.22 Td (\(82) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 519.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 519.17 Td (\(536) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 519.17 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 493.33 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 480.17 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 480.17 Td (19) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 480.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 480.17 Td (315) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 467.17 Td (Divestiture and other proceeds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 467.17 Td (216) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 467.17 Td (374) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 467.17 Td (3,495) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 427.60 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 427.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 427.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 440.6 m 512.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 440.6 m 516.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 440.6 m 576.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 440.6 m 512.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 427.6 m 512.5 427.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 440.6 m 516.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 440.6 m 576.5 440.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 427.6 m 576.5 427.6 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 444.33 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 444.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 431.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 431.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 431.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 418.17 Td (Deferred income – Services not yet performed for AstraZeneca) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 418.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 418.17 Td (38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 418.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 418.17 Td (144) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 389.53505859375 m 63.2314453125 389.53505859375 l s q 0 0 0 rg BT 36.00 391.10 Td (Sanofi) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 367.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.19 367.10 Td (and ) Tj ET Q q 0 0 0 rg BT 77.70 367.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 106.88 367.10 Td (have ) Tj ET Q q 0 0 0 rg BT 128.83 367.10 Td (co-development ) Tj ET Q q 0 0 0 rg BT 196.32 367.10 Td (and ) Tj ET Q q 0 0 0 rg BT 213.83 367.10 Td (co-commercialization ) Tj ET Q q 0 0 0 rg BT 304.07 367.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 352.68 367.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 367.41 367.10 Td (Plavix* ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.02 367.10 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 418.53 367.10 Td (A) Tj ET Q q 0 0 0 rg BT 424.08 367.10 Td (vapr) Tj ET Q q 0 0 0 rg BT 442.04 367.10 Td (o*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.04 367.10 Td (/) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 454.82 367.10 Td (A) Tj ET Q q 0 0 0 rg BT 460.38 367.10 Td (valide*.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.31 367.10 Td ( ) Tj ET Q q 0 0 0 rg BT 495.38 367.10 Td (Ef) Tj ET Q q 0 0 0 rg BT 504.64 367.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 534.91 367.10 Td (January 1, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.10 Td (2013, ) Tj ET Q q 0 0 0 rg BT 61.46 355.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 90.52 355.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 127.92 355.10 Td (essentially ) Tj ET Q q 0 0 0 rg BT 173.08 355.10 Td (all ) Tj ET Q q 0 0 0 rg BT 186.04 355.10 Td (of ) Tj ET Q q 0 0 0 rg BT 197.32 355.10 Td (the ) Tj ET Q q 0 0 0 rg BT 212.50 355.10 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 258.22 355.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 302.83 355.10 Td (of ) Tj ET Q q 0 0 0 rg BT 314.12 355.10 Td (the ) Tj ET Q q 0 0 0 rg BT 329.29 355.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 363.34 355.10 Td (with ) Tj ET Q q 0 0 0 rg BT 384.07 355.10 Td (the ) Tj ET Q q 0 0 0 rg BT 399.25 355.10 Td (exception ) Tj ET Q q 0 0 0 rg BT 441.08 355.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 452.36 355.10 Td (Plavix*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.90 355.10 Td ( ) Tj ET Q q 0 0 0 rg BT 485.86 355.10 Td (in ) Tj ET Q q 0 0 0 rg BT 496.60 355.10 Td (the ) Tj ET Q q 0 0 0 rg BT 511.77 355.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 532.51 355.10 Td (and ) Tj ET Q q 0 0 0 rg BT 549.90 355.10 Td (Puerto ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 343.10 Td (Rico ) Tj ET Q q 0 0 0 rg BT 56.81 343.10 Td (where ) Tj ET Q q 0 0 0 rg BT 83.17 343.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 106.21 343.10 Td (is ) Tj ET Q q 0 0 0 rg BT 114.81 343.10 Td (the ) Tj ET Q q 0 0 0 rg BT 128.95 343.10 Td (operating ) Tj ET Q q 0 0 0 rg BT 168.64 343.10 Td (partner ) Tj ET Q q 0 0 0 rg BT 198.88 343.10 Td (with ) Tj ET Q q 0 0 0 rg BT 218.58 343.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 224.95 343.10 Td (50.1%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 250.78 343.10 Td ( ) Tj ET Q q 0 0 0 rg BT 252.70 343.10 Td (controlling ) Tj ET Q q 0 0 0 rg BT 298.51 343.10 Td (interest. ) Tj ET Q q 0 0 0 rg BT 332.37 343.10 Td (In ) Tj ET Q q 0 0 0 rg BT 342.63 343.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 382.30 343.10 Td (for ) Tj ET Q q 0 0 0 rg BT 395.89 343.10 Td (the ) Tj ET Q q 0 0 0 rg BT 410.03 343.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 434.74 343.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 479.97 343.10 Td (to ) Tj ET Q q 0 0 0 rg BT 489.67 343.10 Td (Sanofi, ) Tj ET Q q 0 0 0 rg BT 520.20 343.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 543.25 343.10 Td (receives ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 331.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 74.02 331.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 110.38 331.10 Td (from ) Tj ET Q q 0 0 0 rg BT 131.74 331.10 Td (January 1, ) Tj ET Q q 0 0 0 rg BT 174.77 331.10 Td (2013 ) Tj ET Q q 0 0 0 rg BT 196.69 331.10 Td (until ) Tj ET Q q 0 0 0 rg BT 216.95 331.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 274.96 331.10 Td (2018 ) Tj ET Q q 0 0 0 rg BT 296.89 331.10 Td (and ) Tj ET Q q 0 0 0 rg BT 313.25 331.10 Td (a ) Tj ET Q q 0 0 0 rg BT 319.61 331.10 Td (terminal ) Tj ET Q q 0 0 0 rg BT 354.86 331.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 391.22 331.10 Td (from ) Tj ET Q q 0 0 0 rg BT 412.58 331.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 440.62 331.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.87 331.10 Td ($200 ) Tj ET Q q 0 0 0 rg BT 472.80 331.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.69 331.10 Td ( ) Tj ET Q q 0 0 0 rg BT 503.61 331.10 Td (at ) Tj ET Q q 0 0 0 rg BT 512.75 331.10 Td (the ) Tj ET Q q 0 0 0 rg BT 526.90 331.10 Td (end ) Tj ET Q q 0 0 0 rg BT 543.26 331.10 Td (of ) Tj ET Q q 0 0 0 rg BT 553.52 331.10 Td (2018. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 307.10 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 76.20 307.10 Td (received ) Tj ET Q q 0 0 0 rg BT 112.49 307.10 Td (from ) Tj ET Q q 0 0 0 rg BT 134.35 307.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 162.89 307.10 Td (in ) Tj ET Q q 0 0 0 rg BT 173.09 307.10 Td (the ) Tj ET Q q 0 0 0 rg BT 187.74 307.10 Td (territory ) Tj ET Q q 0 0 0 rg BT 222.93 307.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 260.34 307.10 Td (the ) Tj ET Q q 0 0 0 rg BT 274.45 307.10 Td (Americas ) Tj ET Q q 0 0 0 rg BT 315.19 307.10 Td (and ) Tj ET Q q 0 0 0 rg BT 331.52 307.10 Td (Australia, ) Tj ET Q q 0 0 0 rg BT 373.10 307.10 Td (opt-out ) Tj ET Q q 0 0 0 rg BT 404.42 307.10 Td (markets, ) Tj ET Q q 0 0 0 rg BT 441.00 307.10 Td (and ) Tj ET Q q 0 0 0 rg BT 457.86 307.10 Td (former ) Tj ET Q q 0 0 0 rg BT 487.50 307.10 Td (development ) Tj ET Q q 0 0 0 rg BT 541.57 307.10 Td (royalties ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 295.10 Td (are ) Tj ET Q q 0 0 0 rg BT 50.88 295.10 Td (presented ) Tj ET Q q 0 0 0 rg BT 91.86 295.10 Td (in ) Tj ET Q q 0 0 0 rg BT 102.31 295.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 136.06 295.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 174.27 295.10 Td (and ) Tj ET Q q 0 0 0 rg BT 191.38 295.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 213.47 295.10 Td ($195 ) Tj ET Q q 0 0 0 rg BT 236.14 295.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 265.03 295.10 Td ( ) Tj ET Q q 0 0 0 rg BT 267.70 295.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 278.15 295.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.15 295.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.32 295.10 Td ($21) Tj ET Q q 0 0 0 rg BT 317.95 295.10 Td (1 ) Tj ET Q q 0 0 0 rg BT 325.61 295.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.51 295.10 Td ( ) Tj ET Q q 0 0 0 rg BT 357.17 295.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.62 295.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.62 295.10 Td ( ) Tj ET Q q 0 0 0 rg BT 390.29 295.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.40 295.10 Td ($223 ) Tj ET Q q 0 0 0 rg BT 430.06 295.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.96 295.10 Td ( ) Tj ET Q q 0 0 0 rg BT 461.63 295.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.07 295.10 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.07 295.10 Td (. ) Tj ET Q q 0 0 0 rg BT 497.24 295.10 Td (Royalties ) Tj ET Q q 0 0 0 rg BT 537.68 295.10 Td (attributed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 283.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.45 283.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.33 283.10 Td (territory ) Tj ET Q q 0 0 0 rg BT 96.76 283.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 134.41 283.10 Td (Europe ) Tj ET Q q 0 0 0 rg BT 165.96 283.10 Td (and ) Tj ET Q q 0 0 0 rg BT 182.48 283.10 Td (Asia ) Tj ET Q q 0 0 0 rg BT 203.47 283.10 Td (continue ) Tj ET Q q 0 0 0 rg BT 240.57 283.10 Td (to ) Tj ET Q q 0 0 0 rg BT 251.02 283.10 Td (be ) Tj ET Q q 0 0 0 rg BT 263.13 283.10 Td (earned ) Tj ET Q q 0 0 0 rg BT 292.44 283.10 Td (by ) Tj ET Q q 0 0 0 rg BT 305.11 283.10 Td (the ) Tj ET Q q 0 0 0 rg BT 319.99 283.10 Td (territory ) Tj ET Q q 0 0 0 rg BT 355.42 283.10 Td (partnership ) Tj ET Q q 0 0 0 rg BT 403.07 283.10 Td (and ) Tj ET Q q 0 0 0 rg BT 420.18 283.10 Td (are ) Tj ET Q q 0 0 0 rg BT 435.06 283.10 Td (included ) Tj ET Q q 0 0 0 rg BT 472.16 283.10 Td (in ) Tj ET Q q 0 0 0 rg BT 482.60 283.10 Td (equity ) Tj ET Q q 0 0 0 rg BT 510.26 283.10 Td (in ) Tj ET Q q 0 0 0 rg BT 520.71 283.10 Td (net ) Tj ET Q q 0 0 0 rg BT 535.59 283.10 Td (income ) Tj ET Q q 0 0 0 rg BT 567.70 283.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 271.10 Td (af) Tj ET Q q 0 0 0 rg BT 43.59 271.10 Td (filiates. ) Tj ET Q q 0 0 0 rg BT 75.31 271.10 Td (Alliance ) Tj ET Q q 0 0 0 rg BT 111.75 271.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 149.86 271.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 190.76 271.10 Td (to ) Tj ET Q q 0 0 0 rg BT 201.11 271.10 Td (the ) Tj ET Q q 0 0 0 rg BT 215.90 271.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 245.15 271.10 Td (of ) Tj ET Q q 0 0 0 rg BT 256.05 271.10 Td (irbesartan ) Tj ET Q q 0 0 0 rg BT 297.48 271.10 Td (API ) Tj ET Q q 0 0 0 rg BT 316.17 271.10 Td (to ) Tj ET Q q 0 0 0 rg BT 326.52 271.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 355.21 271.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 377.21 271.10 Td ($80 ) Tj ET Q q 0 0 0 rg BT 394.79 271.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.68 271.10 Td ( ) Tj ET Q q 0 0 0 rg BT 426.25 271.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.61 271.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.61 271.10 Td ( ) Tj ET Q q 0 0 0 rg BT 459.18 271.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.19 271.10 Td ($90 ) Tj ET Q q 0 0 0 rg BT 493.77 271.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.66 271.10 Td ( ) Tj ET Q q 0 0 0 rg BT 525.23 271.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 535.59 271.10 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.59 271.10 Td (. ) Tj ET Q q 0 0 0 rg BT 560.48 271.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 259.10 Td (supply ) Tj ET Q q 0 0 0 rg BT 65.17 259.10 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 117.64 259.10 Td (for ) Tj ET Q q 0 0 0 rg BT 131.80 259.10 Td (irbesartan ) Tj ET Q q 0 0 0 rg BT 173.72 259.10 Td (expired ) Tj ET Q q 0 0 0 rg BT 206.21 259.10 Td (in ) Tj ET Q q 0 0 0 rg BT 216.49 259.10 Td (2015.) Tj ET Q endstream endobj 141 0 obj <> endobj 142 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized financial information related to this alliance was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 712.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 712.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 686.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 660.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 660.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 634.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 634.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 634.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 608.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 608.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 608.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 582.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 582.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 582.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 582.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 582.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 582.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 582.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 725.6 m 448.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 725.6 m 452.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 725.6 m 512.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 725.6 m 516.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 712.6 m 448.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 712.6 m 512.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 673.6 m 448.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 661.6 m 448.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 659.6 m 448.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 673.6 m 512.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 661.6 m 512.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 659.6 m 512.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 673.6 m 576.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 661.6 m 576.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 659.6 m 576.5 659.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 716.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 703.33 Td (Revenues from Sanofi alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 690.17 Td (38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 690.17 Td (110) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 690.17 Td (102) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 677.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 677.17 Td (200) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 677.17 Td (296) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 677.17 Td (317) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.00 664.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 664.17 Td (238) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 664.17 Td (406) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 664.17 Td (419) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 638.33 Td (Payments to/\(from\) Sanofi:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 625.17 Td (Equity in net income of affiliates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.30 625.22 Td (\(95) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 625.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.30 625.22 Td (\(104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 625.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 625.17 Td (\(146) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 625.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 612.17 Td (Noncontrolling interest – pretax) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 612.17 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 612.17 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 612.17 Td (38) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 586.33 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 573.17 Td (Distributions \(to\)/from Sanofi – Noncontrolling interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.30 573.22 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 573.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.30 573.22 Td (\(45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 573.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 573.17 Td (\(49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 573.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 560.17 Td (Distributions from Sanofi – Investment in affiliates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 560.17 Td (99) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 560.17 Td (105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 560.17 Td (153) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 519.60 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 519.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 519.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 530.6 m 512.5 530.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 519.6 m 512.5 519.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 530.6 m 576.5 530.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 519.6 m 576.5 519.6 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 532.38 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 533.68 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 522.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 522.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 522.68 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 510.17 Td (Investment in af) Tj ET Q q 0 0 0 rg BT 103.80 510.17 Td (filiates – territory covering Europe and ) Tj ET Q q 0 0 0 rg BT 261.52 510.17 Td (Asia) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 279.85 514.70 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 510.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 510.17 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 510.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 510.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 497.17 Td (Noncontrolling interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 497.17 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 497.17 Td (44) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 479.50 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 479.50 Td (Included ) Tj ET Q q 0 0 0 rg BT 83.99 479.50 Td (in ) Tj ET Q q 0 0 0 rg BT 92.21 479.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 119.08 479.50 Td (receivables.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 455.50 Td (The ) Tj ET Q q 0 0 0 rg BT 54.61 455.50 Td (following ) Tj ET Q q 0 0 0 rg BT 96.56 455.50 Td (is ) Tj ET Q q 0 0 0 rg BT 106.30 455.50 Td (summarized ) Tj ET Q q 0 0 0 rg BT 158.23 455.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 196.28 455.50 Td (information ) Tj ET Q q 0 0 0 rg BT 246.55 455.50 Td (for ) Tj ET Q q 0 0 0 rg BT 261.28 455.50 Td (interests ) Tj ET Q q 0 0 0 rg BT 297.67 455.50 Td (in ) Tj ET Q q 0 0 0 rg BT 308.51 455.50 Td (the ) Tj ET Q q 0 0 0 rg BT 323.79 455.50 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 375.73 455.50 Td (with ) Tj ET Q q 0 0 0 rg BT 396.57 455.50 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 425.74 455.50 Td (for ) Tj ET Q q 0 0 0 rg BT 440.47 455.50 Td (the ) Tj ET Q q 0 0 0 rg BT 455.75 455.50 Td (territory ) Tj ET Q q 0 0 0 rg BT 491.58 455.50 Td (covering ) Tj ET Q q 0 0 0 rg BT 529.63 455.50 Td (Europe ) Tj ET Q q 0 0 0 rg BT 561.57 455.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 443.50 Td (Asia, ) Tj ET Q q 0 0 0 rg BT 59.33 443.50 Td (which ) Tj ET Q q 0 0 0 rg BT 86.27 443.50 Td (are ) Tj ET Q q 0 0 0 rg BT 100.98 443.50 Td (not ) Tj ET Q q 0 0 0 rg BT 116.25 443.50 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 169.30 443.50 Td (but ) Tj ET Q q 0 0 0 rg BT 184.57 443.50 Td (are ) Tj ET Q q 0 0 0 rg BT 199.28 443.50 Td (accounted ) Tj ET Q q 0 0 0 rg BT 242.31 443.50 Td (for ) Tj ET Q q 0 0 0 rg BT 256.47 443.50 Td (using ) Tj ET Q q 0 0 0 rg BT 280.64 443.50 Td (the ) Tj ET Q q 0 0 0 rg BT 295.36 443.50 Td (equity ) Tj ET Q q 0 0 0 rg BT 322.86 443.50 Td (method:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 407.00 348.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 407.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 407.00 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 407.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 407.00 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 407.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 407.00 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 383.00 348.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 383.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 383.00 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 383.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 383.00 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 383.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 383.00 60.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 420 m 448.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 420 m 452.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 420 m 512.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 420 m 516.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 420 m 576.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 407 m 448.5 407 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 407 m 512.5 407 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 407 m 576.5 407 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 424.25 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 424.23 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 411.25 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 411.23 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 411.23 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 411.23 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 397.62 Td (Net sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 397.62 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 397.62 Td (235) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 397.62 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 397.62 Td (257) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 397.62 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 397.62 Td (360) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 385.62 Td (Gross profit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 385.62 Td (195) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 385.62 Td (213) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 385.62 Td (297) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 373.62 Td (Net income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 373.62 Td (192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 373.62 Td (209) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 373.62 Td (292) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 347.50 Td (Cost ) Tj ET Q q 0 0 0 rg BT 56.55 347.50 Td (of ) Tj ET Q q 0 0 0 rg BT 67.09 347.50 Td (products ) Tj ET Q q 0 0 0 rg BT 103.74 347.50 Td (sold ) Tj ET Q q 0 0 0 rg BT 122.62 347.50 Td (for ) Tj ET Q q 0 0 0 rg BT 136.49 347.50 Td (the ) Tj ET Q q 0 0 0 rg BT 150.92 347.50 Td (territory ) Tj ET Q q 0 0 0 rg BT 185.90 347.50 Td (covering ) Tj ET Q q 0 0 0 rg BT 223.09 347.50 Td (Europe ) Tj ET Q q 0 0 0 rg BT 254.18 347.50 Td (and ) Tj ET Q q 0 0 0 rg BT 270.34 347.50 Td (Asia ) Tj ET Q q 0 0 0 rg BT 290.88 347.50 Td (includes ) Tj ET Q q 0 0 0 rg BT 326.42 347.50 Td (discovery ) Tj ET Q q 0 0 0 rg BT 367.51 347.50 Td (royalties ) Tj ET Q q 0 0 0 rg BT 404.15 347.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.69 347.50 Td ($20 ) Tj ET Q q 0 0 0 rg BT 431.90 347.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.79 347.50 Td ( ) Tj ET Q q 0 0 0 rg BT 463.00 347.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.99 347.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.99 347.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.71 347.50 Td ($22 ) Tj ET Q q 0 0 0 rg BT 514.92 347.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.81 347.50 Td ( ) Tj ET Q q 0 0 0 rg BT 546.02 347.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.01 347.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 335.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.63 335.50 Td ($32 ) Tj ET Q q 0 0 0 rg BT 69.81 335.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.71 335.50 Td ( ) Tj ET Q q 0 0 0 rg BT 100.89 335.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 110.86 335.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.86 335.50 Td (, ) Tj ET Q q 0 0 0 rg BT 135.55 335.50 Td (which ) Tj ET Q q 0 0 0 rg BT 162.17 335.50 Td (are ) Tj ET Q q 0 0 0 rg BT 176.57 335.50 Td (paid ) Tj ET Q q 0 0 0 rg BT 195.97 335.50 Td (directly ) Tj ET Q q 0 0 0 rg BT 228.70 335.50 Td (to ) Tj ET Q q 0 0 0 rg BT 238.67 335.50 Td (Sanofi. ) Tj ET Q q 0 0 0 rg BT 268.98 335.50 Td (All ) Tj ET Q q 0 0 0 rg BT 283.94 335.50 Td (other ) Tj ET Q q 0 0 0 rg BT 306.68 335.50 Td (expenses ) Tj ET Q q 0 0 0 rg BT 344.97 335.50 Td (are ) Tj ET Q q 0 0 0 rg BT 359.36 335.50 Td (shared ) Tj ET Q q 0 0 0 rg BT 387.65 335.50 Td (based ) Tj ET Q q 0 0 0 rg BT 412.60 335.50 Td (on ) Tj ET Q q 0 0 0 rg BT 424.79 335.50 Td (the ) Tj ET Q q 0 0 0 rg BT 439.19 335.50 Td (applicable ) Tj ET Q q 0 0 0 rg BT 482.47 335.50 Td (ownership ) Tj ET Q q 0 0 0 rg BT 526.32 335.50 Td (percentages. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.50 Td (Current ) Tj ET Q q 0 0 0 rg BT 69.02 323.50 Td (assets ) Tj ET Q q 0 0 0 rg BT 94.83 323.50 Td (and ) Tj ET Q q 0 0 0 rg BT 111.75 323.50 Td (current ) Tj ET Q q 0 0 0 rg BT 142.54 323.50 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 182.24 323.50 Td (include ) Tj ET Q q 0 0 0 rg BT 214.15 323.50 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.39 323.50 Td ($69 ) Tj ET Q q 0 0 0 rg BT 291.86 323.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.76 323.50 Td ( ) Tj ET Q q 0 0 0 rg BT 323.23 323.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.49 323.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.49 323.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.47 323.50 Td ($76 ) Tj ET Q q 0 0 0 rg BT 375.95 323.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.84 323.50 Td ( ) Tj ET Q q 0 0 0 rg BT 407.32 323.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.57 323.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.57 323.50 Td ( ) Tj ET Q q 0 0 0 rg BT 440.05 323.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.97 323.50 Td ($94 ) Tj ET Q q 0 0 0 rg BT 474.44 323.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.34 323.50 Td ( ) Tj ET Q q 0 0 0 rg BT 505.81 323.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.07 323.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 536.07 323.50 Td ( ) Tj ET Q q 0 0 0 rg BT 538.55 323.50 Td (related ) Tj ET Q q 0 0 0 rg BT 568.23 323.50 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.50 Td (receivables/payables ) Tj ET Q q 0 0 0 rg BT 121.42 311.50 Td (attributed ) Tj ET Q q 0 0 0 rg BT 162.42 311.50 Td (to ) Tj ET Q q 0 0 0 rg BT 172.88 311.50 Td (cash ) Tj ET Q q 0 0 0 rg BT 193.33 311.50 Td (distributions ) Tj ET Q q 0 0 0 rg BT 246.02 311.50 Td (to ) Tj ET Q q 0 0 0 rg BT 256.48 311.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 280.29 311.50 Td (and ) Tj ET Q q 0 0 0 rg BT 297.41 311.50 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 326.20 311.50 Td (as ) Tj ET Q q 0 0 0 rg BT 337.22 311.50 Td (well ) Tj ET Q q 0 0 0 rg BT 357.12 311.50 Td (as ) Tj ET Q q 0 0 0 rg BT 368.13 311.50 Td (intercompany ) Tj ET Q q 0 0 0 rg BT 425.79 311.50 Td (balances ) Tj ET Q q 0 0 0 rg BT 462.90 311.50 Td (between ) Tj ET Q q 0 0 0 rg BT 498.90 311.50 Td (partnerships ) Tj ET Q q 0 0 0 rg BT 550.46 311.50 Td (within ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.50 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 299.50 Td (territory) Tj ET Q q 0 0 0 rg BT 82.83 299.50 Td (. ) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 273.93505859375 m 54.33984375 273.93505859375 l s q 0 0 0 rg BT 36.00 275.50 Td (Ono) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 251.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.60 251.50 Td (is ) Tj ET Q q 0 0 0 rg BT 68.75 251.50 Td (the ) Tj ET Q q 0 0 0 rg BT 83.45 251.50 Td (principal ) Tj ET Q q 0 0 0 rg BT 121.47 251.50 Td (in ) Tj ET Q q 0 0 0 rg BT 131.73 251.50 Td (the ) Tj ET Q q 0 0 0 rg BT 146.43 251.50 Td (end ) Tj ET Q q 0 0 0 rg BT 163.35 251.50 Td (customer ) Tj ET Q q 0 0 0 rg BT 202.48 251.50 Td (product ) Tj ET Q q 0 0 0 rg BT 235.51 251.50 Td (sales ) Tj ET Q q 0 0 0 rg BT 257.43 251.50 Td (and ) Tj ET Q q 0 0 0 rg BT 274.35 251.50 Td (has ) Tj ET Q q 0 0 0 rg BT 290.16 251.50 Td (the ) Tj ET Q q 0 0 0 rg BT 304.86 251.50 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 345.10 251.50 Td (right ) Tj ET Q q 0 0 0 rg BT 366.47 251.50 Td (to ) Tj ET Q q 0 0 0 rg BT 376.73 251.50 Td (develop, ) Tj ET Q q 0 0 0 rg BT 413.36 251.50 Td (manufacture ) Tj ET Q q 0 0 0 rg BT 465.81 251.50 Td (and ) Tj ET Q q 0 0 0 rg BT 482.73 251.50 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 544.07 251.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.50 251.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 239.50 Td (an ) Tj ET Q q 0 0 0 rg BT 47.47 239.50 Td (anti-PD-1 ) Tj ET Q q 0 0 0 rg BT 88.95 239.50 Td (human ) Tj ET Q q 0 0 0 rg BT 118.20 239.50 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 167.45 239.50 Td (antibody ) Tj ET Q q 0 0 0 rg BT 204.48 239.50 Td (being ) Tj ET Q q 0 0 0 rg BT 228.73 239.50 Td (investigated ) Tj ET Q q 0 0 0 rg BT 279.09 239.50 Td (as ) Tj ET Q q 0 0 0 rg BT 289.46 239.50 Td (an ) Tj ET Q q 0 0 0 rg BT 300.93 239.50 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 347.38 239.50 Td (treatment, ) Tj ET Q q 0 0 0 rg BT 389.67 239.50 Td (in ) Tj ET Q q 0 0 0 rg BT 399.49 239.50 Td (all ) Tj ET Q q 0 0 0 rg BT 411.52 239.50 Td (territories ) Tj ET Q q 0 0 0 rg BT 452.43 239.50 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 497.23 239.50 Td (except ) Tj ET Q q 0 0 0 rg BT 525.36 239.50 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 552.67 239.50 Td (South ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 227.50 Td (Korea ) Tj ET Q q 0 0 0 rg BT 62.49 227.50 Td (and ) Tj ET Q q 0 0 0 rg BT 78.83 227.50 Td (T) Tj ET Q q 0 0 0 rg BT 84.24 227.50 Td (aiwan. ) Tj ET Q q 0 0 0 rg BT 112.68 227.50 Td (Ono ) Tj ET Q q 0 0 0 rg BT 131.96 227.50 Td (is ) Tj ET Q q 0 0 0 rg BT 140.68 227.50 Td (entitled ) Tj ET Q q 0 0 0 rg BT 172.73 227.50 Td (to ) Tj ET Q q 0 0 0 rg BT 182.57 227.50 Td (receive ) Tj ET Q q 0 0 0 rg BT 213.48 227.50 Td (royalties ) Tj ET Q q 0 0 0 rg BT 249.98 227.50 Td (following ) Tj ET Q q 0 0 0 rg BT 290.92 227.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 334.07 227.50 Td (approvals ) Tj ET Q q 0 0 0 rg BT 375.00 227.50 Td (in ) Tj ET Q q 0 0 0 rg BT 384.84 227.50 Td (all ) Tj ET Q q 0 0 0 rg BT 396.89 227.50 Td (territories ) Tj ET Q q 0 0 0 rg BT 437.82 227.50 Td (excluding ) Tj ET Q q 0 0 0 rg BT 479.31 227.50 Td (the ) Tj ET Q q 0 0 0 rg BT 493.59 227.50 Td (three ) Tj ET Q q 0 0 0 rg BT 515.63 227.50 Td (countries ) Tj ET Q q 0 0 0 rg BT 554.34 227.50 Td (listed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.50 Td (above. ) Tj ET Q q 0 0 0 rg BT 64.72 215.50 Td (Royalty ) Tj ET Q q 0 0 0 rg BT 98.74 215.50 Td (rates ) Tj ET Q q 0 0 0 rg BT 119.96 215.50 Td (on ) Tj ET Q q 0 0 0 rg BT 132.31 215.50 Td (net ) Tj ET Q q 0 0 0 rg BT 146.87 215.50 Td (sales ) Tj ET Q q 0 0 0 rg BT 168.66 215.50 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 183.21 215.50 Td (4%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 196.54 215.50 Td ( ) Tj ET Q q 0 0 0 rg BT 198.89 215.50 Td (in ) Tj ET Q q 0 0 0 rg BT 209.02 215.50 Td (North ) Tj ET Q q 0 0 0 rg BT 234.18 215.50 Td (America ) Tj ET Q q 0 0 0 rg BT 270.95 215.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 287.74 215.50 Td (15%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 306.07 215.50 Td ( ) Tj ET Q q 0 0 0 rg BT 308.41 215.50 Td (in ) Tj ET Q q 0 0 0 rg BT 318.54 215.50 Td (all ) Tj ET Q q 0 0 0 rg BT 330.88 215.50 Td (other ) Tj ET Q q 0 0 0 rg BT 353.78 215.50 Td (applicable ) Tj ET Q q 0 0 0 rg BT 397.21 215.50 Td (territories, ) Tj ET Q q 0 0 0 rg BT 440.93 215.50 Td (subject ) Tj ET Q q 0 0 0 rg BT 471.61 215.50 Td (to ) Tj ET Q q 0 0 0 rg BT 481.73 215.50 Td (customary ) Tj ET Q q 0 0 0 rg BT 525.73 215.50 Td (adjustments.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 191.50 Td (The ) Tj ET Q q 0 0 0 rg BT 53.26 191.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 86.06 191.50 Td (arrangement ) Tj ET Q q 0 0 0 rg BT 137.75 191.50 Td (also ) Tj ET Q q 0 0 0 rg BT 155.57 191.50 Td (includes ) Tj ET Q q 0 0 0 rg BT 190.60 191.50 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 245.08 191.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 282.89 191.50 Td (in ) Tj ET Q q 0 0 0 rg BT 292.38 191.50 Td (Japan, ) Tj ET Q q 0 0 0 rg BT 319.36 191.50 Td (South ) Tj ET Q q 0 0 0 rg BT 344.41 191.50 Td (Korea ) Tj ET Q q 0 0 0 rg BT 370.55 191.50 Td (and ) Tj ET Q q 0 0 0 rg BT 386.58 191.50 Td (T) Tj ET Q q 0 0 0 rg BT 391.99 191.50 Td (aiwan ) Tj ET Q q 0 0 0 rg BT 417.58 191.50 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 459.84 191.50 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 469.33 191.50 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.77 191.50 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 502.98 191.50 Td (Y) Tj ET Q q 0 0 0 rg BT 507.62 191.50 Td (ervoy) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 529.83 191.50 Td ( ) Tj ET Q q 0 0 0 rg BT 531.54 191.50 Td (and ) Tj ET Q q 0 0 0 rg BT 547.69 191.50 Td (several ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 179.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.45 179.50 Td (investigational ) Tj ET Q q 0 0 0 rg BT 120.65 179.50 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 171.59 179.50 Td (Both ) Tj ET Q q 0 0 0 rg BT 193.36 179.50 Td (parties ) Tj ET Q q 0 0 0 rg BT 222.34 179.50 Td (have ) Tj ET Q q 0 0 0 rg BT 243.54 179.50 Td (the ) Tj ET Q q 0 0 0 rg BT 258.09 179.50 Td (right ) Tj ET Q q 0 0 0 rg BT 279.30 179.50 Td (and ) Tj ET Q q 0 0 0 rg BT 296.06 179.50 Td (obligation ) Tj ET Q q 0 0 0 rg BT 338.94 179.50 Td (to ) Tj ET Q q 0 0 0 rg BT 349.04 179.50 Td (jointly ) Tj ET Q q 0 0 0 rg BT 377.48 179.50 Td (develop ) Tj ET Q q 0 0 0 rg BT 411.46 179.50 Td (and ) Tj ET Q q 0 0 0 rg BT 428.23 179.50 Td (commercialize ) Tj ET Q q 0 0 0 rg BT 489.41 179.50 Td (the ) Tj ET Q q 0 0 0 rg BT 503.95 179.50 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 554.88 179.50 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 167.50 Td (is ) Tj ET Q q 0 0 0 rg BT 44.72 167.50 Td (responsible ) Tj ET Q q 0 0 0 rg BT 92.32 167.50 Td (for ) Tj ET Q q 0 0 0 rg BT 106.04 167.50 Td (supply ) Tj ET Q q 0 0 0 rg BT 134.76 167.50 Td (of ) Tj ET Q q 0 0 0 rg BT 145.14 167.50 Td (the ) Tj ET Q q 0 0 0 rg BT 159.41 167.50 Td (products. ) Tj ET Q q 0 0 0 rg BT 198.40 167.50 Td (Profits, ) Tj ET Q q 0 0 0 rg BT 229.63 167.50 Td (losses ) Tj ET Q q 0 0 0 rg BT 255.57 167.50 Td (and ) Tj ET Q q 0 0 0 rg BT 272.06 167.50 Td (development ) Tj ET Q q 0 0 0 rg BT 325.77 167.50 Td (costs ) Tj ET Q q 0 0 0 rg BT 347.82 167.50 Td (are ) Tj ET Q q 0 0 0 rg BT 362.08 167.50 Td (shared ) Tj ET Q q 0 0 0 rg BT 390.23 167.50 Td (equally ) Tj ET Q q 0 0 0 rg BT 421.72 167.50 Td (for ) Tj ET Q q 0 0 0 rg BT 435.43 167.50 Td (all ) Tj ET Q q 0 0 0 rg BT 447.48 167.50 Td (combination ) Tj ET Q q 0 0 0 rg BT 499.53 167.50 Td (therapies ) Tj ET Q q 0 0 0 rg BT 537.67 167.50 Td (involving ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 155.50 Td (compounds ) Tj ET Q q 0 0 0 rg BT 84.61 155.50 Td (of ) Tj ET Q q 0 0 0 rg BT 95.44 155.50 Td (both ) Tj ET Q q 0 0 0 rg BT 115.72 155.50 Td (parties. ) Tj ET Q q 0 0 0 rg BT 147.37 155.50 Td (Otherwise, ) Tj ET Q q 0 0 0 rg BT 193.47 155.50 Td (sharing ) Tj ET Q q 0 0 0 rg BT 225.41 155.50 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 234.58 155.50 Td (80%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.91 155.50 Td ( ) Tj ET Q q 0 0 0 rg BT 255.41 155.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.35 155.50 Td (20%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.68 155.50 Td ( ) Tj ET Q q 0 0 0 rg BT 293.18 155.50 Td (for ) Tj ET Q q 0 0 0 rg BT 307.34 155.50 Td (activities ) Tj ET Q q 0 0 0 rg BT 345.94 155.50 Td (involving ) Tj ET Q q 0 0 0 rg BT 386.77 155.50 Td (only ) Tj ET Q q 0 0 0 rg BT 407.05 155.50 Td (one ) Tj ET Q q 0 0 0 rg BT 423.99 155.50 Td (of ) Tj ET Q q 0 0 0 rg BT 434.82 155.50 Td (the ) Tj ET Q q 0 0 0 rg BT 449.54 155.50 Td (party’) Tj ET Q q 0 0 0 rg BT 472.86 155.50 Td (s ) Tj ET Q q 0 0 0 rg BT 479.25 155.50 Td (compounds. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 131.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.47 131.50 Td (and ) Tj ET Q q 0 0 0 rg BT 76.25 131.50 Td (Ono ) Tj ET Q q 0 0 0 rg BT 95.82 131.50 Td (also ) Tj ET Q q 0 0 0 rg BT 114.28 131.50 Td (have ) Tj ET Q q 0 0 0 rg BT 135.50 131.50 Td (an ) Tj ET Q q 0 0 0 rg BT 147.28 131.50 Td (alliance ) Tj ET Q q 0 0 0 rg BT 180.72 131.50 Td (to ) Tj ET Q q 0 0 0 rg BT 190.84 131.50 Td (co-develop ) Tj ET Q q 0 0 0 rg BT 237.61 131.50 Td (and ) Tj ET Q q 0 0 0 rg BT 254.40 131.50 Td (co-commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 328.37 131.50 Td (Or) Tj ET Q q 0 0 0 rg BT 339.11 131.50 Td (encia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.76 131.50 Td ( ) Tj ET Q q 0 0 0 rg BT 363.11 131.50 Td (in ) Tj ET Q q 0 0 0 rg BT 373.23 131.50 Td (Japan. ) Tj ET Q q 0 0 0 rg BT 400.85 131.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 424.32 131.50 Td (is ) Tj ET Q q 0 0 0 rg BT 433.33 131.50 Td (responsible ) Tj ET Q q 0 0 0 rg BT 481.23 131.50 Td (for ) Tj ET Q q 0 0 0 rg BT 495.23 131.50 Td (the ) Tj ET Q q 0 0 0 rg BT 509.80 131.50 Td (order ) Tj ET Q q 0 0 0 rg BT 533.24 131.50 Td (fulfillment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 119.50 Td (and ) Tj ET Q q 0 0 0 rg BT 53.08 119.50 Td (distribution ) Tj ET Q q 0 0 0 rg BT 101.83 119.50 Td (of ) Tj ET Q q 0 0 0 rg BT 112.79 119.50 Td (the ) Tj ET Q q 0 0 0 rg BT 127.65 119.50 Td (intravenous ) Tj ET Q q 0 0 0 rg BT 176.94 119.50 Td (formulation ) Tj ET Q q 0 0 0 rg BT 226.79 119.50 Td (and ) Tj ET Q q 0 0 0 rg BT 243.86 119.50 Td (Ono ) Tj ET Q q 0 0 0 rg BT 263.72 119.50 Td (is ) Tj ET Q q 0 0 0 rg BT 273.03 119.50 Td (responsible ) Tj ET Q q 0 0 0 rg BT 321.21 119.50 Td (for ) Tj ET Q q 0 0 0 rg BT 335.51 119.50 Td (the ) Tj ET Q q 0 0 0 rg BT 350.36 119.50 Td (subcutaneous ) Tj ET Q q 0 0 0 rg BT 406.87 119.50 Td (formulation. ) Tj ET Q q 0 0 0 rg BT 459.22 119.50 Td (Both ) Tj ET Q q 0 0 0 rg BT 481.31 119.50 Td (formulations ) Tj ET Q q 0 0 0 rg BT 535.05 119.50 Td (are ) Tj ET Q q 0 0 0 rg BT 549.89 119.50 Td (jointly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 107.50 Td (promoted ) Tj ET Q q 0 0 0 rg BT 76.99 107.50 Td (by ) Tj ET Q q 0 0 0 rg BT 89.66 107.50 Td (both ) Tj ET Q q 0 0 0 rg BT 110.10 107.50 Td (parties ) Tj ET Q q 0 0 0 rg BT 139.42 107.50 Td (with ) Tj ET Q q 0 0 0 rg BT 159.86 107.50 Td (assigned ) Tj ET Q q 0 0 0 rg BT 196.97 107.50 Td (customer ) Tj ET Q q 0 0 0 rg BT 236.29 107.50 Td (accounts ) Tj ET Q q 0 0 0 rg BT 273.94 107.50 Td (and ) Tj ET Q q 0 0 0 rg BT 291.04 107.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 314.83 107.50 Td (is ) Tj ET Q q 0 0 0 rg BT 324.16 107.50 Td (responsible ) Tj ET Q q 0 0 0 rg BT 372.38 107.50 Td (for ) Tj ET Q q 0 0 0 rg BT 386.70 107.50 Td (the ) Tj ET Q q 0 0 0 rg BT 401.58 107.50 Td (product ) Tj ET Q q 0 0 0 rg BT 434.79 107.50 Td (supply) Tj ET Q q 0 0 0 rg BT 460.81 107.50 Td (. ) Tj ET Q q 0 0 0 rg BT 465.39 107.50 Td (A) Tj ET Q q 0 0 0 rg BT 472.06 107.50 Td ( ) Tj ET Q q 0 0 0 rg BT 474.73 107.50 Td (co-promotion ) Tj ET Q q 0 0 0 rg BT 531.82 107.50 Td (fee ) Tj ET Q q 0 0 0 rg BT 546.70 107.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.69 107.50 Td (60%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 95.50 Td (is ) Tj ET Q q 0 0 0 rg BT 45.17 95.50 Td (paid ) Tj ET Q q 0 0 0 rg BT 64.89 95.50 Td (to ) Tj ET Q q 0 0 0 rg BT 75.17 95.50 Td (the ) Tj ET Q q 0 0 0 rg BT 89.88 95.50 Td (other ) Tj ET Q q 0 0 0 rg BT 112.93 95.50 Td (party ) Tj ET Q q 0 0 0 rg BT 135.98 95.50 Td (when ) Tj ET Q q 0 0 0 rg BT 160.14 95.50 Td (a ) Tj ET Q q 0 0 0 rg BT 167.07 95.50 Td (sale ) Tj ET Q q 0 0 0 rg BT 185.12 95.50 Td (is ) Tj ET Q q 0 0 0 rg BT 194.29 95.50 Td (made ) Tj ET Q q 0 0 0 rg BT 218.45 95.50 Td (to ) Tj ET Q q 0 0 0 rg BT 228.72 95.50 Td (that ) Tj ET Q q 0 0 0 rg BT 246.22 95.50 Td (party’) Tj ET Q q 0 0 0 rg BT 269.54 95.50 Td (s ) Tj ET Q q 0 0 0 rg BT 275.94 95.50 Td (assigned ) Tj ET Q q 0 0 0 rg BT 312.88 95.50 Td (customer ) Tj ET Q q 0 0 0 rg BT 352.03 95.50 Td (and ) Tj ET Q q 0 0 0 rg BT 368.97 95.50 Td (is ) Tj ET Q q 0 0 0 rg BT 378.14 95.50 Td (recorded ) Tj ET Q q 0 0 0 rg BT 415.61 95.50 Td (in ) Tj ET Q q 0 0 0 rg BT 425.89 95.50 Td (cost ) Tj ET Q q 0 0 0 rg BT 444.50 95.50 Td (of ) Tj ET Q q 0 0 0 rg BT 455.33 95.50 Td (products ) Tj ET Q q 0 0 0 rg BT 492.27 95.50 Td (sold.) Tj ET Q endstream endobj 143 0 obj <> endobj 144 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized financial information related to this alliance was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 712.60 357.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 712.60 57.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 712.60 57.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 712.60 57.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 686.60 357.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 392.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 396.50 686.60 57.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 686.60 57.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 514.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 686.60 57.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 725.6 m 453.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 453.5 725.6 m 457.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 725.6 m 514.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 725.6 m 518.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 725.6 m 575.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 725.6 m 453.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 712.6 m 453.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 453.5 725.6 m 457.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 725.6 m 514.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 712.6 m 514.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 514.5 725.6 m 518.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 725.6 m 575.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 712.6 m 575.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 673.6 m 453.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 661.6 m 453.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 396.5 659.6 m 453.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 673.6 m 514.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 661.6 m 514.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 659.6 m 514.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 673.6 m 575.5 673.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 661.6 m 575.5 661.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 659.6 m 575.5 659.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 441.20 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 416.50 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 477.50 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.50 716.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 703.33 Td (Revenues from Ono alliances:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 690.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 690.17 Td (147) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.65 690.17 Td (113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.00 690.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 690.17 Td (113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 677.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 677.17 Td (280) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 677.17 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 677.17 Td (28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 44.00 664.17 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 664.17 Td (427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.65 664.17 Td (174) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.00 664.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 664.17 Td (141) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 635.53505859375 m 68.412109375 635.53505859375 l s q 0 0 0 rg BT 36.00 637.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 61.20 637.10 Td (ie) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 613.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.92 613.10 Td (and ) Tj ET Q q 0 0 0 rg BT 76.53 613.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 100.37 613.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 110.38 613.10 Td (have ) Tj ET Q q 0 0 0 rg BT 132.05 613.10 Td (an ) Tj ET Q q 0 0 0 rg BT 144.28 613.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 178.16 613.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 192.61 613.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.27 613.10 Td (, ) Tj ET Q q 0 0 0 rg BT 234.57 613.10 Td (a ) Tj ET Q q 0 0 0 rg BT 241.80 613.10 Td (humanized ) Tj ET Q q 0 0 0 rg BT 288.46 613.10 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 338.46 613.10 Td (antibody ) Tj ET Q q 0 0 0 rg BT 376.25 613.10 Td (for ) Tj ET Q q 0 0 0 rg BT 390.70 613.10 Td (the ) Tj ET Q q 0 0 0 rg BT 405.71 613.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 446.26 613.10 Td (of ) Tj ET Q q 0 0 0 rg BT 457.38 613.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 493.51 613.10 Td (myeloma. ) Tj ET Q q 0 0 0 rg BT 536.01 613.10 Td (Under ) Tj ET Q q 0 0 0 rg BT 563.79 613.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 601.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 60.92 601.10 Td (of ) Tj ET Q q 0 0 0 rg BT 71.95 601.10 Td (the ) Tj ET Q q 0 0 0 rg BT 86.86 601.10 Td (alliance, ) Tj ET Q q 0 0 0 rg BT 123.15 601.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 146.97 601.10 Td (was ) Tj ET Q q 0 0 0 rg BT 165.22 601.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 197.91 601.10 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 238.37 601.10 Td (global ) Tj ET Q q 0 0 0 rg BT 266.06 601.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 291.54 601.10 Td (to ) Tj ET Q q 0 0 0 rg BT 302.02 601.10 Td (co-develop ) Tj ET Q q 0 0 0 rg BT 349.14 601.10 Td (and ) Tj ET Q q 0 0 0 rg BT 366.28 601.10 Td (commercialize ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 427.83 601.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.49 601.10 Td ( ) Tj ET Q q 0 0 0 rg BT 467.19 601.10 Td (from ) Tj ET Q q 0 0 0 rg BT 489.33 601.10 Td (PDL) Tj ET Q q 0 0 0 rg BT 507.85 601.10 Td ( ) Tj ET Q q 0 0 0 rg BT 510.55 601.10 Td (BioPharma, ) Tj ET Q q 0 0 0 rg BT 560.74 601.10 Td (Inc. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 589.10 Td (\(now ) Tj ET Q q 0 0 0 rg BT 58.83 589.10 Td (part ) Tj ET Q q 0 0 0 rg BT 76.66 589.10 Td (of ) Tj ET Q q 0 0 0 rg BT 86.76 589.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 110.61 589.10 Td (ie\). ) Tj ET Q q 0 0 0 rg BT 125.43 589.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 149.27 589.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 158.77 589.10 Td (currently ) Tj ET Q q 0 0 0 rg BT 197.14 589.10 Td (participates ) Tj ET Q q 0 0 0 rg BT 245.51 589.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.57 589.10 Td (joint ) Tj ET Q q 0 0 0 rg BT 276.18 589.10 Td (development ) Tj ET Q q 0 0 0 rg BT 330.11 589.10 Td (and ) Tj ET Q q 0 0 0 rg BT 346.83 589.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 366.89 589.10 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 443.58 589.10 Td (committees ) Tj ET Q q 0 0 0 rg BT 491.96 589.10 Td (which ) Tj ET Q q 0 0 0 rg BT 518.67 589.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 542.08 589.10 Td (has ) Tj ET Q q 0 0 0 rg BT 557.69 589.10 Td (final ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 577.10 Td (decision ) Tj ET Q q 0 0 0 rg BT 71.20 577.10 Td (making ) Tj ET Q q 0 0 0 rg BT 103.08 577.10 Td (authority) Tj ET Q q 0 0 0 rg BT 138.53 577.10 Td (. ) Tj ET Q q 0 0 0 rg BT 142.91 577.10 Td (Both ) Tj ET Q q 0 0 0 rg BT 164.23 577.10 Td (parties ) Tj ET Q q 0 0 0 rg BT 192.77 577.10 Td (are ) Tj ET Q q 0 0 0 rg BT 206.85 577.10 Td (co-developing ) Tj ET Q q 0 0 0 rg BT 265.93 577.10 Td (the ) Tj ET Q q 0 0 0 rg BT 280.02 577.10 Td (product ) Tj ET Q q 0 0 0 rg BT 312.45 577.10 Td (and ) Tj ET Q q 0 0 0 rg BT 328.35 577.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 352.19 577.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 361.29 577.10 Td (funds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 385.39 577.10 Td (20%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.72 577.10 Td ( ) Tj ET Q q 0 0 0 rg BT 405.59 577.10 Td (of ) Tj ET Q q 0 0 0 rg BT 415.80 577.10 Td (global ) Tj ET Q q 0 0 0 rg BT 442.67 577.10 Td (development ) Tj ET Q q 0 0 0 rg BT 496.20 577.10 Td (costs. ) Tj ET Q q 0 0 0 rg BT 520.58 577.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 543.58 577.10 Td (is ) Tj ET Q q 0 0 0 rg BT 552.13 577.10 Td (solely ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 565.10 Td (responsible ) Tj ET Q q 0 0 0 rg BT 83.74 565.10 Td (for ) Tj ET Q q 0 0 0 rg BT 97.59 565.10 Td (supply) Tj ET Q q 0 0 0 rg BT 123.61 565.10 Td (, ) Tj ET Q q 0 0 0 rg BT 128.30 565.10 Td (distribution ) Tj ET Q q 0 0 0 rg BT 176.61 565.10 Td (and ) Tj ET Q q 0 0 0 rg BT 193.24 565.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 214.87 565.10 Td (and ) Tj ET Q q 0 0 0 rg BT 231.50 565.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 274.24 565.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 312.53 565.10 Td (within ) Tj ET Q q 0 0 0 rg BT 340.28 565.10 Td (the ) Tj ET Q q 0 0 0 rg BT 354.69 565.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 387.97 565.10 Td (and ) Tj ET Q q 0 0 0 rg BT 404.60 565.10 Td (is ) Tj ET Q q 0 0 0 rg BT 413.46 565.10 Td (the ) Tj ET Q q 0 0 0 rg BT 427.87 565.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 465.60 565.10 Td (in ) Tj ET Q q 0 0 0 rg BT 475.58 565.10 Td (the ) Tj ET Q q 0 0 0 rg BT 489.98 565.10 Td (end ) Tj ET Q q 0 0 0 rg BT 506.62 565.10 Td (customer ) Tj ET Q q 0 0 0 rg BT 545.46 565.10 Td (product ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 553.10 Td (sales. ) Tj ET Q q 0 0 0 rg BT 59.53 553.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 83.37 553.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 92.63 553.10 Td (shares ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 119.66 553.10 Td (30%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.99 553.10 Td ( ) Tj ET Q q 0 0 0 rg BT 140.04 553.10 Td (of ) Tj ET Q q 0 0 0 rg BT 150.41 553.10 Td (all ) Tj ET Q q 0 0 0 rg BT 162.45 553.10 Td (profits ) Tj ET Q q 0 0 0 rg BT 190.60 553.10 Td (and ) Tj ET Q q 0 0 0 rg BT 207.08 553.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 233.01 553.10 Td (in ) Tj ET Q q 0 0 0 rg BT 242.83 553.10 Td (the ) Tj ET Q q 0 0 0 rg BT 257.09 553.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 276.92 553.10 Td (and ) Tj ET Q q 0 0 0 rg BT 293.40 553.10 Td (is ) Tj ET Q q 0 0 0 rg BT 302.11 553.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 321.37 553.10 Td (tiered ) Tj ET Q q 0 0 0 rg BT 346.18 553.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 382.65 553.10 Td (on ) Tj ET Q q 0 0 0 rg BT 394.70 553.10 Td (net ) Tj ET Q q 0 0 0 rg BT 408.96 553.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 430.44 553.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 440.81 553.10 Td (Empliciti) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.47 553.10 Td ( ) Tj ET Q q 0 0 0 rg BT 479.51 553.10 Td (outside ) Tj ET Q q 0 0 0 rg BT 510.44 553.10 Td (of ) Tj ET Q q 0 0 0 rg BT 520.81 553.10 Td (the ) Tj ET Q q 0 0 0 rg BT 535.07 553.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 554.90 553.10 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 541.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 55.20 541.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 79.04 541.10 Td (ie ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.80 541.10 Td ($140 ) Tj ET Q q 0 0 0 rg BT 111.35 541.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 140.24 541.10 Td ( ) Tj ET Q q 0 0 0 rg BT 142.78 541.10 Td (for ) Tj ET Q q 0 0 0 rg BT 156.99 541.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 186.73 541.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 230.37 541.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 271.80 541.10 Td (events ) Tj ET Q q 0 0 0 rg BT 299.89 541.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.20 541.10 Td ($52 ) Tj ET Q q 0 0 0 rg BT 357.75 541.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.64 541.10 Td ( ) Tj ET Q q 0 0 0 rg BT 389.18 541.10 Td (for ) Tj ET Q q 0 0 0 rg BT 403.39 541.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 440.92 541.10 Td (milestones ) Tj ET Q q 0 0 0 rg BT 486.23 541.10 Td (through ) Tj ET Q q 0 0 0 rg BT 519.89 541.10 Td (December ) Tj ET Q q 0 0 0 rg BT 563.51 541.10 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 529.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 60.46 529.10 Td (AbbV) Tj ET Q q 0 0 0 rg BT 84.30 529.10 Td (ie ) Tj ET Q q 0 0 0 rg BT 94.03 529.10 Td (is ) Tj ET Q q 0 0 0 rg BT 103.21 529.10 Td (also ) Tj ET Q q 0 0 0 rg BT 121.82 529.10 Td (entitled ) Tj ET Q q 0 0 0 rg BT 154.32 529.10 Td (to ) Tj ET Q q 0 0 0 rg BT 164.61 529.10 Td (receive ) Tj ET Q q 0 0 0 rg BT 195.98 529.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 238.48 529.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 279.88 529.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 320.71 529.10 Td (from ) Tj ET Q q 0 0 0 rg BT 342.66 529.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 366.29 529.10 Td (if ) Tj ET Q q 0 0 0 rg BT 374.91 529.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 404.62 529.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 448.22 529.10 Td (events ) Tj ET Q q 0 0 0 rg BT 476.28 529.10 Td (occur ) Tj ET Q q 0 0 0 rg BT 501.00 529.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.33 529.10 Td ($120 ) Tj ET Q q 0 0 0 rg BT 526.84 529.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.73 529.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 561.57 529.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 517.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 57.74 517.10 Td (thresholds ) Tj ET Q q 0 0 0 rg BT 101.15 517.10 Td (are ) Tj ET Q q 0 0 0 rg BT 115.66 517.10 Td (achieved ) Tj ET Q q 0 0 0 rg BT 153.49 517.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 156.82 517.10 Td ($200 ) Tj ET Q q 0 0 0 rg BT 179.12 517.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 208.01 517.10 Td (\). ) Tj ET Q q 0 0 0 rg BT 215.98 517.10 Td (The ) Tj ET Q q 0 0 0 rg BT 233.83 517.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 277.77 517.10 Td (may ) Tj ET Q q 0 0 0 rg BT 297.29 517.10 Td (be ) Tj ET Q q 0 0 0 rg BT 309.03 517.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 354.09 517.10 Td (at ) Tj ET Q q 0 0 0 rg BT 363.60 517.10 Td (will ) Tj ET Q q 0 0 0 rg BT 381.46 517.10 Td (by ) Tj ET Q q 0 0 0 rg BT 393.76 517.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 417.19 517.10 Td (or ) Tj ET Q q 0 0 0 rg BT 427.82 517.10 Td (by ) Tj ET Q q 0 0 0 rg BT 440.12 517.10 Td (either ) Tj ET Q q 0 0 0 rg BT 465.19 517.10 Td (party ) Tj ET Q q 0 0 0 rg BT 488.03 517.10 Td (for ) Tj ET Q q 0 0 0 rg BT 502.00 517.10 Td (material ) Tj ET Q q 0 0 0 rg BT 537.06 517.10 Td (breach ) Tj ET Q q 0 0 0 rg BT 566.00 517.10 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 505.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 505.10 Td (other ) Tj ET Q q 0 0 0 rg BT 73.76 505.10 Td (party ) Tj ET Q q 0 0 0 rg BT 96.81 505.10 Td (\(subsequent ) Tj ET Q q 0 0 0 rg BT 147.08 505.10 Td (to ) Tj ET Q q 0 0 0 rg BT 157.36 505.10 Td (a ) Tj ET Q q 0 0 0 rg BT 164.30 505.10 Td (notice ) Tj ET Q q 0 0 0 rg BT 191.23 505.10 Td (period\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 481.10 Td (Summarized financial information related to this alliance was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 444.60 348.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 383.50 444.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 387.50 444.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 444.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 444.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 444.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 444.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 387.5 457.6 m 447.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 457.6 m 451.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 457.6 m 511.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 457.6 m 515.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 457.6 m 575.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 387.5 457.6 m 447.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 387.5 444.6 m 447.5 444.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 457.6 m 451.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 457.6 m 511.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 444.6 m 511.5 444.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 457.6 m 515.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 457.6 m 575.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 444.6 m 575.5 444.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 461.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 436.70 461.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 448.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 409.00 448.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 473.00 448.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.00 448.83 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 435.33 Td (Revenues from AbbVie alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 422.17 Td (Net product sales) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.00 422.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 422.17 Td (132) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 422.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 422.17 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 422.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 422.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 393.53505859375 m 63.67822265625 393.53505859375 l s q 0 0 0 rg BT 36.00 395.10 Td (F-Star) Tj ET Q BT /F1 11.00 Tf ET q 0 0 0 rg BT 36.00 369.90 Td (I) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.66 369.90 Td (n ) Tj ET Q q 0 0 0 rg BT 46.83 369.90 Td (October ) Tj ET Q q 0 0 0 rg BT 81.20 369.90 Td (2014, ) Tj ET Q q 0 0 0 rg BT 105.86 369.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 129.15 369.90 Td (entered ) Tj ET Q q 0 0 0 rg BT 160.74 369.90 Td (into ) Tj ET Q q 0 0 0 rg BT 178.46 369.90 Td (an ) Tj ET Q q 0 0 0 rg BT 190.06 369.90 Td (agreement ) Tj ET Q q 0 0 0 rg BT 233.87 369.90 Td (with ) Tj ET Q q 0 0 0 rg BT 253.81 369.90 Td (F-Star) Tj ET Q q 0 0 0 rg BT 278.26 369.90 Td (. ) Tj ET Q q 0 0 0 rg BT 282.77 369.90 Td (The ) Tj ET Q q 0 0 0 rg BT 300.48 369.90 Td (agreement ) Tj ET Q q 0 0 0 rg BT 344.28 369.90 Td (provides ) Tj ET Q q 0 0 0 rg BT 380.89 369.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 404.18 369.90 Td (with ) Tj ET Q q 0 0 0 rg BT 424.12 369.90 Td (an ) Tj ET Q q 0 0 0 rg BT 435.72 369.90 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 475.65 369.90 Td (option ) Tj ET Q q 0 0 0 rg BT 503.37 369.90 Td (to ) Tj ET Q q 0 0 0 rg BT 513.31 369.90 Td (purchase ) Tj ET Q q 0 0 0 rg BT 551.02 369.90 Td (F-Star ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 357.90 Td (and ) Tj ET Q q 0 0 0 rg BT 53.20 357.90 Td (its ) Tj ET Q q 0 0 0 rg BT 65.40 357.90 Td (Phase ) Tj ET Q q 0 0 0 rg BT 91.49 357.90 Td (I ) Tj ET Q q 0 0 0 rg BT 97.58 357.90 Td (ready ) Tj ET Q q 0 0 0 rg BT 122.55 357.90 Td (lead ) Tj ET Q q 0 0 0 rg BT 141.96 357.90 Td (asset ) Tj ET Q q 0 0 0 rg BT 164.16 357.90 Td (FS102, ) Tj ET Q q 0 0 0 rg BT 195.54 357.90 Td (a ) Tj ET Q q 0 0 0 rg BT 202.74 357.90 Td (tar) Tj ET Q q 0 0 0 rg BT 213.10 357.90 Td (geted ) Tj ET Q q 0 0 0 rg BT 237.52 357.90 Td (therapy ) Tj ET Q q 0 0 0 rg BT 270.26 357.90 Td (in ) Tj ET Q q 0 0 0 rg BT 280.80 357.90 Td (development ) Tj ET Q q 0 0 0 rg BT 335.21 357.90 Td (for ) Tj ET Q q 0 0 0 rg BT 349.63 357.90 Td (the ) Tj ET Q q 0 0 0 rg BT 364.60 357.90 Td (treatment ) Tj ET Q q 0 0 0 rg BT 405.12 357.90 Td (of ) Tj ET Q q 0 0 0 rg BT 416.21 357.90 Td (breast ) Tj ET Q q 0 0 0 rg BT 442.85 357.90 Td (and ) Tj ET Q q 0 0 0 rg BT 460.04 357.90 Td (gastric ) Tj ET Q q 0 0 0 rg BT 489.46 357.90 Td (cancer ) Tj ET Q q 0 0 0 rg BT 518.30 357.90 Td (among ) Tj ET Q q 0 0 0 rg BT 548.28 357.90 Td (a ) Tj ET Q q 0 0 0 rg BT 555.47 357.90 Td (well-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 345.90 Td (defined ) Tj ET Q q 0 0 0 rg BT 68.49 345.90 Td (population ) Tj ET Q q 0 0 0 rg BT 113.76 345.90 Td (of ) Tj ET Q q 0 0 0 rg BT 124.59 345.90 Td (HER2-positive ) Tj ET Q q 0 0 0 rg BT 187.08 345.90 Td (patients.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.64 323.90 Td (paid ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.38 323.90 Td ($50 ) Tj ET Q q 0 0 0 rg BT 96.90 323.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 125.79 323.90 Td ( ) Tj ET Q q 0 0 0 rg BT 128.31 323.90 Td (to ) Tj ET Q q 0 0 0 rg BT 138.60 323.90 Td (F-Star ) Tj ET Q q 0 0 0 rg BT 166.12 323.90 Td (and ) Tj ET Q q 0 0 0 rg BT 183.08 323.90 Td (its ) Tj ET Q q 0 0 0 rg BT 195.04 323.90 Td (shareholders ) Tj ET Q q 0 0 0 rg BT 248.10 323.90 Td (in ) Tj ET Q q 0 0 0 rg BT 258.40 323.90 Td (2014 ) Tj ET Q q 0 0 0 rg BT 280.92 323.90 Td (in ) Tj ET Q q 0 0 0 rg BT 291.21 323.90 Td (consideration ) Tj ET Q q 0 0 0 rg BT 347.60 323.90 Td (for ) Tj ET Q q 0 0 0 rg BT 361.78 323.90 Td (the ) Tj ET Q q 0 0 0 rg BT 376.52 323.90 Td (option ) Tj ET Q q 0 0 0 rg BT 404.59 323.90 Td (grant ) Tj ET Q q 0 0 0 rg BT 427.66 323.90 Td (and ) Tj ET Q q 0 0 0 rg BT 444.62 323.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 474.34 323.90 Td (licensing ) Tj ET Q q 0 0 0 rg BT 512.96 323.90 Td (rights ) Tj ET Q q 0 0 0 rg BT 538.25 323.90 Td (\(included ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.90 Td (in ) Tj ET Q q 0 0 0 rg BT 45.44 311.90 Td (research ) Tj ET Q q 0 0 0 rg BT 80.42 311.90 Td (and ) Tj ET Q q 0 0 0 rg BT 96.52 311.90 Td (development ) Tj ET Q q 0 0 0 rg BT 149.84 311.90 Td (expenses\) ) Tj ET Q q 0 0 0 rg BT 190.93 311.90 Td (and ) Tj ET Q q 0 0 0 rg BT 207.04 311.90 Td (is ) Tj ET Q q 0 0 0 rg BT 215.38 311.90 Td (responsible ) Tj ET Q q 0 0 0 rg BT 262.59 311.90 Td (for ) Tj ET Q q 0 0 0 rg BT 275.92 311.90 Td (conducting ) Tj ET Q q 0 0 0 rg BT 322.02 311.90 Td (and ) Tj ET Q q 0 0 0 rg BT 338.12 311.90 Td (funding ) Tj ET Q q 0 0 0 rg BT 370.90 311.90 Td (the ) Tj ET Q q 0 0 0 rg BT 384.78 311.90 Td (development ) Tj ET Q q 0 0 0 rg BT 438.10 311.90 Td (of ) Tj ET Q q 0 0 0 rg BT 448.09 311.90 Td (FS102. ) Tj ET Q q 0 0 0 rg BT 478.26 311.90 Td (The ) Tj ET Q q 0 0 0 rg BT 495.47 311.90 Td (option ) Tj ET Q q 0 0 0 rg BT 522.70 311.90 Td (is ) Tj ET Q q 0 0 0 rg BT 531.03 311.90 Td (exercisable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.90 Td (at ) Tj ET Q q 0 0 0 rg BT 45.09 299.90 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 73.78 299.90 Td (discretion ) Tj ET Q q 0 0 0 rg BT 115.09 299.90 Td (and ) Tj ET Q q 0 0 0 rg BT 131.40 299.90 Td (expires ) Tj ET Q q 0 0 0 rg BT 162.15 299.90 Td (upon ) Tj ET Q q 0 0 0 rg BT 184.03 299.90 Td (the ) Tj ET Q q 0 0 0 rg BT 198.12 299.90 Td (earlier ) Tj ET Q q 0 0 0 rg BT 225.52 299.90 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.73 299.90 Td (60 ) Tj ET Q q 0 0 0 rg BT 247.60 299.90 Td (days) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 265.93 299.90 Td ( ) Tj ET Q q 0 0 0 rg BT 267.81 299.90 Td (following ) Tj ET Q q 0 0 0 rg BT 308.57 299.90 Td (obtaining ) Tj ET Q q 0 0 0 rg BT 348.21 299.90 Td (proof ) Tj ET Q q 0 0 0 rg BT 371.75 299.90 Td (of ) Tj ET Q q 0 0 0 rg BT 381.95 299.90 Td (concept ) Tj ET Q q 0 0 0 rg BT 414.92 299.90 Td (or ) Tj ET Q q 0 0 0 rg BT 425.12 299.90 Td (June ) Tj ET Q q 0 0 0 rg BT 445.33 299.90 Td (2018. ) Tj ET Q q 0 0 0 rg BT 469.29 299.90 Td (An ) Tj ET Q q 0 0 0 rg BT 483.38 299.90 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.25 299.90 Td ($100 ) Tj ET Q q 0 0 0 rg BT 547.12 299.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.90 Td (will ) Tj ET Q q 0 0 0 rg BT 53.15 287.90 Td (be ) Tj ET Q q 0 0 0 rg BT 64.18 287.90 Td (payable ) Tj ET Q q 0 0 0 rg BT 96.87 287.90 Td (upon ) Tj ET Q q 0 0 0 rg BT 118.47 287.90 Td (the ) Tj ET Q q 0 0 0 rg BT 132.28 287.90 Td (exercise ) Tj ET Q q 0 0 0 rg BT 166.63 287.90 Td (of ) Tj ET Q q 0 0 0 rg BT 176.55 287.90 Td (the ) Tj ET Q q 0 0 0 rg BT 190.36 287.90 Td (option ) Tj ET Q q 0 0 0 rg BT 217.51 287.90 Td (plus ) Tj ET Q q 0 0 0 rg BT 235.78 287.90 Td (an ) Tj ET Q q 0 0 0 rg BT 246.81 287.90 Td (additional ) Tj ET Q q 0 0 0 rg BT 288.39 287.90 Td (aggregate ) Tj ET Q q 0 0 0 rg BT 328.85 287.90 Td (consideration ) Tj ET Q q 0 0 0 rg BT 384.32 287.90 Td (of ) Tj ET Q q 0 0 0 rg BT 394.24 287.90 Td (up ) Tj ET Q q 0 0 0 rg BT 405.83 287.90 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.21 287.90 Td ($325 ) Tj ET Q q 0 0 0 rg BT 436.80 287.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.69 287.90 Td ( ) Tj ET Q q 0 0 0 rg BT 467.29 287.90 Td (for ) Tj ET Q q 0 0 0 rg BT 480.54 287.90 Td (contingent ) Tj ET Q q 0 0 0 rg BT 524.35 287.90 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.90 Td (and ) Tj ET Q q 0 0 0 rg BT 52.71 275.90 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 96.07 275.90 Td (approval ) Tj ET Q q 0 0 0 rg BT 133.33 275.90 Td (milestone ) Tj ET Q q 0 0 0 rg BT 174.48 275.90 Td (payments ) Tj ET Q q 0 0 0 rg BT 215.07 275.90 Td (in ) Tj ET Q q 0 0 0 rg BT 225.12 275.90 Td (the ) Tj ET Q q 0 0 0 rg BT 239.61 275.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 259.66 275.90 Td (and ) Tj ET Q q 0 0 0 rg BT 276.37 275.90 Td (Europe. ) Tj ET Q q 0 0 0 rg BT 310.01 275.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 333.41 275.90 Td (is ) Tj ET Q q 0 0 0 rg BT 342.35 275.90 Td (not ) Tj ET Q q 0 0 0 rg BT 357.39 275.90 Td (obligated ) Tj ET Q q 0 0 0 rg BT 396.88 275.90 Td (to ) Tj ET Q q 0 0 0 rg BT 406.92 275.90 Td (provide ) Tj ET Q q 0 0 0 rg BT 439.74 275.90 Td (any ) Tj ET Q q 0 0 0 rg BT 456.45 275.90 Td (additional ) Tj ET Q q 0 0 0 rg BT 498.71 275.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 535.96 275.90 Td (support ) Tj ET Q q 0 0 0 rg BT 568.23 275.90 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.90 Td (F-Star) Tj ET Q q 0 0 0 rg BT 60.45 263.90 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 241.90 Td (F-Star ) Tj ET Q q 0 0 0 rg BT 63.73 241.90 Td (was ) Tj ET Q q 0 0 0 rg BT 82.02 241.90 Td (determined ) Tj ET Q q 0 0 0 rg BT 129.73 241.90 Td (not ) Tj ET Q q 0 0 0 rg BT 145.24 241.90 Td (to ) Tj ET Q q 0 0 0 rg BT 155.76 241.90 Td (be ) Tj ET Q q 0 0 0 rg BT 167.93 241.90 Td (a ) Tj ET Q q 0 0 0 rg BT 175.10 241.90 Td (business ) Tj ET Q q 0 0 0 rg BT 211.72 241.90 Td (as ) Tj ET Q q 0 0 0 rg BT 222.79 241.90 Td (defined ) Tj ET Q q 0 0 0 rg BT 255.51 241.90 Td (in ) Tj ET Q q 0 0 0 rg BT 265.42 241.90 Td (ASC ) Tj ET Q q 0 0 0 rg BT 287.60 241.90 Td (805 ) Tj ET Q q 0 0 0 rg BT 305.33 241.90 Td (- ) Tj ET Q q 0 0 0 rg BT 311.40 241.90 Td (Business ) Tj ET Q q 0 0 0 rg BT 349.69 241.90 Td (Combinations. ) Tj ET Q q 0 0 0 rg BT 410.44 241.90 Td (As ) Tj ET Q q 0 0 0 rg BT 424.28 241.90 Td (a ) Tj ET Q q 0 0 0 rg BT 431.46 241.90 Td (result, ) Tj ET Q q 0 0 0 rg BT 458.91 241.90 Td (contingent ) Tj ET Q q 0 0 0 rg BT 503.85 241.90 Td (consideration ) Tj ET Q q 0 0 0 rg BT 560.46 241.90 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 229.90 Td (not ) Tj ET Q q 0 0 0 rg BT 50.93 229.90 Td (included ) Tj ET Q q 0 0 0 rg BT 87.51 229.90 Td (in ) Tj ET Q q 0 0 0 rg BT 97.43 229.90 Td (the ) Tj ET Q q 0 0 0 rg BT 111.80 229.90 Td (purchase ) Tj ET Q q 0 0 0 rg BT 149.48 229.90 Td (price ) Tj ET Q q 0 0 0 rg BT 171.61 229.90 Td (and ) Tj ET Q q 0 0 0 rg BT 188.20 229.90 Td (no ) Tj ET Q q 0 0 0 rg BT 200.35 229.90 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 238.05 229.90 Td (was ) Tj ET Q q 0 0 0 rg BT 255.75 229.90 Td (recognized. ) Tj ET Q q 0 0 0 rg BT 304.26 229.90 Td (However) Tj ET Q q 0 0 0 rg BT 340.51 229.90 Td (, ) Tj ET Q q 0 0 0 rg BT 345.16 229.90 Td (F-Star ) Tj ET Q q 0 0 0 rg BT 372.31 229.90 Td (is ) Tj ET Q q 0 0 0 rg BT 381.12 229.90 Td (a ) Tj ET Q q 0 0 0 rg BT 387.71 229.90 Td (variable ) Tj ET Q q 0 0 0 rg BT 422.06 229.90 Td (interest ) Tj ET Q q 0 0 0 rg BT 453.64 229.90 Td (entity ) Tj ET Q q 0 0 0 rg BT 478.56 229.90 Td (as ) Tj ET Q q 0 0 0 rg BT 489.04 229.90 Td (its ) Tj ET Q q 0 0 0 rg BT 500.63 229.90 Td (equity ) Tj ET Q q 0 0 0 rg BT 527.78 229.90 Td (holders ) Tj ET Q q 0 0 0 rg BT 559.36 229.90 Td (lack ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 217.90 Td (the ) Tj ET Q q 0 0 0 rg BT 51.18 217.90 Td (characteristics ) Tj ET Q q 0 0 0 rg BT 111.34 217.90 Td (of ) Tj ET Q q 0 0 0 rg BT 122.64 217.90 Td (a ) Tj ET Q q 0 0 0 rg BT 130.04 217.90 Td (controlling ) Tj ET Q q 0 0 0 rg BT 176.89 217.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 214.84 217.90 Td (interest. ) Tj ET Q q 0 0 0 rg BT 249.74 217.90 Td (BMS ) Tj ET Q q 0 0 0 rg BT 273.83 217.90 Td (was ) Tj ET Q q 0 0 0 rg BT 292.35 217.90 Td (determined ) Tj ET Q q 0 0 0 rg BT 340.30 217.90 Td (to ) Tj ET Q q 0 0 0 rg BT 351.05 217.90 Td (be ) Tj ET Q q 0 0 0 rg BT 363.45 217.90 Td (the ) Tj ET Q q 0 0 0 rg BT 378.64 217.90 Td (primary ) Tj ET Q q 0 0 0 rg BT 413.26 217.90 Td (beneficiary ) Tj ET Q q 0 0 0 rg BT 461.20 217.90 Td (because ) Tj ET Q q 0 0 0 rg BT 495.81 217.90 Td (of ) Tj ET Q q 0 0 0 rg BT 507.11 217.90 Td (both ) Tj ET Q q 0 0 0 rg BT 527.86 217.90 Td (its ) Tj ET Q q 0 0 0 rg BT 540.27 217.90 Td (power ) Tj ET Q q 0 0 0 rg BT 568.23 217.90 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 205.90 Td (direct ) Tj ET Q q 0 0 0 rg BT 62.04 205.90 Td (the ) Tj ET Q q 0 0 0 rg BT 77.54 205.90 Td (activities ) Tj ET Q q 0 0 0 rg BT 116.92 205.90 Td (most ) Tj ET Q q 0 0 0 rg BT 139.65 205.90 Td (significantly ) Tj ET Q q 0 0 0 rg BT 192.92 205.90 Td (and ) Tj ET Q q 0 0 0 rg BT 210.64 205.90 Td (directly ) Tj ET Q q 0 0 0 rg BT 244.46 205.90 Td (impacting ) Tj ET Q q 0 0 0 rg BT 287.73 205.90 Td (the ) Tj ET Q q 0 0 0 rg BT 303.23 205.90 Td (economic ) Tj ET Q q 0 0 0 rg BT 345.38 205.90 Td (performance ) Tj ET Q q 0 0 0 rg BT 399.18 205.90 Td (of ) Tj ET Q q 0 0 0 rg BT 410.79 205.90 Td (the ) Tj ET Q q 0 0 0 rg BT 426.29 205.90 Td (entity ) Tj ET Q q 0 0 0 rg BT 452.34 205.90 Td (and ) Tj ET Q q 0 0 0 rg BT 470.06 205.90 Td (its ) Tj ET Q q 0 0 0 rg BT 482.79 205.90 Td (option ) Tj ET Q q 0 0 0 rg BT 511.63 205.90 Td (rights ) Tj ET Q q 0 0 0 rg BT 537.69 205.90 Td (described ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 193.90 Td (above. ) Tj ET Q q 0 0 0 rg BT 64.63 193.90 Td (Upon ) Tj ET Q q 0 0 0 rg BT 89.11 193.90 Td (consolidation ) Tj ET Q q 0 0 0 rg BT 145.25 193.90 Td (in ) Tj ET Q q 0 0 0 rg BT 155.28 193.90 Td (2014, ) Tj ET Q q 0 0 0 rg BT 180.03 193.90 Td (noncontrolling ) Tj ET Q q 0 0 0 rg BT 241.17 193.90 Td (interest ) Tj ET Q q 0 0 0 rg BT 272.86 193.90 Td (was ) Tj ET Q q 0 0 0 rg BT 290.67 193.90 Td (credited ) Tj ET Q q 0 0 0 rg BT 325.12 193.90 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.38 193.90 Td ($59 ) Tj ET Q q 0 0 0 rg BT 354.63 193.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.52 193.90 Td ( ) Tj ET Q q 0 0 0 rg BT 385.78 193.90 Td (to ) Tj ET Q q 0 0 0 rg BT 395.81 193.90 Td (reflect ) Tj ET Q q 0 0 0 rg BT 423.60 193.90 Td (the ) Tj ET Q q 0 0 0 rg BT 438.07 193.90 Td (fair ) Tj ET Q q 0 0 0 rg BT 454.20 193.90 Td (value ) Tj ET Q q 0 0 0 rg BT 478.11 193.90 Td (of ) Tj ET Q q 0 0 0 rg BT 488.70 193.90 Td (the ) Tj ET Q q 0 0 0 rg BT 503.17 193.90 Td (FS102 ) Tj ET Q q 0 0 0 rg BT 531.55 193.90 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 556.58 193.90 Td (asset ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 181.90 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.33 181.90 Td ($75 ) Tj ET Q q 0 0 0 rg BT 56.83 181.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 85.72 181.90 Td (\) ) Tj ET Q q 0 0 0 rg BT 91.55 181.90 Td (and ) Tj ET Q q 0 0 0 rg BT 108.49 181.90 Td (deferred ) Tj ET Q q 0 0 0 rg BT 144.30 181.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 159.01 181.90 Td (liabilities.) Tj ET Q endstream endobj 145 0 obj <> endobj 146 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (72) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 747.68505859375 m 81.82275390625 747.68505859375 l s q 0 0 0 rg BT 36.00 749.25 Td (Pr) Tj ET Q q 0 0 0 rg BT 46.37 749.25 Td (omedior) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.35 725.25 Td (September ) Tj ET Q q 0 0 0 rg BT 91.13 725.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 115.64 725.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 138.78 725.25 Td (purchased ) Tj ET Q q 0 0 0 rg BT 181.34 725.25 Td (a ) Tj ET Q q 0 0 0 rg BT 187.79 725.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 220.35 725.25 Td (that ) Tj ET Q q 0 0 0 rg BT 237.36 725.25 Td (gives ) Tj ET Q q 0 0 0 rg BT 260.48 725.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 283.62 725.25 Td (the ) Tj ET Q q 0 0 0 rg BT 297.86 725.25 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 337.64 725.25 Td (right ) Tj ET Q q 0 0 0 rg BT 358.54 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 368.33 725.25 Td (acquire ) Tj ET Q q 0 0 0 rg BT 399.77 725.25 Td (Promedior) Tj ET Q q 0 0 0 rg BT 441.59 725.25 Td (, ) Tj ET Q q 0 0 0 rg BT 446.11 725.25 Td (a ) Tj ET Q q 0 0 0 rg BT 452.56 725.25 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 511.79 725.25 Td (company ) Tj ET Q q 0 0 0 rg BT 550.46 725.25 Td (whose ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (lead ) Tj ET Q q 0 0 0 rg BT 55.40 713.25 Td (asset, ) Tj ET Q q 0 0 0 rg BT 80.08 713.25 Td (PRM-151, ) Tj ET Q q 0 0 0 rg BT 124.77 713.25 Td (is ) Tj ET Q q 0 0 0 rg BT 134.18 713.25 Td (being ) Tj ET Q q 0 0 0 rg BT 159.14 713.25 Td (developed ) Tj ET Q q 0 0 0 rg BT 202.98 713.25 Td (for ) Tj ET Q q 0 0 0 rg BT 217.38 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 232.34 713.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 272.84 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 283.91 713.25 Td (IPF ) Tj ET Q q 0 0 0 rg BT 301.10 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 318.29 713.25 Td (MF) Tj ET Q q 0 0 0 rg BT 331.94 713.25 Td (. ) Tj ET Q q 0 0 0 rg BT 336.98 713.25 Td (The ) Tj ET Q q 0 0 0 rg BT 355.27 713.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 388.55 713.25 Td (is ) Tj ET Q q 0 0 0 rg BT 397.96 713.25 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 445.67 713.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 468.41 713.25 Td (completion ) Tj ET Q q 0 0 0 rg BT 516.15 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 527.22 713.25 Td (either ) Tj ET Q q 0 0 0 rg BT 552.72 713.25 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 713.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (IPF ) Tj ET Q q 0 0 0 rg BT 52.58 701.25 Td (or ) Tj ET Q q 0 0 0 rg BT 63.04 701.25 Td (MF ) Tj ET Q q 0 0 0 rg BT 79.62 701.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 105.08 701.25 Td (II ) Tj ET Q q 0 0 0 rg BT 113.87 701.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 145.42 701.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 175.33 701.25 Td (being ) Tj ET Q q 0 0 0 rg BT 199.67 701.25 Td (conducted ) Tj ET Q q 0 0 0 rg BT 242.90 701.25 Td (by ) Tj ET Q q 0 0 0 rg BT 255.02 701.25 Td (Promedior) Tj ET Q q 0 0 0 rg BT 296.84 701.25 Td (, ) Tj ET Q q 0 0 0 rg BT 301.47 701.25 Td (which ) Tj ET Q q 0 0 0 rg BT 328.03 701.25 Td (is ) Tj ET Q q 0 0 0 rg BT 336.83 701.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 374.49 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 384.40 701.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 408.73 701.25 Td (no ) Tj ET Q q 0 0 0 rg BT 420.86 701.25 Td (earlier ) Tj ET Q q 0 0 0 rg BT 448.52 701.25 Td (than ) Tj ET Q q 0 0 0 rg BT 467.87 701.25 Td (2017. ) Tj ET Q q 0 0 0 rg BT 492.34 701.25 Td (The ) Tj ET Q q 0 0 0 rg BT 510.02 701.25 Td (upfront ) Tj ET Q q 0 0 0 rg BT 541.58 701.25 Td (payment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 74.39 689.25 Td (to ) Tj ET Q q 0 0 0 rg BT 84.46 689.25 Td (the ) Tj ET Q q 0 0 0 rg BT 98.98 689.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 131.81 689.25 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 149.66 689.25 Td ($84 ) Tj ET Q q 0 0 0 rg BT 166.96 689.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 195.85 689.25 Td ( ) Tj ET Q q 0 0 0 rg BT 198.15 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 214.88 689.25 Td (included ) Tj ET Q q 0 0 0 rg BT 251.61 689.25 Td (in ) Tj ET Q q 0 0 0 rg BT 261.69 689.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 285.66 689.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 324.05 689.25 Td (in ) Tj ET Q q 0 0 0 rg BT 334.13 689.25 Td (2015. ) Tj ET Q q 0 0 0 rg BT 358.76 689.25 Td (The ) Tj ET Q q 0 0 0 rg BT 376.60 689.25 Td (remaining ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.44 689.25 Td ($66 ) Tj ET Q q 0 0 0 rg BT 436.74 689.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.63 689.25 Td ( ) Tj ET Q q 0 0 0 rg BT 467.93 689.25 Td (of ) Tj ET Q q 0 0 0 rg BT 478.56 689.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.07 689.25 Td ($150 ) Tj ET Q q 0 0 0 rg BT 515.37 689.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.26 689.25 Td ( ) Tj ET Q q 0 0 0 rg BT 546.56 689.25 Td (upfront ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (payment ) Tj ET Q q 0 0 0 rg BT 73.09 677.25 Td (was ) Tj ET Q q 0 0 0 rg BT 91.30 677.25 Td (allocated ) Tj ET Q q 0 0 0 rg BT 130.04 677.25 Td (to ) Tj ET Q q 0 0 0 rg BT 140.48 677.25 Td (Promedior) Tj ET Q q 0 0 0 rg BT 183.07 677.25 Td (’) Tj ET Q q 0 0 0 rg BT 185.84 677.25 Td (s ) Tj ET Q q 0 0 0 rg BT 192.39 677.25 Td (obligation ) Tj ET Q q 0 0 0 rg BT 235.60 677.25 Td (to ) Tj ET Q q 0 0 0 rg BT 246.03 677.25 Td (complete ) Tj ET Q q 0 0 0 rg BT 285.34 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 300.21 677.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 326.20 677.25 Td (II ) Tj ET Q q 0 0 0 rg BT 335.52 677.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 365.95 677.25 Td (which ) Tj ET Q q 0 0 0 rg BT 393.05 677.25 Td (will ) Tj ET Q q 0 0 0 rg BT 411.26 677.25 Td (be ) Tj ET Q q 0 0 0 rg BT 423.35 677.25 Td (amortized ) Tj ET Q q 0 0 0 rg BT 465.99 677.25 Td (over ) Tj ET Q q 0 0 0 rg BT 486.42 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 501.29 677.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 539.48 677.25 Td (period ) Tj ET Q q 0 0 0 rg BT 567.68 677.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.62 665.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 76.35 665.25 Td (II ) Tj ET Q q 0 0 0 rg BT 85.41 665.25 Td (studies. ) Tj ET Q q 0 0 0 rg BT 117.92 665.25 Td (The ) Tj ET Q q 0 0 0 rg BT 135.87 665.25 Td (allocation ) Tj ET Q q 0 0 0 rg BT 177.70 665.25 Td (was ) Tj ET Q q 0 0 0 rg BT 195.65 665.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 243.03 665.25 Td (using ) Tj ET Q q 0 0 0 rg BT 267.10 665.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 292.27 665.25 Td (3 ) Tj ET Q q 0 0 0 rg BT 299.67 665.25 Td (inputs. ) Tj ET Q q 0 0 0 rg BT 329.02 665.25 Td (Following ) Tj ET Q q 0 0 0 rg BT 372.54 665.25 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 401.75 665.25 Td (review ) Tj ET Q q 0 0 0 rg BT 431.36 665.25 Td (of ) Tj ET Q q 0 0 0 rg BT 442.09 665.25 Td (the ) Tj ET Q q 0 0 0 rg BT 456.71 665.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 482.44 665.25 Td (II ) Tj ET Q q 0 0 0 rg BT 491.51 665.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 523.34 665.25 Td (study ) Tj ET Q q 0 0 0 rg BT 547.41 665.25 Td (results, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (if ) Tj ET Q q 0 0 0 rg BT 44.91 653.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 68.84 653.25 Td (elects ) Tj ET Q q 0 0 0 rg BT 94.41 653.25 Td (to ) Tj ET Q q 0 0 0 rg BT 104.99 653.25 Td (exercise ) Tj ET Q q 0 0 0 rg BT 140.55 653.25 Td (the ) Tj ET Q q 0 0 0 rg BT 155.57 653.25 Td (warrant ) Tj ET Q q 0 0 0 rg BT 188.91 653.25 Td (it ) Tj ET Q q 0 0 0 rg BT 197.27 653.25 Td (will ) Tj ET Q q 0 0 0 rg BT 215.63 653.25 Td (be ) Tj ET Q q 0 0 0 rg BT 227.88 653.25 Td (obligated ) Tj ET Q q 0 0 0 rg BT 267.89 653.25 Td (to ) Tj ET Q q 0 0 0 rg BT 278.47 653.25 Td (pay ) Tj ET Q q 0 0 0 rg BT 295.72 653.25 Td (an ) Tj ET Q q 0 0 0 rg BT 307.96 653.25 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.75 653.25 Td ($300 ) Tj ET Q q 0 0 0 rg BT 373.56 653.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 402.45 653.25 Td ( ) Tj ET Q q 0 0 0 rg BT 405.25 653.25 Td (\(if ) Tj ET Q q 0 0 0 rg BT 417.50 653.25 Td (based ) Tj ET Q q 0 0 0 rg BT 443.07 653.25 Td (on ) Tj ET Q q 0 0 0 rg BT 455.87 653.25 Td (the ) Tj ET Q q 0 0 0 rg BT 470.89 653.25 Td (IPF ) Tj ET Q q 0 0 0 rg BT 488.15 653.25 Td (study ) Tj ET Q q 0 0 0 rg BT 512.63 653.25 Td (results\) ) Tj ET Q q 0 0 0 rg BT 544.87 653.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.00 653.25 Td ($250 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 641.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 641.25 Td ( ) Tj ET Q q 0 0 0 rg BT 67.10 641.25 Td (\(if ) Tj ET Q q 0 0 0 rg BT 78.76 641.25 Td (based ) Tj ET Q q 0 0 0 rg BT 103.74 641.25 Td (on ) Tj ET Q q 0 0 0 rg BT 115.95 641.25 Td (the ) Tj ET Q q 0 0 0 rg BT 130.38 641.25 Td (MF ) Tj ET Q q 0 0 0 rg BT 147.05 641.25 Td (study ) Tj ET Q q 0 0 0 rg BT 170.93 641.25 Td (results\), ) Tj ET Q q 0 0 0 rg BT 205.08 641.25 Td (plus ) Tj ET Q q 0 0 0 rg BT 223.97 641.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 266.17 641.25 Td (aggregate ) Tj ET Q q 0 0 0 rg BT 307.25 641.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 363.33 641.25 Td (of ) Tj ET Q q 0 0 0 rg BT 373.88 641.25 Td (up ) Tj ET Q q 0 0 0 rg BT 386.09 641.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.08 641.25 Td ($800 ) Tj ET Q q 0 0 0 rg BT 418.29 641.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 447.19 641.25 Td ( ) Tj ET Q q 0 0 0 rg BT 449.40 641.25 Td (for ) Tj ET Q q 0 0 0 rg BT 463.27 641.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 507.70 641.25 Td (development ) Tj ET Q q 0 0 0 rg BT 561.56 641.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.59 629.25 Td (approval ) Tj ET Q q 0 0 0 rg BT 117.08 629.25 Td (milestone ) Tj ET Q q 0 0 0 rg BT 158.46 629.25 Td (payments ) Tj ET Q q 0 0 0 rg BT 199.29 629.25 Td (in ) Tj ET Q q 0 0 0 rg BT 209.56 629.25 Td (the ) Tj ET Q q 0 0 0 rg BT 224.28 629.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 244.56 629.25 Td (and ) Tj ET Q q 0 0 0 rg BT 261.50 629.25 Td (Europe.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 603.68505859375 m 82.9189453125 603.68505859375 l s q 0 0 0 rg BT 36.00 605.25 Td (Five ) Tj ET Q q 0 0 0 rg BT 56.83 605.25 Td (Prime) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.24 581.25 Td (November ) Tj ET Q q 0 0 0 rg BT 90.35 581.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 114.76 581.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 137.79 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 154.13 581.25 Td (Five ) Tj ET Q q 0 0 0 rg BT 173.82 581.25 Td (Prime ) Tj ET Q q 0 0 0 rg BT 199.61 581.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 230.94 581.25 Td (into ) Tj ET Q q 0 0 0 rg BT 248.40 581.25 Td (an ) Tj ET Q q 0 0 0 rg BT 259.75 581.25 Td (exclusive ) Tj ET Q q 0 0 0 rg BT 299.42 581.25 Td (worldwide ) Tj ET Q q 0 0 0 rg BT 344.10 581.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 382.11 581.25 Td (and ) Tj ET Q q 0 0 0 rg BT 398.45 581.25 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 453.12 581.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 496.66 581.25 Td (for ) Tj ET Q q 0 0 0 rg BT 510.23 581.25 Td (the ) Tj ET Q q 0 0 0 rg BT 524.35 581.25 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 569.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.34 569.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 128.65 569.25 Td (of ) Tj ET Q q 0 0 0 rg BT 138.89 569.25 Td (Five ) Tj ET Q q 0 0 0 rg BT 158.57 569.25 Td (Prime’) Tj ET Q q 0 0 0 rg BT 185.23 569.25 Td (s ) Tj ET Q q 0 0 0 rg BT 191.03 569.25 Td (CSF1R ) Tj ET Q q 0 0 0 rg BT 222.40 569.25 Td (antibody ) Tj ET Q q 0 0 0 rg BT 259.29 569.25 Td (program, ) Tj ET Q q 0 0 0 rg BT 297.57 569.25 Td (including ) Tj ET Q q 0 0 0 rg BT 337.25 569.25 Td (cabiralizumab ) Tj ET Q q 0 0 0 rg BT 395.79 569.25 Td (\(FP) Tj ET Q q 0 0 0 rg BT 409.33 569.25 Td (A008\) ) Tj ET Q q 0 0 0 rg BT 436.78 569.25 Td (currently ) Tj ET Q q 0 0 0 rg BT 474.78 569.25 Td (in ) Tj ET Q q 0 0 0 rg BT 484.46 569.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 509.69 569.25 Td (I/II ) Tj ET Q q 0 0 0 rg BT 524.36 569.25 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (for ) Tj ET Q q 0 0 0 rg BT 51.26 557.25 Td (immunology ) Tj ET Q q 0 0 0 rg BT 105.98 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 124.02 557.25 Td (oncology ) Tj ET Q q 0 0 0 rg BT 164.83 557.25 Td (indications. ) Tj ET Q q 0 0 0 rg BT 214.82 557.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 239.54 557.25 Td (will ) Tj ET Q q 0 0 0 rg BT 258.70 557.25 Td (be ) Tj ET Q q 0 0 0 rg BT 271.74 557.25 Td (responsible ) Tj ET Q q 0 0 0 rg BT 320.89 557.25 Td (for ) Tj ET Q q 0 0 0 rg BT 336.15 557.25 Td (the ) Tj ET Q q 0 0 0 rg BT 351.96 557.25 Td (development, ) Tj ET Q q 0 0 0 rg BT 409.72 557.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 471.63 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 489.67 557.25 Td (commercialization ) Tj ET Q q 0 0 0 rg BT 567.68 557.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td (cabiralizumab, ) Tj ET Q q 0 0 0 rg BT 97.24 545.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 127.67 545.25 Td (to ) Tj ET Q q 0 0 0 rg BT 137.55 545.25 Td (Five ) Tj ET Q q 0 0 0 rg BT 157.43 545.25 Td (Prime’) Tj ET Q q 0 0 0 rg BT 184.10 545.25 Td (s ) Tj ET Q q 0 0 0 rg BT 190.09 545.25 Td (option ) Tj ET Q q 0 0 0 rg BT 217.75 545.25 Td (to ) Tj ET Q q 0 0 0 rg BT 227.63 545.25 Td (conduct ) Tj ET Q q 0 0 0 rg BT 261.39 545.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 290.70 545.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 320.58 545.25 Td (at ) Tj ET Q q 0 0 0 rg BT 329.90 545.25 Td (its ) Tj ET Q q 0 0 0 rg BT 341.45 545.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 359.66 545.25 Td (to ) Tj ET Q q 0 0 0 rg BT 369.55 545.25 Td (develop ) Tj ET Q q 0 0 0 rg BT 403.30 545.25 Td (cabiralizumab ) Tj ET Q q 0 0 0 rg BT 462.04 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 471.93 545.25 Td (PVNS ) Tj ET Q q 0 0 0 rg BT 499.60 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 516.14 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 526.02 545.25 Td (combination ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (with ) Tj ET Q q 0 0 0 rg BT 56.59 533.25 Td (its ) Tj ET Q q 0 0 0 rg BT 68.84 533.25 Td (own ) Tj ET Q q 0 0 0 rg BT 88.87 533.25 Td (internal ) Tj ET Q q 0 0 0 rg BT 122.22 533.25 Td (oncology ) Tj ET Q q 0 0 0 rg BT 162.25 533.25 Td (pipeline ) Tj ET Q q 0 0 0 rg BT 197.26 533.25 Td (assets. ) Tj ET Q q 0 0 0 rg BT 225.90 533.25 Td (Five ) Tj ET Q q 0 0 0 rg BT 246.49 533.25 Td (Prime ) Tj ET Q q 0 0 0 rg BT 273.18 533.25 Td (also ) Tj ET Q q 0 0 0 rg BT 292.10 533.25 Td (retained ) Tj ET Q q 0 0 0 rg BT 327.11 533.25 Td (an ) Tj ET Q q 0 0 0 rg BT 339.35 533.25 Td (option ) Tj ET Q q 0 0 0 rg BT 367.72 533.25 Td (to ) Tj ET Q q 0 0 0 rg BT 378.30 533.25 Td (co-promote ) Tj ET Q q 0 0 0 rg BT 427.21 533.25 Td (in ) Tj ET Q q 0 0 0 rg BT 437.79 533.25 Td (the ) Tj ET Q q 0 0 0 rg BT 452.82 533.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 473.20 533.25 Td (The ) Tj ET Q q 0 0 0 rg BT 491.56 533.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 536.01 533.25 Td (replaces ) Tj ET Q q 0 0 0 rg BT 571.57 533.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (previous ) Tj ET Q q 0 0 0 rg BT 72.94 521.25 Td (clinical ) Tj ET Q q 0 0 0 rg BT 104.87 521.25 Td (collaboration ) Tj ET Q q 0 0 0 rg BT 160.13 521.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 204.27 521.25 Td (between ) Tj ET Q q 0 0 0 rg BT 240.08 521.25 Td (the ) Tj ET Q q 0 0 0 rg BT 254.80 521.25 Td (two ) Tj ET Q q 0 0 0 rg BT 272.30 521.25 Td (parties.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.42 497.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 102.39 497.25 Td (for ) Tj ET Q q 0 0 0 rg BT 116.14 497.25 Td (licensing ) Tj ET Q q 0 0 0 rg BT 154.34 497.25 Td (rights, ) Tj ET Q q 0 0 0 rg BT 181.71 497.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 204.93 497.25 Td (made ) Tj ET Q q 0 0 0 rg BT 228.68 497.25 Td (an ) Tj ET Q q 0 0 0 rg BT 240.21 497.25 Td (upfront ) Tj ET Q q 0 0 0 rg BT 271.74 497.25 Td (payment ) Tj ET Q q 0 0 0 rg BT 308.27 497.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.69 497.25 Td ($350 ) Tj ET Q q 0 0 0 rg BT 340.79 497.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 369.68 497.25 Td ( ) Tj ET Q q 0 0 0 rg BT 371.77 497.25 Td (in ) Tj ET Q q 0 0 0 rg BT 381.65 497.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 403.74 497.25 Td (which ) Tj ET Q q 0 0 0 rg BT 430.27 497.25 Td (was ) Tj ET Q q 0 0 0 rg BT 447.92 497.25 Td (included ) Tj ET Q q 0 0 0 rg BT 484.44 497.25 Td (in ) Tj ET Q q 0 0 0 rg BT 494.32 497.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 518.08 497.25 Td (expense. ) Tj ET Q q 0 0 0 rg BT 554.88 497.25 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.25 Td (will ) Tj ET Q q 0 0 0 rg BT 54.19 485.25 Td (also ) Tj ET Q q 0 0 0 rg BT 72.94 485.25 Td (be ) Tj ET Q q 0 0 0 rg BT 85.02 485.25 Td (committed ) Tj ET Q q 0 0 0 rg BT 130.42 485.25 Td (to ) Tj ET Q q 0 0 0 rg BT 140.84 485.25 Td (pay ) Tj ET Q q 0 0 0 rg BT 157.92 485.25 Td (up ) Tj ET Q q 0 0 0 rg BT 170.56 485.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 180.97 485.25 Td ($1.4 ) Tj ET Q q 0 0 0 rg BT 201.11 485.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.22 485.25 Td ( ) Tj ET Q q 0 0 0 rg BT 229.86 485.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 252.50 485.25 Td (the ) Tj ET Q q 0 0 0 rg BT 267.36 485.25 Td (achievement ) Tj ET Q q 0 0 0 rg BT 320.52 485.25 Td (of ) Tj ET Q q 0 0 0 rg BT 331.49 485.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 376.34 485.25 Td (development ) Tj ET Q q 0 0 0 rg BT 430.63 485.25 Td (and ) Tj ET Q q 0 0 0 rg BT 447.70 485.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 491.44 485.25 Td (milestones ) Tj ET Q q 0 0 0 rg BT 536.85 485.25 Td (as ) Tj ET Q q 0 0 0 rg BT 547.82 485.25 Td (well ) Tj ET Q q 0 0 0 rg BT 567.67 485.25 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.25 Td (future ) Tj ET Q q 0 0 0 rg BT 62.38 473.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 99.31 473.25 Td (if ) Tj ET Q q 0 0 0 rg BT 107.92 473.25 Td (the ) Tj ET Q q 0 0 0 rg BT 122.64 473.25 Td (product ) Tj ET Q q 0 0 0 rg BT 155.68 473.25 Td (is ) Tj ET Q q 0 0 0 rg BT 164.85 473.25 Td (approved ) Tj ET Q q 0 0 0 rg BT 204.56 473.25 Td (and ) Tj ET Q q 0 0 0 rg BT 221.50 473.25 Td (commercialized.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 447.68505859375 m 67.0986328125 447.68505859375 l s q 0 0 0 rg BT 36.00 449.25 Td (Reckitt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.67 425.25 Td (May ) Tj ET Q q 0 0 0 rg BT 69.34 425.25 Td (2013, ) Tj ET Q q 0 0 0 rg BT 95.18 425.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 119.65 425.25 Td (and ) Tj ET Q q 0 0 0 rg BT 137.43 425.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 169.65 425.25 Td (started ) Tj ET Q q 0 0 0 rg BT 199.65 425.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 207.43 425.25 Td (three) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.41 425.25 Td (-year ) Tj ET Q q 0 0 0 rg BT 251.29 425.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 285.72 425.25 Td (for ) Tj ET Q q 0 0 0 rg BT 300.72 425.25 Td (several ) Tj ET Q q 0 0 0 rg BT 332.38 425.25 Td (OTC ) Tj ET Q q 0 0 0 rg BT 355.72 425.25 Td (products ) Tj ET Q q 0 0 0 rg BT 393.50 425.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 413.51 425.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 454.07 425.25 Td (in ) Tj ET Q q 0 0 0 rg BT 465.19 425.25 Td (Mexico ) Tj ET Q q 0 0 0 rg BT 499.07 425.25 Td (and ) Tj ET Q q 0 0 0 rg BT 516.85 425.25 Td (Brazil. ) Tj ET Q q 0 0 0 rg BT 547.13 425.25 Td (Reckitt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (received ) Tj ET Q q 0 0 0 rg BT 72.22 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 86.79 413.25 Td (right ) Tj ET Q q 0 0 0 rg BT 108.03 413.25 Td (to ) Tj ET Q q 0 0 0 rg BT 118.16 413.25 Td (sell, ) Tj ET Q q 0 0 0 rg BT 136.91 413.25 Td (distribute ) Tj ET Q q 0 0 0 rg BT 177.03 413.25 Td (and ) Tj ET Q q 0 0 0 rg BT 193.83 413.25 Td (market ) Tj ET Q q 0 0 0 rg BT 223.95 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 238.52 413.25 Td (products ) Tj ET Q q 0 0 0 rg BT 275.31 413.25 Td (through ) Tj ET Q q 0 0 0 rg BT 308.77 413.25 Td (May ) Tj ET Q q 0 0 0 rg BT 329.46 413.25 Td (2016. ) Tj ET Q q 0 0 0 rg BT 354.31 413.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 377.79 413.25 Td (received ) Tj ET Q q 0 0 0 rg BT 414.01 413.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 450.80 413.25 Td (on ) Tj ET Q q 0 0 0 rg BT 463.15 413.25 Td (net ) Tj ET Q q 0 0 0 rg BT 477.73 413.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 499.52 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 510.20 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 524.78 413.25 Td (products ) Tj ET Q q 0 0 0 rg BT 561.57 413.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 84.83 401.25 Td (supplied ) Tj ET Q q 0 0 0 rg BT 122.00 401.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 152.49 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 164.10 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 179.60 401.25 Td (products ) Tj ET Q q 0 0 0 rg BT 217.33 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 228.39 401.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 260.56 401.25 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 298.28 401.25 Td (to ) Tj ET Q q 0 0 0 rg BT 309.34 401.25 Td (a ) Tj ET Q q 0 0 0 rg BT 317.07 401.25 Td (supply ) Tj ET Q q 0 0 0 rg BT 347.02 401.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 391.95 401.25 Td (at ) Tj ET Q q 0 0 0 rg BT 402.45 401.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 421.84 401.25 Td (plus ) Tj ET Q q 0 0 0 rg BT 441.80 401.25 Td (a ) Tj ET Q q 0 0 0 rg BT 449.52 401.25 Td (markup. ) Tj ET Q q 0 0 0 rg BT 485.86 401.25 Td (Certain ) Tj ET Q q 0 0 0 rg BT 518.57 401.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 550.19 401.25 Td (assets, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (including ) Tj ET Q q 0 0 0 rg BT 76.61 389.25 Td (marketing ) Tj ET Q q 0 0 0 rg BT 119.98 389.25 Td (authorizations ) Tj ET Q q 0 0 0 rg BT 179.47 389.25 Td (and ) Tj ET Q q 0 0 0 rg BT 196.74 389.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 226.78 389.25 Td (employees ) Tj ET Q q 0 0 0 rg BT 272.38 389.25 Td (directly ) Tj ET Q q 0 0 0 rg BT 305.75 389.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 346.91 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 357.52 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 372.57 389.25 Td (business, ) Tj ET Q q 0 0 0 rg BT 411.80 389.25 Td (were ) Tj ET Q q 0 0 0 rg BT 434.06 389.25 Td (transferred ) Tj ET Q q 0 0 0 rg BT 480.20 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 490.81 389.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 522.53 389.25 Td (at ) Tj ET Q q 0 0 0 rg BT 532.58 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 547.63 389.25 Td (start ) Tj ET Q q 0 0 0 rg BT 567.68 389.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 377.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 84.31 377.25 Td (period. ) Tj ET Q q 0 0 0 rg BT 114.85 377.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 138.48 377.25 Td (retained ) Tj ET Q q 0 0 0 rg BT 173.18 377.25 Td (ownership ) Tj ET Q q 0 0 0 rg BT 217.34 377.25 Td (of ) Tj ET Q q 0 0 0 rg BT 228.17 377.25 Td (all ) Tj ET Q q 0 0 0 rg BT 240.66 377.25 Td (other ) Tj ET Q q 0 0 0 rg BT 263.71 377.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 289.54 377.25 Td (related ) Tj ET Q q 0 0 0 rg BT 319.24 377.25 Td (to ) Tj ET Q q 0 0 0 rg BT 329.52 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 344.24 377.25 Td (business ) Tj ET Q q 0 0 0 rg BT 380.63 377.25 Td (including ) Tj ET Q q 0 0 0 rg BT 420.90 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 435.62 377.25 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 482.54 377.25 Td (covering ) Tj ET Q q 0 0 0 rg BT 520.03 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 534.75 377.25 Td (products.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.84 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 63.56 353.25 Td (framework ) Tj ET Q q 0 0 0 rg BT 110.94 353.25 Td (of ) Tj ET Q q 0 0 0 rg BT 122.78 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 138.50 353.25 Td (alliance, ) Tj ET Q q 0 0 0 rg BT 175.60 353.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 200.23 353.25 Td (also ) Tj ET Q q 0 0 0 rg BT 219.85 353.25 Td (granted ) Tj ET Q q 0 0 0 rg BT 253.34 353.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 285.73 353.25 Td (an ) Tj ET Q q 0 0 0 rg BT 298.68 353.25 Td (option ) Tj ET Q q 0 0 0 rg BT 327.74 353.25 Td (to ) Tj ET Q q 0 0 0 rg BT 339.03 353.25 Td (acquire ) Tj ET Q q 0 0 0 rg BT 371.96 353.25 Td (the ) Tj ET Q q 0 0 0 rg BT 387.69 353.25 Td (trademarks, ) Tj ET Q q 0 0 0 rg BT 438.12 353.25 Td (inventory ) Tj ET Q q 0 0 0 rg BT 479.95 353.25 Td (and ) Tj ET Q q 0 0 0 rg BT 497.90 353.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 528.61 353.25 Td (other ) Tj ET Q q 0 0 0 rg BT 552.67 353.25 Td (assets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 84.16 341.25 Td (related ) Tj ET Q q 0 0 0 rg BT 113.98 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 124.37 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 139.21 341.25 Td (products ) Tj ET Q q 0 0 0 rg BT 176.26 341.25 Td (at ) Tj ET Q q 0 0 0 rg BT 186.10 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 200.93 341.25 Td (end ) Tj ET Q q 0 0 0 rg BT 217.99 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 228.93 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 243.77 341.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 277.47 341.25 Td (period ) Tj ET Q q 0 0 0 rg BT 305.64 341.25 Td (at ) Tj ET Q q 0 0 0 rg BT 315.47 341.25 Td (a ) Tj ET Q q 0 0 0 rg BT 322.53 341.25 Td (price ) Tj ET Q q 0 0 0 rg BT 345.13 341.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 392.73 341.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 432.56 341.25 Td (based ) Tj ET Q q 0 0 0 rg BT 457.94 341.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 480.56 341.25 Td (a ) Tj ET Q q 0 0 0 rg BT 487.62 341.25 Td (multiple ) Tj ET Q q 0 0 0 rg BT 523.56 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 534.51 341.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 556.57 341.25 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (May ) Tj ET Q q 0 0 0 rg BT 56.43 329.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 78.52 329.25 Td (through ) Tj ET Q q 0 0 0 rg BT 111.73 329.25 Td (May ) Tj ET Q q 0 0 0 rg BT 132.16 329.25 Td (2016. ) Tj ET Q q 0 0 0 rg BT 156.75 329.25 Td (In ) Tj ET Q q 0 0 0 rg BT 166.72 329.25 Td (April ) Tj ET Q q 0 0 0 rg BT 189.92 329.25 Td (2014, ) Tj ET Q q 0 0 0 rg BT 214.52 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 228.84 329.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 262.02 329.25 Td (was ) Tj ET Q q 0 0 0 rg BT 279.67 329.25 Td (modified ) Tj ET Q q 0 0 0 rg BT 317.87 329.25 Td (to ) Tj ET Q q 0 0 0 rg BT 327.75 329.25 Td (provide ) Tj ET Q q 0 0 0 rg BT 360.39 329.25 Td (an ) Tj ET Q q 0 0 0 rg BT 371.93 329.25 Td (option ) Tj ET Q q 0 0 0 rg BT 399.58 329.25 Td (to ) Tj ET Q q 0 0 0 rg BT 409.46 329.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 440.43 329.25 Td (to ) Tj ET Q q 0 0 0 rg BT 450.31 329.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 487.94 329.25 Td (a ) Tj ET Q q 0 0 0 rg BT 494.48 329.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 517.70 329.25 Td (manufacturing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 317.25 Td (facility ) Tj ET Q q 0 0 0 rg BT 67.32 317.25 Td (located ) Tj ET Q q 0 0 0 rg BT 99.19 317.25 Td (in ) Tj ET Q q 0 0 0 rg BT 109.96 317.25 Td (Mexico ) Tj ET Q q 0 0 0 rg BT 143.51 317.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 183.72 317.25 Td (dedicated ) Tj ET Q q 0 0 0 rg BT 225.03 317.25 Td (to ) Tj ET Q q 0 0 0 rg BT 235.80 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 251.02 317.25 Td (products ) Tj ET Q q 0 0 0 rg BT 288.46 317.25 Td (included ) Tj ET Q q 0 0 0 rg BT 325.89 317.25 Td (in ) Tj ET Q q 0 0 0 rg BT 336.66 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 351.88 317.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 385.97 317.25 Td (as ) Tj ET Q q 0 0 0 rg BT 397.29 317.25 Td (well ) Tj ET Q q 0 0 0 rg BT 417.51 317.25 Td (as ) Tj ET Q q 0 0 0 rg BT 428.84 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 444.05 317.25 Td (related ) Tj ET Q q 0 0 0 rg BT 474.25 317.25 Td (employees. ) Tj ET Q q 0 0 0 rg BT 522.51 317.25 Td (In ) Tj ET Q q 0 0 0 rg BT 533.84 317.25 Td (July ) Tj ET Q q 0 0 0 rg BT 553.51 317.25 Td (2015, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 68.39 305.25 Td (notified ) Tj ET Q q 0 0 0 rg BT 102.99 305.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 127.62 305.25 Td (that ) Tj ET Q q 0 0 0 rg BT 146.12 305.25 Td (it ) Tj ET Q q 0 0 0 rg BT 155.18 305.25 Td (was ) Tj ET Q q 0 0 0 rg BT 174.23 305.25 Td (exercising ) Tj ET Q q 0 0 0 rg BT 218.83 305.25 Td (its ) Tj ET Q q 0 0 0 rg BT 231.78 305.25 Td (option. ) Tj ET Q q 0 0 0 rg BT 263.34 305.25 Td (In ) Tj ET Q q 0 0 0 rg BT 275.17 305.25 Td (May ) Tj ET Q q 0 0 0 rg BT 297.01 305.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 323.01 305.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 347.64 305.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 367.81 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 383.53 305.25 Td (business ) Tj ET Q q 0 0 0 rg BT 420.93 305.25 Td (for ) Tj ET Q q 0 0 0 rg BT 436.09 305.25 Td ($317 ) Tj ET Q q 0 0 0 rg BT 459.59 305.25 Td (million. ) Tj ET Q q 0 0 0 rg BT 494.49 305.25 Td (Refer ) Tj ET Q q 0 0 0 rg BT 520.20 305.25 Td (to ) Tj ET Q q 0 0 0 rg BT 531.48 305.25 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 568.50 305.25 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.50 305.25 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 293.25 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 89.06 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 106.00 293.25 Td (Divestitures” ) Tj ET Q q 0 0 0 rg BT 161.26 293.25 Td (for ) Tj ET Q q 0 0 0 rg BT 175.42 293.25 Td (further ) Tj ET Q q 0 0 0 rg BT 205.13 293.25 Td (information.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 271.65 Td (Non-refundable ) Tj ET Q q 0 0 0 rg BT 102.43 271.65 Td (upfront ) Tj ET Q q 0 0 0 rg BT 134.99 271.65 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 173.65 271.65 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.10 271.65 Td ($485 ) Tj ET Q q 0 0 0 rg BT 208.22 271.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 237.11 271.65 Td ( ) Tj ET Q q 0 0 0 rg BT 240.23 271.65 Td (received ) Tj ET Q q 0 0 0 rg BT 277.22 271.65 Td (by ) Tj ET Q q 0 0 0 rg BT 290.34 271.65 Td (BMS ) Tj ET Q q 0 0 0 rg BT 314.58 271.65 Td (in ) Tj ET Q q 0 0 0 rg BT 325.48 271.65 Td (2013 ) Tj ET Q q 0 0 0 rg BT 348.60 271.65 Td (were ) Tj ET Q q 0 0 0 rg BT 371.15 271.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 410.36 271.65 Td (to ) Tj ET Q q 0 0 0 rg BT 421.26 271.65 Td (two ) Tj ET Q q 0 0 0 rg BT 439.39 271.65 Td (units ) Tj ET Q q 0 0 0 rg BT 461.96 271.65 Td (of ) Tj ET Q q 0 0 0 rg BT 473.41 271.65 Td (accounting, ) Tj ET Q q 0 0 0 rg BT 522.90 271.65 Td (including ) Tj ET Q q 0 0 0 rg BT 563.80 271.65 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 259.65 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.35 259.65 Td (transferred ) Tj ET Q q 0 0 0 rg BT 107.22 259.65 Td (to ) Tj ET Q q 0 0 0 rg BT 117.56 259.65 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 149.01 259.65 Td (and ) Tj ET Q q 0 0 0 rg BT 166.02 259.65 Td (the ) Tj ET Q q 0 0 0 rg BT 180.80 259.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 197.25 259.65 Td (value ) Tj ET Q q 0 0 0 rg BT 221.47 259.65 Td (of ) Tj ET Q q 0 0 0 rg BT 232.37 259.65 Td (the ) Tj ET Q q 0 0 0 rg BT 247.15 259.65 Td (option ) Tj ET Q q 0 0 0 rg BT 275.28 259.65 Td (to ) Tj ET Q q 0 0 0 rg BT 285.62 259.65 Td (purchase ) Tj ET Q q 0 0 0 rg BT 323.73 259.65 Td (the ) Tj ET Q q 0 0 0 rg BT 338.51 259.65 Td (remaining ) Tj ET Q q 0 0 0 rg BT 381.62 259.65 Td (assets ) Tj ET Q q 0 0 0 rg BT 407.52 259.65 Td (using ) Tj ET Q q 0 0 0 rg BT 431.75 259.65 Td (the ) Tj ET Q q 0 0 0 rg BT 446.54 259.65 Td (best ) Tj ET Q q 0 0 0 rg BT 465.21 259.65 Td (estimate ) Tj ET Q q 0 0 0 rg BT 501.10 259.65 Td (of ) Tj ET Q q 0 0 0 rg BT 512.00 259.65 Td (the ) Tj ET Q q 0 0 0 rg BT 526.78 259.65 Td (selling ) Tj ET Q q 0 0 0 rg BT 556.02 259.65 Td (price ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 247.65 Td (for ) Tj ET Q q 0 0 0 rg BT 49.86 247.65 Td (these ) Tj ET Q q 0 0 0 rg BT 72.61 247.65 Td (elements ) Tj ET Q q 0 0 0 rg BT 110.35 247.65 Td (after ) Tj ET Q q 0 0 0 rg BT 130.86 247.65 Td (considering ) Tj ET Q q 0 0 0 rg BT 179.72 247.65 Td (various ) Tj ET Q q 0 0 0 rg BT 211.36 247.65 Td (market ) Tj ET Q q 0 0 0 rg BT 241.32 247.65 Td (factors. ) Tj ET Q q 0 0 0 rg BT 273.07 247.65 Td (These ) Tj ET Q q 0 0 0 rg BT 299.14 247.65 Td (market ) Tj ET Q q 0 0 0 rg BT 329.11 247.65 Td (factors ) Tj ET Q q 0 0 0 rg BT 358.51 247.65 Td (included ) Tj ET Q q 0 0 0 rg BT 395.15 247.65 Td (an ) Tj ET Q q 0 0 0 rg BT 406.79 247.65 Td (analysis ) Tj ET Q q 0 0 0 rg BT 441.20 247.65 Td (of ) Tj ET Q q 0 0 0 rg BT 451.73 247.65 Td (any ) Tj ET Q q 0 0 0 rg BT 468.37 247.65 Td (estimated ) Tj ET Q q 0 0 0 rg BT 508.89 247.65 Td (excess ) Tj ET Q q 0 0 0 rg BT 537.19 247.65 Td (of ) Tj ET Q q 0 0 0 rg BT 547.72 247.65 Td (the ) Tj ET Q q 0 0 0 rg BT 562.13 247.65 Td (fair ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 235.65 Td (value ) Tj ET Q q 0 0 0 rg BT 59.86 235.65 Td (of ) Tj ET Q q 0 0 0 rg BT 70.39 235.65 Td (the ) Tj ET Q q 0 0 0 rg BT 84.81 235.65 Td (business ) Tj ET Q q 0 0 0 rg BT 120.90 235.65 Td (over ) Tj ET Q q 0 0 0 rg BT 140.87 235.65 Td (the ) Tj ET Q q 0 0 0 rg BT 155.29 235.65 Td (potential ) Tj ET Q q 0 0 0 rg BT 192.48 235.65 Td (purchase ) Tj ET Q q 0 0 0 rg BT 230.22 235.65 Td (price ) Tj ET Q q 0 0 0 rg BT 252.40 235.65 Td (if ) Tj ET Q q 0 0 0 rg BT 260.71 235.65 Td (the ) Tj ET Q q 0 0 0 rg BT 275.13 235.65 Td (option ) Tj ET Q q 0 0 0 rg BT 302.89 235.65 Td (is ) Tj ET Q q 0 0 0 rg BT 311.76 235.65 Td (exercised. ) Tj ET Q q 0 0 0 rg BT 354.05 235.65 Td (The ) Tj ET Q q 0 0 0 rg BT 371.80 235.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 387.88 235.65 Td (value ) Tj ET Q q 0 0 0 rg BT 411.74 235.65 Td (of ) Tj ET Q q 0 0 0 rg BT 422.27 235.65 Td (the ) Tj ET Q q 0 0 0 rg BT 436.69 235.65 Td (option ) Tj ET Q q 0 0 0 rg BT 464.44 235.65 Td (was ) Tj ET Q q 0 0 0 rg BT 482.20 235.65 Td (determined ) Tj ET Q q 0 0 0 rg BT 529.38 235.65 Td (using ) Tj ET Q q 0 0 0 rg BT 553.25 235.65 Td (Level ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 223.65 Td (3 ) Tj ET Q q 0 0 0 rg BT 43.73 223.65 Td (inputs ) Tj ET Q q 0 0 0 rg BT 70.92 223.65 Td (and ) Tj ET Q q 0 0 0 rg BT 88.09 223.65 Td (included ) Tj ET Q q 0 0 0 rg BT 125.25 223.65 Td (in ) Tj ET Q q 0 0 0 rg BT 135.77 223.65 Td (other ) Tj ET Q q 0 0 0 rg BT 159.05 223.65 Td (liabilities. ) Tj ET Q q 0 0 0 rg BT 201.50 223.65 Td (During ) Tj ET Q q 0 0 0 rg BT 232.56 223.65 Td (2015, ) Tj ET Q q 0 0 0 rg BT 257.79 223.65 Td (BMS ) Tj ET Q q 0 0 0 rg BT 281.65 223.65 Td (recognized ) Tj ET Q q 0 0 0 rg BT 328.25 223.65 Td (other ) Tj ET Q q 0 0 0 rg BT 351.53 223.65 Td (income ) Tj ET Q q 0 0 0 rg BT 383.69 223.65 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.76 223.65 Td ($123 ) Tj ET Q q 0 0 0 rg BT 417.49 223.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.38 223.65 Td ( ) Tj ET Q q 0 0 0 rg BT 449.11 223.65 Td (to ) Tj ET Q q 0 0 0 rg BT 459.63 223.65 Td (decrease ) Tj ET Q q 0 0 0 rg BT 496.77 223.65 Td (the ) Tj ET Q q 0 0 0 rg BT 511.72 223.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 528.33 223.65 Td (value ) Tj ET Q q 0 0 0 rg BT 552.72 223.65 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 223.65 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 211.65 Td (option ) Tj ET Q q 0 0 0 rg BT 63.53 211.65 Td (to ) Tj ET Q q 0 0 0 rg BT 73.28 211.65 Td (zero ) Tj ET Q q 0 0 0 rg BT 92.46 211.65 Td (due ) Tj ET Q q 0 0 0 rg BT 108.87 211.65 Td (to ) Tj ET Q q 0 0 0 rg BT 118.62 211.65 Td (the ) Tj ET Q q 0 0 0 rg BT 132.81 211.65 Td (strengthening ) Tj ET Q q 0 0 0 rg BT 189.21 211.65 Td (of ) Tj ET Q q 0 0 0 rg BT 199.51 211.65 Td (the ) Tj ET Q q 0 0 0 rg BT 213.70 211.65 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 233.46 211.65 Td (dollar ) Tj ET Q q 0 0 0 rg BT 258.75 211.65 Td (against ) Tj ET Q q 0 0 0 rg BT 289.05 211.65 Td (local ) Tj ET Q q 0 0 0 rg BT 310.46 211.65 Td (currencies. ) Tj ET Q q 0 0 0 rg BT 355.87 211.65 Td (The ) Tj ET Q q 0 0 0 rg BT 373.39 211.65 Td (amount ) Tj ET Q q 0 0 0 rg BT 405.35 211.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 443.41 211.65 Td (to ) Tj ET Q q 0 0 0 rg BT 453.16 211.65 Td (the ) Tj ET Q q 0 0 0 rg BT 467.35 211.65 Td (rights ) Tj ET Q q 0 0 0 rg BT 492.10 211.65 Td (transferred ) Tj ET Q q 0 0 0 rg BT 537.38 211.65 Td (to ) Tj ET Q q 0 0 0 rg BT 547.13 211.65 Td (Reckitt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 199.65 Td (is ) Tj ET Q q 0 0 0 rg BT 45.17 199.65 Td (amortized ) Tj ET Q q 0 0 0 rg BT 87.65 199.65 Td (as ) Tj ET Q q 0 0 0 rg BT 98.48 199.65 Td (alliance ) Tj ET Q q 0 0 0 rg BT 132.07 199.65 Td (revenue ) Tj ET Q q 0 0 0 rg BT 166.21 199.65 Td (over ) Tj ET Q q 0 0 0 rg BT 186.48 199.65 Td (the ) Tj ET Q q 0 0 0 rg BT 201.20 199.65 Td (contractual ) Tj ET Q q 0 0 0 rg BT 248.12 199.65 Td (term. ) Tj ET Q endstream endobj 147 0 obj <> endobj 148 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (73) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 749.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 749.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 749.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 749.10 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 749.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 749.10 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 749.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 749.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 714.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 714.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 714.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 686.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 686.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 686.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 686.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 658.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 658.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 658.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 658.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 658.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 658.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 658.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 630.60 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 630.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 630.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 630.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 630.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 630.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 630.60 60.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 726.6 m 448.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 726.6 m 452.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 726.6 m 512.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 726.6 m 516.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 714.6 m 448.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 726.6 m 512.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 714.6 m 512.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 714.6 m 576.5 714.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 714.6 m 512.5 714.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 730.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 730.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 718.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 718.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 718.68 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 705.33 Td (Revenues from Reckitt alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 691.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 691.17 Td (48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 691.17 Td (140) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 691.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 691.17 Td (170) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 663.17 Td (Other \(income\)/expense – Divestiture gain) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 663.17 Td (277) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 663.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 663.17 Td (—) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 635.33 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 621.17 Td (Other changes in operating assets and liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 621.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 621.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 621.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.30 621.22 Td (\(129) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.65 621.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 621.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 621.17 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 607.17 Td (Divestiture and other proceeds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 607.17 Td (317) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 607.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 607.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 566.60 412.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 566.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 566.60 60.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 566.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 566.60 60.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 579.6 m 512.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 579.6 m 516.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 579.6 m 576.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 566.6 m 512.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 566.6 m 576.5 566.6 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 583.33 Td (Selected Alliance Balance Sheet Information:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.75 583.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 570.85 Td (Dollars ) Tj ET Q q 0 0 0 rg BT 64.55 570.85 Td (in ) Tj ET Q q 0 0 0 rg BT 72.77 570.85 Td (Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 570.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 570.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 557.17 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 557.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 557.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 557.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 557.17 Td (36) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 528.53505859375 m 142.669921875 528.53505859375 l s q 0 0 0 rg BT 36.00 530.10 Td (The Medicines Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 506.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.79 506.10 Td (February ) Tj ET Q q 0 0 0 rg BT 85.36 506.10 Td (2013, ) Tj ET Q q 0 0 0 rg BT 110.32 506.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 133.91 506.10 Td (and ) Tj ET Q q 0 0 0 rg BT 150.64 506.10 Td (The ) Tj ET Q q 0 0 0 rg BT 168.65 506.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 212.77 506.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 254.12 506.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 286.01 506.10 Td (into ) Tj ET Q q 0 0 0 rg BT 304.03 506.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.93 506.10 Td (two) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.93 506.10 Td (-year ) Tj ET Q q 0 0 0 rg BT 348.94 506.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 382.49 506.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 396.61 506.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 427.90 506.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.12 506.10 Td (, ) Tj ET Q q 0 0 0 rg BT 450.08 506.10 Td (a ) Tj ET Q q 0 0 0 rg BT 456.99 506.10 Td (recombinant ) Tj ET Q q 0 0 0 rg BT 509.43 506.10 Td (thrombin ) Tj ET Q q 0 0 0 rg BT 548.56 506.10 Td (for ) Tj ET Q q 0 0 0 rg BT 562.69 506.10 Td (use ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.10 Td (as ) Tj ET Q q 0 0 0 rg BT 47.40 494.10 Td (a ) Tj ET Q q 0 0 0 rg BT 54.92 494.10 Td (topical ) Tj ET Q q 0 0 0 rg BT 85.20 494.10 Td (hemostat ) Tj ET Q q 0 0 0 rg BT 124.38 494.10 Td (to ) Tj ET Q q 0 0 0 rg BT 135.23 494.10 Td (control ) Tj ET Q q 0 0 0 rg BT 166.63 494.10 Td (non-arterial ) Tj ET Q q 0 0 0 rg BT 216.34 494.10 Td (bleeding ) Tj ET Q q 0 0 0 rg BT 253.85 494.10 Td (during ) Tj ET Q q 0 0 0 rg BT 283.03 494.10 Td (sur) Tj ET Q q 0 0 0 rg BT 295.07 494.10 Td (gical ) Tj ET Q q 0 0 0 rg BT 317.58 494.10 Td (procedures ) Tj ET Q q 0 0 0 rg BT 364.52 494.10 Td (\(previously ) Tj ET Q q 0 0 0 rg BT 413.14 494.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 450.64 494.10 Td (by ) Tj ET Q q 0 0 0 rg BT 463.71 494.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 487.91 494.10 Td (in ) Tj ET Q q 0 0 0 rg BT 498.76 494.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 545.71 494.10 Td (with ) Tj ET Q q 0 0 0 rg BT 566.56 494.10 Td (its ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 482.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 82.49 482.10 Td (of ) Tj ET Q q 0 0 0 rg BT 93.43 482.10 Td (ZymoGenetics, ) Tj ET Q q 0 0 0 rg BT 157.41 482.10 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 175.29 482.10 Td (in ) Tj ET Q q 0 0 0 rg BT 185.68 482.10 Td (2010\). ) Tj ET Q q 0 0 0 rg BT 213.93 482.10 Td (The ) Tj ET Q q 0 0 0 rg BT 232.09 482.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 276.35 482.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 317.85 482.10 Td (received ) Tj ET Q q 0 0 0 rg BT 354.32 482.10 Td (the ) Tj ET Q q 0 0 0 rg BT 369.15 482.10 Td (right ) Tj ET Q q 0 0 0 rg BT 390.65 482.10 Td (to ) Tj ET Q q 0 0 0 rg BT 401.03 482.10 Td (sell, ) Tj ET Q q 0 0 0 rg BT 420.03 482.10 Td (distribute ) Tj ET Q q 0 0 0 rg BT 460.41 482.10 Td (and ) Tj ET Q q 0 0 0 rg BT 477.46 482.10 Td (market ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 507.84 482.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 539.12 482.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.34 482.10 Td ( ) Tj ET Q q 0 0 0 rg BT 558.95 482.10 Td (on ) Tj ET Q q 0 0 0 rg BT 571.56 482.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 470.10 Td (global ) Tj ET Q q 0 0 0 rg BT 62.71 470.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 84.42 470.10 Td (for ) Tj ET Q q 0 0 0 rg BT 97.79 470.10 Td (two ) Tj ET Q q 0 0 0 rg BT 114.50 470.10 Td (years. ) Tj ET Q q 0 0 0 rg BT 139.81 470.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 162.65 470.10 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 209.90 470.10 Td (supplied ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 245.50 470.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 276.78 470.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 294.00 470.10 Td ( ) Tj ET Q q 0 0 0 rg BT 295.71 470.10 Td (to ) Tj ET Q q 0 0 0 rg BT 305.08 470.10 Td (The ) Tj ET Q q 0 0 0 rg BT 322.34 470.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 365.71 470.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 406.30 470.10 Td (at ) Tj ET Q q 0 0 0 rg BT 415.23 470.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 433.05 470.10 Td (plus ) Tj ET Q q 0 0 0 rg BT 451.43 470.10 Td (a ) Tj ET Q q 0 0 0 rg BT 457.58 470.10 Td (markup ) Tj ET Q q 0 0 0 rg BT 489.84 470.10 Td (and ) Tj ET Q q 0 0 0 rg BT 505.99 470.10 Td (received ) Tj ET Q q 0 0 0 rg BT 541.56 470.10 Td (royalties ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 458.10 Td (on ) Tj ET Q q 0 0 0 rg BT 48.71 458.10 Td (net ) Tj ET Q q 0 0 0 rg BT 63.65 458.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 85.80 458.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 96.84 458.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 128.13 458.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 145.35 458.10 Td (. ) Tj ET Q q 0 0 0 rg BT 150.57 458.10 Td (Certain ) Tj ET Q q 0 0 0 rg BT 182.71 458.10 Td (employees ) Tj ET Q q 0 0 0 rg BT 228.19 458.10 Td (directly ) Tj ET Q q 0 0 0 rg BT 261.45 458.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 302.48 458.10 Td (to ) Tj ET Q q 0 0 0 rg BT 312.98 458.10 Td (the ) Tj ET Q q 0 0 0 rg BT 327.91 458.10 Td (business ) Tj ET Q q 0 0 0 rg BT 364.52 458.10 Td (and ) Tj ET Q q 0 0 0 rg BT 381.67 458.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 411.59 458.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 437.63 458.10 Td (were ) Tj ET Q q 0 0 0 rg BT 459.77 458.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 505.79 458.10 Td (to ) Tj ET Q q 0 0 0 rg BT 516.09 458.10 Td (The ) Tj ET Q q 0 0 0 rg BT 534.35 458.10 Td (Medicines ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 446.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.35 446.10 Td (at ) Tj ET Q q 0 0 0 rg BT 87.03 446.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.71 446.10 Td (start ) Tj ET Q q 0 0 0 rg BT 121.39 446.10 Td (of ) Tj ET Q q 0 0 0 rg BT 132.18 446.10 Td (the ) Tj ET Q q 0 0 0 rg BT 146.86 446.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 180.42 446.10 Td (period, ) Tj ET Q q 0 0 0 rg BT 210.93 446.10 Td (including ) Tj ET Q q 0 0 0 rg BT 251.16 446.10 Td (the ) Tj ET Q q 0 0 0 rg BT 265.84 446.10 Td (Biologics ) Tj ET Q q 0 0 0 rg BT 306.64 446.10 Td (License ) Tj ET Q q 0 0 0 rg BT 339.66 446.10 Td (Application ) Tj ET Q q 0 0 0 rg BT 389.33 446.10 Td (and ) Tj ET Q q 0 0 0 rg BT 406.23 446.10 Td (related ) Tj ET Q q 0 0 0 rg BT 435.90 446.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 479.46 446.10 Td (assets. ) Tj ET Q q 0 0 0 rg BT 507.75 446.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 531.34 446.10 Td (retained ) Tj ET Q q 0 0 0 rg BT 566.00 446.10 Td (all ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 434.10 Td (other ) Tj ET Q q 0 0 0 rg BT 59.05 434.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 84.88 434.10 Td (related ) Tj ET Q q 0 0 0 rg BT 114.58 434.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 124.86 434.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 156.14 434.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 173.36 434.10 Td ( ) Tj ET Q q 0 0 0 rg BT 175.86 434.10 Td (including ) Tj ET Q q 0 0 0 rg BT 216.14 434.10 Td (the ) Tj ET Q q 0 0 0 rg BT 230.85 434.10 Td (patents, ) Tj ET Q q 0 0 0 rg BT 264.18 434.10 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 311.10 434.10 Td (and ) Tj ET Q q 0 0 0 rg BT 328.04 434.10 Td (inventory) Tj ET Q q 0 0 0 rg BT 365.72 434.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 410.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.64 410.10 Td (also ) Tj ET Q q 0 0 0 rg BT 78.27 410.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 110.59 410.10 Td (The ) Tj ET Q q 0 0 0 rg BT 128.66 410.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 172.83 410.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 214.23 410.10 Td (an ) Tj ET Q q 0 0 0 rg BT 226.19 410.10 Td (option ) Tj ET Q q 0 0 0 rg BT 254.27 410.10 Td (to ) Tj ET Q q 0 0 0 rg BT 264.56 410.10 Td (acquire ) Tj ET Q q 0 0 0 rg BT 296.51 410.10 Td (the ) Tj ET Q q 0 0 0 rg BT 311.24 410.10 Td (patents, ) Tj ET Q q 0 0 0 rg BT 344.59 410.10 Td (trademarks, ) Tj ET Q q 0 0 0 rg BT 394.03 410.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 434.87 410.10 Td (and ) Tj ET Q q 0 0 0 rg BT 451.83 410.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 481.55 410.10 Td (other ) Tj ET Q q 0 0 0 rg BT 504.61 410.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 530.46 410.10 Td (exclusively ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 398.10 Td (related ) Tj ET Q q 0 0 0 rg BT 65.75 398.10 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 76.07 398.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 107.36 398.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 124.58 398.10 Td ( ) Tj ET Q q 0 0 0 rg BT 127.12 398.10 Td (at ) Tj ET Q q 0 0 0 rg BT 136.88 398.10 Td (a ) Tj ET Q q 0 0 0 rg BT 143.87 398.10 Td (price ) Tj ET Q q 0 0 0 rg BT 166.40 398.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 213.93 398.10 Td (based ) Tj ET Q q 0 0 0 rg BT 239.24 398.10 Td (on ) Tj ET Q q 0 0 0 rg BT 251.78 398.10 Td (a ) Tj ET Q q 0 0 0 rg BT 258.77 398.10 Td (multiple ) Tj ET Q q 0 0 0 rg BT 294.64 398.10 Td (of ) Tj ET Q q 0 0 0 rg BT 305.52 398.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 327.50 398.10 Td (\(plus ) Tj ET Q q 0 0 0 rg BT 350.05 398.10 Td (the ) Tj ET Q q 0 0 0 rg BT 364.81 398.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 383.46 398.10 Td (of ) Tj ET Q q 0 0 0 rg BT 394.34 398.10 Td (any ) Tj ET Q q 0 0 0 rg BT 411.32 398.10 Td (remaining ) Tj ET Q q 0 0 0 rg BT 454.41 398.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 495.28 398.10 Td (held ) Tj ET Q q 0 0 0 rg BT 515.04 398.10 Td (by ) Tj ET Q q 0 0 0 rg BT 527.59 398.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 551.26 398.10 Td (at ) Tj ET Q q 0 0 0 rg BT 561.02 398.10 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 386.10 Td (time\). ) Tj ET Q q 0 0 0 rg BT 61.92 386.10 Td (The ) Tj ET Q q 0 0 0 rg BT 79.97 386.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 124.13 386.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 165.51 386.10 Td (exercised ) Tj ET Q q 0 0 0 rg BT 205.77 386.10 Td (the ) Tj ET Q q 0 0 0 rg BT 220.48 386.10 Td (option ) Tj ET Q q 0 0 0 rg BT 248.54 386.10 Td (and ) Tj ET Q q 0 0 0 rg BT 265.48 386.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 302.40 386.10 Td (the ) Tj ET Q q 0 0 0 rg BT 317.12 386.10 Td (business ) Tj ET Q q 0 0 0 rg BT 353.51 386.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.67 386.10 Td ($132 ) Tj ET Q q 0 0 0 rg BT 390.17 386.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.06 386.10 Td ( ) Tj ET Q q 0 0 0 rg BT 421.56 386.10 Td (in ) Tj ET Q q 0 0 0 rg BT 431.84 386.10 Td (February ) Tj ET Q q 0 0 0 rg BT 470.44 386.10 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 362.10 Td (Non-refundable ) Tj ET Q q 0 0 0 rg BT 102.45 362.10 Td (upfront ) Tj ET Q q 0 0 0 rg BT 135.03 362.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 173.70 362.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.18 362.10 Td ($1) Tj ET Q q 0 0 0 rg BT 194.80 362.10 Td (15 ) Tj ET Q q 0 0 0 rg BT 207.95 362.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.84 362.10 Td ( ) Tj ET Q q 0 0 0 rg BT 239.98 362.10 Td (received ) Tj ET Q q 0 0 0 rg BT 276.98 362.10 Td (by ) Tj ET Q q 0 0 0 rg BT 290.12 362.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 314.39 362.10 Td (in ) Tj ET Q q 0 0 0 rg BT 325.31 362.10 Td (2013 ) Tj ET Q q 0 0 0 rg BT 348.45 362.10 Td (were ) Tj ET Q q 0 0 0 rg BT 371.02 362.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 410.25 362.10 Td (to ) Tj ET Q q 0 0 0 rg BT 421.17 362.10 Td (two ) Tj ET Q q 0 0 0 rg BT 439.31 362.10 Td (units ) Tj ET Q q 0 0 0 rg BT 461.90 362.10 Td (of ) Tj ET Q q 0 0 0 rg BT 473.37 362.10 Td (accounting, ) Tj ET Q q 0 0 0 rg BT 522.88 362.10 Td (including ) Tj ET Q q 0 0 0 rg BT 563.80 362.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 350.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.09 350.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 106.71 350.10 Td (to ) Tj ET Q q 0 0 0 rg BT 116.64 350.10 Td (The ) Tj ET Q q 0 0 0 rg BT 134.50 350.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 178.46 350.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 219.66 350.10 Td (and ) Tj ET Q q 0 0 0 rg BT 236.42 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 250.95 350.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 267.14 350.10 Td (value ) Tj ET Q q 0 0 0 rg BT 291.11 350.10 Td (of ) Tj ET Q q 0 0 0 rg BT 301.75 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 316.28 350.10 Td (option ) Tj ET Q q 0 0 0 rg BT 344.15 350.10 Td (to ) Tj ET Q q 0 0 0 rg BT 354.24 350.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 392.09 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 406.62 350.10 Td (remaining ) Tj ET Q q 0 0 0 rg BT 449.48 350.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 475.12 350.10 Td (using ) Tj ET Q q 0 0 0 rg BT 499.10 350.10 Td (the ) Tj ET Q q 0 0 0 rg BT 513.64 350.10 Td (best ) Tj ET Q q 0 0 0 rg BT 532.06 350.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 567.69 350.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 338.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.62 338.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 79.69 338.10 Td (price ) Tj ET Q q 0 0 0 rg BT 102.08 338.10 Td (for ) Tj ET Q q 0 0 0 rg BT 116.14 338.10 Td (these ) Tj ET Q q 0 0 0 rg BT 139.09 338.10 Td (elements ) Tj ET Q q 0 0 0 rg BT 177.04 338.10 Td (after ) Tj ET Q q 0 0 0 rg BT 197.76 338.10 Td (considering ) Tj ET Q q 0 0 0 rg BT 246.82 338.10 Td (various ) Tj ET Q q 0 0 0 rg BT 278.66 338.10 Td (market ) Tj ET Q q 0 0 0 rg BT 308.83 338.10 Td (factors. ) Tj ET Q q 0 0 0 rg BT 340.76 338.10 Td (These ) Tj ET Q q 0 0 0 rg BT 367.04 338.10 Td (market ) Tj ET Q q 0 0 0 rg BT 397.21 338.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 426.82 338.10 Td (included ) Tj ET Q q 0 0 0 rg BT 463.66 338.10 Td (an ) Tj ET Q q 0 0 0 rg BT 475.50 338.10 Td (analysis ) Tj ET Q q 0 0 0 rg BT 510.12 338.10 Td (of ) Tj ET Q q 0 0 0 rg BT 520.86 338.10 Td (any ) Tj ET Q q 0 0 0 rg BT 537.70 338.10 Td (estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 326.10 Td (excess ) Tj ET Q q 0 0 0 rg BT 64.68 326.10 Td (of ) Tj ET Q q 0 0 0 rg BT 75.59 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 90.39 326.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 106.85 326.10 Td (value ) Tj ET Q q 0 0 0 rg BT 131.09 326.10 Td (of ) Tj ET Q q 0 0 0 rg BT 142.00 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 156.80 326.10 Td (business ) Tj ET Q q 0 0 0 rg BT 193.27 326.10 Td (over ) Tj ET Q q 0 0 0 rg BT 213.62 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 228.42 326.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 265.99 326.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 304.11 326.10 Td (price ) Tj ET Q q 0 0 0 rg BT 326.68 326.10 Td (if ) Tj ET Q q 0 0 0 rg BT 335.37 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 350.17 326.10 Td (option ) Tj ET Q q 0 0 0 rg BT 378.31 326.10 Td (is ) Tj ET Q q 0 0 0 rg BT 387.56 326.10 Td (exercised. ) Tj ET Q q 0 0 0 rg BT 430.21 326.10 Td (The ) Tj ET Q q 0 0 0 rg BT 448.34 326.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 464.80 326.10 Td (value ) Tj ET Q q 0 0 0 rg BT 489.03 326.10 Td (of ) Tj ET Q q 0 0 0 rg BT 499.95 326.10 Td (the ) Tj ET Q q 0 0 0 rg BT 514.75 326.10 Td (option ) Tj ET Q q 0 0 0 rg BT 542.88 326.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.02 326.10 Td ($35 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 314.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 314.10 Td ( ) Tj ET Q q 0 0 0 rg BT 67.45 314.10 Td (at ) Tj ET Q q 0 0 0 rg BT 77.22 314.10 Td (December ) Tj ET Q q 0 0 0 rg BT 120.86 314.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 135.92 314.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 158.47 314.10 Td (and ) Tj ET Q q 0 0 0 rg BT 175.47 314.10 Td (was ) Tj ET Q q 0 0 0 rg BT 193.58 314.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 241.11 314.10 Td (using ) Tj ET Q q 0 0 0 rg BT 265.34 314.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 290.66 314.10 Td (3 ) Tj ET Q q 0 0 0 rg BT 298.21 314.10 Td (inputs ) Tj ET Q q 0 0 0 rg BT 325.22 314.10 Td (and ) Tj ET Q q 0 0 0 rg BT 342.21 314.10 Td (included ) Tj ET Q q 0 0 0 rg BT 379.20 314.10 Td (in ) Tj ET Q q 0 0 0 rg BT 389.54 314.10 Td (accrued ) Tj ET Q q 0 0 0 rg BT 423.18 314.10 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 464.15 314.10 Td (The ) Tj ET Q q 0 0 0 rg BT 482.25 314.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 514.80 314.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 553.45 314.10 Td (to ) Tj ET Q q 0 0 0 rg BT 563.78 314.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 302.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 61.28 302.10 Td (transferred ) Tj ET Q q 0 0 0 rg BT 107.08 302.10 Td (to ) Tj ET Q q 0 0 0 rg BT 117.18 302.10 Td (The ) Tj ET Q q 0 0 0 rg BT 135.23 302.10 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 179.38 302.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 220.77 302.10 Td (was ) Tj ET Q q 0 0 0 rg BT 238.82 302.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 281.30 302.10 Td (as ) Tj ET Q q 0 0 0 rg BT 292.13 302.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 325.72 302.10 Td (revenue ) Tj ET Q q 0 0 0 rg BT 359.87 302.10 Td (over ) Tj ET Q q 0 0 0 rg BT 380.14 302.10 Td (the ) Tj ET Q q 0 0 0 rg BT 394.85 302.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 441.77 302.10 Td (term. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 278.10 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 278.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 278.10 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 278.10 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 278.10 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 278.10 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 278.10 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 278.10 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 278.10 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 278.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 243.60 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 243.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 243.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 243.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 243.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 215.60 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 215.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 215.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 215.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 215.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 187.60 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 187.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 187.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 187.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 187.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 159.60 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 159.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 159.60 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 159.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 159.60 60.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 255.60000000000002 m 511.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 255.60000000000002 m 515.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 255.60000000000002 m 575.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 255.60000000000002 m 511.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 243.60000000000002 m 511.5 243.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 255.60000000000002 m 515.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 255.60000000000002 m 575.5 255.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 243.60000000000002 m 575.5 243.60000000000002 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 259.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 468.70 259.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 247.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 473.00 247.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.00 247.68 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 234.33 Td (Revenues from The Medicines Company alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 220.17 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 220.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 220.17 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 220.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 220.17 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 192.17 Td (Other \(income\)/expense – Divestiture gain) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.30 192.22 Td (\(59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 192.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 192.17 Td (—) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 164.33 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 150.17 Td (Divestiture and other proceeds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 150.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 150.17 Td (132) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 150.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 150.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 149 0 obj <> endobj 150 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (74) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 747.68505859375 m 68.412109375 747.68505859375 l s q 0 0 0 rg BT 36.00 749.25 Td (V) Tj ET Q q 0 0 0 rg BT 42.30 749.25 Td (aleant) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.27 725.25 Td (October ) Tj ET Q q 0 0 0 rg BT 82.42 725.25 Td (2012, ) Tj ET Q q 0 0 0 rg BT 107.87 725.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 131.93 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 149.32 725.25 Td (PharmaSwiss ) Tj ET Q q 0 0 0 rg BT 206.15 725.25 Td (SA, ) Tj ET Q q 0 0 0 rg BT 224.38 725.25 Td (a ) Tj ET Q q 0 0 0 rg BT 231.76 725.25 Td (wholly-owned ) Tj ET Q q 0 0 0 rg BT 292.47 725.25 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 336.52 725.25 Td (of ) Tj ET Q q 0 0 0 rg BT 347.58 725.25 Td (V) Tj ET Q q 0 0 0 rg BT 353.70 725.25 Td (aleant ) Tj ET Q q 0 0 0 rg BT 380.51 725.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 412.88 725.25 Td (into ) Tj ET Q q 0 0 0 rg BT 431.38 725.25 Td (an ) Tj ET Q q 0 0 0 rg BT 443.76 725.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 477.79 725.25 Td (for ) Tj ET Q q 0 0 0 rg BT 492.40 725.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 522.54 725.25 Td (mature ) Tj ET Q q 0 0 0 rg BT 553.25 725.25 Td (brand ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (products ) Tj ET Q q 0 0 0 rg BT 73.12 713.25 Td (in ) Tj ET Q q 0 0 0 rg BT 83.57 713.25 Td (Europe. ) Tj ET Q q 0 0 0 rg BT 117.44 713.25 Td (V) Tj ET Q q 0 0 0 rg BT 123.55 713.25 Td (aleant ) Tj ET Q q 0 0 0 rg BT 150.10 713.25 Td (received ) Tj ET Q q 0 0 0 rg BT 186.64 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 201.53 713.25 Td (right ) Tj ET Q q 0 0 0 rg BT 223.10 713.25 Td (to ) Tj ET Q q 0 0 0 rg BT 233.56 713.25 Td (sell, ) Tj ET Q q 0 0 0 rg BT 252.62 713.25 Td (distribute, ) Tj ET Q q 0 0 0 rg BT 295.57 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 312.69 713.25 Td (market ) Tj ET Q q 0 0 0 rg BT 343.13 713.25 Td (the ) Tj ET Q q 0 0 0 rg BT 358.03 713.25 Td (products ) Tj ET Q q 0 0 0 rg BT 395.14 713.25 Td (in ) Tj ET Q q 0 0 0 rg BT 405.60 713.25 Td (Europe ) Tj ET Q q 0 0 0 rg BT 437.15 713.25 Td (through ) Tj ET Q q 0 0 0 rg BT 470.94 713.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 529.70 713.25 Td (2014. ) Tj ET Q q 0 0 0 rg BT 554.88 713.25 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 84.04 701.25 Td (supplied ) Tj ET Q q 0 0 0 rg BT 120.43 701.25 Td (the ) Tj ET Q q 0 0 0 rg BT 135.15 701.25 Td (products ) Tj ET Q q 0 0 0 rg BT 172.08 701.25 Td (to ) Tj ET Q q 0 0 0 rg BT 182.18 701.25 Td (V) Tj ET Q q 0 0 0 rg BT 188.29 701.25 Td (aleant ) Tj ET Q q 0 0 0 rg BT 214.67 701.25 Td (at ) Tj ET Q q 0 0 0 rg BT 224.38 701.25 Td (cost ) Tj ET Q q 0 0 0 rg BT 242.99 701.25 Td (plus ) Tj ET Q q 0 0 0 rg BT 262.16 701.25 Td (a ) Tj ET Q q 0 0 0 rg BT 269.10 701.25 Td (markup.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 679.65 Td (BMS ) Tj ET Q q 0 0 0 rg BT 60.26 679.65 Td (also ) Tj ET Q q 0 0 0 rg BT 79.50 679.65 Td (granted ) Tj ET Q q 0 0 0 rg BT 112.39 679.65 Td (V) Tj ET Q q 0 0 0 rg BT 118.50 679.65 Td (aleant ) Tj ET Q q 0 0 0 rg BT 145.50 679.65 Td (an ) Tj ET Q q 0 0 0 rg BT 158.08 679.65 Td (option ) Tj ET Q q 0 0 0 rg BT 186.76 679.65 Td (to ) Tj ET Q q 0 0 0 rg BT 197.68 679.65 Td (acquire ) Tj ET Q q 0 0 0 rg BT 230.23 679.65 Td (the ) Tj ET Q q 0 0 0 rg BT 245.58 679.65 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 293.14 679.65 Td (and ) Tj ET Q q 0 0 0 rg BT 310.71 679.65 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 358.26 679.65 Td (property ) Tj ET Q q 0 0 0 rg BT 395.27 679.65 Td (exclusively ) Tj ET Q q 0 0 0 rg BT 443.95 679.65 Td (related ) Tj ET Q q 0 0 0 rg BT 474.28 679.65 Td (to ) Tj ET Q q 0 0 0 rg BT 485.19 679.65 Td (the ) Tj ET Q q 0 0 0 rg BT 500.54 679.65 Td (products ) Tj ET Q q 0 0 0 rg BT 538.11 679.65 Td (at ) Tj ET Q q 0 0 0 rg BT 548.46 679.65 Td (a ) Tj ET Q q 0 0 0 rg BT 556.03 679.65 Td (price ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 667.65 Td (determined ) Tj ET Q q 0 0 0 rg BT 83.48 667.65 Td (based ) Tj ET Q q 0 0 0 rg BT 108.75 667.65 Td (on ) Tj ET Q q 0 0 0 rg BT 121.25 667.65 Td (a ) Tj ET Q q 0 0 0 rg BT 128.19 667.65 Td (multiple ) Tj ET Q q 0 0 0 rg BT 164.02 667.65 Td (of ) Tj ET Q q 0 0 0 rg BT 174.85 667.65 Td (sales. ) Tj ET Q q 0 0 0 rg BT 199.11 667.65 Td (V) Tj ET Q q 0 0 0 rg BT 205.22 667.65 Td (aleant ) Tj ET Q q 0 0 0 rg BT 231.59 667.65 Td (exercised ) Tj ET Q q 0 0 0 rg BT 271.84 667.65 Td (the ) Tj ET Q q 0 0 0 rg BT 286.56 667.65 Td (option ) Tj ET Q q 0 0 0 rg BT 314.62 667.65 Td (and ) Tj ET Q q 0 0 0 rg BT 331.56 667.65 Td (acquired ) Tj ET Q q 0 0 0 rg BT 368.48 667.65 Td (the ) Tj ET Q q 0 0 0 rg BT 383.20 667.65 Td (business ) Tj ET Q q 0 0 0 rg BT 419.59 667.65 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.75 667.65 Td ($61 ) Tj ET Q q 0 0 0 rg BT 451.25 667.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.14 667.65 Td ( ) Tj ET Q q 0 0 0 rg BT 482.64 667.65 Td (in ) Tj ET Q q 0 0 0 rg BT 492.92 667.65 Td (January ) Tj ET Q q 0 0 0 rg BT 526.52 667.65 Td (2015. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 643.65 Td (Non-refundable ) Tj ET Q q 0 0 0 rg BT 101.38 643.65 Td (upfront ) Tj ET Q q 0 0 0 rg BT 132.90 643.65 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 170.51 643.65 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 180.92 643.65 Td ($79 ) Tj ET Q q 0 0 0 rg BT 197.99 643.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 226.89 643.65 Td ( ) Tj ET Q q 0 0 0 rg BT 228.96 643.65 Td (received ) Tj ET Q q 0 0 0 rg BT 264.90 643.65 Td (by ) Tj ET Q q 0 0 0 rg BT 276.98 643.65 Td (BMS ) Tj ET Q q 0 0 0 rg BT 300.18 643.65 Td (in ) Tj ET Q q 0 0 0 rg BT 310.03 643.65 Td (2012 ) Tj ET Q q 0 0 0 rg BT 332.11 643.65 Td (were ) Tj ET Q q 0 0 0 rg BT 353.62 643.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 391.78 643.65 Td (to ) Tj ET Q q 0 0 0 rg BT 401.64 643.65 Td (two ) Tj ET Q q 0 0 0 rg BT 418.71 643.65 Td (units ) Tj ET Q q 0 0 0 rg BT 440.24 643.65 Td (of ) Tj ET Q q 0 0 0 rg BT 450.64 643.65 Td (accounting, ) Tj ET Q q 0 0 0 rg BT 499.09 643.65 Td (including ) Tj ET Q q 0 0 0 rg BT 538.94 643.65 Td (the ) Tj ET Q q 0 0 0 rg BT 553.24 643.65 Td (rights ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 631.65 Td (transferred ) Tj ET Q q 0 0 0 rg BT 81.33 631.65 Td (to ) Tj ET Q q 0 0 0 rg BT 90.99 631.65 Td (V) Tj ET Q q 0 0 0 rg BT 97.11 631.65 Td (aleant ) Tj ET Q q 0 0 0 rg BT 123.01 631.65 Td (and ) Tj ET Q q 0 0 0 rg BT 139.47 631.65 Td (the ) Tj ET Q q 0 0 0 rg BT 153.72 631.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 169.62 631.65 Td (value ) Tj ET Q q 0 0 0 rg BT 193.30 631.65 Td (of ) Tj ET Q q 0 0 0 rg BT 203.66 631.65 Td (the ) Tj ET Q q 0 0 0 rg BT 217.91 631.65 Td (option ) Tj ET Q q 0 0 0 rg BT 245.49 631.65 Td (to ) Tj ET Q q 0 0 0 rg BT 255.30 631.65 Td (purchase ) Tj ET Q q 0 0 0 rg BT 292.86 631.65 Td (the ) Tj ET Q q 0 0 0 rg BT 307.11 631.65 Td (remaining ) Tj ET Q q 0 0 0 rg BT 349.68 631.65 Td (assets ) Tj ET Q q 0 0 0 rg BT 375.04 631.65 Td (using ) Tj ET Q q 0 0 0 rg BT 398.73 631.65 Td (the ) Tj ET Q q 0 0 0 rg BT 412.98 631.65 Td (best ) Tj ET Q q 0 0 0 rg BT 431.11 631.65 Td (estimate ) Tj ET Q q 0 0 0 rg BT 466.46 631.65 Td (of ) Tj ET Q q 0 0 0 rg BT 476.82 631.65 Td (the ) Tj ET Q q 0 0 0 rg BT 491.06 631.65 Td (selling ) Tj ET Q q 0 0 0 rg BT 519.76 631.65 Td (price ) Tj ET Q q 0 0 0 rg BT 541.77 631.65 Td (for ) Tj ET Q q 0 0 0 rg BT 555.46 631.65 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 619.65 Td (elements ) Tj ET Q q 0 0 0 rg BT 73.85 619.65 Td (after ) Tj ET Q q 0 0 0 rg BT 94.48 619.65 Td (considering ) Tj ET Q q 0 0 0 rg BT 143.45 619.65 Td (various ) Tj ET Q q 0 0 0 rg BT 175.20 619.65 Td (market ) Tj ET Q q 0 0 0 rg BT 205.27 619.65 Td (factors. ) Tj ET Q q 0 0 0 rg BT 237.12 619.65 Td (These ) Tj ET Q q 0 0 0 rg BT 263.31 619.65 Td (market ) Tj ET Q q 0 0 0 rg BT 293.38 619.65 Td (factors ) Tj ET Q q 0 0 0 rg BT 322.90 619.65 Td (included ) Tj ET Q q 0 0 0 rg BT 359.65 619.65 Td (an ) Tj ET Q q 0 0 0 rg BT 371.40 619.65 Td (analysis ) Tj ET Q q 0 0 0 rg BT 405.92 619.65 Td (of ) Tj ET Q q 0 0 0 rg BT 416.56 619.65 Td (any ) Tj ET Q q 0 0 0 rg BT 433.31 619.65 Td (estimated ) Tj ET Q q 0 0 0 rg BT 473.95 619.65 Td (excess ) Tj ET Q q 0 0 0 rg BT 502.36 619.65 Td (of ) Tj ET Q q 0 0 0 rg BT 513.00 619.65 Td (the ) Tj ET Q q 0 0 0 rg BT 527.52 619.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 543.71 619.65 Td (value ) Tj ET Q q 0 0 0 rg BT 567.68 619.65 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 607.65 Td (the ) Tj ET Q q 0 0 0 rg BT 50.44 607.65 Td (business ) Tj ET Q q 0 0 0 rg BT 86.56 607.65 Td (over ) Tj ET Q q 0 0 0 rg BT 106.55 607.65 Td (the ) Tj ET Q q 0 0 0 rg BT 120.99 607.65 Td (potential ) Tj ET Q q 0 0 0 rg BT 158.20 607.65 Td (purchase ) Tj ET Q q 0 0 0 rg BT 195.97 607.65 Td (price ) Tj ET Q q 0 0 0 rg BT 218.18 607.65 Td (if ) Tj ET Q q 0 0 0 rg BT 226.51 607.65 Td (the ) Tj ET Q q 0 0 0 rg BT 240.95 607.65 Td (option ) Tj ET Q q 0 0 0 rg BT 268.73 607.65 Td (is ) Tj ET Q q 0 0 0 rg BT 277.62 607.65 Td (exercised. ) Tj ET Q q 0 0 0 rg BT 319.94 607.65 Td (The ) Tj ET Q q 0 0 0 rg BT 337.71 607.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 353.81 607.65 Td (value ) Tj ET Q q 0 0 0 rg BT 377.69 607.65 Td (of ) Tj ET Q q 0 0 0 rg BT 388.25 607.65 Td (the ) Tj ET Q q 0 0 0 rg BT 402.69 607.65 Td (option ) Tj ET Q q 0 0 0 rg BT 430.47 607.65 Td (was ) Tj ET Q q 0 0 0 rg BT 448.24 607.65 Td (determined ) Tj ET Q q 0 0 0 rg BT 495.45 607.65 Td (using ) Tj ET Q q 0 0 0 rg BT 519.34 607.65 Td (Level ) Tj ET Q q 0 0 0 rg BT 544.33 607.65 Td (3 ) Tj ET Q q 0 0 0 rg BT 551.55 607.65 Td (inputs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 595.65 Td (and ) Tj ET Q q 0 0 0 rg BT 53.29 595.65 Td (included ) Tj ET Q q 0 0 0 rg BT 90.58 595.65 Td (in ) Tj ET Q q 0 0 0 rg BT 101.22 595.65 Td (accrued ) Tj ET Q q 0 0 0 rg BT 135.16 595.65 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 175.98 595.65 Td (A) Tj ET Q q 0 0 0 rg BT 182.65 595.65 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.51 595.65 Td ($16 ) Tj ET Q q 0 0 0 rg BT 203.37 595.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 232.26 595.65 Td ( ) Tj ET Q q 0 0 0 rg BT 235.12 595.65 Td (char) Tj ET Q q 0 0 0 rg BT 252.14 595.65 Td (ge ) Tj ET Q q 0 0 0 rg BT 264.44 595.65 Td (was ) Tj ET Q q 0 0 0 rg BT 282.85 595.65 Td (included ) Tj ET Q q 0 0 0 rg BT 320.14 595.65 Td (in ) Tj ET Q q 0 0 0 rg BT 330.77 595.65 Td (other ) Tj ET Q q 0 0 0 rg BT 354.17 595.65 Td (expenses ) Tj ET Q q 0 0 0 rg BT 393.13 595.65 Td (to ) Tj ET Q q 0 0 0 rg BT 403.76 595.65 Td (increase ) Tj ET Q q 0 0 0 rg BT 439.37 595.65 Td (the ) Tj ET Q q 0 0 0 rg BT 454.45 595.65 Td (fair ) Tj ET Q q 0 0 0 rg BT 471.18 595.65 Td (value ) Tj ET Q q 0 0 0 rg BT 495.69 595.65 Td (of ) Tj ET Q q 0 0 0 rg BT 506.88 595.65 Td (the ) Tj ET Q q 0 0 0 rg BT 521.95 595.65 Td (option ) Tj ET Q q 0 0 0 rg BT 550.36 595.65 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.00 595.65 Td ($34 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 583.65 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 583.65 Td ( ) Tj ET Q q 0 0 0 rg BT 67.39 583.65 Td (in ) Tj ET Q q 0 0 0 rg BT 77.67 583.65 Td (2014. ) Tj ET Q q 0 0 0 rg BT 102.49 583.65 Td (The ) Tj ET Q q 0 0 0 rg BT 120.54 583.65 Td (amount ) Tj ET Q q 0 0 0 rg BT 153.03 583.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 191.62 583.65 Td (to ) Tj ET Q q 0 0 0 rg BT 201.90 583.65 Td (the ) Tj ET Q q 0 0 0 rg BT 216.62 583.65 Td (rights ) Tj ET Q q 0 0 0 rg BT 241.89 583.65 Td (transferred ) Tj ET Q q 0 0 0 rg BT 287.70 583.65 Td (to ) Tj ET Q q 0 0 0 rg BT 297.80 583.65 Td (V) Tj ET Q q 0 0 0 rg BT 303.91 583.65 Td (aleant ) Tj ET Q q 0 0 0 rg BT 330.28 583.65 Td (was ) Tj ET Q q 0 0 0 rg BT 348.33 583.65 Td (amortized ) Tj ET Q q 0 0 0 rg BT 390.81 583.65 Td (as ) Tj ET Q q 0 0 0 rg BT 401.64 583.65 Td (alliance ) Tj ET Q q 0 0 0 rg BT 435.23 583.65 Td (revenue ) Tj ET Q q 0 0 0 rg BT 469.38 583.65 Td (over ) Tj ET Q q 0 0 0 rg BT 489.65 583.65 Td (the ) Tj ET Q q 0 0 0 rg BT 504.36 583.65 Td (contractual ) Tj ET Q q 0 0 0 rg BT 551.28 583.65 Td (term. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 559.65 Td (Summarized ) Tj ET Q q 0 0 0 rg BT 89.04 559.65 Td (financial ) Tj ET Q q 0 0 0 rg BT 126.52 559.65 Td (information ) Tj ET Q q 0 0 0 rg BT 176.23 559.65 Td (related ) Tj ET Q q 0 0 0 rg BT 205.94 559.65 Td (to ) Tj ET Q q 0 0 0 rg BT 216.21 559.65 Td (this ) Tj ET Q q 0 0 0 rg BT 233.16 559.65 Td (alliance ) Tj ET Q q 0 0 0 rg BT 266.75 559.65 Td (was ) Tj ET Q q 0 0 0 rg BT 284.80 559.65 Td (as ) Tj ET Q q 0 0 0 rg BT 295.63 559.65 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 525.15 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 525.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 525.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 525.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 525.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 497.15 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 497.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 497.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 497.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 497.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 469.15 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 469.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 469.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 469.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 469.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 441.15 412.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 441.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 441.15 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 441.15 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 441.15 60.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 537.15 m 511.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 537.15 m 515.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 537.15 m 575.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 537.15 m 511.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 525.15 m 511.5 525.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 537.15 m 515.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 537.15 m 575.5 537.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 525.15 m 575.5 525.15 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 541.10 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 468.70 541.23 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 529.10 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 473.00 529.23 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 537.00 529.23 Td (2014) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 515.88 Td (Revenues from Valeant alliance:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 501.72 Td (Alliance revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 501.72 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.30 501.77 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 501.72 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 501.72 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 501.72 Td (44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 473.72 Td (Other \(income\)/expense – Divestiture gain) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.30 473.77 Td (\(88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 473.72 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 473.72 Td (—) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 445.88 Td (Selected Alliance Cash Flow Information:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 431.72 Td (Other changes in operating assets and liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 431.72 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 431.72 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 431.72 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 431.72 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 417.72 Td (Divestiture and other proceeds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 417.72 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 417.72 Td (—) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 387.65 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 387.65 Td (4) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 387.65 Td (. ) Tj ET Q q 0 0 0 rg BT 67.94 387.65 Td (ACQUISITIONS ) Tj ET Q q 0 0 0 rg BT 143.80 387.65 Td (AND DIVESTITURES) Tj ET Q BT /F4 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 362.08505859375 m 87.1279296875 362.08505859375 l s q 0 0 0 rg BT 36.00 363.65 Td (Acquisitions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 345.65 Td (Acquisitions ) Tj ET Q q 0 0 0 rg BT 88.69 345.65 Td (are ) Tj ET Q q 0 0 0 rg BT 103.03 345.65 Td (evaluated ) Tj ET Q q 0 0 0 rg BT 143.47 345.65 Td (to ) Tj ET Q q 0 0 0 rg BT 153.38 345.65 Td (determine ) Tj ET Q q 0 0 0 rg BT 195.49 345.65 Td (whether ) Tj ET Q q 0 0 0 rg BT 229.83 345.65 Td (it ) Tj ET Q q 0 0 0 rg BT 237.52 345.65 Td (is ) Tj ET Q q 0 0 0 rg BT 246.32 345.65 Td (a ) Tj ET Q q 0 0 0 rg BT 252.89 345.65 Td (business, ) Tj ET Q q 0 0 0 rg BT 291.41 345.65 Td (an ) Tj ET Q q 0 0 0 rg BT 302.98 345.65 Td (asset ) Tj ET Q q 0 0 0 rg BT 324.55 345.65 Td (or ) Tj ET Q q 0 0 0 rg BT 335.01 345.65 Td (a ) Tj ET Q q 0 0 0 rg BT 341.58 345.65 Td (group ) Tj ET Q q 0 0 0 rg BT 367.04 345.65 Td (of ) Tj ET Q q 0 0 0 rg BT 377.50 345.65 Td (assets. ) Tj ET Q q 0 0 0 rg BT 405.31 345.65 Td (The ) Tj ET Q q 0 0 0 rg BT 422.99 345.65 Td (following ) Tj ET Q q 0 0 0 rg BT 464.01 345.65 Td (transactions ) Tj ET Q q 0 0 0 rg BT 513.90 345.65 Td (were ) Tj ET Q q 0 0 0 rg BT 535.46 345.65 Td (accounted ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 333.65 Td (for ) Tj ET Q q 0 0 0 rg BT 50.59 333.65 Td (as ) Tj ET Q q 0 0 0 rg BT 61.85 333.65 Td (asset ) Tj ET Q q 0 0 0 rg BT 84.22 333.65 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 134.93 333.65 Td (since ) Tj ET Q q 0 0 0 rg BT 158.40 333.65 Td (they ) Tj ET Q q 0 0 0 rg BT 178.55 333.65 Td (were ) Tj ET Q q 0 0 0 rg BT 200.91 333.65 Td (determined ) Tj ET Q q 0 0 0 rg BT 248.82 333.65 Td (not ) Tj ET Q q 0 0 0 rg BT 264.53 333.65 Td (to ) Tj ET Q q 0 0 0 rg BT 275.24 333.65 Td (be ) Tj ET Q q 0 0 0 rg BT 287.61 333.65 Td (a ) Tj ET Q q 0 0 0 rg BT 294.98 333.65 Td (business ) Tj ET Q q 0 0 0 rg BT 331.81 333.65 Td (as ) Tj ET Q q 0 0 0 rg BT 343.07 333.65 Td (that ) Tj ET Q q 0 0 0 rg BT 360.99 333.65 Td (term ) Tj ET Q q 0 0 0 rg BT 382.25 333.65 Td (is ) Tj ET Q q 0 0 0 rg BT 391.85 333.65 Td (defined ) Tj ET Q q 0 0 0 rg BT 424.77 333.65 Td (in ) Tj ET Q q 0 0 0 rg BT 434.83 333.65 Td (ASC ) Tj ET Q q 0 0 0 rg BT 457.21 333.65 Td (805 ) Tj ET Q q 0 0 0 rg BT 475.14 333.65 Td (- ) Tj ET Q q 0 0 0 rg BT 481.41 333.65 Td (Business ) Tj ET Q q 0 0 0 rg BT 519.90 333.65 Td (Combinations ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 321.65 Td (primarily ) Tj ET Q q 0 0 0 rg BT 75.50 321.65 Td (because ) Tj ET Q q 0 0 0 rg BT 109.44 321.65 Td (no ) Tj ET Q q 0 0 0 rg BT 121.73 321.65 Td (significant ) Tj ET Q q 0 0 0 rg BT 166.24 321.65 Td (processes ) Tj ET Q q 0 0 0 rg BT 206.85 321.65 Td (were ) Tj ET Q q 0 0 0 rg BT 228.57 321.65 Td (acquired. ) Tj ET Q q 0 0 0 rg BT 267.28 321.65 Td (As ) Tj ET Q q 0 0 0 rg BT 280.68 321.65 Td (a ) Tj ET Q q 0 0 0 rg BT 287.41 321.65 Td (result, ) Tj ET Q q 0 0 0 rg BT 314.42 321.65 Td (the ) Tj ET Q q 0 0 0 rg BT 328.93 321.65 Td (amounts ) Tj ET Q q 0 0 0 rg BT 365.11 321.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 403.49 321.65 Td (to ) Tj ET Q q 0 0 0 rg BT 413.56 321.65 Td (the ) Tj ET Q q 0 0 0 rg BT 428.06 321.65 Td (lead ) Tj ET Q q 0 0 0 rg BT 447.01 321.65 Td (investigational ) Tj ET Q q 0 0 0 rg BT 508.18 321.65 Td (compounds ) Tj ET Q q 0 0 0 rg BT 556.58 321.65 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 309.65 Td (expensed ) Tj ET Q q 0 0 0 rg BT 75.71 309.65 Td (and ) Tj ET Q q 0 0 0 rg BT 92.65 309.65 Td (not ) Tj ET Q q 0 0 0 rg BT 107.92 309.65 Td (capitalized. ) Tj ET Q q 0 0 0 rg BT 156.05 309.65 Td (The ) Tj ET Q q 0 0 0 rg BT 174.10 309.65 Td (consideration ) Tj ET Q q 0 0 0 rg BT 230.47 309.65 Td (of ) Tj ET Q q 0 0 0 rg BT 241.30 309.65 Td (each ) Tj ET Q q 0 0 0 rg BT 262.11 309.65 Td (transaction ) Tj ET Q q 0 0 0 rg BT 308.49 309.65 Td (was ) Tj ET Q q 0 0 0 rg BT 326.54 309.65 Td (allocated ) Tj ET Q q 0 0 0 rg BT 365.13 309.65 Td (as ) Tj ET Q q 0 0 0 rg BT 375.96 309.65 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 278.15 194.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 278.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 278.15 50.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 278.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 287.50 278.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 278.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 278.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 278.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 278.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 278.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 278.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 248.15 194.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 248.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 248.15 50.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 248.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 287.50 248.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 248.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 248.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 248.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 248.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 248.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 248.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 226.15 194.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 226.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 226.15 50.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 226.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 287.50 226.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 226.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 226.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 226.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 226.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 226.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 226.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 196.15 194.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 196.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 196.15 50.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 196.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 287.50 196.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 196.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 196.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 196.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 196.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 196.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 196.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 174.15 194.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 174.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 174.15 50.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 283.50 174.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 287.50 174.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 174.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 174.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 174.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 174.15 69.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 174.15 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 174.15 69.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 233.5 278.15 m 283.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 287.5 278.15 m 356.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 278.15 m 429.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 278.15 m 502.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 278.15 m 575.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 278.15 m 575.5 278.15 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 287.5 248.14999999999998 m 356.5 248.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 248.14999999999998 m 429.5 248.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 248.14999999999998 m 502.5 248.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 248.14999999999998 m 575.5 248.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 287.5 196.14999999999998 m 356.5 196.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 196.14999999999998 m 429.5 196.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 196.14999999999998 m 502.5 196.14999999999998 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 196.14999999999998 m 575.5 196.14999999999998 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 282.40 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 250.05 282.38 Td (Year) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 291.65 282.38 Td (Upfront Payment) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 370.15 282.38 Td (R&D Expense) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 445.00 290.38 Td (Deferr) Tj ET Q q 0 0 0 rg BT 467.50 290.38 Td (ed ) Tj ET Q q 0 0 0 rg BT 477.36 290.38 Td (T) Tj ET Q q 0 0 0 rg BT 481.96 290.38 Td (ax ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 453.80 282.38 Td (Assets) Tj ET Q BT /F2 8.00 Tf ET BT /F2 5.20 Tf ET q 0 0 0 rg BT 475.13 286.01 Td (\(a\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 521.35 290.38 Td (Contingent) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 516.25 282.38 Td (Consideration) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 267.82 Td (Cormorant) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.00 267.82 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.00 267.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 267.82 Td (35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 267.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 267.82 Td (35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 267.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 267.82 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 267.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 267.82 Td (485) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 252.82 Td (Padlock) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.00 252.82 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.65 252.82 Td (150) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 252.82 Td (139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 252.82 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 252.82 Td (453) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.00 237.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.65 237.82 Td (185) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 237.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 237.82 Td (174) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 237.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 237.82 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 237.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 237.82 Td (938) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 215.82 Td (Cardioxyl) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.00 215.82 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.00 215.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.65 215.82 Td (200) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 215.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 215.82 Td (167) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 215.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 215.82 Td (33) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 215.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 215.82 Td (1,875) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 200.82 Td (Flexus) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 64.67 205.35 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.00 200.82 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.65 200.82 Td (814) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 200.82 Td (800) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 200.82 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 200.82 Td (450) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.00 185.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.15 185.82 Td (1,014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 185.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 185.82 Td (967) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 185.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 185.82 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 185.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 185.82 Td (2,325) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 163.82 Td (iPierian) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.00 163.82 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.00 163.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.65 163.82 Td (175) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 163.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 163.82 Td (148) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 163.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 163.82 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 163.82 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 163.82 Td (554) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 147.05 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 147.05 Td (Relates ) Tj ET Q q 0 0 0 rg BT 79.55 147.05 Td (to ) Tj ET Q q 0 0 0 rg BT 87.77 147.05 Td (net ) Tj ET Q q 0 0 0 rg BT 99.54 147.05 Td (operating ) Tj ET Q q 0 0 0 rg BT 131.75 147.05 Td (loss ) Tj ET Q q 0 0 0 rg BT 146.20 147.05 Td (and ) Tj ET Q q 0 0 0 rg BT 159.75 147.05 Td (tax ) Tj ET Q q 0 0 0 rg BT 171.53 147.05 Td (credit ) Tj ET Q q 0 0 0 rg BT 191.74 147.05 Td (carryforwards) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 137.45 Td (\(b\) ) Tj ET Q q 0 0 0 rg BT 54.00 137.45 Td (Includes ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 83.10 137.45 Td ($14 ) Tj ET Q q 0 0 0 rg BT 97.10 137.45 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 120.21 137.45 Td ( ) Tj ET Q q 0 0 0 rg BT 122.21 137.45 Td (of ) Tj ET Q q 0 0 0 rg BT 130.88 137.45 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 167.98 137.45 Td (costs.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 115.85 Td (Cormorant) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 100.85 Td (In ) Tj ET Q q 0 0 0 rg BT 46.74 100.85 Td (July ) Tj ET Q q 0 0 0 rg BT 65.81 100.85 Td (2016, ) Tj ET Q q 0 0 0 rg BT 90.72 100.85 Td (BMS ) Tj ET Q q 0 0 0 rg BT 114.25 100.85 Td (acquired ) Tj ET Q q 0 0 0 rg BT 151.08 100.85 Td (all ) Tj ET Q q 0 0 0 rg BT 163.48 100.85 Td (of ) Tj ET Q q 0 0 0 rg BT 174.22 100.85 Td (the ) Tj ET Q q 0 0 0 rg BT 188.84 100.85 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 237.91 100.85 Td (shares ) Tj ET Q q 0 0 0 rg BT 265.31 100.85 Td (of ) Tj ET Q q 0 0 0 rg BT 276.04 100.85 Td (Cormorant, ) Tj ET Q q 0 0 0 rg BT 324.27 100.85 Td (a ) Tj ET Q q 0 0 0 rg BT 331.12 100.85 Td (private ) Tj ET Q q 0 0 0 rg BT 361.29 100.85 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 424.77 100.85 Td (company ) Tj ET Q q 0 0 0 rg BT 463.83 100.85 Td (focused ) Tj ET Q q 0 0 0 rg BT 497.34 100.85 Td (on ) Tj ET Q q 0 0 0 rg BT 509.74 100.85 Td (the ) Tj ET Q q 0 0 0 rg BT 524.37 100.85 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 88.85 Td (of ) Tj ET Q q 0 0 0 rg BT 47.30 88.85 Td (therapies ) Tj ET Q q 0 0 0 rg BT 86.36 88.85 Td (for ) Tj ET Q q 0 0 0 rg BT 100.98 88.85 Td (cancer ) Tj ET Q q 0 0 0 rg BT 130.03 88.85 Td (and ) Tj ET Q q 0 0 0 rg BT 147.44 88.85 Td (rare ) Tj ET Q q 0 0 0 rg BT 165.94 88.85 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 203.96 88.85 Td (The ) Tj ET Q q 0 0 0 rg BT 222.48 88.85 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 269.32 88.85 Td (provides ) Tj ET Q q 0 0 0 rg BT 306.73 88.85 Td (BMS ) Tj ET Q q 0 0 0 rg BT 330.82 88.85 Td (with ) Tj ET Q q 0 0 0 rg BT 351.56 88.85 Td (full ) Tj ET Q q 0 0 0 rg BT 368.42 88.85 Td (rights ) Tj ET Q q 0 0 0 rg BT 394.16 88.85 Td (to ) Tj ET Q q 0 0 0 rg BT 404.90 88.85 Td (Cormorant's ) Tj ET Q q 0 0 0 rg BT 456.89 88.85 Td (lead ) Tj ET Q q 0 0 0 rg BT 476.51 88.85 Td (candidate ) Tj ET Q q 0 0 0 rg BT 517.79 88.85 Td (HuMax-IL8, ) Tj ET Q q 0 0 0 rg BT 571.57 88.85 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 76.85 Td (Phase ) Tj ET Q q 0 0 0 rg BT 62.12 76.85 Td (I/II ) Tj ET Q q 0 0 0 rg BT 77.68 76.85 Td (monoclonal ) Tj ET Q q 0 0 0 rg BT 127.68 76.85 Td (antibody ) Tj ET Q q 0 0 0 rg BT 165.46 76.85 Td (that ) Tj ET Q q 0 0 0 rg BT 183.25 76.85 Td (represents ) Tj ET Q q 0 0 0 rg BT 226.58 76.85 Td (a ) Tj ET Q q 0 0 0 rg BT 233.80 76.85 Td (potentially ) Tj ET Q q 0 0 0 rg BT 279.36 76.85 Td (complementary ) Tj ET Q q 0 0 0 rg BT 344.35 76.85 Td (immuno-oncology ) Tj ET Q q 0 0 0 rg BT 421.02 76.85 Td (mechanism ) Tj ET Q q 0 0 0 rg BT 469.35 76.85 Td (of ) Tj ET Q q 0 0 0 rg BT 480.47 76.85 Td (action ) Tj ET Q q 0 0 0 rg BT 507.69 76.85 Td (to ) Tj ET Q q 0 0 0 rg BT 518.06 76.85 Td (T) Tj ET Q q 0 0 0 rg BT 523.25 76.85 Td (-cell ) Tj ET Q q 0 0 0 rg BT 543.80 76.85 Td (directed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 64.85 Td (antibodies ) Tj ET Q q 0 0 0 rg BT 79.60 64.85 Td (and ) Tj ET Q q 0 0 0 rg BT 96.54 64.85 Td (co-stimulatory ) Tj ET Q q 0 0 0 rg BT 157.36 64.85 Td (molecules. ) Tj ET Q q 0 0 0 rg BT 202.90 64.85 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 249.85 64.85 Td (consideration ) Tj ET Q q 0 0 0 rg BT 306.22 64.85 Td (includes ) Tj ET Q q 0 0 0 rg BT 342.04 64.85 Td (development ) Tj ET Q q 0 0 0 rg BT 396.20 64.85 Td (and ) Tj ET Q q 0 0 0 rg BT 413.13 64.85 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 456.73 64.85 Td (milestone ) Tj ET Q q 0 0 0 rg BT 498.11 64.85 Td (payments.) Tj ET Q endstream endobj 151 0 obj <> endobj 152 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (75) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Padlock ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 734.10 Td (In ) Tj ET Q q 0 0 0 rg BT 47.08 734.10 Td (April ) Tj ET Q q 0 0 0 rg BT 71.72 734.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 97.74 734.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 122.39 734.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 160.35 734.10 Td (all ) Tj ET Q q 0 0 0 rg BT 173.87 734.10 Td (of ) Tj ET Q q 0 0 0 rg BT 185.73 734.10 Td (the ) Tj ET Q q 0 0 0 rg BT 201.47 734.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 251.66 734.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 280.18 734.10 Td (of ) Tj ET Q q 0 0 0 rg BT 292.04 734.10 Td (Padlock, ) Tj ET Q q 0 0 0 rg BT 330.28 734.10 Td (a ) Tj ET Q q 0 0 0 rg BT 338.25 734.10 Td (private ) Tj ET Q q 0 0 0 rg BT 369.54 734.10 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 430.28 734.10 Td (company ) Tj ET Q q 0 0 0 rg BT 470.47 734.10 Td (dedicated ) Tj ET Q q 0 0 0 rg BT 512.30 734.10 Td (to ) Tj ET Q q 0 0 0 rg BT 523.61 734.10 Td (creating ) Tj ET Q q 0 0 0 rg BT 559.34 734.10 Td (new ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 722.10 Td (medicines ) Tj ET Q q 0 0 0 rg BT 78.69 722.10 Td (to ) Tj ET Q q 0 0 0 rg BT 88.61 722.10 Td (treat ) Tj ET Q q 0 0 0 rg BT 108.51 722.10 Td (destructive ) Tj ET Q q 0 0 0 rg BT 154.53 722.10 Td (autoimmune ) Tj ET Q q 0 0 0 rg BT 206.66 722.10 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 243.92 722.10 Td (The ) Tj ET Q q 0 0 0 rg BT 261.61 722.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 307.64 722.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 344.22 722.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 367.49 722.10 Td (with ) Tj ET Q q 0 0 0 rg BT 387.41 722.10 Td (full ) Tj ET Q q 0 0 0 rg BT 403.44 722.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 428.36 722.10 Td (to ) Tj ET Q q 0 0 0 rg BT 438.28 722.10 Td (Padlock’) Tj ET Q q 0 0 0 rg BT 473.28 722.10 Td (s ) Tj ET Q q 0 0 0 rg BT 479.31 722.10 Td (P) Tj ET Q q 0 0 0 rg BT 483.96 722.10 Td (AD ) Tj ET Q q 0 0 0 rg BT 500.54 722.10 Td (inhibitor ) Tj ET Q q 0 0 0 rg BT 537.13 722.10 Td (discovery ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 710.10 Td (program ) Tj ET Q q 0 0 0 rg BT 71.39 710.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 104.00 710.10 Td (on ) Tj ET Q q 0 0 0 rg BT 115.51 710.10 Td (the ) Tj ET Q q 0 0 0 rg BT 129.24 710.10 Td (development ) Tj ET Q q 0 0 0 rg BT 182.40 710.10 Td (of ) Tj ET Q q 0 0 0 rg BT 192.24 710.10 Td (potentially ) Tj ET Q q 0 0 0 rg BT 236.52 710.10 Td (transformational ) Tj ET Q q 0 0 0 rg BT 304.12 710.10 Td (treatment ) Tj ET Q q 0 0 0 rg BT 343.39 710.10 Td (approaches ) Tj ET Q q 0 0 0 rg BT 389.88 710.10 Td (for ) Tj ET Q q 0 0 0 rg BT 403.05 710.10 Td (patients ) Tj ET Q q 0 0 0 rg BT 435.66 710.10 Td (with ) Tj ET Q q 0 0 0 rg BT 454.95 710.10 Td (rheumatoid ) Tj ET Q q 0 0 0 rg BT 502.01 710.10 Td (arthritis. ) Tj ET Q q 0 0 0 rg BT 537.12 710.10 Td (Padlock’) Tj ET Q q 0 0 0 rg BT 572.12 710.10 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 698.10 Td (P) Tj ET Q q 0 0 0 rg BT 40.64 698.10 Td (AD ) Tj ET Q q 0 0 0 rg BT 57.01 698.10 Td (discovery ) Tj ET Q q 0 0 0 rg BT 97.81 698.10 Td (program ) Tj ET Q q 0 0 0 rg BT 133.60 698.10 Td (may ) Tj ET Q q 0 0 0 rg BT 152.74 698.10 Td (have ) Tj ET Q q 0 0 0 rg BT 173.54 698.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 215.45 698.10 Td (utility ) Tj ET Q q 0 0 0 rg BT 241.27 698.10 Td (in ) Tj ET Q q 0 0 0 rg BT 250.97 698.10 Td (treating ) Tj ET Q q 0 0 0 rg BT 283.43 698.10 Td (systemic ) Tj ET Q q 0 0 0 rg BT 320.35 698.10 Td (lupus ) Tj ET Q q 0 0 0 rg BT 343.94 698.10 Td (erythematosus ) Tj ET Q q 0 0 0 rg BT 403.62 698.10 Td (and ) Tj ET Q q 0 0 0 rg BT 419.98 698.10 Td (other ) Tj ET Q q 0 0 0 rg BT 442.45 698.10 Td (autoimmune ) Tj ET Q q 0 0 0 rg BT 494.36 698.10 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 531.55 698.10 Td (Contingent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 686.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 92.37 686.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 128.20 686.10 Td (development ) Tj ET Q q 0 0 0 rg BT 182.35 686.10 Td (and ) Tj ET Q q 0 0 0 rg BT 199.29 686.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 242.88 686.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 284.26 686.10 Td (payments.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 662.10 Td (Car) Tj ET Q q 0 0 0 rg BT 51.19 662.10 Td (dioxyl ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 647.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.50 647.10 Td (December ) Tj ET Q q 0 0 0 rg BT 89.76 647.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 114.43 647.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 137.72 647.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 174.32 647.10 Td (all ) Tj ET Q q 0 0 0 rg BT 186.49 647.10 Td (of ) Tj ET Q q 0 0 0 rg BT 196.99 647.10 Td (the ) Tj ET Q q 0 0 0 rg BT 211.38 647.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 260.21 647.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 287.38 647.10 Td (of ) Tj ET Q q 0 0 0 rg BT 297.88 647.10 Td (Cardioxyl, ) Tj ET Q q 0 0 0 rg BT 342.55 647.10 Td (a ) Tj ET Q q 0 0 0 rg BT 349.16 647.10 Td (private ) Tj ET Q q 0 0 0 rg BT 379.09 647.10 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 438.48 647.10 Td (company ) Tj ET Q q 0 0 0 rg BT 477.30 647.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 510.57 647.10 Td (on ) Tj ET Q q 0 0 0 rg BT 522.75 647.10 Td (the ) Tj ET Q q 0 0 0 rg BT 537.13 647.10 Td (discovery ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 635.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.86 635.10 Td (development ) Tj ET Q q 0 0 0 rg BT 106.94 635.10 Td (of ) Tj ET Q q 0 0 0 rg BT 117.70 635.10 Td (novel ) Tj ET Q q 0 0 0 rg BT 142.34 635.10 Td (therapeutic ) Tj ET Q q 0 0 0 rg BT 189.18 635.10 Td (agents ) Tj ET Q q 0 0 0 rg BT 217.16 635.10 Td (for ) Tj ET Q q 0 0 0 rg BT 231.24 635.10 Td (cardiovascular ) Tj ET Q q 0 0 0 rg BT 291.97 635.10 Td (disease. ) Tj ET Q q 0 0 0 rg BT 325.60 635.10 Td (The ) Tj ET Q q 0 0 0 rg BT 343.57 635.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 389.88 635.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 427.85 635.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 451.40 635.10 Td (with ) Tj ET Q q 0 0 0 rg BT 471.60 635.10 Td (full ) Tj ET Q q 0 0 0 rg BT 487.91 635.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 513.12 635.10 Td (to ) Tj ET Q q 0 0 0 rg BT 523.32 635.10 Td (CXL-1427, ) Tj ET Q q 0 0 0 rg BT 571.58 635.10 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (nitroxyl ) Tj ET Q q 0 0 0 rg BT 71.84 623.10 Td (prodrug ) Tj ET Q q 0 0 0 rg BT 107.68 623.10 Td (in ) Tj ET Q q 0 0 0 rg BT 119.64 623.10 Td (Phase ) Tj ET Q q 0 0 0 rg BT 147.14 623.10 Td (II ) Tj ET Q q 0 0 0 rg BT 157.98 623.10 Td (development ) Tj ET Q q 0 0 0 rg BT 213.81 623.10 Td (for ) Tj ET Q q 0 0 0 rg BT 229.65 623.10 Td (acute ) Tj ET Q q 0 0 0 rg BT 254.92 623.10 Td (decompensated ) Tj ET Q q 0 0 0 rg BT 320.74 623.10 Td (heart ) Tj ET Q q 0 0 0 rg BT 344.90 623.10 Td (failure. ) Tj ET Q q 0 0 0 rg BT 377.67 623.10 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 426.29 623.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 484.34 623.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 521.85 623.10 Td (development, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 611.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 79.59 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 96.53 611.10 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 144.57 611.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 185.95 611.10 Td (payments.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 587.10 Td (Flexus ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 572.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.70 572.10 Td (April ) Tj ET Q q 0 0 0 rg BT 70.85 572.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 96.39 572.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 120.55 572.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 158.01 572.10 Td (all ) Tj ET Q q 0 0 0 rg BT 171.05 572.10 Td (of ) Tj ET Q q 0 0 0 rg BT 182.42 572.10 Td (the ) Tj ET Q q 0 0 0 rg BT 197.67 572.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 247.38 572.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 275.41 572.10 Td (of ) Tj ET Q q 0 0 0 rg BT 286.78 572.10 Td (Flexus, ) Tj ET Q q 0 0 0 rg BT 318.99 572.10 Td (a ) Tj ET Q q 0 0 0 rg BT 326.46 572.10 Td (private ) Tj ET Q q 0 0 0 rg BT 357.27 572.10 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 417.52 572.10 Td (company ) Tj ET Q q 0 0 0 rg BT 457.21 572.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 491.35 572.10 Td (on ) Tj ET Q q 0 0 0 rg BT 504.39 572.10 Td (the ) Tj ET Q q 0 0 0 rg BT 519.65 572.10 Td (discovery ) Tj ET Q q 0 0 0 rg BT 561.56 572.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 560.10 Td (development ) Tj ET Q q 0 0 0 rg BT 90.09 560.10 Td (of ) Tj ET Q q 0 0 0 rg BT 100.86 560.10 Td (novel ) Tj ET Q q 0 0 0 rg BT 125.51 560.10 Td (anti-cancer ) Tj ET Q q 0 0 0 rg BT 172.36 560.10 Td (therapeutics. ) Tj ET Q q 0 0 0 rg BT 225.43 560.10 Td (The ) Tj ET Q q 0 0 0 rg BT 243.42 560.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 289.74 560.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 327.72 560.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 351.28 560.10 Td (with ) Tj ET Q q 0 0 0 rg BT 371.50 560.10 Td (full ) Tj ET Q q 0 0 0 rg BT 387.82 560.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 413.04 560.10 Td (to ) Tj ET Q q 0 0 0 rg BT 423.25 560.10 Td (F001287, ) Tj ET Q q 0 0 0 rg BT 463.75 560.10 Td (a ) Tj ET Q q 0 0 0 rg BT 470.63 560.10 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 515.27 560.10 Td (small ) Tj ET Q q 0 0 0 rg BT 539.37 560.10 Td (molecule ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 548.10 Td (IDO1-inhibitor ) Tj ET Q q 0 0 0 rg BT 100.02 548.10 Td (tar) Tj ET Q q 0 0 0 rg BT 110.38 548.10 Td (geted ) Tj ET Q q 0 0 0 rg BT 135.51 548.10 Td (immunotherapy) Tj ET Q q 0 0 0 rg BT 198.18 548.10 Td (. ) Tj ET Q q 0 0 0 rg BT 204.15 548.10 Td (In ) Tj ET Q q 0 0 0 rg BT 215.95 548.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 254.70 548.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 279.29 548.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 317.18 548.10 Td (Flexus's ) Tj ET Q q 0 0 0 rg BT 353.02 548.10 Td (IDO/TDO ) Tj ET Q q 0 0 0 rg BT 397.59 548.10 Td (discovery ) Tj ET Q q 0 0 0 rg BT 439.94 548.10 Td (program ) Tj ET Q q 0 0 0 rg BT 477.29 548.10 Td (which ) Tj ET Q q 0 0 0 rg BT 505.20 548.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 541.99 548.10 Td (its ) Tj ET Q q 0 0 0 rg BT 554.91 548.10 Td (IDO-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 536.10 Td (selective, ) Tj ET Q q 0 0 0 rg BT 77.22 536.10 Td (IDO/TDO ) Tj ET Q q 0 0 0 rg BT 122.06 536.10 Td (dual ) Tj ET Q q 0 0 0 rg BT 143.01 536.10 Td (and ) Tj ET Q q 0 0 0 rg BT 160.92 536.10 Td (TDO-selective ) Tj ET Q q 0 0 0 rg BT 223.52 536.10 Td (compounds. ) Tj ET Q q 0 0 0 rg BT 275.87 536.10 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 324.05 536.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 381.66 536.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 418.72 536.10 Td (development ) Tj ET Q q 0 0 0 rg BT 474.11 536.10 Td (and ) Tj ET Q q 0 0 0 rg BT 492.29 536.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 537.12 536.10 Td (milestone ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 524.10 Td (payments. ) Tj ET Q q 0 0 0 rg BT 78.74 524.10 Td (A) Tj ET Q q 0 0 0 rg BT 85.41 524.10 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 87.86 524.10 Td ($100 ) Tj ET Q q 0 0 0 rg BT 110.31 524.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 139.21 524.10 Td ( ) Tj ET Q q 0 0 0 rg BT 141.66 524.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 183.00 524.10 Td (was ) Tj ET Q q 0 0 0 rg BT 201.00 524.10 Td (achieved ) Tj ET Q q 0 0 0 rg BT 238.99 524.10 Td (and ) Tj ET Q q 0 0 0 rg BT 255.88 524.10 Td (paid ) Tj ET Q q 0 0 0 rg BT 275.55 524.10 Td (to ) Tj ET Q q 0 0 0 rg BT 285.78 524.10 Td (former ) Tj ET Q q 0 0 0 rg BT 315.44 524.10 Td (shareowners ) Tj ET Q q 0 0 0 rg BT 367.88 524.10 Td (of ) Tj ET Q q 0 0 0 rg BT 378.66 524.10 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 407.78 524.10 Td (in ) Tj ET Q q 0 0 0 rg BT 418.01 524.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 440.47 524.10 Td (for ) Tj ET Q q 0 0 0 rg BT 454.58 524.10 Td (the ) Tj ET Q q 0 0 0 rg BT 469.25 524.10 Td (commencement ) Tj ET Q q 0 0 0 rg BT 535.01 524.10 Td (of ) Tj ET Q q 0 0 0 rg BT 545.80 524.10 Td (a ) Tj ET Q q 0 0 0 rg BT 552.69 524.10 Td (Phase ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 512.10 Td (I ) Tj ET Q q 0 0 0 rg BT 41.83 512.10 Td (clinical ) Tj ET Q q 0 0 0 rg BT 73.76 512.10 Td (trial ) Tj ET Q q 0 0 0 rg BT 92.36 512.10 Td (and ) Tj ET Q q 0 0 0 rg BT 109.30 512.10 Td (included ) Tj ET Q q 0 0 0 rg BT 146.23 512.10 Td (in ) Tj ET Q q 0 0 0 rg BT 156.51 512.10 Td (R&D ) Tj ET Q q 0 0 0 rg BT 180.68 512.10 Td (expense.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 488.10 Td (iPierian) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.35 473.10 Td (April ) Tj ET Q q 0 0 0 rg BT 70.05 473.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 95.14 473.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 118.86 473.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 155.87 473.10 Td (all ) Tj ET Q q 0 0 0 rg BT 168.46 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 179.38 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 194.19 473.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 243.45 473.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 271.03 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 281.95 473.10 Td (iPierian, ) Tj ET Q q 0 0 0 rg BT 318.15 473.10 Td (a ) Tj ET Q q 0 0 0 rg BT 325.18 473.10 Td (private ) Tj ET Q q 0 0 0 rg BT 355.53 473.10 Td (biotechnology ) Tj ET Q q 0 0 0 rg BT 415.33 473.10 Td (company ) Tj ET Q q 0 0 0 rg BT 454.58 473.10 Td (focused ) Tj ET Q q 0 0 0 rg BT 488.27 473.10 Td (on ) Tj ET Q q 0 0 0 rg BT 500.86 473.10 Td (new ) Tj ET Q q 0 0 0 rg BT 520.12 473.10 Td (treatments ) Tj ET Q q 0 0 0 rg BT 564.36 473.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (tauopathies, ) Tj ET Q q 0 0 0 rg BT 86.54 461.10 Td (a ) Tj ET Q q 0 0 0 rg BT 93.49 461.10 Td (class ) Tj ET Q q 0 0 0 rg BT 115.43 461.10 Td (of ) Tj ET Q q 0 0 0 rg BT 126.26 461.10 Td (neurodegenerative ) Tj ET Q q 0 0 0 rg BT 202.61 461.10 Td (diseases. ) Tj ET Q q 0 0 0 rg BT 240.38 461.10 Td ( ) Tj ET Q q 0 0 0 rg BT 242.70 461.10 Td (The ) Tj ET Q q 0 0 0 rg BT 260.75 461.10 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 307.14 461.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 345.18 461.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 368.81 461.10 Td (with ) Tj ET Q q 0 0 0 rg BT 389.09 461.10 Td (full ) Tj ET Q q 0 0 0 rg BT 405.48 461.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 430.76 461.10 Td (to ) Tj ET Q q 0 0 0 rg BT 441.04 461.10 Td (IPN007, ) Tj ET Q q 0 0 0 rg BT 477.16 461.10 Td (a ) Tj ET Q q 0 0 0 rg BT 484.10 461.10 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 528.80 461.10 Td (monoclonal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 449.10 Td (antibody ) Tj ET Q q 0 0 0 rg BT 73.80 449.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.39 449.10 Td (treat ) Tj ET Q q 0 0 0 rg BT 104.96 449.10 Td (progressive ) Tj ET Q q 0 0 0 rg BT 153.87 449.10 Td (supranuclear ) Tj ET Q q 0 0 0 rg BT 207.77 449.10 Td (palsy ) Tj ET Q q 0 0 0 rg BT 231.68 449.10 Td (and ) Tj ET Q q 0 0 0 rg BT 248.93 449.10 Td (other ) Tj ET Q q 0 0 0 rg BT 272.29 449.10 Td (tauopathies. ) Tj ET Q q 0 0 0 rg BT 323.14 449.10 Td (Contingent ) Tj ET Q q 0 0 0 rg BT 370.39 449.10 Td (consideration ) Tj ET Q q 0 0 0 rg BT 427.07 449.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 463.21 449.10 Td (development ) Tj ET Q q 0 0 0 rg BT 517.66 449.10 Td (and ) Tj ET Q q 0 0 0 rg BT 534.91 449.10 Td (regulatory ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 77.38 437.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 118.21 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 135.15 437.10 Td (future ) Tj ET Q q 0 0 0 rg BT 161.52 437.10 Td (royalties ) Tj ET Q q 0 0 0 rg BT 198.46 437.10 Td (on ) Tj ET Q q 0 0 0 rg BT 210.96 437.10 Td (net ) Tj ET Q q 0 0 0 rg BT 225.67 437.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 247.61 437.10 Td (if ) Tj ET Q q 0 0 0 rg BT 256.22 437.10 Td (any ) Tj ET Q q 0 0 0 rg BT 273.16 437.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.99 437.10 Td (the ) Tj ET Q q 0 0 0 rg BT 298.71 437.10 Td (acquired ) Tj ET Q q 0 0 0 rg BT 335.63 437.10 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 380.33 437.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 406.16 437.10 Td (are ) Tj ET Q q 0 0 0 rg BT 420.86 437.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 460.57 437.10 Td (and ) Tj ET Q q 0 0 0 rg BT 477.51 437.10 Td (commercialized.) Tj ET Q BT /F4 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 411.53505859375 m 84.88671875 411.53505859375 l s q 0 0 0 rg BT 36.00 413.10 Td (Divestitures) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 372.60 151.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 186.50 372.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 225.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 372.60 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 270.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 274.50 372.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 372.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 372.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 372.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 444.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 372.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 488.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 372.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 372.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 372.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 342.60 151.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 186.50 342.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 225.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 342.60 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 270.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 274.50 342.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 342.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 342.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 342.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 444.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 342.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 488.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 342.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 342.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 342.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 312.60 151.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 186.50 312.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 225.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 312.60 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 270.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 274.50 312.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 312.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 312.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 312.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 444.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 312.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 488.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 312.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 312.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 312.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 282.60 151.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 186.50 282.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 225.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 282.60 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 270.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 274.50 282.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 282.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 282.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 282.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 444.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 282.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 488.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 282.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 282.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 282.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 252.60 151.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 186.50 252.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 225.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 229.50 252.60 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 270.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 274.50 252.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 313.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 317.50 252.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 252.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 252.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 444.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 252.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 488.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 252.60 40.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 252.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 252.60 39.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 387.6 m 225.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 387.6 m 356.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 387.6 m 400.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 387.6 m 444.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 387.6 m 488.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 387.6 m 532.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 387.6 m 575.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 387.6 m 225.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 372.6 m 225.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 225.5 387.6 m 229.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 387.6 m 270.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 372.6 m 270.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 270.5 387.6 m 274.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 387.6 m 313.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 372.6 m 313.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 387.6 m 356.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 372.6 m 356.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 387.6 m 360.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 387.6 m 400.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 372.6 m 400.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 400.5 387.6 m 404.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 387.6 m 444.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 372.6 m 444.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 387.6 m 488.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 372.6 m 488.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 488.5 387.6 m 492.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 387.6 m 532.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 372.6 m 532.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 532.5 387.6 m 536.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 387.6 m 575.5 387.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 372.6 m 575.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 372.6 m 225.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 372.6 m 270.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 372.6 m 313.5 372.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 252.60000000000002 m 225.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 238.60000000000002 m 225.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 186.5 236.60000000000002 m 225.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 252.60000000000002 m 270.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 238.60000000000002 m 270.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 229.5 236.60000000000002 m 270.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 252.60000000000002 m 313.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 238.60000000000002 m 313.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 274.5 236.60000000000002 m 313.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 252.60000000000002 m 356.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 238.60000000000002 m 356.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 317.5 236.60000000000002 m 356.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 252.60000000000002 m 400.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 238.60000000000002 m 400.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 236.60000000000002 m 400.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 252.60000000000002 m 444.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 238.60000000000002 m 444.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 236.60000000000002 m 444.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 252.60000000000002 m 488.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 238.60000000000002 m 488.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 236.60000000000002 m 488.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 252.60000000000002 m 532.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 238.60000000000002 m 532.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 236.60000000000002 m 532.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 252.60000000000002 m 575.5 252.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 238.60000000000002 m 575.5 238.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 236.60000000000002 m 575.5 236.60000000000002 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 230.80 391.83 Td (Pr) Tj ET Q q 0 0 0 rg BT 239.09 391.83 Td (oceeds) Tj ET Q BT /F2 9.00 Tf ET BT /F2 5.85 Tf ET q 0 0 0 rg BT 261.31 395.91 Td (\(a\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 333.75 391.83 Td (Divestiture \(Gains\) / Losses) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 495.70 391.83 Td (Royalties) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 376.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 197.50 376.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 241.50 376.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 285.50 376.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 328.50 376.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 372.00 376.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 416.00 376.83 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.00 376.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 504.00 376.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 547.50 376.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 362.27 Td (Investigational HIV medicines) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.65 362.27 Td (387) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 232.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 277.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 334.30 362.32 Td (\(272) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 362.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.00 362.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 362.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 347.27 Td (OTC products \(Reckitt\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.65 347.27 Td (317) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 334.30 347.32 Td (\(277) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 347.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 347.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 332.27 Td (Diabetes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.65 332.27 Td (333) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.65 332.27 Td (374) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 287.10 332.27 Td (3,495) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 332.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.30 332.32 Td (\(82) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 332.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.30 332.32 Td (\(536) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 440.65 332.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.30 332.32 Td (\(361) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 332.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.30 332.32 Td (\(215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 332.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 332.27 Td (\(192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 332.27 Td (\)) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 38.00 317.31 Td (Erbitux*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.65 317.27 Td (252) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 261.65 317.27 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 317.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 317.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.65 317.27 Td (171) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 317.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.30 317.32 Td (\(246) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 317.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.30 317.32 Td (\(70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 317.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 317.27 Td (—) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 38.00 302.31 Td (Recothrom*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.65 302.27 Td (132) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.30 302.32 Td (\(59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 302.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 302.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 287.27 Td (Mature brand products \(Valeant\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.65 287.27 Td (61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.30 287.32 Td (\(88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 287.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 287.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 287.27 Td (—) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 38.00 272.31 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.65 272.27 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.65 272.27 Td (113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 272.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 272.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.30 272.32 Td (\(88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 272.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.65 272.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 272.32 Td (\(11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 272.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.30 272.32 Td (\(8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 272.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 272.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 257.27 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.65 257.27 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 261.65 257.27 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.65 257.27 Td (70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 339.30 257.32 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 257.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.30 257.32 Td (\(48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 257.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.30 257.32 Td (\(28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 440.65 257.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 257.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 257.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 257.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.10 242.27 Td (1,317) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 232.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 251.65 242.27 Td (697) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 277.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 287.10 242.27 Td (3,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 334.30 242.32 Td (\(564) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.30 242.32 Td (\(194) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.30 242.32 Td (\(564) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 440.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.30 242.32 Td (\(618) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.30 242.32 Td (\(293) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.00 242.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 242.27 Td (\(192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 242.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 225.50 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 54.00 225.50 Td (Includes ) Tj ET Q q 0 0 0 rg BT 83.10 225.50 Td (royalties ) Tj ET Q q 0 0 0 rg BT 112.65 225.50 Td (received ) Tj ET Q q 0 0 0 rg BT 141.74 225.50 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 179.29 225.50 Td (to ) Tj ET Q q 0 0 0 rg BT 187.51 225.50 Td (the ) Tj ET Q q 0 0 0 rg BT 199.29 225.50 Td (related ) Tj ET Q q 0 0 0 rg BT 223.05 225.50 Td (sale ) Tj ET Q q 0 0 0 rg BT 237.48 225.50 Td (of ) Tj ET Q q 0 0 0 rg BT 246.15 225.50 Td (the ) Tj ET Q q 0 0 0 rg BT 257.92 225.50 Td (asset ) Tj ET Q q 0 0 0 rg BT 275.47 225.50 Td (or ) Tj ET Q q 0 0 0 rg BT 284.14 225.50 Td (business.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 201.50 Td (V) Tj ET Q q 0 0 0 rg BT 41.37 201.50 Td (iiV) Tj ET Q q 0 0 0 rg BT 52.85 201.50 Td ( ) Tj ET Q q 0 0 0 rg BT 55.35 201.50 Td (Healthcar) Tj ET Q q 0 0 0 rg BT 95.53 201.50 Td (e) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 186.50 Td (In ) Tj ET Q q 0 0 0 rg BT 47.42 186.50 Td (February ) Tj ET Q q 0 0 0 rg BT 86.62 186.50 Td (2016, ) Tj ET Q q 0 0 0 rg BT 112.21 186.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 136.43 186.50 Td (sold ) Tj ET Q q 0 0 0 rg BT 156.20 186.50 Td (its ) Tj ET Q q 0 0 0 rg BT 168.74 186.50 Td (investigational ) Tj ET Q q 0 0 0 rg BT 230.71 186.50 Td (HIV) Tj ET Q q 0 0 0 rg BT 248.30 186.50 Td ( ) Tj ET Q q 0 0 0 rg BT 251.40 186.50 Td (medicines ) Tj ET Q q 0 0 0 rg BT 295.03 186.50 Td (business ) Tj ET Q q 0 0 0 rg BT 332.02 186.50 Td (to ) Tj ET Q q 0 0 0 rg BT 342.67 186.50 Td (V) Tj ET Q q 0 0 0 rg BT 349.29 186.50 Td (iiV) Tj ET Q q 0 0 0 rg BT 361.89 186.50 Td ( ) Tj ET Q q 0 0 0 rg BT 364.98 186.50 Td (Healthcare ) Tj ET Q q 0 0 0 rg BT 411.38 186.50 Td (which ) Tj ET Q q 0 0 0 rg BT 438.91 186.50 Td (includes ) Tj ET Q q 0 0 0 rg BT 475.33 186.50 Td (a ) Tj ET Q q 0 0 0 rg BT 482.87 186.50 Td (number ) Tj ET Q q 0 0 0 rg BT 516.51 186.50 Td (of ) Tj ET Q q 0 0 0 rg BT 527.93 186.50 Td (programs ) Tj ET Q q 0 0 0 rg BT 568.79 186.50 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 174.50 Td (dif) Tj ET Q q 0 0 0 rg BT 46.93 174.50 Td (ferent ) Tj ET Q q 0 0 0 rg BT 73.64 174.50 Td (stages ) Tj ET Q q 0 0 0 rg BT 101.48 174.50 Td (of ) Tj ET Q q 0 0 0 rg BT 113.21 174.50 Td (discovery) Tj ET Q q 0 0 0 rg BT 151.44 174.50 Td (, ) Tj ET Q q 0 0 0 rg BT 157.34 174.50 Td (preclinical ) Tj ET Q q 0 0 0 rg BT 202.94 174.50 Td (and ) Tj ET Q q 0 0 0 rg BT 220.78 174.50 Td (clinical ) Tj ET Q q 0 0 0 rg BT 253.61 174.50 Td (development. ) Tj ET Q q 0 0 0 rg BT 310.92 174.50 Td (The ) Tj ET Q q 0 0 0 rg BT 329.86 174.50 Td (transaction ) Tj ET Q q 0 0 0 rg BT 377.14 174.50 Td (excluded ) Tj ET Q q 0 0 0 rg BT 416.63 174.50 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 446.85 174.50 Td (HIV) Tj ET Q q 0 0 0 rg BT 464.44 174.50 Td ( ) Tj ET Q q 0 0 0 rg BT 467.84 174.50 Td (marketed ) Tj ET Q q 0 0 0 rg BT 508.44 174.50 Td (medicines. ) Tj ET Q q 0 0 0 rg BT 554.89 174.50 Td (BMS ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 162.50 Td (earned ) Tj ET Q q 0 0 0 rg BT 64.64 162.50 Td (transitional ) Tj ET Q q 0 0 0 rg BT 111.62 162.50 Td (fees ) Tj ET Q q 0 0 0 rg BT 129.71 162.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 140.03 162.50 Td ($105 ) Tj ET Q q 0 0 0 rg BT 162.02 162.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 190.91 162.50 Td ( ) Tj ET Q q 0 0 0 rg BT 192.90 162.50 Td (for ) Tj ET Q q 0 0 0 rg BT 206.55 162.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 235.75 162.50 Td (R&D ) Tj ET Q q 0 0 0 rg BT 259.41 162.50 Td (and ) Tj ET Q q 0 0 0 rg BT 275.84 162.50 Td (other ) Tj ET Q q 0 0 0 rg BT 298.38 162.50 Td (services ) Tj ET Q q 0 0 0 rg BT 332.58 162.50 Td (in ) Tj ET Q q 0 0 0 rg BT 342.34 162.50 Td (2016. ) Tj ET Q q 0 0 0 rg BT 366.84 162.50 Td (In ) Tj ET Q q 0 0 0 rg BT 377.16 162.50 Td (February ) Tj ET Q q 0 0 0 rg BT 415.25 162.50 Td (2016, ) Tj ET Q q 0 0 0 rg BT 439.74 162.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 462.85 162.50 Td (received ) Tj ET Q q 0 0 0 rg BT 498.71 162.50 Td (an ) Tj ET Q q 0 0 0 rg BT 510.14 162.50 Td (upfront ) Tj ET Q q 0 0 0 rg BT 541.57 162.50 Td (payment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 150.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.79 150.50 Td ($350 ) Tj ET Q q 0 0 0 rg BT 69.24 150.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.13 150.50 Td (. ) Tj ET Q q 0 0 0 rg BT 103.09 150.50 Td (BMS ) Tj ET Q q 0 0 0 rg BT 126.67 150.50 Td (will ) Tj ET Q q 0 0 0 rg BT 144.68 150.50 Td (also ) Tj ET Q q 0 0 0 rg BT 163.24 150.50 Td (receive ) Tj ET Q q 0 0 0 rg BT 194.56 150.50 Td (from ) Tj ET Q q 0 0 0 rg BT 216.27 150.50 Td (V) Tj ET Q q 0 0 0 rg BT 222.89 150.50 Td (iiV) Tj ET Q q 0 0 0 rg BT 235.49 150.50 Td ( ) Tj ET Q q 0 0 0 rg BT 237.95 150.50 Td (Healthcare ) Tj ET Q q 0 0 0 rg BT 283.70 150.50 Td (contingent ) Tj ET Q q 0 0 0 rg BT 328.37 150.50 Td (development ) Tj ET Q q 0 0 0 rg BT 382.48 150.50 Td (and ) Tj ET Q q 0 0 0 rg BT 399.37 150.50 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 442.92 150.50 Td (milestone ) Tj ET Q q 0 0 0 rg BT 484.25 150.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 525.04 150.50 Td (of ) Tj ET Q q 0 0 0 rg BT 535.82 150.50 Td (up ) Tj ET Q q 0 0 0 rg BT 548.28 150.50 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.51 150.50 Td ($1.1 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 138.50 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.11 138.50 Td (, ) Tj ET Q q 0 0 0 rg BT 66.74 138.50 Td (sales-based ) Tj ET Q q 0 0 0 rg BT 114.41 138.50 Td (milestone ) Tj ET Q q 0 0 0 rg BT 155.42 138.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 195.87 138.50 Td (of ) Tj ET Q q 0 0 0 rg BT 206.33 138.50 Td (up ) Tj ET Q q 0 0 0 rg BT 218.46 138.50 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.37 138.50 Td ($4.3 ) Tj ET Q q 0 0 0 rg BT 248.00 138.50 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.11 138.50 Td ( ) Tj ET Q q 0 0 0 rg BT 276.24 138.50 Td (and ) Tj ET Q q 0 0 0 rg BT 292.81 138.50 Td (future ) Tj ET Q q 0 0 0 rg BT 318.81 138.50 Td (tiered ) Tj ET Q q 0 0 0 rg BT 343.71 138.50 Td (royalties ) Tj ET Q q 0 0 0 rg BT 380.27 138.50 Td (if ) Tj ET Q q 0 0 0 rg BT 388.50 138.50 Td (the ) Tj ET Q q 0 0 0 rg BT 402.85 138.50 Td (products ) Tj ET Q q 0 0 0 rg BT 439.42 138.50 Td (are ) Tj ET Q q 0 0 0 rg BT 453.75 138.50 Td (approved ) Tj ET Q q 0 0 0 rg BT 493.09 138.50 Td (and ) Tj ET Q q 0 0 0 rg BT 509.66 138.50 Td (commercialized.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 114.50 Td (Other Divestitur) Tj ET Q q 0 0 0 rg BT 101.45 114.50 Td (es) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 99.50 Td (Refer ) Tj ET Q q 0 0 0 rg BT 60.59 99.50 Td (to ) Tj ET Q q 0 0 0 rg BT 70.75 99.50 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 106.65 99.50 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.65 99.50 Td (. ) Tj ET Q q 0 0 0 rg BT 116.01 99.50 Td (Alliances" ) Tj ET Q q 0 0 0 rg BT 160.23 99.50 Td (for ) Tj ET Q q 0 0 0 rg BT 174.28 99.50 Td (a ) Tj ET Q q 0 0 0 rg BT 181.10 99.50 Td (discussion ) Tj ET Q q 0 0 0 rg BT 225.15 99.50 Td (on ) Tj ET Q q 0 0 0 rg BT 237.53 99.50 Td (the ) Tj ET Q q 0 0 0 rg BT 252.13 99.50 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 296.72 99.50 Td (transactions ) Tj ET Q q 0 0 0 rg BT 346.87 99.50 Td (with ) Tj ET Q q 0 0 0 rg BT 367.03 99.50 Td (Reckitt, ) Tj ET Q q 0 0 0 rg BT 400.79 99.50 Td (Lilly) Tj ET Q q 0 0 0 rg BT 419.59 99.50 Td (, ) Tj ET Q q 0 0 0 rg BT 424.30 99.50 Td (The ) Tj ET Q q 0 0 0 rg BT 442.22 99.50 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 486.26 99.50 Td (Company) Tj ET Q q 0 0 0 rg BT 524.50 99.50 Td (, ) Tj ET Q q 0 0 0 rg BT 529.21 99.50 Td (V) Tj ET Q q 0 0 0 rg BT 535.32 99.50 Td (aleant ) Tj ET Q q 0 0 0 rg BT 561.58 99.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 87.50 Td (AstraZeneca. ) Tj ET Q q 0 0 0 rg BT 90.61 87.50 Td (Revenues ) Tj ET Q q 0 0 0 rg BT 131.08 87.50 Td (and ) Tj ET Q q 0 0 0 rg BT 147.10 87.50 Td (pretax ) Tj ET Q q 0 0 0 rg BT 173.68 87.50 Td (earnings ) Tj ET Q q 0 0 0 rg BT 209.14 87.50 Td (related ) Tj ET Q q 0 0 0 rg BT 237.93 87.50 Td (to ) Tj ET Q q 0 0 0 rg BT 247.30 87.50 Td (these ) Tj ET Q q 0 0 0 rg BT 269.43 87.50 Td (businesses ) Tj ET Q q 0 0 0 rg BT 313.24 87.50 Td (were ) Tj ET Q q 0 0 0 rg BT 334.26 87.50 Td (not ) Tj ET Q q 0 0 0 rg BT 348.63 87.50 Td (material ) Tj ET Q q 0 0 0 rg BT 382.98 87.50 Td (in ) Tj ET Q q 0 0 0 rg BT 392.34 87.50 Td (2016, ) Tj ET Q q 0 0 0 rg BT 416.43 87.50 Td (2015 ) Tj ET Q q 0 0 0 rg BT 438.02 87.50 Td (and ) Tj ET Q q 0 0 0 rg BT 454.05 87.50 Td (2014 ) Tj ET Q q 0 0 0 rg BT 475.63 87.50 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 519.99 87.50 Td (the ) Tj ET Q q 0 0 0 rg BT 533.79 87.50 Td (divestiture ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 75.50 Td (gains\).) Tj ET Q endstream endobj 153 0 obj <> endobj 154 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (76) Tj ET Q BT /F4 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 747.68505859375 m 124.056640625 747.68505859375 l s q 0 0 0 rg BT 36.00 749.25 Td (Assets ) Tj ET Q q 0 0 0 rg BT 64.06 749.25 Td (Held-For-Sale) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 734.25 Td (Assets ) Tj ET Q q 0 0 0 rg BT 63.88 734.25 Td (held-for) Tj ET Q q 0 0 0 rg BT 95.89 734.25 Td (-sale ) Tj ET Q q 0 0 0 rg BT 116.54 734.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.74 734.25 Td ($134 ) Tj ET Q q 0 0 0 rg BT 159.51 734.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 188.40 734.25 Td ( ) Tj ET Q q 0 0 0 rg BT 190.17 734.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.16 734.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 257.02 734.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 277.02 734.25 Td ( ) Tj ET Q q 0 0 0 rg BT 278.79 734.25 Td (and ) Tj ET Q q 0 0 0 rg BT 295.00 734.25 Td (included ) Tj ET Q q 0 0 0 rg BT 331.21 734.25 Td (in ) Tj ET Q q 0 0 0 rg BT 340.75 734.25 Td (prepaid ) Tj ET Q q 0 0 0 rg BT 372.51 734.25 Td (expenses ) Tj ET Q q 0 0 0 rg BT 410.38 734.25 Td (and ) Tj ET Q q 0 0 0 rg BT 426.59 734.25 Td (other) Tj ET Q q 0 0 0 rg BT 446.59 734.25 Td (. ) Tj ET Q q 0 0 0 rg BT 450.73 734.25 Td (The ) Tj ET Q q 0 0 0 rg BT 468.05 734.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 499.81 734.25 Td (consisted ) Tj ET Q q 0 0 0 rg BT 538.80 734.25 Td (primarily ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 722.25 Td (of ) Tj ET Q q 0 0 0 rg BT 47.00 722.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 85.22 722.25 Td (related ) Tj ET Q q 0 0 0 rg BT 115.09 722.25 Td (to ) Tj ET Q q 0 0 0 rg BT 125.54 722.25 Td (the ) Tj ET Q q 0 0 0 rg BT 140.42 722.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 201.97 722.25 Td (HIV) Tj ET Q q 0 0 0 rg BT 219.56 722.25 Td ( ) Tj ET Q q 0 0 0 rg BT 222.23 722.25 Td (medicines ) Tj ET Q q 0 0 0 rg BT 265.44 722.25 Td (business ) Tj ET Q q 0 0 0 rg BT 301.99 722.25 Td (and ) Tj ET Q q 0 0 0 rg BT 319.10 722.25 Td (the ) Tj ET Q q 0 0 0 rg BT 333.98 722.25 Td (business ) Tj ET Q q 0 0 0 rg BT 370.54 722.25 Td (comprising ) Tj ET Q q 0 0 0 rg BT 418.21 722.25 Td (an ) Tj ET Q q 0 0 0 rg BT 430.31 722.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 464.07 722.25 Td (with ) Tj ET Q q 0 0 0 rg BT 484.51 722.25 Td (Reckitt. ) Tj ET Q q 0 0 0 rg BT 518.37 722.25 Td (The ) Tj ET Q q 0 0 0 rg BT 536.59 722.25 Td (allocation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 710.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.48 710.25 Td (goodwill ) Tj ET Q q 0 0 0 rg BT 84.19 710.25 Td (was ) Tj ET Q q 0 0 0 rg BT 101.90 710.25 Td (determined ) Tj ET Q q 0 0 0 rg BT 149.03 710.25 Td (using ) Tj ET Q q 0 0 0 rg BT 172.86 710.25 Td (the ) Tj ET Q q 0 0 0 rg BT 187.23 710.25 Td (relative ) Tj ET Q q 0 0 0 rg BT 219.36 710.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 235.39 710.25 Td (value ) Tj ET Q q 0 0 0 rg BT 259.20 710.25 Td (of ) Tj ET Q q 0 0 0 rg BT 269.68 710.25 Td (the ) Tj ET Q q 0 0 0 rg BT 284.05 710.25 Td (applicable ) Tj ET Q q 0 0 0 rg BT 327.29 710.25 Td (business ) Tj ET Q q 0 0 0 rg BT 363.34 710.25 Td (to ) Tj ET Q q 0 0 0 rg BT 373.27 710.25 Td (the ) Tj ET Q q 0 0 0 rg BT 387.64 710.25 Td (Company's ) Tj ET Q q 0 0 0 rg BT 434.37 710.25 Td (reporting ) Tj ET Q q 0 0 0 rg BT 473.18 710.25 Td (unit. ) Tj ET Q q 0 0 0 rg BT 493.39 710.25 Td (Revenues ) Tj ET Q q 0 0 0 rg BT 534.42 710.25 Td (and ) Tj ET Q q 0 0 0 rg BT 551.01 710.25 Td (pretax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 698.25 Td (earnings ) Tj ET Q q 0 0 0 rg BT 72.38 698.25 Td (related ) Tj ET Q q 0 0 0 rg BT 102.08 698.25 Td (to ) Tj ET Q q 0 0 0 rg BT 112.36 698.25 Td (these ) Tj ET Q q 0 0 0 rg BT 135.40 698.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 180.13 698.25 Td (were ) Tj ET Q q 0 0 0 rg BT 202.05 698.25 Td (not ) Tj ET Q q 0 0 0 rg BT 217.33 698.25 Td (material ) Tj ET Q q 0 0 0 rg BT 252.59 698.25 Td (in ) Tj ET Q q 0 0 0 rg BT 262.87 698.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 287.87 698.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 310.37 698.25 Td (and ) Tj ET Q q 0 0 0 rg BT 327.31 698.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 349.81 698.25 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 395.07 698.25 Td (the ) Tj ET Q q 0 0 0 rg BT 409.79 698.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 454.50 698.25 Td (gains\).) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 672.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 672.25 Td (5) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 672.25 Td (. OTHER \(INCOME\)/EXPENSE) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 655.25 Td (Other \(income\)/expense includes:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 618.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 618.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 618.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 618.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 592.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 592.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 592.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 592.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 592.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 592.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 592.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 566.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 566.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 566.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 566.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 566.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 566.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 566.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 540.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 540.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 540.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 540.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 540.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 514.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 514.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 514.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 514.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 514.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 514.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 514.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 488.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 488.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 488.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 488.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 488.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 488.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 488.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 462.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 462.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 462.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 462.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 462.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 462.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 462.75 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 436.75 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 436.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 436.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 436.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 436.75 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 436.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 436.75 70.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 631.75 m 429.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 429.5 631.75 m 433.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 631.75 m 502.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 631.75 m 506.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 631.75 m 576.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 631.75 m 429.5 631.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 618.75 m 429.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 618.75 m 576.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 618.75 m 502.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 618.75 m 576.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 436.75 m 502.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 436.75 m 576.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 436.75 m 429.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 424.75 m 429.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 422.75 m 429.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 424.75 m 502.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 422.75 m 502.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 424.75 m 576.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 422.75 m 576.5 422.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 636.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 423.70 635.98 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 623.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 622.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 622.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.00 622.98 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 609.32 Td (Interest expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 609.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 609.32 Td (167) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 609.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 609.32 Td (184) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 609.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 609.32 Td (203) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 596.32 Td (Investment income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 596.37 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 596.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 596.37 Td (\(101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 596.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 596.32 Td (\(101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 596.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 583.32 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 583.32 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 583.32 Td (118) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 583.32 Td (163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 570.32 Td (Litigation and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 570.32 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 570.32 Td (159) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 570.32 Td (23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 557.32 Td (Equity in net income of affiliates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.30 557.37 Td (\(77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 557.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.30 557.37 Td (\(83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 557.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 557.32 Td (\(107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 557.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 544.32 Td (Divestiture gains) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 544.37 Td (\(576) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 544.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 544.37 Td (\(196) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 544.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 544.32 Td (\(564) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 544.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 531.32 Td (Royalties and licensing income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 531.37 Td (\(719) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 531.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 531.37 Td (\(383) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 531.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 531.32 Td (\(283) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 531.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 518.32 Td (Transition and other service fees) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.30 518.37 Td (\(238) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 518.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 518.37 Td (\(122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 518.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 518.32 Td (\(170) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 518.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 505.32 Td (Pension charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 505.32 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 505.32 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 505.32 Td (877) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 492.32 Td (Intangible asset impairment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 492.32 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 492.32 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 492.32 Td (29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 479.32 Td (Equity investment impairment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 479.32 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 479.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 479.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 466.32 Td (Written option adjustment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 466.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 466.37 Td (\(123) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 466.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 466.32 Td (32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 453.32 Td (Loss on debt redemption) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 453.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 453.32 Td (180) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 453.32 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 440.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.30 440.37 Td (\(44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 440.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 440.32 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 440.32 Td (63) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 427.32 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.80 427.37 Td (\(1,285) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 427.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 427.37 Td (\(187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 427.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 427.32 Td (210) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 400.25 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 400.25 Td (Litigation ) Tj ET Q q 0 0 0 rg BT 104.94 400.25 Td (and ) Tj ET Q q 0 0 0 rg BT 121.88 400.25 Td (other ) Tj ET Q q 0 0 0 rg BT 144.92 400.25 Td (settlements ) Tj ET Q q 0 0 0 rg BT 192.41 400.25 Td (includes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.24 400.25 Td ($90 ) Tj ET Q q 0 0 0 rg BT 245.74 400.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.63 400.25 Td ( ) Tj ET Q q 0 0 0 rg BT 277.13 400.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 287.41 400.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.41 400.25 Td ( ) Tj ET Q q 0 0 0 rg BT 309.91 400.25 Td (for ) Tj ET Q q 0 0 0 rg BT 324.07 400.25 Td (a ) Tj ET Q q 0 0 0 rg BT 331.01 400.25 Td (contractual ) Tj ET Q q 0 0 0 rg BT 377.93 400.25 Td (dispute ) Tj ET Q q 0 0 0 rg BT 409.31 400.25 Td (related ) Tj ET Q q 0 0 0 rg BT 439.02 400.25 Td (to ) Tj ET Q q 0 0 0 rg BT 449.29 400.25 Td (a ) Tj ET Q q 0 0 0 rg BT 456.23 400.25 Td (license.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 388.25 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 388.25 Td (T) Tj ET Q q 0 0 0 rg BT 68.76 388.25 Td (ransition ) Tj ET Q q 0 0 0 rg BT 105.91 388.25 Td (and ) Tj ET Q q 0 0 0 rg BT 122.50 388.25 Td (other ) Tj ET Q q 0 0 0 rg BT 145.21 388.25 Td (service ) Tj ET Q q 0 0 0 rg BT 175.68 388.25 Td (fees ) Tj ET Q q 0 0 0 rg BT 193.94 388.25 Td (were ) Tj ET Q q 0 0 0 rg BT 215.52 388.25 Td (related ) Tj ET Q q 0 0 0 rg BT 244.88 388.25 Td (to ) Tj ET Q q 0 0 0 rg BT 254.82 388.25 Td (the ) Tj ET Q q 0 0 0 rg BT 269.19 388.25 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 313.56 388.25 Td (of ) Tj ET Q q 0 0 0 rg BT 324.05 388.25 Td (the ) Tj ET Q q 0 0 0 rg BT 338.42 388.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 373.34 388.25 Td (and ) Tj ET Q q 0 0 0 rg BT 389.94 388.25 Td (investigational ) Tj ET Q q 0 0 0 rg BT 450.97 388.25 Td (HIV) Tj ET Q q 0 0 0 rg BT 468.57 388.25 Td ( ) Tj ET Q q 0 0 0 rg BT 470.72 388.25 Td (businesses ) Tj ET Q q 0 0 0 rg BT 515.10 388.25 Td (in ) Tj ET Q q 0 0 0 rg BT 525.04 388.25 Td (2016 ) Tj ET Q q 0 0 0 rg BT 547.20 388.25 Td (and ) Tj ET Q q 0 0 0 rg BT 563.79 388.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 376.25 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 98.26 376.25 Td (business ) Tj ET Q q 0 0 0 rg BT 134.66 376.25 Td (in ) Tj ET Q q 0 0 0 rg BT 144.93 376.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 167.43 376.25 Td (and ) Tj ET Q q 0 0 0 rg BT 184.37 376.25 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 364.25 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 364.25 Td (W) Tj ET Q q 0 0 0 rg BT 72.04 364.25 Td (ritten ) Tj ET Q q 0 0 0 rg BT 95.12 364.25 Td (option ) Tj ET Q q 0 0 0 rg BT 122.66 364.25 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 172.42 364.25 Td (included ) Tj ET Q q 0 0 0 rg BT 208.83 364.25 Td (the ) Tj ET Q q 0 0 0 rg BT 223.03 364.25 Td (change ) Tj ET Q q 0 0 0 rg BT 253.33 364.25 Td (in ) Tj ET Q q 0 0 0 rg BT 263.09 364.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 278.95 364.25 Td (value ) Tj ET Q q 0 0 0 rg BT 302.59 364.25 Td (of ) Tj ET Q q 0 0 0 rg BT 312.90 364.25 Td (the ) Tj ET Q q 0 0 0 rg BT 327.10 364.25 Td (written ) Tj ET Q q 0 0 0 rg BT 357.41 364.25 Td (option ) Tj ET Q q 0 0 0 rg BT 384.95 364.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 418.04 364.25 Td (attributed ) Tj ET Q q 0 0 0 rg BT 458.34 364.25 Td (to ) Tj ET Q q 0 0 0 rg BT 468.10 364.25 Td (the ) Tj ET Q q 0 0 0 rg BT 482.30 364.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 513.17 364.25 Td (alliance ) Tj ET Q q 0 0 0 rg BT 546.24 364.25 Td (in ) Tj ET Q q 0 0 0 rg BT 556.00 364.25 Td (2015 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 352.25 Td (and ) Tj ET Q q 0 0 0 rg BT 79.76 352.25 Td (V) Tj ET Q q 0 0 0 rg BT 85.87 352.25 Td (aleant ) Tj ET Q q 0 0 0 rg BT 112.24 352.25 Td (and ) Tj ET Q q 0 0 0 rg BT 129.18 352.25 Td (Reckitt ) Tj ET Q q 0 0 0 rg BT 160.56 352.25 Td (in ) Tj ET Q q 0 0 0 rg BT 170.84 352.25 Td (2014.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 340.25 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 340.25 Td (A) Tj ET Q q 0 0 0 rg BT 69.67 340.25 Td ( ) Tj ET Q q 0 0 0 rg BT 72.17 340.25 Td (debt ) Tj ET Q q 0 0 0 rg BT 91.89 340.25 Td (redemption ) Tj ET Q q 0 0 0 rg BT 139.93 340.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 158.00 340.25 Td (of ) Tj ET Q q 0 0 0 rg BT 168.83 340.25 Td ($180 ) Tj ET Q q 0 0 0 rg BT 191.33 340.25 Td (million ) Tj ET Q q 0 0 0 rg BT 222.72 340.25 Td (resulted ) Tj ET Q q 0 0 0 rg BT 256.88 340.25 Td (from ) Tj ET Q q 0 0 0 rg BT 278.82 340.25 Td (the ) Tj ET Q q 0 0 0 rg BT 293.54 340.25 Td (early ) Tj ET Q q 0 0 0 rg BT 316.02 340.25 Td (redemption ) Tj ET Q q 0 0 0 rg BT 364.07 340.25 Td (of ) Tj ET Q q 0 0 0 rg BT 374.90 340.25 Td (euro ) Tj ET Q q 0 0 0 rg BT 395.17 340.25 Td (notes ) Tj ET Q q 0 0 0 rg BT 418.78 340.25 Td (and ) Tj ET Q q 0 0 0 rg BT 435.72 340.25 Td (a ) Tj ET Q q 0 0 0 rg BT 442.66 340.25 Td (tender ) Tj ET Q q 0 0 0 rg BT 470.15 340.25 Td (of) Tj ET Q q 0 0 0 rg BT 478.29 340.25 Td (fer ) Tj ET Q q 0 0 0 rg BT 491.90 340.25 Td (for ) Tj ET Q q 0 0 0 rg BT 506.06 340.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 535.76 340.25 Td (other ) Tj ET Q q 0 0 0 rg BT 558.81 340.25 Td (debt ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 328.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 103.26 328.25 Td (in ) Tj ET Q q 0 0 0 rg BT 113.54 328.25 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 316.25 Td (• ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 316.25 Td (Other ) Tj ET Q q 0 0 0 rg BT 89.23 316.25 Td (includes ) Tj ET Q q 0 0 0 rg BT 126.01 316.25 Td (an ) Tj ET Q q 0 0 0 rg BT 138.91 316.25 Td (unrealized ) Tj ET Q q 0 0 0 rg BT 184.01 316.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 216.34 316.25 Td (exchange ) Tj ET Q q 0 0 0 rg BT 257.55 316.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 276.57 316.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 288.36 316.25 Td ($52 ) Tj ET Q q 0 0 0 rg BT 306.82 316.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.71 316.25 Td ( ) Tj ET Q q 0 0 0 rg BT 339.17 316.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.41 316.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.41 316.25 Td ( ) Tj ET Q q 0 0 0 rg BT 373.87 316.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 412.32 316.25 Td (from ) Tj ET Q q 0 0 0 rg BT 435.22 316.25 Td (the ) Tj ET Q q 0 0 0 rg BT 450.89 316.25 Td (remeasurement ) Tj ET Q q 0 0 0 rg BT 515.43 316.25 Td (of ) Tj ET Q q 0 0 0 rg BT 527.22 316.25 Td (the ) Tj ET Q q 0 0 0 rg BT 542.89 316.25 Td (Bolivar) Tj ET Q q 0 0 0 rg BT 572.69 316.25 Td (-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 304.25 Td (denominated ) Tj ET Q q 0 0 0 rg BT 117.28 304.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 137.67 304.25 Td (and ) Tj ET Q q 0 0 0 rg BT 154.74 304.25 Td (other ) Tj ET Q q 0 0 0 rg BT 177.91 304.25 Td (monetary ) Tj ET Q q 0 0 0 rg BT 218.30 304.25 Td (balances ) Tj ET Q q 0 0 0 rg BT 255.35 304.25 Td (of ) Tj ET Q q 0 0 0 rg BT 266.30 304.25 Td (BMS’) Tj ET Q q 0 0 0 rg BT 290.21 304.25 Td (s ) Tj ET Q q 0 0 0 rg BT 296.72 304.25 Td (wholly-owned ) Tj ET Q q 0 0 0 rg BT 357.12 304.25 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 400.85 304.25 Td (in ) Tj ET Q q 0 0 0 rg BT 411.07 304.25 Td (V) Tj ET Q q 0 0 0 rg BT 417.18 304.25 Td (enezuela ) Tj ET Q q 0 0 0 rg BT 454.78 304.25 Td (as ) Tj ET Q q 0 0 0 rg BT 465.73 304.25 Td (of ) Tj ET Q q 0 0 0 rg BT 476.69 304.25 Td (December ) Tj ET Q q 0 0 0 rg BT 520.40 304.25 Td (31, ) Tj ET Q q 0 0 0 rg BT 535.52 304.25 Td (2015. ) Tj ET Q q 0 0 0 rg BT 560.46 304.25 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 292.25 Td (exchange ) Tj ET Q q 0 0 0 rg BT 102.59 292.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 119.42 292.25 Td (was ) Tj ET Q q 0 0 0 rg BT 136.81 292.25 Td (changed ) Tj ET Q q 0 0 0 rg BT 171.97 292.25 Td (to ) Tj ET Q q 0 0 0 rg BT 181.58 292.25 Td (the ) Tj ET Q q 0 0 0 rg BT 195.64 292.25 Td (SIMADI ) Tj ET Q q 0 0 0 rg BT 233.04 292.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 249.86 292.25 Td (of ) Tj ET Q q 0 0 0 rg BT 260.03 292.25 Td (200 ) Tj ET Q q 0 0 0 rg BT 276.87 292.25 Td (from ) Tj ET Q q 0 0 0 rg BT 298.15 292.25 Td (the ) Tj ET Q q 0 0 0 rg BT 312.21 292.25 Td (of) Tj ET Q q 0 0 0 rg BT 320.36 292.25 Td (ficial ) Tj ET Q q 0 0 0 rg BT 342.74 292.25 Td (CENCOEX ) Tj ET Q q 0 0 0 rg BT 391.80 292.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 408.63 292.25 Td (of ) Tj ET Q q 0 0 0 rg BT 418.79 292.25 Td (6.3 ) Tj ET Q q 0 0 0 rg BT 433.13 292.25 Td (after ) Tj ET Q q 0 0 0 rg BT 453.29 292.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 501.79 292.25 Td (the ) Tj ET Q q 0 0 0 rg BT 515.84 292.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 546.01 292.25 Td (amount ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 280.25 Td (of ) Tj ET Q q 0 0 0 rg BT 74.93 280.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 107.41 280.25 Td (currency ) Tj ET Q q 0 0 0 rg BT 145.99 280.25 Td (exchanged ) Tj ET Q q 0 0 0 rg BT 192.35 280.25 Td (during ) Tj ET Q q 0 0 0 rg BT 222.06 280.25 Td (the ) Tj ET Q q 0 0 0 rg BT 237.88 280.25 Td (second ) Tj ET Q q 0 0 0 rg BT 269.25 280.25 Td (half ) Tj ET Q q 0 0 0 rg BT 288.40 280.25 Td (of ) Tj ET Q q 0 0 0 rg BT 300.33 280.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 326.43 280.25 Td (published ) Tj ET Q q 0 0 0 rg BT 368.92 280.25 Td (exchange ) Tj ET Q q 0 0 0 rg BT 410.28 280.25 Td (rates ) Tj ET Q q 0 0 0 rg BT 432.76 280.25 Td (and ) Tj ET Q q 0 0 0 rg BT 450.80 280.25 Td (the ) Tj ET Q q 0 0 0 rg BT 466.62 280.25 Td (continuing ) Tj ET Q q 0 0 0 rg BT 512.99 280.25 Td (deterioration ) Tj ET Q q 0 0 0 rg BT 567.69 280.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 268.25 Td (economic ) Tj ET Q q 0 0 0 rg BT 104.37 268.25 Td (conditions ) Tj ET Q q 0 0 0 rg BT 148.54 268.25 Td (in ) Tj ET Q q 0 0 0 rg BT 158.63 268.25 Td (V) Tj ET Q q 0 0 0 rg BT 164.75 268.25 Td (enezuela.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 244.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 244.25 Td (6) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 244.25 Td (. RESTRUCTURING) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 220.25 Td (In ) Tj ET Q q 0 0 0 rg BT 47.00 220.25 Td (October ) Tj ET Q q 0 0 0 rg BT 81.88 220.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 107.05 220.25 Td (the ) Tj ET Q q 0 0 0 rg BT 121.93 220.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 163.49 220.25 Td (announced ) Tj ET Q q 0 0 0 rg BT 209.48 220.25 Td (a ) Tj ET Q q 0 0 0 rg BT 216.58 220.25 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 270.35 220.25 Td (to ) Tj ET Q q 0 0 0 rg BT 280.80 220.25 Td (evolve ) Tj ET Q q 0 0 0 rg BT 310.12 220.25 Td (and ) Tj ET Q q 0 0 0 rg BT 327.23 220.25 Td (streamline ) Tj ET Q q 0 0 0 rg BT 371.55 220.25 Td (its ) Tj ET Q q 0 0 0 rg BT 383.67 220.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 424.10 220.25 Td (model ) Tj ET Q q 0 0 0 rg BT 451.77 220.25 Td (and ) Tj ET Q q 0 0 0 rg BT 468.88 220.25 Td (expects ) Tj ET Q q 0 0 0 rg BT 501.53 220.25 Td (to ) Tj ET Q q 0 0 0 rg BT 511.98 220.25 Td (incur ) Tj ET Q q 0 0 0 rg BT 535.20 220.25 Td (char) Tj ET Q q 0 0 0 rg BT 552.22 220.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 568.22 220.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 208.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 81.65 208.25 Td (with ) Tj ET Q q 0 0 0 rg BT 101.21 208.25 Td (employee ) Tj ET Q q 0 0 0 rg BT 141.87 208.25 Td (workforce ) Tj ET Q q 0 0 0 rg BT 184.74 208.25 Td (reductions ) Tj ET Q q 0 0 0 rg BT 228.18 208.25 Td (and ) Tj ET Q q 0 0 0 rg BT 244.40 208.25 Td (early ) Tj ET Q q 0 0 0 rg BT 266.17 208.25 Td (site ) Tj ET Q q 0 0 0 rg BT 281.83 208.25 Td (exits. ) Tj ET Q q 0 0 0 rg BT 304.88 208.25 Td (The ) Tj ET Q q 0 0 0 rg BT 322.20 208.25 Td (char) Tj ET Q q 0 0 0 rg BT 339.23 208.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 354.34 208.25 Td (are ) Tj ET Q q 0 0 0 rg BT 368.33 208.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 405.65 208.25 Td (to ) Tj ET Q q 0 0 0 rg BT 415.21 208.25 Td (be ) Tj ET Q q 0 0 0 rg BT 426.43 208.25 Td (incurred ) Tj ET Q q 0 0 0 rg BT 461.53 208.25 Td (through ) Tj ET Q q 0 0 0 rg BT 494.42 208.25 Td (2020, ) Tj ET Q q 0 0 0 rg BT 518.70 208.25 Td (range ) Tj ET Q q 0 0 0 rg BT 542.69 208.25 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 196.25 Td ($1.5 ) Tj ET Q q 0 0 0 rg BT 56.68 196.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 82.79 196.25 Td ( ) Tj ET Q q 0 0 0 rg BT 85.97 196.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 96.93 196.25 Td ($2.0 ) Tj ET Q q 0 0 0 rg BT 117.61 196.25 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 143.72 196.25 Td ( ) Tj ET Q q 0 0 0 rg BT 146.90 196.25 Td (and ) Tj ET Q q 0 0 0 rg BT 164.52 196.25 Td (consist ) Tj ET Q q 0 0 0 rg BT 195.47 196.25 Td (of ) Tj ET Q q 0 0 0 rg BT 206.98 196.25 Td (employee ) Tj ET Q q 0 0 0 rg BT 249.03 196.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 298.31 196.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 329.25 196.25 Td (costs, ) Tj ET Q q 0 0 0 rg BT 354.93 196.25 Td (contract ) Tj ET Q q 0 0 0 rg BT 390.31 196.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 439.59 196.25 Td (costs, ) Tj ET Q q 0 0 0 rg BT 465.27 196.25 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 513.40 196.25 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 566.00 196.25 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 184.25 Td (property) Tj ET Q q 0 0 0 rg BT 69.23 184.25 Td (, ) Tj ET Q q 0 0 0 rg BT 74.59 184.25 Td (plant ) Tj ET Q q 0 0 0 rg BT 97.46 184.25 Td (and ) Tj ET Q q 0 0 0 rg BT 114.76 184.25 Td (equipment, ) Tj ET Q q 0 0 0 rg BT 162.34 184.25 Td (impairments ) Tj ET Q q 0 0 0 rg BT 215.19 184.25 Td (on ) Tj ET Q q 0 0 0 rg BT 228.06 184.25 Td (long-lived ) Tj ET Q q 0 0 0 rg BT 272.03 184.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 298.23 184.25 Td (and ) Tj ET Q q 0 0 0 rg BT 315.53 184.25 Td (other ) Tj ET Q q 0 0 0 rg BT 338.94 184.25 Td (site ) Tj ET Q q 0 0 0 rg BT 355.70 184.25 Td (shutdown ) Tj ET Q q 0 0 0 rg BT 397.46 184.25 Td (costs. ) Tj ET Q q 0 0 0 rg BT 422.82 184.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 445.69 184.25 Td (outlays ) Tj ET Q q 0 0 0 rg BT 477.44 184.25 Td (in ) Tj ET Q q 0 0 0 rg BT 488.08 184.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 534.82 184.25 Td (with ) Tj ET Q q 0 0 0 rg BT 555.47 184.25 Td (these ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 172.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 67.12 172.25 Td (are ) Tj ET Q q 0 0 0 rg BT 82.12 172.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 120.44 172.25 Td (to ) Tj ET Q q 0 0 0 rg BT 131.01 172.25 Td (be ) Tj ET Q q 0 0 0 rg BT 143.24 172.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 203.79 172.25 Td (40%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 222.12 172.25 Td ( ) Tj ET Q q 0 0 0 rg BT 224.91 172.25 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.48 172.25 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.81 172.25 Td ( ) Tj ET Q q 0 0 0 rg BT 256.61 172.25 Td (of ) Tj ET Q q 0 0 0 rg BT 267.73 172.25 Td (the ) Tj ET Q q 0 0 0 rg BT 282.74 172.25 Td (total ) Tj ET Q q 0 0 0 rg BT 303.30 172.25 Td (char) Tj ET Q q 0 0 0 rg BT 320.33 172.25 Td (ges. ) Tj ET Q q 0 0 0 rg BT 338.95 172.25 Td (Char) Tj ET Q q 0 0 0 rg BT 358.21 172.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 374.33 172.25 Td (of ) Tj ET Q q 0 0 0 rg BT 385.45 172.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.00 172.25 Td ($90 ) Tj ET Q q 0 0 0 rg BT 463.80 172.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.69 172.25 Td ( ) Tj ET Q q 0 0 0 rg BT 495.48 172.25 Td (were ) Tj ET Q q 0 0 0 rg BT 517.70 172.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 564.35 172.25 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 160.25 Td (these ) Tj ET Q q 0 0 0 rg BT 59.35 160.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 90.48 160.25 Td (during ) Tj ET Q q 0 0 0 rg BT 119.40 160.25 Td (the ) Tj ET Q q 0 0 0 rg BT 134.42 160.25 Td (fourth ) Tj ET Q q 0 0 0 rg BT 161.66 160.25 Td (quarter ) Tj ET Q q 0 0 0 rg BT 192.78 160.25 Td (of ) Tj ET Q q 0 0 0 rg BT 203.92 160.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 229.22 160.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 269.24 160.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 307.04 160.25 Td (from ) Tj ET Q q 0 0 0 rg BT 329.28 160.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 359.29 160.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 383.77 160.25 Td (employee ) Tj ET Q q 0 0 0 rg BT 425.44 160.25 Td (workforce ) Tj ET Q q 0 0 0 rg BT 469.34 160.25 Td (reductions ) Tj ET Q q 0 0 0 rg BT 513.80 160.25 Td (and ) Tj ET Q q 0 0 0 rg BT 531.04 160.25 Td (accelerated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 148.25 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 88.36 148.25 Td (on ) Tj ET Q q 0 0 0 rg BT 101.30 148.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 139.78 148.25 Td (early ) Tj ET Q q 0 0 0 rg BT 162.70 148.25 Td (site ) Tj ET Q q 0 0 0 rg BT 179.53 148.25 Td (exits. ) Tj ET Q q 0 0 0 rg BT 203.86 148.25 Td (Restructuring ) Tj ET Q q 0 0 0 rg BT 261.24 148.25 Td (char) Tj ET Q q 0 0 0 rg BT 278.26 148.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 294.54 148.25 Td (are ) Tj ET Q q 0 0 0 rg BT 309.68 148.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 356.49 148.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 379.43 148.25 Td (meeting ) Tj ET Q q 0 0 0 rg BT 414.58 148.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 444.73 148.25 Td (criteria, ) Tj ET Q q 0 0 0 rg BT 478.48 148.25 Td (including ) Tj ET Q q 0 0 0 rg BT 519.20 148.25 Td (finalization ) Tj ET Q q 0 0 0 rg BT 567.67 148.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 136.25 Td (committed ) Tj ET Q q 0 0 0 rg BT 81.27 136.25 Td (plans, ) Tj ET Q q 0 0 0 rg BT 107.38 136.25 Td (reliable ) Tj ET Q q 0 0 0 rg BT 139.86 136.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 179.57 136.25 Td (and ) Tj ET Q q 0 0 0 rg BT 196.51 136.25 Td (discussions ) Tj ET Q q 0 0 0 rg BT 244.57 136.25 Td (with ) Tj ET Q q 0 0 0 rg BT 264.85 136.25 Td (local ) Tj ET Q q 0 0 0 rg BT 286.78 136.25 Td (works ) Tj ET Q q 0 0 0 rg BT 313.72 136.25 Td (councils ) Tj ET Q q 0 0 0 rg BT 349.55 136.25 Td (in ) Tj ET Q q 0 0 0 rg BT 359.83 136.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 389.53 136.25 Td (markets.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 112.25 Td (Other ) Tj ET Q q 0 0 0 rg BT 62.40 112.25 Td (restructuring ) Tj ET Q q 0 0 0 rg BT 117.13 112.25 Td (char) Tj ET Q q 0 0 0 rg BT 134.16 112.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 151.12 112.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 198.62 112.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 221.70 112.25 Td (to ) Tj ET Q q 0 0 0 rg BT 233.11 112.25 Td (the ) Tj ET Q q 0 0 0 rg BT 248.96 112.25 Td (above ) Tj ET Q q 0 0 0 rg BT 276.47 112.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 308.43 112.25 Td (were ) Tj ET Q q 0 0 0 rg BT 331.50 112.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 372.35 112.25 Td (related ) Tj ET Q q 0 0 0 rg BT 403.18 112.25 Td (to ) Tj ET Q q 0 0 0 rg BT 414.60 112.25 Td (specialty ) Tj ET Q q 0 0 0 rg BT 453.77 112.25 Td (care ) Tj ET Q q 0 0 0 rg BT 474.05 112.25 Td (transformation ) Tj ET Q q 0 0 0 rg BT 536.56 112.25 Td (initiatives ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 100.25 Td (designed ) Tj ET Q q 0 0 0 rg BT 73.89 100.25 Td (to ) Tj ET Q q 0 0 0 rg BT 84.01 100.25 Td (create ) Tj ET Q q 0 0 0 rg BT 110.22 100.25 Td (a ) Tj ET Q q 0 0 0 rg BT 117.00 100.25 Td (more ) Tj ET Q q 0 0 0 rg BT 139.89 100.25 Td (simplified ) Tj ET Q q 0 0 0 rg BT 182.79 100.25 Td (or) Tj ET Q q 0 0 0 rg BT 190.94 100.25 Td (ganization ) Tj ET Q q 0 0 0 rg BT 234.93 100.25 Td (across ) Tj ET Q q 0 0 0 rg BT 262.26 100.25 Td (all ) Tj ET Q q 0 0 0 rg BT 274.60 100.25 Td (functions ) Tj ET Q q 0 0 0 rg BT 314.16 100.25 Td (and ) Tj ET Q q 0 0 0 rg BT 330.95 100.25 Td (geographic ) Tj ET Q q 0 0 0 rg BT 377.71 100.25 Td (markets. ) Tj ET Q q 0 0 0 rg BT 414.21 100.25 Td (In ) Tj ET Q q 0 0 0 rg BT 424.89 100.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 462.50 100.25 Td (accelerated ) Tj ET Q q 0 0 0 rg BT 509.80 100.25 Td (depreciation ) Tj ET Q q 0 0 0 rg BT 561.57 100.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 88.25 Td (other ) Tj ET Q q 0 0 0 rg BT 59.05 88.25 Td (char) Tj ET Q q 0 0 0 rg BT 76.07 88.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 91.90 88.25 Td (were ) Tj ET Q q 0 0 0 rg BT 113.83 88.25 Td (incurred ) Tj ET Q q 0 0 0 rg BT 149.65 88.25 Td (in ) Tj ET Q q 0 0 0 rg BT 159.93 88.25 Td (connection ) Tj ET Q q 0 0 0 rg BT 206.30 88.25 Td (with ) Tj ET Q q 0 0 0 rg BT 226.58 88.25 Td (early ) Tj ET Q q 0 0 0 rg BT 249.06 88.25 Td (exits ) Tj ET Q q 0 0 0 rg BT 270.45 88.25 Td (of ) Tj ET Q q 0 0 0 rg BT 281.28 88.25 Td (a ) Tj ET Q q 0 0 0 rg BT 288.22 88.25 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 349.03 88.25 Td (site ) Tj ET Q q 0 0 0 rg BT 365.41 88.25 Td (in ) Tj ET Q q 0 0 0 rg BT 375.69 88.25 Td (Ireland ) Tj ET Q q 0 0 0 rg BT 406.51 88.25 Td (and ) Tj ET Q q 0 0 0 rg BT 423.45 88.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 447.62 88.25 Td (site ) Tj ET Q q 0 0 0 rg BT 464.00 88.25 Td (in ) Tj ET Q q 0 0 0 rg BT 474.28 88.25 Td (the ) Tj ET Q q 0 0 0 rg BT 489.00 88.25 Td (U.S. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 64.25 Td (Employee ) Tj ET Q q 0 0 0 rg BT 78.96 64.25 Td (termination ) Tj ET Q q 0 0 0 rg BT 127.47 64.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 157.65 64.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 180.06 64.25 Td (were ) Tj ET Q q 0 0 0 rg BT 201.90 64.25 Td (incurred ) Tj ET Q q 0 0 0 rg BT 237.63 64.25 Td (for ) Tj ET Q q 0 0 0 rg BT 251.70 64.25 Td (manufacturing, ) Tj ET Q q 0 0 0 rg BT 314.93 64.25 Td (selling, ) Tj ET Q q 0 0 0 rg BT 346.51 64.25 Td (administrative, ) Tj ET Q q 0 0 0 rg BT 408.63 64.25 Td (and ) Tj ET Q q 0 0 0 rg BT 425.48 64.25 Td (R&D ) Tj ET Q q 0 0 0 rg BT 449.56 64.25 Td (employee ) Tj ET Q q 0 0 0 rg BT 490.85 64.25 Td (workforce ) Tj ET Q q 0 0 0 rg BT 534.35 64.25 Td (reductions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 52.25 Td (across ) Tj ET Q q 0 0 0 rg BT 63.49 52.25 Td (all ) Tj ET Q q 0 0 0 rg BT 75.99 52.25 Td (geographic ) Tj ET Q q 0 0 0 rg BT 122.91 52.25 Td (regions ) Tj ET Q q 0 0 0 rg BT 154.85 52.25 Td (of ) Tj ET Q q 0 0 0 rg BT 165.68 52.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 225.94 52.25 Td (1,100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 248.44 52.25 Td ( ) Tj ET Q q 0 0 0 rg BT 250.94 52.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 261.21 52.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 281.21 52.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.21 52.25 Td (1,200) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.71 52.25 Td ( ) Tj ET Q q 0 0 0 rg BT 311.21 52.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.49 52.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 341.49 52.25 Td ( ) Tj ET Q q 0 0 0 rg BT 343.99 52.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.93 52.25 Td (1,400) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.43 52.25 Td ( ) Tj ET Q q 0 0 0 rg BT 385.93 52.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.21 52.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.21 52.25 Td (. ) Tj ET Q endstream endobj 155 0 obj <> endobj 156 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The following tables summarize the char) Tj ET Q q 0 0 0 rg BT 199.37 749.10 Td (ges and activity related to the restructuring actions:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 708.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 708.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 708.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 708.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 708.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 678.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 678.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 678.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 678.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 678.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 648.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 648.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 648.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 648.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 648.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 648.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 648.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 618.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 618.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 618.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 618.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 618.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 618.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 618.60 70.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 723.6 m 427.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 723.6 m 431.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 723.6 m 501.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 723.6 m 505.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 723.6 m 575.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 723.6 m 427.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 708.6 m 427.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 723.6 m 431.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 723.6 m 501.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 708.6 m 501.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 723.6 m 505.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 723.6 m 575.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 708.6 m 575.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 708.6 m 427.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 708.6 m 501.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 708.6 m 575.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 678.6 m 427.5 678.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 678.6 m 501.5 678.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 678.6 m 575.5 678.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 618.6 m 427.5 618.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 604.6 m 427.5 604.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 602.6 m 427.5 602.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 618.6 m 501.5 618.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 604.6 m 501.5 604.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 602.6 m 501.5 602.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 618.6 m 575.5 618.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 604.6 m 575.5 604.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 602.6 m 575.5 602.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 727.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 727.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 712.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.00 712.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.00 712.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.00 712.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 699.17 Td (Employee termination costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 698.27 Td (97) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 698.27 Td (110) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 698.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 698.27 Td (157) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 684.17 Td (Other termination costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 683.27 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 683.27 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 566.65 683.27 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 669.17 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 668.27 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 668.27 Td (118) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 668.27 Td (163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 654.17 Td (Accelerated depreciation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 653.27 Td (72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 653.27 Td (104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 653.27 Td (138) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 638.27 Td (Asset impairments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 638.27 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 638.27 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 638.27 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 623.27 Td (Other shutdown costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 623.27 Td (19) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 623.27 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 623.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 608.27 Td (Total charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 608.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 608.27 Td (213) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 608.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 608.27 Td (233) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 608.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 608.27 Td (314) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 551.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 551.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 551.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 551.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 551.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 551.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 551.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 521.60 318.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 521.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 521.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 521.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 521.60 70.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 521.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 521.60 70.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 566.6 m 427.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 566.6 m 431.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 566.6 m 501.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 566.6 m 505.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 566.6 m 575.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 566.6 m 427.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 551.6 m 427.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 566.6 m 431.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 566.6 m 501.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 551.6 m 501.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 566.6 m 505.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 566.6 m 575.5 566.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 551.6 m 575.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 551.6 m 427.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 551.6 m 501.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 551.6 m 575.5 551.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 506.6 m 427.5 506.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 506.6 m 501.5 506.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 506.6 m 575.5 506.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 492.6 m 427.5 492.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 490.6 m 427.5 490.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 492.6 m 501.5 492.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 490.6 m 501.5 490.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 492.6 m 575.5 492.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 490.6 m 575.5 490.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 570.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 570.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 555.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.00 555.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.00 555.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.00 555.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 542.17 Td (Cost of products sold) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 541.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 541.27 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 541.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 541.27 Td (84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 541.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 541.27 Td (151) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 527.17 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 526.27 Td (83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 526.27 Td (31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 526.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 512.17 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 511.27 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 511.27 Td (118) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 511.27 Td (163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 497.17 Td (Total charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 496.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 496.27 Td (213) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 496.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 496.27 Td (233) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 496.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 496.27 Td (314) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 445.60 317.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 445.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 445.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 445.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 445.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 445.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 445.60 71.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 417.60 317.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 417.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 417.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 417.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 417.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 417.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 417.60 71.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 389.60 317.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 389.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 389.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 389.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 389.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 389.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 389.60 71.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 361.60 317.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 361.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 361.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 361.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 361.60 70.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 361.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 361.60 71.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 457.6 m 427.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 457.6 m 431.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 457.6 m 501.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 457.6 m 505.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 457.6 m 576.5 457.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 445.6 m 427.5 445.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 445.6 m 501.5 445.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 445.6 m 576.5 445.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 403.6 m 427.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 403.6 m 501.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 403.6 m 576.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 361.6 m 427.5 361.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 361.6 m 501.5 361.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 361.6 m 576.5 361.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 348.6 m 427.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 346.6 m 427.5 346.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 348.6 m 501.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 346.6 m 501.5 346.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 348.6 m 576.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 346.6 m 576.5 346.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 461.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 422.20 461.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 449.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.00 449.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.00 449.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 449.68 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 436.17 Td (Liability at January 1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 436.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 436.17 Td (125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 436.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 436.17 Td (156) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 436.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 436.17 Td (102) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 422.17 Td (Charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 422.17 Td (116) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 422.17 Td (133) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 422.17 Td (155) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 408.17 Td (Change in estimates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.30 408.22 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.65 408.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.30 408.22 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 408.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 408.17 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 394.17 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 394.17 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 394.17 Td (118) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 394.17 Td (163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 380.17 Td (Foreign currency translation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 380.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.30 380.22 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 380.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 380.17 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 380.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 366.17 Td (Spending) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.30 366.22 Td (\(120) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.65 366.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 366.22 Td (\(134) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 366.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 366.17 Td (\(107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 366.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 352.17 Td (Liability at December 31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 352.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 352.17 Td (114) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 352.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 352.17 Td (125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 352.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 352.17 Td (156) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 322.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 322.10 Td (7) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 322.10 Td (. INCOME ) Tj ET Q q 0 0 0 rg BT 113.03 322.10 Td (T) Tj ET Q q 0 0 0 rg BT 118.96 322.10 Td (AXES) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 298.10 Td (The provision/\(benefit\) for income taxes consisted of:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 263.60 316.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 263.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 263.60 70.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 263.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 263.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 263.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 263.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 239.60 316.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 239.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 239.60 70.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 239.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 239.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 239.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 239.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 215.60 316.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 215.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 215.60 70.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 215.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 215.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 215.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 215.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 191.60 316.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 191.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 191.60 70.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 191.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 191.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 191.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 191.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 167.60 316.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 167.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 167.60 70.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 167.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 167.60 71.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 167.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 167.60 71.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 275.6 m 426.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 426.5 275.6 m 430.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 275.6 m 501.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 275.6 m 505.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 275.6 m 576.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 263.6 m 426.5 263.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 263.6 m 501.5 263.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 263.6 m 576.5 263.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 227.60000000000002 m 426.5 227.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 227.60000000000002 m 501.5 227.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 227.60000000000002 m 576.5 227.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 215.60000000000002 m 426.5 215.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 215.60000000000002 m 501.5 215.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 215.60000000000002 m 576.5 215.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 179.60000000000002 m 426.5 179.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 179.60000000000002 m 501.5 179.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 179.60000000000002 m 576.5 179.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 167.60000000000002 m 426.5 167.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 167.60000000000002 m 501.5 167.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 167.60000000000002 m 576.5 167.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 156.60000000000002 m 426.5 156.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 154.60000000000002 m 426.5 154.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 167.60000000000002 m 501.5 167.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 156.60000000000002 m 501.5 156.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 154.60000000000002 m 501.5 154.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 156.60000000000002 m 576.5 156.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 154.60000000000002 m 576.5 154.60000000000002 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 279.68 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 267.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.00 267.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 457.50 267.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 267.68 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 254.22 Td (Current:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 242.22 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.00 242.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 242.22 Td (1,144) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 242.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 242.22 Td (337) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 242.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 242.22 Td (334) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 230.22 Td (Non-U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 230.22 Td (468) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 230.22 Td (456) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 230.22 Td (560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 218.22 Td (Total Current) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 218.22 Td (1,612) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 218.22 Td (793) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 218.22 Td (894) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 206.22 Td (Deferred:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 194.22 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 194.22 Td (\(101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 194.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 194.22 Td (\(394) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 194.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 194.22 Td (\(403) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 194.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 182.22 Td (Non-U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 182.22 Td (\(103) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 182.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 182.22 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 182.22 Td (\(139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 182.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 170.22 Td (Total Deferred) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 170.22 Td (\(204) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 170.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 170.22 Td (\(347) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 170.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 170.22 Td (\(542) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 170.22 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 158.22 Td (Total Provision) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.00 158.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 158.22 Td (1,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 158.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 158.22 Td (446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 158.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 158.22 Td (352) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 157 0 obj <> endobj 158 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (78) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 108.3828125 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Effective T) Tj ET Q q 0 0 0 rg BT 78.12 749.10 Td (ax Rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (The reconciliation of the ef) Tj ET Q q 0 0 0 rg BT 144.66 725.10 Td (fective tax/\(benefit\) rate to the U.S. statutory Federal income tax rate was:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 688.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 688.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 662.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 662.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 636.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 636.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 598.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 598.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 598.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 598.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 598.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 598.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 598.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 572.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 572.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 572.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 572.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 572.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 572.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 572.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 546.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 546.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 546.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 546.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 546.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 546.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 546.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 520.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 520.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 520.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 520.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 520.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 520.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 520.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 494.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 494.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 494.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 494.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 494.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 494.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 494.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 468.60 282.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 318.50 468.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 468.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 468.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 400.50 468.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 468.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 468.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 468.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 468.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 468.60 39.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 468.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 533.50 468.60 39.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 701.6 m 357.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 701.6 m 361.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 701.6 m 400.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 400.5 701.6 m 404.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 701.6 m 443.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 701.6 m 447.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 701.6 m 486.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 486.5 701.6 m 490.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 701.6 m 529.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 529.5 701.6 m 533.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 533.5 701.6 m 572.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 688.6 m 357.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 688.6 m 361.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 688.6 m 400.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 688.6 m 443.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 688.6 m 447.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 688.6 m 486.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 688.6 m 529.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 529.5 688.6 m 533.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 533.5 688.6 m 572.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 649.6 m 357.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 649.6 m 443.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 649.6 m 529.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 636.6 m 357.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 636.6 m 443.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 636.6 m 529.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 455.6 m 357.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 455.6 m 400.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 455.6 m 443.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 455.6 m 486.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 455.6 m 529.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 533.5 455.6 m 572.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 443.6 m 357.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 318.5 441.6 m 357.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 443.6 m 400.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 441.6 m 400.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 443.6 m 443.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 441.6 m 443.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 455.6 m 486.5 455.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 443.6 m 486.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 441.6 m 486.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 443.6 m 529.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 441.6 m 529.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 533.5 443.6 m 572.5 443.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 533.5 441.6 m 572.5 441.6 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.60 705.83 Td (% of Earnings Before Income Taxes) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 692.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 351.00 692.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.00 692.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 523.00 692.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.17 Td (Earnings/\(Loss\) before income taxes:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 666.17 Td (U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.00 666.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.10 666.17 Td (3,100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.00 666.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.80 666.22 Td (\(1,329) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 666.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.00 666.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.30 666.22 Td (\(349) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 666.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 653.17 Td (Non-U.S.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.10 653.17 Td (2,815) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.10 653.17 Td (3,406) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.10 653.17 Td (2,730) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 640.17 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.10 640.17 Td (5,915) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.10 640.17 Td (2,077) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.10 640.17 Td (2,381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 627.17 Td (U.S. statutory rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.10 627.17 Td (2,070) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.80 627.17 Td (35.0) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 627.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.65 627.17 Td (727) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.80 627.17 Td (35.0) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 627.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 627.17 Td (833) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.80 627.17 Td (35.0) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 627.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 614.17 Td (Foreign tax effect of certain operations in Ireland, Puerto Rico and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 604.17 Td (Switzerland) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.30 603.32 Td (\(442) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 603.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 603.27 Td (\(7.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 603.27 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.30 603.32 Td (\(535) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 603.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.45 603.27 Td (\(25.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 603.27 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.30 603.32 Td (\(509) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 603.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.45 603.27 Td (\(21.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.30 603.27 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 589.17 Td (U.S. tax effect of capital losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.65 589.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.30 589.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 589.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.30 589.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.30 589.22 Td (\(361) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 589.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.45 589.17 Td (\(15.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.30 589.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 576.17 Td (U.S. Federal valuation allowance release) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.30 576.22 Td (\(29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 576.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 576.17 Td (\(0.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 576.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 576.22 Td (\(84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 576.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.45 576.17 Td (\(4.0) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 576.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 576.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.30 576.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 563.17 Td (U.S. Federal, state and foreign contingent tax matters) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.65 563.17 Td (87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.80 563.17 Td (1.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 563.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 563.17 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 563.17 Td (2.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 563.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 563.17 Td (228) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.80 563.17 Td (9.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 563.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 550.17 Td (U.S. Federal research based credits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.30 550.22 Td (\(144) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 550.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 550.17 Td (\(2.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 550.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.30 550.22 Td (\(132) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 550.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.45 550.17 Td (\(6.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 550.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.30 550.22 Td (\(131) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 550.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.45 550.17 Td (\(5.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.30 550.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 537.17 Td (Goodwill allocated to divestitures) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.65 537.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.80 537.17 Td (0.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 537.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 537.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 537.17 Td (1.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 537.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 537.17 Td (210) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.80 537.17 Td (8.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 537.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 524.17 Td (U.S. Branded Prescription Drug Fee) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.65 524.17 Td (52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.80 524.17 Td (0.9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 524.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 524.17 Td (44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 524.17 Td (2.1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 524.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 524.17 Td (84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.80 524.17 Td (3.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 524.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 511.17 Td (R&D charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.65 511.17 Td (100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.80 511.17 Td (1.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 511.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.65 511.17 Td (369) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.80 511.17 Td (17.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 511.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 511.17 Td (52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.80 511.17 Td (2.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 511.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 498.17 Td (Puerto Rico excise tax) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.30 498.22 Td (\(131) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 498.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 498.17 Td (\(2.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 498.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 498.22 Td (\(55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 498.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.45 498.17 Td (\(2.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 498.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.30 498.22 Td (\(28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 498.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.45 498.17 Td (\(1.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.30 498.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 485.17 Td (Domestic manufacturing deduction) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.30 485.22 Td (\(122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 485.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 485.17 Td (\(2.1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 485.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.30 485.22 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 485.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.45 485.17 Td (\(0.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.30 485.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 485.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.30 485.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 472.17 Td (State and local taxes \(net of valuation allowance\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.65 472.17 Td (23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.80 472.17 Td (0.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 472.17 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 472.17 Td (0.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 472.17 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.80 472.17 Td (0.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 459.17 Td (Foreign and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 340.30 459.22 Td (\(90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.65 459.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.45 459.17 Td (\(1.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.30 459.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 459.17 Td (32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 459.17 Td (1.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 459.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.30 459.22 Td (\(46) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.65 459.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.45 459.17 Td (\(1.9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.30 459.17 Td (\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.00 446.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.10 446.17 Td (1,408) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.80 446.17 Td (23.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.65 446.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.00 446.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.65 446.17 Td (446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.80 446.17 Td (21.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 446.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.00 446.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 446.17 Td (352) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.80 446.17 Td (14.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.65 446.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 419.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.93 419.10 Td (ef) Tj ET Q q 0 0 0 rg BT 62.51 419.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 93.09 419.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 108.69 419.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 127.05 419.10 Td (is ) Tj ET Q q 0 0 0 rg BT 137.10 419.10 Td (lower ) Tj ET Q q 0 0 0 rg BT 163.25 419.10 Td (than ) Tj ET Q q 0 0 0 rg BT 183.85 419.10 Td (the ) Tj ET Q q 0 0 0 rg BT 199.44 419.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 220.60 419.10 Td (statutory ) Tj ET Q q 0 0 0 rg BT 258.98 419.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 277.34 419.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 289.05 419.10 Td (35%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.38 419.10 Td ( ) Tj ET Q q 0 0 0 rg BT 310.76 419.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 351.35 419.10 Td (attributable ) Tj ET Q q 0 0 0 rg BT 400.27 419.10 Td (to ) Tj ET Q q 0 0 0 rg BT 411.42 419.10 Td (undistributed ) Tj ET Q q 0 0 0 rg BT 467.58 419.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 504.83 419.10 Td (of ) Tj ET Q q 0 0 0 rg BT 516.54 419.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 547.12 419.10 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 407.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 86.70 407.10 Td (that ) Tj ET Q q 0 0 0 rg BT 105.18 407.10 Td (have ) Tj ET Q q 0 0 0 rg BT 127.54 407.10 Td (been ) Tj ET Q q 0 0 0 rg BT 149.90 407.10 Td (considered ) Tj ET Q q 0 0 0 rg BT 196.70 407.10 Td (or ) Tj ET Q q 0 0 0 rg BT 208.51 407.10 Td (are ) Tj ET Q q 0 0 0 rg BT 224.21 407.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 263.22 407.10 Td (to ) Tj ET Q q 0 0 0 rg BT 274.48 407.10 Td (be ) Tj ET Q q 0 0 0 rg BT 287.41 407.10 Td (indefinitely ) Tj ET Q q 0 0 0 rg BT 336.99 407.10 Td (reinvested ) Tj ET Q q 0 0 0 rg BT 381.57 407.10 Td (of) Tj ET Q q 0 0 0 rg BT 389.72 407.10 Td (fshore. ) Tj ET Q q 0 0 0 rg BT 420.69 407.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 441.96 407.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 465.99 407.10 Td (have ) Tj ET Q q 0 0 0 rg BT 488.35 407.10 Td (not ) Tj ET Q q 0 0 0 rg BT 504.61 407.10 Td (been ) Tj ET Q q 0 0 0 rg BT 526.97 407.10 Td (provided ) Tj ET Q q 0 0 0 rg BT 566.00 407.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 395.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 96.96 395.10 Td ($25.7 ) Tj ET Q q 0 0 0 rg BT 122.66 395.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 148.77 395.10 Td ( ) Tj ET Q q 0 0 0 rg BT 151.97 395.10 Td (of ) Tj ET Q q 0 0 0 rg BT 163.50 395.10 Td (undistributed ) Tj ET Q q 0 0 0 rg BT 219.47 395.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 256.55 395.10 Td (of ) Tj ET Q q 0 0 0 rg BT 268.08 395.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 300.16 395.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 350.57 395.10 Td (as ) Tj ET Q q 0 0 0 rg BT 362.10 395.10 Td (of ) Tj ET Q q 0 0 0 rg BT 373.63 395.10 Td (December ) Tj ET Q q 0 0 0 rg BT 417.92 395.10 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.62 395.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 453.62 395.10 Td (. ) Tj ET Q q 0 0 0 rg BT 459.08 395.10 Td (These ) Tj ET Q q 0 0 0 rg BT 486.16 395.10 Td (undistributed ) Tj ET Q q 0 0 0 rg BT 542.13 395.10 Td (earnings ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 383.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 76.03 383.10 Td (relate ) Tj ET Q q 0 0 0 rg BT 101.04 383.10 Td (to ) Tj ET Q q 0 0 0 rg BT 111.63 383.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 156.10 383.10 Td (in ) Tj ET Q q 0 0 0 rg BT 166.70 383.10 Td (Switzerland, ) Tj ET Q q 0 0 0 rg BT 219.77 383.10 Td (Ireland ) Tj ET Q q 0 0 0 rg BT 250.90 383.10 Td (and ) Tj ET Q q 0 0 0 rg BT 268.16 383.10 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 297.08 383.10 Td (Rico. ) Tj ET Q q 0 0 0 rg BT 321.28 383.10 Td (If ) Tj ET Q q 0 0 0 rg BT 330.75 383.10 Td (these ) Tj ET Q q 0 0 0 rg BT 354.11 383.10 Td (undistributed ) Tj ET Q q 0 0 0 rg BT 409.70 383.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 446.39 383.10 Td (are ) Tj ET Q q 0 0 0 rg BT 461.41 383.10 Td (repatriated ) Tj ET Q q 0 0 0 rg BT 506.98 383.10 Td (to ) Tj ET Q q 0 0 0 rg BT 517.57 383.10 Td (the ) Tj ET Q q 0 0 0 rg BT 532.60 383.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 553.20 383.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.79 383.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 371.10 Td (future, ) Tj ET Q q 0 0 0 rg BT 64.34 371.10 Td (or ) Tj ET Q q 0 0 0 rg BT 74.64 371.10 Td (if ) Tj ET Q q 0 0 0 rg BT 82.72 371.10 Td (it ) Tj ET Q q 0 0 0 rg BT 90.24 371.10 Td (were ) Tj ET Q q 0 0 0 rg BT 111.63 371.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 158.58 371.10 Td (that ) Tj ET Q q 0 0 0 rg BT 175.54 371.10 Td (such ) Tj ET Q q 0 0 0 rg BT 195.84 371.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 231.68 371.10 Td (are ) Tj ET Q q 0 0 0 rg BT 245.86 371.10 Td (to ) Tj ET Q q 0 0 0 rg BT 255.60 371.10 Td (be ) Tj ET Q q 0 0 0 rg BT 267.01 371.10 Td (remitted ) Tj ET Q q 0 0 0 rg BT 302.30 371.10 Td (in ) Tj ET Q q 0 0 0 rg BT 312.04 371.10 Td (the ) Tj ET Q q 0 0 0 rg BT 326.22 371.10 Td (foreseeable ) Tj ET Q q 0 0 0 rg BT 373.71 371.10 Td (future, ) Tj ET Q q 0 0 0 rg BT 402.06 371.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 444.01 371.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 458.20 371.10 Td (provisions ) Tj ET Q q 0 0 0 rg BT 501.83 371.10 Td (would ) Tj ET Q q 0 0 0 rg BT 528.80 371.10 Td (be ) Tj ET Q q 0 0 0 rg BT 540.21 371.10 Td (required. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 359.10 Td (Due ) Tj ET Q q 0 0 0 rg BT 54.99 359.10 Td (to ) Tj ET Q q 0 0 0 rg BT 65.10 359.10 Td (complexities ) Tj ET Q q 0 0 0 rg BT 118.53 359.10 Td (in ) Tj ET Q q 0 0 0 rg BT 128.64 359.10 Td (the ) Tj ET Q q 0 0 0 rg BT 143.19 359.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 157.74 359.10 Td (laws ) Tj ET Q q 0 0 0 rg BT 178.40 359.10 Td (and ) Tj ET Q q 0 0 0 rg BT 195.17 359.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 246.95 359.10 Td (that ) Tj ET Q q 0 0 0 rg BT 264.28 359.10 Td (would ) Tj ET Q q 0 0 0 rg BT 291.61 359.10 Td (have ) Tj ET Q q 0 0 0 rg BT 312.82 359.10 Td (to ) Tj ET Q q 0 0 0 rg BT 322.93 359.10 Td (be ) Tj ET Q q 0 0 0 rg BT 334.70 359.10 Td (made, ) Tj ET Q q 0 0 0 rg BT 361.18 359.10 Td (it ) Tj ET Q q 0 0 0 rg BT 369.07 359.10 Td (is ) Tj ET Q q 0 0 0 rg BT 378.07 359.10 Td (not ) Tj ET Q q 0 0 0 rg BT 393.18 359.10 Td (practicable ) Tj ET Q q 0 0 0 rg BT 439.37 359.10 Td (to ) Tj ET Q q 0 0 0 rg BT 449.48 359.10 Td (estimate ) Tj ET Q q 0 0 0 rg BT 485.13 359.10 Td (the ) Tj ET Q q 0 0 0 rg BT 499.68 359.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 535.90 359.10 Td (of ) Tj ET Q q 0 0 0 rg BT 546.56 359.10 Td (income ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 347.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 59.05 347.10 Td (that ) Tj ET Q q 0 0 0 rg BT 76.54 347.10 Td (will ) Tj ET Q q 0 0 0 rg BT 94.60 347.10 Td (have ) Tj ET Q q 0 0 0 rg BT 115.98 347.10 Td (to ) Tj ET Q q 0 0 0 rg BT 126.25 347.10 Td (be ) Tj ET Q q 0 0 0 rg BT 138.19 347.10 Td (provided. ) Tj ET Q q 0 0 0 rg BT 178.74 347.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 202.36 347.10 Td (operates ) Tj ET Q q 0 0 0 rg BT 238.18 347.10 Td (under ) Tj ET Q q 0 0 0 rg BT 263.45 347.10 Td (a ) Tj ET Q q 0 0 0 rg BT 270.38 347.10 Td (favorable ) Tj ET Q q 0 0 0 rg BT 310.64 347.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 325.36 347.10 Td (grant ) Tj ET Q q 0 0 0 rg BT 348.40 347.10 Td (in ) Tj ET Q q 0 0 0 rg BT 358.68 347.10 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 387.29 347.10 Td (Rico ) Tj ET Q q 0 0 0 rg BT 408.68 347.10 Td (not ) Tj ET Q q 0 0 0 rg BT 423.95 347.10 Td (scheduled ) Tj ET Q q 0 0 0 rg BT 466.44 347.10 Td (to ) Tj ET Q q 0 0 0 rg BT 476.72 347.10 Td (expire ) Tj ET Q q 0 0 0 rg BT 504.20 347.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 526.14 347.10 Td (to ) Tj ET Q q 0 0 0 rg BT 536.42 347.10 Td (2023.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.00 323.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 98.66 323.10 Td (of ) Tj ET Q q 0 0 0 rg BT 109.45 323.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 139.10 323.10 Td (businesses ) Tj ET Q q 0 0 0 rg BT 183.78 323.10 Td (resulted ) Tj ET Q q 0 0 0 rg BT 217.88 323.10 Td (in ) Tj ET Q q 0 0 0 rg BT 228.11 323.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 257.22 323.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 275.23 323.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 289.90 323.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 324.01 323.10 Td (including ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.24 323.10 Td ($361 ) Tj ET Q q 0 0 0 rg BT 386.69 323.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.58 323.10 Td ( ) Tj ET Q q 0 0 0 rg BT 418.03 323.10 Td (from ) Tj ET Q q 0 0 0 rg BT 439.92 323.10 Td (the ) Tj ET Q q 0 0 0 rg BT 454.59 323.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 472.59 323.10 Td (of ) Tj ET Q q 0 0 0 rg BT 482.83 323.10 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 515.84 323.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 543.29 323.10 Td (in ) Tj ET Q q 0 0 0 rg BT 553.52 323.10 Td (2014. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.10 Td (V) Tj ET Q q 0 0 0 rg BT 42.11 311.10 Td (aluation ) Tj ET Q q 0 0 0 rg BT 76.95 311.10 Td (allowances ) Tj ET Q q 0 0 0 rg BT 123.99 311.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 164.93 311.10 Td (to ) Tj ET Q q 0 0 0 rg BT 175.33 311.10 Td (capital ) Tj ET Q q 0 0 0 rg BT 204.60 311.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 222.79 311.10 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 281.49 311.10 Td (were ) Tj ET Q q 0 0 0 rg BT 303.54 311.10 Td (released ) Tj ET Q q 0 0 0 rg BT 338.91 311.10 Td (in ) Tj ET Q q 0 0 0 rg BT 349.31 311.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 371.93 311.10 Td (following ) Tj ET Q q 0 0 0 rg BT 413.44 311.10 Td (the ) Tj ET Q q 0 0 0 rg BT 428.28 311.10 Td (divestiture ) Tj ET Q q 0 0 0 rg BT 473.11 311.10 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 484.06 311.10 Td (Recothr) Tj ET Q q 0 0 0 rg BT 515.35 311.10 Td (om*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 532.57 311.10 Td (, ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 537.69 311.10 Td (Ixempra*) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.93 299.10 Td (other ) Tj ET Q q 0 0 0 rg BT 75.98 299.10 Td (mature ) Tj ET Q q 0 0 0 rg BT 106.23 299.10 Td (brands. ) Tj ET Q q 0 0 0 rg BT 137.34 299.10 Td (Additional ) Tj ET Q q 0 0 0 rg BT 182.61 299.10 Td (reserves ) Tj ET Q q 0 0 0 rg BT 217.86 299.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 228.69 299.10 Td ($123 ) Tj ET Q q 0 0 0 rg BT 251.18 299.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 280.07 299.10 Td ( ) Tj ET Q q 0 0 0 rg BT 282.57 299.10 Td (were ) Tj ET Q q 0 0 0 rg BT 304.49 299.10 Td (established ) Tj ET Q q 0 0 0 rg BT 351.42 299.10 Td (in ) Tj ET Q q 0 0 0 rg BT 361.69 299.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 384.19 299.10 Td (for ) Tj ET Q q 0 0 0 rg BT 398.34 299.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 428.04 299.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 461.07 299.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 491.89 299.10 Td (matters ) Tj ET Q q 0 0 0 rg BT 523.82 299.10 Td (related ) Tj ET Q q 0 0 0 rg BT 553.52 299.10 Td (to ) Tj ET Q q 0 0 0 rg BT 563.79 299.10 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 68.11 287.10 Td (from ) Tj ET Q q 0 0 0 rg BT 90.23 287.10 Td (2008 ) Tj ET Q q 0 0 0 rg BT 112.90 287.10 Td (through ) Tj ET Q q 0 0 0 rg BT 146.68 287.10 Td (2014. ) Tj ET Q q 0 0 0 rg BT 171.86 287.10 Td (Orphan ) Tj ET Q q 0 0 0 rg BT 204.52 287.10 Td (drug ) Tj ET Q q 0 0 0 rg BT 225.53 287.10 Td (credits ) Tj ET Q q 0 0 0 rg BT 254.86 287.10 Td (are ) Tj ET Q q 0 0 0 rg BT 269.74 287.10 Td (included ) Tj ET Q q 0 0 0 rg BT 306.85 287.10 Td (in ) Tj ET Q q 0 0 0 rg BT 317.30 287.10 Td (the ) Tj ET Q q 0 0 0 rg BT 332.19 287.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 352.65 287.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 385.31 287.10 Td (research ) Tj ET Q q 0 0 0 rg BT 421.29 287.10 Td (based ) Tj ET Q q 0 0 0 rg BT 446.74 287.10 Td (credits ) Tj ET Q q 0 0 0 rg BT 476.07 287.10 Td (for ) Tj ET Q q 0 0 0 rg BT 490.40 287.10 Td (all ) Tj ET Q q 0 0 0 rg BT 503.07 287.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 535.18 287.10 Td (presented. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.10 Td (Goodwill ) Tj ET Q q 0 0 0 rg BT 76.37 275.10 Td (allocated ) Tj ET Q q 0 0 0 rg BT 115.05 275.10 Td (to ) Tj ET Q q 0 0 0 rg BT 125.41 275.10 Td (business ) Tj ET Q q 0 0 0 rg BT 161.89 275.10 Td (divestitures ) Tj ET Q q 0 0 0 rg BT 210.59 275.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 254.28 275.10 Td (the ) Tj ET Q q 0 0 0 rg BT 269.09 275.10 Td (diabetes ) Tj ET Q q 0 0 0 rg BT 304.44 275.10 Td (business ) Tj ET Q q 0 0 0 rg BT 340.92 275.10 Td (in ) Tj ET Q q 0 0 0 rg BT 351.29 275.10 Td (2014\) ) Tj ET Q q 0 0 0 rg BT 377.21 275.10 Td (was ) Tj ET Q q 0 0 0 rg BT 395.35 275.10 Td (not ) Tj ET Q q 0 0 0 rg BT 410.72 275.10 Td (deductible ) Tj ET Q q 0 0 0 rg BT 454.96 275.10 Td (for ) Tj ET Q q 0 0 0 rg BT 469.21 275.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 484.01 275.10 Td (purposes ) Tj ET Q q 0 0 0 rg BT 522.15 275.10 Td (as ) Tj ET Q q 0 0 0 rg BT 533.07 275.10 Td (well ) Tj ET Q q 0 0 0 rg BT 552.88 275.10 Td (as ) Tj ET Q q 0 0 0 rg BT 563.80 275.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 55.69 263.10 Td (Branded ) Tj ET Q q 0 0 0 rg BT 91.47 263.10 Td (Prescription ) Tj ET Q q 0 0 0 rg BT 141.70 263.10 Td (Drug ) Tj ET Q q 0 0 0 rg BT 164.15 263.10 Td (Fee ) Tj ET Q q 0 0 0 rg BT 180.49 263.10 Td (in ) Tj ET Q q 0 0 0 rg BT 190.17 263.10 Td (all ) Tj ET Q q 0 0 0 rg BT 202.07 263.10 Td (periods. ) Tj ET Q q 0 0 0 rg BT 235.91 263.10 Td (R&D ) Tj ET Q q 0 0 0 rg BT 259.49 263.10 Td (char) Tj ET Q q 0 0 0 rg BT 276.51 263.10 Td (ges ) Tj ET Q q 0 0 0 rg BT 291.75 263.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 328.65 263.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 367.76 263.10 Td (from ) Tj ET Q q 0 0 0 rg BT 389.10 263.10 Td (a ) Tj ET Q q 0 0 0 rg BT 395.44 263.10 Td (milestone ) Tj ET Q q 0 0 0 rg BT 436.23 263.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 472.57 263.10 Td (to ) Tj ET Q q 0 0 0 rg BT 482.25 263.10 Td (the ) Tj ET Q q 0 0 0 rg BT 496.37 263.10 Td (former ) Tj ET Q q 0 0 0 rg BT 525.48 263.10 Td (shareholders ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 251.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.58 251.10 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 77.50 251.10 Td (and ) Tj ET Q q 0 0 0 rg BT 95.18 251.10 Td (the ) Tj ET Q q 0 0 0 rg BT 110.65 251.10 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 161.67 251.10 Td (of ) Tj ET Q q 0 0 0 rg BT 173.25 251.10 Td (Padlock ) Tj ET Q q 0 0 0 rg BT 208.72 251.10 Td (and ) Tj ET Q q 0 0 0 rg BT 226.40 251.10 Td (Cormorant ) Tj ET Q q 0 0 0 rg BT 272.98 251.10 Td (in ) Tj ET Q q 0 0 0 rg BT 284.00 251.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 309.75 251.10 Td (Flexus ) Tj ET Q q 0 0 0 rg BT 339.67 251.10 Td (and ) Tj ET Q q 0 0 0 rg BT 357.36 251.10 Td (Cardioxyl ) Tj ET Q q 0 0 0 rg BT 400.60 251.10 Td (in ) Tj ET Q q 0 0 0 rg BT 411.63 251.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 434.88 251.10 Td (and ) Tj ET Q q 0 0 0 rg BT 452.56 251.10 Td (iPierian ) Tj ET Q q 0 0 0 rg BT 486.92 251.10 Td (in ) Tj ET Q q 0 0 0 rg BT 497.94 251.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 521.19 251.10 Td (were ) Tj ET Q q 0 0 0 rg BT 543.87 251.10 Td (also ) Tj ET Q q 0 0 0 rg BT 563.22 251.10 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 239.10 Td (deductible ) Tj ET Q q 0 0 0 rg BT 79.63 239.10 Td (for ) Tj ET Q q 0 0 0 rg BT 93.27 239.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 107.46 239.10 Td (purposes. ) Tj ET Q q 0 0 0 rg BT 147.50 239.10 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 175.58 239.10 Td (Rico ) Tj ET Q q 0 0 0 rg BT 196.45 239.10 Td (imposes ) Tj ET Q q 0 0 0 rg BT 231.21 239.10 Td (an ) Tj ET Q q 0 0 0 rg BT 242.62 239.10 Td (excise ) Tj ET Q q 0 0 0 rg BT 269.59 239.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 283.78 239.10 Td (on ) Tj ET Q q 0 0 0 rg BT 295.76 239.10 Td (the ) Tj ET Q q 0 0 0 rg BT 309.96 239.10 Td (gross ) Tj ET Q q 0 0 0 rg BT 333.05 239.10 Td (company ) Tj ET Q q 0 0 0 rg BT 371.68 239.10 Td (purchase ) Tj ET Q q 0 0 0 rg BT 409.20 239.10 Td (price ) Tj ET Q q 0 0 0 rg BT 431.17 239.10 Td (of ) Tj ET Q q 0 0 0 rg BT 441.47 239.10 Td (goods ) Tj ET Q q 0 0 0 rg BT 467.34 239.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 485.99 239.10 Td (from ) Tj ET Q q 0 0 0 rg BT 507.41 239.10 Td (our ) Tj ET Q q 0 0 0 rg BT 522.72 239.10 Td (manufacturer ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 227.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.05 227.10 Td (Puerto ) Tj ET Q q 0 0 0 rg BT 74.43 227.10 Td (Rico. ) Tj ET Q q 0 0 0 rg BT 97.92 227.10 Td (The ) Tj ET Q q 0 0 0 rg BT 115.74 227.10 Td (excise ) Tj ET Q q 0 0 0 rg BT 143.00 227.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 157.49 227.10 Td (is ) Tj ET Q q 0 0 0 rg BT 166.43 227.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 212.57 227.10 Td (in ) Tj ET Q q 0 0 0 rg BT 222.62 227.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 241.00 227.10 Td (of ) Tj ET Q q 0 0 0 rg BT 251.60 227.10 Td (products ) Tj ET Q q 0 0 0 rg BT 288.31 227.10 Td (sold ) Tj ET Q q 0 0 0 rg BT 307.25 227.10 Td (when ) Tj ET Q q 0 0 0 rg BT 331.18 227.10 Td (the ) Tj ET Q q 0 0 0 rg BT 345.67 227.10 Td (intra-entity ) Tj ET Q q 0 0 0 rg BT 392.37 227.10 Td (sale ) Tj ET Q q 0 0 0 rg BT 410.19 227.10 Td (occurs. ) Tj ET Q q 0 0 0 rg BT 441.06 227.10 Td (For ) Tj ET Q q 0 0 0 rg BT 457.23 227.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 477.28 227.10 Td (income ) Tj ET Q q 0 0 0 rg BT 508.99 227.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 523.48 227.10 Td (purposes, ) Tj ET Q q 0 0 0 rg BT 563.80 227.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.10 Td (excise ) Tj ET Q q 0 0 0 rg BT 63.92 215.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 79.08 215.10 Td (is ) Tj ET Q q 0 0 0 rg BT 88.68 215.10 Td (not ) Tj ET Q q 0 0 0 rg BT 104.40 215.10 Td (deductible ) Tj ET Q q 0 0 0 rg BT 148.99 215.10 Td (but ) Tj ET Q q 0 0 0 rg BT 164.70 215.10 Td (results ) Tj ET Q q 0 0 0 rg BT 193.75 215.10 Td (in ) Tj ET Q q 0 0 0 rg BT 204.46 215.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 236.28 215.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 251.43 215.10 Td (credits ) Tj ET Q q 0 0 0 rg BT 281.02 215.10 Td (that ) Tj ET Q q 0 0 0 rg BT 298.95 215.10 Td (are ) Tj ET Q q 0 0 0 rg BT 314.10 215.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 354.24 215.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 401.04 215.10 Td (in ) Tj ET Q q 0 0 0 rg BT 411.75 215.10 Td (our ) Tj ET Q q 0 0 0 rg BT 428.02 215.10 Td (provision ) Tj ET Q q 0 0 0 rg BT 468.73 215.10 Td (for ) Tj ET Q q 0 0 0 rg BT 483.33 215.10 Td (income ) Tj ET Q q 0 0 0 rg BT 515.70 215.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 539.19 215.10 Td (when ) Tj ET Q q 0 0 0 rg BT 563.78 215.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 203.10 Td (excise ) Tj ET Q q 0 0 0 rg BT 63.49 203.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 78.20 203.10 Td (is ) Tj ET Q q 0 0 0 rg BT 87.37 203.10 Td (incurred. ) Tj ET Q q 0 0 0 rg BT 125.69 203.10 Td (Increased ) Tj ET Q q 0 0 0 rg BT 166.49 203.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 227.30 203.10 Td (activities ) Tj ET Q q 0 0 0 rg BT 265.90 203.10 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 280.06 203.10 Td (Opdivo) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.50 203.10 Td ( ) Tj ET Q q 0 0 0 rg BT 312.00 203.10 Td (resulted ) Tj ET Q q 0 0 0 rg BT 346.16 203.10 Td (in ) Tj ET Q q 0 0 0 rg BT 356.43 203.10 Td (the ) Tj ET Q q 0 0 0 rg BT 371.15 203.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 399.20 203.10 Td (domestic ) Tj ET Q q 0 0 0 rg BT 437.80 203.10 Td (manufacturing ) Tj ET Q q 0 0 0 rg BT 498.61 203.10 Td (deduction ) Tj ET Q q 0 0 0 rg BT 540.55 203.10 Td (in ) Tj ET Q q 0 0 0 rg BT 550.82 203.10 Td (2016.) Tj ET Q endstream endobj 159 0 obj <> endobj 160 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (79) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Deferr) Tj ET Q q 0 0 0 rg BT 62.29 749.10 Td (ed T) Tj ET Q q 0 0 0 rg BT 78.87 749.10 Td (axes and V) Tj ET Q q 0 0 0 rg BT 121.64 749.10 Td (aluation ) Tj ET Q q 0 0 0 rg BT 157.29 749.10 Td (Allowance) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 729.90 Td (The components of current and non-current deferred income tax assets/\(liabilities\) were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 693.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 693.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 693.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 693.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 693.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 667.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 667.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 667.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 667.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 667.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 641.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 641.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 641.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 641.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 641.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 615.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 615.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 615.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 615.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 615.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 589.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 589.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 589.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 589.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 589.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 563.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 563.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 563.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 563.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 563.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 537.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 537.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 537.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 537.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 537.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 511.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 511.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 511.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 511.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 511.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 485.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 485.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 485.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 485.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 485.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 459.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 459.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 459.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 459.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 459.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 433.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 433.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 433.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 433.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 433.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 407.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 407.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 407.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 407.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 407.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 381.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 381.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 381.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 381.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 381.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 355.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 355.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 355.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 355.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 355.40 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 329.40 373.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 329.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 329.40 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 329.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 329.40 80.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 706.4 m 492.5 706.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 706.4 m 496.5 706.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 706.4 m 576.5 706.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 693.4 m 492.5 693.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 693.4 m 576.5 693.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 498.4 m 492.5 498.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 498.4 m 576.5 498.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 472.4 m 492.5 472.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 472.4 m 576.5 472.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 394.4 m 492.5 394.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 394.4 m 576.5 394.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 381.4 m 492.5 381.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 381.4 m 576.5 381.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 369.4 m 492.5 369.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 367.4 m 492.5 367.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 369.4 m 576.5 369.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 367.4 m 576.5 367.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 316.4 m 492.5 316.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 316.4 m 576.5 316.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 304.4 m 492.5 304.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 302.4 m 492.5 302.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 304.4 m 576.5 304.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 302.4 m 576.5 302.4 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 710.65 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.25 710.63 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 697.65 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 697.63 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 697.63 Td (2015) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 684.13 Td (Deferred tax assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 670.97 Td (Foreign net operating loss carryforwards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 670.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 670.97 Td (2,945) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 670.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 670.97 Td (3,090) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 657.97 Td (U.S. capital loss carryforwards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 657.97 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 657.97 Td (39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 644.97 Td (State net operating loss and credit carryforwards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 644.97 Td (114) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 644.97 Td (324) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 631.97 Td (U.S. Federal net operating loss and credit carryforwards) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 631.97 Td (156) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 631.97 Td (173) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 618.97 Td (Deferred income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 618.97 Td (764) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 618.97 Td (1,009) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 605.97 Td (Milestone payments and license fees) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 605.97 Td (534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 605.97 Td (560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 592.97 Td (Pension and postretirement benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 592.97 Td (358) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 592.97 Td (462) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 579.97 Td (Intercompany profit and other inventory items) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 579.97 Td (1,241) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 579.97 Td (607) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 566.97 Td (Other foreign deferred tax assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 566.97 Td (188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 566.97 Td (172) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 553.97 Td (Share-based compensation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 553.97 Td (114) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 553.97 Td (122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 540.97 Td (Legal and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 540.97 Td (5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 540.97 Td (63) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 527.97 Td (Repatriation of foreign earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 527.97 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 527.97 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 527.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 514.97 Td (Internal transfer of intellectual property) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 514.97 Td (629) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 514.97 Td (635) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 501.97 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 501.97 Td (287) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 501.97 Td (337) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 488.97 Td (Total deferred tax assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 488.97 Td (7,351) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 488.97 Td (7,592) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 475.97 Td (Valuation allowance) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.80 476.02 Td (\(3,078) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 475.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 475.97 Td (\(3,534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 475.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 462.97 Td (Deferred tax assets net of valuation allowance) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 462.97 Td (4,273) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 462.97 Td (4,058) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 437.13 Td (Deferred tax liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 423.97 Td (Depreciation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.30 424.02 Td (\(125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 423.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 423.97 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 423.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 410.97 Td (Acquired intangible assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.30 411.02 Td (\(344) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 410.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 410.97 Td (\(338) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 410.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 397.97 Td (Goodwill and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.30 398.02 Td (\(855) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 397.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 397.97 Td (\(802) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 397.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 384.97 Td (Total deferred tax liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.80 385.02 Td (\(1,324) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 384.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 384.97 Td (\(1,245) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 384.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 371.97 Td (Deferred tax assets, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 371.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 371.97 Td (2,949) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 371.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 371.97 Td (2,813) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 345.97 Td (Recognized as:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 332.97 Td (Deferred income taxes – non-current) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 332.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 332.97 Td (2,996) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 332.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 332.97 Td (2,844) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 319.97 Td (Income taxes payable – non-current) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.30 320.02 Td (\(47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 319.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 319.97 Td (\(31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 319.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 306.97 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 306.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 306.97 Td (2,949) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 306.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 306.97 Td (2,813) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 279.90 Td (Internal ) Tj ET Q q 0 0 0 rg BT 69.02 279.90 Td (transfers ) Tj ET Q q 0 0 0 rg BT 105.38 279.90 Td (of ) Tj ET Q q 0 0 0 rg BT 115.64 279.90 Td (intellectual ) Tj ET Q q 0 0 0 rg BT 161.99 279.90 Td (property ) Tj ET Q q 0 0 0 rg BT 197.79 279.90 Td (resulted ) Tj ET Q q 0 0 0 rg BT 231.38 279.90 Td (in ) Tj ET Q q 0 0 0 rg BT 241.08 279.90 Td (the ) Tj ET Q q 0 0 0 rg BT 255.23 279.90 Td (deferred ) Tj ET Q q 0 0 0 rg BT 290.46 279.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 304.60 279.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 329.86 279.90 Td (included ) Tj ET Q q 0 0 0 rg BT 366.22 279.90 Td (above ) Tj ET Q q 0 0 0 rg BT 392.03 279.90 Td (and ) Tj ET Q q 0 0 0 rg BT 408.39 279.90 Td (prepaid ) Tj ET Q q 0 0 0 rg BT 440.31 279.90 Td (taxes ) Tj ET Q q 0 0 0 rg BT 462.78 279.90 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.04 279.90 Td ($372 ) Tj ET Q q 0 0 0 rg BT 494.97 279.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.86 279.90 Td ( ) Tj ET Q q 0 0 0 rg BT 525.79 279.90 Td (at ) Tj ET Q q 0 0 0 rg BT 534.93 279.90 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 267.90 Td (31, ) Tj ET Q q 0 0 0 rg BT 51.12 267.90 Td (2016 ) Tj ET Q q 0 0 0 rg BT 73.74 267.90 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 90.79 267.90 Td ($484 ) Tj ET Q q 0 0 0 rg BT 113.41 267.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 142.30 267.90 Td ( ) Tj ET Q q 0 0 0 rg BT 144.92 267.90 Td (of ) Tj ET Q q 0 0 0 rg BT 155.87 267.90 Td (prepaid ) Tj ET Q q 0 0 0 rg BT 188.48 267.90 Td (taxes ) Tj ET Q q 0 0 0 rg BT 211.64 267.90 Td (at ) Tj ET Q q 0 0 0 rg BT 221.48 267.90 Td (December ) Tj ET Q q 0 0 0 rg BT 265.18 267.90 Td (31, ) Tj ET Q q 0 0 0 rg BT 280.30 267.90 Td (2015. ) Tj ET Q q 0 0 0 rg BT 305.23 267.90 Td (These ) Tj ET Q q 0 0 0 rg BT 331.72 267.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 357.67 267.90 Td (are ) Tj ET Q q 0 0 0 rg BT 372.50 267.90 Td (being ) Tj ET Q q 0 0 0 rg BT 397.33 267.90 Td (amortized ) Tj ET Q q 0 0 0 rg BT 439.93 267.90 Td (over ) Tj ET Q q 0 0 0 rg BT 460.32 267.90 Td (their ) Tj ET Q q 0 0 0 rg BT 481.26 267.90 Td (expected ) Tj ET Q q 0 0 0 rg BT 519.41 267.90 Td (lives. ) Tj ET Q q 0 0 0 rg BT 543.42 267.90 Td (Refer ) Tj ET Q q 0 0 0 rg BT 568.25 267.90 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 255.90 Td (Recently ) Tj ET Q q 0 0 0 rg BT 74.40 255.90 Td (Issued ) Tj ET Q q 0 0 0 rg BT 102.18 255.90 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 151.69 255.90 Td (Standards ) Tj ET Q q 0 0 0 rg BT 193.99 255.90 Td (in ) Tj ET Q q 0 0 0 rg BT 204.63 255.90 Td ("—Note ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 241.01 255.90 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.01 255.90 Td (. ) Tj ET Q q 0 0 0 rg BT 250.74 255.90 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 300.25 255.90 Td (Policies" ) Tj ET Q q 0 0 0 rg BT 338.86 255.90 Td (for ) Tj ET Q q 0 0 0 rg BT 353.38 255.90 Td (information ) Tj ET Q q 0 0 0 rg BT 403.45 255.90 Td (regarding ) Tj ET Q q 0 0 0 rg BT 444.62 255.90 Td (the ) Tj ET Q q 0 0 0 rg BT 459.70 255.90 Td (impact ) Tj ET Q q 0 0 0 rg BT 489.77 255.90 Td (of ) Tj ET Q q 0 0 0 rg BT 500.96 255.90 Td (amended ) Tj ET Q q 0 0 0 rg BT 539.91 255.90 Td (guidance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 243.90 Td (that ) Tj ET Q q 0 0 0 rg BT 53.50 243.90 Td (the ) Tj ET Q q 0 0 0 rg BT 68.21 243.90 Td (Company ) Tj ET Q q 0 0 0 rg BT 109.60 243.90 Td (expects ) Tj ET Q q 0 0 0 rg BT 142.08 243.90 Td (to ) Tj ET Q q 0 0 0 rg BT 152.36 243.90 Td (adopt ) Tj ET Q q 0 0 0 rg BT 177.08 243.90 Td (in ) Tj ET Q q 0 0 0 rg BT 187.36 243.90 Td (2017. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 219.90 Td (The ) Tj ET Q q 0 0 0 rg BT 54.58 219.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 75.39 219.90 Td (Federal ) Tj ET Q q 0 0 0 rg BT 108.41 219.90 Td (net ) Tj ET Q q 0 0 0 rg BT 123.66 219.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 164.46 219.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 183.05 219.90 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 242.16 219.90 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.62 219.90 Td ($368 ) Tj ET Q q 0 0 0 rg BT 287.66 219.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 316.55 219.90 Td ( ) Tj ET Q q 0 0 0 rg BT 319.58 219.90 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.83 219.90 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 388.94 219.90 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.94 219.90 Td (. ) Tj ET Q q 0 0 0 rg BT 414.26 219.90 Td (These ) Tj ET Q q 0 0 0 rg BT 441.17 219.90 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 500.28 219.90 Td (were ) Tj ET Q q 0 0 0 rg BT 522.74 219.90 Td (acquired ) Tj ET Q q 0 0 0 rg BT 560.19 219.90 Td (as ) Tj ET Q q 0 0 0 rg BT 571.56 219.90 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 207.90 Td (result ) Tj ET Q q 0 0 0 rg BT 61.78 207.90 Td (of ) Tj ET Q q 0 0 0 rg BT 73.67 207.90 Td (certain ) Tj ET Q q 0 0 0 rg BT 104.43 207.90 Td (acquisitions ) Tj ET Q q 0 0 0 rg BT 155.76 207.90 Td (and ) Tj ET Q q 0 0 0 rg BT 173.76 207.90 Td (are ) Tj ET Q q 0 0 0 rg BT 189.53 207.90 Td (subject ) Tj ET Q q 0 0 0 rg BT 221.41 207.90 Td (to ) Tj ET Q q 0 0 0 rg BT 232.75 207.90 Td (limitations ) Tj ET Q q 0 0 0 rg BT 279.09 207.90 Td (under ) Tj ET Q q 0 0 0 rg BT 305.41 207.90 Td (Section 382 ) Tj ET Q q 0 0 0 rg BT 356.47 207.90 Td (of ) Tj ET Q q 0 0 0 rg BT 368.36 207.90 Td (the ) Tj ET Q q 0 0 0 rg BT 384.13 207.90 Td (Internal ) Tj ET Q q 0 0 0 rg BT 418.79 207.90 Td (Revenue ) Tj ET Q q 0 0 0 rg BT 457.33 207.90 Td (Code. ) Tj ET Q q 0 0 0 rg BT 484.24 207.90 Td (The ) Tj ET Q q 0 0 0 rg BT 503.35 207.90 Td (net ) Tj ET Q q 0 0 0 rg BT 519.13 207.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 560.45 207.90 Td (loss ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 195.90 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 95.11 195.90 Td (expire ) Tj ET Q q 0 0 0 rg BT 123.13 195.90 Td (in ) Tj ET Q q 0 0 0 rg BT 133.94 195.90 Td (varying ) Tj ET Q q 0 0 0 rg BT 167.51 195.90 Td (amounts ) Tj ET Q q 0 0 0 rg BT 204.43 195.90 Td (beginning ) Tj ET Q q 0 0 0 rg BT 247.46 195.90 Td (in ) Tj ET Q q 0 0 0 rg BT 258.27 195.90 Td (2022. ) Tj ET Q q 0 0 0 rg BT 283.58 195.90 Td (The ) Tj ET Q q 0 0 0 rg BT 302.16 195.90 Td (foreign ) Tj ET Q q 0 0 0 rg BT 334.07 195.90 Td (and ) Tj ET Q q 0 0 0 rg BT 351.54 195.90 Td (state ) Tj ET Q q 0 0 0 rg BT 372.89 195.90 Td (net ) Tj ET Q q 0 0 0 rg BT 388.14 195.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 428.94 195.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 447.53 195.90 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 506.64 195.90 Td (expire ) Tj ET Q q 0 0 0 rg BT 534.66 195.90 Td (in ) Tj ET Q q 0 0 0 rg BT 545.47 195.90 Td (varying ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 183.90 Td (amounts ) Tj ET Q q 0 0 0 rg BT 72.39 183.90 Td (beginning ) Tj ET Q q 0 0 0 rg BT 114.88 183.90 Td (in ) Tj ET Q q 0 0 0 rg BT 125.16 183.90 Td (2017 ) Tj ET Q q 0 0 0 rg BT 147.66 183.90 Td (\(certain ) Tj ET Q q 0 0 0 rg BT 180.69 183.90 Td (amounts ) Tj ET Q q 0 0 0 rg BT 217.08 183.90 Td (have ) Tj ET Q q 0 0 0 rg BT 238.46 183.90 Td (unlimited ) Tj ET Q q 0 0 0 rg BT 279.29 183.90 Td (lives\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 159.90 Td (At ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 48.89 159.90 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 107.87 159.90 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 127.87 159.90 Td (, ) Tj ET Q q 0 0 0 rg BT 133.26 159.90 Td (a ) Tj ET Q q 0 0 0 rg BT 140.59 159.90 Td (valuation ) Tj ET Q q 0 0 0 rg BT 180.69 159.90 Td (allowance ) Tj ET Q q 0 0 0 rg BT 224.12 159.90 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.34 159.90 Td ($3,078 ) Tj ET Q q 0 0 0 rg BT 265.73 159.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 294.63 159.90 Td ( ) Tj ET Q q 0 0 0 rg BT 297.52 159.90 Td (was ) Tj ET Q q 0 0 0 rg BT 315.96 159.90 Td (established ) Tj ET Q q 0 0 0 rg BT 363.29 159.90 Td (for ) Tj ET Q q 0 0 0 rg BT 377.84 159.90 Td (the ) Tj ET Q q 0 0 0 rg BT 392.95 159.90 Td (following ) Tj ET Q q 0 0 0 rg BT 434.73 159.90 Td (items: ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.06 159.90 Td ($2,894 ) Tj ET Q q 0 0 0 rg BT 492.45 159.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.35 159.90 Td ( ) Tj ET Q q 0 0 0 rg BT 524.24 159.90 Td (primarily ) Tj ET Q q 0 0 0 rg BT 564.34 159.90 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 147.90 Td (foreign ) Tj ET Q q 0 0 0 rg BT 67.87 147.90 Td (net ) Tj ET Q q 0 0 0 rg BT 83.08 147.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 123.84 147.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 142.40 147.90 Td (and ) Tj ET Q q 0 0 0 rg BT 159.83 147.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 175.04 147.90 Td (credit ) Tj ET Q q 0 0 0 rg BT 200.80 147.90 Td (carryforwards, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.37 147.90 Td ($101 ) Tj ET Q q 0 0 0 rg BT 285.37 147.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.26 147.90 Td ( ) Tj ET Q q 0 0 0 rg BT 317.25 147.90 Td (for ) Tj ET Q q 0 0 0 rg BT 331.91 147.90 Td (state ) Tj ET Q q 0 0 0 rg BT 353.23 147.90 Td (deferred ) Tj ET Q q 0 0 0 rg BT 389.53 147.90 Td (tax ) Tj ET Q q 0 0 0 rg BT 404.74 147.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 431.07 147.90 Td (including ) Tj ET Q q 0 0 0 rg BT 471.83 147.90 Td (net ) Tj ET Q q 0 0 0 rg BT 487.05 147.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 527.80 147.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 546.36 147.90 Td (and ) Tj ET Q q 0 0 0 rg BT 563.79 147.90 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 135.90 Td (credit ) Tj ET Q q 0 0 0 rg BT 61.41 135.90 Td (carryforwards, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 122.63 135.90 Td ($1) Tj ET Q q 0 0 0 rg BT 132.26 135.90 Td (1 ) Tj ET Q q 0 0 0 rg BT 139.91 135.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 168.80 135.90 Td ( ) Tj ET Q q 0 0 0 rg BT 171.45 135.90 Td (for ) Tj ET Q q 0 0 0 rg BT 185.75 135.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 206.18 135.90 Td (Federal ) Tj ET Q q 0 0 0 rg BT 238.81 135.90 Td (net ) Tj ET Q q 0 0 0 rg BT 253.67 135.90 Td (operating ) Tj ET Q q 0 0 0 rg BT 294.08 135.90 Td (loss ) Tj ET Q q 0 0 0 rg BT 312.29 135.90 Td (carryforwards ) Tj ET Q q 0 0 0 rg BT 371.01 135.90 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.10 135.90 Td ($72 ) Tj ET Q q 0 0 0 rg BT 405.74 135.90 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.63 135.90 Td ( ) Tj ET Q q 0 0 0 rg BT 437.28 135.90 Td (for ) Tj ET Q q 0 0 0 rg BT 451.59 135.90 Td (other ) Tj ET Q q 0 0 0 rg BT 474.78 135.90 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 495.21 135.90 Td (Federal ) Tj ET Q q 0 0 0 rg BT 527.84 135.90 Td (deferred ) Tj ET Q q 0 0 0 rg BT 563.79 135.90 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 123.90 Td (assets.) Tj ET Q endstream endobj 161 0 obj <> endobj 162 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (80) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Changes in the valuation allowance were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 712.60 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 712.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 712.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 712.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 712.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 686.60 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 686.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 686.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 686.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 686.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 660.60 316.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 352.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 660.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 660.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 660.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 660.60 71.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 725.6 m 426.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 426.5 725.6 m 430.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 725.6 m 501.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 501.5 725.6 m 505.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 712.6 m 426.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 712.6 m 501.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 712.6 m 576.5 712.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 647.6 m 426.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 635.6 m 426.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 356.5 633.6 m 426.5 633.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 647.6 m 501.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 635.6 m 501.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 633.6 m 501.5 633.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 647.6 m 576.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 635.6 m 576.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 633.6 m 576.5 633.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 421.70 729.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 716.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.00 716.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 457.50 716.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 716.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 703.17 Td (Balance at beginning of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.00 703.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 703.17 Td (3,534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 703.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 703.17 Td (4,259) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 703.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 703.17 Td (4,623) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Provision) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 690.17 Td (39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 690.17 Td (71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 690.17 Td (140) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 677.17 Td (Utilization) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 677.22 Td (\(355) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 677.22 Td (\(436) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 677.17 Td (\(109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 664.17 Td (Foreign currency translation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 664.22 Td (\(142) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 664.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 664.22 Td (\(366) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 664.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 664.17 Td (\(395) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 664.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 651.17 Td (Acquisitions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 651.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 651.17 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 651.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 638.17 Td (Balance at end of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.00 638.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 638.17 Td (3,078) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 638.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 638.17 Td (3,534) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 638.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 638.17 Td (4,259) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 613.50 Td (Income ) Tj ET Q q 0 0 0 rg BT 68.38 613.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 82.99 613.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 123.71 613.50 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 145.53 613.50 Td ($2,041 ) Tj ET Q q 0 0 0 rg BT 175.42 613.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 204.31 613.50 Td ( ) Tj ET Q q 0 0 0 rg BT 206.70 613.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 216.87 613.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.87 613.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 241.77 613.50 Td ($577 ) Tj ET Q q 0 0 0 rg BT 264.16 613.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.05 613.50 Td ( ) Tj ET Q q 0 0 0 rg BT 295.44 613.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.61 613.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.61 613.50 Td ( ) Tj ET Q q 0 0 0 rg BT 328.01 613.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.84 613.50 Td ($544 ) Tj ET Q q 0 0 0 rg BT 367.23 613.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.12 613.50 Td ( ) Tj ET Q q 0 0 0 rg BT 398.51 613.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.69 613.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.69 613.50 Td (. ) Tj ET Q q 0 0 0 rg BT 433.41 613.50 Td (The ) Tj ET Q q 0 0 0 rg BT 451.34 613.50 Td (current ) Tj ET Q q 0 0 0 rg BT 482.05 613.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 496.66 613.50 Td (benefit ) Tj ET Q q 0 0 0 rg BT 526.82 613.50 Td (realized ) Tj ET Q q 0 0 0 rg BT 560.85 613.50 Td (as ) Tj ET Q q 0 0 0 rg BT 571.57 613.50 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 601.50 Td (result ) Tj ET Q q 0 0 0 rg BT 60.39 601.50 Td (of ) Tj ET Q q 0 0 0 rg BT 70.89 601.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 94.17 601.50 Td (related ) Tj ET Q q 0 0 0 rg BT 123.54 601.50 Td (compensation ) Tj ET Q q 0 0 0 rg BT 181.25 601.50 Td (credited ) Tj ET Q q 0 0 0 rg BT 215.62 601.50 Td (to ) Tj ET Q q 0 0 0 rg BT 225.57 601.50 Td (capital ) Tj ET Q q 0 0 0 rg BT 254.39 601.50 Td (in ) Tj ET Q q 0 0 0 rg BT 264.34 601.50 Td (excess ) Tj ET Q q 0 0 0 rg BT 292.61 601.50 Td (of ) Tj ET Q q 0 0 0 rg BT 303.11 601.50 Td (par ) Tj ET Q q 0 0 0 rg BT 318.05 601.50 Td (value ) Tj ET Q q 0 0 0 rg BT 341.88 601.50 Td (of ) Tj ET Q q 0 0 0 rg BT 352.38 601.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 375.66 601.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 393.38 601.50 Td ($92 ) Tj ET Q q 0 0 0 rg BT 410.55 601.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.44 601.50 Td ( ) Tj ET Q q 0 0 0 rg BT 441.61 601.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.56 601.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.56 601.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.23 601.50 Td ($147 ) Tj ET Q q 0 0 0 rg BT 498.40 601.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.29 601.50 Td ( ) Tj ET Q q 0 0 0 rg BT 529.46 601.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.41 601.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.41 601.50 Td ( ) Tj ET Q q 0 0 0 rg BT 561.58 601.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 589.50 Td ($131 ) Tj ET Q q 0 0 0 rg BT 58.50 589.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 87.39 589.50 Td ( ) Tj ET Q q 0 0 0 rg BT 89.89 589.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.17 589.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 120.17 589.50 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 565.50 Td (Business ) Tj ET Q q 0 0 0 rg BT 73.94 565.50 Td (is ) Tj ET Q q 0 0 0 rg BT 82.99 565.50 Td (conducted ) Tj ET Q q 0 0 0 rg BT 126.46 565.50 Td (in ) Tj ET Q q 0 0 0 rg BT 136.62 565.50 Td (various ) Tj ET Q q 0 0 0 rg BT 168.43 565.50 Td (countries ) Tj ET Q q 0 0 0 rg BT 207.46 565.50 Td (throughout ) Tj ET Q q 0 0 0 rg BT 253.73 565.50 Td (the ) Tj ET Q q 0 0 0 rg BT 268.32 565.50 Td (world ) Tj ET Q q 0 0 0 rg BT 294.03 565.50 Td (and ) Tj ET Q q 0 0 0 rg BT 310.85 565.50 Td (is ) Tj ET Q q 0 0 0 rg BT 319.90 565.50 Td (subject ) Tj ET Q q 0 0 0 rg BT 350.60 565.50 Td (to ) Tj ET Q q 0 0 0 rg BT 360.76 565.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 375.35 565.50 Td (in ) Tj ET Q q 0 0 0 rg BT 385.51 565.50 Td (numerous ) Tj ET Q q 0 0 0 rg BT 427.32 565.50 Td (jurisdictions. ) Tj ET Q q 0 0 0 rg BT 481.12 565.50 Td (A) Tj ET Q q 0 0 0 rg BT 487.79 565.50 Td ( ) Tj ET Q q 0 0 0 rg BT 490.17 565.50 Td (significant ) Tj ET Q q 0 0 0 rg BT 534.76 565.50 Td (number ) Tj ET Q q 0 0 0 rg BT 567.68 565.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 553.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 50.03 553.50 Td (returns ) Tj ET Q q 0 0 0 rg BT 79.60 553.50 Td (that ) Tj ET Q q 0 0 0 rg BT 96.41 553.50 Td (are ) Tj ET Q q 0 0 0 rg BT 110.42 553.50 Td (filed ) Tj ET Q q 0 0 0 rg BT 130.56 553.50 Td (are ) Tj ET Q q 0 0 0 rg BT 144.57 553.50 Td (subject ) Tj ET Q q 0 0 0 rg BT 174.71 553.50 Td (to ) Tj ET Q q 0 0 0 rg BT 184.30 553.50 Td (examination ) Tj ET Q q 0 0 0 rg BT 235.53 553.50 Td (by ) Tj ET Q q 0 0 0 rg BT 247.34 553.50 Td (various ) Tj ET Q q 0 0 0 rg BT 278.59 553.50 Td (Federal, ) Tj ET Q q 0 0 0 rg BT 312.88 553.50 Td (state ) Tj ET Q q 0 0 0 rg BT 333.02 553.50 Td (and ) Tj ET Q q 0 0 0 rg BT 349.27 553.50 Td (local ) Tj ET Q q 0 0 0 rg BT 370.51 553.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 384.54 553.50 Td (authorities. ) Tj ET Q q 0 0 0 rg BT 430.93 553.50 Td (T) Tj ET Q q 0 0 0 rg BT 436.34 553.50 Td (ax ) Tj ET Q q 0 0 0 rg BT 447.58 553.50 Td (examinations ) Tj ET Q q 0 0 0 rg BT 502.71 553.50 Td (are ) Tj ET Q q 0 0 0 rg BT 516.73 553.50 Td (often ) Tj ET Q q 0 0 0 rg BT 539.08 553.50 Td (complex, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 541.50 Td (as ) Tj ET Q q 0 0 0 rg BT 47.57 541.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 63.03 541.50 Td (authorities ) Tj ET Q q 0 0 0 rg BT 108.48 541.50 Td (may ) Tj ET Q q 0 0 0 rg BT 128.94 541.50 Td (disagree ) Tj ET Q q 0 0 0 rg BT 165.50 541.50 Td (with ) Tj ET Q q 0 0 0 rg BT 186.52 541.50 Td (the ) Tj ET Q q 0 0 0 rg BT 201.97 541.50 Td (treatment ) Tj ET Q q 0 0 0 rg BT 242.97 541.50 Td (of ) Tj ET Q q 0 0 0 rg BT 254.55 541.50 Td (items ) Tj ET Q q 0 0 0 rg BT 279.45 541.50 Td (reported ) Tj ET Q q 0 0 0 rg BT 316.01 541.50 Td (requiring ) Tj ET Q q 0 0 0 rg BT 355.91 541.50 Td (several ) Tj ET Q q 0 0 0 rg BT 387.46 541.50 Td (years ) Tj ET Q q 0 0 0 rg BT 411.80 541.50 Td (to ) Tj ET Q q 0 0 0 rg BT 422.82 541.50 Td (resolve. ) Tj ET Q q 0 0 0 rg BT 457.44 541.50 Td (Liabilities ) Tj ET Q q 0 0 0 rg BT 501.23 541.50 Td (are ) Tj ET Q q 0 0 0 rg BT 516.68 541.50 Td (established ) Tj ET Q q 0 0 0 rg BT 564.35 541.50 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 529.50 Td (possible ) Tj ET Q q 0 0 0 rg BT 71.73 529.50 Td (assessments ) Tj ET Q q 0 0 0 rg BT 123.01 529.50 Td (by ) Tj ET Q q 0 0 0 rg BT 135.97 529.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 151.14 529.50 Td (authorities ) Tj ET Q q 0 0 0 rg BT 196.30 529.50 Td (resulting ) Tj ET Q q 0 0 0 rg BT 234.25 529.50 Td (from ) Tj ET Q q 0 0 0 rg BT 256.64 529.50 Td (known ) Tj ET Q q 0 0 0 rg BT 286.82 529.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 301.99 529.50 Td (exposures ) Tj ET Q q 0 0 0 rg BT 344.93 529.50 Td (including, ) Tj ET Q q 0 0 0 rg BT 388.16 529.50 Td (but ) Tj ET Q q 0 0 0 rg BT 403.89 529.50 Td (not ) Tj ET Q q 0 0 0 rg BT 419.62 529.50 Td (limited ) Tj ET Q q 0 0 0 rg BT 450.90 529.50 Td (to, ) Tj ET Q q 0 0 0 rg BT 464.13 529.50 Td (transfer ) Tj ET Q q 0 0 0 rg BT 497.63 529.50 Td (pricing ) Tj ET Q q 0 0 0 rg BT 528.90 529.50 Td (matters, ) Tj ET Q q 0 0 0 rg BT 563.79 529.50 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 517.50 Td (credits ) Tj ET Q q 0 0 0 rg BT 65.58 517.50 Td (and ) Tj ET Q q 0 0 0 rg BT 82.95 517.50 Td (deductibility ) Tj ET Q q 0 0 0 rg BT 136.42 517.50 Td (of ) Tj ET Q q 0 0 0 rg BT 147.68 517.50 Td (certain ) Tj ET Q q 0 0 0 rg BT 177.81 517.50 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 219.33 517.50 Td (Such ) Tj ET Q q 0 0 0 rg BT 242.26 517.50 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 282.41 517.50 Td (represent ) Tj ET Q q 0 0 0 rg BT 321.98 517.50 Td (a ) Tj ET Q q 0 0 0 rg BT 329.34 517.50 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 375.03 517.50 Td (provision ) Tj ET Q q 0 0 0 rg BT 415.73 517.50 Td (for ) Tj ET Q q 0 0 0 rg BT 430.32 517.50 Td (taxes ) Tj ET Q q 0 0 0 rg BT 453.79 517.50 Td (ultimately ) Tj ET Q q 0 0 0 rg BT 497.27 517.50 Td (expected ) Tj ET Q q 0 0 0 rg BT 535.73 517.50 Td (to ) Tj ET Q q 0 0 0 rg BT 546.43 517.50 Td (be ) Tj ET Q q 0 0 0 rg BT 558.80 517.50 Td (paid ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 505.50 Td (and ) Tj ET Q q 0 0 0 rg BT 52.70 505.50 Td (may ) Tj ET Q q 0 0 0 rg BT 72.17 505.50 Td (need ) Tj ET Q q 0 0 0 rg BT 93.31 505.50 Td (to ) Tj ET Q q 0 0 0 rg BT 103.35 505.50 Td (be ) Tj ET Q q 0 0 0 rg BT 115.05 505.50 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 150.63 505.50 Td (over ) Tj ET Q q 0 0 0 rg BT 170.66 505.50 Td (time ) Tj ET Q q 0 0 0 rg BT 190.69 505.50 Td (as ) Tj ET Q q 0 0 0 rg BT 201.28 505.50 Td (more ) Tj ET Q q 0 0 0 rg BT 224.09 505.50 Td (information ) Tj ET Q q 0 0 0 rg BT 273.56 505.50 Td (becomes ) Tj ET Q q 0 0 0 rg BT 310.81 505.50 Td (known. ) Tj ET Q q 0 0 0 rg BT 342.63 505.50 Td (The ) Tj ET Q q 0 0 0 rg BT 360.43 505.50 Td (ef) Tj ET Q q 0 0 0 rg BT 368.02 505.50 Td (fect ) Tj ET Q q 0 0 0 rg BT 385.27 505.50 Td (of ) Tj ET Q q 0 0 0 rg BT 395.85 505.50 Td (changes ) Tj ET Q q 0 0 0 rg BT 430.32 505.50 Td (in ) Tj ET Q q 0 0 0 rg BT 440.36 505.50 Td (estimates ) Tj ET Q q 0 0 0 rg BT 479.83 505.50 Td (related ) Tj ET Q q 0 0 0 rg BT 509.29 505.50 Td (to ) Tj ET Q q 0 0 0 rg BT 519.33 505.50 Td (contingent ) Tj ET Q q 0 0 0 rg BT 563.80 505.50 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 493.50 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 75.72 493.50 Td (is ) Tj ET Q q 0 0 0 rg BT 84.89 493.50 Td (included ) Tj ET Q q 0 0 0 rg BT 121.82 493.50 Td (in ) Tj ET Q q 0 0 0 rg BT 132.10 493.50 Td (the ) Tj ET Q q 0 0 0 rg BT 146.82 493.50 Td (ef) Tj ET Q q 0 0 0 rg BT 154.40 493.50 Td (fective ) Tj ET Q q 0 0 0 rg BT 184.11 493.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 198.82 493.50 Td (rate ) Tj ET Q q 0 0 0 rg BT 216.31 493.50 Td (reconciliation ) Tj ET Q q 0 0 0 rg BT 273.78 493.50 Td (above.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 471.90 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 471.90 Td ( reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 435.40 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 435.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 435.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 435.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 435.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 435.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 435.40 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 409.40 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 409.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 409.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 409.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 409.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 409.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 409.40 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 383.40 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 383.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 383.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 383.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 383.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 383.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 383.40 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 357.40 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 357.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 357.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 357.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 357.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 357.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 357.40 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 331.40 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 331.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 331.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 331.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 331.40 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 331.40 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 331.40 70.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 448.4 m 429.5 448.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 429.5 448.4 m 433.5 448.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 448.4 m 502.5 448.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 448.4 m 506.5 448.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 448.4 m 576.5 448.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 435.4 m 429.5 435.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 435.4 m 502.5 435.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 435.4 m 576.5 435.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 331.4 m 429.5 331.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 331.4 m 502.5 331.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 331.4 m 576.5 331.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 319.4 m 429.5 319.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 317.4 m 429.5 317.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 319.4 m 502.5 319.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 317.4 m 502.5 317.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 319.4 m 576.5 319.4 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 317.4 m 576.5 317.4 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 452.65 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 423.70 452.63 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 439.65 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 439.63 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 439.63 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.00 439.63 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 425.97 Td (Balance at beginning of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 425.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 425.97 Td (944) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 425.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 425.97 Td (934) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 425.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 425.97 Td (756) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 412.97 Td (Gross additions to tax positions related to current year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 412.97 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 412.97 Td (52) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 412.97 Td (106) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 399.97 Td (Gross additions to tax positions related to prior years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 399.97 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 399.97 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 399.97 Td (218) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 386.97 Td (Gross additions to tax positions assumed in acquisitions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 386.97 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 386.97 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 386.97 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 373.97 Td (Gross reductions to tax positions related to prior years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.30 374.02 Td (\(22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 373.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.30 374.02 Td (\(34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 373.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 373.97 Td (\(57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 373.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 360.97 Td (Settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.30 361.02 Td (\(13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 360.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.30 361.02 Td (\(46) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 360.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 360.97 Td (\(65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 360.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 347.97 Td (Reductions to tax positions related to lapse of statute) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.30 348.02 Td (\(4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 347.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 490.30 348.02 Td (\(9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 347.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 347.97 Td (\(12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 347.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 334.97 Td (Cumulative translation adjustment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.30 335.02 Td (\(9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 334.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.30 335.02 Td (\(10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 334.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 334.97 Td (\(12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 334.97 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 321.97 Td (Balance at end of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 321.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 321.97 Td (995) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 321.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 321.97 Td (944) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 321.97 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 321.97 Td (934) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 297.30 Td (Additional information regarding unrecognized tax benefits is as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 262.80 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 262.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 262.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 262.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 262.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 262.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 262.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 234.80 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 234.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 234.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 234.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 234.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 234.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 234.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 206.80 348.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 206.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 388.50 206.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 448.50 206.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 452.50 206.80 60.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 512.50 206.80 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 516.50 206.80 60.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 274.79999999999995 m 448.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 274.79999999999995 m 452.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 274.79999999999995 m 512.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 274.79999999999995 m 516.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 274.79999999999995 m 576.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 274.79999999999995 m 448.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 388.5 262.79999999999995 m 448.5 262.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 448.5 274.79999999999995 m 452.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 274.79999999999995 m 512.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 452.5 262.79999999999995 m 512.5 262.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 512.5 274.79999999999995 m 516.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 274.79999999999995 m 576.5 274.79999999999995 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 516.5 262.79999999999995 m 576.5 262.79999999999995 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 278.75 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 437.70 278.88 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 266.75 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 410.00 266.88 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 266.88 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.00 266.88 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 253.37 Td (Unrecognized tax benefits that if recognized would impact the effective tax rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.00 253.37 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 253.37 Td (854) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.00 253.37 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 253.37 Td (671) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.00 253.37 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 253.37 Td (668) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 239.37 Td (Accrued interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 429.65 239.37 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 239.37 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 239.37 Td (96) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 225.37 Td (Accrued penalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 225.37 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 225.37 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 225.37 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 211.37 Td (Interest expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 211.37 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 211.37 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 211.37 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 197.37 Td (Penalty expense/\(benefit\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 197.37 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.65 197.37 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 197.37 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 197.37 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 171.70 Td (Accrued ) Tj ET Q q 0 0 0 rg BT 72.21 171.70 Td (interest ) Tj ET Q q 0 0 0 rg BT 103.99 171.70 Td (and ) Tj ET Q q 0 0 0 rg BT 120.77 171.70 Td (penalties ) Tj ET Q q 0 0 0 rg BT 158.66 171.70 Td (payable ) Tj ET Q q 0 0 0 rg BT 192.09 171.70 Td (for ) Tj ET Q q 0 0 0 rg BT 206.10 171.70 Td (unrecognized ) Tj ET Q q 0 0 0 rg BT 262.30 171.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 276.86 171.70 Td (benefits ) Tj ET Q q 0 0 0 rg BT 310.86 171.70 Td (are ) Tj ET Q q 0 0 0 rg BT 325.41 171.70 Td (included ) Tj ET Q q 0 0 0 rg BT 362.19 171.70 Td (in ) Tj ET Q q 0 0 0 rg BT 372.31 171.70 Td (either ) Tj ET Q q 0 0 0 rg BT 397.42 171.70 Td (current ) Tj ET Q q 0 0 0 rg BT 428.08 171.70 Td (or ) Tj ET Q q 0 0 0 rg BT 438.75 171.70 Td (non-current ) Tj ET Q q 0 0 0 rg BT 487.74 171.70 Td (income ) Tj ET Q q 0 0 0 rg BT 519.52 171.70 Td (taxes ) Tj ET Q q 0 0 0 rg BT 542.41 171.70 Td (payable. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 159.70 Td (Interest ) Tj ET Q q 0 0 0 rg BT 68.49 159.70 Td (and ) Tj ET Q q 0 0 0 rg BT 85.42 159.70 Td (penalties ) Tj ET Q q 0 0 0 rg BT 123.47 159.70 Td (related ) Tj ET Q q 0 0 0 rg BT 153.17 159.70 Td (to ) Tj ET Q q 0 0 0 rg BT 163.45 159.70 Td (unrecognized ) Tj ET Q q 0 0 0 rg BT 219.81 159.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 234.53 159.70 Td (benefits ) Tj ET Q q 0 0 0 rg BT 268.68 159.70 Td (are ) Tj ET Q q 0 0 0 rg BT 283.39 159.70 Td (included ) Tj ET Q q 0 0 0 rg BT 320.32 159.70 Td (in ) Tj ET Q q 0 0 0 rg BT 330.60 159.70 Td (income ) Tj ET Q q 0 0 0 rg BT 362.53 159.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 377.25 159.70 Td (expense.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 135.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 59.64 135.70 Td (is ) Tj ET Q q 0 0 0 rg BT 68.83 135.70 Td (currently ) Tj ET Q q 0 0 0 rg BT 107.44 135.70 Td (under ) Tj ET Q q 0 0 0 rg BT 132.72 135.70 Td (examination ) Tj ET Q q 0 0 0 rg BT 184.67 135.70 Td (by ) Tj ET Q q 0 0 0 rg BT 197.19 135.70 Td (a ) Tj ET Q q 0 0 0 rg BT 204.14 135.70 Td (number ) Tj ET Q q 0 0 0 rg BT 237.21 135.70 Td (of ) Tj ET Q q 0 0 0 rg BT 248.05 135.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 262.79 135.70 Td (authorities, ) Tj ET Q q 0 0 0 rg BT 310.02 135.70 Td (including ) Tj ET Q q 0 0 0 rg BT 350.31 135.70 Td (but ) Tj ET Q q 0 0 0 rg BT 365.60 135.70 Td (not ) Tj ET Q q 0 0 0 rg BT 380.90 135.70 Td (limited ) Tj ET Q q 0 0 0 rg BT 411.74 135.70 Td (to ) Tj ET Q q 0 0 0 rg BT 422.04 135.70 Td (the ) Tj ET Q q 0 0 0 rg BT 436.77 135.70 Td (major ) Tj ET Q q 0 0 0 rg BT 462.62 135.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 477.35 135.70 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 529.31 135.70 Td (listed ) Tj ET Q q 0 0 0 rg BT 553.49 135.70 Td (in ) Tj ET Q q 0 0 0 rg BT 563.79 135.70 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 123.70 Td (table ) Tj ET Q q 0 0 0 rg BT 57.61 123.70 Td (below) Tj ET Q q 0 0 0 rg BT 81.40 123.70 Td (, ) Tj ET Q q 0 0 0 rg BT 86.08 123.70 Td (which ) Tj ET Q q 0 0 0 rg BT 112.70 123.70 Td (have ) Tj ET Q q 0 0 0 rg BT 133.76 123.70 Td (proposed ) Tj ET Q q 0 0 0 rg BT 172.60 123.70 Td (or ) Tj ET Q q 0 0 0 rg BT 183.11 123.70 Td (are ) Tj ET Q q 0 0 0 rg BT 197.50 123.70 Td (considering ) Tj ET Q q 0 0 0 rg BT 246.33 123.70 Td (proposing ) Tj ET Q q 0 0 0 rg BT 288.51 123.70 Td (material ) Tj ET Q q 0 0 0 rg BT 323.45 123.70 Td (adjustments ) Tj ET Q q 0 0 0 rg BT 373.40 123.70 Td (to ) Tj ET Q q 0 0 0 rg BT 383.36 123.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 397.76 123.70 Td (for ) Tj ET Q q 0 0 0 rg BT 411.60 123.70 Td (issues ) Tj ET Q q 0 0 0 rg BT 437.67 123.70 Td (such ) Tj ET Q q 0 0 0 rg BT 458.18 123.70 Td (as ) Tj ET Q q 0 0 0 rg BT 468.69 123.70 Td (transfer ) Tj ET Q q 0 0 0 rg BT 501.41 123.70 Td (pricing, ) Tj ET Q q 0 0 0 rg BT 534.42 123.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 563.80 123.70 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 111.70 Td (credits ) Tj ET Q q 0 0 0 rg BT 65.20 111.70 Td (and ) Tj ET Q q 0 0 0 rg BT 82.19 111.70 Td (the ) Tj ET Q q 0 0 0 rg BT 96.96 111.70 Td (deductibility ) Tj ET Q q 0 0 0 rg BT 150.05 111.70 Td (of ) Tj ET Q q 0 0 0 rg BT 160.93 111.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 190.68 111.70 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 231.83 111.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 255.50 111.70 Td (estimates ) Tj ET Q q 0 0 0 rg BT 295.26 111.70 Td (that ) Tj ET Q q 0 0 0 rg BT 312.81 111.70 Td (it ) Tj ET Q q 0 0 0 rg BT 320.91 111.70 Td (is ) Tj ET Q q 0 0 0 rg BT 330.13 111.70 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 376.00 111.70 Td (possible ) Tj ET Q q 0 0 0 rg BT 411.32 111.70 Td (that ) Tj ET Q q 0 0 0 rg BT 428.87 111.70 Td (the ) Tj ET Q q 0 0 0 rg BT 443.63 111.70 Td (total ) Tj ET Q q 0 0 0 rg BT 463.95 111.70 Td (amount ) Tj ET Q q 0 0 0 rg BT 496.50 111.70 Td (of ) Tj ET Q q 0 0 0 rg BT 507.38 111.70 Td (unrecognized ) Tj ET Q q 0 0 0 rg BT 563.79 111.70 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 99.70 Td (benefits ) Tj ET Q q 0 0 0 rg BT 70.16 99.70 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.88 99.70 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 138.48 99.70 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 158.48 99.70 Td ( ) Tj ET Q q 0 0 0 rg BT 160.98 99.70 Td (will ) Tj ET Q q 0 0 0 rg BT 179.04 99.70 Td (decrease ) Tj ET Q q 0 0 0 rg BT 215.96 99.70 Td (in ) Tj ET Q q 0 0 0 rg BT 226.25 99.70 Td (the ) Tj ET Q q 0 0 0 rg BT 240.97 99.70 Td (range ) Tj ET Q q 0 0 0 rg BT 265.69 99.70 Td (of ) Tj ET Q q 0 0 0 rg BT 276.52 99.70 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 336.79 99.70 Td ($255 ) Tj ET Q q 0 0 0 rg BT 359.29 99.70 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.19 99.70 Td ( ) Tj ET Q q 0 0 0 rg BT 390.69 99.70 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.98 99.70 Td ($315 ) Tj ET Q q 0 0 0 rg BT 423.48 99.70 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.37 99.70 Td ( ) Tj ET Q q 0 0 0 rg BT 454.88 99.70 Td (in ) Tj ET Q q 0 0 0 rg BT 465.17 99.70 Td (the ) Tj ET Q q 0 0 0 rg BT 479.89 99.70 Td (next ) Tj ET Q q 0 0 0 rg BT 499.61 99.70 Td (twelve ) Tj ET Q q 0 0 0 rg BT 528.77 99.70 Td (months ) Tj ET Q q 0 0 0 rg BT 560.73 99.70 Td (as ) Tj ET Q q 0 0 0 rg BT 571.56 99.70 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 87.70 Td (result ) Tj ET Q q 0 0 0 rg BT 61.16 87.70 Td (of ) Tj ET Q q 0 0 0 rg BT 72.44 87.70 Td (the ) Tj ET Q q 0 0 0 rg BT 87.60 87.70 Td (settlement ) Tj ET Q q 0 0 0 rg BT 131.65 87.70 Td (of ) Tj ET Q q 0 0 0 rg BT 142.92 87.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 173.07 87.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 188.23 87.70 Td (audits ) Tj ET Q q 0 0 0 rg BT 215.06 87.70 Td (and ) Tj ET Q q 0 0 0 rg BT 232.45 87.70 Td (other ) Tj ET Q q 0 0 0 rg BT 255.94 87.70 Td (events. ) Tj ET Q q 0 0 0 rg BT 286.72 87.70 Td (The ) Tj ET Q q 0 0 0 rg BT 305.21 87.70 Td (expected ) Tj ET Q q 0 0 0 rg BT 343.69 87.70 Td (change ) Tj ET Q q 0 0 0 rg BT 374.95 87.70 Td (in ) Tj ET Q q 0 0 0 rg BT 385.68 87.70 Td (unrecognized ) Tj ET Q q 0 0 0 rg BT 442.49 87.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 457.65 87.70 Td (benefits, ) Tj ET Q q 0 0 0 rg BT 494.75 87.70 Td (primarily ) Tj ET Q q 0 0 0 rg BT 534.91 87.70 Td (settlement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 75.70 Td (related, ) Tj ET Q q 0 0 0 rg BT 68.11 75.70 Td (will ) Tj ET Q q 0 0 0 rg BT 86.07 75.70 Td (involve ) Tj ET Q q 0 0 0 rg BT 118.47 75.70 Td (the ) Tj ET Q q 0 0 0 rg BT 133.09 75.70 Td (payment ) Tj ET Q q 0 0 0 rg BT 169.92 75.70 Td (of ) Tj ET Q q 0 0 0 rg BT 180.66 75.70 Td (additional ) Tj ET Q q 0 0 0 rg BT 223.05 75.70 Td (taxes, ) Tj ET Q q 0 0 0 rg BT 248.50 75.70 Td (the ) Tj ET Q q 0 0 0 rg BT 263.12 75.70 Td (adjustment ) Tj ET Q q 0 0 0 rg BT 309.41 75.70 Td (of ) Tj ET Q q 0 0 0 rg BT 320.14 75.70 Td (certain ) Tj ET Q q 0 0 0 rg BT 349.75 75.70 Td (deferred ) Tj ET Q q 0 0 0 rg BT 385.46 75.70 Td (taxes ) Tj ET Q q 0 0 0 rg BT 408.41 75.70 Td (and/or ) Tj ET Q q 0 0 0 rg BT 436.36 75.70 Td (the ) Tj ET Q q 0 0 0 rg BT 450.98 75.70 Td (recognition ) Tj ET Q q 0 0 0 rg BT 498.93 75.70 Td (of ) Tj ET Q q 0 0 0 rg BT 509.66 75.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 524.28 75.70 Td (benefits. ) Tj ET Q q 0 0 0 rg BT 560.84 75.70 Td (It ) Tj ET Q q 0 0 0 rg BT 569.35 75.70 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 63.70 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 81.96 63.70 Td (possible ) Tj ET Q q 0 0 0 rg BT 117.39 63.70 Td (that ) Tj ET Q q 0 0 0 rg BT 135.03 63.70 Td (new ) Tj ET Q q 0 0 0 rg BT 154.34 63.70 Td (issues ) Tj ET Q q 0 0 0 rg BT 180.88 63.70 Td (will ) Tj ET Q q 0 0 0 rg BT 199.08 63.70 Td (be ) Tj ET Q q 0 0 0 rg BT 211.17 63.70 Td (raised ) Tj ET Q q 0 0 0 rg BT 237.70 63.70 Td (by ) Tj ET Q q 0 0 0 rg BT 250.34 63.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 265.21 63.70 Td (authorities ) Tj ET Q q 0 0 0 rg BT 310.07 63.70 Td (that ) Tj ET Q q 0 0 0 rg BT 327.71 63.70 Td (may ) Tj ET Q q 0 0 0 rg BT 347.58 63.70 Td (increase ) Tj ET Q q 0 0 0 rg BT 382.98 63.70 Td (unrecognized ) Tj ET Q q 0 0 0 rg BT 439.49 63.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 454.35 63.70 Td (benefits; ) Tj ET Q q 0 0 0 rg BT 491.44 63.70 Td (however) Tj ET Q q 0 0 0 rg BT 525.46 63.70 Td (, ) Tj ET Q q 0 0 0 rg BT 530.61 63.70 Td (an ) Tj ET Q q 0 0 0 rg BT 542.70 63.70 Td (estimate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 51.70 Td (of ) Tj ET Q q 0 0 0 rg BT 47.39 51.70 Td (such ) Tj ET Q q 0 0 0 rg BT 68.79 51.70 Td (increases ) Tj ET Q q 0 0 0 rg BT 108.49 51.70 Td (cannot ) Tj ET Q q 0 0 0 rg BT 138.21 51.70 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 184.59 51.70 Td (be ) Tj ET Q q 0 0 0 rg BT 197.09 51.70 Td (made ) Tj ET Q q 0 0 0 rg BT 221.81 51.70 Td (at ) Tj ET Q q 0 0 0 rg BT 232.09 51.70 Td (this ) Tj ET Q q 0 0 0 rg BT 249.60 51.70 Td (time. ) Tj ET Q q 0 0 0 rg BT 272.94 51.70 Td (BMS ) Tj ET Q q 0 0 0 rg BT 297.12 51.70 Td (believes ) Tj ET Q q 0 0 0 rg BT 332.95 51.70 Td (that ) Tj ET Q q 0 0 0 rg BT 351.01 51.70 Td (it ) Tj ET Q q 0 0 0 rg BT 359.63 51.70 Td (has ) Tj ET Q q 0 0 0 rg BT 376.02 51.70 Td (adequately ) Tj ET Q q 0 0 0 rg BT 422.40 51.70 Td (provided ) Tj ET Q q 0 0 0 rg BT 461.01 51.70 Td (for ) Tj ET Q q 0 0 0 rg BT 475.73 51.70 Td (all ) Tj ET Q q 0 0 0 rg BT 488.79 51.70 Td (open ) Tj ET Q q 0 0 0 rg BT 511.29 51.70 Td (tax ) Tj ET Q q 0 0 0 rg BT 526.57 51.70 Td (years ) Tj ET Q q 0 0 0 rg BT 550.73 51.70 Td (by ) Tj ET Q q 0 0 0 rg BT 563.79 51.70 Td (tax ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 39.70 Td (jurisdiction.) Tj ET Q endstream endobj 163 0 obj <> endobj 164 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.49 749.10 Td (following ) Tj ET Q q 0 0 0 rg BT 94.31 749.10 Td (is ) Tj ET Q q 0 0 0 rg BT 102.92 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 109.30 749.10 Td (summary ) Tj ET Q q 0 0 0 rg BT 148.45 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 158.72 749.10 Td (major ) Tj ET Q q 0 0 0 rg BT 183.98 749.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 198.14 749.10 Td (jurisdictions ) Tj ET Q q 0 0 0 rg BT 249.52 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 263.12 749.10 Td (which ) Tj ET Q q 0 0 0 rg BT 289.50 749.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 303.65 749.10 Td (authorities ) Tj ET Q q 0 0 0 rg BT 347.80 749.10 Td (may ) Tj ET Q q 0 0 0 rg BT 366.96 749.10 Td (assert ) Tj ET Q q 0 0 0 rg BT 391.66 749.10 Td (additional ) Tj ET Q q 0 0 0 rg BT 433.59 749.10 Td (taxes ) Tj ET Q q 0 0 0 rg BT 456.08 749.10 Td (based ) Tj ET Q q 0 0 0 rg BT 480.79 749.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 502.72 749.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 516.88 749.10 Td (years ) Tj ET Q q 0 0 0 rg BT 539.92 749.10 Td (currently ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (under ) Tj ET Q q 0 0 0 rg BT 61.27 737.10 Td (audit ) Tj ET Q q 0 0 0 rg BT 83.76 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 100.70 737.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 147.64 737.10 Td (years ) Tj ET Q q 0 0 0 rg BT 171.24 737.10 Td (that ) Tj ET Q q 0 0 0 rg BT 188.73 737.10 Td (will ) Tj ET Q q 0 0 0 rg BT 206.79 737.10 Td (likely ) Tj ET Q q 0 0 0 rg BT 232.06 737.10 Td (be ) Tj ET Q q 0 0 0 rg BT 244.00 737.10 Td (audited:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 726.60 470.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 726.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 726.60 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 700.60 470.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 700.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 700.60 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 674.60 470.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 674.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 510.50 674.60 66.00 -13.00 re f /GS0 gs BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 717.17 Td (U.S.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 717.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.20 717.17 Td (2008 to 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 704.17 Td (Canada) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 704.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.20 704.17 Td (2006 to 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 691.17 Td (France) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 691.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.20 691.17 Td (2013 to 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 678.17 Td (Germany) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 678.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.20 678.17 Td (2007 to 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 665.17 Td (Italy) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 665.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.55 665.17 Td (2011 to 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 652.17 Td (Mexico) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 509.00 652.85 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.55 652.17 Td (2011 to 2016) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 623.10 Td (8) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 623.10 Td (. EARNINGS PER SHARE) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 586.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 586.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 586.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 586.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 586.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 586.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 586.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 560.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 560.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 560.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 560.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 560.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 560.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 560.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 534.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 534.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 534.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 534.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 534.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 534.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 534.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 508.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 508.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 508.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 508.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 508.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 508.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 508.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 482.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 482.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 482.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 482.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 482.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 482.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 482.60 69.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 599.6 m 430.5 599.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 599.6 m 434.5 599.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 599.6 m 503.5 599.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 503.5 599.6 m 507.5 599.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 599.6 m 576.5 599.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 586.6 m 430.5 586.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 586.6 m 503.5 586.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 586.6 m 576.5 586.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 573.6 m 430.5 573.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 586.6 m 503.5 586.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 573.6 m 503.5 573.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 573.6 m 576.5 573.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 521.6 m 430.5 521.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 521.6 m 503.5 521.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 521.6 m 576.5 521.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 509.6 m 430.5 509.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 507.6 m 430.5 507.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 509.6 m 503.5 509.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 507.6 m 503.5 507.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 509.6 m 576.5 509.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 507.6 m 576.5 507.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 603.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 424.20 603.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 590.85 Td (Amounts in Millions, Except Per Share Data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.50 590.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.50 590.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.50 590.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 577.17 Td (Net Earnings Attributable to BMS used for Basic and Diluted EPS Calculation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 577.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.15 577.17 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 577.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 577.17 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 577.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 577.17 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 551.17 Td (Weighted-average common shares outstanding - basic) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.15 551.17 Td (1,671) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 551.17 Td (1,667) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 551.17 Td (1,657) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 538.17 Td (Contingently convertible debt common stock equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 538.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 538.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 538.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 525.17 Td (Incremental shares attributable to share-based compensation plans) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 525.17 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 525.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 525.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 512.17 Td (Weighted-average common shares outstanding - diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.15 512.17 Td (1,680) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.15 512.17 Td (1,679) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 512.17 Td (1,670) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 486.17 Td (Earnings per share - basic) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 486.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.15 486.17 Td (2.67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 486.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 486.17 Td (0.94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 486.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 486.17 Td (1.21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 473.17 Td (Earnings per share - diluted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 473.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.15 473.17 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 473.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 473.17 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 473.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 473.17 Td (1.20) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 444.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 444.10 Td (9) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 63.49 444.10 Td (. FINANCIAL) Tj ET Q q 0 0 0 rg BT 124.61 444.10 Td ( INSTRUMENTS ) Tj ET Q q 0 0 0 rg BT 202.41 444.10 Td (AND F) Tj ET Q q 0 0 0 rg BT 231.94 444.10 Td (AIR ) Tj ET Q q 0 0 0 rg BT 252.59 444.10 Td (V) Tj ET Q q 0 0 0 rg BT 258.52 444.10 Td (ALUE MEASUREMENTS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 420.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 75.98 420.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 125.42 420.10 Td (include ) Tj ET Q q 0 0 0 rg BT 157.63 420.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 178.17 420.10 Td (and ) Tj ET Q q 0 0 0 rg BT 195.38 420.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 215.92 420.10 Td (equivalents, ) Tj ET Q q 0 0 0 rg BT 266.74 420.10 Td (marketable ) Tj ET Q q 0 0 0 rg BT 313.93 420.10 Td (securities, ) Tj ET Q q 0 0 0 rg BT 356.96 420.10 Td (accounts ) Tj ET Q q 0 0 0 rg BT 394.72 420.10 Td (receivable ) Tj ET Q q 0 0 0 rg BT 438.57 420.10 Td (and ) Tj ET Q q 0 0 0 rg BT 455.78 420.10 Td (payable, ) Tj ET Q q 0 0 0 rg BT 492.15 420.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 512.14 420.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 561.58 420.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 408.10 Td (derivatives.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 384.10 Td (Changes ) Tj ET Q q 0 0 0 rg BT 73.89 384.10 Td (in ) Tj ET Q q 0 0 0 rg BT 85.12 384.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 126.33 384.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 148.66 384.10 Td (and ) Tj ET Q q 0 0 0 rg BT 166.55 384.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 199.43 384.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 221.76 384.10 Td (create ) Tj ET Q q 0 0 0 rg BT 249.08 384.10 Td (exposure ) Tj ET Q q 0 0 0 rg BT 288.63 384.10 Td (to ) Tj ET Q q 0 0 0 rg BT 299.86 384.10 Td (market ) Tj ET Q q 0 0 0 rg BT 331.07 384.10 Td (risk. ) Tj ET Q q 0 0 0 rg BT 352.03 384.10 Td (Certain ) Tj ET Q q 0 0 0 rg BT 384.91 384.10 Td (derivative ) Tj ET Q q 0 0 0 rg BT 428.34 384.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 466.78 384.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 516.89 384.10 Td (are ) Tj ET Q q 0 0 0 rg BT 532.55 384.10 Td (used ) Tj ET Q q 0 0 0 rg BT 554.33 384.10 Td (when ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 372.10 Td (available ) Tj ET Q q 0 0 0 rg BT 74.84 372.10 Td (on ) Tj ET Q q 0 0 0 rg BT 87.59 372.10 Td (a ) Tj ET Q q 0 0 0 rg BT 94.78 372.10 Td (cost-ef) Tj ET Q q 0 0 0 rg BT 121.81 372.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 151.76 372.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 174.51 372.10 Td (to ) Tj ET Q q 0 0 0 rg BT 185.04 372.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 211.67 372.10 Td (the ) Tj ET Q q 0 0 0 rg BT 226.64 372.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 272.72 372.10 Td (economic ) Tj ET Q q 0 0 0 rg BT 314.34 372.10 Td (exposure. ) Tj ET Q q 0 0 0 rg BT 355.49 372.10 Td (These ) Tj ET Q q 0 0 0 rg BT 382.12 372.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 431.54 372.10 Td (qualify ) Tj ET Q q 0 0 0 rg BT 462.61 372.10 Td (as ) Tj ET Q q 0 0 0 rg BT 473.69 372.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 494.21 372.10 Td (flow) Tj ET Q q 0 0 0 rg BT 511.90 372.10 Td (, ) Tj ET Q q 0 0 0 rg BT 517.15 372.10 Td (net ) Tj ET Q q 0 0 0 rg BT 532.11 372.10 Td (investment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 360.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.68 360.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 70.80 360.10 Td (value ) Tj ET Q q 0 0 0 rg BT 95.69 360.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 126.70 360.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 149.95 360.10 Td (meeting ) Tj ET Q q 0 0 0 rg BT 185.40 360.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 215.84 360.10 Td (criteria, ) Tj ET Q q 0 0 0 rg BT 249.89 360.10 Td (including ) Tj ET Q q 0 0 0 rg BT 290.91 360.10 Td (ef) Tj ET Q q 0 0 0 rg BT 298.50 360.10 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 346.16 360.10 Td (of ) Tj ET Q q 0 0 0 rg BT 357.73 360.10 Td (of) Tj ET Q q 0 0 0 rg BT 365.88 360.10 Td (fsetting ) Tj ET Q q 0 0 0 rg BT 399.12 360.10 Td (hedged ) Tj ET Q q 0 0 0 rg BT 431.24 360.10 Td (exposures. ) Tj ET Q q 0 0 0 rg BT 476.97 360.10 Td (Changes ) Tj ET Q q 0 0 0 rg BT 514.65 360.10 Td (in ) Tj ET Q q 0 0 0 rg BT 525.67 360.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 542.79 360.10 Td (value ) Tj ET Q q 0 0 0 rg BT 567.68 360.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 348.10 Td (derivatives ) Tj ET Q q 0 0 0 rg BT 82.73 348.10 Td (that ) Tj ET Q q 0 0 0 rg BT 100.59 348.10 Td (do ) Tj ET Q q 0 0 0 rg BT 113.45 348.10 Td (not ) Tj ET Q q 0 0 0 rg BT 129.09 348.10 Td (qualify ) Tj ET Q q 0 0 0 rg BT 160.28 348.10 Td (for ) Tj ET Q q 0 0 0 rg BT 174.80 348.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 201.54 348.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 248.27 348.10 Td (are ) Tj ET Q q 0 0 0 rg BT 263.34 348.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 310.06 348.10 Td (in ) Tj ET Q q 0 0 0 rg BT 320.70 348.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 357.44 348.10 Td (as ) Tj ET Q q 0 0 0 rg BT 368.63 348.10 Td (they ) Tj ET Q q 0 0 0 rg BT 388.71 348.10 Td (occur) Tj ET Q q 0 0 0 rg BT 410.37 348.10 Td (. ) Tj ET Q q 0 0 0 rg BT 415.73 348.10 Td (Derivative ) Tj ET Q q 0 0 0 rg BT 460.79 348.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 498.63 348.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 548.16 348.10 Td (are ) Tj ET Q q 0 0 0 rg BT 563.23 348.10 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 336.10 Td (used ) Tj ET Q q 0 0 0 rg BT 56.83 336.10 Td (for ) Tj ET Q q 0 0 0 rg BT 70.99 336.10 Td (trading ) Tj ET Q q 0 0 0 rg BT 101.82 336.10 Td (purposes.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 312.10 Td (Financial ) Tj ET Q q 0 0 0 rg BT 74.73 312.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 122.91 312.10 Td (are ) Tj ET Q q 0 0 0 rg BT 136.63 312.10 Td (subject ) Tj ET Q q 0 0 0 rg BT 166.47 312.10 Td (to ) Tj ET Q q 0 0 0 rg BT 175.77 312.10 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 227.82 312.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 252.10 312.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 268.61 312.10 Td (which ) Tj ET Q q 0 0 0 rg BT 294.57 312.10 Td (is ) Tj ET Q q 0 0 0 rg BT 302.75 312.10 Td (considered ) Tj ET Q q 0 0 0 rg BT 347.58 312.10 Td (as ) Tj ET Q q 0 0 0 rg BT 357.43 312.10 Td (part ) Tj ET Q q 0 0 0 rg BT 374.49 312.10 Td (of ) Tj ET Q q 0 0 0 rg BT 384.34 312.10 Td (the ) Tj ET Q q 0 0 0 rg BT 398.07 312.10 Td (overall ) Tj ET Q q 0 0 0 rg BT 427.35 312.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 442.75 312.10 Td (value ) Tj ET Q q 0 0 0 rg BT 465.92 312.10 Td (measurement. ) Tj ET Q q 0 0 0 rg BT 523.24 312.10 Td (Counterparty ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 300.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 61.51 300.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 79.25 300.10 Td (is ) Tj ET Q q 0 0 0 rg BT 88.66 300.10 Td (monitored ) Tj ET Q q 0 0 0 rg BT 132.50 300.10 Td (on ) Tj ET Q q 0 0 0 rg BT 145.25 300.10 Td (an ) Tj ET Q q 0 0 0 rg BT 157.43 300.10 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 192.95 300.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 215.69 300.10 Td (and ) Tj ET Q q 0 0 0 rg BT 232.87 300.10 Td (mitigated ) Tj ET Q q 0 0 0 rg BT 273.38 300.10 Td (by ) Tj ET Q q 0 0 0 rg BT 286.12 300.10 Td (limiting ) Tj ET Q q 0 0 0 rg BT 320.53 300.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 357.16 300.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 406.57 300.10 Td (with ) Tj ET Q q 0 0 0 rg BT 427.09 300.10 Td (any ) Tj ET Q q 0 0 0 rg BT 444.27 300.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 487.56 300.10 Td (counterparty) Tj ET Q q 0 0 0 rg BT 537.44 300.10 Td (, ) Tj ET Q q 0 0 0 rg BT 542.68 300.10 Td (utilizing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 288.10 Td (conventional ) Tj ET Q q 0 0 0 rg BT 89.10 288.10 Td (derivative ) Tj ET Q q 0 0 0 rg BT 130.53 288.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 166.97 288.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 215.08 288.10 Td (and ) Tj ET Q q 0 0 0 rg BT 230.97 288.10 Td (only ) Tj ET Q q 0 0 0 rg BT 250.20 288.10 Td (entering ) Tj ET Q q 0 0 0 rg BT 284.42 288.10 Td (into ) Tj ET Q q 0 0 0 rg BT 301.43 288.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 348.41 288.10 Td (with ) Tj ET Q q 0 0 0 rg BT 367.64 288.10 Td (counterparties ) Tj ET Q q 0 0 0 rg BT 425.73 288.10 Td (that ) Tj ET Q q 0 0 0 rg BT 442.18 288.10 Td (meet ) Tj ET Q q 0 0 0 rg BT 463.06 288.10 Td (high ) Tj ET Q q 0 0 0 rg BT 482.29 288.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 506.51 288.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 535.74 288.10 Td (standards. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.10 276.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 107.20 276.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 144.73 276.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 189.50 276.10 Td (would ) Tj ET Q q 0 0 0 rg BT 217.05 276.10 Td (not ) Tj ET Q q 0 0 0 rg BT 232.38 276.10 Td (be ) Tj ET Q q 0 0 0 rg BT 244.37 276.10 Td (materially ) Tj ET Q q 0 0 0 rg BT 287.46 276.10 Td (impacted ) Tj ET Q q 0 0 0 rg BT 326.67 276.10 Td (if ) Tj ET Q q 0 0 0 rg BT 335.33 276.10 Td (any ) Tj ET Q q 0 0 0 rg BT 352.32 276.10 Td (counterparty ) Tj ET Q q 0 0 0 rg BT 405.41 276.10 Td (failed ) Tj ET Q q 0 0 0 rg BT 430.73 276.10 Td (to ) Tj ET Q q 0 0 0 rg BT 441.06 276.10 Td (perform ) Tj ET Q q 0 0 0 rg BT 475.82 276.10 Td (according ) Tj ET Q q 0 0 0 rg BT 517.80 276.10 Td (to ) Tj ET Q q 0 0 0 rg BT 528.13 276.10 Td (the ) Tj ET Q q 0 0 0 rg BT 542.90 276.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 567.67 276.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.10 Td (its ) Tj ET Q q 0 0 0 rg BT 48.85 264.10 Td (agreement. ) Tj ET Q q 0 0 0 rg BT 96.40 264.10 Td (Collateral ) Tj ET Q q 0 0 0 rg BT 139.23 264.10 Td (is ) Tj ET Q q 0 0 0 rg BT 149.30 264.10 Td (not ) Tj ET Q q 0 0 0 rg BT 165.48 264.10 Td (required ) Tj ET Q q 0 0 0 rg BT 202.20 264.10 Td (by ) Tj ET Q q 0 0 0 rg BT 215.60 264.10 Td (any ) Tj ET Q q 0 0 0 rg BT 233.45 264.10 Td (party ) Tj ET Q q 0 0 0 rg BT 257.40 264.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 293.01 264.10 Td (derivatives ) Tj ET Q q 0 0 0 rg BT 340.28 264.10 Td (are ) Tj ET Q q 0 0 0 rg BT 355.89 264.10 Td (in ) Tj ET Q q 0 0 0 rg BT 367.07 264.10 Td (an ) Tj ET Q q 0 0 0 rg BT 379.92 264.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 402.76 264.10 Td (or ) Tj ET Q q 0 0 0 rg BT 414.49 264.10 Td (liability ) Tj ET Q q 0 0 0 rg BT 449.00 264.10 Td (position ) Tj ET Q q 0 0 0 rg BT 484.63 264.10 Td (under ) Tj ET Q q 0 0 0 rg BT 510.80 264.10 Td (the ) Tj ET Q q 0 0 0 rg BT 526.42 264.10 Td (terms ) Tj ET Q q 0 0 0 rg BT 552.04 264.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.78 264.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 252.10 Td (agreements.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 228.10 Td (Fair V) Tj ET Q q 0 0 0 rg BT 61.28 228.10 Td (alue Measur) Tj ET Q q 0 0 0 rg BT 111.18 228.10 Td (ements –) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.44 228.10 Td ( ) Tj ET Q q 0 0 0 rg BT 148.76 228.10 Td (The fair value of financial instruments are classified into one of the following categories:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 211.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 87.38 211.10 Td (1 ) Tj ET Q q 0 0 0 rg BT 93.99 211.10 Td (inputs ) Tj ET Q q 0 0 0 rg BT 120.06 211.10 Td (utilize ) Tj ET Q q 0 0 0 rg BT 146.66 211.10 Td (unadjusted ) Tj ET Q q 0 0 0 rg BT 191.60 211.10 Td (quoted ) Tj ET Q q 0 0 0 rg BT 220.44 211.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 245.93 211.10 Td (in ) Tj ET Q q 0 0 0 rg BT 255.32 211.10 Td (active ) Tj ET Q q 0 0 0 rg BT 280.81 211.10 Td (markets ) Tj ET Q q 0 0 0 rg BT 314.08 211.10 Td (accessible ) Tj ET Q q 0 0 0 rg BT 356.23 211.10 Td (at ) Tj ET Q q 0 0 0 rg BT 365.06 211.10 Td (the ) Tj ET Q q 0 0 0 rg BT 378.89 211.10 Td (measurement ) Tj ET Q q 0 0 0 rg BT 433.82 211.10 Td (date ) Tj ET Q q 0 0 0 rg BT 452.09 211.10 Td (for ) Tj ET Q q 0 0 0 rg BT 465.36 211.10 Td (identical ) Tj ET Q q 0 0 0 rg BT 501.41 211.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 526.35 211.10 Td (or ) Tj ET Q q 0 0 0 rg BT 536.30 211.10 Td (liabilities. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 199.10 Td (The ) Tj ET Q q 0 0 0 rg BT 81.05 199.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 97.42 199.10 Td (value ) Tj ET Q q 0 0 0 rg BT 121.58 199.10 Td (hierarchy ) Tj ET Q q 0 0 0 rg BT 161.83 199.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 198.77 199.10 Td (the ) Tj ET Q q 0 0 0 rg BT 213.49 199.10 Td (highest ) Tj ET Q q 0 0 0 rg BT 244.88 199.10 Td (priority ) Tj ET Q q 0 0 0 rg BT 277.37 199.10 Td (to ) Tj ET Q q 0 0 0 rg BT 287.65 199.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 312.91 199.10 Td (1 ) Tj ET Q q 0 0 0 rg BT 320.41 199.10 Td (inputs. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 175.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 87.88 175.10 Td (2 ) Tj ET Q q 0 0 0 rg BT 95.00 175.10 Td (inputs ) Tj ET Q q 0 0 0 rg BT 121.57 175.10 Td (utilize ) Tj ET Q q 0 0 0 rg BT 148.68 175.10 Td (observable ) Tj ET Q q 0 0 0 rg BT 194.11 175.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 220.11 175.10 Td (for ) Tj ET Q q 0 0 0 rg BT 233.89 175.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 263.78 175.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 312.57 175.10 Td (and ) Tj ET Q q 0 0 0 rg BT 329.12 175.10 Td (quoted ) Tj ET Q q 0 0 0 rg BT 358.46 175.10 Td (prices ) Tj ET Q q 0 0 0 rg BT 384.46 175.10 Td (for ) Tj ET Q q 0 0 0 rg BT 398.23 175.10 Td (identical ) Tj ET Q q 0 0 0 rg BT 434.78 175.10 Td (or ) Tj ET Q q 0 0 0 rg BT 445.23 175.10 Td (similar ) Tj ET Q q 0 0 0 rg BT 475.12 175.10 Td (instruments ) Tj ET Q q 0 0 0 rg BT 523.91 175.10 Td (in ) Tj ET Q q 0 0 0 rg BT 533.81 175.10 Td (non-active ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 163.10 Td (markets. ) Tj ET Q q 0 0 0 rg BT 100.92 163.10 Td (Additionally) Tj ET Q q 0 0 0 rg BT 150.82 163.10 Td (, ) Tj ET Q q 0 0 0 rg BT 158.15 163.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 190.19 163.10 Td (corporate ) Tj ET Q q 0 0 0 rg BT 232.77 163.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 254.82 163.10 Td (securities ) Tj ET Q q 0 0 0 rg BT 297.41 163.10 Td (utilize ) Tj ET Q q 0 0 0 rg BT 327.23 163.10 Td (a ) Tj ET Q q 0 0 0 rg BT 336.50 163.10 Td (third-party ) Tj ET Q q 0 0 0 rg BT 384.10 163.10 Td (matrix ) Tj ET Q q 0 0 0 rg BT 415.03 163.10 Td (pricing ) Tj ET Q q 0 0 0 rg BT 448.19 163.10 Td (model ) Tj ET Q q 0 0 0 rg BT 478.01 163.10 Td (using ) Tj ET Q q 0 0 0 rg BT 504.51 163.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 551.55 163.10 Td (inputs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 151.10 Td (corroborated ) Tj ET Q q 0 0 0 rg BT 116.62 151.10 Td (by ) Tj ET Q q 0 0 0 rg BT 129.15 151.10 Td (market ) Tj ET Q q 0 0 0 rg BT 159.45 151.10 Td (data ) Tj ET Q q 0 0 0 rg BT 178.64 151.10 Td (for ) Tj ET Q q 0 0 0 rg BT 192.83 151.10 Td (substantially ) Tj ET Q q 0 0 0 rg BT 245.91 151.10 Td (the ) Tj ET Q q 0 0 0 rg BT 260.66 151.10 Td (full ) Tj ET Q q 0 0 0 rg BT 277.08 151.10 Td (term ) Tj ET Q q 0 0 0 rg BT 297.94 151.10 Td (of ) Tj ET Q q 0 0 0 rg BT 308.81 151.10 Td (the ) Tj ET Q q 0 0 0 rg BT 323.56 151.10 Td (assets. ) Tj ET Q q 0 0 0 rg BT 351.92 151.10 Td (Equity ) Tj ET Q q 0 0 0 rg BT 381.12 151.10 Td (and ) Tj ET Q q 0 0 0 rg BT 398.09 151.10 Td (fixed ) Tj ET Q q 0 0 0 rg BT 421.17 151.10 Td (income ) Tj ET Q q 0 0 0 rg BT 453.14 151.10 Td (funds ) Tj ET Q q 0 0 0 rg BT 477.89 151.10 Td (are ) Tj ET Q q 0 0 0 rg BT 492.63 151.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 532.38 151.10 Td (invested ) Tj ET Q q 0 0 0 rg BT 568.23 151.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 139.10 Td (publicly ) Tj ET Q q 0 0 0 rg BT 98.66 139.10 Td (traded ) Tj ET Q q 0 0 0 rg BT 126.52 139.10 Td (securities ) Tj ET Q q 0 0 0 rg BT 167.17 139.10 Td (valued ) Tj ET Q q 0 0 0 rg BT 196.71 139.10 Td (at ) Tj ET Q q 0 0 0 rg BT 206.81 139.10 Td (the ) Tj ET Q q 0 0 0 rg BT 221.91 139.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 265.32 139.10 Td (net ) Tj ET Q q 0 0 0 rg BT 280.42 139.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 302.74 139.10 Td (value ) Tj ET Q q 0 0 0 rg BT 327.28 139.10 Td (of ) Tj ET Q q 0 0 0 rg BT 338.49 139.10 Td (the ) Tj ET Q q 0 0 0 rg BT 353.59 139.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 399.80 139.10 Td (investments. ) Tj ET Q q 0 0 0 rg BT 452.95 139.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 478.60 139.10 Td (2 ) Tj ET Q q 0 0 0 rg BT 486.48 139.10 Td (derivative ) Tj ET Q q 0 0 0 rg BT 529.34 139.10 Td (instruments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 127.10 Td (are ) Tj ET Q q 0 0 0 rg BT 78.40 127.10 Td (valued ) Tj ET Q q 0 0 0 rg BT 108.25 127.10 Td (using ) Tj ET Q q 0 0 0 rg BT 133.11 127.10 Td (LIBOR ) Tj ET Q q 0 0 0 rg BT 166.31 127.10 Td (yield ) Tj ET Q q 0 0 0 rg BT 189.49 127.10 Td (curves, ) Tj ET Q q 0 0 0 rg BT 221.29 127.10 Td (less ) Tj ET Q q 0 0 0 rg BT 239.48 127.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 265.44 127.10 Td (valuation ) Tj ET Q q 0 0 0 rg BT 305.84 127.10 Td (adjustments, ) Tj ET Q q 0 0 0 rg BT 359.31 127.10 Td (and ) Tj ET Q q 0 0 0 rg BT 376.94 127.10 Td (observable ) Tj ET Q q 0 0 0 rg BT 423.45 127.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 458.29 127.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 490.36 127.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 531.31 127.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 553.38 127.10 Td (at ) Tj ET Q q 0 0 0 rg BT 563.79 127.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 115.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 102.08 115.10 Td (date. ) Tj ET Q q 0 0 0 rg BT 123.49 115.10 Td (V) Tj ET Q q 0 0 0 rg BT 129.60 115.10 Td (aluations ) Tj ET Q q 0 0 0 rg BT 168.13 115.10 Td (of ) Tj ET Q q 0 0 0 rg BT 178.89 115.10 Td (derivative ) Tj ET Q q 0 0 0 rg BT 221.30 115.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 259.82 115.10 Td (may ) Tj ET Q q 0 0 0 rg BT 279.46 115.10 Td (fluctuate ) Tj ET Q q 0 0 0 rg BT 316.87 115.10 Td (considerably ) Tj ET Q q 0 0 0 rg BT 370.39 115.10 Td (from ) Tj ET Q q 0 0 0 rg BT 392.25 115.10 Td (volatility ) Tj ET Q q 0 0 0 rg BT 430.79 115.10 Td (in ) Tj ET Q q 0 0 0 rg BT 440.99 115.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 486.75 115.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 518.05 115.10 Td (currencies ) Tj ET Q q 0 0 0 rg BT 561.56 115.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 103.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 108.83 103.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 140.76 103.10 Td (rates ) Tj ET Q q 0 0 0 rg BT 162.14 103.10 Td (driven ) Tj ET Q q 0 0 0 rg BT 190.18 103.10 Td (by ) Tj ET Q q 0 0 0 rg BT 202.68 103.10 Td (market ) Tj ET Q q 0 0 0 rg BT 232.95 103.10 Td (conditions ) Tj ET Q q 0 0 0 rg BT 277.11 103.10 Td (and ) Tj ET Q q 0 0 0 rg BT 294.05 103.10 Td (the ) Tj ET Q q 0 0 0 rg BT 308.77 103.10 Td (duration ) Tj ET Q q 0 0 0 rg BT 344.59 103.10 Td (of ) Tj ET Q q 0 0 0 rg BT 355.42 103.10 Td (the ) Tj ET Q q 0 0 0 rg BT 370.14 103.10 Td (contract. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 79.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 87.80 79.10 Td (3 ) Tj ET Q q 0 0 0 rg BT 94.83 79.10 Td (unobservable ) Tj ET Q q 0 0 0 rg BT 150.18 79.10 Td (inputs ) Tj ET Q q 0 0 0 rg BT 176.66 79.10 Td (are ) Tj ET Q q 0 0 0 rg BT 190.90 79.10 Td (used ) Tj ET Q q 0 0 0 rg BT 211.26 79.10 Td (when ) Tj ET Q q 0 0 0 rg BT 234.95 79.10 Td (little ) Tj ET Q q 0 0 0 rg BT 255.32 79.10 Td (or ) Tj ET Q q 0 0 0 rg BT 265.68 79.10 Td (no ) Tj ET Q q 0 0 0 rg BT 277.71 79.10 Td (market ) Tj ET Q q 0 0 0 rg BT 307.51 79.10 Td (data ) Tj ET Q q 0 0 0 rg BT 326.20 79.10 Td (is ) Tj ET Q q 0 0 0 rg BT 334.90 79.10 Td (available. ) Tj ET Q q 0 0 0 rg BT 375.37 79.10 Td (There ) Tj ET Q q 0 0 0 rg BT 400.72 79.10 Td (were ) Tj ET Q q 0 0 0 rg BT 422.18 79.10 Td (no ) Tj ET Q q 0 0 0 rg BT 434.22 79.10 Td (Level ) Tj ET Q q 0 0 0 rg BT 459.01 79.10 Td (3 ) Tj ET Q q 0 0 0 rg BT 466.04 79.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 503.06 79.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 528.42 79.10 Td (or ) Tj ET Q q 0 0 0 rg BT 538.78 79.10 Td (liabilities ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 67.10 Td (as ) Tj ET Q q 0 0 0 rg BT 73.83 67.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 84.66 67.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 143.24 67.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 163.24 67.10 Td ( ) Tj ET Q q 0 0 0 rg BT 165.74 67.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 182.68 67.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 202.68 67.10 Td (.) Tj ET Q endstream endobj 165 0 obj <> endobj 166 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (82) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Financial assets and liabilities measured at fair value on a recurring basis are summarized below:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 710.60 384.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 710.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 710.60 35.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 710.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 710.60 35.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 710.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 710.60 35.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 710.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 541.50 710.60 35.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 682.60 384.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 682.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 682.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 682.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 682.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 682.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 682.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 682.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 541.50 682.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 656.60 384.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 656.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 656.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 656.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 656.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 656.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 656.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 656.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 541.50 656.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 630.60 384.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 630.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 630.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 630.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 630.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 630.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 630.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 630.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 541.50 630.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 604.60 384.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 604.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 604.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 459.50 604.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 463.50 604.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 604.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 604.60 35.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 537.50 604.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 541.50 604.60 35.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 424.5 723.6 m 459.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 459.5 723.6 m 463.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 463.5 723.6 m 498.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 723.6 m 537.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 537.5 723.6 m 541.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 541.5 723.6 m 576.5 723.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 424.5 710.6 m 459.5 710.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 463.5 710.6 m 498.5 710.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 710.6 m 537.5 710.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 541.5 710.6 m 576.5 710.6 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 428.75 727.83 Td (December 31, 2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 506.75 727.83 Td (December 31, 2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 714.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 429.15 714.83 Td (Level 1) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 468.15 714.83 Td (Level 2) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 507.15 714.83 Td (Level 1) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 546.15 714.83 Td (Level 2) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 45.00 701.33 Td (Cash and cash equivalents - Money market and other securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.00 700.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 700.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.00 700.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.10 700.27 Td (3,532) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.00 700.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 700.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 544.00 700.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 700.27 Td (1,825) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 45.00 686.33 Td (Marketable securities:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 673.17 Td (Certificates of deposit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 673.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 673.17 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 673.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.60 673.17 Td (804) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 660.17 Td (Commercial paper) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 660.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.60 660.17 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 660.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 660.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 647.17 Td (Corporate debt securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 647.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.10 647.17 Td (3,947) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 647.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 647.17 Td (5,638) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 634.17 Td (Equity funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 634.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.60 634.17 Td (101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 634.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 634.17 Td (92) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 621.17 Td (Fixed income funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 621.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 621.17 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 621.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 621.17 Td (11) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 45.00 608.33 Td (Derivative assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 608.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 608.17 Td (75) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 608.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 608.17 Td (96) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 45.00 595.33 Td (Equity investments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 595.17 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 595.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 595.17 Td (60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 595.17 Td (—) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 45.00 582.33 Td (Derivative liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 445.65 582.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 582.22 Td (\(30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.65 582.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 523.65 582.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 582.17 Td (\(18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 582.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 561.10 Td (A) Tj ET Q q 0 0 0 rg BT 41.56 561.10 Td (vailable-for) Tj ET Q q 0 0 0 rg BT 88.57 561.10 Td (-sale Securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.50 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 539.50 Td (following ) Tj ET Q q 0 0 0 rg BT 95.43 539.50 Td (table ) Tj ET Q q 0 0 0 rg BT 117.37 539.50 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 167.63 539.50 Td (available-for) Tj ET Q q 0 0 0 rg BT 218.51 539.50 Td (-sale ) Tj ET Q q 0 0 0 rg BT 239.89 539.50 Td (securities:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 485.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 485.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 485.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 485.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 485.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 485.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 485.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 485.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 485.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 459.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 459.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 459.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 459.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 459.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 459.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 459.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 459.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 459.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 433.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 433.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 433.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 433.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 433.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 433.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 433.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 433.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 433.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 407.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 407.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 407.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 407.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 407.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 407.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 407.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 407.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 407.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 381.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 381.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 381.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 381.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 381.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 381.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 381.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 381.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 381.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 355.00 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 351.50 355.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 355.50 355.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 407.50 355.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 355.00 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 464.50 355.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 468.50 355.00 52.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 520.50 355.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 355.00 52.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 485 m 407.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 485 m 464.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 485 m 520.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 485 m 576.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 485 m 407.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 485 m 464.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 485 m 520.5 485 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 420 m 407.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 408 m 407.5 408 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 406 m 407.5 406 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 420 m 464.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 408 m 464.5 408 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 406 m 464.5 406 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 420 m 520.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 408 m 520.5 408 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 406 m 520.5 406 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 420 m 576.5 420 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 408 m 576.5 408 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 406 m 576.5 406 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 342 m 407.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 342 m 464.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 342 m 520.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 342 m 576.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 342 m 407.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 330 m 407.5 330 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 355.5 328 m 407.5 328 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 342 m 464.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 330 m 464.5 330 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 328 m 464.5 328 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 342 m 520.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 330 m 520.5 330 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 468.5 328 m 520.5 328 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 342 m 576.5 342 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 330 m 576.5 330 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 328 m 576.5 328 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 489.25 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 362.75 497.23 Td (Amortized) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 373.20 489.23 Td (Cost) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 427.55 521.08 Td (Gross) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 418.90 513.08 Td (Unrealized) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 424.70 505.08 Td (Gain in) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 414.80 497.08 Td (Accumulated) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 429.90 489.08 Td (OCI) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 484.05 521.08 Td (Gross) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 475.40 513.08 Td (Unrealized) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.85 505.08 Td (Loss in) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.30 497.08 Td (Accumulated) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 486.40 489.08 Td (OCI) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.15 489.23 Td (Fair Value) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 475.73 Td (December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 462.57 Td (Certificates of deposit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.00 462.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 393.65 462.57 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 462.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 462.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.00 462.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 462.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.00 462.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 462.57 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 449.57 Td (Commercial paper) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.65 449.57 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 449.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 449.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 449.57 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 436.57 Td (Corporate debt securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.15 436.57 Td (3,945) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 436.57 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.30 436.62 Td (\(8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 436.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 436.57 Td (3,947) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 423.57 Td (Equity investments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 393.65 423.57 Td (31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 423.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.30 423.62 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 423.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 423.57 Td (24) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 60.00 410.73 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.00 410.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.15 410.57 Td (4,753) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 410.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 410.57 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.00 410.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.30 410.62 Td (\(15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 410.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.00 410.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 410.57 Td (4,748) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 384.73 Td (December 31, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 371.57 Td (Certificates of deposit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.00 371.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 388.65 371.57 Td (804) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 371.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 371.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.00 371.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 371.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.00 371.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 371.57 Td (804) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 358.57 Td (Corporate debt securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.15 358.57 Td (5,646) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 358.57 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.30 358.62 Td (\(23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 358.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 358.57 Td (5,638) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 345.57 Td (Equity investments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 393.65 345.57 Td (74) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 345.57 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.30 345.62 Td (\(24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 345.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 345.57 Td (60) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 60.00 332.73 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.00 332.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.15 332.57 Td (6,524) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 332.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.65 332.57 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.00 332.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.30 332.62 Td (\(47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.65 332.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.00 332.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 332.57 Td (6,502) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 298.00 408.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 298.00 64.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 298.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 298.00 64.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 272.00 408.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 443.50 272.00 64.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 272.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 272.00 64.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 298 m 507.5 298 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 298 m 575.5 298 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 298 m 507.5 298 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 298 m 575.5 298 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 259 m 507.5 259 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 247 m 507.5 247 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 443.5 245 m 507.5 245 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 259 m 575.5 259 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 247 m 575.5 247 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 245 m 575.5 245 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 302.25 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 451.75 310.23 Td (December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 467.00 302.23 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 519.75 310.23 Td (December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 535.00 302.23 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 288.57 Td (Current marketable securities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 155.73 293.10 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.00 288.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 288.57 Td (2,113) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 288.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 288.57 Td (1,885) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 275.57 Td (Non-current marketable securities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 174.05 280.10 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 275.57 Td (2,719) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 275.57 Td (4,660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 262.57 Td (Other assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 262.57 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 262.57 Td (60) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 59.00 249.73 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.00 249.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 249.57 Td (4,856) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 249.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 249.57 Td (6,605) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 230.90 Td (\(a\) ) Tj ET Q q 0 0 0 rg BT 49.50 230.90 Td (The ) Tj ET Q q 0 0 0 rg BT 64.50 230.90 Td (fair ) Tj ET Q q 0 0 0 rg BT 78.16 230.90 Td (value ) Tj ET Q q 0 0 0 rg BT 98.05 230.90 Td (option ) Tj ET Q q 0 0 0 rg BT 121.06 230.90 Td (for ) Tj ET Q q 0 0 0 rg BT 132.95 230.90 Td (financial ) Tj ET Q q 0 0 0 rg BT 163.50 230.90 Td (assets ) Tj ET Q q 0 0 0 rg BT 184.72 230.90 Td (was ) Tj ET Q q 0 0 0 rg BT 199.73 230.90 Td (elected ) Tj ET Q q 0 0 0 rg BT 224.94 230.90 Td (for ) Tj ET Q q 0 0 0 rg BT 236.83 230.90 Td (investments ) Tj ET Q q 0 0 0 rg BT 277.61 230.90 Td (in ) Tj ET Q q 0 0 0 rg BT 286.39 230.90 Td (equity ) Tj ET Q q 0 0 0 rg BT 308.95 230.90 Td (and ) Tj ET Q q 0 0 0 rg BT 323.07 230.90 Td (fixed ) Tj ET Q q 0 0 0 rg BT 342.07 230.90 Td (income ) Tj ET Q q 0 0 0 rg BT 368.18 230.90 Td (funds. ) Tj ET Q q 0 0 0 rg BT 390.33 230.90 Td (The ) Tj ET Q q 0 0 0 rg BT 405.33 230.90 Td (fair ) Tj ET Q q 0 0 0 rg BT 418.99 230.90 Td (value ) Tj ET Q q 0 0 0 rg BT 438.88 230.90 Td (of ) Tj ET Q q 0 0 0 rg BT 448.11 230.90 Td (these ) Tj ET Q q 0 0 0 rg BT 467.11 230.90 Td (investments ) Tj ET Q q 0 0 0 rg BT 507.89 230.90 Td (were ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 525.99 230.90 Td ($108 ) Tj ET Q q 0 0 0 rg BT 544.56 230.90 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 567.67 230.90 Td ( ) Tj ET Q q 0 0 0 rg BT 570.23 230.90 Td (at ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 49.50 221.30 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 96.37 221.30 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 112.37 221.30 Td ( ) Tj ET Q q 0 0 0 rg BT 114.37 221.30 Td (and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 127.92 221.30 Td ($103 ) Tj ET Q q 0 0 0 rg BT 145.92 221.30 Td (million) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 169.03 221.30 Td ( ) Tj ET Q q 0 0 0 rg BT 171.03 221.30 Td (at ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 178.80 221.30 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 225.67 221.30 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 241.67 221.30 Td ( ) Tj ET Q q 0 0 0 rg BT 243.67 221.30 Td (and ) Tj ET Q q 0 0 0 rg BT 257.22 221.30 Td (were ) Tj ET Q q 0 0 0 rg BT 274.77 221.30 Td (included ) Tj ET Q q 0 0 0 rg BT 304.31 221.30 Td (in ) Tj ET Q q 0 0 0 rg BT 312.54 221.30 Td (current ) Tj ET Q q 0 0 0 rg BT 337.19 221.30 Td (marketable ) Tj ET Q q 0 0 0 rg BT 374.72 221.30 Td (securities. ) Tj ET Q q 0 0 0 rg BT 408.93 221.30 Td (Changes ) Tj ET Q q 0 0 0 rg BT 438.48 221.30 Td (in ) Tj ET Q q 0 0 0 rg BT 446.71 221.30 Td (fair ) Tj ET Q q 0 0 0 rg BT 459.81 221.30 Td (value ) Tj ET Q q 0 0 0 rg BT 479.13 221.30 Td (were ) Tj ET Q q 0 0 0 rg BT 496.68 221.30 Td (not ) Tj ET Q q 0 0 0 rg BT 508.90 221.30 Td (significant.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 208.70 Td (\(b\) ) Tj ET Q q 0 0 0 rg BT 49.50 208.70 Td (All non-current marketable securities mature within five years as of ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 268.09 208.70 Td (December 31, 2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 330.95 208.70 Td ( and ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 346.50 208.70 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 362.50 208.70 Td (.) Tj ET Q endstream endobj 167 0 obj <> endobj 168 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (83) Tj ET Q BT /F3 10.00 Tf ET 0 0 0 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 36 747.7669921875 m 111.263671875 747.7669921875 l s q 0 0 0 rg BT 36.00 749.10 Td (Qualifying Hedges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 732.10 Td (The following summarizes the fair value of outstanding derivatives:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 695.60 214.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 695.60 118.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 695.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 695.60 48.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 695.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 695.60 48.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 695.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 695.60 48.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 695.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 695.60 48.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 668.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 668.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 668.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 668.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 668.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 668.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 668.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 668.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 668.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 668.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 642.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 642.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 642.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 642.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 642.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 642.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 642.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 642.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 642.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 642.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 616.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 616.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 616.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 616.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 616.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 616.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 616.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 616.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 616.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 616.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 590.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 590.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 590.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 590.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 590.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 590.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 590.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 590.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 590.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 590.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 564.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 564.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 564.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 564.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 564.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 564.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 564.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 564.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 564.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 564.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 538.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 538.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 538.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 538.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 538.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 538.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 538.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 538.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 538.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 538.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 512.60 214.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 250.50 512.60 118.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 368.50 512.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 372.50 512.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 420.50 512.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 512.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 472.50 512.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 512.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 524.50 512.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 528.50 512.60 48.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 372.5 708.6 m 420.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 420.5 708.6 m 424.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 424.5 708.6 m 472.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 476.5 708.6 m 524.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 524.5 708.6 m 528.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 528.5 708.6 m 576.5 708.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 250.5 695.6 m 368.5 695.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 372.5 695.6 m 420.5 695.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 424.5 695.6 m 472.5 695.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 476.5 695.6 m 524.5 695.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 528.5 695.6 m 576.5 695.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 712.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 253.00 712.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 389.75 712.83 Td (December 31, 2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 493.75 712.83 Td (December 31, 2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 699.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 269.00 699.83 Td (Balance Sheet Location) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 381.30 699.83 Td (Notional) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 430.15 699.83 Td (Fair Value) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 485.30 699.83 Td (Notional) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 534.15 699.83 Td (Fair Value) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 686.16 Td (Derivatives designated as hedging instruments:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 672.17 Td (Interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 672.17 Td (Prepaid expenses and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 375.00 672.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 672.17 Td (250) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.00 672.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 672.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.00 672.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 672.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 531.00 672.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 672.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 659.17 Td (Interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 659.17 Td (Other assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 659.17 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 463.65 659.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.15 659.17 Td (1,100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 659.17 Td (31) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 646.17 Td (Interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 646.17 Td (Accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 646.17 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 646.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 646.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 646.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 633.17 Td (Interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 633.17 Td (Pension and other liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 633.17 Td (255) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.30 633.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.65 633.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.65 633.17 Td (650) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 633.17 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 633.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 620.17 Td (Forward starting interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 620.17 Td (Prepaid expenses and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 620.17 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 463.65 620.17 Td (8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 620.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 620.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 607.17 Td (Forward starting interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 607.17 Td (Other assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.65 607.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 607.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.65 607.17 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 607.17 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 594.17 Td (Forward starting interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 594.17 Td (Accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 594.17 Td (250) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 455.30 594.22 Td (\(11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.65 594.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 594.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 594.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 581.17 Td (Forward starting interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 581.17 Td (Pension and other liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.65 581.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 581.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.65 581.17 Td (250) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 581.17 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 581.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 568.17 Td (Foreign currency forward contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 568.17 Td (Prepaid expenses and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 568.17 Td (967) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 568.17 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.15 568.17 Td (1,016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 568.17 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 555.17 Td (Foreign currency forward contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 555.17 Td (Accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 555.17 Td (198) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.30 555.22 Td (\(9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.65 555.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.65 555.17 Td (342) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 555.17 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 555.17 Td (\)) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 39.00 529.16 Td (Derivatives not designated as hedging instruments:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 516.17 Td (Foreign currency forward contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 516.17 Td (Prepaid expenses and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 516.17 Td (106) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 458.65 516.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 516.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 516.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 503.17 Td (Foreign currency forward contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 503.17 Td (Accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.65 503.17 Td (291) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.30 503.22 Td (\(4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.65 503.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 505.65 503.17 Td (445) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 503.17 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 503.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 490.17 Td (Foreign currency forward contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 253.00 490.17 Td (Pension and other liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.65 490.17 Td (69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.30 490.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.65 490.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.65 490.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 490.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 463.10 Td (Cash ) Tj ET Q q 0 0 0 rg BT 60.74 463.10 Td (Flow ) Tj ET Q q 0 0 0 rg BT 85.47 463.10 Td (Hedges ) Tj ET Q q 0 0 0 rg BT 119.64 463.10 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 128.53 463.10 Td ( ) Tj ET Q q 0 0 0 rg BT 132.71 463.10 Td (Foreign ) Tj ET Q q 0 0 0 rg BT 168.00 463.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 207.15 463.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 242.98 463.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 283.25 463.10 Td (are ) Tj ET Q q 0 0 0 rg BT 299.64 463.10 Td (used ) Tj ET Q q 0 0 0 rg BT 322.15 463.10 Td (to ) Tj ET Q q 0 0 0 rg BT 334.10 463.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 362.16 463.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 393.54 463.10 Td (forecasted ) Tj ET Q q 0 0 0 rg BT 438.80 463.10 Td (intercompany ) Tj ET Q q 0 0 0 rg BT 497.96 463.10 Td (inventory ) Tj ET Q q 0 0 0 rg BT 540.46 463.10 Td (purchase ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 451.10 Td (transactions ) Tj ET Q q 0 0 0 rg BT 86.78 451.10 Td (and ) Tj ET Q q 0 0 0 rg BT 104.23 451.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 134.44 451.10 Td (other ) Tj ET Q q 0 0 0 rg BT 158.00 451.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 189.89 451.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 227.88 451.10 Td (transactions. ) Tj ET Q q 0 0 0 rg BT 280.94 451.10 Td (The ) Tj ET Q q 0 0 0 rg BT 299.50 451.10 Td (ef) Tj ET Q q 0 0 0 rg BT 307.09 451.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 337.30 451.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 369.20 451.10 Td (of ) Tj ET Q q 0 0 0 rg BT 380.54 451.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 415.76 451.10 Td (in ) Tj ET Q q 0 0 0 rg BT 426.55 451.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 443.44 451.10 Td (value ) Tj ET Q q 0 0 0 rg BT 468.11 451.10 Td (for ) Tj ET Q q 0 0 0 rg BT 482.78 451.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 521.89 451.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 567.67 451.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 439.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 56.99 439.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 78.54 439.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 109.53 439.10 Td (are ) Tj ET Q q 0 0 0 rg BT 124.96 439.10 Td (temporarily ) Tj ET Q q 0 0 0 rg BT 174.83 439.10 Td (reported ) Tj ET Q q 0 0 0 rg BT 211.36 439.10 Td (in ) Tj ET Q q 0 0 0 rg BT 222.36 439.10 Td (accumulated ) Tj ET Q q 0 0 0 rg BT 276.11 439.10 Td (other ) Tj ET Q q 0 0 0 rg BT 299.87 439.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 363.63 439.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 382.41 439.10 Td (and ) Tj ET Q q 0 0 0 rg BT 400.07 439.10 Td (included ) Tj ET Q q 0 0 0 rg BT 437.72 439.10 Td (in ) Tj ET Q q 0 0 0 rg BT 448.72 439.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 485.82 439.10 Td (when ) Tj ET Q q 0 0 0 rg BT 510.70 439.10 Td (the ) Tj ET Q q 0 0 0 rg BT 526.13 439.10 Td (hedged ) Tj ET Q q 0 0 0 rg BT 558.23 439.10 Td (item ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 427.10 Td (af) Tj ET Q q 0 0 0 rg BT 43.59 427.10 Td (fects ) Tj ET Q q 0 0 0 rg BT 64.97 427.10 Td (earnings. ) Tj ET Q q 0 0 0 rg BT 103.67 427.10 Td (The ) Tj ET Q q 0 0 0 rg BT 121.72 427.10 Td (net ) Tj ET Q q 0 0 0 rg BT 136.43 427.10 Td (gains ) Tj ET Q q 0 0 0 rg BT 160.05 427.10 Td (on ) Tj ET Q q 0 0 0 rg BT 172.55 427.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 203.93 427.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 241.41 427.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 275.56 427.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 314.15 427.10 Td (are ) Tj ET Q q 0 0 0 rg BT 328.86 427.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 366.90 427.10 Td (to ) Tj ET Q q 0 0 0 rg BT 377.18 427.10 Td (be ) Tj ET Q q 0 0 0 rg BT 389.12 427.10 Td (reclassified ) Tj ET Q q 0 0 0 rg BT 437.15 427.10 Td (to ) Tj ET Q q 0 0 0 rg BT 447.44 427.10 Td (net ) Tj ET Q q 0 0 0 rg BT 462.15 427.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 498.53 427.10 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 541.58 427.10 Td (included ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.10 Td (in ) Tj ET Q q 0 0 0 rg BT 45.89 415.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 64.11 415.10 Td (of ) Tj ET Q q 0 0 0 rg BT 74.55 415.10 Td (products ) Tj ET Q q 0 0 0 rg BT 111.10 415.10 Td (sold\) ) Tj ET Q q 0 0 0 rg BT 133.21 415.10 Td (within ) Tj ET Q q 0 0 0 rg BT 160.88 415.10 Td (the ) Tj ET Q q 0 0 0 rg BT 175.21 415.10 Td (next ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.54 415.10 Td (two) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 209.54 415.10 Td ( ) Tj ET Q q 0 0 0 rg BT 211.65 415.10 Td (years. ) Tj ET Q q 0 0 0 rg BT 237.21 415.10 Td (The ) Tj ET Q q 0 0 0 rg BT 254.87 415.10 Td (notional ) Tj ET Q q 0 0 0 rg BT 289.75 415.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 321.86 415.10 Td (of ) Tj ET Q q 0 0 0 rg BT 332.30 415.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 381.08 415.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 412.07 415.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 449.16 415.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 482.92 415.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 521.12 415.10 Td (was ) Tj ET Q q 0 0 0 rg BT 538.79 415.10 Td (primarily ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 403.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 76.82 403.10 Td (to ) Tj ET Q q 0 0 0 rg BT 87.10 403.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.82 403.10 Td (euro ) Tj ET Q q 0 0 0 rg BT 122.08 403.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 125.41 403.10 Td ($617 ) Tj ET Q q 0 0 0 rg BT 147.91 403.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 176.81 403.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 182.64 403.10 Td (and ) Tj ET Q q 0 0 0 rg BT 199.57 403.10 Td (Japanese ) Tj ET Q q 0 0 0 rg BT 237.61 403.10 Td (yen ) Tj ET Q q 0 0 0 rg BT 254.55 403.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 257.88 403.10 Td ($321 ) Tj ET Q q 0 0 0 rg BT 280.38 403.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 309.27 403.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 315.10 403.10 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 324.82 403.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 383.40 403.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.40 403.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 379.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.63 379.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 71.42 379.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 94.84 379.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 126.56 379.10 Td (into ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 144.41 379.10 Td ($750 ) Tj ET Q q 0 0 0 rg BT 166.70 379.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 195.59 379.10 Td ( ) Tj ET Q q 0 0 0 rg BT 197.89 379.10 Td (of ) Tj ET Q q 0 0 0 rg BT 208.51 379.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 242.46 379.10 Td (starting ) Tj ET Q q 0 0 0 rg BT 274.75 379.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 306.48 379.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 323.76 379.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 346.61 379.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 384.99 379.10 Td (maturing ) Tj ET Q q 0 0 0 rg BT 423.39 379.10 Td (in ) Tj ET Q q 0 0 0 rg BT 433.47 379.10 Td (March ) Tj ET Q q 0 0 0 rg BT 461.86 379.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 484.15 379.10 Td (to ) Tj ET Q q 0 0 0 rg BT 494.23 379.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 520.40 379.10 Td (the ) Tj ET Q q 0 0 0 rg BT 534.91 379.10 Td (variability ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 367.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.64 367.10 Td (probable ) Tj ET Q q 0 0 0 rg BT 85.94 367.10 Td (forecasted ) Tj ET Q q 0 0 0 rg BT 130.34 367.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 163.08 367.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 198.60 367.10 Td (associated ) Tj ET Q q 0 0 0 rg BT 243.01 367.10 Td (with ) Tj ET Q q 0 0 0 rg BT 264.10 367.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 302.40 367.10 Td (future ) Tj ET Q q 0 0 0 rg BT 329.59 367.10 Td (issuances ) Tj ET Q q 0 0 0 rg BT 370.67 367.10 Td (of ) Tj ET Q q 0 0 0 rg BT 382.31 367.10 Td (debt. ) Tj ET Q q 0 0 0 rg BT 405.10 367.10 Td (The ) Tj ET Q q 0 0 0 rg BT 423.96 367.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 463.36 367.10 Td (are ) Tj ET Q q 0 0 0 rg BT 478.88 367.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 524.96 367.10 Td (as ) Tj ET Q q 0 0 0 rg BT 536.60 367.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 557.68 367.10 Td (flow ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 355.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 66.27 355.10 Td (with ) Tj ET Q q 0 0 0 rg BT 86.55 355.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.26 355.10 Td (ef) Tj ET Q q 0 0 0 rg BT 108.85 355.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 138.55 355.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 169.94 355.10 Td (of ) Tj ET Q q 0 0 0 rg BT 180.77 355.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 197.15 355.10 Td (value ) Tj ET Q q 0 0 0 rg BT 221.30 355.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 256.01 355.10 Td (included ) Tj ET Q q 0 0 0 rg BT 292.94 355.10 Td (in ) Tj ET Q q 0 0 0 rg BT 303.22 355.10 Td (other ) Tj ET Q q 0 0 0 rg BT 326.27 355.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 389.30 355.10 Td (income.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 331.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.68 331.10 Td (earnings ) Tj ET Q q 0 0 0 rg BT 89.69 331.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 119.04 331.10 Td (related ) Tj ET Q q 0 0 0 rg BT 148.37 331.10 Td (to ) Tj ET Q q 0 0 0 rg BT 158.29 331.10 Td (discontinued ) Tj ET Q q 0 0 0 rg BT 211.52 331.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 231.42 331.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 251.89 331.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 281.79 331.10 Td (and ) Tj ET Q q 0 0 0 rg BT 298.36 331.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 324.37 331.10 Td (inef) Tj ET Q q 0 0 0 rg BT 339.74 331.10 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 386.30 331.10 Td (was ) Tj ET Q q 0 0 0 rg BT 403.98 331.10 Td (not ) Tj ET Q q 0 0 0 rg BT 418.90 331.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 463.24 331.10 Td (during ) Tj ET Q q 0 0 0 rg BT 491.48 331.10 Td (all ) Tj ET Q q 0 0 0 rg BT 503.61 331.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 535.18 331.10 Td (presented. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 319.10 Td (Cash ) Tj ET Q q 0 0 0 rg BT 58.45 319.10 Td (flow ) Tj ET Q q 0 0 0 rg BT 79.24 319.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 105.56 319.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 151.89 319.10 Td (is ) Tj ET Q q 0 0 0 rg BT 161.01 319.10 Td (discontinued ) Tj ET Q q 0 0 0 rg BT 214.57 319.10 Td (when ) Tj ET Q q 0 0 0 rg BT 238.68 319.10 Td (the ) Tj ET Q q 0 0 0 rg BT 253.35 319.10 Td (forecasted ) Tj ET Q q 0 0 0 rg BT 296.89 319.10 Td (transaction ) Tj ET Q q 0 0 0 rg BT 343.21 319.10 Td (is ) Tj ET Q q 0 0 0 rg BT 352.33 319.10 Td (no ) Tj ET Q q 0 0 0 rg BT 364.79 319.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 392.79 319.10 Td (probable ) Tj ET Q q 0 0 0 rg BT 430.22 319.10 Td (of ) Tj ET Q q 0 0 0 rg BT 441.01 319.10 Td (occurring ) Tj ET Q q 0 0 0 rg BT 481.78 319.10 Td (within ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.78 319.10 Td (60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.78 319.10 Td ( ) Tj ET Q q 0 0 0 rg BT 522.24 319.10 Td (days ) Tj ET Q q 0 0 0 rg BT 543.02 319.10 Td (after ) Tj ET Q q 0 0 0 rg BT 563.79 319.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 307.10 Td (originally ) Tj ET Q q 0 0 0 rg BT 76.61 307.10 Td (forecasted ) Tj ET Q q 0 0 0 rg BT 119.41 307.10 Td (date ) Tj ET Q q 0 0 0 rg BT 137.79 307.10 Td (or ) Tj ET Q q 0 0 0 rg BT 147.85 307.10 Td (when ) Tj ET Q q 0 0 0 rg BT 171.23 307.10 Td (the ) Tj ET Q q 0 0 0 rg BT 185.17 307.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 210.77 307.10 Td (is ) Tj ET Q q 0 0 0 rg BT 219.16 307.10 Td (no ) Tj ET Q q 0 0 0 rg BT 230.89 307.10 Td (longer ) Tj ET Q q 0 0 0 rg BT 258.16 307.10 Td (ef) Tj ET Q q 0 0 0 rg BT 265.75 307.10 Td (fective. ) Tj ET Q q 0 0 0 rg BT 296.79 307.10 Td (Assessments ) Tj ET Q q 0 0 0 rg BT 349.63 307.10 Td (to ) Tj ET Q q 0 0 0 rg BT 359.13 307.10 Td (determine ) Tj ET Q q 0 0 0 rg BT 400.83 307.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 434.77 307.10 Td (derivatives ) Tj ET Q q 0 0 0 rg BT 480.36 307.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 524.85 307.10 Td (as ) Tj ET Q q 0 0 0 rg BT 534.90 307.10 Td (qualifying ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 295.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 66.27 295.10 Td (are ) Tj ET Q q 0 0 0 rg BT 80.98 295.10 Td (highly ) Tj ET Q q 0 0 0 rg BT 109.03 295.10 Td (ef) Tj ET Q q 0 0 0 rg BT 116.62 295.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 146.32 295.10 Td (in ) Tj ET Q q 0 0 0 rg BT 156.60 295.10 Td (of) Tj ET Q q 0 0 0 rg BT 164.75 295.10 Td (fsetting ) Tj ET Q q 0 0 0 rg BT 197.25 295.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 231.95 295.10 Td (in ) Tj ET Q q 0 0 0 rg BT 242.23 295.10 Td (the ) Tj ET Q q 0 0 0 rg BT 256.95 295.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 277.22 295.10 Td (flows ) Tj ET Q q 0 0 0 rg BT 301.94 295.10 Td (of ) Tj ET Q q 0 0 0 rg BT 312.77 295.10 Td (hedged ) Tj ET Q q 0 0 0 rg BT 344.14 295.10 Td (items ) Tj ET Q q 0 0 0 rg BT 368.31 295.10 Td (are ) Tj ET Q q 0 0 0 rg BT 383.02 295.10 Td (performed ) Tj ET Q q 0 0 0 rg BT 427.16 295.10 Td (at ) Tj ET Q q 0 0 0 rg BT 436.88 295.10 Td (inception ) Tj ET Q q 0 0 0 rg BT 476.59 295.10 Td (and ) Tj ET Q q 0 0 0 rg BT 493.53 295.10 Td (on ) Tj ET Q q 0 0 0 rg BT 506.03 295.10 Td (a ) Tj ET Q q 0 0 0 rg BT 512.97 295.10 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 551.56 295.10 Td (basis.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 271.10 Td (Net ) Tj ET Q q 0 0 0 rg BT 52.10 271.10 Td (Investment ) Tj ET Q q 0 0 0 rg BT 97.63 271.10 Td (Hedges ) Tj ET Q q 0 0 0 rg BT 129.84 271.10 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 138.73 271.10 Td ( ) Tj ET Q q 0 0 0 rg BT 140.94 271.10 Td (Non-U.S. ) Tj ET Q q 0 0 0 rg BT 181.49 271.10 Td (dollar ) Tj ET Q q 0 0 0 rg BT 207.03 271.10 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 254.80 271.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 265.34 271.10 Td (€950 ) Tj ET Q q 0 0 0 rg BT 287.56 271.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 316.45 271.10 Td ( ) Tj ET Q q 0 0 0 rg BT 318.66 271.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 321.99 271.10 Td ($993 ) Tj ET Q q 0 0 0 rg BT 344.21 271.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.10 271.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 378.64 271.10 Td (at ) Tj ET Q q 0 0 0 rg BT 388.07 271.10 Td (December ) Tj ET Q q 0 0 0 rg BT 431.37 271.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 446.09 271.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 468.30 271.10 Td (are ) Tj ET Q q 0 0 0 rg BT 482.72 271.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 527.70 271.10 Td (to ) Tj ET Q q 0 0 0 rg BT 537.69 271.10 Td (hedge ) Tj ET Q q 0 0 0 rg BT 563.78 271.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 259.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 67.21 259.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 104.51 259.10 Td (exposures ) Tj ET Q q 0 0 0 rg BT 146.83 259.10 Td (of ) Tj ET Q q 0 0 0 rg BT 157.49 259.10 Td (the ) Tj ET Q q 0 0 0 rg BT 172.04 259.10 Td (net ) Tj ET Q q 0 0 0 rg BT 186.58 259.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 232.79 259.10 Td (in ) Tj ET Q q 0 0 0 rg BT 242.90 259.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 272.43 259.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 303.64 259.10 Td (af) Tj ET Q q 0 0 0 rg BT 311.22 259.10 Td (filiates. ) Tj ET Q q 0 0 0 rg BT 343.10 259.10 Td (These ) Tj ET Q q 0 0 0 rg BT 369.30 259.10 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 417.18 259.10 Td (are ) Tj ET Q q 0 0 0 rg BT 431.72 259.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 476.81 259.10 Td (as ) Tj ET Q q 0 0 0 rg BT 487.47 259.10 Td (net ) Tj ET Q q 0 0 0 rg BT 502.02 259.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 548.23 259.10 Td (hedges ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 247.10 Td (and ) Tj ET Q q 0 0 0 rg BT 53.03 247.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 99.49 247.10 Td (in ) Tj ET Q q 0 0 0 rg BT 109.86 247.10 Td (long ) Tj ET Q q 0 0 0 rg BT 130.23 247.10 Td (term ) Tj ET Q q 0 0 0 rg BT 151.15 247.10 Td (debt. ) Tj ET Q q 0 0 0 rg BT 173.27 247.10 Td (The ) Tj ET Q q 0 0 0 rg BT 191.41 247.10 Td (ef) Tj ET Q q 0 0 0 rg BT 199.00 247.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 228.79 247.10 Td (portion ) Tj ET Q q 0 0 0 rg BT 260.27 247.10 Td (of ) Tj ET Q q 0 0 0 rg BT 271.19 247.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 302.66 247.10 Td (exchange ) Tj ET Q q 0 0 0 rg BT 343.01 247.10 Td (gains ) Tj ET Q q 0 0 0 rg BT 366.71 247.10 Td (on ) Tj ET Q q 0 0 0 rg BT 379.30 247.10 Td (the ) Tj ET Q q 0 0 0 rg BT 394.11 247.10 Td (remeasurement ) Tj ET Q q 0 0 0 rg BT 457.79 247.10 Td (of ) Tj ET Q q 0 0 0 rg BT 468.71 247.10 Td (euro ) Tj ET Q q 0 0 0 rg BT 489.07 247.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 508.88 247.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.02 247.10 Td ($48 ) Tj ET Q q 0 0 0 rg BT 544.62 247.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.51 247.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 235.10 Td ($80 ) Tj ET Q q 0 0 0 rg BT 53.32 235.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 82.21 235.10 Td (, ) Tj ET Q q 0 0 0 rg BT 87.03 235.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 103.79 235.10 Td ($79 ) Tj ET Q q 0 0 0 rg BT 121.10 235.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 150.00 235.10 Td ( ) Tj ET Q q 0 0 0 rg BT 152.31 235.10 Td (for ) Tj ET Q q 0 0 0 rg BT 166.29 235.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 191.11 235.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 213.43 235.10 Td (and ) Tj ET Q q 0 0 0 rg BT 230.19 235.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 255.00 235.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 302.67 235.10 Td (, ) Tj ET Q q 0 0 0 rg BT 307.48 235.10 Td (and ) Tj ET Q q 0 0 0 rg BT 324.24 235.10 Td (were ) Tj ET Q q 0 0 0 rg BT 345.99 235.10 Td (recorded ) Tj ET Q q 0 0 0 rg BT 383.28 235.10 Td (in ) Tj ET Q q 0 0 0 rg BT 393.38 235.10 Td (the ) Tj ET Q q 0 0 0 rg BT 407.91 235.10 Td (foreign ) Tj ET Q q 0 0 0 rg BT 439.11 235.10 Td (currency ) Tj ET Q q 0 0 0 rg BT 476.40 235.10 Td (translation ) Tj ET Q q 0 0 0 rg BT 520.93 235.10 Td (component ) Tj ET Q q 0 0 0 rg BT 567.68 235.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 223.10 Td (accumulated ) Tj ET Q q 0 0 0 rg BT 89.03 223.10 Td (other ) Tj ET Q q 0 0 0 rg BT 112.07 223.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 175.11 223.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 193.17 223.10 Td (with ) Tj ET Q q 0 0 0 rg BT 213.45 223.10 Td (the ) Tj ET Q q 0 0 0 rg BT 228.16 223.10 Td (related ) Tj ET Q q 0 0 0 rg BT 257.87 223.10 Td (of) Tj ET Q q 0 0 0 rg BT 266.01 223.10 Td (fset ) Tj ET Q q 0 0 0 rg BT 282.95 223.10 Td (in ) Tj ET Q q 0 0 0 rg BT 293.23 223.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 335.17 223.10 Td (debt.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 199.10 Td (Fair ) Tj ET Q q 0 0 0 rg BT 57.26 199.10 Td (V) Tj ET Q q 0 0 0 rg BT 62.26 199.10 Td (alue ) Tj ET Q q 0 0 0 rg BT 82.96 199.10 Td (Hedges ) Tj ET Q q 0 0 0 rg BT 116.43 199.10 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 125.32 199.10 Td ( ) Tj ET Q q 0 0 0 rg BT 128.80 199.10 Td (Fixed-to-floating ) Tj ET Q q 0 0 0 rg BT 200.60 199.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 233.52 199.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 251.99 199.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 276.02 199.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 315.59 199.10 Td (are ) Tj ET Q q 0 0 0 rg BT 331.28 199.10 Td (designated ) Tj ET Q q 0 0 0 rg BT 377.53 199.10 Td (as ) Tj ET Q q 0 0 0 rg BT 389.34 199.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 406.70 199.10 Td (value ) Tj ET Q q 0 0 0 rg BT 431.83 199.10 Td (hedges ) Tj ET Q q 0 0 0 rg BT 463.08 199.10 Td (used ) Tj ET Q q 0 0 0 rg BT 484.90 199.10 Td (as ) Tj ET Q q 0 0 0 rg BT 496.71 199.10 Td (an ) Tj ET Q q 0 0 0 rg BT 509.63 199.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 542.54 199.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 561.01 199.10 Td (risk ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 187.10 Td (management ) Tj ET Q q 0 0 0 rg BT 89.68 187.10 Td (strategy ) Tj ET Q q 0 0 0 rg BT 123.92 187.10 Td (to ) Tj ET Q q 0 0 0 rg BT 134.29 187.10 Td (create ) Tj ET Q q 0 0 0 rg BT 160.75 187.10 Td (an ) Tj ET Q q 0 0 0 rg BT 172.77 187.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 220.90 187.10 Td (balance ) Tj ET Q q 0 0 0 rg BT 254.02 187.10 Td (of ) Tj ET Q q 0 0 0 rg BT 264.94 187.10 Td (fixed ) Tj ET Q q 0 0 0 rg BT 288.08 187.10 Td (and ) Tj ET Q q 0 0 0 rg BT 305.11 187.10 Td (floating ) Tj ET Q q 0 0 0 rg BT 338.80 187.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 356.38 187.10 Td (debt. ) Tj ET Q q 0 0 0 rg BT 378.50 187.10 Td (The ) Tj ET Q q 0 0 0 rg BT 396.63 187.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 435.32 187.10 Td (and ) Tj ET Q q 0 0 0 rg BT 452.35 187.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 498.26 187.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 518.07 187.10 Td (for ) Tj ET Q q 0 0 0 rg BT 532.32 187.10 Td (the ) Tj ET Q q 0 0 0 rg BT 547.13 187.10 Td (hedged ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 175.10 Td (benchmark ) Tj ET Q q 0 0 0 rg BT 83.01 175.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 100.59 175.10 Td (are ) Tj ET Q q 0 0 0 rg BT 115.39 175.10 Td (recorded ) Tj ET Q q 0 0 0 rg BT 152.95 175.10 Td (at ) Tj ET Q q 0 0 0 rg BT 162.75 175.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 179.21 175.10 Td (value. ) Tj ET Q q 0 0 0 rg BT 205.77 175.10 Td (The ) Tj ET Q q 0 0 0 rg BT 223.90 175.10 Td (ef) Tj ET Q q 0 0 0 rg BT 231.49 175.10 Td (fective ) Tj ET Q q 0 0 0 rg BT 261.27 175.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 293.29 175.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 310.86 175.10 Td (for ) Tj ET Q q 0 0 0 rg BT 325.11 175.10 Td (the ) Tj ET Q q 0 0 0 rg BT 339.91 175.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 378.59 175.10 Td (is ) Tj ET Q q 0 0 0 rg BT 387.85 175.10 Td (one-month ) Tj ET Q q 0 0 0 rg BT 433.76 175.10 Td (LIBOR ) Tj ET Q q 0 0 0 rg BT 466.34 175.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.67 175.10 Td (0.70%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.50 175.10 Td ( ) Tj ET Q q 0 0 0 rg BT 498.09 175.10 Td (as ) Tj ET Q q 0 0 0 rg BT 509.00 175.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.92 175.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 163.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 163.10 Td (\) ) Tj ET Q q 0 0 0 rg BT 61.67 163.10 Td (plus ) Tj ET Q q 0 0 0 rg BT 80.69 163.10 Td (an ) Tj ET Q q 0 0 0 rg BT 92.47 163.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 124.24 163.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 141.57 163.10 Td (spread ) Tj ET Q q 0 0 0 rg BT 170.01 163.10 Td (ranging ) Tj ET Q q 0 0 0 rg BT 202.90 163.10 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 224.68 163.10 Td (\(0.1\)%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.17 163.10 Td ( ) Tj ET Q q 0 0 0 rg BT 254.52 163.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.64 163.10 Td (4.6%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 285.47 163.10 Td (. ) Tj ET Q q 0 0 0 rg BT 290.14 163.10 Td (When ) Tj ET Q q 0 0 0 rg BT 316.36 163.10 Td (the ) Tj ET Q q 0 0 0 rg BT 330.92 163.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 376.59 163.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 399.48 163.10 Td (is ) Tj ET Q q 0 0 0 rg BT 408.50 163.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 453.60 163.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 475.38 163.10 Td (to ) Tj ET Q q 0 0 0 rg BT 485.50 163.10 Td (maturity) Tj ET Q q 0 0 0 rg BT 518.73 163.10 Td (, ) Tj ET Q q 0 0 0 rg BT 523.57 163.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.13 163.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 554.35 163.10 Td (value ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 151.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 58.50 151.10 Td (adjustment ) Tj ET Q q 0 0 0 rg BT 104.88 151.10 Td (to ) Tj ET Q q 0 0 0 rg BT 115.16 151.10 Td (the ) Tj ET Q q 0 0 0 rg BT 129.88 151.10 Td (underlying ) Tj ET Q q 0 0 0 rg BT 175.70 151.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 195.42 151.10 Td (instrument ) Tj ET Q q 0 0 0 rg BT 240.69 151.10 Td (is ) Tj ET Q q 0 0 0 rg BT 249.86 151.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 292.34 151.10 Td (as ) Tj ET Q q 0 0 0 rg BT 303.17 151.10 Td (a ) Tj ET Q q 0 0 0 rg BT 310.11 151.10 Td (reduction ) Tj ET Q q 0 0 0 rg BT 350.38 151.10 Td (to ) Tj ET Q q 0 0 0 rg BT 360.65 151.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 392.59 151.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 427.29 151.10 Td (over ) Tj ET Q q 0 0 0 rg BT 447.56 151.10 Td (the ) Tj ET Q q 0 0 0 rg BT 462.28 151.10 Td (remaining ) Tj ET Q q 0 0 0 rg BT 505.32 151.10 Td (life ) Tj ET Q q 0 0 0 rg BT 521.15 151.10 Td (of ) Tj ET Q q 0 0 0 rg BT 531.98 151.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.69 151.10 Td (debt.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 127.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.02 127.10 Td (notional ) Tj ET Q q 0 0 0 rg BT 89.27 127.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 121.74 127.10 Td (of ) Tj ET Q q 0 0 0 rg BT 132.54 127.10 Td (fixed-to-floating ) Tj ET Q q 0 0 0 rg BT 201.11 127.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 233.02 127.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 250.48 127.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 273.50 127.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 312.07 127.10 Td (executed ) Tj ET Q q 0 0 0 rg BT 350.08 127.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.10 127.10 Td ($255 ) Tj ET Q q 0 0 0 rg BT 390.58 127.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.47 127.10 Td ( ) Tj ET Q q 0 0 0 rg BT 421.94 127.10 Td (in ) Tj ET Q q 0 0 0 rg BT 432.20 127.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 454.67 127.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.58 127.10 Td ($200 ) Tj ET Q q 0 0 0 rg BT 494.06 127.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.95 127.10 Td ( ) Tj ET Q q 0 0 0 rg BT 525.43 127.10 Td (in ) Tj ET Q q 0 0 0 rg BT 535.68 127.10 Td (2014. ) Tj ET Q q 0 0 0 rg BT 560.47 127.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 115.10 Td (notional ) Tj ET Q q 0 0 0 rg BT 71.57 115.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 104.36 115.10 Td (of ) Tj ET Q q 0 0 0 rg BT 115.49 115.10 Td (fixed-to-floating ) Tj ET Q q 0 0 0 rg BT 184.38 115.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 216.61 115.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 234.39 115.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 257.74 115.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 296.63 115.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 342.19 115.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.54 115.10 Td ($500 ) Tj ET Q q 0 0 0 rg BT 383.34 115.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.23 115.10 Td ( ) Tj ET Q q 0 0 0 rg BT 415.03 115.10 Td (in ) Tj ET Q q 0 0 0 rg BT 425.60 115.10 Td (2016, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.90 115.10 Td ($147 ) Tj ET Q q 0 0 0 rg BT 473.70 115.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.59 115.10 Td ( ) Tj ET Q q 0 0 0 rg BT 505.39 115.10 Td (in ) Tj ET Q q 0 0 0 rg BT 515.97 115.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 538.76 115.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.00 115.10 Td ($426 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 103.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 103.10 Td ( ) Tj ET Q q 0 0 0 rg BT 67.43 103.10 Td (in ) Tj ET Q q 0 0 0 rg BT 77.74 103.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 100.28 103.10 Td (generating ) Tj ET Q q 0 0 0 rg BT 145.01 103.10 Td (proceeds ) Tj ET Q q 0 0 0 rg BT 183.09 103.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.95 103.10 Td ($43 ) Tj ET Q q 0 0 0 rg BT 211.49 103.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.38 103.10 Td ( ) Tj ET Q q 0 0 0 rg BT 242.92 103.10 Td (in ) Tj ET Q q 0 0 0 rg BT 253.23 103.10 Td (2016, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 278.27 103.10 Td ($28 ) Tj ET Q q 0 0 0 rg BT 295.80 103.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 324.69 103.10 Td ( ) Tj ET Q q 0 0 0 rg BT 327.23 103.10 Td (in ) Tj ET Q q 0 0 0 rg BT 337.54 103.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 360.08 103.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 377.05 103.10 Td ($1) Tj ET Q q 0 0 0 rg BT 386.68 103.10 Td (19 ) Tj ET Q q 0 0 0 rg BT 399.22 103.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.11 103.10 Td ( ) Tj ET Q q 0 0 0 rg BT 430.64 103.10 Td (in ) Tj ET Q q 0 0 0 rg BT 440.96 103.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 463.49 103.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 507.13 103.10 Td (accrued ) Tj ET Q q 0 0 0 rg BT 540.75 103.10 Td (interest\). ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 91.10 Td (Additional ) Tj ET Q q 0 0 0 rg BT 81.27 91.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 119.87 91.10 Td (were ) Tj ET Q q 0 0 0 rg BT 141.80 91.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 187.05 91.10 Td (in ) Tj ET Q q 0 0 0 rg BT 197.33 91.10 Td (connection ) Tj ET Q q 0 0 0 rg BT 243.71 91.10 Td (with ) Tj ET Q q 0 0 0 rg BT 263.98 91.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 283.70 91.10 Td (redemptions ) Tj ET Q q 0 0 0 rg BT 335.63 91.10 Td (in ) Tj ET Q q 0 0 0 rg BT 345.91 91.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 368.41 91.10 Td (and ) Tj ET Q q 0 0 0 rg BT 385.35 91.10 Td (2014.) Tj ET Q endstream endobj 169 0 obj <> endobj 170 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (84) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Debt Obligations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 727.50 Td (Short-term ) Tj ET Q q 0 0 0 rg BT 81.83 727.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 129.88 727.50 Td (and ) Tj ET Q q 0 0 0 rg BT 146.82 727.50 Td (the ) Tj ET Q q 0 0 0 rg BT 161.53 727.50 Td (current ) Tj ET Q q 0 0 0 rg BT 192.35 727.50 Td (portion ) Tj ET Q q 0 0 0 rg BT 223.73 727.50 Td (of ) Tj ET Q q 0 0 0 rg BT 234.56 727.50 Td (long-term ) Tj ET Q q 0 0 0 rg BT 276.50 727.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 296.21 727.50 Td (includes:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 687.00 376.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 687.00 80.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 687.00 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 687.00 80.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 657.00 376.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 411.50 657.00 80.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 657.00 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 657.00 80.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 702 m 491.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 491.5 702 m 495.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 702 m 575.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 702 m 491.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 687 m 491.5 687 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 491.5 702 m 495.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 702 m 575.5 702 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 687 m 575.5 687 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 687 m 491.5 687 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 687 m 575.5 687 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 657 m 491.5 657 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 657 m 575.5 657 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 643 m 491.5 643 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 411.5 641 m 491.5 641 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 643 m 575.5 643 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 641 m 575.5 641 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 706.25 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 469.75 706.23 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 691.25 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 443.00 691.23 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.00 691.23 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 677.57 Td (Bank drafts and short-term borrowings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 676.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 676.67 Td (243) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 676.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 676.67 Td (139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 662.57 Td (Current portion of long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 661.67 Td (749) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 661.67 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 647.57 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.00 646.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 646.67 Td (992) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 646.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 646.67 Td (139) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 618.50 Td (The ) Tj ET Q q 0 0 0 rg BT 54.14 618.50 Td (average ) Tj ET Q q 0 0 0 rg BT 87.82 618.50 Td (amount ) Tj ET Q q 0 0 0 rg BT 120.40 618.50 Td (of ) Tj ET Q q 0 0 0 rg BT 131.33 618.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 181.12 618.50 Td (paper ) Tj ET Q q 0 0 0 rg BT 205.92 618.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 255.17 618.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 273.32 618.50 Td ($254 ) Tj ET Q q 0 0 0 rg BT 295.91 618.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 324.80 618.50 Td ( ) Tj ET Q q 0 0 0 rg BT 327.40 618.50 Td (at ) Tj ET Q q 0 0 0 rg BT 337.21 618.50 Td (a ) Tj ET Q q 0 0 0 rg BT 344.24 618.50 Td (weighted-average ) Tj ET Q q 0 0 0 rg BT 417.90 618.50 Td (interest ) Tj ET Q q 0 0 0 rg BT 449.93 618.50 Td (rate ) Tj ET Q q 0 0 0 rg BT 467.50 618.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.43 618.50 Td (0.16%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.26 618.50 Td ( ) Tj ET Q q 0 0 0 rg BT 506.85 618.50 Td (during ) Tj ET Q q 0 0 0 rg BT 535.55 618.50 Td (2015. ) Tj ET Q q 0 0 0 rg BT 560.46 618.50 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 606.50 Td (maximum ) Tj ET Q q 0 0 0 rg BT 78.60 606.50 Td (month ) Tj ET Q q 0 0 0 rg BT 106.21 606.50 Td (end ) Tj ET Q q 0 0 0 rg BT 122.69 606.50 Td (amount ) Tj ET Q q 0 0 0 rg BT 154.74 606.50 Td (of ) Tj ET Q q 0 0 0 rg BT 165.11 606.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 214.36 606.50 Td (paper ) Tj ET Q q 0 0 0 rg BT 238.61 606.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 287.33 606.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 304.93 606.50 Td ($755 ) Tj ET Q q 0 0 0 rg BT 326.98 606.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.87 606.50 Td ( ) Tj ET Q q 0 0 0 rg BT 357.92 606.50 Td (with ) Tj ET Q q 0 0 0 rg BT 377.74 606.50 Td (no ) Tj ET Q q 0 0 0 rg BT 389.79 606.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 438.50 606.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 486.10 606.50 Td (at ) Tj ET Q q 0 0 0 rg BT 495.37 606.50 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 553.50 606.50 Td (2015.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 594.50 Td (There ) Tj ET Q q 0 0 0 rg BT 61.82 594.50 Td (were ) Tj ET Q q 0 0 0 rg BT 83.74 594.50 Td (no ) Tj ET Q q 0 0 0 rg BT 96.24 594.50 Td (commercial ) Tj ET Q q 0 0 0 rg BT 145.94 594.50 Td (paper ) Tj ET Q q 0 0 0 rg BT 170.65 594.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 218.70 594.50 Td (in ) Tj ET Q q 0 0 0 rg BT 228.98 594.50 Td (2016.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 570.50 Td (Long-term debt and the current portion of long-term debt includes:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 536.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 536.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 536.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 536.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 536.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 512.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 512.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 512.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 512.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 512.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 488.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 488.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 488.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 488.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 488.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 464.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 464.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 464.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 464.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 464.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 440.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 440.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 440.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 440.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 440.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 416.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 416.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 416.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 416.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 416.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 392.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 392.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 392.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 392.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 392.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 368.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 368.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 368.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 368.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 368.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 344.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 344.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 344.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 344.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 344.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 320.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 320.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 320.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 320.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 320.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 296.00 372.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 296.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 296.00 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 296.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 296.00 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 268.00 372.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 268.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 268.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 268.00 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 268.00 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 243.00 372.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 243.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 243.00 80.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 243.00 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 243.00 80.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 548 m 492.5 548 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 548 m 496.5 548 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 548 m 576.5 548 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 536 m 492.5 536 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 536 m 576.5 536 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 356 m 492.5 356 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 356 m 576.5 356 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 344 m 492.5 344 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 344 m 576.5 344 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 283 m 492.5 283 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 283 m 576.5 283 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 269 m 492.5 269 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 267 m 492.5 267 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 269 m 576.5 269 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 267 m 576.5 267 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 551.95 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 470.75 552.08 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 539.95 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.00 540.08 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 540.08 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 526.62 Td (Principal Value:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 514.62 Td (0.875% Notes due 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.00 514.62 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 514.62 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 514.62 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 514.62 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 502.62 Td (1.750% Notes due 2019) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 502.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 502.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 490.62 Td (2.000% Notes due 2022) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 490.62 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 490.62 Td (750) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 478.62 Td (7.150% Notes due 2023) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 478.62 Td (302) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 478.62 Td (302) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 466.62 Td (3.250% Notes due 2023) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 466.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 466.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 454.62 Td (1.000% Euro Notes due 2025) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 454.62 Td (601) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 454.62 Td (630) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 442.62 Td (6.800% Notes due 2026) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 442.62 Td (256) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 442.62 Td (256) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 430.62 Td (1.750% Euro Notes due 2035) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 430.62 Td (601) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 430.62 Td (630) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 418.62 Td (5.875% Notes due 2036) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 418.62 Td (404) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 418.62 Td (404) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 406.62 Td (6.125% Notes due 2038) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 406.62 Td (278) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 406.62 Td (278) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 394.62 Td (3.250% Notes due 2042) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 394.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 394.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 382.62 Td (4.500% Notes due 2044) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 382.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 382.62 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 370.62 Td (6.880% Notes due 2097) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 370.62 Td (260) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 370.62 Td (260) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 358.62 Td (0% - 5.75% Other - maturing 2017 - 2030) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 358.62 Td (59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 358.62 Td (79) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 346.62 Td (Subtotal) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 346.62 Td (6,261) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 346.62 Td (6,339) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 322.62 Td (Adjustments to Principal Value:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 310.62 Td (Fair value of interest rate swap contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.30 310.62 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 310.62 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 310.62 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 298.62 Td (Unamortized basis adjustment from swap terminations) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 298.62 Td (287) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 298.62 Td (272) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 286.57 Td (Unamortized bond discounts and issuance costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.30 286.62 Td (\(81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 286.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 286.57 Td (\(91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 286.57 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 273.57 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.00 272.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 272.67 Td (6,465) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 272.67 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 272.67 Td (6,550) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 246.57 Td (Current portion of long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.00 246.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 246.57 Td (749) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 246.57 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 246.57 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 233.57 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 233.57 Td (5,716) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 233.57 Td (6,550) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 206.50 Td (The ) Tj ET Q q 0 0 0 rg BT 53.67 206.50 Td (fair ) Tj ET Q q 0 0 0 rg BT 69.67 206.50 Td (value ) Tj ET Q q 0 0 0 rg BT 93.45 206.50 Td (of ) Tj ET Q q 0 0 0 rg BT 103.90 206.50 Td (long-term ) Tj ET Q q 0 0 0 rg BT 145.46 206.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 164.80 206.50 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 182.47 206.50 Td ($6,932 ) Tj ET Q q 0 0 0 rg BT 212.10 206.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.99 206.50 Td ( ) Tj ET Q q 0 0 0 rg BT 243.11 206.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.67 206.50 Td ($6,909 ) Tj ET Q q 0 0 0 rg BT 289.29 206.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.19 206.50 Td ( ) Tj ET Q q 0 0 0 rg BT 320.31 206.50 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 329.65 206.50 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 387.86 206.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.86 206.50 Td ( ) Tj ET Q q 0 0 0 rg BT 409.98 206.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.54 206.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.54 206.50 Td (, ) Tj ET Q q 0 0 0 rg BT 451.16 206.50 Td (respectively) Tj ET Q q 0 0 0 rg BT 498.83 206.50 Td (, ) Tj ET Q q 0 0 0 rg BT 503.45 206.50 Td (and ) Tj ET Q q 0 0 0 rg BT 520.01 206.50 Td (was ) Tj ET Q q 0 0 0 rg BT 537.68 206.50 Td (estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 194.50 Td (using ) Tj ET Q q 0 0 0 rg BT 60.55 194.50 Td (Level ) Tj ET Q q 0 0 0 rg BT 86.19 194.50 Td (2 ) Tj ET Q q 0 0 0 rg BT 94.07 194.50 Td (inputs ) Tj ET Q q 0 0 0 rg BT 121.40 194.50 Td (which ) Tj ET Q q 0 0 0 rg BT 148.71 194.50 Td (are ) Tj ET Q q 0 0 0 rg BT 163.80 194.50 Td (based ) Tj ET Q q 0 0 0 rg BT 189.44 194.50 Td (upon ) Tj ET Q q 0 0 0 rg BT 212.32 194.50 Td (the ) Tj ET Q q 0 0 0 rg BT 227.42 194.50 Td (quoted ) Tj ET Q q 0 0 0 rg BT 257.51 194.50 Td (market ) Tj ET Q q 0 0 0 rg BT 288.16 194.50 Td (prices ) Tj ET Q q 0 0 0 rg BT 314.91 194.50 Td (for ) Tj ET Q q 0 0 0 rg BT 329.45 194.50 Td (the ) Tj ET Q q 0 0 0 rg BT 344.54 194.50 Td (same ) Tj ET Q q 0 0 0 rg BT 367.97 194.50 Td (or ) Tj ET Q q 0 0 0 rg BT 379.18 194.50 Td (similar ) Tj ET Q q 0 0 0 rg BT 409.83 194.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 429.93 194.50 Td (instruments. ) Tj ET Q q 0 0 0 rg BT 481.76 194.50 Td (The ) Tj ET Q q 0 0 0 rg BT 500.19 194.50 Td (fair ) Tj ET Q q 0 0 0 rg BT 516.94 194.50 Td (value ) Tj ET Q q 0 0 0 rg BT 541.48 194.50 Td (of ) Tj ET Q q 0 0 0 rg BT 552.68 194.50 Td (short-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 182.50 Td (term ) Tj ET Q q 0 0 0 rg BT 56.83 182.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 104.88 182.50 Td (approximates ) Tj ET Q q 0 0 0 rg BT 161.25 182.50 Td (the ) Tj ET Q q 0 0 0 rg BT 175.97 182.50 Td (carrying ) Tj ET Q q 0 0 0 rg BT 211.78 182.50 Td (value ) Tj ET Q q 0 0 0 rg BT 235.94 182.50 Td (due ) Tj ET Q q 0 0 0 rg BT 252.88 182.50 Td (to ) Tj ET Q q 0 0 0 rg BT 263.15 182.50 Td (the ) Tj ET Q q 0 0 0 rg BT 277.87 182.50 Td (short ) Tj ET Q q 0 0 0 rg BT 300.37 182.50 Td (maturities ) Tj ET Q q 0 0 0 rg BT 342.86 182.50 Td (of ) Tj ET Q q 0 0 0 rg BT 353.69 182.50 Td (the ) Tj ET Q q 0 0 0 rg BT 368.41 182.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 388.12 182.50 Td (instruments.) Tj ET Q endstream endobj 171 0 obj <> endobj 172 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (85) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Senior ) Tj ET Q q 0 0 0 rg BT 64.24 749.10 Td (unsecured ) Tj ET Q q 0 0 0 rg BT 106.90 749.10 Td (notes ) Tj ET Q q 0 0 0 rg BT 130.14 749.10 Td (were ) Tj ET Q q 0 0 0 rg BT 151.69 749.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 178.82 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 188.73 749.10 Td (a ) Tj ET Q q 0 0 0 rg BT 195.29 749.10 Td (registered ) Tj ET Q q 0 0 0 rg BT 236.85 749.10 Td (public ) Tj ET Q q 0 0 0 rg BT 263.97 749.10 Td (of) Tj ET Q q 0 0 0 rg BT 272.12 749.10 Td (ferings ) Tj ET Q q 0 0 0 rg BT 302.02 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 311.92 749.10 Td (2015. ) Tj ET Q q 0 0 0 rg BT 336.40 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 354.07 749.10 Td (notes ) Tj ET Q q 0 0 0 rg BT 377.31 749.10 Td (rank ) Tj ET Q q 0 0 0 rg BT 397.20 749.10 Td (equally ) Tj ET Q q 0 0 0 rg BT 428.77 749.10 Td (in ) Tj ET Q q 0 0 0 rg BT 438.67 749.10 Td (right ) Tj ET Q q 0 0 0 rg BT 459.69 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 470.14 749.10 Td (payment ) Tj ET Q q 0 0 0 rg BT 506.71 749.10 Td (with ) Tj ET Q q 0 0 0 rg BT 526.61 749.10 Td (all ) Tj ET Q q 0 0 0 rg BT 538.73 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 549.19 749.10 Td (BMS's ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (existing ) Tj ET Q q 0 0 0 rg BT 70.66 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 88.09 737.10 Td (future ) Tj ET Q q 0 0 0 rg BT 114.97 737.10 Td (senior ) Tj ET Q q 0 0 0 rg BT 142.40 737.10 Td (unsecured ) Tj ET Q q 0 0 0 rg BT 185.93 737.10 Td (indebtedness ) Tj ET Q q 0 0 0 rg BT 240.58 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 258.02 737.10 Td (are ) Tj ET Q q 0 0 0 rg BT 273.22 737.10 Td (redeemable ) Tj ET Q q 0 0 0 rg BT 322.30 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 333.07 737.10 Td (whole ) Tj ET Q q 0 0 0 rg BT 360.50 737.10 Td (or ) Tj ET Q q 0 0 0 rg BT 371.83 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 382.60 737.10 Td (part, ) Tj ET Q q 0 0 0 rg BT 403.65 737.10 Td (at ) Tj ET Q q 0 0 0 rg BT 413.86 737.10 Td (any ) Tj ET Q q 0 0 0 rg BT 431.29 737.10 Td (time ) Tj ET Q q 0 0 0 rg BT 452.06 737.10 Td (at ) Tj ET Q q 0 0 0 rg BT 462.27 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 469.71 737.10 Td (predetermined ) Tj ET Q q 0 0 0 rg BT 530.45 737.10 Td (redemption ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (price. ) Tj ET Q q 0 0 0 rg BT 60.66 725.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 83.96 725.10 Td (also ) Tj ET Q q 0 0 0 rg BT 102.24 725.10 Td (terminated ) Tj ET Q q 0 0 0 rg BT 147.17 725.10 Td (forward ) Tj ET Q q 0 0 0 rg BT 181.00 725.10 Td (starting ) Tj ET Q q 0 0 0 rg BT 213.17 725.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 244.77 725.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 261.93 725.10 Td (swap ) Tj ET Q q 0 0 0 rg BT 284.66 725.10 Td (contracts ) Tj ET Q q 0 0 0 rg BT 322.93 725.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 354.53 725.10 Td (into ) Tj ET Q q 0 0 0 rg BT 372.26 725.10 Td (during ) Tj ET Q q 0 0 0 rg BT 400.54 725.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 425.21 725.10 Td (resulting ) Tj ET Q q 0 0 0 rg BT 462.38 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 472.34 725.10 Td (an ) Tj ET Q q 0 0 0 rg BT 483.95 725.10 Td (unrealized ) Tj ET Q q 0 0 0 rg BT 527.76 725.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 545.50 725.10 Td (in ) Tj ET Q q 0 0 0 rg BT 555.45 725.10 Td (other ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 99.03 713.10 Td (income. ) Tj ET Q q 0 0 0 rg BT 133.29 713.10 Td (The ) Tj ET Q q 0 0 0 rg BT 151.33 713.10 Td (following ) Tj ET Q q 0 0 0 rg BT 192.72 713.10 Td (table ) Tj ET Q q 0 0 0 rg BT 214.65 713.10 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 264.92 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 279.63 713.10 Td (issuance ) Tj ET Q q 0 0 0 rg BT 316.01 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 326.84 713.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 368.77 713.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 388.49 713.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 435.43 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 445.71 713.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 468.21 713.10 Td (\(none ) Tj ET Q q 0 0 0 rg BT 493.48 713.10 Td (in ) Tj ET Q q 0 0 0 rg BT 503.76 713.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 526.26 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 543.20 713.10 Td (2014\):) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 672.60 430.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 466.50 672.60 53.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 519.50 672.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 523.50 672.60 53.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 642.60 430.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 466.50 642.60 53.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 519.50 642.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 523.50 642.60 53.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 612.60 430.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 466.50 612.60 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 519.50 612.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 523.50 612.60 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 584.60 430.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 466.50 584.60 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 519.50 584.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 523.50 584.60 53.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 556.60 430.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 466.50 556.60 53.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 519.50 556.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 523.50 556.60 53.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 466.5 687.6 m 519.5 687.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 519.5 687.6 m 523.5 687.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 523.5 687.6 m 576.5 687.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 466.5 672.6 m 519.5 672.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 523.5 672.6 m 576.5 672.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 466.5 627.6 m 519.5 627.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 466.5 613.6 m 519.5 613.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 466.5 611.6 m 519.5 611.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 523.5 627.6 m 576.5 627.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 523.5 613.6 m 576.5 613.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 523.5 611.6 m 576.5 611.6 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 513.00 691.83 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 676.85 Td (Amounts in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 483.90 676.83 Td (Euro) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 529.60 676.83 Td (U.S. dollars) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 662.27 Td (Principal Value:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 647.27 Td (1.000% Euro Notes due 2025) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.00 647.27 Td (€) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 647.27 Td (575) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.00 647.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 647.27 Td (643) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 632.27 Td (1.750% Euro Notes due 2035) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 632.27 Td (575) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 632.27 Td (643) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 617.27 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.00 617.27 Td (€) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.15 617.27 Td (1,150) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.00 617.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 617.27 Td (1,286) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 589.27 Td (Proceeds net of discount and deferred loan issuance costs) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.00 589.27 Td (€) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.15 589.27 Td (1,133) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.00 589.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 589.27 Td (1,268) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 561.27 Td (Forward starting interest rate swap contracts terminated:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 546.27 Td (Notional amount) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.00 546.27 Td (€) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.65 546.27 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.00 546.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 546.27 Td (559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 531.27 Td (Unrealized loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.30 531.32 Td (\(16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 531.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 531.27 Td (\(18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 531.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 503.10 Td (following ) Tj ET Q q 0 0 0 rg BT 95.43 503.10 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 145.70 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 160.41 503.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 180.13 503.10 Td (redemption ) Tj ET Q q 0 0 0 rg BT 228.17 503.10 Td (activity ) Tj ET Q q 0 0 0 rg BT 260.66 503.10 Td (for ) Tj ET Q q 0 0 0 rg BT 274.82 503.10 Td (2015 ) Tj ET Q q 0 0 0 rg BT 297.32 503.10 Td (and ) Tj ET Q q 0 0 0 rg BT 314.26 503.10 Td (2014 ) Tj ET Q q 0 0 0 rg BT 336.76 503.10 Td (\(none ) Tj ET Q q 0 0 0 rg BT 362.03 503.10 Td (in ) Tj ET Q q 0 0 0 rg BT 372.31 503.10 Td (2016\):) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 479.60 388.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 479.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 428.50 479.60 72.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 479.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 479.60 72.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 453.60 388.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 453.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 428.50 453.60 72.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 453.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 453.60 72.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 427.60 388.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 424.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 428.50 427.60 72.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 500.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 504.50 427.60 72.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 428.5 479.6 m 500.5 479.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 504.5 479.6 m 576.5 479.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 483.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 456.00 483.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.00 483.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 470.17 Td (Principal amount) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.00 470.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 470.17 Td (1,624) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.00 470.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 470.17 Td (582) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 457.17 Td (Carrying value) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 457.17 Td (1,795) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 457.17 Td (633) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 444.17 Td (Debt redemption price) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 444.17 Td (1,957) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 444.17 Td (676) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 431.17 Td (Notional amount of interest rate swap contracts terminated) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 431.17 Td (735) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 431.17 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 418.17 Td (Interest rate swap termination payments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.65 418.17 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 418.17 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 405.17 Td (Loss on debt redemption) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 138.15 409.70 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.65 405.17 Td (180) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 405.17 Td (45) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 36.00 386.50 Td (\(a\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 49.50 386.50 Td (Including ) Tj ET Q q 0 0 0 rg BT 82.16 386.50 Td (acceleration ) Tj ET Q q 0 0 0 rg BT 122.80 386.50 Td (of ) Tj ET Q q 0 0 0 rg BT 131.46 386.50 Td (debt ) Tj ET Q q 0 0 0 rg BT 147.23 386.50 Td (issuance ) Tj ET Q q 0 0 0 rg BT 176.34 386.50 Td (costs, ) Tj ET Q q 0 0 0 rg BT 196.34 386.50 Td (loss ) Tj ET Q q 0 0 0 rg BT 210.79 386.50 Td (on ) Tj ET Q q 0 0 0 rg BT 220.79 386.50 Td (interest ) Tj ET Q q 0 0 0 rg BT 246.33 386.50 Td (rate ) Tj ET Q q 0 0 0 rg BT 260.32 386.50 Td (lock ) Tj ET Q q 0 0 0 rg BT 276.09 386.50 Td (contract ) Tj ET Q q 0 0 0 rg BT 303.86 386.50 Td (and ) Tj ET Q q 0 0 0 rg BT 317.41 386.50 Td (other ) Tj ET Q q 0 0 0 rg BT 335.84 386.50 Td (related ) Tj ET Q q 0 0 0 rg BT 359.61 386.50 Td (fees.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 362.50 Td (Interest ) Tj ET Q q 0 0 0 rg BT 68.40 362.50 Td (payments ) Tj ET Q q 0 0 0 rg BT 109.14 362.50 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 130.99 362.50 Td ($191 ) Tj ET Q q 0 0 0 rg BT 153.41 362.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 182.30 362.50 Td ( ) Tj ET Q q 0 0 0 rg BT 184.72 362.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.91 362.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.91 362.50 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.83 362.50 Td ($205 ) Tj ET Q q 0 0 0 rg BT 242.25 362.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.14 362.50 Td ( ) Tj ET Q q 0 0 0 rg BT 273.55 362.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 283.75 362.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.75 362.50 Td ( ) Tj ET Q q 0 0 0 rg BT 306.17 362.50 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 323.02 362.50 Td ($238 ) Tj ET Q q 0 0 0 rg BT 345.44 362.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 374.33 362.50 Td ( ) Tj ET Q q 0 0 0 rg BT 376.75 362.50 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.94 362.50 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.94 362.50 Td ( ) Tj ET Q q 0 0 0 rg BT 409.36 362.50 Td (net ) Tj ET Q q 0 0 0 rg BT 423.99 362.50 Td (of ) Tj ET Q q 0 0 0 rg BT 434.74 362.50 Td (amounts ) Tj ET Q q 0 0 0 rg BT 471.04 362.50 Td (received ) Tj ET Q q 0 0 0 rg BT 507.32 362.50 Td (from ) Tj ET Q q 0 0 0 rg BT 529.18 362.50 Td (interest ) Tj ET Q q 0 0 0 rg BT 561.03 362.50 Td (rate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 350.50 Td (swap ) Tj ET Q q 0 0 0 rg BT 59.05 350.50 Td (contracts.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 326.50 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 326.50 Td (e ) Tj ET Q q 0 0 0 rg BT 51.71 326.50 Td (currently ) Tj ET Q q 0 0 0 rg BT 90.44 326.50 Td (have ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.95 326.50 Td (two) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 126.95 326.50 Td ( ) Tj ET Q q 0 0 0 rg BT 129.59 326.50 Td (separate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 164.98 326.50 Td ($1.5 ) Tj ET Q q 0 0 0 rg BT 185.12 326.50 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.23 326.50 Td ( ) Tj ET Q q 0 0 0 rg BT 213.86 326.50 Td (revolving ) Tj ET Q q 0 0 0 rg BT 254.83 326.50 Td (credit ) Tj ET Q q 0 0 0 rg BT 280.22 326.50 Td (facilities ) Tj ET Q q 0 0 0 rg BT 317.29 326.50 Td (from ) Tj ET Q q 0 0 0 rg BT 339.36 326.50 Td (a ) Tj ET Q q 0 0 0 rg BT 346.44 326.50 Td (syndicate ) Tj ET Q q 0 0 0 rg BT 386.84 326.50 Td (of ) Tj ET Q q 0 0 0 rg BT 397.80 326.50 Td (lenders. ) Tj ET Q q 0 0 0 rg BT 431.62 326.50 Td (The ) Tj ET Q q 0 0 0 rg BT 449.81 326.50 Td (facilities ) Tj ET Q q 0 0 0 rg BT 486.87 326.50 Td (provide ) Tj ET Q q 0 0 0 rg BT 520.05 326.50 Td (for ) Tj ET Q q 0 0 0 rg BT 534.35 326.50 Td (customary ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 314.50 Td (terms ) Tj ET Q q 0 0 0 rg BT 60.35 314.50 Td (and ) Tj ET Q q 0 0 0 rg BT 76.92 314.50 Td (conditions ) Tj ET Q q 0 0 0 rg BT 120.72 314.50 Td (with ) Tj ET Q q 0 0 0 rg BT 140.63 314.50 Td (no ) Tj ET Q q 0 0 0 rg BT 152.77 314.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 189.88 314.50 Td (covenants ) Tj ET Q q 0 0 0 rg BT 232.00 314.50 Td (and ) Tj ET Q q 0 0 0 rg BT 248.57 314.50 Td (were ) Tj ET Q q 0 0 0 rg BT 270.14 314.50 Td (extended ) Tj ET Q q 0 0 0 rg BT 308.36 314.50 Td (to ) Tj ET Q q 0 0 0 rg BT 318.28 314.50 Td (October ) Tj ET Q q 0 0 0 rg BT 352.62 314.50 Td (2020 ) Tj ET Q q 0 0 0 rg BT 374.75 314.50 Td (and ) Tj ET Q q 0 0 0 rg BT 391.32 314.50 Td (July ) Tj ET Q q 0 0 0 rg BT 410.13 314.50 Td (2021. ) Tj ET Q q 0 0 0 rg BT 434.76 314.50 Td (Each ) Tj ET Q q 0 0 0 rg BT 456.88 314.50 Td (facility ) Tj ET Q q 0 0 0 rg BT 487.33 314.50 Td (is ) Tj ET Q q 0 0 0 rg BT 496.14 314.50 Td (extendable ) Tj ET Q q 0 0 0 rg BT 541.58 314.50 Td (annually ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 302.50 Td (by ) Tj ET Q q 0 0 0 rg BT 47.89 302.50 Td (one ) Tj ET Q q 0 0 0 rg BT 64.22 302.50 Td (year ) Tj ET Q q 0 0 0 rg BT 83.31 302.50 Td (on ) Tj ET Q q 0 0 0 rg BT 95.20 302.50 Td (the ) Tj ET Q q 0 0 0 rg BT 109.31 302.50 Td (anniversary ) Tj ET Q q 0 0 0 rg BT 157.85 302.50 Td (date ) Tj ET Q q 0 0 0 rg BT 176.39 302.50 Td (with ) Tj ET Q q 0 0 0 rg BT 196.06 302.50 Td (the ) Tj ET Q q 0 0 0 rg BT 210.17 302.50 Td (consent ) Tj ET Q q 0 0 0 rg BT 242.60 302.50 Td (of ) Tj ET Q q 0 0 0 rg BT 252.82 302.50 Td (the ) Tj ET Q q 0 0 0 rg BT 266.93 302.50 Td (lenders. ) Tj ET Q q 0 0 0 rg BT 300.19 302.50 Td ( ) Tj ET Q q 0 0 0 rg BT 302.08 302.50 Td (No ) Tj ET Q q 0 0 0 rg BT 316.20 302.50 Td (borrowings ) Tj ET Q q 0 0 0 rg BT 363.64 302.50 Td (were ) Tj ET Q q 0 0 0 rg BT 384.96 302.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 433.51 302.50 Td (under ) Tj ET Q q 0 0 0 rg BT 458.17 302.50 Td (either ) Tj ET Q q 0 0 0 rg BT 482.82 302.50 Td (revolving ) Tj ET Q q 0 0 0 rg BT 523.04 302.50 Td (credit ) Tj ET Q q 0 0 0 rg BT 547.69 302.50 Td (facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 290.50 Td (at ) Tj ET Q q 0 0 0 rg BT 45.72 290.50 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 104.30 290.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 124.30 290.50 Td ( ) Tj ET Q q 0 0 0 rg BT 126.80 290.50 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.63 290.50 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.63 290.50 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 266.50 Td (A) Tj ET Q q 0 0 0 rg BT 42.48 266.50 Td (vailable ) Tj ET Q q 0 0 0 rg BT 75.73 266.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 112.31 266.50 Td (guarantees ) Tj ET Q q 0 0 0 rg BT 156.66 266.50 Td (provided ) Tj ET Q q 0 0 0 rg BT 193.81 266.50 Td (in ) Tj ET Q q 0 0 0 rg BT 203.19 266.50 Td (the ) Tj ET Q q 0 0 0 rg BT 217.00 266.50 Td (form ) Tj ET Q q 0 0 0 rg BT 238.04 266.50 Td (of ) Tj ET Q q 0 0 0 rg BT 247.97 266.50 Td (stand-by ) Tj ET Q q 0 0 0 rg BT 284.01 266.50 Td (letters ) Tj ET Q q 0 0 0 rg BT 310.04 266.50 Td (of ) Tj ET Q q 0 0 0 rg BT 319.97 266.50 Td (credit ) Tj ET Q q 0 0 0 rg BT 344.33 266.50 Td (and ) Tj ET Q q 0 0 0 rg BT 360.37 266.50 Td (performance ) Tj ET Q q 0 0 0 rg BT 412.49 266.50 Td (bonds ) Tj ET Q q 0 0 0 rg BT 437.98 266.50 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.01 266.50 Td ($812 ) Tj ET Q q 0 0 0 rg BT 480.61 266.50 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.50 266.50 Td ( ) Tj ET Q q 0 0 0 rg BT 511.10 266.50 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.91 266.50 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 254.50 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 254.50 Td (. ) Tj ET Q q 0 0 0 rg BT 61.45 254.50 Td (Stand-by ) Tj ET Q q 0 0 0 rg BT 100.51 254.50 Td (letters ) Tj ET Q q 0 0 0 rg BT 127.89 254.50 Td (of ) Tj ET Q q 0 0 0 rg BT 139.17 254.50 Td (credit ) Tj ET Q q 0 0 0 rg BT 164.88 254.50 Td (are ) Tj ET Q q 0 0 0 rg BT 180.04 254.50 Td (issued ) Tj ET Q q 0 0 0 rg BT 207.99 254.50 Td (through ) Tj ET Q q 0 0 0 rg BT 242.04 254.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 279.97 254.50 Td (institutions ) Tj ET Q q 0 0 0 rg BT 327.38 254.50 Td (in ) Tj ET Q q 0 0 0 rg BT 338.10 254.50 Td (support ) Tj ET Q q 0 0 0 rg BT 371.05 254.50 Td (of ) Tj ET Q q 0 0 0 rg BT 382.33 254.50 Td (guarantees ) Tj ET Q q 0 0 0 rg BT 428.04 254.50 Td (for ) Tj ET Q q 0 0 0 rg BT 442.65 254.50 Td (various ) Tj ET Q q 0 0 0 rg BT 475.03 254.50 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 524.93 254.50 Td (Performance ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 242.50 Td (bonds ) Tj ET Q q 0 0 0 rg BT 61.78 242.50 Td (are ) Tj ET Q q 0 0 0 rg BT 75.87 242.50 Td (issued ) Tj ET Q q 0 0 0 rg BT 102.75 242.50 Td (to ) Tj ET Q q 0 0 0 rg BT 112.41 242.50 Td (support ) Tj ET Q q 0 0 0 rg BT 144.30 242.50 Td (a ) Tj ET Q q 0 0 0 rg BT 150.62 242.50 Td (range ) Tj ET Q q 0 0 0 rg BT 174.71 242.50 Td (of ) Tj ET Q q 0 0 0 rg BT 184.92 242.50 Td (ongoing ) Tj ET Q q 0 0 0 rg BT 219.58 242.50 Td (operating ) Tj ET Q q 0 0 0 rg BT 259.23 242.50 Td (activities, ) Tj ET Q q 0 0 0 rg BT 299.71 242.50 Td (including ) Tj ET Q q 0 0 0 rg BT 339.37 242.50 Td (sale ) Tj ET Q q 0 0 0 rg BT 356.80 242.50 Td (of ) Tj ET Q q 0 0 0 rg BT 367.02 242.50 Td (products ) Tj ET Q q 0 0 0 rg BT 403.34 242.50 Td (to ) Tj ET Q q 0 0 0 rg BT 413.00 242.50 Td (hospitals ) Tj ET Q q 0 0 0 rg BT 450.44 242.50 Td (and ) Tj ET Q q 0 0 0 rg BT 466.76 242.50 Td (foreign ) Tj ET Q q 0 0 0 rg BT 497.52 242.50 Td (ministries ) Tj ET Q q 0 0 0 rg BT 538.85 242.50 Td (of ) Tj ET Q q 0 0 0 rg BT 549.07 242.50 Td (health, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 230.50 Td (bonds ) Tj ET Q q 0 0 0 rg BT 63.66 230.50 Td (for ) Tj ET Q q 0 0 0 rg BT 79.08 230.50 Td (customs, ) Tj ET Q q 0 0 0 rg BT 118.13 230.50 Td (duties ) Tj ET Q q 0 0 0 rg BT 145.78 230.50 Td (and ) Tj ET Q q 0 0 0 rg BT 163.98 230.50 Td (value ) Tj ET Q q 0 0 0 rg BT 189.40 230.50 Td (added ) Tj ET Q q 0 0 0 rg BT 217.04 230.50 Td (tax ) Tj ET Q q 0 0 0 rg BT 233.03 230.50 Td (and ) Tj ET Q q 0 0 0 rg BT 251.23 230.50 Td (guarantees ) Tj ET Q q 0 0 0 rg BT 297.75 230.50 Td (related ) Tj ET Q q 0 0 0 rg BT 328.72 230.50 Td (to ) Tj ET Q q 0 0 0 rg BT 340.26 230.50 Td (miscellaneous ) Tj ET Q q 0 0 0 rg BT 400.67 230.50 Td (legal ) Tj ET Q q 0 0 0 rg BT 423.87 230.50 Td (actions. ) Tj ET Q q 0 0 0 rg BT 457.63 230.50 Td (A) Tj ET Q q 0 0 0 rg BT 464.30 230.50 Td ( ) Tj ET Q q 0 0 0 rg BT 468.07 230.50 Td (significant ) Tj ET Q q 0 0 0 rg BT 514.04 230.50 Td (majority ) Tj ET Q q 0 0 0 rg BT 551.69 230.50 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 230.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 218.50 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 85.17 218.50 Td (financial ) Tj ET Q q 0 0 0 rg BT 122.65 218.50 Td (guarantees ) Tj ET Q q 0 0 0 rg BT 167.90 218.50 Td (will ) Tj ET Q q 0 0 0 rg BT 185.96 218.50 Td (expire ) Tj ET Q q 0 0 0 rg BT 213.44 218.50 Td (within ) Tj ET Q q 0 0 0 rg BT 241.50 218.50 Td (the ) Tj ET Q q 0 0 0 rg BT 256.21 218.50 Td (year ) Tj ET Q q 0 0 0 rg BT 275.92 218.50 Td (and ) Tj ET Q q 0 0 0 rg BT 292.86 218.50 Td (are ) Tj ET Q q 0 0 0 rg BT 307.57 218.50 Td (not ) Tj ET Q q 0 0 0 rg BT 322.85 218.50 Td (expected ) Tj ET Q q 0 0 0 rg BT 360.88 218.50 Td (to ) Tj ET Q q 0 0 0 rg BT 371.16 218.50 Td (be ) Tj ET Q q 0 0 0 rg BT 383.09 218.50 Td (funded.) Tj ET Q endstream endobj 173 0 obj <> endobj 174 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (86) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 749.25 Td (10) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 749.25 Td (. RECEIV) Tj ET Q q 0 0 0 rg BT 111.10 749.25 Td (ABLES) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 702.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 702.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 702.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 674.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 674.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 674.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 646.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 646.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 646.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 618.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 618.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 618.75 80.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 714.75 m 492.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 714.75 m 496.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 714.75 m 576.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 702.75 m 492.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 702.75 m 576.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 660.75 m 492.5 660.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 660.75 m 576.5 660.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 604.75 m 492.5 604.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 604.75 m 576.5 604.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 591.75 m 492.5 591.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 589.75 m 492.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 591.75 m 576.5 591.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 589.75 m 576.5 589.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.25 718.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 706.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 706.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 706.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 693.32 Td (Trade receivables) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 693.32 Td (3,948) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 693.32 Td (3,070) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.32 Td (Less charge-backs and cash discounts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.30 679.37 Td (\(126) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 679.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 679.32 Td (\(97) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 679.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 665.32 Td (Less bad debt allowances) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.30 665.37 Td (\(48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 665.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 665.32 Td (\(25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 665.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 651.32 Td (Net trade receivables) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 651.32 Td (3,774) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 651.32 Td (2,948) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 637.32 Td (Alliance receivables) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 637.32 Td (903) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 637.32 Td (958) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 623.32 Td (Prepaid and refundable income taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 623.32 Td (627) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 623.32 Td (182) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 609.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 609.32 Td (239) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 609.32 Td (211) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 595.32 Td (Receivables) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 595.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 595.32 Td (5,543) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 595.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 595.32 Td (4,299) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 567.25 Td (Non-U.S. ) Tj ET Q q 0 0 0 rg BT 77.28 567.25 Td (receivables ) Tj ET Q q 0 0 0 rg BT 125.20 567.25 Td (sold ) Tj ET Q q 0 0 0 rg BT 144.81 567.25 Td (on ) Tj ET Q q 0 0 0 rg BT 157.76 567.25 Td (a ) Tj ET Q q 0 0 0 rg BT 165.14 567.25 Td (nonrecourse ) Tj ET Q q 0 0 0 rg BT 216.96 567.25 Td (basis ) Tj ET Q q 0 0 0 rg BT 239.90 567.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.28 567.25 Td ($618 ) Tj ET Q q 0 0 0 rg BT 285.22 567.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 314.11 567.25 Td ( ) Tj ET Q q 0 0 0 rg BT 317.06 567.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.78 567.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.78 567.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 353.23 567.25 Td ($476 ) Tj ET Q q 0 0 0 rg BT 376.18 567.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.07 567.25 Td ( ) Tj ET Q q 0 0 0 rg BT 408.01 567.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.74 567.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.74 567.25 Td (, ) Tj ET Q q 0 0 0 rg BT 444.18 567.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.57 567.25 Td ($812 ) Tj ET Q q 0 0 0 rg BT 484.51 567.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.40 567.25 Td ( ) Tj ET Q q 0 0 0 rg BT 516.35 567.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 527.07 567.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.07 567.25 Td (. ) Tj ET Q q 0 0 0 rg BT 552.52 567.25 Td (In ) Tj ET Q q 0 0 0 rg BT 563.80 567.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 555.25 Td (aggregate, ) Tj ET Q q 0 0 0 rg BT 81.64 555.25 Td (receivables ) Tj ET Q q 0 0 0 rg BT 130.89 555.25 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 154.60 555.25 Td (three) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 174.59 555.25 Td ( ) Tj ET Q q 0 0 0 rg BT 178.87 555.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 244.22 555.25 Td (wholesalers ) Tj ET Q q 0 0 0 rg BT 295.71 555.25 Td (in ) Tj ET Q q 0 0 0 rg BT 307.76 555.25 Td (the ) Tj ET Q q 0 0 0 rg BT 324.26 555.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 346.32 555.25 Td (represented ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 396.68 555.25 Td (66%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.01 555.25 Td ( ) Tj ET Q q 0 0 0 rg BT 419.29 555.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.00 555.25 Td (53%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 456.33 555.25 Td ( ) Tj ET Q q 0 0 0 rg BT 460.61 555.25 Td (of ) Tj ET Q q 0 0 0 rg BT 473.22 555.25 Td (total ) Tj ET Q q 0 0 0 rg BT 495.27 555.25 Td (trade ) Tj ET Q q 0 0 0 rg BT 519.53 555.25 Td (receivables ) Tj ET Q q 0 0 0 rg BT 568.78 555.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 543.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 94.58 543.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 114.58 543.25 Td ( ) Tj ET Q q 0 0 0 rg BT 117.08 543.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 134.02 543.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 154.02 543.25 Td (, ) Tj ET Q q 0 0 0 rg BT 159.02 543.25 Td (respectively) Tj ET Q q 0 0 0 rg BT 206.68 543.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 519.25 Td (Changes to the allowances for bad debt, char) Tj ET Q q 0 0 0 rg BT 215.20 519.25 Td (ge-backs and cash discounts were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 484.75 321.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 484.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 484.75 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 484.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 484.75 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 484.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 484.75 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 456.75 321.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 456.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 456.75 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 456.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 456.75 69.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 456.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 456.75 69.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 496.75 m 429.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 429.5 496.75 m 433.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 496.75 m 502.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 496.75 m 506.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 496.75 m 575.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 496.75 m 429.5 496.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 484.75 m 429.5 484.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 484.75 m 502.5 484.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 484.75 m 575.5 484.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 484.75 m 502.5 484.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 484.75 m 575.5 484.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 442.75 m 429.5 442.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 429.75 m 429.5 429.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 427.75 m 429.5 427.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 442.75 m 502.5 442.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 429.75 m 502.5 429.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 427.75 m 502.5 427.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 442.75 m 575.5 442.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 429.75 m 575.5 429.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 427.75 m 575.5 427.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 500.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 423.20 500.83 Td (Year Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 488.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 488.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 488.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 488.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 475.32 Td (Balance at beginning of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 475.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 475.32 Td (122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 475.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 475.32 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 475.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 475.32 Td (89) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 461.32 Td (Provision) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 461.32 Td (1,613) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.15 461.32 Td (1,059) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 461.32 Td (773) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 447.32 Td (Utilization) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.80 447.37 Td (\(1,561) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 425.65 447.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.80 447.37 Td (\(1,030) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.65 447.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 447.32 Td (\(769) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 447.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 433.32 Td (Balance at end of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 433.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 433.32 Td (174) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 433.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 433.32 Td (122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 433.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 433.32 Td (93) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 403.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 403.25 Td (1) Tj ET Q q 0 0 0 rg BT 62.94 403.25 Td (1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 67.94 403.25 Td (. INVENT) Tj ET Q q 0 0 0 rg BT 111.65 403.25 Td (ORIES) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 356.75 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 356.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 356.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 356.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 356.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 328.75 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 328.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 328.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 328.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 328.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 300.75 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 300.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 300.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 300.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 300.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 272.75 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 272.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 272.75 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 272.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 272.75 81.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 368.75 m 491.5 368.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 491.5 368.75 m 495.5 368.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 368.75 m 576.5 368.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 356.75 m 491.5 356.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 356.75 m 576.5 356.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 314.75 m 491.5 314.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 301.75 m 491.5 301.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 299.75 m 491.5 299.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 314.75 m 576.5 314.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 301.75 m 576.5 301.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 299.75 m 576.5 299.75 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 469.75 372.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 360.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 442.50 360.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.50 360.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 347.32 Td (Finished goods) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.00 347.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 347.32 Td (310) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 347.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 347.32 Td (381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 333.32 Td (Work in process) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 333.32 Td (988) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 333.32 Td (868) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 319.32 Td (Raw and packaging materials) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 319.32 Td (264) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 319.32 Td (199) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 305.32 Td (Inventories) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.00 305.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 305.32 Td (1,562) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 305.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 305.32 Td (1,448) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 277.32 Td (Inventories) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.00 277.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.15 277.32 Td (1,241) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 277.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 277.32 Td (1,221) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 263.32 Td (Other assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 263.32 Td (321) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 263.32 Td (227) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 235.25 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.03 235.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 86.62 235.25 Td (include ) Tj ET Q q 0 0 0 rg BT 118.31 235.25 Td (inventory ) Tj ET Q q 0 0 0 rg BT 158.90 235.25 Td (pending ) Tj ET Q q 0 0 0 rg BT 193.38 235.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 236.73 235.25 Td (approval ) Tj ET Q q 0 0 0 rg BT 273.98 235.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 284.57 235.25 Td ($54 ) Tj ET Q q 0 0 0 rg BT 301.83 235.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.72 235.25 Td ( ) Tj ET Q q 0 0 0 rg BT 332.98 235.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.46 235.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 400.80 235.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.80 235.25 Td ( ) Tj ET Q q 0 0 0 rg BT 423.07 235.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.76 235.25 Td ($85 ) Tj ET Q q 0 0 0 rg BT 457.03 235.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.92 235.25 Td ( ) Tj ET Q q 0 0 0 rg BT 488.18 235.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.66 235.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 556.00 235.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 223.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.94 223.25 Td (other ) Tj ET Q q 0 0 0 rg BT 75.99 223.25 Td (amounts ) Tj ET Q q 0 0 0 rg BT 112.37 223.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 150.40 223.25 Td (to ) Tj ET Q q 0 0 0 rg BT 160.68 223.25 Td (remain ) Tj ET Q q 0 0 0 rg BT 190.95 223.25 Td (on-hand ) Tj ET Q q 0 0 0 rg BT 226.21 223.25 Td (beyond ) Tj ET Q q 0 0 0 rg BT 258.15 223.25 Td (one ) Tj ET Q q 0 0 0 rg BT 275.09 223.25 Td (year) Tj ET Q q 0 0 0 rg BT 291.75 223.25 Td (.) Tj ET Q endstream endobj 175 0 obj <> endobj 176 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (87) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 749.25 Td (12) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 749.25 Td (. PROPER) Tj ET Q q 0 0 0 rg BT 114.25 749.25 Td (TY) Tj ET Q q 0 0 0 rg BT 127.22 749.25 Td (, PLANT) Tj ET Q q 0 0 0 rg BT 165.93 749.25 Td ( ) Tj ET Q q 0 0 0 rg BT 167.88 749.25 Td (AND EQUIPMENT) Tj ET Q q 0 0 0 rg BT 253.53 749.25 Td ( ) Tj ET Q q 0 0 0 rg BT 255.48 749.25 Td (AND LEASES) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 702.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 702.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 702.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 674.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 674.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 674.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 646.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 646.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 646.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 618.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 618.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 618.75 80.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 714.75 m 492.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 714.75 m 496.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 714.75 m 576.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 702.75 m 492.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 702.75 m 576.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 646.75 m 492.5 646.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 646.75 m 576.5 646.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 618.75 m 492.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 618.75 m 576.5 618.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 605.75 m 492.5 605.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 603.75 m 492.5 603.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 605.75 m 576.5 605.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 603.75 m 576.5 603.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.25 718.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 706.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 706.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 706.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 693.32 Td (Land) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 693.32 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 693.32 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.32 Td (Buildings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 679.32 Td (4,930) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 679.32 Td (4,515) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 665.32 Td (Machinery, equipment and fixtures) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 665.32 Td (3,287) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 665.32 Td (3,347) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 651.32 Td (Construction in progress) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 651.32 Td (849) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 651.32 Td (662) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 637.32 Td (Gross property, plant and equipment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 637.32 Td (9,173) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 637.32 Td (8,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 623.32 Td (Less accumulated depreciation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.80 623.37 Td (\(4,193) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 623.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 623.32 Td (\(4,219) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 623.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 609.32 Td (Property, plant and equipment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 609.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 609.32 Td (4,980) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 609.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 609.32 Td (4,412) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.25 Td (Depreciation ) Tj ET Q q 0 0 0 rg BT 90.14 581.25 Td (expense ) Tj ET Q q 0 0 0 rg BT 124.85 581.25 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 142.90 581.25 Td ($448 ) Tj ET Q q 0 0 0 rg BT 165.40 581.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.29 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 196.79 581.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 207.07 581.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.07 581.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 232.07 581.25 Td ($500 ) Tj ET Q q 0 0 0 rg BT 254.57 581.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 283.46 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 285.96 581.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 296.24 581.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 316.24 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 318.74 581.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.68 581.25 Td ($543 ) Tj ET Q q 0 0 0 rg BT 358.18 581.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.07 581.25 Td ( ) Tj ET Q q 0 0 0 rg BT 389.57 581.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.85 581.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.85 581.25 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.25 Td (Annual ) Tj ET Q q 0 0 0 rg BT 67.97 557.25 Td (minimum ) Tj ET Q q 0 0 0 rg BT 109.39 557.25 Td (rental ) Tj ET Q q 0 0 0 rg BT 134.69 557.25 Td (commitments ) Tj ET Q q 0 0 0 rg BT 191.66 557.25 Td (for ) Tj ET Q q 0 0 0 rg BT 205.85 557.25 Td (non-cancelable ) Tj ET Q q 0 0 0 rg BT 268.90 557.25 Td (operating ) Tj ET Q q 0 0 0 rg BT 309.20 557.25 Td (leases ) Tj ET Q q 0 0 0 rg BT 335.60 557.25 Td (\(primarily ) Tj ET Q q 0 0 0 rg BT 378.68 557.25 Td (real ) Tj ET Q q 0 0 0 rg BT 396.20 557.25 Td (estate ) Tj ET Q q 0 0 0 rg BT 421.49 557.25 Td (and ) Tj ET Q q 0 0 0 rg BT 438.46 557.25 Td (motor ) Tj ET Q q 0 0 0 rg BT 464.88 557.25 Td (vehicles\) ) Tj ET Q q 0 0 0 rg BT 503.50 557.25 Td (are ) Tj ET Q q 0 0 0 rg BT 518.24 557.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.25 Td ($100 ) Tj ET Q q 0 0 0 rg BT 58.66 545.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 87.55 545.25 Td ( ) Tj ET Q q 0 0 0 rg BT 90.22 545.25 Td (in ) Tj ET Q q 0 0 0 rg BT 100.66 545.25 Td (each ) Tj ET Q q 0 0 0 rg BT 121.64 545.25 Td (of ) Tj ET Q q 0 0 0 rg BT 132.63 545.25 Td (the ) Tj ET Q q 0 0 0 rg BT 147.51 545.25 Td (next ) Tj ET Q q 0 0 0 rg BT 167.39 545.25 Td (five ) Tj ET Q q 0 0 0 rg BT 185.60 545.25 Td (years ) Tj ET Q q 0 0 0 rg BT 209.36 545.25 Td (and ) Tj ET Q q 0 0 0 rg BT 226.46 545.25 Td (an ) Tj ET Q q 0 0 0 rg BT 238.56 545.25 Td (aggregate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 280.08 545.25 Td ($300 ) Tj ET Q q 0 0 0 rg BT 302.75 545.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.64 545.25 Td ( ) Tj ET Q q 0 0 0 rg BT 334.30 545.25 Td (thereafter) Tj ET Q q 0 0 0 rg BT 372.05 545.25 Td (. ) Tj ET Q q 0 0 0 rg BT 377.21 545.25 Td (Operating ) Tj ET Q q 0 0 0 rg BT 419.86 545.25 Td (lease ) Tj ET Q q 0 0 0 rg BT 442.51 545.25 Td (expense ) Tj ET Q q 0 0 0 rg BT 477.38 545.25 Td (was ) Tj ET Q q 0 0 0 rg BT 495.59 545.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.01 545.25 Td ($145 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 533.25 Td ( ) Tj ET Q q 0 0 0 rg BT 68.16 533.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.22 533.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 99.22 533.25 Td ( ) Tj ET Q q 0 0 0 rg BT 102.49 533.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 120.20 533.25 Td ($140 ) Tj ET Q q 0 0 0 rg BT 143.47 533.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 172.36 533.25 Td ( ) Tj ET Q q 0 0 0 rg BT 175.64 533.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 186.69 533.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 206.69 533.25 Td ( ) Tj ET Q q 0 0 0 rg BT 209.96 533.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 227.67 533.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.67 533.25 Td (. ) Tj ET Q q 0 0 0 rg BT 253.45 533.25 Td (Sublease ) Tj ET Q q 0 0 0 rg BT 292.27 533.25 Td (income ) Tj ET Q q 0 0 0 rg BT 324.97 533.25 Td (and ) Tj ET Q q 0 0 0 rg BT 342.68 533.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 372.61 533.25 Td (lease ) Tj ET Q q 0 0 0 rg BT 395.87 533.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 443.58 533.25 Td (were ) Tj ET Q q 0 0 0 rg BT 466.28 533.25 Td (not ) Tj ET Q q 0 0 0 rg BT 482.33 533.25 Td (material ) Tj ET Q q 0 0 0 rg BT 518.37 533.25 Td (for ) Tj ET Q q 0 0 0 rg BT 533.30 533.25 Td (all ) Tj ET Q q 0 0 0 rg BT 546.57 533.25 Td (periods ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (presented.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 495.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 495.25 Td (13) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 495.25 Td (. GOODWILL) Tj ET Q q 0 0 0 rg BT 130.73 495.25 Td ( ) Tj ET Q q 0 0 0 rg BT 132.67 495.25 Td (AND OTHER INT) Tj ET Q q 0 0 0 rg BT 212.50 495.25 Td (ANGIBLE ) Tj ET Q q 0 0 0 rg BT 260.57 495.25 Td (ASSETS) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 441.75 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 350.50 441.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 441.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 441.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 441.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 441.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 441.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 415.75 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 350.50 415.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 415.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 415.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 415.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 415.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 415.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 389.75 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 350.50 389.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 389.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 389.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 389.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 389.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 389.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 363.75 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 350.50 363.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 363.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 363.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 363.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 363.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 363.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 337.75 315.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 350.50 337.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 354.50 337.75 55.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 337.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 337.75 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 337.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 337.75 79.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 460.75 m 492.5 460.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 460.75 m 496.5 460.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 460.75 m 575.5 460.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 354.5 441.75 m 409.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 441.75 m 492.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 441.75 m 575.5 441.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 350.75 m 492.5 350.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 350.75 m 575.5 350.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 324.75 m 492.5 324.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 324.75 m 575.5 324.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 312.75 m 492.5 312.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 310.75 m 492.5 310.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 312.75 m 575.5 312.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 310.75 m 575.5 310.75 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 470.75 464.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 446.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 364.15 452.83 Td (Estimated) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 360.50 444.83 Td (Useful Lives) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 445.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.50 445.98 Td (2015) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 432.48 Td (Goodwill) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 432.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 432.32 Td (6,875) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 432.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 432.32 Td (6,881) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 38.00 406.48 Td (Other intangible assets:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 393.32 Td (Licenses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.40 393.32 Td (5 – 15 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 393.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 393.32 Td (564) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 393.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 393.32 Td (574) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 380.32 Td (Developed technology rights) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.40 380.32 Td (9 – 15 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 380.32 Td (2,357) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 380.32 Td (2,357) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 367.32 Td (Capitalized software) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.40 367.32 Td (3 – 10 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 367.32 Td (1,441) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 367.32 Td (1,302) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 354.32 Td (IPRD) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 354.32 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 354.32 Td (120) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 341.32 Td (Gross other intangible assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 341.32 Td (4,469) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 341.32 Td (4,353) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 328.32 Td (Less accumulated amortization) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.80 328.37 Td (\(3,084) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 328.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.80 328.32 Td (\(2,934) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 328.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.00 315.32 Td (Total other intangible assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 315.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 315.32 Td (1,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 315.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 549.15 315.32 Td (1,419) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 288.25 Td (Amortization ) Tj ET Q q 0 0 0 rg BT 91.44 288.25 Td (expense ) Tj ET Q q 0 0 0 rg BT 125.77 288.25 Td (of ) Tj ET Q q 0 0 0 rg BT 136.22 288.25 Td (other ) Tj ET Q q 0 0 0 rg BT 158.89 288.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 201.00 288.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 226.45 288.25 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 244.12 288.25 Td ($178 ) Tj ET Q q 0 0 0 rg BT 266.24 288.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.13 288.25 Td ( ) Tj ET Q q 0 0 0 rg BT 297.25 288.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.15 288.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.15 288.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.77 288.25 Td ($183 ) Tj ET Q q 0 0 0 rg BT 353.89 288.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.79 288.25 Td ( ) Tj ET Q q 0 0 0 rg BT 384.91 288.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.80 288.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.80 288.25 Td ( ) Tj ET Q q 0 0 0 rg BT 416.93 288.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.48 288.25 Td ($286 ) Tj ET Q q 0 0 0 rg BT 455.60 288.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.50 288.25 Td ( ) Tj ET Q q 0 0 0 rg BT 486.62 288.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.52 288.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.52 288.25 Td (. ) Tj ET Q q 0 0 0 rg BT 521.14 288.25 Td (Future ) Tj ET Q q 0 0 0 rg BT 549.37 288.25 Td (annual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 276.25 Td (amortization ) Tj ET Q q 0 0 0 rg BT 88.57 276.25 Td (expense ) Tj ET Q q 0 0 0 rg BT 122.81 276.25 Td (of ) Tj ET Q q 0 0 0 rg BT 133.17 276.25 Td (other ) Tj ET Q q 0 0 0 rg BT 155.75 276.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 197.77 276.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 223.14 276.25 Td (is ) Tj ET Q q 0 0 0 rg BT 231.84 276.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 269.41 276.25 Td (to ) Tj ET Q q 0 0 0 rg BT 279.22 276.25 Td (be ) Tj ET Q q 0 0 0 rg BT 290.69 276.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 350.48 276.25 Td ($220 ) Tj ET Q q 0 0 0 rg BT 372.51 276.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.40 276.25 Td ( ) Tj ET Q q 0 0 0 rg BT 403.44 276.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.25 276.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.25 276.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.78 276.25 Td ($200 ) Tj ET Q q 0 0 0 rg BT 459.81 276.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.70 276.25 Td ( ) Tj ET Q q 0 0 0 rg BT 490.74 276.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.55 276.25 Td (2018) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.55 276.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.08 276.25 Td ($170 ) Tj ET Q q 0 0 0 rg BT 547.11 276.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 264.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.86 264.25 Td (2019) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.86 264.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.44 264.25 Td ($130 ) Tj ET Q q 0 0 0 rg BT 95.52 264.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 124.41 264.25 Td ( ) Tj ET Q q 0 0 0 rg BT 127.49 264.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 138.35 264.25 Td (2020) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 158.35 264.25 Td (, ) Tj ET Q q 0 0 0 rg BT 163.93 264.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.45 264.25 Td ($100 ) Tj ET Q q 0 0 0 rg BT 204.54 264.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 233.43 264.25 Td ( ) Tj ET Q q 0 0 0 rg BT 236.51 264.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.37 264.25 Td (2021) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.37 264.25 Td (. ) Tj ET Q q 0 0 0 rg BT 272.95 264.25 Td (Other ) Tj ET Q q 0 0 0 rg BT 298.80 264.25 Td (intangible ) Tj ET Q q 0 0 0 rg BT 341.87 264.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 364.39 264.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 413.57 264.25 Td (char) Tj ET Q q 0 0 0 rg BT 430.59 264.25 Td (ges ) Tj ET Q q 0 0 0 rg BT 447.01 264.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.52 264.25 Td ($33 ) Tj ET Q q 0 0 0 rg BT 487.60 264.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 516.49 264.25 Td ( ) Tj ET Q q 0 0 0 rg BT 519.57 264.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 530.43 264.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.43 264.25 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.01 264.25 Td ($181 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 252.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 64.89 252.25 Td ( ) Tj ET Q q 0 0 0 rg BT 67.39 252.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 77.67 252.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 97.67 252.25 Td ( ) Tj ET Q q 0 0 0 rg BT 100.17 252.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 117.11 252.25 Td ($380 ) Tj ET Q q 0 0 0 rg BT 139.61 252.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 168.50 252.25 Td ( ) Tj ET Q q 0 0 0 rg BT 171.00 252.25 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.28 252.25 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 201.28 252.25 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 228.25 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 228.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 44.42 228.25 Td ($160 ) Tj ET Q q 0 0 0 rg BT 66.17 228.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 95.06 228.25 Td ( ) Tj ET Q q 0 0 0 rg BT 96.81 228.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 121.35 228.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 169.20 228.25 Td (char) Tj ET Q q 0 0 0 rg BT 186.22 228.25 Td (ge ) Tj ET Q q 0 0 0 rg BT 197.41 228.25 Td (was ) Tj ET Q q 0 0 0 rg BT 214.71 228.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 260.33 228.25 Td (in ) Tj ET Q q 0 0 0 rg BT 269.85 228.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 291.61 228.25 Td (for ) Tj ET Q q 0 0 0 rg BT 305.02 228.25 Td (BMS-986020 ) Tj ET Q q 0 0 0 rg BT 361.22 228.25 Td (\(LP) Tj ET Q q 0 0 0 rg BT 375.30 228.25 Td (A1 ) Tj ET Q q 0 0 0 rg BT 388.89 228.25 Td (Antagonist\) ) Tj ET Q q 0 0 0 rg BT 437.85 228.25 Td (which ) Tj ET Q q 0 0 0 rg BT 464.04 228.25 Td (was ) Tj ET Q q 0 0 0 rg BT 481.35 228.25 Td (in ) Tj ET Q q 0 0 0 rg BT 490.88 228.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 515.96 228.25 Td (II ) Tj ET Q q 0 0 0 rg BT 524.37 228.25 Td (development ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 216.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.13 216.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 90.36 216.25 Td (of ) Tj ET Q q 0 0 0 rg BT 101.16 216.25 Td (IPF) Tj ET Q q 0 0 0 rg BT 114.81 216.25 Td (. ) Tj ET Q q 0 0 0 rg BT 119.60 216.25 Td (The ) Tj ET Q q 0 0 0 rg BT 137.62 216.25 Td (full ) Tj ET Q q 0 0 0 rg BT 153.97 216.25 Td (write-of) Tj ET Q q 0 0 0 rg BT 186.00 216.25 Td (f ) Tj ET Q q 0 0 0 rg BT 191.80 216.25 Td (was ) Tj ET Q q 0 0 0 rg BT 209.82 216.25 Td (required ) Tj ET Q q 0 0 0 rg BT 245.61 216.25 Td (after ) Tj ET Q q 0 0 0 rg BT 266.39 216.25 Td (considering ) Tj ET Q q 0 0 0 rg BT 315.52 216.25 Td (the ) Tj ET Q q 0 0 0 rg BT 330.20 216.25 Td (occurrence ) Tj ET Q q 0 0 0 rg BT 376.53 216.25 Td (of ) Tj ET Q q 0 0 0 rg BT 387.33 216.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 417.00 216.25 Td (adverse ) Tj ET Q q 0 0 0 rg BT 450.00 216.25 Td (events, ) Tj ET Q q 0 0 0 rg BT 480.52 216.25 Td (voluntary ) Tj ET Q q 0 0 0 rg BT 521.32 216.25 Td (suspension ) Tj ET Q q 0 0 0 rg BT 567.68 216.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 204.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.18 204.25 Td (study ) Tj ET Q q 0 0 0 rg BT 75.82 204.25 Td (and ) Tj ET Q q 0 0 0 rg BT 93.22 204.25 Td (an ) Tj ET Q q 0 0 0 rg BT 105.63 204.25 Td (internal ) Tj ET Q q 0 0 0 rg BT 139.14 204.25 Td (assessment ) Tj ET Q q 0 0 0 rg BT 186.54 204.25 Td (indicating ) Tj ET Q q 0 0 0 rg BT 229.50 204.25 Td (a ) Tj ET Q q 0 0 0 rg BT 236.90 204.25 Td (significantly ) Tj ET Q q 0 0 0 rg BT 289.86 204.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 315.59 204.25 Td (likelihood ) Tj ET Q q 0 0 0 rg BT 359.11 204.25 Td (of ) Tj ET Q q 0 0 0 rg BT 370.41 204.25 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 414.47 204.25 Td (and ) Tj ET Q q 0 0 0 rg BT 431.87 204.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 482.04 204.25 Td (success. ) Tj ET Q q 0 0 0 rg BT 517.49 204.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 541.58 204.25 Td (acquired ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 192.25 Td (BMS-986020 ) Tj ET Q q 0 0 0 rg BT 92.98 192.25 Td (with ) Tj ET Q q 0 0 0 rg BT 113.28 192.25 Td (its ) Tj ET Q q 0 0 0 rg BT 125.26 192.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 171.67 192.25 Td (of ) Tj ET Q q 0 0 0 rg BT 181.96 192.25 Td (Amira ) Tj ET Q q 0 0 0 rg BT 210.04 192.25 Td (Pharmaceuticals, ) Tj ET Q q 0 0 0 rg BT 280.59 192.25 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 298.38 192.25 Td (in ) Tj ET Q q 0 0 0 rg BT 308.69 192.25 Td (201) Tj ET Q q 0 0 0 rg BT 323.32 192.25 Td (1. ) Tj ET Q q 0 0 0 rg BT 333.34 192.25 Td (In ) Tj ET Q q 0 0 0 rg BT 344.20 192.25 Td (addition, ) Tj ET Q q 0 0 0 rg BT 382.00 192.25 Td (a ) Tj ET Q q 0 0 0 rg BT 388.96 192.25 Td (contingent ) Tj ET Q q 0 0 0 rg BT 433.70 192.25 Td (consideration ) Tj ET Q q 0 0 0 rg BT 490.10 192.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 523.73 192.25 Td (of ) Tj ET Q q 0 0 0 rg BT 534.59 192.25 Td ($8 ) Tj ET Q q 0 0 0 rg BT 547.11 192.25 Td (million ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 180.25 Td (related ) Tj ET Q q 0 0 0 rg BT 65.70 180.25 Td (to ) Tj ET Q q 0 0 0 rg BT 75.98 180.25 Td (the ) Tj ET Q q 0 0 0 rg BT 90.70 180.25 Td (acquisition ) Tj ET Q q 0 0 0 rg BT 137.08 180.25 Td (was ) Tj ET Q q 0 0 0 rg BT 155.13 180.25 Td (also ) Tj ET Q q 0 0 0 rg BT 173.74 180.25 Td (reversed ) Tj ET Q q 0 0 0 rg BT 210.11 180.25 Td (because ) Tj ET Q q 0 0 0 rg BT 244.25 180.25 Td (of ) Tj ET Q q 0 0 0 rg BT 255.08 180.25 Td (the ) Tj ET Q q 0 0 0 rg BT 269.80 180.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 295.07 180.25 Td (likelihood ) Tj ET Q q 0 0 0 rg BT 338.12 180.25 Td (of ) Tj ET Q q 0 0 0 rg BT 348.95 180.25 Td (success.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 156.25 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 156.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.96 156.25 Td ($310 ) Tj ET Q q 0 0 0 rg BT 69.25 156.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.15 156.25 Td ( ) Tj ET Q q 0 0 0 rg BT 101.44 156.25 Td (IPRD ) Tj ET Q q 0 0 0 rg BT 127.51 156.25 Td (impairment ) Tj ET Q q 0 0 0 rg BT 176.91 156.25 Td (char) Tj ET Q q 0 0 0 rg BT 193.93 156.25 Td (ge ) Tj ET Q q 0 0 0 rg BT 206.66 156.25 Td (was ) Tj ET Q q 0 0 0 rg BT 225.51 156.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 272.66 156.25 Td (in ) Tj ET Q q 0 0 0 rg BT 283.73 156.25 Td (2014 ) Tj ET Q q 0 0 0 rg BT 307.03 156.25 Td (for ) Tj ET Q q 0 0 0 rg BT 321.98 156.25 Td (peginterferon ) Tj ET Q q 0 0 0 rg BT 379.13 156.25 Td (lambda ) Tj ET Q q 0 0 0 rg BT 411.86 156.25 Td (which ) Tj ET Q q 0 0 0 rg BT 439.59 156.25 Td (was ) Tj ET Q q 0 0 0 rg BT 458.43 156.25 Td (in ) Tj ET Q q 0 0 0 rg BT 469.50 156.25 Td (Phase ) Tj ET Q q 0 0 0 rg BT 496.13 156.25 Td (III ) Tj ET Q q 0 0 0 rg BT 509.41 156.25 Td (development ) Tj ET Q q 0 0 0 rg BT 564.35 156.25 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 144.25 Td (treatment ) Tj ET Q q 0 0 0 rg BT 76.53 144.25 Td (of ) Tj ET Q q 0 0 0 rg BT 87.63 144.25 Td (HCV) Tj ET Q q 0 0 0 rg BT 107.46 144.25 Td (. ) Tj ET Q q 0 0 0 rg BT 112.53 144.25 Td (The ) Tj ET Q q 0 0 0 rg BT 130.85 144.25 Td (full ) Tj ET Q q 0 0 0 rg BT 147.51 144.25 Td (write-of) Tj ET Q q 0 0 0 rg BT 179.53 144.25 Td (f ) Tj ET Q q 0 0 0 rg BT 185.64 144.25 Td (was ) Tj ET Q q 0 0 0 rg BT 203.96 144.25 Td (required ) Tj ET Q q 0 0 0 rg BT 240.05 144.25 Td (after ) Tj ET Q q 0 0 0 rg BT 261.14 144.25 Td (assessing ) Tj ET Q q 0 0 0 rg BT 301.13 144.25 Td (the ) Tj ET Q q 0 0 0 rg BT 316.12 144.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 353.88 144.25 Td (commercial ) Tj ET Q q 0 0 0 rg BT 403.85 144.25 Td (viability ) Tj ET Q q 0 0 0 rg BT 439.96 144.25 Td (of ) Tj ET Q q 0 0 0 rg BT 451.06 144.25 Td (the ) Tj ET Q q 0 0 0 rg BT 466.05 144.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 488.26 144.25 Td (and ) Tj ET Q q 0 0 0 rg BT 505.47 144.25 Td (estimating ) Tj ET Q q 0 0 0 rg BT 549.90 144.25 Td (its ) Tj ET Q q 0 0 0 rg BT 562.12 144.25 Td (fair ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 132.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 62.71 132.25 Td (The ) Tj ET Q q 0 0 0 rg BT 81.00 132.25 Td (assessment ) Tj ET Q q 0 0 0 rg BT 128.19 132.25 Td (considered ) Tj ET Q q 0 0 0 rg BT 174.26 132.25 Td (the ) Tj ET Q q 0 0 0 rg BT 189.23 132.25 Td (lower ) Tj ET Q q 0 0 0 rg BT 214.75 132.25 Td (likelihood ) Tj ET Q q 0 0 0 rg BT 258.05 132.25 Td (of ) Tj ET Q q 0 0 0 rg BT 269.13 132.25 Td (filing ) Tj ET Q q 0 0 0 rg BT 293.54 132.25 Td (for ) Tj ET Q q 0 0 0 rg BT 307.95 132.25 Td (registration ) Tj ET Q q 0 0 0 rg BT 356.25 132.25 Td (in ) Tj ET Q q 0 0 0 rg BT 366.78 132.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 396.73 132.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 431.13 132.25 Td (after ) Tj ET Q q 0 0 0 rg BT 452.20 132.25 Td (completing ) Tj ET Q q 0 0 0 rg BT 499.94 132.25 Td (revised ) Tj ET Q q 0 0 0 rg BT 531.57 132.25 Td (projections ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 120.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.27 120.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 83.74 120.25 Td (and ) Tj ET Q q 0 0 0 rg BT 100.12 120.25 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 140.67 120.25 Td (A) Tj ET Q q 0 0 0 rg BT 147.34 120.25 Td ( ) Tj ET Q q 0 0 0 rg BT 149.28 120.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 193.43 120.25 Td (decline ) Tj ET Q q 0 0 0 rg BT 224.24 120.25 Td (from ) Tj ET Q q 0 0 0 rg BT 245.61 120.25 Td (prior ) Tj ET Q q 0 0 0 rg BT 266.99 120.25 Td (projected ) Tj ET Q q 0 0 0 rg BT 306.13 120.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 343.61 120.25 Td (resulted ) Tj ET Q q 0 0 0 rg BT 377.20 120.25 Td (from ) Tj ET Q q 0 0 0 rg BT 398.58 120.25 Td (the ) Tj ET Q q 0 0 0 rg BT 412.73 120.25 Td (global ) Tj ET Q q 0 0 0 rg BT 439.67 120.25 Td (introduction ) Tj ET Q q 0 0 0 rg BT 490.49 120.25 Td (of ) Tj ET Q q 0 0 0 rg BT 500.76 120.25 Td (oral ) Tj ET Q q 0 0 0 rg BT 518.24 120.25 Td (non-interferon ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 108.25 Td (products ) Tj ET Q q 0 0 0 rg BT 72.94 108.25 Td (being ) Tj ET Q q 0 0 0 rg BT 97.66 108.25 Td (used ) Tj ET Q q 0 0 0 rg BT 118.49 108.25 Td (to ) Tj ET Q q 0 0 0 rg BT 128.76 108.25 Td (treat ) Tj ET Q q 0 0 0 rg BT 149.03 108.25 Td (patients ) Tj ET Q q 0 0 0 rg BT 182.63 108.25 Td (with ) Tj ET Q q 0 0 0 rg BT 202.91 108.25 Td (HCV) Tj ET Q q 0 0 0 rg BT 223.84 108.25 Td ( ) Tj ET Q q 0 0 0 rg BT 226.34 108.25 Td (and ) Tj ET Q q 0 0 0 rg BT 243.28 108.25 Td (no ) Tj ET Q q 0 0 0 rg BT 255.78 108.25 Td (other ) Tj ET Q q 0 0 0 rg BT 278.83 108.25 Td (alternative ) Tj ET Q q 0 0 0 rg BT 323.52 108.25 Td (uses ) Tj ET Q q 0 0 0 rg BT 343.25 108.25 Td (for ) Tj ET Q q 0 0 0 rg BT 357.41 108.25 Td (the ) Tj ET Q q 0 0 0 rg BT 372.12 108.25 Td (product.) Tj ET Q endstream endobj 177 0 obj <> endobj 178 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (88) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 749.25 Td (14) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 749.25 Td (. ) Tj ET Q q 0 0 0 rg BT 72.94 749.25 Td (ACCRUED LIABILITIES) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 702.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 702.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 702.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 702.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 674.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 674.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 674.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 674.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 646.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 646.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 646.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 646.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 618.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 618.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 618.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 618.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 590.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 590.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 590.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 590.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 590.75 80.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 562.75 373.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 562.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 562.75 79.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 562.75 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 562.75 80.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 714.75 m 492.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 714.75 m 496.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 714.75 m 576.5 714.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 702.75 m 492.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 702.75 m 576.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 702.75 m 492.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 702.75 m 576.5 702.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 562.75 m 492.5 562.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 562.75 m 576.5 562.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 549.75 m 492.5 549.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 547.75 m 492.5 547.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 549.75 m 576.5 549.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 547.75 m 576.5 547.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 718.70 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 471.25 718.83 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 706.70 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 706.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 706.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 693.32 Td (Accrued rebates and returns) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 693.32 Td (1,680) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 693.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 693.32 Td (1,324) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.32 Td (Employee compensation and benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 679.32 Td (818) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 679.32 Td (904) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 665.32 Td (Accrued research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 665.32 Td (718) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 665.32 Td (553) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 651.32 Td (Dividends payable) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 651.32 Td (660) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 651.32 Td (655) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 637.32 Td (Royalties) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 637.32 Td (246) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 637.32 Td (161) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 623.32 Td (Branded Prescription Drug Fee) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 623.32 Td (234) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 623.32 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 609.32 Td (Restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 609.32 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 609.32 Td (89) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 595.32 Td (Pension and postretirement benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 595.32 Td (44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 595.32 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 581.32 Td (Litigation and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 581.32 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 581.32 Td (189) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 567.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 567.32 Td (738) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 567.32 Td (704) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 553.32 Td (Total accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 553.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 553.32 Td (5,271) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 553.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 553.32 Td (4,738) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 523.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 523.25 Td (15) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 523.25 Td (. EQUITY) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 475.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 475.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 475.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 475.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 475.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 475.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 475.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 475.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 475.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 475.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 445.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 445.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 445.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 445.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 445.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 445.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 445.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 445.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 445.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 445.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 415.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 415.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 415.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 415.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 415.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 415.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 415.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 415.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 415.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 415.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 385.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 385.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 385.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 385.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 385.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 385.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 385.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 385.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 385.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 385.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 355.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 355.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 355.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 355.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 355.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 355.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 355.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 355.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 355.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 355.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 325.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 325.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 325.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 325.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 325.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 325.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 325.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 325.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 325.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 325.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 295.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 295.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 295.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 295.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 295.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 295.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 295.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 295.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 295.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 295.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 265.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 265.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 265.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 265.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 265.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 265.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 265.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 265.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 265.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 265.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 235.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 235.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 235.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 235.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 235.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 235.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 235.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 235.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 235.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 235.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 205.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 205.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 205.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 205.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 205.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 205.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 205.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 205.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 205.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 205.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 175.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 175.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 175.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 175.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 175.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 175.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 175.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 175.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 175.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 175.75 61.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 145.75 134.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 170.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 174.50 145.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 207.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 211.50 145.75 43.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 254.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 258.50 145.75 54.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 312.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 316.50 145.75 60.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 145.75 41.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 421.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 425.50 145.75 33.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 458.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 462.50 145.75 49.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 145.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 515.50 145.75 61.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 499.75 m 207.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 207.5 499.75 m 211.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 499.75 m 254.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 499.75 m 458.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 458.5 499.75 m 462.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 499.75 m 511.5 499.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 475.75 m 207.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 475.75 m 254.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 475.75 m 312.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 475.75 m 421.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 475.75 m 458.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 475.75 m 511.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 475.75 m 576.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 475.75 m 376.5 475.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 355.75 m 207.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 355.75 m 254.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 355.75 m 312.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 355.75 m 421.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 355.75 m 458.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 355.75 m 511.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 355.75 m 576.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 355.75 m 376.5 355.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 250.75 m 207.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 250.75 m 254.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 250.75 m 312.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 250.75 m 421.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 250.75 m 458.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 250.75 m 511.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 250.75 m 576.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 250.75 m 376.5 250.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 145.75 m 207.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 145.75 m 254.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 145.75 m 312.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 145.75 m 421.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 145.75 m 458.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 145.75 m 511.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 145.75 m 576.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 131.75 m 207.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 174.5 129.75 m 207.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 131.75 m 254.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 211.5 129.75 m 254.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 131.75 m 312.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 258.5 129.75 m 312.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 145.75 m 376.5 145.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 131.75 m 376.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 316.5 129.75 m 376.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 131.75 m 421.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 129.75 m 421.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 131.75 m 458.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 425.5 129.75 m 458.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 131.75 m 511.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 462.5 129.75 m 511.5 129.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 131.75 m 576.5 131.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 515.5 129.75 m 576.5 129.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 504.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 187.65 503.98 Td (Common Stock) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 267.95 503.98 Td (Capital in  ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 273.65 495.98 Td (Excess) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 263.95 487.98 Td (of Par) Tj ET Q q 0 0 0 rg BT 284.91 487.98 Td ( ) Tj ET Q q 0 0 0 rg BT 286.76 487.98 Td (V) Tj ET Q q 0 0 0 rg BT 291.81 487.98 Td (alue) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 271.10 479.98 Td (of Stock) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 323.30 503.98 Td (Accumulated) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 335.85 495.98 Td (Other) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 319.40 487.98 Td (Comprehensive) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 338.20 479.98 Td (Loss) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 385.15 487.98 Td (Retained) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.90 479.98 Td (Earnings) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 442.00 503.98 Td (Treasury Stock) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 519.75 487.98 Td (Noncontr) Tj ET Q q 0 0 0 rg BT 552.05 487.98 Td (olling) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.20 479.98 Td (Inter) Tj ET Q q 0 0 0 rg BT 549.38 479.98 Td (est) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 480.00 Td (Dollars and Shares in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 179.00 479.98 Td (Shares) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 215.75 479.98 Td (Par Value) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 430.00 479.98 Td (Shares) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 478.70 479.98 Td (Cost        ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 466.32 Td (Balance at January 1, 2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.10 465.42 Td (2,208) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.65 465.42 Td (221) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 261.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.15 465.42 Td (1,922) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 319.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.80 465.47 Td (\(2,141) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 465.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.10 465.42 Td (32,952) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.60 465.42 Td (559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.80 465.47 Td (\(17,800) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 465.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 465.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 465.42 Td (82) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 451.32 Td (Net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.10 450.42 Td (2,004) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 450.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 450.42 Td (39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 436.32 Td (Other comprehensive loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.30 435.47 Td (\(284) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 435.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 435.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 421.32 Td (Cash dividends) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.80 420.47 Td (\(2,415) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 420.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 420.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 406.32 Td (Stock compensation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 405.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 405.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 290.30 405.47 Td (\(393) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.65 405.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 405.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 405.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.30 405.47 Td (\(11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 405.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 405.42 Td (755) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 405.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 391.32 Td (Debt conversion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 390.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 390.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.30 390.47 Td (\(22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.65 390.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 390.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 390.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.30 390.47 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 390.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 390.42 Td (53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 390.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 376.32 Td (Variable interest entity) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 375.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 375.42 Td (59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 361.32 Td (Distributions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 360.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 360.42 Td (\(49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 360.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 346.32 Td (Balance at December 31, 2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.10 345.42 Td (2,208) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.65 345.42 Td (221) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.15 345.42 Td (1,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.80 345.47 Td (\(2,425) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 345.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.10 345.42 Td (32,541) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.60 345.42 Td (547) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.80 345.47 Td (\(16,992) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 345.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 345.42 Td (131) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 331.32 Td (Net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.10 330.42 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 330.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 330.42 Td (84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 316.32 Td (Other comprehensive loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.30 315.47 Td (\(43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 315.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 315.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 301.32 Td (Cash dividends) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.80 300.47 Td (\(2,493) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 300.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 300.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 286.32 Td (Stock compensation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 285.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 285.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.30 285.47 Td (\(48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 308.65 285.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 285.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 285.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.30 285.47 Td (\(8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 285.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 492.65 285.42 Td (431) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 285.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 271.32 Td (Debt conversion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.65 270.42 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 270.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 256.32 Td (Distributions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 255.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 255.42 Td (\(57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 255.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 241.32 Td (Balance at December 31, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.10 240.42 Td (2,208) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.65 240.42 Td (221) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.15 240.42 Td (1,459) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.80 240.47 Td (\(2,468) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 240.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.10 240.42 Td (31,613) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.60 240.42 Td (539) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.80 240.47 Td (\(16,559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 240.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 240.42 Td (158) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 226.32 Td (Net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.10 225.42 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 225.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 225.42 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 211.32 Td (Other comprehensive loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.30 210.47 Td (\(35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 210.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 210.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 196.32 Td (Cash dividends) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.80 195.47 Td (\(2,557) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 195.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 195.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 181.32 Td (Stock repurchase program) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 449.65 180.42 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.30 180.47 Td (\(231) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 180.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 180.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 166.32 Td (Stock compensation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 165.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 165.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 293.65 165.42 Td (266) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 165.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 165.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.30 165.47 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.65 165.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 165.42 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 165.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 151.32 Td (Distributions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 193.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.65 150.42 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 150.42 Td (\(38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 150.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 136.32 Td (Balance at December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 181.10 135.42 Td (2,208) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 214.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 235.65 135.42 Td (221) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 261.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.15 135.42 Td (1,725) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 319.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.80 135.47 Td (\(2,503) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 135.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.10 135.42 Td (33,513) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.60 135.42 Td (536) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.80 135.47 Td (\(16,779) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 135.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.00 135.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 135.42 Td (170) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 112.05 Td (T) Tj ET Q q 0 0 0 rg BT 41.76 112.05 Td (reasury ) Tj ET Q q 0 0 0 rg BT 73.62 112.05 Td (stock ) Tj ET Q q 0 0 0 rg BT 97.16 112.05 Td (is ) Tj ET Q q 0 0 0 rg BT 106.26 112.05 Td (recognized ) Tj ET Q q 0 0 0 rg BT 152.55 112.05 Td (at ) Tj ET Q q 0 0 0 rg BT 162.20 112.05 Td (the ) Tj ET Q q 0 0 0 rg BT 176.84 112.05 Td (cost ) Tj ET Q q 0 0 0 rg BT 195.38 112.05 Td (to ) Tj ET Q q 0 0 0 rg BT 205.59 112.05 Td (reacquire ) Tj ET Q q 0 0 0 rg BT 245.21 112.05 Td (the ) Tj ET Q q 0 0 0 rg BT 259.86 112.05 Td (shares. ) Tj ET Q q 0 0 0 rg BT 289.78 112.05 Td (Shares ) Tj ET Q q 0 0 0 rg BT 318.87 112.05 Td (issued ) Tj ET Q q 0 0 0 rg BT 346.30 112.05 Td (from ) Tj ET Q q 0 0 0 rg BT 368.17 112.05 Td (treasury ) Tj ET Q q 0 0 0 rg BT 402.81 112.05 Td (are ) Tj ET Q q 0 0 0 rg BT 417.45 112.05 Td (recognized ) Tj ET Q q 0 0 0 rg BT 463.74 112.05 Td (utilizing ) Tj ET Q q 0 0 0 rg BT 499.50 112.05 Td (the ) Tj ET Q q 0 0 0 rg BT 514.15 112.05 Td (first-in ) Tj ET Q q 0 0 0 rg BT 543.80 112.05 Td (first-out ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 100.05 Td (method.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 78.45 Td (In ) Tj ET Q q 0 0 0 rg BT 46.12 78.45 Td (October ) Tj ET Q q 0 0 0 rg BT 80.11 78.45 Td (2016, ) Tj ET Q q 0 0 0 rg BT 104.40 78.45 Td (the ) Tj ET Q q 0 0 0 rg BT 118.40 78.45 Td (Board ) Tj ET Q q 0 0 0 rg BT 144.63 78.45 Td (of ) Tj ET Q q 0 0 0 rg BT 154.75 78.45 Td (Directors ) Tj ET Q q 0 0 0 rg BT 193.74 78.45 Td (approved ) Tj ET Q q 0 0 0 rg BT 232.73 78.45 Td (a ) Tj ET Q q 0 0 0 rg BT 238.96 78.45 Td (new ) Tj ET Q q 0 0 0 rg BT 257.41 78.45 Td (share ) Tj ET Q q 0 0 0 rg BT 280.29 78.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 325.38 78.45 Td (program ) Tj ET Q q 0 0 0 rg BT 361.05 78.45 Td (authorizing ) Tj ET Q q 0 0 0 rg BT 408.38 78.45 Td (the ) Tj ET Q q 0 0 0 rg BT 422.38 78.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 467.47 78.45 Td (of ) Tj ET Q q 0 0 0 rg BT 477.59 78.45 Td (an ) Tj ET Q q 0 0 0 rg BT 488.82 78.45 Td (additional ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 530.59 78.45 Td ($3.0 ) Tj ET Q q 0 0 0 rg BT 549.88 78.45 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 576.00 78.45 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 66.45 Td (of ) Tj ET Q q 0 0 0 rg BT 46.53 66.45 Td (common ) Tj ET Q q 0 0 0 rg BT 83.73 66.45 Td (stock. ) Tj ET Q q 0 0 0 rg BT 109.54 66.45 Td (Repurchases ) Tj ET Q q 0 0 0 rg BT 162.28 66.45 Td (may ) Tj ET Q q 0 0 0 rg BT 181.70 66.45 Td (be ) Tj ET Q q 0 0 0 rg BT 193.34 66.45 Td (made ) Tj ET Q q 0 0 0 rg BT 217.20 66.45 Td (either ) Tj ET Q q 0 0 0 rg BT 242.16 66.45 Td (in ) Tj ET Q q 0 0 0 rg BT 252.14 66.45 Td (the ) Tj ET Q q 0 0 0 rg BT 266.56 66.45 Td (open ) Tj ET Q q 0 0 0 rg BT 288.20 66.45 Td (market ) Tj ET Q q 0 0 0 rg BT 318.17 66.45 Td (or ) Tj ET Q q 0 0 0 rg BT 328.70 66.45 Td (through ) Tj ET Q q 0 0 0 rg BT 362.01 66.45 Td (private ) Tj ET Q q 0 0 0 rg BT 391.98 66.45 Td (transactions, ) Tj ET Q q 0 0 0 rg BT 444.44 66.45 Td (including ) Tj ET Q q 0 0 0 rg BT 484.42 66.45 Td (under ) Tj ET Q q 0 0 0 rg BT 509.39 66.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 554.90 66.45 Td (plans ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 54.45 Td (established ) Tj ET Q q 0 0 0 rg BT 82.74 54.45 Td (in ) Tj ET Q q 0 0 0 rg BT 92.83 54.45 Td (accordance ) Tj ET Q q 0 0 0 rg BT 140.09 54.45 Td (with ) Tj ET Q q 0 0 0 rg BT 160.18 54.45 Td (Rule ) Tj ET Q q 0 0 0 rg BT 181.37 54.45 Td (10b5-1 ) Tj ET Q q 0 0 0 rg BT 212.01 54.45 Td (under ) Tj ET Q q 0 0 0 rg BT 237.09 54.45 Td (the ) Tj ET Q q 0 0 0 rg BT 251.61 54.45 Td (Securities ) Tj ET Q q 0 0 0 rg BT 293.35 54.45 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 334.57 54.45 Td (Act ) Tj ET Q q 0 0 0 rg BT 351.32 54.45 Td (of ) Tj ET Q q 0 0 0 rg BT 361.96 54.45 Td (1934. ) Tj ET Q q 0 0 0 rg BT 386.60 54.45 Td (The ) Tj ET Q q 0 0 0 rg BT 404.45 54.45 Td (stock ) Tj ET Q q 0 0 0 rg BT 427.87 54.45 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 473.48 54.45 Td (program ) Tj ET Q q 0 0 0 rg BT 509.66 54.45 Td (does ) Tj ET Q q 0 0 0 rg BT 530.30 54.45 Td (not ) Tj ET Q q 0 0 0 rg BT 545.39 54.45 Td (have ) Tj ET Q q 0 0 0 rg BT 566.57 54.45 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 42.45 Td (expiration ) Tj ET Q q 0 0 0 rg BT 79.04 42.45 Td (date ) Tj ET Q q 0 0 0 rg BT 98.20 42.45 Td (and ) Tj ET Q q 0 0 0 rg BT 115.14 42.45 Td (may ) Tj ET Q q 0 0 0 rg BT 134.85 42.45 Td (be ) Tj ET Q q 0 0 0 rg BT 146.79 42.45 Td (suspended ) Tj ET Q q 0 0 0 rg BT 190.95 42.45 Td (or ) Tj ET Q q 0 0 0 rg BT 201.78 42.45 Td (discontinued ) Tj ET Q q 0 0 0 rg BT 255.38 42.45 Td (at ) Tj ET Q q 0 0 0 rg BT 265.10 42.45 Td (any ) Tj ET Q q 0 0 0 rg BT 282.04 42.45 Td (time.) Tj ET Q endstream endobj 179 0 obj <> endobj 180 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (89) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (On ) Tj ET Q q 0 0 0 rg BT 51.51 749.10 Td (February ) Tj ET Q q 0 0 0 rg BT 90.90 749.10 Td (21, ) Tj ET Q q 0 0 0 rg BT 106.69 749.10 Td (2017, ) Tj ET Q q 0 0 0 rg BT 132.48 749.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 156.89 749.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 189.61 749.10 Td (into ) Tj ET Q q 0 0 0 rg BT 207.73 749.10 Td (ASR ) Tj ET Q q 0 0 0 rg BT 230.47 749.10 Td (agreements ) Tj ET Q q 0 0 0 rg BT 279.29 749.10 Td (with ) Tj ET Q q 0 0 0 rg BT 300.36 749.10 Td (each ) Tj ET Q q 0 0 0 rg BT 321.97 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 333.59 749.10 Td (Goldman, ) Tj ET Q q 0 0 0 rg BT 376.59 749.10 Td (Sachs ) Tj ET Q q 0 0 0 rg BT 403.21 749.10 Td (& ) Tj ET Q q 0 0 0 rg BT 414.28 749.10 Td (Co. ) Tj ET Q q 0 0 0 rg BT 431.74 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 449.47 749.10 Td (Mor) Tj ET Q q 0 0 0 rg BT 466.51 749.10 Td (gan ) Tj ET Q q 0 0 0 rg BT 484.24 749.10 Td (Stanley ) Tj ET Q q 0 0 0 rg BT 517.53 749.10 Td (& ) Tj ET Q q 0 0 0 rg BT 528.59 749.10 Td (Co. ) Tj ET Q q 0 0 0 rg BT 546.05 749.10 Td (LLC ) Tj ET Q q 0 0 0 rg BT 568.23 749.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 82.16 737.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 142.77 737.10 Td ($2.0 ) Tj ET Q q 0 0 0 rg BT 163.13 737.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.24 737.10 Td ( ) Tj ET Q q 0 0 0 rg BT 192.09 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 203.28 737.10 Td (common ) Tj ET Q q 0 0 0 rg BT 241.13 737.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 265.09 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 275.72 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 290.79 737.10 Td (aggregate. ) Tj ET Q q 0 0 0 rg BT 334.80 737.10 Td (The ) Tj ET Q q 0 0 0 rg BT 352.57 737.10 Td (ASR ) Tj ET Q q 0 0 0 rg BT 374.88 737.10 Td (will ) Tj ET Q q 0 0 0 rg BT 393.29 737.10 Td (be ) Tj ET Q q 0 0 0 rg BT 405.58 737.10 Td (funded ) Tj ET Q q 0 0 0 rg BT 436.21 737.10 Td (through ) Tj ET Q q 0 0 0 rg BT 470.17 737.10 Td (a ) Tj ET Q q 0 0 0 rg BT 477.46 737.10 Td (combination ) Tj ET Q q 0 0 0 rg BT 530.31 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 541.49 737.10 Td (debt ) Tj ET Q q 0 0 0 rg BT 561.56 737.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 56.41 725.10 Td (and ) Tj ET Q q 0 0 0 rg BT 73.50 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 88.35 725.10 Td (part ) Tj ET Q q 0 0 0 rg BT 106.54 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 117.52 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 132.38 725.10 Td (existing ) Tj ET Q q 0 0 0 rg BT 166.69 725.10 Td (share ) Tj ET Q q 0 0 0 rg BT 190.44 725.10 Td (repurchase ) Tj ET Q q 0 0 0 rg BT 236.39 725.10 Td (authorization. ) Tj ET Q q 0 0 0 rg BT 294.10 725.10 Td (The ) Tj ET Q q 0 0 0 rg BT 312.29 725.10 Td (total ) Tj ET Q q 0 0 0 rg BT 332.71 725.10 Td (number ) Tj ET Q q 0 0 0 rg BT 365.90 725.10 Td (of ) Tj ET Q q 0 0 0 rg BT 376.88 725.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 404.51 725.10 Td (ultimately ) Tj ET Q q 0 0 0 rg BT 447.71 725.10 Td (repurchased ) Tj ET Q q 0 0 0 rg BT 498.66 725.10 Td (under ) Tj ET Q q 0 0 0 rg BT 524.07 725.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.35 725.10 Td (ASR ) Tj ET Q q 0 0 0 rg BT 560.45 725.10 Td (will ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (be ) Tj ET Q q 0 0 0 rg BT 47.94 713.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 95.42 713.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 117.92 713.10 Td (final ) Tj ET Q q 0 0 0 rg BT 138.74 713.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 182.34 713.10 Td (and ) Tj ET Q q 0 0 0 rg BT 199.28 713.10 Td (based ) Tj ET Q q 0 0 0 rg BT 224.55 713.10 Td (on ) Tj ET Q q 0 0 0 rg BT 237.05 713.10 Td (a ) Tj ET Q q 0 0 0 rg BT 243.99 713.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 280.38 713.10 Td (to ) Tj ET Q q 0 0 0 rg BT 290.65 713.10 Td (the ) Tj ET Q q 0 0 0 rg BT 305.37 713.10 Td (volume-weighted ) Tj ET Q q 0 0 0 rg BT 377.85 713.10 Td (average ) Tj ET Q q 0 0 0 rg BT 411.43 713.10 Td (price ) Tj ET Q q 0 0 0 rg BT 433.92 713.10 Td (of ) Tj ET Q q 0 0 0 rg BT 444.75 713.10 Td (BMS's ) Tj ET Q q 0 0 0 rg BT 474.07 713.10 Td (common ) Tj ET Q q 0 0 0 rg BT 511.56 713.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 535.17 713.10 Td (during ) Tj ET Q q 0 0 0 rg BT 563.78 713.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.10 Td (ASR ) Tj ET Q q 0 0 0 rg BT 57.95 701.10 Td (period ) Tj ET Q q 0 0 0 rg BT 86.00 701.10 Td (which ) Tj ET Q q 0 0 0 rg BT 112.94 701.10 Td (is ) Tj ET Q q 0 0 0 rg BT 122.11 701.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 160.14 701.10 Td (to ) Tj ET Q q 0 0 0 rg BT 170.42 701.10 Td (be ) Tj ET Q q 0 0 0 rg BT 182.36 701.10 Td (completed ) Tj ET Q q 0 0 0 rg BT 226.51 701.10 Td (by ) Tj ET Q q 0 0 0 rg BT 239.01 701.10 Td (June ) Tj ET Q q 0 0 0 rg BT 259.84 701.10 Td (30, ) Tj ET Q q 0 0 0 rg BT 274.84 701.10 Td (2017.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (The components of other comprehensive income/\(loss\) were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 621.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 621.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 621.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 621.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 621.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 621.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 591.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 591.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 591.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 591.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 591.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 591.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 561.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 561.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 561.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 561.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 561.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 561.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 531.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 531.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 531.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 531.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 531.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 531.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 501.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 501.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 501.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 501.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 501.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 501.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 471.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 471.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 471.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 471.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 471.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 471.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 441.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 441.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 441.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 441.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 441.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 441.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 35.50 411.60 160.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 195.50 411.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 233.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 237.50 411.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 276.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 280.50 411.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 319.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 323.50 411.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 365.50 411.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 404.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 411.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 447.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 451.50 411.60 38.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 489.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 411.60 39.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 532.50 411.60 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 536.50 411.60 39.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 319.5 651.6 m 323.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 651.6 m 361.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 651.6 m 365.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 651.6 m 404.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 651.6 m 408.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 651.6 m 447.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 447.5 651.6 m 451.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 651.6 m 489.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 489.5 651.6 m 493.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 651.6 m 532.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 532.5 651.6 m 536.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 651.6 m 575.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 651.6 m 233.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 636.6 m 233.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 233.5 651.6 m 237.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 233.5 636.6 m 237.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 651.6 m 276.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 636.6 m 276.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 651.6 m 280.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 276.5 636.6 m 280.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 651.6 m 319.5 651.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 636.6 m 319.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 636.6 m 361.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 636.6 m 365.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 636.6 m 404.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 636.6 m 408.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 636.6 m 447.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 636.6 m 489.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 489.5 636.6 m 493.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 636.6 m 532.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 532.5 636.6 m 536.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 636.6 m 575.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 621.6 m 233.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 621.6 m 276.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 621.6 m 319.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 636.6 m 361.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 621.6 m 361.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 636.6 m 365.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 636.6 m 404.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 621.6 m 404.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 404.5 636.6 m 408.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 636.6 m 447.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 621.6 m 447.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 636.6 m 489.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 621.6 m 489.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 489.5 636.6 m 493.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 636.6 m 532.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 621.6 m 532.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 532.5 636.6 m 536.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 636.6 m 575.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 621.6 m 575.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 576.6 m 233.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 576.6 m 276.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 576.6 m 319.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 576.6 m 361.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 576.6 m 404.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 576.6 m 447.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 576.6 m 489.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 576.6 m 532.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 576.6 m 575.5 576.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 501.6 m 233.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 501.6 m 276.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 501.6 m 319.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 501.6 m 361.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 501.6 m 404.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 501.6 m 447.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 501.6 m 489.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 501.6 m 532.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 501.6 m 575.5 501.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 441.6 m 233.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 441.6 m 276.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 441.6 m 319.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 441.6 m 361.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 441.6 m 404.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 441.6 m 447.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 441.6 m 489.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 441.6 m 532.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 441.6 m 575.5 441.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 411.6 m 233.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 397.6 m 233.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 195.5 395.6 m 233.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 411.6 m 276.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 397.6 m 276.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 237.5 395.6 m 276.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 411.6 m 319.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 397.6 m 319.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 280.5 395.6 m 319.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 411.6 m 361.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 397.6 m 361.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 323.5 395.6 m 361.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 411.6 m 404.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 397.6 m 404.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 365.5 395.6 m 404.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 411.6 m 447.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 397.6 m 447.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 408.5 395.6 m 447.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 411.6 m 489.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 397.6 m 489.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 451.5 395.6 m 489.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 411.6 m 532.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 397.6 m 532.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 493.5 395.6 m 532.5 395.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 411.6 m 575.5 411.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 397.6 m 575.5 397.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 536.5 395.6 m 575.5 395.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 655.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 340.20 655.83 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 249.00 640.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 377.00 640.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 505.00 640.83 Td (2014) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.00 625.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 202.70 625.83 Td (Pretax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 250.15 625.83 Td (Tax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 283.20 625.83 Td (After Tax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 330.70 625.83 Td (Pretax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 378.15 625.83 Td (Tax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 411.20 625.83 Td (After Tax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.70 625.83 Td (Pretax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 506.15 625.83 Td (Tax) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 539.20 625.83 Td (After Tax) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 610.96 Td (Derivatives qualifying as cash flow hedges) Tj ET Q BT /F1 8.50 Tf ET BT /F1 5.52 Tf ET q 0 0 0 rg BT 184.12 614.81 Td (\(a\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 598.21 Td (Unrealized gains/\(losses\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 198.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 221.30 596.27 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.65 596.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.65 596.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 283.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.30 596.32 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 596.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 326.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 596.27 Td (59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 596.32 Td (\(22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 596.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.65 596.27 Td (37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.65 596.27 Td (139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.30 596.32 Td (\(45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 596.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.00 596.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 596.27 Td (94) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 583.21 Td (Reclassified to net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 581.27 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 581.27 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 581.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 581.27 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 339.30 581.32 Td (\(130) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 581.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 581.27 Td (42) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 581.32 Td (\(88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 581.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.30 581.32 Td (\(41) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 581.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 581.27 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.30 581.27 Td (\(25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 581.27 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 568.21 Td (Derivatives qualifying as cash flow hedges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 224.65 566.27 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 566.27 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 566.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 566.27 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.30 566.32 Td (\(71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 566.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 566.27 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 566.32 Td (\(51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 566.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.65 566.27 Td (98) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.30 566.32 Td (\(29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 566.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 566.27 Td (69) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 550.96 Td (Pension and other postretirement benefits:) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 538.21 Td (Actuarial losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 211.30 536.27 Td (\(126) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 536.27 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.30 536.32 Td (\(129) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.30 536.32 Td (\(88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 536.27 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 536.32 Td (\(61) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.80 536.32 Td (\(1,414) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 536.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.65 536.27 Td (464) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 536.27 Td (\(950) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 536.27 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 523.21 Td (Amortization) Tj ET Q BT /F1 8.50 Tf ET BT /F1 5.52 Tf ET q 0 0 0 rg BT 101.32 527.06 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 521.27 Td (78) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.30 521.27 Td (\(25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 521.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 521.27 Td (53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 521.27 Td (85) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 521.32 Td (\(28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 521.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.65 521.27 Td (57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.65 521.27 Td (104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.30 521.32 Td (\(37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 521.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 561.65 521.27 Td (67) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 508.21 Td (Settlements and curtailments) Tj ET Q BT /F1 8.50 Tf ET BT /F1 5.52 Tf ET q 0 0 0 rg BT 154.20 512.06 Td (\(c\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 506.27 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.30 506.27 Td (\(32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 506.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 506.27 Td (59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 506.27 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 506.32 Td (\(55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 506.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 506.27 Td (105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.65 506.27 Td (867) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.30 506.32 Td (\(308) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 506.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 556.65 506.27 Td (559) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 493.21 Td (Pension and other postretirement benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 491.27 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.30 491.27 Td (\(60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 491.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.30 491.32 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 491.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.65 491.27 Td (157) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 491.32 Td (\(56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 491.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.65 491.27 Td (101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.30 491.32 Td (\(443) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 491.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 513.65 491.27 Td (119) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 491.27 Td (\(324) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 491.27 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 478.21 Td (Available-for-sale securities:) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 463.21 Td (Unrealized gains/\(losses\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 216.30 461.27 Td (\(12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 461.27 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.30 461.32 Td (\(13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.30 461.32 Td (\(71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 461.27 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 461.32 Td (\(57) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.65 461.27 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.30 461.32 Td (\(6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 461.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 566.65 461.27 Td (4) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 56.00 448.21 Td (Realized \(gains\)/losses) Tj ET Q BT /F1 8.50 Tf ET BT /F1 5.52 Tf ET q 0 0 0 rg BT 134.13 452.06 Td (\(c\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 446.27 Td (29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.65 446.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 446.27 Td (29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 446.27 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 446.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 438.65 446.27 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.30 446.32 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 446.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 446.27 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 563.30 446.27 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 446.27 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 430.96 Td (Available-for-sale securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 431.27 Td (17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 431.27 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 431.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 431.27 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.30 431.32 Td (\(68) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 431.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 431.27 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 431.32 Td (\(54) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 431.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.65 431.27 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.30 431.32 Td (\(6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 431.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 566.65 431.27 Td (3) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 418.21 Td (Foreign currency translation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 216.30 416.27 Td (\(33) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 264.30 416.27 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.30 416.32 Td (\(38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 344.30 416.32 Td (\(17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 416.32 Td (\(22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 416.32 Td (\(39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.30 416.32 Td (\(8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.30 416.32 Td (\(24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 528.65 416.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 558.30 416.27 Td (\(32) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 416.27 Td (\)) Tj ET Q BT /F1 8.50 Tf ET q 0 0 0 rg BT 38.00 400.96 Td (Total Other Comprehensive Income/\(Loss\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 198.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 219.65 401.27 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 240.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.30 401.27 Td (\(69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 283.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 302.30 401.32 Td (\(35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 326.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 401.27 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 368.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 387.30 401.32 Td (\(44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 430.30 401.32 Td (\(43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 443.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.30 401.32 Td (\(344) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 518.65 401.27 Td (60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.00 401.27 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.30 401.27 Td (\(284) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 571.65 401.27 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 380.30 Td (\(a\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 380.30 Td (Included ) Tj ET Q q 0 0 0 rg BT 91.34 380.30 Td (in ) Tj ET Q q 0 0 0 rg BT 99.56 380.30 Td (cost ) Tj ET Q q 0 0 0 rg BT 114.45 380.30 Td (of ) Tj ET Q q 0 0 0 rg BT 123.11 380.30 Td (products ) Tj ET Q q 0 0 0 rg BT 152.66 380.30 Td (sold) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 370.70 Td (\(b\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 370.70 Td (Included ) Tj ET Q q 0 0 0 rg BT 91.34 370.70 Td (in ) Tj ET Q q 0 0 0 rg BT 99.56 370.70 Td (cost ) Tj ET Q q 0 0 0 rg BT 114.45 370.70 Td (of ) Tj ET Q q 0 0 0 rg BT 123.11 370.70 Td (products ) Tj ET Q q 0 0 0 rg BT 152.66 370.70 Td (sold, ) Tj ET Q q 0 0 0 rg BT 170.00 370.70 Td (research ) Tj ET Q q 0 0 0 rg BT 198.64 370.70 Td (and ) Tj ET Q q 0 0 0 rg BT 212.19 370.70 Td (development, ) Tj ET Q q 0 0 0 rg BT 257.51 370.70 Td (and ) Tj ET Q q 0 0 0 rg BT 271.06 370.70 Td (marketing, ) Tj ET Q q 0 0 0 rg BT 307.50 370.70 Td (selling ) Tj ET Q q 0 0 0 rg BT 330.83 370.70 Td (and ) Tj ET Q q 0 0 0 rg BT 344.38 370.70 Td (administrative ) Tj ET Q q 0 0 0 rg BT 392.15 370.70 Td (expenses) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 38.85 361.10 Td (\(c\) ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.35 361.10 Td (Included ) Tj ET Q q 0 0 0 rg BT 91.34 361.10 Td (in ) Tj ET Q q 0 0 0 rg BT 99.56 361.10 Td (other ) Tj ET Q q 0 0 0 rg BT 118.00 361.10 Td (\(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 340.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 340.10 Td (accumulated ) Tj ET Q q 0 0 0 rg BT 107.07 340.10 Td (balances ) Tj ET Q q 0 0 0 rg BT 144.00 340.10 Td (related ) Tj ET Q q 0 0 0 rg BT 173.70 340.10 Td (to ) Tj ET Q q 0 0 0 rg BT 183.98 340.10 Td (each ) Tj ET Q q 0 0 0 rg BT 204.79 340.10 Td (component ) Tj ET Q q 0 0 0 rg BT 251.73 340.10 Td (of ) Tj ET Q q 0 0 0 rg BT 262.56 340.10 Td (other ) Tj ET Q q 0 0 0 rg BT 285.60 340.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 348.64 340.10 Td (loss, ) Tj ET Q q 0 0 0 rg BT 369.20 340.10 Td (net ) Tj ET Q q 0 0 0 rg BT 383.92 340.10 Td (of ) Tj ET Q q 0 0 0 rg BT 394.75 340.10 Td (taxes, ) Tj ET Q q 0 0 0 rg BT 420.29 340.10 Td (were ) Tj ET Q q 0 0 0 rg BT 442.22 340.10 Td (as ) Tj ET Q q 0 0 0 rg BT 453.05 340.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 305.60 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 305.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 305.60 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 305.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 305.60 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 277.60 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 277.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 277.60 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 277.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 277.60 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 249.60 370.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 406.50 249.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 249.60 81.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 491.50 249.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 495.50 249.60 81.00 -14.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 317.6 m 491.5 317.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 491.5 317.6 m 495.5 317.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 317.6 m 576.5 317.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 305.6 m 491.5 305.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 305.6 m 576.5 305.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 249.60000000000002 m 491.5 249.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 249.60000000000002 m 576.5 249.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 236.60000000000002 m 491.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 410.5 234.60000000000002 m 491.5 234.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 236.60000000000002 m 576.5 236.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 495.5 234.60000000000002 m 576.5 234.60000000000002 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 321.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 469.75 321.68 Td (December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 309.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 442.50 309.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 527.50 309.68 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 296.17 Td (Derivatives qualifying as cash flow hedges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.00 296.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.65 296.17 Td (38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 296.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 296.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 282.17 Td (Pension and other postretirement benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 282.22 Td (\(2,097) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 282.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 282.17 Td (\(2,080) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 282.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 268.17 Td (Available-for-sale securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.30 268.22 Td (\(7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 268.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 268.17 Td (\(23) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 268.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 254.17 Td (Foreign currency translation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 469.30 254.22 Td (\(437) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 254.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 254.17 Td (\(399) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 254.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 240.17 Td (Accumulated other comprehensive loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.00 240.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.80 240.22 Td (\(2,503) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 240.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.00 240.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.80 240.17 Td (\(2,468) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 240.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 210.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 210.10 Td (16) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 210.10 Td (. PENSION ) Tj ET Q q 0 0 0 rg BT 119.89 210.10 Td (AND POSTRETIREMENT) Tj ET Q q 0 0 0 rg BT 238.34 210.10 Td ( BENEFIT) Tj ET Q q 0 0 0 rg BT 284.56 210.10 Td ( PLANS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 193.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 58.94 193.10 Td (sponsors ) Tj ET Q q 0 0 0 rg BT 95.75 193.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 127.55 193.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 157.13 193.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 190.05 193.10 Td (plans, ) Tj ET Q q 0 0 0 rg BT 215.47 193.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 247.27 193.10 Td (contribution ) Tj ET Q q 0 0 0 rg BT 297.96 193.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 320.89 193.10 Td (and ) Tj ET Q q 0 0 0 rg BT 337.14 193.10 Td (termination ) Tj ET Q q 0 0 0 rg BT 385.05 193.10 Td (indemnity ) Tj ET Q q 0 0 0 rg BT 427.41 193.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 450.34 193.10 Td (for ) Tj ET Q q 0 0 0 rg BT 463.81 193.10 Td (regular ) Tj ET Q q 0 0 0 rg BT 493.94 193.10 Td (full-time ) Tj ET Q q 0 0 0 rg BT 530.74 193.10 Td (employees. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 181.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.81 181.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 93.61 181.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 126.85 181.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 157.87 181.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 192.24 181.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 212.71 181.10 Td (is ) Tj ET Q q 0 0 0 rg BT 222.64 181.10 Td (the ) Tj ET Q q 0 0 0 rg BT 238.12 181.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 297.48 181.10 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 329.08 181.10 Td (Retirement ) Tj ET Q q 0 0 0 rg BT 376.77 181.10 Td (Income ) Tj ET Q q 0 0 0 rg BT 410.01 181.10 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 433.55 181.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 471.79 181.10 Td (most ) Tj ET Q q 0 0 0 rg BT 494.50 181.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 515.54 181.10 Td (employees ) Tj ET Q q 0 0 0 rg BT 561.56 181.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 169.10 Td (representing ) Tj ET Q q 0 0 0 rg BT 88.23 169.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 148.79 169.10 Td (66%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 167.12 169.10 Td ( ) Tj ET Q q 0 0 0 rg BT 169.92 169.10 Td (of ) Tj ET Q q 0 0 0 rg BT 181.05 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 196.07 169.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 249.41 169.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 283.32 169.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 303.34 169.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 329.47 169.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.71 169.10 Td (61%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 365.04 169.10 Td ( ) Tj ET Q q 0 0 0 rg BT 367.84 169.10 Td (of ) Tj ET Q q 0 0 0 rg BT 378.98 169.10 Td (the ) Tj ET Q q 0 0 0 rg BT 394.00 169.10 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 443.74 169.10 Td (Future ) Tj ET Q q 0 0 0 rg BT 472.65 169.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 507.11 169.10 Td (related ) Tj ET Q q 0 0 0 rg BT 537.11 169.10 Td (to ) Tj ET Q q 0 0 0 rg BT 547.69 169.10 Td (service ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 157.10 Td (for ) Tj ET Q q 0 0 0 rg BT 50.58 157.10 Td (this ) Tj ET Q q 0 0 0 rg BT 67.94 157.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 88.07 157.10 Td (were ) Tj ET Q q 0 0 0 rg BT 110.42 157.10 Td (eliminated ) Tj ET Q q 0 0 0 rg BT 155.54 157.10 Td (in ) Tj ET Q q 0 0 0 rg BT 166.24 157.10 Td (2009. ) Tj ET Q q 0 0 0 rg BT 191.65 157.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 215.69 157.10 Td (contributes ) Tj ET Q q 0 0 0 rg BT 263.04 157.10 Td (at ) Tj ET Q q 0 0 0 rg BT 273.18 157.10 Td (least ) Tj ET Q q 0 0 0 rg BT 294.42 157.10 Td (the ) Tj ET Q q 0 0 0 rg BT 309.55 157.10 Td (minimum ) Tj ET Q q 0 0 0 rg BT 351.36 157.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 384.27 157.10 Td (required ) Tj ET Q q 0 0 0 rg BT 420.50 157.10 Td (by ) Tj ET Q q 0 0 0 rg BT 433.42 157.10 Td (the ) Tj ET Q q 0 0 0 rg BT 448.55 157.10 Td (ERISA. ) Tj ET Q q 0 0 0 rg BT 482.86 157.10 Td (Plan ) Tj ET Q q 0 0 0 rg BT 503.56 157.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 538.13 157.10 Td (are ) Tj ET Q q 0 0 0 rg BT 553.25 157.10 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 145.10 Td (primarily ) Tj ET Q q 0 0 0 rg BT 75.08 145.10 Td (on ) Tj ET Q q 0 0 0 rg BT 86.95 145.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.03 145.10 Td (participant’) Tj ET Q q 0 0 0 rg BT 146.57 145.10 Td (s ) Tj ET Q q 0 0 0 rg BT 152.32 145.10 Td (years ) Tj ET Q q 0 0 0 rg BT 175.29 145.10 Td (of ) Tj ET Q q 0 0 0 rg BT 185.49 145.10 Td (credited ) Tj ET Q q 0 0 0 rg BT 219.56 145.10 Td (service ) Tj ET Q q 0 0 0 rg BT 249.74 145.10 Td (and ) Tj ET Q q 0 0 0 rg BT 266.04 145.10 Td (final ) Tj ET Q q 0 0 0 rg BT 286.23 145.10 Td (average ) Tj ET Q q 0 0 0 rg BT 319.19 145.10 Td (compensation. ) Tj ET Q q 0 0 0 rg BT 379.09 145.10 Td (Plan ) Tj ET Q q 0 0 0 rg BT 398.74 145.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 423.94 145.10 Td (consist ) Tj ET Q q 0 0 0 rg BT 453.58 145.10 Td (principally ) Tj ET Q q 0 0 0 rg BT 498.77 145.10 Td (of ) Tj ET Q q 0 0 0 rg BT 508.96 145.10 Td (equity ) Tj ET Q q 0 0 0 rg BT 535.83 145.10 Td (and ) Tj ET Q q 0 0 0 rg BT 552.13 145.10 Td (fixed-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 133.10 Td (income ) Tj ET Q q 0 0 0 rg BT 67.93 133.10 Td (securities. ) Tj ET Q endstream endobj 181 0 obj <> endobj 182 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The net periodic benefit cost/\(credit\) of defined benefit pension plans includes:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 725.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 725.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 725.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 725.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 725.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 725.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 725.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 699.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 699.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 699.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 699.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 699.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 699.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 699.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 673.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 673.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 673.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 673.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 673.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 673.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 673.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 647.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 647.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 647.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 647.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 647.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 647.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 647.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 621.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 621.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 621.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 621.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 621.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 621.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 621.60 69.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 725.6 m 430.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 725.6 m 503.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 621.6 m 430.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 621.6 m 503.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 621.6 m 576.5 621.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 609.6 m 430.5 609.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 607.6 m 430.5 607.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 609.6 m 503.5 609.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 607.6 m 503.5 607.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 609.6 m 576.5 609.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 607.6 m 576.5 607.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.50 729.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.50 729.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.50 729.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 716.17 Td (Service cost — benefits earned during the year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 716.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 716.17 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 716.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 716.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 716.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 716.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 703.17 Td (Interest cost on projected benefit obligation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.65 703.17 Td (192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 703.17 Td (242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 703.17 Td (305) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 690.17 Td (Expected return on plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.30 690.22 Td (\(418) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 690.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.30 690.22 Td (\(405) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 690.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 690.17 Td (\(508) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 690.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 677.17 Td (Amortization of prior service credits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 418.30 677.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.30 677.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 677.17 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 677.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 664.17 Td (Amortization of net actuarial loss) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 664.17 Td (84) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 664.17 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 664.17 Td (110) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 651.17 Td (Curtailments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 651.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 491.30 651.22 Td (\(1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.65 651.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 651.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 638.17 Td (Settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.65 638.17 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 638.17 Td (161) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 638.17 Td (866) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 625.17 Td (Special termination benefits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 625.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 625.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 625.17 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 612.17 Td (Net periodic benefit cost/\(credit\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.30 612.22 Td (\(29) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.65 612.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 437.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 612.17 Td (110) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 510.00 612.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 612.17 Td (819) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 585.10 Td (In ) Tj ET Q q 0 0 0 rg BT 46.61 585.10 Td (September ) Tj ET Q q 0 0 0 rg BT 91.65 585.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 116.42 585.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 139.82 585.10 Td (and ) Tj ET Q q 0 0 0 rg BT 156.54 585.10 Td (Fiduciary ) Tj ET Q q 0 0 0 rg BT 197.14 585.10 Td (Counselors ) Tj ET Q q 0 0 0 rg BT 244.42 585.10 Td (Inc., ) Tj ET Q q 0 0 0 rg BT 264.46 585.10 Td (as ) Tj ET Q q 0 0 0 rg BT 275.07 585.10 Td (an ) Tj ET Q q 0 0 0 rg BT 286.79 585.10 Td (independent ) Tj ET Q q 0 0 0 rg BT 337.94 585.10 Td (fiduciary ) Tj ET Q q 0 0 0 rg BT 376.31 585.10 Td (of ) Tj ET Q q 0 0 0 rg BT 386.91 585.10 Td (the ) Tj ET Q q 0 0 0 rg BT 401.41 585.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 459.79 585.10 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 490.41 585.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 531.57 585.10 Td (Retirement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 573.10 Td (Income ) Tj ET Q q 0 0 0 rg BT 68.27 573.10 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 90.84 573.10 Td (entered ) Tj ET Q q 0 0 0 rg BT 122.55 573.10 Td (into ) Tj ET Q q 0 0 0 rg BT 140.40 573.10 Td (a ) Tj ET Q q 0 0 0 rg BT 147.13 573.10 Td (definitive ) Tj ET Q q 0 0 0 rg BT 187.74 573.10 Td (agreement ) Tj ET Q q 0 0 0 rg BT 231.67 573.10 Td (to ) Tj ET Q q 0 0 0 rg BT 241.73 573.10 Td (transfer ) Tj ET Q q 0 0 0 rg BT 274.56 573.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 304.05 573.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 324.12 573.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 357.52 573.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 383.14 573.10 Td (to ) Tj ET Q q 0 0 0 rg BT 393.21 573.10 Td (Prudential ) Tj ET Q q 0 0 0 rg BT 436.60 573.10 Td (to ) Tj ET Q q 0 0 0 rg BT 446.67 573.10 Td (settle ) Tj ET Q q 0 0 0 rg BT 470.06 573.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 530.11 573.10 Td ($1.5 ) Tj ET Q q 0 0 0 rg BT 549.90 573.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 561.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.97 561.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 82.71 561.10 Td (obligations. BMS ) Tj ET Q q 0 0 0 rg BT 156.92 561.10 Td (purchased ) Tj ET Q q 0 0 0 rg BT 201.09 561.10 Td (a ) Tj ET Q q 0 0 0 rg BT 209.16 561.10 Td (group ) Tj ET Q q 0 0 0 rg BT 236.13 561.10 Td (annuity ) Tj ET Q q 0 0 0 rg BT 269.76 561.10 Td (contract ) Tj ET Q q 0 0 0 rg BT 305.60 561.10 Td (from ) Tj ET Q q 0 0 0 rg BT 328.68 561.10 Td (Prudential ) Tj ET Q q 0 0 0 rg BT 373.42 561.10 Td (in ) Tj ET Q q 0 0 0 rg BT 384.83 561.10 Td (December ) Tj ET Q q 0 0 0 rg BT 429.55 561.10 Td (2014, ) Tj ET Q q 0 0 0 rg BT 455.69 561.10 Td (who ) Tj ET Q q 0 0 0 rg BT 476.55 561.10 Td (irrevocably ) Tj ET Q q 0 0 0 rg BT 525.72 561.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 563.79 561.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 549.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 78.73 549.10 Td (to ) Tj ET Q q 0 0 0 rg BT 88.69 549.10 Td (make ) Tj ET Q q 0 0 0 rg BT 112.53 549.10 Td (future ) Tj ET Q q 0 0 0 rg BT 138.58 549.10 Td (annuity ) Tj ET Q q 0 0 0 rg BT 170.76 549.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 211.26 549.10 Td (to ) Tj ET Q q 0 0 0 rg BT 221.22 549.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 250.60 549.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 273.91 549.10 Td (retirees. ) Tj ET Q q 0 0 0 rg BT 308.15 549.10 Td (The ) Tj ET Q q 0 0 0 rg BT 325.88 549.10 Td (transaction ) Tj ET Q q 0 0 0 rg BT 371.93 549.10 Td (does ) Tj ET Q q 0 0 0 rg BT 392.44 549.10 Td (not ) Tj ET Q q 0 0 0 rg BT 407.40 549.10 Td (change ) Tj ET Q q 0 0 0 rg BT 437.89 549.10 Td (the ) Tj ET Q q 0 0 0 rg BT 452.29 549.10 Td (amount ) Tj ET Q q 0 0 0 rg BT 484.47 549.10 Td (of ) Tj ET Q q 0 0 0 rg BT 494.98 549.10 Td (the ) Tj ET Q q 0 0 0 rg BT 509.37 549.10 Td (monthly ) Tj ET Q q 0 0 0 rg BT 544.89 549.10 Td (pension ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 537.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 67.17 537.10 Td (received ) Tj ET Q q 0 0 0 rg BT 104.45 537.10 Td (by ) Tj ET Q q 0 0 0 rg BT 117.86 537.10 Td (af) Tj ET Q q 0 0 0 rg BT 125.45 537.10 Td (fected ) Tj ET Q q 0 0 0 rg BT 153.28 537.10 Td (retirees ) Tj ET Q q 0 0 0 rg BT 186.11 537.10 Td (and ) Tj ET Q q 0 0 0 rg BT 203.96 537.10 Td (surviving ) Tj ET Q q 0 0 0 rg BT 245.15 537.10 Td (beneficiaries ) Tj ET Q q 0 0 0 rg BT 299.64 537.10 Td (and ) Tj ET Q q 0 0 0 rg BT 317.49 537.10 Td (resulted ) Tj ET Q q 0 0 0 rg BT 352.56 537.10 Td (in ) Tj ET Q q 0 0 0 rg BT 363.75 537.10 Td (a ) Tj ET Q q 0 0 0 rg BT 371.60 537.10 Td (pretax ) Tj ET Q q 0 0 0 rg BT 399.99 537.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 444.50 537.10 Td (char) Tj ET Q q 0 0 0 rg BT 461.53 537.10 Td (ge ) Tj ET Q q 0 0 0 rg BT 474.38 537.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.12 537.10 Td ($713 ) Tj ET Q q 0 0 0 rg BT 509.53 537.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 538.42 537.10 Td (. ) Tj ET Q q 0 0 0 rg BT 544.33 537.10 Td (Pension ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 525.10 Td (settlement ) Tj ET Q q 0 0 0 rg BT 80.08 525.10 Td (char) Tj ET Q q 0 0 0 rg BT 97.11 525.10 Td (ges ) Tj ET Q q 0 0 0 rg BT 113.42 525.10 Td (were ) Tj ET Q q 0 0 0 rg BT 135.84 525.10 Td (also ) Tj ET Q q 0 0 0 rg BT 154.93 525.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 201.78 525.10 Td (after ) Tj ET Q q 0 0 0 rg BT 223.08 525.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 274.38 525.10 Td (the ) Tj ET Q q 0 0 0 rg BT 289.59 525.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 319.23 525.10 Td (lump ) Tj ET Q q 0 0 0 rg BT 342.77 525.10 Td (sum ) Tj ET Q q 0 0 0 rg BT 362.42 525.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 403.73 525.10 Td (will ) Tj ET Q q 0 0 0 rg BT 422.27 525.10 Td (exceed ) Tj ET Q q 0 0 0 rg BT 453.01 525.10 Td (the ) Tj ET Q q 0 0 0 rg BT 468.21 525.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 497.85 525.10 Td (interest ) Tj ET Q q 0 0 0 rg BT 530.27 525.10 Td (and ) Tj ET Q q 0 0 0 rg BT 547.70 525.10 Td (service ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 513.10 Td (costs ) Tj ET Q q 0 0 0 rg BT 58.50 513.10 Td (for ) Tj ET Q q 0 0 0 rg BT 72.66 513.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 102.36 513.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 135.97 513.10 Td (plans, ) Tj ET Q q 0 0 0 rg BT 162.08 513.10 Td (including ) Tj ET Q q 0 0 0 rg BT 202.35 513.10 Td (the ) Tj ET Q q 0 0 0 rg BT 217.07 513.10 Td (primary ) Tj ET Q q 0 0 0 rg BT 251.22 513.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 271.51 513.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 305.12 513.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 324.83 513.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.11 513.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.11 513.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.11 513.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.11 513.10 Td ( ) Tj ET Q q 0 0 0 rg BT 382.61 513.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 399.55 513.10 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 419.55 513.10 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 489.10 Td (Changes ) Tj ET Q q 0 0 0 rg BT 73.42 489.10 Td (in ) Tj ET Q q 0 0 0 rg BT 84.18 489.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 117.15 489.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 147.90 489.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 181.99 489.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 202.19 489.10 Td (obligations, ) Tj ET Q q 0 0 0 rg BT 252.11 489.10 Td (assets, ) Tj ET Q q 0 0 0 rg BT 280.92 489.10 Td (funded ) Tj ET Q q 0 0 0 rg BT 311.67 489.10 Td (status ) Tj ET Q q 0 0 0 rg BT 337.44 489.10 Td (and ) Tj ET Q q 0 0 0 rg BT 354.86 489.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 391.73 489.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 438.57 489.10 Td (in ) Tj ET Q q 0 0 0 rg BT 449.33 489.10 Td (the ) Tj ET Q q 0 0 0 rg BT 464.53 489.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 518.05 489.10 Td (balance ) Tj ET Q q 0 0 0 rg BT 551.57 489.10 Td (sheets ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 477.10 Td (were ) Tj ET Q q 0 0 0 rg BT 57.93 477.10 Td (as ) Tj ET Q q 0 0 0 rg BT 68.76 477.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 453.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 453.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 453.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 453.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 453.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 427.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 427.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 427.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 427.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 401.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 401.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 401.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 401.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 401.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 375.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 375.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 375.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 375.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 375.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 349.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 349.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 349.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 349.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 349.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 323.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 323.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 323.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 323.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 323.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 297.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 297.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 297.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 297.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 297.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 271.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 271.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 271.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 271.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 271.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 245.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 245.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 245.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 245.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 245.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 219.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 219.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 219.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 219.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 219.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 193.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 193.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 193.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 193.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 193.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 167.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 167.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 167.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 167.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 167.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 141.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 141.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 141.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 141.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 141.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 115.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 115.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 115.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 115.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 115.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 89.60 374.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 89.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 89.60 79.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 89.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 89.60 79.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 453.6 m 493.5 453.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 453.6 m 576.5 453.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 362.6 m 493.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 362.6 m 576.5 362.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 350.6 m 493.5 350.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 348.6 m 493.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 350.6 m 576.5 350.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 348.6 m 576.5 348.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 258.6 m 493.5 258.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 258.6 m 576.5 258.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 246.60000000000002 m 493.5 246.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 244.60000000000002 m 493.5 244.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 246.60000000000002 m 576.5 246.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 244.60000000000002 m 576.5 244.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 232.60000000000002 m 493.5 232.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 220.60000000000002 m 493.5 220.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 218.60000000000002 m 493.5 218.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 232.60000000000002 m 576.5 232.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 220.60000000000002 m 576.5 220.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 218.60000000000002 m 576.5 218.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 154.60000000000002 m 493.5 154.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 154.60000000000002 m 576.5 154.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 142.60000000000002 m 493.5 142.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 140.60000000000002 m 493.5 140.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 142.60000000000002 m 576.5 142.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 140.60000000000002 m 576.5 140.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 89.60000000000002 m 493.5 89.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 89.60000000000002 m 576.5 89.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 77.60000000000002 m 493.5 77.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 75.60000000000002 m 493.5 75.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 77.60000000000002 m 576.5 77.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 75.60000000000002 m 576.5 75.60000000000002 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 457.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 445.50 457.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.50 457.83 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 444.17 Td (Benefit obligations at beginning of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 444.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 444.17 Td (6,418) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 444.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 444.17 Td (7,068) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 431.17 Td (Service cost—benefits earned during the year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.65 431.17 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 431.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 418.17 Td (Interest cost) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 418.17 Td (192) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 418.17 Td (242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 405.17 Td (Settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 405.22 Td (\(173) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 405.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 405.17 Td (\(336) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 405.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 392.17 Td (Actuarial \(gains\)/losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 392.17 Td (253) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 392.17 Td (\(321) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 392.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 379.17 Td (Benefits paid) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 379.22 Td (\(109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 379.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 379.17 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 379.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 366.17 Td (Foreign currency and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 366.22 Td (\(165) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 366.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 366.17 Td (\(155) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 366.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 353.17 Td (Benefit obligations at end of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 353.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 353.17 Td (6,440) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 353.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 353.17 Td (6,418) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 327.17 Td (Fair value of plan assets at beginning of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 327.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 327.17 Td (5,687) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 327.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 327.17 Td (6,148) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 314.17 Td (Actual return on plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.65 314.17 Td (513) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 314.17 Td (\(5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 314.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 301.17 Td (Employer contributions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.65 301.17 Td (81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 301.17 Td (118) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 288.17 Td (Settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 288.22 Td (\(173) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 288.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 288.17 Td (\(336) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 288.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 275.17 Td (Benefits paid) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 275.22 Td (\(109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 275.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 275.17 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 275.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 262.17 Td (Foreign currency and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 262.22 Td (\(168) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 262.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 262.17 Td (\(133) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 262.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 249.17 Td (Fair value of plan assets at end of year) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 249.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 249.17 Td (5,831) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 249.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 249.17 Td (5,687) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 223.17 Td (Funded status) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 223.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 223.22 Td (\(609) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 223.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 223.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 223.17 Td (\(731) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 223.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 197.17 Td (Assets/\(Liabilities\) recognized:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 184.17 Td (Other assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 184.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.65 184.17 Td (26) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 184.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 184.17 Td (71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 171.17 Td (Accrued liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.30 171.22 Td (\(35) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 171.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 171.17 Td (\(37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 171.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 158.17 Td (Pension and other liabilities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 158.22 Td (\(600) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 158.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 158.17 Td (\(765) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 158.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 145.17 Td (Funded status) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 145.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 471.30 145.22 Td (\(609) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 145.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 145.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 145.17 Td (\(731) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 145.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 119.17 Td (Recognized in accumulated other comprehensive loss:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 106.17 Td (Net actuarial losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 106.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 106.17 Td (3,123) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 106.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 106.17 Td (3,140) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 93.17 Td (Prior service credit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 476.30 93.22 Td (\(39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.65 93.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 93.17 Td (\(39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 93.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 80.17 Td (Total) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.00 80.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.15 80.17 Td (3,084) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.00 80.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 80.17 Td (3,101) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 53.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.96 53.10 Td (accumulated ) Tj ET Q q 0 0 0 rg BT 106.91 53.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 137.09 53.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 180.05 53.10 Td (for ) Tj ET Q q 0 0 0 rg BT 194.13 53.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 226.53 53.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 256.71 53.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 290.24 53.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 313.76 53.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.73 53.10 Td ($6,381 ) Tj ET Q q 0 0 0 rg BT 361.64 53.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.54 53.10 Td ( ) Tj ET Q q 0 0 0 rg BT 392.95 53.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.81 53.10 Td ($6,363 ) Tj ET Q q 0 0 0 rg BT 439.72 53.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 468.61 53.10 Td ( ) Tj ET Q q 0 0 0 rg BT 471.03 53.10 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.66 53.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 539.16 53.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.16 53.10 Td ( ) Tj ET Q q 0 0 0 rg BT 561.58 53.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 41.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 41.10 Td (, ) Tj ET Q q 0 0 0 rg BT 61.00 41.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 108.66 41.10 Td (.) Tj ET Q endstream endobj 183 0 obj <> endobj 184 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Additional information related to pension plans was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 726.60 373.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 726.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 726.60 79.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 726.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 726.60 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 702.60 373.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 702.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 702.60 79.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 702.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 702.60 80.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 678.60 373.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 409.50 678.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 413.50 678.60 79.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 678.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 678.60 80.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 413.5 726.6 m 492.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 726.6 m 576.5 726.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 730.55 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.50 730.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 730.68 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 717.22 Td (Pension plans with projected benefit obligations in excess of plan assets:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 705.22 Td (Projected benefit obligation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 705.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 705.22 Td (6,195) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 705.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 705.22 Td (5,310) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 693.22 Td (Fair value of plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 693.22 Td (5,559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 693.22 Td (4,508) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 681.22 Td (Pension plans with accumulated benefit obligations in excess of plan assets) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 340.04 681.22 Td (:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 669.22 Td (Accumulated benefit obligation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 416.00 669.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 669.22 Td (5,978) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 669.22 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 669.22 Td (5,156) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 657.22 Td (Fair value of plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.15 657.22 Td (5,380) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 657.22 Td (4,386) Tj ET Q BT /F1 10.00 Tf ET BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (Actuarial ) Tj ET Q q 0 0 0 rg BT 77.03 629.10 Td (Assumptions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 612.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 612.10 Td (eighted-average assumptions used to determine defined benefit pension plan obligations at December 31 were as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 589.60 374.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 410.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 414.50 589.60 79.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 493.50 589.60 4.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 497.50 589.60 79.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 414.5 589.6 m 493.5 589.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 497.5 589.6 m 576.5 589.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 593.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 445.50 593.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.50 593.68 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 580.22 Td (Discount rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.15 580.22 Td (3.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 580.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 580.22 Td (3.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 580.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 568.22 Td (Rate of compensation increase) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.15 568.22 Td (0.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.65 568.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 568.22 Td (0.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 568.22 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 542.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 542.10 Td (eighted-average ) Tj ET Q q 0 0 0 rg BT 111.33 542.10 Td (actuarial ) Tj ET Q q 0 0 0 rg BT 148.59 542.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 200.88 542.10 Td (used ) Tj ET Q q 0 0 0 rg BT 222.05 542.10 Td (to ) Tj ET Q q 0 0 0 rg BT 232.67 542.10 Td (determine ) Tj ET Q q 0 0 0 rg BT 275.49 542.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 308.32 542.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 338.92 542.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 372.88 542.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 392.93 542.10 Td (net ) Tj ET Q q 0 0 0 rg BT 407.99 542.10 Td (periodic ) Tj ET Q q 0 0 0 rg BT 443.60 542.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 474.20 542.10 Td (\(credit\)/cost ) Tj ET Q q 0 0 0 rg BT 525.36 542.10 Td (for ) Tj ET Q q 0 0 0 rg BT 539.86 542.10 Td (the ) Tj ET Q q 0 0 0 rg BT 554.92 542.10 Td (years ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 530.10 Td (ended ) Tj ET Q q 0 0 0 rg BT 62.38 530.10 Td (December 31 ) Tj ET Q q 0 0 0 rg BT 118.46 530.10 Td (were ) Tj ET Q q 0 0 0 rg BT 140.39 530.10 Td (as ) Tj ET Q q 0 0 0 rg BT 151.22 530.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 507.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 507.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 507.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 507.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 507.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 507.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 507.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 481.60 321.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 481.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 361.50 481.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 481.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 481.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 503.50 481.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 481.60 69.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 361.5 507.6 m 430.5 507.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 434.5 507.6 m 503.5 507.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 507.6 m 576.5 507.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 511.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.50 511.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.50 511.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.50 511.68 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 498.17 Td (Discount rate) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.15 498.17 Td (3.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 498.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 498.17 Td (3.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.65 498.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 498.17 Td (4.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 498.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 485.17 Td (Expected long-term return on plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.15 485.17 Td (7.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 485.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 485.17 Td (7.2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.65 485.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 485.17 Td (7.6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 485.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 472.17 Td (Rate of compensation increase) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.15 472.17 Td (0.5) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.15 472.17 Td (0.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 494.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 472.17 Td (2.3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 472.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 445.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.01 445.10 Td (yield ) Tj ET Q q 0 0 0 rg BT 76.47 445.10 Td (on ) Tj ET Q q 0 0 0 rg BT 88.93 445.10 Td (high ) Tj ET Q q 0 0 0 rg BT 109.17 445.10 Td (quality ) Tj ET Q q 0 0 0 rg BT 139.41 445.10 Td (corporate ) Tj ET Q q 0 0 0 rg BT 179.62 445.10 Td (bonds ) Tj ET Q q 0 0 0 rg BT 205.98 445.10 Td (matching ) Tj ET Q q 0 0 0 rg BT 245.65 445.10 Td (the ) Tj ET Q q 0 0 0 rg BT 260.33 445.10 Td (duration ) Tj ET Q q 0 0 0 rg BT 296.12 445.10 Td (of ) Tj ET Q q 0 0 0 rg BT 306.91 445.10 Td (the ) Tj ET Q q 0 0 0 rg BT 321.59 445.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 351.81 445.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 398.72 445.10 Td (is ) Tj ET Q q 0 0 0 rg BT 407.85 445.10 Td (used ) Tj ET Q q 0 0 0 rg BT 428.65 445.10 Td (in ) Tj ET Q q 0 0 0 rg BT 438.89 445.10 Td (determining ) Tj ET Q q 0 0 0 rg BT 489.67 445.10 Td (the ) Tj ET Q q 0 0 0 rg BT 504.35 445.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 540.70 445.10 Td (rate. ) Tj ET Q q 0 0 0 rg BT 560.47 445.10 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 433.10 Td (Citi ) Tj ET Q q 0 0 0 rg BT 53.50 433.10 Td (Pension ) Tj ET Q q 0 0 0 rg BT 87.67 433.10 Td (Discount ) Tj ET Q q 0 0 0 rg BT 126.28 433.10 Td (curve ) Tj ET Q q 0 0 0 rg BT 150.99 433.10 Td (is ) Tj ET Q q 0 0 0 rg BT 160.16 433.10 Td (used ) Tj ET Q q 0 0 0 rg BT 180.99 433.10 Td (in ) Tj ET Q q 0 0 0 rg BT 191.27 433.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 238.20 433.10 Td (the ) Tj ET Q q 0 0 0 rg BT 252.92 433.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 289.31 433.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 306.79 433.10 Td (for ) Tj ET Q q 0 0 0 rg BT 320.95 433.10 Td (the ) Tj ET Q q 0 0 0 rg BT 335.67 433.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 355.95 433.10 Td (plans.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 409.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.25 409.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 92.49 409.10 Td (return ) Tj ET Q q 0 0 0 rg BT 119.07 409.10 Td (on ) Tj ET Q q 0 0 0 rg BT 131.77 409.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 151.69 409.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 177.73 409.10 Td (was ) Tj ET Q q 0 0 0 rg BT 195.98 409.10 Td (determined ) Tj ET Q q 0 0 0 rg BT 243.67 409.10 Td (using ) Tj ET Q q 0 0 0 rg BT 268.04 409.10 Td (the ) Tj ET Q q 0 0 0 rg BT 282.96 409.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 321.20 409.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 338.89 409.10 Td (of ) Tj ET Q q 0 0 0 rg BT 349.92 409.10 Td (return ) Tj ET Q q 0 0 0 rg BT 376.50 409.10 Td (and ) Tj ET Q q 0 0 0 rg BT 393.65 409.10 Td (a ) Tj ET Q q 0 0 0 rg BT 400.79 409.10 Td (calculated ) Tj ET Q q 0 0 0 rg BT 444.02 409.10 Td (value ) Tj ET Q q 0 0 0 rg BT 468.38 409.10 Td (of ) Tj ET Q q 0 0 0 rg BT 479.41 409.10 Td (assets, ) Tj ET Q q 0 0 0 rg BT 507.95 409.10 Td (referred ) Tj ET Q q 0 0 0 rg BT 542.29 409.10 Td (to ) Tj ET Q q 0 0 0 rg BT 552.77 409.10 Td (as ) Tj ET Q q 0 0 0 rg BT 563.80 409.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 397.10 Td (“market-related ) Tj ET Q q 0 0 0 rg BT 100.90 397.10 Td (value” ) Tj ET Q q 0 0 0 rg BT 129.16 397.10 Td (which ) Tj ET Q q 0 0 0 rg BT 155.76 397.10 Td (approximated ) Tj ET Q q 0 0 0 rg BT 212.91 397.10 Td (the ) Tj ET Q q 0 0 0 rg BT 227.29 397.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 243.33 397.10 Td (value ) Tj ET Q q 0 0 0 rg BT 267.15 397.10 Td (of ) Tj ET Q q 0 0 0 rg BT 277.65 397.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 297.03 397.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 322.53 397.10 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.91 397.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 390.16 397.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.16 397.10 Td (. ) Tj ET Q q 0 0 0 rg BT 414.83 397.10 Td (Dif) Tj ET Q q 0 0 0 rg BT 427.98 397.10 Td (ferences ) Tj ET Q q 0 0 0 rg BT 463.45 397.10 Td (between ) Tj ET Q q 0 0 0 rg BT 498.93 397.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 535.53 397.10 Td (and ) Tj ET Q q 0 0 0 rg BT 552.14 397.10 Td (actual ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 385.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 67.25 385.10 Td (are ) Tj ET Q q 0 0 0 rg BT 82.93 385.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 126.39 385.10 Td (to ) Tj ET Q q 0 0 0 rg BT 137.65 385.10 Td (the ) Tj ET Q q 0 0 0 rg BT 153.34 385.10 Td (market-related ) Tj ET Q q 0 0 0 rg BT 215.12 385.10 Td (value ) Tj ET Q q 0 0 0 rg BT 240.25 385.10 Td (on ) Tj ET Q q 0 0 0 rg BT 253.73 385.10 Td (a ) Tj ET Q q 0 0 0 rg BT 261.64 385.10 Td (straight-line ) Tj ET Q q 0 0 0 rg BT 313.44 385.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 336.92 385.10 Td (over ) Tj ET Q q 0 0 0 rg BT 358.17 385.10 Td (a ) Tj ET Q q 0 0 0 rg BT 366.08 385.10 Td (three-year ) Tj ET Q q 0 0 0 rg BT 410.08 385.10 Td (period. ) Tj ET Q q 0 0 0 rg BT 441.61 385.10 Td (Several ) Tj ET Q q 0 0 0 rg BT 475.07 385.10 Td (factors ) Tj ET Q q 0 0 0 rg BT 505.76 385.10 Td (are ) Tj ET Q q 0 0 0 rg BT 521.44 385.10 Td (considered ) Tj ET Q q 0 0 0 rg BT 568.23 385.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 373.10 Td (developing ) Tj ET Q q 0 0 0 rg BT 83.12 373.10 Td (the ) Tj ET Q q 0 0 0 rg BT 98.03 373.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 136.25 373.10 Td (return ) Tj ET Q q 0 0 0 rg BT 162.81 373.10 Td (on ) Tj ET Q q 0 0 0 rg BT 175.50 373.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 195.40 373.10 Td (assets, ) Tj ET Q q 0 0 0 rg BT 223.92 373.10 Td (including ) Tj ET Q q 0 0 0 rg BT 264.38 373.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 306.51 373.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 346.41 373.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 376.86 373.10 Td (and ) Tj ET Q q 0 0 0 rg BT 393.99 373.10 Td (input ) Tj ET Q q 0 0 0 rg BT 417.23 373.10 Td (from ) Tj ET Q q 0 0 0 rg BT 439.36 373.10 Td (external ) Tj ET Q q 0 0 0 rg BT 474.25 373.10 Td (advisors. ) Tj ET Q q 0 0 0 rg BT 512.77 373.10 Td (Individual ) Tj ET Q q 0 0 0 rg BT 556.56 373.10 Td (asset ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 361.10 Td (class ) Tj ET Q q 0 0 0 rg BT 57.61 361.10 Td (return ) Tj ET Q q 0 0 0 rg BT 83.65 361.10 Td (forecasts ) Tj ET Q q 0 0 0 rg BT 121.36 361.10 Td (were ) Tj ET Q q 0 0 0 rg BT 142.95 361.10 Td (developed ) Tj ET Q q 0 0 0 rg BT 186.21 361.10 Td (based ) Tj ET Q q 0 0 0 rg BT 211.15 361.10 Td (upon ) Tj ET Q q 0 0 0 rg BT 233.32 361.10 Td (market ) Tj ET Q q 0 0 0 rg BT 263.25 361.10 Td (conditions, ) Tj ET Q q 0 0 0 rg BT 309.58 361.10 Td (for ) Tj ET Q q 0 0 0 rg BT 323.41 361.10 Td (example, ) Tj ET Q q 0 0 0 rg BT 361.95 361.10 Td (price-earnings ) Tj ET Q q 0 0 0 rg BT 421.31 361.10 Td (levels ) Tj ET Q q 0 0 0 rg BT 446.81 361.10 Td (and ) Tj ET Q q 0 0 0 rg BT 463.41 361.10 Td (yields ) Tj ET Q q 0 0 0 rg BT 489.47 361.10 Td (and ) Tj ET Q q 0 0 0 rg BT 506.07 361.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 547.67 361.10 Td (growth ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 349.10 Td (expectations. ) Tj ET Q q 0 0 0 rg BT 90.90 349.10 Td (The ) Tj ET Q q 0 0 0 rg BT 109.05 349.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 147.18 349.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 189.22 349.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 206.81 349.10 Td (of ) Tj ET Q q 0 0 0 rg BT 217.74 349.10 Td (return ) Tj ET Q q 0 0 0 rg BT 244.23 349.10 Td (is ) Tj ET Q q 0 0 0 rg BT 253.50 349.10 Td (the ) Tj ET Q q 0 0 0 rg BT 268.32 349.10 Td (weighted-average ) Tj ET Q q 0 0 0 rg BT 341.99 349.10 Td (of ) Tj ET Q q 0 0 0 rg BT 352.93 349.10 Td (the ) Tj ET Q q 0 0 0 rg BT 367.75 349.10 Td (tar) Tj ET Q q 0 0 0 rg BT 378.11 349.10 Td (get ) Tj ET Q q 0 0 0 rg BT 392.94 349.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 414.98 349.10 Td (allocation ) Tj ET Q q 0 0 0 rg BT 457.01 349.10 Td (of ) Tj ET Q q 0 0 0 rg BT 467.94 349.10 Td (each ) Tj ET Q q 0 0 0 rg BT 488.86 349.10 Td (individual ) Tj ET Q q 0 0 0 rg BT 532.02 349.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 554.06 349.10 Td (class. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 337.10 Td (Historical ) Tj ET Q q 0 0 0 rg BT 77.93 337.10 Td (long-term ) Tj ET Q q 0 0 0 rg BT 119.87 337.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 146.24 337.10 Td (annualized ) Tj ET Q q 0 0 0 rg BT 192.05 337.10 Td (returns ) Tj ET Q q 0 0 0 rg BT 222.32 337.10 Td (for ) Tj ET Q q 0 0 0 rg BT 236.48 337.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 256.76 337.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 290.37 337.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 313.98 337.10 Td (were ) Tj ET Q q 0 0 0 rg BT 335.91 337.10 Td (as ) Tj ET Q q 0 0 0 rg BT 346.74 337.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 314.60 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 314.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 314.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 314.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 314.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 314.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 314.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 288.60 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 288.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 288.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 288.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 288.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 288.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 288.60 70.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 314.6 m 429.5 314.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 314.6 m 502.5 314.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 314.6 m 576.5 314.6 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 318.68 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 318.68 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.00 318.68 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 305.17 Td (10 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 305.17 Td (6.1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 305.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 305.17 Td (6.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 305.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 305.17 Td (7.9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 305.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 292.17 Td (15 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 292.17 Td (7.1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 292.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 292.17 Td (6.0) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 292.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 292.17 Td (6.4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 292.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 279.17 Td (20 years) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 279.17 Td (7.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 279.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 279.17 Td (8.1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 279.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 279.17 Td (9.3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 279.17 Td (%) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 252.10 Td (Actuarial ) Tj ET Q q 0 0 0 rg BT 76.22 252.10 Td (gains ) Tj ET Q q 0 0 0 rg BT 100.35 252.10 Td (and ) Tj ET Q q 0 0 0 rg BT 117.81 252.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 144.72 252.10 Td (resulted ) Tj ET Q q 0 0 0 rg BT 179.40 252.10 Td (from ) Tj ET Q q 0 0 0 rg BT 201.85 252.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 237.08 252.10 Td (in ) Tj ET Q q 0 0 0 rg BT 247.88 252.10 Td (actuarial ) Tj ET Q q 0 0 0 rg BT 285.32 252.10 Td (assumptions ) Tj ET Q q 0 0 0 rg BT 337.79 252.10 Td (\(such ) Tj ET Q q 0 0 0 rg BT 362.47 252.10 Td (as ) Tj ET Q q 0 0 0 rg BT 373.82 252.10 Td (changes ) Tj ET Q q 0 0 0 rg BT 409.04 252.10 Td (in ) Tj ET Q q 0 0 0 rg BT 419.84 252.10 Td (the ) Tj ET Q q 0 0 0 rg BT 435.08 252.10 Td (discount ) Tj ET Q q 0 0 0 rg BT 471.99 252.10 Td (rate ) Tj ET Q q 0 0 0 rg BT 489.99 252.10 Td (and ) Tj ET Q q 0 0 0 rg BT 507.45 252.10 Td (revised ) Tj ET Q q 0 0 0 rg BT 539.35 252.10 Td (mortality ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 240.10 Td (rates\) ) Tj ET Q q 0 0 0 rg BT 61.42 240.10 Td (and ) Tj ET Q q 0 0 0 rg BT 79.07 240.10 Td (from ) Tj ET Q q 0 0 0 rg BT 101.73 240.10 Td (dif) Tj ET Q q 0 0 0 rg BT 112.65 240.10 Td (ferences ) Tj ET Q q 0 0 0 rg BT 149.17 240.10 Td (between ) Tj ET Q q 0 0 0 rg BT 185.70 240.10 Td (assumed ) Tj ET Q q 0 0 0 rg BT 223.36 240.10 Td (and ) Tj ET Q q 0 0 0 rg BT 241.01 240.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 268.10 240.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 314.61 240.10 Td (\(such ) Tj ET Q q 0 0 0 rg BT 339.49 240.10 Td (as ) Tj ET Q q 0 0 0 rg BT 351.03 240.10 Td (dif) Tj ET Q q 0 0 0 rg BT 361.96 240.10 Td (ferences ) Tj ET Q q 0 0 0 rg BT 398.48 240.10 Td (between ) Tj ET Q q 0 0 0 rg BT 435.01 240.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 462.09 240.10 Td (and ) Tj ET Q q 0 0 0 rg BT 479.75 240.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 518.49 240.10 Td (return ) Tj ET Q q 0 0 0 rg BT 545.59 240.10 Td (on ) Tj ET Q q 0 0 0 rg BT 558.80 240.10 Td (plan ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 228.10 Td (assets\). ) Tj ET Q q 0 0 0 rg BT 67.81 228.10 Td (Gains ) Tj ET Q q 0 0 0 rg BT 93.79 228.10 Td (and ) Tj ET Q q 0 0 0 rg BT 110.87 228.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 137.41 228.10 Td (are ) Tj ET Q q 0 0 0 rg BT 152.27 228.10 Td (amortized ) Tj ET Q q 0 0 0 rg BT 194.90 228.10 Td (over ) Tj ET Q q 0 0 0 rg BT 215.31 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 230.18 228.10 Td (life ) Tj ET Q q 0 0 0 rg BT 246.15 228.10 Td (expectancy ) Tj ET Q q 0 0 0 rg BT 293.77 228.10 Td (of ) Tj ET Q q 0 0 0 rg BT 304.75 228.10 Td (the ) Tj ET Q q 0 0 0 rg BT 319.61 228.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 339.48 228.10 Td (participants ) Tj ET Q q 0 0 0 rg BT 388.77 228.10 Td (for ) Tj ET Q q 0 0 0 rg BT 403.08 228.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 423.51 228.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 447.27 228.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 450.60 228.10 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.60 228.10 Td ( ) Tj ET Q q 0 0 0 rg BT 463.25 228.10 Td (years ) Tj ET Q q 0 0 0 rg BT 486.99 228.10 Td (in ) Tj ET Q q 0 0 0 rg BT 497.42 228.10 Td (2017\) ) Tj ET Q q 0 0 0 rg BT 523.40 228.10 Td (and ) Tj ET Q q 0 0 0 rg BT 540.49 228.10 Td (expected ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 216.10 Td (remaining ) Tj ET Q q 0 0 0 rg BT 79.13 216.10 Td (service ) Tj ET Q q 0 0 0 rg BT 110.03 216.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 142.05 216.10 Td (for ) Tj ET Q q 0 0 0 rg BT 156.30 216.10 Td (most ) Tj ET Q q 0 0 0 rg BT 178.33 216.10 Td (other ) Tj ET Q q 0 0 0 rg BT 201.46 216.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 225.16 216.10 Td (to ) Tj ET Q q 0 0 0 rg BT 235.52 216.10 Td (the ) Tj ET Q q 0 0 0 rg BT 250.32 216.10 Td (extent ) Tj ET Q q 0 0 0 rg BT 277.34 216.10 Td (they ) Tj ET Q q 0 0 0 rg BT 297.15 216.10 Td (exceed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 327.48 216.10 Td (10%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 345.81 216.10 Td ( ) Tj ET Q q 0 0 0 rg BT 348.40 216.10 Td (of ) Tj ET Q q 0 0 0 rg BT 359.32 216.10 Td (the ) Tj ET Q q 0 0 0 rg BT 374.12 216.10 Td (higher ) Tj ET Q q 0 0 0 rg BT 402.25 216.10 Td (of ) Tj ET Q q 0 0 0 rg BT 413.17 216.10 Td (the ) Tj ET Q q 0 0 0 rg BT 427.97 216.10 Td (market-related ) Tj ET Q q 0 0 0 rg BT 488.85 216.10 Td (value ) Tj ET Q q 0 0 0 rg BT 513.09 216.10 Td (or ) Tj ET Q q 0 0 0 rg BT 524.01 216.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.81 216.10 Td (projected ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 204.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 65.91 204.10 Td (obligation ) Tj ET Q q 0 0 0 rg BT 108.60 204.10 Td (for ) Tj ET Q q 0 0 0 rg BT 122.41 204.10 Td (each ) Tj ET Q q 0 0 0 rg BT 142.87 204.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 185.54 204.10 Td (plan. ) Tj ET Q q 0 0 0 rg BT 207.25 204.10 Td (The ) Tj ET Q q 0 0 0 rg BT 224.94 204.10 Td (amortization ) Tj ET Q q 0 0 0 rg BT 277.62 204.10 Td (of ) Tj ET Q q 0 0 0 rg BT 288.09 204.10 Td (net ) Tj ET Q q 0 0 0 rg BT 302.45 204.10 Td (actuarial ) Tj ET Q q 0 0 0 rg BT 339.01 204.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 356.72 204.10 Td (and ) Tj ET Q q 0 0 0 rg BT 373.30 204.10 Td (prior ) Tj ET Q q 0 0 0 rg BT 394.88 204.10 Td (service ) Tj ET Q q 0 0 0 rg BT 425.34 204.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 450.25 204.10 Td (is ) Tj ET Q q 0 0 0 rg BT 459.06 204.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 496.74 204.10 Td (to ) Tj ET Q q 0 0 0 rg BT 506.66 204.10 Td (be ) Tj ET Q q 0 0 0 rg BT 518.24 204.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 192.10 Td ($75 ) Tj ET Q q 0 0 0 rg BT 53.69 192.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 82.58 192.10 Td ( ) Tj ET Q q 0 0 0 rg BT 85.27 192.10 Td (in ) Tj ET Q q 0 0 0 rg BT 95.73 192.10 Td (2017. ) Tj ET Q q 0 0 0 rg BT 120.73 192.10 Td (The ) Tj ET Q q 0 0 0 rg BT 138.96 192.10 Td (periodic ) Tj ET Q q 0 0 0 rg BT 174.41 192.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 204.87 192.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 223.66 192.10 Td (or ) Tj ET Q q 0 0 0 rg BT 234.68 192.10 Td (credit ) Tj ET Q q 0 0 0 rg BT 260.13 192.10 Td (is ) Tj ET Q q 0 0 0 rg BT 269.49 192.10 Td (included ) Tj ET Q q 0 0 0 rg BT 306.61 192.10 Td (in ) Tj ET Q q 0 0 0 rg BT 317.08 192.10 Td (cost ) Tj ET Q q 0 0 0 rg BT 335.87 192.10 Td (of ) Tj ET Q q 0 0 0 rg BT 346.89 192.10 Td (products ) Tj ET Q q 0 0 0 rg BT 384.02 192.10 Td (sold, ) Tj ET Q q 0 0 0 rg BT 405.88 192.10 Td (research ) Tj ET Q q 0 0 0 rg BT 441.87 192.10 Td (and ) Tj ET Q q 0 0 0 rg BT 459.00 192.10 Td (development, ) Tj ET Q q 0 0 0 rg BT 515.83 192.10 Td (and ) Tj ET Q q 0 0 0 rg BT 532.96 192.10 Td (marketing, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 180.10 Td (selling ) Tj ET Q q 0 0 0 rg BT 65.73 180.10 Td (and ) Tj ET Q q 0 0 0 rg BT 83.24 180.10 Td (administrative ) Tj ET Q q 0 0 0 rg BT 143.51 180.10 Td (expenses, ) Tj ET Q q 0 0 0 rg BT 185.17 180.10 Td (except ) Tj ET Q q 0 0 0 rg BT 214.33 180.10 Td (for ) Tj ET Q q 0 0 0 rg BT 229.06 180.10 Td (curtailments, ) Tj ET Q q 0 0 0 rg BT 284.06 180.10 Td (settlements ) Tj ET Q q 0 0 0 rg BT 332.11 180.10 Td (and ) Tj ET Q q 0 0 0 rg BT 349.62 180.10 Td (other ) Tj ET Q q 0 0 0 rg BT 373.23 180.10 Td (special ) Tj ET Q q 0 0 0 rg BT 404.06 180.10 Td (termination ) Tj ET Q q 0 0 0 rg BT 453.23 180.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 487.95 180.10 Td (which ) Tj ET Q q 0 0 0 rg BT 515.45 180.10 Td (are ) Tj ET Q q 0 0 0 rg BT 530.73 180.10 Td (included ) Tj ET Q q 0 0 0 rg BT 568.23 180.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 168.10 Td (other ) Tj ET Q q 0 0 0 rg BT 59.05 168.10 Td (expenses.) Tj ET Q endstream endobj 185 0 obj <> endobj 186 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (92) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Postretirement ) Tj ET Q q 0 0 0 rg BT 99.05 749.25 Td (Benefit ) Tj ET Q q 0 0 0 rg BT 131.55 749.25 Td (Plans) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.25 Td (Comprehensive ) Tj ET Q q 0 0 0 rg BT 101.45 725.25 Td (medical ) Tj ET Q q 0 0 0 rg BT 135.79 725.25 Td (and ) Tj ET Q q 0 0 0 rg BT 152.92 725.25 Td (group ) Tj ET Q q 0 0 0 rg BT 178.94 725.25 Td (life ) Tj ET Q q 0 0 0 rg BT 194.96 725.25 Td (benefits ) Tj ET Q q 0 0 0 rg BT 229.31 725.25 Td (are ) Tj ET Q q 0 0 0 rg BT 244.20 725.25 Td (provided ) Tj ET Q q 0 0 0 rg BT 282.44 725.25 Td (for ) Tj ET Q q 0 0 0 rg BT 296.79 725.25 Td (substantially ) Tj ET Q q 0 0 0 rg BT 350.03 725.25 Td (all ) Tj ET Q q 0 0 0 rg BT 362.72 725.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 383.19 725.25 Td (retirees ) Tj ET Q q 0 0 0 rg BT 415.31 725.25 Td (electing ) Tj ET Q q 0 0 0 rg BT 449.65 725.25 Td (to ) Tj ET Q q 0 0 0 rg BT 460.12 725.25 Td (participate ) Tj ET Q q 0 0 0 rg BT 505.00 725.25 Td (in ) Tj ET Q q 0 0 0 rg BT 515.47 725.25 Td (comprehensive ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.25 Td (medical ) Tj ET Q q 0 0 0 rg BT 69.31 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 85.40 713.25 Td (group ) Tj ET Q q 0 0 0 rg BT 110.39 713.25 Td (life ) Tj ET Q q 0 0 0 rg BT 125.38 713.25 Td (plans ) Tj ET Q q 0 0 0 rg BT 148.14 713.25 Td (and ) Tj ET Q q 0 0 0 rg BT 164.24 713.25 Td (to ) Tj ET Q q 0 0 0 rg BT 173.67 713.25 Td (a ) Tj ET Q q 0 0 0 rg BT 179.77 713.25 Td (lesser ) Tj ET Q q 0 0 0 rg BT 204.20 713.25 Td (extent ) Tj ET Q q 0 0 0 rg BT 230.29 713.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 259.15 713.25 Td (benefits ) Tj ET Q q 0 0 0 rg BT 292.46 713.25 Td (for ) Tj ET Q q 0 0 0 rg BT 305.78 713.25 Td (non-U.S. ) Tj ET Q q 0 0 0 rg BT 343.55 713.25 Td (employees. ) Tj ET Q q 0 0 0 rg BT 390.35 713.25 Td (The ) Tj ET Q q 0 0 0 rg BT 407.56 713.25 Td (medical ) Tj ET Q q 0 0 0 rg BT 440.86 713.25 Td (plan ) Tj ET Q q 0 0 0 rg BT 459.74 713.25 Td (is ) Tj ET Q q 0 0 0 rg BT 468.07 713.25 Td (contributory) Tj ET Q q 0 0 0 rg BT 516.85 713.25 Td (. ) Tj ET Q q 0 0 0 rg BT 521.01 713.25 Td (Contributions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 701.25 Td (are ) Tj ET Q q 0 0 0 rg BT 51.27 701.25 Td (adjusted ) Tj ET Q q 0 0 0 rg BT 87.67 701.25 Td (periodically ) Tj ET Q q 0 0 0 rg BT 138.49 701.25 Td (and ) Tj ET Q q 0 0 0 rg BT 156.00 701.25 Td (vary ) Tj ET Q q 0 0 0 rg BT 176.83 701.25 Td (by ) Tj ET Q q 0 0 0 rg BT 189.90 701.25 Td (date ) Tj ET Q q 0 0 0 rg BT 209.62 701.25 Td (of ) Tj ET Q q 0 0 0 rg BT 221.01 701.25 Td (retirement. ) Tj ET Q q 0 0 0 rg BT 267.45 701.25 Td (The ) Tj ET Q q 0 0 0 rg BT 286.06 701.25 Td (life ) Tj ET Q q 0 0 0 rg BT 302.45 701.25 Td (insurance ) Tj ET Q q 0 0 0 rg BT 343.83 701.25 Td (plan ) Tj ET Q q 0 0 0 rg BT 364.12 701.25 Td (is ) Tj ET Q q 0 0 0 rg BT 373.85 701.25 Td (noncontributory) Tj ET Q q 0 0 0 rg BT 437.64 701.25 Td (. ) Tj ET Q q 0 0 0 rg BT 443.21 701.25 Td (Plan ) Tj ET Q q 0 0 0 rg BT 464.05 701.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 490.45 701.25 Td (consist ) Tj ET Q q 0 0 0 rg BT 521.29 701.25 Td (principally ) Tj ET Q q 0 0 0 rg BT 567.68 701.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 63.76 689.25 Td (and ) Tj ET Q q 0 0 0 rg BT 80.97 689.25 Td (fixed-income ) Tj ET Q q 0 0 0 rg BT 137.05 689.25 Td (securities. ) Tj ET Q q 0 0 0 rg BT 180.08 689.25 Td (Postretirement ) Tj ET Q q 0 0 0 rg BT 241.17 689.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 271.70 689.25 Td (plan ) Tj ET Q q 0 0 0 rg BT 291.69 689.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 338.90 689.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 361.10 689.25 Td ($308 ) Tj ET Q q 0 0 0 rg BT 383.87 689.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.76 689.25 Td ( ) Tj ET Q q 0 0 0 rg BT 415.53 689.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.73 689.25 Td ($355 ) Tj ET Q q 0 0 0 rg BT 455.50 689.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.39 689.25 Td ( ) Tj ET Q q 0 0 0 rg BT 487.16 689.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 497.15 689.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 556.00 689.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.33 677.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 72.33 677.25 Td (, ) Tj ET Q q 0 0 0 rg BT 76.73 677.25 Td (respectively) Tj ET Q q 0 0 0 rg BT 124.39 677.25 Td (, ) Tj ET Q q 0 0 0 rg BT 128.78 677.25 Td (and ) Tj ET Q q 0 0 0 rg BT 145.12 677.25 Td (the ) Tj ET Q q 0 0 0 rg BT 159.23 677.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 175.00 677.25 Td (value ) Tj ET Q q 0 0 0 rg BT 198.55 677.25 Td (of ) Tj ET Q q 0 0 0 rg BT 208.77 677.25 Td (plan ) Tj ET Q q 0 0 0 rg BT 227.88 677.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 253.11 677.25 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.43 677.25 Td ($331 ) Tj ET Q q 0 0 0 rg BT 296.33 677.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.22 677.25 Td ( ) Tj ET Q q 0 0 0 rg BT 327.11 677.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.45 677.25 Td ($328 ) Tj ET Q q 0 0 0 rg BT 365.34 677.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.23 677.25 Td ( ) Tj ET Q q 0 0 0 rg BT 396.13 677.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.24 677.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 463.22 677.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.22 677.25 Td ( ) Tj ET Q q 0 0 0 rg BT 485.11 677.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.44 677.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.44 677.25 Td (, ) Tj ET Q q 0 0 0 rg BT 525.84 677.25 Td (respectively) Tj ET Q q 0 0 0 rg BT 573.50 677.25 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.28 665.25 Td (weighted-average ) Tj ET Q q 0 0 0 rg BT 128.09 665.25 Td (discount ) Tj ET Q q 0 0 0 rg BT 164.71 665.25 Td (rate ) Tj ET Q q 0 0 0 rg BT 182.44 665.25 Td (used ) Tj ET Q q 0 0 0 rg BT 203.50 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 214.02 665.25 Td (determine ) Tj ET Q q 0 0 0 rg BT 256.73 665.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 287.24 665.25 Td (obligations ) Tj ET Q q 0 0 0 rg BT 334.42 665.25 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.70 665.25 Td (3.6%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.53 665.25 Td ( ) Tj ET Q q 0 0 0 rg BT 376.27 665.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.22 665.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 445.05 665.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.05 665.25 Td ( ) Tj ET Q q 0 0 0 rg BT 467.78 665.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.96 665.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.96 665.25 Td (. ) Tj ET Q q 0 0 0 rg BT 510.00 665.25 Td (The ) Tj ET Q q 0 0 0 rg BT 528.28 665.25 Td (net ) Tj ET Q q 0 0 0 rg BT 543.23 665.25 Td (periodic ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.25 Td (benefit ) Tj ET Q q 0 0 0 rg BT 66.26 653.25 Td (credits ) Tj ET Q q 0 0 0 rg BT 95.42 653.25 Td (were ) Tj ET Q q 0 0 0 rg BT 117.35 653.25 Td (not ) Tj ET Q q 0 0 0 rg BT 132.63 653.25 Td (material.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 629.25 Td (Plan ) Tj ET Q q 0 0 0 rg BT 57.58 629.25 Td (Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 613.25 Td (The fair value of pension and postretirement plan assets by asset category at December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.42 613.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 421.42 613.25 Td ( and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 440.86 613.25 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.86 613.25 Td ( was as follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 576.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 576.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 576.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 550.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 550.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 550.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 524.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 524.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 524.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 498.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 498.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 498.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 472.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 472.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 472.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 446.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 446.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 446.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 429.75 246.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 429.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 429.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 403.75 204.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 240.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 244.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 403.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 403.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 377.75 246.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 324.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 328.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 366.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 370.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 408.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 412.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 450.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 454.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 492.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 496.50 377.75 38.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 534.50 377.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 538.50 377.75 38.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 589.75 m 282.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 282.5 589.75 m 286.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 589.75 m 324.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 324.5 589.75 m 328.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 589.75 m 366.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 366.5 589.75 m 370.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 589.75 m 408.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 589.75 m 450.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 450.5 589.75 m 454.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 589.75 m 492.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 492.5 589.75 m 496.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 589.75 m 534.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 534.5 589.75 m 538.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 589.75 m 576.5 589.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 576.75 m 282.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 576.75 m 324.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 576.75 m 366.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 576.75 m 408.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 576.75 m 450.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 576.75 m 492.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 576.75 m 534.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 576.75 m 576.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 576.75 m 282.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 576.75 m 324.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 576.75 m 366.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 576.75 m 408.5 576.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 446.75 m 282.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 446.75 m 324.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 446.75 m 366.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 446.75 m 408.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 446.75 m 450.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 446.75 m 492.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 446.75 m 534.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 446.75 m 576.5 446.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 434.75 m 282.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 244.5 432.75 m 282.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 434.75 m 324.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 432.75 m 324.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 434.75 m 366.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 328.5 432.75 m 366.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 434.75 m 408.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 432.75 m 408.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 434.75 m 450.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 412.5 432.75 m 450.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 434.75 m 492.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 454.5 432.75 m 492.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 434.75 m 534.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 496.5 432.75 m 534.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 434.75 m 576.5 434.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 432.75 m 576.5 432.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 377.75 m 408.5 377.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 377.75 m 576.5 377.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 364.75 m 408.5 364.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 352.75 m 408.5 352.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 370.5 350.75 m 408.5 350.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 364.75 m 576.5 364.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 352.75 m 576.5 352.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 538.5 350.75 m 576.5 350.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 594.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 293.75 593.98 Td (December 31, 2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 461.75 593.98 Td (December 31, 2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 581.00 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 250.65 580.98 Td (Level 1) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 292.65 580.98 Td (Level 2) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 334.65 580.98 Td (Level 3) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 380.25 580.98 Td (Total) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 418.65 580.98 Td (Level 1) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 460.65 580.98 Td (Level 2) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 502.65 580.98 Td (Level 3) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 548.25 580.98 Td (Total) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 567.48 Td (Plan Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 554.32 Td (Equity securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.65 554.32 Td (833) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 289.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 554.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 554.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 554.32 Td (833) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 554.32 Td (785) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 554.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 554.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.00 554.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 554.32 Td (785) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 541.32 Td (Equity funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.65 541.32 Td (138) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.10 541.32 Td (1,230) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 541.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 541.32 Td (1,368) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 541.32 Td (452) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 541.32 Td (748) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 541.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 541.32 Td (1,200) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 528.32 Td (Fixed income funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 528.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 528.32 Td (804) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 528.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 528.32 Td (804) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 528.32 Td (249) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 528.32 Td (724) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 528.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 528.32 Td (973) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 515.32 Td (Corporate debt securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 515.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.10 515.32 Td (1,405) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 515.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 515.32 Td (1,405) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.65 515.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.10 515.32 Td (1,382) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 515.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 515.32 Td (1,382) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 502.32 Td (U.S. Treasury and agency securities) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 502.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 305.65 502.32 Td (536) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 502.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 502.32 Td (536) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.65 502.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 502.32 Td (517) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 502.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 502.32 Td (517) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 489.32 Td (Short-term investment funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 489.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 489.32 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 489.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.65 489.32 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.65 489.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 473.65 489.32 Td (103) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 489.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 489.32 Td (103) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 476.32 Td (Insurance contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 476.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 476.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 476.32 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 476.32 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.65 476.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 476.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 476.32 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 476.32 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 463.32 Td (Cash and cash equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 463.32 Td (81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 463.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 463.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.65 463.32 Td (81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 431.65 463.32 Td (106) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 463.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 463.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 463.32 Td (106) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 450.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 450.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.65 450.32 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.65 450.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 394.65 450.32 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.65 450.32 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.65 450.32 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 520.65 450.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 450.32 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 437.32 Td (Plan assets subject to leveling) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 247.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.10 437.32 Td (1,052) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 289.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.10 437.32 Td (4,158) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.65 437.32 Td (112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 437.32 Td (5,322) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 424.10 437.32 Td (1,596) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 466.10 437.32 Td (3,488) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 515.65 437.32 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.00 437.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 437.32 Td (5,199) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 420.48 Td (Plan assets measured at NAV as a practical expedient) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 407.32 Td (Equity funds) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.00 407.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 407.32 Td (476) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.00 407.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 407.32 Td (495) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 394.32 Td (Venture capital and limited partnerships) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 394.32 Td (198) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 394.32 Td (249) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 381.32 Td (Other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 381.32 Td (166) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 381.32 Td (72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 368.32 Td (Total plan assets measured at NAV as a practical expedient) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.65 368.32 Td (840) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 368.32 Td (816) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 355.32 Td (Net plan assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.00 355.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.10 355.32 Td (6,162) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 541.00 355.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.10 355.32 Td (6,015) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 334.25 Td (The investment valuation policies per investment class are as follows:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 317.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 87.38 317.25 Td (1 ) Tj ET Q q 0 0 0 rg BT 93.99 317.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 120.06 317.25 Td (utilize ) Tj ET Q q 0 0 0 rg BT 146.66 317.25 Td (unadjusted ) Tj ET Q q 0 0 0 rg BT 191.60 317.25 Td (quoted ) Tj ET Q q 0 0 0 rg BT 220.44 317.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 245.93 317.25 Td (in ) Tj ET Q q 0 0 0 rg BT 255.32 317.25 Td (active ) Tj ET Q q 0 0 0 rg BT 280.81 317.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 314.08 317.25 Td (accessible ) Tj ET Q q 0 0 0 rg BT 356.23 317.25 Td (at ) Tj ET Q q 0 0 0 rg BT 365.06 317.25 Td (the ) Tj ET Q q 0 0 0 rg BT 378.89 317.25 Td (measurement ) Tj ET Q q 0 0 0 rg BT 433.82 317.25 Td (date ) Tj ET Q q 0 0 0 rg BT 452.09 317.25 Td (for ) Tj ET Q q 0 0 0 rg BT 465.36 317.25 Td (identical ) Tj ET Q q 0 0 0 rg BT 501.41 317.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 526.35 317.25 Td (or ) Tj ET Q q 0 0 0 rg BT 536.30 317.25 Td (liabilities. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 305.25 Td (The ) Tj ET Q q 0 0 0 rg BT 80.98 305.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 97.30 305.25 Td (value ) Tj ET Q q 0 0 0 rg BT 121.39 305.25 Td (hierarchy ) Tj ET Q q 0 0 0 rg BT 161.58 305.25 Td (provides ) Tj ET Q q 0 0 0 rg BT 198.46 305.25 Td (the ) Tj ET Q q 0 0 0 rg BT 213.12 305.25 Td (highest ) Tj ET Q q 0 0 0 rg BT 244.44 305.25 Td (priority ) Tj ET Q q 0 0 0 rg BT 276.87 305.25 Td (to ) Tj ET Q q 0 0 0 rg BT 287.09 305.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 312.29 305.25 Td (1 ) Tj ET Q q 0 0 0 rg BT 319.73 305.25 Td (inputs. ) Tj ET Q q 0 0 0 rg BT 348.94 305.25 Td (These ) Tj ET Q q 0 0 0 rg BT 375.25 305.25 Td (instruments ) Tj ET Q q 0 0 0 rg BT 424.36 305.25 Td (include ) Tj ET Q q 0 0 0 rg BT 456.23 305.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 483.66 305.25 Td (securities, ) Tj ET Q q 0 0 0 rg BT 526.36 305.25 Td (equity ) Tj ET Q q 0 0 0 rg BT 553.80 305.25 Td (funds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 79.21 293.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 101.54 293.25 Td (income ) Tj ET Q q 0 0 0 rg BT 132.74 293.25 Td (funds ) Tj ET Q q 0 0 0 rg BT 156.74 293.25 Td (publicly ) Tj ET Q q 0 0 0 rg BT 191.29 293.25 Td (traded ) Tj ET Q q 0 0 0 rg BT 218.05 293.25 Td (on ) Tj ET Q q 0 0 0 rg BT 229.82 293.25 Td (a ) Tj ET Q q 0 0 0 rg BT 236.04 293.25 Td (national ) Tj ET Q q 0 0 0 rg BT 270.02 293.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 309.56 293.25 Td (exchange, ) Tj ET Q q 0 0 0 rg BT 351.59 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 367.80 293.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 387.35 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 403.56 293.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 423.10 293.25 Td (equivalents. ) Tj ET Q q 0 0 0 rg BT 472.92 293.25 Td (Cash ) Tj ET Q q 0 0 0 rg BT 494.70 293.25 Td (and ) Tj ET Q q 0 0 0 rg BT 510.91 293.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 530.45 293.25 Td (equivalents ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 281.25 Td (are ) Tj ET Q q 0 0 0 rg BT 77.91 281.25 Td (highly ) Tj ET Q q 0 0 0 rg BT 106.17 281.25 Td (liquid ) Tj ET Q q 0 0 0 rg BT 132.21 281.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 182.68 281.25 Td (with ) Tj ET Q q 0 0 0 rg BT 203.16 281.25 Td (original ) Tj ET Q q 0 0 0 rg BT 236.97 281.25 Td (maturities ) Tj ET Q q 0 0 0 rg BT 279.66 281.25 Td (of ) Tj ET Q q 0 0 0 rg BT 290.70 281.25 Td (three ) Tj ET Q q 0 0 0 rg BT 313.38 281.25 Td (months ) Tj ET Q q 0 0 0 rg BT 345.53 281.25 Td (or ) Tj ET Q q 0 0 0 rg BT 356.57 281.25 Td (less ) Tj ET Q q 0 0 0 rg BT 374.27 281.25 Td (at ) Tj ET Q q 0 0 0 rg BT 384.19 281.25 Td (the ) Tj ET Q q 0 0 0 rg BT 399.11 281.25 Td (time ) Tj ET Q q 0 0 0 rg BT 419.58 281.25 Td (of ) Tj ET Q q 0 0 0 rg BT 430.62 281.25 Td (purchase ) Tj ET Q q 0 0 0 rg BT 468.86 281.25 Td (and ) Tj ET Q q 0 0 0 rg BT 486.00 281.25 Td (are ) Tj ET Q q 0 0 0 rg BT 500.91 281.25 Td (recognized ) Tj ET Q q 0 0 0 rg BT 547.47 281.25 Td (at ) Tj ET Q q 0 0 0 rg BT 557.39 281.25 Td (cost, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 269.25 Td (which ) Tj ET Q q 0 0 0 rg BT 89.68 269.25 Td (approximates ) Tj ET Q q 0 0 0 rg BT 145.80 269.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 161.92 269.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 188.32 269.25 Td (Pending ) Tj ET Q q 0 0 0 rg BT 223.35 269.25 Td (trade ) Tj ET Q q 0 0 0 rg BT 245.58 269.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 267.26 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 283.94 269.25 Td (purchases ) Tj ET Q q 0 0 0 rg BT 325.62 269.25 Td (are ) Tj ET Q q 0 0 0 rg BT 340.07 269.25 Td (included ) Tj ET Q q 0 0 0 rg BT 376.75 269.25 Td (in ) Tj ET Q q 0 0 0 rg BT 386.77 269.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 406.79 269.25 Td (and ) Tj ET Q q 0 0 0 rg BT 423.47 269.25 Td (cash ) Tj ET Q q 0 0 0 rg BT 443.48 269.25 Td (equivalents ) Tj ET Q q 0 0 0 rg BT 491.27 269.25 Td (until ) Tj ET Q q 0 0 0 rg BT 511.85 269.25 Td (final ) Tj ET Q q 0 0 0 rg BT 532.42 269.25 Td (settlement.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 252.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 88.71 252.25 Td (2 ) Tj ET Q q 0 0 0 rg BT 96.66 252.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 124.05 252.25 Td (utilize ) Tj ET Q q 0 0 0 rg BT 151.99 252.25 Td (observable ) Tj ET Q q 0 0 0 rg BT 198.25 252.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 225.07 252.25 Td (for ) Tj ET Q q 0 0 0 rg BT 239.68 252.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 270.39 252.25 Td (instruments, ) Tj ET Q q 0 0 0 rg BT 322.51 252.25 Td (quoted ) Tj ET Q q 0 0 0 rg BT 352.67 252.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 379.49 252.25 Td (for ) Tj ET Q q 0 0 0 rg BT 394.10 252.25 Td (identical ) Tj ET Q q 0 0 0 rg BT 431.47 252.25 Td (or ) Tj ET Q q 0 0 0 rg BT 442.75 252.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 473.47 252.25 Td (instruments ) Tj ET Q q 0 0 0 rg BT 523.08 252.25 Td (in ) Tj ET Q q 0 0 0 rg BT 533.80 252.25 Td (non-active ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 240.25 Td (markets, ) Tj ET Q q 0 0 0 rg BT 98.76 240.25 Td (and ) Tj ET Q q 0 0 0 rg BT 114.81 240.25 Td (other ) Tj ET Q q 0 0 0 rg BT 136.96 240.25 Td (observable ) Tj ET Q q 0 0 0 rg BT 181.88 240.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 207.94 240.25 Td (that ) Tj ET Q q 0 0 0 rg BT 224.54 240.25 Td (can ) Tj ET Q q 0 0 0 rg BT 240.02 240.25 Td (be ) Tj ET Q q 0 0 0 rg BT 251.07 240.25 Td (corroborated ) Tj ET Q q 0 0 0 rg BT 303.76 240.25 Td (by ) Tj ET Q q 0 0 0 rg BT 315.36 240.25 Td (market ) Tj ET Q q 0 0 0 rg BT 344.73 240.25 Td (data ) Tj ET Q q 0 0 0 rg BT 363.00 240.25 Td (for ) Tj ET Q q 0 0 0 rg BT 376.26 240.25 Td (substantially ) Tj ET Q q 0 0 0 rg BT 428.42 240.25 Td (the ) Tj ET Q q 0 0 0 rg BT 442.24 240.25 Td (full ) Tj ET Q q 0 0 0 rg BT 457.74 240.25 Td (term ) Tj ET Q q 0 0 0 rg BT 477.67 240.25 Td (of ) Tj ET Q q 0 0 0 rg BT 487.60 240.25 Td (the ) Tj ET Q q 0 0 0 rg BT 501.43 240.25 Td (assets ) Tj ET Q q 0 0 0 rg BT 526.36 240.25 Td (or ) Tj ET Q q 0 0 0 rg BT 536.30 240.25 Td (liabilities. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 228.25 Td (Equity ) Tj ET Q q 0 0 0 rg BT 91.82 228.25 Td (funds, ) Tj ET Q q 0 0 0 rg BT 118.70 228.25 Td (fixed ) Tj ET Q q 0 0 0 rg BT 141.40 228.25 Td (income ) Tj ET Q q 0 0 0 rg BT 172.99 228.25 Td (funds, ) Tj ET Q q 0 0 0 rg BT 199.86 228.25 Td (and ) Tj ET Q q 0 0 0 rg BT 216.46 228.25 Td (short-term ) Tj ET Q q 0 0 0 rg BT 260.27 228.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 306.30 228.25 Td (funds ) Tj ET Q q 0 0 0 rg BT 330.68 228.25 Td (classified ) Tj ET Q q 0 0 0 rg BT 370.60 228.25 Td (as ) Tj ET Q q 0 0 0 rg BT 381.08 228.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 406.00 228.25 Td (2 ) Tj ET Q q 0 0 0 rg BT 413.16 228.25 Td (within ) Tj ET Q q 0 0 0 rg BT 440.87 228.25 Td (the ) Tj ET Q q 0 0 0 rg BT 455.24 228.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 471.27 228.25 Td (value ) Tj ET Q q 0 0 0 rg BT 495.08 228.25 Td (hierarchy ) Tj ET Q q 0 0 0 rg BT 534.99 228.25 Td (are ) Tj ET Q q 0 0 0 rg BT 549.35 228.25 Td (valued ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 216.25 Td (at ) Tj ET Q q 0 0 0 rg BT 72.51 216.25 Td (the ) Tj ET Q q 0 0 0 rg BT 87.01 216.25 Td (net ) Tj ET Q q 0 0 0 rg BT 101.52 216.25 Td (asset ) Tj ET Q q 0 0 0 rg BT 123.25 216.25 Td (value ) Tj ET Q q 0 0 0 rg BT 147.19 216.25 Td (of ) Tj ET Q q 0 0 0 rg BT 157.81 216.25 Td (their ) Tj ET Q q 0 0 0 rg BT 178.43 216.25 Td (shares ) Tj ET Q q 0 0 0 rg BT 205.71 216.25 Td (held ) Tj ET Q q 0 0 0 rg BT 225.22 216.25 Td (at ) Tj ET Q q 0 0 0 rg BT 234.72 216.25 Td (year ) Tj ET Q q 0 0 0 rg BT 254.22 216.25 Td (end, ) Tj ET Q q 0 0 0 rg BT 273.45 216.25 Td (which ) Tj ET Q q 0 0 0 rg BT 300.18 216.25 Td (represents ) Tj ET Q q 0 0 0 rg BT 343.00 216.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 359.17 216.25 Td (value. ) Tj ET Q q 0 0 0 rg BT 385.62 216.25 Td (Corporate ) Tj ET Q q 0 0 0 rg BT 427.89 216.25 Td (debt ) Tj ET Q q 0 0 0 rg BT 447.40 216.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 487.45 216.25 Td (and ) Tj ET Q q 0 0 0 rg BT 504.18 216.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 524.09 216.25 Td (T) Tj ET Q q 0 0 0 rg BT 529.85 216.25 Td (reasury ) Tj ET Q q 0 0 0 rg BT 561.56 216.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 204.25 Td (agency ) Tj ET Q q 0 0 0 rg BT 93.34 204.25 Td (securities ) Tj ET Q q 0 0 0 rg BT 133.14 204.25 Td (classified ) Tj ET Q q 0 0 0 rg BT 172.93 204.25 Td (as ) Tj ET Q q 0 0 0 rg BT 183.29 204.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 208.08 204.25 Td (2 ) Tj ET Q q 0 0 0 rg BT 215.11 204.25 Td (within ) Tj ET Q q 0 0 0 rg BT 242.69 204.25 Td (the ) Tj ET Q q 0 0 0 rg BT 256.94 204.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 272.85 204.25 Td (value ) Tj ET Q q 0 0 0 rg BT 296.53 204.25 Td (hierarchy ) Tj ET Q q 0 0 0 rg BT 336.31 204.25 Td (are ) Tj ET Q q 0 0 0 rg BT 350.55 204.25 Td (valued ) Tj ET Q q 0 0 0 rg BT 379.23 204.25 Td (utilizing ) Tj ET Q q 0 0 0 rg BT 414.59 204.25 Td (observable ) Tj ET Q q 0 0 0 rg BT 459.94 204.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 485.84 204.25 Td (for ) Tj ET Q q 0 0 0 rg BT 499.53 204.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 529.33 204.25 Td (instruments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 192.25 Td (and ) Tj ET Q q 0 0 0 rg BT 79.94 192.25 Td (quoted ) Tj ET Q q 0 0 0 rg BT 109.66 192.25 Td (prices ) Tj ET Q q 0 0 0 rg BT 136.03 192.25 Td (for ) Tj ET Q q 0 0 0 rg BT 150.19 192.25 Td (identical ) Tj ET Q q 0 0 0 rg BT 187.12 192.25 Td (or ) Tj ET Q q 0 0 0 rg BT 197.95 192.25 Td (similar ) Tj ET Q q 0 0 0 rg BT 228.22 192.25 Td (instruments ) Tj ET Q q 0 0 0 rg BT 277.39 192.25 Td (in ) Tj ET Q q 0 0 0 rg BT 287.67 192.25 Td (markets ) Tj ET Q q 0 0 0 rg BT 321.82 192.25 Td (that ) Tj ET Q q 0 0 0 rg BT 339.32 192.25 Td (are ) Tj ET Q q 0 0 0 rg BT 354.03 192.25 Td (not ) Tj ET Q q 0 0 0 rg BT 369.30 192.25 Td (active.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 175.25 Td (Level ) Tj ET Q q 0 0 0 rg BT 88.69 175.25 Td (3 ) Tj ET Q q 0 0 0 rg BT 96.61 175.25 Td (unobservable ) Tj ET Q q 0 0 0 rg BT 152.85 175.25 Td (inputs ) Tj ET Q q 0 0 0 rg BT 180.22 175.25 Td (are ) Tj ET Q q 0 0 0 rg BT 195.35 175.25 Td (used ) Tj ET Q q 0 0 0 rg BT 216.61 175.25 Td (when ) Tj ET Q q 0 0 0 rg BT 241.19 175.25 Td (little ) Tj ET Q q 0 0 0 rg BT 262.45 175.25 Td (or ) Tj ET Q q 0 0 0 rg BT 273.70 175.25 Td (no ) Tj ET Q q 0 0 0 rg BT 286.62 175.25 Td (market ) Tj ET Q q 0 0 0 rg BT 317.31 175.25 Td (data ) Tj ET Q q 0 0 0 rg BT 336.89 175.25 Td (is ) Tj ET Q q 0 0 0 rg BT 346.48 175.25 Td (available. ) Tj ET Q q 0 0 0 rg BT 388.00 175.25 Td (Insurance ) Tj ET Q q 0 0 0 rg BT 429.79 175.25 Td (contracts ) Tj ET Q q 0 0 0 rg BT 468.80 175.25 Td (are ) Tj ET Q q 0 0 0 rg BT 483.94 175.25 Td (held ) Tj ET Q q 0 0 0 rg BT 504.08 175.25 Td (by ) Tj ET Q q 0 0 0 rg BT 517.00 175.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 547.13 175.25 Td (foreign ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 163.25 Td (pension ) Tj ET Q q 0 0 0 rg BT 96.67 163.25 Td (plans ) Tj ET Q q 0 0 0 rg BT 120.33 163.25 Td (and ) Tj ET Q q 0 0 0 rg BT 137.33 163.25 Td (are ) Tj ET Q q 0 0 0 rg BT 152.09 163.25 Td (carried ) Tj ET Q q 0 0 0 rg BT 182.40 163.25 Td (at ) Tj ET Q q 0 0 0 rg BT 192.18 163.25 Td (contract ) Tj ET Q q 0 0 0 rg BT 226.94 163.25 Td (value, ) Tj ET Q q 0 0 0 rg BT 253.65 163.25 Td (which ) Tj ET Q q 0 0 0 rg BT 280.65 163.25 Td (approximates ) Tj ET Q q 0 0 0 rg BT 337.08 163.25 Td (the ) Tj ET Q q 0 0 0 rg BT 351.85 163.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 392.73 163.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 409.16 163.25 Td (value ) Tj ET Q q 0 0 0 rg BT 433.38 163.25 Td (and ) Tj ET Q q 0 0 0 rg BT 450.37 163.25 Td (is ) Tj ET Q q 0 0 0 rg BT 459.60 163.25 Td (based ) Tj ET Q q 0 0 0 rg BT 484.93 163.25 Td (on ) Tj ET Q q 0 0 0 rg BT 497.48 163.25 Td (the ) Tj ET Q q 0 0 0 rg BT 512.26 163.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 528.69 163.25 Td (value ) Tj ET Q q 0 0 0 rg BT 552.91 163.25 Td (of ) Tj ET Q q 0 0 0 rg BT 563.79 163.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.00 151.25 Td (underlying ) Tj ET Q q 0 0 0 rg BT 108.83 151.25 Td (investment ) Tj ET Q q 0 0 0 rg BT 155.21 151.25 Td (of ) Tj ET Q q 0 0 0 rg BT 166.04 151.25 Td (the ) Tj ET Q q 0 0 0 rg BT 180.75 151.25 Td (insurance ) Tj ET Q q 0 0 0 rg BT 221.57 151.25 Td (company) Tj ET Q q 0 0 0 rg BT 257.58 151.25 Td (. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 130.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.47 130.25 Td (May ) Tj ET Q q 0 0 0 rg BT 66.94 130.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 91.58 130.25 Td (the ) Tj ET Q q 0 0 0 rg BT 105.93 130.25 Td (F) Tj ET Q q 0 0 0 rg BT 110.75 130.25 Td (ASB ) Tj ET Q q 0 0 0 rg BT 132.34 130.25 Td (issued ) Tj ET Q q 0 0 0 rg BT 159.48 130.25 Td (amended ) Tj ET Q q 0 0 0 rg BT 197.71 130.25 Td (guidance ) Tj ET Q q 0 0 0 rg BT 235.95 130.25 Td (removing ) Tj ET Q q 0 0 0 rg BT 276.41 130.25 Td (the ) Tj ET Q q 0 0 0 rg BT 290.77 130.25 Td (requirement ) Tj ET Q q 0 0 0 rg BT 341.21 130.25 Td (to ) Tj ET Q q 0 0 0 rg BT 351.13 130.25 Td (categorize ) Tj ET Q q 0 0 0 rg BT 394.35 130.25 Td (within ) Tj ET Q q 0 0 0 rg BT 422.04 130.25 Td (the ) Tj ET Q q 0 0 0 rg BT 436.40 130.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 452.42 130.25 Td (value ) Tj ET Q q 0 0 0 rg BT 476.21 130.25 Td (hierarchy ) Tj ET Q q 0 0 0 rg BT 516.10 130.25 Td (all ) Tj ET Q q 0 0 0 rg BT 528.24 130.25 Td (investments ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 118.25 Td (for ) Tj ET Q q 0 0 0 rg BT 49.19 118.25 Td (which ) Tj ET Q q 0 0 0 rg BT 75.17 118.25 Td (fair ) Tj ET Q q 0 0 0 rg BT 90.58 118.25 Td (value ) Tj ET Q q 0 0 0 rg BT 113.76 118.25 Td (is ) Tj ET Q q 0 0 0 rg BT 121.97 118.25 Td (measured ) Tj ET Q q 0 0 0 rg BT 161.82 118.25 Td (using ) Tj ET Q q 0 0 0 rg BT 185.02 118.25 Td (the ) Tj ET Q q 0 0 0 rg BT 198.77 118.25 Td (NA) Tj ET Q q 0 0 0 rg BT 211.92 118.25 Td (V) Tj ET Q q 0 0 0 rg BT 218.96 118.25 Td ( ) Tj ET Q q 0 0 0 rg BT 220.50 118.25 Td (per ) Tj ET Q q 0 0 0 rg BT 234.80 118.25 Td (share ) Tj ET Q q 0 0 0 rg BT 257.43 118.25 Td (\(or ) Tj ET Q q 0 0 0 rg BT 270.62 118.25 Td (its ) Tj ET Q q 0 0 0 rg BT 281.61 118.25 Td (equivalent\) ) Tj ET Q q 0 0 0 rg BT 328.12 118.25 Td (as ) Tj ET Q q 0 0 0 rg BT 337.98 118.25 Td (a ) Tj ET Q q 0 0 0 rg BT 343.95 118.25 Td (practical ) Tj ET Q q 0 0 0 rg BT 379.91 118.25 Td (expedient. ) Tj ET Q q 0 0 0 rg BT 422.70 118.25 Td (The ) Tj ET Q q 0 0 0 rg BT 439.78 118.25 Td (guidance ) Tj ET Q q 0 0 0 rg BT 477.41 118.25 Td (is ) Tj ET Q q 0 0 0 rg BT 485.61 118.25 Td (applied ) Tj ET Q q 0 0 0 rg BT 516.58 118.25 Td (retrospectively ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 106.25 Td (in ) Tj ET Q q 0 0 0 rg BT 45.28 106.25 Td (the ) Tj ET Q q 0 0 0 rg BT 59.00 106.25 Td (table ) Tj ET Q q 0 0 0 rg BT 79.93 106.25 Td (above. ) Tj ET Q q 0 0 0 rg BT 107.70 106.25 Td (V) Tj ET Q q 0 0 0 rg BT 113.82 106.25 Td (enture ) Tj ET Q q 0 0 0 rg BT 140.30 106.25 Td (capital ) Tj ET Q q 0 0 0 rg BT 168.46 106.25 Td (and ) Tj ET Q q 0 0 0 rg BT 184.40 106.25 Td (limited ) Tj ET Q q 0 0 0 rg BT 214.23 106.25 Td (partnership ) Tj ET Q q 0 0 0 rg BT 260.71 106.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 309.99 106.25 Td (are ) Tj ET Q q 0 0 0 rg BT 323.70 106.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 360.19 106.25 Td (only ) Tj ET Q q 0 0 0 rg BT 379.47 106.25 Td (redeemable ) Tj ET Q q 0 0 0 rg BT 427.05 106.25 Td (through ) Tj ET Q q 0 0 0 rg BT 459.66 106.25 Td (distributions ) Tj ET Q q 0 0 0 rg BT 511.17 106.25 Td (upon ) Tj ET Q q 0 0 0 rg BT 532.67 106.25 Td (liquidation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 94.25 Td (of ) Tj ET Q q 0 0 0 rg BT 47.70 94.25 Td (the ) Tj ET Q q 0 0 0 rg BT 63.29 94.25 Td (underlying ) Tj ET Q q 0 0 0 rg BT 109.99 94.25 Td (assets. ) Tj ET Q q 0 0 0 rg BT 138.95 94.25 Td (There ) Tj ET Q q 0 0 0 rg BT 165.64 94.25 Td (were ) Tj ET Q q 0 0 0 rg BT 188.44 94.25 Td (no ) Tj ET Q q 0 0 0 rg BT 201.81 94.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 247.40 94.25 Td (unfunded ) Tj ET Q q 0 0 0 rg BT 288.54 94.25 Td (commitments ) Tj ET Q q 0 0 0 rg BT 346.35 94.25 Td (for ) Tj ET Q q 0 0 0 rg BT 361.38 94.25 Td (these ) Tj ET Q q 0 0 0 rg BT 385.30 94.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 436.45 94.25 Td (and ) Tj ET Q q 0 0 0 rg BT 454.26 94.25 Td (essentially ) Tj ET Q q 0 0 0 rg BT 499.85 94.25 Td (all ) Tj ET Q q 0 0 0 rg BT 513.22 94.25 Td (liquidations ) Tj ET Q q 0 0 0 rg BT 563.81 94.25 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 82.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 74.67 82.25 Td (to ) Tj ET Q q 0 0 0 rg BT 85.59 82.25 Td (occur ) Tj ET Q q 0 0 0 rg BT 110.93 82.25 Td (by ) Tj ET Q q 0 0 0 rg BT 124.07 82.25 Td (2019. Most ) Tj ET Q q 0 0 0 rg BT 172.77 82.25 Td (of ) Tj ET Q q 0 0 0 rg BT 184.24 82.25 Td (the ) Tj ET Q q 0 0 0 rg BT 199.60 82.25 Td (remaining ) Tj ET Q q 0 0 0 rg BT 243.28 82.25 Td (investments ) Tj ET Q q 0 0 0 rg BT 294.19 82.25 Td (using ) Tj ET Q q 0 0 0 rg BT 319.00 82.25 Td (the ) Tj ET Q q 0 0 0 rg BT 334.35 82.25 Td (practical ) Tj ET Q q 0 0 0 rg BT 371.91 82.25 Td (expedient ) Tj ET Q q 0 0 0 rg BT 413.92 82.25 Td (are ) Tj ET Q q 0 0 0 rg BT 429.27 82.25 Td (redeemable ) Tj ET Q q 0 0 0 rg BT 478.49 82.25 Td (on ) Tj ET Q q 0 0 0 rg BT 491.62 82.25 Td (a ) Tj ET Q q 0 0 0 rg BT 499.20 82.25 Td (weekly ) Tj ET Q q 0 0 0 rg BT 531.22 82.25 Td (or ) Tj ET Q q 0 0 0 rg BT 542.69 82.25 Td (monthly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 70.25 Td (basis.) Tj ET Q endstream endobj 187 0 obj <> endobj 188 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The following summarizes the activity for financial assets utilizing Level 3 fair value measurements:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 725.60 458.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 725.60 4.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 725.60 78.00 -14.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 698.60 458.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 698.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 698.60 78.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 672.60 458.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 494.50 672.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 498.50 672.60 78.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 498.5 725.6 m 576.5 725.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 498.5 685.6 m 576.5 685.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 498.5 659.6 m 576.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 498.5 647.6 m 576.5 647.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 498.5 645.6 m 576.5 645.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 729.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 503.10 729.83 Td (Insurance contracts) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 716.17 Td (Fair value at January 1, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.00 716.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 716.17 Td (119) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 702.17 Td (Purchases, sales and settlements, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 567.65 702.17 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 689.17 Td (Realized losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 689.17 Td (\(11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 689.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 676.17 Td (Fair value at December 31, 2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 676.17 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 663.17 Td (Purchases, sales and settlements, net) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 564.30 663.17 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 663.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 650.17 Td (Fair value at December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.00 650.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 650.17 Td (112) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 623.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.40 623.10 Td (investment ) Tj ET Q q 0 0 0 rg BT 101.14 623.10 Td (strategy ) Tj ET Q q 0 0 0 rg BT 135.65 623.10 Td (is ) Tj ET Q q 0 0 0 rg BT 145.17 623.10 Td (to ) Tj ET Q q 0 0 0 rg BT 155.80 623.10 Td (maximize ) Tj ET Q q 0 0 0 rg BT 198.08 623.10 Td (return ) Tj ET Q q 0 0 0 rg BT 224.82 623.10 Td (while ) Tj ET Q q 0 0 0 rg BT 249.89 623.10 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 300.51 623.10 Td (an ) Tj ET Q q 0 0 0 rg BT 312.80 623.10 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 361.19 623.10 Td (level ) Tj ET Q q 0 0 0 rg BT 383.48 623.10 Td (of ) Tj ET Q q 0 0 0 rg BT 394.66 623.10 Td (risk ) Tj ET Q q 0 0 0 rg BT 412.51 623.10 Td (to ) Tj ET Q q 0 0 0 rg BT 423.15 623.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 456.55 623.10 Td (suf) Tj ET Q q 0 0 0 rg BT 468.59 623.10 Td (ficient ) Tj ET Q q 0 0 0 rg BT 496.98 623.10 Td (liquidity ) Tj ET Q q 0 0 0 rg BT 533.73 623.10 Td (for ) Tj ET Q q 0 0 0 rg BT 548.24 623.10 Td (benefit ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 611.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 82.61 611.10 Td (and ) Tj ET Q q 0 0 0 rg BT 99.22 611.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 118.60 611.10 Td (expenses. ) Tj ET Q q 0 0 0 rg BT 159.37 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 161.06 611.10 Td (A) Tj ET Q q 0 0 0 rg BT 167.73 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 169.90 611.10 Td (tar) Tj ET Q q 0 0 0 rg BT 180.26 611.10 Td (get ) Tj ET Q q 0 0 0 rg BT 194.65 611.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 216.25 611.10 Td (allocation ) Tj ET Q q 0 0 0 rg BT 257.85 611.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.35 611.10 Td (43%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 286.68 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 288.85 611.10 Td (public ) Tj ET Q q 0 0 0 rg BT 316.01 611.10 Td (equity ) Tj ET Q q 0 0 0 rg BT 343.17 611.10 Td (\() Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 346.50 611.10 Td (16%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 364.83 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 367.00 611.10 Td (international, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.21 611.10 Td (14%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 440.54 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 442.70 611.10 Td (global ) Tj ET Q q 0 0 0 rg BT 469.87 611.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.47 611.10 Td (13%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.80 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 506.97 611.10 Td (U.S.\), ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 532.75 611.10 Td (7%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 546.08 611.10 Td ( ) Tj ET Q q 0 0 0 rg BT 548.25 611.10 Td (private ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 599.10 Td (equity ) Tj ET Q q 0 0 0 rg BT 63.13 599.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.70 599.10 Td (50%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.03 599.10 Td ( ) Tj ET Q q 0 0 0 rg BT 100.16 599.10 Td (long-duration ) Tj ET Q q 0 0 0 rg BT 156.73 599.10 Td (fixed ) Tj ET Q q 0 0 0 rg BT 179.41 599.10 Td (income ) Tj ET Q q 0 0 0 rg BT 210.97 599.10 Td (is ) Tj ET Q q 0 0 0 rg BT 219.78 599.10 Td (maintained ) Tj ET Q q 0 0 0 rg BT 266.34 599.10 Td (for ) Tj ET Q q 0 0 0 rg BT 280.13 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 294.48 599.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 314.40 599.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 347.64 599.10 Td (plans. ) Tj ET Q q 0 0 0 rg BT 373.38 599.10 Td (Investments ) Tj ET Q q 0 0 0 rg BT 423.84 599.10 Td (are ) Tj ET Q q 0 0 0 rg BT 438.18 599.10 Td (diversified ) Tj ET Q q 0 0 0 rg BT 483.07 599.10 Td (within ) Tj ET Q q 0 0 0 rg BT 510.76 599.10 Td (each ) Tj ET Q q 0 0 0 rg BT 531.21 599.10 Td (of ) Tj ET Q q 0 0 0 rg BT 541.67 599.10 Td (the ) Tj ET Q q 0 0 0 rg BT 556.02 599.10 Td (three ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 587.10 Td (major ) Tj ET Q q 0 0 0 rg BT 62.45 587.10 Td (asset ) Tj ET Q q 0 0 0 rg BT 85.00 587.10 Td (categories. ) Tj ET Q q 0 0 0 rg BT 130.47 587.10 Td (Approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 194.13 587.10 Td (90%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 212.46 587.10 Td ( ) Tj ET Q q 0 0 0 rg BT 215.58 587.10 Td (of ) Tj ET Q q 0 0 0 rg BT 227.03 587.10 Td (the ) Tj ET Q q 0 0 0 rg BT 242.37 587.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 263.27 587.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 297.50 587.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 321.73 587.10 Td (equity ) Tj ET Q q 0 0 0 rg BT 349.84 587.10 Td (investments ) Tj ET Q q 0 0 0 rg BT 400.74 587.10 Td (are ) Tj ET Q q 0 0 0 rg BT 416.06 587.10 Td (actively ) Tj ET Q q 0 0 0 rg BT 450.83 587.10 Td (managed. ) Tj ET Q q 0 0 0 rg BT 492.55 587.10 Td (BMS ) Tj ET Q q 0 0 0 rg BT 516.79 587.10 Td (common ) Tj ET Q q 0 0 0 rg BT 554.91 587.10 Td (stock ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 575.10 Td (represents ) Tj ET Q q 0 0 0 rg BT 79.04 575.10 Td (less ) Tj ET Q q 0 0 0 rg BT 96.54 575.10 Td (than ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 116.25 575.10 Td (1%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 129.58 575.10 Td ( ) Tj ET Q q 0 0 0 rg BT 132.08 575.10 Td (of ) Tj ET Q q 0 0 0 rg BT 142.91 575.10 Td (the ) Tj ET Q q 0 0 0 rg BT 157.63 575.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 177.35 575.10 Td (assets ) Tj ET Q q 0 0 0 rg BT 203.18 575.10 Td (at ) Tj ET Q q 0 0 0 rg BT 212.89 575.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 271.48 575.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 291.48 575.10 Td ( ) Tj ET Q q 0 0 0 rg BT 293.98 575.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.92 575.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.92 575.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 551.10 Td (Contributions and Estimated Futur) Tj ET Q q 0 0 0 rg BT 176.47 551.10 Td (e Benefit Payments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 527.10 Td (Contributions ) Tj ET Q q 0 0 0 rg BT 94.85 527.10 Td (to ) Tj ET Q q 0 0 0 rg BT 106.47 527.10 Td (pension ) Tj ET Q q 0 0 0 rg BT 141.43 527.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 166.38 527.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.65 527.10 Td ($81 ) Tj ET Q q 0 0 0 rg BT 208.50 527.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 237.39 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 241.24 527.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 252.86 527.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.86 527.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.21 527.10 Td ($1) Tj ET Q q 0 0 0 rg BT 288.83 527.10 Td (18 ) Tj ET Q q 0 0 0 rg BT 302.68 527.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 331.57 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 335.42 527.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 347.04 527.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.04 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 370.89 527.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 389.17 527.10 Td ($124 ) Tj ET Q q 0 0 0 rg BT 413.01 527.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.91 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 445.75 527.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.37 527.10 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.37 527.10 Td ( ) Tj ET Q q 0 0 0 rg BT 481.22 527.10 Td (and ) Tj ET Q q 0 0 0 rg BT 499.50 527.10 Td (are ) Tj ET Q q 0 0 0 rg BT 515.56 527.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 554.93 527.10 Td (to ) Tj ET Q q 0 0 0 rg BT 566.56 527.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 515.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 95.45 515.10 Td ($100 ) Tj ET Q q 0 0 0 rg BT 117.14 515.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 146.03 515.10 Td ( ) Tj ET Q q 0 0 0 rg BT 147.73 515.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.20 515.10 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 177.20 515.10 Td (. ) Tj ET Q q 0 0 0 rg BT 181.39 515.10 Td (Estimated ) Tj ET Q q 0 0 0 rg BT 223.07 515.10 Td (annual ) Tj ET Q q 0 0 0 rg BT 251.42 515.10 Td (future ) Tj ET Q q 0 0 0 rg BT 276.99 515.10 Td (benefit ) Tj ET Q q 0 0 0 rg BT 306.44 515.10 Td (payments ) Tj ET Q q 0 0 0 rg BT 346.46 515.10 Td (\(including ) Tj ET Q q 0 0 0 rg BT 389.25 515.10 Td (lump ) Tj ET Q q 0 0 0 rg BT 411.50 515.10 Td (sum ) Tj ET Q q 0 0 0 rg BT 429.86 515.10 Td (payments\) ) Tj ET Q q 0 0 0 rg BT 473.21 515.10 Td (range ) Tj ET Q q 0 0 0 rg BT 497.11 515.10 Td (from ) Tj ET Q q 0 0 0 rg BT 518.24 515.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.10 Td ($250 ) Tj ET Q q 0 0 0 rg BT 58.50 503.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 87.39 503.10 Td ( ) Tj ET Q q 0 0 0 rg BT 89.89 503.10 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 100.17 503.10 Td ($400 ) Tj ET Q q 0 0 0 rg BT 122.67 503.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 151.56 503.10 Td ( ) Tj ET Q q 0 0 0 rg BT 154.06 503.10 Td (in ) Tj ET Q q 0 0 0 rg BT 164.34 503.10 Td (each ) Tj ET Q q 0 0 0 rg BT 185.16 503.10 Td (of ) Tj ET Q q 0 0 0 rg BT 195.99 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 210.70 503.10 Td (next ) Tj ET Q q 0 0 0 rg BT 230.42 503.10 Td (five ) Tj ET Q q 0 0 0 rg BT 248.47 503.10 Td (years, ) Tj ET Q q 0 0 0 rg BT 274.56 503.10 Td (and ) Tj ET Q q 0 0 0 rg BT 291.50 503.10 Td (aggregate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.87 503.10 Td ($1.4 ) Tj ET Q q 0 0 0 rg BT 352.87 503.10 Td (billion) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.98 503.10 Td ( ) Tj ET Q q 0 0 0 rg BT 381.48 503.10 Td (in ) Tj ET Q q 0 0 0 rg BT 391.76 503.10 Td (the ) Tj ET Q q 0 0 0 rg BT 406.47 503.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 453.41 503.10 Td (five ) Tj ET Q q 0 0 0 rg BT 471.46 503.10 Td (year ) Tj ET Q q 0 0 0 rg BT 491.17 503.10 Td (period.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 479.10 Td (Savings Plans) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 455.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.98 455.10 Td (principal ) Tj ET Q q 0 0 0 rg BT 93.96 455.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 127.38 455.10 Td (contribution ) Tj ET Q q 0 0 0 rg BT 179.70 455.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 200.35 455.10 Td (is ) Tj ET Q q 0 0 0 rg BT 210.45 455.10 Td (the ) Tj ET Q q 0 0 0 rg BT 226.10 455.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 285.65 455.10 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 317.42 455.10 Td (Savings ) Tj ET Q q 0 0 0 rg BT 352.53 455.10 Td (and ) Tj ET Q q 0 0 0 rg BT 370.40 455.10 Td (Investment ) Tj ET Q q 0 0 0 rg BT 418.27 455.10 Td (Program. ) Tj ET Q q 0 0 0 rg BT 458.40 455.10 Td (The ) Tj ET Q q 0 0 0 rg BT 477.38 455.10 Td (contribution ) Tj ET Q q 0 0 0 rg BT 529.69 455.10 Td (is ) Tj ET Q q 0 0 0 rg BT 539.80 455.10 Td (based ) Tj ET Q q 0 0 0 rg BT 566.00 455.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 443.10 Td (employee ) Tj ET Q q 0 0 0 rg BT 79.39 443.10 Td (contributions ) Tj ET Q q 0 0 0 rg BT 136.68 443.10 Td (and ) Tj ET Q q 0 0 0 rg BT 155.63 443.10 Td (the ) Tj ET Q q 0 0 0 rg BT 172.36 443.10 Td (level ) Tj ET Q q 0 0 0 rg BT 196.31 443.10 Td (of ) Tj ET Q q 0 0 0 rg BT 209.16 443.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 252.56 443.10 Td (match. ) Tj ET Q q 0 0 0 rg BT 283.68 443.10 Td (The ) Tj ET Q q 0 0 0 rg BT 303.75 443.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 340.47 443.10 Td (attributed ) Tj ET Q q 0 0 0 rg BT 383.30 443.10 Td (to ) Tj ET Q q 0 0 0 rg BT 395.60 443.10 Td (defined ) Tj ET Q q 0 0 0 rg BT 430.10 443.10 Td (contribution ) Tj ET Q q 0 0 0 rg BT 483.50 443.10 Td (plans ) Tj ET Q q 0 0 0 rg BT 509.12 443.10 Td (in ) Tj ET Q q 0 0 0 rg BT 521.42 443.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.15 443.10 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 560.45 443.10 Td (was ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 431.10 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 96.26 431.10 Td ($190 ) Tj ET Q q 0 0 0 rg BT 118.76 431.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 147.65 431.10 Td ( ) Tj ET Q q 0 0 0 rg BT 150.15 431.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 160.43 431.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 180.43 431.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 185.43 431.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 205.43 431.10 Td ( ) Tj ET Q q 0 0 0 rg BT 207.93 431.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 224.87 431.10 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 244.87 431.10 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 405.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 405.10 Td (17) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 405.10 Td (. EMPLOYEE ST) Tj ET Q q 0 0 0 rg BT 145.27 405.10 Td (OCK BENEFIT) Tj ET Q q 0 0 0 rg BT 214.27 405.10 Td ( PLANS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 388.10 Td (On ) Tj ET Q q 0 0 0 rg BT 50.94 388.10 Td (May ) Tj ET Q q 0 0 0 rg BT 71.98 388.10 Td (1, ) Tj ET Q q 0 0 0 rg BT 82.19 388.10 Td (2012, ) Tj ET Q q 0 0 0 rg BT 107.41 388.10 Td (the ) Tj ET Q q 0 0 0 rg BT 122.34 388.10 Td (shareholders ) Tj ET Q q 0 0 0 rg BT 175.59 388.10 Td (approved ) Tj ET Q q 0 0 0 rg BT 215.51 388.10 Td (the ) Tj ET Q q 0 0 0 rg BT 230.44 388.10 Td (2012 ) Tj ET Q q 0 0 0 rg BT 253.15 388.10 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 276.15 388.10 Td (which ) Tj ET Q q 0 0 0 rg BT 303.30 388.10 Td (replaced ) Tj ET Q q 0 0 0 rg BT 339.88 388.10 Td (the ) Tj ET Q q 0 0 0 rg BT 354.81 388.10 Td (2007 ) Tj ET Q q 0 0 0 rg BT 377.52 388.10 Td (Stock ) Tj ET Q q 0 0 0 rg BT 403.01 388.10 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 442.93 388.10 Td (Plan. ) Tj ET Q q 0 0 0 rg BT 465.72 388.10 Td (The ) Tj ET Q q 0 0 0 rg BT 483.98 388.10 Td (2012 ) Tj ET Q q 0 0 0 rg BT 506.70 388.10 Td (Plan ) Tj ET Q q 0 0 0 rg BT 527.19 388.10 Td (provides ) Tj ET Q q 0 0 0 rg BT 564.34 388.10 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 376.10 Td (109 ) Tj ET Q q 0 0 0 rg BT 53.15 376.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 82.05 376.10 Td ( ) Tj ET Q q 0 0 0 rg BT 84.20 376.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 111.35 376.10 Td (to ) Tj ET Q q 0 0 0 rg BT 121.28 376.10 Td (be ) Tj ET Q q 0 0 0 rg BT 132.87 376.10 Td (authorized ) Tj ET Q q 0 0 0 rg BT 177.23 376.10 Td (for ) Tj ET Q q 0 0 0 rg BT 191.04 376.10 Td (grants, ) Tj ET Q q 0 0 0 rg BT 220.14 376.10 Td (plus ) Tj ET Q q 0 0 0 rg BT 238.96 376.10 Td (any ) Tj ET Q q 0 0 0 rg BT 255.56 376.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 282.70 376.10 Td (from ) Tj ET Q q 0 0 0 rg BT 304.29 376.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 353.11 376.10 Td (awards ) Tj ET Q q 0 0 0 rg BT 383.59 376.10 Td (under ) Tj ET Q q 0 0 0 rg BT 408.51 376.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.88 376.10 Td (2007 ) Tj ET Q q 0 0 0 rg BT 445.04 376.10 Td (Plan ) Tj ET Q q 0 0 0 rg BT 464.97 376.10 Td (as ) Tj ET Q q 0 0 0 rg BT 475.46 376.10 Td (of ) Tj ET Q q 0 0 0 rg BT 485.94 376.10 Td (February ) Tj ET Q q 0 0 0 rg BT 524.19 376.10 Td (29, ) Tj ET Q q 0 0 0 rg BT 538.85 376.10 Td (2012 ) Tj ET Q q 0 0 0 rg BT 561.00 376.10 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 364.10 Td (expire, ) Tj ET Q q 0 0 0 rg BT 66.57 364.10 Td (are ) Tj ET Q q 0 0 0 rg BT 81.86 364.10 Td (forfeited, ) Tj ET Q q 0 0 0 rg BT 121.87 364.10 Td (canceled, ) Tj ET Q q 0 0 0 rg BT 162.43 364.10 Td (or ) Tj ET Q q 0 0 0 rg BT 173.85 364.10 Td (withheld ) Tj ET Q q 0 0 0 rg BT 211.93 364.10 Td (to ) Tj ET Q q 0 0 0 rg BT 222.79 364.10 Td (satisfy ) Tj ET Q q 0 0 0 rg BT 251.99 364.10 Td (tax ) Tj ET Q q 0 0 0 rg BT 267.29 364.10 Td (withholding ) Tj ET Q q 0 0 0 rg BT 318.71 364.10 Td (obligations. ) Tj ET Q q 0 0 0 rg BT 368.06 364.10 Td (As ) Tj ET Q q 0 0 0 rg BT 382.26 364.10 Td (of ) Tj ET Q q 0 0 0 rg BT 393.67 364.10 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.84 364.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.84 364.10 Td (, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 478.43 364.10 Td (106 ) Tj ET Q q 0 0 0 rg BT 496.52 364.10 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.41 364.10 Td ( ) Tj ET Q q 0 0 0 rg BT 528.49 364.10 Td (shares ) Tj ET Q q 0 0 0 rg BT 556.57 364.10 Td (were ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 352.10 Td (available ) Tj ET Q q 0 0 0 rg BT 74.59 352.10 Td (for ) Tj ET Q q 0 0 0 rg BT 88.75 352.10 Td (award. ) Tj ET Q q 0 0 0 rg BT 118.18 352.10 Td (Shares ) Tj ET Q q 0 0 0 rg BT 147.34 352.10 Td (are ) Tj ET Q q 0 0 0 rg BT 162.04 352.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 189.54 352.10 Td (from ) Tj ET Q q 0 0 0 rg BT 211.48 352.10 Td (treasury ) Tj ET Q q 0 0 0 rg BT 246.19 352.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 269.80 352.10 Td (to ) Tj ET Q q 0 0 0 rg BT 280.08 352.10 Td (satisfy ) Tj ET Q q 0 0 0 rg BT 308.69 352.10 Td (our ) Tj ET Q q 0 0 0 rg BT 324.52 352.10 Td (obligations ) Tj ET Q q 0 0 0 rg BT 371.46 352.10 Td (under ) Tj ET Q q 0 0 0 rg BT 396.73 352.10 Td (this ) Tj ET Q q 0 0 0 rg BT 413.68 352.10 Td (Plan.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 330.50 Td (Executive ) Tj ET Q q 0 0 0 rg BT 78.24 330.50 Td (of) Tj ET Q q 0 0 0 rg BT 86.39 330.50 Td (ficers ) Tj ET Q q 0 0 0 rg BT 110.86 330.50 Td (and ) Tj ET Q q 0 0 0 rg BT 127.56 330.50 Td (key ) Tj ET Q q 0 0 0 rg BT 144.26 330.50 Td (employees ) Tj ET Q q 0 0 0 rg BT 189.29 330.50 Td (may ) Tj ET Q q 0 0 0 rg BT 208.77 330.50 Td (be ) Tj ET Q q 0 0 0 rg BT 220.47 330.50 Td (granted ) Tj ET Q q 0 0 0 rg BT 252.72 330.50 Td (options ) Tj ET Q q 0 0 0 rg BT 284.43 330.50 Td (to ) Tj ET Q q 0 0 0 rg BT 294.47 330.50 Td (purchase ) Tj ET Q q 0 0 0 rg BT 332.27 330.50 Td (common ) Tj ET Q q 0 0 0 rg BT 369.52 330.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 392.89 330.50 Td (at ) Tj ET Q q 0 0 0 rg BT 402.37 330.50 Td (no ) Tj ET Q q 0 0 0 rg BT 414.64 330.50 Td (less ) Tj ET Q q 0 0 0 rg BT 431.90 330.50 Td (than ) Tj ET Q q 0 0 0 rg BT 451.38 330.50 Td (the ) Tj ET Q q 0 0 0 rg BT 465.86 330.50 Td (market ) Tj ET Q q 0 0 0 rg BT 495.88 330.50 Td (price ) Tj ET Q q 0 0 0 rg BT 518.13 330.50 Td (on ) Tj ET Q q 0 0 0 rg BT 530.39 330.50 Td (the ) Tj ET Q q 0 0 0 rg BT 544.87 330.50 Td (date ) Tj ET Q q 0 0 0 rg BT 563.79 330.50 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 318.50 Td (option ) Tj ET Q q 0 0 0 rg BT 63.42 318.50 Td (is ) Tj ET Q q 0 0 0 rg BT 71.96 318.50 Td (granted. ) Tj ET Q q 0 0 0 rg BT 106.31 318.50 Td (Options ) Tj ET Q q 0 0 0 rg BT 139.85 318.50 Td (generally ) Tj ET Q q 0 0 0 rg BT 178.92 318.50 Td (become ) Tj ET Q q 0 0 0 rg BT 211.88 318.50 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 258.72 318.50 Td (ratably ) Tj ET Q q 0 0 0 rg BT 288.35 318.50 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.99 318.50 Td (four) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 324.65 318.50 Td ( ) Tj ET Q q 0 0 0 rg BT 326.52 318.50 Td (years ) Tj ET Q q 0 0 0 rg BT 349.48 318.50 Td (and ) Tj ET Q q 0 0 0 rg BT 365.79 318.50 Td (have ) Tj ET Q q 0 0 0 rg BT 386.53 318.50 Td (a ) Tj ET Q q 0 0 0 rg BT 392.84 318.50 Td (maximum ) Tj ET Q q 0 0 0 rg BT 435.26 318.50 Td (term ) Tj ET Q q 0 0 0 rg BT 455.45 318.50 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 465.65 318.50 Td (ten) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 477.87 318.50 Td ( ) Tj ET Q q 0 0 0 rg BT 479.74 318.50 Td (years. ) Tj ET Q q 0 0 0 rg BT 505.07 318.50 Td (The ) Tj ET Q q 0 0 0 rg BT 522.48 318.50 Td (plan ) Tj ET Q q 0 0 0 rg BT 541.57 318.50 Td (provides ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 306.50 Td (for ) Tj ET Q q 0 0 0 rg BT 49.75 306.50 Td (the ) Tj ET Q q 0 0 0 rg BT 64.05 306.50 Td (granting ) Tj ET Q q 0 0 0 rg BT 99.46 306.50 Td (of ) Tj ET Q q 0 0 0 rg BT 109.88 306.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 133.08 306.50 Td (appreciation ) Tj ET Q q 0 0 0 rg BT 184.58 306.50 Td (rights ) Tj ET Q q 0 0 0 rg BT 209.45 306.50 Td (whereby ) Tj ET Q q 0 0 0 rg BT 245.97 306.50 Td (the ) Tj ET Q q 0 0 0 rg BT 260.27 306.50 Td (grantee ) Tj ET Q q 0 0 0 rg BT 291.78 306.50 Td (may ) Tj ET Q q 0 0 0 rg BT 311.09 306.50 Td (surrender ) Tj ET Q q 0 0 0 rg BT 350.93 306.50 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 397.99 306.50 Td (rights ) Tj ET Q q 0 0 0 rg BT 422.86 306.50 Td (and ) Tj ET Q q 0 0 0 rg BT 439.38 306.50 Td (receive ) Tj ET Q q 0 0 0 rg BT 470.33 306.50 Td (common ) Tj ET Q q 0 0 0 rg BT 507.41 306.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 530.61 306.50 Td (and/or ) Tj ET Q q 0 0 0 rg BT 558.24 306.50 Td (cash ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 294.50 Td (measured ) Tj ET Q q 0 0 0 rg BT 76.57 294.50 Td (by ) Tj ET Q q 0 0 0 rg BT 88.82 294.50 Td (the ) Tj ET Q q 0 0 0 rg BT 103.28 294.50 Td (excess ) Tj ET Q q 0 0 0 rg BT 131.63 294.50 Td (of ) Tj ET Q q 0 0 0 rg BT 142.21 294.50 Td (the ) Tj ET Q q 0 0 0 rg BT 156.68 294.50 Td (market ) Tj ET Q q 0 0 0 rg BT 186.69 294.50 Td (price ) Tj ET Q q 0 0 0 rg BT 208.93 294.50 Td (of ) Tj ET Q q 0 0 0 rg BT 219.51 294.50 Td (the ) Tj ET Q q 0 0 0 rg BT 233.97 294.50 Td (common ) Tj ET Q q 0 0 0 rg BT 271.22 294.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 294.58 294.50 Td (over ) Tj ET Q q 0 0 0 rg BT 314.60 294.50 Td (the ) Tj ET Q q 0 0 0 rg BT 329.06 294.50 Td (option ) Tj ET Q q 0 0 0 rg BT 356.87 294.50 Td (exercise ) Tj ET Q q 0 0 0 rg BT 391.87 294.50 Td (price. ) Tj ET Q q 0 0 0 rg BT 416.45 294.50 Td (The ) Tj ET Q q 0 0 0 rg BT 434.24 294.50 Td (Company ) Tj ET Q q 0 0 0 rg BT 475.38 294.50 Td (has ) Tj ET Q q 0 0 0 rg BT 490.96 294.50 Td (not ) Tj ET Q q 0 0 0 rg BT 505.99 294.50 Td (granted ) Tj ET Q q 0 0 0 rg BT 538.22 294.50 Td (any ) Tj ET Q q 0 0 0 rg BT 554.91 294.50 Td (stock ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 282.50 Td (options ) Tj ET Q q 0 0 0 rg BT 67.95 282.50 Td (or ) Tj ET Q q 0 0 0 rg BT 78.78 282.50 Td (stock ) Tj ET Q q 0 0 0 rg BT 102.39 282.50 Td (appreciation ) Tj ET Q q 0 0 0 rg BT 154.31 282.50 Td (rights ) Tj ET Q q 0 0 0 rg BT 179.58 282.50 Td (since ) Tj ET Q q 0 0 0 rg BT 202.63 282.50 Td (2009.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 260.90 Td (Restricted ) Tj ET Q q 0 0 0 rg BT 79.07 260.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 102.71 260.90 Td (units ) Tj ET Q q 0 0 0 rg BT 124.68 260.90 Td (may ) Tj ET Q q 0 0 0 rg BT 144.43 260.90 Td (be ) Tj ET Q q 0 0 0 rg BT 156.40 260.90 Td (granted ) Tj ET Q q 0 0 0 rg BT 188.91 260.90 Td (to ) Tj ET Q q 0 0 0 rg BT 199.22 260.90 Td (key ) Tj ET Q q 0 0 0 rg BT 216.18 260.90 Td (employees, ) Tj ET Q q 0 0 0 rg BT 263.97 260.90 Td (subject ) Tj ET Q q 0 0 0 rg BT 294.83 260.90 Td (to ) Tj ET Q q 0 0 0 rg BT 305.13 260.90 Td (restrictions ) Tj ET Q q 0 0 0 rg BT 352.10 260.90 Td (as ) Tj ET Q q 0 0 0 rg BT 362.96 260.90 Td (to ) Tj ET Q q 0 0 0 rg BT 373.26 260.90 Td (continuous ) Tj ET Q q 0 0 0 rg BT 419.68 260.90 Td (employment. ) Tj ET Q q 0 0 0 rg BT 474.70 260.90 Td (Generally) Tj ET Q q 0 0 0 rg BT 513.47 260.90 Td (, ) Tj ET Q q 0 0 0 rg BT 518.50 260.90 Td (vesting ) Tj ET Q q 0 0 0 rg BT 549.91 260.90 Td (occurs ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 248.90 Td (ratably ) Tj ET Q q 0 0 0 rg BT 66.35 248.90 Td (over ) Tj ET Q q 0 0 0 rg BT 86.71 248.90 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 93.74 248.90 Td (four) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 110.40 248.90 Td ( ) Tj ET Q q 0 0 0 rg BT 112.99 248.90 Td (year ) Tj ET Q q 0 0 0 rg BT 132.78 248.90 Td (period ) Tj ET Q q 0 0 0 rg BT 160.92 248.90 Td (from ) Tj ET Q q 0 0 0 rg BT 182.95 248.90 Td (grant ) Tj ET Q q 0 0 0 rg BT 206.08 248.90 Td (date. ) Tj ET Q q 0 0 0 rg BT 227.26 248.90 Td (A) Tj ET Q q 0 0 0 rg BT 233.93 248.90 Td ( ) Tj ET Q q 0 0 0 rg BT 236.52 248.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 260.21 248.90 Td (unit ) Tj ET Q q 0 0 0 rg BT 278.36 248.90 Td (is ) Tj ET Q q 0 0 0 rg BT 287.62 248.90 Td (a ) Tj ET Q q 0 0 0 rg BT 294.65 248.90 Td (right ) Tj ET Q q 0 0 0 rg BT 316.12 248.90 Td (to ) Tj ET Q q 0 0 0 rg BT 326.49 248.90 Td (receive ) Tj ET Q q 0 0 0 rg BT 357.94 248.90 Td (stock ) Tj ET Q q 0 0 0 rg BT 381.64 248.90 Td (at ) Tj ET Q q 0 0 0 rg BT 391.45 248.90 Td (the ) Tj ET Q q 0 0 0 rg BT 406.25 248.90 Td (end ) Tj ET Q q 0 0 0 rg BT 423.28 248.90 Td (of ) Tj ET Q q 0 0 0 rg BT 434.20 248.90 Td (the ) Tj ET Q q 0 0 0 rg BT 449.01 248.90 Td (specified ) Tj ET Q q 0 0 0 rg BT 487.69 248.90 Td (vesting ) Tj ET Q q 0 0 0 rg BT 519.17 248.90 Td (period ) Tj ET Q q 0 0 0 rg BT 547.30 248.90 Td (but ) Tj ET Q q 0 0 0 rg BT 562.67 248.90 Td (has ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 236.90 Td (no ) Tj ET Q q 0 0 0 rg BT 48.50 236.90 Td (voting ) Tj ET Q q 0 0 0 rg BT 76.56 236.90 Td (rights.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 215.30 Td (Market ) Tj ET Q q 0 0 0 rg BT 67.83 215.30 Td (share ) Tj ET Q q 0 0 0 rg BT 91.89 215.30 Td (units ) Tj ET Q q 0 0 0 rg BT 114.29 215.30 Td (are ) Tj ET Q q 0 0 0 rg BT 129.46 215.30 Td (granted ) Tj ET Q q 0 0 0 rg BT 162.40 215.30 Td (to ) Tj ET Q q 0 0 0 rg BT 173.13 215.30 Td (executives. ) Tj ET Q q 0 0 0 rg BT 220.58 215.30 Td (V) Tj ET Q q 0 0 0 rg BT 226.69 215.30 Td (esting ) Tj ET Q q 0 0 0 rg BT 253.54 215.30 Td (is ) Tj ET Q q 0 0 0 rg BT 263.16 215.30 Td (conditioned ) Tj ET Q q 0 0 0 rg BT 313.33 215.30 Td (upon ) Tj ET Q q 0 0 0 rg BT 336.29 215.30 Td (continuous ) Tj ET Q q 0 0 0 rg BT 383.13 215.30 Td (employment ) Tj ET Q q 0 0 0 rg BT 436.08 215.30 Td (until ) Tj ET Q q 0 0 0 rg BT 457.37 215.30 Td (the ) Tj ET Q q 0 0 0 rg BT 472.54 215.30 Td (vesting ) Tj ET Q q 0 0 0 rg BT 504.38 215.30 Td (date ) Tj ET Q q 0 0 0 rg BT 524.00 215.30 Td (and ) Tj ET Q q 0 0 0 rg BT 541.39 215.30 Td (a ) Tj ET Q q 0 0 0 rg BT 548.79 215.30 Td (payout ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 203.30 Td (factor ) Tj ET Q q 0 0 0 rg BT 61.71 203.30 Td (of ) Tj ET Q q 0 0 0 rg BT 72.43 203.30 Td (at ) Tj ET Q q 0 0 0 rg BT 82.04 203.30 Td (least ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 102.75 203.30 Td (60%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 121.08 203.30 Td ( ) Tj ET Q q 0 0 0 rg BT 123.48 203.30 Td (of ) Tj ET Q q 0 0 0 rg BT 134.20 203.30 Td (the ) Tj ET Q q 0 0 0 rg BT 148.81 203.30 Td (share ) Tj ET Q q 0 0 0 rg BT 172.30 203.30 Td (price ) Tj ET Q q 0 0 0 rg BT 194.67 203.30 Td (on ) Tj ET Q q 0 0 0 rg BT 207.06 203.30 Td (the ) Tj ET Q q 0 0 0 rg BT 221.67 203.30 Td (award ) Tj ET Q q 0 0 0 rg BT 248.49 203.30 Td (date. ) Tj ET Q q 0 0 0 rg BT 269.87 203.30 Td (The ) Tj ET Q q 0 0 0 rg BT 287.81 203.30 Td (payout ) Tj ET Q q 0 0 0 rg BT 317.41 203.30 Td (factor ) Tj ET Q q 0 0 0 rg BT 343.12 203.30 Td (is ) Tj ET Q q 0 0 0 rg BT 352.18 203.30 Td (the ) Tj ET Q q 0 0 0 rg BT 366.79 203.30 Td (share ) Tj ET Q q 0 0 0 rg BT 390.28 203.30 Td (price ) Tj ET Q q 0 0 0 rg BT 412.66 203.30 Td (on ) Tj ET Q q 0 0 0 rg BT 425.05 203.30 Td (vesting ) Tj ET Q q 0 0 0 rg BT 456.33 203.30 Td (date ) Tj ET Q q 0 0 0 rg BT 475.38 203.30 Td (divided ) Tj ET Q q 0 0 0 rg BT 507.76 203.30 Td (by ) Tj ET Q q 0 0 0 rg BT 520.15 203.30 Td (share ) Tj ET Q q 0 0 0 rg BT 543.64 203.30 Td (price ) Tj ET Q q 0 0 0 rg BT 566.02 203.30 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 191.30 Td (award ) Tj ET Q q 0 0 0 rg BT 62.99 191.30 Td (date, ) Tj ET Q q 0 0 0 rg BT 84.71 191.30 Td (with ) Tj ET Q q 0 0 0 rg BT 105.05 191.30 Td (a ) Tj ET Q q 0 0 0 rg BT 112.05 191.30 Td (maximum ) Tj ET Q q 0 0 0 rg BT 155.17 191.30 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 166.06 191.30 Td (200%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 189.39 191.30 Td (. ) Tj ET Q q 0 0 0 rg BT 194.26 191.30 Td (The ) Tj ET Q q 0 0 0 rg BT 212.37 191.30 Td (share ) Tj ET Q q 0 0 0 rg BT 236.04 191.30 Td (price ) Tj ET Q q 0 0 0 rg BT 258.58 191.30 Td (used ) Tj ET Q q 0 0 0 rg BT 279.48 191.30 Td (in ) Tj ET Q q 0 0 0 rg BT 289.82 191.30 Td (the ) Tj ET Q q 0 0 0 rg BT 304.60 191.30 Td (payout ) Tj ET Q q 0 0 0 rg BT 334.38 191.30 Td (factor ) Tj ET Q q 0 0 0 rg BT 360.25 191.30 Td (is ) Tj ET Q q 0 0 0 rg BT 369.49 191.30 Td (calculated ) Tj ET Q q 0 0 0 rg BT 412.58 191.30 Td (using ) Tj ET Q q 0 0 0 rg BT 436.81 191.30 Td (an ) Tj ET Q q 0 0 0 rg BT 448.81 191.30 Td (average ) Tj ET Q q 0 0 0 rg BT 482.46 191.30 Td (of ) Tj ET Q q 0 0 0 rg BT 493.35 191.30 Td (the ) Tj ET Q q 0 0 0 rg BT 508.13 191.30 Td (closing ) Tj ET Q q 0 0 0 rg BT 539.58 191.30 Td (prices ) Tj ET Q q 0 0 0 rg BT 566.02 191.30 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 179.30 Td (the ) Tj ET Q q 0 0 0 rg BT 50.72 179.30 Td (grant ) Tj ET Q q 0 0 0 rg BT 73.76 179.30 Td (or ) Tj ET Q q 0 0 0 rg BT 84.59 179.30 Td (vest ) Tj ET Q q 0 0 0 rg BT 103.20 179.30 Td (date, ) Tj ET Q q 0 0 0 rg BT 124.86 179.30 Td (and ) Tj ET Q q 0 0 0 rg BT 141.80 179.30 Td (the ) Tj ET Q q 0 0 0 rg BT 156.51 179.30 Td (nine ) Tj ET Q q 0 0 0 rg BT 176.23 179.30 Td (trading ) Tj ET Q q 0 0 0 rg BT 207.05 179.30 Td (days ) Tj ET Q q 0 0 0 rg BT 227.88 179.30 Td (immediately ) Tj ET Q q 0 0 0 rg BT 280.37 179.30 Td (preceding ) Tj ET Q q 0 0 0 rg BT 322.29 179.30 Td (the ) Tj ET Q q 0 0 0 rg BT 337.01 179.30 Td (grant ) Tj ET Q q 0 0 0 rg BT 360.06 179.30 Td (or ) Tj ET Q q 0 0 0 rg BT 370.89 179.30 Td (vest ) Tj ET Q q 0 0 0 rg BT 389.50 179.30 Td (date. ) Tj ET Q q 0 0 0 rg BT 410.97 179.30 Td (V) Tj ET Q q 0 0 0 rg BT 417.08 179.30 Td (esting ) Tj ET Q q 0 0 0 rg BT 443.47 179.30 Td (occurs ) Tj ET Q q 0 0 0 rg BT 472.07 179.30 Td (ratably ) Tj ET Q q 0 0 0 rg BT 502.33 179.30 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.60 179.30 Td (four) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 539.26 179.30 Td ( ) Tj ET Q q 0 0 0 rg BT 541.76 179.30 Td (years.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 157.70 Td (Performance ) Tj ET Q q 0 0 0 rg BT 88.79 157.70 Td (share ) Tj ET Q q 0 0 0 rg BT 111.60 157.70 Td (units ) Tj ET Q q 0 0 0 rg BT 132.76 157.70 Td (are ) Tj ET Q q 0 0 0 rg BT 146.67 157.70 Td (granted ) Tj ET Q q 0 0 0 rg BT 178.37 157.70 Td (to ) Tj ET Q q 0 0 0 rg BT 187.86 157.70 Td (executives, ) Tj ET Q q 0 0 0 rg BT 234.27 157.70 Td (have ) Tj ET Q q 0 0 0 rg BT 254.85 157.70 Td (a ) Tj ET Q q 0 0 0 rg BT 261.00 157.70 Td (three ) Tj ET Q q 0 0 0 rg BT 282.69 157.70 Td (year ) Tj ET Q q 0 0 0 rg BT 301.61 157.70 Td (cycle ) Tj ET Q q 0 0 0 rg BT 324.41 157.70 Td (and ) Tj ET Q q 0 0 0 rg BT 340.56 157.70 Td (are ) Tj ET Q q 0 0 0 rg BT 354.48 157.70 Td (granted ) Tj ET Q q 0 0 0 rg BT 386.17 157.70 Td (as ) Tj ET Q q 0 0 0 rg BT 396.21 157.70 Td (a ) Tj ET Q q 0 0 0 rg BT 402.36 157.70 Td (tar) Tj ET Q q 0 0 0 rg BT 412.72 157.70 Td (get ) Tj ET Q q 0 0 0 rg BT 426.65 157.70 Td (number ) Tj ET Q q 0 0 0 rg BT 458.91 157.70 Td (of ) Tj ET Q q 0 0 0 rg BT 468.94 157.70 Td (units ) Tj ET Q q 0 0 0 rg BT 490.10 157.70 Td (subject ) Tj ET Q q 0 0 0 rg BT 520.14 157.70 Td (to ) Tj ET Q q 0 0 0 rg BT 529.62 157.70 Td (adjustment. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 145.70 Td (The ) Tj ET Q q 0 0 0 rg BT 53.67 145.70 Td (number ) Tj ET Q q 0 0 0 rg BT 86.34 145.70 Td (of ) Tj ET Q q 0 0 0 rg BT 96.79 145.70 Td (shares ) Tj ET Q q 0 0 0 rg BT 123.90 145.70 Td (issued ) Tj ET Q q 0 0 0 rg BT 151.02 145.70 Td (when ) Tj ET Q q 0 0 0 rg BT 174.80 145.70 Td (performance ) Tj ET Q q 0 0 0 rg BT 227.45 145.70 Td (share ) Tj ET Q q 0 0 0 rg BT 250.67 145.70 Td (units ) Tj ET Q q 0 0 0 rg BT 272.24 145.70 Td (vest ) Tj ET Q q 0 0 0 rg BT 290.47 145.70 Td (is ) Tj ET Q q 0 0 0 rg BT 299.26 145.70 Td (determined ) Tj ET Q q 0 0 0 rg BT 346.36 145.70 Td (based ) Tj ET Q q 0 0 0 rg BT 371.25 145.70 Td (on ) Tj ET Q q 0 0 0 rg BT 383.37 145.70 Td (the ) Tj ET Q q 0 0 0 rg BT 397.71 145.70 Td (achievement ) Tj ET Q q 0 0 0 rg BT 450.36 145.70 Td (of ) Tj ET Q q 0 0 0 rg BT 460.81 145.70 Td (performance ) Tj ET Q q 0 0 0 rg BT 513.46 145.70 Td (goals ) Tj ET Q q 0 0 0 rg BT 536.69 145.70 Td (and ) Tj ET Q q 0 0 0 rg BT 553.25 145.70 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 133.70 Td (on ) Tj ET Q q 0 0 0 rg BT 49.36 133.70 Td (the ) Tj ET Q q 0 0 0 rg BT 64.94 133.70 Td (Company's ) Tj ET Q q 0 0 0 rg BT 112.89 133.70 Td (three-year ) Tj ET Q q 0 0 0 rg BT 156.77 133.70 Td (total ) Tj ET Q q 0 0 0 rg BT 177.91 133.70 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 227.92 133.70 Td (return ) Tj ET Q q 0 0 0 rg BT 255.16 133.70 Td (relative ) Tj ET Q q 0 0 0 rg BT 288.50 133.70 Td (to ) Tj ET Q q 0 0 0 rg BT 299.64 133.70 Td (a ) Tj ET Q q 0 0 0 rg BT 307.45 133.70 Td (peer ) Tj ET Q q 0 0 0 rg BT 328.02 133.70 Td (group ) Tj ET Q q 0 0 0 rg BT 354.71 133.70 Td (of ) Tj ET Q q 0 0 0 rg BT 366.40 133.70 Td (companies. ) Tj ET Q q 0 0 0 rg BT 414.79 133.70 Td (V) Tj ET Q q 0 0 0 rg BT 420.90 133.70 Td (esting ) Tj ET Q q 0 0 0 rg BT 448.15 133.70 Td (is ) Tj ET Q q 0 0 0 rg BT 458.18 133.70 Td (conditioned ) Tj ET Q q 0 0 0 rg BT 508.76 133.70 Td (upon ) Tj ET Q q 0 0 0 rg BT 532.12 133.70 Td (continuous ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 121.70 Td (employment ) Tj ET Q q 0 0 0 rg BT 88.49 121.70 Td (and ) Tj ET Q q 0 0 0 rg BT 105.43 121.70 Td (occurs ) Tj ET Q q 0 0 0 rg BT 134.03 121.70 Td (on ) Tj ET Q q 0 0 0 rg BT 146.53 121.70 Td (the ) Tj ET Q q 0 0 0 rg BT 161.24 121.70 Td (third ) Tj ET Q q 0 0 0 rg BT 182.63 121.70 Td (anniversary ) Tj ET Q q 0 0 0 rg BT 231.78 121.70 Td (of ) Tj ET Q q 0 0 0 rg BT 242.61 121.70 Td (the ) Tj ET Q q 0 0 0 rg BT 257.32 121.70 Td (grant ) Tj ET Q q 0 0 0 rg BT 280.37 121.70 Td (date.) Tj ET Q endstream endobj 189 0 obj <> endobj 190 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (Stock-based ) Tj ET Q q 0 0 0 rg BT 86.73 749.10 Td (compensation ) Tj ET Q q 0 0 0 rg BT 144.13 749.10 Td (expense ) Tj ET Q q 0 0 0 rg BT 178.20 749.10 Td (for ) Tj ET Q q 0 0 0 rg BT 191.72 749.10 Td (awards ) Tj ET Q q 0 0 0 rg BT 221.90 749.10 Td (ultimately ) Tj ET Q q 0 0 0 rg BT 264.30 749.10 Td (expected ) Tj ET Q q 0 0 0 rg BT 301.69 749.10 Td (to ) Tj ET Q q 0 0 0 rg BT 311.33 749.10 Td (vest ) Tj ET Q q 0 0 0 rg BT 329.29 749.10 Td (is ) Tj ET Q q 0 0 0 rg BT 337.82 749.10 Td (recognized ) Tj ET Q q 0 0 0 rg BT 383.54 749.10 Td (over ) Tj ET Q q 0 0 0 rg BT 403.17 749.10 Td (the ) Tj ET Q q 0 0 0 rg BT 417.24 749.10 Td (vesting ) Tj ET Q q 0 0 0 rg BT 447.99 749.10 Td (period. ) Tj ET Q q 0 0 0 rg BT 477.89 749.10 Td (Forfeitures ) Tj ET Q q 0 0 0 rg BT 523.63 749.10 Td (are ) Tj ET Q q 0 0 0 rg BT 537.69 749.10 Td (estimated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 737.10 Td (based ) Tj ET Q q 0 0 0 rg BT 61.86 737.10 Td (on ) Tj ET Q q 0 0 0 rg BT 74.95 737.10 Td (historical ) Tj ET Q q 0 0 0 rg BT 115.25 737.10 Td (experience ) Tj ET Q q 0 0 0 rg BT 161.63 737.10 Td (at ) Tj ET Q q 0 0 0 rg BT 171.94 737.10 Td (the ) Tj ET Q q 0 0 0 rg BT 187.25 737.10 Td (time ) Tj ET Q q 0 0 0 rg BT 208.11 737.10 Td (of ) Tj ET Q q 0 0 0 rg BT 219.53 737.10 Td (grant ) Tj ET Q q 0 0 0 rg BT 243.16 737.10 Td (and ) Tj ET Q q 0 0 0 rg BT 260.69 737.10 Td (revised ) Tj ET Q q 0 0 0 rg BT 292.65 737.10 Td (in ) Tj ET Q q 0 0 0 rg BT 303.52 737.10 Td (subsequent ) Tj ET Q q 0 0 0 rg BT 351.05 737.10 Td (periods ) Tj ET Q q 0 0 0 rg BT 383.57 737.10 Td (if ) Tj ET Q q 0 0 0 rg BT 392.77 737.10 Td (actual ) Tj ET Q q 0 0 0 rg BT 419.73 737.10 Td (forfeitures ) Tj ET Q q 0 0 0 rg BT 464.46 737.10 Td (dif) Tj ET Q q 0 0 0 rg BT 475.39 737.10 Td (fer ) Tj ET Q q 0 0 0 rg BT 489.58 737.10 Td (from ) Tj ET Q q 0 0 0 rg BT 512.11 737.10 Td (those ) Tj ET Q q 0 0 0 rg BT 536.30 737.10 Td (estimates. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (Other ) Tj ET Q q 0 0 0 rg BT 61.27 725.10 Td (information ) Tj ET Q q 0 0 0 rg BT 110.98 725.10 Td (related ) Tj ET Q q 0 0 0 rg BT 140.68 725.10 Td (to ) Tj ET Q q 0 0 0 rg BT 150.96 725.10 Td (stock-based ) Tj ET Q q 0 0 0 rg BT 200.67 725.10 Td (compensation ) Tj ET Q q 0 0 0 rg BT 258.71 725.10 Td (benefits ) Tj ET Q q 0 0 0 rg BT 292.87 725.10 Td (are ) Tj ET Q q 0 0 0 rg BT 307.57 725.10 Td (as ) Tj ET Q q 0 0 0 rg BT 318.40 725.10 Td (follows:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 688.60 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 688.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 688.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 688.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 688.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 662.60 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 662.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 662.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 662.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 662.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 636.60 320.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 356.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 360.50 636.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 429.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 433.50 636.60 69.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 502.50 636.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 506.50 636.60 70.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 701.6 m 429.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 429.5 701.6 m 433.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 701.6 m 502.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 502.5 701.6 m 506.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 701.6 m 576.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 688.6 m 429.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 688.6 m 502.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 688.6 m 576.5 688.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 649.6 m 429.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 649.6 m 502.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 649.6 m 576.5 649.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 637.6 m 429.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 635.6 m 429.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 637.6 m 502.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 635.6 m 502.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 637.6 m 576.5 637.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 635.6 m 576.5 635.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 623.6 m 429.5 623.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 611.6 m 429.5 611.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 360.5 609.6 m 429.5 609.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 623.6 m 502.5 623.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 611.6 m 502.5 611.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 433.5 609.6 m 502.5 609.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 623.6 m 576.5 623.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 611.6 m 576.5 611.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 506.5 609.6 m 576.5 609.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 705.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 422.05 705.83 Td (Years Ended December 31,) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 692.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 386.50 692.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 459.50 692.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 533.00 692.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 679.17 Td (Restricted stock units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 679.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 679.17 Td (89) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 679.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 679.17 Td (82) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 679.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 679.17 Td (75) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 666.17 Td (Market share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 666.17 Td (37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 666.17 Td (36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 666.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 653.17 Td (Performance share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 653.17 Td (79) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 653.17 Td (117) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 653.17 Td (104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.17 Td (Total stock-based compensation expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.65 640.17 Td (205) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.65 640.17 Td (235) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 640.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 640.17 Td (213) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 614.17 Td (Income tax benefit) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.00 614.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 614.17 Td (69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.00 614.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 614.17 Td (77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.00 614.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 614.17 Td (71) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 541.60 131.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 167.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 171.50 541.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 541.60 56.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 541.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 329.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 333.50 541.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 541.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 541.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 478.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 482.50 541.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 525.50 541.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 541.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 515.60 131.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 167.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 171.50 515.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 515.60 56.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 515.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 329.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 333.50 515.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 515.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 515.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 478.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 482.50 515.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 525.50 515.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 515.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 489.60 131.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 167.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 171.50 489.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 489.60 56.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 489.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 329.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 333.50 489.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 489.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 489.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 478.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 482.50 489.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 525.50 489.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 489.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 463.60 131.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 167.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 171.50 463.60 51.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 463.60 56.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 282.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 286.50 463.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 329.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 333.50 463.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 384.50 463.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 463.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 478.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 482.50 463.60 43.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 525.50 463.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 529.50 463.60 47.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 171.5 579.6 m 222.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 222.5 579.6 m 226.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 226.5 579.6 m 282.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 579.6 m 329.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 329.5 579.6 m 333.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 333.5 579.6 m 380.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 579.6 m 427.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 427.5 579.6 m 431.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 579.6 m 478.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 482.5 579.6 m 525.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 525.5 579.6 m 529.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 529.5 579.6 m 576.5 579.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 171.5 541.6 m 222.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 226.5 541.6 m 282.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 541.6 m 329.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 333.5 541.6 m 380.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 541.6 m 427.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 541.6 m 478.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 482.5 541.6 m 525.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 529.5 541.6 m 576.5 541.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 171.5 476.6 m 222.5 476.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 476.6 m 329.5 476.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 476.6 m 427.5 476.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 482.5 476.6 m 525.5 476.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 171.5 464.6 m 222.5 464.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 171.5 462.6 m 222.5 462.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 464.6 m 329.5 464.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 286.5 462.6 m 329.5 462.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 464.6 m 427.5 464.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 384.5 462.6 m 427.5 462.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 482.5 464.6 m 525.5 464.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 482.5 462.6 m 525.5 462.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 583.85 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 202.35 583.83 Td (Stock Options) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 294.75 583.83 Td (Restricted Stock Units) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 397.05 583.83 Td (Market Share Units) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 485.75 583.83 Td (Performance Share Units) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 178.00 561.83 Td (Number) Tj ET Q q 0 0 0 rg BT 206.30 561.83 Td ( of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 182.90 553.83 Td (Options ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 175.15 545.83 Td (Outstanding) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 236.40 569.83 Td (W) Tj ET Q q 0 0 0 rg BT 243.96 569.83 Td (eighted-) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 240.05 561.83 Td (A) Tj ET Q q 0 0 0 rg BT 245.23 561.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 229.75 553.83 Td (Exer) Tj ET Q q 0 0 0 rg BT 246.04 553.83 Td (cise Price ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 238.15 545.83 Td (of Shar) Tj ET Q q 0 0 0 rg BT 263.12 545.83 Td (es) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 293.35 569.83 Td (Number) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 304.15 561.83 Td (of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 289.70 553.83 Td (Nonvested ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 294.45 545.83 Td (A) Tj ET Q q 0 0 0 rg BT 299.63 545.83 Td (wards) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 338.90 569.83 Td (W) Tj ET Q q 0 0 0 rg BT 346.46 569.83 Td (eighted-) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 342.55 561.83 Td (A) Tj ET Q q 0 0 0 rg BT 347.73 561.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 336.70 553.83 Td (Grant-Date ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 338.65 545.83 Td (Fair) Tj ET Q q 0 0 0 rg BT 353.17 545.83 Td ( ) Tj ET Q q 0 0 0 rg BT 355.02 545.83 Td (V) Tj ET Q q 0 0 0 rg BT 360.06 545.83 Td (alue) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 391.35 569.83 Td (Number) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 402.15 561.83 Td (of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 387.70 553.83 Td (Nonvested ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 392.45 545.83 Td (A) Tj ET Q q 0 0 0 rg BT 397.63 545.83 Td (wards) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 436.90 569.83 Td (W) Tj ET Q q 0 0 0 rg BT 444.46 569.83 Td (eighted-) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 440.55 561.83 Td (A) Tj ET Q q 0 0 0 rg BT 445.73 561.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 434.70 553.83 Td (Grant-Date ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 436.65 545.83 Td (Fair) Tj ET Q q 0 0 0 rg BT 451.17 545.83 Td ( ) Tj ET Q q 0 0 0 rg BT 453.02 545.83 Td (V) Tj ET Q q 0 0 0 rg BT 458.06 545.83 Td (alue) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.35 569.83 Td (Number) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 500.15 561.83 Td (of) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 485.70 553.83 Td (Nonvested ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 490.45 545.83 Td (A) Tj ET Q q 0 0 0 rg BT 495.63 545.83 Td (wards) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 534.90 569.83 Td (W) Tj ET Q q 0 0 0 rg BT 542.46 569.83 Td (eighted-) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.55 561.83 Td (A) Tj ET Q q 0 0 0 rg BT 543.73 561.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.70 553.83 Td (Grant-Date ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 534.65 545.83 Td (Fair) Tj ET Q q 0 0 0 rg BT 549.17 545.83 Td ( ) Tj ET Q q 0 0 0 rg BT 551.02 545.83 Td (V) Tj ET Q q 0 0 0 rg BT 556.06 545.83 Td (alue) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 544.55 Td (Shares in Thousands) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 532.17 Td (Balance at January 1, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 191.15 532.17 Td (10,327) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 532.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.15 532.17 Td (21.62) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.10 532.17 Td (4,499) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 336.00 532.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 532.17 Td (50.02) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.10 532.17 Td (1,809) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 532.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 532.17 Td (53.10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.10 532.17 Td (4,078) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 532.00 532.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 532.17 Td (56.17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 519.17 Td (Granted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 208.65 519.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 519.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.10 519.17 Td (2,348) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 519.17 Td (60.56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 519.17 Td (731) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 519.17 Td (65.26) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.10 519.17 Td (1,097) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 519.17 Td (64.87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 506.17 Td (Released/Exercised) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 192.80 506.17 Td (\(3,851) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.65 506.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.15 506.17 Td (22.60) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 299.80 506.22 Td (\(1,810) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.65 506.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 506.17 Td (45.00) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 397.80 506.22 Td (\(1,117) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.65 506.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 506.17 Td (44.33) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 495.80 506.22 Td (\(1,730) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.65 506.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 506.17 Td (54.02) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 493.17 Td (Adjustments for actual payout) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 208.65 493.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 268.65 493.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.65 493.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 366.65 493.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 493.17 Td (261) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 493.17 Td (35.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 506.65 493.17 Td (912) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 493.17 Td (64.90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 480.17 Td (Forfeited/Canceled) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 205.30 480.17 Td (\(73) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 218.65 480.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.15 480.17 Td (22.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 307.30 480.22 Td (\(446) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.65 480.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 480.17 Td (55.06) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 405.30 480.22 Td (\(157) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 423.65 480.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 480.17 Td (60.55) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 503.30 480.22 Td (\(242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 521.65 480.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 480.17 Td (62.30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 467.17 Td (Balance at December 31, 2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 196.15 467.17 Td (6,403) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.15 467.17 Td (21.02) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.10 467.17 Td (4,591) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 467.17 Td (56.90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.10 467.17 Td (1,527) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 467.17 Td (61.63) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.10 467.17 Td (4,115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 467.17 Td (60.97) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 441.17 Td (Vested or expected to vest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 196.15 441.17 Td (6,403) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.15 441.17 Td (21.02) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 303.10 441.17 Td (4,112) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.15 441.17 Td (56.64) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.10 441.17 Td (1,401) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 452.15 441.17 Td (61.39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 499.10 441.17 Td (3,956) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 441.17 Td (60.81) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 383.60 379.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 415.50 383.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 419.50 383.60 48.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 467.50 383.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 471.50 383.60 47.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 518.50 383.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 522.50 383.60 54.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 419.5 383.6 m 467.5 383.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 471.5 383.6 m 518.5 383.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 522.5 383.6 m 576.5 383.6 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 425.45 400.83 Td (Restricted) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 481.60 400.83 Td (Market) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 526.75 400.83 Td (Performance) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 387.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 423.30 387.83 Td (Stock Units) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.45 387.83 Td (Share Units) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.95 387.83 Td (Share Units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 374.17 Td (Unrecognized compensation cost) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.00 374.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 448.65 374.17 Td (188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.00 374.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.65 374.17 Td (42) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 525.00 374.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 374.17 Td (94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 361.17 Td (Expected weighted-average period in years of compensation cost to be recognized) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 451.50 361.17 Td (2.7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 502.50 361.17 Td (2.8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 560.50 361.17 Td (1.6) Tj ET Q BT /F1 10.00 Tf ET 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 322.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 322.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 322.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 322.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 322.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 322.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 322.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 296.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 296.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 296.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 296.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 296.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 296.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 296.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 270.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 270.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 270.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 270.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 270.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 270.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 270.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 244.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 244.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 244.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 244.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 244.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 244.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 244.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 218.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 218.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 218.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 218.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 218.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 218.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 218.60 71.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 192.60 317.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 353.50 192.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 357.50 192.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 427.50 192.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 431.50 192.60 70.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 501.50 192.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 192.60 71.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 357.5 322.6 m 427.5 322.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 431.5 322.6 m 501.5 322.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 505.5 322.6 m 576.5 322.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 326.85 Td (Amounts in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 384.00 326.83 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 458.00 326.83 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.50 326.83 Td (2014) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 313.17 Td (Weighted-average grant date fair value \(per share\):) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 300.17 Td (Restricted stock units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 300.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.15 300.17 Td (60.56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 300.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 300.17 Td (61.18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 300.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 300.17 Td (52.22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 287.17 Td (Market share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.15 287.17 Td (65.26) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 287.17 Td (67.03) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 287.17 Td (55.44) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 274.17 Td (Performance share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 401.15 274.17 Td (64.87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.15 274.17 Td (65.07) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 274.17 Td (55.17) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 248.17 Td (Fair value of awards that vested:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 235.17 Td (Restricted stock units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 235.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 235.17 Td (81) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 235.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 235.17 Td (77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 235.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 235.17 Td (68) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 222.17 Td (Market share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 222.17 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 222.17 Td (47) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 222.17 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.00 209.17 Td (Performance share units) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.65 209.17 Td (93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 487.65 209.17 Td (75) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 209.17 Td (90) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 183.17 Td (Total intrinsic value of stock options exercised) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 360.00 183.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.65 183.17 Td (158) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.00 183.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.65 183.17 Td (206) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 508.00 183.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 183.17 Td (199) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 159.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.95 159.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 70.23 159.10 Td (value ) Tj ET Q q 0 0 0 rg BT 94.29 159.10 Td (of ) Tj ET Q q 0 0 0 rg BT 105.03 159.10 Td (restricted ) Tj ET Q q 0 0 0 rg BT 144.64 159.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 168.15 159.10 Td (units, ) Tj ET Q q 0 0 0 rg BT 192.50 159.10 Td (market ) Tj ET Q q 0 0 0 rg BT 222.67 159.10 Td (share ) Tj ET Q q 0 0 0 rg BT 246.17 159.10 Td (units ) Tj ET Q q 0 0 0 rg BT 268.03 159.10 Td (and ) Tj ET Q q 0 0 0 rg BT 284.87 159.10 Td (performance ) Tj ET Q q 0 0 0 rg BT 337.80 159.10 Td (share ) Tj ET Q q 0 0 0 rg BT 361.30 159.10 Td (units ) Tj ET Q q 0 0 0 rg BT 383.15 159.10 Td (approximates ) Tj ET Q q 0 0 0 rg BT 439.43 159.10 Td (the ) Tj ET Q q 0 0 0 rg BT 454.05 159.10 Td (closing ) Tj ET Q q 0 0 0 rg BT 485.34 159.10 Td (trading ) Tj ET Q q 0 0 0 rg BT 516.07 159.10 Td (price ) Tj ET Q q 0 0 0 rg BT 538.46 159.10 Td (of ) Tj ET Q q 0 0 0 rg BT 549.20 159.10 Td (BMS's ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 147.10 Td (common ) Tj ET Q q 0 0 0 rg BT 73.20 147.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 96.52 147.10 Td (on ) Tj ET Q q 0 0 0 rg BT 108.72 147.10 Td (the ) Tj ET Q q 0 0 0 rg BT 123.14 147.10 Td (grant ) Tj ET Q q 0 0 0 rg BT 145.90 147.10 Td (date ) Tj ET Q q 0 0 0 rg BT 164.76 147.10 Td (after ) Tj ET Q q 0 0 0 rg BT 185.28 147.10 Td (adjusting ) Tj ET Q q 0 0 0 rg BT 224.15 147.10 Td (for ) Tj ET Q q 0 0 0 rg BT 238.02 147.10 Td (the ) Tj ET Q q 0 0 0 rg BT 252.44 147.10 Td (units ) Tj ET Q q 0 0 0 rg BT 274.09 147.10 Td (not ) Tj ET Q q 0 0 0 rg BT 289.08 147.10 Td (eligible ) Tj ET Q q 0 0 0 rg BT 321.28 147.10 Td (for ) Tj ET Q q 0 0 0 rg BT 335.14 147.10 Td (accrued ) Tj ET Q q 0 0 0 rg BT 368.43 147.10 Td (dividends. ) Tj ET Q q 0 0 0 rg BT 412.02 147.10 Td (In ) Tj ET Q q 0 0 0 rg BT 422.56 147.10 Td (addition, ) Tj ET Q q 0 0 0 rg BT 460.04 147.10 Td (the ) Tj ET Q q 0 0 0 rg BT 474.46 147.10 Td (fair ) Tj ET Q q 0 0 0 rg BT 490.55 147.10 Td (value ) Tj ET Q q 0 0 0 rg BT 514.41 147.10 Td (of ) Tj ET Q q 0 0 0 rg BT 524.94 147.10 Td (market ) Tj ET Q q 0 0 0 rg BT 554.91 147.10 Td (share ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 135.10 Td (units ) Tj ET Q q 0 0 0 rg BT 57.95 135.10 Td (and ) Tj ET Q q 0 0 0 rg BT 74.89 135.10 Td (performance ) Tj ET Q q 0 0 0 rg BT 127.91 135.10 Td (share ) Tj ET Q q 0 0 0 rg BT 151.51 135.10 Td (units ) Tj ET Q q 0 0 0 rg BT 173.46 135.10 Td (considers ) Tj ET Q q 0 0 0 rg BT 213.72 135.10 Td (the ) Tj ET Q q 0 0 0 rg BT 228.44 135.10 Td (probability ) Tj ET Q q 0 0 0 rg BT 274.82 135.10 Td (of ) Tj ET Q q 0 0 0 rg BT 285.65 135.10 Td (satisfying ) Tj ET Q q 0 0 0 rg BT 327.04 135.10 Td (the ) Tj ET Q q 0 0 0 rg BT 341.76 135.10 Td (payout ) Tj ET Q q 0 0 0 rg BT 371.47 135.10 Td (factor ) Tj ET Q q 0 0 0 rg BT 397.29 135.10 Td (and ) Tj ET Q q 0 0 0 rg BT 414.23 135.10 Td (total ) Tj ET Q q 0 0 0 rg BT 434.50 135.10 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 483.65 135.10 Td (return, ) Tj ET Q q 0 0 0 rg BT 512.52 135.10 Td (respectively) Tj ET Q q 0 0 0 rg BT 560.18 135.10 Td (.) Tj ET Q endstream endobj 191 0 obj <> endobj 192 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (95) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The ) Tj ET Q q 0 0 0 rg BT 54.05 749.10 Td (following ) Tj ET Q q 0 0 0 rg BT 95.43 749.10 Td (table ) Tj ET Q q 0 0 0 rg BT 117.37 749.10 Td (summarizes ) Tj ET Q q 0 0 0 rg BT 167.63 749.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 212.34 749.10 Td (ranges ) Tj ET Q q 0 0 0 rg BT 240.94 749.10 Td (of ) Tj ET Q q 0 0 0 rg BT 251.77 749.10 Td (outstanding ) Tj ET Q q 0 0 0 rg BT 300.94 749.10 Td (and ) Tj ET Q q 0 0 0 rg BT 317.88 749.10 Td (exercisable ) Tj ET Q q 0 0 0 rg BT 365.35 749.10 Td (options ) Tj ET Q q 0 0 0 rg BT 397.29 749.10 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.01 749.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 465.59 749.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.59 749.10 Td (:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 697.60 156.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 192.50 697.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 196.50 697.60 108.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 304.50 697.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 308.50 697.60 89.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 397.50 697.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 697.60 85.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 697.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 697.60 86.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 671.60 156.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 192.50 671.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 196.50 671.60 108.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 304.50 671.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 308.50 671.60 89.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 397.50 671.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 401.50 671.60 85.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 486.50 671.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 490.50 671.60 86.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 196.5 726.6 m 304.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 304.5 726.6 m 308.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 308.5 726.6 m 397.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 397.5 726.6 m 401.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 401.5 726.6 m 486.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 486.5 726.6 m 490.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 726.6 m 576.5 726.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 196.5 697.6 m 304.5 697.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 308.5 697.6 m 397.5 697.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 401.5 697.6 m 486.5 697.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 697.6 m 576.5 697.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 196.5 671.6 m 304.5 671.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 196.5 659.6 m 304.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 196.5 657.6 m 304.5 657.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 671.6 m 576.5 671.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 659.6 m 576.5 659.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 490.5 657.6 m 576.5 657.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 730.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 321.90 730.68 Td (Options Outstanding and Exercisable) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 39.00 701.83 Td ( Range of Exercise Prices) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 235.85 717.83 Td (Number) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 200.50 709.83 Td (Outstanding and Exer) Tj ET Q q 0 0 0 rg BT 276.38 709.83 Td (cisable ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 225.65 701.83 Td (\(in thousands\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 321.00 717.83 Td (W) Tj ET Q q 0 0 0 rg BT 328.56 717.83 Td (eighted-A) Tj ET Q q 0 0 0 rg BT 361.29 717.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 312.15 709.83 Td (Remaining Contractual) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 328.50 701.83 Td (Life \(in years\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 412.00 717.83 Td (W) Tj ET Q q 0 0 0 rg BT 419.56 717.83 Td (eighted-A) Tj ET Q q 0 0 0 rg BT 452.29 717.83 Td (verage) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 419.25 709.83 Td (Exer) Tj ET Q q 0 0 0 rg BT 435.54 709.83 Td (cise Price ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 426.65 701.83 Td (Per) Tj ET Q q 0 0 0 rg BT 438.49 701.83 Td ( Shar) Tj ET Q q 0 0 0 rg BT 456.80 701.83 Td (e) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 515.50 717.83 Td (Aggr) Tj ET Q q 0 0 0 rg BT 532.68 717.83 Td (egate) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 507.75 709.83 Td (Intrinsic ) Tj ET Q q 0 0 0 rg BT 538.94 709.83 Td (V) Tj ET Q q 0 0 0 rg BT 543.98 709.83 Td (alue ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 512.40 701.83 Td (\(in millions\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 688.17 Td ($1 - $20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 278.15 688.17 Td (3,052) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 376.50 688.17 Td (2.15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.00 688.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.15 688.17 Td (17.54) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.00 688.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 688.17 Td (125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 675.17 Td ($20 - $30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 278.15 675.17 Td (3,351) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 376.50 675.17 Td (0.78) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.15 675.17 Td (24.18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 675.17 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 278.15 662.17 Td (6,403) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 376.50 662.17 Td (1.43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.00 662.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.15 662.17 Td (21.02) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.00 662.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 662.17 Td (240) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 638.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.88 638.10 Td (aggregate ) Tj ET Q q 0 0 0 rg BT 95.08 638.10 Td (intrinsic ) Tj ET Q q 0 0 0 rg BT 130.20 638.10 Td (value ) Tj ET Q q 0 0 0 rg BT 154.19 638.10 Td (in ) Tj ET Q q 0 0 0 rg BT 164.31 638.10 Td (the ) Tj ET Q q 0 0 0 rg BT 178.86 638.10 Td (preceding ) Tj ET Q q 0 0 0 rg BT 220.62 638.10 Td (table ) Tj ET Q q 0 0 0 rg BT 242.39 638.10 Td (represents ) Tj ET Q q 0 0 0 rg BT 285.27 638.10 Td (the ) Tj ET Q q 0 0 0 rg BT 299.82 638.10 Td (total ) Tj ET Q q 0 0 0 rg BT 319.93 638.10 Td (pretax ) Tj ET Q q 0 0 0 rg BT 347.26 638.10 Td (intrinsic ) Tj ET Q q 0 0 0 rg BT 382.37 638.10 Td (value, ) Tj ET Q q 0 0 0 rg BT 408.86 638.10 Td (based ) Tj ET Q q 0 0 0 rg BT 433.97 638.10 Td (on ) Tj ET Q q 0 0 0 rg BT 446.31 638.10 Td (the ) Tj ET Q q 0 0 0 rg BT 460.86 638.10 Td (closing ) Tj ET Q q 0 0 0 rg BT 492.09 638.10 Td (stock ) Tj ET Q q 0 0 0 rg BT 515.53 638.10 Td (price ) Tj ET Q q 0 0 0 rg BT 537.86 638.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 548.52 638.10 Td ($58.44) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 626.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 48.50 626.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 107.08 626.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 127.08 626.10 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 600.10 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 600.10 Td (18) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 600.10 Td (. LEGAL) Tj ET Q q 0 0 0 rg BT 107.95 600.10 Td ( PROCEEDINGS ) Tj ET Q q 0 0 0 rg BT 185.74 600.10 Td (AND CONTINGENCIES) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 579.10 Td (The ) Tj ET Q q 0 0 0 rg BT 52.91 579.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 93.17 579.10 Td (and ) Tj ET Q q 0 0 0 rg BT 108.97 579.10 Td (certain ) Tj ET Q q 0 0 0 rg BT 137.54 579.10 Td (of ) Tj ET Q q 0 0 0 rg BT 147.24 579.10 Td (its ) Tj ET Q q 0 0 0 rg BT 158.05 579.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 206.63 579.10 Td (are ) Tj ET Q q 0 0 0 rg BT 220.21 579.10 Td (involved ) Tj ET Q q 0 0 0 rg BT 256.57 579.10 Td (in ) Tj ET Q q 0 0 0 rg BT 265.71 579.10 Td (various ) Tj ET Q q 0 0 0 rg BT 296.52 579.10 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 333.16 579.10 Td (claims, ) Tj ET Q q 0 0 0 rg BT 363.13 579.10 Td (government ) Tj ET Q q 0 0 0 rg BT 412.26 579.10 Td (investigations ) Tj ET Q q 0 0 0 rg BT 469.18 579.10 Td (and ) Tj ET Q q 0 0 0 rg BT 484.98 579.10 Td (other ) Tj ET Q q 0 0 0 rg BT 506.90 579.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 527.70 579.10 Td (proceedings ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 567.10 Td (that ) Tj ET Q q 0 0 0 rg BT 53.69 567.10 Td (arise ) Tj ET Q q 0 0 0 rg BT 75.26 567.10 Td (in ) Tj ET Q q 0 0 0 rg BT 85.73 567.10 Td (the ) Tj ET Q q 0 0 0 rg BT 100.64 567.10 Td (ordinary ) Tj ET Q q 0 0 0 rg BT 137.22 567.10 Td (course ) Tj ET Q q 0 0 0 rg BT 166.01 567.10 Td (of ) Tj ET Q q 0 0 0 rg BT 177.03 567.10 Td (business. ) Tj ET Q q 0 0 0 rg BT 215.92 567.10 Td (These ) Tj ET Q q 0 0 0 rg BT 242.50 567.10 Td (claims ) Tj ET Q q 0 0 0 rg BT 271.29 567.10 Td (or ) Tj ET Q q 0 0 0 rg BT 282.32 567.10 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 333.33 567.10 Td (can ) Tj ET Q q 0 0 0 rg BT 349.90 567.10 Td (involve ) Tj ET Q q 0 0 0 rg BT 382.59 567.10 Td (various ) Tj ET Q q 0 0 0 rg BT 414.72 567.10 Td (types ) Tj ET Q q 0 0 0 rg BT 438.52 567.10 Td (of ) Tj ET Q q 0 0 0 rg BT 449.55 567.10 Td (parties, ) Tj ET Q q 0 0 0 rg BT 481.40 567.10 Td (including ) Tj ET Q q 0 0 0 rg BT 521.87 567.10 Td (governments, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 555.10 Td (competitors, ) Tj ET Q q 0 0 0 rg BT 87.51 555.10 Td (customers, ) Tj ET Q q 0 0 0 rg BT 132.35 555.10 Td (suppliers, ) Tj ET Q q 0 0 0 rg BT 172.76 555.10 Td (service ) Tj ET Q q 0 0 0 rg BT 202.87 555.10 Td (providers, ) Tj ET Q q 0 0 0 rg BT 244.94 555.10 Td (licensees, ) Tj ET Q q 0 0 0 rg BT 285.33 555.10 Td (employees, ) Tj ET Q q 0 0 0 rg BT 332.39 555.10 Td (or ) Tj ET Q q 0 0 0 rg BT 342.51 555.10 Td (shareholders, ) Tj ET Q q 0 0 0 rg BT 397.35 555.10 Td (among ) Tj ET Q q 0 0 0 rg BT 426.36 555.10 Td (others. ) Tj ET Q q 0 0 0 rg BT 454.97 555.10 Td (The ) Tj ET Q q 0 0 0 rg BT 472.31 555.10 Td (resolution ) Tj ET Q q 0 0 0 rg BT 514.10 555.10 Td (of ) Tj ET Q q 0 0 0 rg BT 524.23 555.10 Td (these ) Tj ET Q q 0 0 0 rg BT 546.57 555.10 Td (matters ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 543.10 Td (often ) Tj ET Q q 0 0 0 rg BT 60.39 543.10 Td (develops ) Tj ET Q q 0 0 0 rg BT 99.78 543.10 Td (over ) Tj ET Q q 0 0 0 rg BT 121.39 543.10 Td (a ) Tj ET Q q 0 0 0 rg BT 129.67 543.10 Td (long ) Tj ET Q q 0 0 0 rg BT 151.30 543.10 Td (period ) Tj ET Q q 0 0 0 rg BT 180.69 543.10 Td (of ) Tj ET Q q 0 0 0 rg BT 192.86 543.10 Td (time ) Tj ET Q q 0 0 0 rg BT 214.48 543.10 Td (and ) Tj ET Q q 0 0 0 rg BT 232.76 543.10 Td (expectations ) Tj ET Q q 0 0 0 rg BT 286.58 543.10 Td (can ) Tj ET Q q 0 0 0 rg BT 304.30 543.10 Td (change ) Tj ET Q q 0 0 0 rg BT 336.46 543.10 Td (as ) Tj ET Q q 0 0 0 rg BT 348.63 543.10 Td (a ) Tj ET Q q 0 0 0 rg BT 356.92 543.10 Td (result ) Tj ET Q q 0 0 0 rg BT 382.98 543.10 Td (of ) Tj ET Q q 0 0 0 rg BT 395.15 543.10 Td (new ) Tj ET Q q 0 0 0 rg BT 415.65 543.10 Td (findings, ) Tj ET Q q 0 0 0 rg BT 454.77 543.10 Td (rulings, ) Tj ET Q q 0 0 0 rg BT 488.90 543.10 Td (appeals ) Tj ET Q q 0 0 0 rg BT 522.72 543.10 Td (or ) Tj ET Q q 0 0 0 rg BT 534.90 543.10 Td (settlement ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 531.10 Td (arrangements. ) Tj ET Q q 0 0 0 rg BT 93.96 531.10 Td (The ) Tj ET Q q 0 0 0 rg BT 111.23 531.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 151.84 531.10 Td (recognizes ) Tj ET Q q 0 0 0 rg BT 196.32 531.10 Td (accruals ) Tj ET Q q 0 0 0 rg BT 230.80 531.10 Td (for ) Tj ET Q q 0 0 0 rg BT 244.18 531.10 Td (such ) Tj ET Q q 0 0 0 rg BT 264.23 531.10 Td (contingencies ) Tj ET Q q 0 0 0 rg BT 320.94 531.10 Td (when ) Tj ET Q q 0 0 0 rg BT 344.32 531.10 Td (it ) Tj ET Q q 0 0 0 rg BT 351.60 531.10 Td (is ) Tj ET Q q 0 0 0 rg BT 360.00 531.10 Td (probable ) Tj ET Q q 0 0 0 rg BT 396.71 531.10 Td (that ) Tj ET Q q 0 0 0 rg BT 413.42 531.10 Td (a ) Tj ET Q q 0 0 0 rg BT 419.59 531.10 Td (liability ) Tj ET Q q 0 0 0 rg BT 452.42 531.10 Td (will ) Tj ET Q q 0 0 0 rg BT 469.70 531.10 Td (be ) Tj ET Q q 0 0 0 rg BT 480.86 531.10 Td (incurred ) Tj ET Q q 0 0 0 rg BT 515.90 531.10 Td (and ) Tj ET Q q 0 0 0 rg BT 532.06 531.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.00 531.10 Td (amount ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 519.10 Td (of ) Tj ET Q q 0 0 0 rg BT 45.98 519.10 Td (loss ) Tj ET Q q 0 0 0 rg BT 63.20 519.10 Td (can ) Tj ET Q q 0 0 0 rg BT 78.72 519.10 Td (be ) Tj ET Q q 0 0 0 rg BT 89.81 519.10 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 134.78 519.10 Td (estimated. ) Tj ET Q q 0 0 0 rg BT 177.13 519.10 Td (These ) Tj ET Q q 0 0 0 rg BT 202.66 519.10 Td (matters ) Tj ET Q q 0 0 0 rg BT 233.75 519.10 Td (involve ) Tj ET Q q 0 0 0 rg BT 265.40 519.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 291.48 519.10 Td (infringement, ) Tj ET Q q 0 0 0 rg BT 347.28 519.10 Td (antitrust, ) Tj ET Q q 0 0 0 rg BT 384.21 519.10 Td (securities, ) Tj ET Q q 0 0 0 rg BT 426.12 519.10 Td (pricing, ) Tj ET Q q 0 0 0 rg BT 458.60 519.10 Td (sales ) Tj ET Q q 0 0 0 rg BT 479.69 519.10 Td (and ) Tj ET Q q 0 0 0 rg BT 495.78 519.10 Td (marketing ) Tj ET Q q 0 0 0 rg BT 537.98 519.10 Td (practices, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 507.10 Td (environmental, ) Tj ET Q q 0 0 0 rg BT 99.20 507.10 Td (commercial, ) Tj ET Q q 0 0 0 rg BT 151.84 507.10 Td (contractual ) Tj ET Q q 0 0 0 rg BT 199.20 507.10 Td (rights, ) Tj ET Q q 0 0 0 rg BT 227.42 507.10 Td (licensing ) Tj ET Q q 0 0 0 rg BT 266.46 507.10 Td (obligations, ) Tj ET Q q 0 0 0 rg BT 316.35 507.10 Td (health ) Tj ET Q q 0 0 0 rg BT 343.72 507.10 Td (and ) Tj ET Q q 0 0 0 rg BT 361.10 507.10 Td (safety ) Tj ET Q q 0 0 0 rg BT 387.92 507.10 Td (matters, ) Tj ET Q q 0 0 0 rg BT 422.79 507.10 Td (consumer ) Tj ET Q q 0 0 0 rg BT 464.61 507.10 Td (fraud, ) Tj ET Q q 0 0 0 rg BT 491.15 507.10 Td (employment ) Tj ET Q q 0 0 0 rg BT 544.08 507.10 Td (matters, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 495.10 Td (product ) Tj ET Q q 0 0 0 rg BT 69.35 495.10 Td (liability ) Tj ET Q q 0 0 0 rg BT 103.27 495.10 Td (and ) Tj ET Q q 0 0 0 rg BT 120.51 495.10 Td (insurance ) Tj ET Q q 0 0 0 rg BT 161.63 495.10 Td (coverage. ) Tj ET Q q 0 0 0 rg BT 203.02 495.10 Td (Legal ) Tj ET Q q 0 0 0 rg BT 228.59 495.10 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 279.71 495.10 Td (that ) Tj ET Q q 0 0 0 rg BT 297.51 495.10 Td (are ) Tj ET Q q 0 0 0 rg BT 312.52 495.10 Td (material ) Tj ET Q q 0 0 0 rg BT 348.08 495.10 Td (or ) Tj ET Q q 0 0 0 rg BT 359.22 495.10 Td (that ) Tj ET Q q 0 0 0 rg BT 377.02 495.10 Td (the ) Tj ET Q q 0 0 0 rg BT 392.04 495.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 433.73 495.10 Td (believes ) Tj ET Q q 0 0 0 rg BT 469.30 495.10 Td (could ) Tj ET Q q 0 0 0 rg BT 494.33 495.10 Td (become ) Tj ET Q q 0 0 0 rg BT 528.22 495.10 Td (material ) Tj ET Q q 0 0 0 rg BT 563.79 495.10 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 483.10 Td (described ) Tj ET Q q 0 0 0 rg BT 76.82 483.10 Td (below) Tj ET Q q 0 0 0 rg BT 100.60 483.10 Td (.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 465.10 Td (Although ) Tj ET Q q 0 0 0 rg BT 76.27 465.10 Td (the ) Tj ET Q q 0 0 0 rg BT 90.99 465.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 132.37 465.10 Td (believes ) Tj ET Q q 0 0 0 rg BT 167.63 465.10 Td (it ) Tj ET Q q 0 0 0 rg BT 175.68 465.10 Td (has ) Tj ET Q q 0 0 0 rg BT 191.50 465.10 Td (substantial ) Tj ET Q q 0 0 0 rg BT 236.77 465.10 Td (defenses ) Tj ET Q q 0 0 0 rg BT 273.70 465.10 Td (in ) Tj ET Q q 0 0 0 rg BT 283.97 465.10 Td (these ) Tj ET Q q 0 0 0 rg BT 307.01 465.10 Td (matters, ) Tj ET Q q 0 0 0 rg BT 341.44 465.10 Td (there ) Tj ET Q q 0 0 0 rg BT 363.92 465.10 Td (can ) Tj ET Q q 0 0 0 rg BT 380.29 465.10 Td (be ) Tj ET Q q 0 0 0 rg BT 392.23 465.10 Td (no ) Tj ET Q q 0 0 0 rg BT 404.72 465.10 Td (assurance ) Tj ET Q q 0 0 0 rg BT 446.08 465.10 Td (that ) Tj ET Q q 0 0 0 rg BT 463.57 465.10 Td (there ) Tj ET Q q 0 0 0 rg BT 486.05 465.10 Td (will ) Tj ET Q q 0 0 0 rg BT 504.11 465.10 Td (not ) Tj ET Q q 0 0 0 rg BT 519.38 465.10 Td (be ) Tj ET Q q 0 0 0 rg BT 531.31 465.10 Td (an ) Tj ET Q q 0 0 0 rg BT 543.25 465.10 Td (increase ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 453.10 Td (in ) Tj ET Q q 0 0 0 rg BT 46.98 453.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.40 453.10 Td (scope ) Tj ET Q q 0 0 0 rg BT 88.37 453.10 Td (of ) Tj ET Q q 0 0 0 rg BT 99.90 453.10 Td (pending ) Tj ET Q q 0 0 0 rg BT 135.31 453.10 Td (matters ) Tj ET Q q 0 0 0 rg BT 167.95 453.10 Td (or ) Tj ET Q q 0 0 0 rg BT 179.48 453.10 Td (that ) Tj ET Q q 0 0 0 rg BT 197.67 453.10 Td (any ) Tj ET Q q 0 0 0 rg BT 215.31 453.10 Td (future ) Tj ET Q q 0 0 0 rg BT 242.39 453.10 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 280.87 453.10 Td (claims, ) Tj ET Q q 0 0 0 rg BT 312.67 453.10 Td (government ) Tj ET Q q 0 0 0 rg BT 363.64 453.10 Td (investigations ) Tj ET Q q 0 0 0 rg BT 422.39 453.10 Td (or ) Tj ET Q q 0 0 0 rg BT 433.92 453.10 Td (other ) Tj ET Q q 0 0 0 rg BT 457.67 453.10 Td (legal ) Tj ET Q q 0 0 0 rg BT 480.30 453.10 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 531.82 453.10 Td (will ) Tj ET Q q 0 0 0 rg BT 550.58 453.10 Td (not ) Tj ET Q q 0 0 0 rg BT 566.56 453.10 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 441.10 Td (material. ) Tj ET Q q 0 0 0 rg BT 74.14 441.10 Td (Unless ) Tj ET Q q 0 0 0 rg BT 104.25 441.10 Td (otherwise ) Tj ET Q q 0 0 0 rg BT 146.01 441.10 Td (noted, ) Tj ET Q q 0 0 0 rg BT 173.61 441.10 Td (the ) Tj ET Q q 0 0 0 rg BT 188.71 441.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 230.49 441.10 Td (is ) Tj ET Q q 0 0 0 rg BT 240.04 441.10 Td (unable ) Tj ET Q q 0 0 0 rg BT 269.58 441.10 Td (to ) Tj ET Q q 0 0 0 rg BT 280.24 441.10 Td (assess ) Tj ET Q q 0 0 0 rg BT 307.57 441.10 Td (the ) Tj ET Q q 0 0 0 rg BT 322.67 441.10 Td (outcome ) Tj ET Q q 0 0 0 rg BT 359.99 441.10 Td (of ) Tj ET Q q 0 0 0 rg BT 371.21 441.10 Td (the ) Tj ET Q q 0 0 0 rg BT 386.31 441.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 429.73 441.10 Td (litigation ) Tj ET Q q 0 0 0 rg BT 468.72 441.10 Td (nor ) Tj ET Q q 0 0 0 rg BT 484.93 441.10 Td (is ) Tj ET Q q 0 0 0 rg BT 494.49 441.10 Td (it ) Tj ET Q q 0 0 0 rg BT 502.93 441.10 Td (able ) Tj ET Q q 0 0 0 rg BT 522.47 441.10 Td (to ) Tj ET Q q 0 0 0 rg BT 533.13 441.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 566.56 441.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 429.10 Td (estimated ) Tj ET Q q 0 0 0 rg BT 77.60 429.10 Td (range ) Tj ET Q q 0 0 0 rg BT 103.09 429.10 Td (of ) Tj ET Q q 0 0 0 rg BT 114.71 429.10 Td (potential ) Tj ET Q q 0 0 0 rg BT 152.98 429.10 Td (loss. ) Tj ET Q q 0 0 0 rg BT 174.33 429.10 Td (Furthermore, ) Tj ET Q q 0 0 0 rg BT 230.10 429.10 Td (failure ) Tj ET Q q 0 0 0 rg BT 259.47 429.10 Td (to ) Tj ET Q q 0 0 0 rg BT 270.54 429.10 Td (enforce ) Tj ET Q q 0 0 0 rg BT 303.80 429.10 Td (our ) Tj ET Q q 0 0 0 rg BT 320.41 429.10 Td (patent ) Tj ET Q q 0 0 0 rg BT 348.13 429.10 Td (rights ) Tj ET Q q 0 0 0 rg BT 374.19 429.10 Td (would ) Tj ET Q q 0 0 0 rg BT 402.47 429.10 Td (likely ) Tj ET Q q 0 0 0 rg BT 428.53 429.10 Td (result ) Tj ET Q q 0 0 0 rg BT 454.03 429.10 Td (in ) Tj ET Q q 0 0 0 rg BT 465.09 429.10 Td (substantial ) Tj ET Q q 0 0 0 rg BT 511.15 429.10 Td (decreases ) Tj ET Q q 0 0 0 rg BT 552.74 429.10 Td (in ) Tj ET Q q 0 0 0 rg BT 563.80 429.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 417.10 Td (respective ) Tj ET Q q 0 0 0 rg BT 79.03 417.10 Td (product ) Tj ET Q q 0 0 0 rg BT 112.08 417.10 Td (revenues ) Tj ET Q q 0 0 0 rg BT 150.12 417.10 Td (from ) Tj ET Q q 0 0 0 rg BT 172.05 417.10 Td (generic ) Tj ET Q q 0 0 0 rg BT 203.98 417.10 Td (competition.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 393.10 Td (INTELLECTUAL) Tj ET Q q 0 0 0 rg BT 114.92 393.10 Td ( PROPER) Tj ET Q q 0 0 0 rg BT 158.17 393.10 Td (TY) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 372.10 Td (Plavix* ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 69.60 372.10 Td (— ) Tj ET Q q 0 0 0 rg BT 81.55 372.10 Td (Australia) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 354.10 Td (As ) Tj ET Q q 0 0 0 rg BT 49.42 354.10 Td (previously ) Tj ET Q q 0 0 0 rg BT 93.94 354.10 Td (disclosed, ) Tj ET Q q 0 0 0 rg BT 135.97 354.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 164.38 354.10 Td (was ) Tj ET Q q 0 0 0 rg BT 182.24 354.10 Td (notified ) Tj ET Q q 0 0 0 rg BT 215.65 354.10 Td (that, ) Tj ET Q q 0 0 0 rg BT 235.46 354.10 Td (in ) Tj ET Q q 0 0 0 rg BT 245.03 354.10 Td (August ) Tj ET Q q 0 0 0 rg BT 276.23 354.10 Td (2007, ) Tj ET Q q 0 0 0 rg BT 301.04 354.10 Td (GenRx ) Tj ET Q q 0 0 0 rg BT 331.67 354.10 Td (Proprietary ) Tj ET Q q 0 0 0 rg BT 378.97 354.10 Td (Limited ) Tj ET Q q 0 0 0 rg BT 412.93 354.10 Td (\(GenRx\) ) Tj ET Q q 0 0 0 rg BT 450.23 354.10 Td (obtained ) Tj ET Q q 0 0 0 rg BT 486.97 354.10 Td (regulatory ) Tj ET Q q 0 0 0 rg BT 530.37 354.10 Td (approval ) Tj ET Q q 0 0 0 rg BT 567.67 354.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 342.10 Td (an ) Tj ET Q q 0 0 0 rg BT 46.97 342.10 Td (application ) Tj ET Q q 0 0 0 rg BT 92.94 342.10 Td (for ) Tj ET Q q 0 0 0 rg BT 106.13 342.10 Td (clopidogrel ) Tj ET Q q 0 0 0 rg BT 153.21 342.10 Td (bisulfate ) Tj ET Q q 0 0 0 rg BT 189.18 342.10 Td (75mg ) Tj ET Q q 0 0 0 rg BT 213.50 342.10 Td (tablets ) Tj ET Q q 0 0 0 rg BT 241.13 342.10 Td (in ) Tj ET Q q 0 0 0 rg BT 250.11 342.10 Td (Australia. ) Tj ET Q q 0 0 0 rg BT 290.80 342.10 Td (GenRx, ) Tj ET Q q 0 0 0 rg BT 323.17 342.10 Td (formerly ) Tj ET Q q 0 0 0 rg BT 359.69 342.10 Td (a ) Tj ET Q q 0 0 0 rg BT 365.66 342.10 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 408.31 342.10 Td (of ) Tj ET Q q 0 0 0 rg BT 417.83 342.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 448.81 342.10 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 465.61 342.10 Td (\(Apotex\), ) Tj ET Q q 0 0 0 rg BT 505.74 342.10 Td (has ) Tj ET Q q 0 0 0 rg BT 520.61 342.10 Td (since ) Tj ET Q q 0 0 0 rg BT 542.69 342.10 Td (changed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 330.10 Td (its ) Tj ET Q q 0 0 0 rg BT 47.72 330.10 Td (name ) Tj ET Q q 0 0 0 rg BT 71.65 330.10 Td (to ) Tj ET Q q 0 0 0 rg BT 81.20 330.10 Td (Apotex. ) Tj ET Q q 0 0 0 rg BT 115.41 330.10 Td (In ) Tj ET Q q 0 0 0 rg BT 125.51 330.10 Td (August ) Tj ET Q q 0 0 0 rg BT 156.67 330.10 Td (2007, ) Tj ET Q q 0 0 0 rg BT 180.94 330.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 212.65 330.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 233.25 330.10 Td (an ) Tj ET Q q 0 0 0 rg BT 244.96 330.10 Td (application ) Tj ET Q q 0 0 0 rg BT 291.66 330.10 Td (in ) Tj ET Q q 0 0 0 rg BT 301.71 330.10 Td (the ) Tj ET Q q 0 0 0 rg BT 316.20 330.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 348.46 330.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 373.51 330.10 Td (of ) Tj ET Q q 0 0 0 rg BT 383.61 330.10 Td (Australia ) Tj ET Q q 0 0 0 rg BT 422.53 330.10 Td (\(the ) Tj ET Q q 0 0 0 rg BT 440.35 330.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 472.61 330.10 Td (Court\) ) Tj ET Q q 0 0 0 rg BT 500.99 330.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 533.81 330.10 Td (revocation ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 318.10 Td (of ) Tj ET Q q 0 0 0 rg BT 47.83 318.10 Td (Sanofi’) Tj ET Q q 0 0 0 rg BT 76.72 318.10 Td (s ) Tj ET Q q 0 0 0 rg BT 83.34 318.10 Td (Australian ) Tj ET Q q 0 0 0 rg BT 128.50 318.10 Td (Patent ) Tj ET Q q 0 0 0 rg BT 157.00 318.10 Td (No. 597784 ) Tj ET Q q 0 0 0 rg BT 207.73 318.10 Td (\(Case ) Tj ET Q q 0 0 0 rg BT 234.00 318.10 Td (No. ) Tj ET Q q 0 0 0 rg BT 252.23 318.10 Td (NSD ) Tj ET Q q 0 0 0 rg BT 275.74 318.10 Td (1639 ) Tj ET Q q 0 0 0 rg BT 299.25 318.10 Td (of ) Tj ET Q q 0 0 0 rg BT 311.08 318.10 Td (2007\). ) Tj ET Q q 0 0 0 rg BT 340.42 318.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 370.03 318.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 391.86 318.10 Td (counterclaims ) Tj ET Q q 0 0 0 rg BT 451.45 318.10 Td (of ) Tj ET Q q 0 0 0 rg BT 463.29 318.10 Td (infringement ) Tj ET Q q 0 0 0 rg BT 518.44 318.10 Td (and ) Tj ET Q q 0 0 0 rg BT 536.39 318.10 Td (sought ) Tj ET Q q 0 0 0 rg BT 566.56 318.10 Td (an ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 306.10 Td (injunction. ) Tj ET Q q 0 0 0 rg BT 81.13 306.10 Td (On ) Tj ET Q q 0 0 0 rg BT 95.42 306.10 Td (September 21, ) Tj ET Q q 0 0 0 rg BT 155.26 306.10 Td (2007, ) Tj ET Q q 0 0 0 rg BT 179.84 306.10 Td (the ) Tj ET Q q 0 0 0 rg BT 194.13 306.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 226.19 306.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 251.04 306.10 Td (granted ) Tj ET Q q 0 0 0 rg BT 283.10 306.10 Td (Sanofi’) Tj ET Q q 0 0 0 rg BT 311.99 306.10 Td (s ) Tj ET Q q 0 0 0 rg BT 317.96 306.10 Td (injunction. ) Tj ET Q q 0 0 0 rg BT 362.63 306.10 Td (A) Tj ET Q q 0 0 0 rg BT 369.30 306.10 Td ( ) Tj ET Q q 0 0 0 rg BT 371.37 306.10 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 414.56 306.10 Td (of ) Tj ET Q q 0 0 0 rg BT 424.96 306.10 Td (the ) Tj ET Q q 0 0 0 rg BT 439.25 306.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 480.21 306.10 Td (was ) Tj ET Q q 0 0 0 rg BT 497.84 306.10 Td (subsequently ) Tj ET Q q 0 0 0 rg BT 552.13 306.10 Td (added ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 294.10 Td (as ) Tj ET Q q 0 0 0 rg BT 46.83 294.10 Td (a ) Tj ET Q q 0 0 0 rg BT 53.77 294.10 Td (party ) Tj ET Q q 0 0 0 rg BT 76.82 294.10 Td (to ) Tj ET Q q 0 0 0 rg BT 87.10 294.10 Td (the ) Tj ET Q q 0 0 0 rg BT 101.82 294.10 Td (proceedings. ) Tj ET Q q 0 0 0 rg BT 155.14 294.10 Td (In ) Tj ET Q q 0 0 0 rg BT 165.97 294.10 Td (February ) Tj ET Q q 0 0 0 rg BT 204.57 294.10 Td (2008, ) Tj ET Q q 0 0 0 rg BT 229.58 294.10 Td (a ) Tj ET Q q 0 0 0 rg BT 236.52 294.10 Td (second ) Tj ET Q q 0 0 0 rg BT 266.79 294.10 Td (company) Tj ET Q q 0 0 0 rg BT 302.79 294.10 Td (, ) Tj ET Q q 0 0 0 rg BT 307.80 294.10 Td (Spirit ) Tj ET Q q 0 0 0 rg BT 332.53 294.10 Td (Pharmaceuticals ) Tj ET Q q 0 0 0 rg BT 400.56 294.10 Td (Pty) Tj ET Q q 0 0 0 rg BT 413.25 294.10 Td (. ) Tj ET Q q 0 0 0 rg BT 418.25 294.10 Td (Ltd., ) Tj ET Q q 0 0 0 rg BT 439.64 294.10 Td (also ) Tj ET Q q 0 0 0 rg BT 458.25 294.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 479.08 294.10 Td (a ) Tj ET Q q 0 0 0 rg BT 486.02 294.10 Td (revocation ) Tj ET Q q 0 0 0 rg BT 530.72 294.10 Td (suit ) Tj ET Q q 0 0 0 rg BT 547.67 294.10 Td (against ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 282.10 Td (the ) Tj ET Q q 0 0 0 rg BT 50.94 282.10 Td (same ) Tj ET Q q 0 0 0 rg BT 74.21 282.10 Td (patent. ) Tj ET Q q 0 0 0 rg BT 103.67 282.10 Td (This ) Tj ET Q q 0 0 0 rg BT 124.18 282.10 Td (case ) Tj ET Q q 0 0 0 rg BT 144.11 282.10 Td (was ) Tj ET Q q 0 0 0 rg BT 162.39 282.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 215.65 282.10 Td (with ) Tj ET Q q 0 0 0 rg BT 236.15 282.10 Td (the ) Tj ET Q q 0 0 0 rg BT 250.49 282.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 282.66 282.10 Td (case, ) Tj ET Q q 0 0 0 rg BT 305.09 282.10 Td (and ) Tj ET Q q 0 0 0 rg BT 322.25 282.10 Td (a ) Tj ET Q q 0 0 0 rg BT 329.42 282.10 Td (trial ) Tj ET Q q 0 0 0 rg BT 348.24 282.10 Td (occurred ) Tj ET Q q 0 0 0 rg BT 385.94 282.10 Td (in ) Tj ET Q q 0 0 0 rg BT 395.85 282.10 Td (April ) Tj ET Q q 0 0 0 rg BT 419.68 282.10 Td (2008. ) Tj ET Q q 0 0 0 rg BT 444.90 282.10 Td (On ) Tj ET Q q 0 0 0 rg BT 459.25 282.10 Td (August 12, ) Tj ET Q q 0 0 0 rg BT 505.86 282.10 Td (2008, ) Tj ET Q q 0 0 0 rg BT 531.09 282.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.03 282.10 Td (Federal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 270.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 61.10 270.10 Td (of ) Tj ET Q q 0 0 0 rg BT 71.24 270.10 Td (Australia ) Tj ET Q q 0 0 0 rg BT 110.22 270.10 Td (held ) Tj ET Q q 0 0 0 rg BT 129.76 270.10 Td (that ) Tj ET Q q 0 0 0 rg BT 147.07 270.10 Td (claims ) Tj ET Q q 0 0 0 rg BT 175.50 270.10 Td (of ) Tj ET Q q 0 0 0 rg BT 186.15 270.10 Td (Patent ) Tj ET Q q 0 0 0 rg BT 213.47 270.10 Td (No. 597784 ) Tj ET Q q 0 0 0 rg BT 263.01 270.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 300.32 270.10 Td (clopidogrel ) Tj ET Q q 0 0 0 rg BT 348.18 270.10 Td (bisulfate, ) Tj ET Q q 0 0 0 rg BT 387.44 270.10 Td (hydrochloride, ) Tj ET Q q 0 0 0 rg BT 448.35 270.10 Td (hydrobromide, ) Tj ET Q q 0 0 0 rg BT 509.83 270.10 Td (and ) Tj ET Q q 0 0 0 rg BT 526.59 270.10 Td (taurocholate ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 258.10 Td (salts ) Tj ET Q q 0 0 0 rg BT 55.45 258.10 Td (were ) Tj ET Q q 0 0 0 rg BT 76.54 258.10 Td (valid. ) Tj ET Q q 0 0 0 rg BT 100.58 258.10 Td (The ) Tj ET Q q 0 0 0 rg BT 117.80 258.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 149.45 258.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 173.90 258.10 Td (also ) Tj ET Q q 0 0 0 rg BT 191.67 258.10 Td (held ) Tj ET Q q 0 0 0 rg BT 210.56 258.10 Td (that ) Tj ET Q q 0 0 0 rg BT 227.22 258.10 Td (the ) Tj ET Q q 0 0 0 rg BT 241.10 258.10 Td (process ) Tj ET Q q 0 0 0 rg BT 272.76 258.10 Td (claims, ) Tj ET Q q 0 0 0 rg BT 303.03 258.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 365.77 258.10 Td (composition ) Tj ET Q q 0 0 0 rg BT 416.89 258.10 Td (claims, ) Tj ET Q q 0 0 0 rg BT 447.16 258.10 Td (and ) Tj ET Q q 0 0 0 rg BT 463.26 258.10 Td (claim ) Tj ET Q q 0 0 0 rg BT 487.14 258.10 Td (directed ) Tj ET Q q 0 0 0 rg BT 521.01 258.10 Td (to ) Tj ET Q q 0 0 0 rg BT 530.46 258.10 Td (clopidogrel ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 246.10 Td (and ) Tj ET Q q 0 0 0 rg BT 52.93 246.10 Td (its ) Tj ET Q q 0 0 0 rg BT 64.87 246.10 Td (pharmaceutically ) Tj ET Q q 0 0 0 rg BT 136.21 246.10 Td (acceptable ) Tj ET Q q 0 0 0 rg BT 180.89 246.10 Td (salts ) Tj ET Q q 0 0 0 rg BT 201.16 246.10 Td (were ) Tj ET Q q 0 0 0 rg BT 223.08 246.10 Td (invalid. ) Tj ET Q q 0 0 0 rg BT 255.66 246.10 Td (The ) Tj ET Q q 0 0 0 rg BT 273.70 246.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 315.07 246.10 Td (and ) Tj ET Q q 0 0 0 rg BT 332.00 246.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 360.60 246.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 381.42 246.10 Td (notices ) Tj ET Q q 0 0 0 rg BT 412.23 246.10 Td (of ) Tj ET Q q 0 0 0 rg BT 423.05 246.10 Td (appeal ) Tj ET Q q 0 0 0 rg BT 451.64 246.10 Td (in ) Tj ET Q q 0 0 0 rg BT 461.90 246.10 Td (the ) Tj ET Q q 0 0 0 rg BT 476.61 246.10 Td (Full ) Tj ET Q q 0 0 0 rg BT 495.22 246.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 520.49 246.10 Td (of ) Tj ET Q q 0 0 0 rg BT 531.31 246.10 Td (the ) Tj ET Q q 0 0 0 rg BT 546.02 246.10 Td (Federal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 234.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 61.04 234.10 Td (of ) Tj ET Q q 0 0 0 rg BT 71.13 234.10 Td (Australia ) Tj ET Q q 0 0 0 rg BT 110.04 234.10 Td (\(Full ) Tj ET Q q 0 0 0 rg BT 131.75 234.10 Td (Court\) ) Tj ET Q q 0 0 0 rg BT 160.12 234.10 Td (appealing ) Tj ET Q q 0 0 0 rg BT 201.25 234.10 Td (the ) Tj ET Q q 0 0 0 rg BT 215.73 234.10 Td (holding ) Tj ET Q q 0 0 0 rg BT 248.54 234.10 Td (of ) Tj ET Q q 0 0 0 rg BT 259.13 234.10 Td (invalidity ) Tj ET Q q 0 0 0 rg BT 299.72 234.10 Td (of ) Tj ET Q q 0 0 0 rg BT 310.31 234.10 Td (the ) Tj ET Q q 0 0 0 rg BT 324.79 234.10 Td (claim ) Tj ET Q q 0 0 0 rg BT 349.26 234.10 Td (covering ) Tj ET Q q 0 0 0 rg BT 386.51 234.10 Td (clopidogrel ) Tj ET Q q 0 0 0 rg BT 434.31 234.10 Td (and ) Tj ET Q q 0 0 0 rg BT 451.01 234.10 Td (its ) Tj ET Q q 0 0 0 rg BT 462.72 234.10 Td (pharmaceutically ) Tj ET Q q 0 0 0 rg BT 533.83 234.10 Td (acceptable ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 222.10 Td (salts, ) Tj ET Q q 0 0 0 rg BT 59.55 222.10 Td (process ) Tj ET Q q 0 0 0 rg BT 92.82 222.10 Td (claims, ) Tj ET Q q 0 0 0 rg BT 124.69 222.10 Td (and ) Tj ET Q q 0 0 0 rg BT 142.41 222.10 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 206.75 222.10 Td (composition ) Tj ET Q q 0 0 0 rg BT 259.47 222.10 Td (claims ) Tj ET Q q 0 0 0 rg BT 288.85 222.10 Td (which ) Tj ET Q q 0 0 0 rg BT 316.56 222.10 Td (have ) Tj ET Q q 0 0 0 rg BT 338.71 222.10 Td (stayed ) Tj ET Q q 0 0 0 rg BT 367.53 222.10 Td (the ) Tj ET Q q 0 0 0 rg BT 383.02 222.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 416.28 222.10 Td (Court’) Tj ET Q q 0 0 0 rg BT 441.84 222.10 Td (s ) Tj ET Q q 0 0 0 rg BT 449.01 222.10 Td (ruling. ) Tj ET Q q 0 0 0 rg BT 477.94 222.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 510.66 222.10 Td (filed ) Tj ET Q q 0 0 0 rg BT 532.25 222.10 Td (a ) Tj ET Q q 0 0 0 rg BT 539.97 222.10 Td (notice ) Tj ET Q q 0 0 0 rg BT 567.67 222.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 210.10 Td (appeal ) Tj ET Q q 0 0 0 rg BT 64.85 210.10 Td (appealing ) Tj ET Q q 0 0 0 rg BT 106.48 210.10 Td (the ) Tj ET Q q 0 0 0 rg BT 121.45 210.10 Td (holding ) Tj ET Q q 0 0 0 rg BT 154.76 210.10 Td (of ) Tj ET Q q 0 0 0 rg BT 165.85 210.10 Td (validity ) Tj ET Q q 0 0 0 rg BT 199.16 210.10 Td (of ) Tj ET Q q 0 0 0 rg BT 210.25 210.10 Td (the ) Tj ET Q q 0 0 0 rg BT 225.22 210.10 Td (clopidogrel ) Tj ET Q q 0 0 0 rg BT 273.52 210.10 Td (bisulfate, ) Tj ET Q q 0 0 0 rg BT 313.21 210.10 Td (hydrochloride, ) Tj ET Q q 0 0 0 rg BT 374.56 210.10 Td (hydrobromide, ) Tj ET Q q 0 0 0 rg BT 436.47 210.10 Td (and ) Tj ET Q q 0 0 0 rg BT 453.66 210.10 Td (taurocholate ) Tj ET Q q 0 0 0 rg BT 505.84 210.10 Td (claims. ) Tj ET Q q 0 0 0 rg BT 536.59 210.10 Td (A) Tj ET Q q 0 0 0 rg BT 543.26 210.10 Td ( ) Tj ET Q q 0 0 0 rg BT 546.02 210.10 Td (hearing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 198.10 Td (on ) Tj ET Q q 0 0 0 rg BT 48.27 198.10 Td (the ) Tj ET Q q 0 0 0 rg BT 62.75 198.10 Td (appeals ) Tj ET Q q 0 0 0 rg BT 95.00 198.10 Td (occurred ) Tj ET Q q 0 0 0 rg BT 132.24 198.10 Td (in ) Tj ET Q q 0 0 0 rg BT 142.28 198.10 Td (February ) Tj ET Q q 0 0 0 rg BT 180.65 198.10 Td (2009. ) Tj ET Q q 0 0 0 rg BT 205.41 198.10 Td (On ) Tj ET Q q 0 0 0 rg BT 219.90 198.10 Td (September 29, ) Tj ET Q q 0 0 0 rg BT 279.93 198.10 Td (2009, ) Tj ET Q q 0 0 0 rg BT 304.70 198.10 Td (the ) Tj ET Q q 0 0 0 rg BT 319.18 198.10 Td (Full ) Tj ET Q q 0 0 0 rg BT 337.56 198.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 362.61 198.10 Td (held ) Tj ET Q q 0 0 0 rg BT 382.09 198.10 Td (all ) Tj ET Q q 0 0 0 rg BT 394.35 198.10 Td (of ) Tj ET Q q 0 0 0 rg BT 404.95 198.10 Td (the ) Tj ET Q q 0 0 0 rg BT 419.43 198.10 Td (claims ) Tj ET Q q 0 0 0 rg BT 447.80 198.10 Td (of ) Tj ET Q q 0 0 0 rg BT 458.39 198.10 Td (Patent ) Tj ET Q q 0 0 0 rg BT 485.65 198.10 Td (No. 597784 ) Tj ET Q q 0 0 0 rg BT 535.14 198.10 Td (invalid. ) Tj ET Q q 0 0 0 rg BT 567.68 198.10 Td (In ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 186.10 Td (November ) Tj ET Q q 0 0 0 rg BT 80.74 186.10 Td (2009, ) Tj ET Q q 0 0 0 rg BT 105.77 186.10 Td (the ) Tj ET Q q 0 0 0 rg BT 120.52 186.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 161.94 186.10 Td (and ) Tj ET Q q 0 0 0 rg BT 178.92 186.10 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 207.56 186.10 Td (applied ) Tj ET Q q 0 0 0 rg BT 239.52 186.10 Td (to ) Tj ET Q q 0 0 0 rg BT 249.83 186.10 Td (the ) Tj ET Q q 0 0 0 rg BT 264.58 186.10 Td (High ) Tj ET Q q 0 0 0 rg BT 287.12 186.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 312.43 186.10 Td (of ) Tj ET Q q 0 0 0 rg BT 322.73 186.10 Td (Australia ) Tj ET Q q 0 0 0 rg BT 361.92 186.10 Td (\(High ) Tj ET Q q 0 0 0 rg BT 387.79 186.10 Td (Court\) ) Tj ET Q q 0 0 0 rg BT 416.43 186.10 Td (for ) Tj ET Q q 0 0 0 rg BT 430.62 186.10 Td (special ) Tj ET Q q 0 0 0 rg BT 460.92 186.10 Td (leave ) Tj ET Q q 0 0 0 rg BT 484.54 186.10 Td (to ) Tj ET Q q 0 0 0 rg BT 494.86 186.10 Td (appeal ) Tj ET Q q 0 0 0 rg BT 523.48 186.10 Td (the ) Tj ET Q q 0 0 0 rg BT 538.23 186.10 Td (judgment ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 174.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.57 174.10 Td (the ) Tj ET Q q 0 0 0 rg BT 61.02 174.10 Td (Full ) Tj ET Q q 0 0 0 rg BT 79.38 174.10 Td (Court. ) Tj ET Q q 0 0 0 rg BT 106.90 174.10 Td (In ) Tj ET Q q 0 0 0 rg BT 117.47 174.10 Td (March ) Tj ET Q q 0 0 0 rg BT 145.80 174.10 Td (2010, ) Tj ET Q q 0 0 0 rg BT 170.54 174.10 Td (the ) Tj ET Q q 0 0 0 rg BT 185.00 174.10 Td (High ) Tj ET Q q 0 0 0 rg BT 207.24 174.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 232.25 174.10 Td (denied ) Tj ET Q q 0 0 0 rg BT 261.15 174.10 Td (the ) Tj ET Q q 0 0 0 rg BT 275.60 174.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 316.73 174.10 Td (and ) Tj ET Q q 0 0 0 rg BT 333.41 174.10 Td (Sanofi’) Tj ET Q q 0 0 0 rg BT 362.29 174.10 Td (s ) Tj ET Q q 0 0 0 rg BT 368.42 174.10 Td (request ) Tj ET Q q 0 0 0 rg BT 399.54 174.10 Td (to ) Tj ET Q q 0 0 0 rg BT 409.56 174.10 Td (hear ) Tj ET Q q 0 0 0 rg BT 429.00 174.10 Td (the ) Tj ET Q q 0 0 0 rg BT 443.46 174.10 Td (appeal ) Tj ET Q q 0 0 0 rg BT 471.79 174.10 Td (of ) Tj ET Q q 0 0 0 rg BT 482.36 174.10 Td (the ) Tj ET Q q 0 0 0 rg BT 496.82 174.10 Td (Full ) Tj ET Q q 0 0 0 rg BT 515.17 174.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 540.19 174.10 Td (decision. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 162.10 Td (The ) Tj ET Q q 0 0 0 rg BT 53.20 162.10 Td (case ) Tj ET Q q 0 0 0 rg BT 72.05 162.10 Td (has ) Tj ET Q q 0 0 0 rg BT 87.03 162.10 Td (been ) Tj ET Q q 0 0 0 rg BT 107.56 162.10 Td (remanded ) Tj ET Q q 0 0 0 rg BT 148.63 162.10 Td (to ) Tj ET Q q 0 0 0 rg BT 158.06 162.10 Td (the ) Tj ET Q q 0 0 0 rg BT 171.93 162.10 Td (Federal ) Tj ET Q q 0 0 0 rg BT 203.56 162.10 Td (Court ) Tj ET Q q 0 0 0 rg BT 227.99 162.10 Td (for ) Tj ET Q q 0 0 0 rg BT 241.30 162.10 Td (further ) Tj ET Q q 0 0 0 rg BT 270.15 162.10 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 320.12 162.10 Td (related ) Tj ET Q q 0 0 0 rg BT 348.97 162.10 Td (to ) Tj ET Q q 0 0 0 rg BT 358.40 162.10 Td (damages ) Tj ET Q q 0 0 0 rg BT 395.03 162.10 Td (sought ) Tj ET Q q 0 0 0 rg BT 423.35 162.10 Td (by ) Tj ET Q q 0 0 0 rg BT 434.64 162.10 Td (Apotex. ) Tj ET Q q 0 0 0 rg BT 468.11 162.10 Td (The ) Tj ET Q q 0 0 0 rg BT 484.94 162.10 Td (Australian ) Tj ET Q q 0 0 0 rg BT 528.24 162.10 Td (government ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 150.10 Td (has ) Tj ET Q q 0 0 0 rg BT 52.17 150.10 Td (intervened ) Tj ET Q q 0 0 0 rg BT 97.21 150.10 Td (in ) Tj ET Q q 0 0 0 rg BT 107.83 150.10 Td (this ) Tj ET Q q 0 0 0 rg BT 125.11 150.10 Td (matter ) Tj ET Q q 0 0 0 rg BT 153.49 150.10 Td (and ) Tj ET Q q 0 0 0 rg BT 170.77 150.10 Td (is ) Tj ET Q q 0 0 0 rg BT 180.28 150.10 Td (also ) Tj ET Q q 0 0 0 rg BT 199.22 150.10 Td (seeking ) Tj ET Q q 0 0 0 rg BT 232.61 150.10 Td (damages ) Tj ET Q q 0 0 0 rg BT 270.43 150.10 Td (for ) Tj ET Q q 0 0 0 rg BT 284.93 150.10 Td (alleged ) Tj ET Q q 0 0 0 rg BT 316.64 150.10 Td (losses ) Tj ET Q q 0 0 0 rg BT 343.37 150.10 Td (experienced ) Tj ET Q q 0 0 0 rg BT 394.51 150.10 Td (during ) Tj ET Q q 0 0 0 rg BT 423.46 150.10 Td (the ) Tj ET Q q 0 0 0 rg BT 438.51 150.10 Td (period ) Tj ET Q q 0 0 0 rg BT 466.90 150.10 Td (when ) Tj ET Q q 0 0 0 rg BT 491.40 150.10 Td (the ) Tj ET Q q 0 0 0 rg BT 506.45 150.10 Td (injunction ) Tj ET Q q 0 0 0 rg BT 549.84 150.10 Td (was ) Tj ET Q q 0 0 0 rg BT 568.23 150.10 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 138.10 Td (place. ) Tj ET Q q 0 0 0 rg BT 62.21 138.10 Td (The ) Tj ET Q q 0 0 0 rg BT 80.58 138.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 122.29 138.10 Td (and ) Tj ET Q q 0 0 0 rg BT 138.93 138.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 171.20 138.10 Td (have ) Tj ET Q q 0 0 0 rg BT 192.90 138.10 Td (settled ) Tj ET Q q 0 0 0 rg BT 221.82 138.10 Td (the ) Tj ET Q q 0 0 0 rg BT 236.24 138.10 Td (Apotex ) Tj ET Q q 0 0 0 rg BT 268.50 138.10 Td (case, ) Tj ET Q q 0 0 0 rg BT 291.03 138.10 Td (and ) Tj ET Q q 0 0 0 rg BT 308.30 138.10 Td (the ) Tj ET Q q 0 0 0 rg BT 323.34 138.10 Td (case ) Tj ET Q q 0 0 0 rg BT 343.37 138.10 Td (has ) Tj ET Q q 0 0 0 rg BT 359.52 138.10 Td (been ) Tj ET Q q 0 0 0 rg BT 381.22 138.10 Td (dismissed. ) Tj ET Q q 0 0 0 rg BT 425.79 138.10 Td (The ) Tj ET Q q 0 0 0 rg BT 443.54 138.10 Td (Australian ) Tj ET Q q 0 0 0 rg BT 488.02 138.10 Td (government's ) Tj ET Q q 0 0 0 rg BT 544.30 138.10 Td (claim ) Tj ET Q q 0 0 0 rg BT 569.33 138.10 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 126.10 Td (still ) Tj ET Q q 0 0 0 rg BT 54.42 126.10 Td (pending ) Tj ET Q q 0 0 0 rg BT 90.05 126.10 Td (and ) Tj ET Q q 0 0 0 rg BT 107.90 126.10 Td (a ) Tj ET Q q 0 0 0 rg BT 115.75 126.10 Td (trial ) Tj ET Q q 0 0 0 rg BT 135.26 126.10 Td (has ) Tj ET Q q 0 0 0 rg BT 152.00 126.10 Td (been ) Tj ET Q q 0 0 0 rg BT 174.29 126.10 Td (scheduled ) Tj ET Q q 0 0 0 rg BT 217.69 126.10 Td (for ) Tj ET Q q 0 0 0 rg BT 232.01 126.10 Td (August ) Tj ET Q q 0 0 0 rg BT 264.31 126.10 Td (2017. ) Tj ET Q q 0 0 0 rg BT 290.23 126.10 Td (It ) Tj ET Q q 0 0 0 rg BT 299.75 126.10 Td (is ) Tj ET Q q 0 0 0 rg BT 309.83 126.10 Td (not ) Tj ET Q q 0 0 0 rg BT 326.02 126.10 Td (possible ) Tj ET Q q 0 0 0 rg BT 362.21 126.10 Td (at ) Tj ET Q q 0 0 0 rg BT 372.84 126.10 Td (this ) Tj ET Q q 0 0 0 rg BT 390.70 126.10 Td (time ) Tj ET Q q 0 0 0 rg BT 411.88 126.10 Td (to ) Tj ET Q q 0 0 0 rg BT 423.07 126.10 Td (predict ) Tj ET Q q 0 0 0 rg BT 454.25 126.10 Td (the ) Tj ET Q q 0 0 0 rg BT 469.88 126.10 Td (outcome ) Tj ET Q q 0 0 0 rg BT 507.73 126.10 Td (of ) Tj ET Q q 0 0 0 rg BT 519.47 126.10 Td (the ) Tj ET Q q 0 0 0 rg BT 534.34 126.10 Td (Australian ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 114.10 Td (government’) Tj ET Q q 0 0 0 rg BT 86.54 114.10 Td (s ) Tj ET Q q 0 0 0 rg BT 92.93 114.10 Td (claim ) Tj ET Q q 0 0 0 rg BT 117.65 114.10 Td (or ) Tj ET Q q 0 0 0 rg BT 128.48 114.10 Td (its ) Tj ET Q q 0 0 0 rg BT 140.42 114.10 Td (impact ) Tj ET Q q 0 0 0 rg BT 170.14 114.10 Td (on ) Tj ET Q q 0 0 0 rg BT 182.64 114.10 Td (the ) Tj ET Q q 0 0 0 rg BT 197.35 114.10 Td (Company) Tj ET Q q 0 0 0 rg BT 235.59 114.10 Td (.) Tj ET Q endstream endobj 193 0 obj <> endobj 194 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (96) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Sprycel) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 66.55 749.25 Td ( ) Tj ET Q q 0 0 0 rg BT 69.05 749.25 Td (- ) Tj ET Q q 0 0 0 rg BT 74.88 749.25 Td (Eur) Tj ET Q q 0 0 0 rg BT 91.37 749.25 Td (opean ) Tj ET Q q 0 0 0 rg BT 119.43 749.25 Td (Union) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 731.25 Td (In ) Tj ET Q q 0 0 0 rg BT 45.77 731.25 Td (May ) Tj ET Q q 0 0 0 rg BT 65.54 731.25 Td (2013, ) Tj ET Q q 0 0 0 rg BT 89.17 731.25 Td (Apotex, ) Tj ET Q q 0 0 0 rg BT 122.23 731.25 Td (Actavis ) Tj ET Q q 0 0 0 rg BT 154.22 731.25 Td (Group ) Tj ET Q q 0 0 0 rg BT 181.21 731.25 Td (PTC ) Tj ET Q q 0 0 0 rg BT 200.99 731.25 Td (ehf, ) Tj ET Q q 0 0 0 rg BT 217.70 731.25 Td (Generics ) Tj ET Q q 0 0 0 rg BT 254.68 731.25 Td ([UK] ) Tj ET Q q 0 0 0 rg BT 277.23 731.25 Td (Limited ) Tj ET Q q 0 0 0 rg BT 310.33 731.25 Td (\(Mylan\) ) Tj ET Q q 0 0 0 rg BT 344.54 731.25 Td (and ) Tj ET Q q 0 0 0 rg BT 360.42 731.25 Td (an ) Tj ET Q q 0 0 0 rg BT 371.30 731.25 Td (unnamed ) Tj ET Q q 0 0 0 rg BT 409.40 731.25 Td (company ) Tj ET Q q 0 0 0 rg BT 447.50 731.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 467.26 731.25 Td (oppositions ) Tj ET Q q 0 0 0 rg BT 514.82 731.25 Td (in ) Tj ET Q q 0 0 0 rg BT 524.04 731.25 Td (the ) Tj ET Q q 0 0 0 rg BT 537.70 731.25 Td (European ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 719.25 Td (Patent ) Tj ET Q q 0 0 0 rg BT 63.81 719.25 Td (Of) Tj ET Q q 0 0 0 rg BT 74.18 719.25 Td (fice ) Tj ET Q q 0 0 0 rg BT 91.99 719.25 Td (\(EPO\) ) Tj ET Q q 0 0 0 rg BT 120.36 719.25 Td (seeking ) Tj ET Q q 0 0 0 rg BT 153.72 719.25 Td (revocation ) Tj ET Q q 0 0 0 rg BT 198.74 719.25 Td (of ) Tj ET Q q 0 0 0 rg BT 209.89 719.25 Td (European ) Tj ET Q q 0 0 0 rg BT 251.02 719.25 Td (Patent ) Tj ET Q q 0 0 0 rg BT 278.83 719.25 Td (No. ) Tj ET Q q 0 0 0 rg BT 296.37 719.25 Td (1) Tj ET Q q 0 0 0 rg BT 301.00 719.25 Td (169038 ) Tj ET Q q 0 0 0 rg BT 333.82 719.25 Td (\(the ) Tj ET Q q 0 0 0 rg BT 352.18 719.25 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 373.33 719.25 Td (patent\) ) Tj ET Q q 0 0 0 rg BT 403.91 719.25 Td (covering ) Tj ET Q q 0 0 0 rg BT 441.71 719.25 Td (dasatinib, ) Tj ET Q q 0 0 0 rg BT 483.13 719.25 Td (the ) Tj ET Q q 0 0 0 rg BT 498.17 719.25 Td (active ) Tj ET Q q 0 0 0 rg BT 524.86 719.25 Td (ingredient ) Tj ET Q q 0 0 0 rg BT 568.22 719.25 Td (in ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 707.25 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.99 707.25 Td (. ) Tj ET Q q 0 0 0 rg BT 70.45 707.25 Td (The ) Tj ET Q q 0 0 0 rg BT 88.12 707.25 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 108.57 707.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 135.13 707.25 Td (is ) Tj ET Q q 0 0 0 rg BT 143.92 707.25 Td (scheduled ) Tj ET Q q 0 0 0 rg BT 186.02 707.25 Td (to ) Tj ET Q q 0 0 0 rg BT 195.92 707.25 Td (expire ) Tj ET Q q 0 0 0 rg BT 223.03 707.25 Td (in ) Tj ET Q q 0 0 0 rg BT 232.46 707.25 Td (April ) Tj ET Q q 0 0 0 rg BT 255.69 707.25 Td (2020 ) Tj ET Q q 0 0 0 rg BT 277.81 707.25 Td (\(excluding ) Tj ET Q q 0 0 0 rg BT 322.69 707.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 359.80 707.25 Td (term ) Tj ET Q q 0 0 0 rg BT 380.25 707.25 Td (extensions\). ) Tj ET Q q 0 0 0 rg BT 430.42 707.25 Td (On ) Tj ET Q q 0 0 0 rg BT 444.76 707.25 Td (January ) Tj ET Q q 0 0 0 rg BT 477.98 707.25 Td (20, ) Tj ET Q q 0 0 0 rg BT 492.60 707.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 517.22 707.25 Td (the ) Tj ET Q q 0 0 0 rg BT 531.56 707.25 Td (Opposition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 695.25 Td (Division ) Tj ET Q q 0 0 0 rg BT 72.83 695.25 Td (of ) Tj ET Q q 0 0 0 rg BT 83.54 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 98.14 695.25 Td (EPO ) Tj ET Q q 0 0 0 rg BT 119.42 695.25 Td (revoked ) Tj ET Q q 0 0 0 rg BT 154.01 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 168.61 695.25 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 189.32 695.25 Td (patent. ) Tj ET Q q 0 0 0 rg BT 218.64 695.25 Td (In ) Tj ET Q q 0 0 0 rg BT 229.35 695.25 Td (May ) Tj ET Q q 0 0 0 rg BT 250.06 695.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 274.95 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 289.54 695.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 330.81 695.25 Td (appealed ) Tj ET Q q 0 0 0 rg BT 368.73 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 383.33 695.25 Td (EPO’) Tj ET Q q 0 0 0 rg BT 405.00 695.25 Td (s ) Tj ET Q q 0 0 0 rg BT 411.27 695.25 Td (decision ) Tj ET Q q 0 0 0 rg BT 446.98 695.25 Td (to ) Tj ET Q q 0 0 0 rg BT 457.14 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 471.74 695.25 Td (EPO ) Tj ET Q q 0 0 0 rg BT 493.02 695.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 519.84 695.25 Td (of ) Tj ET Q q 0 0 0 rg BT 530.02 695.25 Td (Appeal. ) Tj ET Q q 0 0 0 rg BT 563.78 695.25 Td (On ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.25 Td (February ) Tj ET Q q 0 0 0 rg BT 74.88 683.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 85.16 683.25 Td (2017, ) Tj ET Q q 0 0 0 rg BT 110.44 683.25 Td (the ) Tj ET Q q 0 0 0 rg BT 125.43 683.25 Td (EPO ) Tj ET Q q 0 0 0 rg BT 147.11 683.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 174.32 683.25 Td (of ) Tj ET Q q 0 0 0 rg BT 184.82 683.25 Td (Appeal ) Tj ET Q q 0 0 0 rg BT 216.48 683.25 Td (upheld ) Tj ET Q q 0 0 0 rg BT 246.47 683.25 Td (the ) Tj ET Q q 0 0 0 rg BT 261.47 683.25 Td (Opposition ) Tj ET Q q 0 0 0 rg BT 308.70 683.25 Td (Division's ) Tj ET Q q 0 0 0 rg BT 351.62 683.25 Td (decision, ) Tj ET Q q 0 0 0 rg BT 390.22 683.25 Td (and ) Tj ET Q q 0 0 0 rg BT 407.44 683.25 Td (the ) Tj ET Q q 0 0 0 rg BT 422.44 683.25 Td (‘038 ) Tj ET Q q 0 0 0 rg BT 443.55 683.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 470.76 683.25 Td (has ) Tj ET Q q 0 0 0 rg BT 486.87 683.25 Td (been ) Tj ET Q q 0 0 0 rg BT 508.53 683.25 Td (revoked. ) Tj ET Q q 0 0 0 rg BT 546.02 683.25 Td (Orphan ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 671.25 Td (drug ) Tj ET Q q 0 0 0 rg BT 57.19 671.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 103.93 671.25 Td (and ) Tj ET Q q 0 0 0 rg BT 121.22 671.25 Td (data ) Tj ET Q q 0 0 0 rg BT 140.74 671.25 Td (exclusivity ) Tj ET Q q 0 0 0 rg BT 187.48 671.25 Td (for ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 202.00 671.25 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 231.98 671.25 Td ( ) Tj ET Q q 0 0 0 rg BT 234.84 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 245.47 671.25 Td (the ) Tj ET Q q 0 0 0 rg BT 260.55 671.25 Td (EU ) Tj ET Q q 0 0 0 rg BT 276.74 671.25 Td (expired ) Tj ET Q q 0 0 0 rg BT 309.58 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 320.22 671.25 Td (November ) Tj ET Q q 0 0 0 rg BT 365.28 671.25 Td (2016. ) Tj ET Q q 0 0 0 rg BT 390.43 671.25 Td (The ) Tj ET Q q 0 0 0 rg BT 408.84 671.25 Td (EPO ) Tj ET Q q 0 0 0 rg BT 430.59 671.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 457.88 671.25 Td (of ) Tj ET Q q 0 0 0 rg BT 468.44 671.25 Td (Appeal's ) Tj ET Q q 0 0 0 rg BT 505.87 671.25 Td (decision ) Tj ET Q q 0 0 0 rg BT 542.05 671.25 Td (does ) Tj ET Q q 0 0 0 rg BT 563.24 671.25 Td (not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 659.25 Td (af) Tj ET Q q 0 0 0 rg BT 43.59 659.25 Td (fect ) Tj ET Q q 0 0 0 rg BT 61.28 659.25 Td (the ) Tj ET Q q 0 0 0 rg BT 76.20 659.25 Td (validity ) Tj ET Q q 0 0 0 rg BT 109.45 659.25 Td (of ) Tj ET Q q 0 0 0 rg BT 120.49 659.25 Td (our ) Tj ET Q q 0 0 0 rg BT 136.52 659.25 Td (other ) Tj ET Q q 0 0 0 rg BT 159.77 659.25 Td (Sprycel ) Tj ET Q q 0 0 0 rg BT 193.02 659.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 224.05 659.25 Td (within ) Tj ET Q q 0 0 0 rg BT 252.31 659.25 Td (and ) Tj ET Q q 0 0 0 rg BT 269.46 659.25 Td (outside ) Tj ET Q q 0 0 0 rg BT 301.05 659.25 Td (Europe, ) Tj ET Q q 0 0 0 rg BT 335.13 659.25 Td (including ) Tj ET Q q 0 0 0 rg BT 375.61 659.25 Td (dif) Tj ET Q q 0 0 0 rg BT 386.53 659.25 Td (ferent ) Tj ET Q q 0 0 0 rg BT 412.55 659.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 443.58 659.25 Td (that ) Tj ET Q q 0 0 0 rg BT 461.28 659.25 Td (cover ) Tj ET Q q 0 0 0 rg BT 486.19 659.25 Td (the ) Tj ET Q q 0 0 0 rg BT 501.11 659.25 Td (monohydrate ) Tj ET Q q 0 0 0 rg BT 556.58 659.25 Td (form ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 647.25 Td (of ) Tj ET Q q 0 0 0 rg BT 46.97 647.25 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 85.71 647.25 Td (and ) Tj ET Q q 0 0 0 rg BT 102.78 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 117.64 647.25 Td (use ) Tj ET Q q 0 0 0 rg BT 133.60 647.25 Td (of ) Tj ET Q q 0 0 0 rg BT 144.57 647.25 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 183.31 647.25 Td (to ) Tj ET Q q 0 0 0 rg BT 193.72 647.25 Td (treat ) Tj ET Q q 0 0 0 rg BT 214.13 647.25 Td (chronic ) Tj ET Q q 0 0 0 rg BT 246.75 647.25 Td (myelogenous ) Tj ET Q q 0 0 0 rg BT 302.71 647.25 Td (leukemia ) Tj ET Q q 0 0 0 rg BT 342.00 647.25 Td (\(CML\). ) Tj ET Q q 0 0 0 rg BT 374.88 647.25 Td (Additionally) Tj ET Q q 0 0 0 rg BT 424.78 647.25 Td (, ) Tj ET Q q 0 0 0 rg BT 429.92 647.25 Td (in ) Tj ET Q q 0 0 0 rg BT 440.33 647.25 Td (February ) Tj ET Q q 0 0 0 rg BT 479.07 647.25 Td (2017, ) Tj ET Q q 0 0 0 rg BT 504.21 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 519.06 647.25 Td (EPO ) Tj ET Q q 0 0 0 rg BT 540.59 647.25 Td (Board ) Tj ET Q q 0 0 0 rg BT 567.66 647.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 635.25 Td (Appeal ) Tj ET Q q 0 0 0 rg BT 66.95 635.25 Td (reversed ) Tj ET Q q 0 0 0 rg BT 102.90 635.25 Td (and ) Tj ET Q q 0 0 0 rg BT 119.42 635.25 Td (remanded ) Tj ET Q q 0 0 0 rg BT 160.92 635.25 Td (an ) Tj ET Q q 0 0 0 rg BT 172.43 635.25 Td (invalidity ) Tj ET Q q 0 0 0 rg BT 212.84 635.25 Td (decision ) Tj ET Q q 0 0 0 rg BT 248.24 635.25 Td (on ) Tj ET Q q 0 0 0 rg BT 260.32 635.25 Td (European ) Tj ET Q q 0 0 0 rg BT 300.71 635.25 Td (Patent ) Tj ET Q q 0 0 0 rg BT 327.79 635.25 Td (No. ) Tj ET Q q 0 0 0 rg BT 344.59 635.25 Td (1610780 ) Tj ET Q q 0 0 0 rg BT 381.66 635.25 Td (and ) Tj ET Q q 0 0 0 rg BT 398.18 635.25 Td (its ) Tj ET Q q 0 0 0 rg BT 409.71 635.25 Td (claim ) Tj ET Q q 0 0 0 rg BT 434.00 635.25 Td (to ) Tj ET Q q 0 0 0 rg BT 443.85 635.25 Td (the ) Tj ET Q q 0 0 0 rg BT 458.15 635.25 Td (use ) Tj ET Q q 0 0 0 rg BT 473.55 635.25 Td (of ) Tj ET Q q 0 0 0 rg BT 483.96 635.25 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 522.14 635.25 Td (to ) Tj ET Q q 0 0 0 rg BT 532.00 635.25 Td (treat ) Tj ET Q q 0 0 0 rg BT 551.84 635.25 Td (CML, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 623.25 Td (which ) Tj ET Q q 0 0 0 rg BT 63.30 623.25 Td (the ) Tj ET Q q 0 0 0 rg BT 78.38 623.25 Td (EPO's ) Tj ET Q q 0 0 0 rg BT 105.82 623.25 Td (Opposition ) Tj ET Q q 0 0 0 rg BT 153.13 623.25 Td (Division ) Tj ET Q q 0 0 0 rg BT 190.44 623.25 Td (had ) Tj ET Q q 0 0 0 rg BT 207.74 623.25 Td (revoked ) Tj ET Q q 0 0 0 rg BT 242.81 623.25 Td (in ) Tj ET Q q 0 0 0 rg BT 253.45 623.25 Td (October ) Tj ET Q q 0 0 0 rg BT 288.52 623.25 Td (2012. ) Tj ET Q q 0 0 0 rg BT 313.67 623.25 Td (The ) Tj ET Q q 0 0 0 rg BT 332.08 623.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 373.83 623.25 Td (intends ) Tj ET Q q 0 0 0 rg BT 405.58 623.25 Td (to ) Tj ET Q q 0 0 0 rg BT 416.22 623.25 Td (take ) Tj ET Q q 0 0 0 rg BT 435.73 623.25 Td (appropriate ) Tj ET Q q 0 0 0 rg BT 484.13 623.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 506.42 623.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 537.61 623.25 Td (to ) Tj ET Q q 0 0 0 rg BT 548.25 623.25 Td (protect ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 611.25 Td (Sprycel) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.99 611.25 Td (. ) Tj ET Q q 0 0 0 rg BT 70.80 611.25 Td (W) Tj ET Q q 0 0 0 rg BT 79.44 611.25 Td (e ) Tj ET Q q 0 0 0 rg BT 86.38 611.25 Td (may ) Tj ET Q q 0 0 0 rg BT 106.10 611.25 Td (experience ) Tj ET Q q 0 0 0 rg BT 151.90 611.25 Td (a ) Tj ET Q q 0 0 0 rg BT 158.84 611.25 Td (decline ) Tj ET Q q 0 0 0 rg BT 190.21 611.25 Td (in ) Tj ET Q q 0 0 0 rg BT 200.49 611.25 Td (European ) Tj ET Q q 0 0 0 rg BT 241.30 611.25 Td (revenues ) Tj ET Q q 0 0 0 rg BT 279.34 611.25 Td (in ) Tj ET Q q 0 0 0 rg BT 289.62 611.25 Td (the ) Tj ET Q q 0 0 0 rg BT 304.33 611.25 Td (event ) Tj ET Q q 0 0 0 rg BT 328.49 611.25 Td (that ) Tj ET Q q 0 0 0 rg BT 345.99 611.25 Td (generic ) Tj ET Q q 0 0 0 rg BT 377.91 611.25 Td (dasatinib ) Tj ET Q q 0 0 0 rg BT 416.51 611.25 Td (product ) Tj ET Q q 0 0 0 rg BT 449.56 611.25 Td (enters ) Tj ET Q q 0 0 0 rg BT 475.94 611.25 Td (the ) Tj ET Q q 0 0 0 rg BT 490.65 611.25 Td (market.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 590.25 Td (Anti-PD-1 ) Tj ET Q q 0 0 0 rg BT 81.83 590.25 Td (Antibody ) Tj ET Q q 0 0 0 rg BT 124.34 590.25 Td (Patent ) Tj ET Q q 0 0 0 rg BT 154.61 590.25 Td (Oppositions ) Tj ET Q q 0 0 0 rg BT 208.25 590.25 Td (and ) Tj ET Q q 0 0 0 rg BT 226.87 590.25 Td (Litigation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 572.25 Td (On ) Tj ET Q q 0 0 0 rg BT 51.06 572.25 Td (January ) Tj ET Q q 0 0 0 rg BT 85.00 572.25 Td (20, ) Tj ET Q q 0 0 0 rg BT 100.34 572.25 Td (2017, ) Tj ET Q q 0 0 0 rg BT 125.67 572.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 149.64 572.25 Td (and ) Tj ET Q q 0 0 0 rg BT 166.91 572.25 Td (Ono ) Tj ET Q q 0 0 0 rg BT 186.97 572.25 Td (announced ) Tj ET Q q 0 0 0 rg BT 233.13 572.25 Td (the ) Tj ET Q q 0 0 0 rg BT 248.18 572.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 293.78 572.25 Td (have ) Tj ET Q q 0 0 0 rg BT 315.50 572.25 Td (signed ) Tj ET Q q 0 0 0 rg BT 344.45 572.25 Td (a ) Tj ET Q q 0 0 0 rg BT 351.72 572.25 Td (global ) Tj ET Q q 0 0 0 rg BT 379.56 572.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 406.83 572.25 Td (license ) Tj ET Q q 0 0 0 rg BT 437.43 572.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 481.91 572.25 Td (with ) Tj ET Q q 0 0 0 rg BT 502.53 572.25 Td (Merck ) Tj ET Q q 0 0 0 rg BT 531.46 572.25 Td (to ) Tj ET Q q 0 0 0 rg BT 542.08 572.25 Td (settle ) Tj ET Q q 0 0 0 rg BT 566.02 572.25 Td (all ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 560.25 Td (patent-infringement ) Tj ET Q q 0 0 0 rg BT 117.71 560.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 156.12 560.25 Td (related ) Tj ET Q q 0 0 0 rg BT 185.62 560.25 Td (to ) Tj ET Q q 0 0 0 rg BT 195.70 560.25 Td (Merck’) Tj ET Q q 0 0 0 rg BT 224.58 560.25 Td (s ) Tj ET Q q 0 0 0 rg BT 230.77 560.25 Td (PD-1 ) Tj ET Q q 0 0 0 rg BT 254.18 560.25 Td (antibody ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 291.47 560.25 Td (Keytruda*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.69 560.25 Td ( ) Tj ET Q q 0 0 0 rg BT 335.99 560.25 Td (\(pembrolizumab\). ) Tj ET Q q 0 0 0 rg BT 410.04 560.25 Td (The ) Tj ET Q q 0 0 0 rg BT 427.88 560.25 Td (agreement ) Tj ET Q q 0 0 0 rg BT 471.82 560.25 Td (will ) Tj ET Q q 0 0 0 rg BT 489.68 560.25 Td (result ) Tj ET Q q 0 0 0 rg BT 514.19 560.25 Td (in ) Tj ET Q q 0 0 0 rg BT 524.27 560.25 Td (the ) Tj ET Q q 0 0 0 rg BT 538.79 560.25 Td (dismissal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 548.25 Td (with ) Tj ET Q q 0 0 0 rg BT 55.47 548.25 Td (prejudice ) Tj ET Q q 0 0 0 rg BT 94.35 548.25 Td (of ) Tj ET Q q 0 0 0 rg BT 104.37 548.25 Td (all ) Tj ET Q q 0 0 0 rg BT 116.05 548.25 Td (patent ) Tj ET Q q 0 0 0 rg BT 142.17 548.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 179.97 548.25 Td (between ) Tj ET Q q 0 0 0 rg BT 214.97 548.25 Td (the ) Tj ET Q q 0 0 0 rg BT 228.88 548.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 273.33 548.25 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 315.56 548.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 325.02 548.25 Td (Keytruda*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.24 548.25 Td (. ) Tj ET Q q 0 0 0 rg BT 371.42 548.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 394.23 548.25 Td (and ) Tj ET Q q 0 0 0 rg BT 410.36 548.25 Td (Ono ) Tj ET Q q 0 0 0 rg BT 429.27 548.25 Td (had ) Tj ET Q q 0 0 0 rg BT 445.39 548.25 Td (asserted ) Tj ET Q q 0 0 0 rg BT 479.29 548.25 Td (in ) Tj ET Q q 0 0 0 rg BT 488.75 548.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 526.55 548.25 Td (that ) Tj ET Q q 0 0 0 rg BT 543.23 548.25 Td (Merck’) Tj ET Q q 0 0 0 rg BT 572.11 548.25 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 536.25 Td (sale ) Tj ET Q q 0 0 0 rg BT 55.16 536.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 67.11 536.25 Td (Keytruda*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 109.32 536.25 Td ( ) Tj ET Q q 0 0 0 rg BT 112.94 536.25 Td (infringed ) Tj ET Q q 0 0 0 rg BT 153.21 536.25 Td (the ) Tj ET Q q 0 0 0 rg BT 169.04 536.25 Td (companies’) Tj ET Q q 0 0 0 rg BT 214.39 536.25 Td ( ) Tj ET Q q 0 0 0 rg BT 218.01 536.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 249.95 536.25 Td (relating ) Tj ET Q q 0 0 0 rg BT 284.10 536.25 Td (to ) Tj ET Q q 0 0 0 rg BT 295.50 536.25 Td (the ) Tj ET Q q 0 0 0 rg BT 311.33 536.25 Td (use ) Tj ET Q q 0 0 0 rg BT 328.27 536.25 Td (of ) Tj ET Q q 0 0 0 rg BT 340.22 536.25 Td (PD-1 ) Tj ET Q q 0 0 0 rg BT 364.94 536.25 Td (antibodies ) Tj ET Q q 0 0 0 rg BT 409.66 536.25 Td (to ) Tj ET Q q 0 0 0 rg BT 421.06 536.25 Td (treat ) Tj ET Q q 0 0 0 rg BT 442.43 536.25 Td (cancer ) Tj ET Q q 0 0 0 rg BT 472.13 536.25 Td (in ) Tj ET Q q 0 0 0 rg BT 483.53 536.25 Td (the ) Tj ET Q q 0 0 0 rg BT 499.36 536.25 Td (U.S., ) Tj ET Q q 0 0 0 rg BT 523.26 536.25 Td (Europe ) Tj ET Q q 0 0 0 rg BT 555.75 536.25 Td (\(UK, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 524.25 Td (Netherlands, ) Tj ET Q q 0 0 0 rg BT 89.32 524.25 Td (France, ) Tj ET Q q 0 0 0 rg BT 121.52 524.25 Td (Germany) Tj ET Q q 0 0 0 rg BT 158.08 524.25 Td (, ) Tj ET Q q 0 0 0 rg BT 163.08 524.25 Td (Ireland, ) Tj ET Q q 0 0 0 rg BT 196.40 524.25 Td (Spain ) Tj ET Q q 0 0 0 rg BT 221.67 524.25 Td (and ) Tj ET Q q 0 0 0 rg BT 238.61 524.25 Td (Switzerland\), ) Tj ET Q q 0 0 0 rg BT 294.15 524.25 Td (Australia ) Tj ET Q q 0 0 0 rg BT 333.31 524.25 Td (and ) Tj ET Q q 0 0 0 rg BT 350.25 524.25 Td (Japan. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 506.25 Td (As ) Tj ET Q q 0 0 0 rg BT 49.48 506.25 Td (part ) Tj ET Q q 0 0 0 rg BT 67.39 506.25 Td (of ) Tj ET Q q 0 0 0 rg BT 78.09 506.25 Td (the ) Tj ET Q q 0 0 0 rg BT 92.67 506.25 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 139.18 506.25 Td (Merck ) Tj ET Q q 0 0 0 rg BT 167.64 506.25 Td (will ) Tj ET Q q 0 0 0 rg BT 185.56 506.25 Td (make ) Tj ET Q q 0 0 0 rg BT 209.58 506.25 Td (an ) Tj ET Q q 0 0 0 rg BT 221.39 506.25 Td (initial ) Tj ET Q q 0 0 0 rg BT 247.08 506.25 Td (payment ) Tj ET Q q 0 0 0 rg BT 283.88 506.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 294.58 506.25 Td ($625 ) Tj ET Q q 0 0 0 rg BT 316.94 506.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 345.84 506.25 Td ( ) Tj ET Q q 0 0 0 rg BT 348.20 506.25 Td (to ) Tj ET Q q 0 0 0 rg BT 358.35 506.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 381.83 506.25 Td (and ) Tj ET Q q 0 0 0 rg BT 398.64 506.25 Td (Ono. ) Tj ET Q q 0 0 0 rg BT 420.73 506.25 Td (Merck ) Tj ET Q q 0 0 0 rg BT 449.19 506.25 Td (is ) Tj ET Q q 0 0 0 rg BT 458.23 506.25 Td (also ) Tj ET Q q 0 0 0 rg BT 476.70 506.25 Td (obligated ) Tj ET Q q 0 0 0 rg BT 516.28 506.25 Td (to ) Tj ET Q q 0 0 0 rg BT 526.42 506.25 Td (pay ) Tj ET Q q 0 0 0 rg BT 543.23 506.25 Td (ongoing ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 494.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 72.33 494.25 Td (on ) Tj ET Q q 0 0 0 rg BT 84.23 494.25 Td (global ) Tj ET Q q 0 0 0 rg BT 111.13 494.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 132.46 494.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 142.69 494.25 Td (Keytruda*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 184.91 494.25 Td ( ) Tj ET Q q 0 0 0 rg BT 186.81 494.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 197.04 494.25 Td (6.5%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 217.87 494.25 Td ( ) Tj ET Q q 0 0 0 rg BT 219.77 494.25 Td (from ) Tj ET Q q 0 0 0 rg BT 241.11 494.25 Td (January ) Tj ET Q q 0 0 0 rg BT 274.11 494.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 283.50 494.25 Td (2017 ) Tj ET Q q 0 0 0 rg BT 305.40 494.25 Td (through ) Tj ET Q q 0 0 0 rg BT 338.41 494.25 Td (December ) Tj ET Q q 0 0 0 rg BT 381.40 494.25 Td (31, ) Tj ET Q q 0 0 0 rg BT 395.79 494.25 Td (2023, ) Tj ET Q q 0 0 0 rg BT 420.19 494.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 436.53 494.25 Td (2.5%) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.36 494.25 Td ( ) Tj ET Q q 0 0 0 rg BT 459.26 494.25 Td (from ) Tj ET Q q 0 0 0 rg BT 480.60 494.25 Td (January ) Tj ET Q q 0 0 0 rg BT 513.60 494.25 Td (1, ) Tj ET Q q 0 0 0 rg BT 523.00 494.25 Td (2024 ) Tj ET Q q 0 0 0 rg BT 544.90 494.25 Td (through ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 482.25 Td (December ) Tj ET Q q 0 0 0 rg BT 80.24 482.25 Td (31, ) Tj ET Q q 0 0 0 rg BT 95.89 482.25 Td (2026. ) Tj ET Q q 0 0 0 rg BT 121.55 482.25 Td (Under ) Tj ET Q q 0 0 0 rg BT 149.69 482.25 Td (the ) Tj ET Q q 0 0 0 rg BT 165.06 482.25 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 212.36 482.25 Td (the ) Tj ET Q q 0 0 0 rg BT 227.73 482.25 Td (companies ) Tj ET Q q 0 0 0 rg BT 273.65 482.25 Td (have ) Tj ET Q q 0 0 0 rg BT 295.68 482.25 Td (also ) Tj ET Q q 0 0 0 rg BT 314.94 482.25 Td (granted ) Tj ET Q q 0 0 0 rg BT 348.08 482.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 378.44 482.25 Td (rights ) Tj ET Q q 0 0 0 rg BT 404.37 482.25 Td (to ) Tj ET Q q 0 0 0 rg BT 415.30 482.25 Td (each ) Tj ET Q q 0 0 0 rg BT 436.77 482.25 Td (other ) Tj ET Q q 0 0 0 rg BT 460.47 482.25 Td (under ) Tj ET Q q 0 0 0 rg BT 486.40 482.25 Td (their ) Tj ET Q q 0 0 0 rg BT 507.88 482.25 Td (respective ) Tj ET Q q 0 0 0 rg BT 551.56 482.25 Td (patent ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 470.25 Td (portfolios ) Tj ET Q q 0 0 0 rg BT 77.96 470.25 Td (pertaining ) Tj ET Q q 0 0 0 rg BT 121.58 470.25 Td (to ) Tj ET Q q 0 0 0 rg BT 132.43 470.25 Td (PD-1. ) Tj ET Q q 0 0 0 rg BT 158.89 470.25 Td (The ) Tj ET Q q 0 0 0 rg BT 177.51 470.25 Td (initial ) Tj ET Q q 0 0 0 rg BT 203.92 470.25 Td (payment ) Tj ET Q q 0 0 0 rg BT 241.42 470.25 Td (and ) Tj ET Q q 0 0 0 rg BT 258.94 470.25 Td (royalties ) Tj ET Q q 0 0 0 rg BT 296.44 470.25 Td (will ) Tj ET Q q 0 0 0 rg BT 315.07 470.25 Td (be ) Tj ET Q q 0 0 0 rg BT 327.59 470.25 Td (shared ) Tj ET Q q 0 0 0 rg BT 356.76 470.25 Td (between ) Tj ET Q q 0 0 0 rg BT 393.15 470.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 417.35 470.25 Td (and ) Tj ET Q q 0 0 0 rg BT 434.86 470.25 Td (Ono ) Tj ET Q q 0 0 0 rg BT 455.15 470.25 Td (on ) Tj ET Q q 0 0 0 rg BT 468.23 470.25 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 475.74 470.25 Td (75) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.74 470.25 Td (/) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.52 470.25 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 498.52 470.25 Td ( ) Tj ET Q q 0 0 0 rg BT 501.59 470.25 Td (percent ) Tj ET Q q 0 0 0 rg BT 534.09 470.25 Td (allocation, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 458.25 Td (respectively ) Tj ET Q q 0 0 0 rg BT 86.81 458.25 Td (after ) Tj ET Q q 0 0 0 rg BT 107.63 458.25 Td (adjusting ) Tj ET Q q 0 0 0 rg BT 146.79 458.25 Td (for ) Tj ET Q q 0 0 0 rg BT 160.95 458.25 Td (each ) Tj ET Q q 0 0 0 rg BT 181.77 458.25 Td (parties ) Tj ET Q q 0 0 0 rg BT 210.92 458.25 Td (incurred ) Tj ET Q q 0 0 0 rg BT 246.74 458.25 Td (legal ) Tj ET Q q 0 0 0 rg BT 268.67 458.25 Td (fees.  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 440.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.84 440.25 Td (September ) Tj ET Q q 0 0 0 rg BT 92.12 440.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 117.13 440.25 Td (Dana-Farber ) Tj ET Q q 0 0 0 rg BT 170.17 440.25 Td (Cancer ) Tj ET Q q 0 0 0 rg BT 201.00 440.25 Td (Institute ) Tj ET Q q 0 0 0 rg BT 236.28 440.25 Td (\(Dana-Farber\) ) Tj ET Q q 0 0 0 rg BT 295.98 440.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 316.82 440.25 Td (a ) Tj ET Q q 0 0 0 rg BT 323.77 440.25 Td (complaint ) Tj ET Q q 0 0 0 rg BT 366.27 440.25 Td (in ) Tj ET Q q 0 0 0 rg BT 376.56 440.25 Td (Massachusetts ) Tj ET Q q 0 0 0 rg BT 436.84 440.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 467.11 440.25 Td (court ) Tj ET Q q 0 0 0 rg BT 490.17 440.25 Td (seeking ) Tj ET Q q 0 0 0 rg BT 523.23 440.25 Td (to ) Tj ET Q q 0 0 0 rg BT 533.52 440.25 Td (correct ) Tj ET Q q 0 0 0 rg BT 563.79 440.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 428.25 Td (inventorship ) Tj ET Q q 0 0 0 rg BT 87.71 428.25 Td (of ) Tj ET Q q 0 0 0 rg BT 97.76 428.25 Td (five ) Tj ET Q q 0 0 0 rg BT 115.02 428.25 Td (related ) Tj ET Q q 0 0 0 rg BT 143.94 428.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 163.43 428.25 Td (patents ) Tj ET Q q 0 0 0 rg BT 193.47 428.25 Td (directed ) Tj ET Q q 0 0 0 rg BT 227.39 428.25 Td (to ) Tj ET Q q 0 0 0 rg BT 236.89 428.25 Td (methods ) Tj ET Q q 0 0 0 rg BT 272.49 428.25 Td (of ) Tj ET Q q 0 0 0 rg BT 282.53 428.25 Td (treating ) Tj ET Q q 0 0 0 rg BT 314.79 428.25 Td (cancer ) Tj ET Q q 0 0 0 rg BT 342.59 428.25 Td (using ) Tj ET Q q 0 0 0 rg BT 365.98 428.25 Td (a ) Tj ET Q q 0 0 0 rg BT 372.13 428.25 Td (PD-1 ) Tj ET Q q 0 0 0 rg BT 394.96 428.25 Td (antibody) Tj ET Q q 0 0 0 rg BT 429.30 428.25 Td (. ) Tj ET Q q 0 0 0 rg BT 433.52 428.25 Td (Specifically) Tj ET Q q 0 0 0 rg BT 480.63 428.25 Td (, ) Tj ET Q q 0 0 0 rg BT 484.84 428.25 Td (Dana-Farber ) Tj ET Q q 0 0 0 rg BT 537.09 428.25 Td (is ) Tj ET Q q 0 0 0 rg BT 545.47 428.25 Td (seeking ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 416.25 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 416.25 Td (add ) Tj ET Q q 0 0 0 rg BT 63.22 416.25 Td (two ) Tj ET Q q 0 0 0 rg BT 80.72 416.25 Td (scientists ) Tj ET Q q 0 0 0 rg BT 119.88 416.25 Td (as ) Tj ET Q q 0 0 0 rg BT 130.71 416.25 Td (inventors ) Tj ET Q q 0 0 0 rg BT 170.43 416.25 Td (to ) Tj ET Q q 0 0 0 rg BT 180.71 416.25 Td (these ) Tj ET Q q 0 0 0 rg BT 203.75 416.25 Td (patents.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 392.25 Td (PRICING, SALES ) Tj ET Q q 0 0 0 rg BT 117.97 392.25 Td (AND PROMOTIONAL) Tj ET Q q 0 0 0 rg BT 219.36 392.25 Td ( PRACTICES LITIGA) Tj ET Q q 0 0 0 rg BT 317.53 392.25 Td (TION) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 371.25 Td (Plavix*) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 67.10 371.25 Td ( ) Tj ET Q q 0 0 0 rg BT 69.60 371.25 Td (State ) Tj ET Q q 0 0 0 rg BT 93.21 371.25 Td (Attorneys ) Tj ET Q q 0 0 0 rg BT 137.92 371.25 Td (General ) Tj ET Q q 0 0 0 rg BT 174.86 371.25 Td (Lawsuits) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.07 353.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 95.48 353.25 Td (and ) Tj ET Q q 0 0 0 rg BT 112.44 353.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 142.16 353.25 Td (af) Tj ET Q q 0 0 0 rg BT 149.75 353.25 Td (filiates ) Tj ET Q q 0 0 0 rg BT 179.48 353.25 Td (of ) Tj ET Q q 0 0 0 rg BT 190.33 353.25 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 218.96 353.25 Td (are ) Tj ET Q q 0 0 0 rg BT 233.69 353.25 Td (defendants ) Tj ET Q q 0 0 0 rg BT 279.52 353.25 Td (in ) Tj ET Q q 0 0 0 rg BT 289.82 353.25 Td (consumer ) Tj ET Q q 0 0 0 rg BT 331.22 353.25 Td (protection ) Tj ET Q q 0 0 0 rg BT 374.28 353.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 402.35 353.25 Td (false ) Tj ET Q q 0 0 0 rg BT 423.75 353.25 Td (advertising ) Tj ET Q q 0 0 0 rg BT 470.70 353.25 Td (actions ) Tj ET Q q 0 0 0 rg BT 501.55 353.25 Td (brought ) Tj ET Q q 0 0 0 rg BT 535.18 353.25 Td (by ) Tj ET Q q 0 0 0 rg BT 547.70 353.25 Td (several ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 341.25 Td (states ) Tj ET Q q 0 0 0 rg BT 60.73 341.25 Td (relating ) Tj ET Q q 0 0 0 rg BT 93.79 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 104.09 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 118.82 341.25 Td (sales ) Tj ET Q q 0 0 0 rg BT 140.77 341.25 Td (and ) Tj ET Q q 0 0 0 rg BT 157.73 341.25 Td (promotion ) Tj ET Q q 0 0 0 rg BT 201.91 341.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 212.75 341.25 Td (Plavix*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 243.30 341.25 Td (. ) Tj ET Q q 0 0 0 rg BT 248.31 341.25 Td (It ) Tj ET Q q 0 0 0 rg BT 256.94 341.25 Td (is ) Tj ET Q q 0 0 0 rg BT 266.12 341.25 Td (not ) Tj ET Q q 0 0 0 rg BT 281.42 341.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 316.71 341.25 Td (at ) Tj ET Q q 0 0 0 rg BT 326.45 341.25 Td (this ) Tj ET Q q 0 0 0 rg BT 343.41 341.25 Td (time ) Tj ET Q q 0 0 0 rg BT 363.70 341.25 Td (to ) Tj ET Q q 0 0 0 rg BT 373.99 341.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 419.83 341.25 Td (assess ) Tj ET Q q 0 0 0 rg BT 446.78 341.25 Td (the ) Tj ET Q q 0 0 0 rg BT 461.52 341.25 Td (outcome ) Tj ET Q q 0 0 0 rg BT 498.47 341.25 Td (of ) Tj ET Q q 0 0 0 rg BT 509.31 341.25 Td (these ) Tj ET Q q 0 0 0 rg BT 532.38 341.25 Td (lawsuits ) Tj ET Q q 0 0 0 rg BT 567.67 341.25 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 329.25 Td (their ) Tj ET Q q 0 0 0 rg BT 56.83 329.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 94.32 329.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 124.03 329.25 Td (on ) Tj ET Q q 0 0 0 rg BT 136.53 329.25 Td (the ) Tj ET Q q 0 0 0 rg BT 151.24 329.25 Td (Company) Tj ET Q q 0 0 0 rg BT 189.48 329.25 Td (.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 305.25 Td (PRODUCT) Tj ET Q q 0 0 0 rg BT 85.26 305.25 Td ( ) Tj ET Q q 0 0 0 rg BT 87.76 305.25 Td (LIABILITY) Tj ET Q q 0 0 0 rg BT 140.19 305.25 Td ( ) Tj ET Q q 0 0 0 rg BT 142.69 305.25 Td (LITIGA) Tj ET Q q 0 0 0 rg BT 178.07 305.25 Td (TION) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.09 287.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 95.52 287.25 Td (is ) Tj ET Q q 0 0 0 rg BT 104.73 287.25 Td (a ) Tj ET Q q 0 0 0 rg BT 111.71 287.25 Td (party ) Tj ET Q q 0 0 0 rg BT 134.80 287.25 Td (to ) Tj ET Q q 0 0 0 rg BT 145.12 287.25 Td (various ) Tj ET Q q 0 0 0 rg BT 177.10 287.25 Td (product ) Tj ET Q q 0 0 0 rg BT 210.18 287.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 243.83 287.25 Td (lawsuits. ) Tj ET Q q 0 0 0 rg BT 281.65 287.25 Td (Plaintif) Tj ET Q q 0 0 0 rg BT 310.92 287.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 320.68 287.25 Td (in ) Tj ET Q q 0 0 0 rg BT 331.00 287.25 Td (these ) Tj ET Q q 0 0 0 rg BT 354.09 287.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 377.73 287.25 Td (seek ) Tj ET Q q 0 0 0 rg BT 398.04 287.25 Td (damages ) Tj ET Q q 0 0 0 rg BT 435.57 287.25 Td (and ) Tj ET Q q 0 0 0 rg BT 452.55 287.25 Td (other ) Tj ET Q q 0 0 0 rg BT 475.63 287.25 Td (relief ) Tj ET Q q 0 0 0 rg BT 499.27 287.25 Td (on ) Tj ET Q q 0 0 0 rg BT 511.81 287.25 Td (various ) Tj ET Q q 0 0 0 rg BT 543.79 287.25 Td (grounds ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 275.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.26 275.25 Td (alleged ) Tj ET Q q 0 0 0 rg BT 81.74 275.25 Td (personal ) Tj ET Q q 0 0 0 rg BT 118.22 275.25 Td (injury ) Tj ET Q q 0 0 0 rg BT 144.71 275.25 Td (and ) Tj ET Q q 0 0 0 rg BT 161.75 275.25 Td (economic ) Tj ET Q q 0 0 0 rg BT 203.23 275.25 Td (loss. ) Tj ET Q q 0 0 0 rg BT 223.90 275.25 Td ( ) Tj ET Q q 0 0 0 rg BT 225.93 275.25 Td (As ) Tj ET Q q 0 0 0 rg BT 239.64 275.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 284.46 275.25 Td (disclosed, ) Tj ET Q q 0 0 0 rg BT 326.78 275.25 Td (in ) Tj ET Q q 0 0 0 rg BT 337.17 275.25 Td (addition ) Tj ET Q q 0 0 0 rg BT 372.54 275.25 Td (to ) Tj ET Q q 0 0 0 rg BT 382.93 275.25 Td (lawsuits, ) Tj ET Q q 0 0 0 rg BT 420.81 275.25 Td (the ) Tj ET Q q 0 0 0 rg BT 435.63 275.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 477.12 275.25 Td (also ) Tj ET Q q 0 0 0 rg BT 495.83 275.25 Td (faces ) Tj ET Q q 0 0 0 rg BT 518.97 275.25 Td (unfiled ) Tj ET Q q 0 0 0 rg BT 549.90 275.25 Td (claims ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 263.25 Td (involving ) Tj ET Q q 0 0 0 rg BT 76.83 263.25 Td (its ) Tj ET Q q 0 0 0 rg BT 88.78 263.25 Td (products.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 242.25 Td (Plavix*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 224.25 Td (As ) Tj ET Q q 0 0 0 rg BT 49.59 224.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 94.28 224.25 Td (disclosed, ) Tj ET Q q 0 0 0 rg BT 136.47 224.25 Td (the ) Tj ET Q q 0 0 0 rg BT 151.16 224.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 192.52 224.25 Td (and ) Tj ET Q q 0 0 0 rg BT 209.44 224.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 239.11 224.25 Td (af) Tj ET Q q 0 0 0 rg BT 246.70 224.25 Td (filiates ) Tj ET Q q 0 0 0 rg BT 276.39 224.25 Td (of ) Tj ET Q q 0 0 0 rg BT 287.19 224.25 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 315.78 224.25 Td (are ) Tj ET Q q 0 0 0 rg BT 330.46 224.25 Td (defendants ) Tj ET Q q 0 0 0 rg BT 376.25 224.25 Td (in ) Tj ET Q q 0 0 0 rg BT 386.50 224.25 Td (a ) Tj ET Q q 0 0 0 rg BT 393.41 224.25 Td (number ) Tj ET Q q 0 0 0 rg BT 426.43 224.25 Td (of ) Tj ET Q q 0 0 0 rg BT 437.24 224.25 Td (individual ) Tj ET Q q 0 0 0 rg BT 480.27 224.25 Td (lawsuits ) Tj ET Q q 0 0 0 rg BT 515.52 224.25 Td (in ) Tj ET Q q 0 0 0 rg BT 525.77 224.25 Td (various ) Tj ET Q q 0 0 0 rg BT 557.68 224.25 Td (state ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 212.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.43 212.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 82.18 212.25 Td (courts ) Tj ET Q q 0 0 0 rg BT 108.61 212.25 Td (claiming ) Tj ET Q q 0 0 0 rg BT 145.59 212.25 Td (personal ) Tj ET Q q 0 0 0 rg BT 181.46 212.25 Td (injury ) Tj ET Q q 0 0 0 rg BT 207.34 212.25 Td (damage ) Tj ET Q q 0 0 0 rg BT 240.42 212.25 Td (allegedly ) Tj ET Q q 0 0 0 rg BT 279.07 212.25 Td (sustained ) Tj ET Q q 0 0 0 rg BT 318.28 212.25 Td (after ) Tj ET Q q 0 0 0 rg BT 338.58 212.25 Td (using ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 362.25 212.25 Td (Plavix*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 392.79 212.25 Td (. ) Tj ET Q q 0 0 0 rg BT 397.28 212.25 Td (Currently) Tj ET Q q 0 0 0 rg BT 434.96 212.25 Td (, ) Tj ET Q q 0 0 0 rg BT 439.45 212.25 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.21 212.25 Td (5,300) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.71 212.25 Td ( ) Tj ET Q q 0 0 0 rg BT 483.70 212.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 511.80 212.25 Td (involving ) Tj ET Q q 0 0 0 rg BT 552.12 212.25 Td (injury ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 200.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 64.70 200.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 73.82 200.25 Td (as ) Tj ET Q q 0 0 0 rg BT 84.04 200.25 Td (well ) Tj ET Q q 0 0 0 rg BT 103.16 200.25 Td (as ) Tj ET Q q 0 0 0 rg BT 113.38 200.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 141.38 200.25 Td (by ) Tj ET Q q 0 0 0 rg BT 153.28 200.25 Td (spouses ) Tj ET Q q 0 0 0 rg BT 186.29 200.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 213.73 200.25 Td (other ) Tj ET Q q 0 0 0 rg BT 236.17 200.25 Td (beneficiaries, ) Tj ET Q q 0 0 0 rg BT 291.65 200.25 Td (are ) Tj ET Q q 0 0 0 rg BT 305.75 200.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 325.97 200.25 Td (in ) Tj ET Q q 0 0 0 rg BT 335.65 200.25 Td (state ) Tj ET Q q 0 0 0 rg BT 355.87 200.25 Td (and ) Tj ET Q q 0 0 0 rg BT 372.20 200.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 401.85 200.25 Td (courts ) Tj ET Q q 0 0 0 rg BT 428.19 200.25 Td (in ) Tj ET Q q 0 0 0 rg BT 437.86 200.25 Td (various ) Tj ET Q q 0 0 0 rg BT 469.20 200.25 Td (states ) Tj ET Q q 0 0 0 rg BT 493.31 200.25 Td (including ) Tj ET Q q 0 0 0 rg BT 532.98 200.25 Td (California, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 188.25 Td (New ) Tj ET Q q 0 0 0 rg BT 57.02 188.25 Td (Jersey) Tj ET Q q 0 0 0 rg BT 81.37 188.25 Td (, ) Tj ET Q q 0 0 0 rg BT 86.01 188.25 Td (Delaware ) Tj ET Q q 0 0 0 rg BT 126.46 188.25 Td (and ) Tj ET Q q 0 0 0 rg BT 143.04 188.25 Td (New ) Tj ET Q q 0 0 0 rg BT 163.74 188.25 Td (Y) Tj ET Q q 0 0 0 rg BT 169.96 188.25 Td (ork. ) Tj ET Q q 0 0 0 rg BT 187.94 188.25 Td (In ) Tj ET Q q 0 0 0 rg BT 198.41 188.25 Td (February ) Tj ET Q q 0 0 0 rg BT 236.65 188.25 Td (2013, ) Tj ET Q q 0 0 0 rg BT 261.29 188.25 Td (the ) Tj ET Q q 0 0 0 rg BT 275.65 188.25 Td (Judicial ) Tj ET Q q 0 0 0 rg BT 308.90 188.25 Td (Panel ) Tj ET Q q 0 0 0 rg BT 333.26 188.25 Td (on ) Tj ET Q q 0 0 0 rg BT 345.40 188.25 Td (Multidistrict ) Tj ET Q q 0 0 0 rg BT 397.54 188.25 Td (Litigation ) Tj ET Q q 0 0 0 rg BT 439.12 188.25 Td (granted ) Tj ET Q q 0 0 0 rg BT 471.25 188.25 Td (the ) Tj ET Q q 0 0 0 rg BT 485.61 188.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 526.64 188.25 Td (and ) Tj ET Q q 0 0 0 rg BT 543.22 188.25 Td (Sanofi’) Tj ET Q q 0 0 0 rg BT 572.11 188.25 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 176.25 Td (motion ) Tj ET Q q 0 0 0 rg BT 67.19 176.25 Td (to ) Tj ET Q q 0 0 0 rg BT 77.82 176.25 Td (establish ) Tj ET Q q 0 0 0 rg BT 115.66 176.25 Td (a ) Tj ET Q q 0 0 0 rg BT 122.95 176.25 Td (multi-district ) Tj ET Q q 0 0 0 rg BT 178.02 176.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 216.98 176.25 Td (\(MDL\) ) Tj ET Q q 0 0 0 rg BT 248.71 176.25 Td (to ) Tj ET Q q 0 0 0 rg BT 259.34 176.25 Td (coordinate ) Tj ET Q q 0 0 0 rg BT 304.40 176.25 Td (Federal ) Tj ET Q q 0 0 0 rg BT 337.24 176.25 Td (pretrial ) Tj ET Q q 0 0 0 rg BT 368.96 176.25 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 420.13 176.25 Td (in ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 430.76 176.25 Td (Plavix*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 461.30 176.25 Td ( ) Tj ET Q q 0 0 0 rg BT 464.15 176.25 Td (product ) Tj ET Q q 0 0 0 rg BT 497.55 176.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 531.51 176.25 Td (and ) Tj ET Q q 0 0 0 rg BT 548.80 176.25 Td (related ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 164.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 59.08 164.25 Td (in ) Tj ET Q q 0 0 0 rg BT 68.85 164.25 Td (New ) Tj ET Q q 0 0 0 rg BT 89.71 164.25 Td (Jersey ) Tj ET Q q 0 0 0 rg BT 116.69 164.25 Td (Federal ) Tj ET Q q 0 0 0 rg BT 148.66 164.25 Td (Court. ) Tj ET Q q 0 0 0 rg BT 175.92 164.25 Td (It ) Tj ET Q q 0 0 0 rg BT 184.02 164.25 Td (is ) Tj ET Q q 0 0 0 rg BT 192.67 164.25 Td (not ) Tj ET Q q 0 0 0 rg BT 207.43 164.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 242.20 164.25 Td (at ) Tj ET Q q 0 0 0 rg BT 251.40 164.25 Td (this ) Tj ET Q q 0 0 0 rg BT 267.83 164.25 Td (time ) Tj ET Q q 0 0 0 rg BT 287.59 164.25 Td (to ) Tj ET Q q 0 0 0 rg BT 297.35 164.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 342.65 164.25 Td (assess ) Tj ET Q q 0 0 0 rg BT 369.08 164.25 Td (the ) Tj ET Q q 0 0 0 rg BT 383.28 164.25 Td (outcome ) Tj ET Q q 0 0 0 rg BT 419.70 164.25 Td (of ) Tj ET Q q 0 0 0 rg BT 430.02 164.25 Td (these ) Tj ET Q q 0 0 0 rg BT 452.55 164.25 Td (lawsuits ) Tj ET Q q 0 0 0 rg BT 487.31 164.25 Td (or ) Tj ET Q q 0 0 0 rg BT 497.63 164.25 Td (the ) Tj ET Q q 0 0 0 rg BT 511.83 164.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 548.80 164.25 Td (impact ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 152.25 Td (on ) Tj ET Q q 0 0 0 rg BT 48.50 152.25 Td (the ) Tj ET Q q 0 0 0 rg BT 63.22 152.25 Td (Company) Tj ET Q q 0 0 0 rg BT 101.45 152.25 Td (.) Tj ET Q endstream endobj 195 0 obj <> endobj 196 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (97) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 731.25 Td (Amylin, ) Tj ET Q q 0 0 0 rg BT 71.45 731.25 Td (a ) Tj ET Q q 0 0 0 rg BT 78.28 731.25 Td (former ) Tj ET Q q 0 0 0 rg BT 107.87 731.25 Td (subsidiary ) Tj ET Q q 0 0 0 rg BT 151.37 731.25 Td (of ) Tj ET Q q 0 0 0 rg BT 162.09 731.25 Td (the ) Tj ET Q q 0 0 0 rg BT 176.70 731.25 Td (Company) Tj ET Q q 0 0 0 rg BT 214.94 731.25 Td (, ) Tj ET Q q 0 0 0 rg BT 219.83 731.25 Td (and ) Tj ET Q q 0 0 0 rg BT 236.65 731.25 Td (Lilly ) Tj ET Q q 0 0 0 rg BT 258.49 731.25 Td (are ) Tj ET Q q 0 0 0 rg BT 273.08 731.25 Td (co-defendants ) Tj ET Q q 0 0 0 rg BT 331.56 731.25 Td (in ) Tj ET Q q 0 0 0 rg BT 341.73 731.25 Td (product ) Tj ET Q q 0 0 0 rg BT 374.66 731.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 408.16 731.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 446.66 731.25 Td (related ) Tj ET Q q 0 0 0 rg BT 476.25 731.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 486.42 731.25 Td (Byetta*.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 519.46 731.25 Td ( ) Tj ET Q q 0 0 0 rg BT 521.68 731.25 Td (T) Tj ET Q q 0 0 0 rg BT 527.09 731.25 Td (o ) Tj ET Q q 0 0 0 rg BT 534.48 731.25 Td (date, ) Tj ET Q q 0 0 0 rg BT 556.03 731.25 Td (there ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 719.25 Td (are ) Tj ET Q q 0 0 0 rg BT 50.32 719.25 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 70.20 719.25 Td (500) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 85.20 719.25 Td ( ) Tj ET Q q 0 0 0 rg BT 87.31 719.25 Td (separate ) Tj ET Q q 0 0 0 rg BT 122.18 719.25 Td (lawsuits ) Tj ET Q q 0 0 0 rg BT 157.07 719.25 Td (pending ) Tj ET Q q 0 0 0 rg BT 191.40 719.25 Td (on ) Tj ET Q q 0 0 0 rg BT 203.51 719.25 Td (behalf ) Tj ET Q q 0 0 0 rg BT 230.60 719.25 Td (of ) Tj ET Q q 0 0 0 rg BT 241.05 719.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.92 719.25 Td (2,000) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 323.42 719.25 Td ( ) Tj ET Q q 0 0 0 rg BT 325.53 719.25 Td (active ) Tj ET Q q 0 0 0 rg BT 351.51 719.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 380.21 719.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 389.55 719.25 Td (\(including ) Tj ET Q q 0 0 0 rg BT 432.76 719.25 Td (pending ) Tj ET Q q 0 0 0 rg BT 467.09 719.25 Td (settlements\), ) Tj ET Q q 0 0 0 rg BT 520.02 719.25 Td (which ) Tj ET Q q 0 0 0 rg BT 546.57 719.25 Td (include ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 707.25 Td (injury ) Tj ET Q q 0 0 0 rg BT 61.81 707.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 90.52 707.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 99.67 707.25 Td (as ) Tj ET Q q 0 0 0 rg BT 109.92 707.25 Td (well ) Tj ET Q q 0 0 0 rg BT 129.07 707.25 Td (as ) Tj ET Q q 0 0 0 rg BT 139.33 707.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 167.36 707.25 Td (by ) Tj ET Q q 0 0 0 rg BT 179.28 707.25 Td (spouses ) Tj ET Q q 0 0 0 rg BT 212.33 707.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 239.80 707.25 Td (other ) Tj ET Q q 0 0 0 rg BT 262.27 707.25 Td (beneficiaries, ) Tj ET Q q 0 0 0 rg BT 317.78 707.25 Td (in ) Tj ET Q q 0 0 0 rg BT 327.49 707.25 Td (various ) Tj ET Q q 0 0 0 rg BT 358.85 707.25 Td (courts ) Tj ET Q q 0 0 0 rg BT 385.22 707.25 Td (in ) Tj ET Q q 0 0 0 rg BT 394.93 707.25 Td (the ) Tj ET Q q 0 0 0 rg BT 409.07 707.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 428.64 707.25 Td (The ) Tj ET Q q 0 0 0 rg BT 446.12 707.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 486.93 707.25 Td (has ) Tj ET Q q 0 0 0 rg BT 502.19 707.25 Td (agreed ) Tj ET Q q 0 0 0 rg BT 530.76 707.25 Td (in ) Tj ET Q q 0 0 0 rg BT 540.47 707.25 Td (principle ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 695.25 Td (to ) Tj ET Q q 0 0 0 rg BT 46.61 695.25 Td (resolve ) Tj ET Q q 0 0 0 rg BT 78.32 695.25 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 98.93 695.25 Td (30) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 108.93 695.25 Td ( ) Tj ET Q q 0 0 0 rg BT 111.76 695.25 Td (of ) Tj ET Q q 0 0 0 rg BT 122.93 695.25 Td (these ) Tj ET Q q 0 0 0 rg BT 146.31 695.25 Td (claims. ) Tj ET Q q 0 0 0 rg BT 177.54 695.25 Td (The ) Tj ET Q q 0 0 0 rg BT 195.92 695.25 Td (majority ) Tj ET Q q 0 0 0 rg BT 232.64 695.25 Td (of ) Tj ET Q q 0 0 0 rg BT 243.80 695.25 Td (these ) Tj ET Q q 0 0 0 rg BT 267.18 695.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 291.12 695.25 Td (have ) Tj ET Q q 0 0 0 rg BT 312.83 695.25 Td (been ) Tj ET Q q 0 0 0 rg BT 334.54 695.25 Td (brought ) Tj ET Q q 0 0 0 rg BT 368.48 695.25 Td (by ) Tj ET Q q 0 0 0 rg BT 381.32 695.25 Td (individuals ) Tj ET Q q 0 0 0 rg BT 428.60 695.25 Td (who ) Tj ET Q q 0 0 0 rg BT 448.65 695.25 Td (allege ) Tj ET Q q 0 0 0 rg BT 475.36 695.25 Td (personal ) Tj ET Q q 0 0 0 rg BT 512.07 695.25 Td (injury ) Tj ET Q q 0 0 0 rg BT 538.79 695.25 Td (sustained ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.25 Td (after ) Tj ET Q q 0 0 0 rg BT 56.98 683.25 Td (using ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 81.31 683.25 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 111.85 683.25 Td (, ) Tj ET Q q 0 0 0 rg BT 117.01 683.25 Td (primarily ) Tj ET Q q 0 0 0 rg BT 156.88 683.25 Td (pancreatic ) Tj ET Q q 0 0 0 rg BT 200.62 683.25 Td (cancer ) Tj ET Q q 0 0 0 rg BT 229.37 683.25 Td (and ) Tj ET Q q 0 0 0 rg BT 246.47 683.25 Td (pancreatitis, ) Tj ET Q q 0 0 0 rg BT 297.72 683.25 Td (and, ) Tj ET Q q 0 0 0 rg BT 317.32 683.25 Td (in ) Tj ET Q q 0 0 0 rg BT 327.76 683.25 Td (some ) Tj ET Q q 0 0 0 rg BT 351.53 683.25 Td (cases, ) Tj ET Q q 0 0 0 rg BT 377.79 683.25 Td (claiming ) Tj ET Q q 0 0 0 rg BT 415.44 683.25 Td (alleged ) Tj ET Q q 0 0 0 rg BT 446.97 683.25 Td (wrongful ) Tj ET Q q 0 0 0 rg BT 486.29 683.25 Td (death. ) Tj ET Q q 0 0 0 rg BT 512.92 683.25 Td (The ) Tj ET Q q 0 0 0 rg BT 531.13 683.25 Td (majority ) Tj ET Q q 0 0 0 rg BT 567.67 683.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 671.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 59.17 671.25 Td (were ) Tj ET Q q 0 0 0 rg BT 80.67 671.25 Td (pending ) Tj ET Q q 0 0 0 rg BT 114.96 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 124.81 671.25 Td (Federal ) Tj ET Q q 0 0 0 rg BT 156.87 671.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 181.72 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 191.57 671.25 Td (San ) Tj ET Q q 0 0 0 rg BT 208.64 671.25 Td (Diego ) Tj ET Q q 0 0 0 rg BT 235.15 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 245.00 671.25 Td (an ) Tj ET Q q 0 0 0 rg BT 256.51 671.25 Td (MDL) Tj ET Q q 0 0 0 rg BT 278.36 671.25 Td ( ) Tj ET Q q 0 0 0 rg BT 280.43 671.25 Td (or ) Tj ET Q q 0 0 0 rg BT 290.83 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 300.68 671.25 Td (a ) Tj ET Q q 0 0 0 rg BT 307.19 671.25 Td (coordinated ) Tj ET Q q 0 0 0 rg BT 356.47 671.25 Td (proceeding ) Tj ET Q q 0 0 0 rg BT 402.96 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 412.81 671.25 Td (California ) Tj ET Q q 0 0 0 rg BT 455.43 671.25 Td (Superior ) Tj ET Q q 0 0 0 rg BT 491.94 671.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 516.79 671.25 Td (in ) Tj ET Q q 0 0 0 rg BT 526.64 671.25 Td (Los ) Tj ET Q q 0 0 0 rg BT 543.25 671.25 Td (Angeles ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 659.25 Td (\(JCCP\). ) Tj ET Q q 0 0 0 rg BT 70.66 659.25 Td (In ) Tj ET Q q 0 0 0 rg BT 81.70 659.25 Td (November ) Tj ET Q q 0 0 0 rg BT 126.62 659.25 Td (2015, ) Tj ET Q q 0 0 0 rg BT 151.83 659.25 Td (the ) Tj ET Q q 0 0 0 rg BT 166.75 659.25 Td (defendants' ) Tj ET Q q 0 0 0 rg BT 214.58 659.25 Td (motion ) Tj ET Q q 0 0 0 rg BT 245.62 659.25 Td (for ) Tj ET Q q 0 0 0 rg BT 259.99 659.25 Td (summary ) Tj ET Q q 0 0 0 rg BT 299.92 659.25 Td (judgment ) Tj ET Q q 0 0 0 rg BT 340.40 659.25 Td (based ) Tj ET Q q 0 0 0 rg BT 365.88 659.25 Td (on ) Tj ET Q q 0 0 0 rg BT 378.59 659.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 409.05 659.25 Td (preemption ) Tj ET Q q 0 0 0 rg BT 457.30 659.25 Td (was ) Tj ET Q q 0 0 0 rg BT 475.56 659.25 Td (granted ) Tj ET Q q 0 0 0 rg BT 508.25 659.25 Td (in ) Tj ET Q q 0 0 0 rg BT 518.74 659.25 Td (both ) Tj ET Q q 0 0 0 rg BT 539.23 659.25 Td (the ) Tj ET Q q 0 0 0 rg BT 554.16 659.25 Td (MDL) Tj ET Q q 0 0 0 rg BT 576.01 659.25 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 647.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.03 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 67.84 647.25 Td (JCCP) Tj ET Q q 0 0 0 rg BT 89.53 647.25 Td (. ) Tj ET Q q 0 0 0 rg BT 94.44 647.25 Td (The ) Tj ET Q q 0 0 0 rg BT 112.58 647.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 141.28 647.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 151.09 647.25 Td (in ) Tj ET Q q 0 0 0 rg BT 161.47 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 176.28 647.25 Td (MDL) Tj ET Q q 0 0 0 rg BT 198.13 647.25 Td ( ) Tj ET Q q 0 0 0 rg BT 200.72 647.25 Td (have ) Tj ET Q q 0 0 0 rg BT 222.19 647.25 Td (appealed ) Tj ET Q q 0 0 0 rg BT 260.32 647.25 Td (to ) Tj ET Q q 0 0 0 rg BT 270.69 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 285.50 647.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 305.88 647.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 331.25 647.25 Td (of ) Tj ET Q q 0 0 0 rg BT 341.60 647.25 Td (Appeals ) Tj ET Q q 0 0 0 rg BT 376.97 647.25 Td (for ) Tj ET Q q 0 0 0 rg BT 391.22 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 406.03 647.25 Td (Ninth ) Tj ET Q q 0 0 0 rg BT 431.41 647.25 Td (Circuit ) Tj ET Q q 0 0 0 rg BT 461.77 647.25 Td (and ) Tj ET Q q 0 0 0 rg BT 478.81 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 493.62 647.25 Td (JCCP) Tj ET Q q 0 0 0 rg BT 516.04 647.25 Td ( ) Tj ET Q q 0 0 0 rg BT 518.63 647.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 547.33 647.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 557.15 647.25 Td (have ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 635.25 Td (appealed ) Tj ET Q q 0 0 0 rg BT 74.50 635.25 Td (to ) Tj ET Q q 0 0 0 rg BT 85.24 635.25 Td (the ) Tj ET Q q 0 0 0 rg BT 100.43 635.25 Td (California ) Tj ET Q q 0 0 0 rg BT 143.93 635.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 169.68 635.25 Td (of ) Tj ET Q q 0 0 0 rg BT 180.32 635.25 Td (Appeal. ) Tj ET Q q 0 0 0 rg BT 214.01 635.25 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 247.53 635.25 Td (has ) Tj ET Q q 0 0 0 rg BT 263.83 635.25 Td (product ) Tj ET Q q 0 0 0 rg BT 297.34 635.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 331.42 635.25 Td (insurance ) Tj ET Q q 0 0 0 rg BT 372.70 635.25 Td (covering ) Tj ET Q q 0 0 0 rg BT 410.65 635.25 Td (a ) Tj ET Q q 0 0 0 rg BT 418.05 635.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 463.79 635.25 Td (number ) Tj ET Q q 0 0 0 rg BT 497.31 635.25 Td (of ) Tj ET Q q 0 0 0 rg BT 508.60 635.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 537.67 635.25 Td (involving ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 623.25 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.54 623.25 Td ( ) Tj ET Q q 0 0 0 rg BT 69.07 623.25 Td (and ) Tj ET Q q 0 0 0 rg BT 86.03 623.25 Td (any ) Tj ET Q q 0 0 0 rg BT 102.99 623.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 145.50 623.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 179.13 623.25 Td (to ) Tj ET Q q 0 0 0 rg BT 188.88 623.25 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 221.96 623.25 Td (with ) Tj ET Q q 0 0 0 rg BT 242.26 623.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 273.10 623.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 283.40 623.25 Td (Byetta*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.94 623.25 Td ( ) Tj ET Q q 0 0 0 rg BT 316.47 623.25 Td (is ) Tj ET Q q 0 0 0 rg BT 325.66 623.25 Td (expected ) Tj ET Q q 0 0 0 rg BT 363.72 623.25 Td (to ) Tj ET Q q 0 0 0 rg BT 374.02 623.25 Td (be ) Tj ET Q q 0 0 0 rg BT 385.98 623.25 Td (shared ) Tj ET Q q 0 0 0 rg BT 414.60 623.25 Td (between ) Tj ET Q q 0 0 0 rg BT 450.44 623.25 Td (the ) Tj ET Q q 0 0 0 rg BT 465.18 623.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 506.59 623.25 Td (and ) Tj ET Q q 0 0 0 rg BT 523.00 623.25 Td (AstraZeneca. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 611.25 Td (It ) Tj ET Q q 0 0 0 rg BT 44.61 611.25 Td (is ) Tj ET Q q 0 0 0 rg BT 53.78 611.25 Td (not ) Tj ET Q q 0 0 0 rg BT 69.06 611.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 104.33 611.25 Td (to ) Tj ET Q q 0 0 0 rg BT 114.61 611.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 160.43 611.25 Td (predict ) Tj ET Q q 0 0 0 rg BT 190.69 611.25 Td (the ) Tj ET Q q 0 0 0 rg BT 205.41 611.25 Td (outcome ) Tj ET Q q 0 0 0 rg BT 242.34 611.25 Td (of ) Tj ET Q q 0 0 0 rg BT 253.17 611.25 Td (any ) Tj ET Q q 0 0 0 rg BT 270.11 611.25 Td (lawsuit, ) Tj ET Q q 0 0 0 rg BT 304.00 611.25 Td (claim ) Tj ET Q q 0 0 0 rg BT 328.71 611.25 Td (or ) Tj ET Q q 0 0 0 rg BT 339.54 611.25 Td (proceeding ) Tj ET Q q 0 0 0 rg BT 386.46 611.25 Td (or ) Tj ET Q q 0 0 0 rg BT 397.29 611.25 Td (the ) Tj ET Q q 0 0 0 rg BT 412.01 611.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 449.50 611.25 Td (impact ) Tj ET Q q 0 0 0 rg BT 479.21 611.25 Td (on ) Tj ET Q q 0 0 0 rg BT 491.71 611.25 Td (the ) Tj ET Q q 0 0 0 rg BT 506.43 611.25 Td (Company) Tj ET Q q 0 0 0 rg BT 544.67 611.25 Td (.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 593.25 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 575.25 Td (The ) Tj ET Q q 0 0 0 rg BT 53.20 575.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 93.74 575.25 Td (and ) Tj ET Q q 0 0 0 rg BT 109.84 575.25 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 139.82 575.25 Td (are ) Tj ET Q q 0 0 0 rg BT 153.69 575.25 Td (co-defendants ) Tj ET Q q 0 0 0 rg BT 211.42 575.25 Td (in ) Tj ET Q q 0 0 0 rg BT 220.86 575.25 Td (product ) Tj ET Q q 0 0 0 rg BT 253.06 575.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 285.82 575.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 323.59 575.25 Td (related ) Tj ET Q q 0 0 0 rg BT 352.45 575.25 Td (to ) Tj ET Q q 0 0 0 rg BT 361.51 575.25 Td (Abilify) Tj ET Q q 0 0 0 rg BT 389.75 575.25 Td (. ) Tj ET Q q 0 0 0 rg BT 393.91 575.25 Td (Plaintif) Tj ET Q q 0 0 0 rg BT 423.17 575.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 432.05 575.25 Td (allege ) Tj ET Q q 0 0 0 rg BT 457.21 575.25 Td (Abilify ) Tj ET Q q 0 0 0 rg BT 487.75 575.25 Td (caused ) Tj ET Q q 0 0 0 rg BT 516.61 575.25 Td (them ) Tj ET Q q 0 0 0 rg BT 538.26 575.25 Td (to ) Tj ET Q q 0 0 0 rg BT 547.70 575.25 Td (engage ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 563.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.33 563.25 Td (compulsive ) Tj ET Q q 0 0 0 rg BT 94.98 563.25 Td (gambling ) Tj ET Q q 0 0 0 rg BT 135.30 563.25 Td (and ) Tj ET Q q 0 0 0 rg BT 152.29 563.25 Td (other ) Tj ET Q q 0 0 0 rg BT 175.38 563.25 Td (impulse ) Tj ET Q q 0 0 0 rg BT 209.59 563.25 Td (control ) Tj ET Q q 0 0 0 rg BT 240.47 563.25 Td (disorders. ) Tj ET Q q 0 0 0 rg BT 281.99 563.25 Td (There ) Tj ET Q q 0 0 0 rg BT 307.85 563.25 Td (have ) Tj ET Q q 0 0 0 rg BT 329.28 563.25 Td (been ) Tj ET Q q 0 0 0 rg BT 350.70 563.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 411.01 563.25 Td (130) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 426.01 563.25 Td ( ) Tj ET Q q 0 0 0 rg BT 428.56 563.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 452.20 563.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 473.08 563.25 Td (in ) Tj ET Q q 0 0 0 rg BT 483.40 563.25 Td (state ) Tj ET Q q 0 0 0 rg BT 504.28 563.25 Td (and ) Tj ET Q q 0 0 0 rg BT 521.26 563.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 551.56 563.25 Td (courts ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 551.25 Td (and ) Tj ET Q q 0 0 0 rg BT 52.43 551.25 Td (several ) Tj ET Q q 0 0 0 rg BT 82.74 551.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 124.72 551.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 147.81 551.25 Td (are ) Tj ET Q q 0 0 0 rg BT 162.01 551.25 Td (pending ) Tj ET Q q 0 0 0 rg BT 196.21 551.25 Td (in ) Tj ET Q q 0 0 0 rg BT 205.98 551.25 Td (Canada. ) Tj ET Q q 0 0 0 rg BT 240.32 551.25 Td (The ) Tj ET Q q 0 0 0 rg BT 257.85 551.25 Td (Judicial ) Tj ET Q q 0 0 0 rg BT 290.95 551.25 Td (Panel ) Tj ET Q q 0 0 0 rg BT 315.16 551.25 Td (on ) Tj ET Q q 0 0 0 rg BT 327.15 551.25 Td (Multidistrict ) Tj ET Q q 0 0 0 rg BT 379.14 551.25 Td (Litigation ) Tj ET Q q 0 0 0 rg BT 420.57 551.25 Td (has ) Tj ET Q q 0 0 0 rg BT 435.89 551.25 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 488.42 551.25 Td (the ) Tj ET Q q 0 0 0 rg BT 502.63 551.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 532.38 551.25 Td (court ) Tj ET Q q 0 0 0 rg BT 554.91 551.25 Td (cases ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 539.25 Td (for ) Tj ET Q q 0 0 0 rg BT 50.16 539.25 Td (pretrial ) Tj ET Q q 0 0 0 rg BT 81.53 539.25 Td (purposes ) Tj ET Q q 0 0 0 rg BT 119.58 539.25 Td (in ) Tj ET Q q 0 0 0 rg BT 129.86 539.25 Td (the ) Tj ET Q q 0 0 0 rg BT 144.58 539.25 Td (United ) Tj ET Q q 0 0 0 rg BT 174.30 539.25 Td (States ) Tj ET Q q 0 0 0 rg BT 200.68 539.25 Td (District ) Tj ET Q q 0 0 0 rg BT 233.18 539.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 258.46 539.25 Td (for ) Tj ET Q q 0 0 0 rg BT 272.62 539.25 Td (the ) Tj ET Q q 0 0 0 rg BT 287.33 539.25 Td (Northern ) Tj ET Q q 0 0 0 rg BT 325.93 539.25 Td (District ) Tj ET Q q 0 0 0 rg BT 358.43 539.25 Td (of ) Tj ET Q q 0 0 0 rg BT 369.26 539.25 Td (Florida.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 521.25 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 503.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.00 503.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 95.35 503.25 Td (and ) Tj ET Q q 0 0 0 rg BT 112.24 503.25 Td (Pfizer ) Tj ET Q q 0 0 0 rg BT 138.57 503.25 Td (are ) Tj ET Q q 0 0 0 rg BT 153.24 503.25 Td (co-defendants ) Tj ET Q q 0 0 0 rg BT 211.78 503.25 Td (in ) Tj ET Q q 0 0 0 rg BT 222.01 503.25 Td (product ) Tj ET Q q 0 0 0 rg BT 255.01 503.25 Td (liability ) Tj ET Q q 0 0 0 rg BT 288.58 503.25 Td (litigation ) Tj ET Q q 0 0 0 rg BT 327.14 503.25 Td (related ) Tj ET Q q 0 0 0 rg BT 356.80 503.25 Td (to ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 367.04 503.25 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 395.37 503.25 Td (. ) Tj ET Q q 0 0 0 rg BT 400.33 503.25 Td (Plaintif) Tj ET Q q 0 0 0 rg BT 429.59 503.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 439.27 503.25 Td (assert ) Tj ET Q q 0 0 0 rg BT 464.49 503.25 Td (claims, ) Tj ET Q q 0 0 0 rg BT 495.55 503.25 Td (including ) Tj ET Q q 0 0 0 rg BT 535.78 503.25 Td (claims ) Tj ET Q q 0 0 0 rg BT 564.34 503.25 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 491.25 Td (wrongful ) Tj ET Q q 0 0 0 rg BT 75.39 491.25 Td (death, ) Tj ET Q q 0 0 0 rg BT 102.27 491.25 Td (as ) Tj ET Q q 0 0 0 rg BT 113.33 491.25 Td (a ) Tj ET Q q 0 0 0 rg BT 120.49 491.25 Td (result ) Tj ET Q q 0 0 0 rg BT 145.44 491.25 Td (of ) Tj ET Q q 0 0 0 rg BT 156.49 491.25 Td (bleeding ) Tj ET Q q 0 0 0 rg BT 193.65 491.25 Td (they ) Tj ET Q q 0 0 0 rg BT 213.60 491.25 Td (allege ) Tj ET Q q 0 0 0 rg BT 240.20 491.25 Td (was ) Tj ET Q q 0 0 0 rg BT 258.48 491.25 Td (caused ) Tj ET Q q 0 0 0 rg BT 288.41 491.25 Td (by ) Tj ET Q q 0 0 0 rg BT 301.14 491.25 Td (their ) Tj ET Q q 0 0 0 rg BT 322.19 491.25 Td (use ) Tj ET Q q 0 0 0 rg BT 338.25 491.25 Td (of ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 349.30 491.25 Td (Eliquis) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 377.64 491.25 Td (. ) Tj ET Q q 0 0 0 rg BT 382.67 491.25 Td (There ) Tj ET Q q 0 0 0 rg BT 408.71 491.25 Td (have ) Tj ET Q q 0 0 0 rg BT 430.31 491.25 Td (been ) Tj ET Q q 0 0 0 rg BT 451.92 491.25 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.41 491.25 Td (80) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 482.41 491.25 Td ( ) Tj ET Q q 0 0 0 rg BT 485.14 491.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 508.97 491.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 530.02 491.25 Td (in ) Tj ET Q q 0 0 0 rg BT 540.52 491.25 Td (state ) Tj ET Q q 0 0 0 rg BT 561.58 491.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 479.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 66.93 479.25 Td (courts ) Tj ET Q q 0 0 0 rg BT 94.54 479.25 Td (in ) Tj ET Q q 0 0 0 rg BT 105.48 479.25 Td (the ) Tj ET Q q 0 0 0 rg BT 120.87 479.25 Td (United ) Tj ET Q q 0 0 0 rg BT 151.26 479.25 Td (States ) Tj ET Q q 0 0 0 rg BT 178.32 479.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 195.93 479.25 Td (two) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 210.93 479.25 Td ( ) Tj ET Q q 0 0 0 rg BT 214.10 479.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 238.37 479.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 259.87 479.25 Td (in ) Tj ET Q q 0 0 0 rg BT 270.82 479.25 Td (Canada. ) Tj ET Q q 0 0 0 rg BT 306.24 479.25 Td (The ) Tj ET Q q 0 0 0 rg BT 324.96 479.25 Td (Judicial ) Tj ET Q q 0 0 0 rg BT 359.24 479.25 Td (Panel ) Tj ET Q q 0 0 0 rg BT 384.63 479.25 Td (on ) Tj ET Q q 0 0 0 rg BT 397.80 479.25 Td (Multidistrict ) Tj ET Q q 0 0 0 rg BT 450.97 479.25 Td (Litigation ) Tj ET Q q 0 0 0 rg BT 493.58 479.25 Td (has ) Tj ET Q q 0 0 0 rg BT 510.08 479.25 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 563.79 479.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 467.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 66.25 467.25 Td (court ) Tj ET Q q 0 0 0 rg BT 89.30 467.25 Td (cases ) Tj ET Q q 0 0 0 rg BT 112.90 467.25 Td (for ) Tj ET Q q 0 0 0 rg BT 127.06 467.25 Td (pretrial ) Tj ET Q q 0 0 0 rg BT 158.43 467.25 Td (purposes ) Tj ET Q q 0 0 0 rg BT 196.48 467.25 Td (in ) Tj ET Q q 0 0 0 rg BT 206.76 467.25 Td (the ) Tj ET Q q 0 0 0 rg BT 221.48 467.25 Td (United ) Tj ET Q q 0 0 0 rg BT 251.20 467.25 Td (States ) Tj ET Q q 0 0 0 rg BT 277.58 467.25 Td (District ) Tj ET Q q 0 0 0 rg BT 310.08 467.25 Td (Court ) Tj ET Q q 0 0 0 rg BT 335.36 467.25 Td (for ) Tj ET Q q 0 0 0 rg BT 349.52 467.25 Td (the ) Tj ET Q q 0 0 0 rg BT 364.23 467.25 Td (Southern ) Tj ET Q q 0 0 0 rg BT 402.84 467.25 Td (District ) Tj ET Q q 0 0 0 rg BT 435.34 467.25 Td (of ) Tj ET Q q 0 0 0 rg BT 446.17 467.25 Td (New ) Tj ET Q q 0 0 0 rg BT 467.18 467.25 Td (Y) Tj ET Q q 0 0 0 rg BT 473.40 467.25 Td (ork.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 443.25 Td (SHAREHOLDER ) Tj ET Q q 0 0 0 rg BT 116.29 443.25 Td (DERIV) Tj ET Q q 0 0 0 rg BT 147.23 443.25 Td (A) Tj ET Q q 0 0 0 rg BT 153.71 443.25 Td (TIVE ) Tj ET Q q 0 0 0 rg BT 180.66 443.25 Td (LITIGA) Tj ET Q q 0 0 0 rg BT 216.04 443.25 Td (TION) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 425.25 Td (Since ) Tj ET Q q 0 0 0 rg BT 60.78 425.25 Td (December ) Tj ET Q q 0 0 0 rg BT 104.43 425.25 Td (2015, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 129.50 425.25 Td (three) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 149.48 425.25 Td ( ) Tj ET Q q 0 0 0 rg BT 152.05 425.25 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 201.26 425.25 Td (derivative ) Tj ET Q q 0 0 0 rg BT 243.80 425.25 Td (lawsuits ) Tj ET Q q 0 0 0 rg BT 279.15 425.25 Td (were ) Tj ET Q q 0 0 0 rg BT 301.14 425.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 322.03 425.25 Td (in ) Tj ET Q q 0 0 0 rg BT 332.37 425.25 Td (New ) Tj ET Q q 0 0 0 rg BT 353.44 425.25 Td (Y) Tj ET Q q 0 0 0 rg BT 359.66 425.25 Td (ork ) Tj ET Q q 0 0 0 rg BT 375.55 425.25 Td (state ) Tj ET Q q 0 0 0 rg BT 396.44 425.25 Td (court ) Tj ET Q q 0 0 0 rg BT 419.56 425.25 Td (against ) Tj ET Q q 0 0 0 rg BT 450.45 425.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 480.21 425.25 Td (of) Tj ET Q q 0 0 0 rg BT 488.36 425.25 Td (ficers ) Tj ET Q q 0 0 0 rg BT 513.13 425.25 Td (and ) Tj ET Q q 0 0 0 rg BT 530.14 425.25 Td (directors ) Tj ET Q q 0 0 0 rg BT 567.69 425.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 51.47 413.25 Td (Company) Tj ET Q q 0 0 0 rg BT 89.71 413.25 Td (. ) Tj ET Q q 0 0 0 rg BT 95.22 413.25 Td (The ) Tj ET Q q 0 0 0 rg BT 114.02 413.25 Td (plaintif) Tj ET Q q 0 0 0 rg BT 142.72 413.25 Td (fs ) Tj ET Q q 0 0 0 rg BT 153.19 413.25 Td (allege, ) Tj ET Q q 0 0 0 rg BT 182.82 413.25 Td (among ) Tj ET Q q 0 0 0 rg BT 213.28 413.25 Td (other ) Tj ET Q q 0 0 0 rg BT 237.08 413.25 Td (things, ) Tj ET Q q 0 0 0 rg BT 267.28 413.25 Td (breaches ) Tj ET Q q 0 0 0 rg BT 305.51 413.25 Td (of ) Tj ET Q q 0 0 0 rg BT 317.09 413.25 Td (fiduciary ) Tj ET Q q 0 0 0 rg BT 356.43 413.25 Td (duty ) Tj ET Q q 0 0 0 rg BT 377.46 413.25 Td (surrounding ) Tj ET Q q 0 0 0 rg BT 429.04 413.25 Td (the ) Tj ET Q q 0 0 0 rg BT 444.51 413.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 486.18 413.25 Td (s ) Tj ET Q q 0 0 0 rg BT 493.32 413.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 538.79 413.25 Td (disclosed ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.25 Td (October ) Tj ET Q q 0 0 0 rg BT 70.12 401.25 Td (2015 ) Tj ET Q q 0 0 0 rg BT 92.03 401.25 Td (civil ) Tj ET Q q 0 0 0 rg BT 111.72 401.25 Td (settlement ) Tj ET Q q 0 0 0 rg BT 154.73 401.25 Td (with ) Tj ET Q q 0 0 0 rg BT 174.42 401.25 Td (the ) Tj ET Q q 0 0 0 rg BT 188.55 401.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 229.90 401.25 Td (and ) Tj ET Q q 0 0 0 rg BT 246.25 401.25 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 287.59 401.25 Td (Commission ) Tj ET Q q 0 0 0 rg BT 340.07 401.25 Td (of ) Tj ET Q q 0 0 0 rg BT 350.31 401.25 Td (alleged ) Tj ET Q q 0 0 0 rg BT 381.10 401.25 Td (Foreign ) Tj ET Q q 0 0 0 rg BT 414.12 401.25 Td (Corrupt ) Tj ET Q q 0 0 0 rg BT 447.14 401.25 Td (Practices ) Tj ET Q q 0 0 0 rg BT 484.72 401.25 Td (Act ) Tj ET Q q 0 0 0 rg BT 501.07 401.25 Td (violations ) Tj ET Q q 0 0 0 rg BT 542.43 401.25 Td (in ) Tj ET Q q 0 0 0 rg BT 552.12 401.25 Td (China ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 389.25 Td (in ) Tj ET Q q 0 0 0 rg BT 46.68 389.25 Td (which ) Tj ET Q q 0 0 0 rg BT 74.03 389.25 Td (the ) Tj ET Q q 0 0 0 rg BT 89.15 389.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 130.94 389.25 Td (agreed ) Tj ET Q q 0 0 0 rg BT 160.49 389.25 Td (to ) Tj ET Q q 0 0 0 rg BT 171.17 389.25 Td (a ) Tj ET Q q 0 0 0 rg BT 178.51 389.25 Td (payment ) Tj ET Q q 0 0 0 rg BT 215.85 389.25 Td (of ) Tj ET Q q 0 0 0 rg BT 227.08 389.25 Td (approximately ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 287.75 389.25 Td ($14.7 ) Tj ET Q q 0 0 0 rg BT 313.15 389.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.04 389.25 Td ( ) Tj ET Q q 0 0 0 rg BT 344.95 389.25 Td (in ) Tj ET Q q 0 0 0 rg BT 355.63 389.25 Td (disgor) Tj ET Q q 0 0 0 rg BT 380.45 389.25 Td (gement, ) Tj ET Q q 0 0 0 rg BT 415.29 389.25 Td (penalties ) Tj ET Q q 0 0 0 rg BT 453.73 389.25 Td (and ) Tj ET Q q 0 0 0 rg BT 471.08 389.25 Td (interest. ) Tj ET Q q 0 0 0 rg BT 505.92 389.25 Td (In ) Tj ET Q q 0 0 0 rg BT 517.15 389.25 Td (May ) Tj ET Q q 0 0 0 rg BT 538.38 389.25 Td (2016, ) Tj ET Q q 0 0 0 rg BT 563.79 389.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 377.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.39 377.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 98.21 377.25 Td (motions ) Tj ET Q q 0 0 0 rg BT 132.94 377.25 Td (to ) Tj ET Q q 0 0 0 rg BT 143.22 377.25 Td (dismiss ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 175.73 377.25 Td (two) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 190.73 377.25 Td ( ) Tj ET Q q 0 0 0 rg BT 193.23 377.25 Td (of ) Tj ET Q q 0 0 0 rg BT 204.06 377.25 Td (the ) Tj ET Q q 0 0 0 rg BT 218.77 377.25 Td (shareholder ) Tj ET Q q 0 0 0 rg BT 267.92 377.25 Td (derivative ) Tj ET Q q 0 0 0 rg BT 310.40 377.25 Td (lawsuits.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 353.25 Td (GOVERNMENT) Tj ET Q q 0 0 0 rg BT 109.71 353.25 Td ( ) Tj ET Q q 0 0 0 rg BT 112.21 353.25 Td (INVESTIGA) Tj ET Q q 0 0 0 rg BT 167.60 353.25 Td (TIONS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 335.25 Td (Like ) Tj ET Q q 0 0 0 rg BT 56.96 335.25 Td (other ) Tj ET Q q 0 0 0 rg BT 80.14 335.25 Td (pharmaceutical ) Tj ET Q q 0 0 0 rg BT 143.85 335.25 Td (companies, ) Tj ET Q q 0 0 0 rg BT 191.74 335.25 Td (the ) Tj ET Q q 0 0 0 rg BT 206.59 335.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 248.11 335.25 Td (and ) Tj ET Q q 0 0 0 rg BT 265.19 335.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 295.02 335.25 Td (of ) Tj ET Q q 0 0 0 rg BT 305.98 335.25 Td (its ) Tj ET Q q 0 0 0 rg BT 318.07 335.25 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 367.92 335.25 Td (are ) Tj ET Q q 0 0 0 rg BT 382.76 335.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 413.71 335.25 Td (to ) Tj ET Q q 0 0 0 rg BT 424.13 335.25 Td (extensive ) Tj ET Q q 0 0 0 rg BT 464.52 335.25 Td (regulation ) Tj ET Q q 0 0 0 rg BT 507.70 335.25 Td (by ) Tj ET Q q 0 0 0 rg BT 520.33 335.25 Td (national, ) Tj ET Q q 0 0 0 rg BT 557.68 335.25 Td (state ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 323.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.08 323.25 Td (local ) Tj ET Q q 0 0 0 rg BT 75.16 323.25 Td (government ) Tj ET Q q 0 0 0 rg BT 125.57 323.25 Td (agencies ) Tj ET Q q 0 0 0 rg BT 162.64 323.25 Td (in ) Tj ET Q q 0 0 0 rg BT 173.06 323.25 Td (the ) Tj ET Q q 0 0 0 rg BT 187.92 323.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 208.35 323.25 Td (and ) Tj ET Q q 0 0 0 rg BT 225.43 323.25 Td (other ) Tj ET Q q 0 0 0 rg BT 248.62 323.25 Td (countries ) Tj ET Q q 0 0 0 rg BT 287.92 323.25 Td (in ) Tj ET Q q 0 0 0 rg BT 298.34 323.25 Td (which ) Tj ET Q q 0 0 0 rg BT 325.42 323.25 Td (BMS ) Tj ET Q q 0 0 0 rg BT 349.19 323.25 Td (operates. ) Tj ET Q q 0 0 0 rg BT 387.07 323.25 Td (As ) Tj ET Q q 0 0 0 rg BT 400.82 323.25 Td (a ) Tj ET Q q 0 0 0 rg BT 407.91 323.25 Td (result, ) Tj ET Q q 0 0 0 rg BT 435.27 323.25 Td (the ) Tj ET Q q 0 0 0 rg BT 450.13 323.25 Td (Company) Tj ET Q q 0 0 0 rg BT 488.37 323.25 Td (, ) Tj ET Q q 0 0 0 rg BT 493.51 323.25 Td (from ) Tj ET Q q 0 0 0 rg BT 515.59 323.25 Td (time ) Tj ET Q q 0 0 0 rg BT 536.01 323.25 Td (to ) Tj ET Q q 0 0 0 rg BT 546.43 323.25 Td (time, ) Tj ET Q q 0 0 0 rg BT 569.35 323.25 Td (is ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 311.25 Td (subject ) Tj ET Q q 0 0 0 rg BT 66.78 311.25 Td (to ) Tj ET Q q 0 0 0 rg BT 77.01 311.25 Td (various ) Tj ET Q q 0 0 0 rg BT 108.90 311.25 Td (governmental ) Tj ET Q q 0 0 0 rg BT 166.33 311.25 Td (inquiries ) Tj ET Q q 0 0 0 rg BT 203.78 311.25 Td (and ) Tj ET Q q 0 0 0 rg BT 220.67 311.25 Td (investigations. ) Tj ET Q q 0 0 0 rg BT 281.18 311.25 Td (It ) Tj ET Q q 0 0 0 rg BT 289.74 311.25 Td (is ) Tj ET Q q 0 0 0 rg BT 298.86 311.25 Td (possible ) Tj ET Q q 0 0 0 rg BT 334.09 311.25 Td (that ) Tj ET Q q 0 0 0 rg BT 351.54 311.25 Td (criminal ) Tj ET Q q 0 0 0 rg BT 387.31 311.25 Td (char) Tj ET Q q 0 0 0 rg BT 404.34 311.25 Td (ges, ) Tj ET Q q 0 0 0 rg BT 422.62 311.25 Td (substantial ) Tj ET Q q 0 0 0 rg BT 467.85 311.25 Td (fines ) Tj ET Q q 0 0 0 rg BT 489.74 311.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 517.74 311.25 Td (civil ) Tj ET Q q 0 0 0 rg BT 537.96 311.25 Td (penalties, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 299.25 Td (could ) Tj ET Q q 0 0 0 rg BT 62.02 299.25 Td (result ) Tj ET Q q 0 0 0 rg BT 88.04 299.25 Td (from ) Tj ET Q q 0 0 0 rg BT 111.28 299.25 Td (government ) Tj ET Q q 0 0 0 rg BT 162.85 299.25 Td (investigations. ) Tj ET Q q 0 0 0 rg BT 224.43 299.25 Td (The ) Tj ET Q q 0 0 0 rg BT 243.78 299.25 Td (most ) Tj ET Q q 0 0 0 rg BT 267.04 299.25 Td (significant ) Tj ET Q q 0 0 0 rg BT 313.05 299.25 Td (investigations ) Tj ET Q q 0 0 0 rg BT 372.41 299.25 Td (conducted ) Tj ET Q q 0 0 0 rg BT 417.31 299.25 Td (by ) Tj ET Q q 0 0 0 rg BT 431.11 299.25 Td (government ) Tj ET Q q 0 0 0 rg BT 482.68 299.25 Td (agencies, ) Tj ET Q q 0 0 0 rg BT 523.41 299.25 Td (of ) Tj ET Q q 0 0 0 rg BT 535.54 299.25 Td (which ) Tj ET Q q 0 0 0 rg BT 563.78 299.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 287.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.39 287.25 Td (is ) Tj ET Q q 0 0 0 rg BT 86.56 287.25 Td (aware, ) Tj ET Q q 0 0 0 rg BT 115.42 287.25 Td (are ) Tj ET Q q 0 0 0 rg BT 130.13 287.25 Td (listed ) Tj ET Q q 0 0 0 rg BT 154.30 287.25 Td (below) Tj ET Q q 0 0 0 rg BT 178.08 287.25 Td (.) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 36.00 266.25 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.77 266.25 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 71.27 266.25 Td (State ) Tj ET Q q 0 0 0 rg BT 94.88 266.25 Td (Attorneys ) Tj ET Q q 0 0 0 rg BT 139.59 266.25 Td (General ) Tj ET Q q 0 0 0 rg BT 176.53 266.25 Td (Investigation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 248.25 Td (In ) Tj ET Q q 0 0 0 rg BT 46.23 248.25 Td (March ) Tj ET Q q 0 0 0 rg BT 74.23 248.25 Td (2009, ) Tj ET Q q 0 0 0 rg BT 98.62 248.25 Td (the ) Tj ET Q q 0 0 0 rg BT 112.74 248.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 153.52 248.25 Td (received ) Tj ET Q q 0 0 0 rg BT 189.29 248.25 Td (a ) Tj ET Q q 0 0 0 rg BT 195.62 248.25 Td (letter ) Tj ET Q q 0 0 0 rg BT 218.06 248.25 Td (from ) Tj ET Q q 0 0 0 rg BT 239.40 248.25 Td (the ) Tj ET Q q 0 0 0 rg BT 253.51 248.25 Td (Delaware ) Tj ET Q q 0 0 0 rg BT 293.30 248.25 Td (Attorney ) Tj ET Q q 0 0 0 rg BT 330.75 248.25 Td (General’) Tj ET Q q 0 0 0 rg BT 365.17 248.25 Td (s ) Tj ET Q q 0 0 0 rg BT 370.96 248.25 Td (Of) Tj ET Q q 0 0 0 rg BT 381.33 248.25 Td (fice ) Tj ET Q q 0 0 0 rg BT 398.21 248.25 Td (advising ) Tj ET Q q 0 0 0 rg BT 434.00 248.25 Td (of ) Tj ET Q q 0 0 0 rg BT 444.23 248.25 Td (a ) Tj ET Q q 0 0 0 rg BT 450.56 248.25 Td (multi-state ) Tj ET Q q 0 0 0 rg BT 495.23 248.25 Td (coalition ) Tj ET Q q 0 0 0 rg BT 532.12 248.25 Td (\(Coalition\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 236.25 Td (investigating ) Tj ET Q q 0 0 0 rg BT 90.26 236.25 Td (whether ) Tj ET Q q 0 0 0 rg BT 125.07 236.25 Td (certain ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 154.87 236.25 Td (Abilify*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 186.53 236.25 Td ( ) Tj ET Q q 0 0 0 rg BT 189.13 236.25 Td (marketing ) Tj ET Q q 0 0 0 rg BT 232.27 236.25 Td (practices ) Tj ET Q q 0 0 0 rg BT 270.40 236.25 Td (violated ) Tj ET Q q 0 0 0 rg BT 305.21 236.25 Td (those ) Tj ET Q q 0 0 0 rg BT 328.92 236.25 Td (respective ) Tj ET Q q 0 0 0 rg BT 372.05 236.25 Td (states’) Tj ET Q q 0 0 0 rg BT 396.85 236.25 Td ( ) Tj ET Q q 0 0 0 rg BT 399.45 236.25 Td (consumer ) Tj ET Q q 0 0 0 rg BT 440.93 236.25 Td (protection ) Tj ET Q q 0 0 0 rg BT 484.07 236.25 Td (statutes. ) Tj ET Q q 0 0 0 rg BT 518.98 236.25 Td (The ) Tj ET Q q 0 0 0 rg BT 537.12 236.25 Td (Company ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 224.25 Td (and ) Tj ET Q q 0 0 0 rg BT 53.06 224.25 Td (the ) Tj ET Q q 0 0 0 rg BT 67.90 224.25 Td (Executive ) Tj ET Q q 0 0 0 rg BT 110.50 224.25 Td (Committee ) Tj ET Q q 0 0 0 rg BT 157.56 224.25 Td (of ) Tj ET Q q 0 0 0 rg BT 168.51 224.25 Td (the ) Tj ET Q q 0 0 0 rg BT 183.35 224.25 Td (Coalition ) Tj ET Q q 0 0 0 rg BT 223.20 224.25 Td (have ) Tj ET Q q 0 0 0 rg BT 244.70 224.25 Td (reached ) Tj ET Q q 0 0 0 rg BT 278.40 224.25 Td (a ) Tj ET Q q 0 0 0 rg BT 285.46 224.25 Td (settlement ) Tj ET Q q 0 0 0 rg BT 329.18 224.25 Td (in ) Tj ET Q q 0 0 0 rg BT 339.58 224.25 Td (this ) Tj ET Q q 0 0 0 rg BT 356.65 224.25 Td (matter) Tj ET Q q 0 0 0 rg BT 381.80 224.25 Td (, ) Tj ET Q q 0 0 0 rg BT 386.92 224.25 Td (and ) Tj ET Q q 0 0 0 rg BT 403.98 224.25 Td (all ) Tj ET Q q 0 0 0 rg BT 416.60 224.25 Td (but ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.00 224.25 Td (one) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 446.43 224.25 Td ( ) Tj ET Q q 0 0 0 rg BT 449.06 224.25 Td (of ) Tj ET Q q 0 0 0 rg BT 460.01 224.25 Td (the ) Tj ET Q q 0 0 0 rg BT 474.85 224.25 Td (states ) Tj ET Q q 0 0 0 rg BT 499.69 224.25 Td (\(New ) Tj ET Q q 0 0 0 rg BT 524.52 224.25 Td (Mexico\) ) Tj ET Q q 0 0 0 rg BT 561.02 224.25 Td (that ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 212.25 Td (are ) Tj ET Q q 0 0 0 rg BT 49.73 212.25 Td (members ) Tj ET Q q 0 0 0 rg BT 87.91 212.25 Td (of ) Tj ET Q q 0 0 0 rg BT 97.77 212.25 Td (the ) Tj ET Q q 0 0 0 rg BT 111.51 212.25 Td (Coalition ) Tj ET Q q 0 0 0 rg BT 150.26 212.25 Td (are ) Tj ET Q q 0 0 0 rg BT 163.99 212.25 Td (participating ) Tj ET Q q 0 0 0 rg BT 216.05 212.25 Td (in ) Tj ET Q q 0 0 0 rg BT 225.35 212.25 Td (the ) Tj ET Q q 0 0 0 rg BT 239.09 212.25 Td (settlement. ) Tj ET Q q 0 0 0 rg BT 284.22 212.25 Td (Consent ) Tj ET Q q 0 0 0 rg BT 318.52 212.25 Td (decrees ) Tj ET Q q 0 0 0 rg BT 350.02 212.25 Td (were ) Tj ET Q q 0 0 0 rg BT 370.98 212.25 Td (entered ) Tj ET Q q 0 0 0 rg BT 401.92 212.25 Td (into ) Tj ET Q q 0 0 0 rg BT 419.01 212.25 Td (with ) Tj ET Q q 0 0 0 rg BT 438.31 212.25 Td (all ) Tj ET Q q 0 0 0 rg BT 449.83 212.25 Td (participating ) Tj ET Q q 0 0 0 rg BT 501.89 212.25 Td (states ) Tj ET Q q 0 0 0 rg BT 525.63 212.25 Td (in ) Tj ET Q q 0 0 0 rg BT 534.94 212.25 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 200.25 Td (2016.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 176.25 Td (ENVIRONMENT) Tj ET Q q 0 0 0 rg BT 112.48 176.25 Td (AL) Tj ET Q q 0 0 0 rg BT 125.82 176.25 Td ( PROCEEDINGS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 158.25 Td (As ) Tj ET Q q 0 0 0 rg BT 49.23 158.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 93.56 158.25 Td (reported, ) Tj ET Q q 0 0 0 rg BT 131.49 158.25 Td (the ) Tj ET Q q 0 0 0 rg BT 145.82 158.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 186.82 158.25 Td (is ) Tj ET Q q 0 0 0 rg BT 195.60 158.25 Td (a ) Tj ET Q q 0 0 0 rg BT 202.15 158.25 Td (party ) Tj ET Q q 0 0 0 rg BT 224.81 158.25 Td (to ) Tj ET Q q 0 0 0 rg BT 234.70 158.25 Td (several ) Tj ET Q q 0 0 0 rg BT 265.13 158.25 Td (environmental ) Tj ET Q q 0 0 0 rg BT 325.00 158.25 Td (proceedings ) Tj ET Q q 0 0 0 rg BT 375.43 158.25 Td (and ) Tj ET Q q 0 0 0 rg BT 391.98 158.25 Td (other ) Tj ET Q q 0 0 0 rg BT 414.64 158.25 Td (matters, ) Tj ET Q q 0 0 0 rg BT 448.69 158.25 Td (and ) Tj ET Q q 0 0 0 rg BT 465.24 158.25 Td (is ) Tj ET Q q 0 0 0 rg BT 474.03 158.25 Td (responsible ) Tj ET Q q 0 0 0 rg BT 521.69 158.25 Td (under ) Tj ET Q q 0 0 0 rg BT 546.57 158.25 Td (various ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 146.25 Td (state, ) Tj ET Q q 0 0 0 rg BT 59.56 146.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 90.05 146.25 Td (and ) Tj ET Q q 0 0 0 rg BT 107.23 146.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 138.84 146.25 Td (laws, ) Tj ET Q q 0 0 0 rg BT 162.40 146.25 Td (including ) Tj ET Q q 0 0 0 rg BT 202.91 146.25 Td (CERCLA, ) Tj ET Q q 0 0 0 rg BT 247.60 146.25 Td (for ) Tj ET Q q 0 0 0 rg BT 261.99 146.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 291.93 146.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 314.67 146.25 Td (of ) Tj ET Q q 0 0 0 rg BT 325.73 146.25 Td (investigating ) Tj ET Q q 0 0 0 rg BT 380.13 146.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 408.41 146.25 Td (remediating ) Tj ET Q q 0 0 0 rg BT 458.91 146.25 Td (contamination ) Tj ET Q q 0 0 0 rg BT 518.85 146.25 Td (resulting ) Tj ET Q q 0 0 0 rg BT 556.58 146.25 Td (from ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 134.25 Td (past ) Tj ET Q q 0 0 0 rg BT 54.61 134.25 Td (industrial ) Tj ET Q q 0 0 0 rg BT 94.88 134.25 Td (activity ) Tj ET Q q 0 0 0 rg BT 127.37 134.25 Td (at ) Tj ET Q q 0 0 0 rg BT 137.09 134.25 Td (the ) Tj ET Q q 0 0 0 rg BT 151.81 134.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 193.47 134.25 Td (s ) Tj ET Q q 0 0 0 rg BT 199.86 134.25 Td (current ) Tj ET Q q 0 0 0 rg BT 230.68 134.25 Td (or ) Tj ET Q q 0 0 0 rg BT 241.51 134.25 Td (former ) Tj ET Q q 0 0 0 rg BT 271.21 134.25 Td (sites ) Tj ET Q q 0 0 0 rg BT 291.49 134.25 Td (or ) Tj ET Q q 0 0 0 rg BT 302.32 134.25 Td (at ) Tj ET Q q 0 0 0 rg BT 312.04 134.25 Td (waste ) Tj ET Q q 0 0 0 rg BT 337.31 134.25 Td (disposal ) Tj ET Q q 0 0 0 rg BT 372.59 134.25 Td (or ) Tj ET Q q 0 0 0 rg BT 383.42 134.25 Td (reprocessing ) Tj ET Q q 0 0 0 rg BT 436.45 134.25 Td (facilities ) Tj ET Q q 0 0 0 rg BT 473.38 134.25 Td (operated ) Tj ET Q q 0 0 0 rg BT 510.31 134.25 Td (by ) Tj ET Q q 0 0 0 rg BT 522.81 134.25 Td (third ) Tj ET Q q 0 0 0 rg BT 544.19 134.25 Td (parties.) Tj ET Q endstream endobj 197 0 obj <> endobj 198 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (98) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (CERCLA) Tj ET Q q 0 0 0 rg BT 77.67 749.25 Td ( Matters) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 731.25 Td (W) Tj ET Q q 0 0 0 rg BT 45.04 731.25 Td (ith ) Tj ET Q q 0 0 0 rg BT 58.78 731.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 90.28 731.25 Td (to ) Tj ET Q q 0 0 0 rg BT 101.25 731.25 Td (CERCLA) Tj ET Q q 0 0 0 rg BT 140.14 731.25 Td ( ) Tj ET Q q 0 0 0 rg BT 143.33 731.25 Td (matters ) Tj ET Q q 0 0 0 rg BT 175.95 731.25 Td (for ) Tj ET Q q 0 0 0 rg BT 190.79 731.25 Td (which ) Tj ET Q q 0 0 0 rg BT 218.42 731.25 Td (the ) Tj ET Q q 0 0 0 rg BT 233.82 731.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 275.90 731.25 Td (is ) Tj ET Q q 0 0 0 rg BT 285.75 731.25 Td (responsible ) Tj ET Q q 0 0 0 rg BT 334.48 731.25 Td (under ) Tj ET Q q 0 0 0 rg BT 360.44 731.25 Td (various ) Tj ET Q q 0 0 0 rg BT 393.06 731.25 Td (state, ) Tj ET Q q 0 0 0 rg BT 417.07 731.25 Td (federal ) Tj ET Q q 0 0 0 rg BT 448.01 731.25 Td (and ) Tj ET Q q 0 0 0 rg BT 465.64 731.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 497.70 731.25 Td (laws, ) Tj ET Q q 0 0 0 rg BT 521.72 731.25 Td (the ) Tj ET Q q 0 0 0 rg BT 537.12 731.25 Td (Company ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 719.25 Td (typically ) Tj ET Q q 0 0 0 rg BT 73.73 719.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 113.69 719.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 151.42 719.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 174.17 719.25 Td (based ) Tj ET Q q 0 0 0 rg BT 199.68 719.25 Td (on ) Tj ET Q q 0 0 0 rg BT 212.42 719.25 Td (information ) Tj ET Q q 0 0 0 rg BT 262.38 719.25 Td (obtained ) Tj ET Q q 0 0 0 rg BT 299.55 719.25 Td (from ) Tj ET Q q 0 0 0 rg BT 321.73 719.25 Td (the ) Tj ET Q q 0 0 0 rg BT 336.69 719.25 Td (U.S. ) Tj ET Q q 0 0 0 rg BT 357.22 719.25 Td (Environmental ) Tj ET Q q 0 0 0 rg BT 419.39 719.25 Td (Protection ) Tj ET Q q 0 0 0 rg BT 462.63 719.25 Td (Agency) Tj ET Q q 0 0 0 rg BT 493.08 719.25 Td (, ) Tj ET Q q 0 0 0 rg BT 498.33 719.25 Td (or ) Tj ET Q q 0 0 0 rg BT 509.40 719.25 Td (counterpart ) Tj ET Q q 0 0 0 rg BT 557.67 719.25 Td (state ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 707.25 Td (or ) Tj ET Q q 0 0 0 rg BT 47.16 707.25 Td (foreign ) Tj ET Q q 0 0 0 rg BT 78.87 707.25 Td (agency ) Tj ET Q q 0 0 0 rg BT 110.02 707.25 Td (and/or ) Tj ET Q q 0 0 0 rg BT 138.39 707.25 Td (studies ) Tj ET Q q 0 0 0 rg BT 169.00 707.25 Td (prepared ) Tj ET Q q 0 0 0 rg BT 206.81 707.25 Td (by ) Tj ET Q q 0 0 0 rg BT 219.64 707.25 Td (independent ) Tj ET Q q 0 0 0 rg BT 271.34 707.25 Td (consultants, ) Tj ET Q q 0 0 0 rg BT 321.67 707.25 Td (including ) Tj ET Q q 0 0 0 rg BT 362.27 707.25 Td (the ) Tj ET Q q 0 0 0 rg BT 377.32 707.25 Td (total ) Tj ET Q q 0 0 0 rg BT 397.93 707.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 439.08 707.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 461.91 707.25 Td (for ) Tj ET Q q 0 0 0 rg BT 476.40 707.25 Td (the ) Tj ET Q q 0 0 0 rg BT 491.45 707.25 Td (site ) Tj ET Q q 0 0 0 rg BT 508.17 707.25 Td (and ) Tj ET Q q 0 0 0 rg BT 525.44 707.25 Td (the ) Tj ET Q q 0 0 0 rg BT 540.48 707.25 Td (expected ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 695.25 Td (cost-sharing, ) Tj ET Q q 0 0 0 rg BT 88.77 695.25 Td (if ) Tj ET Q q 0 0 0 rg BT 96.26 695.25 Td (any) Tj ET Q q 0 0 0 rg BT 110.05 695.25 Td (, ) Tj ET Q q 0 0 0 rg BT 113.94 695.25 Td (with ) Tj ET Q q 0 0 0 rg BT 133.11 695.25 Td (other ) Tj ET Q q 0 0 0 rg BT 155.05 695.25 Td (“potentially ) Tj ET Q q 0 0 0 rg BT 203.64 695.25 Td (responsible ) Tj ET Q q 0 0 0 rg BT 250.58 695.25 Td (parties,” ) Tj ET Q q 0 0 0 rg BT 285.56 695.25 Td (and ) Tj ET Q q 0 0 0 rg BT 301.39 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 314.99 695.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 355.27 695.25 Td (accrues ) Tj ET Q q 0 0 0 rg BT 386.63 695.25 Td (liabilities ) Tj ET Q q 0 0 0 rg BT 425.24 695.25 Td (when ) Tj ET Q q 0 0 0 rg BT 448.29 695.25 Td (they ) Tj ET Q q 0 0 0 rg BT 466.90 695.25 Td (are ) Tj ET Q q 0 0 0 rg BT 480.49 695.25 Td (probable ) Tj ET Q q 0 0 0 rg BT 516.87 695.25 Td (and ) Tj ET Q q 0 0 0 rg BT 532.69 695.25 Td (reasonably ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 683.25 Td (estimable. ) Tj ET Q q 0 0 0 rg BT 79.02 683.25 Td (The ) Tj ET Q q 0 0 0 rg BT 96.94 683.25 Td (Company ) Tj ET Q q 0 0 0 rg BT 138.19 683.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 178.88 683.25 Td (its ) Tj ET Q q 0 0 0 rg BT 190.70 683.25 Td (share ) Tj ET Q q 0 0 0 rg BT 214.17 683.25 Td (of ) Tj ET Q q 0 0 0 rg BT 224.87 683.25 Td (future ) Tj ET Q q 0 0 0 rg BT 251.11 683.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 273.48 683.25 Td (for ) Tj ET Q q 0 0 0 rg BT 287.51 683.25 Td (these ) Tj ET Q q 0 0 0 rg BT 310.43 683.25 Td (sites ) Tj ET Q q 0 0 0 rg BT 330.58 683.25 Td (to ) Tj ET Q q 0 0 0 rg BT 340.73 683.25 Td (be ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.53 683.25 Td ($62 ) Tj ET Q q 0 0 0 rg BT 369.90 683.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 398.79 683.25 Td ( ) Tj ET Q q 0 0 0 rg BT 401.16 683.25 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 410.75 683.25 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 469.20 683.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 489.20 683.25 Td (, ) Tj ET Q q 0 0 0 rg BT 494.07 683.25 Td (which ) Tj ET Q q 0 0 0 rg BT 520.88 683.25 Td (represents ) Tj ET Q q 0 0 0 rg BT 563.79 683.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 671.25 Td (sum ) Tj ET Q q 0 0 0 rg BT 55.32 671.25 Td (of ) Tj ET Q q 0 0 0 rg BT 66.31 671.25 Td (best ) Tj ET Q q 0 0 0 rg BT 85.07 671.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 124.93 671.25 Td (or) Tj ET Q q 0 0 0 rg BT 132.86 671.25 Td (, ) Tj ET Q q 0 0 0 rg BT 138.01 671.25 Td (where ) Tj ET Q q 0 0 0 rg BT 165.10 671.25 Td (no ) Tj ET Q q 0 0 0 rg BT 177.75 671.25 Td (best ) Tj ET Q q 0 0 0 rg BT 196.51 671.25 Td (estimate ) Tj ET Q q 0 0 0 rg BT 232.48 671.25 Td (can ) Tj ET Q q 0 0 0 rg BT 249.01 671.25 Td (reasonably ) Tj ET Q q 0 0 0 rg BT 294.98 671.25 Td (be ) Tj ET Q q 0 0 0 rg BT 307.07 671.25 Td (made, ) Tj ET Q q 0 0 0 rg BT 333.88 671.25 Td (estimates ) Tj ET Q q 0 0 0 rg BT 373.75 671.25 Td (of ) Tj ET Q q 0 0 0 rg BT 384.73 671.25 Td (the ) Tj ET Q q 0 0 0 rg BT 399.60 671.25 Td (minimal ) Tj ET Q q 0 0 0 rg BT 435.58 671.25 Td (probable ) Tj ET Q q 0 0 0 rg BT 473.22 671.25 Td (amount ) Tj ET Q q 0 0 0 rg BT 505.87 671.25 Td (among ) Tj ET Q q 0 0 0 rg BT 535.74 671.25 Td (a ) Tj ET Q q 0 0 0 rg BT 542.83 671.25 Td (range ) Tj ET Q q 0 0 0 rg BT 567.69 671.25 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 659.25 Td (such ) Tj ET Q q 0 0 0 rg BT 56.53 659.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 78.72 659.25 Td (\(without ) Tj ET Q q 0 0 0 rg BT 114.81 659.25 Td (taking ) Tj ET Q q 0 0 0 rg BT 142.00 659.25 Td (into ) Tj ET Q q 0 0 0 rg BT 159.75 659.25 Td (account ) Tj ET Q q 0 0 0 rg BT 193.04 659.25 Td (any ) Tj ET Q q 0 0 0 rg BT 209.67 659.25 Td (potential ) Tj ET Q q 0 0 0 rg BT 246.86 659.25 Td (recoveries ) Tj ET Q q 0 0 0 rg BT 290.14 659.25 Td (from ) Tj ET Q q 0 0 0 rg BT 311.78 659.25 Td (other ) Tj ET Q q 0 0 0 rg BT 334.52 659.25 Td (parties\). ) Tj ET Q q 0 0 0 rg BT 369.04 659.25 Td (The ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 386.79 659.25 Td ($62 ) Tj ET Q q 0 0 0 rg BT 403.98 659.25 Td (million) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 432.87 659.25 Td ( ) Tj ET Q q 0 0 0 rg BT 435.07 659.25 Td (includes ) Tj ET Q q 0 0 0 rg BT 470.59 659.25 Td (the ) Tj ET Q q 0 0 0 rg BT 485.00 659.25 Td (estimated ) Tj ET Q q 0 0 0 rg BT 525.52 659.25 Td (costs ) Tj ET Q q 0 0 0 rg BT 547.72 659.25 Td (for ) Tj ET Q q 0 0 0 rg BT 561.57 659.25 Td (any ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 647.25 Td (additional ) Tj ET Q q 0 0 0 rg BT 78.49 647.25 Td (probable ) Tj ET Q q 0 0 0 rg BT 115.98 647.25 Td (loss ) Tj ET Q q 0 0 0 rg BT 134.04 647.25 Td (associated ) Tj ET Q q 0 0 0 rg BT 177.63 647.25 Td (with ) Tj ET Q q 0 0 0 rg BT 197.91 647.25 Td (the ) Tj ET Q q 0 0 0 rg BT 212.63 647.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 257.34 647.25 Td (disclosed ) Tj ET Q q 0 0 0 rg BT 297.06 647.25 Td (North ) Tj ET Q q 0 0 0 rg BT 322.89 647.25 Td (Brunswick ) Tj ET Q q 0 0 0 rg BT 368.54 647.25 Td (T) Tj ET Q q 0 0 0 rg BT 373.95 647.25 Td (ownship ) Tj ET Q q 0 0 0 rg BT 410.34 647.25 Td (High ) Tj ET Q q 0 0 0 rg BT 432.84 647.25 Td (School ) Tj ET Q q 0 0 0 rg BT 463.12 647.25 Td (Remediation ) Tj ET Q q 0 0 0 rg BT 516.72 647.25 Td (Site.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 621.25 Td (Note ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 58.49 621.25 Td (19) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 68.49 621.25 Td (. SELECTED QUAR) Tj ET Q q 0 0 0 rg BT 158.44 621.25 Td (TERL) Tj ET Q q 0 0 0 rg BT 184.75 621.25 Td (Y) Tj ET Q q 0 0 0 rg BT 191.60 621.25 Td ( FINANCIAL) Tj ET Q q 0 0 0 rg BT 250.22 621.25 Td ( DA) Tj ET Q q 0 0 0 rg BT 266.42 621.25 Td (T) Tj ET Q q 0 0 0 rg BT 272.35 621.25 Td (A) Tj ET Q q 0 0 0 rg BT 279.02 621.25 Td ( \(UNAUDITED\)) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 597.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 597.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 597.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 597.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 597.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 597.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 597.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 571.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 571.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 571.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 571.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 571.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 571.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 571.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 571.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 571.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 571.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 571.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 545.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 545.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 545.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 545.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 545.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 545.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 545.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 545.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 545.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 545.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 545.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 519.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 519.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 519.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 519.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 519.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 519.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 519.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 519.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 519.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 519.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 519.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 493.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 493.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 493.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 493.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 493.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 493.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 493.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 463.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 463.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 463.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 463.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 463.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 463.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 463.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 463.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 463.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 463.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 463.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 437.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 437.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 437.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 437.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 437.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 437.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 437.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 437.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 437.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 437.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 437.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 411.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 411.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 411.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 411.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 411.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 411.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 411.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 411.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 411.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 411.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 411.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 383.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 383.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 383.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 383.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 383.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 383.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 383.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 383.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 383.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 383.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 383.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 329.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 329.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 329.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 329.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 329.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 329.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 329.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 329.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 329.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 329.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 329.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 303.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 303.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 303.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 303.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 303.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 303.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 303.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 303.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 303.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 303.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 303.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 277.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 277.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 277.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 277.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 277.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 277.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 277.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 277.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 277.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 277.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 277.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 251.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 251.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 251.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 251.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 251.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 251.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 251.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 251.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 251.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 251.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 251.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 225.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 225.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 225.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 225.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 225.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 225.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 225.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 225.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 225.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 225.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 225.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 195.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 195.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 195.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 195.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 195.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 195.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 195.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 195.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 195.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 195.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 195.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 169.75 186.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 169.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 169.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 169.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 169.75 66.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 169.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 169.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 169.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 169.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 169.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 169.75 67.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 143.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 143.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 143.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 143.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 143.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 143.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 143.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 143.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 143.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 143.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 143.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 115.75 186.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 222.50 115.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 226.50 115.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 293.50 115.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 297.50 115.75 66.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 363.50 115.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 367.50 115.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 434.50 115.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 438.50 115.75 67.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 505.50 115.75 4.00 -15.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 509.50 115.75 67.00 -15.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 226.5 597.75 m 293.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 297.5 597.75 m 363.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 597.75 m 434.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 438.5 597.75 m 505.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 509.5 597.75 m 576.5 597.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 226.5 329.75 m 293.5 329.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 297.5 329.75 m 363.5 329.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 367.5 329.75 m 434.5 329.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 438.5 329.75 m 505.5 329.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 509.5 329.75 m 576.5 329.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 602.00 Td (Dollars in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 236.35 601.98 Td (First Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 302.85 601.98 Td (Second Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 375.55 601.98 Td (Third Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.55 601.98 Td (Fourth Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 534.55 601.98 Td (Year) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 39 586.91259765625 m 59 586.91259765625 l s q 0 0 0 rg BT 39.00 588.48 Td (2016) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 229.00 589.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 300.00 589.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 370.00 589.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 441.00 589.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 512.00 589.00 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 575.32 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 575.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 575.32 Td (4,391) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 575.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 575.32 Td (4,871) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 575.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 575.32 Td (4,922) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 575.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 575.32 Td (5,243) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 575.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 575.32 Td (19,427) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 562.32 Td (Gross Margin) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 562.32 Td (3,339) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 562.32 Td (3,665) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 562.32 Td (3,617) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 562.32 Td (3,860) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 562.32 Td (14,481) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 549.32 Td (Net Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 549.32 Td (1,206) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 549.32 Td (1,188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 549.32 Td (1,215) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.65 549.32 Td (898) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 549.32 Td (4,507) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 536.32 Td (Net Earnings Attributable to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 523.32 Td (Noncontrolling Interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.65 523.32 Td (11) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 349.65 523.32 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 523.32 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.65 523.32 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 523.32 Td (50) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 510.32 Td (BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 510.32 Td (1,195) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 510.32 Td (1,166) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 510.32 Td (1,202) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 486.65 510.32 Td (894) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 510.32 Td (4,457) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 483.42 Td (Earnings per Share - Basic) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 145.63 487.95 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 483.42 Td (0.72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.15 483.42 Td (0.70) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 483.42 Td (0.72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 483.42 Td (0.53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 483.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 483.42 Td (2.67) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 468.42 Td (Earnings per Share - Diluted) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 153.41 472.95 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 468.42 Td (0.71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.15 468.42 Td (0.69) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 468.42 Td (0.72) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 468.42 Td (0.53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 468.42 Td (2.65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 441.32 Td (Cash dividends declared per common share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 441.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 441.32 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 441.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.15 441.32 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 441.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 441.32 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 441.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 441.32 Td (0.39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 441.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 441.32 Td (1.53) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 415.32 Td (Cash and cash equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 415.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 415.32 Td (2,644) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 415.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 415.32 Td (2,934) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 415.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 415.32 Td (3,432) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 415.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 415.32 Td (4,237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 415.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 415.32 Td (4,237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 401.42 Td (Marketable securities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 124.80 405.95 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 401.42 Td (5,352) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 401.42 Td (4,998) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 401.42 Td (5,163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 401.42 Td (4,832) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 401.42 Td (4,832) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 387.32 Td (Total Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.15 387.32 Td (31,892) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.15 387.32 Td (32,831) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 387.32 Td (33,727) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 387.32 Td (33,707) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 387.32 Td (33,707) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 373.42 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 101.48 377.95 Td (\(c\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 373.42 Td (6,593) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 373.42 Td (6,581) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 373.42 Td (6,585) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 373.42 Td (6,465) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 373.42 Td (6,465) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 359.32 Td (Equity) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.15 359.32 Td (14,551) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.15 359.32 Td (15,078) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 359.32 Td (15,781) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 359.32 Td (16,347) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 359.32 Td (16,347) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 334.00 Td (Dollars in Millions, except per share data) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 236.35 333.98 Td (First Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 302.85 333.98 Td (Second Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 375.55 333.98 Td (Third Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 444.55 333.98 Td (Fourth Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 534.55 333.98 Td (Year) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 39 318.91259765625 m 59 318.91259765625 l s q 0 0 0 rg BT 39.00 320.48 Td (2015) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 229.00 321.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 300.00 321.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 370.00 321.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 441.00 321.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 512.00 321.00 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 307.32 Td (Total Revenues) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 307.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 307.32 Td (4,041) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 307.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 307.32 Td (4,163) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 307.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 307.32 Td (4,069) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 307.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 307.32 Td (4,287) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 307.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 307.32 Td (16,560) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 294.32 Td (Gross Margin) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 294.32 Td (3,194) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 294.32 Td (3,150) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 294.32 Td (2,972) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 294.32 Td (3,335) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 294.32 Td (12,651) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 281.32 Td (Net Earnings/\(Loss\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 281.32 Td (1,199) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 341.30 281.37 Td (\(110) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 281.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 281.32 Td (730) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.30 281.37 Td (\(188) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 281.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 281.32 Td (1,631) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 268.32 Td (Net Earnings/\(Loss\) Attributable to:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 255.32 Td (Noncontrolling Interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 279.65 255.32 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 349.65 255.32 Td (20) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 420.65 255.32 Td (24) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 496.65 255.32 Td (9) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 255.32 Td (66) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.00 242.32 Td (BMS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 242.32 Td (1,186) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 341.30 242.37 Td (\(130) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 242.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 415.65 242.32 Td (706) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.30 242.37 Td (\(197) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 242.32 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 242.32 Td (1,565) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 215.42 Td (Earnings/\(Loss\) per Share - Basic) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 173.96 219.95 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 215.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 215.42 Td (0.71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 215.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.80 215.47 Td (\(0.08) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 215.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 215.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 215.42 Td (0.42) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 215.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.80 215.47 Td (\(0.12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 215.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 215.42 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 215.42 Td (0.94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 200.42 Td (Earnings/\(Loss\) per Share - Diluted) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 181.74 204.95 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 200.42 Td (0.71) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.80 200.47 Td (\(0.08) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.65 200.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 200.42 Td (0.42) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 480.80 200.47 Td (\(0.12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 501.65 200.42 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 200.42 Td (0.93) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 173.32 Td (Cash dividends declared per common share) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 173.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 272.15 173.32 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 173.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 342.15 173.32 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 173.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 413.15 173.32 Td (0.37) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 173.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 484.15 173.32 Td (0.38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 173.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 555.15 173.32 Td (1.49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 147.32 Td (Cash and cash equivalents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 229.00 147.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 147.32 Td (6,294) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 300.00 147.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 147.32 Td (4,199) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 370.00 147.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 147.32 Td (3,975) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 441.00 147.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 147.32 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.00 147.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 147.32 Td (2,385) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 133.42 Td (Marketable securities) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 124.80 137.95 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 133.42 Td (5,592) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 133.42 Td (5,909) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 133.42 Td (6,065) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 133.42 Td (6,545) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 133.42 Td (6,545) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 119.32 Td (Total Assets) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.15 119.32 Td (33,579) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.15 119.32 Td (31,954) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 119.32 Td (31,779) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 119.32 Td (31,748) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 119.32 Td (31,748) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 106.32 Td (Long-term debt) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 267.15 105.42 Td (7,127) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 337.15 105.42 Td (6,615) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 408.15 105.42 Td (6,632) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 479.15 105.42 Td (6,550) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 105.42 Td (6,550) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 91.32 Td (Equity) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 262.15 91.32 Td (15,689) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 332.15 91.32 Td (15,291) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 403.15 91.32 Td (15,273) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.15 91.32 Td (14,424) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 545.15 91.32 Td (14,424) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 69.70 Td (\(a\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 69.70 Td (Earnings per share for the quarters may not add to the amounts for the year, as each period is computed on a discrete basis.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 58.70 Td (\(b\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 58.70 Td (Marketable securities includes current and non-current assets.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 47.70 Td (\(c\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 47.70 Td (Long-term debt includes the current portion.) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 199 0 obj <> endobj 200 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 301.00 24.60 Td (99) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (The following specified items af) Tj ET Q q 0 0 0 rg BT 165.78 749.10 Td (fected the comparability of results in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 315.17 749.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 335.17 749.10 Td ( and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.61 749.10 Td (2015) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 374.61 749.10 Td (:) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 730.53505859375 m 56 730.53505859375 l s q 0 0 0 rg BT 36.00 732.10 Td (2016) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 701.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 701.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 701.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 701.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 701.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 701.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 701.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 701.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 701.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 701.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 701.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 675.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 675.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 675.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 675.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 675.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 675.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 675.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 675.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 675.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 675.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 675.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 649.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 649.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 649.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 649.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 649.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 649.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 649.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 649.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 649.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 649.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 649.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 623.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 623.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 623.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 623.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 623.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 623.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 623.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 623.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 623.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 623.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 623.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 597.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 597.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 597.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 597.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 597.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 597.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 597.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 597.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 597.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 597.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 597.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 571.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 571.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 571.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 571.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 571.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 571.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 571.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 571.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 571.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 571.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 571.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 545.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 545.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 545.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 545.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 545.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 545.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 545.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 545.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 545.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 545.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 545.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 519.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 519.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 519.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 519.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 519.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 519.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 519.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 493.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 493.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 493.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 493.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 493.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 493.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 493.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 493.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 493.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 493.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 493.60 46.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 701.6 m 376.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 701.6 m 426.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 701.6 m 476.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 701.6 m 526.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 701.6 m 576.5 701.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 636.6 m 376.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 636.6 m 426.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 636.6 m 476.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 636.6 m 526.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 636.6 m 576.5 636.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 532.6 m 376.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 532.6 m 426.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 532.6 m 476.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 532.6 m 526.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 532.6 m 576.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 480.6 m 376.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 468.6 m 376.5 468.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 466.6 m 376.5 466.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 480.6 m 426.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 468.6 m 426.5 468.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 466.6 m 426.5 466.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 480.6 m 476.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 468.6 m 476.5 468.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 466.6 m 476.5 466.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 480.6 m 526.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 468.6 m 526.5 468.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 466.6 m 526.5 466.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 480.6 m 576.5 480.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 468.6 m 576.5 468.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 466.6 m 576.5 466.6 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 705.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 344.75 713.68 Td (First) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 339.05 705.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 390.75 713.68 Td (Second) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 389.05 705.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 442.95 713.68 Td (Third) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 439.05 705.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 491.00 713.68 Td (Fourth) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.05 705.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 545.05 705.83 Td (Year) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 692.33 Td (Cost of pr) Tj ET Q q 0 0 0 rg BT 81.59 692.33 Td (oducts sold) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 129.11 696.86 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.00 692.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.65 692.17 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 692.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 692.17 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 692.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.65 692.17 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.00 692.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.65 692.17 Td (6) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.00 692.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 692.17 Td (21) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 666.17 Td (License and asset acquisition charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 666.17 Td (125) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 666.17 Td (139) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 666.17 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 666.17 Td (130) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 666.17 Td (439) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 653.17 Td (IPRD impairments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 653.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 653.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 653.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 653.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 653.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 640.17 Td (Accelerated depreciation and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 640.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 640.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 640.17 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 640.17 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 640.17 Td (83) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 627.33 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 627.17 Td (138) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 627.17 Td (152) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 627.17 Td (59) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 627.17 Td (186) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 627.17 Td (535) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 601.17 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.65 601.17 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 601.17 Td (18) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 601.17 Td (19) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 601.17 Td (68) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 601.17 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 588.17 Td (Litigation and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 588.17 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 588.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.30 588.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 588.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 588.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 588.17 Td (40) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 575.17 Td (Divestiture gains) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.30 575.22 Td (\(269) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 575.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 575.22 Td (\(277) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 575.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.30 575.22 Td (\(13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 575.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 575.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 575.17 Td (\(559) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 575.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 562.17 Td (Royalties and licensing income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 562.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 562.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 562.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 509.30 562.22 Td (\(10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.65 562.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 559.30 562.17 Td (\(10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 562.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 549.17 Td (Pension charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 549.17 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 549.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 549.17 Td (19) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 549.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 549.17 Td (91) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 536.17 Td (Intangible asset impairment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 536.17 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 536.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 536.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 536.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 536.17 Td (15) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 523.33 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.30 523.22 Td (\(185) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 523.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 523.22 Td (\(234) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 523.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 523.17 Td (22) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 523.17 Td (83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 523.17 Td (\(314) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 523.17 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 497.33 Td (Increase/\(decrease\) to pretax income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.30 497.22 Td (\(43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 497.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 409.30 497.22 Td (\(78) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 497.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 497.17 Td (88) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 497.17 Td (275) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 497.17 Td (242) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 484.17 Td (Income tax on items above) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 484.17 Td (83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 484.17 Td (76) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 464.30 484.22 Td (\(3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 484.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.30 484.22 Td (\(105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.65 484.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 484.17 Td (51) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 471.33 Td (Increase/\(decrease\) to net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.00 471.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 471.17 Td (40) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 471.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.30 471.22 Td (\(2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 471.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 471.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 471.17 Td (85) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.00 471.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 471.17 Td (170) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.00 471.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 471.17 Td (293) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 449.55 Td (\(a\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 449.55 Td (Specified items in cost of products sold are accelerated depreciation, asset impairment and other shutdown costs.) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 36 418.53505859375 m 56 418.53505859375 l s q 0 0 0 rg BT 36.00 420.10 Td (2015) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 389.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 389.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 389.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 389.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 389.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 389.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 389.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 389.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 389.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 389.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 389.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 363.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 363.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 363.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 363.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 363.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 363.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 363.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 363.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 363.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 363.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 363.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 337.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 337.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 337.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 337.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 337.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 337.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 337.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 337.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 337.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 337.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 337.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 311.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 311.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 311.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 311.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 311.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 311.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 311.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 311.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 311.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 311.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 311.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 285.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 285.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 285.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 285.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 285.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 285.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 285.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 285.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 285.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 285.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 285.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 259.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 259.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 259.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 259.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 259.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 259.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 259.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 259.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 259.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 259.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 259.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 233.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 233.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 233.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 233.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 233.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 233.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 233.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 233.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 233.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 233.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 233.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 207.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 207.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 207.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 207.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 207.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 207.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 207.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 207.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 207.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 207.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 207.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 181.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 181.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 181.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 181.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 181.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 181.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 181.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 181.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 181.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 181.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 181.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 156.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 156.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 156.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 156.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 156.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 156.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 156.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 156.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 156.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 156.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 156.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 36.50 130.60 290.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 326.50 130.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 330.50 130.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 376.50 130.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.50 130.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 426.50 130.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 430.50 130.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 476.50 130.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 480.50 130.60 46.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 526.50 130.60 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 530.50 130.60 46.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 389.6 m 376.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 389.6 m 426.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 389.6 m 476.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 389.6 m 526.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 389.6 m 576.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 389.6 m 426.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 389.6 m 476.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 389.6 m 526.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 389.6 m 576.5 389.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 298.6 m 376.5 298.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 298.6 m 426.5 298.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 298.6 m 476.5 298.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 298.6 m 526.5 298.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 298.6 m 576.5 298.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 181.60000000000002 m 376.5 181.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 181.60000000000002 m 426.5 181.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 181.60000000000002 m 476.5 181.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 181.60000000000002 m 526.5 181.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 181.60000000000002 m 576.5 181.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 130.60000000000002 m 376.5 130.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 118.60000000000002 m 376.5 118.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 330.5 116.60000000000002 m 376.5 116.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 130.60000000000002 m 426.5 130.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 118.60000000000002 m 426.5 118.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380.5 116.60000000000002 m 426.5 116.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 130.60000000000002 m 476.5 130.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 118.60000000000002 m 476.5 118.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 430.5 116.60000000000002 m 476.5 116.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 130.60000000000002 m 526.5 130.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 118.60000000000002 m 526.5 118.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 480.5 116.60000000000002 m 526.5 116.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 130.60000000000002 m 576.5 130.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 118.60000000000002 m 576.5 118.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 530.5 116.60000000000002 m 576.5 116.60000000000002 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 393.85 Td (Dollars in Millions) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 344.75 401.68 Td (First) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 339.05 393.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 390.75 401.68 Td (Second) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 389.05 393.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 442.95 401.68 Td (Third) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 439.05 393.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 491.00 401.68 Td (Fourth) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 489.05 393.68 Td (Quarter) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 545.05 393.83 Td (Year) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 380.33 Td (Cost of pr) Tj ET Q q 0 0 0 rg BT 81.59 380.33 Td (oducts sold) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 129.11 384.86 Td (\(a\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.00 380.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 380.17 Td (34) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 380.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 380.17 Td (25) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 380.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 380.17 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.00 380.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 380.17 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.00 380.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 380.17 Td (84) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 354.33 Td (Marketing, selling and administrative) Tj ET Q BT /F2 10.00 Tf ET BT /F2 6.50 Tf ET q 0 0 0 rg BT 200.11 358.86 Td (\(b\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.65 354.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 354.17 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 467.65 354.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 517.65 354.17 Td (4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 354.17 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 328.17 Td (License and asset acquisition charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 328.17 Td (162) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 328.17 Td (869) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 328.17 Td (94) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 328.17 Td (554) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 328.17 Td (1,679) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 315.17 Td (IPRD impairments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 315.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 315.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 315.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 315.17 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 315.17 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 302.17 Td (Accelerated depreciation and other) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 302.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 302.17 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 302.17 Td (15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 302.17 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 302.17 Td (44) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 289.33 Td (Research and development) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 357.65 289.17 Td (162) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 289.17 Td (871) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 457.65 289.17 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 289.17 Td (741) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 289.17 Td (1,883) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 263.17 Td (Provision for restructuring) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 263.17 Td (12) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 263.17 Td (28) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 263.17 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 263.17 Td (65) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 263.17 Td (115) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 250.17 Td (Litigation and other settlements) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 250.17 Td (14) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.65 250.17 Td (1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 250.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 250.17 Td (143) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 250.17 Td (158) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 237.17 Td (Divestiture \(gains\)/losses) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.30 237.22 Td (\(152) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 237.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 414.30 237.22 Td (\(8) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 237.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.30 237.22 Td (\(198) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 237.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 237.17 Td (171) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 237.17 Td (\(187) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 237.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 224.17 Td (Pension charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 224.17 Td (27) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 224.17 Td (36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 224.17 Td (48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 224.17 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 224.17 Td (160) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 211.17 Td (Intangible asset impairment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 211.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 211.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 211.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 211.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 562.65 211.17 Td (13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 198.17 Td (Written option adjustment) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.30 198.22 Td (\(36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 198.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 412.65 198.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.30 198.22 Td (\(87) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 198.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 198.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 198.17 Td (\(123) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 198.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 185.17 Td (Loss on debt redemption) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 185.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 185.17 Td (180) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 185.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 512.65 185.17 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 185.17 Td (180) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 172.33 Td (Other \(income\)/expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 354.30 172.22 Td (\(122) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 172.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 407.65 172.17 Td (237) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.30 172.22 Td (\(227) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 172.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 172.17 Td (428) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 557.65 172.17 Td (316) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 147.33 Td (Increase/\(decrease\) to pretax income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 362.65 147.17 Td (75) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 147.17 Td (1,136) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.30 147.22 Td (\(101) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 147.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 500.15 147.17 Td (1,183) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 147.17 Td (2,293) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 134.17 Td (Income tax on items above) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 359.30 134.22 Td (\(68) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.65 134.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 404.30 134.22 Td (\(116) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 422.65 134.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 462.65 134.17 Td (43) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 504.30 134.22 Td (\(339) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 522.65 134.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.30 134.17 Td (\(480) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 572.65 134.17 Td (\)) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 121.33 Td (Increase/\(decrease\) to net earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 333.00 121.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 367.65 121.17 Td (7) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 383.00 121.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 400.15 121.17 Td (1,020) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 433.00 121.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.30 121.22 Td (\(58) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 472.65 121.17 Td (\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 483.00 121.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.65 121.17 Td (844) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 533.00 121.17 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 550.15 121.17 Td (1,813) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 99.55 Td (\(a\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 99.55 Td (Specified items in cost of products sold are accelerated depreciation, asset impairment and other shutdown costs.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 88.55 Td (\(b\)) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 56.00 88.55 Td (Specified items in marketing, selling and administrative are process standardization implementation costs.) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 201 0 obj <> endobj 202 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (100) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (REPOR) Tj ET Q q 0 0 0 rg BT 67.63 749.10 Td (T) Tj ET Q q 0 0 0 rg BT 73.56 749.10 Td ( OF INDEPENDENT) Tj ET Q q 0 0 0 rg BT 160.59 749.10 Td ( REGISTERED PUBLIC ) Tj ET Q q 0 0 0 rg BT 264.21 749.10 Td (ACCOUNTING FIRM) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 725.10 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 725.10 Td (o the Board of Directors and Shareholders of) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 713.10 Td (Bristol-Myers Squibb Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 689.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 689.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.92 689.10 Td (have ) Tj ET Q q 0 0 0 rg BT 73.63 689.10 Td (audited ) Tj ET Q q 0 0 0 rg BT 105.91 689.10 Td (the ) Tj ET Q q 0 0 0 rg BT 120.97 689.10 Td (accompanying ) Tj ET Q q 0 0 0 rg BT 182.12 689.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 235.50 689.10 Td (balance ) Tj ET Q q 0 0 0 rg BT 268.87 689.10 Td (sheets ) Tj ET Q q 0 0 0 rg BT 296.15 689.10 Td (of ) Tj ET Q q 0 0 0 rg BT 307.32 689.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 366.27 689.10 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 397.45 689.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 439.18 689.10 Td (and ) Tj ET Q q 0 0 0 rg BT 456.46 689.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 506.52 689.10 Td (\(the ) Tj ET Q q 0 0 0 rg BT 524.91 689.10 Td (“Company”\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 677.10 Td (as ) Tj ET Q q 0 0 0 rg BT 46.56 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 57.12 677.10 Td (December ) Tj ET Q q 0 0 0 rg BT 100.44 677.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 115.17 677.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 137.40 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 154.07 677.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 178.80 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 195.47 677.10 Td (the ) Tj ET Q q 0 0 0 rg BT 209.92 677.10 Td (related ) Tj ET Q q 0 0 0 rg BT 239.35 677.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 292.13 677.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 336.57 677.10 Td (of ) Tj ET Q q 0 0 0 rg BT 347.13 677.10 Td (earnings, ) Tj ET Q q 0 0 0 rg BT 385.74 677.10 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 448.50 677.10 Td (income, ) Tj ET Q q 0 0 0 rg BT 482.67 677.10 Td (and ) Tj ET Q q 0 0 0 rg BT 499.34 677.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 519.34 677.10 Td (flows ) Tj ET Q q 0 0 0 rg BT 543.79 677.10 Td (for ) Tj ET Q q 0 0 0 rg BT 557.68 677.10 Td (each ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 46.00 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 59.88 665.10 Td (three ) Tj ET Q q 0 0 0 rg BT 81.54 665.10 Td (years ) Tj ET Q q 0 0 0 rg BT 104.31 665.10 Td (in ) Tj ET Q q 0 0 0 rg BT 113.75 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 127.64 665.10 Td (period ) Tj ET Q q 0 0 0 rg BT 154.86 665.10 Td (ended ) Tj ET Q q 0 0 0 rg BT 180.40 665.10 Td (December ) Tj ET Q q 0 0 0 rg BT 223.15 665.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 237.32 665.10 Td (2016. ) Tj ET Q q 0 0 0 rg BT 261.37 665.10 Td (These ) Tj ET Q q 0 0 0 rg BT 286.92 665.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 323.57 665.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 367.45 665.10 Td (are ) Tj ET Q q 0 0 0 rg BT 381.32 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 395.21 665.10 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 451.32 665.10 Td (of ) Tj ET Q q 0 0 0 rg BT 461.32 665.10 Td (the ) Tj ET Q q 0 0 0 rg BT 475.21 665.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 516.87 665.10 Td (s ) Tj ET Q q 0 0 0 rg BT 522.43 665.10 Td (management. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 653.10 Td (Our ) Tj ET Q q 0 0 0 rg BT 54.05 653.10 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 111.00 653.10 Td (is ) Tj ET Q q 0 0 0 rg BT 120.17 653.10 Td (to ) Tj ET Q q 0 0 0 rg BT 130.44 653.10 Td (express ) Tj ET Q q 0 0 0 rg BT 162.93 653.10 Td (an ) Tj ET Q q 0 0 0 rg BT 174.87 653.10 Td (opinion ) Tj ET Q q 0 0 0 rg BT 207.93 653.10 Td (on ) Tj ET Q q 0 0 0 rg BT 220.43 653.10 Td (these ) Tj ET Q q 0 0 0 rg BT 243.48 653.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 280.96 653.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 325.67 653.10 Td (based ) Tj ET Q q 0 0 0 rg BT 350.94 653.10 Td (on ) Tj ET Q q 0 0 0 rg BT 363.44 653.10 Td (our ) Tj ET Q q 0 0 0 rg BT 379.27 653.10 Td (audits. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 629.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 629.10 Td (e ) Tj ET Q q 0 0 0 rg BT 51.78 629.10 Td (conducted ) Tj ET Q q 0 0 0 rg BT 95.58 629.10 Td (our ) Tj ET Q q 0 0 0 rg BT 111.62 629.10 Td (audits ) Tj ET Q q 0 0 0 rg BT 138.21 629.10 Td (in ) Tj ET Q q 0 0 0 rg BT 148.69 629.10 Td (accordance ) Tj ET Q q 0 0 0 rg BT 196.36 629.10 Td (with ) Tj ET Q q 0 0 0 rg BT 216.84 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 231.76 629.10 Td (standards ) Tj ET Q q 0 0 0 rg BT 272.24 629.10 Td (of ) Tj ET Q q 0 0 0 rg BT 283.27 629.10 Td (the ) Tj ET Q q 0 0 0 rg BT 298.19 629.10 Td (Public ) Tj ET Q q 0 0 0 rg BT 326.45 629.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 367.45 629.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 416.81 629.10 Td (Oversight ) Tj ET Q q 0 0 0 rg BT 458.95 629.10 Td (Board ) Tj ET Q q 0 0 0 rg BT 486.10 629.10 Td (\(United ) Tj ET Q q 0 0 0 rg BT 519.35 629.10 Td (States\). ) Tj ET Q q 0 0 0 rg BT 551.57 629.10 Td (Those ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 617.10 Td (standards ) Tj ET Q q 0 0 0 rg BT 76.61 617.10 Td (require ) Tj ET Q q 0 0 0 rg BT 107.77 617.10 Td (that ) Tj ET Q q 0 0 0 rg BT 125.61 617.10 Td (we ) Tj ET Q q 0 0 0 rg BT 140.12 617.10 Td (plan ) Tj ET Q q 0 0 0 rg BT 160.18 617.10 Td (and ) Tj ET Q q 0 0 0 rg BT 177.46 617.10 Td (perform ) Tj ET Q q 0 0 0 rg BT 212.51 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 227.57 617.10 Td (audit ) Tj ET Q q 0 0 0 rg BT 250.41 617.10 Td (to ) Tj ET Q q 0 0 0 rg BT 261.03 617.10 Td (obtain ) Tj ET Q q 0 0 0 rg BT 288.87 617.10 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 334.47 617.10 Td (assurance ) Tj ET Q q 0 0 0 rg BT 376.18 617.10 Td (about ) Tj ET Q q 0 0 0 rg BT 401.24 617.10 Td (whether ) Tj ET Q q 0 0 0 rg BT 436.30 617.10 Td (the ) Tj ET Q q 0 0 0 rg BT 451.36 617.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 489.18 617.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 534.24 617.10 Td (are ) Tj ET Q q 0 0 0 rg BT 549.29 617.10 Td (free ) Tj ET Q q 0 0 0 rg BT 567.67 617.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 605.10 Td (material ) Tj ET Q q 0 0 0 rg BT 71.72 605.10 Td (misstatement. ) Tj ET Q q 0 0 0 rg BT 129.29 605.10 Td (An ) Tj ET Q q 0 0 0 rg BT 144.48 605.10 Td (audit ) Tj ET Q q 0 0 0 rg BT 167.43 605.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 203.72 605.10 Td (examining, ) Tj ET Q q 0 0 0 rg BT 251.39 605.10 Td (on ) Tj ET Q q 0 0 0 rg BT 264.35 605.10 Td (a ) Tj ET Q q 0 0 0 rg BT 271.75 605.10 Td (test ) Tj ET Q q 0 0 0 rg BT 288.60 605.10 Td (basis, ) Tj ET Q q 0 0 0 rg BT 314.06 605.10 Td (evidence ) Tj ET Q q 0 0 0 rg BT 352.55 605.10 Td (supporting ) Tj ET Q q 0 0 0 rg BT 398.29 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 413.47 605.10 Td (amounts ) Tj ET Q q 0 0 0 rg BT 450.31 605.10 Td (and ) Tj ET Q q 0 0 0 rg BT 467.71 605.10 Td (disclosures ) Tj ET Q q 0 0 0 rg BT 515.11 605.10 Td (in ) Tj ET Q q 0 0 0 rg BT 525.85 605.10 Td (the ) Tj ET Q q 0 0 0 rg BT 541.03 605.10 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 593.10 Td (statements. ) Tj ET Q q 0 0 0 rg BT 82.89 593.10 Td (An ) Tj ET Q q 0 0 0 rg BT 97.90 593.10 Td (audit ) Tj ET Q q 0 0 0 rg BT 120.68 593.10 Td (also ) Tj ET Q q 0 0 0 rg BT 139.58 593.10 Td (includes ) Tj ET Q q 0 0 0 rg BT 175.69 593.10 Td (assessing ) Tj ET Q q 0 0 0 rg BT 215.71 593.10 Td (the ) Tj ET Q q 0 0 0 rg BT 230.71 593.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 277.37 593.10 Td (principles ) Tj ET Q q 0 0 0 rg BT 319.60 593.10 Td (used ) Tj ET Q q 0 0 0 rg BT 340.72 593.10 Td (and ) Tj ET Q q 0 0 0 rg BT 357.94 593.10 Td (significant ) Tj ET Q q 0 0 0 rg BT 402.95 593.10 Td (estimates ) Tj ET Q q 0 0 0 rg BT 442.95 593.10 Td (made ) Tj ET Q q 0 0 0 rg BT 467.39 593.10 Td (by ) Tj ET Q q 0 0 0 rg BT 480.18 593.10 Td (management, ) Tj ET Q q 0 0 0 rg BT 536.56 593.10 Td (as ) Tj ET Q q 0 0 0 rg BT 547.68 593.10 Td (well ) Tj ET Q q 0 0 0 rg BT 567.69 593.10 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 581.10 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 80.15 581.10 Td (the ) Tj ET Q q 0 0 0 rg BT 94.87 581.10 Td (overall ) Tj ET Q q 0 0 0 rg BT 125.13 581.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 162.61 581.10 Td (statement ) Tj ET Q q 0 0 0 rg BT 203.43 581.10 Td (presentation. ) Tj ET Q q 0 0 0 rg BT 257.12 581.10 Td (W) Tj ET Q q 0 0 0 rg BT 265.76 581.10 Td (e ) Tj ET Q q 0 0 0 rg BT 272.70 581.10 Td (believe ) Tj ET Q q 0 0 0 rg BT 304.07 581.10 Td (that ) Tj ET Q q 0 0 0 rg BT 321.57 581.10 Td (our ) Tj ET Q q 0 0 0 rg BT 337.40 581.10 Td (audits ) Tj ET Q q 0 0 0 rg BT 363.78 581.10 Td (provide ) Tj ET Q q 0 0 0 rg BT 396.83 581.10 Td (a ) Tj ET Q q 0 0 0 rg BT 403.77 581.10 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 449.02 581.10 Td (basis ) Tj ET Q q 0 0 0 rg BT 471.52 581.10 Td (for ) Tj ET Q q 0 0 0 rg BT 485.68 581.10 Td (our ) Tj ET Q q 0 0 0 rg BT 501.51 581.10 Td (opinion. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 557.10 Td (In ) Tj ET Q q 0 0 0 rg BT 45.96 557.10 Td (our ) Tj ET Q q 0 0 0 rg BT 60.93 557.10 Td (opinion, ) Tj ET Q q 0 0 0 rg BT 95.62 557.10 Td (such ) Tj ET Q q 0 0 0 rg BT 115.58 557.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 167.76 557.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 204.37 557.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 248.21 557.10 Td (present ) Tj ET Q q 0 0 0 rg BT 278.72 557.10 Td (fairly) Tj ET Q q 0 0 0 rg BT 299.73 557.10 Td (, ) Tj ET Q q 0 0 0 rg BT 303.86 557.10 Td (in ) Tj ET Q q 0 0 0 rg BT 313.28 557.10 Td (all ) Tj ET Q q 0 0 0 rg BT 324.90 557.10 Td (material ) Tj ET Q q 0 0 0 rg BT 359.30 557.10 Td (respects, ) Tj ET Q q 0 0 0 rg BT 395.64 557.10 Td (the ) Tj ET Q q 0 0 0 rg BT 409.49 557.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 446.10 557.10 Td (position ) Tj ET Q q 0 0 0 rg BT 479.96 557.10 Td (of ) Tj ET Q q 0 0 0 rg BT 489.92 557.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 547.67 557.10 Td (Squibb ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 545.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 77.84 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 95.23 545.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 145.40 545.10 Td (as ) Tj ET Q q 0 0 0 rg BT 156.69 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 167.97 545.10 Td (December ) Tj ET Q q 0 0 0 rg BT 212.01 545.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 227.46 545.10 Td (2016 ) Tj ET Q q 0 0 0 rg BT 250.42 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 267.81 545.10 Td (2015, ) Tj ET Q q 0 0 0 rg BT 293.27 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 310.66 545.10 Td (the ) Tj ET Q q 0 0 0 rg BT 325.83 545.10 Td (results ) Tj ET Q q 0 0 0 rg BT 354.89 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 366.18 545.10 Td (their ) Tj ET Q q 0 0 0 rg BT 387.46 545.10 Td (operations ) Tj ET Q q 0 0 0 rg BT 432.06 545.10 Td (and ) Tj ET Q q 0 0 0 rg BT 449.46 545.10 Td (their ) Tj ET Q q 0 0 0 rg BT 470.74 545.10 Td (cash ) Tj ET Q q 0 0 0 rg BT 491.46 545.10 Td (flows ) Tj ET Q q 0 0 0 rg BT 516.63 545.10 Td (for ) Tj ET Q q 0 0 0 rg BT 531.25 545.10 Td (each ) Tj ET Q q 0 0 0 rg BT 552.52 545.10 Td (of ) Tj ET Q q 0 0 0 rg BT 563.80 545.10 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 533.10 Td (three ) Tj ET Q q 0 0 0 rg BT 58.41 533.10 Td (years ) Tj ET Q q 0 0 0 rg BT 81.94 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 92.14 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 106.78 533.10 Td (period ) Tj ET Q q 0 0 0 rg BT 134.75 533.10 Td (ended ) Tj ET Q q 0 0 0 rg BT 161.06 533.10 Td (December ) Tj ET Q q 0 0 0 rg BT 204.57 533.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 219.49 533.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 244.42 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 254.62 533.10 Td (conformity ) Tj ET Q q 0 0 0 rg BT 301.48 533.10 Td (with ) Tj ET Q q 0 0 0 rg BT 321.69 533.10 Td (accounting ) Tj ET Q q 0 0 0 rg BT 367.98 533.10 Td (principles ) Tj ET Q q 0 0 0 rg BT 409.84 533.10 Td (generally ) Tj ET Q q 0 0 0 rg BT 449.47 533.10 Td (accepted ) Tj ET Q q 0 0 0 rg BT 486.87 533.10 Td (in ) Tj ET Q q 0 0 0 rg BT 497.07 533.10 Td (the ) Tj ET Q q 0 0 0 rg BT 511.71 533.10 Td (United ) Tj ET Q q 0 0 0 rg BT 541.36 533.10 Td (States ) Tj ET Q q 0 0 0 rg BT 567.67 533.10 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 521.10 Td (America. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 497.10 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 497.10 Td (e ) Tj ET Q q 0 0 0 rg BT 50.46 497.10 Td (have ) Tj ET Q q 0 0 0 rg BT 70.72 497.10 Td (also ) Tj ET Q q 0 0 0 rg BT 88.21 497.10 Td (audited, ) Tj ET Q q 0 0 0 rg BT 121.52 497.10 Td (in ) Tj ET Q q 0 0 0 rg BT 130.68 497.10 Td (accordance ) Tj ET Q q 0 0 0 rg BT 177.03 497.10 Td (with ) Tj ET Q q 0 0 0 rg BT 196.19 497.10 Td (the ) Tj ET Q q 0 0 0 rg BT 209.78 497.10 Td (standards ) Tj ET Q q 0 0 0 rg BT 248.93 497.10 Td (of ) Tj ET Q q 0 0 0 rg BT 258.65 497.10 Td (the ) Tj ET Q q 0 0 0 rg BT 272.25 497.10 Td (Public ) Tj ET Q q 0 0 0 rg BT 299.18 497.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 339.15 497.10 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 387.18 497.10 Td (Oversight ) Tj ET Q q 0 0 0 rg BT 428.00 497.10 Td (Board ) Tj ET Q q 0 0 0 rg BT 453.82 497.10 Td (\(United ) Tj ET Q q 0 0 0 rg BT 485.75 497.10 Td (States\), ) Tj ET Q q 0 0 0 rg BT 516.85 497.10 Td (the ) Tj ET Q q 0 0 0 rg BT 530.45 497.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 572.12 497.10 Td (s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 485.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 70.54 485.10 Td (control ) Tj ET Q q 0 0 0 rg BT 102.86 485.10 Td (over ) Tj ET Q q 0 0 0 rg BT 124.63 485.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 163.61 485.10 Td (reporting ) Tj ET Q q 0 0 0 rg BT 204.26 485.10 Td (as ) Tj ET Q q 0 0 0 rg BT 216.59 485.10 Td (of ) Tj ET Q q 0 0 0 rg BT 228.92 485.10 Td (December ) Tj ET Q q 0 0 0 rg BT 274.00 485.10 Td (31, ) Tj ET Q q 0 0 0 rg BT 290.50 485.10 Td (2016, ) Tj ET Q q 0 0 0 rg BT 317.00 485.10 Td (based ) Tj ET Q q 0 0 0 rg BT 343.76 485.10 Td (on ) Tj ET Q q 0 0 0 rg BT 357.76 485.10 Td (the ) Tj ET Q q 0 0 0 rg BT 373.98 485.10 Td (criteria ) Tj ET Q q 0 0 0 rg BT 406.28 485.10 Td (established ) Tj ET Q q 0 0 0 rg BT 454.72 485.10 Td (in ) Tj ET Q q 0 0 0 rg BT 466.49 485.10 Td (Internal ) Tj ET Q q 0 0 0 rg BT 501.58 485.10 Td (Control-Integrated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 473.10 Td (Framework ) Tj ET Q q 0 0 0 rg BT 84.80 473.10 Td (\(2013\) ) Tj ET Q q 0 0 0 rg BT 114.15 473.10 Td (issued ) Tj ET Q q 0 0 0 rg BT 141.85 473.10 Td (by ) Tj ET Q q 0 0 0 rg BT 154.55 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 169.46 473.10 Td (Committee ) Tj ET Q q 0 0 0 rg BT 216.59 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 227.62 473.10 Td (Sponsoring ) Tj ET Q q 0 0 0 rg BT 275.88 473.10 Td (Or) Tj ET Q q 0 0 0 rg BT 286.25 473.10 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 334.49 473.10 Td (of ) Tj ET Q q 0 0 0 rg BT 345.52 473.10 Td (the ) Tj ET Q q 0 0 0 rg BT 360.23 473.10 Td (T) Tj ET Q q 0 0 0 rg BT 365.99 473.10 Td (readway ) Tj ET Q q 0 0 0 rg BT 402.56 473.10 Td (Commission ) Tj ET Q q 0 0 0 rg BT 455.82 473.10 Td (and ) Tj ET Q q 0 0 0 rg BT 472.95 473.10 Td (our ) Tj ET Q q 0 0 0 rg BT 488.98 473.10 Td (report ) Tj ET Q q 0 0 0 rg BT 515.55 473.10 Td (dated ) Tj ET Q q 0 0 0 rg BT 539.91 473.10 Td (February ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 461.10 Td (21, ) Tj ET Q q 0 0 0 rg BT 51.00 461.10 Td (2017 ) Tj ET Q q 0 0 0 rg BT 73.50 461.10 Td (expressed ) Tj ET Q q 0 0 0 rg BT 115.43 461.10 Td (an ) Tj ET Q q 0 0 0 rg BT 127.37 461.10 Td (unqualified ) Tj ET Q q 0 0 0 rg BT 175.41 461.10 Td (opinion ) Tj ET Q q 0 0 0 rg BT 208.47 461.10 Td (on ) Tj ET Q q 0 0 0 rg BT 220.97 461.10 Td (the ) Tj ET Q q 0 0 0 rg BT 235.68 461.10 Td (Company’) Tj ET Q q 0 0 0 rg BT 277.35 461.10 Td (s ) Tj ET Q q 0 0 0 rg BT 283.74 461.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 316.78 461.10 Td (control ) Tj ET Q q 0 0 0 rg BT 347.61 461.10 Td (over ) Tj ET Q q 0 0 0 rg BT 367.88 461.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 405.36 461.10 Td (reporting. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 437.10 Td (/s/ DELOITTE & T) Tj ET Q q 0 0 0 rg BT 112.78 437.10 Td (OUCHE LLP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 413.10 Td (Parsippany) Tj ET Q q 0 0 0 rg BT 79.79 413.10 Td (, New Jersey) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 401.10 Td (February 21, 2017) Tj ET Q endstream endobj 203 0 obj <> endobj 204 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (101) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 746.23 Td (Item 9.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 746.23 Td (CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 736.23 Td (DISCLOSURE.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 715.00 Td (None.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 683.23 Td (Item 9A.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 683.23 Td (CONTROLS AND PROCEDURES.) Tj ET Q BT /F1 10.00 Tf ET BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 655.00 Td (Evaluation of Disclosur) Tj ET Q q 0 0 0 rg BT 135.83 655.00 Td (e Contr) Tj ET Q q 0 0 0 rg BT 168.14 655.00 Td (ols and Pr) Tj ET Q q 0 0 0 rg BT 211.30 655.00 Td (ocedur) Tj ET Q q 0 0 0 rg BT 240.56 655.00 Td (es) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 631.00 Td (As ) Tj ET Q q 0 0 0 rg BT 49.46 631.00 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.14 631.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 118.57 631.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 138.57 631.00 Td (, ) Tj ET Q q 0 0 0 rg BT 143.42 631.00 Td (management ) Tj ET Q q 0 0 0 rg BT 196.86 631.00 Td (carried ) Tj ET Q q 0 0 0 rg BT 226.96 631.00 Td (out ) Tj ET Q q 0 0 0 rg BT 242.09 631.00 Td (an ) Tj ET Q q 0 0 0 rg BT 253.88 631.00 Td (evaluation, ) Tj ET Q q 0 0 0 rg BT 300.38 631.00 Td (under ) Tj ET Q q 0 0 0 rg BT 325.49 631.00 Td (the ) Tj ET Q q 0 0 0 rg BT 340.06 631.00 Td (supervision ) Tj ET Q q 0 0 0 rg BT 388.51 631.00 Td (and ) Tj ET Q q 0 0 0 rg BT 405.30 631.00 Td (with ) Tj ET Q q 0 0 0 rg BT 425.43 631.00 Td (the ) Tj ET Q q 0 0 0 rg BT 439.99 631.00 Td (participation ) Tj ET Q q 0 0 0 rg BT 492.88 631.00 Td (of ) Tj ET Q q 0 0 0 rg BT 503.56 631.00 Td (its ) Tj ET Q q 0 0 0 rg BT 515.36 631.00 Td (chief ) Tj ET Q q 0 0 0 rg BT 537.69 631.00 Td (executive ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 619.00 Td (of) Tj ET Q q 0 0 0 rg BT 44.15 619.00 Td (ficer ) Tj ET Q q 0 0 0 rg BT 64.86 619.00 Td (and ) Tj ET Q q 0 0 0 rg BT 81.70 619.00 Td (chief ) Tj ET Q q 0 0 0 rg BT 104.08 619.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 141.46 619.00 Td (of) Tj ET Q q 0 0 0 rg BT 149.60 619.00 Td (ficer) Tj ET Q q 0 0 0 rg BT 167.52 619.00 Td (, ) Tj ET Q q 0 0 0 rg BT 172.42 619.00 Td (of ) Tj ET Q q 0 0 0 rg BT 183.14 619.00 Td (the ) Tj ET Q q 0 0 0 rg BT 197.76 619.00 Td (ef) Tj ET Q q 0 0 0 rg BT 205.34 619.00 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 252.16 619.00 Td (of ) Tj ET Q q 0 0 0 rg BT 262.89 619.00 Td (the ) Tj ET Q q 0 0 0 rg BT 277.50 619.00 Td (design ) Tj ET Q q 0 0 0 rg BT 306.01 619.00 Td (and ) Tj ET Q q 0 0 0 rg BT 322.84 619.00 Td (operation ) Tj ET Q q 0 0 0 rg BT 363.00 619.00 Td (of ) Tj ET Q q 0 0 0 rg BT 373.73 619.00 Td (its ) Tj ET Q q 0 0 0 rg BT 385.58 619.00 Td (disclosure ) Tj ET Q q 0 0 0 rg BT 428.52 619.00 Td (controls ) Tj ET Q q 0 0 0 rg BT 463.13 619.00 Td (and ) Tj ET Q q 0 0 0 rg BT 479.97 619.00 Td (procedures ) Tj ET Q q 0 0 0 rg BT 526.23 619.00 Td (as ) Tj ET Q q 0 0 0 rg BT 536.96 619.00 Td (such ) Tj ET Q q 0 0 0 rg BT 557.68 619.00 Td (term ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 607.00 Td (is ) Tj ET Q q 0 0 0 rg BT 44.76 607.00 Td (defined ) Tj ET Q q 0 0 0 rg BT 76.84 607.00 Td (under ) Tj ET Q q 0 0 0 rg BT 101.71 607.00 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 142.76 607.00 Td (Act ) Tj ET Q q 0 0 0 rg BT 159.30 607.00 Td (Rule ) Tj ET Q q 0 0 0 rg BT 180.28 607.00 Td (13a-15\(e\). ) Tj ET Q q 0 0 0 rg BT 223.74 607.00 Td (Based ) Tj ET Q q 0 0 0 rg BT 250.27 607.00 Td (on ) Tj ET Q q 0 0 0 rg BT 262.37 607.00 Td (this ) Tj ET Q q 0 0 0 rg BT 278.91 607.00 Td (evaluation, ) Tj ET Q q 0 0 0 rg BT 325.16 607.00 Td (management ) Tj ET Q q 0 0 0 rg BT 378.34 607.00 Td (has ) Tj ET Q q 0 0 0 rg BT 393.77 607.00 Td (concluded ) Tj ET Q q 0 0 0 rg BT 436.95 607.00 Td (that ) Tj ET Q q 0 0 0 rg BT 454.04 607.00 Td (as ) Tj ET Q q 0 0 0 rg BT 464.47 607.00 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 474.89 607.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 533.07 607.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 553.07 607.00 Td (, ) Tj ET Q q 0 0 0 rg BT 557.67 607.00 Td (such ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 595.00 Td (disclosure ) Tj ET Q q 0 0 0 rg BT 79.05 595.00 Td (controls ) Tj ET Q q 0 0 0 rg BT 113.76 595.00 Td (and ) Tj ET Q q 0 0 0 rg BT 130.70 595.00 Td (procedures ) Tj ET Q q 0 0 0 rg BT 177.07 595.00 Td (were ) Tj ET Q q 0 0 0 rg BT 199.00 595.00 Td (ef) Tj ET Q q 0 0 0 rg BT 206.59 595.00 Td (fective.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 571.00 Td (Management’) Tj ET Q q 0 0 0 rg BT 95.06 571.00 Td (s Report on Internal Contr) Tj ET Q q 0 0 0 rg BT 209.87 571.00 Td (ol Over) Tj ET Q q 0 0 0 rg BT 241.63 571.00 Td ( Financial Reporting) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 547.00 Td (Management ) Tj ET Q q 0 0 0 rg BT 91.16 547.00 Td (is ) Tj ET Q q 0 0 0 rg BT 100.78 547.00 Td (responsible ) Tj ET Q q 0 0 0 rg BT 149.29 547.00 Td (for ) Tj ET Q q 0 0 0 rg BT 163.90 547.00 Td (establishing ) Tj ET Q q 0 0 0 rg BT 214.63 547.00 Td (and ) Tj ET Q q 0 0 0 rg BT 232.02 547.00 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 282.75 547.00 Td (adequate ) Tj ET Q q 0 0 0 rg BT 321.24 547.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 354.73 547.00 Td (control ) Tj ET Q q 0 0 0 rg BT 386.01 547.00 Td (over ) Tj ET Q q 0 0 0 rg BT 406.74 547.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 444.67 547.00 Td (reporting. ) Tj ET Q q 0 0 0 rg BT 486.79 547.00 Td (Under ) Tj ET Q q 0 0 0 rg BT 514.73 547.00 Td (the ) Tj ET Q q 0 0 0 rg BT 529.90 547.00 Td (supervision ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 535.00 Td (and ) Tj ET Q q 0 0 0 rg BT 53.57 535.00 Td (with ) Tj ET Q q 0 0 0 rg BT 74.48 535.00 Td (the ) Tj ET Q q 0 0 0 rg BT 89.82 535.00 Td (participation ) Tj ET Q q 0 0 0 rg BT 143.49 535.00 Td (of ) Tj ET Q q 0 0 0 rg BT 154.95 535.00 Td (management, ) Tj ET Q q 0 0 0 rg BT 211.67 535.00 Td (including ) Tj ET Q q 0 0 0 rg BT 252.57 535.00 Td (the ) Tj ET Q q 0 0 0 rg BT 267.92 535.00 Td (chief ) Tj ET Q q 0 0 0 rg BT 291.03 535.00 Td (executive ) Tj ET Q q 0 0 0 rg BT 332.47 535.00 Td (of) Tj ET Q q 0 0 0 rg BT 340.62 535.00 Td (ficer ) Tj ET Q q 0 0 0 rg BT 362.07 535.00 Td (and ) Tj ET Q q 0 0 0 rg BT 379.64 535.00 Td (chief ) Tj ET Q q 0 0 0 rg BT 402.75 535.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 440.86 535.00 Td (of) Tj ET Q q 0 0 0 rg BT 449.01 535.00 Td (ficer) Tj ET Q q 0 0 0 rg BT 466.93 535.00 Td (, ) Tj ET Q q 0 0 0 rg BT 472.56 535.00 Td (management ) Tj ET Q q 0 0 0 rg BT 526.78 535.00 Td (assessed ) Tj ET Q q 0 0 0 rg BT 563.79 535.00 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 523.00 Td (ef) Tj ET Q q 0 0 0 rg BT 43.59 523.00 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 89.51 523.00 Td (of ) Tj ET Q q 0 0 0 rg BT 99.33 523.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 131.37 523.00 Td (control ) Tj ET Q q 0 0 0 rg BT 161.19 523.00 Td (over ) Tj ET Q q 0 0 0 rg BT 180.45 523.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 216.92 523.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 255.07 523.00 Td (as ) Tj ET Q q 0 0 0 rg BT 264.90 523.00 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 274.72 523.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 332.30 523.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.30 523.00 Td ( ) Tj ET Q q 0 0 0 rg BT 353.79 523.00 Td (based ) Tj ET Q q 0 0 0 rg BT 378.06 523.00 Td (on ) Tj ET Q q 0 0 0 rg BT 389.55 523.00 Td (the ) Tj ET Q q 0 0 0 rg BT 403.26 523.00 Td (framework ) Tj ET Q q 0 0 0 rg BT 448.62 523.00 Td (in ) Tj ET Q q 0 0 0 rg BT 457.89 523.00 Td (“Internal ) Tj ET Q q 0 0 0 rg BT 494.92 523.00 Td (Control—Integrated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 511.00 Td (Framework” ) Tj ET Q q 0 0 0 rg BT 89.79 511.00 Td (\(2013\) ) Tj ET Q q 0 0 0 rg BT 119.69 511.00 Td (issued ) Tj ET Q q 0 0 0 rg BT 147.94 511.00 Td (by ) Tj ET Q q 0 0 0 rg BT 161.19 511.00 Td (the ) Tj ET Q q 0 0 0 rg BT 176.66 511.00 Td (Committee ) Tj ET Q q 0 0 0 rg BT 224.34 511.00 Td (of ) Tj ET Q q 0 0 0 rg BT 235.92 511.00 Td (Sponsoring ) Tj ET Q q 0 0 0 rg BT 284.73 511.00 Td (Or) Tj ET Q q 0 0 0 rg BT 295.10 511.00 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 343.89 511.00 Td (of ) Tj ET Q q 0 0 0 rg BT 355.47 511.00 Td (the ) Tj ET Q q 0 0 0 rg BT 370.70 511.00 Td (T) Tj ET Q q 0 0 0 rg BT 376.46 511.00 Td (readway ) Tj ET Q q 0 0 0 rg BT 413.58 511.00 Td (Commission. ) Tj ET Q q 0 0 0 rg BT 469.89 511.00 Td (Based ) Tj ET Q q 0 0 0 rg BT 497.58 511.00 Td (on ) Tj ET Q q 0 0 0 rg BT 510.83 511.00 Td (that ) Tj ET Q q 0 0 0 rg BT 529.07 511.00 Td (assessment, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 499.00 Td (management ) Tj ET Q q 0 0 0 rg BT 89.53 499.00 Td (has ) Tj ET Q q 0 0 0 rg BT 105.30 499.00 Td (concluded ) Tj ET Q q 0 0 0 rg BT 148.83 499.00 Td (that ) Tj ET Q q 0 0 0 rg BT 166.27 499.00 Td (the ) Tj ET Q q 0 0 0 rg BT 180.93 499.00 Td (Company’) Tj ET Q q 0 0 0 rg BT 222.59 499.00 Td (s ) Tj ET Q q 0 0 0 rg BT 228.92 499.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 261.91 499.00 Td (control ) Tj ET Q q 0 0 0 rg BT 292.67 499.00 Td (over ) Tj ET Q q 0 0 0 rg BT 312.88 499.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 350.30 499.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 389.40 499.00 Td (was ) Tj ET Q q 0 0 0 rg BT 407.39 499.00 Td (ef) Tj ET Q q 0 0 0 rg BT 414.98 499.00 Td (fective ) Tj ET Q q 0 0 0 rg BT 444.62 499.00 Td (at ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 454.28 499.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 512.80 499.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 532.80 499.00 Td ( ) Tj ET Q q 0 0 0 rg BT 535.24 499.00 Td (to ) Tj ET Q q 0 0 0 rg BT 545.46 499.00 Td (provide ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 487.00 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 80.59 487.00 Td (assurance ) Tj ET Q q 0 0 0 rg BT 121.29 487.00 Td (regarding ) Tj ET Q q 0 0 0 rg BT 161.43 487.00 Td (the ) Tj ET Q q 0 0 0 rg BT 175.48 487.00 Td (reliability ) Tj ET Q q 0 0 0 rg BT 216.19 487.00 Td (of ) Tj ET Q q 0 0 0 rg BT 226.36 487.00 Td (its ) Tj ET Q q 0 0 0 rg BT 237.64 487.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 274.45 487.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 312.94 487.00 Td (and ) Tj ET Q q 0 0 0 rg BT 329.21 487.00 Td (the ) Tj ET Q q 0 0 0 rg BT 343.26 487.00 Td (preparation ) Tj ET Q q 0 0 0 rg BT 390.62 487.00 Td (of ) Tj ET Q q 0 0 0 rg BT 400.78 487.00 Td (its ) Tj ET Q q 0 0 0 rg BT 412.07 487.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 448.88 487.00 Td (statements ) Tj ET Q q 0 0 0 rg BT 492.92 487.00 Td (for ) Tj ET Q q 0 0 0 rg BT 506.42 487.00 Td (external ) Tj ET Q q 0 0 0 rg BT 540.45 487.00 Td (purposes ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 475.00 Td (in ) Tj ET Q q 0 0 0 rg BT 45.95 475.00 Td (accordance ) Tj ET Q q 0 0 0 rg BT 93.08 475.00 Td (with ) Tj ET Q q 0 0 0 rg BT 113.02 475.00 Td (United ) Tj ET Q q 0 0 0 rg BT 142.41 475.00 Td (States ) Tj ET Q q 0 0 0 rg BT 168.46 475.00 Td (generally ) Tj ET Q q 0 0 0 rg BT 207.83 475.00 Td (accepted ) Tj ET Q q 0 0 0 rg BT 244.97 475.00 Td (accounting ) Tj ET Q q 0 0 0 rg BT 291.01 475.00 Td (principles. ) Tj ET Q q 0 0 0 rg BT 335.11 475.00 Td (Due ) Tj ET Q q 0 0 0 rg BT 353.94 475.00 Td (to ) Tj ET Q q 0 0 0 rg BT 363.89 475.00 Td (its ) Tj ET Q q 0 0 0 rg BT 375.50 475.00 Td (inherent ) Tj ET Q q 0 0 0 rg BT 410.43 475.00 Td (limitations, ) Tj ET Q q 0 0 0 rg BT 457.88 475.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 490.59 475.00 Td (control ) Tj ET Q q 0 0 0 rg BT 521.08 475.00 Td (over ) Tj ET Q q 0 0 0 rg BT 541.02 475.00 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 463.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 75.43 463.00 Td (may ) Tj ET Q q 0 0 0 rg BT 95.41 463.00 Td (not ) Tj ET Q q 0 0 0 rg BT 110.96 463.00 Td (prevent ) Tj ET Q q 0 0 0 rg BT 143.72 463.00 Td (or ) Tj ET Q q 0 0 0 rg BT 154.82 463.00 Td (detect ) Tj ET Q q 0 0 0 rg BT 181.46 463.00 Td (misstatements. ) Tj ET Q q 0 0 0 rg BT 242.78 463.00 Td (Also, ) Tj ET Q q 0 0 0 rg BT 266.94 463.00 Td (projections ) Tj ET Q q 0 0 0 rg BT 314.14 463.00 Td (of ) Tj ET Q q 0 0 0 rg BT 325.24 463.00 Td (any ) Tj ET Q q 0 0 0 rg BT 342.45 463.00 Td (evaluation ) Tj ET Q q 0 0 0 rg BT 386.87 463.00 Td (of ) Tj ET Q q 0 0 0 rg BT 397.97 463.00 Td (ef) Tj ET Q q 0 0 0 rg BT 405.56 463.00 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 452.75 463.00 Td (to ) Tj ET Q q 0 0 0 rg BT 463.30 463.00 Td (future ) Tj ET Q q 0 0 0 rg BT 489.95 463.00 Td (periods ) Tj ET Q q 0 0 0 rg BT 522.16 463.00 Td (are ) Tj ET Q q 0 0 0 rg BT 537.13 463.00 Td (subject ) Tj ET Q q 0 0 0 rg BT 568.23 463.00 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 451.00 Td (the ) Tj ET Q q 0 0 0 rg BT 51.26 451.00 Td (risk ) Tj ET Q q 0 0 0 rg BT 69.29 451.00 Td (that ) Tj ET Q q 0 0 0 rg BT 87.33 451.00 Td (controls ) Tj ET Q q 0 0 0 rg BT 122.58 451.00 Td (may ) Tj ET Q q 0 0 0 rg BT 142.84 451.00 Td (become ) Tj ET Q q 0 0 0 rg BT 176.97 451.00 Td (inadequate ) Tj ET Q q 0 0 0 rg BT 223.32 451.00 Td (because ) Tj ET Q q 0 0 0 rg BT 258.00 451.00 Td (of ) Tj ET Q q 0 0 0 rg BT 269.37 451.00 Td (changes ) Tj ET Q q 0 0 0 rg BT 304.62 451.00 Td (in ) Tj ET Q q 0 0 0 rg BT 315.44 451.00 Td (conditions, ) Tj ET Q q 0 0 0 rg BT 362.64 451.00 Td (or ) Tj ET Q q 0 0 0 rg BT 374.01 451.00 Td (that ) Tj ET Q q 0 0 0 rg BT 392.04 451.00 Td (the ) Tj ET Q q 0 0 0 rg BT 407.30 451.00 Td (degree ) Tj ET Q q 0 0 0 rg BT 436.98 451.00 Td (of ) Tj ET Q q 0 0 0 rg BT 448.35 451.00 Td (compliance ) Tj ET Q q 0 0 0 rg BT 497.48 451.00 Td (with ) Tj ET Q q 0 0 0 rg BT 518.29 451.00 Td (the ) Tj ET Q q 0 0 0 rg BT 533.55 451.00 Td (policies ) Tj ET Q q 0 0 0 rg BT 567.69 451.00 Td (or ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 439.00 Td (procedures ) Tj ET Q q 0 0 0 rg BT 82.37 439.00 Td (may ) Tj ET Q q 0 0 0 rg BT 102.08 439.00 Td (deteriorate.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 415.00 Td (Deloitte & ) Tj ET Q q 0 0 0 rg BT 80.98 415.00 Td (T) Tj ET Q q 0 0 0 rg BT 86.39 415.00 Td (ouche ) Tj ET Q q 0 0 0 rg BT 112.96 415.00 Td (LLP) Tj ET Q q 0 0 0 rg BT 129.63 415.00 Td (, ) Tj ET Q q 0 0 0 rg BT 134.81 415.00 Td (an ) Tj ET Q q 0 0 0 rg BT 146.94 415.00 Td (independent ) Tj ET Q q 0 0 0 rg BT 198.50 415.00 Td (registered ) Tj ET Q q 0 0 0 rg BT 240.61 415.00 Td (public ) Tj ET Q q 0 0 0 rg BT 268.29 415.00 Td (accounting ) Tj ET Q q 0 0 0 rg BT 314.85 415.00 Td (firm, ) Tj ET Q q 0 0 0 rg BT 337.25 415.00 Td (has ) Tj ET Q q 0 0 0 rg BT 353.27 415.00 Td (audited ) Tj ET Q q 0 0 0 rg BT 385.39 415.00 Td (the ) Tj ET Q q 0 0 0 rg BT 400.30 415.00 Td (Company’) Tj ET Q q 0 0 0 rg BT 441.96 415.00 Td (s ) Tj ET Q q 0 0 0 rg BT 448.54 415.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 486.21 415.00 Td (statements ) Tj ET Q q 0 0 0 rg BT 531.11 415.00 Td (included ) Tj ET Q q 0 0 0 rg BT 568.23 415.00 Td (in ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 403.00 Td (this ) Tj ET Q q 0 0 0 rg BT 53.85 403.00 Td (report ) Tj ET Q q 0 0 0 rg BT 81.13 403.00 Td (on ) Tj ET Q q 0 0 0 rg BT 94.53 403.00 Td (Form ) Tj ET Q q 0 0 0 rg BT 119.60 403.00 Td (10-K ) Tj ET Q q 0 0 0 rg BT 143.56 403.00 Td (and ) Tj ET Q q 0 0 0 rg BT 161.40 403.00 Td (issued ) Tj ET Q q 0 0 0 rg BT 189.80 403.00 Td (its ) Tj ET Q q 0 0 0 rg BT 202.65 403.00 Td (report ) Tj ET Q q 0 0 0 rg BT 229.93 403.00 Td (on ) Tj ET Q q 0 0 0 rg BT 243.33 403.00 Td (the ) Tj ET Q q 0 0 0 rg BT 258.95 403.00 Td (ef) Tj ET Q q 0 0 0 rg BT 266.54 403.00 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 314.37 403.00 Td (of ) Tj ET Q q 0 0 0 rg BT 326.10 403.00 Td (the ) Tj ET Q q 0 0 0 rg BT 341.72 403.00 Td (Company’) Tj ET Q q 0 0 0 rg BT 383.38 403.00 Td (s ) Tj ET Q q 0 0 0 rg BT 390.68 403.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 424.62 403.00 Td (control ) Tj ET Q q 0 0 0 rg BT 456.35 403.00 Td (over ) Tj ET Q q 0 0 0 rg BT 477.52 403.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 515.90 403.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 555.96 403.00 Td (as ) Tj ET Q q 0 0 0 rg BT 567.69 403.00 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 391.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 94.58 391.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 114.58 391.00 Td (, ) Tj ET Q q 0 0 0 rg BT 119.58 391.00 Td (which ) Tj ET Q q 0 0 0 rg BT 146.52 391.00 Td (is ) Tj ET Q q 0 0 0 rg BT 155.69 391.00 Td (included ) Tj ET Q q 0 0 0 rg BT 192.63 391.00 Td (herein.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 367.00 Td (Changes ) Tj ET Q q 0 0 0 rg BT 75.17 367.00 Td (in ) Tj ET Q q 0 0 0 rg BT 86.01 367.00 Td (Internal ) Tj ET Q q 0 0 0 rg BT 123.51 367.00 Td (Contr) Tj ET Q q 0 0 0 rg BT 148.89 367.00 Td (ol ) Tj ET Q q 0 0 0 rg BT 159.16 367.00 Td (Over) Tj ET Q q 0 0 0 rg BT 180.64 367.00 Td ( ) Tj ET Q q 0 0 0 rg BT 183.14 367.00 Td (Financial ) Tj ET Q q 0 0 0 rg BT 225.64 367.00 Td (Reporting) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 343.00 Td (There ) Tj ET Q q 0 0 0 rg BT 61.51 343.00 Td (were ) Tj ET Q q 0 0 0 rg BT 83.14 343.00 Td (no ) Tj ET Q q 0 0 0 rg BT 95.33 343.00 Td (changes ) Tj ET Q q 0 0 0 rg BT 129.74 343.00 Td (in ) Tj ET Q q 0 0 0 rg BT 139.71 343.00 Td (the ) Tj ET Q q 0 0 0 rg BT 154.12 343.00 Td (Company's ) Tj ET Q q 0 0 0 rg BT 200.90 343.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 233.64 343.00 Td (control ) Tj ET Q q 0 0 0 rg BT 264.16 343.00 Td (over ) Tj ET Q q 0 0 0 rg BT 284.13 343.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 321.30 343.00 Td (reporting ) Tj ET Q q 0 0 0 rg BT 360.15 343.00 Td (during ) Tj ET Q q 0 0 0 rg BT 388.46 343.00 Td (the ) Tj ET Q q 0 0 0 rg BT 402.87 343.00 Td (quarter ) Tj ET Q q 0 0 0 rg BT 433.38 343.00 Td (ended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.46 343.00 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 517.74 343.00 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 537.74 343.00 Td ( ) Tj ET Q q 0 0 0 rg BT 539.93 343.00 Td (that ) Tj ET Q q 0 0 0 rg BT 557.12 343.00 Td (have ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 331.00 Td (materially ) Tj ET Q q 0 0 0 rg BT 79.04 331.00 Td (af) Tj ET Q q 0 0 0 rg BT 86.63 331.00 Td (fected, ) Tj ET Q q 0 0 0 rg BT 116.05 331.00 Td (or ) Tj ET Q q 0 0 0 rg BT 126.88 331.00 Td (are ) Tj ET Q q 0 0 0 rg BT 141.59 331.00 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 186.84 331.00 Td (likely ) Tj ET Q q 0 0 0 rg BT 212.11 331.00 Td (to ) Tj ET Q q 0 0 0 rg BT 222.39 331.00 Td (materially ) Tj ET Q q 0 0 0 rg BT 265.43 331.00 Td (af) Tj ET Q q 0 0 0 rg BT 273.02 331.00 Td (fect, ) Tj ET Q q 0 0 0 rg BT 293.00 331.00 Td (the ) Tj ET Q q 0 0 0 rg BT 307.72 331.00 Td (Company's ) Tj ET Q q 0 0 0 rg BT 354.80 331.00 Td (internal ) Tj ET Q q 0 0 0 rg BT 387.84 331.00 Td (control ) Tj ET Q q 0 0 0 rg BT 418.67 331.00 Td (over ) Tj ET Q q 0 0 0 rg BT 438.93 331.00 Td (financial ) Tj ET Q q 0 0 0 rg BT 476.42 331.00 Td (reporting.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 299.23 Td (Item 9B.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 299.23 Td (OTHER INFORMATION.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 271.00 Td (None.) Tj ET Q endstream endobj 205 0 obj <> endobj 206 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (102) Tj ET Q BT /F1 11.00 Tf ET q 0 0 0 rg BT 36.00 748.40 Td (REPOR) Tj ET Q q 0 0 0 rg BT 70.79 748.40 Td (T) Tj ET Q q 0 0 0 rg BT 77.31 748.40 Td ( OF INDEPENDENT) Tj ET Q q 0 0 0 rg BT 173.05 748.40 Td ( REGISTERED PUBLIC ) Tj ET Q q 0 0 0 rg BT 287.03 748.40 Td (ACCOUNTING FIRM) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 724.40 Td (T) Tj ET Q q 0 0 0 rg BT 41.41 724.40 Td (o the Board of Directors and Shareholders of) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 712.40 Td (Bristol-Myers Squibb Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 688.40 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 688.40 Td (e ) Tj ET Q q 0 0 0 rg BT 51.38 688.40 Td (have ) Tj ET Q q 0 0 0 rg BT 72.57 688.40 Td (audited ) Tj ET Q q 0 0 0 rg BT 104.31 688.40 Td (the ) Tj ET Q q 0 0 0 rg BT 118.83 688.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 151.68 688.40 Td (control ) Tj ET Q q 0 0 0 rg BT 182.31 688.40 Td (over ) Tj ET Q q 0 0 0 rg BT 202.38 688.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 239.67 688.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 278.63 688.40 Td (of ) Tj ET Q q 0 0 0 rg BT 289.27 688.40 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 347.68 688.40 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 378.33 688.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 419.52 688.40 Td (and ) Tj ET Q q 0 0 0 rg BT 436.26 688.40 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 485.79 688.40 Td (\(the ) Tj ET Q q 0 0 0 rg BT 503.64 688.40 Td (“Company”\) ) Tj ET Q q 0 0 0 rg BT 557.04 688.40 Td (as ) Tj ET Q q 0 0 0 rg BT 567.68 688.40 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 676.40 Td (December ) Tj ET Q q 0 0 0 rg BT 78.66 676.40 Td (31, ) Tj ET Q q 0 0 0 rg BT 92.74 676.40 Td (2016, ) Tj ET Q q 0 0 0 rg BT 116.82 676.40 Td (based ) Tj ET Q q 0 0 0 rg BT 141.16 676.40 Td (on ) Tj ET Q q 0 0 0 rg BT 152.74 676.40 Td (criteria ) Tj ET Q q 0 0 0 rg BT 182.63 676.40 Td (established ) Tj ET Q q 0 0 0 rg BT 228.64 676.40 Td (in ) Tj ET Q q 0 0 0 rg BT 237.99 676.40 Td (Internal ) Tj ET Q q 0 0 0 rg BT 270.66 676.40 Td (Control-Integrated ) Tj ET Q q 0 0 0 rg BT 346.66 676.40 Td (Framework ) Tj ET Q q 0 0 0 rg BT 394.33 676.40 Td (\(2013\) ) Tj ET Q q 0 0 0 rg BT 422.57 676.40 Td (issued ) Tj ET Q q 0 0 0 rg BT 449.15 676.40 Td (by ) Tj ET Q q 0 0 0 rg BT 460.73 676.40 Td (the ) Tj ET Q q 0 0 0 rg BT 474.52 676.40 Td (Committee ) Tj ET Q q 0 0 0 rg BT 520.54 676.40 Td (of ) Tj ET Q q 0 0 0 rg BT 530.44 676.40 Td (Sponsoring ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 664.40 Td (Or) Tj ET Q q 0 0 0 rg BT 46.37 664.40 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 94.31 664.40 Td (of ) Tj ET Q q 0 0 0 rg BT 105.04 664.40 Td (the ) Tj ET Q q 0 0 0 rg BT 119.48 664.40 Td (T) Tj ET Q q 0 0 0 rg BT 125.23 664.40 Td (readway ) Tj ET Q q 0 0 0 rg BT 161.50 664.40 Td (Commission. ) Tj ET Q q 0 0 0 rg BT 216.79 664.40 Td (The ) Tj ET Q q 0 0 0 rg BT 234.73 664.40 Td (Company’) Tj ET Q q 0 0 0 rg BT 276.39 664.40 Td (s ) Tj ET Q q 0 0 0 rg BT 282.68 664.40 Td (management ) Tj ET Q q 0 0 0 rg BT 336.17 664.40 Td (is ) Tj ET Q q 0 0 0 rg BT 345.23 664.40 Td (responsible ) Tj ET Q q 0 0 0 rg BT 393.18 664.40 Td (for ) Tj ET Q q 0 0 0 rg BT 407.23 664.40 Td (maintaining ) Tj ET Q q 0 0 0 rg BT 457.40 664.40 Td (ef) Tj ET Q q 0 0 0 rg BT 464.99 664.40 Td (fective ) Tj ET Q q 0 0 0 rg BT 494.59 664.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 527.52 664.40 Td (control ) Tj ET Q q 0 0 0 rg BT 558.25 664.40 Td (over ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 652.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 73.42 652.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 112.52 652.40 Td (and ) Tj ET Q q 0 0 0 rg BT 129.41 652.40 Td (for ) Tj ET Q q 0 0 0 rg BT 143.51 652.40 Td (its ) Tj ET Q q 0 0 0 rg BT 155.40 652.40 Td (assessment ) Tj ET Q q 0 0 0 rg BT 202.28 652.40 Td (of ) Tj ET Q q 0 0 0 rg BT 213.06 652.40 Td (the ) Tj ET Q q 0 0 0 rg BT 227.72 652.40 Td (ef) Tj ET Q q 0 0 0 rg BT 235.31 652.40 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 282.17 652.40 Td (of ) Tj ET Q q 0 0 0 rg BT 292.95 652.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 325.93 652.40 Td (control ) Tj ET Q q 0 0 0 rg BT 356.70 652.40 Td (over ) Tj ET Q q 0 0 0 rg BT 376.92 652.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 414.34 652.40 Td (reporting, ) Tj ET Q q 0 0 0 rg BT 455.94 652.40 Td (included ) Tj ET Q q 0 0 0 rg BT 492.82 652.40 Td (in ) Tj ET Q q 0 0 0 rg BT 503.04 652.40 Td (the ) Tj ET Q q 0 0 0 rg BT 517.70 652.40 Td (accompanying ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 640.40 Td (Management’) Tj ET Q q 0 0 0 rg BT 90.98 640.40 Td (s ) Tj ET Q q 0 0 0 rg BT 96.53 640.40 Td (Report ) Tj ET Q q 0 0 0 rg BT 125.40 640.40 Td (on ) Tj ET Q q 0 0 0 rg BT 137.06 640.40 Td (Internal ) Tj ET Q q 0 0 0 rg BT 169.81 640.40 Td (Control ) Tj ET Q q 0 0 0 rg BT 202.02 640.40 Td (Over ) Tj ET Q q 0 0 0 rg BT 223.67 640.40 Td (Financial ) Tj ET Q q 0 0 0 rg BT 262.54 640.40 Td (Reporting. ) Tj ET Q q 0 0 0 rg BT 306.69 640.40 Td (Our ) Tj ET Q q 0 0 0 rg BT 323.90 640.40 Td (responsibility ) Tj ET Q q 0 0 0 rg BT 380.00 640.40 Td (is ) Tj ET Q q 0 0 0 rg BT 388.33 640.40 Td (to ) Tj ET Q q 0 0 0 rg BT 397.76 640.40 Td (express ) Tj ET Q q 0 0 0 rg BT 429.41 640.40 Td (an ) Tj ET Q q 0 0 0 rg BT 440.50 640.40 Td (opinion ) Tj ET Q q 0 0 0 rg BT 472.72 640.40 Td (on ) Tj ET Q q 0 0 0 rg BT 484.37 640.40 Td (the ) Tj ET Q q 0 0 0 rg BT 498.25 640.40 Td (Company’) Tj ET Q q 0 0 0 rg BT 539.91 640.40 Td (s ) Tj ET Q q 0 0 0 rg BT 545.46 640.40 Td (internal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 628.40 Td (control ) Tj ET Q q 0 0 0 rg BT 66.83 628.40 Td (over ) Tj ET Q q 0 0 0 rg BT 87.09 628.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 124.57 628.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 163.73 628.40 Td (based ) Tj ET Q q 0 0 0 rg BT 189.00 628.40 Td (on ) Tj ET Q q 0 0 0 rg BT 201.50 628.40 Td (our ) Tj ET Q q 0 0 0 rg BT 217.33 628.40 Td (audit.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 604.40 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 604.40 Td (e ) Tj ET Q q 0 0 0 rg BT 52.00 604.40 Td (conducted ) Tj ET Q q 0 0 0 rg BT 96.02 604.40 Td (our ) Tj ET Q q 0 0 0 rg BT 112.27 604.40 Td (audit ) Tj ET Q q 0 0 0 rg BT 135.19 604.40 Td (in ) Tj ET Q q 0 0 0 rg BT 145.90 604.40 Td (accordance ) Tj ET Q q 0 0 0 rg BT 193.78 604.40 Td (with ) Tj ET Q q 0 0 0 rg BT 214.49 604.40 Td (the ) Tj ET Q q 0 0 0 rg BT 229.63 604.40 Td (standards ) Tj ET Q q 0 0 0 rg BT 270.32 604.40 Td (of ) Tj ET Q q 0 0 0 rg BT 281.58 604.40 Td (the ) Tj ET Q q 0 0 0 rg BT 296.72 604.40 Td (Public ) Tj ET Q q 0 0 0 rg BT 325.20 604.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 366.37 604.40 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 415.95 604.40 Td (Oversight ) Tj ET Q q 0 0 0 rg BT 458.31 604.40 Td (Board ) Tj ET Q q 0 0 0 rg BT 485.67 604.40 Td (\(United ) Tj ET Q q 0 0 0 rg BT 519.14 604.40 Td (States\). ) Tj ET Q q 0 0 0 rg BT 551.57 604.40 Td (Those ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 592.40 Td (standards ) Tj ET Q q 0 0 0 rg BT 75.66 592.40 Td (require ) Tj ET Q q 0 0 0 rg BT 105.87 592.40 Td (that ) Tj ET Q q 0 0 0 rg BT 122.76 592.40 Td (we ) Tj ET Q q 0 0 0 rg BT 136.31 592.40 Td (plan ) Tj ET Q q 0 0 0 rg BT 155.42 592.40 Td (and ) Tj ET Q q 0 0 0 rg BT 171.76 592.40 Td (perform ) Tj ET Q q 0 0 0 rg BT 205.86 592.40 Td (the ) Tj ET Q q 0 0 0 rg BT 219.97 592.40 Td (audit ) Tj ET Q q 0 0 0 rg BT 241.86 592.40 Td (to ) Tj ET Q q 0 0 0 rg BT 251.53 592.40 Td (obtain ) Tj ET Q q 0 0 0 rg BT 278.42 592.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 323.06 592.40 Td (assurance ) Tj ET Q q 0 0 0 rg BT 363.82 592.40 Td (about ) Tj ET Q q 0 0 0 rg BT 387.93 592.40 Td (whether ) Tj ET Q q 0 0 0 rg BT 422.04 592.40 Td (ef) Tj ET Q q 0 0 0 rg BT 429.62 592.40 Td (fective ) Tj ET Q q 0 0 0 rg BT 458.72 592.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 491.15 592.40 Td (control ) Tj ET Q q 0 0 0 rg BT 521.37 592.40 Td (over ) Tj ET Q q 0 0 0 rg BT 541.04 592.40 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 580.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 74.05 580.40 Td (was ) Tj ET Q q 0 0 0 rg BT 91.00 580.40 Td (maintained ) Tj ET Q q 0 0 0 rg BT 136.83 580.40 Td (in ) Tj ET Q q 0 0 0 rg BT 146.01 580.40 Td (all ) Tj ET Q q 0 0 0 rg BT 157.40 580.40 Td (material ) Tj ET Q q 0 0 0 rg BT 191.56 580.40 Td (respects. ) Tj ET Q q 0 0 0 rg BT 227.67 580.40 Td (Our ) Tj ET Q q 0 0 0 rg BT 244.62 580.40 Td (audit ) Tj ET Q q 0 0 0 rg BT 266.01 580.40 Td (included ) Tj ET Q q 0 0 0 rg BT 301.84 580.40 Td (obtaining ) Tj ET Q q 0 0 0 rg BT 341.02 580.40 Td (an ) Tj ET Q q 0 0 0 rg BT 351.85 580.40 Td (understanding ) Tj ET Q q 0 0 0 rg BT 409.91 580.40 Td (of ) Tj ET Q q 0 0 0 rg BT 419.64 580.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 451.58 580.40 Td (control ) Tj ET Q q 0 0 0 rg BT 481.30 580.40 Td (over ) Tj ET Q q 0 0 0 rg BT 500.47 580.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 536.85 580.40 Td (reporting, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 568.40 Td (assessing ) Tj ET Q q 0 0 0 rg BT 75.56 568.40 Td (the ) Tj ET Q q 0 0 0 rg BT 90.12 568.40 Td (risk ) Tj ET Q q 0 0 0 rg BT 107.47 568.40 Td (that ) Tj ET Q q 0 0 0 rg BT 124.80 568.40 Td (a ) Tj ET Q q 0 0 0 rg BT 131.59 568.40 Td (material ) Tj ET Q q 0 0 0 rg BT 166.69 568.40 Td (weakness ) Tj ET Q q 0 0 0 rg BT 207.35 568.40 Td (exists, ) Tj ET Q q 0 0 0 rg BT 234.97 568.40 Td (testing ) Tj ET Q q 0 0 0 rg BT 263.98 568.40 Td (and ) Tj ET Q q 0 0 0 rg BT 280.76 568.40 Td (evaluating ) Tj ET Q q 0 0 0 rg BT 324.75 568.40 Td (the ) Tj ET Q q 0 0 0 rg BT 339.31 568.40 Td (design ) Tj ET Q q 0 0 0 rg BT 367.76 568.40 Td (and ) Tj ET Q q 0 0 0 rg BT 384.55 568.40 Td (operating ) Tj ET Q q 0 0 0 rg BT 424.65 568.40 Td (ef) Tj ET Q q 0 0 0 rg BT 432.24 568.40 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 479.01 568.40 Td (of ) Tj ET Q q 0 0 0 rg BT 489.68 568.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 522.56 568.40 Td (control ) Tj ET Q q 0 0 0 rg BT 553.23 568.40 Td (based ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 556.40 Td (on ) Tj ET Q q 0 0 0 rg BT 48.64 556.40 Td (the ) Tj ET Q q 0 0 0 rg BT 63.50 556.40 Td (assessed ) Tj ET Q q 0 0 0 rg BT 100.03 556.40 Td (risk, ) Tj ET Q q 0 0 0 rg BT 120.17 556.40 Td (and ) Tj ET Q q 0 0 0 rg BT 137.25 556.40 Td (performing ) Tj ET Q q 0 0 0 rg BT 184.88 556.40 Td (such ) Tj ET Q q 0 0 0 rg BT 205.85 556.40 Td (other ) Tj ET Q q 0 0 0 rg BT 229.04 556.40 Td (procedures ) Tj ET Q q 0 0 0 rg BT 275.55 556.40 Td (as ) Tj ET Q q 0 0 0 rg BT 286.53 556.40 Td (we ) Tj ET Q q 0 0 0 rg BT 300.83 556.40 Td (considered ) Tj ET Q q 0 0 0 rg BT 346.79 556.40 Td (necessary ) Tj ET Q q 0 0 0 rg BT 388.30 556.40 Td (in ) Tj ET Q q 0 0 0 rg BT 398.72 556.40 Td (the ) Tj ET Q q 0 0 0 rg BT 413.58 556.40 Td (circumstances. ) Tj ET Q q 0 0 0 rg BT 475.17 556.40 Td (W) Tj ET Q q 0 0 0 rg BT 483.81 556.40 Td (e ) Tj ET Q q 0 0 0 rg BT 490.89 556.40 Td (believe ) Tj ET Q q 0 0 0 rg BT 522.41 556.40 Td (that ) Tj ET Q q 0 0 0 rg BT 540.05 556.40 Td (our ) Tj ET Q q 0 0 0 rg BT 556.02 556.40 Td (audit ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 544.40 Td (provides ) Tj ET Q q 0 0 0 rg BT 72.94 544.40 Td (a ) Tj ET Q q 0 0 0 rg BT 79.88 544.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 125.13 544.40 Td (basis ) Tj ET Q q 0 0 0 rg BT 147.63 544.40 Td (for ) Tj ET Q q 0 0 0 rg BT 161.79 544.40 Td (our ) Tj ET Q q 0 0 0 rg BT 177.62 544.40 Td (opinion. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 520.40 Td (A) Tj ET Q q 0 0 0 rg BT 42.67 520.40 Td ( ) Tj ET Q q 0 0 0 rg BT 45.93 520.40 Td (company’) Tj ET Q q 0 0 0 rg BT 85.36 520.40 Td (s ) Tj ET Q q 0 0 0 rg BT 92.51 520.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 126.31 520.40 Td (control ) Tj ET Q q 0 0 0 rg BT 157.90 520.40 Td (over ) Tj ET Q q 0 0 0 rg BT 178.92 520.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 217.16 520.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 257.07 520.40 Td (is ) Tj ET Q q 0 0 0 rg BT 267.00 520.40 Td (a ) Tj ET Q q 0 0 0 rg BT 274.70 520.40 Td (process ) Tj ET Q q 0 0 0 rg BT 307.95 520.40 Td (designed ) Tj ET Q q 0 0 0 rg BT 346.75 520.40 Td (by) Tj ET Q q 0 0 0 rg BT 356.10 520.40 Td (, ) Tj ET Q q 0 0 0 rg BT 361.86 520.40 Td (or ) Tj ET Q q 0 0 0 rg BT 373.45 520.40 Td (under ) Tj ET Q q 0 0 0 rg BT 399.48 520.40 Td (the ) Tj ET Q q 0 0 0 rg BT 414.95 520.40 Td (supervision ) Tj ET Q q 0 0 0 rg BT 464.32 520.40 Td (of, ) Tj ET Q q 0 0 0 rg BT 478.41 520.40 Td (the ) Tj ET Q q 0 0 0 rg BT 493.88 520.40 Td (company’) Tj ET Q q 0 0 0 rg BT 533.32 520.40 Td (s ) Tj ET Q q 0 0 0 rg BT 540.47 520.40 Td (principal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 508.40 Td (executive ) Tj ET Q q 0 0 0 rg BT 77.37 508.40 Td (and ) Tj ET Q q 0 0 0 rg BT 94.86 508.40 Td (principal ) Tj ET Q q 0 0 0 rg BT 133.46 508.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 171.49 508.40 Td (of) Tj ET Q q 0 0 0 rg BT 179.64 508.40 Td (ficers, ) Tj ET Q q 0 0 0 rg BT 207.41 508.40 Td (or ) Tj ET Q q 0 0 0 rg BT 218.79 508.40 Td (persons ) Tj ET Q q 0 0 0 rg BT 252.40 508.40 Td (performing ) Tj ET Q q 0 0 0 rg BT 300.44 508.40 Td (similar ) Tj ET Q q 0 0 0 rg BT 331.27 508.40 Td (functions, ) Tj ET Q q 0 0 0 rg BT 374.04 508.40 Td (and ) Tj ET Q q 0 0 0 rg BT 391.54 508.40 Td (ef) Tj ET Q q 0 0 0 rg BT 399.12 508.40 Td (fected ) Tj ET Q q 0 0 0 rg BT 426.60 508.40 Td (by ) Tj ET Q q 0 0 0 rg BT 439.66 508.40 Td (the ) Tj ET Q q 0 0 0 rg BT 454.93 508.40 Td (company’) Tj ET Q q 0 0 0 rg BT 494.37 508.40 Td (s ) Tj ET Q q 0 0 0 rg BT 501.31 508.40 Td (board ) Tj ET Q q 0 0 0 rg BT 527.14 508.40 Td (of ) Tj ET Q q 0 0 0 rg BT 538.52 508.40 Td (directors, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 496.40 Td (management, ) Tj ET Q q 0 0 0 rg BT 92.10 496.40 Td (and ) Tj ET Q q 0 0 0 rg BT 109.05 496.40 Td (other ) Tj ET Q q 0 0 0 rg BT 132.11 496.40 Td (personnel ) Tj ET Q q 0 0 0 rg BT 173.50 496.40 Td (to ) Tj ET Q q 0 0 0 rg BT 183.79 496.40 Td (provide ) Tj ET Q q 0 0 0 rg BT 216.85 496.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 262.12 496.40 Td (assurance ) Tj ET Q q 0 0 0 rg BT 303.50 496.40 Td (regarding ) Tj ET Q q 0 0 0 rg BT 344.32 496.40 Td (the ) Tj ET Q q 0 0 0 rg BT 359.05 496.40 Td (reliability ) Tj ET Q q 0 0 0 rg BT 400.44 496.40 Td (of ) Tj ET Q q 0 0 0 rg BT 411.28 496.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 448.78 496.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 487.94 496.40 Td (and ) Tj ET Q q 0 0 0 rg BT 504.89 496.40 Td (the ) Tj ET Q q 0 0 0 rg BT 519.62 496.40 Td (preparation ) Tj ET Q q 0 0 0 rg BT 567.67 496.40 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 484.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 74.10 484.40 Td (statements ) Tj ET Q q 0 0 0 rg BT 119.42 484.40 Td (for ) Tj ET Q q 0 0 0 rg BT 134.20 484.40 Td (external ) Tj ET Q q 0 0 0 rg BT 169.52 484.40 Td (purposes ) Tj ET Q q 0 0 0 rg BT 208.18 484.40 Td (in ) Tj ET Q q 0 0 0 rg BT 219.08 484.40 Td (accordance ) Tj ET Q q 0 0 0 rg BT 267.15 484.40 Td (with ) Tj ET Q q 0 0 0 rg BT 288.05 484.40 Td (generally ) Tj ET Q q 0 0 0 rg BT 328.36 484.40 Td (accepted ) Tj ET Q q 0 0 0 rg BT 366.45 484.40 Td (accounting ) Tj ET Q q 0 0 0 rg BT 413.44 484.40 Td (principles. ) Tj ET Q q 0 0 0 rg BT 457.80 484.40 Td (A) Tj ET Q q 0 0 0 rg BT 464.47 484.40 Td ( ) Tj ET Q q 0 0 0 rg BT 467.58 484.40 Td (company’) Tj ET Q q 0 0 0 rg BT 507.02 484.40 Td (s ) Tj ET Q q 0 0 0 rg BT 514.02 484.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 547.68 484.40 Td (control ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 472.40 Td (over ) Tj ET Q q 0 0 0 rg BT 56.47 472.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 94.15 472.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 133.51 472.40 Td (includes ) Tj ET Q q 0 0 0 rg BT 169.54 472.40 Td (those ) Tj ET Q q 0 0 0 rg BT 193.35 472.40 Td (policies ) Tj ET Q q 0 0 0 rg BT 227.15 472.40 Td (and ) Tj ET Q q 0 0 0 rg BT 244.29 472.40 Td (procedures ) Tj ET Q q 0 0 0 rg BT 290.86 472.40 Td (that ) Tj ET Q q 0 0 0 rg BT 308.56 472.40 Td (\(1\) ) Tj ET Q q 0 0 0 rg BT 322.92 472.40 Td (pertain ) Tj ET Q q 0 0 0 rg BT 353.38 472.40 Td (to ) Tj ET Q q 0 0 0 rg BT 363.86 472.40 Td (the ) Tj ET Q q 0 0 0 rg BT 378.78 472.40 Td (maintenance ) Tj ET Q q 0 0 0 rg BT 432.01 472.40 Td (of ) Tj ET Q q 0 0 0 rg BT 443.04 472.40 Td (records ) Tj ET Q q 0 0 0 rg BT 475.17 472.40 Td (that, ) Tj ET Q q 0 0 0 rg BT 495.37 472.40 Td (in ) Tj ET Q q 0 0 0 rg BT 505.85 472.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 551.31 472.40 Td (detail, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 460.40 Td (accurately ) Tj ET Q q 0 0 0 rg BT 78.38 460.40 Td (and ) Tj ET Q q 0 0 0 rg BT 94.11 460.40 Td (fairly ) Tj ET Q q 0 0 0 rg BT 117.07 460.40 Td (reflect ) Tj ET Q q 0 0 0 rg BT 143.90 460.40 Td (the ) Tj ET Q q 0 0 0 rg BT 157.41 460.40 Td (transactions ) Tj ET Q q 0 0 0 rg BT 206.47 460.40 Td (and ) Tj ET Q q 0 0 0 rg BT 222.21 460.40 Td (dispositions ) Tj ET Q q 0 0 0 rg BT 271.29 460.40 Td (of ) Tj ET Q q 0 0 0 rg BT 280.92 460.40 Td (the ) Tj ET Q q 0 0 0 rg BT 294.44 460.40 Td (assets ) Tj ET Q q 0 0 0 rg BT 319.07 460.40 Td (of ) Tj ET Q q 0 0 0 rg BT 328.69 460.40 Td (the ) Tj ET Q q 0 0 0 rg BT 342.21 460.40 Td (company; ) Tj ET Q q 0 0 0 rg BT 382.94 460.40 Td (\(2\) ) Tj ET Q q 0 0 0 rg BT 395.90 460.40 Td (provide ) Tj ET Q q 0 0 0 rg BT 427.74 460.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 471.79 460.40 Td (assurance ) Tj ET Q q 0 0 0 rg BT 511.96 460.40 Td (that ) Tj ET Q q 0 0 0 rg BT 528.25 460.40 Td (transactions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 448.40 Td (are ) Tj ET Q q 0 0 0 rg BT 50.43 448.40 Td (recorded ) Tj ET Q q 0 0 0 rg BT 87.62 448.40 Td (as ) Tj ET Q q 0 0 0 rg BT 98.17 448.40 Td (necessary ) Tj ET Q q 0 0 0 rg BT 139.26 448.40 Td (to ) Tj ET Q q 0 0 0 rg BT 149.26 448.40 Td (permit ) Tj ET Q q 0 0 0 rg BT 177.59 448.40 Td (preparation ) Tj ET Q q 0 0 0 rg BT 225.34 448.40 Td (of ) Tj ET Q q 0 0 0 rg BT 235.89 448.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 273.09 448.40 Td (statements ) Tj ET Q q 0 0 0 rg BT 317.52 448.40 Td (in ) Tj ET Q q 0 0 0 rg BT 327.52 448.40 Td (accordance ) Tj ET Q q 0 0 0 rg BT 374.70 448.40 Td (with ) Tj ET Q q 0 0 0 rg BT 394.70 448.40 Td (generally ) Tj ET Q q 0 0 0 rg BT 434.13 448.40 Td (accepted ) Tj ET Q q 0 0 0 rg BT 471.32 448.40 Td (accounting ) Tj ET Q q 0 0 0 rg BT 517.41 448.40 Td (principles, ) Tj ET Q q 0 0 0 rg BT 561.56 448.40 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 436.40 Td (that ) Tj ET Q q 0 0 0 rg BT 53.78 436.40 Td (receipts ) Tj ET Q q 0 0 0 rg BT 87.67 436.40 Td (and ) Tj ET Q q 0 0 0 rg BT 104.89 436.40 Td (expenditures ) Tj ET Q q 0 0 0 rg BT 158.77 436.40 Td (of ) Tj ET Q q 0 0 0 rg BT 169.89 436.40 Td (the ) Tj ET Q q 0 0 0 rg BT 184.90 436.40 Td (company ) Tj ET Q q 0 0 0 rg BT 224.34 436.40 Td (are ) Tj ET Q q 0 0 0 rg BT 239.33 436.40 Td (being ) Tj ET Q q 0 0 0 rg BT 264.34 436.40 Td (made ) Tj ET Q q 0 0 0 rg BT 288.78 436.40 Td (only ) Tj ET Q q 0 0 0 rg BT 309.35 436.40 Td (in ) Tj ET Q q 0 0 0 rg BT 319.92 436.40 Td (accordance ) Tj ET Q q 0 0 0 rg BT 367.67 436.40 Td (with ) Tj ET Q q 0 0 0 rg BT 388.23 436.40 Td (authorizations ) Tj ET Q q 0 0 0 rg BT 447.67 436.40 Td (of ) Tj ET Q q 0 0 0 rg BT 458.79 436.40 Td (management ) Tj ET Q q 0 0 0 rg BT 512.67 436.40 Td (and ) Tj ET Q q 0 0 0 rg BT 529.89 436.40 Td (directors ) Tj ET Q q 0 0 0 rg BT 567.67 436.40 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 424.40 Td (the ) Tj ET Q q 0 0 0 rg BT 49.60 424.40 Td (company; ) Tj ET Q q 0 0 0 rg BT 90.42 424.40 Td (and ) Tj ET Q q 0 0 0 rg BT 106.24 424.40 Td (\(3\) ) Tj ET Q q 0 0 0 rg BT 119.28 424.40 Td (provide ) Tj ET Q q 0 0 0 rg BT 151.21 424.40 Td (reasonable ) Tj ET Q q 0 0 0 rg BT 195.35 424.40 Td (assurance ) Tj ET Q q 0 0 0 rg BT 235.60 424.40 Td (regarding ) Tj ET Q q 0 0 0 rg BT 275.30 424.40 Td (prevention ) Tj ET Q q 0 0 0 rg BT 319.45 424.40 Td (or ) Tj ET Q q 0 0 0 rg BT 329.16 424.40 Td (timely ) Tj ET Q q 0 0 0 rg BT 356.09 424.40 Td (detection ) Tj ET Q q 0 0 0 rg BT 394.13 424.40 Td (of ) Tj ET Q q 0 0 0 rg BT 403.84 424.40 Td (unauthorized ) Tj ET Q q 0 0 0 rg BT 457.43 424.40 Td (acquisition, ) Tj ET Q q 0 0 0 rg BT 505.19 424.40 Td (use, ) Tj ET Q q 0 0 0 rg BT 522.41 424.40 Td (or ) Tj ET Q q 0 0 0 rg BT 532.12 424.40 Td (disposition ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 412.40 Td (of ) Tj ET Q q 0 0 0 rg BT 46.83 412.40 Td (the ) Tj ET Q q 0 0 0 rg BT 61.55 412.40 Td (company’) Tj ET Q q 0 0 0 rg BT 100.98 412.40 Td (s ) Tj ET Q q 0 0 0 rg BT 107.37 412.40 Td (assets ) Tj ET Q q 0 0 0 rg BT 133.20 412.40 Td (that ) Tj ET Q q 0 0 0 rg BT 150.70 412.40 Td (could ) Tj ET Q q 0 0 0 rg BT 175.41 412.40 Td (have ) Tj ET Q q 0 0 0 rg BT 196.79 412.40 Td (a ) Tj ET Q q 0 0 0 rg BT 203.73 412.40 Td (material ) Tj ET Q q 0 0 0 rg BT 238.99 412.40 Td (ef) Tj ET Q q 0 0 0 rg BT 246.58 412.40 Td (fect ) Tj ET Q q 0 0 0 rg BT 264.06 412.40 Td (on ) Tj ET Q q 0 0 0 rg BT 276.56 412.40 Td (the ) Tj ET Q q 0 0 0 rg BT 291.28 412.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 328.76 412.40 Td (statements. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 388.40 Td (Because ) Tj ET Q q 0 0 0 rg BT 73.42 388.40 Td (of ) Tj ET Q q 0 0 0 rg BT 85.86 388.40 Td (the ) Tj ET Q q 0 0 0 rg BT 102.19 388.40 Td (inherent ) Tj ET Q q 0 0 0 rg BT 139.06 388.40 Td (limitations ) Tj ET Q q 0 0 0 rg BT 185.95 388.40 Td (of ) Tj ET Q q 0 0 0 rg BT 198.39 388.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 233.04 388.40 Td (control ) Tj ET Q q 0 0 0 rg BT 265.47 388.40 Td (over ) Tj ET Q q 0 0 0 rg BT 287.35 388.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 326.44 388.40 Td (reporting, ) Tj ET Q q 0 0 0 rg BT 369.70 388.40 Td (including ) Tj ET Q q 0 0 0 rg BT 411.59 388.40 Td (the ) Tj ET Q q 0 0 0 rg BT 427.91 388.40 Td (possibility ) Tj ET Q q 0 0 0 rg BT 473.70 388.40 Td (of ) Tj ET Q q 0 0 0 rg BT 486.13 388.40 Td (collusion ) Tj ET Q q 0 0 0 rg BT 526.91 388.40 Td (or ) Tj ET Q q 0 0 0 rg BT 539.35 388.40 Td (improper ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 376.40 Td (management ) Tj ET Q q 0 0 0 rg BT 89.38 376.40 Td (override ) Tj ET Q q 0 0 0 rg BT 124.99 376.40 Td (of ) Tj ET Q q 0 0 0 rg BT 135.62 376.40 Td (controls, ) Tj ET Q q 0 0 0 rg BT 172.63 376.40 Td (material ) Tj ET Q q 0 0 0 rg BT 207.68 376.40 Td (misstatements ) Tj ET Q q 0 0 0 rg BT 266.64 376.40 Td (due ) Tj ET Q q 0 0 0 rg BT 283.37 376.40 Td (to ) Tj ET Q q 0 0 0 rg BT 293.45 376.40 Td (error ) Tj ET Q q 0 0 0 rg BT 315.17 376.40 Td (or ) Tj ET Q q 0 0 0 rg BT 325.79 376.40 Td (fraud ) Tj ET Q q 0 0 0 rg BT 349.19 376.40 Td (may ) Tj ET Q q 0 0 0 rg BT 368.70 376.40 Td (not ) Tj ET Q q 0 0 0 rg BT 383.77 376.40 Td (be ) Tj ET Q q 0 0 0 rg BT 395.51 376.40 Td (prevented ) Tj ET Q q 0 0 0 rg BT 437.23 376.40 Td (or ) Tj ET Q q 0 0 0 rg BT 447.85 376.40 Td (detected ) Tj ET Q q 0 0 0 rg BT 483.46 376.40 Td (on ) Tj ET Q q 0 0 0 rg BT 495.75 376.40 Td (a ) Tj ET Q q 0 0 0 rg BT 502.48 376.40 Td (timely ) Tj ET Q q 0 0 0 rg BT 530.33 376.40 Td (basis. ) Tj ET Q q 0 0 0 rg BT 554.62 376.40 Td (Also, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 364.40 Td (projections ) Tj ET Q q 0 0 0 rg BT 82.97 364.40 Td (of ) Tj ET Q q 0 0 0 rg BT 93.83 364.40 Td (any ) Tj ET Q q 0 0 0 rg BT 110.80 364.40 Td (evaluation ) Tj ET Q q 0 0 0 rg BT 154.98 364.40 Td (of ) Tj ET Q q 0 0 0 rg BT 165.84 364.40 Td (the ) Tj ET Q q 0 0 0 rg BT 180.59 364.40 Td (ef) Tj ET Q q 0 0 0 rg BT 188.18 364.40 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 235.13 364.40 Td (of ) Tj ET Q q 0 0 0 rg BT 246.00 364.40 Td (the ) Tj ET Q q 0 0 0 rg BT 260.74 364.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 293.82 364.40 Td (control ) Tj ET Q q 0 0 0 rg BT 324.67 364.40 Td (over ) Tj ET Q q 0 0 0 rg BT 344.97 364.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 382.49 364.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 421.67 364.40 Td (to ) Tj ET Q q 0 0 0 rg BT 431.98 364.40 Td (future ) Tj ET Q q 0 0 0 rg BT 458.39 364.40 Td (periods ) Tj ET Q q 0 0 0 rg BT 490.36 364.40 Td (are ) Tj ET Q q 0 0 0 rg BT 505.10 364.40 Td (subject ) Tj ET Q q 0 0 0 rg BT 535.96 364.40 Td (to ) Tj ET Q q 0 0 0 rg BT 546.27 364.40 Td (the ) Tj ET Q q 0 0 0 rg BT 561.02 364.40 Td (risk ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 352.40 Td (that ) Tj ET Q q 0 0 0 rg BT 52.66 352.40 Td (the ) Tj ET Q q 0 0 0 rg BT 66.54 352.40 Td (controls ) Tj ET Q q 0 0 0 rg BT 100.42 352.40 Td (may ) Tj ET Q q 0 0 0 rg BT 119.30 352.40 Td (become ) Tj ET Q q 0 0 0 rg BT 152.06 352.40 Td (inadequate ) Tj ET Q q 0 0 0 rg BT 197.03 352.40 Td (because ) Tj ET Q q 0 0 0 rg BT 230.34 352.40 Td (of ) Tj ET Q q 0 0 0 rg BT 240.34 352.40 Td (changes ) Tj ET Q q 0 0 0 rg BT 274.21 352.40 Td (in ) Tj ET Q q 0 0 0 rg BT 283.65 352.40 Td (conditions, ) Tj ET Q q 0 0 0 rg BT 329.48 352.40 Td (or ) Tj ET Q q 0 0 0 rg BT 339.47 352.40 Td (that ) Tj ET Q q 0 0 0 rg BT 356.13 352.40 Td (the ) Tj ET Q q 0 0 0 rg BT 370.01 352.40 Td (degree ) Tj ET Q q 0 0 0 rg BT 398.32 352.40 Td (of ) Tj ET Q q 0 0 0 rg BT 408.32 352.40 Td (compliance ) Tj ET Q q 0 0 0 rg BT 456.07 352.40 Td (with ) Tj ET Q q 0 0 0 rg BT 475.51 352.40 Td (the ) Tj ET Q q 0 0 0 rg BT 489.39 352.40 Td (policies ) Tj ET Q q 0 0 0 rg BT 522.16 352.40 Td (or ) Tj ET Q q 0 0 0 rg BT 532.16 352.40 Td (procedures ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 340.40 Td (may ) Tj ET Q q 0 0 0 rg BT 55.72 340.40 Td (deteriorate. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 316.40 Td (In ) Tj ET Q q 0 0 0 rg BT 46.89 316.40 Td (our ) Tj ET Q q 0 0 0 rg BT 62.79 316.40 Td (opinion, ) Tj ET Q q 0 0 0 rg BT 98.41 316.40 Td (the ) Tj ET Q q 0 0 0 rg BT 113.19 316.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 154.64 316.40 Td (maintained, ) Tj ET Q q 0 0 0 rg BT 204.13 316.40 Td (in ) Tj ET Q q 0 0 0 rg BT 214.47 316.40 Td (all ) Tj ET Q q 0 0 0 rg BT 227.03 316.40 Td (material ) Tj ET Q q 0 0 0 rg BT 262.35 316.40 Td (respects, ) Tj ET Q q 0 0 0 rg BT 299.62 316.40 Td (ef) Tj ET Q q 0 0 0 rg BT 307.21 316.40 Td (fective ) Tj ET Q q 0 0 0 rg BT 336.98 316.40 Td (internal ) Tj ET Q q 0 0 0 rg BT 370.08 316.40 Td (control ) Tj ET Q q 0 0 0 rg BT 400.97 316.40 Td (over ) Tj ET Q q 0 0 0 rg BT 421.30 316.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 458.85 316.40 Td (reporting ) Tj ET Q q 0 0 0 rg BT 498.07 316.40 Td (as ) Tj ET Q q 0 0 0 rg BT 508.96 316.40 Td (of ) Tj ET Q q 0 0 0 rg BT 519.85 316.40 Td (December ) Tj ET Q q 0 0 0 rg BT 563.50 316.40 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 304.40 Td (2016, ) Tj ET Q q 0 0 0 rg BT 62.76 304.40 Td (based ) Tj ET Q q 0 0 0 rg BT 89.79 304.40 Td (on ) Tj ET Q q 0 0 0 rg BT 104.05 304.40 Td (the ) Tj ET Q q 0 0 0 rg BT 120.53 304.40 Td (criteria ) Tj ET Q q 0 0 0 rg BT 153.10 304.40 Td (established ) Tj ET Q q 0 0 0 rg BT 201.79 304.40 Td (in ) Tj ET Q q 0 0 0 rg BT 213.83 304.40 Td (Internal ) Tj ET Q q 0 0 0 rg BT 249.19 304.40 Td (Control-Integrated ) Tj ET Q q 0 0 0 rg BT 327.87 304.40 Td (Framework ) Tj ET Q q 0 0 0 rg BT 378.23 304.40 Td (\(2013\) ) Tj ET Q q 0 0 0 rg BT 409.15 304.40 Td (issued ) Tj ET Q q 0 0 0 rg BT 438.41 304.40 Td (by ) Tj ET Q q 0 0 0 rg BT 452.67 304.40 Td (the ) Tj ET Q q 0 0 0 rg BT 469.15 304.40 Td (Committee ) Tj ET Q q 0 0 0 rg BT 517.85 304.40 Td (of ) Tj ET Q q 0 0 0 rg BT 530.44 304.40 Td (Sponsoring ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 292.40 Td (Or) Tj ET Q q 0 0 0 rg BT 46.37 292.40 Td (ganizations ) Tj ET Q q 0 0 0 rg BT 94.41 292.40 Td (of ) Tj ET Q q 0 0 0 rg BT 105.24 292.40 Td (the ) Tj ET Q q 0 0 0 rg BT 119.78 292.40 Td (T) Tj ET Q q 0 0 0 rg BT 125.54 292.40 Td (readway ) Tj ET Q q 0 0 0 rg BT 161.90 292.40 Td (Commission.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 268.40 Td (W) Tj ET Q q 0 0 0 rg BT 44.64 268.40 Td (e ) Tj ET Q q 0 0 0 rg BT 53.10 268.40 Td (have ) Tj ET Q q 0 0 0 rg BT 76.00 268.40 Td (also ) Tj ET Q q 0 0 0 rg BT 96.13 268.40 Td (audited, ) Tj ET Q q 0 0 0 rg BT 132.08 268.40 Td (in ) Tj ET Q q 0 0 0 rg BT 143.88 268.40 Td (accordance ) Tj ET Q q 0 0 0 rg BT 192.86 268.40 Td (with ) Tj ET Q q 0 0 0 rg BT 214.66 268.40 Td (the ) Tj ET Q q 0 0 0 rg BT 230.90 268.40 Td (standards ) Tj ET Q q 0 0 0 rg BT 272.69 268.40 Td (of ) Tj ET Q q 0 0 0 rg BT 285.04 268.40 Td (the ) Tj ET Q q 0 0 0 rg BT 301.28 268.40 Td (Public ) Tj ET Q q 0 0 0 rg BT 330.86 268.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 372.88 268.40 Td (Accounting ) Tj ET Q q 0 0 0 rg BT 423.56 268.40 Td (Oversight ) Tj ET Q q 0 0 0 rg BT 467.02 268.40 Td (Board ) Tj ET Q q 0 0 0 rg BT 495.48 268.40 Td (\(United ) Tj ET Q q 0 0 0 rg BT 530.04 268.40 Td (States\), ) Tj ET Q q 0 0 0 rg BT 563.78 268.40 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 256.40 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 89.46 256.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 127.36 256.40 Td (statements ) Tj ET Q q 0 0 0 rg BT 172.49 256.40 Td (as ) Tj ET Q q 0 0 0 rg BT 183.74 256.40 Td (of ) Tj ET Q q 0 0 0 rg BT 194.99 256.40 Td (and ) Tj ET Q q 0 0 0 rg BT 212.35 256.40 Td (for ) Tj ET Q q 0 0 0 rg BT 226.93 256.40 Td (the ) Tj ET Q q 0 0 0 rg BT 242.06 256.40 Td (year ) Tj ET Q q 0 0 0 rg BT 262.19 256.40 Td (ended ) Tj ET Q q 0 0 0 rg BT 288.98 256.40 Td (December ) Tj ET Q q 0 0 0 rg BT 332.99 256.40 Td (31, ) Tj ET Q q 0 0 0 rg BT 348.41 256.40 Td (2016 ) Tj ET Q q 0 0 0 rg BT 371.32 256.40 Td (of ) Tj ET Q q 0 0 0 rg BT 382.57 256.40 Td (the ) Tj ET Q q 0 0 0 rg BT 397.71 256.40 Td (Company ) Tj ET Q q 0 0 0 rg BT 439.51 256.40 Td (and ) Tj ET Q q 0 0 0 rg BT 456.87 256.40 Td (our ) Tj ET Q q 0 0 0 rg BT 473.12 256.40 Td (report ) Tj ET Q q 0 0 0 rg BT 499.92 256.40 Td (dated ) Tj ET Q q 0 0 0 rg BT 524.49 256.40 Td (February ) Tj ET Q q 0 0 0 rg BT 563.51 256.40 Td (21, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 244.40 Td (2017 ) Tj ET Q q 0 0 0 rg BT 58.50 244.40 Td (expressed ) Tj ET Q q 0 0 0 rg BT 100.43 244.40 Td (an ) Tj ET Q q 0 0 0 rg BT 112.37 244.40 Td (unqualified ) Tj ET Q q 0 0 0 rg BT 160.41 244.40 Td (opinion ) Tj ET Q q 0 0 0 rg BT 193.47 244.40 Td (on ) Tj ET Q q 0 0 0 rg BT 205.97 244.40 Td (those ) Tj ET Q q 0 0 0 rg BT 229.57 244.40 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 282.62 244.40 Td (financial ) Tj ET Q q 0 0 0 rg BT 320.10 244.40 Td (statements.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 36.00 220.40 Td (/s/ DELOITTE & T) Tj ET Q q 0 0 0 rg BT 112.78 220.40 Td (OUCHE LLP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 196.40 Td (Parsippany) Tj ET Q q 0 0 0 rg BT 79.79 196.40 Td (, New Jersey) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 184.40 Td (February 21, 2017) Tj ET Q endstream endobj 207 0 obj <><><><><><><><><><><><>] /Rotate 0 /Contents 208 0 R>> endobj 208 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (103) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (P) Tj ET Q q 0 0 0 rg BT 41.37 749.25 Td (AR) Tj ET Q q 0 0 0 rg BT 55.46 749.25 Td (T) Tj ET Q q 0 0 0 rg BT 61.95 749.25 Td ( III) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 717.48 Td (Item 10.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 717.48 Td (DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.45 695.25 Td (\(a\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.45 695.25 Td (Reference ) Tj ET Q q 0 0 0 rg BT 110.42 695.25 Td (is ) Tj ET Q q 0 0 0 rg BT 120.53 695.25 Td (made ) Tj ET Q q 0 0 0 rg BT 145.63 695.25 Td (to ) Tj ET Q q 0 0 0 rg BT 156.85 695.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 172.51 695.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 192.51 695.25 Td ( ) Tj ET Q q 0 0 0 rg BT 195.96 695.25 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 223.29 695.25 Td (Statement ) Tj ET Q q 0 0 0 rg BT 266.73 695.25 Td (to ) Tj ET Q q 0 0 0 rg BT 277.95 695.25 Td (be ) Tj ET Q q 0 0 0 rg BT 290.83 695.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 312.60 695.25 Td (on ) Tj ET Q q 0 0 0 rg BT 326.04 695.25 Td (or ) Tj ET Q q 0 0 0 rg BT 337.82 695.25 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 363.48 695.25 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 408.02 695.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 428.02 695.25 Td ( ) Tj ET Q q 0 0 0 rg BT 431.46 695.25 Td (with ) Tj ET Q q 0 0 0 rg BT 452.69 695.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 484.45 695.25 Td (to ) Tj ET Q q 0 0 0 rg BT 495.67 695.25 Td (the ) Tj ET Q q 0 0 0 rg BT 511.33 695.25 Td (Directors ) Tj ET Q q 0 0 0 rg BT 551.98 695.25 Td (of ) Tj ET Q q 0 0 0 rg BT 563.75 695.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.45 683.25 Td (Registrant, ) Tj ET Q q 0 0 0 rg BT 112.36 683.25 Td (which ) Tj ET Q q 0 0 0 rg BT 139.11 683.25 Td (is ) Tj ET Q q 0 0 0 rg BT 148.09 683.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 200.93 683.25 Td (herein ) Tj ET Q q 0 0 0 rg BT 228.23 683.25 Td (by ) Tj ET Q q 0 0 0 rg BT 240.54 683.25 Td (reference ) Tj ET Q q 0 0 0 rg BT 280.03 683.25 Td (and ) Tj ET Q q 0 0 0 rg BT 296.78 683.25 Td (made ) Tj ET Q q 0 0 0 rg BT 320.74 683.25 Td (a ) Tj ET Q q 0 0 0 rg BT 327.49 683.25 Td (part ) Tj ET Q q 0 0 0 rg BT 345.35 683.25 Td (hereof ) Tj ET Q q 0 0 0 rg BT 373.19 683.25 Td (in ) Tj ET Q q 0 0 0 rg BT 383.28 683.25 Td (response ) Tj ET Q q 0 0 0 rg BT 420.58 683.25 Td (to ) Tj ET Q q 0 0 0 rg BT 430.67 683.25 Td (the ) Tj ET Q q 0 0 0 rg BT 445.20 683.25 Td (information ) Tj ET Q q 0 0 0 rg BT 494.72 683.25 Td (required ) Tj ET Q q 0 0 0 rg BT 530.34 683.25 Td (by ) Tj ET Q q 0 0 0 rg BT 542.65 683.25 Td (Item 10.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.45 665.25 Td (\(b\) ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.45 665.25 Td (The ) Tj ET Q q 0 0 0 rg BT 84.33 665.25 Td (information ) Tj ET Q q 0 0 0 rg BT 133.88 665.25 Td (required ) Tj ET Q q 0 0 0 rg BT 169.53 665.25 Td (by ) Tj ET Q q 0 0 0 rg BT 181.86 665.25 Td (Item 10 ) Tj ET Q q 0 0 0 rg BT 215.02 665.25 Td (with ) Tj ET Q q 0 0 0 rg BT 235.13 665.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 265.78 665.25 Td (to ) Tj ET Q q 0 0 0 rg BT 275.89 665.25 Td (the ) Tj ET Q q 0 0 0 rg BT 290.44 665.25 Td (Executive ) Tj ET Q q 0 0 0 rg BT 332.76 665.25 Td (Of) Tj ET Q q 0 0 0 rg BT 343.13 665.25 Td (ficers ) Tj ET Q q 0 0 0 rg BT 367.67 665.25 Td (of ) Tj ET Q q 0 0 0 rg BT 378.33 665.25 Td (the ) Tj ET Q q 0 0 0 rg BT 392.89 665.25 Td (Registrant ) Tj ET Q q 0 0 0 rg BT 436.32 665.25 Td (has ) Tj ET Q q 0 0 0 rg BT 451.99 665.25 Td (been ) Tj ET Q q 0 0 0 rg BT 473.20 665.25 Td (included ) Tj ET Q q 0 0 0 rg BT 509.97 665.25 Td (in ) Tj ET Q q 0 0 0 rg BT 520.08 665.25 Td (Part ) Tj ET Q q 0 0 0 rg BT 538.52 665.25 Td (IA) Tj ET Q q 0 0 0 rg BT 548.52 665.25 Td ( ) Tj ET Q q 0 0 0 rg BT 550.85 665.25 Td (of ) Tj ET Q q 0 0 0 rg BT 561.52 665.25 Td (this ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.45 653.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 90.62 653.25 Td (10-K ) Tj ET Q q 0 0 0 rg BT 113.67 653.25 Td (in ) Tj ET Q q 0 0 0 rg BT 123.95 653.25 Td (reliance ) Tj ET Q q 0 0 0 rg BT 158.09 653.25 Td (on ) Tj ET Q q 0 0 0 rg BT 170.59 653.25 Td (General ) Tj ET Q q 0 0 0 rg BT 204.74 653.25 Td (Instruction ) Tj ET Q q 0 0 0 rg BT 250.56 653.25 Td (G ) Tj ET Q q 0 0 0 rg BT 260.28 653.25 Td (of ) Tj ET Q q 0 0 0 rg BT 271.11 653.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 295.28 653.25 Td (10-K ) Tj ET Q q 0 0 0 rg BT 318.33 653.25 Td (and ) Tj ET Q q 0 0 0 rg BT 335.27 653.25 Td (Instruction ) Tj ET Q q 0 0 0 rg BT 381.10 653.25 Td (3 ) Tj ET Q q 0 0 0 rg BT 388.60 653.25 Td (to ) Tj ET Q q 0 0 0 rg BT 398.88 653.25 Td (Item 401\(b\) ) Tj ET Q q 0 0 0 rg BT 448.86 653.25 Td (of ) Tj ET Q q 0 0 0 rg BT 459.69 653.25 Td (Regulation ) Tj ET Q q 0 0 0 rg BT 506.07 653.25 Td (S-K.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 621.48 Td (Item 11.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 621.48 Td (EXECUTIVE COMPENSATION.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 600.25 Td (Reference ) Tj ET Q q 0 0 0 rg BT 78.98 600.25 Td (is ) Tj ET Q q 0 0 0 rg BT 88.10 600.25 Td (made ) Tj ET Q q 0 0 0 rg BT 112.21 600.25 Td (to ) Tj ET Q q 0 0 0 rg BT 122.44 600.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.11 600.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.11 600.25 Td ( ) Tj ET Q q 0 0 0 rg BT 159.56 600.25 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 185.91 600.25 Td (Statement ) Tj ET Q q 0 0 0 rg BT 228.35 600.25 Td (to ) Tj ET Q q 0 0 0 rg BT 238.59 600.25 Td (be ) Tj ET Q q 0 0 0 rg BT 250.48 600.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 271.26 600.25 Td (on ) Tj ET Q q 0 0 0 rg BT 283.71 600.25 Td (or ) Tj ET Q q 0 0 0 rg BT 294.49 600.25 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 319.16 600.25 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 362.72 600.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 382.72 600.25 Td ( ) Tj ET Q q 0 0 0 rg BT 385.17 600.25 Td (with ) Tj ET Q q 0 0 0 rg BT 405.40 600.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 436.17 600.25 Td (to ) Tj ET Q q 0 0 0 rg BT 446.40 600.25 Td (Executive ) Tj ET Q q 0 0 0 rg BT 488.84 600.25 Td (Compensation, ) Tj ET Q q 0 0 0 rg BT 551.56 600.25 Td (which ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 588.25 Td (is ) Tj ET Q q 0 0 0 rg BT 45.17 588.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 98.20 588.25 Td (herein ) Tj ET Q q 0 0 0 rg BT 125.69 588.25 Td (by ) Tj ET Q q 0 0 0 rg BT 138.19 588.25 Td (reference ) Tj ET Q q 0 0 0 rg BT 177.87 588.25 Td (and ) Tj ET Q q 0 0 0 rg BT 194.81 588.25 Td (made ) Tj ET Q q 0 0 0 rg BT 218.96 588.25 Td (a ) Tj ET Q q 0 0 0 rg BT 225.90 588.25 Td (part ) Tj ET Q q 0 0 0 rg BT 243.95 588.25 Td (hereof ) Tj ET Q q 0 0 0 rg BT 271.99 588.25 Td (in ) Tj ET Q q 0 0 0 rg BT 282.26 588.25 Td (response ) Tj ET Q q 0 0 0 rg BT 319.75 588.25 Td (to ) Tj ET Q q 0 0 0 rg BT 330.03 588.25 Td (the ) Tj ET Q q 0 0 0 rg BT 344.75 588.25 Td (information ) Tj ET Q q 0 0 0 rg BT 394.46 588.25 Td (required ) Tj ET Q q 0 0 0 rg BT 430.28 588.25 Td (by ) Tj ET Q q 0 0 0 rg BT 442.78 588.25 Td (Item 1) Tj ET Q q 0 0 0 rg BT 468.23 588.25 Td (1.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 556.48 Td (Item 12.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 556.48 Td (SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 546.48 Td (STOCKHOLDER MATTERS.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 525.25 Td (Reference ) Tj ET Q q 0 0 0 rg BT 78.92 525.25 Td (is ) Tj ET Q q 0 0 0 rg BT 87.99 525.25 Td (made ) Tj ET Q q 0 0 0 rg BT 112.04 525.25 Td (to ) Tj ET Q q 0 0 0 rg BT 122.22 525.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 136.84 525.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 156.84 525.25 Td ( ) Tj ET Q q 0 0 0 rg BT 159.24 525.25 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 185.53 525.25 Td (Statement ) Tj ET Q q 0 0 0 rg BT 227.92 525.25 Td (to ) Tj ET Q q 0 0 0 rg BT 238.09 525.25 Td (be ) Tj ET Q q 0 0 0 rg BT 249.93 525.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 270.65 525.25 Td (on ) Tj ET Q q 0 0 0 rg BT 283.05 525.25 Td (or ) Tj ET Q q 0 0 0 rg BT 293.78 525.25 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.40 525.25 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 361.90 525.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 381.90 525.25 Td ( ) Tj ET Q q 0 0 0 rg BT 384.29 525.25 Td (with ) Tj ET Q q 0 0 0 rg BT 404.47 525.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 435.19 525.25 Td (to ) Tj ET Q q 0 0 0 rg BT 445.36 525.25 Td (the ) Tj ET Q q 0 0 0 rg BT 459.98 525.25 Td (security ) Tj ET Q q 0 0 0 rg BT 494.03 525.25 Td (ownership ) Tj ET Q q 0 0 0 rg BT 538.09 525.25 Td (of ) Tj ET Q q 0 0 0 rg BT 548.82 525.25 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 513.25 Td (beneficial ) Tj ET Q q 0 0 0 rg BT 78.49 513.25 Td (owners ) Tj ET Q q 0 0 0 rg BT 110.44 513.25 Td (and ) Tj ET Q q 0 0 0 rg BT 127.94 513.25 Td (management, ) Tj ET Q q 0 0 0 rg BT 184.60 513.25 Td (which ) Tj ET Q q 0 0 0 rg BT 212.11 513.25 Td (is ) Tj ET Q q 0 0 0 rg BT 221.84 513.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 275.44 513.25 Td (herein ) Tj ET Q q 0 0 0 rg BT 303.50 513.25 Td (by ) Tj ET Q q 0 0 0 rg BT 316.56 513.25 Td (reference ) Tj ET Q q 0 0 0 rg BT 356.82 513.25 Td (and ) Tj ET Q q 0 0 0 rg BT 374.32 513.25 Td (made ) Tj ET Q q 0 0 0 rg BT 399.04 513.25 Td (a ) Tj ET Q q 0 0 0 rg BT 406.55 513.25 Td (part ) Tj ET Q q 0 0 0 rg BT 425.17 513.25 Td (hereof ) Tj ET Q q 0 0 0 rg BT 453.77 513.25 Td (in ) Tj ET Q q 0 0 0 rg BT 464.62 513.25 Td (response ) Tj ET Q q 0 0 0 rg BT 502.68 513.25 Td (to ) Tj ET Q q 0 0 0 rg BT 513.52 513.25 Td (the ) Tj ET Q q 0 0 0 rg BT 528.81 513.25 Td (information ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 501.25 Td (required ) Tj ET Q q 0 0 0 rg BT 71.82 501.25 Td (by ) Tj ET Q q 0 0 0 rg BT 84.32 501.25 Td (Item 12.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 481.48 Td (Item 13.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 481.48 Td (CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 460.25 Td (Reference ) Tj ET Q q 0 0 0 rg BT 79.08 460.25 Td (is ) Tj ET Q q 0 0 0 rg BT 88.31 460.25 Td (made ) Tj ET Q q 0 0 0 rg BT 112.52 460.25 Td (to ) Tj ET Q q 0 0 0 rg BT 122.86 460.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 137.64 460.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 157.64 460.25 Td ( ) Tj ET Q q 0 0 0 rg BT 160.19 460.25 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 186.64 460.25 Td (Statement ) Tj ET Q q 0 0 0 rg BT 229.19 460.25 Td (to ) Tj ET Q q 0 0 0 rg BT 239.53 460.25 Td (be ) Tj ET Q q 0 0 0 rg BT 251.53 460.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 272.41 460.25 Td (on ) Tj ET Q q 0 0 0 rg BT 284.97 460.25 Td (or ) Tj ET Q q 0 0 0 rg BT 295.86 460.25 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 320.63 460.25 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 364.29 460.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 384.29 460.25 Td ( ) Tj ET Q q 0 0 0 rg BT 386.85 460.25 Td (with ) Tj ET Q q 0 0 0 rg BT 407.19 460.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 438.06 460.25 Td (to ) Tj ET Q q 0 0 0 rg BT 448.40 460.25 Td (certain ) Tj ET Q q 0 0 0 rg BT 478.16 460.25 Td (relationships ) Tj ET Q q 0 0 0 rg BT 531.82 460.25 Td (and ) Tj ET Q q 0 0 0 rg BT 548.82 460.25 Td (related ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 448.25 Td (transactions, ) Tj ET Q q 0 0 0 rg BT 88.76 448.25 Td (which ) Tj ET Q q 0 0 0 rg BT 115.70 448.25 Td (is ) Tj ET Q q 0 0 0 rg BT 124.87 448.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 177.90 448.25 Td (herein ) Tj ET Q q 0 0 0 rg BT 205.39 448.25 Td (by ) Tj ET Q q 0 0 0 rg BT 217.89 448.25 Td (reference ) Tj ET Q q 0 0 0 rg BT 257.57 448.25 Td (and ) Tj ET Q q 0 0 0 rg BT 274.51 448.25 Td (made ) Tj ET Q q 0 0 0 rg BT 298.67 448.25 Td (a ) Tj ET Q q 0 0 0 rg BT 305.60 448.25 Td (part ) Tj ET Q q 0 0 0 rg BT 323.65 448.25 Td (hereof ) Tj ET Q q 0 0 0 rg BT 351.69 448.25 Td (in ) Tj ET Q q 0 0 0 rg BT 361.97 448.25 Td (response ) Tj ET Q q 0 0 0 rg BT 399.46 448.25 Td (to ) Tj ET Q q 0 0 0 rg BT 409.74 448.25 Td (the ) Tj ET Q q 0 0 0 rg BT 424.45 448.25 Td (information ) Tj ET Q q 0 0 0 rg BT 474.16 448.25 Td (required ) Tj ET Q q 0 0 0 rg BT 509.98 448.25 Td (by ) Tj ET Q q 0 0 0 rg BT 522.48 448.25 Td (Item 13.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 428.48 Td (Item 14.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 428.48 Td (AUDITOR FEES.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 408.25 Td (Reference ) Tj ET Q q 0 0 0 rg BT 78.59 408.25 Td (is ) Tj ET Q q 0 0 0 rg BT 87.34 408.25 Td (made ) Tj ET Q q 0 0 0 rg BT 111.06 408.25 Td (to ) Tj ET Q q 0 0 0 rg BT 120.91 408.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 135.20 408.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 155.20 408.25 Td ( ) Tj ET Q q 0 0 0 rg BT 157.27 408.25 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 183.24 408.25 Td (Statement ) Tj ET Q q 0 0 0 rg BT 225.30 408.25 Td (to ) Tj ET Q q 0 0 0 rg BT 235.15 408.25 Td (be ) Tj ET Q q 0 0 0 rg BT 246.66 408.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 267.06 408.25 Td (on ) Tj ET Q q 0 0 0 rg BT 279.13 408.25 Td (or ) Tj ET Q q 0 0 0 rg BT 289.53 408.25 Td (about ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.82 408.25 Td (March 23, ) Tj ET Q q 0 0 0 rg BT 356.99 408.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 376.99 408.25 Td ( ) Tj ET Q q 0 0 0 rg BT 379.06 408.25 Td (with ) Tj ET Q q 0 0 0 rg BT 398.91 408.25 Td (respect ) Tj ET Q q 0 0 0 rg BT 429.30 408.25 Td (to ) Tj ET Q q 0 0 0 rg BT 439.15 408.25 Td (auditor ) Tj ET Q q 0 0 0 rg BT 469.54 408.25 Td (fees, ) Tj ET Q q 0 0 0 rg BT 490.22 408.25 Td (which ) Tj ET Q q 0 0 0 rg BT 516.73 408.25 Td (is ) Tj ET Q q 0 0 0 rg BT 525.47 408.25 Td (incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 396.25 Td (herein ) Tj ET Q q 0 0 0 rg BT 63.49 396.25 Td (by ) Tj ET Q q 0 0 0 rg BT 75.99 396.25 Td (reference ) Tj ET Q q 0 0 0 rg BT 115.67 396.25 Td (and ) Tj ET Q q 0 0 0 rg BT 132.61 396.25 Td (made ) Tj ET Q q 0 0 0 rg BT 156.76 396.25 Td (a ) Tj ET Q q 0 0 0 rg BT 163.70 396.25 Td (part ) Tj ET Q q 0 0 0 rg BT 181.75 396.25 Td (hereof ) Tj ET Q q 0 0 0 rg BT 209.78 396.25 Td (in ) Tj ET Q q 0 0 0 rg BT 220.06 396.25 Td (response ) Tj ET Q q 0 0 0 rg BT 257.55 396.25 Td (to ) Tj ET Q q 0 0 0 rg BT 267.83 396.25 Td (the ) Tj ET Q q 0 0 0 rg BT 282.55 396.25 Td (information ) Tj ET Q q 0 0 0 rg BT 332.26 396.25 Td (required ) Tj ET Q q 0 0 0 rg BT 368.08 396.25 Td (by ) Tj ET Q q 0 0 0 rg BT 380.58 396.25 Td (Item 14.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 372.25 Td (P) Tj ET Q q 0 0 0 rg BT 41.37 372.25 Td (AR) Tj ET Q q 0 0 0 rg BT 55.46 372.25 Td (T) Tj ET Q q 0 0 0 rg BT 61.95 372.25 Td ( IV) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 352.48 Td (Item 15.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 352.48 Td (EXHIBITS and FINANCIAL STATEMENT SCHEDULE.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 48.45 336.25 Td (\(a\) ) Tj ET Q BT /F1 10.00 Tf ET 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 518.5 290.75 m 576.5 290.75 l s BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 295.00 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 61.00 295.00 Td ( ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 538.75 302.83 Td (Page) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 532.85 294.83 Td (Number) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 281.32 Td (1.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.00 281.32 Td (Consolidated Financial Statements) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 265.9833984375 m 254.0322265625 265.9833984375 l s q 0 0 1 rg BT 106.00 267.32 Td (Consolidated ) Tj ET Q q 0 0 1 rg BT 161.27 267.32 Td (Statements ) Tj ET Q q 0 0 1 rg BT 207.66 267.32 Td (of ) Tj ET Q q 0 0 1 rg BT 218.49 267.32 Td (Earnings) Tj ET Q BT /F1 10.00 Tf ET 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 254.0322265625 265.9833984375 m 368.7197265625 265.9833984375 l s q 0 0 1 rg BT 254.03 267.32 Td ( ) Tj ET Q q 0 0 1 rg BT 256.53 267.32 Td (and ) Tj ET Q q 0 0 1 rg BT 273.47 267.32 Td (Comprehensive ) Tj ET Q q 0 0 1 rg BT 338.73 267.32 Td (Income) Tj ET Q BT /F1 10.00 Tf ET 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 251.9833984375 m 222.083984375 251.9833984375 l s q 0 0 1 rg BT 106.00 253.32 Td (Consolidated ) Tj ET Q q 0 0 1 rg BT 161.27 253.32 Td (Balance ) Tj ET Q q 0 0 1 rg BT 195.98 253.32 Td (Sheets) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 237.9833984375 m 265.4384765625 237.9833984375 l s q 0 0 1 rg BT 106.00 239.32 Td (Consolidated ) Tj ET Q q 0 0 1 rg BT 161.27 239.32 Td (Statements ) Tj ET Q q 0 0 1 rg BT 207.66 239.32 Td (of ) Tj ET Q q 0 0 1 rg BT 218.49 239.32 Td (Cash ) Tj ET Q q 0 0 1 rg BT 240.99 239.32 Td (Flows) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 223.9833984375 m 280.9755859375 223.9833984375 l s q 0 0 1 rg BT 106.00 225.32 Td (Notes ) Tj ET Q q 0 0 1 rg BT 131.83 225.32 Td (to ) Tj ET Q q 0 0 1 rg BT 142.11 225.32 Td (Consolidated ) Tj ET Q q 0 0 1 rg BT 197.38 225.32 Td (Financial ) Tj ET Q q 0 0 1 rg BT 237.09 225.32 Td (Statements) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 209.9833984375 m 339.8427734375 209.9833984375 l s q 0 0 1 rg BT 106.00 211.32 Td (Report ) Tj ET Q q 0 0 1 rg BT 135.72 211.32 Td (of ) Tj ET Q q 0 0 1 rg BT 146.55 211.32 Td (Independent ) Tj ET Q q 0 0 1 rg BT 198.47 211.32 Td (Registered ) Tj ET Q q 0 0 1 rg BT 243.73 211.32 Td (Public ) Tj ET Q q 0 0 1 rg BT 271.24 211.32 Td (Accounting ) Tj ET Q q 0 0 1 rg BT 320.39 211.32 Td (Firm) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL q 0 0 0 rg BT 39.00 192.42 Td (All ) Tj ET Q q 0 0 0 rg BT 53.38 192.42 Td (other ) Tj ET Q q 0 0 0 rg BT 75.52 192.42 Td (schedules ) Tj ET Q q 0 0 0 rg BT 116.00 192.42 Td (not ) Tj ET Q q 0 0 0 rg BT 130.37 192.42 Td (included ) Tj ET Q q 0 0 0 rg BT 166.40 192.42 Td (with ) Tj ET Q q 0 0 0 rg BT 185.78 192.42 Td (this ) Tj ET Q q 0 0 0 rg BT 201.83 192.42 Td (additional ) Tj ET Q q 0 0 0 rg BT 243.42 192.42 Td (financial ) Tj ET Q q 0 0 0 rg BT 279.99 192.42 Td (data ) Tj ET Q q 0 0 0 rg BT 298.25 192.42 Td (are ) Tj ET Q q 0 0 0 rg BT 312.05 192.42 Td (omitted ) Tj ET Q q 0 0 0 rg BT 344.20 192.42 Td (because ) Tj ET Q q 0 0 0 rg BT 377.45 192.42 Td (they ) Tj ET Q q 0 0 0 rg BT 396.26 192.42 Td (are ) Tj ET Q q 0 0 0 rg BT 410.07 192.42 Td (not ) Tj ET Q q 0 0 0 rg BT 424.44 192.42 Td (applicable ) Tj ET Q q 0 0 0 rg BT 467.13 192.42 Td (or ) Tj ET Q q 0 0 0 rg BT 477.06 192.42 Td (the ) Tj ET Q q 0 0 0 rg BT 490.87 192.42 Td (required ) Tj ET Q q 0 0 0 rg BT 525.79 192.42 Td (information ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 182.42 Td (is ) Tj ET Q q 0 0 0 rg BT 48.17 182.42 Td (included ) Tj ET Q q 0 0 0 rg BT 85.10 182.42 Td (in ) Tj ET Q q 0 0 0 rg BT 95.38 182.42 Td (the ) Tj ET Q q 0 0 0 rg BT 110.10 182.42 Td (financial ) Tj ET Q q 0 0 0 rg BT 147.58 182.42 Td (statements ) Tj ET Q q 0 0 0 rg BT 192.29 182.42 Td (or ) Tj ET Q q 0 0 0 rg BT 203.12 182.42 Td (notes ) Tj ET Q q 0 0 0 rg BT 226.73 182.42 Td (thereto.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 164.32 Td (2.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 106 162.9833984375 m 348.1826171875 162.9833984375 l s q 0 0 1 rg BT 106.00 164.32 Td (Exhibits ) Tj ET Q q 0 0 1 rg BT 141.83 164.32 Td (Required ) Tj ET Q q 0 0 1 rg BT 180.99 164.32 Td (to ) Tj ET Q q 0 0 1 rg BT 191.27 164.32 Td (be ) Tj ET Q q 0 0 1 rg BT 203.21 164.32 Td (filed ) Tj ET Q q 0 0 1 rg BT 224.03 164.32 Td (by ) Tj ET Q q 0 0 1 rg BT 236.53 164.32 Td (Item 601 ) Tj ET Q q 0 0 1 rg BT 274.86 164.32 Td (of ) Tj ET Q q 0 0 1 rg BT 285.69 164.32 Td (Regulation ) Tj ET Q q 0 0 1 rg BT 332.07 164.32 Td (S-K) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 139.25 Td (The information called for by this Item is incorporated herein by reference to the Exhibit Index in this Form 10-K.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 39.00 119.48 Td (Item 16.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 95.00 119.48 Td (FORM 10-K SUMMARY.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 99.25 Td (None.) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 563 265.9833984375 m 573 265.9833984375 l s q 0 0 1 rg BT 563.00 267.32 Td (53) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 563 251.9833984375 m 573 251.9833984375 l s q 0 0 1 rg BT 563.00 253.32 Td (54) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 563 237.9833984375 m 573 237.9833984375 l s q 0 0 1 rg BT 563.00 239.32 Td (55) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 563 223.9833984375 m 573 223.9833984375 l s q 0 0 1 rg BT 563.00 225.32 Td (56) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 558 209.9833984375 m 573 209.9833984375 l s q 0 0 1 rg BT 558.00 211.32 Td (100) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL 0 0 1 RG /GS0 gs 0.49 w 0 i [] 0 d 1 J 1 j 3 M 558 162.9833984375 m 573 162.9833984375 l s q 0 0 1 rg BT 558.00 164.32 Td (106) Tj ET Q BT /F1 10.00 Tf ET 0 Tr /GS0 gs 0 Tw 0 Tc 100 Tz 0 TL endstream endobj 209 0 obj <> endobj 210 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (104) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 749.10 Td (SIGNA) Tj ET Q q 0 0 0 rg BT 65.45 749.10 Td (TURES) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 732.10 Td (Pursuant ) Tj ET Q q 0 0 0 rg BT 73.48 732.10 Td (to ) Tj ET Q q 0 0 0 rg BT 83.74 732.10 Td (the ) Tj ET Q q 0 0 0 rg BT 98.43 732.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 153.12 732.10 Td (of ) Tj ET Q q 0 0 0 rg BT 163.92 732.10 Td (Section 13 ) Tj ET Q q 0 0 0 rg BT 208.90 732.10 Td (or ) Tj ET Q q 0 0 0 rg BT 219.71 732.10 Td (15 ) Tj ET Q q 0 0 0 rg BT 232.19 732.10 Td (\(d\) of ) Tj ET Q q 0 0 0 rg BT 257.16 732.10 Td (the ) Tj ET Q q 0 0 0 rg BT 271.85 732.10 Td (Securities ) Tj ET Q q 0 0 0 rg BT 313.77 732.10 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 355.12 732.10 Td (Act ) Tj ET Q q 0 0 0 rg BT 372.04 732.10 Td (of ) Tj ET Q q 0 0 0 rg BT 382.85 732.10 Td (1934, ) Tj ET Q q 0 0 0 rg BT 407.83 732.10 Td (the ) Tj ET Q q 0 0 0 rg BT 422.53 732.10 Td (Registrant ) Tj ET Q q 0 0 0 rg BT 466.11 732.10 Td (has ) Tj ET Q q 0 0 0 rg BT 481.92 732.10 Td (duly ) Tj ET Q q 0 0 0 rg BT 502.18 732.10 Td (caused ) Tj ET Q q 0 0 0 rg BT 531.86 732.10 Td (this ) Tj ET Q q 0 0 0 rg BT 548.79 732.10 Td (Report ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 720.10 Td (to ) Tj ET Q q 0 0 0 rg BT 46.28 720.10 Td (be ) Tj ET Q q 0 0 0 rg BT 58.22 720.10 Td (signed ) Tj ET Q q 0 0 0 rg BT 86.83 720.10 Td (on ) Tj ET Q q 0 0 0 rg BT 99.33 720.10 Td (its ) Tj ET Q q 0 0 0 rg BT 111.27 720.10 Td (behalf ) Tj ET Q q 0 0 0 rg BT 138.76 720.10 Td (by ) Tj ET Q q 0 0 0 rg BT 151.26 720.10 Td (the ) Tj ET Q q 0 0 0 rg BT 165.98 720.10 Td (undersigned, ) Tj ET Q q 0 0 0 rg BT 219.85 720.10 Td (thereunto ) Tj ET Q q 0 0 0 rg BT 260.12 720.10 Td (duly ) Tj ET Q q 0 0 0 rg BT 280.39 720.10 Td (authorized.) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 372.5 658.6 m 574.5 658.6 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.00 700.17 Td (BRIST) Tj ET Q q 0 0 0 rg BT 366.16 700.17 Td (OL-MYERS SQUIBB COMP) Tj ET Q q 0 0 0 rg BT 486.37 700.17 Td (ANY) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.00 690.17 Td (\(Registrant\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.00 663.17 Td (By) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 371.00 662.85 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 416.65 663.33 Td (/s/ GIOVANNI CAFORIO) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 338.00 649.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 371.00 649.85 Td ( ) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 435.60 649.33 Td (Giovanni Caforio) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 338.00 636.85 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 371.00 636.85 Td ( ) Tj ET Q BT /F4 10.00 Tf ET q 0 0 0 rg BT 424.20 636.33 Td (Chief Executive Officer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 338.00 610.17 Td (Date: February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 585.10 Td (Pursuant ) Tj ET Q q 0 0 0 rg BT 73.99 585.10 Td (to ) Tj ET Q q 0 0 0 rg BT 84.75 585.10 Td (the ) Tj ET Q q 0 0 0 rg BT 99.96 585.10 Td (requirements ) Tj ET Q q 0 0 0 rg BT 155.15 585.10 Td (of ) Tj ET Q q 0 0 0 rg BT 166.46 585.10 Td (the ) Tj ET Q q 0 0 0 rg BT 181.67 585.10 Td (Securities ) Tj ET Q q 0 0 0 rg BT 224.09 585.10 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 265.84 585.10 Td (Act ) Tj ET Q q 0 0 0 rg BT 283.27 585.10 Td (of ) Tj ET Q q 0 0 0 rg BT 294.58 585.10 Td (1934, ) Tj ET Q q 0 0 0 rg BT 320.07 585.10 Td (this ) Tj ET Q q 0 0 0 rg BT 337.51 585.10 Td (Report ) Tj ET Q q 0 0 0 rg BT 367.71 585.10 Td (has ) Tj ET Q q 0 0 0 rg BT 384.03 585.10 Td (been ) Tj ET Q q 0 0 0 rg BT 405.89 585.10 Td (signed ) Tj ET Q q 0 0 0 rg BT 434.99 585.10 Td (below ) Tj ET Q q 0 0 0 rg BT 462.41 585.10 Td (by ) Tj ET Q q 0 0 0 rg BT 475.40 585.10 Td (the ) Tj ET Q q 0 0 0 rg BT 490.60 585.10 Td (following ) Tj ET Q q 0 0 0 rg BT 532.48 585.10 Td (persons ) Tj ET Q q 0 0 0 rg BT 566.02 585.10 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 573.10 Td (behalf ) Tj ET Q q 0 0 0 rg BT 63.49 573.10 Td (of ) Tj ET Q q 0 0 0 rg BT 74.32 573.10 Td (the ) Tj ET Q q 0 0 0 rg BT 89.03 573.10 Td (Registrant ) Tj ET Q q 0 0 0 rg BT 132.64 573.10 Td (and ) Tj ET Q q 0 0 0 rg BT 149.57 573.10 Td (in ) Tj ET Q q 0 0 0 rg BT 159.85 573.10 Td (the ) Tj ET Q q 0 0 0 rg BT 174.57 573.10 Td (capacities ) Tj ET Q q 0 0 0 rg BT 216.49 573.10 Td (and ) Tj ET Q q 0 0 0 rg BT 233.43 573.10 Td (on ) Tj ET Q q 0 0 0 rg BT 245.93 573.10 Td (the ) Tj ET Q q 0 0 0 rg BT 260.64 573.10 Td (dates ) Tj ET Q q 0 0 0 rg BT 283.69 573.10 Td (indicated.) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 532.6 m 256.5 532.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 500.6 m 256.5 500.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 467.6 m 256.5 467.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 435.6 m 256.5 435.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 403.6 m 256.5 403.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 371.6 m 256.5 371.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 339.6 m 256.5 339.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 307.6 m 256.5 307.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 275.6 m 256.5 275.6 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 243.60000000000002 m 256.5 243.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 211.60000000000002 m 256.5 211.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 179.60000000000002 m 256.5 179.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 147.60000000000002 m 256.5 147.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 115.60000000000002 m 256.5 115.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 83.60000000000002 m 256.5 83.60000000000002 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 36.5 51.60000000000002 m 256.5 51.60000000000002 l s BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 39 553.430078125 m 72.19140625 553.430078125 l s q 0 0 0 rg BT 39.00 554.68 Td (Signature) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 259.00 554.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 350.05 553.430078125 m 365.9015625 553.430078125 l s q 0 0 0 rg BT 350.05 554.68 Td (Title) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 459.00 554.55 Td ( ) Tj ET Q BT /F2 8.00 Tf ET 0 0 0 RG /GS0 gs 0.76 w 0 i [] 0 d 1 J 1 j 3 M 499.5 553.430078125 m 515.4921875 553.430078125 l s q 0 0 0 rg BT 499.50 554.68 Td (Date) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 537.17 Td (/s/ GIOVANNI CAFORIO, M.D.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 537.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 537.17 Td (Chief Executive Officer and Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 537.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 537.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 523.17 Td (\(Giovanni Caforio, M.D.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 523.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 523.17 Td (\(Principal Executive Officer\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 523.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 505.17 Td (/s/ CHARLES BANCROFT) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 505.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 505.17 Td (Chief Financial Officer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 505.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 505.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 491.17 Td (\(Charles Bancroft\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 491.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 491.17 Td (\(Principal Financial Officer\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 491.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 472.27 Td (/s/ JOSEPH C. CALDARELLA) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 472.27 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 472.27 Td (Senior Vice President and Corporate Controller) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 472.27 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 472.27 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 458.17 Td (\(Joseph C. Caldarella\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 458.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 458.17 Td (\(Principal Accounting Officer\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 458.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 440.17 Td (/s/ LAMBERTO ANDREOTTI) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 440.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 440.17 Td (Chairman of the Board of Directors) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 440.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 440.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 426.17 Td (\(Lamberto Andreotti\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 426.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 426.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 408.17 Td (/s/ PETER J. ARDUINI) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 408.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 408.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 408.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 408.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 394.17 Td (\(Peter J. Arduini\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 394.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 394.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 376.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 376.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 362.17 Td (\(Robert J. Bertolini\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 344.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 344.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 330.17 Td (\(Matthew W. Emmens\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 312.17 Td (/s/ LAURIE H. GLIMCHER, M.D.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 312.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 312.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 312.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 312.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 298.17 Td (\(Laurie H. Glimcher, M.D.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 298.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 298.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 280.17 Td (/s/ MICHAEL GROBSTEIN) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 280.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 280.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 280.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 280.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 266.17 Td (\(Michael Grobstein\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 266.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 266.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 248.17 Td (/s/ ALAN J. LACY) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 248.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 248.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 248.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 248.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 234.17 Td (\(Alan J. Lacy\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 234.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 234.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 216.17 Td (/s/ THOMAS J. LYNCH, JR., M.D.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 216.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 216.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 216.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 216.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 202.17 Td (\(Thomas J. Lynch, Jr., M.D.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 202.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 202.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 184.17 Td (/s/ DINESH C. PALIWAL) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 184.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 184.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 184.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 170.17 Td (\(Dinesh C. Paliwal\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 152.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 152.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 138.17 Td (\(Theodore R. Samuels\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 120.17 Td (/s/ VICKI L. SATO, PH.D.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 120.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 120.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 120.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 120.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 106.17 Td (\(Vicki L. Sato, Ph.D.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 106.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 106.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 88.17 Td (/s/ GERALD L. STORCH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 88.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 88.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 88.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 88.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 74.17 Td (\(Gerald L. Storch\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 74.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 74.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 56.17 Td (/s/ TOGO D. WEST, JR.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 56.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 263.00 56.17 Td (Director) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 56.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 470.70 56.17 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.00 42.17 Td (\(Togo D. West, Jr.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 259.00 42.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 459.00 42.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 211 0 obj <> endobj 212 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (105) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 22.50 750.60 Td (SUMMAR) Tj ET Q q 0 0 0 rg BT 59.10 750.60 Td (Y) Tj ET Q q 0 0 0 rg BT 64.58 750.60 Td ( OF) Tj ET Q q 0 0 0 rg BT 77.39 750.60 Td ( ) Tj ET Q q 0 0 0 rg BT 78.95 750.60 Td (ABBREVIA) Tj ET Q q 0 0 0 rg BT 120.59 750.60 Td (TED ) Tj ET Q q 0 0 0 rg BT 138.89 750.60 Td (TERMS) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 22.50 736.80 Td (Bristol-Myers Squibb Company may be referred to as Bristol-Myers Squibb, BMS, the Company) Tj ET Q q 0 0 0 rg BT 372.38 736.80 Td (, we, our or us in this 2016 Form 10-K. ) Tj ET Q q 0 0 0 rg BT 515.47 736.80 Td (Throughout this ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 22.50 726.00 Td (2016 Form 10-K we have used terms which are defined below:) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 715.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 715.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 715.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 715.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 691.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 691.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 691.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 691.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 667.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 667.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 667.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 667.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 643.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 643.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 643.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 643.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 619.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 619.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 619.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 619.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 595.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 595.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 595.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 595.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 571.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 571.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 571.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 571.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 547.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 547.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 547.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 547.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 523.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 523.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 523.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 523.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 499.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 499.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 499.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 499.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 475.50 60.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 475.50 245.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 475.50 53.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 475.50 209.00 -20.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 442.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 442.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 442.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 442.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 418.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 418.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 418.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 418.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 394.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 394.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 394.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 394.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 370.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 370.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 370.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 370.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 346.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 346.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 346.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 346.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 322.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 322.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 322.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 322.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 298.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 298.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 298.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 298.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 274.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 274.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 274.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 274.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 250.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 250.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 250.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 250.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 226.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 226.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 226.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 226.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 202.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 202.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 202.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 202.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 178.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 178.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 178.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 178.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 154.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 154.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 154.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 154.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 130.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 130.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 130.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 130.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 106.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 106.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 106.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 106.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 81.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 81.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 81.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 81.50 209.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 22.00 57.50 60.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 82.00 57.50 245.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 327.00 57.50 53.00 -12.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 380.00 57.50 209.00 -12.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 715.5 m 22 703.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 715.5 m 82 715.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 715.5 m 327 703.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 82 715.5 m 327 715.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 715.5 m 380 715.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 715.5 m 589 703.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380 715.5 m 589 715.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 703.5 m 22 691.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 703.5 m 327 691.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 703.5 m 589 691.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 691.5 m 22 679.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 691.5 m 327 679.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 691.5 m 589 679.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 679.5 m 22 667.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 679.5 m 327 667.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 679.5 m 589 667.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 667.5 m 22 655.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 667.5 m 327 655.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 667.5 m 589 655.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 655.5 m 22 643.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 655.5 m 327 643.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 655.5 m 589 643.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 643.5 m 22 631.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 643.5 m 327 631.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 643.5 m 589 631.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 631.5 m 22 619.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 631.5 m 327 619.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 631.5 m 589 619.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 619.5 m 22 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 619.5 m 327 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 619.5 m 589 607.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 607.5 m 22 595.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 607.5 m 327 595.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 607.5 m 589 595.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 595.5 m 22 583.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 595.5 m 327 583.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 595.5 m 589 583.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 583.5 m 22 571.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 583.5 m 327 571.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 583.5 m 589 571.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 571.5 m 22 559.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 571.5 m 327 559.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 571.5 m 589 559.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 559.5 m 22 547.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 559.5 m 327 547.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 559.5 m 589 547.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 547.5 m 22 535.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 547.5 m 327 535.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 547.5 m 589 535.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 535.5 m 22 523.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 535.5 m 327 523.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 535.5 m 589 523.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 523.5 m 22 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 523.5 m 327 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 523.5 m 589 511.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 511.5 m 22 499.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 511.5 m 327 499.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 511.5 m 589 499.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 499.5 m 22 487.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 499.5 m 327 487.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 499.5 m 589 487.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 487.5 m 22 475.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 487.5 m 327 475.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 487.5 m 589 475.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 475.5 m 22 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 475.5 m 327 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 475.5 m 589 455.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 455.5 m 22 442.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 455.5 m 327 442.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 455.5 m 589 442.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 442.5 m 22 430.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 442.5 m 327 430.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 442.5 m 589 430.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 430.5 m 22 418.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 430.5 m 327 418.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 430.5 m 589 418.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 418.5 m 22 406.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 418.5 m 327 406.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 418.5 m 589 406.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 406.5 m 22 394.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 406.5 m 327 394.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 406.5 m 589 394.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 394.5 m 22 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 394.5 m 327 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 394.5 m 589 382.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 382.5 m 22 370.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 382.5 m 327 370.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 382.5 m 589 370.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 370.5 m 22 358.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 370.5 m 327 358.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 370.5 m 589 358.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 358.5 m 22 346.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 358.5 m 327 346.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 358.5 m 589 346.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 346.5 m 22 334.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 346.5 m 327 334.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 346.5 m 589 334.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 334.5 m 22 322.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 334.5 m 327 322.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 334.5 m 589 322.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 322.5 m 22 310.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 322.5 m 327 310.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 322.5 m 589 310.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 310.5 m 22 298.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 310.5 m 327 298.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 310.5 m 589 298.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 298.5 m 22 286.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 298.5 m 327 286.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 298.5 m 589 286.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 286.5 m 22 274.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 286.5 m 327 274.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 286.5 m 589 274.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 274.5 m 22 262.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 274.5 m 327 262.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 274.5 m 589 262.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 262.5 m 22 250.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 262.5 m 327 250.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 262.5 m 589 250.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 250.5 m 22 238.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 250.5 m 327 238.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 250.5 m 327 238.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 250.5 m 589 238.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 238.5 m 22 226.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 238.5 m 327 226.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 238.5 m 327 226.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 238.5 m 589 226.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 226.5 m 22 214.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 226.5 m 327 214.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 226.5 m 589 214.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 214.5 m 22 202.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 214.5 m 327 202.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 214.5 m 589 202.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 202.5 m 22 190.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 202.5 m 327 190.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 202.5 m 589 190.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 190.5 m 22 178.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 190.5 m 327 178.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 190.5 m 589 178.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 178.5 m 22 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 178.5 m 327 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 178.5 m 589 166.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 166.5 m 22 154.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 166.5 m 327 154.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 166.5 m 589 154.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 154.5 m 22 142.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 154.5 m 327 142.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 154.5 m 589 142.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 142.5 m 22 130.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 142.5 m 327 130.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 142.5 m 589 130.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 130.5 m 22 118.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 130.5 m 327 118.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 130.5 m 589 118.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 118.5 m 22 106.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 118.5 m 327 106.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 118.5 m 589 106.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 106.5 m 22 94.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 106.5 m 327 94.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 106.5 m 589 94.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 94.5 m 22 81.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 94.5 m 327 81.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 94.5 m 589 81.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 81.5 m 22 69.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 81.5 m 327 69.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 81.5 m 589 69.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 69.5 m 22 57.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 69.5 m 327 57.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 69.5 m 589 57.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 57.5 m 22 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 22 45.5 m 82 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 82 45.5 m 327 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 57.5 m 327 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 327 45.5 m 380 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 589 57.5 m 589 45.5 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 380 45.5 m 589 45.5 l s BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 707.77 Td (2016 Form 10-K) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 707.77 Td (Annual Report on Form 10-K for the fiscal year ended December 31, 2016) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 707.77 Td (Lilly) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 707.77 Td (Eli Lilly and Company) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 695.77 Td (AbbVie) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 695.77 Td (AbbVie Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 695.77 Td (MAA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 695.77 Td (Marketing Authorization Application) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 683.77 Td (Amira) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 683.77 Td (Amira Pharmaceuticals, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 683.77 Td (MCOs) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 683.77 Td (Managed Care Organizations) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 671.77 Td (Amylin) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 671.77 Td (Amylin Pharmaceuticals, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 671.77 Td (mCRC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 671.77 Td (metastatic colorectal cancer) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 659.77 Td (aNDA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 659.77 Td (abbreviated New Drug Application) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 659.77 Td (Mead Johnson) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 659.77 Td (Mead Johnson Nutrition Company) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 647.77 Td (anti-CCP) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 647.77 Td (anti-cyclic citrullinated peptide \(also ACPA\)) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 647.77 Td (Medarex) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 647.77 Td (Medarex, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 635.77 Td (API) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 635.77 Td (active pharmaceutical ingredient) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 635.77 Td (Merck) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 635.77 Td (Merck & Co., Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 623.77 Td (ASCT) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 623.77 Td (autologous stem cell transplant) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 623.77 Td (MF) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 623.77 Td (myelofibrosis) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 611.77 Td (ASR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 611.77 Td (accelerated share repurchase) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 611.77 Td (MSI-H) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 611.77 Td (high microsatellite instability) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 599.77 Td (AstraZeneca) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 599.77 Td (AstraZeneca PLC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 599.77 Td (MTX) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 599.77 Td (methotrexate) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 587.77 Td (auto-HSCT) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 587.77 Td (autologous hematopoietic stem cell transplantation) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 587.77 Td (mUC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 587.77 Td (metastatic urothelial carcinoma) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 575.77 Td (BLA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 575.77 Td (Biologics License Application) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 575.77 Td (NAV) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 575.77 Td (net asset value) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 563.77 Td (Cardioxyl) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 563.77 Td (Cardioxyl Pharmaceuticals, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 563.77 Td (NDA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 563.77 Td (New Drug Application) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 551.77 Td (CDAI) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 551.77 Td (Clinical Disease Activity Index) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 551.77 Td (Nitto Denko) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 551.77 Td (Nitto Denko Corporation) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 539.77 Td (CERCLA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 539.77 Td (U.S. Comprehensive Environmental Response, Compensation and Liability Act) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 539.77 Td (NKT) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 539.77 Td (natural killer T cells) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 527.77 Td (cGMP) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 527.77 Td (current Good Manufacturing Practices) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 527.77 Td (Novartis) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 527.77 Td (Novartis Pharmaceutical Corporation) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 515.77 Td (cHL) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 515.77 Td (classical Hodgkin lymphoma) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 515.77 Td (NSCLC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 515.77 Td (non-small cell lung cancer) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 503.77 Td (CHMP) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 503.77 Td (Committee for Medicinal Products for Human Use) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 503.77 Td (NSQ) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 503.77 Td (non-squamous) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 491.77 Td (Cormorant) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 491.77 Td (Cormorant Pharmaceuticals) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 491.77 Td (NVAF) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 491.77 Td (nonvalvular atrial fibrillation) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 479.77 Td (CPPIB) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 479.77 Td (CPPIB Credit Europe S.A.R.L., a Luxembourg private limited liability company) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 479.77 Td (OCI) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 479.77 Td (Other Comprehensive Income) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 463.77 Td (CSF1R) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 463.77 Td (colony stimulating factor 1 receptor) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 463.77 Td (OIG) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 467.47 Td (Office of Inspector General of the U.S. Dept. of Health and Human) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 460.07 Td (Services) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 447.27 Td (DMC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 447.27 Td (Data Monitoring Committee) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 447.27 Td (Ono) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 447.27 Td (Ono Pharmaceutical Co., Ltd.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 434.77 Td (EBITDA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 434.77 Td (Earnings Before Interest, Taxes, Depreciation and Amortization) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 434.77 Td (ORR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 434.77 Td (objective response rate) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 422.77 Td (EC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 422.77 Td (European Commission) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 422.77 Td (OTC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 422.77 Td (Over-the-counter) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 410.77 Td (EGFR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 410.77 Td (Epidermal Growth Factor Receptor) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 410.77 Td (Otsuka) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 410.77 Td (Otsuka Pharmaceutical Co., Ltd.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 398.77 Td (ELA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 398.77 Td (excess loss account) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 398.77 Td (PAD) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 398.77 Td (Protein/Peptidyl Arginine Deiminase) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 386.77 Td (EMA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 386.77 Td (European Medicines Agency) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 386.77 Td (Padlock) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 386.77 Td (Padlock Therapeutics, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 374.77 Td (EPO) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 374.77 Td (European Patent Office) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 374.77 Td (PBMs) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 374.77 Td (Pharmacy Benefit Managers) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 362.77 Td (EPS) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 362.77 Td (earnings per share) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 362.77 Td (PD-1) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 362.77 Td (programmed death receptor-1) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 350.77 Td (ERISA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 350.77 Td (Employee Retirement Income Security Act of 1974) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 350.77 Td (PDMA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 350.77 Td (Prescription Drug Marketing Act) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 338.77 Td (EU) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 338.77 Td (European Union) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 338.77 Td (Pfizer) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 338.77 Td (Pfizer, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 326.77 Td (FASB) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 326.77 Td (Financial Accounting Standards Board) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 326.77 Td (PFS) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 326.77 Td (progression-free survival) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 314.77 Td (FCPA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 314.77 Td (Foreign Corrupt Practices Act) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 314.77 Td (Portola) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 314.77 Td (Portola Pharmaceuticals, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 302.77 Td (FDA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 302.77 Td (U.S. Food and Drug Administration) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 302.77 Td (Promedior) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 302.77 Td (Promedior, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 290.77 Td (Five Prime) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 290.77 Td (Five Prime Therapeutics, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 290.77 Td (PRP) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 290.77 Td (potentially responsible party) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 278.77 Td (Flexus) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 278.77 Td (Flexus Biosciences, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 278.77 Td (Prudential) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 278.77 Td (The Prudential Insurance Company of America) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 266.77 Td (F-Star) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 266.77 Td (F-Star Alpha Ltd.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 266.77 Td (PSA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 266.77 Td (prostate-specific antigen) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 254.77 Td (GAAP) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 254.77 Td (U.S. generally accepted accounting principles) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 254.77 Td (PVNS) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 254.77 Td (pigmented vilonodular synovitis) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 242.77 Td (GDD) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 242.77 Td (Genetically Defined Diseases) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 242.77 Td (R&D) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 242.77 Td (Research and Development) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 230.77 Td (Gilead) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 230.77 Td (Gilead Sciences, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 230.77 Td (RA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 230.77 Td (rheumatoid arthritis) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 218.77 Td (HCV) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 218.77 Td (hepatitis C virus) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 218.77 Td (RAVs) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 218.77 Td (resistance-associated variants) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 206.62 Td (HIV) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 206.62 Td (human immunodeficiency virus) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 206.77 Td (RCC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 206.77 Td (renal cell carcinoma) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 194.77 Td (HR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 194.77 Td (hazard ratio) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 194.77 Td (Reckitt) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 194.77 Td (Reckitt Benckiser Group plc) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 182.77 Td (HR 3590) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 182.77 Td (The Patient Protection and Affordable Care Act) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 182.77 Td (RF) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 182.77 Td (rheumatoid factor) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 170.77 Td (HSP47) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 170.77 Td (heat shock protein 47) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 170.77 Td (SCCHN) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 170.77 Td (squamous cell carcinoma of the head and neck) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 158.77 Td (IMAs) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 158.77 Td (inventory management agreements) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 158.77 Td (SCLC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 158.77 Td (small cell lung cancer) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 146.77 Td (ImClone) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 146.77 Td (ImClone Systems Incorporated) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 146.77 Td (SEC) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 146.77 Td (U.S. Securities and Exchange Commission) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 134.77 Td (IO) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 134.77 Td (Immuno-Oncology) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 134.77 Td (SQ) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 134.77 Td (squamous) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 122.77 Td (Inhibitex) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 122.77 Td (Inhibitex, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 122.77 Td (SVR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 122.77 Td (Sustained virologic response) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 110.77 Td (IPF) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 110.77 Td (idiopathic pulmonary fibrosis) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 110.77 Td (the 2012 Plan) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 110.77 Td (The 2012 Stock Award and Incentive Plan) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 98.77 Td (iPierian) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 98.77 Td (iPierian, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 98.77 Td (U.S.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 98.77 Td (United States) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 86.27 Td (IPRD) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 86.27 Td (in-process research and development) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 86.27 Td (UK) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 86.27 Td (United Kingdom) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 73.77 Td (JMHLW) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 73.77 Td (Japanese Ministry of Health, Labour and Welfare) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 73.77 Td (Valeant) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 73.77 Td (Valeant Pharmaceuticals International, Inc.) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 61.77 Td (LDA) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 61.77 Td (Low Disease Activity) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 61.77 Td (VTE) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 61.77 Td (venous thromboembolic) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 24.50 49.77 Td (LIBOR) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 84.50 49.77 Td (London Interbank Offered Rate) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 329.50 49.77 Td (WTO) Tj ET Q BT /F1 7.40 Tf ET q 0 0 0 rg BT 382.50 49.77 Td (World Trade Organization) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 213 0 obj <> endobj 214 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (106) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 36.00 749.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 78.61 749.25 Td ( INDEX) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 732.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.60 732.25 Td (Exhibits ) Tj ET Q q 0 0 0 rg BT 90.98 732.25 Td (listed ) Tj ET Q q 0 0 0 rg BT 115.69 732.25 Td (below ) Tj ET Q q 0 0 0 rg BT 143.18 732.25 Td (are ) Tj ET Q q 0 0 0 rg BT 158.43 732.25 Td (identified ) Tj ET Q q 0 0 0 rg BT 199.80 732.25 Td (by ) Tj ET Q q 0 0 0 rg BT 212.85 732.25 Td (numbers ) Tj ET Q q 0 0 0 rg BT 250.34 732.25 Td (corresponding ) Tj ET Q q 0 0 0 rg BT 310.59 732.25 Td (to ) Tj ET Q q 0 0 0 rg BT 321.42 732.25 Td (the ) Tj ET Q q 0 0 0 rg BT 336.69 732.25 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 368.96 732.25 Td (T) Tj ET Q q 0 0 0 rg BT 374.37 732.25 Td (able ) Tj ET Q q 0 0 0 rg BT 394.07 732.25 Td (of ) Tj ET Q q 0 0 0 rg BT 405.45 732.25 Td (Item 601 ) Tj ET Q q 0 0 0 rg BT 444.32 732.25 Td (of ) Tj ET Q q 0 0 0 rg BT 455.70 732.25 Td (Regulation ) Tj ET Q q 0 0 0 rg BT 502.63 732.25 Td (S-K. ) Tj ET Q q 0 0 0 rg BT 524.07 732.25 Td (The ) Tj ET Q q 0 0 0 rg BT 542.67 732.25 Td (Exhibits ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 720.25 Td (designated ) Tj ET Q q 0 0 0 rg BT 81.08 720.25 Td (by ) Tj ET Q q 0 0 0 rg BT 93.40 720.25 Td (the ) Tj ET Q q 0 0 0 rg BT 107.94 720.25 Td (symbol ) Tj ET Q q 0 0 0 rg BT 139.71 720.25 Td (‡‡ ) Tj ET Q q 0 0 0 rg BT 152.03 720.25 Td (are ) Tj ET Q q 0 0 0 rg BT 166.55 720.25 Td (management ) Tj ET Q q 0 0 0 rg BT 219.96 720.25 Td (contracts ) Tj ET Q q 0 0 0 rg BT 258.37 720.25 Td (or ) Tj ET Q q 0 0 0 rg BT 269.02 720.25 Td (compensatory ) Tj ET Q q 0 0 0 rg BT 327.44 720.25 Td (plans ) Tj ET Q q 0 0 0 rg BT 350.86 720.25 Td (or ) Tj ET Q q 0 0 0 rg BT 361.51 720.25 Td (arrangements ) Tj ET Q q 0 0 0 rg BT 417.69 720.25 Td (required ) Tj ET Q q 0 0 0 rg BT 453.33 720.25 Td (to ) Tj ET Q q 0 0 0 rg BT 463.43 720.25 Td (be ) Tj ET Q q 0 0 0 rg BT 475.18 720.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 495.83 720.25 Td (pursuant ) Tj ET Q q 0 0 0 rg BT 532.59 720.25 Td (to ) Tj ET Q q 0 0 0 rg BT 542.68 720.25 Td (Item 15. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 708.25 Td (The ) Tj ET Q q 0 0 0 rg BT 54.33 708.25 Td (symbol ) Tj ET Q q 0 0 0 rg BT 86.56 708.25 Td (‡ ) Tj ET Q q 0 0 0 rg BT 94.34 708.25 Td (in ) Tj ET Q q 0 0 0 rg BT 104.91 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 119.91 708.25 Td (Page ) Tj ET Q q 0 0 0 rg BT 142.13 708.25 Td (column ) Tj ET Q q 0 0 0 rg BT 174.91 708.25 Td (indicates ) Tj ET Q q 0 0 0 rg BT 213.23 708.25 Td (that ) Tj ET Q q 0 0 0 rg BT 231.01 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 246.01 708.25 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 278.24 708.25 Td (has ) Tj ET Q q 0 0 0 rg BT 294.35 708.25 Td (been ) Tj ET Q q 0 0 0 rg BT 316.01 708.25 Td (previously ) Tj ET Q q 0 0 0 rg BT 361.01 708.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 382.12 708.25 Td (with ) Tj ET Q q 0 0 0 rg BT 402.68 708.25 Td (the ) Tj ET Q q 0 0 0 rg BT 417.68 708.25 Td (Commission ) Tj ET Q q 0 0 0 rg BT 471.03 708.25 Td (and ) Tj ET Q q 0 0 0 rg BT 488.25 708.25 Td (is ) Tj ET Q q 0 0 0 rg BT 497.70 708.25 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 551.02 708.25 Td (herein ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 36.00 696.25 Td (by ) Tj ET Q q 0 0 0 rg BT 48.50 696.25 Td (reference. ) Tj ET Q q 0 0 0 rg BT 90.68 696.25 Td (Unless ) Tj ET Q q 0 0 0 rg BT 120.40 696.25 Td (otherwise ) Tj ET Q q 0 0 0 rg BT 161.78 696.25 Td (indicated, ) Tj ET Q q 0 0 0 rg BT 203.43 696.25 Td (all ) Tj ET Q q 0 0 0 rg BT 215.93 696.25 Td (Exhibits ) Tj ET Q q 0 0 0 rg BT 251.76 696.25 Td (are ) Tj ET Q q 0 0 0 rg BT 266.47 696.25 Td (part ) Tj ET Q q 0 0 0 rg BT 284.52 696.25 Td (of ) Tj ET Q q 0 0 0 rg BT 295.35 696.25 Td (Commission ) Tj ET Q q 0 0 0 rg BT 348.41 696.25 Td (File ) Tj ET Q q 0 0 0 rg BT 366.47 696.25 Td (Number ) Tj ET Q q 0 0 0 rg BT 401.74 696.25 Td (1-1) Tj ET Q q 0 0 0 rg BT 414.70 696.25 Td (136.) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 35.5 667.75 m 81.5 667.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 85.5 667.75 m 535.5 667.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 539.5 667.75 m 575.5 667.75 l s BT /F2 8.00 Tf ET q 0 0 0 rg BT 38.00 671.98 Td (Exhibit No.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 672.00 Td (  ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 88.00 671.98 Td (Description) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 672.00 Td (    ) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 542.85 671.98 Td (Page No) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 658.32 Td (3a.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 647.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 658.32 Td (Amended ) Tj ET Q q 0 0 0 rg BT 129.44 658.32 Td (and ) Tj ET Q q 0 0 0 rg BT 146.45 658.32 Td (Restated ) Tj ET Q q 0 0 0 rg BT 183.45 658.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 228.21 658.32 Td (of ) Tj ET Q q 0 0 0 rg BT 239.11 658.32 Td (Incorporation ) Tj ET Q q 0 0 0 rg BT 296.10 658.32 Td (of ) Tj ET Q q 0 0 0 rg BT 306.99 658.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 365.67 658.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 396.57 658.32 Td (Company ) Tj ET Q q 0 0 0 rg BT 438.02 658.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 494.45 658.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 522.00 658.32 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 648.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 127.68 648.32 Td (to ) Tj ET Q q 0 0 0 rg BT 137.96 648.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 169.90 648.32 Td (3a ) Tj ET Q q 0 0 0 rg BT 181.84 648.32 Td (to ) Tj ET Q q 0 0 0 rg BT 192.12 648.32 Td (the ) Tj ET Q q 0 0 0 rg BT 206.84 648.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 231.01 648.32 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 254.06 648.32 Td (for ) Tj ET Q q 0 0 0 rg BT 268.22 648.32 Td (the ) Tj ET Q q 0 0 0 rg BT 282.94 648.32 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 321.53 648.32 Td (period ) Tj ET Q q 0 0 0 rg BT 349.58 648.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 375.95 648.32 Td (June ) Tj ET Q q 0 0 0 rg BT 396.78 648.32 Td (30, ) Tj ET Q q 0 0 0 rg BT 411.78 648.32 Td (2005\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 647.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 658.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 629.32 Td (3b.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 608.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 629.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 132.26 629.32 Td (of ) Tj ET Q q 0 0 0 rg BT 142.65 629.32 Td (Correction ) Tj ET Q q 0 0 0 rg BT 187.48 629.32 Td (to ) Tj ET Q q 0 0 0 rg BT 197.32 629.32 Td (the ) Tj ET Q q 0 0 0 rg BT 211.42 629.32 Td (Amended ) Tj ET Q q 0 0 0 rg BT 252.09 629.32 Td (and ) Tj ET Q q 0 0 0 rg BT 268.59 629.32 Td (Restated ) Tj ET Q q 0 0 0 rg BT 305.08 629.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 349.34 629.32 Td (of ) Tj ET Q q 0 0 0 rg BT 359.74 629.32 Td (Incorporation, ) Tj ET Q q 0 0 0 rg BT 418.72 629.32 Td (ef) Tj ET Q q 0 0 0 rg BT 426.40 629.32 Td (fective ) Tj ET Q q 0 0 0 rg BT 455.58 629.32 Td (as ) Tj ET Q q 0 0 0 rg BT 465.97 629.32 Td (of ) Tj ET Q q 0 0 0 rg BT 476.36 629.32 Td (December ) Tj ET Q q 0 0 0 rg BT 519.51 629.32 Td (24, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 619.32 Td (2009 ) Tj ET Q q 0 0 0 rg BT 110.69 619.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 167.23 619.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 194.90 619.32 Td (by ) Tj ET Q q 0 0 0 rg BT 207.59 619.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 247.46 619.32 Td (to ) Tj ET Q q 0 0 0 rg BT 257.92 619.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 290.05 619.32 Td (3b ) Tj ET Q q 0 0 0 rg BT 302.74 619.32 Td (to ) Tj ET Q q 0 0 0 rg BT 313.20 619.32 Td (the ) Tj ET Q q 0 0 0 rg BT 328.10 619.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 352.46 619.32 Td (10-K ) Tj ET Q q 0 0 0 rg BT 375.70 619.32 Td (for ) Tj ET Q q 0 0 0 rg BT 390.04 619.32 Td (the ) Tj ET Q q 0 0 0 rg BT 404.94 619.32 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 429.28 619.32 Td (year ) Tj ET Q q 0 0 0 rg BT 449.18 619.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 475.74 619.32 Td (December ) Tj ET Q q 0 0 0 rg BT 519.51 619.32 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 609.32 Td (2010\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 608.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 629.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 590.32 Td (3c.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 579.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 590.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 132.23 590.32 Td (of ) Tj ET Q q 0 0 0 rg BT 142.41 590.32 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 193.60 590.32 Td (to ) Tj ET Q q 0 0 0 rg BT 203.41 590.32 Td (the ) Tj ET Q q 0 0 0 rg BT 217.48 590.32 Td (Amended ) Tj ET Q q 0 0 0 rg BT 258.11 590.32 Td (and ) Tj ET Q q 0 0 0 rg BT 274.58 590.32 Td (Restated ) Tj ET Q q 0 0 0 rg BT 311.04 590.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 355.27 590.32 Td (of ) Tj ET Q q 0 0 0 rg BT 365.63 590.32 Td (Incorporation, ) Tj ET Q q 0 0 0 rg BT 424.58 590.32 Td (ef) Tj ET Q q 0 0 0 rg BT 432.26 590.32 Td (fective ) Tj ET Q q 0 0 0 rg BT 461.40 590.32 Td (as ) Tj ET Q q 0 0 0 rg BT 471.76 590.32 Td (of ) Tj ET Q q 0 0 0 rg BT 482.11 590.32 Td (May ) Tj ET Q q 0 0 0 rg BT 502.47 590.32 Td (7, ) Tj ET Q q 0 0 0 rg BT 512.00 590.32 Td (2010 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 580.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 144.22 580.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 171.57 580.32 Td (by ) Tj ET Q q 0 0 0 rg BT 183.93 580.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 223.47 580.32 Td (to ) Tj ET Q q 0 0 0 rg BT 233.61 580.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 265.41 580.32 Td (3a ) Tj ET Q q 0 0 0 rg BT 277.21 580.32 Td (to ) Tj ET Q q 0 0 0 rg BT 287.35 580.32 Td (the ) Tj ET Q q 0 0 0 rg BT 301.92 580.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 325.95 580.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 343.87 580.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 367.88 580.32 Td (May ) Tj ET Q q 0 0 0 rg BT 388.57 580.32 Td (4, ) Tj ET Q q 0 0 0 rg BT 398.43 580.32 Td (2010 ) Tj ET Q q 0 0 0 rg BT 420.79 580.32 Td (and ) Tj ET Q q 0 0 0 rg BT 437.59 580.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 458.27 580.32 Td (on ) Tj ET Q q 0 0 0 rg BT 470.63 580.32 Td (May ) Tj ET Q q 0 0 0 rg BT 491.32 580.32 Td (10, ) Tj ET Q q 0 0 0 rg BT 506.18 580.32 Td (2010\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 579.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 590.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 561.32 Td (3d.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 550.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 561.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 132.23 561.32 Td (of ) Tj ET Q q 0 0 0 rg BT 142.41 561.32 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 193.60 561.32 Td (to ) Tj ET Q q 0 0 0 rg BT 203.41 561.32 Td (the ) Tj ET Q q 0 0 0 rg BT 217.48 561.32 Td (Amended ) Tj ET Q q 0 0 0 rg BT 258.11 561.32 Td (and ) Tj ET Q q 0 0 0 rg BT 274.58 561.32 Td (Restated ) Tj ET Q q 0 0 0 rg BT 311.04 561.32 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 355.27 561.32 Td (of ) Tj ET Q q 0 0 0 rg BT 365.63 561.32 Td (Incorporation, ) Tj ET Q q 0 0 0 rg BT 424.58 561.32 Td (ef) Tj ET Q q 0 0 0 rg BT 432.26 561.32 Td (fective ) Tj ET Q q 0 0 0 rg BT 461.40 561.32 Td (as ) Tj ET Q q 0 0 0 rg BT 471.76 561.32 Td (of ) Tj ET Q q 0 0 0 rg BT 482.11 561.32 Td (May ) Tj ET Q q 0 0 0 rg BT 502.47 561.32 Td (7, ) Tj ET Q q 0 0 0 rg BT 512.00 561.32 Td (2010 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 551.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 144.19 551.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 171.51 551.32 Td (by ) Tj ET Q q 0 0 0 rg BT 183.84 551.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 223.36 551.32 Td (to ) Tj ET Q q 0 0 0 rg BT 233.47 551.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 265.24 551.32 Td (3b ) Tj ET Q q 0 0 0 rg BT 277.57 551.32 Td (to ) Tj ET Q q 0 0 0 rg BT 287.68 551.32 Td (the ) Tj ET Q q 0 0 0 rg BT 302.23 551.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 326.23 551.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 344.12 551.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 368.10 551.32 Td (May ) Tj ET Q q 0 0 0 rg BT 388.76 551.32 Td (4, ) Tj ET Q q 0 0 0 rg BT 398.60 551.32 Td (2010 ) Tj ET Q q 0 0 0 rg BT 420.93 551.32 Td (and ) Tj ET Q q 0 0 0 rg BT 437.70 551.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 458.35 551.32 Td (on ) Tj ET Q q 0 0 0 rg BT 470.69 551.32 Td (May ) Tj ET Q q 0 0 0 rg BT 491.35 551.32 Td (10, ) Tj ET Q q 0 0 0 rg BT 506.18 551.32 Td (2010\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 550.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 561.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 532.32 Td (3e.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 521.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 532.32 Td (Bylaws ) Tj ET Q q 0 0 0 rg BT 119.58 532.32 Td (of ) Tj ET Q q 0 0 0 rg BT 129.49 532.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 187.17 532.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 217.09 532.32 Td (Company) Tj ET Q q 0 0 0 rg BT 255.65 532.32 Td (, ) Tj ET Q q 0 0 0 rg BT 259.41 532.32 Td (as ) Tj ET Q q 0 0 0 rg BT 269.32 532.32 Td (amended ) Tj ET Q q 0 0 0 rg BT 306.99 532.32 Td (as ) Tj ET Q q 0 0 0 rg BT 316.90 532.32 Td (of ) Tj ET Q q 0 0 0 rg BT 326.81 532.32 Td (November ) Tj ET Q q 0 0 0 rg BT 370.59 532.32 Td (2, ) Tj ET Q q 0 0 0 rg BT 379.67 532.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 401.25 532.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 456.69 532.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 483.25 532.32 Td (by ) Tj ET Q q 0 0 0 rg BT 494.83 532.32 Td (reference ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 522.32 Td (to ) Tj ET Q q 0 0 0 rg BT 98.28 522.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 130.22 522.32 Td (3.1 ) Tj ET Q q 0 0 0 rg BT 145.22 522.32 Td (to ) Tj ET Q q 0 0 0 rg BT 155.50 522.32 Td (the ) Tj ET Q q 0 0 0 rg BT 170.22 522.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 194.39 522.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 212.44 522.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 236.59 522.32 Td (November ) Tj ET Q q 0 0 0 rg BT 281.30 522.32 Td (2, ) Tj ET Q q 0 0 0 rg BT 291.30 522.32 Td (2016 ) Tj ET Q q 0 0 0 rg BT 313.80 522.32 Td (and ) Tj ET Q q 0 0 0 rg BT 330.74 522.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 351.56 522.32 Td (November ) Tj ET Q q 0 0 0 rg BT 396.27 522.32 Td (4, ) Tj ET Q q 0 0 0 rg BT 406.27 522.32 Td (2016\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 521.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 532.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 503.32 Td (4a.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 492.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 503.32 Td (Letter ) Tj ET Q q 0 0 0 rg BT 114.40 503.32 Td (of ) Tj ET Q q 0 0 0 rg BT 124.98 503.32 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 171.66 503.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 195.85 503.32 Td (March ) Tj ET Q q 0 0 0 rg BT 224.48 503.32 Td (28, ) Tj ET Q q 0 0 0 rg BT 239.51 503.32 Td (1984 ) Tj ET Q q 0 0 0 rg BT 262.04 503.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 318.43 503.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 345.95 503.32 Td (by ) Tj ET Q q 0 0 0 rg BT 358.48 503.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 398.19 503.32 Td (to ) Tj ET Q q 0 0 0 rg BT 408.50 503.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 440.47 503.32 Td (4 ) Tj ET Q q 0 0 0 rg BT 448.00 503.32 Td (to ) Tj ET Q q 0 0 0 rg BT 458.31 503.32 Td (the ) Tj ET Q q 0 0 0 rg BT 473.06 503.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 497.26 503.32 Td (10-K ) Tj ET Q q 0 0 0 rg BT 520.34 503.32 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 493.32 Td (the ) Tj ET Q q 0 0 0 rg BT 102.72 493.32 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 126.87 493.32 Td (year ) Tj ET Q q 0 0 0 rg BT 146.58 493.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 172.96 493.32 Td (December ) Tj ET Q q 0 0 0 rg BT 216.54 493.32 Td (31, ) Tj ET Q q 0 0 0 rg BT 231.54 493.32 Td (1983\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 492.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 503.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 474.32 Td (4b.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 453.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 474.32 Td (Indenture, ) Tj ET Q q 0 0 0 rg BT 131.97 474.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 156.78 474.32 Td (as ) Tj ET Q q 0 0 0 rg BT 168.26 474.32 Td (of ) Tj ET Q q 0 0 0 rg BT 179.75 474.32 Td (June ) Tj ET Q q 0 0 0 rg BT 201.23 474.32 Td (1, ) Tj ET Q q 0 0 0 rg BT 211.89 474.32 Td (1993, ) Tj ET Q q 0 0 0 rg BT 237.54 474.32 Td (between ) Tj ET Q q 0 0 0 rg BT 274.01 474.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 333.27 474.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 364.77 474.32 Td (Company ) Tj ET Q q 0 0 0 rg BT 406.81 474.32 Td (and ) Tj ET Q q 0 0 0 rg BT 424.40 474.32 Td (JPMor) Tj ET Q q 0 0 0 rg BT 450.99 474.32 Td (gan ) Tj ET Q q 0 0 0 rg BT 468.49 474.32 Td (Chase ) Tj ET Q q 0 0 0 rg BT 496.08 474.32 Td (Bank ) Tj ET Q q 0 0 0 rg BT 520.34 474.32 Td (\(as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 464.32 Td (successor ) Tj ET Q q 0 0 0 rg BT 129.62 464.32 Td (trustee ) Tj ET Q q 0 0 0 rg BT 159.58 464.32 Td (to ) Tj ET Q q 0 0 0 rg BT 170.51 464.32 Td (The ) Tj ET Q q 0 0 0 rg BT 189.27 464.32 Td (Chase ) Tj ET Q q 0 0 0 rg BT 217.00 464.32 Td (Manhattan ) Tj ET Q q 0 0 0 rg BT 263.07 464.32 Td (Bank ) Tj ET Q q 0 0 0 rg BT 287.48 464.32 Td (\(National ) Tj ET Q q 0 0 0 rg BT 328.09 464.32 Td (Association\)\) ) Tj ET Q q 0 0 0 rg BT 384.99 464.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 442.15 464.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 470.44 464.32 Td (by ) Tj ET Q q 0 0 0 rg BT 483.74 464.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 524.23 464.32 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 454.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 119.94 454.32 Td (4.1 ) Tj ET Q q 0 0 0 rg BT 134.94 454.32 Td (to ) Tj ET Q q 0 0 0 rg BT 145.22 454.32 Td (the ) Tj ET Q q 0 0 0 rg BT 159.94 454.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 184.11 454.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 202.16 454.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 226.32 454.32 Td (May ) Tj ET Q q 0 0 0 rg BT 247.15 454.32 Td (27, ) Tj ET Q q 0 0 0 rg BT 262.15 454.32 Td (1993 ) Tj ET Q q 0 0 0 rg BT 284.65 454.32 Td (and ) Tj ET Q q 0 0 0 rg BT 301.58 454.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 322.41 454.32 Td (on ) Tj ET Q q 0 0 0 rg BT 334.91 454.32 Td (June ) Tj ET Q q 0 0 0 rg BT 355.74 454.32 Td (3, ) Tj ET Q q 0 0 0 rg BT 365.74 454.32 Td (1993\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 453.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 474.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 435.32 Td (4c.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 424.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 435.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 113.00 435.32 Td (of ) Tj ET Q q 0 0 0 rg BT 124.66 435.32 Td (7.15% ) Tj ET Q q 0 0 0 rg BT 153.82 435.32 Td (Debenture ) Tj ET Q q 0 0 0 rg BT 198.80 435.32 Td (due ) Tj ET Q q 0 0 0 rg BT 216.56 435.32 Td (2023 ) Tj ET Q q 0 0 0 rg BT 239.89 435.32 Td (of ) Tj ET Q q 0 0 0 rg BT 251.55 435.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 310.99 435.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 342.66 435.32 Td (Company ) Tj ET Q q 0 0 0 rg BT 384.88 435.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 442.07 435.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 470.39 435.32 Td (by ) Tj ET Q q 0 0 0 rg BT 483.72 435.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 524.23 435.32 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 425.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 119.94 425.32 Td (4.2 ) Tj ET Q q 0 0 0 rg BT 134.94 425.32 Td (to ) Tj ET Q q 0 0 0 rg BT 145.22 425.32 Td (the ) Tj ET Q q 0 0 0 rg BT 159.94 425.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 184.11 425.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 202.16 425.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 226.32 425.32 Td (May ) Tj ET Q q 0 0 0 rg BT 247.15 425.32 Td (27, ) Tj ET Q q 0 0 0 rg BT 262.15 425.32 Td (1993 ) Tj ET Q q 0 0 0 rg BT 284.65 425.32 Td (and ) Tj ET Q q 0 0 0 rg BT 301.58 425.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 322.41 425.32 Td (on ) Tj ET Q q 0 0 0 rg BT 334.91 425.32 Td (June ) Tj ET Q q 0 0 0 rg BT 355.74 425.32 Td (3, ) Tj ET Q q 0 0 0 rg BT 365.74 425.32 Td (1993\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 424.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 435.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 406.32 Td (4d.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 395.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 406.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 113.00 406.32 Td (of ) Tj ET Q q 0 0 0 rg BT 124.66 406.32 Td (6.80% ) Tj ET Q q 0 0 0 rg BT 153.82 406.32 Td (Debenture ) Tj ET Q q 0 0 0 rg BT 198.80 406.32 Td (due ) Tj ET Q q 0 0 0 rg BT 216.56 406.32 Td (2026 ) Tj ET Q q 0 0 0 rg BT 239.89 406.32 Td (of ) Tj ET Q q 0 0 0 rg BT 251.55 406.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 310.99 406.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 342.66 406.32 Td (Company ) Tj ET Q q 0 0 0 rg BT 384.88 406.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 442.07 406.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 470.39 406.32 Td (by ) Tj ET Q q 0 0 0 rg BT 483.72 406.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 524.23 406.32 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 396.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 119.94 396.32 Td (4e ) Tj ET Q q 0 0 0 rg BT 131.88 396.32 Td (to ) Tj ET Q q 0 0 0 rg BT 142.16 396.32 Td (the ) Tj ET Q q 0 0 0 rg BT 156.88 396.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 181.05 396.32 Td (10-K ) Tj ET Q q 0 0 0 rg BT 204.10 396.32 Td (for ) Tj ET Q q 0 0 0 rg BT 218.26 396.32 Td (the ) Tj ET Q q 0 0 0 rg BT 232.98 396.32 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 257.13 396.32 Td (year ) Tj ET Q q 0 0 0 rg BT 276.84 396.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 303.21 396.32 Td (December ) Tj ET Q q 0 0 0 rg BT 346.80 396.32 Td (31, ) Tj ET Q q 0 0 0 rg BT 361.80 396.32 Td (1996\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 395.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 406.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.05 377.32 Td (4e.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 366.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 377.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.64 377.32 Td (of ) Tj ET Q q 0 0 0 rg BT 123.95 377.32 Td (6.875% ) Tj ET Q q 0 0 0 rg BT 157.75 377.32 Td (Debenture ) Tj ET Q q 0 0 0 rg BT 202.37 377.32 Td (due ) Tj ET Q q 0 0 0 rg BT 219.78 377.32 Td (2097 ) Tj ET Q q 0 0 0 rg BT 242.75 377.32 Td (of ) Tj ET Q q 0 0 0 rg BT 254.05 377.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 313.13 377.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 344.45 377.32 Td (Company ) Tj ET Q q 0 0 0 rg BT 386.31 377.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 443.14 377.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 471.10 377.32 Td (by ) Tj ET Q q 0 0 0 rg BT 484.07 377.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 524.23 377.32 Td (to ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 367.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 119.94 367.32 Td (4f ) Tj ET Q q 0 0 0 rg BT 130.77 367.32 Td (to ) Tj ET Q q 0 0 0 rg BT 141.05 367.32 Td (the ) Tj ET Q q 0 0 0 rg BT 155.77 367.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 179.94 367.32 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 202.99 367.32 Td (for ) Tj ET Q q 0 0 0 rg BT 217.15 367.32 Td (the ) Tj ET Q q 0 0 0 rg BT 231.87 367.32 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 270.46 367.32 Td (period ) Tj ET Q q 0 0 0 rg BT 298.51 367.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 324.88 367.32 Td (September ) Tj ET Q q 0 0 0 rg BT 370.15 367.32 Td (30, ) Tj ET Q q 0 0 0 rg BT 385.15 367.32 Td (1997\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 366.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 377.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.15 348.32 Td (4f.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 327.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 348.32 Td (Indenture, ) Tj ET Q q 0 0 0 rg BT 130.46 348.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 153.77 348.32 Td (October ) Tj ET Q q 0 0 0 rg BT 187.63 348.32 Td (1, ) Tj ET Q q 0 0 0 rg BT 196.78 348.32 Td (2003, ) Tj ET Q q 0 0 0 rg BT 220.92 348.32 Td (between ) Tj ET Q q 0 0 0 rg BT 255.89 348.32 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 313.65 348.32 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 343.64 348.32 Td (Company) Tj ET Q q 0 0 0 rg BT 382.20 348.32 Td (, ) Tj ET Q q 0 0 0 rg BT 386.02 348.32 Td (as ) Tj ET Q q 0 0 0 rg BT 396.00 348.32 Td (Issuer) Tj ET Q q 0 0 0 rg BT 419.68 348.32 Td (, ) Tj ET Q q 0 0 0 rg BT 423.63 348.32 Td (and ) Tj ET Q q 0 0 0 rg BT 439.72 348.32 Td (JPMor) Tj ET Q q 0 0 0 rg BT 466.31 348.32 Td (gan ) Tj ET Q q 0 0 0 rg BT 482.30 348.32 Td (Chase ) Tj ET Q q 0 0 0 rg BT 508.39 348.32 Td (Bank, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 338.32 Td (as ) Tj ET Q q 0 0 0 rg BT 99.77 338.32 Td (T) Tj ET Q q 0 0 0 rg BT 105.62 338.32 Td (rustee ) Tj ET Q q 0 0 0 rg BT 132.93 338.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 190.41 338.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 219.01 338.32 Td (by ) Tj ET Q q 0 0 0 rg BT 232.62 338.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 273.42 338.32 Td (to ) Tj ET Q q 0 0 0 rg BT 284.81 338.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 317.87 338.32 Td (4q ) Tj ET Q q 0 0 0 rg BT 331.49 338.32 Td (to ) Tj ET Q q 0 0 0 rg BT 342.88 338.32 Td (the ) Tj ET Q q 0 0 0 rg BT 358.71 338.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 384.00 338.32 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 408.16 338.32 Td (for ) Tj ET Q q 0 0 0 rg BT 423.44 338.32 Td (the ) Tj ET Q q 0 0 0 rg BT 439.27 338.32 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 478.98 338.32 Td (period ) Tj ET Q q 0 0 0 rg BT 508.14 338.32 Td (ended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 328.32 Td (September ) Tj ET Q q 0 0 0 rg BT 133.26 328.32 Td (30, ) Tj ET Q q 0 0 0 rg BT 148.26 328.32 Td (2003\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 327.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 348.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 309.32 Td (4g.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 298.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 309.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.39 309.32 Td (of ) Tj ET Q q 0 0 0 rg BT 123.44 309.32 Td (Floating ) Tj ET Q q 0 0 0 rg BT 159.49 309.32 Td (Rate ) Tj ET Q q 0 0 0 rg BT 180.54 309.32 Td (Convertible ) Tj ET Q q 0 0 0 rg BT 230.47 309.32 Td (Senior ) Tj ET Q q 0 0 0 rg BT 259.30 309.32 Td (Debenture ) Tj ET Q q 0 0 0 rg BT 303.66 309.32 Td (due ) Tj ET Q q 0 0 0 rg BT 320.82 309.32 Td (2023 ) Tj ET Q q 0 0 0 rg BT 343.54 309.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 400.12 309.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 427.83 309.32 Td (by ) Tj ET Q q 0 0 0 rg BT 440.55 309.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 480.45 309.32 Td (to ) Tj ET Q q 0 0 0 rg BT 490.95 309.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 523.11 309.32 Td (4s ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 299.32 Td (to ) Tj ET Q q 0 0 0 rg BT 98.28 299.32 Td (the ) Tj ET Q q 0 0 0 rg BT 113.00 299.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 137.17 299.32 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 160.22 299.32 Td (for ) Tj ET Q q 0 0 0 rg BT 174.38 299.32 Td (the ) Tj ET Q q 0 0 0 rg BT 189.09 299.32 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 227.69 299.32 Td (period ) Tj ET Q q 0 0 0 rg BT 255.73 299.32 Td (ended ) Tj ET Q q 0 0 0 rg BT 282.11 299.32 Td (September ) Tj ET Q q 0 0 0 rg BT 327.38 299.32 Td (30, ) Tj ET Q q 0 0 0 rg BT 342.38 299.32 Td (2003\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 298.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 309.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 280.32 Td (4h.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 269.00 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 279.42 Td (Specimen ) Tj ET Q q 0 0 0 rg BT 129.49 279.42 Td (Certificate ) Tj ET Q q 0 0 0 rg BT 173.74 279.42 Td (of ) Tj ET Q q 0 0 0 rg BT 184.12 279.42 Td (Common ) Tj ET Q q 0 0 0 rg BT 223.40 279.42 Td (Stock ) Tj ET Q q 0 0 0 rg BT 248.23 279.42 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 304.15 279.42 Td (herein ) Tj ET Q q 0 0 0 rg BT 331.19 279.42 Td (by ) Tj ET Q q 0 0 0 rg BT 343.24 279.42 Td (reference ) Tj ET Q q 0 0 0 rg BT 382.48 279.42 Td (to ) Tj ET Q q 0 0 0 rg BT 392.31 279.42 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 423.80 279.42 Td (4s ) Tj ET Q q 0 0 0 rg BT 434.75 279.42 Td (to ) Tj ET Q q 0 0 0 rg BT 444.58 279.42 Td (the ) Tj ET Q q 0 0 0 rg BT 458.85 279.42 Td (Form ) Tj ET Q q 0 0 0 rg BT 482.57 279.42 Td (10-K for the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 269.42 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 112.16 269.42 Td (year ) Tj ET Q q 0 0 0 rg BT 131.86 269.42 Td (ended ) Tj ET Q q 0 0 0 rg BT 158.24 269.42 Td (December ) Tj ET Q q 0 0 0 rg BT 201.82 269.42 Td (31, ) Tj ET Q q 0 0 0 rg BT 216.82 269.42 Td (2003\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 269.00 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 280.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.70 251.32 Td (4i.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 250.42 Td (Form of Fourth Supplemental Indenture between Bristol-Myers Squibb Company and The Bank of New York,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 240.42 Td (as Trustee, to the indenture dated June 1, 1993 \(incorporated herein by reference to Exhibit 4r to the Form 8-K) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 230.42 Td (dated November 20, 2006 and filed on November 27, 2006\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 251.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.70 212.32 Td (4j.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 84.00 201.42 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 211.42 Td (Form of 5.875% Notes due 2036 \(incorporated herein by reference to Exhibit 4s to the Form 8-K dated) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 201.42 Td (November 20, 2006 and filed November 27, 2006\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 538.00 201.42 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 212.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 183.32 Td (4k.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 183.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 113.98 183.32 Td (of ) Tj ET Q q 0 0 0 rg BT 126.62 183.32 Td (4.625% ) Tj ET Q q 0 0 0 rg BT 161.76 183.32 Td (Notes ) Tj ET Q q 0 0 0 rg BT 189.40 183.32 Td (due ) Tj ET Q q 0 0 0 rg BT 208.15 183.32 Td (2021 ) Tj ET Q q 0 0 0 rg BT 232.46 183.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 290.63 183.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 319.93 183.32 Td (by ) Tj ET Q q 0 0 0 rg BT 334.24 183.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 375.73 183.32 Td (to ) Tj ET Q q 0 0 0 rg BT 387.82 183.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 421.58 183.32 Td (4u ) Tj ET Q q 0 0 0 rg BT 435.89 183.32 Td (to ) Tj ET Q q 0 0 0 rg BT 447.98 183.32 Td (the ) Tj ET Q q 0 0 0 rg BT 464.50 183.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 490.48 183.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 510.35 183.32 Td (dated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 173.32 Td (November 20, ) Tj ET Q q 0 0 0 rg BT 147.71 173.32 Td (2006 ) Tj ET Q q 0 0 0 rg BT 170.21 173.32 Td (and ) Tj ET Q q 0 0 0 rg BT 187.15 173.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 207.97 173.32 Td (November 27, ) Tj ET Q q 0 0 0 rg BT 267.68 173.32 Td (2006\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 183.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.70 154.32 Td (4l.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 153.42 Td (Form of Fifth Supplemental Indenture between Bristol-Myers Squibb Company and The Bank of New York,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 143.42 Td (as Trustee, to the indenture dated June 1, 1993 \(incorporated herein by reference to Exhibit 4.1 to the Form 8-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 133.42 Td (K dated May 1, 2008 and filed on May 7, 2008\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 154.32 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 115.32 Td (4m.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 115.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.04 115.32 Td (of ) Tj ET Q q 0 0 0 rg BT 122.73 115.32 Td (6.125% ) Tj ET Q q 0 0 0 rg BT 155.93 115.32 Td (Notes ) Tj ET Q q 0 0 0 rg BT 181.62 115.32 Td (due ) Tj ET Q q 0 0 0 rg BT 198.43 115.32 Td (2038 ) Tj ET Q q 0 0 0 rg BT 220.79 115.32 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 277.02 115.32 Td (herein ) Tj ET Q q 0 0 0 rg BT 304.37 115.32 Td (by ) Tj ET Q q 0 0 0 rg BT 316.74 115.32 Td (reference ) Tj ET Q q 0 0 0 rg BT 356.29 115.32 Td (to ) Tj ET Q q 0 0 0 rg BT 366.43 115.32 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 398.24 115.32 Td (4.3 ) Tj ET Q q 0 0 0 rg BT 413.10 115.32 Td (to ) Tj ET Q q 0 0 0 rg BT 423.25 115.32 Td (the ) Tj ET Q q 0 0 0 rg BT 437.83 115.32 Td (Form ) Tj ET Q q 0 0 0 rg BT 461.87 115.32 Td (8-K ) Tj ET Q q 0 0 0 rg BT 479.78 115.32 Td (dated ) Tj ET Q q 0 0 0 rg BT 503.81 115.32 Td (May ) Tj ET Q q 0 0 0 rg BT 524.50 115.32 Td (1, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 105.32 Td (2008 ) Tj ET Q q 0 0 0 rg BT 110.50 105.32 Td (and ) Tj ET Q q 0 0 0 rg BT 127.44 105.32 Td (filed ) Tj ET Q q 0 0 0 rg BT 148.26 105.32 Td (on ) Tj ET Q q 0 0 0 rg BT 160.76 105.32 Td (May ) Tj ET Q q 0 0 0 rg BT 181.59 105.32 Td (7, ) Tj ET Q q 0 0 0 rg BT 191.59 105.32 Td (2008\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 115.32 Td (‡) Tj ET Q endstream endobj 215 0 obj <> endobj 216 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 742.07 Td (4n.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 720.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 742.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 111.99 742.07 Td (of ) Tj ET Q q 0 0 0 rg BT 122.63 742.07 Td (Sixth ) Tj ET Q q 0 0 0 rg BT 146.07 742.07 Td (Supplemental ) Tj ET Q q 0 0 0 rg BT 203.38 742.07 Td (Indenture ) Tj ET Q q 0 0 0 rg BT 244.01 742.07 Td (between ) Tj ET Q q 0 0 0 rg BT 279.64 742.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 338.07 742.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 368.72 742.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 409.93 742.07 Td (and ) Tj ET Q q 0 0 0 rg BT 426.60 742.07 Td (The ) Tj ET Q q 0 0 0 rg BT 444.38 742.07 Td (Bank ) Tj ET Q q 0 0 0 rg BT 467.80 742.07 Td (of ) Tj ET Q q 0 0 0 rg BT 478.45 742.07 Td (New ) Tj ET Q q 0 0 0 rg BT 499.49 742.07 Td (Y) Tj ET Q q 0 0 0 rg BT 506.03 742.07 Td (ork, ) Tj ET Q q 0 0 0 rg BT 523.67 742.07 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 732.07 Td (T) Tj ET Q q 0 0 0 rg BT 93.93 732.07 Td (rustee, ) Tj ET Q q 0 0 0 rg BT 123.11 732.07 Td (to ) Tj ET Q q 0 0 0 rg BT 133.87 732.07 Td (the ) Tj ET Q q 0 0 0 rg BT 149.07 732.07 Td (indenture ) Tj ET Q q 0 0 0 rg BT 189.82 732.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 214.45 732.07 Td (June ) Tj ET Q q 0 0 0 rg BT 235.76 732.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 246.24 732.07 Td (1993 ) Tj ET Q q 0 0 0 rg BT 269.23 732.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 326.07 732.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 354.04 732.07 Td (by ) Tj ET Q q 0 0 0 rg BT 367.02 732.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 407.18 732.07 Td (to ) Tj ET Q q 0 0 0 rg BT 417.94 732.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 450.36 732.07 Td (4.1 ) Tj ET Q q 0 0 0 rg BT 465.84 732.07 Td (to ) Tj ET Q q 0 0 0 rg BT 476.60 732.07 Td (the ) Tj ET Q q 0 0 0 rg BT 491.80 732.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 516.45 732.07 Td (8-K ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 722.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 112.16 722.07 Td (July ) Tj ET Q q 0 0 0 rg BT 131.33 722.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 146.33 722.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 168.83 722.07 Td (and ) Tj ET Q q 0 0 0 rg BT 185.76 722.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 206.59 722.07 Td (on ) Tj ET Q q 0 0 0 rg BT 219.09 722.07 Td (July ) Tj ET Q q 0 0 0 rg BT 238.26 722.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 253.26 722.07 Td (2012\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 720.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 742.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 703.07 Td (4o.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 703.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.55 703.07 Td (of ) Tj ET Q q 0 0 0 rg BT 123.77 703.07 Td (0.875% ) Tj ET Q q 0 0 0 rg BT 157.48 703.07 Td (Notes ) Tj ET Q q 0 0 0 rg BT 183.69 703.07 Td (Due ) Tj ET Q q 0 0 0 rg BT 203.24 703.07 Td (2017 ) Tj ET Q q 0 0 0 rg BT 226.12 703.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 282.87 703.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 310.73 703.07 Td (by ) Tj ET Q q 0 0 0 rg BT 323.62 703.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 363.68 703.07 Td (to ) Tj ET Q q 0 0 0 rg BT 374.35 703.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 406.67 703.07 Td (4.1 ) Tj ET Q q 0 0 0 rg BT 422.06 703.07 Td (to ) Tj ET Q q 0 0 0 rg BT 432.72 703.07 Td (the ) Tj ET Q q 0 0 0 rg BT 447.82 703.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 472.37 703.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 490.81 703.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 515.34 703.07 Td (July ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 693.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 103.00 693.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 125.50 693.07 Td (and ) Tj ET Q q 0 0 0 rg BT 142.44 693.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 163.26 693.07 Td (on ) Tj ET Q q 0 0 0 rg BT 175.76 693.07 Td (July ) Tj ET Q q 0 0 0 rg BT 194.93 693.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 209.93 693.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 703.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 674.07 Td (4p.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 674.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.55 674.07 Td (of ) Tj ET Q q 0 0 0 rg BT 123.77 674.07 Td (2.000% ) Tj ET Q q 0 0 0 rg BT 157.48 674.07 Td (Notes ) Tj ET Q q 0 0 0 rg BT 183.69 674.07 Td (Due ) Tj ET Q q 0 0 0 rg BT 203.24 674.07 Td (2022 ) Tj ET Q q 0 0 0 rg BT 226.12 674.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 282.87 674.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 310.73 674.07 Td (by ) Tj ET Q q 0 0 0 rg BT 323.62 674.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 363.68 674.07 Td (to ) Tj ET Q q 0 0 0 rg BT 374.35 674.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 406.67 674.07 Td (4.1 ) Tj ET Q q 0 0 0 rg BT 422.06 674.07 Td (to ) Tj ET Q q 0 0 0 rg BT 432.72 674.07 Td (the ) Tj ET Q q 0 0 0 rg BT 447.82 674.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 472.37 674.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 490.81 674.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 515.34 674.07 Td (July ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 664.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 103.00 664.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 125.50 664.07 Td (and ) Tj ET Q q 0 0 0 rg BT 142.44 664.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 163.26 664.07 Td (on ) Tj ET Q q 0 0 0 rg BT 175.76 664.07 Td (July ) Tj ET Q q 0 0 0 rg BT 194.93 664.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 209.93 664.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 674.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 645.07 Td (4q.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 645.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.55 645.07 Td (of ) Tj ET Q q 0 0 0 rg BT 123.77 645.07 Td (3.250% ) Tj ET Q q 0 0 0 rg BT 157.48 645.07 Td (Notes ) Tj ET Q q 0 0 0 rg BT 183.69 645.07 Td (Due ) Tj ET Q q 0 0 0 rg BT 203.24 645.07 Td (2042 ) Tj ET Q q 0 0 0 rg BT 226.12 645.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 282.87 645.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 310.73 645.07 Td (by ) Tj ET Q q 0 0 0 rg BT 323.62 645.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 363.68 645.07 Td (to ) Tj ET Q q 0 0 0 rg BT 374.35 645.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 406.67 645.07 Td (4.1 ) Tj ET Q q 0 0 0 rg BT 422.06 645.07 Td (to ) Tj ET Q q 0 0 0 rg BT 432.72 645.07 Td (the ) Tj ET Q q 0 0 0 rg BT 447.82 645.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 472.37 645.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 490.81 645.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 515.34 645.07 Td (July ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 635.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 103.00 635.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 125.50 635.07 Td (and ) Tj ET Q q 0 0 0 rg BT 142.44 635.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 163.26 635.07 Td (on ) Tj ET Q q 0 0 0 rg BT 175.76 635.07 Td (July ) Tj ET Q q 0 0 0 rg BT 194.93 635.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 209.93 635.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 645.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.70 617.07 Td (4r.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 617.07 Td (Seventh Supplemental Indenture, dated as of October 31, 2013, between Bristol-Myers Squibb Company and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 607.07 Td (The Bank of New York Mellon, as Trustee to the Indenture dated as of June 1, 1993 \(incorporated herein by) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 597.07 Td (reference to Exhibit 4.1 to the Form 8-K dated and filed on October 31, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 617.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.60 580.07 Td (4s.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 580.07 Td (Form of 1.750% Notes Due 2019 \(incorporated herein by reference to Exhibit 4.2 to the Form 8-K dated and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 570.07 Td (filed on October 31, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 580.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 67.70 550.07 Td (4t.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 550.07 Td (Form of 3.250% Notes Due 2023 \(incorporated herein by reference to Exhibit 4.3 to the Form 8-K dated and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 540.07 Td (filed on October 31, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 550.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 521.07 Td (4u.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 521.07 Td (Form of 4.500% Notes Due 2044 \(incorporated herein by reference to Exhibit 4.4 to the Form 8-K dated and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 511.07 Td (filed on October 31, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 521.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 66.10 493.07 Td (4v.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 493.07 Td (Eighth Supplemental Indenture, dated as of May 5, 2015, between Bristol-Myers Squibb Company and The) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 483.07 Td (Bank of New York Mellon, as Trustee, to the Indenture dated as of June 1, 1993 \(incorporated herein by) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 473.07 Td (reference to Exhibit 4.1 to the Form 8-K dated and filed on May 5, 2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 493.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.90 454.07 Td (4w.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 454.07 Td (Form of €575,000,000 1.000% Notes Due 2025 \(incorporated herein by reference to Exhibit 4.2 to the Form) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 444.07 Td (8-K dated and filed on May 5, 2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 454.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 65.50 425.07 Td (4x.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 425.07 Td (Form of €575,000,000 1.750% Notes Due 2035 \(incorporated herein by reference to Exhibit 4.3 to the Form) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 415.07 Td (8-K dated and filed on May 5, 2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 425.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.05 396.07 Td (10a.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 395.17 Td ($1,500,000,000 Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 385.17 Td (September 29, 2011 among Bristol-Myers Squibb Company, the borrowing subsidiaries, the lenders named in) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 375.17 Td (the agreement, BNP Paribas and The Royal Bank of Scotland plc, as documentation agents, Bank of America) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 365.17 Td (N.A., as syndication agent, and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 355.17 Td (\(incorporated herein by reference to Exhibit 10.1 to the Form 8-K dated September 29, 2011 and filed on) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 345.17 Td (October 4, 2011\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 396.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 327.07 Td (10b.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 327.07 Td (First Amendment dated June 21, 2013 to the Five Year Competitive Advance and Revolving Credit Facility) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 317.07 Td (Agreement dated as of September 29, 2011 among Bristol-Myers Squibb Company, the several financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 307.07 Td (institutions from time to time party to the agreement, and JPMorgan Chase Bank, N.A. and Citibank N.A. as) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 297.07 Td (administrative agents \(incorporated herein by reference to Exhibit 10a to the Form 10-Q for the quarterly) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 287.07 Td (period ended June 30, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 327.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.05 267.07 Td (10c.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 267.07 Td (Extension notice dated June 3, 2013 for the Five Year Competitive Advance and Revolving Credit Facility) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 257.07 Td (Agreement dated as of September 29, 2011 among Bristol-Myers Squibb Company, the several financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 247.07 Td (institutions from time to time party to the agreement, and JPMorgan Chase Bank, N.A. and Citibank N.A. as) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 237.07 Td (administrative agents \(incorporated herein by reference to Exhibit 10b to the Form 10-Q for the quarterly) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 227.07 Td (period ended June 30, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 267.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 204.07 Td (10d.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 203.17 Td ($1,500,000,000 Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 31,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 193.17 Td (2012 among Bristol-Myers Squibb Company, the borrowing subsidiaries, the lenders named in the agreement,) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 183.17 Td (Bank of America N.A., Barclays Bank plc, Deutsche Bank Securities Inc., and Wells Fargo Bank, National) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 173.17 Td (Association as documentation agents, Citibank, N.A. and JPMorgan Chase Bank, N.A., as administrative) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 163.17 Td (agents \(incorporated herein by reference to Exhibit 10.1 to the Form 8-K dated July 26, 2012 and filed on July) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 153.17 Td (31, 2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 204.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.05 135.07 Td (10e.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 135.07 Td (Extension notice dated May 31, 2013 for the Five Year Competitive Advance and Revolving Credit Facility) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 125.07 Td (Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company, the several financial institutions) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 115.07 Td (from time to time party to the agreement, and JPMorgan Chase Bank, N.A. and Citibank N.A. as) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 105.07 Td (administrative agents \(incorporated herein by reference to Exhibit 10c to the Form 10-Q for the quarterly) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 95.07 Td (period ended June 30, 2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 135.07 Td (‡) Tj ET Q endstream endobj 217 0 obj <> endobj 218 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (108) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.15 746.07 Td (10f.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 745.17 Td (Extension ) Tj ET Q q 0 0 0 rg BT 131.78 745.17 Td (notice ) Tj ET Q q 0 0 0 rg BT 160.00 745.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 185.44 745.17 Td (June ) Tj ET Q q 0 0 0 rg BT 207.55 745.17 Td (2, ) Tj ET Q q 0 0 0 rg BT 218.84 745.17 Td (2014 ) Tj ET Q q 0 0 0 rg BT 242.63 745.17 Td (for ) Tj ET Q q 0 0 0 rg BT 258.07 745.17 Td (the ) Tj ET Q q 0 0 0 rg BT 274.07 745.17 Td (Five ) Tj ET Q q 0 0 0 rg BT 295.26 745.17 Td (Y) Tj ET Q q 0 0 0 rg BT 301.79 745.17 Td (ear ) Tj ET Q q 0 0 0 rg BT 317.29 745.17 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 369.95 745.17 Td (Advance ) Tj ET Q q 0 0 0 rg BT 409.00 745.17 Td (and ) Tj ET Q q 0 0 0 rg BT 427.22 745.17 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 472.67 745.17 Td (Credit ) Tj ET Q q 0 0 0 rg BT 501.45 745.17 Td (Facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 735.17 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 136.92 735.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 163.07 735.17 Td (as ) Tj ET Q q 0 0 0 rg BT 175.90 735.17 Td (of ) Tj ET Q q 0 0 0 rg BT 188.73 735.17 Td (September ) Tj ET Q q 0 0 0 rg BT 235.99 735.17 Td (29, ) Tj ET Q q 0 0 0 rg BT 252.98 735.17 Td (201) Tj ET Q q 0 0 0 rg BT 267.80 735.17 Td (1 ) Tj ET Q q 0 0 0 rg BT 277.11 735.17 Td (among ) Tj ET Q q 0 0 0 rg BT 308.82 735.17 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 369.43 735.17 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 402.26 735.17 Td (Company) Tj ET Q q 0 0 0 rg BT 440.82 735.17 Td (, ) Tj ET Q q 0 0 0 rg BT 447.50 735.17 Td (the ) Tj ET Q q 0 0 0 rg BT 464.21 735.17 Td (several ) Tj ET Q q 0 0 0 rg BT 497.02 735.17 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 725.17 Td (institutions ) Tj ET Q q 0 0 0 rg BT 135.55 725.17 Td (from ) Tj ET Q q 0 0 0 rg BT 158.08 725.17 Td (time ) Tj ET Q q 0 0 0 rg BT 178.94 725.17 Td (to ) Tj ET Q q 0 0 0 rg BT 189.82 725.17 Td (time ) Tj ET Q q 0 0 0 rg BT 210.68 725.17 Td (party ) Tj ET Q q 0 0 0 rg BT 234.32 725.17 Td (to ) Tj ET Q q 0 0 0 rg BT 245.19 725.17 Td (the ) Tj ET Q q 0 0 0 rg BT 260.50 725.17 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 307.74 725.17 Td (and ) Tj ET Q q 0 0 0 rg BT 325.27 725.17 Td (JPMor) Tj ET Q q 0 0 0 rg BT 351.85 725.17 Td (gan ) Tj ET Q q 0 0 0 rg BT 369.30 725.17 Td (Chase ) Tj ET Q q 0 0 0 rg BT 396.83 725.17 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 423.53 725.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 446.07 725.17 Td (and ) Tj ET Q q 0 0 0 rg BT 463.60 725.17 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 501.13 725.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 523.67 725.17 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 715.17 Td (administrative ) Tj ET Q q 0 0 0 rg BT 147.45 715.17 Td (agents ) Tj ET Q q 0 0 0 rg BT 175.23 715.17 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 231.33 715.17 Td (herein ) Tj ET Q q 0 0 0 rg BT 258.56 715.17 Td (by ) Tj ET Q q 0 0 0 rg BT 270.80 715.17 Td (reference ) Tj ET Q q 0 0 0 rg BT 310.22 715.17 Td (to ) Tj ET Q q 0 0 0 rg BT 320.23 715.17 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 351.92 715.17 Td (10a ) Tj ET Q q 0 0 0 rg BT 368.59 715.17 Td (to ) Tj ET Q q 0 0 0 rg BT 378.61 715.17 Td (the ) Tj ET Q q 0 0 0 rg BT 393.07 715.17 Td (Form ) Tj ET Q q 0 0 0 rg BT 416.97 715.17 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 439.77 715.17 Td (for ) Tj ET Q q 0 0 0 rg BT 453.66 715.17 Td (the ) Tj ET Q q 0 0 0 rg BT 468.12 715.17 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 506.45 715.17 Td (period ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 705.17 Td (ended ) Tj ET Q q 0 0 0 rg BT 114.38 705.17 Td (June ) Tj ET Q q 0 0 0 rg BT 135.21 705.17 Td (30, ) Tj ET Q q 0 0 0 rg BT 150.21 705.17 Td (2014\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 746.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 687.07 Td (10g.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 686.17 Td (Extension ) Tj ET Q q 0 0 0 rg BT 131.78 686.17 Td (notice ) Tj ET Q q 0 0 0 rg BT 160.00 686.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 185.44 686.17 Td (June ) Tj ET Q q 0 0 0 rg BT 207.55 686.17 Td (2, ) Tj ET Q q 0 0 0 rg BT 218.84 686.17 Td (2014 ) Tj ET Q q 0 0 0 rg BT 242.63 686.17 Td (for ) Tj ET Q q 0 0 0 rg BT 258.07 686.17 Td (the ) Tj ET Q q 0 0 0 rg BT 274.07 686.17 Td (Five ) Tj ET Q q 0 0 0 rg BT 295.26 686.17 Td (Y) Tj ET Q q 0 0 0 rg BT 301.79 686.17 Td (ear ) Tj ET Q q 0 0 0 rg BT 317.29 686.17 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 369.95 686.17 Td (Advance ) Tj ET Q q 0 0 0 rg BT 409.00 686.17 Td (and ) Tj ET Q q 0 0 0 rg BT 427.22 686.17 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 472.67 686.17 Td (Credit ) Tj ET Q q 0 0 0 rg BT 501.45 686.17 Td (Facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 676.17 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 135.26 676.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 159.76 676.17 Td (as ) Tj ET Q q 0 0 0 rg BT 170.92 676.17 Td (of ) Tj ET Q q 0 0 0 rg BT 182.09 676.17 Td (July ) Tj ET Q q 0 0 0 rg BT 201.60 676.17 Td (30, ) Tj ET Q q 0 0 0 rg BT 216.94 676.17 Td (2012 ) Tj ET Q q 0 0 0 rg BT 239.78 676.17 Td (among ) Tj ET Q q 0 0 0 rg BT 269.83 676.17 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 328.78 676.17 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 359.96 676.17 Td (Company) Tj ET Q q 0 0 0 rg BT 398.52 676.17 Td (, ) Tj ET Q q 0 0 0 rg BT 403.53 676.17 Td (the ) Tj ET Q q 0 0 0 rg BT 418.59 676.17 Td (several ) Tj ET Q q 0 0 0 rg BT 449.74 676.17 Td (financial ) Tj ET Q q 0 0 0 rg BT 487.56 676.17 Td (institutions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 666.17 Td (from ) Tj ET Q q 0 0 0 rg BT 109.78 666.17 Td (time ) Tj ET Q q 0 0 0 rg BT 129.90 666.17 Td (to ) Tj ET Q q 0 0 0 rg BT 140.02 666.17 Td (time ) Tj ET Q q 0 0 0 rg BT 160.14 666.17 Td (party ) Tj ET Q q 0 0 0 rg BT 183.03 666.17 Td (to ) Tj ET Q q 0 0 0 rg BT 193.15 666.17 Td (the ) Tj ET Q q 0 0 0 rg BT 207.71 666.17 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 254.20 666.17 Td (and ) Tj ET Q q 0 0 0 rg BT 270.98 666.17 Td (JPMor) Tj ET Q q 0 0 0 rg BT 297.56 666.17 Td (gan ) Tj ET Q q 0 0 0 rg BT 314.25 666.17 Td (Chase ) Tj ET Q q 0 0 0 rg BT 341.04 666.17 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 366.99 666.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 388.78 666.17 Td (and ) Tj ET Q q 0 0 0 rg BT 405.56 666.17 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 442.35 666.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 464.13 666.17 Td (as ) Tj ET Q q 0 0 0 rg BT 474.81 666.17 Td (administrative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 656.17 Td (agents ) Tj ET Q q 0 0 0 rg BT 115.65 656.17 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 171.61 656.17 Td (herein ) Tj ET Q q 0 0 0 rg BT 198.69 656.17 Td (by ) Tj ET Q q 0 0 0 rg BT 210.79 656.17 Td (reference ) Tj ET Q q 0 0 0 rg BT 250.07 656.17 Td (to ) Tj ET Q q 0 0 0 rg BT 259.95 656.17 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 291.49 656.17 Td (10b ) Tj ET Q q 0 0 0 rg BT 308.59 656.17 Td (to ) Tj ET Q q 0 0 0 rg BT 318.46 656.17 Td (the ) Tj ET Q q 0 0 0 rg BT 332.78 656.17 Td (Form ) Tj ET Q q 0 0 0 rg BT 356.55 656.17 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 379.20 656.17 Td (for ) Tj ET Q q 0 0 0 rg BT 392.96 656.17 Td (the ) Tj ET Q q 0 0 0 rg BT 407.27 656.17 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 445.47 656.17 Td (period ) Tj ET Q q 0 0 0 rg BT 473.11 656.17 Td (ended ) Tj ET Q q 0 0 0 rg BT 499.09 656.17 Td (June ) Tj ET Q q 0 0 0 rg BT 519.52 656.17 Td (30, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 646.17 Td (2014\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 687.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 628.07 Td (10h.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 627.17 Td (Extension ) Tj ET Q q 0 0 0 rg BT 131.61 627.17 Td (notice ) Tj ET Q q 0 0 0 rg BT 159.66 627.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 184.93 627.17 Td (June ) Tj ET Q q 0 0 0 rg BT 206.87 627.17 Td (1, ) Tj ET Q q 0 0 0 rg BT 217.99 627.17 Td (2015, ) Tj ET Q q 0 0 0 rg BT 244.10 627.17 Td (for ) Tj ET Q q 0 0 0 rg BT 259.38 627.17 Td (the ) Tj ET Q q 0 0 0 rg BT 275.21 627.17 Td (Five ) Tj ET Q q 0 0 0 rg BT 296.25 627.17 Td (Y) Tj ET Q q 0 0 0 rg BT 302.79 627.17 Td (ear ) Tj ET Q q 0 0 0 rg BT 318.11 627.17 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 370.64 627.17 Td (Advance ) Tj ET Q q 0 0 0 rg BT 409.52 627.17 Td (and ) Tj ET Q q 0 0 0 rg BT 427.57 627.17 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 472.85 627.17 Td (Credit ) Tj ET Q q 0 0 0 rg BT 501.46 627.17 Td (Facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 617.17 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 135.57 617.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 160.37 617.17 Td (as ) Tj ET Q q 0 0 0 rg BT 171.84 617.17 Td (of ) Tj ET Q q 0 0 0 rg BT 183.32 617.17 Td (September ) Tj ET Q q 0 0 0 rg BT 229.23 617.17 Td (29, ) Tj ET Q q 0 0 0 rg BT 244.87 617.17 Td (201) Tj ET Q q 0 0 0 rg BT 259.68 617.17 Td (1 ) Tj ET Q q 0 0 0 rg BT 267.64 617.17 Td (among ) Tj ET Q q 0 0 0 rg BT 298.00 617.17 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 357.26 617.17 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 388.74 617.17 Td (Company) Tj ET Q q 0 0 0 rg BT 427.30 617.17 Td (, ) Tj ET Q q 0 0 0 rg BT 432.62 617.17 Td (and ) Tj ET Q q 0 0 0 rg BT 450.21 617.17 Td (the ) Tj ET Q q 0 0 0 rg BT 465.57 617.17 Td (several ) Tj ET Q q 0 0 0 rg BT 497.03 617.17 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 607.17 Td (institutions ) Tj ET Q q 0 0 0 rg BT 135.55 607.17 Td (from ) Tj ET Q q 0 0 0 rg BT 158.08 607.17 Td (time ) Tj ET Q q 0 0 0 rg BT 178.94 607.17 Td (to ) Tj ET Q q 0 0 0 rg BT 189.82 607.17 Td (time ) Tj ET Q q 0 0 0 rg BT 210.68 607.17 Td (party ) Tj ET Q q 0 0 0 rg BT 234.32 607.17 Td (to ) Tj ET Q q 0 0 0 rg BT 245.19 607.17 Td (the ) Tj ET Q q 0 0 0 rg BT 260.50 607.17 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 307.74 607.17 Td (and ) Tj ET Q q 0 0 0 rg BT 325.27 607.17 Td (JPMor) Tj ET Q q 0 0 0 rg BT 351.85 607.17 Td (gan ) Tj ET Q q 0 0 0 rg BT 369.30 607.17 Td (Chase ) Tj ET Q q 0 0 0 rg BT 396.83 607.17 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 423.53 607.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 446.07 607.17 Td (and ) Tj ET Q q 0 0 0 rg BT 463.60 607.17 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 501.13 607.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 523.67 607.17 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 597.17 Td (administrative ) Tj ET Q q 0 0 0 rg BT 147.45 597.17 Td (agents ) Tj ET Q q 0 0 0 rg BT 175.23 597.17 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 231.33 597.17 Td (herein ) Tj ET Q q 0 0 0 rg BT 258.56 597.17 Td (by ) Tj ET Q q 0 0 0 rg BT 270.80 597.17 Td (reference ) Tj ET Q q 0 0 0 rg BT 310.22 597.17 Td (to ) Tj ET Q q 0 0 0 rg BT 320.23 597.17 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 351.92 597.17 Td (10a ) Tj ET Q q 0 0 0 rg BT 368.59 597.17 Td (to ) Tj ET Q q 0 0 0 rg BT 378.61 597.17 Td (the ) Tj ET Q q 0 0 0 rg BT 393.07 597.17 Td (Form ) Tj ET Q q 0 0 0 rg BT 416.97 597.17 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 439.77 597.17 Td (for ) Tj ET Q q 0 0 0 rg BT 453.66 597.17 Td (the ) Tj ET Q q 0 0 0 rg BT 468.12 597.17 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 506.45 597.17 Td (period ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 587.17 Td (ended ) Tj ET Q q 0 0 0 rg BT 114.38 587.17 Td (June ) Tj ET Q q 0 0 0 rg BT 135.21 587.17 Td (30, ) Tj ET Q q 0 0 0 rg BT 150.21 587.17 Td (2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 628.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 569.07 Td (10i.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 568.17 Td (Extension ) Tj ET Q q 0 0 0 rg BT 131.61 568.17 Td (notice ) Tj ET Q q 0 0 0 rg BT 159.66 568.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 184.93 568.17 Td (June ) Tj ET Q q 0 0 0 rg BT 206.87 568.17 Td (1, ) Tj ET Q q 0 0 0 rg BT 217.99 568.17 Td (2015, ) Tj ET Q q 0 0 0 rg BT 244.10 568.17 Td (for ) Tj ET Q q 0 0 0 rg BT 259.38 568.17 Td (the ) Tj ET Q q 0 0 0 rg BT 275.21 568.17 Td (Five ) Tj ET Q q 0 0 0 rg BT 296.07 568.17 Td (Y) Tj ET Q q 0 0 0 rg BT 302.29 568.17 Td (ear ) Tj ET Q q 0 0 0 rg BT 318.11 568.17 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 370.36 568.17 Td (Advance ) Tj ET Q q 0 0 0 rg BT 409.52 568.17 Td (and ) Tj ET Q q 0 0 0 rg BT 427.57 568.17 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 472.85 568.17 Td (Credit ) Tj ET Q q 0 0 0 rg BT 501.46 568.17 Td (Facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 558.17 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 135.26 558.17 Td (dated ) Tj ET Q q 0 0 0 rg BT 159.76 558.17 Td (as ) Tj ET Q q 0 0 0 rg BT 170.92 558.17 Td (of ) Tj ET Q q 0 0 0 rg BT 182.09 558.17 Td (July ) Tj ET Q q 0 0 0 rg BT 201.60 558.17 Td (30, ) Tj ET Q q 0 0 0 rg BT 216.94 558.17 Td (2012 ) Tj ET Q q 0 0 0 rg BT 239.78 558.17 Td (among ) Tj ET Q q 0 0 0 rg BT 269.83 558.17 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 328.78 558.17 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 359.96 558.17 Td (Company) Tj ET Q q 0 0 0 rg BT 398.20 558.17 Td (, ) Tj ET Q q 0 0 0 rg BT 403.53 558.17 Td (the ) Tj ET Q q 0 0 0 rg BT 418.59 558.17 Td (several ) Tj ET Q q 0 0 0 rg BT 449.74 558.17 Td (financial ) Tj ET Q q 0 0 0 rg BT 487.56 558.17 Td (institutions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 548.17 Td (from ) Tj ET Q q 0 0 0 rg BT 109.78 548.17 Td (time ) Tj ET Q q 0 0 0 rg BT 129.90 548.17 Td (to ) Tj ET Q q 0 0 0 rg BT 140.02 548.17 Td (time ) Tj ET Q q 0 0 0 rg BT 160.14 548.17 Td (party ) Tj ET Q q 0 0 0 rg BT 183.03 548.17 Td (to ) Tj ET Q q 0 0 0 rg BT 193.15 548.17 Td (the ) Tj ET Q q 0 0 0 rg BT 207.71 548.17 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 254.20 548.17 Td (and ) Tj ET Q q 0 0 0 rg BT 270.98 548.17 Td (JPMor) Tj ET Q q 0 0 0 rg BT 297.47 548.17 Td (gan ) Tj ET Q q 0 0 0 rg BT 314.25 548.17 Td (Chase ) Tj ET Q q 0 0 0 rg BT 341.04 548.17 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 366.99 548.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 388.78 548.17 Td (and ) Tj ET Q q 0 0 0 rg BT 405.56 548.17 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 442.35 548.17 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 464.13 548.17 Td (as ) Tj ET Q q 0 0 0 rg BT 474.81 548.17 Td (administrative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 538.17 Td (agents ) Tj ET Q q 0 0 0 rg BT 115.65 538.17 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 171.61 538.17 Td (herein ) Tj ET Q q 0 0 0 rg BT 198.69 538.17 Td (by ) Tj ET Q q 0 0 0 rg BT 210.79 538.17 Td (reference ) Tj ET Q q 0 0 0 rg BT 250.07 538.17 Td (to ) Tj ET Q q 0 0 0 rg BT 259.95 538.17 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 291.49 538.17 Td (10b ) Tj ET Q q 0 0 0 rg BT 308.59 538.17 Td (to ) Tj ET Q q 0 0 0 rg BT 318.46 538.17 Td (the ) Tj ET Q q 0 0 0 rg BT 332.78 538.17 Td (Form ) Tj ET Q q 0 0 0 rg BT 356.55 538.17 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 379.20 538.17 Td (for ) Tj ET Q q 0 0 0 rg BT 392.96 538.17 Td (the ) Tj ET Q q 0 0 0 rg BT 407.27 538.17 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 445.47 538.17 Td (period ) Tj ET Q q 0 0 0 rg BT 473.11 538.17 Td (ended ) Tj ET Q q 0 0 0 rg BT 499.09 538.17 Td (June ) Tj ET Q q 0 0 0 rg BT 519.52 538.17 Td (30, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 528.17 Td (2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 569.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 510.07 Td (10j.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 510.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 139.70 510.07 Td (and ) Tj ET Q q 0 0 0 rg BT 156.34 510.07 Td (W) Tj ET Q q 0 0 0 rg BT 165.29 510.07 Td (aiver ) Tj ET Q q 0 0 0 rg BT 187.14 510.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 211.07 510.07 Td (as ) Tj ET Q q 0 0 0 rg BT 221.67 510.07 Td (of ) Tj ET Q q 0 0 0 rg BT 232.27 510.07 Td (June ) Tj ET Q q 0 0 0 rg BT 252.87 510.07 Td (21, ) Tj ET Q q 0 0 0 rg BT 267.64 510.07 Td (2016, ) Tj ET Q q 0 0 0 rg BT 292.41 510.07 Td (to ) Tj ET Q q 0 0 0 rg BT 302.46 510.07 Td (the ) Tj ET Q q 0 0 0 rg BT 316.95 510.07 Td (Five ) Tj ET Q q 0 0 0 rg BT 336.84 510.07 Td (Y) Tj ET Q q 0 0 0 rg BT 343.38 510.07 Td (ear ) Tj ET Q q 0 0 0 rg BT 357.36 510.07 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 408.84 510.07 Td (Advance ) Tj ET Q q 0 0 0 rg BT 446.37 510.07 Td (and ) Tj ET Q q 0 0 0 rg BT 463.08 510.07 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 507.02 510.07 Td (Credit ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 500.07 Td (Facility ) Tj ET Q q 0 0 0 rg BT 120.41 500.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 166.58 500.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 190.26 500.07 Td (as ) Tj ET Q q 0 0 0 rg BT 200.62 500.07 Td (of ) Tj ET Q q 0 0 0 rg BT 210.97 500.07 Td (September ) Tj ET Q q 0 0 0 rg BT 255.76 500.07 Td (29, ) Tj ET Q q 0 0 0 rg BT 270.29 500.07 Td (201) Tj ET Q q 0 0 0 rg BT 285.10 500.07 Td (1 ) Tj ET Q q 0 0 0 rg BT 291.94 500.07 Td (among ) Tj ET Q q 0 0 0 rg BT 321.18 500.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 379.32 500.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 409.68 500.07 Td (Company) Tj ET Q q 0 0 0 rg BT 448.24 500.07 Td (, ) Tj ET Q q 0 0 0 rg BT 452.44 500.07 Td (the ) Tj ET Q q 0 0 0 rg BT 466.69 500.07 Td (several ) Tj ET Q q 0 0 0 rg BT 497.03 500.07 Td (financial ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 490.07 Td (institutions ) Tj ET Q q 0 0 0 rg BT 135.55 490.07 Td (from ) Tj ET Q q 0 0 0 rg BT 158.08 490.07 Td (time ) Tj ET Q q 0 0 0 rg BT 178.94 490.07 Td (to ) Tj ET Q q 0 0 0 rg BT 189.82 490.07 Td (time ) Tj ET Q q 0 0 0 rg BT 210.68 490.07 Td (party ) Tj ET Q q 0 0 0 rg BT 234.32 490.07 Td (to ) Tj ET Q q 0 0 0 rg BT 245.19 490.07 Td (the ) Tj ET Q q 0 0 0 rg BT 260.50 490.07 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 307.74 490.07 Td (and ) Tj ET Q q 0 0 0 rg BT 325.27 490.07 Td (JPMor) Tj ET Q q 0 0 0 rg BT 351.85 490.07 Td (gan ) Tj ET Q q 0 0 0 rg BT 369.30 490.07 Td (Chase ) Tj ET Q q 0 0 0 rg BT 396.83 490.07 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 423.53 490.07 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 446.07 490.07 Td (and ) Tj ET Q q 0 0 0 rg BT 463.60 490.07 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 501.13 490.07 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 523.67 490.07 Td (as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 480.07 Td (administrative ) Tj ET Q q 0 0 0 rg BT 147.45 480.07 Td (agents ) Tj ET Q q 0 0 0 rg BT 175.23 480.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 231.33 480.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 258.56 480.07 Td (by ) Tj ET Q q 0 0 0 rg BT 270.80 480.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 310.22 480.07 Td (to ) Tj ET Q q 0 0 0 rg BT 320.23 480.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 351.92 480.07 Td (10a ) Tj ET Q q 0 0 0 rg BT 368.59 480.07 Td (to ) Tj ET Q q 0 0 0 rg BT 378.61 480.07 Td (the ) Tj ET Q q 0 0 0 rg BT 393.07 480.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 416.97 480.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 439.77 480.07 Td (for ) Tj ET Q q 0 0 0 rg BT 453.66 480.07 Td (the ) Tj ET Q q 0 0 0 rg BT 468.12 480.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 506.45 480.07 Td (period ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 470.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 114.38 470.07 Td (June ) Tj ET Q q 0 0 0 rg BT 135.21 470.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 150.21 470.07 Td (2016\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 510.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 451.07 Td (10k.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 451.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 140.64 451.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 165.50 451.07 Td (as ) Tj ET Q q 0 0 0 rg BT 177.04 451.07 Td (of ) Tj ET Q q 0 0 0 rg BT 188.57 451.07 Td (June ) Tj ET Q q 0 0 0 rg BT 210.11 451.07 Td (21, ) Tj ET Q q 0 0 0 rg BT 225.81 451.07 Td (2016, ) Tj ET Q q 0 0 0 rg BT 251.52 451.07 Td (to ) Tj ET Q q 0 0 0 rg BT 262.50 451.07 Td (the ) Tj ET Q q 0 0 0 rg BT 277.92 451.07 Td (Five ) Tj ET Q q 0 0 0 rg BT 298.62 451.07 Td (Y) Tj ET Q q 0 0 0 rg BT 305.15 451.07 Td (ear ) Tj ET Q q 0 0 0 rg BT 320.07 451.07 Td (Competitive ) Tj ET Q q 0 0 0 rg BT 372.28 451.07 Td (Advance ) Tj ET Q q 0 0 0 rg BT 410.75 451.07 Td (and ) Tj ET Q q 0 0 0 rg BT 428.39 451.07 Td (Revolving ) Tj ET Q q 0 0 0 rg BT 473.26 451.07 Td (Credit ) Tj ET Q q 0 0 0 rg BT 501.46 451.07 Td (Facility ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 441.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 135.26 441.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 159.76 441.07 Td (as ) Tj ET Q q 0 0 0 rg BT 170.92 441.07 Td (of ) Tj ET Q q 0 0 0 rg BT 182.09 441.07 Td (July ) Tj ET Q q 0 0 0 rg BT 201.60 441.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 216.94 441.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 239.78 441.07 Td (among ) Tj ET Q q 0 0 0 rg BT 269.83 441.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 328.78 441.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 359.96 441.07 Td (Company) Tj ET Q q 0 0 0 rg BT 398.52 441.07 Td (, ) Tj ET Q q 0 0 0 rg BT 403.53 441.07 Td (the ) Tj ET Q q 0 0 0 rg BT 418.59 441.07 Td (several ) Tj ET Q q 0 0 0 rg BT 449.74 441.07 Td (financial ) Tj ET Q q 0 0 0 rg BT 487.56 441.07 Td (institutions ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 431.07 Td (from ) Tj ET Q q 0 0 0 rg BT 109.78 431.07 Td (time ) Tj ET Q q 0 0 0 rg BT 129.90 431.07 Td (to ) Tj ET Q q 0 0 0 rg BT 140.02 431.07 Td (time ) Tj ET Q q 0 0 0 rg BT 160.14 431.07 Td (party ) Tj ET Q q 0 0 0 rg BT 183.03 431.07 Td (to ) Tj ET Q q 0 0 0 rg BT 193.15 431.07 Td (the ) Tj ET Q q 0 0 0 rg BT 207.71 431.07 Td (agreement, ) Tj ET Q q 0 0 0 rg BT 254.20 431.07 Td (and ) Tj ET Q q 0 0 0 rg BT 270.98 431.07 Td (JPMor) Tj ET Q q 0 0 0 rg BT 297.56 431.07 Td (gan ) Tj ET Q q 0 0 0 rg BT 314.25 431.07 Td (Chase ) Tj ET Q q 0 0 0 rg BT 341.04 431.07 Td (Bank, ) Tj ET Q q 0 0 0 rg BT 366.99 431.07 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 388.78 431.07 Td (and ) Tj ET Q q 0 0 0 rg BT 405.56 431.07 Td (Citibank ) Tj ET Q q 0 0 0 rg BT 442.35 431.07 Td (N.A. ) Tj ET Q q 0 0 0 rg BT 464.13 431.07 Td (as ) Tj ET Q q 0 0 0 rg BT 474.81 431.07 Td (administrative ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 421.07 Td (agents ) Tj ET Q q 0 0 0 rg BT 115.65 421.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 171.61 421.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 198.69 421.07 Td (by ) Tj ET Q q 0 0 0 rg BT 210.79 421.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 250.07 421.07 Td (to ) Tj ET Q q 0 0 0 rg BT 259.95 421.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 291.49 421.07 Td (10b ) Tj ET Q q 0 0 0 rg BT 308.59 421.07 Td (to ) Tj ET Q q 0 0 0 rg BT 318.46 421.07 Td (the ) Tj ET Q q 0 0 0 rg BT 332.78 421.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 356.55 421.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 379.20 421.07 Td (for ) Tj ET Q q 0 0 0 rg BT 392.96 421.07 Td (the ) Tj ET Q q 0 0 0 rg BT 407.27 421.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 445.47 421.07 Td (period ) Tj ET Q q 0 0 0 rg BT 473.11 421.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 499.09 421.07 Td (June ) Tj ET Q q 0 0 0 rg BT 519.52 421.07 Td (30, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 411.07 Td (2016\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 451.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 392.07 Td (10l.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 392.07 Td (SEC ) Tj ET Q q 0 0 0 rg BT 108.97 392.07 Td (Consent ) Tj ET Q q 0 0 0 rg BT 144.38 392.07 Td (Order ) Tj ET Q q 0 0 0 rg BT 170.32 392.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 226.81 392.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 254.43 392.07 Td (by ) Tj ET Q q 0 0 0 rg BT 267.06 392.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 306.87 392.07 Td (to ) Tj ET Q q 0 0 0 rg BT 317.27 392.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 349.35 392.07 Td (10s ) Tj ET Q q 0 0 0 rg BT 365.87 392.07 Td (to ) Tj ET Q q 0 0 0 rg BT 376.27 392.07 Td (the ) Tj ET Q q 0 0 0 rg BT 391.12 392.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 415.42 392.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 438.60 392.07 Td (for ) Tj ET Q q 0 0 0 rg BT 452.89 392.07 Td (the ) Tj ET Q q 0 0 0 rg BT 467.73 392.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 506.45 392.07 Td (period ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 382.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 114.38 382.07 Td (September ) Tj ET Q q 0 0 0 rg BT 159.64 382.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 174.64 382.07 Td (2004\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 392.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 57.70 363.07 Td (10m.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 363.07 Td (Master ) Tj ET Q q 0 0 0 rg BT 117.85 363.07 Td (Restructuring ) Tj ET Q q 0 0 0 rg BT 174.18 363.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 220.41 363.07 Td (between ) Tj ET Q q 0 0 0 rg BT 255.81 363.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 314.00 363.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 344.42 363.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 385.39 363.07 Td (and ) Tj ET Q q 0 0 0 rg BT 401.91 363.07 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 430.10 363.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 453.83 363.07 Td (as ) Tj ET Q q 0 0 0 rg BT 464.25 363.07 Td (of ) Tj ET Q q 0 0 0 rg BT 474.66 363.07 Td (September ) Tj ET Q q 0 0 0 rg BT 519.50 363.07 Td (27, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 353.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 109.88 353.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 165.62 353.07 Td (by ) Tj ET Q q 0 0 0 rg BT 177.50 353.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 216.56 353.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 243.42 353.07 Td (to ) Tj ET Q q 0 0 0 rg BT 253.08 353.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 284.40 353.07 Td (10a ) Tj ET Q q 0 0 0 rg BT 300.72 353.07 Td (to ) Tj ET Q q 0 0 0 rg BT 310.38 353.07 Td (the ) Tj ET Q q 0 0 0 rg BT 324.47 353.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 348.02 353.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 370.45 353.07 Td (for ) Tj ET Q q 0 0 0 rg BT 383.99 353.07 Td (the ) Tj ET Q q 0 0 0 rg BT 398.09 353.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 436.06 353.07 Td (period ) Tj ET Q q 0 0 0 rg BT 463.49 353.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 489.24 353.07 Td (September ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 343.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 103.00 343.07 Td (2012\). ) Tj ET Q q 0 0 0 rg BT 131.33 343.07 Td (†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 363.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 321.07 Td (10n.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 321.07 Td (Side ) Tj ET Q q 0 0 0 rg BT 108.13 321.07 Td (Letter ) Tj ET Q q 0 0 0 rg BT 134.36 321.07 Td (to ) Tj ET Q q 0 0 0 rg BT 144.49 321.07 Td (Master ) Tj ET Q q 0 0 0 rg BT 174.61 321.07 Td (Restructuring ) Tj ET Q q 0 0 0 rg BT 231.15 321.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 277.66 321.07 Td (between ) Tj ET Q q 0 0 0 rg BT 313.33 321.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 371.79 321.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 402.48 321.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 443.72 321.07 Td (and ) Tj ET Q q 0 0 0 rg BT 460.51 321.07 Td (Sanofi ) Tj ET Q q 0 0 0 rg BT 488.97 321.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 512.98 321.07 Td (as ) Tj ET Q q 0 0 0 rg BT 523.67 321.07 Td (of ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 311.07 Td (January 1, ) Tj ET Q q 0 0 0 rg BT 132.38 311.07 Td (2013 ) Tj ET Q q 0 0 0 rg BT 155.67 311.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 212.81 311.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 241.08 311.07 Td (by ) Tj ET Q q 0 0 0 rg BT 254.36 311.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 294.83 311.07 Td (to ) Tj ET Q q 0 0 0 rg BT 305.89 311.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 338.62 311.07 Td (10p ) Tj ET Q q 0 0 0 rg BT 356.90 311.07 Td (to ) Tj ET Q q 0 0 0 rg BT 367.97 311.07 Td (the ) Tj ET Q q 0 0 0 rg BT 383.47 311.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 408.42 311.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 432.26 311.07 Td (for ) Tj ET Q q 0 0 0 rg BT 447.20 311.07 Td (the ) Tj ET Q q 0 0 0 rg BT 462.70 311.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 487.64 311.07 Td (year ) Tj ET Q q 0 0 0 rg BT 508.13 311.07 Td (ended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 301.12 Td (December ) Tj ET Q q 0 0 0 rg BT 131.58 301.12 Td (31, ) Tj ET Q q 0 0 0 rg BT 146.58 301.12 Td (2012\). ) Tj ET Q q 0 0 0 rg BT 174.91 301.12 Td (†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 321.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 285.07 Td (10o.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 285.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 125.31 285.07 Td (Development ) Tj ET Q q 0 0 0 rg BT 182.06 285.07 Td (and ) Tj ET Q q 0 0 0 rg BT 199.37 285.07 Td (Commercialization ) Tj ET Q q 0 0 0 rg BT 278.89 285.07 Td (Collaboration ) Tj ET Q q 0 0 0 rg BT 336.40 285.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 383.42 285.07 Td (between ) Tj ET Q q 0 0 0 rg BT 419.61 285.07 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 450.82 285.07 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 515.33 285.07 Td (Co., ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 275.07 Td (Ltd. ) Tj ET Q q 0 0 0 rg BT 105.86 275.07 Td (and ) Tj ET Q q 0 0 0 rg BT 121.77 275.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 179.35 275.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 209.17 275.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 249.53 275.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 272.66 275.07 Td (as ) Tj ET Q q 0 0 0 rg BT 282.46 275.07 Td (of ) Tj ET Q q 0 0 0 rg BT 292.26 275.07 Td (October ) Tj ET Q q 0 0 0 rg BT 325.95 275.07 Td (23, ) Tj ET Q q 0 0 0 rg BT 339.92 275.07 Td (2001 ) Tj ET Q q 0 0 0 rg BT 361.39 275.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 416.73 275.07 Td (by ) Tj ET Q q 0 0 0 rg BT 428.20 275.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 466.86 275.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 493.32 275.07 Td (to ) Tj ET Q q 0 0 0 rg BT 502.57 275.07 Td (Exhibit ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 265.07 Td (10.12 ) Tj ET Q q 0 0 0 rg BT 113.00 265.07 Td (to ) Tj ET Q q 0 0 0 rg BT 123.28 265.07 Td (the ) Tj ET Q q 0 0 0 rg BT 138.00 265.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 162.17 265.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 180.22 265.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 201.04 265.07 Td (on ) Tj ET Q q 0 0 0 rg BT 213.27 265.07 Td (August ) Tj ET Q q 0 0 0 rg BT 244.38 265.07 Td (17, ) Tj ET Q q 0 0 0 rg BT 259.38 265.07 Td (2009\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 285.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 244.07 Td (10p.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 244.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 141.40 244.07 Td (No. ) Tj ET Q q 0 0 0 rg BT 160.08 244.07 Td (3 ) Tj ET Q q 0 0 0 rg BT 169.05 244.07 Td (to ) Tj ET Q q 0 0 0 rg BT 180.79 244.07 Td (the ) Tj ET Q q 0 0 0 rg BT 196.97 244.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 235.37 244.07 Td (Development ) Tj ET Q q 0 0 0 rg BT 293.21 244.07 Td (and ) Tj ET Q q 0 0 0 rg BT 311.61 244.07 Td (Commercialization ) Tj ET Q q 0 0 0 rg BT 392.21 244.07 Td (Collaboration ) Tj ET Q q 0 0 0 rg BT 450.57 244.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 498.68 244.07 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 234.07 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 121.69 234.07 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 188.68 234.07 Td (Co., ) Tj ET Q q 0 0 0 rg BT 210.70 234.07 Td (Ltd. ) Tj ET Q q 0 0 0 rg BT 232.45 234.07 Td (and ) Tj ET Q q 0 0 0 rg BT 252.24 234.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 313.71 234.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 347.40 234.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 391.64 234.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 418.65 234.07 Td (as ) Tj ET Q q 0 0 0 rg BT 432.34 234.07 Td (of ) Tj ET Q q 0 0 0 rg BT 446.03 234.07 Td (September ) Tj ET Q q 0 0 0 rg BT 494.15 234.07 Td (25, ) Tj ET Q q 0 0 0 rg BT 512.00 234.07 Td (2006 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 224.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 144.36 224.07 Td (by ) Tj ET Q q 0 0 0 rg BT 156.86 224.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 196.54 224.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 224.03 224.07 Td (to ) Tj ET Q q 0 0 0 rg BT 234.31 224.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 266.25 224.07 Td (10.13 ) Tj ET Q q 0 0 0 rg BT 291.25 224.07 Td (to ) Tj ET Q q 0 0 0 rg BT 301.53 224.07 Td (the ) Tj ET Q q 0 0 0 rg BT 316.25 224.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 340.42 224.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 358.47 224.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 379.29 224.07 Td (on ) Tj ET Q q 0 0 0 rg BT 391.52 224.07 Td (August ) Tj ET Q q 0 0 0 rg BT 422.63 224.07 Td (17, ) Tj ET Q q 0 0 0 rg BT 437.63 224.07 Td (2009\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 244.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 204.07 Td (10q.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 204.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 141.55 204.07 Td (No. 5 ) Tj ET Q q 0 0 0 rg BT 167.88 204.07 Td (to ) Tj ET Q q 0 0 0 rg BT 179.78 204.07 Td (the ) Tj ET Q q 0 0 0 rg BT 196.11 204.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 234.66 204.07 Td (Development ) Tj ET Q q 0 0 0 rg BT 292.64 204.07 Td (and ) Tj ET Q q 0 0 0 rg BT 311.19 204.07 Td (Commercialization ) Tj ET Q q 0 0 0 rg BT 391.95 204.07 Td (Collaboration ) Tj ET Q q 0 0 0 rg BT 450.42 204.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 498.68 204.07 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 194.07 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 118.39 194.07 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 182.09 194.07 Td (Co., ) Tj ET Q q 0 0 0 rg BT 200.82 194.07 Td (Ltd. ) Tj ET Q q 0 0 0 rg BT 219.27 194.07 Td (and ) Tj ET Q q 0 0 0 rg BT 235.77 194.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 293.94 194.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 324.34 194.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 365.29 194.07 Td (ef) Tj ET Q q 0 0 0 rg BT 372.97 194.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 402.14 194.07 Td (as ) Tj ET Q q 0 0 0 rg BT 412.54 194.07 Td (of ) Tj ET Q q 0 0 0 rg BT 422.75 194.07 Td (April 4, ) Tj ET Q q 0 0 0 rg BT 455.64 194.07 Td (2009 \(incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 184.07 Td (by ) Tj ET Q q 0 0 0 rg BT 100.50 184.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 140.18 184.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 167.67 184.07 Td (to ) Tj ET Q q 0 0 0 rg BT 177.95 184.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 209.89 184.07 Td (10.14 ) Tj ET Q q 0 0 0 rg BT 234.89 184.07 Td (to ) Tj ET Q q 0 0 0 rg BT 245.17 184.07 Td (the ) Tj ET Q q 0 0 0 rg BT 259.88 184.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 284.05 184.07 Td (8-K ) Tj ET Q q 0 0 0 rg BT 302.11 184.07 Td (filed ) Tj ET Q q 0 0 0 rg BT 322.93 184.07 Td (on ) Tj ET Q q 0 0 0 rg BT 335.16 184.07 Td (August ) Tj ET Q q 0 0 0 rg BT 366.27 184.07 Td (17, ) Tj ET Q q 0 0 0 rg BT 381.27 184.07 Td (2009\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 204.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 163.07 Td (10r.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 163.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 141.40 163.07 Td (No. ) Tj ET Q q 0 0 0 rg BT 160.08 163.07 Td (9 ) Tj ET Q q 0 0 0 rg BT 169.05 163.07 Td (to ) Tj ET Q q 0 0 0 rg BT 180.79 163.07 Td (the ) Tj ET Q q 0 0 0 rg BT 196.97 163.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 235.37 163.07 Td (Development ) Tj ET Q q 0 0 0 rg BT 293.21 163.07 Td (and ) Tj ET Q q 0 0 0 rg BT 311.61 163.07 Td (Commercialization ) Tj ET Q q 0 0 0 rg BT 392.21 163.07 Td (Collaboration ) Tj ET Q q 0 0 0 rg BT 450.57 163.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 498.68 163.07 Td (between ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 153.07 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 123.58 153.07 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 192.47 153.07 Td (Co., ) Tj ET Q q 0 0 0 rg BT 216.40 153.07 Td (Ltd. ) Tj ET Q q 0 0 0 rg BT 240.04 153.07 Td (and ) Tj ET Q q 0 0 0 rg BT 261.73 153.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 325.09 153.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 360.69 153.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 406.83 153.07 Td (ef) Tj ET Q q 0 0 0 rg BT 414.51 153.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 448.87 153.07 Td (as ) Tj ET Q q 0 0 0 rg BT 464.46 153.07 Td (of ) Tj ET Q q 0 0 0 rg BT 480.04 153.07 Td (October ) Tj ET Q q 0 0 0 rg BT 519.50 153.07 Td (29, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 143.07 Td (2012 \(incorporated ) Tj ET Q q 0 0 0 rg BT 166.83 143.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 194.28 143.07 Td (by ) Tj ET Q q 0 0 0 rg BT 206.75 143.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 246.40 143.07 Td (to ) Tj ET Q q 0 0 0 rg BT 256.65 143.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 288.56 143.07 Td (1ee ) Tj ET Q q 0 0 0 rg BT 304.91 143.07 Td (to ) Tj ET Q q 0 0 0 rg BT 315.15 143.07 Td (the ) Tj ET Q q 0 0 0 rg BT 329.84 143.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 353.98 143.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 377.00 143.07 Td (for ) Tj ET Q q 0 0 0 rg BT 391.13 143.07 Td (the ) Tj ET Q q 0 0 0 rg BT 405.81 143.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 429.93 143.07 Td (year ) Tj ET Q q 0 0 0 rg BT 449.61 143.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 475.95 143.07 Td (December ) Tj ET Q q 0 0 0 rg BT 519.51 143.07 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 133.07 Td (2012\). ) Tj ET Q q 0 0 0 rg BT 116.33 133.07 Td (†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 163.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.60 112.07 Td (10s.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 112.07 Td (Amended ) Tj ET Q q 0 0 0 rg BT 130.35 112.07 Td (and ) Tj ET Q q 0 0 0 rg BT 148.26 112.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 186.17 112.07 Td (Co-Development ) Tj ET Q q 0 0 0 rg BT 258.52 112.07 Td (and ) Tj ET Q q 0 0 0 rg BT 276.43 112.07 Td (Co-Promotion ) Tj ET Q q 0 0 0 rg BT 336.64 112.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 384.26 112.07 Td (\(Apixaban\) ) Tj ET Q q 0 0 0 rg BT 433.27 112.07 Td (by ) Tj ET Q q 0 0 0 rg BT 446.75 112.07 Td (and ) Tj ET Q q 0 0 0 rg BT 464.66 112.07 Td (between ) Tj ET Q q 0 0 0 rg BT 501.45 112.07 Td (Bristol-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 102.07 Td (Myers ) Tj ET Q q 0 0 0 rg BT 116.53 102.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 147.85 102.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 189.71 102.07 Td (and ) Tj ET Q q 0 0 0 rg BT 207.13 102.07 Td (Pfizer) Tj ET Q q 0 0 0 rg BT 230.80 102.07 Td (, ) Tj ET Q q 0 0 0 rg BT 236.08 102.07 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 254.33 102.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 278.58 102.07 Td (April ) Tj ET Q q 0 0 0 rg BT 302.39 102.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 317.87 102.07 Td (2007 ) Tj ET Q q 0 0 0 rg BT 340.84 102.07 Td (as ) Tj ET Q q 0 0 0 rg BT 352.15 102.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 391.22 102.07 Td (and ) Tj ET Q q 0 0 0 rg BT 408.64 102.07 Td (restated ) Tj ET Q q 0 0 0 rg BT 442.71 102.07 Td (as ) Tj ET Q q 0 0 0 rg BT 454.02 102.07 Td (of ) Tj ET Q q 0 0 0 rg BT 464.94 102.07 Td (August ) Tj ET Q q 0 0 0 rg BT 496.54 102.07 Td (23, ) Tj ET Q q 0 0 0 rg BT 512.01 102.07 Td (2007 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 92.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 143.70 92.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 170.52 92.07 Td (by ) Tj ET Q q 0 0 0 rg BT 182.36 92.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 221.37 92.07 Td (to ) Tj ET Q q 0 0 0 rg BT 230.99 92.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 262.27 92.07 Td (10c ) Tj ET Q q 0 0 0 rg BT 278.54 92.07 Td (to ) Tj ET Q q 0 0 0 rg BT 288.16 92.07 Td (the ) Tj ET Q q 0 0 0 rg BT 302.21 92.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 325.71 92.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 348.10 92.07 Td (for ) Tj ET Q q 0 0 0 rg BT 361.60 92.07 Td (the ) Tj ET Q q 0 0 0 rg BT 375.65 92.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 413.58 92.07 Td (period ) Tj ET Q q 0 0 0 rg BT 440.96 92.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 466.68 92.07 Td (June ) Tj ET Q q 0 0 0 rg BT 486.84 92.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 501.18 92.07 Td (2016\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 112.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.70 73.07 Td (10t.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 73.07 Td (Second ) Tj ET Q q 0 0 0 rg BT 119.63 73.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 171.88 73.07 Td (to ) Tj ET Q q 0 0 0 rg BT 181.85 73.07 Td (Amended ) Tj ET Q q 0 0 0 rg BT 223.54 73.07 Td (and ) Tj ET Q q 0 0 0 rg BT 240.80 73.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 278.05 73.07 Td (Co-Development ) Tj ET Q q 0 0 0 rg BT 349.73 73.07 Td (and ) Tj ET Q q 0 0 0 rg BT 366.99 73.07 Td (Co-Promotion ) Tj ET Q q 0 0 0 rg BT 426.41 73.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 473.65 73.07 Td (\(Apixaban\) ) Tj ET Q q 0 0 0 rg BT 522.00 73.07 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 63.07 Td (and ) Tj ET Q q 0 0 0 rg BT 105.04 63.07 Td (between ) Tj ET Q q 0 0 0 rg BT 140.95 63.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 199.66 63.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 230.59 63.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 272.08 63.07 Td (and ) Tj ET Q q 0 0 0 rg BT 289.11 63.07 Td ( Pfizer) Tj ET Q q 0 0 0 rg BT 315.09 63.07 Td (, ) Tj ET Q q 0 0 0 rg BT 320.19 63.07 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 338.05 63.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 362.31 63.07 Td (as ) Tj ET Q q 0 0 0 rg BT 373.23 63.07 Td (of ) Tj ET Q q 0 0 0 rg BT 384.16 63.07 Td (March ) Tj ET Q q 0 0 0 rg BT 412.86 63.07 Td (15, ) Tj ET Q q 0 0 0 rg BT 427.96 63.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 450.55 63.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 507.01 63.07 Td (herein ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 53.07 Td (by ) Tj ET Q q 0 0 0 rg BT 100.50 53.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 140.18 53.07 Td (to ) Tj ET Q q 0 0 0 rg BT 150.46 53.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 182.40 53.07 Td (10d ) Tj ET Q q 0 0 0 rg BT 199.90 53.07 Td (to ) Tj ET Q q 0 0 0 rg BT 210.18 53.07 Td (the ) Tj ET Q q 0 0 0 rg BT 224.90 53.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 249.07 53.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 272.12 53.07 Td (for ) Tj ET Q q 0 0 0 rg BT 286.28 53.07 Td (the ) Tj ET Q q 0 0 0 rg BT 301.00 53.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 339.59 53.07 Td (period ) Tj ET Q q 0 0 0 rg BT 367.64 53.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 394.02 53.07 Td (June ) Tj ET Q q 0 0 0 rg BT 414.85 53.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 429.85 53.07 Td (2016\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 73.07 Td (‡) Tj ET Q endstream endobj 219 0 obj <> endobj 220 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.50 24.60 Td (109) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 746.07 Td (10u.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 746.07 Td (Fourth ) Tj ET Q q 0 0 0 rg BT 117.35 746.07 Td (Amendment ) Tj ET Q q 0 0 0 rg BT 169.59 746.07 Td (to ) Tj ET Q q 0 0 0 rg BT 180.05 746.07 Td (Amended ) Tj ET Q q 0 0 0 rg BT 221.73 746.07 Td (and ) Tj ET Q q 0 0 0 rg BT 239.25 746.07 Td (Restated ) Tj ET Q q 0 0 0 rg BT 276.77 746.07 Td (Co-Development ) Tj ET Q q 0 0 0 rg BT 348.73 746.07 Td (and ) Tj ET Q q 0 0 0 rg BT 366.25 746.07 Td (Co-Promotion ) Tj ET Q q 0 0 0 rg BT 426.15 746.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 473.38 746.07 Td (\(Apixaban\) ) Tj ET Q q 0 0 0 rg BT 522.01 746.07 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 736.07 Td (and ) Tj ET Q q 0 0 0 rg BT 104.89 736.07 Td (between ) Tj ET Q q 0 0 0 rg BT 140.66 736.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 199.22 736.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 230.01 736.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 271.35 736.07 Td (and ) Tj ET Q q 0 0 0 rg BT 288.24 736.07 Td (Pfizer) Tj ET Q q 0 0 0 rg BT 311.92 736.07 Td (, ) Tj ET Q q 0 0 0 rg BT 316.67 736.07 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 334.39 736.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 358.50 736.07 Td (as ) Tj ET Q q 0 0 0 rg BT 369.28 736.07 Td (of ) Tj ET Q q 0 0 0 rg BT 380.07 736.07 Td (May ) Tj ET Q q 0 0 0 rg BT 400.85 736.07 Td (18, ) Tj ET Q q 0 0 0 rg BT 415.80 736.07 Td (2015 ) Tj ET Q q 0 0 0 rg BT 438.25 736.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 494.57 736.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 522.01 736.07 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 726.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 127.68 726.07 Td (to ) Tj ET Q q 0 0 0 rg BT 137.96 726.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 169.90 726.07 Td (10e ) Tj ET Q q 0 0 0 rg BT 186.84 726.07 Td (to ) Tj ET Q q 0 0 0 rg BT 197.12 726.07 Td (the ) Tj ET Q q 0 0 0 rg BT 211.84 726.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 236.01 726.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 259.06 726.07 Td (for ) Tj ET Q q 0 0 0 rg BT 273.22 726.07 Td (the ) Tj ET Q q 0 0 0 rg BT 287.94 726.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 326.53 726.07 Td (period ) Tj ET Q q 0 0 0 rg BT 354.58 726.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 380.95 726.07 Td (June ) Tj ET Q q 0 0 0 rg BT 401.78 726.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 416.78 726.07 Td (2016\).†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 746.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.10 707.07 Td (‡‡10v.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 707.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 145.95 707.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 176.13 707.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 216.86 707.07 Td (2002 ) Tj ET Q q 0 0 0 rg BT 238.70 707.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 263.32 707.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 302.37 707.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 324.49 707.07 Td (ef) Tj ET Q q 0 0 0 rg BT 332.17 707.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 361.12 707.07 Td (as ) Tj ET Q q 0 0 0 rg BT 371.29 707.07 Td (of ) Tj ET Q q 0 0 0 rg BT 381.47 707.07 Td (May ) Tj ET Q q 0 0 0 rg BT 401.64 707.07 Td (7, ) Tj ET Q q 0 0 0 rg BT 410.98 707.07 Td (2002 ) Tj ET Q q 0 0 0 rg BT 432.82 707.07 Td (and ) Tj ET Q q 0 0 0 rg BT 449.10 707.07 Td (as ) Tj ET Q q 0 0 0 rg BT 459.28 707.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 497.21 707.07 Td (ef) Tj ET Q q 0 0 0 rg BT 504.89 707.07 Td (fective ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 697.07 Td (June ) Tj ET Q q 0 0 0 rg BT 108.60 697.07 Td (10, ) Tj ET Q q 0 0 0 rg BT 123.36 697.07 Td (2008 ) Tj ET Q q 0 0 0 rg BT 145.63 697.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 201.76 697.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 229.01 697.07 Td (by ) Tj ET Q q 0 0 0 rg BT 241.28 697.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 280.73 697.07 Td (to ) Tj ET Q q 0 0 0 rg BT 290.78 697.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 322.49 697.07 Td (10.1 ) Tj ET Q q 0 0 0 rg BT 342.25 697.07 Td (to ) Tj ET Q q 0 0 0 rg BT 352.30 697.07 Td (the ) Tj ET Q q 0 0 0 rg BT 366.78 697.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 390.72 697.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 413.54 697.07 Td (for ) Tj ET Q q 0 0 0 rg BT 427.47 697.07 Td (the ) Tj ET Q q 0 0 0 rg BT 441.95 697.07 Td (quarterly ) Tj ET Q q 0 0 0 rg BT 480.31 697.07 Td (period ) Tj ET Q q 0 0 0 rg BT 508.12 697.07 Td (ended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 687.07 Td (September ) Tj ET Q q 0 0 0 rg BT 133.26 687.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 148.26 687.07 Td (2008\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 707.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 48.90 668.07 Td (‡‡10w.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 668.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.04 668.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 176.31 668.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 217.13 668.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 239.06 668.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 263.62 668.07 Td (A) Tj ET Q q 0 0 0 rg BT 270.11 668.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 291.57 668.07 Td (and ) Tj ET Q q 0 0 0 rg BT 307.94 668.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 347.07 668.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 369.28 668.07 Td (ef) Tj ET Q q 0 0 0 rg BT 376.96 668.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 406.00 668.07 Td (as ) Tj ET Q q 0 0 0 rg BT 416.26 668.07 Td (of ) Tj ET Q q 0 0 0 rg BT 426.52 668.07 Td (May ) Tj ET Q q 0 0 0 rg BT 446.79 668.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 456.22 668.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 478.15 668.07 Td (\(incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 658.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 115.49 658.07 Td (by ) Tj ET Q q 0 0 0 rg BT 127.99 658.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 167.67 658.07 Td (to ) Tj ET Q q 0 0 0 rg BT 177.95 658.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 209.89 658.07 Td (B ) Tj ET Q q 0 0 0 rg BT 219.06 658.07 Td (to ) Tj ET Q q 0 0 0 rg BT 229.34 658.07 Td (the ) Tj ET Q q 0 0 0 rg BT 244.05 658.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 266.55 658.07 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 292.95 658.07 Td (Statement ) Tj ET Q q 0 0 0 rg BT 335.44 658.07 Td (dated ) Tj ET Q q 0 0 0 rg BT 359.59 658.07 Td (March ) Tj ET Q q 0 0 0 rg BT 388.19 658.07 Td (20, ) Tj ET Q q 0 0 0 rg BT 403.19 658.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 668.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.50 639.07 Td (‡‡10x.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 639.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 145.51 639.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 175.25 639.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 215.54 639.07 Td (2007 ) Tj ET Q q 0 0 0 rg BT 236.95 639.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 261.09 639.07 Td (A) Tj ET Q q 0 0 0 rg BT 267.58 639.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 288.51 639.07 Td (and ) Tj ET Q q 0 0 0 rg BT 304.36 639.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 342.96 639.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 364.64 639.07 Td (ef) Tj ET Q q 0 0 0 rg BT 372.32 639.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 400.83 639.07 Td (as ) Tj ET Q q 0 0 0 rg BT 410.57 639.07 Td (of ) Tj ET Q q 0 0 0 rg BT 420.30 639.07 Td (May ) Tj ET Q q 0 0 0 rg BT 440.03 639.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 448.94 639.07 Td (2007 ) Tj ET Q q 0 0 0 rg BT 470.34 639.07 Td (and ) Tj ET Q q 0 0 0 rg BT 486.18 639.07 Td (as ) Tj ET Q q 0 0 0 rg BT 495.91 639.07 Td (amended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 629.07 Td (ef) Tj ET Q q 0 0 0 rg BT 95.68 629.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 126.05 629.07 Td (June ) Tj ET Q q 0 0 0 rg BT 147.64 629.07 Td (10, ) Tj ET Q q 0 0 0 rg BT 163.41 629.07 Td (2008 ) Tj ET Q q 0 0 0 rg BT 186.67 629.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 243.79 629.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 272.04 629.07 Td (by ) Tj ET Q q 0 0 0 rg BT 285.30 629.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 325.74 629.07 Td (to ) Tj ET Q q 0 0 0 rg BT 336.78 629.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 369.49 629.07 Td (10.2 ) Tj ET Q q 0 0 0 rg BT 390.25 629.07 Td (to ) Tj ET Q q 0 0 0 rg BT 401.29 629.07 Td (the ) Tj ET Q q 0 0 0 rg BT 416.77 629.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 441.70 629.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 465.51 629.07 Td (for ) Tj ET Q q 0 0 0 rg BT 480.44 629.07 Td (the ) Tj ET Q q 0 0 0 rg BT 495.92 629.07 Td (quarterly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 619.07 Td (period ) Tj ET Q q 0 0 0 rg BT 116.05 619.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 142.42 619.07 Td (September ) Tj ET Q q 0 0 0 rg BT 187.69 619.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 202.69 619.07 Td (2008\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 639.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.10 598.07 Td (‡‡10y.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 598.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.04 598.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 176.32 598.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 217.09 598.07 Td (T) Tj ET Q q 0 0 0 rg BT 222.76 598.07 Td (eamShare ) Tj ET Q q 0 0 0 rg BT 263.76 598.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 288.48 598.07 Td (Option ) Tj ET Q q 0 0 0 rg BT 318.19 598.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 340.40 598.07 Td (as ) Tj ET Q q 0 0 0 rg BT 350.66 598.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 388.69 598.07 Td (and ) Tj ET Q q 0 0 0 rg BT 405.06 598.07 Td (restated ) Tj ET Q q 0 0 0 rg BT 438.09 598.07 Td (ef) Tj ET Q q 0 0 0 rg BT 445.77 598.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 474.81 598.07 Td (September ) Tj ET Q q 0 0 0 rg BT 519.51 598.07 Td (10, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 588.07 Td (2002 ) Tj ET Q q 0 0 0 rg BT 110.44 588.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 166.74 588.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 194.16 588.07 Td (by ) Tj ET Q q 0 0 0 rg BT 206.60 588.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 246.23 588.07 Td (to ) Tj ET Q q 0 0 0 rg BT 256.44 588.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 288.32 588.07 Td (10c ) Tj ET Q q 0 0 0 rg BT 305.20 588.07 Td (to ) Tj ET Q q 0 0 0 rg BT 315.42 588.07 Td (the ) Tj ET Q q 0 0 0 rg BT 330.08 588.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 354.18 588.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 377.17 588.07 Td (for ) Tj ET Q q 0 0 0 rg BT 391.27 588.07 Td (the ) Tj ET Q q 0 0 0 rg BT 405.93 588.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 430.02 588.07 Td (year ) Tj ET Q q 0 0 0 rg BT 449.67 588.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 475.99 588.07 Td (December ) Tj ET Q q 0 0 0 rg BT 519.51 588.07 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 578.07 Td (2002\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 598.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 51.05 558.07 Td (‡‡10z.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 558.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.13 558.07 Td (of ) Tj ET Q q 0 0 0 rg BT 122.92 558.07 Td (Non-Qualified ) Tj ET Q q 0 0 0 rg BT 183.70 558.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 208.94 558.07 Td (Option ) Tj ET Q q 0 0 0 rg BT 238.91 558.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 285.52 558.07 Td (under ) Tj ET Q q 0 0 0 rg BT 310.75 558.07 Td (the ) Tj ET Q q 0 0 0 rg BT 325.43 558.07 Td (2002 ) Tj ET Q q 0 0 0 rg BT 347.89 558.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 372.86 558.07 Td (A) Tj ET Q q 0 0 0 rg BT 379.35 558.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 401.34 558.07 Td (and ) Tj ET Q q 0 0 0 rg BT 418.24 558.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 457.90 558.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 478.14 558.07 Td (\(incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 548.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 115.49 548.07 Td (by ) Tj ET Q q 0 0 0 rg BT 127.99 548.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 167.67 548.07 Td (to ) Tj ET Q q 0 0 0 rg BT 177.95 548.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 209.89 548.07 Td (10s ) Tj ET Q q 0 0 0 rg BT 226.28 548.07 Td (to ) Tj ET Q q 0 0 0 rg BT 236.56 548.07 Td (the ) Tj ET Q q 0 0 0 rg BT 251.28 548.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 275.45 548.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 298.50 548.07 Td (for ) Tj ET Q q 0 0 0 rg BT 312.66 548.07 Td (the ) Tj ET Q q 0 0 0 rg BT 327.38 548.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 351.53 548.07 Td (year ) Tj ET Q q 0 0 0 rg BT 371.24 548.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 397.61 548.07 Td (December ) Tj ET Q q 0 0 0 rg BT 441.20 548.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 456.20 548.07 Td (2005\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 558.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.60 530.07 Td (‡‡10aa.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 530.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 111.62 530.07 Td (of ) Tj ET Q q 0 0 0 rg BT 121.90 530.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 174.93 530.07 Td (Share ) Tj ET Q q 0 0 0 rg BT 199.65 530.07 Td (Units ) Tj ET Q q 0 0 0 rg BT 223.12 530.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 269.21 530.07 Td (for ) Tj ET Q q 0 0 0 rg BT 282.82 530.07 Td (the ) Tj ET Q q 0 0 0 rg BT 296.99 530.07 Td (2013-2015 ) Tj ET Q q 0 0 0 rg BT 342.27 530.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 395.30 530.07 Td (Cycle ) Tj ET Q q 0 0 0 rg BT 420.58 530.07 Td (under ) Tj ET Q q 0 0 0 rg BT 445.30 530.07 Td (the ) Tj ET Q q 0 0 0 rg BT 459.46 530.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 481.41 530.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 505.99 530.07 Td (A) Tj ET Q q 0 0 0 rg BT 512.47 530.07 Td (ward ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 520.07 Td (and ) Tj ET Q q 0 0 0 rg BT 103.91 520.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 142.58 520.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 161.82 520.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 217.15 520.07 Td (by ) Tj ET Q q 0 0 0 rg BT 228.62 520.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 267.27 520.07 Td (to ) Tj ET Q q 0 0 0 rg BT 276.51 520.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 307.42 520.07 Td (10oo ) Tj ET Q q 0 0 0 rg BT 328.89 520.07 Td (to ) Tj ET Q q 0 0 0 rg BT 338.14 520.07 Td (the ) Tj ET Q q 0 0 0 rg BT 351.82 520.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 374.96 520.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 396.98 520.07 Td (for ) Tj ET Q q 0 0 0 rg BT 410.10 520.07 Td (the ) Tj ET Q q 0 0 0 rg BT 423.79 520.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 446.91 520.07 Td (year ) Tj ET Q q 0 0 0 rg BT 465.59 520.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 490.93 520.07 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 510.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 103.00 510.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 530.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 492.07 Td (‡‡10bb.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 492.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 113.89 492.07 Td (of ) Tj ET Q q 0 0 0 rg BT 126.44 492.07 Td (2014-2016 ) Tj ET Q q 0 0 0 rg BT 174.00 492.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 229.30 492.07 Td (Share ) Tj ET Q q 0 0 0 rg BT 256.29 492.07 Td (Units ) Tj ET Q q 0 0 0 rg BT 281.53 492.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 329.90 492.07 Td (under ) Tj ET Q q 0 0 0 rg BT 356.89 492.07 Td (the ) Tj ET Q q 0 0 0 rg BT 373.33 492.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 397.55 492.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 423.90 492.07 Td (A) Tj ET Q q 0 0 0 rg BT 430.38 492.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 454.14 492.07 Td (and ) Tj ET Q q 0 0 0 rg BT 472.80 492.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 514.22 492.07 Td (Plan ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 482.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 144.36 482.07 Td (by ) Tj ET Q q 0 0 0 rg BT 156.86 482.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 196.54 482.07 Td (to ) Tj ET Q q 0 0 0 rg BT 206.82 482.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 238.77 482.07 Td (10hh ) Tj ET Q q 0 0 0 rg BT 261.27 482.07 Td (to ) Tj ET Q q 0 0 0 rg BT 271.54 482.07 Td (the ) Tj ET Q q 0 0 0 rg BT 286.26 482.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 310.43 482.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 333.48 482.07 Td (for ) Tj ET Q q 0 0 0 rg BT 347.64 482.07 Td (the ) Tj ET Q q 0 0 0 rg BT 362.36 482.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 386.52 482.07 Td (year ) Tj ET Q q 0 0 0 rg BT 406.22 482.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 432.60 482.07 Td (December ) Tj ET Q q 0 0 0 rg BT 476.18 482.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 491.18 482.07 Td (2013\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 492.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.60 463.07 Td (‡‡10cc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 462.17 Td (Form of 2015-2017 Performance Share Units Agreement under the 2012 Stock Award and Incentive Plan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 452.17 Td (\(incorporated by reference to Exhibit 10x to the Form 10-K for the fiscal year ended December 31, 2014\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 463.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 434.07 Td (‡‡10dd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 433.17 Td (Form of 2016-2018 Performance Share Units Agreement under the 2012 Stock Award and Incentive Plan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 423.17 Td (\(incorporated by reference to Exhibit 10y to the Form 10-K for the fiscal year ended December 31, 2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 434.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.60 405.07 Td (‡‡10ee.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 403.17 Td (Form of 2017-2019 Performance Share Units Agreement under the 2012 Stock Award and Incentive Plan) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 393.17 Td (\(filed herewith\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 405.07 Td (E-10-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.00 375.07 Td (‡‡10ff.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 375.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 111.58 375.07 Td (of ) Tj ET Q q 0 0 0 rg BT 121.83 375.07 Td (Restricted ) Tj ET Q q 0 0 0 rg BT 164.28 375.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 188.98 375.07 Td (Units ) Tj ET Q q 0 0 0 rg BT 212.41 375.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 258.48 375.07 Td (with ) Tj ET Q q 0 0 0 rg BT 278.17 375.07 Td (five ) Tj ET Q q 0 0 0 rg BT 295.63 375.07 Td (year ) Tj ET Q q 0 0 0 rg BT 314.75 375.07 Td (vesting ) Tj ET Q q 0 0 0 rg BT 345.55 375.07 Td (under ) Tj ET Q q 0 0 0 rg BT 370.23 375.07 Td (the ) Tj ET Q q 0 0 0 rg BT 384.36 375.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 406.28 375.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 430.82 375.07 Td (A) Tj ET Q q 0 0 0 rg BT 437.31 375.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 458.76 375.07 Td (and ) Tj ET Q q 0 0 0 rg BT 475.11 375.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 514.23 375.07 Td (Plan ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 365.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 112.16 365.07 Td (herewith\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 375.07 Td (E-10-2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 345.07 Td (‡‡10gg.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 345.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.78 345.07 Td (of ) Tj ET Q q 0 0 0 rg BT 124.22 345.07 Td (Restricted ) Tj ET Q q 0 0 0 rg BT 167.87 345.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 193.75 345.07 Td (Units ) Tj ET Q q 0 0 0 rg BT 218.12 345.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 265.38 345.07 Td (with ) Tj ET Q q 0 0 0 rg BT 286.26 345.07 Td (four ) Tj ET Q q 0 0 0 rg BT 306.03 345.07 Td (year ) Tj ET Q q 0 0 0 rg BT 326.34 345.07 Td (vesting ) Tj ET Q q 0 0 0 rg BT 358.34 345.07 Td (under ) Tj ET Q q 0 0 0 rg BT 384.22 345.07 Td (the ) Tj ET Q q 0 0 0 rg BT 399.54 345.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 422.65 345.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 448.12 345.07 Td (A) Tj ET Q q 0 0 0 rg BT 454.61 345.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 477.25 345.07 Td (and ) Tj ET Q q 0 0 0 rg BT 494.80 345.07 Td (Incentive ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 335.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 108.28 335.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 132.43 335.07 Td (herewith\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 345.07 Td (E-10-3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 315.07 Td (‡‡10hh.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 315.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.17 315.07 Td (of ) Tj ET Q q 0 0 0 rg BT 123.00 315.07 Td (Market ) Tj ET Q q 0 0 0 rg BT 154.38 315.07 Td (Share ) Tj ET Q q 0 0 0 rg BT 179.65 315.07 Td (Units ) Tj ET Q q 0 0 0 rg BT 203.54 315.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 250.19 315.07 Td (under ) Tj ET Q q 0 0 0 rg BT 275.46 315.07 Td (the ) Tj ET Q q 0 0 0 rg BT 290.17 315.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 312.67 315.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 337.68 315.07 Td (A) Tj ET Q q 0 0 0 rg BT 344.16 315.07 Td (ward ) Tj ET Q q 0 0 0 rg BT 366.19 315.07 Td (and ) Tj ET Q q 0 0 0 rg BT 383.13 315.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 422.83 315.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 443.11 315.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 467.27 315.07 Td (herewith\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 315.07 Td (E-10-4) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.90 293.07 Td (‡‡10ii.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 293.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 147.14 293.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 178.51 293.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 220.42 293.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 274.53 293.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 314.77 293.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 338.07 293.07 Td (as ) Tj ET Q q 0 0 0 rg BT 349.43 293.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 388.55 293.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 403.24 293.07 Td (adopted, ) Tj ET Q q 0 0 0 rg BT 440.43 293.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 493.99 293.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 522.00 293.07 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 283.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 127.54 283.07 Td (to ) Tj ET Q q 0 0 0 rg BT 137.68 283.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 169.49 283.07 Td (2 ) Tj ET Q q 0 0 0 rg BT 176.85 283.07 Td (to ) Tj ET Q q 0 0 0 rg BT 186.99 283.07 Td (the ) Tj ET Q q 0 0 0 rg BT 201.56 283.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 225.60 283.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 248.51 283.07 Td (for ) Tj ET Q q 0 0 0 rg BT 262.53 283.07 Td (the ) Tj ET Q q 0 0 0 rg BT 277.11 283.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 301.12 283.07 Td (year ) Tj ET Q q 0 0 0 rg BT 320.69 283.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 346.93 283.07 Td (December ) Tj ET Q q 0 0 0 rg BT 390.37 283.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 405.23 283.07 Td (1978; ) Tj ET Q q 0 0 0 rg BT 430.37 283.07 Td (as ) Tj ET Q q 0 0 0 rg BT 441.06 283.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 479.52 283.07 Td (as ) Tj ET Q q 0 0 0 rg BT 490.21 283.07 Td (of ) Tj ET Q q 0 0 0 rg BT 500.90 283.07 Td (January ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 273.07 Td (8, ) Tj ET Q q 0 0 0 rg BT 98.23 273.07 Td (1990, ) Tj ET Q q 0 0 0 rg BT 123.46 273.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 176.73 273.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 204.45 273.07 Td (by ) Tj ET Q q 0 0 0 rg BT 217.18 273.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 257.09 273.07 Td (to ) Tj ET Q q 0 0 0 rg BT 267.60 273.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 299.78 273.07 Td (19b ) Tj ET Q q 0 0 0 rg BT 317.51 273.07 Td (to ) Tj ET Q q 0 0 0 rg BT 328.02 273.07 Td (the ) Tj ET Q q 0 0 0 rg BT 342.97 273.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 367.37 273.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 390.65 273.07 Td (for ) Tj ET Q q 0 0 0 rg BT 405.05 273.07 Td (the ) Tj ET Q q 0 0 0 rg BT 419.99 273.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 444.38 273.07 Td (year ) Tj ET Q q 0 0 0 rg BT 464.32 273.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 490.93 273.07 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 263.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 102.63 263.07 Td (1990; ) Tj ET Q q 0 0 0 rg BT 127.54 263.07 Td (as ) Tj ET Q q 0 0 0 rg BT 138.01 263.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 176.23 263.07 Td (on ) Tj ET Q q 0 0 0 rg BT 188.17 263.07 Td (April ) Tj ET Q q 0 0 0 rg BT 211.14 263.07 Td (2, ) Tj ET Q q 0 0 0 rg BT 220.77 263.07 Td (1991, ) Tj ET Q q 0 0 0 rg BT 245.40 263.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 298.07 263.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 325.19 263.07 Td (by ) Tj ET Q q 0 0 0 rg BT 337.32 263.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 376.63 263.07 Td (to ) Tj ET Q q 0 0 0 rg BT 386.54 263.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 418.12 263.07 Td (19b ) Tj ET Q q 0 0 0 rg BT 435.25 263.07 Td (to ) Tj ET Q q 0 0 0 rg BT 445.17 263.07 Td (the ) Tj ET Q q 0 0 0 rg BT 459.51 263.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 483.32 263.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 506.00 263.07 Td (for ) Tj ET Q q 0 0 0 rg BT 519.79 263.07 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 253.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 112.45 253.07 Td (year ) Tj ET Q q 0 0 0 rg BT 132.45 253.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 159.12 253.07 Td (December ) Tj ET Q q 0 0 0 rg BT 203.00 253.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 218.29 253.07 Td (1991; ) Tj ET Q q 0 0 0 rg BT 243.86 253.07 Td (as ) Tj ET Q q 0 0 0 rg BT 254.98 253.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 293.87 253.07 Td (ef) Tj ET Q q 0 0 0 rg BT 301.55 253.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 331.45 253.07 Td (January ) Tj ET Q q 0 0 0 rg BT 365.34 253.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 375.64 253.07 Td (1994, ) Tj ET Q q 0 0 0 rg BT 400.93 253.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 454.25 253.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 482.03 253.07 Td (by ) Tj ET Q q 0 0 0 rg BT 494.83 253.07 Td (reference ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 243.07 Td (to ) Tj ET Q q 0 0 0 rg BT 97.98 243.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 129.63 243.07 Td (10d ) Tj ET Q q 0 0 0 rg BT 146.83 243.07 Td (to ) Tj ET Q q 0 0 0 rg BT 156.81 243.07 Td (the ) Tj ET Q q 0 0 0 rg BT 171.23 243.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 195.10 243.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 217.85 243.07 Td (for ) Tj ET Q q 0 0 0 rg BT 231.72 243.07 Td (the ) Tj ET Q q 0 0 0 rg BT 246.13 243.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 269.99 243.07 Td (year ) Tj ET Q q 0 0 0 rg BT 289.40 243.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 315.48 243.07 Td (December ) Tj ET Q q 0 0 0 rg BT 358.77 243.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 373.47 243.07 Td (1993; ) Tj ET Q q 0 0 0 rg BT 398.45 243.07 Td (and ) Tj ET Q q 0 0 0 rg BT 415.09 243.07 Td (as ) Tj ET Q q 0 0 0 rg BT 425.62 243.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 463.92 243.07 Td (ef) Tj ET Q q 0 0 0 rg BT 471.60 243.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 500.91 243.07 Td (January ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 233.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 98.23 233.07 Td (1994, ) Tj ET Q q 0 0 0 rg BT 123.46 233.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 176.73 233.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 204.45 233.07 Td (by ) Tj ET Q q 0 0 0 rg BT 217.18 233.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 257.09 233.07 Td (to ) Tj ET Q q 0 0 0 rg BT 267.60 233.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 299.78 233.07 Td (10d ) Tj ET Q q 0 0 0 rg BT 317.51 233.07 Td (to ) Tj ET Q q 0 0 0 rg BT 328.02 233.07 Td (the ) Tj ET Q q 0 0 0 rg BT 342.97 233.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 367.37 233.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 390.65 233.07 Td (for ) Tj ET Q q 0 0 0 rg BT 405.05 233.07 Td (the ) Tj ET Q q 0 0 0 rg BT 419.99 233.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 444.38 233.07 Td (year ) Tj ET Q q 0 0 0 rg BT 464.32 233.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 490.93 233.07 Td (December ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 223.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 103.00 223.07 Td (1994\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 293.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.90 205.07 Td (‡‡10jj.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 205.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.60 205.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 177.43 205.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 218.80 205.07 Td (Executive ) Tj ET Q q 0 0 0 rg BT 261.27 205.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 314.85 205.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 354.54 205.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 374.80 205.07 Td (ef) Tj ET Q q 0 0 0 rg BT 382.48 205.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 412.08 205.07 Td (January ) Tj ET Q q 0 0 0 rg BT 445.67 205.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 455.66 205.07 Td (1997 ) Tj ET Q q 0 0 0 rg BT 478.15 205.07 Td (\(incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 195.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 115.49 195.07 Td (by ) Tj ET Q q 0 0 0 rg BT 127.99 195.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 167.67 195.07 Td (to ) Tj ET Q q 0 0 0 rg BT 177.95 195.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 209.89 195.07 Td (10b ) Tj ET Q q 0 0 0 rg BT 227.39 195.07 Td (to ) Tj ET Q q 0 0 0 rg BT 237.67 195.07 Td (the ) Tj ET Q q 0 0 0 rg BT 252.38 195.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 276.55 195.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 299.61 195.07 Td (for ) Tj ET Q q 0 0 0 rg BT 313.77 195.07 Td (the ) Tj ET Q q 0 0 0 rg BT 328.48 195.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 352.64 195.07 Td (year ) Tj ET Q q 0 0 0 rg BT 372.35 195.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 398.72 195.07 Td (December ) Tj ET Q q 0 0 0 rg BT 442.31 195.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 457.31 195.07 Td (1996\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 205.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 175.07 Td (‡‡10kk.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 175.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 145.83 175.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 175.89 175.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 216.50 175.07 Td (Executive ) Tj ET Q q 0 0 0 rg BT 258.20 175.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 311.01 175.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 349.93 175.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 369.43 175.07 Td (ef) Tj ET Q q 0 0 0 rg BT 377.11 175.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 405.94 175.07 Td (January ) Tj ET Q q 0 0 0 rg BT 438.76 175.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 447.98 175.07 Td (2003 ) Tj ET Q q 0 0 0 rg BT 469.70 175.07 Td (and ) Tj ET Q q 0 0 0 rg BT 485.86 175.07 Td (as ) Tj ET Q q 0 0 0 rg BT 495.91 175.07 Td (amended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 165.07 Td (ef) Tj ET Q q 0 0 0 rg BT 95.68 165.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 126.05 165.07 Td (June ) Tj ET Q q 0 0 0 rg BT 147.64 165.07 Td (10, ) Tj ET Q q 0 0 0 rg BT 163.41 165.07 Td (2008 ) Tj ET Q q 0 0 0 rg BT 186.67 165.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 243.79 165.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 272.04 165.07 Td (by ) Tj ET Q q 0 0 0 rg BT 285.30 165.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 325.74 165.07 Td (to ) Tj ET Q q 0 0 0 rg BT 336.78 165.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 369.49 165.07 Td (10.3 ) Tj ET Q q 0 0 0 rg BT 390.25 165.07 Td (to ) Tj ET Q q 0 0 0 rg BT 401.29 165.07 Td (the ) Tj ET Q q 0 0 0 rg BT 416.77 165.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 441.70 165.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 465.51 165.07 Td (for ) Tj ET Q q 0 0 0 rg BT 480.44 165.07 Td (the ) Tj ET Q q 0 0 0 rg BT 495.92 165.07 Td (quarterly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 155.07 Td (period ) Tj ET Q q 0 0 0 rg BT 116.05 155.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 142.42 155.07 Td (September ) Tj ET Q q 0 0 0 rg BT 187.69 155.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 202.69 155.07 Td (2008\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 175.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.90 135.07 Td (‡‡10ll.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 135.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 147.04 135.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 178.32 135.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 220.14 135.07 Td (2007 ) Tj ET Q q 0 0 0 rg BT 243.08 135.07 Td (Senior ) Tj ET Q q 0 0 0 rg BT 272.12 135.07 Td (Executive ) Tj ET Q q 0 0 0 rg BT 315.04 135.07 Td (Performance ) Tj ET Q q 0 0 0 rg BT 369.06 135.07 Td (Incentive ) Tj ET Q q 0 0 0 rg BT 409.20 135.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 429.91 135.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 444.51 135.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 483.54 135.07 Td (and ) Tj ET Q q 0 0 0 rg BT 500.91 135.07 Td (restated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 125.07 Td (ef) Tj ET Q q 0 0 0 rg BT 95.68 125.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 125.56 125.07 Td (June ) Tj ET Q q 0 0 0 rg BT 146.67 125.07 Td (8, ) Tj ET Q q 0 0 0 rg BT 156.94 125.07 Td (2010 ) Tj ET Q q 0 0 0 rg BT 179.71 125.07 Td (and ) Tj ET Q q 0 0 0 rg BT 196.92 125.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 250.23 125.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 277.98 125.07 Td (by ) Tj ET Q q 0 0 0 rg BT 290.76 125.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 330.71 125.07 Td (to ) Tj ET Q q 0 0 0 rg BT 341.26 125.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 373.48 125.07 Td (10a. ) Tj ET Q q 0 0 0 rg BT 393.19 125.07 Td (to ) Tj ET Q q 0 0 0 rg BT 403.74 125.07 Td (the ) Tj ET Q q 0 0 0 rg BT 418.73 125.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 443.17 125.07 Td (10-Q ) Tj ET Q q 0 0 0 rg BT 466.50 125.07 Td (for ) Tj ET Q q 0 0 0 rg BT 480.93 125.07 Td (the ) Tj ET Q q 0 0 0 rg BT 495.92 125.07 Td (quarterly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 115.07 Td (period ) Tj ET Q q 0 0 0 rg BT 116.05 115.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 142.42 115.07 Td (June ) Tj ET Q q 0 0 0 rg BT 163.25 115.07 Td (30, ) Tj ET Q q 0 0 0 rg BT 178.25 115.07 Td (2010\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 135.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 39.90 98.07 Td (‡‡10mm.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 98.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.67 98.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 177.57 98.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 219.02 98.07 Td (Benefit ) Tj ET Q q 0 0 0 rg BT 251.01 98.07 Td (Equalization ) Tj ET Q q 0 0 0 rg BT 304.11 98.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 324.44 98.07 Td (– ) Tj ET Q q 0 0 0 rg BT 332.00 98.07 Td (Retirement ) Tj ET Q q 0 0 0 rg BT 378.99 98.07 Td (Income ) Tj ET Q q 0 0 0 rg BT 411.54 98.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 434.38 98.07 Td (as ) Tj ET Q q 0 0 0 rg BT 445.27 98.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 483.92 98.07 Td (and ) Tj ET Q q 0 0 0 rg BT 500.92 98.07 Td (restated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 88.07 Td (ef) Tj ET Q q 0 0 0 rg BT 95.59 88.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 124.69 88.07 Td (as ) Tj ET Q q 0 0 0 rg BT 134.91 88.07 Td (of ) Tj ET Q q 0 0 0 rg BT 145.14 88.07 Td (January ) Tj ET Q q 0 0 0 rg BT 178.13 88.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 187.53 88.07 Td (2012, ) Tj ET Q q 0 0 0 rg BT 211.92 88.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 267.68 88.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 294.56 88.07 Td (by ) Tj ET Q q 0 0 0 rg BT 306.46 88.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 345.54 88.07 Td (to ) Tj ET Q q 0 0 0 rg BT 355.21 88.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 386.55 88.07 Td (10ww ) Tj ET Q q 0 0 0 rg BT 412.89 88.07 Td (to ) Tj ET Q q 0 0 0 rg BT 422.57 88.07 Td (the ) Tj ET Q q 0 0 0 rg BT 436.68 88.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 460.25 88.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 482.69 88.07 Td (for ) Tj ET Q q 0 0 0 rg BT 496.25 88.07 Td (the ) Tj ET Q q 0 0 0 rg BT 510.36 88.07 Td (fiscal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 78.07 Td (year ) Tj ET Q q 0 0 0 rg BT 107.71 78.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 134.08 78.07 Td (December ) Tj ET Q q 0 0 0 rg BT 177.67 78.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 192.67 78.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 98.07 Td (‡) Tj ET Q endstream endobj 221 0 obj <> endobj 222 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 298.65 24.60 Td (1) Tj ET Q q 0 0 0 rg BT 303.28 24.60 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 745.07 Td (‡‡10nn.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 745.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.54 745.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 177.31 745.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 218.62 745.07 Td (Benefit ) Tj ET Q q 0 0 0 rg BT 250.49 745.07 Td (Equalization ) Tj ET Q q 0 0 0 rg BT 303.45 745.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 323.66 745.07 Td (– ) Tj ET Q q 0 0 0 rg BT 331.09 745.07 Td (Savings ) Tj ET Q q 0 0 0 rg BT 365.19 745.07 Td (and ) Tj ET Q q 0 0 0 rg BT 382.06 745.07 Td (Investment ) Tj ET Q q 0 0 0 rg BT 428.92 745.07 Td (Program, ) Tj ET Q q 0 0 0 rg BT 468.29 745.07 Td (as ) Tj ET Q q 0 0 0 rg BT 479.04 745.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 517.57 745.07 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 735.07 Td (restated ) Tj ET Q q 0 0 0 rg BT 121.63 735.07 Td (ef) Tj ET Q q 0 0 0 rg BT 129.31 735.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 158.96 735.07 Td (as ) Tj ET Q q 0 0 0 rg BT 169.84 735.07 Td (of ) Tj ET Q q 0 0 0 rg BT 180.71 735.07 Td (January ) Tj ET Q q 0 0 0 rg BT 214.35 735.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 224.39 735.07 Td (2012 ) Tj ET Q q 0 0 0 rg BT 246.93 735.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 303.33 735.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 330.85 735.07 Td (by ) Tj ET Q q 0 0 0 rg BT 343.40 735.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 383.12 735.07 Td (to ) Tj ET Q q 0 0 0 rg BT 393.44 735.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 425.42 735.07 Td (10xx ) Tj ET Q q 0 0 0 rg BT 447.96 735.07 Td (to ) Tj ET Q q 0 0 0 rg BT 458.28 735.07 Td (the ) Tj ET Q q 0 0 0 rg BT 473.04 735.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 497.25 735.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 520.34 735.07 Td (for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 725.07 Td (the ) Tj ET Q q 0 0 0 rg BT 102.72 725.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 126.87 725.07 Td (year ) Tj ET Q q 0 0 0 rg BT 146.58 725.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 172.96 725.07 Td (December ) Tj ET Q q 0 0 0 rg BT 216.54 725.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 231.54 725.07 Td (2012\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 745.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 707.07 Td (‡‡10oo.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 707.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 118.16 707.07 Td (Corporation ) Tj ET Q q 0 0 0 rg BT 168.31 707.07 Td (Supplementary ) Tj ET Q q 0 0 0 rg BT 230.68 707.07 Td (Pension ) Tj ET Q q 0 0 0 rg BT 264.17 707.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 286.27 707.07 Td (as ) Tj ET Q q 0 0 0 rg BT 296.43 707.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 334.35 707.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 347.83 707.07 Td (previously ) Tj ET Q q 0 0 0 rg BT 391.87 707.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 429.79 707.07 Td (and ) Tj ET Q q 0 0 0 rg BT 446.05 707.07 Td (restated, ) Tj ET Q q 0 0 0 rg BT 481.47 707.07 Td (incorporated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 697.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 115.62 697.07 Td (by ) Tj ET Q q 0 0 0 rg BT 128.25 697.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 168.06 697.07 Td (to ) Tj ET Q q 0 0 0 rg BT 178.47 697.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 210.55 697.07 Td (19g ) Tj ET Q q 0 0 0 rg BT 228.18 697.07 Td (to ) Tj ET Q q 0 0 0 rg BT 238.59 697.07 Td (the ) Tj ET Q q 0 0 0 rg BT 253.44 697.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 277.74 697.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 300.92 697.07 Td (for ) Tj ET Q q 0 0 0 rg BT 315.22 697.07 Td (the ) Tj ET Q q 0 0 0 rg BT 330.07 697.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 354.35 697.07 Td (year ) Tj ET Q q 0 0 0 rg BT 374.19 697.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 400.70 697.07 Td (December ) Tj ET Q q 0 0 0 rg BT 444.42 697.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 459.55 697.07 Td (1991; ) Tj ET Q q 0 0 0 rg BT 484.96 697.07 Td (as ) Tj ET Q q 0 0 0 rg BT 495.92 697.07 Td (amended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 687.07 Td (as ) Tj ET Q q 0 0 0 rg BT 99.09 687.07 Td (of ) Tj ET Q q 0 0 0 rg BT 110.18 687.07 Td (September ) Tj ET Q q 0 0 0 rg BT 155.71 687.07 Td (14, ) Tj ET Q q 0 0 0 rg BT 170.97 687.07 Td (1993, ) Tj ET Q q 0 0 0 rg BT 196.23 687.07 Td (and ) Tj ET Q q 0 0 0 rg BT 213.43 687.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 266.72 687.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 294.47 687.07 Td (by ) Tj ET Q q 0 0 0 rg BT 307.23 687.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 347.17 687.07 Td (to ) Tj ET Q q 0 0 0 rg BT 357.71 687.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 389.92 687.07 Td (10g ) Tj ET Q q 0 0 0 rg BT 407.68 687.07 Td (to ) Tj ET Q q 0 0 0 rg BT 418.22 687.07 Td (the ) Tj ET Q q 0 0 0 rg BT 433.20 687.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 457.63 687.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 480.94 687.07 Td (for ) Tj ET Q q 0 0 0 rg BT 495.36 687.07 Td (the ) Tj ET Q q 0 0 0 rg BT 510.34 687.07 Td (fiscal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 677.07 Td (year ) Tj ET Q q 0 0 0 rg BT 107.71 677.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 134.08 677.07 Td (December ) Tj ET Q q 0 0 0 rg BT 177.67 677.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 192.67 677.07 Td (1993\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 707.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 658.07 Td (‡‡10pp.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 658.07 Td (Senior ) Tj ET Q q 0 0 0 rg BT 117.23 658.07 Td (Executive ) Tj ET Q q 0 0 0 rg BT 160.33 658.07 Td (Severance ) Tj ET Q q 0 0 0 rg BT 204.54 658.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 227.94 658.07 Td (ef) Tj ET Q q 0 0 0 rg BT 235.62 658.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 265.85 658.07 Td (as ) Tj ET Q q 0 0 0 rg BT 277.30 658.07 Td (of ) Tj ET Q q 0 0 0 rg BT 288.34 658.07 Td (April ) Tj ET Q q 0 0 0 rg BT 312.29 658.07 Td (26, ) Tj ET Q q 0 0 0 rg BT 327.92 658.07 Td (2007 ) Tj ET Q q 0 0 0 rg BT 351.04 658.07 Td (and ) Tj ET Q q 0 0 0 rg BT 368.60 658.07 Td (as ) Tj ET Q q 0 0 0 rg BT 380.05 658.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 419.26 658.07 Td (ef) Tj ET Q q 0 0 0 rg BT 426.94 658.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 457.18 658.07 Td (February ) Tj ET Q q 0 0 0 rg BT 496.40 658.07 Td (16, ) Tj ET Q q 0 0 0 rg BT 512.02 658.07 Td (2012 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 648.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 144.36 648.07 Td (by ) Tj ET Q q 0 0 0 rg BT 156.86 648.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 196.54 648.07 Td (to ) Tj ET Q q 0 0 0 rg BT 206.82 648.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 238.77 648.07 Td (10ll ) Tj ET Q q 0 0 0 rg BT 256.82 648.07 Td (to ) Tj ET Q q 0 0 0 rg BT 267.10 648.07 Td (the ) Tj ET Q q 0 0 0 rg BT 281.82 648.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 305.99 648.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 329.04 648.07 Td (for ) Tj ET Q q 0 0 0 rg BT 343.20 648.07 Td (the ) Tj ET Q q 0 0 0 rg BT 357.92 648.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 382.07 648.07 Td (year ) Tj ET Q q 0 0 0 rg BT 401.78 648.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 428.16 648.07 Td (December ) Tj ET Q q 0 0 0 rg BT 471.74 648.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 486.74 648.07 Td (201) Tj ET Q q 0 0 0 rg BT 501.55 648.07 Td (1\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 658.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 628.07 Td (‡‡10qq.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 628.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.69 628.07 Td (of ) Tj ET Q q 0 0 0 rg BT 123.65 628.07 Td (Agreement ) Tj ET Q q 0 0 0 rg BT 170.82 628.07 Td (entered ) Tj ET Q q 0 0 0 rg BT 203.27 628.07 Td (into ) Tj ET Q q 0 0 0 rg BT 221.85 628.07 Td (between ) Tj ET Q q 0 0 0 rg BT 258.19 628.07 Td (the ) Tj ET Q q 0 0 0 rg BT 273.43 628.07 Td (Registrant ) Tj ET Q q 0 0 0 rg BT 317.55 628.07 Td (and ) Tj ET Q q 0 0 0 rg BT 335.01 628.07 Td (each ) Tj ET Q q 0 0 0 rg BT 356.35 628.07 Td (of ) Tj ET Q q 0 0 0 rg BT 367.70 628.07 Td (the ) Tj ET Q q 0 0 0 rg BT 382.94 628.07 Td (named ) Tj ET Q q 0 0 0 rg BT 412.62 628.07 Td (executive ) Tj ET Q q 0 0 0 rg BT 453.95 628.07 Td (of) Tj ET Q q 0 0 0 rg BT 462.19 628.07 Td (ficers ) Tj ET Q q 0 0 0 rg BT 487.33 628.07 Td (and ) Tj ET Q q 0 0 0 rg BT 504.79 628.07 Td (certain ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 618.07 Td (other ) Tj ET Q q 0 0 0 rg BT 111.11 618.07 Td (executives ) Tj ET Q q 0 0 0 rg BT 155.87 618.07 Td (ef) Tj ET Q q 0 0 0 rg BT 163.55 618.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 193.22 618.07 Td (January ) Tj ET Q q 0 0 0 rg BT 226.88 618.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 236.94 618.07 Td (2016 ) Tj ET Q q 0 0 0 rg BT 259.50 618.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 315.92 618.07 Td (by ) Tj ET Q q 0 0 0 rg BT 328.48 618.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 368.22 618.07 Td (to ) Tj ET Q q 0 0 0 rg BT 378.56 618.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 410.56 618.07 Td (10kk ) Tj ET Q q 0 0 0 rg BT 433.13 618.07 Td (to ) Tj ET Q q 0 0 0 rg BT 443.46 618.07 Td (the ) Tj ET Q q 0 0 0 rg BT 458.24 618.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 482.47 618.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 505.58 618.07 Td (for ) Tj ET Q q 0 0 0 rg BT 519.80 618.07 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 608.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 112.16 608.07 Td (year ) Tj ET Q q 0 0 0 rg BT 131.86 608.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 158.24 608.07 Td (December ) Tj ET Q q 0 0 0 rg BT 201.82 608.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 216.82 608.07 Td (2015\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 628.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.35 589.07 Td (‡‡10rr.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 589.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 147.27 589.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 178.78 589.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 220.83 589.07 Td (Retirement ) Tj ET Q q 0 0 0 rg BT 268.43 589.07 Td (Income ) Tj ET Q q 0 0 0 rg BT 301.58 589.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 322.53 589.07 Td (for ) Tj ET Q q 0 0 0 rg BT 337.35 589.07 Td (Non-Employee ) Tj ET Q q 0 0 0 rg BT 401.61 589.07 Td (Directors, ) Tj ET Q q 0 0 0 rg BT 444.49 589.07 Td (as ) Tj ET Q q 0 0 0 rg BT 455.98 589.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 495.24 589.07 Td (March ) Tj ET Q q 0 0 0 rg BT 524.51 589.07 Td (5, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 579.07 Td (1996 ) Tj ET Q q 0 0 0 rg BT 110.41 579.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 166.68 579.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 194.07 579.07 Td (by ) Tj ET Q q 0 0 0 rg BT 206.48 579.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 246.07 579.07 Td (to ) Tj ET Q q 0 0 0 rg BT 256.25 579.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 288.10 579.07 Td (10k ) Tj ET Q q 0 0 0 rg BT 305.51 579.07 Td (to ) Tj ET Q q 0 0 0 rg BT 315.70 579.07 Td (the ) Tj ET Q q 0 0 0 rg BT 330.32 579.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 354.40 579.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 377.36 579.07 Td (for ) Tj ET Q q 0 0 0 rg BT 391.42 579.07 Td (the ) Tj ET Q q 0 0 0 rg BT 406.05 579.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 430.11 579.07 Td (year ) Tj ET Q q 0 0 0 rg BT 449.72 579.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 476.01 579.07 Td (December ) Tj ET Q q 0 0 0 rg BT 519.50 579.07 Td (31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 569.07 Td (1996\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 589.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 47.70 552.07 Td (‡‡10ss.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 552.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 147.08 552.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 178.40 552.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 220.26 552.07 Td (1987 ) Tj ET Q q 0 0 0 rg BT 243.23 552.07 Td (Deferred ) Tj ET Q q 0 0 0 rg BT 281.73 552.07 Td (Compensation ) Tj ET Q q 0 0 0 rg BT 342.48 552.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 363.23 552.07 Td (for ) Tj ET Q q 0 0 0 rg BT 377.86 552.07 Td (Non-Employee ) Tj ET Q q 0 0 0 rg BT 441.93 552.07 Td (Directors, ) Tj ET Q q 0 0 0 rg BT 484.61 552.07 Td (as ) Tj ET Q q 0 0 0 rg BT 495.92 552.07 Td (amended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 542.07 Td (and ) Tj ET Q q 0 0 0 rg BT 104.57 542.07 Td (restated ) Tj ET Q q 0 0 0 rg BT 137.79 542.07 Td (January ) Tj ET Q q 0 0 0 rg BT 171.02 542.07 Td (20, ) Tj ET Q q 0 0 0 rg BT 185.65 542.07 Td (2015 ) Tj ET Q q 0 0 0 rg BT 207.78 542.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 263.77 542.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 290.88 542.07 Td (by ) Tj ET Q q 0 0 0 rg BT 303.01 542.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 342.32 542.07 Td (to ) Tj ET Q q 0 0 0 rg BT 352.23 542.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 383.80 542.07 Td (10mm ) Tj ET Q q 0 0 0 rg BT 411.49 542.07 Td (to ) Tj ET Q q 0 0 0 rg BT 421.39 542.07 Td (the ) Tj ET Q q 0 0 0 rg BT 435.74 542.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 459.54 542.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 482.22 542.07 Td (for ) Tj ET Q q 0 0 0 rg BT 496.01 542.07 Td (the ) Tj ET Q q 0 0 0 rg BT 510.35 542.07 Td (fiscal ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 532.07 Td (year ) Tj ET Q q 0 0 0 rg BT 107.71 532.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 134.08 532.07 Td (December ) Tj ET Q q 0 0 0 rg BT 177.67 532.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 192.67 532.07 Td (2014\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 552.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 49.90 513.07 Td (‡‡10tt.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 513.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.68 513.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 177.59 513.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 219.05 513.07 Td (Non-Employee ) Tj ET Q q 0 0 0 rg BT 282.72 513.07 Td (Directors’) Tj ET Q q 0 0 0 rg BT 322.88 513.07 Td ( ) Tj ET Q q 0 0 0 rg BT 325.08 513.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 350.44 513.07 Td (Option ) Tj ET Q q 0 0 0 rg BT 380.79 513.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 403.64 513.07 Td (as ) Tj ET Q q 0 0 0 rg BT 414.54 513.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 453.21 513.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 467.44 513.07 Td (approved ) Tj ET Q q 0 0 0 rg BT 507.22 513.07 Td (by ) Tj ET Q q 0 0 0 rg BT 519.79 513.07 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 503.07 Td (Stockholders ) Tj ET Q q 0 0 0 rg BT 143.69 503.07 Td (on ) Tj ET Q q 0 0 0 rg BT 157.17 503.07 Td (May ) Tj ET Q q 0 0 0 rg BT 178.98 503.07 Td (1, ) Tj ET Q q 0 0 0 rg BT 189.96 503.07 Td (1990, ) Tj ET Q q 0 0 0 rg BT 215.94 503.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 269.95 503.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 298.41 503.07 Td (by ) Tj ET Q q 0 0 0 rg BT 311.89 503.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 352.55 503.07 Td (to ) Tj ET Q q 0 0 0 rg BT 363.81 503.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 396.73 503.07 Td (28 ) Tj ET Q q 0 0 0 rg BT 410.21 503.07 Td (to ) Tj ET Q q 0 0 0 rg BT 421.46 503.07 Td (Registration ) Tj ET Q q 0 0 0 rg BT 473.82 503.07 Td (Statement ) Tj ET Q q 0 0 0 rg BT 517.29 503.07 Td (No. ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 493.07 Td (33-38587 ) Tj ET Q q 0 0 0 rg BT 129.03 493.07 Td (on ) Tj ET Q q 0 0 0 rg BT 141.73 493.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 166.09 493.07 Td (S-8; ) Tj ET Q q 0 0 0 rg BT 185.46 493.07 Td (as ) Tj ET Q q 0 0 0 rg BT 196.49 493.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 235.28 493.07 Td (May ) Tj ET Q q 0 0 0 rg BT 256.31 493.07 Td (7, ) Tj ET Q q 0 0 0 rg BT 266.51 493.07 Td (1991, ) Tj ET Q q 0 0 0 rg BT 291.70 493.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 344.93 493.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 372.62 493.07 Td (by ) Tj ET Q q 0 0 0 rg BT 385.31 493.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 425.19 493.07 Td (to ) Tj ET Q q 0 0 0 rg BT 435.67 493.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 467.81 493.07 Td (19c ) Tj ET Q q 0 0 0 rg BT 484.95 493.07 Td (to ) Tj ET Q q 0 0 0 rg BT 495.42 493.07 Td (the ) Tj ET Q q 0 0 0 rg BT 510.34 493.07 Td (Form ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 483.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 109.93 483.07 Td (for ) Tj ET Q q 0 0 0 rg BT 122.96 483.07 Td (the ) Tj ET Q q 0 0 0 rg BT 136.55 483.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 159.58 483.07 Td (year ) Tj ET Q q 0 0 0 rg BT 178.16 483.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 203.42 483.07 Td (December ) Tj ET Q q 0 0 0 rg BT 245.87 483.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 259.75 483.07 Td (1991\), ) Tj ET Q q 0 0 0 rg BT 286.95 483.07 Td (as ) Tj ET Q q 0 0 0 rg BT 296.66 483.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 334.13 483.07 Td (January ) Tj ET Q q 0 0 0 rg BT 366.60 483.07 Td (12, ) Tj ET Q q 0 0 0 rg BT 380.47 483.07 Td (1999 ) Tj ET Q q 0 0 0 rg BT 401.85 483.07 Td (\(incorporated ) Tj ET Q q 0 0 0 rg BT 457.08 483.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 483.44 483.07 Td (by ) Tj ET Q q 0 0 0 rg BT 494.82 483.07 Td (reference ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 473.07 Td (to ) Tj ET Q q 0 0 0 rg BT 98.28 473.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 130.22 473.07 Td (10m ) Tj ET Q q 0 0 0 rg BT 150.50 473.07 Td (to ) Tj ET Q q 0 0 0 rg BT 160.78 473.07 Td (the ) Tj ET Q q 0 0 0 rg BT 175.50 473.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 199.67 473.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 222.72 473.07 Td (for ) Tj ET Q q 0 0 0 rg BT 236.88 473.07 Td (the ) Tj ET Q q 0 0 0 rg BT 251.59 473.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 275.75 473.07 Td (year ) Tj ET Q q 0 0 0 rg BT 295.46 473.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 321.83 473.07 Td (December ) Tj ET Q q 0 0 0 rg BT 365.42 473.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 380.42 473.07 Td (1998\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 513.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 45.50 456.07 Td (‡‡10uu.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 456.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 146.68 456.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 177.59 456.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 219.05 456.07 Td (Non-Employee ) Tj ET Q q 0 0 0 rg BT 282.72 456.07 Td (Directors’) Tj ET Q q 0 0 0 rg BT 322.88 456.07 Td ( ) Tj ET Q q 0 0 0 rg BT 325.08 456.07 Td (Stock ) Tj ET Q q 0 0 0 rg BT 350.44 456.07 Td (Option ) Tj ET Q q 0 0 0 rg BT 380.79 456.07 Td (Plan, ) Tj ET Q q 0 0 0 rg BT 403.64 456.07 Td (as ) Tj ET Q q 0 0 0 rg BT 414.54 456.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 453.21 456.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 467.44 456.07 Td (approved ) Tj ET Q q 0 0 0 rg BT 507.22 456.07 Td (by ) Tj ET Q q 0 0 0 rg BT 519.79 456.07 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 446.07 Td (Stockholders ) Tj ET Q q 0 0 0 rg BT 142.68 446.07 Td (on ) Tj ET Q q 0 0 0 rg BT 155.14 446.07 Td (May ) Tj ET Q q 0 0 0 rg BT 175.94 446.07 Td (2, ) Tj ET Q q 0 0 0 rg BT 185.90 446.07 Td (2000, ) Tj ET Q q 0 0 0 rg BT 210.86 446.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 263.86 446.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 291.31 446.07 Td (by ) Tj ET Q q 0 0 0 rg BT 303.77 446.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 343.42 446.07 Td (to ) Tj ET Q q 0 0 0 rg BT 353.66 446.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 385.30 446.07 Td (A) Tj ET Q q 0 0 0 rg BT 391.97 446.07 Td ( ) Tj ET Q q 0 0 0 rg BT 394.16 446.07 Td (to ) Tj ET Q q 0 0 0 rg BT 404.40 446.07 Td (the ) Tj ET Q q 0 0 0 rg BT 419.08 446.07 Td (2000 ) Tj ET Q q 0 0 0 rg BT 441.54 446.07 Td (Proxy ) Tj ET Q q 0 0 0 rg BT 467.90 446.07 Td (Statement ) Tj ET Q q 0 0 0 rg BT 510.35 446.07 Td (dated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 436.07 Td (March ) Tj ET Q q 0 0 0 rg BT 116.60 436.07 Td (20, ) Tj ET Q q 0 0 0 rg BT 131.60 436.07 Td (2000\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 456.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 46.10 415.07 Td (‡‡10vv.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 415.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 118.43 415.07 Td (Corporation ) Tj ET Q q 0 0 0 rg BT 168.85 415.07 Td (Deferral ) Tj ET Q q 0 0 0 rg BT 204.24 415.07 Td (Plan ) Tj ET Q q 0 0 0 rg BT 224.11 415.07 Td (for ) Tj ET Q q 0 0 0 rg BT 237.87 415.07 Td (Fees ) Tj ET Q q 0 0 0 rg BT 258.29 415.07 Td (of ) Tj ET Q q 0 0 0 rg BT 268.71 415.07 Td (Outside ) Tj ET Q q 0 0 0 rg BT 301.91 415.07 Td (Directors, ) Tj ET Q q 0 0 0 rg BT 343.71 415.07 Td (as ) Tj ET Q q 0 0 0 rg BT 354.13 415.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 392.31 415.07 Td (\(as ) Tj ET Q q 0 0 0 rg BT 406.06 415.07 Td (adopted, ) Tj ET Q q 0 0 0 rg BT 442.31 415.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 494.93 415.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 522.01 415.07 Td (by ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 405.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 127.42 405.07 Td (to ) Tj ET Q q 0 0 0 rg BT 137.43 405.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 169.11 405.07 Td (10e ) Tj ET Q q 0 0 0 rg BT 185.79 405.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 216.36 405.07 Td (Corporation ) Tj ET Q q 0 0 0 rg BT 266.93 405.07 Td (1991 ) Tj ET Q q 0 0 0 rg BT 289.16 405.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 313.07 405.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 335.86 405.07 Td (for ) Tj ET Q q 0 0 0 rg BT 349.75 405.07 Td (the ) Tj ET Q q 0 0 0 rg BT 364.21 405.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 388.10 405.07 Td (year ) Tj ET Q q 0 0 0 rg BT 407.54 405.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 433.65 405.07 Td (December ) Tj ET Q q 0 0 0 rg BT 476.97 405.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 491.71 405.07 Td (1987, ) Tj ET Q q 0 0 0 rg BT 516.45 405.07 Td (File ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 395.07 Td (No. ) Tj ET Q q 0 0 0 rg BT 105.70 395.07 Td (1-5514; ) Tj ET Q q 0 0 0 rg BT 139.79 395.07 Td (as ) Tj ET Q q 0 0 0 rg BT 151.10 395.07 Td (amended ) Tj ET Q q 0 0 0 rg BT 190.17 395.07 Td (ef) Tj ET Q q 0 0 0 rg BT 197.85 395.07 Td (fective ) Tj ET Q q 0 0 0 rg BT 227.94 395.07 Td (December ) Tj ET Q q 0 0 0 rg BT 272.01 395.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 287.49 395.07 Td (1991 ) Tj ET Q q 0 0 0 rg BT 310.47 395.07 Td (incorporated ) Tj ET Q q 0 0 0 rg BT 363.98 395.07 Td (herein ) Tj ET Q q 0 0 0 rg BT 391.95 395.07 Td (by ) Tj ET Q q 0 0 0 rg BT 404.93 395.07 Td (reference ) Tj ET Q q 0 0 0 rg BT 445.09 395.07 Td (to ) Tj ET Q q 0 0 0 rg BT 455.85 395.07 Td (Exhibit ) Tj ET Q q 0 0 0 rg BT 488.27 395.07 Td (10m ) Tj ET Q q 0 0 0 rg BT 509.03 395.07 Td (to ) Tj ET Q q 0 0 0 rg BT 519.79 395.07 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 385.07 Td (Form ) Tj ET Q q 0 0 0 rg BT 112.17 385.07 Td (10-K ) Tj ET Q q 0 0 0 rg BT 135.22 385.07 Td (for ) Tj ET Q q 0 0 0 rg BT 149.38 385.07 Td (the ) Tj ET Q q 0 0 0 rg BT 164.10 385.07 Td (fiscal ) Tj ET Q q 0 0 0 rg BT 188.25 385.07 Td (year ) Tj ET Q q 0 0 0 rg BT 207.96 385.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 234.34 385.07 Td (December ) Tj ET Q q 0 0 0 rg BT 277.92 385.07 Td (31, ) Tj ET Q q 0 0 0 rg BT 292.92 385.07 Td (1992\).) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 554.50 415.07 Td (‡) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.00 365.07 Td (12) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 363.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 365.07 Td (Statement ) Tj ET Q q 0 0 0 rg BT 130.49 365.07 Td (re ) Tj ET Q q 0 0 0 rg BT 140.76 365.07 Td (computation ) Tj ET Q q 0 0 0 rg BT 193.25 365.07 Td (of ) Tj ET Q q 0 0 0 rg BT 204.08 365.07 Td (ratios ) Tj ET Q q 0 0 0 rg BT 228.80 365.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 252.95 365.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 363.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 365.07 Td (E-12-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.00 346.07 Td (21) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 344.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 346.07 Td (Subsidiaries ) Tj ET Q q 0 0 0 rg BT 139.39 346.07 Td (of ) Tj ET Q q 0 0 0 rg BT 150.22 346.07 Td (the ) Tj ET Q q 0 0 0 rg BT 164.93 346.07 Td (Registrant ) Tj ET Q q 0 0 0 rg BT 208.54 346.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 232.69 346.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 344.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 346.07 Td (E-21-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.00 327.07 Td (23) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 325.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 327.07 Td (Consent ) Tj ET Q q 0 0 0 rg BT 123.28 327.07 Td (of ) Tj ET Q q 0 0 0 rg BT 134.11 327.07 Td (Deloitte ) Tj ET Q q 0 0 0 rg BT 168.82 327.07 Td (& ) Tj ET Q q 0 0 0 rg BT 179.01 327.07 Td (T) Tj ET Q q 0 0 0 rg BT 184.68 327.07 Td (ouche ) Tj ET Q q 0 0 0 rg BT 210.71 327.07 Td (LLP) Tj ET Q q 0 0 0 rg BT 228.30 327.07 Td ( ) Tj ET Q q 0 0 0 rg BT 230.61 327.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 254.77 327.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 325.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 327.07 Td (E-23-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.05 308.07 Td (31a.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 306.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 308.07 Td (Section ) Tj ET Q q 0 0 0 rg BT 120.50 308.07 Td (302 ) Tj ET Q q 0 0 0 rg BT 138.00 308.07 Td (Certification ) Tj ET Q q 0 0 0 rg BT 191.03 308.07 Td (Letter ) Tj ET Q q 0 0 0 rg BT 217.40 308.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 241.56 308.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 306.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 308.07 Td (E-31-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 289.07 Td (31b.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 287.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 289.07 Td (Section ) Tj ET Q q 0 0 0 rg BT 120.50 289.07 Td (302 ) Tj ET Q q 0 0 0 rg BT 138.00 289.07 Td (Certification ) Tj ET Q q 0 0 0 rg BT 191.03 289.07 Td (Letter ) Tj ET Q q 0 0 0 rg BT 217.40 289.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 241.56 289.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 287.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 289.07 Td (E-31-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 61.05 270.07 Td (32a.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 268.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 270.07 Td (Section ) Tj ET Q q 0 0 0 rg BT 120.50 270.07 Td (906 ) Tj ET Q q 0 0 0 rg BT 138.00 270.07 Td (Certification ) Tj ET Q q 0 0 0 rg BT 191.03 270.07 Td (Letter ) Tj ET Q q 0 0 0 rg BT 217.40 270.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 241.56 270.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 268.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 270.07 Td (E-32-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 251.07 Td (32b.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 249.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 251.07 Td (Section ) Tj ET Q q 0 0 0 rg BT 120.50 251.07 Td (906 ) Tj ET Q q 0 0 0 rg BT 138.00 251.07 Td (Certification ) Tj ET Q q 0 0 0 rg BT 191.03 251.07 Td (Letter ) Tj ET Q q 0 0 0 rg BT 217.40 251.07 Td (\(filed ) Tj ET Q q 0 0 0 rg BT 241.56 251.07 Td (herewith\).) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 249.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 543.10 251.07 Td (E-32-2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 60.50 232.07 Td (101.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 84.00 192.75 Td (  ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 232.07 Td (The ) Tj ET Q q 0 0 0 rg BT 106.25 232.07 Td (following ) Tj ET Q q 0 0 0 rg BT 147.84 232.07 Td (financial ) Tj ET Q q 0 0 0 rg BT 185.53 232.07 Td (statements ) Tj ET Q q 0 0 0 rg BT 230.44 232.07 Td (from ) Tj ET Q q 0 0 0 rg BT 252.58 232.07 Td (the ) Tj ET Q q 0 0 0 rg BT 267.51 232.07 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 326.32 232.07 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 357.36 232.07 Td (Company ) Tj ET Q q 0 0 0 rg BT 398.36 232.07 Td (Annual ) Tj ET Q q 0 0 0 rg BT 430.50 232.07 Td (Report ) Tj ET Q q 0 0 0 rg BT 460.42 232.07 Td (on ) Tj ET Q q 0 0 0 rg BT 473.12 232.07 Td (Form 10-K for ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 222.07 Td (the ) Tj ET Q q 0 0 0 rg BT 103.87 222.07 Td (years ) Tj ET Q q 0 0 0 rg BT 128.62 222.07 Td (ended ) Tj ET Q q 0 0 0 rg BT 156.14 222.07 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 215.88 222.07 Td (2016, ) Tj ET Q q 0 0 0 rg BT 242.03 222.07 Td (2015 ) Tj ET Q q 0 0 0 rg BT 265.68 222.07 Td (and ) Tj ET Q q 0 0 0 rg BT 283.76 222.07 Td (2014, ) Tj ET Q q 0 0 0 rg BT 309.91 222.07 Td (formatted ) Tj ET Q q 0 0 0 rg BT 352.44 222.07 Td (in ) Tj ET Q q 0 0 0 rg BT 363.86 222.07 Td (Extensible ) Tj ET Q q 0 0 0 rg BT 409.73 222.07 Td (Business ) Tj ET Q q 0 0 0 rg BT 448.94 222.07 Td (Reporting ) Tj ET Q q 0 0 0 rg BT 492.58 222.07 Td (Language ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 212.07 Td (\(XBRL\): ) Tj ET Q q 0 0 0 rg BT 129.38 212.07 Td (\(i\) consolidated ) Tj ET Q q 0 0 0 rg BT 197.13 212.07 Td (statements ) Tj ET Q q 0 0 0 rg BT 244.62 212.07 Td (of ) Tj ET Q q 0 0 0 rg BT 258.22 212.07 Td (earnings, ) Tj ET Q q 0 0 0 rg BT 299.87 212.07 Td (\(ii\) ) Tj ET Q q 0 0 0 rg BT 317.36 212.07 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 373.17 212.07 Td (statements ) Tj ET Q q 0 0 0 rg BT 420.66 212.07 Td (of ) Tj ET Q q 0 0 0 rg BT 434.26 212.07 Td (comprehensive ) Tj ET Q q 0 0 0 rg BT 500.07 212.07 Td (income, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 202.07 Td (\(iii\) consolidated ) Tj ET Q q 0 0 0 rg BT 158.04 202.07 Td (balance ) Tj ET Q q 0 0 0 rg BT 190.57 202.07 Td (sheets, ) Tj ET Q q 0 0 0 rg BT 219.51 202.07 Td (\(iv\) ) Tj ET Q q 0 0 0 rg BT 235.95 202.07 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 288.50 202.07 Td (statements ) Tj ET Q q 0 0 0 rg BT 332.71 202.07 Td (of ) Tj ET Q q 0 0 0 rg BT 343.04 202.07 Td (cash ) Tj ET Q q 0 0 0 rg BT 362.81 202.07 Td (flows, ) Tj ET Q q 0 0 0 rg BT 389.54 202.07 Td (and ) Tj ET Q q 0 0 0 rg BT 405.98 202.07 Td (\(v\) the ) Tj ET Q q 0 0 0 rg BT 434.36 202.07 Td (notes ) Tj ET Q q 0 0 0 rg BT 457.47 202.07 Td (to ) Tj ET Q q 0 0 0 rg BT 467.25 202.07 Td (the ) Tj ET Q q 0 0 0 rg BT 481.47 202.07 Td (consolidated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 88.00 192.07 Td (financial ) Tj ET Q q 0 0 0 rg BT 125.48 192.07 Td (statements.) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 538.00 192.75 Td (    ) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 170.45 Td (†) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 169.07 Td (Confidential treatment has been granted for certain portions which are omitted in the copy of the exhibit electronically filed with) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 56.00 159.12 Td (the Commission.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 39.00 126.45 Td (*) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 124.17 Td (Indicates, ) Tj ET Q q 0 0 0 rg BT 96.35 124.17 Td (in ) Tj ET Q q 0 0 0 rg BT 107.89 124.17 Td (this ) Tj ET Q q 0 0 0 rg BT 126.10 124.17 Td (Form ) Tj ET Q q 0 0 0 rg BT 151.53 124.17 Td (10-K, ) Tj ET Q q 0 0 0 rg BT 178.34 124.17 Td (brand ) Tj ET Q q 0 0 0 rg BT 204.86 124.17 Td (names ) Tj ET Q q 0 0 0 rg BT 234.17 124.17 Td (of ) Tj ET Q q 0 0 0 rg BT 246.26 124.17 Td (products, ) Tj ET Q q 0 0 0 rg BT 286.96 124.17 Td (which ) Tj ET Q q 0 0 0 rg BT 315.15 124.17 Td (are ) Tj ET Q q 0 0 0 rg BT 331.12 124.17 Td (registered ) Tj ET Q q 0 0 0 rg BT 374.30 124.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 422.48 124.17 Td (not ) Tj ET Q q 0 0 0 rg BT 439.02 124.17 Td (solely ) Tj ET Q q 0 0 0 rg BT 466.67 124.17 Td (owned ) Tj ET Q q 0 0 0 rg BT 497.08 124.17 Td (by ) Tj ET Q q 0 0 0 rg BT 510.84 124.17 Td (the ) Tj ET Q q 0 0 0 rg BT 526.82 124.17 Td (Company ) Tj ET Q q 0 0 0 rg BT 569.46 124.17 Td (or ) Tj ET Q q 0 0 0 rg BT 581.55 124.17 Td (its ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 114.17 Td (subsidiaries. ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 106.69 114.17 Td (Abilify) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 133.35 114.17 Td ( ) Tj ET Q q 0 0 0 rg BT 136.31 114.17 Td (is ) Tj ET Q q 0 0 0 rg BT 145.95 114.17 Td (a ) Tj ET Q q 0 0 0 rg BT 153.36 114.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 196.86 114.17 Td (of ) Tj ET Q q 0 0 0 rg BT 208.16 114.17 Td (Otsuka ) Tj ET Q q 0 0 0 rg BT 239.46 114.17 Td (Pharmaceutical ) Tj ET Q q 0 0 0 rg BT 304.06 114.17 Td (Co., ) Tj ET Q q 0 0 0 rg BT 323.70 114.17 Td (Ltd.; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 345.84 114.17 Td (Adcetris) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 379.16 114.17 Td ( ) Tj ET Q q 0 0 0 rg BT 382.13 114.17 Td (is ) Tj ET Q q 0 0 0 rg BT 391.77 114.17 Td (a ) Tj ET Q q 0 0 0 rg BT 399.18 114.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 442.68 114.17 Td (of ) Tj ET Q q 0 0 0 rg BT 453.98 114.17 Td (Seattle ) Tj ET Q q 0 0 0 rg BT 484.16 114.17 Td (Genetics, ) Tj ET Q q 0 0 0 rg BT 524.61 114.17 Td (Inc.; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 545.63 114.17 Td (Atripla) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.96 114.17 Td ( ) Tj ET Q q 0 0 0 rg BT 576.93 114.17 Td (is ) Tj ET Q q 0 0 0 rg BT 586.57 114.17 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 104.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 97.53 104.17 Td (of ) Tj ET Q q 0 0 0 rg BT 108.86 104.17 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 167.96 104.17 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 199.30 104.17 Td (and ) Tj ET Q q 0 0 0 rg BT 216.73 104.17 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 246.39 104.17 Td (Sciences, ) Tj ET Q q 0 0 0 rg BT 286.87 104.17 Td (LLC; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 311.53 104.17 Td (A) Tj ET Q q 0 0 0 rg BT 317.09 104.17 Td (vapr) Tj ET Q q 0 0 0 rg BT 335.05 104.17 Td (o/A) Tj ET Q q 0 0 0 rg BT 348.38 104.17 Td (valide) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 372.82 104.17 Td ( ) Tj ET Q q 0 0 0 rg BT 375.81 104.17 Td (\(known ) Tj ET Q q 0 0 0 rg BT 409.36 104.17 Td (in ) Tj ET Q q 0 0 0 rg BT 420.14 104.17 Td (the ) Tj ET Q q 0 0 0 rg BT 435.35 104.17 Td (EU ) Tj ET Q q 0 0 0 rg BT 451.68 104.17 Td (as ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 463.00 104.17 Td (Apr) Tj ET Q q 0 0 0 rg BT 477.63 104.17 Td (ovel/Karvea) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 526.51 104.17 Td (\) ) Tj ET Q q 0 0 0 rg BT 532.83 104.17 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 550.27 104.17 Td (Plavix) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 575.81 104.17 Td ( ) Tj ET Q q 0 0 0 rg BT 578.81 104.17 Td (are ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 94.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 100.50 94.17 Td (of ) Tj ET Q q 0 0 0 rg BT 110.91 94.17 Td (Sanofi; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 141.88 94.17 Td (Bydur) Tj ET Q q 0 0 0 rg BT 165.95 94.17 Td (eon, ) Tj ET Q q 0 0 0 rg BT 184.97 94.17 Td (Byetta) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 210.51 94.17 Td ( ) Tj ET Q q 0 0 0 rg BT 212.59 94.17 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 229.11 94.17 Td (Symlin) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 256.32 94.17 Td ( ) Tj ET Q q 0 0 0 rg BT 258.40 94.17 Td (are ) Tj ET Q q 0 0 0 rg BT 272.69 94.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 319.20 94.17 Td (of ) Tj ET Q q 0 0 0 rg BT 329.15 94.17 Td (Amylin ) Tj ET Q q 0 0 0 rg BT 361.78 94.17 Td (Pharmaceuticals, ) Tj ET Q q 0 0 0 rg BT 431.89 94.17 Td (LLC; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 455.64 94.17 Td (Erbitux) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 485.63 94.17 Td ( ) Tj ET Q q 0 0 0 rg BT 487.71 94.17 Td (is ) Tj ET Q q 0 0 0 rg BT 496.46 94.17 Td (a ) Tj ET Q q 0 0 0 rg BT 502.98 94.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 545.59 94.17 Td (of ) Tj ET Q q 0 0 0 rg BT 556.00 94.17 Td (ImClone ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 84.17 Td (LLC; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 78.42 84.17 Td (Farxiga ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 113.40 84.17 Td (and) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 127.84 84.17 Td ( ) Tj ET Q q 0 0 0 rg BT 130.59 84.17 Td (Onglyza ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 166.68 84.17 Td (are ) Tj ET Q q 0 0 0 rg BT 181.65 84.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 228.83 84.17 Td (of ) Tj ET Q q 0 0 0 rg BT 239.31 84.17 Td (AstraZeneca ) Tj ET Q q 0 0 0 rg BT 291.98 84.17 Td (AB; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 311.41 84.17 Td (Gleevec) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 343.60 84.17 Td ( ) Tj ET Q q 0 0 0 rg BT 346.36 84.17 Td (is ) Tj ET Q q 0 0 0 rg BT 355.78 84.17 Td (a ) Tj ET Q q 0 0 0 rg BT 362.98 84.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 406.27 84.17 Td (of ) Tj ET Q q 0 0 0 rg BT 417.36 84.17 Td (Novartis ) Tj ET Q q 0 0 0 rg BT 453.95 84.17 Td (AG; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 473.93 84.17 Td (Ixempra) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 507.25 84.17 Td ( ) Tj ET Q q 0 0 0 rg BT 510.00 84.17 Td (is ) Tj ET Q q 0 0 0 rg BT 519.43 84.17 Td (a ) Tj ET Q q 0 0 0 rg BT 526.63 84.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 569.92 84.17 Td (of ) Tj ET Q q 0 0 0 rg BT 581.01 84.17 Td (R-) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 74.17 Td (Pharm ) Tj ET Q q 0 0 0 rg BT 81.47 74.17 Td (US ) Tj ET Q q 0 0 0 rg BT 95.61 74.17 Td (Operating, ) Tj ET Q q 0 0 0 rg BT 139.45 74.17 Td (LLC; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 162.48 74.17 Td (Keytruda) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 199.69 74.17 Td ( ) Tj ET Q q 0 0 0 rg BT 201.05 74.17 Td (is ) Tj ET Q q 0 0 0 rg BT 209.08 74.17 Td (a ) Tj ET Q q 0 0 0 rg BT 214.88 74.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 256.77 74.17 Td (of ) Tj ET Q q 0 0 0 rg BT 266.46 74.17 Td (Merck ) Tj ET Q q 0 0 0 rg BT 293.92 74.17 Td (Sharp ) Tj ET Q q 0 0 0 rg BT 318.61 74.17 Td (& ) Tj ET Q q 0 0 0 rg BT 327.74 74.17 Td (Dohme ) Tj ET Q q 0 0 0 rg BT 358.54 74.17 Td (Corp.; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 385.18 74.17 Td (Myalept) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 417.94 74.17 Td ( ) Tj ET Q q 0 0 0 rg BT 419.30 74.17 Td (is ) Tj ET Q q 0 0 0 rg BT 427.33 74.17 Td (a ) Tj ET Q q 0 0 0 rg BT 433.13 74.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 475.02 74.17 Td (of ) Tj ET Q q 0 0 0 rg BT 484.41 74.17 Td (Aegerion ) Tj ET Q q 0 0 0 rg BT 522.97 74.17 Td (Pharmaceuticals, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 64.17 Td (Inc.; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 75.08 64.17 Td (Pr) Tj ET Q q 0 0 0 rg BT 84.71 64.17 Td (ostvac) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 110.25 64.17 Td ( ) Tj ET Q q 0 0 0 rg BT 113.28 64.17 Td (is ) Tj ET Q q 0 0 0 rg BT 122.98 64.17 Td (a ) Tj ET Q q 0 0 0 rg BT 130.45 64.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 174.01 64.17 Td (of ) Tj ET Q q 0 0 0 rg BT 185.37 64.17 Td (BN ) Tj ET Q q 0 0 0 rg BT 202.29 64.17 Td (ImmunoTherapeutics ) Tj ET Q q 0 0 0 rg BT 290.85 64.17 Td (Inc.; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 311.93 64.17 Td (Recothr) Tj ET Q q 0 0 0 rg BT 343.21 64.17 Td (om) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 355.43 64.17 Td ( ) Tj ET Q q 0 0 0 rg BT 358.46 64.17 Td (is ) Tj ET Q q 0 0 0 rg BT 368.16 64.17 Td (a ) Tj ET Q q 0 0 0 rg BT 375.63 64.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 419.19 64.17 Td (of ) Tj ET Q q 0 0 0 rg BT 430.33 64.17 Td (The ) Tj ET Q q 0 0 0 rg BT 448.91 64.17 Td (Medicines ) Tj ET Q q 0 0 0 rg BT 493.60 64.17 Td (Company; ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 538.29 64.17 Td (Revlimid) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 573.83 64.17 Td ( ) Tj ET Q q 0 0 0 rg BT 576.86 64.17 Td (is ) Tj ET Q q 0 0 0 rg BT 586.56 64.17 Td (a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 54.17 Td (trademark ) Tj ET Q q 0 0 0 rg BT 97.43 54.17 Td (of ) Tj ET Q q 0 0 0 rg BT 108.66 54.17 Td (Celgene ) Tj ET Q q 0 0 0 rg BT 144.32 54.17 Td (Corporation ) Tj ET Q q 0 0 0 rg BT 195.54 54.17 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 212.87 54.17 Td (T) Tj ET Q q 0 0 0 rg BT 217.88 54.17 Td (ruvada) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 246.21 54.17 Td ( ) Tj ET Q q 0 0 0 rg BT 249.11 54.17 Td (and ) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 266.45 54.17 Td (T) Tj ET Q q 0 0 0 rg BT 271.27 54.17 Td (ybost ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 295.27 54.17 Td (are) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 307.48 54.17 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 310.38 54.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 357.70 54.17 Td (of ) Tj ET Q q 0 0 0 rg BT 368.92 54.17 Td (Gilead ) Tj ET Q q 0 0 0 rg BT 398.48 54.17 Td (Sciences, ) Tj ET Q q 0 0 0 rg BT 438.86 54.17 Td (Inc. ) Tj ET Q q 0 0 0 rg BT 457.02 54.17 Td (and/or ) Tj ET Q q 0 0 0 rg BT 485.47 54.17 Td (one ) Tj ET Q q 0 0 0 rg BT 502.80 54.17 Td (of ) Tj ET Q q 0 0 0 rg BT 514.03 54.17 Td (its ) Tj ET Q q 0 0 0 rg BT 526.38 54.17 Td (af) Tj ET Q q 0 0 0 rg BT 533.96 54.17 Td (filiates. ) Tj ET Q q 0 0 0 rg BT 566.57 54.17 Td (Brand ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 54.00 44.17 Td (names ) Tj ET Q q 0 0 0 rg BT 82.05 44.17 Td (of ) Tj ET Q q 0 0 0 rg BT 92.88 44.17 Td (products ) Tj ET Q q 0 0 0 rg BT 129.82 44.17 Td (that ) Tj ET Q q 0 0 0 rg BT 147.31 44.17 Td (are ) Tj ET Q q 0 0 0 rg BT 162.02 44.17 Td (in ) Tj ET Q q 0 0 0 rg BT 172.30 44.17 Td (all ) Tj ET Q q 0 0 0 rg BT 184.79 44.17 Td (italicized ) Tj ET Q q 0 0 0 rg BT 223.94 44.17 Td (letters, ) Tj ET Q q 0 0 0 rg BT 253.37 44.17 Td (without ) Tj ET Q q 0 0 0 rg BT 286.43 44.17 Td (an ) Tj ET Q q 0 0 0 rg BT 298.37 44.17 Td (asterisk, ) Tj ET Q q 0 0 0 rg BT 333.91 44.17 Td (are ) Tj ET Q q 0 0 0 rg BT 348.62 44.17 Td (registered ) Tj ET Q q 0 0 0 rg BT 390.54 44.17 Td (trademarks ) Tj ET Q q 0 0 0 rg BT 437.47 44.17 Td (of ) Tj ET Q q 0 0 0 rg BT 448.30 44.17 Td (BMS ) Tj ET Q q 0 0 0 rg BT 471.92 44.17 Td (and/or ) Tj ET Q q 0 0 0 rg BT 499.97 44.17 Td (one ) Tj ET Q q 0 0 0 rg BT 516.91 44.17 Td (of ) Tj ET Q q 0 0 0 rg BT 527.74 44.17 Td (its ) Tj ET Q q 0 0 0 rg BT 539.68 44.17 Td (subsidiaries.) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 223 0 obj <> endobj 224 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 31.60 Td (E-12-1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 504.35 742.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 546.96 742.25 Td ( 12.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 213.90 718.25 Td (Computation of Earnings to Fixed Charges) Tj ET Q 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 670.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 670.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 670.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 670.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 670.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 670.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 670.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 670.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 670.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 670.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 644.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 644.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 644.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 644.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 644.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 644.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 644.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 644.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 644.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 644.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 618.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 618.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 618.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 618.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 618.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 618.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 618.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 618.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 605.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 605.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 605.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 605.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 605.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 605.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 605.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 605.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 605.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 605.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 579.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 579.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 579.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 579.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 579.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 579.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 579.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 579.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 579.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 579.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 553.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 553.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 553.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 553.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 553.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 553.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 553.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 553.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 553.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 553.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 527.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 527.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 527.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 527.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 527.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 527.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 527.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 527.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 527.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 527.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 501.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 501.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 501.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 501.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 501.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 501.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 501.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 501.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 501.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 501.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 475.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 475.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 475.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 475.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 475.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 475.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 475.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 475.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 475.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 475.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 449.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 449.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 449.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 449.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 449.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 449.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 449.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 449.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 449.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 449.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 49.50 423.75 245.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 294.50 423.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 344.50 423.75 5.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 349.50 423.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 399.50 423.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 403.50 423.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 453.50 423.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 457.50 423.75 50.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 507.50 423.75 4.00 -13.00 re f /GS0 gs 0.8 0.9333333333333333 1 rg /GS0 gs 511.50 423.75 50.00 -13.00 re f /GS0 gs 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 683.75 m 344.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 344.5 683.75 m 349.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 683.75 m 399.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 399.5 683.75 m 403.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 683.75 m 453.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 453.5 683.75 m 457.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 683.75 m 507.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 507.5 683.75 m 511.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 683.75 m 561.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 683.75 m 344.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 670.75 m 344.5 670.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 683.75 m 399.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 670.75 m 399.5 670.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 683.75 m 453.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 670.75 m 453.5 670.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 683.75 m 507.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 670.75 m 507.5 670.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 683.75 m 561.5 683.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 670.75 m 561.5 670.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 566.75 m 344.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 566.75 m 399.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 566.75 m 453.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 566.75 m 507.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 566.75 m 561.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 566.75 m 399.5 566.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 514.75 m 344.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 514.75 m 399.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 514.75 m 453.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 514.75 m 507.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 514.75 m 561.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 502.75 m 344.5 502.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 500.75 m 344.5 500.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 502.75 m 399.5 502.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 500.75 m 399.5 500.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 514.75 m 453.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 502.75 m 453.5 502.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 500.75 m 453.5 500.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 514.75 m 507.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 502.75 m 507.5 502.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 500.75 m 507.5 500.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 514.75 m 561.5 514.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 502.75 m 561.5 502.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 500.75 m 561.5 500.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 436.75 m 344.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 436.75 m 399.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 436.75 m 453.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 436.75 m 507.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 436.75 m 561.5 436.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 424.75 m 344.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 294.5 422.75 m 344.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 424.75 m 399.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 349.5 422.75 m 399.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 424.75 m 453.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 403.5 422.75 m 453.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 424.75 m 507.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 457.5 422.75 m 507.5 422.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 424.75 m 561.5 424.75 l s 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 511.5 422.75 m 561.5 422.75 l s BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 686.48 Td (Ratio of Earnings to Fixed Charges:) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 383.20 687.83 Td (Year Ended December 31,) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 311.00 674.98 Td (2016) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 366.00 674.98 Td (2015) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 420.00 674.98 Td (2014) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 474.00 674.98 Td (2013) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 528.00 674.98 Td (2012) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 52.00 662.00 Td (Dollars in Millions) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 648.48 Td (Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 635.32 Td (Earnings from continuing operations before income taxes) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.00 635.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.15 635.32 Td (5,915) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.00 635.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 635.32 Td (2,077) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 635.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.15 635.32 Td (2,381) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 635.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 635.32 Td (2,891) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 635.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 535.15 635.32 Td (2,340) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 622.32 Td (Less:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 609.32 Td (Noncontrolling interest in pre-tax income of subsidiaries) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 596.32 Td (that have not incurred fixed charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 596.32 Td (16) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 385.65 596.32 Td (51) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 596.32 Td (38) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 596.32 Td (36) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 596.32 Td (844) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 583.32 Td (Equity in net income of affiliates) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 583.32 Td (77) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 385.65 583.32 Td (83) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 583.32 Td (107) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 583.32 Td (166) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 583.32 Td (183) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 570.32 Td (Capitalized interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 570.32 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 570.32 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 570.32 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 570.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.65 570.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 557.32 Td (Adjusted Income) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.15 557.32 Td (5,812) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 557.32 Td (1,941) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.15 557.32 Td (2,233) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 557.32 Td (2,689) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 535.15 557.32 Td (1,313) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 544.32 Td (Add:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 531.32 Td (Fixed charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.65 531.32 Td (226) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.65 531.32 Td (231) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 531.32 Td (254) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 531.32 Td (255) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 531.32 Td (227) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 58.00 518.32 Td (Distributed income of equity investments) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 518.32 Td (99) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.65 518.32 Td (105) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 518.32 Td (153) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 518.32 Td (149) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 518.32 Td (229) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 505.48 Td (Total Earnings) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.00 505.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.15 505.32 Td (6,137) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.00 505.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 373.15 505.32 Td (2,277) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 505.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.15 505.32 Td (2,640) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 505.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 505.32 Td (3,093) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 505.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 535.15 505.32 Td (1,769) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 479.48 Td (Fixed Charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 466.32 Td (Interest expense) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.00 466.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.65 466.32 Td (167) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.00 466.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.65 466.32 Td (184) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 466.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 466.32 Td (203) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 466.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 466.32 Td (199) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 466.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 466.32 Td (182) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 453.32 Td (Capitalized interest) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 453.32 Td (10) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 390.65 453.32 Td (2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 444.65 453.32 Td (3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 453.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.65 453.32 Td (—) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 52.00 440.32 Td (One-third of rental expense) Tj ET Q BT /F1 10.00 Tf ET BT /F1 6.50 Tf ET q 0 0 0 rg BT 161.68 444.85 Td (\(1\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 330.65 440.32 Td (49) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 385.65 440.32 Td (45) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 439.65 440.32 Td (48) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 493.65 440.32 Td (56) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 547.65 440.32 Td (45) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 427.48 Td (Total Fixed Charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 297.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 325.65 427.32 Td (226) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 352.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 380.65 427.32 Td (231) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 406.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 434.65 427.32 Td (254) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 460.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 488.65 427.32 Td (255) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 514.00 427.32 Td ($) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 542.65 427.32 Td (227) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 52.00 401.48 Td (Ratio of Earnings to Fixed Charges) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 318.15 401.32 Td (27.15) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.15 401.32 Td (9.86) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 427.15 401.32 Td (10.39) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 481.15 401.32 Td (12.13) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 540.15 401.32 Td (7.79) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 50.00 379.05 Td (\(1\)) Tj ET Q BT /F2 8.00 Tf ET q 0 0 0 rg BT 59.33 379.05 Td ( ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 68.00 379.05 Td (Rents included in the computation consist of one-third of rental expense which the Company believes to be a reasonable estimate of an interest factor in ) Tj ET Q BT /F1 8.00 Tf ET q 0 0 0 rg BT 68.00 369.45 Td (its leases.) Tj ET Q endstream endobj 225 0 obj <> endobj 226 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 24.60 Td (E-21-1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 518.35 749.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 560.96 749.25 Td ( 21.) Tj ET Q BT /F2 10.00 Tf ET 0 0 0 RG /GS0 gs 0.95 w 0 i [] 0 d 1 J 1 j 3 M 204.85 723.68505859375 m 407.105859375 723.68505859375 l s q 0 0 0 rg BT 204.85 725.25 Td (Subsidiaries of Bristol-Myers Squibb Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 693.32 Td (345 Park LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 679.37 Td (A.G. Medical Services, P.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 667.37 Td (Adnexus, a Bristol-Myers Squibb R&D Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 655.37 Td (Allard Labs Acquisition G.P.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 643.37 Td (Amira Pharmaceuticals, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 631.37 Td (Apothecon LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 619.37 Td (Blisa Acquisition G.P.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 607.37 Td (BMS Benelux Holdings B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 595.37 Td (BMS Bermuda Nominees L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 583.37 Td (BMS Data Acquisition Company LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 571.37 Td (BMS Forex Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 559.37 Td (B-MS Generx Unlimited Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 547.37 Td (BMS Holdings Sarl) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 535.37 Td (BMS Holdings Spain, S.L.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 523.37 Td (BMS International Insurance Designated Activity Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 511.37 Td (BMS Investco SAS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 499.37 Td (BMS Korea Holdings L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 487.37 Td (BMS Latin American Nominees L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 475.37 Td (BMS Luxembourg Partners L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 463.37 Td (BMS Omega Bermuda Holdings Finance Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 451.37 Td (BMS Pharmaceutical Korea Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 439.37 Td (BMS Pharmaceuticals Germany Holdings B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 427.37 Td (BMS Pharmaceuticals International Holdings Netherlands B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 415.37 Td (BMS Pharmaceuticals Korea Holdings B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 403.37 Td (BMS Pharmaceuticals Mexico Holdings B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 391.37 Td (BMS Pharmaceuticals Netherlands Holdings B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 379.37 Td (BMS Real Estate LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 367.37 Td (BMS Spain Investments LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 355.37 Td (Bristol \(Iran\) S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 343.37 Td (Bristol Iran Private Company Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 331.37 Td (Bristol Laboratories Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 319.37 Td (Bristol Laboratories International, S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 307.37 Td (Bristol Laboratories Medical Information Systems Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 295.37 Td (Bristol-Myers \(Andes\) L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 283.37 Td (Bristol-Myers \(Private\) Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 271.37 Td (Bristol-Myers de Venezuela S.C.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 259.37 Td (Bristol-Myers Middle East S.A.L.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 247.37 Td (Bristol-Myers Overseas Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 235.37 Td (Bristol-Myers Squibb \(China\) Investment Co., Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 223.37 Td (Bristol-Myers Squibb \(China\) Pharmaceuticals Co., Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 211.37 Td (Bristol-Myers Squibb \(Israel\) Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 199.37 Td (Bristol-Myers Squibb \(NZ\) Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 187.37 Td (Bristol-Myers Squibb \(Proprietary\) Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 175.37 Td (Bristol-Myers Squibb \(Shanghai\) Trading Co. Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 163.37 Td (Bristol-Myers Squibb \(Singapore\) Pte. Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 151.37 Td (Bristol-Myers Squibb \(Taiwan\) Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 139.37 Td (Bristol-Myers Squibb \(West Indies\) Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 127.37 Td (Bristol-Myers Squibb A.E.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 115.37 Td (Bristol-Myers Squibb Aktiebolag) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 103.37 Td (Bristol-Myers Squibb Argentina S. R. L.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 91.37 Td (Bristol-Myers Squibb Australia Pty. Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 79.37 Td (Bristol-Myers Squibb Axia Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 67.37 Td (Bristol-Myers Squibb B.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 55.37 Td (Bristol-Myers Squibb Belgium S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 43.37 Td (Bristol-Myers Squibb Business Services Limited) Tj ET Q endstream endobj 227 0 obj <> endobj 228 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 24.60 Td (E-21-2) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 746.12 Td (Bristol-Myers Squibb Canada Co.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 734.12 Td (Bristol-Myers Squibb Canada International Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 722.12 Td (Bristol-Myers Squibb de Colombia S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 710.12 Td (Bristol-Myers Squibb de Costa Rica Sociedad Anonima) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 698.12 Td (Bristol-Myers Squibb de Guatemala, S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 686.12 Td (Bristol-Myers Squibb de Mexico, S. de R.L. de C.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 674.12 Td (Bristol-Myers Squibb Delta Company Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 662.12 Td (Bristol-Myers Squibb Denmark Filial of Bristol-Myers Squibb AB) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 650.12 Td (Bristol-Myers Squibb Egypt, LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 638.12 Td (Bristol-Myers Squibb EMEA Sarl) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 626.12 Td (Bristol-Myers Squibb Epsilon Holdings Unlimited Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 614.12 Td (Bristol-Myers Squibb Farmaceutica Ltda.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 602.12 Td (Bristol-Myers Squibb Farmaceutica Portuguesa S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 590.12 Td (Bristol-Myers Squibb GesmbH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 578.12 Td (Bristol-Myers Squibb GmbH & Co. KGaA) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 566.12 Td (Bristol-Myers Squibb Holding Germany GmbH & Co. KG) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 554.12 Td (Bristol-Myers Squibb Holdings 2002 Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 542.12 Td (Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 530.12 Td (Bristol-Myers Squibb Holdings Ireland) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 518.12 Td (Bristol-Myers Squibb Holdings Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 506.12 Td (Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 494.12 Td (Bristol-Myers Squibb Ilaclari, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 482.12 Td (Bristol-Myers Squibb India Pvt. Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 470.12 Td (Bristol-Myers Squibb International Company Unlimited Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 458.12 Td (Bristol-Myers Squibb International Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 446.12 Td (Bristol-Myers Squibb Investco, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 434.12 Td (Bristol-Myers Squibb K.K.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 422.12 Td (Bristol-Myers Squibb Luxembourg International S.C.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 410.12 Td (Bristol-Myers Squibb Luxembourg S.a.r.l.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 398.12 Td (Bristol-Myers Squibb Manufacturing Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 386.12 Td (Bristol-Myers Squibb Marketing Services S.R.L.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 374.12 Td (Bristol-Myers Squibb MEA GmbH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 362.12 Td (Bristol-Myers Squibb Middle East & Africa FZ-LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 350.12 Td (Bristol-Myers Squibb Norway Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 338.12 Td (Bristol-Myers Squibb Nutricionales de Mexico, S. de R.L. de C.V.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 326.12 Td (Bristol-Myers Squibb Peru S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 314.12 Td (Bristol-Myers Squibb Pharma \(HK\) Ltd) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 302.12 Td (Bristol-Myers Squibb Pharma \(Thailand\) Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 290.12 Td (Bristol-Myers Squibb Pharma Company) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 278.12 Td (Bristol-Myers Squibb Pharma EEIG) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 266.12 Td (Bristol-Myers Squibb Pharma Holding Company, LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 254.12 Td (Bristol-Myers Squibb Pharma Ventures Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 242.12 Td (Bristol-Myers Squibb Pharmaceutical Trading Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 230.12 Td (Bristol-Myers Squibb Pharmaceuticals) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 218.12 Td (Bristol-Myers Squibb Pharmaceuticals Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 206.12 Td (Bristol-Myers Squibb Polska Sp. z o.o.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 194.12 Td (Bristol-Myers Squibb Products SA) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 182.12 Td (Bristol-Myers Squibb Puerto Rico, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 170.12 Td (Bristol-Myers Squibb Puerto Rico/Sanofi Pharmaceutical Partnership Puerto Rico) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 158.12 Td (Bristol-Myers Squibb S.r.l.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 146.12 Td (Bristol-Myers Squibb SA) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 134.12 Td (Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 122.12 Td (Bristol-Myers Squibb Sarl) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 110.12 Td (Bristol-Myers Squibb Service Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 98.12 Td (Bristol-Myers Squibb Services Sp. z o.o.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 86.12 Td (Bristol-Myers Squibb spol. s r.o.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 74.12 Td (Bristol-Myers Squibb Trustees Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 62.12 Td (Bristol-Myers Squibb Verwaltungs GmbH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 50.12 Td (Bristol-Myers Squibb, S.A.U.) Tj ET Q endstream endobj 229 0 obj <> endobj 230 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 24.60 Td (E-21-3) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 745.12 Td (Bristol-Myers Squibb/Astrazeneca EEIG) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 733.12 Td (Bristol-Myers Squibb/Pfizer EEIG) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 721.12 Td (Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 709.12 Td (Cardioxyl Pharmaceuticals, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 697.12 Td (Compania Bristol-Myers Squibb de Centro America) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 685.12 Td (Cormorant Pharmaceuticals AB) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 673.12 Td (E. R. Squibb & Sons Inter-American Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 661.12 Td (E. R. Squibb & Sons Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 649.12 Td (E. R. Squibb & Sons, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 637.12 Td (EWI Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 625.12 Td (FermaVir Pharmaceuticals, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 613.12 Td (FermaVir Research, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 601.12 Td (Flexus Biosciences, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 589.12 Td (GenPharm International, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 577.12 Td (Grove Insurance Company Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 565.12 Td (Heyden Farmaceutica Portugesa Limitada) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 553.12 Td (Inhibitex, L.L.C.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 541.12 Td (iPierian, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 529.12 Td (Kosan Biosciences Incorporated) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 517.12 Td (Linson Investments Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 505.12 Td (Mead Johnson \(Manufacturing\) Jamaica Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 493.12 Td (Mead Johnson Jamaica Ltd.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 481.12 Td (O.o.o. Bristol-Myers Squibb) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 469.12 Td (O.o.o. Bristol-Myers Squibb Manufacturing) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 457.12 Td (Oy Bristol-Myers Squibb \(Finland\) AB) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 445.12 Td (Padlock Therapeutics, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 433.12 Td (Princeton Pharmaceutical Products, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 421.12 Td (Route 22 Real Estate Holding Corporation) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 409.12 Td (Sino-American Shanghai Squibb Pharmaceuticals Limited) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 397.12 Td (Societe Francaise de Complements Alimentaires\(S.O.F.C.A.\)) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 385.12 Td (Squibb Middle East S.A.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 373.12 Td (Swords Laboratories) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 361.12 Td (Unterstutzungskasse Bristol-Myers Squibb GmbH) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 349.12 Td (UPSA SAS) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 337.12 Td (Westwood-Intrafin SA) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 325.12 Td (Westwood-Squibb Pharmaceuticals, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 313.12 Td (ZymoGenetics Paymaster, LLC) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 301.12 Td (ZymoGenetics, Inc.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 38.00 289.12 Td (ZymoGenetics, LLC) Tj ET Q BT /F1 10.00 Tf ET endstream endobj 231 0 obj <> endobj 232 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 31.60 Td (E-23-1) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 742.10 Td (CONSENT) Tj ET Q q 0 0 0 rg BT 95.93 742.10 Td ( OF INDEPENDENT) Tj ET Q q 0 0 0 rg BT 182.97 742.10 Td ( REGISTERED PUBLIC ) Tj ET Q q 0 0 0 rg BT 286.59 742.10 Td (ACCOUNTING FIRM) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 718.10 Td (W) Tj ET Q q 0 0 0 rg BT 58.64 718.10 Td (e ) Tj ET Q q 0 0 0 rg BT 66.83 718.10 Td (consent ) Tj ET Q q 0 0 0 rg BT 101.13 718.10 Td (to ) Tj ET Q q 0 0 0 rg BT 112.66 718.10 Td (the ) Tj ET Q q 0 0 0 rg BT 128.63 718.10 Td (incorporation ) Tj ET Q q 0 0 0 rg BT 186.25 718.10 Td (by ) Tj ET Q q 0 0 0 rg BT 200.00 718.10 Td (reference ) Tj ET Q q 0 0 0 rg BT 240.94 718.10 Td (in ) Tj ET Q q 0 0 0 rg BT 252.47 718.10 Td (Registration ) Tj ET Q q 0 0 0 rg BT 305.10 718.10 Td (No. ) Tj ET Q q 0 0 0 rg BT 323.58 718.10 Td (33-33682, ) Tj ET Q q 0 0 0 rg BT 368.16 718.10 Td (33-62496, ) Tj ET Q q 0 0 0 rg BT 412.74 718.10 Td (033-61) Tj ET Q q 0 0 0 rg BT 440.70 718.10 Td (147, ) Tj ET Q q 0 0 0 rg BT 461.96 718.10 Td (333-49227, ) Tj ET Q q 0 0 0 rg BT 511.54 718.10 Td (333-1) Tj ET Q q 0 0 0 rg BT 534.50 718.10 Td (14107, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 706.10 Td (333-1) Tj ET Q q 0 0 0 rg BT 72.96 706.10 Td (17818, ) Tj ET Q q 0 0 0 rg BT 104.88 706.10 Td (333-150471, ) Tj ET Q q 0 0 0 rg BT 160.13 706.10 Td (333-182852, ) Tj ET Q q 0 0 0 rg BT 215.38 706.10 Td (and ) Tj ET Q q 0 0 0 rg BT 234.24 706.10 Td (333-206991 ) Tj ET Q q 0 0 0 rg BT 286.99 706.10 Td (on ) Tj ET Q q 0 0 0 rg BT 301.41 706.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 327.50 706.10 Td (S-3 and ) Tj ET Q q 0 0 0 rg BT 362.75 706.10 Td (Nos. ) Tj ET Q q 0 0 0 rg BT 385.79 706.10 Td (33-30856, ) Tj ET Q q 0 0 0 rg BT 431.04 706.10 Td (33-3841) Tj ET Q q 0 0 0 rg BT 464.00 706.10 Td (1, ) Tj ET Q q 0 0 0 rg BT 475.92 706.10 Td (33-38587, ) Tj ET Q q 0 0 0 rg BT 521.17 706.10 Td (33-44788, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 694.10 Td (333-47403, ) Tj ET Q q 0 0 0 rg BT 98.43 694.10 Td (33-52691, ) Tj ET Q q 0 0 0 rg BT 141.86 694.10 Td (33-30756-02, ) Tj ET Q q 0 0 0 rg BT 198.62 694.10 Td (33-58187, ) Tj ET Q q 0 0 0 rg BT 242.05 694.10 Td (333-02873, ) Tj ET Q q 0 0 0 rg BT 290.48 694.10 Td (333-65424, ) Tj ET Q q 0 0 0 rg BT 338.91 694.10 Td (333-107414, ) Tj ET Q q 0 0 0 rg BT 392.34 694.10 Td (333-144893 ) Tj ET Q q 0 0 0 rg BT 443.27 694.10 Td (and ) Tj ET Q q 0 0 0 rg BT 460.31 694.10 Td (333-182405 ) Tj ET Q q 0 0 0 rg BT 511.24 694.10 Td (on ) Tj ET Q q 0 0 0 rg BT 523.84 694.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 548.11 694.10 Td (S-8 ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 682.10 Td (of ) Tj ET Q q 0 0 0 rg BT 61.01 682.10 Td (our ) Tj ET Q q 0 0 0 rg BT 77.03 682.10 Td (reports ) Tj ET Q q 0 0 0 rg BT 107.48 682.10 Td (dated ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 131.82 682.10 Td (February 21, ) Tj ET Q q 0 0 0 rg BT 185.61 682.10 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 205.61 682.10 Td (, ) Tj ET Q q 0 0 0 rg BT 210.79 682.10 Td (relating ) Tj ET Q q 0 0 0 rg BT 244.02 682.10 Td (to ) Tj ET Q q 0 0 0 rg BT 254.48 682.10 Td (the ) Tj ET Q q 0 0 0 rg BT 269.38 682.10 Td (consolidated ) Tj ET Q q 0 0 0 rg BT 322.61 682.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 360.27 682.10 Td (statements ) Tj ET Q q 0 0 0 rg BT 405.17 682.10 Td (of ) Tj ET Q q 0 0 0 rg BT 416.18 682.10 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 474.98 682.10 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 506.00 682.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 547.57 682.10 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 670.10 Td (subsidiaries ) Tj ET Q q 0 0 0 rg BT 99.84 670.10 Td (\(the ) Tj ET Q q 0 0 0 rg BT 118.01 670.10 Td (“Company”\) ) Tj ET Q q 0 0 0 rg BT 171.72 670.10 Td (and ) Tj ET Q q 0 0 0 rg BT 188.78 670.10 Td (the ) Tj ET Q q 0 0 0 rg BT 203.62 670.10 Td (ef) Tj ET Q q 0 0 0 rg BT 211.21 670.10 Td (fectiveness ) Tj ET Q q 0 0 0 rg BT 258.25 670.10 Td (of ) Tj ET Q q 0 0 0 rg BT 269.20 670.10 Td (the ) Tj ET Q q 0 0 0 rg BT 284.04 670.10 Td (Company's ) Tj ET Q q 0 0 0 rg BT 331.24 670.10 Td (internal ) Tj ET Q q 0 0 0 rg BT 364.40 670.10 Td (control ) Tj ET Q q 0 0 0 rg BT 395.35 670.10 Td (over ) Tj ET Q q 0 0 0 rg BT 415.74 670.10 Td (financial ) Tj ET Q q 0 0 0 rg BT 453.34 670.10 Td (reporting, ) Tj ET Q q 0 0 0 rg BT 495.12 670.10 Td (appearing ) Tj ET Q q 0 0 0 rg BT 537.16 670.10 Td (in ) Tj ET Q q 0 0 0 rg BT 547.56 670.10 Td (this ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 658.10 Td (Annual ) Tj ET Q q 0 0 0 rg BT 81.94 658.10 Td (Report ) Tj ET Q q 0 0 0 rg BT 111.66 658.10 Td (on ) Tj ET Q q 0 0 0 rg BT 124.16 658.10 Td (Form ) Tj ET Q q 0 0 0 rg BT 148.33 658.10 Td (10-K ) Tj ET Q q 0 0 0 rg BT 171.38 658.10 Td (of ) Tj ET Q q 0 0 0 rg BT 182.21 658.10 Td (the ) Tj ET Q q 0 0 0 rg BT 196.92 658.10 Td (Company ) Tj ET Q q 0 0 0 rg BT 238.31 658.10 Td (for ) Tj ET Q q 0 0 0 rg BT 252.47 658.10 Td (the ) Tj ET Q q 0 0 0 rg BT 267.19 658.10 Td (year ) Tj ET Q q 0 0 0 rg BT 286.89 658.10 Td (ended ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 313.27 658.10 Td (December 31, ) Tj ET Q q 0 0 0 rg BT 371.86 658.10 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 391.86 658.10 Td (.) Tj ET Q BT /F3 10.00 Tf ET q 0 0 0 rg BT 50.00 634.10 Td (/s/ DELOITTE & T) Tj ET Q q 0 0 0 rg BT 126.78 634.10 Td (OUCHE LLP) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 610.10 Td (Parsippany) Tj ET Q q 0 0 0 rg BT 93.79 610.10 Td (, New Jersey) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 598.10 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 123.60 598.10 Td ( ) Tj ET Q endstream endobj 233 0 obj <> endobj 234 0 obj <> stream BT /F2 10.00 Tf ET q 0 0 0 rg BT 499.35 742.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 541.96 742.25 Td ( 31a.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 50.00 721.25 Td (CER) Tj ET Q q 0 0 0 rg BT 70.76 721.25 Td (TIFICA) Tj ET Q q 0 0 0 rg BT 105.02 721.25 Td (TION BY) Tj ET Q q 0 0 0 rg BT 146.61 721.25 Td ( ) Tj ET Q q 0 0 0 rg BT 148.93 721.25 Td (THE CHIEF) Tj ET Q q 0 0 0 rg BT 203.84 721.25 Td ( EXECUTIVE OFFICER) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 50.00 709.25 Td (PURSUANT) Tj ET Q q 0 0 0 rg BT 104.27 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 106.59 709.25 Td (T) Tj ET Q q 0 0 0 rg BT 113.08 709.25 Td (O SECTION 302 OF) Tj ET Q q 0 0 0 rg BT 201.88 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 204.20 709.25 Td (THE SARBANES-OXLEY) Tj ET Q q 0 0 0 rg BT 319.69 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 321.64 709.25 Td (ACT) Tj ET Q q 0 0 0 rg BT 342.57 709.25 Td ( OF) Tj ET Q q 0 0 0 rg BT 358.59 709.25 Td ( 2002) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 692.25 Td (I, Giovanni Caforio, certify that:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 675.25 Td (1. I have reviewed this annual report on Form 10-K of Bristol-Myers Squibb Company;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 654.25 Td (2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 642.25 Td (material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 630.25 Td (misleading with respect to the period covered by this annual report;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 609.25 Td (3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 597.25 Td (present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for) Tj ET Q q 0 0 0 rg BT 532.78 597.25 Td (, the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 585.25 Td (periods presented in this annual report;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 564.25 Td (4. ) Tj ET Q q 0 0 0 rg BT 83.82 564.25 Td (The registrant’) Tj ET Q q 0 0 0 rg BT 142.41 564.25 Td (s other certifying of) Tj ET Q q 0 0 0 rg BT 221.37 564.25 Td (ficers and I are responsible for establishing and maintaining disclosure controls and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 552.25 Td (procedures \(as defined in Exchange ) Tj ET Q q 0 0 0 rg BT 194.66 552.25 Td (Act Rules 13a-15\(e\) and 15d-15\(e\)\) and internal control over financial reporting \(as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 540.25 Td (defined in Exchange ) Tj ET Q q 0 0 0 rg BT 134.14 540.25 Td (Act Rules 13a-15\(f\) and 15d-15\(f\)\) for the registrant and have:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 520.32 Td (a.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 520.32 Td (designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 510.32 Td (designed under our supervision, to ensure that material information relating to the registrant, including its) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 500.32 Td (consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 490.32 Td (which this annual report is being prepared;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 465.32 Td (b.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 465.32 Td (designed such internal control over financial reporting, or caused such internal control over financial reporting) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 455.32 Td (to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 445.32 Td (reporting and the preparation of financial statements for external purposes in accordance with generally accepted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 435.32 Td (accounting principles;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 410.32 Td (c.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 410.32 Td (evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 400.32 Td (conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 390.32 Td (by this report based on such evaluation; and) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 365.32 Td (d.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 365.32 Td (disclosed in this report any change in the registrant’s internal control over financial reporting that occurred) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 355.32 Td (during the registrant’s most recent fiscal quarter \(the registrant’s fourth fiscal quarter in the case of an annual) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 345.32 Td (report\) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 335.32 Td (over financial reporting;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 309.25 Td (5. ) Tj ET Q q 0 0 0 rg BT 83.82 309.25 Td (The registrant’) Tj ET Q q 0 0 0 rg BT 142.41 309.25 Td (s other certifying of) Tj ET Q q 0 0 0 rg BT 221.37 309.25 Td (ficers and I have disclosed, based on our most recent evaluation of internal control ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 297.25 Td (over financial reporting, to the registrant’) Tj ET Q q 0 0 0 rg BT 214.94 297.25 Td (s auditors and the audit committee of registrant’) Tj ET Q q 0 0 0 rg BT 406.28 297.25 Td (s board of directors \(or persons ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 285.25 Td (performing the equivalent function\):) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 265.32 Td (a.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 265.32 Td (all significant deficiencies and material weaknesses in the design or operation of internal control over financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 255.32 Td (reporting that are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 245.32 Td (report financial information; and) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 220.32 Td (b.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 220.32 Td (any fraud, whether or not material, that involves management or other employees who have a significant role in) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 210.32 Td (the registrant’s internal control over financial reporting.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 184.25 Td (Date: ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.16 184.25 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 147.75 184.25 Td ( ) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 50.00 173.45 Td ( ) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 50.5 133.95000000000005 m 182.5 133.95000000000005 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.45 138.52 Td (/s/ GIOVANNI CAFORIO) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 80.85 124.52 Td (Giovanni Caforio) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.05 110.52 Td (Chief Executive Officer) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 50.00 96.85 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 84.85 Td (E-31-1) Tj ET Q endstream endobj 235 0 obj <> endobj 236 0 obj <> stream BT /F2 10.00 Tf ET q 0 0 0 rg BT 498.80 742.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 541.41 742.25 Td ( 31b.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 50.00 721.25 Td (CER) Tj ET Q q 0 0 0 rg BT 70.76 721.25 Td (TIFICA) Tj ET Q q 0 0 0 rg BT 105.02 721.25 Td (TION BY) Tj ET Q q 0 0 0 rg BT 146.61 721.25 Td ( ) Tj ET Q q 0 0 0 rg BT 148.93 721.25 Td (THE CHIEF) Tj ET Q q 0 0 0 rg BT 203.84 721.25 Td ( FINANCIAL) Tj ET Q q 0 0 0 rg BT 262.46 721.25 Td ( OFFICER) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 50.00 709.25 Td (PURSUANT) Tj ET Q q 0 0 0 rg BT 104.27 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 106.59 709.25 Td (T) Tj ET Q q 0 0 0 rg BT 113.08 709.25 Td (O SECTION 302 OF) Tj ET Q q 0 0 0 rg BT 201.88 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 204.20 709.25 Td (THE SARBANES-OXLEY) Tj ET Q q 0 0 0 rg BT 319.69 709.25 Td ( ) Tj ET Q q 0 0 0 rg BT 321.64 709.25 Td (ACT) Tj ET Q q 0 0 0 rg BT 342.57 709.25 Td ( OF) Tj ET Q q 0 0 0 rg BT 358.59 709.25 Td ( 2002) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 692.25 Td (I, Charles Bancroft, certify that:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 675.25 Td (1. I have reviewed this annual report on Form 10-K of Bristol-Myers Squibb Company;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 654.25 Td (2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 642.25 Td (material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 630.25 Td (misleading with respect to the period covered by this annual report;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 609.25 Td (3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 597.25 Td (present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for) Tj ET Q q 0 0 0 rg BT 532.78 597.25 Td (, the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 585.25 Td (periods presented in this annual report;) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 564.25 Td (4. ) Tj ET Q q 0 0 0 rg BT 83.82 564.25 Td (The registrant’) Tj ET Q q 0 0 0 rg BT 142.41 564.25 Td (s other certifying of) Tj ET Q q 0 0 0 rg BT 221.37 564.25 Td (ficers and I are responsible for establishing and maintaining disclosure controls and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 552.25 Td (procedures \(as defined in Exchange ) Tj ET Q q 0 0 0 rg BT 194.66 552.25 Td (Act Rules 13a-15\(e\) and 15d-15\(e\)\) and internal control over financial reporting \(as ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 540.25 Td (defined in Exchange ) Tj ET Q q 0 0 0 rg BT 134.14 540.25 Td (Act Rules 13a-15\(f\) and 15d-15\(f\)\) for the registrant and have:) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 520.32 Td (a.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 520.32 Td (designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 510.32 Td (designed under our supervision, to ensure that material information relating to the registrant, including its) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 500.32 Td (consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 490.32 Td (which this annual report is being prepared;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 465.32 Td (b.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 465.32 Td (designed such internal control over financial reporting, or caused such internal control over financial reporting) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 455.32 Td (to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 445.32 Td (reporting and the preparation of financial statements for external purposes in accordance with generally accepted) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 435.32 Td (accounting principles;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 410.32 Td (c.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 410.32 Td (evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 400.32 Td (conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 390.32 Td (by this report based on such evaluation; and) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 365.32 Td (d.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 365.32 Td (disclosed in this report any change in the registrant’s internal control over financial reporting that occurred) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 355.32 Td (during the registrant’s most recent fiscal quarter \(the registrant’s fourth fiscal quarter in the case of an annual) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 345.32 Td (report\) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 335.32 Td (over financial reporting;) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.00 309.25 Td (5. ) Tj ET Q q 0 0 0 rg BT 83.82 309.25 Td (The registrant’) Tj ET Q q 0 0 0 rg BT 142.41 309.25 Td (s other certifying of) Tj ET Q q 0 0 0 rg BT 221.37 309.25 Td (ficers and I have disclosed, based on our most recent evaluation of internal control ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 297.25 Td (over financial reporting, to the registrant’) Tj ET Q q 0 0 0 rg BT 214.94 297.25 Td (s auditors and the audit committee of registrant’) Tj ET Q q 0 0 0 rg BT 406.28 297.25 Td (s board of directors \(or persons ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 285.25 Td (performing the equivalent function\):) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 265.32 Td (a.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 265.32 Td (all significant deficiencies and material weaknesses in the design or operation of internal control over financial) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 255.32 Td (reporting that are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 245.32 Td (report financial information; and) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.50 220.32 Td (b.) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 220.32 Td (any fraud, whether or not material, that involves management or other employees who have a significant role in) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 105.50 210.32 Td (the registrant’s internal control over financial reporting.) Tj ET Q BT /F1 10.00 Tf ET BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 184.25 Td (Date: ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 74.16 184.25 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET BT /F1 9.00 Tf ET q 0 0 0 rg BT 50.00 173.45 Td ( ) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 50.5 133.95000000000005 m 170.5 133.95000000000005 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 53.40 138.52 Td (/s/ CHARLES BANCROFT) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.95 124.52 Td (Charles Bancroft) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.40 110.52 Td (Chief Financial Officer) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 50.00 96.85 Td ( ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 84.85 Td (E-31-2) Tj ET Q endstream endobj 237 0 obj <> endobj 238 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 21.00 Td (E-32-1) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 499.35 742.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 541.96 742.25 Td ( 32a.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 127.75 721.25 Td (Certification by the Chief Executive Officer) Tj ET Q q 0 0 0 rg BT 313.90 721.25 Td ( Pursuant to 18 U. S. C. Section 1350, as) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 162.10 709.25 Td (Adopted Pursuant to Section 906 of the Sarbanes-Oxley ) Tj ET Q q 0 0 0 rg BT 401.55 709.25 Td (Act of 2002) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 688.25 Td (Pursuant ) Tj ET Q q 0 0 0 rg BT 87.12 688.25 Td (to ) Tj ET Q q 0 0 0 rg BT 97.01 688.25 Td (18 ) Tj ET Q q 0 0 0 rg BT 109.13 688.25 Td (U. ) Tj ET Q q 0 0 0 rg BT 120.97 688.25 Td (S. ) Tj ET Q q 0 0 0 rg BT 131.15 688.25 Td (C. ) Tj ET Q q 0 0 0 rg BT 142.44 688.25 Td (Section 1350, ) Tj ET Q q 0 0 0 rg BT 199.55 688.25 Td (I, ) Tj ET Q q 0 0 0 rg BT 207.50 688.25 Td (Giovanni ) Tj ET Q q 0 0 0 rg BT 246.84 688.25 Td (Caforio, ) Tj ET Q q 0 0 0 rg BT 282.00 688.25 Td (hereby ) Tj ET Q q 0 0 0 rg BT 311.33 688.25 Td (certify ) Tj ET Q q 0 0 0 rg BT 339.54 688.25 Td (that, ) Tj ET Q q 0 0 0 rg BT 359.15 688.25 Td (to ) Tj ET Q q 0 0 0 rg BT 369.05 688.25 Td (the ) Tj ET Q q 0 0 0 rg BT 383.38 688.25 Td (best ) Tj ET Q q 0 0 0 rg BT 401.61 688.25 Td (of ) Tj ET Q q 0 0 0 rg BT 412.06 688.25 Td (my ) Tj ET Q q 0 0 0 rg BT 426.96 688.25 Td (knowledge, ) Tj ET Q q 0 0 0 rg BT 475.45 688.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 533.68 688.25 Td (Squibb ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 676.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 91.67 676.25 Td (s ) Tj ET Q q 0 0 0 rg BT 97.94 676.25 Td (Annual ) Tj ET Q q 0 0 0 rg BT 130.43 676.25 Td (Report ) Tj ET Q q 0 0 0 rg BT 160.71 676.25 Td (on ) Tj ET Q q 0 0 0 rg BT 173.76 676.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 198.49 676.25 Td (10-K ) Tj ET Q q 0 0 0 rg BT 222.10 676.25 Td (for ) Tj ET Q q 0 0 0 rg BT 236.82 676.25 Td (the ) Tj ET Q q 0 0 0 rg BT 252.09 676.25 Td (year ) Tj ET Q q 0 0 0 rg BT 272.35 676.25 Td (ended ) Tj ET Q q 0 0 0 rg BT 299.29 676.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.43 676.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.43 676.25 Td ( ) Tj ET Q q 0 0 0 rg BT 381.48 676.25 Td (\(the ) Tj ET Q q 0 0 0 rg BT 400.09 676.25 Td (Report\), ) Tj ET Q q 0 0 0 rg BT 436.19 676.25 Td (as ) Tj ET Q q 0 0 0 rg BT 447.58 676.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 468.96 676.25 Td (with ) Tj ET Q q 0 0 0 rg BT 489.79 676.25 Td (the ) Tj ET Q q 0 0 0 rg BT 505.07 676.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 547.56 676.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 664.25 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 93.17 664.25 Td (Commission ) Tj ET Q q 0 0 0 rg BT 147.49 664.25 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.24 664.25 Td (February 21, ) Tj ET Q q 0 0 0 rg BT 216.09 664.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.09 664.25 Td (, ) Tj ET Q q 0 0 0 rg BT 242.34 664.25 Td (fully ) Tj ET Q q 0 0 0 rg BT 264.98 664.25 Td (complies ) Tj ET Q q 0 0 0 rg BT 304.84 664.25 Td (with ) Tj ET Q q 0 0 0 rg BT 326.37 664.25 Td (the ) Tj ET Q q 0 0 0 rg BT 342.33 664.25 Td (requirements ) Tj ET Q q 0 0 0 rg BT 398.29 664.25 Td (of ) Tj ET Q q 0 0 0 rg BT 410.37 664.25 Td (Section 13\(a\) ) Tj ET Q q 0 0 0 rg BT 467.71 664.25 Td (or ) Tj ET Q q 0 0 0 rg BT 479.79 664.25 Td (Section 15\(d\) ) Tj ET Q q 0 0 0 rg BT 537.70 664.25 Td (of ) Tj ET Q q 0 0 0 rg BT 549.78 664.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 652.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 92.55 652.25 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 134.40 652.25 Td (Act ) Tj ET Q q 0 0 0 rg BT 151.96 652.25 Td (of ) Tj ET Q q 0 0 0 rg BT 163.41 652.25 Td (1934, ) Tj ET Q q 0 0 0 rg BT 189.03 652.25 Td (as ) Tj ET Q q 0 0 0 rg BT 200.47 652.25 Td (amended, ) Tj ET Q q 0 0 0 rg BT 242.19 652.25 Td (and ) Tj ET Q q 0 0 0 rg BT 259.74 652.25 Td (that ) Tj ET Q q 0 0 0 rg BT 277.85 652.25 Td (the ) Tj ET Q q 0 0 0 rg BT 293.19 652.25 Td (information ) Tj ET Q q 0 0 0 rg BT 343.52 652.25 Td (contained ) Tj ET Q q 0 0 0 rg BT 385.51 652.25 Td (in ) Tj ET Q q 0 0 0 rg BT 396.40 652.25 Td (the ) Tj ET Q q 0 0 0 rg BT 411.74 652.25 Td (Report ) Tj ET Q q 0 0 0 rg BT 442.07 652.25 Td (fairly ) Tj ET Q q 0 0 0 rg BT 466.85 652.25 Td (presents, ) Tj ET Q q 0 0 0 rg BT 505.23 652.25 Td (in ) Tj ET Q q 0 0 0 rg BT 516.13 652.25 Td (all ) Tj ET Q q 0 0 0 rg BT 529.24 652.25 Td (material ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 640.25 Td (respects, ) Tj ET Q q 0 0 0 rg BT 87.21 640.25 Td (the ) Tj ET Q q 0 0 0 rg BT 101.92 640.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 139.40 640.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 179.68 640.25 Td (and ) Tj ET Q q 0 0 0 rg BT 196.62 640.25 Td (results ) Tj ET Q q 0 0 0 rg BT 225.22 640.25 Td (of ) Tj ET Q q 0 0 0 rg BT 236.05 640.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 280.21 640.25 Td (of ) Tj ET Q q 0 0 0 rg BT 291.04 640.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 349.65 640.25 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 380.49 640.25 Td (Company) Tj ET Q q 0 0 0 rg BT 418.73 640.25 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 50.00 629.45 Td ( ) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 50.5 589.95 m 182.5 589.95 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 62.45 594.52 Td (/s/ GIOVANNI CAFORIO) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 80.85 580.52 Td (Giovanni Caforio) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 68.05 565.62 Td (Chief Executive Officer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 79.20 550.62 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 50.00 536.85 Td ( ) Tj ET Q endstream endobj 239 0 obj <> endobj 240 0 obj <> stream BT /F1 10.00 Tf ET q 0 0 0 rg BT 292.10 21.00 Td (E-32-2) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 498.80 742.25 Td (EXHIBIT) Tj ET Q q 0 0 0 rg BT 541.41 742.25 Td ( 32b.) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 128.60 721.25 Td (Certification by the Chief Financial Officer) Tj ET Q q 0 0 0 rg BT 313.10 721.25 Td ( Pursuant to 18 U. S. C. Section 1350, as) Tj ET Q BT /F2 10.00 Tf ET q 0 0 0 rg BT 162.10 709.25 Td (Adopted Pursuant to Section 906 of the Sarbanes-Oxley ) Tj ET Q q 0 0 0 rg BT 401.55 709.25 Td (Act of 2002) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 688.25 Td (Pursuant ) Tj ET Q q 0 0 0 rg BT 87.23 688.25 Td (to ) Tj ET Q q 0 0 0 rg BT 97.24 688.25 Td (18 ) Tj ET Q q 0 0 0 rg BT 109.47 688.25 Td (U. ) Tj ET Q q 0 0 0 rg BT 121.42 688.25 Td (S. ) Tj ET Q q 0 0 0 rg BT 131.71 688.25 Td (C. ) Tj ET Q q 0 0 0 rg BT 143.11 688.25 Td (Section 1350, ) Tj ET Q q 0 0 0 rg BT 200.33 688.25 Td (I, ) Tj ET Q q 0 0 0 rg BT 208.39 688.25 Td (Charles ) Tj ET Q q 0 0 0 rg BT 241.16 688.25 Td (Bancroft, ) Tj ET Q q 0 0 0 rg BT 280.88 688.25 Td (hereby ) Tj ET Q q 0 0 0 rg BT 310.31 688.25 Td (certify ) Tj ET Q q 0 0 0 rg BT 338.64 688.25 Td (that, ) Tj ET Q q 0 0 0 rg BT 358.36 688.25 Td (to ) Tj ET Q q 0 0 0 rg BT 368.37 688.25 Td (the ) Tj ET Q q 0 0 0 rg BT 382.81 688.25 Td (best ) Tj ET Q q 0 0 0 rg BT 401.15 688.25 Td (of ) Tj ET Q q 0 0 0 rg BT 411.71 688.25 Td (my ) Tj ET Q q 0 0 0 rg BT 426.72 688.25 Td (knowledge, ) Tj ET Q q 0 0 0 rg BT 475.32 688.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 533.66 688.25 Td (Squibb ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 676.25 Td (Company’) Tj ET Q q 0 0 0 rg BT 91.67 676.25 Td (s ) Tj ET Q q 0 0 0 rg BT 97.94 676.25 Td (Annual ) Tj ET Q q 0 0 0 rg BT 130.43 676.25 Td (Report ) Tj ET Q q 0 0 0 rg BT 160.71 676.25 Td (on ) Tj ET Q q 0 0 0 rg BT 173.76 676.25 Td (Form ) Tj ET Q q 0 0 0 rg BT 198.49 676.25 Td (10-K ) Tj ET Q q 0 0 0 rg BT 222.10 676.25 Td (for ) Tj ET Q q 0 0 0 rg BT 236.82 676.25 Td (the ) Tj ET Q q 0 0 0 rg BT 252.09 676.25 Td (year ) Tj ET Q q 0 0 0 rg BT 272.35 676.25 Td (ended ) Tj ET Q q 0 0 0 rg BT 299.29 676.25 Td (December 31, ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 358.43 676.25 Td (2016) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 378.43 676.25 Td ( ) Tj ET Q q 0 0 0 rg BT 381.48 676.25 Td (\(the ) Tj ET Q q 0 0 0 rg BT 400.09 676.25 Td (Report\), ) Tj ET Q q 0 0 0 rg BT 436.19 676.25 Td (as ) Tj ET Q q 0 0 0 rg BT 447.58 676.25 Td (filed ) Tj ET Q q 0 0 0 rg BT 468.96 676.25 Td (with ) Tj ET Q q 0 0 0 rg BT 489.79 676.25 Td (the ) Tj ET Q q 0 0 0 rg BT 505.07 676.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 547.56 676.25 Td (and ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 664.25 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 93.17 664.25 Td (Commission ) Tj ET Q q 0 0 0 rg BT 147.49 664.25 Td (on ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 161.24 664.25 Td (February 21, ) Tj ET Q q 0 0 0 rg BT 216.09 664.25 Td (2017) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 236.09 664.25 Td (, ) Tj ET Q q 0 0 0 rg BT 242.34 664.25 Td (fully ) Tj ET Q q 0 0 0 rg BT 264.98 664.25 Td (complies ) Tj ET Q q 0 0 0 rg BT 304.84 664.25 Td (with ) Tj ET Q q 0 0 0 rg BT 326.37 664.25 Td (the ) Tj ET Q q 0 0 0 rg BT 342.33 664.25 Td (requirements ) Tj ET Q q 0 0 0 rg BT 398.29 664.25 Td (of ) Tj ET Q q 0 0 0 rg BT 410.37 664.25 Td (Section 13\(a\) ) Tj ET Q q 0 0 0 rg BT 467.71 664.25 Td (or ) Tj ET Q q 0 0 0 rg BT 479.79 664.25 Td (Section 15\(d\) ) Tj ET Q q 0 0 0 rg BT 537.70 664.25 Td (of ) Tj ET Q q 0 0 0 rg BT 549.78 664.25 Td (the ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 652.25 Td (Securities ) Tj ET Q q 0 0 0 rg BT 92.55 652.25 Td (Exchange ) Tj ET Q q 0 0 0 rg BT 134.40 652.25 Td (Act ) Tj ET Q q 0 0 0 rg BT 151.96 652.25 Td (of ) Tj ET Q q 0 0 0 rg BT 163.41 652.25 Td (1934, ) Tj ET Q q 0 0 0 rg BT 189.03 652.25 Td (as ) Tj ET Q q 0 0 0 rg BT 200.47 652.25 Td (amended, ) Tj ET Q q 0 0 0 rg BT 242.19 652.25 Td (and ) Tj ET Q q 0 0 0 rg BT 259.74 652.25 Td (that ) Tj ET Q q 0 0 0 rg BT 277.85 652.25 Td (the ) Tj ET Q q 0 0 0 rg BT 293.19 652.25 Td (information ) Tj ET Q q 0 0 0 rg BT 343.52 652.25 Td (contained ) Tj ET Q q 0 0 0 rg BT 385.51 652.25 Td (in ) Tj ET Q q 0 0 0 rg BT 396.40 652.25 Td (the ) Tj ET Q q 0 0 0 rg BT 411.74 652.25 Td (Report ) Tj ET Q q 0 0 0 rg BT 442.07 652.25 Td (fairly ) Tj ET Q q 0 0 0 rg BT 466.85 652.25 Td (presents, ) Tj ET Q q 0 0 0 rg BT 505.23 652.25 Td (in ) Tj ET Q q 0 0 0 rg BT 516.13 652.25 Td (all ) Tj ET Q q 0 0 0 rg BT 529.24 652.25 Td (material ) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 50.00 640.25 Td (respects, ) Tj ET Q q 0 0 0 rg BT 87.21 640.25 Td (the ) Tj ET Q q 0 0 0 rg BT 101.92 640.25 Td (financial ) Tj ET Q q 0 0 0 rg BT 139.40 640.25 Td (condition ) Tj ET Q q 0 0 0 rg BT 179.68 640.25 Td (and ) Tj ET Q q 0 0 0 rg BT 196.62 640.25 Td (results ) Tj ET Q q 0 0 0 rg BT 225.22 640.25 Td (of ) Tj ET Q q 0 0 0 rg BT 236.05 640.25 Td (operations ) Tj ET Q q 0 0 0 rg BT 280.21 640.25 Td (of ) Tj ET Q q 0 0 0 rg BT 291.04 640.25 Td (Bristol-Myers ) Tj ET Q q 0 0 0 rg BT 349.65 640.25 Td (Squibb ) Tj ET Q q 0 0 0 rg BT 380.49 640.25 Td (Company) Tj ET Q q 0 0 0 rg BT 418.73 640.25 Td (.) Tj ET Q BT /F1 9.00 Tf ET q 0 0 0 rg BT 50.00 629.45 Td ( ) Tj ET Q 0 0 0 RG /GS0 gs 1.00 w 0 i [] 0 d 0 J 0 j 3 M 50.5 604.95 m 170.5 604.95 l s BT /F1 10.00 Tf ET q 0 0 0 rg BT 53.40 609.52 Td (/s/ CHARLES BANCROFT) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 75.95 595.52 Td (Charles Bancroft) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 63.40 580.62 Td (Chief Financial Officer) Tj ET Q BT /F1 10.00 Tf ET q 0 0 0 rg BT 73.20 565.62 Td (February 21, 2017) Tj ET Q BT /F1 10.00 Tf ET BT /F1 8.00 Tf ET q 0 0 0 rg BT 50.00 551.85 Td ( ) Tj ET Q endstream endobj 241 0 obj <> /View <>>>>> endobj 242 0 obj <> /View <>>>>> endobj 243 0 obj <> endobj 244 0 obj <> stream xÚì½yœ\EÕ7~nïÛí{{½½wßÞ»§»§§'³d¦'™52Á ÁHÖaG¢ÜPPA!€€"Š ²È"“ bÀ-®È&²h‚,Š+î¨éß÷TÏLÏûyóþ¶?ž§Ê:uk?uΩoêøH""?ˆ‰†Ç×±üW£~‡Œß.X¹vÍä¶3üŸ&rm 2\¹jMgãµw¾m'‘ôCŒÚ´zlåÚõ½ÿyô¿åÞcǏ\÷¦ÌÉ r¿Bä¹jë›·Ÿxµá¢\D–»¶žsVê@ý´½{˜Èú³·ŸtÆwoŒcñmßC{×I›wl§Ù1ß1ŸzÒéï:1òñm!ºt-¶\qò¶3Þùüý™ÝD©ˆ†.:yzó¶'ûWöŸ•¼þɨp÷[_Fí”=ùŒ³Þùñ³>ïïE"Ç¢Ó¦ßþÖ/|öK&Ãï_À¦·~æÖÍÆé=!¢ÄÐÞÆæwn·‡-çaüÍŸzëæ3¦¿ñ¦§Éhœ$Š7·Ÿ¹ã,ÛØ‘2òúÞäö·Oo_üÒe¢SÿF¤LËÒl¸üœk¾}ÜF¥ùg[ØF>ÿ|ü;œÿà¤çŽ

Advertisement

Close

û$F_efɦ ÅRLp2Ÿn¡Œãt¡‰(‡tºåš´,¦)émtÚÖ"ÕP¥éƒ”Cÿ·¢¼ù•†Åà”hÒ+H¤5H)¤-HëV"‹túÎ }„ç˜OÆËhƒõÚl¾—Tó±”FZïŒéy*›vŽïI.c½ncœÊøN£­d£ï½­¹ýҢ߱·ƒÎGû”H^ëeE® ùPÁ<73ÏȧŒß潶þ€ïsÀÇøþòeàuùJÔ¯Â÷’Œ1MÃâÖV|{ð=ÙxðíBšÀ¸¿óô—Áã6´ûQ6p_¬+#r_ÌY2>)E¥OÑõÆ'i—i-ùžï%7ï›÷<¿'æŸyú/Ò2æïÐÔæO$æÕp·ÿ”oHÓÆn¡«÷Ïíõ3†i»ñºÖ«øÎXü4ÁÉú$%°¿ß"-6m£°5Þúx<Â|'õ lC ‰Äs~†>dü £­Ãr5Õ]¨ìi½fxÅ-9ZŽ½BÖT ßëÙî`YŒ]#Æn£„éEŠà{˜NÜKB>í4 ½O!ƒÌo£Öï0Ç'Ìs7Ò·1^Ãڝ¼Ö¹tì[Ñ÷e´½iì#Œ¤¡ýa¿Ãã±Î¯ÑÖ©ÂþØîóiN7óÉ9Ÿ„ìo)ˆ¤!õ!ñºW#} éMHqîƒyƒèŸ ïc{a»dÛ`»¶[öÊ:ÜÙ°}µÏË †é"$?RÅBô¡¹TF_qVX‡Ì3Ÿž›íŠíe>G{~ÎæËûd{:$Ϙ+bmqþØ®ÉKl÷œ‡ÅJ†½ÔËöÚ–õ|.x˜à³Èça>Ÿç‡Ï¦8ȍ§‘eÇzŸÏçe±_G9´­4ÿ”–›ºè8ã÷aûð½yäó9qþþ`ú8½`¸Ö½T.ùÜ^ó†ü“œ¬K§b¾½eÞô ]#òÇ iÓã’Ù|këeó­†÷µÓü÷¡ù“´·ÝÆ9§CÛ·þÿ$ž0ßJ'âû×æÇ[-ÓãôQ¾¡¬¿‘êH©ùõ³Hç#•mÒ'm§I{¬Ç »ùÒ™¦a0SŸi/-5ĹˡþÌÝi:1Î(í¥‹ÇÐç-·Ò"ããÐ#Ö2Ä>ß`§‡Øç Æ©o´Ë7æs÷Š<N1&È÷ï_`ã±â< œCÛì|ÿ7æão¡=†[Zû?HÇÏŸk¤.¤Ú¿;‡#À`è›ïËZ,ïhm0®hmÀ>ï²|ù«­Ý†Bk×Â}š£Æ–EæïQ–“ùAŠ-Ü¡9Z5‡g9¾KM7ãþnß¡>qwþ’BæW¶5¿|ùv÷ ¸ÃÿÒzÍ䥷/†‡sÉõ°‘£¸Íd£€ñ9`î :Ëø¹ÖcÆ+MÐzcÎ0ÆBf!³bæqšÂóqä\Çü[L°OÆ‚I”¡«y\fÝ[^#©`þ=ðèXô¹Eì5'pü“”e9ˆ±gã^Á\ÖòšÔ1×''Æœ_AÈxˆ,æîå%<§åha³ŠÓÝz ~ÝbNæ©ëçÄZ“4`[Lyó±­ßŸÂKo2ÞKuxœI|G„ÝwT wå$|*$ãóH`›j»,îi‘·þ.îúóÄ]î2wÒq—à6%,%ªq2eж‰ªÆ1Ï™°«×ðýåVKø?'¯úes¾ ûq^Ÿû¨ÊgŒy÷ óó)ØÛÔä;ÑúyÈÐÑöaØcµJ’tÒɶºí­-‹eƒM{‹m(±–Ÿl³Ù~Ô=1émY¾dzzëthxxýpÇ⣇Ç~26¼¹5ý—U¶éÆ K'§^ضvpvËò?®=á„:ÓÝk7oØzï´çOVÙb±Y-‹õ`°½.lݼeKÿ7o±6þÚš¾)aáʃÔ'í~ ÛÙñÚI6)"ùï»1‰;`“þà½õ)›Áf‘8zÍòš×bÅô–…0¸Ñ2-MK'ÿCÚ[n³mžþÓ„Íb[®d³Z7[‡­ÊòmÓ‹Óî¥î¥.ۍ‰Æp¹›ŠMM/§Õᵈ'ttvt.NǤ£%.ožÞ<- {¥@Dr9¤¿KéLéÌâ™g†kÒ)–'´Z­ÕR!¼ ;$éÀ¿¤.IrE¿íÂG}è_/µ&̳›Z¾ã’µKÖNÎÅÝ[·$¦—¯•´á˜ÓÅ飻׈[Þ<üsy¢qSg­CÚòfŽÃ?—¤-skÿSš –òʼnI)¶yÉôV)4, /Yï‚Bƒùéaˆºè—œY)\TÝR0‚ßã—ýé¢ÿ?„!)‹§§§+•„[^2áš”$T-YâVBK0…ûh9<¶$Y«IiH1{*(y½‡ê=Á{ÂRåç±­a@’dÉ™ x¼éÁÁÝRl­ÇëÅ —Ô~‘·³Ñ($ Xò[ç^ú›­E6²µà]æ uê$gë_ä"¨,¨›dPôŸxƒ) A½¤‚ú@ÿA~ò€È$?¨úÞ¶Ð0i A£jýbš (h’b )п‘NqÐ4%A3”Í‚þ•r¤ƒæ) Z´HÙÖ_¨D9Ð2åA;¨ Z¡bëÏT¥hÊ ‚Ö©£õ'ê¢ hƒª Ý‚.¢ÎÖ©‡ê ½‚öQh?5Z¯Òbê ÐAA›Ô:ú´„ú@—R?(üÐÐWh”AǨ :NC   e´t9 ƒN z´~O+htŠÆ@WÒ8è‘4Ñú½‰–®¢å «=Š&[¿¥£ièA×Òè1´²õ¼‘=NÐu´ t=­=žŽjýšÞ,è:ô-´ôZÛz™6Ò1 ›èXÐÍtèÐ_ÑVZºŽ¦7ƒžúK:‰6€žLo=EÐSicë%:6žN›AÏô­´¥õ"Þð[A·Ó6зÑ4èÛéÄÖ´ƒN=KгédÐsèÐwÐi­ç靂¾‹N}7úzkët® ï¥í ï£·žúOo}?í ý úA:»µŸ. s@/¤w€~ˆÞ úaÐgé"zèÅôН‚^B綞¡Ké½ —Ñû@?"èåt~ëçt½ôJú èGý}ô*º õ4}œ.½š>ú ú0F}’.Bë5‚~Š.ý4]úº}>+èçè2Ðké# ×î£ëé ÐÏÓ• _ ‚~ôgt}ôFº ô&ºôfПҗ蠷Ð'Ao¥kP› ·Ó§Qóeúè‚ÎÐgAwÑçZOÑ,]º›®½“®ý }¾õ$ÝE_ ýª {è‹ wӍ­'èA¿F7~ný}©õ8}SÐoÑ­ {é6ÐoÓí­ŸÐwý.}ô{4ú}ÐÇè´ô^Ú úCºô>A璘´~LÐ] ?¢¯‚>H{@¢»[ÒÃtè#‚>J_ý1}½õ=Fßý‰ àô ÚÛz˜ž¤oƒ>%èOé» ?£ïµ¢}‚>Mßý9ý ôº·õ =K?ÝO÷>G÷ƒþ‚hýˆžôúè‹ôèK‚þ’n=@¿¢G@_¦GA-èoè±Öýô[ú èïèqÐßúzôzô?è)ÐW駠¤Ÿµî£?Ñ>Ð?úzô¯ôLë‡ô7zôFûAÿAϵî¥ ú/zô ½ Ú¢[?øLÿoŽé¿˜þé¿˜þké¿˜þké/LY`úËÓ_˜þ²Àô—¦¿,0ýeé¿˜þ+é¿˜þ+é¿˜þKé¿˜þKé/ LI`úKÓ_˜þ’Àô¦¿(0ýEé/ LA`úÓ_˜þ‚Àôç¦?/0ýyéÏLÿ…Àô_Lÿ…Àô_LN`úsÓŸ˜þœÀôýÓ÷Lß/0}¿Àôg¦?+0ýYéÏ LV`ú3ÓŸ˜þÌÿ˜þÉ9Lÿéÿ¦?%0ý)éO LJ`úSÓŸ˜þ”Àô'¦?)0ýIéO LR`úÓŸ˜þ„Àô'¦?.0ý'Ó"0ý'Ó"0ý1é LL`úcÓ,0ýÇÓ,0ýÇÓ˜þ¨ÀôG¦ÿX`ú£Ó˜þ¨ÀôG¦?"0ýéLD`úÃÓ˜þ°Àô‡¦?$0ý!é LH`úCÓ˜þ Àô¦ÿH`úÓ˜þ€Àô¦? 0ýéLÿ‘Àô¦? 0ýéL¿_`úýÓï˜~¿Àôû¦ß'0ý>é÷ Lÿá#LïøLÿLÿoƒé×üßÂô'ÿ_Âô;þÓÿ?Àtâ’á §ËNF£Él±Øí“Éb1šŒÆƒ?»‰o³ÃfµÚ¬«Íd²Y6 fP'’‰ÇšÌðîF;0™P²âÃl0[l6ñû ù`0çiäfL阵Ý`³ƒ¸Y¬lsØ,NžÞ‚i f›Ì’‹šÚ¿?MàËÈe“Õh6YÍ›Å6·!Li³X±ª­f0o3#ò–V“ÕÄ}Ñ_ècÍÜÆ[XÙb6:ŽàVüPi;œàr¹¬NV«Õér0;Vñ‹*xµ›± ëÜ‚‡FfIlJDlœYæ95›lím :­6Þ‹Ñè´r´±œ‹m Ù!Z›Ñ&~¶5±H­sBìÐb´ˆmñÉ9dmµ±ºÐg29ÄŒA•C¨×a[˜Â†V6f5åZY¹fk[¥l!~0Êí&¡ö2©…\ò¼=:„=Zßh`Úì´cV«Ýn2Û­.»Ýj‡ì6®†p,°Gfý =ZQƒj;³a`K·a¬ýßÚcÛ(-ÂèìvØ£Õ‰ù±S«Åî /v¶Gkû·i¬lwÚ-.¶G>íÑ–Úöh¡mŠsöh.Á•¿µÝÅjg)³öÀ¼F`ÇþÚöÚ-¡ÖìQ”Xï`†7 VL.—…#xÓÚ'ÀÙ&a•6«KÆ~-v+ïžíê…öÀ‘mÁ&íí&æ­Ñ,„Ì{šã{™ãÚnV°Ø£öhçˆ2Ë+ Ùf»Ãɨ쐆›·³1q‡ƒöh1Ϋ†M¨mvaÛf§“‡ €èdõÚ\¢È•vl öhsÙÄP!b‹°C¡Õ&€|c?Â^av»XÈäb{”ݶGp:`V¶GÓ!öhbÛà3Ìb(Ød»8q8ŸŒÌö(ÔÎ%;cŠÁbåãdo¯º`æÂÐç8ãèwÐQkwòQ„{„9¹H—ÿuæ =¢ öèvX¯³Gó¼9šmFœb³…7gÄôkÛ˜Õä°8,l¼ X”iåÈöhe«´ˆˆ‹0Ta¯²låh•…Vl‡m2€‰ìÆ® K@f2šl66K‹@^cGfâP{„°Û|2§Ìç|IfûsXXŒ&ÙΑíÑ Ør8LB¢N³Ýé0:^oàÅŽ|M±¨ÙÊ™µmI0f®³1)Û#> ¶ Tk³ÏÛ£CØ£ÝiŲ<‹ %>lm=³I@ÍVØ‚£mìÂܘe—ÕJŠê"ß•VÙedfU4#_€V·ÓáÀ‘p8ÍئŒÓÁü8nT2*ÚÚxF«Ñ)¾ÙlGF« ìÛÛ·Ó´¯³G+ÿsž™û)°Ìoèï„ušp„oÀçAÁ$²Ó¦¸G»‘sÈlQ ‹{ÐilûìG؍"F— 2j; hÇh²Ûø‚CÄVX›P´ÝÔ¾åfú@a. ìÁ@¶bÌcV+Gðdcu:'Àí (QQݘ•oZ—¡23/É̵ Ì!"3a6¶#_ÄèÜæ“9µ-p턲œVd‡Ófr;9:…œxeŠÓá²8]Nt ¾Í,RTŠod€UV'o'¶}†-âf—€Óîà{VCP@”Y½¹]ħӡ(NÙîPíYâ_usšfTâ·°9´‘‰-™·ÍFªgÎmÂq`,óNXÛcÃWÚƒ]ÜOnHÓÅ[qÂ>Ø…- Äaó…”XííQH˜ðŸìÑÖ6;0c.– ]È.&tÊàË0ÛÛ7Š Uº6•¯tpùj³²=ªö]ÏÛ£yÎÙ”ŒÐ9Ÿn{» 涝ý{´¸pèqçÀípgÁ]ì1ÛÛö¨Z9‚'ÖŠã°íQå ÄR= ³°r±=Ze\³–6kÎ9{t.Ä{4¹€EFx¡à“9µbÊœ=:]6“âä(ìÑÁBûÄÊð\óöèr¡…È™1ቛھ ©})²jN¶ hb†=ºÝ,da€v·?Ý°pö `—ln»SeÙZÚ÷9ÀÙ.î ÞÛ#lÁÕvÊp7Ãoa¸±¨ ìÑã•…=Úín>‚Ý{4¼ZÌâvc`‚ ‚]Ü™ŸàßåT]N‡™m¸í,[l⪁D…ÇÚ~ïØÚöÈÒ8äÿø`Ä·Á÷_þpHeÙFØÞEƒËÍGvbv°´l6¸P\vã# {Q¸ìà^¨|.söÈro»>Â-63ÂeL ?›ûࢴû¢m ·¶î]ü®p° â@³Ž!y